p_val	avg_log2FC	pct.1	pct.2	p_val_adj	Gene_symbol	Cell_type	dataset_subgroup	ensembl_gene_id	entrezgene_id	entrezgene_description	external_synonym	gene_biotype	uniprotswissprot	Dataset	Original_Dataset	Cancer_type_level1	Cancer_type_level2	Drug_type	Timepoint	Regimen	Organism	Source	Tissue	Sample_size	Sample_size_all	Cell_number_all	Date	PMID	Description	RawData_ID	Extract_protocol	Data_processing	Cancer_type_level1_forDB	Drug_type_forDB	primary_key
7.23013518335309e-287	1.57450241510378	0.977	0.696	5.57949532099358e-283	FTL	Malignant cells	GSE104987	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	1
7.69537690308737e-221	1.32958782160074	0.994	0.919	5.93852235611252e-217	IFITM1	Malignant cells	GSE104987	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	2
3.56981675434626e-185	0.605578219736342	1	1	2.75482758932901e-181	GNAS	Malignant cells	GSE104987	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	3
1.42163273401176e-181	1.62774355012718	0.969	0.638	1.09707398083687e-177	DHRS2	Malignant cells	GSE104987	ENSG00000100867	10202	dehydrogenase/reductase 2	HEP27|SDR25C1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	4
2.36424441853794e-181	0.83385463700608	1	0.997	1.82448741778573e-177	HSPB1	Malignant cells	GSE104987	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	5
2.60792075769062e-171	0.575374225521704	1	1	2.01253244870985e-167	RPS11	Malignant cells	GSE104987	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	6
2.4488816789853e-165	1.08239139994484	0.8	0.307	1.88980199167295e-161	ZMYND8	Malignant cells	GSE104987	ENSG00000101040	23613	zinc finger MYND-type containing 8	KIAA1125|PRKCBP1|RACK7	protein_coding	Q9ULU4	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	7
3.21885977995875e-153	-1.10856230831807	0.778	0.962	2.48399409219417e-149	LY6E	Malignant cells	GSE104987	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	8
1.31420807618147e-149	0.778224427921916	0.997	0.952	1.01417437238924e-145	RPS13	Malignant cells	GSE104987	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	9
1.00662411752323e-145	0.894167601337945	1	0.995	7.76811831492679e-142	COX6C	Malignant cells	GSE104987	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	10
3.40063322733194e-136	-1.2662168771453	0.147	0.591	2.62426866153206e-132	MGP	Malignant cells	GSE104987	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	11
1.71921513468076e-128	-1.36105657160071	0.165	0.587	1.32671831943314e-124	AREG	Malignant cells	GSE104987	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	12
2.44295017763834e-122	0.895459434439759	0.993	0.971	1.88522465208351e-118	MT-ATP8	Malignant cells	GSE104987	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	13
1.24818315440366e-121	-1.83569212246918	0.335	0.702	9.63222940253305e-118	PRSS23	Malignant cells	GSE104987	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	14
1.06234482971254e-116	0.981655592439494	0.824	0.463	8.19811505089165e-113	BAMBI	Malignant cells	GSE104987	ENSG00000095739	25805	BMP and activin membrane bound inhibitor	NMA	protein_coding	Q13145	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	15
3.06753713369484e-114	0.784542787366733	0.995	0.948	2.36721840607231e-110	KRT18	Malignant cells	GSE104987	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	16
3.56744003607578e-114	0.616364600208561	0.997	0.988	2.75299347583968e-110	UBB	Malignant cells	GSE104987	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	17
7.2904637460946e-113	0.522792802952602	1	1	5.62605087286121e-109	RPL10	Malignant cells	GSE104987	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	18
8.49680183357545e-113	-0.980627931249964	0.499	0.812	6.55698197497018e-109	LGALS3	Malignant cells	GSE104987	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	19
1.40287851828205e-112	-0.854143526679279	0.858	0.972	1.08260135255826e-108	SPTSSB	Malignant cells	GSE104987	ENSG00000196542	165679	serine palmitoyltransferase small subunit B	ADMP|C3orf57|ssSPTb	protein_coding	Q8NFR3	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	20
2.68226634632503e-108	-0.737385943667271	0.041	0.367	2.06990493945903e-104	CPE	Malignant cells	GSE104987	ENSG00000109472	1363	carboxypeptidase E	NA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	21
7.03468677671285e-108	0.538605173952512	1	1	5.42866778558931e-104	RPS12	Malignant cells	GSE104987	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	22
5.26236544782891e-105	0.488098703618077	1	1	4.06096741608957e-101	RPL4	Malignant cells	GSE104987	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	23
3.80199893127304e-99	0.708168665111859	0.986	0.927	2.93400257526341e-95	ATP1A1	Malignant cells	GSE104987	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	24
4.03879314682788e-97	0.481238445062202	1	0.999	3.11673667140707e-93	RPL31	Malignant cells	GSE104987	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	25
1.74248469516344e-90	0.401062062815537	1	1	1.34467543925763e-86	RPS24	Malignant cells	GSE104987	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	26
4.40293183609256e-87	0.707761211699847	0.934	0.787	3.39774249791263e-83	EEF1A2	Malignant cells	GSE104987	ENSG00000101210	1917	eukaryotic translation elongation factor 1 alpha 2	EEF1AL|HS1|STN|STNL	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	27
1.12084980214735e-84	-1.17663401860678	0.771	0.928	8.64959792317109e-81	H19	Malignant cells	GSE104987	ENSG00000288237	283120	H19 imprinted maternally expressed transcript	ASM|ASM1|D11S813E|LINC00008|MIR675HG|NCRNA00008	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	28
4.171540387891e-84	-0.502637927215487	0.021	0.27	3.21917771733549e-80	RASGRP1	Malignant cells	GSE104987	ENSG00000172575	10125	RAS guanyl releasing protein 1	CalDAG-GEFII|RASGRP	protein_coding	O95267	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	29
6.85501119397451e-82	-1.23363315028432	0.543	0.785	5.29001213839013e-78	STC2	Malignant cells	GSE104987	ENSG00000113739	8614	stanniocalcin 2	STC-2	protein_coding	O76061	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	30
9.17196316399481e-81	0.542990246616962	0.994	0.958	7.07800397365479e-77	RPS20	Malignant cells	GSE104987	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	31
2.74938419450594e-80	0.7331286313076	0.789	0.486	2.12169978290023e-76	S100A6	Malignant cells	GSE104987	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	32
7.46311882805148e-79	0.5546514799008	0.999	0.996	5.75928879960733e-75	RPS14	Malignant cells	GSE104987	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	33
7.29876676153955e-78	-0.605642699983652	0.214	0.536	5.63245830988007e-74	RHOD	Malignant cells	GSE104987	ENSG00000173156	29984	ras homolog family member D	ARHD|Rho|RhoHP1	protein_coding	O00212	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	34
2.38274511810055e-71	-0.584888024321569	0.833	0.94	1.83876440763819e-67	NRAS	Malignant cells	GSE104987	ENSG00000213281	4893	NRAS proto-oncogene, GTPase	N-ras	protein_coding	P01111	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	35
8.17414799171541e-69	-0.502675339662513	0.081	0.343	6.30799000520678e-65	RBBP8	Malignant cells	GSE104987	ENSG00000101773	5932	RB binding protein 8, endonuclease	COM1|CtIP|RIM|SCKL2	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	36
1.92448971391215e-68	-0.564410852956822	0.955	0.976	1.485128712226e-64	GREB1	Malignant cells	GSE104987	ENSG00000196208	9687	growth regulating estrogen receptor binding 1	KIAA0575	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	37
2.69288351525578e-68	0.403056876404538	1	1	2.07809820872288e-64	RPS2	Malignant cells	GSE104987	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	38
6.88474284805167e-68	-0.852391788050664	0.306	0.598	5.31295605584147e-64	RHOBTB3	Malignant cells	GSE104987	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	39
1.09661271851335e-67	-0.725232749822576	0.296	0.59	8.46256034876749e-64	ZFP36L2	Malignant cells	GSE104987	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	40
1.49693379778471e-66	-0.408145846976201	0.043	0.274	1.15518381175046e-62	FN1	Malignant cells	GSE104987	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	41
2.49546342463462e-65	0.594165096243235	0.994	0.972	1.92574912479053e-61	CTD-2090I13.1	Malignant cells	GSE104987	NA	NA	NA	NA	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	42
3.90806311870508e-63	0.461233204580602	1	0.999	3.01585230870471e-59	KRT8	Malignant cells	GSE104987	ENSG00000170421	3856	keratin 8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	protein_coding	P05787	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	43
7.92531707923498e-63	0.666829190008785	0.643	0.345	6.11596719004563e-59	ISOC1	Malignant cells	GSE104987	ENSG00000066583	51015	isochorismatase domain containing 1	CGI-111	protein_coding	Q96CN7	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	44
3.88897054735616e-62	-0.573317652497197	0.742	0.89	3.00111857139475e-58	BZW1	Malignant cells	GSE104987	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	45
1.04371288156515e-61	0.434299838118155	0.999	0.995	8.05433230703829e-58	RPL34	Malignant cells	GSE104987	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	46
6.129834023064e-61	-0.507863088138254	0.98	0.991	4.73039291559849e-57	XBP1	Malignant cells	GSE104987	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	47
6.42686935055127e-61	-0.638914325877533	0.506	0.757	4.95961507782041e-57	TPM1	Malignant cells	GSE104987	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	48
2.09663084771128e-60	0.4001132384053	0.998	1	1.61797002517879e-56	MT-ND2	Malignant cells	GSE104987	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	49
1.89364748160163e-59	-0.600175349117743	0.696	0.87	1.46132776155198e-55	G6PD	Malignant cells	GSE104987	ENSG00000160211	2539	glucose-6-phosphate dehydrogenase	G6PD1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	50
4.41566016258628e-59	-0.471835955461729	0.979	0.997	3.40756494746783e-55	HMGN1	Malignant cells	GSE104987	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	51
2.16680810620521e-57	-0.482828088432597	0.979	0.992	1.67212581555856e-53	ACTB	Malignant cells	GSE104987	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	52
2.17485915948976e-57	0.478563787118964	0.542	0.234	1.67833881337825e-53	MUC1	Malignant cells	GSE104987	ENSG00000185499	4582	mucin 1, cell surface associated	ADMCKD|ADMCKD1|Ca15-3|CD227|EMA|KL-6|MCD|MCKD|MCKD1|PEM|PUM	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	53
5.69324809012052e-56	-0.49863828028939	0.887	0.958	4.393479551146e-52	ARPC1B	Malignant cells	GSE104987	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	54
1.0477754196284e-55	0.42863566800617	0.991	0.968	8.08568291327233e-52	COX7C	Malignant cells	GSE104987	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	55
1.11562429130609e-51	-0.589337207202068	0.25	0.521	8.60927265600908e-48	KRT80	Malignant cells	GSE104987	ENSG00000167767	144501	keratin 80	KB20	protein_coding	Q6KB66	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	56
2.45429725125665e-51	-0.666682569284077	0.513	0.721	1.89398118879476e-47	RDX	Malignant cells	GSE104987	ENSG00000137710	5962	radixin	DFNB24	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	57
6.03533836408003e-51	0.314998244480126	1	1	4.65747061556056e-47	RPS28	Malignant cells	GSE104987	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	58
2.47512813795424e-49	-0.491731023354564	0.349	0.603	1.91005638405928e-45	LSM7	Malignant cells	GSE104987	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	59
3.13330935912858e-49	0.497379204011042	0.749	0.497	2.41797483243953e-45	LGALS1	Malignant cells	GSE104987	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	60
4.56311622488692e-49	-0.647543876205856	0.339	0.599	3.52135679074524e-45	SLC7A5	Malignant cells	GSE104987	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	61
7.660793457167e-49	-0.454424231478073	0.797	0.919	5.91183431089578e-45	THOC7	Malignant cells	GSE104987	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	62
1.55501153790605e-48	-0.488596940091599	0.441	0.687	1.2000024038021e-44	CERS2	Malignant cells	GSE104987	ENSG00000143418	29956	ceramide synthase 2	FLJ10243|LASS2|SP260	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	63
1.95472021077372e-48	0.470980059522189	0.796	0.538	1.50845758665408e-44	CD24	Malignant cells	GSE104987	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	64
1.81566067412812e-47	-0.328711141170094	1	1	1.40114534222467e-43	TPT1	Malignant cells	GSE104987	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	65
3.81971493228138e-47	-0.524602403706123	0.87	0.95	2.94767401324154e-43	CALM2	Malignant cells	GSE104987	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	66
1.76590076447727e-46	0.412793835146251	0.972	0.925	1.36274561994711e-42	COX7A2	Malignant cells	GSE104987	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	67
2.54107236568677e-46	-0.474471203161599	0.823	0.924	1.96094554460048e-42	CRABP2	Malignant cells	GSE104987	ENSG00000143320	1382	cellular retinoic acid binding protein 2	CRABP-II	protein_coding	P29373	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	68
4.03686689705451e-46	0.42494059304654	0.993	0.967	3.11525018445697e-42	KRT19	Malignant cells	GSE104987	ENSG00000171345	3880	keratin 19	CK19|K19|K1CS|MGC15366	protein_coding	P08727	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	69
4.52257335471706e-46	0.347763900301134	0.999	1	3.49006985783516e-42	FTH1	Malignant cells	GSE104987	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	70
5.95667172508481e-46	-0.51985532760446	0.646	0.815	4.59676357024794e-42	CD9	Malignant cells	GSE104987	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	71
1.57608965341732e-45	-0.310340370742912	1	1	1.21626838554215e-41	RPL41	Malignant cells	GSE104987	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	72
7.17285536065153e-45	-0.475615657008992	0.625	0.808	5.53529248181478e-41	BCAS3	Malignant cells	GSE104987	ENSG00000141376	54828	BCAS3 microtubule associated cell migration factor	FLJ20128|PHAF2	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	73
7.3983374659502e-45	-0.446189106127327	0.193	0.431	5.70929702247377e-41	AC013461.1	Malignant cells	GSE104987	NA	NA	NA	NA	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	74
3.4728366837588e-44	0.504335667936716	0.718	0.493	2.67998806885667e-40	UCP2	Malignant cells	GSE104987	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	75
2.77151242583442e-42	-0.544388714416374	0.346	0.565	2.13877613901642e-38	BEX3	Malignant cells	GSE104987	ENSG00000166681	27018	brain expressed X-linked 3	Bex|DXS6984E|HGR74|NADE|NGFRAP1	protein_coding	Q00994	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	76
1.38685819803087e-41	0.418444412061795	1	0.999	1.07023847142042e-37	RPS3A	Malignant cells	GSE104987	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	77
3.31989284324627e-41	-0.433798694048808	0.31	0.542	2.56196130713315e-37	PIEZO1	Malignant cells	GSE104987	ENSG00000103335	9780	piezo type mechanosensitive ion channel component 1	FAM38A|KIAA0233	protein_coding	Q92508	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	78
7.77901773101865e-41	-0.545340566024828	0.241	0.462	6.00306798302709e-37	ACKR3	Malignant cells	GSE104987	ENSG00000144476	57007	atypical chemokine receptor 3	CMKOR1|CXCR7|GPR159|RDC1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	79
2.0838389601118e-40	-0.426512929079947	0.296	0.526	1.60809852551828e-36	ADIPOR2	Malignant cells	GSE104987	ENSG00000285070	79602	adiponectin receptor 2	ACDCR2|PAQR2	protein_coding	Q86V24	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	80
2.35222237180224e-40	0.333409790262336	1	1	1.81521000431979e-36	FAU	Malignant cells	GSE104987	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	81
4.57136337369664e-40	-0.432840596659913	0.202	0.428	3.5277211154817e-36	SPATS2L	Malignant cells	GSE104987	ENSG00000196141	26010	spermatogenesis associated serine rich 2 like	DNAPTP6|SGNP	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	82
6.6289560756541e-40	0.475159033698829	0.738	0.532	5.11556540358227e-36	IFITM2	Malignant cells	GSE104987	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	83
2.84048776601695e-39	0.421509143618892	0.907	0.778	2.19200440903528e-35	TRIP6	Malignant cells	GSE104987	ENSG00000087077	7205	thyroid hormone receptor interactor 6	MGC10556|MGC10558|MGC29959|MGC3837|MGC4423|OIP1|ZRP-1	protein_coding	Q15654	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	84
3.25301704170573e-39	-0.479999417863562	0.713	0.848	2.51035325108431e-35	PSMB5	Malignant cells	GSE104987	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	85
4.7286688648767e-39	-0.469773363413661	0.999	0.999	3.64911376302535e-35	TMSB4X	Malignant cells	GSE104987	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	86
5.62680801769308e-39	0.426808159703307	0.262	0.065	4.34220774725375e-35	SLC26A2	Malignant cells	GSE104987	ENSG00000155850	1836	solute carrier family 26 member 2	DTD|DTDST	protein_coding	P50443	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	87
9.20542171165957e-39	-0.422911762129011	0.301	0.523	7.10382393488769e-35	ELOVL5	Malignant cells	GSE104987	ENSG00000012660	60481	ELOVL fatty acid elongase 5	dJ483K16.1|HELO1|SCA38	protein_coding	Q9NYP7	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	88
1.70919818286433e-38	-0.537860788999211	0.262	0.479	1.31898823771641e-34	DUSP4	Malignant cells	GSE104987	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	89
2.47643473544439e-38	-0.423056313508411	0.481	0.695	1.91106468534244e-34	GCSH	Malignant cells	GSE104987	ENSG00000140905	2653	glycine cleavage system protein H	NA	protein_coding	P23434	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	90
4.40575546960861e-38	0.382903399184363	0.366	0.141	3.39992149589697e-34	SOX3	Malignant cells	GSE104987	ENSG00000134595	6658	SRY-box transcription factor 3	PHP	protein_coding	P41225	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	91
4.60689650904274e-38	0.356697946172686	1	1	3.55514203602828e-34	MT-ATP6	Malignant cells	GSE104987	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	92
5.2196930578541e-38	0.42494059304654	0.894	0.775	4.02803713274601e-34	P4HB	Malignant cells	GSE104987	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	93
5.08081403697136e-37	0.288669916260015	1	0.999	3.9208641923308e-33	RPS23	Malignant cells	GSE104987	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	94
5.22374527270205e-37	0.35806347784108	0.263	0.07	4.03116422694417e-33	FABP5	Malignant cells	GSE104987	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	95
2.81078418660584e-36	0.339970577115863	0.978	0.858	2.16908215680373e-32	SLC39A6	Malignant cells	GSE104987	ENSG00000141424	25800	solute carrier family 39 member 6	LIV-1	protein_coding	Q13433	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	96
3.62498410324046e-36	-0.373491091547929	0.929	0.963	2.79740023247066e-32	SEC11A	Malignant cells	GSE104987	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	97
5.93541352025927e-36	0.330083291104241	0.994	0.983	4.58035861358408e-32	EEF1D	Malignant cells	GSE104987	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	98
2.17461871439962e-35	0.420016714407255	0.951	0.886	1.67815326190219e-31	NR2F2	Malignant cells	GSE104987	ENSG00000185551	7026	nuclear receptor subfamily 2 group F member 2	ARP1|COUP-TFII|COUPTF2|COUPTFB|NF-E3|SVP40|TFCOUP2	protein_coding	P24468	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	99
4.0626468528022e-35	0.41918267586129	0.744	0.55	3.13514457630746e-31	PHPT1	Malignant cells	GSE104987	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	100
1.16258861937524e-34	-0.372009732920098	0.182	0.39	8.97169637571875e-31	CA12	Malignant cells	GSE104987	ENSG00000074410	771	carbonic anhydrase 12	HsT18816	protein_coding	O43570	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	101
1.22582056337118e-34	-0.542024627709668	0.445	0.641	9.45965728753536e-31	IER3	Malignant cells	GSE104987	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	102
4.56856168259914e-34	-0.343176411944879	0.999	1	3.52555905046176e-30	RPLP1	Malignant cells	GSE104987	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	103
4.60031465023867e-34	-0.383750776573878	0.274	0.488	3.55006281558918e-30	IGFBP4	Malignant cells	GSE104987	ENSG00000141753	3487	insulin like growth factor binding protein 4	BP-4|HT29-IGFBP|IBP4|IGFBP-4	protein_coding	P22692	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	104
6.99980505781388e-34	0.321297563914632	0.996	0.985	5.40174956311497e-30	RPLP2	Malignant cells	GSE104987	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	105
1.54311600977015e-33	0.312959345934512	0.289	0.098	1.19082262473963e-29	AMOTL1	Malignant cells	GSE104987	ENSG00000166025	154810	angiomotin like 1	JEAP	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	106
2.48823697781514e-33	-0.496932626461573	0.349	0.563	1.92017247577994e-29	PLK2	Malignant cells	GSE104987	ENSG00000145632	10769	polo like kinase 2	SNK	protein_coding	Q9NYY3	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	107
2.60148039891342e-33	-0.437029256061015	0.686	0.815	2.00756242384148e-29	ILF2	Malignant cells	GSE104987	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	108
3.4402797882544e-33	0.277221025890618	1	0.999	2.65486391259592e-29	NPM1	Malignant cells	GSE104987	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	109
6.86615435969374e-33	-0.267901632449985	1	1	5.29861131937566e-29	PABPC1	Malignant cells	GSE104987	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	110
9.28624933023812e-33	0.341541435328035	0.955	0.881	7.16619860814476e-29	PPDPF	Malignant cells	GSE104987	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	111
1.33074527146941e-32	-0.298541771756045	0.15	0.344	1.02693612599294e-28	RNFT1	Malignant cells	GSE104987	ENSG00000189050	51136	ring finger protein, transmembrane 1	PTD016	protein_coding	Q5M7Z0	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	112
1.84393688057747e-32	-0.348558817106645	0.11	0.286	1.42296609074163e-28	SOX9	Malignant cells	GSE104987	ENSG00000125398	6662	SRY-box transcription factor 9	CMD1|CMPD1|SRA1	protein_coding	P48436	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	113
2.27076766767604e-32	-0.512453311662734	0.496	0.663	1.7523514091456e-28	UGDH	Malignant cells	GSE104987	ENSG00000109814	7358	UDP-glucose 6-dehydrogenase	NA	protein_coding	O60701	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	114
2.55040439831027e-32	0.266113462512382	1	1	1.96814707417604e-28	RPL13A	Malignant cells	GSE104987	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	115
4.54572856817658e-32	-0.338992048719936	0.286	0.496	3.50793873606187e-28	FGD5-AS1	Malignant cells	GSE104987	ENSG00000225733	100505641	FGD5 antisense RNA 1	NA	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	116
5.0950703499412e-31	0.272422072700232	0.999	0.999	3.93186578904962e-27	RPL18A	Malignant cells	GSE104987	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	117
5.34603156045704e-31	0.356843669486415	0.942	0.884	4.1255325552047e-27	CLDN3	Malignant cells	GSE104987	ENSG00000165215	1365	claudin 3	C7orf1|CPE-R2|CPETR2|HRVP1|RVP1	protein_coding	O15551	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	118
8.92924626707129e-31	-0.261236361703153	0.09	0.256	6.89069934429891e-27	SYTL5	Malignant cells	GSE104987	ENSG00000147041	94122	synaptotagmin like 5	NA	protein_coding	Q8TDW5	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	119
3.13176010026486e-30	-0.439182066025588	0.5	0.683	2.41677926937439e-26	STAT1	Malignant cells	GSE104987	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	120
5.81875975603199e-30	0.26089416453644	0.998	0.998	4.49033690372989e-26	RPS4X	Malignant cells	GSE104987	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	121
6.28292265084823e-30	-0.408236407213681	0.356	0.549	4.84853140965958e-26	MSI2	Malignant cells	GSE104987	ENSG00000153944	124540	musashi RNA binding protein 2	NA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	122
7.63581884652409e-30	-0.388153643127254	0.617	0.766	5.89256140386264e-26	CALM1	Malignant cells	GSE104987	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	123
8.43031243264579e-30	-0.305386898020951	0.98	0.985	6.50567210427275e-26	CFL1	Malignant cells	GSE104987	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	124
1.85208767347163e-29	-0.356304114296793	0.396	0.6	1.42925605761806e-25	STRAP	Malignant cells	GSE104987	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	125
2.76321445553819e-29	0.353298925631287	0.426	0.225	2.13237259533882e-25	DSCAM	Malignant cells	GSE104987	ENSG00000171587	1826	DS cell adhesion molecule	CHD2-42|CHD2-52	protein_coding	O60469	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	126
4.92734632096345e-29	-0.339801681425658	0.123	0.289	3.80243315588749e-25	LACTB	Malignant cells	GSE104987	ENSG00000103642	114294	lactamase beta	FLJ14902|MRPL56	protein_coding	P83111	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	127
7.65857640276018e-29	-0.3807905865314	0.302	0.498	5.91012341001003e-25	PCNA	Malignant cells	GSE104987	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	128
1.3666832858851e-28	0.371512453593351	0.801	0.662	1.05466949171753e-24	TMEM205	Malignant cells	GSE104987	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	129
2.31575521732623e-28	-0.372965054176392	0.991	0.997	1.78706830121065e-24	ACTG1	Malignant cells	GSE104987	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	130
2.52905362820587e-28	-0.355991169209577	0.205	0.391	1.95167068488647e-24	EGR3	Malignant cells	GSE104987	ENSG00000179388	1960	early growth response 3	PILOT	protein_coding	Q06889	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	131
3.4538059257985e-28	-0.409608336932351	0.353	0.545	2.6653020329387e-24	ABAT	Malignant cells	GSE104987	ENSG00000183044	18	4-aminobutyrate aminotransferase	GABA-T|GABAT	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	132
8.69526643008165e-28	-0.363689687213796	0.92	0.956	6.71013710409401e-24	PFN1	Malignant cells	GSE104987	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	133
4.30636225984839e-27	0.32158174682464	0.371	0.186	3.323219755925e-23	LINC00963	Malignant cells	GSE104987	ENSG00000204054	NA	NA	MetaLnc9	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	134
4.52083900379191e-27	-0.326535474467793	0.256	0.446	3.48873145922621e-23	CD59	Malignant cells	GSE104987	ENSG00000085063	966	CD59 molecule (CD59 blood group)	16.3A5|EJ16|EJ30|EL32|G344|MIC11|MIN1|MIN2|MIN3|MSK21|p18-20	protein_coding	P13987	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	135
6.75043662578288e-27	-0.33560767557722	0.883	0.937	5.20931194411665e-23	MORF4L1	Malignant cells	GSE104987	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	136
7.46636859445389e-27	-0.379613884830109	0.381	0.555	5.76179664434007e-23	ITPK1	Malignant cells	GSE104987	ENSG00000274958	3705	inositol-tetrakisphosphate 1-kinase	NA	protein_coding	Q13572	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	137
8.8783844057157e-27	-0.302780267866241	0.966	0.989	6.85144924589081e-23	SPINT2	Malignant cells	GSE104987	ENSG00000167642	10653	serine peptidase inhibitor, Kunitz type 2	HAI-2|HAI2|Kop	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	138
1.86526522890989e-26	-0.341578323516885	0.275	0.463	1.43942517714976e-22	ITGB5	Malignant cells	GSE104987	ENSG00000082781	3693	integrin subunit beta 5	NA	protein_coding	P18084	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	139
1.9798337134622e-26	-0.378222638454415	0.371	0.555	1.52783767667878e-22	NET1	Malignant cells	GSE104987	ENSG00000173848	10276	neuroepithelial cell transforming 1	ARHGEF8|NET1A	protein_coding	Q7Z628	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	140
2.19987539134513e-26	0.27885479184935	0.999	0.999	1.69764383950104e-22	CHCHD2	Malignant cells	GSE104987	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	141
3.26392347984878e-26	-0.354419601796379	0.386	0.57	2.5187697493993e-22	ACTN1	Malignant cells	GSE104987	ENSG00000072110	87	actinin alpha 1	NA	protein_coding	P12814	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	142
5.16888756194811e-26	-0.277536624734376	0.157	0.326	3.98883053155535e-22	NRP1	Malignant cells	GSE104987	ENSG00000099250	8829	neuropilin 1	CD304|NRP|VEGF165R	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	143
7.04504691148244e-26	0.384775060020133	0.776	0.63	5.436662701591e-22	GFRA1	Malignant cells	GSE104987	ENSG00000151892	2674	GDNF family receptor alpha 1	GDNFR|GDNFRA|GFR-ALPHA-1|RET1L|RETL1|TRNR1	protein_coding	P56159	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	144
8.63486479982289e-26	-0.464353172313025	0.567	0.689	6.66352516602333e-22	HNRNPA1L2	Malignant cells	GSE104987	ENSG00000139675	144983	heterogeneous nuclear ribonucleoprotein A1 like 2	LOC144983	protein_coding	Q32P51	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	145
3.40944507733611e-25	0.325102689466053	0.607	0.418	2.63106876618027e-21	FIS1	Malignant cells	GSE104987	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	146
3.68240182565181e-25	0.258614702526698	0.999	0.998	2.84170948885551e-21	RPS16	Malignant cells	GSE104987	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	147
4.26586962337925e-25	-0.391478411439301	0.872	0.924	3.29197158836177e-21	S100A10	Malignant cells	GSE104987	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	148
5.8755772503703e-25	0.301452981974174	0.986	0.965	4.53418296411076e-21	IFITM3	Malignant cells	GSE104987	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	149
6.32737959712798e-25	-0.35590778452578	0.193	0.361	4.88283883510366e-21	IRX2	Malignant cells	GSE104987	ENSG00000170561	153572	iroquois homeobox 2	NA	protein_coding	Q9BZI1	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	150
6.51230088049622e-25	-0.333946715066186	0.419	0.588	5.02554258947894e-21	GNB1	Malignant cells	GSE104987	ENSG00000078369	2782	G protein subunit beta 1	NA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	151
1.17290505108757e-24	-0.352666985617012	0.318	0.498	9.05130827924278e-21	IGF1R	Malignant cells	GSE104987	ENSG00000140443	3480	insulin like growth factor 1 receptor	CD221|IGFIR|IGFR|JTK13|MGC18216	protein_coding	P08069	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	152
1.8326965511376e-24	0.314849028472711	0.486	0.297	1.41429192851289e-20	LYPD3	Malignant cells	GSE104987	ENSG00000124466	27076	LY6/PLAUR domain containing 3	C4.4A	protein_coding	O95274	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	153
1.86445033010146e-24	-0.376558435268772	0.554	0.705	1.4387963197393e-20	RANBP1	Malignant cells	GSE104987	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	154
2.03145350007473e-24	0.345433146062482	0.639	0.457	1.56767266600767e-20	NDUFS3	Malignant cells	GSE104987	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	155
2.10886324664679e-24	-0.332492551774441	0.887	0.931	1.62740976743733e-20	HNRNPA3	Malignant cells	GSE104987	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	156
2.36755138118197e-24	0.373240686625254	0.378	0.196	1.82703940085812e-20	EXOSC10	Malignant cells	GSE104987	ENSG00000171824	5394	exosome component 10	p2|p3|p4|PM-Scl|PM/Scl-100|PMSCL2|RRP6|Rrp6p	protein_coding	Q01780	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	157
2.6346694440185e-24	-0.270655681718245	0.156	0.315	2.03317440994908e-20	SEC23A	Malignant cells	GSE104987	ENSG00000100934	10484	SEC23 homolog A, COPII coat complex component	NA	protein_coding	Q15436	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	158
4.45209266248727e-24	-0.350588582343554	0.418	0.583	3.43567990764142e-20	DTD1	Malignant cells	GSE104987	ENSG00000125821	92675	D-aminoacyl-tRNA deacylase 1	bA379J5.3|bA555E18.1|C20orf88|DUEB|HARS2|MGC119131|MGC41905|pqn-68	protein_coding	Q8TEA8	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	159
5.92565638757034e-24	-0.254095358236878	0.14	0.299	4.57282903428803e-20	INPP4B	Malignant cells	GSE104987	ENSG00000109452	8821	inositol polyphosphate-4-phosphatase type II B	NA	protein_coding	O15327	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	160
1.15120403259866e-23	-0.317122868759345	0.216	0.386	8.88384151956385e-20	DEGS1	Malignant cells	GSE104987	ENSG00000143753	8560	delta 4-desaturase, sphingolipid 1	DEGS-1|Des-1|DES1|FADS7|MLD	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	161
2.09978598211391e-23	-0.308349342976268	0.368	0.535	1.62040484239731e-19	DPY30	Malignant cells	GSE104987	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	162
2.62523310064137e-23	-0.392532951678751	0.62	0.727	2.02589238376495e-19	TPM4	Malignant cells	GSE104987	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	163
4.12969031194481e-23	-0.251972985997539	0.148	0.304	3.18688201372781e-19	PLSCR1	Malignant cells	GSE104987	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	164
5.02982735219275e-23	0.284783875639999	0.935	0.853	3.88151776768715e-19	UQCRB	Malignant cells	GSE104987	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	165
5.54112971536404e-23	-0.294057599459406	0.425	0.598	4.27608980134643e-19	SPG21	Malignant cells	GSE104987	ENSG00000090487	51324	SPG21 abhydrolase domain containing, maspardin	ABHD21|ACP33|BM-019|GL010|MAST	protein_coding	Q9NZD8	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	166
7.28340011830542e-23	-0.353497600552092	0.497	0.649	5.62059987129629e-19	XPOT	Malignant cells	GSE104987	ENSG00000184575	11260	exportin for tRNA	XPO3	protein_coding	O43592	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	167
7.40597363344492e-23	-0.288505642167983	0.262	0.435	5.71518985292945e-19	MYDGF	Malignant cells	GSE104987	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	168
7.73392777027629e-23	-0.34409348271513	0.646	0.775	5.96827206032221e-19	NELFCD	Malignant cells	GSE104987	ENSG00000101158	51497	negative elongation factor complex member C/D	HSPC130|NELF-C|NELF-D|TH1|TH1L	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	169
1.22690173724567e-22	-0.273095033485262	0.133	0.282	9.46800070632486e-19	DST	Malignant cells	GSE104987	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	170
1.48570834928245e-22	-0.275154792770816	0.186	0.346	1.14652113314127e-18	TMEM14A	Malignant cells	GSE104987	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	171
2.10753248246136e-22	-0.361262592919699	0.332	0.491	1.62638281671543e-18	FAM102B	Malignant cells	GSE104987	ENSG00000162636	284611	family with sequence similarity 102 member B	DKFZp779B126|SYM-3B	protein_coding	Q5T8I3	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	172
2.5854894188001e-22	-0.326983886837174	0.376	0.545	1.99522218448804e-18	DHX9	Malignant cells	GSE104987	ENSG00000135829	1660	DExH-box helicase 9	DDX9|LKP|RHA	protein_coding	Q08211	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	173
3.03809326884881e-22	0.32827161359271	0.694	0.549	2.34449657557062e-18	HIGD2A	Malignant cells	GSE104987	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	174
3.36298566074506e-22	0.337597227997361	0.74	0.59	2.59521603439696e-18	ALDOA	Malignant cells	GSE104987	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	175
3.61421511579083e-22	-0.261824267671076	0.997	0.999	2.78908980485579e-18	MT-CO1	Malignant cells	GSE104987	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	176
4.02188886682669e-22	0.308096539862698	0.569	0.385	3.10369163853016e-18	MALAT1	Malignant cells	GSE104987	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	177
4.89447628874118e-22	0.322752462547598	0.58	0.418	3.77706735202157e-18	CYB561	Malignant cells	GSE104987	ENSG00000008283	1534	cytochrome b561	CYB561A1|FRRS2	protein_coding	P49447	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	178
5.0917966257957e-22	-0.269392292440454	0.21	0.372	3.92933945612654e-18	CMTM6	Malignant cells	GSE104987	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	179
5.36990158456129e-22	-0.290125519548299	0.147	0.298	4.14395305280595e-18	NECAB1	Malignant cells	GSE104987	ENSG00000123119	64168	N-terminal EF-hand calcium binding protein 1	EFCBP1	protein_coding	Q8N987	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	180
5.63821742810997e-22	0.287601500849797	0.32	0.156	4.35101238927246e-18	ELOVL2	Malignant cells	GSE104987	ENSG00000197977	54898	ELOVL fatty acid elongase 2	Ssc2	protein_coding	Q9NXB9	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	181
1.4210997357036e-21	-0.315087059754561	0.282	0.448	1.09666266604247e-17	ARMT1	Malignant cells	GSE104987	ENSG00000146476	79624	acidic residue methyltransferase 1	C6orf211|FLJ12910	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	182
1.45003089415979e-21	-0.306181551035248	0.326	0.489	1.11898884102311e-17	PRMT6	Malignant cells	GSE104987	ENSG00000198890	55170	protein arginine methyltransferase 6	FLJ10559|HRMT1L6	protein_coding	Q96LA8	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	183
1.48162202536205e-21	0.326468325441843	0.881	0.778	1.14336771697189e-17	JUND	Malignant cells	GSE104987	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	184
1.87062861225697e-21	-0.366553674101773	0.626	0.746	1.4435641000787e-17	SRSF2	Malignant cells	GSE104987	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	185
2.01838511799011e-21	-0.257611735048767	0.181	0.336	1.55758779555297e-17	HMCES	Malignant cells	GSE104987	ENSG00000183624	56941	5-hydroxymethylcytosine binding, ES cell specific	C3orf37|DC12|SRAPD1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	186
2.14593509281111e-21	-0.31673639568993	0.429	0.587	1.65601811112233e-17	ARPC5	Malignant cells	GSE104987	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	187
3.9481277452166e-21	0.272577770129264	0.355	0.19	3.04677018098365e-17	VGF	Malignant cells	GSE104987	ENSG00000128564	7425	VGF nerve growth factor inducible	SCG7|SgVII	protein_coding	O15240	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	188
7.04663444064113e-21	0.339344391628834	0.582	0.431	5.43788779784276e-17	EPB41L4A-AS1	Malignant cells	GSE104987	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	189
1.31101330861895e-20	-0.351150630581386	0.732	0.814	1.01170897026124e-16	SF3B6	Malignant cells	GSE104987	ENSG00000115128	51639	splicing factor 3b subunit 6	CGI-110|Ht006|P14|SAP14a|SF3B14a	protein_coding	Q9Y3B4	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	190
1.49277746455071e-20	0.278391929693598	0.331	0.173	1.15197636939378e-16	KLF9	Malignant cells	GSE104987	ENSG00000119138	687	KLF transcription factor 9	BTEB1	protein_coding	Q13886	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	191
3.54457653650332e-20	0.304540992875391	0.613	0.465	2.73534971321961e-16	PTPA	Malignant cells	GSE104987	ENSG00000119383	5524	protein phosphatase 2 phosphatase activator	PPP2R4|PR53	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	192
3.94638853204187e-20	-0.322601286706127	0.242	0.396	3.04542803017671e-16	MSMO1	Malignant cells	GSE104987	ENSG00000052802	6307	methylsterol monooxygenase 1	DESP4|ERG25|SC4MOL	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	193
4.36677576560183e-20	-0.298880453509595	0.867	0.907	3.36984085831494e-16	RPL9	Malignant cells	GSE104987	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	194
7.75747332973651e-20	0.322424050241853	0.546	0.382	5.98644216855766e-16	ZFP36	Malignant cells	GSE104987	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	195
9.16978484398663e-20	-0.312103684277543	0.67	0.785	7.07632296410448e-16	TOP1	Malignant cells	GSE104987	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	196
9.3551625719368e-20	0.287856557479151	0.999	1	7.21937895676363e-16	MT-ND3	Malignant cells	GSE104987	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	197
1.03736502212993e-19	-0.305061453529345	0.338	0.496	8.00534587577669e-16	RPA1	Malignant cells	GSE104987	ENSG00000132383	6117	replication protein A1	HSSB|REPA1|RF-A|RP-A|RPA70	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	198
1.06141462133652e-19	-0.296234284641079	0.28	0.438	8.1909366328539e-16	KTN1	Malignant cells	GSE104987	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	199
1.30549260863644e-19	-0.25369096619126	0.177	0.322	1.00744864608474e-15	CHKA	Malignant cells	GSE104987	ENSG00000110721	1119	choline kinase alpha	CHK|CKI	protein_coding	P35790	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	200
1.67294844822541e-19	-0.251179445899139	0.214	0.369	1.29101431749555e-15	CAST	Malignant cells	GSE104987	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	201
2.77126003421992e-19	0.277304415608003	0.55	0.387	2.13858136840751e-15	SLC38A1	Malignant cells	GSE104987	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	202
3.06881683792176e-19	-0.311688865274509	0.621	0.74	2.36820595382422e-15	HSP90B1	Malignant cells	GSE104987	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	203
3.95586711643521e-19	-0.280731910311391	0.41	0.565	3.05274265375305e-15	SPCS1	Malignant cells	GSE104987	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	204
4.22411071251217e-19	-0.301286588476203	0.639	0.761	3.25974623684564e-15	PFN2	Malignant cells	GSE104987	ENSG00000070087	5217	profilin 2	NA	protein_coding	P35080	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	205
4.84531384976315e-19	-0.31610233320021	0.389	0.544	3.73912869786222e-15	SRI	Malignant cells	GSE104987	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	206
4.96772946637169e-19	-0.37284424181498	0.772	0.872	3.83359682919903e-15	S100A14	Malignant cells	GSE104987	ENSG00000189334	57402	S100 calcium binding protein A14	BCMP84|S100A15	protein_coding	Q9HCY8	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	207
9.10130407149626e-19	-0.278919027092716	0.299	0.452	7.02347635197366e-15	DENR	Malignant cells	GSE104987	ENSG00000139726	8562	density regulated re-initiation and release factor	DRP|DRP1|SMAP-3	protein_coding	O43583	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	208
9.93716975027689e-19	-0.30094653541848	0.596	0.719	7.66851389628868e-15	PAPOLA	Malignant cells	GSE104987	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	209
1.11589229754689e-18	-0.315609545578233	0.632	0.747	8.61134086016934e-15	ARCN1	Malignant cells	GSE104987	ENSG00000095139	372	archain 1	COPD	protein_coding	P48444	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	210
1.16984625426885e-18	-0.26895627922778	0.277	0.431	9.02770354419274e-15	TMEM106C	Malignant cells	GSE104987	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	211
1.45810661652768e-18	-0.301158080266019	0.559	0.688	1.12522087597441e-14	CTTN	Malignant cells	GSE104987	ENSG00000288401	2017	cortactin	EMS1	protein_coding	Q14247	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	212
1.54333385101759e-18	-0.269224272476143	0.306	0.461	1.19099073283028e-14	PIAS3	Malignant cells	GSE104987	ENSG00000131788	10401	protein inhibitor of activated STAT 3	FLJ14651|ZMIZ5	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	213
1.67475328541251e-18	0.275451588354793	0.922	0.848	1.29240711035284e-14	PTGES3	Malignant cells	GSE104987	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	214
1.70210657499863e-18	-0.280383860609568	0.902	0.933	1.31351564392644e-14	MYL12B	Malignant cells	GSE104987	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	215
1.97344241706428e-18	-0.311912593543086	0.413	0.554	1.52290551324851e-14	FAM84B	Malignant cells	GSE104987	NA	NA	NA	NA	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	216
2.10423324385174e-18	0.250747259967424	0.359	0.205	1.62383679428039e-14	FAM107B	Malignant cells	GSE104987	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	217
2.25582230188383e-18	0.312001098428504	0.585	0.426	1.74081807036375e-14	TFAP2C	Malignant cells	GSE104987	ENSG00000087510	7022	transcription factor AP-2 gamma	AP2-GAMMA|ERF1|hAP-2g|TFAP2G	protein_coding	Q92754	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	218
3.62162517816749e-18	-0.328257240712714	0.356	0.516	2.79480814999185e-14	THBS1	Malignant cells	GSE104987	ENSG00000137801	7057	thrombospondin 1	THBS|THBS-1|TSP|TSP-1|TSP1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	219
3.8924541844467e-18	0.290291066351758	0.611	0.463	3.00380689413752e-14	PSMC5	Malignant cells	GSE104987	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	220
5.22030213917892e-18	-0.278666404173235	0.671	0.785	4.02850716080437e-14	PPP1CB	Malignant cells	GSE104987	ENSG00000213639	5500	protein phosphatase 1 catalytic subunit beta	MP|PP-1B|PP1B|PP1beta|PP1c|PPP1beta	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	221
5.72645524643452e-18	-0.283723119201393	0.52	0.657	4.41910551367352e-14	SDHC	Malignant cells	GSE104987	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	222
6.13866988416775e-18	-0.286603981601249	0.385	0.532	4.73721154961225e-14	LYPLA1	Malignant cells	GSE104987	ENSG00000120992	10434	lysophospholipase 1	APT-1|LPL1	protein_coding	O75608	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	223
6.58243899325194e-18	-0.27963038800605	0.386	0.535	5.07966817109252e-14	NUTF2	Malignant cells	GSE104987	ENSG00000102898	10204	nuclear transport factor 2	NTF2|PP15	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	224
7.60998400062849e-18	0.302365044958006	0.631	0.484	5.872624653285e-14	BNIP3	Malignant cells	GSE104987	ENSG00000176171	664	BCL2 interacting protein 3	HABON|Nip3	protein_coding	Q12983	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	225
1.29544895843298e-17	0.261112534724249	0.4	0.248	9.99697961222729e-14	TMEM179B	Malignant cells	GSE104987	ENSG00000185475	374395	transmembrane protein 179B	NA	protein_coding	Q7Z7N9	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	226
1.56086236710061e-17	-0.27444181831151	0.636	0.743	1.20451748869154e-13	GNB2	Malignant cells	GSE104987	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	227
1.76604056607216e-17	-0.267145729195554	0.341	0.491	1.36285350483788e-13	RP11-697E2.6	Malignant cells	GSE104987	NA	NA	NA	NA	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	228
2.62034930439758e-17	-0.329083560319313	0.453	0.581	2.02212355820361e-13	PBX1	Malignant cells	GSE104987	ENSG00000185630	5087	PBX homeobox 1	NA	protein_coding	P40424	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	229
3.31517459398522e-17	0.296607071588683	0.589	0.457	2.55832023417839e-13	MRPS15	Malignant cells	GSE104987	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	230
3.92728107421705e-17	0.322350877341838	0.726	0.616	3.0306828049733e-13	TBC1D16	Malignant cells	GSE104987	ENSG00000167291	125058	TBC1 domain family member 16	FLJ20748|MGC25062	protein_coding	Q8TBP0	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	231
4.07179329124114e-17	-0.274392622388473	0.353	0.507	3.14220288285079e-13	SQLE	Malignant cells	GSE104987	ENSG00000104549	6713	squalene epoxidase	NA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	232
4.11792091295001e-17	-0.331836953028477	0.524	0.655	3.17779956852352e-13	CYB5A	Malignant cells	GSE104987	ENSG00000166347	1528	cytochrome b5 type A	CYB5	protein_coding	P00167	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	233
4.46187227032977e-17	0.286288917611052	0.559	0.427	3.44322683101349e-13	ECH1	Malignant cells	GSE104987	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	234
4.65050776054977e-17	0.301134391432142	0.626	0.479	3.58879683881626e-13	JUNB	Malignant cells	GSE104987	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	235
6.39448206594757e-17	-0.260281426025668	0.294	0.446	4.93462181029174e-13	CAMTA1	Malignant cells	GSE104987	ENSG00000171735	23261	calmodulin binding transcription activator 1	KIAA0833	protein_coding	Q9Y6Y1	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	236
7.20146375292828e-17	-0.258687593235104	0.274	0.417	5.55736957813475e-13	PLEKHB2	Malignant cells	GSE104987	ENSG00000115762	55041	pleckstrin homology domain containing B2	EVT2|FLJ20783	protein_coding	Q96CS7	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	237
9.42563372466052e-17	0.287475520144567	0.602	0.461	7.27376154532052e-13	ASS1	Malignant cells	GSE104987	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	238
9.8793380497225e-17	-0.289100010899916	0.337	0.479	7.62388517297085e-13	TIMP1	Malignant cells	GSE104987	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	239
1.01205051215642e-16	-0.259298148987599	0.253	0.396	7.80999380231109e-13	WRB	Malignant cells	GSE104987	NA	NA	NA	NA	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	240
1.11837930378061e-16	-0.252531563547425	0.378	0.523	8.63053308727495e-13	RNF7	Malignant cells	GSE104987	ENSG00000114125	9616	ring finger protein 7	CKBBP1|RBX2|ROC2|SAG	protein_coding	Q9UBF6	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	241
1.37368156775149e-16	-0.267289375062757	0.411	0.558	1.06007006583383e-12	EI24	Malignant cells	GSE104987	ENSG00000149547	9538	EI24 autophagy associated transmembrane protein	EPG4|PIG8|TP53I8	protein_coding	O14681	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	242
1.41143273723614e-16	-0.291195078697227	0.41	0.554	1.08920264332513e-12	ISG15	Malignant cells	GSE104987	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	243
1.9591695151758e-16	-0.275135751262981	0.457	0.599	1.51189111486117e-12	TRA2B	Malignant cells	GSE104987	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	244
2.05255633731246e-16	-0.254040178161605	0.483	0.627	1.58395772550403e-12	NOP10	Malignant cells	GSE104987	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	245
2.45116674267636e-16	-0.288827178456147	0.391	0.523	1.89156537532335e-12	PRDX3	Malignant cells	GSE104987	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	246
2.46391773258509e-16	0.257863265473009	0.478	0.332	1.90140531423591e-12	SLC39A4	Malignant cells	GSE104987	ENSG00000285243	55630	solute carrier family 39 member 4	AEZ|AWMS2|ZIP4	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	247
2.53941777777781e-16	0.264865364786254	0.601	0.451	1.95966869911114e-12	NDUFS2	Malignant cells	GSE104987	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	248
2.6132672346903e-16	-0.303979381568133	0.508	0.635	2.01665832501051e-12	MAPRE1	Malignant cells	GSE104987	ENSG00000101367	22919	microtubule associated protein RP/EB family member 1	EB1	protein_coding	Q15691	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	249
2.86257127429038e-16	-0.282755925603652	0.448	0.577	2.20904625236988e-12	PTPMT1	Malignant cells	GSE104987	ENSG00000285206	114971	protein tyrosine phosphatase mitochondrial 1	DUSP23|MOSP|PLIP	protein_coding	Q8WUK0	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	250
4.12585437003497e-16	-0.265347261775737	0.525	0.658	3.18392181735599e-12	LSM5	Malignant cells	GSE104987	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	251
4.93959886848075e-16	0.279089726583085	0.717	0.59	3.8118884468066e-12	CBX4	Malignant cells	GSE104987	ENSG00000141582	8535	chromobox 4	hPC2|NBP16|PC2	protein_coding	O00257	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	252
7.48463891166941e-16	-0.263576345657666	0.319	0.465	5.77589584813528e-12	OAS3	Malignant cells	GSE104987	ENSG00000111331	4940	2'-5'-oligoadenylate synthetase 3	NA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	253
1.05007705868876e-15	-0.275076456401145	0.43	0.566	8.10344466190119e-12	DDX17	Malignant cells	GSE104987	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	254
1.22761244991048e-15	-0.277719285559988	0.69	0.784	9.47348527595919e-12	CAPZA1	Malignant cells	GSE104987	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	255
1.50428219674826e-15	-0.257461565564831	0.393	0.535	1.16085457123063e-11	DMKN	Malignant cells	GSE104987	ENSG00000161249	93099	dermokine	ZD52F10	protein_coding	Q6E0U4	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	256
2.04728356344263e-15	-0.279337711350832	0.471	0.597	1.57988872590868e-11	RAB1A	Malignant cells	GSE104987	ENSG00000138069	5861	RAB1A, member RAS oncogene family	RAB1|YPT1	protein_coding	P62820	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	257
2.41082013247213e-15	-0.294504902076648	0.591	0.7	1.86042989622874e-11	NAA50	Malignant cells	GSE104987	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	258
3.11602086900334e-15	-0.25147968619494	0.284	0.421	2.40463330460988e-11	SH3BGRL3	Malignant cells	GSE104987	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	259
3.21180042163733e-15	-0.257801071715231	0.241	0.374	2.47854638537752e-11	OLFM1	Malignant cells	GSE104987	ENSG00000130558	10439	olfactomedin 1	AMY|NOE1|NOELIN|OlfA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	260
3.2958529904048e-15	-0.309080627585901	0.53	0.641	2.54340975269539e-11	RPS27L	Malignant cells	GSE104987	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	261
3.33990133170448e-15	-0.355561058886192	0.337	0.463	2.57740185767635e-11	ARMCX6	Malignant cells	GSE104987	ENSG00000198960	54470	armadillo repeat containing X-linked 6	FLJ20811|GASP10	protein_coding	Q7L4S7	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	262
3.40320325582602e-15	-0.250911048840985	0.316	0.455	2.62625195252094e-11	SH3BGRL	Malignant cells	GSE104987	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	263
3.41726532054239e-15	0.302835823587055	0.292	0.166	2.63710364786256e-11	KRT7	Malignant cells	GSE104987	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	264
4.03422995010869e-15	-0.254210182604821	0.659	0.782	3.11321525249888e-11	SUMO3	Malignant cells	GSE104987	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	265
4.1284383477612e-15	-0.305696777768208	0.234	0.362	3.18591587296732e-11	PREX1	Malignant cells	GSE104987	ENSG00000124126	57580	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1	KIAA1415|P-REX1	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	266
4.15187883524268e-15	-0.30300978498187	0.423	0.556	3.20400489715678e-11	ANP32E	Malignant cells	GSE104987	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	267
4.52555607815492e-15	0.266745020808489	0.776	0.685	3.49237162551215e-11	FAM120A	Malignant cells	GSE104987	ENSG00000048828	23196	family with sequence similarity 120A	C9orf10|KIAA0183|OSSA	protein_coding	Q9NZB2	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	268
5.52372453345986e-15	-0.288935045430542	0.504	0.627	4.26265822247097e-11	EIF5	Malignant cells	GSE104987	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	269
7.88260090457114e-15	-0.271893614766347	0.469	0.596	6.08300311805755e-11	TPM3	Malignant cells	GSE104987	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	270
8.24592679688597e-15	0.307169134420789	0.666	0.564	6.3633817091569e-11	SRM	Malignant cells	GSE104987	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	271
8.76772103333997e-15	0.277658364549825	0.491	0.348	6.76605032142845e-11	RARS	Malignant cells	GSE104987	NA	NA	NA	NA	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	272
1.08708854748692e-14	0.28396585070919	0.664	0.544	8.38906232095659e-11	FAM162A	Malignant cells	GSE104987	ENSG00000114023	26355	family with sequence similarity 162 member A	C3orf28|E2IG5	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	273
1.21355701358368e-14	0.282964959889084	0.678	0.535	9.36501947382523e-11	MOCS2	Malignant cells	GSE104987	ENSG00000164172	4338	molybdenum cofactor synthesis 2	MOCO1|MOCS2A|MOCS2B	protein_coding	O96033	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	274
1.60059631916093e-14	0.262148992863539	0.363	0.231	1.23518017949649e-10	C12orf45	Malignant cells	GSE104987	NA	NA	NA	NA	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	275
2.15773502572755e-14	-0.32294683263527	0.351	0.47	1.66512411935395e-10	MYH9	Malignant cells	GSE104987	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	276
3.46394429302692e-14	-0.262766965655529	0.731	0.813	2.67312581092888e-10	VDAC1	Malignant cells	GSE104987	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	277
3.92448650247181e-14	-0.296315537843746	0.531	0.662	3.0285262339575e-10	MCM6	Malignant cells	GSE104987	ENSG00000076003	4175	minichromosome maintenance complex component 6	Mis5	protein_coding	Q14566	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	278
5.13948208783603e-14	-0.296561385253771	0.389	0.509	3.96613832718307e-10	ATP9A	Malignant cells	GSE104987	ENSG00000054793	10079	ATPase phospholipid transporting 9A (putative)	ATPIIA|KIAA0611	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	279
8.89820287621134e-14	-0.301097272523675	0.505	0.622	6.86674315957229e-10	CDV3	Malignant cells	GSE104987	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	280
9.24607593215481e-14	-0.261372196376421	0.344	0.465	7.13519679684387e-10	CECR5	Malignant cells	GSE104987	NA	NA	NA	NA	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	281
9.64614030673224e-14	0.264650130163108	0.674	0.545	7.44392647470527e-10	SEMA3C	Malignant cells	GSE104987	ENSG00000075223	10512	semaphorin 3C	SEMAE|SemE	protein_coding	Q99985	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	282
9.72422131461641e-14	0.255666480422346	0.51	0.382	7.50418158848948e-10	KIF22	Malignant cells	GSE104987	ENSG00000079616	3835	kinesin family member 22	Kid|KNSL4|OBP-1|OBP-2	protein_coding	Q14807	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	283
1.10893431443649e-13	-0.337247594100785	0.999	1	8.5576461045064e-10	TFF1	Malignant cells	GSE104987	ENSG00000160182	7031	trefoil factor 1	BCEI|D21S21|HP1.A|HPS2|pNR-2|pS2	protein_coding	P04155	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	284
1.18680728847403e-13	-0.264630475048789	0.564	0.676	9.1585918451541e-10	SELT	Malignant cells	GSE104987	NA	NA	NA	NA	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	285
1.34695024757925e-13	-0.253436676664738	0.811	0.865	1.03944150605691e-09	ARF1	Malignant cells	GSE104987	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	286
1.58521746799621e-13	-0.660351149162172	0.375	0.489	1.22331232005268e-09	AQP3	Malignant cells	GSE104987	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	287
3.65223125287679e-13	0.385891866624861	0.543	0.409	2.81842685784502e-09	TFF3	Malignant cells	GSE104987	ENSG00000160180	7033	trefoil factor 3	HITF|ITF	protein_coding	Q07654	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	288
5.05452566790181e-13	-0.278657715359116	0.508	0.616	3.90057745791983e-09	CREBZF	Malignant cells	GSE104987	ENSG00000137504	58487	CREB/ATF bZIP transcription factor	ZF	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	289
6.49193621586696e-13	-0.284247436436535	0.858	0.909	5.00982717778453e-09	HSPA5	Malignant cells	GSE104987	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	290
8.8884445115729e-13	-0.295848342969961	0.952	0.961	6.8592126295808e-09	CTSD	Malignant cells	GSE104987	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	291
1.16077995261045e-12	-0.256649605468898	0.674	0.746	8.95773889429483e-09	EIF2S2	Malignant cells	GSE104987	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	292
1.31323282743729e-12	-0.256171766386149	0.413	0.526	1.01342177293335e-08	IDI1	Malignant cells	GSE104987	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	293
1.76597687187222e-12	-0.250146081579654	0.272	0.387	1.36280435202379e-08	SCCPDH	Malignant cells	GSE104987	ENSG00000143653	51097	saccharopine dehydrogenase (putative)	CGI-49|NET11	protein_coding	Q8NBX0	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	294
1.87851945815281e-12	0.265515625088312	0.78	0.704	1.44965346585652e-08	PTP4A1	Malignant cells	GSE104987	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	295
2.04007528928168e-12	-0.262082912910626	0.671	0.753	1.57432610073867e-08	SEPT2	Malignant cells	GSE104987	NA	NA	NA	NA	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	296
2.40679554359422e-12	-0.253131312066098	0.512	0.612	1.85732412099166e-08	KCTD3	Malignant cells	GSE104987	ENSG00000136636	51133	potassium channel tetramerization domain containing 3	NY-REN-45	protein_coding	Q9Y597	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	297
4.16872747534588e-12	-0.250777812293125	0.684	0.757	3.21700699272441e-08	CCT6A	Malignant cells	GSE104987	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	298
1.48022222033897e-11	-0.252162301591368	0.314	0.424	1.14228748743559e-07	NOC2L	Malignant cells	GSE104987	ENSG00000188976	26155	NOC2 like nucleolar associated transcriptional repressor	DKFZP564C186|NET15|NET7|NIR|PPP1R112	protein_coding	Q9Y3T9	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	299
3.80943943617838e-11	-0.272675750964999	0.733	0.802	2.93974441289886e-07	PARD6B	Malignant cells	GSE104987	ENSG00000124171	84612	par-6 family cell polarity regulator beta	PAR-6B	protein_coding	Q9BYG5	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	300
4.68014874043327e-10	-0.270283828147071	0.992	0.985	3.61167078299235e-06	DSCAM-AS1	Malignant cells	GSE104987	ENSG00000235123	100506492	DSCAM antisense RNA 1	M41	NA	NA	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	301
6.93705668329134e-09	-0.335404597213874	0.302	0.386	5.35332664249593e-05	ARMCX3	Malignant cells	GSE104987	ENSG00000102401	51566	armadillo repeat containing X-linked 3	ALEX3|GASP6	protein_coding	Q9UH62	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	302
1.65531637604109e-08	-0.281930686010148	0.341	0.437	0.000127740764739091	AURKA	Malignant cells	GSE104987	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE104987	GSE104987	Breast cancer	ER+ breast cancer	Targeted therapy	NA	KDM5-C70	Homo sapiens	MCF7 cell line	Cell line	resistant 1, sensitive 1	2	2669	Public on Oct 03, 2018	30472020	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA414337	inDrop v3	indrops pipeline	Breast_cancer	Targeted_therapy	303
0	-1.1941288757721	0.565	0.921	0	HES4	Malignant cells	GSE108397	ENSG00000188290	57801	hes family bHLH transcription factor 4	bHLHb42	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	304
0	-0.36607028988448	1	1	0	AURKAIP1	Malignant cells	GSE108397	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	305
0	-0.746022812257717	0.812	0.963	0	ATAD3A	Malignant cells	GSE108397	ENSG00000197785	55210	ATPase family AAA domain containing 3A	FLJ10709	protein_coding	Q9NVI7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	306
0	-0.755895341703535	0.999	1	0	RER1	Malignant cells	GSE108397	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	307
0	-1.21767907264104	0.849	0.983	0	TNFRSF14	Malignant cells	GSE108397	ENSG00000273936	8764	TNF receptor superfamily member 14	ATAR|CD270|HVEA|HVEM|LIGHTR|TR2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	308
0	-0.942866346144278	0.866	0.987	0	KCNAB2	Malignant cells	GSE108397	ENSG00000069424	8514	potassium voltage-gated channel subfamily A regulatory beta subunit 2	AKR6A5|HKvbeta2.1|HKvbeta2.2|KCNA2B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	309
0	-0.569080613350967	1	1	0	ENO1	Malignant cells	GSE108397	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	310
0	0.821736032389734	1	1	0	SRM	Malignant cells	GSE108397	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	311
0	-0.554849847601674	0.998	0.999	0	MAD2L2	Malignant cells	GSE108397	ENSG00000116670	10459	mitotic arrest deficient 2 like 2	FANCV|MAD2B|POLZ2|REV7	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	312
0	0.545656342081989	1	1	0	RPL11	Malignant cells	GSE108397	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	313
0	-0.843450260378948	0.609	0.898	0	RUNX3	Malignant cells	GSE108397	ENSG00000020633	864	RUNX family transcription factor 3	AML2|CBFA3|PEBP2A3	protein_coding	Q13761	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	314
0	-0.445538115137304	1	1	0	YBX1	Malignant cells	GSE108397	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	315
0	-0.881104276911432	0.787	0.964	0	POMGNT1	Malignant cells	GSE108397	ENSG00000085998	55624	protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)	FLJ20277|LGMD2O|MEB|MGAT1.2	protein_coding	Q8WZA1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	316
0	-0.443453697227582	1	1	0	UQCRH	Malignant cells	GSE108397	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	317
0	-0.856107611408127	0.996	1	0	RHOC	Malignant cells	GSE108397	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	318
0	-1.14546786765708	0.909	0.998	0	CSDE1	Malignant cells	GSE108397	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	319
0	-0.920015856951337	0.32	0.719	0	VANGL1	Malignant cells	GSE108397	ENSG00000173218	81839	VANGL planar cell polarity protein 1	STB2	protein_coding	Q8TAA9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	320
0	-1.11728806052122	0.964	0.999	0	ATP1A1	Malignant cells	GSE108397	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	321
0	-0.668495701387342	0.968	0.999	0	APH1A	Malignant cells	GSE108397	ENSG00000117362	51107	aph-1 homolog A, gamma-secretase subunit	APH-1A|CGI-78	protein_coding	Q96BI3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	322
0	-0.786319566512157	0.957	0.998	0	ENSA	Malignant cells	GSE108397	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	323
0	-0.91744495227033	0.64	0.931	0	CERS2	Malignant cells	GSE108397	ENSG00000143418	29956	ceramide synthase 2	FLJ10243|LASS2|SP260	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	324
0	-0.77296794954177	0.999	1	0	S100A10	Malignant cells	GSE108397	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	325
0	-0.805193126718202	0.999	1	0	S100A11	Malignant cells	GSE108397	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	326
0	0.881304306758408	1	0.999	0	S100A6	Malignant cells	GSE108397	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	327
0	-0.850681605138512	0.988	1	0	S100A13	Malignant cells	GSE108397	ENSG00000189171	6284	S100 calcium binding protein A13	NA	protein_coding	Q99584	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	328
0	-2.52826267120829	0.553	0.997	0	S100A1	Malignant cells	GSE108397	ENSG00000160678	6271	S100 calcium binding protein A1	S100-alpha|S100A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	329
0	-0.937629898401374	0.608	0.929	0	SLC27A3	Malignant cells	GSE108397	ENSG00000263163	11000	solute carrier family 27 member 3	ACSVL3|FATP3|MGC4365	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	330
0	-0.696773473902525	0.999	1	0	JTB	Malignant cells	GSE108397	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	331
0	-0.730487839447646	1	1	0	RPS27	Malignant cells	GSE108397	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	332
0	-0.793020371734783	0.994	1	0	TPM3	Malignant cells	GSE108397	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	333
0	-0.508611925858463	0.999	1	0	C1orf43	Malignant cells	GSE108397	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	334
0	-0.74838115450864	0.986	0.999	0	HAX1	Malignant cells	GSE108397	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	335
0	-0.763044305954513	0.835	0.973	0	PMVK	Malignant cells	GSE108397	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	336
0	-0.90772082158268	0.701	0.941	0	SHC1	Malignant cells	GSE108397	ENSG00000160691	6464	SHC adaptor protein 1	p66|SHC|ShcA	protein_coding	P29353	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	337
0	-0.850080173043269	0.692	0.936	0	SCAMP3	Malignant cells	GSE108397	ENSG00000263290	10067	secretory carrier membrane protein 3	C1orf3	protein_coding	O14828	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	338
0	-0.772748992830742	0.953	0.997	0	GPATCH4	Malignant cells	GSE108397	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	339
0	-0.82624458217619	0.885	0.989	0	HDGF	Malignant cells	GSE108397	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	340
0	-0.751039181198039	0.828	0.976	0	PEA15	Malignant cells	GSE108397	ENSG00000162734	8682	proliferation and apoptosis adaptor protein 15	HMAT1|HUMMAT1H|MAT1|MAT1H|PEA-15|PED|PED-PEA15|PED/PEA15	protein_coding	Q15121	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	341
0	1.50034636020196	0.694	0.112	0	MPZ	Malignant cells	GSE108397	ENSG00000158887	4359	myelin protein zero	CMT1|CMT1B|CMT2I|CMT2J|HMSNIB|P0	protein_coding	P25189	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	342
0	0.706670166398443	0.988	0.925	0	SDHC	Malignant cells	GSE108397	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	343
0	0.563711681394193	1	1	0	RPS7	Malignant cells	GSE108397	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	344
0	-1.72003916967082	0.909	0.999	0	HPCAL1	Malignant cells	GSE108397	ENSG00000115756	3241	hippocalcin like 1	BDR1|HLP2|VILIP-3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	345
0	-0.695591249425785	0.993	1	0	PPM1G	Malignant cells	GSE108397	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	346
0	-1.27675514947133	0.893	0.988	0	RHOQ	Malignant cells	GSE108397	ENSG00000119729	23433	ras homolog family member Q	ARHQ|RASL7A|TC10	protein_coding	P17081	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	347
0	-1.14115274437488	0.512	0.926	0	AC104135.3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	348
0	-2.45987234455214	0.665	0.999	0	CAPG	Malignant cells	GSE108397	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	349
0	-0.592917546847525	0.992	0.999	0	EIF5B	Malignant cells	GSE108397	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	350
0	-1.28116229789065	0.441	0.836	0	AC104655.3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	351
0	-0.750082158770126	0.865	0.981	0	UXS1	Malignant cells	GSE108397	ENSG00000115652	80146	UDP-glucuronate decarboxylase 1	FLJ23591|SDR6E1|UGD	protein_coding	Q8NBZ7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	352
0	-0.934086101342521	0.02	0.541	0	TEX41	Malignant cells	GSE108397	ENSG00000226674	401014	testis expressed 41	DKFZp686O1327|LINC00953	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	353
0	3.0289360019264	0.874	0.17	0	IGFBP5	Malignant cells	GSE108397	ENSG00000115461	3488	insulin like growth factor binding protein 5	NA	protein_coding	P24593	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	354
0	-0.492444819775208	1	1	0	ARPC2	Malignant cells	GSE108397	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	355
0	-1.58214850770076	0.431	0.95	0	RAMP1	Malignant cells	GSE108397	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	356
0	3.54617298067423	0.998	0.196	0	PPARG	Malignant cells	GSE108397	ENSG00000132170	5468	peroxisome proliferator activated receptor gamma	NR1C3|PPARG1|PPARG2|PPARgamma	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	357
0	0.398480461475528	1	1	0	RPL15	Malignant cells	GSE108397	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	358
0	-0.896337419949044	0.88	0.986	0	GOLGA4	Malignant cells	GSE108397	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	359
0	0.780838711069415	0.497	0.008	0	KRBOX1.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	360
0	-0.690539497848393	0.973	0.998	0	UQCRC1	Malignant cells	GSE108397	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	361
0	-0.837810882351478	0.599	0.891	0	PRKAR2A	Malignant cells	GSE108397	ENSG00000114302	5576	protein kinase cAMP-dependent type II regulatory subunit alpha	PRKAR2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	362
0	1.02942209138211	0.968	0.78	0	IMPDH2	Malignant cells	GSE108397	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	363
0	-0.981383893483107	0.848	0.989	0	GNAI2	Malignant cells	GSE108397	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	364
0	-0.797741911926906	0.934	0.988	0	SMIM4	Malignant cells	GSE108397	ENSG00000168273	440957	small integral membrane protein 4	C3orf78	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	365
0	-0.652531767709819	0.986	0.997	0	TKT	Malignant cells	GSE108397	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	366
0	-0.973405888167967	0.796	0.981	0	FRMD4B	Malignant cells	GSE108397	ENSG00000114541	23150	FERM domain containing 4B	GRSP1|KIAA1013	protein_coding	Q9Y2L6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	367
0	-1.43113534661864	0.814	0.993	0	DCBLD2	Malignant cells	GSE108397	ENSG00000057019	131566	discoidin, CUB and LCCL domain containing 2	CLCP1|ESDN	protein_coding	Q96PD2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	368
0	0.887456175751338	0.999	0.99	0	FAM162A	Malignant cells	GSE108397	ENSG00000114023	26355	family with sequence similarity 162 member A	C3orf28|E2IG5	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	369
0	-1.33082819947653	0.065	0.734	0	MME	Malignant cells	GSE108397	ENSG00000196549	4311	membrane metalloendopeptidase	CALLA|CD10|NEP	protein_coding	P08473	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	370
0	-0.674041717725002	0.991	0.999	0	AP2M1	Malignant cells	GSE108397	ENSG00000161203	1173	adaptor related protein complex 2 subunit mu 1	AP50|CLAPM1|mu2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	371
0	1.24396864736047	0.801	0.266	0	APOD	Malignant cells	GSE108397	ENSG00000189058	347	apolipoprotein D	Apo-D	protein_coding	P05090	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	372
0	0.664790532413113	1	0.996	0	ATP5I	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	373
0	1.03318535511426	0.973	0.792	0	LRPAP1	Malignant cells	GSE108397	ENSG00000163956	4043	LDL receptor related protein associated protein 1	A2MRAP|HBP44|RAP	protein_coding	P30533	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	374
0	0.758802978009407	0.982	0.858	0	MRFAP1	Malignant cells	GSE108397	ENSG00000179010	93621	Morf4 family associated protein 1	PAM14|PGR1	protein_coding	Q9Y605	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	375
0	0.957051900585141	0.924	0.638	0	GRPEL1	Malignant cells	GSE108397	ENSG00000109519	80273	GrpE like 1, mitochondrial	FLJ25609|GrpE|hMGE	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	376
0	1.83970642451976	0.521	0.02	0	LINC00504	Malignant cells	GSE108397	ENSG00000248360	201853	long intergenic non-protein coding RNA 504	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	377
0	0.754487809687215	0.989	0.931	0	QDPR	Malignant cells	GSE108397	ENSG00000151552	5860	quinoid dihydropteridine reductase	DHPR|PKU2|SDR33C1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	378
0	-0.567143436095519	1	1	0	CCNI	Malignant cells	GSE108397	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	379
0	-0.592818829657292	1	1	0	H2AFZ	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	380
0	-1.0945081423847	0.31	0.761	0	USP53	Malignant cells	GSE108397	ENSG00000145390	54532	ubiquitin specific peptidase 53	KIAA1350	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	381
0	-1.6072477846497	0.433	0.888	0	SLC7A11	Malignant cells	GSE108397	ENSG00000151012	23657	solute carrier family 7 member 11	xCT	protein_coding	Q9UPY5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	382
0	0.806482290727147	1	1	0	RPS3A	Malignant cells	GSE108397	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	383
0	0.932548217259322	0.876	0.552	0	TRIM2	Malignant cells	GSE108397	ENSG00000109654	23321	tripartite motif containing 2	CMT2R|KIAA0517|RNF86	protein_coding	Q9C040	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	384
0	-0.850911096600702	0.026	0.536	0	RNF175	Malignant cells	GSE108397	ENSG00000145428	285533	ring finger protein 175	FLJ34190	protein_coding	Q8N4F7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	385
0	1.3655120855378	0.847	0.483	0	SNHG18	Malignant cells	GSE108397	ENSG00000250786	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	386
0	2.11420017318339	0.999	0.984	0	CCT5	Malignant cells	GSE108397	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	387
0	0.833943000815246	1	1	0	SUB1	Malignant cells	GSE108397	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	388
0	0.86943733226278	0.961	0.805	0	BRIX1	Malignant cells	GSE108397	ENSG00000113460	55299	biogenesis of ribosomes BRX1	BRIX|BXDC2|FLJ11100	protein_coding	Q8TDN6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	389
0	0.746891608273233	1	1	0	RPL37	Malignant cells	GSE108397	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	390
0	0.766312025352058	0.998	0.984	0	PAIP1	Malignant cells	GSE108397	ENSG00000172239	10605	poly(A) binding protein interacting protein 1	NA	protein_coding	Q9H074	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	391
0	0.844740076566366	0.974	0.881	0	NDUFS4	Malignant cells	GSE108397	ENSG00000164258	4724	NADH:ubiquinone oxidoreductase subunit S4	AQDQ|CI-18	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	392
0	0.921422420771	1	1	0	BTF3	Malignant cells	GSE108397	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	393
0	0.715498192885231	1	1	0	RPS23	Malignant cells	GSE108397	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	394
0	-1.47358366376478	0.734	0.981	0	GLRX	Malignant cells	GSE108397	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	395
0	-0.492672418870917	1	1	0	UQCRQ	Malignant cells	GSE108397	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	396
0	-0.69957531360377	0.998	1	0	VDAC1	Malignant cells	GSE108397	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	397
0	-0.528247539091961	1	1	0	ATOX1	Malignant cells	GSE108397	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	398
0	-1.01238636614353	0.908	0.995	0	G3BP1	Malignant cells	GSE108397	ENSG00000145907	10146	G3BP stress granule assembly factor 1	G3BP|HDH-VIII	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	399
0	-0.56537545884966	1	1	0	ATP6V0E1	Malignant cells	GSE108397	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	400
0	-0.932112536353987	0.986	1	0	CLTB	Malignant cells	GSE108397	ENSG00000175416	1212	clathrin light chain B	Lcb	protein_coding	P09497	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	401
0	-0.827626207040511	0.878	0.983	0	F12	Malignant cells	GSE108397	ENSG00000131187	2161	coagulation factor XII	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	402
0	-0.761701515129619	0.961	0.993	0	PRR7	Malignant cells	GSE108397	ENSG00000131188	80758	proline rich 7, synaptic	MGC10772	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	403
0	-0.791328377755609	1	1	0	SQSTM1	Malignant cells	GSE108397	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	404
0	-0.794683696137428	0.864	0.975	0	NQO2	Malignant cells	GSE108397	ENSG00000124588	4835	N-ribosyldihydronicotinamide:quinone reductase 2	DHQV|DIA6|NMOR2|QR2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	405
0	0.623855610258173	1	1	0	HDDC2	Malignant cells	GSE108397	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	406
0	0.311908243043524	1	1	0	RPS12	Malignant cells	GSE108397	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	407
0	0.819592177569215	0.999	0.994	0	PSMB1	Malignant cells	GSE108397	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	408
0	-0.639763987571571	0.984	0.999	0	KDELR2	Malignant cells	GSE108397	ENSG00000136240	11014	KDEL endoplasmic reticulum protein retention receptor 2	ELP-1|ERD2.2	protein_coding	P33947	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	409
0	-0.441679845869854	1	1	0	TOMM7	Malignant cells	GSE108397	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	410
0	-1.09952452631563	0.503	0.89	0	STK17A	Malignant cells	GSE108397	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	411
0	0.819035167989097	1	1	0	PPIA	Malignant cells	GSE108397	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	412
0	-0.995270749737825	0.657	0.919	0	TPST1	Malignant cells	GSE108397	ENSG00000169902	8460	tyrosylprotein sulfotransferase 1	TANGO13A	protein_coding	O60507	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	413
0	-0.746010150487883	0.895	0.988	0	SBDS	Malignant cells	GSE108397	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	414
0	-0.862364229693493	0.915	0.994	0	BCL7B	Malignant cells	GSE108397	ENSG00000106635	9275	BAF chromatin remodeling complex subunit BCL7B	SMARCJ2	protein_coding	Q9BQE9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	415
0	-0.91855107449386	0.642	0.915	0	LIMK1	Malignant cells	GSE108397	ENSG00000106683	3984	LIM domain kinase 1	LIMK	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	416
0	-1.11906194756052	0.316	0.729	0	GNG11	Malignant cells	GSE108397	ENSG00000127920	2791	G protein subunit gamma 11	GNGT11	protein_coding	P61952	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	417
0	-0.457221680948559	1	1	0	SHFM1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	418
0	-0.570818826657448	1	1	0	ARPC1B	Malignant cells	GSE108397	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	419
0	-0.809270168002611	0.675	0.916	0	CPSF4	Malignant cells	GSE108397	ENSG00000160917	10898	cleavage and polyadenylation specific factor 4	CPSF30|NAR	protein_coding	O95639	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	420
0	-0.551157229274421	0.998	1	0	GNB2	Malignant cells	GSE108397	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	421
0	0.857894224659903	0.652	0.166	0	TRIP6	Malignant cells	GSE108397	ENSG00000087077	7205	thyroid hormone receptor interactor 6	MGC10556|MGC10558|MGC29959|MGC3837|MGC4423|OIP1|ZRP-1	protein_coding	Q15654	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	422
0	-1.66781076206514	0.969	0.999	0	VGF	Malignant cells	GSE108397	ENSG00000128564	7425	VGF nerve growth factor inducible	SCG7|SgVII	protein_coding	O15240	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	423
0	-0.764577784341046	0.931	0.996	0	DNAJC2	Malignant cells	GSE108397	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	424
0	0.91415195761159	0.928	0.739	0	IMMP2L	Malignant cells	GSE108397	ENSG00000184903	83943	inner mitochondrial membrane peptidase subunit 2	IMMP2L-IT1|IMP2	protein_coding	Q96T52	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	425
0	-1.10402211798441	0.498	0.89	0	TES	Malignant cells	GSE108397	ENSG00000135269	26136	testin LIM domain protein	DKFZP586B2022|TESS-2|TESTIN	protein_coding	Q9UGI8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	426
0	-0.606117502529439	0.997	1	0	CALU	Malignant cells	GSE108397	ENSG00000128595	813	calumenin	NA	protein_coding	O43852	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	427
0	-0.636637019267178	0.997	1	0	CHCHD3	Malignant cells	GSE108397	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	428
0	-0.431528223446975	1	1	0	NDUFB2	Malignant cells	GSE108397	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	429
0	1.36410871984159	1	1	0	TMSB4X	Malignant cells	GSE108397	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	430
0	0.834442857822129	1	1	0	RPS4X	Malignant cells	GSE108397	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	431
0	1.17153463027419	0.856	0.56	0	PLP1	Malignant cells	GSE108397	ENSG00000123560	5354	proteolipid protein 1	GPM6C|PLP|SPG2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	432
0	-0.629044421611563	0.999	1	0	RPL39	Malignant cells	GSE108397	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	433
0	-0.727508998289254	0.94	0.992	0	NDUFA1	Malignant cells	GSE108397	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	434
0	1.42745537631064	0.815	0.226	0	CSAG1	Malignant cells	GSE108397	ENSG00000198930	158511	chondrosarcoma associated gene 1	CSAGE|CT24.1	protein_coding	Q6PB30	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	435
0	1.45106282697141	0.82	0.044	0	MAGEA3	Malignant cells	GSE108397	ENSG00000221867	4102	MAGE family member A3	CT1.3|HIP8|HYPD|MAGE3|MGC14613	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	436
0	0.785523549798398	1	1	0	RPL10	Malignant cells	GSE108397	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	437
0	0.930604445935613	0.82	0.335	0	RP11-11N9.4	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	438
0	-0.529540300566542	1	1	0	RPS20	Malignant cells	GSE108397	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	439
0	1.17327056333169	0.999	0.986	0	SDCBP	Malignant cells	GSE108397	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	440
0	1.16362661761519	1	1	0	RPL7	Malignant cells	GSE108397	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	441
0	0.69759467069809	1	1	0	FABP5	Malignant cells	GSE108397	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	442
0	-1.33729900520971	0.326	0.838	0	ATP6V0D2	Malignant cells	GSE108397	ENSG00000147614	245972	ATPase H+ transporting V0 subunit d2	ATP6D2|FLJ38708|VMA6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	443
0	1.000476722543	0.977	0.85	0	DCAF13	Malignant cells	GSE108397	ENSG00000164934	25879	DDB1 and CUL4 associated factor 13	DKFZP564O0463|Gm83|HSPC064|Sof1|WDSOF1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	444
0	1.358703632253	1	0.999	0	EIF3E	Malignant cells	GSE108397	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	445
0	0.992379035764795	1	1	0	EIF3H	Malignant cells	GSE108397	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	446
0	-0.857069306872318	0.926	0.995	0	FBXO32	Malignant cells	GSE108397	ENSG00000156804	114907	F-box protein 32	ATROGIN1|Fbx32|MAFbx	protein_coding	Q969P5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	447
0	0.629647149946648	1	1	0	RPL8	Malignant cells	GSE108397	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	448
0	1.31615536225727	1	0.999	0	RPS6	Malignant cells	GSE108397	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	449
0	1.0783463034729	0.999	0.995	0	CDKN2A	Malignant cells	GSE108397	ENSG00000147889	1029	cyclin dependent kinase inhibitor 2A	ARF|CDK4I|CDKN2|CMM2|INK4|INK4a|MLM|MTS1|p14|p14ARF|p16|P16-INK4A|p16INK4a|p19|p19Arf	protein_coding	P42771	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	450
0	0.653040628434876	1	1	0	RPL7A	Malignant cells	GSE108397	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	451
0	-2.07399412491577	0.376	0.851	0	OLFM1	Malignant cells	GSE108397	ENSG00000130558	10439	olfactomedin 1	AMY|NOE1|NOELIN|OlfA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	452
0	0.884675292166069	0.999	0.996	0	ATP5C1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	453
0	-0.688873498037086	0.988	1	0	KIF5B	Malignant cells	GSE108397	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	454
0	0.900238909429506	0.472	0.057	0	KCNMA1	Malignant cells	GSE108397	ENSG00000156113	3778	potassium calcium-activated channel subfamily M alpha 1	KCa1.1|mSLO1|SLO	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	455
0	-1.85634923108365	0.976	1	0	CTSD	Malignant cells	GSE108397	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	456
0	0.654520045505202	1	0.993	0	EIF3F	Malignant cells	GSE108397	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	457
0	-0.875226648514432	0.249	0.685	0	NRIP3	Malignant cells	GSE108397	ENSG00000175352	56675	nuclear receptor interacting protein 3	C11orf14	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	458
0	0.44855074007593	1	1	0	RPS13	Malignant cells	GSE108397	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	459
0	-1.35869992443319	0.017	0.676	0	MDK	Malignant cells	GSE108397	ENSG00000110492	4192	midkine	FLJ27379|MK|NEGF2	protein_coding	P21741	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	460
0	0.914276237874315	0.999	0.991	0	NDUFS3	Malignant cells	GSE108397	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	461
0	-0.636384700947053	0.98	1	0	SSRP1	Malignant cells	GSE108397	ENSG00000149136	6749	structure specific recognition protein 1	FACT80	protein_coding	Q08945	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	462
0	-1.05605769598191	0.483	0.877	0	LPXN	Malignant cells	GSE108397	ENSG00000110031	9404	leupaxin	LDPL	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	463
0	1.21184410802332	1	1	0	FTH1	Malignant cells	GSE108397	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	464
0	-0.979177678387635	0.627	0.964	0	PLA2G16	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	465
0	-0.452250290119287	1	1	0	COX8A	Malignant cells	GSE108397	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	466
0	-1.00186288728293	0.997	0.999	0	NEAT1	Malignant cells	GSE108397	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	467
0	-1.2254979204834	0.432	0.865	0	FOSL1	Malignant cells	GSE108397	ENSG00000175592	8061	FOS like 1, AP-1 transcription factor subunit	fra-1	protein_coding	P15407	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	468
0	0.818455748933074	1	1	0	GSTP1	Malignant cells	GSE108397	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	469
0	-1.42721771510836	0.21	0.733	0	MYEOV	Malignant cells	GSE108397	ENSG00000172927	26579	myeloma overexpressed	OCIM	protein_coding	Q96EZ4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	470
0	-2.04514172035942	0.924	1	0	CCND1	Malignant cells	GSE108397	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	471
0	1.11599742497015	0.978	0.899	0	RP11-660L16.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	472
0	0.785553957583286	1	1	0	RPS3	Malignant cells	GSE108397	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	473
0	-0.593915137810582	1	1	0	NDUFC2	Malignant cells	GSE108397	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	474
0	-1.18543156614396	0.904	0.997	0	OAF	Malignant cells	GSE108397	ENSG00000184232	220323	out at first homolog	MGC52117	protein_coding	Q86UD1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	475
0	-0.814896051256361	0.998	0.999	0	ST3GAL4	Malignant cells	GSE108397	ENSG00000110080	6484	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	CGS23|FLJ11867|NANTA3|SAT3|SIAT4|SIAT4C|STZ	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	476
0	-1.01741181939383	1	1	0	GAPDH	Malignant cells	GSE108397	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	477
0	-0.798984733206253	0.998	1	0	PTMS	Malignant cells	GSE108397	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	478
0	-1.02857405551696	0.663	0.926	0	ENO2	Malignant cells	GSE108397	ENSG00000111674	2026	enolase 2	NSE	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	479
0	-0.946827933465751	0.071	0.523	0	MGST1	Malignant cells	GSE108397	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	480
0	-0.819147324653806	0.838	0.972	0	PPFIBP1	Malignant cells	GSE108397	ENSG00000110841	8496	PPFIA binding protein 1	hSGT2|hSgt2p|L2|SGT2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	481
0	-0.864188660657369	0.769	0.949	0	KRT18	Malignant cells	GSE108397	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	482
0	0.880390931703104	0.96	0.747	0	COPZ1	Malignant cells	GSE108397	ENSG00000111481	22818	COPI coat complex subunit zeta 1	CGI-120|COPZ	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	483
0	-0.636948857503371	0.996	1	0	PA2G4	Malignant cells	GSE108397	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	484
0	-0.357140993823411	1	1	0	RPL41	Malignant cells	GSE108397	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	485
0	0.570720325691479	1	1	0	SLC25A3	Malignant cells	GSE108397	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	486
0	-1.00204610176605	0.864	0.982	0	TXNRD1	Malignant cells	GSE108397	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	487
0	-0.335825385599538	1	1	0	RPLP0	Malignant cells	GSE108397	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	488
0	1.02521077901427	1	0.997	0	SAP18	Malignant cells	GSE108397	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	489
0	0.802546938174186	1	0.999	0	MRP63	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	490
0	0.593657548205447	1	1	0	RPL21	Malignant cells	GSE108397	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	491
0	0.783701963485639	1	1	0	GTF3A	Malignant cells	GSE108397	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	492
0	0.688880162362655	1	1	0	POMP	Malignant cells	GSE108397	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	493
0	1.10961766880756	0.984	0.85	0	EXOSC8	Malignant cells	GSE108397	ENSG00000120699	11340	exosome component 8	bA421P11.3|CIP3|EAP2|OIP2|p9|RRP43|Rrp43p	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	494
0	1.09486567689997	0.989	0.936	0	TSC22D1	Malignant cells	GSE108397	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	495
0	0.740151652463949	1	1	0	TPT1	Malignant cells	GSE108397	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	496
0	0.685533369666529	0.991	0.939	0	EBPL	Malignant cells	GSE108397	ENSG00000123179	84650	EBP like	EBRP	protein_coding	Q9BY08	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	497
0	0.777835156548795	0.988	0.938	0	UCHL3	Malignant cells	GSE108397	ENSG00000118939	7347	ubiquitin C-terminal hydrolase L3	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	498
0	3.33430195158731	0.965	0.579	0	DCT	Malignant cells	GSE108397	ENSG00000080166	1638	dopachrome tautomerase	TRP-2|TRP2|TYRP2	protein_coding	P40126	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	499
0	0.91705110420065	0.947	0.743	0	OXA1L	Malignant cells	GSE108397	ENSG00000155463	5018	OXA1L mitochondrial inner membrane protein	MGC133129|OXA1|OXA1L1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	500
0	1.17001873480963	1	0.998	0	PSMB5	Malignant cells	GSE108397	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	501
0	0.942121502745472	0.514	0.012	0	CMTM5	Malignant cells	GSE108397	ENSG00000166091	116173	CKLF like MARVEL transmembrane domain containing 5	CKLFSF5|FLJ37521	protein_coding	Q96DZ9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	502
0	1.10357883066609	0.544	0.015	0	DHRS2	Malignant cells	GSE108397	ENSG00000100867	10202	dehydrogenase/reductase 2	HEP27|SDR25C1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	503
0	0.671635135271684	1	1	0	C14orf166	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	504
0	0.89692090389826	0.993	0.915	0	CNIH1	Malignant cells	GSE108397	ENSG00000100528	10175	cornichon family AMPA receptor auxiliary protein 1	CNIH|CNIL|TGAM77	protein_coding	O95406	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	505
0	0.803292566494193	0.993	0.917	0	PSMA3	Malignant cells	GSE108397	ENSG00000100567	5684	proteasome 20S subunit alpha 3	HC8	protein_coding	P25788	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	506
0	0.596320911131805	1	1	0	ERH	Malignant cells	GSE108397	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	507
0	0.7905376636671	0.988	0.895	0	TMED10	Malignant cells	GSE108397	ENSG00000170348	10972	transmembrane p24 trafficking protein 10	p23|P24(DELTA)|p24d1|p24delta1|TMP21	protein_coding	P49755	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	508
0	0.486829836619699	1	1	0	SRP14	Malignant cells	GSE108397	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	509
0	1.13786696107462	0.999	0.985	0	EID1	Malignant cells	GSE108397	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	510
0	0.831043676557554	0.994	0.992	0	KIAA0101	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	511
0	0.859476353589853	1	1	0	RPL4	Malignant cells	GSE108397	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	512
0	0.704742022650549	1	1	0	SEC11A	Malignant cells	GSE108397	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	513
0	0.944411257954305	0.996	0.974	0	METRN	Malignant cells	GSE108397	ENSG00000103260	79006	meteorin, glial cell differentiation regulator	C16orf23|MGC2601	protein_coding	Q9UJH8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	514
0	-1.69491428490092	0.828	0.998	0	TNFRSF12A	Malignant cells	GSE108397	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	515
0	0.681202500408763	0.998	0.992	0	RSL1D1	Malignant cells	GSE108397	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	516
0	-1.08373013611064	0.336	0.741	0	LAT	Malignant cells	GSE108397	ENSG00000213658	27040	linker for activation of T cells	LAT1	protein_coding	O43561	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	517
0	-0.583060590398047	1	1	0	ALDOA	Malignant cells	GSE108397	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	518
0	-1.10602669488541	1	1	0	MT2A	Malignant cells	GSE108397	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	519
0	1.19219079591217	0.697	0.112	0	HCCAT5	Malignant cells	GSE108397	ENSG00000260880	283902	hepatocellular carcinoma associated transcript 5	FJ222407|HTA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	520
0	0.551471527792743	1	1	0	COX4I1	Malignant cells	GSE108397	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	521
0	0.736060867046999	1	0.999	0	APRT	Malignant cells	GSE108397	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	522
0	0.865121932914325	1	0.996	0	TRAPPC2L	Malignant cells	GSE108397	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	523
0	0.402288847561657	1	1	0	RPL13	Malignant cells	GSE108397	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	524
0	0.558250767934067	1	1	0	EMC6	Malignant cells	GSE108397	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	525
0	0.699188368677935	1	1	0	ITGAE	Malignant cells	GSE108397	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	526
0	0.668388764367028	1	0.997	0	PSMB6	Malignant cells	GSE108397	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	527
0	0.653855283040304	1	1	0	C1QBP	Malignant cells	GSE108397	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	528
0	0.650647896788772	1	0.999	0	ELP5	Malignant cells	GSE108397	ENSG00000288485	23587	elongator acetyltransferase complex subunit 5	C17orf81|DERP6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	529
0	1.18322493141415	1	1	0	EIF4A1	Malignant cells	GSE108397	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	530
0	-0.575800054880932	0.998	0.999	0	LSMD1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	531
0	0.445239242671676	1	1	0	RPL26	Malignant cells	GSE108397	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	532
0	0.834055616170937	0.998	0.984	0	TMEM11	Malignant cells	GSE108397	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	533
0	-0.597932545735701	0.994	1	0	KRT10	Malignant cells	GSE108397	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	534
0	-0.718513645116869	0.954	0.996	0	RAB5C	Malignant cells	GSE108397	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	535
0	-0.808997973738544	0.826	0.97	0	NMT1	Malignant cells	GSE108397	ENSG00000136448	4836	N-myristoyltransferase 1	NMT	protein_coding	P30419	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	536
0	-1.03515996344626	0.994	1	0	LRRC59	Malignant cells	GSE108397	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	537
0	-2.61869877363356	0.286	0.984	0	BCAS3	Malignant cells	GSE108397	ENSG00000141376	54828	BCAS3 microtubule associated cell migration factor	FLJ20128|PHAF2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	538
0	0.852845446414923	0.962	0.787	0	LIMD2	Malignant cells	GSE108397	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	539
0	-0.988927306278607	0.261	0.724	0	ARSG	Malignant cells	GSE108397	ENSG00000141337	22901	arylsulfatase G	KIAA1001	protein_coding	Q96EG1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	540
0	-1.52175557173596	0.855	0.998	0	WIPI1	Malignant cells	GSE108397	ENSG00000070540	55062	WD repeat domain, phosphoinositide interacting 1	ATG18|ATG18A|FLJ10055|WIPI49	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	541
0	-1.33726348056966	0.098	0.658	0	UNC13D	Malignant cells	GSE108397	ENSG00000092929	201294	unc-13 homolog D	Munc13-4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	542
0	-1.16062013408644	0.713	0.936	0	PRPSAP1	Malignant cells	GSE108397	ENSG00000161542	5635	phosphoribosyl pyrophosphate synthetase associated protein 1	PAP39	protein_coding	Q14558	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	543
0	-1.28669189801459	0.833	0.992	0	SPHK1	Malignant cells	GSE108397	ENSG00000176170	8877	sphingosine kinase 1	SPHK	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	544
0	-1.07066164281227	0.988	1	0	SEPT9	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	545
0	-0.505834800756856	1	1	0	P4HB	Malignant cells	GSE108397	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	546
0	-0.97847580534355	0.929	0.998	0	SLC16A3	Malignant cells	GSE108397	ENSG00000141526	9123	solute carrier family 16 member 3	MCT3|MCT4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	547
0	-0.746064749054078	0.948	0.998	0	WDR45B	Malignant cells	GSE108397	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	548
0	1.09105672876887	1	0.995	0	NDUFV2	Malignant cells	GSE108397	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	549
0	-1.0417821954532	0.522	0.901	0	HSBP1L1	Malignant cells	GSE108397	ENSG00000226742	440498	heat shock factor binding protein 1 like 1	FLJ10967|MGC189743	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	550
0	-0.490854012907573	1	1	0	FKBP1A	Malignant cells	GSE108397	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	551
0	0.537035563847108	1	1	0	TMEM230	Malignant cells	GSE108397	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	552
0	0.871453027469768	0.659	0.188	0	C20orf112	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	553
0	-0.574882567427022	1	1	0	RALY	Malignant cells	GSE108397	ENSG00000125970	22913	RALY heterogeneous nuclear ribonucleoprotein	HNRPCL2|P542	protein_coding	Q9UKM9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	554
0	-0.716232961195521	0.06	0.485	0	PLTP	Malignant cells	GSE108397	ENSG00000100979	5360	phospholipid transfer protein	BPIFE	protein_coding	P55058	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	555
0	1.12586534804633	0.994	0.903	0	DPM1	Malignant cells	GSE108397	ENSG00000000419	8813	dolichyl-phosphate mannosyltransferase subunit 1, catalytic	CDGIE|MPDS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	556
0	-1.00897242128646	0	0.592	0	SLC17A9	Malignant cells	GSE108397	ENSG00000101194	63910	solute carrier family 17 member 9	C20orf59|FLJ23412|VNUT	protein_coding	Q9BYT1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	557
0	-1.03684743680785	0.992	0.996	0	BIRC7	Malignant cells	GSE108397	ENSG00000101197	79444	baculoviral IAP repeat containing 7	KIAP|ML-IAP|mliap|RNF50	protein_coding	Q96CA5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	558
0	0.37286189944786	1	1	0	RPS15	Malignant cells	GSE108397	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	559
0	-0.435868311428953	1	1	0	OAZ1	Malignant cells	GSE108397	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	560
0	-0.946771387068361	0.497	0.877	0	NFIC	Malignant cells	GSE108397	ENSG00000141905	4782	nuclear factor I C	CTF|CTF5|NF-I|NFI	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	561
0	-1.56036277325773	0.995	1	0	MFSD12	Malignant cells	GSE108397	ENSG00000161091	126321	major facilitator superfamily domain containing 12	C19orf28|MGC20700|PP3501	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	562
0	-1.38149259662229	0.981	1	0	HMG20B	Malignant cells	GSE108397	ENSG00000064961	10362	high mobility group 20B	BRAF25|BRAF35|HMGX2|HMGXB2|SMARCE1r|SOXL	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	563
0	-0.567933342973001	0.999	1	0	NDUFB7	Malignant cells	GSE108397	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	564
0	0.604435527801125	1	1	0	UQCRFS1	Malignant cells	GSE108397	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	565
0	1.31218371315218	0.997	0.921	0	FXYD3	Malignant cells	GSE108397	ENSG00000089356	5349	FXYD domain containing ion transport regulator 3	MAT-8|PLML	protein_coding	Q14802	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	566
0	-1.62875072490233	0.969	1	0	FXYD5	Malignant cells	GSE108397	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	567
0	-0.605930828694788	0.997	1	0	TOMM40	Malignant cells	GSE108397	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	568
0	1.62428992358167	0.976	0.701	0	APOE	Malignant cells	GSE108397	ENSG00000130203	348	apolipoprotein E	AD2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	569
0	1.81280490742223	0.975	0.715	0	APOC1	Malignant cells	GSE108397	ENSG00000130208	341	apolipoprotein C1	NA	protein_coding	P02654	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	570
0	0.534288918324903	1	1	0	RPL13A	Malignant cells	GSE108397	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	571
0	0.479405969693292	1	1	0	RPS9	Malignant cells	GSE108397	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	572
0	-0.855385908100231	0.767	0.959	0	TNNT1	Malignant cells	GSE108397	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	573
0	-0.826983530783818	1	1	0	UBE2S	Malignant cells	GSE108397	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	574
0	0.636661971054013	1	1	0	RPS5	Malignant cells	GSE108397	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	575
0	-0.835277832653727	0.973	1	0	SMARCB1	Malignant cells	GSE108397	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	576
0	-0.868278334255182	0.767	0.959	0	GAS2L1	Malignant cells	GSE108397	ENSG00000185340	10634	growth arrest specific 2 like 1	GAR22	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	577
0	-1.42990490800106	0.011	0.692	0	RAC2	Malignant cells	GSE108397	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	578
0	-1.24440946829463	0.328	0.851	0	SH3BP1	Malignant cells	GSE108397	ENSG00000100092	23616	SH3 domain binding protein 1	ARHGAP43	protein_coding	Q9Y3L3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	579
0	-1.23677906715671	0.409	0.805	0	H1F0	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	580
0	0.883551728407145	1	0.998	0	EIF3L	Malignant cells	GSE108397	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	581
0	0.692398159909979	1	1	0	RPL3	Malignant cells	GSE108397	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	582
0	0.626562340504937	1	1	0	RBX1	Malignant cells	GSE108397	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	583
0	-0.58019372963787	0.998	0.999	0	DESI1	Malignant cells	GSE108397	ENSG00000100418	27351	desumoylating isopeptidase 1	D15Wsu75e|DESI-1|FAM152B|POST|PPPDE2	protein_coding	Q6ICB0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	584
0	-0.632948185687356	1	1	0	TSPO	Malignant cells	GSE108397	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	585
0	-0.873607152492978	0.884	0.993	0	PIM3	Malignant cells	GSE108397	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	586
0	-1.06088323151389	0.789	0.979	0	BTG3	Malignant cells	GSE108397	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	587
0	-0.626075967229493	1	1	0	ATP5J	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	588
0	-0.858467754884825	0.583	0.876	0	APP	Malignant cells	GSE108397	ENSG00000142192	351	amyloid beta precursor protein	AD1|alpha-sAPP	protein_coding	P05067	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	589
0	-0.991458814065136	0.918	0.997	0	USP16	Malignant cells	GSE108397	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	590
0	-1.00026443906019	0.89	0.993	0	IFNGR2	Malignant cells	GSE108397	ENSG00000262795	3460	interferon gamma receptor 2	AF-1|IFNGT1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	591
0	-0.792402246273104	0.88	0.978	0	SON	Malignant cells	GSE108397	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	592
0	-1.00836627378677	0.685	0.939	0	CBR3	Malignant cells	GSE108397	ENSG00000159231	874	carbonyl reductase 3	SDR21C2	protein_coding	O75828	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	593
0	-1.00147778165044	0.964	0.998	0	TTC3	Malignant cells	GSE108397	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	594
0	-0.695001705200131	1	1	0	HMGN1	Malignant cells	GSE108397	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	595
0	-1.10817562779473	0.995	1	0	BACE2	Malignant cells	GSE108397	ENSG00000182240	25825	beta-secretase 2	AEPLC|ALP56|CEAP1|DRAP	protein_coding	Q9Y5Z0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	596
0	-0.93830428782739	0.996	1	0	U2AF1	Malignant cells	GSE108397	ENSG00000160201	7307	U2 small nuclear RNA auxiliary factor 1	RN|RNU2AF1|U2AF35|U2AFBP	protein_coding	Q01081	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	597
0	-0.942266094272666	0.851	0.984	0	PDXK	Malignant cells	GSE108397	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	598
0	-0.820609380592517	1	1	0	CSTB	Malignant cells	GSE108397	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	599
0	-0.736497865817063	0.995	1	0	SUMO3	Malignant cells	GSE108397	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	600
0	-0.827636229003224	1	1	0	MT-ND1	Malignant cells	GSE108397	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	601
0	-1.03582126679714	0.999	0.999	0	MT-ND2	Malignant cells	GSE108397	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	602
0	-0.799145781938957	1	1	0	MT-CO1	Malignant cells	GSE108397	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	603
0	-1.00920610728459	0.999	1	0	MT-ATP6	Malignant cells	GSE108397	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	604
0	-1.10308869295433	1	1	0	MT-CO3	Malignant cells	GSE108397	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	605
0	-1.11022739864958	0.974	0.998	0	MT-ND3	Malignant cells	GSE108397	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	606
0	-0.535653384967461	1	1	0	MT-ND4	Malignant cells	GSE108397	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	607
0	-1.16037747007683	0.74	0.966	0	MT-ND6	Malignant cells	GSE108397	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	608
0	-0.630022341849974	0.999	1	0	MT-CYB	Malignant cells	GSE108397	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	609
0	0.634805486976616	0.38	0	0	LIN7A	Malignant cells	GSE108397	ENSG00000111052	8825	lin-7 homolog A, crumbs cell polarity complex component	LIN-7A|MALS-1|TIP-33|VELI1	protein_coding	O14910	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	610
1.90758973021915e-306	0.793947960960301	0.874	0.574	3.45197437580457e-302	PSMG2	Malignant cells	GSE108397	ENSG00000128789	56984	proteasome assembly chaperone 2	CLAST3|HCCA3|HsT1707|MDS003|MGC15092|PAC2|TNFSF5IP1	protein_coding	Q969U7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	611
1.14291714485947e-303	0.544251075674549	0.999	0.999	2.06822286533769e-299	MRPS26	Malignant cells	GSE108397	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	612
1.53530061397143e-302	-0.651590520525315	0.968	0.999	2.7782799910427e-298	FAM3C	Malignant cells	GSE108397	ENSG00000196937	10447	FAM3 metabolism regulating signaling molecule C	GS3876|ILEI	protein_coding	Q92520	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	613
8.74235591673622e-300	-0.512947798770746	0	0.348	1.58201672669259e-295	DSG2	Malignant cells	GSE108397	ENSG00000046604	1829	desmoglein 2	CDHF5	protein_coding	Q14126	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	614
3.86357182222535e-299	0.521133087371638	1	0.998	6.991519569499e-295	GLRX5	Malignant cells	GSE108397	ENSG00000182512	51218	glutaredoxin 5	C14orf87|GRX5|PR01238	protein_coding	Q86SX6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	615
1.4630094991578e-298	-0.663932044480831	0.941	0.994	2.64746198967596e-294	M6PR	Malignant cells	GSE108397	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	616
1.98979672231023e-298	-0.617785484361247	0.965	0.999	3.60073614869259e-294	HDLBP	Malignant cells	GSE108397	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	617
1.99287184484609e-298	-0.726082743480425	0.881	0.978	3.60630089043349e-294	SUCLG2	Malignant cells	GSE108397	ENSG00000172340	8801	succinate-CoA ligase GDP-forming subunit beta	NA	protein_coding	Q96I99	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	618
6.79485060530368e-298	0.716791935287027	0.966	0.827	1.22959616553575e-293	CTD-2336O2.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	619
4.20870325867209e-297	0.759246127384173	0.924	0.716	7.61606941689302e-293	MRPS28	Malignant cells	GSE108397	ENSG00000147586	28957	mitochondrial ribosomal protein S28	HSPC007|MRP-S28|MRPS35	protein_coding	Q9Y2Q9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	620
5.15170134844776e-297	0.789807019381406	0.853	0.533	9.32251876015107e-293	PAAF1	Malignant cells	GSE108397	ENSG00000175575	80227	proteasomal ATPase associated factor 1	FLJ11848|Rpn14|WDR71	protein_coding	Q9BRP4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	621
6.60438106139919e-296	-0.732346351363344	0.885	0.983	1.1951287968708e-291	DDX5	Malignant cells	GSE108397	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	622
4.0524693017676e-294	0.407118335371252	1	1	7.33334844847865e-290	ATP5G2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	623
8.14317931739541e-294	0.695351661100873	0.989	0.934	1.47358972927587e-289	MYL12B	Malignant cells	GSE108397	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	624
3.57193795905993e-293	-0.556986790872105	0.993	0.999	6.46377893071485e-289	COX20	Malignant cells	GSE108397	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	625
5.85025197477396e-293	0.744822204096608	0.995	0.989	1.0586615973551e-288	MLANA	Malignant cells	GSE108397	ENSG00000120215	2315	melan-A	MART-1|MART1	protein_coding	Q16655	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	626
1.17253984735045e-292	0.600691154609326	0.995	0.974	2.12182810776537e-288	FAM96A	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	627
4.48531206910366e-292	0.397670910241052	1	1	8.11662072024999e-288	RPL14	Malignant cells	GSE108397	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	628
1.19831527168236e-291	-0.432549433139204	1	1	2.16847131563639e-287	PDAP1	Malignant cells	GSE108397	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	629
1.47750490612075e-291	0.540589808293753	1	1	2.6736928781161e-287	PSMB7	Malignant cells	GSE108397	ENSG00000136930	5695	proteasome 20S subunit beta 7	Z	protein_coding	Q99436	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	630
1.893403400477e-291	-0.775301598235871	0.895	0.981	3.42630279350319e-287	PRR5	Malignant cells	GSE108397	ENSG00000186654	55615	proline rich 5	FLJ20185k|PP610|Protor-1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	631
7.31874853794517e-291	-0.828831032920626	0.912	0.986	1.32440073542656e-286	AKR1A1	Malignant cells	GSE108397	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	632
1.22703663698369e-290	-0.897107804804901	0.547	0.865	2.22044549828569e-286	RP11-290F20.3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	633
2.46244634886904e-290	-0.614075995833862	0.037	0.412	4.45604291291341e-286	VDR	Malignant cells	GSE108397	ENSG00000111424	7421	vitamin D receptor	NR1I1|PPP1R163	protein_coding	P11473	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	634
2.82129893286959e-290	-1.0718314633818	0.158	0.583	5.10542254892082e-286	ZNF114	Malignant cells	GSE108397	ENSG00000178150	163071	zinc finger protein 114	MGC17986	protein_coding	Q8NC26	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	635
3.47069932257194e-290	-0.590044006100588	0.977	0.999	6.28057749412618e-286	SDF4	Malignant cells	GSE108397	ENSG00000078808	51150	stromal cell derived factor 4	Cab45	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	636
7.6629046478632e-290	0.549444171248847	1	1	1.38667922507732e-285	RPL5	Malignant cells	GSE108397	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	637
1.2299147047742e-289	-0.434893924499434	1	1	2.2256536497594e-285	UBE2D2	Malignant cells	GSE108397	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	638
3.60608220898402e-289	-1.24715881295123	0.012	0.362	6.52556636537749e-285	FHAD1	Malignant cells	GSE108397	ENSG00000142621	114827	forkhead associated phosphopeptide binding domain 1	KIAA1937	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	639
5.66363458175302e-289	-0.746014888177887	0.85	0.968	1.02489131391403e-284	ACOT7	Malignant cells	GSE108397	ENSG00000097021	11332	acyl-CoA thioesterase 7	ACH1|ACT|BACH|CTE-II|hBACH|LACH1|MGC1126	protein_coding	O00154	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	640
6.0208203374251e-289	0.894897085544543	0.47	0.078	1.08952764826045e-284	TNFSF13B	Malignant cells	GSE108397	ENSG00000102524	10673	TNF superfamily member 13b	BAFF|BLYS|CD257|TALL-1|TALL1|THANK|TNFSF20	protein_coding	Q9Y275	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	641
1.28307565228271e-288	-1.03140048665268	0.128	0.539	2.32185370037079e-284	SORBS2	Malignant cells	GSE108397	ENSG00000154556	8470	sorbin and SH3 domain containing 2	ARGBP2|KIAA0777	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	642
9.36352214509979e-288	0.484295608127193	1	0.999	1.69442296737726e-283	NOP10	Malignant cells	GSE108397	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	643
1.40882258175236e-287	-0.528350336286723	0.997	0.999	2.54940534393907e-283	C9orf16	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	644
1.56700939869704e-287	-0.613276889300388	0.95	0.995	2.83566020788217e-283	ANAPC5	Malignant cells	GSE108397	ENSG00000089053	51433	anaphase promoting complex subunit 5	APC5	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	645
2.8365798405261e-287	-0.803040877586326	0.622	0.876	5.13307487941603e-283	FNDC3B	Malignant cells	GSE108397	ENSG00000075420	64778	fibronectin type III domain containing 3B	DKFZp762K137|FAD104|FLJ23399|PRO4979|YVTM2421	protein_coding	Q53EP0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	646
4.71969736095262e-287	-0.902684687555351	0.918	0.988	8.54076434437986e-283	ISG15	Malignant cells	GSE108397	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	647
1.39066901447244e-286	0.679537774025375	0.977	0.887	2.51655464858933e-282	MPV17	Malignant cells	GSE108397	ENSG00000115204	4358	mitochondrial inner membrane protein MPV17	SYM1	protein_coding	P39210	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	648
2.37326224680614e-286	1.25217994986158	0.995	0.992	4.29465536182039e-282	NGFRAP1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	649
2.9564082482567e-286	-0.588004286439643	0.99	0.998	5.34991636604532e-282	RNF145	Malignant cells	GSE108397	ENSG00000145860	153830	ring finger protein 145	FLJ31951	protein_coding	Q96MT1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	650
5.74178815225617e-286	-0.623293343616264	0.994	1	1.03903398403228e-281	CKS1B	Malignant cells	GSE108397	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	651
1.0319728538538e-285	-0.832021863376257	0.675	0.907	1.86745807633384e-281	SH3BP5	Malignant cells	GSE108397	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	652
1.25761418896401e-284	0.570515260640392	1	0.997	2.27577863634926e-280	PPIB	Malignant cells	GSE108397	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	653
2.32004129175415e-284	-0.601905404047041	0.966	0.994	4.19834672155832e-280	ENTPD6	Malignant cells	GSE108397	ENSG00000197586	955	ectonucleoside triphosphate diphosphohydrolase 6	CD39L2|dJ738P15.3|IL6ST2|NTPDase-6	protein_coding	O75354	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	654
1.55089768993845e-283	-0.669362894831137	0.869	0.977	2.80650445971261e-279	FAM133B	Malignant cells	GSE108397	ENSG00000234545	257415	family with sequence similarity 133 member B	MGC40405	protein_coding	Q5BKY9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	655
2.47079095004844e-283	-0.692818829839752	0.887	0.98	4.47114330320765e-279	DDX18	Malignant cells	GSE108397	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	656
3.35230016219762e-283	-0.745272533856967	0.765	0.935	6.06632237351281e-279	ESRRA	Malignant cells	GSE108397	ENSG00000173153	2101	estrogen related receptor alpha	ERR1|ERRa|ERRalpha|ESRL1|NR3B1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	657
2.77103722081816e-282	-0.68784707634961	0.101	0.5	5.01446895479254e-278	LHX8	Malignant cells	GSE108397	ENSG00000162624	431707	LIM homeobox 8	Lhx7	protein_coding	Q68G74	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	658
4.882238401906e-282	-0.638862505341549	0.94	0.994	8.8348986120891e-278	BOD1	Malignant cells	GSE108397	ENSG00000145919	91272	biorientation of chromosomes in cell division 1	FAM44B	protein_coding	Q96IK1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	659
1.04762332957209e-281	0.459432610401007	1	1	1.89577917719365e-277	HSBP1	Malignant cells	GSE108397	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	660
6.06433182459861e-281	-0.695435710588005	0.818	0.958	1.09740148697937e-276	PLOD3	Malignant cells	GSE108397	ENSG00000106397	8985	procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	LH3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	661
1.57245376346591e-279	0.486437628136971	1	1	2.8455123303679e-275	MRPS34	Malignant cells	GSE108397	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	662
8.23091774411968e-279	0.464844379579856	1	1	1.4894668749759e-274	RPS27A	Malignant cells	GSE108397	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	663
1.26648278807104e-278	-0.607865440382131	0.029	0.386	2.29182725329336e-274	IFITM10	Malignant cells	GSE108397	ENSG00000281618	402778	interferon induced transmembrane protein 10	DSPA3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	664
5.37712704245683e-278	-0.380425544326043	1	1	9.73044909602988e-274	MT-CO2	Malignant cells	GSE108397	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	665
1.47176695507727e-277	-0.433721060401557	1	1	2.66330948190783e-273	SOD1	Malignant cells	GSE108397	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	666
3.81364083010524e-276	-0.593847116488784	0.967	0.997	6.90116444615845e-272	RNF126	Malignant cells	GSE108397	ENSG00000070423	55658	ring finger protein 126	FLJ20552	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	667
9.54821278060576e-276	0.811803115266195	0.803	0.467	1.72784458477842e-271	FUNDC1	Malignant cells	GSE108397	ENSG00000069509	139341	FUN14 domain containing 1	MGC51029	protein_coding	Q8IVP5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	668
2.0637209917348e-275	0.579142414899975	0.997	0.983	3.73450950664329e-271	LINC00493	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	669
1.48614508496134e-274	-0.682479093147849	0.75	0.934	2.68932814574604e-270	SF3A1	Malignant cells	GSE108397	ENSG00000099995	10291	splicing factor 3a subunit 1	Prp21|PRPF21|SAP114|SF3a120	protein_coding	Q15459	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	670
9.15095516518346e-274	0.572424800867034	0.999	0.988	1.6559568466916e-269	OSTC	Malignant cells	GSE108397	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	671
8.01323103664097e-273	-0.867184990900198	0.58	0.854	1.45007428839055e-268	GPR137B	Malignant cells	GSE108397	ENSG00000077585	7107	G protein-coupled receptor 137B	TM7SF1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	672
7.91905812262402e-272	-0.762039275232109	0.933	0.992	1.43303275787004e-267	LMNA	Malignant cells	GSE108397	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	673
2.44465723712847e-271	0.757157768529905	0.903	0.696	4.42385173630769e-267	DECR1	Malignant cells	GSE108397	ENSG00000104325	1666	2,4-dienoyl-CoA reductase 1	DECR|SDR18C1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	674
7.79204685625655e-271	-0.631023331487621	0.921	0.986	1.41004879910819e-266	ACTN4	Malignant cells	GSE108397	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	675
8.25462036561437e-271	-0.797216878519156	0.546	0.835	1.49375610136158e-266	DHRS11	Malignant cells	GSE108397	ENSG00000275397	79154	dehydrogenase/reductase 11	MGC4172|SDR24C1	protein_coding	Q6UWP2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	676
2.46329973519971e-270	-0.664397454115683	0.939	0.991	4.4575872008174e-266	RYBP	Malignant cells	GSE108397	ENSG00000281766	23429	RING1 and YY1 binding protein	AAP1|DEDAF|YEAF1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	677
5.56427153330081e-270	-0.771691294142002	0.517	0.825	1.00691057666612e-265	ATXN7	Malignant cells	GSE108397	ENSG00000163635	6314	ataxin 7	ADCAII|OPCA3|SCA7|SGF73	protein_coding	O15265	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	678
5.65875410623427e-270	-0.670619469819016	0.084	0.466	1.02400814306415e-265	RPS6KA2	Malignant cells	GSE108397	ENSG00000071242	6196	ribosomal protein S6 kinase A2	HU-2|RSK3	protein_coding	Q15349	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	679
4.61365165979353e-269	0.30424992277116	1	1	8.34886404356237e-265	CHCHD2	Malignant cells	GSE108397	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	680
7.46847766769984e-269	0.745996816246945	0.699	0.294	1.35149571874696e-264	CDCA7L	Malignant cells	GSE108397	ENSG00000164649	55536	cell division cycle associated 7 like	JPO2|R1|RAM2	protein_coding	Q96GN5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	681
1.15539897993067e-268	-0.777638730279099	0.94	0.982	2.09080999408254e-264	ASRGL1	Malignant cells	GSE108397	ENSG00000162174	80150	asparaginase and isoaspartyl peptidase 1	ALP|ALP1|FLJ22316	protein_coding	Q7L266	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	682
1.65513651713541e-268	0.500243920985388	1	1	2.99513504140824e-264	B2M	Malignant cells	GSE108397	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	683
2.13395915609649e-268	-0.609105379869337	0.933	0.993	3.8616124888722e-264	SLC39A1	Malignant cells	GSE108397	ENSG00000143570	27173	solute carrier family 39 member 1	ZIP1|ZIRTL	protein_coding	Q9NY26	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	684
9.70778589633764e-268	-0.835780383526993	0.893	0.982	1.75672093580126e-263	MBP	Malignant cells	GSE108397	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	685
1.02935063070501e-267	-0.670010840777445	0.847	0.967	1.86271290132378e-263	TFG	Malignant cells	GSE108397	ENSG00000114354	10342	trafficking from ER to golgi regulator	FLJ36137|SPG57|TF6	protein_coding	Q92734	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	686
1.5118315237671e-267	-0.575490739474661	0.979	0.997	2.73581032540894e-263	AGPAT2	Malignant cells	GSE108397	ENSG00000169692	10555	1-acylglycerol-3-phosphate O-acyltransferase 2	BSCL|LPAAT-beta|LPLAT2	protein_coding	O15120	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	687
6.71946105690458e-267	-0.876420457224394	0.476	0.821	1.21595367285745e-262	AHNAK	Malignant cells	GSE108397	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	688
2.4249046185374e-266	0.55034810990297	0.997	0.992	4.38810739770528e-262	NDUFB11	Malignant cells	GSE108397	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	689
2.7742191649117e-266	-0.580562463615405	0.974	0.998	5.02022700082422e-262	CAST	Malignant cells	GSE108397	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	690
4.67559679299227e-266	-0.651689882917036	0.923	0.991	8.46095995659882e-262	MT-ND4L	Malignant cells	GSE108397	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	691
3.07453164856615e-265	-0.656882549931921	0.877	0.977	5.5636724712453e-261	ILF3	Malignant cells	GSE108397	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	692
6.30648232750614e-265	-0.642206212605915	0.878	0.977	1.14122104198551e-260	KRTCAP2	Malignant cells	GSE108397	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	693
2.68270236503789e-264	0.75682917276984	0.792	0.452	4.85461819977256e-260	LINC00667	Malignant cells	GSE108397	ENSG00000263753	339290	long intergenic non-protein coding RNA 667	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	694
3.68018771304464e-264	0.672923547727437	1	1	6.65966768552558e-260	EEF1A1	Malignant cells	GSE108397	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	695
9.9847153542258e-264	-0.564602897687504	0.04	0.392	1.8068340905007e-259	DNAJA4	Malignant cells	GSE108397	ENSG00000140403	55466	DnaJ heat shock protein family (Hsp40) member A4	PRO1472	protein_coding	Q8WW22	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	696
1.51363447163886e-263	0.568821076648984	0.998	0.993	2.73907293987768e-259	DYNLT1	Malignant cells	GSE108397	ENSG00000146425	6993	dynein light chain Tctex-type 1	TCTEL1|Tctex-1|TCTEX1	protein_coding	P63172	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	697
1.52586748989998e-263	-0.479173250113584	0.999	1	2.76120980972301e-259	YBX3	Malignant cells	GSE108397	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	698
4.65571863919604e-262	-0.873571755879817	0.627	0.902	8.42498844948916e-258	CNN3	Malignant cells	GSE108397	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	699
8.93577786779431e-262	-0.593735689097063	0.974	0.996	1.61701836295606e-257	FAM207A	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	700
4.25987311935124e-261	-0.757980004686572	0.296	0.671	7.70866639677801e-257	AZI1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	701
1.57244241338728e-260	0.766980783800119	1	1	2.84549179126562e-256	FTL	Malignant cells	GSE108397	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	702
2.15811551659572e-260	-0.488951633846646	0.997	1	3.90532583883161e-256	COX17	Malignant cells	GSE108397	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	703
3.16125111824749e-260	0.570531106157491	0.998	0.984	5.72060002358066e-256	SUCLG1	Malignant cells	GSE108397	ENSG00000163541	8802	succinate-CoA ligase GDP/ADP-forming subunit alpha	NA	protein_coding	P53597	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	704
4.02448298303028e-260	-0.584870288938741	0.956	0.995	7.28270440609159e-256	NDUFV3	Malignant cells	GSE108397	ENSG00000160194	4731	NADH:ubiquinone oxidoreductase subunit V3	CI-10k	protein_coding	P56181	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	705
5.46974750500453e-260	-0.624679108899042	0.961	0.995	9.89805508505619e-256	CSNK1A1	Malignant cells	GSE108397	ENSG00000113712	1452	casein kinase 1 alpha 1	CK1|CK1a|CK1alpha|CKIa|CKIalpha	protein_coding	P48729	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	706
6.07577816992144e-260	-0.808746736459337	0.609	0.877	1.09947281762898e-255	PPP1R15A	Malignant cells	GSE108397	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	707
1.16174591624422e-259	-0.68908646077024	0.76	0.937	2.10229541003554e-255	UBE2G2	Malignant cells	GSE108397	ENSG00000184787	7327	ubiquitin conjugating enzyme E2 G2	UBC7	protein_coding	P60604	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	708
1.41799265615438e-259	-0.654003970546334	0.797	0.944	2.56599951057696e-255	ASCC2	Malignant cells	GSE108397	ENSG00000100325	84164	activating signal cointegrator 1 complex subunit 2	ASC1p100|DKFZp586O0223|FLJ21588	protein_coding	Q9H1I8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	709
4.07986607801625e-259	-0.724926295004252	0.586	0.897	7.38292565477821e-255	SMIM20	Malignant cells	GSE108397	ENSG00000250317	389203	small integral membrane protein 20	C4orf52|MITRAC7|PNX	protein_coding	Q8N5G0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	710
1.86910256800508e-258	-0.617185128902054	0.958	0.995	3.38232800706199e-254	SLC25A4	Malignant cells	GSE108397	ENSG00000151729	291	solute carrier family 25 member 4	AAC1|ANT1|PEO2|PEO3|T1	protein_coding	P12235	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	711
4.89769201099833e-258	-0.601449700665664	0.948	0.995	8.86286346310258e-254	ETF1	Malignant cells	GSE108397	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	712
8.39430813856682e-258	-0.557536548248549	0.967	0.997	1.51903400075505e-253	BCL2L13	Malignant cells	GSE108397	ENSG00000099968	23786	BCL2 like 13	BCL-RAMBO|MIL1	protein_coding	Q9BXK5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	713
2.42375368404586e-255	-0.711820142775901	0.93	0.984	4.38602466664939e-251	RRAGD	Malignant cells	GSE108397	ENSG00000025039	58528	Ras related GTP binding D	bA11D8.2.1|DKFZP761H171	protein_coding	Q9NQL2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	714
3.67036075229025e-255	-0.624438695648862	0.903	0.979	6.64188481734443e-251	RBMX	Malignant cells	GSE108397	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	715
8.07015715642147e-255	-0.489898366866026	0.015	0.336	1.46037563902603e-250	MFAP2	Malignant cells	GSE108397	ENSG00000117122	4237	microfibril associated protein 2	MAGP|MAGP-1	protein_coding	P55001	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	716
8.48976064815558e-255	-0.493805481921464	0.996	0.999	1.53630708689023e-250	MAF1	Malignant cells	GSE108397	ENSG00000179632	84232	MAF1 homolog, negative regulator of RNA polymerase III	DKFZp586G1123	protein_coding	Q9H063	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	717
9.70689315128615e-255	-0.620916350585648	0.899	0.981	1.75655938465674e-250	COA6	Malignant cells	GSE108397	ENSG00000168275	388753	cytochrome c oxidase assembly factor 6	C1orf31	protein_coding	Q5JTJ3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	718
1.56831368821909e-254	-0.666875063137804	0.736	0.928	2.83802045020127e-250	KHSRP	Malignant cells	GSE108397	ENSG00000088247	8570	KH-type splicing regulatory protein	FBP2|FUBP2|KSRP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	719
2.26951907561978e-254	0.441229462943037	1	1	4.10692171924155e-250	RPS15A	Malignant cells	GSE108397	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	720
6.2034329169221e-254	-0.667758300624081	0.749	0.928	1.12257322064622e-249	SMIM11	Malignant cells	GSE108397	ENSG00000205670	54065	small integral membrane protein 11	C21orf51|FAM165B|SMIM11A	protein_coding	P58511	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	721
1.76601932813472e-253	-0.583867331380003	0.964	0.993	3.1957885761926e-249	MRPL55	Malignant cells	GSE108397	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	722
1.10661225943511e-252	0.747945271257216	0.731	0.353	2.00252554467377e-248	GNG4	Malignant cells	GSE108397	ENSG00000282972	2786	G protein subunit gamma 4	NA	protein_coding	P50150	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	723
1.78576158628063e-252	-0.717021595954547	0.721	0.923	3.23151416653342e-248	LUZP1	Malignant cells	GSE108397	ENSG00000169641	7798	leucine zipper protein 1	LUZP	protein_coding	Q86V48	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	724
1.04275421314713e-251	-0.531329766732347	0.977	0.998	1.88696802411106e-247	MRPS21	Malignant cells	GSE108397	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	725
1.71233038936734e-251	-0.665248767833941	0.807	0.949	3.09863307259914e-247	SEC61A1	Malignant cells	GSE108397	ENSG00000058262	29927	SEC61 translocon subunit alpha 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	726
1.95597217967091e-251	-0.878987450403746	0.67	0.911	3.53952725633249e-247	ZNF689	Malignant cells	GSE108397	ENSG00000156853	115509	zinc finger protein 689	FLJ90415|TIPUH1	protein_coding	Q96CS4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	727
4.42639645613417e-251	-0.723901129514699	0.808	0.937	8.0100070270204e-247	FOXM1	Malignant cells	GSE108397	ENSG00000111206	2305	forkhead box M1	FKHL16|HFH-11|HNF-3|INS-1|MPHOSPH2|MPP2|TGT3|trident	protein_coding	Q08050	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	728
2.18133052676476e-249	0.674024268880645	0.304	0.003	3.94733572123351e-245	HIST1H1A	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	729
2.78508377283817e-249	0.538924507319621	1	1	5.03988759532796e-245	NPM1	Malignant cells	GSE108397	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	730
2.27370888824488e-248	-0.525379555330276	0.989	0.998	4.11450360416793e-244	APOA1BP	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	731
5.19726574151752e-248	-0.5430918082335	0.983	0.996	9.4049720858501e-244	DDX1	Malignant cells	GSE108397	ENSG00000079785	1653	DEAD-box helicase 1	DBP-RB	protein_coding	Q92499	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	732
1.50042945212311e-247	1.05911665460335	0.992	0.993	2.71517713656198e-243	PGK1	Malignant cells	GSE108397	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	733
3.17354530862923e-247	0.604346827947052	0.99	0.952	5.74284759049545e-243	C4orf48	Malignant cells	GSE108397	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	734
1.64502388054614e-246	-0.60875984630437	0.872	0.977	2.97683521423629e-242	UBE2J2	Malignant cells	GSE108397	ENSG00000160087	118424	ubiquitin conjugating enzyme E2 J2	NCUBE2|Ubc6p	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	735
3.29017827436113e-246	-0.4230709369651	1	1	5.9539066052839e-242	ORMDL1	Malignant cells	GSE108397	ENSG00000128699	94101	ORMDL sphingolipid biosynthesis regulator 1	NA	protein_coding	Q9P0S3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	736
5.46985249427115e-246	-0.468847948549967	0.997	1	9.89824507363307e-242	NDUFA2	Malignant cells	GSE108397	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	737
5.83196186103714e-246	0.643764256968495	0.987	0.899	1.05535181837328e-241	RSL24D1	Malignant cells	GSE108397	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	738
6.29624270627565e-246	-0.624444916309289	0.865	0.976	1.13936808012764e-241	AP3D1	Malignant cells	GSE108397	ENSG00000065000	8943	adaptor related protein complex 3 subunit delta 1	ADTD	protein_coding	O14617	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	739
1.68373759884689e-245	0.726873768365781	0.903	0.698	3.04689155887333e-241	MRPL50	Malignant cells	GSE108397	ENSG00000136897	54534	mitochondrial ribosomal protein L50	FLJ20493|MRP-L50	protein_coding	Q8N5N7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	740
9.26269058868951e-245	-0.74116673620584	0.246	0.615	1.67617648892925e-240	USP18	Malignant cells	GSE108397	ENSG00000184979	11274	ubiquitin specific peptidase 18	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	741
2.59837771376744e-244	0.472233793995572	1	0.999	4.70202431083356e-240	TMEM167A	Malignant cells	GSE108397	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	742
4.014349327466e-244	0.426618351296091	1	1	7.26436654298248e-240	RPS18	Malignant cells	GSE108397	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	743
1.05275617307598e-243	-0.699253932144278	0.846	0.96	1.9050675707983e-239	KIFC3	Malignant cells	GSE108397	ENSG00000140859	3801	kinesin family member C3	NA	protein_coding	Q9BVG8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	744
1.26993265243291e-243	0.677236938894039	0.881	0.622	2.2980701278426e-239	MED28	Malignant cells	GSE108397	ENSG00000118579	80306	mediator complex subunit 28	DKFZP434N185|EG1|magicin	protein_coding	Q9H204	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	745
9.5274312457142e-243	-0.433815889113541	0.999	1	1.72408395822444e-238	DRAP1	Malignant cells	GSE108397	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	746
1.50412314119292e-241	-0.391336298432486	1	1	2.72186123630271e-237	USMG5	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	747
2.76038412940427e-241	-0.57635467959232	0.925	0.988	4.99519112056998e-237	MOB1A	Malignant cells	GSE108397	ENSG00000114978	55233	MOB kinase activator 1A	C2orf6|FLJ10788|FLJ11595|Mats1|MOB1|Mob4B|MOBK1B|MOBKL1B	protein_coding	Q9H8S9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	748
3.4352634555786e-241	-0.713216546269016	0.595	0.843	6.21645274921503e-237	RHBDD2	Malignant cells	GSE108397	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	749
1.37309559519001e-240	-0.636789170237831	0.844	0.96	2.48475378905585e-236	THEM4	Malignant cells	GSE108397	ENSG00000159445	117145	thioesterase superfamily member 4	CTMP	protein_coding	Q5T1C6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	750
3.25716830333365e-240	-0.747484214876285	0.689	0.895	5.89417176171257e-236	SPECC1	Malignant cells	GSE108397	ENSG00000128487	92521	sperm antigen with calponin homology and coiled-coil domains 1	CYTSB|FLJ36955|HCMOGT-1|NSP	protein_coding	Q5M775	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	751
3.43468511274084e-240	-0.548628612231044	0.963	0.995	6.21540618001583e-236	CLTC	Malignant cells	GSE108397	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	752
5.85327143623337e-240	-0.622989577135259	0.895	0.98	1.05920799910079e-235	CBR1	Malignant cells	GSE108397	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	753
1.46454696582611e-239	0.390391932690498	1	1	2.65024418935893e-235	RPL9	Malignant cells	GSE108397	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	754
1.61676483173028e-239	0.537879965676901	0.443	0.086	2.92569763949911e-235	FLVCR1-AS1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	755
3.37903567954426e-239	-0.688355365654034	0.79	0.945	6.11470296570329e-235	RRP1B	Malignant cells	GSE108397	ENSG00000160208	23076	ribosomal RNA processing 1B	KIAA0179|Nnp1|PPP1R136|RRP1	protein_coding	Q14684	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	756
3.76489035421823e-239	-0.673502632053701	0.713	0.907	6.81294558499331e-235	RUSC1	Malignant cells	GSE108397	ENSG00000160753	23623	RUN and SH3 domain containing 1	NESCA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	757
7.97499978132407e-239	-0.63633685591355	0.861	0.98	1.4431559604284e-234	BAZ1B	Malignant cells	GSE108397	ENSG00000009954	9031	bromodomain adjacent to zinc finger domain 1B	WBSCR10|WBSCR9|WSTF	protein_coding	Q9UIG0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	758
3.58098344550471e-238	0.765010966897415	0.975	0.891	6.48014764298533e-234	TIMP1	Malignant cells	GSE108397	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	759
3.75100337898045e-238	-0.739875635173718	0.917	0.995	6.78781571460302e-234	TIMP3	Malignant cells	GSE108397	ENSG00000100234	7078	TIMP metallopeptidase inhibitor 3	SFD	protein_coding	P35625	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	760
4.09732509763871e-238	0.535268393150067	0.372	0.044	7.41451949668702e-234	RP11-161M6.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	761
7.46956851335705e-238	-0.623159668389365	0.883	0.977	1.35169311817709e-233	C9orf89	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	762
7.51069437063977e-238	-0.549883221203071	0.975	0.996	1.35913525331097e-233	USF2	Malignant cells	GSE108397	ENSG00000105698	7392	upstream transcription factor 2, c-fos interacting	bHLHb12|FIP	protein_coding	Q15853	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	763
7.78924829267034e-238	-0.713615317437859	0.115	0.473	1.40954237104162e-233	C9orf3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	764
8.06690576850699e-238	0.380168714805362	1	1	1.45978726786902e-233	RPL6	Malignant cells	GSE108397	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	765
1.35219883629743e-237	0.62747088463878	0.917	0.697	2.44693901416383e-233	BEST1	Malignant cells	GSE108397	ENSG00000167995	7439	bestrophin 1	BEST|BMD|RP50|VMD2	protein_coding	O76090	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	766
4.58223774835485e-237	-0.519574897966962	0.027	0.341	8.29201742942294e-233	SLC16A6	Malignant cells	GSE108397	ENSG00000108932	9120	solute carrier family 16 member 6	MCT6|MCT7	protein_coding	O15403	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	767
1.59036863448381e-236	0.690379942382611	0.786	0.455	2.8779310809619e-232	NUDT16L1	Malignant cells	GSE108397	ENSG00000168101	84309	nudix hydrolase 16 like 1	SDOS|TIRR	protein_coding	Q9BRJ7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	768
2.08579626033722e-236	0.606653836467224	0.971	0.876	3.77445691270624e-232	TMEM256	Malignant cells	GSE108397	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	769
2.2818334660024e-236	-0.609816827649373	0.831	0.956	4.12920584007794e-232	MRPL24	Malignant cells	GSE108397	ENSG00000143314	79590	mitochondrial ribosomal protein L24	MRP-L18	protein_coding	Q96A35	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	770
4.92098517701869e-236	0.632292712236549	0.976	0.905	8.90501477633303e-232	ALG5	Malignant cells	GSE108397	ENSG00000120697	29880	ALG5 dolichyl-phosphate beta-glucosyltransferase	bA421P11.2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	771
8.45145615764294e-236	-0.599917283462437	0.885	0.972	1.52937550628707e-231	ZNF259	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	772
1.07081675529506e-235	-0.668374794884824	0.743	0.93	1.93775000038194e-231	SLC43A3	Malignant cells	GSE108397	ENSG00000134802	29015	solute carrier family 43 member 3	DKFZp762A227|Eeg1|FOAP-13|PRO1659|SEEEG-1	protein_coding	Q8NBI5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	773
1.63006907956068e-235	-0.63828985435028	0.77	0.937	2.949773006373e-231	SMARCA4	Malignant cells	GSE108397	ENSG00000127616	6597	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	BAF190|BRG1|FLJ39786|hSNF2b|SNF2|SNF2-BETA|SNF2L4|SNF2LB|SWI2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	774
2.52702964409869e-235	0.66864525845261	0.682	0.311	4.572912843961e-231	BLOC1S4	Malignant cells	GSE108397	ENSG00000186222	55330	biogenesis of lysosomal organelles complex 1 subunit 4	BCAS4L|CNO|FLJ11230	protein_coding	Q9NUP1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	775
2.60224575183276e-235	-0.405819681398876	1	1	4.70902391251657e-231	NAA10	Malignant cells	GSE108397	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	776
2.70097925925904e-235	-0.663965561867321	0.718	0.913	4.88769206755515e-231	DYNC1H1	Malignant cells	GSE108397	ENSG00000197102	1778	dynein cytoplasmic 1 heavy chain 1	CMT2O|DHC1|DNCH1|Dnchc1|DNCL|DNECL|HL-3|p22	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	777
3.12869170736054e-235	-0.75771460827162	0.525	0.825	5.66168051363963e-231	CD9	Malignant cells	GSE108397	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	778
9.53851832212055e-235	-0.695823312618934	0.325	0.68	1.72609027557093e-230	BAG6	Malignant cells	GSE108397	ENSG00000229524	7917	BAG cochaperone 6	BAT3|D6S52E|G3|Scythe	protein_coding	P46379	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	779
3.12236384342404e-234	-0.72148477152689	0.311	0.669	5.65022961106014e-230	DUSP9	Malignant cells	GSE108397	ENSG00000130829	1852	dual specificity phosphatase 9	MKP-4|MKP4	protein_coding	Q99956	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	780
4.89197495714772e-234	0.416194579192407	0.999	1	8.85251788245451e-230	TXNDC17	Malignant cells	GSE108397	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	781
6.18559600386807e-234	0.708650303999982	0.696	0.338	1.11934545285997e-229	AK3	Malignant cells	GSE108397	ENSG00000147853	50808	adenylate kinase 3	AK3L1|AK6|AKL3L1	protein_coding	Q9UIJ7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	782
2.29892601738422e-233	-0.720528593950362	0.727	0.923	4.16013652105848e-229	AVPI1	Malignant cells	GSE108397	ENSG00000119986	60370	arginine vasopressin induced 1	PP5395|VIP32|VIT32	protein_coding	Q5T686	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	783
5.35429502507774e-233	-0.515881267772862	0.987	0.999	9.68913227738068e-229	FAM50A	Malignant cells	GSE108397	ENSG00000071859	9130	family with sequence similarity 50 member A	9F|DXS9928E|HXC-26|XAP5	protein_coding	Q14320	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	784
3.52876308566499e-232	-0.43124567950785	0.006	0.294	6.38564967981936e-228	SV2A	Malignant cells	GSE108397	ENSG00000159164	9900	synaptic vesicle glycoprotein 2A	KIAA0736|SV2	protein_coding	Q7L0J3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	785
7.34663055566099e-232	-0.465329925980555	0.998	1	1.32944626535241e-227	PRMT2	Malignant cells	GSE108397	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	786
9.6638343964078e-232	-0.313514532909272	1	1	1.74876747237396e-227	RPSA	Malignant cells	GSE108397	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	787
9.5375149226795e-231	0.660368913020767	0.937	0.804	1.72590870040808e-226	PSMC4	Malignant cells	GSE108397	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	788
9.76300732332061e-231	-0.632570921324524	0.881	0.97	1.7667138052281e-226	LARP1	Malignant cells	GSE108397	ENSG00000155506	23367	La ribonucleoprotein 1, translational regulator	KIAA0731|Lar1|LARP|Lhp1|MGC19556	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	789
1.02905855487735e-230	-0.682803281317869	0.723	0.913	1.86218436090605e-226	CLDND1	Malignant cells	GSE108397	ENSG00000080822	56650	claudin domain containing 1	C3orf4|Z38	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	790
1.85892430219024e-230	0.574313723222961	0.998	0.99	3.36390941724346e-226	ECHS1	Malignant cells	GSE108397	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	791
2.25838491830394e-230	-0.621439310140962	0.864	0.971	4.08677334816282e-226	SH3KBP1	Malignant cells	GSE108397	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	792
2.86581736070692e-230	-0.531778373177344	0.062	0.396	5.18598309593525e-226	AIM1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	793
3.24575988890662e-230	0.585179144347908	0.994	0.983	5.87352709496542e-226	TFDP1	Malignant cells	GSE108397	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	794
5.69222781884327e-230	-0.668375630882714	0.656	0.884	1.03006554609788e-225	MFI2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	795
6.30477382487869e-230	0.41458399190959	1	1	1.14091187135005e-225	STRA13	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	796
7.71634809385723e-230	-0.528378082664012	0.959	0.993	1.3963503510644e-225	RPL36A	Malignant cells	GSE108397	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	797
1.32169737245621e-229	-0.744289567736579	0.343	0.686	2.39174356519676e-225	OSBPL10	Malignant cells	GSE108397	ENSG00000144645	114884	oxysterol binding protein like 10	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	798
1.63452372002099e-227	0.407995523406389	0.999	0.999	2.95783412374999e-223	GCSH	Malignant cells	GSE108397	ENSG00000140905	2653	glycine cleavage system protein H	NA	protein_coding	P23434	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	799
2.62577131664876e-227	-0.626433172950683	0.836	0.95	4.75159577460759e-223	TROAP	Malignant cells	GSE108397	ENSG00000135451	10024	trophinin associated protein	TASTIN	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	800
4.08673830586861e-227	0.510473757070673	0.999	0.997	7.39536163829984e-223	NPC2	Malignant cells	GSE108397	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	801
4.0961101550419e-227	-0.777656451613643	0.119	0.466	7.41232093656383e-223	PLB1	Malignant cells	GSE108397	ENSG00000163803	151056	phospholipase B1	FLJ30866|PLB	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	802
7.17616507205111e-227	-0.627736558624485	0.833	0.954	1.29859883143837e-222	RNH1	Malignant cells	GSE108397	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	803
7.94764046803287e-227	0.835788867769471	0.48	0.124	1.43820501909523e-222	RP11-574H6.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	804
8.3590938904988e-227	0.799342502068262	0.929	0.796	1.51266163042466e-222	MCF2L	Malignant cells	GSE108397	ENSG00000126217	23263	MCF.2 cell line derived transforming sequence like	ARHGEF14|DBS|KIAA0362|OST	protein_coding	O15068	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	805
8.67997059548463e-227	-0.624474693420376	0.818	0.954	1.5707274789589e-222	DNAJB11	Malignant cells	GSE108397	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	806
1.54234424742526e-226	-0.796779223819414	0.52	0.808	2.79102615014074e-222	TM4SF19.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	807
6.34503760130404e-226	-0.708366214092689	0.432	0.744	1.14819800433198e-221	MAP7D3	Malignant cells	GSE108397	ENSG00000129680	79649	MAP7 domain containing 3	FLJ12649	protein_coding	Q8IWC1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	808
1.75480995462165e-225	0.493617152253098	0.999	0.995	3.17550409388334e-221	EIF6	Malignant cells	GSE108397	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	809
2.37025764909156e-225	0.799474236829338	0.898	0.696	4.28921824179609e-221	CYTL1	Malignant cells	GSE108397	ENSG00000170891	54360	cytokine like 1	C17|C4orf4	protein_coding	Q9NRR1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	810
4.36300167269821e-225	-0.810932236146269	0.315	0.659	7.89528782691468e-221	NAV2	Malignant cells	GSE108397	ENSG00000166833	89797	neuron navigator 2	FLJ10633|FLJ11030|FLJ23707|HELAD1|KIAA1419|POMFIL2|RAINB1	protein_coding	Q8IVL1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	811
3.26842520302065e-222	0.557957765191615	0.421	0.085	5.91454224738617e-218	AIG1	Malignant cells	GSE108397	ENSG00000146416	51390	androgen induced 1	AIG-1|dJ95L4.1|FLJ10485	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	812
3.82825645683427e-222	-0.619871703956379	0.795	0.947	6.9276128842873e-218	PITHD1	Malignant cells	GSE108397	ENSG00000057757	57095	PITH domain containing 1	C1orf128|HT014|TXNL1CL	protein_coding	Q9GZP4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	813
4.28049479730783e-222	-0.633087291316504	0.733	0.919	7.74598338520824e-218	WIPF1	Malignant cells	GSE108397	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	814
4.39911532150448e-222	-0.48433728299772	0.984	0.997	7.9606390857945e-218	TRAPPC3	Malignant cells	GSE108397	ENSG00000054116	27095	trafficking protein particle complex subunit 3	BET3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	815
1.09519535814161e-221	0.430263776058317	0.999	0.999	1.98186552009305e-217	TRMT112	Malignant cells	GSE108397	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	816
1.68542519080659e-221	0.446750276799254	1	1	3.0499454252836e-217	HSP90AA1	Malignant cells	GSE108397	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	817
1.86947375181804e-221	-0.494340358689584	0.985	0.997	3.38299970128993e-217	GIPC1	Malignant cells	GSE108397	ENSG00000123159	10755	GIPC PDZ domain containing family member 1	C19orf3|GIPC|GLUT1CBP|Hs.6454|NIP|RGS19IP1|SEMCAP|SYNECTIN|TIP-2	protein_coding	O14908	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	818
1.08632456965667e-220	-0.570711144339568	0.918	0.99	1.96581294125071e-216	ETV4	Malignant cells	GSE108397	ENSG00000175832	2118	ETS variant transcription factor 4	E1A-F|E1AF|PEA3	protein_coding	P43268	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	819
2.67999192211378e-219	0.775188823718209	0.563	0.218	4.84971338225709e-215	MTMR12	Malignant cells	GSE108397	ENSG00000150712	54545	myotubularin related protein 12	3-PAP|3PAP|FLJ20476|KIAA1682|PIP3AP	protein_coding	Q9C0I1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	820
2.6897322325965e-219	0.646804540631573	0.94	0.802	4.86733944810662e-215	TMEM261	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	821
4.66589135676038e-219	-0.670174996161459	0.743	0.924	8.44339699919359e-215	REEP4	Malignant cells	GSE108397	ENSG00000168476	80346	receptor accessory protein 4	C8orf20|FLJ22246|FLJ22277|PP432|Yip2c	protein_coding	Q9H6H4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	822
5.92252015024533e-218	-0.469893248405672	0.988	0.999	1.07173924638839e-213	ARMC10	Malignant cells	GSE108397	ENSG00000282813	83787	armadillo repeat containing 10	MGC3195|SVH	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	823
1.00530590266773e-217	-0.540064308625043	0.947	0.992	1.81920156146753e-213	LTBR	Malignant cells	GSE108397	ENSG00000111321	4055	lymphotoxin beta receptor	D12S370|TNF-R-III|TNFCR|TNFR-RP|TNFR2-RP|TNFRSF3	protein_coding	P36941	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	824
1.58002901247074e-217	0.549117200716295	0.983	0.926	2.85922050096705e-213	SPAG7	Malignant cells	GSE108397	ENSG00000091640	9552	sperm associated antigen 7	ACRP|FSA-1|MGC20134	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	825
3.33793322684027e-217	-0.448619428792954	0.995	0.999	6.04032396729015e-213	MFF	Malignant cells	GSE108397	ENSG00000168958	56947	mitochondrial fission factor	C2orf33|GL004	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	826
4.58569889491556e-217	0.372429959780488	1	1	8.29828072023919e-213	TXN2	Malignant cells	GSE108397	ENSG00000100348	25828	thioredoxin 2	MT-TRX	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	827
5.37450986172276e-217	-0.606631620917141	0.798	0.93	9.72571304577351e-213	AHCYL1	Malignant cells	GSE108397	ENSG00000168710	10768	adenosylhomocysteinase like 1	IRBIT|PPP1R78|XPVKONA	protein_coding	O43865	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	828
9.15392781237551e-217	-0.568751950919582	0.924	0.979	1.65649477692747e-212	ATG3	Malignant cells	GSE108397	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	829
1.28458368486186e-216	-0.38819066436935	1	1	2.32458263612603e-212	RAD23A	Malignant cells	GSE108397	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	830
5.98420040529846e-216	-0.584761229843832	0.884	0.976	1.08290090534281e-211	SLC52A2	Malignant cells	GSE108397	ENSG00000285112	79581	solute carrier family 52 member 2	D15Ertd747e|FLJ11856|GPCR41|GPR172A|hRFT3|PAR1|RFVT2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	831
1.02393889411547e-215	0.669737177631185	0.501	0.154	1.85291982279135e-211	HIST1H2BH	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	832
1.04473165856182e-215	-0.472805902223401	0.985	0.998	1.89054640933347e-211	TMED2	Malignant cells	GSE108397	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	833
1.63479166366507e-215	-0.703292594941305	0.521	0.807	2.95831899456832e-211	SH2B3	Malignant cells	GSE108397	ENSG00000111252	10019	SH2B adaptor protein 3	IDDM20|LNK	protein_coding	Q9UQQ2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	834
3.80751882349528e-215	-0.315536388074622	1	1	6.89008606299706e-211	GPX1	Malignant cells	GSE108397	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	835
5.92043323617138e-215	0.646415536895879	0.89	0.676	1.07136159841757e-210	GLOD4	Malignant cells	GSE108397	ENSG00000167699	51031	glyoxalase domain containing 4	C17orf25|CGI-150|HC71	protein_coding	Q9HC38	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	836
5.97902461917071e-215	-0.628439244178667	0.9	0.981	1.08196429508513e-210	RCN1	Malignant cells	GSE108397	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	837
7.34052486214692e-215	-0.604770973138571	0.803	0.946	1.32834137905411e-210	TMEM248	Malignant cells	GSE108397	ENSG00000106609	55069	transmembrane protein 248	C7orf42|FLJ10099|FLJ13090	protein_coding	Q9NWD8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	838
1.06147641556112e-214	0.673557886003815	0.616	0.258	1.9208477215994e-210	RXRG	Malignant cells	GSE108397	ENSG00000143171	6258	retinoid X receptor gamma	NR2B3|RXR-gamma|RXRgamma	protein_coding	P48443	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	839
1.29109549538893e-214	-0.659400693502987	0.651	0.863	2.33636640845581e-210	TANGO2	Malignant cells	GSE108397	ENSG00000183597	128989	transport and golgi organization 2 homolog	C22orf25|DKFZp761P1121	protein_coding	Q6ICL3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	840
1.46844419664597e-214	-0.66458167044707	0.775	0.944	2.65729661825054e-210	ABL2	Malignant cells	GSE108397	ENSG00000143322	27	ABL proto-oncogene 2, non-receptor tyrosine kinase	ABLL|ARG	protein_coding	P42684	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	841
2.60840084671903e-214	-0.519219649190692	0.976	0.996	4.72016217222276e-210	LRRFIP1	Malignant cells	GSE108397	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	842
1.30893448107737e-213	-0.656713022881581	0.809	0.932	2.3686478369576e-209	KIAA0930	Malignant cells	GSE108397	ENSG00000100364	23313	KIAA0930	bK268H5.C22.1|C22orf9	protein_coding	Q6ICG6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	843
1.30938958699285e-213	0.660743436496505	0.901	0.703	2.36947139662225e-209	MRPL44	Malignant cells	GSE108397	ENSG00000135900	65080	mitochondrial ribosomal protein L44	FLJ12701|FLJ13990	protein_coding	Q9H9J2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	844
3.44292837922204e-213	-0.685049531739026	0.692	0.879	6.2303231950402e-209	EZH2	Malignant cells	GSE108397	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	845
8.9402943616133e-213	0.54739104480513	0.321	0.03	1.61783566767754e-208	DENND2D	Malignant cells	GSE108397	ENSG00000162777	79961	DENN domain containing 2D	FLJ22457|RP5-1180E21.2	protein_coding	Q9H6A0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	846
1.61603956709634e-212	-0.614850822194284	0.728	0.909	2.92438520061753e-208	TMA16	Malignant cells	GSE108397	ENSG00000198498	55319	translation machinery associated 16 homolog	C4orf43|FLJ11184	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	847
1.72579704467903e-212	-0.607910458670759	0.71	0.902	3.12300233205116e-208	MED15	Malignant cells	GSE108397	ENSG00000099917	51586	mediator complex subunit 15	Arc105|CAG7A|PCQAP|TIG-1|TNRC7	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	848
3.75126770867602e-212	-0.652933314963403	0.604	0.844	6.78829404562013e-208	PSMD3	Malignant cells	GSE108397	ENSG00000108344	5709	proteasome 26S subunit, non-ATPase 3	P58|Rpn3|S3|TSTA2	protein_coding	O43242	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	849
2.47401067241621e-211	-0.707168142194281	0.775	0.925	4.47696971280437e-207	ANP32E	Malignant cells	GSE108397	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	850
3.14685160802303e-211	-0.478718107921876	1	1	5.69454266987848e-207	HN1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	851
1.34066170801263e-210	0.278689280283115	1	1	2.42606142681966e-206	NACA	Malignant cells	GSE108397	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	852
2.20913778418761e-210	-0.611487801115214	0.925	0.989	3.9976557342659e-206	SFPQ	Malignant cells	GSE108397	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	853
2.63242551456949e-210	0.706062720443255	0.926	0.8	4.76363721116494e-206	FAM210A	Malignant cells	GSE108397	ENSG00000177150	125228	family with sequence similarity 210 member A	C18orf19|HsT2329|MGC24180	protein_coding	Q96ND0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	854
3.37695744963389e-210	0.612712996213747	0.917	0.736	6.11094220085749e-206	RAB11A	Malignant cells	GSE108397	ENSG00000103769	8766	RAB11A, member RAS oncogene family	YL8	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	855
4.93516320680945e-210	-0.512710239094712	0.974	0.995	8.93067133904239e-206	ISOC2	Malignant cells	GSE108397	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	856
2.66909664903535e-209	-0.928707042751898	0.776	0.941	4.82999729609437e-205	PMAIP1	Malignant cells	GSE108397	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	857
2.71832303412958e-209	-0.61556678151568	0.734	0.918	4.91907736256088e-205	TM7SF3	Malignant cells	GSE108397	ENSG00000064115	51768	transmembrane 7 superfamily member 3	NA	protein_coding	Q9NS93	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	858
2.95269160525395e-209	-0.411580299310119	1	1	5.34319072886755e-205	KPNB1	Malignant cells	GSE108397	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	859
3.18307808838613e-209	-0.501585337772097	0.966	0.995	5.76009810874354e-205	NARF	Malignant cells	GSE108397	ENSG00000141562	26502	nuclear prelamin A recognition factor	DKFZp434G0420|FLJ10067|IOP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	860
3.7409481990824e-209	-0.555464995806718	0.931	0.989	6.7696198610595e-205	DUSP4	Malignant cells	GSE108397	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	861
7.23518792105657e-209	-0.686384093445721	0.503	0.784	1.3092796061944e-204	GNL2	Malignant cells	GSE108397	ENSG00000134697	29889	G protein nucleolar 2	HUMAUANTIG|Ngp-1|Nog2|Nug2	protein_coding	Q13823	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	862
9.02917774340363e-209	-0.439705937582444	0.022	0.303	1.63392000444632e-204	RP11-119J18.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	863
1.49536734225113e-208	-0.654525333796221	0.601	0.832	2.70601674253764e-204	SORT1	Malignant cells	GSE108397	ENSG00000134243	6272	sortilin 1	Gp95|NT3	protein_coding	Q99523	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	864
1.73820231292677e-208	-0.656124932938285	0.502	0.78	3.14545090547229e-204	PRKCZ	Malignant cells	GSE108397	ENSG00000067606	5590	protein kinase C zeta	PKC2	protein_coding	Q05513	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	865
2.86028033589151e-208	-0.648241649794502	0.601	0.845	5.17596329582929e-204	ADAR	Malignant cells	GSE108397	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	866
3.03176725552341e-208	-0.472245332510689	0.998	1	5.48628602559517e-204	HNRNPAB	Malignant cells	GSE108397	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	867
3.72180682083811e-208	-0.595251847051376	0.804	0.942	6.73498162298865e-204	WNK1	Malignant cells	GSE108397	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	868
4.10167110375388e-208	-0.419618567668923	0.999	1	7.42238402935302e-204	UBE2D3	Malignant cells	GSE108397	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	869
6.99402324362188e-208	-0.580697095375305	0.801	0.936	1.26563844616582e-203	MKNK1	Malignant cells	GSE108397	ENSG00000079277	8569	MAPK interacting serine/threonine kinase 1	MNK1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	870
7.23708848073471e-208	-0.489987036971282	0.987	0.998	1.30962353147375e-203	PARP1	Malignant cells	GSE108397	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	871
8.24446974801365e-208	-0.466085335942157	1	1	1.49191924560055e-203	LGALS1	Malignant cells	GSE108397	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	872
4.42422555121697e-207	-0.655239325069929	0.716	0.894	8.00607855748222e-203	SCARB1	Malignant cells	GSE108397	ENSG00000073060	949	scavenger receptor class B member 1	CD36L1|CLA-1|CLA1|SR-BI|SRB1	protein_coding	Q8WTV0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	873
1.94771427790328e-206	-0.521737706339831	0.958	0.995	3.52458375729378e-202	CANX	Malignant cells	GSE108397	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	874
3.7539923139023e-206	-0.651398112081189	0.525	0.791	6.79322449123761e-202	SLC4A2	Malignant cells	GSE108397	ENSG00000164889	6522	solute carrier family 4 member 2	AE2|BND3L|EPB3L1|HKB3|NBND3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	875
4.60040354743003e-205	-0.705452775044925	0.712	0.905	8.32489025942937e-201	GADD45A	Malignant cells	GSE108397	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	876
2.14642739686226e-204	0.586896098234791	0.953	0.871	3.88417501736194e-200	SDHD	Malignant cells	GSE108397	ENSG00000204370	6392	succinate dehydrogenase complex subunit D	cybS|PGL|PGL1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	877
6.40380495626945e-204	0.32055667374935	1	1	1.15883254488652e-199	RPL19	Malignant cells	GSE108397	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	878
8.79017577626684e-204	0.625603071801338	0.641	0.291	1.59067020847325e-199	PLEKHB1	Malignant cells	GSE108397	ENSG00000021300	58473	pleckstrin homology domain containing B1	KPL1|PHR1|PHRET1	protein_coding	Q9UF11	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	879
1.04929695952438e-203	-0.675082701346255	0.488	0.764	1.89880777795533e-199	ATM	Malignant cells	GSE108397	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	880
1.24780125244395e-203	-0.481570236809719	0.975	0.997	2.25802114642257e-199	RBM17	Malignant cells	GSE108397	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	881
1.84706952313965e-203	-0.644010160313479	0.655	0.872	3.34245700907351e-199	TEAD4	Malignant cells	GSE108397	ENSG00000197905	7004	TEA domain transcription factor 4	EFTR-2|RTEF-1|TCF13L1|TEF-3|TEFR-1	protein_coding	Q15561	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	882
5.81512824477056e-203	0.359996818732857	1	1	1.05230560717368e-198	NEDD8	Malignant cells	GSE108397	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	883
6.24479920346843e-203	-0.673464749104877	0.739	0.924	1.13005886385965e-198	IFRD1	Malignant cells	GSE108397	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	884
7.73002175239374e-203	0.442993600485179	1	1	1.39882473631317e-198	HSPA8	Malignant cells	GSE108397	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	885
9.83574194383164e-203	0.497195328321265	0.389	0.071	1.77987586215577e-198	MAGEA12	Malignant cells	GSE108397	ENSG00000213401	4111	MAGE family member A12	CT1.12|MAGE12	protein_coding	P43365	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	886
1.94217027785891e-202	0.620564623900363	0.918	0.738	3.51455133481348e-198	SEPHS2	Malignant cells	GSE108397	ENSG00000179918	22928	selenophosphate synthetase 2	SPS2|SPS2b	protein_coding	Q99611	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	887
2.25296599260159e-202	-0.488047345106786	0.984	0.998	4.07696726021185e-198	SRRM1	Malignant cells	GSE108397	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	888
1.31101874251593e-201	0.651890742701915	0.847	0.619	2.37241951645683e-197	MRPL46	Malignant cells	GSE108397	ENSG00000259494	26589	mitochondrial ribosomal protein L46	C15orf4|LIECG2|P2ECSL	protein_coding	Q9H2W6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	889
2.59844346881692e-201	0.413016030832744	0.261	0.006	4.7021433011711e-197	GALNT14	Malignant cells	GSE108397	ENSG00000158089	79623	polypeptide N-acetylgalactosaminyltransferase 14	FLJ12691|GalNac-T10|GalNac-T14	protein_coding	Q96FL9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	890
9.51496831119539e-201	-0.626647440249707	0.582	0.831	1.72182866559392e-196	PFKP	Malignant cells	GSE108397	ENSG00000067057	5214	phosphofructokinase, platelet	PFK-C|PFKF	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	891
1.10422017365146e-200	-0.496581299954274	0.984	0.998	1.99819682623968e-196	ATP1B3	Malignant cells	GSE108397	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	892
1.50787370678009e-200	0.622739605237421	0.994	0.989	2.72864825978924e-196	MRPL36	Malignant cells	GSE108397	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	893
2.10162527034157e-200	0.439738227945853	1	1	3.8031010892101e-196	HSPD1	Malignant cells	GSE108397	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	894
2.5536152467326e-200	-0.639734223132922	0.592	0.826	4.62102215048732e-196	TTC37	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	895
2.83184298999924e-200	-0.607511419710746	0.834	0.945	5.12450307470263e-196	FKBP4	Malignant cells	GSE108397	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	896
6.34124416324899e-200	0.616111335916355	0.543	0.189	1.14751154378154e-195	NFATC2	Malignant cells	GSE108397	ENSG00000101096	4773	nuclear factor of activated T cells 2	NF-ATP|NFAT1|NFATp	protein_coding	Q13469	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	897
1.12420918968967e-199	-0.663040589858724	0.744	0.898	2.03436894966244e-195	ABCD1	Malignant cells	GSE108397	ENSG00000101986	215	ATP binding cassette subfamily D member 1	adrenoleukodystrophy|ALD|ALDP|AMN	protein_coding	P33897	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	898
1.16854229217379e-199	-0.667792783099336	0.448	0.739	2.11459413191769e-195	NEDD4L	Malignant cells	GSE108397	ENSG00000049759	23327	NEDD4 like E3 ubiquitin protein ligase	KIAA0439|NEDD4-2|RSP5	protein_coding	Q96PU5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	899
1.30999132541664e-199	-0.422878305165945	1	1	2.37056030247396e-195	MLF2	Malignant cells	GSE108397	ENSG00000089693	8079	myeloid leukemia factor 2	NTN4	protein_coding	Q15773	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	900
2.0039176523893e-199	0.604284067206663	0.937	0.788	3.62628938376368e-195	PSMC6	Malignant cells	GSE108397	ENSG00000100519	5706	proteasome 26S subunit, ATPase 6	p42|RPT5	protein_coding	P62333	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	901
2.20850893135399e-199	-0.69345056710193	0.102	0.43	3.99651776217818e-195	ITGA3	Malignant cells	GSE108397	ENSG00000005884	3675	integrin subunit alpha 3	CD49c|GAP-B3|MSK18|VCA-2|VLA3a	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	902
2.54187224773469e-199	-0.611408933185067	0.869	0.965	4.5997720195007e-195	GPR56	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	903
4.8239523912852e-199	0.429421199903499	0.999	0.997	8.7294242472697e-195	EIF3G	Malignant cells	GSE108397	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	904
8.33158788013837e-199	-0.715541565235619	0.302	0.631	1.50768414278984e-194	IGF2BP3	Malignant cells	GSE108397	ENSG00000136231	10643	insulin like growth factor 2 mRNA binding protein 3	CT98|IMP-3|IMP3	protein_coding	O00425	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	905
1.0893234288248e-198	0.343746329587955	1	1	1.97123967680135e-194	TCEB2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	906
1.53738200273933e-198	-0.608857017597317	0.826	0.947	2.78204647215709e-194	ACTR3	Malignant cells	GSE108397	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	907
1.55830339738637e-198	-0.785065803255624	0.245	0.574	2.81990582791038e-194	NSG1	Malignant cells	GSE108397	ENSG00000168824	27065	neuronal vesicle trafficking associated 1	D4S234E|NEEP21|P21	protein_coding	P42857	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	908
3.2555209935882e-198	0.454493089223348	0.999	0.997	5.89119078999721e-194	EIF3I	Malignant cells	GSE108397	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	909
7.77113743212374e-198	-0.650784834199246	0.696	0.899	1.40626502971711e-193	HSPA4	Malignant cells	GSE108397	ENSG00000170606	3308	heat shock protein family A (Hsp70) member 4	HS24/P52|HSPH2	protein_coding	P34932	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	910
1.76157619152341e-197	-0.476610481794059	0.967	0.995	3.18774827618077e-193	CDKN2AIPNL	Malignant cells	GSE108397	ENSG00000237190	91368	CDKN2A interacting protein N-terminal like	C2AIL|MGC13017	protein_coding	Q96HQ2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	911
9.33268058021663e-197	-0.506020156456687	0.955	0.992	1.688841877796e-192	CMSS1	Malignant cells	GSE108397	ENSG00000184220	84319	cms1 ribosomal small subunit homolog	C3orf26|MGC4308	protein_coding	Q9BQ75	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	912
1.22100791259409e-196	-0.994659592777034	0.075	0.384	2.20953591863026e-192	IGFBP7	Malignant cells	GSE108397	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	913
1.47230807337556e-196	-0.409851613825401	1	1	2.66428868958041e-192	VDAC2	Malignant cells	GSE108397	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	914
2.17794452065152e-196	-0.521776471390603	0.964	0.995	3.94120840457099e-192	ZCCHC17	Malignant cells	GSE108397	ENSG00000121766	51538	zinc finger CCHC-type containing 17	HSPC251|pNO40|PS1D	protein_coding	Q9NP64	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	915
2.97215192209193e-196	-0.550248731090079	0.133	0.465	5.37840611821756e-192	C3orf49	Malignant cells	GSE108397	ENSG00000163632	132200	chromosome 3 open reading frame 49	NA	protein_coding	Q96BT1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	916
3.77467215596798e-196	-0.555357574307337	0.885	0.979	6.83064673343966e-192	NTMT1	Malignant cells	GSE108397	ENSG00000148335	28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1	AD-003|C9orf32|HOMT1A|METTL11A|NRMT|NRMT1	protein_coding	Q9BV86	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	917
1.00243993771357e-194	0.668029572272333	0.919	0.806	1.81401531128648e-190	MRPS30	Malignant cells	GSE108397	ENSG00000112996	10884	mitochondrial ribosomal protein S30	PAP|PDCD9	protein_coding	Q9NP92	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	918
2.05517306596653e-194	-0.595032279573356	0.703	0.892	3.71904118017303e-190	MIIP	Malignant cells	GSE108397	ENSG00000116691	60672	migration and invasion inhibitory protein	FLJ12438|IIp45	protein_coding	Q5JXC2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	919
3.79534772242368e-194	-0.557935037975626	0.851	0.969	6.86806123849789e-190	NAA50	Malignant cells	GSE108397	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	920
6.72252919130603e-194	-0.357887413222421	1	1	1.21650888245874e-189	SSU72	Malignant cells	GSE108397	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	921
1.15110226457359e-193	0.625199463102468	0.976	0.907	2.08303465797236e-189	MYL12A	Malignant cells	GSE108397	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	922
1.68826134197496e-193	-0.460893495791828	0.06	0.356	3.05507772443789e-189	RCN3	Malignant cells	GSE108397	ENSG00000142552	57333	reticulocalbin 3	RLP49	protein_coding	Q96D15	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	923
3.05966640643975e-193	0.693789394804425	0.833	0.592	5.53677232909337e-189	NNT-AS1	Malignant cells	GSE108397	ENSG00000248092	NA	NA	RP11-159F24.1	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	924
4.62702233851653e-193	-0.511469197001759	0.949	0.994	8.3730596237795e-189	WBP11	Malignant cells	GSE108397	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	925
5.70783614814167e-193	-0.566102976533794	0.812	0.937	1.03289002936772e-188	TRMT6	Malignant cells	GSE108397	ENSG00000089195	51605	tRNA methyltransferase 6 non-catalytic subunit	CGI-09|GCD10|Gcd10p|MGC5029	protein_coding	Q9UJA5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	926
7.64911558041874e-193	0.551394109070833	0.941	0.788	1.38418395543258e-188	ETFA	Malignant cells	GSE108397	ENSG00000140374	2108	electron transfer flavoprotein subunit alpha	EMA|GA2|MADD	protein_coding	P13804	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	927
1.5085842509126e-192	-0.564705767166915	0.868	0.961	2.72993406045144e-188	SEC14L1	Malignant cells	GSE108397	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	928
1.18659585295543e-191	-0.490531082824096	0.965	0.995	2.14726385550814e-187	REEP3	Malignant cells	GSE108397	ENSG00000165476	221035	receptor accessory protein 3	C10orf74|Yip2b	protein_coding	Q6NUK4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	929
1.1979401129137e-191	-0.54039508025818	0.936	0.986	2.16779242832864e-187	HOMER3	Malignant cells	GSE108397	ENSG00000051128	9454	homer scaffold protein 3	HOMER-3	protein_coding	Q9NSC5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	930
2.55709796384563e-191	0.531695451501888	0.343	0.055	4.62732447537505e-187	ZNF385D	Malignant cells	GSE108397	ENSG00000151789	79750	zinc finger protein 385D	FLJ22419|ZNF659	protein_coding	Q9H6B1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	931
2.61713186742349e-191	-0.503226166489879	0.991	0.997	4.73596182728955e-187	PPFIA1	Malignant cells	GSE108397	ENSG00000288198	8500	PTPRF interacting protein alpha 1	LIP.1|LIPRIN	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	932
3.78767594949803e-191	-0.389161542544726	1	0.999	6.85417839821164e-187	SLC25A39	Malignant cells	GSE108397	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	933
4.48267563065645e-191	-0.593128580919478	0.654	0.866	8.11184982123591e-187	RNF115	Malignant cells	GSE108397	ENSG00000265491	27246	ring finger protein 115	CL469780|ZNF364	protein_coding	Q9Y4L5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	934
1.34351252637005e-190	-0.58864128499549	0.737	0.9	2.43122026771925e-186	MYH9	Malignant cells	GSE108397	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	935
1.67762103289904e-190	0.57833293317546	0.464	0.143	3.03582302113411e-186	RP11-160O5.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	936
1.85131126252846e-190	-0.556065785987921	0.809	0.937	3.3501328606715e-186	SIKE1	Malignant cells	GSE108397	ENSG00000052723	80143	suppressor of IKBKE 1	FLJ21168|SIKE	protein_coding	Q9BRV8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	937
5.19215300515803e-190	-0.597629105999836	0.583	0.819	9.39572007813397e-186	NR1H2	Malignant cells	GSE108397	ENSG00000131408	7376	nuclear receptor subfamily 1 group H member 2	LXR-b|LXRb|NER|NER-I|RIP15|UNR	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	938
6.46144767539863e-190	-0.42738206281032	0.99	0.998	1.16926357134014e-185	DNAJC19	Malignant cells	GSE108397	ENSG00000205981	131118	DnaJ heat shock protein family (Hsp40) member C19	Pam18|Tim14|TIMM14	protein_coding	Q96DA6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	939
1.7406391734173e-189	0.424985256248844	0.319	0.04	3.14986064821594e-185	LIMCH1	Malignant cells	GSE108397	ENSG00000064042	22998	LIM and calponin homology domains 1	DKFZP686A01247|LIMCH1A|LMO7B	protein_coding	Q9UPQ0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	940
1.85741881263411e-189	0.570029155566938	0.482	0.152	3.36118508334269e-185	CREB5	Malignant cells	GSE108397	ENSG00000146592	9586	cAMP responsive element binding protein 5	CRE-BPA|H_GS165L15.1	protein_coding	Q02930	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	941
2.3552954458599e-189	-0.382586709078383	1	1	4.26214263882807e-185	C20orf24	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	942
3.48001389584955e-189	-0.779589789441496	0.257	0.574	6.29743314592935e-185	C8orf31	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	943
5.21648602177054e-189	-0.372065493438579	1	1	9.43975310499596e-185	MRPL41	Malignant cells	GSE108397	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	944
1.74434645717261e-188	-0.383064660929431	1	1	3.15656934889955e-184	SERBP1	Malignant cells	GSE108397	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	945
4.32410493209193e-188	0.344918648200367	1	1	7.82490028511356e-184	C14orf2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	946
6.81041889888126e-188	0.511541205282356	0.999	0.995	1.23241340394155e-183	MAP1LC3B	Malignant cells	GSE108397	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	947
9.08522536952554e-188	-0.526497990935784	0.956	0.994	1.64406238286934e-183	BLOC1S2	Malignant cells	GSE108397	ENSG00000196072	282991	biogenesis of lysosomal organelles complex 1 subunit 2	BLOS2|BORCS2|FLJ30135|MGC10120	protein_coding	Q6QNY1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	948
1.53694894611766e-187	-0.527103344475861	0.991	0.997	2.78126281289451e-183	RAB13	Malignant cells	GSE108397	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	949
3.03464942311278e-187	-0.605504036215704	0.944	0.99	5.49150159606489e-183	DBF4	Malignant cells	GSE108397	ENSG00000006634	10926	DBF4 zinc finger	ASK|chif|DBF4A|ZDBF1	protein_coding	Q9UBU7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	950
6.09937737962245e-187	-0.639219576157852	0.42	0.708	1.10374333061648e-182	ZFP91	Malignant cells	GSE108397	ENSG00000186660	80829	ZFP91 zinc finger protein, atypical E3 ubiquitin ligase	PZF|ZNF757	protein_coding	Q96JP5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	951
1.44680698961783e-186	-0.691029385707538	0.512	0.771	2.61814192841242e-182	PRR11	Malignant cells	GSE108397	ENSG00000068489	55771	proline rich 11	FLJ11029	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	952
2.53351439211438e-186	0.722206560694899	0.636	0.31	4.58464764397019e-182	SOX4	Malignant cells	GSE108397	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	953
2.76666534176876e-186	-0.540956823387367	0.833	0.948	5.00655760246475e-182	MYO1C	Malignant cells	GSE108397	ENSG00000197879	4641	myosin IC	MyoIC|myr2|NMI	protein_coding	O00159	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	954
2.95524499467238e-186	-0.692849026946778	0.58	0.799	5.34781134235915e-182	TSKU	Malignant cells	GSE108397	ENSG00000182704	25987	tsukushi, small leucine rich proteoglycan	E2IG4|LRRC54|TSK	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	955
4.5762898700978e-186	-0.526003377215582	0.934	0.988	8.28125414892899e-182	IGF2BP2	Malignant cells	GSE108397	ENSG00000073792	10644	insulin like growth factor 2 mRNA binding protein 2	IMP-2|p62	protein_coding	Q9Y6M1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	956
6.40045532685132e-186	-0.615146997070172	0.568	0.813	1.15822639594702e-181	TRMT2A	Malignant cells	GSE108397	ENSG00000099899	27037	tRNA methyltransferase 2 homolog A	HTF9C	protein_coding	Q8IZ69	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	957
1.1529807784295e-185	0.305611161282118	1	1	2.08643401664603e-181	RPS19	Malignant cells	GSE108397	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	958
1.47426363491861e-185	-0.744191014493013	0.459	0.742	2.66782747374872e-181	PDE4B	Malignant cells	GSE108397	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	959
2.08957445967064e-185	0.308322826145925	1	1	3.78129394222e-181	SERF2	Malignant cells	GSE108397	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	960
2.84633854062573e-185	0.517630633899709	0.969	0.889	5.15073422311633e-181	COMMD4	Malignant cells	GSE108397	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	961
4.20813692507199e-185	0.63148272821401	0.85	0.617	7.61504457961027e-181	RAI14	Malignant cells	GSE108397	ENSG00000039560	26064	retinoic acid induced 14	DKFZp564G013|KIAA1334|NORPEG|RAI13	protein_coding	Q9P0K7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	962
1.02797031629522e-184	-0.674105295086145	0.534	0.777	1.86021508436783e-180	GLA	Malignant cells	GSE108397	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	963
1.38907609715584e-184	-0.433882188878008	0.998	1	2.5136721054132e-180	RBM8A	Malignant cells	GSE108397	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	964
3.50313022453626e-184	0.540683884812698	0.972	0.89	6.33926445432081e-180	SUGT1	Malignant cells	GSE108397	ENSG00000165416	10910	SGT1 homolog, MIS12 kinetochore complex assembly cochaperone	SGT1	protein_coding	Q9Y2Z0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	965
3.34098256339842e-183	-0.335162433905491	0.999	1	6.04584204672579e-179	ARL6IP4	Malignant cells	GSE108397	ENSG00000182196	51329	ADP ribosylation factor like GTPase 6 interacting protein 4	SFRS20|SR-25|SRp25|SRrp37	protein_coding	Q66PJ3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	966
1.23027795566479e-182	0.45625644159156	0.998	0.996	2.226310988571e-178	CYBA	Malignant cells	GSE108397	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	967
1.80046388734558e-182	0.698770736042692	0.626	0.316	3.25811945054056e-178	CMBL	Malignant cells	GSE108397	ENSG00000164237	134147	carboxymethylenebutenolidase homolog	FLJ23617	protein_coding	Q96DG6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	968
2.04928774091787e-182	-0.481369786746435	0.957	0.991	3.70839109596498e-178	PON2	Malignant cells	GSE108397	ENSG00000105854	5445	paraoxonase 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	969
5.34610957677375e-182	-0.618348140076591	0.26	0.575	9.67431989012977e-178	INTS3	Malignant cells	GSE108397	ENSG00000262826	65123	integrator complex subunit 3	C1orf60|FLJ21919|INT3|SOSS-A	protein_coding	Q68E01	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	970
4.1721862793542e-181	0.40075914896992	1	1	7.54998829111935e-177	ATP5B	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	971
4.84293629255844e-181	-0.49410615478455	0.954	0.994	8.76377751501374e-177	RAB7A	Malignant cells	GSE108397	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	972
5.1752432924219e-181	-0.445156700318797	0.04	0.308	9.36512026196667e-177	DDR2	Malignant cells	GSE108397	ENSG00000162733	4921	discoidin domain receptor tyrosine kinase 2	NTRKR3|TKT|TYRO10	protein_coding	Q16832	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	973
1.61129406936478e-180	-0.397434007501151	0.024	0.277	2.9157977479225e-176	CTD-2357A8.3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	974
3.35634691522286e-180	0.695000223198875	0.887	0.739	6.07364537778729e-176	APOO	Malignant cells	GSE108397	ENSG00000184831	79135	apolipoprotein O	FAM121B|MGC4825|Mic23|MIC26|MICOS26|My025	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	975
5.69385550343875e-180	-0.407123550652128	0.996	0.998	1.03036009190228e-175	TMEM160	Malignant cells	GSE108397	ENSG00000130748	54958	transmembrane protein 160	FLJ20512	protein_coding	Q9NX00	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	976
5.81700851393261e-180	-0.555234359978171	0.865	0.964	1.05264586068125e-175	DNAJB6	Malignant cells	GSE108397	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	977
1.85576057675251e-179	-0.608035094585577	0.52	0.778	3.35818433969133e-175	TRPM2	Malignant cells	GSE108397	ENSG00000142185	7226	transient receptor potential cation channel subfamily M member 2	EREG1|KNP3|LTRPC2|NUDT9H|NUDT9L1|TRPC7	protein_coding	O94759	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	978
2.19965763962852e-179	0.601558192512329	1	1	3.98050046467177e-175	ANXA2	Malignant cells	GSE108397	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	979
6.65811500475798e-179	-0.43576714004365	0.028	0.282	1.204852491261e-174	DMKN	Malignant cells	GSE108397	ENSG00000161249	93099	dermokine	ZD52F10	protein_coding	Q6E0U4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	980
8.95146740175413e-179	-0.722553441752284	0.347	0.66	1.61985754102143e-174	SMAGP	Malignant cells	GSE108397	ENSG00000170545	57228	small cell adhesion glycoprotein	hSMAGP|MGC149453|MGC149454	protein_coding	Q0VAQ4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	981
2.03162512726369e-178	-0.582037253016032	0.743	0.903	3.67642883029638e-174	DDX39A	Malignant cells	GSE108397	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	982
3.41478640195505e-178	-0.606009453317718	0.51	0.773	6.17939747297786e-174	UBAP2L	Malignant cells	GSE108397	ENSG00000143569	9898	ubiquitin associated protein 2 like	KIAA0144|NICE-4	protein_coding	Q14157	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	983
4.72228725369742e-178	0.594394039209222	0.895	0.721	8.54545101429085e-174	TUBB6	Malignant cells	GSE108397	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	984
4.7384134852248e-178	-0.528931647848562	0.915	0.976	8.5746330428628e-174	RNF130	Malignant cells	GSE108397	ENSG00000113269	55819	ring finger protein 130	G1RZFP|GOLIATH|GP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	985
8.83933102785329e-178	-0.537469840454328	0.868	0.958	1.59956534280033e-173	UBAC1	Malignant cells	GSE108397	ENSG00000130560	10422	UBA domain containing 1	GBDR1|KPC2|UBADC1	protein_coding	Q9BSL1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	986
2.4318874108255e-177	0.325311845426564	1	1	4.40074345862983e-173	POLR2F	Malignant cells	GSE108397	ENSG00000100142	5435	RNA polymerase II, I and III subunit F	HRBP14.4|RPB6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	987
5.58656020024915e-177	-0.604825053610897	0.697	0.878	1.01094393383709e-172	ATAD3B	Malignant cells	GSE108397	ENSG00000160072	83858	ATPase family AAA domain containing 3B	KIAA1273|TOB3	protein_coding	Q5T9A4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	988
6.44940485868184e-177	-0.638648634688435	0.637	0.835	1.16708430322707e-172	EEA1	Malignant cells	GSE108397	ENSG00000102189	8411	early endosome antigen 1	ZFYVE2	protein_coding	Q15075	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	989
2.43794381595687e-176	-0.61678742278043	0.357	0.657	4.41170312935556e-172	MMP20	Malignant cells	GSE108397	ENSG00000137674	9313	matrix metallopeptidase 20	NA	protein_coding	O60882	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	990
1.23915258670422e-175	0.569794328234702	0.709	0.409	2.24237052089995e-171	SUCLA2	Malignant cells	GSE108397	ENSG00000136143	8803	succinate-CoA ligase ADP-forming subunit beta	LINC00444	protein_coding	Q9P2R7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	991
1.5951439113598e-175	0.474836310666432	0.452	0.142	2.8865724219967e-171	TPGS1	Malignant cells	GSE108397	ENSG00000141933	91978	tubulin polyglutamylase complex subunit 1	C19orf20|GTRGEO22|PGs1	protein_coding	Q6ZTW0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	992
2.05627418133788e-175	-0.44419214544323	0.998	0.998	3.72103375854903e-171	FAM210B	Malignant cells	GSE108397	ENSG00000124098	116151	family with sequence similarity 210 member B	C20orf108|dJ1167H4.1|DKFZP434A1114	protein_coding	Q96KR6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	993
2.74273942170342e-175	-0.506037028532678	0.964	0.997	4.96326125751451e-171	EBNA1BP2	Malignant cells	GSE108397	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	994
4.52101393823233e-175	-0.470985528295118	0.983	0.999	8.18122682262522e-171	LSM12	Malignant cells	GSE108397	ENSG00000161654	124801	LSM12 homolog	FLJ30656	protein_coding	Q3MHD2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	995
5.66812974027574e-175	0.536347077672812	0.426	0.123	1.0257047578003e-170	CTD-2207A17.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	996
7.96200007251028e-175	-0.442166111945383	0.984	0.995	1.44080353312146e-170	PPP1CA	Malignant cells	GSE108397	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	997
2.19937726153143e-174	-0.581177848026743	0.662	0.855	3.97999309246727e-170	UBE2R2	Malignant cells	GSE108397	ENSG00000107341	54926	ubiquitin conjugating enzyme E2 R2	CDC34B|FLJ20419|MGC10481|UBC3B	protein_coding	Q712K3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	998
2.83150874726202e-174	-0.424169138188196	0.987	0.999	5.12389822904535e-170	H2AFY	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	999
3.61673239099914e-174	-0.314802394330251	1	1	6.54483893475205e-170	MRPS15	Malignant cells	GSE108397	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1000
4.2466004115593e-174	0.969573535224209	0.823	0.71	7.68464810475771e-170	PBDC1	Malignant cells	GSE108397	ENSG00000102390	51260	polysaccharide biosynthesis domain containing 1	CXorf26|MGC874	protein_coding	Q9BVG4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1001
5.21360823366387e-174	-0.304858842965793	1	1	9.43454545963814e-170	UQCR11.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1002
7.12080626904136e-174	-0.547836386931974	0.743	0.911	1.28858110244573e-169	TCOF1	Malignant cells	GSE108397	ENSG00000070814	6949	treacle ribosome biogenesis factor 1	TCS|treacle	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1003
8.08990898035842e-174	-0.561601568765087	0.726	0.889	1.46394992908566e-169	WRB	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1004
1.0102733084055e-173	0.36466455936679	1	0.999	1.8281905788906e-169	TAF9	Malignant cells	GSE108397	ENSG00000276463	6880	TATA-box binding protein associated factor 9	AD-004|CGI-137|MGC1603|MGC3647|MGC5067|TAF2G|TAFII31|TAFII32|TAFIID32	protein_coding	Q16594	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1005
1.81762048145253e-173	-0.576847553269803	0.296	0.611	3.2891660232365e-169	TMEM39B	Malignant cells	GSE108397	ENSG00000121775	55116	transmembrane protein 39B	FLJ10315	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1006
2.08835872166049e-173	0.357097551783312	1	1	3.77909394271682e-169	PHB	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1007
2.52775050220284e-173	-0.764800267997759	0.768	0.926	4.57421730878626e-169	PHLDA1	Malignant cells	GSE108397	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1008
3.56036284304764e-173	-0.425030614054198	0.987	0.998	6.44283260077902e-169	SH3GLB1	Malignant cells	GSE108397	ENSG00000097033	51100	SH3 domain containing GRB2 like, endophilin B1	Bif-1|CGI-61|KIAA0491|PPP1R70	protein_coding	Q9Y371	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1009
5.98815063068203e-173	0.493600035193127	0.375	0.089	1.08361573812822e-168	CTD-2256P15.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1010
7.80280782580688e-173	-0.621692517261323	0.553	0.776	1.41199610415801e-168	GBA	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1011
8.51494681385292e-173	-0.465293945261084	0.974	0.995	1.54086477543482e-168	PSMG1	Malignant cells	GSE108397	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1012
1.06160595599712e-172	0.657576157417822	0.468	0.161	1.92108213797239e-168	EDNRB	Malignant cells	GSE108397	ENSG00000136160	1910	endothelin receptor type B	ETB|HSCR|HSCR2	protein_coding	P24530	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1013
1.40404004044132e-172	0.586561930924313	0.875	0.698	2.54075085718261e-168	NDUFS2	Malignant cells	GSE108397	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1014
1.53473953581462e-172	-0.433058056767623	0.975	0.997	2.77726466401013e-168	LAMTOR2	Malignant cells	GSE108397	ENSG00000116586	28956	late endosomal/lysosomal adaptor, MAPK and MTOR activator 2	ENDAP|MAPBPIP|MAPKSP1AP|p14|Ragulator2|ROBLD3	protein_coding	Q9Y2Q5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1015
1.72233431151857e-172	0.491211415848263	0.987	0.965	3.116736170124e-168	TMEM208	Malignant cells	GSE108397	ENSG00000168701	29100	transmembrane protein 208	hSND2|HSPC171	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1016
2.47882231522001e-172	0.37305461133935	1	1	4.48567686162212e-168	POLR1D	Malignant cells	GSE108397	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1017
3.69931991534394e-172	0.856313681844844	0.825	0.638	6.69428931880639e-168	FAM167B	Malignant cells	GSE108397	ENSG00000183615	84734	family with sequence similarity 167 member B	C1orf90|DIORA-2|MGC10820	protein_coding	Q9BTA0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1018
9.11064294891191e-172	0.850947148053725	0.999	1	1.6486619480351e-167	COX7B	Malignant cells	GSE108397	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1019
1.86337389156522e-171	-0.518167469026969	0.916	0.982	3.37196139417642e-167	CD59	Malignant cells	GSE108397	ENSG00000085063	966	CD59 molecule (CD59 blood group)	16.3A5|EJ16|EJ30|EL32|G344|MIC11|MIN1|MIN2|MIN3|MSK21|p18-20	protein_coding	P13987	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1020
1.92917227299257e-171	0.575313170895312	0.701	0.4	3.49103014520736e-167	MKRN2	Malignant cells	GSE108397	ENSG00000075975	23609	makorin ring finger protein 2	HSPC070|RNF62	protein_coding	Q9H000	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1021
2.0803452045941e-171	0.431882387353443	0.998	0.992	3.76459268223348e-167	DUT	Malignant cells	GSE108397	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1022
5.50573677823498e-171	0.585697244285051	0.761	0.493	9.96318127389403e-167	C8orf82	Malignant cells	GSE108397	ENSG00000213563	414919	chromosome 8 open reading frame 82	MGC70857	protein_coding	Q6P1X6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1023
8.649034162215e-171	-0.648948194332557	0.786	0.923	1.56512922199443e-166	ATP2B1	Malignant cells	GSE108397	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1024
1.66900366470601e-170	-0.583997732013747	0.697	0.871	3.02022903165199e-166	CEP57	Malignant cells	GSE108397	ENSG00000166037	9702	centrosomal protein 57	KIAA0092|Translokin|TSP57	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1025
1.81594030913178e-170	-0.390053688763611	0.998	0.999	3.28612558340488e-166	PHB2	Malignant cells	GSE108397	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1026
1.96532222785922e-170	-0.540383229424532	0.778	0.923	3.55644710353404e-166	L1CAM	Malignant cells	GSE108397	ENSG00000198910	3897	L1 cell adhesion molecule	CAML1|CD171|HSAS|HSAS1|MASA|MIC5|NCAM-L1|S10|SPG1	protein_coding	P32004	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1027
7.57577382246401e-170	-0.531975437822275	0.938	0.986	1.37091203091309e-165	CTNNAL1	Malignant cells	GSE108397	ENSG00000119326	8727	catenin alpha like 1	alpha-CATU|CLLP	protein_coding	Q9UBT7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1028
8.19829848500602e-170	1.01476106537694	0.289	0.038	1.48356409384669e-165	MGP	Malignant cells	GSE108397	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1029
8.52133017725619e-170	-0.491818578807423	0.952	0.988	1.54201990887628e-165	LINC00116	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1030
1.13952903861116e-169	-0.434313636310192	0.989	0.996	2.06209174827076e-165	MTPN	Malignant cells	GSE108397	ENSG00000105887	136319	myotrophin	GCDP|MYOTROPHIN|V-1	protein_coding	P58546	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1031
1.52335704770744e-169	-0.319449783225735	1	1	2.75666691353138e-165	ATP6V0B	Malignant cells	GSE108397	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1032
2.12304659938369e-169	0.592027515770154	0.394	0.106	3.84186512624473e-165	RP11-252C15.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1033
2.89153882984161e-169	-0.498537796646821	0.934	0.987	5.23252866648138e-165	ITGB1	Malignant cells	GSE108397	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1034
2.92896151850912e-169	-0.519325758072656	0.83	0.933	5.30024876389411e-165	OGFOD3	Malignant cells	GSE108397	ENSG00000181396	79701	2-oxoglutarate and iron dependent oxygenase domain containing 3	C17orf101|FLJ22222	protein_coding	Q6PK18	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1035
3.13213621254044e-169	-0.501993693548603	0.934	0.987	5.66791369021318e-165	EFHD2	Malignant cells	GSE108397	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1036
7.09850893749632e-169	-0.626508308456908	0.396	0.676	1.28454617732933e-164	NOTCH2	Malignant cells	GSE108397	ENSG00000134250	4853	notch receptor 2	NA	protein_coding	Q04721	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1037
1.64908026702926e-168	-0.459153320369334	0.997	1	2.98417565121615e-164	SET	Malignant cells	GSE108397	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1038
2.37597379184283e-168	-0.486516272544619	0.914	0.985	4.29956217371879e-164	ICMT	Malignant cells	GSE108397	ENSG00000116237	23463	isoprenylcysteine carboxyl methyltransferase	HSTE14|PCCMT|PPMT	protein_coding	O60725	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1039
3.48850615278334e-168	-0.381039324774632	0.999	1	6.31280073407674e-164	CNBP	Malignant cells	GSE108397	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1040
3.59113217566199e-168	0.42963489804231	0.999	0.993	6.49851278507793e-164	DAD1	Malignant cells	GSE108397	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1041
5.83547042612731e-168	-0.424751841430427	0.996	0.998	1.055986728312e-163	MT-ND5	Malignant cells	GSE108397	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1042
6.13639151120843e-168	0.50897932774512	0.984	0.942	1.11044140786828e-163	IMP3	Malignant cells	GSE108397	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1043
6.42954187558683e-168	-0.525180799867633	0.901	0.966	1.16348989780619e-163	HGS	Malignant cells	GSE108397	ENSG00000185359	9146	hepatocyte growth factor-regulated tyrosine kinase substrate	Hrs|Vps27|ZFYVE8	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1044
1.27767003870917e-167	0.488741627659853	0.988	0.948	2.31207170204811e-163	PSMB3	Malignant cells	GSE108397	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1045
1.68194761257278e-167	-0.62183549867124	0.463	0.727	3.04365239971169e-163	TNIP1	Malignant cells	GSE108397	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1046
6.9097360283097e-167	0.594751852758981	0.821	0.599	1.25038583168292e-162	VPS25	Malignant cells	GSE108397	ENSG00000131475	84313	vacuolar protein sorting 25 homolog	DERP9|EAP20|MGC10540	protein_coding	Q9BRG1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1047
7.4536098733298e-167	-0.596620713842514	0.421	0.694	1.34880524267776e-162	PFKL	Malignant cells	GSE108397	ENSG00000141959	5211	phosphofructokinase, liver type	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1048
9.95990613646636e-167	0.473855456089965	0.395	0.107	1.80234461445495e-162	BFSP1	Malignant cells	GSE108397	ENSG00000125864	631	beaded filament structural protein 1	CP115|CP94|filensin|LIFL-H	protein_coding	Q12934	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1049
1.06651987046095e-166	0.356889549323248	1	0.999	1.92997435758613e-162	TBCA	Malignant cells	GSE108397	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1050
1.26627125715082e-166	0.471382892972806	0.99	0.965	2.29144446694012e-162	EEF1E1	Malignant cells	GSE108397	ENSG00000124802	9521	eukaryotic translation elongation factor 1 epsilon 1	AIMP3|P18	protein_coding	O43324	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1051
1.78379762623288e-166	0.485001854528724	0.976	0.937	3.22796018443101e-162	EMC7	Malignant cells	GSE108397	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1052
1.80503804694937e-166	-0.591321006838052	0.323	0.621	3.26639684975958e-162	CYTH2	Malignant cells	GSE108397	ENSG00000105443	9266	cytohesin 2	ARNO|CTS18.1|cytohesin-2|PSCD2|PSCD2L|Sec7p-L|Sec7p-like	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1053
1.93218989282365e-166	-0.687269275914475	0.849	0.963	3.49649083005369e-162	FHL2	Malignant cells	GSE108397	ENSG00000115641	2274	four and a half LIM domains 2	DRAL|SLIM3	protein_coding	Q14192	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1054
1.99108660086155e-166	-0.420186305093676	0.987	0.998	3.60307031291906e-162	STK25	Malignant cells	GSE108397	ENSG00000115694	10494	serine/threonine kinase 25	SOK1|YSK1	protein_coding	O00506	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1055
2.74477742062787e-166	-0.541277315780049	0.792	0.916	4.9669492203682e-162	ZFAND2B	Malignant cells	GSE108397	ENSG00000158552	130617	zinc finger AN1-type containing 2B	AIRAPL	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1056
3.01504274775598e-166	0.581883791956716	0.938	0.82	5.45602135633922e-162	C1orf21	Malignant cells	GSE108397	ENSG00000116667	81563	chromosome 1 open reading frame 21	PIG13	protein_coding	Q9H246	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1057
3.49051080319154e-166	0.608901198726591	0.631	0.328	6.31642834945542e-162	SLC24A5	Malignant cells	GSE108397	ENSG00000188467	283652	solute carrier family 24 member 5	JSX|OCA6	protein_coding	Q71RS6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1058
3.50421482779877e-166	-0.475293911116419	0.925	0.981	6.34122715238465e-162	SRPK2	Malignant cells	GSE108397	ENSG00000135250	6733	SRSF protein kinase 2	SFRSK2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1059
4.777425392765e-166	0.657376968833323	0.828	0.612	8.64522899074755e-162	DAB2	Malignant cells	GSE108397	ENSG00000153071	1601	DAB adaptor protein 2	DOC-2	protein_coding	P98082	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1060
9.42546304209671e-166	-0.503825202212011	0.883	0.973	1.70563179209782e-161	RAP1B	Malignant cells	GSE108397	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1061
1.14408314873376e-165	-0.360575270495605	0.998	1	2.07033286594861e-161	H2AFV	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1062
7.20900404289199e-165	-0.366567725753434	0.999	0.999	1.30454137160173e-160	MTCH1	Malignant cells	GSE108397	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1063
1.09132130576057e-164	-0.42305315349179	0.989	0.999	1.97485503490434e-160	RDX	Malignant cells	GSE108397	ENSG00000137710	5962	radixin	DFNB24	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1064
2.52850782217415e-164	-0.549926161248068	0.118	0.409	4.57558775500634e-160	CAPS	Malignant cells	GSE108397	ENSG00000105519	828	calcyphosine	CAPS1|MGC126562	protein_coding	Q13938	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1065
5.3419804456538e-164	0.5191044813104	0.913	0.74	9.66684781445511e-160	TRIAP1	Malignant cells	GSE108397	ENSG00000170855	51499	TP53 regulated inhibitor of apoptosis 1	HSPC132|MDM35|P53CSV|WF-1	protein_coding	O43715	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1066
9.66014635090625e-164	0.467108454639579	0.992	0.975	1.74810008366e-159	SNRPA1	Malignant cells	GSE108397	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1067
1.79920794302534e-163	-0.416267962726192	0.992	0.998	3.25584669369865e-159	MDH2	Malignant cells	GSE108397	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1068
1.84204916393699e-163	0.514950999717909	0.452	0.152	3.33337216706037e-159	GPSM3	Malignant cells	GSE108397	ENSG00000233490	63940	G protein signaling modulator 3	AGS4|C6orf9|G18|G18.1a|G18.1b|G18.2|NG1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1069
2.33162830060929e-163	-0.518373960453506	0.827	0.935	4.21931457278257e-159	DAP3	Malignant cells	GSE108397	ENSG00000132676	7818	death associated protein 3	bMRP-10|DAP-3|DKFZp686G12159|MGC126058|MGC126059|MRP-S29|MRPS29	protein_coding	P51398	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1070
3.58350755882466e-163	-0.419728965160061	0.985	0.995	6.48471527844911e-159	MIEN1	Malignant cells	GSE108397	ENSG00000141741	84299	migration and invasion enhancer 1	C17orf37|C35|MGC14832|ORB3|Rdx12|XTP4	protein_coding	Q9BRT3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1071
3.64829059881198e-163	0.543012176043812	0.608	0.299	6.60194666761015e-159	N6AMT2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1072
5.75573874246942e-163	-0.450120747056851	0.952	0.991	1.04155848283727e-158	GNG12	Malignant cells	GSE108397	ENSG00000172380	55970	G protein subunit gamma 12	NA	protein_coding	Q9UBI6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1073
8.3884065634012e-163	-0.7740508230782	0.362	0.664	1.51796605171308e-158	BAAT	Malignant cells	GSE108397	ENSG00000276559	570	bile acid-CoA:amino acid N-acyltransferase	BAT	protein_coding	Q14032	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1074
9.26674079529348e-163	-0.470366214568291	0.918	0.983	1.67690941431631e-158	PRKAR1A	Malignant cells	GSE108397	ENSG00000108946	5573	protein kinase cAMP-dependent type I regulatory subunit alpha	CNC1|PRKAR1|TSE1	protein_coding	P10644	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1075
2.02875725101071e-162	0.565105556449917	0.966	0.908	3.67123912142899e-158	NMB	Malignant cells	GSE108397	ENSG00000197696	4828	neuromedin B	MGC17211|MGC2277|MGC3936	protein_coding	P08949	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1076
2.49117707012166e-162	-0.561562762125382	0.687	0.873	4.50803402609215e-158	FADS1	Malignant cells	GSE108397	ENSG00000149485	3992	fatty acid desaturase 1	D5D|FADS6|FADSD5|LLCDL1|TU12	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1077
1.43391178336102e-161	0.611086200333241	0.956	0.893	2.59480676317009e-157	NRP2	Malignant cells	GSE108397	ENSG00000118257	8828	neuropilin 2	VEGF165R2	protein_coding	O60462	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1078
1.51244351758449e-161	-0.551478887294916	0.728	0.88	2.73691778942088e-157	AP2B1	Malignant cells	GSE108397	ENSG00000006125	163	adaptor related protein complex 2 subunit beta 1	ADTB2|CLAPB1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1079
1.75134088688877e-161	-0.491908620979801	0.861	0.96	3.16922646891393e-157	JAK1	Malignant cells	GSE108397	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1080
2.77120228676847e-161	-0.594079091040078	0.638	0.829	5.01476765813622e-157	TRIOBP	Malignant cells	GSE108397	ENSG00000100106	11078	TRIO and F-actin binding protein	DFNB28|HRIHFB2122|KIAA1662|TAP68|Tara	protein_coding	Q9H2D6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1081
3.29626204779515e-161	0.53731555467242	0.947	0.863	5.9649158016901e-157	VAPA	Malignant cells	GSE108397	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1082
4.61139518011432e-161	-0.52697464828924	0.891	0.974	8.34478071793488e-157	FLNA	Malignant cells	GSE108397	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1083
2.08525191022307e-160	-0.496590932356123	0.905	0.978	3.77347185673968e-156	GRB2	Malignant cells	GSE108397	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1084
3.27251609523156e-160	0.429647860295908	0.999	1	5.92194512593103e-156	NDUFS6	Malignant cells	GSE108397	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1085
3.66058520544309e-160	0.544418216412579	0.626	0.316	6.62419498776982e-156	MRPS31	Malignant cells	GSE108397	ENSG00000102738	10240	mitochondrial ribosomal protein S31	IMOGN38	protein_coding	Q92665	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1086
5.45500206858453e-160	-0.449208113670586	0.974	0.994	9.87137174331056e-156	DPP7	Malignant cells	GSE108397	ENSG00000176978	29952	dipeptidyl peptidase 7	DPP2|DPPII	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1087
2.13489160170235e-159	-0.513028918175169	0.785	0.911	3.86329984244057e-155	TIPRL	Malignant cells	GSE108397	ENSG00000143155	261726	TOR signaling pathway regulator	dJ69E11.3|MGC3794|TIP41|TIPRL1	protein_coding	O75663	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1088
2.72321502377798e-159	0.436094436050015	1	1	4.92792990702864e-155	TIMM50	Malignant cells	GSE108397	ENSG00000105197	92609	translocase of inner mitochondrial membrane 50	TIM50|TIM50L	protein_coding	Q3ZCQ8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1089
3.25577778898722e-159	-0.504538874369341	0.863	0.959	5.89165548695127e-155	C17orf58	Malignant cells	GSE108397	ENSG00000186665	284018	chromosome 17 open reading frame 58	NA	protein_coding	Q2M2W7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1090
3.47775492884002e-159	0.622427917208385	0.714	0.439	6.29334531922891e-155	ANKRD10	Malignant cells	GSE108397	ENSG00000088448	55608	ankyrin repeat domain 10	FLJ20093	protein_coding	Q9NXR5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1091
3.93558058150932e-159	0.443287371252798	0.994	0.981	7.12182662029927e-155	PFDN4	Malignant cells	GSE108397	ENSG00000101132	5203	prefoldin subunit 4	C-1|C1|PFD4	protein_coding	Q9NQP4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1092
4.22962743334005e-159	-0.304177138380895	1	1	7.65393380337216e-155	LSM4	Malignant cells	GSE108397	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1093
4.61205074037024e-159	0.42625539429634	0.253	0.025	8.34596701977399e-155	COL11A2	Malignant cells	GSE108397	ENSG00000235708	1302	collagen type XI alpha 2 chain	DFNA13|DFNB53|HKE5	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1094
5.36639374870484e-159	-0.632406748676949	0.514	0.741	9.71102612765628e-155	FNIP2	Malignant cells	GSE108397	ENSG00000052795	57600	folliculin interacting protein 2	FNIPL|KIAA1450|MAPO1	protein_coding	Q9P278	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1095
8.7344781301213e-159	-0.567751676388228	0.595	0.813	1.58059116242675e-154	ASUN	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1096
1.38565693938962e-158	-0.420710925333001	0.995	0.998	2.50748479751945e-154	FAM195A	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1097
1.44063492194025e-158	-0.514612730114643	0.774	0.925	2.60697295474307e-154	HNRNPUL1	Malignant cells	GSE108397	ENSG00000105323	11100	heterogeneous nuclear ribonucleoprotein U like 1	E1B-AP5|E1BAP5|FLJ12944|HNRPUL1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1098
1.49525854820627e-158	-0.586373655163093	0.399	0.672	2.70581986883407e-154	CUX1	Malignant cells	GSE108397	ENSG00000257923	1523	cut like homeobox 1	CASP|CDP|CDP/Cut|CDP/Cux|CDP1|Clox|CUT|CUTL1|CUX|Cux/CDP|GOLIM6	protein_coding	Q13948	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1099
1.53090100802651e-158	0.368817412628918	1	0.998	2.77031846412477e-154	DCXR	Malignant cells	GSE108397	ENSG00000169738	51181	dicarbonyl and L-xylulose reductase	DCR|HCR2|KIDCR|P34H|SDR20C1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1100
3.8055798419945e-158	-0.535957337268584	0.787	0.93	6.88657728207325e-154	SRSF4	Malignant cells	GSE108397	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1101
5.55297799856335e-158	-0.424465010686776	0.977	0.995	1.00486689862002e-153	CDC37	Malignant cells	GSE108397	ENSG00000105401	11140	cell division cycle 37, HSP90 cochaperone	P50CDC37	protein_coding	Q16543	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1102
6.30713002616615e-158	0.870621987598141	0.802	0.568	1.14133824953503e-153	LAMA4	Malignant cells	GSE108397	ENSG00000112769	3910	laminin subunit alpha 4	LAMA3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1103
1.10070052740833e-157	-0.479412280930781	0.865	0.958	1.99182767439812e-153	CSNK2A1	Malignant cells	GSE108397	ENSG00000101266	1457	casein kinase 2 alpha 1	Cka1|Cka2	protein_coding	P68400	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1104
1.10070657769545e-157	0.649015555920199	0.896	0.753	1.99183862299769e-153	UBL3	Malignant cells	GSE108397	ENSG00000122042	5412	ubiquitin like 3	DKFZP434K151|FLJ32018|HCG-1|PNSC1	protein_coding	O95164	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1105
1.58374030849651e-157	-0.505316122628298	0.853	0.962	2.86593646225528e-153	AKIRIN1	Malignant cells	GSE108397	ENSG00000174574	79647	akirin 1	C1orf108|FLJ12666	protein_coding	Q9H9L7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1106
2.43355203859823e-157	0.464884367146681	1	1	4.40375576904737e-153	PRDX1	Malignant cells	GSE108397	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1107
3.37461872647128e-157	0.450033043241127	0.992	0.979	6.10671004742242e-153	ATP5A1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1108
6.33379369051508e-157	0.553836045174599	0.908	0.771	1.14616330623561e-152	WDR61	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1109
6.97239428597512e-157	-0.579330365427101	0.416	0.688	1.26172446999006e-152	SLC37A3	Malignant cells	GSE108397	ENSG00000157800	84255	solute carrier family 37 member 3	DKFZp761N0624|SPX3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1110
7.66723351664574e-157	0.420875954922323	0.314	0.059	1.38746257717221e-152	CADM4	Malignant cells	GSE108397	ENSG00000105767	199731	cell adhesion molecule 4	IGSF4C|Necl-4|SynCAM4|TSLL2	protein_coding	Q8NFZ8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1111
1.20421652301424e-156	0.607439012936732	0.696	0.429	2.17915022004657e-152	IGBP1	Malignant cells	GSE108397	ENSG00000089289	3476	immunoglobulin binding protein 1	alpha4|IBP1	protein_coding	P78318	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1112
1.90448481029755e-156	0.505882256135091	0.97	0.889	3.44635571271444e-152	MRPL13	Malignant cells	GSE108397	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1113
2.08500617356487e-156	0.701208304808683	0.927	0.871	3.77302717168299e-152	DAP	Malignant cells	GSE108397	ENSG00000112977	1611	death associated protein	DAP1	protein_coding	P51397	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1114
2.19766024790468e-156	-0.482477477218681	0.902	0.967	3.9768859846083e-152	IMPDH1	Malignant cells	GSE108397	ENSG00000106348	3614	inosine monophosphate dehydrogenase 1	LCA11|RP10|sWSS2608	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1115
5.31980831365949e-156	-0.522210277849598	0.715	0.876	9.62672512439821e-152	UBE2Z	Malignant cells	GSE108397	ENSG00000159202	65264	ubiquitin conjugating enzyme E2 Z	FLJ13855|USE1	protein_coding	Q9H832	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1116
9.39026604670829e-156	0.501626887188704	0.551	0.247	1.69926254381233e-151	STX8	Malignant cells	GSE108397	ENSG00000170310	9482	syntaxin 8	CARB	protein_coding	Q9UNK0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1117
1.40610321438661e-155	-0.382145005644421	0.992	0.999	2.54448437675402e-151	CUTA	Malignant cells	GSE108397	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1118
5.14359983025276e-155	-0.579244648139399	0.494	0.739	9.30785825282539e-151	ABR	Malignant cells	GSE108397	ENSG00000276016	29	ABR activator of RhoGEF and GTPase	MDB	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1119
7.665457421057e-155	-0.530965833273309	0.74	0.895	1.38714117491448e-150	FAM134A	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1120
2.06245366296646e-154	-0.584219996852025	0.483	0.723	3.73221614850411e-150	NECAB3	Malignant cells	GSE108397	ENSG00000125967	63941	N-terminal EF-hand calcium binding protein 3	APBA2BP|dJ63M2.4|dJ63M2.5|EFCBP3|NIP1|SYTIP2|XB51	protein_coding	Q96P71	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1121
2.71602694190473e-154	-0.373121542562079	0.998	1	4.91492235407079e-150	KTN1	Malignant cells	GSE108397	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1122
2.81794454906298e-154	-0.480212968770244	0.885	0.97	5.09935245598436e-150	HMBS	Malignant cells	GSE108397	ENSG00000256269	3145	hydroxymethylbilane synthase	PBGD|PORC|UPS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1123
5.45161499253008e-154	0.55135798649444	0.919	0.773	9.86524249048244e-150	TRIB2	Malignant cells	GSE108397	ENSG00000071575	28951	tribbles pseudokinase 2	GS3955|TRB2	protein_coding	Q92519	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1124
6.92467860654488e-154	-0.282065169680927	1	1	1.25308984064036e-149	EIF2S2	Malignant cells	GSE108397	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1125
1.05402199011988e-153	0.460152931240685	0.324	0.069	1.90735819332094e-149	RP11-59E19.4	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1126
2.27188481423152e-153	0.564611701400029	0.82	0.598	4.11120275983336e-149	ALDH7A1	Malignant cells	GSE108397	ENSG00000164904	501	aldehyde dehydrogenase 7 family member A1	ATQ1|EPD|PDE	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1127
3.02756759843794e-153	0.51230563506041	0.921	0.788	5.47868632613329e-149	MED4	Malignant cells	GSE108397	ENSG00000136146	29079	mediator complex subunit 4	DRIP36|HSPC126|TRAP36|VDRIP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1128
3.22175937668804e-153	-0.587742851962669	0.685	0.855	5.83009576805469e-149	CLN8	Malignant cells	GSE108397	ENSG00000278220	2055	CLN8 transmembrane ER and ERGIC protein	C8orf61|EPMR|FLJ39417|TLCD6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1129
3.45145774158383e-153	-0.652898124269523	0.657	0.852	6.24575792917011e-149	PDE4DIP	Malignant cells	GSE108397	ENSG00000178104	9659	phosphodiesterase 4D interacting protein	CMYA2|KIAA0454|KIAA0477|MMGL	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1130
5.19782758545622e-153	-0.500577785312274	0.884	0.961	9.40598879864158e-149	RFC1	Malignant cells	GSE108397	ENSG00000035928	5981	replication factor C subunit 1	A1|MHCBFB|PO-GA|RFC140	protein_coding	P35251	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1131
5.39951222848293e-153	0.501116311817376	0.968	0.914	9.77095732866271e-149	DERL2	Malignant cells	GSE108397	ENSG00000072849	51009	derlin 2	CGI-101|derlin-2|F-LAN-1|F-LANa|FLANa	protein_coding	Q9GZP9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1132
5.79789878046292e-153	-0.442433693518431	0.955	0.987	1.04918776331257e-148	MPC2	Malignant cells	GSE108397	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1133
1.49148742610334e-152	0.339540941266943	1	1	2.6989956462766e-148	RPL10A	Malignant cells	GSE108397	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1134
2.41534741080812e-152	-0.633365478431843	0.567	0.806	4.37081267459837e-148	CDC42SE1	Malignant cells	GSE108397	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1135
3.15831416782318e-152	-0.510486659809881	0.719	0.88	5.71528531809283e-148	DAZAP1	Malignant cells	GSE108397	ENSG00000071626	26528	DAZ associated protein 1	MGC19907	protein_coding	Q96EP5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1136
1.31906268429892e-151	-0.76837532296238	0.417	0.651	2.38697583350733e-147	SERGEF	Malignant cells	GSE108397	ENSG00000129158	26297	secretion regulating guanine nucleotide exchange factor	DelGEF|Gnefr	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1137
1.48885872339158e-151	-0.499239104325311	0.793	0.925	2.69423874584941e-147	YWHAG	Malignant cells	GSE108397	ENSG00000170027	7532	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma	14-3-3GAMMA|PPP1R170	protein_coding	P61981	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1138
1.63223626274819e-151	0.306163988354891	1	1	2.95369474106912e-147	CYC1	Malignant cells	GSE108397	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1139
1.70221188122928e-151	-0.446715997371093	0.951	0.992	3.08032262027251e-147	DNMT1	Malignant cells	GSE108397	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1140
1.87237609051624e-151	0.43933343327861	0.986	0.953	3.38825177339819e-147	ZSWIM7	Malignant cells	GSE108397	ENSG00000214941	125150	zinc finger SWIM-type containing 7	SWS1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1141
2.48487755832343e-151	-0.352738511147163	0.998	1	4.49663442954208e-147	ZC3H15	Malignant cells	GSE108397	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1142
2.68844294260407e-151	0.715228688318102	0.738	0.515	4.86500634893633e-147	MARCH6	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1143
3.16799019695769e-151	-0.575388895501489	0.426	0.688	5.73279506041464e-147	STXBP1	Malignant cells	GSE108397	ENSG00000136854	6812	syntaxin binding protein 1	hUNC18|MUNC18-1|nSec1|rbSec1|UNC18	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1144
3.29404780345501e-151	-0.545781200874778	0.578	0.794	5.96090890513219e-147	PAK4	Malignant cells	GSE108397	ENSG00000130669	10298	p21 (RAC1) activated kinase 4	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1145
1.1473618191428e-150	0.575972987928783	0.958	0.883	2.07626594792081e-146	HCFC1R1	Malignant cells	GSE108397	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1146
1.24233604836348e-150	0.393102156672389	0.283	0.044	2.24813131311855e-146	CRIP2	Malignant cells	GSE108397	ENSG00000182809	1397	cysteine rich protein 2	CRP2|ESP1	protein_coding	P52943	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1147
1.4261335020944e-150	-0.573210089707529	0.429	0.692	2.58073118539003e-146	RPS6KA5	Malignant cells	GSE108397	ENSG00000100784	9252	ribosomal protein S6 kinase A5	MSK1|RLPK	protein_coding	O75582	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1148
1.47617667861216e-150	0.440063084143346	0.405	0.125	2.67128931761656e-146	KIF5C	Malignant cells	GSE108397	ENSG00000276734	3800	kinesin family member 5C	NKHC2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1149
1.48272611113429e-150	-0.515486193215555	0.887	0.961	2.6831411707086e-146	CHD4	Malignant cells	GSE108397	ENSG00000111642	1108	chromodomain helicase DNA binding protein 4	Mi-2b|Mi2-BETA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1150
3.07865791216038e-150	-0.536009025861659	0.704	0.873	5.57113935784543e-146	MAPKAPK3	Malignant cells	GSE108397	ENSG00000114738	7867	MAPK activated protein kinase 3	3pK|MAPKAP3|MK-3|MK3	protein_coding	Q16644	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1151
7.66550724175266e-150	-0.598443539488508	0.426	0.683	1.38715019046756e-145	ST3GAL5	Malignant cells	GSE108397	ENSG00000115525	8869	ST3 beta-galactoside alpha-2,3-sialyltransferase 5	SIAT9|SIATGM3S|ST3GalV	protein_coding	Q9UNP4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1152
1.49635679980229e-149	-0.57208964450163	0.742	0.891	2.70780726492223e-145	FRMD4A	Malignant cells	GSE108397	ENSG00000151474	55691	FERM domain containing 4A	bA295P9.4|FLJ10210|FRMD4|KIAA1294	protein_coding	Q9P2Q2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1153
1.50779064763687e-149	-0.531491142386195	0.769	0.912	2.72849795596368e-145	CDC27	Malignant cells	GSE108397	ENSG00000004897	996	cell division cycle 27	ANAPC3|APC3|D0S1430E|D17S978E|NUC2	protein_coding	P30260	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1154
1.53040267651038e-149	-0.522039212734743	0.741	0.89	2.76941668341319e-145	NFE2L1	Malignant cells	GSE108397	ENSG00000082641	4779	NFE2 like bZIP transcription factor 1	FLJ00380|LCR-F1|NRF-1|NRF1|TCF11	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1155
2.00616993036734e-149	-0.465345926623697	0.922	0.971	3.63036510599275e-145	MSI2	Malignant cells	GSE108397	ENSG00000153944	124540	musashi RNA binding protein 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1156
2.226553332739e-149	0.395487503539691	0.998	0.995	4.0291709109245e-145	MRPL52	Malignant cells	GSE108397	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1157
2.6754824217362e-149	0.499359468573073	0.95	0.861	4.84155299037382e-145	RPUSD3	Malignant cells	GSE108397	ENSG00000156990	285367	RNA pseudouridine synthase D3	MGC29784	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1158
2.70221432673964e-149	-0.436747233182373	0.074	0.33	4.88992704566806e-145	SOCS3	Malignant cells	GSE108397	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1159
2.90131426917303e-149	0.462916510593245	0.519	0.215	5.25021830149551e-145	ZNF714	Malignant cells	GSE108397	ENSG00000160352	148206	zinc finger protein 714	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1160
4.27136250583109e-149	-0.48219310427322	0.819	0.933	7.72945759055195e-145	ABCF1	Malignant cells	GSE108397	ENSG00000225989	23	ATP binding cassette subfamily F member 1	ABC50|EST123147	protein_coding	Q8NE71	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1161
4.90757092521522e-149	0.363470573898635	1	0.998	8.88074034626946e-145	SPCS2	Malignant cells	GSE108397	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1162
5.25844741018908e-149	-0.554199612385	0.612	0.802	9.51568643347816e-145	ACTR1B	Malignant cells	GSE108397	ENSG00000115073	10120	actin related protein 1B	Arp1B|CTRN2	protein_coding	P42025	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1163
2.83545623812167e-148	-0.416446755135937	0.967	0.991	5.13104160850498e-144	METAP2	Malignant cells	GSE108397	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1164
3.68366492785681e-148	-0.532976541563334	0.277	0.56	6.66596005344968e-144	NOTCH2NL	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1165
3.93805321673704e-148	-0.430869192745615	0.991	0.999	7.12630110100735e-144	CALR	Malignant cells	GSE108397	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1166
4.8774147471407e-148	-0.430085750935507	0.993	0.999	8.82616972642581e-144	SRSF2	Malignant cells	GSE108397	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1167
5.52920562467522e-148	-0.362442555128722	0.996	0.999	1.00056504984123e-143	ARF1	Malignant cells	GSE108397	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1168
7.95729263858162e-148	-0.551337899785635	0.448	0.702	1.43995167587773e-143	ADAM15	Malignant cells	GSE108397	ENSG00000143537	8751	ADAM metallopeptidase domain 15	MDC15	protein_coding	Q13444	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1169
1.10832496769808e-147	-0.475098328014398	0.852	0.945	2.00562486154644e-143	GPI	Malignant cells	GSE108397	ENSG00000282019	2821	glucose-6-phosphate isomerase	AMF|NLK	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1170
1.89365136769512e-147	-0.41880927137367	0.104	0.373	3.42675151498108e-143	NIPSNAP1	Malignant cells	GSE108397	ENSG00000184117	8508	nipsnap homolog 1	NA	protein_coding	Q9BPW8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1171
2.30305865347311e-147	-0.299829196390586	1	1	4.16761493932494e-143	CHCHD10	Malignant cells	GSE108397	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1172
2.73852161291067e-147	0.549538581750009	0.69	0.414	4.95562871072314e-143	HRSP12	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1173
3.48184219431771e-147	-0.576727595576888	0.528	0.756	6.30074163483734e-143	POLR2J3	Malignant cells	GSE108397	ENSG00000168255	NA	NA	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1174
3.78009407608525e-147	-0.569981623362965	0.684	0.864	6.84045824008387e-143	GOLIM4	Malignant cells	GSE108397	ENSG00000173905	27333	golgi integral membrane protein 4	GIMPC|GOLPH4|GPP130|P138	protein_coding	O00461	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1175
4.19727895121395e-147	-0.555027497637111	0.577	0.801	7.59539599011677e-143	PTPN12	Malignant cells	GSE108397	ENSG00000127947	5782	protein tyrosine phosphatase non-receptor type 12	PTP-PEST|PTPG1	protein_coding	Q05209	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1176
5.12833643172291e-147	-0.493276113154122	0.777	0.904	9.28023760684577e-143	CCND3	Malignant cells	GSE108397	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1177
6.20356260972458e-147	-0.409146733254808	1	1	1.12259668985576e-142	LDHA	Malignant cells	GSE108397	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1178
6.5748335757352e-147	0.418581596885841	0.999	0.998	1.18978188386504e-142	SMS	Malignant cells	GSE108397	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1179
9.26440032468693e-147	0.352627260888275	1	1	1.67648588275535e-142	NDUFAB1	Malignant cells	GSE108397	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1180
9.58610028301097e-147	-0.406638965476855	0.984	0.996	1.73470070721367e-142	FAM49B	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1181
9.77414432056619e-147	-0.370181171079639	0.996	0.999	1.76872915624966e-142	CDK4	Malignant cells	GSE108397	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1182
1.49270234290017e-146	-0.553525162369374	0.554	0.772	2.70119415971214e-142	RILPL2	Malignant cells	GSE108397	ENSG00000150977	196383	Rab interacting lysosomal protein like 2	FLJ30380|FLJ32372|MGC7036	protein_coding	Q969X0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1183
1.4976763085867e-146	-0.56283402607643	0.661	0.832	2.71019504801849e-142	SDC3	Malignant cells	GSE108397	ENSG00000162512	9672	syndecan 3	N-syndecan|SYND3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1184
1.69642960848915e-146	0.466680276711871	0.981	0.954	3.06985901952197e-142	RNASEH2B	Malignant cells	GSE108397	ENSG00000136104	79621	ribonuclease H2 subunit B	AGS2|DLEU8|FLJ11712	protein_coding	Q5TBB1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1185
1.76946148827898e-146	0.551959371848304	0.639	0.335	3.20201750918964e-142	DBNDD1	Malignant cells	GSE108397	ENSG00000003249	79007	dysbindin domain containing 1	FLJ12582|MGC3101	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1186
1.78773840671908e-146	-0.509274134513885	0.725	0.883	3.23509142079884e-142	CMTM6	Malignant cells	GSE108397	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1187
1.89201923705292e-146	-0.616475076597103	0.347	0.626	3.42379801137097e-142	SPRY1	Malignant cells	GSE108397	ENSG00000164056	10252	sprouty RTK signaling antagonist 1	hSPRY1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1188
4.01796231633152e-146	-0.481319165443062	0.879	0.958	7.27090460763352e-142	TMEM123	Malignant cells	GSE108397	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1189
5.12138428808657e-146	-0.56899423885631	0.387	0.665	9.26765700772146e-142	CA8	Malignant cells	GSE108397	ENSG00000178538	767	carbonic anhydrase 8	CALS|CARP	protein_coding	P35219	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1190
5.8754108824669e-146	0.350246802440535	1	0.998	1.06321435329121e-141	HMGN3	Malignant cells	GSE108397	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1191
8.18696999761628e-146	0.621391401596697	0.924	0.822	1.48151409076864e-141	DYNLT3	Malignant cells	GSE108397	ENSG00000165169	6990	dynein light chain Tctex-type 3	TCTE1L|TCTEX1L	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1192
8.6381018779859e-146	-0.529083109823192	0.542	0.775	1.56315091584033e-141	SND1	Malignant cells	GSE108397	ENSG00000197157	27044	staphylococcal nuclease and tudor domain containing 1	p100|TDRD11	protein_coding	Q7KZF4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1193
1.54412561411224e-145	-0.546002599333419	0.441	0.698	2.79424971129751e-141	MAP2K7	Malignant cells	GSE108397	ENSG00000076984	5609	mitogen-activated protein kinase kinase 7	Jnkk2|MKK7|PRKMK7	protein_coding	O14733	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1194
4.39596467896553e-145	-0.554096990247957	0.934	0.994	7.95493768305602e-141	PHLDA2	Malignant cells	GSE108397	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1195
5.51942676581576e-145	-0.394544897271343	0.059	0.301	9.9879546754202e-141	RP1-212P9.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1196
5.71609974139146e-145	-0.524340154107122	0.76	0.899	1.0343854092022e-140	TMEM38B	Malignant cells	GSE108397	ENSG00000095209	55151	transmembrane protein 38B	bA219P18.1|C9orf87|D4Ertd89e|FLJ10493|TRIC-B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1197
6.13086402356829e-145	-0.48452949955698	0.88	0.958	1.10944115370492e-140	GTF2I	Malignant cells	GSE108397	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1198
8.01154069346316e-145	0.472793683786055	0.964	0.899	1.44976840388909e-140	COA3	Malignant cells	GSE108397	ENSG00000183978	28958	cytochrome c oxidase assembly factor 3	CCDC56|COX25|hCOA3|HSPC009|MITRAC12	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1199
8.27450245277943e-145	-0.405507773669198	0.979	0.995	1.49735396385497e-140	POPDC3	Malignant cells	GSE108397	ENSG00000132429	64208	popeye domain containing 3	bA355M14.1|MGC22671|POP3	protein_coding	Q9HBV1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1200
1.13719132170463e-144	0.795586294557279	0.392	0.129	2.0578614157567e-140	TTC39A	Malignant cells	GSE108397	ENSG00000085831	22996	tetratricopeptide repeat domain 39A	C1orf34|DEME-6|KIAA0452	protein_coding	Q5SRH9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1201
2.1315305525928e-144	-0.541629039653837	0.677	0.841	3.85721768797194e-140	PLOD1	Malignant cells	GSE108397	ENSG00000083444	5351	procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	LH1|LLH|PLOD	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1202
2.157192857541e-144	-0.416333279040684	0.992	0.999	3.90365619500619e-140	RTN4	Malignant cells	GSE108397	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1203
3.71897328410994e-144	0.529353972783421	0.99	0.978	6.72985405492534e-140	ZNF106	Malignant cells	GSE108397	ENSG00000103994	64397	zinc finger protein 106	SH3BP3|ZFP106|ZNF474	protein_coding	Q9H2Y7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1204
3.84061168679744e-144	0.635066563145984	0.484	0.198	6.94997090842865e-140	PMP2	Malignant cells	GSE108397	ENSG00000147588	5375	peripheral myelin protein 2	FABP8|M-FABP|MP2	protein_coding	P02689	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1205
4.46934707087614e-144	-0.52492057931649	0.315	0.594	8.08773045945746e-140	ATP13A2	Malignant cells	GSE108397	ENSG00000159363	23400	ATPase cation transporting 13A2	CLN12|HSA9947|PARK9	protein_coding	Q9NQ11	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1206
4.51762128592965e-144	0.396874156596458	0.252	0.033	8.17508747901829e-140	WFDC2	Malignant cells	GSE108397	ENSG00000101443	10406	WAP four-disulfide core domain 2	dJ461P17.6|EDDM4|HE4|WAP5	protein_coding	Q14508	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1207
5.49717817812437e-144	0.552928489279076	0.695	0.415	9.94769363113387e-140	SERPINH1	Malignant cells	GSE108397	ENSG00000149257	871	serpin family H member 1	CBP1|CBP2|HSP47|SERPINH2	protein_coding	P50454	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1208
7.49315314152845e-144	-0.550987146985644	0.465	0.713	1.35596099249099e-139	GART	Malignant cells	GSE108397	ENSG00000262473	2618	phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase	GARS-AIRS-GART|PGFT|PRGS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1209
7.77027631689489e-144	-0.550075134528841	0.593	0.798	1.4061092023053e-139	FAM115A	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1210
7.94707643820617e-144	0.493880602624248	0.643	0.355	1.43810295225779e-139	PIGU	Malignant cells	GSE108397	ENSG00000101464	128869	phosphatidylinositol glycan anchor biosynthesis class U	bA346K17.2|CDC91L1|GAB1	protein_coding	Q9H490	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1211
9.56314983685741e-144	-0.528752280546262	0.573	0.793	1.73054759447772e-139	POM121	Malignant cells	GSE108397	ENSG00000196313	9883	POM121 transmembrane nucleoporin	DKFZP586G1822|DKFZP586P2220|KIAA0618|POM121A	protein_coding	Q96HA1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1212
1.73962269336749e-143	-0.491053866424131	0.196	0.477	3.14802122591781e-139	PRKAB2	Malignant cells	GSE108397	ENSG00000131791	5565	protein kinase AMP-activated non-catalytic subunit beta 2	NA	protein_coding	O43741	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1213
2.84801137730842e-143	0.511812569429197	0.622	0.34	5.15376138837731e-139	TM2D3	Malignant cells	GSE108397	ENSG00000184277	80213	TM2 domain containing 3	BLP2|FLJ22604	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1214
3.23892811967708e-143	-0.552555401692822	0.415	0.678	5.86116432536765e-139	C2orf69	Malignant cells	GSE108397	ENSG00000178074	205327	chromosome 2 open reading frame 69	FLJ38973	protein_coding	Q8N8R5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1215
5.03399913632105e-143	-0.544356582442345	0.502	0.74	9.10952483708657e-139	PRCC	Malignant cells	GSE108397	ENSG00000143294	5546	proline rich mitotic checkpoint control factor	RCCP1	protein_coding	Q92733	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1216
6.98842559823796e-143	0.437352759459674	1	0.996	1.26462549625714e-138	MYL6	Malignant cells	GSE108397	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1217
8.25660131709914e-143	-0.55482772720517	0.312	0.589	1.49411457434226e-138	EMB	Malignant cells	GSE108397	ENSG00000170571	133418	embigin	MGC71745	protein_coding	Q6PCB8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1218
9.64312456788492e-143	-0.382448833872698	0.986	0.997	1.74501982180446e-138	SRP72	Malignant cells	GSE108397	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1219
1.51487840379345e-142	-0.570334401813217	0.504	0.73	2.74132395950463e-138	AKAP1	Malignant cells	GSE108397	ENSG00000121057	8165	A-kinase anchoring protein 1	AKAP121|AKAP149|AKAP84|D-AKAP1|PPP1R43|PRKA1|S-AKAP84|SAKAP84|TDRD17	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1220
1.81119783696722e-142	-0.260926962192228	1	1	3.27754360577588e-138	TMSB10	Malignant cells	GSE108397	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1221
2.12606097206658e-142	0.815379209177386	0.746	0.573	3.84731993505168e-138	TMSB15B	Malignant cells	GSE108397	ENSG00000158427	286527	thymosin beta 15B	Tbeta15b|TMSB15A|TMSL8|TMSNB|MGC39900	protein_coding	P0CG35	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1222
2.29154041963166e-142	-0.516917388669615	0.695	0.856	4.14677154336544e-138	DNAJC5	Malignant cells	GSE108397	ENSG00000101152	80331	DnaJ heat shock protein family (Hsp40) member C5	CLN4|DNAJC5A|FLJ00118|FLJ13070	protein_coding	Q9H3Z4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1223
2.8270873869551e-142	-0.525534481354109	0.623	0.828	5.11589733543395e-138	RSAD1	Malignant cells	GSE108397	ENSG00000136444	55316	radical S-adenosyl methionine domain containing 1	FLJ11164|HemW	protein_coding	Q9HA92	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1224
1.17016806998287e-141	-0.49253697037375	0.702	0.87	2.117536139441e-137	MKRN1	Malignant cells	GSE108397	ENSG00000133606	23608	makorin ring finger protein 1	RNF61	protein_coding	Q9UHC7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1225
1.38450760683937e-141	0.612437910510472	0.991	0.984	2.50540496533652e-137	S100B	Malignant cells	GSE108397	ENSG00000160307	6285	S100 calcium binding protein B	S100beta	protein_coding	P04271	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1226
1.47567115438695e-141	-0.44683484385114	0.873	0.957	2.67037452097863e-137	CMC1	Malignant cells	GSE108397	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1227
2.47975394125734e-141	-0.543641744636364	0.503	0.738	4.48736273209927e-137	KPNA6	Malignant cells	GSE108397	ENSG00000025800	23633	karyopherin subunit alpha 6	FLJ11249|IPOA7|KPNA7|MGC17918	protein_coding	O60684	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1228
2.94348722443833e-141	-0.40115610753527	0.984	0.998	5.32653448134361e-137	HNRNPA2B1	Malignant cells	GSE108397	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1229
3.49279063244104e-141	-0.542454622757256	0.828	0.937	6.3205539284653e-137	THRAP3	Malignant cells	GSE108397	ENSG00000054118	9967	thyroid hormone receptor associated protein 3	BCLAF2|TRAP150	protein_coding	Q9Y2W1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1230
3.55995862463141e-141	-0.555106563503791	0.474	0.709	6.442101127133e-137	THOC2	Malignant cells	GSE108397	ENSG00000125676	57187	THO complex subunit 2	CXorf3|dJ506G2.1|MRX12|MRX35|THO2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1231
3.92942482106628e-141	-0.400200918510041	0.974	0.996	7.11068715620154e-137	PAIP2	Malignant cells	GSE108397	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1232
4.36252861918135e-141	-0.565613574004793	0.517	0.732	7.89443178927056e-137	DONSON	Malignant cells	GSE108397	ENSG00000159147	29980	DNA replication fork stabilization factor DONSON	B17|C21orf60|C2TA|DKFZP434M035	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1233
6.0303063832562e-141	0.526357238339847	0.569	0.284	1.09124424311404e-136	MTURN	Malignant cells	GSE108397	ENSG00000180354	222166	maturin, neural progenitor differentiation regulator homolog	C7orf41|Ells1|FLJ25903	protein_coding	Q8N3F0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1234
7.11528077365857e-141	-0.517139002505043	0.595	0.799	1.28758120880125e-136	DIAPH1	Malignant cells	GSE108397	ENSG00000131504	1729	diaphanous related formin 1	DFNA1|hDIA1|LFHL1|mDia1	protein_coding	O60610	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1235
1.37286831004161e-140	-0.721655635199522	0.375	0.624	2.4843424938513e-136	HES1	Malignant cells	GSE108397	ENSG00000114315	3280	hes family bHLH transcription factor 1	bHLHb39|FLJ20408|HES-1|HRY	protein_coding	Q14469	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1236
1.51862312454234e-140	-0.528223590271457	0.539	0.77	2.74810040617181e-136	CCDC109B	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1237
1.92030139374241e-140	0.562241342328816	0.907	0.809	3.47497740211626e-136	EXOSC1	Malignant cells	GSE108397	ENSG00000171311	51013	exosome component 1	CGI-108|CSL4|Csl4p|hCsl4p|p13|SKI4|Ski4p	protein_coding	Q9Y3B2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1238
2.05434742600184e-140	0.514380582703706	0.721	0.458	3.71754710209292e-136	TSFM	Malignant cells	GSE108397	ENSG00000123297	10102	Ts translation elongation factor, mitochondrial	EF-TS|EF-Tsmt	protein_coding	P43897	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1239
2.57601388800755e-140	-0.436466099771179	0.972	0.989	4.66155473173846e-136	TFPT	Malignant cells	GSE108397	ENSG00000276504	29844	TCF3 fusion partner	amida|FB1|INO80F	protein_coding	P0C1Z6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1240
3.81124869694027e-140	-0.400319386647652	0.973	0.99	6.89683564198311e-136	FKBP8	Malignant cells	GSE108397	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1241
4.46864490784182e-140	0.486276309841056	0.974	0.919	8.08645982523056e-136	LARP6	Malignant cells	GSE108397	ENSG00000166173	55323	La ribonucleoprotein 6, translational regulator	acheron|FLJ11196	protein_coding	Q9BRS8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1242
4.53235733814618e-140	-0.471849849705331	0.876	0.952	8.20175383910932e-136	FBXW5	Malignant cells	GSE108397	ENSG00000159069	54461	F-box and WD repeat domain containing 5	DKFZP434B205|Fbw5|MGC20962	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1243
4.55331978890866e-140	-0.514816127292832	0.349	0.628	8.23968749000911e-136	COLGALT1	Malignant cells	GSE108397	ENSG00000130309	79709	collagen beta(1-O)galactosyltransferase 1	FLJ22329|GLT25D1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1244
8.78362990406278e-140	-0.299988843945444	1	1	1.5894856674392e-135	NDUFA4	Malignant cells	GSE108397	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1245
9.48777733105984e-140	-0.519175972178193	0.572	0.795	1.71690818582859e-135	UHMK1	Malignant cells	GSE108397	ENSG00000152332	127933	U2AF homology motif kinase 1	KIS|Kist	protein_coding	Q8TAS1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1246
9.66602151184508e-140	-0.413761448279717	0.959	0.99	1.74916325278349e-135	CRTAP	Malignant cells	GSE108397	ENSG00000170275	10491	cartilage associated protein	CASP|LEPREL3|P3H5	protein_coding	O75718	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1247
9.94908935781431e-140	-0.353090702555103	0.997	1	1.80038721019008e-135	STRAP	Malignant cells	GSE108397	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1248
1.10623035982434e-139	0.509822043420067	0.847	0.64	2.00183445913813e-135	MAGEF1	Malignant cells	GSE108397	ENSG00000177383	64110	MAGE family member F1	NA	protein_coding	Q9HAY2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1249
1.18385484221629e-139	-0.563456624375665	0.535	0.74	2.1423037224746e-135	GSR	Malignant cells	GSE108397	ENSG00000104687	2936	glutathione-disulfide reductase	NA	protein_coding	P00390	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1250
1.86183576701754e-139	0.479951433337764	0.55	0.26	3.36917800399495e-135	SPAG16	Malignant cells	GSE108397	ENSG00000144451	79582	sperm associated antigen 16	DKFZp666P1710|FLJ22724|PF20|WDR29	protein_coding	Q8N0X2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1251
1.95683098773455e-139	-0.545099712953196	0.636	0.815	3.54108135540444e-135	SLC9A3R1	Malignant cells	GSE108397	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1252
3.3730211916743e-139	-0.506215299841387	0.22	0.502	6.10381914845382e-135	PLK3	Malignant cells	GSE108397	ENSG00000173846	1263	polo like kinase 3	CNK|FNK|PRK	protein_coding	Q9H4B4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1253
3.8958817899055e-139	-0.531744475517666	0.359	0.625	7.04998768701299e-135	FBXO18	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1254
5.28154713614473e-139	-0.529639911902049	0.371	0.634	9.5574876975675e-135	ZFPL1	Malignant cells	GSE108397	ENSG00000162300	7542	zinc finger protein like 1	D11S750|MCG4	protein_coding	O95159	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1255
5.59938723086445e-139	-0.488746471772893	0.774	0.904	1.01326511329723e-134	NF2	Malignant cells	GSE108397	ENSG00000186575	4771	NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor	ACN|BANF|merlin|merlin-1|SCH	protein_coding	P35240	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1256
6.85918270887742e-139	0.404544711981507	0.998	0.998	1.24123770299846e-134	CGGBP1	Malignant cells	GSE108397	ENSG00000163320	8545	CGG triplet repeat binding protein 1	CGGBP|p20-CGGBP	protein_coding	Q9UFW8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1257
1.06558286501058e-138	-0.389941003691654	0.972	0.994	1.92827875252315e-134	SLC35B1	Malignant cells	GSE108397	ENSG00000121073	10237	solute carrier family 35 member B1	AXER|UGTREL1	protein_coding	P78383	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1258
1.5640230832494e-138	-0.401795574000352	0.985	0.998	2.83025617144811e-134	NUDC	Malignant cells	GSE108397	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1259
1.74998834003981e-138	0.469411580384019	0.555	0.269	3.16677890013604e-134	MAEA	Malignant cells	GSE108397	ENSG00000090316	10296	macrophage erythroblast attacher, E3 ubiquitin ligase	EMP|GID9|HLC-10|p44EMLP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1260
2.56803314289622e-138	-0.265227801681127	1	1	4.64711277538501e-134	THOC7	Malignant cells	GSE108397	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1261
2.70038143094882e-138	-0.527856089357712	0.877	0.949	4.88661023744498e-134	C12orf49	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1262
3.1255040301137e-138	-0.476700441847845	0.776	0.916	5.65591209289375e-134	ANXA11	Malignant cells	GSE108397	ENSG00000122359	311	annexin A11	ANX11	protein_coding	P50995	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1263
3.60251445536283e-138	0.399121541647201	0.991	0.977	6.51911015842458e-134	RAD51C	Malignant cells	GSE108397	ENSG00000108384	5889	RAD51 paralog C	FANCO|RAD51L2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1264
5.3644710428743e-138	-0.479627046436815	0.748	0.904	9.70754679918533e-134	ELAVL1	Malignant cells	GSE108397	ENSG00000066044	1994	ELAV like RNA binding protein 1	Hua|HUR|MelG	protein_coding	Q15717	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1265
8.24121685673407e-138	-0.294606519215423	1	1	1.4913306023946e-133	H3F3B	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1266
1.22904386538934e-137	0.47635781622629	0.597	0.312	2.22407777880855e-133	CLN5	Malignant cells	GSE108397	ENSG00000102805	1203	CLN5 intracellular trafficking protein	NA	protein_coding	O75503	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1267
1.31422822911037e-137	-0.506286927317428	0.952	0.985	2.37822740339812e-133	TBC1D16	Malignant cells	GSE108397	ENSG00000167291	125058	TBC1 domain family member 16	FLJ20748|MGC25062	protein_coding	Q8TBP0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1268
2.2009547730934e-137	0.588237338931513	0.956	0.923	3.98284775738981e-133	MED10	Malignant cells	GSE108397	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1269
2.96528227047416e-137	0.408387481432725	0.984	0.953	5.36597479665005e-133	MRPS11	Malignant cells	GSE108397	ENSG00000181991	64963	mitochondrial ribosomal protein S11	FLJ22512|FLJ23406|HCC-2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1270
4.13243374643691e-137	0.693198217072943	0.701	0.473	7.47805210755224e-133	ISG20	Malignant cells	GSE108397	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1271
6.69678639753946e-137	0.519286336436019	0.962	0.918	1.21185046649874e-132	CHAMP1	Malignant cells	GSE108397	ENSG00000198824	283489	chromosome alignment maintaining phosphoprotein 1	C13orf8|CAMP|CHAMP|ZNF828	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1272
8.44090834321531e-137	0.412525132890384	0.992	0.979	1.52746677378824e-132	NAA20	Malignant cells	GSE108397	ENSG00000173418	51126	N-alpha-acetyltransferase 20, NatB catalytic subunit	dJ1002M8.1|NAT3|NAT5	protein_coding	P61599	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1273
9.39326495442865e-137	-0.506188606993531	0.652	0.827	1.69980522615341e-132	TARBP2	Malignant cells	GSE108397	ENSG00000139546	6895	TARBP2 subunit of RISC loading complex	Trbp	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1274
1.27033225614855e-136	0.300415713184882	1	1	2.29879325072641e-132	PPDPF	Malignant cells	GSE108397	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1275
1.82466118748466e-136	-0.365911193583057	0.992	0.999	3.30190688487224e-132	PPP1CC	Malignant cells	GSE108397	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1276
1.89441676033764e-136	-0.46406071305593	0.872	0.957	3.428136569507e-132	PLEKHB2	Malignant cells	GSE108397	ENSG00000115762	55041	pleckstrin homology domain containing B2	EVT2|FLJ20783	protein_coding	Q96CS7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1277
2.4813447892525e-136	-0.523230051901964	0.386	0.648	4.49024153063131e-132	BAIAP2L1	Malignant cells	GSE108397	ENSG00000006453	55971	BAR/IMD domain containing adaptor protein 2 like 1	IRTKS	protein_coding	Q9UHR4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1278
4.0473056195729e-136	-0.455087874110622	0.108	0.368	7.32400424917912e-132	AC020571.3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1279
4.32169748547833e-136	-0.519713484593058	0.347	0.624	7.82054376972158e-132	SIGIRR	Malignant cells	GSE108397	ENSG00000185187	59307	single Ig and TIR domain containing	IL-1R8|TIR8	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1280
6.32949491049673e-136	0.26688054432551	1	1	1.14538539900349e-131	COX5A	Malignant cells	GSE108397	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1281
8.52448697536213e-136	-0.50416478776777	0.698	0.863	1.54259116306153e-131	UBTF	Malignant cells	GSE108397	ENSG00000108312	7343	upstream binding transcription factor	NOR-90|UBF|UBF1|UBF2	protein_coding	P17480	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1282
1.37656211993254e-135	0.511168973002714	0.885	0.743	2.49102681222992e-131	GCAT	Malignant cells	GSE108397	ENSG00000100116	23464	glycine C-acetyltransferase	KBL	protein_coding	O75600	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1283
1.56686927609624e-135	0.573355187567455	0.534	0.264	2.83540664202375e-131	FCGR2A	Malignant cells	GSE108397	ENSG00000143226	2212	Fc gamma receptor IIa	CD32|CD32A|CDw32|Fc-gamma-RIIa|FCG2|FcgammaRIIa|FCGR2|FCGR2A1|IGFR2	protein_coding	P12318	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1284
1.87981569758413e-135	-0.507428379991842	0.288	0.56	3.40171448634823e-131	PHF1	Malignant cells	GSE108397	ENSG00000225553	5252	PHD finger protein 1	MTF2L2|PCL1|TDRD19C	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1285
2.13046080993016e-135	-0.458424684525217	0.872	0.965	3.85528188164961e-131	TMEM165	Malignant cells	GSE108397	ENSG00000134851	55858	transmembrane protein 165	GDT1|SLC64A1|TMPT27|TPARL	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1286
2.24471077501753e-135	-0.469337466676978	0.794	0.917	4.06202861847172e-131	EIF2AK2	Malignant cells	GSE108397	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1287
3.32652541097557e-135	-0.457849948554954	0.9	0.964	6.01968038370139e-131	SURF4	Malignant cells	GSE108397	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1288
3.33737421727077e-135	-0.550141276932198	0.854	0.95	6.03931238357318e-131	CLSPN	Malignant cells	GSE108397	ENSG00000092853	63967	claspin	NA	protein_coding	Q9HAW4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1289
3.88217535288633e-135	0.38381917126111	0.354	0.102	7.0251845185831e-131	ARG2	Malignant cells	GSE108397	ENSG00000081181	384	arginase 2	NA	protein_coding	P78540	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1290
5.13755983774129e-135	0.316389727080128	1	1	9.29692828237664e-131	LDHB	Malignant cells	GSE108397	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1291
5.17795589331378e-135	-0.547476345583898	0.5	0.729	9.37002898454062e-131	SLC16A1	Malignant cells	GSE108397	ENSG00000281917	6566	solute carrier family 16 member 1	MCT|MCT1	protein_coding	P53985	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1292
5.50197932638153e-135	0.391553643125498	0.998	0.995	9.95638178902002e-131	DEF8	Malignant cells	GSE108397	ENSG00000140995	54849	differentially expressed in FDCP 8 homolog	FLJ20186	protein_coding	Q6ZN54	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1293
5.78007048491575e-135	-0.500766499515069	0.781	0.901	1.04596155495035e-130	MCM7	Malignant cells	GSE108397	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1294
7.20263285595096e-135	-0.561779545477217	0.33	0.59	1.30338844161288e-130	APOLD1	Malignant cells	GSE108397	ENSG00000178878	81575	apolipoprotein L domain containing 1	DKFZP434F0318|FLJ25138	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1295
1.12788882319071e-134	0.616935888759673	0.575	0.308	2.04102761444591e-130	FABP7	Malignant cells	GSE108397	ENSG00000164434	2173	fatty acid binding protein 7	B-FABP|BLBP	protein_coding	O15540	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1296
1.21162530562262e-134	-0.432936031060832	0.929	0.973	2.19255715305469e-130	TIMM44	Malignant cells	GSE108397	ENSG00000104980	10469	translocase of inner mitochondrial membrane 44	TIM44	protein_coding	O43615	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1297
1.43549592227905e-134	0.483983560134821	0.909	0.776	2.59767342095616e-130	MRPS14	Malignant cells	GSE108397	ENSG00000120333	63931	mitochondrial ribosomal protein S14	HSMRPS14	protein_coding	O60783	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1298
3.9720513670853e-134	0.500885807249355	0.875	0.72	7.18782415387757e-130	MOB4	Malignant cells	GSE108397	ENSG00000115540	25843	MOB family member 4, phocein	2C4D|CGI-95|DKFZP564M112|MOB3|MOBKL3|PHOCN|PREI3	protein_coding	Q9Y3A3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1299
4.3506647762335e-134	-0.370557678355588	0.996	0.999	7.87296297907215e-130	CALD1	Malignant cells	GSE108397	ENSG00000122786	800	caldesmon 1	CDM|H-CAD|h-CD|L-CAD	protein_coding	Q05682	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1300
6.53885383360807e-134	-0.518300057715291	0.606	0.794	1.18327098972972e-129	FAM189B	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1301
8.3022926597179e-134	-0.38355178843298	0.98	0.998	1.50238287970255e-129	TRABD	Malignant cells	GSE108397	ENSG00000170638	80305	TraB domain containing	PP2447	protein_coding	Q9H4I3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1302
9.01685940089941e-134	0.432112865727175	0.44	0.169	1.63169087718676e-129	DUSP15	Malignant cells	GSE108397	ENSG00000149599	128853	dual specificity phosphatase 15	bA243J16.5|bA243J16.6|C20orf57|FLJ20645|VHY	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1303
9.40967710239184e-134	-0.496967945945658	0.305	0.574	1.70277516844883e-129	SMG5	Malignant cells	GSE108397	ENSG00000198952	23381	SMG5 nonsense mediated mRNA decay factor	EST1B|KIAA1089|LPTS-RP1|LPTSRP1|RP11-54H19.7|SMG-5	protein_coding	Q9UPR3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1304
1.132219027495e-133	-0.465668048750135	0.955	0.993	2.04886355215495e-129	UBC	Malignant cells	GSE108397	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1305
2.29641713908754e-133	-0.511354680337779	0.269	0.559	4.15559645489281e-129	PPP1R14A	Malignant cells	GSE108397	ENSG00000167641	94274	protein phosphatase 1 regulatory inhibitor subunit 14A	CPI-17|PPP1INL	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1306
2.66294758953173e-133	0.440133615255746	0.261	0.045	4.81886995801661e-129	ABCB5	Malignant cells	GSE108397	ENSG00000004846	340273	ATP binding cassette subfamily B member 5	ABCB5alpha|ABCB5beta|EST422562	protein_coding	Q2M3G0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1307
3.92964814472825e-133	-0.498948667895943	0.614	0.808	7.11109128270024e-129	LMNB2	Malignant cells	GSE108397	ENSG00000176619	84823	lamin B2	LMN2	protein_coding	Q03252	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1308
5.54557852552248e-133	-0.445817161290871	0.889	0.972	1.00352788997855e-128	SRSF1	Malignant cells	GSE108397	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1309
6.08568009231938e-133	-0.379224282084057	0.975	0.996	1.10126466950611e-128	WASF2	Malignant cells	GSE108397	ENSG00000158195	10163	WASP family member 2	SCAR2|WAVE2	protein_coding	Q9Y6W5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1310
1.13174670623731e-132	0.450841552329404	0.963	0.911	2.04800883960703e-128	HSD17B10	Malignant cells	GSE108397	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1311
1.96529593067141e-132	-0.464378516875823	0.948	0.99	3.55639951614297e-128	SRSF7	Malignant cells	GSE108397	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1312
2.04181107575778e-132	-0.399364005454773	0.971	0.993	3.69486132269128e-128	ACTN1	Malignant cells	GSE108397	ENSG00000072110	87	actinin alpha 1	NA	protein_coding	P12814	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1313
3.20686686383522e-132	-0.490000986363909	0.803	0.91	5.80314627679621e-128	FASN	Malignant cells	GSE108397	ENSG00000169710	2194	fatty acid synthase	FAS|SDR27X1	protein_coding	P49327	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1314
4.35021790687321e-132	-0.53241453200765	0.425	0.671	7.87215432427777e-128	C21orf59	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1315
5.05808645743932e-132	-0.522556013410328	0.492	0.725	9.15311325338219e-128	PHACTR4	Malignant cells	GSE108397	ENSG00000204138	65979	phosphatase and actin regulator 4	FLJ13171|PPP1R124	protein_coding	Q8IZ21	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1316
6.85451429704396e-132	0.496041160056843	0.938	0.849	1.24039290719308e-127	TMEM251	Malignant cells	GSE108397	ENSG00000275947	26175	transmembrane protein 251	C14orf109|DKFZP564F1123	protein_coding	Q8N6I4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1317
1.15383000204145e-131	-0.462327125515154	0.823	0.928	2.08797077169421e-127	MLX	Malignant cells	GSE108397	ENSG00000108788	6945	MAX dimerization protein MLX	bHLHd13|MAD7|MXD7|TCFL4	protein_coding	Q9UH92	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1318
1.41400206715873e-131	-0.414911364044907	0.96	0.991	2.55877814073044e-127	HNRNPK	Malignant cells	GSE108397	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1319
1.78301464951248e-131	-0.43927189321157	0.86	0.955	3.22654330975777e-127	APIP	Malignant cells	GSE108397	ENSG00000149089	51074	APAF1 interacting protein	APIP2|CGI-29|Mmrp19	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1320
1.87477480033947e-131	-0.477178056921807	0.721	0.879	3.39259247869431e-127	WDR5	Malignant cells	GSE108397	ENSG00000196363	11091	WD repeat domain 5	CFAP89|SWD3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1321
2.10186978010147e-131	-0.418070614236604	0.931	0.97	3.80354355407161e-127	STARD3NL	Malignant cells	GSE108397	ENSG00000010270	83930	STARD3 N-terminal like	MENTHO|MGC3251	protein_coding	O95772	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1322
2.88385388280217e-131	-0.524000960908918	0.976	0.994	5.21862198631882e-127	NQO1	Malignant cells	GSE108397	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1323
3.93307607256e-131	0.527924016301705	0.876	0.723	7.11729446090457e-127	DLEU1	Malignant cells	GSE108397	ENSG00000176124	10301	deleted in lymphocytic leukemia 1	BCMS|BCMS1|DLB1|LEU1|LINC00021|NCRNA00021|XTP6	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1324
7.163302116033e-131	-0.480097665389481	0.211	0.48	1.29627115091733e-126	GBE1	Malignant cells	GSE108397	ENSG00000114480	2632	1,4-alpha-glucan branching enzyme 1	NA	protein_coding	Q04446	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1325
7.37549147911752e-131	0.435420044073665	0.978	0.937	1.33466893806111e-126	IDH3B	Malignant cells	GSE108397	ENSG00000101365	3420	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta	RP46	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1326
9.00567697136181e-131	-0.362280565339481	0.99	0.997	1.62966730473763e-126	SNRPF	Malignant cells	GSE108397	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1327
1.98060748270627e-130	-0.454885497935243	0.874	0.957	3.58410730070526e-126	SUPT5H	Malignant cells	GSE108397	ENSG00000196235	6829	SPT5 homolog, DSIF elongation factor subunit	FLJ34157|SPT5|SPT5H	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1328
2.12290624483349e-130	-0.513866166495331	0.511	0.741	3.84161114065068e-126	GSK3B	Malignant cells	GSE108397	ENSG00000082701	2932	glycogen synthase kinase 3 beta	NA	protein_coding	P49841	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1329
5.62381899649279e-130	0.302204789981319	1	1	1.01768628560533e-125	EEF1D	Malignant cells	GSE108397	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1330
5.81659498014388e-130	-0.431825827705939	0.966	0.992	1.05257102760684e-125	EIF3A	Malignant cells	GSE108397	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1331
7.56718127620335e-130	-0.329483422550835	0.997	0.999	1.36935712374176e-125	METTL5	Malignant cells	GSE108397	ENSG00000138382	29081	methyltransferase 5, N6-adenosine	HSPC133	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1332
7.81771524620996e-130	-0.365924239495967	0.985	0.998	1.41469375095415e-125	MLEC	Malignant cells	GSE108397	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1333
7.85357865999848e-130	0.443735215791459	0.516	0.237	1.42118359431333e-125	GDAP1	Malignant cells	GSE108397	ENSG00000104381	54332	ganglioside induced differentiation associated protein 1	CMT2K|CMT4|CMT4A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1334
8.16439813049456e-130	-0.455724843821183	0.852	0.951	1.4774294856943e-125	FDPS	Malignant cells	GSE108397	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1335
1.46604920692709e-129	0.445162925893643	0.47	0.2	2.65296264485527e-125	RP11-1042B17.3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1336
1.48054910050016e-129	-0.497401586357119	0.25	0.516	2.6792016522651e-125	NAB2	Malignant cells	GSE108397	ENSG00000166886	4665	NGFI-A binding protein 2	MADER	protein_coding	Q15742	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1337
1.9384737371344e-129	-0.503888833826361	0.438	0.683	3.50786207471841e-125	GPBP1L1	Malignant cells	GSE108397	ENSG00000159592	60313	GC-rich promoter binding protein 1 like 1	SP192	protein_coding	Q9HC44	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1338
3.10325676528665e-129	-0.380453879662601	0.985	0.997	5.61565344246273e-125	RAB1A	Malignant cells	GSE108397	ENSG00000138069	5861	RAB1A, member RAS oncogene family	RAB1|YPT1	protein_coding	P62820	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1339
5.36699611688826e-129	-0.334347198469693	0.998	1	9.712116173121e-125	PEBP1	Malignant cells	GSE108397	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1340
1.15128509302895e-128	-0.388798206318218	0.966	0.992	2.08336550434519e-124	DENR	Malignant cells	GSE108397	ENSG00000139726	8562	density regulated re-initiation and release factor	DRP|DRP1|SMAP-3	protein_coding	O43583	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1341
1.53402360772784e-128	0.439353093383964	0.954	0.865	2.7759691205443e-124	DDOST	Malignant cells	GSE108397	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1342
1.90995352541455e-128	-0.433752089135179	0.872	0.962	3.45625189959017e-124	RAP1A	Malignant cells	GSE108397	ENSG00000116473	5906	RAP1A, member of RAS oncogene family	KREV-1|SMGP21	protein_coding	P62834	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1343
1.91397253856403e-128	-0.474067268526521	0.72	0.88	3.46352470578547e-124	TXLNA	Malignant cells	GSE108397	ENSG00000084652	200081	taxilin alpha	DKFZp451J0118	protein_coding	P40222	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1344
2.87626883928223e-128	-0.419202223982788	0.176	0.445	5.20489609156512e-124	CTDSPL	Malignant cells	GSE108397	ENSG00000144677	10217	CTD small phosphatase like	C3orf8|HYA22|PSR1|RBSP3|SCP3	protein_coding	O15194	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1345
3.02428435376691e-128	-0.401235174997158	0.951	0.99	5.47274496657661e-124	GNB1	Malignant cells	GSE108397	ENSG00000078369	2782	G protein subunit beta 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1346
3.12698951314914e-128	0.511582675929969	0.781	0.567	5.65860022299468e-124	MRPL39	Malignant cells	GSE108397	ENSG00000154719	54148	mitochondrial ribosomal protein L39	C21orf92|FLJ20451|L39mt|MGC104174|MGC3400|MRP-L5|MSTP003|PRED22|PRED66|RPML5	protein_coding	Q9NYK5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1347
3.78000022698048e-128	-0.51944290368777	0.732	0.877	6.84028841074388e-124	TLN1	Malignant cells	GSE108397	ENSG00000137076	7094	talin 1	ILWEQ|TLN	protein_coding	Q9Y490	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1348
5.35149351168262e-128	0.482769499919579	0.933	0.849	9.68406265874086e-124	SETD9	Malignant cells	GSE108397	ENSG00000155542	133383	SET domain containing 9	C5orf35|MGC33648	protein_coding	Q8NE22	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1349
6.40940786388273e-128	-0.465799592673536	0.731	0.875	1.15984644704822e-123	SNAPIN	Malignant cells	GSE108397	ENSG00000143553	23557	SNAP associated protein	BLOC1S7|BORCS3|SNAPAP	protein_coding	O95295	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1350
8.87314685006968e-128	0.481856806404046	0.94	0.854	1.60568465398861e-123	FAM200B	Malignant cells	GSE108397	ENSG00000237765	285550	family with sequence similarity 200 member B	C4orf53	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1351
1.16457348464705e-127	-0.524743522171226	0.498	0.719	2.1074121778173e-123	MAN1A2	Malignant cells	GSE108397	ENSG00000198162	10905	mannosidase alpha class 1A member 2	MAN1B	protein_coding	O60476	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1352
1.21900612238883e-127	-0.520718137689381	0.582	0.778	2.20591347907483e-123	PHC2	Malignant cells	GSE108397	ENSG00000134686	1912	polyhomeotic homolog 2	EDR2|HPH2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1353
1.35472524093821e-127	-0.524341490587044	0.842	0.931	2.45151079600179e-123	PBK	Malignant cells	GSE108397	ENSG00000168078	55872	PDZ binding kinase	CT84|FLJ14385|Nori-3|SPK|TOPK	protein_coding	Q96KB5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1354
2.20299436008668e-127	-0.50076843057859	0.75	0.881	3.98653859401286e-123	BAG1	Malignant cells	GSE108397	ENSG00000107262	573	BAG cochaperone 1	NA	protein_coding	Q99933	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1355
4.15705244391802e-127	-0.527105796463959	0.437	0.668	7.52260210251404e-123	STK40	Malignant cells	GSE108397	ENSG00000196182	83931	serine/threonine kinase 40	MGC4796|SgK495	protein_coding	Q8N2I9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1356
4.97863383704159e-127	0.496308278305812	0.805	0.601	9.00933579151046e-123	TRAPPC4	Malignant cells	GSE108397	ENSG00000280495	51399	trafficking protein particle complex subunit 4	PTD009|SBDN|TRS23	protein_coding	Q9Y296	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1357
6.74434903944892e-127	-0.527585492122515	0.42	0.658	1.22045740217868e-122	TGFBRAP1	Malignant cells	GSE108397	ENSG00000135966	9392	transforming growth factor beta receptor associated protein 1	TRAP-1|TRAP1|VPS3	protein_coding	Q8WUH2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1358
8.45299434390011e-127	-0.50874068777016	0.767	0.9	1.52965385647216e-122	PLEKHO1	Malignant cells	GSE108397	ENSG00000023902	51177	pleckstrin homology domain containing O1	CKIP-1|OC120	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1359
2.26875270465021e-126	-0.455155415007198	0.745	0.891	4.10553489433502e-122	BRMS1	Malignant cells	GSE108397	ENSG00000174744	25855	BRMS1 transcriptional repressor and anoikis regulator	DKFZP564A063	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1360
2.55880562641397e-126	-0.504782440727874	0.387	0.638	4.63041466155872e-122	ATN1	Malignant cells	GSE108397	ENSG00000111676	1822	atrophin 1	B37|D12S755E|DRPLA	protein_coding	P54259	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1361
2.70614390963705e-126	0.411175930902004	0.975	0.94	4.89703801887921e-122	ARL2	Malignant cells	GSE108397	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1362
3.25416232757568e-126	0.474672199441793	0.322	0.089	5.88873214798094e-122	MXD4	Malignant cells	GSE108397	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1363
5.47016245198738e-126	-0.370468121523016	1	1	9.89880597311637e-122	GYPC	Malignant cells	GSE108397	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1364
8.04075722551201e-126	-0.499443419049811	0.796	0.909	1.45505542752865e-121	CYGB	Malignant cells	GSE108397	ENSG00000161544	114757	cytoglobin	HGB|STAP	protein_coding	Q8WWM9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1365
1.27011641072425e-125	0.40910809768459	0.989	0.981	2.2984026568466e-121	NDUFB5	Malignant cells	GSE108397	ENSG00000136521	4711	NADH:ubiquinone oxidoreductase subunit B5	CI-SGDH|MGC12314|SGDH	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1366
1.56435753780976e-125	-0.410732347274695	0.923	0.977	2.83086140042053e-121	SURF2	Malignant cells	GSE108397	ENSG00000281024	6835	surfeit 2	NA	protein_coding	Q15527	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1367
1.58610281498543e-125	-0.452713553622689	0.943	0.983	2.87021165399763e-121	RHOBTB3	Malignant cells	GSE108397	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1368
5.64937758289777e-125	-0.521948063543493	0.383	0.628	1.02231136740118e-120	CPOX	Malignant cells	GSE108397	ENSG00000080819	1371	coproporphyrinogen oxidase	CPO|CPX|HCP	protein_coding	P36551	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1369
7.4114339361755e-125	-0.391020925889789	0.962	0.988	1.34117308509032e-120	RWDD4	Malignant cells	GSE108397	ENSG00000182552	201965	RWD domain containing 4	FAM28A|MGC10198|RWDD4A	protein_coding	Q6NW29	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1370
8.84029370599897e-125	-0.51463933944445	0.364	0.622	1.59973954903757e-120	MLPH	Malignant cells	GSE108397	ENSG00000115648	79083	melanophilin	exophilin-3|l(1)-3Rk|l1Rk3|ln|Slac-2a	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1371
1.29157182790251e-124	-0.469988241694635	0.703	0.87	2.33722837977239e-120	RBM28	Malignant cells	GSE108397	ENSG00000106344	55131	RNA binding motif protein 28	FLJ10377	protein_coding	Q9NW13	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1372
1.38953328463696e-124	0.373853426772216	0.992	0.982	2.51449943187904e-120	CHPT1	Malignant cells	GSE108397	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1373
1.94055955291308e-124	-0.488367564181022	0.63	0.807	3.5116365669515e-120	IFNAR2	Malignant cells	GSE108397	ENSG00000159110	3455	interferon alpha and beta receptor subunit 2	IFNABR	protein_coding	P48551	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1374
1.95968852587574e-124	-0.460206355398058	0.242	0.506	3.54625235642474e-120	MTRNR2L12	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1375
1.99542791716507e-124	0.826495868603112	0.866	0.74	3.61092635890192e-120	GDF15	Malignant cells	GSE108397	ENSG00000130513	9518	growth differentiation factor 15	MIC-1|MIC1|NAG-1|PDF|PLAB|PTGFB	protein_coding	Q99988	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1376
2.31486423998576e-124	0.443520275254985	0.3	0.074	4.18897832867823e-120	PLCH1-AS1	Malignant cells	GSE108397	ENSG00000239508	100874035	PLCH1 antisense RNA 1	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1377
2.5359997748807e-124	-0.368279464734008	0.981	0.995	4.58914519262411e-120	LAPTM4B	Malignant cells	GSE108397	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1378
3.75254011657887e-124	-0.386695870239708	0.966	0.991	6.79059659496111e-120	UBXN1	Malignant cells	GSE108397	ENSG00000162191	51035	UBX domain protein 1	2B28|LOC51035|SAKS1|UBXD10	protein_coding	Q04323	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1379
4.98630529923245e-124	0.370723524621471	0.999	1	9.02321806949104e-120	HMGB1	Malignant cells	GSE108397	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1380
7.92982340112018e-124	-0.491460964756433	0.632	0.809	1.43498084266671e-119	SDAD1	Malignant cells	GSE108397	ENSG00000198301	55153	SDA1 domain containing 1	FLJ10498	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1381
9.56974585802981e-124	0.605956234171184	0.81	0.636	1.73174121046907e-119	SNHG9	Malignant cells	GSE108397	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1382
1.22752912180665e-123	-0.454191754296053	0.854	0.941	2.22133669882132e-119	TSPAN4	Malignant cells	GSE108397	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1383
2.64457623271499e-123	-0.442845793956616	0.909	0.974	4.78562515072105e-119	HP1BP3	Malignant cells	GSE108397	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1384
3.48671746532443e-123	-0.621791743166028	0.741	0.858	6.30956392525109e-119	BMP7	Malignant cells	GSE108397	ENSG00000101144	655	bone morphogenetic protein 7	OP-1	protein_coding	P18075	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1385
4.86405948190615e-123	-0.411710524528049	0.929	0.98	8.80200203845738e-119	CD151	Malignant cells	GSE108397	ENSG00000177697	977	CD151 molecule (Raph blood group)	PETA-3|RAPH|SFA-1|TSPAN24	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1386
5.97539539624412e-123	-0.481589728131767	0.31	0.565	1.08130755090434e-118	ASL	Malignant cells	GSE108397	ENSG00000126522	435	argininosuccinate lyase	ASAL	protein_coding	P04424	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1387
6.86926117768157e-123	0.29411490533244	1	1	1.24306150271326e-118	SLIRP	Malignant cells	GSE108397	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1388
7.29992365337124e-123	-0.330091094025037	0.064	0.284	1.32099418431406e-118	TMEM220	Malignant cells	GSE108397	ENSG00000187824	388335	transmembrane protein 220	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1389
1.09542796495377e-122	-0.503882947716785	0.397	0.638	1.98228644538035e-118	AIFM1	Malignant cells	GSE108397	ENSG00000156709	9131	apoptosis inducing factor mitochondria associated 1	AIF|AUNX1|CMTX4|DFNX5|NAMSD|PDCD8	protein_coding	O95831	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1390
1.38510814644161e-122	-0.478442085562802	0.651	0.82	2.50649170180073e-118	PACSIN2	Malignant cells	GSE108397	ENSG00000100266	11252	protein kinase C and casein kinase substrate in neurons 2	SDPII	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1391
1.56686285123285e-122	-0.491627675360304	0.658	0.824	2.83539501559096e-118	CCDC88A	Malignant cells	GSE108397	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1392
2.07259476155062e-122	-0.27214872660712	1	1	3.750567480502e-118	POLR2J	Malignant cells	GSE108397	ENSG00000005075	5439	RNA polymerase II subunit J	hRPB14|POLR2J1|RPB11|RPB11A|RPB11m	protein_coding	P52435	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1393
2.07444023375968e-122	-0.370675890048025	0.979	0.996	3.75390704701151e-118	PSMD14	Malignant cells	GSE108397	ENSG00000115233	10213	proteasome 26S subunit, non-ATPase 14	pad1|POH1|Rpn11	protein_coding	O00487	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1394
2.19290296063938e-122	-0.497800041191341	0.421	0.665	3.96827719757302e-118	PXDC1	Malignant cells	GSE108397	ENSG00000168994	221749	PX domain containing 1	C6orf145	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1395
2.2021765104863e-122	-0.48582276659923	0.54	0.752	3.98505861337601e-118	SPATA20	Malignant cells	GSE108397	ENSG00000006282	64847	spermatogenesis associated 20	FLJ21347|SSP411|Tisp78	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1396
3.66272166997263e-122	-0.406628886263142	0.953	0.988	6.62806113398248e-118	NFE2L2	Malignant cells	GSE108397	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1397
4.30606584033289e-122	-0.372415638193357	0.977	0.991	7.79225674466639e-118	PGM1	Malignant cells	GSE108397	ENSG00000079739	5236	phosphoglucomutase 1	NA	protein_coding	P36871	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1398
8.13823975895562e-122	0.500778084356505	0.847	0.673	1.47269586678061e-117	ESD	Malignant cells	GSE108397	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1399
1.27493749325579e-121	-0.443122124868718	0.892	0.955	2.30712688779568e-117	CCDC167	Malignant cells	GSE108397	ENSG00000198937	154467	coiled-coil domain containing 167	C6orf129|dJ153P14.2	protein_coding	Q9P0B6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1400
1.44900358230312e-121	0.643533337753529	0.83	0.673	2.62211688253572e-117	SLC45A2	Malignant cells	GSE108397	ENSG00000281919	51151	solute carrier family 45 member 2	AIM-1|MATP|OCA4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1401
1.53030696989248e-121	0.666017563050161	0.316	0.088	2.76924349271743e-117	NNMT	Malignant cells	GSE108397	ENSG00000166741	4837	nicotinamide N-methyltransferase	NA	protein_coding	P40261	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1402
4.15106937908671e-121	0.392139931320751	0.982	0.946	7.5117751483953e-117	EIF3M	Malignant cells	GSE108397	ENSG00000149100	10480	eukaryotic translation initiation factor 3 subunit M	FLJ29030|GA17|hfl-B5|PCID1|TANGO7	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1403
5.16986669196066e-121	0.494020442897241	0.735	0.501	9.35539076577201e-117	TMEM161B-AS1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1404
1.00996047438575e-120	-0.498363315452767	0.503	0.717	1.82762447444845e-116	ABCF2	Malignant cells	GSE108397	ENSG00000033050	10061	ATP binding cassette subfamily F member 2	ABC28|EST133090|HUSSY-18|M-ABC1	protein_coding	Q9UG63	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1405
1.05799445228178e-120	-0.409980321720667	0.906	0.963	1.91454676084911e-116	PREB	Malignant cells	GSE108397	ENSG00000138073	10113	prolactin regulatory element binding	SEC12	protein_coding	Q9HCU5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1406
1.3165137592898e-120	-0.543364484550488	0.759	0.885	2.38236329881081e-116	HELLS	Malignant cells	GSE108397	ENSG00000119969	3070	helicase, lymphoid specific	LSH|Nbla10143|PASG|SMARCA6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1407
1.76316924935965e-120	-0.39674479230831	0.947	0.982	3.19063107364122e-116	PARVB	Malignant cells	GSE108397	ENSG00000188677	29780	parvin beta	CGI-56	protein_coding	Q9HBI1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1408
3.60865438601773e-120	-0.279019265254489	1	1	6.53022097693768e-116	SERP1	Malignant cells	GSE108397	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1409
4.15541003675693e-120	-0.48810589458196	0.609	0.796	7.51963000251535e-116	RNF11	Malignant cells	GSE108397	ENSG00000123091	26994	ring finger protein 11	CGI-123|MGC51169|Sid1669p	protein_coding	Q9Y3C5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1410
4.97294337625092e-120	0.403668156233608	0.989	0.973	8.99903833366366e-116	UBE2V2	Malignant cells	GSE108397	ENSG00000169139	7336	ubiquitin conjugating enzyme E2 V2	DDVit-1|DDVIT1|EDAF-1|EDPF-1|EDPF1|MMS2|UEV-2|UEV2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1411
5.03305977365244e-120	0.431275355537851	0.943	0.853	9.10782496640145e-116	RALBP1	Malignant cells	GSE108397	ENSG00000017797	10928	ralA binding protein 1	RIP|RIP1|RLIP76	protein_coding	Q15311	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1412
5.23550746401706e-120	-0.418712983910452	0.901	0.964	9.47417430688528e-116	GRSF1	Malignant cells	GSE108397	ENSG00000132463	2926	G-rich RNA sequence binding factor 1	NA	protein_coding	Q12849	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1413
5.37271203624004e-120	-0.395126353422558	0.982	0.995	9.72245970077997e-116	PRADC1	Malignant cells	GSE108397	ENSG00000135617	84279	protease associated domain containing 1	C2orf7|hPAP21|MGC13004|PAP21	protein_coding	Q9BSG0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1414
5.38927411500682e-120	-0.27710951976107	1	1	9.75243043851634e-116	C1orf86	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1415
1.5372885557224e-119	-0.638465539570655	0.874	0.948	2.78187737043525e-115	MKI67	Malignant cells	GSE108397	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1416
1.98897391621221e-119	0.477218231770585	0.957	0.904	3.59924719877762e-115	SQLE	Malignant cells	GSE108397	ENSG00000104549	6713	squalene epoxidase	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1417
2.2417367244235e-119	-0.5100345290516	0.292	0.544	4.05664677651677e-115	RP11-81N13.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1418
2.69623224459275e-119	-0.465005551617931	0.299	0.555	4.87910186981504e-115	SSH1	Malignant cells	GSE108397	ENSG00000084112	54434	slingshot protein phosphatase 1	KIAA1298|SSH1L	protein_coding	Q8WYL5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1419
2.70302938000324e-119	0.373894847964798	0.997	0.996	4.89140196605386e-115	PHF5A	Malignant cells	GSE108397	ENSG00000100410	84844	PHD finger protein 5A	bK223H9.2|INI|MGC1346|Rds3|SAP14b|SF3b14b|SF3B7	protein_coding	Q7RTV0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1420
3.12252827191499e-119	-0.262930640954151	1	1	5.65052716085737e-115	MTDH	Malignant cells	GSE108397	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1421
4.26544627860132e-119	-0.250375957016947	1	1	7.71875158575696e-115	EEF2	Malignant cells	GSE108397	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1422
6.1233436722417e-119	0.469564402043485	0.903	0.779	1.10808027092886e-114	ZNF580	Malignant cells	GSE108397	ENSG00000213015	51157	zinc finger protein 580	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1423
6.87206059070571e-119	-0.499883586673331	0.597	0.778	1.24356808449411e-114	SMARCD2	Malignant cells	GSE108397	ENSG00000108604	6603	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2	BAF60B|CRACD2|PRO2451|Rsc6p	protein_coding	Q92925	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1424
9.08785654206686e-119	-0.339686479038158	0.983	0.999	1.64453851985242e-114	EIF4H	Malignant cells	GSE108397	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1425
1.0164953626999e-118	0.293306235699738	1	1	1.83945000834174e-114	PFDN5	Malignant cells	GSE108397	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1426
1.10666573389296e-118	0.457192265958162	0.887	0.75	2.00262231205271e-114	TMEM223	Malignant cells	GSE108397	ENSG00000168569	79064	transmembrane protein 223	MGC3196|Mrx15	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1427
2.18911314963376e-118	0.453043872084551	0.793	0.59	3.96141915557724e-114	SDR39U1	Malignant cells	GSE108397	ENSG00000100445	56948	short chain dehydrogenase/reductase family 39U member 1	C14orf124|HCDI	protein_coding	Q9NRG7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1428
2.23859346727501e-118	0.426586228330447	0.966	0.914	4.05095873838086e-114	PUF60	Malignant cells	GSE108397	ENSG00000274081	22827	poly(U) binding splicing factor 60	FIR|RoBPI|SIAHBP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1429
3.39794017536223e-118	-0.426177882233105	0.895	0.966	6.14891254133549e-114	AGTRAP	Malignant cells	GSE108397	ENSG00000177674	57085	angiotensin II receptor associated protein	ATRAP	protein_coding	Q6RW13	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1430
3.55246909436676e-118	-0.495082710124761	0.681	0.848	6.42854807316609e-114	CHTOP	Malignant cells	GSE108397	ENSG00000160679	26097	chromatin target of PRMT1	C1orf77|DKFZP547E1010|FOP|SRAG	protein_coding	Q9Y3Y2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1431
4.85986867219706e-118	0.486876171891518	0.616	0.366	8.79441834920781e-114	TBXAS1	Malignant cells	GSE108397	ENSG00000059377	6916	thromboxane A synthase 1	CYP5|CYP5A1|THAS|TS|TXAS|TXS	protein_coding	P24557	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1432
5.58245965971119e-118	-0.4709742471341	0.32	0.571	1.01020190002134e-113	NDST1	Malignant cells	GSE108397	ENSG00000070614	3340	N-deacetylase and N-sulfotransferase 1	HSST|NST1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1433
9.13609334610034e-118	-0.39294933031183	0.941	0.985	1.65326745191032e-113	KHDRBS1	Malignant cells	GSE108397	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1434
9.65179649441157e-118	-0.467706434576891	0.683	0.845	1.74658909362872e-113	RRP1	Malignant cells	GSE108397	ENSG00000160214	8568	ribosomal RNA processing 1	D21S2056E|NNP-1|Nop52|RRP1A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1435
1.12025370269553e-117	-0.37054192641016	0.974	0.993	2.02721110039783e-113	CBX1	Malignant cells	GSE108397	ENSG00000108468	10951	chromobox 1	CBX|HP1-BETA|HP1Hs-beta|M31|MOD1	protein_coding	P83916	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1436
1.35027299958263e-117	-0.334498117704546	0.995	0.999	2.44345402004473e-113	RPL39L	Malignant cells	GSE108397	ENSG00000163923	116832	ribosomal protein L39 like	RPL39L1	protein_coding	Q96EH5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1437
2.33849279157827e-117	-0.463631964695733	0.757	0.883	4.23173655564004e-113	STX3	Malignant cells	GSE108397	ENSG00000166900	6809	syntaxin 3	STX3A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1438
2.98731662155697e-117	-0.476960528043478	0.634	0.808	5.40584815836949e-113	MIS18A	Malignant cells	GSE108397	ENSG00000159055	54069	MIS18 kinetochore protein A	B28|C21orf45|C21orf46|FASP1|hMis18alpha	protein_coding	Q9NYP9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1439
3.1828622500847e-117	-0.399632337283625	0.909	0.978	5.75970752775327e-113	CMPK1	Malignant cells	GSE108397	ENSG00000162368	51727	cytidine/uridine monophosphate kinase 1	CMPK|UMP-CMPK	protein_coding	P30085	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1440
3.44252225470393e-117	0.342908547192397	0.337	0.103	6.22958827211223e-113	SLCO3A1	Malignant cells	GSE108397	ENSG00000176463	28232	solute carrier organic anion transporter family member 3A1	OATP-D|OATP3A1|SLC21A11	protein_coding	Q9UIG8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1441
3.75120411944138e-117	0.414152276530825	0.381	0.138	6.78817897454113e-113	BCAN	Malignant cells	GSE108397	ENSG00000132692	63827	brevican	BEHAB|CSPG7|MGC13038	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1442
5.16044726124846e-117	-0.515957552346761	0.328	0.576	9.33834536395522e-113	STK17B	Malignant cells	GSE108397	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1443
5.25645830507747e-117	0.328953440938278	0.999	0.999	9.5120869488682e-113	MRPL18	Malignant cells	GSE108397	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1444
6.53491495003853e-117	-0.446175500847496	0.212	0.464	1.18255820935897e-112	NBPF10	Malignant cells	GSE108397	ENSG00000271425	100132406	NBPF member 10	AG1	protein_coding	Q6P3W6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1445
1.02380338321017e-116	-0.317888999122455	0.998	0.998	1.85267460225713e-112	CRELD2	Malignant cells	GSE108397	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1446
1.49520018661053e-116	-0.439658895135494	0.803	0.91	2.70571425769041e-112	TOP1MT	Malignant cells	GSE108397	ENSG00000184428	116447	DNA topoisomerase I mitochondrial	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1447
2.58924417086286e-116	-0.488002117720435	0.609	0.801	4.68549625159342e-112	SOAT1	Malignant cells	GSE108397	ENSG00000057252	6646	sterol O-acyltransferase 1	ACAT|ACAT1|SOAT|STAT	protein_coding	P35610	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1448
3.69874580686237e-116	-0.279719248879696	1	1	6.69325041209814e-112	YWHAZ	Malignant cells	GSE108397	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1449
4.02172491617514e-116	-0.466314075540775	0.786	0.91	7.27771340831054e-112	DUSP6	Malignant cells	GSE108397	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1450
4.10998162047214e-116	-0.491234971343433	0.553	0.749	7.43742274040639e-112	TMEM259	Malignant cells	GSE108397	ENSG00000182087	91304	transmembrane protein 259	ASBABP1|C19orf6|MBRL|MGC4022	protein_coding	Q4ZIN3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1451
5.03005339102539e-116	-0.361932115574486	0.109	0.342	9.10238461639955e-112	CLIP2	Malignant cells	GSE108397	ENSG00000106665	7461	CAP-Gly domain containing linker protein 2	CLIP|CLIP-115|CYLN2|KIAA0291|WBSCR3|WBSCR4|WSCR3|WSCR4	protein_coding	Q9UDT6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1452
5.26245367043989e-116	0.405679212670154	0.952	0.881	9.52293616202802e-112	RUVBL2	Malignant cells	GSE108397	ENSG00000183207	10856	RuvB like AAA ATPase 2	ECP51|INO80J|Reptin52|RVB2|TIH2|TIP48|TIP49b	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1453
5.5732231880341e-116	-0.403635804302674	0.903	0.967	1.00853046810665e-111	SLC39A3	Malignant cells	GSE108397	ENSG00000141873	29985	solute carrier family 39 member 3	ZIP3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1454
7.1962942726592e-116	0.417636066358969	0.989	0.971	1.30224141158041e-111	RBM3	Malignant cells	GSE108397	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1455
9.0619728263269e-116	0.458011263386767	0.99	0.992	1.63985460265212e-111	PDCD6	Malignant cells	GSE108397	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1456
1.16225827345107e-115	0.466400023643023	0.877	0.741	2.10322257163705e-111	SNRNP40	Malignant cells	GSE108397	ENSG00000060688	9410	small nuclear ribonucleoprotein U5 subunit 40	HPRP8BP|PRP8BP|PRPF8BP|SPF38|WDR57	protein_coding	Q96DI7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1457
1.36818096237656e-115	-0.281957851614234	0.998	0.998	2.47586026951662e-111	MCUR1	Malignant cells	GSE108397	ENSG00000050393	63933	mitochondrial calcium uniporter regulator 1	C6orf79|CCDC90A|FLJ20958	protein_coding	Q96AQ8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1458
1.81628093480876e-115	-0.44462720694392	0.218	0.469	3.28674197962993e-111	POLR3C	Malignant cells	GSE108397	ENSG00000186141	10623	RNA polymerase III subunit C	C82|RPC3|RPC62	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1459
4.54256327162097e-115	-0.4357970507592	0.813	0.923	8.22022249632531e-111	USP48	Malignant cells	GSE108397	ENSG00000090686	84196	ubiquitin specific peptidase 48	FLJ11328|FLJ20103|FLJ23054|FLJ23277|MGC14879|USP31	protein_coding	Q86UV5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1460
5.06344460344838e-115	-0.432211690709201	0.854	0.944	9.16280935440019e-111	CCDC47	Malignant cells	GSE108397	ENSG00000108588	57003	coiled-coil domain containing 47	GK001	protein_coding	Q96A33	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1461
1.04789056138379e-114	0.410770101737062	0.958	0.898	1.8962627598801e-110	MRPS18B	Malignant cells	GSE108397	ENSG00000233813	28973	mitochondrial ribosomal protein S18B	C6orf14|HSPC183|MRPS18-2|PTD017	protein_coding	Q9Y676	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1462
1.20720241263725e-114	-0.539060284110887	0.065	0.276	2.18455348590837e-110	NUPR1	Malignant cells	GSE108397	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1463
2.53445845866942e-114	0.452184522414915	0.456	0.208	4.58635602680819e-110	TAF9B	Malignant cells	GSE108397	ENSG00000187325	51616	TATA-box binding protein associated factor 9b	DN-7|DN7|TAF9L|TAFII31L|TFIID-31	protein_coding	Q9HBM6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1464
3.40138898393879e-114	-0.305579606553987	0.999	1	6.15515350533564e-110	PCBP2	Malignant cells	GSE108397	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1465
3.5572809968714e-114	-0.477994983073394	0.575	0.773	6.43725569193849e-110	EZR	Malignant cells	GSE108397	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1466
5.00606283057822e-114	-0.469163059322345	0.584	0.774	9.05897129821435e-110	RSBN1L	Malignant cells	GSE108397	ENSG00000187257	222194	round spermatid basic protein 1 like	FLJ42526|FLJ45813|MGC71764	protein_coding	Q6PCB5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1467
6.72842231833277e-114	-0.51360022659644	0.484	0.691	1.2175753027255e-109	RP11-343N15.5	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1468
7.14172367523483e-114	-0.372787510959422	0.962	0.993	1.29236631627049e-109	CAP1	Malignant cells	GSE108397	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1469
7.35599673640446e-114	0.437411611172405	0.882	0.745	1.33114116941975e-109	PSMA2.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1470
8.54265826897833e-114	-0.403492084962546	0.904	0.967	1.54587944035432e-109	ERGIC2	Malignant cells	GSE108397	ENSG00000087502	51290	ERGIC and golgi 2	Erv41|PTX1	protein_coding	Q96RQ1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1471
8.69164544483302e-114	0.459440761893337	0.713	0.478	1.57284015969698e-109	NGDN	Malignant cells	GSE108397	ENSG00000129460	25983	neuroguidin	C14orf120|CANu1|DKFZP564O092|LCP5|lpd-2|NGD	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1472
1.04877327016122e-113	-0.467273641306579	0.576	0.769	1.89786010968374e-109	GATAD1	Malignant cells	GSE108397	ENSG00000157259	57798	GATA zinc finger domain containing 1	FLJ22489|ODAG|RG083M05.2	protein_coding	Q8WUU5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1473
1.65641059147635e-113	-0.456408523978587	0.713	0.862	2.99744060633561e-109	POLR3GL	Malignant cells	GSE108397	ENSG00000121851	84265	RNA polymerase III subunit GL	flj32422|MGC3200	protein_coding	Q9BT43	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1474
2.41283682599355e-113	-0.446198100335735	0.834	0.919	4.36626952031792e-109	SSBP4	Malignant cells	GSE108397	ENSG00000130511	170463	single stranded DNA binding protein 4	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1475
2.87590791786463e-113	-0.412573686572277	0.864	0.948	5.20424296816783e-109	FASTK	Malignant cells	GSE108397	ENSG00000164896	10922	Fas activated serine/threonine kinase	FAST	protein_coding	Q14296	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1476
3.53502681934163e-113	0.29142560568248	1	1	6.39698453228062e-109	TRAPPC1	Malignant cells	GSE108397	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1477
3.76039438548614e-113	-0.460767672042485	0.736	0.886	6.80480967997572e-109	PYGL	Malignant cells	GSE108397	ENSG00000100504	5836	glycogen phosphorylase L	GSD6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1478
3.77251654973292e-113	0.381584324868448	0.381	0.142	6.82674594839669e-109	DLGAP1-AS1	Malignant cells	GSE108397	ENSG00000177337	NA	NA	FLJ35776|HsT914	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1479
2.09675253754471e-112	-0.534463911439595	0.516	0.709	3.79428339194091e-108	TTYH2	Malignant cells	GSE108397	ENSG00000141540	94015	tweety family member 2	C17orf29	protein_coding	Q9BSA4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1480
2.94257446948908e-112	-0.331775335858645	0.992	0.998	5.32488275998744e-108	TMEM106C	Malignant cells	GSE108397	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1481
3.04187306297827e-112	0.479915921457755	0.616	0.373	5.50457349476548e-108	FASTKD3	Malignant cells	GSE108397	ENSG00000124279	79072	FAST kinase domains 3	FLJ23274|MGC5297	protein_coding	Q14CZ7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1482
3.57575400816726e-112	-0.537468943018166	0.683	0.855	6.47068445317947e-108	CITED1	Malignant cells	GSE108397	ENSG00000125931	4435	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1	MSG1	protein_coding	Q99966	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1483
3.96786127905088e-112	-0.382243342337601	0.923	0.976	7.18024177057047e-108	BABAM1	Malignant cells	GSE108397	ENSG00000105393	29086	BRISC and BRCA1 A complex member 1	C19orf62|FLJ20571|HSPC142|MERIT40|NBA1	protein_coding	Q9NWV8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1484
4.63745890789302e-112	0.359783755821049	0.341	0.113	8.39194563972321e-108	LSAMP	Malignant cells	GSE108397	ENSG00000185565	4045	limbic system associated membrane protein	IGLON3|LAMP	protein_coding	Q13449	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1485
4.76410271273347e-112	-0.466546237498388	0.651	0.822	8.62112026896248e-108	KDSR	Malignant cells	GSE108397	ENSG00000119537	2531	3-ketodihydrosphingosine reductase	DHSR|FVT1|SDR35C1	protein_coding	Q06136	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1486
5.12166526358563e-112	-0.534735339851437	0.376	0.608	9.26816546098455e-108	SPEN	Malignant cells	GSE108397	ENSG00000065526	23013	spen family transcriptional repressor	KIAA0929|MINT|RBM15C|SHARP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1487
7.27550852082935e-112	0.396815570533823	0.436	0.188	1.31657602192928e-107	GEMIN2	Malignant cells	GSE108397	ENSG00000092208	8487	gem nuclear organelle associated protein 2	SIP1	protein_coding	O14893	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1488
9.44242892122897e-112	-0.439068274056389	0.781	0.903	1.70870193758559e-107	SNRNP70	Malignant cells	GSE108397	ENSG00000104852	6625	small nuclear ribonucleoprotein U1 subunit 70	RNPU1Z|RPU1|Snp1|SNRP70|U1-70K	protein_coding	P08621	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1489
1.23018048090349e-111	0.383538029275619	0.972	0.924	2.22613459824295e-107	DDRGK1	Malignant cells	GSE108397	ENSG00000198171	65992	DDRGK domain containing 1	C20orf116|dJ1187M17.3|UFBP1	protein_coding	Q96HY6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1490
1.24114230336927e-111	0.489185540328792	0.349	0.117	2.24597111217704e-107	JUN	Malignant cells	GSE108397	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1491
1.31342357493256e-111	0.470074677447037	0.854	0.709	2.37677130119797e-107	MRPS22	Malignant cells	GSE108397	ENSG00000175110	56945	mitochondrial ribosomal protein S22	C3orf5|GIBT|GK002|MRP-S22	protein_coding	P82650	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1492
1.50832682850478e-111	-0.277505145892756	0.999	0.999	2.72946822886225e-107	BCAP31	Malignant cells	GSE108397	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1493
1.79370930140009e-111	0.269301621660676	1	1	3.2458963518136e-107	RPS24	Malignant cells	GSE108397	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1494
1.80296266373834e-111	-0.51602346247274	0.397	0.633	3.26264123630089e-107	MSC	Malignant cells	GSE108397	ENSG00000178860	9242	musculin	ABF-1|bHLHa22	protein_coding	O60682	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1495
2.14772041405988e-111	-0.421307824839225	0.934	0.988	3.88651486128276e-107	RAC3	Malignant cells	GSE108397	ENSG00000169750	5881	Rac family small GTPase 3	NA	protein_coding	P60763	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1496
2.46953534565198e-111	0.419823430134248	0.948	0.857	4.46887116149182e-107	ANP32A	Malignant cells	GSE108397	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1497
2.82518193775725e-111	-0.476200493059311	0.312	0.555	5.11244923456552e-107	ARHGEF2	Malignant cells	GSE108397	ENSG00000116584	9181	Rho/Rac guanine nucleotide exchange factor 2	GEF-H1|GEFH1|KIAA0651|Lfc|LFP40|P40	protein_coding	Q92974	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1498
2.95251664016943e-111	0.630090023162634	0.709	0.549	5.34287411205061e-107	ATRX	Malignant cells	GSE108397	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1499
9.33177140727505e-111	-0.46294712238638	0.7	0.842	1.68867735386049e-106	DCAF7	Malignant cells	GSE108397	ENSG00000136485	10238	DDB1 and CUL4 associated factor 7	HAN11|SWAN-1|WDR68	protein_coding	P61962	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1500
1.82889563715037e-110	-0.466415102432206	0.41	0.645	3.30956954498731e-106	C1orf216	Malignant cells	GSE108397	ENSG00000142686	127703	chromosome 1 open reading frame 216	FLJ38984	protein_coding	Q8TAB5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1501
2.07161812579916e-110	-0.441923976593276	0.784	0.902	3.74880016044616e-106	HEBP1	Malignant cells	GSE108397	ENSG00000013583	50865	heme binding protein 1	HBP|HEBP	protein_coding	Q9NRV9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1502
2.37961663045181e-110	-0.432430008994617	0.765	0.876	4.30615425446559e-106	CHID1	Malignant cells	GSE108397	ENSG00000177830	66005	chitinase domain containing 1	FLJ42707|MGC3234|SI-CLP	protein_coding	Q9BWS9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1503
2.73924762016874e-110	0.461785457490449	0.744	0.527	4.95694249345736e-106	RBPJ	Malignant cells	GSE108397	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1504
2.86659522610781e-110	-0.48253874236411	0.593	0.779	5.18739072116469e-106	CREB3L2	Malignant cells	GSE108397	ENSG00000182158	64764	cAMP responsive element binding protein 3 like 2	BBF2H7|TCAG_1951439	protein_coding	Q70SY1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1505
3.35974130781233e-110	-0.475484682684535	0.475	0.689	6.0797878706172e-106	ATP6V1A	Malignant cells	GSE108397	ENSG00000114573	523	ATPase H+ transporting V1 subunit A	ATP6A1|ATP6V1A1|VA68|Vma1|VPP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1506
3.85589913280721e-110	-0.468492750451353	0.615	0.788	6.97763507072793e-106	FAM120A	Malignant cells	GSE108397	ENSG00000048828	23196	family with sequence similarity 120A	C9orf10|KIAA0183|OSSA	protein_coding	Q9NZB2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1507
4.16721210535954e-110	-0.468529536432159	0.279	0.529	7.54098702585863e-106	BAIAP2L2	Malignant cells	GSE108397	ENSG00000128298	80115	BAR/IMD domain containing adaptor protein 2 like 2	FLJ22582|pinkbar	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1508
4.64731642403256e-110	-0.480365426754924	0.483	0.688	8.40978380092932e-106	NFKBIL1	Malignant cells	GSE108397	ENSG00000236346	4795	NFKB inhibitor like 1	IKBL|NFKBIL	protein_coding	Q9UBC1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1509
4.78784359911406e-110	-0.295570401279453	0.056	0.255	8.6640817769568e-106	FXYD1	Malignant cells	GSE108397	ENSG00000266964	5348	FXYD domain containing ion transport regulator 1	PLM	protein_coding	O00168	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1510
5.63874645775066e-110	-0.471785263212547	0.826	0.916	1.02038755899456e-105	C12orf57	Malignant cells	GSE108397	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1511
5.68696048756973e-110	-0.314946615503401	0.995	0.998	1.02911236983062e-105	FDX1	Malignant cells	GSE108397	ENSG00000137714	2230	ferredoxin 1	ADX|FDX	protein_coding	P10109	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1512
5.95572093051526e-110	0.476392805950409	0.798	0.612	1.07774725958604e-105	PDCD7	Malignant cells	GSE108397	ENSG00000090470	10081	programmed cell death 7	59K|ES18|HES18	protein_coding	Q8N8D1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1513
7.09334489778016e-110	0.427105457020043	0.634	0.378	1.2836116927023e-105	MICU2	Malignant cells	GSE108397	ENSG00000165487	221154	mitochondrial calcium uptake 2	EFHA1	protein_coding	Q8IYU8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1514
7.68426388094184e-110	0.361129633863987	0.42	0.173	1.39054439189524e-105	MSX1	Malignant cells	GSE108397	ENSG00000163132	4487	msh homeobox 1	HOX7|HYD1|OFC5	protein_coding	P28360	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1515
1.13018867094797e-109	-0.455738745484289	0.703	0.847	2.04518941894745e-105	NEK6	Malignant cells	GSE108397	ENSG00000119408	10783	NIMA related kinase 6	SID6-1512	protein_coding	Q9HC98	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1516
1.25129716301511e-109	-0.384653319960474	0.147	0.381	2.26434734619214e-105	LRP8	Malignant cells	GSE108397	ENSG00000157193	7804	LDL receptor related protein 8	APOER2|HSZ75190|LRP-8|MCI1	protein_coding	Q14114	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1517
1.45625424891859e-109	-0.462565633138602	0.454	0.675	2.63523768884307e-105	HK1	Malignant cells	GSE108397	ENSG00000156515	3098	hexokinase 1	NA	protein_coding	P19367	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1518
1.46787038560193e-109	-0.534825836860456	0.326	0.57	2.65625824978526e-105	RP11-429E11.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1519
1.85449626119725e-109	-0.39266369584398	0.912	0.975	3.35589643426255e-105	ASPH	Malignant cells	GSE108397	ENSG00000198363	444	aspartate beta-hydroxylase	BAH|CASQ2BP1|HAAH|JCTN	protein_coding	Q12797	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1520
2.02608735038242e-109	-0.251893807210184	1	1	3.66640766925202e-105	MZT2B	Malignant cells	GSE108397	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1521
2.03615570427562e-109	-0.627791735672268	0.374	0.617	3.68462736245716e-105	PLAUR	Malignant cells	GSE108397	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1522
2.56344569018157e-109	-0.459716002712387	0.501	0.715	4.63881132095256e-105	ISG20L2	Malignant cells	GSE108397	ENSG00000143319	81875	interferon stimulated exonuclease gene 20 like 2	FLJ12671	protein_coding	Q9H9L3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1523
3.27919784415524e-109	-0.440997581298034	0.316	0.559	5.93403641878332e-105	PI4KB	Malignant cells	GSE108397	ENSG00000143393	5298	phosphatidylinositol 4-kinase beta	PI4K-BETA|pi4K92|PIK4CB	protein_coding	Q9UBF8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1524
3.95702849438944e-109	0.377399416486353	0.987	0.961	7.16063876344713e-105	PFDN1	Malignant cells	GSE108397	ENSG00000113068	5201	prefoldin subunit 1	PFD1	protein_coding	O60925	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1525
3.99780866051959e-109	-0.472912881554835	0.384	0.62	7.23443455207626e-105	STRBP	Malignant cells	GSE108397	ENSG00000165209	55342	spermatid perinuclear RNA binding protein	FLJ11307|ILF3L|SPNR	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1526
7.3118055547508e-109	0.291784940735662	1	1	1.32314433318771e-104	ATP6V1G1	Malignant cells	GSE108397	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1527
7.87073113110509e-109	-0.467152415036561	0.4	0.634	1.42428750548478e-104	DAPK3	Malignant cells	GSE108397	ENSG00000167657	1613	death associated protein kinase 3	ZIP|ZIPK	protein_coding	O43293	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1528
9.5324298423751e-109	-0.480046439313092	0.65	0.808	1.7249885042762e-104	MYO19	Malignant cells	GSE108397	ENSG00000278372	80179	myosin XIX	FLJ22865|MYOHD1	protein_coding	Q96H55	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1529
1.08979262563098e-108	-0.362431125840827	0.998	0.998	1.97208873534182e-104	RGS10	Malignant cells	GSE108397	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1530
1.32235999969924e-108	-0.393554393031672	0.935	0.969	2.39294265545575e-104	TMEM243	Malignant cells	GSE108397	ENSG00000135185	79161	transmembrane protein 243	C7orf23|MGC4175|MM-TRAG	protein_coding	Q9BU79	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1531
1.34787992705726e-108	0.441561851603132	0.854	0.698	2.43912351600282e-104	SNW1	Malignant cells	GSE108397	ENSG00000100603	22938	SNW domain containing 1	Bx42|FUN20|NCoA-62|Prp45|PRPF45|SKIIP|SKIP|SKIP1	protein_coding	Q13573	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1532
1.35909978191334e-108	-0.440789198453564	0.685	0.839	2.45942696535037e-104	MGAT1	Malignant cells	GSE108397	ENSG00000131446	4245	alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GLCNAC-TI|GLYT1|GNT-1|GnTI|MGAT	protein_coding	P26572	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1533
1.55137744229204e-108	0.281635371081535	1	0.999	2.80737261957167e-104	SSR3	Malignant cells	GSE108397	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1534
1.61264266266423e-108	0.398372291434012	0.963	0.927	2.91823816235719e-104	UXT	Malignant cells	GSE108397	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1535
2.52296735110769e-108	-0.347150257475953	0.981	0.995	4.56556171856447e-104	COX14	Malignant cells	GSE108397	ENSG00000178449	84987	cytochrome c oxidase assembly factor COX14	C12orf62|MGC14288	protein_coding	Q96I36	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1536
2.99358724951511e-108	-0.402979654622631	0.231	0.477	5.41719548672254e-104	MT-ATP8	Malignant cells	GSE108397	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1537
3.55459111310522e-108	0.454128568981254	0.68	0.448	6.4323880782752e-104	SAAL1	Malignant cells	GSE108397	ENSG00000166788	113174	serum amyloid A like 1	FLJ41463	protein_coding	Q96ER3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1538
5.10479246617706e-108	0.345999337780755	0.991	0.97	9.237632446794e-104	PSMA1	Malignant cells	GSE108397	ENSG00000129084	5682	proteasome 20S subunit alpha 1	HC2|MGC14542|MGC14575|MGC14751|MGC1667|MGC21459|MGC22853|MGC23915|NU|PROS30	protein_coding	P25786	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1539
6.06014171837574e-108	-0.293791024425446	1	1	1.09664324535727e-103	NDUFS5	Malignant cells	GSE108397	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1540
1.0415418397846e-107	-0.431297903902518	0.835	0.936	1.88477411327421e-103	PRPF38B	Malignant cells	GSE108397	ENSG00000134186	55119	pre-mRNA processing factor 38B	FLJ10330|NET1	protein_coding	Q5VTL8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1541
1.06908583827652e-107	-0.418361771260293	0.786	0.909	1.93461773294519e-103	DNM1L	Malignant cells	GSE108397	ENSG00000087470	10059	dynamin 1 like	DRP1|DVLP|DYMPLE|HDYNIV|VPS1	protein_coding	O00429	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1542
1.2535123159354e-107	-0.496158480231996	0.686	0.83	2.26835588691671e-103	IVNS1ABP	Malignant cells	GSE108397	ENSG00000116679	10625	influenza virus NS1A binding protein	ARA3|HSPC068|KIAA0850|KLHL39|ND1|NS-1|NS1-BP	protein_coding	Q9Y6Y0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1543
1.32796543215401e-107	-0.33851723889679	0.984	0.994	2.40308624602589e-103	MRPS5	Malignant cells	GSE108397	ENSG00000144029	64969	mitochondrial ribosomal protein S5	MRP-S5|S5mt	protein_coding	P82675	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1544
1.53362536860573e-107	-0.359098118187976	0.963	0.988	2.77524846702894e-103	ATP6V1E1	Malignant cells	GSE108397	ENSG00000131100	529	ATPase H+ transporting V1 subunit E1	ATP6E|ATP6E2|ATP6V1E|P31|Vma4	protein_coding	P36543	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1545
1.62437004021869e-107	-0.430083689025549	0.774	0.896	2.93946002477974e-103	CORO1C	Malignant cells	GSE108397	ENSG00000110880	23603	coronin 1C	coronin-3|HCRNN4	protein_coding	Q9ULV4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1546
1.62487192975708e-107	0.483655600773866	0.724	0.517	2.94036824408841e-103	C5orf38	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1547
2.19523505946588e-107	0.422640161306659	0.914	0.799	3.97249736360945e-103	COMMD5	Malignant cells	GSE108397	ENSG00000170619	28991	COMM domain containing 5	FLJ13008|HCaRG|HT002	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1548
2.23156998827276e-107	-0.380182718324983	0.974	0.997	4.03824905077838e-103	FUS	Malignant cells	GSE108397	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1549
3.13396665573858e-107	-0.42872373962417	0.777	0.892	5.67122606022453e-103	AAED1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1550
3.3902224836033e-107	0.443027655038812	0.93	0.822	6.13494660632853e-103	PTRH2	Malignant cells	GSE108397	ENSG00000141378	51651	peptidyl-tRNA hydrolase 2	BIT1|CFAP37|CGI-147|PTH2	protein_coding	Q9Y3E5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1551
5.8308267293954e-107	-0.451031111223364	0.131	0.361	1.05514640495139e-102	TXNIP	Malignant cells	GSE108397	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1552
6.43443403183605e-107	-0.385080883325538	0.899	0.966	1.16437518240105e-102	ABI2	Malignant cells	GSE108397	ENSG00000138443	10152	abl interactor 2	ABI-2|ABI2B|AblBP3|AIP-1|argBPIA|SSH3BP2	protein_coding	Q9NYB9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1553
1.00412541698739e-106	0.303529302188434	1	1	1.81706535458038e-102	EIF1	Malignant cells	GSE108397	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1554
1.23770959506245e-106	-0.405595881275249	0.904	0.967	2.23975928322502e-102	SFXN1	Malignant cells	GSE108397	ENSG00000164466	94081	sideroflexin 1	FLJ12876|SLC56A1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1555
1.26847145296391e-106	0.483733733676472	0.797	0.628	2.29542594128348e-102	NIP7	Malignant cells	GSE108397	ENSG00000132603	51388	nucleolar pre-rRNA processing protein NIP7	CGI-37|FLJ10296|HSPC031|KD93	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1556
1.76667482532436e-106	-0.472087660181099	0.741	0.862	3.19697476390697e-102	BAG2	Malignant cells	GSE108397	ENSG00000112208	9532	BAG cochaperone 2	NA	protein_coding	O95816	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1557
2.10195789413291e-106	-0.408295462831568	0.959	0.982	3.80370300522292e-102	SVIP	Malignant cells	GSE108397	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1558
2.31973550579826e-106	-0.650073441532939	0.83	0.949	4.19779337129253e-102	PRNP	Malignant cells	GSE108397	ENSG00000171867	5621	prion protein	AltPrP|CD230|CJD|GSS|PRIP|PRP	protein_coding	P04156	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1559
3.08211979588814e-106	-0.422158657163052	0.255	0.498	5.57740398263918e-102	NCS1	Malignant cells	GSE108397	ENSG00000107130	23413	neuronal calcium sensor 1	FREQ|NCS-1	protein_coding	P62166	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1560
3.44200287004022e-106	-0.402506664488697	0.915	0.968	6.22864839362478e-102	ITM2C	Malignant cells	GSE108397	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1561
5.42824449284396e-106	-0.411034102702347	0.921	0.974	9.82295123425043e-102	ANKRD28	Malignant cells	GSE108397	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1562
5.4981638503329e-106	0.473161848257804	0.906	0.8	9.94947730356241e-102	ZFR	Malignant cells	GSE108397	ENSG00000056097	51663	zinc finger RNA binding protein	SPG71|ZFR1	protein_coding	Q96KR1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1563
6.62830748080614e-106	0.409329379060873	0.993	0.984	1.19945852172668e-101	ARL6IP5	Malignant cells	GSE108397	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1564
9.28947611505792e-106	0.487974151652497	0.512	0.267	1.68102359778088e-101	RP11-838N2.4	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1565
9.88011870559547e-106	0.4416160426689	0.631	0.379	1.78790628096456e-101	RRAGA	Malignant cells	GSE108397	ENSG00000155876	10670	Ras related GTP binding A	FIP-1|RAGA	protein_coding	Q7L523	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1566
1.19270788455928e-105	-0.30303285553023	0.075	0.279	2.15832418789847e-101	KIAA1549L	Malignant cells	GSE108397	ENSG00000110427	25758	KIAA1549 like	C11orf41|C11orf69|G2|MGC34830	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1567
1.38062211617762e-105	-0.435027849672352	0.609	0.797	2.49837378143502e-101	VKORC1L1	Malignant cells	GSE108397	ENSG00000196715	154807	vitamin K epoxide reductase complex subunit 1 like 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1568
1.40731085793738e-105	0.467902074052438	0.837	0.688	2.54666972852349e-101	TUSC1	Malignant cells	GSE108397	ENSG00000198680	286319	tumor suppressor candidate 1	CCDC89B|TSG-9	protein_coding	Q2TAM9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1569
1.5779095796639e-105	-0.386236824345798	0.835	0.947	2.85538517535979e-101	CTSZ	Malignant cells	GSE108397	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1570
1.92122369904332e-105	0.491228020088085	0.885	0.765	3.47664640578879e-101	CDC16	Malignant cells	GSE108397	ENSG00000130177	8881	cell division cycle 16	ANAPC6|APC6|CUT9	protein_coding	Q13042	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1571
2.43941747127052e-105	-0.473181210177151	0.567	0.759	4.41436985601114e-101	MCTS1	Malignant cells	GSE108397	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1572
3.22312863452294e-105	0.442362047033449	0.61	0.359	5.83257357703271e-101	RAB40B	Malignant cells	GSE108397	ENSG00000141542	10966	RAB40B, member RAS oncogene family	RAR|SEC4L	protein_coding	Q12829	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1573
3.53198359884559e-105	-0.273589508918552	0.999	0.999	6.39147752047098e-101	BOLA3	Malignant cells	GSE108397	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1574
4.51728671842722e-105	0.329890564594372	0.994	0.987	8.17448204566589e-101	PRDX3	Malignant cells	GSE108397	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1575
4.64936687098459e-105	0.426392592249041	0.924	0.828	8.41349428973372e-101	TATDN1	Malignant cells	GSE108397	ENSG00000147687	83940	TatD DNase domain containing 1	CDA11	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1576
8.23641861886211e-105	-0.475353722576183	0.54	0.734	1.49046231326929e-100	INPP4B	Malignant cells	GSE108397	ENSG00000109452	8821	inositol polyphosphate-4-phosphatase type II B	NA	protein_coding	O15327	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1577
8.54979994816223e-105	-0.408853570157811	0.109	0.326	1.54717179861944e-100	PRRX1	Malignant cells	GSE108397	ENSG00000116132	5396	paired related homeobox 1	PHOX1|PMX1	protein_coding	P54821	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1578
1.1140904375944e-104	-0.374757104752566	0.907	0.971	2.01605805587082e-100	INTS10	Malignant cells	GSE108397	ENSG00000104613	55174	integrator complex subunit 10	C8orf35|FLJ10569|INT10	protein_coding	Q9NVR2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1579
1.86566586156981e-104	-0.325371516814402	0.982	0.995	3.37610894309673e-100	ABHD12	Malignant cells	GSE108397	ENSG00000100997	26090	abhydrolase domain containing 12, lysophospholipase	ABHD12A|BEM46L2|C20orf22|dJ965G21.2|DKFZP434P106	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1580
2.04755599868723e-104	-0.265567134082357	0.999	1	3.70525733522441e-100	MRPL14	Malignant cells	GSE108397	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1581
2.40665052338117e-104	-0.279742459309646	0.999	0.999	4.35507478711057e-100	LSM2	Malignant cells	GSE108397	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1582
3.53151792026482e-104	-0.4636267116095	0.405	0.627	6.39063482851122e-100	UBR4	Malignant cells	GSE108397	ENSG00000127481	23352	ubiquitin protein ligase E3 component n-recognin 4	KIAA0462|KIAA1307|p600|RBAF600|ZUBR1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1583
3.76594744054267e-104	-0.288075491804353	1	1	6.81485848840601e-100	TMEM14B	Malignant cells	GSE108397	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1584
3.8541116758526e-104	-0.278533118674786	1	1	6.97440048862287e-100	POP7	Malignant cells	GSE108397	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1585
4.38773796039021e-104	-0.446866760065918	0.8	0.919	7.94005061312213e-100	SUMF2	Malignant cells	GSE108397	ENSG00000129103	25870	sulfatase modifying factor 2	DKFZp566I1024	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1586
4.46225376872373e-104	-0.437130539507651	0.68	0.83	8.07489441988247e-100	PRKRIP1	Malignant cells	GSE108397	ENSG00000128563	79706	PRKR interacting protein 1	C114|FLJ13902|KRBOX3	protein_coding	Q9H875	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1587
5.0783158198723e-104	-0.52798043501471	0.586	0.764	9.18972030764091e-100	CEP55	Malignant cells	GSE108397	ENSG00000138180	55165	centrosomal protein 55	C10orf3|CT111|FLJ10540	protein_coding	Q53EZ4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1588
6.71584103929681e-104	-0.464221063866033	0.441	0.659	1.21529859447115e-99	MCOLN1	Malignant cells	GSE108397	ENSG00000090674	57192	mucolipin TRP cation channel 1	ML4|MLIV|MST080|MSTP080|TRPM-L1|TRPML1	protein_coding	Q9GZU1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1589
1.44054335641562e-103	-0.414786847877131	0.815	0.93	2.6068072577697e-99	TTC39C	Malignant cells	GSE108397	ENSG00000168234	125488	tetratricopeptide repeat domain 39C	C18orf17|FLJ33761|HsT2697	protein_coding	Q8N584	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1590
1.61473411846718e-103	0.254433737640529	1	1	2.92202286077821e-99	GTF3C6	Malignant cells	GSE108397	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1591
5.34306548252493e-103	-0.466095412922875	0.395	0.612	9.66881129717711e-99	MICAL1	Malignant cells	GSE108397	ENSG00000135596	64780	microtubule associated monooxygenase, calponin and LIM domain containing 1	DKFZp434B1517|FLJ11937|FLJ21739|MICAL|NICAL	protein_coding	Q8TDZ2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1592
5.49975980211638e-103	-0.419279663070106	0.697	0.834	9.9523653379098e-99	NCLN	Malignant cells	GSE108397	ENSG00000125912	56926	nicalin	NET59|NICALIN	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1593
8.40437352779465e-103	0.451555969910083	0.713	0.492	1.52085543358972e-98	SDHA	Malignant cells	GSE108397	ENSG00000073578	6389	succinate dehydrogenase complex flavoprotein subunit A	FP|SDH2|SDHF	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1594
8.53132032303046e-103	-0.445857272660095	0.576	0.756	1.54382772565559e-98	PARVA	Malignant cells	GSE108397	ENSG00000197702	55742	parvin alpha	FLJ10793|FLJ12254|MXRA2	protein_coding	Q9NVD7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1595
1.17795219659755e-102	-0.466503918176376	0.552	0.731	2.13162229496293e-98	CCSER2	Malignant cells	GSE108397	ENSG00000107771	54462	coiled-coil serine rich protein 2	FAM190B|KIAA1128	protein_coding	Q9H7U1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1596
1.22747068591841e-102	-0.459593571298023	0.635	0.786	2.22123095323796e-98	GSN	Malignant cells	GSE108397	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1597
1.40931047829933e-102	-0.515591092650522	0.481	0.674	2.55028824153046e-98	ASF1B	Malignant cells	GSE108397	ENSG00000288210	55723	anti-silencing function 1B histone chaperone	FLJ10604	protein_coding	Q9NVP2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1598
1.70449762964431e-102	0.427991238399494	0.815	0.634	3.08445891060435e-98	MPHOSPH6	Malignant cells	GSE108397	ENSG00000135698	10200	M-phase phosphoprotein 6	MPP6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1599
2.30443124567885e-102	-0.455556817946606	0.328	0.564	4.17009878218045e-98	USP32	Malignant cells	GSE108397	ENSG00000170832	84669	ubiquitin specific peptidase 32	NY-REN-60|USP10	protein_coding	Q8NFA0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1600
2.60458074910284e-102	-0.425702089556623	0.732	0.862	4.71324932357649e-98	MBD4	Malignant cells	GSE108397	ENSG00000129071	8930	methyl-CpG binding domain 4, DNA glycosylase	MED1	protein_coding	O95243	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1601
2.71390805061369e-102	0.399657691196957	0.981	0.97	4.91108800839054e-98	TIMM17A	Malignant cells	GSE108397	ENSG00000134375	10440	translocase of inner mitochondrial membrane 17A	TIM17|TIM17A	protein_coding	Q99595	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1602
3.22301239113933e-102	-0.287924605315821	0.063	0.257	5.83236322300573e-98	RINL	Malignant cells	GSE108397	ENSG00000282895	126432	Ras and Rab interactor like	FLJ45909	protein_coding	Q6ZS11	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1603
5.47271683254154e-102	0.411084011599536	0.892	0.779	9.90342838016717e-98	HAT1	Malignant cells	GSE108397	ENSG00000128708	8520	histone acetyltransferase 1	KAT1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1604
5.52237309583805e-102	-0.431633106094065	0.789	0.885	9.99328635422853e-98	NPLOC4	Malignant cells	GSE108397	ENSG00000182446	55666	NPL4 homolog, ubiquitin recognition factor	FLJ20657|KIAA1499|NPL4	protein_coding	Q8TAT6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1605
6.43868559980977e-102	-0.400689765393093	0.838	0.925	1.16514454614158e-97	TACO1	Malignant cells	GSE108397	ENSG00000136463	51204	translational activator of cytochrome c oxidase I	CCDC44	protein_coding	Q9BSH4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1606
7.43817693195696e-102	0.387088930891156	0.986	0.975	1.34601249760693e-97	MAZ	Malignant cells	GSE108397	ENSG00000103495	4150	MYC associated zinc finger protein	Pur-1|ZF87|Zif87|ZNF801	protein_coding	P56270	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1607
7.49284752817581e-102	-0.427250601848998	0.281	0.52	1.35590568869869e-97	PTGFRN	Malignant cells	GSE108397	ENSG00000134247	5738	prostaglandin F2 receptor inhibitor	CD315|CD9P-1|EWI-F|FLJ11001|FPRP|KIAA1436|SMAP-6	protein_coding	Q9P2B2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1608
7.57145043673612e-102	-0.381797037299741	0.975	0.993	1.37012967103177e-97	PTTG1IP	Malignant cells	GSE108397	ENSG00000183255	754	PTTG1 interacting protein	C21orf1|C21orf3|PBF|PTTG1IP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1609
8.55291348073398e-102	-0.451600101250689	0.56	0.751	1.54773522347362e-97	SBNO1	Malignant cells	GSE108397	ENSG00000139697	55206	strawberry notch homolog 1	FLJ10701|FLJ10833|MOP3|Sno	protein_coding	A3KN83	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1610
8.67975417569957e-102	-0.409093606637549	0.831	0.917	1.57068831563459e-97	PSMD1	Malignant cells	GSE108397	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1611
9.77994934123699e-102	-0.437095112672313	0.393	0.617	1.76977963279024e-97	SNX27	Malignant cells	GSE108397	ENSG00000143376	81609	sorting nexin 27	KIAA0488|MGC20471|MY014	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1612
1.08877349145965e-101	-0.371740729319396	0.924	0.977	1.97024451014538e-97	GSPT1	Malignant cells	GSE108397	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1613
1.31714564609854e-101	-0.474932685507493	0.719	0.877	2.38350676117993e-97	BTBD10	Malignant cells	GSE108397	ENSG00000148925	84280	BTB domain containing 10	GMRP-1|GMRP1|MGC13007	protein_coding	Q9BSF8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1614
1.40637531251832e-101	-0.43230528741876	0.676	0.833	2.54497676553316e-97	OPA1	Malignant cells	GSE108397	ENSG00000198836	4976	OPA1 mitochondrial dynamin like GTPase	FLJ12460|KIAA0567|MGM1|NPG|NTG	protein_coding	O60313	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1615
1.41888880974789e-101	-0.447589048927594	0.597	0.769	2.56762119011978e-97	MEPCE	Malignant cells	GSE108397	ENSG00000146834	56257	methylphosphate capping enzyme	BCDIN3|FLJ20257	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1616
1.72380777675512e-101	-0.406408730254994	0.781	0.895	3.11940255281607e-97	PPP1R11	Malignant cells	GSE108397	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1617
2.82071155330769e-101	-0.467576040404424	0.529	0.722	5.1043596268656e-97	TPRA1	Malignant cells	GSE108397	ENSG00000163870	131601	transmembrane protein adipocyte associated 1	FLJ32197|GPR175|TMEM227|TPRA40	protein_coding	Q86W33	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1618
3.98260990448487e-101	-0.429683229695987	0.765	0.894	7.20693088315583e-97	NOP58	Malignant cells	GSE108397	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1619
4.10204176471572e-101	0.353065115607869	0.981	0.946	7.42305477742957e-97	MOK	Malignant cells	GSE108397	ENSG00000080823	5891	MOK protein kinase	RAGE|RAGE1|STK30	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1620
5.84114854983601e-101	0.470444917113681	0.655	0.424	1.05701424157832e-96	C5orf55	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1621
6.46586130346162e-101	-0.369607491917898	0.887	0.966	1.17006226147441e-96	SEPT11	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1622
7.15367011258688e-101	-0.425167783899518	0.835	0.918	1.29452814357372e-96	CLEC11A	Malignant cells	GSE108397	ENSG00000105472	6320	C-type lectin domain containing 11A	CLECSF3|LSLCL|P47|SCGF	protein_coding	Q9Y240	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1623
7.71101498681334e-101	0.30283733869123	0.281	0.081	1.39538527201374e-96	FNDC4	Malignant cells	GSE108397	ENSG00000115226	64838	fibronectin type III domain containing 4	FLJ22362|FRCP1	protein_coding	Q9H6D8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1624
9.34874682750093e-101	-0.457222582851238	0.628	0.787	1.69174922590457e-96	GNPTAB	Malignant cells	GSE108397	ENSG00000111670	79158	N-acetylglucosamine-1-phosphate transferase subunits alpha and beta	GNPTA|KIAA1208|MGC4170	protein_coding	Q3T906	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1625
1.45339651992251e-100	-0.27342962848593	1	1	2.63006634245177e-96	CALM1	Malignant cells	GSE108397	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1626
1.9460319442688e-100	0.341444267528041	0.991	0.964	3.52153940634882e-96	WDR83OS	Malignant cells	GSE108397	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1627
2.51621544441751e-100	0.362399984106627	1	0.999	4.55334346821792e-96	PPP4R2	Malignant cells	GSE108397	ENSG00000163605	151987	protein phosphatase 4 regulatory subunit 2	NA	protein_coding	Q9NY27	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1628
4.09899806061301e-100	-0.40950495844499	0.713	0.845	7.41754689048531e-96	TAF6	Malignant cells	GSE108397	ENSG00000106290	6878	TATA-box binding protein associated factor 6	MGC:8964|TAF2E|TAFII70|TAFII80|TAFII85	protein_coding	P49848	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1629
4.57352379635279e-100	0.440501259529789	0.848	0.7	8.27624866188002e-96	TRAP1	Malignant cells	GSE108397	ENSG00000126602	10131	TNF receptor associated protein 1	HSP75|HSP90L	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1630
6.25107118947335e-100	0.526755734097499	0.978	0.958	1.1311938424471e-95	ID3	Malignant cells	GSE108397	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1631
1.30572349029314e-99	0.427350883880419	0.575	0.34	2.36283722803446e-95	FANCL	Malignant cells	GSE108397	ENSG00000115392	55120	FA complementation group L	FAAP43|FLJ10335|PHF9|Pog	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1632
2.05837057076049e-99	-0.358120840310028	0.154	0.376	3.72482738484818e-95	PLCD3	Malignant cells	GSE108397	ENSG00000161714	113026	phospholipase C delta 3	NA	protein_coding	Q8N3E9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1633
3.06019594903281e-99	0.402553616869226	0.962	0.908	5.53773058936978e-95	PSMD7	Malignant cells	GSE108397	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1634
3.83990505728896e-99	0.439940673070489	0.433	0.205	6.94869219167011e-95	RP11-576I22.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1635
5.20352887125436e-99	-0.39842925231092	0.221	0.454	9.4163058454219e-95	LPAR3	Malignant cells	GSE108397	ENSG00000171517	23566	lysophosphatidic acid receptor 3	Edg-7|EDG7|HOFNH30|LP-A3|LPA3|RP4-678I3	protein_coding	Q9UBY5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1636
6.02072418716851e-99	0.283848802780514	1	0.999	1.08951024891001e-94	MRPL27	Malignant cells	GSE108397	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1637
9.05560904987169e-99	-0.422797471322878	0.253	0.484	1.63870301366478e-94	ECE1	Malignant cells	GSE108397	ENSG00000117298	1889	endothelin converting enzyme 1	ECE	protein_coding	P42892	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1638
9.33503333472186e-99	-0.491760907442135	0.749	0.873	1.68926763225127e-94	GCLM	Malignant cells	GSE108397	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1639
9.61687317478194e-99	0.372373406494982	0.985	0.979	1.74026936970854e-94	RRP7A	Malignant cells	GSE108397	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1640
1.65764540858597e-98	-0.492750519623519	0.255	0.489	2.99967513137717e-94	CD82	Malignant cells	GSE108397	ENSG00000085117	3732	CD82 molecule	IA4|KAI1|R2|ST6|TSPAN27	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1641
2.4795946874659e-98	-0.463653911101942	0.443	0.654	4.48707454643829e-94	ASH1L	Malignant cells	GSE108397	ENSG00000116539	55870	ASH1 like histone lysine methyltransferase	ASH1|ASH1L1|huASH1|KMT2H	protein_coding	Q9NR48	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1642
3.31759228891408e-98	-0.355933438603064	0.951	0.984	6.00351500601893e-94	KCMF1	Malignant cells	GSE108397	ENSG00000176407	56888	potassium channel modulatory factor 1	DEBT91|DKFZP434L1021|PCMF|ZZZ1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1643
3.38055781915762e-98	-0.466236292346963	0.403	0.614	6.11745742954763e-94	ANXA6	Malignant cells	GSE108397	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1644
3.38384762434187e-98	-0.509877670016487	0.255	0.497	6.12341066100904e-94	PMEPA1	Malignant cells	GSE108397	ENSG00000124225	56937	prostate transmembrane protein, androgen induced 1	STAG1|TMEPAI	protein_coding	Q969W9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1645
3.7057936027699e-98	0.293552860186608	1	0.998	6.7060041035724e-94	ATF4	Malignant cells	GSE108397	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1646
4.07710381328648e-98	-0.360039711363742	0.929	0.973	7.37792706052322e-94	CWC15	Malignant cells	GSE108397	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1647
4.08401666764037e-98	0.283503623746877	0.999	0.999	7.39043656176202e-94	MRPS7	Malignant cells	GSE108397	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1648
4.81633006127862e-98	0.339014467815717	0.98	0.953	8.7156308788898e-94	SNRPC	Malignant cells	GSE108397	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1649
5.0240131256167e-98	-0.421086101331883	0.401	0.624	9.09145415211598e-94	CNDP2	Malignant cells	GSE108397	ENSG00000133313	55748	carnosine dipeptidase 2	CN2|CPGL|FLJ10830|HsT2298|PEPA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1650
5.82056996041605e-98	-0.430728039636067	0.343	0.573	1.05329034003689e-93	HOXD-AS1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1651
7.78284975205777e-98	-0.440520339931533	0.55	0.735	1.40838449113237e-93	CD109	Malignant cells	GSE108397	ENSG00000156535	135228	CD109 molecule	CPAMD7|DKFZp762L1111|FLJ38569	protein_coding	Q6YHK3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1652
8.28357574634041e-98	-0.266980781048904	0.999	1	1.49899586705776e-93	ZNHIT1	Malignant cells	GSE108397	ENSG00000106400	10467	zinc finger HIT-type containing 1	CG1I|H_DJ0747G18.14|ZNFN4A1	protein_coding	O43257	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1653
9.54868034627836e-98	-0.358193470938236	0.91	0.96	1.72792919546253e-93	TADA3	Malignant cells	GSE108397	ENSG00000171148	10474	transcriptional adaptor 3	ADA3|FLJ20221|FLJ21329|hADA3|NGG1|TADA3L	protein_coding	O75528	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1654
9.96000923731218e-98	0.395955006258053	0.578	0.336	1.80236327158401e-93	LAP3	Malignant cells	GSE108397	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1655
1.23816486041556e-97	0.276172977522081	1	1	2.24058313140799e-93	NENF	Malignant cells	GSE108397	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1656
1.29634132232874e-97	-0.421897172841523	0.224	0.455	2.34585925688608e-93	SUN2	Malignant cells	GSE108397	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1657
1.4410720365271e-97	-0.41226141160878	0.727	0.856	2.60776395729943e-93	RHOG	Malignant cells	GSE108397	ENSG00000177105	391	ras homolog family member G	ARHG|MGC125835|MGC125836	protein_coding	P84095	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1658
1.49098632635848e-97	-0.398342345576285	0.833	0.927	2.6980888561783e-93	SLC39A6	Malignant cells	GSE108397	ENSG00000141424	25800	solute carrier family 39 member 6	LIV-1	protein_coding	Q13433	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1659
1.64711323719075e-97	-0.440681988953407	0.415	0.631	2.98061611402038e-93	GPATCH11	Malignant cells	GSE108397	ENSG00000152133	253635	G-patch domain containing 11	CCDC75|CENP-Y|CENPY|FLJ38348	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1660
1.6576395597331e-97	0.433364905236847	0.864	0.721	2.99966454729302e-93	RNASEH1-AS1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1661
2.15501127133916e-97	-0.379812173611649	0.875	0.951	3.89970839661534e-93	PTDSS1	Malignant cells	GSE108397	ENSG00000156471	9791	phosphatidylserine synthase 1	KIAA0024|PSS1|PSSA	protein_coding	P48651	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1662
3.16355654494715e-97	0.460235212459309	0.838	0.678	5.72477192373636e-93	RFC3	Malignant cells	GSE108397	ENSG00000133119	5983	replication factor C subunit 3	MGC5276|RFC38	protein_coding	P40938	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1663
3.78660317818035e-97	0.30907813969443	0.997	0.995	6.85223711123517e-93	CRNDE	Malignant cells	GSE108397	ENSG00000245694	101927480	uncharacterized LOC101927480	CRNDEP|LINC00180|LOC643911	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1664
7.90151292889176e-97	0.330854729378691	0.996	0.99	1.42985777961225e-92	SF3B5	Malignant cells	GSE108397	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1665
1.00072304320957e-96	-0.432042228792512	0.639	0.788	1.81090841899203e-92	NGLY1	Malignant cells	GSE108397	ENSG00000151092	55768	N-glycanase 1	FLJ11005|PNG-1|PNG1	protein_coding	Q96IV0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1666
1.2101308045215e-96	0.405339341527112	0.551	0.314	2.18985270386211e-92	TRIM61	Malignant cells	GSE108397	ENSG00000183439	391712	tripartite motif containing 61	RNF35	protein_coding	Q5EBN2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1667
1.35438746293007e-96	0.427022799800483	0.937	0.855	2.45089955291825e-92	RP11-111M22.3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1668
2.25778717097882e-96	-0.346646408099804	0.973	0.99	4.08569166460327e-92	FLOT1	Malignant cells	GSE108397	ENSG00000223654	10211	flotillin 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1669
2.84291523499538e-96	-0.34194708877455	0.948	0.985	5.14453940924764e-92	IFRD2	Malignant cells	GSE108397	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1670
3.26278439449302e-96	0.331375953296734	0.368	0.147	5.90433464027457e-92	LYPD6	Malignant cells	GSE108397	ENSG00000187123	130574	LY6/PLAUR domain containing 6	MGC52057	protein_coding	Q86Y78	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1671
3.612896830573e-96	-0.428601631227932	0.596	0.771	6.53789810460491e-92	ZFP36L2	Malignant cells	GSE108397	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1672
3.68472818715462e-96	-0.290055494253255	0.076	0.269	6.667884127475e-92	RNF43	Malignant cells	GSE108397	ENSG00000108375	54894	ring finger protein 43	DKFZp781H0392|FLJ20315|URCC	protein_coding	Q68DV7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1673
4.55202796490369e-96	0.411661244089982	0.492	0.259	8.23734980528972e-92	IGFBP2	Malignant cells	GSE108397	ENSG00000115457	3485	insulin like growth factor binding protein 2	IBP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1674
5.73648238363975e-96	-0.536187280764968	0.505	0.692	1.03807385214345e-91	SNHG12	Malignant cells	GSE108397	ENSG00000197989	85028	small nucleolar RNA host gene 12	ASLNC04080|C1orf79|LINC00100|PNAS-123	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1675
5.81497622444794e-96	-0.40719849811337	0.345	0.574	1.0522780975761e-91	DNM2	Malignant cells	GSE108397	ENSG00000079805	1785	dynamin 2	CMT2M|CMTDI1|CMTDIB|DI-CMTB|DYN2|DYNII	protein_coding	P50570	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1676
6.13182433690409e-96	0.273247640260831	1	1	1.10961493200616e-91	EIF3K	Malignant cells	GSE108397	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1677
7.17870878333927e-96	0.378455938701032	0.377	0.158	1.29905914143307e-91	ABCB7	Malignant cells	GSE108397	ENSG00000131269	22	ATP binding cassette subfamily B member 7	ABC7|ASAT|Atm1p|EST140535	protein_coding	O75027	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1678
8.13129388926307e-96	0.393904337789696	0.911	0.798	1.47143894220105e-91	FKBP3	Malignant cells	GSE108397	ENSG00000100442	2287	FKBP prolyl isomerase 3	FKBP-25|FKBP25	protein_coding	Q00688	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1679
8.57127614045391e-96	-0.386093544758368	0.207	0.433	1.55105813037654e-91	GRAMD4	Malignant cells	GSE108397	ENSG00000075240	23151	GRAM domain containing 4	DIP|KIAA0767	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1680
9.6430374821665e-96	-0.380252577488768	0.871	0.94	1.74500406277285e-91	EIF4G1	Malignant cells	GSE108397	ENSG00000114867	1981	eukaryotic translation initiation factor 4 gamma 1	EIF4F|EIF4G|p220|PARK18	protein_coding	Q04637	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1681
1.07311704682444e-95	-0.439121083206476	0.477	0.679	1.9419126079335e-91	GMPS	Malignant cells	GSE108397	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1682
1.22380679030712e-95	-0.469437206557854	0.455	0.652	2.21460076773977e-91	UPF3B	Malignant cells	GSE108397	ENSG00000125351	65109	UPF3B regulator of nonsense mediated mRNA decay	HUPF3B|MRX62|MRX82|RENT3B|UPF3BP1|UPF3BP2|UPF3BP3|UPF3X	protein_coding	Q9BZI7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1683
1.37122747160462e-95	0.316243386388421	0.357	0.139	2.48137323261571e-91	C17orf100	Malignant cells	GSE108397	ENSG00000256806	388327	chromosome 17 open reading frame 100	LOC388327	protein_coding	A8MU93	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1684
1.57089802786516e-95	-0.373262102709816	0.842	0.94	2.8426970712248e-91	RAD23B	Malignant cells	GSE108397	ENSG00000119318	5887	RAD23 homolog B, nucleotide excision repair protein	HHR23B|HR23B|P58	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1685
2.76162207521087e-95	0.372741290953261	0.982	0.96	4.99743130730159e-91	FDFT1	Malignant cells	GSE108397	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1686
2.86921293072785e-95	-0.398828755890548	0.773	0.89	5.19212771944512e-91	BRD2	Malignant cells	GSE108397	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1687
2.99385692794906e-95	-0.431642315758441	0.456	0.656	5.41768349681661e-91	FLAD1	Malignant cells	GSE108397	ENSG00000160688	80308	flavin adenine dinucleotide synthetase 1	FAD1|PP591	protein_coding	Q8NFF5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1688
4.63655083047784e-95	-0.382220574478326	0.795	0.908	8.3903023828327e-91	PTBP1	Malignant cells	GSE108397	ENSG00000011304	5725	polypyrimidine tract binding protein 1	HNRNP-I|HNRPI|pPTB|PTB|PTB-1|PTB2|PTB3|PTB4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1689
4.83533351212156e-95	-0.420488231621697	0.46	0.667	8.75001952353517e-91	SLC25A46	Malignant cells	GSE108397	ENSG00000164209	91137	solute carrier family 25 member 46	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1690
6.64546123804903e-95	-0.453071049433724	0.57	0.741	1.20256266563735e-90	DAG1	Malignant cells	GSE108397	ENSG00000173402	1605	dystroglycan 1	156DAG|A3a|AGRNR|DAG	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1691
8.91878175145385e-95	-0.461438215830742	0.226	0.452	1.61394274574309e-90	PSCA	Malignant cells	GSE108397	ENSG00000167653	8000	prostate stem cell antigen	lncPSCA	protein_coding	O43653	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1692
1.23522034150734e-94	0.417488586112256	0.831	0.68	2.23525472999167e-90	MDFIC	Malignant cells	GSE108397	ENSG00000135272	29969	MyoD family inhibitor domain containing	HIC|MDFIC1	protein_coding	Q9P1T7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1693
1.27735949080731e-94	-0.411944602682962	0.85	0.925	2.31150973456491e-90	BBX	Malignant cells	GSE108397	ENSG00000114439	56987	BBX high mobility group box domain containing	HBP2|HSPC339|MDS001	protein_coding	Q8WY36	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1694
1.32720339363638e-94	0.405417522432497	0.531	0.295	2.40170726112439e-90	SBF2-AS1	Malignant cells	GSE108397	ENSG00000246273	283104	SBF2 antisense RNA 1	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1695
2.13181308251636e-94	0.391590262856863	0.896	0.795	3.85772895412161e-90	COMMD9	Malignant cells	GSE108397	ENSG00000110442	29099	COMM domain containing 9	FLJ31106|HSPC166	protein_coding	Q9P000	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1696
2.23352755517238e-94	0.439743526351922	0.91	0.806	4.04179146383993e-90	ITM2B	Malignant cells	GSE108397	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1697
2.46922086256349e-94	-0.44191520153303	0.411	0.624	4.4683020728949e-90	RP11-14N7.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1698
2.7702445187773e-94	-0.408670120461504	0.775	0.87	5.0130344811794e-90	CD81	Malignant cells	GSE108397	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1699
3.87305832427374e-94	-0.348220598711511	0.919	0.967	7.00868634360576e-90	CTSB	Malignant cells	GSE108397	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1700
4.31027788910955e-94	0.408236301597122	0.749	0.548	7.79987886813264e-90	CTBP1	Malignant cells	GSE108397	ENSG00000159692	1487	C-terminal binding protein 1	BARS	protein_coding	Q13363	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1701
5.61674663191049e-94	-0.310592944158703	0.994	0.999	1.01640647051052e-89	FAM58A	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1702
6.16993056044027e-94	0.37882830472003	0.962	0.913	1.11651063421727e-89	GTF2H5	Malignant cells	GSE108397	ENSG00000272047	404672	general transcription factor IIH subunit 5	bA120J8.2|C6orf175|FLJ30544|TFB5|TFIIH|TTD|TTD-A|TTDA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1703
6.26934639633631e-94	0.390470526686574	0.541	0.31	1.13450092388102e-89	COQ3	Malignant cells	GSE108397	ENSG00000132423	51805	coenzyme Q3, methyltransferase	bA9819.1	protein_coding	Q9NZJ6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1704
7.99221172061565e-94	0.428295227454004	0.796	0.621	1.44627063296261e-89	RAD1	Malignant cells	GSE108397	ENSG00000113456	5810	RAD1 checkpoint DNA exonuclease	HRAD1|REC1	protein_coding	O60671	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1705
8.03938584572708e-94	-0.397672436930396	0.777	0.891	1.45480726264277e-89	CAPRIN1	Malignant cells	GSE108397	ENSG00000135387	4076	cell cycle associated protein 1	caprin-1|GPIAP1|M11S1|RNG105	protein_coding	Q14444	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1706
9.46411350767868e-94	-0.458497857023452	0.635	0.783	1.71262598034953e-89	MCAM	Malignant cells	GSE108397	ENSG00000076706	4162	melanoma cell adhesion molecule	CD146|HEMCAM|MelCAM|METCAM|MUC18	protein_coding	P43121	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1707
1.11787429193217e-93	-0.384953745074751	0.273	0.502	2.02290531868045e-89	ATP2C1	Malignant cells	GSE108397	ENSG00000017260	27032	ATPase secretory pathway Ca2+ transporting 1	ATP2C1A|BCPM|KIAA1347|PMR1|SPCA1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1708
1.70685790967841e-93	-0.418724537424711	0.65	0.797	3.08873007335406e-89	THOC5	Malignant cells	GSE108397	ENSG00000100296	8563	THO complex subunit 5	C22orf19|Fmip|fSAP79|KIAA0983|PK1.3	protein_coding	Q13769	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1709
1.81257695522961e-93	0.294375577212767	0.999	0.997	3.28003925818349e-89	SUPT4H1	Malignant cells	GSE108397	ENSG00000213246	6827	SPT4 homolog, DSIF elongation factor subunit	Spt4|SPT4H|Supt4a|SUPT4H	protein_coding	P63272	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1710
1.81791139755282e-93	0.451905510500177	0.746	0.562	3.28969246501159e-89	IMPA2	Malignant cells	GSE108397	ENSG00000141401	3613	inositol monophosphatase 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1711
2.02201968644821e-93	-0.399591286724611	0.719	0.857	3.65904682459668e-89	ABHD14B	Malignant cells	GSE108397	ENSG00000114779	84836	abhydrolase domain containing 14B	CIB|MGC15429	protein_coding	Q96IU4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1712
2.25270465057857e-93	0.436776496037595	0.627	0.4	4.07649433568697e-89	ATP6AP2	Malignant cells	GSE108397	ENSG00000182220	10159	ATPase H+ transporting accessory protein 2	APT6M8-9|ATP6IP2|ATP6M8-9|M8-9|PRR|RENR	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1713
2.77314471138398e-93	0.394108879279004	0.836	0.695	5.01828266972045e-89	COMMD3	Malignant cells	GSE108397	ENSG00000148444	23412	COMM domain containing 3	BUP|C10orf8	protein_coding	Q9UBI1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1714
3.12254224635757e-93	-0.350948200624967	0.932	0.973	5.65055244900866e-89	TEX264	Malignant cells	GSE108397	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1715
4.02933602863664e-93	-0.383904743254299	0.764	0.865	7.29148647742086e-89	NME1-NME2	Malignant cells	GSE108397	ENSG00000011052	654364	NME1-NME2 readthrough	NM23-LV|NMELV	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1716
4.11278357445021e-93	-0.307066540685553	0.993	0.999	7.44249315632511e-89	EIF4G2	Malignant cells	GSE108397	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1717
4.39421155870423e-93	0.419279239251005	0.709	0.499	7.95176523663117e-89	COMMD10	Malignant cells	GSE108397	ENSG00000145781	51397	COMM domain containing 10	PTD002	protein_coding	Q9Y6G5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1718
5.35292668656389e-93	-0.48312823161825	0.254	0.477	9.68665613200602e-89	SLC2A1	Malignant cells	GSE108397	ENSG00000117394	6513	solute carrier family 2 member 1	CSE|DYT18|DYT9|GLUT|GLUT-1|GLUT1|HTLVR	protein_coding	P11166	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1719
5.40346927583466e-93	0.409158856829789	0.824	0.655	9.77811800155039e-89	A1BG	Malignant cells	GSE108397	ENSG00000121410	1	alpha-1-B glycoprotein	NA	protein_coding	P04217	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1720
5.42123393882662e-93	0.439197175510141	0.936	0.871	9.81026493570065e-89	HSPH1	Malignant cells	GSE108397	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1721
9.27901003558987e-93	-0.331058980136147	0.148	0.364	1.67912965604034e-88	SLC17A5	Malignant cells	GSE108397	ENSG00000119899	26503	solute carrier family 17 member 5	AST|ISSD|NSD|SD|SIALIN|SIASD|SLD	protein_coding	Q9NRA2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1722
9.51405845275918e-93	0.417335094963943	0.442	0.223	1.7216640176113e-88	CHM	Malignant cells	GSE108397	ENSG00000188419	1121	CHM Rab escort protein	DXS540|REP-1|TCD	protein_coding	P24386	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1723
1.06149534938535e-92	-0.423360813742309	0.591	0.769	1.92088198424773e-88	RPA2	Malignant cells	GSE108397	ENSG00000117748	6118	replication protein A2	NA	protein_coding	P15927	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1724
1.15534013444035e-92	0.55865516707546	0.872	0.753	2.09070350728326e-88	CKLF	Malignant cells	GSE108397	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1725
1.30258685060181e-92	-0.352915626897861	0.92	0.975	2.35716116484903e-88	GSTK1	Malignant cells	GSE108397	ENSG00000197448	373156	glutathione S-transferase kappa 1	GST13	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1726
1.51828537010487e-92	-0.382588013648679	0.249	0.474	2.74748920574178e-88	YY1AP1	Malignant cells	GSE108397	ENSG00000163374	55249	YY1 associated protein 1	HCCA2|YAP|YY1AP	protein_coding	Q9H869	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1727
2.02814322815207e-92	-0.332421729549794	0.146	0.36	3.67012798566398e-88	SOX13	Malignant cells	GSE108397	ENSG00000143842	9580	SRY-box transcription factor 13	ICA12|MGC117216|Sox-13	protein_coding	Q9UN79	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1728
2.09148024419144e-92	-0.34990414208866	0.176	0.396	3.78474264988883e-88	IFI35	Malignant cells	GSE108397	ENSG00000068079	3430	interferon induced protein 35	IFP35	protein_coding	P80217	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1729
2.18042033985348e-92	-0.34959416197455	0.92	0.958	3.94568864699885e-88	TIMM10	Malignant cells	GSE108397	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1730
3.96016651264975e-92	-0.405072096579969	0.22	0.443	7.16631732129098e-88	LDLR	Malignant cells	GSE108397	ENSG00000130164	3949	low density lipoprotein receptor	LDLCQ2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1731
4.48547253271732e-92	-0.433232039730312	0.536	0.714	8.11691109520527e-88	AP1B1	Malignant cells	GSE108397	ENSG00000100280	162	adaptor related protein complex 1 subunit beta 1	ADTB1|AP105A|BAM22|CLAPB2	protein_coding	Q10567	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1732
4.52330571947805e-92	-0.392503518859341	0.786	0.897	8.18537402996748e-88	SLC39A4	Malignant cells	GSE108397	ENSG00000285243	55630	solute carrier family 39 member 4	AEZ|AWMS2|ZIP4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1733
4.7568513859172e-92	-0.622068438299158	0.905	0.961	8.60799826795577e-88	KPNA2	Malignant cells	GSE108397	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1734
1.08034764428617e-91	0.410538275853819	0.832	0.688	1.95499709710026e-87	NTHL1	Malignant cells	GSE108397	ENSG00000065057	4913	nth like DNA glycosylase 1	NTH1|OCTS3	protein_coding	P78549	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1735
1.23783973556793e-91	-0.363222245046477	0.848	0.931	2.23999478548372e-87	NAP1L4	Malignant cells	GSE108397	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1736
1.36897793055139e-91	-0.376645672450572	0.842	0.927	2.47730246312579e-87	DDA1	Malignant cells	GSE108397	ENSG00000130311	79016	DET1 and DDB1 associated 1	C19orf58|MGC2594|PCIA1	protein_coding	Q9BW61	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1737
1.63559045886878e-91	-0.408907706071846	0.206	0.428	2.95976449436894e-87	RP3-395M20.12	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1738
3.51968919040381e-91	-0.41716890132154	0.362	0.578	6.36922955895473e-87	AP2A1	Malignant cells	GSE108397	ENSG00000196961	160	adaptor related protein complex 2 subunit alpha 1	ADTAA|CLAPA1	protein_coding	O95782	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1739
3.66892272431077e-91	-0.386113182438568	0.24	0.462	6.63928256191276e-87	XIAP	Malignant cells	GSE108397	ENSG00000101966	331	X-linked inhibitor of apoptosis	API3|BIRC4|hILP|ILP-1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1740
3.70679389018248e-91	0.369349153404887	0.947	0.886	6.70781422367421e-87	MRPL32	Malignant cells	GSE108397	ENSG00000106591	64983	mitochondrial ribosomal protein L32	bMRP-59b|HSPC283|L32mt|MRP-L32	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1741
4.61694596369252e-91	-0.307548148219411	0.982	0.997	8.35482541589799e-87	UBE2B	Malignant cells	GSE108397	ENSG00000119048	7320	ubiquitin conjugating enzyme E2 B	HHR6B|RAD6B|UBC2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1742
7.11515944130877e-91	-0.45291338855198	0.509	0.693	1.28755925249923e-86	TMEM192	Malignant cells	GSE108397	ENSG00000170088	201931	transmembrane protein 192	FLJ38482	protein_coding	Q8IY95	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1743
1.35532302136225e-90	-0.417023734043769	0.36	0.575	2.45259253945713e-86	CEP164	Malignant cells	GSE108397	ENSG00000110274	22897	centrosomal protein 164	KIAA1052|NPHP15	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1744
1.54210110975973e-90	-0.355067241065578	0.918	0.97	2.7905861682212e-86	NARS	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1745
1.54342303121988e-90	0.373360503906538	0.973	0.943	2.79297831729549e-86	UBL4A	Malignant cells	GSE108397	ENSG00000102178	8266	ubiquitin like 4A	DXS254E|GDX|GET5|MDY2|TMA24|UBL4	protein_coding	P11441	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1746
1.85123266809077e-90	0.324556661716339	0.387	0.167	3.34999063617706e-86	EPB41L1	Malignant cells	GSE108397	ENSG00000088367	2036	erythrocyte membrane protein band 4.1 like 1	4.1N|KIAA0338	protein_coding	Q9H4G0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1747
2.02897574138587e-90	-0.400539455644069	0.731	0.854	3.67163450161187e-86	RALB	Malignant cells	GSE108397	ENSG00000144118	5899	RAS like proto-oncogene B	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1748
2.45609003750042e-90	-0.322403220134029	0.98	0.996	4.44454053186076e-86	GHITM	Malignant cells	GSE108397	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1749
2.5725913038819e-90	-0.432136888249566	0.487	0.672	4.6553612235047e-86	POM121C	Malignant cells	GSE108397	ENSG00000272391	100101267	POM121 transmembrane nucleoporin C	NA	protein_coding	A8CG34	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1750
2.90071702189339e-90	-0.373079548595042	0.833	0.924	5.24913752281829e-86	ARIH2	Malignant cells	GSE108397	ENSG00000177479	10425	ariadne RBR E3 ubiquitin protein ligase 2	TRIAD1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1751
3.01908422517027e-90	-0.43564868911636	0.544	0.728	5.46333481386812e-86	OPTN	Malignant cells	GSE108397	ENSG00000123240	10133	optineurin	FIP-2|FIP2|GLC1E|HIP7|HYPL|NRP|TFIIIA-INTP	protein_coding	Q96CV9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1752
3.18433846784105e-90	0.370853966114909	0.498	0.267	5.76237889140517e-86	LEO1	Malignant cells	GSE108397	ENSG00000166477	123169	LEO1 homolog, Paf1/RNA polymerase II complex component	NA	protein_coding	Q8WVC0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1753
3.72219242771214e-90	-0.351994381146518	0.916	0.969	6.73567941718788e-86	MATR3	Malignant cells	GSE108397	ENSG00000015479	9782	matrin 3	ALS21|MPD2|VCPDM|KIAA0723|MGC9105	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1754
1.22518681627097e-89	0.393599788442097	0.863	0.726	2.21709806272394e-85	ISCA2	Malignant cells	GSE108397	ENSG00000165898	122961	iron-sulfur cluster assembly 2	HBLD1|ISA2	protein_coding	Q86U28	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1755
1.28352029812148e-89	-0.406063702334022	0.735	0.848	2.32265833148063e-85	ATG4D	Malignant cells	GSE108397	ENSG00000130734	84971	autophagy related 4D cysteine peptidase	APG4-D|APG4D|AUTL4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1756
1.46323971046492e-89	-0.365187477185874	0.886	0.949	2.64787858005733e-85	ERO1L	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1757
1.68558175032832e-89	0.270199680096483	1	1	3.05022873539412e-85	UBE2L3	Malignant cells	GSE108397	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1758
2.10262284495655e-89	0.295558622699718	1	1	3.80490630023337e-85	EEF1B2	Malignant cells	GSE108397	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1759
2.12734850147361e-89	0.299573833794669	0.998	0.995	3.84964984826665e-85	FUNDC2	Malignant cells	GSE108397	ENSG00000165775	65991	FUN14 domain containing 2	DC44|HCBP6	protein_coding	Q9BWH2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1760
2.1609380999693e-89	-0.334488526388756	0.946	0.981	3.91043358570445e-85	UBE2J1	Malignant cells	GSE108397	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1761
2.48081029146117e-89	-0.400438564702869	0.72	0.848	4.48927430342814e-85	KIAA1715	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1762
3.41745669797054e-89	0.276125805610733	0.998	0.998	6.18422964064749e-85	ERP29	Malignant cells	GSE108397	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1763
3.63253989231962e-89	-0.345986972281505	0.929	0.972	6.57344418914158e-85	DTD1	Malignant cells	GSE108397	ENSG00000125821	92675	D-aminoacyl-tRNA deacylase 1	bA379J5.3|bA555E18.1|C20orf88|DUEB|HARS2|MGC119131|MGC41905|pqn-68	protein_coding	Q8TEA8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1764
4.82738636938466e-89	0.602376481882509	0.732	0.591	8.73563837403847e-85	TCEAL8	Malignant cells	GSE108397	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1765
5.86437483798646e-89	-0.307878094769216	0.976	0.994	1.06121727068203e-84	PCNP	Malignant cells	GSE108397	ENSG00000081154	57092	PEST proteolytic signal containing nuclear protein	NA	protein_coding	Q8WW12	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1766
1.10711593981987e-88	-0.419383239875971	0.708	0.829	2.00343700469804e-84	MIER1	Malignant cells	GSE108397	ENSG00000198160	57708	MIER1 transcriptional regulator	hMI-ER1|KIAA1610|MI-ER1	protein_coding	Q8N108	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1767
1.62402255554036e-88	-0.381775381465858	0.988	0.997	2.93883121650584e-84	TPM4	Malignant cells	GSE108397	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1768
2.02416031001158e-88	0.353477470033419	0.388	0.174	3.66292049699695e-84	FAM173B	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1769
2.09615022111382e-88	-0.426120000501331	0.424	0.631	3.79319344012757e-84	MMP14	Malignant cells	GSE108397	ENSG00000157227	4323	matrix metallopeptidase 14	MT1-MMP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1770
2.12301754809877e-88	0.44179639479961	0.565	0.348	3.84181255503953e-84	RP11-304L19.5	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1771
2.33616647416456e-88	-0.392963544472999	0.284	0.505	4.22752685164819e-84	PLEKHM2	Malignant cells	GSE108397	ENSG00000116786	23207	pleckstrin homology and RUN domain containing M2	KIAA0842	protein_coding	Q8IWE5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1772
2.57431703717143e-88	-0.309746344083524	0.987	0.994	4.65848411046543e-84	AKR7A2	Malignant cells	GSE108397	ENSG00000053371	8574	aldo-keto reductase family 7 member A2	AFAR	protein_coding	O43488	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1773
2.58527739864382e-88	-0.417312719490494	0.428	0.631	4.67831798058586e-84	STT3B	Malignant cells	GSE108397	ENSG00000163527	201595	STT3 oligosaccharyltransferase complex catalytic subunit B	FLJ90106|SIMP|STT3-B	protein_coding	Q8TCJ2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1774
2.72809193817037e-88	-0.398209591728315	0.326	0.544	4.9367551713131e-84	PHTF2	Malignant cells	GSE108397	ENSG00000006576	57157	putative homeodomain transcription factor 2	DKFZp434D166	protein_coding	Q8N3S3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1775
3.35525699646692e-88	-0.389753181896603	0.683	0.822	6.07167306080655e-84	BRD4	Malignant cells	GSE108397	ENSG00000141867	23476	bromodomain containing 4	CAP|HUNK1|HUNKI|MCAP	protein_coding	O60885	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1776
4.28369851443529e-88	-0.382553957740594	0.806	0.911	7.75178083172211e-84	ZFAND5	Malignant cells	GSE108397	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1777
4.3441178988482e-88	-0.439454088668179	0.531	0.708	7.8611157497557e-84	PRPSAP2	Malignant cells	GSE108397	ENSG00000141127	5636	phosphoribosyl pyrophosphate synthetase associated protein 2	PAP41	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1778
4.69103048650175e-88	-0.389728194351758	0.832	0.916	8.48888876837356e-84	LARS	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1779
4.98605019241586e-88	-0.37364606706601	0.899	0.948	9.02275642819575e-84	LGALS3BP	Malignant cells	GSE108397	ENSG00000108679	3959	galectin 3 binding protein	90K|BTBD17B|CyCAP|gp90|M2BP|MAC-2-BP|TANGO10B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1780
6.45327911840284e-88	-0.381807089152904	0.243	0.462	1.16778538926618e-83	NFX1	Malignant cells	GSE108397	ENSG00000086102	4799	nuclear transcription factor, X-box binding 1	MGC20369|NFX2|TEG-42|Tex42	protein_coding	Q12986	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1781
6.77666056251768e-88	0.379216957736173	0.459	0.237	1.2263044953932e-83	ATF7IP2	Malignant cells	GSE108397	ENSG00000166669	80063	activating transcription factor 7 interacting protein 2	FLJ12668	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1782
9.15226046108186e-88	-0.362434182265387	0.87	0.936	1.65619305303737e-83	BCL2L12	Malignant cells	GSE108397	ENSG00000126453	83596	BCL2 like 12	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1783
9.97337727121084e-88	-0.356036142235457	0.855	0.933	1.80478235099831e-83	MAPKAP1	Malignant cells	GSE108397	ENSG00000119487	79109	MAPK associated protein 1	MGC2745|MIP1|SIN1	protein_coding	Q9BPZ7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1784
1.2980922496049e-87	-0.405846462583508	0.267	0.489	2.34902773488502e-83	UBASH3B	Malignant cells	GSE108397	ENSG00000154127	84959	ubiquitin associated and SH3 domain containing B	KIAA1959|STS-1|TULA-2|TULA2	protein_coding	Q8TF42	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1785
1.38305847319488e-87	0.39798221094334	0.833	0.675	2.50278261309345e-83	TERF1	Malignant cells	GSE108397	ENSG00000147601	7013	telomeric repeat binding factor 1	PIN2|TRBF1|TRF|TRF1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1786
1.47362642808205e-87	-0.413710165632934	0.655	0.824	2.66667438425727e-83	PPAPDC1A	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1787
1.65991020052773e-87	-0.492765618730364	0.375	0.579	3.00377349887498e-83	NR4A1	Malignant cells	GSE108397	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1788
1.75089377370026e-87	0.334178255803897	0.391	0.177	3.16841737288799e-83	TMEM242	Malignant cells	GSE108397	ENSG00000215712	729515	transmembrane protein 242	BM033|C6orf35	protein_coding	Q9NWH2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1789
2.14219156794484e-87	0.383881289743808	0.734	0.526	3.87650986135298e-83	ACTR10	Malignant cells	GSE108397	ENSG00000131966	55860	actin related protein 10	ACTR11|Arp10|Arp11|HARP11	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1790
2.14643916845739e-87	-0.348046528511182	0.185	0.398	3.8841963192405e-83	URB1	Malignant cells	GSE108397	ENSG00000142207	9875	URB1 ribosome biogenesis homolog	C21orf108|KIAA0539|NPA1	protein_coding	O60287	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1791
2.34584840774275e-87	-0.399966783822741	0.646	0.804	4.24504727865128e-83	CELF1	Malignant cells	GSE108397	ENSG00000149187	10658	CUGBP Elav-like family member 1	BRUNOL2|CUG-BP|CUGBP|CUGBP1|EDEN-BP|hNab50|NAB50|NAPOR	protein_coding	Q92879	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1792
2.46535089430709e-87	0.358435356623707	0.995	0.987	4.46129897833811e-83	C4orf3	Malignant cells	GSE108397	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1793
2.68485050925108e-87	-0.419823136227632	0.412	0.616	4.85850548154075e-83	TAF13	Malignant cells	GSE108397	ENSG00000197780	6884	TATA-box binding protein associated factor 13	TAF2K|TAFII18	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1794
3.24243737420322e-87	-0.275740388954667	0.998	0.999	5.86751467235814e-83	MRPL33	Malignant cells	GSE108397	ENSG00000243147	9553	mitochondrial ribosomal protein L33	C2orf1|RPL33L	protein_coding	O75394	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1795
4.97469600157312e-87	-0.408603938618483	0.635	0.787	9.00220988444672e-83	IFNAR1	Malignant cells	GSE108397	ENSG00000142166	3454	interferon alpha and beta receptor subunit 1	IFNAR|IFRC	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1796
5.04856509268596e-87	-0.382781711564956	0.707	0.841	9.13588339172452e-83	NCKAP1	Malignant cells	GSE108397	ENSG00000061676	10787	NCK associated protein 1	HEM2|Nap1|NAP125	protein_coding	Q9Y2A7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1797
5.26688336795696e-87	-0.318753920155376	0.976	0.992	9.53095214265492e-83	ANKRD39	Malignant cells	GSE108397	ENSG00000213337	51239	ankyrin repeat domain 39	MGC41816	protein_coding	Q53RE8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1798
6.17601826087542e-87	-0.268015941062927	0.999	1	1.11761226448802e-82	YWHAQ	Malignant cells	GSE108397	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1799
7.01893864834574e-87	-0.271469521412694	1	1	1.27014713780465e-82	PKM	Malignant cells	GSE108397	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1800
7.06723179019659e-87	-0.379009028954712	0.258	0.479	1.27888626475398e-82	MB21D1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1801
8.13183620268773e-87	-0.350265473057508	0.214	0.433	1.47153707923837e-82	RPRD2	Malignant cells	GSE108397	ENSG00000163125	23248	regulation of nuclear pre-mRNA domain containing 2	FLJ32145|HSPC099|KIAA0460	protein_coding	Q5VT52	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1802
1.12229756751402e-86	0.315326790290515	0.993	0.988	2.03090967817337e-82	NDUFA12	Malignant cells	GSE108397	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1803
1.35118186340524e-86	0.390469875542038	0.624	0.404	2.44509870001812e-82	OPN3	Malignant cells	GSE108397	ENSG00000054277	23596	opsin 3	ECPN|encephalopsin|ERO|NMO-1|PPP1R116	protein_coding	Q9H1Y3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1804
1.35530357384226e-86	-0.391991352970442	0.765	0.877	2.45255734722496e-82	DUSP14	Malignant cells	GSE108397	ENSG00000275932	11072	dual specificity phosphatase 14	MKP-L|MKP6	protein_coding	O95147	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1805
1.5653418798304e-86	-0.393746072082153	0.591	0.769	2.8326426657411e-82	C7orf55-LUC7L2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1806
1.72174643501677e-86	0.390765849942917	0.792	0.62	3.11567234880635e-82	TIMM17B	Malignant cells	GSE108397	ENSG00000126768	10245	translocase of inner mitochondrial membrane 17B	DXS9822|JM3	protein_coding	O60830	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1807
1.82124040515841e-86	-0.477587393461902	0.496	0.671	3.29571663717466e-82	CDKN2C	Malignant cells	GSE108397	ENSG00000123080	1031	cyclin dependent kinase inhibitor 2C	INK4C|p18	protein_coding	P42773	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1808
2.00188474390731e-86	0.423698076805012	0.716	0.509	3.62261063257467e-82	LHFP	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1809
2.320517823846e-86	0.386093782579604	0.776	0.592	4.19920905403172e-82	NEMF	Malignant cells	GSE108397	ENSG00000165525	9147	nuclear export mediator factor	FLJ10051|NY-CO-1|RQC2|SDCCAG1	protein_coding	O60524	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1810
2.52616919980504e-86	0.284770826053638	0.998	0.998	4.5713557839672e-82	ATP5F1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1811
2.94951592998382e-86	0.297687907701509	0.997	0.993	5.33744402689873e-82	PPA1	Malignant cells	GSE108397	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1812
3.37616998608719e-86	-0.355926197980049	0.187	0.401	6.10951720682337e-82	PITPNC1	Malignant cells	GSE108397	ENSG00000154217	26207	phosphatidylinositol transfer protein cytoplasmic 1	RDGB-BETA|RDGBB|RDGBB1	protein_coding	Q9UKF7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1813
5.37778884238137e-86	-0.445276263874135	0.371	0.572	9.73164668917334e-82	HEXIM1	Malignant cells	GSE108397	ENSG00000186834	10614	HEXIM P-TEFb complex subunit 1	CLP-1|EDG1|HIS1|MAQ1	protein_coding	O94992	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1814
7.0378167176809e-86	-0.387250414066441	0.706	0.838	1.27356331323154e-81	RBFOX2	Malignant cells	GSE108397	ENSG00000277564	23543	RNA binding fox-1 homolog 2	FOX-2|HNRBP2|HRNBP2|RBM9	protein_coding	O43251	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1815
7.0713586161376e-86	-0.346651812851265	0.884	0.948	1.27963305517626e-81	UBE2K	Malignant cells	GSE108397	ENSG00000078140	3093	ubiquitin conjugating enzyme E2 K	HIP2|HYPG|UBC1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1816
8.52855027103869e-86	0.497094140356709	0.526	0.31	1.54332645704716e-81	LINC00698	Malignant cells	GSE108397	ENSG00000244342	285401	long intergenic non-protein coding RNA 698	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1817
1.05465338636472e-85	-0.424521057714232	0.439	0.632	1.90850076796559e-81	DHX16	Malignant cells	GSE108397	ENSG00000227222	8449	DEAH-box helicase 16	DBP2|DDX16|Prp2|PRPF2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1818
1.06686208226238e-85	-0.412910673689065	0.397	0.599	1.93059362406201e-81	FXR2	Malignant cells	GSE108397	ENSG00000129245	9513	FMR1 autosomal homolog 2	FMR1L2	protein_coding	P51116	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1819
1.29542831267674e-85	0.399940992464872	0.684	0.47	2.34420707461983e-81	MLF1	Malignant cells	GSE108397	ENSG00000178053	4291	myeloid leukemia factor 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1820
1.54258443627551e-85	0.626105695574362	0.517	0.305	2.79146079588416e-81	BAALC	Malignant cells	GSE108397	ENSG00000164929	79870	BAALC binder of MAP3K1 and KLF4	NA	protein_coding	Q8WXS3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1821
1.58989895666907e-85	-0.261776817637416	0.997	0.999	2.87708115198834e-81	DEK	Malignant cells	GSE108397	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1822
1.62799888409932e-85	0.471676424790294	0.282	0.096	2.94602678066612e-81	LINC00326	Malignant cells	GSE108397	ENSG00000231023	285735	long intergenic non-protein coding RNA 326	NCRNA00326	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1823
1.75704872614386e-85	-0.40319081598718	0.496	0.68	3.17955537482993e-81	LONP1	Malignant cells	GSE108397	ENSG00000196365	9361	lon peptidase 1, mitochondrial	hLON|LonHS|PIM1|PRSS15	protein_coding	P36776	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1824
1.84802061230636e-85	-0.416834770352302	0.62	0.776	3.34417810002959e-81	DNAJA2	Malignant cells	GSE108397	ENSG00000069345	10294	DnaJ heat shock protein family (Hsp40) member A2	CPR3|DNAJ|DNJ3|HIRIP4	protein_coding	O60884	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1825
1.89193120448526e-85	-0.377623710827501	0.267	0.484	3.42363870763653e-81	PRKAG2	Malignant cells	GSE108397	ENSG00000106617	51422	protein kinase AMP-activated non-catalytic subunit gamma 2	AAKG|AAKG2|CMH6|H91620p|WPWS	protein_coding	Q9UGJ0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1826
2.39507584062734e-85	-0.431582913721483	0.387	0.592	4.33412924119924e-81	LPP	Malignant cells	GSE108397	ENSG00000145012	4026	LIM domain containing preferred translocation partner in lipoma	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1827
2.633108087528e-85	-0.341392529921392	0.926	0.979	4.76487239519066e-81	C12orf44	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1828
2.7401075227399e-85	0.377621671290022	0.757	0.558	4.95849857315011e-81	DCTN6	Malignant cells	GSE108397	ENSG00000104671	10671	dynactin subunit 6	WS-3	protein_coding	O00399	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1829
3.13880679570226e-85	-0.384706898798278	0.301	0.512	5.6799847775028e-81	CNOT3	Malignant cells	GSE108397	ENSG00000274941	4849	CCR4-NOT transcription complex subunit 3	KIAA0691|LENG2|NOT3|NOT3H	protein_coding	O75175	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1830
3.73837631418312e-85	-0.392705304257257	0.743	0.852	6.76496577814578e-81	SECISBP2	Malignant cells	GSE108397	ENSG00000187742	79048	SECIS binding protein 2	SBP2	protein_coding	Q96T21	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1831
4.31701428967053e-85	0.303698655670739	0.998	0.998	7.81206905858778e-81	PGP	Malignant cells	GSE108397	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1832
4.41815665246086e-85	-0.410397715698448	0.326	0.541	7.99509627829317e-81	IL10RB	Malignant cells	GSE108397	ENSG00000243646	3588	interleukin 10 receptor subunit beta	CDW210B|CRF2-4|CRFB4|D21S58|D21S66|IL-10R2	protein_coding	Q08334	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1833
4.95517362064543e-85	0.361216810975092	0.428	0.212	8.96688218391997e-81	ARHGAP5-AS1	Malignant cells	GSE108397	ENSG00000258655	NA	NA	C14orf128|MGC15504	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1834
5.04921490792411e-85	-0.401280553795974	0.599	0.764	9.13705929737948e-81	ATXN2L	Malignant cells	GSE108397	ENSG00000168488	11273	ataxin 2 like	A2D|A2lp	protein_coding	Q8WWM7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1835
5.79670661837721e-85	-0.433949564400129	0.416	0.617	1.04897202966154e-80	NAV1	Malignant cells	GSE108397	ENSG00000134369	89796	neuron navigator 1	DKFZp781D0314|FLJ12560|FLJ14203|KIAA1151|MGC14961|POMFIL3|steerin-1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1836
6.04084969647153e-85	-0.366562880661184	0.84	0.935	1.09315216107349e-80	C1orf174	Malignant cells	GSE108397	ENSG00000198912	339448	chromosome 1 open reading frame 174	RP13-531C17.2	protein_coding	Q8IYL3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1837
6.75285201237016e-85	-0.414203195518854	0.468	0.663	1.2219961001585e-80	RYK	Malignant cells	GSE108397	ENSG00000163785	6259	receptor like tyrosine kinase	D3S3195|JTK5|JTK5A|RYK1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1838
7.55624967494286e-85	0.347423497369245	0.449	0.232	1.36737894117766e-80	MRFAP1L1	Malignant cells	GSE108397	ENSG00000178988	114932	Morf4 family associated protein 1 like 1	MGC9651	protein_coding	Q96HT8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1839
8.4066667676499e-85	-0.413788245071791	0.418	0.638	1.52127041827393e-80	TMEM163	Malignant cells	GSE108397	ENSG00000152128	81615	transmembrane protein 163	DKFZP566N034|SV31	protein_coding	Q8TC26	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1840
8.57408878673118e-85	-0.350664033833947	0.845	0.915	1.55156710684687e-80	PSMF1	Malignant cells	GSE108397	ENSG00000125818	9491	proteasome inhibitor subunit 1	PI31	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1841
1.05027196802913e-84	-0.257292582293533	0.999	1	1.90057215334552e-80	LSM7	Malignant cells	GSE108397	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1842
1.05271315864832e-84	-0.443861010478715	0.612	0.768	1.90498973189e-80	CHAF1A	Malignant cells	GSE108397	ENSG00000167670	10036	chromatin assembly factor 1 subunit A	CAF-1|CAF1|CAF1B|CAF1P150|MGC71229|P150	protein_coding	Q13111	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1843
1.27484619273334e-84	-0.405755504646301	0.255	0.483	2.30696167037026e-80	SPRR2D	Malignant cells	GSE108397	ENSG00000163216	6703	small proline rich protein 2D	NA	protein_coding	P22532	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1844
1.3474053032642e-84	-0.378428102164585	0.731	0.858	2.4382646367869e-80	SLC44A1	Malignant cells	GSE108397	ENSG00000070214	23446	solute carrier family 44 member 1	CD92|CDW92|CHTL1|CTL1	protein_coding	Q8WWI5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1845
1.54651547252138e-84	-0.713668506317333	0.253	0.469	2.7985743990747e-80	ERRFI1	Malignant cells	GSE108397	ENSG00000116285	54206	ERBB receptor feedback inhibitor 1	GENE-33|MIG-6|RALT	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1846
1.62316660700739e-84	-0.300996284871099	0.115	0.308	2.93728229204057e-80	SLC25A25	Malignant cells	GSE108397	ENSG00000148339	114789	solute carrier family 25 member 25	KIAA1896|MCSC|PCSCL	protein_coding	Q6KCM7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1847
1.64362218859717e-84	-0.450201952000712	0.375	0.582	2.97429871248544e-80	MCL1	Malignant cells	GSE108397	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1848
2.21891734312291e-84	-0.338024890120672	0.189	0.399	4.01535282411522e-80	DYRK1A	Malignant cells	GSE108397	ENSG00000157540	1859	dual specificity tyrosine phosphorylation regulated kinase 1A	DYRK|DYRK1|MNBH	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1849
2.2208470789021e-84	-0.37512758333738	0.266	0.481	4.01884487398124e-80	PIK3CD	Malignant cells	GSE108397	ENSG00000171608	5293	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta	p110D	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1850
3.50116731905355e-84	-0.401799680991266	0.563	0.73	6.33571238055931e-80	RABEPK	Malignant cells	GSE108397	ENSG00000136933	10244	Rab9 effector protein with kelch motifs	bA65N13.1|RAB9P40	protein_coding	Q7Z6M1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1851
3.53784449285358e-84	-0.445606711622482	0.629	0.781	6.40208339426785e-80	PHGDH	Malignant cells	GSE108397	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1852
3.81271209565153e-84	0.435767911078471	0.838	0.703	6.89948380829102e-80	TUBB2A	Malignant cells	GSE108397	ENSG00000137267	7280	tubulin beta 2A class IIa	dJ40E16.7|TUBB|TUBB2	protein_coding	Q13885	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1853
5.37197804122349e-84	-0.421573242130837	0.534	0.721	9.72113146339802e-80	ITGA6	Malignant cells	GSE108397	ENSG00000091409	3655	integrin subunit alpha 6	CD49f	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1854
6.39487535352803e-84	-0.437570112852592	0.507	0.688	1.15721664397443e-79	PLCB4	Malignant cells	GSE108397	ENSG00000101333	5332	phospholipase C beta 4	NA	protein_coding	Q15147	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1855
6.8674898557725e-84	-0.391497376367192	0.326	0.534	1.24274096430059e-79	SIL1	Malignant cells	GSE108397	ENSG00000120725	64374	SIL1 nucleotide exchange factor	BAP|MSS|ULG5	protein_coding	Q9H173	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1856
7.63608410726343e-84	-0.402951012468717	0.392	0.599	1.38182578005039e-79	DTNBP1	Malignant cells	GSE108397	ENSG00000047579	84062	dystrobrevin binding protein 1	BLOC1S8|DBND|Dysbindin|HPS7|My031	protein_coding	Q96EV8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1857
9.5962850107403e-84	-0.719980050338732	0.408	0.579	1.73654373554356e-79	CIR1	Malignant cells	GSE108397	ENSG00000138433	9541	corepressor interacting with RBPJ, CIR1	CIR	protein_coding	Q86X95	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1858
9.71626741646359e-84	0.414076596799084	0.71	0.516	1.75825575168325e-79	GPX8	Malignant cells	GSE108397	ENSG00000164294	493869	glutathione peroxidase 8 (putative)	EPLA847|UNQ847	protein_coding	Q8TED1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1859
9.73659071439729e-84	-0.359769525699875	0.817	0.904	1.76193345567733e-79	SPATS2	Malignant cells	GSE108397	ENSG00000123352	65244	spermatogenesis associated serine rich 2	FLJ13117|SCR59|SPATA10	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1860
1.18553330599e-83	-0.39454418531434	0.797	0.888	2.1453410705195e-79	TPR	Malignant cells	GSE108397	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1861
1.2822369448152e-83	0.417420354781268	0.804	0.643	2.32033597533758e-79	IDH3A	Malignant cells	GSE108397	ENSG00000166411	3419	isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1862
1.29967997243315e-83	-0.427659469022414	0.473	0.662	2.35190087811502e-79	PLSCR1	Malignant cells	GSE108397	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1863
1.39150867924419e-83	0.375114293859201	0.901	0.818	2.51807410596028e-79	LRR1	Malignant cells	GSE108397	ENSG00000165501	122769	leucine rich repeat protein 1	LRR-1|MGC20689|PPIL5	protein_coding	Q96L50	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1864
1.43435023633015e-83	0.39108129763703	0.864	0.74	2.59560018766304e-79	UBAC2	Malignant cells	GSE108397	ENSG00000134882	337867	UBA domain containing 2	FLJ30548|PHGDHL1|RP11-178C10.1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1865
1.58848389892896e-83	-0.440251420330784	0.47	0.659	2.87452046350184e-79	TNS1	Malignant cells	GSE108397	ENSG00000079308	7145	tensin 1	DKFZp586K0617|MXRA6|PPP1R155|TNS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1866
1.82194795867952e-83	0.325013879408446	0.364	0.159	3.29699702602645e-79	STARD13	Malignant cells	GSE108397	ENSG00000133121	90627	StAR related lipid transfer domain containing 13	ARHGAP37|DLC2|GT650|LINC00464	protein_coding	Q9Y3M8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1867
1.83397548707559e-83	-0.313423721678058	0.97	0.989	3.31876204141199e-79	TMUB1	Malignant cells	GSE108397	ENSG00000164897	83590	transmembrane and ubiquitin like domain containing 1	C7orf21|HOPS|SB144	protein_coding	Q9BVT8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1868
2.75473937200527e-83	-0.403135372464486	0.644	0.794	4.98497636758073e-79	TAF12	Malignant cells	GSE108397	ENSG00000120656	6883	TATA-box binding protein associated factor 12	TAF2J|TAFII20	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1869
3.039510130031e-83	-0.344893324771374	0.93	0.97	5.50029753130409e-79	HNRNPM	Malignant cells	GSE108397	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1870
3.281443170469e-83	0.34123893572681	0.992	0.984	5.93809956128071e-79	MRPL43	Malignant cells	GSE108397	ENSG00000055950	84545	mitochondrial ribosomal protein L43	bMRP36a	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1871
3.30729770747068e-83	-0.403850100780954	0.342	0.547	5.98488593143894e-79	ACAP3	Malignant cells	GSE108397	ENSG00000131584	116983	ArfGAP with coiled-coil, ankyrin repeat and PH domains 3	CENTB5|KIAA1716	protein_coding	Q96P50	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1872
4.12775143121199e-83	-0.398229847329139	0.627	0.768	7.46957898992122e-79	ACOT13	Malignant cells	GSE108397	ENSG00000112304	55856	acyl-CoA thioesterase 13	HT012|THEM2	protein_coding	Q9NPJ3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1873
4.28209771351569e-83	-0.393472111533094	0.661	0.804	7.74888402237799e-79	REPIN1	Malignant cells	GSE108397	ENSG00000214022	29803	replication initiator 1	AP4|H_DJ0584D14.12|RIP60|Zfp464|ZNF464	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1874
5.11197515722873e-83	0.394331107513526	0.579	0.359	9.2506302445211e-79	STK32A	Malignant cells	GSE108397	ENSG00000169302	202374	serine/threonine kinase 32A	MGC22688|YANK1	protein_coding	Q8WU08	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1875
7.24050821721113e-83	-0.399043221747334	0.582	0.748	1.31024236698653e-78	LYPLA2	Malignant cells	GSE108397	ENSG00000011009	11313	lysophospholipase 2	APT-2	protein_coding	O95372	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1876
7.76461334358044e-83	-0.441819793526898	0.754	0.842	1.40508443065432e-78	SLC6A8	Malignant cells	GSE108397	ENSG00000130821	6535	solute carrier family 6 member 8	CRT|CRT-1|CRT1|CRTR|CT1	protein_coding	P48029	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1877
8.1758360921252e-83	0.269108711837043	0.285	0.1	1.47949929923098e-78	AC007405.6	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1878
8.4259133978206e-83	-0.373677943508429	0.691	0.829	1.52475328846962e-78	GTF2F1	Malignant cells	GSE108397	ENSG00000125651	2962	general transcription factor IIF subunit 1	BTF4|RAP74|TF2F1|TFIIF	protein_coding	P35269	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1879
8.66893939619168e-83	0.277135586495317	1	0.998	1.56873127313485e-78	POLR2K	Malignant cells	GSE108397	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1880
9.28190024957018e-83	-0.312972343207247	0.997	0.999	1.67965266916222e-78	CLIC1	Malignant cells	GSE108397	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1881
1.03926384617337e-82	-0.282401022953043	0.103	0.29	1.88065185603533e-78	TMEM63A	Malignant cells	GSE108397	ENSG00000196187	9725	transmembrane protein 63A	KIAA0792	protein_coding	O94886	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1882
1.44403056283733e-82	-0.313876139778896	0.982	0.997	2.61311770651043e-78	COX6A1	Malignant cells	GSE108397	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1883
1.7984131611581e-82	-0.383582169346872	0.338	0.547	3.25440845643169e-78	AGPAT3	Malignant cells	GSE108397	ENSG00000160216	56894	1-acylglycerol-3-phosphate O-acyltransferase 3	LPAAT-gamma|LPAAT3|LPLAT3	protein_coding	Q9NRZ7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1884
1.96957655981326e-82	0.386511013940721	0.826	0.688	3.56414574263807e-78	ECH1	Malignant cells	GSE108397	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1885
1.97292702348404e-82	-0.367643961693703	0.927	0.968	3.57020874169671e-78	KIAA1430	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1886
2.06554352077492e-82	-0.350024239581692	0.212	0.422	3.73780755519429e-78	SCAF4	Malignant cells	GSE108397	ENSG00000156304	57466	SR-related CTD associated factor 4	DKFZp434E098|KIAA1172|SFRS15|SRA4	protein_coding	O95104	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1887
2.45843522000005e-82	-0.489566826049903	0.281	0.495	4.44878437411208e-78	MAP1B	Malignant cells	GSE108397	ENSG00000131711	4131	microtubule associated protein 1B	MAP5|PPP1R102	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1888
2.47562455419861e-82	-0.344935866324658	0.903	0.963	4.4798901932778e-78	GPAA1	Malignant cells	GSE108397	ENSG00000197858	8733	glycosylphosphatidylinositol anchor attachment 1	GAA1|hGAA1	protein_coding	O43292	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1889
3.06805699531059e-82	0.668607242090173	0.874	0.752	5.55195593871404e-78	EIF2S3	Malignant cells	GSE108397	ENSG00000130741	1968	eukaryotic translation initiation factor 2 subunit gamma	EIF2|EIF2G|EIF2gamma	protein_coding	P41091	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1890
3.82979863113088e-82	-0.421972769953627	0.867	0.923	6.93040360289445e-78	SMC4	Malignant cells	GSE108397	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1891
5.41471186384069e-82	-0.3927364154007	0.499	0.681	9.79846258880611e-78	GPATCH8	Malignant cells	GSE108397	ENSG00000186566	23131	G-patch domain containing 8	GPATC8|KIAA0553	protein_coding	Q9UKJ3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1892
8.98675267077079e-82	-0.405469083488912	0.537	0.711	1.62624276330268e-77	USP36	Malignant cells	GSE108397	ENSG00000055483	57602	ubiquitin specific peptidase 36	FLJ12851|KIAA1453	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1893
9.32222432467393e-82	-0.414952881647438	0.548	0.721	1.686949713793e-77	HMCES	Malignant cells	GSE108397	ENSG00000183624	56941	5-hydroxymethylcytosine binding, ES cell specific	C3orf37|DC12|SRAPD1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1894
9.5496008902845e-82	-0.34697070412671	0.898	0.955	1.72809577710588e-77	B3GAT3	Malignant cells	GSE108397	ENSG00000149541	26229	beta-1,3-glucuronyltransferase 3	GlcAT-I	protein_coding	O94766	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1895
9.59011928340488e-82	-0.366768643487573	0.784	0.877	1.73542798552495e-77	TSSC4	Malignant cells	GSE108397	ENSG00000184281	10078	tumor suppressing subtransferable candidate 4	NA	protein_coding	Q9Y5U2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1896
1.15096067738327e-81	-0.384182164646076	0.732	0.844	2.08277844179277e-77	TMC6	Malignant cells	GSE108397	ENSG00000141524	11322	transmembrane channel like 6	EVER1|EVIN1|LAK-4P|TNRC6C-AS1	protein_coding	Q7Z403	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1897
1.18204286281354e-81	-0.350142159758592	0.946	0.978	2.13902476454739e-77	DDX21	Malignant cells	GSE108397	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1898
1.37191664718826e-81	0.356661348904365	0.508	0.294	2.48262036475188e-77	C5orf51	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1899
1.59995141601128e-81	-0.397784853396245	0.448	0.638	2.89527208241402e-77	ARMC6	Malignant cells	GSE108397	ENSG00000105676	93436	armadillo repeat containing 6	MGC19595	protein_coding	Q6NXE6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1900
1.61679157307857e-81	-0.293166591194606	0.985	0.997	2.92574603064297e-77	CTHRC1	Malignant cells	GSE108397	ENSG00000164932	115908	collagen triple helix repeat containing 1	NA	protein_coding	Q96CG8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1901
1.73362050205044e-81	0.374524766107505	0.729	0.533	3.13715966051048e-77	PDHB	Malignant cells	GSE108397	ENSG00000168291	5162	pyruvate dehydrogenase E1 subunit beta	E1beta|PDHE1B	protein_coding	P11177	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1902
2.23684986620785e-81	-0.540543913398317	0.859	0.928	4.04780351788972e-77	HMGB2	Malignant cells	GSE108397	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1903
2.64348290418161e-81	-0.395319267591604	0.296	0.505	4.78364666340704e-77	SLC6A6	Malignant cells	GSE108397	ENSG00000131389	6533	solute carrier family 6 member 6	TAUT	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1904
2.90108658951843e-81	-0.279461587289156	0.992	0.994	5.24980629239256e-77	FIBP	Malignant cells	GSE108397	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1905
3.25209293561319e-81	-0.427595890687153	0.457	0.642	5.88498737628564e-77	PAXBP1	Malignant cells	GSE108397	ENSG00000263141	94104	PAX3 and PAX7 binding protein 1	C21orf66|fSAP105|GCFC|GCFC1	protein_coding	Q9Y5B6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1906
4.20247662649354e-81	-0.331841240836731	0.914	0.967	7.60480170330272e-77	EWSR1	Malignant cells	GSE108397	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1907
4.27194676789122e-81	-0.400357402707917	0.336	0.538	7.73051487117595e-77	MUS81	Malignant cells	GSE108397	ENSG00000172732	80198	MUS81 structure-specific endonuclease subunit	FLJ44872|SLX3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1908
4.91752010785774e-81	-0.407778342825118	0.432	0.62	8.89874438717937e-77	MGAT4B	Malignant cells	GSE108397	ENSG00000284501	11282	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GnT-Ivb	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1909
6.47451890574441e-81	-0.333546825087786	0.899	0.957	1.17162894118351e-76	MRPL42	Malignant cells	GSE108397	ENSG00000198015	28977	mitochondrial ribosomal protein L42	HSPC204|MRP-L31|MRPL31|MRPS32|PTD007|RPML31	protein_coding	Q9Y6G3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1910
8.06752511698507e-81	-0.399447009622343	0.56	0.715	1.45989934516962e-76	ATP2A2	Malignant cells	GSE108397	ENSG00000174437	488	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2	ATP2B|DAR|SERCA2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1911
8.07554762546492e-81	-0.377879105633014	0.774	0.879	1.46135109830413e-76	AAK1	Malignant cells	GSE108397	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1912
9.06193709158074e-81	-0.305287489229005	0.959	0.984	1.63984813609245e-76	ISCA1	Malignant cells	GSE108397	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1913
9.86057433195805e-81	-0.314566148711137	0.955	0.985	1.78436953111113e-76	HNRNPA0	Malignant cells	GSE108397	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1914
1.19475817589173e-80	-0.382927079172112	0.769	0.879	2.16203439509367e-76	TM9SF3	Malignant cells	GSE108397	ENSG00000077147	56889	transmembrane 9 superfamily member 3	SMBP	protein_coding	Q9HD45	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1915
1.32289819787316e-80	0.400766819908563	0.643	0.437	2.39391657887127e-76	SMCHD1	Malignant cells	GSE108397	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1916
1.37643207223634e-80	-0.3468004691347	0.964	0.992	2.49079147791889e-76	USP1	Malignant cells	GSE108397	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1917
1.40676967549461e-80	-0.364573154762224	0.757	0.865	2.54569040477505e-76	CLPTM1	Malignant cells	GSE108397	ENSG00000104853	1209	CLPTM1 regulator of GABA type A receptor forward trafficking	NA	protein_coding	O96005	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1918
1.6679358775186e-80	-0.354196220153512	0.884	0.953	3.01829676395766e-76	SPATS2L	Malignant cells	GSE108397	ENSG00000196141	26010	spermatogenesis associated serine rich 2 like	DNAPTP6|SGNP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1919
2.0697300029731e-80	-0.253884798975754	0.079	0.253	3.74538341338012e-76	MEF2D	Malignant cells	GSE108397	ENSG00000116604	4209	myocyte enhancer factor 2D	NA	protein_coding	Q14814	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1920
2.23708305501659e-80	-0.377208805453169	0.376	0.582	4.04822549635801e-76	PPM1F	Malignant cells	GSE108397	ENSG00000100034	9647	protein phosphatase, Mg2+/Mn2+ dependent 1F	CAMKP|CaMKPase|FEM-2|KIAA0015|POPX2	protein_coding	P49593	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1921
2.35333860684203e-80	-0.428944320907373	0.963	0.981	4.25860154294134e-76	MITF	Malignant cells	GSE108397	ENSG00000187098	4286	melanocyte inducing transcription factor	bHLHe32|MI|WS2|WS2A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1922
2.35772150871441e-80	0.382560150703685	0.992	0.989	4.26653284216959e-76	NCBP2-AS2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1923
2.44449389960543e-80	0.305681127391442	0.988	0.974	4.42355616072599e-76	MPST	Malignant cells	GSE108397	ENSG00000128309	4357	mercaptopyruvate sulfurtransferase	MST|TST2|TUM1	protein_coding	P25325	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1924
2.62521368579953e-80	0.368287663079435	0.959	0.915	4.75058668582283e-76	TARS	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1925
2.7613152286861e-80	0.361194503105376	0.956	0.91	4.99687603783036e-76	PET117	Malignant cells	GSE108397	ENSG00000232838	100303755	PET117 cytochrome c oxidase chaperone	CSRP2BP	protein_coding	Q6UWS5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1926
5.36251034565062e-80	-0.579066762360165	0.653	0.796	9.70399872148937e-76	CDKN2D	Malignant cells	GSE108397	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1927
6.70355159046969e-80	-0.337817504942075	0.935	0.979	1.2130746958114e-75	LUC7L3	Malignant cells	GSE108397	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1928
7.78792000601984e-80	0.409705895505034	0.778	0.627	1.40930200428935e-75	SKA3	Malignant cells	GSE108397	ENSG00000165480	221150	spindle and kinetochore associated complex subunit 3	C13orf3|MGC4832|RAMA1	protein_coding	Q8IX90	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1929
8.20629760733361e-80	-0.387118104185428	0.735	0.855	1.48501161502309e-75	NUMA1	Malignant cells	GSE108397	ENSG00000137497	4926	nuclear mitotic apparatus protein 1	NUMA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1930
8.57429115553235e-80	-0.452344163694904	0.488	0.661	1.55160372750513e-75	XXYLT1	Malignant cells	GSE108397	ENSG00000173950	152002	xyloside xylosyltransferase 1	C3orf21|FLJ35155	protein_coding	Q8NBI6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1931
9.49328582026049e-80	0.37257418687022	0.845	0.711	1.71790500203434e-75	RMDN1	Malignant cells	GSE108397	ENSG00000176623	51115	regulator of microtubule dynamics 1	CGI-90|FAM82B|FLJ20665|RMD1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1932
1.02932502638628e-79	-0.403293018465737	0.237	0.445	1.86266656774862e-75	C16orf74	Malignant cells	GSE108397	ENSG00000154102	404550	chromosome 16 open reading frame 74	MGC17624	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1933
1.58890777326439e-79	-0.316497028981225	0.162	0.362	2.87528750649925e-75	CRTC2	Malignant cells	GSE108397	ENSG00000160741	200186	CREB regulated transcription coactivator 2	TORC2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1934
1.65173376124942e-79	-0.346749630421567	0.797	0.89	2.98897741435696e-75	ARFIP2	Malignant cells	GSE108397	ENSG00000132254	23647	ADP ribosylation factor interacting protein 2	POR1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1935
1.72909008962066e-79	-0.377088603024591	0.698	0.828	3.12896142617755e-75	MAP7D1	Malignant cells	GSE108397	ENSG00000116871	55700	MAP7 domain containing 1	FLJ10350|FLJ39022|PARCC1|RPRC1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1936
1.93372786227622e-79	-0.288112708489812	0.991	0.997	3.49927393957504e-75	GAMT	Malignant cells	GSE108397	ENSG00000130005	2593	guanidinoacetate N-methyltransferase	PIG2|TP53I2	protein_coding	Q14353	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1937
2.04033805033599e-79	-0.364884489959187	0.8	0.886	3.692195735888e-75	CCDC23	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1938
2.19919032591608e-79	-0.325130049365657	0.951	0.985	3.97965481377774e-75	PAK2	Malignant cells	GSE108397	ENSG00000180370	5062	p21 (RAC1) activated kinase 2	PAK65|PAKgamma	protein_coding	Q13177	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1939
2.54548512385906e-79	-0.293587845443761	0.983	0.995	4.60630988013536e-75	REXO2	Malignant cells	GSE108397	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1940
4.09350346871408e-79	-0.357597236408195	0.229	0.434	7.407603876985e-75	ECM1	Malignant cells	GSE108397	ENSG00000143369	1893	extracellular matrix protein 1	NA	protein_coding	Q16610	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1941
4.81363859728266e-79	-0.399915448905366	0.335	0.539	8.71076040564269e-75	KIAA0907	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1942
6.29361684853405e-79	0.280019175462463	0.998	0.991	1.13889290491072e-74	BANF1	Malignant cells	GSE108397	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1943
6.43818894312894e-79	-0.360801190106677	0.867	0.941	1.16505467114861e-74	SLC7A5	Malignant cells	GSE108397	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1944
6.59799275691254e-79	-0.398475217129941	0.426	0.617	1.19397276929089e-74	ALKBH3	Malignant cells	GSE108397	ENSG00000166199	221120	alkB homolog 3, alpha-ketoglutarate dependent dioxygenase	DEPC-1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1945
6.80508581753954e-79	-0.422295094127972	0.649	0.786	1.23144832954196e-74	TNRC6B	Malignant cells	GSE108397	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1946
7.01688792038542e-79	-0.396113912558861	0.418	0.609	1.26977603807295e-74	MYO9B	Malignant cells	GSE108397	ENSG00000099331	4650	myosin IXB	CELIAC4	protein_coding	Q13459	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1947
8.2345042520699e-79	0.331907675626427	0.943	0.883	1.49011588945457e-74	NDUFA10	Malignant cells	GSE108397	ENSG00000130414	4705	NADH:ubiquinone oxidoreductase subunit A10	CI-42k	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1948
1.03691821593444e-78	-0.390895928638599	0.421	0.609	1.87640720355496e-74	SLC38A10	Malignant cells	GSE108397	ENSG00000157637	124565	solute carrier family 38 member 10	MGC15523|PP1744	protein_coding	Q9HBR0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1949
1.11871694517962e-78	-0.338945389669035	0.866	0.935	2.02443018399704e-74	CS	Malignant cells	GSE108397	ENSG00000062485	1431	citrate synthase	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1950
1.12988609379859e-78	-0.366289781436728	0.299	0.503	2.04464187533792e-74	LRCH4	Malignant cells	GSE108397	ENSG00000077454	4034	leucine rich repeats and calponin homology domain containing 4	LRN|LRRN1	protein_coding	O75427	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1951
1.15407364479436e-78	0.351810598101959	0.522	0.31	2.08841166761987e-74	IFT88	Malignant cells	GSE108397	ENSG00000032742	8100	intraflagellar transport 88	D13S1056E|hTg737|MGC26259|Tg737|TTC10	protein_coding	Q13099	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1952
1.1825035649839e-78	-0.360859081229927	0.805	0.898	2.13985845119486e-74	TP53I13	Malignant cells	GSE108397	ENSG00000167543	90313	tumor protein p53 inducible protein 13	DSCP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1953
1.30364888950703e-78	-0.398490878837729	0.4	0.593	2.35908303045192e-74	GFPT1	Malignant cells	GSE108397	ENSG00000198380	2673	glutamine--fructose-6-phosphate transaminase 1	GFA|GFAT|GFAT1|GFPT	protein_coding	Q06210	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1954
1.47811762690218e-78	-0.342554299779574	0.943	0.979	2.67480165764218e-74	WDR43	Malignant cells	GSE108397	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1955
1.80137318470158e-78	0.401708832220379	0.874	0.773	3.25976491503599e-74	SRPX	Malignant cells	GSE108397	ENSG00000101955	8406	sushi repeat containing protein X-linked	ETX1|SRPX1	protein_coding	P78539	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1956
1.81658462506932e-78	-0.353435916811361	0.63	0.795	3.28729153752544e-74	KDELR3	Malignant cells	GSE108397	ENSG00000100196	11015	KDEL endoplasmic reticulum protein retention receptor 3	NA	protein_coding	O43731	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1957
1.86391378466446e-78	-0.39245550665539	0.305	0.511	3.37293838472881e-74	PSD3	Malignant cells	GSE108397	ENSG00000156011	23362	pleckstrin and Sec7 domain containing 3	DKFZp761K1423|EFA6D|EFA6R|HCA67|KIAA0942	protein_coding	Q9NYI0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1958
1.96215392716573e-78	-0.37601209329809	0.637	0.775	3.55071374659911e-74	PSME3	Malignant cells	GSE108397	ENSG00000131467	10197	proteasome activator subunit 3	Ki|PA28-gamma|PA28G|REG-GAMMA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1959
2.77901245103732e-78	0.341023025481001	0.372	0.174	5.02890093139714e-74	TNFRSF19	Malignant cells	GSE108397	ENSG00000127863	55504	TNF receptor superfamily member 19	TAJ|TAJ-alpha|TRADE|TROY	protein_coding	Q9NS68	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1960
2.96823697972731e-78	-0.304199740645323	0.965	0.989	5.37132163851453e-74	ELOF1	Malignant cells	GSE108397	ENSG00000130165	84337	elongation factor 1	ELF1|MGC4549	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1961
4.06859816795711e-78	0.389818028018942	0.743	0.571	7.36253524473518e-74	TMEM177	Malignant cells	GSE108397	ENSG00000144120	80775	transmembrane protein 177	MGC10993	protein_coding	Q53S58	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1962
5.01962838268647e-78	-0.321462832072799	0.903	0.962	9.08351952130943e-74	SPCS3	Malignant cells	GSE108397	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1963
5.31465134167063e-78	-0.430492986354319	0.732	0.865	9.61739306788717e-74	SNAI2	Malignant cells	GSE108397	ENSG00000019549	6591	snail family transcriptional repressor 2	SLUG|SLUGH|SLUGH1|SNAIL2	protein_coding	O43623	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1964
5.83490659159846e-78	0.592062484886547	0.574	0.379	1.05588469681566e-73	SEMA5A	Malignant cells	GSE108397	ENSG00000112902	9037	semaphorin 5A	SEMAF|semF	protein_coding	Q13591	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1965
6.93675144668611e-78	-0.380621738214533	0.447	0.643	1.25527454179232e-73	RPS6KA4	Malignant cells	GSE108397	ENSG00000162302	8986	ribosomal protein S6 kinase A4	MSK2|RSK-B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1966
8.39676816155749e-78	-0.283742861586282	0.102	0.28	1.51947916651544e-73	ITGB5	Malignant cells	GSE108397	ENSG00000082781	3693	integrin subunit beta 5	NA	protein_coding	P18084	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1967
9.8815007217302e-78	-0.353928438569024	0.267	0.474	1.7881563706043e-73	OSTF1	Malignant cells	GSE108397	ENSG00000134996	26578	osteoclast stimulating factor 1	bA235O14.1|OSF|SH3P2	protein_coding	Q92882	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1968
1.07285461713851e-77	-0.396333920157253	0.466	0.648	1.94143771517384e-73	SMPD1	Malignant cells	GSE108397	ENSG00000166311	6609	sphingomyelin phosphodiesterase 1	ASM	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1969
1.22655253227439e-77	-0.325027333546249	0.209	0.416	2.21956946240374e-73	MTRNR2L8	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1970
1.23871271975742e-77	-0.325567285651471	0.891	0.944	2.24157453767304e-73	NABP2	Malignant cells	GSE108397	ENSG00000139579	79035	nucleic acid binding protein 2	hSSB1|MGC2731|OBFC2B|SOSS-B1|SSB1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1971
1.24150315861989e-77	0.455186312900381	0.541	0.343	2.24662411583854e-73	LRGUK	Malignant cells	GSE108397	ENSG00000155530	136332	leucine rich repeats and guanylate kinase domain containing	CFAP246|FLJ32786	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1972
1.43141904894387e-77	-0.33213441031427	0.888	0.947	2.59029591096883e-73	CCDC59	Malignant cells	GSE108397	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1973
1.4645155325724e-77	-0.356638999020399	0.926	0.968	2.65018730774302e-73	NUDT4	Malignant cells	GSE108397	ENSG00000173598	11163	nudix hydrolase 4	DIPP2|DIPP2alpha|DIPP2beta|HDCMB47P|KIAA0487	protein_coding	Q9NZJ9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1974
1.74586993904241e-77	0.268264671140974	1	1	3.15932624169114e-73	BRI3	Malignant cells	GSE108397	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1975
1.7496144618831e-77	0.462493883476204	0.676	0.484	3.16610233022365e-73	PLAT	Malignant cells	GSE108397	ENSG00000104368	5327	plasminogen activator, tissue type	NA	protein_coding	P00750	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1976
1.80782867754349e-77	-0.308899875802048	0.137	0.327	3.27144677488269e-73	IL6R	Malignant cells	GSE108397	ENSG00000160712	3570	interleukin 6 receptor	CD126|gp80|IL-1Ra|IL-6R|IL6RA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1977
1.98655287432789e-77	0.365392389439609	0.85	0.722	3.59486608138375e-73	CHMP4A	Malignant cells	GSE108397	ENSG00000285302	29082	charged multivesicular body protein 4A	C14orf123|HSPC134|VPS32A	protein_coding	Q9BY43	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1978
2.06164405805302e-77	0.31871580388083	0.991	0.98	3.73075108745275e-73	VIMP	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1979
2.35876099233255e-77	0.343272605749498	0.973	0.932	4.26841389172498e-73	C11orf83	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1980
2.60662562279904e-77	-0.403659432516305	0.384	0.573	4.71694972701715e-73	ST6GALNAC4	Malignant cells	GSE108397	ENSG00000136840	27090	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	SIAT3C|SIAT7D|ST6GALNACIV	protein_coding	Q9H4F1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1981
2.89719216856036e-77	-0.369837126750231	0.284	0.487	5.24275894822683e-73	CYTH3	Malignant cells	GSE108397	ENSG00000008256	9265	cytohesin 3	ARNO3|cytohesin-3|GRP1|PSCD3	protein_coding	O43739	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1982
2.93516444332096e-77	-0.361200083418647	0.783	0.877	5.31147357663361e-73	DNAJC4	Malignant cells	GSE108397	ENSG00000110011	3338	DnaJ heat shock protein family (Hsp40) member C4	HSPF2|MCG18	protein_coding	Q9NNZ3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1983
3.06448396053244e-77	-0.409756100710167	0.603	0.755	5.54549017497951e-73	NUP62	Malignant cells	GSE108397	ENSG00000213024	23636	nucleoporin 62	DKFZp547L134|FLJ20822|FLJ43869|IBSN|MGC841|p62|SNDI	protein_coding	P37198	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1984
3.10019095194329e-77	0.366056958907196	0.999	0.999	5.61010554663658e-73	SLC25A6	Malignant cells	GSE108397	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1985
3.21183361306053e-77	-0.387110330884975	0.803	0.924	5.81213410619433e-73	HMGA2	Malignant cells	GSE108397	ENSG00000149948	8091	high mobility group AT-hook 2	BABL|HMGIC|LIPO	protein_coding	P52926	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1986
3.44581461117349e-77	0.347945223497756	0.964	0.933	6.23554612037955e-73	TYMS	Malignant cells	GSE108397	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1987
4.45144582119089e-77	-0.261805214405268	0.096	0.271	8.05533635802704e-73	GPR3	Malignant cells	GSE108397	ENSG00000181773	2827	G protein-coupled receptor 3	ACCA	protein_coding	P46089	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1988
4.65484787305926e-77	-0.361074929496814	0.281	0.482	8.42341271108804e-73	CAPN1	Malignant cells	GSE108397	ENSG00000014216	823	calpain 1	CANP|CANPL1|muCANP|muCL	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1989
4.738205056909e-77	-0.380278014684423	0.322	0.524	8.57425587098253e-73	CHAF1B	Malignant cells	GSE108397	ENSG00000159259	8208	chromatin assembly factor 1 subunit B	CAF-1|CAF1|CAF1A|CAF1P60|MPHOSPH7|MPP7	protein_coding	Q13112	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1990
5.00517615795061e-77	0.318918343216958	0.985	0.973	9.05736677542743e-73	ARPP19	Malignant cells	GSE108397	ENSG00000128989	10776	cAMP regulated phosphoprotein 19	ARPP-16|ARPP-19|ARPP16|ENSAL	protein_coding	P56211	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1991
5.62156555862839e-77	0.362278024630626	0.627	0.414	1.01727850348939e-72	SNAP23	Malignant cells	GSE108397	ENSG00000092531	8773	synaptosome associated protein 23	HsT17016|SNAP23A|SNAP23B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1992
5.83213461230077e-77	-0.358340252172314	0.792	0.9	1.05538307944195e-72	PDIA4	Malignant cells	GSE108397	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1993
6.96008470233453e-77	0.346642391391826	0.452	0.245	1.25949692773446e-72	SEPT1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1994
7.06025103874964e-77	-0.362272602440603	0.169	0.368	1.27762302797213e-72	JUNB	Malignant cells	GSE108397	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1995
8.23771275582478e-77	0.381243154059321	0.758	0.593	1.49069650029405e-72	PTPN2	Malignant cells	GSE108397	ENSG00000175354	5771	protein tyrosine phosphatase non-receptor type 2	PTPT|TC-PTP|TCELLPTP|TCPTP	protein_coding	P17706	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1996
9.43200393698028e-77	-0.263922930794678	0.995	0.999	1.70681543243595e-72	CHMP4B	Malignant cells	GSE108397	ENSG00000101421	128866	charged multivesicular body protein 4B	C20orf178|dJ553F4.4|Shax1|SNF7-2|VPS32B	protein_coding	Q9H444	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1997
1.15015667902057e-76	-0.396605091612994	0.272	0.473	2.08132352635562e-72	LXN	Malignant cells	GSE108397	ENSG00000079257	56925	latexin	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1998
1.3068218767371e-76	-0.390573025190771	0.299	0.501	2.36482486814346e-72	EPHX1	Malignant cells	GSE108397	ENSG00000143819	2052	epoxide hydrolase 1	EPHX	protein_coding	P07099	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	1999
1.64537234934194e-76	-0.388320313294812	0.578	0.726	2.97746580336918e-72	PHF20	Malignant cells	GSE108397	ENSG00000025293	51230	PHD finger protein 20	C20orf104|dJ1121G12.1|TDRD20A	protein_coding	Q9BVI0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2000
1.93978816141943e-76	0.381845633006793	0.704	0.521	3.5102406569046e-72	EXOSC7	Malignant cells	GSE108397	ENSG00000075914	23016	exosome component 7	EAP1|hRrp42p|KIAA0116|p8|RRP42|Rrp42p	protein_coding	Q15024	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2001
2.0842952269478e-76	0.372207134101896	0.721	0.537	3.77174064268474e-72	MRPL45	Malignant cells	GSE108397	ENSG00000277936	84311	mitochondrial ribosomal protein L45	Mba1|MGC11321	protein_coding	Q9BRJ2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2002
2.29586579667307e-76	0.344430566702552	0.584	0.372	4.15459874565959e-72	SLC25A15	Malignant cells	GSE108397	ENSG00000102743	10166	solute carrier family 25 member 15	D13S327|HHH|ORC1|ORNT1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2003
2.6495656548983e-76	-0.383027300468051	0.739	0.859	4.79465400910397e-72	TMPO	Malignant cells	GSE108397	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2004
2.6608246948529e-76	-0.364309678509465	0.806	0.901	4.81502836780581e-72	HMGXB3	Malignant cells	GSE108397	ENSG00000113716	22993	HMG-box containing 3	HMGX3|KIAA0194|SMF	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2005
3.65477567598216e-76	-0.355325198076604	0.913	0.959	6.61368206325732e-72	EPS8	Malignant cells	GSE108397	ENSG00000151491	2059	epidermal growth factor receptor pathway substrate 8	NA	protein_coding	Q12929	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2006
4.78852734410207e-76	-0.34201511080033	0.91	0.96	8.66531908188711e-72	EIF4A2	Malignant cells	GSE108397	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2007
6.33285567065838e-76	-0.366992657530252	0.643	0.779	1.14599356216234e-71	RPN1	Malignant cells	GSE108397	ENSG00000163902	6184	ribophorin I	OST1	protein_coding	P04843	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2008
6.60888730064303e-76	0.37662895428768	0.899	0.795	1.19594424592436e-71	SHISA4	Malignant cells	GSE108397	ENSG00000198892	149345	shisa family member 4	C1orf40|hShisa4|TMEM58	protein_coding	Q96DD7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2009
9.45262212197022e-76	-0.379634293940044	0.422	0.615	1.71054649919173e-71	GOLGA2	Malignant cells	GSE108397	ENSG00000167110	2801	golgin A2	GM130|golgin-95	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2010
1.03442458116041e-75	-0.372292799084884	0.79	0.897	1.87189472206787e-71	CLINT1	Malignant cells	GSE108397	ENSG00000113282	9685	clathrin interactor 1	CLINT|ENTH|EPNR|KIAA0171	protein_coding	Q14677	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2011
1.3518124786183e-75	-0.398589269531771	0.406	0.595	2.44623986130767e-71	ZNF148	Malignant cells	GSE108397	ENSG00000163848	7707	zinc finger protein 148	BERF-1|BFCOL1|HT-BETA|pHZ-52|ZBP-89|ZFP148	protein_coding	Q9UQR1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2012
1.74885970866961e-75	-0.385688349580902	0.6	0.755	3.16473652880853e-71	ACADVL	Malignant cells	GSE108397	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2013
1.88194165576978e-75	0.364224530454317	0.624	0.42	3.40556162028099e-71	RNMTL1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2014
2.80336878849998e-75	0.295005134410898	0.333	0.145	5.07297615966956e-71	NT5M	Malignant cells	GSE108397	ENSG00000205309	56953	5',3'-nucleotidase, mitochondrial	dNT-2|dNT2|mdN	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2015
2.82312373974778e-75	-0.345121570417935	0.81	0.905	5.10872471944758e-71	RFC2	Malignant cells	GSE108397	ENSG00000049541	5982	replication factor C subunit 2	A1|RFC40	protein_coding	P35250	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2016
3.04640524933014e-75	0.367147816364571	0.701	0.509	5.51277493918782e-71	SCO1	Malignant cells	GSE108397	ENSG00000133028	6341	synthesis of cytochrome C oxidase 1	SCOD1	protein_coding	O75880	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2017
3.26969381292958e-75	-0.354329740773328	0.294	0.498	5.91683792387738e-71	NCOR2	Malignant cells	GSE108397	ENSG00000196498	9612	nuclear receptor corepressor 2	CTG26|SMRT|SMRTE|TNRC14|TRAC-1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2018
3.35929947856018e-75	0.28422778731482	0.321	0.135	6.07898833640249e-71	ANKH	Malignant cells	GSE108397	ENSG00000154122	56172	ANKH inorganic pyrophosphate transport regulator	ANK|CCAL2|CMDJ|CPPDD|HANK|SLC62A1	protein_coding	Q9HCJ1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2019
3.62955309975795e-75	-0.379280597363137	0.624	0.773	6.56803928932198e-71	THOP1	Malignant cells	GSE108397	ENSG00000172009	7064	thimet oligopeptidase 1	NA	protein_coding	P52888	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2020
3.68413985826625e-75	-0.396012318971738	0.46	0.639	6.6668194875186e-71	GPANK1	Malignant cells	GSE108397	ENSG00000223932	7918	G-patch domain and ankyrin repeats 1	ANKRD59|BAT4|D6S54E|G5|GPATCH10	protein_coding	O95872	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2021
4.04863649067635e-75	-0.407143573475478	0.468	0.644	7.32641259352792e-71	RELT	Malignant cells	GSE108397	ENSG00000054967	84957	RELT TNF receptor	FLJ14993|TNFRSF19L	protein_coding	Q969Z4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2022
4.52280892254136e-75	0.368943919497404	0.875	0.767	8.18447502623084e-71	SSSCA1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2023
4.72739175431424e-75	0.317460733109115	0.958	0.914	8.55468811860705e-71	ZNHIT3	Malignant cells	GSE108397	ENSG00000278574	9326	zinc finger HIT-type containing 3	Hit1|TRIP3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2024
4.75839278752148e-75	-0.481877803444134	0.473	0.662	8.61078758829886e-71	SRGAP2	Malignant cells	GSE108397	ENSG00000266028	23380	SLIT-ROBO Rho GTPase activating protein 2	ARHGAP34|FNBP2|KIAA0456|SRGAP2A	protein_coding	O75044	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2025
5.15236789951806e-75	0.317500523289736	0.502	0.286	9.32372495096787e-71	MGST2	Malignant cells	GSE108397	ENSG00000085871	4258	microsomal glutathione S-transferase 2	MGST-II	protein_coding	Q99735	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2026
5.60302346249402e-75	-0.326265434869261	0.887	0.948	1.01392312577292e-70	THAP4	Malignant cells	GSE108397	ENSG00000176946	51078	THAP domain containing 4	CGI-36|Nb(III)	protein_coding	Q8WY91	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2027
7.43603983722173e-75	-0.263374316178034	0.091	0.261	1.34562576894364e-70	EPAS1	Malignant cells	GSE108397	ENSG00000116016	2034	endothelial PAS domain protein 1	bHLHe73|HIF2A|HLF|MOP2|PASD2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2028
9.64190612174467e-75	-0.37008755981439	0.324	0.522	1.74479933179092e-70	DNASE2	Malignant cells	GSE108397	ENSG00000105612	1777	deoxyribonuclease 2, lysosomal	DNL|DNL2	protein_coding	O00115	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2029
1.00064741636433e-74	-0.369314808502655	0.666	0.796	1.81077156465289e-70	SNX8	Malignant cells	GSE108397	ENSG00000106266	29886	sorting nexin 8	Mvp1	protein_coding	Q9Y5X2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2030
1.11469798330305e-74	-0.343686673456583	0.773	0.879	2.0171574705852e-70	GALE	Malignant cells	GSE108397	ENSG00000117308	2582	UDP-galactose-4-epimerase	SDR1E1	protein_coding	Q14376	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2031
1.28789525888009e-74	-0.630880974989103	0.442	0.627	2.3305752604694e-70	CD70	Malignant cells	GSE108397	ENSG00000125726	970	CD70 molecule	CD27L|CD27LG|TNFSF7	protein_coding	P32970	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2032
1.33754012898621e-74	0.366311448768795	0.764	0.595	2.42041261741344e-70	PNPLA4	Malignant cells	GSE108397	ENSG00000006757	8228	patatin like phospholipase domain containing 4	DXS1283E|GS2|iPLA2eta	protein_coding	P41247	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2033
1.41228891188958e-74	-0.382442924083432	0.531	0.694	2.55567801495539e-70	STAG1	Malignant cells	GSE108397	ENSG00000118007	10274	stromal antigen 1	SA-1|SA1|SCC3A	protein_coding	Q8WVM7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2034
1.58378067931985e-74	0.317004804908874	0.445	0.24	2.8660095172972e-70	TMEM128	Malignant cells	GSE108397	ENSG00000132406	85013	transmembrane protein 128	MGC13159	protein_coding	Q5BJH2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2035
1.63838970528376e-74	-0.364068107575827	0.299	0.499	2.96483001068149e-70	NPAS2	Malignant cells	GSE108397	ENSG00000170485	4862	neuronal PAS domain protein 2	bHLHe9|MOP4|PASD4	protein_coding	Q99743	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2036
1.68965787308633e-74	-0.332524624635886	0.206	0.403	3.05760488713703e-70	PIP5K1A	Malignant cells	GSE108397	ENSG00000143398	8394	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2037
1.71528167384939e-74	0.453975031191537	0.89	0.793	3.10397371699786e-70	MARCKS	Malignant cells	GSE108397	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2038
1.76265533107795e-74	-0.304677193826644	0.956	0.988	3.18970108711865e-70	PRRC2C	Malignant cells	GSE108397	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2039
1.98072087404323e-74	-0.388790737135095	0.481	0.659	3.58431249366862e-70	RCAN3	Malignant cells	GSE108397	ENSG00000117602	11123	RCAN family member 3	DSCR1L2	protein_coding	Q9UKA8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2040
2.01974023740066e-74	-0.275393114703587	0.142	0.331	3.65492193360023e-70	RNF182	Malignant cells	GSE108397	ENSG00000180537	221687	ring finger protein 182	MGC33993	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2041
2.0774789759477e-74	-0.299024929050275	0.118	0.298	3.75940595487495e-70	FAIM3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2042
2.47912990157109e-74	-0.376910728707415	0.583	0.745	4.48623346988304e-70	TOMM70A	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2043
2.70360087951863e-74	-0.352357661444786	0.28	0.483	4.89243615157691e-70	TULP3	Malignant cells	GSE108397	ENSG00000078246	7289	TUB like protein 3	TUBL3	protein_coding	O75386	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2044
2.72403885230452e-74	-0.338175246238826	0.818	0.903	4.92942070713027e-70	SFXN4	Malignant cells	GSE108397	ENSG00000183605	119559	sideroflexin 4	SLC56A4	protein_coding	Q6P4A7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2045
3.23518438459367e-74	-0.377756577478215	0.329	0.532	5.8543896623607e-70	GXYLT2	Malignant cells	GSE108397	ENSG00000172986	727936	glucoside xylosyltransferase 2	GLT8D4	protein_coding	A0PJZ3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2046
3.72376358896321e-74	-0.406520943924236	0.461	0.631	6.73852259058783e-70	FRA10AC1	Malignant cells	GSE108397	ENSG00000148690	118924	FRA10A associated CGG repeat 1	C10orf4	protein_coding	Q70Z53	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2047
4.52809261310868e-74	0.384380473933476	0.888	0.805	8.19403639268147e-70	PERP	Malignant cells	GSE108397	ENSG00000112378	64065	p53 apoptosis effector related to PMP22	dJ496H19.1|KCP1|KRTCAP1|PIGPC1|THW	protein_coding	Q96FX8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2048
5.65206612579242e-74	0.319989718401657	0.415	0.215	1.0227978861234e-69	AC093323.3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2049
9.0494467874644e-74	0.280306789604206	0.336	0.146	1.63758789065956e-69	PRMT6	Malignant cells	GSE108397	ENSG00000198890	55170	protein arginine methyltransferase 6	FLJ10559|HRMT1L6	protein_coding	Q96LA8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2050
1.07849204052429e-73	0.341269845424217	0.902	0.802	1.95163919653276e-69	MTHFS	Malignant cells	GSE108397	ENSG00000136371	10588	methenyltetrahydrofolate synthetase	HsT19268	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2051
1.10502828818883e-73	-0.336607647715575	0.233	0.433	1.99965919030651e-69	PLXND1	Malignant cells	GSE108397	ENSG00000004399	23129	plexin D1	KIAA0620	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2052
1.13278159815308e-73	-0.348777148118248	0.826	0.899	2.04988158001782e-69	PPP1R2	Malignant cells	GSE108397	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2053
1.18462871348215e-73	-0.321836903235258	0.937	0.974	2.14370411991731e-69	DFFA	Malignant cells	GSE108397	ENSG00000160049	1676	DNA fragmentation factor subunit alpha	DFF-45|DFF1|DFF45|ICAD	protein_coding	O00273	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2054
1.22496320741367e-73	-0.388597437209706	0.749	0.897	2.21669342013579e-69	UCN2	Malignant cells	GSE108397	ENSG00000145040	90226	urocortin 2	SRP|UCN-II|UCNI|URP	protein_coding	Q96RP3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2055
1.26364387312604e-73	0.357373654455658	0.832	0.689	2.28668995280887e-69	ZNF32	Malignant cells	GSE108397	ENSG00000169740	7580	zinc finger protein 32	KOX30|Zfp637|ZNF637	protein_coding	P17041	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2056
1.42079209872305e-73	-0.373981194585892	0.708	0.83	2.57106538184922e-69	NKTR	Malignant cells	GSE108397	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2057
1.50476381030747e-73	0.340317628470582	0.535	0.329	2.72302059113239e-69	ABHD13	Malignant cells	GSE108397	ENSG00000139826	84945	abhydrolase domain containing 13	bA153I24.2|BEM46L1|C13orf6|FLJ14906	protein_coding	Q7L211	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2058
1.65665388439617e-73	-0.369585957051741	0.763	0.868	2.99788086920332e-69	HDAC1	Malignant cells	GSE108397	ENSG00000116478	3065	histone deacetylase 1	GON-10|HD1|KDAC1|RPD3L1	protein_coding	Q13547	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2059
1.93629039205296e-73	-0.397613968967219	0.538	0.697	3.50391109345904e-69	TNIK	Malignant cells	GSE108397	ENSG00000154310	23043	TRAF2 and NCK interacting kinase	KIAA0551	protein_coding	Q9UKE5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2060
2.51211007751061e-73	0.331867824395444	0.51	0.308	4.5459143962632e-69	AGA	Malignant cells	GSE108397	ENSG00000038002	175	aspartylglucosaminidase	ASRG	protein_coding	P20933	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2061
2.56797496693424e-73	0.490261590491454	0.68	0.519	4.6470075001642e-69	CCDC57	Malignant cells	GSE108397	ENSG00000176155	284001	coiled-coil domain containing 57	FLJ00130|FLJ23754	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2062
2.63819817780535e-73	0.360860013464449	0.671	0.474	4.77408342255656e-69	MGMT	Malignant cells	GSE108397	ENSG00000170430	4255	O-6-methylguanine-DNA methyltransferase	NA	protein_coding	P16455	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2063
2.64096730544102e-73	-0.323818385459846	0.193	0.388	4.77909443592607e-69	RP11-138A9.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2064
2.70711522522403e-73	-0.326710174199861	0.886	0.961	4.8987957115654e-69	CHRAC1	Malignant cells	GSE108397	ENSG00000104472	54108	chromatin accessibility complex subunit 1	CHRAC15|YCL1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2065
3.14064321262377e-73	0.362789954510675	0.809	0.664	5.68330795756398e-69	COPS2	Malignant cells	GSE108397	ENSG00000166200	9318	COP9 signalosome subunit 2	ALIEN|CSN2|TRIP15	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2066
3.3700871783259e-73	-0.440255463358387	0.523	0.677	6.09850975789854e-69	RP11-295G20.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2067
3.66118306820212e-73	-0.390223731263037	0.395	0.582	6.62527688021856e-69	SLC29A1	Malignant cells	GSE108397	ENSG00000112759	2030	solute carrier family 29 member 1 (Augustine blood group)	ENT1	protein_coding	Q99808	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2068
3.87799739837569e-73	-0.361090384101137	0.501	0.704	7.01762409210064e-69	CENPV	Malignant cells	GSE108397	ENSG00000166582	201161	centromere protein V	CENP-V|p30|PRR6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2069
4.00627638576009e-73	-0.377022750766198	0.587	0.74	7.24975774767146e-69	SNRNP200	Malignant cells	GSE108397	ENSG00000144028	23020	small nuclear ribonucleoprotein U5 subunit 200	ASCC3L1|BRR2|HELIC2|KIAA0788|RP33|U5-200KD	protein_coding	O75643	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2070
5.20716582356504e-73	0.330010170636946	0.448	0.247	9.4228872743233e-69	SPIRE1	Malignant cells	GSE108397	ENSG00000134278	56907	spire type actin nucleation factor 1	KIAA1135|spir-1	protein_coding	Q08AE8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2071
5.82939169913464e-73	0.482156399541603	0.765	0.645	1.05488672187541e-68	ARHGAP29	Malignant cells	GSE108397	ENSG00000137962	9411	Rho GTPase activating protein 29	PARG1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2072
5.90740368458115e-73	-0.389528912326048	0.568	0.731	1.0690037707618e-68	WDR55	Malignant cells	GSE108397	ENSG00000120314	54853	WD repeat domain 55	FLJ20195|FLJ21702	protein_coding	Q9H6Y2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2073
5.94077987334934e-73	-0.321886374020059	0.225	0.424	1.0750435258813e-68	COPG1	Malignant cells	GSE108397	ENSG00000181789	22820	COPI coat complex subunit gamma 1	COPG	protein_coding	Q9Y678	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2074
7.62526754008783e-73	0.346732029980374	0.54	0.338	1.37986841405429e-68	NELFA	Malignant cells	GSE108397	ENSG00000185049	7469	negative elongation factor complex member A	NELF-A|WHSC2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2075
8.17781096554929e-73	-0.379720032100132	0.609	0.754	1.4798566723258e-68	TRIM37	Malignant cells	GSE108397	ENSG00000108395	4591	tripartite motif containing 37	KIAA0898|MUL|POB1|TEF3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2076
8.24600121553417e-73	0.353392245129497	0.934	0.865	1.49219637996306e-68	RANGRF	Malignant cells	GSE108397	ENSG00000108961	29098	RAN guanine nucleotide release factor	HSPC165|HSPC236|MOG1|RANGNRF	protein_coding	Q9HD47	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2077
9.06569238060509e-73	0.348460941035836	0.858	0.733	1.6405276931943e-68	IFT57	Malignant cells	GSE108397	ENSG00000114446	55081	intraflagellar transport 57	ESRRBL1|FLJ10147|HIPPI|MHS4R2	protein_coding	Q9NWB7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2078
9.11782433539604e-73	0.320312330823111	0.399	0.202	1.64996149173327e-68	PARP9	Malignant cells	GSE108397	ENSG00000138496	83666	poly(ADP-ribose) polymerase family member 9	ARTD9|BAL|BAL1	protein_coding	Q8IXQ6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2079
1.21610015258765e-72	0.384042996460401	0.661	0.473	2.20065483612262e-68	YRDC	Malignant cells	GSE108397	ENSG00000196449	79693	yrdC N6-threonylcarbamoyltransferase domain containing	FLJ23476|IRIP|SUA5	protein_coding	Q86U90	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2080
1.39290323379721e-72	0.48470821656824	0.845	0.716	2.52059769187943e-68	IRS2	Malignant cells	GSE108397	ENSG00000185950	8660	insulin receptor substrate 2	NA	protein_coding	Q9Y4H2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2081
1.39490380839541e-72	-0.287668877994672	0.144	0.328	2.52421793167233e-68	ZDHHC18	Malignant cells	GSE108397	ENSG00000204160	84243	zinc finger DHHC-type palmitoyltransferase 18	DKFZp667O2416	protein_coding	Q9NUE0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2082
1.40030406015842e-72	-0.357103373001561	0.756	0.866	2.53399022726267e-68	EVA1A	Malignant cells	GSE108397	ENSG00000115363	84141	eva-1 homolog A, regulator of programmed cell death	FAM176A|FLJ13391|TMEM166	protein_coding	Q9H8M9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2083
1.51747644659282e-72	0.338503254725555	0.868	0.745	2.74602537775437e-68	ALG8	Malignant cells	GSE108397	ENSG00000159063	79053	ALG8 alpha-1,3-glucosyltransferase	MGC2840	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2084
1.51923624868163e-72	-0.314613647070725	0.897	0.944	2.74920991561428e-68	RPS6KB2	Malignant cells	GSE108397	ENSG00000175634	6199	ribosomal protein S6 kinase B2	KLS|P70-BETA|p70S6Kb|S6KB|S6Kbeta|STK14B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2085
1.75183394983082e-72	0.305652573476121	0.441	0.237	3.17011871561385e-68	PCGF3	Malignant cells	GSE108397	ENSG00000185619	10336	polycomb group ring finger 3	DONG1|FLJ36550|MGC40413|RNF3|RNF3A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2086
1.85975264463305e-72	-0.326227950738789	0.169	0.357	3.36540838572796e-68	RAP1GAP	Malignant cells	GSE108397	ENSG00000076864	5909	RAP1 GTPase activating protein	KIAA0474|RAP1GA1|RAP1GAP1|RAP1GAPII	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2087
2.56634416469644e-72	0.277261682838986	0.996	0.988	4.64405640043469e-68	MRPL48	Malignant cells	GSE108397	ENSG00000175581	51642	mitochondrial ribosomal protein L48	CGI-118	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2088
4.53673204101063e-72	0.329210847183781	0.403	0.207	8.20967030141283e-68	RP11-725P16.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2089
4.54730022464317e-72	-0.291356723201484	0.156	0.343	8.22879448651427e-68	STAT6	Malignant cells	GSE108397	ENSG00000166888	6778	signal transducer and activator of transcription 6	D12S1644|IL-4-STAT	protein_coding	P42226	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2090
5.17395780317206e-72	-0.329461045826422	0.223	0.417	9.36279404062016e-68	DIP2A	Malignant cells	GSE108397	ENSG00000160305	23181	disco interacting protein 2 homolog A	C21orf106|Dip2|KIAA0184	protein_coding	Q14689	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2091
5.74848072910579e-72	-0.386135799899342	0.554	0.715	1.04024507273898e-67	TRPV2	Malignant cells	GSE108397	ENSG00000187688	51393	transient receptor potential cation channel subfamily V member 2	VRL|VRL-1|VRL1	protein_coding	Q9Y5S1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2092
6.14905165702684e-72	0.356413344662372	0.564	0.362	1.11273238785558e-67	FASTKD2	Malignant cells	GSE108397	ENSG00000118246	22868	FAST kinase domains 2	KIAA0971	protein_coding	Q9NYY8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2093
6.18142598769176e-72	-0.372094607962167	0.627	0.763	1.1185908467327e-67	TTLL12	Malignant cells	GSE108397	ENSG00000100304	23170	tubulin tyrosine ligase like 12	KIAA0153	protein_coding	Q14166	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2094
6.46994934545747e-72	-0.391723219792124	0.511	0.683	1.17080203355398e-67	PAG1	Malignant cells	GSE108397	ENSG00000076641	55824	phosphoprotein membrane anchor with glycosphingolipid microdomains 1	CBP|PAG	protein_coding	Q9NWQ8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2095
6.95067188940295e-72	-0.283573525665143	0.968	0.986	1.25779358510636e-67	ARL16	Malignant cells	GSE108397	ENSG00000214087	339231	ADP ribosylation factor like GTPase 16	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2096
9.37501913493297e-72	-0.380285575829328	0.594	0.742	1.69650346265747e-67	GGNBP2	Malignant cells	GSE108397	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2097
9.60137012574262e-72	-0.366537801088317	0.326	0.52	1.73746393795438e-67	MCM3AP	Malignant cells	GSE108397	ENSG00000160294	8888	minichromosome maintenance complex component 3 associated protein	GANP|KIAA0572|Map80|SAC3	protein_coding	O60318	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2098
1.01107454310649e-71	0.339070149119583	0.933	0.878	1.8296404932055e-67	MPDU1	Malignant cells	GSE108397	ENSG00000129255	9526	mannose-P-dolichol utilization defect 1	CDGIf|Lec35|PQLC5|SL15|SLC66A5	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2099
1.0422146312541e-71	-0.28433278773617	0.979	0.994	1.88599159671742e-67	SLC25A33	Malignant cells	GSE108397	ENSG00000171612	84275	solute carrier family 25 member 33	BMSC-MCP|MGC4399|PNC1	protein_coding	Q9BSK2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2100
1.33362637862587e-71	0.318145628396351	0.375	0.184	2.41333029476137e-67	MAF	Malignant cells	GSE108397	ENSG00000178573	4094	MAF bZIP transcription factor	c-MAF	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2101
1.55018158428704e-71	-0.357811707741832	0.71	0.835	2.80520859492583e-67	CACUL1	Malignant cells	GSE108397	ENSG00000151893	143384	CDK2 associated cullin domain 1	C10orf46|CAC1|FLJ40409|MGC33215	protein_coding	Q86Y37	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2102
1.72588001161379e-71	-0.371428215932063	0.635	0.788	3.12315246901632e-67	KRCC1	Malignant cells	GSE108397	ENSG00000172086	51315	lysine rich coiled-coil 1	FLJ22333	protein_coding	Q9NPI7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2103
1.96976067873551e-71	-0.365805927189911	0.468	0.646	3.56447892423978e-67	MED30	Malignant cells	GSE108397	ENSG00000164758	90390	mediator complex subunit 30	THRAP6|TRAP25	protein_coding	Q96HR3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2104
2.0983831143055e-71	-0.313141601145825	0.169	0.354	3.79723408364723e-67	LGALS8	Malignant cells	GSE108397	ENSG00000116977	3964	galectin 8	PCTA-1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2105
2.26580392232369e-71	-0.347687287518886	0.76	0.867	4.10019877783695e-67	OSBPL9	Malignant cells	GSE108397	ENSG00000117859	114883	oxysterol binding protein like 9	NA	protein_coding	Q96SU4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2106
2.81282191952696e-71	-0.308554021795101	0.888	0.938	5.09008254557599e-67	CAPNS1	Malignant cells	GSE108397	ENSG00000126247	826	calpain small subunit 1	30K|CANP|CANPS|CAPN4|CDPS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2107
3.07404770459626e-71	-0.355851856816032	0.712	0.826	5.56279672623739e-67	TOLLIP	Malignant cells	GSE108397	ENSG00000078902	54472	toll interacting protein	IL-1RAcPIP	protein_coding	Q9H0E2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2108
3.33321420690883e-71	-0.401513010967781	0.509	0.666	6.03178442882222e-67	IGSF8	Malignant cells	GSE108397	ENSG00000162729	93185	immunoglobulin superfamily member 8	CD316|CD81P3|EWI2|PGRL	protein_coding	Q969P0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2109
3.47484848863526e-71	-0.32930810130918	0.247	0.444	6.28808582503436e-67	EDEM1	Malignant cells	GSE108397	ENSG00000134109	9695	ER degradation enhancing alpha-mannosidase like protein 1	EDEM|KIAA0212	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2110
4.50126368498522e-71	-0.326493966568919	0.952	0.982	8.14548676434925e-67	HNRNPD	Malignant cells	GSE108397	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2111
6.17166031248068e-71	0.469865438029831	0.981	0.972	1.1168236501465e-66	CAPN3	Malignant cells	GSE108397	ENSG00000092529	825	calpain 3	CANP3|LGMD2|LGMD2A|nCL-1|p94	protein_coding	P20807	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2112
7.98294296243313e-71	-0.381345742952003	0.461	0.631	1.4445933584819e-66	PNKP	Malignant cells	GSE108397	ENSG00000039650	11284	polynucleotide kinase 3'-phosphatase	PNK	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2113
8.00465071819586e-71	0.415308827303939	0.687	0.508	1.44852159396472e-66	Z83851.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2114
8.45712403188097e-71	-0.386437944987825	0.341	0.53	1.53040116480918e-66	LATS2	Malignant cells	GSE108397	ENSG00000150457	26524	large tumor suppressor kinase 2	NA	protein_coding	Q9NRM7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2115
9.66855432951137e-71	0.353773093024499	0.723	0.537	1.74962159146838e-66	AGGF1	Malignant cells	GSE108397	ENSG00000164252	55109	angiogenic factor with G-patch and FHA domains 1	FLJ10283|GPATC7|GPATCH7|HSU84971|VG5Q	protein_coding	Q8N302	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2116
9.76870467832874e-71	-0.308234365689901	0.934	0.975	1.76774479859037e-66	MRPL9	Malignant cells	GSE108397	ENSG00000143436	65005	mitochondrial ribosomal protein L9	NA	protein_coding	Q9BYD2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2117
1.08205534179298e-70	0.63183309416146	0.852	0.799	1.95808734650858e-66	WBP5	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2118
1.13793856448891e-70	-0.336533825876406	0.246	0.438	2.05921362629913e-66	RHBDF2	Malignant cells	GSE108397	ENSG00000129667	79651	rhomboid 5 homolog 2	FLJ22341|iRhom2|RHBDL5|RHBDL6|TOC|TOCG	protein_coding	Q6PJF5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2119
1.25932463097301e-70	-0.359178997927085	0.888	0.956	2.27887385220875e-66	TMF1	Malignant cells	GSE108397	ENSG00000144747	7110	TATA element modulatory factor 1	ARA160|TMF	protein_coding	P82094	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2120
1.45354756042816e-70	-0.367190706175563	0.632	0.775	2.63033966535079e-66	C7orf55	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2121
1.48281094154929e-70	-0.346456197605088	0.7	0.82	2.6832946798276e-66	PDS5A	Malignant cells	GSE108397	ENSG00000121892	23244	PDS5 cohesin associated factor A	KIAA0648|PIG54|SCC-112	protein_coding	Q29RF7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2122
1.70655746566344e-70	0.345016062641903	0.945	0.894	3.08818638986456e-66	CUL4A	Malignant cells	GSE108397	ENSG00000139842	8451	cullin 4A	NA	protein_coding	Q13619	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2123
1.72157821471705e-70	-0.264397387536044	0.998	1	3.11536793735197e-66	CYCS	Malignant cells	GSE108397	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2124
1.73393998000318e-70	0.317828742094448	0.973	0.947	3.13773778781376e-66	EIF4E2	Malignant cells	GSE108397	ENSG00000135930	9470	eukaryotic translation initiation factor 4E family member 2	4EHP|EIF4EL3|IF4e	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2125
1.88191689137335e-70	0.317502785286262	0.964	0.933	3.40551680662922e-66	SNAPC5	Malignant cells	GSE108397	ENSG00000174446	10302	small nuclear RNA activating complex polypeptide 5	SNAP19	protein_coding	O75971	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2126
2.33849033984923e-70	-0.390101767694696	0.442	0.615	4.23173211899117e-66	CLIP4	Malignant cells	GSE108397	ENSG00000115295	79745	CAP-Gly domain containing linker protein family member 4	FLJ21069|RSNL2	protein_coding	Q8N3C7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2127
2.47371124900465e-70	-0.332066870732424	0.262	0.46	4.47642787619882e-66	PWP2	Malignant cells	GSE108397	ENSG00000241945	5822	PWP2 small subunit processome component	EHOC-17|PWP2H|UTP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2128
3.1569240336306e-70	-0.338446057531447	0.247	0.44	5.71276973125793e-66	PFKFB3	Malignant cells	GSE108397	ENSG00000170525	5209	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	NA	protein_coding	Q16875	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2129
3.71965552579323e-70	0.356855638233964	0.704	0.526	6.73108863947543e-66	CECR7	Malignant cells	GSE108397	ENSG00000237438	NA	NA	SAHL1	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2130
5.98401998234661e-70	-0.283865196061745	0.975	0.99	1.08286825600544e-65	TYW3	Malignant cells	GSE108397	ENSG00000162623	127253	tRNA-yW synthesizing protein 3 homolog	C1orf171|FLJ40918	protein_coding	Q6IPR3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2131
6.96336643447285e-70	-0.364445653249282	0.359	0.549	1.26009078998221e-65	POGZ	Malignant cells	GSE108397	ENSG00000143442	23126	pogo transposable element derived with ZNF domain	KIAA0461|ZNF280E|ZNF635	protein_coding	Q7Z3K3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2132
7.75308375938726e-70	-0.406308698786951	0.543	0.687	1.40299803709872e-65	PHTF1	Malignant cells	GSE108397	ENSG00000116793	10745	putative homeodomain transcription factor 1	PHTF	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2133
7.90814630001694e-70	-0.373165670551115	0.383	0.564	1.43105815445107e-65	ACLY	Malignant cells	GSE108397	ENSG00000131473	47	ATP citrate lyase	ACL|ATPCL|CLATP	protein_coding	P53396	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2134
8.26848125212369e-70	0.301641852795343	0.991	0.98	1.4962643673843e-65	SEPT7	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2135
8.86102214531505e-70	-0.338979385926715	0.272	0.469	1.60349056741621e-65	TRIM24	Malignant cells	GSE108397	ENSG00000122779	8805	tripartite motif containing 24	hTIF1|RNF82|TIF1|Tif1a	protein_coding	O15164	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2136
1.01331838483928e-69	-0.344175245211985	0.353	0.546	1.83370094920516e-65	SAMD4B	Malignant cells	GSE108397	ENSG00000179134	55095	sterile alpha motif domain containing 4B	FLJ10211|hSmaug2|MGC99832|SMGB	protein_coding	Q5PRF9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2137
1.43237696350594e-69	-0.414874216955189	0.455	0.648	2.59202935316035e-65	ADM	Malignant cells	GSE108397	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2138
1.74311732160258e-69	-0.361537765141944	0.567	0.724	3.15434510517203e-65	BCAR1	Malignant cells	GSE108397	ENSG00000285460	9564	BCAR1 scaffold protein, Cas family member	CAS|CASS1|Crkas|P130Cas	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2139
2.27778912634215e-69	-0.370211079653502	0.486	0.654	4.12188720302876e-65	NKAP	Malignant cells	GSE108397	ENSG00000101882	79576	NFKB activating protein	FLJ22626	protein_coding	Q8N5F7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2140
2.48400846487984e-69	-0.355351133334185	0.714	0.834	4.49506171804656e-65	TRMT10C	Malignant cells	GSE108397	ENSG00000174173	54931	tRNA methyltransferase 10C, mitochondrial RNase P subunit	FLJ20432|MRPP1|RG9MTD1	protein_coding	Q7L0Y3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2141
2.53952504800952e-69	-0.280667934001067	0.143	0.321	4.59552452687803e-65	RWDD2B	Malignant cells	GSE108397	ENSG00000156253	10069	RWD domain containing 2B	C21orf6|GL011	protein_coding	P57060	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2142
3.84919770803861e-69	-0.380277275217308	0.487	0.662	6.96550817246667e-65	CLIP1	Malignant cells	GSE108397	ENSG00000130779	6249	CAP-Gly domain containing linker protein 1	CLIP|CLIP-170|CLIP170|CYLN1|RSN	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2143
4.19863932489715e-69	-0.360656511673388	0.615	0.76	7.59785772233388e-65	GUCD1	Malignant cells	GSE108397	ENSG00000138867	83606	guanylyl cyclase domain containing 1	C22orf13|LLN4|MGC1842	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2144
4.42631287425437e-69	0.369013451714182	0.868	0.758	8.00985577725071e-65	PDRG1	Malignant cells	GSE108397	ENSG00000088356	81572	p53 and DNA damage regulated 1	C20orf126|dJ310O13.3	protein_coding	Q9NUG6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2145
4.58054752915016e-69	-0.32968892787164	0.855	0.926	8.28895880875013e-65	RBBP4	Malignant cells	GSE108397	ENSG00000162521	5928	RB binding protein 4, chromatin remodeling factor	lin-53|NURF55|RbAp48	protein_coding	Q09028	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2146
4.98934406840192e-69	-0.327640602062939	0.782	0.885	9.02871702618011e-65	ZNF655	Malignant cells	GSE108397	ENSG00000197343	79027	zinc finger protein 655	VIK|VIK-1	protein_coding	Q8N720	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2147
5.13048715549412e-69	-0.353399166091463	0.24	0.429	9.28412955658216e-65	LTBP3	Malignant cells	GSE108397	ENSG00000168056	4054	latent transforming growth factor beta binding protein 3	LTBP2	protein_coding	Q9NS15	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2148
5.45117328241421e-69	-0.339192467843803	0.886	0.947	9.86444317185676e-65	TOP1	Malignant cells	GSE108397	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2149
7.12470464514053e-69	-0.373271040776933	0.562	0.706	1.28928655258463e-64	BBS7	Malignant cells	GSE108397	ENSG00000138686	55212	Bardet-Biedl syndrome 7	BBS2L1|FLJ10715	protein_coding	Q8IWZ6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2150
8.91845672062312e-69	-0.336123218245444	0.793	0.896	1.61388392816396e-64	CSNK1D	Malignant cells	GSE108397	ENSG00000141551	1453	casein kinase 1 delta	CKID|CKIdelta|HCKID	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2151
9.71891381391802e-69	-0.380460606135602	0.486	0.664	1.7587346437666e-64	ESYT2	Malignant cells	GSE108397	ENSG00000117868	57488	extended synaptotagmin 2	CHR2SYT|FAM62B|KIAA1228	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2152
1.14820222474321e-68	0.324797893804637	0.527	0.327	2.07778674589531e-64	TRAF3IP2-AS1	Malignant cells	GSE108397	ENSG00000231889	643749	TRAF3IP2 antisense RNA 1	BetaFAAR|C6orf3|C6UAS|NCRNA00248|TRAF3IP2-AS2	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2153
1.21578908035656e-68	-0.292751305377546	0.944	0.978	2.20009191981323e-64	PLEKHA3	Malignant cells	GSE108397	ENSG00000116095	65977	pleckstrin homology domain containing A3	FAPP1	protein_coding	Q9HB20	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2154
1.56542307152334e-68	-0.29320752546377	0.953	0.981	2.83278959022864e-64	FAM104A	Malignant cells	GSE108397	ENSG00000133193	84923	family with sequence similarity 104 member A	FLJ14775	protein_coding	Q969W3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2155
1.78265867934328e-68	0.312314463453229	0.439	0.243	3.2258991461396e-64	YTHDF3-AS1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2156
1.81380069340799e-68	-0.280896373373063	0.143	0.323	3.2822537347911e-64	ETV3	Malignant cells	GSE108397	ENSG00000117036	2117	ETS variant transcription factor 3	PE-1	protein_coding	P41162	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2157
1.93897395640714e-68	-0.305966900660407	0.952	0.983	3.50876727151436e-64	TCEB3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2158
1.9756402729312e-68	-0.353499619513899	0.936	0.974	3.5751186378963e-64	RRBP1	Malignant cells	GSE108397	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2159
2.00389002568178e-68	-0.345757170326875	0.682	0.806	3.62623939047375e-64	SH3GL1	Malignant cells	GSE108397	ENSG00000141985	6455	SH3 domain containing GRB2 like 1, endophilin A2	CNSA1|EEN|MGC111371|SH3D2B|SH3P8	protein_coding	Q99961	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2160
2.21429169195925e-68	-0.383199656875099	0.494	0.671	4.00698224576945e-64	CUL1	Malignant cells	GSE108397	ENSG00000055130	8454	cullin 1	NA	protein_coding	Q13616	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2161
2.23170883602713e-68	-0.37093217747546	0.63	0.768	4.0385003096747e-64	GCC2	Malignant cells	GSE108397	ENSG00000135968	9648	GRIP and coiled-coil domain containing 2	GCC185|KIAA0336	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2162
2.88748588225785e-68	0.291765435921326	0.303	0.13	5.2251944525338e-64	TRIM51	Malignant cells	GSE108397	ENSG00000124900	84767	tripartite motif-containing 51	SPRYD5|TRIM51A	protein_coding	Q9BSJ1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2163
2.90032451940001e-68	0.332111450611067	0.999	0.996	5.24842725030625e-64	SPARC	Malignant cells	GSE108397	ENSG00000113140	6678	secreted protein acidic and cysteine rich	BM-40|ON|ONT	protein_coding	P09486	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2164
2.99304406900838e-68	0.32498458647986	0.967	0.919	5.41621254727757e-64	UPF3A	Malignant cells	GSE108397	ENSG00000169062	65110	UPF3A regulator of nonsense mediated mRNA decay	HUPF3A|RENT3A|UPF3	protein_coding	Q9H1J1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2165
3.00200483310261e-68	0.253535012951339	0.998	0.995	5.43242794598249e-64	ATRAID	Malignant cells	GSE108397	ENSG00000138085	51374	all-trans retinoic acid induced differentiation factor	APR3|C2orf28|HSPC013|p18	protein_coding	Q6UW56	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2166
3.28171943609176e-68	-0.331686592042819	0.807	0.892	5.93859949155165e-64	AIMP1	Malignant cells	GSE108397	ENSG00000164022	9255	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	EMAP-2|EMAPII|p43|SCYE1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2167
3.53473560484816e-68	0.340555109296627	0.571	0.371	6.39645755053324e-64	MAP6D1	Malignant cells	GSE108397	ENSG00000180834	79929	MAP6 domain containing 1	FLJ12748|SL21	protein_coding	Q9H9H5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2168
3.66708028797088e-68	-0.282252179053705	0.945	0.978	6.6359484891121e-64	HDAC3	Malignant cells	GSE108397	ENSG00000171720	8841	histone deacetylase 3	HD3|KDAC3|RPD3|RPD3-2	protein_coding	O15379	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2169
4.31749571242921e-68	-0.316373184214888	0.884	0.944	7.81294024121191e-64	NUP50	Malignant cells	GSE108397	ENSG00000093000	10762	nucleoporin 50	NPAP60L	protein_coding	Q9UKX7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2170
4.94892690136887e-68	0.288436778414434	0.354	0.169	8.95557812071711e-64	TTLL7	Malignant cells	GSE108397	ENSG00000137941	79739	tubulin tyrosine ligase like 7	FLJ23033	protein_coding	Q6ZT98	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2171
5.39380249208688e-68	-0.316141998053867	0.251	0.44	9.76062498968042e-64	RP5-940J5.9	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2172
5.74189085097216e-68	-0.330723214870865	0.769	0.864	1.03905256839192e-63	SCAF11	Malignant cells	GSE108397	ENSG00000139218	9169	SR-related CTD associated factor 11	CASP11|SFRS2IP|SIP1|SRRP129|SRSF2IP	protein_coding	Q99590	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2173
8.41754955122278e-68	-0.355157247387772	0.458	0.635	1.52323976678927e-63	GPD2	Malignant cells	GSE108397	ENSG00000115159	2820	glycerol-3-phosphate dehydrogenase 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2174
1.06197881855425e-67	0.340578599881884	0.869	0.771	1.92175687005577e-63	C14orf142	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2175
1.10573182915363e-67	0.338059036958723	0.596	0.403	2.00093231803641e-63	TIPIN	Malignant cells	GSE108397	ENSG00000075131	54962	TIMELESS interacting protein	FLJ20516	protein_coding	Q9BVW5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2176
1.56870240226066e-67	-0.374671235243848	0.51	0.669	2.83872386713089e-63	CTPS1	Malignant cells	GSE108397	ENSG00000171793	1503	CTP synthase 1	CTPS|GATD5A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2177
1.94902072707979e-67	-0.308993868100409	0.95	0.977	3.52694790772359e-63	SSR1	Malignant cells	GSE108397	ENSG00000124783	6745	signal sequence receptor subunit 1	TRAPA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2178
2.86780362770157e-67	-0.329145676733543	0.924	0.965	5.18957744468876e-63	SLC25A37	Malignant cells	GSE108397	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2179
3.02267361400506e-67	0.316234466245635	0.478	0.282	5.46983017190356e-63	EIF3J-AS1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2180
3.25809189248993e-67	0.357424801298902	0.674	0.482	5.89584308864978e-63	IQCB1	Malignant cells	GSE108397	ENSG00000173226	9657	IQ motif containing B1	KIAA0036|NPHP5|SLSN5	protein_coding	Q15051	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2181
3.59394834088467e-67	-0.33458895795738	0.695	0.809	6.50360891766489e-63	ZDHHC24	Malignant cells	GSE108397	ENSG00000174165	254359	zinc finger DHHC-type containing 24	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2182
3.92609722752438e-67	-0.343875648179615	0.363	0.554	7.10466554292812e-63	BAZ2A	Malignant cells	GSE108397	ENSG00000076108	11176	bromodomain adjacent to zinc finger domain 2A	KIAA0314|TIP5|WALp3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2183
4.1177869969316e-67	-0.364257721600058	0.677	0.791	7.45154734964742e-63	VCP	Malignant cells	GSE108397	ENSG00000165280	7415	valosin containing protein	CDC48|IBMPFD|p97|TERA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2184
4.98671795606275e-67	-0.274667738255685	0.998	1	9.02396481329115e-63	LINC00152	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2185
5.97400747820715e-67	-0.334092937924683	0.788	0.872	1.08105639325637e-62	APITD1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2186
6.34763418365363e-67	-0.356524691104123	0.33	0.516	1.14866788187396e-62	EPB41	Malignant cells	GSE108397	ENSG00000159023	2035	erythrocyte membrane protein band 4.1	4.1R|EL1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2187
6.44325172043301e-67	-0.359025531123381	0.591	0.734	1.16597083132956e-62	PTPN18	Malignant cells	GSE108397	ENSG00000072135	26469	protein tyrosine phosphatase non-receptor type 18	BDP1	protein_coding	Q99952	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2188
6.68015740811394e-67	0.27200570570176	0.998	0.996	1.2088412845723e-62	PARL	Malignant cells	GSE108397	ENSG00000175193	55486	presenilin associated rhomboid like	PRO2207|PSARL|PSARL1|RHBDS1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2189
6.93501235743511e-67	0.274791404700311	0.998	0.997	1.25495983620146e-62	AHCY	Malignant cells	GSE108397	ENSG00000101444	191	adenosylhomocysteinase	AdoHcyase|SAHH	protein_coding	P23526	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2190
7.41958358964472e-67	-0.33172232798954	0.782	0.876	1.34264784638211e-62	CBFB	Malignant cells	GSE108397	ENSG00000067955	865	core-binding factor subunit beta	PEBP2B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2191
8.15450175949341e-67	0.363037157768974	0.805	0.676	1.47563863839793e-62	CUEDC2	Malignant cells	GSE108397	ENSG00000107874	79004	CUE domain containing 2	C10orf66|MGC2491	protein_coding	Q9H467	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2192
8.57837009469442e-67	-0.297330167978251	0.158	0.335	1.5523418523359e-62	SH3PXD2B	Malignant cells	GSE108397	ENSG00000174705	285590	SH3 and PX domains 2B	FLJ20831|KIAA1295	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2193
9.16756325991424e-67	0.300211049904975	0.395	0.209	1.65896224751408e-62	DDX28	Malignant cells	GSE108397	ENSG00000182810	55794	DEAD-box helicase 28	FLJ11282|MDDX28	protein_coding	Q9NUL7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2194
9.24506632754212e-67	-0.265592919886543	0.979	0.994	1.67298720263202e-62	HSPB11	Malignant cells	GSE108397	ENSG00000081870	51668	heat shock protein family B (small) member 11	C1orf41|FAP232|HSPCO34|IFT25|PP25	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2195
1.12437920508298e-66	-0.366765784085273	0.571	0.708	2.03467660951817e-62	G3BP2	Malignant cells	GSE108397	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2196
1.80101357739093e-66	0.307441870927835	0.982	0.977	3.25911416964662e-62	MRPL47	Malignant cells	GSE108397	ENSG00000136522	57129	mitochondrial ribosomal protein L47	CGI-204|NCM1	protein_coding	Q9HD33	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2197
2.08700601602353e-66	-0.312022787212899	0.826	0.909	3.77664608659618e-62	ARL2BP	Malignant cells	GSE108397	ENSG00000102931	23568	ADP ribosylation factor like GTPase 2 binding protein	BART|BART1|RP66	protein_coding	Q9Y2Y0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2198
2.28756985407761e-66	-0.361053774510262	0.331	0.515	4.13958640793885e-62	BSDC1	Malignant cells	GSE108397	ENSG00000160058	55108	BSD domain containing 1	FLJ10276|RP4-811H24.7	protein_coding	Q9NW68	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2199
3.02343008786704e-66	-0.345922340920126	0.682	0.804	5.47119908700419e-62	MAP4	Malignant cells	GSE108397	ENSG00000047849	4134	microtubule associated protein 4	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2200
4.08780185434095e-66	0.325977277637282	0.59	0.396	7.39728623561539e-62	WDR73	Malignant cells	GSE108397	ENSG00000177082	84942	WD repeat domain 73	FLJ14888|HSPC264	protein_coding	Q6P4I2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2201
4.09045489217022e-66	-0.323831846307638	0.257	0.445	7.40208717287122e-62	BHLHE40	Malignant cells	GSE108397	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2202
4.54266401494599e-66	-0.367130293588503	0.429	0.603	8.22040480144626e-62	FTSJ3	Malignant cells	GSE108397	ENSG00000108592	117246	FtsJ RNA 2'-O-methyltransferase 3	SPB1	protein_coding	Q8IY81	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2203
4.58362606544959e-66	0.350651139835812	0.859	0.729	8.29452972803759e-62	N4BP2L2	Malignant cells	GSE108397	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2204
5.9002356459915e-66	-0.298085657769265	0.886	0.941	1.06770664249862e-61	YKT6	Malignant cells	GSE108397	ENSG00000106636	10652	YKT6 v-SNARE homolog	NA	protein_coding	O15498	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2205
6.13015621051902e-66	-0.266221342637839	0.988	0.995	1.10931306785552e-61	GGCT	Malignant cells	GSE108397	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2206
6.45903733654259e-66	-0.402981471337265	0.539	0.695	1.16882739642075e-61	VASP	Malignant cells	GSE108397	ENSG00000125753	7408	vasodilator stimulated phosphoprotein	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2207
6.92118331144843e-66	-0.360536437796526	0.204	0.388	1.25245733203971e-61	SLC22A18AS	Malignant cells	GSE108397	ENSG00000274454	5003	SLC22A18 antisense RNA	BWR1B|BWSCR1B|ORCTL2S|p27-BWR1B|SLC22A18-AS1|SLC22A1LS	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2208
7.74333961414813e-66	-0.36317442040217	0.612	0.76	1.40123473657625e-61	CDK2	Malignant cells	GSE108397	ENSG00000123374	1017	cyclin dependent kinase 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2209
9.3294866023649e-66	-0.34346692942164	0.333	0.518	1.68826389556395e-61	PPP1R37	Malignant cells	GSE108397	ENSG00000104866	284352	protein phosphatase 1 regulatory subunit 37	LRRC68	protein_coding	O75864	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2210
1.03556916866969e-65	0.339321635712636	0.526	0.335	1.87396596762466e-61	FAXC	Malignant cells	GSE108397	ENSG00000146267	84553	failed axon connections homolog, metaxin like GST domain containing	C6orf168|dJ273F20|MGC2817	protein_coding	Q5TGI0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2211
1.03894728038086e-65	-0.361041958786618	0.558	0.703	1.88007899857721e-61	SMARCC1	Malignant cells	GSE108397	ENSG00000173473	6599	SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1	BAF155|CRACC1|Rsc8|SRG3	protein_coding	Q92922	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2212
1.166998864381e-65	-0.36432838975414	0.638	0.764	2.11180114498387e-61	MBOAT7	Malignant cells	GSE108397	ENSG00000275118	79143	membrane bound O-acyltransferase domain containing 7	BB1|hMBOA-7|LENG4|LPIAT1|LPLAT|LPLAT11	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2213
1.22771451895469e-65	-0.311479332995292	0.932	0.968	2.2216721935004e-61	SLC35B2	Malignant cells	GSE108397	ENSG00000157593	347734	solute carrier family 35 member B2	UGTrel4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2214
1.32945072496836e-65	-0.296146938022953	0.194	0.377	2.40577403190274e-61	EYA4	Malignant cells	GSE108397	ENSG00000112319	2070	EYA transcriptional coactivator and phosphatase 4	CMD1J|DFNA10	protein_coding	O95677	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2215
1.36092190651833e-65	-0.324618196251093	0.681	0.796	2.46272428203557e-61	BECN1	Malignant cells	GSE108397	ENSG00000126581	8678	beclin 1	ATG6|VPS30	protein_coding	Q14457	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2216
1.51783349908931e-65	-0.329257136347968	0.809	0.894	2.74667149995202e-61	CRK	Malignant cells	GSE108397	ENSG00000167193	1398	CRK proto-oncogene, adaptor protein	NA	protein_coding	P46108	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2217
1.63515370535371e-65	0.314792701985183	0.986	0.987	2.95897414520807e-61	C19orf48	Malignant cells	GSE108397	ENSG00000167747	84798	multidrug resistance-related protein	BC006151|MGC13170	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2218
2.56541689185973e-65	-0.32036863445939	0.25	0.437	4.64237840750937e-61	ATP6V0A1	Malignant cells	GSE108397	ENSG00000033627	535	ATPase H+ transporting V0 subunit a1	a1|ATP6N1|ATP6N1A|Stv1|Vph1|VPP1	protein_coding	Q93050	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2219
2.84994775055251e-65	-0.349521616663307	0.381	0.563	5.15726544939981e-61	NOP2	Malignant cells	GSE108397	ENSG00000111641	4839	NOP2 nucleolar protein	NOL1|NOP120|NSUN1|p120	protein_coding	P46087	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2220
3.01308238597707e-65	-0.402840546801509	0.347	0.53	5.45247388566411e-61	PPP3CA	Malignant cells	GSE108397	ENSG00000138814	5530	protein phosphatase 3 catalytic subunit alpha	CALN|CALNA|CNA1|PPP2B	protein_coding	Q08209	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2221
3.0324379473083e-65	-0.385072134206353	0.698	0.798	5.4874997094491e-61	MCM5	Malignant cells	GSE108397	ENSG00000100297	4174	minichromosome maintenance complex component 5	CDC46	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2222
3.09769846745583e-65	-0.31871286391962	0.815	0.883	5.60559514670806e-61	ATPAF1	Malignant cells	GSE108397	ENSG00000123472	64756	ATP synthase mitochondrial F1 complex assembly factor 1	ATP11|Atp11p|FLJ22351	protein_coding	Q5TC12	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2223
3.18014050793562e-65	-0.327491277125029	0.782	0.869	5.75478226316029e-61	PCGF2	Malignant cells	GSE108397	ENSG00000278644	7703	polycomb group ring finger 2	MEL-18|RNF110|ZNF144	protein_coding	P35227	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2224
3.20217247838603e-65	-0.330531297560697	0.269	0.456	5.79465131688736e-61	NAA35	Malignant cells	GSE108397	ENSG00000135040	60560	N-alpha-acetyltransferase 35, NatC auxiliary subunit	bA379P1.1|FLJ21613|FLJ22643|MAK10	protein_coding	Q5VZE5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2225
3.31234664535452e-65	-0.32892593697254	0.326	0.512	5.99402248943353e-61	SLC25A24	Malignant cells	GSE108397	ENSG00000284468	29957	solute carrier family 25 member 24	APC1|DKFZp586G0123	protein_coding	Q6NUK1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2226
3.50008567702141e-65	-0.318044544855162	0.848	0.927	6.33375504113794e-61	LRRC58	Malignant cells	GSE108397	ENSG00000163428	116064	leucine rich repeat containing 58	NA	protein_coding	Q96CX6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2227
3.78746656652222e-65	-0.250745371119482	0.108	0.271	6.85379949877861e-61	IL27RA	Malignant cells	GSE108397	ENSG00000288185	9466	interleukin 27 receptor subunit alpha	CRL1|IL-27R|TCCR|WSX-1|WSX1|zcytor1	protein_coding	Q6UWB1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2228
3.89461593860717e-65	-0.364358167312107	0.746	0.857	7.04769700250354e-61	TBL1XR1	Malignant cells	GSE108397	ENSG00000177565	79718	TBL1X/Y related 1	C21|DC42|FLJ12894|IRA1|TBLR1	protein_coding	Q9BZK7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2229
4.15038868931937e-65	0.378745541650189	0.902	0.82	7.51054337219233e-61	CSRP1	Malignant cells	GSE108397	ENSG00000159176	1465	cysteine and glycine rich protein 1	CSRP|CYRP|D1S181E	protein_coding	P21291	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2230
4.29015115910769e-65	-0.342015315107107	0.712	0.83	7.76345753752128e-61	LSM14A	Malignant cells	GSE108397	ENSG00000262860	26065	LSM14A mRNA processing body assembly factor	C19orf13|DKFZP434D1335|FAM61A|RAP55|RAP55A	protein_coding	Q8ND56	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2231
4.57017095321796e-65	-0.250200165121985	0.98	0.996	8.27018135694323e-61	CYB5R3	Malignant cells	GSE108397	ENSG00000100243	1727	cytochrome b5 reductase 3	DIA1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2232
4.74854257615119e-65	0.254151812209377	0.271	0.109	8.5929626458032e-61	DLX4	Malignant cells	GSE108397	ENSG00000108813	1748	distal-less homeobox 4	BP1|DLX7|DLX8|DLX9	protein_coding	Q92988	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2233
4.91156761675613e-65	-0.346583653546352	0.295	0.484	8.8879727592819e-61	PTPRE	Malignant cells	GSE108397	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2234
6.65991423808186e-65	-0.29302988671192	0.189	0.369	1.20517808052329e-60	LSS	Malignant cells	GSE108397	ENSG00000281289	4047	lanosterol synthase	OSC	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2235
7.23466364096027e-65	0.316019941165247	0.785	0.625	1.30918473246817e-60	MED21	Malignant cells	GSE108397	ENSG00000152944	9412	mediator complex subunit 21	SRB7|SURB7	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2236
9.86380227620244e-65	-0.333554032023671	0.698	0.808	1.78495365990159e-60	NSUN5	Malignant cells	GSE108397	ENSG00000130305	55695	NOP2/Sun RNA methyltransferase 5	FLJ10267|NOL1R|NSUN5A|p120(NOL1)|WBSCR20|WBSCR20A|Ynl022cL	protein_coding	Q96P11	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2237
1.12045021743395e-64	-0.422632213911649	0.45	0.64	2.02756671346847e-60	RASSF3	Malignant cells	GSE108397	ENSG00000153179	283349	Ras association domain family member 3	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2238
1.50843915642069e-64	-0.293691586298245	0.19	0.372	2.72967149745887e-60	RAB3IL1	Malignant cells	GSE108397	ENSG00000167994	5866	RAB3A interacting protein like 1	GRAB	protein_coding	Q8TBN0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2239
1.5243803155362e-64	-0.338044896177271	0.601	0.747	2.7585186189943e-60	OGFR	Malignant cells	GSE108397	ENSG00000060491	11054	opioid growth factor receptor	7-60	protein_coding	Q9NZT2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2240
1.65523424378837e-64	-0.251935338282723	0.999	0.999	2.99531188755943e-60	PSMC5	Malignant cells	GSE108397	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2241
1.69146337609578e-64	0.345507945056001	0.51	0.313	3.06087212538292e-60	TMEM121	Malignant cells	GSE108397	ENSG00000184986	80757	transmembrane protein 121	hole|MGC4659|TMEM121A	protein_coding	Q9BTD3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2242
1.71641030365136e-64	-0.363707801710309	0.524	0.678	3.10601608548751e-60	CREBL2	Malignant cells	GSE108397	ENSG00000111269	1389	cAMP responsive element binding protein like 2	NA	protein_coding	O60519	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2243
1.72266561429197e-64	0.425725419725207	0.95	0.923	3.11733569562276e-60	IFI16	Malignant cells	GSE108397	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2244
1.73054251551379e-64	-0.316698510096816	0.772	0.862	3.13158973607376e-60	DSCR3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2245
1.76753246388247e-64	0.359553115327903	0.975	0.977	3.19852674664171e-60	RGS20	Malignant cells	GSE108397	ENSG00000147509	8601	regulator of G protein signaling 20	RGSZ1|ZGAP1	protein_coding	O76081	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2246
2.03541017351029e-64	-0.288918012546212	0.923	0.972	3.68327824998423e-60	DCUN1D5	Malignant cells	GSE108397	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2247
2.18384030983401e-64	0.317824794906994	0.458	0.268	3.95187742467563e-60	TGDS	Malignant cells	GSE108397	ENSG00000088451	23483	TDP-glucose 4,6-dehydratase	SDR2E1|TDPGD	protein_coding	O95455	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2248
2.43609050452633e-64	0.346152631357851	0.953	0.917	4.40834937699085e-60	FAM101B	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2249
2.84033730728104e-64	-0.310044139184143	0.848	0.912	5.13987439125577e-60	ILKAP	Malignant cells	GSE108397	ENSG00000132323	80895	ILK associated serine/threonine phosphatase	DKFZP434J2031|FLJ10181|PPM1O	protein_coding	Q9H0C8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2250
3.18185687393538e-64	-0.342700167177598	0.744	0.85	5.75788819907346e-60	GMNN	Malignant cells	GSE108397	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2251
3.1860240038128e-64	-0.256352623700095	0.124	0.291	5.76542903729964e-60	C19orf83	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2252
4.00757102624084e-64	-0.388028425677921	0.436	0.607	7.25210052908543e-60	CDC6	Malignant cells	GSE108397	ENSG00000094804	990	cell division cycle 6	CDC18L	protein_coding	Q99741	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2253
4.07114524575607e-64	-0.326202376022783	0.296	0.481	7.36714443672019e-60	NFKB1	Malignant cells	GSE108397	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2254
4.23048537299197e-64	-0.348775936318858	0.774	0.872	7.65548633096628e-60	YARS	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2255
4.49041909707723e-64	-0.368005262019489	0.578	0.721	8.12586239807096e-60	MLXIP	Malignant cells	GSE108397	ENSG00000281178	22877	MLX interacting protein	bHLHe36|KIAA0867|MIR|MONDOA	protein_coding	Q9HAP2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2256
4.76225594914674e-64	0.337701240352073	0.863	0.744	8.61777836557595e-60	SRPRB	Malignant cells	GSE108397	ENSG00000144867	58477	SRP receptor subunit beta	APMCF1|SR-beta	protein_coding	Q9Y5M8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2257
4.96401746389383e-64	-0.362385986993114	0.495	0.659	8.98288600266228e-60	HTATSF1	Malignant cells	GSE108397	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2258
4.96997372696285e-64	-0.338742452983261	0.933	0.985	8.99366445631198e-60	CAPZA1	Malignant cells	GSE108397	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2259
5.7169265915241e-64	0.353584902365015	0.778	0.638	1.0345350360022e-59	DNAJC21	Malignant cells	GSE108397	ENSG00000168724	134218	DnaJ heat shock protein family (Hsp40) member C21	DNAJA5|GS3|JJJ1	protein_coding	Q5F1R6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2260
5.76719611958102e-64	-0.251765479140491	0.994	0.998	1.04363180979938e-59	UFD1L	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2261
6.69299184353976e-64	0.275790359526142	0.975	0.954	1.21116380400695e-59	UFC1	Malignant cells	GSE108397	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2262
8.75091787142307e-64	-0.25719015225476	0.113	0.274	1.58356609801272e-59	CDK5R1	Malignant cells	GSE108397	ENSG00000176749	8851	cyclin dependent kinase 5 regulatory subunit 1	Nck5a|p35|p35nck5a	protein_coding	Q15078	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2263
1.06018828458265e-63	-0.293690771007872	0.926	0.97	1.91851671978075e-59	ERCC1	Malignant cells	GSE108397	ENSG00000012061	2067	ERCC excision repair 1, endonuclease non-catalytic subunit	RAD10	protein_coding	P07992	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2264
1.07778158102462e-63	-0.319812928516097	0.741	0.847	1.95035354902215e-59	MTFR1L	Malignant cells	GSE108397	ENSG00000117640	56181	mitochondrial fission regulator 1 like	FAM54B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2265
1.11096754825517e-63	-0.349832840579252	0.367	0.544	2.01040687532255e-59	POR	Malignant cells	GSE108397	ENSG00000127948	5447	cytochrome p450 oxidoreductase	CYPOR|FLJ26468	protein_coding	P16435	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2266
1.24617277356919e-63	0.25405378438877	0.29	0.125	2.25507425105081e-59	IL17D	Malignant cells	GSE108397	ENSG00000172458	53342	interleukin 17D	FLJ30846|IL-17D|IL-27|IL27	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2267
1.57705671231534e-63	-0.380375241857811	0.695	0.802	2.85384182660584e-59	LSR	Malignant cells	GSE108397	ENSG00000105699	51599	lipolysis stimulated lipoprotein receptor	ILDR3|LISCH7	protein_coding	Q86X29	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2268
1.65254612907598e-63	-0.364993417031966	0.472	0.629	2.9904474751759e-59	LARP7	Malignant cells	GSE108397	ENSG00000174720	51574	La ribonucleoprotein 7, transcriptional regulator	DKFZP564K112|HDCMA18P|PIP7S	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2269
1.72441381310608e-63	-0.326999198818008	0.87	0.932	3.12049923619676e-59	CHD1	Malignant cells	GSE108397	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2270
1.85249855385897e-63	0.360436094277063	0.708	0.543	3.3522813830632e-59	NIPBL	Malignant cells	GSE108397	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2271
2.07635461215732e-63	-0.342391887881275	0.372	0.551	3.75737130615988e-59	ANKRD13D	Malignant cells	GSE108397	ENSG00000172932	338692	ankyrin repeat domain 13D	NA	protein_coding	Q6ZTN6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2272
2.34134811880369e-63	0.273187353988953	0.364	0.182	4.23690355578716e-59	RP11-486G15.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2273
2.4689433773759e-63	-0.3109174317113	0.95	0.983	4.46779993569943e-59	FAM89A	Malignant cells	GSE108397	ENSG00000182118	375061	family with sequence similarity 89 member A	C1orf153|MGC15887	protein_coding	Q96GI7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2274
3.11897554546254e-63	-0.376474636376134	0.761	0.86	5.64409814706901e-59	TMEM33	Malignant cells	GSE108397	ENSG00000109133	55161	transmembrane protein 33	FLJ10525|Pom33	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2275
3.16951876415064e-63	-0.370395968310625	0.626	0.772	5.735561155607e-59	CNN2	Malignant cells	GSE108397	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2276
3.78369666046015e-63	0.29072439744763	0.414	0.23	6.84697747676869e-59	MIPEP	Malignant cells	GSE108397	ENSG00000027001	4285	mitochondrial intermediate peptidase	MIP	protein_coding	Q99797	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2277
4.78629756100016e-63	0.311423525957558	0.944	0.897	8.66128406638589e-59	MPLKIP	Malignant cells	GSE108397	ENSG00000168303	136647	M-phase specific PLK1 interacting protein	C7orf11|ORF20|TTDN1	protein_coding	Q8TAP9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2278
4.83542134003814e-63	-0.351404924533256	0.482	0.646	8.75017845693302e-59	RRAS2	Malignant cells	GSE108397	ENSG00000133818	22800	RAS related 2	TC21	protein_coding	P62070	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2279
5.13328428355153e-63	-0.356553972773971	0.633	0.772	9.28919123951484e-59	IARS	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2280
5.17911210235114e-63	0.355547642607091	0.57	0.381	9.37212126041463e-59	SNHG10	Malignant cells	GSE108397	ENSG00000247092	283596	small nucleolar RNA host gene 10	C14orf62|FLJ40557|LINC00063|NCRNA00063|TP53LC16	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2281
5.25718562863374e-63	-0.273619240916794	0.922	0.966	9.51340311357562e-59	UBA2	Malignant cells	GSE108397	ENSG00000126261	10054	ubiquitin like modifier activating enzyme 2	FLJ13058|HRIHFB2115|SAE2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2282
5.74339924418241e-63	-0.306138877477034	0.181	0.359	1.03932552722725e-58	GPC6	Malignant cells	GSE108397	ENSG00000183098	10082	glypican 6	NA	protein_coding	Q9Y625	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2283
5.91966233337462e-63	-0.261520235407975	0.992	0.998	1.07122209584747e-58	RPS27L	Malignant cells	GSE108397	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2284
6.98581524446784e-63	0.317657037295785	0.331	0.159	1.2641531266389e-58	HAS2	Malignant cells	GSE108397	ENSG00000170961	3037	hyaluronan synthase 2	NA	protein_coding	Q92819	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2285
7.86539918989455e-63	0.28239327721508	0.984	0.983	1.42332263740332e-58	EMG1	Malignant cells	GSE108397	ENSG00000126749	10436	EMG1 N1-specific pseudouridine methyltransferase	C2F|Grcc2f|NEP1	protein_coding	Q92979	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2286
8.07253070950856e-63	-0.259594298343803	0.992	0.997	1.46080515719267e-58	CLTA	Malignant cells	GSE108397	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2287
9.04347446928797e-63	0.332447970995464	0.589	0.403	1.63650713996235e-58	THG1L	Malignant cells	GSE108397	ENSG00000113272	54974	tRNA-histidine guanylyltransferase 1 like	FLJ11601|FLJ20546|hTHG1|ICF45|IHG-1	protein_coding	Q9NWX6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2288
9.41765782307276e-63	-0.305790257390721	0.256	0.441	1.70421935966325e-58	FLYWCH1	Malignant cells	GSE108397	ENSG00000059122	84256	FLYWCH-type zinc finger 1	DKFZp761A132	protein_coding	Q4VC44	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2289
1.10062522136981e-62	-0.265432671297366	0.102	0.26	1.99169140059081e-58	TGM2	Malignant cells	GSE108397	ENSG00000198959	7052	transglutaminase 2	TGC	protein_coding	P21980	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2290
1.12210469891655e-62	-0.295367084348593	0.219	0.402	2.0305606631594e-58	C2CD2	Malignant cells	GSE108397	ENSG00000157617	25966	C2 calcium dependent domain containing 2	C21orf25|C21orf258|DKFZP586F0422|TMEM24L	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2291
1.32567950016582e-62	-0.313575247108866	0.787	0.877	2.39894962350007e-58	DLGAP4	Malignant cells	GSE108397	ENSG00000080845	22839	DLG associated protein 4	DAP4|KIAA0964|SAPAP4	protein_coding	Q9Y2H0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2292
1.40897626314121e-62	-0.271959282359198	0.963	0.988	2.54968344578033e-58	CSNK2B	Malignant cells	GSE108397	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2293
1.42221796721231e-62	0.332450249914839	0.926	0.874	2.5736456334674e-58	ECI1	Malignant cells	GSE108397	ENSG00000167969	1632	enoyl-CoA delta isomerase 1	DCI	protein_coding	P42126	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2294
1.56359957829425e-62	0.257960067221958	0.996	0.994	2.82948979688128e-58	TUFM	Malignant cells	GSE108397	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2295
1.71051589194965e-62	-0.349332358173718	0.332	0.511	3.09534955807209e-58	TAF15	Malignant cells	GSE108397	ENSG00000276833	8148	TATA-box binding protein associated factor 15	hTAFII68|Npl3|RBP56|TAF2N	protein_coding	Q92804	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2296
1.72229796149736e-62	-0.355077200130398	0.565	0.703	3.11667039112562e-58	UBE2Q1	Malignant cells	GSE108397	ENSG00000160714	55585	ubiquitin conjugating enzyme E2 Q1	NICE-5|PRO3094|UBE2Q	protein_coding	Q7Z7E8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2297
1.94948008714933e-62	-0.339680735342554	0.761	0.86	3.52777916570543e-58	IMMT	Malignant cells	GSE108397	ENSG00000132305	10989	inner membrane mitochondrial protein	HMP|Mic60|MICOS60|MINOS2|P87|P89	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2298
2.19897526590129e-62	-0.255661507363566	0.968	0.991	3.97926564117498e-58	STARD7	Malignant cells	GSE108397	ENSG00000084090	56910	StAR related lipid transfer domain containing 7	GTT1	protein_coding	Q9NQZ5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2299
2.23448294022641e-62	-0.290929077405566	0.911	0.958	4.04352032863371e-58	TMEM9B	Malignant cells	GSE108397	ENSG00000175348	56674	TMEM9 domain family member B	C11orf15	protein_coding	Q9NQ34	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2300
3.24626967148983e-62	-0.362359968160824	0.405	0.574	5.874449597528e-58	STK10	Malignant cells	GSE108397	ENSG00000072786	6793	serine/threonine kinase 10	LOK|PRO2729	protein_coding	O94804	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2301
3.73076406121177e-62	-0.296938883504585	0.961	0.978	6.75119064516882e-58	DERA	Malignant cells	GSE108397	ENSG00000023697	51071	deoxyribose-phosphate aldolase	CGI-26|DEOC	protein_coding	Q9Y315	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2302
3.75734294604525e-62	-0.367737028614744	0.481	0.634	6.79928779516348e-58	AFAP1L1	Malignant cells	GSE108397	ENSG00000157510	134265	actin filament associated protein 1 like 1	FLJ36748	protein_coding	Q8TED9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2303
3.93704550125159e-62	-0.348882957401934	0.513	0.666	7.12447753906489e-58	UBE3C	Malignant cells	GSE108397	ENSG00000009335	9690	ubiquitin protein ligase E3C	KIAA0010|KIAA10	protein_coding	Q15386	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2304
3.99623462179578e-62	0.330205134936196	0.353	0.18	7.23158617160164e-58	PCDH7	Malignant cells	GSE108397	ENSG00000169851	5099	protocadherin 7	BH-Pcdh|PPP1R120	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2305
4.42691987735738e-62	-0.280882598882454	0.166	0.339	8.01095421006591e-58	CCDC88B	Malignant cells	GSE108397	ENSG00000168071	283234	coiled-coil domain containing 88B	BRLZ|CCDC88|FLJ00354|FLJ37970|GIPIE|HkRP3	protein_coding	A6NC98	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2306
5.74854375422132e-62	0.295591143235283	0.95	0.914	1.04025647776389e-57	URM1	Malignant cells	GSE108397	ENSG00000167118	81605	ubiquitin related modifier 1	C9orf74|MGC2668	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2307
5.9900422044979e-62	-0.34418811040459	0.343	0.519	1.08395803732594e-57	BRWD1	Malignant cells	GSE108397	ENSG00000185658	54014	bromodomain and WD repeat domain containing 1	C21orf107|DCAF19|FLJ11315|N143|WDR9	protein_coding	Q9NSI6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2308
6.44699496854238e-62	-0.338404739800392	0.548	0.697	1.16664820950743e-57	COPA	Malignant cells	GSE108397	ENSG00000122218	1314	COPI coat complex subunit alpha	HEP-COP	protein_coding	P53621	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2309
6.5124611217406e-62	0.317237036472242	0.636	0.452	1.17849496459018e-57	KIAA1143	Malignant cells	GSE108397	ENSG00000281665	57456	KIAA1143	NA	protein_coding	Q96AT1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2310
7.71878983447838e-62	-0.401862282901572	0.74	0.845	1.39679220844721e-57	PIK3R3	Malignant cells	GSE108397	ENSG00000117461	8503	phosphoinositide-3-kinase regulatory subunit 3	p55	protein_coding	Q92569	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2311
8.85698642647024e-62	-0.339108196131586	0.598	0.745	1.60276026373405e-57	BET1	Malignant cells	GSE108397	ENSG00000105829	10282	Bet1 golgi vesicular membrane trafficking protein	hbet1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2312
8.92972396458963e-62	-0.357621124007889	0.401	0.575	1.61592284863214e-57	KIF21A	Malignant cells	GSE108397	ENSG00000139116	55605	kinesin family member 21A	FEOM1|FLJ20052	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2313
9.36395242594822e-62	-0.391284029191507	0.691	0.804	1.69450083099959e-57	ST3GAL6	Malignant cells	GSE108397	ENSG00000064225	10402	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	SIAT10|ST3GALVI	protein_coding	Q9Y274	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2314
1.03671978933313e-61	-0.328574856025308	0.775	0.861	1.87604813077724e-57	RTCA	Malignant cells	GSE108397	ENSG00000137996	8634	RNA 3'-terminal phosphate cyclase	RPC|RTC1|RTCD1	protein_coding	O00442	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2315
1.12227204066452e-61	0.25104776024563	0.991	0.981	2.03086348478651e-57	ADSL	Malignant cells	GSE108397	ENSG00000239900	158	adenylosuccinate lyase	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2316
1.21837503700799e-61	-0.318475528263978	0.281	0.46	2.20477146696966e-57	ILVBL	Malignant cells	GSE108397	ENSG00000105135	10994	ilvB acetolactate synthase like	209L8|AHAS|FLJ39061|HACL1L|ILV2H|MGC1269|MGC19535	protein_coding	A1L0T0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2317
1.29893214833768e-61	-0.288984583620718	0.156	0.327	2.35054761563187e-57	GPRC5A	Malignant cells	GSE108397	ENSG00000013588	9052	G protein-coupled receptor class C group 5 member A	PEIG-1|RAI3|RAIG1|TIG1	protein_coding	Q8NFJ5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2318
1.39407000303236e-61	0.251464815037158	0.291	0.129	2.52270907748735e-57	CTD-2186M15.3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2319
1.54242173939072e-61	0.326102106210357	0.598	0.41	2.79116637960145e-57	RPP40	Malignant cells	GSE108397	ENSG00000124787	10799	ribonuclease P/MRP subunit p40	bA428J1.3|RNASEP1	protein_coding	O75818	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2320
1.6527098327583e-61	-0.372661440391049	0.578	0.708	2.99074371335942e-57	MAP3K2	Malignant cells	GSE108397	ENSG00000169967	10746	mitogen-activated protein kinase kinase kinase 2	MEKK2|MEKK2B	protein_coding	Q9Y2U5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2321
1.89658059714614e-61	-0.34127711018928	0.348	0.522	3.43205224859565e-57	TAPBP	Malignant cells	GSE108397	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2322
1.90649333913805e-61	-0.340721354215435	0.631	0.757	3.44999034650421e-57	NRAS	Malignant cells	GSE108397	ENSG00000213281	4893	NRAS proto-oncogene, GTPase	N-ras	protein_coding	P01111	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2323
2.4192071084346e-61	-0.307726504249064	0.832	0.909	4.37779718342325e-57	GGA1	Malignant cells	GSE108397	ENSG00000100083	26088	golgi associated, gamma adaptin ear containing, ARF binding protein 1	NA	protein_coding	Q9UJY5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2324
2.62769026755821e-61	0.252632504903277	0.338	0.164	4.75506830817334e-57	ZNF138	Malignant cells	GSE108397	ENSG00000197008	7697	zinc finger protein 138	pHZ-32	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2325
2.89081465133468e-61	-0.330025003243937	0.958	0.985	5.23121819305523e-57	TUBB4B	Malignant cells	GSE108397	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2326
3.15026662743911e-61	-0.456865320278125	0.403	0.579	5.70072248901381e-57	HIST1H2BK	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2327
4.43894957831655e-61	-0.336673448608686	0.252	0.435	8.03272315692164e-57	HERC5	Malignant cells	GSE108397	ENSG00000138646	51191	HECT and RLD domain containing E3 ubiquitin protein ligase 5	CEB1	protein_coding	Q9UII4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2328
4.99918375815618e-61	-0.349756684607818	0.626	0.753	9.04652292875942e-57	VGLL4	Malignant cells	GSE108397	ENSG00000144560	9686	vestigial like family member 4	KIAA0121	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2329
5.27672645003485e-61	-0.349721525157103	0.518	0.665	9.54876418398307e-57	RIPK2	Malignant cells	GSE108397	ENSG00000104312	8767	receptor interacting serine/threonine kinase 2	CARD3|CARDIAK|RICK|RIP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2330
6.17096272868213e-61	0.310260074000771	0.877	0.771	1.11669741538232e-56	PPCS	Malignant cells	GSE108397	ENSG00000127125	79717	phosphopantothenoylcysteine synthetase	FLJ11838	protein_coding	Q9HAB8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2331
6.2111594891688e-61	-0.329200397982097	0.318	0.497	1.12397142115999e-56	GUSB	Malignant cells	GSE108397	ENSG00000169919	2990	glucuronidase beta	NA	protein_coding	P08236	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2332
6.51176348658338e-61	-0.380910357775097	0.59	0.729	1.17836872053213e-56	SMCO4	Malignant cells	GSE108397	ENSG00000166002	56935	single-pass membrane protein with coiled-coil domains 4	C11orf75|FN5	protein_coding	Q9NRQ5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2333
6.55680535827075e-61	-0.394566633238554	0.361	0.53	1.18651949763267e-56	GPSM2	Malignant cells	GSE108397	ENSG00000121957	29899	G protein signaling modulator 2	DFNB82|LGN|Pins	protein_coding	P81274	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2334
7.0928803193413e-61	-0.335982063157887	0.422	0.591	1.283527622588e-56	UBXN6	Malignant cells	GSE108397	ENSG00000167671	80700	UBX domain protein 6	UBXD1|UBXDC2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2335
8.31267787921322e-61	-0.322915868761538	0.733	0.849	1.50426218902242e-56	GMCL1	Malignant cells	GSE108397	ENSG00000087338	64395	germ cell-less 1, spermatogenesis associated	BTBD13|FLJ13057|GCL1|SPATA29	protein_coding	Q96IK5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2336
8.55198715889368e-61	-0.375367870322046	0.624	0.775	1.5475675962734e-56	AKAP12	Malignant cells	GSE108397	ENSG00000131016	9590	A-kinase anchoring protein 12	AKAP250|SSeCKS	protein_coding	Q02952	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2337
8.79792442449164e-61	-0.297996897146986	0.242	0.422	1.59207240385601e-56	PNPLA2	Malignant cells	GSE108397	ENSG00000177666	57104	patatin like phospholipase domain containing 2	ATGL|desnutrin|FP17548|iPLA2zeta|TTS-2.2	protein_coding	Q96AD5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2338
9.85594435603678e-61	-0.282629860081963	0.964	0.988	1.78353169066842e-56	MRPL3	Malignant cells	GSE108397	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2339
1.16435415054871e-60	0.36637493725258	0.465	0.283	2.10701527083295e-56	RP11-408N14.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2340
1.20864502864681e-60	-0.360306996813485	0.466	0.636	2.18716404383927e-56	PDCD11	Malignant cells	GSE108397	ENSG00000148843	22984	programmed cell death 11	ALG-4|KIAA0185|NFBP|RRP5	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2341
1.9732612250325e-60	-0.357172147049857	0.588	0.731	3.57081351281881e-56	P4HA1	Malignant cells	GSE108397	ENSG00000122884	5033	prolyl 4-hydroxylase subunit alpha 1	C-P4Halpha(I)|P4HA	protein_coding	P13674	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2342
2.32475919108373e-60	-0.325939469535046	0.693	0.8	4.20688423218511e-56	HYAL2	Malignant cells	GSE108397	ENSG00000068001	8692	hyaluronidase 2	LuCa-2|LUCA2	protein_coding	Q12891	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2343
2.42161738137755e-60	-0.378495576546864	0.536	0.689	4.38215881334081e-56	SVIL	Malignant cells	GSE108397	ENSG00000197321	6840	supervillin	NA	protein_coding	O95425	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2344
2.75812300911197e-60	-0.366840673542958	0.478	0.631	4.99109939728902e-56	SFT2D2	Malignant cells	GSE108397	ENSG00000213064	375035	SFT2 domain containing 2	dJ747L4.C1.2|UNQ512	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2345
2.95059496912639e-60	0.256848952927218	0.256	0.102	5.33939665613111e-56	A2M	Malignant cells	GSE108397	ENSG00000175899	2	alpha-2-macroglobulin	CPAMD5|FWP007|S863-7	protein_coding	P01023	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2346
2.98526764481415e-60	-0.319513032722533	0.745	0.85	5.40214033005568e-56	PPID	Malignant cells	GSE108397	ENSG00000171497	5481	peptidylprolyl isomerase D	CYP-40|CypD	protein_coding	Q08752	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2347
3.33916007491829e-60	0.285585697727987	0.989	0.986	6.04254407157213e-56	OXLD1	Malignant cells	GSE108397	ENSG00000204237	339229	oxidoreductase like domain containing 1	C17orf90|MGC104712	protein_coding	Q5BKU9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2348
3.79679341148156e-60	-0.279388057013093	0.2	0.375	6.87067735741702e-56	PDIA5	Malignant cells	GSE108397	ENSG00000065485	10954	protein disulfide isomerase family A member 5	FLJ30401|PDIR	protein_coding	Q14554	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2349
4.184487266028e-60	0.303404533581704	0.452	0.269	7.57224815660427e-56	CCDC127	Malignant cells	GSE108397	ENSG00000164366	133957	coiled-coil domain containing 127	FLJ25701	protein_coding	Q96BQ5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2350
4.565967914051e-60	-0.330673896687391	0.441	0.61	8.26257553726668e-56	CEP78	Malignant cells	GSE108397	ENSG00000148019	84131	centrosomal protein 78	C9orf81|FLJ12643	protein_coding	Q5JTW2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2351
4.8735198902983e-60	-0.333603608978444	0.683	0.798	8.8191215934838e-56	CDS2	Malignant cells	GSE108397	ENSG00000101290	8760	CDP-diacylglycerol synthase 2	NA	protein_coding	O95674	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2352
5.10772551240737e-60	-0.308796691745416	0.288	0.468	9.24294008725238e-56	NACC1	Malignant cells	GSE108397	ENSG00000160877	112939	nucleus accumbens associated 1	BEND8|BTBD14B|BTBD30|NAC-1|NAC1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2353
5.79969999864124e-60	-0.354406084908404	0.495	0.643	1.04951371175412e-55	DDB1	Malignant cells	GSE108397	ENSG00000167986	1642	damage specific DNA binding protein 1	NA	protein_coding	Q16531	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2354
6.74578388895348e-60	-0.303724303659344	0.218	0.394	1.22071705254502e-55	PCNT	Malignant cells	GSE108397	ENSG00000160299	5116	pericentrin	KEN|KIAA0402|PCN|PCNT2|PCNTB|SCKL4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2355
8.25196684685599e-60	-0.312521280683856	0.183	0.352	1.49327592060706e-55	FAM171B	Malignant cells	GSE108397	ENSG00000144369	165215	family with sequence similarity 171 member B	FLJ34104|KIAA1946	protein_coding	Q6P995	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2356
8.27993806744601e-60	-0.364635820547465	0.48	0.638	1.49833759268503e-55	NAMPT	Malignant cells	GSE108397	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2357
8.82274951473921e-60	-0.3329966687267	0.317	0.494	1.59656475218721e-55	CDC42BPA	Malignant cells	GSE108397	ENSG00000143776	8476	CDC42 binding protein kinase alpha	FLJ23347|KIAA0451|MRCK|MRCKA|PK428	protein_coding	Q5VT25	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2358
9.63639787059689e-60	0.349999765104956	0.449	0.272	1.74380255866321e-55	MBNL2	Malignant cells	GSE108397	ENSG00000139793	10150	muscleblind like splicing regulator 2	MBLL|MBLL39	protein_coding	Q5VZF2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2359
1.0280112329543e-59	0.385641483658339	0.751	0.607	1.8602891271541e-55	S100A16	Malignant cells	GSE108397	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2360
1.09005688921978e-59	0.267940563077641	0.977	0.956	1.97256694673211e-55	IDH3G	Malignant cells	GSE108397	ENSG00000067829	3421	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma	NA	protein_coding	P51553	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2361
1.10033445328516e-59	-0.292890608509424	0.841	0.915	1.99116522666483e-55	G6PD	Malignant cells	GSE108397	ENSG00000160211	2539	glucose-6-phosphate dehydrogenase	G6PD1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2362
1.11058967144939e-59	-0.3439570620811	0.441	0.605	2.00972306945482e-55	MGAT5	Malignant cells	GSE108397	ENSG00000152127	4249	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase	GNT-V|MGAT5A	protein_coding	Q09328	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2363
1.26351895299355e-59	-0.338139851423697	0.654	0.77	2.28646389733712e-55	EFCAB14	Malignant cells	GSE108397	ENSG00000159658	9813	EF-hand calcium binding domain 14	KIAA0494	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2364
1.31872144569809e-59	-0.314485286134135	0.284	0.462	2.38635832813526e-55	BMPR2	Malignant cells	GSE108397	ENSG00000204217	659	bone morphogenetic protein receptor type 2	BMPR-II|BMPR3|BRK-3|PPH1|T-ALK	protein_coding	Q13873	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2365
1.38871171356411e-59	-0.369873576161648	0.365	0.534	2.51301271686561e-55	SOGA1	Malignant cells	GSE108397	ENSG00000149639	140710	suppressor of glucose, autophagy associated 1	C20orf117|dJ132F21.1|FLJ44670|KIAA0889|SOGA	protein_coding	O94964	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2366
1.5033531189746e-59	0.296153557787891	0.412	0.232	2.72046780409643e-55	C5orf28	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2367
1.51216495694753e-59	-0.323604448252056	0.775	0.863	2.73641370609225e-55	IK	Malignant cells	GSE108397	ENSG00000113141	3550	IK cytokine	RED|RER	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2368
1.56455186708602e-59	-0.332629999202423	0.643	0.758	2.83121305867885e-55	KEAP1	Malignant cells	GSE108397	ENSG00000079999	9817	kelch like ECH associated protein 1	INrf2|KIAA0132|KLHL19|MGC10630|MGC1114|MGC20887|MGC4407|MGC9454	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2369
1.68804444210914e-59	0.337036119777633	0.374	0.207	3.0546852224407e-55	NXT2	Malignant cells	GSE108397	ENSG00000101888	55916	nuclear transport factor 2 like export factor 2	P15-2	protein_coding	Q9NPJ8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2370
1.83658568844734e-59	-0.341237104891798	0.66	0.798	3.32348546181431e-55	PPP1R18	Malignant cells	GSE108397	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2371
2.05705958651686e-59	-0.346311067135711	0.318	0.488	3.72245502776092e-55	PILRB	Malignant cells	GSE108397	ENSG00000121716	29990	paired immunoglobin like type 2 receptor beta	FDFACT1|FDFACT2	protein_coding	Q9UKJ0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2372
2.4614336400741e-59	-0.341531971534257	0.588	0.722	4.4542103150781e-55	GATAD2A	Malignant cells	GSE108397	ENSG00000167491	54815	GATA zinc finger domain containing 2A	p66alpha	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2373
2.94109202150002e-59	-0.349005431726282	0.475	0.624	5.32220012210644e-55	MTOR	Malignant cells	GSE108397	ENSG00000198793	2475	mechanistic target of rapamycin kinase	FLJ44809|FRAP|FRAP1|FRAP2|RAFT1|RAPT1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2374
3.23116319830692e-59	-0.379498570113771	0.589	0.73	5.8471129236562e-55	DST	Malignant cells	GSE108397	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2375
3.70702014006873e-59	-0.373518093832386	0.48	0.636	6.70822364546837e-55	SLC4A7	Malignant cells	GSE108397	ENSG00000033867	9497	solute carrier family 4 member 7	NBC3|SBC2|SLC4A6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2376
4.21752226619284e-59	0.339698489957481	0.871	0.782	7.63202829290256e-55	TCEA2	Malignant cells	GSE108397	ENSG00000171703	6919	transcription elongation factor A2	TFIIS	protein_coding	Q15560	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2377
4.26178065098857e-59	-0.326863721405515	0.328	0.505	7.71211826602892e-55	TRIM33	Malignant cells	GSE108397	ENSG00000197323	51592	tripartite motif containing 33	FLJ11429|KIAA1113|PTC7|RFG7|TF1G|TIF1G|TIF1GAMMA|TIFGAMMA	protein_coding	Q9UPN9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2378
4.28277505010592e-59	-0.292130214314283	0.868	0.925	7.75010973067168e-55	AK1	Malignant cells	GSE108397	ENSG00000106992	203	adenylate kinase 1	NA	protein_coding	P00568	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2379
5.3015543764746e-59	0.308531192096468	0.534	0.348	9.59369279966843e-55	TYR	Malignant cells	GSE108397	ENSG00000077498	7299	tyrosinase	OCA1|OCA1A|OCAIA	protein_coding	P14679	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2380
5.99027110221714e-59	-0.327636169630416	0.301	0.479	1.08399945865721e-54	LARP1B	Malignant cells	GSE108397	ENSG00000138709	55132	La ribonucleoprotein 1B	DKFZp434K245|DKFZp686E0316|FLJ10378|LARP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2381
6.76778393274426e-59	-0.288073952517265	0.211	0.385	1.2246981804694e-54	CXXC1	Malignant cells	GSE108397	ENSG00000154832	30827	CXXC finger protein 1	CFP1|CGBP|hCGBP|HsT2645|PCCX1|PHF18|SPP1|ZCGPC1	protein_coding	Q9P0U4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2382
7.05030977447598e-59	-0.329312248437802	0.348	0.519	1.27582405678917e-54	XPOT	Malignant cells	GSE108397	ENSG00000184575	11260	exportin for tRNA	XPO3	protein_coding	O43592	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2383
7.77097637606486e-59	-0.305183394681976	0.998	1	1.4062358850127e-54	NCL	Malignant cells	GSE108397	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2384
7.79888357920567e-59	-0.364078162821457	0.217	0.384	1.41128597249306e-54	AMOTL2	Malignant cells	GSE108397	ENSG00000114019	51421	angiomotin like 2	LCCP	protein_coding	Q9Y2J4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2385
1.30305224692586e-58	-0.326888058296216	0.353	0.525	2.35800334603704e-54	EFCAB4B	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2386
1.55556387029835e-58	-0.330405014713807	0.613	0.74	2.8149483796919e-54	KIF1C	Malignant cells	GSE108397	ENSG00000129250	10749	kinesin family member 1C	SAX2|SPAX2|SPG58	protein_coding	O43896	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2387
1.62360323283008e-58	0.269411861539147	0.352	0.18	2.93807241012931e-54	HRK	Malignant cells	GSE108397	ENSG00000135116	8739	harakiri, BCL2 interacting protein	DP5	protein_coding	O00198	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2388
1.64561420139028e-58	0.358798775526107	0.933	0.89	2.97790345883585e-54	ENAH	Malignant cells	GSE108397	ENSG00000154380	55740	ENAH actin regulator	FLJ10773|MENA|NDPP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2389
2.30708861804869e-58	-0.334222068575869	0.851	0.927	4.17490756322091e-54	ARF4	Malignant cells	GSE108397	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2390
2.3603202373792e-58	-0.344761417468947	0.435	0.593	4.2712355015614e-54	AGAP3	Malignant cells	GSE108397	ENSG00000133612	116988	ArfGAP with GTPase domain, ankyrin repeat and PH domain 3	CENTG3	protein_coding	Q96P47	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2391
2.68106947068487e-58	-0.321498542936341	0.695	0.802	4.85166331415133e-54	MCRS1	Malignant cells	GSE108397	ENSG00000187778	10445	microspherule protein 1	ICP22BP|INO80Q|MCRS2|MSP58|P78	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2392
3.19081098391612e-58	0.311513679304315	0.849	0.73	5.77409155649461e-54	ACAT2	Malignant cells	GSE108397	ENSG00000120437	39	acetyl-CoA acetyltransferase 2	NA	protein_coding	Q9BWD1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2393
3.33961607121564e-58	-0.3355837600228	0.666	0.782	6.04336924247182e-54	VAPB	Malignant cells	GSE108397	ENSG00000124164	9217	VAMP associated protein B and C	ALS8|VAP-B|VAP-C	protein_coding	O95292	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2394
3.5175625126861e-58	-0.331267956383364	0.525	0.673	6.36538112295677e-54	NRBP1	Malignant cells	GSE108397	ENSG00000115216	29959	nuclear receptor binding protein 1	BCON3|MADM|MUDPNP|NRBP	protein_coding	Q9UHY1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2395
3.84144944879668e-58	-0.333697113438308	0.369	0.535	6.95148692254248e-54	KLHDC10	Malignant cells	GSE108397	ENSG00000128607	23008	kelch domain containing 10	KIAA0265|slim	protein_coding	Q6PID8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2396
4.21873766645324e-58	-0.264928403528412	0.945	0.984	7.63422768121379e-54	TRA2B	Malignant cells	GSE108397	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2397
6.00277173172994e-58	-0.308955181621033	0.917	0.964	1.08626157257385e-53	TAGLN2	Malignant cells	GSE108397	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2398
6.87795360873404e-58	-0.294389123631717	0.901	0.951	1.24463448503651e-53	C5orf24	Malignant cells	GSE108397	ENSG00000181904	134553	chromosome 5 open reading frame 24	FLJ37562	protein_coding	Q7Z6I8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2399
7.1557197338713e-58	-0.342232563514418	0.571	0.71	1.29489904304135e-53	ME2	Malignant cells	GSE108397	ENSG00000082212	4200	malic enzyme 2	NA	protein_coding	P23368	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2400
9.7472946068622e-58	-0.33857115083942	0.39	0.559	1.76387043205778e-53	ZSCAN16-AS1	Malignant cells	GSE108397	ENSG00000269293	100129195	ZSCAN16 antisense RNA 1	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2401
1.09635742096931e-57	0.29040064542443	0.469	0.287	1.98396838898606e-53	RIOK2	Malignant cells	GSE108397	ENSG00000058729	55781	RIO kinase 2	FLJ11159	protein_coding	Q9BVS4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2402
1.11979488679259e-57	-0.326538800463848	0.311	0.483	2.02638082713988e-53	SLC16A1-AS1	Malignant cells	GSE108397	ENSG00000226419	100506392	SLC16A1 antisense RNA 1	ENST00000421157.1	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2403
1.20552605034856e-57	0.315381647684191	0.858	0.759	2.18151994071076e-53	MRPS18A	Malignant cells	GSE108397	ENSG00000096080	55168	mitochondrial ribosomal protein S18A	FLJ10548|MRPS18-3	protein_coding	Q9NVS2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2404
1.89622382158972e-57	-0.286547695470834	0.866	0.913	3.43140662754876e-53	RAB1B	Malignant cells	GSE108397	ENSG00000174903	81876	RAB1B, member RAS oncogene family	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2405
1.92831498915562e-57	-0.288762202881798	0.865	0.924	3.48947880437601e-53	VAMP3	Malignant cells	GSE108397	ENSG00000049245	9341	vesicle associated membrane protein 3	CEB	protein_coding	Q15836	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2406
2.06270753586441e-57	-0.3259865281528	0.689	0.806	3.73267555690023e-53	LINC00969	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2407
2.37366833014281e-57	-0.251261946812843	0.976	0.995	4.29539021022643e-53	POLR2H	Malignant cells	GSE108397	ENSG00000163882	5437	RNA polymerase II, I and III subunit H	RPB8	protein_coding	P52434	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2408
3.04750172280103e-57	0.315140489389927	0.584	0.401	5.51475911758074e-53	RP11-115C21.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2409
3.09773200166882e-57	0.305303250820131	0.555	0.372	5.6056558302199e-53	C7orf13	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2410
3.16186131539782e-57	-0.271484028130652	0.922	0.96	5.72170423634389e-53	RALA	Malignant cells	GSE108397	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2411
3.92070205552265e-57	-0.306857826726478	0.352	0.528	7.09490243967379e-53	RAB35	Malignant cells	GSE108397	ENSG00000111737	11021	RAB35, member RAS oncogene family	H-ray	protein_coding	Q15286	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2412
3.94592131129844e-57	-0.288606329380084	0.184	0.352	7.14053920492565e-53	SEPT4	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2413
4.01105535236697e-57	0.305254595127519	0.66	0.488	7.25840576564327e-53	NEU1	Malignant cells	GSE108397	ENSG00000184494	4758	neuraminidase 1	NEU	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2414
5.01511719725564e-57	-0.276586978488495	0.895	0.949	9.0753560801538e-53	IRAK1	Malignant cells	GSE108397	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2415
5.73340156293134e-57	-0.328303059359088	0.276	0.446	1.03751634682806e-52	JADE2	Malignant cells	GSE108397	ENSG00000043143	23338	jade family PHD finger 2	JADE-2|KIAA0239|PHF15	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2416
5.75992787619375e-57	-0.297643771208366	0.728	0.835	1.04231654847602e-52	MAPK1	Malignant cells	GSE108397	ENSG00000100030	5594	mitogen-activated protein kinase 1	ERK|ERK2|MAPK2|p41mapk|PRKM1|PRKM2	protein_coding	P28482	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2417
6.08328889434311e-57	-0.333455205380848	0.414	0.583	1.10083195832033e-52	RBM6	Malignant cells	GSE108397	ENSG00000004534	10180	RNA binding motif protein 6	3G2|DEF-3|DEF3|g16|NY-LU-12	protein_coding	P78332	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2418
6.71515763374941e-57	0.323395200702581	0.472	0.292	1.21517492540329e-52	YPEL3	Malignant cells	GSE108397	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2419
6.88449185560065e-57	0.321913363199254	0.763	0.623	1.24581764618949e-52	ACD	Malignant cells	GSE108397	ENSG00000102977	65057	ACD shelterin complex subunit and telomerase recruitment factor	Pip1|Ptop|Tint1|Tpp1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2420
7.08488503695579e-57	-0.310554104647126	0.726	0.825	1.28208079628752e-52	ORAI2	Malignant cells	GSE108397	ENSG00000160991	80228	ORAI calcium release-activated calcium modulator 2	C7orf19|CBCIP2|FLJ12474|FLJ14733|H_NH0514P08.8|TMEM142B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2421
8.42168188542196e-57	-0.292166539366474	0.789	0.871	1.52398755398596e-52	SGTA	Malignant cells	GSE108397	ENSG00000104969	6449	small glutamine rich tetratricopeptide repeat co-chaperone alpha	alphaSGT|hSGT|SGT|SGT1|UBP|Vpu	protein_coding	O43765	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2422
8.45850777799532e-57	0.254947817442233	0.361	0.189	1.53065156750603e-52	THOC1	Malignant cells	GSE108397	ENSG00000079134	9984	THO complex subunit 1	HPR1|P84	protein_coding	Q96FV9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2423
9.03237720650185e-57	0.311681724931636	0.638	0.467	1.63449897928857e-52	FAM105B	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2424
1.03558213223309e-56	0.299072627831183	0.453	0.275	1.873989426489e-52	LTA4H	Malignant cells	GSE108397	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2425
1.06218697394483e-56	0.300319207281278	0.854	0.749	1.92213354805056e-52	CINP	Malignant cells	GSE108397	ENSG00000100865	51550	cyclin dependent kinase 2 interacting protein	MGC849	protein_coding	Q9BW66	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2426
1.11399211652541e-56	-0.300153681711434	0.292	0.466	2.01588013406437e-52	YEATS2	Malignant cells	GSE108397	ENSG00000163872	55689	YEATS domain containing 2	FLJ10201|FLJ12841|FLJ13308|KIAA1197	protein_coding	Q9ULM3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2427
1.16292653627896e-56	0.270870047937036	0.985	0.974	2.1044318600504e-52	MDH1	Malignant cells	GSE108397	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2428
1.25690086038959e-56	-0.305298517077841	0.197	0.364	2.274487796961e-52	ADAMTS1	Malignant cells	GSE108397	ENSG00000154734	9510	ADAM metallopeptidase with thrombospondin type 1 motif 1	C3-C5|KIAA1346|METH1	protein_coding	Q9UHI8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2429
1.33178874249599e-56	-0.304968153649956	0.797	0.891	2.41000490842075e-52	LRRFIP2	Malignant cells	GSE108397	ENSG00000093167	9209	LRR binding FLII interacting protein 2	HUFI-2	protein_coding	Q9Y608	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2430
1.33495617951532e-56	-0.328796816053368	0.671	0.794	2.41573670245092e-52	NUDT8	Malignant cells	GSE108397	ENSG00000167799	254552	nudix hydrolase 8	FLJ41567	protein_coding	Q8WV74	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2431
1.3689750396312e-56	0.279248526027986	0.977	0.961	2.47729723171661e-52	BTG1	Malignant cells	GSE108397	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2432
1.41770839131164e-56	-0.267370274815519	0.93	0.97	2.56548510491754e-52	C9orf78	Malignant cells	GSE108397	ENSG00000136819	51759	chromosome 9 open reading frame 78	CSU2|HCA59|HSPC220	protein_coding	Q9NZ63	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2433
1.70879672537321e-56	-0.323406768242501	0.661	0.782	3.09223855423536e-52	TOPBP1	Malignant cells	GSE108397	ENSG00000163781	11073	DNA topoisomerase II binding protein 1	Dpb11|KIAA0259|TOP2BP1	protein_coding	Q92547	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2434
1.81446381150545e-56	-0.296366811194855	0.843	0.925	3.28345371330027e-52	MAP2K3	Malignant cells	GSE108397	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2435
1.97197277198517e-56	0.261726461455607	0.403	0.227	3.56848192818436e-52	PIGL	Malignant cells	GSE108397	ENSG00000108474	9487	phosphatidylinositol glycan anchor biosynthesis class L	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2436
2.08259487171835e-56	-0.314575167840427	0.318	0.491	3.76866367986153e-52	RNPEPL1	Malignant cells	GSE108397	ENSG00000142327	57140	arginyl aminopeptidase like 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2437
2.13647052055695e-56	-0.335954644814818	0.846	0.9	3.86615705399985e-52	TAF1D	Malignant cells	GSE108397	ENSG00000166012	79101	TATA-box binding protein associated factor, RNA polymerase I subunit D	JOSD3|MGC5306|TAF(I)41	protein_coding	Q9H5J8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2438
2.30956567003196e-56	-0.331002035887691	0.489	0.638	4.17939003648984e-52	ZNF598	Malignant cells	GSE108397	ENSG00000167962	90850	zinc finger protein 598, E3 ubiquitin ligase	FLJ00086|HEL2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2439
2.34659933745938e-56	0.402634781855925	0.612	0.465	4.2464061610665e-52	MAGT1	Malignant cells	GSE108397	ENSG00000102158	84061	magnesium transporter 1	DKFZp564K142|IAP|MRX95|OST3B|SLC58A1	protein_coding	Q9H0U3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2440
2.733678979583e-56	-0.297794349561962	0.258	0.428	4.94686548145339e-52	MYPOP	Malignant cells	GSE108397	ENSG00000176182	339344	Myb related transcription factor, partner of profilin	P42pop	protein_coding	Q86VE0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2441
2.84426533966693e-56	-0.33926618634412	0.525	0.674	5.14698255866127e-52	MCMBP	Malignant cells	GSE108397	ENSG00000197771	79892	minichromosome maintenance complex binding protein	C10orf119|FLJ13081|MCM-BP	protein_coding	Q9BTE3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2442
3.06703537891612e-56	0.279340543250958	0.977	0.951	5.55010722168661e-52	PSMA4	Malignant cells	GSE108397	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2443
3.08145223666233e-56	-0.682223169594053	0.604	0.72	5.57619596746416e-52	TOP2A	Malignant cells	GSE108397	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2444
3.20166581971055e-56	-0.315570066263879	0.743	0.848	5.79373446734821e-52	TACC1	Malignant cells	GSE108397	ENSG00000147526	6867	transforming acidic coiled-coil containing protein 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2445
3.63925161772627e-56	-0.280053627493505	0.914	0.96	6.58558972743745e-52	RPIA	Malignant cells	GSE108397	ENSG00000153574	22934	ribose 5-phosphate isomerase A	NA	protein_coding	P49247	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2446
3.71311652772854e-56	-0.260274606709865	0.943	0.977	6.71925566857757e-52	POLD2	Malignant cells	GSE108397	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2447
3.74080326550709e-56	-0.360546279461137	0.829	0.898	6.76935758926164e-52	XBP1	Malignant cells	GSE108397	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2448
3.77540936684164e-56	-0.326837014576122	0.595	0.724	6.83198079023663e-52	WAPAL	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2449
4.1221010503522e-56	-0.343439475618178	0.475	0.627	7.45935406071734e-52	EXT1	Malignant cells	GSE108397	ENSG00000182197	2131	exostosin glycosyltransferase 1	LGCR|LGS|ttv	protein_coding	Q16394	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2450
4.1540804860585e-56	0.303518327872212	0.619	0.433	7.51722404757146e-52	NHLRC3	Malignant cells	GSE108397	ENSG00000188811	387921	NHL repeat containing 3	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2451
4.27499176510312e-56	-0.446576879751554	0.398	0.55	7.7360250981306e-52	UBALD2	Malignant cells	GSE108397	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2452
4.36673379377373e-56	-0.293118401128894	0.922	0.968	7.90204147321295e-52	HNRNPR	Malignant cells	GSE108397	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2453
5.21771218052473e-56	-0.331074961626571	0.367	0.533	9.44197196187755e-52	CABIN1	Malignant cells	GSE108397	ENSG00000281670	23523	calcineurin binding protein 1	KIAA0330|PPP3IN	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2454
5.99480505956099e-56	0.309094471102271	0.941	0.882	1.08481992357816e-51	RABAC1	Malignant cells	GSE108397	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2455
6.46597955230325e-56	-0.325130135569736	0.668	0.775	1.1700836597848e-51	LYRM7	Malignant cells	GSE108397	ENSG00000186687	90624	LYR motif containing 7	C5orf31|FLJ20796|MZM1L	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2456
6.55519479985046e-56	-0.29283378095549	0.784	0.861	1.18622805098094e-51	KLHL7	Malignant cells	GSE108397	ENSG00000122550	55975	kelch like family member 7	KLHL6|RP42|SBBI26	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2457
6.67700536607875e-56	-0.322364715058897	0.369	0.539	1.20827089104561e-51	KRT8	Malignant cells	GSE108397	ENSG00000170421	3856	keratin 8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	protein_coding	P05787	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2458
7.67100194159533e-56	0.296641658516138	0.635	0.46	1.38814451135109e-51	TXNDC15	Malignant cells	GSE108397	ENSG00000113621	79770	thioredoxin domain containing 15	2310047H23Rik|C5orf14|FLJ22625	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2459
8.13899538678835e-56	0.302994220153274	0.887	0.815	1.47283260519322e-51	RPP30	Malignant cells	GSE108397	ENSG00000148688	10556	ribonuclease P/MRP subunit p30	TSG15	protein_coding	P78346	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2460
8.14989054550019e-56	0.307293230328272	0.585	0.404	1.47480419311371e-51	UFL1	Malignant cells	GSE108397	ENSG00000014123	23376	UFM1 specific ligase 1	KIAA0776|Maxer|NLBP|RCAD	protein_coding	O94874	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2461
8.67517041938555e-56	-0.330317303994219	0.513	0.659	1.56985883909201e-51	RNFT1	Malignant cells	GSE108397	ENSG00000189050	51136	ring finger protein, transmembrane 1	PTD016	protein_coding	Q5M7Z0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2462
1.19114435360862e-55	0.329103598504348	0.849	0.757	2.15549482229016e-51	C16orf91	Malignant cells	GSE108397	ENSG00000174109	283951	chromosome 16 open reading frame 91	CCSMST1|gs103|URLC5	protein_coding	Q4G0I0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2463
1.24336016530997e-55	0.26161349265417	0.989	0.981	2.24998455514492e-51	VBP1	Malignant cells	GSE108397	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2464
1.29965974192538e-55	0.304671499334344	0.9	0.796	2.35186426898817e-51	DAAM2	Malignant cells	GSE108397	ENSG00000146122	23500	dishevelled associated activator of morphogenesis 2	KIAA0381|NPHS24	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2465
1.3644281767359e-55	-0.2664096197291	0.183	0.35	2.46906922862129e-51	AP1S3	Malignant cells	GSE108397	ENSG00000152056	130340	adaptor related protein complex 1 subunit sigma 3	sigma1C	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2466
1.49214140664696e-55	-0.272627027377411	0.235	0.41	2.70017908946834e-51	LCOR	Malignant cells	GSE108397	ENSG00000196233	84458	ligand dependent nuclear receptor corepressor	C10orf12|DKFZP564P1916|FLJ13022|FLJ38026|KIAA1795|MLR2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2467
1.68239720809297e-55	0.310580880105215	0.549	0.369	3.04446598776503e-51	RP11-752G15.6	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2468
1.70139854020531e-55	-0.34087973395443	0.633	0.748	3.07885079835553e-51	B4GALT5	Malignant cells	GSE108397	ENSG00000158470	9334	beta-1,4-galactosyltransferase 5	beta4GalT-V	protein_coding	O43286	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2469
1.71108583741997e-55	-0.297803345543764	0.268	0.441	3.09638093139518e-51	ODF2	Malignant cells	GSE108397	ENSG00000136811	4957	outer dense fiber of sperm tails 2	CT134|ODF84	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2470
1.74594832877143e-55	-0.323093273616763	0.397	0.568	3.15946809574478e-51	MTMR2	Malignant cells	GSE108397	ENSG00000087053	8898	myotubularin related protein 2	CMT4B|KIAA1073	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2471
1.7677399685213e-55	-0.274917676395089	0.216	0.384	3.19890224703615e-51	MBD6	Malignant cells	GSE108397	ENSG00000166987	114785	methyl-CpG binding domain protein 6	KIAA1887	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2472
1.7911836439411e-55	0.319658343402927	0.991	0.988	3.24132592207581e-51	TEX30	Malignant cells	GSE108397	ENSG00000151287	93081	testis expressed 30	C13orf27	protein_coding	Q5JUR7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2473
1.8992312019036e-55	0.29631642693115	0.54	0.36	3.43684878296476e-51	TUBGCP3	Malignant cells	GSE108397	ENSG00000282003	10426	tubulin gamma complex associated protein 3	GCP3|SPBC98|Spc98p	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2474
1.93337574844945e-55	-0.336140429945681	0.475	0.626	3.49863675439413e-51	HIBADH	Malignant cells	GSE108397	ENSG00000106049	11112	3-hydroxyisobutyrate dehydrogenase	NS5ATP1	protein_coding	P31937	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2475
2.17737917740945e-55	-0.295351531327128	0.773	0.839	3.94018535944014e-51	AGPAT1	Malignant cells	GSE108397	ENSG00000236873	10554	1-acylglycerol-3-phosphate O-acyltransferase 1	LPAAT-alpha|LPLAT1	protein_coding	Q99943	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2476
2.1876515423255e-55	0.31817089475063	0.898	0.834	3.95877423099223e-51	TMEM203	Malignant cells	GSE108397	ENSG00000187713	94107	transmembrane protein 203	HBEBP1|MGC14327	protein_coding	Q969S6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2477
3.04831444369126e-55	-0.315602283471825	0.729	0.836	5.51622981730371e-51	ZRANB2	Malignant cells	GSE108397	ENSG00000132485	9406	zinc finger RANBP2-type containing 2	ZIS|ZIS1|ZIS2|ZNF265	protein_coding	O95218	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2478
3.31949130428338e-55	0.289897621747692	0.467	0.288	6.0069514642312e-51	RP13-582O9.5	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2479
3.5043007541026e-55	-0.300598097607982	0.319	0.495	6.34138264462407e-51	UNKL	Malignant cells	GSE108397	ENSG00000059145	64718	unk like zinc finger	C16orf28|FLJ23360|ZC3H5L|ZC3HDC5L	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2480
3.59017605024509e-55	-0.328706809188794	0.53	0.673	6.49678258052351e-51	LIMK2	Malignant cells	GSE108397	ENSG00000182541	3985	LIM domain kinase 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2481
3.96466567852805e-55	-0.300206654202718	0.767	0.859	7.17445901186435e-51	DDX42	Malignant cells	GSE108397	ENSG00000198231	11325	DEAD-box helicase 42	RHELP|RNAHP|SF3b125|SF3B8	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2482
4.48949284350558e-55	-0.259355068427881	0.945	0.972	8.1241862496077e-51	SEPT2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2483
5.20174255092912e-55	-0.308937521815866	0.915	0.951	9.41307332016133e-51	HMGB3	Malignant cells	GSE108397	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2484
5.45870480270232e-55	-0.25177527503616	0.163	0.325	9.87807221097012e-51	CCDC130	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2485
5.96531775119118e-55	0.269524848457205	0.347	0.182	1.07948390025556e-50	RP11-1102P16.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2486
6.57174008296158e-55	-0.315358601409059	0.949	0.981	1.18922208541273e-50	RRM2	Malignant cells	GSE108397	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2487
7.05405102618167e-55	-0.328723409464941	0.466	0.621	1.27650107369784e-50	PRRC2A	Malignant cells	GSE108397	ENSG00000231370	7916	proline rich coiled-coil 2A	BAT2|D6S51E|G2	protein_coding	P48634	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2488
8.44939503744161e-55	-0.276228372515034	0.923	0.956	1.52900252597543e-50	RPSAP58	Malignant cells	GSE108397	ENSG00000288920	388524	ribosomal protein SA pseudogene 58	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2489
9.05336650649312e-55	-0.310883369160369	0.783	0.855	1.63829720301499e-50	PTPN1	Malignant cells	GSE108397	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2490
1.03995750239094e-54	-0.275886739474687	0.209	0.373	1.88190709632664e-50	AKAP10	Malignant cells	GSE108397	ENSG00000108599	11216	A-kinase anchoring protein 10	D-AKAP2|MGC9414|PRKA10	protein_coding	O43572	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2491
1.42125748815174e-54	-0.295470973976612	0.738	0.825	2.57190755055939e-50	TMED5	Malignant cells	GSE108397	ENSG00000117500	50999	transmembrane p24 trafficking protein 5	CGI-100|p24g2|p24gamma2	protein_coding	Q9Y3A6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2492
1.49473620942118e-54	-0.34751604434894	0.376	0.54	2.70487464456856e-50	TNC	Malignant cells	GSE108397	ENSG00000041982	3371	tenascin C	DFNA56|HXB|MGC167029|TN	protein_coding	P24821	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2493
1.70556976842292e-54	-0.320906516164856	0.405	0.568	3.08639905293812e-50	PPP2R5A	Malignant cells	GSE108397	ENSG00000066027	5525	protein phosphatase 2 regulatory subunit B'alpha	B56A|B56alpha|PR61A	protein_coding	Q15172	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2494
1.82006109207707e-54	-0.288617158420492	0.703	0.824	3.29358255222267e-50	RFK	Malignant cells	GSE108397	ENSG00000135002	55312	riboflavin kinase	FLJ11149|RIFK	protein_coding	Q969G6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2495
1.98865264245717e-54	-0.312817971059084	0.656	0.778	3.5986658217905e-50	WAC	Malignant cells	GSE108397	ENSG00000095787	51322	WW domain containing adaptor with coiled-coil	BM-016|FLJ31290|MGC10753|PRO1741|Wwp4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2496
2.27016667175394e-54	0.307026387254281	0.886	0.802	4.10809360920593e-50	NOB1	Malignant cells	GSE108397	ENSG00000141101	28987	NIN1 (RPN12) binding protein 1 homolog	ART-4|MST158|NOB1P|PSMD8BP1	protein_coding	Q9ULX3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2497
2.46911681725472e-54	-0.318439377533806	0.627	0.761	4.46811379250413e-50	KDM1A	Malignant cells	GSE108397	ENSG00000004487	23028	lysine demethylase 1A	AOF2|BHC110|KDM1|KIAA0601|LSD1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2498
2.97042993588101e-54	-0.276090268192355	0.212	0.378	5.37529001197028e-50	AGRN	Malignant cells	GSE108397	ENSG00000188157	375790	agrin	AGRIN	protein_coding	O00468	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2499
3.17016142999667e-54	0.330575407705713	0.529	0.361	5.73672412372198e-50	CRYL1	Malignant cells	GSE108397	ENSG00000165475	51084	crystallin lambda 1	GDH|lambda-CRY|MGC149525|MGC149526	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2500
3.24951680618688e-54	-0.315572704683827	0.636	0.762	5.88032561247578e-50	TEAD1	Malignant cells	GSE108397	ENSG00000187079	7003	TEA domain transcription factor 1	AA|TCF13|TEF-1	protein_coding	P28347	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2501
3.31739258544192e-54	-0.292370636116082	0.928	0.967	6.0031536226157e-50	SPAG9	Malignant cells	GSE108397	ENSG00000008294	9043	sperm associated antigen 9	CT89|FLJ13450|FLJ14006|FLJ26141|FLJ34602|HLC4|HSS|JIP-4|JIP4|JLP|KIAA0516|MGC117291|MGC14967|MGC74461|PHET|PIG6|SYD1	protein_coding	O60271	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2502
3.32145205912767e-54	0.304745845370798	0.721	0.556	6.01049964619742e-50	ARL3	Malignant cells	GSE108397	ENSG00000138175	403	ADP ribosylation factor like GTPase 3	ARFL3	protein_coding	P36405	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2503
3.50431445159706e-54	-0.331932111352866	0.494	0.636	6.34140743161005e-50	LIX1L	Malignant cells	GSE108397	ENSG00000271601	128077	limb and CNS expressed 1 like	MGC46719	protein_coding	Q8IVB5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2504
4.01252933688397e-54	-0.28728762787805	0.234	0.401	7.26107308802523e-50	AARSD1	Malignant cells	GSE108397	ENSG00000266967	80755	alanyl-tRNA synthetase domain containing 1	AlaXp|MGC2744	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2505
4.25030536374155e-54	-0.276679325817925	0.921	0.96	7.6913525862267e-50	NSA2	Malignant cells	GSE108397	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2506
4.86135166541527e-54	0.266119663478183	0.975	0.944	8.79710197373548e-50	GGH	Malignant cells	GSE108397	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2507
4.96443463315545e-54	-0.257521323110678	0.203	0.371	8.9836409121581e-50	TRIM26	Malignant cells	GSE108397	ENSG00000231002	7726	tripartite motif containing 26	RNF95|ZNF173	protein_coding	Q12899	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2508
7.05710871464331e-54	-0.308556813764701	0.61	0.732	1.27705439300185e-49	C21orf2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2509
7.12697764330981e-54	0.292645726591393	0.62	0.445	1.28969787433334e-49	PRMT5	Malignant cells	GSE108397	ENSG00000100462	10419	protein arginine methyltransferase 5	HRMT1L5|SKB1|SKB1Hs	protein_coding	O14744	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2510
7.52017162975156e-54	-0.297678838572588	0.738	0.832	1.36085025811984e-49	SEPT10	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2511
8.71542388672523e-54	-0.489795611252355	0.882	0.926	1.5771431065418e-49	CENPF	Malignant cells	GSE108397	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2512
9.06728751185681e-54	-0.287631422626514	0.922	0.954	1.64081634814561e-49	CDK2AP2	Malignant cells	GSE108397	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2513
9.21897789476292e-54	-0.25970562565319	0.945	0.974	1.6682662398363e-49	SYAP1	Malignant cells	GSE108397	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2514
9.42068325632667e-54	-0.335317716819653	0.463	0.601	1.70476684206487e-49	MFN2	Malignant cells	GSE108397	ENSG00000116688	9927	mitofusin 2	CMT2A2|CPRP1|KIAA0214|MARF	protein_coding	O95140	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2515
1.06488598173054e-53	-0.337434799742718	0.529	0.663	1.92701767253958e-49	CERK	Malignant cells	GSE108397	ENSG00000100422	64781	ceramide kinase	dA59H18.2|dA59H18.3|DKFZp434E0211|FLJ21430|FLJ23239|hCERK|KIAA1646|LK4	protein_coding	Q8TCT0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2516
1.20306087733315e-53	-0.28656232475291	0.807	0.884	2.17705896362207e-49	CSE1L	Malignant cells	GSE108397	ENSG00000124207	1434	chromosome segregation 1 like	CAS|CSE1|XPO2	protein_coding	P55060	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2517
1.23268097779394e-53	-0.278341952878663	0.896	0.938	2.23065949741592e-49	TMEM126A	Malignant cells	GSE108397	ENSG00000171202	84233	transmembrane protein 126A	DKFZp586C1924|OPA7	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2518
1.25623125435262e-53	-0.290708714456787	0.846	0.914	2.27327607787651e-49	PTPMT1	Malignant cells	GSE108397	ENSG00000285206	114971	protein tyrosine phosphatase mitochondrial 1	DUSP23|MOSP|PLIP	protein_coding	Q8WUK0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2519
1.41422499441848e-53	0.288106049629104	0.907	0.838	2.55918154989968e-49	EBAG9	Malignant cells	GSE108397	ENSG00000147654	9166	estrogen receptor binding site associated antigen 9	EB9|RCAS1	protein_coding	O00559	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2520
1.56789030266576e-53	-0.305976641133274	0.395	0.558	2.83725429170396e-49	TNPO3	Malignant cells	GSE108397	ENSG00000064419	23534	transportin 3	IPO12|LGMD1F|MTR10A|TRN-SR|TRN-SR2	protein_coding	Q9Y5L0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2521
1.77540832490097e-53	-0.277088060077342	0.193	0.354	3.2127789047408e-49	STIL	Malignant cells	GSE108397	ENSG00000123473	6491	STIL centriolar assembly protein	MCPH7|SIL	protein_coding	Q15468	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2522
1.85377325609153e-53	-0.304781686556949	0.848	0.909	3.35458808422323e-49	HNRNPH3	Malignant cells	GSE108397	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2523
1.90069475103186e-53	-0.328582659625583	0.38	0.54	3.43949722146725e-49	P2RX4	Malignant cells	GSE108397	ENSG00000135124	5025	purinergic receptor P2X 4	P2X4	protein_coding	Q99571	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2524
2.09843089321565e-53	-0.272774981042333	0.219	0.385	3.79732054436303e-49	KCTD13	Malignant cells	GSE108397	ENSG00000174943	253980	potassium channel tetramerization domain containing 13	FKSG86|PDIP1|POLDIP1	protein_coding	Q8WZ19	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2525
2.18252821212229e-53	-0.320481820996013	0.506	0.645	3.94950305265649e-49	KIAA2013	Malignant cells	GSE108397	ENSG00000116685	90231	KIAA2013	MGC33867|RP5-1077B9.1	protein_coding	Q8IYS2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2526
2.40639664227213e-53	-0.303856540112769	0.778	0.866	4.35461536385565e-49	CAPN2	Malignant cells	GSE108397	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2527
2.44864771277267e-53	-0.289254425835095	0.867	0.935	4.43107290103343e-49	MAGOH	Malignant cells	GSE108397	ENSG00000162385	4116	mago homolog, exon junction complex subunit	MAGOH1|MAGOHA	protein_coding	P61326	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2528
2.46858369356657e-53	-0.324960526525612	0.45	0.605	4.46714905187806e-49	CNOT11	Malignant cells	GSE108397	ENSG00000158435	55571	CCR4-NOT transcription complex subunit 11	C2orf29|C40	protein_coding	Q9UKZ1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2529
2.5079506417831e-53	-0.296812438520497	0.731	0.831	4.5383874813707e-49	UBE2E1	Malignant cells	GSE108397	ENSG00000170142	7324	ubiquitin conjugating enzyme E2 E1	UbcH6	protein_coding	P51965	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2530
2.65270323625317e-53	-0.311869213792757	0.474	0.633	4.80033177632374e-49	SRPR	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2531
2.77762163634275e-53	-0.267957077180897	0.204	0.37	5.02638411312584e-49	LTN1	Malignant cells	GSE108397	ENSG00000198862	26046	listerin E3 ubiquitin protein ligase 1	C21orf10|C21orf98|FLJ11053|KIAA0714|LISTERIN|RNF160|ZNF294	protein_coding	O94822	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2532
3.04912310245028e-53	-0.271569811035197	0.241	0.407	5.51769316619402e-49	MOGS	Malignant cells	GSE108397	ENSG00000115275	7841	mannosyl-oligosaccharide glucosidase	CWH41|DER7|GCS1	protein_coding	Q13724	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2533
3.16750403633208e-53	0.265548843565534	0.98	0.978	5.73191530414652e-49	MRPL22	Malignant cells	GSE108397	ENSG00000082515	29093	mitochondrial ribosomal protein L22	HSPC158|MRP-L25|RPML25	protein_coding	Q9NWU5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2534
3.30021400616519e-53	0.265794740054421	0.376	0.21	5.97206726555652e-49	CXorf38	Malignant cells	GSE108397	ENSG00000185753	159013	chromosome X open reading frame 38	MGC39350	protein_coding	Q8TB03	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2535
3.44539942515416e-53	0.287044945269249	0.462	0.287	6.23479479975896e-49	SMIM2-AS1	Malignant cells	GSE108397	ENSG00000227258	NA	NA	C13orf44-AS1	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2536
3.67016443575054e-53	-0.325109985008067	0.532	0.672	6.64152956293418e-49	EIF2B1	Malignant cells	GSE108397	ENSG00000111361	1967	eukaryotic translation initiation factor 2B subunit alpha	EIF-2B|EIF-2Balpha|EIF2B|EIF2BA|EIF2Balpha	protein_coding	Q14232	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2537
4.81643179474925e-53	-0.279175839980546	0.867	0.924	8.71581497577825e-49	DDX27	Malignant cells	GSE108397	ENSG00000124228	55661	DEAD-box helicase 27	dJ686N3.1|DRS1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2538
5.51078997714942e-53	0.313103233347414	0.936	0.885	9.97232554264959e-49	SNHG15	Malignant cells	GSE108397	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2539
5.54338457361042e-53	-0.286891506192175	0.833	0.906	1.00313087244054e-48	B4GALT7	Malignant cells	GSE108397	ENSG00000027847	11285	beta-1,4-galactosyltransferase 7	beta4Gal-T7|XGALT-1	protein_coding	Q9UBV7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2540
6.89214365686653e-53	-0.33368636306263	0.601	0.733	1.24720231614657e-48	SLC25A19	Malignant cells	GSE108397	ENSG00000125454	60386	solute carrier family 25 member 19	DNC|MCPHA|MUP1|TPC	protein_coding	Q9HC21	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2541
9.48776478295891e-53	0.303750722160752	0.941	0.912	1.71690591512424e-48	FAM86C1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2542
9.83850522888955e-53	-0.31520745849857	0.528	0.669	1.78037590621985e-48	AIFM2	Malignant cells	GSE108397	ENSG00000042286	84883	apoptosis inducing factor mitochondria associated 2	AMID|FLJ14497|FSP1|PRG3	protein_coding	Q9BRQ8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2543
1.49380956853904e-52	0.283849288576822	0.603	0.428	2.70319779522824e-48	RNF141	Malignant cells	GSE108397	ENSG00000110315	50862	ring finger protein 141	ZFP26|ZNF230	protein_coding	Q8WVD5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2544
1.49420455371494e-52	-0.32181249659613	0.635	0.759	2.70391256040255e-48	HIF1A	Malignant cells	GSE108397	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2545
2.19299714594406e-52	-0.309900185683031	0.709	0.806	3.96844763530037e-48	SLC5A6	Malignant cells	GSE108397	ENSG00000138074	8884	solute carrier family 5 member 6	SMVT	protein_coding	Q9Y289	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2546
2.37580908883598e-52	-0.295653342912815	0.778	0.861	4.29926412715759e-48	ACTR2	Malignant cells	GSE108397	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2547
2.47530257525931e-52	-0.323200548274107	0.463	0.622	4.47930754018925e-48	C12orf23	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2548
2.50979194304287e-52	-0.324030176076052	0.581	0.705	4.54171950013038e-48	GLS	Malignant cells	GSE108397	ENSG00000115419	2744	glutaminase	GAC|GAM|GLS1|KGA|KIAA0838	protein_coding	O94925	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2549
2.58786387489623e-52	-0.28014881507668	0.962	0.982	4.68299846801222e-48	SNCA	Malignant cells	GSE108397	ENSG00000145335	6622	synuclein alpha	NACP|PARK1|PARK4|PD1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2550
2.68487298109078e-52	0.256149918623055	0.398	0.229	4.85854614658187e-48	TSEN2	Malignant cells	GSE108397	ENSG00000154743	80746	tRNA splicing endonuclease subunit 2	MGC2776|SEN2|SEN2L	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2551
2.8502941233627e-52	0.267851908936008	0.456	0.28	5.15789224563714e-48	AKAP11	Malignant cells	GSE108397	ENSG00000023516	11215	A-kinase anchoring protein 11	AKAP220|DKFZp781I12161|FLJ11304|KIAA0629|PPP1R44|PRKA11	protein_coding	Q9UKA4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2552
2.91469001353363e-52	-0.308265933697516	0.705	0.801	5.27442304849046e-48	SLC35B4	Malignant cells	GSE108397	ENSG00000205060	84912	solute carrier family 35 member B4	FLJ14697|YEA4	protein_coding	Q969S0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2553
3.19325813813626e-52	-0.339680498873106	0.403	0.562	5.77851992677138e-48	MIDN	Malignant cells	GSE108397	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2554
3.2473272496446e-52	-0.280088893236933	0.218	0.384	5.87636339095687e-48	TBX2	Malignant cells	GSE108397	ENSG00000121068	6909	T-box transcription factor 2	NA	protein_coding	Q13207	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2555
3.46821774992178e-52	-0.305361429528927	0.625	0.754	6.27608684025845e-48	EMC10	Malignant cells	GSE108397	ENSG00000161671	284361	ER membrane protein complex subunit 10	C19orf63|HSM1|HSS1|INM02	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2556
3.51271583825195e-52	-0.268654596403783	0.948	0.976	6.35661058090074e-48	NDUFA8	Malignant cells	GSE108397	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2557
4.01593183723936e-52	0.260311689669348	0.391	0.222	7.26723025266835e-48	ST6GAL1	Malignant cells	GSE108397	ENSG00000073849	6480	ST6 beta-galactoside alpha-2,6-sialyltransferase 1	CDw75|SIAT1	protein_coding	P15907	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2558
4.15070360369652e-52	-0.297896256612254	0.745	0.844	7.51111324124922e-48	TWF1	Malignant cells	GSE108397	ENSG00000151239	5756	twinfilin actin binding protein 1	A6|PTK9	protein_coding	Q12792	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2559
4.48649560898257e-52	-0.307305965372426	0.718	0.814	8.11876245401486e-48	RRAGC	Malignant cells	GSE108397	ENSG00000116954	64121	Ras related GTP binding C	FLJ13311|GTR2	protein_coding	Q9HB90	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2560
4.51944114113395e-52	-0.283530231937037	0.273	0.44	8.178380688996e-48	SFMBT1	Malignant cells	GSE108397	ENSG00000163935	51460	Scm like with four mbt domains 1	DKFZp434L243|RU1|SFMBT	protein_coding	Q9UHJ3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2561
4.66949608986598e-52	-0.326812678910846	0.565	0.687	8.44992012422149e-48	SMAP2	Malignant cells	GSE108397	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2562
5.0559019307594e-52	-0.29360862511654	0.804	0.897	9.14916013390222e-48	POLR2D	Malignant cells	GSE108397	ENSG00000144231	5433	RNA polymerase II subunit D	RPB4	protein_coding	O15514	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2563
5.09490693146808e-52	-0.348118633919564	0.644	0.764	9.21974358318464e-48	ALDH3A2	Malignant cells	GSE108397	ENSG00000072210	224	aldehyde dehydrogenase 3 family member A2	ALDH10|FALDH|SLS	protein_coding	P51648	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2564
5.30733512044706e-52	-0.264857636320079	0.2	0.363	9.604153633961e-48	SEC14L2	Malignant cells	GSE108397	ENSG00000100003	23541	SEC14 like lipid binding 2	C22orf6|KIAA1186|KIAA1658|SPF|TAP|TAP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2565
6.69961779465163e-52	0.312159479104217	0.585	0.417	1.21236283612016e-47	FAM229B	Malignant cells	GSE108397	ENSG00000203778	619208	family with sequence similarity 229 member B	C6orf225|DKFZp586F0922|LOC619208	protein_coding	Q4G0N7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2566
6.95334007466272e-52	-0.313614125245159	0.677	0.794	1.25827641991097e-47	ZNF90	Malignant cells	GSE108397	ENSG00000213988	7643	zinc finger protein 90	HTF9	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2567
7.4380531509717e-52	-0.26835475923617	0.856	0.92	1.34599009819984e-47	GOLM1	Malignant cells	GSE108397	ENSG00000135052	51280	golgi membrane protein 1	bA379P1.3|C9orf155|FLJ23608|GOLPH2|GP73	protein_coding	Q8NBJ4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2568
7.44857812177124e-52	0.271519514510299	0.973	0.946	1.34789469691572e-47	MESDC2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2569
7.8880160476427e-52	0.293640970788098	0.518	0.344	1.42741538398142e-47	DYNLL1-AS1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2570
8.52266846419817e-52	-0.322825952462367	0.42	0.578	1.5422620852813e-47	LRWD1	Malignant cells	GSE108397	ENSG00000161036	222229	leucine rich repeats and WD repeat domain containing 1	CENP-33|DKFZp434K1815|ORCA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2571
8.58403367893848e-52	-0.305648991468186	0.383	0.544	1.55336673454071e-47	USP33	Malignant cells	GSE108397	ENSG00000077254	23032	ubiquitin specific peptidase 33	KIAA1097|VDU1	protein_coding	Q8TEY7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2572
8.66780335185402e-52	-0.297646662672362	0.717	0.809	1.5685256945515e-47	TCERG1	Malignant cells	GSE108397	ENSG00000113649	10915	transcription elongation regulator 1	CA150|TAF2S|Urn1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2573
9.38449046795732e-52	-0.267821376323654	0.967	0.984	1.69821739508156e-47	TALDO1	Malignant cells	GSE108397	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2574
1.4837675574885e-51	-0.293903813083197	0.931	0.966	2.68502577203119e-47	SIRPA	Malignant cells	GSE108397	ENSG00000198053	140885	signal regulatory protein alpha	BIT|CD172a|MFR|MYD-1|P84|PTPNS1|SHPS-1|SHPS1|SIRP|SIRP-ALPHA-1|SIRPalpha|SIRPalpha2	protein_coding	P78324	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2575
1.68235697205775e-51	-0.300136526085044	0.353	0.517	3.04439317663571e-47	PACS1	Malignant cells	GSE108397	ENSG00000175115	55690	phosphofurin acidic cluster sorting protein 1	FLJ10209|KIAA1175	protein_coding	Q6VY07	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2576
1.74024648173971e-51	-0.326083904911617	0.414	0.569	3.14915003335618e-47	AATF	Malignant cells	GSE108397	ENSG00000276072	26574	apoptosis antagonizing transcription factor	BFR2|CHE-1|CHE1|DED	protein_coding	Q9NY61	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2577
1.74678440118831e-51	-0.311596941957138	0.533	0.667	3.16098105239037e-47	VPS26B	Malignant cells	GSE108397	ENSG00000151502	112936	VPS26 retromer complex component B	MGC10485|Pep8b	protein_coding	Q4G0F5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2578
1.85707742787262e-51	-0.287877294565864	0.284	0.452	3.3605673134783e-47	DMAP1	Malignant cells	GSE108397	ENSG00000178028	55929	DNA methyltransferase 1 associated protein 1	DNMAP1|DNMTAP1|EAF2|FLJ11543|KIAA1425|MEAF2|SWC4	protein_coding	Q9NPF5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2579
1.87502066179409e-51	-0.261178089850539	0.199	0.359	3.39303738958259e-47	CAMK2G	Malignant cells	GSE108397	ENSG00000148660	818	calcium/calmodulin dependent protein kinase II gamma	CAMKG	protein_coding	Q13555	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2580
1.87938653991912e-51	-0.323629106522207	0.537	0.669	3.40093788263765e-47	AIDA	Malignant cells	GSE108397	ENSG00000186063	64853	axin interactor, dorsalization associated	C1orf80|FLJ12806	protein_coding	Q96BJ3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2581
2.01244480615328e-51	-0.303292829673906	0.723	0.811	3.64172012121498e-47	PCYT2	Malignant cells	GSE108397	ENSG00000185813	5833	phosphate cytidylyltransferase 2, ethanolamine	ET	protein_coding	Q99447	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2582
2.18738379882415e-51	-0.335750257005077	0.687	0.78	3.95828972235219e-47	SFSWAP	Malignant cells	GSE108397	ENSG00000061936	6433	splicing factor SWAP	SFRS8|SWAP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2583
2.21794061247671e-51	-0.254785358749433	0.919	0.961	4.01358533233785e-47	RRP36	Malignant cells	GSE108397	ENSG00000124541	88745	ribosomal RNA processing 36	C6orf153|dJ20C7.4	protein_coding	Q96EU6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2584
2.26937019846861e-51	-0.33817321633567	0.411	0.563	4.1066523111488e-47	CSPG4	Malignant cells	GSE108397	ENSG00000173546	1464	chondroitin sulfate proteoglycan 4	CSPG4A|HMW-MAA|MCSP|MCSPG|MEL-CSPG|MSK16|NG2	protein_coding	Q6UVK1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2585
2.40996159983136e-51	-0.274243848951805	0.206	0.368	4.36106651105483e-47	TRIB1	Malignant cells	GSE108397	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2586
2.47142672059811e-51	-0.291537247184229	0.173	0.329	4.47229379359433e-47	XYLT2	Malignant cells	GSE108397	ENSG00000015532	64132	xylosyltransferase 2	PXYLT2|XT-II	protein_coding	Q9H1B5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2587
2.90211664739164e-51	-0.292810229016314	0.739	0.836	5.25167028511991e-47	ZNF207	Malignant cells	GSE108397	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2588
3.09161902283857e-51	-0.285903345393688	0.197	0.356	5.59459378372868e-47	MGC4294	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2589
3.89486413078399e-51	-0.319038450984796	0.609	0.73	7.0481461310667e-47	DVL2	Malignant cells	GSE108397	ENSG00000004975	1856	dishevelled segment polarity protein 2	NA	protein_coding	O14641	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2590
4.2499228850125e-51	0.258813102143903	0.385	0.219	7.69066045271863e-47	ROPN1	Malignant cells	GSE108397	ENSG00000065371	54763	rhophilin associated tail protein 1	CT91|ODF6|ROPN1A|ropporin	protein_coding	Q9HAT0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2591
4.38492755380872e-51	-0.299303249449784	0.505	0.678	7.93496490137227e-47	LYPD1	Malignant cells	GSE108397	ENSG00000150551	116372	LY6/PLAUR domain containing 1	LYPDC1|MGC29643	protein_coding	Q8N2G4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2592
6.0200915230092e-51	-0.298771502413328	0.598	0.728	1.08939576200375e-46	MACF1	Malignant cells	GSE108397	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2593
6.53241075795722e-51	0.28655259064655	0.807	0.682	1.18210505075994e-46	RNF121	Malignant cells	GSE108397	ENSG00000137522	55298	ring finger protein 121	FLJ11099	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2594
7.23190311462538e-51	-0.330435027114221	0.501	0.641	1.30868518762261e-46	VEZF1	Malignant cells	GSE108397	ENSG00000136451	7716	vascular endothelial zinc finger 1	DB1|ZNF161	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2595
7.46262249103093e-51	-0.320565574810507	0.421	0.573	1.35043616597696e-46	LAMP2	Malignant cells	GSE108397	ENSG00000005893	3920	lysosomal associated membrane protein 2	CD107b	protein_coding	P13473	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2596
7.71372366907999e-51	-0.297353601277198	0.823	0.906	1.39587543515672e-46	RSRC2	Malignant cells	GSE108397	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2597
7.9986116759105e-51	-0.319293428741572	0.379	0.537	1.44742876887276e-46	PCYT1A	Malignant cells	GSE108397	ENSG00000161217	5130	phosphate cytidylyltransferase 1A, choline	CCTalpha|CT|CTPCT|PCYT1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2598
8.52693186809735e-51	0.312678814769303	0.704	0.561	1.5430335908509e-46	COA7	Malignant cells	GSE108397	ENSG00000162377	65260	cytochrome c oxidase assembly factor 7	C1orf163|FLJ12439|RESA1|SELRC1	protein_coding	Q96BR5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2599
9.25256693605607e-51	-0.311665748661395	0.6	0.711	1.67434451274871e-46	DDX54	Malignant cells	GSE108397	ENSG00000123064	79039	DEAD-box helicase 54	APR-5|DP97|MGC2835	protein_coding	Q8TDD1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2600
9.3587836553831e-51	-0.255384595616473	0.95	0.978	1.69356549027812e-46	C19orf60	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2601
1.08837754263929e-50	-0.259522424030005	0.895	0.942	1.96952800116006e-46	RPL7L1	Malignant cells	GSE108397	ENSG00000146223	285855	ribosomal protein L7 like 1	dJ475N16.4	protein_coding	Q6DKI1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2602
1.1378304051059e-50	-0.29143511470531	0.311	0.473	2.05901790107964e-46	PCSK7	Malignant cells	GSE108397	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2603
1.23149811345855e-50	0.313221959970841	0.744	0.609	2.22851898611459e-46	EIF1B	Malignant cells	GSE108397	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2604
1.81779905861409e-50	-0.333883441829398	0.497	0.626	3.28948917646806e-46	TPST2	Malignant cells	GSE108397	ENSG00000128294	8459	tyrosylprotein sulfotransferase 2	TANGO13B	protein_coding	O60704	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2605
1.85867770218739e-50	-0.327606591576225	0.35	0.504	3.3634631698783e-46	NCAPD2	Malignant cells	GSE108397	ENSG00000010292	9918	non-SMC condensin I complex subunit D2	CAP-D2|CNAP1|hCAP-D2|KIAA0159	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2606
1.91268287321034e-50	0.287138915949039	0.981	0.977	3.46119092736143e-46	GLTSCR2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2607
2.04324355702441e-50	-0.290201132828126	0.766	0.845	3.69745354079136e-46	DYNC1I2	Malignant cells	GSE108397	ENSG00000077380	1781	dynein cytoplasmic 1 intermediate chain 2	DIC74|DNCI2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2608
2.65212909301677e-50	-0.325314523944797	0.697	0.82	4.79929280672314e-46	ZYX	Malignant cells	GSE108397	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2609
3.03902289166084e-50	-0.31164485459481	0.707	0.795	5.49941582474946e-46	TRIM47	Malignant cells	GSE108397	ENSG00000132481	91107	tripartite motif containing 47	GOA|RNF100	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2610
3.17659408996273e-50	0.30728028326593	0.761	0.636	5.74836466519655e-46	AGPAT5	Malignant cells	GSE108397	ENSG00000284980	55326	1-acylglycerol-3-phosphate O-acyltransferase 5	FLJ11210|LPAAT-e|LPAAT-epsilon|LPLAT5	protein_coding	Q9NUQ2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2611
3.38383445858479e-50	-0.281744905056086	0.304	0.467	6.12338683625503e-46	TBK1	Malignant cells	GSE108397	ENSG00000183735	29110	TANK binding kinase 1	NAK	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2612
3.4864332010317e-50	-0.266358333585527	0.229	0.39	6.30904952058696e-46	SNX11	Malignant cells	GSE108397	ENSG00000002919	29916	sorting nexin 11	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2613
3.71628456832863e-50	-0.312808928868688	0.577	0.707	6.72498855484749e-46	DPP9	Malignant cells	GSE108397	ENSG00000142002	91039	dipeptidyl peptidase 9	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2614
4.24283901209856e-50	0.251314840501091	0.964	0.937	7.67784147629355e-46	LYRM2	Malignant cells	GSE108397	ENSG00000083099	57226	LYR motif containing 2	DJ122O8.2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2615
5.03294018375175e-50	-0.276021525400311	0.703	0.804	9.10760855651716e-46	YME1L1	Malignant cells	GSE108397	ENSG00000136758	10730	YME1 like 1 ATPase	YME1L	protein_coding	Q96TA2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2616
5.32169023969992e-50	0.286751468196981	0.767	0.623	9.63013065776098e-46	RNASEH2A	Malignant cells	GSE108397	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2617
5.71181843717768e-50	-0.308293366647802	0.474	0.622	1.03361066439167e-45	HDAC8	Malignant cells	GSE108397	ENSG00000147099	55869	histone deacetylase 8	HDACL1|KDAC8|MRXS6|RPD3|WTS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2618
6.04133690406063e-50	0.290023193962817	0.731	0.579	1.09324032615881e-45	TMEM101	Malignant cells	GSE108397	ENSG00000091947	84336	transmembrane protein 101	FLJ23987|MGC4251	protein_coding	Q96IK0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2619
7.85653128765198e-50	-0.318450823201539	0.408	0.555	1.4217179018135e-45	GON4L	Malignant cells	GSE108397	ENSG00000116580	54856	gon-4 like	FLJ20203|GON-4|GON4|YARP	protein_coding	Q3T8J9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2620
7.99991658267884e-50	0.272043754274837	0.381	0.222	1.44766490480156e-45	ROPN1B	Malignant cells	GSE108397	ENSG00000114547	152015	rhophilin associated tail protein 1B	NA	protein_coding	Q9BZX4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2621
8.44803375634279e-50	0.300927299126405	0.882	0.79	1.52875618854779e-45	TMEM87A	Malignant cells	GSE108397	ENSG00000103978	25963	transmembrane protein 87A	DKFZP564G2022	protein_coding	Q8NBN3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2622
8.66301207755882e-50	-0.30764989785235	0.672	0.781	1.56765866555504e-45	UCK1	Malignant cells	GSE108397	ENSG00000130717	83549	uridine-cytidine kinase 1	FLJ12255|URK1	protein_coding	Q9HA47	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2623
8.77317548015171e-50	0.322151070981162	0.712	0.566	1.58759383488825e-45	ENHO	Malignant cells	GSE108397	ENSG00000168913	375704	energy homeostasis associated	C9orf165|UNQ470	protein_coding	Q6UWT2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2624
9.67748166329076e-50	0.285808822896529	0.432	0.266	1.7512370817891e-45	GHR	Malignant cells	GSE108397	ENSG00000112964	2690	growth hormone receptor	GHBP	protein_coding	P10912	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2625
9.92737043147166e-50	-0.312366715297096	0.868	0.925	1.79645695327911e-45	EVA1B	Malignant cells	GSE108397	ENSG00000142694	55194	eva-1 homolog B	C1orf78|FAM176B|FLJ10647	protein_coding	Q9NVM1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2626
1.00531779883895e-49	-0.306551410385351	0.419	0.568	1.81922308877897e-45	NCK1	Malignant cells	GSE108397	ENSG00000158092	4690	NCK adaptor protein 1	NCK|NCKalpha	protein_coding	P16333	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2627
1.06826279405303e-49	0.419716592618831	0.993	0.994	1.93312835211836e-45	PMP22	Malignant cells	GSE108397	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2628
1.11285063553698e-49	0.258904908758264	0.954	0.916	2.01381451006771e-45	RABGGTB	Malignant cells	GSE108397	ENSG00000137955	5876	Rab geranylgeranyltransferase subunit beta	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2629
1.13518721167783e-49	-0.29919099296134	0.646	0.761	2.0542347782522e-45	INPPL1	Malignant cells	GSE108397	ENSG00000165458	3636	inositol polyphosphate phosphatase like 1	SHIP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2630
1.25328778259037e-49	0.270402290207954	0.962	0.929	2.26794957137554e-45	COPS5	Malignant cells	GSE108397	ENSG00000121022	10987	COP9 signalosome subunit 5	CSN5|JAB1|MOV-34|SGN5	protein_coding	Q92905	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2631
1.2551061620098e-49	0.291209260437646	0.905	0.845	2.27124011077293e-45	GOLGA7	Malignant cells	GSE108397	ENSG00000147533	51125	golgin A7	GCP16|GOLGA3AP1|GOLGA7A|HSPC041	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2632
1.36463405857866e-49	-0.278132438174353	0.83	0.9	2.46944179240394e-45	PWP1	Malignant cells	GSE108397	ENSG00000136045	11137	PWP1 homolog, endonuclein	IEF-SSP-9502	protein_coding	Q13610	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2633
1.48054726026569e-49	-0.25635836482924	0.212	0.37	2.6791983221768e-45	SETD4	Malignant cells	GSE108397	ENSG00000185917	54093	SET domain containing 4	C21orf18|C21orf27	protein_coding	Q9NVD3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2634
1.5037397463936e-49	-0.328376810558934	0.521	0.663	2.72116744507387e-45	RGS14	Malignant cells	GSE108397	ENSG00000169220	10636	regulator of G protein signaling 14	NA	protein_coding	O43566	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2635
1.61132371151876e-49	-0.293163298162973	0.77	0.85	2.91585138836435e-45	SUZ12	Malignant cells	GSE108397	ENSG00000178691	23512	SUZ12 polycomb repressive complex 2 subunit	CHET9|JJAZ1|KIAA0160	protein_coding	Q15022	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2636
1.69285604426887e-49	-0.284674996781794	0.804	0.883	3.06339229770895e-45	TGOLN2	Malignant cells	GSE108397	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2637
3.0918069081862e-49	-0.30737965447348	0.446	0.597	5.59493378105374e-45	RAB7L1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2638
3.38580938099041e-49	0.252446699474443	0.969	0.939	6.12696065584025e-45	TMEM179B	Malignant cells	GSE108397	ENSG00000185475	374395	transmembrane protein 179B	NA	protein_coding	Q7Z7N9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2639
3.66564702620313e-49	-0.304842576616693	0.425	0.583	6.63335485861718e-45	LRRC42	Malignant cells	GSE108397	ENSG00000116212	115353	leucine rich repeat containing 42	MGC8974	protein_coding	Q9Y546	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2640
4.47698201310685e-49	0.263247796718838	0.946	0.905	8.10154665091816e-45	FXN	Malignant cells	GSE108397	ENSG00000165060	2395	frataxin	CyaY|FA|FARR|FRDA|X25	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2641
4.69200246800047e-49	-0.273084200691065	0.765	0.86	8.49064766609364e-45	GORASP2	Malignant cells	GSE108397	ENSG00000115806	26003	golgi reassembly stacking protein 2	GOLPH6|GRASP55|GRS2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2642
5.11492133167422e-49	-0.287172584154046	0.28	0.436	9.25596164179766e-45	IL13RA1	Malignant cells	GSE108397	ENSG00000131724	3597	interleukin 13 receptor subunit alpha 1	CD213a1|IL-13Ra|NR4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2643
5.40484362884021e-49	-0.258054170489123	0.252	0.416	9.78060503074924e-45	SLC35A5	Malignant cells	GSE108397	ENSG00000138459	55032	solute carrier family 35 member A5	FLJ20730	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2644
6.1911692020251e-49	0.310762673227776	0.869	0.798	1.12035397879846e-44	MAD2L1	Malignant cells	GSE108397	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2645
6.4794501153113e-49	-0.329697424792851	0.753	0.844	1.17252129286673e-44	TFAP2A	Malignant cells	GSE108397	ENSG00000137203	7020	transcription factor AP-2 alpha	AP-2|AP-2alpha|AP2TF|TFAP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2646
6.96627663220116e-49	-0.33801487083431	0.452	0.592	1.26061741936312e-44	PIP4K2A	Malignant cells	GSE108397	ENSG00000150867	5305	phosphatidylinositol-5-phosphate 4-kinase type 2 alpha	PIP5K2A|PIP5KIIA|PIP5KIIalpha	protein_coding	P48426	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2647
6.97513308312099e-49	-0.304607720916723	0.383	0.542	1.26222008272157e-44	WSB1	Malignant cells	GSE108397	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2648
7.99108551214935e-49	0.283747089583453	0.607	0.436	1.44606683427855e-44	NOP14	Malignant cells	GSE108397	ENSG00000087269	8602	NOP14 nucleolar protein	C4orf9|NOL14|RES4-25|UTP2	protein_coding	P78316	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2649
8.14896630045162e-49	-0.299052280030916	0.333	0.489	1.47463694172973e-44	CAPRIN2	Malignant cells	GSE108397	ENSG00000110888	65981	caprin family member 2	C1QDC1|caprin-2|EEG1|FLJ11391|FLJ22569|RNG140	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2650
8.21971263599495e-49	0.269805876861935	0.914	0.855	1.48743919860965e-44	MRPL10	Malignant cells	GSE108397	ENSG00000159111	124995	mitochondrial ribosomal protein L10	L10MT|MGC17973|MRP-L10|MRP-L8|MRPL8|RPML8	protein_coding	Q7Z7H8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2651
8.45834982412162e-49	0.348689658747482	0.722	0.589	1.53062298417305e-44	FLJ27365	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2652
8.78636224375402e-49	-0.339659649462165	0.394	0.544	1.58998011162973e-44	BARD1	Malignant cells	GSE108397	ENSG00000138376	580	BRCA1 associated RING domain 1	NA	protein_coding	Q99728	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2653
9.11267141448832e-49	-0.294470075084739	0.665	0.774	1.64902901916581e-44	UCK2	Malignant cells	GSE108397	ENSG00000143179	7371	uridine-cytidine kinase 2	UMPK	protein_coding	Q9BZX2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2654
9.20987978394926e-49	-0.342556171550373	0.316	0.473	1.66661984570346e-44	GAPDHS	Malignant cells	GSE108397	ENSG00000105679	26330	glyceraldehyde-3-phosphate dehydrogenase, spermatogenic	GAPD2|GAPDH-2|GAPDS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2655
9.82831358739442e-49	0.393166575032176	0.641	0.483	1.77853162677489e-44	PRSS23	Malignant cells	GSE108397	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2656
9.87706238473695e-49	0.250442199232654	0.403	0.238	1.787353209142e-44	HLA-B	Malignant cells	GSE108397	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2657
1.21759020258732e-48	0.271731594638755	0.968	0.943	2.20335123060202e-44	MOCS2	Malignant cells	GSE108397	ENSG00000164172	4338	molybdenum cofactor synthesis 2	MOCO1|MOCS2A|MOCS2B	protein_coding	O96033	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2658
1.33149792971441e-48	-0.293150933238269	0.28	0.438	2.4094786536112e-44	LAMB1	Malignant cells	GSE108397	ENSG00000091136	3912	laminin subunit beta 1	CLM	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2659
1.36800023785977e-48	-0.293458179269868	0.319	0.485	2.47553323043104e-44	SLC30A7	Malignant cells	GSE108397	ENSG00000162695	148867	solute carrier family 30 member 7	ZNT7|ZnTL2	protein_coding	Q8NEW0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2660
1.52830957090667e-48	-0.278587767372638	0.274	0.446	2.7656289995127e-44	ZNF22	Malignant cells	GSE108397	ENSG00000165512	7570	zinc finger protein 22	HKR-T1|KOX15|Zfp422|ZNF422	protein_coding	P17026	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2661
1.63146321174087e-48	-0.312191277371086	0.361	0.516	2.95229582796628e-44	FAM129B	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2662
1.96500307779064e-48	-0.267586521972809	0.235	0.394	3.55586956956995e-44	PLXNB2	Malignant cells	GSE108397	ENSG00000196576	23654	plexin B2	KIAA0315|MM1|PLEXB2	protein_coding	O15031	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2663
2.19066817113207e-48	-0.313520233331882	0.53	0.658	3.9642331224806e-44	SLAIN2	Malignant cells	GSE108397	ENSG00000109171	57606	SLAIN motif family member 2	FLJ21611|KIAA1458	protein_coding	Q9P270	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2664
2.5548366764957e-48	0.283128136624191	0.834	0.714	4.62323244978662e-44	C14orf119	Malignant cells	GSE108397	ENSG00000179933	55017	chromosome 14 open reading frame 119	FLJ20671	protein_coding	Q9NWQ9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2665
2.8673658403788e-48	-0.263226900018128	0.865	0.93	5.18878522474947e-44	NDFIP1	Malignant cells	GSE108397	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2666
3.21120089514897e-48	-0.2780432704695	0.291	0.452	5.81098913986158e-44	MSTO1	Malignant cells	GSE108397	ENSG00000125459	55154	misato mitochondrial distribution and morphology regulator 1	FLJ10504|LST005|misato|MST	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2667
3.27001217996362e-48	-0.341502600369287	0.501	0.632	5.91741404086216e-44	TCF19	Malignant cells	GSE108397	ENSG00000224472	6941	transcription factor 19	SC1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2668
3.45652275576992e-48	-0.295411879846573	0.579	0.703	6.25492357884125e-44	SUPT6H	Malignant cells	GSE108397	ENSG00000109111	6830	SPT6 homolog, histone chaperone and transcription elongation factor	KIAA0162|SPT6H	protein_coding	Q7KZ85	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2669
4.74340701533163e-48	-0.285035193908689	0.298	0.458	8.58366933494412e-44	MTR	Malignant cells	GSE108397	ENSG00000116984	4548	5-methyltetrahydrofolate-homocysteine methyltransferase	cblG	protein_coding	Q99707	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2670
4.80507016379037e-48	-0.301211382526726	0.316	0.472	8.69525496839506e-44	SKA1	Malignant cells	GSE108397	ENSG00000262634	220134	spindle and kinetochore associated complex subunit 1	C18orf24|MGC10200	protein_coding	Q96BD8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2671
4.90941139642782e-48	-0.31299399937614	0.444	0.586	8.88407086297578e-44	ISY1	Malignant cells	GSE108397	ENSG00000240682	57461	ISY1 splicing factor homolog	fSAP33|KIAA1160	protein_coding	Q9ULR0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2672
5.00097544892588e-48	-0.305994240896259	0.462	0.605	9.04976517237627e-44	CHD1L	Malignant cells	GSE108397	ENSG00000131778	9557	chromodomain helicase DNA binding protein 1 like	ALC1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2673
5.03566635769957e-48	-0.272199227443019	0.904	0.96	9.11254184089314e-44	HNRNPU	Malignant cells	GSE108397	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2674
5.10697760833188e-48	-0.317346344399182	0.388	0.539	9.24158668003736e-44	CIT	Malignant cells	GSE108397	ENSG00000122966	11113	citron rho-interacting serine/threonine kinase	CITK|CRIK|KIAA0949|STK21	protein_coding	O14578	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2675
5.26788615127708e-48	-0.317095290377663	0.476	0.613	9.53276677935101e-44	AEBP1	Malignant cells	GSE108397	ENSG00000106624	165	AE binding protein 1	ACLP	protein_coding	Q8IUX7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2676
5.83870855513782e-48	0.277744794745131	0.728	0.581	1.05657270013774e-43	AGAP2-AS1	Malignant cells	GSE108397	ENSG00000255737	100130776	AGAP2 antisense RNA 1	LOC100130776|PUNISHER	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2677
5.96136759382776e-48	0.284807051094256	0.711	0.568	1.07876907977907e-43	VTA1	Malignant cells	GSE108397	ENSG00000009844	51534	vesicle trafficking 1	C6orf55|HSPC228|My012	protein_coding	Q9NP79	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2678
6.21079435060093e-48	-0.295160819366166	0.252	0.407	1.12390534568474e-43	RAB3A	Malignant cells	GSE108397	ENSG00000105649	5864	RAB3A, member RAS oncogene family	NA	protein_coding	P20336	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2679
7.2868321889401e-48	-0.261580671429784	0.922	0.966	1.3186251529106e-43	DNAJC9	Malignant cells	GSE108397	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2680
7.68876478162201e-48	-0.287776866553479	0.638	0.755	1.39135887488232e-43	GALNT2	Malignant cells	GSE108397	ENSG00000143641	2590	polypeptide N-acetylgalactosaminyltransferase 2	GalNAc-T2	protein_coding	Q10471	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2681
7.96620492964821e-48	-0.301533242928084	0.532	0.673	1.44156444406914e-43	ANKLE2	Malignant cells	GSE108397	ENSG00000176915	23141	ankyrin repeat and LEM domain containing 2	KIAA0692|Lem4|LEMD7	protein_coding	Q86XL3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2682
8.12964288780387e-48	-0.280360086307466	0.732	0.823	1.47114017697699e-43	TBRG1	Malignant cells	GSE108397	ENSG00000154144	84897	transforming growth factor beta regulator 1	FLJ14621|NIAM|TB-5	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2683
9.26719653673033e-48	-0.349737093803157	0.522	0.645	1.67699188528672e-43	PLEKHA5	Malignant cells	GSE108397	ENSG00000052126	54477	pleckstrin homology domain containing A5	FLJ10667|KIAA1686|PEPP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2684
1.02505832665348e-47	0.26985326478803	0.569	0.404	1.85494554791213e-43	MTAP	Malignant cells	GSE108397	ENSG00000099810	4507	methylthioadenosine phosphorylase	c86fus|MSAP	protein_coding	Q13126	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2685
1.02936350966618e-47	-0.28180223525651	0.685	0.793	1.86273620709192e-43	E2F6	Malignant cells	GSE108397	ENSG00000169016	1876	E2F transcription factor 6	E2F-6	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2686
1.12181426242285e-47	-0.254747415408941	0.258	0.42	2.03003508928038e-43	NFRKB	Malignant cells	GSE108397	ENSG00000170322	4798	nuclear factor related to kappaB binding protein	DKFZp547B2013|INO80G	protein_coding	Q6P4R8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2687
1.35936584832001e-47	-0.282050260800974	0.67	0.777	2.45990843911989e-43	NFYC	Malignant cells	GSE108397	ENSG00000066136	4802	nuclear transcription factor Y subunit gamma	CBF-C|NF-YC	protein_coding	Q13952	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2688
1.75436149548407e-47	-0.255777677050565	0.187	0.337	3.17469256222798e-43	BACH1	Malignant cells	GSE108397	ENSG00000156273	571	BTB domain and CNC homolog 1	BACH-1|BTBD24	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2689
1.91854985842593e-47	-0.308198963610298	0.469	0.611	3.47180782380756e-43	RNF138	Malignant cells	GSE108397	ENSG00000134758	51444	ring finger protein 138	NARF|STRIN	protein_coding	Q8WVD3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2690
1.94601085354244e-47	-0.323671158689637	0.421	0.561	3.5215012405704e-43	C6orf62	Malignant cells	GSE108397	ENSG00000112308	81688	chromosome 6 open reading frame 62	DKFZP564G182|FLJ12619|XTP12	protein_coding	Q9GZU0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2691
2.03623027881113e-47	-0.348519328024043	0.409	0.557	3.68476231253662e-43	MAFF	Malignant cells	GSE108397	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2692
2.51362156610435e-47	-0.322391919441189	0.498	0.625	4.54864958602243e-43	ITFG2	Malignant cells	GSE108397	ENSG00000111203	55846	integrin alpha FG-GAP repeat containing 2	FGGAP1|KICS3|MDS028	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2693
3.22241489794782e-47	0.25492121855728	0.425	0.264	5.83128199932638e-43	USP45	Malignant cells	GSE108397	ENSG00000123552	85015	ubiquitin specific peptidase 45	MGC14793	protein_coding	Q70EL2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2694
3.37429495134682e-47	0.303337313232125	0.422	0.267	6.10612414395721e-43	MID1IP1	Malignant cells	GSE108397	ENSG00000165175	58526	MID1 interacting protein 1	FLJ10386|G12-like|MIG12|STRAIT11499|THRSPL	protein_coding	Q9NPA3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2695
3.46001696396294e-47	-0.275459420410865	0.802	0.871	6.26124669798734e-43	USP34	Malignant cells	GSE108397	ENSG00000115464	9736	ubiquitin specific peptidase 34	KIAA0570|KIAA0729	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2696
3.4694368191868e-47	0.270258375527583	0.97	0.932	6.27829286800044e-43	LINC00511	Malignant cells	GSE108397	ENSG00000227036	400619	long intergenic non-protein coding RNA 511	onco-lncRNA-12	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2697
4.37771605955674e-47	-0.252795324709409	0.957	0.982	7.92191498137387e-43	CISD3	Malignant cells	GSE108397	ENSG00000274768	284106	CDGSH iron sulfur domain 3	Miner2|MiNT	protein_coding	P0C7P0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2698
4.55530613713116e-47	-0.312185481725528	0.486	0.618	8.24328198575255e-43	EXOC7	Malignant cells	GSE108397	ENSG00000182473	23265	exocyst complex component 7	BLOM4|EXO70|Exo70p|KIAA1067|YJL085W	protein_coding	Q9UPT5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2699
4.58220520787372e-47	-0.312452722865707	0.543	0.668	8.29195854416828e-43	SMAD2	Malignant cells	GSE108397	ENSG00000175387	4087	SMAD family member 2	JV18-1|MADH2|MADR2	protein_coding	Q15796	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2700
4.73976344105988e-47	-0.313375394934634	0.327	0.489	8.57707592294196e-43	FGFR1	Malignant cells	GSE108397	ENSG00000077782	2260	fibroblast growth factor receptor 1	BFGFR|CD331|CEK|FLG|FLT2|H2|H3|H4|H5|KAL2|N-SAM	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2701
4.78067515222926e-47	0.28499798789412	0.794	0.674	8.65110975547408e-43	TM2D2	Malignant cells	GSE108397	ENSG00000169490	83877	TM2 domain containing 2	BLP1	protein_coding	Q9BX73	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2702
4.87481460605002e-47	-0.289815786023505	0.553	0.691	8.82146451110811e-43	AZIN1	Malignant cells	GSE108397	ENSG00000155096	51582	antizyme inhibitor 1	OAZI|OAZIN|ODC1L	protein_coding	O14977	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2703
5.22653242356458e-47	0.29122940106051	0.675	0.526	9.45793307368247e-43	MRPS27	Malignant cells	GSE108397	ENSG00000113048	23107	mitochondrial ribosomal protein S27	KIAA0264	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2704
5.41857452982252e-47	-0.257762739455531	0.235	0.39	9.80545246916683e-43	SFI1	Malignant cells	GSE108397	ENSG00000198089	9814	SFI1 centrin binding protein	KIAA0542|PISD|PPP1R139	protein_coding	A8K8P3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2705
5.4976677801856e-47	-0.304444506707136	0.365	0.516	9.94857961502387e-43	SLU7	Malignant cells	GSE108397	ENSG00000164609	10569	SLU7 homolog, splicing factor	9G8	protein_coding	O95391	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2706
5.66041852171065e-47	-0.292655425040171	0.5	0.642	1.02430933568876e-42	U2AF2	Malignant cells	GSE108397	ENSG00000063244	11338	U2 small nuclear RNA auxiliary factor 2	U2AF65	protein_coding	P26368	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2707
5.72101673910417e-47	-0.304951359797434	0.415	0.562	1.03527518910829e-42	RFC5	Malignant cells	GSE108397	ENSG00000111445	5985	replication factor C subunit 5	RFC36	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2708
6.3360832545343e-47	-0.287621879220839	0.391	0.546	1.14657762574053e-42	NDRG3	Malignant cells	GSE108397	ENSG00000101079	57446	NDRG family member 3	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2709
6.62282526788212e-47	0.281499457064196	0.773	0.648	1.19846646047595e-42	PCBP4	Malignant cells	GSE108397	ENSG00000090097	57060	poly(rC) binding protein 4	LIP4|MCG10	protein_coding	P57723	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2710
8.10114977773879e-47	-0.302913934266521	0.508	0.638	1.46598406377961e-42	PRKCSH	Malignant cells	GSE108397	ENSG00000130175	5589	protein kinase C substrate 80K-H	G19P1|GIIB|PCLD|PLD1|VASAP-60	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2711
1.05641168877147e-46	-0.297322009834376	0.495	0.635	1.91168259200085e-42	DCK	Malignant cells	GSE108397	ENSG00000156136	1633	deoxycytidine kinase	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2712
1.16291909361324e-46	-0.291016883194853	0.335	0.496	2.10441839180253e-42	CASP4	Malignant cells	GSE108397	ENSG00000196954	837	caspase 4	ICE(rel)II|ICH-2|TX	protein_coding	P49662	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2713
1.1724727204085e-46	-0.31341355349917	0.389	0.538	2.12170663485122e-42	HK2	Malignant cells	GSE108397	ENSG00000159399	3099	hexokinase 2	NA	protein_coding	P52789	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2714
1.35250082734929e-46	0.274292794273242	0.629	0.47	2.44748549717128e-42	GABRB3	Malignant cells	GSE108397	ENSG00000166206	2562	gamma-aminobutyric acid type A receptor subunit beta3	NA	protein_coding	P28472	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2715
1.35739770308171e-46	-0.290276470019305	0.362	0.512	2.45634688349666e-42	FOXK2	Malignant cells	GSE108397	ENSG00000141568	3607	forkhead box K2	ILF|ILF1	protein_coding	Q01167	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2716
1.43922532414595e-46	-0.306991546655524	0.439	0.582	2.60442214657452e-42	GSDMD	Malignant cells	GSE108397	ENSG00000278718	79792	gasdermin D	DF5L|FLJ12150|GSDMDC1	protein_coding	P57764	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2717
1.484711238694e-46	0.296887815716891	0.77	0.649	2.68673345754066e-42	PSIP1	Malignant cells	GSE108397	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2718
1.71051510085895e-46	-0.31014593245828	0.464	0.604	3.09534812651436e-42	ZNF800	Malignant cells	GSE108397	ENSG00000048405	168850	zinc finger protein 800	NA	protein_coding	Q2TB10	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2719
2.00164822036415e-46	0.287461297202841	0.802	0.687	3.62218261957096e-42	C1orf123	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2720
2.04849102281127e-46	0.289537215650649	0.725	0.583	3.70694935487927e-42	FAM104B	Malignant cells	GSE108397	ENSG00000182518	90736	family with sequence similarity 104 member B	CXorf44|FLJ20434	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2721
2.08411467210089e-46	0.280444116957733	0.811	0.711	3.77141391063376e-42	COMMD1	Malignant cells	GSE108397	ENSG00000173163	150684	copper metabolism domain containing 1	C2orf5|MGC27155|MURR1	protein_coding	Q8N668	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2722
2.21611455369328e-46	-0.295895732303842	0.395	0.544	4.01028089636336e-42	LUC7L	Malignant cells	GSE108397	ENSG00000007392	55692	LUC7 like	hLuc7B1|Luc7|LUC7B1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2723
2.88852969319641e-46	-0.271083784152189	0.315	0.475	5.22708333280823e-42	ITSN1	Malignant cells	GSE108397	ENSG00000205726	6453	intersectin 1	ITSN|MGC134948|MGC134949|SH3D1A|SH3P17	protein_coding	Q15811	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2724
3.11843536052171e-46	0.271496026532941	0.376	0.218	5.64312062840008e-42	TGFB1	Malignant cells	GSE108397	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2725
3.29094211450458e-46	-0.289083232808139	0.8	0.892	5.95528885040748e-42	SLC20A1	Malignant cells	GSE108397	ENSG00000144136	6574	solute carrier family 20 member 1	Glvr-1|GLVR1|PiT-1|PiT1	protein_coding	Q8WUM9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2726
3.42360365365961e-46	-0.283258829117197	0.711	0.808	6.19535317166243e-42	AFF4	Malignant cells	GSE108397	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2727
3.94038509233109e-46	-0.287064829457352	0.375	0.532	7.13052086308234e-42	RNF216	Malignant cells	GSE108397	ENSG00000011275	54476	ring finger protein 216	TRIAD3|UBCE7IP1|ZIN	protein_coding	Q9NWF9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2728
3.946585833287e-46	-0.278489997486098	0.708	0.798	7.14174172391616e-42	REXO4	Malignant cells	GSE108397	ENSG00000280706	57109	REX4 homolog, 3'-5' exonuclease	hPMC2|XPMC2H	protein_coding	Q9GZR2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2729
4.0426084852532e-46	-0.289595272815768	0.556	0.685	7.31550431491419e-42	COPS7B	Malignant cells	GSE108397	ENSG00000144524	64708	COP9 signalosome subunit 7B	CSN7B	protein_coding	Q9H9Q2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2730
4.12458987782865e-46	-0.31298357929055	0.61	0.73	7.46385784291873e-42	ODF2L	Malignant cells	GSE108397	ENSG00000122417	57489	outer dense fiber of sperm tails 2 like	KIAA1229	protein_coding	Q9ULJ1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2731
4.2423653946976e-46	-0.281975039238052	0.615	0.731	7.67698441824478e-42	ARMC8	Malignant cells	GSE108397	ENSG00000114098	25852	armadillo repeat containing 8	DKFZP434A043|GID5|HSPC056|VID28	protein_coding	Q8IUR7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2732
4.29580146216223e-46	-0.28507648201219	0.783	0.858	7.77368232592877e-42	C21orf33	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2733
4.46790402839488e-46	0.264800815786249	0.561	0.397	8.08511912978338e-42	WDR41	Malignant cells	GSE108397	ENSG00000164253	55255	WD repeat domain 41	FLJ10904	protein_coding	Q9HAD4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2734
4.50888275853572e-46	-0.285785941265457	0.315	0.47	8.15927423984623e-42	TLE1	Malignant cells	GSE108397	ENSG00000196781	7088	TLE family member 1, transcriptional corepressor	ESG|ESG1|GRG1|TLE-1	protein_coding	Q04724	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2735
4.77133805093887e-46	-0.314510275348366	0.445	0.587	8.63421333697897e-42	SRRT	Malignant cells	GSE108397	ENSG00000087087	51593	serrate, RNA effector molecule	ARS2|Asr2|serrate	protein_coding	Q9BXP5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2736
5.29708569221507e-46	-0.282811313417373	0.312	0.467	9.58560626863239e-42	TMUB2	Malignant cells	GSE108397	ENSG00000168591	79089	transmembrane and ubiquitin like domain containing 2	MGC3123	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2737
6.35877111435347e-46	0.285755533934073	0.598	0.443	1.1506832208534e-41	RENBP	Malignant cells	GSE108397	ENSG00000102032	5973	renin binding protein	RBP|RNBP	protein_coding	P51606	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2738
7.12802380307415e-46	-0.294278883290231	0.329	0.48	1.2898871874043e-41	SERTAD2	Malignant cells	GSE108397	ENSG00000179833	9792	SERTA domain containing 2	KIAA0127|Sei-2|TRIP-Br2	protein_coding	Q14140	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2739
7.6004559264302e-46	-0.344589257513552	0.456	0.591	1.37537850444681e-41	UNG	Malignant cells	GSE108397	ENSG00000076248	7374	uracil DNA glycosylase	DGU|HIGM4|UDG|UNG1|UNG2	protein_coding	P13051	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2740
7.61691345070155e-46	-0.306340133214183	0.478	0.616	1.37835665803895e-41	CANT1	Malignant cells	GSE108397	ENSG00000171302	124583	calcium activated nucleotidase 1	SCAN-1|SHAPY	protein_coding	Q8WVQ1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2741
1.05186871618093e-45	-0.300947120929789	0.506	0.645	1.90346162880102e-41	SLC39A14	Malignant cells	GSE108397	ENSG00000104635	23516	solute carrier family 39 member 14	KIAA0062|NET34|ZIP14	protein_coding	Q15043	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2742
1.15472228852041e-45	-0.295305420291624	0.678	0.788	2.08958545330653e-41	DYNC1I1	Malignant cells	GSE108397	ENSG00000158560	1780	dynein cytoplasmic 1 intermediate chain 1	DNCI1|DNCIC1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2743
1.19963328197446e-45	0.29451742891565	0.769	0.657	2.17085638706099e-41	TJP1	Malignant cells	GSE108397	ENSG00000277401	7082	tight junction protein 1	DKFZp686M05161|MGC133289|ZO-1	protein_coding	Q07157	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2744
1.35863309088842e-45	-0.272957017912162	0.323	0.476	2.45858244127169e-41	DHX37	Malignant cells	GSE108397	ENSG00000150990	57647	DEAH-box helicase 37	DDX37|Dhr1|KIAA1517|MGC2695|MGC4322	protein_coding	Q8IY37	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2745
1.64898843626966e-45	-0.300880663981697	0.542	0.663	2.98400947427358e-41	TMEM184B	Malignant cells	GSE108397	ENSG00000198792	25829	transmembrane protein 184B	C22orf5|DKFZP586A1024|FM08|HS5O6A	protein_coding	Q9Y519	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2746
1.66321506893636e-45	0.34895920878661	0.473	0.318	3.00975398874723e-41	PNRC1	Malignant cells	GSE108397	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2747
1.76012924259602e-45	0.287339637840943	0.72	0.588	3.18512987740176e-41	RELL2	Malignant cells	GSE108397	ENSG00000164620	285613	RELT like 2	C5orf16|FLJ90583	protein_coding	Q8NC24	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2748
1.80433346886869e-45	0.305692507211441	0.816	0.722	3.26512184526478e-41	CENPK	Malignant cells	GSE108397	ENSG00000123219	64105	centromere protein K	CENP-K|FKSG14|SOLT	protein_coding	Q9BS16	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2749
1.97604499113777e-45	-0.264342451093083	0.266	0.418	3.57585101596291e-41	RPS6KA1	Malignant cells	GSE108397	ENSG00000281877	6195	ribosomal protein S6 kinase A1	HU-1|MAPKAPK1|p90Rsk|RSK1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2750
2.16426631077012e-45	-0.25894581017795	0.252	0.405	3.91645631596961e-41	RAD54L2	Malignant cells	GSE108397	ENSG00000164080	23132	RAD54 like 2	ARIP4|KIAA0809|SRISNF2L	protein_coding	Q9Y4B4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2751
2.24177579916826e-45	0.277921925091608	0.678	0.522	4.05671748617488e-41	ZNF131	Malignant cells	GSE108397	ENSG00000172262	7690	zinc finger protein 131	pHZ-10|ZBTB35	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2752
2.27426631228651e-45	-0.265722731215477	0.292	0.448	4.11551231871367e-41	TNFRSF10B	Malignant cells	GSE108397	ENSG00000120889	8795	TNF receptor superfamily member 10b	CD262|DR5|KILLER|TRAIL-R2|TRAILR2|TRICK2A|TRICKB	protein_coding	O14763	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2753
2.48393564091449e-45	0.255071317012478	0.56	0.39	4.49492993579885e-41	EID2	Malignant cells	GSE108397	ENSG00000176396	163126	EP300 interacting inhibitor of differentiation 2	CRI2|EID-2|MGC20452	protein_coding	Q8N6I1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2754
2.56673325300363e-45	-0.290334857051496	0.401	0.546	4.64476049463537e-41	HYOU1	Malignant cells	GSE108397	ENSG00000280682	10525	hypoxia up-regulated 1	Grp170|HSP12A|ORP150	protein_coding	Q9Y4L1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2755
2.61270471589259e-45	-0.250845656260658	0.203	0.352	4.72795045387923e-41	MARK2	Malignant cells	GSE108397	ENSG00000072518	2011	microtubule affinity regulating kinase 2	EMK1|PAR-1|PAR-1B|Par1b	protein_coding	Q7KZI7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2756
2.68130490416728e-45	0.287363259139314	0.573	0.418	4.85208935458111e-41	CC2D2A	Malignant cells	GSE108397	ENSG00000048342	57545	coiled-coil and C2 domain containing 2A	JBTS9|KIAA1345|MKS6	protein_coding	Q9P2K1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2757
2.72075515361254e-45	-0.289747335893858	0.663	0.757	4.92347852597725e-41	SCYL1	Malignant cells	GSE108397	ENSG00000142186	57410	SCY1 like pseudokinase 1	GKLP|HT019|MGC78454|NKTL|NTKL|P105|TAPK|TEIF|TRAP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2758
3.53429814764047e-45	0.293579493550211	0.374	0.224	6.3956659279702e-41	LY96	Malignant cells	GSE108397	ENSG00000154589	23643	lymphocyte antigen 96	MD-2	protein_coding	Q9Y6Y9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2759
3.72591548445993e-45	-0.294233526219068	0.307	0.459	6.74241666067869e-41	CKAP5	Malignant cells	GSE108397	ENSG00000175216	9793	cytoskeleton associated protein 5	ch-TOG|KIAA0097|TOG|TOGp	protein_coding	Q14008	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2760
3.73804887995533e-45	-0.253146688076399	0.244	0.397	6.76437325316717e-41	SGPL1	Malignant cells	GSE108397	ENSG00000166224	8879	sphingosine-1-phosphate lyase 1	SPL	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2761
4.16900205252533e-45	-0.297235674933562	0.419	0.565	7.54422611424983e-41	NACC2	Malignant cells	GSE108397	ENSG00000148411	138151	NACC family member 2	BEND9|BTBD14A|BTBD31|MGC23427	protein_coding	Q96BF6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2762
4.81902246411496e-45	0.259777432017452	0.477	0.318	8.72050305106244e-41	GTF2B	Malignant cells	GSE108397	ENSG00000137947	2959	general transcription factor IIB	TFIIB	protein_coding	Q00403	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2763
4.98899856032167e-45	0.253299390668756	0.978	0.965	9.02809179475809e-41	PTP4A2	Malignant cells	GSE108397	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2764
5.23430258366516e-45	-0.309977018612903	0.504	0.628	9.47199395540048e-41	HELZ	Malignant cells	GSE108397	ENSG00000198265	9931	helicase with zinc finger	DHRC|HUMORF5|KIAA0054	protein_coding	P42694	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2765
5.35629229324354e-45	-0.288443922151252	0.531	0.667	9.69274653385351e-41	GALNT11	Malignant cells	GSE108397	ENSG00000178234	63917	polypeptide N-acetylgalactosaminyltransferase 11	GalNAc-T11	protein_coding	Q8NCW6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2766
6.67235016145398e-45	-0.276026357796741	0.688	0.791	1.20742848521671e-40	RNF14	Malignant cells	GSE108397	ENSG00000013561	9604	ring finger protein 14	ARA54|HFB30|TRIAD2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2767
6.90494481064724e-45	-0.289373552775147	0.458	0.594	1.24951881293472e-40	UBA1	Malignant cells	GSE108397	ENSG00000130985	7317	ubiquitin like modifier activating enzyme 1	A1S9T|CFAP124|GXP1|POC20|UBE1|UBE1X	protein_coding	P22314	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2768
7.53323328193492e-45	0.296732662103731	0.747	0.634	1.36321389469894e-40	CIB2	Malignant cells	GSE108397	ENSG00000136425	10518	calcium and integrin binding family member 2	DFNB48|KIP2|USH1J	protein_coding	O75838	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2769
7.59104854545424e-45	-0.29899970623563	0.369	0.514	1.3736761447854e-40	KLHL21	Malignant cells	GSE108397	ENSG00000162413	9903	kelch like family member 21	KIAA0469	protein_coding	Q9UJP4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2770
7.65211665168194e-45	-0.287120161816748	0.357	0.509	1.38472702928836e-40	ZNF394	Malignant cells	GSE108397	ENSG00000160908	84124	zinc finger protein 394	FLJ12298|ZKSCAN14|ZSCAN46	protein_coding	Q53GI3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2771
8.13984619560525e-45	-0.291402998016792	0.996	0.997	1.47298656755673e-40	PTTG1	Malignant cells	GSE108397	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2772
8.47623871327749e-45	0.302533569278127	0.642	0.492	1.53386015755469e-40	SKP2	Malignant cells	GSE108397	ENSG00000145604	6502	S-phase kinase associated protein 2	FBL1|FBXL1|p45	protein_coding	Q13309	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2773
8.5453545732099e-45	-0.298769942561501	0.508	0.639	1.54636736356806e-40	USO1	Malignant cells	GSE108397	ENSG00000138768	8615	USO1 vesicle transport factor	p115|TAP|VDP	protein_coding	O60763	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2774
9.32346827825834e-45	-0.357142868898899	0.841	0.919	1.68717481963363e-40	CDC20	Malignant cells	GSE108397	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2775
9.95394565939377e-45	-0.294251626629718	0.4	0.548	1.8012660065239e-40	KMT2C	Malignant cells	GSE108397	ENSG00000055609	58508	lysine methyltransferase 2C	HALR|KIAA1506|MLL3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2776
1.18051591485156e-44	-0.291517215063908	0.347	0.497	2.13626159951539e-40	PLIN3	Malignant cells	GSE108397	ENSG00000105355	10226	perilipin 3	M6PRBP1|PP17|TIP47	protein_coding	O60664	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2777
1.21189712047825e-44	-0.290478314598909	0.582	0.698	2.19304902921745e-40	UBQLN1	Malignant cells	GSE108397	ENSG00000135018	29979	ubiquilin 1	DA41|DSK2|PLIC-1|XDRP1	protein_coding	Q9UMX0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2778
1.22071147260586e-44	-0.288454707006656	0.629	0.743	2.20899948082757e-40	PRPF8	Malignant cells	GSE108397	ENSG00000274442	10594	pre-mRNA processing factor 8	hPrp8|Prp8|PRPC8|RP13|SNRNP220	protein_coding	Q6P2Q9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2779
1.27409208882237e-44	-0.275263237757978	0.283	0.436	2.30559704393296e-40	ZNFX1	Malignant cells	GSE108397	ENSG00000124201	57169	zinc finger NFX1-type containing 1	FLJ11277|KIAA1404	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2780
1.32912019448053e-44	-0.257516458415677	0.296	0.452	2.40517590393196e-40	MPHOSPH9	Malignant cells	GSE108397	ENSG00000051825	10198	M-phase phosphoprotein 9	MPP9	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2781
1.36287111672756e-44	-0.260226657465371	0.315	0.47	2.46625157283019e-40	ZNF444	Malignant cells	GSE108397	ENSG00000167685	55311	zinc finger protein 444	EZF2|FLJ11137|ZSCAN17	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2782
1.72759448549383e-44	-0.289420992509618	0.396	0.546	3.12625498094963e-40	CCNL2	Malignant cells	GSE108397	ENSG00000221978	81669	cyclin L2	ania-6b|CCNM|CCNS|HLA-ISO|PCEE|SB138	protein_coding	Q96S94	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2783
1.96152106771233e-44	-0.287212652804207	0.395	0.541	3.54956852413223e-40	DCTN4	Malignant cells	GSE108397	ENSG00000132912	51164	dynactin subunit 4	Dyn4|p62	protein_coding	Q9UJW0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2784
1.99174066444366e-44	-0.29435527092379	0.449	0.593	3.60425390637725e-40	POLR2B	Malignant cells	GSE108397	ENSG00000047315	5431	RNA polymerase II subunit B	RPB2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2785
2.02248126692404e-44	0.262759615868486	0.407	0.25	3.65988210062575e-40	RP11-163N6.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2786
2.15231449305457e-44	0.26787605311275	0.532	0.374	3.89482830663155e-40	LRTOMT	Malignant cells	GSE108397	ENSG00000284922	220074	leucine rich transmembrane and O-methyltransferase domain containing	CFAP111|COMT2|DFNB63|LRRC51|LRTOMT1|LRTOMT2	protein_coding	Q8WZ04	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2787
2.30924198849411e-44	-0.275524317513546	0.213	0.365	4.17880430237894e-40	EFCAB7	Malignant cells	GSE108397	ENSG00000203965	84455	EF-hand calcium binding domain 7	KIAA1799|RP4-534K7.1	protein_coding	A8K855	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2788
2.36966527757184e-44	-0.257154894738044	0.276	0.428	4.288146286294e-40	PRKACA	Malignant cells	GSE108397	ENSG00000288516	5566	protein kinase cAMP-activated catalytic subunit alpha	PKACa	protein_coding	P17612	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2789
2.47597577169616e-44	-0.298361612060776	0.445	0.586	4.48052575646137e-40	SUCO	Malignant cells	GSE108397	ENSG00000094975	51430	SUN domain containing ossification factor	C1orf9|CH1|OPT|SLP1	protein_coding	Q9UBS9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2790
2.65327842411229e-44	-0.282952294022933	0.672	0.768	4.80137263627361e-40	ELP6	Malignant cells	GSE108397	ENSG00000163832	54859	elongator acetyltransferase complex subunit 6	C3orf75|FLJ20211|TMEM103	protein_coding	Q0PNE2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2791
2.84619532058451e-44	-0.297091703524003	0.584	0.704	5.15047505212973e-40	EIF5A2	Malignant cells	GSE108397	ENSG00000163577	56648	eukaryotic translation initiation factor 5A2	NA	protein_coding	Q9GZV4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2792
3.27427740166981e-44	-0.279837905255486	0.389	0.537	5.9251323860617e-40	PI4KA	Malignant cells	GSE108397	ENSG00000241973	5297	phosphatidylinositol 4-kinase alpha	PI4K-ALPHA|pi4K230|PIK4CA	protein_coding	P42356	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2793
3.88605723639262e-44	0.28038604833122	0.848	0.742	7.03220917497608e-40	SLC2A4RG	Malignant cells	GSE108397	ENSG00000125520	56731	SLC2A4 regulator	GEF|HDBP1|Si-1-2|Si-1-2-19	protein_coding	Q9NR83	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2794
4.11196102410851e-44	-0.299332019310368	0.697	0.793	7.44100466922676e-40	ARHGAP4	Malignant cells	GSE108397	ENSG00000089820	393	Rho GTPase activating protein 4	C1|KIAA0131|p115|RhoGAP4|SrGAP4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2795
4.15558004406957e-44	0.283116546194397	0.595	0.443	7.51993764774829e-40	ADAM10	Malignant cells	GSE108397	ENSG00000137845	102	ADAM metallopeptidase domain 10	CD156C|HsT18717|kuz|MADM	protein_coding	O14672	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2796
4.70252524330935e-44	0.265709095671796	0.968	0.949	8.50968968029259e-40	EPB41L4A-AS1	Malignant cells	GSE108397	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2797
4.76426143132137e-44	-0.278874881083768	0.337	0.488	8.62140748611915e-40	LACTB	Malignant cells	GSE108397	ENSG00000103642	114294	lactamase beta	FLJ14902|MRPL56	protein_coding	P83111	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2798
5.02624115332647e-44	-0.259912379460999	0.806	0.88	9.09548599105959e-40	STOM	Malignant cells	GSE108397	ENSG00000148175	2040	stomatin	BND7|EPB7|EPB72	protein_coding	P27105	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2799
5.86247588746937e-44	-0.266483628482065	0.234	0.381	1.06087363659646e-39	C4orf32	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2800
6.05681097718914e-44	-0.315363383408767	0.54	0.659	1.09604051443215e-39	PBRM1	Malignant cells	GSE108397	ENSG00000163939	55193	polybromo 1	BAF180|PB1|SMARCH1	protein_coding	Q86U86	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2801
6.41089219352542e-44	0.280215889885994	0.819	0.707	1.16011505134036e-39	HDGFRP3	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2802
6.97872861521355e-44	-0.295509605711573	0.654	0.754	1.26287073020904e-39	PAFAH1B2	Malignant cells	GSE108397	ENSG00000168092	5049	platelet activating factor acetylhydrolase 1b catalytic subunit 2	NA	protein_coding	P68402	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2803
9.94906148877111e-44	-0.279973626108976	0.352	0.504	1.80038216700802e-39	FHOD1	Malignant cells	GSE108397	ENSG00000135723	29109	formin homology 2 domain containing 1	FHOS	protein_coding	Q9Y613	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2804
1.01719462910584e-43	-0.272293614494643	0.631	0.742	1.84071540082992e-39	DPM3	Malignant cells	GSE108397	ENSG00000179085	54344	dolichyl-phosphate mannosyltransferase subunit 3, regulatory	MGC125904|MGC125905|MGC34275	protein_coding	Q9P2X0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2805
1.07392755311277e-43	-0.294083397361048	0.705	0.806	1.94337930011287e-39	UAP1	Malignant cells	GSE108397	ENSG00000117143	6675	UDP-N-acetylglucosamine pyrophosphorylase 1	AgX|AGX1|SPAG2	protein_coding	Q16222	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2806
1.07979204833628e-43	-0.266341298910811	0.781	0.862	1.95399169066934e-39	SPR	Malignant cells	GSE108397	ENSG00000116096	6697	sepiapterin reductase	SDR38C1	protein_coding	P35270	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2807
1.12690679469754e-43	-0.261342274212791	0.88	0.935	2.03925053568467e-39	RBM25	Malignant cells	GSE108397	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2808
1.18289083406547e-43	-0.256902210275156	0.817	0.881	2.14055925332487e-39	TMED1	Malignant cells	GSE108397	ENSG00000099203	11018	transmembrane p24 trafficking protein 1	Il1rl1l|IL1RL1LG|MGC1270|p24g1|p24gamma1|ST2L	protein_coding	Q13445	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2809
1.38191530512254e-43	-0.308978626129807	0.527	0.648	2.50071393614974e-39	TMEM50B	Malignant cells	GSE108397	ENSG00000263160	757	transmembrane protein 50B	C21orf4	protein_coding	P56557	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2810
1.39700635393416e-43	-0.286546467053461	0.441	0.582	2.52802269807925e-39	STARD3	Malignant cells	GSE108397	ENSG00000131748	10948	StAR related lipid transfer domain containing 3	es64|MLN64	protein_coding	Q14849	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2811
1.4112788846728e-43	-0.275243573140589	0.794	0.865	2.55385026970389e-39	ACADM	Malignant cells	GSE108397	ENSG00000117054	34	acyl-CoA dehydrogenase medium chain	ACAD1|MCAD|MCADH	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2812
1.45026078569999e-43	-0.305210016884286	0.559	0.678	2.62439191780271e-39	FAM60A	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2813
1.61486599498058e-43	-0.296632208561771	0.609	0.73	2.92226150451685e-39	GNAI3	Malignant cells	GSE108397	ENSG00000065135	2773	G protein subunit alpha i3	87U6	protein_coding	P08754	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2814
1.64940982389567e-43	-0.292602032665717	0.564	0.682	2.9847720173216e-39	CIZ1	Malignant cells	GSE108397	ENSG00000148337	25792	CDKN1A interacting zinc finger protein 1	LSFR1|ZNF356	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2815
1.87035512335337e-43	-0.262377077227734	0.315	0.467	3.38459463122025e-39	AP2A2	Malignant cells	GSE108397	ENSG00000280759	161	adaptor related protein complex 2 subunit alpha 2	ADTAB|CLAPA2|DKFZP564D1864|HIP9|HYPJ|KIAA0899	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2816
1.89540698224824e-43	-0.29550859014275	0.601	0.722	3.42992847507641e-39	RNF168	Malignant cells	GSE108397	ENSG00000163961	165918	ring finger protein 168	FLJ35794	protein_coding	Q8IYW5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2817
1.90288361841775e-43	0.253733815199327	0.95	0.924	3.44345819588876e-39	EIF4B	Malignant cells	GSE108397	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2818
1.98726985929192e-43	-0.305605480659631	0.422	0.561	3.59616353737465e-39	DOCK10	Malignant cells	GSE108397	ENSG00000135905	55619	dedicator of cytokinesis 10	KIAA0694|ZIZ3	protein_coding	Q96BY6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2819
2.01173044979763e-43	-0.314754783546123	0.402	0.541	3.6404274219538e-39	CD83	Malignant cells	GSE108397	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2820
2.36068154930702e-43	-0.329222902994006	0.909	0.951	4.27188933162598e-39	SLC3A2	Malignant cells	GSE108397	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2821
2.49936598158485e-43	-0.284253203865308	0.378	0.527	4.52285268027594e-39	TRIM25	Malignant cells	GSE108397	ENSG00000121060	7706	tripartite motif containing 25	EFP|RNF147|ZNF147	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2822
2.55294469433114e-43	-0.277877022476954	0.741	0.822	4.61980871886163e-39	TTC1	Malignant cells	GSE108397	ENSG00000113312	7265	tetratricopeptide repeat domain 1	TPR1	protein_coding	Q99614	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2823
2.66161889929599e-43	-0.326341998722822	0.681	0.8	4.81646556016602e-39	CDC42EP3	Malignant cells	GSE108397	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2824
2.86548573500716e-43	0.258992636582853	0.578	0.422	5.18538298606896e-39	CTC-524C5.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2825
4.79298177116209e-43	-0.292685923947402	0.317	0.461	8.67337981309492e-39	CCDC18	Malignant cells	GSE108397	ENSG00000122483	343099	coiled-coil domain containing 18	NY-SAR-41	protein_coding	Q5T9S5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2826
4.84541512278582e-43	-0.275325225772049	0.208	0.35	8.76826320619321e-39	RIT1	Malignant cells	GSE108397	ENSG00000143622	6016	Ras like without CAAX 1	MGC125864|MGC125865|RIBB|RIT|ROC1	protein_coding	Q92963	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2827
6.09414725138692e-43	-0.264688996381016	0.739	0.833	1.10279688661098e-38	PRPF31	Malignant cells	GSE108397	ENSG00000274651	26121	pre-mRNA processing factor 31	hPrp31|NY-BR-99|PRP31|RP11|SNRNP61	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2828
7.23719674716967e-43	-0.291514012571339	0.67	0.775	1.30964312336782e-38	GARS	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2829
7.71388830385563e-43	0.291110322502705	0.823	0.723	1.39590522746571e-38	C1D	Malignant cells	GSE108397	ENSG00000197223	10438	C1D nuclear receptor corepressor	LRP1|Rrp47|SUN-CoR|SUNCOR	protein_coding	Q13901	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2830
8.36118353864609e-43	-0.272807722144441	0.675	0.769	1.5130397731534e-38	B4GALT3	Malignant cells	GSE108397	ENSG00000158850	8703	beta-1,4-galactosyltransferase 3	beta4Gal-T3	protein_coding	O60512	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2831
8.74544472330297e-43	-0.288844149375745	0.563	0.692	1.58257567712891e-38	CYB561A3	Malignant cells	GSE108397	ENSG00000162144	220002	cytochrome b561 family member A3	CYBASC3	protein_coding	Q8NBI2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2832
9.12735717335549e-43	-0.302669638227617	0.491	0.616	1.65168655409041e-38	CAMK4	Malignant cells	GSE108397	ENSG00000152495	814	calcium/calmodulin dependent protein kinase IV	CaMK-GR|CaMKIV	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2833
1.02284296353014e-42	-0.344702026637309	0.471	0.608	1.85093662680415e-38	SLC12A2	Malignant cells	GSE108397	ENSG00000064651	6558	solute carrier family 12 member 2	BSC-2|BSC2|CCC1|NKCC1|PPP1R141	protein_coding	P55011	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2834
1.03242672470569e-42	-0.296661609914923	0.532	0.654	1.86827940102742e-38	THYN1	Malignant cells	GSE108397	ENSG00000151500	29087	thymocyte nuclear protein 1	THY28	protein_coding	Q9P016	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2835
1.25281954582712e-42	-0.284642067682178	0.456	0.595	2.26710225012876e-38	CLSTN1	Malignant cells	GSE108397	ENSG00000171603	22883	calsyntenin 1	CDHR12|CSTN1|KIAA0911	protein_coding	O94985	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2836
1.27767804715153e-42	-0.260490331886572	0.732	0.833	2.31208619412541e-38	AC010642.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2837
1.51153332976733e-42	-0.291324096123671	0.694	0.785	2.73527071354697e-38	FBXW11	Malignant cells	GSE108397	ENSG00000072803	23291	F-box and WD repeat domain containing 11	BTRC2|BTRCP2|Fbw11|Fbw1b|FBXW1B|Hos|KIAA0696	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2838
1.73311559629381e-42	-0.250309707633866	0.202	0.346	3.13624598305328e-38	RP11-439A17.7	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2839
2.03776800475647e-42	-0.279672011310819	0.393	0.533	3.68754498140731e-38	GIT1	Malignant cells	GSE108397	ENSG00000108262	28964	GIT ArfGAP 1	NA	protein_coding	Q9Y2X7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2840
2.21105447733295e-42	0.268179078984534	0.7	0.563	4.0011241821817e-38	TMEM199	Malignant cells	GSE108397	ENSG00000244045	147007	transmembrane protein 199	C17orf32|MGC45714|VMA12|VPH2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2841
2.21146075471174e-42	0.266054911632981	0.696	0.561	4.00185938172636e-38	AIMP2	Malignant cells	GSE108397	ENSG00000106305	7965	aminoacyl tRNA synthetase complex interacting multifunctional protein 2	JTV-1|JTV1|p38|PRO0992	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2842
2.43085629161758e-42	-0.279797077356329	0.369	0.515	4.39887754531118e-38	TMEM167B	Malignant cells	GSE108397	ENSG00000215717	56900	transmembrane protein 167B	AD-020|C1orf119|FLJ90710	protein_coding	Q9NRX6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2843
2.72000066367586e-42	-0.264181192620145	0.287	0.433	4.92211320098783e-38	ATRNL1	Malignant cells	GSE108397	ENSG00000107518	26033	attractin like 1	ALP|FLJ45344|KIAA0534	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2844
2.81307404117282e-42	-0.261795418888485	0.912	0.955	5.09053878490634e-38	CENPU	Malignant cells	GSE108397	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2845
2.84409459437355e-42	-0.288474738187309	0.56	0.679	5.14667357797837e-38	UBE2A	Malignant cells	GSE108397	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2846
3.79123642460359e-42	0.271726308303047	0.782	0.674	6.86062143396266e-38	DUSP12	Malignant cells	GSE108397	ENSG00000081721	11266	dual specificity phosphatase 12	DUSP1|YVH1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2847
4.0492065963136e-42	0.26743152914286	0.753	0.626	7.3274442566891e-38	PSAT1	Malignant cells	GSE108397	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2848
4.48859762932274e-42	-0.266124392028902	0.296	0.442	8.12256627002243e-38	EOGT	Malignant cells	GSE108397	ENSG00000163378	285203	EGF domain specific O-linked N-acetylglucosamine transferase	AER61|C3orf64|FLJ33770	protein_coding	Q5NDL2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2849
5.16041824976612e-42	0.254750032143085	0.67	0.52	9.33829286477677e-38	DLST	Malignant cells	GSE108397	ENSG00000119689	1743	dihydrolipoamide S-succinyltransferase	DLTS|KGD2|OGDC-E2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2850
5.42155759597111e-42	-0.256167003935655	0.264	0.411	9.81085062566933e-38	DHX8	Malignant cells	GSE108397	ENSG00000067596	1659	DEAH-box helicase 8	DDX8|Dhr2|HRH1|PRP22|PRPF22	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2851
5.45599717412008e-42	-0.295516400453715	0.526	0.641	9.8731724862877e-38	C6orf136	Malignant cells	GSE108397	ENSG00000224120	221545	chromosome 6 open reading frame 136	Em:AB023049.8	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2852
8.93332276543738e-42	0.33136676013532	0.846	0.785	1.61657408763355e-37	SLBP	Malignant cells	GSE108397	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2853
9.68375724894735e-42	-0.262068701769426	0.29	0.435	1.75237271176951e-37	CAD	Malignant cells	GSE108397	ENSG00000084774	790	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	GATD4	protein_coding	P27708	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2854
1.25177239788041e-41	-0.289283488330631	0.506	0.628	2.26520733120439e-37	PRPF19	Malignant cells	GSE108397	ENSG00000110107	27339	pre-mRNA processing factor 19	hPSO4|NMP200|PRP19|PSO4|SNEV|UBOX4	protein_coding	Q9UMS4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2855
1.36467823621835e-41	0.255652214604458	0.692	0.542	2.46952173626073e-37	ZNF280D	Malignant cells	GSE108397	ENSG00000137871	54816	zinc finger protein 280D	FLJ20086|SUHW4|ZNF634	protein_coding	Q6N043	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2856
1.38175659827114e-41	-0.269513059749367	0.281	0.428	2.50042674023145e-37	UBA6	Malignant cells	GSE108397	ENSG00000033178	55236	ubiquitin like modifier activating enzyme 6	FLJ10808|UBE1L2	protein_coding	A0AVT1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2857
1.43151466843325e-41	-0.307158803017656	0.499	0.625	2.59046894399681e-37	GLUL	Malignant cells	GSE108397	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2858
1.47515174929643e-41	-0.337700662658191	0.45	0.581	2.66943460552683e-37	KCNG1	Malignant cells	GSE108397	ENSG00000026559	3755	potassium voltage-gated channel modifier subfamily G member 1	K13|KCNG|kH2|Kv6.1	protein_coding	Q9UIX4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2859
1.83759560957343e-41	-0.288614514484865	0.307	0.458	3.32531301508409e-37	PLOD2	Malignant cells	GSE108397	ENSG00000152952	5352	procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	LH2|TLH	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2860
1.88059104266468e-41	-0.293817737356661	0.538	0.66	3.403117550806e-37	NDUFS1	Malignant cells	GSE108397	ENSG00000283447	4719	NADH:ubiquinone oxidoreductase core subunit S1	CI-75k	protein_coding	P28331	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2861
1.9617829028532e-41	-0.280623450646455	0.58	0.69	3.55004234100314e-37	EIF2D	Malignant cells	GSE108397	ENSG00000143486	1939	eukaryotic translation initiation factor 2D	LGTN	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2862
2.04349321827297e-41	-0.265446737284174	0.716	0.801	3.69790532778676e-37	CDV3	Malignant cells	GSE108397	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2863
3.0368093728241e-41	-0.42710391202691	0.67	0.792	5.4954102410625e-37	CTNNB1	Malignant cells	GSE108397	ENSG00000168036	1499	catenin beta 1	armadillo|beta-catenin|CTNNB	protein_coding	P35222	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2864
3.0732958460257e-41	-0.290916012416609	0.664	0.758	5.5614361629681e-37	RASSF8-AS1	Malignant cells	GSE108397	ENSG00000246695	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2865
3.40231104667152e-41	0.268232926617534	0.899	0.834	6.15682207005678e-37	MPHOSPH10	Malignant cells	GSE108397	ENSG00000124383	10199	M-phase phosphoprotein 10	CT90|MPP10|MPP10P|PPP1R106	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2866
4.06845688207557e-41	-0.307303644099505	0.397	0.532	7.36227957380395e-37	BRCA1	Malignant cells	GSE108397	ENSG00000012048	672	BRCA1 DNA repair associated	BRCC1|FANCS|PPP1R53|RNF53	protein_coding	P38398	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2867
4.23656883415349e-41	0.269958865069265	0.559	0.407	7.66649496228415e-37	HSD17B1	Malignant cells	GSE108397	ENSG00000108786	3292	hydroxysteroid 17-beta dehydrogenase 1	EDH17B2|EDHB17|HSD17|MGC138140|SDR28C1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2868
5.80156494180671e-41	-0.281758646933413	0.503	0.634	1.04985119186934e-36	PDLIM5	Malignant cells	GSE108397	ENSG00000163110	10611	PDZ and LIM domain 5	Enh|LIM	protein_coding	Q96HC4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2869
6.07378050095731e-41	-0.283190123545082	0.597	0.712	1.09911131945324e-36	COQ10B	Malignant cells	GSE108397	ENSG00000115520	80219	coenzyme Q10B	FLJ13448	protein_coding	Q9H8M1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2870
6.09086390465736e-41	-0.290068168762626	0.327	0.463	1.1022027321868e-36	ZNF451	Malignant cells	GSE108397	ENSG00000112200	26036	zinc finger protein 451	COASTER|dJ417I1.1|KIAA0576|KIAA1702|ZATT	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2871
6.42424596205106e-41	0.269149717242412	0.933	0.883	1.16253154929276e-36	FARP1	Malignant cells	GSE108397	ENSG00000152767	10160	FERM, ARH/RhoGEF and pleckstrin domain protein 1	CDEP|GLCC1|MGC87400|PLEKHC2|PPP1R75	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2872
6.61493897544221e-41	-0.266244816598228	0.33	0.477	1.19703935699602e-36	DDX11	Malignant cells	GSE108397	ENSG00000013573	1663	DEAD/H-box helicase 11	CHL1|ChlR1|KRG-2|WABS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2873
7.48237734769326e-41	-0.262529140406573	0.746	0.819	1.35401100483857e-36	ICAM3	Malignant cells	GSE108397	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2874
7.59798075175657e-41	-0.287315269293653	0.33	0.474	1.37493059683787e-36	CRCP	Malignant cells	GSE108397	ENSG00000241258	27297	CGRP receptor component	C17|CGRP-RCP|POLR3I|RCP|RCP9	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2875
9.84191948632125e-41	-0.292825070030773	0.515	0.634	1.78099375024469e-36	PGRMC1	Malignant cells	GSE108397	ENSG00000101856	10857	progesterone receptor membrane component 1	HPR6.6	protein_coding	O00264	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2876
1.005133005981e-40	-0.254902370382319	0.839	0.895	1.81888868762322e-36	RNF220	Malignant cells	GSE108397	ENSG00000187147	55182	ring finger protein 220	C1orf164|FLJ10597	protein_coding	Q5VTB9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2877
1.45989869914549e-40	-0.253197387733617	0.307	0.455	2.64183268597367e-36	MOSPD1	Malignant cells	GSE108397	ENSG00000101928	56180	motile sperm domain containing 1	dJ473B4	protein_coding	Q9UJG1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2878
1.51264899549292e-40	-0.276711947091773	0.613	0.722	2.73728962224398e-36	SPRY2	Malignant cells	GSE108397	ENSG00000136158	10253	sprouty RTK signaling antagonist 2	hSPRY2	protein_coding	O43597	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2879
1.94198783332219e-40	-0.26241875145125	0.219	0.359	3.51422118317984e-36	KIFC1	Malignant cells	GSE108397	ENSG00000233450	3833	kinesin family member C1	HSET|KNSL2	protein_coding	Q9BW19	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2880
2.0116876878934e-40	0.253457338910107	0.507	0.357	3.6403500400119e-36	EMC2	Malignant cells	GSE108397	ENSG00000104412	9694	ER membrane protein complex subunit 2	KIAA0103|TTC35	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2881
2.29596027863633e-40	-0.287076346006294	0.535	0.65	4.15476972022031e-36	RERE	Malignant cells	GSE108397	ENSG00000142599	473	arginine-glutamic acid dipeptide repeats	ARG|ARP|ATN1L|ATN2|DNB1|KIAA0458	protein_coding	Q9P2R6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2882
2.30025168219348e-40	0.25777641315714	0.898	0.841	4.16253544409733e-36	FARSB	Malignant cells	GSE108397	ENSG00000116120	10056	phenylalanyl-tRNA synthetase subunit beta	FARSLB|FRSB|PheHB	protein_coding	Q9NSD9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2883
2.30974022624565e-40	-0.255036715917989	0.737	0.825	4.17970591341414e-36	ARL8B	Malignant cells	GSE108397	ENSG00000134108	55207	ADP ribosylation factor like GTPase 8B	ARL10C|FLJ10702|Gie1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2884
2.34241230718229e-40	-0.265443077772714	0.282	0.425	4.23882931107706e-36	GABARAPL1	Malignant cells	GSE108397	ENSG00000139112	23710	GABA type A receptor associated protein like 1	APG8L|ATG8B|ATG8L|gec1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2885
2.35838220209274e-40	-0.274687197458862	0.413	0.551	4.26772843290703e-36	RING1	Malignant cells	GSE108397	ENSG00000228520	6015	ring finger protein 1	RNF1	protein_coding	Q06587	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2886
3.42183312802669e-40	-0.277493120449902	0.369	0.508	6.1921492284771e-36	ATL3	Malignant cells	GSE108397	ENSG00000184743	25923	atlastin GTPase 3	DKFZP564J0863	protein_coding	Q6DD88	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2887
3.7849171024552e-40	-0.282153567404118	0.483	0.614	6.84918598860293e-36	WLS	Malignant cells	GSE108397	ENSG00000116729	79971	Wnt ligand secretion mediator	C1orf139|EVI|FLJ23091|GPR177|mig-14|MRP	protein_coding	Q5T9L3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2888
4.69431988967388e-40	-0.276288135581968	0.464	0.6	8.49484127235384e-36	RP11-773D16.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2889
4.93082431394064e-40	-0.271233852441668	0.515	0.651	8.92281967850699e-36	GMPR	Malignant cells	GSE108397	ENSG00000137198	2766	guanosine monophosphate reductase	NA	protein_coding	P36959	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2890
5.03697542484052e-40	-0.277504151185483	0.77	0.856	9.11491072879141e-36	KMT2E	Malignant cells	GSE108397	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2891
5.05171833981271e-40	-0.301090589766328	0.273	0.427	9.14158950772508e-36	HIST1H2AC	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2892
5.28641052252574e-40	-0.272374424342455	0.371	0.512	9.56628848156257e-36	IPO9	Malignant cells	GSE108397	ENSG00000198700	55705	importin 9	FLJ10402|Imp9	protein_coding	Q96P70	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2893
7.07704906037507e-40	-0.299062626787218	0.524	0.646	1.28066279796547e-35	SENP5	Malignant cells	GSE108397	ENSG00000119231	205564	SUMO specific peptidase 5	MGC27076	protein_coding	Q96HI0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2894
1.0099004101255e-39	-0.252793867323186	0.259	0.402	1.8275157821631e-35	FYCO1	Malignant cells	GSE108397	ENSG00000163820	79443	FYVE and coiled-coil domain autophagy adaptor 1	FLJ13335|ZFYVE7	protein_coding	Q9BQS8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2895
1.06930554066931e-39	-0.261816762293838	0.328	0.47	1.93501530639518e-35	SYDE1	Malignant cells	GSE108397	ENSG00000105137	85360	synapse defective Rho GTPase homolog 1	7h3|FLJ13511|SYD1	protein_coding	Q6ZW31	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2896
1.1149160525241e-39	-0.270960207848215	0.289	0.429	2.01755208864761e-35	SAPCD2	Malignant cells	GSE108397	ENSG00000186193	89958	suppressor APC domain containing 2	C9orf140|p42.3	protein_coding	Q86UD0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2897
1.27392378859903e-39	-0.299108800894425	0.639	0.736	2.30529248784881e-35	UGDH	Malignant cells	GSE108397	ENSG00000109814	7358	UDP-glucose 6-dehydrogenase	NA	protein_coding	O60701	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2898
1.48575671953372e-39	-0.278911214180608	0.607	0.714	2.68862535966821e-35	PSPH	Malignant cells	GSE108397	ENSG00000146733	5723	phosphoserine phosphatase	PSP	protein_coding	P78330	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2899
1.63561639541642e-39	-0.26149961710984	0.795	0.88	2.95981142914555e-35	NPAS1	Malignant cells	GSE108397	ENSG00000130751	4861	neuronal PAS domain protein 1	bHLHe11|MOP5|PASD5	protein_coding	Q99742	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2900
2.19600246344442e-39	-0.250277829579119	0.851	0.916	3.97388605784902e-35	SMARCA5	Malignant cells	GSE108397	ENSG00000153147	8467	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5	hISWI|hSNF2H|ISWI	protein_coding	O60264	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2901
2.53768250081323e-39	-0.277826724422776	0.689	0.792	4.59219025347163e-35	ROCK2	Malignant cells	GSE108397	ENSG00000134318	9475	Rho associated coiled-coil containing protein kinase 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2902
2.61259665623418e-39	-0.280032633436367	0.449	0.579	4.72775490912138e-35	SFXN5	Malignant cells	GSE108397	ENSG00000144040	94097	sideroflexin 5	BBG-TCC|SLC56A5	protein_coding	Q8TD22	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2903
3.05820195332685e-39	-0.294706573135833	0.429	0.561	5.53412225474026e-35	C16orf52	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2904
3.32399763014947e-39	0.264382517088654	0.832	0.731	6.01510611151848e-35	GTF2F2	Malignant cells	GSE108397	ENSG00000188342	2963	general transcription factor IIF subunit 2	BTF4|RAP30|TFIIF	protein_coding	P13984	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2905
3.37382626807225e-39	-0.283758258033704	0.667	0.753	6.10527601470354e-35	CCDC107	Malignant cells	GSE108397	ENSG00000159884	203260	coiled-coil domain containing 107	MGC31967	protein_coding	Q8WV48	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2906
3.45315214319922e-39	0.262912999151155	0.697	0.555	6.24882411833331e-35	C5orf15	Malignant cells	GSE108397	ENSG00000113583	56951	chromosome 5 open reading frame 15	HTGN29|KCT2	protein_coding	Q8NC54	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2907
3.69004589169461e-39	-0.261974358926561	0.384	0.522	6.67750704561057e-35	HDGFRP2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2908
4.70198891045352e-39	-0.285129403425901	0.464	0.594	8.50871913235668e-35	SETD5	Malignant cells	GSE108397	ENSG00000168137	55209	SET domain containing 5	FLJ10707|SETD5A	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2909
4.71488418473439e-39	-0.262796946323423	0.332	0.471	8.53205442069536e-35	BAP1	Malignant cells	GSE108397	ENSG00000163930	8314	BRCA1 associated protein 1	hucep-6|KIAA0272|UCHL2	protein_coding	Q92560	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2910
4.81094585397745e-39	-0.286158475910187	0.476	0.6	8.7058876173576e-35	NUDT2	Malignant cells	GSE108397	ENSG00000164978	318	nudix hydrolase 2	APAH1	protein_coding	P50583	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2911
5.25903446287423e-39	-0.580099521056669	0.962	0.994	9.51674876401721e-35	SERPINE2	Malignant cells	GSE108397	ENSG00000135919	5270	serpin family E member 2	GDN|nexin|PI7|PN1|PNI	protein_coding	P07093	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2912
5.6311195842224e-39	-0.262172400695428	0.293	0.43	1.01900739996089e-34	TRIP10	Malignant cells	GSE108397	ENSG00000125733	9322	thyroid hormone receptor interactor 10	CIP4|HSTP|STOT|STP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2913
5.72818980077855e-39	-0.282152597232394	0.543	0.657	1.03657322634889e-34	SIRT7	Malignant cells	GSE108397	ENSG00000187531	51547	sirtuin 7	NA	protein_coding	Q9NRC8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2914
6.29446906034834e-39	-0.376463574050733	0.405	0.527	1.13904712116063e-34	KIF2C	Malignant cells	GSE108397	ENSG00000142945	11004	kinesin family member 2C	CT139|KNSL6|MCAK	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2915
9.77776533780984e-39	-0.275554982161846	0.38	0.51	1.76938441553007e-34	REXO1	Malignant cells	GSE108397	ENSG00000079313	57455	RNA exonuclease 1 homolog	EloA-BP1|KIAA1138|TCEB3BP1	protein_coding	Q8N1G1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2916
1.09577211240849e-38	-0.284559007170025	0.59	0.699	1.98290921461441e-34	FNBP4	Malignant cells	GSE108397	ENSG00000285182	23360	formin binding protein 4	KIAA1014	protein_coding	Q8N3X1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2917
1.13565455754882e-38	-0.276694058154018	0.387	0.521	2.05508048734034e-34	CHERP	Malignant cells	GSE108397	ENSG00000085872	10523	calcium homeostasis endoplasmic reticulum protein	DAN16|ERPROT213-21	protein_coding	Q8IWX8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2918
1.36469573158451e-38	-0.257040150127508	0.728	0.814	2.46955339587533e-34	WIPI2	Malignant cells	GSE108397	ENSG00000157954	26100	WD repeat domain, phosphoinositide interacting 2	ATG18B|ATG21|CGI-50|DKFZP434J154|DKFZp686P02188|FLJ12979|FLJ14217|FLJ42984	protein_coding	Q9Y4P8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2919
1.64735887734457e-38	0.289521568608167	0.754	0.633	2.98106062444273e-34	FRMD6	Malignant cells	GSE108397	ENSG00000139926	122786	FERM domain containing 6	C14orf31|EX1|MGC17921|willin	protein_coding	Q96NE9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2920
1.70098581365898e-38	-0.253313574691731	0.306	0.447	3.07810392839729e-34	SLC35E1	Malignant cells	GSE108397	ENSG00000127526	79939	solute carrier family 35 member E1	FLJ14251	protein_coding	Q96K37	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2921
2.05342778648642e-38	0.257588086347642	0.346	0.21	3.71588292242583e-34	TUBA1A	Malignant cells	GSE108397	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2922
2.11094293107428e-38	-0.250976401926301	0.783	0.852	3.81996232807202e-34	SCARB2	Malignant cells	GSE108397	ENSG00000138760	950	scavenger receptor class B member 2	CD36L2|HLGP85|LIMP-2|LIMPII|SR-BII	protein_coding	Q14108	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2923
2.13151888862258e-38	-0.252809557558639	0.75	0.837	3.85719658085142e-34	PQBP1	Malignant cells	GSE108397	ENSG00000102103	10084	polyglutamine binding protein 1	MRX2|MRX55|MRXS3|MRXS8|RENS1|SHS	protein_coding	O60828	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2924
2.21296119943223e-38	-0.290539852070835	0.645	0.751	4.00457458649257e-34	HSPA5	Malignant cells	GSE108397	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2925
2.27298397908413e-38	0.313355517093083	0.663	0.519	4.11319180855063e-34	SFRP1	Malignant cells	GSE108397	ENSG00000104332	6422	secreted frizzled related protein 1	FRP|FRP-1|SARP2	protein_coding	Q8N474	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2926
2.38280134992838e-38	-0.265101542506346	0.673	0.759	4.31191732283039e-34	RP11-792A8.4	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2927
2.53587199695003e-38	-0.295589379445241	0.968	0.977	4.58891396568077e-34	ANKRD11	Malignant cells	GSE108397	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2928
2.56777026049682e-38	-0.282709445227473	0.627	0.719	4.64663706339505e-34	TIMM8A	Malignant cells	GSE108397	ENSG00000126953	1678	translocase of inner mitochondrial membrane 8A	DDP|DFN1|MTS	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2929
2.66945544624903e-38	-0.254522308710119	0.315	0.455	4.83064657553225e-34	ATF6B	Malignant cells	GSE108397	ENSG00000228628	1388	activating transcription factor 6 beta	CREBL1|G13	protein_coding	Q99941	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2930
3.08175698322063e-38	-0.290186996559516	0.457	0.577	5.57674743683606e-34	KDM5A	Malignant cells	GSE108397	ENSG00000073614	5927	lysine demethylase 5A	JARID1A|RBBP2	protein_coding	P29375	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2931
3.2626724653269e-38	-0.299962040301706	0.578	0.673	5.90413209325555e-34	SMPD2	Malignant cells	GSE108397	ENSG00000135587	6610	sphingomyelin phosphodiesterase 2	ISC1|nSMase	protein_coding	O60906	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2932
3.51561012726854e-38	0.254363631204713	0.635	0.498	6.36184808630515e-34	RARS2	Malignant cells	GSE108397	ENSG00000146282	57038	arginyl-tRNA synthetase 2, mitochondrial	DALRD2|dJ382I10.6|MGC14993|MGC23778|PRO1992|RARSL	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2933
3.66571241341979e-38	-0.332218434054228	0.665	0.808	6.63347318332445e-34	TRPM1	Malignant cells	GSE108397	ENSG00000274965	4308	transient receptor potential cation channel subfamily M member 1	CSNB1C|LTRPC1|MLSN1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2934
4.05841273227675e-38	0.265919813789573	0.659	0.516	7.344103680328e-34	NR2F2	Malignant cells	GSE108397	ENSG00000185551	7026	nuclear receptor subfamily 2 group F member 2	ARP1|COUP-TFII|COUPTF2|COUPTFB|NF-E3|SVP40|TFCOUP2	protein_coding	P24468	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2935
4.8141055165587e-38	-0.266856003223243	0.586	0.694	8.71160534276463e-34	GTF3C2	Malignant cells	GSE108397	ENSG00000115207	2976	general transcription factor IIIC subunit 2	KIAA0011|TFIIIC110	protein_coding	Q8WUA4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2936
5.12913268688627e-38	-0.276692721831411	0.528	0.639	9.28167851018939e-34	NUP93	Malignant cells	GSE108397	ENSG00000102900	9688	nucleoporin 93	KIAA0095	protein_coding	Q8N1F7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2937
6.13040057923488e-38	0.255332808699876	0.658	0.521	1.10935728881834e-33	HDDC3	Malignant cells	GSE108397	ENSG00000184508	374659	HD domain containing 3	MESH1|MGC45386	protein_coding	Q8N4P3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2938
7.72088611931503e-38	-0.261106779814238	0.748	0.826	1.39717155215125e-33	SLC25A36	Malignant cells	GSE108397	ENSG00000114120	55186	solute carrier family 25 member 36	FLJ10618|PNC2	protein_coding	Q96CQ1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2939
8.56700520901633e-38	0.277233329244464	0.824	0.738	1.55028526262359e-33	CCNH	Malignant cells	GSE108397	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2940
9.21359574430505e-38	-0.274024057430538	0.594	0.701	1.66729228588944e-33	CMTM3	Malignant cells	GSE108397	ENSG00000140931	123920	CKLF like MARVEL transmembrane domain containing 3	BNAS2|CKLFSF3|FLJ31762	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2941
9.89869397911351e-38	-0.250512930414291	0.818	0.879	1.79126766246038e-33	TRAF4	Malignant cells	GSE108397	ENSG00000076604	9618	TNF receptor associated factor 4	CART1|MLN62|RNF83	protein_coding	Q9BUZ4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2942
9.91483025180496e-38	-0.269252459462283	0.36	0.499	1.79418768236663e-33	FIGNL1	Malignant cells	GSE108397	ENSG00000132436	63979	fidgetin like 1	NA	protein_coding	Q6PIW4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2943
1.65134551623448e-37	-0.387824680403393	0.903	0.943	2.98827484617791e-33	TPX2	Malignant cells	GSE108397	ENSG00000088325	22974	TPX2 microtubule nucleation factor	C20orf1|C20orf2|DIL-2|FLS353|HCA519|p100	protein_coding	Q9ULW0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2944
1.75448346089623e-37	-0.315194462943567	0.539	0.647	3.17491327083781e-33	TNFRSF1A	Malignant cells	GSE108397	ENSG00000067182	7132	TNF receptor superfamily member 1A	CD120a|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR60	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2945
1.89081793184833e-37	-0.270425583981595	0.46	0.582	3.42162412947273e-33	PCGF6	Malignant cells	GSE108397	ENSG00000156374	84108	polycomb group ring finger 6	MBLR|RNF134	protein_coding	Q9BYE7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2946
2.79738318793526e-37	0.280723455401571	0.925	0.89	5.06214461688765e-33	ARGLU1	Malignant cells	GSE108397	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2947
2.82277098989802e-37	-0.269418845603641	0.615	0.725	5.10808638331946e-33	NOL10	Malignant cells	GSE108397	ENSG00000115761	79954	nucleolar protein 10	FLJ14075|PQBP5	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2948
2.94030289829112e-37	-0.264843995474812	0.441	0.568	5.3207721247476e-33	RMND5B	Malignant cells	GSE108397	ENSG00000145916	64777	required for meiotic nuclear division 5 homolog B	FLJ22318|GID2|GID2B	protein_coding	Q96G75	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2949
3.20450174802838e-37	-0.27771329098703	0.813	0.869	5.79886636323216e-33	LMO4	Malignant cells	GSE108397	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2950
3.40970349306457e-37	-0.270351520666253	0.924	0.963	6.17019944104965e-33	DNAJA1	Malignant cells	GSE108397	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2951
3.72254803017613e-37	-0.25088522331297	0.294	0.431	6.73632291540672e-33	STX5	Malignant cells	GSE108397	ENSG00000162236	6811	syntaxin 5	SED5|STX5A	protein_coding	Q13190	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2952
3.97321482392429e-37	0.512325907476622	0.688	0.619	7.1899295453734e-33	CKB	Malignant cells	GSE108397	ENSG00000166165	1152	creatine kinase B	CKBB	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2953
4.1569158863317e-37	-0.267604501284005	0.516	0.636	7.52235498790584e-33	NPEPPS	Malignant cells	GSE108397	ENSG00000141279	9520	aminopeptidase puromycin sensitive	MP100|PSA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2954
4.74602985961578e-37	-0.260513874997249	0.433	0.562	8.58841563396072e-33	NELFB	Malignant cells	GSE108397	ENSG00000188986	25920	negative elongation factor complex member B	COBRA1|KIAA1182|NELF-B	protein_coding	Q8WX92	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2955
5.589107602046e-37	-0.265627184749282	0.354	0.485	1.01140491166624e-32	NCAPG2	Malignant cells	GSE108397	ENSG00000146918	54892	non-SMC condensin II complex subunit G2	CAP-G2|FLJ20311|hCAP-G2|LUZP5|MTB	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2956
5.76912701252118e-37	-0.277742170272058	0.455	0.572	1.04398122418583e-32	CNOT1	Malignant cells	GSE108397	ENSG00000125107	23019	CCR4-NOT transcription complex subunit 1	AD-005|CDC39|KIAA1007|NOT1|NOT1H	protein_coding	A5YKK6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2957
6.65560746659626e-37	-0.25274489036658	0.698	0.784	1.20439872715526e-32	TMBIM4.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2958
7.13642009182704e-37	-0.275886919406979	0.565	0.68	1.29140657981702e-32	SYTL2	Malignant cells	GSE108397	ENSG00000137501	54843	synaptotagmin like 2	CHR11SYT|exophilin-4|FLJ20163|FLJ21219|KIAA1597|MGC102768|PPP1R151|SGA72M|SLP2	protein_coding	Q9HCH5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2959
1.04657904078345e-36	-0.262608062797754	0.366	0.502	1.89388943220172e-32	UBA5	Malignant cells	GSE108397	ENSG00000081307	79876	ubiquitin like modifier activating enzyme 5	FLJ23251|UBE1DC1	protein_coding	Q9GZZ9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2960
1.11899353266898e-36	-0.281902909284836	0.504	0.62	2.02493069671779e-32	SYNC	Malignant cells	GSE108397	ENSG00000162520	81493	syncoilin, intermediate filament protein	SYNC1|SYNCOILIN	protein_coding	Q9H7C4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2961
1.38190380311756e-36	0.266004946550816	0.808	0.73	2.50069312212153e-32	TSR2	Malignant cells	GSE108397	ENSG00000158526	90121	TSR2 ribosome maturation factor	DT1P1A10|RP1-112K5.2|WGG1	protein_coding	Q969E8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2962
1.45063799845929e-36	-0.25481124793082	0.468	0.605	2.62507452201193e-32	CLIC4	Malignant cells	GSE108397	ENSG00000169504	25932	chloride intracellular channel 4	CLIC4L|DKFZP566G223|H1|huH1|P64H1	protein_coding	Q9Y696	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2963
1.61656482921509e-36	-0.268772991543534	0.631	0.729	2.92533571494762e-32	TRIP12	Malignant cells	GSE108397	ENSG00000153827	9320	thyroid hormone receptor interactor 12	KIAA0045|TRIPC|ULF	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2964
1.63149201323155e-36	-0.268117358570678	0.527	0.641	2.95234794714382e-32	TNRC6A	Malignant cells	GSE108397	ENSG00000288130	27327	trinucleotide repeat containing adaptor 6A	CAGH26|GW182|KIAA1460|TNRC6	protein_coding	Q8NDV7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2965
2.05523187329476e-36	-0.266746495684298	0.657	0.743	3.71914759791419e-32	ETHE1	Malignant cells	GSE108397	ENSG00000105755	23474	ETHE1 persulfide dioxygenase	HSCO|YF13H12	protein_coding	O95571	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2966
2.75650149064364e-36	-0.277287624452182	0.389	0.519	4.98816509746873e-32	C21orf91	Malignant cells	GSE108397	ENSG00000154642	54149	chromosome 21 open reading frame 91	C21orf14|C21orf38|CSSG1|EURL|YG81	protein_coding	Q9NYK6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2967
3.09648243351695e-36	-0.257393413255185	0.463	0.591	5.60339461169228e-32	ALYREF	Malignant cells	GSE108397	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2968
3.80129007740205e-36	-0.268854903623817	0.338	0.467	6.87881452406675e-32	MFSD1	Malignant cells	GSE108397	ENSG00000118855	64747	major facilitator superfamily domain containing 1	FLJ14153|Minerva|UG0581B09	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2969
3.86937754597933e-36	-0.293167754775014	0.505	0.614	7.0020256072042e-32	PARD6G	Malignant cells	GSE108397	ENSG00000178184	84552	par-6 family cell polarity regulator gamma	PAR-6G|PAR6gamma	protein_coding	Q9BYG4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2970
5.29831524268158e-36	-0.266971867044355	0.445	0.567	9.58783126315659e-32	CEP95	Malignant cells	GSE108397	ENSG00000258890	90799	centrosomal protein 95	CCDC45|DKFZp667E1824	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2971
5.64060065733157e-36	-0.263130601897526	0.776	0.839	1.02072309495072e-31	BLVRB	Malignant cells	GSE108397	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2972
8.60241541670929e-36	-0.252894413555796	0.394	0.528	1.55669309380771e-31	MTMR14	Malignant cells	GSE108397	ENSG00000163719	64419	myotubularin related protein 14	C3orf29|FLJ22405|FLJ90311|hEDTP|hJumpy	protein_coding	Q8NCE2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2973
9.43285954382606e-36	-0.2698166546375	0.453	0.574	1.70697026305076e-31	FIP1L1	Malignant cells	GSE108397	ENSG00000145216	81608	factor interacting with PAPOLA and CPSF1	DKFZp586K0717|FIP1|hFip1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2974
9.7408089890608e-36	0.284456726486116	0.869	0.813	1.76269679466044e-31	TAF7	Malignant cells	GSE108397	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2975
1.21804284905013e-35	-0.271622047552343	0.449	0.574	2.20417033964111e-31	LRRC45	Malignant cells	GSE108397	ENSG00000169683	201255	leucine rich repeat containing 45	MGC20806	protein_coding	Q96CN5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2976
1.27550257463999e-35	-0.253263246172601	0.635	0.74	2.30814945906852e-31	EIF2AK1	Malignant cells	GSE108397	ENSG00000086232	27102	eukaryotic translation initiation factor 2 alpha kinase 1	HCR|hHRI|HRI|KIAA1369	protein_coding	Q9BQI3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2977
1.39715352884087e-35	-0.253629178251846	0.856	0.899	2.52828902579044e-31	PCM1	Malignant cells	GSE108397	ENSG00000078674	5108	pericentriolar material 1	PTC4	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2978
1.40870280771269e-35	-0.272334572319434	0.507	0.625	2.54918860083689e-31	PTPRG	Malignant cells	GSE108397	ENSG00000144724	5793	protein tyrosine phosphatase receptor type G	PTPG|RPTPG	protein_coding	P23470	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2979
1.71214115249624e-35	-0.272299620085397	0.568	0.672	3.09829062955719e-31	BAZ1A	Malignant cells	GSE108397	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2980
2.11569084944376e-35	-0.30396228192986	0.306	0.444	3.82855416115344e-31	IER2	Malignant cells	GSE108397	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2981
2.15554061321925e-35	-0.254492104748132	0.39	0.523	3.90066629368155e-31	EIF4G3	Malignant cells	GSE108397	ENSG00000075151	8672	eukaryotic translation initiation factor 4 gamma 3	eIF4GII	protein_coding	O43432	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2982
2.29585082994726e-35	-0.275333173848191	0.528	0.64	4.15457166187256e-31	SAFB2	Malignant cells	GSE108397	ENSG00000130254	9667	scaffold attachment factor B2	KIAA0138	protein_coding	Q14151	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2983
2.57227662740379e-35	-0.258866442765135	0.516	0.628	4.6547917849499e-31	CYB561D2	Malignant cells	GSE108397	ENSG00000114395	11068	cytochrome b561 family member D2	101F6|TSP10	protein_coding	O14569	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2984
3.07650133507704e-35	-0.250253594379311	0.651	0.741	5.56723681595541e-31	DYNC1LI1	Malignant cells	GSE108397	ENSG00000144635	51143	dynein cytoplasmic 1 light intermediate chain 1	DNCLI1	protein_coding	Q9Y6G9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2985
3.14779922769145e-35	-0.259358756553663	0.733	0.798	5.69625748243044e-31	NUDT5	Malignant cells	GSE108397	ENSG00000165609	11164	nudix hydrolase 5	hYSAH1|YSA1H	protein_coding	Q9UKK9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2986
3.63167974104469e-35	0.250369918797095	0.467	0.331	6.57188765939448e-31	DIAPH3	Malignant cells	GSE108397	ENSG00000139734	81624	diaphanous related formin 3	AN|AUNA1|DRF3|FLJ34705|NSDAN	protein_coding	Q9NSV4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2987
3.6904722428852e-35	-0.255995746531289	0.316	0.45	6.67827857072506e-31	XRCC2	Malignant cells	GSE108397	ENSG00000196584	7516	X-ray repair cross complementing 2	FANCU	protein_coding	O43543	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2988
4.81785042811108e-35	-0.2584215403106	0.513	0.63	8.71838213470981e-31	PISD	Malignant cells	GSE108397	ENSG00000241878	23761	phosphatidylserine decarboxylase	dJ858B16.2|PSDC	protein_coding	Q9UG56	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2989
5.24955930109088e-35	-0.268618319437586	0.402	0.529	9.49960251125407e-31	RAB5A	Malignant cells	GSE108397	ENSG00000144566	5868	RAB5A, member RAS oncogene family	RAB5	protein_coding	P20339	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2990
6.22120663204369e-35	-0.270519915544701	0.486	0.604	1.12578955213463e-30	ARCN1	Malignant cells	GSE108397	ENSG00000095139	372	archain 1	COPD	protein_coding	P48444	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2991
6.58667135194026e-35	-0.256319279984629	0.701	0.782	1.19192404784711e-30	RIF1	Malignant cells	GSE108397	ENSG00000080345	55183	replication timing regulatory factor 1	FLJ10599|FLJ12870	protein_coding	Q5UIP0	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2992
1.25953555440487e-34	-0.266227778631811	0.382	0.51	2.27925553925105e-30	KANK2	Malignant cells	GSE108397	ENSG00000197256	25959	KN motif and ankyrin repeat domains 2	ANKRD25|KIAA1518|MXRA3	protein_coding	Q63ZY3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2993
1.64552118730602e-34	0.255468883468323	0.639	0.511	2.97773514054898e-30	FAHD1	Malignant cells	GSE108397	ENSG00000180185	81889	fumarylacetoacetate hydrolase domain containing 1	C16orf36|DKFZP566J2046	protein_coding	Q6P587	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2994
1.85018592012186e-34	-0.254513510924074	0.448	0.574	3.34809644105252e-30	IKBKG	Malignant cells	GSE108397	ENSG00000269335	8517	inhibitor of nuclear factor kappa B kinase regulatory subunit gamma	FIP-3|FIP3|Fip3p|IKK-gamma|IKKAP1|IKKG|IP1|IP2|NEMO|ZC2HC9	protein_coding	Q9Y6K9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2995
1.86280352903548e-34	-0.270398209542109	0.54	0.649	3.3709292661426e-30	PPIP5K2	Malignant cells	GSE108397	ENSG00000145725	23262	diphosphoinositol pentakisphosphate kinase 2	CFAP160|DFNB100|HISPPD1|KIAA0433|VIP2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2996
1.90641905998134e-34	-0.271964297402696	0.514	0.633	3.44985593094223e-30	HEY1	Malignant cells	GSE108397	ENSG00000164683	23462	hes related family bHLH transcription factor with YRPW motif 1	bHLHb31|CHF-2|CHF2|HERP2|HESR-1|HESR1|HRT-1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2997
3.08537875001571e-34	-0.269859845582021	0.469	0.579	5.58330138602844e-30	UBE2O	Malignant cells	GSE108397	ENSG00000175931	63893	ubiquitin conjugating enzyme E2 O	E2-230K	protein_coding	Q9C0C9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2998
3.33117583702235e-34	-0.26476196829476	0.506	0.631	6.02809579467564e-30	UGT2B7	Malignant cells	GSE108397	ENSG00000171234	7364	UDP glucuronosyltransferase family 2 member B7	UGT2B9	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	2999
3.78392396176283e-34	-0.250463606960988	0.693	0.778	6.84738880120601e-30	CLCN3	Malignant cells	GSE108397	ENSG00000109572	1182	chloride voltage-gated channel 3	ClC-3|CLC3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3000
3.87501090810687e-34	-0.266037114096145	0.567	0.67	7.01221973931019e-30	PRPS2	Malignant cells	GSE108397	ENSG00000101911	5634	phosphoribosyl pyrophosphate synthetase 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3001
4.51233590304467e-34	-0.369933362346215	0.55	0.638	8.16552305014963e-30	CDCA3	Malignant cells	GSE108397	ENSG00000111665	83461	cell division cycle associated 3	GRCC8|TOME-1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3002
5.72583496806676e-34	-0.269532220954545	0.43	0.561	1.03614709582136e-29	SLC35F2	Malignant cells	GSE108397	ENSG00000110660	54733	solute carrier family 35 member F2	FLJ13018	protein_coding	Q8IXU6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3003
6.33836779482083e-34	-0.261303076524313	0.468	0.585	1.14699103615078e-29	MARCH7	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3004
7.59655133927473e-34	-0.25844027082217	0.485	0.6	1.37467193035515e-29	TTL	Malignant cells	GSE108397	ENSG00000114999	150465	tubulin tyrosine ligase	MGC46235	protein_coding	Q8NG68	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3005
9.40456025419245e-34	0.305833969026249	0.428	0.306	1.70184922359867e-29	PLS3	Malignant cells	GSE108397	ENSG00000102024	5358	plastin 3	T-plastin	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3006
1.05828630869395e-33	-0.271555148845898	0.449	0.569	1.91507490421256e-29	SRGAP1	Malignant cells	GSE108397	ENSG00000196935	57522	SLIT-ROBO Rho GTPase activating protein 1	ARHGAP13|KIAA1304	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3007
1.10177442276965e-33	0.279050615231523	0.604	0.472	1.99377099544396e-29	ZFX	Malignant cells	GSE108397	ENSG00000005889	7543	zinc finger protein X-linked	ZNF926	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3008
1.12289458206995e-33	-0.254081584873799	0.491	0.603	2.03199003571377e-29	AKT2	Malignant cells	GSE108397	ENSG00000105221	208	AKT serine/threonine kinase 2	PKBbeta	protein_coding	P31751	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3009
1.20075513085898e-33	0.250546066772446	0.908	0.861	2.17288648480241e-29	AFG3L2	Malignant cells	GSE108397	ENSG00000141385	10939	AFG3 like matrix AAA peptidase subunit 2	SCA28|SPAX5	protein_coding	Q9Y4W6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3010
1.96728585222109e-33	-0.327716271013952	0.313	0.443	3.56000047817929e-29	RP11-138A9.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3011
2.36650911853535e-33	-0.256929164750092	0.449	0.568	4.28243490090156e-29	FHIT	Malignant cells	GSE108397	ENSG00000189283	2272	fragile histidine triad diadenosine triphosphatase	AP3Aase|FRA3B	protein_coding	P49789	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3012
2.93610252747973e-33	-0.250310805487152	0.681	0.781	5.31317113372732e-29	EVI5	Malignant cells	GSE108397	ENSG00000067208	7813	ecotropic viral integration site 5	NB4S	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3013
3.43975049820991e-33	-0.327018950401387	0.693	0.764	6.22457250156066e-29	SEMA6A	Malignant cells	GSE108397	ENSG00000092421	57556	semaphorin 6A	HT018|KIAA1368|SEMA|SEMA6A1|SEMAQ	protein_coding	Q9H2E6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3014
3.9012342919327e-33	0.276695736562125	0.945	0.927	7.05967357468141e-29	TBC1D7	Malignant cells	GSE108397	ENSG00000145979	51256	TBC1 domain family member 7	dJ257A7.3|FLJ32666	protein_coding	Q9P0N9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3015
4.5480703657639e-33	-0.29359896874563	0.513	0.617	8.23018813388635e-29	SERINC2	Malignant cells	GSE108397	ENSG00000168528	347735	serine incorporator 2	FKSG84|PRO0899|TDE2|TDE2L	protein_coding	Q96SA4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3016
9.0717183551387e-33	0.311393486800546	0.735	0.628	1.6416181535459e-28	CTA-29F11.1	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3017
1.22975000130967e-32	-0.255896792089207	0.469	0.591	2.22535560236997e-28	DEAF1	Malignant cells	GSE108397	ENSG00000282712	10522	DEAF1 transcription factor	NUDR|SPN|ZMYND5	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3018
2.25420042929913e-32	-0.263457706544861	0.479	0.589	4.07920109685971e-28	KPNA1	Malignant cells	GSE108397	ENSG00000114030	3836	karyopherin subunit alpha 1	IPOA5|NPI-1|RCH2|SRP1	protein_coding	P52294	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3019
2.54871074497022e-32	-0.251019285958436	0.436	0.553	4.6121469640981e-28	VPS4B	Malignant cells	GSE108397	ENSG00000119541	9525	vacuolar protein sorting 4 homolog B	SKD1|SKD1B|VPS4-2	protein_coding	O75351	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3020
3.32939009063825e-32	-0.259787247280654	0.438	0.553	6.02486430801898e-28	MED19	Malignant cells	GSE108397	ENSG00000156603	219541	mediator complex subunit 19	LCMR1	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3021
3.7040312552363e-32	-0.253432312404873	0.562	0.668	6.70281495947561e-28	PAQR4	Malignant cells	GSE108397	ENSG00000162073	124222	progestin and adipoQ receptor family member 4	FLJ30002	protein_coding	Q8N4S7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3022
4.28060195125631e-32	-0.250686089891639	0.402	0.522	7.74617729099342e-28	ABHD11	Malignant cells	GSE108397	ENSG00000106077	83451	abhydrolase domain containing 11	PP1226|WBSCR21	protein_coding	Q8NFV4	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3023
6.23681046421515e-32	-0.259524671354797	0.562	0.666	1.12861322160437e-27	KPNA4	Malignant cells	GSE108397	ENSG00000186432	3840	karyopherin subunit alpha 4	IPOA3|MGC12217|MGC26703|QIP1|SRP3	protein_coding	O00629	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3024
7.70249130348048e-32	-0.250939548058017	0.447	0.574	1.39384282627783e-27	PFKFB4	Malignant cells	GSE108397	ENSG00000114268	5210	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4	NA	protein_coding	Q16877	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3025
8.72556139852956e-32	-0.274820296114494	0.527	0.625	1.57897759067791e-27	RIOK1	Malignant cells	GSE108397	ENSG00000124784	83732	RIO kinase 1	AD034|bA288G3.1|FLJ30006|RRP10	protein_coding	Q9BRS2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3026
1.17442427057409e-31	0.289327318524142	0.867	0.813	2.12523816003087e-27	AC147651.4	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3027
2.06738211974367e-31	-0.25597672062698	0.62	0.711	3.74113468388815e-27	EPB41L2	Malignant cells	GSE108397	ENSG00000079819	2037	erythrocyte membrane protein band 4.1 like 2	4.1-G|4.1G	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3028
2.49925645019702e-31	0.263369331562537	0.59	0.471	4.52265447227652e-27	USP9X	Malignant cells	GSE108397	ENSG00000124486	8239	ubiquitin specific peptidase 9 X-linked	DFFRX|FAF|MRX99	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3029
3.50065355153572e-31	-0.328725896011326	0.509	0.606	6.33478266685904e-27	KIF20B	Malignant cells	GSE108397	ENSG00000138182	9585	kinesin family member 20B	CT90|KRMP1|MPHOSPH1|MPP1	protein_coding	Q96Q89	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3030
6.19564305413305e-31	-0.260611217543399	0.562	0.644	1.12116356707592e-26	XPO6	Malignant cells	GSE108397	ENSG00000169180	23214	exportin 6	FLJ22519|KIAA0370|RANBP20	protein_coding	Q96QU8	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3031
8.40942162841076e-31	0.321725882304588	0.991	0.979	1.52176893787721e-26	HIST1H4C	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3032
8.86502837803566e-31	-0.292902994705655	0.856	0.929	1.60421553528933e-26	HNRNPH1	Malignant cells	GSE108397	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3033
3.26065453237089e-30	0.280288543048466	0.553	0.443	5.90048044177836e-26	PSMD10	Malignant cells	GSE108397	ENSG00000101843	5716	proteasome 26S subunit, non-ATPase 10	p28	protein_coding	O75832	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3034
3.3570242216588e-30	0.337859400447102	0.698	0.628	6.07487103151377e-26	CD68	Malignant cells	GSE108397	ENSG00000129226	968	CD68 molecule	DKFZp686M18236|GP110|LAMP4|SCARD1	protein_coding	P34810	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3035
3.54898046221747e-30	-0.251969326640813	0.523	0.626	6.42223504442874e-26	MICAL3	Malignant cells	GSE108397	ENSG00000243156	57553	microtubule associated monooxygenase, calponin and LIM domain containing 3	KIAA0819	protein_coding	Q7RTP6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3036
1.46612868968506e-29	-0.258133828870493	0.518	0.617	2.65310647685408e-25	KIF3C	Malignant cells	GSE108397	ENSG00000084731	3797	kinesin family member 3C	NA	protein_coding	O14782	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3037
1.48314479348875e-29	0.265816731575988	0.744	0.661	2.68389881829725e-25	KIAA0947	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3038
5.29487906569443e-29	0.267447021530594	0.684	0.568	9.58161315728065e-25	LINC00518	Malignant cells	GSE108397	ENSG00000183674	NA	NA	C6orf218|MGC40222	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3039
5.93092900359989e-29	0.262291221941378	0.91	0.899	1.07326091249144e-24	GPM6B	Malignant cells	GSE108397	ENSG00000046653	2824	glycoprotein M6B	M6B|MGC17150|MGC54284	protein_coding	Q13491	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3040
1.02791298586913e-28	0.257161803579907	0.952	0.942	1.86011133922878e-24	LYAR	Malignant cells	GSE108397	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3041
1.25133823302767e-28	-0.333132850666949	0.998	0.998	2.26442166648687e-24	MALAT1	Malignant cells	GSE108397	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3042
1.28413795686453e-28	-0.258727501488603	0.55	0.655	2.32377604674206e-24	SPSB1	Malignant cells	GSE108397	ENSG00000171621	80176	splA/ryanodine receptor domain and SOCS box containing 1	SSB-1	protein_coding	Q96BD6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3043
1.48427860074197e-28	0.279014495316268	0.617	0.506	2.68595055590267e-24	C2orf88	Malignant cells	GSE108397	ENSG00000187699	84281	chromosome 2 open reading frame 88	MGC13057|smAKAP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3044
1.81956084533831e-28	-0.253797868836634	0.502	0.605	3.2926773057242e-24	METTL8	Malignant cells	GSE108397	ENSG00000123600	79828	methyltransferase 8, methylcytidine	FLJ13984|TIP	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3045
3.03831870273345e-28	-0.264586136768061	0.554	0.641	5.49814152446646e-24	CELF2	Malignant cells	GSE108397	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3046
3.07112439508687e-28	0.282613705524896	0.705	0.598	5.5575067053492e-24	ZFP36L1	Malignant cells	GSE108397	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3047
5.00617938572458e-28	0.339353608619986	0.945	0.935	9.0591822164072e-24	BAMBI	Malignant cells	GSE108397	ENSG00000095739	25805	BMP and activin membrane bound inhibitor	NMA	protein_coding	Q13145	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3048
4.20171760573207e-27	0.312873807202763	0.996	0.996	7.60342817933276e-23	RPL22L1	Malignant cells	GSE108397	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3049
4.68843919739104e-27	-0.259787519320551	0.383	0.493	8.48419957159883e-23	INSIG2	Malignant cells	GSE108397	ENSG00000125629	51141	insulin induced gene 2	NA	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3050
6.58314548362788e-27	-0.357459086276564	0.309	0.43	1.1912860067173e-22	B4GALT1	Malignant cells	GSE108397	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3051
1.33914452736568e-26	-0.32529843497547	0.872	0.929	2.42331593672094e-22	IER3	Malignant cells	GSE108397	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3052
7.74789227880038e-26	-0.292691019467238	0.664	0.747	1.40205858677172e-21	DEPDC1	Malignant cells	GSE108397	ENSG00000024526	55635	DEP domain containing 1	DEP.8|DEPDC1A|FLJ20354|SDP35	protein_coding	Q5TB30	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3053
8.92702287623331e-26	-0.349910803743177	0.613	0.693	1.61543405968318e-21	SGOL2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3054
3.9009390820474e-25	-0.251442274870578	0.585	0.678	7.05913936287297e-21	OTUD7B	Malignant cells	GSE108397	ENSG00000264522	56957	OTU deubiquitinase 7B	CEZANNE|ZA20D1	protein_coding	Q6GQQ9	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3055
4.32210455248133e-25	0.263488785874899	0.68	0.573	7.82128039817022e-21	NHSL1	Malignant cells	GSE108397	ENSG00000135540	57224	NHS like 1	bA43P8.1|C6orf63|KIAA1357	protein_coding	Q5SYE7	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3056
1.66503878168424e-24	-0.475390163119989	0.771	0.834	3.0130541793358e-20	AURKA	Malignant cells	GSE108397	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3057
2.47335814329618e-24	-0.579282706016527	0.835	0.865	4.47578889610877e-20	FN1	Malignant cells	GSE108397	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3058
2.90070518665954e-24	-0.447960654704906	0.311	0.409	5.2491161057791e-20	C1orf56	Malignant cells	GSE108397	ENSG00000143443	54964	chromosome 1 open reading frame 56	FLJ20519|MENT	protein_coding	Q9BUN1	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3059
2.93867464484461e-24	-0.371087247172389	0.238	0.341	5.3178256373108e-20	ENPP1	Malignant cells	GSE108397	ENSG00000197594	5167	ectonucleotide pyrophosphatase/phosphodiesterase 1	M6S1|NPPS|PC-1|PCA1|PDNP1	protein_coding	P22413	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3060
2.7270796865999e-23	-0.268714072023318	0.651	0.719	4.93492340087119e-19	PRC1	Malignant cells	GSE108397	ENSG00000198901	9055	protein regulator of cytokinesis 1	ASE1	protein_coding	O43663	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3061
1.14001742496512e-20	0.259827732506346	0.47	0.365	2.06297553221688e-16	NPPC	Malignant cells	GSE108397	ENSG00000163273	4880	natriuretic peptide C	CNP	protein_coding	P23582	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3062
1.56488421137638e-19	-0.442435671888818	0.592	0.669	2.8318144689067e-15	TRIB3	Malignant cells	GSE108397	ENSG00000101255	57761	tribbles pseudokinase 3	C20orf97|dJ1103G7.3|TRB3	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3063
4.20333317227695e-19	-0.254368164582706	0.303	0.393	7.60635170855237e-15	RIN2	Malignant cells	GSE108397	ENSG00000132669	54453	Ras and Rab interactor 2	RASSF4	protein_coding	Q8WYP3	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3064
4.53527909327223e-19	0.418700970438457	0.912	0.943	8.20704104718543e-15	MORF4L2	Malignant cells	GSE108397	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3065
1.67602390454419e-18	0.332565670204796	0.935	0.924	3.03293285766317e-14	SNORA76	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3066
1.90685746629458e-18	-0.28840431104334	0.447	0.523	3.45064927100667e-14	HJURP	Malignant cells	GSE108397	ENSG00000123485	55355	Holliday junction recognition protein	DKFZp762E1312|FAKTS|hFLEG1|URLC9	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3067
8.73402370136857e-18	0.253457291237037	0.998	0.999	1.58050892899966e-13	SNRNP25	Malignant cells	GSE108397	ENSG00000161981	79622	small nuclear ribonucleoprotein U11/U12 subunit 25	C16orf33|U11/U12-25K	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3068
6.64510570553871e-16	-0.264054352117424	0.987	0.997	1.20249832847429e-11	CKS2	Malignant cells	GSE108397	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3069
5.03002863652399e-15	0.351810480849855	0.881	0.912	9.10233982065381e-11	TCEAL4	Malignant cells	GSE108397	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3070
3.01770420736691e-11	-0.30528127006902	0.548	0.615	5.46083753365115e-07	CAV1	Malignant cells	GSE108397	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3071
3.12568488066615e-11	-0.250462650997741	0.402	0.456	5.65623936005346e-07	CCNA2	Malignant cells	GSE108397	ENSG00000145386	890	cyclin A2	CCN1|CCNA	protein_coding	P20248	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3072
3.12858868567981e-11	0.253401825930132	0.753	0.726	5.66149408560618e-07	RP11-669N7.2	Malignant cells	GSE108397	NA	NA	NA	NA	NA	NA	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3073
1.02310076505513e-10	-0.257152009530581	0.441	0.493	1.85140314444376e-06	CDCA8	Malignant cells	GSE108397	ENSG00000134690	55143	cell division cycle associated 8	BOR|DasraB|FLJ12042|MESRGP	protein_coding	Q53HL2	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3074
9.73173086777456e-07	-0.347697889288849	0.319	0.365	0.0176105401783248	S100A2	Malignant cells	GSE108397	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE108397	GSE108397	Melanoma	Melanoma	Targeted therapy	NA	PLX-4720	Homo sapiens	451Lu cell line	Cell line	resistant 1, sensitive 1	2	6548	Public on Jul 01, 2018	30061114	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA427121	10x genomics	CellRanger 1.3.1	Melanoma	Targeted_therapy	3075
0	-0.657156567709299	0.94	0.99	0	SSU72	Malignant cells	GSE115251	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3076
0	-0.549982181804906	0.876	0.964	0	GNB1	Malignant cells	GSE115251	ENSG00000078369	2782	G protein subunit beta 1	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3077
0	-0.968391754213898	1	1	0	RPL22	Malignant cells	GSE115251	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3078
0	-0.623314594141915	0.818	0.961	0	MINOS1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3079
0	-1.02035187958641	0.016	0.61	0	CAMK2N1	Malignant cells	GSE115251	ENSG00000162545	55450	calcium/calmodulin dependent protein kinase II inhibitor 1	CaMKIINalpha	protein_coding	Q7Z7J9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3080
0	0.78555162778753	0.624	0.195	0	TMEM54	Malignant cells	GSE115251	ENSG00000121900	113452	transmembrane protein 54	BCLP|CAC-1	protein_coding	Q969K7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3081
0	0.415929166387976	0.282	0.02	0	COL9A2	Malignant cells	GSE115251	ENSG00000049089	1298	collagen type IX alpha 2 chain	EDM2|MED	protein_coding	Q14055	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3082
0	-0.290040228707977	1	1	0	YBX1	Malignant cells	GSE115251	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3083
0	0.827871898563794	0.517	0.003	0	RP4-792G4.2	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3084
0	0.567285656841983	0.49	0.164	0	PDE4B	Malignant cells	GSE115251	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3085
0	0.91780959646424	0.956	0.731	0	LMO4	Malignant cells	GSE115251	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3086
0	-0.952749635957253	0.195	0.701	0	LPPR5	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3087
0	-0.517676547935938	0.052	0.369	0	LPPR4	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3088
0	-0.529543891539595	0.019	0.341	0	PALMD	Malignant cells	GSE115251	ENSG00000099260	54873	palmdelphin	C1orf11|FLJ20271|PALML	protein_coding	Q9NP74	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3089
0	1.59086937010035	0.982	0.747	0	ATP1A1	Malignant cells	GSE115251	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3090
0	0.588298202204205	0.423	0.057	0	C1orf54	Malignant cells	GSE115251	ENSG00000118292	79630	chromosome 1 open reading frame 54	FLJ23221	protein_coding	Q8WWF1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3091
0	0.874825846776743	0.987	0.9	0	S100A13	Malignant cells	GSE115251	ENSG00000189171	6284	S100 calcium binding protein A13	NA	protein_coding	Q99584	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3092
0	1.52337490966071	0.73	0.034	0	S100A1	Malignant cells	GSE115251	ENSG00000160678	6271	S100 calcium binding protein A1	S100-alpha|S100A	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3093
0	0.390534947149733	1	1	0	RPS27	Malignant cells	GSE115251	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3094
0	-0.794849480514953	0.311	0.714	0	TAGLN2	Malignant cells	GSE115251	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3095
0	-1.89757384374604	0.32	0.97	0	RGS4	Malignant cells	GSE115251	ENSG00000117152	5999	regulator of G protein signaling 4	SCZD9	protein_coding	P49798	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3096
0	-3.79872921406814	0.541	1	0	RGS5	Malignant cells	GSE115251	ENSG00000143248	8490	regulator of G protein signaling 5	MST092|MST106|MST129|MSTP032|MSTP092|MSTP106|MSTP129	protein_coding	O15539	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3097
0	-0.561471499610848	0.811	0.941	0	MGST3	Malignant cells	GSE115251	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3098
0	-0.640092070419589	0.095	0.486	0	C1orf21	Malignant cells	GSE115251	ENSG00000116667	81563	chromosome 1 open reading frame 21	PIG13	protein_coding	Q9H246	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3099
0	1.16627599047679	0.919	0.599	0	TMEM9	Malignant cells	GSE115251	ENSG00000116857	252839	transmembrane protein 9	TMEM9A	protein_coding	Q9P0T7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3100
0	1.37511158028474	0.549	0.001	0	IGFN1	Malignant cells	GSE115251	ENSG00000163395	91156	immunoglobulin like and fibronectin type III domain containing 1	DKFZp434B1231|EEF1A2BP1	protein_coding	Q86VF2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3101
0	-0.436104717705875	0.001	0.283	0	FMOD	Malignant cells	GSE115251	ENSG00000122176	2331	fibromodulin	SLRR2E	protein_coding	Q06828	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3102
0	0.66046967746894	0.458	0.065	0	KLHDC8A	Malignant cells	GSE115251	ENSG00000162873	55220	kelch domain containing 8A	FLJ10748	protein_coding	Q8IYD2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3103
0	-0.472244294898529	1	1	0	H3F3A	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3104
0	-0.413850612776335	0.995	1	0	PARP1	Malignant cells	GSE115251	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3105
0	-0.731992648458037	0.974	0.998	0	GUK1	Malignant cells	GSE115251	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3106
0	-0.624861857301157	0.715	0.914	0	RAB4A	Malignant cells	GSE115251	ENSG00000168118	5867	RAB4A, member RAS oncogene family	HRES-1/RAB4|RAB4	protein_coding	P20338	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3107
0	-0.819421642464336	0.624	0.895	0	GNG4	Malignant cells	GSE115251	ENSG00000282972	2786	G protein subunit gamma 4	NA	protein_coding	P50150	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3108
0	-0.572434098240745	0.063	0.422	0	KIF26B	Malignant cells	GSE115251	ENSG00000281216	55083	kinesin family member 26B	FLJ10157	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3109
0	-0.950317340063711	0.025	0.591	0	COLEC11	Malignant cells	GSE115251	ENSG00000118004	78989	collectin subfamily member 11	CL-11|CL-K1|MGC3279	protein_coding	Q9BWP8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3110
0	-1.11682378094592	0.726	0.986	0	ID2	Malignant cells	GSE115251	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3111
0	-0.783295225085725	0.795	0.949	0	MYCNOS	Malignant cells	GSE115251	ENSG00000233718	10408	MYCN opposite strand	MYCN-AS1|N-CYM|NCYM	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3112
0	-1.35858198187151	0.981	1	0	MYCN	Malignant cells	GSE115251	ENSG00000134323	4613	MYCN proto-oncogene, bHLH transcription factor	bHLHe37|MYCNOT|N-myc|NMYC	protein_coding	P04198	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3113
0	-0.564941600078552	0.052	0.405	0	KCNK3	Malignant cells	GSE115251	ENSG00000171303	3777	potassium two pore domain channel subfamily K member 3	K2p3.1|TASK|TASK-1|TASK1	protein_coding	O14649	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3114
0	1.36026500691132	0.819	0.31	0	CDC42EP3	Malignant cells	GSE115251	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3115
0	-1.32433728769716	0.146	0.812	0	EPAS1	Malignant cells	GSE115251	ENSG00000116016	2034	endothelial PAS domain protein 1	bHLHe73|HIF2A|HLF|MOP2|PASD2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3116
0	-0.43011733854278	0.055	0.335	0	BCL11A	Malignant cells	GSE115251	ENSG00000119866	53335	BAF chromatin remodeling complex subunit BCL11A	BCL11A-L|BCL11A-S|BCL11A-XL|CTIP1|EVI9|HBFQTL5|SMARCM1|ZNF856	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3117
0	0.667921803604715	0.918	0.779	0	POLE4	Malignant cells	GSE115251	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3118
0	-0.498676069715444	0.907	0.998	0	TMSB10	Malignant cells	GSE115251	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3119
0	1.36354816976564	0.471	0.064	0	NEUROD1	Malignant cells	GSE115251	ENSG00000162992	4760	neuronal differentiation 1	BETA2|BHF-1|bHLHa3|MODY6|NEUROD	protein_coding	Q13562	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3120
0	0.727199527002007	0.935	0.733	0	NBEAL1	Malignant cells	GSE115251	ENSG00000144426	65065	neurobeachin like 1	ALS2CR16|ALS2CR17|MGC164581	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3121
0	-0.63663370643207	0.967	0.997	0	IGFBP2	Malignant cells	GSE115251	ENSG00000115457	3485	insulin like growth factor binding protein 2	IBP2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3122
0	-1.52928462385251	0.224	0.841	0	FEV	Malignant cells	GSE115251	ENSG00000163497	54738	FEV transcription factor, ETS family member	Pet-1	protein_coding	Q99581	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3123
0	0.788265002962753	0.418	0.015	0	ECEL1	Malignant cells	GSE115251	ENSG00000171551	9427	endothelin converting enzyme like 1	DINE|XCE	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3124
0	0.974927246868254	0.268	0.001	0	PRSS56	Malignant cells	GSE115251	ENSG00000237412	646960	serine protease 56	NA	protein_coding	P0CW18	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3125
0	1.80193998416089	0.896	0.473	0	HES6	Malignant cells	GSE115251	ENSG00000144485	55502	hes family bHLH transcription factor 6	bHLHb41	protein_coding	Q96HZ4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3126
0	-0.814657253650274	0.032	0.537	0	NEU4	Malignant cells	GSE115251	ENSG00000277926	129807	neuraminidase 4	NA	protein_coding	Q8WWR8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3127
0	0.646997802864723	0.411	0.08	0	ZNF385D	Malignant cells	GSE115251	ENSG00000151789	79750	zinc finger protein 385D	FLJ22419|ZNF659	protein_coding	Q9H6B1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3128
0	-0.320297452960242	1	1	0	RPL15	Malignant cells	GSE115251	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3129
0	-1.40521487231043	1	1	0	RPSA	Malignant cells	GSE115251	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3130
0	-0.742592406200339	1	1	0	RPL14	Malignant cells	GSE115251	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3131
0	-0.568659590104879	0.814	0.952	0	SMARCC1	Malignant cells	GSE115251	ENSG00000173473	6599	SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1	BAF155|CRACC1|Rsc8|SRG3	protein_coding	Q92922	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3132
0	-0.992127083691879	0.988	0.999	0	TMA7	Malignant cells	GSE115251	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3133
0	-0.678124310072714	0.517	0.768	0	IMPDH2	Malignant cells	GSE115251	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3134
0	-0.958717403188962	0.939	0.998	0	GPX1	Malignant cells	GSE115251	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3135
0	-0.626149040599748	0.782	0.947	0	RHOA	Malignant cells	GSE115251	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3136
0	-0.439043436187724	0.074	0.358	0	CAMKV	Malignant cells	GSE115251	ENSG00000164076	79012	CaM kinase like vesicle associated	MGC8407|VACAMKL	protein_coding	Q8NCB2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3137
0	-0.598605005542815	0.365	0.67	0	IFRD2	Malignant cells	GSE115251	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3138
0	-1.09171563056822	1	1	0	RPL29	Malignant cells	GSE115251	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3139
0	-0.573181287157315	0.79	0.932	0	NT5DC2	Malignant cells	GSE115251	ENSG00000168268	64943	5'-nucleotidase domain containing 2	FLJ12442	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3140
0	-0.675764127573288	0.796	0.952	0	SPCS1	Malignant cells	GSE115251	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3141
0	-0.976576656589848	0.628	0.931	0	TKT	Malignant cells	GSE115251	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3142
0	0.862502813505389	0.858	0.606	0	IFT57	Malignant cells	GSE115251	ENSG00000114446	55081	intraflagellar transport 57	ESRRBL1|FLJ10147|HIPPI|MHS4R2	protein_coding	Q9NWB7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3143
0	0.645777357255796	0.499	0.166	0	TAGLN3	Malignant cells	GSE115251	ENSG00000144834	29114	transgelin 3	NP22|NP25	protein_coding	Q9UI15	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3144
0	-0.748688680355107	0.669	0.889	0	GAP43	Malignant cells	GSE115251	ENSG00000172020	2596	growth associated protein 43	B-50|GAP-43|PP46	protein_coding	P17677	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3145
0	-1.78848272871829	0.566	0.987	0	GATA2	Malignant cells	GSE115251	ENSG00000179348	2624	GATA binding protein 2	NFE1B	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3146
0	0.546245495014986	0.945	0.836	0	TFDP2	Malignant cells	GSE115251	ENSG00000114126	7029	transcription factor Dp-2	Dp-2	protein_coding	Q14188	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3147
0	-0.888424560424819	0.828	0.976	0	PFN2	Malignant cells	GSE115251	ENSG00000070087	5217	profilin 2	NA	protein_coding	P35080	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3148
0	1.0648017074492	0.97	0.849	0	RPL22L1	Malignant cells	GSE115251	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3149
0	0.531896529160453	0.374	0.053	0	SLIT2	Malignant cells	GSE115251	ENSG00000145147	9353	slit guidance ligand 2	SLIL3|Slit-2	protein_coding	O94813	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3150
0	-0.293701449332091	1	1	0	RPL9	Malignant cells	GSE115251	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3151
0	1.17920195965432	0.966	0.771	0	PHOX2B	Malignant cells	GSE115251	ENSG00000109132	8929	paired like homeobox 2B	NBPhox|PMX2B	protein_coding	Q99453	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3152
0	1.01823977902342	0.966	0.761	0	OCIAD2	Malignant cells	GSE115251	ENSG00000145247	132299	OCIA domain containing 2	MGC45416	protein_coding	Q56VL3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3153
0	-0.647831424384497	0.024	0.385	0	SYNPO2	Malignant cells	GSE115251	ENSG00000172403	171024	synaptopodin 2	MYOPODIN|SYISL	protein_coding	Q9UMS6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3154
0	1.10924271796459	0.752	0.231	0	CPE	Malignant cells	GSE115251	ENSG00000109472	1363	carboxypeptidase E	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3155
0	0.498045365671194	0.999	0.995	0	NDUFS6	Malignant cells	GSE115251	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3156
0	0.571396930544599	0.879	0.709	0	MED10	Malignant cells	GSE115251	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3157
0	1.06200927212565	0.998	0.983	0	BASP1	Malignant cells	GSE115251	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3158
0	0.511745297209945	1	0.993	0	SUB1	Malignant cells	GSE115251	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3159
0	1.7845824415524	0.912	0.258	0	RAI14	Malignant cells	GSE115251	ENSG00000039560	26064	retinoic acid induced 14	DKFZp564G013|KIAA1334|NORPEG|RAI13	protein_coding	Q9P0K7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3160
0	0.724038069172142	0.53	0.104	0	PDE4D	Malignant cells	GSE115251	ENSG00000113448	5144	phosphodiesterase 4D	DPDE3	protein_coding	Q08499	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3161
0	0.514124848024952	0.324	0.002	0	IQGAP2	Malignant cells	GSE115251	ENSG00000145703	10788	IQ motif containing GTPase activating protein 2	NA	protein_coding	Q13576	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3162
0	0.557280354182492	0.418	0.071	0	F2R	Malignant cells	GSE115251	ENSG00000181104	2149	coagulation factor II thrombin receptor	CF2R|PAR-1|PAR1|TR	protein_coding	P25116	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3163
0	-0.685151740502718	0.218	0.593	0	PPP2R2B	Malignant cells	GSE115251	ENSG00000156475	5521	protein phosphatase 2 regulatory subunit Bbeta	B55beta|PR52B|PR55-BETA|SCA12	protein_coding	Q00005	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3164
0	-1.41003944578314	0.651	0.991	0	HAND1	Malignant cells	GSE115251	ENSG00000113196	9421	heart and neural crest derivatives expressed 1	bHLHa27|eHand|Hxt|Thing1	protein_coding	O96004	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3165
0	-2.29075881895185	0.194	0.948	0	NSG2	Malignant cells	GSE115251	ENSG00000170091	51617	neuronal vesicle trafficking associated 2	CALY3|HMP19	protein_coding	Q9Y328	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3166
0	-0.502839835763974	0.997	1	0	HMGA1	Malignant cells	GSE115251	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3167
0	-0.515720372907155	1	1	0	RPS10	Malignant cells	GSE115251	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3168
0	-0.481470619872366	0.058	0.357	0	PAQR8	Malignant cells	GSE115251	ENSG00000170915	85315	progestin and adipoQ receptor family member 8	C6orf33|LMPB1|MPRB	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3169
0	-0.553659005178854	1	1	0	EEF1A1	Malignant cells	GSE115251	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3170
0	0.622832861689282	0.609	0.289	0	POPDC3	Malignant cells	GSE115251	ENSG00000132429	64208	popeye domain containing 3	bA355M14.1|MGC22671|POP3	protein_coding	Q9HBV1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3171
0	0.696362869862115	0.72	0.449	0	FYN	Malignant cells	GSE115251	ENSG00000010810	2534	FYN proto-oncogene, Src family tyrosine kinase	MGC45350|SLK|SYN	protein_coding	P06241	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3172
0	2.60092394657199	0.909	0.091	0	PKIB	Malignant cells	GSE115251	ENSG00000135549	5570	cAMP-dependent protein kinase inhibitor beta	PRKACN2	protein_coding	Q9C010	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3173
0	-0.875314165861962	0.43	0.8	0	AKAP12	Malignant cells	GSE115251	ENSG00000131016	9590	A-kinase anchoring protein 12	AKAP250|SSeCKS	protein_coding	Q02952	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3174
0	-0.610939358192899	0.818	0.97	0	TCP1	Malignant cells	GSE115251	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3175
0	0.497958743880546	0.29	0.008	0	LINC00473	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3176
0	-1.29703364155776	0.381	0.895	0	ICA1	Malignant cells	GSE115251	ENSG00000003147	3382	islet cell autoantigen 1	ICA69|ICAp69	protein_coding	Q05084	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3177
0	1.01082770290207	0.997	0.971	0	SEPT7	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3178
0	-0.452246809373366	0.107	0.399	0	MRPS24	Malignant cells	GSE115251	ENSG00000062582	64951	mitochondrial ribosomal protein S24	HSPC335|MRP-S24	protein_coding	Q96EL2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3179
0	0.872235779311965	0.882	0.765	0	DDC	Malignant cells	GSE115251	ENSG00000132437	1644	dopa decarboxylase	AADC	protein_coding	P20711	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3180
0	0.625396606121129	0.903	0.77	0	CDK6	Malignant cells	GSE115251	ENSG00000105810	1021	cyclin dependent kinase 6	PLSTIRE	protein_coding	Q00534	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3181
0	-0.47286940213236	0.061	0.354	0	PRRT4	Malignant cells	GSE115251	ENSG00000224940	401399	proline rich transmembrane protein 4	NA	protein_coding	C9JH25	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3182
0	-0.794349523575804	0.867	0.987	0	CALD1	Malignant cells	GSE115251	ENSG00000122786	800	caldesmon 1	CDM|H-CAD|h-CD|L-CAD	protein_coding	Q05682	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3183
0	-1.14708427339796	0.137	0.722	0	KCNH2	Malignant cells	GSE115251	ENSG00000055118	3757	potassium voltage-gated channel subfamily H member 2	erg1|HERG|Kv11.1|LQT2	protein_coding	Q12809	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3184
0	0.717090042434532	0.967	0.835	0	DNAJB6	Malignant cells	GSE115251	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3185
0	2.8606274556056	0.999	0.973	0	TMSB4X	Malignant cells	GSE115251	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3186
0	-0.511935385334588	0.967	0.996	0	RBM3	Malignant cells	GSE115251	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3187
0	-0.509544027684714	0.006	0.334	0	HMGN5	Malignant cells	GSE115251	ENSG00000198157	79366	high mobility group nucleosome binding domain 5	NSBP1	protein_coding	P82970	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3188
0	-0.689873008756821	0.001	0.444	0	SH3BGRL	Malignant cells	GSE115251	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3189
0	0.596170731283896	0.828	0.599	0	BEX2	Malignant cells	GSE115251	ENSG00000133134	84707	brain expressed X-linked 2	DJ79P11.1	protein_coding	Q9BXY8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3190
0	-0.398997479908126	0.003	0.262	0	TCEAL7	Malignant cells	GSE115251	ENSG00000182916	56849	transcription elongation factor A like 7	MGC23947|WEX5	protein_coding	Q9BRU2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3191
0	1.06946409664948	1	0.999	0	NGFRAP1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3192
0	1.19393394431743	0.605	0.004	0	PLP1	Malignant cells	GSE115251	ENSG00000123560	5354	proteolipid protein 1	GPM6C|PLP|SPG2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3193
0	2.57235792404796	0.899	0.088	0	ARHGAP36	Malignant cells	GSE115251	ENSG00000147256	158763	Rho GTPase activating protein 36	FLJ30058	protein_coding	Q6ZRI8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3194
0	-0.477631932210246	0.055	0.372	0	LDOC1	Malignant cells	GSE115251	ENSG00000182195	23641	LDOC1 regulator of NFKB signaling	BCUR1|Mar7|Mart7|RTL7|SIRH7	protein_coding	O95751	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3195
0	0.955653356611921	0.694	0.129	0	MAGEA6	Malignant cells	GSE115251	ENSG00000197172	4105	MAGE family member A6	CT1.6|MAGE-3b|MAGE3B|MAGE6	protein_coding	P43360	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3196
0	-0.50995083010771	1	1	0	RPL10	Malignant cells	GSE115251	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3197
0	-0.484075026601403	0.01	0.311	0	MTUS1	Malignant cells	GSE115251	ENSG00000129422	57509	microtubule associated scaffold protein 1	ATBP|ATIP1|ATIP3|DKFZp586D1519|FLJ14295|ICIS|KIAA1288|MP44|MTSG1	protein_coding	Q9ULD2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3198
0	2.49605772634271	0.807	0.57	0	NEFM	Malignant cells	GSE115251	ENSG00000104722	4741	neurofilament medium chain	NEF3|NF-M|NFM	protein_coding	P07197	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3199
0	-0.837155014089544	0.204	0.641	0	SFRP1	Malignant cells	GSE115251	ENSG00000104332	6422	secreted frizzled related protein 1	FRP|FRP-1|SARP2	protein_coding	Q8N474	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3200
0	0.860775973935738	0.419	0.019	0	CEBPD	Malignant cells	GSE115251	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3201
0	-1.31658493899239	0.432	0.896	0	STMN2	Malignant cells	GSE115251	ENSG00000104435	11075	stathmin 2	SCG10|SCGN10	protein_coding	Q93045	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3202
0	-0.740982370466282	0.322	0.68	0	ZNF704	Malignant cells	GSE115251	ENSG00000164684	619279	zinc finger protein 704	FLJ16218|Gig1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3203
0	0.496177840498815	0.991	0.97	0	ENY2	Malignant cells	GSE115251	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3204
0	-0.866112970168385	0.507	0.865	0	TMEM261	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3205
0	-0.574585231192908	0.869	0.97	0	PSIP1	Malignant cells	GSE115251	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3206
0	-1.12189910793112	1	1	0	RPS6	Malignant cells	GSE115251	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3207
0	0.500823003803744	0.426	0.103	0	TUSC1	Malignant cells	GSE115251	ENSG00000198680	286319	tumor suppressor candidate 1	CCDC89B|TSG-9	protein_coding	Q2TAM9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3208
0	-0.630618335201309	0.741	0.915	0	NDUFB6	Malignant cells	GSE115251	ENSG00000165264	4712	NADH:ubiquinone oxidoreductase subunit B6	B17|CI	protein_coding	O95139	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3209
0	-0.488407056367287	0.024	0.324	0	PRSS3	Malignant cells	GSE115251	ENSG00000010438	5646	serine protease 3	PRSS4|TRY3|TRY4	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3210
0	-0.649842724947219	0.186	0.561	0	ENHO	Malignant cells	GSE115251	ENSG00000168913	375704	energy homeostasis associated	C9orf165|UNQ470	protein_coding	Q6UWT2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3211
0	-0.871649730294426	0.252	0.714	0	CNTFR	Malignant cells	GSE115251	ENSG00000122756	1271	ciliary neurotrophic factor receptor	NA	protein_coding	P26992	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3212
0	-0.665364383086419	0.055	0.473	0	IL11RA	Malignant cells	GSE115251	ENSG00000137070	3590	interleukin 11 receptor subunit alpha	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3213
0	-0.536293949142269	0.926	0.989	0	STOML2	Malignant cells	GSE115251	ENSG00000165283	30968	stomatin like 2	HSPC108|SLP-2	protein_coding	Q9UJZ1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3214
0	-0.531502744577651	0.788	0.932	0	CLTA	Malignant cells	GSE115251	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3215
0	-0.909482107857793	0.291	0.687	0	RFK	Malignant cells	GSE115251	ENSG00000135002	55312	riboflavin kinase	FLJ11149|RIFK	protein_coding	Q969G6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3216
0	0.679176844396543	0.66	0.326	0	C9orf3	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3217
0	0.31103416083641	1	1	0	RPL12	Malignant cells	GSE115251	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3218
0	0.596194140381778	0.806	0.57	0	PRRC2B	Malignant cells	GSE115251	ENSG00000288701	84726	proline rich coiled-coil 2B	BAT2L|BAT2L1|KIAA0515|LQFBS-1|MGC10526	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3219
0	0.611451251041549	0.806	0.579	0	SURF4	Malignant cells	GSE115251	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3220
0	0.877937872809794	0.786	0.593	0	OLFM1	Malignant cells	GSE115251	ENSG00000130558	10439	olfactomedin 1	AMY|NOE1|NOELIN|OlfA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3221
0	0.623832049078742	1	1	0	EDF1	Malignant cells	GSE115251	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3222
0	-0.648100070156865	0.79	0.948	0	DPP7	Malignant cells	GSE115251	ENSG00000176978	29952	dipeptidyl peptidase 7	DPP2|DPPII	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3223
0	0.599450845847836	0.774	0.517	0	DPH7	Malignant cells	GSE115251	ENSG00000148399	92715	diphthamide biosynthesis 7	C9orf112|FLJ90634|RRT2|WDR85	protein_coding	Q9BTV6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3224
0	0.673743795109393	0.775	0.543	0	ZMYND19	Malignant cells	GSE115251	ENSG00000165724	116225	zinc finger MYND-type containing 19	MIZIP	protein_coding	Q96E35	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3225
0	-0.932222245118231	0.737	0.97	0	GATA3	Malignant cells	GSE115251	ENSG00000107485	2625	GATA binding protein 3	HDR	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3226
0	-0.944126530964429	0.039	0.407	0	VIM	Malignant cells	GSE115251	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3227
0	-0.582402099767902	0.306	0.629	0	COMMD3	Malignant cells	GSE115251	ENSG00000148444	23412	COMM domain containing 3	BUP|C10orf8	protein_coding	Q9UBI1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3228
0	-0.57394293182439	0.03	0.395	0	RET	Malignant cells	GSE115251	ENSG00000165731	5979	ret proto-oncogene	CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET51	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3229
0	1.25841294875958	0.513	0.161	0	DKK1	Malignant cells	GSE115251	ENSG00000107984	22943	dickkopf WNT signaling pathway inhibitor 1	DKK-1|SK	protein_coding	O94907	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3230
0	-0.756552591998733	0.172	0.597	0	PHYHIPL	Malignant cells	GSE115251	ENSG00000165443	84457	phytanoyl-CoA 2-hydroxylase interacting protein like	Em:AC025038.1|KIAA1796	protein_coding	Q96FC7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3231
0	-1.39774517886631	0.188	0.838	0	UNC5B	Malignant cells	GSE115251	ENSG00000107731	219699	unc-5 netrin receptor B	p53RDL1|UNC5H2	protein_coding	Q8IZJ1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3232
0	-0.688272096211542	0.018	0.432	0	SLC18A2	Malignant cells	GSE115251	ENSG00000165646	6571	solute carrier family 18 member A2	SVAT|SVMT|VMAT2	protein_coding	Q05940	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3233
0	0.773181320690033	0.493	0.064	0	PPAPDC1A	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3234
0	0.672574007476076	0.782	0.485	0	HRAS	Malignant cells	GSE115251	ENSG00000276536	3265	HRas proto-oncogene, GTPase	HRAS1	protein_coding	P01112	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3235
0	0.921262633919132	1	1	0	RPLP2	Malignant cells	GSE115251	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3236
0	0.595687517439238	0.979	0.91	0	POLR2L	Malignant cells	GSE115251	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3237
0	0.626822144903077	0.623	0.269	0	CD81	Malignant cells	GSE115251	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3238
0	0.85593046507444	1	1	0	RPL27A	Malignant cells	GSE115251	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3239
0	1.71274355995305	0.863	0.279	0	TP53I11	Malignant cells	GSE115251	ENSG00000175274	9537	tumor protein p53 inducible protein 11	PIG11	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3240
0	0.403882214171684	1	1	0	MDK	Malignant cells	GSE115251	ENSG00000110492	4192	midkine	FLJ27379|MK|NEGF2	protein_coding	P21741	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3241
0	1.06093111699986	0.831	0.38	0	UBE2L6	Malignant cells	GSE115251	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3242
0	-0.986981027172128	0.524	0.9	0	GNG3	Malignant cells	GSE115251	ENSG00000162188	2785	G protein subunit gamma 3	NA	protein_coding	P63215	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3243
0	-0.613216047879746	0.994	1	0	PPP1R14B	Malignant cells	GSE115251	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3244
0	0.288940578053901	1	1	0	FAU	Malignant cells	GSE115251	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3245
0	-0.621982974415002	0.748	0.925	0	CCDC85B	Malignant cells	GSE115251	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3246
0	-2.53911925307392	0.577	1	0	GSTP1	Malignant cells	GSE115251	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3247
0	-1.42636675900442	0.89	0.993	0	GAL	Malignant cells	GSE115251	ENSG00000069482	51083	galanin and GMAP prepropeptide	GAL-GMAP|GALN|GLNN|GMAP	protein_coding	P22466	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3248
0	-0.456893902934458	1	1	0	RPS3	Malignant cells	GSE115251	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3249
0	-0.300413065768911	1	1	0	GAPDH	Malignant cells	GSE115251	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3250
0	0.715775960203866	0.889	0.633	0	C12orf57	Malignant cells	GSE115251	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3251
0	1.76757497374943	0.911	0.296	0	MGST1	Malignant cells	GSE115251	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3252
0	-0.980753010799021	0.742	0.934	0	KIF21A	Malignant cells	GSE115251	ENSG00000139116	55605	kinesin family member 21A	FEOM1|FLJ20052	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3253
0	0.579299443741774	0.347	0.024	0	COL2A1	Malignant cells	GSE115251	ENSG00000139219	1280	collagen type II alpha 1 chain	AOM|SEDC|STL1	protein_coding	P02458	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3254
0	-0.99539641591326	0.5	0.886	0	PRPH	Malignant cells	GSE115251	ENSG00000135406	5630	peripherin	NEF4|PRPH1	protein_coding	P41219	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3255
0	-0.496543083993152	0.117	0.417	0	LIMA1	Malignant cells	GSE115251	ENSG00000050405	51474	LIM domain and actin binding 1	EPLIN	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3256
0	-0.548690203324246	0.023	0.367	0	METTL7A	Malignant cells	GSE115251	ENSG00000185432	25840	methyltransferase like 7A	DKFZP586A0522	protein_coding	Q9H8H3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3257
0	-0.373605668547563	1	1	0	ATP5G2	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3258
0	-0.562905425626059	1	1	0	HNRNPA1	Malignant cells	GSE115251	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3259
0	0.503766275958798	1	1	0	RPS26	Malignant cells	GSE115251	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3260
0	0.548904745939043	1	1	0	RPL41	Malignant cells	GSE115251	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3261
0	0.440225190584366	0.995	0.985	0	MYL6B	Malignant cells	GSE115251	ENSG00000196465	140465	myosin light chain 6B	MLC1SA	protein_coding	P14649	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3262
0	0.913516322565377	0.976	0.835	0	NABP2	Malignant cells	GSE115251	ENSG00000139579	79035	nucleic acid binding protein 2	hSSB1|MGC2731|OBFC2B|SOSS-B1|SSB1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3263
0	0.665547179878853	0.981	0.897	0	CNPY2	Malignant cells	GSE115251	ENSG00000257727	10330	canopy FGF signaling regulator 2	HP10390|TMEM4|ZSIG9	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3264
0	0.632525181245044	0.998	0.99	0	PTGES3	Malignant cells	GSE115251	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3265
0	0.412558394425094	1	1	0	NACA	Malignant cells	GSE115251	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3266
0	0.552815995729675	0.993	0.973	0	CDK4	Malignant cells	GSE115251	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3267
0	0.444476243616254	0.298	0.012	0	TBC1D30	Malignant cells	GSE115251	ENSG00000111490	23329	TBC1 domain family member 30	KIAA0984	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3268
0	0.676924484700244	0.989	0.94	0	CCT2	Malignant cells	GSE115251	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3269
0	0.92087772933437	0.765	0.424	0	CSRP2	Malignant cells	GSE115251	ENSG00000175183	1466	cysteine and glycine rich protein 2	CRP2|LMO5|SmLIM	protein_coding	Q16527	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3270
0	0.940810122694659	0.938	0.786	0	SYT1	Malignant cells	GSE115251	ENSG00000067715	6857	synaptotagmin 1	P65|SVP65|SYT	protein_coding	P21579	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3271
0	0.696416329473626	0.888	0.679	0	CCDC59	Malignant cells	GSE115251	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3272
0	0.673137040493251	0.831	0.607	0	BTG1	Malignant cells	GSE115251	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3273
0	0.785219478279899	1	0.996	0	SNRPF	Malignant cells	GSE115251	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3274
0	1.11066781749517	0.956	0.801	0	HSP90B1	Malignant cells	GSE115251	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3275
0	0.77390492262832	0.913	0.734	0	TDG	Malignant cells	GSE115251	ENSG00000139372	6996	thymine DNA glycosylase	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3276
0	0.64933323717957	0.824	0.605	0	C12orf75	Malignant cells	GSE115251	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3277
0	0.641493446163408	0.994	0.957	0	ARPC3	Malignant cells	GSE115251	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3278
0	0.686708761452592	0.765	0.474	0	GPN3	Malignant cells	GSE115251	ENSG00000111231	51184	GPN-loop GTPase 3	ATPBD1C|MGC14560	protein_coding	Q9UHW5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3279
0	0.686499011866379	0.937	0.769	0	ERP29	Malignant cells	GSE115251	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3280
0	-0.559674285630119	0.001	0.337	0	RPH3A	Malignant cells	GSE115251	ENSG00000089169	22895	rabphilin 3A	exophilin-1|KIAA0985|rabphilin	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3281
0	1.34736416141304	0.756	0.189	0	TESC	Malignant cells	GSE115251	ENSG00000088992	54997	tescalcin	CHP3|FLJ20607|TSC	protein_coding	Q96BS2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3282
0	0.624151683810501	1	0.999	0	SRSF9	Malignant cells	GSE115251	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3283
0	0.452320394238376	1	0.999	0	DYNLL1	Malignant cells	GSE115251	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3284
0	0.872014372152813	0.978	0.869	0	TMED2	Malignant cells	GSE115251	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3285
0	0.461968038717649	0.287	0.003	0	TMEM132C	Malignant cells	GSE115251	ENSG00000181234	92293	transmembrane protein 132C	DKFZp761O2018|PPP1R152	protein_coding	Q8N3T6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3286
0	0.621935808086965	1	1	0	RAN	Malignant cells	GSE115251	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3287
0	-0.473527516464929	0.991	0.998	0	GTF3A	Malignant cells	GSE115251	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3288
0	0.868943851788999	0.586	0.107	0	DACH1	Malignant cells	GSE115251	ENSG00000276644	1602	dachshund family transcription factor 1	DACH	protein_coding	Q9UI36	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3289
0	0.721798594723726	0.533	0.14	0	SLAIN1	Malignant cells	GSE115251	ENSG00000139737	122060	SLAIN motif family member 1	C13orf32|FLJ30046	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3290
0	-0.423787432946097	0.017	0.29	0	COL4A2	Malignant cells	GSE115251	ENSG00000134871	1284	collagen type IV alpha 2 chain	DKFZp686I14213|FLJ22259	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3291
0	-0.734719102781622	0.821	0.957	0	TFDP1	Malignant cells	GSE115251	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3292
0	0.684133055627396	0.577	0.213	0	COCH	Malignant cells	GSE115251	ENSG00000100473	1690	cochlin	COCH-5B2|DFNA31|DFNA9	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3293
0	0.546818274024528	0.961	0.881	0	FKBP3	Malignant cells	GSE115251	ENSG00000100442	2287	FKBP prolyl isomerase 3	FKBP-25|FKBP25	protein_coding	Q00688	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3294
0	0.354757434025657	1	1	0	RPS29	Malignant cells	GSE115251	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3295
0	1.40304797376332	0.652	0.002	0	SIX1	Malignant cells	GSE115251	ENSG00000126778	6495	SIX homeobox 1	DFNA23	protein_coding	Q15475	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3296
0	0.593782125127009	0.36	0.012	0	ZFP36L1	Malignant cells	GSE115251	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3297
0	-0.644626825622959	0.183	0.569	0	EML5	Malignant cells	GSE115251	ENSG00000165521	161436	EMAP like 5	EMAP-2|FAP16|HuEMAP-2	protein_coding	Q05BV3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3298
0	-1.40864411244018	0.727	0.991	0	CHGA	Malignant cells	GSE115251	ENSG00000276781	1113	chromogranin A	PHE5|PHES	protein_coding	P10645	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3299
0	-0.791945701211495	0.448	0.795	0	MEIS2	Malignant cells	GSE115251	ENSG00000134138	4212	Meis homeobox 2	HsT18361|MRG1	protein_coding	O14770	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3300
0	1.24791164249037	0.565	0.066	0	GCHFR	Malignant cells	GSE115251	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3301
0	-1.25002265106598	0.695	0.977	0	B2M	Malignant cells	GSE115251	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3302
0	-0.620593643769221	0.033	0.409	0	STRA6	Malignant cells	GSE115251	ENSG00000288257	64220	signaling receptor and transporter of retinol STRA6	FLJ12541	protein_coding	Q9BX79	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3303
0	0.560259470763	0.967	0.894	0	RCN2	Malignant cells	GSE115251	ENSG00000117906	5955	reticulocalbin 2	E6BP|ERC-55|ERC55|TCBP49	protein_coding	Q14257	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3304
0	0.750199229886337	0.8	0.497	0	CIB2	Malignant cells	GSE115251	ENSG00000136425	10518	calcium and integrin binding family member 2	DFNB48|KIP2|USH1J	protein_coding	O75838	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3305
0	1.66233764297234	0.847	0.703	0	CRABP1	Malignant cells	GSE115251	ENSG00000166426	1381	cellular retinoic acid binding protein 1	CRABP|CRABP-I|CRABPI|RBP5	protein_coding	P29762	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3306
0	0.693964116906273	0.382	0.011	0	WFIKKN1	Malignant cells	GSE115251	ENSG00000127578	117166	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1	C16orf12|RJD2|WFDC20A|WFIKKN	protein_coding	Q96NZ8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3307
0	-0.77433712417145	0.131	0.581	0	HAGHL	Malignant cells	GSE115251	ENSG00000103253	84264	hydroxyacylglutathione hydrolase like	MGC2605	protein_coding	Q6PII5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3308
0	-0.400114991631603	1	1	0	RPS2	Malignant cells	GSE115251	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3309
0	0.446304559622921	0.281	0.001	0	SYT17	Malignant cells	GSE115251	ENSG00000103528	51760	synaptotagmin 17	Syt-17	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3310
0	-0.661954468372791	0.711	0.886	0	CRNDE	Malignant cells	GSE115251	ENSG00000245694	101927480	uncharacterized LOC101927480	CRNDEP|LINC00180|LOC643911	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3311
0	-0.699412123578502	0.035	0.474	0	MMP2	Malignant cells	GSE115251	ENSG00000087245	4313	matrix metallopeptidase 2	CLG4|CLG4A|TBE-1	protein_coding	P08253	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3312
0	-0.905962827179779	0.07	0.58	0	SLC6A2	Malignant cells	GSE115251	ENSG00000103546	6530	solute carrier family 6 member 2	NAT1|NET|NET1|SLC6A5	protein_coding	P23975	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3313
0	-0.502366800008829	0.085	0.41	0	GNAO1	Malignant cells	GSE115251	ENSG00000087258	2775	G protein subunit alpha o1	G-ALPHA-o	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3314
0	-0.406716796049191	0.015	0.263	0	MT2A	Malignant cells	GSE115251	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3315
0	-2.44989575239897	0.193	0.981	0	DOK4	Malignant cells	GSE115251	ENSG00000125170	55715	docking protein 4	FLJ10488	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3316
0	-0.421748891642461	0.037	0.299	0	EXOC3L1	Malignant cells	GSE115251	ENSG00000179044	283849	exocyst complex component 3 like 1	EXOC3L|FLJ35539|FLJ35587	protein_coding	Q86VI1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3317
0	-0.610373545737519	0.839	0.962	0	NUTF2	Malignant cells	GSE115251	ENSG00000102898	10204	nuclear transport factor 2	NTF2|PP15	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3318
0	-0.527873890465283	0.883	0.973	0	GABARAPL2	Malignant cells	GSE115251	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3319
0	-0.840749873498856	0.607	0.891	0	CENPN	Malignant cells	GSE115251	ENSG00000166451	55839	centromere protein N	BM039|C16orf60|FLJ13607|FLJ22660	protein_coding	Q96H22	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3320
0	-0.790386750482436	0.833	0.978	0	GCSH	Malignant cells	GSE115251	ENSG00000140905	2653	glycine cleavage system protein H	NA	protein_coding	P23434	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3321
0	-0.841129896092996	0.966	0.999	0	HSBP1	Malignant cells	GSE115251	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3322
0	-0.950640516068331	0.999	1	0	COX4I1	Malignant cells	GSE115251	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3323
0	-0.66055470634259	0.245	0.604	0	CDT1	Malignant cells	GSE115251	ENSG00000167513	81620	chromatin licensing and DNA replication factor 1	DUP|RIS2	protein_coding	Q9H211	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3324
0	-0.730002942904029	0.758	0.949	0	APRT	Malignant cells	GSE115251	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3325
0	-1.07030622387793	1	1	0	RPL13	Malignant cells	GSE115251	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3326
0	-0.601179728398457	0.438	0.728	0	TCF25	Malignant cells	GSE115251	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3327
0	-0.599854574072043	0.774	0.921	0	DEF8	Malignant cells	GSE115251	ENSG00000140995	54849	differentially expressed in FDCP 8 homolog	FLJ20186	protein_coding	Q6ZN54	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3328
0	-0.41305729707323	0.008	0.286	0	P2RX5	Malignant cells	GSE115251	ENSG00000083454	5026	purinergic receptor P2X 5	LRH-1|P2X5	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3329
0	-0.287056162962576	1	1	0	RPL26	Malignant cells	GSE115251	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3330
0	-0.716783130051721	0.009	0.43	0	PMP22	Malignant cells	GSE115251	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3331
0	1.73944640786831	0.998	0.577	0	UBB	Malignant cells	GSE115251	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3332
0	0.414424603729453	0.283	0.02	0	MFAP4	Malignant cells	GSE115251	ENSG00000166482	4239	microfibril associated protein 4	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3333
0	0.780142406589137	0.489	0.019	0	RP11-344E13.3	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3334
0	-0.523203614514737	0.018	0.355	0	KCNJ12	Malignant cells	GSE115251	ENSG00000184185	3768	potassium inwardly rectifying channel subfamily J member 12	hIRK1|IRK2|KCNJN1|Kir2.2|Kir2.2v	protein_coding	Q14500	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3335
0	-0.550610859147401	0.161	0.495	0	IGFBP4	Malignant cells	GSE115251	ENSG00000141753	3487	insulin like growth factor binding protein 4	BP-4|HT29-IGFBP|IBP4|IGFBP-4	protein_coding	P22692	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3336
0	-0.408982232324119	1	1	0	EIF1	Malignant cells	GSE115251	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3337
0	-0.482836843320025	0.058	0.356	0	HSD17B1	Malignant cells	GSE115251	ENSG00000108786	3292	hydroxysteroid 17-beta dehydrogenase 1	EDH17B2|EDHB17|HSD17|MGC138140|SDR28C1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3338
0	-0.708630202588165	0.056	0.476	0	RP11-527L4.2	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3339
0	-0.371950526833277	1	1	0	ATP5G1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3340
0	-1.10621392938674	0.538	0.918	0	NME1-NME2	Malignant cells	GSE115251	ENSG00000011052	654364	NME1-NME2 readthrough	NM23-LV|NMELV	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3341
0	-1.66518792961759	0.114	0.803	0	CYB561	Malignant cells	GSE115251	ENSG00000008283	1534	cytochrome b561	CYB561A1|FRRS2	protein_coding	P49447	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3342
0	-0.615192686976333	0.278	0.613	0	SNORA76	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3343
0	0.56009452994979	0.97	0.896	0	BPTF	Malignant cells	GSE115251	ENSG00000171634	2186	bromodomain PHD finger transcription factor	FAC1|FALZ|NURF301	protein_coding	Q12830	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3344
0	0.558914070242675	0.947	0.836	0	AMZ2	Malignant cells	GSE115251	ENSG00000196704	51321	archaelysin family metallopeptidase 2	NA	protein_coding	Q86W34	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3345
0	0.529181895850603	0.384	0.077	0	SOX9	Malignant cells	GSE115251	ENSG00000125398	6662	SRY-box transcription factor 9	CMD1|CMPD1|SRA1	protein_coding	P48436	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3346
0	0.736746920143831	0.426	0.063	0	SSTR2	Malignant cells	GSE115251	ENSG00000180616	6752	somatostatin receptor 2	NA	protein_coding	P30874	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3347
0	0.585864966667904	0.561	0.224	0	CDC42EP4	Malignant cells	GSE115251	ENSG00000179604	23580	CDC42 effector protein 4	BORG4|CEP4|KAIA1777|MGC17125|MGC3740	protein_coding	Q9H3Q1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3348
0	0.649241635726567	1	1	0	RPL38	Malignant cells	GSE115251	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3349
0	0.385780561792665	1	1	0	SUMO2	Malignant cells	GSE115251	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3350
0	1.10240717069836	1	1	0	H3F3B	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3351
0	0.641608005980237	0.554	0.187	0	RNF157	Malignant cells	GSE115251	ENSG00000141576	114804	ring finger protein 157	KIAA1917	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3352
0	-0.379329156200188	0.013	0.26	0	CYGB	Malignant cells	GSE115251	ENSG00000161544	114757	cytoglobin	HGB|STAP	protein_coding	Q8WWM9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3353
0	-1.21418090230054	0.125	0.739	0	PRCD	Malignant cells	GSE115251	ENSG00000214140	768206	photoreceptor disc component	RP36	protein_coding	Q00LT1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3354
0	-0.740642192711473	0.243	0.648	0	MXRA7	Malignant cells	GSE115251	ENSG00000182534	439921	matrix remodeling associated 7	FLJ46603|PS1TP1|TMAP1	protein_coding	P84157	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3355
0	-0.844880227360219	0.949	0.994	0	C17orf89	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3356
0	-0.63621529376913	0.686	0.893	0	ARHGDIA	Malignant cells	GSE115251	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3357
0	-0.759410554390884	0.995	1	0	ANAPC11	Malignant cells	GSE115251	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3358
0	0.445761850090043	0.27	0.007	0	ADCYAP1	Malignant cells	GSE115251	ENSG00000141433	116	adenylate cyclase activating polypeptide 1	PACAP	protein_coding	P18509	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3359
0	0.635635857352407	0.813	0.562	0	MYL12A	Malignant cells	GSE115251	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3360
0	0.704883009970124	0.926	0.739	0	MYL12B	Malignant cells	GSE115251	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3361
0	0.592201324139667	0.996	0.979	0	NDUFV2	Malignant cells	GSE115251	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3362
0	0.855790365444057	0.44	0.112	0	RAB31	Malignant cells	GSE115251	ENSG00000168461	11031	RAB31, member RAS oncogene family	Rab22B	protein_coding	Q13636	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3363
0	0.624386598360397	0.959	0.863	0	VAPA	Malignant cells	GSE115251	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3364
0	0.585896132654249	0.583	0.249	0	CHMP1B	Malignant cells	GSE115251	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3365
0	-0.873319867242401	0.901	0.992	0	RPL17	Malignant cells	GSE115251	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3366
0	-0.612192192877642	0.871	0.973	0	DSTN	Malignant cells	GSE115251	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3367
0	0.705784813223216	0.986	0.94	0	EIF2S2	Malignant cells	GSE115251	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3368
0	0.612238711898678	0.946	0.814	0	DYNLRB1	Malignant cells	GSE115251	ENSG00000125971	83658	dynein light chain roadblock-type 1	DNCL2A|DNLC2A|ROBLD1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3369
0	0.6210151329388	0.871	0.657	0	EIF6	Malignant cells	GSE115251	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3370
0	0.789429518356511	0.813	0.468	0	CPNE1	Malignant cells	GSE115251	ENSG00000214078	8904	copine 1	CPN1	protein_coding	Q99829	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3371
0	0.915333017179249	0.965	0.779	0	ROMO1	Malignant cells	GSE115251	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3372
0	0.663811062375721	0.987	0.938	0	RBM39	Malignant cells	GSE115251	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3373
0	0.782810627512167	0.917	0.706	0	RPN2	Malignant cells	GSE115251	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3374
0	0.843329016309164	0.664	0.206	0	BLCAP	Malignant cells	GSE115251	ENSG00000166619	10904	BLCAP apoptosis inducing factor	BC10	protein_coding	P62952	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3375
0	-0.71892213354397	0.094	0.518	0	VSTM2L	Malignant cells	GSE115251	ENSG00000132821	128434	V-set and transmembrane domain containing 2 like	C20orf102|dJ1118M15.2	protein_coding	Q96N03	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3376
0	0.723773670053335	0.99	0.938	0	YWHAB	Malignant cells	GSE115251	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3377
0	0.884935450177345	1	0.997	0	ZFAS1	Malignant cells	GSE115251	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3378
0	-0.63174909879435	0.319	0.678	0	BMP7	Malignant cells	GSE115251	ENSG00000101144	655	bone morphogenetic protein 7	OP-1	protein_coding	P18075	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3379
0	1.59412315972232	0.786	0.008	0	CTCFL	Malignant cells	GSE115251	ENSG00000124092	140690	CCCTC-binding factor like	BORIS|CT27|dJ579F20.2	protein_coding	Q8NI51	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3380
0	0.424814330375964	1	1	0	ATP5E	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3381
0	0.639849890864167	1	1	0	RPS21	Malignant cells	GSE115251	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3382
0	0.758906211352269	0.916	0.714	0	STMN3	Malignant cells	GSE115251	ENSG00000197457	50861	stathmin 3	SCLIP	protein_coding	Q9NZ72	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3383
0	0.492771837377346	0.996	0.988	0	GPX4	Malignant cells	GSE115251	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3384
0	-0.596279543905391	0.154	0.515	0	NFIC	Malignant cells	GSE115251	ENSG00000141905	4782	nuclear factor I C	CTF|CTF5|NF-I|NFI	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3385
0	-0.624216373985765	0.672	0.898	0	SHD	Malignant cells	GSE115251	ENSG00000105251	56961	Src homology 2 domain containing transforming protein D	NA	protein_coding	Q96IW2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3386
0	-0.531129811176843	0.939	0.988	0	PRDX2	Malignant cells	GSE115251	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3387
0	1.07855586565092	0.777	0.251	0	HOMER3	Malignant cells	GSE115251	ENSG00000051128	9454	homer scaffold protein 3	HOMER-3	protein_coding	Q9NSC5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3388
0	-0.668156206639888	0.632	0.9	0	RPSAP58	Malignant cells	GSE115251	ENSG00000288920	388524	ribosomal protein SA pseudogene 58	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3389
0	-0.581473372263082	0.849	0.94	0	TTC9B	Malignant cells	GSE115251	ENSG00000174521	148014	tetratricopeptide repeat domain 9B	FLJ30373	protein_coding	Q8N6N2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3390
0	-0.283677548836388	1	1	0	RPS19	Malignant cells	GSE115251	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3391
0	0.704184234689439	0.995	0.981	0	CALM3	Malignant cells	GSE115251	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3392
0	-0.276809946502647	1	1	0	RPL13A	Malignant cells	GSE115251	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3393
0	1.11888725919168	0.737	0.19	0	TNNT1	Malignant cells	GSE115251	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3394
0	-0.572558342746917	0.54	0.799	0	CECR5	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3395
0	-0.658492617913237	0.514	0.792	0	C22orf39	Malignant cells	GSE115251	ENSG00000242259	128977	chromosome 22 open reading frame 39	MGC74441	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3396
0	0.65983347256889	0.274	0.006	0	CLDN5	Malignant cells	GSE115251	ENSG00000184113	7122	claudin 5	AWAL|BEC1|CPETRL1|TMVCF	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3397
0	-0.591584815208656	0.347	0.653	0	COMT	Malignant cells	GSE115251	ENSG00000093010	1312	catechol-O-methyltransferase	NA	protein_coding	P21964	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3398
0	-1.50779436892616	0.832	0.994	0	CHCHD10	Malignant cells	GSE115251	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3399
0	-0.935602222476418	1	1	0	MIF	Malignant cells	GSE115251	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3400
0	-0.72821546818651	0.315	0.679	0	ADRBK2	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3401
0	-1.24166660967852	0.563	0.915	0	NEFH	Malignant cells	GSE115251	ENSG00000100285	4744	neurofilament heavy chain	NF-H|NFH	protein_coding	P12036	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3402
0	-0.421234913926726	0.998	0.999	0	UQCR10	Malignant cells	GSE115251	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3403
0	-0.576405998386122	0.844	0.963	0	YWHAH	Malignant cells	GSE115251	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3404
0	-0.625755070126214	0.884	0.98	0	EIF3D	Malignant cells	GSE115251	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3405
0	-0.527965167635326	0.003	0.349	0	IFT27	Malignant cells	GSE115251	ENSG00000100360	11020	intraflagellar transport 27	BBS19|FAP156|RABL4|RAYL	protein_coding	Q9BW83	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3406
0	-1.00939961158322	0.954	0.999	0	EIF3L	Malignant cells	GSE115251	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3407
0	-0.541078265860159	0.134	0.45	0	APOBEC3C	Malignant cells	GSE115251	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3408
0	-0.689263859249941	1	1	0	RPL3	Malignant cells	GSE115251	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3409
0	-0.540140263835094	0.959	0.992	0	SMDT1	Malignant cells	GSE115251	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3410
0	-0.78391287524498	0.425	0.773	0	RRP7A	Malignant cells	GSE115251	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3411
0	-0.86749596765727	0.301	0.731	0	TSPO	Malignant cells	GSE115251	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3412
0	-0.521853364244152	0.078	0.4	0	PRR5	Malignant cells	GSE115251	ENSG00000186654	55615	proline rich 5	FLJ20185k|PP610|Protor-1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3413
0	-0.372950901626693	0.017	0.255	0	FAM19A5	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3414
0	0.863425883709574	0.669	0.244	0	NRIP1	Malignant cells	GSE115251	ENSG00000180530	8204	nuclear receptor interacting protein 1	RIP140	protein_coding	P48552	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3415
0	0.482469185292054	1	1	0	MT-ND1	Malignant cells	GSE115251	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3416
0	0.751174748449043	1	1	0	MT-ND2	Malignant cells	GSE115251	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3417
0	0.346603315781564	1	1	0	MT-CO1	Malignant cells	GSE115251	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3418
0	-0.684489617248233	0.193	0.591	0	MT-ATP8	Malignant cells	GSE115251	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3419
0	-0.753846583538658	1	1	0	MT-CO3	Malignant cells	GSE115251	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3420
0	0.866485086205857	1	1	0	MT-ND3	Malignant cells	GSE115251	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3421
0	0.655794452482317	0.963	0.861	0	MT-ND4L	Malignant cells	GSE115251	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3422
0	0.634139162467382	1	1	0	MT-ND4	Malignant cells	GSE115251	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3423
0	-0.753430370843557	0.756	0.94	0	MT-ND6	Malignant cells	GSE115251	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3424
0	0.618025237292315	0.34	0	0	RPRM	Malignant cells	GSE115251	ENSG00000177519	56475	reprimo, TP53 dependent G2 arrest mediator homolog	FLJ90327|REPRIMO	protein_coding	Q9NS64	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3425
0	0.592426177506497	0.315	0	0	SLC25A48	Malignant cells	GSE115251	ENSG00000145832	153328	solute carrier family 25 member 48	FLJ44862	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3426
0	1.25468735850636	0.601	0	0	NEUROD4	Malignant cells	GSE115251	ENSG00000123307	58158	neuronal differentiation 4	ATH-3|Atoh3|bHLHa4|MATH-3	protein_coding	Q9HD90	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3427
0	0.484903139142026	0.318	0	0	CD300LG	Malignant cells	GSE115251	ENSG00000161649	146894	CD300 molecule like family member g	CLM9|Trem4	protein_coding	Q6UXG3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3428
0	0.751642912731849	0.396	0	0	MYL1	Malignant cells	GSE115251	ENSG00000168530	4632	myosin light chain 1	MLC-1|MLC1|MLC1/3|MLC1F|MLC3F	protein_coding	P05976	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3429
9.50514113619999e-308	0.527373587213121	0.983	0.964	1.78335457997384e-303	PA2G4	Malignant cells	GSE115251	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3430
2.02684049266881e-307	0.392296554081365	1	0.997	3.80275813234522e-303	SNRPD2	Malignant cells	GSE115251	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3431
2.47738042400483e-306	0.397837202370973	0.282	0.027	4.64806115151786e-302	ZIC3	Malignant cells	GSE115251	ENSG00000156925	7547	Zic family member 3	HTX|HTX1|ZNF203	protein_coding	O60481	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3432
2.51923982808218e-306	0.422536986375754	0.999	0.998	4.72659776544778e-302	SEC61G	Malignant cells	GSE115251	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3433
7.14167512917241e-306	0.572168870178819	0.715	0.416	1.33992108773533e-301	ATXN7L3B	Malignant cells	GSE115251	ENSG00000253719	552889	ataxin 7 like 3B	lnc-SCA7	protein_coding	Q96GX2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3434
3.17403227161023e-305	0.399856098821547	0.281	0.027	5.95511934799511e-301	PHLDB2	Malignant cells	GSE115251	ENSG00000144824	90102	pleckstrin homology like domain family B member 2	FLJ21791|LL5b|LL5beta	protein_coding	Q86SQ0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3435
3.47871343435195e-305	-0.482526397175566	0.951	0.985	6.52676214553113e-301	ARPC1A	Malignant cells	GSE115251	ENSG00000241685	10552	actin related protein 2/3 complex subunit 1A	Arc40|SOP2Hs|SOP2L	protein_coding	Q92747	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3436
6.52576410814851e-305	-0.530702423004306	0.846	0.953	1.22436386197082e-300	COX20	Malignant cells	GSE115251	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3437
1.72379290113804e-304	-0.586555665741322	0.394	0.68	3.23418024111519e-300	QARS	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3438
8.97866133848774e-304	-0.572963686422805	0.727	0.902	1.68457644032707e-299	ANKRD11	Malignant cells	GSE115251	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3439
1.22154170718675e-302	-0.566166131327535	0.392	0.69	2.29185655102378e-298	STAC	Malignant cells	GSE115251	ENSG00000144681	6769	SH3 and cysteine rich domain	STAC1	protein_coding	Q99469	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3440
1.55948222272595e-302	0.568352948680916	0.891	0.727	2.92590054627843e-298	TAF7	Malignant cells	GSE115251	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3441
2.41536072995622e-302	0.576246176400349	0.751	0.472	4.53169980154386e-298	WBP5	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3442
8.21439740651868e-301	-0.457704853107596	0.105	0.393	1.54118524141104e-296	PROX1	Malignant cells	GSE115251	ENSG00000117707	5629	prospero homeobox 1	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3443
3.00542362659104e-299	0.491917158694165	0.975	0.91	5.63877580821011e-295	SUPT4H1	Malignant cells	GSE115251	ENSG00000213246	6827	SPT4 homolog, DSIF elongation factor subunit	Spt4|SPT4H|Supt4a|SUPT4H	protein_coding	P63272	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3444
8.21832981076642e-299	-0.478919250111675	0.124	0.416	1.54192303909599e-294	FOXP1	Malignant cells	GSE115251	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3445
1.05573375989546e-298	-0.468242523764936	0.966	0.991	1.98076768031587e-294	MRPL12	Malignant cells	GSE115251	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3446
1.67558885501704e-298	0.575497784999629	0.698	0.412	3.14373980978297e-294	PRKAR1A	Malignant cells	GSE115251	ENSG00000108946	5573	protein kinase cAMP-dependent type I regulatory subunit alpha	CNC1|PRKAR1|TSE1	protein_coding	P10644	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3447
2.34943277496843e-298	0.38288781896704	0.278	0.028	4.40800577239577e-294	TRIM58	Malignant cells	GSE115251	ENSG00000162722	25893	tripartite motif containing 58	BIA2	protein_coding	Q8NG06	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3448
2.48672559848054e-298	-0.510263983234259	0.868	0.963	4.6655945678692e-294	VDAC1	Malignant cells	GSE115251	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3449
5.74272026734801e-298	0.467780819365258	0.383	0.093	1.07744917655983e-293	FAM212B	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3450
6.96905224518441e-298	-0.415187517419889	0.076	0.345	1.3075335822415e-293	DYRK4	Malignant cells	GSE115251	ENSG00000010219	8798	dual specificity tyrosine phosphorylation regulated kinase 4	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3451
8.28573415409199e-298	0.447044340571035	0.331	0.059	1.55456944199074e-293	AC004540.4	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3452
4.28429223375665e-297	-0.601448467710204	0.502	0.755	8.03818908897422e-293	RP11-834C11.4	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3453
1.93845528431901e-296	-0.518000932468505	0.151	0.445	3.63692980443932e-292	SDC2	Malignant cells	GSE115251	ENSG00000169439	6383	syndecan 2	CD362|fibroglycan|HSPG|HSPG1|SYND2	protein_coding	P34741	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3454
8.7042335142403e-296	-0.613848363789585	0.742	0.902	1.63308829194177e-291	KIF5B	Malignant cells	GSE115251	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3455
4.7338473953999e-295	-0.55077305071008	0.554	0.793	8.88164448324929e-291	KARS	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3456
4.33698205028565e-294	-0.48885019275421	0.186	0.49	8.13704572274594e-290	PLIN2	Malignant cells	GSE115251	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3457
8.23397708465865e-294	-0.602365165853119	0.425	0.723	1.54485878062366e-289	TBX2	Malignant cells	GSE115251	ENSG00000121068	6909	T-box transcription factor 2	NA	protein_coding	Q13207	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3458
1.02656619046924e-293	-0.532212742794765	0.217	0.522	1.92604348655839e-289	ZFHX3	Malignant cells	GSE115251	ENSG00000140836	463	zinc finger homeobox 3	ATBF1|C16orf47|FLJ26184|ZNF927	protein_coding	Q15911	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3459
8.42408368859161e-292	0.505154056034642	0.993	0.983	1.58052658165356e-287	CALM1	Malignant cells	GSE115251	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3460
1.09078101352817e-291	-0.56156485931019	0.614	0.832	2.04652333758156e-287	BAG1	Malignant cells	GSE115251	ENSG00000107262	573	BAG cochaperone 1	NA	protein_coding	Q99933	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3461
6.00998438447178e-290	0.480834709214074	1	0.999	1.1275932702146e-285	STMN1	Malignant cells	GSE115251	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3462
8.23002126243984e-290	-0.502185026268213	0.909	0.975	1.54411658925896e-285	ATF4	Malignant cells	GSE115251	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3463
1.03065716235082e-288	0.535763812191255	0.869	0.702	1.9337189680026e-284	CHMP4B	Malignant cells	GSE115251	ENSG00000101421	128866	charged multivesicular body protein 4B	C20orf178|dJ553F4.4|Shax1|SNF7-2|VPS32B	protein_coding	Q9H444	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3464
3.2347652186591e-287	-0.426375312323602	0.097	0.373	6.0690665032482e-283	ABHD14B	Malignant cells	GSE115251	ENSG00000114779	84836	abhydrolase domain containing 14B	CIB|MGC15429	protein_coding	Q96IU4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3465
6.10140432887293e-287	0.574676789586479	0.758	0.512	1.14474548018314e-282	DDX27	Malignant cells	GSE115251	ENSG00000124228	55661	DEAD-box helicase 27	dJ686N3.1|DRS1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3466
7.61960171224229e-287	0.400061515018423	0.299	0.044	1.4295896732509e-282	PRSS12	Malignant cells	GSE115251	ENSG00000164099	8492	serine protease 12	BSSP-3|MRT1	protein_coding	P56730	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3467
1.41529906847175e-286	0.714001206078652	0.916	0.901	2.6553841122667e-282	TYMS	Malignant cells	GSE115251	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3468
2.96499294501255e-285	-0.637385878480057	0.05	0.292	5.56291976343255e-281	IGFBP5	Malignant cells	GSE115251	ENSG00000115461	3488	insulin like growth factor binding protein 5	NA	protein_coding	P24593	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3469
1.40846828426081e-284	-0.408376291747667	0.077	0.341	2.64256819493014e-280	CNTN1	Malignant cells	GSE115251	ENSG00000018236	1272	contactin 1	F3|GP135	protein_coding	Q12860	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3470
2.26877189555195e-284	0.449734210031763	0.996	0.99	4.25666983043456e-280	SLIRP	Malignant cells	GSE115251	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3471
8.620548675259e-284	-0.688421481107536	0.38	0.682	1.61738734245209e-279	INSM2	Malignant cells	GSE115251	ENSG00000168348	84684	INSM transcriptional repressor 2	IA-6|Mlt1	protein_coding	Q96T92	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3472
2.75503787031234e-283	-0.505141293711959	0.893	0.991	5.16900205228001e-279	ID3	Malignant cells	GSE115251	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3473
7.42281337934131e-281	0.557626021912309	0.72	0.442	1.39266824623202e-276	TALDO1	Malignant cells	GSE115251	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3474
7.52533598885462e-281	-0.538399275144153	0.413	0.703	1.4119035382289e-276	EEF1A2	Malignant cells	GSE115251	ENSG00000101210	1917	eukaryotic translation elongation factor 1 alpha 2	EEF1AL|HS1|STN|STNL	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3475
7.91573900437054e-281	-0.50667628320249	0.23	0.535	1.485150952e-276	RERG	Malignant cells	GSE115251	ENSG00000134533	85004	RAS like estrogen regulated growth inhibitor	MGC15754	protein_coding	Q96A58	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3476
6.58126101064975e-278	0.549712830772009	0.87	0.706	1.23477619081811e-273	VPS29	Malignant cells	GSE115251	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3477
7.928534702716e-278	0.550265341877331	0.714	0.444	1.48755168092357e-273	RNF114	Malignant cells	GSE115251	ENSG00000124226	55905	ring finger protein 114	PSORS12|ZNF313	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3478
1.07688484786208e-277	-0.4178760411645	0.093	0.36	2.02045135155883e-273	GSTO2	Malignant cells	GSE115251	ENSG00000065621	119391	glutathione S-transferase omega 2	NA	protein_coding	Q9H4Y5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3479
2.9599414879698e-276	0.513355290635004	0.914	0.786	5.55344221972894e-272	SURF2	Malignant cells	GSE115251	ENSG00000281024	6835	surfeit 2	NA	protein_coding	Q15527	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3480
1.3401714179792e-275	-0.469038541465098	0.146	0.429	2.51442961441258e-271	RP11-111M22.3	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3481
2.31333291299493e-275	-0.51953059835616	0.695	0.875	4.3402752113611e-271	PABPC4	Malignant cells	GSE115251	ENSG00000090621	8761	poly(A) binding protein cytoplasmic 4	APP-1|iPABP	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3482
3.79577814051057e-274	0.524627311490306	0.851	0.668	7.12163894722593e-270	LAMTOR2	Malignant cells	GSE115251	ENSG00000116586	28956	late endosomal/lysosomal adaptor, MAPK and MTOR activator 2	ENDAP|MAPBPIP|MAPKSP1AP|p14|Ragulator2|ROBLD3	protein_coding	Q9Y2Q5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3483
6.27054890159361e-274	-0.332578999292383	0.03	0.25	1.17648038491699e-269	PDE9A	Malignant cells	GSE115251	ENSG00000160191	5152	phosphodiesterase 9A	NA	protein_coding	O76083	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3484
9.23646208830855e-274	-0.50356067203682	0.811	0.931	1.73294501700845e-269	MPST	Malignant cells	GSE115251	ENSG00000128309	4357	mercaptopyruvate sulfurtransferase	MST|TST2|TUM1	protein_coding	P25325	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3485
1.53645468951762e-273	0.369879579879271	1	0.998	2.88269628847295e-269	PHPT1	Malignant cells	GSE115251	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3486
3.1985539227252e-273	0.554805750119346	0.851	0.683	6.00112686981702e-269	RAP1B	Malignant cells	GSE115251	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3487
1.30329565130996e-272	-0.467417257078392	0.876	0.964	2.44524330098775e-268	FAM96B	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3488
1.8994698601702e-272	0.49883712603536	0.95	0.862	3.56378535165132e-268	UBE2N	Malignant cells	GSE115251	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3489
8.52087817231101e-272	0.429596374993611	0.284	0.041	1.59868716268899e-267	ADRA2A	Malignant cells	GSE115251	ENSG00000150594	150	adrenoceptor alpha 2A	ADRA2|ADRA2R|ADRAR	protein_coding	P08913	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3490
3.04233761121947e-271	-0.34843974912659	0.037	0.262	5.70803382616998e-267	LCP1	Malignant cells	GSE115251	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3491
2.68884616817323e-270	-0.255471178535132	1	1	5.04481318072661e-266	RPS18	Malignant cells	GSE115251	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3492
1.8551958453229e-269	-0.351165489996519	0.999	1	3.48071844499482e-265	AURKAIP1	Malignant cells	GSE115251	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3493
1.80149014714077e-268	-0.495570217749307	0.16	0.445	3.37995581406552e-264	TXNIP	Malignant cells	GSE115251	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3494
7.70223599904488e-267	0.532972745081455	0.542	0.242	1.4450935181408e-262	SCG5	Malignant cells	GSE115251	ENSG00000277614	6447	secretogranin V	7B2|SGNE1|SgV	protein_coding	P05408	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3495
8.9088078645457e-267	0.443294130998634	0.35	0.085	1.67147053154606e-262	RFTN1	Malignant cells	GSE115251	ENSG00000131378	23180	raftlin, lipid raft linker 1	FLJ23866|KIAA0084|MIG2|Raftlin	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3496
2.10720519127342e-266	-0.432538888924748	0.128	0.402	3.95353837986719e-262	CLEC11A	Malignant cells	GSE115251	ENSG00000105472	6320	C-type lectin domain containing 11A	CLECSF3|LSLCL|P47|SCGF	protein_coding	Q9Y240	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3497
6.25738203316196e-265	0.512172632354597	0.887	0.741	1.17401001706185e-260	RNMT	Malignant cells	GSE115251	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3498
9.04856102759728e-265	-0.473791171139099	0.145	0.423	1.6976910199978e-260	RP11-332H18.4	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3499
8.05908958158244e-262	-0.459692310251989	0.154	0.433	1.5120463872965e-257	SLC10A4	Malignant cells	GSE115251	ENSG00000145248	201780	solute carrier family 10 member 4	MGC29802	protein_coding	Q96EP9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3500
9.54312614199976e-262	-0.504992589638774	0.732	0.892	1.790481326762e-257	UQCRC1	Malignant cells	GSE115251	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3501
2.08199203191051e-261	0.512606412028089	0.668	0.388	3.90623345027049e-257	CHID1	Malignant cells	GSE115251	ENSG00000177830	66005	chitinase domain containing 1	FLJ42707|MGC3234|SI-CLP	protein_coding	Q9BWS9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3502
2.18247373721993e-261	-0.446323307075418	0.955	0.987	4.09475722577203e-257	PPA1	Malignant cells	GSE115251	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3503
2.7447327924188e-259	0.551827177625981	0.74	0.486	5.14966766513614e-255	MAGEA10	Malignant cells	GSE115251	ENSG00000124260	4109	MAGE family member A10	CT1.10|MAGE10|MGC10599	protein_coding	P43363	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3504
2.06073059176762e-258	-0.370378069387848	0.054	0.289	3.86634273627442e-254	LRRN3	Malignant cells	GSE115251	ENSG00000173114	54674	leucine rich repeat neuronal 3	FIGLER5|FLJ11129|NLRR3	protein_coding	Q9H3W5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3505
9.02567134556569e-258	-0.390540274556572	0.994	0.998	1.69339645785503e-253	SRM	Malignant cells	GSE115251	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3506
1.27127072595444e-257	-0.44894949322178	0.07	0.312	2.38515813603572e-253	TG	Malignant cells	GSE115251	ENSG00000042832	7038	thyroglobulin	AITD3|TGN	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3507
5.99406276674881e-257	0.522644512944663	0.75	0.505	1.12460605629741e-252	SCCPDH	Malignant cells	GSE115251	ENSG00000143653	51097	saccharopine dehydrogenase (putative)	CGI-49|NET11	protein_coding	Q8NBX0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3508
1.02502633846365e-256	-0.34148398336237	0.046	0.271	1.92315441622551e-252	TNFRSF1A	Malignant cells	GSE115251	ENSG00000067182	7132	TNF receptor superfamily member 1A	CD120a|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR60	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3509
5.27872479083288e-256	-0.399203682958643	0.984	0.998	9.90394345256065e-252	GLTSCR2	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3510
3.17306222127035e-255	-0.388509402121973	0.977	0.994	5.95329933954743e-251	TOMM22	Malignant cells	GSE115251	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3511
4.10507475511822e-255	-0.572744818006497	0.441	0.694	7.70194125555281e-251	CBX6	Malignant cells	GSE115251	ENSG00000183741	23466	chromobox 6	NA	protein_coding	O95503	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3512
6.62528568210971e-255	-0.520459372963599	0.375	0.649	1.24303609967742e-250	PRKAR2A	Malignant cells	GSE115251	ENSG00000114302	5576	protein kinase cAMP-dependent type II regulatory subunit alpha	PRKAR2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3513
4.91360978130713e-254	-0.399564726624062	0.995	1	9.21891467168843e-250	ODC1	Malignant cells	GSE115251	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3514
9.9958679761388e-253	0.481064437868938	0.93	0.798	1.87542474968316e-248	RTFDC1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3515
3.18173715482927e-252	-0.436903808896198	0.924	0.985	5.96957524989068e-248	TTC3	Malignant cells	GSE115251	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3516
5.34207215214687e-252	0.555754735690481	0.612	0.34	1.0022795771858e-247	ARL4A	Malignant cells	GSE115251	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3517
5.16023191039958e-250	0.451460077263139	0.975	0.92	9.68162711029169e-246	RALBP1	Malignant cells	GSE115251	ENSG00000017797	10928	ralA binding protein 1	RIP|RIP1|RLIP76	protein_coding	Q15311	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3518
5.90128856591668e-250	-0.535484855144887	0.438	0.684	1.10719976073729e-245	APPL1	Malignant cells	GSE115251	ENSG00000157500	26060	adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1	APPL	protein_coding	Q9UKG1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3519
7.2794866296775e-250	-0.342787113226847	0.998	1	1.36577728146009e-245	SLC25A6	Malignant cells	GSE115251	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3520
6.92804173130064e-249	-0.451915940685236	0.933	0.98	1.29983918962663e-244	KTN1	Malignant cells	GSE115251	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3521
5.04243615936108e-247	0.412593068093319	0.997	0.992	9.46061872219325e-243	MRPL41	Malignant cells	GSE115251	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3522
1.4220251531696e-246	-0.52576387299921	0.545	0.776	2.6680035923768e-242	MEIS3	Malignant cells	GSE115251	ENSG00000105419	56917	Meis homeobox 3	DKFZp547H236|MRG2	protein_coding	Q99687	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3523
2.8053688869337e-246	-0.273164857796883	1	1	5.263433105665e-242	MT-ATP6	Malignant cells	GSE115251	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3524
3.07209126292417e-246	-0.390945297240047	0.987	0.997	5.76385762749834e-242	SLC25A39	Malignant cells	GSE115251	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3525
1.19376439021885e-245	0.398303423021953	0.309	0.066	2.2397407489286e-241	RASSF3	Malignant cells	GSE115251	ENSG00000153179	283349	Ras association domain family member 3	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3526
3.15815561402365e-245	-0.361942286617028	0.055	0.278	5.92533156303118e-241	ACBD5	Malignant cells	GSE115251	ENSG00000107897	91452	acyl-CoA binding domain containing 5	DKFZp434A2417|KIAA1996	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3527
7.44102334066999e-244	0.521955508631847	0.913	0.798	1.3960847991765e-239	NUDC	Malignant cells	GSE115251	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3528
2.1756245816771e-243	-0.303217895443662	0.999	1	4.08190684014258e-239	COX8A	Malignant cells	GSE115251	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3529
2.39093985538404e-243	-0.519018834928694	0.59	0.789	4.48588135667154e-239	POLR2C	Malignant cells	GSE115251	ENSG00000102978	5432	RNA polymerase II subunit C	RPB3	protein_coding	P19387	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3530
2.95645521367305e-242	-0.525025560943013	0.645	0.833	5.54690127189337e-238	RAC3	Malignant cells	GSE115251	ENSG00000169750	5881	Rac family small GTPase 3	NA	protein_coding	P60763	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3531
4.45737791255559e-242	-0.481434000613596	0.266	0.545	8.36293243953679e-238	CAMK4	Malignant cells	GSE115251	ENSG00000152495	814	calcium/calmodulin dependent protein kinase IV	CaMK-GR|CaMKIV	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3532
1.13447732759891e-241	0.512539849959828	0.727	0.487	2.12850636204107e-237	FAM104A	Malignant cells	GSE115251	ENSG00000133193	84923	family with sequence similarity 104 member A	FLJ14775	protein_coding	Q969W3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3533
1.14225842918619e-241	-0.533786692295281	0.473	0.71	2.14310526483913e-237	PITPNB	Malignant cells	GSE115251	ENSG00000180957	23760	phosphatidylinositol transfer protein beta	VIB1B	protein_coding	P48739	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3534
4.25929674158818e-241	-0.539064864849595	0.273	0.546	7.99129254656774e-237	LIMCH1	Malignant cells	GSE115251	ENSG00000064042	22998	LIM and calponin homology domains 1	DKFZP686A01247|LIMCH1A|LMO7B	protein_coding	Q9UPQ0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3535
2.42225940040868e-240	0.666515380081236	0.626	0.364	4.54464308704677e-236	APLP2	Malignant cells	GSE115251	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3536
2.86588898698747e-239	0.261938511188508	1	1	5.3769809173859e-235	RPL6	Malignant cells	GSE115251	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3537
7.09620688756914e-239	0.622018539328081	0.706	0.482	1.33139033624572e-234	PLEKHA5	Malignant cells	GSE115251	ENSG00000052126	54477	pleckstrin homology domain containing A5	FLJ10667|KIAA1686|PEPP2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3538
7.79997534375267e-239	0.455990677309955	0.375	0.111	1.46343137399488e-234	PCSK1N	Malignant cells	GSE115251	ENSG00000102109	27344	proprotein convertase subtilisin/kexin type 1 inhibitor	BigLEN|PEN|proSAAS|SAAS|SCG8|SgVIII	protein_coding	Q9UHG2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3539
1.24280154391951e-238	-0.478027848587403	0.725	0.89	2.33174425670178e-234	GNL3	Malignant cells	GSE115251	ENSG00000163938	26354	G protein nucleolar 3	C77032|E2IG3|MGC800|NS	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3540
2.42280068364861e-238	0.457736890305142	0.933	0.833	4.54565864266153e-234	ERGIC3	Malignant cells	GSE115251	ENSG00000125991	51614	ERGIC and golgi 3	C20orf47|CGI-54|Erv46|NY-BR-84|PRO0989|SDBCAG84	protein_coding	Q9Y282	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3541
2.43507871991068e-238	0.489421070462198	0.642	0.371	4.56869469429642e-234	TAF10	Malignant cells	GSE115251	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3542
9.09222509671987e-237	-0.411486880827709	0.966	0.991	1.70588327264658e-232	NDUFA6	Malignant cells	GSE115251	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3543
1.8190539530746e-236	0.428798273710614	0.983	0.947	3.41290902675857e-232	NDUFA12	Malignant cells	GSE115251	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3544
4.17474406106508e-236	0.311052320140974	1	0.999	7.83265480737031e-232	CNBP	Malignant cells	GSE115251	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3545
9.17701871990275e-236	0.339909425700774	0.999	0.997	1.72179225222815e-231	COX6A1	Malignant cells	GSE115251	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3546
2.81141116189006e-234	0.47619314045177	0.429	0.164	5.27476962193814e-230	CELF3	Malignant cells	GSE115251	ENSG00000159409	11189	CUGBP Elav-like family member 3	BRUNOL1|CAGH4|ERDA4|MGC57297|TNRC4	protein_coding	Q5SZQ8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3547
3.02860060269821e-234	-0.456244328368919	0.213	0.48	5.68226045078237e-230	ABLIM1	Malignant cells	GSE115251	ENSG00000099204	3983	actin binding LIM protein 1	ABLIM|LIMAB1|limatin	protein_coding	O14639	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3548
5.35833592804914e-234	-0.578843469892296	0.575	0.8	1.00533098682058e-229	SAMD11	Malignant cells	GSE115251	ENSG00000187634	148398	sterile alpha motif domain containing 11	MGC45873	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3549
2.96308037393706e-233	0.508943200432302	0.733	0.502	5.5593313975807e-229	NAP1L4	Malignant cells	GSE115251	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3550
4.70660658445456e-233	-0.44946021645405	0.896	0.963	8.83053527375365e-229	DDX17	Malignant cells	GSE115251	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3551
1.50823343510597e-232	-0.489859640302397	0.337	0.602	2.82974757094581e-228	NME3	Malignant cells	GSE115251	ENSG00000103024	4832	NME/NM23 nucleoside diphosphate kinase 3	DR-nm23|NDPKC|NM23-H3	protein_coding	Q13232	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3552
4.04765384803197e-232	0.437123290874529	0.99	0.971	7.59420814967759e-228	RBM8A	Malignant cells	GSE115251	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3553
1.24782125865993e-231	0.477928859094247	0.579	0.306	2.34116224549776e-227	MMAB	Malignant cells	GSE115251	ENSG00000139428	326625	metabolism of cobalamin associated B	cblB|CFAP23	protein_coding	Q96EY8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3554
1.35865183355541e-231	-0.470186325721613	0.374	0.658	2.54910257011665e-227	LMO1	Malignant cells	GSE115251	ENSG00000166407	4004	LIM domain only 1	RBTN1|RHOM1|TTG1	protein_coding	P25800	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3555
1.72991639632013e-231	0.279990675679911	1	1	3.24566914277584e-227	SRP14	Malignant cells	GSE115251	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3556
5.09723646414403e-231	-0.506329560782872	0.398	0.658	9.56343505402702e-227	NETO2	Malignant cells	GSE115251	ENSG00000171208	81831	neuropilin and tolloid like 2	FLJ10430|NEOT2	protein_coding	Q8NC67	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3557
1.50685846516174e-230	0.554296049682192	0.83	0.659	2.82716785233647e-226	CXXC5	Malignant cells	GSE115251	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3558
4.79729304289243e-230	0.382094943638401	0.251	0.038	9.00068120707477e-226	GCH1	Malignant cells	GSE115251	ENSG00000131979	2643	GTP cyclohydrolase 1	DYT14|DYT5|DYT5a|GCH|GTPCH1	protein_coding	P30793	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3559
6.2659338028084e-229	-0.336263002693606	0.057	0.272	1.17561450008291e-224	RPS6KA2	Malignant cells	GSE115251	ENSG00000071242	6196	ribosomal protein S6 kinase A2	HU-2|RSK3	protein_coding	Q15349	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3560
5.54516102677987e-227	-0.496844795054993	0.509	0.729	1.04038311184444e-222	SMYD2	Malignant cells	GSE115251	ENSG00000143499	56950	SET and MYND domain containing 2	HSKM-B|KMT3C|ZMYND14	protein_coding	Q9NRG4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3561
1.1239934101181e-226	0.46193162938931	0.442	0.178	2.10883643606357e-222	STRADB	Malignant cells	GSE115251	ENSG00000082146	55437	STE20 related adaptor beta	ALS2CR2|CALS-21|ILPIP|ILPIPA|PAPK	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3562
3.2853703815882e-226	0.419751161472044	0.395	0.136	6.16401190993578e-222	GULP1	Malignant cells	GSE115251	ENSG00000144366	51454	GULP PTB domain containing engulfment adaptor 1	CED-6|CED6|GULP	protein_coding	Q9UBP9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3563
3.4507982583177e-226	1.44744432743728	0.596	0.399	6.47438769225566e-222	TH	Malignant cells	GSE115251	ENSG00000180176	7054	tyrosine hydroxylase	DYT5b	protein_coding	P07101	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3564
8.16108846555655e-226	0.481156935784758	0.832	0.663	1.53118341790772e-221	MZT2A	Malignant cells	GSE115251	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3565
4.08856763676412e-225	-0.47323599950072	0.816	0.965	7.67097060009685e-221	KIAA0101	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3566
1.26355916167026e-224	-0.456967816642023	0.295	0.562	2.37068969912575e-220	TRIM2	Malignant cells	GSE115251	ENSG00000109654	23321	tripartite motif containing 2	CMT2R|KIAA0517|RNF86	protein_coding	Q9C040	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3567
2.06253016816805e-224	-0.414184253099114	0.186	0.447	3.8697191015169e-220	COQ9	Malignant cells	GSE115251	ENSG00000088682	57017	coenzyme Q9	C16orf49|DKFZP434K046	protein_coding	O75208	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3568
6.3431368249388e-224	1.04225578044761	0.822	0.74	1.19009933109502e-219	DBH	Malignant cells	GSE115251	ENSG00000123454	1621	dopamine beta-hydroxylase	DBM	protein_coding	P09172	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3569
7.27925415992908e-224	0.478105414408464	0.931	0.849	1.36573366548589e-219	RALY	Malignant cells	GSE115251	ENSG00000125970	22913	RALY heterogeneous nuclear ribonucleoprotein	HNRPCL2|P542	protein_coding	Q9UKM9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3570
1.61791668235408e-223	0.419749241333257	0.994	0.985	3.03553527943272e-219	U2AF1	Malignant cells	GSE115251	ENSG00000160201	7307	U2 small nuclear RNA auxiliary factor 1	RN|RNU2AF1|U2AF35|U2AFBP	protein_coding	Q01081	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3571
1.97532009789697e-222	0.475558886574884	0.688	0.435	3.70609556767429e-218	LLPH	Malignant cells	GSE115251	ENSG00000139233	84298	LLP homolog, long-term synaptic facilitation factor	C12orf31|hLLP|MGC14817	protein_coding	Q9BRT6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3572
3.87000987162785e-222	-0.384344959688319	1	1	7.26091252114816e-218	NPM1	Malignant cells	GSE115251	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3573
1.56291329699377e-221	0.506997220707879	0.656	0.403	2.93233792781971e-217	RP11-620J15.3	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3574
1.58168715682875e-221	0.520949271196437	0.624	0.372	2.96756144364209e-217	PTPRF	Malignant cells	GSE115251	ENSG00000142949	5792	protein tyrosine phosphatase receptor type F	LAR	protein_coding	P10586	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3575
1.58529806104475e-221	0.60120560215134	0.583	0.335	2.97433622213217e-217	ASS1	Malignant cells	GSE115251	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3576
2.04663015562558e-221	0.470107357617856	0.574	0.31	3.83988749798471e-217	SNCA	Malignant cells	GSE115251	ENSG00000145335	6622	synuclein alpha	NACP|PARK1|PARK4|PD1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3577
4.73829729381738e-221	-0.424249538828922	0.201	0.465	8.88999338266016e-217	CYBA	Malignant cells	GSE115251	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3578
4.83305136114113e-221	0.473027196793122	0.563	0.3	9.06777096377298e-217	DNTTIP1	Malignant cells	GSE115251	ENSG00000101457	116092	deoxynucleotidyltransferase terminal interacting protein 1	C20orf167|dJ447F3.4|Tdif1	protein_coding	Q9H147	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3579
1.24257325408984e-220	0.483388636838897	0.852	0.696	2.33131593932335e-216	DENR	Malignant cells	GSE115251	ENSG00000139726	8562	density regulated re-initiation and release factor	DRP|DRP1|SMAP-3	protein_coding	O43583	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3580
2.41493451663631e-220	-0.308166817523745	0.05	0.255	4.53090014011304e-216	ST8SIA2	Malignant cells	GSE115251	ENSG00000140557	8128	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2	HsT19690|SIAT8B|ST8SIA-II|STX	protein_coding	Q92186	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3581
5.98180038314466e-220	-0.4589052187059	0.288	0.55	1.1223053878856e-215	NIPSNAP1	Malignant cells	GSE115251	ENSG00000184117	8508	nipsnap homolog 1	NA	protein_coding	Q9BPW8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3582
7.30604589929393e-220	-0.328759937847639	0.061	0.273	1.37076033162553e-215	MEF2C	Malignant cells	GSE115251	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3583
1.60934650260975e-219	-0.506989443306554	0.397	0.638	3.01945590819642e-215	IMPDH1	Malignant cells	GSE115251	ENSG00000106348	3614	inosine monophosphate dehydrogenase 1	LCA11|RP10|sWSS2608	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3584
6.23763046988008e-219	-0.396644869258048	0.971	0.991	1.1703042287589e-214	ITGB1BP1	Malignant cells	GSE115251	ENSG00000119185	9270	integrin subunit beta 1 binding protein 1	ICAP-1A|ICAP-1alpha|ICAP-1B|ICAP1|ICAP1A|ICAP1B	protein_coding	O14713	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3585
7.67418804473638e-219	0.432419491367934	0.946	0.857	1.43983116095344e-214	SCAND1	Malignant cells	GSE115251	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3586
1.08650162136694e-218	0.470790329459895	0.867	0.723	2.03849434200865e-214	DNAJC21	Malignant cells	GSE115251	ENSG00000168724	134218	DnaJ heat shock protein family (Hsp40) member C21	DNAJA5|GS3|JJJ1	protein_coding	Q5F1R6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3587
1.73806631643494e-218	-0.472360683915516	0.12	0.359	3.26096002289523e-214	KCTD12	Malignant cells	GSE115251	ENSG00000178695	115207	potassium channel tetramerization domain containing 12	C13orf2|KIAA1778|PFET1	protein_coding	Q96CX2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3588
1.81626388876681e-218	0.36437990016696	0.292	0.067	3.40767430810428e-214	WIPI1	Malignant cells	GSE115251	ENSG00000070540	55062	WD repeat domain, phosphoinositide interacting 1	ATG18|ATG18A|FLJ10055|WIPI49	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3589
1.23398149818752e-217	0.351860441599051	0.995	0.989	2.31519608689942e-213	USMG5	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3590
1.87025486432145e-217	-0.449152617313435	0.848	0.947	3.50897217643991e-213	RAD23A	Malignant cells	GSE115251	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3591
1.10883270966717e-216	0.467383744288848	0.723	0.489	2.08039192987754e-212	REXO4	Malignant cells	GSE115251	ENSG00000280706	57109	REX4 homolog, 3'-5' exonuclease	hPMC2|XPMC2H	protein_coding	Q9GZR2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3592
5.05470068061935e-216	0.584365614724019	0.311	0.084	9.48362941697803e-212	GKAP1	Malignant cells	GSE115251	ENSG00000165113	80318	G kinase anchoring protein 1	FKSG21|GKAP42	protein_coding	Q5VSY0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3593
6.34246280737009e-216	-0.322293958365843	0.049	0.25	1.18997287191878e-211	PTPRG	Malignant cells	GSE115251	ENSG00000144724	5793	protein tyrosine phosphatase receptor type G	PTPG|RPTPG	protein_coding	P23470	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3594
1.49336692802765e-215	0.441732384555029	0.917	0.802	2.80185503036548e-211	MRPL23	Malignant cells	GSE115251	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3595
2.72683178078218e-215	0.412931396324814	0.983	0.936	5.11608178710352e-211	ATP5C1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3596
7.05815872757447e-215	0.337491518016556	0.999	0.997	1.32425174046752e-210	SF3B14	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3597
8.14133030454911e-215	-0.387329833438694	0.938	0.983	1.5274763917395e-210	HIGD2A	Malignant cells	GSE115251	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3598
8.73974021107907e-215	-0.404624956113238	0.896	0.966	1.63975005840266e-210	ARF1	Malignant cells	GSE115251	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3599
1.84757066292727e-214	-0.499466724312457	0.594	0.809	3.46641207778415e-210	MCM3	Malignant cells	GSE115251	ENSG00000112118	4172	minichromosome maintenance complex component 3	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3600
9.68637427451816e-214	0.500795989319179	0.727	0.509	1.8173575413851e-209	BCL7A	Malignant cells	GSE115251	ENSG00000282873	605	BAF chromatin remodeling complex subunit BCL7A	BCL7|SMARCJ1	protein_coding	Q4VC05	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3601
1.22292121591455e-211	0.438722827452663	0.897	0.682	2.29444478529888e-207	CSAG1	Malignant cells	GSE115251	ENSG00000198930	158511	chondrosarcoma associated gene 1	CSAGE|CT24.1	protein_coding	Q6PB30	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3602
2.02746334875543e-211	-0.461105433126319	0.453	0.689	3.80392673493493e-207	CFDP1	Malignant cells	GSE115251	ENSG00000153774	10428	craniofacial development protein 1	BCNT|CENP-29|CP27|p97|SWC5|Yeti	protein_coding	Q9UEE9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3603
1.57011629552658e-210	0.355642809616793	0.294	0.072	2.94585219366697e-206	PREX1	Malignant cells	GSE115251	ENSG00000124126	57580	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1	KIAA1415|P-REX1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3604
2.21317091773551e-210	0.443492819874566	0.924	0.828	4.15235127585536e-206	PRPF6	Malignant cells	GSE115251	ENSG00000101161	24148	pre-mRNA processing factor 6	ANT-1|bB152O15.1|C20orf14|hPrp6|Prp6|RP60|SNRNP102|TOM|U5-102K	protein_coding	O94906	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3605
1.730231758821e-209	0.46873334295814	0.832	0.677	3.24626082589995e-205	ARL2	Malignant cells	GSE115251	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3606
5.52545119761755e-209	0.345210969442132	0.997	0.991	1.036685153697e-204	TBCA	Malignant cells	GSE115251	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3607
5.95867191490979e-209	0.32081035036996	0.998	0.998	1.11796602467537e-204	UBL5	Malignant cells	GSE115251	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3608
8.60081121102219e-209	0.356030727215604	0.257	0.05	1.61368419941198e-204	SOX2	Malignant cells	GSE115251	ENSG00000181449	6657	SRY-box transcription factor 2	NA	protein_coding	P48431	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3609
5.28923752342447e-208	-0.379339399285555	0.16	0.408	9.92366744144899e-204	CAMK1D	Malignant cells	GSE115251	ENSG00000183049	57118	calcium/calmodulin dependent protein kinase ID	CKLiK	protein_coding	Q8IU85	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3610
7.28392462310348e-208	0.354288558371571	0.283	0.066	1.36660993778667e-203	PEX5L	Malignant cells	GSE115251	ENSG00000114757	51555	peroxisomal biogenesis factor 5 like	PEX5R|PXR2|TRIP8b	protein_coding	Q8IYB4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3611
8.86078465772291e-208	-0.313367645015735	0.067	0.277	1.66246041748197e-203	RAB33A	Malignant cells	GSE115251	ENSG00000134594	9363	RAB33A, member RAS oncogene family	RabS10	protein_coding	Q14088	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3612
1.6996270231262e-207	-0.453341827472117	0.696	0.869	3.18884022078938e-203	EPRS	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3613
2.17402503313175e-207	-0.431169354759236	0.949	0.99	4.0789057671618e-203	HSPB1	Malignant cells	GSE115251	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3614
4.74641670764925e-207	0.411880141159129	0.383	0.139	8.90522702689153e-203	CBFA2T2	Malignant cells	GSE115251	ENSG00000078699	9139	CBFA2/RUNX1 partner transcriptional co-repressor 2	MTGR1|ZMYND3	protein_coding	O43439	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3615
1.31545373577982e-206	-0.374726548704487	0.15	0.393	2.4680542990701e-202	TYMP	Malignant cells	GSE115251	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3616
1.85347981079822e-206	0.544246321984745	0.855	0.727	3.47749882101963e-202	BUB3	Malignant cells	GSE115251	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3617
6.65881732507587e-206	-0.475133591312143	0.665	0.84	1.24932730653074e-201	METRN	Malignant cells	GSE115251	ENSG00000103260	79006	meteorin, glial cell differentiation regulator	C16orf23|MGC2601	protein_coding	Q9UJH8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3618
7.67736556567555e-206	0.401556025252245	0.986	0.952	1.44042732743205e-201	SNRPC	Malignant cells	GSE115251	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3619
1.00523450900579e-204	0.388984007795143	0.327	0.099	1.88602098579667e-200	B3GAT2	Malignant cells	GSE115251	ENSG00000112309	135152	beta-1,3-glucuronyltransferase 2	GlcAT-S	protein_coding	Q9NPZ5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3620
1.97303938146668e-204	0.564416437731575	0.578	0.324	3.70181648750779e-200	UBALD2	Malignant cells	GSE115251	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3621
6.52487404448902e-204	0.439746101256572	0.452	0.199	1.22419686822703e-199	MYO6	Malignant cells	GSE115251	ENSG00000196586	4646	myosin VI	DFNA22|DFNB37|KIAA0389	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3622
1.2373066034285e-203	0.323352135575219	0.274	0.062	2.32143464935256e-199	GREB1L	Malignant cells	GSE115251	ENSG00000141449	80000	GREB1 like retinoic acid receptor coactivator	C18orf6|FLJ13687|KIAA1772	protein_coding	Q9C091	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3623
1.60605186550439e-203	-0.456074586649355	0.364	0.609	3.01327451005934e-199	MSRB2	Malignant cells	GSE115251	ENSG00000148450	22921	methionine sulfoxide reductase B2	CBS-1|CBS1|CGI-131|MSRB|PILB	protein_coding	Q9Y3D2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3624
2.54317746675329e-203	-0.359928085234781	0.122	0.353	4.77150956312251e-199	IRF2BPL	Malignant cells	GSE115251	ENSG00000119669	64207	interferon regulatory factor 2 binding protein like	C14orf4|EAP1|KIAA1865	protein_coding	Q9H1B7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3625
4.57731013049855e-203	0.410196145646518	0.416	0.168	8.58794926684138e-199	TM7SF2	Malignant cells	GSE115251	ENSG00000149809	7108	transmembrane 7 superfamily member 2	ANG1|DHCR14A|NET47	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3626
5.21539636246331e-203	-0.441480428517408	0.294	0.554	9.78512665525366e-199	SMAD9	Malignant cells	GSE115251	ENSG00000120693	4093	SMAD family member 9	MADH6|MADH9|SMAD8|SMAD8/9	protein_coding	O15198	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3627
5.51160185483376e-203	0.378451615334285	0.373	0.132	1.03408674000391e-198	SRD5A3	Malignant cells	GSE115251	ENSG00000128039	79644	steroid 5 alpha-reductase 3	FLJ13352|SRD5A2L|SRD5A2L1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3628
1.63736162017471e-202	0.516756055492708	0.755	0.539	3.07201787177179e-198	TMSB15A	Malignant cells	GSE115251	ENSG00000158164	11013	thymosin beta 15A	TMSL8|TMSNB	protein_coding	P0CG34	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3629
2.0639073513604e-202	-0.455125266531549	0.417	0.655	3.87230297262238e-198	CHD9	Malignant cells	GSE115251	ENSG00000177200	80205	chromodomain helicase DNA binding protein 9	BC022889|FLJ12178|KIAA0308	protein_coding	Q3L8U1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3630
3.81495319905418e-202	0.40040664635766	0.409	0.161	7.15761519206545e-198	RAPGEF1	Malignant cells	GSE115251	ENSG00000107263	2889	Rap guanine nucleotide exchange factor 1	C3G|GRF2	protein_coding	Q13905	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3631
6.14699319459575e-202	-0.366555116852019	0.135	0.369	1.15329886317005e-197	ARHGEF1	Malignant cells	GSE115251	ENSG00000076928	9138	Rho guanine nucleotide exchange factor 1	LBCL2|P115-RHOGEF|SUB1.5	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3632
9.30972024684623e-202	-0.454977465320943	0.327	0.575	1.74668971271329e-197	PTEN	Malignant cells	GSE115251	ENSG00000284792	5728	phosphatase and tensin homolog	BZS|MHAM|MMAC1|PTEN1|TEP1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3633
1.4849914396118e-201	-0.375267728318215	0.145	0.386	2.78614093899966e-197	CPLX2	Malignant cells	GSE115251	ENSG00000145920	10814	complexin 2	CPX-2|DKFZp547D155	protein_coding	Q6PUV4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3634
2.87063560169232e-201	0.486697378596403	0.955	0.92	5.38588651589512e-197	EIF3F	Malignant cells	GSE115251	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3635
2.90950123564641e-201	0.464702237215474	0.656	0.42	5.4588062183198e-197	WBP2	Malignant cells	GSE115251	ENSG00000132471	23558	WW domain binding protein 2	GRAMD6|WBP-2	protein_coding	Q969T9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3636
3.61617048473492e-201	0.466142762303693	0.565	0.316	6.78465906345965e-197	LINC00662	Malignant cells	GSE115251	ENSG00000261824	148189	long intergenic non-protein coding RNA 662	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3637
9.44292996934197e-201	-0.287771149710006	0.999	1	1.77168252084794e-196	TIMM13	Malignant cells	GSE115251	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3638
1.36859872074983e-200	-0.406956027518351	0.213	0.461	2.56776491987083e-196	PIANP	Malignant cells	GSE115251	ENSG00000139200	196500	PILR alpha associated neural protein	C12orf53|DKFZp547D2210|PANP	protein_coding	Q8IYJ0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3639
1.80384139869877e-199	0.460644948874084	0.727	0.517	3.38436723223864e-195	NELFB	Malignant cells	GSE115251	ENSG00000188986	25920	negative elongation factor complex member B	COBRA1|KIAA1182|NELF-B	protein_coding	Q8WX92	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3640
4.678471529838e-199	0.443411179627616	0.546	0.291	8.77774828428205e-195	NCOR2	Malignant cells	GSE115251	ENSG00000196498	9612	nuclear receptor corepressor 2	CTG26|SMRT|SMRTE|TNRC14|TRAC-1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3641
1.05920792194742e-198	-0.401837193105065	0.211	0.458	1.98728590315775e-194	MACROD1	Malignant cells	GSE115251	ENSG00000133315	28992	mono-ADP ribosylhydrolase 1	LRP16	protein_coding	Q9BQ69	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3642
4.13442095518172e-198	-0.477942414816402	0.516	0.723	7.75700059611194e-194	FASN	Malignant cells	GSE115251	ENSG00000169710	2194	fatty acid synthase	FAS|SDR27X1	protein_coding	P49327	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3643
5.3863369108481e-198	0.435204797017658	0.647	0.395	1.01058453121332e-193	TP53I3	Malignant cells	GSE115251	ENSG00000115129	9540	tumor protein p53 inducible protein 3	PIG3	protein_coding	Q53FA7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3644
1.10436628560968e-197	-0.4404938422637	0.295	0.544	2.07201202506088e-193	RRP9	Malignant cells	GSE115251	ENSG00000114767	9136	ribosomal RNA processing 9, U3 small nucleolar RNA binding protein	RNU3IP2|U3-55K	protein_coding	O43818	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3645
1.03524139684223e-196	0.338107292374774	1	0.999	1.94231990875538e-192	ATP5B	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3646
1.94479360154937e-196	0.465814906359825	0.824	0.666	3.64882175522692e-192	MLEC	Malignant cells	GSE115251	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3647
2.74325892237107e-196	0.488490716534207	0.701	0.485	5.1469023901526e-192	CKAP4	Malignant cells	GSE115251	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3648
1.1774633011495e-195	-0.391830952410369	0.169	0.407	2.2091566456167e-191	TEAD1	Malignant cells	GSE115251	ENSG00000187079	7003	TEA domain transcription factor 1	AA|TCF13|TEF-1	protein_coding	P28347	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3649
2.92674678052531e-194	0.480888885751361	0.727	0.525	5.49116230962159e-190	MRPS6	Malignant cells	GSE115251	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3650
8.56770113594067e-194	-0.373135669017369	0.181	0.423	1.60747208712519e-189	LINC00938	Malignant cells	GSE115251	ENSG00000273015	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3651
9.27828097692671e-194	-0.330076503650569	0.111	0.335	1.74079107689099e-189	CGREF1	Malignant cells	GSE115251	ENSG00000138028	10669	cell growth regulator with EF-hand domain 1	CGR11	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3652
9.62346380451088e-194	-0.329447596269229	0.092	0.304	1.80555427900233e-189	GPM6B	Malignant cells	GSE115251	ENSG00000046653	2824	glycoprotein M6B	M6B|MGC17150|MGC54284	protein_coding	Q13491	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3653
1.5797400407928e-193	0.462317717914561	0.569	0.326	2.96390826453545e-189	PDRG1	Malignant cells	GSE115251	ENSG00000088356	81572	p53 and DNA damage regulated 1	C20orf126|dJ310O13.3	protein_coding	Q9NUG6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3654
1.6940041402009e-193	0.455582101162242	0.4	0.164	3.17829056784493e-189	ABCA5	Malignant cells	GSE115251	ENSG00000154265	23461	ATP binding cassette subfamily A member 5	EST90625	protein_coding	Q8WWZ7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3655
5.04635750545274e-193	-0.436217592427357	0.606	0.793	9.46797595173043e-189	SLIT3	Malignant cells	GSE115251	ENSG00000184347	6586	slit guidance ligand 3	MEGF5|SLIL2|Slit-3|SLIT1|slit2	protein_coding	O75094	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3656
5.56038161761234e-193	0.448414161413439	0.61	0.369	1.04323879909643e-188	PSMD13	Malignant cells	GSE115251	ENSG00000185627	5719	proteasome 26S subunit, non-ATPase 13	p40.5|Rpn9	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3657
8.12054541537714e-193	-0.424013441512173	0.302	0.544	1.52357673083306e-188	HYAL2	Malignant cells	GSE115251	ENSG00000068001	8692	hyaluronidase 2	LuCa-2|LUCA2	protein_coding	Q12891	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3658
1.02264095965947e-192	0.474219169670814	0.717	0.505	1.9186789685131e-188	PAWR	Malignant cells	GSE115251	ENSG00000177425	5074	pro-apoptotic WT1 regulator	par-4|PAR4	protein_coding	Q96IZ0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3659
1.82733548095298e-192	-0.462239088599263	0.78	0.897	3.42844682936399e-188	AK1	Malignant cells	GSE115251	ENSG00000106992	203	adenylate kinase 1	NA	protein_coding	P00568	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3660
4.49072726213062e-192	0.454984242180198	0.96	0.919	8.42550248920946e-188	CCT5	Malignant cells	GSE115251	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3661
3.7732293583363e-191	0.526469600514314	0.527	0.287	7.07933292211057e-187	SLK	Malignant cells	GSE115251	ENSG00000065613	9748	STE20 like kinase	KIAA0204|se20-9|STK2	protein_coding	Q9H2G2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3662
3.58887436522341e-190	0.4187064379108	0.902	0.787	6.73344608403216e-186	TRIAP1	Malignant cells	GSE115251	ENSG00000170855	51499	TP53 regulated inhibitor of apoptosis 1	HSPC132|MDM35|P53CSV|WF-1	protein_coding	O43715	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3663
3.62538333549854e-189	-0.451646025920859	0.25	0.487	6.80194421406237e-185	GLRX	Malignant cells	GSE115251	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3664
4.47827660772802e-189	-0.351915635603737	0.161	0.394	8.40214257141931e-185	NUDT2	Malignant cells	GSE115251	ENSG00000164978	318	nudix hydrolase 2	APAH1	protein_coding	P50583	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3665
4.68338061514931e-189	-0.453928825760265	0.656	0.82	8.78695871014314e-185	C19orf60	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3666
1.02390444465609e-188	0.327443549485379	0.999	0.998	1.92104951906375e-184	SNRPD1	Malignant cells	GSE115251	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3667
2.6564779106909e-188	-0.404398061847663	0.222	0.463	4.98408385603827e-184	FBXO8	Malignant cells	GSE115251	ENSG00000164117	26269	F-box protein 8	FBS|FBX8	protein_coding	Q9NRD0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3668
5.55524205430789e-188	-0.447884234629862	0.431	0.659	1.04227451422925e-183	PBRM1	Malignant cells	GSE115251	ENSG00000163939	55193	polybromo 1	BAF180|PB1|SMARCH1	protein_coding	Q86U86	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3669
1.06884169850514e-187	-0.468380982760812	0.412	0.655	2.00536079473535e-183	MAB21L1	Malignant cells	GSE115251	ENSG00000180660	4081	mab-21 like 1	CAGR1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3670
2.06904363828696e-187	0.342593345137312	0.271	0.068	3.88193967415399e-183	RP11-227F19.2	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3671
2.61313860916372e-187	0.389059094999224	0.962	0.91	4.90277065851297e-183	HEBP2	Malignant cells	GSE115251	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3672
3.06655319351062e-187	-0.353553649772298	0.957	0.984	5.75346710166462e-183	SNX3	Malignant cells	GSE115251	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3673
6.62395032109134e-187	-0.325553566133665	0.987	0.997	1.24278555924316e-182	SRP9	Malignant cells	GSE115251	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3674
8.44412990660591e-187	0.427861636671306	0.867	0.746	1.5842876530774e-182	CISD2	Malignant cells	GSE115251	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3675
1.67245199446113e-186	0.45936461874209	0.513	0.273	3.13785443200797e-182	EFNA5	Malignant cells	GSE115251	ENSG00000184349	1946	ephrin A5	AF1|EPLG7|LERK7	protein_coding	P52803	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3676
2.24321798211777e-186	0.49707006153959	0.522	0.282	4.20872557804935e-182	RUNX1T1	Malignant cells	GSE115251	ENSG00000079102	862	RUNX1 partner transcriptional co-repressor 1	AML1T1|CBFA2T1|CDR|ETO|MTG8|ZMYND2	protein_coding	Q06455	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3677
2.46107028602112e-186	0.432361029350505	0.377	0.149	4.61746007063282e-182	AC002454.1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3678
1.1970215340284e-185	0.439357745911105	0.771	0.586	2.24585180214409e-181	BAZ2A	Malignant cells	GSE115251	ENSG00000076108	11176	bromodomain adjacent to zinc finger domain 2A	KIAA0314|TIP5|WALp3	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3679
2.17208986038407e-185	0.338377503809999	0.994	0.994	4.07527499605259e-181	LSM3	Malignant cells	GSE115251	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3680
7.98983680666069e-185	-0.450715280200225	0.997	0.999	1.49905318166568e-180	ACTG1	Malignant cells	GSE115251	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3681
1.34597247465801e-184	0.432886092796472	0.671	0.442	2.52531355695336e-180	RP1-241P17.4	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3682
3.23868550447507e-184	0.435606636899057	0.874	0.763	6.07642174349613e-180	ARF5	Malignant cells	GSE115251	ENSG00000004059	381	ADP ribosylation factor 5	NA	protein_coding	P84085	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3683
9.66885971328271e-184	-0.459821847308994	0.287	0.525	1.8140714594061e-179	CTA-29F11.1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3684
4.84633229565465e-183	0.391261837955657	0.963	0.909	9.09268865310726e-179	POLR2H	Malignant cells	GSE115251	ENSG00000163882	5437	RNA polymerase II, I and III subunit H	RPB8	protein_coding	P52434	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3685
6.5086789714105e-183	0.384122192265608	0.385	0.155	1.22115834861604e-178	LTBP4	Malignant cells	GSE115251	ENSG00000090006	8425	latent transforming growth factor beta binding protein 4	FLJ46318|FLJ90018|LTBP-4|LTBP-4L	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3686
2.82184199838584e-182	-0.424542535599082	0.665	0.828	5.29433995737152e-178	FAM49B	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3687
1.48757303630892e-181	0.439748788747269	0.646	0.42	2.79098453072279e-177	POP5	Malignant cells	GSE115251	ENSG00000167272	51367	POP5 homolog, ribonuclease P/MRP subunit	NA	protein_coding	Q969H6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3688
3.0936034705985e-181	0.384305581552894	0.949	0.884	5.8042188315369e-177	METAP2	Malignant cells	GSE115251	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3689
2.65490171465036e-180	-0.294226433556417	0.078	0.276	4.98112659702701e-176	WAC-AS1	Malignant cells	GSE115251	ENSG00000254635	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3690
8.33879273124926e-180	-0.296464859215723	0.997	1	1.56452429223699e-175	NME4	Malignant cells	GSE115251	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3691
1.03186066142239e-179	0.648260643828594	0.944	0.869	1.93597697296069e-175	TUBB4B	Malignant cells	GSE115251	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3692
1.21936060623613e-179	0.815019285200338	0.92	0.978	2.28776436942023e-175	DLK1	Malignant cells	GSE115251	ENSG00000185559	8788	delta like non-canonical Notch ligand 1	Delta1|FA1|pG2|Pref-1|ZOG	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3693
1.50983616485216e-179	0.411694917106666	0.922	0.853	2.83275461249563e-175	MTPN	Malignant cells	GSE115251	ENSG00000105887	136319	myotrophin	GCDP|MYOTROPHIN|V-1	protein_coding	P58546	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3694
2.05271025778576e-179	-0.42186268271547	0.332	0.564	3.85129498565764e-175	DHX30	Malignant cells	GSE115251	ENSG00000132153	22907	DExH-box helicase 30	DDX30|FLJ11214|KIAA0890	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3695
5.72112905936081e-179	0.441105153180265	0.976	0.948	1.07339823411728e-174	PDIA6	Malignant cells	GSE115251	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3696
9.27760970360064e-179	-0.418035129695087	0.345	0.578	1.74066513258955e-174	IDS	Malignant cells	GSE115251	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3697
3.55800460383717e-177	-0.374627920992645	0.931	0.975	6.6755282377193e-173	GPATCH4	Malignant cells	GSE115251	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3698
9.33727002173095e-177	-0.427258302350861	0.508	0.727	1.75185860147716e-172	RBP1	Malignant cells	GSE115251	ENSG00000114115	5947	retinol binding protein 1	CRABP-I|CRBP|CRBP1|CRBPI|RBPC	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3699
1.44544828185464e-176	-0.361318604692928	0.14	0.36	2.71195006641568e-172	PHLDA3	Malignant cells	GSE115251	ENSG00000174307	23612	pleckstrin homology like domain family A member 3	TIH1	protein_coding	Q9Y5J5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3700
1.95644074335391e-176	0.412244791992246	0.415	0.186	3.67067412268061e-172	SLC2A8	Malignant cells	GSE115251	ENSG00000136856	29988	solute carrier family 2 member 8	GLUT8|GLUTX1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3701
3.32105964168394e-176	-0.286539837286503	0.068	0.257	6.23097209972742e-172	MAP3K1	Malignant cells	GSE115251	ENSG00000095015	4214	mitogen-activated protein kinase kinase kinase 1	MAPKKK1|MEKK|MEKK1	protein_coding	Q13233	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3702
8.63538791720494e-176	0.431105188772417	0.753	0.566	1.62017148102599e-171	EIF2B1	Malignant cells	GSE115251	ENSG00000111361	1967	eukaryotic translation initiation factor 2B subunit alpha	EIF-2B|EIF-2Balpha|EIF2B|EIF2BA|EIF2Balpha	protein_coding	Q14232	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3703
2.31236178942674e-175	0.390835326349435	0.937	0.866	4.33845318932246e-171	FAM213A	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3704
2.68632754793972e-175	-0.432975996113383	0.276	0.511	5.0400877454445e-171	MCM10	Malignant cells	GSE115251	ENSG00000065328	55388	minichromosome maintenance 10 replication initiation factor	CNA43|DNA43|PRO2249	protein_coding	Q7L590	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3705
1.03739946734911e-174	0.423691189392301	0.742	0.546	1.94636888064041e-170	MANBAL	Malignant cells	GSE115251	ENSG00000101363	63905	mannosidase beta like	dJ1141E15.2	protein_coding	Q9NQG1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3706
2.03422708613629e-174	-0.259132081326023	1	1	3.81661685900891e-170	EEF2	Malignant cells	GSE115251	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3707
3.08522928330774e-174	0.392919662339338	0.897	0.796	5.78850718134198e-170	PDCD6	Malignant cells	GSE115251	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3708
3.57927469207247e-174	0.42886927158736	0.718	0.511	6.71543517726637e-170	NOL11	Malignant cells	GSE115251	ENSG00000130935	25926	nucleolar protein 11	DKFZP586L0724	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3709
4.23342290355085e-174	0.315915047737278	0.997	0.989	7.9427480516421e-170	NDUFB10	Malignant cells	GSE115251	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3710
4.69591819658629e-174	0.333432603028288	0.287	0.085	8.81048172043519e-170	ROBO2	Malignant cells	GSE115251	ENSG00000185008	6092	roundabout guidance receptor 2	KIAA1568	protein_coding	Q9HCK4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3711
8.28133619981121e-174	-0.336015345416723	0.149	0.367	1.55374429780858e-169	MAPKAPK3	Malignant cells	GSE115251	ENSG00000114738	7867	MAPK activated protein kinase 3	3pK|MAPKAP3|MK-3|MK3	protein_coding	Q16644	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3712
9.28195225183325e-174	0.319931501176142	0.303	0.096	1.74147988148895e-169	SERPING1	Malignant cells	GSE115251	ENSG00000149131	710	serpin family G member 1	C1-INH|C1IN|C1INH|C1NH|HAE1|HAE2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3713
9.51040613065098e-174	-0.370726740014165	0.927	0.971	1.78434239823274e-169	SEPW1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3714
1.03414645979433e-173	-0.386376139181544	0.835	0.925	1.94026558786611e-169	TXN2	Malignant cells	GSE115251	ENSG00000100348	25828	thioredoxin 2	MT-TRX	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3715
1.7537798465176e-173	-0.469748478340917	0.456	0.66	3.29044174803632e-169	ORC6	Malignant cells	GSE115251	ENSG00000091651	23594	origin recognition complex subunit 6	ORC6L	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3716
1.77276963996497e-173	-0.42797157089868	0.436	0.652	3.32607039850227e-169	C7orf55	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3717
3.45996611786442e-173	0.429692090449286	0.703	0.503	6.49158843033723e-169	VAPB	Malignant cells	GSE115251	ENSG00000124164	9217	VAMP associated protein B and C	ALS8|VAP-B|VAP-C	protein_coding	O95292	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3718
4.04554560995742e-173	-0.439222887029536	0.735	0.872	7.59025267340211e-169	EIF4A2	Malignant cells	GSE115251	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3719
5.15465930263412e-173	0.332571579598401	1	1	9.67117178360214e-169	MALAT1	Malignant cells	GSE115251	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3720
5.97422258130943e-173	0.384778080750869	0.397	0.17	1.12088364070528e-168	ANXA2	Malignant cells	GSE115251	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3721
9.82585270355295e-173	0.392842181613973	0.918	0.834	1.8435264842406e-168	ZNF22	Malignant cells	GSE115251	ENSG00000165512	7570	zinc finger protein 22	HKR-T1|KOX15|Zfp422|ZNF422	protein_coding	P17026	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3722
1.00333871340183e-172	0.421582787769712	0.713	0.509	1.88246409408451e-168	MRGBP	Malignant cells	GSE115251	ENSG00000101189	55257	MRG domain binding protein	C20orf20|Eaf7|FLJ10914|MRG15BP	protein_coding	Q9NV56	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3723
1.28643542186775e-172	0.454781595725999	0.645	0.421	2.41361013850828e-168	FAM89A	Malignant cells	GSE115251	ENSG00000182118	375061	family with sequence similarity 89 member A	C1orf153|MGC15887	protein_coding	Q96GI7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3724
1.60137898760967e-172	-0.402782222874431	0.747	0.876	3.00450725655326e-168	BRD7	Malignant cells	GSE115251	ENSG00000166164	29117	bromodomain containing 7	BP75|CELTIX1|SMARCI1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3725
1.65991499735913e-172	0.362428704160236	0.972	0.934	3.11433251804521e-168	SEC61B	Malignant cells	GSE115251	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3726
2.36130435907487e-172	-0.418693159322246	0.616	0.787	4.43027923849626e-168	TRAPPC2L	Malignant cells	GSE115251	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3727
9.428889528675e-172	-0.411287795052656	0.463	0.679	1.76904825337e-167	NUDT5	Malignant cells	GSE115251	ENSG00000165609	11164	nudix hydrolase 5	hYSAH1|YSA1H	protein_coding	Q9UKK9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3728
2.39281622932338e-171	0.428952416366931	0.746	0.549	4.48940180945652e-167	SUDS3	Malignant cells	GSE115251	ENSG00000111707	64426	SDS3 homolog, SIN3A corepressor complex component	FLJ00052|SAP45|SDS3	protein_coding	Q9H7L9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3729
6.4319184902349e-171	0.300667205509133	0.268	0.073	1.20675654713787e-166	FZD2	Malignant cells	GSE115251	ENSG00000180340	2535	frizzled class receptor 2	NA	protein_coding	Q14332	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3730
6.92612531556027e-171	-0.389421556673316	0.225	0.454	1.29947963170542e-166	MAP2	Malignant cells	GSE115251	ENSG00000078018	4133	microtubule associated protein 2	MAP2A|MAP2B|MAP2C	protein_coding	P11137	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3731
1.29616710439493e-170	-0.369787896529453	0.963	0.99	2.43186872126577e-166	DUT	Malignant cells	GSE115251	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3732
1.35079439112506e-170	-0.352805713985375	0.182	0.407	2.53436043662883e-166	MPC1	Malignant cells	GSE115251	ENSG00000060762	51660	mitochondrial pyruvate carrier 1	BRP44L|CGI-129|dJ68L15.3|SLC54A1	protein_coding	Q9Y5U8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3733
1.57693930225143e-170	-0.404375264386697	0.626	0.803	2.95865351888413e-166	PMVK	Malignant cells	GSE115251	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3734
4.53259817838386e-170	0.398648975052879	0.459	0.228	8.5040607022838e-166	ANKH	Malignant cells	GSE115251	ENSG00000154122	56172	ANKH inorganic pyrophosphate transport regulator	ANK|CCAL2|CMDJ|CPPDD|HANK|SLC62A1	protein_coding	Q9HCJ1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3735
6.24680128568221e-170	-0.334475314718936	0.149	0.363	1.1720248572197e-165	CPNE2	Malignant cells	GSE115251	ENSG00000140848	221184	copine 2	CPN2	protein_coding	Q96FN4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3736
6.889919576202e-170	0.356859270414224	0.988	0.983	1.29268671088702e-165	H2AFY	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3737
8.43033701029136e-170	0.365878194164657	0.453	0.219	1.58169982987086e-165	TIMM10B	Malignant cells	GSE115251	ENSG00000132286	26515	translocase of inner mitochondrial membrane 10B	FXC1|TIM10B|Tim9b	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3738
9.61672042471168e-170	-0.379006949120119	0.835	0.936	1.80428908608441e-165	NOC2L	Malignant cells	GSE115251	ENSG00000188976	26155	NOC2 like nucleolar associated transcriptional repressor	DKFZP564C186|NET15|NET7|NIR|PPP1R112	protein_coding	Q9Y3T9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3739
1.30577959180333e-169	0.480125344901361	0.85	0.733	2.4499036701414e-165	KIF1A	Malignant cells	GSE115251	ENSG00000130294	547	kinesin family member 1A	ATSV|C2orf20|SPG30|UNC104	protein_coding	Q12756	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3740
1.66393901930487e-169	-0.410439142954992	0.354	0.59	3.1218823880198e-165	LYN	Malignant cells	GSE115251	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3741
2.67397767882291e-169	0.384154218275793	0.941	0.853	5.01691692100755e-165	GTSF1	Malignant cells	GSE115251	ENSG00000170627	121355	gametocyte specific factor 1	Cue110|FAM112B|FLJ32942	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3742
4.73246577515606e-169	0.428944848495743	0.624	0.405	8.8790522873478e-165	MNAT1	Malignant cells	GSE115251	ENSG00000020426	4331	MNAT1 component of CDK activating kinase	MAT1|RNF66	protein_coding	P51948	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3743
9.8837320845498e-169	0.327806098690587	0.362	0.143	1.85438581370323e-164	ARFIP2	Malignant cells	GSE115251	ENSG00000132254	23647	ADP ribosylation factor interacting protein 2	POR1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3744
1.34571795775238e-168	-0.33883365686762	0.139	0.352	2.52483603233502e-164	CMBL	Malignant cells	GSE115251	ENSG00000164237	134147	carboxymethylenebutenolidase homolog	FLJ23617	protein_coding	Q96DG6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3745
1.47627450335553e-168	0.407928321808539	0.713	0.501	2.76978622319565e-164	GTF3C5	Malignant cells	GSE115251	ENSG00000148308	9328	general transcription factor IIIC subunit 5	TFiiiC2-63|TFIIIC63|TFIIICepsilon	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3746
1.8722229127727e-168	0.500813570046067	0.502	0.279	3.51266462894414e-164	LAYN	Malignant cells	GSE115251	ENSG00000204381	143903	layilin	FLJ30977|FLJ31092	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3747
5.19388800147901e-168	-0.381713578831663	0.257	0.486	9.74477266837491e-164	AK3	Malignant cells	GSE115251	ENSG00000147853	50808	adenylate kinase 3	AK3L1|AK6|AKL3L1	protein_coding	Q9UIJ7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3748
9.71636612436366e-168	0.602354458405441	1	1	1.82298461225311e-163	GNAS	Malignant cells	GSE115251	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3749
1.80028369463343e-167	-0.403497072944707	0.382	0.602	3.37769226787123e-163	OXLD1	Malignant cells	GSE115251	ENSG00000204237	339229	oxidoreductase like domain containing 1	C17orf90|MGC104712	protein_coding	Q5BKU9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3750
3.54337864926546e-167	-0.369308743429525	0.855	0.945	6.64808702175186e-163	SSBP4	Malignant cells	GSE115251	ENSG00000130511	170463	single stranded DNA binding protein 4	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3751
5.41004694849056e-167	0.446930400533286	0.628	0.411	1.0150330084758e-162	HSPB11	Malignant cells	GSE115251	ENSG00000081870	51668	heat shock protein family B (small) member 11	C1orf41|FAP232|HSPCO34|IFT25|PP25	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3752
6.31101141782589e-167	0.327545842025259	0.994	0.982	1.18407196221249e-162	EID1	Malignant cells	GSE115251	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3753
1.96992537524067e-166	0.461584094313195	0.605	0.397	3.69597398902655e-162	RABEPK	Malignant cells	GSE115251	ENSG00000136933	10244	Rab9 effector protein with kelch motifs	bA65N13.1|RAB9P40	protein_coding	Q7Z6M1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3754
5.81480756929017e-166	0.423179508177682	0.729	0.532	1.09097419615022e-161	CAND1	Malignant cells	GSE115251	ENSG00000111530	55832	cullin associated and neddylation dissociated 1	DKFZp434M1414|KIAA0829|TIP120|TIP120A	protein_coding	Q86VP6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3755
7.31159318621029e-166	-0.402427600433655	0.485	0.69	1.37180111359677e-161	GNPAT	Malignant cells	GSE115251	ENSG00000116906	8443	glyceronephosphate O-acyltransferase	DAP-AT|DAPAT|DHAPAT	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3756
1.01383848393106e-165	0.442158084185461	0.699	0.497	1.90216376355145e-161	RBM38	Malignant cells	GSE115251	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3757
1.47362810770923e-165	-0.382959056839246	0.267	0.491	2.76482105568406e-161	CIRH1A	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3758
8.61273186285546e-165	-0.398909075873838	0.715	0.85	1.61592075210894e-160	ESD	Malignant cells	GSE115251	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3759
1.64463064082827e-164	0.400930795878252	0.523	0.292	3.085656008322e-160	MAP4K4	Malignant cells	GSE115251	ENSG00000071054	9448	mitogen-activated protein kinase kinase kinase kinase 4	FLH21957|HGK|NIK	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3760
4.90654501480015e-164	0.373474521709422	0.984	0.954	9.20565975676803e-160	DDX5	Malignant cells	GSE115251	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3761
9.25861497793037e-164	0.511721677656848	0.481	0.253	1.7371013421593e-159	FABP6	Malignant cells	GSE115251	ENSG00000170231	2172	fatty acid binding protein 6	I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP	protein_coding	P51161	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3762
2.13964978484327e-163	-0.28217435970325	0.083	0.27	4.01441092632294e-159	AMT	Malignant cells	GSE115251	ENSG00000145020	275	aminomethyltransferase	GCST|NKH	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3763
3.37995831802514e-163	0.352872250615197	0.959	0.903	6.34147779627876e-159	MRPL9	Malignant cells	GSE115251	ENSG00000143436	65005	mitochondrial ribosomal protein L9	NA	protein_coding	Q9BYD2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3764
3.98708349501731e-163	-0.346597599867851	0.151	0.361	7.48056605335149e-159	FAM155A	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3765
5.58745760184079e-163	-0.404506369522839	0.352	0.572	1.04831879525737e-158	SIGMAR1	Malignant cells	GSE115251	ENSG00000147955	10280	sigma non-opioid intracellular receptor 1	OPRS1|SR-BP1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3766
5.91512227464442e-163	-0.415493651541564	0.393	0.609	1.10979524116879e-158	ACOT7	Malignant cells	GSE115251	ENSG00000097021	11332	acyl-CoA thioesterase 7	ACH1|ACT|BACH|CTE-II|hBACH|LACH1|MGC1126	protein_coding	O00154	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3767
2.03600443692499e-162	-0.424836371763827	0.454	0.659	3.81995152455866e-158	VCP	Malignant cells	GSE115251	ENSG00000165280	7415	valosin containing protein	CDC48|IBMPFD|p97|TERA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3768
3.13952936421495e-162	-0.453307307614664	0.543	0.74	5.89038499314009e-158	GINS2	Malignant cells	GSE115251	ENSG00000131153	51659	GINS complex subunit 2	Pfs2|PSF2	protein_coding	Q9Y248	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3769
3.59437098816339e-162	0.330118088345651	0.993	0.983	6.74375884799216e-158	NDUFC2	Malignant cells	GSE115251	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3770
4.87641066125578e-162	0.433476741011217	0.695	0.496	9.14912168264809e-158	SPARC	Malignant cells	GSE115251	ENSG00000113140	6678	secreted protein acidic and cysteine rich	BM-40|ON|ONT	protein_coding	P09486	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3771
9.4072556485285e-162	0.287854186843476	0.998	0.996	1.76498930477692e-157	ARL6IP4	Malignant cells	GSE115251	ENSG00000182196	51329	ADP ribosylation factor like GTPase 6 interacting protein 4	SFRS20|SR-25|SRp25|SRrp37	protein_coding	Q66PJ3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3772
1.37710969243625e-161	0.385649606741415	0.463	0.231	2.58373320494889e-157	TEAD2	Malignant cells	GSE115251	ENSG00000074219	8463	TEA domain transcription factor 2	ETF|TEF-4|TEF4	protein_coding	Q15562	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3773
2.56706060846642e-161	-0.313551959696752	0.122	0.323	4.8163191136047e-157	BOLA3-AS1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3774
3.59630650826051e-161	-0.420521135415302	0.54	0.728	6.74739027079838e-157	ACO2	Malignant cells	GSE115251	ENSG00000100412	50	aconitase 2	ACONM	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3775
4.17526464275675e-161	0.40183539467537	0.917	0.841	7.83363152274022e-157	NDUFC1	Malignant cells	GSE115251	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3776
7.43702131939544e-161	0.436019453138996	0.812	0.677	1.39533393994497e-156	PDIA3	Malignant cells	GSE115251	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3777
8.49832129894168e-161	0.417310533665239	0.562	0.34	1.59445504210744e-156	TIMELESS	Malignant cells	GSE115251	ENSG00000111602	8914	timeless circadian regulator	hTIM|TIM|TIM1	protein_coding	Q9UNS1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3778
9.85811601186472e-161	-0.352328480522302	0.211	0.431	1.84957972614606e-156	BCL2L13	Malignant cells	GSE115251	ENSG00000099968	23786	BCL2 like 13	BCL-RAMBO|MIL1	protein_coding	Q9BXK5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3779
1.78615634103835e-160	0.266778180565991	1	1	3.35118652705615e-156	RAC1	Malignant cells	GSE115251	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3780
2.48441961911443e-160	0.414698404585991	0.905	0.815	4.6612680893825e-156	SNRPB2	Malignant cells	GSE115251	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3781
6.18333029205787e-160	0.383237461055803	0.552	0.325	1.1601164293959e-155	NUP107	Malignant cells	GSE115251	ENSG00000111581	57122	nucleoporin 107	NUP84	protein_coding	P57740	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3782
6.51326047539751e-160	0.402420702228462	0.879	0.773	1.22201793039408e-155	DNAJC8	Malignant cells	GSE115251	ENSG00000285317	22826	DnaJ heat shock protein family (Hsp40) member C8	SPF31	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3783
1.33513876699611e-159	-0.363720846876918	0.727	0.88	2.5049873546381e-155	PDCD2	Malignant cells	GSE115251	ENSG00000071994	5134	programmed cell death 2	RP8|ZMYND7	protein_coding	Q16342	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3784
3.09562603256503e-159	0.413148137930499	0.801	0.646	5.80801356229852e-155	TMED9	Malignant cells	GSE115251	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3785
5.15243487603198e-159	-0.369618508956817	0.207	0.422	9.66699831441119e-155	DCLRE1C	Malignant cells	GSE115251	ENSG00000152457	64421	DNA cross-link repair 1C	A-SCID|ARTEMIS|FLJ11360|SCIDA|SNM1C	protein_coding	Q96SD1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3786
6.63692453496484e-159	0.423288804930172	0.695	0.502	1.2452197812501e-154	CSE1L	Malignant cells	GSE115251	ENSG00000124207	1434	chromosome segregation 1 like	CAS|CSE1|XPO2	protein_coding	P55060	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3787
1.15308267444793e-158	0.403570995448609	0.868	0.765	2.1634137137992e-154	MRPL36	Malignant cells	GSE115251	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3788
1.24463342026936e-158	-0.315475893391914	0.971	0.996	2.33518122310937e-154	MAP1B	Malignant cells	GSE115251	ENSG00000131711	4131	microtubule associated protein 1B	MAP5|PPP1R102	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3789
5.11348341064077e-158	-0.419586252669848	0.414	0.621	9.59391757504421e-154	CMC2	Malignant cells	GSE115251	ENSG00000103121	56942	C-X9-C motif containing 2	C16orf61|DC13|MGC45036	protein_coding	Q9NRP2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3790
6.97640536109445e-158	-0.319180539331741	0.134	0.336	1.30891317384854e-153	ATP1A3	Malignant cells	GSE115251	ENSG00000105409	478	ATPase Na+/K+ transporting subunit alpha 3	DYT12	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3791
2.35223246089569e-157	0.388324095596491	0.855	0.732	4.41325854313249e-153	NELFCD	Malignant cells	GSE115251	ENSG00000101158	51497	negative elongation factor complex member C/D	HSPC130|NELF-C|NELF-D|TH1|TH1L	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3792
1.31298373564579e-156	0.424251181302272	0.538	0.32	2.46342008481863e-152	ARL4D	Malignant cells	GSE115251	ENSG00000175906	379	ADP ribosylation factor like GTPase 4D	ARF4L	protein_coding	P49703	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3793
1.42090570480135e-156	0.387008849482174	0.867	0.75	2.66590328334829e-152	ZNF593	Malignant cells	GSE115251	ENSG00000142684	51042	zinc finger protein 593	ZT86	protein_coding	O00488	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3794
1.83089028610007e-156	-0.385058683728235	0.629	0.794	3.43511635478095e-152	GPI	Malignant cells	GSE115251	ENSG00000282019	2821	glucose-6-phosphate isomerase	AMF|NLK	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3795
2.13774570295672e-156	0.416462165241506	0.818	0.691	4.0108384878874e-152	BRD3	Malignant cells	GSE115251	ENSG00000169925	8019	bromodomain containing 3	KIAA0043|ORFX|RING3L	protein_coding	Q15059	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3796
4.21781649414495e-156	-0.277408979087212	0.078	0.258	7.91346730631476e-152	SH3BP5	Malignant cells	GSE115251	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3797
4.52277652234842e-156	-0.280129196382538	0.078	0.259	8.4856333112301e-152	ETV5	Malignant cells	GSE115251	ENSG00000244405	2119	ETS variant transcription factor 5	ERM	protein_coding	P41161	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3798
7.14930656429778e-156	0.423338130152739	0.364	0.159	1.34135289759355e-151	GADD45G	Malignant cells	GSE115251	ENSG00000130222	10912	growth arrest and DNA damage inducible gamma	CR6|DDIT2|GADD45gamma|GRP17	protein_coding	O95257	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3799
9.2277407849231e-156	0.388882865722026	0.512	0.292	1.73130872606727e-151	TMEM41B	Malignant cells	GSE115251	ENSG00000166471	440026	transmembrane protein 41B	KIAA0033	protein_coding	Q5BJD5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3800
2.42695655121021e-155	-0.250514803903624	1	1	4.5534558813806e-151	EEF1D	Malignant cells	GSE115251	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3801
3.08260093943883e-155	0.375267875455863	0.545	0.321	5.78357588257514e-151	SPPL3	Malignant cells	GSE115251	ENSG00000157837	121665	signal peptide peptidase like 3	DKFZP586C1324|IMP2|MGC126674|MGC126676|MGC90402|PSL4	protein_coding	Q8TCT6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3802
3.4330242007157e-155	-0.393032221030541	0.39	0.603	6.4410400053828e-151	YME1L1	Malignant cells	GSE115251	ENSG00000136758	10730	YME1 like 1 ATPase	YME1L	protein_coding	Q96TA2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3803
5.15741208091941e-155	-0.413896882537963	0.449	0.66	9.67633654622101e-151	NBEA	Malignant cells	GSE115251	ENSG00000172915	26960	neurobeachin	BCL8B|FLJ10197|KIAA1544|LYST2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3804
1.27115050167512e-154	0.386485574980903	0.5	0.28	2.38493257124287e-150	OS9	Malignant cells	GSE115251	ENSG00000135506	10956	OS9 endoplasmic reticulum lectin	ERLEC2|OS-9	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3805
1.38248040321994e-154	-0.326262612654056	0.174	0.382	2.59380973252125e-150	KIF9	Malignant cells	GSE115251	ENSG00000088727	64147	kinesin family member 9	MGC104186	protein_coding	Q9HAQ2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3806
3.47581583614223e-154	0.362135014878508	0.951	0.891	6.52132567177006e-150	ISCU	Malignant cells	GSE115251	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3807
3.95047323711798e-154	0.354367731002664	0.339	0.136	7.41187788748076e-150	CITED2	Malignant cells	GSE115251	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3808
5.64844088408904e-154	-0.264358185711836	0.999	0.999	1.05976047867278e-149	NHP2L1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3809
7.17922561250559e-154	-0.306924077178657	0.135	0.336	1.3469663094183e-149	RAB3C	Malignant cells	GSE115251	ENSG00000152932	115827	RAB3C, member RAS oncogene family	NA	protein_coding	Q96E17	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3810
8.98140051894906e-154	-0.373726940173089	0.779	0.892	1.68509036536522e-149	BCAT1	Malignant cells	GSE115251	ENSG00000060982	586	branched chain amino acid transaminase 1	BCATc|BCT1	protein_coding	P54687	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3811
1.24695300875064e-153	0.373672646275361	0.514	0.292	2.33953323501796e-149	SERINC3	Malignant cells	GSE115251	ENSG00000132824	10955	serine incorporator 3	AIGP1|DIFF33|SBBI99|TDE|TDE1|TMS-1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3812
1.41978103554258e-153	-0.287889735582355	0.116	0.309	2.66379317888499e-149	PAM16	Malignant cells	GSE115251	ENSG00000282228	51025	presequence translocase associated motor 16	Magmas|Tim16|TIMM16	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3813
2.37942245495113e-153	-0.38621634973467	0.673	0.826	4.46427240997932e-149	PODXL2	Malignant cells	GSE115251	ENSG00000114631	50512	podocalyxin like 2	endoglycan|PODLX2	protein_coding	Q9NZ53	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3814
4.30782970255796e-153	0.4138458953926	0.638	0.433	8.08235008793924e-149	DDX55	Malignant cells	GSE115251	ENSG00000111364	57696	DEAD-box helicase 55	KIAA1595	protein_coding	Q8NHQ9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3815
7.36725452256556e-153	-0.416442944013721	0.664	0.825	1.38224429352375e-148	PHGDH	Malignant cells	GSE115251	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3816
8.25025158997417e-153	-0.360983371542727	0.221	0.437	1.54791220331095e-148	GATA3-AS1	Malignant cells	GSE115251	ENSG00000197308	399717	GATA3 antisense RNA 1	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3817
1.40312778973574e-152	-0.396912734442168	0.509	0.698	2.6325483591022e-148	CCDC28B	Malignant cells	GSE115251	ENSG00000160050	79140	coiled-coil domain containing 28B	MGC1203|RP4-622L5.5	protein_coding	Q9BUN5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3818
1.43184136073244e-152	-0.383864533366702	0.258	0.472	2.68642076100621e-148	TRIB2	Malignant cells	GSE115251	ENSG00000071575	28951	tribbles pseudokinase 2	GS3955|TRB2	protein_coding	Q92519	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3819
1.97935027874487e-152	-0.347218962048928	0.21	0.425	3.71365699298112e-148	NMNAT2	Malignant cells	GSE115251	ENSG00000157064	23057	nicotinamide nucleotide adenylyltransferase 2	C1orf15|KIAA0479|PNAT2	protein_coding	Q9BZQ4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3820
1.17456834875928e-151	0.46550466175225	0.786	0.632	2.20372513594217e-147	DNAJB11	Malignant cells	GSE115251	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3821
1.30150474535284e-151	-0.327919110827508	0.184	0.394	2.441883203231e-147	SULF2	Malignant cells	GSE115251	ENSG00000196562	55959	sulfatase 2	HSULF-2|KIAA1247|SULF-2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3822
1.85533560630116e-151	0.38294374460676	0.852	0.729	3.48098066454223e-147	CALU	Malignant cells	GSE115251	ENSG00000128595	813	calumenin	NA	protein_coding	O43852	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3823
2.37119986260383e-151	0.448380052286849	0.92	0.867	4.44884518221731e-147	EZH2	Malignant cells	GSE115251	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3824
4.41067338640307e-151	-0.334335218420904	0.963	0.989	8.27530540756945e-147	PSMB1	Malignant cells	GSE115251	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3825
1.69566626431192e-149	-0.342025001436826	0.894	0.959	3.18140904510202e-145	CSTB	Malignant cells	GSE115251	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3826
2.1637543992808e-149	-0.373200784625015	0.691	0.849	4.05963600393064e-145	TOMM5	Malignant cells	GSE115251	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3827
3.21318385449317e-149	0.340221947839873	0.368	0.16	6.02857554780008e-145	MSI1	Malignant cells	GSE115251	ENSG00000135097	4440	musashi RNA binding protein 1	NA	protein_coding	O43347	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3828
3.88532843700288e-149	-0.389968964526665	0.585	0.748	7.28965321350481e-145	TUSC2	Malignant cells	GSE115251	ENSG00000114383	11334	tumor suppressor 2, mitochondrial calcium regulator	C3orf11|FUS1|PAP|PDAP2	protein_coding	O75896	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3829
4.26680952481763e-149	-0.376924891986575	0.3	0.513	8.00538803046285e-145	CNOT1	Malignant cells	GSE115251	ENSG00000125107	23019	CCR4-NOT transcription complex subunit 1	AD-005|CDC39|KIAA1007|NOT1|NOT1H	protein_coding	A5YKK6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3830
1.1588418815708e-148	0.284559471582103	0.267	0.084	2.17421913820313e-144	EBF3	Malignant cells	GSE115251	ENSG00000108001	253738	EBF transcription factor 3	COE3|DKFZp667B0210	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3831
5.09972644545866e-148	-0.401706486201524	0.248	0.457	9.56810675696953e-144	ZMAT3	Malignant cells	GSE115251	ENSG00000172667	64393	zinc finger matrin-type 3	FLJ12296|MGC10613|PAG608|WIG-1|WIG1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3832
1.89749633536798e-147	0.333482761930954	0.403	0.19	3.5600826244174e-143	ARHGEF25	Malignant cells	GSE115251	ENSG00000240771	115557	Rho guanine nucleotide exchange factor 25	GEFT|p63RhoGEF	protein_coding	Q86VW2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3833
2.11624107397726e-147	-0.292012203773071	0.995	0.999	3.97049150299614e-143	ALDOA	Malignant cells	GSE115251	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3834
2.55507285467541e-147	-0.374863583684558	0.386	0.595	4.79382768994201e-143	OGFOD3	Malignant cells	GSE115251	ENSG00000181396	79701	2-oxoglutarate and iron dependent oxygenase domain containing 3	C17orf101|FLJ22222	protein_coding	Q6PK18	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3835
3.96142878223918e-147	0.395745733253538	0.74	0.566	7.43243268123714e-143	CDC34	Malignant cells	GSE115251	ENSG00000099804	997	cell division cycle 34, ubiqiutin conjugating enzyme	E2-CDC34|UBC3|UBE2R1	protein_coding	P49427	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3836
6.49911966610291e-147	0.401499269882335	0.637	0.433	1.21936483175423e-142	RBM42	Malignant cells	GSE115251	ENSG00000126254	79171	RNA binding motif protein 42	MGC10433	protein_coding	Q9BTD8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3837
9.60119899829931e-147	-0.376736078474493	0.249	0.462	1.80137695606092e-142	NFATC4	Malignant cells	GSE115251	ENSG00000285485	4776	nuclear factor of activated T cells 4	NFAT3	protein_coding	Q14934	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3838
9.76069500309015e-147	0.303169410668286	0.26	0.081	1.83130159647977e-142	CRABP2	Malignant cells	GSE115251	ENSG00000143320	1382	cellular retinoic acid binding protein 2	CRABP-II	protein_coding	P29373	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3839
1.11278024227743e-146	0.404687990040568	0.589	0.379	2.08779829056092e-142	F12	Malignant cells	GSE115251	ENSG00000131187	2161	coagulation factor XII	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3840
1.52661645143733e-146	0.370008379492645	0.587	0.37	2.86423778618672e-142	STK4	Malignant cells	GSE115251	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3841
1.52737334710314e-146	0.398617473746018	0.761	0.605	2.86565787383492e-142	PDLIM7	Malignant cells	GSE115251	ENSG00000196923	9260	PDZ and LIM domain 7	ENIGMA	protein_coding	Q9NR12	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3842
2.01899374317963e-146	-0.323174752704883	0.147	0.345	3.78803606095362e-142	PRKCA	Malignant cells	GSE115251	ENSG00000154229	5578	protein kinase C alpha	PKCA|PKCalpha	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3843
2.11057258908416e-146	0.388607491270502	0.666	0.461	3.9598562916397e-142	CNOT2	Malignant cells	GSE115251	ENSG00000111596	4848	CCR4-NOT transcription complex subunit 2	CDC36|NOT2|NOT2H	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3844
5.59048964354674e-146	0.411372632092755	0.68	0.492	1.04888766692224e-141	PDLIM4	Malignant cells	GSE115251	ENSG00000131435	8572	PDZ and LIM domain 4	RIL	protein_coding	P50479	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3845
7.45491599805652e-146	0.404918563072598	0.783	0.637	1.39869133955536e-141	MPP6	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3846
2.05584216445386e-145	0.353183618926487	0.901	0.809	3.85717106894832e-141	WIPI2	Malignant cells	GSE115251	ENSG00000157954	26100	WD repeat domain, phosphoinositide interacting 2	ATG18B|ATG21|CGI-50|DKFZP434J154|DKFZp686P02188|FLJ12979|FLJ14217|FLJ42984	protein_coding	Q9Y4P8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3847
6.43866521680435e-145	-0.396046620589497	0.333	0.544	1.20802236797683e-140	CD9	Malignant cells	GSE115251	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3848
1.28771872629335e-144	-0.309067193968477	0.134	0.328	2.41601787427159e-140	RP11-561B11.6	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3849
2.02290053250411e-144	0.323786182306715	0.304	0.115	3.79536597908421e-140	FAM184A	Malignant cells	GSE115251	ENSG00000111879	79632	family with sequence similarity 184 member A	C6orf60|FLJ13942	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3850
4.37427844243758e-144	0.383502793573125	0.605	0.395	8.2070212137014e-140	DPM1	Malignant cells	GSE115251	ENSG00000000419	8813	dolichyl-phosphate mannosyltransferase subunit 1, catalytic	CDGIE|MPDS	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3851
4.3979686577043e-144	0.325423343064269	0.99	0.964	8.2514687955848e-140	SAP18	Malignant cells	GSE115251	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3852
8.31521877594247e-144	-0.356363577820367	0.27	0.483	1.56010134674233e-139	KIAA0020	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3853
9.1045881467215e-144	0.302934720653431	0.314	0.121	1.70820282808789e-139	PELI2	Malignant cells	GSE115251	ENSG00000139946	57161	pellino E3 ubiquitin protein ligase family member 2	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3854
9.38342931546987e-144	-0.434429875840637	0.849	0.945	1.76051900816846e-139	CENPF	Malignant cells	GSE115251	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3855
9.87198163390985e-144	-0.357623000859114	0.284	0.494	1.85218119415417e-139	MPHOSPH6	Malignant cells	GSE115251	ENSG00000135698	10200	M-phase phosphoprotein 6	MPP6	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3856
1.39543395572113e-143	-0.363509766758055	0.294	0.504	2.61811318772398e-139	KLHDC8B	Malignant cells	GSE115251	ENSG00000185909	200942	kelch domain containing 8B	MGC35097	protein_coding	Q8IXV7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3857
2.97424895089421e-143	0.361065807642681	0.94	0.886	5.58028588166772e-139	TXNDC17	Malignant cells	GSE115251	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3858
3.11380617852418e-143	0.397247882547306	0.801	0.674	5.84212315214707e-139	C20orf24	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3859
3.65076265085307e-143	0.334189357217322	0.444	0.229	6.84956088553053e-139	WDR70	Malignant cells	GSE115251	ENSG00000082068	55100	WD repeat domain 70	FLJ10233	protein_coding	Q9NW82	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3860
5.82281140264936e-143	0.37604128208175	0.888	0.792	1.09247587536507e-138	SLC35B1	Malignant cells	GSE115251	ENSG00000121073	10237	solute carrier family 35 member B1	AXER|UGTREL1	protein_coding	P78383	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3861
8.3241620623634e-143	-0.347624259421266	0.779	0.904	1.56177928614062e-138	MRPL18	Malignant cells	GSE115251	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3862
8.80501959831591e-143	-0.316694927368249	0.863	0.95	1.65199777703603e-138	LDHA	Malignant cells	GSE115251	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3863
1.39434120890306e-142	0.357078112298617	0.98	0.965	2.61606297614392e-138	PPM1G	Malignant cells	GSE115251	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3864
1.44202876092193e-142	0.315869424959889	0.377	0.172	2.70553436124172e-138	RIC8A	Malignant cells	GSE115251	ENSG00000177963	60626	RIC8 guanine nucleotide exchange factor A	synembryn|synembryn-A	protein_coding	Q9NPQ8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3865
1.7532128378046e-142	-0.387761235210823	0.498	0.682	3.28937792628899e-138	RNF187	Malignant cells	GSE115251	ENSG00000285426	149603	ring finger protein 187	RACO-1|RACO1	protein_coding	Q5TA31	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3866
2.3797728638146e-142	0.380083574405844	0.653	0.449	4.46492984708896e-138	RND2	Malignant cells	GSE115251	ENSG00000108830	8153	Rho family GTPase 2	ARHN|Rho7|RhoN	protein_coding	P52198	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3867
3.83640306688114e-142	0.357642307229378	0.504	0.289	7.19785943408239e-138	WDR60	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3868
8.32984994655223e-142	0.326375867472434	0.987	0.968	1.56284644697213e-137	PTP4A2	Malignant cells	GSE115251	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3869
8.56139203336896e-142	-0.369953471034897	0.297	0.504	1.60628837330068e-137	NOB1	Malignant cells	GSE115251	ENSG00000141101	28987	NIN1 (RPN12) binding protein 1 homolog	ART-4|MST158|NOB1P|PSMD8BP1	protein_coding	Q9ULX3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3870
1.68714981094221e-141	0.318215285405654	0.991	0.989	3.16543047528978e-137	SNRPG	Malignant cells	GSE115251	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3871
2.27325642167509e-141	0.338577636599647	0.418	0.209	4.26508369834681e-137	RAB3IP	Malignant cells	GSE115251	ENSG00000127328	117177	RAB3A interacting protein	FLJ22548|RABIN3|RABIN8	protein_coding	Q96QF0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3872
2.79544679903724e-141	-0.339437440801228	0.838	0.93	5.24481728435368e-137	MRPS33	Malignant cells	GSE115251	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3873
3.67088547500926e-141	0.428842864158463	0.544	0.337	6.88731532821237e-137	IER2	Malignant cells	GSE115251	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3874
3.82284174801866e-141	-0.383011451563127	0.463	0.653	7.17241568763261e-137	ARIH2	Malignant cells	GSE115251	ENSG00000177479	10425	ariadne RBR E3 ubiquitin protein ligase 2	TRIAD1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3875
5.77433185358759e-141	-0.435274976645904	0.893	0.938	1.0833801423701e-136	TPM1	Malignant cells	GSE115251	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3876
8.41160818026657e-141	0.368760091275826	0.659	0.458	1.57818592678161e-136	TSSC4	Malignant cells	GSE115251	ENSG00000184281	10078	tumor suppressing subtransferable candidate 4	NA	protein_coding	Q9Y5U2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3877
1.12869871387908e-140	0.383084228720824	0.658	0.462	2.11766452697993e-136	AAMP	Malignant cells	GSE115251	ENSG00000127837	14	angio associated migratory cell protein	NA	protein_coding	Q13685	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3878
2.87155905547241e-140	0.401576981733697	0.645	0.447	5.38761909987733e-136	RAE1	Malignant cells	GSE115251	ENSG00000101146	8480	ribonucleic acid export 1	Gle2|Mnrp41	protein_coding	P78406	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3879
2.90222357483539e-140	0.302631989607992	0.985	0.973	5.44515187110616e-136	MRPS7	Malignant cells	GSE115251	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3880
4.30042278834211e-140	0.339874223220601	0.948	0.904	8.06845323548747e-136	UBXN1	Malignant cells	GSE115251	ENSG00000162191	51035	UBX domain protein 1	2B28|LOC51035|SAKS1|UBXD10	protein_coding	Q04323	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3881
7.19966082316604e-140	-0.357898893112736	0.652	0.814	1.35080036364241e-135	VAMP2	Malignant cells	GSE115251	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3882
9.66756942700059e-140	0.385768431597203	0.784	0.638	1.81382937589385e-135	STAU1	Malignant cells	GSE115251	ENSG00000124214	6780	staufen double-stranded RNA binding protein 1	PPP1R150|STAU	protein_coding	O95793	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3883
2.05378737039733e-139	0.410651485213271	0.612	0.411	3.85331586433948e-135	KRR1	Malignant cells	GSE115251	ENSG00000111615	11103	KRR1 small subunit processome component homolog	HRB2|RIP-1	protein_coding	Q13601	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3884
2.11135499730082e-139	-0.349414682032927	0.181	0.379	3.9613242459358e-135	SLC2A1	Malignant cells	GSE115251	ENSG00000117394	6513	solute carrier family 2 member 1	CSE|DYT18|DYT9|GLUT|GLUT-1|GLUT1|HTLVR	protein_coding	P11166	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3885
3.02904719806116e-139	0.358846430745765	0.516	0.306	5.68309835300234e-135	PTPN1	Malignant cells	GSE115251	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3886
5.70894186835999e-139	-0.375197975094239	0.297	0.502	1.0711116733417e-134	CNIH2	Malignant cells	GSE115251	ENSG00000174871	254263	cornichon family AMPA receptor auxiliary protein 2	CNIH-2|Cnil|MGC50896	protein_coding	Q6PI25	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3887
2.20164353853268e-138	-0.371413277196899	0.2	0.401	4.13072360699502e-134	LGALS1	Malignant cells	GSE115251	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3888
8.26832372701382e-138	0.423297256249821	0.782	0.654	1.55130289766233e-133	BRIX1	Malignant cells	GSE115251	ENSG00000113460	55299	biogenesis of ribosomes BRX1	BRIX|BXDC2|FLJ11100	protein_coding	Q8TDN6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3889
1.35889124181463e-137	-0.38098813945913	0.49	0.672	2.54955174789261e-133	ARL2BP	Malignant cells	GSE115251	ENSG00000102931	23568	ADP ribosylation factor like GTPase 2 binding protein	BART|BART1|RP66	protein_coding	Q9Y2Y0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3890
1.97815938285753e-137	0.330576556842447	0.971	0.94	3.71142263411731e-133	UBE2E3	Malignant cells	GSE115251	ENSG00000170035	10477	ubiquitin conjugating enzyme E2 E3	UbcH9	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3891
4.57430560196578e-137	0.323517004700859	0.336	0.144	8.5823121704082e-133	ANKS1A	Malignant cells	GSE115251	ENSG00000064999	23294	ankyrin repeat and sterile alpha motif domain containing 1A	ANKS1|KIAA0229	protein_coding	Q92625	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3892
1.33524115566028e-136	0.361728675024715	0.655	0.459	2.50517945624982e-132	TPD52L2	Malignant cells	GSE115251	ENSG00000101150	7165	TPD52 like 2	D54|hD54|TPD54	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3893
1.57965186708482e-136	0.4296569616416	0.545	0.342	2.96374283302455e-132	SPATS2L	Malignant cells	GSE115251	ENSG00000196141	26010	spermatogenesis associated serine rich 2 like	DNAPTP6|SGNP	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3894
2.35488736426039e-136	-0.345801796885755	0.691	0.826	4.41823967282534e-132	CYB5R3	Malignant cells	GSE115251	ENSG00000100243	1727	cytochrome b5 reductase 3	DIA1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3895
3.20127065383854e-136	0.327432341281755	0.452	0.243	6.00622400073187e-132	ZNF90	Malignant cells	GSE115251	ENSG00000213988	7643	zinc finger protein 90	HTF9	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3896
3.69117852188839e-136	0.381347698610589	0.709	0.532	6.92538914276699e-132	VIMP	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3897
3.84058770556357e-136	-0.312903730152261	0.152	0.34	7.20571065317837e-132	CHST2	Malignant cells	GSE115251	ENSG00000175040	9435	carbohydrate sulfotransferase 2	C6ST	protein_coding	Q9Y4C5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3898
4.62006822668204e-136	0.344086110982362	0.943	0.889	8.66817200690085e-132	CHD4	Malignant cells	GSE115251	ENSG00000111642	1108	chromodomain helicase DNA binding protein 4	Mi-2b|Mi2-BETA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3899
4.77768215377098e-136	0.401937585151255	0.74	0.585	8.96388725690511e-132	YEATS4	Malignant cells	GSE115251	ENSG00000127337	8089	YEATS domain containing 4	GAS41|NuBI-1|YAF9	protein_coding	O95619	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3900
4.84855714784646e-136	-0.271217279332845	0.087	0.255	9.09686292078953e-132	PIP4K2A	Malignant cells	GSE115251	ENSG00000150867	5305	phosphatidylinositol-5-phosphate 4-kinase type 2 alpha	PIP5K2A|PIP5KIIA|PIP5KIIalpha	protein_coding	P48426	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3901
6.98234246466315e-136	0.356058862879651	0.883	0.801	1.3100270932201e-131	APOA1BP	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3902
1.20503302032238e-135	-0.364623350941994	0.352	0.555	2.26088295272885e-131	EPC1	Malignant cells	GSE115251	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3903
3.14055816657415e-135	-0.315930640251939	0.903	0.964	5.89231523212642e-131	PCBD1	Malignant cells	GSE115251	ENSG00000166228	5092	pterin-4 alpha-carbinolamine dehydratase 1	DCOH|PCBD|PCD	protein_coding	P61457	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3904
3.56875773334784e-135	0.370128112743964	0.887	0.808	6.69570325930722e-131	SLC25A4	Malignant cells	GSE115251	ENSG00000151729	291	solute carrier family 25 member 4	AAC1|ANT1|PEO2|PEO3|T1	protein_coding	P12235	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3905
4.95060337969431e-135	0.490379473475826	0.701	0.541	9.28832206098247e-131	HIST1H2BK	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3906
1.16354426547805e-134	0.331134483119212	0.438	0.231	2.18304175088992e-130	THOC1	Malignant cells	GSE115251	ENSG00000079134	9984	THO complex subunit 1	HPR1|P84	protein_coding	Q96FV9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3907
1.23978245260888e-134	-0.341607662633964	0.186	0.382	2.32607983758477e-130	CRB2	Malignant cells	GSE115251	ENSG00000148204	286204	crumbs cell polarity complex component 2	FLJ16786|FLJ38464	protein_coding	Q5IJ48	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3908
1.45409859948229e-134	0.351747750271787	0.506	0.301	2.72817979234867e-130	KIN	Malignant cells	GSE115251	ENSG00000151657	22944	Kin17 DNA and RNA binding protein	KIN17|Rts2	protein_coding	O60870	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3909
1.80100415392206e-134	0.380491028881123	0.617	0.426	3.37904399358857e-130	PHF20	Malignant cells	GSE115251	ENSG00000025293	51230	PHD finger protein 20	C20orf104|dJ1121G12.1|TDRD20A	protein_coding	Q9BVI0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3910
3.78891057033275e-134	-0.374963593541758	0.535	0.702	7.10875401205831e-130	DCTN3	Malignant cells	GSE115251	ENSG00000137100	11258	dynactin subunit 3	DCTN-22	protein_coding	O75935	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3911
3.84695303490904e-134	0.379720127272921	0.987	0.981	7.21765328409634e-130	HNRNPD	Malignant cells	GSE115251	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3912
4.45566347711333e-134	-0.369377615022211	0.261	0.461	8.35971581576002e-130	RLTPR	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3913
4.48771597033242e-134	0.378285614705668	0.617	0.42	8.41985270353768e-130	CTNNBL1	Malignant cells	GSE115251	ENSG00000132792	56259	catenin beta like 1	C20orf33|FLJ21108|NAP|NYD-SP19|P14|P14L	protein_coding	Q8WYA6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3914
8.93545364591187e-134	-0.359117217804292	0.368	0.564	1.67646981304598e-129	NADK	Malignant cells	GSE115251	ENSG00000008130	65220	NAD kinase	FLJ13052	protein_coding	O95544	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3915
1.27596195832376e-133	-0.337698735614044	0.282	0.487	2.39395982620704e-129	RSPRY1	Malignant cells	GSE115251	ENSG00000159579	89970	ring finger and SPRY domain containing 1	KIAA1972	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3916
1.36801675896209e-133	-0.387346275280216	0.532	0.703	2.56667304316468e-129	NCAPH2	Malignant cells	GSE115251	ENSG00000025770	29781	non-SMC condensin II complex subunit H2	384D8-2|CAP-H2|hCAP-H2	protein_coding	Q6IBW4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3917
1.38078348051719e-133	0.296109419710453	0.346	0.152	2.59062596614635e-129	TOLLIP	Malignant cells	GSE115251	ENSG00000078902	54472	toll interacting protein	IL-1RAcPIP	protein_coding	Q9H0E2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3918
1.85276829687728e-133	0.267311708009261	0.999	0.998	3.47616387860116e-129	LSM5	Malignant cells	GSE115251	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3919
3.57835240830287e-133	0.353353859293023	0.487	0.282	6.71370478845784e-129	B4GALT5	Malignant cells	GSE115251	ENSG00000158470	9334	beta-1,4-galactosyltransferase 5	beta4GalT-V	protein_coding	O43286	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3920
8.30194181771721e-133	0.362935128392118	0.697	0.511	1.5576103238401e-128	PSMG2	Malignant cells	GSE115251	ENSG00000128789	56984	proteasome assembly chaperone 2	CLAST3|HCCA3|HsT1707|MDS003|MGC15092|PAC2|TNFSF5IP1	protein_coding	Q969U7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3921
1.28827234400241e-132	0.346304222774874	0.341	0.152	2.41705657181733e-128	PDZRN3	Malignant cells	GSE115251	ENSG00000121440	23024	PDZ domain containing ring finger 3	KIAA1095|LNX3|SEMACAP3|SEMCAP3	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3922
1.63965167385339e-132	0.348595042715118	0.575	0.372	3.07631447048373e-128	SPATC1L	Malignant cells	GSE115251	ENSG00000274679	84221	spermatogenesis and centriole associated 1 like	C21orf56	protein_coding	Q9H0A9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3923
3.81276752813838e-132	0.337933298856979	0.426	0.226	7.15351443629323e-128	C10orf35	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3924
5.48328254042335e-132	0.288059043350601	0.992	0.982	1.02877347023423e-127	SNF8	Malignant cells	GSE115251	ENSG00000159210	11267	SNF8 subunit of ESCRT-II	Dot3|EAP30|VPS22	protein_coding	Q96H20	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3925
7.33521272375396e-132	0.353534036082854	0.628	0.428	1.37623261123072e-127	MRPS18A	Malignant cells	GSE115251	ENSG00000096080	55168	mitochondrial ribosomal protein S18A	FLJ10548|MRPS18-3	protein_coding	Q9NVS2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3926
7.58873235967607e-132	-0.397121209862623	0.309	0.506	1.42379796532242e-127	Z83851.1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3927
1.02232671079082e-131	-0.376519688409298	0.534	0.699	1.91808937478573e-127	RNF145	Malignant cells	GSE115251	ENSG00000145860	153830	ring finger protein 145	FLJ31951	protein_coding	Q96MT1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3928
1.30667112526931e-131	-0.325456882010703	0.239	0.439	2.45157636523028e-127	NFATC3	Malignant cells	GSE115251	ENSG00000072736	4775	nuclear factor of activated T cells 3	NFAT4|NFATX	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3929
1.35248958576004e-131	-0.407964522702449	0.551	0.719	2.537540960803e-127	TBX3	Malignant cells	GSE115251	ENSG00000135111	6926	T-box transcription factor 3	TBX3-ISO|UMS|XHL	protein_coding	O15119	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3930
4.13732444376501e-131	0.364120273429429	0.774	0.627	7.7624481213919e-127	POLR2G	Malignant cells	GSE115251	ENSG00000168002	5436	RNA polymerase II subunit G	hRPB19|hsRPB7|RPB7	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3931
5.47844922084418e-131	0.315167202249296	0.383	0.187	1.02786664281479e-126	CD59	Malignant cells	GSE115251	ENSG00000085063	966	CD59 molecule (CD59 blood group)	16.3A5|EJ16|EJ30|EL32|G344|MIC11|MIN1|MIN2|MIN3|MSK21|p18-20	protein_coding	P13987	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3932
6.46047709041663e-131	0.35379177812127	0.575	0.377	1.21211471170397e-126	DTX3	Malignant cells	GSE115251	ENSG00000178498	196403	deltex E3 ubiquitin ligase 3	FLJ34766|RNF154	protein_coding	Q8N9I9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3933
3.09909025141956e-130	0.408870239883065	0.892	0.845	5.81451312971337e-126	TMPO	Malignant cells	GSE115251	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3934
5.94739129951367e-130	-0.331695933136355	0.275	0.493	1.11584955561475e-125	RGS16	Malignant cells	GSE115251	ENSG00000143333	6004	regulator of G protein signaling 16	A28-RGS14|RGS-r	protein_coding	O15492	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3935
9.57040266323378e-130	0.353784517655872	0.655	0.462	1.79559894767592e-125	IFT52	Malignant cells	GSE115251	ENSG00000101052	51098	intraflagellar transport 52	C20orf9|CGI-53|dJ1028D15.1|NGD2|NGD5	protein_coding	Q9Y366	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3936
2.82191477631467e-129	0.367266747117763	0.734	0.568	5.29447650332158e-125	FAM217B	Malignant cells	GSE115251	ENSG00000196227	63939	family with sequence similarity 217 member B	C20orf177|dJ551D2.5	protein_coding	Q9NTX9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3937
3.19347454940339e-129	0.390049179041302	0.716	0.55	5.99159694959065e-125	USP14	Malignant cells	GSE115251	ENSG00000101557	9097	ubiquitin specific peptidase 14	TGT|Ubp6	protein_coding	P54578	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3938
4.36827997319694e-129	0.342238187198119	0.567	0.355	8.19576688571209e-125	MAGEA12	Malignant cells	GSE115251	ENSG00000213401	4111	MAGE family member A12	CT1.12|MAGE12	protein_coding	P43365	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3939
5.01789384041977e-129	-0.293456773290752	0.955	0.989	9.41457242339557e-125	HAND2	Malignant cells	GSE115251	ENSG00000164107	9464	heart and neural crest derivatives expressed 2	bHLHa26|dHand|Hed|Thing2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3940
5.02550686436271e-129	-0.341981868330404	0.356	0.554	9.42885597891732e-125	USP10	Malignant cells	GSE115251	ENSG00000103194	9100	ubiquitin specific peptidase 10	KIAA0190|UBPO	protein_coding	Q14694	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3941
1.17260264649766e-128	-0.337833859416245	0.251	0.448	2.20003708535891e-124	ACAP3	Malignant cells	GSE115251	ENSG00000131584	116983	ArfGAP with coiled-coil, ankyrin repeat and PH domains 3	CENTB5|KIAA1716	protein_coding	Q96P50	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3942
1.42885058537081e-128	0.349523973777774	0.917	0.847	2.68080946827271e-124	FDPS	Malignant cells	GSE115251	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3943
1.66383425391627e-128	-0.263623281914797	0.993	0.998	3.12168582719771e-124	TOMM20	Malignant cells	GSE115251	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3944
3.75545375012847e-128	-0.294917166891525	0.182	0.374	7.04598232599103e-124	RPP25L	Malignant cells	GSE115251	ENSG00000164967	138716	ribonuclease P/MRP subunit p25 like	bA296L22.5|C9orf23|MGC29635	protein_coding	Q8N5L8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3945
5.30695779642435e-128	-0.280405388629081	0.149	0.333	9.95691421765137e-124	TRMT2A	Malignant cells	GSE115251	ENSG00000099899	27037	tRNA methyltransferase 2 homolog A	HTF9C	protein_coding	Q8IZ69	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3946
8.13378746749615e-128	-0.268656623900241	0.138	0.321	1.52606120465163e-123	PLGRKT	Malignant cells	GSE115251	ENSG00000107020	55848	plasminogen receptor with a C-terminal lysine	AD025|C9orf46|FLJ14688|MDS030|Plg-RKT	protein_coding	Q9HBL7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3947
1.05426429948982e-127	-0.373158784956863	0.43	0.615	1.97801067870281e-123	SHC1	Malignant cells	GSE115251	ENSG00000160691	6464	SHC adaptor protein 1	p66|SHC|ShcA	protein_coding	P29353	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3948
2.58180434510904e-127	0.281685978748032	0.304	0.124	4.84398131229358e-123	GPR161	Malignant cells	GSE115251	ENSG00000143147	23432	G protein-coupled receptor 161	RE2	protein_coding	Q8N6U8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3949
3.84575096794759e-127	-0.359018624129709	0.406	0.598	7.21539796606327e-123	TERF2IP	Malignant cells	GSE115251	ENSG00000166848	54386	TERF2 interacting protein	RAP1	protein_coding	Q9NYB0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3950
6.09590183581365e-127	-0.373963228961205	0.802	0.899	1.14371310243536e-122	DNAJA1	Malignant cells	GSE115251	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3951
6.84349199654447e-127	0.315585831900622	0.363	0.173	1.28397596839167e-122	ALPL	Malignant cells	GSE115251	ENSG00000162551	249	alkaline phosphatase, biomineralization associated	HOPS|TNALP|TNAP|TNSALP	protein_coding	P05186	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3952
6.96319040150252e-127	-0.329765345057482	0.289	0.487	1.3064337831299e-122	MLLT10	Malignant cells	GSE115251	ENSG00000078403	8028	MLLT10 histone lysine methyltransferase DOT1L cofactor	AF10	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3953
7.53154382650194e-127	-0.300065946357784	0.172	0.359	1.41306825272829e-122	TEX264	Malignant cells	GSE115251	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3954
9.1435838820346e-127	-0.340377154037786	0.264	0.46	1.71551920794733e-122	FANCA	Malignant cells	GSE115251	ENSG00000187741	2175	FA complementation group A	FA-H|FAA|FACA|FAH|FANCH	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3955
1.67154127516207e-126	-0.359872688003724	0.379	0.567	3.13614574045908e-122	PDHB	Malignant cells	GSE115251	ENSG00000168291	5162	pyruvate dehydrogenase E1 subunit beta	E1beta|PDHE1B	protein_coding	P11177	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3956
2.11223329521833e-126	0.300937024831853	0.977	0.953	3.96297210848864e-122	DGUOK	Malignant cells	GSE115251	ENSG00000114956	1716	deoxyguanosine kinase	dGK	protein_coding	Q16854	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3957
3.63622392116941e-126	0.346638077165434	0.499	0.299	6.82228332089804e-122	MED30	Malignant cells	GSE115251	ENSG00000164758	90390	mediator complex subunit 30	THRAP6|TRAP25	protein_coding	Q96HR3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3958
4.19667843890495e-126	-0.346910071706874	0.758	0.867	7.87380808707347e-122	MRPL40	Malignant cells	GSE115251	ENSG00000185608	64976	mitochondrial ribosomal protein L40	MRP-L22|NLVCF	protein_coding	Q9NQ50	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3959
8.15209707680807e-126	-0.368689880512279	0.723	0.845	1.52949645355073e-121	HTATSF1	Malignant cells	GSE115251	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3960
9.30586887067549e-126	-0.332480802691039	0.672	0.817	1.74596711751614e-121	C9orf16	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3961
1.58840519973071e-125	0.371669421906881	0.677	0.502	2.98016583573475e-121	ZNF664	Malignant cells	GSE115251	ENSG00000179195	144348	zinc finger protein 664	DKFZp761B128|ZFOC1|ZNF176	protein_coding	Q8N3J9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3962
3.62437074899363e-125	0.431933858717974	0.469	0.278	6.80004439926184e-121	C1QL1	Malignant cells	GSE115251	ENSG00000131094	10882	complement C1q like 1	C1QRF|C1QTNF14|CRF|CTRP14	protein_coding	O75973	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3963
1.50707918354676e-124	0.256073827028448	0.997	0.995	2.82758196417044e-120	SHFM1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3964
1.80172975004417e-124	-0.276195286925539	0.98	0.993	3.38040535703287e-120	POLR2F	Malignant cells	GSE115251	ENSG00000100142	5435	RNA polymerase II, I and III subunit F	HRBP14.4|RPB6	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3965
2.37549727900515e-124	0.32266353610461	0.916	0.853	4.45690799486946e-120	AKR1A1	Malignant cells	GSE115251	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3966
3.50495242925925e-124	0.357678350484466	0.537	0.343	6.57599174777621e-120	MARS	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3967
5.60554035432913e-124	0.374590773879648	0.701	0.532	1.05171148127923e-119	ANKRD12	Malignant cells	GSE115251	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3968
6.62408971242717e-124	-0.250171074158564	0.994	0.998	1.24281171184558e-119	DDT	Malignant cells	GSE115251	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3969
1.81482336883919e-123	0.270359856320022	0.296	0.12	3.40497160461609e-119	GNS	Malignant cells	GSE115251	ENSG00000135677	2799	glucosamine (N-acetyl)-6-sulfatase	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3970
2.40274188732326e-123	0.341446477733619	0.453	0.257	4.5080243289959e-119	ZBTB18	Malignant cells	GSE115251	ENSG00000179456	10472	zinc finger and BTB domain containing 18	C2H2-171|RP58|TAZ-1|ZNF238	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3971
3.20881478494567e-123	-0.365032543914494	0.543	0.703	6.02037829951506e-119	NDUFAF3	Malignant cells	GSE115251	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3972
4.37156407512086e-123	0.369009385657036	0.534	0.343	8.20192851774176e-119	TIMP2	Malignant cells	GSE115251	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3973
4.98560184108952e-123	0.335851105930373	0.579	0.38	9.35398617425215e-119	VEZT	Malignant cells	GSE115251	ENSG00000028203	55591	vezatin, adherens junctions transmembrane protein	DKFZP761C241	protein_coding	Q9HBM0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3974
5.40374211492121e-123	0.29466031542406	0.368	0.179	1.01385009560152e-118	BCAS4	Malignant cells	GSE115251	ENSG00000124243	55653	breast carcinoma amplified sequence 4	CNOL|FLJ20495	protein_coding	Q8TDM0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3975
5.63320072355414e-123	0.760407616591772	0.775	0.732	1.05690111975323e-118	ID1	Malignant cells	GSE115251	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3976
9.26262090640108e-123	0.277722807686851	0.992	0.982	1.73785293445897e-118	SUMO1	Malignant cells	GSE115251	ENSG00000116030	7341	small ubiquitin like modifier 1	GMP1|OFC10|PIC1|SMT3C|SMT3H3|SUMO-1|UBL1	protein_coding	P63165	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3977
1.39035446565075e-122	-0.3401782584394	0.31	0.5	2.60858304845393e-118	CIAPIN1	Malignant cells	GSE115251	ENSG00000005194	57019	cytokine induced apoptosis inhibitor 1	CIAE2	protein_coding	Q6FI81	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3978
2.875526813467e-122	0.325999824068703	0.955	0.925	5.39506340742678e-118	TRA2B	Malignant cells	GSE115251	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3979
3.19190469923538e-122	0.359563894412035	0.569	0.377	5.98865159670542e-118	TTC1	Malignant cells	GSE115251	ENSG00000113312	7265	tetratricopeptide repeat domain 1	TPR1	protein_coding	Q99614	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3980
3.71946059607805e-122	0.346941030834301	0.556	0.365	6.97845197036164e-118	PITHD1	Malignant cells	GSE115251	ENSG00000057757	57095	PITH domain containing 1	C1orf128|HT014|TXNL1CL	protein_coding	Q9GZP4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3981
8.76049927318415e-122	-0.358736268194323	0.623	0.785	1.64364487363481e-117	DHFR	Malignant cells	GSE115251	ENSG00000228716	1719	dihydrofolate reductase	NA	protein_coding	P00374	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3982
1.51595576250393e-121	0.348721119493094	0.835	0.726	2.84423620160988e-117	PIN4	Malignant cells	GSE115251	ENSG00000102309	5303	peptidylprolyl cis/trans isomerase, NIMA-interacting 4	EPVH|PAR14|PAR17	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3983
1.64410317006087e-121	0.299477411056701	0.377	0.188	3.0846663676682e-117	CD151	Malignant cells	GSE115251	ENSG00000177697	977	CD151 molecule (Raph blood group)	PETA-3|RAPH|SFA-1|TSPAN24	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3984
1.84270671001531e-121	0.331523870540341	0.435	0.244	3.45728632933072e-117	CMTM8	Malignant cells	GSE115251	ENSG00000170293	152189	CKLF like MARVEL transmembrane domain containing 8	CKLFSF8	protein_coding	Q8IZV2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3985
3.13961278777773e-121	-0.281683120144382	0.171	0.358	5.89054151242857e-117	LRRTM1	Malignant cells	GSE115251	ENSG00000162951	347730	leucine rich repeat transmembrane neuronal 1	FLJ32082	protein_coding	Q86UE6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3986
3.31164348985165e-121	-0.28372154289045	0.174	0.359	6.21330551565967e-117	ZCCHC7	Malignant cells	GSE115251	ENSG00000147905	84186	zinc finger CCHC-type containing 7	AIR1|FLJ22611	protein_coding	Q8N3Z6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3987
4.11286964864027e-121	0.308176156859333	0.3	0.127	7.71656603477888e-117	CTSL	Malignant cells	GSE115251	ENSG00000135047	1514	cathepsin L	CTSL1|FLJ31037	protein_coding	P07711	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3988
4.68854725542445e-121	0.361704474275087	0.745	0.59	8.79665236062735e-117	OSBPL8	Malignant cells	GSE115251	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3989
8.46835318793291e-121	0.32373978858765	0.485	0.286	1.58883242511997e-116	CTNNA1	Malignant cells	GSE115251	ENSG00000044115	1495	catenin alpha 1	CAP102	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3990
1.05649132574112e-120	0.331992099611209	0.447	0.253	1.98218902535549e-116	PKIG	Malignant cells	GSE115251	ENSG00000168734	11142	cAMP-dependent protein kinase inhibitor gamma	NA	protein_coding	Q9Y2B9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3991
1.57026799716694e-120	-0.335260577525323	0.682	0.818	2.94613681628462e-116	EIF2A	Malignant cells	GSE115251	ENSG00000144895	83939	eukaryotic translation initiation factor 2A	EIF-2A	protein_coding	Q9BY44	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3992
1.66025895360245e-120	0.347066518993631	0.83	0.708	3.11497784874892e-116	PAIP2	Malignant cells	GSE115251	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3993
1.83773944077364e-120	0.364337578086857	0.341	0.159	3.44796673877951e-116	CDKN1A	Malignant cells	GSE115251	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3994
1.91267531141169e-120	0.319834358618041	0.461	0.263	3.58856141927061e-116	SDCBP	Malignant cells	GSE115251	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3995
2.52668387530469e-120	0.261300513333929	0.293	0.119	4.74056428684666e-116	TWSG1	Malignant cells	GSE115251	ENSG00000128791	57045	twisted gastrulation BMP signaling modulator 1	TSG	protein_coding	Q9GZX9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3996
2.53309231707279e-120	0.39745339067687	0.713	0.562	4.75258780529197e-116	CPSF6	Malignant cells	GSE115251	ENSG00000111605	11052	cleavage and polyadenylation specific factor 6	CFIM|CFIM68|CFIM72|HPBRII-4|HPBRII-7	protein_coding	Q16630	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3997
3.41217305053131e-120	0.361157093304929	0.765	0.628	6.40191907740684e-116	GRB2	Malignant cells	GSE115251	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3998
3.77217395769054e-120	-0.29203651970724	0.143	0.317	7.07735277941898e-116	GAN	Malignant cells	GSE115251	ENSG00000261609	8139	gigaxonin	GAN1|GIG|KLHL16	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	3999
4.8504167975279e-120	-0.344559338936665	0.303	0.491	9.10035199552185e-116	TLN1	Malignant cells	GSE115251	ENSG00000137076	7094	talin 1	ILWEQ|TLN	protein_coding	Q9Y490	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4000
9.27355079752921e-120	0.487244722689515	0.524	0.338	1.73990360063243e-115	SNCG	Malignant cells	GSE115251	ENSG00000173267	6623	synuclein gamma	BCSG1|persyn|SR	protein_coding	O76070	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4001
1.21020191166842e-119	0.341168126557826	0.546	0.354	2.27058082667229e-115	EAPP	Malignant cells	GSE115251	ENSG00000129518	55837	E2F associated phosphoprotein	BM036|C14orf11|FLJ20578	protein_coding	Q56P03	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4002
1.32645621470971e-119	0.260907564451318	0.304	0.128	2.48869715003836e-115	DEAF1	Malignant cells	GSE115251	ENSG00000282712	10522	DEAF1 transcription factor	NUDR|SPN|ZMYND5	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4003
1.91860225890778e-119	0.324387011875294	0.456	0.263	3.59968155816278e-115	PHC2	Malignant cells	GSE115251	ENSG00000134686	1912	polyhomeotic homolog 2	EDR2|HPH2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4004
3.11483033845136e-119	-0.278814898448688	0.974	0.99	5.84404468100244e-115	ATP5F1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4005
4.50551799637424e-119	-0.339843246158869	0.779	0.875	8.45325286479736e-115	AES	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4006
6.14129867938406e-119	0.349820636921615	0.653	0.477	1.15223045822604e-114	RAD1	Malignant cells	GSE115251	ENSG00000113456	5810	RAD1 checkpoint DNA exonuclease	HRAD1|REC1	protein_coding	O60671	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4007
6.24765422292739e-119	0.304034838357568	0.355	0.172	1.17218488530564e-114	ELOVL4	Malignant cells	GSE115251	ENSG00000118402	6785	ELOVL fatty acid elongase 4	CT118|SCA34|STGD2|STGD3	protein_coding	Q9GZR5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4008
6.87121701295446e-119	0.36334864875178	0.434	0.249	1.28917773597052e-114	AUTS2	Malignant cells	GSE115251	ENSG00000158321	26053	activator of transcription and developmental regulator AUTS2	FBRSL2|KIAA0442	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4009
7.02088937324283e-119	0.339278649950333	0.807	0.678	1.31725926420782e-114	NELFE	Malignant cells	GSE115251	ENSG00000206268	7936	negative elongation factor complex member E	D6S45|NELF-E|RD|RDBP|RDP	protein_coding	P18615	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4010
2.60218148568661e-118	-0.347204095267525	0.397	0.582	4.88221290344521e-114	ACADVL	Malignant cells	GSE115251	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4011
3.06256385042759e-118	-0.268700036905654	0.149	0.325	5.74598229617224e-114	MBTPS1	Malignant cells	GSE115251	ENSG00000140943	8720	membrane bound transcription factor peptidase, site 1	KIAA0091|PCSK8|S1P|SKI-1	protein_coding	Q14703	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4012
3.67789632891998e-118	0.348408799405096	0.509	0.317	6.90046909231967e-114	DYRK2	Malignant cells	GSE115251	ENSG00000127334	8445	dual specificity tyrosine phosphorylation regulated kinase 2	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4013
4.08801378025365e-118	0.332499952309989	0.528	0.336	7.66993145451189e-114	DLGAP4	Malignant cells	GSE115251	ENSG00000080845	22839	DLG associated protein 4	DAP4|KIAA0964|SAPAP4	protein_coding	Q9Y2H0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4014
5.59543568153115e-118	-0.339590063517613	0.434	0.617	1.04981564256888e-113	IP6K2	Malignant cells	GSE115251	ENSG00000068745	51447	inositol hexakisphosphate kinase 2	IHPK2	protein_coding	Q9UHH9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4015
8.42152081338425e-118	0.360026634477431	0.775	0.651	1.58004573500715e-113	LSM6	Malignant cells	GSE115251	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4016
1.37253948365457e-117	-0.25491769055618	0.999	1	2.57515857923271e-113	RANBP1	Malignant cells	GSE115251	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4017
1.98096369835404e-117	0.304552847592769	0.431	0.239	3.71668409085185e-113	COX6A1P2	Malignant cells	GSE115251	ENSG00000226976	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4018
2.10126761076589e-117	0.342234650113668	0.593	0.402	3.94239829131896e-113	RAB22A	Malignant cells	GSE115251	ENSG00000124209	57403	RAB22A, member RAS oncogene family	NA	protein_coding	Q9UL26	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4019
2.26189098936158e-117	0.410068831006823	0.592	0.42	4.2437598742402e-113	CD47	Malignant cells	GSE115251	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4020
2.69917469466196e-117	0.262960714954694	0.993	0.986	5.06419156212477e-113	ENSA	Malignant cells	GSE115251	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4021
3.35021683149044e-117	-0.28062213217263	0.115	0.277	6.28567681924237e-113	TTC8	Malignant cells	GSE115251	ENSG00000165533	123016	tetratricopeptide repeat domain 8	BBS8|RP51	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4022
3.80630432545535e-117	-0.343154302081236	0.394	0.578	7.14138817541934e-113	ZNF580	Malignant cells	GSE115251	ENSG00000213015	51157	zinc finger protein 580	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4023
4.44113203015839e-117	0.313036433794922	0.366	0.182	8.33245191498317e-113	TGIF1	Malignant cells	GSE115251	ENSG00000177426	7050	TGFB induced factor homeobox 1	HPE4|TGIF	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4024
4.70754665623904e-117	0.359589822557882	0.621	0.439	8.83229903643569e-113	NBPF1	Malignant cells	GSE115251	ENSG00000219481	55672	NBPF member 1	FLJ20719|KIAA1693	protein_coding	Q3BBV0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4025
1.69856255534983e-116	0.356383815345778	0.797	0.674	3.18684306634735e-112	ALKBH2	Malignant cells	GSE115251	ENSG00000189046	121642	alkB homolog 2, alpha-ketoglutarate dependent dioxygenase	ABH2|MGC90512	protein_coding	Q6NS38	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4026
1.93662916063875e-116	-0.295570470924915	0.907	0.952	3.63350363119042e-112	MRPL55	Malignant cells	GSE115251	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4027
2.12591522120464e-116	0.357507331962005	0.729	0.569	3.98864213802415e-112	FAM89B	Malignant cells	GSE115251	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4028
2.21998255502232e-116	-0.252198075136302	0.115	0.278	4.16513126973287e-112	UNC5C	Malignant cells	GSE115251	ENSG00000182168	8633	unc-5 netrin receptor C	NA	protein_coding	O95185	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4029
2.62861132319168e-116	0.359728976907611	0.683	0.517	4.93180056457224e-112	NIPBL	Malignant cells	GSE115251	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4030
1.32731623808898e-115	0.345930765730617	0.636	0.451	2.49031072590255e-111	ATP2A2	Malignant cells	GSE115251	ENSG00000174437	488	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2	ATP2B|DAR|SERCA2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4031
1.76659588239471e-115	-0.315339932005289	0.238	0.427	3.31448719454896e-111	NFIB	Malignant cells	GSE115251	ENSG00000147862	4781	nuclear factor I B	NFI-RED|NFIB2|NFIB3	protein_coding	O00712	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4032
2.15226378588835e-115	0.332882592761917	0.539	0.35	4.03807731508372e-111	C12orf43	Malignant cells	GSE115251	ENSG00000157895	64897	chromosome 12 open reading frame 43	Custos|FLJ12448	protein_coding	Q96C57	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4033
3.13808004083576e-115	-0.346719724322106	0.625	0.773	5.88766577261606e-111	NES	Malignant cells	GSE115251	ENSG00000132688	10763	nestin	FLJ21841	protein_coding	P48681	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4034
3.47131336248464e-115	0.347359156907254	0.667	0.497	6.51287813069369e-111	TSFM	Malignant cells	GSE115251	ENSG00000123297	10102	Ts translation elongation factor, mitochondrial	EF-TS|EF-Tsmt	protein_coding	P43897	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4035
5.75438684384135e-115	0.299034163932018	0.974	0.945	1.07963805964151e-110	SRSF5	Malignant cells	GSE115251	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4036
6.00716552678434e-115	0.333768239281482	0.856	0.757	1.12706439613528e-110	FAM133B	Malignant cells	GSE115251	ENSG00000234545	257415	family with sequence similarity 133 member B	MGC40405	protein_coding	Q5BKY9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4037
1.90968024129765e-114	0.332480592553566	0.604	0.418	3.58294206872265e-110	PGLS	Malignant cells	GSE115251	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4038
2.37627309807685e-114	0.344800963344557	0.801	0.687	4.45836358661178e-110	TTF1	Malignant cells	GSE115251	ENSG00000125482	7270	transcription termination factor 1	NA	protein_coding	Q15361	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4039
2.38013678003698e-114	0.331416985799245	0.587	0.401	4.46561262670537e-110	CTDSP2	Malignant cells	GSE115251	ENSG00000175215	10106	CTD small phosphatase 2	OS4|PSR2|SCP2	protein_coding	O14595	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4040
2.46521898853793e-114	0.347022522181073	0.783	0.663	4.62524386629487e-110	TIMM50	Malignant cells	GSE115251	ENSG00000105197	92609	translocase of inner mitochondrial membrane 50	TIM50|TIM50L	protein_coding	Q3ZCQ8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4041
7.31295620194758e-114	0.361410871231256	0.637	0.464	1.37205684260941e-109	PTTG1IP	Malignant cells	GSE115251	ENSG00000183255	754	PTTG1 interacting protein	C21orf1|C21orf3|PBF|PTTG1IP1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4042
1.20338994931034e-113	-0.3672498090279	0.481	0.644	2.25780022289606e-109	CDC123	Malignant cells	GSE115251	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4043
1.72235802249921e-113	0.310721981729282	0.904	0.828	3.23148812181303e-109	TMEM203	Malignant cells	GSE115251	ENSG00000187713	94107	transmembrane protein 203	HBEBP1|MGC14327	protein_coding	Q969S6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4044
2.22233710809594e-113	0.327032262538057	0.456	0.269	4.16954888220961e-109	BNIP3L	Malignant cells	GSE115251	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4045
2.59493826074511e-113	-0.321836994803901	0.361	0.545	4.86862316480997e-109	FAM192A	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4046
9.395776711248e-113	0.30303001474714	0.445	0.257	1.76283562656435e-108	BCL2L1	Malignant cells	GSE115251	ENSG00000171552	598	BCL2 like 1	Bcl-X|bcl-xL|bcl-xS|BCL2L|BCLX|PPP1R52	protein_coding	Q07817	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4047
1.85901686435222e-112	-0.331250139606704	0.465	0.641	3.48788744089764e-108	EIF1B	Malignant cells	GSE115251	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4048
2.80585259145211e-112	0.264617818258369	0.99	0.977	5.26434063208244e-108	NDUFS8	Malignant cells	GSE115251	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4049
3.85372027479007e-112	-0.326472111481601	0.343	0.526	7.23034997956113e-108	DNAJA2	Malignant cells	GSE115251	ENSG00000069345	10294	DnaJ heat shock protein family (Hsp40) member A2	CPR3|DNAJ|DNJ3|HIRIP4	protein_coding	O60884	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4050
5.92730507135295e-112	-0.305155061779276	0.309	0.504	1.11208097748724e-107	HERPUD1	Malignant cells	GSE115251	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4051
9.71084193043081e-112	0.303565889491993	0.433	0.246	1.82194816298743e-107	C1orf53	Malignant cells	GSE115251	ENSG00000203724	388722	chromosome 1 open reading frame 53	NA	protein_coding	Q5VUE5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4052
9.84637499056696e-112	0.316994087803642	0.594	0.404	1.84737687573017e-107	MAPKAPK5	Malignant cells	GSE115251	ENSG00000089022	8550	MAPK activated protein kinase 5	MK5|PRAK	protein_coding	Q8IW41	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4053
1.76480934397172e-111	0.317797560252031	0.565	0.377	3.31113529115974e-107	SURF6	Malignant cells	GSE115251	ENSG00000281309	6838	surfeit 6	FLJ30322|RRP14	protein_coding	O75683	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4054
2.17051487352135e-111	-0.307577175194347	0.28	0.466	4.07232000570076e-107	DNAH14	Malignant cells	GSE115251	ENSG00000185842	127602	dynein axonemal heavy chain 14	C1orf67|DKFZp781B1548|Dnahc14|HL-18|HL18|MGC27277	protein_coding	Q0VDD8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4055
2.20407100344511e-111	0.332935994953437	0.852	0.743	4.13527801666372e-107	ZMAT2	Malignant cells	GSE115251	ENSG00000146007	153527	zinc finger matrin-type 2	FLJ31121|hSNU23|Snu23	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4056
1.3544309700094e-110	-0.342609191279763	0.512	0.681	2.54118338593163e-106	ZFP36L2	Malignant cells	GSE115251	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4057
5.69870083075962e-110	0.350693147092399	0.677	0.522	1.06919024986712e-105	GALNT11	Malignant cells	GSE115251	ENSG00000178234	63917	polypeptide N-acetylgalactosaminyltransferase 11	GalNAc-T11	protein_coding	Q8NCW6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4058
7.18796560868778e-110	0.318327423119315	0.896	0.828	1.348606107502e-105	TMCO1	Malignant cells	GSE115251	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4059
8.81708727309981e-110	0.297556948894278	0.976	0.945	1.65426191417899e-105	MRPL47	Malignant cells	GSE115251	ENSG00000136522	57129	mitochondrial ribosomal protein L47	CGI-204|NCM1	protein_coding	Q9HD33	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4060
1.33518679839168e-109	-0.308871413606186	0.353	0.54	2.50507747114246e-105	SLC35E2B	Malignant cells	GSE115251	ENSG00000189339	728661	solute carrier family 35 member E2B	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4061
1.34488852614291e-109	0.300631991255811	0.993	0.989	2.52327985274933e-105	CENPV	Malignant cells	GSE115251	ENSG00000166582	201161	centromere protein V	CENP-V|p30|PRR6	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4062
1.34498567233151e-109	0.299582570211383	0.974	0.955	2.52346211842839e-105	SSNA1	Malignant cells	GSE115251	ENSG00000176101	8636	SS nuclear autoantigen 1	N14|NA14	protein_coding	O43805	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4063
2.22788205973483e-109	-0.341757177093302	0.543	0.7	4.17995232047449e-105	SUMF2	Malignant cells	GSE115251	ENSG00000129103	25870	sulfatase modifying factor 2	DKFZp566I1024	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4064
2.81420908005033e-109	0.348501040981241	0.63	0.46	5.28001907599042e-105	IPO7	Malignant cells	GSE115251	ENSG00000205339	10527	importin 7	Imp7|RANBP7	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4065
3.31270345933608e-109	0.262792528975437	0.345	0.168	6.21529423040636e-105	STX5	Malignant cells	GSE115251	ENSG00000162236	6811	syntaxin 5	SED5|STX5A	protein_coding	Q13190	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4066
3.76776213684649e-109	0.254897367990791	0.303	0.135	7.06907532115139e-105	TSPAN33	Malignant cells	GSE115251	ENSG00000158457	340348	tetraspanin 33	MGC50844|Penumbra	protein_coding	Q86UF1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4067
3.99097607636067e-109	0.262591978129352	0.992	0.984	7.48786931446789e-105	NENF	Malignant cells	GSE115251	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4068
5.41528063352734e-109	-0.300611469841609	0.894	0.95	1.0160149524624e-104	NDUFB5	Malignant cells	GSE115251	ENSG00000136521	4711	NADH:ubiquinone oxidoreductase subunit B5	CI-SGDH|MGC12314|SGDH	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4069
1.12531615616835e-108	0.274955895481861	0.992	0.983	2.11131817220305e-104	STRAP	Malignant cells	GSE115251	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4070
1.19224372711293e-108	0.341949324104858	0.763	0.639	2.23688768080927e-104	NT5C	Malignant cells	GSE115251	ENSG00000125458	30833	5', 3'-nucleotidase, cytosolic	cdN|DNT-1|DNT1|PN-I|UMPH2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4071
1.31644501198555e-108	-0.309028805977418	0.296	0.477	2.46991413148729e-104	RNASEH1-AS1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4072
2.67316175550179e-108	-0.318899015168293	0.353	0.532	5.01538608567245e-104	RPP14	Malignant cells	GSE115251	ENSG00000163684	11102	ribonuclease P/MRP subunit p14	P14	protein_coding	O95059	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4073
3.62527012547686e-108	-0.281768507071043	0.216	0.394	6.80173180941968e-104	RAB18	Malignant cells	GSE115251	ENSG00000099246	22931	RAB18, member RAS oncogene family	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4074
3.77724295210646e-108	0.374119224067552	0.933	0.909	7.08686322674213e-104	HMGB3	Malignant cells	GSE115251	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4075
1.17959250730105e-107	0.332793811250685	0.812	0.706	2.21315146219822e-103	CANX	Malignant cells	GSE115251	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4076
1.49722176585284e-107	0.338193168688726	0.453	0.271	2.8090874770931e-103	ZFHX4	Malignant cells	GSE115251	ENSG00000091656	79776	zinc finger homeobox 4	FLJ20980|ZFH4	protein_coding	Q86UP3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4077
2.46220131396218e-107	0.279062695955163	0.996	0.989	4.61958210525584e-103	UCHL1	Malignant cells	GSE115251	ENSG00000154277	7345	ubiquitin C-terminal hydrolase L1	PARK5|PGP9.5|Uch-L1|UCHL-1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4078
3.61476549174195e-107	0.343703633998334	0.644	0.469	6.78202301560625e-103	ASXL1	Malignant cells	GSE115251	ENSG00000171456	171023	ASXL transcriptional regulator 1	KIAA0978	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4079
5.12534511313861e-107	0.342888486361671	0.935	0.889	9.61617250127066e-103	RTN4	Malignant cells	GSE115251	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4080
5.93607124489264e-107	0.315084269685421	0.868	0.778	1.11372568696676e-102	SRI	Malignant cells	GSE115251	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4081
7.56114922797719e-107	0.326539855907646	0.534	0.353	1.41862281815308e-102	CBR1	Malignant cells	GSE115251	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4082
1.08226651304397e-106	0.329462617226557	0.554	0.373	2.0305484317731e-102	SHMT2	Malignant cells	GSE115251	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4083
1.49340008928854e-106	0.308001091158441	0.943	0.897	2.80191724752315e-102	TPM3	Malignant cells	GSE115251	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4084
1.52662754167051e-106	0.26869941416335	0.35	0.175	2.86425859368221e-102	EFHC1	Malignant cells	GSE115251	ENSG00000096093	114327	EF-hand domain containing 1	EJM|EJM1|FLJ10466|POC9|RIB72	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4085
1.54642810416724e-106	0.259411324457949	0.316	0.148	2.90140840903858e-102	TCTN1	Malignant cells	GSE115251	ENSG00000204852	79600	tectonic family member 1	FLJ21127|JBTS13|TECT1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4086
1.92391528239226e-106	0.327460995863828	0.558	0.38	3.60964985282436e-102	MLXIP	Malignant cells	GSE115251	ENSG00000281178	22877	MLX interacting protein	bHLHe36|KIAA0867|MIR|MONDOA	protein_coding	Q9HAP2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4087
2.15558080519122e-106	0.326867402629649	0.664	0.497	4.04430070669976e-102	YTHDF1	Malignant cells	GSE115251	ENSG00000149658	54915	YTH N6-methyladenosine RNA binding protein 1	C20orf21|FLJ20391	protein_coding	Q9BYJ9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4088
3.25204827983182e-106	0.333811321352284	0.815	0.705	6.10149298262047e-102	CLPTM1L	Malignant cells	GSE115251	ENSG00000274811	81037	CLPTM1 like	CRR9|FLJ14400	protein_coding	Q96KA5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4089
3.46059625561881e-106	0.3356370116319	0.697	0.542	6.49277069479202e-102	ATP2B1	Malignant cells	GSE115251	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4090
3.91591999149739e-106	-0.309860873074129	0.309	0.496	7.3470490880474e-102	POU2F2	Malignant cells	GSE115251	ENSG00000028277	5452	POU class 2 homeobox 2	OCT2|OTF2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4091
4.06462926254788e-106	0.299359650480669	0.433	0.25	7.62605742239233e-102	NBN	Malignant cells	GSE115251	ENSG00000104320	4683	nibrin	AT-V1|AT-V2|ATV|NBS|NBS1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4092
5.41689971787773e-106	0.320565208208843	0.374	0.201	1.01631872506822e-101	SRRM4	Malignant cells	GSE115251	ENSG00000139767	84530	serine/arginine repetitive matrix 4	KIAA1853|nSR100	protein_coding	A7MD48	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4093
5.79678563745384e-106	-0.347572110901876	0.529	0.683	1.08759292129909e-101	ILF3-AS1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4094
7.89467627495114e-106	0.294793271498372	0.443	0.261	1.48119916270633e-101	PSMD9	Malignant cells	GSE115251	ENSG00000110801	5715	proteasome 26S subunit, non-ATPase 9	p27|Rpn4	protein_coding	O00233	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4095
1.40814375352643e-105	0.32681097542245	0.797	0.674	2.64195931036629e-101	SF3B1	Malignant cells	GSE115251	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4096
1.86826157055065e-105	0.318364691623005	0.666	0.503	3.50523235866714e-101	GID8	Malignant cells	GSE115251	ENSG00000101193	54994	GID complex subunit 8 homolog	bA305P22.1|C20orf11|FLJ20602|TWA1	protein_coding	Q9NWU2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4097
7.61186425509929e-105	0.32787571444964	0.771	0.633	1.42813797154173e-100	MAGOH	Malignant cells	GSE115251	ENSG00000162385	4116	mago homolog, exon junction complex subunit	MAGOH1|MAGOHA	protein_coding	P61326	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4098
1.29832130000874e-104	-0.324971490452243	0.381	0.554	2.43591042307639e-100	ITGB1	Malignant cells	GSE115251	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4099
1.67130677816232e-104	-0.332423897391132	0.551	0.7	3.13570577718815e-100	THOC5	Malignant cells	GSE115251	ENSG00000100296	8563	THO complex subunit 5	C22orf19|Fmip|fSAP79|KIAA0983|PK1.3	protein_coding	Q13769	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4100
1.86012462169735e-104	-0.288611294351085	0.905	0.969	3.48996581522857e-100	FSCN1	Malignant cells	GSE115251	ENSG00000075618	6624	fascin actin-bundling protein 1	FLJ38511|p55|SNL	protein_coding	Q16658	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4101
1.87705640700524e-104	0.322589392730021	0.952	0.914	3.52173323082323e-100	CCT7	Malignant cells	GSE115251	ENSG00000135624	10574	chaperonin containing TCP1 subunit 7	Ccth|Nip7-1	protein_coding	Q99832	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4102
1.88912273796202e-104	0.34174708889647	0.642	0.478	3.54437208096435e-100	PTPN11	Malignant cells	GSE115251	ENSG00000179295	5781	protein tyrosine phosphatase non-receptor type 11	BPTP3|NS1|PTP2C|SH-PTP2|SHP-2|SHP2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4103
2.0306079573741e-104	0.358687104302175	0.929	0.879	3.80982664962528e-100	TOP1	Malignant cells	GSE115251	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4104
3.20668431097701e-104	0.437652106555615	0.506	0.342	6.01638110425507e-100	SPC25	Malignant cells	GSE115251	ENSG00000277909	57405	SPC25 component of NDC80 kinetochore complex	AD024|MGC22228|SPBC25	protein_coding	Q9HBM1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4105
4.92289106224896e-104	-0.251671919478887	0.164	0.33	9.2363282109915e-100	RSU1	Malignant cells	GSE115251	ENSG00000148484	6251	Ras suppressor protein 1	FLJ31034|RSP-1	protein_coding	Q15404	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4106
1.9156936813871e-103	-0.321400896627419	0.55	0.703	3.59422448501848e-99	WAC	Malignant cells	GSE115251	ENSG00000095787	51322	WW domain containing adaptor with coiled-coil	BM-016|FLJ31290|MGC10753|PRO1741|Wwp4	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4107
2.1245748407013e-103	0.308237075051278	0.553	0.371	3.98612731612378e-99	TSR2	Malignant cells	GSE115251	ENSG00000158526	90121	TSR2 ribosome maturation factor	DT1P1A10|RP1-112K5.2|WGG1	protein_coding	Q969E8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4108
3.20381926033621e-103	-0.255417451844033	0.139	0.298	6.01100569624279e-99	MELK	Malignant cells	GSE115251	ENSG00000165304	9833	maternal embryonic leucine zipper kinase	KIAA0175	protein_coding	Q14680	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4109
3.32309925707095e-103	-0.331302086842471	0.552	0.703	6.23479882611652e-99	NDFIP1	Malignant cells	GSE115251	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4110
3.78725402178121e-103	0.30686440716881	0.257	0.107	7.10564599566591e-99	SCG2	Malignant cells	GSE115251	ENSG00000171951	7857	secretogranin II	CHGC|SgII|SN	protein_coding	P13521	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4111
3.80684026414344e-103	-0.306034874050312	0.682	0.811	7.14239370358592e-99	TMEM208	Malignant cells	GSE115251	ENSG00000168701	29100	transmembrane protein 208	hSND2|HSPC171	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4112
4.76462009408784e-103	0.300739565805687	0.933	0.881	8.9393802205276e-99	SURF1	Malignant cells	GSE115251	ENSG00000280627	6834	SURF1 cytochrome c oxidase assembly factor	SHY1	protein_coding	Q15526	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4113
8.32586289324058e-103	0.333755184481854	0.693	0.542	1.5620983960298e-98	SYF2	Malignant cells	GSE115251	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4114
1.33378436357339e-102	0.299191898842571	0.87	0.79	2.50244622293639e-98	C8orf59	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4115
1.59813908153957e-102	-0.276095534534999	0.239	0.419	2.99842854478454e-98	KAZN	Malignant cells	GSE115251	ENSG00000189337	23254	kazrin, periplakin interacting protein	C1orf196|FLJ43806|KAZRIN|KIAA1026	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4116
1.7968904783378e-102	0.328434883267808	0.612	0.441	3.37132591545737e-98	C17orf58	Malignant cells	GSE115251	ENSG00000186665	284018	chromosome 17 open reading frame 58	NA	protein_coding	Q2M2W7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4117
3.2690921679202e-102	0.323051870864978	0.601	0.43	6.13347072545189e-98	ICT1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4118
4.70067884468041e-102	0.407085561592976	0.608	0.439	8.81941364838938e-98	PNRC1	Malignant cells	GSE115251	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4119
7.84711656266013e-102	-0.322170616882577	0.488	0.65	1.47227600948629e-97	NKTR	Malignant cells	GSE115251	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4120
8.19610564122034e-102	-0.301273481510417	0.338	0.515	1.53775334040576e-97	GOT2	Malignant cells	GSE115251	ENSG00000125166	2806	glutamic-oxaloacetic transaminase 2	KAT4|KATIV|KYAT4|mitAAT	protein_coding	P00505	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4121
8.3558354085007e-102	0.367124493053767	0.602	0.434	1.5677218393429e-97	KDM5B	Malignant cells	GSE115251	ENSG00000117139	10765	lysine demethylase 5B	CT31|JARID1B|PLU-1|PPP1R98|RBBP2H1A	protein_coding	Q9UGL1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4122
9.00482988150753e-102	-0.295707965197404	0.256	0.431	1.68948618236844e-97	HAUS6	Malignant cells	GSE115251	ENSG00000147874	54801	HAUS augmin like complex subunit 6	dgt6|FAM29A|FLJ20060|KIAA1574	protein_coding	Q7Z4H7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4123
1.0646970887611e-101	0.2998900792333	0.911	0.851	1.99758467793357e-97	OAZ2	Malignant cells	GSE115251	ENSG00000180304	4947	ornithine decarboxylase antizyme 2	NA	protein_coding	O95190	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4124
1.11733713515283e-101	0.310727497797906	0.853	0.763	2.09634793297374e-97	SBDS	Malignant cells	GSE115251	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4125
1.60461735028134e-101	0.271971933035038	0.342	0.174	3.01058307259786e-97	ACTR6	Malignant cells	GSE115251	ENSG00000075089	64431	actin related protein 6	ARP6|FLJ13433	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4126
1.89604797558958e-101	-0.25924113161399	0.176	0.342	3.55736521180117e-97	LONP2	Malignant cells	GSE115251	ENSG00000102910	83752	lon peptidase 2, peroxisomal	LONP|LONPL|MGC4840	protein_coding	Q86WA8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4127
2.33373264467726e-101	-0.255382786376651	0.174	0.34	4.37854918794347e-97	MAP4	Malignant cells	GSE115251	ENSG00000047849	4134	microtubule associated protein 4	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4128
3.4894881181696e-101	0.354258734722518	0.81	0.729	6.54697760730981e-97	ASRGL1	Malignant cells	GSE115251	ENSG00000162174	80150	asparaginase and isoaspartyl peptidase 1	ALP|ALP1|FLJ22316	protein_coding	Q7L266	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4129
3.81620569389761e-101	0.324793446116363	0.631	0.46	7.15996512289069e-97	KIAA0947	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4130
4.72862597228894e-101	-0.317560352586468	0.613	0.761	8.8718480492085e-97	AP1S2	Malignant cells	GSE115251	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4131
5.04252750205609e-101	-0.317289987089215	0.524	0.676	9.46079009935764e-97	CCDC12	Malignant cells	GSE115251	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4132
5.76694328170101e-101	-0.304785288472045	0.34	0.515	1.08199389851274e-96	NUDT21	Malignant cells	GSE115251	ENSG00000167005	11051	nudix hydrolase 21	CFIM25|CPSF5	protein_coding	O43809	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4133
7.72173113473869e-101	0.334439652932652	0.808	0.696	1.44875119549967e-96	TMBIM6	Malignant cells	GSE115251	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4134
8.48623132433371e-101	0.286908383504823	0.273	0.119	1.59218672107149e-96	PRICKLE1	Malignant cells	GSE115251	ENSG00000139174	144165	prickle planar cell polarity protein 1	EPM1B|FLJ31937|RILP	protein_coding	Q96MT3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4135
8.61216764142802e-101	-0.306606478660592	0.795	0.888	1.61581489288473e-96	LIMD2	Malignant cells	GSE115251	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4136
9.75553467904878e-101	0.327751851541697	0.69	0.536	1.83033341648313e-96	DCTN2	Malignant cells	GSE115251	ENSG00000175203	10540	dynactin subunit 2	DCTN-50|RBP50	protein_coding	Q13561	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4137
1.22352387058056e-100	0.281197255176739	0.99	0.981	2.29557548598324e-96	HNRNPU	Malignant cells	GSE115251	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4138
1.41122614054378e-100	-0.300341527985037	0.789	0.896	2.64774248488823e-96	QPRT	Malignant cells	GSE115251	ENSG00000103485	23475	quinolinate phosphoribosyltransferase	QPRTase	protein_coding	Q15274	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4139
1.62787586019829e-100	0.275340772413495	0.375	0.202	3.05422068890403e-96	IFT81	Malignant cells	GSE115251	ENSG00000122970	28981	intraflagellar transport 81	CDV-1R|CDV1|MGC4027	protein_coding	Q8WYA0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4140
1.79065456556822e-100	0.28967795472705	0.469	0.288	3.35962609591909e-96	C12orf29	Malignant cells	GSE115251	ENSG00000133641	91298	chromosome 12 open reading frame 29	DKFZp434N2030	protein_coding	Q8N999	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4141
1.90175131460727e-100	-0.298180644205642	0.346	0.525	3.56806581646616e-96	FOXN3	Malignant cells	GSE115251	ENSG00000053254	1112	forkhead box N3	C14orf116|CHES1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4142
2.97035745310866e-100	0.288438329945072	0.986	0.966	5.57298465352247e-96	SKP1	Malignant cells	GSE115251	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4143
3.37441739423744e-100	-0.328346977667497	0.48	0.641	6.33108191506829e-96	DDR2	Malignant cells	GSE115251	ENSG00000162733	4921	discoidin domain receptor tyrosine kinase 2	NTRKR3|TKT|TYRO10	protein_coding	Q16832	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4144
3.99592210060448e-100	-0.254984808892115	0.163	0.327	7.49714904515413e-96	DPP6	Malignant cells	GSE115251	ENSG00000130226	1804	dipeptidyl peptidase like 6	DPL1|DPPX	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4145
4.04656834340112e-100	0.274937430099935	0.346	0.178	7.59217152588919e-96	PAK1	Malignant cells	GSE115251	ENSG00000149269	5058	p21 (RAC1) activated kinase 1	NA	protein_coding	Q13153	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4146
4.94578895042226e-100	0.268250245443654	0.358	0.188	9.27928922878223e-96	CCS	Malignant cells	GSE115251	ENSG00000173992	9973	copper chaperone for superoxide dismutase	NA	protein_coding	O14618	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4147
6.60522144784606e-100	-0.3109381955192	0.627	0.765	1.23927164804488e-95	HMGXB4	Malignant cells	GSE115251	ENSG00000100281	10042	HMG-box containing 4	HMG2L1|P53N|THC211630	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4148
8.04706966636172e-100	0.279852813079671	0.436	0.258	1.50979121080279e-95	GSS	Malignant cells	GSE115251	ENSG00000100983	2937	glutathione synthetase	NA	protein_coding	P48637	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4149
9.88047701044002e-100	0.320449118323259	0.781	0.652	1.85377509669876e-95	BEX4	Malignant cells	GSE115251	ENSG00000102409	56271	brain expressed X-linked 4	BEXL1|FLJ10097	protein_coding	Q9NWD9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4150
1.50665027778322e-99	-0.300661483862299	0.261	0.435	2.82677725117688e-95	TCEA3	Malignant cells	GSE115251	ENSG00000282941	6920	transcription elongation factor A3	TFIIS.H	protein_coding	O75764	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4151
1.5388785257238e-99	0.28190600783552	0.971	0.953	2.887243889963e-95	SRSF11	Malignant cells	GSE115251	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4152
2.34378413310157e-99	0.32077389149191	0.845	0.741	4.39740779052516e-95	YTHDF2	Malignant cells	GSE115251	ENSG00000198492	51441	YTH N6-methyladenosine RNA binding protein 2	CAHL|HGRG8|NY-REN-2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4153
2.48718594387957e-99	-0.324706501671358	0.648	0.785	4.66645826790686e-95	PSMD7	Malignant cells	GSE115251	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4154
2.85525253111451e-99	-0.332133530172094	0.275	0.451	5.35702479887704e-95	RAMP1	Malignant cells	GSE115251	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4155
2.94644800553651e-99	0.28400807206602	0.374	0.205	5.5281257479876e-95	TMEM19	Malignant cells	GSE115251	ENSG00000139291	55266	transmembrane protein 19	FLJ10936	protein_coding	Q96HH6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4156
4.53819182778908e-99	0.314358913774262	0.638	0.478	8.51455550729787e-95	AC010642.1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4157
9.17995044350074e-99	0.275135741422862	0.399	0.227	1.72234230220961e-94	ILK	Malignant cells	GSE115251	ENSG00000166333	3611	integrin linked kinase	NA	protein_coding	Q13418	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4158
1.25193790975201e-98	0.282191808736548	0.411	0.237	2.34888590627671e-94	SETX	Malignant cells	GSE115251	ENSG00000107290	23064	senataxin	ALS4|AOA2|KIAA0625|SCAR1|Sen1|STEX	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4159
1.40191986001263e-98	0.281026742427083	0.334	0.171	2.63028204135569e-94	UBL3	Malignant cells	GSE115251	ENSG00000122042	5412	ubiquitin like 3	DKFZP434K151|FLJ32018|HCG-1|PNSC1	protein_coding	O95164	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4160
1.7459634964738e-98	0.293519558045156	0.572	0.393	3.27577671208415e-94	PIGH	Malignant cells	GSE115251	ENSG00000100564	5283	phosphatidylinositol glycan anchor biosynthesis class H	GPI-H	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4161
2.09839219416266e-98	0.277313496704217	0.457	0.276	3.93700343468798e-94	CTSD	Malignant cells	GSE115251	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4162
2.32577326622127e-98	-0.279180364083161	0.236	0.407	4.36361580208435e-94	FAM107B	Malignant cells	GSE115251	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4163
2.44507015180969e-98	0.319280364245475	0.636	0.48	4.58744061882535e-94	GOPC	Malignant cells	GSE115251	ENSG00000047932	57120	golgi associated PDZ and coiled-coil motif containing	CAL|dJ94G16.2|FIG|GOPC1|PIST	protein_coding	Q9HD26	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4164
2.52591884105924e-98	-0.274986799655025	0.29	0.467	4.73912892959535e-94	EXOSC7	Malignant cells	GSE115251	ENSG00000075914	23016	exosome component 7	EAP1|hRrp42p|KIAA0116|p8|RRP42|Rrp42p	protein_coding	Q15024	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4165
3.81046673004465e-98	0.316142482019805	0.48	0.308	7.14919767890977e-94	PLXNA1	Malignant cells	GSE115251	ENSG00000114554	5361	plexin A1	NOV|PLXN1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4166
2.67147295955387e-97	-0.257223067417736	0.199	0.366	5.01221756671497e-93	SPG7	Malignant cells	GSE115251	ENSG00000197912	6687	SPG7 matrix AAA peptidase subunit, paraplegin	CAR|CMAR|SPG5C	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4167
3.49034749879833e-97	-0.286635672186748	0.3	0.474	6.54858997724542e-93	SEPHS1	Malignant cells	GSE115251	ENSG00000086475	22929	selenophosphate synthetase 1	SPS|SPS1	protein_coding	P49903	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4168
1.19573764746334e-96	-0.302443601524742	0.377	0.546	2.24344297417072e-92	COPS7A	Malignant cells	GSE115251	ENSG00000111652	50813	COP9 signalosome subunit 7A	CSN7A	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4169
1.4329973668847e-96	0.25988315268229	0.28	0.127	2.68858965974907e-92	ADCK1	Malignant cells	GSE115251	ENSG00000063761	57143	aarF domain containing kinase 1	FLJ39600	protein_coding	Q86TW2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4170
3.39964838450123e-96	0.335224903719985	0.79	0.7	6.3784202990012e-92	RGS10	Malignant cells	GSE115251	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4171
3.60290179461113e-96	0.264145060769245	0.408	0.234	6.75976434704941e-92	DAP	Malignant cells	GSE115251	ENSG00000112977	1611	death associated protein	DAP1	protein_coding	P51397	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4172
3.75651339987365e-96	0.305948560220941	0.87	0.793	7.04797044084294e-92	MRPL42	Malignant cells	GSE115251	ENSG00000198015	28977	mitochondrial ribosomal protein L42	HSPC204|MRP-L31|MRPL31|MRPS32|PTD007|RPML31	protein_coding	Q9Y6G3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4173
3.81490295371773e-96	-0.273679547335899	0.221	0.388	7.15752092176521e-92	APTX	Malignant cells	GSE115251	ENSG00000137074	54840	aprataxin	AOA|AOA1|AXA1|EAOH|EOAHA|FLJ20157	protein_coding	Q7Z2E3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4174
6.23709723315101e-96	0.310249796865421	0.872	0.793	1.17020418288379e-91	MRPS18C	Malignant cells	GSE115251	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4175
7.65731655241968e-96	-0.315839436623563	0.47	0.629	1.43666573156498e-91	EMC8	Malignant cells	GSE115251	ENSG00000131148	10328	ER membrane protein complex subunit 8	C16orf2|C16orf4|COX4NB|FAM158B|NOC4	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4176
1.51868839930885e-95	-0.250036417265562	0.165	0.324	2.84936317478327e-91	NLN	Malignant cells	GSE115251	ENSG00000123213	57486	neurolysin	AGTBP|KIAA1226	protein_coding	Q9BYT8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4177
1.99251293373923e-95	-0.325316107994005	0.727	0.841	3.73835276628154e-91	UFD1L	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4178
2.0685579773167e-95	0.295696483896727	0.544	0.369	3.8810284770416e-91	CCDC104	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4179
2.91605328293016e-95	0.297182123643381	0.893	0.83	5.47109916943357e-91	ZCCHC17	Malignant cells	GSE115251	ENSG00000121766	51538	zinc finger CCHC-type containing 17	HSPC251|pNO40|PS1D	protein_coding	Q9NP64	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4180
3.12633654841394e-95	-0.293128777105797	0.269	0.437	5.86563263213423e-91	ICMT	Malignant cells	GSE115251	ENSG00000116237	23463	isoprenylcysteine carboxyl methyltransferase	HSTE14|PCCMT|PPMT	protein_coding	O60725	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4181
8.72610684172351e-95	-0.263081095913322	0.212	0.378	1.63719216564417e-90	SNAPC3	Malignant cells	GSE115251	ENSG00000164975	6619	small nuclear RNA activating complex polypeptide 3	MGC132011|MGC33124|PTFbeta|SNAP50	protein_coding	Q92966	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4182
8.98396236741399e-95	0.295090146515581	0.569	0.399	1.68557101937421e-90	ZNF75A	Malignant cells	GSE115251	ENSG00000162086	7627	zinc finger protein 75a	FLJ31529	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4183
1.15566144012901e-94	0.290493115985399	0.924	0.883	2.16825199397006e-90	RBM17	Malignant cells	GSE115251	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4184
1.28470565156042e-94	-0.304162479388701	0.753	0.859	2.41036474345766e-90	YDJC	Malignant cells	GSE115251	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4185
2.42418402147072e-94	-0.28649333748538	0.742	0.851	4.54825406108336e-90	HADHA	Malignant cells	GSE115251	ENSG00000084754	3030	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha	GBP|LCEH|LCHAD|MTPA	protein_coding	P40939	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4186
5.1455698286067e-94	0.304264905956067	0.402	0.238	9.65411811243188e-90	PLSCR1	Malignant cells	GSE115251	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4187
5.54978666256262e-94	-0.295729975241556	0.344	0.512	1.04125097363e-89	RARS	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4188
5.85474782667211e-94	0.26758942229886	0.416	0.244	1.09846778724022e-89	TSPAN6	Malignant cells	GSE115251	ENSG00000000003	7105	tetraspanin 6	T245|TM4SF6|TSPAN-6	protein_coding	O43657	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4189
9.19515804157868e-94	-0.25395238330755	0.191	0.355	1.72519555176099e-89	RP11-752G15.6	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4190
1.03920944551009e-93	0.319152067760575	0.503	0.341	1.94976476166604e-89	UCK1	Malignant cells	GSE115251	ENSG00000130717	83549	uridine-cytidine kinase 1	FLJ12255|URK1	protein_coding	Q9HA47	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4191
1.07477417504582e-93	0.308767858887113	0.586	0.424	2.01649130722097e-89	PMPCA	Malignant cells	GSE115251	ENSG00000165688	23203	peptidase, mitochondrial processing subunit alpha	Alpha-MPP|CLA1|INPP5E|KIAA0123|MAS2|SCAR2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4192
1.17415326674358e-93	0.322048699384173	0.686	0.548	2.2029463590643e-89	TMX2	Malignant cells	GSE115251	ENSG00000213593	51075	thioredoxin related transmembrane protein 2	PDIA12|TXNDC14	protein_coding	Q9Y320	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4193
1.22793828966359e-93	0.384894572233261	0.395	0.239	2.30385781906682e-89	HPCA	Malignant cells	GSE115251	ENSG00000121905	3208	hippocalcin	DYT2	protein_coding	P84074	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4194
1.60432037857866e-93	-0.312943295889105	0.531	0.682	3.01002589428928e-89	MSI2	Malignant cells	GSE115251	ENSG00000153944	124540	musashi RNA binding protein 2	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4195
2.04420334794163e-93	-0.323605607803227	0.772	0.884	3.83533432140809e-89	H1F0	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4196
2.16773095484458e-93	-0.272724210186626	0.19	0.351	4.0670968174794e-89	AFMID	Malignant cells	GSE115251	ENSG00000183077	125061	arylformamidase	DKFZp686F03259|KF	protein_coding	Q63HM1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4197
2.5064244496765e-93	-0.297783008611182	0.314	0.481	4.70255355248305e-89	PCOLCE	Malignant cells	GSE115251	ENSG00000106333	5118	procollagen C-endopeptidase enhancer	PCPE|PCPE1	protein_coding	Q15113	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4198
3.0853412754495e-93	0.310458935995583	0.794	0.683	5.78871730099835e-89	NR2F6	Malignant cells	GSE115251	ENSG00000160113	2063	nuclear receptor subfamily 2 group F member 6	EAR-2|EAR2|ERBAL2	protein_coding	P10588	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4199
4.75396711924105e-93	-0.269037285392034	0.912	0.955	8.91939310912007e-89	ATP5A1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4200
5.52027691016852e-93	-0.297131701059769	0.493	0.657	1.03571435388582e-88	ENO2	Malignant cells	GSE115251	ENSG00000111674	2026	enolase 2	NSE	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4201
6.08711534147296e-93	-0.303004621918566	0.272	0.435	1.14206458036716e-88	CEP44	Malignant cells	GSE115251	ENSG00000164118	80817	centrosomal protein 44	KIAA1712	protein_coding	Q9C0F1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4202
6.18089700568122e-93	0.250649275965517	0.967	0.946	1.15965989620591e-88	TUFM	Malignant cells	GSE115251	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4203
8.51318651337147e-93	0.318289351334511	0.887	0.825	1.59724405363876e-88	PGP	Malignant cells	GSE115251	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4204
1.13305580865046e-92	0.298714898672394	0.824	0.731	2.12583930819e-88	GLUL	Malignant cells	GSE115251	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4205
1.43197469396916e-92	-0.290700261305692	0.377	0.543	2.68667092082494e-88	THAP11	Malignant cells	GSE115251	ENSG00000168286	57215	THAP domain containing 11	CTG-B43a|CTG-B45d|HRIHFB2206|RONIN	protein_coding	Q96EK4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4206
2.48000145856786e-92	0.305405109357393	0.454	0.287	4.65297873656502e-88	CDK2AP2	Malignant cells	GSE115251	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4207
3.28788655119253e-92	0.261311717804557	0.957	0.925	6.16873274734743e-88	BRI3	Malignant cells	GSE115251	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4208
5.05104407404539e-92	0.292905138377357	0.552	0.382	9.47676889172396e-88	LZIC	Malignant cells	GSE115251	ENSG00000162441	84328	leucine zipper and CTNNBIP1 domain containing	MGC15436	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4209
8.65431614128614e-92	0.261154851578916	0.971	0.94	1.62372279442811e-87	EMC4	Malignant cells	GSE115251	ENSG00000128463	51234	ER membrane protein complex subunit 4	FLJ90746|MGC24415|PIG17|TMEM85	protein_coding	Q5J8M3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4210
3.09270965445056e-91	0.269264669644153	0.423	0.253	5.80254185368015e-87	NUDT16L1	Malignant cells	GSE115251	ENSG00000168101	84309	nudix hydrolase 16 like 1	SDOS|TIRR	protein_coding	Q9BRJ7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4211
4.39849947512457e-91	0.317436708777233	0.529	0.367	8.25246471522872e-87	PGRMC2	Malignant cells	GSE115251	ENSG00000164040	10424	progesterone receptor membrane component 2	DG6|PMBP	protein_coding	O15173	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4212
5.25498625899707e-91	-0.281121271783871	0.407	0.578	9.8594052191303e-87	PRRT2	Malignant cells	GSE115251	ENSG00000167371	112476	proline rich transmembrane protein 2	DKFZp547J199|DSPB3|DYT10|EKD1|FICCA|FLJ25513|ICCA|IFITMD1|PKC	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4213
5.93709272153585e-91	0.297838973758427	0.512	0.343	1.11391733641456e-86	CCDC112	Malignant cells	GSE115251	ENSG00000164221	153733	coiled-coil domain containing 112	MGC39633	protein_coding	Q8NEF3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4214
6.14163776621504e-91	0.254194621111111	0.976	0.956	1.15229407769727e-86	POLR2I	Malignant cells	GSE115251	ENSG00000105258	5438	RNA polymerase II subunit I	hRPB14.5|RPB9	protein_coding	P36954	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4215
7.1634114134802e-91	0.299590400001218	0.534	0.371	1.34399924939715e-86	RFXANK	Malignant cells	GSE115251	ENSG00000064490	8625	regulatory factor X associated ankyrin containing protein	ANKRA1|BLS|F14150_1|MGC138628|RFX-B	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4216
7.91454065921446e-91	-0.320571945654382	0.564	0.707	1.48492611848182e-86	CENPK	Malignant cells	GSE115251	ENSG00000123219	64105	centromere protein K	CENP-K|FKSG14|SOLT	protein_coding	Q9BS16	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4217
9.39126501871634e-91	-0.258449075047443	0.179	0.335	1.76198914281156e-86	MAGI3	Malignant cells	GSE115251	ENSG00000081026	260425	membrane associated guanylate kinase, WW and PDZ domain containing 3	MAGI-3	protein_coding	Q5TCQ9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4218
9.62654280427872e-91	0.386189110456452	0.535	0.382	1.80613196093877e-86	RP11-395G23.3	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4219
1.07889477222272e-90	0.282450752957032	0.937	0.892	2.02422237164428e-86	DAD1	Malignant cells	GSE115251	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4220
1.25073631024313e-90	0.277274607565976	0.928	0.885	2.34663146527816e-86	PPP1CA	Malignant cells	GSE115251	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4221
1.34202938603859e-90	-0.294538613283017	0.367	0.528	2.5179155340856e-86	AGBL5	Malignant cells	GSE115251	ENSG00000084693	60509	AGBL carboxypeptidase 5	CCP5|FLJ21839	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4222
1.40407293164785e-90	0.263354322340626	0.97	0.942	2.63432163435769e-86	CD63	Malignant cells	GSE115251	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4223
1.71323130834614e-90	0.32421932127618	0.545	0.382	3.21436458071903e-86	FDFT1	Malignant cells	GSE115251	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4224
2.3251731452917e-90	-0.29394851327274	0.892	0.932	4.36248985519628e-86	C3orf14	Malignant cells	GSE115251	ENSG00000114405	57415	chromosome 3 open reading frame 14	HT021	protein_coding	Q9HBI5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4225
2.37572752847274e-90	0.286143786380398	0.416	0.249	4.45733998892056e-86	DNAJB1	Malignant cells	GSE115251	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4226
2.76361160673805e-90	-0.282500429326266	0.265	0.429	5.18508809656194e-86	OSBPL1A	Malignant cells	GSE115251	ENSG00000141447	114876	oxysterol binding protein like 1A	ORP-1|ORP1|OSBPL1B	protein_coding	Q9BXW6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4227
6.11906933767662e-90	0.271430006532553	0.442	0.273	1.14805978913489e-85	DMAP1	Malignant cells	GSE115251	ENSG00000178028	55929	DNA methyltransferase 1 associated protein 1	DNMAP1|DNMTAP1|EAF2|FLJ11543|KIAA1425|MEAF2|SWC4	protein_coding	Q9NPF5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4228
6.18081971225446e-90	0.399589567059929	0.834	0.725	1.15964539441318e-85	SOX11	Malignant cells	GSE115251	ENSG00000176887	6664	SRY-box transcription factor 11	NA	protein_coding	P35716	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4229
7.97393670889718e-90	0.251384520457155	0.334	0.177	1.49607000532329e-85	PPP4R1	Malignant cells	GSE115251	ENSG00000154845	9989	protein phosphatase 4 regulatory subunit 1	PP4R1	protein_coding	Q8TF05	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4230
9.04437731785441e-90	0.268922759782938	0.442	0.271	1.69690607237584e-85	XXYLT1	Malignant cells	GSE115251	ENSG00000173950	152002	xyloside xylosyltransferase 1	C3orf21|FLJ35155	protein_coding	Q8NBI6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4231
1.14968318682965e-89	0.266706917760055	0.435	0.264	2.15703559512979e-85	GLTP	Malignant cells	GSE115251	ENSG00000139433	51228	glycolipid transfer protein	NA	protein_coding	Q9NZD2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4232
1.25981560924844e-89	-0.28564849930257	0.347	0.51	2.36366604607192e-85	ELP6	Malignant cells	GSE115251	ENSG00000163832	54859	elongator acetyltransferase complex subunit 6	C3orf75|FLJ20211|TMEM103	protein_coding	Q0PNE2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4233
1.50895674005423e-89	0.275117633605975	0.427	0.258	2.83110463568975e-85	USP47	Malignant cells	GSE115251	ENSG00000170242	55031	ubiquitin specific peptidase 47	NA	protein_coding	Q96K76	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4234
3.01534361210888e-89	-0.281668130881823	0.283	0.445	5.65738768503868e-85	SMIM4	Malignant cells	GSE115251	ENSG00000168273	440957	small integral membrane protein 4	C3orf78	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4235
4.61638714153345e-89	-0.392644755284528	0.754	0.842	8.66126555494507e-85	CDC42	Malignant cells	GSE115251	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4236
5.20971334918396e-89	0.265301584244503	0.362	0.203	9.77446418573895e-85	RIC3	Malignant cells	GSE115251	ENSG00000166405	79608	RIC3 acetylcholine receptor chaperone	AYST720|FLJ11608|PRO1385	protein_coding	Q7Z5B4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4237
5.47407331932481e-89	0.294966597271132	0.725	0.595	1.02704563617172e-84	COMMD7	Malignant cells	GSE115251	ENSG00000149600	149951	COMM domain containing 7	C20orf92|dJ1085F17.3	protein_coding	Q86VX2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4238
6.6585640581215e-89	-0.288508021785681	0.693	0.811	1.24927978858476e-84	PYCR1	Malignant cells	GSE115251	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4239
1.21905658199314e-88	-0.287170537642528	0.334	0.499	2.28719395913553e-84	GSE1	Malignant cells	GSE115251	ENSG00000131149	23199	Gse1 coiled-coil protein	KIAA0182	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4240
1.24653459373527e-88	0.291144962868645	0.617	0.455	2.3387482047661e-84	GRN	Malignant cells	GSE115251	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4241
1.31265944710679e-88	0.329823745116537	0.819	0.711	2.46281165466175e-84	LINC00682	Malignant cells	GSE115251	ENSG00000245870	101927074	long intergenic non-protein coding RNA 682	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4242
1.70224395170722e-88	0.302676630640229	0.856	0.779	3.19375010219308e-84	ITGAE	Malignant cells	GSE115251	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4243
3.32235769533868e-88	0.256915877223467	0.963	0.933	6.23340750799442e-84	HNRNPK	Malignant cells	GSE115251	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4244
5.81005568174984e-88	0.288621734512904	0.506	0.342	1.0900826470099e-83	BIN1	Malignant cells	GSE115251	ENSG00000136717	274	bridging integrator 1	AMPH2|AMPHL|SH3P9	protein_coding	O00499	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4245
6.54684899736142e-88	0.252518853647856	0.956	0.923	1.22831980888495e-83	WDR83OS	Malignant cells	GSE115251	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4246
9.12215509999034e-88	0.298730678199351	0.821	0.721	1.71149873986019e-83	KDELR1	Malignant cells	GSE115251	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4247
9.63705457209844e-88	-0.267032786598486	0.27	0.435	1.80810417881711e-83	ASPHD1	Malignant cells	GSE115251	ENSG00000174939	253982	aspartate beta-hydroxylase domain containing 1	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4248
1.25909442871875e-87	-0.274663325457117	0.333	0.498	2.36231296716213e-83	SOD2	Malignant cells	GSE115251	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4249
1.36103358580834e-87	0.263678850419938	0.358	0.201	2.5535712136936e-83	ZDHHC24	Malignant cells	GSE115251	ENSG00000174165	254359	zinc finger DHHC-type containing 24	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4250
2.3387424704406e-87	-0.25094085702076	0.204	0.362	4.38794862304065e-83	LINC01003	Malignant cells	GSE115251	ENSG00000261455	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4251
2.50877422131826e-87	-0.286136305973708	0.419	0.578	4.70696219403732e-83	CD27-AS1	Malignant cells	GSE115251	ENSG00000215039	678655	CD27 antisense RNA 1	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4252
2.52280000498553e-87	-0.277424336074639	0.313	0.474	4.73327736935385e-83	ZDHHC3	Malignant cells	GSE115251	ENSG00000163812	51304	zinc finger DHHC-type palmitoyltransferase 3	DHHC3|GODZ|ZNF373	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4253
2.61115589518644e-87	-0.281893734329697	0.438	0.6	4.89905069054881e-83	AKAP1	Malignant cells	GSE115251	ENSG00000121057	8165	A-kinase anchoring protein 1	AKAP121|AKAP149|AKAP84|D-AKAP1|PPP1R43|PRKA1|S-AKAP84|SAKAP84|TDRD17	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4254
3.44319411822652e-87	0.272489469295017	0.405	0.244	6.4601208046166e-83	TP53RK	Malignant cells	GSE115251	ENSG00000172315	112858	TP53 regulating kinase	BUD32|C20orf64|dJ101A2.2|Nori-2p|prpk|TPRKB	protein_coding	Q96S44	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4255
6.09446000769336e-87	0.287141437794843	0.615	0.45	1.14344258664343e-82	PPP1R12A	Malignant cells	GSE115251	ENSG00000058272	4659	protein phosphatase 1 regulatory subunit 12A	M130|MBS|MYPT1	protein_coding	O14974	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4256
6.18433556654605e-87	0.255598997346633	0.968	0.94	1.16030503899537e-82	DPY30	Malignant cells	GSE115251	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4257
9.53152638501619e-87	0.321706776870351	0.58	0.421	1.78830498035674e-82	KHDRBS3	Malignant cells	GSE115251	ENSG00000131773	10656	KH RNA binding domain containing, signal transduction associated 3	Etle|etoile|SALP|SLM-2|SLM2|T-STAR	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4258
1.06106011759454e-86	-0.256127492950295	0.242	0.402	1.99076099263087e-82	RP11-792A8.4	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4259
1.15129212655704e-86	0.283472372241892	0.508	0.342	2.16005428784631e-82	AHI1	Malignant cells	GSE115251	ENSG00000135541	54806	Abelson helper integration site 1	FLJ20069|JBTS3|ORF1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4260
1.28403045888101e-86	0.381782485406051	0.717	0.62	2.40909794695255e-82	ZWINT	Malignant cells	GSE115251	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4261
2.6380720470722e-86	-0.273440085275522	0.323	0.486	4.94955077471687e-82	ZC3H18	Malignant cells	GSE115251	ENSG00000158545	124245	zinc finger CCCH-type containing 18	NHN1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4262
3.11371196619464e-86	0.277354760466857	0.925	0.877	5.84194639097439e-82	POLR2K	Malignant cells	GSE115251	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4263
3.19658180871737e-86	0.318198024562284	0.559	0.401	5.99742678951554e-82	MCC	Malignant cells	GSE115251	ENSG00000171444	4163	MCC regulator of WNT signaling pathway	NA	protein_coding	P23508	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4264
3.41537734051935e-86	0.292749472013538	0.586	0.424	6.40793096628241e-82	EMC3	Malignant cells	GSE115251	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4265
3.98221057508166e-86	0.280233263004649	0.92	0.875	7.47142348096822e-82	METTL5	Malignant cells	GSE115251	ENSG00000138382	29081	methyltransferase 5, N6-adenosine	HSPC133	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4266
4.24872322386777e-86	0.276224265210784	0.469	0.307	7.97145451262071e-82	PGAM5	Malignant cells	GSE115251	ENSG00000247077	192111	PGAM family member 5, mitochondrial serine/threonine protein phosphatase	BXLBv68|MGC5352	protein_coding	Q96HS1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4267
4.60921873146128e-86	-0.289458492513195	0.577	0.718	8.64781618396766e-82	GBAS	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4268
2.6850674112683e-85	0.288941654802628	0.641	0.488	5.03772347702159e-81	MESDC2	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4269
3.12992426890039e-85	0.303619338522482	0.733	0.607	5.87236391331091e-81	FAM50A	Malignant cells	GSE115251	ENSG00000071859	9130	family with sequence similarity 50 member A	9F|DXS9928E|HXC-26|XAP5	protein_coding	Q14320	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4270
3.65329401508893e-85	0.271001090995177	0.968	0.934	6.85431023110986e-81	PSMB2	Malignant cells	GSE115251	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4271
4.36164945174226e-85	-0.29202300724292	0.484	0.628	8.18332670135883e-81	MRPS25	Malignant cells	GSE115251	ENSG00000131368	64432	mitochondrial ribosomal protein S25	DKFZp313H0817|FLJ00023|MRP-S25|RPMS25	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4272
6.04560715313533e-85	0.280466242860772	0.499	0.335	1.13427681407125e-80	RNF34	Malignant cells	GSE115251	ENSG00000170633	80196	ring finger protein 34	FLJ21786|RIF|RIFF	protein_coding	Q969K3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4273
1.75289947459986e-84	0.304003848602583	0.585	0.437	3.28878999424426e-80	TSEN54	Malignant cells	GSE115251	ENSG00000182173	283989	tRNA splicing endonuclease subunit 54	SEN54|SEN54L	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4274
1.91843232600593e-84	0.287864695181933	0.592	0.434	3.59936273005233e-80	BRD9	Malignant cells	GSE115251	ENSG00000028310	65980	bromodomain containing 9	FLJ13441|SMARCI2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4275
2.84029019300895e-84	0.294449366351056	0.702	0.562	5.32895246012339e-80	EHMT1	Malignant cells	GSE115251	ENSG00000181090	79813	euchromatic histone lysine methyltransferase 1	bA188C12.1|EHMT1-IT1|Eu-HMTase1|FLJ12879|FLJ40292|GLP|KIAA1876|KMT1D	protein_coding	Q9H9B1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4276
2.92668271302032e-84	-0.285806263826939	0.44	0.59	5.49104210616873e-80	AIDA	Malignant cells	GSE115251	ENSG00000186063	64853	axin interactor, dorsalization associated	C1orf80|FLJ12806	protein_coding	Q96BJ3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4277
3.10365282775801e-84	0.316770384435505	0.593	0.442	5.82307343543957e-80	TEX30	Malignant cells	GSE115251	ENSG00000151287	93081	testis expressed 30	C13orf27	protein_coding	Q5JUR7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4278
5.36710191060432e-84	-0.283434722583727	0.593	0.726	1.00697566046758e-79	CTD-2314B22.3	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4279
8.80620853793726e-84	-0.271920543312327	0.577	0.72	1.65222084588779e-79	GTF2H5	Malignant cells	GSE115251	ENSG00000272047	404672	general transcription factor IIH subunit 5	bA120J8.2|C6orf175|FLJ30544|TFB5|TFIIH|TTD|TTD-A|TTDA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4280
1.21330741427711e-83	0.295656303052623	0.803	0.703	2.27640737066672e-79	TXNRD1	Malignant cells	GSE115251	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4281
1.4204195048868e-83	-0.292436157271976	0.54	0.67	2.66499107506861e-79	SNX17	Malignant cells	GSE115251	ENSG00000115234	9784	sorting nexin 17	KIAA0064	protein_coding	Q15036	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4282
2.11076448078677e-83	0.310264665644403	0.438	0.282	3.96021631885214e-79	PCGF5	Malignant cells	GSE115251	ENSG00000180628	84333	polycomb group ring finger 5	MGC16202|RNF159	protein_coding	Q86SE9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4283
2.12046192656158e-83	0.261131094562125	0.455	0.29	3.97841066661483e-79	PTPN2	Malignant cells	GSE115251	ENSG00000175354	5771	protein tyrosine phosphatase non-receptor type 2	PTPT|TC-PTP|TCELLPTP|TCPTP	protein_coding	P17706	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4284
2.18994565147363e-83	-0.281006528787423	0.349	0.506	4.10877603129482e-79	DYNC1LI2	Malignant cells	GSE115251	ENSG00000135720	1783	dynein cytoplasmic 1 light intermediate chain 2	DNCLI2	protein_coding	O43237	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4285
3.48676003160829e-83	-0.299469739663299	0.624	0.745	6.54185917130348e-79	ITPA	Malignant cells	GSE115251	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4286
4.13907779744662e-83	0.255484215373611	0.369	0.214	7.76573776356936e-79	ARID3B	Malignant cells	GSE115251	ENSG00000179361	10620	AT-rich interaction domain 3B	BDP|DRIL2	protein_coding	Q8IVW6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4287
5.09045992567145e-83	-0.26346026742248	0.995	0.999	9.55072091254478e-79	EIF4A1	Malignant cells	GSE115251	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4288
6.3845009115492e-83	0.412437328037337	0.654	0.529	1.19786006102486e-78	PDIA4	Malignant cells	GSE115251	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4289
7.33610947434031e-83	0.26753823673568	0.527	0.365	1.37640085957573e-78	RAB21	Malignant cells	GSE115251	ENSG00000080371	23011	RAB21, member RAS oncogene family	KIAA0118	protein_coding	Q9UL25	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4290
7.51772859116593e-83	0.304905409059208	0.814	0.713	1.41047623827455e-78	PLEKHO1	Malignant cells	GSE115251	ENSG00000023902	51177	pleckstrin homology domain containing O1	CKIP-1|OC120	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4291
8.24297527486558e-83	-0.280743192688922	0.516	0.665	1.54654702107028e-78	AMD1	Malignant cells	GSE115251	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4292
8.96402464572755e-83	-0.284271673226291	0.527	0.671	1.6818303040314e-78	ARF4	Malignant cells	GSE115251	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4293
1.04874551646718e-82	-0.298170212286877	0.606	0.725	1.96765633799572e-78	CLTB	Malignant cells	GSE115251	ENSG00000175416	1212	clathrin light chain B	Lcb	protein_coding	P09497	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4294
1.27875317342737e-82	0.314636974812567	0.381	0.228	2.39919670398444e-78	TOB1	Malignant cells	GSE115251	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4295
1.46701991069153e-82	0.267082497387247	0.509	0.345	2.75242275643945e-78	CD2BP2	Malignant cells	GSE115251	ENSG00000169217	10421	CD2 cytoplasmic tail binding protein 2	LIN1|PPP1R59|Snu40|U5-52K	protein_coding	O95400	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4296
1.78341838362077e-82	0.291933438841487	0.639	0.494	3.34604957134929e-78	TSTA3	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4297
4.40497275087735e-82	0.284671927467067	0.673	0.533	8.26460987519608e-78	FES	Malignant cells	GSE115251	ENSG00000182511	2242	FES proto-oncogene, tyrosine kinase	FPS	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4298
5.15209938664626e-82	0.305050928913389	0.642	0.493	9.66636886922571e-78	LINC00657	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4299
5.3810092658483e-82	0.291329529183995	0.678	0.532	1.00958495845846e-77	MARCH6	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4300
5.83849141009693e-82	-0.268971748363363	0.387	0.546	1.09541775836239e-77	TMEM18	Malignant cells	GSE115251	ENSG00000151353	129787	transmembrane protein 18	DKFZp434C1714|lncND	protein_coding	Q96B42	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4301
7.36976498458838e-82	-0.256995507448449	0.5	0.694	1.38271530640847e-77	TFAP2B	Malignant cells	GSE115251	ENSG00000008196	7021	transcription factor AP-2 beta	AP-2beta|AP2-B	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4302
8.05721417584393e-82	-0.25502924904361	0.211	0.365	1.51169452367184e-77	ZNF503	Malignant cells	GSE115251	ENSG00000165655	84858	zinc finger protein 503	FLJ45745|MGC2555|Nlz2	protein_coding	Q96F45	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4303
8.93470114057361e-82	0.296730595518334	0.585	0.441	1.67632862799442e-77	RABIF	Malignant cells	GSE115251	ENSG00000183155	5877	RAB interacting factor	mss4|RASGRF3	protein_coding	P47224	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4304
1.21903382853947e-81	0.312244594643455	0.297	0.157	2.28715126910575e-77	ANK2	Malignant cells	GSE115251	ENSG00000145362	287	ankyrin 2	CFAP87|FAP87|LQT4	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4305
1.53436516513551e-81	-0.294518824523583	0.698	0.803	2.87877592282725e-77	CENPM	Malignant cells	GSE115251	ENSG00000100162	79019	centromere protein M	C22orf18|CENP-M|MGC861|Pane1	protein_coding	Q9NSP4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4306
1.9598170207572e-81	-0.250329231977403	0.24	0.394	3.67700869434467e-77	AP2A1	Malignant cells	GSE115251	ENSG00000196961	160	adaptor related protein complex 2 subunit alpha 1	ADTAA|CLAPA1	protein_coding	O95782	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4307
1.99528704518722e-81	-0.255119337278528	0.895	0.943	3.74355755418025e-77	BID	Malignant cells	GSE115251	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4308
2.73947884110096e-81	0.294171985821264	0.918	0.88	5.13981020167363e-77	PPIB	Malignant cells	GSE115251	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4309
3.26059092901422e-81	-0.289980580732908	0.51	0.646	6.11752070101647e-77	VPS35	Malignant cells	GSE115251	ENSG00000069329	55737	VPS35 retromer complex component	FLJ10752|MEM3|PARK17	protein_coding	Q96QK1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4310
3.53686486589629e-81	0.293344624497076	0.86	0.786	6.63586586139462e-77	RSRC2	Malignant cells	GSE115251	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4311
4.69001629444493e-81	-0.269107809307962	0.353	0.512	8.79940857163757e-77	PSMG4	Malignant cells	GSE115251	ENSG00000180822	389362	proteasome assembly chaperone 4	C6orf86|PAC4	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4312
4.81362652251252e-81	0.293212335989161	0.809	0.718	9.03132608153799e-77	CELF1	Malignant cells	GSE115251	ENSG00000149187	10658	CUGBP Elav-like family member 1	BRUNOL2|CUG-BP|CUGBP|CUGBP1|EDEN-BP|hNab50|NAB50|NAPOR	protein_coding	Q92879	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4313
5.10632775671408e-81	-0.28059726119784	0.403	0.555	9.58049213714696e-77	HEATR2	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4314
9.43675732340478e-81	0.307467855979517	0.515	0.365	1.7705244090172e-76	RRM1	Malignant cells	GSE115251	ENSG00000167325	6240	ribonucleotide reductase catalytic subunit M1	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4315
1.00593474478484e-80	0.278651394411265	0.491	0.332	1.88733476816532e-76	OSER1	Malignant cells	GSE115251	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4316
2.47786862018269e-80	0.5404346816244	0.902	0.895	4.64897710518677e-76	CCND1	Malignant cells	GSE115251	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4317
2.55255289966679e-80	0.280042733002832	0.615	0.466	4.78909975035484e-76	SCOC	Malignant cells	GSE115251	ENSG00000153130	60592	short coiled-coil protein	HRIHFB2072|SCOCO|UNC-69	protein_coding	Q9UIL1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4318
3.23153979686408e-80	0.265561816996431	0.863	0.781	6.06301496687639e-76	NOSIP	Malignant cells	GSE115251	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4319
4.10234916583291e-80	0.286901502195782	0.613	0.468	7.69682750493571e-76	FRG1	Malignant cells	GSE115251	ENSG00000275145	2483	FSHD region gene 1	FRG1A|FSG1	protein_coding	Q14331	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4320
8.59713995243304e-80	0.250970628381518	0.407	0.249	1.61299539787549e-75	TMBIM4.1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4321
1.13505983866046e-79	0.441817365362137	0.727	0.641	2.12959926929475e-75	SVIP	Malignant cells	GSE115251	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4322
1.20767913561214e-79	-0.268861008112559	0.695	0.798	2.2658475942355e-75	DGCR6L	Malignant cells	GSE115251	ENSG00000128185	85359	DiGeorge syndrome critical region gene 6 like	FLJ10666	protein_coding	Q9BY27	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4323
1.49883332551931e-79	-0.29430619749758	0.872	0.938	2.81211108533933e-75	TUBB2B	Malignant cells	GSE115251	ENSG00000137285	347733	tubulin beta 2B class IIb	bA506K6.1|DKFZp566F223|MGC8685	protein_coding	Q9BVA1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4324
1.60784389335588e-79	0.268141414177825	0.918	0.872	3.01663671271429e-75	C19orf10	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4325
2.60046386688749e-79	0.272171072557838	0.581	0.429	4.8789903070543e-75	CCDC23	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4326
9.50376768261341e-79	0.261340542540079	0.505	0.346	1.78309689261193e-74	MSRB1	Malignant cells	GSE115251	ENSG00000198736	51734	methionine sulfoxide reductase B1	SELENOR|SELENOX|SelR|SelX|SepR|SEPX1	protein_coding	Q9NZV6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4327
1.48234746087369e-78	0.277331766414042	0.628	0.483	2.78118030609122e-74	RNF10	Malignant cells	GSE115251	ENSG00000022840	9921	ring finger protein 10	KIAA0262|RIE2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4328
1.91542001865571e-78	0.274606288806825	0.869	0.807	3.59371103900185e-74	MALSU1	Malignant cells	GSE115251	ENSG00000156928	115416	mitochondrial assembly of ribosomal large subunit 1	C7orf30|mtRsfA	protein_coding	Q96EH3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4329
2.85626417724943e-78	0.253402587238055	0.376	0.225	5.35892284935538e-74	NUCB2	Malignant cells	GSE115251	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4330
2.98313626422273e-78	0.28945398508763	0.763	0.658	5.59696025893469e-74	SEC11C	Malignant cells	GSE115251	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4331
3.73397480943712e-78	0.267100292973751	0.858	0.782	7.00568353746592e-74	RNF5	Malignant cells	GSE115251	ENSG00000223767	6048	ring finger protein 5	G16|NG2|RING5|RMA1	protein_coding	Q99942	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4332
5.60630895355677e-78	0.26489814527632	0.955	0.92	1.05185568586632e-73	ADRM1	Malignant cells	GSE115251	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4333
7.46410326427781e-78	0.253124807849154	0.922	0.882	1.4004150544438e-73	TCEAL4	Malignant cells	GSE115251	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4334
9.4687484931198e-78	0.307259134964905	0.73	0.614	1.77652659227914e-73	STIP1	Malignant cells	GSE115251	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4335
1.46197235503702e-77	0.253357937610395	0.988	0.975	2.74295253252046e-73	COX17	Malignant cells	GSE115251	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4336
3.23193655819992e-77	0.261312119601443	0.952	0.924	6.06375937049469e-73	EIF4G2	Malignant cells	GSE115251	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4337
3.70895692691479e-77	0.253603159692883	0.938	0.898	6.95874498627753e-73	TRIM28	Malignant cells	GSE115251	ENSG00000130726	10155	tripartite motif containing 28	KAP-1|KAP1|PPP1R157|RNF96|TF1B|TIF1-beta|TIF1B|TIF1beta	protein_coding	Q13263	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4338
4.50010704485017e-77	-0.275535810848625	0.474	0.611	8.44310083754788e-73	PES1	Malignant cells	GSE115251	ENSG00000100029	23481	pescadillo ribosomal biogenesis factor 1	NOP7|PES	protein_coding	O00541	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4339
4.73361773374187e-77	0.254656120785309	0.501	0.341	8.88121359204649e-73	ANAPC7	Malignant cells	GSE115251	ENSG00000196510	51434	anaphase promoting complex subunit 7	APC7	protein_coding	Q9UJX3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4340
4.87550766729427e-77	0.250887026930422	0.348	0.2	9.14742748537751e-73	SRGAP1	Malignant cells	GSE115251	ENSG00000196935	57522	SLIT-ROBO Rho GTPase activating protein 1	ARHGAP13|KIAA1304	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4341
6.44653600868531e-77	0.250924863226028	0.447	0.291	1.20949908594954e-72	BSDC1	Malignant cells	GSE115251	ENSG00000160058	55108	BSD domain containing 1	FLJ10276|RP4-811H24.7	protein_coding	Q9NW68	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4342
7.04238928642391e-77	0.260654873981161	0.555	0.399	1.32129307791885e-72	PIGT	Malignant cells	GSE115251	ENSG00000124155	51604	phosphatidylinositol glycan anchor biosynthesis class T	NA	protein_coding	Q969N2	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4343
1.49072180857532e-76	0.279413301757141	0.797	0.703	2.79689225724902e-72	MAF1	Malignant cells	GSE115251	ENSG00000179632	84232	MAF1 homolog, negative regulator of RNA polymerase III	DKFZp586G1123	protein_coding	Q9H063	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4344
4.28402856206672e-76	0.291514817725375	0.672	0.542	8.03769438814958e-72	NSRP1	Malignant cells	GSE115251	ENSG00000126653	84081	nuclear speckle splicing regulatory protein 1	CCDC55|DKFZP434K1421|NSrp70	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4345
1.39606351476562e-75	-0.258451970058961	0.376	0.53	2.61929436640326e-71	GRHPR	Malignant cells	GSE115251	ENSG00000137106	9380	glyoxylate and hydroxypyruvate reductase	GLXR|PH2	protein_coding	Q9UBQ7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4346
3.83807000323864e-75	-0.278475121883776	0.515	0.649	7.20098694007634e-71	MIEF1	Malignant cells	GSE115251	ENSG00000100335	54471	mitochondrial elongation factor 1	FLJ20232|L0R8F8|MiD51|SMCR7L	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4347
4.07347658793499e-75	0.252419704842675	0.411	0.261	7.64265677428363e-71	ORMDL2	Malignant cells	GSE115251	ENSG00000123353	29095	ORMDL sphingolipid biosynthesis regulator 2	adoplin-2|HSPC160|MST095|MSTP095	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4348
4.10820515697236e-75	-0.2503393601398	0.282	0.432	7.70781451551155e-71	TMEM243	Malignant cells	GSE115251	ENSG00000135185	79161	transmembrane protein 243	C7orf23|MGC4175|MM-TRAG	protein_coding	Q9BU79	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4349
4.11101858081299e-75	0.275688581872766	0.574	0.425	7.71309306132132e-71	NFE2L2	Malignant cells	GSE115251	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4350
4.83733138241005e-75	0.269389622879661	0.645	0.508	9.07580113967774e-71	ECHS1	Malignant cells	GSE115251	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4351
5.06672298835781e-75	-0.267977558072363	0.748	0.839	9.50618567075692e-71	MKKS	Malignant cells	GSE115251	ENSG00000125863	8195	MKKS centrosomal shuttling protein	BBS6|HMCS|KMS|MKS	protein_coding	Q9NPJ1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4352
6.84907933510715e-75	0.271121329822759	0.488	0.338	1.2850242648528e-70	GUSB	Malignant cells	GSE115251	ENSG00000169919	2990	glucuronidase beta	NA	protein_coding	P08236	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4353
6.96815491581565e-75	-0.25441095852677	0.187	0.327	1.30736522530533e-70	ALCAM	Malignant cells	GSE115251	ENSG00000170017	214	activated leukocyte cell adhesion molecule	CD166|MEMD	protein_coding	Q13740	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4354
3.77557156796425e-74	0.270021475361508	0.646	0.507	7.08372737581452e-70	TIMM22	Malignant cells	GSE115251	ENSG00000278501	29928	translocase of inner mitochondrial membrane 22	TEX4|TIM22	protein_coding	Q9Y584	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4355
3.81430846819618e-74	0.260392685947073	0.794	0.692	7.15640554802967e-70	ZNHIT3	Malignant cells	GSE115251	ENSG00000278574	9326	zinc finger HIT-type containing 3	Hit1|TRIP3	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4356
5.71072197205507e-74	0.279655690477419	0.704	0.575	1.07144565639697e-69	SBNO1	Malignant cells	GSE115251	ENSG00000139697	55206	strawberry notch homolog 1	FLJ10701|FLJ10833|MOP3|Sno	protein_coding	A3KN83	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4357
6.51933974605753e-74	0.308669708235321	0.901	0.885	1.22315852315531e-69	DTYMK	Malignant cells	GSE115251	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4358
1.13118212085825e-73	0.274269976896866	0.751	0.638	2.12232389515424e-69	TARS	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4359
1.17408068637572e-73	0.264265053517779	0.55	0.4	2.20281018377813e-69	ZNF787	Malignant cells	GSE115251	ENSG00000142409	126208	zinc finger protein 787	NA	protein_coding	Q6DD87	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4360
3.39098725302262e-73	0.258237423591018	0.295	0.162	6.36217028412103e-69	GFRA1	Malignant cells	GSE115251	ENSG00000151892	2674	GDNF family receptor alpha 1	GDNFR|GDNFRA|GFR-ALPHA-1|RET1L|RETL1|TRNR1	protein_coding	P56159	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4361
6.29848842923658e-73	-0.250792423932418	0.326	0.474	1.18172239909337e-68	GAGE12J	Malignant cells	GSE115251	ENSG00000224659	729396	G antigen 12J	GAGE11|OTTHUMG00000024137	protein_coding	A6NER3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4362
6.46192902425753e-73	0.275758996252179	0.521	0.373	1.2123871235312e-68	SMCHD1	Malignant cells	GSE115251	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4363
8.84820944834424e-73	0.355349567930415	0.931	0.899	1.66010105669835e-68	CALR	Malignant cells	GSE115251	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4364
1.68597948332202e-72	-0.25017460635451	0.355	0.506	3.16323470660878e-68	LYRM1	Malignant cells	GSE115251	ENSG00000102897	57149	LYR motif containing 1	A211C6.1	protein_coding	O43325	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4365
2.01039005029488e-72	0.262096248241296	0.567	0.422	3.77189381236326e-68	SEPHS2	Malignant cells	GSE115251	ENSG00000179918	22928	selenophosphate synthetase 2	SPS2|SPS2b	protein_coding	Q99611	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4366
2.5072522631942e-72	-0.281349479742719	0.458	0.597	4.70410669620495e-68	HIF1A	Malignant cells	GSE115251	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4367
3.07421949660633e-72	-0.253940662813628	0.333	0.48	5.7678506195328e-68	PEX2	Malignant cells	GSE115251	ENSG00000164751	5828	peroxisomal biogenesis factor 2	PAF-1|PMP35|PXMP3|RNF72|ZWS3	protein_coding	P28328	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4368
3.29944798574888e-72	0.271557452945109	0.821	0.735	6.19042431086204e-68	CHD7	Malignant cells	GSE115251	ENSG00000171316	55636	chromodomain helicase DNA binding protein 7	CRG|FLJ20357|FLJ20361|KIAA1416	protein_coding	Q9P2D1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4369
3.78246465241843e-72	-0.502428932186882	0.411	0.549	7.09666018086745e-68	CTNNB1	Malignant cells	GSE115251	ENSG00000168036	1499	catenin beta 1	armadillo|beta-catenin|CTNNB	protein_coding	P35222	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4370
3.94129851346092e-72	0.254471392243978	0.449	0.3	7.39466427095538e-68	DNAJC5	Malignant cells	GSE115251	ENSG00000101152	80331	DnaJ heat shock protein family (Hsp40) member C5	CLN4|DNAJC5A|FLJ00118|FLJ13070	protein_coding	Q9H3Z4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4371
5.62217020240344e-72	0.256037265901136	0.516	0.366	1.05483157337493e-67	CPSF4	Malignant cells	GSE115251	ENSG00000160917	10898	cleavage and polyadenylation specific factor 4	CPSF30|NAR	protein_coding	O95639	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4372
5.67935671429324e-72	-0.266352620574409	0.517	0.65	1.0655609067357e-67	WDR45B	Malignant cells	GSE115251	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4373
7.58792340325851e-72	-0.279499970079553	0.67	0.774	1.42364618891936e-67	C6orf48	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4374
8.60390116714022e-72	0.306369126622086	0.316	0.18	1.61426393697885e-67	DCX	Malignant cells	GSE115251	ENSG00000077279	1641	doublecortin	DBCN|DC|LISX|SCLH|XLIS	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4375
1.23486670128421e-71	0.265959969993549	0.589	0.445	2.31685690494943e-67	THAP9-AS1	Malignant cells	GSE115251	ENSG00000251022	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4376
1.60805030296412e-71	-0.275399566463126	0.513	0.638	3.01702397842128e-67	GNB2	Malignant cells	GSE115251	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4377
3.39697197222769e-71	-0.285599561380683	0.425	0.576	6.37339881429359e-67	MCM5	Malignant cells	GSE115251	ENSG00000100297	4174	minichromosome maintenance complex component 5	CDC46	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4378
4.3031889245002e-71	0.276033594190352	0.743	0.642	8.07364306014728e-67	CNRIP1	Malignant cells	GSE115251	ENSG00000119865	25927	cannabinoid receptor interacting protein 1	C2orf32|CRIP1|CRIP1a|CRIP1b|DKFZP566K1924	protein_coding	Q96F85	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4379
8.12986949742381e-71	-0.273714943501322	0.385	0.53	1.52532611510666e-66	TPM4	Malignant cells	GSE115251	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4380
9.00082076924986e-71	0.335794088120964	0.708	0.614	1.68873399272666e-66	RNASEH2B	Malignant cells	GSE115251	ENSG00000136104	79621	ribonuclease H2 subunit B	AGS2|DLEU8|FLJ11712	protein_coding	Q5TBB1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4381
1.17530327903164e-70	-0.290520679342283	0.642	0.754	2.20510401211916e-66	TNRC6B	Malignant cells	GSE115251	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4382
1.36840680489216e-70	-0.254356398025747	0.359	0.505	2.56740484733867e-66	RBM6	Malignant cells	GSE115251	ENSG00000004534	10180	RNA binding motif protein 6	3G2|DEF-3|DEF3|g16|NY-LU-12	protein_coding	P78332	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4383
1.71617560040716e-70	0.305309965301519	0.407	0.265	3.21988866148392e-66	LINC01116	Malignant cells	GSE115251	ENSG00000163364	NA	NA	TALNEC2	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4384
2.41473443033057e-70	-0.264957592863849	0.499	0.63	4.53052473818621e-66	NOL12	Malignant cells	GSE115251	ENSG00000273899	79159	nucleolar protein 12	MGC3731|Nop25|RRP17	protein_coding	Q9UGY1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4385
2.55652011392029e-70	0.264950039938407	0.564	0.42	4.79654303773725e-66	HDAC1	Malignant cells	GSE115251	ENSG00000116478	3065	histone deacetylase 1	GON-10|HD1|KDAC1|RPD3L1	protein_coding	Q13547	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4386
3.4999367329512e-70	0.256189606922813	0.58	0.436	6.56658129836305e-66	SMARCC2	Malignant cells	GSE115251	ENSG00000139613	6601	SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2	BAF170|CRACC2|Rsc8	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4387
3.99238260460713e-70	0.259064558594459	0.634	0.498	7.49050824276391e-66	FBXW5	Malignant cells	GSE115251	ENSG00000159069	54461	F-box and WD repeat domain containing 5	DKFZP434B205|Fbw5|MGC20962	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4388
1.35852024320312e-69	0.250919920407214	0.524	0.377	2.5488556802977e-65	FBXO9	Malignant cells	GSE115251	ENSG00000112146	26268	F-box protein 9	FBX9|NY-REN-57	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4389
1.45346194169221e-69	0.349223152505862	0.783	0.739	2.72698529500292e-65	CENPU	Malignant cells	GSE115251	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4390
1.69724159270752e-69	-0.25374441016689	0.339	0.481	3.18436467623785e-65	ABHD14A	Malignant cells	GSE115251	ENSG00000248487	25864	abhydrolase domain containing 14A	DKFZP564O243|DORZ1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4391
2.15731234354372e-69	0.267222271438536	0.796	0.71	4.04754941895674e-65	FADS1	Malignant cells	GSE115251	ENSG00000149485	3992	fatty acid desaturase 1	D5D|FADS6|FADSD5|LLCDL1|TU12	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4392
2.37542748628566e-69	-0.250515610556884	0.782	0.871	4.45677704976915e-65	UBE2R2	Malignant cells	GSE115251	ENSG00000107341	54926	ubiquitin conjugating enzyme E2 R2	CDC34B|FLJ20419|MGC10481|UBC3B	protein_coding	Q712K3	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4393
3.46511214215341e-69	0.260456862588484	0.766	0.666	6.50124340110823e-65	TFG	Malignant cells	GSE115251	ENSG00000114354	10342	trafficking from ER to golgi regulator	FLJ36137|SPG57|TF6	protein_coding	Q92734	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4394
3.76004796942642e-69	0.278015400833271	0.807	0.729	7.05460200023785e-65	ACLY	Malignant cells	GSE115251	ENSG00000131473	47	ATP citrate lyase	ACL|ATPCL|CLATP	protein_coding	P53396	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4395
4.06569590372669e-69	0.258351620443143	0.733	0.625	7.62805865457202e-65	SRP19	Malignant cells	GSE115251	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4396
4.08748739924686e-69	0.260108863522096	0.473	0.33	7.66894385846695e-65	ILKAP	Malignant cells	GSE115251	ENSG00000132323	80895	ILK associated serine/threonine phosphatase	DKFZP434J2031|FLJ10181|PPM1O	protein_coding	Q9H0C8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4397
1.18225294014248e-68	0.262961777731622	0.96	0.937	2.21814296629533e-64	HNRNPM	Malignant cells	GSE115251	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4398
1.70906279939781e-68	0.285882844879608	0.716	0.607	3.20654362423018e-64	KLHL23	Malignant cells	GSE115251	ENSG00000213160	151230	kelch like family member 23	FLJ37812|MGC22679|MGC2610	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4399
1.89058457349026e-68	-0.256263705049732	0.556	0.681	3.54711477678242e-64	MRPL24	Malignant cells	GSE115251	ENSG00000143314	79590	mitochondrial ribosomal protein L24	MRP-L18	protein_coding	Q96A35	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4400
3.10491852711991e-68	-0.250553236726098	0.391	0.534	5.82544814058237e-64	HGS	Malignant cells	GSE115251	ENSG00000185359	9146	hepatocyte growth factor-regulated tyrosine kinase substrate	Hrs|Vps27|ZFYVE8	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4401
4.30133892983053e-68	0.253153882635925	0.537	0.391	8.07017210014804e-64	CMTM6	Malignant cells	GSE115251	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4402
6.68169266288898e-68	0.275808677606862	0.631	0.505	1.25361917741123e-63	C12orf45	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4403
7.59115512121996e-68	0.278156583509904	0.449	0.308	1.42425252384329e-63	BRI3BP	Malignant cells	GSE115251	ENSG00000184992	140707	BRI3 binding protein	BNAS1|HCCR-2|HCCRBP-3|KG19	protein_coding	Q8WY22	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4404
1.23989985254203e-67	0.259869431057689	0.749	0.635	2.32630010333935e-63	SLC25A36	Malignant cells	GSE115251	ENSG00000114120	55186	solute carrier family 25 member 36	FLJ10618|PNC2	protein_coding	Q96CQ1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4405
1.88812468762688e-67	0.26382907781153	0.68	0.558	3.54249953892555e-63	SNRNP40	Malignant cells	GSE115251	ENSG00000060688	9410	small nuclear ribonucleoprotein U5 subunit 40	HPRP8BP|PRP8BP|PRPF8BP|SPF38|WDR57	protein_coding	Q96DI7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4406
1.90865104796008e-67	0.250030600004831	0.919	0.881	3.5810110961827e-63	RTF1	Malignant cells	GSE115251	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4407
2.86526555198327e-67	-0.259570950432656	0.498	0.627	5.37581122863101e-63	THAP7	Malignant cells	GSE115251	ENSG00000184436	80764	THAP domain containing 7	MGC10963	protein_coding	Q9BT49	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4408
2.87367703710635e-67	0.257063280312255	0.851	0.78	5.39159285701894e-63	AK2	Malignant cells	GSE115251	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4409
3.40050576521774e-67	0.250388567534808	0.455	0.312	6.38002891670152e-63	ARL1	Malignant cells	GSE115251	ENSG00000120805	400	ADP ribosylation factor like GTPase 1	ARFL1	protein_coding	P40616	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4410
3.57899674636414e-67	0.250405283769105	0.552	0.409	6.71491369552839e-63	EXOC7	Malignant cells	GSE115251	ENSG00000182473	23265	exocyst complex component 7	BLOM4|EXO70|Exo70p|KIAA1067|YJL085W	protein_coding	Q9UPT5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4411
3.71409342394554e-67	0.258267941709632	0.74	0.635	6.96838208200662e-63	TSEN34	Malignant cells	GSE115251	ENSG00000274078	79042	tRNA splicing endonuclease subunit 34	LENG5|SEN34|SEN34L	protein_coding	Q9BSV6	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4412
4.83743555223839e-67	0.254850705847684	0.581	0.438	9.07599658310967e-63	JARID2	Malignant cells	GSE115251	ENSG00000008083	3720	jumonji and AT-rich interaction domain containing 2	JMJ	protein_coding	Q92833	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4413
7.32765883179717e-67	0.269678120004599	0.808	0.729	1.37481535002179e-62	RPL39L	Malignant cells	GSE115251	ENSG00000163923	116832	ribosomal protein L39 like	RPL39L1	protein_coding	Q96EH5	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4414
9.89776552649261e-67	0.299198763833124	0.772	0.687	1.85701876808054e-62	KRAS	Malignant cells	GSE115251	ENSG00000133703	3845	KRAS proto-oncogene, GTPase	K-Ras4B|KRAS1|KRAS2	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4415
1.38111310710521e-66	0.589253584977369	0.742	0.692	2.59124441155079e-62	TPX2	Malignant cells	GSE115251	ENSG00000088325	22974	TPX2 microtubule nucleation factor	C20orf1|C20orf2|DIL-2|FLS353|HCA519|p100	protein_coding	Q9ULW0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4416
1.68829327212171e-66	-0.254416667462236	0.414	0.55	3.16757583715476e-62	AL589743.1	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4417
1.75750318603933e-66	0.255341193313443	0.625	0.493	3.29742747764698e-62	RPN1	Malignant cells	GSE115251	ENSG00000163902	6184	ribophorin I	OST1	protein_coding	P04843	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4418
5.24667701842634e-66	0.251989007878023	0.863	0.799	9.8438154219715e-62	UPF3A	Malignant cells	GSE115251	ENSG00000169062	65110	UPF3A regulator of nonsense mediated mRNA decay	HUPF3A|RENT3A|UPF3	protein_coding	Q9H1J1	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4419
8.24875311594624e-66	-0.280066516900771	0.585	0.699	1.54763105961383e-61	ENDOG	Malignant cells	GSE115251	ENSG00000167136	2021	endonuclease G	NA	protein_coding	Q14249	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4420
2.90704929726427e-65	-0.254339691738108	0.626	0.73	5.45420589152722e-61	POLR3H	Malignant cells	GSE115251	ENSG00000100413	171568	RNA polymerase III subunit H	C25|KIAA1665|RPC8	protein_coding	Q9Y535	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4421
3.06101704842622e-65	0.319051527822812	0.992	0.995	5.74308018625727e-61	HSP90AA1	Malignant cells	GSE115251	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4422
4.58584086144032e-65	-0.268794631493605	0.627	0.737	8.60395462423432e-61	TMSB15B	Malignant cells	GSE115251	ENSG00000158427	286527	thymosin beta 15B	Tbeta15b|TMSB15A|TMSL8|TMSNB|MGC39900	protein_coding	P0CG35	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4423
6.85729806973992e-65	0.257967934870872	0.534	0.398	1.2865662638446e-60	IDH1	Malignant cells	GSE115251	ENSG00000138413	3417	isocitrate dehydrogenase (NADP(+)) 1	NA	protein_coding	O75874	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4424
8.71971395824749e-65	0.257481140417225	0.535	0.399	1.63599273284639e-60	YRDC	Malignant cells	GSE115251	ENSG00000196449	79693	yrdC N6-threonylcarbamoyltransferase domain containing	FLJ23476|IRIP|SUA5	protein_coding	Q86U90	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4425
9.22768280874808e-65	0.258309966051403	0.606	0.465	1.73129784857732e-60	ADNP	Malignant cells	GSE115251	ENSG00000101126	23394	activity dependent neuroprotector homeobox	ADNP1|KIAA0784	protein_coding	Q9H2P0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4426
1.5691682138644e-64	-0.27964684982941	0.516	0.627	2.94407340285239e-60	DUS1L	Malignant cells	GSE115251	ENSG00000169718	64118	dihydrouridine synthase 1 like	DUS1|PP3111	protein_coding	Q6P1R4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4427
1.85214826693006e-64	0.254378966821164	0.828	0.756	3.47500057841418e-60	C1orf122	Malignant cells	GSE115251	ENSG00000197982	127687	chromosome 1 open reading frame 122	FLJ45459	protein_coding	Q6ZSJ8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4428
2.11592499143178e-64	-0.277129958548348	0.564	0.679	3.9698984689243e-60	CD3EAP	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4429
5.47232965784891e-64	0.254259479380707	0.542	0.405	1.02671849040561e-59	EMC7	Malignant cells	GSE115251	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4430
1.50125358827141e-63	0.25698688100804	0.745	0.64	2.81665198231481e-59	YY1	Malignant cells	GSE115251	ENSG00000100811	7528	YY1 transcription factor	DELTA|INO80S|NF-E1|UCRBP|YIN-YANG-1	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4431
1.92654854018065e-63	0.254961972353625	0.609	0.475	3.61459037108693e-59	BCL7B	Malignant cells	GSE115251	ENSG00000106635	9275	BAF chromatin remodeling complex subunit BCL7B	SMARCJ2	protein_coding	Q9BQE9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4432
3.98678359387684e-63	-0.259737140425967	0.478	0.601	7.48000337883173e-59	CTCF	Malignant cells	GSE115251	ENSG00000102974	10664	CCCTC-binding factor	CFAP108|FAP108	protein_coding	P49711	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4433
4.56318555554038e-63	0.266236519055266	0.605	0.474	8.56144873930485e-59	CEP290	Malignant cells	GSE115251	ENSG00000198707	80184	centrosomal protein 290	3H11Ag|BBS14|CT87|FLJ13615|JBTS5|KIAA0373|LCA10|MKS4|NPHP6|POC3|rd16|SLSN6	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4434
5.47799663170915e-63	0.29298214808836	0.798	0.732	1.02778172804127e-58	C14orf132	Malignant cells	GSE115251	ENSG00000227051	56967	chromosome 14 open reading frame 132	C14orf88	protein_coding	Q9NPU4	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4435
1.67039435493489e-62	0.268436700740791	0.616	0.493	3.13399388872884e-58	KLHL13	Malignant cells	GSE115251	ENSG00000003096	90293	kelch like family member 13	BKLHD2|FLJ10262|KIAA1309	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4436
4.37958324437275e-62	0.257396614965272	0.614	0.49	8.21697408309216e-58	ACVR2B	Malignant cells	GSE115251	ENSG00000114739	93	activin A receptor type 2B	ActR-IIB	protein_coding	Q13705	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4437
6.14552665838233e-62	0.275631387893473	0.748	0.66	1.15302371164569e-57	UPF3B	Malignant cells	GSE115251	ENSG00000125351	65109	UPF3B regulator of nonsense mediated mRNA decay	HUPF3B|MRX62|MRX82|RENT3B|UPF3BP1|UPF3BP2|UPF3BP3|UPF3X	protein_coding	Q9BZI7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4438
1.11668304818518e-61	0.262491546000495	0.77	0.682	2.09512073500503e-57	MAPRE1	Malignant cells	GSE115251	ENSG00000101367	22919	microtubule associated protein RP/EB family member 1	EB1	protein_coding	Q15691	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4439
1.37321242438113e-61	0.25337700932039	0.763	0.674	2.57642115062387e-57	TMEM50A	Malignant cells	GSE115251	ENSG00000183726	23585	transmembrane protein 50A	SMP1	protein_coding	O95807	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4440
2.2509175338151e-60	0.255511190588622	0.729	0.621	4.22317147694389e-56	C11orf83	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4441
3.02618470779774e-59	0.250662518827737	0.603	0.481	5.67772774877012e-55	CYSTM1	Malignant cells	GSE115251	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4442
4.43692646476527e-59	0.334937879452198	0.681	0.574	8.3245614331926e-55	TSC22D1	Malignant cells	GSE115251	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4443
5.59326279524408e-59	0.27984439270022	0.692	0.596	1.04940796564369e-54	TMEM237	Malignant cells	GSE115251	ENSG00000155755	65062	transmembrane protein 237	ALS2CR4|JBTS14	protein_coding	Q96Q45	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4444
8.09896729330157e-59	0.250536214458086	0.824	0.747	1.51952824356924e-54	PHIP	Malignant cells	GSE115251	ENSG00000146247	55023	pleckstrin homology domain interacting protein	BRWD2|DCAF14|FLJ20705|ndrp|WDR11	protein_coding	Q8WWQ0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4445
1.21904380607559e-58	0.256240717344472	0.626	0.506	2.28716998895903e-54	TAF3	Malignant cells	GSE115251	ENSG00000165632	83860	TATA-box binding protein associated factor 3	TAF140|TAFII140	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4446
6.21194820538632e-58	0.257911194630937	0.921	0.89	1.16548572229458e-53	NASP	Malignant cells	GSE115251	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4447
1.77839034365946e-57	0.251178540564202	0.639	0.527	3.33661596277387e-53	TMEM141	Malignant cells	GSE115251	ENSG00000244187	85014	transmembrane protein 141	MGC14141	protein_coding	Q96I45	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4448
5.2392622086836e-57	0.260436846500954	0.375	0.246	9.82990375593217e-53	DDIT4	Malignant cells	GSE115251	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4449
2.66187732426358e-56	0.27753777128896	0.492	0.368	4.99421423578333e-52	CDC25B	Malignant cells	GSE115251	ENSG00000101224	994	cell division cycle 25B	NA	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4450
1.77374447100663e-53	0.256885390484497	0.706	0.615	3.32789937650263e-49	MAD2L2	Malignant cells	GSE115251	ENSG00000116670	10459	mitotic arrest deficient 2 like 2	FANCV|MAD2B|POLZ2|REV7	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4451
6.40104555151896e-51	0.280936850459932	0.619	0.512	1.20096416637599e-46	DESI2	Malignant cells	GSE115251	ENSG00000121644	51029	desumoylating isopeptidase 2	C1orf121|CGI-146|DESI-2|FAM152A|FLJ21998|PNAS-4|PPPDE1	protein_coding	Q9BSY9	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4452
3.55591003739261e-50	0.251639388033819	0.565	0.453	6.67159841215602e-46	GFRA2	Malignant cells	GSE115251	ENSG00000168546	2675	GDNF family receptor alpha 2	GDNFRB|NTNRA|RETL2|TRNR2	protein_coding	O00451	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4453
8.32578466013572e-49	0.260871602246458	0.545	0.434	1.56208371793466e-44	C21orf59	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4454
1.52690152145136e-47	1.90851163630666	0.469	0.403	2.86477263454704e-43	SST	Malignant cells	GSE115251	ENSG00000157005	6750	somatostatin	SMST|SST1	protein_coding	P61278	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4455
2.39503889193415e-47	0.263265958581553	0.636	0.543	4.49357196904685e-43	DDX39A	Malignant cells	GSE115251	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4456
6.36671453179216e-47	0.332186545764576	0.753	0.721	1.19452298045485e-42	MAD2L1	Malignant cells	GSE115251	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4457
4.30922808163763e-44	0.630600496103394	0.487	0.428	8.08497372676852e-40	PGF	Malignant cells	GSE115251	ENSG00000119630	5228	placental growth factor	D12S1900|PGFL|PIGF|PLGF|PlGF-2|SHGC-10760	protein_coding	P49763	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4458
1.15212958477526e-41	0.276411224380843	0.878	0.83	2.16162552695535e-37	ASCL1	Malignant cells	GSE115251	ENSG00000139352	429	achaete-scute family bHLH transcription factor 1	ASH1|bHLHa46|HASH1	protein_coding	P50553	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4459
5.96986971000062e-41	0.276070021201383	0.261	0.17	1.12006695499032e-36	FAM43A	Malignant cells	GSE115251	ENSG00000185112	131583	family with sequence similarity 43 member A	FLJ90022	protein_coding	Q8N2R8	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4460
6.38829266672053e-40	0.347385272311876	0.564	0.466	1.19857147013011e-35	HSPA5	Malignant cells	GSE115251	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4461
4.93997527325096e-38	0.372897762427497	0.547	0.471	9.26838160767346e-34	SLC8A1	Malignant cells	GSE115251	ENSG00000183023	6546	solute carrier family 8 member A1	NCX1	protein_coding	P32418	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4462
2.6565465777342e-36	0.896715047806472	0.736	0.739	4.9842126891449e-32	UBE2C	Malignant cells	GSE115251	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4463
3.34261570301512e-31	0.264440121191289	0.371	0.283	6.27141558199696e-27	NEK2	Malignant cells	GSE115251	ENSG00000117650	4751	NIMA related kinase 2	NEK2A|NLK1|PPP1R111|RP67	protein_coding	P51955	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4464
1.46963300600383e-29	0.45378599970975	0.743	0.742	2.75732544586438e-25	ATP1B1	Malignant cells	GSE115251	ENSG00000143153	481	ATPase Na+/K+ transporting subunit beta 1	ATP1B	protein_coding	P05026	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4465
2.56059590503848e-29	0.269018774973701	0.543	0.461	4.80419003703319e-25	SAPCD2	Malignant cells	GSE115251	ENSG00000186193	89958	suppressor APC domain containing 2	C9orf140|p42.3	protein_coding	Q86UD0	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4466
1.02819472594975e-21	0.327949746029011	0.447	0.386	1.92909894482693e-17	CDC20	Malignant cells	GSE115251	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4467
6.21054535937816e-20	0.425444072400214	0.871	0.849	1.16522252032653e-15	KPNA2	Malignant cells	GSE115251	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4468
1.44168799858879e-13	0.31433227227913	0.567	0.547	2.70489502295228e-09	CDKN3	Malignant cells	GSE115251	ENSG00000100526	1033	cyclin dependent kinase inhibitor 3	CDI1|KAP	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4469
3.09974991468201e-13	0.460744687173024	0.52	0.507	5.81575078992638e-09	GADD45A	Malignant cells	GSE115251	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4470
4.18462003854459e-13	0.254625523656207	0.94	0.97	7.85118411631736e-09	HIST1H4C	Malignant cells	GSE115251	NA	NA	NA	NA	NA	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4471
1.22291249036963e-12	0.571441726898078	0.489	0.456	2.2944284144315e-08	AURKA	Malignant cells	GSE115251	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4472
1.11975823904919e-09	0.335908791793659	0.452	0.419	2.1008904081041e-05	CCNB1	Malignant cells	GSE115251	ENSG00000134057	891	cyclin B1	CCNB	protein_coding	NA	GSE115251	GSE115251	Neuroblastoma	Neuroblastoma	Targeted therapy	NA	TAE684	Homo sapiens	Kelly cell line	Cell line	resistant 1, sensitive 1	2	11790	Public on Aug 07, 2019	31391581	This dataset has 2 cell lines, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA474340	10x genomics	CellRanger	Neuroblastoma	Targeted_therapy	4473
0	0.467096111068705	0.556	0.268	0	NOC2L	Malignant cells	GSE138267	ENSG00000188976	26155	NOC2 like nucleolar associated transcriptional repressor	DKFZP564C186|NET15|NET7|NIR|PPP1R112	protein_coding	Q9Y3T9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4474
0	0.717769178947084	0.361	0.083	0	HES4	Malignant cells	GSE138267	ENSG00000188290	57801	hes family bHLH transcription factor 4	bHLHb42	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4475
0	0.668621686602473	0.386	0.138	0	ISG15	Malignant cells	GSE138267	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4476
0	0.297308972544048	0.535	0.321	0	SDF4	Malignant cells	GSE138267	ENSG00000078808	51150	stromal cell derived factor 4	Cab45	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4477
0	0.292431433715056	0.538	0.309	0	UBE2J2	Malignant cells	GSE138267	ENSG00000160087	118424	ubiquitin conjugating enzyme E2 J2	NCUBE2|Ubc6p	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4478
0	0.308642147953423	0.414	0.201	0	CPSF3L	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4479
0	0.534668126537788	0.454	0.177	0	ANKRD65	Malignant cells	GSE138267	ENSG00000235098	441869	ankyrin repeat domain 65	NA	protein_coding	E5RJM6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4480
0	0.265545611563338	0.783	0.733	0	SSU72	Malignant cells	GSE138267	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4481
0	0.318024464591051	0.329	0.12	0	CDK11A	Malignant cells	GSE138267	ENSG00000008128	728642	cyclin dependent kinase 11A	CDC2L2|CDC2L3|CDK11-p110|CDK11-p46|CDK11-p58|p58GTA|PITSLRE	protein_coding	Q9UQ88	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4482
0	0.349958969203638	0.566	0.385	0	C1orf86	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4483
0	0.416223904357863	0.375	0.122	0	TP73	Malignant cells	GSE138267	ENSG00000078900	7161	tumor protein p73	P73	protein_coding	O15350	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4484
0	0.32442647439164	0.384	0.169	0	RERE	Malignant cells	GSE138267	ENSG00000142599	473	arginine-glutamic acid dipeptide repeats	ARG|ARP|ATN1L|ATN2|DNB1|KIAA0458	protein_coding	Q9P2R6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4485
0	0.629235475373797	0.982	0.987	0	ENO1	Malignant cells	GSE138267	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4486
0	0.250036472442942	0.34	0.165	0	CLSTN1	Malignant cells	GSE138267	ENSG00000171603	22883	calsyntenin 1	CDHR12|CSTN1|KIAA0911	protein_coding	O94985	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4487
0	0.256285697233866	0.31	0.132	0	LZIC	Malignant cells	GSE138267	ENSG00000162441	84328	leucine zipper and CTNNBIP1 domain containing	MGC15436	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4488
0	0.4161811649409	0.298	0.086	0	RBP7	Malignant cells	GSE138267	ENSG00000162444	116362	retinol binding protein 7	CRBPIV	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4489
0	0.463402652984924	0.387	0.125	0	EXOSC10	Malignant cells	GSE138267	ENSG00000171824	5394	exosome component 10	p2|p3|p4|PM-Scl|PM/Scl-100|PMSCL2|RRP6|Rrp6p	protein_coding	Q01780	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4490
0	0.925408771119635	0.588	0.242	0	EFHD2	Malignant cells	GSE138267	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4491
0	0.375188353731148	0.389	0.162	0	ARHGEF19	Malignant cells	GSE138267	ENSG00000142632	128272	Rho guanine nucleotide exchange factor 19	FLJ33962|WGEF	protein_coding	Q8IW93	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4492
0	0.269484164552672	0.412	0.216	0	NECAP2	Malignant cells	GSE138267	ENSG00000157191	55707	NECAP endocytosis associated 2	FLJ10420	protein_coding	Q9NVZ3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4493
0	0.513400571085874	0.334	0.113	0	MFAP2	Malignant cells	GSE138267	ENSG00000117122	4237	microfibril associated protein 2	MAGP|MAGP-1	protein_coding	P55001	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4494
0	0.319838201108538	0.719	0.661	0	SDHB	Malignant cells	GSE138267	ENSG00000117118	6390	succinate dehydrogenase complex iron sulfur subunit B	SDH|SDH1	protein_coding	P21912	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4495
0	0.277487596060507	0.401	0.228	0	RCC2	Malignant cells	GSE138267	ENSG00000281540	55920	regulator of chromosome condensation 2	TD-60	protein_coding	Q9P258	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4496
0	0.337438893407167	0.832	0.778	0	CAPZB	Malignant cells	GSE138267	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4497
0	0.425611738283617	0.863	0.759	0	MINOS1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4498
0	0.379063161531234	0.301	0.098	0	NBL1	Malignant cells	GSE138267	ENSG00000158747	4681	NBL1, DAN family BMP antagonist	D1S1733E|DAN|DAND1|NB|NO3	protein_coding	P41271	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4499
0	0.263551623266104	0.299	0.138	0	PINK1	Malignant cells	GSE138267	ENSG00000158828	65018	PTEN induced kinase 1	BRPK|PARK6	protein_coding	Q9BXM7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4500
0	0.575978907491754	0.732	0.618	0	HP1BP3	Malignant cells	GSE138267	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4501
0	0.368770060637187	0.445	0.2	0	USP48	Malignant cells	GSE138267	ENSG00000090686	84196	ubiquitin specific peptidase 48	FLJ11328|FLJ20103|FLJ23054|FLJ23277|MGC14879|USP31	protein_coding	Q86UV5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4502
0	0.277434387086155	0.846	0.777	0	CDC42	Malignant cells	GSE138267	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4503
0	0.420957916169605	0.5	0.245	0	KDM1A	Malignant cells	GSE138267	ENSG00000004487	23028	lysine demethylase 1A	AOF2|BHC110|KDM1|KIAA0601|LSD1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4504
0	0.633168790823277	0.92	0.829	0	HNRNPR	Malignant cells	GSE138267	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4505
0	0.543689749607888	0.344	0.071	0	TCEA3	Malignant cells	GSE138267	ENSG00000282941	6920	transcription elongation factor A3	TFIIS.H	protein_coding	O75764	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4506
0	0.988659440909588	0.653	0.456	0	ID3	Malignant cells	GSE138267	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4507
0	0.428675158088383	1	1	0	RPL11	Malignant cells	GSE138267	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4508
0	0.368288299889459	0.365	0.115	0	TCEB3	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4509
0	0.408378445950863	0.654	0.538	0	PITHD1	Malignant cells	GSE138267	ENSG00000057757	57095	PITH domain containing 1	C1orf128|HT014|TXNL1CL	protein_coding	Q9GZP4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4510
0	0.325748004076893	0.431	0.208	0	LYPLA2	Malignant cells	GSE138267	ENSG00000011009	11313	lysophospholipase 2	APT-2	protein_coding	O95372	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4511
0	0.403998425190424	0.64	0.589	0	SRSF10	Malignant cells	GSE138267	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4512
0	0.345073970763362	0.297	0.075	0	NIPAL3	Malignant cells	GSE138267	ENSG00000001461	57185	NIPA like domain containing 3	DJ462O23.2|NPAL3|SLC57A5	protein_coding	Q6P499	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4513
0	0.59420673514924	0.836	0.73	0	SRRM1	Malignant cells	GSE138267	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4514
0	0.326893874724277	0.746	0.681	0	SYF2	Malignant cells	GSE138267	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4515
0	0.58718992556592	0.543	0.215	0	C1orf63	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4516
0	0.428695644336459	0.387	0.105	0	TMEM57	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4517
0	0.287825729587384	0.363	0.177	0	MTFR1L	Malignant cells	GSE138267	ENSG00000117640	56181	mitochondrial fission regulator 1 like	FAM54B	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4518
0	0.641892943925663	1	0.999	0	STMN1	Malignant cells	GSE138267	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4519
0	0.522444626085274	0.855	0.744	0	SH3BGRL3	Malignant cells	GSE138267	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4520
0	0.303690650417546	0.299	0.106	0	UBXN11	Malignant cells	GSE138267	ENSG00000158062	91544	UBX domain protein 11	SOC|SOCI|UBXD5	protein_coding	Q5T124	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4521
0	0.683691800386263	1	0.995	0	HMGN2	Malignant cells	GSE138267	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4522
0	0.309931445378391	0.367	0.158	0	ARID1A	Malignant cells	GSE138267	ENSG00000117713	8289	AT-rich interaction domain 1A	B120|BAF250|BAF250a|C10rf4|C1orf4|P270|SMARCF1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4523
0	0.858443741261324	0.592	0.598	0	SFN	Malignant cells	GSE138267	ENSG00000175793	2810	stratifin	YWHAS	protein_coding	P31947	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4524
0	0.418610841256157	0.943	0.877	0	NUDC	Malignant cells	GSE138267	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4525
0	0.361107082698347	0.389	0.243	0	NR0B2	Malignant cells	GSE138267	ENSG00000131910	8431	nuclear receptor subfamily 0 group B member 2	SHP	protein_coding	Q15466	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4526
0	0.341513098056855	0.444	0.208	0	TMEM222	Malignant cells	GSE138267	ENSG00000186501	84065	transmembrane protein 222	C1orf160|DKFZP564D0478	protein_coding	Q9H0R3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4527
0	0.417075545618607	0.366	0.126	0	SYTL1	Malignant cells	GSE138267	ENSG00000142765	84958	synaptotagmin like 1	exophilin-7|FLJ14996|JFC1|SLP1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4528
0	0.367716946668283	0.651	0.532	0	WASF2	Malignant cells	GSE138267	ENSG00000158195	10163	WASP family member 2	SCAR2|WAVE2	protein_coding	Q9Y6W5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4529
0	1.34917568310047	0.605	0.101	0	IFI6	Malignant cells	GSE138267	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4530
0	0.310873941634454	0.411	0.185	0	PPP1R8	Malignant cells	GSE138267	ENSG00000117751	5511	protein phosphatase 1 regulatory subunit 8	ard-1|ARD1|NIPP-1|NIPP1|PRO2047	protein_coding	Q12972	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4531
0	0.415784831285327	0.771	0.668	0	DNAJC8	Malignant cells	GSE138267	ENSG00000285317	22826	DnaJ heat shock protein family (Hsp40) member C8	SPF31	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4532
0	0.821255370365995	0.908	0.725	0	ATPIF1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4533
0	0.255462093687326	0.302	0.125	0	PHACTR4	Malignant cells	GSE138267	ENSG00000204138	65979	phosphatase and actin regulator 4	FLJ13171|PPP1R124	protein_coding	Q8IZ21	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4534
0	0.30039311307896	0.41	0.201	0	TRNAU1AP	Malignant cells	GSE138267	ENSG00000180098	54952	tRNA selenocysteine 1 associated protein 1	FLJ20503|SECP43|TRSPAP1	protein_coding	Q9NX07	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4535
0	0.374533964788631	0.37	0.145	0	SNHG12	Malignant cells	GSE138267	ENSG00000197989	85028	small nucleolar RNA host gene 12	ASLNC04080|C1orf79|LINC00100|PNAS-123	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4536
0	0.407994687840142	0.764	0.701	0	YTHDF2	Malignant cells	GSE138267	ENSG00000198492	51441	YTH N6-methyladenosine RNA binding protein 2	CAHL|HGRG8|NY-REN-2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4537
0	0.250502294521715	0.465	0.296	0	SERINC2	Malignant cells	GSE138267	ENSG00000168528	347735	serine incorporator 2	FKSG84|PRO0899|TDE2|TDE2L	protein_coding	Q96SA4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4538
0	-0.57245032946322	0.522	0.812	0	PTP4A2	Malignant cells	GSE138267	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4539
0	-0.431826300898301	0.852	0.946	0	EIF3I	Malignant cells	GSE138267	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4540
0	-0.427848126661145	0.525	0.805	0	HDAC1	Malignant cells	GSE138267	ENSG00000116478	3065	histone deacetylase 1	GON-10|HD1|KDAC1|RPD3L1	protein_coding	Q13547	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4541
0	-0.294212449435859	0.446	0.632	0	BSDC1	Malignant cells	GSE138267	ENSG00000160058	55108	BSD domain containing 1	FLJ10276|RP4-811H24.7	protein_coding	Q9NW68	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4542
0	-0.499583209602915	0.457	0.781	0	ZBTB8OS	Malignant cells	GSE138267	ENSG00000176261	339487	zinc finger and BTB domain containing 8 opposite strand	ARCH	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4543
0	-0.558229513644317	0.113	0.352	0	TMEM54	Malignant cells	GSE138267	ENSG00000121900	113452	transmembrane protein 54	BCLP|CAC-1	protein_coding	Q969K7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4544
0	-0.343307020462096	0.604	0.826	0	AK2	Malignant cells	GSE138267	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4545
0	-0.37259988403166	0.459	0.726	0	SMIM12	Malignant cells	GSE138267	ENSG00000163866	113444	small integral membrane protein 12	C1orf212|FLJ90372	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4546
0	-0.422306894717102	0.873	0.964	0	PSMB2	Malignant cells	GSE138267	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4547
0	-0.344132380316035	0.69	0.875	0	TRAPPC3	Malignant cells	GSE138267	ENSG00000054116	27095	trafficking protein particle complex subunit 3	BET3	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4548
0	-0.309686787330082	0.267	0.397	0	LSM10	Malignant cells	GSE138267	ENSG00000181817	84967	LSM10, U7 small nuclear RNA associated	MGC15749	protein_coding	Q969L4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4549
0	-0.407354095805697	0.641	0.869	0	MRPS15	Malignant cells	GSE138267	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4550
0	-0.461946917786629	0.792	0.924	0	MEAF6	Malignant cells	GSE138267	ENSG00000163875	64769	MYST/Esa1 associated factor 6	C1orf149|CENP-28|Eaf6|FLJ11730|NY-SAR-91	protein_coding	Q9HAF1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4551
0	-0.294742622920965	0.487	0.674	0	GNL2	Malignant cells	GSE138267	ENSG00000134697	29889	G protein nucleolar 2	HUMAUANTIG|Ngp-1|Nog2|Nug2	protein_coding	Q13823	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4552
0	-0.323766996164962	0.634	0.874	0	C1orf122	Malignant cells	GSE138267	ENSG00000197982	127687	chromosome 1 open reading frame 122	FLJ45459	protein_coding	Q6ZSJ8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4553
0	-0.294292352641602	0.511	0.707	0	SF3A3	Malignant cells	GSE138267	ENSG00000183431	10946	splicing factor 3a subunit 3	PRP9|PRPF9|SAP61|SF3a60	protein_coding	Q12874	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4554
0	-0.292469696330889	0.505	0.679	0	UTP11L	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4555
0	-0.54250086714732	0.972	0.996	0	NDUFS5	Malignant cells	GSE138267	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4556
0	-0.374063919754817	0.491	0.766	0	PPIE	Malignant cells	GSE138267	ENSG00000084072	10450	peptidylprolyl isomerase E	CyP-33|MGC111222|MGC3736	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4557
0	-0.808014899964663	0.286	0.655	0	TRIT1	Malignant cells	GSE138267	ENSG00000043514	54802	tRNA isopentenyltransferase 1	FLJ20061|IPT	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4558
0	-0.26186046589678	0.453	0.661	0	PPCS	Malignant cells	GSE138267	ENSG00000127125	79717	phosphopantothenoylcysteine synthetase	FLJ11838	protein_coding	Q9HAB8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4559
0	-0.467367267253516	0.999	1	0	YBX1	Malignant cells	GSE138267	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4560
0	0.450074447091174	0.55	0.272	0	HYI	Malignant cells	GSE138267	ENSG00000178922	81888	hydroxypyruvate isomerase (putative)	HT036	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4561
0	-0.38695440307296	1	1	0	RPS8	Malignant cells	GSE138267	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4562
0	-0.499838575020572	0.825	0.979	0	PRDX1	Malignant cells	GSE138267	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4563
0	-0.466568693298115	0.69	0.926	0	AKR1A1	Malignant cells	GSE138267	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4564
0	-0.391901010136324	0.99	0.997	0	UQCRH	Malignant cells	GSE138267	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4565
0	-0.429085145780833	0.479	0.756	0	CMPK1	Malignant cells	GSE138267	ENSG00000162368	51727	cytidine/uridine monophosphate kinase 1	CMPK|UMP-CMPK	protein_coding	P30085	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4566
0	0.262388182266838	0.445	0.29	0	ELAVL4	Malignant cells	GSE138267	ENSG00000162374	1996	ELAV like RNA binding protein 4	HUD|PNEM	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4567
0	0.521626538234338	0.906	0.855	0	CDKN2C	Malignant cells	GSE138267	ENSG00000123080	1031	cyclin dependent kinase inhibitor 2C	INK4C|p18	protein_coding	P42773	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4568
0	0.936482095152711	0.419	0.053	0	NFIA	Malignant cells	GSE138267	ENSG00000162599	4774	nuclear factor I A	KIAA1439|NFI-L	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4569
0	0.578216175802825	0.823	0.818	0	USP1	Malignant cells	GSE138267	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4570
0	-0.300747839881426	0.487	0.71	0	ITGB3BP	Malignant cells	GSE138267	ENSG00000142856	23421	integrin subunit beta 3 binding protein	CENPR|HSU37139|NRIF3|TAP20	protein_coding	Q13352	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4571
0	0.25635491070029	0.353	0.182	0	MIER1	Malignant cells	GSE138267	ENSG00000198160	57708	MIER1 transcriptional regulator	hMI-ER1|KIAA1610|MI-ER1	protein_coding	Q8N108	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4572
0	-0.2792412007295	0.149	0.299	0	WLS	Malignant cells	GSE138267	ENSG00000116729	79971	Wnt ligand secretion mediator	C1orf139|EVI|FLJ23091|GPR177|mig-14|MRP	protein_coding	Q5T9L3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4573
0	0.379251627612101	0.548	0.297	0	ZRANB2	Malignant cells	GSE138267	ENSG00000132485	9406	zinc finger RANBP2-type containing 2	ZIS|ZIS1|ZIS2|ZNF265	protein_coding	O95218	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4574
0	-0.342363670676113	0.444	0.696	0	ACADM	Malignant cells	GSE138267	ENSG00000117054	34	acyl-CoA dehydrogenase medium chain	ACAD1|MCAD|MCADH	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4575
0	0.517964230393843	0.565	0.356	0	TTLL7	Malignant cells	GSE138267	ENSG00000137941	79739	tubulin tyrosine ligase like 7	FLJ23033	protein_coding	Q6ZT98	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4576
0	0.288350269720015	0.365	0.189	0	MCOLN3	Malignant cells	GSE138267	ENSG00000055732	55283	mucolipin TRP cation channel 3	FLJ11006|TRP-ML3|TRPML3	protein_coding	Q8TDD5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4577
0	0.27617826985105	0.503	0.307	0	ODF2L	Malignant cells	GSE138267	ENSG00000122417	57489	outer dense fiber of sperm tails 2 like	KIAA1229	protein_coding	Q9ULJ1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4578
0	0.473811948541065	0.322	0.065	0	GFI1	Malignant cells	GSE138267	ENSG00000162676	2672	growth factor independent 1 transcriptional repressor	GFI-1|GFI1A|ZNF163	protein_coding	Q99684	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4579
0	-0.383521645241254	1	1	0	RPL5	Malignant cells	GSE138267	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4580
0	-0.389599725558675	0.573	0.837	0	CNN3	Malignant cells	GSE138267	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4581
0	0.263557827815043	0.79	0.779	0	PRPF38B	Malignant cells	GSE138267	ENSG00000134186	55119	pre-mRNA processing factor 38B	FLJ10330|NET1	protein_coding	Q5VTL8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4582
0	0.529718408180147	0.404	0.156	0	GPSM2	Malignant cells	GSE138267	ENSG00000121957	29899	G protein signaling modulator 2	DFNB82|LGN|Pins	protein_coding	P81274	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4583
0	0.273144189876346	0.467	0.288	0	AHCYL1	Malignant cells	GSE138267	ENSG00000168710	10768	adenosylhomocysteinase like 1	IRBIT|PPP1R78|XPVKONA	protein_coding	O43865	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4584
0	0.418287478676885	0.89	0.793	0	ATP5F1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4585
0	-0.321961306699194	0.209	0.347	0	RHOC	Malignant cells	GSE138267	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4586
0	0.250755643408974	0.414	0.237	0	RSBN1	Malignant cells	GSE138267	ENSG00000081019	54665	round spermatid basic protein 1	FLJ11220|ROSBIN	protein_coding	Q5VWQ0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4587
0	-0.712052570883971	0.404	0.814	0	PHGDH	Malignant cells	GSE138267	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4588
0	0.287206501824177	0.29	0.138	0	PDE4DIP	Malignant cells	GSE138267	ENSG00000178104	9659	phosphodiesterase 4D interacting protein	CMYA2|KIAA0454|KIAA0477|MMGL	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4589
0	0.561053952804534	0.654	0.635	0	TXNIP	Malignant cells	GSE138267	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4590
0	0.299204387223649	0.419	0.219	0	RNF115	Malignant cells	GSE138267	ENSG00000265491	27246	ring finger protein 115	CL469780|ZNF364	protein_coding	Q9Y4L5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4591
0	0.696138917175162	0.38	0.11	0	HIST2H2BE	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4592
0	0.605629737408734	0.963	0.943	0	ENSA	Malignant cells	GSE138267	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4593
0	0.266668699052774	0.49	0.3	0	SCNM1	Malignant cells	GSE138267	ENSG00000163156	79005	sodium channel modifier 1	MGC3180	protein_coding	Q9BWG6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4594
0	0.338126706146701	0.405	0.18	0	POGZ	Malignant cells	GSE138267	ENSG00000143442	23126	pogo transposable element derived with ZNF domain	KIAA0461|ZNF280E|ZNF635	protein_coding	Q7Z3K3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4595
0	-1.06213152358382	0.059	0.413	0	S100A10	Malignant cells	GSE138267	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4596
0	0.787151167493544	0.308	0.048	0	S100A2	Malignant cells	GSE138267	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4597
0	1.08383573181484	0.328	0.038	0	S100A16	Malignant cells	GSE138267	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4598
0	1.24142789206629	0.453	0.043	0	S100A14	Malignant cells	GSE138267	ENSG00000189334	57402	S100 calcium binding protein A14	BCMP84|S100A15	protein_coding	Q9HCY8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4599
0	0.30153467391219	0.478	0.281	0	SLC39A1	Malignant cells	GSE138267	ENSG00000143570	27173	solute carrier family 39 member 1	ZIP1|ZIRTL	protein_coding	Q9NY26	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4600
0	-0.276957432372034	1	1	0	RPS27	Malignant cells	GSE138267	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4601
0	0.467389191969052	0.802	0.785	0	HAX1	Malignant cells	GSE138267	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4602
0	0.431891438687286	0.457	0.199	0	ADAR	Malignant cells	GSE138267	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4603
0	0.259500205689159	0.511	0.328	0	PMVK	Malignant cells	GSE138267	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4604
0	-0.336904959461821	0.672	0.873	0	KRTCAP2	Malignant cells	GSE138267	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4605
0	0.299120503008403	0.446	0.3	0	RUSC1	Malignant cells	GSE138267	ENSG00000160753	23623	RUN and SH3 domain containing 1	NESCA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4606
0	0.398708798560222	0.477	0.227	0	ASH1L	Malignant cells	GSE138267	ENSG00000116539	55870	ASH1 like histone lysine methyltransferase	ASH1|ASH1L1|huASH1|KMT2H	protein_coding	Q9NR48	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4607
0	0.347496372268174	0.394	0.171	0	GON4L	Malignant cells	GSE138267	ENSG00000116580	54856	gon-4 like	FLJ20203|GON-4|GON4|YARP	protein_coding	Q3T8J9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4608
0	0.255312492140411	0.322	0.143	0	RIT1	Malignant cells	GSE138267	ENSG00000143622	6016	Ras like without CAAX 1	MGC125864|MGC125865|RIBB|RIT|ROC1	protein_coding	Q92963	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4609
0	0.278679913249482	0.462	0.244	0	KIAA0907	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4610
0	0.419268202298043	0.474	0.217	0	ARHGEF2	Malignant cells	GSE138267	ENSG00000116584	9181	Rho/Rac guanine nucleotide exchange factor 2	GEF-H1|GEFH1|KIAA0651|Lfc|LFP40|P40	protein_coding	Q92974	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4611
0	0.370464193593427	0.344	0.149	0	MEX3A	Malignant cells	GSE138267	ENSG00000254726	92312	mex-3 RNA binding family member A	RKHD4|RNF162	protein_coding	A1L020	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4612
0	0.865600833943494	0.794	0.64	0	LMNA	Malignant cells	GSE138267	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4613
0	0.452532364984014	0.768	0.74	0	PMF1	Malignant cells	GSE138267	ENSG00000160783	11243	polyamine modulated factor 1	NA	protein_coding	Q6P1K2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4614
0	-0.495621870032477	0.455	0.776	0	DUSP23	Malignant cells	GSE138267	ENSG00000158716	54935	dual specificity phosphatase 23	DUSP25|FLJ20442	protein_coding	Q9BVJ7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4615
0	0.957015636075331	0.294	0.003	0	NHLH1	Malignant cells	GSE138267	ENSG00000171786	4807	nescient helix-loop-helix 1	bHLHa35|HEN1|NSCL|NSCL1	protein_coding	Q02575	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4616
0	0.319024832518403	0.846	0.861	0	TSTD1	Malignant cells	GSE138267	ENSG00000215845	100131187	thiosulfate sulfurtransferase like domain containing 1	KAT	protein_coding	Q8NFU3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4617
0	0.285781093060548	0.924	0.881	0	PFDN2	Malignant cells	GSE138267	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4618
0	0.324549265123938	0.388	0.171	0	UHMK1	Malignant cells	GSE138267	ENSG00000152332	127933	U2AF homology motif kinase 1	KIS|Kist	protein_coding	Q8TAS1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4619
0	0.385851976325749	0.814	0.815	0	MPC2	Malignant cells	GSE138267	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4620
0	0.776102548037161	0.776	0.686	0	ATP1B1	Malignant cells	GSE138267	ENSG00000143153	481	ATPase Na+/K+ transporting subunit beta 1	ATP1B	protein_coding	P05026	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4621
0	0.588387576263342	0.8	0.719	0	PRRC2C	Malignant cells	GSE138267	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4622
0	0.278119896379374	0.252	0.098	0	CENPL	Malignant cells	GSE138267	ENSG00000120334	91687	centromere protein L	C1orf155|dJ383J4.3|FLJ31044	protein_coding	Q8N0S6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4623
0	0.284633600916741	0.537	0.325	0	MRPS14	Malignant cells	GSE138267	ENSG00000120333	63931	mitochondrial ribosomal protein S14	HSMRPS14	protein_coding	O60783	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4624
0	0.333852546749546	0.311	0.103	0	CEP350	Malignant cells	GSE138267	ENSG00000135837	9857	centrosomal protein 350	CAP350|KIAA0480	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4625
0	0.252738583992881	0.312	0.138	0	IER5	Malignant cells	GSE138267	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4626
0	0.474741857232973	0.529	0.264	0	IVNS1ABP	Malignant cells	GSE138267	ENSG00000116679	10625	influenza virus NS1A binding protein	ARA3|HSPC068|KIAA0850|KLHL39|ND1|NS-1|NS1-BP	protein_coding	Q9Y6Y0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4627
0	0.566470379402293	0.751	0.689	0	TPR	Malignant cells	GSE138267	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4628
0	0.268046738493231	0.317	0.155	0	RGS2	Malignant cells	GSE138267	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4629
0	0.310464328667907	0.375	0.169	0	ZNF281	Malignant cells	GSE138267	ENSG00000162702	23528	zinc finger protein 281	ZBP-99	protein_coding	Q9Y2X9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4630
0	0.299276696324114	0.435	0.247	0	IPO9	Malignant cells	GSE138267	ENSG00000198700	55705	importin 9	FLJ10402|Imp9	protein_coding	Q96P70	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4631
0	0.662976998922269	0.825	0.885	0	ELF3	Malignant cells	GSE138267	ENSG00000163435	1999	E74 like ETS transcription factor 3	EPR-1|ERT|ESE-1|ESX	protein_coding	P78545	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4632
0	0.291035779210552	0.346	0.175	0	KDM5B	Malignant cells	GSE138267	ENSG00000117139	10765	lysine demethylase 5B	CT31|JARID1B|PLU-1|PPP1R98|RBBP2H1A	protein_coding	Q9UGL1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4633
0	0.260334668617294	0.332	0.152	0	ZC3H11A	Malignant cells	GSE138267	ENSG00000058673	9877	zinc finger CCCH-type containing 11A	KIAA0663|ZC3HDC11A	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4634
0	0.271318588865829	0.431	0.245	0	MDM4	Malignant cells	GSE138267	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4635
0	0.632990822257414	0.977	0.967	0	NUCKS1	Malignant cells	GSE138267	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4636
0	-0.339602902675092	0.826	0.95	0	NENF	Malignant cells	GSE138267	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4637
0	-0.452174306039738	0.423	0.713	0	ATF3	Malignant cells	GSE138267	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4638
0	0.254109202749222	0.427	0.274	0	PROX1	Malignant cells	GSE138267	ENSG00000117707	5629	prospero homeobox 1	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4639
0	-0.291596276658594	0.471	0.709	0	CNIH4	Malignant cells	GSE138267	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4640
0	0.288270775761484	0.464	0.291	0	LBR	Malignant cells	GSE138267	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4641
0	0.470186267442968	1	1	0	H3F3A	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4642
0	-0.308444386653486	0.217	0.391	0	RAB4A	Malignant cells	GSE138267	ENSG00000168118	5867	RAB4A, member RAS oncogene family	HRES-1/RAB4|RAB4	protein_coding	P20338	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4643
0	0.372681219030387	0.923	0.893	0	HNRNPU	Malignant cells	GSE138267	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4644
0	-0.298747567515454	0.327	0.569	0	SCCPDH	Malignant cells	GSE138267	ENSG00000143653	51097	saccharopine dehydrogenase (putative)	CGI-49|NET11	protein_coding	Q8NBX0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4645
0	0.272266360017201	0.363	0.189	0	ZNF672	Malignant cells	GSE138267	ENSG00000171161	79894	zinc finger protein 672	FLJ22301	protein_coding	Q499Z4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4646
0	-0.474057539541053	1	0.999	0	RPS7	Malignant cells	GSE138267	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4647
0	-0.7466304629036	0.844	0.945	0	ID2	Malignant cells	GSE138267	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4648
0	0.619165315628917	0.382	0.216	0	RRM2	Malignant cells	GSE138267	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4649
0	0.258293915714464	0.442	0.28	0	FAM84A	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4650
0	-0.674534565336604	0.524	0.722	0	DDX1	Malignant cells	GSE138267	ENSG00000079785	1653	DEAD-box helicase 1	DBP-RB	protein_coding	Q92499	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4651
0	0.316751090587739	0.391	0.171	0	TTC32	Malignant cells	GSE138267	ENSG00000183891	130502	tetratricopeptide repeat domain 32	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4652
0	0.25607531564738	0.325	0.151	0	DNMT3A	Malignant cells	GSE138267	ENSG00000119772	1788	DNA methyltransferase 3 alpha	NA	protein_coding	Q9Y6K1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4653
0	-0.259415662148339	0.892	0.957	0	OST4	Malignant cells	GSE138267	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4654
0	0.276265374012951	0.468	0.269	0	YIPF4	Malignant cells	GSE138267	ENSG00000119820	84272	Yip1 domain family member 4	FinGER4|MGC11061	protein_coding	Q9BSR8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4655
0	0.440634204439926	0.45	0.231	0	EIF2AK2	Malignant cells	GSE138267	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4656
0	0.28175285135242	0.532	0.329	0	CEBPZ	Malignant cells	GSE138267	ENSG00000115816	10153	CCAAT enhancer binding protein zeta	CBF2|CTF2	protein_coding	Q03701	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4657
0	-0.336037978042755	0.409	0.687	0	QPCT	Malignant cells	GSE138267	ENSG00000115828	25797	glutaminyl-peptide cyclotransferase	GCT|QC	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4658
0	0.335802355449684	0.527	0.293	0	MORN2	Malignant cells	GSE138267	ENSG00000188010	729967	MORN repeat containing 2	MOPT	protein_coding	Q502X0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4659
0	0.379113293351742	0.475	0.246	0	ZFP36L2	Malignant cells	GSE138267	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4660
0	0.367415917621735	0.296	0.074	0	SIX3	Malignant cells	GSE138267	ENSG00000138083	6496	SIX homeobox 3	HPE2	protein_coding	O95343	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4661
0	0.471814125199397	0.999	0.989	0	CALM2	Malignant cells	GSE138267	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4662
0	0.410188115595129	0.397	0.165	0	NRXN1	Malignant cells	GSE138267	ENSG00000179915	9378	neurexin 1	Hs.22998|KIAA0578	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4663
0	0.304741164195033	0.88	0.856	0	RTN4	Malignant cells	GSE138267	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4664
0	0.278975817743721	0.463	0.273	0	CCDC104	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4665
0	0.309219788714776	0.392	0.186	0	USP34	Malignant cells	GSE138267	ENSG00000115464	9736	ubiquitin specific peptidase 34	KIAA0570|KIAA0729	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4666
0	0.256695563973679	0.504	0.3	0	SNRNP27	Malignant cells	GSE138267	ENSG00000124380	11017	small nuclear ribonucleoprotein U4/U6.U5 subunit 27	RY1|U4/U6.U5-27K	protein_coding	Q8WVK2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4667
0	0.374714873561718	0.506	0.259	0	MPHOSPH10	Malignant cells	GSE138267	ENSG00000124383	10199	M-phase phosphoprotein 10	CT90|MPP10|MPP10P|PPP1R106	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4668
0	-0.43326268055373	0.647	0.865	0	DGUOK	Malignant cells	GSE138267	ENSG00000114956	1716	deoxyguanosine kinase	dGK	protein_coding	Q16854	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4669
0	-0.300635249687016	0.696	0.873	0	MTHFD2	Malignant cells	GSE138267	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4670
0	-0.296796517997439	0.161	0.318	0	POLE4	Malignant cells	GSE138267	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4671
0	0.947187874472016	1	0.991	0	TMSB10	Malignant cells	GSE138267	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4672
0	0.300043437711128	0.382	0.187	0	TGOLN2	Malignant cells	GSE138267	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4673
0	0.42152911460129	0.504	0.247	0	MAT2A	Malignant cells	GSE138267	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4674
0	0.284233002397102	0.441	0.241	0	RPIA	Malignant cells	GSE138267	ENSG00000153574	22934	ribose 5-phosphate isomerase A	NA	protein_coding	P49247	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4675
0	0.257368167134302	0.459	0.276	0	MRPS5	Malignant cells	GSE138267	ENSG00000144029	64969	mitochondrial ribosomal protein S5	MRP-S5|S5mt	protein_coding	P82675	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4676
0	0.340350127432083	0.342	0.166	0	ANKRD36C	Malignant cells	GSE138267	ENSG00000174501	400986	ankyrin repeat domain 36C	DKFZp667P0924	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4677
0	0.332595954908112	0.454	0.238	0	SNRNP200	Malignant cells	GSE138267	ENSG00000144028	23020	small nuclear ribonucleoprotein U5 subunit 200	ASCC3L1|BRR2|HELIC2|KIAA0788|RP33|U5-200KD	protein_coding	O75643	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4678
0	0.284465162994016	0.407	0.24	0	ANKRD36	Malignant cells	GSE138267	ENSG00000135976	375248	ankyrin repeat domain 36	UNQ2430	protein_coding	A6QL64	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4679
0	0.284878803432691	0.483	0.274	0	TXNDC9	Malignant cells	GSE138267	ENSG00000115514	10190	thioredoxin domain containing 9	APACD	protein_coding	O14530	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4680
0	0.2952501379901	0.765	0.752	0	EIF5B	Malignant cells	GSE138267	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4681
0	0.254077756251372	0.332	0.166	0	REV1	Malignant cells	GSE138267	ENSG00000135945	51455	REV1 DNA directed polymerase	REV1L	protein_coding	Q9UBZ9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4682
0	-0.600194805134974	0.961	0.999	0	RPL31	Malignant cells	GSE138267	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4683
0	0.407135793582874	0.342	0.088	0	RP11-332H14.2	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4684
0	0.38177494833368	0.486	0.246	0	GCC2	Malignant cells	GSE138267	ENSG00000135968	9648	GRIP and coiled-coil domain containing 2	GCC185|KIAA0336	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4685
0	0.484030933502491	0.425	0.177	0	FBLN7	Malignant cells	GSE138267	ENSG00000144152	129804	fibulin 7	FLJ37440|TM14	protein_coding	Q53RD9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4686
0	0.387624541144039	0.4	0.188	0	SLC20A1	Malignant cells	GSE138267	ENSG00000144136	6574	solute carrier family 20 member 1	Glvr-1|GLVR1|PiT-1|PiT1	protein_coding	Q8WUM9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4687
0	0.312403204065442	0.71	0.688	0	DDX18	Malignant cells	GSE138267	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4688
0	0.295945012736875	0.381	0.18	0	IWS1	Malignant cells	GSE138267	ENSG00000163166	55677	interacts with SUPT6H, CTD assembly factor 1	DKFZp761G0123|FLJ10006|FLJ14655|FLJ32319	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4689
0	0.532513685900302	0.388	0.149	0	CCDC74A	Malignant cells	GSE138267	ENSG00000163040	90557	coiled-coil domain containing 74A	FLJ40345	protein_coding	Q96AQ1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4690
0	0.56296757074792	0.341	0.165	0	LYPD1	Malignant cells	GSE138267	ENSG00000150551	116372	LY6/PLAUR domain containing 1	LYPDC1|MGC29643	protein_coding	Q8N2G4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4691
0	0.330322717222711	0.859	0.836	0	UBXN4	Malignant cells	GSE138267	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4692
0	0.389601558857205	0.489	0.307	0	KIF5C	Malignant cells	GSE138267	ENSG00000276734	3800	kinesin family member 5C	NKHC2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4693
0	0.318927095375971	0.452	0.252	0	RIF1	Malignant cells	GSE138267	ENSG00000080345	55183	replication timing regulatory factor 1	FLJ10599|FLJ12870	protein_coding	Q5UIP0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4694
0	1.11964176273124	0.371	0.035	0	NEB	Malignant cells	GSE138267	ENSG00000183091	4703	nebulin	NEB177D|NEM2	protein_coding	P20929	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4695
0	0.27729762787917	0.507	0.294	0	ARL5A	Malignant cells	GSE138267	ENSG00000162980	26225	ADP ribosylation factor like GTPase 5A	ARL5	protein_coding	Q9Y689	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4696
0	0.414906907651659	0.767	0.742	0	PRPF40A	Malignant cells	GSE138267	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4697
0	0.665094159654836	0.412	0.141	0	RPRM	Malignant cells	GSE138267	ENSG00000177519	56475	reprimo, TP53 dependent G2 arrest mediator homolog	FLJ90327|REPRIMO	protein_coding	Q9NS64	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4698
0	0.383663116166928	0.359	0.136	0	NR4A2	Malignant cells	GSE138267	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4699
0	0.287696523689024	0.423	0.222	0	MARCH7	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4700
0	0.258864318703081	0.43	0.243	0	GCA	Malignant cells	GSE138267	ENSG00000115271	25801	grancalcin	GCL	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4701
0	0.313637643465006	0.334	0.14	0	CERS6	Malignant cells	GSE138267	ENSG00000172292	253782	ceramide synthase 6	LASS6	protein_coding	Q6ZMG9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4702
0	0.369815626943788	0.817	0.78	0	PPIG	Malignant cells	GSE138267	ENSG00000138398	9360	peptidylprolyl isomerase G	CARS-Cyp|SCAF10|SRCyp	protein_coding	Q13427	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4703
0	0.267335357194199	0.535	0.355	0	GORASP2	Malignant cells	GSE138267	ENSG00000115806	26003	golgi reassembly stacking protein 2	GOLPH6|GRASP55|GRS2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4704
0	0.285866641242105	0.391	0.196	0	SP3	Malignant cells	GSE138267	ENSG00000172845	6670	Sp3 transcription factor	SPR-2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4705
0	0.37588456054112	0.566	0.313	0	CIR1	Malignant cells	GSE138267	ENSG00000138433	9541	corepressor interacting with RBPJ, CIR1	CIR	protein_coding	Q86X95	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4706
0	0.46811917945855	0.97	0.87	0	ATP5G3	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4707
0	0.26895132280851	0.3	0.118	0	KIAA1715	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4708
0	0.353736097180396	0.323	0.127	0	HOXD1	Malignant cells	GSE138267	ENSG00000128645	3231	homeobox D1	HOX4|HOX4G	protein_coding	Q9GZZ0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4709
0	0.563060146338567	0.985	0.965	0	HNRNPA3	Malignant cells	GSE138267	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4710
0	0.413433410076976	0.864	0.832	0	UBE2E3	Malignant cells	GSE138267	ENSG00000170035	10477	ubiquitin conjugating enzyme E2 E3	UbcH9	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4711
0	0.319465651308185	0.287	0.101	0	INPP1	Malignant cells	GSE138267	ENSG00000151689	3628	inositol polyphosphate-1-phosphatase	NA	protein_coding	P49441	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4712
0	0.444417996819432	0.322	0.091	0	STAT1	Malignant cells	GSE138267	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4713
0	0.332390950212252	0.528	0.295	0	MOB4	Malignant cells	GSE138267	ENSG00000115540	25843	MOB family member 4, phocein	2C4D|CGI-95|DKFZP564M112|MOB3|MOBKL3|PHOCN|PREI3	protein_coding	Q9Y3A3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4714
0	0.317824653042292	0.381	0.173	0	C2orf69	Malignant cells	GSE138267	ENSG00000178074	205327	chromosome 2 open reading frame 69	FLJ38973	protein_coding	Q8N8R5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4715
0	0.403525468930831	0.499	0.241	0	ABI2	Malignant cells	GSE138267	ENSG00000138443	10152	abl interactor 2	ABI-2|ABI2B|AblBP3|AIP-1|argBPIA|SSH3BP2	protein_coding	Q9NYB9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4716
0	0.30823176558336	0.432	0.218	0	NDUFS1	Malignant cells	GSE138267	ENSG00000283447	4719	NADH:ubiquinone oxidoreductase core subunit S1	CI-75k	protein_coding	P28331	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4717
0	-0.39119093352773	0.969	0.988	0	EEF1B2	Malignant cells	GSE138267	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4718
0	0.277044717524009	0.36	0.166	0	CREB1	Malignant cells	GSE138267	ENSG00000118260	1385	cAMP responsive element binding protein 1	NA	protein_coding	P16220	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4719
0	0.60323105765957	0.448	0.207	0	BARD1	Malignant cells	GSE138267	ENSG00000138376	580	BRCA1 associated RING domain 1	NA	protein_coding	Q99728	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4720
0	0.513133992385131	0.925	0.866	0	XRCC5	Malignant cells	GSE138267	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4721
0	0.300673805654495	0.463	0.251	0	FAM134A	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4722
0	0.262677573844445	0.373	0.195	0	ZFAND2B	Malignant cells	GSE138267	ENSG00000158552	130617	zinc finger AN1-type containing 2B	AIRAPL	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4723
0	0.451400610508985	0.497	0.234	0	TUBA4A	Malignant cells	GSE138267	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4724
0	0.260236659046901	0.428	0.246	0	DNAJB2	Malignant cells	GSE138267	ENSG00000135924	3300	DnaJ heat shock protein family (Hsp40) member B2	CMT2T|HSJ1|HSPF3	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4725
0	0.9302507939319	0.636	0.165	0	ITM2C	Malignant cells	GSE138267	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4726
0	0.433089941122569	0.517	0.228	0	PSMD1	Malignant cells	GSE138267	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4727
0	0.813453206438853	0.916	0.766	0	NCL	Malignant cells	GSE138267	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4728
0	0.844866855755767	1	0.999	0	PTMA	Malignant cells	GSE138267	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4729
0	0.265501824204198	0.339	0.148	0	COPS7B	Malignant cells	GSE138267	ENSG00000144524	64708	COP9 signalosome subunit 7B	CSN7B	protein_coding	Q9H9Q2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4730
0	0.360716401422013	0.534	0.276	0	EIF4E2	Malignant cells	GSE138267	ENSG00000135930	9470	eukaryotic translation initiation factor 4E family member 2	4EHP|EIF4EL3|IF4e	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4731
0	0.253661238702858	0.259	0.088	0	GIGYF2	Malignant cells	GSE138267	ENSG00000204120	26058	GRB10 interacting GYF protein 2	GYF2|KIAA0642|PARK11|PERQ2|PERQ3|TNRC15	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4732
0	0.453286690263094	0.65	0.425	0	COPS8	Malignant cells	GSE138267	ENSG00000198612	10920	COP9 signalosome subunit 8	COP9|CSN8|MGC1297|SGN8	protein_coding	Q99627	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4733
0	0.530059683087266	0.603	0.341	0	LRRFIP1	Malignant cells	GSE138267	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4734
0	0.434785987313144	0.486	0.196	0	ILKAP	Malignant cells	GSE138267	ENSG00000132323	80895	ILK associated serine/threonine phosphatase	DKFZP434J2031|FLJ10181|PPM1O	protein_coding	Q9H0C8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4735
0	0.573952905668442	0.986	0.978	0	HES6	Malignant cells	GSE138267	ENSG00000144485	55502	hes family bHLH transcription factor 6	bHLHb41	protein_coding	Q96HZ4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4736
0	0.455294593429129	0.586	0.285	0	NDUFA10	Malignant cells	GSE138267	ENSG00000130414	4705	NADH:ubiquinone oxidoreductase subunit A10	CI-42k	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4737
0	0.350623278316827	0.793	0.679	0	MYEOV2	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4738
0	0.571798209004249	0.584	0.261	0	KIF1A	Malignant cells	GSE138267	ENSG00000130294	547	kinesin family member 1A	ATSV|C2orf20|SPG30|UNC104	protein_coding	Q12756	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4739
0	0.274823863268645	0.296	0.109	0	MTERFD2	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4740
0	0.512997736965311	0.536	0.213	0	PPP1R7	Malignant cells	GSE138267	ENSG00000115685	5510	protein phosphatase 1 regulatory subunit 7	sds22	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4741
0	0.403838801308849	0.457	0.193	0	HDLBP	Malignant cells	GSE138267	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4742
0	0.481021130994809	0.646	0.471	0	STK25	Malignant cells	GSE138267	ENSG00000115694	10494	serine/threonine kinase 25	SOK1|YSK1	protein_coding	O00506	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4743
0	0.268810047431598	0.391	0.192	0	ATG4B	Malignant cells	GSE138267	ENSG00000168397	23192	autophagy related 4B cysteine peptidase	APG4B|AUTL1|DKFZp586D1822|KIAA0943	protein_coding	Q9Y4P1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4744
0	0.262612400211888	0.355	0.173	0	CRBN	Malignant cells	GSE138267	ENSG00000113851	51185	cereblon	MRT2|MRT2A	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4745
0	-0.379095416722336	0.999	1	0	RPL32	Malignant cells	GSE138267	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4746
0	0.339894951475417	0.396	0.172	0	DYNC1LI1	Malignant cells	GSE138267	ENSG00000144635	51143	dynein cytoplasmic 1 light intermediate chain 1	DNCLI1	protein_coding	Q9Y6G9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4747
0	0.89710768639563	0.295	0.011	0	CCK	Malignant cells	GSE138267	ENSG00000187094	885	cholecystokinin	NA	protein_coding	P06307	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4748
0	0.314718931858318	0.486	0.268	0	NKTR	Malignant cells	GSE138267	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4749
0	-0.269153036484947	0.912	0.981	0	TMA7	Malignant cells	GSE138267	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4750
0	0.383542472679467	0.436	0.19	0	PBRM1	Malignant cells	GSE138267	ENSG00000163939	55193	polybromo 1	BAF180|PB1|SMARCH1	protein_coding	Q86U86	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4751
0	-0.481174949382295	0.359	0.61	0	TKT	Malignant cells	GSE138267	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4752
0	0.632591540798364	0.336	0.049	0	CADM2	Malignant cells	GSE138267	ENSG00000175161	253559	cell adhesion molecule 2	IGSF4D|Necl-3|NECL3|SynCAM2	protein_coding	Q8N3J6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4753
0	-0.559409103083458	0.996	1	0	RPL24	Malignant cells	GSE138267	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4754
0	-0.450495209387308	0.185	0.331	0	ALCAM	Malignant cells	GSE138267	ENSG00000170017	214	activated leukocyte cell adhesion molecule	CD166|MEMD	protein_coding	Q13740	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4755
0	0.433147964497851	0.504	0.275	0	BBX	Malignant cells	GSE138267	ENSG00000114439	56987	BBX high mobility group box domain containing	HBP2|HSPC339|MDS001	protein_coding	Q8WY36	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4756
0	-0.741565542474027	0.53	0.839	0	CD47	Malignant cells	GSE138267	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4757
0	-0.565031596388167	0.458	0.754	0	IFT57	Malignant cells	GSE138267	ENSG00000114446	55081	intraflagellar transport 57	ESRRBL1|FLJ10147|HIPPI|MHS4R2	protein_coding	Q9NWB7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4758
0	-0.694378950945282	0.417	0.823	0	TAGLN3	Malignant cells	GSE138267	ENSG00000144834	29114	transgelin 3	NP22|NP25	protein_coding	Q9UI15	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4759
0	-0.396421749170358	0.831	0.941	0	COX17	Malignant cells	GSE138267	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4760
0	0.333191718338556	0.976	0.98	0	NDUFB4	Malignant cells	GSE138267	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4761
0	-0.255915030131509	0.456	0.68	0	SEC61A1	Malignant cells	GSE138267	ENSG00000058262	29927	SEC61 translocon subunit alpha 1	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4762
0	-0.424362357105547	0.763	0.976	0	RBP1	Malignant cells	GSE138267	ENSG00000114115	5947	retinol binding protein 1	CRABP-I|CRBP|CRBP1|CRBPI|RBPC	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4763
0	-0.328914642016962	0.702	0.889	0	RNF7	Malignant cells	GSE138267	ENSG00000114125	9616	ring finger protein 7	CKBBP1|RBX2|ROC2|SAG	protein_coding	Q9UBF6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4764
0	0.318302115420947	0.747	0.744	0	U2SURP	Malignant cells	GSE138267	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4765
0	0.256035497062147	0.315	0.158	0	PLOD2	Malignant cells	GSE138267	ENSG00000152952	5352	procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	LH2|TLH	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4766
0	0.476865688636653	0.395	0.201	0	PLSCR1	Malignant cells	GSE138267	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4767
0	-0.301997990228164	0.888	0.959	0	SERP1	Malignant cells	GSE138267	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4768
0	-0.417184686536773	0.548	0.814	0	SSR3	Malignant cells	GSE138267	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4769
0	0.490177653313077	0.543	0.282	0	MLF1	Malignant cells	GSE138267	ENSG00000178053	4291	myeloid leukemia factor 1	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4770
0	0.375930689169138	0.412	0.201	0	GOLIM4	Malignant cells	GSE138267	ENSG00000173905	27333	golgi integral membrane protein 4	GIMPC|GOLPH4|GPP130|P138	protein_coding	O00461	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4771
0	-0.570022371732753	0.568	0.826	0	RPL22L1	Malignant cells	GSE138267	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4772
0	0.251308494844299	0.274	0.124	0	USP13	Malignant cells	GSE138267	ENSG00000058056	8975	ubiquitin specific peptidase 13	IsoT-3	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4773
0	0.337561983809794	0.342	0.151	0	PEX5L	Malignant cells	GSE138267	ENSG00000114757	51555	peroxisomal biogenesis factor 5 like	PEX5R|PXR2|TRIP8b	protein_coding	Q8IYB4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4774
0	0.306807595482684	0.402	0.2	0	TTC14	Malignant cells	GSE138267	ENSG00000163728	151613	tetratricopeptide repeat domain 14	FLJ00166|KIAA1980	protein_coding	Q96N46	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4775
0	0.318545844749023	0.42	0.226	0	KLHL24	Malignant cells	GSE138267	ENSG00000114796	54800	kelch like family member 24	DRE1|FLJ20059	protein_coding	Q6TFL4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4776
0	0.496357567141937	0.297	0.072	0	MAP6D1	Malignant cells	GSE138267	ENSG00000180834	79929	MAP6 domain containing 1	FLJ12748|SL21	protein_coding	Q9H9H5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4777
0	0.330174553403645	0.776	0.778	0	MAP3K13	Malignant cells	GSE138267	ENSG00000073803	9175	mitogen-activated protein kinase kinase kinase 13	LZK|MEKK13	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4778
0	0.286649943125402	0.28	0.108	0	ETV5	Malignant cells	GSE138267	ENSG00000244405	2119	ETS variant transcription factor 5	ERM	protein_coding	P41161	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4779
0	-0.744624531337476	0.12	0.445	0	RPL39L	Malignant cells	GSE138267	ENSG00000163923	116832	ribosomal protein L39 like	RPL39L1	protein_coding	Q96EH5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4780
0	-0.269373371715839	0.489	0.744	0	PIGX	Malignant cells	GSE138267	ENSG00000163964	54965	phosphatidylinositol glycan anchor biosynthesis class X	FLJ20522	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4781
0	-0.379026931130465	0.555	0.822	0	NCBP2-AS2	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4782
0	-0.344970307448963	1	1	0	RPL35A	Malignant cells	GSE138267	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4783
0	0.253721502220119	0.365	0.192	0	WHSC1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4784
0	0.466411094978112	0.443	0.189	0	NSG1	Malignant cells	GSE138267	ENSG00000168824	27065	neuronal vesicle trafficking associated 1	D4S234E|NEEP21|P21	protein_coding	P42857	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4785
0	-0.90076760829089	0.082	0.382	0	SH3TC1	Malignant cells	GSE138267	ENSG00000125089	54436	SH3 domain and tetratricopeptide repeats 1	FLJ20356	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4786
0	0.294289564539219	0.482	0.303	0	RFC1	Malignant cells	GSE138267	ENSG00000035928	5981	replication factor C subunit 1	A1|MHCBFB|PO-GA|RFC140	protein_coding	P35251	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4787
0	-0.41932865553937	0.999	0.999	0	RPL9	Malignant cells	GSE138267	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4788
0	-0.925914782148296	0.638	0.977	0	UCHL1	Malignant cells	GSE138267	ENSG00000154277	7345	ubiquitin C-terminal hydrolase L1	PARK5|PGP9.5|Uch-L1|UCHL-1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4789
0	0.283504839801305	0.259	0.119	0	RASL11B	Malignant cells	GSE138267	ENSG00000128045	65997	RAS like family 11 member B	NA	protein_coding	Q9BPW5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4790
0	-0.371348055345414	0.416	0.693	0	PAICS	Malignant cells	GSE138267	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4791
0	0.325611685075085	0.53	0.307	0	YTHDC1	Malignant cells	GSE138267	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4792
0	0.314586081344481	0.45	0.26	0	DCK	Malignant cells	GSE138267	ENSG00000156136	1633	deoxycytidine kinase	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4793
0	-0.751770850264719	0.354	0.774	0	RASSF6	Malignant cells	GSE138267	ENSG00000169435	166824	Ras association domain family member 6	NA	protein_coding	Q6ZTQ3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4794
0	1.04706697399775	0.582	0.554	0	SEPT11	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4795
0	0.298957569348936	0.964	0.947	0	CCNI	Malignant cells	GSE138267	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4796
0	-0.437038527435589	0.295	0.415	0	HSD17B11	Malignant cells	GSE138267	ENSG00000198189	51170	hydroxysteroid 17-beta dehydrogenase 11	17-BETA-HSD11|17-BETA-HSDXI|DHRS8|PAN1B|RetSDR2|SDR16C2	protein_coding	Q8NBQ5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4797
0	0.49456098709095	0.287	0.122	0	FAM13A	Malignant cells	GSE138267	ENSG00000138640	10144	family with sequence similarity 13 member A	ARHGAP48|FAM13A1|KIAA0914	protein_coding	O94988	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4798
0	-0.271969019344599	0.56	0.814	0	CISD2	Malignant cells	GSE138267	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4799
0	-0.290895619236397	0.507	0.732	0	PPA2	Malignant cells	GSE138267	ENSG00000138777	27068	inorganic pyrophosphatase 2	FLJ20459	protein_coding	Q9H2U2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4800
0	0.302654537450203	0.438	0.287	0	HADH	Malignant cells	GSE138267	ENSG00000138796	3033	hydroxyacyl-CoA dehydrogenase	HADH1|HADHSC|SCHAD	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4801
0	-0.574621828123764	0.999	0.999	0	RPL34	Malignant cells	GSE138267	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4802
0	-0.564661505458781	0.578	0.863	0	OSTC	Malignant cells	GSE138267	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4803
0	0.465034079675813	0.479	0.219	0	CCDC109B	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4804
0	0.360484966788598	0.415	0.227	0	TIFA	Malignant cells	GSE138267	ENSG00000145365	92610	TRAF interacting protein with forkhead associated domain	MGC20791|T2BP|T6BP|TIFAA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4805
0	0.255693924009207	0.499	0.315	0	LARP7	Malignant cells	GSE138267	ENSG00000174720	51574	La ribonucleoprotein 7, transcriptional regulator	DKFZP564K112|HDCMA18P|PIP7S	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4806
0	-0.27617083567228	0.52	0.779	0	C4orf3	Malignant cells	GSE138267	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4807
0	0.264172215551843	0.452	0.268	0	PGRMC2	Malignant cells	GSE138267	ENSG00000164040	10424	progesterone receptor membrane component 2	DG6|PMBP	protein_coding	O15173	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4808
0	0.411192932127926	0.364	0.137	0	JADE1	Malignant cells	GSE138267	ENSG00000077684	79960	jade family PHD finger 1	JADE-1|PHF17	protein_coding	Q6IE81	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4809
0	0.305321997667268	0.363	0.149	0	ELF2	Malignant cells	GSE138267	ENSG00000109381	1998	E74 like ETS transcription factor 2	EU32|NERF|NERF-1A|NERF-1B|NERF-2	protein_coding	Q15723	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4810
0	1.09628351420758	0.961	0.754	0	CPE	Malignant cells	GSE138267	ENSG00000109472	1363	carboxypeptidase E	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4811
0	0.342493487768867	0.412	0.165	0	C4orf27	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4812
0	0.922899963340803	0.958	0.9	0	HMGB2	Malignant cells	GSE138267	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4813
0	0.331315910412927	0.316	0.109	0	RP11-798M19.6	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4814
0	0.262510037082834	0.335	0.145	0	CDKN2AIP	Malignant cells	GSE138267	ENSG00000168564	55602	CDKN2A interacting protein	CARF|FLJ20036	protein_coding	Q9NXV6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4815
0	0.275836101185203	0.387	0.188	0	ING2	Malignant cells	GSE138267	ENSG00000168556	3622	inhibitor of growth family member 2	ING1L|p33ING2	protein_coding	Q9H160	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4816
0	0.272115663392965	0.378	0.193	0	RWDD4	Malignant cells	GSE138267	ENSG00000182552	201965	RWD domain containing 4	FAM28A|MGC10198|RWDD4A	protein_coding	Q6NW29	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4817
0	0.437401008348576	0.447	0.285	0	CENPU	Malignant cells	GSE138267	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4818
0	0.368527285470242	0.315	0.098	0	SORBS2	Malignant cells	GSE138267	ENSG00000154556	8470	sorbin and SH3 domain containing 2	ARGBP2|KIAA0777	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4819
0	0.351947530116602	0.507	0.269	0	FRG1	Malignant cells	GSE138267	ENSG00000275145	2483	FSHD region gene 1	FRG1A|FSG1	protein_coding	Q14331	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4820
0	0.813074553020963	0.439	0.143	0	IRX2	Malignant cells	GSE138267	ENSG00000170561	153572	iroquois homeobox 2	NA	protein_coding	Q9BZI1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4821
0	0.325179642584839	0.895	0.872	0	CCT5	Malignant cells	GSE138267	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4822
0	0.271591202382265	0.474	0.296	0	DAP	Malignant cells	GSE138267	ENSG00000112977	1611	death associated protein	DAP1	protein_coding	P51397	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4823
0	0.473815210723418	0.537	0.277	0	FAM105A	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4824
0	0.253797854504119	0.446	0.272	0	ZFR	Malignant cells	GSE138267	ENSG00000056097	51663	zinc finger RNA binding protein	SPG71|ZFR1	protein_coding	Q96KR1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4825
0	-0.433664686448662	0.985	0.995	0	SUB1	Malignant cells	GSE138267	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4826
0	0.379422768907259	0.498	0.239	0	NIPBL	Malignant cells	GSE138267	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4827
0	-0.37412355456149	0.975	1	0	RPL37	Malignant cells	GSE138267	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4828
0	0.264680654855778	0.327	0.167	0	OXCT1	Malignant cells	GSE138267	ENSG00000083720	5019	3-oxoacid CoA-transferase 1	OXCT|SCOT	protein_coding	P55809	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4829
0	-0.306502101892703	0.56	0.775	0	ISL1	Malignant cells	GSE138267	ENSG00000016082	3670	ISL LIM homeobox 1	Isl-1|ISLET1	protein_coding	P61371	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4830
0	0.347702107997449	0.754	0.772	0	NDUFS4	Malignant cells	GSE138267	ENSG00000164258	4724	NADH:ubiquinone oxidoreductase subunit S4	AQDQ|CI-18	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4831
0	0.25779859914437	0.358	0.191	0	DHX29	Malignant cells	GSE138267	ENSG00000067248	54505	DExH-box helicase 29	DDX29	protein_coding	Q7Z478	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4832
0	0.666674593965212	0.316	0.033	0	PLK2	Malignant cells	GSE138267	ENSG00000145632	10769	polo like kinase 2	SNK	protein_coding	Q9NYY3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4833
0	0.437658599404599	0.451	0.214	0	CWC27	Malignant cells	GSE138267	ENSG00000153015	10283	CWC27 spliceosome associated cyclophilin	NY-CO-10|SDCCAG-10|SDCCAG10	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4834
0	0.561464867045411	0.536	0.254	0	BDP1	Malignant cells	GSE138267	ENSG00000274803	55814	B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB	HSA238520|KIAA1241|KIAA1689|TAF3B1|TFC5|TFIIIB150|TFIIIB90|TFNR	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4835
0	-0.35524534940101	0.993	0.997	0	BTF3	Malignant cells	GSE138267	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4836
0	0.440611413289688	0.296	0.073	0	ENC1	Malignant cells	GSE138267	ENSG00000171617	8507	ectodermal-neural cortex 1	ENC-1|KLHL37|NRPB|PIG10|TP53I10	protein_coding	O14682	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4837
0	0.329385616246905	0.37	0.229	0	DHFR	Malignant cells	GSE138267	ENSG00000228716	1719	dihydrofolate reductase	NA	protein_coding	P00374	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4838
0	0.342947300386178	0.352	0.132	0	SSBP2	Malignant cells	GSE138267	ENSG00000145687	23635	single stranded DNA binding protein 2	HSPC116	protein_coding	P81877	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4839
0	0.277291713994834	0.452	0.282	0	TMEM167A	Malignant cells	GSE138267	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4840
0	0.978317179985842	0.32	0	0	HAPLN1	Malignant cells	GSE138267	ENSG00000145681	1404	hyaluronan and proteoglycan link protein 1	CRTL1	protein_coding	P10915	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4841
0	0.30675196507537	0.364	0.164	0	CCNH	Malignant cells	GSE138267	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4842
0	0.568317430477479	0.543	0.297	0	RHOBTB3	Malignant cells	GSE138267	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4843
0	0.373156372513902	0.307	0.097	0	PCSK1	Malignant cells	GSE138267	ENSG00000175426	5122	proprotein convertase subtilisin/kexin type 1	NEC1|PC1|PC1/3|PC3|SPC3	protein_coding	P29120	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4844
0	0.293623900692186	0.346	0.158	0	CHD1	Malignant cells	GSE138267	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4845
0	0.292453988599972	0.452	0.255	0	ATG12	Malignant cells	GSE138267	ENSG00000145782	9140	autophagy related 12	APG12|APG12L	protein_coding	O94817	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4846
0	0.325313296465184	0.508	0.298	0	AP3S1	Malignant cells	GSE138267	ENSG00000177879	1176	adaptor related protein complex 3 subunit sigma 1	CLAPS3	protein_coding	Q92572	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4847
0	-0.465538360747017	0.992	0.997	0	HINT1	Malignant cells	GSE138267	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4848
0	0.487125381820699	0.409	0.207	0	IRF1	Malignant cells	GSE138267	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4849
0	0.359671433950812	0.958	0.958	0	H2AFY	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4850
0	0.31240530298675	0.308	0.124	0	CXXC5	Malignant cells	GSE138267	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4851
0	0.465272973231716	0.75	0.77	0	TAF7	Malignant cells	GSE138267	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4852
0	0.653952280850062	0.407	0.065	0	NR3C1	Malignant cells	GSE138267	ENSG00000113580	2908	nuclear receptor subfamily 3 group C member 1	GR|GRL	protein_coding	P04150	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4853
0	0.283919502011431	0.38	0.194	0	RBM27	Malignant cells	GSE138267	ENSG00000091009	54439	RNA binding motif protein 27	ARRS1|KIAA1311|Psc1|ZC3H20	protein_coding	Q9P2N5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4854
0	0.310343698868766	0.406	0.204	0	TCERG1	Malignant cells	GSE138267	ENSG00000113649	10915	transcription elongation regulator 1	CA150|TAF2S|Urn1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4855
0	-0.253762870104547	0.489	0.689	0	DPYSL3	Malignant cells	GSE138267	ENSG00000113657	1809	dihydropyrimidinase like 3	CRMP4|DRP-3|ULIP	protein_coding	Q14195	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4856
0	0.265943240325087	0.253	0.097	0	JAKMIP2	Malignant cells	GSE138267	ENSG00000176049	9832	janus kinase and microtubule interacting protein 2	JAMIP2|KIAA0555	protein_coding	Q96AA8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4857
0	0.296884963697117	0.778	0.76	0	CSNK1A1	Malignant cells	GSE138267	ENSG00000113712	1452	casein kinase 1 alpha 1	CK1|CK1a|CK1alpha|CKIa|CKIalpha	protein_coding	P48729	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4858
0	0.381825299006324	0.471	0.223	0	RBM22	Malignant cells	GSE138267	ENSG00000086589	55696	RNA binding motif protein 22	Cwc2|FLJ10290|fSAP47|ZC3H16	protein_coding	Q9NW64	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4859
0	0.546731720170446	0.387	0.087	0	ANXA6	Malignant cells	GSE138267	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4860
0	-0.331629508175338	0.484	0.732	0	ATOX1	Malignant cells	GSE138267	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4861
0	0.253484903225588	0.524	0.354	0	G3BP1	Malignant cells	GSE138267	ENSG00000145907	10146	G3BP stress granule assembly factor 1	G3BP|HDH-VIII	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4862
0	0.30488447880818	0.492	0.285	0	TTC1	Malignant cells	GSE138267	ENSG00000113312	7265	tetratricopeptide repeat domain 1	TPR1	protein_coding	Q99614	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4863
0	0.282758090335804	0.462	0.264	0	SLU7	Malignant cells	GSE138267	ENSG00000164609	10569	SLU7 homolog, splicing factor	9G8	protein_coding	O95391	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4864
0	0.439592741915757	0.522	0.282	0	CCNG1	Malignant cells	GSE138267	ENSG00000113328	900	cyclin G1	CCNG	protein_coding	P51959	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4865
0	0.367880080800994	0.298	0.088	0	NEURL1B	Malignant cells	GSE138267	ENSG00000214357	54492	neuralized E3 ubiquitin protein ligase 1B	DKFZP761M1511|Neur2|RNF67B	protein_coding	A8MQ27	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4866
0	-0.390302372103785	0.61	0.837	0	ATP6V0E1	Malignant cells	GSE138267	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4867
0	0.28934657531645	0.517	0.326	0	CLTB	Malignant cells	GSE138267	ENSG00000175416	1212	clathrin light chain B	Lcb	protein_coding	P09497	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4868
0	0.362821303091547	0.519	0.307	0	DBN1	Malignant cells	GSE138267	ENSG00000113758	1627	drebrin 1	D0S117E	protein_coding	Q16643	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4869
0	0.475728206146824	0.597	0.367	0	PRPF4B	Malignant cells	GSE138267	ENSG00000112739	8899	pre-mRNA processing factor 4B	KIAA0536|PR4H|Prp4	protein_coding	Q13523	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4870
0	0.352652640762038	0.349	0.129	0	TFAP2A	Malignant cells	GSE138267	ENSG00000137203	7020	transcription factor AP-2 alpha	AP-2|AP-2alpha|AP2TF|TFAP2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4871
0	-0.320563992555589	0.636	0.871	0	TMEM14C	Malignant cells	GSE138267	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4872
0	0.610443440988794	0.656	0.579	0	MYLIP	Malignant cells	GSE138267	ENSG00000007944	29116	myosin regulatory light chain interacting protein	IDOL|MIR	protein_coding	Q8WY64	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4873
0	0.603794645671929	0.983	0.978	0	DEK	Malignant cells	GSE138267	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4874
0	-0.587318037540503	0.187	0.402	0	CDKAL1	Malignant cells	GSE138267	ENSG00000145996	54901	CDK5 regulatory subunit associated protein 1 like 1	FLJ20342	protein_coding	Q5VV42	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4875
0	0.759988593759441	0.29	0.075	0	HIST1H2AC	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4876
0	0.357073606982338	0.339	0.146	0	ZNF322	Malignant cells	GSE138267	ENSG00000181315	79692	zinc finger protein 322	bA457M11.2|bA457M11.3|HCG12|ZNF322A|ZNF388|ZNF489	protein_coding	Q6U7Q0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4877
0	0.334060518438635	0.411	0.235	0	ZSCAN16-AS1	Malignant cells	GSE138267	ENSG00000269293	100129195	ZSCAN16 antisense RNA 1	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4878
0	0.932829380643822	0.848	0.852	0	HLA-A	Malignant cells	GSE138267	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4879
0	0.372249709151176	0.427	0.195	0	PPP1R10	Malignant cells	GSE138267	ENSG00000230995	5514	protein phosphatase 1 regulatory subunit 10	CAT53|FB19|p99|PNUTS	protein_coding	Q96QC0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4880
0	0.403952386819631	0.999	0.995	0	TUBB	Malignant cells	GSE138267	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4881
0	0.579847865421682	0.283	0.14	0	IER3	Malignant cells	GSE138267	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4882
0	0.452003037591021	0.427	0.269	0	TCF19	Malignant cells	GSE138267	ENSG00000224472	6941	transcription factor 19	SC1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4883
0	0.624910843296162	0.743	0.719	0	HLA-C	Malignant cells	GSE138267	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4884
0	0.667447252498467	0.506	0.384	0	HLA-B	Malignant cells	GSE138267	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4885
0	0.32327747694739	0.503	0.29	0	GPANK1	Malignant cells	GSE138267	ENSG00000223932	7918	G-patch domain and ankyrin repeats 1	ANKRD59|BAT4|D6S54E|G5|GPATCH10	protein_coding	O95872	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4886
0	-0.297551336534859	0.498	0.729	0	DDAH2	Malignant cells	GSE138267	ENSG00000226634	23564	dimethylarginine dimethylaminohydrolase 2	G6A	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4887
0	0.277219459327817	0.766	0.758	0	NELFE	Malignant cells	GSE138267	ENSG00000206268	7936	negative elongation factor complex member E	D6S45|NELF-E|RD|RDBP|RDP	protein_coding	P18615	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4888
0	0.459193995897345	0.575	0.282	0	ATF6B	Malignant cells	GSE138267	ENSG00000228628	1388	activating transcription factor 6 beta	CREBL1|G13	protein_coding	Q99941	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4889
0	0.742983861529248	0.515	0.191	0	PSMB8	Malignant cells	GSE138267	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4890
0	0.608484358485699	0.311	0.035	0	PSMB9	Malignant cells	GSE138267	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4891
0	0.439284816479374	0.275	0.03	0	TAP1	Malignant cells	GSE138267	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4892
0	0.531985278080821	0.795	0.739	0	BRD2	Malignant cells	GSE138267	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4893
0	0.308342128496861	0.49	0.289	0	SLC39A7	Malignant cells	GSE138267	ENSG00000229802	7922	solute carrier family 39 member 7	D6S2244E|H2-KE4|HKE4|KE4|RING5|ZIP7	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4894
0	0.28360564390014	0.45	0.249	0	RING1	Malignant cells	GSE138267	ENSG00000228520	6015	ring finger protein 1	RNF1	protein_coding	Q06587	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4895
0	0.550662612308015	0.418	0.201	0	KIFC1	Malignant cells	GSE138267	ENSG00000233450	3833	kinesin family member C1	HSET|KNSL2	protein_coding	Q9BW19	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4896
0	0.32024211197268	0.379	0.176	0	PHF1	Malignant cells	GSE138267	ENSG00000225553	5252	PHD finger protein 1	MTF2L2|PCL1|TDRD19C	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4897
0	-0.549349186847208	0.658	0.926	0	HMGA1	Malignant cells	GSE138267	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4898
0	0.457489718045011	0.488	0.267	0	NUDT3	Malignant cells	GSE138267	ENSG00000272325	11165	nudix hydrolase 3	DIPP	protein_coding	O95989	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4899
0	-0.368684859699642	0.999	1	0	RPL10A	Malignant cells	GSE138267	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4900
0	0.681160179975858	0.498	0.311	0	PIM1	Malignant cells	GSE138267	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4901
0	0.322969836484139	0.542	0.315	0	MRPS10	Malignant cells	GSE138267	ENSG00000048544	55173	mitochondrial ribosomal protein S10	FLJ10567	protein_coding	P82664	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4902
0	0.254703648279652	0.351	0.186	0	PTK7	Malignant cells	GSE138267	ENSG00000112655	5754	protein tyrosine kinase 7 (inactive)	CCK4	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4903
0	0.48668510816975	0.279	0.009	0	RCAN2	Malignant cells	GSE138267	ENSG00000172348	10231	regulator of calcineurin 2	DSCR1L1|ZAKI-4	protein_coding	Q14206	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4904
0	0.982480489191283	0.375	0.005	0	TFAP2B	Malignant cells	GSE138267	ENSG00000008196	7021	transcription factor AP-2 beta	AP-2beta|AP2-B	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4905
0	0.493240518675175	0.513	0.212	0	EFHC1	Malignant cells	GSE138267	ENSG00000096093	114327	EF-hand domain containing 1	EJM|EJM1|FLJ10466|POC9|RIB72	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4906
0	-0.343634614263516	0.49	0.762	0	TMEM14A	Malignant cells	GSE138267	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4907
0	-0.45883193634779	1	1	0	EEF1A1	Malignant cells	GSE138267	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4908
0	1.39916214637767	0.369	0.165	0	MYO6	Malignant cells	GSE138267	ENSG00000196586	4646	myosin VI	DFNA22|DFNB37|KIAA0389	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4909
0	0.416874043114281	0.727	0.696	0	PHIP	Malignant cells	GSE138267	ENSG00000146247	55023	pleckstrin homology domain interacting protein	BRWD2|DCAF14|FLJ20705|ndrp|WDR11	protein_coding	Q8WWQ0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4910
0	0.547659273791985	0.465	0.174	0	FAM46A	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4911
0	0.331974138978696	0.271	0.109	0	TPBG	Malignant cells	GSE138267	ENSG00000283085	7162	trophoblast glycoprotein	5T4|5T4-AG	protein_coding	Q13641	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4912
0	0.423127130050036	0.506	0.254	0	ZNF292	Malignant cells	GSE138267	ENSG00000188994	23036	zinc finger protein 292	bA393I2.3|KIAA0530|ZFP292|Zn-15|Zn-16	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4913
0	0.466139840120304	0.818	0.797	0	PNISR	Malignant cells	GSE138267	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4914
0	-0.757673826387519	0.997	1	0	RPS12	Malignant cells	GSE138267	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4915
0	0.420528868038821	0.283	0.071	0	SGK1	Malignant cells	GSE138267	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4916
0	0.538892622918948	0.514	0.268	0	AHI1	Malignant cells	GSE138267	ENSG00000135541	54806	Abelson helper integration site 1	FLJ20069|JBTS3|ORF1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4917
0	-0.395176681880906	0.796	0.962	0	PERP	Malignant cells	GSE138267	ENSG00000112378	64065	p53 apoptosis effector related to PMP22	dJ496H19.1|KCP1|KRTCAP1|PIGPC1|THW	protein_coding	Q96FX8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4918
0	0.780558573156263	0.602	0.356	0	CITED2	Malignant cells	GSE138267	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4919
0	-0.443946964715988	0.84	0.968	0	SF3B5	Malignant cells	GSE138267	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4920
0	0.376408393658218	0.468	0.298	0	RGS17	Malignant cells	GSE138267	ENSG00000091844	26575	regulator of G protein signaling 17	RGS-17|RGSZ2	protein_coding	Q9UGC6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4921
0	0.434954036327967	0.775	0.772	0	EZR	Malignant cells	GSE138267	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4922
0	-0.906064897086089	1	1	0	ACTB	Malignant cells	GSE138267	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4923
0	0.273369099997024	0.457	0.306	0	FSCN1	Malignant cells	GSE138267	ENSG00000075618	6624	fascin actin-bundling protein 1	FLJ38511|p55|SNL	protein_coding	Q16658	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4924
0	-0.333460275443908	0.672	0.836	0	RPA3	Malignant cells	GSE138267	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4925
0	-0.395107892348696	0.455	0.814	0	ICA1	Malignant cells	GSE138267	ENSG00000003147	3382	islet cell autoantigen 1	ICA69|ICAp69	protein_coding	Q05084	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4926
0	-0.680754110126796	0.955	0.996	0	NDUFA4	Malignant cells	GSE138267	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4927
0	0.408230247633456	0.34	0.1	0	SCIN	Malignant cells	GSE138267	ENSG00000006747	85477	scinderin	KIAA1905	protein_coding	Q9Y6U3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4928
0	-0.294532140181324	0.904	0.975	0	TOMM7	Malignant cells	GSE138267	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4929
0	1.11638537365594	0.5	0.139	0	CAMK2B	Malignant cells	GSE138267	ENSG00000058404	816	calcium/calmodulin dependent protein kinase II beta	CAM2|CAMK2|CAMKB|CaMKIIbeta	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4930
0	-0.347562094931156	0.997	1	0	PPIA	Malignant cells	GSE138267	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4931
0	-0.318226966308356	0.451	0.793	0	DDC	Malignant cells	GSE138267	ENSG00000132437	1644	dopa decarboxylase	AADC	protein_coding	P20711	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4932
0	-0.616553499065022	0.893	0.987	0	SEC61G	Malignant cells	GSE138267	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4933
0	0.500858977443573	0.358	0.125	0	LANCL2	Malignant cells	GSE138267	ENSG00000132434	55915	LanC like glutathione S-transferase 2	GPR69B|TASP	protein_coding	Q9NS86	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4934
0	-0.367247175168286	0.998	0.999	0	CHCHD2	Malignant cells	GSE138267	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4935
0	0.571797987283434	0.906	0.809	0	HSPB1	Malignant cells	GSE138267	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4936
0	-0.263146361139097	0.469	0.701	0	BRI3	Malignant cells	GSE138267	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4937
0	-0.306730919302137	0.346	0.553	0	ARPC1B	Malignant cells	GSE138267	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4938
0	-0.299800995620909	0.726	0.897	0	BUD31	Malignant cells	GSE138267	ENSG00000106245	8896	BUD31 homolog	Cwc14|EDG-2|EDG2|fSAP17|G10|YCR063W	protein_coding	P41223	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4939
0	-0.259592938731725	0.679	0.863	0	MCM7	Malignant cells	GSE138267	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4940
0	-0.414853727482446	0.694	0.894	0	LAMTOR4	Malignant cells	GSE138267	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4941
0	-0.347855308284401	0.593	0.83	0	POP7	Malignant cells	GSE138267	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4942
0	-0.400094307772226	0.529	0.845	0	ZNHIT1	Malignant cells	GSE138267	ENSG00000106400	10467	zinc finger HIT-type containing 1	CG1I|H_DJ0747G18.14|ZNFN4A1	protein_coding	O43257	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4943
0	-0.437068571115011	0.518	0.832	0	FIS1	Malignant cells	GSE138267	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4944
0	-0.404808544818707	0.592	0.842	0	POLR2J	Malignant cells	GSE138267	ENSG00000005075	5439	RNA polymerase II subunit J	hRPB14|POLR2J1|RPB11|RPB11A|RPB11m	protein_coding	P52435	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4945
0	-0.254639595815136	0.539	0.763	0	CAPZA2	Malignant cells	GSE138267	ENSG00000198898	830	capping actin protein of muscle Z-line subunit alpha 2	CAPPA2|CAPZ	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4946
0	-0.70246647590206	0.56	0.917	0	ARF5	Malignant cells	GSE138267	ENSG00000004059	381	ADP ribosylation factor 5	NA	protein_coding	P84085	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4947
0	-0.291864958119095	0.417	0.619	0	CHCHD3	Malignant cells	GSE138267	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4948
0	-0.389039922498561	0.835	0.955	0	NDUFB2	Malignant cells	GSE138267	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4949
0	-0.371934671070638	0.532	0.811	0	MRPS33	Malignant cells	GSE138267	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4950
0	-0.440061053821273	0.4	0.668	0	PDIA4	Malignant cells	GSE138267	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4951
0	-0.415784307449843	0.387	0.701	0	REPIN1	Malignant cells	GSE138267	ENSG00000214022	29803	replication initiator 1	AP4|H_DJ0584D14.12|RIP60|Zfp464|ZNF464	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4952
0	-0.853876998552663	0.118	0.284	0	TMEM176A	Malignant cells	GSE138267	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4953
0	0.261678776494426	0.328	0.162	0	LINC00685	Malignant cells	GSE138267	ENSG00000280741	NA	NA	CXYorf10|NCRNA00107|OTTHUMT00000055574|PPP2R3B-AS1	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4954
0	-0.672176724174916	0.994	0.999	0	SLC25A6	Malignant cells	GSE138267	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4955
0	-1.49153576681569	0.998	1	0	TMSB4X	Malignant cells	GSE138267	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4956
0	-1.29425947713035	0.873	0.977	0	SMS	Malignant cells	GSE138267	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4957
0	-0.433564103145692	0.612	0.873	0	PRDX4	Malignant cells	GSE138267	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4958
0	-0.308529004944366	0.971	0.992	0	NDUFB11	Malignant cells	GSE138267	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4959
0	-0.505975134649954	0.059	0.326	0	TIMP1	Malignant cells	GSE138267	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4960
0	-0.275723496841097	0.542	0.774	0	EBP	Malignant cells	GSE138267	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4961
0	0.58965280092801	0.423	0.812	0	PCSK1N	Malignant cells	GSE138267	ENSG00000102109	27344	proprotein convertase subtilisin/kexin type 1 inhibitor	BigLEN|PEN|proSAAS|SAAS|SCG8|SgVIII	protein_coding	Q9UHG2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4962
0	0.277143111015028	0.499	0.321	0	MAGED1	Malignant cells	GSE138267	ENSG00000179222	9500	MAGE family member D1	DLXIN-1|NRAGE	protein_coding	Q9Y5V3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4963
0	0.364615884796304	0.403	0.166	0	MSN	Malignant cells	GSE138267	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4964
0	-0.593534949874782	0.999	0.999	0	RPS4X	Malignant cells	GSE138267	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4965
0	0.83229402985816	0.396	0.009	0	HMGN5	Malignant cells	GSE138267	ENSG00000198157	79366	high mobility group nucleosome binding domain 5	NSBP1	protein_coding	P82970	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4966
0	0.279608612637143	0.422	0.235	0	ARMCX3	Malignant cells	GSE138267	ENSG00000102401	51566	armadillo repeat containing X-linked 3	ALEX3|GASP6	protein_coding	Q9UH62	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4967
0	-0.27682052221154	0.113	0.256	0	BEX5	Malignant cells	GSE138267	ENSG00000184515	340542	brain expressed X-linked 5	NGFRAP1L1	protein_coding	Q5H9J7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4968
0	-0.802824825194593	0.432	0.738	0	TMSB15A	Malignant cells	GSE138267	ENSG00000158164	11013	thymosin beta 15A	TMSL8|TMSNB	protein_coding	P0CG34	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4969
0	-0.404587100981961	0.922	0.981	0	BEX1	Malignant cells	GSE138267	ENSG00000133169	55859	brain expressed X-linked 1	NA	protein_coding	Q9HBH7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4970
0	-0.390553433437255	0.632	0.853	0	TCEAL8	Malignant cells	GSE138267	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4971
0	-0.351047389138415	0.131	0.304	0	TCEAL5	Malignant cells	GSE138267	ENSG00000204065	340543	transcription elongation factor A like 5	WEX4	protein_coding	Q5H9L2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4972
0	-0.369921002199575	0.723	0.936	0	BEX2	Malignant cells	GSE138267	ENSG00000133134	84707	brain expressed X-linked 2	DJ79P11.1	protein_coding	Q9BXY8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4973
0	0.394389568518058	0.325	0.108	0	PLS3	Malignant cells	GSE138267	ENSG00000102024	5358	plastin 3	T-plastin	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4974
0	-0.255831830963972	0.493	0.708	0	PGRMC1	Malignant cells	GSE138267	ENSG00000101856	10857	progesterone receptor membrane component 1	HPR6.6	protein_coding	O00264	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4975
0	-0.406835964180896	0.943	0.991	0	SLC25A5	Malignant cells	GSE138267	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4976
0	-0.647642827966898	0.999	0.999	0	RPL39	Malignant cells	GSE138267	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4977
0	0.299856631068344	0.422	0.224	0	STAG2	Malignant cells	GSE138267	ENSG00000101972	10735	stromal antigen 2	SA-2|SA2|SCC3B	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4978
0	-0.283642435658882	0.809	0.925	0	HMGB3	Malignant cells	GSE138267	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4979
0	-0.404541285464631	0.626	0.858	0	BCAP31	Malignant cells	GSE138267	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4980
0	-0.504297706457148	0.861	0.969	0	SSR4	Malignant cells	GSE138267	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4981
0	-0.271916374798226	0.569	0.773	0	NAA10	Malignant cells	GSE138267	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4982
0	-0.669133034324092	1	1	0	RPL10	Malignant cells	GSE138267	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4983
0	-0.324922354934353	0.12	0.292	0	MPP1	Malignant cells	GSE138267	ENSG00000130830	4354	MAGUK p55 scaffold protein 1	DXS552E|PEMP	protein_coding	Q00013	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4984
0	1.68135699307331	0.437	0.049	0	DEFB1	Malignant cells	GSE138267	ENSG00000164825	1672	defensin beta 1	BD1|DEFB-1|DEFB101|HBD-1|HBD1|MGC51822	protein_coding	P60022	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4985
0	0.252621363430588	0.312	0.157	0	BIN3	Malignant cells	GSE138267	ENSG00000147439	55909	bridging integrator 3	NA	protein_coding	Q9NQY0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4986
0	0.317228972911726	0.45	0.256	0	R3HCC1	Malignant cells	GSE138267	ENSG00000104679	203069	R3H domain and coiled-coil containing 1	DKFZp564N123	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4987
0	0.274039762626305	0.291	0.123	0	SLC25A37	Malignant cells	GSE138267	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4988
0	0.840048653202079	0.292	0.061	0	STC1	Malignant cells	GSE138267	ENSG00000159167	6781	stanniocalcin 1	STC	protein_coding	P52823	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4989
0	-0.318587140758608	0.654	0.837	0	TMEM66	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4990
0	0.275238612798922	0.427	0.27	0	PPP2CB	Malignant cells	GSE138267	ENSG00000104695	5516	protein phosphatase 2 catalytic subunit beta	PP2Abeta	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4991
0	0.47456362110961	0.401	0.162	0	DUSP26	Malignant cells	GSE138267	ENSG00000133878	78986	dual specificity phosphatase 26	DUSP24|MGC1136|NEAP	protein_coding	Q9BV47	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4992
0	-0.372011818845853	0.691	0.884	0	EIF4EBP1	Malignant cells	GSE138267	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4993
0	0.280606424992391	0.772	0.7	0	WHSC1L1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4994
0	0.937853540051698	0.251	0	0	C8orf22	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4995
0	-0.376504883364949	0.454	0.717	0	LYPLA1	Malignant cells	GSE138267	ENSG00000120992	10434	lysophospholipase 1	APT-1|LPL1	protein_coding	O75608	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4996
0	-0.46454583562429	1	1	0	RPS20	Malignant cells	GSE138267	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4997
0	-0.34370324557969	0.493	0.739	0	SDCBP	Malignant cells	GSE138267	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4998
0	-0.293587005853633	0.413	0.599	0	TRAM1	Malignant cells	GSE138267	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	4999
0	-0.630220340112496	1	1	0	RPL7	Malignant cells	GSE138267	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5000
0	0.598935199429964	0.409	0.113	0	RALYL	Malignant cells	GSE138267	ENSG00000184672	138046	RALY RNA binding protein like	HNRPCL3	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5001
0	0.381899947591333	0.418	0.254	0	CCNE2	Malignant cells	GSE138267	ENSG00000175305	9134	cyclin E2	CYCE2	protein_coding	O96020	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5002
0	-0.602558048434598	0.56	0.897	0	LAPTM4B	Malignant cells	GSE138267	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5003
0	-0.253451689859831	1	1	0	RPL30	Malignant cells	GSE138267	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5004
0	0.518458150577914	0.276	0.053	0	OSR2	Malignant cells	GSE138267	ENSG00000164920	116039	odd-skipped related transciption factor 2	FLJ90037	protein_coding	Q8N2R0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5005
0	-0.383570120679934	0.976	0.996	0	COX6C	Malignant cells	GSE138267	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5006
0	-0.710490292729609	0.901	0.998	0	PABPC1	Malignant cells	GSE138267	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5007
0	-0.452156290793974	0.117	0.311	0	BAALC	Malignant cells	GSE138267	ENSG00000164929	79870	BAALC binder of MAP3K1 and KLF4	NA	protein_coding	Q8WXS3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5008
0	-0.455000903735423	0.198	0.401	0	CTHRC1	Malignant cells	GSE138267	ENSG00000164932	115908	collagen triple helix repeat containing 1	NA	protein_coding	Q96CG8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5009
0	0.279612700912222	0.337	0.158	0	MTSS1	Malignant cells	GSE138267	ENSG00000170873	9788	MTSS I-BAR domain containing 1	KIAA0429|MIM|MIMA|MIMB	protein_coding	O43312	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5010
0	0.565334399014484	0.378	0.168	0	NDRG1	Malignant cells	GSE138267	ENSG00000104419	10397	N-myc downstream regulated 1	CAP43|DRG1|NDR1|RTP|TDD5	protein_coding	Q92597	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5011
0	0.403984310631248	0.628	0.574	0	LY6E	Malignant cells	GSE138267	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5012
0	-0.25367176136692	0.636	0.836	0	MAF1	Malignant cells	GSE138267	ENSG00000179632	84232	MAF1 homolog, negative regulator of RNA polymerase III	DKFZp586G1123	protein_coding	Q9H063	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5013
0	-0.379844259652672	0.414	0.699	0	C8orf82	Malignant cells	GSE138267	ENSG00000213563	414919	chromosome 8 open reading frame 82	MGC70857	protein_coding	Q6P1X6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5014
0	-0.610808587776013	1	1	0	RPL8	Malignant cells	GSE138267	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5015
0	0.27950944580234	0.455	0.261	0	CBWD1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5016
0	0.358036059389809	0.51	0.316	0	AK3	Malignant cells	GSE138267	ENSG00000147853	50808	adenylate kinase 3	AK3L1|AK6|AKL3L1	protein_coding	Q9UIJ7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5017
0	0.634796788117081	0.804	0.731	0	NFIB	Malignant cells	GSE138267	ENSG00000147862	4781	nuclear factor I B	NFI-RED|NFIB2|NFIB3	protein_coding	O00712	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5018
0	0.328510835256625	0.252	0.055	0	TTC39B	Malignant cells	GSE138267	ENSG00000155158	158219	tetratricopeptide repeat domain 39B	C9orf52|FLJ33868	protein_coding	Q5VTQ0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5019
0	0.487809168850514	0.956	0.942	0	PSIP1	Malignant cells	GSE138267	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5020
0	0.392712225864801	0.324	0.128	0	SH3GL2	Malignant cells	GSE138267	ENSG00000107295	6456	SH3 domain containing GRB2 like 2, endophilin A1	CNSA2|EEN-B1|SH3D2A|SH3P4	protein_coding	Q99962	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5021
0	-0.269752003458457	1	1	0	RPS6	Malignant cells	GSE138267	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5022
0	0.735392827810751	0.986	0.99	0	CDKN2A	Malignant cells	GSE138267	ENSG00000147889	1029	cyclin dependent kinase inhibitor 2A	ARF|CDK4I|CDKN2|CMM2|INK4|INK4a|MLM|MTS1|p14|p14ARF|p16|P16-INK4A|p16INK4a|p19|p19Arf	protein_coding	P42771	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5023
0	0.896211952996804	0.496	0.085	0	CDKN2B	Malignant cells	GSE138267	ENSG00000147883	1030	cyclin dependent kinase inhibitor 2B	CDK4I|INK4B|MTS2|P15|p15INK4b|TP15	protein_coding	P42772	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5024
0	2.15143794158729	0.373	0.024	0	AQP3	Malignant cells	GSE138267	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5025
0	0.312468555520391	0.533	0.323	0	CCDC107	Malignant cells	GSE138267	ENSG00000159884	203260	coiled-coil domain containing 107	MGC31967	protein_coding	Q8WV48	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5026
0	1.20665392299284	0.416	0.077	0	CA9	Malignant cells	GSE138267	ENSG00000107159	768	carbonic anhydrase 9	CAIX|MN	protein_coding	Q16790	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5027
0	0.25919407734538	0.331	0.162	0	TLN1	Malignant cells	GSE138267	ENSG00000137076	7094	talin 1	ILWEQ|TLN	protein_coding	Q9Y490	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5028
0	-0.46581190868659	0.383	0.655	0	TOMM5	Malignant cells	GSE138267	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5029
0	-0.427489010230594	0.532	0.805	0	CKS2	Malignant cells	GSE138267	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5030
0	-0.490152044382758	0.934	0.99	0	SEC61B	Malignant cells	GSE138267	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5031
0	-0.295016591754522	0.593	0.822	0	NDUFA8	Malignant cells	GSE138267	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5032
0	-0.780687413463199	1	1	0	RPL35	Malignant cells	GSE138267	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5033
0	-0.29969644446439	0.731	0.885	0	ARPC5L	Malignant cells	GSE138267	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5034
0	-0.567863909266817	0.994	1	0	RPL12	Malignant cells	GSE138267	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5035
0	0.604387065064636	0.61	0.266	0	AK1	Malignant cells	GSE138267	ENSG00000106992	203	adenylate kinase 1	NA	protein_coding	P00568	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5036
0	-0.457926923774069	0.382	0.705	0	ZDHHC12	Malignant cells	GSE138267	ENSG00000160446	84885	zinc finger DHHC-type palmitoyltransferase 12	FLJ14524|ZNF400	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5037
0	0.787235253820113	0.354	0.076	0	CEL	Malignant cells	GSE138267	ENSG00000170835	1056	carboxyl ester lipase	BSSL|MODY8	protein_coding	P19835	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5038
0	-0.264036838702902	0.525	0.755	0	SURF1	Malignant cells	GSE138267	ENSG00000280627	6834	SURF1 cytochrome c oxidase assembly factor	SHY1	protein_coding	Q15526	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5039
0	0.399804886525719	0.346	0.141	0	OLFM1	Malignant cells	GSE138267	ENSG00000130558	10439	olfactomedin 1	AMY|NOE1|NOELIN|OlfA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5040
0	0.580206425956776	0.574	0.26	0	AGPAT2	Malignant cells	GSE138267	ENSG00000169692	10555	1-acylglycerol-3-phosphate O-acyltransferase 2	BSCL|LPAAT-beta|LPLAT2	protein_coding	O15120	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5041
0	0.391736413788219	0.742	0.733	0	SNHG7	Malignant cells	GSE138267	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5042
0	0.938526682196797	0.986	0.924	0	TUBB4B	Malignant cells	GSE138267	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5043
0	-0.421530289104741	0.51	0.783	0	MRPL41	Malignant cells	GSE138267	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5044
0	0.305658743945276	0.314	0.148	0	EHMT1	Malignant cells	GSE138267	ENSG00000181090	79813	euchromatic histone lysine methyltransferase 1	bA188C12.1|EHMT1-IT1|Eu-HMTase1|FLJ12879|FLJ40292|GLP|KIAA1876|KMT1D	protein_coding	Q9H9B1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5045
0	-0.798397056365443	0.004	0.258	0	AKR1C1	Malignant cells	GSE138267	ENSG00000187134	1645	aldo-keto reductase family 1 member C1	DD1|DDH|DDH1|HAKRC|MBAB	protein_coding	Q04828	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5046
0	-0.401796597859646	0.677	0.883	0	GDI2	Malignant cells	GSE138267	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5047
0	0.412052415207882	0.328	0.116	0	CELF2	Malignant cells	GSE138267	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5048
0	-0.291642572041879	0.506	0.733	0	CDC123	Malignant cells	GSE138267	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5049
0	-0.295643080937536	0.141	0.291	0	MSRB2	Malignant cells	GSE138267	ENSG00000148450	22921	methionine sulfoxide reductase B2	CBS-1|CBS1|CGI-131|MSRB|PILB	protein_coding	Q9Y3D2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5050
0	0.424679250944376	0.519	0.265	0	EPC1	Malignant cells	GSE138267	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5051
0	-0.561517491679421	0.385	0.774	0	CISD1	Malignant cells	GSE138267	ENSG00000122873	55847	CDGSH iron sulfur domain 1	C10orf70|MDS029|mitoNEET|ZCD1	protein_coding	Q9NZ45	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5052
0	-0.571418391242113	0.243	0.407	0	DNAJC12	Malignant cells	GSE138267	ENSG00000108176	56521	DnaJ heat shock protein family (Hsp40) member C12	JDP1	protein_coding	Q9UKB3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5053
0	0.256452556095923	0.815	0.81	0	HNRNPH3	Malignant cells	GSE138267	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5054
0	0.329490130854602	0.276	0.077	0	TET1	Malignant cells	GSE138267	ENSG00000138336	80312	tet methylcytosine dioxygenase 1	bA119F7.1|CXXC6|KIAA1676|LCX	protein_coding	Q8NFU7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5055
0	0.278724610911388	0.472	0.298	0	CCAR1	Malignant cells	GSE138267	ENSG00000060339	55749	cell division cycle and apoptosis regulator 1	CARP-1|CARP1|FLJ10590	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5056
0	-0.370626329924927	0.692	0.889	0	PPA1	Malignant cells	GSE138267	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5057
0	-0.53373193064898	0.525	0.846	0	PCBD1	Malignant cells	GSE138267	ENSG00000166228	5092	pterin-4 alpha-carbinolamine dehydratase 1	DCOH|PCBD|PCD	protein_coding	P61457	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5058
0	-0.365940084967395	0.633	0.883	0	ANAPC16	Malignant cells	GSE138267	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5059
0	-0.268475287705879	0.502	0.723	0	ANXA7	Malignant cells	GSE138267	ENSG00000138279	310	annexin A7	ANX7	protein_coding	P20073	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5060
0	0.333211391574232	0.334	0.143	0	ZNF503	Malignant cells	GSE138267	ENSG00000165655	84858	zinc finger protein 503	FLJ45745|MGC2555|Nlz2	protein_coding	Q96F45	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5061
0	0.976580182530272	0.507	0.112	0	KCNMA1	Malignant cells	GSE138267	ENSG00000156113	3778	potassium calcium-activated channel subfamily M alpha 1	KCa1.1|mSLO1|SLO	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5062
0	-0.42676675643874	0.998	1	0	RPS24	Malignant cells	GSE138267	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5063
0	-0.399467245250441	0.558	0.822	0	FAM213A	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5064
0	0.366235504969881	0.457	0.253	0	CCSER2	Malignant cells	GSE138267	ENSG00000107771	54462	coiled-coil serine rich protein 2	FAM190B|KIAA1128	protein_coding	Q9H7U1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5065
0	0.803610375591889	0.604	0.54	0	ADIRF	Malignant cells	GSE138267	ENSG00000148671	10974	adipogenesis regulatory factor	AFRO|APM2|C10orf116	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5066
0	-0.389320020079912	0.519	0.778	0	PDLIM1	Malignant cells	GSE138267	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5067
0	-0.308971571118497	0.497	0.753	0	CUEDC2	Malignant cells	GSE138267	ENSG00000107874	79004	CUE domain containing 2	C10orf66|MGC2491	protein_coding	Q9H467	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5068
0	-0.357949350290287	0.612	0.851	0	ARL3	Malignant cells	GSE138267	ENSG00000138175	403	ADP ribosylation factor like GTPase 3	ARFL3	protein_coding	P36405	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5069
0	0.313988305705135	0.256	0.104	0	NEURL1	Malignant cells	GSE138267	ENSG00000107954	9148	neuralized E3 ubiquitin protein ligase 1	h-neu|neu-1|NEURL|RNF67	protein_coding	O76050	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5070
0	0.262626488199417	0.29	0.122	0	SH3PXD2A	Malignant cells	GSE138267	ENSG00000107957	9644	SH3 and PX domains 2A	FISH|KIAA0418|SH3MD1	protein_coding	Q5TCZ1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5071
0	-0.378746481882608	0.445	0.71	0	GSTO1	Malignant cells	GSE138267	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5072
0	0.435391759863422	0.777	0.78	0	SMC3	Malignant cells	GSE138267	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5073
0	0.303105034315246	0.312	0.123	0	C10orf118	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5074
0	-0.397759538477311	0.645	0.863	0	PRDX3	Malignant cells	GSE138267	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5075
0	-0.393539926320529	0.09	0.263	0	TACC2	Malignant cells	GSE138267	ENSG00000138162	10579	transforming acidic coiled-coil containing protein 2	AZU-1|ECTACC	protein_coding	O95359	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5076
0	0.670909940989124	0.454	0.171	0	PLEKHA1	Malignant cells	GSE138267	ENSG00000107679	59338	pleckstrin homology domain containing A1	TAPP1	protein_coding	Q9HB21	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5077
0	0.642111091898197	0.387	0.249	0	MKI67	Malignant cells	GSE138267	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5078
0	-0.304161738759388	0.555	0.805	0	ZNF511	Malignant cells	GSE138267	ENSG00000198546	118472	zinc finger protein 511	MGC30006|Zfp511	protein_coding	Q8NB15	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5079
0	-0.356230441041528	0.328	0.504	0	SIGIRR	Malignant cells	GSE138267	ENSG00000185187	59307	single Ig and TIR domain containing	IL-1R8|TIR8	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5080
0	0.298384836247608	0.382	0.201	0	RASSF7	Malignant cells	GSE138267	ENSG00000273859	8045	Ras association domain family member 7	C11orf13|CFAP88|FAP88|HRAS1|HRC1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5081
0	0.397140550404092	0.362	0.125	0	IRF7	Malignant cells	GSE138267	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5082
0	0.263762801383311	0.316	0.153	0	TMEM80	Malignant cells	GSE138267	ENSG00000177042	283232	transmembrane protein 80	FLJ38216	protein_coding	Q96HE8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5083
0	0.277970153583218	0.274	0.112	0	PIDD	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5084
0	1.12455917651907	0.318	0.011	0	IGF2	Malignant cells	GSE138267	ENSG00000167244	3481	insulin like growth factor 2	C11orf43|FLJ44734|IGF-II	protein_coding	P01344	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5085
0	0.272052968196564	0.478	0.28	0	TSSC4	Malignant cells	GSE138267	ENSG00000184281	10078	tumor suppressing subtransferable candidate 4	NA	protein_coding	Q9Y5U2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5086
0	0.822146550356498	0.648	0.412	0	KCNQ1OT1	Malignant cells	GSE138267	ENSG00000269821	10984	KCNQ1 opposite strand/antisense transcript 1	KCNQ1-AS2|KvDMR1|KvLQT1-AS|LIT1|NCRNA00012	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5087
0	0.504795579627469	0.319	0.055	0	CDKN1C	Malignant cells	GSE138267	ENSG00000273707	1028	cyclin dependent kinase inhibitor 1C	BWCR|BWS|KIP2|P57	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5088
0	1.16791144773189	0.411	0.117	0	PHLDA2	Malignant cells	GSE138267	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5089
0	0.257763070192928	0.336	0.17	0	RHOG	Malignant cells	GSE138267	ENSG00000177105	391	ras homolog family member G	ARHG|MGC125835|MGC125836	protein_coding	P84095	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5090
0	0.371349973071714	0.425	0.211	0	TMEM41B	Malignant cells	GSE138267	ENSG00000166471	440026	transmembrane protein 41B	KIAA0033	protein_coding	Q5BJD5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5091
0	0.747854754215878	0.482	0.234	0	ADM	Malignant cells	GSE138267	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5092
0	0.369436675548851	0.911	0.881	0	EIF4G2	Malignant cells	GSE138267	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5093
0	0.295978677330233	0.36	0.162	0	ZBED5	Malignant cells	GSE138267	ENSG00000236287	58486	zinc finger BED-type containing 5	Buster1	protein_coding	Q49AG3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5094
0	0.367479969428091	0.936	0.9	0	C11orf58	Malignant cells	GSE138267	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5095
0	0.655692019223357	0.933	0.933	0	LDHA	Malignant cells	GSE138267	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5096
0	0.333499230862377	0.318	0.119	0	NAV2	Malignant cells	GSE138267	ENSG00000166833	89797	neuron navigator 2	FLJ10633|FLJ11030|FLJ23707|HELAD1|KIAA1419|POMFIL2|RAINB1	protein_coding	Q8IVL1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5097
0	0.445025393115492	0.325	0.106	0	NELL1	Malignant cells	GSE138267	ENSG00000165973	4745	neural EGFL like 1	FLJ45906|IDH3GL	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5098
0	0.937172384959639	0.435	0.099	0	LMO2	Malignant cells	GSE138267	ENSG00000135363	4005	LIM domain only 2	RBTN2|RBTNL1|RHOM2|TTG2	protein_coding	P25791	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5099
0	0.338250377043096	0.51	0.278	0	CAPRIN1	Malignant cells	GSE138267	ENSG00000135387	4076	cell cycle associated protein 1	caprin-1|GPIAP1|M11S1|RNG105	protein_coding	Q14444	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5100
0	-0.499669189227436	0.042	0.268	0	EHF	Malignant cells	GSE138267	ENSG00000135373	26298	ETS homologous factor	ESE3|ESEJ	protein_coding	Q9NZC4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5101
0	0.391013207737022	0.518	0.264	0	COMMD9	Malignant cells	GSE138267	ENSG00000110442	29099	COMM domain containing 9	FLJ31106|HSPC166	protein_coding	Q9P000	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5102
0	0.750422341900374	0.474	0.373	0	FAM111B	Malignant cells	GSE138267	ENSG00000189057	374393	FAM111 trypsin like peptidase B	CANP	protein_coding	Q6SJ93	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5103
0	0.50527173539572	0.304	0.113	0	FAM111A	Malignant cells	GSE138267	ENSG00000166801	63901	FAM111 trypsin like peptidase A	FLJ22794|KIAA1895	protein_coding	Q96PZ2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5104
0	-0.349728033906853	0.217	0.523	0	MS4A8	Malignant cells	GSE138267	ENSG00000166959	83661	membrane spanning 4-domains A8	CD20L5|MS4A4|MS4A8B	protein_coding	Q9BY19	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5105
0	-0.29059924385019	0.587	0.804	0	SLC3A2	Malignant cells	GSE138267	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5106
0	-0.377726328773372	0.421	0.68	0	ARL2	Malignant cells	GSE138267	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5107
0	0.506420029286421	0.999	1	0	MALAT1	Malignant cells	GSE138267	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5108
0	-0.286021657831319	0.745	0.909	0	DRAP1	Malignant cells	GSE138267	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5109
0	-0.316080134308563	0.926	0.966	0	BANF1	Malignant cells	GSE138267	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5110
0	-0.311415087883592	0.636	0.858	0	MRPL11	Malignant cells	GSE138267	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5111
0	-0.34738920815313	0.444	0.723	0	TMEM134	Malignant cells	GSE138267	ENSG00000172663	80194	transmembrane protein 134	FLJ21749	protein_coding	Q9H6X4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5112
0	-0.458284035990746	0.969	0.992	0	GSTP1	Malignant cells	GSE138267	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5113
0	-0.259079559845253	0.545	0.764	0	NDUFV1	Malignant cells	GSE138267	ENSG00000167792	4723	NADH:ubiquinone oxidoreductase core subunit V1	CI-51K	protein_coding	P49821	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5114
0	0.29004706868784	0.387	0.194	0	NUMA1	Malignant cells	GSE138267	ENSG00000137497	4926	nuclear mitotic apparatus protein 1	NUMA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5115
0	-0.484548567316955	1	1	0	RPS3	Malignant cells	GSE138267	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5116
0	0.287377750461195	0.698	0.689	0	RSF1	Malignant cells	GSE138267	ENSG00000048649	51773	remodeling and spacing factor 1	HBXAP|p325|RSF-1|XAP8	protein_coding	Q96T23	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5117
0	0.409536088304459	0.449	0.199	0	RAB30-AS1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5118
0	0.308474329090259	0.471	0.264	0	TMEM126A	Malignant cells	GSE138267	ENSG00000171202	84233	transmembrane protein 126A	DKFZp586C1924|OPA7	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5119
0	0.496261730539514	0.27	0.098	0	PRSS23	Malignant cells	GSE138267	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5120
0	-0.342529361195766	0.412	0.67	0	SMCO4	Malignant cells	GSE138267	ENSG00000166002	56935	single-pass membrane protein with coiled-coil domains 4	C11orf75|FN5	protein_coding	Q9NRQ5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5121
0	0.40616623872053	0.336	0.092	0	AMOTL1	Malignant cells	GSE138267	ENSG00000166025	154810	angiomotin like 1	JEAP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5122
0	-0.287605594853393	0.577	0.794	0	PTS	Malignant cells	GSE138267	ENSG00000150787	5805	6-pyruvoyltetrahydropterin synthase	PTPS	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5123
0	-0.46882043685908	0.453	0.791	0	REXO2	Malignant cells	GSE138267	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5124
0	0.308369815727628	0.429	0.238	0	PCSK7	Malignant cells	GSE138267	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5125
0	0.3026693450776	0.449	0.266	0	KMT2A	Malignant cells	GSE138267	ENSG00000118058	4297	lysine methyltransferase 2A	ALL-1|ALL1|CXXC7|HRX|HTRX|HTRX1|MLL|MLL1|MLL1A|TRX1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5126
0	-0.410171591745085	0.999	1	0	RPS25	Malignant cells	GSE138267	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5127
0	0.290300884236652	0.332	0.194	0	HYLS1	Malignant cells	GSE138267	ENSG00000198331	219844	HYLS1 centriolar and ciliogenesis associated	FLJ32915	protein_coding	Q96M11	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5128
0	0.277837242570223	0.405	0.22	0	WNK1	Malignant cells	GSE138267	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5129
0	-0.377977672071363	0.277	0.683	0	CD9	Malignant cells	GSE138267	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5130
0	-0.442461857162125	0.668	0.869	0	MGST1	Malignant cells	GSE138267	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5131
0	0.378273715672765	0.498	0.28	0	LMO3	Malignant cells	GSE138267	ENSG00000048540	55885	LIM domain only 3	DAT1|RBTNL2|Rhom-3	protein_coding	Q8TAP4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5132
0	0.312713512686579	0.337	0.156	0	PLEKHA5	Malignant cells	GSE138267	ENSG00000052126	54477	pleckstrin homology domain containing A5	FLJ10667|KIAA1686|PEPP2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5133
0	-1.02203494771375	0.791	0.972	0	LDHB	Malignant cells	GSE138267	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5134
0	0.277740338675471	0.346	0.171	0	CCDC91	Malignant cells	GSE138267	ENSG00000123106	55297	coiled-coil domain containing 91	DKFZp779L1558|FLJ11088|p56	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5135
0	0.325104297621157	0.518	0.304	0	ERGIC2	Malignant cells	GSE138267	ENSG00000087502	51290	ERGIC and golgi 2	Erv41|PTX1	protein_coding	Q96RQ1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5136
0	-0.316280871382824	0.537	0.756	0	FAM60A	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5137
0	0.477321713009967	0.378	0.138	0	KIF21A	Malignant cells	GSE138267	ENSG00000139116	55605	kinesin family member 21A	FEOM1|FLJ20052	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5138
0	0.415552229389279	0.409	0.165	0	CACNB3	Malignant cells	GSE138267	ENSG00000167535	784	calcium voltage-gated channel auxiliary subunit beta 3	CACNLB3	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5139
0	0.344829391788203	0.427	0.209	0	DDX23	Malignant cells	GSE138267	ENSG00000174243	9416	DEAD-box helicase 23	prp28|PRPF28|SNRNP100|U5-100KD	protein_coding	Q9BUQ8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5140
0	-0.309126951413044	0.912	0.96	0	TMBIM6	Malignant cells	GSE138267	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5141
0	-0.404665272937559	0.519	0.814	0	COX14	Malignant cells	GSE138267	ENSG00000178449	84987	cytochrome c oxidase assembly factor COX14	C12orf62|MGC14288	protein_coding	Q96I36	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5142
0	-0.327454335409398	0.581	0.786	0	DAZAP2	Malignant cells	GSE138267	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5143
0	-0.273480395212281	0.54	0.766	0	EIF4B	Malignant cells	GSE138267	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5144
0	-0.28847532126085	0.983	0.997	0	PFDN5	Malignant cells	GSE138267	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5145
0	-0.296364128223915	0.464	0.683	0	PRR13	Malignant cells	GSE138267	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5146
0	0.687091469459511	0.301	0.113	0	ZNF385A	Malignant cells	GSE138267	ENSG00000161642	25946	zinc finger protein 385A	DKFZp586G1122|Hzf|ZFP385|ZNF385	protein_coding	Q96PM9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5147
0	-0.301625960098475	0.953	0.99	0	CD63	Malignant cells	GSE138267	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5148
0	-0.487856856159862	1	1	0	RPL41	Malignant cells	GSE138267	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5149
0	0.623641267914592	0.486	0.215	0	NXPH4	Malignant cells	GSE138267	ENSG00000182379	11247	neurexophilin 4	NPH4	protein_coding	O95158	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5150
0	-0.347270351466894	0.499	0.765	0	SHMT2	Malignant cells	GSE138267	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5151
0	-0.383232559620418	0.788	0.933	0	CDK4	Malignant cells	GSE138267	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5152
0	0.488977254500445	0.39	0.123	0	MDM1	Malignant cells	GSE138267	ENSG00000111554	56890	Mdm1 nuclear protein	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5153
0	0.494685156277883	0.255	0.003	0	RP11-81H14.2	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5154
0	-0.36046948734205	0.46	0.76	0	SYT1	Malignant cells	GSE138267	ENSG00000067715	6857	synaptotagmin 1	P65|SVP65|SYT	protein_coding	P21579	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5155
0	0.315184116242104	0.513	0.286	0	PPP1R12A	Malignant cells	GSE138267	ENSG00000058272	4659	protein phosphatase 1 regulatory subunit 12A	M130|MBS|MYPT1	protein_coding	O14974	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5156
0	0.340045249434603	0.255	0.049	0	LRRIQ1	Malignant cells	GSE138267	ENSG00000133640	84125	leucine rich repeats and IQ motif containing 1	FLJ12303|KIAA1801	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5157
0	-1.33576527220391	0.021	0.266	0	NTS	Malignant cells	GSE138267	ENSG00000133636	4922	neurotensin	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5158
0	-0.449727079208452	0.926	0.972	0	SNRPF	Malignant cells	GSE138267	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5159
0	0.62407134354095	0.394	0.165	0	CHPT1	Malignant cells	GSE138267	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5160
0	-0.483469278864625	0.411	0.73	0	TXNRD1	Malignant cells	GSE138267	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5161
0	-0.767782892313105	0.607	0.803	0	C12orf75	Malignant cells	GSE138267	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5162
0	-0.454645127176152	0.447	0.761	0	UNG	Malignant cells	GSE138267	ENSG00000076248	7374	uracil DNA glycosylase	DGU|HIGM4|UDG|UNG1|UNG2	protein_coding	P13051	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5163
0	-0.436993815442577	0.921	0.982	0	ARPC3	Malignant cells	GSE138267	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5164
0	-0.393394569060015	0.753	0.92	0	VPS29	Malignant cells	GSE138267	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5165
0	-0.531137550265393	0.999	1	0	RPL6	Malignant cells	GSE138267	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5166
0	-0.833288957923748	1	1	0	RPLP0	Malignant cells	GSE138267	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5167
0	-0.295325343124423	0.991	0.997	0	COX6A1	Malignant cells	GSE138267	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5168
0	-0.29839858751984	0.925	0.979	0	SRSF9	Malignant cells	GSE138267	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5169
0	-0.261803733740729	0.463	0.665	0	MLEC	Malignant cells	GSE138267	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5170
0	-0.250140590108717	0.547	0.757	0	ANAPC5	Malignant cells	GSE138267	ENSG00000089053	51433	anaphase promoting complex subunit 5	APC5	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5171
0	-0.291990915160814	0.928	0.98	0	ARL6IP4	Malignant cells	GSE138267	ENSG00000182196	51329	ADP ribosylation factor like GTPase 6 interacting protein 4	SFRS20|SR-25|SRp25|SRrp37	protein_coding	Q66PJ3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5172
0	-0.289573417001696	0.993	0.992	0	UBC	Malignant cells	GSE138267	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5173
0	-0.32291543340041	0.988	0.998	0	RAN	Malignant cells	GSE138267	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5174
0	-0.311718190902108	0.424	0.695	0	PXMP2	Malignant cells	GSE138267	ENSG00000176894	5827	peroxisomal membrane protein 2	MPV17L3|PMP22	protein_coding	Q9NR77	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5175
0	0.396564974132644	0.549	0.282	0	MPHOSPH8	Malignant cells	GSE138267	ENSG00000196199	54737	M-phase phosphoprotein 8	HSMPP8|mpp8	protein_coding	Q99549	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5176
0	0.318124490972135	0.429	0.209	0	PSPC1	Malignant cells	GSE138267	ENSG00000121390	55269	paraspeckle component 1	FLJ10955|PSP1	protein_coding	Q8WXF1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5177
0	0.276418203870904	0.37	0.175	0	MICU2	Malignant cells	GSE138267	ENSG00000165487	221154	mitochondrial calcium uptake 2	EFHA1	protein_coding	Q8IYU8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5178
0	0.256661432148439	0.325	0.15	0	N4BP2L1	Malignant cells	GSE138267	ENSG00000139597	90634	NEDD4 binding protein 2 like 1	CG018	protein_coding	Q5TBK1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5179
0	0.392737837027768	0.771	0.672	0	TSC22D1	Malignant cells	GSE138267	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5180
0	0.30306930216175	0.445	0.233	0	ZC3H13	Malignant cells	GSE138267	ENSG00000123200	23091	zinc finger CCCH-type containing 13	DKFZp434D1812|KIAA0853|Xio	protein_coding	Q5T200	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5181
0	0.323788895618376	0.814	0.797	0	ITM2B	Malignant cells	GSE138267	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5182
0	0.253772446394766	0.329	0.154	0	TRIM13	Malignant cells	GSE138267	ENSG00000204977	10206	tripartite motif containing 13	DLEU5|Leu5|RFP2|RNF77	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5183
0	0.414460046596298	0.357	0.19	0	CKAP2	Malignant cells	GSE138267	ENSG00000136108	26586	cytoskeleton associated protein 2	FLJ10749|LB1|se20-10|TMAP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5184
0	0.258653674039979	0.396	0.231	0	SUGT1	Malignant cells	GSE138267	ENSG00000165416	10910	SGT1 homolog, MIS12 kinetochore complex assembly cochaperone	SGT1	protein_coding	Q9Y2Z0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5185
0	0.345823928994439	0.29	0.092	0	LMO7	Malignant cells	GSE138267	ENSG00000136153	4008	LIM domain 7	FBX20|FBXO20|KIAA0858	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5186
0	0.302435860115796	0.336	0.125	0	FBXL3	Malignant cells	GSE138267	ENSG00000005812	26224	F-box and leucine rich repeat protein 3	FBL3|FBL3A|FBXL3A	protein_coding	Q9UKT7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5187
0	0.293025945215793	0.358	0.158	0	RBM26	Malignant cells	GSE138267	ENSG00000139746	64062	RNA binding motif protein 26	ARRS2|C13orf10|FLJ20957|PPP1R132|PRO1777|SE70-2|ZC3H17	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5188
0	0.423121584250393	0.333	0.097	0	ZIC2	Malignant cells	GSE138267	ENSG00000043355	7546	Zic family member 2	HPE5	protein_coding	O95409	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5189
0	-0.779824144135137	0.39	0.762	0	TMCO3	Malignant cells	GSE138267	ENSG00000150403	55002	transmembrane and coiled-coil domains 3	C13orf11|FLJ20623	protein_coding	Q6UWJ1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5190
0	0.45084074886906	0.396	0.147	0	GAS6	Malignant cells	GSE138267	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5191
0	-0.546165237338208	0.439	0.776	0	CCNB1IP1	Malignant cells	GSE138267	ENSG00000100814	57820	cyclin B1 interacting protein 1	C14orf18|HEI10	protein_coding	Q9NPC3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5192
0	0.321369973691427	0.382	0.193	0	PARP2	Malignant cells	GSE138267	ENSG00000129484	10038	poly(ADP-ribose) polymerase 2	ADPRTL2|ARTD2	protein_coding	Q9UGN5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5193
0	0.268782741108138	0.343	0.186	0	SLC22A17	Malignant cells	GSE138267	ENSG00000092096	51310	solute carrier family 22 member 17	BOCT|BOIT|NGALR	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5194
0	0.467787318070955	0.454	0.243	0	REC8	Malignant cells	GSE138267	ENSG00000285007	9985	REC8 meiotic recombination protein	kleisin-alpha|REC8L1|Rec8p	protein_coding	O95072	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5195
0	0.389979083066296	0.442	0.233	0	NOVA1	Malignant cells	GSE138267	ENSG00000139910	4857	NOVA alternative splicing regulator 1	NOVA-1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5196
0	-0.369205247689214	0.617	0.838	0	SPTSSA	Malignant cells	GSE138267	ENSG00000165389	171546	serine palmitoyltransferase small subunit A	C14orf147|ssSPTa	protein_coding	Q969W0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5197
0	0.264543835171518	0.287	0.156	0	CFL2	Malignant cells	GSE138267	ENSG00000165410	1073	cofilin 2	NEM7	protein_coding	Q9Y281	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5198
0	0.450294696921643	0.623	0.541	0	BAZ1A	Malignant cells	GSE138267	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5199
0	0.603113598221192	0.609	0.523	0	MBIP	Malignant cells	GSE138267	ENSG00000151332	51562	MAP3K12 binding inhibitory protein 1	NA	protein_coding	Q9NS73	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5200
0	0.692203651433084	0.637	0.638	0	NKX2-1	Malignant cells	GSE138267	ENSG00000136352	7080	NK2 homeobox 1	BCH|NKX2A|TITF1|TTF-1|TTF1	protein_coding	P43699	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5201
0	0.374017571194149	0.827	0.824	0	PNN	Malignant cells	GSE138267	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5202
0	-0.510943462340823	0.977	0.998	0	RPL36AL	Malignant cells	GSE138267	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5203
0	0.301927141891771	0.381	0.186	0	ATL1	Malignant cells	GSE138267	ENSG00000198513	51062	atlastin GTPase 1	AD-FSP|FSP1|SPG3|SPG3A	protein_coding	Q8WXF7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5204
0	-0.264864071720451	0.47	0.682	0	CNIH1	Malignant cells	GSE138267	ENSG00000100528	10175	cornichon family AMPA receptor auxiliary protein 1	CNIH|CNIL|TGAM77	protein_coding	O95406	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5205
0	0.285357736476309	0.396	0.189	0	ARID4A	Malignant cells	GSE138267	ENSG00000032219	5926	AT-rich interaction domain 4A	RBBP1|RBP-1|RBP1	protein_coding	P29374	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5206
0	0.524432524678444	0.487	0.214	0	DAAM1	Malignant cells	GSE138267	ENSG00000100592	23002	dishevelled associated activator of morphogenesis 1	KIAA0666	protein_coding	Q9Y4D1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5207
0	0.307914268556625	0.452	0.249	0	HIF1A	Malignant cells	GSE138267	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5208
0	0.276800816663512	0.309	0.161	0	SNAPC1	Malignant cells	GSE138267	ENSG00000023608	6617	small nuclear RNA activating complex polypeptide 1	PTFgamma|SNAP43	protein_coding	Q16533	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5209
0	0.556037127677528	0.692	0.671	0	SYNE2	Malignant cells	GSE138267	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5210
0	-0.600380723214304	0.177	0.324	0	HSPA2	Malignant cells	GSE138267	ENSG00000126803	3306	heat shock protein family A (Hsp70) member 2	NA	protein_coding	P54652	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5211
0	-0.469265005102538	0.254	0.616	0	GPX2	Malignant cells	GSE138267	ENSG00000176153	2877	glutathione peroxidase 2	GSHPX-GI	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5212
0	0.644591464951907	0.469	0.217	0	ZFP36L1	Malignant cells	GSE138267	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5213
0	-0.424714437412005	0.612	0.796	0	COX16	Malignant cells	GSE138267	ENSG00000133983	51241	cytochrome c oxidase assembly factor COX16	C14orf112|HSPC203	protein_coding	Q9P0S2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5214
0	-0.625609173309944	0.29	0.577	0	NPC2	Malignant cells	GSE138267	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5215
0	0.906466328301675	0.394	0.077	0	PGF	Malignant cells	GSE138267	ENSG00000119630	5228	placental growth factor	D12S1900|PGFL|PIGF|PLGF|PlGF-2|SHGC-10760	protein_coding	P49763	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5216
0	0.298831816918384	0.984	0.962	0	CALM1	Malignant cells	GSE138267	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5217
0	0.259926594766365	0.405	0.221	0	LGMN	Malignant cells	GSE138267	ENSG00000100600	5641	legumain	LGMN1|PRSC1	protein_coding	Q99538	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5218
0	0.416477009418154	0.798	0.739	0	DDX24	Malignant cells	GSE138267	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5219
0	3.17777988220492	0.443	0.316	0	IFI27	Malignant cells	GSE138267	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5220
0	0.46665742085437	0.484	0.238	0	IFI27L2	Malignant cells	GSE138267	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5221
0	0.451048352662107	0.404	0.133	0	C14orf132	Malignant cells	GSE138267	ENSG00000227051	56967	chromosome 14 open reading frame 132	C14orf88	protein_coding	Q9NPU4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5222
0	-1.9596453186276	0.229	0.551	0	DLK1	Malignant cells	GSE138267	ENSG00000185559	8788	delta like non-canonical Notch ligand 1	Delta1|FA1|pG2|Pref-1|ZOG	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5223
0	-2.03829661132059	0.178	0.687	0	MEG3	Malignant cells	GSE138267	ENSG00000214548	55384	maternally expressed 3	GTL2|LINC00023|NCRNA00023|onco-lncRNA-83	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5224
0	0.530153029293697	0.905	0.867	0	CRIP2	Malignant cells	GSE138267	ENSG00000182809	1397	cysteine rich protein 2	CRP2|ESP1	protein_coding	P52943	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5225
0	-0.703998060003143	0.425	0.656	0	CRIP1	Malignant cells	GSE138267	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5226
0	0.295076579439416	0.457	0.245	0	NIPA2	Malignant cells	GSE138267	ENSG00000140157	81614	NIPA magnesium transporter 2	SLC57A2	protein_coding	Q8N8Q9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5227
0	0.432608868514707	0.487	0.223	0	UBE3A	Malignant cells	GSE138267	ENSG00000114062	7337	ubiquitin protein ligase E3A	ANCR|AS|E6-AP|EPVE6AP|FLJ26981|HPVE6A	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5228
0	0.346347011423788	0.377	0.152	0	HERC2	Malignant cells	GSE138267	ENSG00000277278	8924	HECT and RLD domain containing E3 ubiquitin protein ligase 2	D15F37S1|jdf2|p528	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5229
0	0.406502611625259	0.995	0.988	0	SRP14	Malignant cells	GSE138267	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5230
0	0.265875304361325	0.288	0.138	0	ZFYVE19	Malignant cells	GSE138267	ENSG00000166140	84936	zinc finger FYVE-type containing 19	ANCHR|FLJ14840|MPFYVE	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5231
0	0.313360251616334	0.682	0.631	0	RTF1	Malignant cells	GSE138267	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5232
0	0.345666235892153	0.34	0.134	0	ZNF106	Malignant cells	GSE138267	ENSG00000103994	64397	zinc finger protein 106	SH3BP3|ZFP106|ZNF474	protein_coding	Q9H2Y7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5233
0	0.265051131720681	0.387	0.215	0	CCNDBP1	Malignant cells	GSE138267	ENSG00000166946	23582	cyclin D1 binding protein 1	DIP1|GCIP|HHM	protein_coding	O95273	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5234
0	0.360338701033012	0.863	0.856	0	PDIA3	Malignant cells	GSE138267	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5235
0	0.294995146095165	0.346	0.174	0	WDR76	Malignant cells	GSE138267	ENSG00000092470	79968	WD repeat domain 76	FLJ12973	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5236
0	0.26236600439851	0.296	0.124	0	CTDSPL2	Malignant cells	GSE138267	ENSG00000137770	51496	CTD small phosphatase like 2	FLJ10523|HSPC129	protein_coding	Q05D32	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5237
0	1.72137663170856	0.955	0.904	0	B2M	Malignant cells	GSE138267	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5238
0	0.291953304155114	0.334	0.135	0	BLOC1S6	Malignant cells	GSE138267	ENSG00000104164	26258	biogenesis of lysosomal organelles complex 1 subunit 6	HPS9|PA|PLDN	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5239
0	0.479603013266023	0.896	0.882	0	EID1	Malignant cells	GSE138267	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5240
0	0.284382569872871	0.345	0.15	0	USP8	Malignant cells	GSE138267	ENSG00000138592	9101	ubiquitin specific peptidase 8	HumORF8|KIAA0055|SPG59|UBPY	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5241
0	0.250029448202839	0.269	0.098	0	SPPL2A	Malignant cells	GSE138267	ENSG00000138600	84888	signal peptide peptidase like 2A	IMP3|PSL2	protein_coding	Q8TCT8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5242
0	0.259003158913951	0.358	0.194	0	LYSMD2	Malignant cells	GSE138267	ENSG00000140280	256586	LysM domain containing 2	MGC35274	protein_coding	Q8IV50	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5243
0	0.33995251039681	0.308	0.14	0	MNS1	Malignant cells	GSE138267	ENSG00000138587	55329	meiosis specific nuclear structural 1	FLJ11222|SPATA40	protein_coding	Q8NEH6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5244
0	0.46517661343159	0.394	0.114	0	FAM63B	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5245
0	0.435157306429869	0.62	0.423	0	SLTM	Malignant cells	GSE138267	ENSG00000137776	79811	SAFB like transcription modulator	FLJ13213|Met	protein_coding	Q9NWH9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5246
0	0.738108452823839	0.315	0.17	0	CCNB2	Malignant cells	GSE138267	ENSG00000157456	9133	cyclin B2	HsT17299	protein_coding	O95067	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5247
0	0.350580790087121	0.395	0.157	0	BNIP2	Malignant cells	GSE138267	ENSG00000140299	663	BCL2 interacting protein 2	BNIP-2|Nip2	protein_coding	Q12982	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5248
0	1.47886019687153	0.696	0.765	0	ANXA2	Malignant cells	GSE138267	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5249
0	0.451207867576622	0.779	0.775	0	TPM1	Malignant cells	GSE138267	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5250
0	0.581743938334692	0.844	0.882	0	RPS27L	Malignant cells	GSE138267	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5251
0	-0.318614973972173	0.852	0.939	0	PPIB	Malignant cells	GSE138267	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5252
0	-0.264617792106561	0.482	0.69	0	PTPLAD1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5253
0	-0.690303852781809	1	1	0	RPLP1	Malignant cells	GSE138267	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5254
0	0.499291747222208	0.992	0.982	0	PKM	Malignant cells	GSE138267	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5255
0	-0.298742953703294	0.441	0.711	0	TSPAN3	Malignant cells	GSE138267	ENSG00000140391	10099	tetraspanin 3	TM4-A|TM4SF8|TSPAN-3	protein_coding	O60637	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5256
0	-0.399041775402412	0.693	0.895	0	SEC11A	Malignant cells	GSE138267	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5257
0	0.639143843508644	0.488	0.341	0	PRC1	Malignant cells	GSE138267	ENSG00000198901	9055	protein regulator of cytokinesis 1	ASE1	protein_coding	O43663	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5258
0	1.16271184051332	0.303	0.003	0	LINC00930	Malignant cells	GSE138267	ENSG00000258647	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5259
0	0.357752477707591	0.462	0.239	0	CHD2	Malignant cells	GSE138267	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5260
0	0.290858918761308	0.437	0.228	0	WASH4P	Malignant cells	GSE138267	ENSG00000234769	NA	NA	FAM39CP|FLJ31670	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5261
0	-0.662712989239466	1	1	0	RPS2	Malignant cells	GSE138267	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5262
0	0.697236215300701	0.395	0.051	0	NPW	Malignant cells	GSE138267	ENSG00000183971	283869	neuropeptide W	PPL8	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5263
0	0.501479510238021	0.357	0.12	0	SLC9A3R2	Malignant cells	GSE138267	ENSG00000065054	9351	SLC9A3 regulator 2	E3KARP|NHERF-2|SIP-1|TKA-1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5264
0	0.466973626190342	0.855	0.833	0	SRRM2	Malignant cells	GSE138267	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5265
0	0.347268952919267	0.989	0.884	0	TCEB2	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5266
0	-0.289257120094345	0.224	0.368	0	FLYWCH2	Malignant cells	GSE138267	ENSG00000162076	114984	FLYWCH family member 2	NA	protein_coding	Q96CP2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5267
0	0.64752024376838	0.416	0.155	0	TNFRSF12A	Malignant cells	GSE138267	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5268
0	0.294417698662296	0.438	0.244	0	ZNF75A	Malignant cells	GSE138267	ENSG00000162086	7627	zinc finger protein 75a	FLJ31529	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5269
0	0.339564290741867	0.43	0.21	0	UBN1	Malignant cells	GSE138267	ENSG00000118900	29855	ubinuclein 1	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5270
0	0.399192461007505	0.896	0.875	0	CARHSP1	Malignant cells	GSE138267	ENSG00000153048	23589	calcium regulated heat stable protein 1	CRHSP-24|CSDC1	protein_coding	Q9Y2V2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5271
0	-0.431898710601531	0.574	0.815	0	LITAF	Malignant cells	GSE138267	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5272
0	0.373140133645586	0.457	0.207	0	COQ7	Malignant cells	GSE138267	ENSG00000167186	10229	coenzyme Q7, hydroxylase	CAT5|CLK-1	protein_coding	Q99807	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5273
0	0.335245581148598	0.474	0.253	0	GDE1	Malignant cells	GSE138267	ENSG00000006007	51573	glycerophosphodiester phosphodiesterase 1	MIR16	protein_coding	Q9NZC3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5274
0	0.500142988101842	0.483	0.195	0	CCP110	Malignant cells	GSE138267	ENSG00000103540	9738	centriolar coiled-coil protein 110	CP110|KIAA0419	protein_coding	O43303	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5275
0	0.262605252311368	0.497	0.31	0	KNOP1	Malignant cells	GSE138267	ENSG00000103550	400506	lysine rich nucleolar protein 1	101F10.1|C16orf88|FAM191A|TSG118	protein_coding	Q1ED39	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5276
0	0.542732986712028	0.257	0.091	0	CRYM	Malignant cells	GSE138267	ENSG00000103316	1428	crystallin mu	DFNA40	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5277
0	0.505648588301378	0.564	0.271	0	SEZ6L2	Malignant cells	GSE138267	ENSG00000174938	26470	seizure related 6 homolog like 2	FLJ90517|PSK-1	protein_coding	Q6UXD5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5278
0	0.987787476517133	0.989	0.913	0	ALDOA	Malignant cells	GSE138267	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5279
0	0.265291265452624	0.37	0.194	0	CORO1A	Malignant cells	GSE138267	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5280
0	-0.542980165027477	0.527	0.854	0	DCTPP1	Malignant cells	GSE138267	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5281
0	-0.269638296763205	0.485	0.742	0	SEPHS2	Malignant cells	GSE138267	ENSG00000179918	22928	selenophosphate synthetase 2	SPS2|SPS2b	protein_coding	Q99611	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5282
0	0.281493917139981	0.587	0.453	0	VPS35	Malignant cells	GSE138267	ENSG00000069329	55737	VPS35 retromer complex component	FLJ10752|MEM3|PARK17	protein_coding	Q96QK1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5283
0	0.310204600399381	0.325	0.176	0	ORC6	Malignant cells	GSE138267	ENSG00000091651	23594	origin recognition complex subunit 6	ORC6L	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5284
0	0.281484243263158	0.36	0.165	0	ITFG1	Malignant cells	GSE138267	ENSG00000129636	81533	integrin alpha FG-GAP repeat containing 1	CDA08|LNKN-1|TIP	protein_coding	Q8TB96	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5285
0	0.374422367480144	0.448	0.196	0	SIAH1	Malignant cells	GSE138267	ENSG00000196470	6477	siah E3 ubiquitin protein ligase 1	hSIAH1	protein_coding	Q8IUQ4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5286
0	0.373733301524562	0.421	0.183	0	BRD7	Malignant cells	GSE138267	ENSG00000166164	29117	bromodomain containing 7	BP75|CELTIX1|SMARCI1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5287
0	0.347141315895226	0.392	0.178	0	CHD9	Malignant cells	GSE138267	ENSG00000177200	80205	chromodomain helicase DNA binding protein 9	BC022889|FLJ12178|KIAA0308	protein_coding	Q3L8U1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5288
0	0.489800579707248	0.315	0.045	0	IRX3	Malignant cells	GSE138267	ENSG00000177508	79191	iroquois homeobox 3	IRX-1	protein_coding	P78415	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5289
0	0.506939282227201	0.52	0.27	0	CRNDE	Malignant cells	GSE138267	ENSG00000245694	101927480	uncharacterized LOC101927480	CRNDEP|LINC00180|LOC643911	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5290
0	0.396684032951413	0.513	0.265	0	NUDT21	Malignant cells	GSE138267	ENSG00000167005	11051	nudix hydrolase 21	CFIM25|CPSF5	protein_coding	O43809	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5291
0	-0.338758456620083	0.806	0.924	0	MT2A	Malignant cells	GSE138267	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5292
0	-1.87258463270258	0.021	0.815	0	MT1E	Malignant cells	GSE138267	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5293
0	-1.06519410123733	0.27	0.798	0	MT1F	Malignant cells	GSE138267	ENSG00000198417	4494	metallothionein 1F	MT1	protein_coding	P04733	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5294
0	-1.71092314338176	0.055	0.653	0	MT1G	Malignant cells	GSE138267	ENSG00000125144	4495	metallothionein 1G	MT1|MT1K	protein_coding	P13640	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5295
0	-0.436376380470559	0.482	0.763	0	MT1X	Malignant cells	GSE138267	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5296
0	0.266647067039362	0.435	0.235	0	FAM192A	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5297
0	0.339461313471333	0.343	0.12	0	RSPRY1	Malignant cells	GSE138267	ENSG00000159579	89970	ring finger and SPRY domain containing 1	KIAA1972	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5298
0	0.327024603208205	0.448	0.232	0	ARL2BP	Malignant cells	GSE138267	ENSG00000102931	23568	ADP ribosylation factor like GTPase 2 binding protein	BART|BART1|RP66	protein_coding	Q9Y2Y0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5299
0	0.283170124284987	0.43	0.221	0	CIAPIN1	Malignant cells	GSE138267	ENSG00000005194	57019	cytokine induced apoptosis inhibitor 1	CIAE2	protein_coding	Q6FI81	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5300
0	0.391198133898303	0.682	0.598	0	POLR2C	Malignant cells	GSE138267	ENSG00000102978	5432	RNA polymerase II subunit C	RPB3	protein_coding	P19387	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5301
0	0.335706727176113	0.255	0.05	0	KIFC3	Malignant cells	GSE138267	ENSG00000140859	3801	kinesin family member C3	NA	protein_coding	Q9BVG8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5302
0	0.453304612060982	0.534	0.271	0	C16orf80	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5303
0	0.478135179477191	0.509	0.222	0	DYNC1LI2	Malignant cells	GSE138267	ENSG00000135720	1783	dynein cytoplasmic 1 light intermediate chain 2	DNCLI2	protein_coding	O43237	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5304
0	0.250883619699315	0.358	0.194	0	CBFB	Malignant cells	GSE138267	ENSG00000067955	865	core-binding factor subunit beta	PEBP2B	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5305
0	0.643109872024633	0.393	0.131	0	NOL3	Malignant cells	GSE138267	ENSG00000140939	8996	nucleolar protein 3	ARC|CARD2|MYP|NOP30	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5306
0	0.264380555292117	0.254	0.09	0	KIAA0895L	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5307
0	0.615291060143188	0.646	0.448	0	ATP6V0D1	Malignant cells	GSE138267	ENSG00000159720	9114	ATPase H+ transporting V0 subunit d1	ATP6D|ATP6DV|P39|VATX|Vma6|VPATPD	protein_coding	P61421	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5308
0	0.317196744942242	0.417	0.204	0	CTCF	Malignant cells	GSE138267	ENSG00000102974	10664	CCCTC-binding factor	CFAP108|FAP108	protein_coding	P49711	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5309
0	0.266598857931903	0.336	0.165	0	PARD6A	Malignant cells	GSE138267	ENSG00000102981	50855	par-6 family cell polarity regulator alpha	PAR-6|PAR-6A|PAR6alpha|TAX40|TIP-40	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5310
0	0.275603633174113	0.488	0.291	0	CYB5B	Malignant cells	GSE138267	ENSG00000103018	80777	cytochrome b5 type B	CYB5-M	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5311
0	-0.440459993180609	0.182	0.332	0	NQO1	Malignant cells	GSE138267	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5312
0	0.273457927629207	0.304	0.117	0	COG4	Malignant cells	GSE138267	ENSG00000103051	25839	component of oligomeric golgi complex 4	COD1|DKFZP586E1519	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5313
0	0.25544534421335	0.328	0.157	0	SF3B3	Malignant cells	GSE138267	ENSG00000189091	23450	splicing factor 3b subunit 3	KIAA0017|RSE1|SAP130|SF3b130	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5314
0	0.258540913036656	0.261	0.096	0	CMTR2	Malignant cells	GSE138267	ENSG00000180917	55783	cap methyltransferase 2	AFT|FLJ11171|FTSJD1|MTr2	protein_coding	Q8IYT2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5315
0	0.65922143761291	0.29	0.028	0	CALB2	Malignant cells	GSE138267	ENSG00000282830	794	calbindin 2	CAL2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5316
0	0.286721320768662	0.397	0.195	0	IST1	Malignant cells	GSE138267	ENSG00000182149	9798	IST1 factor associated with ESCRT-III	CHMP8|KIAA0174	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5317
0	0.265706039902795	0.323	0.141	0	ZNF821	Malignant cells	GSE138267	ENSG00000102984	55565	zinc finger protein 821	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5318
0	0.52420772500721	0.403	0.13	0	ZFHX3	Malignant cells	GSE138267	ENSG00000140836	463	zinc finger homeobox 3	ATBF1|C16orf47|FLJ26184|ZNF927	protein_coding	Q15911	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5319
0	0.370819836950237	0.9	0.859	0	GABARAPL2	Malignant cells	GSE138267	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5320
0	0.376108132789168	0.765	0.723	0	TERF2IP	Malignant cells	GSE138267	ENSG00000166848	54386	TERF2 interacting protein	RAP1	protein_coding	Q9NYB0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5321
0	0.408613490085799	0.496	0.268	0	CMIP	Malignant cells	GSE138267	ENSG00000153815	80790	c-Maf inducing protein	NA	protein_coding	Q8IY22	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5322
0	0.27429319073028	0.972	0.971	0	HSBP1	Malignant cells	GSE138267	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5323
0	0.373097264105981	0.449	0.274	0	CDT1	Malignant cells	GSE138267	ENSG00000167513	81620	chromatin licensing and DNA replication factor 1	DUP|RIS2	protein_coding	Q9H211	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5324
0	0.316031162755279	0.398	0.19	0	ANKRD11	Malignant cells	GSE138267	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5325
0	0.353376685558291	0.477	0.228	0	CHMP1A	Malignant cells	GSE138267	ENSG00000131165	5119	charged multivesicular body protein 1A	CHMP1|KIAA0047|PCOLN3|PRSM1|Vps46A	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5326
0	0.329222275454292	0.428	0.226	0	SPATA33	Malignant cells	GSE138267	ENSG00000167523	124045	spermatogenesis associated 33	C16orf55|FLJ31606	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5327
0	0.266924526092524	0.255	0.082	0	SPATA2L	Malignant cells	GSE138267	ENSG00000158792	124044	spermatogenesis associated 2 like	C16orf76|MGC26885|tamo	protein_coding	Q8IUW3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5328
0	0.376736648504649	0.55	0.321	0	TCF25	Malignant cells	GSE138267	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5329
0	0.349866391944019	0.416	0.191	0	DEF8	Malignant cells	GSE138267	ENSG00000140995	54849	differentially expressed in FDCP 8 homolog	FLJ20186	protein_coding	Q6ZN54	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5330
0	-0.262357299536756	0.489	0.66	0	GLOD4	Malignant cells	GSE138267	ENSG00000167699	51031	glyoxalase domain containing 4	C17orf25|CGI-150|HC71	protein_coding	Q9HC38	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5331
0	-0.292849445563601	0.568	0.784	0	EMC6	Malignant cells	GSE138267	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5332
0	-0.348069756198589	0.353	0.529	0	ITGAE	Malignant cells	GSE138267	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5333
0	-0.461746990209465	0.987	0.997	0	PFN1	Malignant cells	GSE138267	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5334
0	-0.363992225192004	0.72	0.883	0	C1QBP	Malignant cells	GSE138267	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5335
0	-0.292013489900075	0.19	0.325	0	SAT2	Malignant cells	GSE138267	ENSG00000141504	112483	spermidine/spermine N1-acetyltransferase family member 2	SSAT2	protein_coding	Q96F10	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5336
0	0.266387640377783	0.285	0.13	0	TP53	Malignant cells	GSE138267	ENSG00000141510	7157	tumor protein p53	LFS1|p53	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5337
0	-0.255449540158618	0.621	0.812	0	TRAPPC1	Malignant cells	GSE138267	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5338
0	-0.435933615756755	1	0.999	0	RPL26	Malignant cells	GSE138267	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5339
0	0.402466239932834	0.521	0.266	0	TTC19	Malignant cells	GSE138267	ENSG00000011295	54902	tetratricopeptide repeat domain 19	FLJ20343|MGC19520	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5340
0	0.662705624115828	0.607	0.233	0	NCOR1	Malignant cells	GSE138267	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5341
0	0.408906650848161	0.783	0.773	0	CENPV	Malignant cells	GSE138267	ENSG00000166582	201161	centromere protein V	CENP-V|p30|PRR6	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5342
0	0.424619541564125	0.999	0.998	0	UBB	Malignant cells	GSE138267	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5343
0	0.306999316868313	0.268	0.072	0	FLCN	Malignant cells	GSE138267	ENSG00000154803	201163	folliculin	BHD|DENND8B|MGC17998|MGC23445	protein_coding	Q8NFG4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5344
0	0.403178115073585	0.684	0.616	0	COPS3	Malignant cells	GSE138267	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5345
0	0.305432510549657	0.32	0.115	0	DRG2	Malignant cells	GSE138267	ENSG00000108591	1819	developmentally regulated GTP binding protein 2	NA	protein_coding	P55039	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5346
0	0.491163647315656	0.522	0.228	0	ALKBH5	Malignant cells	GSE138267	ENSG00000091542	54890	alkB homolog 5, RNA demethylase	FLJ20308|OFOXD1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5347
0	0.31725834561793	0.315	0.147	0	SHMT1	Malignant cells	GSE138267	ENSG00000284320	6470	serine hydroxymethyltransferase 1	cSHMT|MGC15229|MGC24556|SHMT	protein_coding	P34896	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5348
0	0.354077542967155	0.414	0.167	0	PRPSAP2	Malignant cells	GSE138267	ENSG00000141127	5636	phosphoribosyl pyrophosphate synthetase associated protein 2	PAP41	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5349
0	0.38199460604481	0.359	0.131	0	ALDH3A2	Malignant cells	GSE138267	ENSG00000072210	224	aldehyde dehydrogenase 3 family member A2	ALDH10|FALDH|SLS	protein_coding	P51648	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5350
0	0.408021656700375	0.478	0.202	0	USP22	Malignant cells	GSE138267	ENSG00000124422	23326	ubiquitin specific peptidase 22	KIAA1063|USP3L	protein_coding	Q9UPT9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5351
0	0.519543876945606	0.6	0.271	0	TMEM11	Malignant cells	GSE138267	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5352
0	0.336631624739149	0.33	0.128	0	MAP2K3	Malignant cells	GSE138267	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5353
0	0.375408775182385	0.376	0.164	0	SEZ6	Malignant cells	GSE138267	ENSG00000063015	124925	seizure related 6 homolog	NA	protein_coding	Q53EL9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5354
0	0.356650971344145	0.529	0.306	0	NSRP1	Malignant cells	GSE138267	ENSG00000126653	84081	nuclear speckle splicing regulatory protein 1	CCDC55|DKFZP434K1421|NSrp70	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5355
0	0.335329215718316	0.447	0.232	0	GOSR1	Malignant cells	GSE138267	ENSG00000108587	9527	golgi SNAP receptor complex member 1	GOLIM2|GOS-28|GOS28|GS28|P28	protein_coding	O95249	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5356
0	0.305279349811571	0.324	0.18	0	ATAD5	Malignant cells	GSE138267	ENSG00000176208	79915	ATPase family AAA domain containing 5	C17orf41|ELG1|FLJ12735|FRAG1	protein_coding	Q96QE3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5357
0	0.401351530239899	0.525	0.302	0	SUZ12	Malignant cells	GSE138267	ENSG00000178691	23512	SUZ12 polycomb repressive complex 2 subunit	CHET9|JJAZ1|KIAA0160	protein_coding	Q15022	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5358
0	0.273073141275322	0.451	0.261	0	ZNF830	Malignant cells	GSE138267	ENSG00000198783	91603	zinc finger protein 830	CCDC16|MGC20398|OMCG1	protein_coding	Q96NB3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5359
0	0.361335134429098	0.516	0.296	0	TAF15	Malignant cells	GSE138267	ENSG00000276833	8148	TATA-box binding protein associated factor 15	hTAFII68|Npl3|RBP56|TAF2N	protein_coding	Q92804	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5360
0	0.352236803875976	0.721	0.704	0	GGNBP2	Malignant cells	GSE138267	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5361
0	0.731236382998736	0.285	0	0	RP11-445F12.1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5362
0	0.907414897686007	0.314	0.005	0	LHX1	Malignant cells	GSE138267	ENSG00000274577	3975	LIM homeobox 1	LIM-1|LIM1	protein_coding	P48742	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5363
0	0.296520858592745	0.463	0.272	0	AATF	Malignant cells	GSE138267	ENSG00000276072	26574	apoptosis antagonizing transcription factor	BFR2|CHE-1|CHE1|DED	protein_coding	Q9NY61	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5364
0	0.273968779302055	0.305	0.125	0	SYNRG	Malignant cells	GSE138267	ENSG00000274047	11276	synergin gamma	AP1GBP1|MGC104959|SYNG	protein_coding	Q9UMZ2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5365
0	0.283966593436965	0.427	0.231	0	DDX52	Malignant cells	GSE138267	ENSG00000277594	11056	DExD-box helicase 52	ROK1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5366
0	0.298764794970602	0.389	0.196	0	PCGF2	Malignant cells	GSE138267	ENSG00000278644	7703	polycomb group ring finger 2	MEL-18|RNF110|ZNF144	protein_coding	P35227	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5367
0	0.265457267136122	0.393	0.207	0	CWC25	Malignant cells	GSE138267	ENSG00000276761	54883	CWC25 spliceosome associated protein homolog	CCDC49|FLJ20291	protein_coding	Q9NXE8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5368
0	0.289794113454253	0.346	0.16	0	CDK12	Malignant cells	GSE138267	ENSG00000167258	51755	cyclin dependent kinase 12	CRK7|CRKR|CRKRS|KIAA0904	protein_coding	Q9NYV4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5369
0	0.365755777132558	0.327	0.118	0	THRA	Malignant cells	GSE138267	ENSG00000126351	7067	thyroid hormone receptor alpha	AR7|EAR-7.1/EAR-7.2|ERBA|ERBA1|NR1A1|THRA1|THRA2|THRA3|TRalpha	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5370
0	0.280087298205736	0.41	0.209	0	CASC3	Malignant cells	GSE138267	ENSG00000108349	22794	CASC3 exon junction complex subunit	BTZ|MLN51	protein_coding	O15234	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5371
0	0.252016969642816	0.331	0.165	0	WIPF2	Malignant cells	GSE138267	ENSG00000171475	147179	WAS/WASL interacting protein family member 2	WICH|WIRE	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5372
0	-0.302835203641925	0.445	0.762	0	KRT19	Malignant cells	GSE138267	ENSG00000171345	3880	keratin 19	CK19|K19|K1CS|MGC15366	protein_coding	P08727	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5373
0	0.343187186768819	0.488	0.272	0	JUP	Malignant cells	GSE138267	ENSG00000173801	3728	junction plakoglobin	CTNNG|DP3|DPIII|PDGB|PG|PKGB	protein_coding	P14923	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5374
0	0.293995990328483	0.454	0.265	0	CNP	Malignant cells	GSE138267	ENSG00000173786	1267	2',3'-cyclic nucleotide 3' phosphodiesterase	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5375
0	0.614431739001434	0.61	0.5	0	STAT3	Malignant cells	GSE138267	ENSG00000168610	6774	signal transducer and activator of transcription 3	APRF	protein_coding	P40763	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5376
0	0.37708091226	0.522	0.293	0	MLX	Malignant cells	GSE138267	ENSG00000108788	6945	MAX dimerization protein MLX	bHLHd13|MAD7|MXD7|TCFL4	protein_coding	Q9UH92	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5377
0	0.302964413144998	0.451	0.259	0	UBTF	Malignant cells	GSE138267	ENSG00000108312	7343	upstream binding transcription factor	NOR-90|UBF|UBF1|UBF2	protein_coding	P17480	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5378
0	-0.252446316485787	0.61	0.836	0	SLC25A39	Malignant cells	GSE138267	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5379
0	0.293141540530601	0.475	0.268	0	GPATCH8	Malignant cells	GSE138267	ENSG00000186566	23131	G-patch domain containing 8	GPATC8|KIAA0553	protein_coding	Q9UKJ3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5380
0	0.812529644920436	0.352	0.056	0	C1QL1	Malignant cells	GSE138267	ENSG00000131094	10882	complement C1q like 1	C1QRF|C1QTNF14|CRF|CTRP14	protein_coding	O75973	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5381
0	0.292898210257182	0.375	0.17	0	NMT1	Malignant cells	GSE138267	ENSG00000136448	4836	N-myristoyltransferase 1	NMT	protein_coding	P30419	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5382
0	0.513352496042628	0.465	0.182	0	HEXIM1	Malignant cells	GSE138267	ENSG00000186834	10614	HEXIM P-TEFb complex subunit 1	CLP-1|EDG1|HIS1|MAQ1	protein_coding	O94992	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5383
0	0.302332066427344	0.331	0.148	0	CDC27	Malignant cells	GSE138267	ENSG00000004897	996	cell division cycle 27	ANAPC3|APC3|D0S1430E|D17S978E|NUC2	protein_coding	P30260	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5384
0	0.452824048300222	0.822	0.823	0	KPNB1	Malignant cells	GSE138267	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5385
0	0.548064167668923	0.25	0	0	HOXB1	Malignant cells	GSE138267	ENSG00000120094	3211	homeobox B1	HOX2|HOX2I	protein_coding	P14653	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5386
0	-0.419444890812907	0.527	0.84	0	HOXB2	Malignant cells	GSE138267	ENSG00000173917	3212	homeobox B2	HOX2|HOX2H	protein_coding	P14652	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5387
0	0.252358708124598	0.401	0.254	0	HOXB3	Malignant cells	GSE138267	ENSG00000120093	3213	homeobox B3	HOX2|HOX2G	protein_coding	P14651	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5388
0	0.362607574297845	0.452	0.265	0	HOXB4	Malignant cells	GSE138267	ENSG00000182742	3214	homeobox B4	HOX2|HOX2F	protein_coding	P17483	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5389
0	0.257313601496102	0.34	0.179	0	CALCOCO2	Malignant cells	GSE138267	ENSG00000136436	10241	calcium binding and coiled-coil domain 2	MGC17318|NDP52	protein_coding	Q13137	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5390
0	0.328131931769843	0.837	0.78	0	ATP5G1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5391
0	0.309168266967262	0.498	0.282	0	SPOP	Malignant cells	GSE138267	ENSG00000121067	8405	speckle type BTB/POZ protein	BTBD32|TEF2	protein_coding	O43791	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5392
0	0.466682927194337	0.821	0.785	0	LUC7L3	Malignant cells	GSE138267	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5393
0	0.476798608798637	0.538	0.274	0	TOB1	Malignant cells	GSE138267	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5394
0	0.314258138383195	0.369	0.18	0	SPAG9	Malignant cells	GSE138267	ENSG00000008294	9043	sperm associated antigen 9	CT89|FLJ13450|FLJ14006|FLJ26141|FLJ34602|HLC4|HSS|JIP-4|JIP4|JLP|KIAA0516|MGC117291|MGC14967|MGC74461|PHET|PIG6|SYD1	protein_coding	O60271	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5395
0	0.534581148767191	0.506	0.218	0	COIL	Malignant cells	GSE138267	ENSG00000121058	8161	coilin	CLN80|p80-coilin	protein_coding	P38432	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5396
0	1.43553234836181	0.685	0.652	0	SCPEP1	Malignant cells	GSE138267	ENSG00000121064	59342	serine carboxypeptidase 1	RISC	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5397
0	0.454734888497747	0.464	0.252	0	AKAP1	Malignant cells	GSE138267	ENSG00000121057	8165	A-kinase anchoring protein 1	AKAP121|AKAP149|AKAP84|D-AKAP1|PPP1R43|PRKA1|S-AKAP84|SAKAP84|TDRD17	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5398
0	0.444690432397603	0.512	0.238	0	VEZF1	Malignant cells	GSE138267	ENSG00000136451	7716	vascular endothelial zinc finger 1	DB1|ZNF161	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5399
0	0.29583035490229	0.464	0.243	0	DYNLL2	Malignant cells	GSE138267	ENSG00000264364	140735	dynein light chain LC8-type 2	Dlc2|DNCL1B|MGC17810|RSPH22	protein_coding	Q96FJ2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5400
0	0.327649327773171	0.331	0.129	0	PPM1D	Malignant cells	GSE138267	ENSG00000170836	8493	protein phosphatase, Mg2+/Mn2+ dependent 1D	PP2C-DELTA|Wip1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5401
0	0.594169179433856	0.266	0.082	0	KCNH6	Malignant cells	GSE138267	ENSG00000173826	81033	potassium voltage-gated channel subfamily H member 6	erg2|HERG2|Kv11.2	protein_coding	Q9H252	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5402
0	0.285873846170644	0.82	0.838	0	PSMC5	Malignant cells	GSE138267	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5403
0	0.579518968562031	0.991	0.972	0	DDX5	Malignant cells	GSE138267	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5404
0	0.345672894789307	0.452	0.245	0	BPTF	Malignant cells	GSE138267	ENSG00000171634	2186	bromodomain PHD finger transcription factor	FAC1|FALZ|NURF301	protein_coding	Q12830	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5405
0	0.430592283070661	0.729	0.671	0	PRKAR1A	Malignant cells	GSE138267	ENSG00000108946	5573	protein kinase cAMP-dependent type I regulatory subunit alpha	CNC1|PRKAR1|TSE1	protein_coding	P10644	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5406
0	0.400510259140722	0.292	0.155	0	ABCA5	Malignant cells	GSE138267	ENSG00000154265	23461	ATP binding cassette subfamily A member 5	EST90625	protein_coding	Q8WWZ7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5407
0	0.904162044964171	0.537	0.184	0	KIF19	Malignant cells	GSE138267	ENSG00000196169	124602	kinesin family member 19	FLJ37300|KIF19A	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5408
0	0.441359157152143	0.254	0.038	0	BTBD17	Malignant cells	GSE138267	ENSG00000204347	388419	BTB domain containing 17	BTBD17A|LGALS3BPL|TANGO10A	protein_coding	A6NE02	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5409
0	-0.309389534888528	0.581	0.761	0	NT5C	Malignant cells	GSE138267	ENSG00000125458	30833	5', 3'-nucleotidase, cytosolic	cdN|DNT-1|DNT1|PN-I|UMPH2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5410
0	-0.295397223083757	0.161	0.305	0	TEN1	Malignant cells	GSE138267	ENSG00000257949	100134934	TEN1 subunit of CST complex	C17orf106|FLJ39785	protein_coding	Q86WV5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5411
0	0.697667289695946	0.464	0.135	0	FOXJ1	Malignant cells	GSE138267	ENSG00000129654	2302	forkhead box J1	FKHL13|HFH-4|HFH4	protein_coding	Q92949	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5412
0	0.339365226191655	0.407	0.205	0	JMJD6	Malignant cells	GSE138267	ENSG00000070495	23210	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	KIAA0585|PTDSR|PTDSR1	protein_coding	Q6NYC1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5413
0	0.326843582466138	0.977	0.983	0	SRSF2	Malignant cells	GSE138267	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5414
0	0.512564240637708	0.522	0.251	0	SEPT9	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5415
0	0.382505443060444	0.334	0.196	0	TK1	Malignant cells	GSE138267	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5416
0	0.496129673481518	0.36	0.22	0	SOCS3	Malignant cells	GSE138267	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5417
0	0.406706405612107	0.737	0.742	0	LGALS3BP	Malignant cells	GSE138267	ENSG00000108679	3959	galectin 3 binding protein	90K|BTBD17B|CyCAP|gp90|M2BP|MAC-2-BP|TANGO10B	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5418
0	0.542817810655293	0.856	0.819	0	EIF4A3	Malignant cells	GSE138267	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5419
0	0.331823848049949	0.464	0.246	0	ENDOV	Malignant cells	GSE138267	ENSG00000173818	284131	endonuclease V	FLJ35220	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5420
0	0.255692637509351	0.525	0.334	0	GPS1	Malignant cells	GSE138267	ENSG00000169727	2873	G protein pathway suppressor 1	COPS1|CSN1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5421
0	0.269473477313366	0.422	0.229	0	CSNK1D	Malignant cells	GSE138267	ENSG00000141551	1453	casein kinase 1 delta	CKID|CKIdelta|HCKID	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5422
0	0.287818539866578	0.378	0.185	0	C17orf62	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5423
0	0.251950709633804	0.435	0.265	0	USP14	Malignant cells	GSE138267	ENSG00000101557	9097	ubiquitin specific peptidase 14	TGT|Ubp6	protein_coding	P54578	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5424
0	0.338607877429578	0.35	0.163	0	SMCHD1	Malignant cells	GSE138267	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5425
0	0.29906623197899	0.637	0.582	0	ANKRD12	Malignant cells	GSE138267	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5426
0	0.34402041692183	0.477	0.251	0	RNMT	Malignant cells	GSE138267	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5427
0	0.345319355772511	0.559	0.388	0	ROCK1	Malignant cells	GSE138267	ENSG00000067900	6093	Rho associated coiled-coil containing protein kinase 1	p160ROCK	protein_coding	Q13464	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5428
0	0.257652356945423	0.339	0.165	0	RIOK3	Malignant cells	GSE138267	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5429
0	0.44779071451994	0.374	0.101	0	CDH2	Malignant cells	GSE138267	ENSG00000170558	1000	cadherin 2	CD325|CDHN|NCAD	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5430
0	0.317497461297936	0.456	0.259	0	RNF138	Malignant cells	GSE138267	ENSG00000134758	51444	ring finger protein 138	NARF|STRIN	protein_coding	Q8WVD3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5431
0	0.300924655035786	0.366	0.174	0	ZNF397	Malignant cells	GSE138267	ENSG00000186812	84307	zinc finger protein 397	MGC13250|ZNF47|ZSCAN15	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5432
0	0.396182149006408	0.64	0.597	0	ZNF24	Malignant cells	GSE138267	ENSG00000172466	7572	zinc finger protein 24	KOX17|Zfp191|ZNF191|ZSCAN3	protein_coding	P17028	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5433
0	0.438584848212896	0.489	0.218	0	INO80C	Malignant cells	GSE138267	ENSG00000153391	125476	INO80 complex subunit C	C18orf37|FLJ38183|hIes6|IES6	protein_coding	Q6PI98	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5434
0	0.339655775437045	0.432	0.204	0	RPRD1A	Malignant cells	GSE138267	ENSG00000141425	55197	regulation of nuclear pre-mRNA domain containing 1A	FLJ10656|HsT3101|P15RS	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5435
0	0.302599506423079	0.405	0.203	0	ELP2	Malignant cells	GSE138267	ENSG00000134759	55250	elongator acetyltransferase complex subunit 2	FLJ10879|STATIP1|StIP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5436
0	0.820143449192455	0.619	0.195	0	CELF4	Malignant cells	GSE138267	ENSG00000101489	56853	CUGBP Elav-like family member 4	BRUNOL4	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5437
0	0.568719837001324	0.319	0.095	0	SYT4	Malignant cells	GSE138267	ENSG00000132872	6860	synaptotagmin 4	HsT1192|KIAA1342	protein_coding	Q9H2B2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5438
0	0.505487983986719	0.961	0.859	0	ATP5A1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5439
0	0.38387087827543	0.447	0.197	0	HDHD2	Malignant cells	GSE138267	ENSG00000167220	84064	haloacid dehalogenase like hydrolase domain containing 2	DKFZP564D1378	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5440
0	0.337248355767785	0.442	0.231	0	SMAD2	Malignant cells	GSE138267	ENSG00000175387	4087	SMAD family member 2	JV18-1|MADH2|MADR2	protein_coding	Q15796	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5441
0	-0.493983223658043	0.777	0.911	0	RPL17	Malignant cells	GSE138267	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5442
0	0.363964149813942	0.777	0.766	0	ACAA2	Malignant cells	GSE138267	ENSG00000167315	10449	acetyl-CoA acyltransferase 2	DSAEC	protein_coding	P42765	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5443
0	0.287989838831169	0.447	0.247	0	CXXC1	Malignant cells	GSE138267	ENSG00000154832	30827	CXXC finger protein 1	CFP1|CGBP|hCGBP|HsT2645|PCCX1|PHF18|SPP1|ZCGPC1	protein_coding	Q9P0U4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5444
0	1.18130872345096	0.489	0.138	0	TCF4	Malignant cells	GSE138267	ENSG00000196628	6925	transcription factor 4	bHLHb19|E2-2|ITF2|SEF2-1B	protein_coding	P15884	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5445
0	0.289481730668317	0.294	0.118	0	ONECUT2	Malignant cells	GSE138267	ENSG00000119547	9480	one cut homeobox 2	OC-2	protein_coding	O95948	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5446
0	0.340718699978798	0.513	0.294	0	VPS4B	Malignant cells	GSE138267	ENSG00000119541	9525	vacuolar protein sorting 4 homolog B	SKD1|SKD1B|VPS4-2	protein_coding	O75351	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5447
0	0.326481896282185	0.472	0.242	0	CSNK2A1	Malignant cells	GSE138267	ENSG00000101266	1457	casein kinase 2 alpha 1	Cka1|Cka2	protein_coding	P68400	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5448
0	0.322003652158272	0.36	0.146	0	FAM110A	Malignant cells	GSE138267	ENSG00000125898	83541	family with sequence similarity 110 member A	bA371L19.3|C20orf55	protein_coding	Q9BQ89	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5449
0	0.376282477537995	0.677	0.6	0	PSMF1	Malignant cells	GSE138267	ENSG00000125818	9491	proteasome inhibitor subunit 1	PI31	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5450
0	0.474020151293712	0.941	0.891	0	FKBP1A	Malignant cells	GSE138267	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5451
0	0.512398743154675	0.65	0.447	0	NSFL1C	Malignant cells	GSE138267	ENSG00000088833	55968	NSFL1 cofactor	dJ776F14.1|p47|UBX1|UBXD10|UBXN2C	protein_coding	Q9UNZ2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5452
0	0.261299007295847	0.986	0.975	0	SNRPB	Malignant cells	GSE138267	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5453
0	0.331228482855337	0.69	0.606	0	IDH3B	Malignant cells	GSE138267	ENSG00000101365	3420	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta	RP46	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5454
0	0.336318287284512	0.442	0.201	0	PTPRA	Malignant cells	GSE138267	ENSG00000132670	5786	protein tyrosine phosphatase receptor type A	HLPR|HPTPA|LRP|PTPA|PTPRL2|RPTPA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5455
0	0.493554563884016	0.876	0.834	0	MRPS26	Malignant cells	GSE138267	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5456
0	0.678528032035705	0.288	0.023	0	OXT	Malignant cells	GSE138267	ENSG00000101405	5020	oxytocin/neurophysin I prepropeptide	OT|OT-NPI|OXT-NPI	protein_coding	P01178	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5457
0	3.01295830095992	0.519	0.091	0	AVP	Malignant cells	GSE138267	ENSG00000101200	551	arginine vasopressin	ADH|ARVP	protein_coding	P01185	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5458
0	0.3562287610561	0.521	0.265	0	ITPA	Malignant cells	GSE138267	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5459
0	0.338352042521476	0.398	0.217	0	CDC25B	Malignant cells	GSE138267	ENSG00000101224	994	cell division cycle 25B	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5460
0	0.430666546166757	0.504	0.225	0	PANK2	Malignant cells	GSE138267	ENSG00000125779	80025	pantothenate kinase 2	C20orf48|FLJ11729|HARP|HSS|NBIA1|PKAN	protein_coding	Q9BZ23	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5461
0	0.281778575659126	0.327	0.148	0	RNF24	Malignant cells	GSE138267	ENSG00000101236	11237	ring finger protein 24	G1L	protein_coding	Q9Y225	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5462
0	0.326873731142668	0.819	0.77	0	TMEM230	Malignant cells	GSE138267	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5463
0	0.645326400782601	0.527	0.227	0	CHGB	Malignant cells	GSE138267	ENSG00000089199	1114	chromogranin B	SCG1|SgI	protein_coding	P05060	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5464
0	0.419408873549375	0.465	0.187	0	TRMT6	Malignant cells	GSE138267	ENSG00000089195	51605	tRNA methyltransferase 6 non-catalytic subunit	CGI-09|GCD10|Gcd10p|MGC5029	protein_coding	Q9UJA5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5465
0	0.433738880926442	0.511	0.235	0	TMX4	Malignant cells	GSE138267	ENSG00000125827	56255	thioredoxin related transmembrane protein 4	DJ971N18.2|KIAA1162|PDIA14|TXNDC13	protein_coding	Q9H1E5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5466
0	0.29736574794581	0.438	0.249	0	SNAP25	Malignant cells	GSE138267	ENSG00000132639	6616	synaptosome associated protein 25	bA416N4.2|dJ1068F16.2|RIC-4|RIC4|SEC9|SNAP|SNAP-25	protein_coding	P60880	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5467
0	0.389326537262339	0.516	0.238	0	ESF1	Malignant cells	GSE138267	ENSG00000089048	51575	ESF1 nucleolar pre-rRNA processing protein homolog	bA526K24.1|C20orf6	protein_coding	Q9H501	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5468
0	0.320454181741272	0.876	0.779	0	SNRPB2	Malignant cells	GSE138267	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5469
0	0.281153118460761	0.974	0.954	0	DSTN	Malignant cells	GSE138267	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5470
0	0.345741542369979	0.326	0.124	0	RRBP1	Malignant cells	GSE138267	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5471
0	0.250819428578506	0.436	0.259	0	SNX5	Malignant cells	GSE138267	ENSG00000089006	27131	sorting nexin 5	NA	protein_coding	Q9Y5X3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5472
0	0.309675193970076	0.308	0.126	0	MGME1	Malignant cells	GSE138267	ENSG00000125871	92667	mitochondrial genome maintenance exonuclease 1	bA504H3.4|C20orf72|DDK1	protein_coding	Q9BQP7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5473
0	0.422536439879542	0.812	0.676	0	LINC00493	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5474
0	0.328885665506065	0.305	0.11	0	CRNKL1	Malignant cells	GSE138267	ENSG00000101343	51340	crooked neck pre-mRNA splicing factor 1	CLF|Clf1|CRN|SYF3	protein_coding	Q9BZJ0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5475
0	0.310326913227992	0.672	0.624	0	XRN2	Malignant cells	GSE138267	ENSG00000088930	22803	5'-3' exoribonuclease 2	NA	protein_coding	Q9H0D6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5476
0	1.29187193375508	0.726	0.578	0	ID1	Malignant cells	GSE138267	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5477
0	0.344002225525064	0.481	0.274	0	BCL2L1	Malignant cells	GSE138267	ENSG00000171552	598	BCL2 like 1	Bcl-X|bcl-xL|bcl-xS|BCL2L|BCLX|PPP1R52	protein_coding	Q07817	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5478
0	0.484614010923771	0.339	0.197	0	TPX2	Malignant cells	GSE138267	ENSG00000088325	22974	TPX2 microtubule nucleation factor	C20orf1|C20orf2|DIL-2|FLS353|HCA519|p100	protein_coding	Q9ULW0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5479
0	0.462748639104302	0.436	0.187	0	NECAB3	Malignant cells	GSE138267	ENSG00000125967	63941	N-terminal EF-hand calcium binding protein 3	APBA2BP|dJ63M2.4|dJ63M2.5|EFCBP3|NIP1|SYTIP2|XB51	protein_coding	Q96P71	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5480
0	-0.326667011009805	0.524	0.792	0	AHCY	Malignant cells	GSE138267	ENSG00000101444	191	adenosylhomocysteinase	AdoHcyase|SAHH	protein_coding	P23526	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5481
0	0.266596765202106	0.266	0.109	0	CEP250	Malignant cells	GSE138267	ENSG00000126001	11190	centrosomal protein 250	C-NAP1|CEP2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5482
0	0.408341438672009	0.948	0.9	0	RBM39	Malignant cells	GSE138267	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5483
0	0.301858577009036	0.439	0.235	0	LINC00657	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5484
0	0.507023134238636	0.788	0.702	0	C20orf24	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5485
0	0.268235000935053	0.483	0.326	0	BLCAP	Malignant cells	GSE138267	ENSG00000166619	10904	BLCAP apoptosis inducing factor	BC10	protein_coding	P62952	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5486
0	0.312026966227021	0.458	0.235	0	CTNNBL1	Malignant cells	GSE138267	ENSG00000132792	56259	catenin beta like 1	C20orf33|FLJ21108|NAP|NYD-SP19|P14|P14L	protein_coding	Q8WYA6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5487
0	0.929968829361971	0.506	0.149	0	MAFB	Malignant cells	GSE138267	ENSG00000204103	9935	MAF bZIP transcription factor B	KRML	protein_coding	Q9Y5Q3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5488
0	0.362009860186643	0.582	0.436	0	TOP1	Malignant cells	GSE138267	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5489
0	0.380182112919831	0.49	0.25	0	CHD6	Malignant cells	GSE138267	ENSG00000124177	84181	chromodomain helicase DNA binding protein 6	CHD5|dJ620E11.1|FLJ22369|KIAA1335|RIGB	protein_coding	Q8TD26	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5490
0	0.257116083862332	0.394	0.208	0	IFT52	Malignant cells	GSE138267	ENSG00000101052	51098	intraflagellar transport 52	C20orf9|CGI-53|dJ1028D15.1|NGD2|NGD5	protein_coding	Q9Y366	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5491
0	0.349568286625605	0.356	0.192	0	MYBL2	Malignant cells	GSE138267	ENSG00000101057	4605	MYB proto-oncogene like 2	B-MYB|BMYB	protein_coding	P10244	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5492
0	0.39436750078488	0.949	0.926	0	YWHAB	Malignant cells	GSE138267	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5493
0	-0.530176367652135	0.59	0.913	0	WFDC2	Malignant cells	GSE138267	ENSG00000101443	10406	WAP four-disulfide core domain 2	dJ461P17.6|EDDM4|HE4|WAP5	protein_coding	Q14508	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5494
0	0.310271305837698	0.484	0.284	0	DNTTIP1	Malignant cells	GSE138267	ENSG00000101457	116092	deoxynucleotidyltransferase terminal interacting protein 1	C20orf167|dJ447F3.4|Tdif1	protein_coding	Q9H147	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5495
0	0.449247689684676	0.475	0.202	0	EYA2	Malignant cells	GSE138267	ENSG00000064655	2139	EYA transcriptional coactivator and phosphatase 2	EAB1	protein_coding	O00167	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5496
0	0.519305462411817	0.554	0.244	0	DDX27	Malignant cells	GSE138267	ENSG00000124228	55661	DEAD-box helicase 27	dJ686N3.1|DRS1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5497
0	0.266083433059355	0.518	0.318	0	RNF114	Malignant cells	GSE138267	ENSG00000124226	55905	ring finger protein 114	PSORS12|ZNF313	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5498
0	0.408977214730238	0.627	0.567	0	CEBPB	Malignant cells	GSE138267	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5499
0	0.266665658134132	0.305	0.133	0	PTPN1	Malignant cells	GSE138267	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5500
0	0.446889532905286	0.557	0.268	0	FAM210B	Malignant cells	GSE138267	ENSG00000124098	116151	family with sequence similarity 210 member B	C20orf108|dJ1167H4.1|DKFZP434A1114	protein_coding	Q96KR6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5501
0	0.384681442767549	0.251	0.122	0	AURKA	Malignant cells	GSE138267	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5502
0	0.253189154284802	0.694	0.643	0	RTFDC1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5503
0	0.268621138046026	0.46	0.268	0	VAPB	Malignant cells	GSE138267	ENSG00000124164	9217	VAMP associated protein B and C	ALS8|VAP-B|VAP-C	protein_coding	O95292	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5504
0	0.57759052737135	0.922	0.889	0	GNAS	Malignant cells	GSE138267	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5505
0	0.316974929418525	1	1	0	RPS21	Malignant cells	GSE138267	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5506
0	0.307516352292962	0.549	0.319	0	PRPF6	Malignant cells	GSE138267	ENSG00000101161	24148	pre-mRNA processing factor 6	ANT-1|bB152O15.1|C20orf14|hPrp6|Prp6|RP60|SNRNP102|TOM|U5-102K	protein_coding	O94906	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5507
0	0.363191184480042	0.779	0.799	0	PTBP1	Malignant cells	GSE138267	ENSG00000011304	5725	polypyrimidine tract binding protein 1	HNRNP-I|HNRPI|pPTB|PTB|PTB-1|PTB2|PTB3|PTB4	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5508
0	0.408351535942657	0.488	0.215	0	MIDN	Malignant cells	GSE138267	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5509
0	0.299491260627346	0.408	0.267	0	GAMT	Malignant cells	GSE138267	ENSG00000130005	2593	guanidinoacetate N-methyltransferase	PIG2|TP53I2	protein_coding	Q14353	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5510
0	-0.332016525633616	0.885	0.97	0	TIMM13	Malignant cells	GSE138267	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5511
0	-0.516950942031239	0.168	0.34	0	GADD45B	Malignant cells	GSE138267	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5512
0	0.894131525583682	0.424	0.014	0	SHD	Malignant cells	GSE138267	ENSG00000105251	56961	Src homology 2 domain containing transforming protein D	NA	protein_coding	Q96IW2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5513
0	0.272783225760704	0.389	0.253	0	CHAF1A	Malignant cells	GSE138267	ENSG00000167670	10036	chromatin assembly factor 1 subunit A	CAF-1|CAF1|CAF1B|CAF1P150|MGC71229|P150	protein_coding	Q13111	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5514
0	0.32023990577774	0.411	0.207	0	UBXN6	Malignant cells	GSE138267	ENSG00000167671	80700	UBX domain protein 6	UBXD1|UBXDC2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5515
0	0.3844583172927	0.259	0.107	0	MIR7-3HG	Malignant cells	GSE138267	ENSG00000176840	284424	MIR7-3 host gene	C19orf30|Huh7|LINC00306|NCRNA00306|PGSF1|PGSF1a|PGSF1b|uc002mbe.2	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5516
0	0.29209635281819	0.952	0.931	0	NDUFA11	Malignant cells	GSE138267	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5517
0	0.328017985864962	0.455	0.242	0	RANBP3	Malignant cells	GSE138267	ENSG00000031823	8498	RAN binding protein 3	NA	protein_coding	Q9H6Z4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5518
0	0.322568043600971	0.475	0.251	0	MAP2K7	Malignant cells	GSE138267	ENSG00000076984	5609	mitogen-activated protein kinase kinase 7	Jnkk2|MKK7|PRKMK7	protein_coding	O14733	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5519
0	-0.36868317873106	0.432	0.786	0	CD320	Malignant cells	GSE138267	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5520
0	0.302381029323404	0.887	0.877	0	PIN1	Malignant cells	GSE138267	ENSG00000127445	5300	peptidylprolyl cis/trans isomerase, NIMA-interacting 1	dod	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5521
0	0.33156328876147	0.338	0.126	0	C19orf66	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5522
0	0.279627537972475	0.834	0.845	0	EIF3G	Malignant cells	GSE138267	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5523
0	0.305279088822098	0.675	0.601	0	ILF3-AS1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5524
0	0.309658977913609	0.827	0.824	0	ILF3	Malignant cells	GSE138267	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5525
0	-0.422890396380562	0.652	0.854	0	TMEM205	Malignant cells	GSE138267	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5526
0	-0.260648944193631	0.443	0.645	0	DNASE2	Malignant cells	GSE138267	ENSG00000105612	1777	deoxyribonuclease 2, lysosomal	DNL|DNL2	protein_coding	O00115	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5527
0	0.614047170223488	0.98	0.947	0	CALR	Malignant cells	GSE138267	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5528
0	0.322761804509113	0.278	0.06	0	NFIX	Malignant cells	GSE138267	ENSG00000008441	4784	nuclear factor I X	NF1A	protein_coding	Q14938	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5529
0	0.273840732984397	0.435	0.251	0	BRD4	Malignant cells	GSE138267	ENSG00000141867	23476	bromodomain containing 4	CAP|HUNK1|HUNKI|MCAP	protein_coding	O60885	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5530
0	0.307484944586396	0.479	0.277	0	AKAP8L	Malignant cells	GSE138267	ENSG00000011243	26993	A-kinase anchoring protein 8 like	HAP95|NAKAP95	protein_coding	Q9ULX6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5531
0	-0.292359640332544	0.549	0.747	0	TPM4	Malignant cells	GSE138267	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5532
0	0.328833555906194	0.46	0.244	0	USE1	Malignant cells	GSE138267	ENSG00000053501	55850	unconventional SNARE in the ER 1	D12|MDS032|p31|SLT1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5533
0	-0.305433970054506	0.641	0.847	0	MRPL34	Malignant cells	GSE138267	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5534
0	0.733979710795494	0.297	0.014	0	BST2	Malignant cells	GSE138267	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5535
0	-0.314236945762867	0.553	0.803	0	PGLS	Malignant cells	GSE138267	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5536
0	-0.348098689810311	1	1	0	RPL18A	Malignant cells	GSE138267	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5537
0	0.255814156149301	0.877	0.881	0	FKBP8	Malignant cells	GSE138267	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5538
0	0.399814166740819	0.474	0.231	0	PEPD	Malignant cells	GSE138267	ENSG00000124299	5184	peptidase D	NA	protein_coding	P12955	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5539
0	0.286600532181933	0.458	0.307	0	GPI	Malignant cells	GSE138267	ENSG00000282019	2821	glucose-6-phosphate isomerase	AMF|NLK	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5540
0	0.297253893289192	0.72	0.719	0	UBA2	Malignant cells	GSE138267	ENSG00000126261	10054	ubiquitin like modifier activating enzyme 2	FLJ13058|HRIHFB2115|SAE2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5541
0	0.28785223771398	0.406	0.211	0	ZNF302	Malignant cells	GSE138267	ENSG00000089335	55900	zinc finger protein 302	ZNF135L|ZNF140L|ZNF327	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5542
0	0.385410553488972	0.459	0.25	0	APLP1	Malignant cells	GSE138267	ENSG00000105290	333	amyloid beta precursor like protein 1	APLP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5543
0	-0.299058629209909	0.894	0.968	0	TBCB	Malignant cells	GSE138267	ENSG00000105254	1155	tubulin folding cofactor B	CG22|CKAP1|CKAPI	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5544
0	0.397967421783384	0.954	0.92	0	PSMD8	Malignant cells	GSE138267	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5545
0	0.273397033503222	0.943	0.959	0	EIF3K	Malignant cells	GSE138267	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5546
0	0.337607643077684	0.535	0.291	0	HNRNPL	Malignant cells	GSE138267	ENSG00000282947	3191	heterogeneous nuclear ribonucleoprotein L	HNRPL	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5547
0	0.369640919242961	0.453	0.215	0	SIRT2	Malignant cells	GSE138267	ENSG00000283100	22933	sirtuin 2	SIR2L	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5548
0	0.278309837913899	0.42	0.223	0	PAF1	Malignant cells	GSE138267	ENSG00000006712	54623	PAF1 homolog, Paf1/RNA polymerase II complex component	F23149_1|FLJ11123|PD2	protein_coding	Q8N7H5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5549
0	0.284917538221169	0.426	0.217	0	EGLN2	Malignant cells	GSE138267	ENSG00000269858	112398	egl-9 family hypoxia inducible factor 2	HIFPH1|PHD1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5550
0	0.438177368664121	0.831	0.786	0	HNRNPUL1	Malignant cells	GSE138267	ENSG00000105323	11100	heterogeneous nuclear ribonucleoprotein U like 1	E1B-AP5|E1BAP5|FLJ12944|HNRPUL1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5551
0	0.287656419989443	0.519	0.287	0	ATP5SL	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5552
0	-0.364084577859615	1	1	0	RPS19	Malignant cells	GSE138267	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5553
0	-0.274912908022691	0.633	0.839	0	RABAC1	Malignant cells	GSE138267	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5554
0	0.354062864534419	0.289	0.071	0	TMEM145	Malignant cells	GSE138267	ENSG00000167619	284339	transmembrane protein 145	FLJ90805	protein_coding	Q8NBT3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5555
0	0.964438068237031	0.314	0.009	0	CXCL17	Malignant cells	GSE138267	ENSG00000189377	284340	C-X-C motif chemokine ligand 17	Dcip1|DMC|UNQ473|VCC1	protein_coding	Q6UXB2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5556
0	0.318250300931685	0.511	0.295	0	CLPTM1	Malignant cells	GSE138267	ENSG00000104853	1209	CLPTM1 regulator of GABA type A receptor forward trafficking	NA	protein_coding	O96005	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5557
0	0.462379832829142	0.55	0.265	0	ERCC1	Malignant cells	GSE138267	ENSG00000012061	2067	ERCC excision repair 1, endonuclease non-catalytic subunit	RAD10	protein_coding	P07992	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5558
0	0.266077899169288	0.338	0.163	0	IRF2BP1	Malignant cells	GSE138267	ENSG00000170604	26145	interferon regulatory factor 2 binding protein 1	DKFZP434M154|IRF-2BP1	protein_coding	Q8IU81	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5559
0	0.28226396638835	0.513	0.313	0	PPP5C	Malignant cells	GSE138267	ENSG00000011485	5536	protein phosphatase 5 catalytic subunit	PP5|PPP5	protein_coding	P53041	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5560
0	0.427779051348198	0.869	0.832	0	CALM3	Malignant cells	GSE138267	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5561
0	0.264023392354707	0.274	0.101	0	KPTN	Malignant cells	GSE138267	ENSG00000118162	11133	kaptin, actin binding protein	2E4|KICS4	protein_coding	Q9Y664	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5562
0	0.419720683858061	0.866	0.858	0	KDELR1	Malignant cells	GSE138267	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5563
0	0.284897993046235	0.513	0.327	0	NUCB1	Malignant cells	GSE138267	ENSG00000104805	4924	nucleobindin 1	Calnuc|NUC	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5564
0	-0.358869594706152	0.999	1	0	FTL	Malignant cells	GSE138267	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5565
0	0.49096202298819	0.451	0.237	0	FCGRT	Malignant cells	GSE138267	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5566
0	0.26444248727079	0.463	0.286	0	MED25	Malignant cells	GSE138267	ENSG00000104973	81857	mediator complex subunit 25	ACID1|ARC92|DKFZp434K0512|TCBAP0758	protein_coding	Q71SY5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5567
0	0.283790595414931	0.451	0.253	0	PNKP	Malignant cells	GSE138267	ENSG00000039650	11284	polynucleotide kinase 3'-phosphatase	PNK	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5568
0	0.425770321738182	0.541	0.287	0	NUP62	Malignant cells	GSE138267	ENSG00000213024	23636	nucleoporin 62	DKFZp547L134|FLJ20822|FLJ43869|IBSN|MGC841|p62|SNDI	protein_coding	P37198	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5569
0	-0.486711397610842	0.384	0.745	0	ATF5	Malignant cells	GSE138267	ENSG00000169136	22809	activating transcription factor 5	NA	protein_coding	Q9Y2D1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5570
0	0.45098167863014	0.48	0.212	0	VRK3	Malignant cells	GSE138267	ENSG00000105053	51231	VRK serine/threonine kinase 3	NA	protein_coding	Q8IV63	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5571
0	-0.413223410515908	0.355	0.575	0	KLK12	Malignant cells	GSE138267	ENSG00000186474	43849	kallikrein related peptidase 12	KLK-L5	protein_coding	Q9UKR0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5572
0	0.317596517671101	0.688	0.614	0	ETFB	Malignant cells	GSE138267	ENSG00000105379	2109	electron transfer flavoprotein subunit beta	NA	protein_coding	P38117	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5573
0	0.278546433504366	0.825	0.796	0	PPP2R1A	Malignant cells	GSE138267	ENSG00000105568	5518	protein phosphatase 2 scaffold subunit Aalpha	PP2A-Aalpha|PP2AA|PR65A	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5574
0	0.315925321310454	0.358	0.178	0	ZNF83	Malignant cells	GSE138267	ENSG00000167766	55769	zinc finger protein 83	FLJ11015|HPF1|ZNF816B	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5575
0	0.250530916279673	0.354	0.181	0	CNOT3	Malignant cells	GSE138267	ENSG00000274941	4849	CCR4-NOT transcription complex subunit 3	KIAA0691|LENG2|NOT3|NOT3H	protein_coding	O75175	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5576
0	0.317322653740127	0.389	0.167	0	LENG1	Malignant cells	GSE138267	ENSG00000276628	79165	leukocyte receptor cluster member 1	NA	protein_coding	Q96BZ8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5577
0	-0.352656826356236	1	1	0	RPS9	Malignant cells	GSE138267	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5578
0	0.601814410101001	0.727	0.621	0	TNNT1	Malignant cells	GSE138267	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5579
0	0.341809208867011	0.423	0.22	0	SUV420H2	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5580
0	0.412143266780289	0.519	0.254	0	NAT14	Malignant cells	GSE138267	ENSG00000090971	57106	N-acetyltransferase 14 (putative)	KLP1	protein_coding	Q8WUY8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5581
0	0.410876639603931	0.57	0.296	0	U2AF2	Malignant cells	GSE138267	ENSG00000063244	11338	U2 small nuclear RNA auxiliary factor 2	U2AF65	protein_coding	P26368	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5582
0	0.263504054693839	0.496	0.31	0	EPN1	Malignant cells	GSE138267	ENSG00000063245	29924	epsin 1	NA	protein_coding	Q9Y6I3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5583
0	0.341029619404907	0.327	0.162	0	ZNF667-AS1	Malignant cells	GSE138267	ENSG00000166770	100128252	ZNF667 antisense RNA 1 (head to head)	MORT	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5584
0	0.31563544910659	0.392	0.166	0	TRAPPC2P1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5585
0	0.371865030583061	0.485	0.255	0	AC010642.1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5586
0	0.436738457343738	0.82	0.767	0	CHMP2A	Malignant cells	GSE138267	ENSG00000130724	27243	charged multivesicular body protein 2A	BC-2|CHMP2|VPS2|VPS2A	protein_coding	O43633	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5587
0	0.986062805381015	0.389	0.072	0	RPS4Y1	Malignant cells	GSE138267	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5588
0	0.352604175366465	0.295	0.087	0	EIF1AY	Malignant cells	GSE138267	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5589
0	0.393936902044796	0.288	0.121	0	CLDN5	Malignant cells	GSE138267	ENSG00000184113	7122	claudin 5	AWAL|BEC1|CPETRL1|TMVCF	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5590
0	-0.436320367162	0.935	0.987	0	RANBP1	Malignant cells	GSE138267	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5591
0	-0.384704993738911	0.386	0.592	0	SDF2L1	Malignant cells	GSE138267	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5592
0	-0.284053808420784	0.508	0.724	0	CHCHD10	Malignant cells	GSE138267	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5593
0	-0.816795213302738	0.964	0.99	0	MIF	Malignant cells	GSE138267	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5594
0	0.537979986880133	0.434	0.101	0	SEZ6L	Malignant cells	GSE138267	ENSG00000100095	23544	seizure related 6 homolog like	NA	protein_coding	Q9BYH1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5595
0	0.326186336948559	0.529	0.298	0	HMGXB4	Malignant cells	GSE138267	ENSG00000100281	10042	HMG-box containing 4	HMG2L1|P53N|THC211630	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5596
0	-0.786641567892961	0.132	0.284	0	LGALS1	Malignant cells	GSE138267	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5597
0	-0.467880990723197	0.865	0.948	0	EIF3L	Malignant cells	GSE138267	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5598
0	-0.446614501867082	0.527	0.774	0	CBX6	Malignant cells	GSE138267	ENSG00000183741	23466	chromobox 6	NA	protein_coding	O95503	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5599
0	-0.635203623031115	0.999	1	0	RPL3	Malignant cells	GSE138267	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5600
0	-0.365893248631836	0.763	0.918	0	RPS19BP1	Malignant cells	GSE138267	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5601
0	-0.2970413929787	0.799	0.93	0	ST13	Malignant cells	GSE138267	ENSG00000100380	6767	ST13 Hsp70 interacting protein	FAM10A1|HIP|HSPABP1|P48|SNC6	protein_coding	P50502	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5602
0	0.267898245155914	0.397	0.234	0	ARFGAP3	Malignant cells	GSE138267	ENSG00000242247	26286	ADP ribosylation factor GTPase activating protein 3	ARFGAP1	protein_coding	Q9NP61	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5603
0	0.520678664722965	0.34	0.089	0	FBLN1	Malignant cells	GSE138267	ENSG00000077942	2192	fibulin 1	FBLN	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5604
0	0.394310506624018	0.289	0.107	0	TBC1D22A	Malignant cells	GSE138267	ENSG00000054611	25771	TBC1 domain family member 22A	C22orf4	protein_coding	Q8WUA7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5605
0	0.304796428348672	0.972	0.884	0	ATP5J	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5606
0	1.07945223063635	0.733	0.597	0	C21orf59	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5607
0	0.542541487431642	0.903	0.843	0	SON	Malignant cells	GSE138267	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5608
0	0.359220554383354	0.959	0.865	0	ATP5O	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5609
0	0.494437856628974	0.39	0.139	0	RCAN1	Malignant cells	GSE138267	ENSG00000159200	1827	regulator of calcineurin 1	DSCR1	protein_coding	P53805	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5610
0	-0.351008715767569	0.429	0.712	0	CBR1	Malignant cells	GSE138267	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5611
0	0.575608455462133	0.884	0.849	0	TTC3	Malignant cells	GSE138267	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5612
0	-0.321599608984816	0.601	0.855	0	FAM3B	Malignant cells	GSE138267	ENSG00000183844	54097	FAM3 metabolism regulating signaling molecule B	2-21|C21orf11|C21orf76|D21M16SJHU19e|ORF9|PANDER|PRED44	protein_coding	P58499	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5613
0	-0.679119664365221	0.755	0.985	0	TFF3	Malignant cells	GSE138267	ENSG00000160180	7033	trefoil factor 3	HITF|ITF	protein_coding	Q07654	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5614
0	0.444282342600119	0.406	0.192	0	C21orf58	Malignant cells	GSE138267	ENSG00000160298	54058	chromosome 21 open reading frame 58	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5615
0	-0.315567415662182	0.997	0.999	0	MT-ND2	Malignant cells	GSE138267	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5616
0	-0.265411921230577	1	1	0	MT-CO1	Malignant cells	GSE138267	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5617
0	-0.595729955954064	0.999	0.999	0	MT-CO2	Malignant cells	GSE138267	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5618
0	-0.360655177092597	0.995	0.998	0	MT-ATP6	Malignant cells	GSE138267	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5619
0	-0.659786746744314	1	0.999	0	MT-CO3	Malignant cells	GSE138267	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5620
0	-0.743715461277689	0.991	0.997	0	MT-ND3	Malignant cells	GSE138267	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5621
0	-0.746110152089236	0.517	0.873	0	MT-ND4L	Malignant cells	GSE138267	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5622
0	-0.500458418536842	0.999	0.999	0	MT-ND4	Malignant cells	GSE138267	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5623
0	-0.796105173689064	0.953	0.994	0	MT-ND5	Malignant cells	GSE138267	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5624
0	0.276430150738276	0.466	0.286	0	MT-ND6	Malignant cells	GSE138267	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5625
0	-0.634000952699616	0.994	0.998	0	MT-CYB	Malignant cells	GSE138267	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5626
0	0.345267178584764	0.317	0.069	0	SRSF10.1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5627
0	-0.495380218521256	0.128	0.274	0	TMEM176B	Malignant cells	GSE138267	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5628
0	-0.894994962699207	0.021	0.28	0	AKR1C3	Malignant cells	GSE138267	ENSG00000196139	8644	aldo-keto reductase family 1 member C3	DDX|HAKRB|HSD17B5|KIAA0119|PGFS	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5629
0	-0.880598248796616	0.004	0.273	0	AKR1C2	Malignant cells	GSE138267	ENSG00000151632	1646	aldo-keto reductase family 1 member C2	BABP|DD|DD2|DDH2|HAKRD|MCDR2|TDD	protein_coding	P52895	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5630
0	-1.05194617605597	0.359	0.772	0	RTN1	Malignant cells	GSE138267	ENSG00000139970	6252	reticulon 1	NSP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5631
1.35964339750073e-307	-0.267225415197964	0.912	0.966	3.79177350695003e-303	RBX1	Malignant cells	GSE138267	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5632
1.93072037297764e-307	0.297708599489691	0.618	0.557	5.38439297616005e-303	USP16	Malignant cells	GSE138267	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5633
3.51984531225378e-305	0.380035889856143	0.332	0.213	9.81614460681334e-301	CIB2	Malignant cells	GSE138267	ENSG00000136425	10518	calcium and integrin binding family member 2	DFNB48|KIP2|USH1J	protein_coding	O75838	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5634
7.18762950734257e-305	-0.818130633210195	0.239	0.336	2.0044861170077e-300	DLX5	Malignant cells	GSE138267	ENSG00000105880	1749	distal-less homeobox 5	NA	protein_coding	P56178	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5635
8.13827357053642e-305	0.259035215238301	0.612	0.528	2.2696017333512e-300	CHMP3	Malignant cells	GSE138267	ENSG00000115561	51652	charged multivesicular body protein 3	CGI-149|NEDF|VPS24	protein_coding	Q9Y3E7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5636
1.65390441929591e-303	-0.261240122039018	0.143	0.264	4.61240864453244e-299	SMAD9	Malignant cells	GSE138267	ENSG00000120693	4093	SMAD family member 9	MADH6|MADH9|SMAD8|SMAD8/9	protein_coding	O15198	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5637
4.86683996832052e-300	-0.276925759254641	0.922	0.964	1.35726433036523e-295	PSMB7	Malignant cells	GSE138267	ENSG00000136930	5695	proteasome 20S subunit beta 7	Z	protein_coding	Q99436	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5638
1.726801392297e-299	-0.288226554610206	0.853	0.93	4.81570372283786e-295	NDUFA1	Malignant cells	GSE138267	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5639
4.14847699215158e-299	-0.252564994664182	0.618	0.798	1.15692726357123e-294	PHF5A	Malignant cells	GSE138267	ENSG00000100410	84844	PHD finger protein 5A	bK223H9.2|INI|MGC1346|Rds3|SAP14b|SF3b14b|SF3B7	protein_coding	Q7RTV0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5640
8.190969107579e-299	-0.256837128263657	0.713	0.88	2.28429746472163e-294	ARPC1A	Malignant cells	GSE138267	ENSG00000241685	10552	actin related protein 2/3 complex subunit 1A	Arc40|SOP2Hs|SOP2L	protein_coding	Q92747	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5641
1.80913637850692e-298	-0.261118583278364	0.937	0.98	5.04531953238011e-294	COX5A	Malignant cells	GSE138267	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5642
1.67326135694984e-297	0.258631007188747	0.779	0.785	4.66639127226172e-293	LAMP1	Malignant cells	GSE138267	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5643
5.11496716430701e-295	0.250115593962119	0.379	0.247	1.42646204278194e-290	RBBP8	Malignant cells	GSE138267	ENSG00000101773	5932	RB binding protein 8, endonuclease	COM1|CtIP|RIM|SCKL2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5644
3.93937164592169e-294	0.270836204343325	0.983	0.974	1.09861196461464e-289	CKB	Malignant cells	GSE138267	ENSG00000166165	1152	creatine kinase B	CKBB	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5645
5.11308568875198e-294	-0.294164202765593	0.277	0.404	1.42593733687915e-289	YDJC	Malignant cells	GSE138267	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5646
9.06075960452163e-294	0.534347394331672	0.75	0.717	2.52686463850899e-289	RGS16	Malignant cells	GSE138267	ENSG00000143333	6004	regulator of G protein signaling 16	A28-RGS14|RGS-r	protein_coding	O15492	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5647
5.68074985035965e-289	0.288429790727175	0.718	0.735	1.5842475182683e-284	NAP1L4	Malignant cells	GSE138267	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5648
5.42355141646361e-288	0.321286616184152	0.356	0.227	1.51252001902337e-283	FBXO5	Malignant cells	GSE138267	ENSG00000112029	26271	F-box protein 5	EMI1|FBX5|Fbxo31	protein_coding	Q9UKT4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5649
4.35682573164647e-287	-0.48428778229021	0.552	0.752	1.21503156004157e-282	DDIT4	Malignant cells	GSE138267	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5650
1.11769826378462e-285	0.364394253592013	0.319	0.194	3.11703691804255e-281	GTSE1	Malignant cells	GSE138267	ENSG00000075218	51512	G2 and S-phase expressed 1	B99|GTSE-1|Lnc_bc060912	protein_coding	Q9NYZ3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5651
1.78071520032336e-285	0.266633172962099	0.83	0.86	4.96605855066177e-281	UCP2	Malignant cells	GSE138267	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5652
3.83081211007276e-285	0.299971155864648	0.596	0.525	1.06833688125709e-280	CDC5L	Malignant cells	GSE138267	ENSG00000096401	988	cell division cycle 5 like	CDC5|CEF1|hCDC5|PCDC5RP	protein_coding	Q99459	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5653
6.3000224463964e-285	-0.263857064882014	0.232	0.366	1.75695025985103e-280	PYCR1	Malignant cells	GSE138267	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5654
1.69489825166423e-284	0.296609688445441	0.558	0.461	4.72673224424121e-280	GNL1	Malignant cells	GSE138267	ENSG00000229470	2794	G protein nucleolar 1 (putative)	HSR1	protein_coding	P36915	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5655
9.37131530642881e-284	0.266592453311819	0.687	0.67	2.61347241265687e-279	SMARCE1	Malignant cells	GSE138267	ENSG00000073584	6605	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1	BAF57	protein_coding	Q969G3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5656
2.23290474814922e-282	0.310621944244239	0.711	0.735	6.22712476163856e-278	TPGS2	Malignant cells	GSE138267	ENSG00000134779	25941	tubulin polyglutamylase complex subunit 2	C18orf10|DKFZP586M1523|HsT3006|PGs2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5657
4.66020893662635e-282	0.272128446367815	0.689	0.679	1.29963906824636e-277	NAPA	Malignant cells	GSE138267	ENSG00000105402	8775	NSF attachment protein alpha	NA	protein_coding	P54920	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5658
5.17903715328055e-282	0.332951161880445	0.738	0.743	1.44432988130688e-277	CXADR	Malignant cells	GSE138267	ENSG00000154639	1525	CXADR Ig-like cell adhesion molecule	CAR	protein_coding	P78310	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5659
1.28857757456279e-281	0.325886603780174	0.667	0.652	3.5935851399407e-277	BNIP3L	Malignant cells	GSE138267	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5660
8.23928499965351e-281	0.286680459639399	0.622	0.571	2.29777180070337e-276	CYSTM1	Malignant cells	GSE138267	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5661
8.74441529682538e-280	-0.495179535230425	0.261	0.376	2.43864253797866e-275	SLC39A4	Malignant cells	GSE138267	ENSG00000285243	55630	solute carrier family 39 member 4	AEZ|AWMS2|ZIP4	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5662
1.04976231714701e-279	0.25445472886504	0.77	0.788	2.92757715005959e-275	TXNL1	Malignant cells	GSE138267	ENSG00000091164	9352	thioredoxin like 1	TRP32|Txl|TXNL	protein_coding	O43396	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5663
1.07818907579633e-278	0.548407253123352	0.389	0.261	3.00685369458079e-274	HES1	Malignant cells	GSE138267	ENSG00000114315	3280	hes family bHLH transcription factor 1	bHLHb39|FLJ20408|HES-1|HRY	protein_coding	Q14469	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5664
3.21781062747308e-278	0.273253348399034	0.633	0.595	8.97383027789692e-274	SNAPIN	Malignant cells	GSE138267	ENSG00000143553	23557	SNAP associated protein	BLOC1S7|BORCS3|SNAPAP	protein_coding	O95295	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5665
4.98391127856741e-277	0.271430548748683	0.86	0.887	1.38991317736688e-272	CSDE1	Malignant cells	GSE138267	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5666
1.07537130077846e-275	0.43514725674221	0.712	0.718	2.99899548361096e-271	WSB1	Malignant cells	GSE138267	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5667
8.99956685599285e-273	0.303944674659715	0.617	0.563	2.50979920479929e-268	CDKN1B	Malignant cells	GSE138267	ENSG00000111276	1027	cyclin dependent kinase inhibitor 1B	KIP1|P27KIP1	protein_coding	P46527	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5668
2.97671803017672e-272	0.402251529950031	0.982	0.954	8.30147124255683e-268	SOX4	Malignant cells	GSE138267	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5669
3.08629225616158e-271	-0.250508088829275	0.998	1	8.6070518439834e-267	CFL1	Malignant cells	GSE138267	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5670
1.4728816608255e-269	0.305242132255586	0.368	0.245	4.10757237571015e-265	TMEM150C	Malignant cells	GSE138267	ENSG00000249242	441027	transmembrane protein 150C	FLJ12993|TTN3	protein_coding	B9EJG8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5671
2.10303734200501e-268	0.307786845447526	0.72	0.711	5.86495053938357e-264	PNRC1	Malignant cells	GSE138267	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5672
3.73382358426174e-268	0.261890062355608	0.971	0.973	1.04128872117891e-263	SRSF7	Malignant cells	GSE138267	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5673
4.87464231988893e-268	-0.264722853909888	0.745	0.901	1.35944025017063e-263	ATP6V1F	Malignant cells	GSE138267	ENSG00000128524	9296	ATPase H+ transporting V1 subunit F	ATP6S14|VATF|Vma7	protein_coding	Q16864	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5674
2.56877454650093e-267	-0.266356375385228	0.853	0.943	7.16379845528179e-263	TPD52	Malignant cells	GSE138267	ENSG00000076554	7163	tumor protein D52	D52|hD52|N8L	protein_coding	P55327	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5675
1.04849120387837e-265	0.636793333547469	0.775	0.774	2.92403226937599e-261	BTG2	Malignant cells	GSE138267	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5676
9.28797111568874e-262	0.307869503553405	0.253	0.149	2.59022938474328e-257	DDAH1	Malignant cells	GSE138267	ENSG00000153904	23576	dimethylarginine dimethylaminohydrolase 1	DDAH	protein_coding	O94760	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5677
1.48253917409542e-258	0.276349021433426	0.268	0.159	4.13450524871731e-254	MELK	Malignant cells	GSE138267	ENSG00000165304	9833	maternal embryonic leucine zipper kinase	KIAA0175	protein_coding	Q14680	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5678
4.74269946286943e-256	0.355794210801105	0.291	0.177	1.32264402620503e-251	SPC25	Malignant cells	GSE138267	ENSG00000277909	57405	SPC25 component of NDC80 kinetochore complex	AD024|MGC22228|SPBC25	protein_coding	Q9HBM1	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5679
2.2182645788887e-252	0.91401269595594	0.561	0.553	6.18629625760481e-248	NUSAP1	Malignant cells	GSE138267	ENSG00000137804	51203	nucleolar and spindle associated protein 1	ANKT|BM037|FLJ13421|LNP|PRO0310p1|Q0310|SAPL	protein_coding	Q9BXS6	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5680
1.39239931210271e-250	0.44351884379602	0.611	0.595	3.88312320159204e-246	DTYMK	Malignant cells	GSE138267	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5681
7.31280817542432e-249	0.294934195890368	0.579	0.5	2.03939594396233e-244	C6orf62	Malignant cells	GSE138267	ENSG00000112308	81688	chromosome 6 open reading frame 62	DKFZP564G182|FLJ12619|XTP12	protein_coding	Q9GZU0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5682
4.74636276150785e-248	0.302464557227038	0.262	0.154	1.32366564692931e-243	KIF20B	Malignant cells	GSE138267	ENSG00000138182	9585	kinesin family member 20B	CT90|KRMP1|MPHOSPH1|MPP1	protein_coding	Q96Q89	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5683
9.30965743042574e-247	0.269463316524679	0.696	0.709	2.59627726419713e-242	RRAGA	Malignant cells	GSE138267	ENSG00000155876	10670	Ras related GTP binding A	FIP-1|RAGA	protein_coding	Q7L523	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5684
1.16862337455675e-245	-0.279433692836814	0.294	0.406	3.25905686696387e-241	COA1	Malignant cells	GSE138267	ENSG00000106603	55744	cytochrome c oxidase assembly factor 1	C7orf44|FLJ10803|MITRAC15	protein_coding	Q9GZY4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5685
4.9018825703626e-244	0.443038420072555	0.661	0.689	1.36703701122272e-239	LMO4	Malignant cells	GSE138267	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5686
3.03300415596722e-243	0.333176071875182	0.878	0.9	8.45844199016138e-239	TPM3	Malignant cells	GSE138267	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5687
2.03879661323934e-242	-0.255266007531029	0.245	0.363	5.68579599500187e-238	DNALI1	Malignant cells	GSE138267	ENSG00000163879	7802	dynein axonemal light intermediate chain 1	dJ423B22.5|hp28|P28	protein_coding	O14645	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5688
5.2026219058454e-237	1.40849577840141	0.254	0.165	1.45090719710216e-232	RPS17	Malignant cells	GSE138267	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5689
6.71621311210593e-233	-0.28516974508443	0.251	0.362	1.8730175127041e-228	ASNS	Malignant cells	GSE138267	ENSG00000070669	440	asparagine synthetase (glutamine-hydrolyzing)	NA	protein_coding	P08243	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5690
1.11430685738909e-231	0.488582378849976	0.933	0.956	3.1075789638867e-227	AES	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5691
1.13624300346685e-230	0.306692621730208	0.626	0.606	3.16875448806834e-226	CTSD	Malignant cells	GSE138267	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5692
3.10496469469698e-226	0.307300158752007	0.338	0.226	8.65912554057095e-222	RAD51AP1	Malignant cells	GSE138267	ENSG00000111247	10635	RAD51 associated protein 1	PIR51	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5693
1.69709563565566e-225	-0.270518722682102	0.568	0.711	4.7328603087165e-221	LSM1	Malignant cells	GSE138267	ENSG00000175324	27257	LSM1 homolog, mRNA degradation associated	CASM|YJL124C	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5694
2.84855900280163e-225	0.287366689738937	0.736	0.784	7.94406134701318e-221	SNRPA1	Malignant cells	GSE138267	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5695
5.42809735253688e-225	-0.27947589923406	0.76	0.847	1.51378778967549e-220	SEP15	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5696
1.53537740558242e-223	-0.253993301329581	0.579	0.746	4.28186050868826e-219	TUSC3	Malignant cells	GSE138267	ENSG00000104723	7991	tumor suppressor candidate 3	MagT2|MGC13453|MRT22|MRT7|N33|OST3A|SLC58A2	protein_coding	Q13454	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5697
1.53308844514298e-222	0.262549201754237	0.265	0.159	4.27547705581474e-218	FAM64A	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5698
4.53420556552608e-222	0.273167785022007	0.464	0.333	1.26449924811391e-217	INSR	Malignant cells	GSE138267	ENSG00000171105	3643	insulin receptor	CD220	protein_coding	P06213	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5699
2.53698796643755e-218	0.355178216038523	0.313	0.206	7.07515204080105e-214	SCGB2A1	Malignant cells	GSE138267	ENSG00000124939	4246	secretoglobin family 2A member 1	LPHC|MGB2|MGC71973|UGB3	protein_coding	O75556	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5700
3.29086449463678e-218	0.260409084069185	0.251	0.151	9.17756290264306e-214	FHL2	Malignant cells	GSE138267	ENSG00000115641	2274	four and a half LIM domains 2	DRAL|SLIM3	protein_coding	Q14192	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5701
2.02664162370969e-217	-0.261439794091471	0.359	0.468	5.65189816020157e-213	TMUB1	Malignant cells	GSE138267	ENSG00000164897	83590	transmembrane and ubiquitin like domain containing 1	C7orf21|HOPS|SB144	protein_coding	Q9BVT8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5702
1.71746433033609e-215	-0.264917841644656	0.949	0.975	4.7896645244413e-211	NEDD8	Malignant cells	GSE138267	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5703
8.99716975462814e-214	0.261371925950127	0.679	0.684	2.5091307011707e-209	SEPT2	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5704
3.30139488696699e-213	0.288337126115387	0.798	0.84	9.20693006077353e-209	DDX46	Malignant cells	GSE138267	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5705
1.07624704568351e-207	0.396654909551584	0.348	0.247	3.00143776100216e-203	C5orf38	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5706
1.642925034754e-203	0.271877902650821	0.574	0.499	4.58178933692195e-199	PTP4A1	Malignant cells	GSE138267	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5707
4.33546334484483e-201	0.337361719085048	0.266	0.168	1.20907401761033e-196	TROAP	Malignant cells	GSE138267	ENSG00000135451	10024	trophinin associated protein	TASTIN	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5708
1.0281888571468e-200	-0.295307034025314	0.195	0.295	2.867413084811e-196	PSAT1	Malignant cells	GSE138267	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5709
5.59382304269244e-200	0.416799628900922	0.343	0.236	1.56000537014607e-195	CDKN3	Malignant cells	GSE138267	ENSG00000100526	1033	cyclin dependent kinase inhibitor 3	CDI1|KAP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5710
2.93856436481492e-197	0.271068784615	0.484	0.38	8.19506830059585e-193	ARG2	Malignant cells	GSE138267	ENSG00000081181	384	arginase 2	NA	protein_coding	P78540	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5711
5.59013383664778e-196	-0.351244682466916	0.454	0.578	1.55897652436433e-191	TSPAN13	Malignant cells	GSE138267	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5712
7.75601973193113e-196	0.288778486285862	0.648	0.665	2.16299878284095e-191	HRAS	Malignant cells	GSE138267	ENSG00000276536	3265	HRas proto-oncogene, GTPase	HRAS1	protein_coding	P01112	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5713
1.45182730159997e-191	0.542577711360502	0.593	0.651	4.04885597870199e-187	TYMS	Malignant cells	GSE138267	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5714
1.62753802051602e-189	0.312560352259347	0.691	0.727	4.53887803161509e-185	ETS2	Malignant cells	GSE138267	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5715
1.34607274395951e-186	1.03919329668032	0.477	0.45	3.75392766835429e-182	TOP2A	Malignant cells	GSE138267	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5716
3.59145052908628e-182	-0.279800120319639	0.953	0.985	1.00158372355158e-177	NDUFB9	Malignant cells	GSE138267	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5717
7.01302810895811e-181	0.378169237349248	0.902	0.957	1.95579327902624e-176	H1FX	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5718
1.27838295888823e-180	0.267916797992163	0.995	0.997	3.5651543957475e-176	TPI1	Malignant cells	GSE138267	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5719
7.97456214492748e-178	-0.293309287285025	0.673	0.802	2.22394589097738e-173	KLF6	Malignant cells	GSE138267	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5720
4.39225499463141e-175	0.278258886171903	0.739	0.75	1.22491207290281e-170	ENO2	Malignant cells	GSE138267	ENSG00000111674	2026	enolase 2	NSE	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5721
4.55185807676643e-174	0.29418845988291	0.761	0.82	1.26942218044862e-169	HNRNPAB	Malignant cells	GSE138267	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5722
2.1326952178171e-173	0.735599097517457	0.66	0.729	5.94766042344832e-169	CST3	Malignant cells	GSE138267	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5723
5.59151130442373e-173	0.263902279746855	0.353	0.252	1.55936067257769e-168	SLC2A1	Malignant cells	GSE138267	ENSG00000117394	6513	solute carrier family 2 member 1	CSE|DYT18|DYT9|GLUT|GLUT-1|GLUT1|HTLVR	protein_coding	P11166	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5724
2.48292733358994e-172	1.23654916756741	0.464	0.412	6.92438774791562e-168	HIST1H1C	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5725
1.38769893865311e-167	0.261383727873573	0.891	0.922	3.87001480011579e-163	IDH2	Malignant cells	GSE138267	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5726
6.19824793036077e-166	0.255691550516336	0.596	0.569	1.72856738281901e-161	GRN	Malignant cells	GSE138267	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5727
2.49652416430539e-165	-0.382803200543826	0.613	0.776	6.96230658941487e-161	ADI1	Malignant cells	GSE138267	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5728
3.00112459215098e-161	0.342372756315053	0.404	0.584	8.36953626259064e-157	UBE2C	Malignant cells	GSE138267	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5729
6.36785649803245e-159	-0.26645727091835	0.301	0.381	1.77586782017129e-154	SRPRB	Malignant cells	GSE138267	ENSG00000144867	58477	SRP receptor subunit beta	APMCF1|SR-beta	protein_coding	Q9Y5M8	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5730
3.19705502518838e-156	0.380204940588607	0.502	0.425	8.91594705424536e-152	FOSB	Malignant cells	GSE138267	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5731
2.1166375959658e-155	0.299192885736876	0.86	0.874	5.90287892762943e-151	CLDN4	Malignant cells	GSE138267	ENSG00000189143	1364	claudin 4	CPE-R|CPETR|CPETR1|hCPE-R|WBSCR8	protein_coding	O14493	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5732
6.05511020853029e-154	0.254491510697342	0.542	0.483	1.68864913495493e-149	SREK1	Malignant cells	GSE138267	ENSG00000153914	140890	splicing regulatory glutamic acid and lysine rich protein 1	DKFZp564B176|SFRS12|SRrp508|SRrp86	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5733
5.72338540495793e-152	1.08922474588572	0.472	0.463	1.59613772173467e-147	NDUFA4L2	Malignant cells	GSE138267	ENSG00000185633	56901	NDUFA4 mitochondrial complex associated like 2	COXFA4L2|FLJ26118|MISTRH|NUOMS	protein_coding	Q9NRX3	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5734
7.09289671640731e-147	0.306832557120218	0.52	0.46	1.97806703627167e-142	INSM1	Malignant cells	GSE138267	ENSG00000173404	3642	INSM transcriptional repressor 1	IA-1|IA1	protein_coding	Q01101	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5735
9.66300245812641e-144	0.668722723213497	0.637	0.689	2.69481812552229e-139	SMC4	Malignant cells	GSE138267	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5736
3.09377559757019e-140	0.401886920146748	0.603	0.607	8.62792138650376e-136	CXCR4	Malignant cells	GSE138267	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5737
1.25359853812839e-139	0.376659435528752	0.571	0.592	3.49603560313246e-135	SFTA3	Malignant cells	GSE138267	ENSG00000229415	NA	NA	NANCI|PAHRF|SFTPH|SP-H	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5738
2.24975593066309e-139	0.728865180809478	0.726	0.743	6.27411933943323e-135	PTTG1	Malignant cells	GSE138267	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5739
5.92246324608443e-139	-0.250438795947594	0.302	0.378	1.65165655006803e-134	SERGEF	Malignant cells	GSE138267	ENSG00000129158	26297	secretion regulating guanine nucleotide exchange factor	DelGEF|Gnefr	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5740
4.92480972942234e-135	-0.32869745229832	0.271	0.341	1.3734309373413e-130	MYCL	Malignant cells	GSE138267	ENSG00000116990	4610	MYCL proto-oncogene, bHLH transcription factor	bHLHe38|LMYC|MYCL1	protein_coding	P12524	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5741
7.25205581385852e-134	0.329557154754101	0.629	0.693	2.02245332536886e-129	CSRP1	Malignant cells	GSE138267	ENSG00000159176	1465	cysteine and glycine rich protein 1	CSRP|CYRP|D1S181E	protein_coding	P21291	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5742
3.18676009734597e-128	0.345871311803492	0.333	0.268	8.88723655947843e-124	NOL4	Malignant cells	GSE138267	ENSG00000101746	8715	nucleolar protein 4	CT125|HRIHFB2255|NOLP	protein_coding	O94818	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5743
1.2562681144925e-127	0.354527729770593	0.513	0.474	3.50348051769667e-123	KLK11	Malignant cells	GSE138267	ENSG00000167757	11012	kallikrein related peptidase 11	PRSS20|TLSP	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5744
1.01375872751178e-122	0.440560455854683	0.299	0.242	2.82717033928486e-118	BCAM	Malignant cells	GSE138267	ENSG00000187244	4059	basal cell adhesion molecule (Lutheran blood group)	CD239|LU	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5745
3.00796405620337e-121	0.578556433608123	0.984	0.99	8.38861015993995e-117	RPS10	Malignant cells	GSE138267	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5746
6.40531004088552e-121	0.430967434992618	0.284	0.204	1.78631286420215e-116	CCNB1	Malignant cells	GSE138267	ENSG00000134057	891	cyclin B1	CCNB	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5747
3.66055463366334e-118	0.312911495415236	0.855	0.856	1.02085547623603e-113	PCNA	Malignant cells	GSE138267	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5748
4.19331971786561e-111	0.383437960275673	0.641	0.738	1.16943300291836e-106	HOXB5	Malignant cells	GSE138267	ENSG00000120075	3215	homeobox B5	HOX2|HOX2A	protein_coding	P09067	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5749
7.14449467924604e-110	-0.26229086351706	0.319	0.378	1.99245667614814e-105	YARS	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5750
1.0824705130891e-109	0.287240091094188	0.259	0.188	3.01879376690288e-105	NUF2	Malignant cells	GSE138267	ENSG00000143228	83540	NUF2 component of NDC80 kinetochore complex	CDCA1|CT106|NUF2R	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5751
2.0452585761055e-109	0.754309024640289	0.311	0.259	5.70381711704301e-105	TPPP3	Malignant cells	GSE138267	ENSG00000159713	51673	tubulin polymerization promoting protein family member 3	CGI-38|p20|p25gamma	protein_coding	Q9BW30	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5752
1.53563644654662e-104	0.269440492603416	0.747	0.773	4.28258292212921e-100	STRA13	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5753
5.55053360494143e-104	0.59169954941502	0.432	0.673	1.54793281174606e-99	PCP4	Malignant cells	GSE138267	ENSG00000183036	5121	Purkinje cell protein 4	PEP-19	protein_coding	P48539	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5754
3.21480574015484e-103	-0.287820310736164	0.265	0.327	8.96545024814381e-99	RAB11FIP1	Malignant cells	GSE138267	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5755
1.47082495515244e-98	1.21123847133187	0.515	0.631	4.10183663492911e-94	PLIN2	Malignant cells	GSE138267	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5756
2.73829788879353e-97	0.320087418419331	0.687	0.752	7.6365651522674e-93	PMAIP1	Malignant cells	GSE138267	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5757
5.32431555533421e-94	0.262446421146845	0.38	0.308	1.4848451220716e-89	FBXO32	Malignant cells	GSE138267	ENSG00000156804	114907	F-box protein 32	ATROGIN1|Fbx32|MAFbx	protein_coding	Q969P5	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5758
2.14229059339026e-93	0.467881865534121	0.374	0.308	5.97442000684675e-89	KLF4	Malignant cells	GSE138267	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5759
5.39234397880007e-92	0.285931938535402	0.578	0.584	1.50381688880776e-87	ANP32E	Malignant cells	GSE138267	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5760
1.22160970648039e-91	-0.263414037566992	0.47	0.542	3.40682514943252e-87	TRA2A	Malignant cells	GSE138267	ENSG00000164548	29896	transformer 2 alpha homolog	AWMS1|htra-2-alpha	protein_coding	Q13595	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5761
5.44710575945286e-91	0.369786111901549	0.928	0.944	1.51908885419621e-86	C6orf48	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5762
1.51236533146118e-90	0.297810042057679	0.605	0.655	4.21768443637893e-86	GINS2	Malignant cells	GSE138267	ENSG00000131153	51659	GINS complex subunit 2	Pfs2|PSF2	protein_coding	Q9Y248	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5763
1.20662733059996e-86	0.274053195791	0.918	0.891	3.36504229957717e-82	SEPW1	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5764
5.060906479418e-86	0.339531156282567	0.781	0.848	1.41138559898009e-81	MIAT	Malignant cells	GSE138267	ENSG00000225783	440823	myocardial infarction associated transcript	C22orf35|FLJ25967|gomafu|LINC00066|lncRNA-MIAT|NCRNA00066|Rncr2	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5765
1.76173725104601e-85	0.348708606451709	0.543	0.556	4.91313284571711e-81	PCSK2	Malignant cells	GSE138267	ENSG00000125851	5126	proprotein convertase subtilisin/kexin type 2	NEC2|PC2|SPC2	protein_coding	P16519	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5766
4.68812363755707e-84	0.284514236691108	0.733	0.785	1.30742392004191e-79	RNASEH2A	Malignant cells	GSE138267	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5767
2.15616661517425e-78	0.352957322195601	0.481	0.641	6.01311745639795e-74	HILPDA	Malignant cells	GSE138267	ENSG00000135245	29923	hypoxia inducible lipid droplet associated	C7orf68|FLJ21076|HIG-2|HIG2	protein_coding	Q9Y5L2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5768
4.83583711777879e-71	0.260093954052321	0.589	0.63	1.34861825540615e-66	LMNB1	Malignant cells	GSE138267	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5769
4.76585267783455e-66	0.312042095143973	0.653	0.74	1.3291009947945e-61	GLRX3	Malignant cells	GSE138267	ENSG00000108010	10539	glutaredoxin 3	bA500G10.4|GLRX4|GRX3|GRX4|PICOT|TXNL2	protein_coding	O76003	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5770
4.24455341932133e-65	-0.264339695709292	0.335	0.416	1.18372105758033e-60	CEACAM5	Malignant cells	GSE138267	ENSG00000105388	1048	CEA cell adhesion molecule 5	CD66e|CEA	protein_coding	P06731	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5771
1.56323959306424e-64	1.12566148843906	0.722	0.865	4.35956257713755e-60	FABP5	Malignant cells	GSE138267	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5772
7.56285149925862e-64	0.29174833742192	0.645	0.734	2.10912802611324e-59	SOX2	Malignant cells	GSE138267	ENSG00000181449	6657	SRY-box transcription factor 2	NA	protein_coding	P48431	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5773
3.08487046759273e-60	0.275612414836265	1	1	8.6030867600226e-56	GAPDH	Malignant cells	GSE138267	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5774
2.26162489880322e-57	0.436247918438722	0.432	0.372	6.30721951778243e-53	HSPA1B	Malignant cells	GSE138267	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5775
1.07691492824422e-53	0.481781105527924	0.598	0.839	3.00330035188748e-49	NEAT1	Malignant cells	GSE138267	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5776
1.15981791719142e-52	-0.286131564511633	0.629	0.758	3.23450020746342e-48	INO80E	Malignant cells	GSE138267	ENSG00000169592	283899	INO80 complex subunit E	CCDC95|FLJ90652	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5777
8.2158174610167e-51	0.414548091449768	0.546	0.558	2.29122717352834e-46	ZFP36	Malignant cells	GSE138267	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5778
1.51374641507711e-48	0.284356520335915	0.466	0.441	4.22153600236704e-44	CDKN2D	Malignant cells	GSE138267	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5779
8.54256728770852e-41	0.598913215189832	0.4	0.4	2.38235116519615e-36	CENPF	Malignant cells	GSE138267	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5780
8.49451205727317e-40	0.370997998379913	0.266	0.223	2.36894952253234e-35	CDC20	Malignant cells	GSE138267	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5781
3.34831490904965e-28	0.616995982777979	0.481	0.564	9.33778061835766e-24	ASF1B	Malignant cells	GSE138267	ENSG00000288210	55723	anti-silencing function 1B histone chaperone	FLJ10604	protein_coding	Q9NVP2	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5782
2.58239762195608e-25	0.417812899925621	0.804	0.84	7.20179048811113e-21	ARL6IP1	Malignant cells	GSE138267	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5783
6.28950713706239e-20	0.250792964118731	0.563	0.628	1.75401775038396e-15	ENAH	Malignant cells	GSE138267	ENSG00000154380	55740	ENAH actin regulator	FLJ10773|MENA|NDPP1	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5784
9.9809144743707e-20	-0.321688477172423	0.549	0.557	2.7834774286125e-15	SOX11	Malignant cells	GSE138267	ENSG00000176887	6664	SRY-box transcription factor 11	NA	protein_coding	P35716	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5785
5.28012439726172e-19	0.269864583126218	0.59	0.675	1.47252109190835e-14	GADD45A	Malignant cells	GSE138267	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5786
1.74951905162961e-17	0.472000502035101	0.623	0.76	4.87905873118466e-13	ATP1A1	Malignant cells	GSE138267	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5787
3.93821524204577e-16	0.348187898773389	0.587	0.701	1.09828946670173e-11	ZWINT	Malignant cells	GSE138267	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5788
1.24735843627554e-12	0.729097855490166	0.301	0.294	3.47863320708522e-08	HIST1H2BK	Malignant cells	GSE138267	NA	NA	NA	NA	NA	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5789
5.47641770260353e-10	1.48842865610004	0.733	0.906	1.52726336890207e-05	GRP	Malignant cells	GSE138267	ENSG00000134443	2922	gastrin releasing peptide	NA	protein_coding	P07492	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5790
3.49420199581091e-08	0.320855666407844	0.413	0.436	0.000974463052591748	CDK1	Malignant cells	GSE138267	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5791
1.13021926563326e-06	0.286214233988659	0.602	0.749	0.0315195548799804	UBE2T	Malignant cells	GSE138267	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE138267	GSE138267	Lung cancer	Small cell lung cancer (SCLC)	Chemotherapy	NA	NA	Homo sapiens	CDX	Tumor tissue	resistant 4, sensitive 4	8	61001	Public on Feb 12, 2020	33521652	This dataset has 8 PDX.	PRJNA575243	10x genomics	CellRanger 2.0.0	Lung_cancer	Chemotherapy	5792
0	1.53857561573771	0.994	0.881	0	ISG15	Malignant cells	GSE139386	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5793
0	2.12086416292946	0.956	0.322	0	ERRFI1	Malignant cells	GSE139386	ENSG00000116285	54206	ERBB receptor feedback inhibitor 1	GENE-33|MIG-6|RALT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5794
0	-1.13919084513306	0.756	0.977	0	SRM	Malignant cells	GSE139386	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5795
0	1.6708830295112	0.837	0.108	0	DHRS3	Malignant cells	GSE139386	ENSG00000162496	9249	dehydrogenase/reductase 3	RDH17|retSDR1|Rsdr1|SDR1|SDR16C1	protein_coding	O75911	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5796
0	1.16247778005378	0.972	0.827	0	EFHD2	Malignant cells	GSE139386	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5797
0	-2.32913904693575	0.096	0.952	0	CDA	Malignant cells	GSE139386	ENSG00000158825	978	cytidine deaminase	CDD	protein_coding	P32320	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5798
0	1.16026348008188	0.915	0.52	0	DDOST	Malignant cells	GSE139386	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5799
0	1.01167427841602	0.763	0.295	0	ECE1	Malignant cells	GSE139386	ENSG00000117298	1889	endothelin converting enzyme 1	ECE	protein_coding	P42892	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5800
0	-1.08516276808858	0.289	0.724	0	ID3	Malignant cells	GSE139386	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5801
0	1.23748370423675	1	1	0	RPL11	Malignant cells	GSE139386	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5802
0	-1.22692662865074	0.703	0.98	0	STMN1	Malignant cells	GSE139386	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5803
0	-0.828450444726349	0.996	1	0	SH3BGRL3	Malignant cells	GSE139386	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5804
0	-1.77750784141054	0.982	1	0	HMGN2	Malignant cells	GSE139386	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5805
0	-2.52224554137667	0.353	0.984	0	SFN	Malignant cells	GSE139386	ENSG00000175793	2810	stratifin	YWHAS	protein_coding	P31947	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5806
0	-0.844285561344568	0.51	0.876	0	ZCCHC17	Malignant cells	GSE139386	ENSG00000121766	51538	zinc finger CCHC-type containing 17	HSPC251|pNO40|PS1D	protein_coding	Q9NP64	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5807
0	-1.22054424154434	0.111	0.721	0	CLSPN	Malignant cells	GSE139386	ENSG00000092853	63967	claspin	NA	protein_coding	Q9HAW4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5808
0	-0.955148664338967	0.261	0.787	0	MAP7D1	Malignant cells	GSE139386	ENSG00000116871	55700	MAP7 domain containing 1	FLJ10350|FLJ39022|PARCC1|RPRC1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5809
0	-0.734615504253854	0.967	0.996	0	MRPS15	Malignant cells	GSE139386	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5810
0	-1.16687709406336	0.968	1	0	NDUFS5	Malignant cells	GSE139386	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5811
0	-0.833426336802832	1	1	0	YBX1	Malignant cells	GSE139386	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5812
0	-0.955388194964271	0.137	0.694	0	CDC20	Malignant cells	GSE139386	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5813
0	0.566936380771576	1	1	0	RPS8	Malignant cells	GSE139386	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5814
0	1.08850801433669	0.689	0.179	0	TSPAN1	Malignant cells	GSE139386	ENSG00000117472	10103	tetraspanin 1	NET-1|TSPAN-1	protein_coding	O60635	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5815
0	-2.02576999022045	0.578	0.99	0	HSPB11	Malignant cells	GSE139386	ENSG00000081870	51668	heat shock protein family B (small) member 11	C1orf41|FAP232|HSPCO34|IFT25|PP25	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5816
0	-1.06115062860397	0.274	0.799	0	DHCR24	Malignant cells	GSE139386	ENSG00000116133	1718	24-dehydrocholesterol reductase	DCE|KIAA0018|seladin-1	protein_coding	Q15392	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5817
0	-0.921476404500061	0.293	0.743	0	JUN	Malignant cells	GSE139386	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5818
0	1.01936450532537	0.893	0.577	0	JAK1	Malignant cells	GSE139386	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5819
0	-0.885942790031591	0.337	0.802	0	LEPROT	Malignant cells	GSE139386	ENSG00000213625	54741	leptin receptor overlapping transcript	FLJ90360|OB-RGRP|OBRGRP|VPS55	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5820
0	-0.732795308636629	0.307	0.729	0	TYW3	Malignant cells	GSE139386	ENSG00000162623	127253	tRNA-yW synthesizing protein 3 homolog	C1orf171|FLJ40918	protein_coding	Q6IPR3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5821
0	-0.675042880129734	0.002	0.387	0	NEXN	Malignant cells	GSE139386	ENSG00000162614	91624	nexilin F-actin binding protein	NELIN|nexilin	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5822
0	-1.20033434782053	0.989	1	0	GNG5	Malignant cells	GSE139386	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5823
0	-2.51829361241653	0.11	0.904	0	CYR61	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5824
0	-0.99650466345117	0.804	0.986	0	SEP15	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5825
0	0.582766909719549	1	1	0	RPL5	Malignant cells	GSE139386	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5826
0	-2.49667738698732	0.343	0.992	0	GCLM	Malignant cells	GSE139386	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5827
0	-1.79759091351021	0.24	0.924	0	F3	Malignant cells	GSE139386	ENSG00000117525	2152	coagulation factor III, tissue factor	CD142|TF	protein_coding	P13726	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5828
0	-1.38325519444343	0.154	0.814	0	CNN3	Malignant cells	GSE139386	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5829
0	1.70797498863707	0.98	0.554	0	SARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5830
0	-1.09687372240618	0.903	1	0	LAMTOR5	Malignant cells	GSE139386	ENSG00000134248	10542	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	HBXIP|MGC71071|XIP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5831
0	-0.60927906527095	0.005	0.409	0	SLC16A1	Malignant cells	GSE139386	ENSG00000281917	6566	solute carrier family 16 member 1	MCT|MCT1	protein_coding	P53985	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5832
0	-0.876037566116436	0.896	0.991	0	CSDE1	Malignant cells	GSE139386	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5833
0	-0.703265178478737	0.011	0.428	0	TSPAN2	Malignant cells	GSE139386	ENSG00000134198	10100	tetraspanin 2	FLJ12082|TSN2|TSPAN-2	protein_coding	O60636	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5834
0	0.874851953141055	0.704	0.267	0	RP11-640M9.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5835
0	0.877975433629786	0.992	0.937	0	MCL1	Malignant cells	GSE139386	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5836
0	1.07097826422693	0.998	0.943	0	SCNM1	Malignant cells	GSE139386	ENSG00000163156	79005	sodium channel modifier 1	MGC3180	protein_coding	Q9BWG6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5837
0	1.25505498520337	1	0.996	0	PSMD4	Malignant cells	GSE139386	ENSG00000159352	5710	proteasome 26S subunit ubiquitin receptor, non-ATPase 4	AF|AF-1|Rpn10|S5A	protein_coding	P55036	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5838
0	1.15563368747689	0.593	0.018	0	SELENBP1	Malignant cells	GSE139386	ENSG00000143416	8991	selenium binding protein 1	hSBP|hSP56|LPSB	protein_coding	Q13228	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5839
0	0.849203041525532	0.999	0.982	0	PSMB4	Malignant cells	GSE139386	ENSG00000159377	5692	proteasome 20S subunit beta 4	HN3|PROS26	protein_coding	P28070	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5840
0	-1.79030306102338	1	1	0	S100A10	Malignant cells	GSE139386	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5841
0	1.79392741269363	0.744	0.017	0	SPRR2D	Malignant cells	GSE139386	ENSG00000163216	6703	small proline rich protein 2D	NA	protein_coding	P22532	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5842
0	3.54137766108143	0.934	0.37	0	S100A9	Malignant cells	GSE139386	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5843
0	1.45817468021159	1	1	0	S100A6	Malignant cells	GSE139386	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5844
0	-1.14942499783284	0.534	0.921	0	S100A4	Malignant cells	GSE139386	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5845
0	-1.36117760025362	0.218	0.839	0	S100A3	Malignant cells	GSE139386	ENSG00000188015	6274	S100 calcium binding protein A3	S100E	protein_coding	P33764	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5846
0	0.891789476945382	1	1	0	S100A16	Malignant cells	GSE139386	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5847
0	4.18088953971946	1	0.897	0	S100A14	Malignant cells	GSE139386	ENSG00000189334	57402	S100 calcium binding protein A14	BCMP84|S100A15	protein_coding	Q9HCY8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5848
0	1.03388139298071	1	0.991	0	ILF2	Malignant cells	GSE139386	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5849
0	1.69810649547322	1	1	0	RPS27	Malignant cells	GSE139386	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5850
0	-1.19308577855576	0.688	0.986	0	CKS1B	Malignant cells	GSE139386	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5851
0	1.3813002217392	0.997	0.87	0	SSR2	Malignant cells	GSE139386	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5852
0	0.920384884322822	0.975	0.838	0	CRABP2	Malignant cells	GSE139386	ENSG00000143320	1382	cellular retinoic acid binding protein 2	CRABP-II	protein_coding	P29373	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5853
0	-1.10820083404315	0.779	0.991	0	HDGF	Malignant cells	GSE139386	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5854
0	-1.1340183758085	0.952	0.998	0	TAGLN2	Malignant cells	GSE139386	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5855
0	1.50331531950489	1	0.935	0	PFDN2	Malignant cells	GSE139386	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5856
0	-0.915971836631691	0.504	0.862	0	MGST3	Malignant cells	GSE139386	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5857
0	-1.19755988668452	0.805	0.991	0	ARPC5	Malignant cells	GSE139386	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5858
0	-0.82057975321489	0.214	0.67	0	PHLDA3	Malignant cells	GSE139386	ENSG00000174307	23612	pleckstrin homology like domain family A member 3	TIH1	protein_coding	Q9Y5J5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5859
0	-0.915455429249029	0.319	0.803	0	UBE2T	Malignant cells	GSE139386	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5860
0	-0.81762237291425	0.664	0.949	0	TMEM183A	Malignant cells	GSE139386	ENSG00000163444	92703	transmembrane protein 183A	C1orf37	protein_coding	Q8IXX5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5861
0	-1.71226968145144	0.969	1	0	SNRPE	Malignant cells	GSE139386	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5862
0	-1.23763630380086	0.963	0.998	0	NUCKS1	Malignant cells	GSE139386	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5863
0	1.16689551393201	0.805	0.285	0	CD55	Malignant cells	GSE139386	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5864
0	-1.49947651942649	0.016	0.691	0	MIR205HG	Malignant cells	GSE139386	ENSG00000230937	642587	MIR205 host gene	LINC00510	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5865
0	-1.10606153560976	0.882	0.997	0	NENF	Malignant cells	GSE139386	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5866
0	-0.935432242967326	0.128	0.698	0	SMYD2	Malignant cells	GSE139386	ENSG00000143499	56950	SET and MYND domain containing 2	HSKM-B|KMT3C|ZMYND14	protein_coding	Q9NRG4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5867
0	-1.19984667178355	0.185	0.716	0	CENPF	Malignant cells	GSE139386	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5868
0	-0.972953128737445	0.993	1	0	CAPN2	Malignant cells	GSE139386	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5869
0	-1.17239063585335	0.904	0.997	0	SRP9	Malignant cells	GSE139386	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5870
0	-0.800171184761366	1	1	0	H3F3A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5871
0	-1.40428347727865	0.981	1	0	GUK1	Malignant cells	GSE139386	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5872
0	-1.29306044219429	0.641	0.973	0	COA6	Malignant cells	GSE139386	ENSG00000168275	388753	cytochrome c oxidase assembly factor 6	C1orf31	protein_coding	Q5JTJ3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5873
0	-0.434313849773084	0.002	0.297	0	AKT3	Malignant cells	GSE139386	ENSG00000275199	10000	AKT serine/threonine kinase 3	PKBG|PRKBG|RAC-gamma	protein_coding	Q9Y243	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5874
0	-1.34544521486111	0.689	0.984	0	COX20	Malignant cells	GSE139386	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5875
0	0.882422625113153	0.871	0.582	0	SH3YL1	Malignant cells	GSE139386	ENSG00000035115	26751	SH3 and SYLF domain containing 1	DKFZP586F1318|Ray	protein_coding	Q96HL8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5876
0	-0.684373837316372	0.986	1	0	ACP1	Malignant cells	GSE139386	ENSG00000143727	52	acid phosphatase 1	HAAP|LMW-PTP|LMWPTP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5877
0	0.522526691938539	1	1	0	RPS7	Malignant cells	GSE139386	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5878
0	-1.50638112661622	0.866	1	0	ITGB1BP1	Malignant cells	GSE139386	ENSG00000119185	9270	integrin subunit beta 1 binding protein 1	ICAP-1A|ICAP-1alpha|ICAP-1B|ICAP1|ICAP1A|ICAP1B	protein_coding	O14713	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5879
0	-1.16052681284232	0.915	0.997	0	YWHAQ	Malignant cells	GSE139386	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5880
0	-0.724908002234051	0.195	0.744	0	RRM2	Malignant cells	GSE139386	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5881
0	-0.989313530620098	0.814	0.965	0	ODC1	Malignant cells	GSE139386	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5882
0	1.59428464813504	0.997	0.868	0	PDIA6	Malignant cells	GSE139386	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5883
0	-2.28599420463633	0.175	0.964	0	TP53I3	Malignant cells	GSE139386	ENSG00000115129	9540	tumor protein p53 inducible protein 3	PIG3	protein_coding	Q53FA7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5884
0	-1.13054943514983	0.149	0.63	0	CENPA	Malignant cells	GSE139386	ENSG00000115163	1058	centromere protein A	CenH3|CENP-A	protein_coding	P49450	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5885
0	-0.77887922274899	1	1	0	OST4	Malignant cells	GSE139386	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5886
0	-0.43153056693322	0.001	0.291	0	TRIM54	Malignant cells	GSE139386	ENSG00000138100	57159	tripartite motif containing 54	MURF|MURF-3|RNF30	protein_coding	Q9BYV2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5887
0	-1.86055044509196	0.951	1	0	MRPL33	Malignant cells	GSE139386	ENSG00000243147	9553	mitochondrial ribosomal protein L33	C2orf1|RPL33L	protein_coding	O75394	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5888
0	-0.742699804034224	0.89	0.987	0	DPY30	Malignant cells	GSE139386	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5889
0	0.867684989971119	0.773	0.374	0	YIPF4	Malignant cells	GSE139386	ENSG00000119820	84272	Yip1 domain family member 4	FinGER4|MGC11061	protein_coding	Q9BSR8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5890
0	-0.940076264658996	0.568	0.896	0	CDC42EP3	Malignant cells	GSE139386	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5891
0	-0.967100503906626	0.469	0.882	0	MORN2	Malignant cells	GSE139386	ENSG00000188010	729967	MORN repeat containing 2	MOPT	protein_coding	Q502X0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5892
0	0.722484317710238	0.998	0.984	0	COX7A2L	Malignant cells	GSE139386	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5893
0	0.913698094218762	0.536	0.035	0	PLEKHH2	Malignant cells	GSE139386	ENSG00000152527	130271	pleckstrin homology, MyTH4 and FERM domain containing H2	KIAA2028|PLEKHH1L	protein_coding	Q8IVE3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5894
0	0.814402271946834	0.967	0.839	0	EPCAM	Malignant cells	GSE139386	ENSG00000119888	4072	epithelial cell adhesion molecule	17-1A|323/A3|Ber-Ep4|BerEp4|CD326|CO-17A|EGP-2|EGP34|EGP40|Ep-CAM|ESA|GA733-2|HEA125|KS1/4|KSA|Ly74|M4S1|MH99|MIC18|MK-1|MOC-31|MOC31|TACST-1|TACSTD1|TROP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5895
0	0.401855399435816	1	1	0	RPS27A	Malignant cells	GSE139386	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5896
0	0.941392649782783	0.645	0.124	0	GFPT1	Malignant cells	GSE139386	ENSG00000198380	2673	glutamine--fructose-6-phosphate transaminase 1	GFA|GFAT|GFAT1|GFPT	protein_coding	Q06210	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5897
0	-1.3594867229844	0.982	1	0	SNRPG	Malignant cells	GSE139386	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5898
0	-1.06501810467646	0.962	0.998	0	BOLA3	Malignant cells	GSE139386	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5899
0	1.43233196677892	0.981	0.727	0	MTHFD2	Malignant cells	GSE139386	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5900
0	-1.66729588076681	0.664	0.995	0	POLE4	Malignant cells	GSE139386	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5901
0	-0.59179426154933	0.041	0.401	0	EVA1A	Malignant cells	GSE139386	ENSG00000115363	84141	eva-1 homolog A, regulator of programmed cell death	FAM176A|FLJ13391|TMEM166	protein_coding	Q9H8M9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5902
0	-1.4193638273644	0.652	0.977	0	LINC00152	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5903
0	1.1159481591465	0.598	0.06	0	ANKRD36C	Malignant cells	GSE139386	ENSG00000174501	400986	ankyrin repeat domain 36C	DKFZp667P0924	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5904
0	1.03089471992274	1	1	0	RPL31	Malignant cells	GSE139386	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5905
0	-1.21661421070329	0.44	0.888	0	MIR4435-1HG	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5906
0	-0.429549989173081	0.001	0.295	0	NT5DC4	Malignant cells	GSE139386	ENSG00000144130	284958	5'-nucleotidase domain containing 4	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5907
0	-1.14683202400299	0.875	0.993	0	DBI	Malignant cells	GSE139386	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5908
0	-0.77959493931876	0.17	0.64	0	MLTK	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5909
0	-0.825727239441931	0.082	0.57	0	CDCA7	Malignant cells	GSE139386	ENSG00000144354	83879	cell division cycle associated 7	FLJ14736|JPO1	protein_coding	Q9BWT1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5910
0	-1.28064347817519	0.966	0.999	0	ATP5G3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5911
0	-1.94023790562886	0.48	0.984	0	PRKRA	Malignant cells	GSE139386	ENSG00000180228	8575	protein activator of interferon induced protein kinase EIF2AK2	DYT16|HSD14|PACT|RAX	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5912
0	-0.850834003873717	0.343	0.778	0	PLEKHA3	Malignant cells	GSE139386	ENSG00000116095	65977	pleckstrin homology domain containing A3	FAPP1	protein_coding	Q9HB20	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5913
0	-2.34305113344338	0.754	1	0	UBE2E3	Malignant cells	GSE139386	ENSG00000170035	10477	ubiquitin conjugating enzyme E2 E3	UbcH9	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5914
0	-0.690520317294856	0.134	0.575	0	SSFA2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5915
0	-0.534266891105882	0.025	0.376	0	PPP1R1C	Malignant cells	GSE139386	ENSG00000150722	151242	protein phosphatase 1 regulatory inhibitor subunit 1C	Inhibitor-1-like	protein_coding	Q8WVI7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5916
0	-0.852497722981184	0.546	0.894	0	NCKAP1	Malignant cells	GSE139386	ENSG00000061676	10787	NCK associated protein 1	HEM2|Nap1|NAP125	protein_coding	Q9Y2A7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5917
0	-1.40186490996459	0.955	0.999	0	ZC3H15	Malignant cells	GSE139386	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5918
0	-2.43344275114121	0.922	1	0	HSPE1	Malignant cells	GSE139386	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5919
0	-1.64390815198322	0.906	1	0	SPATS2L	Malignant cells	GSE139386	ENSG00000196141	26010	spermatogenesis associated serine rich 2 like	DNAPTP6|SGNP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5920
0	-1.425165168077	0.612	0.977	0	NDUFB3	Malignant cells	GSE139386	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5921
0	-0.686273563700518	0.031	0.478	0	MAP2	Malignant cells	GSE139386	ENSG00000078018	4133	microtubule associated protein 2	MAP2A|MAP2B|MAP2C	protein_coding	P11137	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5922
0	-1.05482207864179	0.507	0.927	0	PNKD	Malignant cells	GSE139386	ENSG00000127838	25953	PNKD metallo-beta-lactamase domain containing	BRP17|DKFZp564N1362|DYT8|FKSG19|FPD1|KIAA1184|KIPP1184|MGC31943|MR-1|MR-1S|PDC|PKND1|TAHCCP2	protein_coding	Q8N490	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5923
0	-1.12677129157353	0.175	0.745	0	TUBA4A	Malignant cells	GSE139386	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5924
0	-1.72761356499818	0.14	0.896	0	USP40	Malignant cells	GSE139386	ENSG00000085982	55230	ubiquitin specific peptidase 40	FLJ10785	protein_coding	Q9NVE5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5925
0	-0.692091787969832	0.142	0.57	0	GPC1	Malignant cells	GSE139386	ENSG00000063660	2817	glypican 1	glypican	protein_coding	P35052	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5926
0	-1.12153566018701	0.545	0.938	0	DTYMK	Malignant cells	GSE139386	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5927
0	0.542757966304428	1	1	0	RPL32	Malignant cells	GSE139386	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5928
0	-1.88808565368935	0.735	0.999	0	LSM3	Malignant cells	GSE139386	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5929
0	-0.682884693934826	0.123	0.543	0	SGOL1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5930
0	0.755757724492952	1	1	0	RPL15	Malignant cells	GSE139386	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5931
0	0.870316516806111	0.806	0.406	0	CMTM8	Malignant cells	GSE139386	ENSG00000170293	152189	CKLF like MARVEL transmembrane domain containing 8	CKLFSF8	protein_coding	Q8IZV2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5932
0	-0.587858598030015	1	1	0	RPSA	Malignant cells	GSE139386	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5933
0	-0.81023296037482	0.37	0.801	0	DHX30	Malignant cells	GSE139386	ENSG00000132153	22907	DExH-box helicase 30	DDX30|FLJ11214|KIAA0890	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5934
0	-1.33902662063179	0.999	1	0	TMA7	Malignant cells	GSE139386	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5935
0	-1.14902629322498	0.968	0.999	0	GPX1	Malignant cells	GSE139386	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5936
0	-0.853484723082166	0.637	0.933	0	IFRD2	Malignant cells	GSE139386	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5937
0	-0.971550330641001	0.744	0.975	0	TUSC2	Malignant cells	GSE139386	ENSG00000114383	11334	tumor suppressor 2, mitochondrial calcium regulator	C3orf11|FUS1|PAP|PDAP2	protein_coding	O75896	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5938
0	1.73836531921388	0.989	0.842	0	MANF	Malignant cells	GSE139386	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5939
0	0.293958606351389	1	1	0	RPL29	Malignant cells	GSE139386	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5940
0	-0.701528181119769	0.2	0.628	0	NT5DC2	Malignant cells	GSE139386	ENSG00000168268	64943	5'-nucleotidase domain containing 2	FLJ12442	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5941
0	1.47045502706345	0.999	0.963	0	TKT	Malignant cells	GSE139386	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5942
0	1.04281517924787	0.947	0.72	0	SELK	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5943
0	-0.558068904066722	0.017	0.367	0	WNT5A	Malignant cells	GSE139386	ENSG00000114251	7474	Wnt family member 5A	hWNT5A	protein_coding	P41221	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5944
0	-1.11332034948716	0.287	0.839	0	C3orf14	Malignant cells	GSE139386	ENSG00000114405	57415	chromosome 3 open reading frame 14	HT021	protein_coding	Q9HBI5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5945
0	-0.795349852866307	0.745	0.948	0	THOC7	Malignant cells	GSE139386	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5946
0	-0.608545877484605	0.056	0.455	0	GBE1	Malignant cells	GSE139386	ENSG00000114480	2632	1,4-alpha-glucan branching enzyme 1	NA	protein_coding	Q04446	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5947
0	-1.02808562375289	0.014	0.543	0	COL8A1	Malignant cells	GSE139386	ENSG00000144810	1295	collagen type VIII alpha 1 chain	C3orf7|MGC9568	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5948
0	-0.871778763488226	0.047	0.588	0	CCDC80	Malignant cells	GSE139386	ENSG00000091986	151887	coiled-coil domain containing 80	CL2|DRO1|LINC01279|SSG1|TCONS_00006930|URB	protein_coding	Q76M96	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5949
0	-0.920256738356164	0.986	0.998	0	NDUFB4	Malignant cells	GSE139386	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5950
0	-0.941424622498448	0.377	0.835	0	CCDC58	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5951
0	-0.606383988961164	0.066	0.438	0	HEG1	Malignant cells	GSE139386	ENSG00000173706	57493	heart development protein with EGF like domains 1	HEG|KIAA1237	protein_coding	Q9ULI3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5952
0	-0.854205794462631	0.079	0.601	0	AMOTL2	Malignant cells	GSE139386	ENSG00000114019	51421	angiomotin like 2	LCCP	protein_coding	Q9Y2J4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5953
0	-0.531554331509276	0.003	0.305	0	TM4SF1	Malignant cells	GSE139386	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5954
0	-1.15568393337434	0.698	0.977	0	PFN2	Malignant cells	GSE139386	ENSG00000070087	5217	profilin 2	NA	protein_coding	P35080	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5955
0	-1.02146456748809	0.708	0.971	0	SELT	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5956
0	-2.10141237388854	0.679	0.991	0	RPL22L1	Malignant cells	GSE139386	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5957
0	-0.860633591408822	0.887	0.993	0	DNAJC19	Malignant cells	GSE139386	ENSG00000205981	131118	DnaJ heat shock protein family (Hsp40) member C19	Pam18|Tim14|TIMM14	protein_coding	Q96DA6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5958
0	-0.922752381952437	0.839	0.982	0	AP2M1	Malignant cells	GSE139386	ENSG00000161203	1173	adaptor related protein complex 2 subunit mu 1	AP50|CLAPM1|mu2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5959
0	1.5766017564479	0.948	0.511	0	DNAJB11	Malignant cells	GSE139386	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5960
0	1.3026113450627	0.957	0.698	0	EIF4A2	Malignant cells	GSE139386	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5961
0	-1.14536370184737	0.713	0.978	0	RPL39L	Malignant cells	GSE139386	ENSG00000163923	116832	ribosomal protein L39 like	RPL39L1	protein_coding	Q96EH5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5962
0	-1.02191081711717	0.349	0.843	0	CTBP1	Malignant cells	GSE139386	ENSG00000159692	1487	C-terminal binding protein 1	BARS	protein_coding	Q13363	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5963
0	-0.876703450211224	0.36	0.773	0	SLBP	Malignant cells	GSE139386	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5964
0	-0.640998335026938	0.064	0.458	0	TACC3	Malignant cells	GSE139386	ENSG00000013810	10460	transforming acidic coiled-coil containing protein 3	ERIC-1|ERIC1|maskin|Tacc4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5965
0	-0.658186515169862	0.957	0.998	0	C4orf48	Malignant cells	GSE139386	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5966
0	-0.820727801415295	0.712	0.949	0	MRFAP1	Malignant cells	GSE139386	ENSG00000179010	93621	Morf4 family associated protein 1	PAM14|PGR1	protein_coding	Q9Y605	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5967
0	2.54004834791176	0.963	0.179	0	S100P	Malignant cells	GSE139386	ENSG00000163993	6286	S100 calcium binding protein P	NA	protein_coding	P25815	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5968
0	-1.30140887404544	0.346	0.901	0	FAM200B	Malignant cells	GSE139386	ENSG00000237765	285550	family with sequence similarity 200 member B	C4orf53	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5969
0	-0.950089098964689	0.516	0.904	0	UBE2K	Malignant cells	GSE139386	ENSG00000078140	3093	ubiquitin conjugating enzyme E2 K	HIP2|HYPG|UBC1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5970
0	0.713265861645584	1	1	0	OCIAD2	Malignant cells	GSE139386	ENSG00000145247	132299	OCIA domain containing 2	MGC45416	protein_coding	Q56VL3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5971
0	1.77269226242598	0.85	0.275	0	SRD5A3	Malignant cells	GSE139386	ENSG00000128039	79644	steroid 5 alpha-reductase 3	FLJ13352|SRD5A2L|SRD5A2L1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5972
0	0.702572338767828	1	0.999	0	CCNI	Malignant cells	GSE139386	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5973
0	-1.22398897847126	0.449	0.885	0	ANXA3	Malignant cells	GSE139386	ENSG00000138772	306	annexin A3	ANX3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5974
0	-0.751689338363248	0.001	0.407	0	SPP1	Malignant cells	GSE139386	ENSG00000118785	6696	secreted phosphoprotein 1	BNSP|BSPI|ETA-1|OPN	protein_coding	P10451	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5975
0	-1.28262442763025	1	1	0	H2AFZ	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5976
0	1.0231177307876	1	1	0	RPL34	Malignant cells	GSE139386	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5977
0	1.1579816767667	0.994	0.883	0	SNHG8	Malignant cells	GSE139386	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5978
0	-1.06265306171196	0.672	0.975	0	C4orf3	Malignant cells	GSE139386	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5979
0	-0.868311494484187	0.137	0.655	0	MAD2L1	Malignant cells	GSE139386	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5980
0	-0.841492523052009	0.882	0.986	0	NDUFC1	Malignant cells	GSE139386	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5981
0	0.88173687706858	0.482	0.022	0	CLGN	Malignant cells	GSE139386	ENSG00000153132	1047	calmegin	NA	protein_coding	O14967	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5982
0	-0.951303479285891	0.669	0.956	0	LSM6	Malignant cells	GSE139386	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5983
0	0.523119440481899	1	1	0	RPS3A	Malignant cells	GSE139386	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5984
0	-1.33129947188975	0.216	0.863	0	PALLD	Malignant cells	GSE139386	ENSG00000129116	23022	palladin, cytoskeletal associated protein	CGI-151|KIAA0992|SIH002	protein_coding	Q8WX93	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5985
0	-2.2332693192308	0.322	0.954	0	HMGB2	Malignant cells	GSE139386	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5986
0	-0.608708485147769	0.025	0.431	0	VEGFC	Malignant cells	GSE139386	ENSG00000150630	7424	vascular endothelial growth factor C	VEGF-C|VRP	protein_coding	P49767	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5987
0	-0.720854215511469	0.209	0.648	0	ING2	Malignant cells	GSE139386	ENSG00000168556	3622	inhibitor of growth family member 2	ING1L|p33ING2	protein_coding	Q9H160	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5988
0	-1.05551836144556	0.207	0.804	0	CENPU	Malignant cells	GSE139386	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5989
0	-2.92744795454855	0.734	0.996	0	CLPTM1L	Malignant cells	GSE139386	ENSG00000274811	81037	CLPTM1 like	CRR9|FLJ14400	protein_coding	Q96KA5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5990
0	-1.48943635951529	0.159	0.827	0	LPCAT1	Malignant cells	GSE139386	ENSG00000275079	79888	lysophosphatidylcholine acyltransferase 1	AGPAT10|AGPAT9|AYTL2|FLJ12443|LPLAT8	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5991
0	-1.38021778203076	0.999	1	0	NDUFS6	Malignant cells	GSE139386	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5992
0	-0.882306321025107	0.119	0.667	0	C5orf38	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5993
0	-2.19722539359735	0.601	0.989	0	BASP1	Malignant cells	GSE139386	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5994
0	-1.33200634174548	0.999	1	0	SUB1	Malignant cells	GSE139386	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5995
0	-0.486057510663633	0.01	0.337	0	NPR3	Malignant cells	GSE139386	ENSG00000113389	4883	natriuretic peptide receptor 3	ANPRC|C5orf23|FLJ14054|GUCY2B|NPRC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5996
0	-0.780746796323847	0.464	0.839	0	RAD1	Malignant cells	GSE139386	ENSG00000113456	5810	RAD1 checkpoint DNA exonuclease	HRAD1|REC1	protein_coding	O60671	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5997
0	-0.82254655029458	0.113	0.629	0	SKP2	Malignant cells	GSE139386	ENSG00000145604	6502	S-phase kinase associated protein 2	FBL1|FBXL1|p45	protein_coding	Q13309	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5998
0	-0.553426194299464	1	1	0	RPL37	Malignant cells	GSE139386	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	5999
0	-0.73334654753754	0.873	0.989	0	PAIP1	Malignant cells	GSE139386	ENSG00000172239	10605	poly(A) binding protein interacting protein 1	NA	protein_coding	Q9H074	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6000
0	-0.767415943297486	0.271	0.712	0	NNT-AS1	Malignant cells	GSE139386	ENSG00000248092	NA	NA	RP11-159F24.1	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6001
0	-1.05387743529804	0.164	0.733	0	PLK2	Malignant cells	GSE139386	ENSG00000145632	10769	polo like kinase 2	SNK	protein_coding	Q9NYY3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6002
0	-0.817773682870746	0.194	0.701	0	CENPK	Malignant cells	GSE139386	ENSG00000123219	64105	centromere protein K	CENP-K|FKSG14|SOLT	protein_coding	Q9BS16	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6003
0	-1.08752613711815	0.143	0.629	0	CCNB1	Malignant cells	GSE139386	ENSG00000134057	891	cyclin B1	CCNB	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6004
0	-1.21109348187951	0.891	0.997	0	TAF9	Malignant cells	GSE139386	ENSG00000276463	6880	TATA-box binding protein associated factor 9	AD-004|CGI-137|MGC1603|MGC3647|MGC5067|TAF2G|TAFII31|TAFII32|TAFIID32	protein_coding	Q16594	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6005
0	0.589794340944924	1	1	0	BTF3	Malignant cells	GSE139386	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6006
0	-0.887904301282475	0.219	0.727	0	CTD-2015H6.3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6007
0	-1.24798377551304	0.313	0.899	0	DHFR	Malignant cells	GSE139386	ENSG00000228716	1719	dihydrofolate reductase	NA	protein_coding	P00374	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6008
0	-1.14971481694873	0.876	0.997	0	TMEM167A	Malignant cells	GSE139386	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6009
0	-0.620690381382102	0.005	0.393	0	EDIL3	Malignant cells	GSE139386	ENSG00000164176	10085	EGF like repeats and discoidin domains 3	DEL1	protein_coding	O43854	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6010
0	-0.516778112847272	1	1	0	COX7C	Malignant cells	GSE139386	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6011
0	0.914523471500394	0.742	0.314	0	GLRX	Malignant cells	GSE139386	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6012
0	1.54727750775297	0.954	0.528	0	EPB41L4A-AS1	Malignant cells	GSE139386	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6013
0	-0.935559220937619	0.743	0.973	0	AP3S1	Malignant cells	GSE139386	ENSG00000177879	1176	adaptor related protein complex 3 subunit sigma 1	CLAPS3	protein_coding	Q92572	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6014
0	-0.695164402113358	0.078	0.523	0	LMNB1	Malignant cells	GSE139386	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6015
0	-0.634324184346175	1	1	0	HINT1	Malignant cells	GSE139386	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6016
0	-1.09230695834145	1	1	0	UQCRQ	Malignant cells	GSE139386	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6017
0	-0.8620290058814	0.973	0.999	0	SKP1	Malignant cells	GSE139386	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6018
0	-0.775975579106978	0.913	0.992	0	HNRNPA0	Malignant cells	GSE139386	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6019
0	1.61686889608426	0.979	0.57	0	CYSTM1	Malignant cells	GSE139386	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6020
0	-1.16799369136442	0.881	0.998	0	NDUFA2	Malignant cells	GSE139386	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6021
0	0.741502899482193	0.983	0.924	0	CSNK1A1	Malignant cells	GSE139386	ENSG00000113712	1452	casein kinase 1 alpha 1	CK1|CK1a|CK1alpha|CKIa|CKIalpha	protein_coding	P48729	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6022
0	0.732041594086689	1	1	0	RPS14	Malignant cells	GSE139386	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6023
0	-0.622727002213817	0.067	0.472	0	NDST1	Malignant cells	GSE139386	ENSG00000070614	3340	N-deacetylase and N-sulfotransferase 1	HSST|NST1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6024
0	-1.11066879431134	0.641	0.961	0	TNIP1	Malignant cells	GSE139386	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6025
0	-1.32360137132025	0.879	0.999	0	ATOX1	Malignant cells	GSE139386	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6026
0	-1.51668638055167	0.398	0.92	0	PTTG1	Malignant cells	GSE139386	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6027
0	-0.758226958114479	0.183	0.645	0	WWC1	Malignant cells	GSE139386	ENSG00000113645	23286	WW and C2 domain containing 1	KIAA0869|KIBRA|PPP1R168	protein_coding	Q8IX03	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6028
0	0.706135239101797	1	1	0	NPM1	Malignant cells	GSE139386	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6029
0	-1.31444529849536	0.899	0.994	0	CLTB	Malignant cells	GSE139386	ENSG00000175416	1212	clathrin light chain B	Lcb	protein_coding	P09497	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6030
0	-1.21417036919283	0.996	1	0	PRELID1	Malignant cells	GSE139386	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6031
0	-0.840227264396303	0.714	0.954	0	PDLIM7	Malignant cells	GSE139386	ENSG00000196923	9260	PDZ and LIM domain 7	ENIGMA	protein_coding	Q9NR12	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6032
0	-0.781985472439867	0.993	1	0	NHP2	Malignant cells	GSE139386	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6033
0	-1.13664689347242	0.74	0.981	0	HNRNPAB	Malignant cells	GSE139386	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6034
0	0.915670089790978	0.737	0.261	0	RNF130	Malignant cells	GSE139386	ENSG00000113269	55819	ring finger protein 130	G1RZFP|GOLIATH|GP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6035
0	1.42054853701981	1	1	0	GNB2L1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6036
0	-0.517431392069781	0.007	0.345	0	FOXQ1	Malignant cells	GSE139386	ENSG00000164379	94234	forkhead box Q1	HFH1	protein_coding	Q9C009	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6037
0	-0.827046382978601	0.519	0.863	0	NQO2	Malignant cells	GSE139386	ENSG00000124588	4835	N-ribosyldihydronicotinamide:quinone reductase 2	DHQV|DIA6|NMOR2|QR2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6038
0	-1.3620843663402	0.799	0.993	0	TMEM14C	Malignant cells	GSE139386	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6039
0	-2.19720472909807	0.853	1	0	TMEM14B	Malignant cells	GSE139386	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6040
0	-0.719022563169292	0.189	0.635	0	SMIM13	Malignant cells	GSE139386	ENSG00000224531	221710	small integral membrane protein 13	C6orf228	protein_coding	P0DJ93	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6041
0	-1.01480135002062	0.014	0.561	0	EDN1	Malignant cells	GSE139386	ENSG00000078401	1906	endothelin 1	ET1	protein_coding	P05305	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6042
0	-1.42429875951524	0.928	0.996	0	DEK	Malignant cells	GSE139386	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6043
0	-1.12188012709679	0.586	0.941	0	ACOT13	Malignant cells	GSE139386	ENSG00000112304	55856	acyl-CoA thioesterase 13	HT012|THEM2	protein_coding	Q9NPJ3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6044
0	-1.36382463489173	0.158	0.818	0	GMNN	Malignant cells	GSE139386	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6045
0	-0.598266163664673	0.035	0.393	0	HIST1H2BC	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6046
0	-0.659079761417432	0.041	0.416	0	HIST1H2BD	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6047
0	-2.22122626702465	0.429	0.987	0	HIST1H2BK	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6048
0	0.99635963468292	0.972	0.825	0	HLA-A	Malignant cells	GSE139386	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6049
0	-0.961284323642355	0.979	1	0	TUBB	Malignant cells	GSE139386	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6050
0	-1.32296447006107	0.002	0.64	0	C6orf15	Malignant cells	GSE139386	ENSG00000206461	29113	chromosome 6 open reading frame 15	STG	protein_coding	Q6UXA7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6051
0	-0.580571613713378	0.015	0.396	0	PSORS1C1	Malignant cells	GSE139386	ENSG00000231094	170679	psoriasis susceptibility 1 candidate 1	C6orf16|SEEK1	protein_coding	Q9UIG5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6052
0	-0.887259555903597	0.055	0.592	0	TCF19	Malignant cells	GSE139386	ENSG00000224472	6941	transcription factor 19	SC1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6053
0	-1.68751509835923	0.55	0.954	0	LTB	Malignant cells	GSE139386	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6054
0	-1.23698970392789	0.903	0.997	0	LSM2	Malignant cells	GSE139386	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6055
0	1.71507979462904	1	0.936	0	C6orf48	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6056
0	1.02041840933175	1	1	0	RPS18	Malignant cells	GSE139386	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6057
0	-0.939019006695908	0.568	0.916	0	PFDN6	Malignant cells	GSE139386	ENSG00000235692	10471	prefoldin subunit 6	H2-KE2|HKE2|KE-2|PFD6	protein_coding	O15212	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6058
0	-0.637969082553524	0.995	0.999	0	UQCC2	Malignant cells	GSE139386	ENSG00000137288	84300	ubiquinol-cytochrome c reductase complex assembly factor 2	bA6B20.2|C6orf125|Cbp6|M19|MGC14833|MNF1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6059
0	1.90530054340623	1	1	0	HMGA1	Malignant cells	GSE139386	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6060
0	1.29002752058677	1	1	0	RPL10A	Malignant cells	GSE139386	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6061
0	-1.17531683075791	0.162	0.76	0	CCND3	Malignant cells	GSE139386	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6062
0	1.05515651139847	0.687	0.104	0	VEGFA	Malignant cells	GSE139386	ENSG00000112715	7422	vascular endothelial growth factor A	VEGF|VEGF-A|VPF	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6063
0	-0.781915470803171	0.982	1	0	MRPL14	Malignant cells	GSE139386	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6064
0	0.886239222601352	0.518	0.022	0	GPR110	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6065
0	-0.7316547101124	0.141	0.585	0	MCM3	Malignant cells	GSE139386	ENSG00000112118	4172	minichromosome maintenance complex component 3	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6066
0	-1.5718552582551	0.401	0.959	0	TMEM14A	Malignant cells	GSE139386	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6067
0	-1.12771930057189	0.007	0.633	0	RP1-27K12.2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6068
0	-0.799187924128442	0.045	0.56	0	BEND6	Malignant cells	GSE139386	ENSG00000151917	221336	BEN domain containing 6	bA203B9.1|C6orf65|FLJ30162	protein_coding	Q5SZJ8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6069
0	1.51607443693673	1	1	0	EEF1A1	Malignant cells	GSE139386	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6070
0	0.976895150462355	0.795	0.368	0	TMEM30A	Malignant cells	GSE139386	ENSG00000112697	55754	transmembrane protein 30A	C6orf67|CDC50A|FLJ10856	protein_coding	Q9NV96	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6071
0	-2.50902400231652	0.492	0.999	0	HMGN3	Malignant cells	GSE139386	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6072
0	0.978246302354344	0.732	0.22	0	TPBG	Malignant cells	GSE139386	ENSG00000283085	7162	trophoblast glycoprotein	5T4|5T4-AG	protein_coding	Q13641	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6073
0	-1.09541029399619	0.329	0.858	0	POPDC3	Malignant cells	GSE139386	ENSG00000132429	64208	popeye domain containing 3	bA355M14.1|MGC22671|POP3	protein_coding	Q9HBV1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6074
0	1.04558902454897	0.775	0.283	0	SEC63	Malignant cells	GSE139386	ENSG00000025796	11231	SEC63 homolog, protein translocation regulator	DNAJC23|ERdj2|PRO2507|SEC63L	protein_coding	Q9UGP8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6075
0	0.967790745553242	0.859	0.493	0	CD164	Malignant cells	GSE139386	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6076
0	0.912194257142368	0.871	0.583	0	HDAC2	Malignant cells	GSE139386	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6077
0	-1.05243440261712	0.407	0.921	0	CENPW	Malignant cells	GSE139386	ENSG00000203760	387103	centromere protein W	C6orf173|CUG2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6078
0	-1.3327975239836	0.354	0.883	0	RAB32	Malignant cells	GSE139386	ENSG00000118508	10981	RAB32, member RAS oncogene family	NA	protein_coding	Q13637	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6079
0	1.21955539931851	0.662	0.043	0	RGS17	Malignant cells	GSE139386	ENSG00000091844	26575	regulator of G protein signaling 17	RGS-17|RGSZ2	protein_coding	Q9UGC6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6080
0	-0.483587141839325	0.011	0.324	0	C6orf99	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6081
0	-1.12069140072464	0.42	0.895	0	SOD2	Malignant cells	GSE139386	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6082
0	-0.971787368433115	0.827	0.988	0	C7orf50	Malignant cells	GSE139386	ENSG00000146540	84310	chromosome 7 open reading frame 50	MGC11257|YCR016W	protein_coding	Q9BRJ6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6083
0	-1.56201103295033	0.341	0.941	0	FSCN1	Malignant cells	GSE139386	ENSG00000075618	6624	fascin actin-bundling protein 1	FLJ38511|p55|SNL	protein_coding	Q16658	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6084
0	-1.24497207040607	0.791	0.991	0	RPA3	Malignant cells	GSE139386	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6085
0	-0.58002517231447	1	1	0	NDUFA4	Malignant cells	GSE139386	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6086
0	-0.565404937475804	0.031	0.399	0	SCIN	Malignant cells	GSE139386	ENSG00000006747	85477	scinderin	KIAA1905	protein_coding	Q9Y6U3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6087
0	4.00471930710356	1	0.361	0	AGR2	Malignant cells	GSE139386	ENSG00000106541	10551	anterior gradient 2, protein disulphide isomerase family member	AG2|HAG-2|PDIA17|XAG-2	protein_coding	O95994	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6088
0	-0.642358222352248	0.998	1	0	TOMM7	Malignant cells	GSE139386	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6089
0	-1.16220469862887	0.944	0.997	0	HNRNPA2B1	Malignant cells	GSE139386	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6090
0	-1.24595277272115	0.871	1	0	CBX3	Malignant cells	GSE139386	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6091
0	-0.727773556282391	0.231	0.666	0	HIBADH	Malignant cells	GSE139386	ENSG00000106049	11112	3-hydroxyisobutyrate dehydrogenase	NS5ATP1	protein_coding	P31937	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6092
0	-0.807198697339872	0.873	0.988	0	GGCT	Malignant cells	GSE139386	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6093
0	-1.19118661900944	0.976	1	0	LSM5	Malignant cells	GSE139386	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6094
0	-0.805516354596227	0.055	0.526	0	ANLN	Malignant cells	GSE139386	ENSG00000011426	54443	anillin, actin binding protein	ANILLIN|scra|Scraps	protein_coding	Q9NQW6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6095
0	-0.712079164758981	0.202	0.649	0	UBE2D4	Malignant cells	GSE139386	ENSG00000078967	51619	ubiquitin conjugating enzyme E2 D4 (putative)	HBUCE1	protein_coding	Q9Y2X8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6096
0	-0.741850100986752	1	1	0	PPIA	Malignant cells	GSE139386	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6097
0	-1.46039839718716	0.973	1	0	H2AFV	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6098
0	-0.866595660809839	0.393	0.827	0	CCM2	Malignant cells	GSE139386	ENSG00000136280	83605	CCM2 scaffold protein	C7orf22|MGC4607|OSM	protein_coding	Q9BSQ5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6099
0	1.30218944856343	0.63	0.111	0	IGFBP3	Malignant cells	GSE139386	ENSG00000146674	3486	insulin like growth factor binding protein 3	BP-53|IBP3	protein_coding	P17936	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6100
0	-0.795520876023619	0.233	0.651	0	TNS3	Malignant cells	GSE139386	ENSG00000136205	64759	tensin 3	FLJ13732|H_NH0549I23.2|TEM6|TENS1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6101
0	-1.00244141285326	0.223	0.725	0	EGFR	Malignant cells	GSE139386	ENSG00000146648	1956	epidermal growth factor receptor	ERBB|ERBB1|ERRP	protein_coding	P00533	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6102
0	-0.809932182175872	0.528	0.88	0	VOPP1	Malignant cells	GSE139386	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6103
0	-0.818687980016394	1	1	0	CHCHD2	Malignant cells	GSE139386	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6104
0	-1.06957844888012	0.389	0.872	0	BCL7B	Malignant cells	GSE139386	ENSG00000106635	9275	BAF chromatin remodeling complex subunit BCL7B	SMARCJ2	protein_coding	Q9BQE9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6105
0	0.81812240897273	0.991	0.91	0	MDH2	Malignant cells	GSE139386	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6106
0	-1.08498568162671	0.78	0.976	0	HSPB1	Malignant cells	GSE139386	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6107
0	-0.805049939999019	0.578	0.893	0	YWHAG	Malignant cells	GSE139386	ENSG00000170027	7532	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma	14-3-3GAMMA|PPP1R170	protein_coding	P61981	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6108
0	0.861567052358871	0.643	0.174	0	STEAP1	Malignant cells	GSE139386	ENSG00000164647	26872	STEAP family member 1	PRSS24|STEAP	protein_coding	Q9UHE8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6109
0	-1.99893243844784	0.33	0.953	0	PEG10	Malignant cells	GSE139386	ENSG00000242265	23089	paternally expressed 10	HB-1|KIAA1051|Mar2|Mart2|MEF3L|RGAG3|RTL2|SIRH1	protein_coding	Q86TG7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6110
0	-1.26768834506646	0.991	1	0	SHFM1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6111
0	1.20117284430677	0.699	0.135	0	ASNS	Malignant cells	GSE139386	ENSG00000070669	440	asparagine synthetase (glutamine-hydrolyzing)	NA	protein_coding	P08243	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6112
0	-1.08074006542136	0.992	0.999	0	BRI3	Malignant cells	GSE139386	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6113
0	-1.22867304833226	0.966	0.998	0	ARPC1A	Malignant cells	GSE139386	ENSG00000241685	10552	actin related protein 2/3 complex subunit 1A	Arc40|SOP2Hs|SOP2L	protein_coding	Q92747	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6114
0	-1.41318745697287	0.875	0.998	0	ATP5J2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6115
0	-0.93466197032809	0.902	0.995	0	LAMTOR4	Malignant cells	GSE139386	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6116
0	-0.976336987046137	0.958	0.998	0	POLR2J	Malignant cells	GSE139386	ENSG00000005075	5439	RNA polymerase II subunit J	hRPB14|POLR2J1|RPB11|RPB11A|RPB11m	protein_coding	P52435	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6117
0	-0.428162486364258	0.002	0.285	0	NRCAM	Malignant cells	GSE139386	ENSG00000091129	4897	neuronal cell adhesion molecule	Bravo|KIAA0343	protein_coding	Q92823	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6118
0	-0.991959241463613	0.424	0.866	0	LINC00998	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6119
0	-2.92111338489901	0.297	0.992	0	CAV2	Malignant cells	GSE139386	ENSG00000105971	858	caveolin 2	CAV	protein_coding	P51636	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6120
0	-3.21937978443746	0.086	0.99	0	CAV1	Malignant cells	GSE139386	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6121
0	-0.90401338652085	0.526	0.889	0	NAA38	Malignant cells	GSE139386	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6122
0	-3.21990828319045	0.037	0.994	0	AKR1B1	Malignant cells	GSE139386	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6123
0	-1.60096262564311	0.021	0.747	0	AKR1B10	Malignant cells	GSE139386	ENSG00000198074	57016	aldo-keto reductase family 1 member B10	AKR1B11|AKR1B12|ALDRLn|ARL-1|ARL1|HIS|HSI	protein_coding	O60218	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6124
0	-0.909923238902113	0.203	0.724	0	C7orf49	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6125
0	-1.43699522018201	0.622	0.984	0	C7orf73	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6126
0	-0.917342373607249	0.938	0.997	0	NDUFB2	Malignant cells	GSE139386	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6127
0	4.92076340451777	0.956	0.059	0	PRSS1	Malignant cells	GSE139386	ENSG00000274247	5644	serine protease 1	TRY1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6128
0	-0.705965651982842	0.019	0.46	0	CNTNAP2	Malignant cells	GSE139386	ENSG00000278728	26047	contactin associated protein 2	Caspr2|KIAA0868|NRXN4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6129
0	-0.640259410367909	0.105	0.532	0	EZH2	Malignant cells	GSE139386	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6130
0	-1.60318622197503	0.005	0.734	0	RARRES2	Malignant cells	GSE139386	ENSG00000106538	5919	retinoic acid receptor responder 2	HP10433|TIG2	protein_coding	Q99969	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6131
0	-0.937185192500679	0.839	0.977	0	RHEB	Malignant cells	GSE139386	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6132
0	1.94330329497964	1	0.926	0	SLC25A6	Malignant cells	GSE139386	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6133
0	2.44925869259511	0.999	0.931	0	SAT1	Malignant cells	GSE139386	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6134
0	-0.541041852183519	0.006	0.379	0	TSPAN7	Malignant cells	GSE139386	ENSG00000156298	7102	tetraspanin 7	A15|CD231|DXS1692E|MRX58|MXS1|TALLA-1|TM4SF2	protein_coding	P41732	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6135
0	1.46196282554121	0.921	0.483	0	TIMP1	Malignant cells	GSE139386	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6136
0	-0.976480831987703	0.097	0.677	0	MSN	Malignant cells	GSE139386	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6137
0	-0.856513513016384	0.499	0.871	0	PDZD11	Malignant cells	GSE139386	ENSG00000120509	51248	PDZ domain containing 11	PDZK11	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6138
0	0.89608887653515	1	1	0	RPS4X	Malignant cells	GSE139386	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6139
0	-0.857668333585475	0.367	0.797	0	JPX	Malignant cells	GSE139386	ENSG00000225470	554203	JPX transcript, XIST activator	DCBALD06|ENOX|LINC00183|NCRNA00183	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6140
0	-2.06422415088148	0.782	0.997	0	COX7B	Malignant cells	GSE139386	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6141
0	-1.0121548903943	0.511	0.89	0	PGK1	Malignant cells	GSE139386	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6142
0	-1.06807679549273	0.175	0.752	0	GLA	Malignant cells	GSE139386	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6143
0	1.3252725268335	0.811	0.188	0	BEX2	Malignant cells	GSE139386	ENSG00000133134	84707	brain expressed X-linked 2	DJ79P11.1	protein_coding	Q9BXY8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6144
0	-1.0858015562404	0.983	0.999	0	NGFRAP1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6145
0	1.10337690175508	1	0.995	0	SLC25A5	Malignant cells	GSE139386	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6146
0	0.400739914353139	1	1	0	RPL39	Malignant cells	GSE139386	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6147
0	-1.63541490667815	0.171	0.891	0	SPANXC	Malignant cells	GSE139386	ENSG00000198573	64663	SPANX family member C	CT11.3|CTp11	protein_coding	Q9NY87	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6148
0	-1.16330537303868	0.448	0.905	0	SPANXD	Malignant cells	GSE139386	ENSG00000196406	64648	SPANX family member D	CT11.4|SPANXE	protein_coding	Q9BXN6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6149
0	-0.941206736312773	0.738	0.968	0	HMGB3	Malignant cells	GSE139386	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6150
0	-1.11857212511738	0.533	0.93	0	VMA21	Malignant cells	GSE139386	ENSG00000160131	203547	vacuolar ATPase assembly factor VMA21	MEAX|XMEA	protein_coding	Q3ZAQ7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6151
0	1.27754714681583	1	0.989	0	SSR4	Malignant cells	GSE139386	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6152
0	-0.935601451192583	0.518	0.891	0	IRAK1	Malignant cells	GSE139386	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6153
0	1.07408753477996	1	1	0	RPL10	Malignant cells	GSE139386	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6154
0	-0.687061497208498	0.916	0.992	0	LAGE3	Malignant cells	GSE139386	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6155
0	-0.889864276525238	0.36	0.814	0	UBL4A	Malignant cells	GSE139386	ENSG00000102178	8266	ubiquitin like 4A	DXS254E|GDX|GET5|MDY2|TMA24|UBL4	protein_coding	P11441	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6156
0	0.785486017544751	0.561	0.099	0	TNFRSF10B	Malignant cells	GSE139386	ENSG00000120889	8795	TNF receptor superfamily member 10b	CD262|DR5|KILLER|TRAIL-R2|TRAILR2|TRICK2A|TRICKB	protein_coding	O14763	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6157
0	1.35893690390037	0.998	0.936	0	EIF4EBP1	Malignant cells	GSE139386	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6158
0	-0.579846224782204	0.033	0.394	0	FGFR1	Malignant cells	GSE139386	ENSG00000077782	2260	fibroblast growth factor receptor 1	BFGFR|CD331|CEK|FLG|FLT2|H2|H3|H4|H5|KAL2|N-SAM	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6159
0	1.00602196769222	0.574	0.019	0	C8orf4	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6160
0	-1.01644170907189	0.392	0.823	0	VDAC3	Malignant cells	GSE139386	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6161
0	-0.797680804066015	0.096	0.585	0	SLC20A2	Malignant cells	GSE139386	ENSG00000168575	6575	solute carrier family 20 member 2	Glvr-2|GLVR2|MLVAR|PiT-2|Ram-1	protein_coding	Q08357	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6162
0	-1.0359885843617	0.538	0.933	0	PRKDC	Malignant cells	GSE139386	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6163
0	-1.0181793054812	0.104	0.71	0	MCM4	Malignant cells	GSE139386	ENSG00000104738	4173	minichromosome maintenance complex component 4	CDC21|CDC54|hCdc21|MGC33310|P1-Cdc21	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6164
0	-1.65287602958736	0.681	0.995	0	UBE2V2	Malignant cells	GSE139386	ENSG00000169139	7336	ubiquitin conjugating enzyme E2 V2	DDVit-1|DDVIT1|EDAF-1|EDPF-1|EDPF1|MMS2|UEV-2|UEV2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6165
0	-0.538788753508732	0.009	0.344	0	SNAI2	Malignant cells	GSE139386	ENSG00000019549	6591	snail family transcriptional repressor 2	SLUG|SLUGH|SLUGH1|SNAIL2	protein_coding	O43623	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6166
0	-0.818340041839133	0.12	0.636	0	RGS20	Malignant cells	GSE139386	ENSG00000147509	8601	regulator of G protein signaling 20	RGSZ1|ZGAP1	protein_coding	O76081	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6167
0	-0.891384135304957	0.459	0.855	0	MRPL15	Malignant cells	GSE139386	ENSG00000137547	29088	mitochondrial ribosomal protein L15	HSPC145|L15mt|MRP-L15|MRP-L7|RPML7	protein_coding	Q9P015	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6168
0	-1.21698743919522	1	1	0	RPS20	Malignant cells	GSE139386	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6169
0	-0.907719519908248	0.549	0.912	0	CHCHD7	Malignant cells	GSE139386	ENSG00000170791	79145	coiled-coil-helix-coiled-coil-helix domain containing 7	COX23|MGC2217	protein_coding	Q9BUK0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6170
0	-0.84822238565393	0.27	0.744	0	GGH	Malignant cells	GSE139386	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6171
0	-0.754326586876871	0.066	0.562	0	RP11-383H13.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6172
0	-1.53648688382612	0.021	0.788	0	MSC	Malignant cells	GSE139386	ENSG00000178860	9242	musculin	ABF-1|bHLHa22	protein_coding	O60682	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6173
0	0.965277932188148	1	1	0	RPL7	Malignant cells	GSE139386	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6174
0	1.53609716727912	0.751	0.143	0	RDH10	Malignant cells	GSE139386	ENSG00000121039	157506	retinol dehydrogenase 10	SDR16C4	protein_coding	Q8IZV5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6175
0	-1.78301202775902	0.919	1	0	TCEB1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6176
0	-1.01916927861586	0.348	0.842	0	MRPS28	Malignant cells	GSE139386	ENSG00000147586	28957	mitochondrial ribosomal protein S28	HSPC007|MRP-S28|MRPS35	protein_coding	Q9Y2Q9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6177
0	-1.28660265070114	0.532	0.941	0	FABP5	Malignant cells	GSE139386	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6178
0	-1.34701210598312	0.564	0.965	0	C8orf59	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6179
0	-0.766936280455914	0.134	0.604	0	OSGIN2	Malignant cells	GSE139386	ENSG00000164823	734	oxidative stress induced growth inhibitor family member 2	C8orf1|hT41	protein_coding	Q9Y236	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6180
0	-1.024962935187	0.398	0.875	0	GS1-251I9.4	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6181
0	-0.678073522256798	0.163	0.601	0	NDUFAF6	Malignant cells	GSE139386	ENSG00000156170	137682	NADH:ubiquinone oxidoreductase complex assembly factor 6	C8orf38|MGC40214	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6182
0	-1.57157749920802	0.952	1	0	UQCRB	Malignant cells	GSE139386	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6183
0	-0.808460902002954	1	1	0	RPL30	Malignant cells	GSE139386	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6184
0	-1.25063020540939	0.997	1	0	COX6C	Malignant cells	GSE139386	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6185
0	-1.07094792221255	0.887	0.997	0	POLR2K	Malignant cells	GSE139386	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6186
0	-1.45827067570465	0.989	1	0	YWHAZ	Malignant cells	GSE139386	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6187
0	-1.80173133763562	0.987	1	0	ZNF706	Malignant cells	GSE139386	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6188
0	0.850839114727363	1	0.979	0	EIF3E	Malignant cells	GSE139386	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6189
0	-1.65454781582651	0.917	0.999	0	ENY2	Malignant cells	GSE139386	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6190
0	0.728102204071724	1	0.994	0	EIF3H	Malignant cells	GSE139386	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6191
0	-0.891429984120382	0.21	0.718	0	ATAD2	Malignant cells	GSE139386	ENSG00000156802	29028	ATPase family AAA domain containing 2	ANCCA|CT137|DKFZp667N1320|MGC29843|MGC5254|PRO2000	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6192
0	-1.08947612309836	0.341	0.827	0	FBXO32	Malignant cells	GSE139386	ENSG00000156804	114907	F-box protein 32	ATROGIN1|Fbx32|MAFbx	protein_coding	Q969P5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6193
0	-0.672031160969793	0.999	1	0	NDUFB9	Malignant cells	GSE139386	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6194
0	-1.08529150832981	0.297	0.766	0	SQLE	Malignant cells	GSE139386	ENSG00000104549	6713	squalene epoxidase	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6195
0	-0.897940790571881	0.664	0.942	0	FAM49B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6196
0	-0.997968955696664	0.257	0.761	0	ASAP1	Malignant cells	GSE139386	ENSG00000153317	50807	ArfGAP with SH3 domain, ankyrin repeat and PH domain 1	CENTB4|DDEF1|KIAA1249|PAP|ZG14P	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6197
0	-0.90196322916063	0.381	0.823	0	CHRAC1	Malignant cells	GSE139386	ENSG00000104472	54108	chromatin accessibility complex subunit 1	CHRAC15|YCL1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6198
0	-1.18325014950647	0.33	0.813	0	LY6D	Malignant cells	GSE139386	ENSG00000167656	8581	lymphocyte antigen 6 family member D	E48	protein_coding	Q14210	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6199
0	-0.735630278439131	0.826	0.978	0	MAF1	Malignant cells	GSE139386	ENSG00000179632	84232	MAF1 homolog, negative regulator of RNA polymerase III	DKFZp586G1123	protein_coding	Q9H063	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6200
0	-1.81608794751369	0.607	0.99	0	SLC39A4	Malignant cells	GSE139386	ENSG00000285243	55630	solute carrier family 39 member 4	AEZ|AWMS2|ZIP4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6201
0	0.389777877756898	1	1	0	RPL8	Malignant cells	GSE139386	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6202
0	0.868147877280039	1	1	0	RPS6	Malignant cells	GSE139386	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6203
0	-0.754827338164911	0.151	0.609	0	TUSC1	Malignant cells	GSE139386	ENSG00000198680	286319	tumor suppressor candidate 1	CCDC89B|TSG-9	protein_coding	Q2TAM9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6204
0	3.08042450149203	0.947	0.083	0	PRSS3	Malignant cells	GSE139386	ENSG00000010438	5646	serine protease 3	PRSS4|TRY3|TRY4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6205
0	0.889180635219375	0.981	0.885	0	HINT2	Malignant cells	GSE139386	ENSG00000137133	84681	histidine triad nucleotide binding protein 2	NA	protein_coding	Q9BX68	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6206
0	0.777501247112497	0.992	0.919	0	CLTA	Malignant cells	GSE139386	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6207
0	-1.50061644705466	0.331	0.92	0	ANXA1	Malignant cells	GSE139386	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6208
0	1.12269613725769	0.821	0.35	0	GOLM1	Malignant cells	GSE139386	ENSG00000135052	51280	golgi membrane protein 1	bA379P1.3|C9orf155|FLJ23608|GOLPH2|GP73	protein_coding	Q8NBJ4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6209
0	-2.16153507847958	0.353	0.957	0	CKS2	Malignant cells	GSE139386	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6210
0	-0.893400222994458	0.139	0.656	0	C9orf3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6211
0	0.92254898892811	0.788	0.381	0	NANS	Malignant cells	GSE139386	ENSG00000095380	54187	N-acetylneuraminate synthase	SAS	protein_coding	Q9NR45	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6212
0	0.619491727010798	1	0.999	0	SEC61B	Malignant cells	GSE139386	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6213
0	0.97757706381906	0.745	0.275	0	ERP44	Malignant cells	GSE139386	ENSG00000023318	23071	endoplasmic reticulum protein 44	KIAA0573|PDIA10|TXNDC4	protein_coding	Q9BS26	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6214
0	-1.63424255457854	1	1	0	TXN	Malignant cells	GSE139386	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6215
0	-2.58381163175372	0.458	0.996	0	PTGR1	Malignant cells	GSE139386	ENSG00000106853	22949	prostaglandin reductase 1	LTB4DH|ZADH3	protein_coding	Q14914	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6216
0	-1.08156387689202	0.185	0.715	0	CDK5RAP2	Malignant cells	GSE139386	ENSG00000136861	55755	CDK5 regulatory subunit associated protein 2	C48|CEP215|FLJ10867|MCPH3	protein_coding	Q96SN8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6217
0	-1.71269453951306	0.275	0.916	0	PHF19	Malignant cells	GSE139386	ENSG00000119403	26147	PHD finger protein 19	DKFZP727G051|MTF2L1|PCL3|TDRD19B	protein_coding	Q5T6S3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6218
0	-1.07003390594061	0.178	0.777	0	NEK6	Malignant cells	GSE139386	ENSG00000119408	10783	NIMA related kinase 6	SID6-1512	protein_coding	Q9HC98	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6219
0	3.03181636887557	0.996	0.513	0	HSPA5	Malignant cells	GSE139386	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6220
0	0.758369019787378	0.987	0.92	0	PTGES2	Malignant cells	GSE139386	ENSG00000148334	80142	prostaglandin E synthase 2	C9orf15|FLJ14038	protein_coding	Q9H7Z7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6221
0	5.0793589738082	1	0.666	0	LCN2	Malignant cells	GSE139386	ENSG00000148346	3934	lipocalin 2	24p3|NGAL	protein_coding	P80188	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6222
0	1.66282364237137	1	0.994	0	C9orf16	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6223
0	-0.942844464704756	0.486	0.901	0	WDR34	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6224
0	-0.998720599059871	0.812	0.988	0	ZDHHC12	Malignant cells	GSE139386	ENSG00000160446	84885	zinc finger DHHC-type palmitoyltransferase 12	FLJ14524|ZNF400	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6225
0	-0.663407206274192	0.12	0.546	0	RP11-545E17.3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6226
0	0.967327295899159	0.614	0.06	0	PRRX2	Malignant cells	GSE139386	ENSG00000167157	51450	paired related homeobox 2	PMX2|PRX2	protein_coding	Q99811	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6227
0	2.28313279821254	0.965	0.201	0	ASS1	Malignant cells	GSE139386	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6228
0	0.505903168062952	1	1	0	RPL7A	Malignant cells	GSE139386	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6229
0	-0.978268663553125	0.731	0.968	0	RABL6	Malignant cells	GSE139386	ENSG00000196642	55684	RAB, member RAS oncogene family like 6	bA216L13.9|C9orf86|FLJ10101|FLJ13045|Parf|pp8875|RBEL1	protein_coding	Q3YEC7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6230
0	-0.953834540093486	0.997	1	0	PHPT1	Malignant cells	GSE139386	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6231
0	-1.08833949757546	0.063	0.602	0	LRRC26	Malignant cells	GSE139386	ENSG00000184709	389816	leucine rich repeat containing 26	bA350O14.10|OTTHUMG00000020980	protein_coding	Q2I0M4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6232
0	-1.13808268252296	0.854	0.996	0	SSNA1	Malignant cells	GSE139386	ENSG00000176101	8636	SS nuclear autoantigen 1	N14|NA14	protein_coding	O43805	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6233
0	-0.921079070755564	0.223	0.756	0	RNF208	Malignant cells	GSE139386	ENSG00000212864	727800	ring finger protein 208	DKFZP761H1710	protein_coding	Q9H0X6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6234
0	-0.991370116914035	0.687	0.967	0	TUBB4B	Malignant cells	GSE139386	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6235
0	-2.31961116335857	0.046	0.94	0	AKR1C1	Malignant cells	GSE139386	ENSG00000187134	1645	aldo-keto reductase family 1 member C1	DD1|DDH|DDH1|HAKRC|MBAB	protein_coding	Q04828	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6236
0	-2.75717449946248	0.127	0.978	0	AKR1C2	Malignant cells	GSE139386	ENSG00000151632	1646	aldo-keto reductase family 1 member C2	BABP|DD|DD2|DDH2|HAKRD|MCDR2|TDD	protein_coding	P52895	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6237
0	-1.32771399312329	0.295	0.865	0	AKR1C3	Malignant cells	GSE139386	ENSG00000196139	8644	aldo-keto reductase family 1 member C3	DDX|HAKRB|HSD17B5|KIAA0119|PGFS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6238
0	0.878710797233081	0.815	0.455	0	GDI2	Malignant cells	GSE139386	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6239
0	-1.00262280594643	0.003	0.626	0	RP11-554I8.2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6240
0	-0.815729053228248	0.013	0.509	0	SFTA1P	Malignant cells	GSE139386	ENSG00000225383	207107	surfactant associated 1, lncRNA	SFTPF	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6241
0	-0.930583687401404	0.153	0.698	0	PTPLA	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6242
0	1.09735381972311	0.819	0.328	0	DNAJC1	Malignant cells	GSE139386	ENSG00000136770	64215	DnaJ heat shock protein family (Hsp40) member C1	DNAJL1|ERdj1|MTJ1	protein_coding	Q96KC8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6243
0	-1.19517278740392	0.01	0.572	0	DKK1	Malignant cells	GSE139386	ENSG00000107984	22943	dickkopf WNT signaling pathway inhibitor 1	DKK-1|SK	protein_coding	O94907	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6244
0	-1.12792724683797	0.153	0.781	0	ZWINT	Malignant cells	GSE139386	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6245
0	0.931249348021192	0.517	0.001	0	UNC5B-AS1	Malignant cells	GSE139386	ENSG00000237512	728978	UNC5B antisense RNA 1	TP53LC05|UASR1	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6246
0	2.0726155097175	1	0.785	0	PSAP	Malignant cells	GSE139386	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6247
0	2.15674534775904	0.997	0.535	0	DDIT4	Malignant cells	GSE139386	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6248
0	-0.812381658023776	0.659	0.944	0	CHCHD1	Malignant cells	GSE139386	ENSG00000172586	118487	coiled-coil-helix-coiled-coil-helix domain containing 1	C10orf34|FLJ25854	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6249
0	-0.936467204499667	0.434	0.857	0	ADK	Malignant cells	GSE139386	ENSG00000156110	132	adenosine kinase	AK	protein_coding	P55263	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6250
0	-1.10230119601434	0.218	0.78	0	PPIF	Malignant cells	GSE139386	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6251
0	1.15779175843968	0.936	0.601	0	ANXA11	Malignant cells	GSE139386	ENSG00000122359	311	annexin A11	ANX11	protein_coding	P50995	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6252
0	-1.07029954778701	0.319	0.811	0	SNCG	Malignant cells	GSE139386	ENSG00000173267	6623	synuclein gamma	BCSG1|persyn|SR	protein_coding	O76070	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6253
0	1.60045585792295	0.699	0.004	0	ADIRF	Malignant cells	GSE139386	ENSG00000148671	10974	adipogenesis regulatory factor	AFRO|APM2|C10orf116	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6254
0	-0.723195261701032	0.194	0.638	0	MYOF	Malignant cells	GSE139386	ENSG00000138119	26509	myoferlin	FER1L3|KIAA1207	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6255
0	-0.8110486549107	0.208	0.679	0	HELLS	Malignant cells	GSE139386	ENSG00000119969	3070	helicase, lymphoid specific	LSH|Nbla10143|PASG|SMARCA6	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6256
0	-1.17161460602136	0.547	0.941	0	PGAM1	Malignant cells	GSE139386	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6257
0	-0.919518065119544	0.968	0.999	0	USMG5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6258
0	1.77632940097851	0.926	0.335	0	DUSP5	Malignant cells	GSE139386	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6259
0	-0.837567383238062	0.597	0.913	0	PRDX3	Malignant cells	GSE139386	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6260
0	-0.944456515909213	0.182	0.722	0	MKI67	Malignant cells	GSE139386	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6261
0	-1.11332762578663	0.487	0.918	0	HRAS	Malignant cells	GSE139386	ENSG00000276536	3265	HRas proto-oncogene, GTPase	HRAS1	protein_coding	P01112	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6262
0	-0.780501456795736	0.437	0.824	0	EPS8L2	Malignant cells	GSE139386	ENSG00000177106	64787	EPS8 like 2	FLJ21935|FLJ22171|MGC3088	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6263
0	0.53239443060072	1	1	0	RPLP2	Malignant cells	GSE139386	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6264
0	-0.864119002256825	0.992	1	0	POLR2L	Malignant cells	GSE139386	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6265
0	1.83529767811035	0.886	0.108	0	SLC22A18	Malignant cells	GSE139386	ENSG00000276130	5002	solute carrier family 22 member 18	BWR1A|BWSCR1A|IMPT1|ITM|ORCTL2|SLC22A1L|TSSC5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6266
0	1.93469580132309	0.999	0.844	0	PHLDA2	Malignant cells	GSE139386	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6267
0	0.862553658834154	0.741	0.316	0	CARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6268
0	1.32276873089422	0.999	0.929	0	EIF3F	Malignant cells	GSE139386	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6269
0	0.517206118876304	1	1	0	RPL27A	Malignant cells	GSE139386	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6270
0	-1.27922314281986	0.053	0.725	0	ADM	Malignant cells	GSE139386	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6271
0	0.975436334459816	1	1	0	RPS13	Malignant cells	GSE139386	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6272
0	1.46915422264075	0.908	0.463	0	NUCB2	Malignant cells	GSE139386	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6273
0	1.97823164498555	0.881	0.313	0	SAA1	Malignant cells	GSE139386	ENSG00000288411	6288	serum amyloid A1	PIG4|SAA|TP53I4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6274
0	-1.03836182377291	0.704	0.968	0	SVIP	Malignant cells	GSE139386	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6275
0	-0.969261040638421	0.523	0.903	0	CCDC34	Malignant cells	GSE139386	ENSG00000109881	91057	coiled-coil domain containing 34	L15|NY-REN-41|RAMA3	protein_coding	Q96HJ3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6276
0	1.54328373254864	0.994	0.788	0	EIF3M	Malignant cells	GSE139386	ENSG00000149100	10480	eukaryotic translation initiation factor 3 subunit M	FLJ29030|GA17|hfl-B5|PCID1|TANGO7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6277
0	-0.838588544130781	0.503	0.857	0	CD59	Malignant cells	GSE139386	ENSG00000085063	966	CD59 molecule (CD59 blood group)	16.3A5|EJ16|EJ30|EL32|G344|MIC11|MIN1|MIN2|MIN3|MSK21|p18-20	protein_coding	P13987	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6278
0	0.825931215179801	0.631	0.154	0	EHF	Malignant cells	GSE139386	ENSG00000135373	26298	ETS homologous factor	ESE3|ESEJ	protein_coding	Q9NZC4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6279
0	0.907202049331969	1	0.997	0	TMEM258	Malignant cells	GSE139386	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6280
0	1.8686225895481	1	0.856	0	UBXN1	Malignant cells	GSE139386	ENSG00000162191	51035	UBX domain protein 1	2B28|LOC51035|SAKS1|UBXD10	protein_coding	Q04323	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6281
0	1.2683820079907	0.977	0.758	0	SLC3A2	Malignant cells	GSE139386	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6282
0	0.875964354458277	0.723	0.261	0	MACROD1	Malignant cells	GSE139386	ENSG00000133315	28992	mono-ADP ribosylhydrolase 1	LRP16	protein_coding	Q9BQ69	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6283
0	-1.5217484346286	1	1	0	PPP1R14B	Malignant cells	GSE139386	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6284
0	1.0318879210388	0.999	0.987	0	PRDX5	Malignant cells	GSE139386	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6285
0	-0.77402515589576	0.245	0.69	0	SAC3D1	Malignant cells	GSE139386	ENSG00000168061	29901	SAC3 domain containing 1	HSU79266|SHD1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6286
0	0.878645802390794	1	1	0	FAU	Malignant cells	GSE139386	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6287
0	-0.780108765139543	0.931	0.995	0	RNASEH2C	Malignant cells	GSE139386	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6288
0	-1.8387457131489	1	1	0	CFL1	Malignant cells	GSE139386	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6289
0	-0.732975239598902	0.946	0.995	0	FIBP	Malignant cells	GSE139386	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6290
0	-2.48606243025995	0.722	0.999	0	CCDC85B	Malignant cells	GSE139386	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6291
0	-1.39137797182183	0.165	0.764	0	FOSL1	Malignant cells	GSE139386	ENSG00000175592	8061	FOS like 1, AP-1 transcription factor subunit	fra-1	protein_coding	P15407	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6292
0	-1.70996180781195	0.973	1	0	DRAP1	Malignant cells	GSE139386	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6293
0	-1.68282665941939	0.911	1	0	BANF1	Malignant cells	GSE139386	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6294
0	-2.47230390390196	0.521	0.988	0	CST6	Malignant cells	GSE139386	ENSG00000175315	1474	cystatin E/M	NA	protein_coding	Q15828	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6295
0	-1.12086343897049	0.499	0.939	0	RAB1B	Malignant cells	GSE139386	ENSG00000174903	81876	RAB1B, member RAS oncogene family	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6296
0	-1.44948333078765	0.925	1	0	MRPL11	Malignant cells	GSE139386	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6297
0	-1.54965618381734	0.289	0.89	0	RHOD	Malignant cells	GSE139386	ENSG00000173156	29984	ras homolog family member D	ARHD|Rho|RhoHP1	protein_coding	O00212	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6298
0	-1.14807484576883	0.737	0.984	0	RPS6KB2	Malignant cells	GSE139386	ENSG00000175634	6199	ribosomal protein S6 kinase B2	KLS|P70-BETA|p70S6Kb|S6KB|S6Kbeta|STK14B	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6299
0	-1.29228547322537	0.999	1	0	GSTP1	Malignant cells	GSE139386	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6300
0	1.2213783341107	1	0.992	0	CCND1	Malignant cells	GSE139386	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6301
0	-0.672085839531005	0.939	0.995	0	LAMTOR1	Malignant cells	GSE139386	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6302
0	-1.75267456386808	0.487	0.983	0	ANAPC15	Malignant cells	GSE139386	ENSG00000110200	25906	anaphase promoting complex subunit 15	APC15|C11orf51|DKFZP564M082|HSPC020	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6303
0	-0.810454394447608	0.868	0.988	0	COA4	Malignant cells	GSE139386	ENSG00000181924	51287	cytochrome c oxidase assembly factor 4 homolog	CHCHD8|CMC3|E2IG2	protein_coding	Q9NYJ1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6304
0	0.485268224537083	1	1	0	RPS3	Malignant cells	GSE139386	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6305
0	-0.902377432894319	0.391	0.822	0	TSKU	Malignant cells	GSE139386	ENSG00000182704	25987	tsukushi, small leucine rich proteoglycan	E2IG4|LRRC54|TSK	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6306
0	-0.900842503865335	0.977	0.997	0	NDUFC2	Malignant cells	GSE139386	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6307
0	-1.12623137053174	0.516	0.934	0	TMEM126B	Malignant cells	GSE139386	ENSG00000171204	55863	transmembrane protein 126B	HT007	protein_coding	Q8IUX1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6308
0	-1.23196306523283	0.454	0.913	0	TMEM126A	Malignant cells	GSE139386	ENSG00000171202	84233	transmembrane protein 126A	DKFZp586C1924|OPA7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6309
0	-0.730060741783584	0.844	0.979	0	C11orf73	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6310
0	-2.6676247316439	0.144	0.97	0	PRSS23	Malignant cells	GSE139386	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6311
0	-1.28790437402511	0.162	0.808	0	CHORDC1	Malignant cells	GSE139386	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6312
0	-0.860372020373586	0.142	0.673	0	SLC36A4	Malignant cells	GSE139386	ENSG00000180773	120103	solute carrier family 36 member 4	FLJ38932|PAT4	protein_coding	Q6YBV0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6313
0	-1.44587519011707	0.684	0.991	0	CWC15	Malignant cells	GSE139386	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6314
0	-0.878156103012873	0.156	0.682	0	MTMR2	Malignant cells	GSE139386	ENSG00000087053	8898	myotubularin related protein 2	CMT4B|KIAA1073	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6315
0	-0.783147919746435	0.884	0.987	0	TMEM123	Malignant cells	GSE139386	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6316
0	-0.914072253460604	0.602	0.914	0	DCUN1D5	Malignant cells	GSE139386	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6317
0	0.927891801620109	0.766	0.34	0	CASP4	Malignant cells	GSE139386	ENSG00000196954	837	caspase 4	ICE(rel)II|ICH-2|TX	protein_coding	P49662	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6318
0	-0.539771178942211	0.021	0.373	0	LAYN	Malignant cells	GSE139386	ENSG00000204381	143903	layilin	FLJ30977|FLJ31092	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6319
0	0.912717032045519	1	1	0	RPS25	Malignant cells	GSE139386	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6320
0	1.00027666020949	0.696	0.167	0	HYOU1	Malignant cells	GSE139386	ENSG00000280682	10525	hypoxia up-regulated 1	Grp170|HSP12A|ORP150	protein_coding	Q9Y4L1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6321
0	-1.22405494509399	0.215	0.799	0	H2AFX	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6322
0	1.40012141203099	0.893	0.395	0	APLP2	Malignant cells	GSE139386	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6323
0	-1.25437088559511	0.101	0.782	0	FOXM1	Malignant cells	GSE139386	ENSG00000111206	2305	forkhead box M1	FKHL16|HFH-11|HNF-3|INS-1|MPHOSPH2|MPP2|TGT3|trident	protein_coding	Q08050	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6324
0	-0.941110302252019	0.349	0.8	0	RHNO1	Malignant cells	GSE139386	ENSG00000171792	83695	RAD9-HUS1-RAD1 interacting nuclear orphan 1	C12orf32|HKMT1188|MGC13204|RHINO	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6325
0	-0.653595279502501	0.101	0.522	0	RAD51AP1	Malignant cells	GSE139386	ENSG00000111247	10635	RAD51 associated protein 1	PIR51	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6326
0	-1.25089036126093	0.995	1	0	MRPL51	Malignant cells	GSE139386	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6327
0	-1.00476192970876	0.071	0.583	0	CDCA3	Malignant cells	GSE139386	ENSG00000111665	83461	cell division cycle associated 3	GRCC8|TOME-1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6328
0	-0.797595540285447	1	1	0	TPI1	Malignant cells	GSE139386	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6329
0	1.08558079956654	0.988	0.86	0	C12orf57	Malignant cells	GSE139386	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6330
0	-1.56895864913596	0.15	0.857	0	CD163L1	Malignant cells	GSE139386	ENSG00000177675	283316	CD163 molecule like 1	CD163B|M160|SCARI2|WC1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6331
0	-1.03740113368585	0.293	0.752	0	GPRC5A	Malignant cells	GSE139386	ENSG00000013588	9052	G protein-coupled receptor class C group 5 member A	PEIG-1|RAI3|RAIG1|TIG1	protein_coding	Q8NFJ5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6332
0	-1.54636055271907	0.992	1	0	MGST1	Malignant cells	GSE139386	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6333
0	1.34843874098473	0.728	0.041	0	C12orf39	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6334
0	0.887696856236471	1	0.998	0	LDHB	Malignant cells	GSE139386	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6335
0	-1.12168966535559	0.142	0.777	0	ARNTL2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6336
0	0.88991450732177	0.867	0.568	0	SLC38A2	Malignant cells	GSE139386	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6337
0	-0.853580426422582	0.771	0.979	0	TMEM106C	Malignant cells	GSE139386	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6338
0	-1.38049567158805	0.928	1	0	TUBA1B	Malignant cells	GSE139386	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6339
0	-1.05225106512698	0.186	0.784	0	TROAP	Malignant cells	GSE139386	ENSG00000135451	10024	trophinin associated protein	TASTIN	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6340
0	0.765884097595074	0.991	0.942	0	TMBIM6	Malignant cells	GSE139386	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6341
0	-0.673922264114493	0.016	0.44	0	KRT6A	Malignant cells	GSE139386	ENSG00000205420	3853	keratin 6A	CK6C|CK6D|K6C|K6D|KRT6C|KRT6D	protein_coding	P02538	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6342
0	0.716168676931969	1	1	0	KRT8	Malignant cells	GSE139386	ENSG00000170421	3856	keratin 8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	protein_coding	P05787	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6343
0	1.81737681872071	1	1	0	KRT18	Malignant cells	GSE139386	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6344
0	1.07607061484542	0.976	0.802	0	EIF4B	Malignant cells	GSE139386	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6345
0	0.63921033768968	1	1	0	PFDN5	Malignant cells	GSE139386	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6346
0	0.879530268014105	1	1	0	ATP5G2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6347
0	0.774809604714232	0.999	1	0	HNRNPA1	Malignant cells	GSE139386	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6348
0	-1.54479189156871	0.685	0.995	0	BLOC1S1	Malignant cells	GSE139386	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6349
0	-1.48515643453465	1	1	0	RPS26	Malignant cells	GSE139386	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6350
0	-1.71706604179767	0.998	1	0	MYL6	Malignant cells	GSE139386	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6351
0	-0.800718350560035	0.966	0.999	0	PTGES3	Malignant cells	GSE139386	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6352
0	0.513057563406623	1	1	0	NACA	Malignant cells	GSE139386	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6353
0	1.19512236291075	0.906	0.477	0	SHMT2	Malignant cells	GSE139386	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6354
0	2.59926610936875	0.981	0.142	0	DDIT3	Malignant cells	GSE139386	ENSG00000175197	1649	DNA damage inducible transcript 3	CHOP|CHOP10|GADD153	protein_coding	P35638	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6355
0	-0.960262912328046	0.908	0.99	0	CDK4	Malignant cells	GSE139386	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6356
0	-0.773875774462011	0.144	0.601	0	SRGAP1	Malignant cells	GSE139386	ENSG00000196935	57522	SLIT-ROBO Rho GTPase activating protein 1	ARHGAP13|KIAA1304	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6357
0	-1.15323189844969	0.009	0.648	0	GLIPR1	Malignant cells	GSE139386	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6358
0	2.22835061936294	0.987	0.479	0	PHLDA1	Malignant cells	GSE139386	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6359
0	-0.551531021278907	0.014	0.382	0	KITLG	Malignant cells	GSE139386	ENSG00000049130	4254	KIT ligand	DFNA69|FPH2|Kitl|KL-1|MGF|SCF|SF|SLF	protein_coding	P21583	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6360
0	1.7715155519834	0.88	0.099	0	DUSP6	Malignant cells	GSE139386	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6361
0	1.40373634560893	0.984	0.71	0	BTG1	Malignant cells	GSE139386	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6362
0	-0.828566869363717	0.762	0.964	0	UBE2N	Malignant cells	GSE139386	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6363
0	-0.902533670359416	0.824	0.979	0	MRPL42	Malignant cells	GSE139386	ENSG00000198015	28977	mitochondrial ribosomal protein L42	HSPC204|MRP-L31|MRPL31|MRPS32|PTD007|RPML31	protein_coding	Q9Y6G3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6364
0	-0.980391480770124	0.984	1	0	SNRPF	Malignant cells	GSE139386	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6365
0	2.3261155004872	0.994	0.803	0	HSP90B1	Malignant cells	GSE139386	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6366
0	-1.89611237508124	0.937	1	0	TXNRD1	Malignant cells	GSE139386	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6367
0	-0.591984817534596	0.019	0.405	0	RP11-818F20.5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6368
0	-1.94528726229918	0.307	0.96	0	C12orf75	Malignant cells	GSE139386	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6369
0	-1.3700606918723	0.309	0.899	0	CORO1C	Malignant cells	GSE139386	ENSG00000110880	23603	coronin 1C	coronin-3|HCRNN4	protein_coding	Q9ULV4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6370
0	-0.755305484580887	0.116	0.568	0	UNG	Malignant cells	GSE139386	ENSG00000076248	7374	uracil DNA glycosylase	DGU|HIGM4|UDG|UNG1|UNG2	protein_coding	P13051	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6371
0	0.802483533567866	0.988	0.898	0	ERP29	Malignant cells	GSE139386	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6372
0	0.559308728525036	1	1	0	RPL6	Malignant cells	GSE139386	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6373
0	-0.63651662082485	1	1	0	RPLP0	Malignant cells	GSE139386	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6374
0	-1.05016668479976	0.988	1	0	SRSF9	Malignant cells	GSE139386	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6375
0	-1.32336611983266	0.987	1	0	DYNLL1	Malignant cells	GSE139386	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6376
0	-1.12072450132701	0.001	0.538	0	HPD	Malignant cells	GSE139386	ENSG00000158104	3242	4-hydroxyphenylpyruvate dioxygenase	4-HPPD|4HPPD|GLOD3|PPD	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6377
0	-1.05319123941849	0.999	1	0	RAN	Malignant cells	GSE139386	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6378
0	-0.786472106916703	0.555	0.889	0	PXMP2	Malignant cells	GSE139386	ENSG00000176894	5827	peroxisomal membrane protein 2	MPV17L3|PMP22	protein_coding	Q9NR77	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6379
0	-1.07290316225036	0.986	0.999	0	GTF3A	Malignant cells	GSE139386	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6380
0	-0.794811160911989	0.109	0.626	0	ATP5EP2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6381
0	-0.703556412261537	0.997	1	0	POMP	Malignant cells	GSE139386	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6382
0	-1.45069250980458	0.998	1	0	HMGB1	Malignant cells	GSE139386	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6383
0	-0.945775003382176	0.008	0.589	0	LCP1	Malignant cells	GSE139386	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6384
0	-0.881991073337186	0.236	0.745	0	NUDT15	Malignant cells	GSE139386	ENSG00000136159	55270	nudix hydrolase 15	FLJ10956|MTH2	protein_coding	Q9NV35	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6385
0	-0.891927463744355	0.466	0.843	0	MZT1	Malignant cells	GSE139386	ENSG00000204899	440145	mitotic spindle organizing protein 1	C13orf37|FLJ21869|LOC440145|MGC150539|MOZART1|RP11-11C5.2	protein_coding	Q08AG7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6386
0	1.77290542569586	0.791	0.152	0	CLDN10	Malignant cells	GSE139386	ENSG00000134873	9071	claudin 10	CPETRL3|OSP-L	protein_coding	P78369	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6387
0	1.32669227929537	0.863	0.41	0	DNAJC3	Malignant cells	GSE139386	ENSG00000102580	5611	DnaJ heat shock protein family (Hsp40) member C3	ERdj6|HP58|P58|p58(IPK)|P58IPK|PRKRI	protein_coding	Q13217	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6388
0	-0.761731217412812	0.09	0.553	0	EFNB2	Malignant cells	GSE139386	ENSG00000125266	1948	ephrin B2	EPLG5|Htk-L|HTKL|LERK5|MGC126226|MGC126227|MGC126228	protein_coding	P52799	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6389
0	-0.787298984441232	0.126	0.585	0	IRS2	Malignant cells	GSE139386	ENSG00000185950	8660	insulin receptor substrate 2	NA	protein_coding	Q9Y4H2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6390
0	-1.00329805839591	0.094	0.665	0	COL4A2	Malignant cells	GSE139386	ENSG00000134871	1284	collagen type IV alpha 2 chain	DKFZp686I14213|FLJ22259	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6391
0	-0.774242744192062	0.203	0.667	0	CARS2	Malignant cells	GSE139386	ENSG00000134905	79587	cysteinyl-tRNA synthetase 2, mitochondrial	FLJ12118	protein_coding	Q9HA77	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6392
0	-0.763445199325431	0.238	0.673	0	ANKRD10	Malignant cells	GSE139386	ENSG00000088448	55608	ankyrin repeat domain 10	FLJ20093	protein_coding	Q9NXR5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6393
0	-1.98188237740966	0.42	0.985	0	TFDP1	Malignant cells	GSE139386	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6394
0	-2.20286630019548	0.042	0.909	0	GAS6	Malignant cells	GSE139386	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6395
0	0.933517159919168	0.894	0.593	0	CCNB1IP1	Malignant cells	GSE139386	ENSG00000100814	57820	cyclin B1 interacting protein 1	C14orf18|HEI10	protein_coding	Q9NPC3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6396
0	-0.747959143194858	0.204	0.642	0	ABHD4	Malignant cells	GSE139386	ENSG00000100439	63874	abhydrolase domain containing 4, N-acyl phospholipase B	FLJ12816	protein_coding	Q8TB40	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6397
0	-0.555616911044391	0.998	1	0	MRPL52	Malignant cells	GSE139386	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6398
0	-1.11648078414832	0.455	0.9	0	AJUBA	Malignant cells	GSE139386	ENSG00000129474	84962	ajuba LIM protein	JUB|MGC15563	protein_coding	Q96IF1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6399
0	0.870932560653321	0.553	0.059	0	PCK2	Malignant cells	GSE139386	ENSG00000285241	5106	phosphoenolpyruvate carboxykinase 2, mitochondrial	PEPCK|PEPCK2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6400
0	-1.18358141938657	1	1	0	NEDD8	Malignant cells	GSE139386	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6401
0	-2.05317826536591	0.088	0.888	0	STXBP6	Malignant cells	GSE139386	ENSG00000168952	29091	syntaxin binding protein 6	amisyn|HSPC156	protein_coding	Q8NFX7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6402
0	1.07358462301199	0.995	0.908	0	EAPP	Malignant cells	GSE139386	ENSG00000129518	55837	E2F associated phosphoprotein	BM036|C14orf11|FLJ20578	protein_coding	Q56P03	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6403
0	1.03102684952578	1	0.986	0	SNX6	Malignant cells	GSE139386	ENSG00000129515	58533	sorting nexin 6	NA	protein_coding	Q9UNH7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6404
0	-1.05039529909977	0.765	0.975	0	CFL2	Malignant cells	GSE139386	ENSG00000165410	1073	cofilin 2	NEM7	protein_coding	Q9Y281	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6405
0	1.17874401660345	0.947	0.642	0	SRP54	Malignant cells	GSE139386	ENSG00000100883	6729	signal recognition particle 54	NA	protein_coding	P61011	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6406
0	0.556305618431441	1	1	0	FAM177A1	Malignant cells	GSE139386	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6407
0	0.635799134389258	1	1	0	RPS29	Malignant cells	GSE139386	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6408
0	-0.722920833604336	0.161	0.602	0	LRR1	Malignant cells	GSE139386	ENSG00000165501	122769	leucine rich repeat protein 1	LRR-1|MGC20689|PPIL5	protein_coding	Q96L50	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6409
0	-0.561989899051433	0.03	0.366	0	FRMD6	Malignant cells	GSE139386	ENSG00000139926	122786	FERM domain containing 6	C14orf31|EX1|MGC17921|willin	protein_coding	Q96NE9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6410
0	-1.79411401419453	0.205	0.894	0	CDKN3	Malignant cells	GSE139386	ENSG00000100526	1033	cyclin dependent kinase inhibitor 3	CDI1|KAP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6411
0	0.844351066422136	0.999	0.983	0	LGALS3	Malignant cells	GSE139386	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6412
0	-0.935876573680351	0.912	0.99	0	KTN1	Malignant cells	GSE139386	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6413
0	-0.867951245533729	0.005	0.456	0	RP11-47I22.3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6414
0	-0.745820695620507	0.01	0.437	0	GPX2	Malignant cells	GSE139386	ENSG00000176153	2877	glutathione peroxidase 2	GSHPX-GI	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6415
0	-0.818559367600122	0.821	0.983	0	VTI1B	Malignant cells	GSE139386	ENSG00000100568	10490	vesicle transport through interaction with t-SNAREs 1B	VTI2	protein_coding	Q9UEU0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6416
0	-0.976082293811159	0.974	1	0	ERH	Malignant cells	GSE139386	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6417
0	-1.00728088170657	0.862	0.996	0	COX16	Malignant cells	GSE139386	ENSG00000133983	51241	cytochrome c oxidase assembly factor COX16	C14orf112|HSPC203	protein_coding	Q9P0S2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6418
0	1.02671299562252	0.961	0.747	0	TMED10	Malignant cells	GSE139386	ENSG00000170348	10972	transmembrane p24 trafficking protein 10	p23|P24(DELTA)|p24d1|p24delta1|TMP21	protein_coding	P49755	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6419
0	-1.83742551789349	0.088	0.912	0	BATF	Malignant cells	GSE139386	ENSG00000156127	10538	basic leucine zipper ATF-like transcription factor	B-ATF|BATF1|SFA-2	protein_coding	Q16520	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6420
0	-0.674831719054175	0.995	1	0	SLIRP	Malignant cells	GSE139386	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6421
0	1.70785740613818	0.891	0.31	0	WARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6422
0	-1.29520716364613	0.995	1	0	HSP90AA1	Malignant cells	GSE139386	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6423
0	1.58336091190572	0.969	0.685	0	TNFAIP2	Malignant cells	GSE139386	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6424
0	-1.20911762426431	0.99	1	0	SIVA1	Malignant cells	GSE139386	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6425
0	-0.638995771587398	0.007	0.423	0	GREM1	Malignant cells	GSE139386	ENSG00000276886	26585	gremlin 1, DAN family BMP antagonist	CKTSF1B1|CRAC1|DAND2|DRM|gremlin|HMPS	protein_coding	O60565	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6426
0	-0.628211822788318	0.007	0.402	0	THBS1	Malignant cells	GSE139386	ENSG00000137801	7057	thrombospondin 1	THBS|THBS-1|TSP|TSP-1|TSP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6427
0	-1.02096775005198	0.4	0.863	0	EIF2AK4	Malignant cells	GSE139386	ENSG00000128829	440275	eukaryotic translation initiation factor 2 alpha kinase 4	GCN2|KIAA1338	protein_coding	Q9P2K8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6428
0	-0.775273195208114	1	1	0	SRP14	Malignant cells	GSE139386	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6429
0	2.22892254288074	0.939	0.109	0	GCHFR	Malignant cells	GSE139386	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6430
0	1.3997287601258	0.953	0.657	0	PDIA3	Malignant cells	GSE139386	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6431
0	-0.52200432852923	1	1	0	SERF2	Malignant cells	GSE139386	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6432
0	-1.83609287258165	0.506	0.939	0	C15orf48	Malignant cells	GSE139386	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6433
0	-0.928737153482393	0.72	0.956	0	DUT	Malignant cells	GSE139386	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6434
0	1.58768694472887	0.998	0.838	0	RSL24D1	Malignant cells	GSE139386	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6435
0	2.03684618043082	0.889	0.098	0	CCPG1	Malignant cells	GSE139386	ENSG00000260916	9236	cell cycle progression 1	CPR8|KIAA1254	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6436
0	0.842563189498588	0.485	0.012	0	GCNT3	Malignant cells	GSE139386	ENSG00000140297	9245	glucosaminyl (N-acetyl) transferase 3, mucin type	C2/4GnT|C2GnT-M|C2GnT2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6437
0	-1.60437245608739	0.437	0.937	0	TPM1	Malignant cells	GSE139386	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6438
0	1.42837752027077	0.998	0.91	0	PPIB	Malignant cells	GSE139386	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6439
0	-1.82402565678699	0.329	0.962	0	KIAA0101	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6440
0	1.10420431499051	1	1	0	RPL4	Malignant cells	GSE139386	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6441
0	-0.805810617136022	1	1	0	RPLP1	Malignant cells	GSE139386	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6442
0	1.30652636247091	0.891	0.408	0	LARP6	Malignant cells	GSE139386	ENSG00000166173	55323	La ribonucleoprotein 6, translational regulator	acheron|FLJ11196	protein_coding	Q9BRS8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6443
0	-0.950685178653	0.995	1	0	PKM	Malignant cells	GSE139386	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6444
0	0.79470147462084	0.523	0.053	0	STRA6	Malignant cells	GSE139386	ENSG00000288257	64220	signaling receptor and transporter of retinol STRA6	FLJ12541	protein_coding	Q9BX79	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6445
0	1.01773689611549	0.824	0.462	0	TSPAN3	Malignant cells	GSE139386	ENSG00000140391	10099	tetraspanin 3	TM4-A|TM4SF8|TSPAN-3	protein_coding	O60637	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6446
0	1.56611483665702	0.814	0.09	0	ISG20	Malignant cells	GSE139386	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6447
0	1.79206436502033	0.997	0.819	0	CIB1	Malignant cells	GSE139386	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6448
0	0.990367805242247	0.898	0.616	0	VIMP	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6449
0	-1.15270225094949	0.589	0.944	0	POLR3K	Malignant cells	GSE139386	ENSG00000161980	51728	RNA polymerase III subunit K	C11|RPC11	protein_coding	Q9Y2Y1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6450
0	-1.52207136612616	0.68	0.99	0	SNRNP25	Malignant cells	GSE139386	ENSG00000161981	79622	small nuclear ribonucleoprotein U11/U12 subunit 25	C16orf33|U11/U12-25K	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6451
0	-1.74936912338279	0.834	0.998	0	NME4	Malignant cells	GSE139386	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6452
0	-0.914574743512433	0.699	0.955	0	FAM195A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6453
0	-1.5514246205902	0.655	0.981	0	METRN	Malignant cells	GSE139386	ENSG00000103260	79006	meteorin, glial cell differentiation regulator	C16orf23|MGC2601	protein_coding	Q9UJH8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6454
0	-0.796437775902698	0.199	0.665	0	RPUSD1	Malignant cells	GSE139386	ENSG00000007376	113000	RNA pseudouridine synthase domain containing 1	C16orf40|MGC19600|RLUCL	protein_coding	Q9UJJ7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6455
0	-0.684803547642598	0.986	1	0	UBE2I	Malignant cells	GSE139386	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6456
0	-0.81009709615308	0.839	0.977	0	TSR3	Malignant cells	GSE139386	ENSG00000007520	115939	TSR3 ribosome maturation factor	C16orf42|MGC24381	protein_coding	Q9UJK0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6457
0	-1.05526086455315	0.667	0.955	0	HN1L	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6458
0	-1.25289937214896	0.384	0.895	0	MSRB1	Malignant cells	GSE139386	ENSG00000198736	51734	methionine sulfoxide reductase B1	SELENOR|SELENOX|SelR|SelX|SepR|SEPX1	protein_coding	Q9NZV6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6459
0	-0.429243544648704	1	1	0	RPS2	Malignant cells	GSE139386	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6460
0	1.49976150739271	0.958	0.506	0	NPW	Malignant cells	GSE139386	ENSG00000183971	283869	neuropeptide W	PPL8	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6461
0	1.46108903048286	0.991	0.83	0	NTHL1	Malignant cells	GSE139386	ENSG00000065057	4913	nth like DNA glycosylase 1	NTH1|OCTS3	protein_coding	P78549	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6462
0	-1.51930527517188	0.668	0.986	0	PGP	Malignant cells	GSE139386	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6463
0	1.10539853937641	0.974	0.794	0	ECI1	Malignant cells	GSE139386	ENSG00000167969	1632	enoyl-CoA delta isomerase 1	DCI	protein_coding	P42126	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6464
0	-0.759628812070075	0.868	0.988	0	RNPS1	Malignant cells	GSE139386	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6465
0	-1.13907536339344	0.018	0.692	0	PRSS21	Malignant cells	GSE139386	ENSG00000282838	10942	serine protease 21	ESP-1|TEST1	protein_coding	Q9Y6M0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6466
0	1.14634227894171	0.596	0.016	0	ZG16B	Malignant cells	GSE139386	ENSG00000283056	124220	zymogen granule protein 16B	HRPE773|JCLN2|PRO1567	protein_coding	Q96DA0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6467
0	-1.18275925546773	0.606	0.947	0	HCFC1R1	Malignant cells	GSE139386	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6468
0	-1.9318251912772	0.504	0.987	0	IL32	Malignant cells	GSE139386	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6469
0	-1.33644395579597	0.901	0.999	0	CARHSP1	Malignant cells	GSE139386	ENSG00000153048	23589	calcium regulated heat stable protein 1	CRHSP-24|CSDC1	protein_coding	Q9Y2V2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6470
0	-1.52833562380957	0.76	0.989	0	EMP2	Malignant cells	GSE139386	ENSG00000213853	2013	epithelial membrane protein 2	XMP	protein_coding	P54851	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6471
0	-1.0727996244928	0.501	0.92	0	NTAN1	Malignant cells	GSE139386	ENSG00000275779	123803	N-terminal asparagine amidase	NA	protein_coding	Q96AB6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6472
0	-0.709304123044345	0.122	0.577	0	ABCC1	Malignant cells	GSE139386	ENSG00000278183	4363	ATP binding cassette subfamily C member 1	GS-X|MRP|MRP1	protein_coding	P33527	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6473
0	0.692706820883652	1	1	0	RPS15A	Malignant cells	GSE139386	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6474
0	2.10662434311442	0.887	0.234	0	TMC5	Malignant cells	GSE139386	ENSG00000103534	79838	transmembrane channel like 5	FLJ13593	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6475
0	-0.770718830527284	0.767	0.973	0	METTL9	Malignant cells	GSE139386	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6476
0	-1.12637974252147	0.474	0.899	0	DCTPP1	Malignant cells	GSE139386	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6477
0	-1.10589130691167	0.59	0.949	0	SRCAP	Malignant cells	GSE139386	ENSG00000080603	10847	Snf2 related CREBBP activator protein	DOMO1|KIAA0309|SWR1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6478
0	-1.47456203008691	0.587	0.984	0	BCL7C	Malignant cells	GSE139386	ENSG00000099385	9274	BAF chromatin remodeling complex subunit BCL7C	SMARCJ3	protein_coding	Q8WUZ0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6479
0	-0.618004170494969	0.002	0.34	0	CES1	Malignant cells	GSE139386	ENSG00000262243	1066	carboxylesterase 1	CEH|CES1A1|CES1A2|CES2|HMSE|HMSE1|SES1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6480
0	2.06146876290177	0.922	0.139	0	HERPUD1	Malignant cells	GSE139386	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6481
0	-0.842664864892168	0.661	0.939	0	NUTF2	Malignant cells	GSE139386	ENSG00000102898	10204	nuclear transport factor 2	NTF2|PP15	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6482
0	-0.756560363457948	0.299	0.727	0	CMC2	Malignant cells	GSE139386	ENSG00000103121	56942	C-X9-C motif containing 2	C16orf61|DC13|MGC45036	protein_coding	Q9NRP2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6483
0	-0.832743360603606	0.246	0.743	0	CENPN	Malignant cells	GSE139386	ENSG00000166451	55839	centromere protein N	BM039|C16orf60|FLJ13607|FLJ22660	protein_coding	Q96H22	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6484
0	-1.15535356720606	0.49	0.918	0	GCSH	Malignant cells	GSE139386	ENSG00000140905	2653	glycine cleavage system protein H	NA	protein_coding	P23434	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6485
0	-1.25262164892565	0.318	0.88	0	COTL1	Malignant cells	GSE139386	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6486
0	-0.764129312031769	0.158	0.615	0	GINS2	Malignant cells	GSE139386	ENSG00000131153	51659	GINS complex subunit 2	Pfs2|PSF2	protein_coding	Q9Y248	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6487
0	-1.36027812888027	0.236	0.866	0	C16orf74	Malignant cells	GSE139386	ENSG00000154102	404550	chromosome 16 open reading frame 74	MGC17624	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6488
0	2.23885245009638	0.998	0.61	0	CYBA	Malignant cells	GSE139386	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6489
0	0.829090041700804	1	1	0	RPL13	Malignant cells	GSE139386	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6490
0	-0.995399081830361	0.535	0.917	0	DEF8	Malignant cells	GSE139386	ENSG00000140995	54849	differentially expressed in FDCP 8 homolog	FLJ20186	protein_coding	Q6ZN54	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6491
0	-0.78699641343915	0.034	0.533	0	NXN	Malignant cells	GSE139386	ENSG00000281300	64359	nucleoredoxin	FLJ12614|NRX	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6492
0	-1.57726287892146	0.5	0.977	0	ITGAE	Malignant cells	GSE139386	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6493
0	-1.01352178196872	1	1	0	PFN1	Malignant cells	GSE139386	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6494
0	-1.10103778087511	0.921	0.994	0	TXNDC17	Malignant cells	GSE139386	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6495
0	-0.915046383547079	0.817	0.978	0	CTDNEP1	Malignant cells	GSE139386	ENSG00000288307	23399	CTD nuclear envelope phosphatase 1	DULLARD|HSA011916|NET56	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6496
0	-1.33266389652174	0.642	0.975	0	EIF5A	Malignant cells	GSE139386	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6497
0	-0.821817037975057	0.867	0.981	0	TMEM256	Malignant cells	GSE139386	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6498
0	-0.907644744520136	0.941	0.997	0	TRAPPC1	Malignant cells	GSE139386	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6499
0	-0.891243678511255	0.13	0.618	0	AURKB	Malignant cells	GSE139386	ENSG00000178999	9212	aurora kinase B	Aik2|AIM-1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5	protein_coding	Q96GD4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6500
0	-0.989168147075812	0.393	0.856	0	TRIM16	Malignant cells	GSE139386	ENSG00000221926	10626	tripartite motif containing 16	EBBP	protein_coding	O95361	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6501
0	-1.50053344415358	0.191	0.871	0	TRIM16L	Malignant cells	GSE139386	ENSG00000108448	NA	NA	TRIM70	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6502
0	-1.50836424842152	0.085	0.787	0	ALDH3A1	Malignant cells	GSE139386	ENSG00000108602	218	aldehyde dehydrogenase 3 family member A1	ALDH3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6503
0	0.964316120843708	0.669	0.195	0	CPD	Malignant cells	GSE139386	ENSG00000108582	1362	carboxypeptidase D	GP180	protein_coding	O75976	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6504
0	1.05412121328988	0.659	0.088	0	SLFN5	Malignant cells	GSE139386	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6505
0	-0.680911636421475	0.157	0.571	0	DUSP14	Malignant cells	GSE139386	ENSG00000275932	11072	dual specificity phosphatase 14	MKP-L|MKP6	protein_coding	O95147	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6506
0	0.408582138190625	1	1	0	RPL19	Malignant cells	GSE139386	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6507
0	-0.983487424474954	0.947	0.998	0	KRT10	Malignant cells	GSE139386	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6508
0	0.894002565959363	0.999	0.996	0	KRT19	Malignant cells	GSE139386	ENSG00000171345	3880	keratin 19	CK19|K19|K1CS|MGC15366	protein_coding	P08727	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6509
0	1.06200377815931	1	1	0	EIF1	Malignant cells	GSE139386	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6510
0	-0.779901766264786	0.038	0.517	0	PTRF	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6511
0	-1.09222352512934	0.93	0.999	0	SLC25A39	Malignant cells	GSE139386	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6512
0	-0.511360893898389	0.011	0.354	0	GJC1	Malignant cells	GSE139386	ENSG00000182963	10052	gap junction protein gamma 1	CX45|GJA7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6513
0	1.12061697682323	0.77	0.259	0	NFE2L1	Malignant cells	GSE139386	ENSG00000082641	4779	NFE2 like bZIP transcription factor 1	FLJ00380|LCR-F1|NRF-1|NRF1|TCF11	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6514
0	-1.778312714918	0.937	1	0	ATP5G1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6515
0	-0.667948329445275	0.978	0.998	0	SNF8	Malignant cells	GSE139386	ENSG00000159210	11267	SNF8 subunit of ESCRT-II	Dot3|EAP30|VPS22	protein_coding	Q96H20	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6516
0	-0.888217312857604	0.759	0.971	0	MRPL27	Malignant cells	GSE139386	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6517
0	-1.48760360288439	0.975	1	0	NME1	Malignant cells	GSE139386	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6518
0	-0.980207681957421	0.524	0.92	0	SKA2	Malignant cells	GSE139386	ENSG00000182628	348235	spindle and kinetochore associated complex subunit 2	FAM33A|FLJ12758	protein_coding	Q8WVK7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6519
0	1.28070098437388	0.731	0.057	0	ERN1	Malignant cells	GSE139386	ENSG00000178607	2081	endoplasmic reticulum to nucleus signaling 1	IRE1|IRE1P	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6520
0	-0.848468410082686	0.151	0.641	0	RP11-160O5.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6521
0	0.574920308638868	1	1	0	RPL38	Malignant cells	GSE139386	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6522
0	-0.950855349857915	0.993	1	0	HN1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6523
0	-0.560295346200041	1	1	0	SUMO2	Malignant cells	GSE139386	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6524
0	-0.89927198270027	0.289	0.766	0	UNK	Malignant cells	GSE139386	ENSG00000132478	85451	unk zinc finger	KIAA1753|ZC3H5|ZC3HDC5	protein_coding	Q9C0B0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6525
0	-0.755663001280968	0.454	0.836	0	TEN1	Malignant cells	GSE139386	ENSG00000257949	100134934	TEN1 subunit of CST complex	C17orf106|FLJ39785	protein_coding	Q86WV5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6526
0	-0.823136270006997	0.93	0.993	0	SRSF2	Malignant cells	GSE139386	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6527
0	-1.40931377672196	0.29	0.941	0	TK1	Malignant cells	GSE139386	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6528
0	-1.46426491413178	0.285	0.95	0	BIRC5	Malignant cells	GSE139386	ENSG00000089685	332	baculoviral IAP repeat containing 5	API4|EPR-1|survivin	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6529
0	1.20994962962232	0.883	0.473	0	LGALS3BP	Malignant cells	GSE139386	ENSG00000108679	3959	galectin 3 binding protein	90K|BTBD17B|CyCAP|gp90|M2BP|MAC-2-BP|TANGO10B	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6530
0	-1.53419479455842	0.886	1	0	C17orf89	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6531
0	0.865973256531368	1	1	0	ACTG1	Malignant cells	GSE139386	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6532
0	-0.784863995985729	0.936	0.995	0	MRPL12	Malignant cells	GSE139386	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6533
0	-0.761438536142023	0.104	0.595	0	SLC25A10.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6534
0	1.36042902295867	0.999	0.925	0	P4HB	Malignant cells	GSE139386	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6535
0	-0.994545938763185	0.447	0.867	0	ALYREF	Malignant cells	GSE139386	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6536
0	-0.641063686449231	0.999	1	0	ANAPC11	Malignant cells	GSE139386	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6537
0	1.02225029495755	0.861	0.469	0	PYCR1	Malignant cells	GSE139386	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6538
0	-2.16436976377071	0.828	0.998	0	STRA13	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6539
0	-0.794202126276275	0.62	0.912	0	RAC3	Malignant cells	GSE139386	ENSG00000169750	5881	Rac family small GTPase 3	NA	protein_coding	P60763	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6540
0	-1.01851402657634	0.717	0.97	0	DUS1L	Malignant cells	GSE139386	ENSG00000169718	64118	dihydrouridine synthase 1 like	DUS1|PP3111	protein_coding	Q6P1R4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6541
0	1.54657693574204	0.987	0.721	0	SLC16A3	Malignant cells	GSE139386	ENSG00000141526	9123	solute carrier family 16 member 3	MCT3|MCT4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6542
0	-1.30722326832822	0.21	0.849	0	TYMS	Malignant cells	GSE139386	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6543
0	-0.949490403398467	0.772	0.975	0	RALBP1	Malignant cells	GSE139386	ENSG00000017797	10928	ralA binding protein 1	RIP|RIP1|RLIP76	protein_coding	Q15311	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6544
0	-1.75284660460401	0.435	0.965	0	IMPA2	Malignant cells	GSE139386	ENSG00000141401	3613	inositol monophosphatase 2	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6545
0	-0.85924555041066	0.129	0.635	0	TUBB6	Malignant cells	GSE139386	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6546
0	-1.01516467574551	0.982	0.999	0	SNRPD1	Malignant cells	GSE139386	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6547
0	-0.705295427624266	0.016	0.457	0	CDH2	Malignant cells	GSE139386	ENSG00000170558	1000	cadherin 2	CD325|CDHN|NCAD	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6548
0	-0.810454905396124	0.67	0.944	0	TPGS2	Malignant cells	GSE139386	ENSG00000134779	25941	tubulin polyglutamylase complex subunit 2	C18orf10|DKFZP586M1523|HsT3006|PGs2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6549
0	0.899353065349739	0.815	0.426	0	LMAN1	Malignant cells	GSE139386	ENSG00000074695	3998	lectin, mannose binding 1	ERGIC-53|ERGIC53|F5F8D|FMFD1|gp58|MCFD1|MR60	protein_coding	P49257	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6550
0	-0.733590929563111	0.002	0.469	0	CCBE1	Malignant cells	GSE139386	ENSG00000183287	147372	collagen and calcium binding EGF domains 1	FLJ30681|KIAA1983	protein_coding	Q6UXH8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6551
0	1.92393584697767	0.977	0.41	0	TRIB3	Malignant cells	GSE139386	ENSG00000101255	57761	tribbles pseudokinase 3	C20orf97|dJ1103G7.3|TRB3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6552
0	2.19446996365782	0.998	0.741	0	RBCK1	Malignant cells	GSE139386	ENSG00000125826	10616	RANBP2-type and C3HC4-type zinc finger containing 1	C20orf18|HOIL1|RBCK2|RNF54|UBCE7IP3|XAP4|ZRANB4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6553
0	0.87177402331876	0.78	0.393	0	CSNK2A1	Malignant cells	GSE139386	ENSG00000101266	1457	casein kinase 2 alpha 1	Cka1|Cka2	protein_coding	P68400	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6554
0	0.943953986564404	0.778	0.319	0	DDRGK1	Malignant cells	GSE139386	ENSG00000198171	65992	DDRGK domain containing 1	C20orf116|dJ1187M17.3|UFBP1	protein_coding	Q96HY6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6555
0	1.24181064354737	0.716	0.062	0	GPCPD1	Malignant cells	GSE139386	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6556
0	-0.831783769444591	0.963	0.998	0	MKKS	Malignant cells	GSE139386	ENSG00000125863	8195	MKKS centrosomal shuttling protein	BBS6|HMCS|KMS|MKS	protein_coding	Q9NPJ1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6557
0	1.36826805997584	0.984	0.708	0	LINC00493	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6558
0	0.923556612913403	0.984	0.885	0	CST3	Malignant cells	GSE139386	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6559
0	0.978270015969867	0.677	0.154	0	PYGB	Malignant cells	GSE139386	ENSG00000100994	5834	glycogen phosphorylase B	NA	protein_coding	P11216	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6560
0	1.04310610253455	0.863	0.497	0	HM13	Malignant cells	GSE139386	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6561
0	-0.843105079037997	0.153	0.599	0	TPX2	Malignant cells	GSE139386	ENSG00000088325	22974	TPX2 microtubule nucleation factor	C20orf1|C20orf2|DIL-2|FLS353|HCA519|p100	protein_coding	Q9ULW0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6562
0	2.47029707133619	0.793	0.036	0	BPIFA2	Malignant cells	GSE139386	ENSG00000131050	140683	BPI fold containing family A member 2	bA49G10.1|C20orf70|PSP|SPLUNC2	protein_coding	Q96DR5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6563
0	3.34408455479064	0.655	0.023	0	BPIFB1	Malignant cells	GSE139386	ENSG00000125999	92747	BPI fold containing family B member 1	bA49G10.6|C20orf114|dJ1187J4.1|LPLUNC1|MGC14597|VEMSGP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6564
0	-0.772162403358664	0.111	0.562	0	E2F1	Malignant cells	GSE139386	ENSG00000101412	1869	E2F transcription factor 1	RBBP3|RBP3	protein_coding	Q01094	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6565
0	1.29816337532595	0.999	0.971	0	EIF2S2	Malignant cells	GSE139386	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6566
0	1.04873118930374	0.99	0.897	0	ERGIC3	Malignant cells	GSE139386	ENSG00000125991	51614	ERGIC and golgi 3	C20orf47|CGI-54|Erv46|NY-BR-84|PRO0989|SDBCAG84	protein_coding	Q9Y282	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6567
0	-1.46951531968173	0.635	0.979	0	C20orf24	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6568
0	1.70612786293374	0.97	0.602	0	TOP1	Malignant cells	GSE139386	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6569
0	-1.39109033290542	0.145	0.85	0	MYBL2	Malignant cells	GSE139386	ENSG00000101057	4605	MYB proto-oncogene like 2	B-MYB|BMYB	protein_coding	P10244	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6570
0	1.91616735573594	0.921	0.56	0	SLPI	Malignant cells	GSE139386	ENSG00000124107	6590	secretory leukocyte peptidase inhibitor	ALK1|ALP|BLPI|HUSI|HUSI-I|WAP4|WFDC4	protein_coding	P03973	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6571
0	2.11763178244775	0.963	0.453	0	WFDC2	Malignant cells	GSE139386	ENSG00000101443	10406	WAP four-disulfide core domain 2	dJ461P17.6|EDDM4|HE4|WAP5	protein_coding	Q14508	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6572
0	-1.54905836982775	0.207	0.826	0	UBE2C	Malignant cells	GSE139386	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6573
0	2.4130917413374	1	0.994	0	ZFAS1	Malignant cells	GSE139386	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6574
0	-0.729078473767855	0.252	0.694	0	TMEM189	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6575
0	-1.04343408162954	0.129	0.544	0	AURKA	Malignant cells	GSE139386	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6576
0	-0.837530856313088	1	1	0	ATP5E	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6577
0	-0.619948280605352	1	1	0	PSMA7	Malignant cells	GSE139386	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6578
0	-0.73319607662147	1	1	0	RPS21	Malignant cells	GSE139386	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6579
0	1.17995645851802	0.66	0.026	0	SLCO4A1	Malignant cells	GSE139386	ENSG00000101187	28231	solute carrier organic anion transporter family member 4A1	OATP-E|OATP4A1|SLC21A12	protein_coding	Q96BD0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6580
0	-1.05933761141786	0.558	0.934	0	MRGBP	Malignant cells	GSE139386	ENSG00000101189	55257	MRG domain binding protein	C20orf20|Eaf7|FLJ10914|MRG15BP	protein_coding	Q9NV56	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6581
0	-1.16791898984078	0.58	0.949	0	SLC2A4RG	Malignant cells	GSE139386	ENSG00000125520	56731	SLC2A4 regulator	GEF|HDBP1|Si-1-2|Si-1-2-19	protein_coding	Q9NR83	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6582
0	0.851884843093607	0.977	0.893	0	BSG	Malignant cells	GSE139386	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6583
0	-0.909012660727209	0.347	0.773	0	ABCA7	Malignant cells	GSE139386	ENSG00000064687	10347	ATP binding cassette subfamily A member 7	ABCX	protein_coding	Q8IZY2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6584
0	-0.48202037319856	1	1	0	GPX4	Malignant cells	GSE139386	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6585
0	0.711837871068281	1	0.992	0	ATP5D	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6586
0	1.68743069148279	0.998	0.828	0	CIRBP	Malignant cells	GSE139386	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6587
0	1.00478567733302	1	1	0	RPS15	Malignant cells	GSE139386	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6588
0	-0.82470711880354	1	1	0	OAZ1	Malignant cells	GSE139386	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6589
0	2.18038852979572	1	0.981	0	EEF2	Malignant cells	GSE139386	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6590
0	1.30450488174979	0.998	0.927	0	C19orf10	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6591
0	1.25079783177629	1	1	0	RPL36	Malignant cells	GSE139386	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6592
0	0.965394056686394	0.905	0.595	0	ALKBH7	Malignant cells	GSE139386	ENSG00000125652	84266	alkB homolog 7	MGC10974|SPATA11	protein_coding	Q9BT30	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6593
0	0.658534185438752	1	1	0	RPS28	Malignant cells	GSE139386	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6594
0	-0.711460505865525	0.989	1	0	UBL5	Malignant cells	GSE139386	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6595
0	0.973589294195553	0.978	0.851	0	EIF3G	Malignant cells	GSE139386	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6596
0	1.24663460025772	0.991	0.953	0	CALR	Malignant cells	GSE139386	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6597
0	0.98995540221055	0.857	0.46	0	BRD4	Malignant cells	GSE139386	ENSG00000141867	23476	bromodomain containing 4	CAP|HUNK1|HUNKI|MCAP	protein_coding	O60885	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6598
0	-0.45909884539256	0.003	0.308	0	CYP4F3	Malignant cells	GSE139386	ENSG00000186529	4051	cytochrome P450 family 4 subfamily F member 3	CYP4F|LTB4H	protein_coding	Q08477	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6599
0	1.26141866052771	0.977	0.738	0	PGLS	Malignant cells	GSE139386	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6600
0	1.06734108984028	1	1	0	RPL18A	Malignant cells	GSE139386	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6601
0	-1.11437657647587	0.925	0.998	0	LSM4	Malignant cells	GSE139386	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6602
0	3.88248884801575	0.981	0.103	0	GDF15	Malignant cells	GSE139386	ENSG00000130513	9518	growth differentiation factor 15	MIC-1|MIC1|NAG-1|PDF|PLAB|PTGFB	protein_coding	Q99988	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6603
0	0.541809526816209	1	1	0	UBA52	Malignant cells	GSE139386	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6604
0	0.9191323274243	0.973	0.831	0	COPE	Malignant cells	GSE139386	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6605
0	-0.866279033848226	0.494	0.874	0	RPSAP58	Malignant cells	GSE139386	ENSG00000288920	388524	ribosomal protein SA pseudogene 58	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6606
0	-1.43732708397308	0.95	0.999	0	PDCD5	Malignant cells	GSE139386	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6607
0	1.2755322532809	0.788	0.267	0	FXYD3	Malignant cells	GSE139386	ENSG00000089356	5349	FXYD domain containing ion transport regulator 3	MAT-8|PLML	protein_coding	Q14802	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6608
0	-0.900540247880407	0.328	0.799	0	USF2	Malignant cells	GSE139386	ENSG00000105698	7392	upstream transcription factor 2, c-fos interacting	bHLHb12|FIP	protein_coding	Q15853	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6609
0	-0.975277128155252	0.975	0.999	0	POLR2I	Malignant cells	GSE139386	ENSG00000105258	5438	RNA polymerase II subunit I	hRPB14.5|RPB9	protein_coding	P36954	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6610
0	-1.01249573545166	0.465	0.895	0	LINC00665	Malignant cells	GSE139386	ENSG00000232677	100506930	long intergenic non-protein coding RNA 665	CIP2A-BP	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6611
0	-1.7464256830158	0.797	1	0	C19orf33	Malignant cells	GSE139386	ENSG00000167644	64073	chromosome 19 open reading frame 33	H2RSP|IMUP|IMUP-1|IMUP-2	protein_coding	Q9GZP8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6612
0	-1.25931439442726	0.798	0.991	0	ACTN4	Malignant cells	GSE139386	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6613
0	0.936206479510922	0.619	0.128	0	CAPN12	Malignant cells	GSE139386	ENSG00000182472	147968	calpain 12	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6614
0	-1.13316506753866	0.891	0.996	0	MRPS12	Malignant cells	GSE139386	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6615
0	-1.88890562251776	0.006	0.771	0	AXL	Malignant cells	GSE139386	ENSG00000167601	558	AXL receptor tyrosine kinase	ARK|JTK11|Tyro7|UFO	protein_coding	P30530	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6616
0	-0.746480115275087	0.237	0.689	0	ZNF576	Malignant cells	GSE139386	ENSG00000124444	79177	zinc finger protein 576	MGC2508	protein_coding	Q9H609	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6617
0	-1.12366909899417	0.717	0.966	0	TOMM40	Malignant cells	GSE139386	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6618
0	-0.833767744352454	0.29	0.758	0	GEMIN7	Malignant cells	GSE139386	ENSG00000142252	79760	gem nuclear organelle associated protein 7	FLJ13956	protein_coding	Q9H840	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6619
0	-0.74446513530867	0.177	0.61	0	CD3EAP	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6620
0	-0.713446738050977	0.002	0.42	0	AC006262.5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6621
0	-0.723487977499443	0.038	0.453	0	IGFL1	Malignant cells	GSE139386	ENSG00000188293	374918	IGF like family member 1	UNQ644	protein_coding	Q6UW32	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6622
0	-1.25121969118918	0.811	0.996	0	CALM3	Malignant cells	GSE139386	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6623
0	-1.05553294154019	0.987	1	0	AP2S1	Malignant cells	GSE139386	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6624
0	-0.892343062348369	0.907	0.999	0	TMEM160	Malignant cells	GSE139386	ENSG00000130748	54958	transmembrane protein 160	FLJ20512	protein_coding	Q9NX00	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6625
0	0.80351455910436	0.998	0.938	0	GLTSCR2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6626
0	-0.498318673991807	0.022	0.347	0	ZNF114	Malignant cells	GSE139386	ENSG00000178150	163071	zinc finger protein 114	MGC17986	protein_coding	Q8NC26	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6627
0	-1.33580487854727	0.153	0.758	0	EMP3	Malignant cells	GSE139386	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6628
0	-0.675741461821515	0.107	0.522	0	LMTK3	Malignant cells	GSE139386	ENSG00000142235	114783	lemur tyrosine kinase 3	KIAA1883|LMR3|PPP1R101|TYKLM3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6629
0	0.439143849480517	1	1	0	RPL18	Malignant cells	GSE139386	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6630
0	-1.44766939260084	0.764	0.996	0	BAX	Malignant cells	GSE139386	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6631
0	-2.91618049120291	1	1	0	FTL	Malignant cells	GSE139386	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6632
0	-0.881396802858513	0.515	0.874	0	SNRNP70	Malignant cells	GSE139386	ENSG00000104852	6625	small nuclear ribonucleoprotein U1 subunit 70	RNPU1Z|RPU1|Snp1|SNRP70|U1-70K	protein_coding	P08621	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6633
0	0.477533106061402	1	1	0	RPL13A	Malignant cells	GSE139386	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6634
0	-0.99180443627693	0.424	0.888	0	BCL2L12	Malignant cells	GSE139386	ENSG00000126453	83596	BCL2 like 12	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6635
0	-0.845219934900648	0.409	0.826	0	AKT1S1	Malignant cells	GSE139386	ENSG00000204673	84335	AKT1 substrate 1	Lobe|MGC2865|PRAS40	protein_coding	Q96B36	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6636
0	-0.773225316966276	0.241	0.71	0	NUP62	Malignant cells	GSE139386	ENSG00000213024	23636	nucleoporin 62	DKFZp547L134|FLJ20822|FLJ43869|IBSN|MGC841|p62|SNDI	protein_coding	P37198	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6637
0	-0.871832554093215	0.818	0.976	0	C19orf48	Malignant cells	GSE139386	ENSG00000167747	84798	multidrug resistance-related protein	BC006151|MGC13170	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6638
0	-0.748094526369336	0.915	0.994	0	NDUFA3	Malignant cells	GSE139386	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6639
0	0.706376541207218	1	1	0	RPS9	Malignant cells	GSE139386	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6640
0	-1.79269094068225	0.895	0.995	0	UBE2S	Malignant cells	GSE139386	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6641
0	-1.18775619443163	0.552	0.951	0	EPN1	Malignant cells	GSE139386	ENSG00000063245	29924	epsin 1	NA	protein_coding	Q9Y6I3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6642
0	0.476038819401619	1	1	0	RPS5	Malignant cells	GSE139386	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6643
0	-0.862010891788881	0.805	0.973	0	UBE2M	Malignant cells	GSE139386	ENSG00000130725	9040	ubiquitin conjugating enzyme E2 M	hUbc12|UBC12	protein_coding	P61081	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6644
0	-1.10067674181583	0.942	0.997	0	BID	Malignant cells	GSE139386	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6645
0	-0.818001125894947	0.527	0.861	0	SLC25A1	Malignant cells	GSE139386	ENSG00000100075	6576	solute carrier family 25 member 1	CTP|SLC20A3	protein_coding	P53007	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6646
0	-1.63225333968249	0.995	1	0	RANBP1	Malignant cells	GSE139386	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6647
0	-1.00928004291129	0.594	0.944	0	DGCR6L	Malignant cells	GSE139386	ENSG00000128185	85359	DiGeorge syndrome critical region gene 6 like	FLJ10666	protein_coding	Q9BY27	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6648
0	-1.3921037525458	0.891	0.999	0	UBE2L3	Malignant cells	GSE139386	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6649
0	-0.85143829895859	0.886	0.991	0	YDJC	Malignant cells	GSE139386	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6650
0	1.28866363991767	0.998	0.993	0	SDF2L1	Malignant cells	GSE139386	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6651
0	-0.589728617209148	0.997	1	0	MIF	Malignant cells	GSE139386	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6652
0	-0.970901688238131	0.75	0.964	0	SNRPD3	Malignant cells	GSE139386	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6653
0	-0.581296183523386	0	0.326	0	RP5-1172A22.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6654
0	1.14071763807046	0.906	0.493	0	XBP1	Malignant cells	GSE139386	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6655
0	-1.13424475378301	0.993	1	0	UQCR10	Malignant cells	GSE139386	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6656
0	-1.28125251995949	0.566	0.946	0	YWHAH	Malignant cells	GSE139386	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6657
0	-0.983404341305266	0.909	0.993	0	MYH9	Malignant cells	GSE139386	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6658
0	1.42402304989209	0.986	0.734	0	EIF3D	Malignant cells	GSE139386	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6659
0	1.08568815172851	0.97	0.772	0	MPST	Malignant cells	GSE139386	ENSG00000128309	4357	mercaptopyruvate sulfurtransferase	MST|TST2|TUM1	protein_coding	P25325	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6660
0	1.62676025817639	0.88	0.561	0	H1F0	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6661
0	1.06195179565758	1	0.953	0	EIF3L	Malignant cells	GSE139386	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6662
0	-0.899091661327335	0.961	0.999	0	POLR2F	Malignant cells	GSE139386	ENSG00000100142	5435	RNA polymerase II, I and III subunit F	HRBP14.4|RPB6	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6663
0	-1.0337373184056	0.854	0.993	0	TOMM22	Malignant cells	GSE139386	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6664
0	1.72725989814279	1	1	0	RPL3	Malignant cells	GSE139386	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6665
0	-1.0169198772018	0.924	0.997	0	RPS19BP1	Malignant cells	GSE139386	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6666
0	-1.46827100591835	0.81	0.999	0	RBX1	Malignant cells	GSE139386	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6667
0	-1.07297565133433	0.595	0.949	0	PHF5A	Malignant cells	GSE139386	ENSG00000100410	84844	PHD finger protein 5A	bK223H9.2|INI|MGC1346|Rds3|SAP14b|SF3b14b|SF3B7	protein_coding	Q7RTV0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6668
0	-0.924312206594974	0.258	0.769	0	POLR3H	Malignant cells	GSE139386	ENSG00000100413	171568	RNA polymerase III subunit H	C25|KIAA1665|RPC8	protein_coding	Q9Y535	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6669
0	-1.14135830599745	0.24	0.827	0	CENPM	Malignant cells	GSE139386	ENSG00000100162	79019	centromere protein M	C22orf18|CENP-M|MGC861|Pane1	protein_coding	Q9NSP4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6670
0	-0.68649088230302	0.941	0.995	0	SMDT1	Malignant cells	GSE139386	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6671
0	-1.20801977494486	0.192	0.8	0	CTA-217C2.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6672
0	-0.866894970609589	0.335	0.781	0	WNT7B	Malignant cells	GSE139386	ENSG00000188064	7477	Wnt family member 7B	NA	protein_coding	P56706	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6673
0	-1.01038894130008	0.08	0.597	0	GTSE1	Malignant cells	GSE139386	ENSG00000075218	51512	G2 and S-phase expressed 1	B99|GTSE-1|Lnc_bc060912	protein_coding	Q9NYZ3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6674
0	1.69835147892138	0.966	0.72	0	CRELD2	Malignant cells	GSE139386	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6675
0	1.47994836336491	0.905	0.333	0	APP	Malignant cells	GSE139386	ENSG00000142192	351	amyloid beta precursor protein	AD1|alpha-sAPP	protein_coding	P05067	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6676
0	0.883562893399486	0.852	0.523	0	CCT8	Malignant cells	GSE139386	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6677
0	-0.912292599207103	0.936	0.994	0	SOD1	Malignant cells	GSE139386	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6678
0	-1.46880865640231	0.999	1	0	HMGN1	Malignant cells	GSE139386	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6679
0	0.886139194575665	0.595	0.071	0	BACE2	Malignant cells	GSE139386	ENSG00000182240	25825	beta-secretase 2	AEPLC|ALP56|CEAP1|DRAP	protein_coding	Q9Y5Z0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6680
0	2.95016464819353	0.764	0.042	0	TFF3	Malignant cells	GSE139386	ENSG00000160180	7033	trefoil factor 3	HITF|ITF	protein_coding	Q07654	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6681
0	2.48171263866507	0.892	0.058	0	TFF1	Malignant cells	GSE139386	ENSG00000160182	7031	trefoil factor 1	BCEI|D21S21|HP1.A|HPS2|pNR-2|pS2	protein_coding	P04155	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6682
0	-1.83013382675008	0.715	0.997	0	SUMO3	Malignant cells	GSE139386	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6683
0	-1.3401334931696	0.002	0.74	0	LINC00162	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6684
0	-0.74568922245214	1	1	0	MT-ND1	Malignant cells	GSE139386	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6685
0	-0.856205153610139	1	1	0	MT-ND2	Malignant cells	GSE139386	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6686
0	-0.789539517178746	1	1	0	MT-CO2	Malignant cells	GSE139386	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6687
0	-0.743692268673117	1	0.999	0	MT-ATP6	Malignant cells	GSE139386	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6688
0	-0.858679200219869	0.999	0.999	0	MT-ND3	Malignant cells	GSE139386	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6689
0	-0.685528152748922	1	0.999	0	MT-ND4	Malignant cells	GSE139386	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6690
0	-0.841729476026589	0.999	0.998	0	MT-ND5	Malignant cells	GSE139386	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6691
0	2.51148239518567	0.97	0.029	0	TSTD1	Malignant cells	GSE139386	ENSG00000215845	100131187	thiosulfate sulfurtransferase like domain containing 1	KAT	protein_coding	Q8NFU3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6692
0	0.861872068085854	0.475	0	0	RGS16	Malignant cells	GSE139386	ENSG00000143333	6004	regulator of G protein signaling 16	A28-RGS14|RGS-r	protein_coding	O15492	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6693
0	1.32541979519538	0.72	0	0	UNC5B	Malignant cells	GSE139386	ENSG00000107731	219699	unc-5 netrin receptor B	p53RDL1|UNC5H2	protein_coding	Q8IZJ1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6694
0	1.23363004670681	0.438	0	0	MUC5B	Malignant cells	GSE139386	ENSG00000117983	727897	mucin 5B, oligomeric mucus/gel-forming	MG1|MUC5	protein_coding	Q9HC84	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6695
0	3.59842879920285	0.596	0.015	0	BPIFA1	Malignant cells	GSE139386	ENSG00000198183	51297	BPI fold containing family A member 1	bA49G10.5|LUNX|PLUNC|SPLUNC1	protein_coding	Q9NP55	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6696
0	1.05496791779911	0.441	0	0	FCGBP	Malignant cells	GSE139386	ENSG00000281123	8857	Fc gamma binding protein	FC(GAMMA)BP|FcgammaBP	protein_coding	Q9Y6R7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6697
7.30277845449281e-308	-0.725741048337832	0.23	0.647	1.32457795607591e-303	SH3GL1	Malignant cells	GSE139386	ENSG00000141985	6455	SH3 domain containing GRB2 like 1, endophilin A2	CNSA1|EEN|MGC111371|SH3D2B|SH3P8	protein_coding	Q99961	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6698
8.59160147771155e-308	0.760331763062729	0.974	0.876	1.55834467602732e-303	RSL1D1	Malignant cells	GSE139386	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6699
2.19682017525271e-307	-0.489619774000613	0.026	0.35	3.98459243387336e-303	TMPO-AS1	Malignant cells	GSE139386	ENSG00000257167	100128191	TMPO antisense RNA 1	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6700
2.74838672413836e-307	-0.62406358311568	0.121	0.522	4.98502384024216e-303	CTDSPL	Malignant cells	GSE139386	ENSG00000144677	10217	CTD small phosphatase like	C3orf8|HYA22|PSR1|RBSP3|SCP3	protein_coding	O15194	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6701
5.56516304256677e-306	0.707407468674213	0.441	0.005	1.00940927266076e-301	SLC44A4	Malignant cells	GSE139386	ENSG00000235336	80736	solute carrier family 44 member 4	C6orf29|CTL4|DFNA72|FLJ14491|NG22|TPPT	protein_coding	Q53GD3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6702
1.19571485039686e-305	0.882884631969119	0.861	0.567	2.16878759564983e-301	MKNK2	Malignant cells	GSE139386	ENSG00000099875	2872	MAPK interacting serine/threonine kinase 2	GPRK7|MNK2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6703
1.77070686640297e-305	0.852733009409516	0.876	0.602	3.2117081142817e-301	GARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6704
4.12461850449269e-305	-0.562525871581208	0.038	0.373	7.48123304344884e-301	CBR3	Malignant cells	GSE139386	ENSG00000159231	874	carbonyl reductase 3	SDR21C2	protein_coding	O75828	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6705
4.88399987156937e-305	0.820176550118467	0.599	0.142	8.85859896705253e-301	ARHGEF2	Malignant cells	GSE139386	ENSG00000116584	9181	Rho/Rac guanine nucleotide exchange factor 2	GEF-H1|GEFH1|KIAA0651|Lfc|LFP40|P40	protein_coding	Q92974	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6706
6.5124687641902e-305	-0.75252614855812	0.617	0.915	1.18123158444882e-300	OAZ2	Malignant cells	GSE139386	ENSG00000180304	4947	ornithine decarboxylase antizyme 2	NA	protein_coding	O95190	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6707
1.8736419293928e-304	-0.963154082718015	0.272	0.676	3.39841173153267e-300	BIRC3	Malignant cells	GSE139386	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6708
2.80201042068776e-304	0.305733739049259	1	1	5.08228650104345e-300	RPL41	Malignant cells	GSE139386	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6709
6.00041521843808e-304	-0.570761127777167	0.093	0.478	1.0883553123203e-299	RP11-452F19.3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6710
8.72782654394008e-304	-0.680966188896917	0.961	0.994	1.58305317853985e-299	TNNT1	Malignant cells	GSE139386	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6711
1.86190565528319e-303	-0.566888678798154	0.071	0.438	3.37712447755264e-299	TTF2	Malignant cells	GSE139386	ENSG00000116830	8458	transcription termination factor 2	HuF2|ZGRF6	protein_coding	Q9UNY4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6712
2.02082440888286e-303	-0.546016088347242	0.067	0.432	3.66537131283173e-299	CHST11	Malignant cells	GSE139386	ENSG00000171310	50515	carbohydrate sulfotransferase 11	C4ST|C4St-1|C4ST1|HSA269537	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6713
8.6980607246502e-303	-0.792830006919679	0.538	0.868	1.57765425423705e-298	MAFG	Malignant cells	GSE139386	ENSG00000197063	4097	MAF bZIP transcription factor G	MGC13090|MGC20149	protein_coding	O15525	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6714
2.00493359690815e-302	-0.68169109845257	0.218	0.639	3.63654855807199e-298	MKNK1	Malignant cells	GSE139386	ENSG00000079277	8569	MAPK interacting serine/threonine kinase 1	MNK1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6715
3.26892175415151e-302	0.855445036318575	0.88	0.635	5.92917027768e-298	SPINT1	Malignant cells	GSE139386	ENSG00000166145	6692	serine peptidase inhibitor, Kunitz type 1	HAI|HAI-1|MANSC2	protein_coding	O43278	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6716
7.17242646007043e-302	0.739032813111873	0.974	0.89	1.30093471132757e-297	CANX	Malignant cells	GSE139386	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6717
2.33585419325425e-301	0.846827366584854	0.746	0.336	4.23677233572456e-297	UBE2J1	Malignant cells	GSE139386	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6718
2.73435580175899e-301	-0.65841287130934	0.137	0.545	4.95957455323046e-297	MCM5	Malignant cells	GSE139386	ENSG00000100297	4174	minichromosome maintenance complex component 5	CDC46	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6719
5.80311097137417e-301	0.83507354907719	0.861	0.561	1.05256826798785e-296	SYF2	Malignant cells	GSE139386	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6720
6.12828895289421e-301	0.816351192688646	0.903	0.695	1.11154905027595e-296	DTD1	Malignant cells	GSE139386	ENSG00000125821	92675	D-aminoacyl-tRNA deacylase 1	bA379J5.3|bA555E18.1|C20orf88|DUEB|HARS2|MGC119131|MGC41905|pqn-68	protein_coding	Q8TEA8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6721
6.39756047120227e-301	-0.748579266769503	0.425	0.805	1.16038951826667e-296	GNAI2	Malignant cells	GSE139386	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6722
1.36364767945318e-300	0.842233896315334	1	0.995	2.47338416099218e-296	CTTN	Malignant cells	GSE139386	ENSG00000288401	2017	cortactin	EMS1	protein_coding	Q14247	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6723
2.72623522479369e-300	-0.74375532335813	0.292	0.71	4.94484545073079e-296	DST	Malignant cells	GSE139386	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6724
2.64398908565825e-299	-0.759056575651682	0.561	0.879	4.79566740356693e-295	C8orf33	Malignant cells	GSE139386	ENSG00000182307	65265	chromosome 8 open reading frame 33	FLJ20989	protein_coding	Q9H7E9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6725
2.91606457165187e-299	0.97928973874374	0.734	0.325	5.28915792006216e-295	PRSS22	Malignant cells	GSE139386	ENSG00000282937	64063	serine protease 22	BSSP-4|hBSSP-4|SP001LA	protein_coding	Q9GZN4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6726
1.5702427756355e-298	-0.627673692910751	0.978	0.998	2.84810634644767e-294	NHP2L1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6727
2.74548772574368e-298	-0.719640387782754	0.212	0.628	4.97976563695389e-294	TDP2	Malignant cells	GSE139386	ENSG00000111802	51567	tyrosyl-DNA phosphodiesterase 2	TTRAP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6728
8.22778273060005e-298	-0.726196739208753	0.305	0.713	1.49235523167624e-293	COPRS	Malignant cells	GSE139386	ENSG00000172301	55352	coordinator of PRMT5 and differentiation stimulator	C17orf79|COPR5|HSA272196|TTP1	protein_coding	Q9NQ92	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6729
1.31003594028215e-297	1.30441509810349	0.598	0.138	2.37614318848377e-293	CCL20	Malignant cells	GSE139386	ENSG00000115009	6364	C-C motif chemokine ligand 20	CKb4|exodus-1|LARC|MIP-3a|SCYA20|ST38	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6730
2.16719930105806e-297	0.817002504702994	0.897	0.685	3.93086609225911e-293	HDLBP	Malignant cells	GSE139386	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6731
3.27791627084094e-297	-0.70207576262789	0.209	0.63	5.94548453205129e-293	TRIP13	Malignant cells	GSE139386	ENSG00000071539	9319	thyroid hormone receptor interactor 13	16E1BP	protein_coding	Q15645	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6732
8.4958375262381e-297	-0.874077357168108	0.603	0.884	1.54097501050907e-292	MRPL13	Malignant cells	GSE139386	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6733
4.84331317177023e-296	0.951563178589936	0.784	0.417	8.78480143095685e-292	SH3KBP1	Malignant cells	GSE139386	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6734
8.01188130514589e-296	-0.857459196988287	0.531	0.861	1.45319503112736e-291	ANXA5	Malignant cells	GSE139386	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6735
8.23942841861935e-296	-0.751731528623188	0.582	0.886	1.49446752656918e-291	MAPKAP1	Malignant cells	GSE139386	ENSG00000119487	79109	MAPK associated protein 1	MGC2745|MIP1|SIN1	protein_coding	Q9BPZ7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6736
1.82474972130656e-295	0.745634891074744	0.98	0.91	3.30973104450585e-291	OSTC	Malignant cells	GSE139386	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6737
2.13356919390047e-295	-0.660032845388523	0.917	0.992	3.86986780389668e-291	MRPL55	Malignant cells	GSE139386	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6738
2.74196004999538e-295	0.853941438116731	0.697	0.257	4.97336713868162e-291	PNRC1	Malignant cells	GSE139386	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6739
8.0324344641094e-295	0.841008483611661	0.553	0.107	1.45692296310016e-290	IFNGR1	Malignant cells	GSE139386	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6740
3.61443685641087e-294	-0.502986668037982	0.034	0.357	6.55586557015804e-290	NUAK2	Malignant cells	GSE139386	ENSG00000163545	81788	NUAK family kinase 2	FLJ90349|SNARK	protein_coding	Q9H093	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6741
7.79632821970329e-294	-0.694771584051911	0.826	0.977	1.41409801248978e-289	MYEOV2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6742
1.50526283947611e-293	-0.704079719285075	0.731	0.957	2.73024573824177e-289	LYRM4	Malignant cells	GSE139386	ENSG00000214113	57128	LYR motif containing 4	C6orf149|CGI-203|ISD11	protein_coding	Q9HD34	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6743
1.69520492436852e-293	-0.499023479945116	0.041	0.372	3.07476269181962e-289	KIF3C	Malignant cells	GSE139386	ENSG00000084731	3797	kinesin family member 3C	NA	protein_coding	O14782	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6744
5.08679232086521e-293	-0.695669193324762	0.891	0.984	9.22642391158532e-289	MRPS34	Malignant cells	GSE139386	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6745
9.07214930479407e-293	-0.743673597355073	0.574	0.888	1.64550644090355e-288	TAX1BP3	Malignant cells	GSE139386	ENSG00000213977	30851	Tax1 binding protein 3	TIP-1	protein_coding	O14907	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6746
1.1041817290751e-292	-0.604636635123239	0.1	0.478	2.00276482019641e-288	TXNRD2	Malignant cells	GSE139386	ENSG00000184470	10587	thioredoxin reductase 2	SELZ|TR|TR3|TRXR2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6747
2.96496113955294e-292	-0.780639014374653	0.561	0.861	5.37784651492112e-288	ZNF511	Malignant cells	GSE139386	ENSG00000198546	118472	zinc finger protein 511	MGC30006|Zfp511	protein_coding	Q8NB15	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6748
4.70241873227426e-292	-0.672135711394096	0.24	0.664	8.52924709659904e-288	WHSC1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6749
8.06462625974099e-292	-0.716531892035563	0.339	0.737	1.46276191099182e-287	DERA	Malignant cells	GSE139386	ENSG00000023697	51071	deoxyribose-phosphate aldolase	CGI-26|DEOC	protein_coding	Q9Y315	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6750
1.20889066716582e-291	0.826062098836819	0.712	0.289	2.19268589210536e-287	DHPS	Malignant cells	GSE139386	ENSG00000095059	1725	deoxyhypusine synthase	MIG13	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6751
2.05015147279633e-291	-0.58328658347939	0.102	0.482	3.71856474135798e-287	CTD-2270L9.4	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6752
7.74465639506902e-291	0.853550194535331	0.899	0.65	1.40472577693762e-286	SLC7A5	Malignant cells	GSE139386	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6753
8.92955565234839e-291	-0.764366056286292	0.511	0.854	1.61964280422295e-286	EMG1	Malignant cells	GSE139386	ENSG00000126749	10436	EMG1 N1-specific pseudouridine methyltransferase	C2F|Grcc2f|NEP1	protein_coding	Q92979	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6754
9.45115862239881e-291	0.855153468944328	0.886	0.642	1.7142511509307e-286	EML4	Malignant cells	GSE139386	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6755
1.42499604115564e-290	-0.679924336489794	0.824	0.971	2.58465781944811e-286	MINOS1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6756
1.7585482152582e-290	-0.885140176048026	0.698	0.923	3.18965475283532e-286	CACYBP	Malignant cells	GSE139386	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6757
6.42675850462741e-290	-0.541916011615653	0.084	0.453	1.16568545756932e-285	DSP	Malignant cells	GSE139386	ENSG00000096696	1832	desmoplakin	DPI|DPII|KPPS2|PPKS2	protein_coding	P15924	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6758
6.92174802006549e-290	0.846543561484121	0.777	0.408	1.25546665587948e-285	STK24	Malignant cells	GSE139386	ENSG00000102572	8428	serine/threonine kinase 24	MST-3|MST3|MST3B|STE20|STK3	protein_coding	Q9Y6E0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6759
7.19989486991849e-290	-0.710740680990161	0.795	0.967	1.30591693150582e-285	ARHGDIA	Malignant cells	GSE139386	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6760
7.22240922038729e-290	1.07888795956397	0.785	0.421	1.31000058439385e-285	PLAU	Malignant cells	GSE139386	ENSG00000122861	5328	plasminogen activator, urokinase	UPA|URK	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6761
1.23068207623865e-288	-0.663517821340381	0.959	0.995	2.23221114988165e-284	COX17	Malignant cells	GSE139386	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6762
1.69203813888569e-288	-0.749058427895187	0.624	0.908	3.06901877631086e-284	MCUR1	Malignant cells	GSE139386	ENSG00000050393	63933	mitochondrial calcium uniporter regulator 1	C6orf79|CCDC90A|FLJ20958	protein_coding	Q96AQ8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6763
2.38352335312753e-288	-0.492226256518826	0.043	0.372	4.32323465790271e-284	AC009948.5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6764
9.28063040605739e-288	-0.746559531297475	0.369	0.758	1.68332074305069e-283	RFC1	Malignant cells	GSE139386	ENSG00000035928	5981	replication factor C subunit 1	A1|MHCBFB|PO-GA|RFC140	protein_coding	P35251	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6765
5.14417571845766e-287	0.74953900808482	0.505	0.068	9.3305059181385e-283	CTSH	Malignant cells	GSE139386	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6766
8.73686682166916e-287	-0.632725511285495	0.122	0.508	1.58469290411435e-282	PAQR4	Malignant cells	GSE139386	ENSG00000162073	124222	progestin and adipoQ receptor family member 4	FLJ30002	protein_coding	Q8N4S7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6767
2.58419014600152e-286	-0.729672215749959	0.481	0.833	4.68720408681756e-282	ARL16	Malignant cells	GSE139386	ENSG00000214087	339231	ADP ribosylation factor like GTPase 16	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6768
3.63443716638736e-286	-0.640638835745354	0.184	0.588	6.59214213239339e-282	KIFC3	Malignant cells	GSE139386	ENSG00000140859	3801	kinesin family member C3	NA	protein_coding	Q9BVG8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6769
4.3454802447214e-286	-0.540020874262364	0.04	0.363	7.88183206787567e-282	FAM101B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6770
5.10420277368584e-286	-0.740556910934229	0.537	0.857	9.25800299091138e-282	TMEM203	Malignant cells	GSE139386	ENSG00000187713	94107	transmembrane protein 203	HBEBP1|MGC14327	protein_coding	Q969S6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6771
5.11812575777041e-286	-0.468442130418538	0.034	0.352	9.28325649944397e-282	GINS4	Malignant cells	GSE139386	ENSG00000147536	84296	GINS complex subunit 4	MGC14799|SLD5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6772
8.23018655420568e-286	0.871966466433121	0.871	0.593	1.49279123720183e-281	STRN3	Malignant cells	GSE139386	ENSG00000196792	29966	striatin 3	PPP2R6B|S/G2NA|SG2NA	protein_coding	Q13033	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6773
1.8709945566939e-285	-0.723789334069018	0.766	0.954	3.39360992693139e-281	CDC26	Malignant cells	GSE139386	ENSG00000176386	246184	cell division cycle 26	ANAPC12|APC12|C9orf17	protein_coding	Q8NHZ8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6774
2.12507751243118e-285	0.834219189524703	0.875	0.613	3.85446559204768e-281	MIDN	Malignant cells	GSE139386	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6775
3.28570624665148e-285	-0.578149690432041	0.98	0.997	5.95961399017645e-281	ATP5I	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6776
1.83136317197715e-284	-0.738992994596827	0.722	0.945	3.32172652133216e-280	ADIPOR1	Malignant cells	GSE139386	ENSG00000159346	51094	adiponectin receptor 1	ACDCR1|PAQR1	protein_coding	Q96A54	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6777
1.97400404268283e-284	-0.393306427400501	0.005	0.274	3.58044853261812e-280	CASC8	Malignant cells	GSE139386	ENSG00000246228	727677	cancer susceptibility 8	CARLo-1|LINC00860	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6778
2.59961149859731e-284	-0.46600847150612	0.021	0.318	4.7151753361558e-280	NGF	Malignant cells	GSE139386	ENSG00000134259	4803	nerve growth factor	NGFB	protein_coding	P01138	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6779
7.25277397157335e-284	0.960669617763243	0.878	0.673	1.31550814296397e-279	RP11-423O2.7	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6780
2.91686966443827e-283	-0.726803436116718	0.766	0.952	5.29061819735814e-279	DDX46	Malignant cells	GSE139386	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6781
7.04531657562904e-283	0.76530557660665	0.929	0.728	1.2778795204876e-278	IMPDH2	Malignant cells	GSE139386	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6782
7.12491451746919e-283	-0.729955628317618	0.643	0.909	1.29231699517856e-278	ARPP19	Malignant cells	GSE139386	ENSG00000128989	10776	cAMP regulated phosphoprotein 19	ARPP-16|ARPP-19|ARPP16|ENSAL	protein_coding	P56211	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6783
8.60225585056024e-283	-0.587868880284213	0.063	0.406	1.56027716617462e-278	NEDD9	Malignant cells	GSE139386	ENSG00000111859	4739	neural precursor cell expressed, developmentally down-regulated 9	CAS-L|CASS2|HEF1	protein_coding	Q14511	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6784
2.32382907464383e-282	-0.806506112122963	0.855	0.964	4.21496117558899e-278	SSBP1	Malignant cells	GSE139386	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6785
2.52084141692926e-282	-0.400062684729173	0.006	0.273	4.5723021620263e-278	RP4-555D20.2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6786
8.9109514952788e-282	0.752941257918148	0.993	0.969	1.61626838221367e-277	CDK2AP2	Malignant cells	GSE139386	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6787
3.46072732706568e-281	-0.823838830920166	0.552	0.872	6.27706722583173e-277	BRIX1	Malignant cells	GSE139386	ENSG00000113460	55299	biogenesis of ribosomes BRX1	BRIX|BXDC2|FLJ11100	protein_coding	Q8TDN6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6788
3.46761602937687e-281	-0.775853722167467	0.58	0.883	6.28956195408377e-277	CBX1	Malignant cells	GSE139386	ENSG00000108468	10951	chromobox 1	CBX|HP1-BETA|HP1Hs-beta|M31|MOD1	protein_coding	P83916	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6789
4.01175115137865e-281	0.772068351557754	0.937	0.807	7.27651423837059e-277	SNX27	Malignant cells	GSE139386	ENSG00000143376	81609	sorting nexin 27	KIAA0488|MGC20471|MY014	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6790
4.8544686556392e-281	0.656783618543589	0.436	0.019	8.80503524759837e-277	KCNG1	Malignant cells	GSE139386	ENSG00000026559	3755	potassium voltage-gated channel modifier subfamily G member 1	K13|KCNG|kH2|Kv6.1	protein_coding	Q9UIX4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6791
9.96517901846885e-281	-0.719969080488001	0.42	0.79	1.80748417036988e-276	NR2F6	Malignant cells	GSE139386	ENSG00000160113	2063	nuclear receptor subfamily 2 group F member 6	EAR-2|EAR2|ERBAL2	protein_coding	P10588	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6792
1.89525356311365e-280	0.839925651290663	0.624	0.189	3.43761091277554e-276	NFKBIZ	Malignant cells	GSE139386	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6793
1.93191623116013e-280	-0.557390607659982	0.069	0.414	3.50410966007824e-276	LRRC61	Malignant cells	GSE139386	ENSG00000127399	65999	leucine rich repeat containing 61	FLJ31392|HSPC295|MGC3036	protein_coding	Q9BV99	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6794
2.00255420581627e-280	-0.644260408250639	0.971	0.997	3.63223281850956e-276	NDUFAB1	Malignant cells	GSE139386	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6795
2.73881461564956e-280	-0.604873657616443	0.13	0.511	4.96766194986518e-276	C1orf53	Malignant cells	GSE139386	ENSG00000203724	388722	chromosome 1 open reading frame 53	NA	protein_coding	Q5VUE5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6796
8.32976519099317e-280	-0.658797503727541	0.214	0.619	1.51085281034234e-275	FOSL2	Malignant cells	GSE139386	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6797
5.14350293150059e-279	-0.510213158442156	0.071	0.421	9.32928561715577e-275	NXT2	Malignant cells	GSE139386	ENSG00000101888	55916	nuclear transport factor 2 like export factor 2	P15-2	protein_coding	Q9NPJ8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6798
7.35252526006278e-279	-0.714459932748461	0.402	0.797	1.33360103167019e-274	NUDT1	Malignant cells	GSE139386	ENSG00000106268	4521	nudix hydrolase 1	MTH1	protein_coding	P36639	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6799
1.39851328516051e-278	-0.705199617341539	0.391	0.776	2.53662339662413e-274	JMJD8	Malignant cells	GSE139386	ENSG00000161999	339123	jumonji domain containing 8	C16orf20	protein_coding	Q96S16	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6800
1.67547334719591e-278	-0.526036650559315	0.073	0.426	3.03897355714395e-274	ORC6	Malignant cells	GSE139386	ENSG00000091651	23594	origin recognition complex subunit 6	ORC6L	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6801
1.82656873661154e-278	-0.629790004925679	0.202	0.635	3.31303037446601e-274	RMI2	Malignant cells	GSE139386	ENSG00000175643	116028	RecQ mediated genome instability 2	BLAP18|C16orf75|MGC24665	protein_coding	Q96E14	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6802
8.95524374247389e-278	0.783648947875052	0.953	0.844	1.62430211000991e-273	LITAF	Malignant cells	GSE139386	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6803
1.30238412235079e-277	-0.594252809744591	0.973	0.997	2.36226432111986e-273	STUB1	Malignant cells	GSE139386	ENSG00000103266	10273	STIP1 homology and U-box containing protein 1	CHIP|HSPABP2|NY-CO-7|SDCCAG7|UBOX1	protein_coding	Q9UNE7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6804
1.36339359426345e-277	-0.627996711964953	0.177	0.573	2.47292330127504e-273	HRSP12	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6805
1.37862639234738e-277	0.812245096138202	0.826	0.509	2.50055255043968e-273	CORO1B	Malignant cells	GSE139386	ENSG00000172725	57175	coronin 1B	coronin-2	protein_coding	Q9BR76	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6806
2.78675006669394e-277	-0.711742491557271	0.269	0.664	5.05460727096947e-273	BIN1	Malignant cells	GSE139386	ENSG00000136717	274	bridging integrator 1	AMPH2|AMPHL|SH3P9	protein_coding	O00499	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6807
6.98923468011861e-277	-0.783675070962538	0.917	0.992	1.26770738627991e-272	LDHA	Malignant cells	GSE139386	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6808
9.80456260022219e-277	-0.907665782219493	0.469	0.826	1.7783515644283e-272	ARL6IP1	Malignant cells	GSE139386	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6809
1.4182176760945e-276	-0.438878830494906	0.019	0.308	2.57236322090021e-272	GSTM4	Malignant cells	GSE139386	ENSG00000168765	2948	glutathione S-transferase mu 4	NA	protein_coding	Q03013	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6810
1.83911134165185e-276	-0.455423149792167	1	1	3.33578015148812e-272	COX6B1	Malignant cells	GSE139386	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6811
1.97617725649513e-276	0.579862299458541	1	0.999	3.58439030783087e-272	CD63	Malignant cells	GSE139386	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6812
2.21322324183938e-276	1.37706405693087	0.896	0.734	4.01434431604827e-272	MT1X	Malignant cells	GSE139386	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6813
3.56441170158014e-276	-0.400726695520732	0.011	0.284	6.46512994432605e-272	RP11-500C11.3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6814
4.22476846342075e-276	-0.716773534837498	0.813	0.966	7.66288503895255e-272	ISOC2	Malignant cells	GSE139386	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6815
4.47774120821998e-276	-0.667566569815407	0.965	0.993	8.1217270034694e-272	U2AF1	Malignant cells	GSE139386	ENSG00000160201	7307	U2 small nuclear RNA auxiliary factor 1	RN|RNU2AF1|U2AF35|U2AFBP	protein_coding	Q01081	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6816
5.15046405039582e-276	-0.797249894040092	0.603	0.883	9.34191169460794e-272	PARP1	Malignant cells	GSE139386	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6817
7.29613213308245e-276	0.77916414550171	0.927	0.769	1.3233724462985e-271	TMEM205	Malignant cells	GSE139386	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6818
8.30996603217253e-276	-0.739635642077613	0.796	0.955	1.50726163891545e-271	POP7	Malignant cells	GSE139386	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6819
9.72094319325307e-276	-0.586870415220652	0.147	0.536	1.76318467639224e-271	RNASEH1-AS1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6820
2.48104587336253e-275	0.75580619529455	0.921	0.742	4.50012100510495e-271	HECTD1	Malignant cells	GSE139386	ENSG00000092148	25831	HECT domain E3 ubiquitin protein ligase 1	KIAA1131	protein_coding	Q9ULT8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6821
2.84567535071563e-275	-0.41505266861051	0.018	0.304	5.16148595112801e-271	MDFIC	Malignant cells	GSE139386	ENSG00000135272	29969	MyoD family inhibitor domain containing	HIC|MDFIC1	protein_coding	Q9P1T7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6822
8.64533426437623e-275	-0.556158824100297	0.084	0.438	1.56809072887256e-270	NUP35	Malignant cells	GSE139386	ENSG00000163002	129401	nucleoporin 35	MP44	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6823
1.02733745169774e-274	-0.789764232678438	0.573	0.871	1.86338466988936e-270	SNRPA1	Malignant cells	GSE139386	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6824
2.02041110185847e-274	-0.715409995112901	0.659	0.918	3.66462165655089e-270	U2SURP	Malignant cells	GSE139386	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6825
8.23872377432077e-274	-0.631287292688318	0.125	0.5	1.4943397181863e-269	INHBB	Malignant cells	GSE139386	ENSG00000163083	3625	inhibin subunit beta B	NA	protein_coding	P09529	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6826
1.47931999403609e-273	-0.494582972616121	0.039	0.353	2.68319060518266e-269	PDGFB	Malignant cells	GSE139386	ENSG00000100311	5155	platelet derived growth factor subunit B	SIS|SSV	protein_coding	P01127	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6827
2.36066758674049e-273	-0.699918928258112	0.28	0.673	4.28177886882989e-269	EXT1	Malignant cells	GSE139386	ENSG00000182197	2131	exostosin glycosyltransferase 1	LGCR|LGS|ttv	protein_coding	Q16394	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6828
7.84086628495888e-273	-0.677007251385955	0.331	0.742	1.42217632676584e-268	TMPO	Malignant cells	GSE139386	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6829
9.80360180913391e-273	0.79577989015486	0.662	0.245	1.77817729614071e-268	SEL1L	Malignant cells	GSE139386	ENSG00000071537	6400	SEL1L adaptor subunit of ERAD E3 ubiquitin ligase	Hrd3|IBD2|SEL1L1	protein_coding	Q9UBV2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6830
1.32796242562626e-272	-0.518607939946396	0.062	0.399	2.40865824760091e-268	PSMC3IP	Malignant cells	GSE139386	ENSG00000131470	29893	PSMC3 interacting protein	GT198|Hop2|HUMGT198A|TBPIP	protein_coding	Q9P2W1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6831
2.47650806543863e-272	0.813231215468667	0.807	0.476	4.49189032909258e-268	NPDC1	Malignant cells	GSE139386	ENSG00000107281	56654	neural proliferation, differentiation and control 1	CAB-|CAB1|DKFZp586J0523	protein_coding	Q9NQX5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6832
7.89225441685173e-272	-0.714855093528642	0.396	0.768	1.43149710612857e-267	RAP1A	Malignant cells	GSE139386	ENSG00000116473	5906	RAP1A, member of RAS oncogene family	KREV-1|SMGP21	protein_coding	P62834	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6833
8.29686283468902e-272	0.784915248225181	0.641	0.221	1.50488498095589e-267	GMDS	Malignant cells	GSE139386	ENSG00000112699	2762	GDP-mannose 4,6-dehydratase	GMD|SDR3E1	protein_coding	O60547	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6834
9.77024836916832e-272	-0.78641014196124	0.351	0.738	1.77212764919975e-267	NCF2	Malignant cells	GSE139386	ENSG00000116701	4688	neutrophil cytosolic factor 2	NOXA2|p67phox	protein_coding	P19878	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6835
5.89242158447911e-271	-0.629294916894529	0.178	0.568	1.06876742699282e-266	FAIM	Malignant cells	GSE139386	ENSG00000158234	55179	Fas apoptotic inhibitory molecule	FAIM1|FLJ10582	protein_coding	Q9NVQ4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6836
6.60439285723454e-271	-0.433486300650454	0.024	0.315	1.1979047764452e-266	CELSR2	Malignant cells	GSE139386	ENSG00000143126	1952	cadherin EGF LAG seven-pass G-type receptor 2	ADGRC2|CDHF10|EGFL2|Flamingo1|KIAA0279|MEGF3	protein_coding	Q9HCU4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6837
2.50656990903665e-270	-0.704252818456305	0.583	0.884	4.54641650101068e-266	C22orf39	Malignant cells	GSE139386	ENSG00000242259	128977	chromosome 22 open reading frame 39	MGC74441	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6838
4.3622207063176e-270	-0.73241885566992	0.658	0.914	7.91219591711887e-266	C20orf27	Malignant cells	GSE139386	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6839
6.37095449473676e-270	-0.499464150280859	0.053	0.376	1.15556372625535e-265	HSF2BP	Malignant cells	GSE139386	ENSG00000160207	11077	heat shock transcription factor 2 binding protein	MEILB2	protein_coding	O75031	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6840
6.96770466135367e-270	-0.523658074470779	0.095	0.458	1.26380227147633e-265	C16orf59	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6841
9.00599168438181e-270	-0.736228940912439	0.55	0.86	1.63350677171317e-265	FOPNL	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6842
9.42580915147681e-270	-0.398854828491429	0.013	0.285	1.70965326389486e-265	AC074091.13	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6843
1.63438947084081e-269	-0.605859435911176	0.183	0.577	2.96445562221106e-265	MYCBP	Malignant cells	GSE139386	ENSG00000214114	26292	MYC binding protein	AMY-1	protein_coding	Q99417	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6844
2.84159319506118e-269	0.775572944126961	0.811	0.476	5.15408173720196e-265	C12orf10	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6845
5.17977544179343e-269	-0.642130327634153	0.232	0.635	9.39507669632492e-265	RCC1	Malignant cells	GSE139386	ENSG00000180198	1104	regulator of chromosome condensation 1	CHC1	protein_coding	P18754	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6846
1.42093109962381e-268	-0.747895835817987	0.508	0.837	2.57728482849767e-264	MT-ND4L	Malignant cells	GSE139386	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6847
2.10107019436799e-268	-0.606537568311329	0.945	0.994	3.81092111854466e-264	DDT	Malignant cells	GSE139386	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6848
2.92827503905969e-268	0.773478938567429	0.794	0.449	5.31130526584647e-264	CHID1	Malignant cells	GSE139386	ENSG00000177830	66005	chitinase domain containing 1	FLJ42707|MGC3234|SI-CLP	protein_coding	Q9BWS9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6849
1.40600109816551e-267	-0.684576104156207	0.394	0.768	2.5502047918526e-263	MED4	Malignant cells	GSE139386	ENSG00000136146	29079	mediator complex subunit 4	DRIP36|HSPC126|TRAP36|VDRIP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6850
1.74967184111314e-267	-0.611677994396245	0.937	0.995	3.17355478541102e-263	MYL6B	Malignant cells	GSE139386	ENSG00000196465	140465	myosin light chain 6B	MLC1SA	protein_coding	P14649	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6851
2.10235095163243e-267	0.822761257826112	0.44	0.033	3.81324415607091e-263	PDZK1IP1	Malignant cells	GSE139386	ENSG00000162366	10158	PDZK1 interacting protein 1	DD96|MAP17|SPAP	protein_coding	Q13113	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6852
4.47440117265015e-267	-0.750099277490037	0.151	0.538	8.11566884695284e-263	KRT81	Malignant cells	GSE139386	ENSG00000205426	3887	keratin 81	Hb-1|KRTHB1	protein_coding	Q14533	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6853
6.50072019584536e-267	0.641070022650679	0.985	0.926	1.17910062912243e-262	HSPD1	Malignant cells	GSE139386	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6854
7.33451363683684e-267	0.749523417329703	0.657	0.241	1.33033408344947e-262	YIPF2	Malignant cells	GSE139386	ENSG00000130733	78992	Yip1 domain family member 2	FinGER2|MGC3262	protein_coding	Q9BWQ6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6855
1.08094526738586e-266	-0.663673008178925	0.307	0.701	1.96061852598446e-262	LINC00511	Malignant cells	GSE139386	ENSG00000227036	400619	long intergenic non-protein coding RNA 511	onco-lncRNA-12	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6856
1.11379944822993e-266	-0.6785141250411	0.932	0.989	2.02020943919945e-262	PTMS	Malignant cells	GSE139386	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6857
1.15203844399737e-266	-0.385116136966502	0.003	0.254	2.08956732972244e-262	CCL26	Malignant cells	GSE139386	ENSG00000006606	10344	C-C motif chemokine ligand 26	eotaxin-3|IMAC|MIP-4a|MIP-4alpha|SCYA26|TSC-1	protein_coding	Q9Y258	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6858
1.27595492027202e-266	0.764707227725838	0.604	0.181	2.31432703438939e-262	LETMD1	Malignant cells	GSE139386	ENSG00000050426	25875	LETM1 domain containing 1	HCCR|HCCR-1|HCCR-2|HCCR1|HCCR2|SLC55A3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6859
8.43745326588214e-266	-0.702099203523316	0.666	0.918	1.5303852733657e-261	C14orf1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6860
1.1816468055775e-265	-0.50070345908568	0.062	0.393	2.14327097595647e-261	ENC1	Malignant cells	GSE139386	ENSG00000171617	8507	ectodermal-neural cortex 1	ENC-1|KLHL37|NRPB|PIG10|TP53I10	protein_coding	O14682	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6861
5.97316149685563e-265	-0.741708998996496	0.518	0.842	1.08341203229967e-260	CHAMP1	Malignant cells	GSE139386	ENSG00000198824	283489	chromosome alignment maintaining phosphoprotein 1	C13orf8|CAMP|CHAMP|ZNF828	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6862
1.00791428747373e-264	-0.662432642761678	0.229	0.616	1.82815493461986e-260	AP006222.2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6863
3.00253613437698e-264	-0.72960194433023	0.675	0.907	5.44600004053296e-260	MALSU1	Malignant cells	GSE139386	ENSG00000156928	115416	mitochondrial assembly of ribosomal large subunit 1	C7orf30|mtRsfA	protein_coding	Q96EH3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6864
9.39215536572736e-264	-0.479737225226887	0.058	0.382	1.70354914023563e-259	KLF10	Malignant cells	GSE139386	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6865
2.14965408338221e-263	0.678527883395053	0.419	0.021	3.89904257643866e-259	SLC22A18AS	Malignant cells	GSE139386	ENSG00000274454	5003	SLC22A18 antisense RNA	BWR1B|BWSCR1B|ORCTL2S|p27-BWR1B|SLC22A18-AS1|SLC22A1LS	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6866
2.28740445199923e-263	-0.518568114000732	0.077	0.416	4.14889419503621e-259	UNKL	Malignant cells	GSE139386	ENSG00000059145	64718	unk like zinc finger	C16orf28|FLJ23360|ZC3H5L|ZC3HDC5L	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6867
5.62198588748317e-263	-0.628002642703731	0.254	0.649	1.0197158002717e-258	NRAS	Malignant cells	GSE139386	ENSG00000213281	4893	NRAS proto-oncogene, GTPase	N-ras	protein_coding	P01111	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6868
7.66769308384635e-263	0.617268367659248	0.385	0	1.39076617154805e-258	GAL	Malignant cells	GSE139386	ENSG00000069482	51083	galanin and GMAP prepropeptide	GAL-GMAP|GALN|GLNN|GMAP	protein_coding	P22466	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6869
2.79952631261726e-262	-0.702489671226908	0.409	0.796	5.07778082582518e-258	DNAJC9	Malignant cells	GSE139386	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6870
2.96539836160052e-262	-0.67146526343897	0.769	0.954	5.37863954827103e-258	COA1	Malignant cells	GSE139386	ENSG00000106603	55744	cytochrome c oxidase assembly factor 1	C7orf44|FLJ10803|MITRAC15	protein_coding	Q9GZY4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6871
4.46387381949005e-262	-0.703114469156843	0.684	0.93	8.09657433379106e-258	PSMG3	Malignant cells	GSE139386	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6872
5.43586913401451e-262	-0.725433836910422	0.364	0.732	9.85957943527552e-258	KCNS3	Malignant cells	GSE139386	ENSG00000170745	3790	potassium voltage-gated channel modifier subfamily S member 3	Kv9.3	protein_coding	Q9BQ31	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6873
9.80380602583621e-262	0.677373752156189	0.468	0.058	1.77821433696617e-257	TMEM45B	Malignant cells	GSE139386	ENSG00000151715	120224	transmembrane protein 45B	BC016153|FLJ40787	protein_coding	Q96B21	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6874
1.41306018940875e-261	-0.609470795359083	0.187	0.574	2.56300857154958e-257	POLR2D	Malignant cells	GSE139386	ENSG00000144231	5433	RNA polymerase II subunit D	RPB4	protein_coding	O15514	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6875
3.72916951797309e-261	-0.583349641048573	0.951	0.994	6.76396767169959e-257	NBEAL1	Malignant cells	GSE139386	ENSG00000144426	65065	neurobeachin like 1	ALS2CR16|ALS2CR17|MGC164581	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6876
5.35580263190666e-261	-0.577331522244493	0.135	0.514	9.7143548137523e-257	NCAPD2	Malignant cells	GSE139386	ENSG00000010292	9918	non-SMC condensin I complex subunit D2	CAP-D2|CNAP1|hCAP-D2|KIAA0159	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6877
1.41021626063855e-260	-1.52404615142297	0.95	0.985	2.55785025354619e-256	HIST1H4C	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6878
2.85654911479739e-260	-0.702042312333286	0.516	0.848	5.18120878441951e-256	SMS	Malignant cells	GSE139386	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6879
8.51775566052398e-260	-0.676076610573795	0.701	0.943	1.54495052170584e-255	HNRNPUL1	Malignant cells	GSE139386	ENSG00000105323	11100	heterogeneous nuclear ribonucleoprotein U like 1	E1B-AP5|E1BAP5|FLJ12944|HNRPUL1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6880
9.48765183414362e-260	-0.618040400601042	0.193	0.578	1.72087028967697e-255	ASAP2	Malignant cells	GSE139386	ENSG00000151693	8853	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	CENTB3|DDEF2|KIAA0400|PAP|SHAG1	protein_coding	O43150	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6881
2.77520687368537e-259	-0.790969537522131	0.482	0.824	5.03367022749052e-255	CTNNAL1	Malignant cells	GSE139386	ENSG00000119326	8727	catenin alpha like 1	alpha-CATU|CLLP	protein_coding	Q9UBT7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6882
4.21427516327892e-259	-0.660623464311399	0.877	0.981	7.64385229115531e-255	EMC6	Malignant cells	GSE139386	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6883
8.21298566192173e-259	-0.632885034232396	0.916	0.985	1.48967133935936e-254	ATP6V0E1	Malignant cells	GSE139386	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6884
8.74928197873992e-259	0.54026990005536	1	1	1.58694476530385e-254	COX7A2	Malignant cells	GSE139386	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6885
1.99602281689878e-258	-0.676078311864113	0.349	0.733	3.62038618529101e-254	COMMD4	Malignant cells	GSE139386	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6886
3.55009982709198e-258	-0.373928802447886	0.006	0.256	6.43917106637943e-254	TTYH1	Malignant cells	GSE139386	ENSG00000276537	57348	tweety family member 1	NA	protein_coding	Q9H313	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6887
5.17522283119942e-258	-0.748078761224196	0.412	0.782	9.38681917122951e-254	FLNB	Malignant cells	GSE139386	ENSG00000136068	2317	filamin B	ABP-278|FH1|FLN1L|LRS1|TABP|TAP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6888
2.41504557328794e-257	-0.442573089426531	0.048	0.358	4.38040966082967e-253	SLC44A3	Malignant cells	GSE139386	ENSG00000143036	126969	solute carrier family 44 member 3	CTL3|MGC45474	protein_coding	Q8N4M1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6889
3.62716829286817e-257	0.776089679942599	0.582	0.162	6.57895784960429e-253	HLA-DQB1	Malignant cells	GSE139386	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6890
5.69818166466579e-257	-0.42175486839748	0.03	0.318	1.03353619033708e-252	NALCN	Malignant cells	GSE139386	ENSG00000102452	259232	sodium leak channel, non-selective	bA430M15.1|CanIon|VGCNL1	protein_coding	Q8IZF0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6891
7.16098382262145e-257	-0.701480585015325	0.357	0.741	1.29885924574708e-252	NASP	Malignant cells	GSE139386	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6892
1.01919720560057e-256	0.925903081232689	0.85	0.536	1.84861989151832e-252	UBALD2	Malignant cells	GSE139386	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6893
1.0223420777593e-256	-0.689826092963751	0.529	0.846	1.85432406063982e-252	SS18L2	Malignant cells	GSE139386	ENSG00000008324	51188	SS18 like 2	KIAA-iso	protein_coding	Q9UHA2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6894
1.19554646513822e-256	-0.671583156514065	0.615	0.901	2.1684821784677e-252	FAM96A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6895
1.25214200746955e-256	-0.689974030005922	0.492	0.821	2.27113517314827e-252	TMUB1	Malignant cells	GSE139386	ENSG00000164897	83590	transmembrane and ubiquitin like domain containing 1	C7orf21|HOPS|SB144	protein_coding	Q9BVT8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6896
1.6577254746917e-256	-0.662889561131033	0.812	0.967	3.0067824659958e-252	C9orf142	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6897
2.57304308543071e-255	-0.512308371659432	0.081	0.429	4.66698554835422e-251	CEP55	Malignant cells	GSE139386	ENSG00000138180	55165	centrosomal protein 55	C10orf3|CT111|FLJ10540	protein_coding	Q53EZ4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6898
5.64653553279024e-255	-0.370853788201818	0.011	0.266	1.02416861493749e-250	AC002480.3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6899
1.01102277525524e-254	-0.574432451561285	0.952	0.991	1.83379310975796e-250	MRPL20	Malignant cells	GSE139386	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6900
1.43384644695776e-254	-0.612354862350428	0.144	0.521	2.60071068549199e-250	SAPCD2	Malignant cells	GSE139386	ENSG00000186193	89958	suppressor APC domain containing 2	C9orf140|p42.3	protein_coding	Q86UD0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6901
2.43552116845009e-254	0.61917987870599	0.988	0.949	4.41754829533478e-250	SEC11A	Malignant cells	GSE139386	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6902
3.19448773817346e-254	-0.571959349043627	0.134	0.498	5.79416185949901e-250	PLCD3	Malignant cells	GSE139386	ENSG00000161714	113026	phospholipase C delta 3	NA	protein_coding	Q8N3E9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6903
7.86738682060465e-254	-0.686133477315092	0.542	0.851	1.42698662152127e-249	BRMS1	Malignant cells	GSE139386	ENSG00000174744	25855	BRMS1 transcriptional repressor and anoikis regulator	DKFZP564A063	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6904
1.25931149945181e-253	0.635000425084933	0.416	0.027	2.28413919770569e-249	ITPKA	Malignant cells	GSE139386	ENSG00000137825	3706	inositol-trisphosphate 3-kinase A	IP3-3KA|IP3KA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6905
2.12811689652886e-253	0.666990404348679	0.489	0.081	3.85997842692404e-249	ESPN	Malignant cells	GSE139386	ENSG00000187017	83715	espin	DFNB36	protein_coding	B1AK53	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6906
1.26343362363423e-252	-0.621480726834094	0.148	0.531	2.29161590654776e-248	PRC1	Malignant cells	GSE139386	ENSG00000198901	9055	protein regulator of cytokinesis 1	ASE1	protein_coding	O43663	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6907
2.23579095180886e-252	-0.656190202556897	0.782	0.955	4.05527762839091e-248	EIF4H	Malignant cells	GSE139386	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6908
5.58181199507457e-252	-0.467452812476881	0.06	0.377	1.01242905966663e-247	EIF5A2	Malignant cells	GSE139386	ENSG00000163577	56648	eukaryotic translation initiation factor 5A2	NA	protein_coding	Q9GZV4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6909
7.67964965440991e-252	0.606886480520202	0.405	0.02	1.39293485431687e-247	TP53I11	Malignant cells	GSE139386	ENSG00000175274	9537	tumor protein p53 inducible protein 11	PIG11	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6910
2.03263740866058e-251	-0.65975461230145	0.821	0.97	3.68679773182857e-247	PABPN1	Malignant cells	GSE139386	ENSG00000100836	8106	poly(A) binding protein nuclear 1	OPMD|PAB2|PABP2	protein_coding	Q86U42	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6911
2.64332264740621e-251	-0.518764303306192	0.075	0.408	4.79445861786538e-247	CDC45	Malignant cells	GSE139386	ENSG00000093009	8318	cell division cycle 45	CDC45L|CDC45L2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6912
7.49080471285547e-251	-0.73889804458218	0.618	0.883	1.35868215881773e-246	SRI	Malignant cells	GSE139386	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6913
3.29430502512305e-250	-0.671742959286833	0.344	0.714	5.97521045456818e-246	VKORC1L1	Malignant cells	GSE139386	ENSG00000196715	154807	vitamin K epoxide reductase complex subunit 1 like 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6914
3.34426675547371e-250	-0.625852266711607	0.818	0.968	6.06583104107822e-246	LYPLA1	Malignant cells	GSE139386	ENSG00000120992	10434	lysophospholipase 1	APT-1|LPL1	protein_coding	O75608	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6915
6.0094766617419e-250	-0.680282809118461	0.507	0.831	1.08999887690675e-245	GRAMD1A	Malignant cells	GSE139386	ENSG00000089351	57655	GRAM domain containing 1A	FLJ90346|KIAA1533	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6916
6.70189997278828e-250	-0.583566844582722	0.188	0.564	1.21559061706434e-245	YAP1	Malignant cells	GSE139386	ENSG00000137693	10413	Yes1 associated transcriptional regulator	YAP-1|YAP65	protein_coding	P46937	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6917
1.94475700569437e-249	-0.636003684785817	0.226	0.616	3.52740025692845e-245	RFC2	Malignant cells	GSE139386	ENSG00000049541	5982	replication factor C subunit 2	A1|RFC40	protein_coding	P35250	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6918
1.99848221357095e-249	-0.596534192685485	0.183	0.559	3.62484703897499e-245	DNAL1	Malignant cells	GSE139386	ENSG00000119661	83544	dynein axonemal light chain 1	1700010H15RiK|C14orf168|CILD16|MGC12435	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6919
7.68055576996576e-249	-0.683737675804928	0.686	0.92	1.39309920555639e-244	LUC7L3	Malignant cells	GSE139386	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6920
1.06817108888274e-248	-0.526814309907334	0.11	0.459	1.93744872101552e-244	CCDC82	Malignant cells	GSE139386	ENSG00000149231	79780	coiled-coil domain containing 82	FLJ23518	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6921
1.66136585838601e-248	0.789607082049858	0.583	0.178	3.01338539394054e-244	WIPI1	Malignant cells	GSE139386	ENSG00000070540	55062	WD repeat domain, phosphoinositide interacting 1	ATG18|ATG18A|FLJ10055|WIPI49	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6922
2.28643526284732e-248	-0.517061465943129	0.09	0.427	4.14713627975246e-244	FLNC	Malignant cells	GSE139386	ENSG00000128591	2318	filamin C	ABP-280|ABPL|FLN2	protein_coding	Q14315	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6923
2.69587455221362e-248	-0.355835356770886	0.01	0.259	4.88977726280506e-244	HKDC1	Malignant cells	GSE139386	ENSG00000156510	80201	hexokinase domain containing 1	FLJ22761|FLJ37767	protein_coding	Q2TB90	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6924
4.38720167550028e-248	0.747698579909443	0.525	0.121	7.95750639902241e-244	SEMA4B	Malignant cells	GSE139386	ENSG00000185033	10509	semaphorin 4B	KIAA1745|MGC131831|SEMAC|SemC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6925
4.50431099352975e-248	0.719881930111996	0.627	0.219	8.16991928006425e-244	WDR66	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6926
5.49150788903032e-248	-0.66034493217734	0.756	0.946	9.96049700912319e-244	POLR2E	Malignant cells	GSE139386	ENSG00000099817	5434	RNA polymerase II, I and III subunit E	hRPB25|hsRPB5|RPABC1|RPB5|XAP4	protein_coding	P19388	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6927
5.58104483702423e-248	-0.641975077018593	0.853	0.974	1.01228991253946e-243	RPS27L	Malignant cells	GSE139386	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6928
8.7347315595437e-248	-0.396999724726509	1	1	1.58430561027004e-243	PTMA	Malignant cells	GSE139386	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6929
1.05988655981933e-247	-0.625924831617287	0.983	1	1.9224222422003e-243	LGALS1	Malignant cells	GSE139386	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6930
3.03359495878264e-247	-0.545835723307182	0.996	0.998	5.50233453623995e-243	MZT2B	Malignant cells	GSE139386	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6931
5.05940822219821e-247	-0.679830916339583	0.738	0.941	9.17675463342311e-243	PYURF	Malignant cells	GSE139386	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6932
6.94420021328013e-247	0.636227999090715	0.959	0.871	1.25953903468475e-242	NDUFS7	Malignant cells	GSE139386	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6933
1.53144605323401e-246	0.935495749262645	0.529	0.125	2.77773685135584e-242	SAA2	Malignant cells	GSE139386	ENSG00000134339	6289	serum amyloid A2	NA	protein_coding	P0DJI9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6934
3.09122639734962e-246	-0.601829562080619	0.234	0.618	5.60686643951274e-242	TMEM161B-AS1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6935
3.52976420161967e-246	0.71638130139096	0.925	0.757	6.40228630889776e-242	EID1	Malignant cells	GSE139386	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6936
4.44732534037565e-246	-0.715698889513439	0.38	0.73	8.06655870237336e-242	LYAR	Malignant cells	GSE139386	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6937
6.28897199459807e-246	0.620195945781594	0.436	0.046	1.1406937403802e-241	ATP2C2	Malignant cells	GSE139386	ENSG00000064270	9914	ATPase secretory pathway Ca2+ transporting 2	KIAA0703|SPCA2	protein_coding	O75185	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6938
9.3003613112558e-246	-0.628909468738188	0.778	0.956	1.68689953463558e-241	MRPS36	Malignant cells	GSE139386	ENSG00000278461	92259	mitochondrial ribosomal protein S36	DC47|MRP-S36	protein_coding	P82909	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6939
9.49204237542747e-246	-0.595136972024071	0.188	0.558	1.72166664605503e-241	TRPM2	Malignant cells	GSE139386	ENSG00000142185	7226	transient receptor potential cation channel subfamily M member 2	EREG1|KNP3|LTRPC2|NUDT9H|NUDT9L1|TRPC7	protein_coding	O94759	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6940
9.57370309712343e-246	-0.560151592471946	0.172	0.544	1.73647826775625e-241	FAM122B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6941
2.69718135014155e-245	0.608216608552423	0.992	0.965	4.89214753288674e-241	TCEA1	Malignant cells	GSE139386	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6942
4.32169715173491e-245	-0.528178290451848	0.103	0.445	7.83869429381677e-241	FZD2	Malignant cells	GSE139386	ENSG00000180340	2535	frizzled class receptor 2	NA	protein_coding	Q14332	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6943
5.04068126231418e-245	0.526226672780494	0.999	0.999	9.14278767358546e-241	NAP1L1	Malignant cells	GSE139386	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6944
5.50466891108225e-245	-0.360383945756925	0.01	0.256	9.98436847092098e-241	SOCS2	Malignant cells	GSE139386	ENSG00000120833	8835	suppressor of cytokine signaling 2	CIS2|Cish2|SOCS-2|SSI-2|SSI2|STATI2	protein_coding	O14508	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6945
8.393728606697e-245	-0.735685515090311	0.778	0.952	1.5224544946827e-240	CNIH4	Malignant cells	GSE139386	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6946
1.46567367199033e-244	-0.58651354153406	0.24	0.624	2.65843890625607e-240	TNIP2	Malignant cells	GSE139386	ENSG00000168884	79155	TNFAIP3 interacting protein 2	ABIN-2|FLIP1|KLIP|MGC4289	protein_coding	Q8NFZ5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6947
4.76120399861663e-244	0.760633230273101	0.75	0.394	8.63587181269084e-240	RRBP1	Malignant cells	GSE139386	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6948
6.27378829050959e-244	-0.649876556269401	0.559	0.862	1.13793972013263e-239	TRIAP1	Malignant cells	GSE139386	ENSG00000170855	51499	TP53 regulated inhibitor of apoptosis 1	HSPC132|MDM35|P53CSV|WF-1	protein_coding	O43715	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6949
1.63533889907377e-243	-0.475864149747747	0.039	0.327	2.96617769514e-239	TNFAIP3	Malignant cells	GSE139386	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6950
3.47120409214354e-243	-0.852302226267939	0.215	0.577	6.29606998232994e-239	MYL9	Malignant cells	GSE139386	ENSG00000101335	10398	myosin light chain 9	LC20|MLC2|MRLC1|MYRL2	protein_coding	P24844	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6951
7.85229057953136e-243	-0.417897177653111	0.032	0.31	1.4242484653154e-238	COL4A1	Malignant cells	GSE139386	ENSG00000187498	1282	collagen type IV alpha 1 chain	NA	protein_coding	P02462	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6952
1.21408669719482e-242	-0.454959033696547	0.998	1	2.20211045137196e-238	ARL6IP4	Malignant cells	GSE139386	ENSG00000182196	51329	ADP ribosylation factor like GTPase 6 interacting protein 4	SFRS20|SR-25|SRp25|SRrp37	protein_coding	Q66PJ3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6953
9.31302980939913e-242	-0.641689081529667	0.44	0.785	1.68919734682881e-237	SMIM12	Malignant cells	GSE139386	ENSG00000163866	113444	small integral membrane protein 12	C1orf212|FLJ90372	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6954
1.59078902514342e-241	0.643407508637999	0.431	0.046	2.88537313380513e-237	SPDEF	Malignant cells	GSE139386	ENSG00000124664	25803	SAM pointed domain containing ETS transcription factor	bA375E1.3|PDEF	protein_coding	O95238	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6955
2.13843112741723e-241	-0.494972571498204	0.095	0.431	3.87868637890936e-237	CDK6	Malignant cells	GSE139386	ENSG00000105810	1021	cyclin dependent kinase 6	PLSTIRE	protein_coding	Q00534	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6956
3.21357156676742e-241	0.692624687268383	0.597	0.196	5.82877610780275e-237	CCDC64B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6957
1.54818364730827e-240	-0.661457381375869	0.401	0.773	2.80809549948773e-236	AHNAK	Malignant cells	GSE139386	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6958
1.86715928819966e-240	-0.678328051392267	0.536	0.839	3.38665351693655e-236	FUNDC2	Malignant cells	GSE139386	ENSG00000165775	65991	FUN14 domain containing 2	DC44|HCBP6	protein_coding	Q9BWH2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6959
3.10047631895298e-240	-0.5863824099304	0.215	0.591	5.62364394731692e-236	GALNT2	Malignant cells	GSE139386	ENSG00000143641	2590	polypeptide N-acetylgalactosaminyltransferase 2	GalNAc-T2	protein_coding	Q10471	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6960
5.86233985809522e-240	0.651192402583833	0.439	0.054	1.06331120346131e-235	SMOX	Malignant cells	GSE139386	ENSG00000088826	54498	spermine oxidase	C20orf16|dJ779E11.1|FLJ20746|MGC1010|PAO|PAOh1|SMO	protein_coding	Q9NWM0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6961
9.40958209060096e-240	0.720965388821822	0.637	0.242	1.7067099995932e-235	KRTCAP3	Malignant cells	GSE139386	ENSG00000157992	200634	keratinocyte associated protein 3	KCP3	protein_coding	Q53RY4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6962
1.0073972360195e-239	-0.637974725223829	0.458	0.799	1.82721710669217e-235	TMEM11	Malignant cells	GSE139386	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6963
2.05866725628703e-239	-0.472109145466752	0.08	0.408	3.73401066945341e-235	MELK	Malignant cells	GSE139386	ENSG00000165304	9833	maternal embryonic leucine zipper kinase	KIAA0175	protein_coding	Q14680	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6964
5.6079023071808e-239	-0.524502075185104	0.127	0.478	1.01716132047645e-234	RIPK2	Malignant cells	GSE139386	ENSG00000104312	8767	receptor interacting serine/threonine kinase 2	CARD3|CARDIAK|RICK|RIP2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6965
1.06083233732049e-238	-0.478669786160508	0.998	0.999	1.9241376934319e-234	ARPC2	Malignant cells	GSE139386	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6966
1.77174843301924e-238	-0.574763415319945	0.2	0.57	3.21359730781029e-234	C6orf132	Malignant cells	GSE139386	ENSG00000188112	647024	chromosome 6 open reading frame 132	bA7K24.2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6967
4.37292037684297e-238	0.751713024600991	0.737	0.36	7.93160297951779e-234	BBC3	Malignant cells	GSE139386	ENSG00000105327	27113	BCL2 binding component 3	JFY1|PUMA	protein_coding	Q9BXH1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6968
5.16393004051819e-238	0.731930216138045	0.834	0.563	9.3663363074919e-234	IARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6969
5.17502859480603e-238	-0.650681000620365	0.201	0.567	9.38646686525918e-234	FSTL3	Malignant cells	GSE139386	ENSG00000070404	10272	follistatin like 3	FLRG|FSRP	protein_coding	O95633	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6970
5.98405401337498e-238	-0.517746526411564	0.121	0.467	1.08538771694595e-233	IMPDH1	Malignant cells	GSE139386	ENSG00000106348	3614	inosine monophosphate dehydrogenase 1	LCA11|RP10|sWSS2608	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6971
6.09611401655032e-238	-0.650832874583797	0.623	0.903	1.1057131603219e-233	MPC2	Malignant cells	GSE139386	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6972
1.47587851066528e-237	-0.472685428226694	0.999	1	2.67694844264468e-233	NDUFB10	Malignant cells	GSE139386	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6973
2.43590507055721e-237	-0.747317898094058	0.382	0.772	4.41824461697666e-233	HIST1H1C	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6974
4.29774715408059e-237	-0.590328205593971	0.214	0.583	7.79525378807137e-233	DLEU1	Malignant cells	GSE139386	ENSG00000176124	10301	deleted in lymphocytic leukemia 1	BCMS|BCMS1|DLB1|LEU1|LINC00021|NCRNA00021|XTP6	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6975
4.91819088865865e-237	0.768644027183926	0.362	0.003	8.92061463384906e-233	PAEP	Malignant cells	GSE139386	ENSG00000122133	5047	progestagen associated endometrial protein	GD|GdA|GdF|GdS|MGC138509|MGC142288|PAEG|PEP|PP14	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6976
8.75808243814987e-237	-0.385670281187048	0.025	0.288	1.58854099263162e-232	DPF1	Malignant cells	GSE139386	ENSG00000011332	8193	double PHD fingers 1	BAF45b|NEUD4|neuro-d4|SMARCG1	protein_coding	Q92782	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6977
1.25868801801239e-236	-0.68336140804528	0.484	0.806	2.28300832707088e-232	POLE3	Malignant cells	GSE139386	ENSG00000148229	54107	DNA polymerase epsilon 3, accessory subunit	CHARAC17|CHRAC17|CHRAC2|p17|Ybl1	protein_coding	Q9NRF9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6978
1.38345454625329e-236	-0.668163286618035	0.551	0.849	2.50930985599421e-232	TPD52L2	Malignant cells	GSE139386	ENSG00000101150	7165	TPD52 like 2	D54|hD54|TPD54	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6979
2.69918157434558e-236	-0.572095167589191	0.946	0.993	4.89577553954801e-232	GLRX5	Malignant cells	GSE139386	ENSG00000182512	51218	glutaredoxin 5	C14orf87|GRX5|PR01238	protein_coding	Q86SX6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6980
4.47556809609122e-236	0.76788915635933	0.693	0.331	8.11778541269026e-232	EGFL7	Malignant cells	GSE139386	ENSG00000172889	51162	EGF like domain multiple 7	ZNEU1	protein_coding	Q9UHF1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6981
5.08609983954809e-236	0.753745248020104	0.79	0.484	9.22516788897233e-232	CKAP4	Malignant cells	GSE139386	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6982
5.13583639481758e-236	-0.582824088066832	0.944	0.994	9.31538005292012e-232	ARF1	Malignant cells	GSE139386	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6983
6.2217717368378e-236	-0.499185240708582	0.079	0.398	1.12850495762764e-231	HSPA1B	Malignant cells	GSE139386	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6984
1.02487306315367e-235	-0.542943183637405	0.083	0.412	1.85891476194813e-231	CCNA2	Malignant cells	GSE139386	ENSG00000145386	890	cyclin A2	CCN1|CCNA	protein_coding	P20248	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6985
1.10635873509115e-235	0.78425117096338	0.355	0	2.00671347370833e-231	MUC5AC	Malignant cells	GSE139386	ENSG00000215182	4586	mucin 5AC, oligomeric mucus/gel-forming	MUC5	protein_coding	P98088	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6986
2.14638077521705e-235	0.739389366291009	0.824	0.543	3.89310545008869e-231	ALG5	Malignant cells	GSE139386	ENSG00000120697	29880	ALG5 dolichyl-phosphate beta-glucosyltransferase	bA421P11.2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6987
2.18277483570405e-235	0.754163796669097	0.608	0.21	3.95911699700001e-231	CREB3L1	Malignant cells	GSE139386	ENSG00000157613	90993	cAMP responsive element binding protein 3 like 1	OASIS	protein_coding	Q96BA8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6988
2.31057502738346e-235	0.524901287796977	0.999	0.997	4.19092098466813e-231	SERP1	Malignant cells	GSE139386	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6989
2.91252798048986e-235	0.550186567844766	0.367	0.008	5.28274325101251e-231	KIF1A	Malignant cells	GSE139386	ENSG00000130294	547	kinesin family member 1A	ATSV|C2orf20|SPG30|UNC104	protein_coding	Q12756	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6990
3.80714190469242e-235	-0.513111331104296	0.118	0.459	6.9053939867311e-231	NBN	Malignant cells	GSE139386	ENSG00000104320	4683	nibrin	AT-V1|AT-V2|ATV|NBS|NBS1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6991
7.63220946952603e-235	-0.703715001100258	0.493	0.809	1.38433015358263e-230	CSRP1	Malignant cells	GSE139386	ENSG00000159176	1465	cysteine and glycine rich protein 1	CSRP|CYRP|D1S181E	protein_coding	P21291	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6992
2.80501570334814e-234	-0.582386307724319	0.208	0.577	5.08773748273285e-230	RPA1	Malignant cells	GSE139386	ENSG00000132383	6117	replication protein A1	HSSB|REPA1|RF-A|RP-A|RPA70	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6993
4.63039273480453e-234	-0.443996834359231	0.072	0.385	8.39860634238846e-230	FOXRED2	Malignant cells	GSE139386	ENSG00000100350	80020	FAD dependent oxidoreductase domain containing 2	ERFAD|FLJ23322	protein_coding	Q8IWF2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6994
6.82927834149098e-234	0.958318400146296	0.427	0.052	1.23869450557963e-229	CEACAM6	Malignant cells	GSE139386	ENSG00000086548	4680	CEA cell adhesion molecule 6	CD66c|NCA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6995
1.42968458656791e-233	0.847489939429199	0.627	0.241	2.59316190311687e-229	ITGA2	Malignant cells	GSE139386	ENSG00000164171	3673	integrin subunit alpha 2	CD49B	protein_coding	P17301	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6996
1.75786901944341e-233	-0.482447389987335	0.112	0.465	3.18842282746646e-229	ASF1B	Malignant cells	GSE139386	ENSG00000288210	55723	anti-silencing function 1B histone chaperone	FLJ10604	protein_coding	Q9NVP2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6997
2.66343100879816e-233	0.684920445799623	0.623	0.231	4.83093116375809e-229	CBS	Malignant cells	GSE139386	ENSG00000160200	875	cystathionine beta-synthase	HIP4	protein_coding	P35520	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6998
4.32119317548834e-233	-0.466329447670859	0.999	1	7.83778018170074e-229	SNRPD2	Malignant cells	GSE139386	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	6999
4.6819676409073e-233	-0.637865121318534	0.69	0.917	8.49215290707766e-229	RNASEH1	Malignant cells	GSE139386	ENSG00000171865	246243	ribonuclease H1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7000
6.32596914602411e-233	-0.639372948277359	0.319	0.687	1.14740428370585e-228	BRI3BP	Malignant cells	GSE139386	ENSG00000184992	140707	BRI3 binding protein	BNAS1|HCCR-2|HCCRBP-3|KG19	protein_coding	Q8WY22	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7001
6.41815695959878e-233	-0.640901522594557	0.329	0.691	1.16412530933203e-228	MLXIP	Malignant cells	GSE139386	ENSG00000281178	22877	MLX interacting protein	bHLHe36|KIAA0867|MIR|MONDOA	protein_coding	Q9HAP2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7002
9.61484154616142e-233	-0.630886909635885	0.145	0.516	1.74393995964276e-228	CDK1	Malignant cells	GSE139386	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7003
1.03674518384836e-232	0.696362656063885	0.943	0.808	1.88044841446415e-228	ECH1	Malignant cells	GSE139386	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7004
1.46354971958551e-232	-0.566297499496887	0.185	0.549	2.65458648138419e-228	ATP13A3	Malignant cells	GSE139386	ENSG00000133657	79572	ATPase 13A3	AFURS1	protein_coding	Q9H7F0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7005
6.63947735623008e-232	-0.678126131760033	0.425	0.768	1.20426840287301e-227	UGDH	Malignant cells	GSE139386	ENSG00000109814	7358	UDP-glucose 6-dehydrogenase	NA	protein_coding	O60701	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7006
1.05443850089044e-231	-0.533435693394814	0.972	0.997	1.91254055291508e-227	MRPL36	Malignant cells	GSE139386	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7007
1.06404012676213e-231	-0.669039307246673	0.4	0.74	1.92995598192115e-227	AGPS	Malignant cells	GSE139386	ENSG00000018510	8540	alkylglycerone phosphate synthase	ADAP-S|ADAS|ADHAPS|ADPS|ALDHPSY	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7008
1.27218939456064e-231	-0.60526318078867	0.253	0.621	2.30749712385408e-227	AAMDC	Malignant cells	GSE139386	ENSG00000087884	28971	adipogenesis associated Mth938 domain containing	C11orf67|CK067|FLJ21035|PTD015	protein_coding	Q9H7C9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7009
1.72321304769088e-231	-0.64016831167541	0.669	0.907	3.12556382590171e-227	SMIM15	Malignant cells	GSE139386	ENSG00000188725	643155	small integral membrane protein 15	C5orf43|DKFZP686E2158	protein_coding	Q7Z3B0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7010
2.12063735038815e-231	-0.600786644556389	0.83	0.964	3.84641202613403e-227	GPAA1	Malignant cells	GSE139386	ENSG00000197858	8733	glycosylphosphatidylinositol anchor attachment 1	GAA1|hGAA1	protein_coding	O43292	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7011
5.23794798720343e-231	-0.525324293721825	0.983	0.995	9.50059005918959e-227	TMEM147	Malignant cells	GSE139386	ENSG00000105677	10430	transmembrane protein 147	MGC1936|NIFIE14	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7012
6.03685993529062e-231	0.685536359209437	0.901	0.727	1.09496565506301e-226	AKR1A1	Malignant cells	GSE139386	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7013
7.87147388789862e-231	-0.703756474348678	0.49	0.804	1.42772793378705e-226	LY6K	Malignant cells	GSE139386	ENSG00000160886	54742	lymphocyte antigen 6 family member K	CT97|FLJ35226|HSJ001348	protein_coding	Q17RY6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7014
9.3103810880418e-231	0.565571780669841	0.99	0.943	1.68871692174902e-226	VDAC2	Malignant cells	GSE139386	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7015
1.09385527915367e-230	0.651846646718211	0.933	0.774	1.98403470532893e-226	OXA1L	Malignant cells	GSE139386	ENSG00000155463	5018	OXA1L mitochondrial inner membrane protein	MGC133129|OXA1|OXA1L1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7016
1.72254713372409e-230	-0.647295357456317	0.267	0.632	3.12435599114875e-226	OPN3	Malignant cells	GSE139386	ENSG00000054277	23596	opsin 3	ECPN|encephalopsin|ERO|NMO-1|PPP1R116	protein_coding	Q9H1Y3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7017
1.8034071624737e-230	-0.642626401910321	0.64	0.895	3.2710199112948e-226	CISD3	Malignant cells	GSE139386	ENSG00000274768	284106	CDGSH iron sulfur domain 3	Miner2|MiNT	protein_coding	P0C7P0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7018
1.84878502221786e-230	-0.653028787913343	0.495	0.812	3.35332627329876e-226	PRMT2	Malignant cells	GSE139386	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7019
4.42346023850656e-230	0.708596861397139	0.817	0.529	8.0232721806032e-226	YARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7020
5.17018072644106e-230	-0.695743709149646	0.693	0.915	9.37767380161879e-226	LAPTM4B	Malignant cells	GSE139386	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7021
6.7383596517299e-230	0.659299369222551	0.535	0.142	1.22220367363077e-225	SLC9A3R1	Malignant cells	GSE139386	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7022
7.86706185944945e-230	0.873457286755718	0.803	0.527	1.42692768006694e-225	PDIA4	Malignant cells	GSE139386	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7023
9.68388490080428e-230	0.717974918126734	0.529	0.143	1.75646304330788e-225	EDEM1	Malignant cells	GSE139386	ENSG00000134109	9695	ER degradation enhancing alpha-mannosidase like protein 1	EDEM|KIAA0212	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7024
1.13454075327666e-229	-0.583432463197657	0.223	0.591	2.0578300182932e-225	PCGF5	Malignant cells	GSE139386	ENSG00000180628	84333	polycomb group ring finger 5	MGC16202|RNF159	protein_coding	Q86SE9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7025
3.35100233552825e-229	-0.60346611996383	0.285	0.651	6.07804803618113e-225	GEMIN6	Malignant cells	GSE139386	ENSG00000152147	79833	gem nuclear organelle associated protein 6	FLJ23459	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7026
3.51306306950041e-229	-0.455431582587922	0.062	0.361	6.37199379545985e-225	PTPN14	Malignant cells	GSE139386	ENSG00000152104	5784	protein tyrosine phosphatase non-receptor type 14	PEZ|PTPD2	protein_coding	Q15678	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7027
1.21411788625493e-228	-0.482153598023394	0.054	0.345	2.2021670220892e-224	DTL	Malignant cells	GSE139386	ENSG00000143476	51514	denticleless E3 ubiquitin protein ligase homolog	CDT2|DCAF2|L2DTL|RAMP	protein_coding	Q9NZJ0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7028
1.56919103965864e-228	-0.5909242676026	0.315	0.684	2.84619870773284e-224	AKT2	Malignant cells	GSE139386	ENSG00000105221	208	AKT serine/threonine kinase 2	PKBbeta	protein_coding	P31751	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7029
2.85734834756161e-228	-0.616506300057153	0.932	0.986	5.18265843280725e-224	EIF4G2	Malignant cells	GSE139386	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7030
4.11253324596312e-228	-0.559445226415459	0.185	0.543	7.45931280152791e-224	MAEA	Malignant cells	GSE139386	ENSG00000090316	10296	macrophage erythroblast attacher, E3 ubiquitin ligase	EMP|GID9|HLC-10|p44EMLP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7031
9.94848463850315e-228	-0.432668109258582	0.064	0.363	1.8044561437317e-223	ME3	Malignant cells	GSE139386	ENSG00000151376	10873	malic enzyme 3	NA	protein_coding	Q16798	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7032
2.3778258931388e-227	-0.645965613229115	0.527	0.825	4.31290060497516e-223	CS	Malignant cells	GSE139386	ENSG00000062485	1431	citrate synthase	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7033
2.78361549434986e-227	-0.65738356311186	0.765	0.955	5.04892178365178e-223	FAM89B	Malignant cells	GSE139386	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7034
4.41014046302619e-227	-0.65348999776123	0.492	0.816	7.9991127718369e-223	IDS	Malignant cells	GSE139386	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7035
6.65961112770921e-227	-0.558831848513383	0.172	0.526	1.2079202663439e-222	TRIM7	Malignant cells	GSE139386	ENSG00000146054	81786	tripartite motif containing 7	GNIP|RNF90	protein_coding	Q9C029	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7036
1.09217228982583e-226	0.610313126781689	0.453	0.075	1.9809820992861e-222	FAM129A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7037
1.19303270356084e-226	-0.606625494905237	0.244	0.602	2.16392271771866e-222	MSANTD3	Malignant cells	GSE139386	ENSG00000066697	91283	Myb/SANT DNA binding domain containing 3	C9orf30|MGC17337	protein_coding	Q96H12	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7038
1.26041051495528e-226	-0.598216146003593	0.206	0.575	2.28613259202589e-222	FEN1	Malignant cells	GSE139386	ENSG00000168496	2237	flap structure-specific endonuclease 1	FEN-1|MF1|RAD2	protein_coding	P39748	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7039
1.82251602036202e-226	-0.565938481775029	0.235	0.603	3.30567955773264e-222	REPIN1	Malignant cells	GSE139386	ENSG00000214022	29803	replication initiator 1	AP4|H_DJ0584D14.12|RIP60|Zfp464|ZNF464	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7040
2.44738507449232e-226	-0.625771108116799	0.378	0.735	4.43906704811418e-222	RSRC1	Malignant cells	GSE139386	ENSG00000174891	51319	arginine and serine rich coiled-coil 1	BM-011|MGC12197|SFRS21|SRrp53	protein_coding	Q96IZ7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7041
3.14965957320263e-226	-0.456137404222164	0.072	0.379	5.71285253387493e-222	KIAA1731	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7042
4.6920926327273e-226	-0.555972811053972	0.167	0.53	8.51051761724078e-222	CHAF1A	Malignant cells	GSE139386	ENSG00000167670	10036	chromatin assembly factor 1 subunit A	CAF-1|CAF1|CAF1B|CAF1P150|MGC71229|P150	protein_coding	Q13111	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7043
1.57407868615152e-225	0.732510125506578	0.712	0.369	2.85506392094163e-221	RPF2	Malignant cells	GSE139386	ENSG00000197498	84154	ribosome production factor 2 homolog	bA397G5.4|BXDC1|FLJ21087	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7044
1.90968852866698e-225	-0.581267978690974	0.23	0.592	3.46379305329616e-221	SRRD	Malignant cells	GSE139386	ENSG00000100104	402055	SRR1 domain containing	HC/HCC|SRR1L	protein_coding	Q9UH36	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7045
4.55298341887403e-225	-0.620120446865569	0.457	0.787	8.25820132515372e-221	MAZ	Malignant cells	GSE139386	ENSG00000103495	4150	MYC associated zinc finger protein	Pur-1|ZF87|Zif87|ZNF801	protein_coding	P56270	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7046
4.87526504856087e-225	-0.659324282716806	0.605	0.877	8.84275574507971e-221	MGAT4B	Malignant cells	GSE139386	ENSG00000284501	11282	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GnT-Ivb	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7047
1.82786891491757e-224	-0.611937871799712	0.312	0.675	3.31538863787749e-220	TCOF1	Malignant cells	GSE139386	ENSG00000070814	6949	treacle ribosome biogenesis factor 1	TCS|treacle	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7048
2.89917576642993e-224	0.715404530209732	0.873	0.663	5.2585250051506e-220	SEC61A1	Malignant cells	GSE139386	ENSG00000058262	29927	SEC61 translocon subunit alpha 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7049
5.43501802548536e-224	0.593959506893368	0.971	0.89	9.85803569462535e-220	PPA1	Malignant cells	GSE139386	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7050
5.9731467114004e-224	-0.68215793209065	0.617	0.881	1.0834093505138e-219	EEF1E1	Malignant cells	GSE139386	ENSG00000124802	9521	eukaryotic translation elongation factor 1 epsilon 1	AIMP3|P18	protein_coding	O43324	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7051
8.5105995577082e-224	0.721688426941274	0.811	0.543	1.54365254777711e-219	PSMA6	Malignant cells	GSE139386	ENSG00000100902	5687	proteasome 20S subunit alpha 6	IOTA|MGC22756|MGC2333|MGC23846|p27K|PROS27	protein_coding	P60900	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7052
9.16207001596068e-224	0.705772102832747	0.744	0.392	1.66181625949495e-219	TNNI3	Malignant cells	GSE139386	ENSG00000129991	7137	troponin I3, cardiac type	CMD2A|CMH7|TNNC1	protein_coding	P19429	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7053
9.48591857836753e-224	0.733829021432389	0.84	0.602	1.7205559117443e-219	SLC1A5	Malignant cells	GSE139386	ENSG00000105281	6510	solute carrier family 1 member 5	AAAT|ASCT2|M7V1|RDRC	protein_coding	Q15758	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7054
1.54807955932618e-223	-0.579830734797927	0.863	0.971	2.80790670470583e-219	PDAP1	Malignant cells	GSE139386	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7055
1.59759668715146e-223	-0.640135038823243	0.662	0.903	2.89772087115532e-219	NUDCD2	Malignant cells	GSE139386	ENSG00000170584	134492	NudC domain containing 2	DKFZp686E10109|NudCL2	protein_coding	Q8WVJ2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7056
1.62128614894827e-223	-0.666724326791226	0.161	0.51	2.94068881696238e-219	KNSTRN	Malignant cells	GSE139386	ENSG00000128944	90417	kinetochore localized astrin (SPAG5) binding protein	C15orf23|FLJ14502|kinastrin|SKAP|TRAF4AF1	protein_coding	Q9Y448	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7057
1.87984362816591e-223	0.665539561923325	0.953	0.837	3.40966037276732e-219	PRDX2	Malignant cells	GSE139386	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7058
2.65345530246909e-223	-0.601450762779939	0.945	0.993	4.81283722761843e-219	RHOC	Malignant cells	GSE139386	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7059
2.85108649408073e-223	-0.520126124786696	0.126	0.461	5.17130068296363e-219	GJB3	Malignant cells	GSE139386	ENSG00000188910	2707	gap junction protein beta 3	CX31|DFNA2|EKV	protein_coding	O75712	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7060
4.63637123718172e-223	-0.634929076779233	0.484	0.816	8.4094501500002e-219	DNMT1	Malignant cells	GSE139386	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7061
1.07261652490792e-222	-0.495699976425985	0.1	0.42	1.94551185287799e-218	LRRC45	Malignant cells	GSE139386	ENSG00000169683	201255	leucine rich repeat containing 45	MGC20806	protein_coding	Q96CN5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7062
2.11630662590821e-222	0.702006598034021	0.426	0.058	3.83855695807231e-218	IFITM2	Malignant cells	GSE139386	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7063
2.49217670106923e-222	-0.393057873917757	0.027	0.28	4.52031010039937e-218	CCNE1	Malignant cells	GSE139386	ENSG00000105173	898	cyclin E1	CCNE	protein_coding	P24864	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7064
3.2880136057266e-222	-0.555848129019485	0.931	0.986	5.96379907806691e-218	LSMD1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7065
4.80097490192119e-222	0.62831410819385	0.433	0.064	8.70800827710465e-218	TSC22D3	Malignant cells	GSE139386	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7066
6.2023034762604e-222	0.771644899457664	0.712	0.379	1.12497380452411e-217	FIBCD1	Malignant cells	GSE139386	ENSG00000130720	84929	fibrinogen C domain containing 1	FLJ14810	protein_coding	Q8N539	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7067
7.55417537291829e-222	-0.633016225114838	0.356	0.703	1.37017632913992e-217	RASSF7	Malignant cells	GSE139386	ENSG00000273859	8045	Ras association domain family member 7	C11orf13|CFAP88|FAP88|HRAS1|HRC1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7068
8.36913285746999e-222	-0.581819431190544	0.272	0.635	1.51799331768791e-217	SNAP47	Malignant cells	GSE139386	ENSG00000143740	116841	synaptosome associated protein 47	C1orf142|SNAP-47|SVAP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7069
1.0764394919048e-221	-0.667570728989198	0.473	0.789	1.95244595041693e-217	PIN4	Malignant cells	GSE139386	ENSG00000102309	5303	peptidylprolyl cis/trans isomerase, NIMA-interacting 4	EPVH|PAR14|PAR17	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7070
1.50282446113644e-221	-0.455128056572921	0.081	0.39	2.72582300760927e-217	GPX8	Malignant cells	GSE139386	ENSG00000164294	493869	glutathione peroxidase 8 (putative)	EPLA847|UNQ847	protein_coding	Q8TED1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7071
1.84198311381698e-221	-0.680455817834645	0.875	0.971	3.34098897184125e-217	SRSF7	Malignant cells	GSE139386	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7072
1.84588797316493e-221	-0.623837099802222	0.355	0.71	3.34807160572655e-217	GLRX2	Malignant cells	GSE139386	ENSG00000023572	51022	glutaredoxin 2	bA101E13.1|GRX2	protein_coding	Q9NS18	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7073
3.77689792295278e-221	-0.487224272880671	0.122	0.466	6.85053745265175e-217	CDCA5	Malignant cells	GSE139386	ENSG00000146670	113130	cell division cycle associated 5	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7074
4.15957056555445e-221	-0.591313902623254	0.172	0.546	7.54462909180265e-217	NUSAP1	Malignant cells	GSE139386	ENSG00000137804	51203	nucleolar and spindle associated protein 1	ANKT|BM037|FLJ13421|LNP|PRO0310p1|Q0310|SAPL	protein_coding	Q9BXS6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7075
8.83371736790411e-221	-0.6216199646681	0.23	0.583	1.60225965619045e-216	DNTTIP2	Malignant cells	GSE139386	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7076
1.00106699069379e-220	-0.5580772075119	0.846	0.969	1.8157353077204e-216	PCNP	Malignant cells	GSE139386	ENSG00000081154	57092	PEST proteolytic signal containing nuclear protein	NA	protein_coding	Q8WW12	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7077
1.3930271098286e-220	-0.454574706437763	0.085	0.4	2.52667257180712e-216	SKA3	Malignant cells	GSE139386	ENSG00000165480	221150	spindle and kinetochore associated complex subunit 3	C13orf3|MGC4832|RAMA1	protein_coding	Q8IX90	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7078
2.5469417117537e-220	-0.631025634882305	0.196	0.548	4.61964287677886e-216	PSMB9	Malignant cells	GSE139386	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7079
2.70325566522436e-220	-0.341656400263557	0.015	0.25	4.90316512558394e-216	EIF5AL1	Malignant cells	GSE139386	ENSG00000253626	143244	eukaryotic translation initiation factor 5A like 1	bA342M3.3|EIF5AP1	protein_coding	Q6IS14	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7080
3.55952602961483e-220	-0.452755544580488	0.065	0.36	6.45626831251537e-216	OIP5	Malignant cells	GSE139386	ENSG00000104147	11339	Opa interacting protein 5	CT86|hMIS18beta|MIS18B	protein_coding	O43482	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7081
7.07026927977266e-220	-0.615194279120836	0.487	0.807	1.28240544196517e-215	ZDHHC3	Malignant cells	GSE139386	ENSG00000163812	51304	zinc finger DHHC-type palmitoyltransferase 3	DHHC3|GODZ|ZNF373	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7082
2.38584568576126e-219	-0.78461900982094	0.975	0.998	4.32744690483377e-215	PRDX1	Malignant cells	GSE139386	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7083
4.09158219283483e-219	-0.590682036782422	0.238	0.601	7.42131178136381e-215	RFC4	Malignant cells	GSE139386	ENSG00000163918	5984	replication factor C subunit 4	A1|RFC37	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7084
1.21615659542684e-218	0.745862240960554	0.818	0.558	2.20586483278521e-214	RPN2	Malignant cells	GSE139386	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7085
1.38677038774911e-218	-0.620880666347187	0.446	0.77	2.51532412929933e-214	MLST8	Malignant cells	GSE139386	ENSG00000167965	64223	MTOR associated protein, LST8 homolog	GbetaL|GBL|Lst8|Pop3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7086
2.16572372114016e-218	0.694289972355071	0.764	0.448	3.92818968540403e-214	MVB12A	Malignant cells	GSE139386	ENSG00000141971	93343	multivesicular body subunit 12A	FAM125A|FLJ32495	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7087
1.16639668590852e-217	0.662601750821253	0.889	0.699	2.11561030890088e-213	HSPA9	Malignant cells	GSE139386	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7088
1.39448934671488e-217	0.62814778128979	0.929	0.789	2.52932477707145e-213	RAB25	Malignant cells	GSE139386	ENSG00000132698	57111	RAB25, member RAS oncogene family	CATX-8	protein_coding	P57735	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7089
2.04051366060409e-217	0.694096336669289	0.733	0.392	3.70108367760371e-213	CFD	Malignant cells	GSE139386	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7090
2.47760027859197e-217	0.630822703789084	0.486	0.108	4.49387138531012e-213	GPRC5C	Malignant cells	GSE139386	ENSG00000170412	55890	G protein-coupled receptor class C group 5 member C	RAIG-3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7091
3.45824297423485e-217	-0.822254942210197	0.318	0.687	6.27256110666716e-213	KPNA2	Malignant cells	GSE139386	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7092
4.83704296465118e-217	0.700264758236526	0.854	0.644	8.77342852928432e-213	AHCY	Malignant cells	GSE139386	ENSG00000101444	191	adenosylhomocysteinase	AdoHcyase|SAHH	protein_coding	P23526	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7093
6.64122899200447e-217	-0.645884502618384	0.578	0.851	1.20458611456977e-212	DDA1	Malignant cells	GSE139386	ENSG00000130311	79016	DET1 and DDB1 associated 1	C19orf58|MGC2594|PCIA1	protein_coding	Q9BW61	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7094
7.02488962735186e-217	-0.465143800969358	0.086	0.393	1.27417448060908e-212	ECI2	Malignant cells	GSE139386	ENSG00000198721	10455	enoyl-CoA delta isomerase 2	ACBD2|DRS1|HCA88|PECI	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7095
8.1057548549111e-217	-0.724582278271946	0.822	0.963	1.47022181558377e-212	MAP1B	Malignant cells	GSE139386	ENSG00000131711	4131	microtubule associated protein 1B	MAP5|PPP1R102	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7096
8.70006414955269e-217	0.732503132013575	0.883	0.688	1.57801763544587e-212	PPP1R15A	Malignant cells	GSE139386	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7097
1.2274890920315e-216	0.710761654990155	0.756	0.42	2.22641971512674e-212	DHRS7	Malignant cells	GSE139386	ENSG00000100612	51635	dehydrogenase/reductase 7	retDSR4|SDR34C1	protein_coding	Q9Y394	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7098
2.99994861720754e-216	-0.457968304510358	0.094	0.407	5.44130680189104e-212	CLCF1	Malignant cells	GSE139386	ENSG00000175505	23529	cardiotrophin like cytokine factor 1	BSF-3|BSF3|CISS2|CLC|NNT-1|NNT1|NR6	protein_coding	Q9UBD9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7099
3.10398642635058e-216	0.531129025983434	0.35	0.012	5.63001058011469e-212	ARG2	Malignant cells	GSE139386	ENSG00000081181	384	arginase 2	NA	protein_coding	P78540	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7100
5.31047022488427e-216	-0.512876591141522	0.094	0.41	9.63213089389508e-212	KIF20B	Malignant cells	GSE139386	ENSG00000138182	9585	kinesin family member 20B	CT90|KRMP1|MPHOSPH1|MPP1	protein_coding	Q96Q89	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7101
7.37589210585967e-216	-0.389672804211974	0.037	0.298	1.33783931016083e-211	NMT2	Malignant cells	GSE139386	ENSG00000152465	9397	N-myristoyltransferase 2	NA	protein_coding	O60551	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7102
2.08022887840434e-215	0.899041423160774	0.824	0.621	3.7731191396498e-211	DCBLD2	Malignant cells	GSE139386	ENSG00000057019	131566	discoidin, CUB and LCCL domain containing 2	CLCP1|ESDN	protein_coding	Q96PD2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7103
2.16786788801719e-215	-0.579103284902475	0.262	0.622	3.93207877528557e-211	MFI2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7104
3.99587471424318e-215	-0.490202462958178	0.99	0.999	7.24771755669427e-211	MRP63	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7105
1.22135334198961e-214	-0.581700954398306	0.223	0.574	2.21529069170075e-210	PPIH	Malignant cells	GSE139386	ENSG00000171960	10465	peptidylprolyl isomerase H	CYP-20|CYPH|MGC5016|SnuCyp-20|USA-CYP	protein_coding	O43447	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7106
1.41497278419847e-214	-0.470090644966163	0.998	1	2.56647763597919e-210	TBCA	Malignant cells	GSE139386	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7107
2.14509197840336e-214	-0.60084461557654	0.382	0.722	3.89076783042802e-210	WSB2	Malignant cells	GSE139386	ENSG00000176871	55884	WD repeat and SOCS box containing 2	MGC10210|SBA2	protein_coding	Q9NYS7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7108
2.1647900106114e-214	-0.498630338732709	0.133	0.475	3.92649612124697e-210	PKMYT1	Malignant cells	GSE139386	ENSG00000127564	9088	protein kinase, membrane associated tyrosine/threonine 1	MYT1|PPP1R126	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7109
2.94023735044758e-214	-0.611446184896688	0.421	0.755	5.33300250624182e-210	DR1	Malignant cells	GSE139386	ENSG00000117505	1810	down-regulator of transcription 1	NC2-BETA|NC2B|NCB2	protein_coding	Q01658	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7110
3.0468940934217e-214	-0.656310866676055	0.662	0.898	5.52645650664828e-210	NOP16	Malignant cells	GSE139386	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7111
1.23643519737228e-213	-0.65191449301359	0.661	0.901	2.24264616099384e-209	NONO	Malignant cells	GSE139386	ENSG00000147140	4841	non-POU domain containing octamer binding	NMT55|NRB54|P54|P54NRB|PPP1R114	protein_coding	Q15233	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7112
1.29507976254788e-213	-0.604134002197011	0.298	0.647	2.34901567330934e-209	TCTEX1D2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7113
2.3133770715334e-213	-0.403848050763041	0.056	0.335	4.19600333234729e-209	LRTOMT	Malignant cells	GSE139386	ENSG00000284922	220074	leucine rich transmembrane and O-methyltransferase domain containing	CFAP111|COMT2|DFNB63|LRRC51|LRTOMT1|LRTOMT2	protein_coding	Q8WZ04	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7114
2.74901313405918e-213	-0.587543295118916	0.346	0.699	4.98616002255653e-209	MOCS2	Malignant cells	GSE139386	ENSG00000164172	4338	molybdenum cofactor synthesis 2	MOCO1|MOCS2A|MOCS2B	protein_coding	O96033	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7115
2.93977667321036e-213	-0.59968036022118	0.777	0.945	5.33216692986895e-209	RP11-345J4.5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7116
3.18455180269587e-213	-0.570031411955045	0.279	0.633	5.77614005972977e-209	DAXX	Malignant cells	GSE139386	ENSG00000231617	1616	death domain associated protein	DAP6	protein_coding	Q9UER7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7117
4.03477111799702e-213	0.694922806448023	0.915	0.766	7.31826785382299e-209	TSPAN13	Malignant cells	GSE139386	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7118
6.16584058119196e-213	-0.551636237857283	0.923	0.986	1.1183601646166e-208	DGUOK	Malignant cells	GSE139386	ENSG00000114956	1716	deoxyguanosine kinase	dGK	protein_coding	Q16854	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7119
6.58547869109517e-213	-0.59289924377399	0.406	0.741	1.19447412499084e-208	ABT1	Malignant cells	GSE139386	ENSG00000146109	29777	activator of basal transcription 1	Esf2	protein_coding	Q9ULW3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7120
7.20823718796535e-213	-0.583835081227112	0.093	0.413	1.30743006115315e-208	PLK1	Malignant cells	GSE139386	ENSG00000166851	5347	polo like kinase 1	PLK	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7121
1.99608643708109e-212	-0.465683451267386	0.096	0.405	3.62050157957769e-208	GLS	Malignant cells	GSE139386	ENSG00000115419	2744	glutaminase	GAC|GAM|GLS1|KGA|KIAA0838	protein_coding	O94925	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7122
2.15556238061081e-212	0.680300611585259	0.831	0.569	3.90975904595188e-208	N4BP2L2	Malignant cells	GSE139386	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7123
4.35682981395641e-212	-0.532911486904883	0.21	0.563	7.90241791655413e-208	TLE1	Malignant cells	GSE139386	ENSG00000196781	7088	TLE family member 1, transcriptional corepressor	ESG|ESG1|GRG1|TLE-1	protein_coding	Q04724	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7124
4.82300628909157e-212	-0.470031547678413	0.119	0.442	8.74796880715429e-208	MYPOP	Malignant cells	GSE139386	ENSG00000176182	339344	Myb related transcription factor, partner of profilin	P42pop	protein_coding	Q86VE0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7125
5.40465037078846e-212	0.494525034093727	0.326	0.001	9.80295484253611e-208	HOXB9	Malignant cells	GSE139386	ENSG00000170689	3219	homeobox B9	HOX2|HOX2E	protein_coding	P17482	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7126
2.0495293938292e-211	0.569564514827871	0.978	0.935	3.7174364145274e-207	SSR3	Malignant cells	GSE139386	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7127
3.39870941696647e-211	-0.618484982091683	0.49	0.796	6.16457914049378e-207	TMEM248	Malignant cells	GSE139386	ENSG00000106609	55069	transmembrane protein 248	C7orf42|FLJ10099|FLJ13090	protein_coding	Q9NWD8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7128
5.16874095778076e-211	-0.584619971545057	0.291	0.64	9.37506234922273e-207	RABIF	Malignant cells	GSE139386	ENSG00000183155	5877	RAB interacting factor	mss4|RASGRF3	protein_coding	P47224	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7129
5.34664269555067e-211	-0.565563483275332	0.858	0.969	9.6977405211898e-207	MEA1	Malignant cells	GSE139386	ENSG00000124733	4201	male-enhanced antigen 1	MEA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7130
6.12327470198381e-211	0.630647348399377	0.514	0.143	1.11063956544582e-206	NRP1	Malignant cells	GSE139386	ENSG00000099250	8829	neuropilin 1	CD304|NRP|VEGF165R	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7131
9.0919607907676e-211	-0.582951984515604	0.823	0.967	1.64909984822943e-206	APOPT1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7132
1.47901344707793e-210	-0.366478235542466	0.036	0.294	2.68263459030994e-206	XRCC2	Malignant cells	GSE139386	ENSG00000196584	7516	X-ray repair cross complementing 2	FANCU	protein_coding	O43543	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7133
1.9175002151978e-210	-0.573880535622084	0.843	0.973	3.47796189032578e-206	SSU72	Malignant cells	GSE139386	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7134
2.20270384568531e-210	0.552141778137773	0.379	0.035	3.99526423530401e-206	SV2A	Malignant cells	GSE139386	ENSG00000159164	9900	synaptic vesicle glycoprotein 2A	KIAA0736|SV2	protein_coding	Q7L0J3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7135
2.52549658812975e-210	0.565772704123949	0.345	0.013	4.58074571154975e-206	TMEM59L	Malignant cells	GSE139386	ENSG00000105696	25789	transmembrane protein 59 like	BSMAP|C19orf4	protein_coding	Q9UK28	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7136
2.98913606299808e-210	-0.61180357264049	0.398	0.732	5.42169499106593e-206	TIMM8A	Malignant cells	GSE139386	ENSG00000126953	1678	translocase of inner mitochondrial membrane 8A	DDP|DFN1|MTS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7137
4.08138610514607e-210	0.686062251411308	0.71	0.371	7.40281811751395e-206	FAM107B	Malignant cells	GSE139386	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7138
5.20646434735917e-210	-0.475027048186207	0.116	0.435	9.44348503324006e-206	FAM115A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7139
6.95615063833649e-210	-0.533774348381099	0.163	0.499	1.26170660278147e-205	GPC6	Malignant cells	GSE139386	ENSG00000183098	10082	glypican 6	NA	protein_coding	Q9Y625	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7140
7.8728621153853e-210	-0.608249533232586	0.419	0.747	1.42797973048859e-205	PABPC4	Malignant cells	GSE139386	ENSG00000090621	8761	poly(A) binding protein cytoplasmic 4	APP-1|iPABP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7141
8.64718306799014e-210	-0.520485047402534	0.96	0.996	1.56842606487205e-205	MZT2A	Malignant cells	GSE139386	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7142
1.12657672318148e-209	-0.511793974012417	0.177	0.519	2.04338486050656e-205	MRFAP1L1	Malignant cells	GSE139386	ENSG00000178988	114932	Morf4 family associated protein 1 like 1	MGC9651	protein_coding	Q96HT8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7143
1.50654043622129e-209	-0.653342169190802	0.167	0.505	2.73256304321818e-205	CKAP2	Malignant cells	GSE139386	ENSG00000136108	26586	cytoskeleton associated protein 2	FLJ10749|LB1|se20-10|TMAP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7144
1.91501158106817e-209	-0.570429741076276	0.338	0.687	3.47344800574145e-205	APITD1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7145
2.22883153893911e-209	-0.566022574632987	0.264	0.618	4.04265464532776e-205	DAG1	Malignant cells	GSE139386	ENSG00000173402	1605	dystroglycan 1	156DAG|A3a|AGRNR|DAG	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7146
2.48097114172599e-209	-0.612268162641279	0.604	0.862	4.49998545686261e-205	PFDN1	Malignant cells	GSE139386	ENSG00000113068	5201	prefoldin subunit 1	PFD1	protein_coding	O60925	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7147
3.13772408803824e-209	-0.590124529033154	0.563	0.85	5.69120395088376e-205	SZRD1	Malignant cells	GSE139386	ENSG00000055070	26099	SUZ RNA binding domain containing 1	C1orf144|DKFZp566C0424	protein_coding	Q7Z422	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7148
3.20285709604266e-209	-0.675030660683402	0.763	0.929	5.80934220080219e-205	EBNA1BP2	Malignant cells	GSE139386	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7149
4.32960632624327e-209	-0.476923271478925	0.997	0.999	7.85303995454005e-205	COX5A	Malignant cells	GSE139386	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7150
4.39449603959969e-209	0.579303465558539	0.425	0.068	7.97073691662591e-205	DNAJB9	Malignant cells	GSE139386	ENSG00000128590	4189	DnaJ heat shock protein family (Hsp40) member B9	MDG1	protein_coding	Q9UBS3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7151
2.50183293312515e-208	-0.489987337198735	0.109	0.422	4.5378245741024e-204	MID1	Malignant cells	GSE139386	ENSG00000101871	4281	midline 1	FXY|OS|RNF59|TRIM18	protein_coding	O15344	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7152
2.63091617946785e-208	0.62479004878866	0.498	0.132	4.77195576631879e-204	P2RX4	Malignant cells	GSE139386	ENSG00000135124	5025	purinergic receptor P2X 4	P2X4	protein_coding	Q99571	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7153
3.13071477332603e-208	-0.594634548597187	0.426	0.755	5.67849045585875e-204	MEST	Malignant cells	GSE139386	ENSG00000106484	4232	mesoderm specific transcript	PEG1	protein_coding	Q5EB52	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7154
4.06899489865444e-208	-0.504680446633212	0.08	0.382	7.38034294717943e-204	ASPM	Malignant cells	GSE139386	ENSG00000066279	259266	assembly factor for spindle microtubules	ASP|Calmbp1|FLJ10517|FLJ10549|MCPH5	protein_coding	Q8IZT6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7155
4.58645756201157e-208	-0.477254822447542	0.132	0.456	8.31891672597659e-204	SNX12	Malignant cells	GSE139386	ENSG00000147164	29934	sorting nexin 12	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7156
6.58040938065718e-208	-0.390458436594978	0.05	0.319	1.1935546534636e-203	CENPO	Malignant cells	GSE139386	ENSG00000138092	79172	centromere protein O	CENP-O|MGC11266	protein_coding	Q9BU64	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7157
7.145230478942e-208	0.668340514537715	0.807	0.546	1.2960019042705e-203	SIGIRR	Malignant cells	GSE139386	ENSG00000185187	59307	single Ig and TIR domain containing	IL-1R8|TIR8	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7158
9.37918227023523e-208	-0.464832242258109	0.134	0.462	1.70119608017527e-203	SPIDR	Malignant cells	GSE139386	ENSG00000164808	23514	scaffold protein involved in DNA repair	KIAA0146	protein_coding	Q14159	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7159
2.69613697979519e-207	-0.608342598142228	0.617	0.885	4.89025325395252e-203	GTF2I	Malignant cells	GSE139386	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7160
7.00203068718913e-207	0.599740176209609	0.965	0.896	1.27002832604236e-202	VPS72	Malignant cells	GSE139386	ENSG00000163159	6944	vacuolar protein sorting 72 homolog	Swc2|TCFL1|YL-1|YL1	protein_coding	Q15906	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7161
8.11655651135262e-207	-0.589552508912505	0.296	0.641	1.47218102002914e-202	NF2	Malignant cells	GSE139386	ENSG00000186575	4771	NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor	ACN|BANF|merlin|merlin-1|SCH	protein_coding	P35240	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7162
1.3425659040095e-206	-0.459365197097649	0.099	0.406	2.43514603669244e-202	SEMA3C	Malignant cells	GSE139386	ENSG00000075223	10512	semaphorin 3C	SEMAE|SemE	protein_coding	Q99985	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7163
4.97339308708931e-206	-0.629477412403071	0.498	0.799	9.02074038136259e-202	EGLN2	Malignant cells	GSE139386	ENSG00000269858	112398	egl-9 family hypoxia inducible factor 2	HIFPH1|PHD1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7164
5.66515810994943e-206	-0.603737189300163	0.607	0.868	1.02754637798263e-201	MRPS14	Malignant cells	GSE139386	ENSG00000120333	63931	mitochondrial ribosomal protein S14	HSMRPS14	protein_coding	O60783	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7165
6.34423801333733e-206	-0.57461141247934	0.259	0.604	1.15071789085912e-201	GMFB	Malignant cells	GSE139386	ENSG00000197045	2764	glia maturation factor beta	GMF	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7166
1.02771221873489e-204	-0.417970102135606	0.055	0.328	1.86406442234135e-200	KIFC1	Malignant cells	GSE139386	ENSG00000233450	3833	kinesin family member C1	HSET|KNSL2	protein_coding	Q9BW19	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7167
1.99205407768259e-204	0.65087507164008	1	1	3.61318768610068e-200	MALAT1	Malignant cells	GSE139386	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7168
2.12456603029475e-204	0.469617777817033	0.999	0.977	3.85353786574861e-200	EIF3K	Malignant cells	GSE139386	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7169
4.07571837307456e-204	0.601095466053665	0.497	0.13	7.39253798508264e-200	SCNN1A	Malignant cells	GSE139386	ENSG00000111319	6337	sodium channel epithelial 1 subunit alpha	ENaCalpha|SCNN1	protein_coding	P37088	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7170
5.81408704026916e-204	-0.5940434901753	0.873	0.97	1.05455910736402e-199	ARPC5L	Malignant cells	GSE139386	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7171
1.57378523692287e-203	-0.473419304506033	0.064	0.343	2.8545316627307e-199	MXD3	Malignant cells	GSE139386	ENSG00000213347	83463	MAX dimerization protein 3	bHLHc13|MAD3	protein_coding	Q9BW11	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7172
1.66195880801459e-203	-0.618735087859019	0.296	0.644	3.01446088597687e-199	AMIGO2	Malignant cells	GSE139386	ENSG00000139211	347902	adhesion molecule with Ig like domain 2	ALI1|DEGA	protein_coding	Q86SJ2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7173
1.71206398506048e-203	0.645195938020147	0.88	0.67	3.1053416561027e-199	RNH1	Malignant cells	GSE139386	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7174
1.77318376359956e-203	-0.537884012369566	0.85	0.971	3.21620071041687e-199	RPL26L1	Malignant cells	GSE139386	ENSG00000037241	51121	ribosomal protein L26 like 1	RPL26P1	protein_coding	Q9UNX3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7175
2.56481070730643e-203	-0.525495593921761	0.167	0.497	4.65205366091241e-199	RP11-111M22.3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7176
2.73120582702482e-203	-0.606039448085128	0.514	0.811	4.95386112905761e-199	RP11-532F12.5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7177
4.99169779017206e-203	-0.522377238406417	0.939	0.989	9.05394145181408e-199	FIS1	Malignant cells	GSE139386	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7178
6.44367286161777e-203	-0.384692709395422	0.051	0.318	1.16875338364023e-198	SLC39A8	Malignant cells	GSE139386	ENSG00000138821	64116	solute carrier family 39 member 8	BIGM103	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7179
7.1574123502608e-203	-0.547283472117905	0.256	0.599	1.2982114520903e-198	USB1	Malignant cells	GSE139386	ENSG00000103005	79650	U6 snRNA biogenesis phosphodiesterase 1	C16orf57|FLJ13154|HVSL1|Mpn1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7180
1.08326615578885e-202	0.651569304734716	0.886	0.726	1.96482815336981e-198	TECR	Malignant cells	GSE139386	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7181
1.21295328933375e-202	-0.569118282307243	0.301	0.65	2.20005467619355e-198	LIMS1	Malignant cells	GSE139386	ENSG00000169756	3987	LIM zinc finger domain containing 1	PINCH|PINCH1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7182
1.26373703045737e-202	-0.533965222438365	0.218	0.557	2.29216622584359e-198	MRPS17.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7183
2.52295525459796e-202	-0.497903322902224	0.155	0.486	4.57613624078977e-198	RANGAP1	Malignant cells	GSE139386	ENSG00000100401	5905	Ran GTPase activating protein 1	Fug1|KIAA1835|SD	protein_coding	P46060	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7184
1.02927413804889e-201	-0.591212016813026	0.673	0.9	1.86689743159308e-197	HTATIP2	Malignant cells	GSE139386	ENSG00000109854	10553	HIV-1 Tat interactive protein 2	CC3|FLJ26963|SDR44U1|TIP30	protein_coding	Q9BUP3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7185
1.92943152423935e-201	-0.58817847448791	0.476	0.786	3.49960289866533e-197	FGFR1OP2	Malignant cells	GSE139386	ENSG00000111790	26127	FGFR1 oncogene partner 2	DKFZp564O1863	protein_coding	Q9NVK5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7186
7.26945333722163e-201	0.657386345814157	0.643	0.294	1.31853344630526e-196	PEX16	Malignant cells	GSE139386	ENSG00000121680	9409	peroxisomal biogenesis factor 16	NA	protein_coding	Q9Y5Y5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7187
7.84504875604844e-201	-0.403576289860155	0.067	0.346	1.42293494337207e-196	SEPT10	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7188
9.39506523440157e-201	0.564066307120161	0.403	0.059	1.70407693221576e-196	CHAC1	Malignant cells	GSE139386	ENSG00000128965	79094	ChaC glutathione specific gamma-glutamylcyclotransferase 1	MGC4504	protein_coding	Q9BUX1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7189
1.30830112832267e-200	0.564649313547634	0.989	0.961	2.37299658655166e-196	RNF181	Malignant cells	GSE139386	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7190
2.08362119716121e-200	-0.593641078077092	0.393	0.717	3.779272127411e-196	MAPK12	Malignant cells	GSE139386	ENSG00000188130	6300	mitogen-activated protein kinase 12	ERK6|p38gamma|PRKM12|SAPK-3|SAPK3	protein_coding	P53778	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7191
2.40688080879043e-200	-0.588799716088327	0.758	0.933	4.36560041098408e-196	MRPS33	Malignant cells	GSE139386	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7192
5.76855272144789e-200	-0.580679145786961	0.388	0.709	1.04630009261622e-195	AC010642.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7193
8.88186629362129e-200	0.594446619643192	0.429	0.08	1.61099290833703e-195	LPIN1	Malignant cells	GSE139386	ENSG00000134324	23175	lipin 1	KIAA0188	protein_coding	Q14693	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7194
1.20253923395886e-199	-0.593680590931704	0.329	0.669	2.18116566255458e-195	PEA15	Malignant cells	GSE139386	ENSG00000162734	8682	proliferation and apoptosis adaptor protein 15	HMAT1|HUMMAT1H|MAT1|MAT1H|PEA-15|PED|PED-PEA15|PED/PEA15	protein_coding	Q15121	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7195
1.38430054231225e-199	-0.376821369659755	0.048	0.308	2.51084432364597e-195	KIAA1524	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7196
1.86564070600213e-199	-0.553646557498192	0.275	0.618	3.38389911254667e-195	POLR2A	Malignant cells	GSE139386	ENSG00000284832	5430	RNA polymerase II subunit A	POLR2|POLRA|RPB1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7197
2.02452011815951e-199	-0.476961597707018	0.112	0.418	3.67207459031771e-195	DDAH1	Malignant cells	GSE139386	ENSG00000153904	23576	dimethylarginine dimethylaminohydrolase 1	DDAH	protein_coding	O94760	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7198
2.64723970595339e-199	-0.567398126723765	0.359	0.695	4.80156337865826e-195	MAP3K11	Malignant cells	GSE139386	ENSG00000173327	4296	mitogen-activated protein kinase kinase kinase 11	MEKK11|MLK3|PTK1|SPRK	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7199
3.30009716804268e-199	0.572537629058038	0.448	0.093	5.98571624339581e-195	ST3GAL5	Malignant cells	GSE139386	ENSG00000115525	8869	ST3 beta-galactoside alpha-2,3-sialyltransferase 5	SIAT9|SIATGM3S|ST3GalV	protein_coding	Q9UNP4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7200
4.3302442827402e-199	-0.463264834470959	0.108	0.415	7.85419708003418e-195	SPDL1	Malignant cells	GSE139386	ENSG00000040275	54908	spindle apparatus coiled-coil protein 1	CCDC99|FLJ20364|hSpindly	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7201
4.42674914089314e-199	-0.592496386590841	0.436	0.755	8.02923759175198e-195	GLTP	Malignant cells	GSE139386	ENSG00000139433	51228	glycolipid transfer protein	NA	protein_coding	Q9NZD2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7202
5.10302139738395e-199	-0.445595209854535	0.097	0.395	9.25586021057501e-195	RP11-44F21.5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7203
5.53754444383307e-199	-0.540805738179135	0.264	0.602	1.00439981122244e-194	OSBPL9	Malignant cells	GSE139386	ENSG00000117859	114883	oxysterol binding protein like 9	NA	protein_coding	Q96SU4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7204
5.54256678935428e-199	-0.581977294760103	0.235	0.573	1.00531076425308e-194	ADORA2B	Malignant cells	GSE139386	ENSG00000170425	136	adenosine A2b receptor	NA	protein_coding	P29275	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7205
6.16285356561756e-199	0.963660856106337	0.813	0.577	1.11781837973171e-194	SDC4	Malignant cells	GSE139386	ENSG00000124145	6385	syndecan 4	amphiglycan|ryudocan|SYND4	protein_coding	P31431	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7206
6.71225618475194e-199	-0.587148436010839	0.693	0.909	1.21746902679031e-194	NMRAL1	Malignant cells	GSE139386	ENSG00000274684	57407	NmrA like redox sensor 1	FLJ25918|HSCARG|SDR48A1	protein_coding	Q9HBL8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7207
1.10674007849639e-198	-0.532965433735228	0.214	0.55	2.00740515437675e-194	PCBD2	Malignant cells	GSE139386	ENSG00000132570	84105	pterin-4 alpha-carbinolamine dehydratase 2	DCOH2|DCOHM	protein_coding	Q9H0N5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7208
1.29956150550944e-198	0.658936109563943	0.639	0.294	2.35714465869302e-194	FNDC3B	Malignant cells	GSE139386	ENSG00000075420	64778	fibronectin type III domain containing 3B	DKFZp762K137|FAD104|FLJ23399|PRO4979|YVTM2421	protein_coding	Q53EP0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7209
1.63188156701459e-198	-0.384671046575868	0.06	0.331	2.95990678625106e-194	ABCC5	Malignant cells	GSE139386	ENSG00000114770	10057	ATP binding cassette subfamily C member 5	EST277145|MOAT-C|MRP5|SMRP	protein_coding	O15440	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7210
3.92345518985062e-198	-0.719113509073324	0.572	0.848	7.11636302335105e-194	EPHX1	Malignant cells	GSE139386	ENSG00000143819	2052	epoxide hydrolase 1	EPHX	protein_coding	P07099	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7211
6.24632334940766e-198	-0.44268257264114	0.995	0.999	1.13295812911556e-193	ATP5J	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7212
6.2826475145956e-198	0.660147544838282	0.645	0.308	1.13954660619735e-193	GPR108	Malignant cells	GSE139386	ENSG00000125734	56927	G protein-coupled receptor 108	LUSTR2	protein_coding	Q9NPR9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7213
7.02964951009155e-198	-0.463674336922755	0.113	0.419	1.27503782814041e-193	PDE7A	Malignant cells	GSE139386	ENSG00000205268	5150	phosphodiesterase 7A	HCP1	protein_coding	Q13946	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7214
1.16830790537279e-197	-0.43060255806317	0.084	0.371	2.11907687876517e-193	PKP2	Malignant cells	GSE139386	ENSG00000057294	5318	plakophilin 2	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7215
1.20465481419779e-197	0.716831420651608	0.443	0.094	2.18500290199195e-193	SOX11	Malignant cells	GSE139386	ENSG00000176887	6664	SRY-box transcription factor 11	NA	protein_coding	P35716	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7216
3.17039418141886e-197	-0.536915205973728	0.211	0.544	5.75046096625753e-193	ACAA1	Malignant cells	GSE139386	ENSG00000060971	30	acetyl-CoA acyltransferase 1	Lnc-Myd88	protein_coding	P09110	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7217
5.71254733101289e-197	-0.574233648413367	0.694	0.912	1.03614183489912e-192	BAD	Malignant cells	GSE139386	ENSG00000002330	572	BCL2 associated agonist of cell death	BBC2|BCL2L8	protein_coding	Q92934	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7218
8.3595022441733e-197	0.557751873392231	0.438	0.089	1.51624651704815e-192	PDE8A	Malignant cells	GSE139386	ENSG00000073417	5151	phosphodiesterase 8A	HsT19550	protein_coding	O60658	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7219
8.86774409121048e-197	-0.57578434658288	0.822	0.964	1.60843142326376e-192	TPM3	Malignant cells	GSE139386	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7220
1.02802206601221e-196	0.638763497851797	0.886	0.72	1.86462642333294e-192	ARHGAP5	Malignant cells	GSE139386	ENSG00000100852	394	Rho GTPase activating protein 5	GFI2|p190-B|p190BRhoGAP|RhoGAP5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7221
1.29553157080058e-196	0.640420151518903	0.882	0.694	2.34983516311809e-192	UQCRC2	Malignant cells	GSE139386	ENSG00000140740	7385	ubiquinol-cytochrome c reductase core protein 2	QCR2|UQCR2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7222
1.50952745074203e-196	-0.587350321790331	0.733	0.93	2.73798089015589e-192	PLA2G12A	Malignant cells	GSE139386	ENSG00000123739	81579	phospholipase A2 group XIIA	PLA2G12	protein_coding	Q9BZM1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7223
1.56131565399477e-196	0.590879957796696	0.411	0.069	2.83191433321571e-192	JAG1	Malignant cells	GSE139386	ENSG00000101384	182	jagged canonical Notch ligand 1	AGS|AHD|AWS|CD339|HJ1|JAGL1	protein_coding	P78504	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7224
1.73182211535851e-196	-0.57728512042857	0.492	0.798	3.14117895283726e-192	UBE2E2	Malignant cells	GSE139386	ENSG00000182247	7325	ubiquitin conjugating enzyme E2 E2	FLJ25157|UbcH8	protein_coding	Q96LR5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7225
2.24470244598327e-196	-0.460648015921023	0.115	0.421	4.07144129652445e-192	OVOL2	Malignant cells	GSE139386	ENSG00000125850	58495	ovo like zinc finger 2	bA504H3.3|CHED|CHED1|HOVO2|ZNF339	protein_coding	Q9BRP0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7226
5.86392488502429e-196	0.655315059376177	0.557	0.201	1.06359869564571e-191	GOT1	Malignant cells	GSE139386	ENSG00000120053	2805	glutamic-oxaloacetic transaminase 1	AST|AST1|SGOT	protein_coding	P17174	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7227
6.62662379920926e-196	0.577677945362233	0.453	0.102	1.20193702470058e-191	TC2N	Malignant cells	GSE139386	ENSG00000276776	123036	tandem C2 domains, nuclear	C14orf47|C2CD1|FLJ36557|MTAC2D1|Tac2-N	protein_coding	Q8N9U0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7228
9.44144941462595e-196	-0.606878842429789	0.619	0.863	1.71249009482485e-191	NAA50	Malignant cells	GSE139386	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7229
1.18843323267699e-195	0.528807597966618	0.382	0.049	2.15558019742952e-191	DIRC2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7230
1.41225750640909e-195	0.61802033623679	0.518	0.164	2.56155266512481e-191	LPIN2	Malignant cells	GSE139386	ENSG00000101577	9663	lipin 2	KIAA0249	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7231
1.45858093321616e-195	-0.630578665346603	0.35	0.674	2.64557409666748e-191	TLK1	Malignant cells	GSE139386	ENSG00000198586	9874	tousled like kinase 1	KIAA0137|PKU-BETA	protein_coding	Q9UKI8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7232
1.46158978730649e-195	-0.689779040879628	0.527	0.814	2.65103155621652e-191	PSMD2	Malignant cells	GSE139386	ENSG00000175166	5708	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	MGC14274|P97|Rpn1|S2|TRAP2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7233
3.58636826688144e-195	0.46073632671562	0.303	0	6.50495476246955e-191	HOXD-AS2	Malignant cells	GSE139386	ENSG00000237380	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7234
2.51980814522066e-194	0.699182444511959	0.728	0.433	4.57042801380123e-190	LTBP3	Malignant cells	GSE139386	ENSG00000168056	4054	latent transforming growth factor beta binding protein 3	LTBP2	protein_coding	Q9NS15	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7235
2.79901580152473e-194	-0.325448648028735	1	1	5.07685486080556e-190	RPS10	Malignant cells	GSE139386	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7236
2.83601069107249e-194	0.499941874441135	0.316	0.008	5.14395619146727e-190	TMPRSS4	Malignant cells	GSE139386	ENSG00000137648	56649	transmembrane serine protease 4	CAP2|MT-SP2|TMPRSS3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7237
2.87721203803681e-194	-0.452075832011361	0.112	0.414	5.21868719459117e-190	FECH	Malignant cells	GSE139386	ENSG00000066926	2235	ferrochelatase	NA	protein_coding	P22830	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7238
3.20264930063859e-194	-0.54741027982751	0.35	0.685	5.80896530149827e-190	PEX2	Malignant cells	GSE139386	ENSG00000164751	5828	peroxisomal biogenesis factor 2	PAF-1|PMP35|PXMP3|RNF72|ZWS3	protein_coding	P28328	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7239
8.29455379156223e-194	0.657279350782279	0.419	0.077	1.50446616671356e-189	RND1	Malignant cells	GSE139386	ENSG00000172602	27289	Rho family GTPase 1	ARHS|Rho6|RHOS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7240
1.35569780901034e-193	0.588635603479704	0.428	0.086	2.45896468598295e-189	STEAP2	Malignant cells	GSE139386	ENSG00000157214	261729	STEAP2 metalloreductase	IPCA-1|PCANAP1|STAMP1|STMP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7241
1.50564821365447e-193	-0.381148693309495	0.057	0.321	2.73094472992647e-189	POP1	Malignant cells	GSE139386	ENSG00000104356	10940	POP1 homolog, ribonuclease P/MRP subunit	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7242
1.70783464428139e-193	-0.552693153642651	0.319	0.659	3.09767047779759e-189	FTSJ2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7243
2.05407524146236e-193	-0.375989672617774	0.058	0.323	3.72568167296444e-189	LRRC20	Malignant cells	GSE139386	ENSG00000172731	55222	leucine rich repeat containing 20	FLJ10751|FLJ10844	protein_coding	Q8TCA0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7244
2.83213157025742e-193	0.557741829660425	0.419	0.077	5.13692024213291e-189	CDC42EP5	Malignant cells	GSE139386	ENSG00000273633	148170	CDC42 effector protein 5	Borg3|CEP5	protein_coding	Q6NZY7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7245
4.62832104873039e-193	-0.609370626533635	0.478	0.775	8.39484871818717e-189	FLOT1	Malignant cells	GSE139386	ENSG00000223654	10211	flotillin 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7246
4.97867079386976e-193	-0.58194180325815	0.595	0.847	9.03031308592096e-189	NCBP2	Malignant cells	GSE139386	ENSG00000114503	22916	nuclear cap binding protein subunit 2	Cbc2|CBP20|NIP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7247
1.02375969434326e-192	-0.598317362490502	0.506	0.797	1.85689533359981e-188	NDUFA5	Malignant cells	GSE139386	ENSG00000128609	4698	NADH:ubiquinone oxidoreductase subunit A5	B13|CI-13kB|CI-13KD-B|NUFM|UQOR13	protein_coding	Q16718	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7248
1.12223467236332e-192	-0.599804583622066	0.533	0.806	2.03550924873259e-188	CCDC23	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7249
1.38942256070195e-192	0.536812088509625	0.973	0.917	2.52013464060121e-188	DDX5	Malignant cells	GSE139386	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7250
4.81370836780222e-192	-0.46900302238824	0.154	0.473	8.73110423751967e-188	C7orf55-LUC7L2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7251
5.94844838567489e-192	0.628249973845745	0.643	0.304	1.07892956819371e-187	MIF4GD	Malignant cells	GSE139386	ENSG00000125457	57409	MIF4G domain containing	AD023|MGC45027|MIFD|SLIP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7252
2.50301825022823e-191	-0.382471659968814	0.055	0.316	4.53997450226395e-187	DIAPH3	Malignant cells	GSE139386	ENSG00000139734	81624	diaphanous related formin 3	AN|AUNA1|DRF3|FLJ34705|NSDAN	protein_coding	Q9NSV4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7253
2.77837245942315e-191	0.705138117681397	0.634	0.285	5.0394119669017e-187	APOE	Malignant cells	GSE139386	ENSG00000130203	348	apolipoprotein E	AD2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7254
3.34134900435012e-191	-0.590259600866401	0.451	0.758	6.06053882409024e-187	LAD1	Malignant cells	GSE139386	ENSG00000159166	3898	ladinin 1	NA	protein_coding	O00515	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7255
4.7031188192027e-191	0.363057733721903	1	1	8.53051691426985e-187	EDF1	Malignant cells	GSE139386	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7256
5.24612501828845e-191	0.710997326565556	0.661	0.331	9.51542155817158e-187	SERPINE2	Malignant cells	GSE139386	ENSG00000135919	5270	serpin family E member 2	GDN|nexin|PI7|PN1|PNI	protein_coding	P07093	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7257
5.60604418223167e-191	0.51887335265276	0.965	0.869	1.01682429377318e-186	TUFM	Malignant cells	GSE139386	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7258
6.13165719851591e-191	0.603485984266364	0.955	0.851	1.11215998266682e-186	CLDN7	Malignant cells	GSE139386	ENSG00000288292	1366	claudin 7	CEPTRL2|CPETRL2|Hs.84359	protein_coding	O95471	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7259
1.17798862752675e-190	-0.584509145741988	0.455	0.758	2.13663577260802e-186	THAP7	Malignant cells	GSE139386	ENSG00000184436	80764	THAP domain containing 7	MGC10963	protein_coding	Q9BT49	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7260
1.18459873826847e-190	-0.57551562220297	0.577	0.845	2.14862519147135e-186	UBAC1	Malignant cells	GSE139386	ENSG00000130560	10422	UBA domain containing 1	GBDR1|KPC2|UBADC1	protein_coding	Q9BSL1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7261
2.11458564085046e-190	0.577411406217331	0.491	0.14	3.83543543537457e-186	TNFRSF18	Malignant cells	GSE139386	ENSG00000186891	8784	TNF receptor superfamily member 18	AITR|CD357|GITR	protein_coding	Q9Y5U5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7262
2.26993391474354e-190	-0.510062732345777	0.909	0.988	4.11720613456183e-186	TMEM54	Malignant cells	GSE139386	ENSG00000121900	113452	transmembrane protein 54	BCLP|CAC-1	protein_coding	Q969K7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7263
2.38230840634505e-190	0.620009906649953	0.928	0.714	4.32103098742865e-186	SMIM22	Malignant cells	GSE139386	ENSG00000267795	440335	small integral membrane protein 22	CASIMO1	protein_coding	K7EJ46	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7264
7.00724708136574e-190	-0.531875640023358	0.219	0.547	1.27097447561812e-185	MED31	Malignant cells	GSE139386	ENSG00000108590	51003	mediator complex subunit 31	CGI-125|Soh1	protein_coding	Q9Y3C7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7265
7.26519023618252e-190	0.525091137453126	0.996	0.985	1.31776020503879e-185	NDUFV2	Malignant cells	GSE139386	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7266
1.07207111824258e-189	-0.432238713307957	0.106	0.404	1.94452259426839e-185	EGLN3	Malignant cells	GSE139386	ENSG00000129521	112399	egl-9 family hypoxia inducible factor 3	HIFPH3|PHD3	protein_coding	Q9H6Z9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7267
1.65462826262555e-189	-0.520445622290394	0.243	0.575	3.00116474275021e-185	NUTM2A-AS1	Malignant cells	GSE139386	ENSG00000223482	728190	NUTM2A antisense RNA 1	FAM22A-AS1	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7268
2.37257348389245e-189	-0.477099753803928	0.112	0.41	4.30337378508412e-185	CSRP2	Malignant cells	GSE139386	ENSG00000175183	1466	cysteine and glycine rich protein 2	CRP2|LMO5|SmLIM	protein_coding	Q16527	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7269
2.641455505762e-189	-0.570927338236442	0.59	0.852	4.79107199635111e-185	UPF3A	Malignant cells	GSE139386	ENSG00000169062	65110	UPF3A regulator of nonsense mediated mRNA decay	HUPF3A|RENT3A|UPF3	protein_coding	Q9H1J1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7270
3.40352667573854e-189	-0.49238263475807	0.186	0.511	6.17331668445457e-185	ALG14	Malignant cells	GSE139386	ENSG00000172339	199857	ALG14 UDP-N-acetylglucosaminyltransferase subunit	MGC19780	protein_coding	Q96F25	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7271
6.05443323350116e-189	-0.487731764321283	0.196	0.522	1.09815309989244e-184	SSH2	Malignant cells	GSE139386	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7272
6.71323014656898e-189	0.498665552237468	0.326	0.018	1.21764568398468e-184	SEMA3F	Malignant cells	GSE139386	ENSG00000001617	6405	semaphorin 3F	Sema4|SEMAK	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7273
6.82450582214511e-189	-0.566160855604206	0.879	0.973	1.23782886602068e-184	SRRM2	Malignant cells	GSE139386	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7274
1.88791939652969e-188	-0.476072573357792	0.135	0.44	3.42430820142555e-184	PPARG	Malignant cells	GSE139386	ENSG00000132170	5468	peroxisome proliferator activated receptor gamma	NR1C3|PPARG1|PPARG2|PPARgamma	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7275
2.01093345833097e-188	-0.57075397664517	0.598	0.857	3.64743110672072e-184	C9orf78	Malignant cells	GSE139386	ENSG00000136819	51759	chromosome 9 open reading frame 78	CSU2|HCA59|HSPC220	protein_coding	Q9NZ63	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7276
2.32977103738255e-188	-0.492716401701636	0.192	0.519	4.22573870760446e-184	RBFA	Malignant cells	GSE139386	ENSG00000101546	79863	ribosome binding factor A	C18orf22|FLJ21172|HsT169	protein_coding	Q8N0V3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7277
3.74670950005659e-188	0.573713634576484	0.485	0.138	6.79578169120265e-184	PRNP	Malignant cells	GSE139386	ENSG00000171867	5621	prion protein	AltPrP|CD230|CJD|GSS|PRIP|PRP	protein_coding	P04156	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7278
4.96795473659713e-188	0.685594292660145	0.83	0.627	9.01087630123988e-184	SEC11C	Malignant cells	GSE139386	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7279
5.79078199806814e-188	-0.536218285858223	0.259	0.59	1.0503320388096e-183	WDR77	Malignant cells	GSE139386	ENSG00000116455	79084	WD repeat domain 77	MEP50|p44	protein_coding	Q9BQA1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7280
7.10109086371158e-188	-0.370784854596437	0.062	0.328	1.28799586086001e-183	RECQL4	Malignant cells	GSE139386	ENSG00000160957	9401	RecQ like helicase 4	RecQ4	protein_coding	O94761	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7281
2.12924754150661e-187	-0.443777339088915	1	1	3.86202919078468e-183	DSTN	Malignant cells	GSE139386	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7282
2.46809349204124e-187	-0.385080311818288	0.071	0.341	4.47662797586439e-183	EPN3	Malignant cells	GSE139386	ENSG00000049283	55040	epsin 3	FLJ20778|MGC129899	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7283
2.56271465465581e-187	-0.500581403556391	0.996	0.998	4.64825184061471e-183	CYCS	Malignant cells	GSE139386	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7284
1.1272869864436e-186	0.544894321606955	0.972	0.914	2.04467313601141e-182	SF3B5	Malignant cells	GSE139386	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7285
1.86073323921634e-186	-0.464583060495481	0.136	0.441	3.3749979492906e-182	SCCPDH	Malignant cells	GSE139386	ENSG00000143653	51097	saccharopine dehydrogenase (putative)	CGI-49|NET11	protein_coding	Q8NBX0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7286
3.79242810047346e-186	-0.496956644474623	0.194	0.516	6.87870608863876e-182	RPS6KA4	Malignant cells	GSE139386	ENSG00000162302	8986	ribosomal protein S6 kinase A4	MSK2|RSK-B	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7287
6.30471731446043e-186	-0.48325888453272	0.176	0.499	1.14354962649683e-181	HK1	Malignant cells	GSE139386	ENSG00000156515	3098	hexokinase 1	NA	protein_coding	P19367	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7288
8.30148807881399e-186	-0.583767237414263	0.954	0.991	1.50572390773528e-181	CHCHD10	Malignant cells	GSE139386	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7289
1.03707751018311e-185	-0.520737982069782	0.236	0.562	1.88105118797012e-181	BAIAP2	Malignant cells	GSE139386	ENSG00000175866	10458	BAR/IMD domain containing adaptor protein 2	BAP2|IRSp53|WAML	protein_coding	Q9UQB8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7290
1.24008375808219e-185	-0.566693816037637	0.668	0.899	2.24926392040947e-181	ZNF22	Malignant cells	GSE139386	ENSG00000165512	7570	zinc finger protein 22	HKR-T1|KOX15|Zfp422|ZNF422	protein_coding	P17026	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7291
3.24578582246044e-185	0.521227218738614	0.986	0.962	5.88720632477875e-181	POLR1D	Malignant cells	GSE139386	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7292
3.50253985817696e-185	-0.59045986828674	0.408	0.715	6.35290679476138e-181	SIRT7	Malignant cells	GSE139386	ENSG00000187531	51547	sirtuin 7	NA	protein_coding	Q9NRC8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7293
4.33071048927661e-185	-0.553926896012669	0.172	0.514	7.85504268544992e-181	TOP2A	Malignant cells	GSE139386	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7294
4.47335554292546e-185	-0.578654552878666	0.148	0.452	8.1137722837582e-181	CYP1B1	Malignant cells	GSE139386	ENSG00000138061	1545	cytochrome P450 family 1 subfamily B member 1	CP1B|GLC3A	protein_coding	Q16678	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7295
6.1619304498418e-185	0.641471684888493	0.794	0.554	1.11765094499231e-180	WBP2	Malignant cells	GSE139386	ENSG00000132471	23558	WW domain binding protein 2	GRAMD6|WBP-2	protein_coding	Q969T9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7296
6.26057738243571e-185	-0.559656224411817	0.468	0.766	1.13554352562619e-180	URM1	Malignant cells	GSE139386	ENSG00000167118	81605	ubiquitin related modifier 1	C9orf74|MGC2668	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7297
6.69435337272365e-185	0.652590730545354	0.88	0.7	1.21422181474462e-180	ERO1L	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7298
7.52185918304302e-185	-0.386978582575159	0.069	0.334	1.36431481862034e-180	SLC12A8	Malignant cells	GSE139386	ENSG00000221955	84561	solute carrier family 12 member 8	CCC9	protein_coding	A0AV02	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7299
7.5903757050481e-185	-0.457268408937465	0.156	0.474	1.37674234538162e-180	NRM	Malignant cells	GSE139386	ENSG00000236843	11270	nurim	NRM29	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7300
8.11171954509337e-185	-0.52692154506523	0.107	0.406	1.47130369108904e-180	CCNB2	Malignant cells	GSE139386	ENSG00000157456	9133	cyclin B2	HsT17299	protein_coding	O95067	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7301
1.05263123647938e-184	-0.548156140875927	0.339	0.664	1.9092625367263e-180	MAPK9	Malignant cells	GSE139386	ENSG00000050748	5601	mitogen-activated protein kinase 9	JNK2|p54a|PRKM9|SAPK	protein_coding	P45984	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7302
1.36480449813715e-184	0.641597665754289	0.916	0.764	2.47548239872117e-180	HLA-C	Malignant cells	GSE139386	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7303
1.7734293954482e-184	-0.531753673672494	0.314	0.646	3.21664623746394e-180	NUP50	Malignant cells	GSE139386	ENSG00000093000	10762	nucleoporin 50	NPAP60L	protein_coding	Q9UKX7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7304
1.98321260308708e-184	-0.57007368084391	0.415	0.726	3.59715101947934e-180	HMGXB4	Malignant cells	GSE139386	ENSG00000100281	10042	HMG-box containing 4	HMG2L1|P53N|THC211630	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7305
2.02105018925045e-184	0.540915893023238	0.319	0.017	3.66578083326246e-180	THBD	Malignant cells	GSE139386	ENSG00000178726	7056	thrombomodulin	BDCA-3|CD141|THRM	protein_coding	P07204	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7306
2.53612990189483e-184	-0.595284261437026	0.635	0.877	4.60003241605684e-180	DNAJC8	Malignant cells	GSE139386	ENSG00000285317	22826	DnaJ heat shock protein family (Hsp40) member C8	SPF31	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7307
2.56137518795761e-184	-0.599416925551985	0.492	0.775	4.64582231591752e-180	DUSP23	Malignant cells	GSE139386	ENSG00000158716	54935	dual specificity phosphatase 23	DUSP25|FLJ20442	protein_coding	Q9BVJ7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7308
2.64845355382323e-184	0.586899824482334	0.521	0.177	4.80376505592458e-180	AHR	Malignant cells	GSE139386	ENSG00000106546	196	aryl hydrocarbon receptor	bHLHe76	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7309
3.46885979653663e-184	-0.620218037490521	0.47	0.761	6.29181789895813e-180	SMCO4	Malignant cells	GSE139386	ENSG00000166002	56935	single-pass membrane protein with coiled-coil domains 4	C11orf75|FN5	protein_coding	Q9NRQ5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7310
3.77245279926263e-184	-0.515168787308711	0.247	0.577	6.84247488730256e-180	TSPAN17	Malignant cells	GSE139386	ENSG00000048140	26262	tetraspanin 17	FBX23|FBXO23|TM4SF17	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7311
5.89809245017596e-184	-0.475743839852703	0.174	0.491	1.06979600861292e-179	LIMK2	Malignant cells	GSE139386	ENSG00000182541	3985	LIM domain kinase 2	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7312
6.14465344273232e-184	-0.364862410180604	0.059	0.315	1.11451724144279e-179	PRKAG2	Malignant cells	GSE139386	ENSG00000106617	51422	protein kinase AMP-activated non-catalytic subunit gamma 2	AAKG|AAKG2|CMH6|H91620p|WPWS	protein_coding	Q9UGJ0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7313
6.3895557170983e-184	-0.574676292812883	0.454	0.759	1.15893761596729e-179	JOSD2	Malignant cells	GSE139386	ENSG00000161677	126119	Josephin domain containing 2	SBBI54	protein_coding	Q8TAC2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7314
7.21121584723059e-184	-0.594940530714761	0.448	0.754	1.30797033037069e-179	WBP5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7315
7.70511473845966e-184	-0.503505391159836	0.25	0.582	1.39755371126181e-179	CHMP1A	Malignant cells	GSE139386	ENSG00000131165	5119	charged multivesicular body protein 1A	CHMP1|KIAA0047|PCOLN3|PRSM1|Vps46A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7316
2.38386354798165e-183	0.597250458405158	0.508	0.165	4.32385170332912e-179	TMC6	Malignant cells	GSE139386	ENSG00000141524	11322	transmembrane channel like 6	EVER1|EVIN1|LAK-4P|TNRC6C-AS1	protein_coding	Q7Z403	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7317
2.44181645275785e-183	-0.410309061483957	0.095	0.376	4.42896668201219e-179	NUP153	Malignant cells	GSE139386	ENSG00000124789	9972	nucleoporin 153	HNUP153	protein_coding	P49790	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7318
2.61535685850954e-183	0.656158506910636	0.786	0.531	4.74373426996461e-179	ITM2C	Malignant cells	GSE139386	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7319
3.92682007901904e-183	-0.554150412950885	0.333	0.657	7.12246625932474e-179	ANKLE2	Malignant cells	GSE139386	ENSG00000176915	23141	ankyrin repeat and LEM domain containing 2	KIAA0692|Lem4|LEMD7	protein_coding	Q86XL3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7320
4.27710328628777e-183	-0.562448474595854	0.366	0.682	7.75780994066876e-179	KIAA0947	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7321
4.90780310070069e-183	-0.370916446597455	0.054	0.305	8.9017732640509e-179	APOBEC3C	Malignant cells	GSE139386	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7322
6.76843842752099e-183	-0.617684923588733	0.446	0.749	1.22765936198376e-178	ITGAV	Malignant cells	GSE139386	ENSG00000138448	3685	integrin subunit alpha V	CD51|MSK8|VNRA|VTNR	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7323
6.9834980550327e-183	-0.460577399441293	0.16	0.473	1.26666687722183e-178	TMEM107	Malignant cells	GSE139386	ENSG00000179029	84314	transmembrane protein 107	JBTS29|MGC10744|MKS13	protein_coding	Q6UX40	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7324
1.08998894963379e-182	-0.386258752780778	0.066	0.327	1.97702195684577e-178	FKBP7	Malignant cells	GSE139386	ENSG00000079150	51661	FKBP prolyl isomerase 7	FKBP23	protein_coding	Q9Y680	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7325
2.34189527436811e-182	-0.407293719910179	0.094	0.376	4.24772964864888e-178	C4orf46	Malignant cells	GSE139386	ENSG00000205208	201725	chromosome 4 open reading frame 46	LOC201725|RCDG1	protein_coding	Q504U0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7326
2.351586465096e-182	-0.378200209717757	0.057	0.309	4.26530753039112e-178	HOMER2	Malignant cells	GSE139386	ENSG00000103942	9455	homer scaffold protein 2	CPD|Cupidin|DFNA68|HOMER-2|HOMER-2A|HOMER-2B|Vesl-2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7327
2.74580953111159e-182	-0.558599774754244	0.654	0.876	4.98034932753021e-178	DPH3	Malignant cells	GSE139386	ENSG00000154813	285381	diphthamide biosynthesis 3	DELGIP|DELGIP1|DESR1|DPH3A|KTI11|MGC20197|ZCSL2	protein_coding	Q96FX2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7328
4.51899813295752e-182	-0.579054040266222	0.763	0.931	8.19655881355835e-178	SRRM1	Malignant cells	GSE139386	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7329
5.58238309654974e-182	-0.589606088466511	0.67	0.893	1.01253264605219e-177	CISD1	Malignant cells	GSE139386	ENSG00000122873	55847	CDGSH iron sulfur domain 1	C10orf70|MDS029|mitoNEET|ZCD1	protein_coding	Q9NZ45	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7330
6.45681050760643e-182	0.444660254265633	1	1	1.17113628986965e-177	CLIC1	Malignant cells	GSE139386	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7331
6.51249044978503e-182	-0.396376818963964	0.048	0.291	1.18123551778201e-177	L3HYPDH	Malignant cells	GSE139386	ENSG00000126790	112849	trans-L-3-hydroxyproline dehydratase	C14orf149|FLJ25436	protein_coding	Q96EM0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7332
7.0562419647281e-182	-0.348547711584518	0.045	0.286	1.27986116756238e-177	KCTD1	Malignant cells	GSE139386	ENSG00000134504	284252	potassium channel tetramerization domain containing 1	C18orf5	protein_coding	Q719H9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7333
8.47474007893777e-182	-0.738182116476454	0.68	0.908	1.53714835551773e-177	TUBA1C	Malignant cells	GSE139386	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7334
1.11891603458058e-181	-0.340016587282308	0.043	0.282	2.02948990352225e-177	TMEM19	Malignant cells	GSE139386	ENSG00000139291	55266	transmembrane protein 19	FLJ10936	protein_coding	Q96HH6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7335
1.93804575266325e-181	-0.449232268272233	0.057	0.308	3.51522738618061e-177	CLIC3	Malignant cells	GSE139386	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7336
1.96735181966009e-181	-0.490416837169394	0.174	0.484	3.56838273049946e-177	ANKRD9	Malignant cells	GSE139386	ENSG00000156381	122416	ankyrin repeat domain 9	NA	protein_coding	Q96BM1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7337
3.97553551114069e-181	-0.501255364997439	0.249	0.575	7.21082631010698e-177	PPP5C	Malignant cells	GSE139386	ENSG00000011485	5536	protein phosphatase 5 catalytic subunit	PP5|PPP5	protein_coding	P53041	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7338
5.1628137035983e-181	-0.408279264738749	0.091	0.368	9.36431149558659e-177	LRRCC1	Malignant cells	GSE139386	ENSG00000133739	85444	leucine rich repeat and coiled-coil centrosomal protein 1	CLERC|KIAA1764|VFL1	protein_coding	Q9C099	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7339
5.36258664775106e-181	-0.556139603035454	0.631	0.864	9.72665966169087e-177	ERI3	Malignant cells	GSE139386	ENSG00000117419	79033	ERI1 exoribonuclease family member 3	FLJ22943|PINT1|PRNPIP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7340
5.42912408419176e-181	-0.334686412923081	0.031	0.254	9.84734526390702e-177	AMOTL1	Malignant cells	GSE139386	ENSG00000166025	154810	angiomotin like 1	JEAP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7341
5.87233514259929e-181	-0.618689449122636	0.474	0.76	1.06512414816466e-176	VCL	Malignant cells	GSE139386	ENSG00000035403	7414	vinculin	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7342
8.62180056020254e-181	-0.428747664863333	0.11	0.398	1.56382218560954e-176	EED	Malignant cells	GSE139386	ENSG00000074266	8726	embryonic ectoderm development	HEED|WAIT-1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7343
9.65563400388545e-181	0.62129598714707	0.588	0.252	1.75133889562474e-176	ACP6	Malignant cells	GSE139386	ENSG00000162836	51205	acid phosphatase 6, lysophosphatidic	ACPL1|LPAP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7344
9.70262472834777e-181	-0.443640345371981	0.135	0.435	1.75986207322772e-176	SNHG9	Malignant cells	GSE139386	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7345
1.92374441580981e-180	-0.539252762196378	0.734	0.929	3.48928762139583e-176	HDDC2	Malignant cells	GSE139386	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7346
3.08899590413842e-180	-0.503430707542075	0.262	0.587	5.60282077092626e-176	LRRC58	Malignant cells	GSE139386	ENSG00000163428	116064	leucine rich repeat containing 58	NA	protein_coding	Q96CX6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7347
5.37515847047364e-180	0.598057591161918	0.931	0.853	9.74946243374509e-176	MLEC	Malignant cells	GSE139386	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7348
5.6095504044313e-180	0.59746815729291	0.497	0.158	1.01746025235575e-175	TM7SF2	Malignant cells	GSE139386	ENSG00000149809	7108	transmembrane 7 superfamily member 2	ANG1|DHCR14A|NET47	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7349
7.76377573001821e-180	-0.578199591440956	0.593	0.839	1.4081936419107e-175	CHCHD3	Malignant cells	GSE139386	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7350
1.35729767708345e-179	-0.358367295977473	0.056	0.305	2.46186652669396e-175	RASAL2	Malignant cells	GSE139386	ENSG00000075391	9462	RAS protein activator like 2	nGAP	protein_coding	Q9UJF2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7351
2.67824929098351e-179	-0.446745093666096	0.112	0.398	4.85780856398588e-175	C1orf21	Malignant cells	GSE139386	ENSG00000116667	81563	chromosome 1 open reading frame 21	PIG13	protein_coding	Q9H246	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7352
2.70632878774981e-179	-0.469332913131403	0.97	0.996	4.9087391552206e-175	SUMO1	Malignant cells	GSE139386	ENSG00000116030	7341	small ubiquitin like modifier 1	GMP1|OFC10|PIC1|SMT3C|SMT3H3|SUMO-1|UBL1	protein_coding	P63165	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7353
3.01825418740555e-179	-0.375856546665512	0.058	0.31	5.47450944511619e-175	CSF1	Malignant cells	GSE139386	ENSG00000184371	1435	colony stimulating factor 1	M-CSF|MCSF|MGC31930	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7354
3.64057152125371e-179	-0.460135338611438	0.177	0.492	6.60326862524997e-175	SNN	Malignant cells	GSE139386	ENSG00000184602	8303	stannin	NA	protein_coding	O75324	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7355
6.40978504630131e-179	-0.489887112265007	0.936	0.991	1.16260681169813e-174	NAA10	Malignant cells	GSE139386	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7356
9.04876425388193e-179	-0.394171803587185	0.077	0.345	1.6412648603691e-174	MCM2	Malignant cells	GSE139386	ENSG00000073111	4171	minichromosome maintenance complex component 2	BM28|CCNL1|cdc19|CDCL1|D3S3194|DFNA70|KIAA0030	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7357
1.17464078819075e-178	0.451527559025593	0.297	0.008	2.13056346162039e-174	TMEM61	Malignant cells	GSE139386	ENSG00000143001	199964	transmembrane protein 61	NA	protein_coding	Q8N0U2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7358
1.89766001965172e-178	-0.445369307378887	0.132	0.431	3.4419757436443e-174	SASS6	Malignant cells	GSE139386	ENSG00000156876	163786	SAS-6 centriolar assembly protein	DKFZp761A078|FLJ22097|SAS-6|SAS6	protein_coding	Q6UVJ0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7359
3.79997615817325e-178	-0.327917432920692	0.037	0.264	6.89239675569464e-174	MARC1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7360
4.20637711279452e-178	-0.562316673181373	0.496	0.785	7.6295268071867e-174	STARD7	Malignant cells	GSE139386	ENSG00000084090	56910	StAR related lipid transfer domain containing 7	GTT1	protein_coding	Q9NQZ5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7361
4.33786448720115e-178	-0.467317358679862	0.145	0.444	7.86801860688545e-174	TEAD2	Malignant cells	GSE139386	ENSG00000074219	8463	TEA domain transcription factor 2	ETF|TEF-4|TEF4	protein_coding	Q15562	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7362
6.76855328277518e-178	-0.491991139885315	0.225	0.549	1.22768019442976e-173	RAB27A	Malignant cells	GSE139386	ENSG00000069974	5873	RAB27A, member RAS oncogene family	GS2|HsT18676|RAB27|RAM	protein_coding	P51159	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7363
7.05305291953592e-178	-0.540852995568638	0.338	0.659	1.27928273854543e-173	KIAA1522	Malignant cells	GSE139386	ENSG00000162522	57648	KIAA1522	NA	protein_coding	Q9P206	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7364
7.66076836243017e-178	-0.558622430439426	0.55	0.826	1.38951016557758e-173	NAP1L4	Malignant cells	GSE139386	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7365
8.2011845910544e-178	-0.513285909509776	0.222	0.542	1.48753086112545e-173	PAK1IP1	Malignant cells	GSE139386	ENSG00000285226	55003	PAK1 interacting protein 1	bA421M1.5|FLJ20624|hPIP1|MAK11|PIP1|WDR84	protein_coding	Q9NWT1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7366
8.32498694120933e-178	-0.557387220923339	0.424	0.741	1.50998613139655e-173	USP1	Malignant cells	GSE139386	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7367
9.5521345259205e-178	-0.578375205343546	0.543	0.822	1.73256616031146e-173	TGOLN2	Malignant cells	GSE139386	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7368
1.43268613792814e-177	-0.364480401571508	0.053	0.297	2.59860611697407e-173	C15orf52	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7369
3.05360346718616e-177	-0.503121503613825	0.304	0.632	5.53862596878226e-173	UBE3B	Malignant cells	GSE139386	ENSG00000151148	89910	ubiquitin protein ligase E3B	NA	protein_coding	Q7Z3V4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7370
3.44079635793057e-177	0.537314082447386	0.452	0.119	6.24091643401447e-173	CTAGE5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7371
4.15609855720268e-177	-0.415968306409273	0.113	0.4	7.53833156305423e-173	PHTF1	Malignant cells	GSE139386	ENSG00000116793	10745	putative homeodomain transcription factor 1	PHTF	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7372
4.71490798323825e-177	0.536074147838052	0.974	0.934	8.55190009999754e-173	CHMP4B	Malignant cells	GSE139386	ENSG00000101421	128866	charged multivesicular body protein 4B	C20orf178|dJ553F4.4|Shax1|SNF7-2|VPS32B	protein_coding	Q9H444	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7373
6.06065999622996e-177	-0.57789934690387	0.65	0.874	1.09928251011619e-172	MRPL17	Malignant cells	GSE139386	ENSG00000158042	63875	mitochondrial ribosomal protein L17	MRP-L26|RPML26	protein_coding	Q9NRX2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7374
6.97455313663153e-177	-0.500776976074887	0.237	0.556	1.26504444792223e-172	ELP5	Malignant cells	GSE139386	ENSG00000288485	23587	elongator acetyltransferase complex subunit 5	C17orf81|DERP6	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7375
9.00183170756132e-177	-0.514162540262277	0.316	0.641	1.63275223511747e-172	E2F4	Malignant cells	GSE139386	ENSG00000205250	1874	E2F transcription factor 4	E2F-4	protein_coding	Q16254	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7376
1.30479791145024e-176	-0.447086653923933	1	1	2.36664245178844e-172	ACTB	Malignant cells	GSE139386	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7377
1.49167965020238e-176	-0.413628296135692	0.076	0.338	2.70560854953707e-172	RP11-803D5.4	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7378
2.54756699051823e-176	0.653206322782392	0.709	0.414	4.62077700740196e-172	GALE	Malignant cells	GSE139386	ENSG00000117308	2582	UDP-galactose-4-epimerase	SDR1E1	protein_coding	Q14376	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7379
3.26187921534385e-176	-0.540297964581252	0.378	0.692	5.91639652079068e-172	EMC8	Malignant cells	GSE139386	ENSG00000131148	10328	ER membrane protein complex subunit 8	C16orf2|C16orf4|COX4NB|FAM158B|NOC4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7380
3.53910249756549e-176	-0.57908427200086	0.655	0.877	6.41922411008428e-172	MRPL22	Malignant cells	GSE139386	ENSG00000082515	29093	mitochondrial ribosomal protein L22	HSPC158|MRP-L25|RPML25	protein_coding	Q9NWU5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7381
3.66879916037631e-176	-0.447009007615306	0.14	0.435	6.65446791709055e-172	C22orf29	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7382
3.82002701733697e-176	-0.470382564225946	0.205	0.523	6.9287650040458e-172	HCFC1	Malignant cells	GSE139386	ENSG00000172534	3054	host cell factor C1	CFF|HCF-1|HCF1|HFC1|MGC70925|MRX3|PPP1R89|VCAF	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7383
8.46252650600584e-176	-0.562222749626154	0.287	0.603	1.53493305765934e-171	CTXN1	Malignant cells	GSE139386	ENSG00000178531	404217	cortexin 1	FLJ25968	protein_coding	P60606	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7384
1.33434663488004e-175	-0.382751745931358	0.074	0.341	2.42023792634542e-171	PBK	Malignant cells	GSE139386	ENSG00000168078	55872	PDZ binding kinase	CT84|FLJ14385|Nori-3|SPK|TOPK	protein_coding	Q96KB5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7385
1.45608882415758e-175	-0.43045427805041	0.141	0.443	2.64105390925702e-171	CATSPER1	Malignant cells	GSE139386	ENSG00000175294	117144	cation channel sperm associated 1	CATSPER	protein_coding	Q8NEC5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7386
2.1934401246325e-175	0.624766380535964	0.879	0.73	3.97846169805844e-171	POGZ	Malignant cells	GSE139386	ENSG00000143442	23126	pogo transposable element derived with ZNF domain	KIAA0461|ZNF280E|ZNF635	protein_coding	Q7Z3K3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7387
2.41720958297526e-175	-0.43890363790242	0.156	0.483	4.38433474160052e-171	PRR11	Malignant cells	GSE139386	ENSG00000068489	55771	proline rich 11	FLJ11029	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7388
3.39687212050179e-175	-0.34698673978129	0.048	0.286	6.16124665216614e-171	C1QTNF6	Malignant cells	GSE139386	ENSG00000133466	114904	C1q and TNF related 6	CTRP6|ZACRP6	protein_coding	Q9BXI9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7389
4.85255476096446e-175	-0.551292144994024	0.573	0.853	8.80156382543733e-171	CBX5	Malignant cells	GSE139386	ENSG00000094916	23468	chromobox 5	HP1|HP1-ALPHA|HP1Hs-alpha	protein_coding	P45973	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7390
5.38224082638035e-175	-0.554362945018341	0.75	0.937	9.76230841088868e-171	TPRKB	Malignant cells	GSE139386	ENSG00000144034	51002	TP53RK binding protein	CGI-121|CGI121	protein_coding	Q9Y3C4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7391
6.1881017816066e-175	-0.58996391260396	0.537	0.798	1.1223979011478e-170	C6orf62	Malignant cells	GSE139386	ENSG00000112308	81688	chromosome 6 open reading frame 62	DKFZP564G182|FLJ12619|XTP12	protein_coding	Q9GZU0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7392
6.7189095377661e-175	0.56535065302153	0.917	0.829	1.21867581196002e-170	CCT4	Malignant cells	GSE139386	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7393
7.2551121376143e-175	-0.52993065085684	0.617	0.852	1.31593223952048e-170	LSM1	Malignant cells	GSE139386	ENSG00000175324	27257	LSM1 homolog, mRNA degradation associated	CASM|YJL124C	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7394
9.98691239059133e-175	-0.400278242233301	0.066	0.325	1.81142616940546e-170	SGOL2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7395
1.04217092916962e-174	-0.499280371122349	0.237	0.556	1.89028963132785e-170	BAG2	Malignant cells	GSE139386	ENSG00000112208	9532	BAG cochaperone 2	NA	protein_coding	O95816	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7396
1.15107599037601e-174	-0.520219991273735	0.346	0.667	2.08782163134402e-170	ALKBH5	Malignant cells	GSE139386	ENSG00000091542	54890	alkB homolog 5, RNA demethylase	FLJ20308|OFOXD1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7397
1.20475016955266e-174	-0.582614821380441	0.807	0.956	2.18517585753461e-170	NFE2L2	Malignant cells	GSE139386	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7398
2.40559192239904e-174	0.633047515869461	0.752	0.492	4.36326262884739e-170	IFT27	Malignant cells	GSE139386	ENSG00000100360	11020	intraflagellar transport 27	BBS19|FAP156|RABL4|RAYL	protein_coding	Q9BW83	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7399
4.06109847599083e-174	0.439231595420622	0.286	0.005	7.36602041575216e-170	LAMP3	Malignant cells	GSE139386	ENSG00000078081	27074	lysosomal associated membrane protein 3	CD208|DC-LAMP|DCLAMP|LAMP|TSC403	protein_coding	Q9UQV4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7400
6.52252989141799e-174	0.578400375978886	0.974	0.919	1.18305647170539e-169	TMED9	Malignant cells	GSE139386	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7401
1.08076708472477e-173	-0.38319829007513	0.057	0.304	1.96029533827378e-169	KIF23	Malignant cells	GSE139386	ENSG00000137807	9493	kinesin family member 23	KNSL5|MKLP-1|MKLP1	protein_coding	Q02241	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7402
1.33870458368812e-173	-0.487359593336721	0.91	0.981	2.42814237389352e-169	RAB34	Malignant cells	GSE139386	ENSG00000109113	83871	RAB34, member RAS oncogene family	NARR|RAB39|RAH	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7403
2.19442362387862e-173	-0.507826672765199	0.282	0.605	3.98024556899104e-169	GSR	Malignant cells	GSE139386	ENSG00000104687	2936	glutathione-disulfide reductase	NA	protein_coding	P00390	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7404
2.22362099044084e-173	0.551575896881633	0.977	0.911	4.03320375246159e-169	SPCS2	Malignant cells	GSE139386	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7405
3.194308357976e-173	-0.47476225221869	0.207	0.519	5.79383649969687e-169	SEH1L	Malignant cells	GSE139386	ENSG00000085415	81929	SEH1 like nucleoporin	SEC13L|Seh1|SEH1A|SEH1B	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7406
3.32581244674871e-173	-0.523228335032985	0.275	0.587	6.0323586159128e-169	WDR5	Malignant cells	GSE139386	ENSG00000196363	11091	WD repeat domain 5	CFAP89|SWD3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7407
4.55715683682339e-173	-0.425773508642062	0.096	0.37	8.26577107063027e-169	FBXO5	Malignant cells	GSE139386	ENSG00000112029	26271	F-box protein 5	EMI1|FBX5|Fbxo31	protein_coding	Q9UKT4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7408
5.10992148471224e-173	0.602706273674547	0.79	0.547	9.26837558897105e-169	MTIF3	Malignant cells	GSE139386	ENSG00000122033	219402	mitochondrial translational initiation factor 3	IF-3mt|IF3(mt)	protein_coding	Q9H2K0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7409
6.84687449255386e-173	-0.395733422437307	0.091	0.363	1.24188609545942e-168	CCDC85C	Malignant cells	GSE139386	ENSG00000205476	317762	coiled-coil domain containing 85C	NA	protein_coding	A6NKD9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7410
8.93360999611066e-173	0.491038117902462	0.28	0.003	1.62037818109455e-168	ALPL	Malignant cells	GSE139386	ENSG00000162551	249	alkaline phosphatase, biomineralization associated	HOPS|TNALP|TNAP|TNSALP	protein_coding	P05186	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7411
9.15337490554103e-173	-0.513331850891669	0.352	0.673	1.66023914036703e-168	RNF141	Malignant cells	GSE139386	ENSG00000110315	50862	ring finger protein 141	ZFP26|ZNF230	protein_coding	Q8WVD5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7412
1.02130714404318e-172	-0.414393579796052	0.113	0.395	1.85244689786551e-168	GAS2L1	Malignant cells	GSE139386	ENSG00000185340	10634	growth arrest specific 2 like 1	GAR22	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7413
1.18219724078214e-172	-0.479712415205354	0.954	0.995	2.14426935533065e-168	NDUFA12	Malignant cells	GSE139386	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7414
1.20573539541935e-172	0.630697619581878	0.803	0.585	2.18696286021162e-168	RTN3	Malignant cells	GSE139386	ENSG00000133318	10313	reticulon 3	ASYIP|HAP|NSPL2|NSPLII|RTN3-A1	protein_coding	O95197	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7415
1.82737053190734e-172	-0.383190427189812	0.075	0.334	3.31448467077354e-168	EID3	Malignant cells	GSE139386	ENSG00000255150	493861	EP300 interacting inhibitor of differentiation 3	FLJ25832|NSE4B|NSMCE4B	protein_coding	Q8N140	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7416
3.46915185775448e-172	0.507300117993344	0.341	0.04	6.29234763959508e-168	PITPNC1	Malignant cells	GSE139386	ENSG00000154217	26207	phosphatidylinositol transfer protein cytoplasmic 1	RDGB-BETA|RDGBB|RDGBB1	protein_coding	Q9UKF7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7417
3.55601430086349e-172	-0.530379361567781	0.537	0.812	6.4498987389062e-168	BLOC1S2	Malignant cells	GSE139386	ENSG00000196072	282991	biogenesis of lysosomal organelles complex 1 subunit 2	BLOS2|BORCS2|FLJ30135|MGC10120	protein_coding	Q6QNY1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7418
6.32258416781895e-172	0.455254008032723	0.966	0.884	1.146790316359e-167	ATP5A1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7419
8.85547606303601e-172	0.528005324498074	0.991	0.947	1.60620624831347e-167	PSMB1	Malignant cells	GSE139386	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7420
1.17425558183909e-171	0.572315966608592	0.532	0.199	2.12986477433975e-167	PREPL	Malignant cells	GSE139386	ENSG00000138078	9581	prolyl endopeptidase like	KIAA0436	protein_coding	Q4J6C6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7421
6.89852853753576e-171	0.533098895710382	0.418	0.097	1.25125510613824e-166	SORL1	Malignant cells	GSE139386	ENSG00000137642	6653	sortilin related receptor 1	C11orf32|gp250|LR11|LRP9|SorLA|SorLA-1	protein_coding	Q92673	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7422
7.53998772600123e-171	-0.403093311887514	0.103	0.378	1.3676029737421e-166	PROM2	Malignant cells	GSE139386	ENSG00000155066	150696	prominin 2	NA	protein_coding	Q8N271	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7423
8.61163754241717e-171	-0.356833967791524	0.06	0.306	1.56197881744363e-166	C21orf58	Malignant cells	GSE139386	ENSG00000160298	54058	chromosome 21 open reading frame 58	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7424
8.90811843153254e-171	-0.474237764146207	0.2	0.508	1.61575452111137e-166	PGAM5	Malignant cells	GSE139386	ENSG00000247077	192111	PGAM family member 5, mitochondrial serine/threonine protein phosphatase	BXLBv68|MGC5352	protein_coding	Q96HS1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7425
1.07301621831295e-170	0.615557190374533	0.791	0.559	1.94623681677603e-166	AIG1	Malignant cells	GSE139386	ENSG00000146416	51390	androgen induced 1	AIG-1|dJ95L4.1|FLJ10485	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7426
1.08527313411999e-170	0.469461947967718	0.988	0.952	1.96846841066684e-166	ATP5B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7427
1.51799197758165e-170	-0.548031223402579	0.463	0.752	2.75333384893759e-166	HGS	Malignant cells	GSE139386	ENSG00000185359	9146	hepatocyte growth factor-regulated tyrosine kinase substrate	Hrs|Vps27|ZFYVE8	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7428
1.55589754506431e-170	-0.436129647439315	0.154	0.459	2.82208696723765e-166	C14orf80	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7429
1.86464589252771e-170	0.712563224348658	0.461	0.14	3.38209471986677e-166	PHACTR3	Malignant cells	GSE139386	ENSG00000087495	116154	phosphatase and actin regulator 3	C20orf101|PPP1R123	protein_coding	Q96KR7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7430
2.15051499575617e-170	-0.386995533123154	0.064	0.31	3.90060409930254e-166	RABGAP1L	Malignant cells	GSE139386	ENSG00000152061	9910	RAB GTPase activating protein 1 like	FLJ38519|HHL|KIAA0471|TBC1D18	protein_coding	Q5R372	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7431
5.01503044641331e-170	-0.436447619513015	0.158	0.457	9.09626222370446e-166	AGPAT6	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7432
5.30496549082958e-170	-0.541866302426307	0.26	0.57	9.62214640726668e-166	ZMYND19	Malignant cells	GSE139386	ENSG00000165724	116225	zinc finger MYND-type containing 19	MIZIP	protein_coding	Q96E35	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7433
8.00465233007055e-170	-0.590830776739604	0.447	0.736	1.4518838396282e-165	NIT2	Malignant cells	GSE139386	ENSG00000114021	56954	nitrilase family member 2	NA	protein_coding	Q9NQR4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7434
9.69872820478476e-170	-0.343922031085261	0.06	0.304	1.75915532178386e-165	MTFP1	Malignant cells	GSE139386	ENSG00000242114	51537	mitochondrial fission process 1	HSPC242|MTP18	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7435
1.18720540405678e-169	-0.435448812626553	0.163	0.463	2.15335316187819e-165	GUCD1	Malignant cells	GSE139386	ENSG00000138867	83606	guanylyl cyclase domain containing 1	C22orf13|LLN4|MGC1842	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7436
1.34423814363249e-169	0.599265476971286	0.272	0.001	2.43817914492061e-165	AZGP1	Malignant cells	GSE139386	ENSG00000160862	563	alpha-2-glycoprotein 1, zinc-binding	ZA2G|ZAG	protein_coding	P25311	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7437
5.3185003309399e-169	-0.53599470921663	0.599	0.853	9.64669590025879e-165	ZBTB8OS	Malignant cells	GSE139386	ENSG00000176261	339487	zinc finger and BTB domain containing 8 opposite strand	ARCH	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7438
6.97805726285413e-169	-0.495469369678988	0.847	0.969	1.26568002633648e-164	COX14	Malignant cells	GSE139386	ENSG00000178449	84987	cytochrome c oxidase assembly factor COX14	C12orf62|MGC14288	protein_coding	Q96I36	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7439
8.25697680401671e-169	-0.542294644371575	0.17	0.467	1.49765045271255e-164	HMGCS1	Malignant cells	GSE139386	ENSG00000112972	3157	3-hydroxy-3-methylglutaryl-CoA synthase 1	HMGCS	protein_coding	Q01581	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7440
8.94565460350544e-169	0.760394558051162	0.987	0.975	1.62256283198382e-164	NPC2	Malignant cells	GSE139386	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7441
1.08566781975024e-168	0.449893788264986	0.321	0.03	1.96918429146298e-164	CAMK1D	Malignant cells	GSE139386	ENSG00000183049	57118	calcium/calmodulin dependent protein kinase ID	CKLiK	protein_coding	Q8IU85	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7442
1.17395150895849e-168	-0.470356805779739	0.167	0.467	2.12931324694891e-164	FSTL1	Malignant cells	GSE139386	ENSG00000163430	11167	follistatin like 1	FRP|FSL1|OCC-1|OCC1|tsc36	protein_coding	Q12841	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7443
1.26211389001712e-168	0.509068009525228	0.329	0.036	2.28922217371306e-164	LINC00342	Malignant cells	GSE139386	ENSG00000232931	NA	NA	NCRNA00342	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7444
1.60911785186315e-168	-0.402520137665269	0.106	0.381	2.91861795970938e-164	STX2	Malignant cells	GSE139386	ENSG00000111450	2054	syntaxin 2	EPIM|EPM|STX2A|STX2B|STX2C	protein_coding	P32856	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7445
3.09077180224918e-168	-0.533590269779654	0.369	0.676	5.60604189491956e-164	ZNRF1	Malignant cells	GSE139386	ENSG00000186187	84937	zinc and ring finger 1	DKFZp434E229|FLJ14846|nin283	protein_coding	Q8ND25	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7446
3.35605545632174e-168	-0.527202705929135	0.54	0.805	6.08721338667637e-164	YKT6	Malignant cells	GSE139386	ENSG00000106636	10652	YKT6 v-SNARE homolog	NA	protein_coding	O15498	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7447
5.204407188415e-168	-0.424659179048968	0.133	0.419	9.43975375834713e-164	TRMU	Malignant cells	GSE139386	ENSG00000100416	55687	tRNA mitochondrial 2-thiouridylase	FLJ10140|MTO2|MTU1|TRMT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7448
5.89269027511914e-168	-0.476176375833575	0.242	0.557	1.06881616210111e-163	CCDC137	Malignant cells	GSE139386	ENSG00000185298	339230	coiled-coil domain containing 137	MGC16597	protein_coding	Q6PK04	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7449
8.32004191088624e-168	0.589652262636197	0.625	0.299	1.50908920179655e-163	LTA4H	Malignant cells	GSE139386	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7450
9.14316300465161e-168	-0.450782512966442	0.182	0.491	1.65838690578371e-163	MIS18A	Malignant cells	GSE139386	ENSG00000159055	54069	MIS18 kinetochore protein A	B28|C21orf45|C21orf46|FASP1|hMis18alpha	protein_coding	Q9NYP9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7451
1.20010798806859e-167	-0.535940958577662	0.621	0.854	2.17675586875882e-163	CRIPT	Malignant cells	GSE139386	ENSG00000119878	9419	CXXC repeat containing interactor of PDZ3 domain	HSPC139	protein_coding	Q9P021	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7452
1.82600956010087e-167	-0.365541238912029	0.056	0.292	3.31201614011097e-163	F2RL1	Malignant cells	GSE139386	ENSG00000164251	2150	F2R like trypsin receptor 1	GPR11|PAR2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7453
1.9082760377638e-167	0.600130250983685	0.751	0.479	3.46123107729598e-163	YIPF3	Malignant cells	GSE139386	ENSG00000137207	25844	Yip1 domain family member 3	C6orf109|dJ337H4.3|DKFZp566C243|FinGER3|KLIP1	protein_coding	Q9GZM5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7454
2.19009262579874e-167	0.557636738971985	0.513	0.184	3.97239000467376e-163	PRSS8	Malignant cells	GSE139386	ENSG00000052344	5652	serine protease 8	CAP1	protein_coding	Q16651	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7455
3.15497048220827e-167	-0.402675777758205	0.064	0.311	5.72248546062936e-163	FAM64A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7456
2.92548264936835e-166	0.57256190456922	0.874	0.734	5.30624042942432e-162	CTBP2	Malignant cells	GSE139386	ENSG00000175029	1488	C-terminal binding protein 2	ribeye	protein_coding	P56545	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7457
3.77843329163856e-166	-0.384189319496989	0.083	0.341	6.85332230437402e-162	PXDC1	Malignant cells	GSE139386	ENSG00000168994	221749	PX domain containing 1	C6orf145	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7458
5.33922959119819e-166	-0.343906608808021	0.051	0.283	9.68429463251528e-162	NOXO1	Malignant cells	GSE139386	ENSG00000196408	124056	NADPH oxidase organizer 1	P41NOXA|P41NOXB|P41NOXC|SH3PXD5|SNX28	protein_coding	Q8NFA2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7459
8.91283922559107e-166	-0.337010224567861	0.048	0.276	1.61661077873771e-161	PRTFDC1	Malignant cells	GSE139386	ENSG00000099256	56952	phosphoribosyl transferase domain containing 1	HHGP	protein_coding	Q9NRG1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7460
1.90486556161869e-165	0.415565300011157	0.272	0.004	3.45504515566398e-161	BEX4	Malignant cells	GSE139386	ENSG00000102409	56271	brain expressed X-linked 4	BEXL1|FLJ10097	protein_coding	Q9NWD9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7461
2.51364246960613e-165	-0.35815104992736	0.069	0.317	4.55924471137161e-161	LIG1	Malignant cells	GSE139386	ENSG00000105486	3978	DNA ligase 1	hLig1|LIGI	protein_coding	P18858	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7462
3.37171347274553e-165	-0.310740915739171	0.036	0.252	6.11561389686584e-161	GINS1	Malignant cells	GSE139386	ENSG00000101003	9837	GINS complex subunit 1	KIAA0186|PSF1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7463
3.80353631541344e-165	-0.543260941784	0.41	0.706	6.8988541688969e-161	CETN2	Malignant cells	GSE139386	ENSG00000147400	1069	centrin 2	CALT|CEN2	protein_coding	P41208	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7464
4.19668562990106e-165	-0.437597190894605	0.159	0.453	7.61194839551455e-161	GRWD1	Malignant cells	GSE139386	ENSG00000105447	83743	glutamate rich WD repeat containing 1	GRWD|RRB1|WDR28	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7465
4.59412779061248e-165	-0.41683673468369	0.134	0.419	8.33282898661293e-161	WBSCR16	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7466
4.9367065016745e-165	-0.492999124635809	0.261	0.573	8.95419825273722e-161	NSUN2	Malignant cells	GSE139386	ENSG00000037474	54888	NOP2/Sun RNA methyltransferase 2	FLJ20303|Misu|MRT5|SAKI|TRM4	protein_coding	Q08J23	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7467
5.29040086681037e-165	0.547180368749581	0.461	0.14	9.59572909222066e-161	TPCN1	Malignant cells	GSE139386	ENSG00000186815	53373	two pore segment channel 1	FLJ20612|KIAA1169|TPC1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7468
7.17125527181038e-165	-0.55634219647773	0.626	0.853	1.30072228120097e-160	ISCA2	Malignant cells	GSE139386	ENSG00000165898	122961	iron-sulfur cluster assembly 2	HBLD1|ISA2	protein_coding	Q86U28	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7469
8.17763724373644e-165	-0.551204672418735	0.702	0.902	1.48325984326892e-160	HNRNPF	Malignant cells	GSE139386	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7470
1.11336956126002e-164	-0.536613093970355	0.485	0.764	2.01942971021343e-160	RWDD4	Malignant cells	GSE139386	ENSG00000182552	201965	RWD domain containing 4	FAM28A|MGC10198|RWDD4A	protein_coding	Q6NW29	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7471
1.38022779271029e-164	0.521845974605011	0.471	0.147	2.50345717041793e-160	SIL1	Malignant cells	GSE139386	ENSG00000120725	64374	SIL1 nucleotide exchange factor	BAP|MSS|ULG5	protein_coding	Q9H173	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7472
1.4049797635685e-164	-0.39813025657518	0.103	0.371	2.54835229516054e-160	TGFBR2	Malignant cells	GSE139386	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7473
1.44041998564155e-164	-0.363238882438044	0.082	0.339	2.61263376995664e-160	AC009403.2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7474
1.69162085099268e-164	0.498073617223219	0.992	0.971	3.06826189953052e-160	ATF4	Malignant cells	GSE139386	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7475
1.92702346410399e-164	-0.553904366245063	0.817	0.949	3.49523515919182e-160	SNRPC	Malignant cells	GSE139386	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7476
2.04755124342389e-164	0.417376625945227	0.272	0.005	3.71384844532225e-160	TMPRSS2	Malignant cells	GSE139386	ENSG00000184012	7113	transmembrane serine protease 2	PRSS10	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7477
2.25175473663392e-164	-0.549585253547631	0.521	0.781	4.0842327413066e-160	TSEN34	Malignant cells	GSE139386	ENSG00000274078	79042	tRNA splicing endonuclease subunit 34	LENG5|SEN34|SEN34L	protein_coding	Q9BSV6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7478
2.96793628642701e-164	-0.335122860104973	0.05	0.279	5.38324283632132e-160	PDGFC	Malignant cells	GSE139386	ENSG00000145431	56034	platelet derived growth factor C	fallotein|SCDGF	protein_coding	Q9NRA1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7479
3.57769438466447e-164	0.630117637662594	0.886	0.737	6.48922207490442e-160	SERPINB1	Malignant cells	GSE139386	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7480
3.58293112102374e-164	-0.507953704795455	0.384	0.708	6.49872046731286e-160	CENPH	Malignant cells	GSE139386	ENSG00000153044	64946	centromere protein H	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7481
1.39330328303343e-163	0.605301306472613	0.727	0.455	2.52717349476603e-159	LARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7482
1.63427717338937e-163	-0.479144618881467	0.225	0.531	2.96425193709364e-159	NLN	Malignant cells	GSE139386	ENSG00000123213	57486	neurolysin	AGTBP|KIAA1226	protein_coding	Q9BYT8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7483
1.71864110139531e-163	0.432281305788784	0.282	0.011	3.11727122971081e-159	CAPN8	Malignant cells	GSE139386	ENSG00000203697	388743	calpain 8	nCL-2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7484
1.78358606294383e-163	-0.356440189351643	0.072	0.32	3.23506840096752e-159	C19orf40	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7485
2.4557136376452e-163	-0.533537268222343	0.312	0.612	4.45417339596087e-159	C12orf65	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7486
2.94975248711673e-163	-0.42121030005868	0.163	0.466	5.35026106113233e-159	RFC5	Malignant cells	GSE139386	ENSG00000111445	5985	replication factor C subunit 5	RFC36	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7487
3.24823808736239e-163	0.617758302071508	0.838	0.56	5.89165424285789e-159	ELF3	Malignant cells	GSE139386	ENSG00000163435	1999	E74 like ETS transcription factor 3	EPR-1|ERT|ESE-1|ESX	protein_coding	P78545	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7488
3.41338667200752e-163	-0.500531232076915	0.405	0.704	6.19120074568723e-159	GOLGA7	Malignant cells	GSE139386	ENSG00000147533	51125	golgin A7	GCP16|GOLGA3AP1|GOLGA7A|HSPC041	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7489
3.5566866880707e-163	-0.460712622253658	0.205	0.52	6.45111831482263e-159	SMC2	Malignant cells	GSE139386	ENSG00000136824	10592	structural maintenance of chromosomes 2	CAP-E|hCAP-E|SMC2L1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7490
3.57971464295013e-163	0.257484676957004	1	1	6.49288641938295e-159	RPL14	Malignant cells	GSE139386	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7491
3.76811260374481e-163	-0.534376261299381	0.577	0.825	6.83460264067234e-159	LLPH	Malignant cells	GSE139386	ENSG00000139233	84298	LLP homolog, long-term synaptic facilitation factor	C12orf31|hLLP|MGC14817	protein_coding	Q9BRT6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7492
6.36243390900715e-163	0.417026443078289	0.263	0.001	1.15401826241572e-158	HOXB5	Malignant cells	GSE139386	ENSG00000120075	3215	homeobox B5	HOX2|HOX2A	protein_coding	P09067	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7493
7.66003601693696e-163	-0.536010116849857	0.57	0.819	1.38937733275203e-158	RNF167	Malignant cells	GSE139386	ENSG00000108523	26001	ring finger protein 167	DKFZP566H073	protein_coding	Q9H6Y7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7494
8.72566394727899e-163	-0.346383052873086	0.062	0.301	1.58266092675746e-158	XRCC3	Malignant cells	GSE139386	ENSG00000126215	7517	X-ray repair cross complementing 3	NA	protein_coding	O43542	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7495
1.35066130055375e-162	-0.539931912404982	0.593	0.834	2.44982946694439e-158	POP5	Malignant cells	GSE139386	ENSG00000167272	51367	POP5 homolog, ribonuclease P/MRP subunit	NA	protein_coding	Q969H6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7496
1.40995464004894e-162	-0.517663422609236	0.644	0.868	2.55737572612076e-158	MTPN	Malignant cells	GSE139386	ENSG00000105887	136319	myotrophin	GCDP|MYOTROPHIN|V-1	protein_coding	P58546	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7497
1.74656662319826e-162	-0.36809930524219	0.058	0.294	3.16792254115701e-158	DEPDC1B	Malignant cells	GSE139386	ENSG00000035499	55789	DEP domain containing 1B	BRCC3|XTP1	protein_coding	Q8WUY9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7498
1.86116353311156e-162	-0.405569657831754	0.096	0.359	3.37577841635774e-158	SULT2B1	Malignant cells	GSE139386	ENSG00000088002	6820	sulfotransferase family 2B member 1	HSST2	protein_coding	O00204	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7499
2.59664734651695e-162	-0.471517170102003	0.876	0.975	4.70979895711244e-158	EI24	Malignant cells	GSE139386	ENSG00000149547	9538	EI24 autophagy associated transmembrane protein	EPG4|PIG8|TP53I8	protein_coding	O14681	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7500
3.86826890821668e-162	-0.378909707726383	0.043	0.263	7.01626614572341e-158	KIF14	Malignant cells	GSE139386	ENSG00000118193	9928	kinesin family member 14	KIAA0042	protein_coding	Q15058	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7501
4.22582610314565e-162	-0.480077298784781	0.246	0.553	7.66480338588558e-158	AIF1L	Malignant cells	GSE139386	ENSG00000126878	83543	allograft inflammatory factor 1 like	C9orf58|FLJ12783|IBA2	protein_coding	Q9BQI0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7502
4.79390006940859e-162	-0.430584439608026	0.07	0.321	8.6951759458933e-158	HMMR	Malignant cells	GSE139386	ENSG00000072571	3161	hyaluronan mediated motility receptor	CD168|RHAMM	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7503
5.2958085748059e-162	-0.517207211864441	0.386	0.696	9.60553759298295e-158	LINC00969	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7504
5.49167041867003e-162	-0.538183028762671	0.59	0.846	9.96079180538369e-158	EMC9	Malignant cells	GSE139386	ENSG00000285377	51016	ER membrane protein complex subunit 9	C14orf122|CGI-112|FAM158A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7505
7.57660044542893e-162	-0.417177027516082	0.14	0.424	1.3742437887919e-157	RP11-385J1.2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7506
8.11200914017551e-162	-0.529519203594889	0.499	0.777	1.47135621784503e-157	SHKBP1	Malignant cells	GSE139386	ENSG00000160410	92799	SH3KBP1 binding protein 1	PP203|Sb1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7507
9.827401714781e-162	0.584010376780005	0.64	0.338	1.78249412302698e-157	GTF2F1	Malignant cells	GSE139386	ENSG00000125651	2962	general transcription factor IIF subunit 1	BTF4|RAP74|TF2F1|TFIIF	protein_coding	P35269	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7508
1.1599155176822e-161	-0.458758871927574	0.207	0.509	2.10385476597198e-157	CYB5B	Malignant cells	GSE139386	ENSG00000103018	80777	cytochrome b5 type B	CYB5-M	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7509
1.28872361479572e-161	-0.428053312582148	0.139	0.423	2.33748689251648e-157	PLOD2	Malignant cells	GSE139386	ENSG00000152952	5352	procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	LH2|TLH	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7510
1.43874783480264e-161	-0.562510073027106	0.746	0.914	2.60960082276503e-157	FUS	Malignant cells	GSE139386	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7511
1.73872611965114e-161	-0.497557016104128	0.277	0.589	3.15370143582323e-157	CDCA4	Malignant cells	GSE139386	ENSG00000170779	55038	cell division cycle associated 4	FLJ20764|Hepp	protein_coding	Q9BXL8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7512
2.29104704480998e-161	-0.514543031538456	0.803	0.953	4.15550112987634e-157	DAP	Malignant cells	GSE139386	ENSG00000112977	1611	death associated protein	DAP1	protein_coding	P51397	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7513
4.40513129929412e-161	0.58742979994444	0.84	0.657	7.99002715065968e-157	EMC7	Malignant cells	GSE139386	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7514
5.34763690936072e-161	-0.521639497034709	0.722	0.913	9.69954382619847e-157	NABP2	Malignant cells	GSE139386	ENSG00000139579	79035	nucleic acid binding protein 2	hSSB1|MGC2731|OBFC2B|SOSS-B1|SSB1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7515
5.38087219905653e-161	-0.500014543633609	0.303	0.609	9.75982599464873e-157	FAM83H	Malignant cells	GSE139386	ENSG00000273889	286077	family with sequence similarity 83 member H	FLJ46072	protein_coding	Q6ZRV2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7516
6.26330389200252e-161	0.438200290802191	0.998	0.992	1.13603805993142e-156	MRPS21	Malignant cells	GSE139386	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7517
6.30033888220365e-161	-0.394517811886877	0.995	0.999	1.1427554664541e-156	LY6E	Malignant cells	GSE139386	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7518
8.63761970801863e-161	-0.453047446985517	0.182	0.477	1.56669146264042e-156	ACLY	Malignant cells	GSE139386	ENSG00000131473	47	ATP citrate lyase	ACL|ATPCL|CLATP	protein_coding	P53396	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7519
1.42045208916261e-160	-0.479050307014911	0.264	0.569	2.57641599932314e-156	ATP6V1C1	Malignant cells	GSE139386	ENSG00000155097	528	ATPase H+ transporting V1 subunit C1	ATP6C|ATP6D|VATC|Vma5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7520
1.58706116473807e-160	-0.381307154350857	0.057	0.291	2.87861154060191e-156	CCNF	Malignant cells	GSE139386	ENSG00000162063	899	cyclin F	FBX1|FBXO1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7521
2.78377800704696e-160	-0.443788565152736	0.2	0.502	5.04921654918178e-156	FAM105B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7522
1.04534723289231e-159	0.582960390200996	0.78	0.536	1.89605081102006e-155	RALGAPA1	Malignant cells	GSE139386	ENSG00000174373	253959	Ral GTPase activating protein catalytic subunit alpha 1	DKFZp667F074|GARNL1|GRIPE|KIAA0884|RalGAPalpha1|Tulip1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7523
1.08647089935015e-159	-0.374430339762068	0.078	0.332	1.9706409172413e-155	SPC25	Malignant cells	GSE139386	ENSG00000277909	57405	SPC25 component of NDC80 kinetochore complex	AD024|MGC22228|SPBC25	protein_coding	Q9HBM1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7524
1.10788471123383e-159	-0.482734787218208	0.245	0.545	2.00948128923592e-155	UCK2	Malignant cells	GSE139386	ENSG00000143179	7371	uridine-cytidine kinase 2	UMPK	protein_coding	Q9BZX2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7525
1.32144633261013e-159	0.608287090519108	0.623	0.319	2.39683935808825e-155	GPR56	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7526
1.4913741838897e-159	-0.46846595042373	0.267	0.576	2.70505449473913e-155	PANK3	Malignant cells	GSE139386	ENSG00000120137	79646	pantothenate kinase 3	FLJ12899	protein_coding	Q9H999	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7527
2.28097632321173e-159	-0.418983194147791	0.076	0.321	4.13723485504143e-155	LYPD1	Malignant cells	GSE139386	ENSG00000150551	116372	LY6/PLAUR domain containing 1	LYPDC1|MGC29643	protein_coding	Q8N2G4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7528
2.8004865225633e-159	0.554856562281376	0.891	0.755	5.07952245462531e-155	ZFAND5	Malignant cells	GSE139386	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7529
7.49403564333689e-159	-0.590193646149462	0.477	0.746	1.35926818498844e-154	FKBP4	Malignant cells	GSE139386	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7530
1.17206833193777e-158	-0.512614244587356	0.792	0.951	2.12589754046873e-154	VPS29	Malignant cells	GSE139386	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7531
2.32224570399146e-158	-0.492456152814256	0.344	0.644	4.21208925789972e-154	FAM58A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7532
4.38907186725277e-158	0.582639956983315	0.65	0.353	7.96089855282307e-154	STX5	Malignant cells	GSE139386	ENSG00000162236	6811	syntaxin 5	SED5|STX5A	protein_coding	Q13190	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7533
4.50339833375988e-158	-0.497576818878585	0.382	0.675	8.16826389777366e-154	WIBG	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7534
4.70874681809985e-158	-0.350443075645591	0.078	0.325	8.54072497866951e-154	RP6-65G23.3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7535
5.65497858363842e-158	-0.50591714180398	0.393	0.685	1.02570001550034e-153	ZDHHC16	Malignant cells	GSE139386	ENSG00000171307	84287	zinc finger DHHC-type palmitoyltransferase 16	APH2	protein_coding	Q969W1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7536
6.76049100914333e-158	-0.412528040608238	0.132	0.409	1.22621785923842e-153	ANKRD52	Malignant cells	GSE139386	ENSG00000139645	283373	ankyrin repeat domain 52	FLJ34236|PP6-ARS-C	protein_coding	Q8NB46	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7537
7.88908381120286e-158	-0.505078520982227	0.407	0.702	1.43092202167597e-153	SIKE1	Malignant cells	GSE139386	ENSG00000052723	80143	suppressor of IKBKE 1	FLJ21168|SIKE	protein_coding	Q9BRV8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7538
1.27030402983807e-157	-0.476098696845905	0.273	0.58	2.3040774493203e-153	FAM210B	Malignant cells	GSE139386	ENSG00000124098	116151	family with sequence similarity 210 member B	C20orf108|dJ1167H4.1|DKFZP434A1114	protein_coding	Q96KR6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7539
3.61352303149835e-157	-0.476837707567632	0.266	0.569	6.5542080745317e-153	PUS1	Malignant cells	GSE139386	ENSG00000177192	80324	pseudouridine synthase 1	MLASA1	protein_coding	Q9Y606	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7540
3.68231245880772e-157	-0.467243730306793	0.164	0.447	6.67897833778545e-153	NABP1	Malignant cells	GSE139386	ENSG00000173559	64859	nucleic acid binding protein 1	DKFZp667M1322|FLJ13624|FLJ22833|hSSB2|MGC111163|NABP1-OT1|OBFC2A|SOSS-B2|SSB2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7541
4.81446420122715e-157	-0.329923405026031	0.048	0.267	8.73247516818581e-153	NTF4	Malignant cells	GSE139386	ENSG00000225950	4909	neurotrophin 4	GLC1O|NT-4/5|NTF5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7542
6.14072149438605e-157	-0.54929754075381	0.674	0.879	1.11380406465174e-152	RBM17	Malignant cells	GSE139386	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7543
6.44992346516302e-157	-0.424190269885653	0.157	0.443	1.16988711811127e-152	HILPDA	Malignant cells	GSE139386	ENSG00000135245	29923	hypoxia inducible lipid droplet associated	C7orf68|FLJ21076|HIG-2|HIG2	protein_coding	Q9Y5L2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7544
7.34662285558355e-157	-0.429689049939697	0.182	0.474	1.33253045354574e-152	NDUFA7.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7545
8.33655283377527e-157	-0.393917353568924	0.058	0.288	1.51208395299016e-152	CDCA8	Malignant cells	GSE139386	ENSG00000134690	55143	cell division cycle associated 8	BOR|DasraB|FLJ12042|MESRGP	protein_coding	Q53HL2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7546
9.08170306821868e-157	-0.475268595857564	0.324	0.635	1.6472393025135e-152	LASP1	Malignant cells	GSE139386	ENSG00000002834	3927	LIM and SH3 protein 1	Lasp-1|MLN50	protein_coding	Q14847	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7547
9.81354999930857e-157	-0.409866287001805	0.113	0.386	1.77998169887459e-152	GPSM2	Malignant cells	GSE139386	ENSG00000121957	29899	G protein signaling modulator 2	DFNB82|LGN|Pins	protein_coding	P81274	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7548
1.05995583816916e-156	-0.539802947080143	0.608	0.847	1.92254789927123e-152	HSBP1L1	Malignant cells	GSE139386	ENSG00000226742	440498	heat shock factor binding protein 1 like 1	FLJ10967|MGC189743	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7549
1.76665572825668e-156	-0.416253269789088	0.145	0.426	3.20436015991196e-152	PTDSS1	Malignant cells	GSE139386	ENSG00000156471	9791	phosphatidylserine synthase 1	KIAA0024|PSS1|PSSA	protein_coding	P48651	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7550
2.2735447252473e-156	-0.400046493528721	0.142	0.422	4.12375542265356e-152	WWP1	Malignant cells	GSE139386	ENSG00000123124	11059	WW domain containing E3 ubiquitin protein ligase 1	AIP5|DKFZP434D2111	protein_coding	Q9H0M0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7551
2.60425762341057e-156	0.431714336827257	0.293	0.023	4.7236024773421e-152	ANTXR2	Malignant cells	GSE139386	ENSG00000163297	118429	ANTXR cell adhesion molecule 2	CMG-2|CMG2|FLJ31074	protein_coding	P58335	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7552
3.22055836160897e-156	0.458513616465918	0.269	0.009	5.84144875628635e-152	CALCB	Malignant cells	GSE139386	ENSG00000175868	797	calcitonin related polypeptide beta	CALC2|CGRP-II|FLJ30166	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7553
3.3170249681637e-156	-0.327037681989698	0.057	0.284	6.01641988725532e-152	PIGW	Malignant cells	GSE139386	ENSG00000275600	284098	phosphatidylinositol glycan anchor biosynthesis class W	FLJ37433|Gwt1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7554
4.12279160001086e-156	-0.410457862553039	0.124	0.396	7.4779194040997e-152	CWC22	Malignant cells	GSE139386	ENSG00000163510	57703	CWC22 spliceosome associated protein homolog	EIF4GL|fSAPb|KIAA1604|NCM	protein_coding	Q9HCG8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7555
4.67081628360605e-156	0.62634475128753	0.783	0.555	8.47192657520466e-152	DUSP4	Malignant cells	GSE139386	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7556
4.78829422083881e-156	-0.525774976822611	0.38	0.671	8.68500805775743e-152	TFAP2A	Malignant cells	GSE139386	ENSG00000137203	7020	transcription factor AP-2 alpha	AP-2|AP-2alpha|AP2TF|TFAP2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7557
5.88391247729274e-156	-0.339722467573377	0.999	1	1.06722404513136e-151	COX8A	Malignant cells	GSE139386	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7558
6.67610356435403e-156	-0.436148111176803	0.222	0.528	1.21091166450253e-151	ACYP1	Malignant cells	GSE139386	ENSG00000119640	97	acylphosphatase 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7559
6.67785344435937e-156	-0.540211392832423	0.559	0.807	1.2112290577379e-151	TRIM28	Malignant cells	GSE139386	ENSG00000130726	10155	tripartite motif containing 28	KAP-1|KAP1|PPP1R157|RNF96|TF1B|TIF1-beta|TIF1B|TIF1beta	protein_coding	Q13263	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7560
8.90013257989764e-156	-0.435844285784894	1	1	1.61430604734183e-151	SET	Malignant cells	GSE139386	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7561
1.84252855359363e-155	-0.539731556469474	0.499	0.764	3.34197829050813e-151	MAGOHB	Malignant cells	GSE139386	ENSG00000111196	55110	mago homolog B, exon junction complex subunit	FLJ10292|MGN2	protein_coding	Q96A72	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7562
2.9116112328206e-155	-0.412534326484034	0.119	0.385	5.28108045409e-151	FJX1	Malignant cells	GSE139386	ENSG00000179431	24147	four-jointed box kinase 1	FLJ22416|FLJ25593	protein_coding	Q86VR8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7563
3.77884868639071e-155	-0.39008665812865	0.13	0.404	6.85407574737547e-151	SLC2A8	Malignant cells	GSE139386	ENSG00000136856	29988	solute carrier family 2 member 8	GLUT8|GLUTX1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7564
4.62677750096541e-155	0.451530606777107	0.357	0.066	8.39204903125107e-151	AL589743.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7565
5.63188392907743e-155	-0.536727563024439	0.937	0.985	1.02151110705606e-150	SRSF3	Malignant cells	GSE139386	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7566
7.66293035242812e-155	-0.438821908681263	0.215	0.515	1.38990230732341e-150	QDPR	Malignant cells	GSE139386	ENSG00000151552	5860	quinoid dihydropteridine reductase	DHPR|PKU2|SDR33C1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7567
1.28913868383708e-154	-0.474124474245463	0.895	0.976	2.3382397447437e-150	PCBP1	Malignant cells	GSE139386	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7568
1.61006832794209e-154	-0.328226660554253	0.056	0.284	2.92034193322137e-150	NCAPH	Malignant cells	GSE139386	ENSG00000121152	23397	non-SMC condensin I complex subunit H	BRRN1|CAP-H|hCAP-H	protein_coding	Q15003	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7569
1.62533276612932e-154	-0.527651576798051	0.285	0.594	2.94802857120536e-150	PCNA	Malignant cells	GSE139386	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7570
2.00039861552152e-154	-0.499797815381977	0.376	0.67	3.62832300883294e-150	GAR1	Malignant cells	GSE139386	ENSG00000109534	54433	GAR1 ribonucleoprotein	NOLA1	protein_coding	Q9NY12	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7571
2.74093978060691e-154	-0.49530623435847	0.735	0.926	4.97151657406482e-150	EIF1AX	Malignant cells	GSE139386	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7572
2.77537356809213e-154	-0.51334232178045	0.951	0.993	5.03397257780551e-150	UBC	Malignant cells	GSE139386	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7573
4.79003605800041e-154	-0.402216441657397	0.087	0.333	8.68816740200115e-150	SLC26A2	Malignant cells	GSE139386	ENSG00000155850	1836	solute carrier family 26 member 2	DTD|DTDST	protein_coding	P50443	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7574
5.0649866996134e-154	-0.489759237465825	0.289	0.599	9.18687287575878e-150	TEX30	Malignant cells	GSE139386	ENSG00000151287	93081	testis expressed 30	C13orf27	protein_coding	Q5JUR7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7575
5.50020567583945e-154	0.558767701357008	0.932	0.865	9.97627305483759e-150	CERS2	Malignant cells	GSE139386	ENSG00000143418	29956	ceramide synthase 2	FLJ10243|LASS2|SP260	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7576
6.63176929699394e-154	-0.485508174135001	0.26	0.558	1.20287031508876e-149	PXN-AS1	Malignant cells	GSE139386	ENSG00000255857	NA	NA	EyeLinc4	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7577
8.9147705337196e-154	0.54954779222132	0.89	0.752	1.61696107940606e-149	KIF5B	Malignant cells	GSE139386	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7578
9.4577050496238e-154	-0.480149316621397	0.29	0.589	1.71543854190076e-149	ZNF787	Malignant cells	GSE139386	ENSG00000142409	126208	zinc finger protein 787	NA	protein_coding	Q6DD87	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7579
9.6222463919561e-154	-0.496008432452657	0.845	0.964	1.745283050573e-149	MRPL18	Malignant cells	GSE139386	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7580
1.15062619917181e-153	-0.433563524785957	0.189	0.479	2.08700580005783e-149	SORBS3	Malignant cells	GSE139386	ENSG00000120896	10174	sorbin and SH3 domain containing 3	SCAM-1|SH3D4|vinexin	protein_coding	O60504	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7581
1.25786167910743e-153	-0.491659410589261	0.397	0.692	2.28150951356506e-149	CDK16	Malignant cells	GSE139386	ENSG00000102225	5127	cyclin dependent kinase 16	FLJ16665|PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	protein_coding	Q00536	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7582
1.4985944570048e-153	-0.436830596455914	0.175	0.46	2.71815062611531e-149	FAT1	Malignant cells	GSE139386	ENSG00000083857	2195	FAT atypical cadherin 1	CDHF7|CDHR8|FAT	protein_coding	Q14517	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7583
1.93292424252853e-153	-0.424452969954659	0.187	0.48	3.50593799109825e-149	CDH24	Malignant cells	GSE139386	ENSG00000139880	64403	cadherin 24	CDH11L	protein_coding	Q86UP0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7584
2.1536564427831e-153	-0.401818211097551	0.122	0.398	3.90630205591999e-149	ARHGAP11A	Malignant cells	GSE139386	ENSG00000275568	9824	Rho GTPase activating protein 11A	KIAA0013	protein_coding	Q6P4F7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7585
4.43425078266781e-153	-0.357126100027187	0.052	0.275	8.04284406960288e-149	DLGAP5	Malignant cells	GSE139386	ENSG00000126787	9787	DLG associated protein 5	DLG1|DLG7|HURP|KIAA0008	protein_coding	Q15398	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7586
5.19661006377841e-153	-0.366482535441215	0.085	0.332	9.42561133368127e-149	DSCC1	Malignant cells	GSE139386	ENSG00000136982	79075	DNA replication and sister chromatid cohesion 1	DCC1|hDCC1|MGC5528	protein_coding	Q9BVC3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7587
5.93342460318397e-153	-0.508240724856628	0.394	0.679	1.07620455452551e-148	PET117	Malignant cells	GSE139386	ENSG00000232838	100303755	PET117 cytochrome c oxidase chaperone	CSRP2BP	protein_coding	Q6UWS5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7588
7.11333149804849e-153	0.51591123725782	0.965	0.908	1.29021606711604e-148	LMAN2	Malignant cells	GSE139386	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7589
1.09161154989464e-152	0.416070905864343	0.305	0.033	1.9799650291989e-148	HOXC10	Malignant cells	GSE139386	ENSG00000180818	3226	homeobox C10	HOX3I	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7590
1.9877770742902e-152	-0.502366160985411	0.888	0.964	3.60543005734757e-148	TXNL4A	Malignant cells	GSE139386	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7591
2.64620876924284e-152	0.418041621674503	0.997	0.988	4.79969346565266e-148	FKBP2	Malignant cells	GSE139386	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7592
3.13653758741254e-152	-0.466926602012809	0.262	0.566	5.68905187604887e-148	PRADC1	Malignant cells	GSE139386	ENSG00000135617	84279	protease associated domain containing 1	C2orf7|hPAP21|MGC13004|PAP21	protein_coding	Q9BSG0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7593
4.54051135079715e-152	-0.376801219389551	0.098	0.35	8.23557948807587e-148	TMEM56	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7594
4.6663589509464e-152	-0.460734614388488	0.275	0.575	8.46384186522658e-148	EIF4EBP2	Malignant cells	GSE139386	ENSG00000148730	1979	eukaryotic translation initiation factor 4E binding protein 2	NA	protein_coding	Q13542	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7595
1.88100455620273e-151	-0.523971067823363	0.707	0.919	3.41176606404052e-147	PLEC	Malignant cells	GSE139386	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7596
3.44968066975176e-151	-0.305611439048656	0.046	0.258	6.25703079879574e-147	OSBPL1A	Malignant cells	GSE139386	ENSG00000141447	114876	oxysterol binding protein like 1A	ORP-1|ORP1|OSBPL1B	protein_coding	Q9BXW6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7597
4.49608303060626e-151	-0.454662084095332	0.22	0.513	8.15499540091363e-147	DHX15	Malignant cells	GSE139386	ENSG00000109606	1665	DEAH-box helicase 15	DBP1|DDX15|HRH2|PRP43|PRPF43|PrPp43p	protein_coding	O43143	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7598
4.8205115045147e-151	-0.492120434188323	0.252	0.552	8.74344376688877e-147	RRM1	Malignant cells	GSE139386	ENSG00000167325	6240	ribonucleotide reductase catalytic subunit M1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7599
9.75614873648547e-151	-0.312208600366835	1	1	1.76957025782374e-146	TMSB10	Malignant cells	GSE139386	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7600
1.47122622808733e-150	0.571787529192128	0.629	0.34	2.6685101325048e-146	R3HDM4	Malignant cells	GSE139386	ENSG00000198858	91300	R3H domain containing 4	C19orf22|MGC16353	protein_coding	Q96D70	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7601
1.77948757888408e-150	-0.473468045435678	0.311	0.614	3.22763457057994e-146	POP4	Malignant cells	GSE139386	ENSG00000105171	10775	POP4 homolog, ribonuclease P/MRP subunit	RPP29	protein_coding	O95707	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7602
1.97295065187643e-150	0.539741938293429	0.869	0.701	3.57853789237347e-146	KRTCAP2	Malignant cells	GSE139386	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7603
2.32044051459646e-150	-0.381906974893404	0.091	0.342	4.20881500537506e-146	RACGAP1	Malignant cells	GSE139386	ENSG00000161800	29127	Rac GTPase activating protein 1	CYK4|MgcRacGAP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7604
2.72027462189092e-150	0.540137649055179	0.5	0.193	4.93403410918575e-146	TMEM50B	Malignant cells	GSE139386	ENSG00000263160	757	transmembrane protein 50B	C21orf4	protein_coding	P56557	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7605
2.72075339712844e-150	-0.43528365808778	0.222	0.517	4.93490251171156e-146	PPP1R16A	Malignant cells	GSE139386	ENSG00000160972	84988	protein phosphatase 1 regulatory subunit 16A	MGC14333|MYPT3	protein_coding	Q96I34	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7606
2.92900714430674e-150	-0.394567545389052	0.993	0.998	5.31263315834356e-146	MRPL23	Malignant cells	GSE139386	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7607
3.18478542372685e-150	0.56056463989628	0.846	0.682	5.77656380155577e-146	TMEM66	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7608
3.32259965554748e-150	-0.504922120206256	0.426	0.706	6.02653125523202e-146	TP53TG1	Malignant cells	GSE139386	ENSG00000182165	NA	NA	H_RG012D21.9|LINC00096|TP53AP1|TP53LC12	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7609
3.72601278145525e-150	-0.497898355266382	0.379	0.662	6.75824198300352e-146	RBPJ	Malignant cells	GSE139386	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7610
4.00162213303182e-150	-0.508474614376642	0.458	0.727	7.25814222489311e-146	CINP	Malignant cells	GSE139386	ENSG00000100865	51550	cyclin dependent kinase 2 interacting protein	MGC849	protein_coding	Q9BW66	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7611
4.91001458678012e-150	-0.497978493034732	0.515	0.783	8.90578445750178e-146	SCOC	Malignant cells	GSE139386	ENSG00000153130	60592	short coiled-coil protein	HRIHFB2072|SCOCO|UNC-69	protein_coding	Q9UIL1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7612
6.83083980862563e-150	0.64678910862146	0.597	0.308	1.23897772448852e-145	IDH1	Malignant cells	GSE139386	ENSG00000138413	3417	isocitrate dehydrogenase (NADP(+)) 1	NA	protein_coding	O75874	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7613
6.85336031983074e-150	-0.480949748491932	0.298	0.594	1.2430624948109e-145	C9orf69	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7614
6.93523605857906e-150	-0.444934877544679	0.267	0.568	1.25791311630507e-145	MUS81	Malignant cells	GSE139386	ENSG00000172732	80198	MUS81 structure-specific endonuclease subunit	FLJ44872|SLX3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7615
1.80358612079474e-149	-0.499220671929918	0.965	0.987	3.27134450589751e-145	CYC1	Malignant cells	GSE139386	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7616
2.16444192975653e-149	0.577946176565748	0.854	0.684	3.9258647721924e-145	CLDND1	Malignant cells	GSE139386	ENSG00000080822	56650	claudin domain containing 1	C3orf4|Z38	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7617
2.34416360383264e-149	-0.495233421571085	0.287	0.583	4.25184394463165e-145	BNIP3	Malignant cells	GSE139386	ENSG00000176171	664	BCL2 interacting protein 3	HABON|Nip3	protein_coding	Q12983	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7618
3.0795536965283e-149	-0.40925457479009	0.15	0.423	5.58569449476303e-145	DPH2	Malignant cells	GSE139386	ENSG00000132768	1802	diphthamide biosynthesis 2	DPH2L2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7619
3.24398460292711e-149	-0.437293618321524	0.177	0.458	5.8839392727892e-145	THOC3	Malignant cells	GSE139386	ENSG00000051596	84321	THO complex subunit 3	MGC5469|TEX1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7620
3.40502990313332e-149	-0.367699159808782	0.114	0.375	6.17604323830322e-145	UNC13D	Malignant cells	GSE139386	ENSG00000092929	201294	unc-13 homolog D	Munc13-4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7621
4.7555708995468e-149	-0.492797929697956	0.525	0.787	8.62565449759798e-145	CIZ1	Malignant cells	GSE139386	ENSG00000148337	25792	CDKN1A interacting zinc finger protein 1	LSFR1|ZNF356	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7622
5.55776884709446e-149	-0.448201912309248	0.251	0.547	1.00806811348599e-144	CCAR1	Malignant cells	GSE139386	ENSG00000060339	55749	cell division cycle and apoptosis regulator 1	CARP-1|CARP1|FLJ10590	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7623
9.03930679803067e-149	-0.406922788642749	0.137	0.407	1.6395494670268e-144	RAB3B	Malignant cells	GSE139386	ENSG00000169213	5865	RAB3B, member RAS oncogene family	NA	protein_coding	P20337	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7624
1.05279178174164e-148	-0.459635550221061	0.273	0.568	1.90955373372298e-144	PAK4	Malignant cells	GSE139386	ENSG00000130669	10298	p21 (RAC1) activated kinase 4	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7625
1.21163317024735e-148	-0.395260036910831	0.107	0.362	2.19766024419465e-144	IDI1	Malignant cells	GSE139386	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7626
1.98102848052115e-148	-0.491380368579955	0.79	0.94	3.59318945796926e-144	DENR	Malignant cells	GSE139386	ENSG00000139726	8562	density regulated re-initiation and release factor	DRP|DRP1|SMAP-3	protein_coding	O43583	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7627
4.96583232137524e-148	-0.387543426218476	0.122	0.385	9.00702666451041e-144	SBF2-AS1	Malignant cells	GSE139386	ENSG00000246273	283104	SBF2 antisense RNA 1	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7628
6.66725995003946e-148	0.433993841408078	0.348	0.065	1.20930760973816e-143	JMY	Malignant cells	GSE139386	ENSG00000152409	133746	junction mediating and regulatory protein, p53 cofactor	FLJ37870|WHAMM2	protein_coding	Q8N9B5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7629
7.30208245450073e-148	-0.344059320806928	0.082	0.323	1.32445171559734e-143	TIMELESS	Malignant cells	GSE139386	ENSG00000111602	8914	timeless circadian regulator	hTIM|TIM|TIM1	protein_coding	Q9UNS1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7630
9.41179980486278e-148	-0.356836301742145	0.066	0.294	1.70711224860601e-143	MCM6	Malignant cells	GSE139386	ENSG00000076003	4175	minichromosome maintenance complex component 6	Mis5	protein_coding	Q14566	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7631
1.15698196283851e-147	-0.652806294425176	0.707	0.89	2.09853388419649e-143	MT-ND6	Malignant cells	GSE139386	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7632
1.2728578033718e-147	0.540838592126009	0.599	0.301	2.30870948375576e-143	USP3	Malignant cells	GSE139386	ENSG00000140455	9960	ubiquitin specific peptidase 3	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7633
1.64086794590332e-147	-0.393625607795388	0.156	0.436	2.97620628027943e-143	TOPBP1	Malignant cells	GSE139386	ENSG00000163781	11073	DNA topoisomerase II binding protein 1	Dpb11|KIAA0259|TOP2BP1	protein_coding	Q92547	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7634
1.70621932328065e-147	-0.39506057999725	0.143	0.414	3.09474060856644e-143	PPP1R18	Malignant cells	GSE139386	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7635
2.26114224071172e-147	-0.510814306785036	0.254	0.538	4.10125979620292e-143	ARHGAP29	Malignant cells	GSE139386	ENSG00000137962	9411	Rho GTPase activating protein 29	PARG1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7636
3.06557244982146e-147	-0.491751586977494	0.727	0.905	5.56033530948616e-143	EMD	Malignant cells	GSE139386	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7637
4.41019342644259e-147	-0.412514666095316	0.97	0.997	7.99920883688157e-143	UBE2D3	Malignant cells	GSE139386	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7638
4.7381783474988e-147	-0.495113885005714	0.518	0.791	8.59410788669333e-143	ZNF428	Malignant cells	GSE139386	ENSG00000131116	126299	zinc finger protein 428	C19orf37|MGC51082|Zfp428	protein_coding	Q96B54	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7639
8.19150213550658e-147	-0.379181706319117	0.999	1	1.48577465733818e-142	COX6A1	Malignant cells	GSE139386	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7640
8.9749477765986e-147	-0.454065911978873	0.249	0.537	1.62787602771945e-142	WRNIP1	Malignant cells	GSE139386	ENSG00000124535	56897	WRN helicase interacting protein 1	bA420G6.2|CFAP93|FAP93|FLJ22526|WHIP	protein_coding	Q96S55	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7641
1.4111026998757e-146	0.566247458528321	0.807	0.614	2.55945807703454e-142	AP3D1	Malignant cells	GSE139386	ENSG00000065000	8943	adaptor related protein complex 3 subunit delta 1	ADTD	protein_coding	O14617	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7642
1.44932126208078e-146	-0.503272499785209	0.798	0.938	2.62877890516211e-142	NDUFAF2	Malignant cells	GSE139386	ENSG00000164182	91942	NADH:ubiquinone oxidoreductase complex assembly factor 2	B17.2L|mimitin|MMTN|NDUFA12L	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7643
1.51766482747951e-146	-0.540052841848294	0.453	0.719	2.75274046408234e-142	C1orf35	Malignant cells	GSE139386	ENSG00000143793	79169	chromosome 1 open reading frame 35	MGC4174|MMTAG2	protein_coding	Q9BU76	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7644
1.88968149162654e-146	-0.527214316629369	0.809	0.934	3.42750428951222e-142	C11orf83	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7645
2.24602148756196e-146	0.503769719466826	0.313	0.044	4.07383377413988e-142	LAPTM5	Malignant cells	GSE139386	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7646
2.95188340899893e-146	1.01776806588868	0.776	0.553	5.35412612724226e-142	B4GALT1	Malignant cells	GSE139386	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7647
3.49845363364056e-146	-0.535554787274812	0.51	0.765	6.34549520069725e-142	TRIO	Malignant cells	GSE139386	ENSG00000038382	7204	trio Rho guanine nucleotide exchange factor	ARHGEF23	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7648
4.76484473748204e-146	0.608637863364598	0.652	0.371	8.64247538484493e-142	PLEK2	Malignant cells	GSE139386	ENSG00000100558	26499	pleckstrin 2	NA	protein_coding	Q9NYT0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7649
5.29533843622131e-146	-0.352700724341245	0.096	0.344	9.60468485561821e-142	EFCAB11	Malignant cells	GSE139386	ENSG00000140025	90141	EF-hand calcium binding domain 11	C14orf143	protein_coding	Q9BUY7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7650
7.49987495809546e-146	-0.36696636169569	0.111	0.366	1.36032731989936e-141	SYT12	Malignant cells	GSE139386	ENSG00000173227	91683	synaptotagmin 12	SRG1	protein_coding	Q8IV01	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7651
9.88033519111435e-146	0.556812686336079	0.79	0.582	1.79209519696432e-141	RAB6A	Malignant cells	GSE139386	ENSG00000175582	5870	RAB6A, member RAS oncogene family	RAB6	protein_coding	P20340	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7652
1.01482858098601e-145	-0.405220995586408	0.162	0.441	1.84069608019243e-141	NUP155	Malignant cells	GSE139386	ENSG00000113569	9631	nucleoporin 155	KIAA0791|N155	protein_coding	O75694	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7653
1.20819812537033e-145	-0.439302664397115	0.206	0.489	2.1914297597967e-141	CUTC	Malignant cells	GSE139386	ENSG00000119929	51076	cutC copper transporter	CGI-32	protein_coding	Q9NTM9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7654
1.29583634367333e-145	-0.434313926490364	0.229	0.52	2.35038796015468e-141	C9orf37	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7655
1.71281450802335e-145	0.542429953002654	0.883	0.766	3.10670295465274e-141	THEM4	Malignant cells	GSE139386	ENSG00000159445	117145	thioesterase superfamily member 4	CTMP	protein_coding	Q5T1C6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7656
2.28264297275658e-145	0.502013263949912	0.923	0.757	4.14025782398589e-141	RNF187	Malignant cells	GSE139386	ENSG00000285426	149603	ring finger protein 187	RACO-1|RACO1	protein_coding	Q5TA31	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7657
2.75053592357724e-145	-0.371073389171184	0.105	0.356	4.98892205818439e-141	ANKRD49	Malignant cells	GSE139386	ENSG00000168876	54851	ankyrin repeat domain 49	FGIF|FLJ20189|GBIF	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7658
4.86011735888427e-145	0.597845038034079	0.661	0.387	8.8152808655443e-141	GOLPH3L	Malignant cells	GSE139386	ENSG00000143457	55204	golgi phosphoprotein 3 like	GPP34R	protein_coding	Q9H4A5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7659
5.80147224091596e-145	-0.409552111137841	0.205	0.492	1.05227103505734e-140	FDX1L	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7660
7.70721871800362e-145	0.458135319178703	0.396	0.104	1.3979353310715e-140	TFPI	Malignant cells	GSE139386	ENSG00000003436	7035	tissue factor pathway inhibitor	EPI|LACI|TFI|TFPI1	protein_coding	P10646	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7661
8.35322686800508e-145	0.494421735058265	0.941	0.854	1.51510828931876e-140	EIF6	Malignant cells	GSE139386	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7662
8.38339130159324e-145	-0.502092487023739	0.502	0.762	1.52057951428298e-140	TFAM	Malignant cells	GSE139386	ENSG00000108064	7019	transcription factor A, mitochondrial	TCF6|TCF6L2	protein_coding	Q00059	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7663
8.77689643787356e-145	-0.501399174348077	0.815	0.946	1.59195347590151e-140	PAWR	Malignant cells	GSE139386	ENSG00000177425	5074	pro-apoptotic WT1 regulator	par-4|PAR4	protein_coding	Q96IZ0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7664
1.08522485831783e-144	0.524085984360715	0.513	0.207	1.96838084801689e-140	RHBDL1	Malignant cells	GSE139386	ENSG00000103269	9028	rhomboid like 1	RHBDL|RRP	protein_coding	O75783	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7665
1.25259195349909e-144	-0.439031642861117	0.967	0.994	2.27195128525665e-140	ATPIF1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7666
1.47377719484204e-144	-0.47185278510717	0.913	0.982	2.6731370760045e-140	KPNB1	Malignant cells	GSE139386	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7667
1.89353118781946e-144	-0.424984073490934	0.188	0.467	3.43448686846695e-140	LRP11	Malignant cells	GSE139386	ENSG00000120256	84918	LDL receptor related protein 11	bA350J20.3|MANSC3	protein_coding	Q86VZ4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7668
2.06402415037245e-144	-0.451460917012691	0.311	0.607	3.74372700394555e-140	TNRC6A	Malignant cells	GSE139386	ENSG00000288130	27327	trinucleotide repeat containing adaptor 6A	CAGH26|GW182|KIAA1460|TNRC6	protein_coding	Q8NDV7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7669
2.4355266268158e-144	-0.319951936804213	0.075	0.309	4.41755819571851e-140	SPC24	Malignant cells	GSE139386	ENSG00000161888	147841	SPC24 component of NDC80 kinetochore complex	FLJ90806|SPBC24	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7670
3.13589808943213e-144	0.718632755040534	0.912	0.718	5.68789195461199e-140	IL8	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7671
3.45673655145661e-144	-0.301523578214996	0.055	0.272	6.269828757032e-140	NCAPG2	Malignant cells	GSE139386	ENSG00000146918	54892	non-SMC condensin II complex subunit G2	CAP-G2|FLJ20311|hCAP-G2|LUZP5|MTB	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7672
4.13962714923489e-144	0.602224762497987	0.655	0.384	7.50845572328225e-140	ACSL3	Malignant cells	GSE139386	ENSG00000123983	2181	acyl-CoA synthetase long chain family member 3	ACS3|FACL3|PRO2194	protein_coding	O95573	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7673
4.26159482069903e-144	-0.40046336169197	0.11	0.36	7.7296806857839e-140	SYNGR1	Malignant cells	GSE139386	ENSG00000100321	9145	synaptogyrin 1	NA	protein_coding	O43759	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7674
5.96832148796037e-144	-0.410339099738539	0.143	0.409	1.08253415148625e-139	DECR1	Malignant cells	GSE139386	ENSG00000104325	1666	2,4-dienoyl-CoA reductase 1	DECR|SDR18C1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7675
1.25629648042922e-143	-0.293063692349207	0.051	0.261	2.27867055620251e-139	ELF4	Malignant cells	GSE139386	ENSG00000102034	2000	E74 like ETS transcription factor 4	ELFR|MEF	protein_coding	Q99607	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7676
1.27888053816479e-143	-0.449570128116021	0.32	0.615	2.3196335201233e-139	MTF2	Malignant cells	GSE139386	ENSG00000143033	22823	metal response element binding transcription factor 2	M96|PCL2|TDRD19A	protein_coding	Q9Y483	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7677
1.48197447904929e-143	0.56162663601405	0.825	0.659	2.68800531009959e-139	ERLEC1	Malignant cells	GSE139386	ENSG00000068912	27248	endoplasmic reticulum lectin 1	C2orf30|CL25084|ERLECTIN|XTP3-B|XTP3TPB	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7678
1.53467356450982e-143	-0.49619391537572	0.684	0.876	2.78359091130792e-139	DPM2	Malignant cells	GSE139386	ENSG00000136908	8818	dolichyl-phosphate mannosyltransferase subunit 2, regulatory	MGC111193|MGC21559	protein_coding	O94777	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7679
1.95852355726761e-143	-0.365500100927583	0.105	0.356	3.55237002817199e-139	MMS22L	Malignant cells	GSE139386	ENSG00000146263	253714	MMS22 like, DNA repair protein	C6orf167|dJ39B17.2	protein_coding	Q6ZRQ5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7680
2.23746407761839e-143	-0.428166717023641	0.235	0.524	4.05831234398424e-139	CHTF8	Malignant cells	GSE139386	ENSG00000168802	54921	chromosome transmission fidelity factor 8	CTF8|FLJ20400	protein_coding	P0CG13	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7681
2.43248243278726e-143	-0.323648816241335	0.071	0.297	4.41203663658953e-139	NOP14-AS1	Malignant cells	GSE139386	ENSG00000249673	NA	NA	C4orf10|RES4-24	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7682
3.61895714737709e-143	0.68597491746121	0.691	0.433	6.56406447391257e-139	IGFBP2	Malignant cells	GSE139386	ENSG00000115457	3485	insulin like growth factor binding protein 2	IBP2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7683
4.34261402718595e-143	-0.462448872747969	0.3	0.591	7.87663332250988e-139	KRR1	Malignant cells	GSE139386	ENSG00000111615	11103	KRR1 small subunit processome component homolog	HRB2|RIP-1	protein_coding	Q13601	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7684
9.05464917933586e-143	-0.444870575322165	0.247	0.535	1.64233226814794e-138	TRMT2A	Malignant cells	GSE139386	ENSG00000099899	27037	tRNA methyltransferase 2 homolog A	HTF9C	protein_coding	Q8IZ69	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7685
9.36403781524229e-143	-0.537391115107571	0.759	0.918	1.69844917892865e-138	MRPS18C	Malignant cells	GSE139386	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7686
1.35878727451315e-142	-0.45001559821236	0.344	0.64	2.46456835851195e-138	RBM15B	Malignant cells	GSE139386	ENSG00000259956	29890	RNA binding motif protein 15B	HUMAGCGB|OTT3	protein_coding	Q8NDT2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7687
1.40348906866973e-142	-0.500732106419666	0.769	0.926	2.54564847275316e-138	PPP1CC	Malignant cells	GSE139386	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7688
1.78166176076437e-142	0.527905672767858	0.51	0.213	3.23157810167442e-138	CBX4	Malignant cells	GSE139386	ENSG00000141582	8535	chromobox 4	hPC2|NBP16|PC2	protein_coding	O00257	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7689
2.02122287291138e-142	-0.486506211888271	0.528	0.786	3.66609404688666e-138	EIF4E	Malignant cells	GSE139386	ENSG00000151247	1977	eukaryotic translation initiation factor 4E	EIF4E1|EIF4EL1|EIF4F	protein_coding	P06730	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7690
2.21246057715278e-142	-0.524161391029529	0.491	0.747	4.01296099483972e-138	RP11-295G20.2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7691
2.84252734224922e-142	-0.375385496715241	0.996	0.999	5.15577609337163e-138	C14orf2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7692
3.00465435730595e-142	0.564831558443632	0.55	0.254	5.44984207328154e-138	NKX2-8	Malignant cells	GSE139386	ENSG00000136327	26257	NK2 homeobox 8	Nkx2-9|NKX2.8|NKX2H	protein_coding	O15522	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7693
3.2115631374887e-142	-0.349831525310773	0.069	0.295	5.825133218777e-138	KIF2C	Malignant cells	GSE139386	ENSG00000142945	11004	kinesin family member 2C	CT139|KNSL6|MCAK	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7694
3.42452066445601e-142	-0.458191491226224	0.358	0.65	6.21139558119031e-138	APPL1	Malignant cells	GSE139386	ENSG00000157500	26060	adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1	APPL	protein_coding	Q9UKG1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7695
4.17935547731322e-142	0.409544271152148	0.996	0.98	7.58051496475072e-138	PSME1	Malignant cells	GSE139386	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7696
4.53253660917373e-142	0.616760482679113	0.674	0.419	8.22111490171932e-138	ZNF581	Malignant cells	GSE139386	ENSG00000171425	51545	zinc finger protein 581	FLJ22550|HSPC189	protein_coding	Q9P0T4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7697
6.61569392936452e-142	-0.470758226930102	0.554	0.811	1.19995456490814e-137	SNAPC5	Malignant cells	GSE139386	ENSG00000174446	10302	small nuclear RNA activating complex polypeptide 5	SNAP19	protein_coding	O75971	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7698
9.11020436349067e-142	-0.314283941268221	0.057	0.27	1.65240886744994e-137	P2RY2	Malignant cells	GSE139386	ENSG00000175591	5029	purinergic receptor P2Y2	P2U	protein_coding	P41231	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7699
1.9147292284194e-141	-0.514802856786305	0.512	0.767	3.47293587450711e-137	LAMP1	Malignant cells	GSE139386	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7700
2.1779281077993e-141	-0.392395009047733	0.154	0.424	3.95032600192637e-137	TRIM52-AS1	Malignant cells	GSE139386	ENSG00000248275	100507602	TRIM52 antisense RNA 1 (head to head)	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7701
4.67520550626065e-141	-0.466842390522107	0.34	0.629	8.47988774725556e-137	MRPL35	Malignant cells	GSE139386	ENSG00000132313	51318	mitochondrial ribosomal protein L35	NA	protein_coding	Q9NZE8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7702
8.49317662535363e-141	-0.298364075675927	0.05	0.257	1.54049237630664e-136	ANXA9	Malignant cells	GSE139386	ENSG00000143412	8416	annexin A9	ANX31	protein_coding	O76027	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7703
1.24706348890311e-140	0.514895627539201	0.499	0.203	2.26192375617247e-136	LONP1	Malignant cells	GSE139386	ENSG00000196365	9361	lon peptidase 1, mitochondrial	hLON|LonHS|PIM1|PRSS15	protein_coding	P36776	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7704
1.41333522329627e-140	-0.485626511032575	0.489	0.753	2.56350742801477e-136	ABCF1	Malignant cells	GSE139386	ENSG00000225989	23	ATP binding cassette subfamily F member 1	ABC50|EST123147	protein_coding	Q8NE71	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7705
1.98173070678376e-140	0.394922070637277	0.289	0.033	3.59446315596438e-136	CTD-2314B22.3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7706
2.25320228295102e-140	-0.342474740036435	0.085	0.319	4.08685830081657e-136	CHTF18	Malignant cells	GSE139386	ENSG00000127586	63922	chromosome transmission fidelity factor 18	C16orf41|C321D2.4|CHL12|Ctf18	protein_coding	Q8WVB6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7707
2.33746051402452e-140	-0.493765950732681	0.214	0.491	4.23968588033767e-136	KLF6	Malignant cells	GSE139386	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7708
4.50195197137446e-140	-0.420870118850222	0.18	0.456	8.165640485679e-136	PLS3	Malignant cells	GSE139386	ENSG00000102024	5358	plastin 3	T-plastin	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7709
4.93348987956128e-140	-0.470336389355473	0.278	0.561	8.94836394354824e-136	ATRX	Malignant cells	GSE139386	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7710
6.85958998293877e-140	-0.509562145413979	0.826	0.946	1.24419243110543e-135	UCHL3	Malignant cells	GSE139386	ENSG00000118939	7347	ubiquitin C-terminal hydrolase L3	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7711
7.81843612721889e-140	-0.326266650654082	0.08	0.313	1.41810794475496e-135	FANCI	Malignant cells	GSE139386	ENSG00000140525	55215	FA complementation group I	FLJ10719|KIAA1794	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7712
8.80271770248577e-140	-0.307097169053936	0.056	0.266	1.59663693687687e-135	C19orf47	Malignant cells	GSE139386	ENSG00000160392	126526	chromosome 19 open reading frame 47	FLJ36888	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7713
1.04929197624947e-139	-0.48473823383702	0.49	0.752	1.90320578652128e-135	GRK6	Malignant cells	GSE139386	ENSG00000198055	2870	G protein-coupled receptor kinase 6	GPRK6	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7714
1.13579146438593e-139	-0.344816419830761	0.095	0.334	2.06009855810319e-135	KIAA1429	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7715
2.32126791485932e-139	-0.378776999179883	0.132	0.389	4.21031574397183e-135	CREBZF	Malignant cells	GSE139386	ENSG00000137504	58487	CREB/ATF bZIP transcription factor	ZF	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7716
3.04496784298005e-139	0.403559208039133	0.996	0.977	5.52296267359722e-135	ATP5O	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7717
4.32904635868331e-139	-0.478733275091886	0.355	0.635	7.8520242853798e-135	RB1CC1	Malignant cells	GSE139386	ENSG00000023287	9821	RB1 inducible coiled-coil 1	ATG17|Cc1|DRAGOU14|FIP200|KIAA0203|PPP1R131	protein_coding	Q8TDY2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7718
6.13685464663285e-139	0.595515689576146	0.757	0.535	1.11310269580627e-134	QSOX1	Malignant cells	GSE139386	ENSG00000116260	5768	quiescin sulfhydryl oxidase 1	QSCN6	protein_coding	O00391	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7719
6.55875908988742e-139	-0.412804345339335	0.096	0.33	1.18962772372378e-134	PODXL	Malignant cells	GSE139386	ENSG00000128567	5420	podocalyxin like	gp135|Gp200|PC|PCLP|PDX|PODXL1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7720
8.4579853851552e-139	0.409084364516942	0.315	0.051	1.53410938915945e-134	ADM2	Malignant cells	GSE139386	ENSG00000128165	79924	adrenomedullin 2	AM2|FLJ21135	protein_coding	Q7Z4H4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7721
8.75758742818842e-139	-0.482661783081798	0.407	0.684	1.58845120772482e-134	CCDC50	Malignant cells	GSE139386	ENSG00000152492	152137	coiled-coil domain containing 50	C3orf6|DFNA44|Ymer	protein_coding	Q8IVM0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7722
9.12167564724076e-139	-0.537749501803404	0.42	0.695	1.65448952889653e-134	EFNA5	Malignant cells	GSE139386	ENSG00000184349	1946	ephrin A5	AF1|EPLG7|LERK7	protein_coding	P52803	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7723
1.70724476236967e-138	-0.402402839814775	0.149	0.412	3.09660054998611e-134	CLDN9	Malignant cells	GSE139386	ENSG00000213937	9080	claudin 9	NA	protein_coding	O95484	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7724
1.74314864990773e-138	0.574891362563172	0.831	0.669	3.16172302120264e-134	POLR3GL	Malignant cells	GSE139386	ENSG00000121851	84265	RNA polymerase III subunit GL	flj32422|MGC3200	protein_coding	Q9BT43	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7725
2.00523350470843e-138	-0.307088276238263	1	1	3.63709253084015e-134	NDUFS8	Malignant cells	GSE139386	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7726
2.02056684467356e-138	-0.428539583035007	0.245	0.531	3.66490414286891e-134	PACS1	Malignant cells	GSE139386	ENSG00000175115	55690	phosphofurin acidic cluster sorting protein 1	FLJ10209|KIAA1175	protein_coding	Q6VY07	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7727
2.09693501552568e-138	-0.467108195671037	0.387	0.67	3.80342073116048e-134	PIGX	Malignant cells	GSE139386	ENSG00000163964	54965	phosphatidylinositol glycan anchor biosynthesis class X	FLJ20522	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7728
2.15553867780437e-138	-0.409284467549076	0.166	0.434	3.90971605380156e-134	SRP14-AS1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7729
2.34657616258787e-138	-0.509570925771163	0.574	0.806	4.25621984370187e-134	ARL3	Malignant cells	GSE139386	ENSG00000138175	403	ADP ribosylation factor like GTPase 3	ARFL3	protein_coding	P36405	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7730
2.35304124549754e-138	-0.47236351510449	0.368	0.654	4.26794621108344e-134	MRPS6	Malignant cells	GSE139386	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7731
2.87516068092825e-138	-0.41839865963821	0.207	0.484	5.21496644306766e-134	C11orf68	Malignant cells	GSE139386	ENSG00000175573	83638	chromosome 11 open reading frame 68	BLES03|P5326	protein_coding	Q9H3H3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7732
3.58308254974689e-138	-0.34692294826735	0.057	0.27	6.4989951287309e-134	DEPDC1	Malignant cells	GSE139386	ENSG00000024526	55635	DEP domain containing 1	DEP.8|DEPDC1A|FLJ20354|SDP35	protein_coding	Q5TB30	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7733
4.20151840426705e-138	0.518175684237693	0.465	0.168	7.62071408165957e-134	NT5E	Malignant cells	GSE139386	ENSG00000135318	4907	5'-nucleotidase ecto	CALJA|CD73|eN|eNT|NT5	protein_coding	P21589	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7734
4.26938968475446e-138	-0.346403827231852	0.999	1	7.74381901020764e-134	SEC61G	Malignant cells	GSE139386	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7735
5.502335929641e-138	-0.416918592782685	0.204	0.481	9.98013690918284e-134	ANKRD28	Malignant cells	GSE139386	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7736
7.13424809317734e-138	-0.324747683099792	0.077	0.302	1.29400991914051e-133	ZBTB2	Malignant cells	GSE139386	ENSG00000181472	57621	zinc finger and BTB domain containing 2	bA351K16.2|KIAA1483|ZNF437	protein_coding	Q8N680	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7737
8.08095677946162e-138	-0.481501696212765	0.497	0.754	1.46572394065875e-133	HDGFRP3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7738
1.33492521274566e-137	-0.510565325989909	0.586	0.813	2.42128735087808e-133	RAD21	Malignant cells	GSE139386	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7739
1.39276223295621e-137	0.255685295096084	1	1	2.52619213813597e-133	EEF1D	Malignant cells	GSE139386	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7740
2.42643375707323e-137	-0.425261329712784	0.236	0.52	4.40106554857943e-133	NCAPH2	Malignant cells	GSE139386	ENSG00000025770	29781	non-SMC condensin II complex subunit H2	384D8-2|CAP-H2|hCAP-H2	protein_coding	Q6IBW4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7741
3.83938168117845e-137	0.421701729115799	0.292	0.038	6.96387049332148e-133	ATF3	Malignant cells	GSE139386	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7742
4.28626613848824e-137	-0.351379879807128	0.106	0.349	7.77442952198998e-133	RP5-940J5.9	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7743
6.46821979153804e-137	-0.328647709985835	0.064	0.282	1.17320570578917e-132	NEK2	Malignant cells	GSE139386	ENSG00000117650	4751	NIMA related kinase 2	NEK2A|NLK1|PPP1R111|RP67	protein_coding	P51955	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7744
1.05714087162805e-136	-0.429877073964771	0.225	0.505	1.91744211295896e-132	SNX10	Malignant cells	GSE139386	ENSG00000086300	29887	sorting nexin 10	NA	protein_coding	Q9Y5X0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7745
1.06414625230568e-136	-0.30913971529527	0.064	0.28	1.93014847243204e-132	C5orf30	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7746
1.37860855375313e-136	-0.458530124333972	0.184	0.449	2.50052019479743e-132	RHOB	Malignant cells	GSE139386	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7747
1.39140860559746e-136	-0.456621194258888	0.285	0.567	2.52373692883266e-132	VARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7748
1.41206677363821e-136	0.558034384420969	0.792	0.602	2.56120671402498e-132	LRRFIP1	Malignant cells	GSE139386	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7749
1.68280975779041e-136	-0.410400730985356	0.225	0.508	3.05228033868024e-132	PSMD10	Malignant cells	GSE139386	ENSG00000101843	5716	proteasome 26S subunit, non-ATPase 10	p28	protein_coding	O75832	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7750
1.82348221850731e-136	0.540551553858629	0.729	0.484	3.30743204792856e-132	PRKCSH	Malignant cells	GSE139386	ENSG00000130175	5589	protein kinase C substrate 80K-H	G19P1|GIIB|PCLD|PLD1|VASAP-60	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7751
2.09731933667421e-136	-0.545812651522418	0.985	0.997	3.80411781285968e-132	TALDO1	Malignant cells	GSE139386	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7752
2.99429417229838e-136	0.764478886681268	0.927	0.854	5.4310507697148e-132	ATP1B1	Malignant cells	GSE139386	ENSG00000143153	481	ATPase Na+/K+ transporting subunit beta 1	ATP1B	protein_coding	P05026	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7753
6.93646263132344e-136	0.380215235207593	0.285	0.035	1.25813559206945e-131	PDE4D	Malignant cells	GSE139386	ENSG00000113448	5144	phosphodiesterase 4D	DPDE3	protein_coding	Q08499	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7754
1.00316185811851e-135	-0.42534207383546	0.279	0.564	1.81953497825536e-131	U2AF2	Malignant cells	GSE139386	ENSG00000063244	11338	U2 small nuclear RNA auxiliary factor 2	U2AF65	protein_coding	P26368	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7755
1.03567508316492e-135	-0.485748950593981	0.669	0.861	1.87850746584453e-131	CNOT7	Malignant cells	GSE139386	ENSG00000198791	29883	CCR4-NOT transcription complex subunit 7	CAF1	protein_coding	Q9UIV1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7756
1.10772739849448e-135	0.559970796153732	0.935	0.862	2.00919595538929e-131	EZR	Malignant cells	GSE139386	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7757
1.29028286610975e-135	-0.42062751818878	0.214	0.489	2.34031506254987e-131	RUSC1	Malignant cells	GSE139386	ENSG00000160753	23623	RUN and SH3 domain containing 1	NESCA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7758
1.4746883402235e-135	-0.493117992417365	0.714	0.912	2.67478971149738e-131	PLP2	Malignant cells	GSE139386	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7759
1.77733233354904e-135	-0.429503073526286	0.275	0.561	3.22372538659126e-131	CLN6	Malignant cells	GSE139386	ENSG00000128973	54982	CLN6 transmembrane ER protein	FLJ20561|HsT18960|nclf	protein_coding	Q9NWW5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7760
2.1722249763014e-135	-0.382455728794085	0.169	0.438	3.93998166201548e-131	LRRC14	Malignant cells	GSE139386	ENSG00000160959	9684	leucine rich repeat containing 14	KIAA0014|LRRC14A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7761
2.31095992347308e-135	0.515378178381316	0.896	0.797	4.19161910919548e-131	TMEM179B	Malignant cells	GSE139386	ENSG00000185475	374395	transmembrane protein 179B	NA	protein_coding	Q7Z7N9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7762
2.40086291745812e-135	-0.441986233159923	0.314	0.602	4.35468515968554e-131	MAP2K3	Malignant cells	GSE139386	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7763
3.0562693265958e-135	-0.404357001207592	0.169	0.433	5.54346130457945e-131	KIF1C	Malignant cells	GSE139386	ENSG00000129250	10749	kinesin family member 1C	SAX2|SPAX2|SPG58	protein_coding	O43896	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7764
3.17356709864374e-135	-0.413504746025184	0.218	0.495	5.75621600352002e-131	IER5	Malignant cells	GSE139386	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7765
3.34973212333223e-135	-0.35027775860432	0.103	0.341	6.07574412530001e-131	ABHD5	Malignant cells	GSE139386	ENSG00000011198	51099	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	CGI-58|NCIE2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7766
3.56844125320395e-135	0.487540860794584	0.468	0.178	6.47243874506133e-131	AARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7767
4.17270087133857e-135	-0.392846529270744	0.122	0.371	7.56844484043391e-131	FN1	Malignant cells	GSE139386	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7768
4.86817148685508e-135	-0.311883869934547	0.055	0.261	8.82988944285775e-131	CASC15	Malignant cells	GSE139386	ENSG00000272168	NA	NA	LINC00340|lnc-SOX4-1	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7769
5.17102492251727e-135	-0.479964464624141	0.488	0.743	9.37920500446183e-131	BEST1	Malignant cells	GSE139386	ENSG00000167995	7439	bestrophin 1	BEST|BMD|RP50|VMD2	protein_coding	O76090	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7770
8.78923195949505e-135	0.540016088005591	0.868	0.74	1.59419089281321e-130	CTSB	Malignant cells	GSE139386	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7771
9.51392029838273e-135	-0.377637383503986	0.147	0.407	1.72563486372066e-130	MGME1	Malignant cells	GSE139386	ENSG00000125871	92667	mitochondrial genome maintenance exonuclease 1	bA504H3.4|C20orf72|DDK1	protein_coding	Q9BQP7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7772
1.5805050067254e-134	0.539716453996915	0.678	0.419	2.86671998119853e-130	GATAD2B	Malignant cells	GSE139386	ENSG00000261992	57459	GATA zinc finger domain containing 2B	P66beta	protein_coding	Q8WXI9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7773
1.96398028801948e-134	-0.30576761379612	0.059	0.267	3.56226744640972e-130	PANX1	Malignant cells	GSE139386	ENSG00000110218	24145	pannexin 1	MRS1|PX1|UNQ2529	protein_coding	Q96RD7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7774
2.51671812196124e-134	-0.42623360438673	0.327	0.61	4.5648233296133e-130	DPF2	Malignant cells	GSE139386	ENSG00000133884	5977	double PHD fingers 2	BAF45d|REQ|SMARCG2|ubi-d4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7775
4.14048924922013e-134	-0.411200476476871	0.219	0.498	7.51001940023547e-130	KIAA0930	Malignant cells	GSE139386	ENSG00000100364	23313	KIAA0930	bK268H5.C22.1|C22orf9	protein_coding	Q6ICG6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7776
4.54653723815619e-134	-0.406540306171903	0.196	0.465	8.2465092425677e-130	MED11	Malignant cells	GSE139386	ENSG00000161920	400569	mediator complex subunit 11	HSPC296|MGC88387	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7777
5.22352228265558e-134	-0.482253497169348	0.498	0.755	9.47442471628069e-130	ENAH	Malignant cells	GSE139386	ENSG00000154380	55740	ENAH actin regulator	FLJ10773|MENA|NDPP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7778
6.59783625659284e-134	-0.360054633141202	0.114	0.357	1.19671554022081e-129	ZNF480	Malignant cells	GSE139386	ENSG00000198464	147657	zinc finger protein 480	MGC32104	protein_coding	Q8WV37	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7779
6.88301407493035e-134	-0.367536148327159	0.131	0.382	1.24844109291087e-129	N6AMT2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7780
9.83136718023936e-134	-0.413557470067443	0.204	0.474	1.78321337915181e-129	PLXNA1	Malignant cells	GSE139386	ENSG00000114554	5361	plexin A1	NOV|PLXN1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7781
1.01087726999865e-133	-0.406006009819776	0.227	0.507	1.83352919232355e-129	MPDU1	Malignant cells	GSE139386	ENSG00000129255	9526	mannose-P-dolichol utilization defect 1	CDGIf|Lec35|PQLC5|SL15|SLC66A5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7782
1.02824160565351e-133	-0.335076394086864	0.082	0.306	1.86502462433433e-129	CDK2	Malignant cells	GSE139386	ENSG00000123374	1017	cyclin dependent kinase 2	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7783
2.09682473458468e-133	-0.306312839243076	0.067	0.28	3.80322070358969e-129	ABAT	Malignant cells	GSE139386	ENSG00000183044	18	4-aminobutyrate aminotransferase	GABA-T|GABAT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7784
2.37621048498414e-133	0.409900015418157	0.322	0.061	4.30997057766424e-129	PCDH1	Malignant cells	GSE139386	ENSG00000156453	5097	protocadherin 1	pc42	protein_coding	Q08174	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7785
2.46239365175253e-133	-0.431856749909422	0.273	0.552	4.46628960554874e-129	ATXN2L	Malignant cells	GSE139386	ENSG00000168488	11273	ataxin 2 like	A2D|A2lp	protein_coding	Q8WWM7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7786
2.57486755747486e-133	-0.410908389873338	0.227	0.505	4.67029477574791e-129	CREM	Malignant cells	GSE139386	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7787
7.60630833885382e-133	-0.3000507205394	0.06	0.27	1.37963220650131e-128	BUB1B	Malignant cells	GSE139386	ENSG00000156970	701	BUB1 mitotic checkpoint serine/threonine kinase B	Bub1A|BUBR1|MAD3L|SSK1	protein_coding	O60566	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7788
2.31138762533713e-132	-0.328771634174241	0.081	0.304	4.19239487483648e-128	C6orf141	Malignant cells	GSE139386	ENSG00000197261	135398	chromosome 6 open reading frame 141	MGC46457	protein_coding	Q5SZD1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7789
2.3785269101337e-132	0.485820460890518	0.914	0.792	4.31417210960051e-128	RAB1A	Malignant cells	GSE139386	ENSG00000138069	5861	RAB1A, member RAS oncogene family	RAB1|YPT1	protein_coding	P62820	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7790
3.36459462048411e-132	-0.441698944854124	0.35	0.628	6.10270172263407e-128	C16orf91	Malignant cells	GSE139386	ENSG00000174109	283951	chromosome 16 open reading frame 91	CCSMST1|gs103|URLC5	protein_coding	Q4G0I0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7791
4.15108337953593e-132	-0.382458572902516	0.151	0.407	7.52923503380227e-128	DYNLL1-AS1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7792
4.62934309442895e-132	0.466766301791233	0.405	0.127	8.39670250467522e-128	DENND6B	Malignant cells	GSE139386	ENSG00000205593	414918	DENN domain containing 6B	AFI1B|FAM116B|MGC33692	protein_coding	Q8NEG7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7793
4.76091994315076e-132	-0.447875240385199	0.304	0.58	8.63535659288684e-128	RPP30	Malignant cells	GSE139386	ENSG00000148688	10556	ribonuclease P/MRP subunit p30	TSG15	protein_coding	P78346	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7794
6.10754327058374e-132	-0.523204999443787	0.943	0.989	1.10778619841848e-127	ETFB	Malignant cells	GSE139386	ENSG00000105379	2109	electron transfer flavoprotein subunit beta	NA	protein_coding	P38117	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7795
6.23718809927202e-132	0.568991363602763	0.68	0.423	1.13130117744596e-127	PLSCR1	Malignant cells	GSE139386	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7796
6.91985302613264e-132	-0.440855994724257	0.941	0.986	1.25512294187994e-127	NDUFA1	Malignant cells	GSE139386	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7797
7.44566038143397e-132	-0.30193763134141	0.066	0.278	1.35049387998449e-127	PLEKHG6	Malignant cells	GSE139386	ENSG00000008323	55200	pleckstrin homology and RhoGEF domain containing G6	FLJ10665|MYOGEF	protein_coding	Q3KR16	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7798
8.3933048679176e-132	0.40381878318723	0.318	0.06	1.52237763694289e-127	ARSJ	Malignant cells	GSE139386	ENSG00000180801	79642	arylsulfatase family member J	FLJ23548	protein_coding	Q5FYB0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7799
1.06696462656349e-131	-0.437450731394872	0.304	0.586	1.93526043966086e-127	NPLOC4	Malignant cells	GSE139386	ENSG00000182446	55666	NPL4 homolog, ubiquitin recognition factor	FLJ20657|KIAA1499|NPL4	protein_coding	Q8TAT6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7800
2.22570555014734e-131	-0.430271597387218	0.939	0.991	4.03698472685724e-127	YWHAB	Malignant cells	GSE139386	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7801
2.9784271140413e-131	-0.283931477192063	0.051	0.25	5.40227109944811e-127	POLD1	Malignant cells	GSE139386	ENSG00000062822	5424	DNA polymerase delta 1, catalytic subunit	CDC2|POLD	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7802
4.08607206002491e-131	-0.360979272563001	0.142	0.395	7.41131750247318e-127	LIMK1	Malignant cells	GSE139386	ENSG00000106683	3984	LIM domain kinase 1	LIMK	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7803
5.08733854450703e-131	-0.46218623955889	0.977	0.991	9.22741465202686e-127	PNN	Malignant cells	GSE139386	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7804
5.463300858866e-131	-0.426913324274055	0.261	0.539	9.90933509781116e-127	MTURN	Malignant cells	GSE139386	ENSG00000180354	222166	maturin, neural progenitor differentiation regulator homolog	C7orf41|Ells1|FLJ25903	protein_coding	Q8N3F0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7805
6.81389402990665e-131	-0.445739669688861	0.878	0.955	1.23590409914447e-126	C19orf24	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7806
9.01926953474291e-131	-0.448382088724753	0.35	0.629	1.63591510821167e-126	TMEM70	Malignant cells	GSE139386	ENSG00000175606	54968	transmembrane protein 70	FLJ20533	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7807
1.13012587416268e-130	-0.298987548115103	0.138	0.404	2.04982231055628e-126	HIST1H2AC	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7808
1.52986646581532e-130	-0.373279583965935	0.147	0.4	2.77487179569583e-126	SMPD4	Malignant cells	GSE139386	ENSG00000136699	55627	sphingomyelin phosphodiesterase 4	FLJ20297|FLJ20756|KIAA1418|NET13|nSMase-3|NSMASE3	protein_coding	Q9NXE4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7809
1.63067045074725e-130	-0.321900418982211	0.08	0.299	2.95771006356536e-126	RUNX2	Malignant cells	GSE139386	ENSG00000124813	860	RUNX family transcription factor 2	AML3|CBFA1|CCD|CCD1|PEBP2A1|PEBP2aA1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7810
3.64601211562489e-130	-0.425565809409278	0.253	0.529	6.61313677532042e-126	TTYH3	Malignant cells	GSE139386	ENSG00000136295	80727	tweety family member 3	KIAA1691	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7811
4.21770532878845e-130	-0.465583204938548	0.358	0.627	7.65007392535649e-126	RRP15	Malignant cells	GSE139386	ENSG00000067533	51018	ribosomal RNA processing 15 homolog	CGI-115|KIAA0507	protein_coding	Q9Y3B9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7812
6.43295226079598e-130	-0.465684127197316	0.522	0.769	1.16680888106317e-125	WBP11	Malignant cells	GSE139386	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7813
7.38279203553498e-130	0.514022075615967	0.838	0.678	1.33909081940534e-125	CNIH1	Malignant cells	GSE139386	ENSG00000100528	10175	cornichon family AMPA receptor auxiliary protein 1	CNIH|CNIL|TGAM77	protein_coding	O95406	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7814
1.17119857742381e-129	0.400048081738635	0.308	0.055	2.1243199797313e-125	CPE	Malignant cells	GSE139386	ENSG00000109472	1363	carboxypeptidase E	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7815
1.42861429950712e-129	-0.488747838348102	0.581	0.805	2.59122061644602e-125	UBE2A	Malignant cells	GSE139386	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7816
1.72139595704126e-129	-0.455398041815074	0.516	0.763	3.12226798688144e-125	ZNF146	Malignant cells	GSE139386	ENSG00000167635	7705	zinc finger protein 146	OZF	protein_coding	Q15072	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7817
2.31082063433521e-129	0.490761343273379	0.524	0.239	4.1913664665572e-125	MFAP2	Malignant cells	GSE139386	ENSG00000117122	4237	microfibril associated protein 2	MAGP|MAGP-1	protein_coding	P55001	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7818
2.81600840249785e-129	0.301899993761381	1	1	5.10767604045059e-125	COX4I1	Malignant cells	GSE139386	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7819
3.0632803431878e-129	-0.380484383403904	0.166	0.424	5.55617788647404e-125	MPHOSPH6	Malignant cells	GSE139386	ENSG00000135698	10200	M-phase phosphoprotein 6	MPP6	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7820
3.19930144411605e-129	-0.438899971315992	0.341	0.618	5.80289295933769e-125	MFSD3	Malignant cells	GSE139386	ENSG00000167700	113655	major facilitator superfamily domain containing 3	NA	protein_coding	Q96ES6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7821
5.00474989238359e-129	-0.452138663260627	0.36	0.638	9.07761535480535e-125	ACIN1	Malignant cells	GSE139386	ENSG00000100813	22985	apoptotic chromatin condensation inducer 1	ACINUS|fSAP152|KIAA0670	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7822
5.32541323796696e-129	-0.467508391292299	0.47	0.732	9.65923453102446e-125	TFRC	Malignant cells	GSE139386	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7823
5.48176456411401e-129	-0.450428593491865	0.416	0.684	9.94282456638999e-125	C1orf52	Malignant cells	GSE139386	ENSG00000162642	148423	chromosome 1 open reading frame 52	FLJ44982|gm117	protein_coding	Q8N6N3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7824
6.45929498223382e-129	-0.446515141989849	0.29	0.562	1.17158692387757e-124	RRP1B	Malignant cells	GSE139386	ENSG00000160208	23076	ribosomal RNA processing 1B	KIAA0179|Nnp1|PPP1R136|RRP1	protein_coding	Q14684	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7825
7.13218545505803e-129	-0.376555584040969	0.123	0.363	1.29363579783843e-124	POLD3	Malignant cells	GSE139386	ENSG00000077514	10714	DNA polymerase delta 3, accessory subunit	KIAA0039|P66|P68|PPP1R128	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7826
1.02972303405303e-128	-0.298567382521842	0.075	0.29	1.86771163916538e-124	GABARAP	Malignant cells	GSE139386	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7827
1.1624157594578e-128	-0.459706519180446	0.46	0.714	2.10838970450456e-124	ACO2	Malignant cells	GSE139386	ENSG00000100412	50	aconitase 2	ACONM	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7828
1.26580905685295e-128	0.502716337830466	0.763	0.546	2.29592446731988e-124	DAP3	Malignant cells	GSE139386	ENSG00000132676	7818	death associated protein 3	bMRP-10|DAP-3|DKFZp686G12159|MGC126058|MGC126059|MRP-S29|MRPS29	protein_coding	P51398	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7829
4.57022984078034e-128	-0.382973154988411	0.181	0.442	8.28948288520739e-124	LINC00094	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7830
5.51663466165282e-128	-0.441309288188091	0.465	0.722	1.00060719493059e-123	ZNF131	Malignant cells	GSE139386	ENSG00000172262	7690	zinc finger protein 131	pHZ-10|ZBTB35	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7831
9.63099468966277e-128	-0.285450946419707	0.058	0.258	1.74686981681103e-123	AC011043.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7832
1.03464071421823e-127	-0.441683434644849	0.639	0.846	1.87663132744902e-123	NUBP2	Malignant cells	GSE139386	ENSG00000095906	10101	NUBP iron-sulfur cluster assembly factor 2, cytosolic	CFD1|CIAO6	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7833
1.26453681330044e-127	-0.490724029088287	0.578	0.798	2.29361687196433e-123	SDHC	Malignant cells	GSE139386	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7834
1.84202204119741e-127	-0.399497595779478	0.191	0.453	3.34105957832385e-123	ABLIM1	Malignant cells	GSE139386	ENSG00000099204	3983	actin binding LIM protein 1	ABLIM|LIMAB1|limatin	protein_coding	O14639	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7835
2.44372245004118e-127	-0.320874117484495	0.079	0.295	4.4324237798847e-123	MYD88	Malignant cells	GSE139386	ENSG00000172936	4615	MYD88 innate immune signal transduction adaptor	NA	protein_coding	Q99836	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7836
2.45489907296258e-127	-0.299178562301721	0.071	0.282	4.45269593853952e-123	C16orf62	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7837
2.69613741232046e-127	-0.452621889048064	0.348	0.621	4.89025403846685e-123	TRMT10C	Malignant cells	GSE139386	ENSG00000174173	54931	tRNA methyltransferase 10C, mitochondrial RNase P subunit	FLJ20432|MRPP1|RG9MTD1	protein_coding	Q7L0Y3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7838
3.66128311755315e-127	-0.392851549119866	0.146	0.397	6.64083531861791e-123	DBF4	Malignant cells	GSE139386	ENSG00000006634	10926	DBF4 zinc finger	ASK|chif|DBF4A|ZDBF1	protein_coding	Q9UBU7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7839
3.76787970505517e-127	0.425187158184284	0.372	0.104	6.83418020902906e-123	CRELD1	Malignant cells	GSE139386	ENSG00000163703	78987	cysteine rich with EGF like domains 1	AVSD2|CIRRIN	protein_coding	Q96HD1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7840
5.01677117958428e-127	-0.348904989000259	0.112	0.346	9.09941956552996e-123	DLGAP1-AS1	Malignant cells	GSE139386	ENSG00000177337	NA	NA	FLJ35776|HsT914	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7841
5.10134376533032e-127	-0.310585574710415	0.078	0.292	9.25281732155613e-123	GLIS3	Malignant cells	GSE139386	ENSG00000107249	169792	GLIS family zinc finger 3	MGC33662|ZNF515	protein_coding	Q8NEA6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7842
5.42226778619547e-127	-0.369735561006195	0.111	0.346	9.83490931060135e-123	CITED4	Malignant cells	GSE139386	ENSG00000179862	163732	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4	NA	protein_coding	Q96RK1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7843
5.81950829000219e-127	0.47456732250465	0.356	0.093	1.0555424136406e-122	HES6	Malignant cells	GSE139386	ENSG00000144485	55502	hes family bHLH transcription factor 6	bHLHb41	protein_coding	Q96HZ4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7844
6.83474242061941e-127	0.491717360993712	0.925	0.853	1.23968558025195e-122	SYNGR2	Malignant cells	GSE139386	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7845
6.92584909649385e-127	-0.407615642866681	0.243	0.514	1.25621050912206e-122	RNF4	Malignant cells	GSE139386	ENSG00000063978	6047	ring finger protein 4	RES4-26|SLX5|SNURF	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7846
9.9697708508209e-127	-0.411322839520546	0.278	0.551	1.80831703692189e-122	SETD9	Malignant cells	GSE139386	ENSG00000155542	133383	SET domain containing 9	C5orf35|MGC33648	protein_coding	Q8NE22	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7847
1.25268138890591e-126	-0.404016066692218	0.215	0.48	2.27211350319754e-122	VEGFB	Malignant cells	GSE139386	ENSG00000173511	7423	vascular endothelial growth factor B	VEGFL|VRF	protein_coding	P49765	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7848
1.55421821224698e-126	-0.450179148838862	0.618	0.835	2.81904099337357e-122	ARPC4	Malignant cells	GSE139386	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7849
1.63340004424113e-126	0.480123159911254	0.505	0.224	2.96266100024455e-122	ZCCHC7	Malignant cells	GSE139386	ENSG00000147905	84186	zinc finger CCHC-type containing 7	AIR1|FLJ22611	protein_coding	Q8N3Z6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7850
1.63370635426498e-126	-0.327288172836689	0.078	0.291	2.96321658536582e-122	TMEM45A	Malignant cells	GSE139386	ENSG00000181458	55076	transmembrane protein 45A	DERP7|FLJ10134	protein_coding	Q9NWC5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7851
2.64860849349917e-126	-0.379605954346987	0.173	0.433	4.80404608550879e-122	FASN	Malignant cells	GSE139386	ENSG00000169710	2194	fatty acid synthase	FAS|SDR27X1	protein_coding	P49327	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7852
3.30850400460782e-126	-0.415295879443953	0.245	0.513	6.00096456355766e-122	TSNAX	Malignant cells	GSE139386	ENSG00000116918	7257	translin associated factor X	C3PO|TRAX	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7853
3.34547464599514e-126	-0.423486091418197	0.271	0.541	6.06802191290598e-122	MOSPD3	Malignant cells	GSE139386	ENSG00000106330	64598	motile sperm domain containing 3	CDS3|NET30	protein_coding	O75425	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7854
5.12615428792414e-126	-0.370565010106469	0.14	0.389	9.29781864743681e-122	COL7A1	Malignant cells	GSE139386	ENSG00000114270	1294	collagen type VII alpha 1 chain	EBD1|EBDCT|EBR1	protein_coding	Q02388	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7855
5.56736774263439e-126	-0.535651846053478	0.538	0.763	1.00980916115903e-121	CXXC5	Malignant cells	GSE139386	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7856
7.65006673569165e-126	0.581076592344791	0.662	0.415	1.38756910451975e-121	PSAT1	Malignant cells	GSE139386	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7857
8.52449271703733e-126	-0.461211429537088	0.371	0.636	1.54617248901623e-121	RP11-792A8.4	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7858
1.56716254549978e-125	-0.469608670276193	0.478	0.726	2.84251942502751e-121	MBOAT2	Malignant cells	GSE139386	ENSG00000143797	129642	membrane bound O-acyltransferase domain containing 2	FLJ14415|FLJ90298|LPLAT13|OACT2	protein_coding	Q6ZWT7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7859
1.75873756030035e-125	0.533097996919609	0.674	0.435	3.18999818687277e-121	THYN1	Malignant cells	GSE139386	ENSG00000151500	29087	thymocyte nuclear protein 1	THY28	protein_coding	Q9P016	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7860
2.41121057174657e-125	-0.473187427193244	0.925	0.978	4.37345373503394e-121	PDLIM1	Malignant cells	GSE139386	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7861
2.53825676984874e-125	-0.317370220728138	0.083	0.3	4.60389012915165e-121	POLA2	Malignant cells	GSE139386	ENSG00000014138	23649	DNA polymerase alpha 2, accessory subunit	FLJ21662	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7862
3.60622301505097e-125	0.489033901706607	0.574	0.294	6.54096730469944e-121	C21orf59	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7863
5.486073326676e-125	-0.439939263942949	0.349	0.621	9.95063979992492e-121	PACSIN3	Malignant cells	GSE139386	ENSG00000165912	29763	protein kinase C and casein kinase substrate in neurons 3	SDPIII	protein_coding	Q9UKS6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7864
5.6585338132461e-125	-0.409118401579279	0.17	0.424	1.02634486304658e-120	FERMT2	Malignant cells	GSE139386	ENSG00000073712	10979	FERM domain containing kindlin 2	KIND2|mig-2|PLEKHC1|UNC112B	protein_coding	Q96AC1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7865
6.37506912826884e-125	-0.330968779107971	0.115	0.35	1.1563100384854e-120	RP11-421L21.3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7866
6.58898054164752e-125	0.498501889864078	0.563	0.285	1.19510929064403e-120	MED19	Malignant cells	GSE139386	ENSG00000156603	219541	mediator complex subunit 19	LCMR1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7867
7.18259658702449e-125	0.426413452851192	0.372	0.107	1.3027793689545e-120	ISYNA1	Malignant cells	GSE139386	ENSG00000105655	51477	inositol-3-phosphate synthase 1	Ino1|INOS|IPS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7868
9.3811612919706e-125	-0.409107325430661	0.261	0.533	1.70155503513763e-120	CPNE3	Malignant cells	GSE139386	ENSG00000085719	8895	copine 3	NA	protein_coding	O75131	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7869
1.00071456125621e-124	-0.397105767275464	0.174	0.429	1.81509607120651e-120	AVPI1	Malignant cells	GSE139386	ENSG00000119986	60370	arginine vasopressin induced 1	PP5395|VIP32|VIT32	protein_coding	Q5T686	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7870
2.43689906155949e-124	-0.404413202970592	0.22	0.483	4.42004751785661e-120	BCAP29	Malignant cells	GSE139386	ENSG00000283852	55973	B cell receptor associated protein 29	BAP29|DKFZp686M2086	protein_coding	Q9UHQ4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7871
4.43098151788968e-124	-0.369911527185979	0.166	0.418	8.0369142771483e-120	MCAT	Malignant cells	GSE139386	ENSG00000100294	27349	malonyl-CoA-acyl carrier protein transacylase	fabD|FASN2C|MCT|MCT1|MT|NET62	protein_coding	Q8IVS2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7872
4.43741994777796e-124	-0.325763662538487	0.101	0.327	8.04859230127967e-120	NXPE3	Malignant cells	GSE139386	ENSG00000144815	91775	neurexophilin and PC-esterase domain family member 3	FAM55C|MGC15606	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7873
5.43550878511347e-124	-0.439551148969414	0.469	0.725	9.8589258344388e-120	DEXI	Malignant cells	GSE139386	ENSG00000182108	28955	Dexi homolog	MYLE	protein_coding	O95424	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7874
6.07540285512071e-124	0.562490989013645	0.797	0.652	1.10195656986179e-119	MAP1LC3B	Malignant cells	GSE139386	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7875
7.77741723314984e-124	-0.312884225071093	0.09	0.308	1.41066793774872e-119	AGAP3	Malignant cells	GSE139386	ENSG00000133612	116988	ArfGAP with GTPase domain, ankyrin repeat and PH domain 3	CENTG3	protein_coding	Q96P47	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7876
8.62910761399884e-124	0.510353664479286	0.837	0.682	1.56514753902711e-119	VPS28	Malignant cells	GSE139386	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7877
1.07244688196659e-123	-0.404919169336408	0.998	1	1.94520415451101e-119	TNFRSF12A	Malignant cells	GSE139386	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7878
1.16076556885468e-123	0.511826861731646	0.632	0.366	2.10539658878862e-119	TSG101	Malignant cells	GSE139386	ENSG00000074319	7251	tumor susceptibility 101	TSG10|VPS23	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7879
1.62189316999799e-123	0.495503406437113	0.586	0.313	2.94178983174235e-119	YPEL5	Malignant cells	GSE139386	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7880
1.65074818811733e-123	-0.30664387007748	0.081	0.294	2.99412706360721e-119	ZSCAN16-AS1	Malignant cells	GSE139386	ENSG00000269293	100129195	ZSCAN16 antisense RNA 1	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7881
1.858769218556e-123	-0.431704857890206	0.333	0.602	3.37143560861688e-119	HPS1	Malignant cells	GSE139386	ENSG00000107521	3257	HPS1 biogenesis of lysosomal organelles complex 3 subunit 1	BLOC3S1|HPS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7882
2.06954946870599e-123	-0.429354032307016	0.857	0.958	3.75374882633892e-119	PPP4C	Malignant cells	GSE139386	ENSG00000149923	5531	protein phosphatase 4 catalytic subunit	PP4|PPX	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7883
2.37973639550711e-123	-0.425219854670698	0.324	0.592	4.3163658741708e-119	TIMM22	Malignant cells	GSE139386	ENSG00000278501	29928	translocase of inner mitochondrial membrane 22	TEX4|TIM22	protein_coding	Q9Y584	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7884
3.13187960610241e-123	-0.444378867011499	0.889	0.96	5.68060322954856e-119	TBCB	Malignant cells	GSE139386	ENSG00000105254	1155	tubulin folding cofactor B	CG22|CKAP1|CKAPI	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7885
3.3619491927622e-123	-0.4027719632513	0.257	0.525	6.09790344583208e-119	GPANK1	Malignant cells	GSE139386	ENSG00000223932	7918	G-patch domain and ankyrin repeats 1	ANKRD59|BAT4|D6S54E|G5|GPATCH10	protein_coding	O95872	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7886
3.9924516474106e-123	0.405247846379661	0.354	0.093	7.24150879807335e-119	HELZ2	Malignant cells	GSE139386	ENSG00000130589	85441	helicase with zinc finger 2	KIAA1769|PDIP1|PRIC285	protein_coding	Q9BYK8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7887
4.06049415764731e-123	-0.390156356051249	0.22	0.483	7.36492430314069e-119	FAM104B	Malignant cells	GSE139386	ENSG00000182518	90736	family with sequence similarity 104 member B	CXorf44|FLJ20434	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7888
7.04434618387102e-123	0.523329907366263	0.802	0.625	1.27770351083053e-118	CAMLG	Malignant cells	GSE139386	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7889
7.89780357755169e-123	-0.421042378524415	0.275	0.542	1.43250361289633e-118	PITHD1	Malignant cells	GSE139386	ENSG00000057757	57095	PITH domain containing 1	C1orf128|HT014|TXNL1CL	protein_coding	Q9GZP4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7890
9.53427203677508e-123	0.566591471336451	0.389	0.126	1.72932626203026e-118	HPGD	Malignant cells	GSE139386	ENSG00000164120	3248	15-hydroxyprostaglandin dehydrogenase	SDR36C1	protein_coding	P15428	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7891
1.07593865045658e-122	-0.286822934691176	0.065	0.267	1.95153752419815e-118	CENPL	Malignant cells	GSE139386	ENSG00000120334	91687	centromere protein L	C1orf155|dJ383J4.3|FLJ31044	protein_coding	Q8N0S6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7892
1.29691934788589e-122	-0.418566970701599	0.32	0.593	2.35235231319542e-118	IARS2	Malignant cells	GSE139386	ENSG00000067704	55699	isoleucyl-tRNA synthetase 2, mitochondrial	FLJ10326	protein_coding	Q9NSE4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7893
1.49493623282522e-122	-0.409358490018665	0.952	0.988	2.71151533909838e-118	MTDH	Malignant cells	GSE139386	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7894
2.85632771345846e-122	-0.341929635852217	0.138	0.381	5.18080720667096e-118	MBD2	Malignant cells	GSE139386	ENSG00000134046	8932	methyl-CpG binding domain protein 2	NA	protein_coding	Q9UBB5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7895
3.72407672557567e-122	0.358646068841293	0.261	0.031	6.75473036484915e-118	BEX5	Malignant cells	GSE139386	ENSG00000184515	340542	brain expressed X-linked 5	NGFRAP1L1	protein_coding	Q5H9J7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7896
3.75499660569775e-122	-0.448646430513251	0.444	0.692	6.81081284341459e-118	BRD7	Malignant cells	GSE139386	ENSG00000166164	29117	bromodomain containing 7	BP75|CELTIX1|SMARCI1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7897
4.05212446455586e-122	-0.426638427384838	0.328	0.596	7.34974335381142e-118	RRS1	Malignant cells	GSE139386	ENSG00000179041	23212	ribosome biogenesis regulator 1 homolog	KIAA0112	protein_coding	Q15050	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7898
4.86176416175106e-122	-0.450774510445534	0.422	0.685	8.81826783658407e-118	CAPZA2	Malignant cells	GSE139386	ENSG00000198898	830	capping actin protein of muscle Z-line subunit alpha 2	CAPPA2|CAPZ	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7899
5.18362017186228e-122	-0.443903714328342	0.46	0.711	9.4020502677238e-118	KLHDC3	Malignant cells	GSE139386	ENSG00000124702	116138	kelch domain containing 3	dJ20C7.3|hPeas|PEAS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7900
6.03090856728266e-122	-0.463417934419803	0.397	0.651	1.09388619593373e-117	CHPT1	Malignant cells	GSE139386	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7901
6.50265805400228e-122	-0.354769001048381	0.177	0.434	1.17945211783493e-117	SCAF1	Malignant cells	GSE139386	ENSG00000126461	58506	SR-related CTD associated factor 1	FLJ00034|SR-A1	protein_coding	Q9H7N4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7902
7.13865383274372e-122	-0.421615237203159	0.286	0.552	1.29480903218306e-117	ALG13	Malignant cells	GSE139386	ENSG00000101901	79868	ALG13 UDP-N-acetylglucosaminyltransferase subunit	CDG1S|CXorf45|FLJ23018|GLT28D1|MDS031|TDRD13|YGL047W	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7903
8.86996128113864e-122	-0.42967984897514	0.319	0.594	1.60883357717293e-117	TERF1	Malignant cells	GSE139386	ENSG00000147601	7013	telomeric repeat binding factor 1	PIN2|TRBF1|TRF|TRF1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7904
1.12223041877255e-121	-0.303079538936154	0.086	0.301	2.03550153356965e-117	PLEKHF2	Malignant cells	GSE139386	ENSG00000175895	79666	pleckstrin homology and FYVE domain containing 2	FLJ13187|PHAFIN2|ZFYVE18	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7905
1.44284734572873e-121	-0.454054638554686	0.438	0.685	2.61703651568278e-117	RBFOX2	Malignant cells	GSE139386	ENSG00000277564	23543	RNA binding fox-1 homolog 2	FOX-2|HNRBP2|HRNBP2|RBM9	protein_coding	O43251	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7906
1.53541350684894e-121	-0.397511127383618	0.287	0.56	2.7849330187226e-117	PDS5A	Malignant cells	GSE139386	ENSG00000121892	23244	PDS5 cohesin associated factor A	KIAA0648|PIG54|SCC-112	protein_coding	Q29RF7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7907
2.60313604319536e-121	-0.447851381487282	0.56	0.784	4.72156815514774e-117	NT5C3B	Malignant cells	GSE139386	ENSG00000141698	115024	5'-nucleotidase, cytosolic IIIB	cN-IIIB|MGC20781|NT5C3L	protein_coding	Q969T7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7908
5.92731170186869e-121	-0.451764786500907	0.606	0.822	1.07509579648494e-116	EIF4G1	Malignant cells	GSE139386	ENSG00000114867	1981	eukaryotic translation initiation factor 4 gamma 1	EIF4F|EIF4G|p220|PARK18	protein_coding	Q04637	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7909
6.734174467311e-121	-0.329202871801081	0.106	0.33	1.22144456488087e-116	NSMAF	Malignant cells	GSE139386	ENSG00000035681	8439	neutral sphingomyelinase activation associated factor	FAN|GRAMD5	protein_coding	Q92636	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7910
1.21394912362684e-120	0.502299152497971	0.718	0.491	2.20186092043435e-116	PLD3	Malignant cells	GSE139386	ENSG00000105223	23646	phospholipase D family member 3	HU-K4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7911
1.26442543715091e-120	-0.385433847312006	0.221	0.482	2.29341485790433e-116	MPPE1	Malignant cells	GSE139386	ENSG00000154889	65258	metallophosphoesterase 1	Cdc1|PGAP5	protein_coding	Q53F39	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7912
1.81510484040009e-120	0.466836116119644	0.92	0.858	3.29223715951769e-116	EIF3J	Malignant cells	GSE139386	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7913
2.6002342119802e-120	-0.393534531644126	0.212	0.47	4.71630481368968e-116	CRTAP	Malignant cells	GSE139386	ENSG00000170275	10491	cartilage associated protein	CASP|LEPREL3|P3H5	protein_coding	O75718	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7914
2.80965592961448e-120	-0.456537069149655	0.527	0.76	5.09615392513475e-116	COPS3	Malignant cells	GSE139386	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7915
2.86314830061907e-120	-0.402129130902274	0.315	0.587	5.19317838766286e-116	SNX7	Malignant cells	GSE139386	ENSG00000162627	51375	sorting nexin 7	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7916
2.96215568222267e-120	-0.311138106328218	0.091	0.307	5.37275797641547e-116	FAM83H-AS1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7917
2.96336968945622e-120	0.515740617035397	0.773	0.53	5.3749599427357e-116	CDKN1A	Malignant cells	GSE139386	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7918
3.50276139002801e-120	-0.300962081855021	0.082	0.291	6.35330860923281e-116	ZDHHC18	Malignant cells	GSE139386	ENSG00000204160	84243	zinc finger DHHC-type palmitoyltransferase 18	DKFZp667O2416	protein_coding	Q9NUE0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7919
4.1758251297294e-120	-0.448374548294394	0.563	0.783	7.57411162030318e-116	TMEM261	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7920
4.85820248740496e-120	0.489168059682851	0.558	0.286	8.81180767165511e-116	SPSB3	Malignant cells	GSE139386	ENSG00000162032	90864	splA/ryanodine receptor domain and SOCS box containing 3	C16orf31|SSB-3	protein_coding	Q6PJ21	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7921
5.20250224591059e-120	-0.36316265383532	0.158	0.403	9.43629857363263e-116	PQLC1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7922
5.65851558312946e-120	0.367021615414052	0.286	0.049	1.02634155646802e-115	PVRL1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7923
6.08934504812962e-120	-0.410951527069079	0.237	0.497	1.10448540482975e-115	C12orf49	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7924
8.82096056291613e-120	0.537363958107191	0.631	0.383	1.59994582690173e-115	WSB1	Malignant cells	GSE139386	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7925
1.00131097212012e-119	-0.325075822175267	0.115	0.344	1.81617784123147e-115	HDAC8	Malignant cells	GSE139386	ENSG00000147099	55869	histone deacetylase 8	HDACL1|KDAC8|MRXS6|RPD3|WTS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7926
1.24734393598332e-119	-0.41759688106313	0.293	0.558	2.26243243108655e-115	PEX26	Malignant cells	GSE139386	ENSG00000215193	55670	peroxisomal biogenesis factor 26	FLJ20695	protein_coding	Q7Z412	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7927
1.57201580326091e-119	0.621015125888329	0.699	0.487	2.85132226395464e-115	EIF2S3	Malignant cells	GSE139386	ENSG00000130741	1968	eukaryotic translation initiation factor 2 subunit gamma	EIF2|EIF2G|EIF2gamma	protein_coding	P41091	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7928
1.94913215942798e-119	-0.365009026941655	0.177	0.426	3.53533591077047e-115	SLC10A3	Malignant cells	GSE139386	ENSG00000126903	8273	solute carrier family 10 member 3	DXS253E|P3	protein_coding	P09131	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7929
3.14227360209472e-119	-0.319992791170002	0.099	0.319	5.69945585947941e-115	ETNK2	Malignant cells	GSE139386	ENSG00000143845	55224	ethanolamine kinase 2	EKI2|FLJ10761	protein_coding	Q9NVF9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7930
3.17236764257043e-119	-0.406194338396514	0.282	0.547	5.75404043009425e-115	GTF3C5	Malignant cells	GSE139386	ENSG00000148308	9328	general transcription factor IIIC subunit 5	TFiiiC2-63|TFIIIC63|TFIIICepsilon	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7931
3.22264374075914e-119	-0.434602676650685	0.456	0.704	5.84523121698893e-115	UBN1	Malignant cells	GSE139386	ENSG00000118900	29855	ubinuclein 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7932
5.18883330760569e-119	-0.428327887090561	0.384	0.646	9.4115058533352e-115	ICMT	Malignant cells	GSE139386	ENSG00000116237	23463	isoprenylcysteine carboxyl methyltransferase	HSTE14|PCCMT|PPMT	protein_coding	O60725	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7933
6.45430040757188e-119	0.511857115861361	0.595	0.335	1.17068100792539e-114	CLSTN1	Malignant cells	GSE139386	ENSG00000171603	22883	calsyntenin 1	CDHR12|CSTN1|KIAA0911	protein_coding	O94985	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7934
7.12534460604427e-119	0.402702233960835	0.34	0.088	1.29239500464431e-114	RPS6KA2	Malignant cells	GSE139386	ENSG00000071242	6196	ribosomal protein S6 kinase A2	HU-2|RSK3	protein_coding	Q15349	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7935
7.45980397919817e-119	-0.446719488295383	0.897	0.973	1.35305924574696e-114	FLNA	Malignant cells	GSE139386	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7936
1.08830669683699e-118	-0.296600706454968	0.066	0.266	1.97397068672293e-114	CKAP2L	Malignant cells	GSE139386	ENSG00000169607	150468	cytoskeleton associated protein 2 like	FLJ40629|radmis	protein_coding	Q8IYA6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7937
1.1937841456878e-118	-0.416091931938643	0.838	0.955	2.16528568344853e-114	VAMP8	Malignant cells	GSE139386	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7938
1.55025317827314e-118	-0.342010587054121	0.132	0.366	2.81184921475182e-114	TSC22D2	Malignant cells	GSE139386	ENSG00000196428	9819	TSC22 domain family member 2	KIAA0669|TILZ4a|TILZ4b|TILZ4c	protein_coding	O75157	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7939
1.85269026416856e-118	0.496063362483931	0.862	0.725	3.36040960114894e-114	CTNNA1	Malignant cells	GSE139386	ENSG00000044115	1495	catenin alpha 1	CAP102	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7940
2.10221618789205e-118	-0.417018478165494	0.319	0.583	3.81299972159859e-114	ZNF655	Malignant cells	GSE139386	ENSG00000197343	79027	zinc finger protein 655	VIK|VIK-1	protein_coding	Q8N720	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7941
2.20172196317367e-118	-0.449566419269719	0.637	0.843	3.9934832968044e-114	RTFDC1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7942
3.14092958752879e-118	-0.493891054285596	0.565	0.787	5.69701808585973e-114	PUF60	Malignant cells	GSE139386	ENSG00000274081	22827	poly(U) binding splicing factor 60	FIR|RoBPI|SIAHBP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7943
5.55637558376115e-118	0.420676815425108	0.413	0.147	1.0078154033826e-113	NPAS2	Malignant cells	GSE139386	ENSG00000170485	4862	neuronal PAS domain protein 2	bHLHe9|MOP4|PASD4	protein_coding	Q99743	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7944
6.74806330066274e-118	-0.383915144381403	0.241	0.502	1.22396372147421e-113	PGAP2	Malignant cells	GSE139386	ENSG00000148985	27315	post-GPI attachment to proteins 2	CWH43-N|FRAG1|MRT17|MRT21	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7945
7.02165634813602e-118	-0.291220455067838	0.085	0.296	1.27358802842491e-113	MKL1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7946
7.92805143216703e-118	-0.407910133763415	0.26	0.519	1.43798996876646e-113	FAM86A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7947
8.87547671127007e-118	-0.322654272036083	0.096	0.312	1.60983396589016e-113	ANKRD32	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7948
9.22536778427038e-118	0.497869537789615	0.599	0.339	1.67329720871096e-113	MAPK6	Malignant cells	GSE139386	ENSG00000069956	5597	mitogen-activated protein kinase 6	ERK3|HsT17250|p97MAPK|PRKM6	protein_coding	Q16659	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7949
1.18424577698068e-117	-0.377855367081828	0.248	0.512	2.14798499028756e-113	WDR70	Malignant cells	GSE139386	ENSG00000082068	55100	WD repeat domain 70	FLJ10233	protein_coding	Q9NW82	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7950
1.52048704547695e-117	-0.370079304607769	0.193	0.444	2.75785940308609e-113	CHMP6	Malignant cells	GSE139386	ENSG00000176108	79643	charged multivesicular body protein 6	FLJ11749|VPS20	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7951
2.81105213157895e-117	-0.30273476233516	0.092	0.307	5.0986863562579e-113	PACRGL	Malignant cells	GSE139386	ENSG00000163138	133015	parkin coregulated like	C4orf28|MGC29898	protein_coding	Q8N7B6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7952
2.85720675067525e-117	-0.380003411658821	0.182	0.432	5.18240160437477e-113	PARP2	Malignant cells	GSE139386	ENSG00000129484	10038	poly(ADP-ribose) polymerase 2	ADPRTL2|ARTD2	protein_coding	Q9UGN5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7953
3.00229734979969e-117	-0.449491113924411	0.654	0.847	5.44556693306667e-113	ZMAT2	Malignant cells	GSE139386	ENSG00000146007	153527	zinc finger matrin-type 2	FLJ31121|hSNU23|Snu23	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7954
3.19456003639534e-117	0.375957406441353	0.306	0.065	5.79429299401387e-113	MYLIP	Malignant cells	GSE139386	ENSG00000007944	29116	myosin regulatory light chain interacting protein	IDOL|MIR	protein_coding	Q8WY64	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7955
3.88326408243783e-117	-0.406287654735544	0.36	0.626	7.04346439272573e-113	ABHD17A	Malignant cells	GSE139386	ENSG00000129968	81926	abhydrolase domain containing 17A, depalmitoylase	C19orf27|FAM108A1|MGC5244	protein_coding	Q96GS6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7956
4.9861523091672e-117	-0.412635257531442	0.312	0.574	9.04388305836746e-113	NELFB	Malignant cells	GSE139386	ENSG00000188986	25920	negative elongation factor complex member B	COBRA1|KIAA1182|NELF-B	protein_coding	Q8WX92	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7957
5.86202075599749e-117	-0.406391797191856	0.216	0.469	1.06325332472282e-112	SESTD1	Malignant cells	GSE139386	ENSG00000187231	91404	SEC14 and spectrin domain containing 1	DKFZp434O0515|Solo	protein_coding	Q86VW0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7958
6.66122561904357e-117	-0.43417129878947	0.563	0.786	1.20821310278212e-112	WDR45B	Malignant cells	GSE139386	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7959
6.72803014799782e-117	-0.503931100077122	0.602	0.817	1.22033010824384e-112	LAMB3	Malignant cells	GSE139386	ENSG00000196878	3914	laminin subunit beta 3	BM600-125kDa|kalinin-140kDa|LAMNB1|nicein-125kDa	protein_coding	Q13751	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7960
8.62556510148349e-117	-0.292197726233993	0.063	0.255	1.56450499810707e-112	STON2	Malignant cells	GSE139386	ENSG00000140022	85439	stonin 2	STN2|STNB2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7961
9.9511726231319e-117	-0.387735451169108	0.228	0.485	1.80494369038366e-112	LRRC42	Malignant cells	GSE139386	ENSG00000116212	115353	leucine rich repeat containing 42	MGC8974	protein_coding	Q9Y546	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7962
1.01422676814835e-116	-0.278910724296256	0.069	0.269	1.83960451206748e-112	PARPBP	Malignant cells	GSE139386	ENSG00000185480	55010	PARP1 binding protein	C12orf48|FLJ20641|PARI	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7963
1.0448684379615e-116	-0.493242007223023	0.985	0.998	1.89518237277456e-112	HSP90AB1	Malignant cells	GSE139386	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7964
1.27231844205117e-116	0.388214172940908	0.995	0.991	2.30773119019241e-112	TMED2	Malignant cells	GSE139386	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7965
1.47728819449922e-116	0.54062229388301	0.767	0.589	2.67950532718268e-112	TMEM165	Malignant cells	GSE139386	ENSG00000134851	55858	transmembrane protein 165	GDT1|SLC64A1|TMPT27|TPARL	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7966
1.51894073119209e-116	-0.485988282742533	0.782	0.913	2.75505469823622e-112	PRDX6	Malignant cells	GSE139386	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7967
2.32304699049887e-116	-0.369073265377154	0.209	0.464	4.21354263136684e-112	AP2A1	Malignant cells	GSE139386	ENSG00000196961	160	adaptor related protein complex 2 subunit alpha 1	ADTAA|CLAPA1	protein_coding	O95782	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7968
3.42006775955032e-116	-0.414548693554681	0.31	0.567	6.20331890227237e-112	LINC00667	Malignant cells	GSE139386	ENSG00000263753	339290	long intergenic non-protein coding RNA 667	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7969
3.89243506653742e-116	-0.413039184264523	0.378	0.639	7.06009872368557e-112	MAPKAPK5	Malignant cells	GSE139386	ENSG00000089022	8550	MAPK activated protein kinase 5	MK5|PRAK	protein_coding	Q8IW41	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7970
4.06980721828092e-116	-0.323326809860646	0.115	0.338	7.38181633251794e-112	CARD8	Malignant cells	GSE139386	ENSG00000105483	22900	caspase recruitment domain family member 8	CARDINAL|Dakar|KIAA0955|NDPP|TUCAN	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7971
4.61119001634644e-116	-0.412101657369019	0.233	0.493	8.36377645164918e-112	HAT1	Malignant cells	GSE139386	ENSG00000128708	8520	histone acetyltransferase 1	KAT1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7972
4.67684214520616e-116	-0.427416422137985	0.217	0.467	8.48285628297493e-112	PLEKHO1	Malignant cells	GSE139386	ENSG00000023902	51177	pleckstrin homology domain containing O1	CKIP-1|OC120	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7973
4.79196425076546e-116	0.505612046020878	0.702	0.478	8.69166475803839e-112	BAIAP2L1	Malignant cells	GSE139386	ENSG00000006453	55971	BAR/IMD domain containing adaptor protein 2 like 1	IRTKS	protein_coding	Q9UHR4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7974
5.1963861480995e-116	0.4816699242641	0.853	0.731	9.42520519542288e-112	SSR1	Malignant cells	GSE139386	ENSG00000124783	6745	signal sequence receptor subunit 1	TRAPA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7975
6.4826624325697e-116	-0.406174429643385	0.373	0.672	1.17582531201949e-111	SMC4	Malignant cells	GSE139386	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7976
8.37956784246479e-116	0.484929264305509	0.777	0.584	1.51988601526626e-111	TM9SF3	Malignant cells	GSE139386	ENSG00000077147	56889	transmembrane 9 superfamily member 3	SMBP	protein_coding	Q9HD45	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7977
1.10328017703661e-115	-0.37611623613547	0.184	0.43	2.00112958510901e-111	COMMD10	Malignant cells	GSE139386	ENSG00000145781	51397	COMM domain containing 10	PTD002	protein_coding	Q9Y6G5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7978
1.16170802509006e-115	-0.432699437062774	0.57	0.792	2.10710601590835e-111	IMP3	Malignant cells	GSE139386	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7979
1.74825493543249e-115	0.36853346929192	0.291	0.057	3.17098480188745e-111	FICD	Malignant cells	GSE139386	ENSG00000198855	11153	FIC domain protein adenylyltransferase	HIP13|HYPE	protein_coding	Q9BVA6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7980
1.93567587004837e-115	0.474518692845396	0.527	0.264	3.51092889309374e-111	CHPF	Malignant cells	GSE139386	ENSG00000123989	79586	chondroitin polymerizing factor	CHSY2|CSS2	protein_coding	Q8IZ52	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7981
2.54748599095093e-115	0.444752167796015	0.441	0.177	4.62063009038679e-111	MLPH	Malignant cells	GSE139386	ENSG00000115648	79083	melanophilin	exophilin-3|l(1)-3Rk|l1Rk3|ln|Slac-2a	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7982
2.86712155021882e-115	0.498067172789336	0.539	0.278	5.2003850677869e-111	ARMCX3	Malignant cells	GSE139386	ENSG00000102401	51566	armadillo repeat containing X-linked 3	ALEX3|GASP6	protein_coding	Q9UH62	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7983
3.24767511582591e-115	-0.294242825141871	0.097	0.312	5.89063312508504e-111	OPA3	Malignant cells	GSE139386	ENSG00000125741	80207	outer mitochondrial membrane lipid metabolism regulator OPA3	FLJ22187|MGA3	protein_coding	Q9H6K4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7984
3.9409515188312e-115	-0.298577706856002	0.998	0.999	7.14809786485604e-111	C19orf53	Malignant cells	GSE139386	ENSG00000104979	28974	chromosome 19 open reading frame 53	HSPC023|LYDG10	protein_coding	Q9UNZ5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7985
4.59655248428676e-115	0.466886439809519	0.564	0.303	8.33722689599932e-111	TMEM101	Malignant cells	GSE139386	ENSG00000091947	84336	transmembrane protein 101	FLJ23987|MGC4251	protein_coding	Q96IK0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7986
4.84168802962473e-115	-0.416479328626942	0.489	0.736	8.78185374813333e-111	HDAC3	Malignant cells	GSE139386	ENSG00000171720	8841	histone deacetylase 3	HD3|KDAC3|RPD3|RPD3-2	protein_coding	O15379	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7987
5.90666110790072e-115	-0.28648903861135	0.074	0.272	1.07135019175103e-110	IKBKE	Malignant cells	GSE139386	ENSG00000263528	9641	inhibitor of nuclear factor kappa B kinase subunit epsilon	IKK-i|IKKE|KIAA0151	protein_coding	Q14164	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7988
6.015535562982e-115	-0.375862898592798	0.206	0.457	1.09109784041368e-110	BIRC2	Malignant cells	GSE139386	ENSG00000110330	329	baculoviral IAP repeat containing 2	API1|c-IAP1|cIAP1|hiap-2|MIHB|RNF48	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7989
6.94246866054519e-115	0.432472368405255	0.412	0.153	1.25922496564969e-110	GAA	Malignant cells	GSE139386	ENSG00000171298	2548	alpha glucosidase	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7990
7.33424839979778e-115	-0.448365936648082	0.636	0.834	1.33028597475532e-110	PXN	Malignant cells	GSE139386	ENSG00000089159	5829	paxillin	NA	protein_coding	P49023	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7991
9.03990316872307e-115	-0.468168597591795	0.596	0.795	1.63965763674299e-110	UBA2	Malignant cells	GSE139386	ENSG00000126261	10054	ubiquitin like modifier activating enzyme 2	FLJ13058|HRIHFB2115|SAE2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7992
1.36451823090881e-114	-0.429118935047884	0.625	0.828	2.4749631672224e-110	RNF115	Malignant cells	GSE139386	ENSG00000265491	27246	ring finger protein 115	CL469780|ZNF364	protein_coding	Q9Y4L5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7993
1.49722211064239e-114	0.409936370483459	0.987	0.963	2.71566146428316e-110	ATP6V1G1	Malignant cells	GSE139386	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7994
2.13360298621701e-114	-0.422375224933356	0.535	0.764	3.8699290964004e-110	C15orf40	Malignant cells	GSE139386	ENSG00000169609	123207	chromosome 15 open reading frame 40	MGC29937	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7995
3.37099740557032e-114	0.509112001229029	0.717	0.512	6.11431509422344e-110	SMAP1	Malignant cells	GSE139386	ENSG00000112305	60682	small ArfGAP 1	FLJ13159|SMAP-1	protein_coding	Q8IYB5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7996
3.44926625159839e-114	0.409290573844223	0.387	0.129	6.25627912714916e-110	CREB3L2	Malignant cells	GSE139386	ENSG00000182158	64764	cAMP responsive element binding protein 3 like 2	BBF2H7|TCAG_1951439	protein_coding	Q70SY1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7997
3.6183534685793e-114	-0.40612585103485	0.28	0.539	6.56296952130913e-110	MBNL1	Malignant cells	GSE139386	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7998
4.55408299965621e-114	0.518076599886929	0.803	0.624	8.26019574477644e-110	TGIF1	Malignant cells	GSE139386	ENSG00000177426	7050	TGFB induced factor homeobox 1	HPE4|TGIF	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	7999
5.03681208114426e-114	-0.35574221020526	0.164	0.403	9.13576975277945e-110	SAMD1	Malignant cells	GSE139386	ENSG00000288488	90378	sterile alpha motif domain containing 1	NA	protein_coding	Q6SPF0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8000
5.6777171639068e-114	-0.581901368299741	0.401	0.643	1.02982433918942e-109	CALD1	Malignant cells	GSE139386	ENSG00000122786	800	caldesmon 1	CDM|H-CAD|h-CD|L-CAD	protein_coding	Q05682	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8001
7.53272322639609e-114	-0.407071385904628	0.304	0.563	1.36628533880372e-109	COMMD9	Malignant cells	GSE139386	ENSG00000110442	29099	COMM domain containing 9	FLJ31106|HSPC166	protein_coding	Q9P000	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8002
9.22723710768525e-114	-0.434377645131562	0.355	0.618	1.67363626659195e-109	TIMP2	Malignant cells	GSE139386	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8003
9.44654883873159e-114	0.476305909375425	0.542	0.281	1.71341502836914e-109	P4HTM	Malignant cells	GSE139386	ENSG00000178467	54681	prolyl 4-hydroxylase, transmembrane	EGLN4|FLJ20262|HIFPH4|P4H-TM|PH-4|PH4|PHD4	protein_coding	Q9NXG6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8004
1.0187775437744e-113	-0.330263067997799	0.072	0.271	1.847858708898e-109	CENPE	Malignant cells	GSE139386	ENSG00000138778	1062	centromere protein E	KIF10|PPP1R61	protein_coding	Q02224	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8005
1.11724177762527e-113	-0.401929281508454	0.256	0.51	2.02645313625672e-109	PTPRK	Malignant cells	GSE139386	ENSG00000273993	5796	protein tyrosine phosphatase receptor type K	R-PTP-kappa	protein_coding	Q15262	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8006
1.37163314965999e-113	-0.319742861968605	0.122	0.35	2.48786820685328e-109	ATF5	Malignant cells	GSE139386	ENSG00000169136	22809	activating transcription factor 5	NA	protein_coding	Q9Y2D1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8007
1.98843723742437e-113	-0.381555080957524	0.183	0.429	3.60662746124032e-109	EMC2	Malignant cells	GSE139386	ENSG00000104412	9694	ER membrane protein complex subunit 2	KIAA0103|TTC35	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8008
2.15873616713082e-113	-0.301647550791243	0.092	0.301	3.91551565994188e-109	MCOLN3	Malignant cells	GSE139386	ENSG00000055732	55283	mucolipin TRP cation channel 3	FLJ11006|TRP-ML3|TRPML3	protein_coding	Q8TDD5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8009
3.39360468757376e-113	-0.451660242760077	0.331	0.588	6.15532018232129e-109	RAP2B	Malignant cells	GSE139386	ENSG00000181467	5912	RAP2B, member of RAS oncogene family	NA	protein_coding	P61225	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8010
3.67057756007538e-113	-0.370973799232414	0.211	0.461	6.65769357846472e-109	NARS2	Malignant cells	GSE139386	ENSG00000137513	79731	asparaginyl-tRNA synthetase 2, mitochondrial	DFNB94|FLJ23441|SLM5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8011
5.56296170659143e-113	0.476937145220697	0.759	0.553	1.00900999434155e-108	DCTN2	Malignant cells	GSE139386	ENSG00000175203	10540	dynactin subunit 2	DCTN-50|RBP50	protein_coding	Q13561	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8012
5.72407115772017e-113	-0.374147334581173	0.24	0.495	1.03823202658728e-108	MIEF1	Malignant cells	GSE139386	ENSG00000100335	54471	mitochondrial elongation factor 1	FLJ20232|L0R8F8|MiD51|SMCR7L	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8013
8.3744434359916e-113	-0.328326917362965	0.122	0.346	1.51895655042016e-108	NFKB1	Malignant cells	GSE139386	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8014
1.14305401002044e-112	0.451540070261281	0.504	0.219	2.07327136337508e-108	DMKN	Malignant cells	GSE139386	ENSG00000161249	93099	dermokine	ZD52F10	protein_coding	Q6E0U4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8015
1.82415231461006e-112	0.77428696969736	0.756	0.564	3.30864746823973e-108	C1orf56	Malignant cells	GSE139386	ENSG00000143443	54964	chromosome 1 open reading frame 56	FLJ20519|MENT	protein_coding	Q9BUN1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8016
2.32898567360297e-112	-0.422547014960524	0.553	0.776	4.22431421478107e-108	LSM14A	Malignant cells	GSE139386	ENSG00000262860	26065	LSM14A mRNA processing body assembly factor	C19orf13|DKFZP434D1335|FAM61A|RAP55|RAP55A	protein_coding	Q8ND56	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8017
2.47674599040341e-112	-0.459336993654075	0.573	0.791	4.4923218773937e-108	FDPS	Malignant cells	GSE139386	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8018
2.72772032270701e-112	-0.428319656356425	0.478	0.717	4.94753912132598e-108	PTPRF	Malignant cells	GSE139386	ENSG00000142949	5792	protein tyrosine phosphatase receptor type F	LAR	protein_coding	P10586	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8019
3.6674747906358e-112	-0.321723476084567	0.086	0.294	6.65206577525522e-108	NUF2	Malignant cells	GSE139386	ENSG00000143228	83540	NUF2 component of NDC80 kinetochore complex	CDCA1|CT106|NUF2R	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8020
3.70082422363789e-112	-0.326702491481963	0.14	0.371	6.71255497683441e-108	UBE3C	Malignant cells	GSE139386	ENSG00000009335	9690	ubiquitin protein ligase E3C	KIAA0010|KIAA10	protein_coding	Q15386	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8021
5.59794909626054e-112	-0.402927843615399	0.316	0.571	1.01535600707974e-107	ZDHHC6	Malignant cells	GSE139386	ENSG00000023041	64429	zinc finger DHHC-type palmitoyltransferase 6	FLJ21952|ZNF376	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8022
5.73205720657476e-112	-0.343872165713391	0.156	0.392	1.03968053612853e-107	PRMT6	Malignant cells	GSE139386	ENSG00000198890	55170	protein arginine methyltransferase 6	FLJ10559|HRMT1L6	protein_coding	Q96LA8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8023
7.09223059180706e-112	-0.421092602381878	0.631	0.839	1.28638878474196e-107	CYB5R3	Malignant cells	GSE139386	ENSG00000100243	1727	cytochrome b5 reductase 3	DIA1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8024
7.2126982560768e-112	-0.424066323242151	0.486	0.727	1.30823920968721e-107	ACBD6	Malignant cells	GSE139386	ENSG00000230124	84320	acyl-CoA binding domain containing 6	MGC2404	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8025
7.64106736829257e-112	-0.296794567103648	0.073	0.269	1.38593679926091e-107	OSGIN1	Malignant cells	GSE139386	ENSG00000140961	29948	oxidative stress induced growth inhibitor 1	BDGI|OKL38	protein_coding	Q9UJX0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8026
8.71955683496952e-112	0.466119850737397	0.861	0.721	1.58155321872677e-107	SDHB	Malignant cells	GSE139386	ENSG00000117118	6390	succinate dehydrogenase complex iron sulfur subunit B	SDH|SDH1	protein_coding	P21912	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8027
1.03929920037119e-111	-0.435914588793127	0.458	0.697	1.88508088963326e-107	MRPS25	Malignant cells	GSE139386	ENSG00000131368	64432	mitochondrial ribosomal protein S25	DKFZp313H0817|FLJ00023|MRP-S25|RPMS25	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8028
1.23160728745678e-111	-0.339771987033375	0.162	0.407	2.2338892979891e-107	KIF22	Malignant cells	GSE139386	ENSG00000079616	3835	kinesin family member 22	Kid|KNSL4|OBP-1|OBP-2	protein_coding	Q14807	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8029
1.56740058176855e-111	-0.293346767305591	0.093	0.302	2.84295117521179e-107	KIFC2	Malignant cells	GSE139386	ENSG00000167702	90990	kinesin family member C2	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8030
1.69164869536158e-111	-0.428497351651414	0.598	0.813	3.06831240364683e-107	TAPBP	Malignant cells	GSE139386	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8031
1.77834746149484e-111	-0.455042857520313	0.56	0.768	3.22556662565934e-107	GTF2F2	Malignant cells	GSE139386	ENSG00000188342	2963	general transcription factor IIF subunit 2	BTF4|RAP30|TFIIF	protein_coding	P13984	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8032
1.79719224350569e-111	-0.375172404738064	0.211	0.461	3.25974729127063e-107	CSE1L	Malignant cells	GSE139386	ENSG00000124207	1434	chromosome segregation 1 like	CAS|CSE1|XPO2	protein_coding	P55060	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8033
1.87742000269043e-111	0.466982308715386	0.889	0.767	3.40526440087991e-107	UBXN4	Malignant cells	GSE139386	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8034
1.94258612366073e-111	0.36002727451258	0.289	0.059	3.52346271109583e-107	PLLP	Malignant cells	GSE139386	ENSG00000102934	51090	plasmolipin	PMLP|TM4SF11	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8035
3.43621623805491e-111	-0.349949811464358	0.183	0.43	6.23260901258399e-107	C9orf40	Malignant cells	GSE139386	ENSG00000135045	55071	chromosome 9 open reading frame 40	FLJ10110	protein_coding	Q8IXQ3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8036
3.74944988363712e-111	-0.415791434125472	0.741	0.903	6.80075219894101e-107	KXD1	Malignant cells	GSE139386	ENSG00000105700	79036	KxDL motif containing 1	BORCS4|C19orf50|FLJ25480|KXDL|MGC2749	protein_coding	Q9BQD3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8037
3.81128546845289e-111	-0.336434043389848	0.142	0.371	6.91290958267986e-107	STAG1	Malignant cells	GSE139386	ENSG00000118007	10274	stromal antigen 1	SA-1|SA1|SCC3A	protein_coding	Q8WVM7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8038
4.3323779390026e-111	-0.438924746570744	0.535	0.755	7.85806710576292e-107	PRRC2A	Malignant cells	GSE139386	ENSG00000231370	7916	proline rich coiled-coil 2A	BAT2|D6S51E|G2	protein_coding	P48634	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8039
4.7352058036027e-111	-0.417504655598498	0.658	0.861	8.58871628657457e-107	MRPS11	Malignant cells	GSE139386	ENSG00000181991	64963	mitochondrial ribosomal protein S11	FLJ22512|FLJ23406|HCC-2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8040
4.88000673775036e-111	-0.426535808578324	0.4	0.651	8.8513562209316e-107	BROX	Malignant cells	GSE139386	ENSG00000162819	148362	BRO1 domain and CAAX motif containing	C1orf58|FLJ32421	protein_coding	Q5VW32	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8041
5.12306285134872e-111	-0.491807930687463	0.909	0.966	9.29221139977632e-107	PSMB2	Malignant cells	GSE139386	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8042
5.14176064168367e-111	-0.343067331977031	0.979	0.995	9.32612545188584e-107	RNF7	Malignant cells	GSE139386	ENSG00000114125	9616	ring finger protein 7	CKBBP1|RBX2|ROC2|SAG	protein_coding	Q9UBF6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8043
6.00718325329321e-111	-0.330756148846976	0.975	0.996	1.08958289848232e-106	FKBP1A	Malignant cells	GSE139386	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8044
7.63351043607182e-111	0.475149753417596	0.755	0.564	1.38456612289471e-106	C12orf44	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8045
7.72543370011279e-111	-0.344286903251134	0.144	0.374	1.40123916452646e-106	PANX2	Malignant cells	GSE139386	ENSG00000073150	56666	pannexin 2	hPANX2|PX2	protein_coding	Q96RD6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8046
9.85911140569303e-111	-0.337851565306132	0.156	0.39	1.7882456267646e-106	FN3KRP	Malignant cells	GSE139386	ENSG00000141560	79672	fructosamine 3 kinase related protein	FLJ12171|FN3KL	protein_coding	Q9HA64	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8047
1.29708929686602e-110	-0.392521338456978	0.254	0.505	2.35266056665559e-106	ARMC1	Malignant cells	GSE139386	ENSG00000104442	55156	armadillo repeat containing 1	Arcp|FLJ10511	protein_coding	Q9NVT9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8048
1.62242991996106e-110	-0.409607884075099	0.306	0.556	2.94276338882536e-106	CCDC53	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8049
2.13624851691469e-110	0.402719361362412	0.999	0.994	3.87472755997987e-106	RAB13	Malignant cells	GSE139386	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8050
2.27638510263287e-110	0.399122781025816	0.375	0.124	4.1289072991555e-106	SPIRE1	Malignant cells	GSE139386	ENSG00000134278	56907	spire type actin nucleation factor 1	KIAA1135|spir-1	protein_coding	Q08AE8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8051
3.34325114816876e-110	-0.423658734123033	0.408	0.656	6.0639889325485e-106	BAZ1B	Malignant cells	GSE139386	ENSG00000009954	9031	bromodomain adjacent to zinc finger domain 1B	WBSCR10|WBSCR9|WSTF	protein_coding	Q9UIG0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8052
3.4116773243923e-110	-0.394770847225215	0.323	0.581	6.18810033098275e-106	FGD5-AS1	Malignant cells	GSE139386	ENSG00000225733	100505641	FGD5 antisense RNA 1	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8053
3.65930487182302e-110	-0.408970577984938	0.193	0.436	6.6372471765126e-106	PPP1R14C	Malignant cells	GSE139386	ENSG00000198729	81706	protein phosphatase 1 regulatory inhibitor subunit 14C	CPI17-like|KEPI|NY-BR-81	protein_coding	Q8TAE6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8054
5.16955127741116e-110	-0.405044800069026	0.311	0.563	9.37653210696837e-106	IPO9	Malignant cells	GSE139386	ENSG00000198700	55705	importin 9	FLJ10402|Imp9	protein_coding	Q96P70	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8055
6.56203999887838e-110	0.469267751575532	0.642	0.397	1.19022281499656e-105	NDUFA10	Malignant cells	GSE139386	ENSG00000130414	4705	NADH:ubiquinone oxidoreductase subunit A10	CI-42k	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8056
7.15359667294301e-110	-0.417387516821025	0.997	0.997	1.2975193645384e-105	MAL2	Malignant cells	GSE139386	ENSG00000147676	114569	mal, T cell differentiation protein 2	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8057
7.4421841892931e-110	-0.394266732796818	0.339	0.596	1.34986336825398e-105	PRPF8	Malignant cells	GSE139386	ENSG00000274442	10594	pre-mRNA processing factor 8	hPrp8|Prp8|PRPC8|RP13|SNRNP220	protein_coding	Q6P2Q9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8058
7.59449924829262e-110	0.48274272832825	0.545	0.291	1.37749027365531e-105	KLF3	Malignant cells	GSE139386	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8059
8.30322534360561e-110	-0.437825339164635	0.621	0.835	1.50603901282319e-105	SDC1	Malignant cells	GSE139386	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8060
9.35423984318707e-110	-0.422654131953942	0.498	0.733	1.69667202275727e-105	PTBP1	Malignant cells	GSE139386	ENSG00000011304	5725	polypyrimidine tract binding protein 1	HNRNP-I|HNRPI|pPTB|PTB|PTB-1|PTB2|PTB3|PTB4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8061
1.5261403637937e-109	-0.373334426431557	0.242	0.494	2.76811339184902e-105	RNF139	Malignant cells	GSE139386	ENSG00000170881	11236	ring finger protein 139	HRCA1|RCA1|TRC8	protein_coding	Q8WU17	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8062
1.60104057695602e-109	0.394975735340201	0.341	0.1	2.90396739848283e-105	USP53	Malignant cells	GSE139386	ENSG00000145390	54532	ubiquitin specific peptidase 53	KIAA1350	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8063
2.11231893896762e-109	-0.383667140192169	0.138	0.362	3.83132409149947e-105	PTHLH	Malignant cells	GSE139386	ENSG00000087494	5744	parathyroid hormone like hormone	HHM|PLP|PTHR|PTHRP	protein_coding	P12272	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8064
2.30670873932259e-109	0.468802311090859	0.569	0.311	4.18390831138332e-105	FCGRT	Malignant cells	GSE139386	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8065
2.37745107981852e-109	-0.422379037065233	0.413	0.658	4.31222076857482e-105	SAE1	Malignant cells	GSE139386	ENSG00000142230	10055	SUMO1 activating enzyme subunit 1	AOS1|FLJ3091|Sua1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8066
3.55827394219007e-109	0.442199002490624	0.903	0.827	6.45399727634436e-105	TATDN1	Malignant cells	GSE139386	ENSG00000147687	83940	TatD DNase domain containing 1	CDA11	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8067
3.78888412348621e-109	-0.415923249842533	0.554	0.776	6.87227802317929e-105	MEAF6	Malignant cells	GSE139386	ENSG00000163875	64769	MYST/Esa1 associated factor 6	C1orf149|CENP-28|Eaf6|FLJ11730|NY-SAR-91	protein_coding	Q9HAF1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8068
4.43925551406185e-109	-0.337179972714368	0.158	0.39	8.05192165140538e-105	PPP4R1	Malignant cells	GSE139386	ENSG00000154845	9989	protein phosphatase 4 regulatory subunit 1	PP4R1	protein_coding	Q8TF05	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8069
4.45866653176421e-109	-0.364482984028366	0.208	0.454	8.08712935531393e-105	CCDC71L	Malignant cells	GSE139386	ENSG00000253276	168455	coiled-coil domain containing 71 like	C7orf74|FLJ36031	protein_coding	Q8N9Z2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8070
5.39058673862844e-109	-0.290342865183186	0.101	0.31	9.77744622652427e-105	GLE1	Malignant cells	GSE139386	ENSG00000119392	2733	GLE1 RNA export mediator	GLE1L|hGLE1|LCCS1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8071
6.45993877191886e-109	-0.426834189322891	0.597	0.794	1.17170369445064e-104	CMC1	Malignant cells	GSE139386	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8072
6.9044397731359e-109	-0.425554000837997	0.36	0.613	1.25232728605139e-104	IFT57	Malignant cells	GSE139386	ENSG00000114446	55081	intraflagellar transport 57	ESRRBL1|FLJ10147|HIPPI|MHS4R2	protein_coding	Q9NWB7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8073
9.05276542232223e-109	-0.396814584651034	0.345	0.599	1.64199059230081e-104	PRKRIR	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8074
1.37613718924351e-108	-0.26966252175606	0.075	0.268	2.49603763384989e-104	CASP2	Malignant cells	GSE139386	ENSG00000106144	835	caspase 2	ICH1|MGC2181|NEDD2|PPP1R57	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8075
1.55815630959035e-108	-0.365725341482092	0.228	0.475	2.82618391433498e-104	MRS2	Malignant cells	GSE139386	ENSG00000124532	57380	magnesium transporter MRS2	MRS2L	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8076
4.34456993196388e-108	-0.425580007172591	0.561	0.777	7.88018094259608e-104	G3BP1	Malignant cells	GSE139386	ENSG00000145907	10146	G3BP stress granule assembly factor 1	G3BP|HDH-VIII	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8077
4.52797348947925e-108	-0.386999557673731	0.879	0.974	8.21283831521746e-104	CISD2	Malignant cells	GSE139386	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8078
4.71680944469769e-108	-0.362935738460752	0.217	0.463	8.55534897079268e-104	RAB35	Malignant cells	GSE139386	ENSG00000111737	11021	RAB35, member RAS oncogene family	H-ray	protein_coding	Q15286	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8079
4.90946191019347e-108	-0.397523041178555	0.349	0.596	8.90478201270892e-104	FASTK	Malignant cells	GSE139386	ENSG00000164896	10922	Fas activated serine/threonine kinase	FAST	protein_coding	Q14296	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8080
5.12702306687507e-108	0.451727344460154	0.555	0.296	9.29939443869801e-104	ICA1	Malignant cells	GSE139386	ENSG00000003147	3382	islet cell autoantigen 1	ICA69|ICAp69	protein_coding	Q05084	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8081
7.34416732898085e-108	-0.388265509768927	0.288	0.544	1.33208507013055e-103	NFYB	Malignant cells	GSE139386	ENSG00000120837	4801	nuclear transcription factor Y subunit beta	CBF-A|HAP3|NF-YB	protein_coding	P25208	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8082
1.02000541296573e-107	-0.300077435840766	0.106	0.315	1.85008581803723e-103	OGG1	Malignant cells	GSE139386	ENSG00000114026	4968	8-oxoguanine DNA glycosylase	HMMH|HOGG1|MUTM|OGH1	protein_coding	O15527	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8083
1.14820348908154e-107	0.382901469302962	0.363	0.117	2.0826114884961e-103	SPRED1	Malignant cells	GSE139386	ENSG00000166068	161742	sprouty related EVH1 domain containing 1	FLJ33903|PPP1R147	protein_coding	Q7Z699	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8084
1.35655026138312e-107	-0.396320347226291	0.321	0.573	2.4605108640967e-103	MAPKAPK3	Malignant cells	GSE139386	ENSG00000114738	7867	MAPK activated protein kinase 3	3pK|MAPKAP3|MK-3|MK3	protein_coding	Q16644	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8085
1.57249717770277e-107	-0.415029889206564	0.442	0.681	2.85219538091728e-103	XPO1	Malignant cells	GSE139386	ENSG00000082898	7514	exportin 1	CRM-1|CRM1|emb	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8086
1.64744447329962e-107	0.491230138904125	0.778	0.607	2.98813478567085e-103	SURF4	Malignant cells	GSE139386	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8087
2.07319535018562e-107	-0.368978030927	0.251	0.504	3.76036172616668e-103	EHMT2	Malignant cells	GSE139386	ENSG00000238134	10919	euchromatic histone lysine methyltransferase 2	BAT8|C6orf30|Em:AF134726.3|G9A|KMT1C|NG36/G9a	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8088
2.09068905305265e-107	-0.316544648930134	0.122	0.341	3.79209180442689e-103	PIEZO1	Malignant cells	GSE139386	ENSG00000103335	9780	piezo type mechanosensitive ion channel component 1	FAM38A|KIAA0233	protein_coding	Q92508	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8089
3.26351031645832e-107	-0.418220272087083	0.634	0.83	5.91935501199211e-103	HIGD1A	Malignant cells	GSE139386	ENSG00000181061	25994	HIG1 hypoxia inducible domain family member 1A	DKFZP564K247|HIG1|RCF1A	protein_coding	Q9Y241	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8090
4.54854613360776e-107	0.486350327610247	0.796	0.626	8.25015297713776e-103	PSMC4	Malignant cells	GSE139386	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8091
5.60763458388497e-107	0.35475642023818	0.275	0.055	1.01711276082506e-102	KIAA1244	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8092
5.9668125198127e-107	-0.318472699910703	0.131	0.353	1.08226045484363e-102	ESYT2	Malignant cells	GSE139386	ENSG00000117868	57488	extended synaptotagmin 2	CHR2SYT|FAM62B|KIAA1228	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8093
1.14380050833517e-106	0.349677159544723	1	1	2.07462536201832e-102	CALM2	Malignant cells	GSE139386	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8094
1.18146716884717e-106	-0.431383278160897	0.461	0.699	2.142945150855e-102	BCAS2	Malignant cells	GSE139386	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8095
1.25739226597954e-106	-0.315875842076371	0.126	0.345	2.28065809203368e-102	RECK	Malignant cells	GSE139386	ENSG00000122707	8434	reversion inducing cysteine rich protein with kazal motifs	hRECK|ST15	protein_coding	O95980	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8096
1.37697440724794e-106	0.464660674842022	0.601	0.357	2.49755617986632e-102	ORAOV1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8097
1.67964971684579e-106	-0.288714006249191	0.103	0.313	3.0465486564149e-102	DDX11	Malignant cells	GSE139386	ENSG00000013573	1663	DEAD/H-box helicase 11	CHL1|ChlR1|KRG-2|WABS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8098
2.02817616295703e-106	-0.364042096719722	0.265	0.516	3.67870592437146e-102	GNPAT	Malignant cells	GSE139386	ENSG00000116906	8443	glyceronephosphate O-acyltransferase	DAP-AT|DAPAT|DHAPAT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8099
2.60734219881571e-106	-0.360347985019639	0.225	0.469	4.72919728021194e-102	NR3C1	Malignant cells	GSE139386	ENSG00000113580	2908	nuclear receptor subfamily 3 group C member 1	GR|GRL	protein_coding	P04150	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8100
3.42471219547235e-106	-0.425356738932377	0.381	0.62	6.21174298014775e-102	PSMG1	Malignant cells	GSE139386	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8101
3.52756095000491e-106	0.371947540962354	0.348	0.107	6.3982900511189e-102	LURAP1L	Malignant cells	GSE139386	ENSG00000153714	286343	leucine rich adaptor protein 1 like	bA3L8.2|C9orf150|FLJ38505|LRAP35b|MGC46502	protein_coding	Q8IV03	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8102
5.82291449410818e-106	-0.31083220690967	0.121	0.336	1.05616023094134e-101	TOR3A	Malignant cells	GSE139386	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8103
5.88363026612174e-106	-0.413110848988593	0.535	0.756	1.06717285766916e-101	COA3	Malignant cells	GSE139386	ENSG00000183978	28958	cytochrome c oxidase assembly factor 3	CCDC56|COX25|hCOA3|HSPC009|MITRAC12	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8104
1.09002430062244e-105	0.339695369082382	0.265	0.049	1.97708607646899e-101	SH3PXD2A	Malignant cells	GSE139386	ENSG00000107957	9644	SH3 and PX domains 2A	FISH|KIAA0418|SH3MD1	protein_coding	Q5TCZ1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8105
1.18528818398655e-105	-0.312107069469159	0.125	0.342	2.14987570811481e-101	ING1	Malignant cells	GSE139386	ENSG00000153487	3621	inhibitor of growth family member 1	p24ING1c|p33|p33ING1|p33ING1b|p47|p47ING1a	protein_coding	Q9UK53	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8106
1.28137066746328e-105	0.419198871127945	0.437	0.185	2.3241501166449e-101	NIT1	Malignant cells	GSE139386	ENSG00000158793	4817	nitrilase 1	NA	protein_coding	Q86X76	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8107
1.51873822117631e-105	-0.271699583495155	0.072	0.259	2.75468738556959e-101	METTL4	Malignant cells	GSE139386	ENSG00000101574	64863	methyltransferase 4, N6-adenosine	FLJ23017|HsT661	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8108
1.87541862619616e-105	-0.436762402314234	0.847	0.95	3.40163430419459e-101	RHOBTB3	Malignant cells	GSE139386	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8109
3.51513484471996e-105	-0.324153383489238	0.171	0.405	6.37575158135306e-101	XPNPEP3	Malignant cells	GSE139386	ENSG00000196236	63929	X-prolyl aminopeptidase 3	APP3|ICP55|NPHPL1	protein_coding	Q9NQH7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8110
4.47334829112866e-105	-0.325850320806113	0.134	0.351	8.11375913044917e-101	PRR5	Malignant cells	GSE139386	ENSG00000186654	55615	proline rich 5	FLJ20185k|PP610|Protor-1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8111
4.6150002647807e-105	0.437583248831746	0.467	0.215	8.37068748025923e-101	CREB3L4	Malignant cells	GSE139386	ENSG00000143578	148327	cAMP responsive element binding protein 3 like 4	AIbZIP|ATCE1|CREB3|CREB4|hJAL	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8112
5.09454324953935e-105	-0.390057820685387	0.257	0.501	9.24048254601447e-101	LARP7	Malignant cells	GSE139386	ENSG00000174720	51574	La ribonucleoprotein 7, transcriptional regulator	DKFZP564K112|HDCMA18P|PIP7S	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8113
5.86119610227406e-105	-0.38762388486524	0.321	0.575	1.06310374903047e-100	GSK3A	Malignant cells	GSE139386	ENSG00000105723	2931	glycogen synthase kinase 3 alpha	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8114
7.12512476448537e-105	-0.269834416216892	0.074	0.263	1.29235512978236e-100	BRCA1	Malignant cells	GSE139386	ENSG00000012048	672	BRCA1 DNA repair associated	BRCC1|FANCS|PPP1R53|RNF53	protein_coding	P38398	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8115
7.23270298854871e-105	0.415415064914001	0.416	0.167	1.31186766806297e-100	CAMK2N1	Malignant cells	GSE139386	ENSG00000162545	55450	calcium/calmodulin dependent protein kinase II inhibitor 1	CaMKIINalpha	protein_coding	Q7Z7J9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8116
7.93116056504142e-105	-0.263663705990433	0.073	0.261	1.43855390328721e-100	RFWD3	Malignant cells	GSE139386	ENSG00000168411	55159	ring finger and WD repeat domain 3	FANCW|FLJ10520|RNF201	protein_coding	Q6PCD5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8117
8.3829009457303e-105	-0.362942932494081	0.239	0.484	1.52049057353656e-100	DHX33	Malignant cells	GSE139386	ENSG00000005100	56919	DEAH-box helicase 33	DDX33|DKFZp762F2011|FLJ21972	protein_coding	Q9H6R0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8118
9.49327116834493e-105	-0.320250312362478	0.136	0.355	1.7218895245144e-100	DNAJC30	Malignant cells	GSE139386	ENSG00000176410	84277	DnaJ heat shock protein family (Hsp40) member C30	WBSCR18	protein_coding	Q96LL9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8119
1.2158122274105e-104	-0.54935838119703	0.797	0.905	2.20524021807717e-100	PMEPA1	Malignant cells	GSE139386	ENSG00000124225	56937	prostate transmembrane protein, androgen induced 1	STAG1|TMEPAI	protein_coding	Q969W9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8120
1.88671583724237e-104	-0.326829610977239	0.166	0.395	3.42212518559021e-100	YTHDF3	Malignant cells	GSE139386	ENSG00000185728	253943	YTH N6-methyladenosine RNA binding protein 3	FLJ31657	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8121
2.16995195484949e-104	0.430564421159612	0.46	0.208	3.93585885570601e-100	INTS6	Malignant cells	GSE139386	ENSG00000102786	26512	integrator complex subunit 6	DBI-1|DDX26|DDX26A|DICE1|HDB|INT6|Notchl2	protein_coding	Q9UL03	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8122
2.45826516109918e-104	-0.353689960880538	0.252	0.508	4.4588013492017e-100	ITGB3BP	Malignant cells	GSE139386	ENSG00000142856	23421	integrin subunit beta 3 binding protein	CENPR|HSU37139|NRIF3|TAP20	protein_coding	Q13352	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8123
3.02635030567015e-104	-0.365729398825877	0.257	0.503	5.48919418442451e-100	NSL1	Malignant cells	GSE139386	ENSG00000117697	25936	NSL1 component of MIS12 kinetochore complex	C1orf48|DC8|DKFZP566O1646|MIS14	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8124
3.28996442236004e-104	0.426489052313064	0.405	0.16	5.96733746927664e-100	ITGB5	Malignant cells	GSE139386	ENSG00000082781	3693	integrin subunit beta 5	NA	protein_coding	P18084	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8125
5.4282303383189e-104	-0.376117055199665	0.285	0.527	9.84572418764282e-100	DUSP3	Malignant cells	GSE139386	ENSG00000108861	1845	dual specificity phosphatase 3	VHR	protein_coding	P51452	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8126
6.14498658231096e-104	0.380616576794423	0.348	0.11	1.11457766629956e-99	KLF4	Malignant cells	GSE139386	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8127
6.81676674690296e-104	0.439416366592704	0.458	0.21	1.23642515255326e-99	GCAT	Malignant cells	GSE139386	ENSG00000100116	23464	glycine C-acetyltransferase	KBL	protein_coding	O75600	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8128
1.09743049413078e-103	-0.419161491749314	0.463	0.721	1.99051943025442e-99	SERPINA1	Malignant cells	GSE139386	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8129
1.10195393764108e-103	-0.315527934904005	0.112	0.319	1.9987240520934e-99	SERTAD4	Malignant cells	GSE139386	ENSG00000281230	56256	SERTA domain containing 4	DJ667H12.2	protein_coding	Q9NUC0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8130
1.10899913711455e-103	-0.310966957245633	0.124	0.338	2.01150263489836e-99	DCAF16	Malignant cells	GSE139386	ENSG00000163257	54876	DDB1 and CUL4 associated factor 16	C4orf30|FLJ20280	protein_coding	Q9NXF7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8131
1.16654278710901e-103	-0.410116146007765	0.342	0.59	2.11587530725832e-99	TRIP6	Malignant cells	GSE139386	ENSG00000087077	7205	thyroid hormone receptor interactor 6	MGC10556|MGC10558|MGC29959|MGC3837|MGC4423|OIP1|ZRP-1	protein_coding	Q15654	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8132
1.4085883911035e-103	-0.390234678751047	0.845	0.959	2.55489762378352e-99	DNPH1	Malignant cells	GSE139386	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8133
1.44682129557788e-103	-0.332271856608107	0.178	0.412	2.62424446591916e-99	DTX3L	Malignant cells	GSE139386	ENSG00000163840	151636	deltex E3 ubiquitin ligase 3L	BBAP|RNF143	protein_coding	Q8TDB6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8134
1.68616643453919e-103	-0.394042004666661	0.397	0.643	3.05836867896718e-99	VPS35	Malignant cells	GSE139386	ENSG00000069329	55737	VPS35 retromer complex component	FLJ10752|MEM3|PARK17	protein_coding	Q96QK1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8135
1.92719473481714e-103	0.472905090051958	0.706	0.495	3.49554581001133e-99	SIPA1	Malignant cells	GSE139386	ENSG00000213445	6494	signal-induced proliferation-associated 1	SPA1	protein_coding	Q96FS4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8136
2.10544394477417e-103	-0.391206644454687	0.389	0.635	3.81885422703138e-99	PHAX	Malignant cells	GSE139386	ENSG00000164902	51808	phosphorylated adaptor for RNA export	FLJ13193|RNUXA	protein_coding	Q9H814	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8137
2.66407410368487e-103	-0.259487358899751	0.068	0.251	4.83209760926361e-99	METTL8	Malignant cells	GSE139386	ENSG00000123600	79828	methyltransferase 8, methylcytidine	FLJ13984|TIP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8138
2.68278425428681e-103	-0.402448708241566	0.525	0.752	4.86603408042541e-99	PLEKHJ1	Malignant cells	GSE139386	ENSG00000104886	55111	pleckstrin homology domain containing J1	FLJ10297	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8139
3.40084183968024e-103	-0.391244516653185	0.392	0.636	6.16844692881201e-99	IMMP1L	Malignant cells	GSE139386	ENSG00000148950	196294	inner mitochondrial membrane peptidase subunit 1	FLJ25059|IMMP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8140
4.4365230082352e-103	0.459132135249622	0.828	0.697	8.04696543233701e-99	CEBPG	Malignant cells	GSE139386	ENSG00000153879	1054	CCAAT enhancer binding protein gamma	GPE1BP|IG/EBP-1	protein_coding	P53567	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8141
8.54421179978178e-103	0.398926725655233	0.391	0.147	1.54974913624442e-98	TMEM63A	Malignant cells	GSE139386	ENSG00000196187	9725	transmembrane protein 63A	KIAA0792	protein_coding	O94886	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8142
9.14095731329326e-103	-0.40488388981588	0.399	0.637	1.65798683748513e-98	RITA1	Malignant cells	GSE139386	ENSG00000139405	84934	RBPJ interacting and tubulin associated 1	C12orf52|FLJ14827|RITA	protein_coding	Q96K30	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8143
9.91689467899629e-103	-0.332558065896703	0.18	0.412	1.79872635687635e-98	TEAD4	Malignant cells	GSE139386	ENSG00000197905	7004	TEA domain transcription factor 4	EFTR-2|RTEF-1|TCF13L1|TEF-3|TEFR-1	protein_coding	Q15561	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8144
1.01793877903793e-102	-0.29942505160989	0.121	0.333	1.846337357419e-98	BPGM	Malignant cells	GSE139386	ENSG00000172331	669	bisphosphoglycerate mutase	NA	protein_coding	P07738	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8145
1.20673861918592e-102	0.463866584931242	0.633	0.407	2.18878250747942e-98	MTHFD1L	Malignant cells	GSE139386	ENSG00000120254	25902	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like	DKFZP586G1517|FLJ21145|FTHFSDC1	protein_coding	Q6UB35	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8146
1.35177036156134e-102	-0.398811718052746	0.418	0.657	2.45184108179996e-98	SCO2	Malignant cells	GSE139386	ENSG00000284194	9997	synthesis of cytochrome C oxidase 2	MYP6|SCO1L	protein_coding	O43819	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8147
1.74287544422698e-102	0.359189035414179	0.995	0.985	3.16122748073889e-98	KDELR2	Malignant cells	GSE139386	ENSG00000136240	11014	KDEL endoplasmic reticulum protein retention receptor 2	ELP-1|ERD2.2	protein_coding	P33947	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8148
1.77102407578138e-102	0.417355514622147	0.457	0.209	3.21228346865227e-98	PRAF2	Malignant cells	GSE139386	ENSG00000243279	11230	PRA1 domain family member 2	JM4|Yip6a	protein_coding	O60831	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8149
1.79312152776003e-102	-0.469752452925663	0.408	0.634	3.25236382705113e-98	THOC6	Malignant cells	GSE139386	ENSG00000131652	79228	THO complex subunit 6	fSAP35|MGC2655|WDR58	protein_coding	Q86W42	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8150
2.95419152813578e-102	-0.303554520315652	0.132	0.35	5.35831259373267e-98	IKBIP	Malignant cells	GSE139386	ENSG00000166130	121457	IKBKB interacting protein	FLJ31051|IKIP	protein_coding	Q70UQ0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8151
4.11909002890484e-102	-0.31693417790455	0.125	0.337	7.4712054944276e-98	DCBLD1	Malignant cells	GSE139386	ENSG00000164465	285761	discoidin, CUB and LCCL domain containing 1	dJ94G16.1|MGC46341	protein_coding	Q8N8Z6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8152
6.62316668408963e-102	-0.262560363685101	0.072	0.255	1.20130997316018e-97	SELO	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8153
7.39620360957127e-102	-0.412688537452404	0.597	0.796	1.34152341070404e-97	STARD3NL	Malignant cells	GSE139386	ENSG00000010270	83930	STARD3 N-terminal like	MENTHO|MGC3251	protein_coding	O95772	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8154
7.43499591116732e-102	-0.380951382160249	0.296	0.54	1.34855955836753e-97	MBOAT7	Malignant cells	GSE139386	ENSG00000275118	79143	membrane bound O-acyltransferase domain containing 7	BB1|hMBOA-7|LENG4|LPIAT1|LPLAT|LPLAT11	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8155
1.09582865835416e-101	-0.339986152237804	0.183	0.412	1.98761402052277e-97	SLC25A24	Malignant cells	GSE139386	ENSG00000284468	29957	solute carrier family 25 member 24	APC1|DKFZp586G0123	protein_coding	Q6NUK1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8156
1.35803633693059e-101	-0.408633395798737	0.533	0.746	2.46320630792471e-97	AZIN1	Malignant cells	GSE139386	ENSG00000155096	51582	antizyme inhibitor 1	OAZI|OAZIN|ODC1L	protein_coding	O14977	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8157
1.75642067501214e-101	-0.38647815969201	0.381	0.624	3.18579582033701e-97	ZFYVE21	Malignant cells	GSE139386	ENSG00000100711	79038	zinc finger FYVE-type containing 21	MGC2550|ZF21	protein_coding	Q9BQ24	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8158
1.84981363065215e-101	-0.318346656227924	0.15	0.371	3.35519196327687e-97	BAP1	Malignant cells	GSE139386	ENSG00000163930	8314	BRCA1 associated protein 1	hucep-6|KIAA0272|UCHL2	protein_coding	Q92560	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8159
3.34292688899548e-101	0.481954628331306	0.499	0.253	6.06340079126e-97	BMF	Malignant cells	GSE139386	ENSG00000104081	90427	Bcl2 modifying factor	FLJ00065	protein_coding	Q96LC9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8160
3.59343120623816e-101	0.429667916005288	0.283	0.067	6.51776552187478e-97	AQP3	Malignant cells	GSE139386	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8161
4.21096695328673e-101	-0.431928840769238	0.387	0.624	7.63785185987148e-97	HPRT1	Malignant cells	GSE139386	ENSG00000165704	3251	hypoxanthine phosphoribosyltransferase 1	HGPRT|HPRT	protein_coding	P00492	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8162
4.28083736494401e-101	-0.381502347076921	0.803	0.934	7.76458281253544e-97	TXN2	Malignant cells	GSE139386	ENSG00000100348	25828	thioredoxin 2	MT-TRX	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8163
4.4368794369525e-101	0.340599932119567	0.253	0.046	8.04761192274445e-97	OLFM1	Malignant cells	GSE139386	ENSG00000130558	10439	olfactomedin 1	AMY|NOE1|NOELIN|OlfA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8164
5.04270643198226e-101	-0.272756896444289	0.082	0.271	9.14646092632942e-97	TMEM44-AS1	Malignant cells	GSE139386	ENSG00000231770	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8165
5.1243922689709e-101	0.3167664713013	0.25	0.044	9.29462269745942e-97	PLCB1	Malignant cells	GSE139386	ENSG00000182621	23236	phospholipase C beta 1	KIAA0581|PLC-I|PLC154	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8166
7.55487678009506e-101	0.458531274911952	0.505	0.262	1.37030355037364e-96	ITPRIPL2	Malignant cells	GSE139386	ENSG00000205730	162073	ITPRIP like 2	FLJ22994|LOC162073|MGC126798|MGC126800	protein_coding	Q3MIP1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8167
7.88850876164027e-101	-0.406213666070671	0.485	0.71	1.43081771918631e-96	RAP1B	Malignant cells	GSE139386	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8168
1.05120561444028e-100	-0.36043436984261	0.232	0.471	1.90667674347179e-96	POLR2J3	Malignant cells	GSE139386	ENSG00000168255	NA	NA	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8169
1.13591057405843e-100	-0.34528026211613	0.211	0.45	2.06031459922718e-96	MYH14	Malignant cells	GSE139386	ENSG00000105357	79784	myosin heavy chain 14	DFNA4|FLJ13881|KIAA2034|MHC16|MYH17	protein_coding	Q7Z406	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8170
1.30817708786107e-100	-0.290788718926186	0.102	0.301	2.37277160196241e-96	CRYZ	Malignant cells	GSE139386	ENSG00000116791	1429	crystallin zeta	NA	protein_coding	Q08257	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8171
1.47332132738772e-100	-0.295704088636834	0.113	0.318	2.67231022361585e-96	TTC7A	Malignant cells	GSE139386	ENSG00000068724	57217	tetratricopeptide repeat domain 7A	KIAA1140|TTC7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8172
1.95637205411959e-100	-0.408024041334974	0.63	0.827	3.54846763176211e-96	SWI5	Malignant cells	GSE139386	ENSG00000175854	375757	SWI5 homologous recombination repair protein	bA395P17.9|C9orf119|SAE3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8173
2.03121771515401e-100	-0.283070304535127	0.101	0.3	3.68422269174635e-96	FAM86C1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8174
2.46244906050173e-100	-0.414090440289871	0.357	0.599	4.46639010593803e-96	PPP3CA	Malignant cells	GSE139386	ENSG00000138814	5530	protein phosphatase 3 catalytic subunit alpha	CALN|CALNA|CNA1|PPP2B	protein_coding	Q08209	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8175
3.15191644649198e-100	-0.336521033955817	0.191	0.421	5.71694605064715e-96	TBC1D10B	Malignant cells	GSE139386	ENSG00000169221	26000	TBC1 domain family member 10B	DKFZP434P1750|EPI64B|FLJ13130|Rab27A-GAPbeta	protein_coding	Q4KMP7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8176
3.50833225394416e-100	0.465230799752235	0.956	0.936	6.36341304220392e-96	TRA2B	Malignant cells	GSE139386	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8177
3.9344264120382e-100	-0.478803075644271	0.886	0.965	7.13626262615489e-96	LMNA	Malignant cells	GSE139386	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8178
4.17938263869744e-100	0.391990908336244	0.38	0.14	7.58056423006941e-96	GRB10	Malignant cells	GSE139386	ENSG00000106070	2887	growth factor receptor bound protein 10	NA	protein_coding	Q13322	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8179
5.01190925750512e-100	-0.37827789050624	0.315	0.555	9.09060101126279e-96	AGTRAP	Malignant cells	GSE139386	ENSG00000177674	57085	angiotensin II receptor associated protein	ATRAP	protein_coding	Q6RW13	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8180
5.10148582677194e-100	0.367486566820109	0.318	0.092	9.25307499259894e-96	PTPN3	Malignant cells	GSE139386	ENSG00000070159	5774	protein tyrosine phosphatase non-receptor type 3	PTPH1	protein_coding	P26045	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8181
5.61409531807194e-100	0.408660545508701	0.468	0.223	1.01828460879189e-95	ZNF90	Malignant cells	GSE139386	ENSG00000213988	7643	zinc finger protein 90	HTF9	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8182
5.65605888685294e-100	-0.412916878704817	0.661	0.845	1.02589596089739e-95	ADI1	Malignant cells	GSE139386	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8183
6.2663761996465e-100	-0.367525349904779	0.293	0.537	1.13659531509188e-95	TARBP2	Malignant cells	GSE139386	ENSG00000139546	6895	TARBP2 subunit of RISC loading complex	Trbp	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8184
6.61023111646412e-100	-0.540612984403946	0.708	0.883	1.19896371990426e-95	XRCC6	Malignant cells	GSE139386	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8185
8.83705461633397e-100	-0.309088348927296	0.146	0.364	1.60286496631066e-95	KCTD3	Malignant cells	GSE139386	ENSG00000136636	51133	potassium channel tetramerization domain containing 3	NY-REN-45	protein_coding	Q9Y597	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8186
1.25236315458151e-99	-0.368205032808662	0.345	0.592	2.27153628977994e-95	C12orf29	Malignant cells	GSE139386	ENSG00000133641	91298	chromosome 12 open reading frame 29	DKFZp434N2030	protein_coding	Q8N999	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8187
1.7760524787558e-99	-0.277545038182811	0.089	0.282	3.22140398596727e-95	CCDC18	Malignant cells	GSE139386	ENSG00000122483	343099	coiled-coil domain containing 18	NY-SAR-41	protein_coding	Q5T9S5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8188
1.94410099908605e-99	-0.367692802601693	0.244	0.48	3.52621039214228e-95	FAM210A	Malignant cells	GSE139386	ENSG00000177150	125228	family with sequence similarity 210 member A	C18orf19|HsT2329|MGC24180	protein_coding	Q96ND0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8189
2.04858299820112e-99	-0.372757959113112	0.357	0.599	3.7157198421372e-95	MRTO4	Malignant cells	GSE139386	ENSG00000053372	51154	MRT4 homolog, ribosome maturation factor	C1orf33|dJ657E11.4|MRT4	protein_coding	Q9UKD2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8190
2.29437333969201e-99	0.27839278427343	1	1	4.16153436353336e-95	RAC1	Malignant cells	GSE139386	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8191
2.35794087007362e-99	-0.340088926429115	0.199	0.43	4.27683315013953e-95	CMIP	Malignant cells	GSE139386	ENSG00000153815	80790	c-Maf inducing protein	NA	protein_coding	Q8IY22	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8192
2.72291537234359e-99	-0.342046712682721	0.218	0.453	4.93882390235681e-95	UBAP2L	Malignant cells	GSE139386	ENSG00000143569	9898	ubiquitin associated protein 2 like	KIAA0144|NICE-4	protein_coding	Q14157	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8193
2.89804170875236e-99	-0.395119575679368	0.783	0.918	5.25646805133503e-95	PTRHD1	Malignant cells	GSE139386	ENSG00000184924	391356	peptidyl-tRNA hydrolase domain containing 1	C2orf79|LOC391356	protein_coding	Q6GMV3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8194
3.50032624202741e-99	-0.404646730372652	0.779	0.922	6.34889173778931e-95	ALCAM	Malignant cells	GSE139386	ENSG00000170017	214	activated leukocyte cell adhesion molecule	CD166|MEMD	protein_coding	Q13740	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8195
4.77116178646046e-99	-0.257804159383003	0.083	0.272	8.65393324828199e-95	DSN1	Malignant cells	GSE139386	ENSG00000149636	79980	DSN1 component of MIS12 kinetochore complex	C20orf172|dJ469A13.2|hKNL-3|KNL3|MIS13	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8196
4.7867063619636e-99	-0.307127322942457	0.151	0.371	8.68212799932957e-95	HUS1	Malignant cells	GSE139386	ENSG00000136273	3364	HUS1 checkpoint clamp component	NA	protein_coding	O60921	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8197
4.83802440144744e-99	-0.407055139442527	0.372	0.604	8.77520865934537e-95	NOLC1	Malignant cells	GSE139386	ENSG00000166197	9221	nucleolar and coiled-body phosphoprotein 1	KIAA0035|NOPP130|NOPP140|P130|Srp40	protein_coding	Q14978	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8198
5.27925328119481e-99	0.441264707275542	0.532	0.291	9.57550960143115e-95	AKAP13	Malignant cells	GSE139386	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8199
5.74544002496137e-99	-0.284942662983542	0.104	0.303	1.04210791172749e-94	ASB16-AS1	Malignant cells	GSE139386	ENSG00000267080	339201	ASB16 antisense RNA 1	C17orf65|DKFZp762C2414	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8200
7.30314213257937e-99	0.354416832233448	0.309	0.086	1.32464392000725e-94	SEC24D	Malignant cells	GSE139386	ENSG00000150961	9871	SEC24 homolog D, COPII coat complex component	KIAA0755	protein_coding	O94855	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8201
9.10034671976938e-99	-0.391686234089629	0.286	0.526	1.65062088803177e-94	NUDT8	Malignant cells	GSE139386	ENSG00000167799	254552	nudix hydrolase 8	FLJ41567	protein_coding	Q8WV74	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8202
1.06051858287485e-98	-0.367417222380888	0.218	0.448	1.9235686056184e-94	MAP7D3	Malignant cells	GSE139386	ENSG00000129680	79649	MAP7 domain containing 3	FLJ12649	protein_coding	Q8IWC1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8203
1.21152724512293e-98	-0.409332983962475	0.481	0.703	2.19746811720398e-94	RBBP6	Malignant cells	GSE139386	ENSG00000122257	5930	RB binding protein 6, ubiquitin ligase	P2P-R|PACT|SNAMA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8204
1.60198132991992e-98	-0.271556371053341	0.085	0.273	2.90567373620875e-94	ARHGAP10	Malignant cells	GSE139386	ENSG00000071205	79658	Rho GTPase activating protein 10	FLJ20896|FLJ41791|GRAF2	protein_coding	A1A4S6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8205
1.6572352779533e-98	-0.32270925426211	0.974	0.995	3.0058933471517e-94	UBE2D2	Malignant cells	GSE139386	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8206
1.66999406425997e-98	-0.261018427346809	0.077	0.26	3.02903523375474e-94	ZNF71	Malignant cells	GSE139386	ENSG00000197951	58491	zinc finger protein 71	Cos26|EZFIT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8207
1.81485387450027e-98	-0.336643951460292	0.204	0.434	3.2917819575686e-94	CRCP	Malignant cells	GSE139386	ENSG00000241258	27297	CGRP receptor component	C17|CGRP-RCP|POLR3I|RCP|RCP9	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8208
2.73427683005627e-98	-0.291606235137482	0.099	0.297	4.95943131435605e-94	CDC6	Malignant cells	GSE139386	ENSG00000094804	990	cell division cycle 6	CDC18L	protein_coding	Q99741	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8209
3.53652675526804e-98	-0.361810088508971	0.234	0.469	6.41455222870517e-94	LRP12	Malignant cells	GSE139386	ENSG00000147650	29967	LDL receptor related protein 12	FLJ12929|ST7	protein_coding	Q9Y561	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8210
4.24039036937126e-98	-0.480901599705519	0.461	0.694	7.69122005196559e-94	DCAF13	Malignant cells	GSE139386	ENSG00000164934	25879	DDB1 and CUL4 associated factor 13	DKFZP564O0463|Gm83|HSPC064|Sof1|WDSOF1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8211
4.24557544007231e-98	-0.379913356763716	0.694	0.881	7.70062473320316e-94	CD99	Malignant cells	GSE139386	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8212
5.25806657444596e-98	-0.306758091835002	0.99	0.998	9.53708115273008e-94	HNRNPC	Malignant cells	GSE139386	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8213
6.54447644266557e-98	-0.314783757986575	0.136	0.346	1.18703713717068e-93	KAT5	Malignant cells	GSE139386	ENSG00000172977	10524	lysine acetyltransferase 5	cPLA2|ESA1|HTATIP|HTATIP1|PLIP|TIP60|ZC2HC5	protein_coding	Q92993	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8214
8.8118832262537e-98	0.333873963650321	0.265	0.057	1.5982993795779e-93	PTP4A3	Malignant cells	GSE139386	ENSG00000275575	11156	protein tyrosine phosphatase 4A3	PRL-3|PRL-R|PRL3	protein_coding	O75365	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8215
8.92518230953435e-98	-0.263904230648273	0.072	0.25	1.61884956730334e-93	AGPAT9	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8216
1.14080300690083e-97	-0.411087129496614	0.531	0.743	2.06918849391672e-93	MMAB	Malignant cells	GSE139386	ENSG00000139428	326625	metabolism of cobalamin associated B	cblB|CFAP23	protein_coding	Q96EY8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8217
1.15144871978603e-97	-0.327948063575373	0.164	0.385	2.0884976879479e-93	MED17	Malignant cells	GSE139386	ENSG00000042429	9440	mediator complex subunit 17	CRSP6|CRSP77|DRIP80|SRB4|TRAP80	protein_coding	Q9NVC6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8218
1.20527825325626e-97	-0.338307978264282	0.191	0.42	2.18613369575621e-93	EXOSC2	Malignant cells	GSE139386	ENSG00000130713	23404	exosome component 2	hRrp4p|p7|RRP4|Rrp4p	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8219
1.29123606990288e-97	0.441299451083163	0.498	0.256	2.34204398358985e-93	NEU1	Malignant cells	GSE139386	ENSG00000184494	4758	neuraminidase 1	NEU	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8220
1.34303857558386e-97	-0.390198008760793	0.339	0.581	2.436003368394e-93	BRE	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8221
1.49995203776089e-97	-0.373482612224012	0.29	0.531	2.72061300609071e-93	TSPAN14	Malignant cells	GSE139386	ENSG00000108219	81619	tetraspanin 14	DC-TM4F2|MGC11352|TM4SF14	protein_coding	Q8NG11	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8222
1.56401910423775e-97	0.380317538271778	0.969	0.93	2.83681785126643e-93	TSPO	Malignant cells	GSE139386	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8223
1.57671379047301e-97	-0.307260286136475	0.145	0.359	2.85984347315994e-93	SLC25A32	Malignant cells	GSE139386	ENSG00000164933	81034	solute carrier family 25 member 32	MFTC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8224
1.58365456927055e-97	-0.330761257730886	0.106	0.3	2.87243265774293e-93	PCNXL4	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8225
2.05715790933088e-97	-0.377937628684904	0.327	0.569	3.73127301594436e-93	SLC6A6	Malignant cells	GSE139386	ENSG00000131389	6533	solute carrier family 6 member 6	TAUT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8226
2.12521852097872e-97	-0.378750023323106	0.622	0.821	3.85472135335121e-93	EIF2AK1	Malignant cells	GSE139386	ENSG00000086232	27102	eukaryotic translation initiation factor 2 alpha kinase 1	HCR|hHRI|HRI|KIAA1369	protein_coding	Q9BQI3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8227
2.78525795211393e-97	0.437741664274232	0.444	0.207	5.05190087354425e-93	QPCT	Malignant cells	GSE139386	ENSG00000115828	25797	glutaminyl-peptide cyclotransferase	GCT|QC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8228
2.87376307516201e-97	-0.351089577535201	0.928	0.979	5.21243146572885e-93	PRR13	Malignant cells	GSE139386	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8229
3.82806036458756e-97	-0.496334743627715	0.825	0.932	6.94333588928892e-93	PSMB3	Malignant cells	GSE139386	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8230
4.1107444539264e-97	0.426332857756298	0.454	0.209	7.4560682905317e-93	LMO7	Malignant cells	GSE139386	ENSG00000136153	4008	LIM domain 7	FBX20|FBXO20|KIAA0858	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8231
4.60082464397085e-97	0.307498236877057	1	1	8.34497573923434e-93	KRT7	Malignant cells	GSE139386	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8232
4.81957577330962e-97	-0.401745662640772	0.529	0.738	8.74174653762899e-93	ISCA1	Malignant cells	GSE139386	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8233
5.62149558546808e-97	-0.355061917261947	0.21	0.448	1.0196268692922e-92	MIS18BP1	Malignant cells	GSE139386	ENSG00000129534	55320	MIS18 binding protein 1	C14orf106|FLJ11186|KIAA1903|KNL2|M18BP1	protein_coding	Q6P0N0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8234
6.9216823143744e-97	-0.254311126011542	0.072	0.25	1.25545473818123e-92	EXOC2	Malignant cells	GSE139386	ENSG00000112685	55770	exocyst complex component 2	FLJ11026|Sec5|SEC5L1	protein_coding	Q96KP1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8235
7.08703293635852e-97	0.453403909896583	0.489	0.247	1.28544603399671e-92	ALDH2	Malignant cells	GSE139386	ENSG00000111275	217	aldehyde dehydrogenase 2 family member	NA	protein_coding	P05091	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8236
8.70167697384075e-97	-0.409980428476888	0.825	0.931	1.57831016951524e-92	PPM1G	Malignant cells	GSE139386	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8237
1.24887735587223e-96	0.388503649866061	0.323	0.101	2.26521374808104e-92	HS3ST1	Malignant cells	GSE139386	ENSG00000002587	9957	heparan sulfate-glucosamine 3-sulfotransferase 1	3OST1	protein_coding	O14792	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8238
1.34676098257619e-96	-0.41413180580122	0.508	0.725	2.44275507019669e-92	PRPF31	Malignant cells	GSE139386	ENSG00000274651	26121	pre-mRNA processing factor 31	hPrp31|NY-BR-99|PRP31|RP11|SNRNP61	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8239
1.47433027461809e-96	-0.324434859099611	0.197	0.426	2.67414025210229e-92	ATN1	Malignant cells	GSE139386	ENSG00000111676	1822	atrophin 1	B37|D12S755E|DRPLA	protein_coding	P54259	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8240
1.59775098530163e-96	-0.370204047192735	0.298	0.537	2.89800073714009e-92	STRN4	Malignant cells	GSE139386	ENSG00000090372	29888	striatin 4	PPP2R6C|ZIN	protein_coding	Q9NRL3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8241
1.62424463743855e-96	-0.383512615806404	0.349	0.584	2.94605492338605e-92	MED15	Malignant cells	GSE139386	ENSG00000099917	51586	mediator complex subunit 15	Arc105|CAG7A|PCQAP|TIG-1|TNRC7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8242
1.86567468976987e-96	0.450882076333406	0.734	0.549	3.3839607523046e-92	KRAS	Malignant cells	GSE139386	ENSG00000133703	3845	KRAS proto-oncogene, GTPase	K-Ras4B|KRAS1|KRAS2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8243
2.00658491077354e-96	-0.374345008767764	0.312	0.551	3.63954371116105e-92	CUL4A	Malignant cells	GSE139386	ENSG00000139842	8451	cullin 4A	NA	protein_coding	Q13619	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8244
2.25923986943196e-96	-0.30316189378521	0.193	0.437	4.09780927517568e-92	MND1	Malignant cells	GSE139386	ENSG00000121211	84057	meiotic nuclear divisions 1	GAJ	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8245
3.95813514806309e-96	-0.428394913776364	0.704	0.872	7.17926553155684e-92	CTSD	Malignant cells	GSE139386	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8246
3.96792958421158e-96	0.381887943228185	0.329	0.105	7.19703067984295e-92	CELF4	Malignant cells	GSE139386	ENSG00000101489	56853	CUGBP Elav-like family member 4	BRUNOL4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8247
4.30730583068833e-96	-0.313963420552308	0.163	0.381	7.8125913157025e-92	SLC4A2	Malignant cells	GSE139386	ENSG00000164889	6522	solute carrier family 4 member 2	AE2|BND3L|EPB3L1|HKB3|NBND3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8248
4.77580749281634e-96	0.462306288850365	0.869	0.785	8.66235963047027e-92	TMEM59	Malignant cells	GSE139386	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8249
5.01402782033037e-96	-0.398149690730625	0.513	0.723	9.09444366051523e-92	TSEN15	Malignant cells	GSE139386	ENSG00000198860	116461	tRNA splicing endonuclease subunit 15	C1orf19	protein_coding	Q8WW01	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8250
5.12594515814902e-96	-0.302099994099756	0.133	0.341	9.2974393278507e-92	NUP98	Malignant cells	GSE139386	ENSG00000110713	4928	nucleoporin 98 and 96 precursor	NUP196|NUP96|Nup98-96|Nup98-Nup96	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8251
8.30188330377719e-96	-0.250236959977987	0.08	0.262	1.50579559363911e-91	TRIQK	Malignant cells	GSE139386	ENSG00000205133	286144	triple QxxK/R motif containing	C8orf83|DKFZp779L1068|LOC286144|PRO0845	protein_coding	Q629K1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8252
9.32838275626583e-96	-0.403077485460154	0.824	0.929	1.6919820643315e-91	NELFE	Malignant cells	GSE139386	ENSG00000206268	7936	negative elongation factor complex member E	D6S45|NELF-E|RD|RDBP|RDP	protein_coding	P18615	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8253
9.67756811391425e-96	-0.386015156893625	0.523	0.733	1.75531730450177e-91	MANBAL	Malignant cells	GSE139386	ENSG00000101363	63905	mannosidase beta like	dJ1141E15.2	protein_coding	Q9NQG1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8254
9.85300431997034e-96	-0.380115147535624	0.367	0.607	1.78713792355622e-91	ARHGAP35	Malignant cells	GSE139386	ENSG00000160007	2909	Rho GTPase activating protein 35	GRF-1|GRLF1|KIAA1722|P190A|p190ARhoGAP|p190RhoGAP	protein_coding	Q9NRY4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8255
1.02358354444359e-95	-0.286078054780026	0.999	1	1.85657583291178e-91	COMMD6	Malignant cells	GSE139386	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8256
1.16429156816966e-95	-0.326996061530958	0.19	0.415	2.11179204634613e-91	PDCD6IP	Malignant cells	GSE139386	ENSG00000170248	10015	programmed cell death 6 interacting protein	AIP1|Alix|Hp95	protein_coding	Q8WUM4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8257
1.78872616773406e-95	-0.311118977602457	0.143	0.352	3.24439152303604e-91	ZNF672	Malignant cells	GSE139386	ENSG00000171161	79894	zinc finger protein 672	FLJ22301	protein_coding	Q499Z4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8258
2.21341748580683e-95	-0.305915087227668	0.115	0.314	4.01469663575643e-91	CHML	Malignant cells	GSE139386	ENSG00000203668	1122	CHM like Rab escort protein	REP-2	protein_coding	P26374	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8259
2.28357473756875e-95	-0.338890941488582	0.207	0.437	4.14194785900221e-91	NUP107	Malignant cells	GSE139386	ENSG00000111581	57122	nucleoporin 107	NUP84	protein_coding	P57740	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8260
3.09301563605469e-95	0.446108672261778	0.691	0.485	5.610111760676e-91	IFT43	Malignant cells	GSE139386	ENSG00000119650	112752	intraflagellar transport 43	C14orf179|FLJ32173|MGC16028	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8261
4.07883141659326e-95	-0.360417103845146	0.284	0.516	7.39818442341685e-91	MAPK3	Malignant cells	GSE139386	ENSG00000102882	5595	mitogen-activated protein kinase 3	ERK1|p44erk1|p44mapk|PRKM3	protein_coding	P27361	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8262
4.94223432315798e-95	0.330960532944836	0.286	0.074	8.96422461534394e-91	STK39	Malignant cells	GSE139386	ENSG00000198648	27347	serine/threonine kinase 39	DCHT|SPAK	protein_coding	Q9UEW8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8263
6.821238626016e-95	0.440226741029024	0.758	0.585	1.23723626198678e-90	DPP7	Malignant cells	GSE139386	ENSG00000176978	29952	dipeptidyl peptidase 7	DPP2|DPPII	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8264
8.09160178681715e-95	-0.325021082146678	0.187	0.411	1.4676547320929e-90	DVL2	Malignant cells	GSE139386	ENSG00000004975	1856	dishevelled segment polarity protein 2	NA	protein_coding	O14641	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8265
8.45937469068641e-95	0.375253341891506	0.973	0.948	1.5343613813967e-90	YIF1A	Malignant cells	GSE139386	ENSG00000174851	10897	Yip1 interacting factor homolog A, membrane trafficking protein	54TM|FinGER7|YIF1|YIF1P	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8266
8.75296555664309e-95	-0.347202930419511	0.239	0.472	1.58761289266392e-90	RIC8A	Malignant cells	GSE139386	ENSG00000177963	60626	RIC8 guanine nucleotide exchange factor A	synembryn|synembryn-A	protein_coding	Q9NPQ8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8267
9.19034632767879e-95	-0.411095459814884	0.648	0.823	1.66694501691438e-90	TIMM17A	Malignant cells	GSE139386	ENSG00000134375	10440	translocase of inner mitochondrial membrane 17A	TIM17|TIM17A	protein_coding	Q99595	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8268
9.79661762290957e-95	0.424839459162275	0.625	0.387	1.77691050444334e-90	PQBP1	Malignant cells	GSE139386	ENSG00000102103	10084	polyglutamine binding protein 1	MRX2|MRX55|MRXS3|MRXS8|RENS1|SHS	protein_coding	O60828	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8269
1.0618483501508e-94	-0.344985811254895	0.23	0.461	1.92598053750351e-90	UBAP2	Malignant cells	GSE139386	ENSG00000137073	55833	ubiquitin associated protein 2	bA176F3.5|FLJ22435|KIAA1491	protein_coding	Q5T6F2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8270
1.62916301926785e-94	-0.34110759905106	0.194	0.418	2.95497588434803e-90	ELK3	Malignant cells	GSE139386	ENSG00000111145	2004	ETS transcription factor ELK3	ERP|NET|SAP2	protein_coding	P41970	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8271
1.81048933164484e-94	-0.392935677613853	0.711	0.873	3.2838655497374e-90	SRSF1	Malignant cells	GSE139386	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8272
2.13312190040887e-94	-0.295567346289616	0.133	0.339	3.86905650296161e-90	SPATA33	Malignant cells	GSE139386	ENSG00000167523	124045	spermatogenesis associated 33	C16orf55|FLJ31606	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8273
2.22682610837499e-94	0.342030912011928	0.268	0.061	4.03901719537056e-90	RASD1	Malignant cells	GSE139386	ENSG00000108551	51655	ras related dexamethasone induced 1	AGS1|DEXRAS1	protein_coding	Q9Y272	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8274
2.23093644868996e-94	-0.348351967989247	0.261	0.497	4.04647253063384e-90	SLC35A4	Malignant cells	GSE139386	ENSG00000176087	113829	solute carrier family 35 member A4	NA	protein_coding	L0R6Q1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8275
2.39320821558143e-94	-0.354201122654554	0.281	0.518	4.34080106142159e-90	UCHL5	Malignant cells	GSE139386	ENSG00000116750	51377	ubiquitin C-terminal hydrolase L5	CGI-70|INO80R|UCH37	protein_coding	Q9Y5K5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8276
2.88537349630374e-94	-0.293508893760484	0.121	0.321	5.23349044759573e-90	ZWILCH	Malignant cells	GSE139386	ENSG00000174442	55055	zwilch kinetochore protein	FLJ10036|KNTC1AP	protein_coding	Q9H900	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8277
4.370296434658e-94	-0.327468735180704	0.195	0.419	7.92684367318268e-90	CTD-2228K2.5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8278
6.91060690718741e-94	-0.258533890259752	0.086	0.269	1.25344588082565e-89	ENTPD3-AS1	Malignant cells	GSE139386	ENSG00000223797	285266	ENTPD3 antisense RNA 1	FLJ36665	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8279
7.96004419871036e-94	-0.349508359253184	0.189	0.409	1.44379281676209e-89	PDLIM2	Malignant cells	GSE139386	ENSG00000120913	64236	PDZ and LIM domain 2	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8280
8.23903857077553e-94	-0.260174164126592	0.085	0.267	1.49439681596726e-89	IMMP2L	Malignant cells	GSE139386	ENSG00000184903	83943	inner mitochondrial membrane peptidase subunit 2	IMMP2L-IT1|IMP2	protein_coding	Q96T52	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8281
1.09122503598861e-93	-0.398310952849426	0.722	0.875	1.97926397027614e-89	REEP3	Malignant cells	GSE139386	ENSG00000165476	221035	receptor accessory protein 3	C10orf74|Yip2b	protein_coding	Q6NUK4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8282
1.3502401006283e-93	0.482128778895099	0.677	0.475	2.44906549451962e-89	FAM3C	Malignant cells	GSE139386	ENSG00000196937	10447	FAM3 metabolism regulating signaling molecule C	GS3876|ILEI	protein_coding	Q92520	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8283
1.50719076515643e-93	-0.263647757340378	0.091	0.277	2.73374260984074e-89	CBX2	Malignant cells	GSE139386	ENSG00000173894	84733	chromobox 2	CDCA6|M33|MGC10561	protein_coding	Q14781	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8284
1.97492135695488e-93	-0.296673391342402	0.124	0.324	3.58211235724477e-89	APEX2	Malignant cells	GSE139386	ENSG00000169188	27301	apurinic/apyrimidinic endodeoxyribonuclease 2	APE2|APEXL2|XTH2|ZGRF2	protein_coding	Q9UBZ4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8285
2.18857122697516e-93	-0.338476698599687	0.309	0.551	3.96963049148755e-89	COASY	Malignant cells	GSE139386	ENSG00000068120	80347	Coenzyme A synthase	DPCK|NBP|PPAT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8286
2.72568918489357e-93	-0.319693735298538	0.171	0.387	4.94385504355995e-89	UBTD2	Malignant cells	GSE139386	ENSG00000168246	92181	ubiquitin domain containing 2	DC-UbP|MGC30022	protein_coding	Q8WUN7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8287
3.10813576849353e-93	-0.278378657917234	0.093	0.277	5.63753665689357e-89	VANGL1	Malignant cells	GSE139386	ENSG00000173218	81839	VANGL planar cell polarity protein 1	STB2	protein_coding	Q8TAA9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8288
3.3273553508387e-93	-0.399741776646352	0.428	0.653	6.03515713535124e-89	TPRA1	Malignant cells	GSE139386	ENSG00000163870	131601	transmembrane protein adipocyte associated 1	FLJ32197|GPR175|TMEM227|TPRA40	protein_coding	Q86W33	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8289
3.59956245084517e-93	-0.290267391064914	0.116	0.313	6.52888637334296e-89	C7orf55	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8290
5.53603009546897e-93	-0.285570705594273	0.136	0.343	1.00412513871616e-88	TMEM234	Malignant cells	GSE139386	ENSG00000160055	56063	transmembrane protein 234	C1orf91|dJ622L5.7|FLJ90779|RP4-622L5	protein_coding	Q8WY98	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8291
5.79295566602772e-93	0.421613989035694	0.522	0.288	1.05072629870411e-88	DCAF10	Malignant cells	GSE139386	ENSG00000122741	79269	DDB1 and CUL4 associated factor 10	FLJ23201|MGC10765|WDR32	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8292
6.07720605668728e-93	-0.325800717235791	0.226	0.456	1.10228363456194e-88	FLOT2	Malignant cells	GSE139386	ENSG00000132589	2319	flotillin 2	ECS-1|ECS1|ESA|ESA1|M17S1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8293
6.1883636707322e-93	-0.358902907750155	0.307	0.542	1.12244540259741e-88	KIAA1143	Malignant cells	GSE139386	ENSG00000281665	57456	KIAA1143	NA	protein_coding	Q96AT1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8294
7.00044660565647e-93	-0.341432580908087	0.283	0.524	1.26974100533397e-88	DCTN6	Malignant cells	GSE139386	ENSG00000104671	10671	dynactin subunit 6	WS-3	protein_coding	O00399	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8295
7.02788385294699e-93	-0.276770552810816	0.087	0.268	1.27471757324753e-88	RAB15	Malignant cells	GSE139386	ENSG00000139998	376267	RAB15, member RAS oncogene family	NA	protein_coding	P59190	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8296
7.87154187663992e-93	0.454860664151935	0.82	0.692	1.42774026558495e-88	MBIP	Malignant cells	GSE139386	ENSG00000151332	51562	MAP3K12 binding inhibitory protein 1	NA	protein_coding	Q9NS73	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8297
8.23576188226097e-93	-0.329742840405872	0.187	0.406	1.4938024902045e-88	MESDC1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8298
8.43861324136883e-93	-0.360440596704998	0.291	0.524	1.53059566971948e-88	RMDN1	Malignant cells	GSE139386	ENSG00000176623	51115	regulator of microtubule dynamics 1	CGI-90|FAM82B|FLJ20665|RMD1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8299
8.53237188183004e-93	0.357336993678496	0.348	0.123	1.54760161192633e-88	KDELR3	Malignant cells	GSE139386	ENSG00000100196	11015	KDEL endoplasmic reticulum protein retention receptor 3	NA	protein_coding	O43731	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8300
1.1853575733251e-92	-0.29589014852136	0.15	0.361	2.15000156649707e-88	TMEM99	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8301
1.27672970361438e-92	-0.305377198847507	0.164	0.379	2.31573233641576e-88	ZHX1	Malignant cells	GSE139386	ENSG00000165156	11244	zinc fingers and homeoboxes 1	NA	protein_coding	Q9UKY1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8302
1.338396386301e-92	-0.328521093138523	0.195	0.414	2.42758336547275e-88	B4GALT2	Malignant cells	GSE139386	ENSG00000117411	8704	beta-1,4-galactosyltransferase 2	beta4Gal-T2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8303
2.23543289747478e-92	0.405110169415013	0.462	0.223	4.05462818943975e-88	GALNT6	Malignant cells	GSE139386	ENSG00000139629	11226	polypeptide N-acetylgalactosaminyltransferase 6	GalNAc-T6	protein_coding	Q8NCL4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8304
2.31741987184817e-92	0.373373332860273	0.368	0.141	4.20333616355821e-88	PGPEP1	Malignant cells	GSE139386	ENSG00000130517	54858	pyroglutamyl-peptidase I	Pcp|PGP|PGP-I|PGPI	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8305
2.41084044180256e-92	-0.339214371463783	0.296	0.534	4.37278239334148e-88	BBIP1	Malignant cells	GSE139386	ENSG00000214413	92482	BBSome interacting protein 1	bA348N5.3|BBIP10|BBS18|NCRNA00081	protein_coding	A8MTZ0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8306
2.71972361694581e-92	0.406194229455126	0.892	0.809	4.93303469641631e-88	OLA1	Malignant cells	GSE139386	ENSG00000138430	29789	Obg like ATPase 1	GTPBP9|PTD004	protein_coding	Q9NTK5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8307
2.90038921359956e-92	0.373314802990897	0.4	0.168	5.26072595562688e-88	ZNF277	Malignant cells	GSE139386	ENSG00000198839	11179	zinc finger protein 277	NRIF4|ZNF277P	protein_coding	Q9NRM2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8308
4.62756139269655e-92	-0.36564482771895	0.423	0.655	8.393470854073e-88	RNF220	Malignant cells	GSE139386	ENSG00000187147	55182	ring finger protein 220	C1orf164|FLJ10597	protein_coding	Q5VTB9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8309
4.88166878179903e-92	-0.345387349039793	0.234	0.462	8.85437083642708e-88	TMEM237	Malignant cells	GSE139386	ENSG00000155755	65062	transmembrane protein 237	ALS2CR4|JBTS14	protein_coding	Q96Q45	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8310
4.9069915935186e-92	-0.361402663595663	0.494	0.717	8.90030135232405e-88	RAD51C	Malignant cells	GSE139386	ENSG00000108384	5889	RAD51 paralog C	FANCO|RAD51L2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8311
5.08970269054857e-92	-0.346517977761039	0.257	0.485	9.23170274011699e-88	LAMTOR3	Malignant cells	GSE139386	ENSG00000109270	8649	late endosomal/lysosomal adaptor, MAPK and MTOR activator 3	MAP2K1IP1|MAPBP|MAPKSP1|MP1|Ragulator3	protein_coding	Q9UHA4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8312
6.21982179473962e-92	-0.351300364989905	0.286	0.516	1.12815127712987e-87	UTP23	Malignant cells	GSE139386	ENSG00000147679	84294	UTP23 small subunit processome component	C8orf53|MGC14595	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8313
6.48232933776071e-92	-0.309143553759857	0.195	0.418	1.17576489528304e-87	GTF3C2	Malignant cells	GSE139386	ENSG00000115207	2976	general transcription factor IIIC subunit 2	KIAA0011|TFIIIC110	protein_coding	Q8WUA4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8314
8.89659899713614e-92	-0.279916628993372	0.129	0.331	1.61366512610055e-87	C19orf12	Malignant cells	GSE139386	ENSG00000131943	83636	chromosome 19 open reading frame 12	DKFZP762D096|MGC10922|MPAN|NBIA4|SPG43	protein_coding	Q9NSK7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8315
9.22708717097527e-92	-0.378881535679463	0.391	0.632	1.67360907107149e-87	IGFBP6	Malignant cells	GSE139386	ENSG00000167779	3489	insulin like growth factor binding protein 6	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8316
9.29129133442401e-92	-0.254649036380714	0.082	0.26	1.68525442223783e-87	TTN-AS1	Malignant cells	GSE139386	ENSG00000237298	100506866	TTN antisense RNA 1	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8317
1.09193044932771e-91	-0.324263070286213	0.205	0.429	1.98054344899061e-87	MYO19	Malignant cells	GSE139386	ENSG00000278372	80179	myosin XIX	FLJ22865|MYOHD1	protein_coding	Q96H55	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8318
1.12197370530862e-91	-0.35381348069827	0.25	0.478	2.03503590668878e-87	SCRIB	Malignant cells	GSE139386	ENSG00000274287	23513	scribble planar cell polarity protein	KIAA0147|SCRB1|Vartul	protein_coding	Q14160	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8319
1.32187741367503e-91	-0.36461441700125	0.323	0.551	2.39762125292377e-87	DMWD	Malignant cells	GSE139386	ENSG00000185800	1762	DM1 locus, WD repeat containing	D19S593E|DMR-N9|gene59	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8320
1.37385965023895e-91	0.456642285653337	0.764	0.598	2.49190663360341e-87	FAM60A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8321
2.66718558562161e-91	0.435749293466358	0.844	0.736	4.83774121520048e-87	GIPC1	Malignant cells	GSE139386	ENSG00000123159	10755	GIPC PDZ domain containing family member 1	C19orf3|GIPC|GLUT1CBP|Hs.6454|NIP|RGS19IP1|SEMCAP|SYNECTIN|TIP-2	protein_coding	O14908	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8322
3.09431548684084e-91	-0.288124434406476	0.131	0.333	5.61246943003191e-87	NDC1	Malignant cells	GSE139386	ENSG00000058804	55706	NDC1 transmembrane nucleoporin	FLJ10407|NET3|TMEM48	protein_coding	Q9BTX1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8323
3.45096029208559e-91	-0.331922991687955	0.242	0.474	6.25935177778483e-87	PKIG	Malignant cells	GSE139386	ENSG00000168734	11142	cAMP-dependent protein kinase inhibitor gamma	NA	protein_coding	Q9Y2B9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8324
3.53091692787557e-91	-0.36287696134072	0.545	0.752	6.4043771237807e-87	FBXW5	Malignant cells	GSE139386	ENSG00000159069	54461	F-box and WD repeat domain containing 5	DKFZP434B205|Fbw5|MGC20962	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8325
6.28844589527394e-91	-0.394121336527858	0.775	0.909	1.14059831648479e-86	PAFAH1B3	Malignant cells	GSE139386	ENSG00000079462	5050	platelet activating factor acetylhydrolase 1b catalytic subunit 3	NA	protein_coding	Q15102	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8326
6.4105834820465e-91	-0.35556032836051	0.318	0.551	1.16275163197359e-86	R3HCC1	Malignant cells	GSE139386	ENSG00000104679	203069	R3H domain and coiled-coil containing 1	DKFZp564N123	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8327
8.42762174458996e-91	-0.33190200085258	0.24	0.471	1.52860203203373e-86	INIP	Malignant cells	GSE139386	ENSG00000148153	58493	INTS3 and NABP interacting protein	C9orf80|HSPC043|hSSBIP1|MISE|SOSS-C	protein_coding	Q9NRY2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8328
1.29828821287984e-90	-0.319373264683728	0.971	0.994	2.35483516052146e-86	ZCRB1	Malignant cells	GSE139386	ENSG00000139168	85437	zinc finger CCHC-type and RNA binding motif containing 1	MADP-1|MADP1|RBM36|SNRNP31|ZCCHC19	protein_coding	Q8TBF4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8329
1.32073419088935e-90	0.440514342390359	0.55	0.324	2.39554767543511e-86	CCDC112	Malignant cells	GSE139386	ENSG00000164221	153733	coiled-coil domain containing 112	MGC39633	protein_coding	Q8NEF3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8330
1.34557517602265e-90	-0.347973218778165	0.338	0.571	2.44060425426989e-86	HYAL2	Malignant cells	GSE139386	ENSG00000068001	8692	hyaluronidase 2	LuCa-2|LUCA2	protein_coding	Q12891	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8331
1.66427040221823e-90	-0.321821408341036	0.2	0.419	3.01865365554342e-86	TWSG1	Malignant cells	GSE139386	ENSG00000128791	57045	twisted gastrulation BMP signaling modulator 1	TSG	protein_coding	Q9GZX9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8332
1.81304578802544e-90	-0.369316244663781	0.359	0.588	3.28850245032055e-86	UBE2G2	Malignant cells	GSE139386	ENSG00000184787	7327	ubiquitin conjugating enzyme E2 G2	UBC7	protein_coding	P60604	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8333
1.9691811644261e-90	-0.264506332005408	0.097	0.281	3.57170079603605e-86	HTT	Malignant cells	GSE139386	ENSG00000197386	3064	huntingtin	HD|IT15	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8334
2.00103015434084e-90	-0.350902234853714	0.196	0.415	3.62946849394341e-86	LETM1	Malignant cells	GSE139386	ENSG00000168924	3954	leucine zipper and EF-hand containing transmembrane protein 1	Mdm38|SLC55A1.	protein_coding	O95202	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8335
2.30345824129426e-90	0.368504893130749	0.409	0.173	4.17801255805953e-86	TRIM2	Malignant cells	GSE139386	ENSG00000109654	23321	tripartite motif containing 2	CMT2R|KIAA0517|RNF86	protein_coding	Q9C040	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8336
2.30891912855144e-90	0.389240502655646	0.402	0.173	4.18791751536659e-86	GMPPA	Malignant cells	GSE139386	ENSG00000144591	29926	GDP-mannose pyrophosphorylase A	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8337
2.76572277081039e-90	0.339240899465297	0.899	0.801	5.01646796169588e-86	CCT3	Malignant cells	GSE139386	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8338
4.69377522884021e-90	-0.282404264247325	0.119	0.313	8.51356951007038e-86	CASP6	Malignant cells	GSE139386	ENSG00000138794	839	caspase 6	MCH2	protein_coding	P55212	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8339
6.75103889720087e-90	-0.374452170074286	0.345	0.569	1.22450343517429e-85	HSPH1	Malignant cells	GSE139386	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8340
6.99583591772192e-90	-0.260121145207682	0.093	0.275	1.2689047187564e-85	RLIM	Malignant cells	GSE139386	ENSG00000131263	51132	ring finger protein, LIM domain interacting	MGC15161|NY-REN-43|RNF12	protein_coding	Q9NVW2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8341
7.25151264735093e-90	-0.340822290265523	0.24	0.465	1.31527936397651e-85	RNF168	Malignant cells	GSE139386	ENSG00000163961	165918	ring finger protein 168	FLJ35794	protein_coding	Q8IYW5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8342
8.89304267625085e-90	0.399746445522041	0.909	0.829	1.61302008061838e-85	GLRX3	Malignant cells	GSE139386	ENSG00000108010	10539	glutaredoxin 3	bA500G10.4|GLRX4|GRX3|GRX4|PICOT|TXNL2	protein_coding	O76003	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8343
9.28597976464914e-90	-0.291636174666351	0.146	0.35	1.68429100971206e-85	ITPK1	Malignant cells	GSE139386	ENSG00000274958	3705	inositol-tetrakisphosphate 1-kinase	NA	protein_coding	Q13572	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8344
1.12392707228818e-89	0.418219666371769	0.423	0.192	2.0385789237163e-85	MUC20	Malignant cells	GSE139386	ENSG00000275430	200958	mucin 20, cell surface associated	FLJ14408|KIAA1359	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8345
2.05456142401596e-89	-0.376776859557002	0.553	0.756	3.72656351088014e-85	EBAG9	Malignant cells	GSE139386	ENSG00000147654	9166	estrogen receptor binding site associated antigen 9	EB9|RCAS1	protein_coding	O00559	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8346
2.55912781376749e-89	-0.289943344949623	0.104	0.289	4.64174602861148e-85	KLK6	Malignant cells	GSE139386	ENSG00000167755	5653	kallikrein related peptidase 6	Bssp|Klk7|neurosin|PRSS18|PRSS9	protein_coding	Q92876	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8347
2.88807364623455e-89	-0.350743037964338	0.262	0.486	5.23838797954023e-85	MOB4	Malignant cells	GSE139386	ENSG00000115540	25843	MOB family member 4, phocein	2C4D|CGI-95|DKFZP564M112|MOB3|MOBKL3|PHOCN|PREI3	protein_coding	Q9Y3A3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8348
3.46006069982317e-89	-0.412079038946133	0.773	0.904	6.27585809733927e-85	MRPL3	Malignant cells	GSE139386	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8349
3.73981714003173e-89	0.441467434178724	0.632	0.421	6.78328032858956e-85	OS9	Malignant cells	GSE139386	ENSG00000135506	10956	OS9 endoplasmic reticulum lectin	ERLEC2|OS-9	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8350
4.230061136498e-89	-0.345457340845373	0.318	0.554	7.67248488938007e-85	CPSF4	Malignant cells	GSE139386	ENSG00000160917	10898	cleavage and polyadenylation specific factor 4	CPSF30|NAR	protein_coding	O95639	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8351
5.05116656431663e-89	-0.366081782546282	0.401	0.629	9.1618059143575e-85	CECR5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8352
5.92928426235677e-89	-0.365725733116443	0.347	0.578	1.07545357950627e-84	HIPK2	Malignant cells	GSE139386	ENSG00000064393	28996	homeodomain interacting protein kinase 2	NA	protein_coding	Q9H2X6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8353
7.49979470476128e-89	-0.396105640675902	0.527	0.728	1.3603127635496e-84	PAK2	Malignant cells	GSE139386	ENSG00000180370	5062	p21 (RAC1) activated kinase 2	PAK65|PAKgamma	protein_coding	Q13177	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8354
9.45248359514374e-89	-0.315660783643596	0.154	0.361	1.71449147448717e-84	EFEMP1	Malignant cells	GSE139386	ENSG00000115380	2202	EGF containing fibulin extracellular matrix protein 1	DHRD|FBLN3|FBNL|MTLV|S1-5	protein_coding	Q12805	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8355
9.83116554936597e-89	-0.325252570261384	0.218	0.438	1.783176807344e-84	VRK3	Malignant cells	GSE139386	ENSG00000105053	51231	VRK serine/threonine kinase 3	NA	protein_coding	Q8IV63	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8356
1.00271484142922e-88	-0.545501535224855	0.731	0.896	1.81872417938432e-84	CAPZA1	Malignant cells	GSE139386	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8357
1.07473392637849e-88	-0.363770105805033	0.225	0.443	1.9493523956653e-84	RBM14	Malignant cells	GSE139386	ENSG00000239306	10432	RNA binding motif protein 14	COAA|DKFZp779J0927|SIP|SYTIP1	protein_coding	Q96PK6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8358
1.19503389820896e-88	-0.379895943465193	0.7	0.855	2.16755248457142e-84	PARL	Malignant cells	GSE139386	ENSG00000175193	55486	presenilin associated rhomboid like	PRO2207|PSARL|PSARL1|RHBDS1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8359
1.21803503583211e-88	0.317183803007588	0.297	0.089	2.20927194799229e-84	MFSD2B	Malignant cells	GSE139386	ENSG00000205639	388931	major facilitator superfamily domain containing 2B	SLC59A2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8360
1.28455327152791e-88	0.434789423835526	0.615	0.403	2.32992272389732e-84	SYTL1	Malignant cells	GSE139386	ENSG00000142765	84958	synaptotagmin like 1	exophilin-7|FLJ14996|JFC1|SLP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8361
1.28983101907747e-88	-0.398326318429289	0.819	0.934	2.33949550240271e-84	REEP5	Malignant cells	GSE139386	ENSG00000129625	7905	receptor accessory protein 5	C5orf18|D5S346|DP1|POB16|TB2|Yip2e	protein_coding	Q00765	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8362
1.74901629250343e-88	-0.266252674138467	0.107	0.295	3.17236575134272e-84	DPY19L4	Malignant cells	GSE139386	ENSG00000156162	286148	dpy-19 like 4	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8363
1.82669214147058e-88	-0.357278999722471	0.353	0.582	3.31325420619934e-84	FLII	Malignant cells	GSE139386	ENSG00000284571	2314	FLII actin remodeling protein	FLI|Fli1|FLIL|MGC39265	protein_coding	Q13045	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8364
2.03081223958939e-88	-0.321074881920771	0.289	0.523	3.68348724016724e-84	RAF1	Malignant cells	GSE139386	ENSG00000132155	5894	Raf-1 proto-oncogene, serine/threonine kinase	c-Raf|CRAF|Raf-1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8365
2.2986193694587e-88	-0.352420378890409	0.341	0.57	4.1692358123242e-84	MGAT1	Malignant cells	GSE139386	ENSG00000131446	4245	alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GLCNAC-TI|GLYT1|GNT-1|GnTI|MGAT	protein_coding	P26572	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8366
7.50600721857246e-88	-0.308603835204933	0.246	0.475	1.36143958930467e-83	ANAPC7	Malignant cells	GSE139386	ENSG00000196510	51434	anaphase promoting complex subunit 7	APC7	protein_coding	Q9UJX3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8367
8.9800884977463e-88	0.373900560746203	0.377	0.154	1.62880845172122e-83	SREBF1	Malignant cells	GSE139386	ENSG00000072310	6720	sterol regulatory element binding transcription factor 1	bHLHd1|SREBP-1c|SREBP1|SREBP1a	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8368
1.16825664062071e-87	-0.344606482778954	0.347	0.577	2.11898389475784e-83	TIMM23	Malignant cells	GSE139386	ENSG00000265354	100287932	translocase of inner mitochondrial membrane 23	TIM23	protein_coding	O14925	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8369
1.22824113053818e-87	-0.32385766000847	0.228	0.454	2.22778376257014e-83	CCDC109B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8370
1.31628491329926e-87	-0.31772441038295	0.194	0.409	2.38747757574219e-83	TRAF3	Malignant cells	GSE139386	ENSG00000131323	7187	TNF receptor associated factor 3	CAP-1|CD40bp|CRAF1|LAP1|RNF118	protein_coding	Q13114	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8371
1.34643687060598e-87	-0.380535334141545	0.583	0.785	2.44216719590513e-83	WTAP	Malignant cells	GSE139386	ENSG00000146457	9589	WT1 associated protein	KIAA0105|MGC3925|Mum2	protein_coding	Q15007	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8372
1.36016477120518e-87	0.445585226820341	0.583	0.357	2.46706686201195e-83	CAPG	Malignant cells	GSE139386	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8373
1.43713671827312e-87	-0.272590754022201	0.114	0.304	2.60667857960379e-83	BPHL	Malignant cells	GSE139386	ENSG00000137274	670	biphenyl hydrolase like	Bph-rp|MCNAA|VACVase	protein_coding	Q86WA6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8374
1.63610498973469e-87	-0.256560036275774	0.087	0.263	2.96756723038077e-83	SS18	Malignant cells	GSE139386	ENSG00000141380	6760	SS18 subunit of BAF chromatin remodeling complex	SMARCL1|SSXT|SYT	protein_coding	Q15532	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8375
4.04238733231025e-87	0.369632830934632	0.979	0.945	7.33208214334433e-83	BAZ1A	Malignant cells	GSE139386	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8376
4.68407284060326e-87	0.33276972069314	0.319	0.107	8.49597131828619e-83	PGM3	Malignant cells	GSE139386	ENSG00000013375	5238	phosphoglucomutase 3	AGM1|DKFZP434B187|PAGM	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8377
6.27875288600654e-87	-0.368044656066127	0.669	0.846	1.13884019846387e-82	ARL2	Malignant cells	GSE139386	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8378
9.14540512152376e-87	-0.312476242026413	0.21	0.427	1.65879358094198e-82	PRR3	Malignant cells	GSE139386	ENSG00000223887	80742	proline rich 3	CAT56|Em:AB014077.1|Em:AB023052.2	protein_coding	P79522	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8379
1.47343221110108e-86	0.364119564063769	0.332	0.119	2.67251134449514e-82	MAGED2	Malignant cells	GSE139386	ENSG00000102316	10916	MAGE family member D2	11B6|BCG1|HCA10|JCL-1|MAGE-D2|MAGED|MGC8386	protein_coding	Q9UNF1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8380
1.48781704923889e-86	-0.302393607957539	0.156	0.36	2.6986025639095e-82	UMPS	Malignant cells	GSE139386	ENSG00000114491	7372	uridine monophosphate synthetase	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8381
1.5245589413363e-86	-0.324569037122277	0.229	0.448	2.76524500779577e-82	GLYR1	Malignant cells	GSE139386	ENSG00000140632	84656	glyoxylate reductase 1 homolog	BM045|HIBDL|N-PAC|NP60	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8382
1.55232800661081e-86	0.312820694902637	0.273	0.073	2.81561253839068e-82	SESN2	Malignant cells	GSE139386	ENSG00000285069	83667	sestrin 2	DKFZp761M0212|HI95|SES2|SEST2	protein_coding	P58004	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8383
1.93951974105053e-86	0.350302571338109	0.363	0.143	3.51790090631745e-82	PSD3	Malignant cells	GSE139386	ENSG00000156011	23362	pleckstrin and Sec7 domain containing 3	DKFZp761K1423|EFA6D|EFA6R|HCA67|KIAA0942	protein_coding	Q9NYI0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8384
1.99654804821316e-86	-0.266160082949795	0.124	0.318	3.62133884984903e-82	WDR20	Malignant cells	GSE139386	ENSG00000140153	91833	WD repeat domain 20	Bun107|DMR|FLJ33659|MGC33177	protein_coding	Q8TBZ3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8385
2.19540210470356e-86	-0.345727569905372	0.281	0.504	3.98202033751131e-82	MTHFD2L	Malignant cells	GSE139386	ENSG00000163738	441024	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like	MGC72244	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8386
2.78790408688842e-86	0.377342374693548	0.432	0.204	5.05670043279821e-82	MIPOL1	Malignant cells	GSE139386	ENSG00000151338	145282	mirror-image polydactyly 1	CCDC193	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8387
2.79525441085903e-86	0.392125614564593	0.443	0.218	5.07003245041611e-82	METTL12	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8388
6.64688744423628e-86	-0.315028834947815	0.201	0.414	1.20561244463558e-81	STYX	Malignant cells	GSE139386	ENSG00000198252	6815	serine/threonine/tyrosine interacting protein	NA	protein_coding	Q8WUJ0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8389
7.26507056723943e-86	0.343999537599357	0.256	0.062	1.31773849948589e-81	SPRY1	Malignant cells	GSE139386	ENSG00000164056	10252	sprouty RTK signaling antagonist 1	hSPRY1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8390
9.04364804199938e-86	0.485237709938494	0.711	0.548	1.64033688185785e-81	PLAUR	Malignant cells	GSE139386	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8391
1.26447073462661e-85	-0.304028746538362	0.209	0.427	2.29349701846574e-81	RAB28	Malignant cells	GSE139386	ENSG00000157869	9364	RAB28, member RAS oncogene family	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8392
1.36338148853537e-85	-0.357432655138068	0.316	0.544	2.47290134390546e-81	PSMD1	Malignant cells	GSE139386	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8393
1.38922028604661e-85	0.333622647470128	0.363	0.143	2.51976775483135e-81	SDSL	Malignant cells	GSE139386	ENSG00000139410	113675	serine dehydratase like	cSDH|SDS-RS1	protein_coding	Q96GA7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8394
1.45149181281597e-85	-0.374630993608312	0.736	0.883	2.63271585008561e-81	BOD1	Malignant cells	GSE139386	ENSG00000145919	91272	biorientation of chromosomes in cell division 1	FAM44B	protein_coding	Q96IK1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8395
1.67534786843115e-85	-0.253806467608961	0.096	0.275	3.03874596376043e-81	TRAF2	Malignant cells	GSE139386	ENSG00000127191	7186	TNF receptor associated factor 2	RNF117|TRAP3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8396
1.86543667689637e-85	-0.384992208544871	0.475	0.681	3.38352904455464e-81	EBP	Malignant cells	GSE139386	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8397
2.00132691120282e-85	-0.380654849604452	0.608	0.798	3.63000675153968e-81	DSG2	Malignant cells	GSE139386	ENSG00000046604	1829	desmoglein 2	CDHF5	protein_coding	Q14126	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8398
2.99296460911637e-85	-0.370913137608038	0.457	0.668	5.42863920801528e-81	GID8	Malignant cells	GSE139386	ENSG00000101193	54994	GID complex subunit 8 homolog	bA305P22.1|C20orf11|FLJ20602|TWA1	protein_coding	Q9NWU2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8399
3.81016600223641e-85	-0.374133916819371	0.482	0.684	6.91087909485641e-81	VASP	Malignant cells	GSE139386	ENSG00000125753	7408	vasodilator stimulated phosphoprotein	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8400
3.86273890034519e-85	-0.295880515469688	0.161	0.363	7.0062358174461e-81	KIAA1715	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8401
4.25091390921793e-85	-0.289753738680217	0.145	0.343	7.71030764853948e-81	TARBP1	Malignant cells	GSE139386	ENSG00000059588	6894	TAR (HIV-1) RNA binding protein 1	TRM3|TRMT3|TRP-185	protein_coding	Q13395	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8402
4.78499112629169e-85	-0.345016548535526	0.38	0.609	8.67901690486787e-81	CLIP4	Malignant cells	GSE139386	ENSG00000115295	79745	CAP-Gly domain containing linker protein family member 4	FLJ21069|RSNL2	protein_coding	Q8N3C7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8403
4.91619961759996e-85	-0.274753432307632	0.148	0.351	8.9170028664028e-81	RCCD1	Malignant cells	GSE139386	ENSG00000166965	91433	RCC1 domain containing 1	MGC14386	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8404
5.60440938358705e-85	-0.306136828563351	0.195	0.407	1.01652777399502e-80	KCTD20	Malignant cells	GSE139386	ENSG00000112078	222658	potassium channel tetramerization domain containing 20	C6orf69|dJ108K11.3|MGC14254	protein_coding	Q7Z5Y7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8405
6.0160775521984e-85	-0.27150921823222	0.118	0.307	1.09119614641775e-80	RP4-665J23.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8406
6.23464095900268e-85	-0.330764716146315	0.266	0.492	1.13083917714391e-80	HAGHL	Malignant cells	GSE139386	ENSG00000103253	84264	hydroxyacylglutathione hydrolase like	MGC2605	protein_coding	Q6PII5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8407
6.75170559522551e-85	-0.332524082938297	0.93	0.979	1.224624360862e-80	POLD2	Malignant cells	GSE139386	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8408
7.52494385830336e-85	0.445982569421828	0.799	0.665	1.36487431701906e-80	MYO10	Malignant cells	GSE139386	ENSG00000145555	4651	myosin X	KIAA0799|MyoX	protein_coding	Q9HD67	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8409
1.08212291159313e-84	-0.29388897623362	0.187	0.398	1.96275453704763e-80	PBX2	Malignant cells	GSE139386	ENSG00000236353	5089	PBX homeobox 2	G17|HOX12|PBX2MHC	protein_coding	P40425	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8410
1.24605312892624e-84	-0.346228591981455	0.305	0.533	2.26009116524641e-80	PPL	Malignant cells	GSE139386	ENSG00000118898	5493	periplakin	NA	protein_coding	O60437	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8411
2.61762461717197e-84	0.328699827939333	0.306	0.101	4.74784753062652e-80	ARHGAP18	Malignant cells	GSE139386	ENSG00000146376	93663	Rho GTPase activating protein 18	bA307O14.2|MacGAP	protein_coding	Q8N392	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8412
2.63512484631418e-84	-0.349241013354352	0.818	0.933	4.77958944624466e-80	AES	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8413
2.70840875820107e-84	0.379356482397853	0.944	0.913	4.9125118056251e-80	TMEM230	Malignant cells	GSE139386	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8414
3.28618629593336e-84	-0.363683040588139	0.56	0.747	5.96048470356393e-80	TRAPPC2L	Malignant cells	GSE139386	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8415
3.57357139682587e-84	-0.361041973392517	0.74	0.882	6.48174379956277e-80	SHARPIN	Malignant cells	GSE139386	ENSG00000179526	81858	SHANK associated RH domain interactor	DKFZP434N1923|SIPL1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8416
3.88119249307066e-84	-0.371239625160207	0.813	0.924	7.03970694393157e-80	MRPL40	Malignant cells	GSE139386	ENSG00000185608	64976	mitochondrial ribosomal protein L40	MRP-L22|NLVCF	protein_coding	Q9NQ50	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8417
3.90881093553331e-84	0.430549122085482	0.537	0.32	7.08980127487031e-80	GLUL	Malignant cells	GSE139386	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8418
4.43329710426431e-84	-0.454084065447069	0.857	0.94	8.04111428771461e-80	CLDN4	Malignant cells	GSE139386	ENSG00000189143	1364	claudin 4	CPE-R|CPETR|CPETR1|hCPE-R|WBSCR8	protein_coding	O14493	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8419
4.43666597998058e-84	0.417824241787648	0.494	0.267	8.04722475448877e-80	FHL1	Malignant cells	GSE139386	ENSG00000022267	2273	four and a half LIM domains 1	bA535K18.1|FHL1B|FLH1A|KYO-T|MGC111107|SLIM1|XMPMA	protein_coding	Q13642	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8420
4.47211088140385e-84	-0.374528483785932	0.502	0.708	8.11151471669031e-80	LDOC1	Malignant cells	GSE139386	ENSG00000182195	23641	LDOC1 regulator of NFKB signaling	BCUR1|Mar7|Mart7|RTL7|SIRH7	protein_coding	O95751	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8421
5.01395563718415e-84	-0.270364764802653	0.147	0.347	9.0943127347246e-80	FAM76B	Malignant cells	GSE139386	ENSG00000077458	143684	family with sequence similarity 76 member B	MGC33371	protein_coding	Q5HYJ3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8422
5.400120099307e-84	0.483037899582715	0.656	0.468	9.79473783612304e-80	PON2	Malignant cells	GSE139386	ENSG00000105854	5445	paraoxonase 2	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8423
5.94792469903912e-84	-0.275493893951212	0.127	0.316	1.07883458191171e-79	TAP2.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8424
5.99069709110726e-84	0.755625825059657	0.822	0.773	1.08659263838504e-79	UPP1	Malignant cells	GSE139386	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8425
6.34066591102164e-84	-0.377780054842648	0.758	0.891	1.1500699829411e-79	MED10	Malignant cells	GSE139386	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8426
7.15720209299027e-84	0.375595897346191	0.468	0.242	1.29817331562658e-79	ALKBH2	Malignant cells	GSE139386	ENSG00000189046	121642	alkB homolog 2, alpha-ketoglutarate dependent dioxygenase	ABH2|MGC90512	protein_coding	Q6NS38	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8427
7.27784122628626e-84	0.312017021020207	0.259	0.066	1.3200548416238e-79	ARSG	Malignant cells	GSE139386	ENSG00000141337	22901	arylsulfatase G	KIAA1001	protein_coding	Q96EG1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8428
7.42241900649664e-84	-0.3286463927036	0.269	0.489	1.34627835939836e-79	UBXN2A	Malignant cells	GSE139386	ENSG00000173960	165324	UBX domain protein 2A	UBXD4	protein_coding	P68543	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8429
1.14738082048874e-83	0.386869062737531	0.457	0.231	2.08111933220248e-79	R3HDM2	Malignant cells	GSE139386	ENSG00000179912	22864	R3H domain containing 2	KIAA1002	protein_coding	Q9Y2K5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8430
1.50860641480706e-83	-0.38808608372152	0.709	0.864	2.73631031517704e-79	RALA	Malignant cells	GSE139386	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8431
2.03523882730354e-83	-0.337745741227559	0.375	0.607	3.69151618496316e-79	REXO4	Malignant cells	GSE139386	ENSG00000280706	57109	REX4 homolog, 3'-5' exonuclease	hPMC2|XPMC2H	protein_coding	Q9GZR2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8432
2.25320958589787e-83	-0.299964455301787	0.224	0.443	4.08687154690156e-79	RCHY1	Malignant cells	GSE139386	ENSG00000163743	25898	ring finger and CHY zinc finger domain containing 1	ARNIP|CHIMP|DKFZp586C1620|PIRH2|PRO1996|RNF199|ZCHY|ZNF363	protein_coding	Q96PM5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8433
2.27240302467316e-83	-0.316459494253205	0.245	0.462	4.12168460615218e-79	ELP6	Malignant cells	GSE139386	ENSG00000163832	54859	elongator acetyltransferase complex subunit 6	C3orf75|FLJ20211|TMEM103	protein_coding	Q0PNE2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8434
3.2883933586017e-83	-0.372251001555834	0.541	0.738	5.96448787383176e-79	STIP1	Malignant cells	GSE139386	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8435
3.41484039759922e-83	-0.271082052554656	0.114	0.297	6.19383751316546e-79	TBC1D13	Malignant cells	GSE139386	ENSG00000107021	54662	TBC1 domain family member 13	FLJ10743	protein_coding	Q9NVG8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8436
3.43118456936216e-83	-0.290828771395083	0.146	0.341	6.22348257190909e-79	LINC01137	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8437
4.37004094385127e-83	-0.344868729541491	0.764	0.899	7.92638026395744e-79	SRP19	Malignant cells	GSE139386	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8438
4.69198232479157e-83	-0.379756808161766	0.679	0.852	8.51031754070696e-79	PAICS	Malignant cells	GSE139386	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8439
6.30516532557761e-83	-0.287817233318751	0.168	0.376	1.14363088675327e-78	BARD1	Malignant cells	GSE139386	ENSG00000138376	580	BRCA1 associated RING domain 1	NA	protein_coding	Q99728	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8440
9.0867775011507e-83	0.251116122829104	1	1	1.64815970315871e-78	MDK	Malignant cells	GSE139386	ENSG00000110492	4192	midkine	FLJ27379|MK|NEGF2	protein_coding	P21741	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8441
1.14034103220601e-82	-0.268275670565105	0.122	0.316	2.06835056421526e-78	ARHGAP11B	Malignant cells	GSE139386	ENSG00000274734	89839	Rho GTPase activating protein 11B	B'-T|FAM7B1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8442
1.6519960243506e-82	0.428174331118005	0.615	0.409	2.99639038896711e-78	NOB1	Malignant cells	GSE139386	ENSG00000141101	28987	NIN1 (RPN12) binding protein 1 homolog	ART-4|MST158|NOB1P|PSMD8BP1	protein_coding	Q9ULX3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8443
1.75592352725714e-82	0.321211270549294	0.344	0.128	3.184894093739e-78	ZNF32	Malignant cells	GSE139386	ENSG00000169740	7580	zinc finger protein 32	KOX30|Zfp637|ZNF637	protein_coding	P17041	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8444
1.75737295987614e-82	-0.321229233573833	0.977	0.992	3.18752307462334e-78	PPP1CA	Malignant cells	GSE139386	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8445
2.14307341595763e-82	-0.326206580703671	0.282	0.502	3.88710656186395e-78	EFTUD2	Malignant cells	GSE139386	ENSG00000108883	9343	elongation factor Tu GTP binding domain containing 2	SNRNP116|Snrp116|Snu114|U5-116KD	protein_coding	Q15029	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8446
2.23035875474071e-82	0.392641192353267	0.413	0.196	4.0454247093487e-78	PRKD1	Malignant cells	GSE139386	ENSG00000184304	5587	protein kinase D1	PKC-mu|PKCM|PKD|PRKCM	protein_coding	Q15139	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8447
2.24715950299009e-82	0.417433725393039	0.649	0.448	4.07589790652342e-78	TRAPPC6B	Malignant cells	GSE139386	ENSG00000182400	122553	trafficking protein particle complex subunit 6B	NA	protein_coding	Q86SZ2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8448
2.7864033088339e-82	-0.256742628512611	0.103	0.28	5.05397832156293e-78	NCS1	Malignant cells	GSE139386	ENSG00000107130	23413	neuronal calcium sensor 1	FREQ|NCS-1	protein_coding	P62166	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8449
3.69926903913044e-82	-0.343249210785278	0.188	0.393	6.70973418317479e-78	G2E3	Malignant cells	GSE139386	ENSG00000092140	55632	G2/M-phase specific E3 ubiquitin protein ligase	FLJ20333|KIAA1333|PHF7B	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8450
4.26109362566156e-82	-0.256256539183844	0.104	0.281	7.72877161822494e-78	HPS3	Malignant cells	GSE139386	ENSG00000163755	84343	HPS3 biogenesis of lysosomal organelles complex 2 subunit 1	BLOC2S1|SUTAL	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8451
5.35080041594185e-82	-0.296375629512148	0.169	0.371	9.70528179443534e-78	ZFHX4	Malignant cells	GSE139386	ENSG00000091656	79776	zinc finger homeobox 4	FLJ20980|ZFH4	protein_coding	Q86UP3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8452
5.86088563032577e-82	-0.334431491388415	0.294	0.513	1.06304743562849e-77	ANAPC10	Malignant cells	GSE139386	ENSG00000164162	10393	anaphase promoting complex subunit 10	APC10|DKFZP564L0562|DOC1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8453
6.35865591368409e-82	-0.33260046302726	0.33	0.553	1.15333300962402e-77	CYHR1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8454
8.98681242174813e-82	-0.275513582423661	0.14	0.332	1.63002803705668e-77	ZDHHC2	Malignant cells	GSE139386	ENSG00000104219	51201	zinc finger DHHC-type palmitoyltransferase 2	DHHC2|ZNF372	protein_coding	Q9UIJ5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8455
9.22370657326621e-82	-0.270745482939321	0.128	0.315	1.67299589825902e-77	ARHGAP27	Malignant cells	GSE139386	ENSG00000276836	201176	Rho GTPase activating protein 27	CAMGAP1|FLJ43547|SH3D20|SH3P20	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8456
9.29475841066482e-82	-0.284097082311938	0.185	0.393	1.68588328052638e-77	GCFC2	Malignant cells	GSE139386	ENSG00000005436	6936	GC-rich sequence DNA-binding factor 2	C2orf3|DNABF|GCF|TCF9	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8457
9.50230692952777e-82	0.290677200715562	0.251	0.064	1.72352843087775e-77	AMN	Malignant cells	GSE139386	ENSG00000166126	81693	amnion associated transmembrane protein	amnionless	protein_coding	Q9BXJ7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8458
9.58322403769515e-82	0.29229999276109	0.267	0.074	1.73820517595715e-77	ALDH6A1	Malignant cells	GSE139386	ENSG00000119711	4329	aldehyde dehydrogenase 6 family member A1	MMSDH	protein_coding	Q02252	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8459
1.14417276452605e-81	-0.258271308063785	0.107	0.285	2.07530056029735e-77	CPNE2	Malignant cells	GSE139386	ENSG00000140848	221184	copine 2	CPN2	protein_coding	Q96FN4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8460
1.15305422213862e-81	-0.264025910731683	0.125	0.312	2.09140974811503e-77	METTL2B	Malignant cells	GSE139386	ENSG00000165055	55798	methyltransferase 2B, methylcytidine	FLJ11350|METL|METTL2	protein_coding	Q6P1Q9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8461
1.36888333750971e-81	-0.429567205236426	0.824	0.915	2.4828805975751e-77	PSMA5	Malignant cells	GSE139386	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8462
1.38321003280029e-81	0.383039331647921	0.505	0.283	2.50886635749317e-77	WDR18	Malignant cells	GSE139386	ENSG00000065268	57418	WD repeat domain 18	Ipi3	protein_coding	Q9BV38	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8463
1.50194416777256e-81	0.366477312589801	0.413	0.194	2.72422633150588e-77	NRIP1	Malignant cells	GSE139386	ENSG00000180530	8204	nuclear receptor interacting protein 1	RIP140	protein_coding	P48552	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8464
1.71953144866479e-81	-0.255788864229518	0.118	0.302	3.1188861415882e-77	LAP3	Malignant cells	GSE139386	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8465
2.57350701731206e-81	0.432311254737919	0.658	0.467	4.66782702800062e-77	DCAF7	Malignant cells	GSE139386	ENSG00000136485	10238	DDB1 and CUL4 associated factor 7	HAN11|SWAN-1|WDR68	protein_coding	P61962	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8466
2.62055235445649e-81	-0.306749371309743	0.213	0.423	4.75315786051318e-77	TOR2A	Malignant cells	GSE139386	ENSG00000160404	27433	torsin family 2 member A	FLJ14771|TORP1	protein_coding	Q8N2E6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8467
3.0130028368798e-81	-0.350743037964338	0.245	0.457	5.46498454553258e-77	EFNA1	Malignant cells	GSE139386	ENSG00000169242	1942	ephrin A1	ECKLG|EPLG1|GMAN|LERK1|TNFAIP4	protein_coding	P20827	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8468
3.56866853187831e-81	-0.336822920670505	0.316	0.538	6.47285098312088e-77	UBE2D1	Malignant cells	GSE139386	ENSG00000072401	7321	ubiquitin conjugating enzyme E2 D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UbcH5A	protein_coding	P51668	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8469
3.72817627163584e-81	-0.334581159032096	0.42	0.638	6.76216612149308e-77	SAMD4B	Malignant cells	GSE139386	ENSG00000179134	55095	sterile alpha motif domain containing 4B	FLJ10211|hSmaug2|MGC99832|SMGB	protein_coding	Q5PRF9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8470
3.74136225571707e-81	-0.336190265230715	0.379	0.595	6.78608285941963e-77	FBXO9	Malignant cells	GSE139386	ENSG00000112146	26268	F-box protein 9	FBX9|NY-REN-57	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8471
3.94634558430112e-81	-0.341561854657358	0.327	0.542	7.15788162080537e-77	PRKRIP1	Malignant cells	GSE139386	ENSG00000128563	79706	PRKR interacting protein 1	C114|FLJ13902|KRBOX3	protein_coding	Q9H875	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8472
4.91207652908866e-81	0.39718614698133	0.601	0.393	8.909524408461e-77	NARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8473
5.23867640598242e-81	0.416829717386801	0.787	0.647	9.50191126517092e-77	RPN1	Malignant cells	GSE139386	ENSG00000163902	6184	ribophorin I	OST1	protein_coding	P04843	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8474
5.31475263313849e-81	0.326901069711535	0.34	0.131	9.63989832598659e-77	ARHGAP26	Malignant cells	GSE139386	ENSG00000145819	23092	Rho GTPase activating protein 26	GRAF|KIAA0621|OPHN1L|OPHN1L1	protein_coding	Q9UNA1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8475
5.67706031894103e-81	0.392485101838933	0.507	0.288	1.02970520064952e-76	APMAP	Malignant cells	GSE139386	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8476
8.04090085609325e-81	-0.346124999072277	0.763	0.893	1.45845859727819e-76	TPD52	Malignant cells	GSE139386	ENSG00000076554	7163	tumor protein D52	D52|hD52|N8L	protein_coding	P55327	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8477
8.08090465841823e-81	0.308656742814247	0.98	0.955	1.4657144869439e-76	PSMC5	Malignant cells	GSE139386	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8478
8.29082873915144e-81	-0.300546791533446	0.184	0.386	1.50379051670729e-76	ABL2	Malignant cells	GSE139386	ENSG00000143322	27	ABL proto-oncogene 2, non-receptor tyrosine kinase	ABLL|ARG	protein_coding	P42684	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8479
8.42065465364068e-81	-0.352118291233324	0.721	0.88	1.52733834107735e-76	TRAF7	Malignant cells	GSE139386	ENSG00000131653	84231	TNF receptor associated factor 7	DKFZp586I021|MGC7807|RFWD1|RNF119	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8480
1.04294705001852e-80	-0.360034493939389	0.5	0.701	1.89169735932359e-76	RNF10	Malignant cells	GSE139386	ENSG00000022840	9921	ring finger protein 10	KIAA0262|RIE2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8481
1.14454328109002e-80	0.392509056187707	0.779	0.606	2.07597260324108e-76	TXNL1	Malignant cells	GSE139386	ENSG00000091164	9352	thioredoxin like 1	TRP32|Txl|TXNL	protein_coding	O43396	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8482
1.17995538198873e-80	0.297428971173691	0.276	0.082	2.14020307185116e-76	CD40	Malignant cells	GSE139386	ENSG00000101017	958	CD40 molecule	Bp50|p50|TNFRSF5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8483
1.27459903564641e-80	-0.397147682353131	0.477	0.676	2.31186773085546e-76	YPEL3	Malignant cells	GSE139386	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8484
1.53410394409682e-80	-0.287628689044538	0.995	0.998	2.78255773380281e-76	TRMT112	Malignant cells	GSE139386	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8485
1.54689024138603e-80	0.360925421960151	0.432	0.214	2.80574951982598e-76	ARHGEF12	Malignant cells	GSE139386	ENSG00000196914	23365	Rho guanine nucleotide exchange factor 12	KIAA0382|LARG	protein_coding	Q9NZN5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8486
1.58544095033681e-80	-0.369945700839236	0.336	0.549	2.8756727957209e-76	GRPEL1	Malignant cells	GSE139386	ENSG00000109519	80273	GrpE like 1, mitochondrial	FLJ25609|GrpE|hMGE	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8487
2.26501747567066e-80	-0.353491880171863	0.38	0.595	4.10828869737144e-76	RP11-349A22.5	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8488
2.53933344045152e-80	-0.265563157661845	0.142	0.334	4.60584299429097e-76	FAM173B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8489
2.5782136695925e-80	-0.309129761331494	0.228	0.439	4.67636395390687e-76	SAP30L	Malignant cells	GSE139386	ENSG00000164576	79685	SAP30 like	FLJ11526|NS4ATP2	protein_coding	Q9HAJ7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8490
2.86464500654905e-80	0.371492969595377	0.876	0.789	5.19589311287866e-76	RPAIN	Malignant cells	GSE139386	ENSG00000129197	84268	RPA interacting protein	hRIP|MGC4189|RIP	protein_coding	Q86UA6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8491
4.00598309274837e-80	-0.30417743015776	0.225	0.435	7.26605213362699e-76	KIAA0100	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8492
4.56748506921991e-80	0.363817158333709	0.425	0.209	8.28450441855107e-76	DDX19B	Malignant cells	GSE139386	ENSG00000157349	11269	DEAD-box helicase 19B	DBP5|DDX19	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8493
4.75431336013321e-80	0.338615350082502	0.951	0.928	8.62337357260961e-76	C19orf70	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8494
4.78043140262094e-80	-0.28643205267178	0.144	0.335	8.67074647807386e-76	RP11-660L16.2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8495
5.13167429170118e-80	-0.367948995673199	0.559	0.755	9.30783083028759e-76	SREK1IP1	Malignant cells	GSE139386	ENSG00000153006	285672	SREK1 interacting protein 1	FLJ36754|P18SRP|SFRS12IP1	protein_coding	Q8N9Q2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8496
7.15927728360557e-80	-0.392814306342177	0.716	0.855	1.29854971370038e-75	PSMA2.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8497
8.67952078552913e-80	-0.403942934412661	0.664	0.819	1.57429148007927e-75	MCTS1	Malignant cells	GSE139386	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8498
9.46803227612136e-80	0.323984128129745	0.344	0.136	1.71731169424289e-75	TUBE1	Malignant cells	GSE139386	ENSG00000074935	51175	tubulin epsilon 1	dJ142L7.2|FLJ22589|TUBE	protein_coding	Q9UJT0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8499
1.18298236983391e-79	0.371286229957159	0.907	0.84	2.14569342240474e-75	PDCD2	Malignant cells	GSE139386	ENSG00000071994	5134	programmed cell death 2	RP8|ZMYND7	protein_coding	Q16342	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8500
1.24779872941729e-79	0.39824249920653	0.469	0.254	2.26325733541708e-75	NOA1	Malignant cells	GSE139386	ENSG00000084092	84273	nitric oxide associated 1	C4orf14|hAtNOS1|hNOA1|MGC3232|MTG3	protein_coding	Q8NC60	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8501
1.30340753223342e-79	-0.305040465480802	0.224	0.437	2.36412058196497e-75	SNX8	Malignant cells	GSE139386	ENSG00000106266	29886	sorting nexin 8	Mvp1	protein_coding	Q9Y5X2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8502
1.66714233127722e-79	-0.357443975987307	0.411	0.621	3.02386276047063e-75	PMF1	Malignant cells	GSE139386	ENSG00000160783	11243	polyamine modulated factor 1	NA	protein_coding	Q6P1K2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8503
2.57915408277541e-79	-0.314152061116557	0.936	0.986	4.67806967533804e-75	FAM96B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8504
2.76900083401059e-79	-0.314633507388389	0.205	0.409	5.02241371272841e-75	PPIL1	Malignant cells	GSE139386	ENSG00000137168	51645	peptidylprolyl isomerase like 1	CYPL1	protein_coding	Q9Y3C6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8505
2.93008892342603e-79	-0.34036722028001	0.326	0.538	5.31459528931013e-75	UBE2G1	Malignant cells	GSE139386	ENSG00000132388	7326	ubiquitin conjugating enzyme E2 G1	UBC7|UBE2G	protein_coding	P62253	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8506
2.97365636818706e-79	0.379499303823222	0.463	0.248	5.39361792061769e-75	TMC4	Malignant cells	GSE139386	ENSG00000274905	147798	transmembrane channel like 4	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8507
3.09549917883252e-79	-0.277515778511057	0.157	0.351	5.61461641056642e-75	SEPHS1	Malignant cells	GSE139386	ENSG00000086475	22929	selenophosphate synthetase 1	SPS|SPS1	protein_coding	P49903	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8508
3.25143670825075e-79	-0.266847506149006	0.13	0.314	5.89745590142522e-75	ABCD3	Malignant cells	GSE139386	ENSG00000117528	5825	ATP binding cassette subfamily D member 3	PMP70|PXMP1|ZWS2	protein_coding	P28288	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8509
3.59554541186922e-79	-0.378900745491656	0.827	0.923	6.5216002680484e-75	TJP1	Malignant cells	GSE139386	ENSG00000277401	7082	tight junction protein 1	DKFZp686M05161|MGC133289|ZO-1	protein_coding	Q07157	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8510
3.78515128852893e-79	0.299672256493423	0.29	0.094	6.86550740713377e-75	TMEM161A	Malignant cells	GSE139386	ENSG00000064545	54929	transmembrane protein 161A	FLJ20422|FLJ39645	protein_coding	Q9NX61	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8511
5.00830842720991e-79	0.386811283445845	0.567	0.349	9.08406982527334e-75	JMJD1C	Malignant cells	GSE139386	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8512
5.72746127648888e-79	-0.325602999403735	0.291	0.506	1.03884692632955e-74	R3HCC1L	Malignant cells	GSE139386	ENSG00000166024	27291	R3H domain and coiled-coil containing 1 like	C10orf28|GIDRP86|PSORT	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8513
7.08768742693823e-79	-0.363126150082101	0.314	0.522	1.28556474549806e-74	MED21	Malignant cells	GSE139386	ENSG00000152944	9412	mediator complex subunit 21	SRB7|SURB7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8514
7.1609549977934e-79	-0.318042252417757	0.255	0.469	1.29885401749977e-74	FAM217B	Malignant cells	GSE139386	ENSG00000196227	63939	family with sequence similarity 217 member B	C20orf177|dJ551D2.5	protein_coding	Q9NTX9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8515
8.79757836973392e-79	-0.258320856522244	0.14	0.334	1.59570476470234e-74	ECT2	Malignant cells	GSE139386	ENSG00000114346	1894	epithelial cell transforming 2	ARHGEF31	protein_coding	Q9H8V3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8516
1.22391541021165e-78	-0.314448590450236	0.284	0.499	2.2199377710419e-74	PSMD9	Malignant cells	GSE139386	ENSG00000110801	5715	proteasome 26S subunit, non-ATPase 9	p27|Rpn4	protein_coding	O00233	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8517
1.62700115060804e-78	-0.282386602429789	0.17	0.368	2.95105468697285e-74	DROSHA	Malignant cells	GSE139386	ENSG00000113360	29102	drosha ribonuclease III	Etohi2|HSA242976|RN3|RNASE3L|RNASEN	protein_coding	Q9NRR4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8518
2.00965817555366e-78	-0.309713873086531	0.233	0.442	3.64511799881923e-74	CDC73	Malignant cells	GSE139386	ENSG00000134371	79577	cell division cycle 73	C1orf28|FIHP|HRPT1|HRPT2|parafibromin	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8519
2.12908278149309e-78	-0.347209420115182	0.791	0.912	3.86173034907216e-74	MTCH2	Malignant cells	GSE139386	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8520
2.20076849476834e-78	-0.265237068453209	0.125	0.307	3.99175389581081e-74	BCAR3	Malignant cells	GSE139386	ENSG00000137936	8412	BCAR3 adaptor protein, NSP family member	AND-34|MIG7|NSP2|SH2D3B	protein_coding	O75815	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8521
2.50460823499896e-78	-0.260496268799778	0.123	0.304	4.54285841664112e-74	CIC	Malignant cells	GSE139386	ENSG00000079432	23152	capicua transcriptional repressor	KIAA0306	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8522
2.62097385070561e-78	-0.379352850974346	0.635	0.799	4.75392237040983e-74	HEBP1	Malignant cells	GSE139386	ENSG00000013583	50865	heme binding protein 1	HBP|HEBP	protein_coding	Q9NRV9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8523
2.76186013973676e-78	-0.272092076576472	0.176	0.376	5.00946192145453e-74	SFT2D2	Malignant cells	GSE139386	ENSG00000213064	375035	SFT2 domain containing 2	dJ747L4.C1.2|UNQ512	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8524
3.44493601086223e-78	-0.368032970710774	0.402	0.611	6.24842493650192e-74	BCCIP	Malignant cells	GSE139386	ENSG00000107949	56647	BRCA2 and CDKN1A interacting protein	BCCIPalpha|TOK-1	protein_coding	Q9P287	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8525
5.19274522565154e-78	-0.34804624998833	0.502	0.704	9.41860129028676e-74	MAP4	Malignant cells	GSE139386	ENSG00000047849	4134	microtubule associated protein 4	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8526
6.93670525013371e-78	0.37439111773649	0.453	0.236	1.25817959826925e-73	SNX9	Malignant cells	GSE139386	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8527
6.99964441877833e-78	-0.26705265297351	0.127	0.309	1.26959550467801e-73	ERAP2	Malignant cells	GSE139386	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8528
7.79706580941229e-78	-0.349490405042189	0.662	0.825	1.4142317965112e-73	HSF1	Malignant cells	GSE139386	ENSG00000284774	3297	heat shock transcription factor 1	HSTF1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8529
9.6008151622004e-78	-0.358258968532295	0.878	0.951	1.74139585411991e-73	STRAP	Malignant cells	GSE139386	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8530
1.2016827968741e-77	-0.270067808916649	0.143	0.331	2.17961225697024e-73	PRELID2	Malignant cells	GSE139386	ENSG00000186314	153768	PRELI domain containing 2	FLJ38376|MGC21644	protein_coding	Q8N945	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8531
1.2087737838903e-77	-0.318699513790285	0.322	0.537	2.19247388922023e-73	TIMM10B	Malignant cells	GSE139386	ENSG00000132286	26515	translocase of inner mitochondrial membrane 10B	FXC1|TIM10B|Tim9b	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8532
1.34535545618608e-77	-0.295873082671181	0.219	0.426	2.44020572643031e-73	GNPDA1	Malignant cells	GSE139386	ENSG00000113552	10007	glucosamine-6-phosphate deaminase 1	GNPDA|GNPI|GPI|HLN|KIAA0060	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8533
1.43622204907538e-77	0.399539271846952	0.879	0.74	2.60501955261293e-73	FHL2	Malignant cells	GSE139386	ENSG00000115641	2274	four and a half LIM domains 2	DRAL|SLIM3	protein_coding	Q14192	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8534
1.53589508074852e-77	-0.309112311662105	0.274	0.489	2.78580649746166e-73	BCAT2	Malignant cells	GSE139386	ENSG00000105552	587	branched chain amino acid transaminase 2	BCAM|BCATm|BCT2	protein_coding	O15382	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8535
2.18694812310284e-77	-0.261931787862146	0.152	0.343	3.96668650568393e-73	ATG10	Malignant cells	GSE139386	ENSG00000152348	83734	autophagy related 10	APG10L|DKFZP586I0418|FLJ13954	protein_coding	Q9H0Y0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8536
2.50678711512184e-77	-0.293584493640265	0.157	0.347	4.54681046940798e-73	MIR24-2	Malignant cells	GSE139386	ENSG00000288126	407013	microRNA 24-2	hsa-mir-24-2|MIRN24-2	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8537
2.84161115471123e-77	-0.40621167363076	0.982	0.982	5.15411431241522e-73	ARPC1B	Malignant cells	GSE139386	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8538
3.0588312586317e-77	0.427784380228659	0.618	0.432	5.54810813690618e-73	SLC7A1	Malignant cells	GSE139386	ENSG00000139514	6541	solute carrier family 7 member 1	ATRC1|CAT-1|ERR|HCAT1|REC1L	protein_coding	P30825	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8539
3.34842594828889e-77	-0.256165451660052	0.117	0.295	6.07337498500639e-73	E2F3	Malignant cells	GSE139386	ENSG00000112242	1871	E2F transcription factor 3	NA	protein_coding	O00716	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8540
3.59440724682222e-77	-0.291067699112093	0.187	0.387	6.51953586428614e-73	CDK5	Malignant cells	GSE139386	ENSG00000164885	1020	cyclin dependent kinase 5	PSSALRE	protein_coding	Q00535	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8541
3.80149105253245e-77	0.440064644467924	0.465	0.261	6.89514447108335e-73	FAM83A	Malignant cells	GSE139386	ENSG00000147689	84985	family with sequence similarity 83 member A	BJ-TSA-9|MGC14128	protein_coding	Q86UY5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8542
4.28314364741562e-77	-0.37822466924429	0.974	0.988	7.76876594768244e-73	C1QBP	Malignant cells	GSE139386	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8543
4.44556995468398e-77	-0.354765068946556	0.778	0.892	8.0633747838058e-73	MRPS5	Malignant cells	GSE139386	ENSG00000144029	64969	mitochondrial ribosomal protein S5	MRP-S5|S5mt	protein_coding	P82675	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8544
4.66308065296633e-77	0.43608057574488	0.718	0.57	8.45789568835033e-73	LRP5	Malignant cells	GSE139386	ENSG00000162337	4041	LDL receptor related protein 5	BMND1|EVR1|EVR4|HBM|LR3|LRP7|OPPG|OPS|OPTA1|VBCH2	protein_coding	O75197	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8545
5.13759932672919e-77	-0.297171841018385	0.207	0.41	9.31857765882141e-73	BOK	Malignant cells	GSE139386	ENSG00000176720	666	BCL2 family apoptosis regulator BOK	BCL2L9|BOKL|MGC4631	protein_coding	Q9UMX3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8546
5.30764934031472e-77	-0.296517569898672	0.199	0.402	9.62701437346285e-73	SMC1A	Malignant cells	GSE139386	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8547
6.17775421209453e-77	-0.442665587249648	0.725	0.874	1.12052105898971e-72	DNAJA1	Malignant cells	GSE139386	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8548
7.8917367026323e-77	-0.353543230372436	0.473	0.675	1.43140320312345e-72	RRAS2	Malignant cells	GSE139386	ENSG00000133818	22800	RAS related 2	TC21	protein_coding	P62070	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8549
8.13876385107092e-77	-0.282798196948536	0.191	0.393	1.47620898730724e-72	AGPAT5	Malignant cells	GSE139386	ENSG00000284980	55326	1-acylglycerol-3-phosphate O-acyltransferase 5	FLJ11210|LPAAT-e|LPAAT-epsilon|LPLAT5	protein_coding	Q9NUQ2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8550
8.4824999212308e-77	-0.306606696506471	0.182	0.376	1.53855583571284e-72	TRAPPC2P1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8551
8.51144736872381e-77	-0.293158188646916	0.166	0.358	1.54380632373912e-72	USP5	Malignant cells	GSE139386	ENSG00000111667	8078	ubiquitin specific peptidase 5	IsoT	protein_coding	P45974	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8552
1.06600074862424e-76	0.390881333636541	0.845	0.74	1.93351215785464e-72	TAX1BP1	Malignant cells	GSE139386	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8553
1.31123472876729e-76	-0.332101010366197	0.551	0.764	2.37831755103811e-72	ANP32E	Malignant cells	GSE139386	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8554
1.62659479706572e-76	0.34159578558545	0.392	0.182	2.9503176429178e-72	CALCOCO2	Malignant cells	GSE139386	ENSG00000136436	10241	calcium binding and coiled-coil domain 2	MGC17318|NDP52	protein_coding	Q13137	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8555
1.91297048490245e-76	-0.342250465099378	0.306	0.515	3.46974586551607e-72	UTP18	Malignant cells	GSE139386	ENSG00000011260	51096	UTP18 small subunit processome component	CGI-48|WDR50	protein_coding	Q9Y5J1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8556
2.86726701564558e-76	0.311959679501388	0.314	0.116	5.20064891297795e-72	BACH1	Malignant cells	GSE139386	ENSG00000156273	571	BTB domain and CNC homolog 1	BACH-1|BTBD24	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8557
3.30021312699127e-76	-0.266746774529619	0.147	0.334	5.98592656973677e-72	SLC25A13	Malignant cells	GSE139386	ENSG00000004864	10165	solute carrier family 25 member 13	ARALAR2|CITRIN|CTLN2	protein_coding	Q9UJS0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8558
3.50999065904241e-76	-0.290227381681882	0.205	0.408	6.36642105737112e-72	AP1B1	Malignant cells	GSE139386	ENSG00000100280	162	adaptor related protein complex 1 subunit beta 1	ADTB1|AP105A|BAM22|CLAPB2	protein_coding	Q10567	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8559
3.63996666926103e-76	-0.287448393003273	0.204	0.407	6.60217154470565e-72	AFG3L2	Malignant cells	GSE139386	ENSG00000141385	10939	AFG3 like matrix AAA peptidase subunit 2	SCA28|SPAX5	protein_coding	Q9Y4W6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8560
5.4566851740078e-76	-0.337557342186496	0.318	0.535	9.89733556861535e-72	ANKRD40	Malignant cells	GSE139386	ENSG00000154945	91369	ankyrin repeat domain 40	MGC15396	protein_coding	Q6AI12	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8561
6.01858503650574e-76	-0.283558692629447	0.188	0.387	1.09165095392141e-71	PDK2	Malignant cells	GSE139386	ENSG00000005882	5164	pyruvate dehydrogenase kinase 2	PDHK2	protein_coding	Q15119	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8562
7.06995705237467e-76	-0.355584875616521	0.237	0.442	1.28234881015972e-71	NUP37	Malignant cells	GSE139386	ENSG00000075188	79023	nucleoporin 37	FLJ22618|MGC5585	protein_coding	Q8NFH4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8563
8.55326684835919e-76	-0.303997346962511	0.289	0.504	1.55139154095539e-71	ZMIZ2	Malignant cells	GSE139386	ENSG00000122515	83637	zinc finger MIZ-type containing 2	DKFZp761I2123|hZIMP7|KIAA1886|NET27|ZIMP7	protein_coding	Q8NF64	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8564
8.64470833943287e-76	0.314370908465904	0.325	0.126	1.56797719860633e-71	NT5DC1	Malignant cells	GSE139386	ENSG00000178425	221294	5'-nucleotidase domain containing 1	dJ486I3.1|MGC24302|NT5C2L1	protein_coding	Q5TFE4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8565
1.15254976882187e-75	-0.25435656196581	0.133	0.314	2.09049477068911e-71	AEN	Malignant cells	GSE139386	ENSG00000181026	64782	apoptosis enhancing nuclease	FLJ12484|FLJ12562|ISG20L1	protein_coding	Q8WTP8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8566
1.16675507916458e-75	0.379761983350128	0.535	0.324	2.11626036258872e-71	NUDT4	Malignant cells	GSE139386	ENSG00000173598	11163	nudix hydrolase 4	DIPP2|DIPP2alpha|DIPP2beta|HDCMB47P|KIAA0487	protein_coding	Q9NZJ9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8567
1.24897983844315e-75	-0.295006298646079	0.185	0.382	2.26539963096818e-71	TAF13	Malignant cells	GSE139386	ENSG00000197780	6884	TATA-box binding protein associated factor 13	TAF2K|TAFII18	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8568
1.35815373445706e-75	-0.268745229697798	0.171	0.365	2.46341924355821e-71	MTRR	Malignant cells	GSE139386	ENSG00000124275	4552	5-methyltetrahydrofolate-homocysteine methyltransferase reductase	cblE	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8569
1.68015072448139e-75	-0.254100343422484	0.117	0.292	3.04745738406434e-71	KANSL1-AS1	Malignant cells	GSE139386	ENSG00000281569	644246	KANSL1 antisense RNA 1	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8570
1.68852543899054e-75	0.323688097290577	0.96	0.932	3.06264744124104e-71	FKBP8	Malignant cells	GSE139386	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8571
1.82136991442695e-75	0.398308008312273	0.774	0.64	3.3036007507876e-71	TRPT1	Malignant cells	GSE139386	ENSG00000149743	83707	tRNA phosphotransferase 1	MGC11134	protein_coding	Q86TN4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8572
1.84601255994096e-75	-0.314675713389176	0.276	0.484	3.34829758122091e-71	ZNF75A	Malignant cells	GSE139386	ENSG00000162086	7627	zinc finger protein 75a	FLJ31529	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8573
2.31803964557256e-75	-0.311947157369702	0.272	0.481	4.20446030913951e-71	ZNF639	Malignant cells	GSE139386	ENSG00000121864	51193	zinc finger protein 639	ANC-2H01|ZASC1	protein_coding	Q9UID6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8574
2.87825416513607e-75	-0.295710546723194	0.235	0.44	5.2205774047238e-71	INF2	Malignant cells	GSE139386	ENSG00000203485	64423	inverted formin 2	C14orf151|C14orf173|MGC13251	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8575
3.37337146905521e-75	0.484632514276127	0.53	0.323	6.11862117057233e-71	RP11-841O20.2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8576
3.86082445894112e-75	-0.330816000617345	0.355	0.563	7.0027634036274e-71	GGPS1	Malignant cells	GSE139386	ENSG00000152904	9453	geranylgeranyl diphosphate synthase 1	GGPPS1	protein_coding	O95749	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8577
3.99748713478466e-75	-0.296120398454881	0.184	0.377	7.25064216507242e-71	SRRT	Malignant cells	GSE139386	ENSG00000087087	51593	serrate, RNA effector molecule	ARS2|Asr2|serrate	protein_coding	Q9BXP5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8578
4.03027954372149e-75	0.380382309394713	0.608	0.403	7.31012103640204e-71	GMPS	Malignant cells	GSE139386	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8579
4.64934978354133e-75	-0.30859832634406	0.269	0.476	8.43299063738727e-71	ATP2C1	Malignant cells	GSE139386	ENSG00000017260	27032	ATPase secretory pathway Ca2+ transporting 1	ATP2C1A|BCPM|KIAA1347|PMR1|SPCA1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8580
4.65458808842933e-75	-0.322395693146708	0.806	0.925	8.44249187479311e-71	DCXR	Malignant cells	GSE139386	ENSG00000169738	51181	dicarbonyl and L-xylulose reductase	DCR|HCR2|KIDCR|P34H|SDR20C1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8581
5.05034849074268e-75	-0.35718545990886	0.616	0.777	9.16032209250907e-71	SLTM	Malignant cells	GSE139386	ENSG00000137776	79811	SAFB like transcription modulator	FLJ13213|Met	protein_coding	Q9NWH9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8582
7.68971416943381e-75	-0.306974573519274	0.256	0.463	1.3947603560519e-70	SPATA20	Malignant cells	GSE139386	ENSG00000006282	64847	spermatogenesis associated 20	FLJ21347|SSP411|Tisp78	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8583
8.1444182900302e-75	-0.338953514840588	0.51	0.705	1.47723458944568e-70	ENOPH1	Malignant cells	GSE139386	ENSG00000145293	58478	enolase-phosphatase 1	E1|MASA|mtnC	protein_coding	Q9UHY7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8584
1.04201583605712e-74	-0.309252099345612	0.273	0.481	1.89000832344041e-70	KEAP1	Malignant cells	GSE139386	ENSG00000079999	9817	kelch like ECH associated protein 1	INrf2|KIAA0132|KLHL19|MGC10630|MGC1114|MGC20887|MGC4407|MGC9454	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8585
1.09453520801464e-74	-0.364190306277614	0.641	0.81	1.98526796029695e-70	NCBP2-AS2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8586
1.12300008693419e-74	-0.336207983061481	0.597	0.775	2.03689755768123e-70	NTPCR	Malignant cells	GSE139386	ENSG00000135778	84284	nucleoside-triphosphatase, cancer-related	C1orf57|HCR-NTPase|MGC13186|THEP1	protein_coding	Q9BSD7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8587
1.34289099145368e-74	0.346672651386862	0.92	0.866	2.43573568029869e-70	CLNS1A	Malignant cells	GSE139386	ENSG00000074201	1207	chloride nucleotide-sensitive channel 1A	CLCI|ICln	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8588
1.38520523453347e-74	0.396178539896312	0.692	0.508	2.51248525439681e-70	ZFR	Malignant cells	GSE139386	ENSG00000056097	51663	zinc finger RNA binding protein	SPG71|ZFR1	protein_coding	Q96KR1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8589
1.93397825388735e-74	-0.295543494254329	0.209	0.405	3.50784975690087e-70	USP10	Malignant cells	GSE139386	ENSG00000103194	9100	ubiquitin specific peptidase 10	KIAA0190|UBPO	protein_coding	Q14694	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8590
2.56170026269565e-74	0.409429144350575	0.711	0.547	4.64641193647738e-70	ETHE1	Malignant cells	GSE139386	ENSG00000105755	23474	ETHE1 persulfide dioxygenase	HSCO|YF13H12	protein_coding	O95571	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8591
2.86458021431749e-74	-0.278279841496305	0.176	0.371	5.19577559272906e-70	RECQL	Malignant cells	GSE139386	ENSG00000004700	5965	RecQ like helicase	RecQ1|RecQL1	protein_coding	P46063	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8592
2.87277373614557e-74	-0.266714287159957	0.153	0.338	5.21063700262083e-70	DCK	Malignant cells	GSE139386	ENSG00000156136	1633	deoxycytidine kinase	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8593
3.02444383975398e-74	-0.267823972319708	0.149	0.332	5.48573623654577e-70	PCNXL3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8594
3.76098928107564e-74	-0.452648683886378	0.28	0.481	6.82168235801499e-70	SNAPC1	Malignant cells	GSE139386	ENSG00000023608	6617	small nuclear RNA activating complex polypeptide 1	PTFgamma|SNAP43	protein_coding	Q16533	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8595
4.30216275034932e-74	-0.345185256353242	0.443	0.642	7.80326279658359e-70	RAB30-AS1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8596
4.82459986531293e-74	-0.254460778157828	0.113	0.283	8.75085923570459e-70	MEPCE	Malignant cells	GSE139386	ENSG00000146834	56257	methylphosphate capping enzyme	BCDIN3|FLJ20257	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8597
5.60814569630244e-74	0.32514025154141	0.378	0.171	1.01720546639534e-69	XPNPEP1	Malignant cells	GSE139386	ENSG00000108039	7511	X-prolyl aminopeptidase 1	XPNPEP|XPNPEPL|XPNPEPL1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8598
5.8824579040231e-74	-0.266070418356475	0.984	0.998	1.06696021463171e-69	BRK1	Malignant cells	GSE139386	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8599
6.30839499081617e-74	-0.275429508084135	0.177	0.37	1.14421668343424e-69	INO80C	Malignant cells	GSE139386	ENSG00000153391	125476	INO80 complex subunit C	C18orf37|FLJ38183|hIes6|IES6	protein_coding	Q6PI98	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8600
7.77622333185719e-74	-0.293526754011985	0.261	0.472	1.41045138793226e-69	ZNF444	Malignant cells	GSE139386	ENSG00000167685	55311	zinc finger protein 444	EZF2|FLJ11137|ZSCAN17	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8601
8.70313919602522e-74	-0.298803071388038	0.181	0.374	1.57857538737505e-69	LINC00958	Malignant cells	GSE139386	ENSG00000251381	100506305	long intergenic non-protein coding RNA 958	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8602
9.00848737930308e-74	-0.29847402839701	0.222	0.423	1.63395944085799e-69	C15orf39	Malignant cells	GSE139386	ENSG00000167173	56905	chromosome 15 open reading frame 39	DKFZP434H132|FLJ46337	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8603
1.0057523648953e-73	-0.255892743073607	0.15	0.335	1.82423363944709e-69	PPP1R37	Malignant cells	GSE139386	ENSG00000104866	284352	protein phosphatase 1 regulatory subunit 37	LRRC68	protein_coding	O75864	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8604
1.01931950086859e-73	0.329754531981483	0.367	0.164	1.84884171067545e-69	DNASE2	Malignant cells	GSE139386	ENSG00000105612	1777	deoxyribonuclease 2, lysosomal	DNL|DNL2	protein_coding	O00115	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8605
1.14719380318084e-73	0.369194476291951	0.481	0.276	2.08078012020941e-69	PIGH	Malignant cells	GSE139386	ENSG00000100564	5283	phosphatidylinositol glycan anchor biosynthesis class H	GPI-H	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8606
1.1659374895802e-73	0.391015166114669	0.479	0.273	2.11477741860057e-69	EPHA2	Malignant cells	GSE139386	ENSG00000142627	1969	EPH receptor A2	ECK	protein_coding	P29317	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8607
1.23707926472846e-73	-0.256413193204231	0.11	0.278	2.24381437036447e-69	C1orf116	Malignant cells	GSE139386	ENSG00000182795	79098	chromosome 1 open reading frame 116	FLJ36507|MGC2742|MGC4309|SARG	protein_coding	Q9BW04	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8608
1.25473293611391e-73	0.312130830281172	0.331	0.134	2.27583459952341e-69	TFB1M	Malignant cells	GSE139386	ENSG00000029639	51106	transcription factor B1, mitochondrial	CGI-75|mtTFB	protein_coding	Q8WVM0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8609
1.54885609958628e-73	-0.369125814888361	0.353	0.562	2.80931519342959e-69	SDHA	Malignant cells	GSE139386	ENSG00000073578	6389	succinate dehydrogenase complex flavoprotein subunit A	FP|SDH2|SDHF	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8610
1.95087340464858e-73	-0.254137058107135	0.133	0.311	3.5384941813516e-69	SLC25A17	Malignant cells	GSE139386	ENSG00000100372	10478	solute carrier family 25 member 17	PMP34	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8611
2.08704605714222e-73	-0.333258550926148	0.468	0.664	3.78548413844456e-69	SNRNP27	Malignant cells	GSE139386	ENSG00000124380	11017	small nuclear ribonucleoprotein U4/U6.U5 subunit 27	RY1|U4/U6.U5-27K	protein_coding	Q8WVK2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8612
2.2285236998985e-73	-0.322354442140033	0.336	0.544	4.04209628687591e-69	SREK1	Malignant cells	GSE139386	ENSG00000153914	140890	splicing regulatory glutamic acid and lysine rich protein 1	DKFZp564B176|SFRS12|SRrp508|SRrp86	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8613
2.37064718097873e-73	-0.376859223709971	0.427	0.627	4.29987985685923e-69	MLF1	Malignant cells	GSE139386	ENSG00000178053	4291	myeloid leukemia factor 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8614
2.72949776951788e-73	-0.325597636314861	0.417	0.624	4.95076305435152e-69	ARIH2	Malignant cells	GSE139386	ENSG00000177479	10425	ariadne RBR E3 ubiquitin protein ligase 2	TRIAD1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8615
3.57063498353369e-73	-0.317953851479021	0.339	0.549	6.47641773313341e-69	ESF1	Malignant cells	GSE139386	ENSG00000089048	51575	ESF1 nucleolar pre-rRNA processing protein homolog	bA526K24.1|C20orf6	protein_coding	Q9H501	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8616
4.08658026477823e-73	-0.337870410404664	0.521	0.712	7.41223928425475e-69	MED28	Malignant cells	GSE139386	ENSG00000118579	80306	mediator complex subunit 28	DKFZP434N185|EG1|magicin	protein_coding	Q9H204	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8617
4.31545694398169e-73	0.259029332857031	0.998	0.994	7.827375804994e-69	PCBP2	Malignant cells	GSE139386	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8618
4.59844262393618e-73	-0.307131276260383	0.254	0.455	8.34065523129545e-69	OPA1	Malignant cells	GSE139386	ENSG00000198836	4976	OPA1 mitochondrial dynamin like GTPase	FLJ12460|KIAA0567|MGM1|NPG|NTG	protein_coding	O60313	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8619
5.06083606983453e-73	-0.327039894043887	0.394	0.599	9.17934446346587e-69	PKP3	Malignant cells	GSE139386	ENSG00000184363	11187	plakophilin 3	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8620
9.01540184273265e-73	-0.347569709771672	0.35	0.555	1.63521358623485e-68	CDC123	Malignant cells	GSE139386	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8621
1.13680784230963e-72	-0.306224658309261	0.281	0.487	2.0619420643812e-68	ERBB2IP	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8622
1.27246075469918e-72	-0.281902710344706	0.225	0.425	2.30798931687338e-68	TRMT61A	Malignant cells	GSE139386	ENSG00000166166	115708	tRNA methyltransferase 61A	C14orf172|FLJ40452|GCD14|Gcd14p|hTRM61	protein_coding	Q96FX7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8623
1.32243692649065e-72	-0.260223115837754	0.146	0.327	2.39863609726875e-68	RNF2	Malignant cells	GSE139386	ENSG00000121481	6045	ring finger protein 2	BAP-1|BAP1|DING|HIPI3|RING1B|RING2	protein_coding	Q99496	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8624
1.37726601812487e-72	0.384017068499096	0.547	0.349	2.49808510367489e-68	GINM1	Malignant cells	GSE139386	ENSG00000055211	116254	glycosylated integral membrane protein 1	C6orf72|dJ12G14.2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8625
1.61413472488701e-72	-0.294998840536596	0.237	0.438	2.92771756400005e-68	AGBL5	Malignant cells	GSE139386	ENSG00000084693	60509	AGBL carboxypeptidase 5	CCP5|FLJ21839	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8626
2.15479441247828e-72	-0.254046813970059	0.153	0.338	3.9083661053531e-68	SNHG10	Malignant cells	GSE139386	ENSG00000247092	283596	small nucleolar RNA host gene 10	C14orf62|FLJ40557|LINC00063|NCRNA00063|TP53LC16	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8627
2.42952653036069e-72	0.330138056901031	0.4	0.194	4.40667522076822e-68	ARFGAP3	Malignant cells	GSE139386	ENSG00000242247	26286	ADP ribosylation factor GTPase activating protein 3	ARFGAP1	protein_coding	Q9NP61	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8628
3.04482662554759e-72	0.342766424962095	0.899	0.843	5.52270653341822e-68	AUP1	Malignant cells	GSE139386	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8629
3.67141845993435e-72	0.403519495006734	0.615	0.423	6.65921880262892e-68	AIMP2	Malignant cells	GSE139386	ENSG00000106305	7965	aminoacyl tRNA synthetase complex interacting multifunctional protein 2	JTV-1|JTV1|p38|PRO0992	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8630
3.79529200141751e-72	-0.257746575030747	0.147	0.329	6.88390063217108e-68	HIAT1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8631
6.44600054385064e-72	0.271110091339273	0.264	0.083	1.16917557864363e-67	RHPN1	Malignant cells	GSE139386	ENSG00000158106	114822	rhophilin Rho GTPase binding protein 1	KIAA1929|ODF5|RHPN	protein_coding	Q8TCX5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8632
7.86881667334987e-72	-0.268650731746494	0.17	0.357	1.4272459682122e-67	DPP9	Malignant cells	GSE139386	ENSG00000142002	91039	dipeptidyl peptidase 9	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8633
7.99379162507094e-72	0.397969716785451	0.775	0.644	1.44991392495537e-67	PNISR	Malignant cells	GSE139386	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8634
8.35282203133624e-72	0.373137214214653	0.543	0.342	1.51503486004377e-67	ELL2	Malignant cells	GSE139386	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8635
8.71004870234087e-72	-0.359750322339431	0.318	0.523	1.57982863363059e-67	ACAT2	Malignant cells	GSE139386	ENSG00000120437	39	acetyl-CoA acetyltransferase 2	NA	protein_coding	Q9BWD1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8636
9.16094177941551e-72	-0.261325922003991	0.158	0.342	1.66161161995039e-67	SCO1	Malignant cells	GSE139386	ENSG00000133028	6341	synthesis of cytochrome C oxidase 1	SCOD1	protein_coding	O75880	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8637
1.37438956645104e-71	0.292092559698767	0.313	0.121	2.49286779562889e-67	TPCN2	Malignant cells	GSE139386	ENSG00000162341	219931	two pore segment channel 2	TPC2	protein_coding	Q8NHX9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8638
1.39508483288244e-71	0.444888024527821	0.6	0.418	2.53040486988216e-67	CHP1	Malignant cells	GSE139386	ENSG00000187446	11261	calcineurin like EF-hand protein 1	CHP|p22|p24|Sid470p|SLC9A1BP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8639
1.50918664230412e-71	-0.311994849140971	0.343	0.55	2.73736273181121e-67	TSPAN6	Malignant cells	GSE139386	ENSG00000000003	7105	tetraspanin 6	T245|TM4SF6|TSPAN-6	protein_coding	O43657	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8640
1.61357307231903e-71	-0.25371252358016	0.125	0.296	2.92669883857226e-67	NOM1	Malignant cells	GSE139386	ENSG00000146909	64434	nucleolar protein with MIF4G domain 1	C7orf3|PPP1R113|SGD1	protein_coding	Q5C9Z4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8641
2.06656824240761e-71	-0.268850217720084	0.186	0.377	3.74834147807892e-67	GPR137	Malignant cells	GSE139386	ENSG00000173264	56834	G protein-coupled receptor 137	C11orf4|GPR137A|TM7SF1L1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8642
2.19511264064215e-71	-0.255744227003799	0.126	0.297	3.98149530759673e-67	ZNHIT6	Malignant cells	GSE139386	ENSG00000117174	54680	zinc finger HIT-type containing 6	BCD1|C1orf181|FLJ20729|NY-BR-75	protein_coding	Q9NWK9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8643
2.87510558932575e-71	0.367776526709783	0.559	0.358	5.21486651791904e-67	PMPCB	Malignant cells	GSE139386	ENSG00000105819	9512	peptidase, mitochondrial processing subunit beta	beta-MPP|MAS1|MPPB|MPPP52	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8644
2.98396622565981e-71	0.432543688145789	0.682	0.508	5.41231794010177e-67	DNAJB1	Malignant cells	GSE139386	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8645
3.00772094537463e-71	-0.298860950133177	0.244	0.442	5.45540425072051e-67	RALB	Malignant cells	GSE139386	ENSG00000144118	5899	RAS like proto-oncogene B	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8646
3.0310175058851e-71	0.334988236925267	0.437	0.229	5.49765955217439e-67	C10orf118	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8647
4.85281378130366e-71	-0.268341237127198	0.153	0.335	8.80203363652859e-67	RN7SL1	Malignant cells	GSE139386	ENSG00000276168	6029	RNA component of signal recognition particle 7SL1	7L1a|7SL|RN7SL|RNSRP1	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8648
5.531577607936e-71	0.362964190270492	0.771	0.619	1.00331754652743e-66	IGBP1	Malignant cells	GSE139386	ENSG00000089289	3476	immunoglobulin binding protein 1	alpha4|IBP1	protein_coding	P78318	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8649
6.49027259460744e-71	-0.287136578836436	0.225	0.423	1.1772056432099e-66	NUP54	Malignant cells	GSE139386	ENSG00000138750	53371	nucleoporin 54	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8650
7.1229296928694e-71	-0.251138288902327	0.135	0.311	1.29195698769265e-66	TMEM109	Malignant cells	GSE139386	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8651
1.14170032167091e-70	-0.305533987619499	0.298	0.504	2.07081604344669e-66	CDYL	Malignant cells	GSE139386	ENSG00000153046	9425	chromodomain Y like	CDYL1|DKFZP586C1622	protein_coding	Q9Y232	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8652
1.36715171262932e-70	-0.320080559238402	0.404	0.605	2.47973977636705e-66	SUPT5H	Malignant cells	GSE139386	ENSG00000196235	6829	SPT5 homolog, DSIF elongation factor subunit	FLJ34157|SPT5|SPT5H	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8653
1.42236722962347e-70	-0.284375680150951	0.247	0.448	2.57988968109105e-66	C16orf72	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8654
1.65364361734482e-70	0.387339799017849	0.558	0.359	2.99937879314004e-66	COPS2	Malignant cells	GSE139386	ENSG00000166200	9318	COP9 signalosome subunit 2	ALIEN|CSN2|TRIP15	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8655
2.20459949984451e-70	-0.263263336814641	0.142	0.318	3.99870257281798e-66	NREP	Malignant cells	GSE139386	ENSG00000134986	9315	neuronal regeneration related protein	C5orf13|D4S114|P311|PRO1873|PTZ17|SEZ17	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8656
2.26932909292757e-70	-0.345433346116997	0.642	0.803	4.11610910875203e-66	BCL2L1	Malignant cells	GSE139386	ENSG00000171552	598	BCL2 like 1	Bcl-X|bcl-xL|bcl-xS|BCL2L|BCLX|PPP1R52	protein_coding	Q07817	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8657
2.83506442703294e-70	0.33321969210009	0.363	0.166	5.14223985775234e-66	NKD2	Malignant cells	GSE139386	ENSG00000276920	85409	NKD inhibitor of WNT signaling pathway 2	Naked2	protein_coding	Q969F2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8658
2.84974336134651e-70	-0.284818683152519	0.217	0.412	5.16886450881029e-66	CCDC127	Malignant cells	GSE139386	ENSG00000164366	133957	coiled-coil domain containing 127	FLJ25701	protein_coding	Q96BQ5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8659
3.9176902166075e-70	0.3019404919698	0.284	0.102	7.10590651488268e-66	TBC1D16	Malignant cells	GSE139386	ENSG00000167291	125058	TBC1 domain family member 16	FLJ20748|MGC25062	protein_coding	Q8TBP0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8660
4.12974153740512e-70	0.346540583369957	0.461	0.257	7.49052520054541e-66	TOM1L1	Malignant cells	GSE139386	ENSG00000141198	10040	target of myb1 like 1 membrane trafficking protein	SRCASM	protein_coding	O75674	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8661
4.19140313849503e-70	-0.273204734862852	0.217	0.418	7.60236701260228e-66	FBXO2	Malignant cells	GSE139386	ENSG00000116661	26232	F-box protein 2	Fbg1|Fbs1|FBX2|Nfb42|OCP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8662
4.47532177706119e-70	-0.328464324078742	0.819	0.926	8.11733863923359e-66	TMEM134	Malignant cells	GSE139386	ENSG00000172663	80194	transmembrane protein 134	FLJ21749	protein_coding	Q9H6X4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8663
4.59477082438038e-70	-0.346826629576769	0.549	0.739	8.33399532126114e-66	SUPT16H	Malignant cells	GSE139386	ENSG00000092201	11198	SPT16 homolog, facilitates chromatin remodeling subunit	CDC68|FACT|FACTP140|FLJ10857|FLJ14010|SPT16/CDC68	protein_coding	Q9Y5B9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8664
5.47573543925131e-70	-0.311465803122842	0.394	0.618	9.93188893971403e-66	RNASEH2A	Malignant cells	GSE139386	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8665
6.40550870763872e-70	-0.294475210228616	0.293	0.498	1.16183116939151e-65	ARMCX6	Malignant cells	GSE139386	ENSG00000198960	54470	armadillo repeat containing X-linked 6	FLJ20811|GASP10	protein_coding	Q7L4S7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8666
1.06938182658196e-69	-0.328385916458139	0.359	0.558	1.93964475705436e-65	PGRMC2	Malignant cells	GSE139386	ENSG00000164040	10424	progesterone receptor membrane component 2	DG6|PMBP	protein_coding	O15173	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8667
1.09741965213119e-69	-0.308175406549252	0.34	0.544	1.99049976503556e-65	TRIOBP	Malignant cells	GSE139386	ENSG00000100106	11078	TRIO and F-actin binding protein	DFNB28|HRIHFB2122|KIAA1662|TAP68|Tara	protein_coding	Q9H2D6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8668
1.81808979183596e-69	-0.2953954510157	0.297	0.503	3.29765126443206e-65	SMIM11	Malignant cells	GSE139386	ENSG00000205670	54065	small integral membrane protein 11	C21orf51|FAM165B|SMIM11A	protein_coding	P58511	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8669
2.60673753260544e-69	0.402674932325575	0.754	0.615	4.72810053663975e-65	SNHG15	Malignant cells	GSE139386	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8670
3.13272180188317e-69	0.406057091507649	0.57	0.374	5.68213080425569e-65	RAB31	Malignant cells	GSE139386	ENSG00000168461	11031	RAB31, member RAS oncogene family	Rab22B	protein_coding	Q13636	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8671
3.40130325101428e-69	-0.28451520152651	0.254	0.453	6.1692838366897e-65	RBM4	Malignant cells	GSE139386	ENSG00000173933	5936	RNA binding motif protein 4	LARK|RBM4A|ZCCHC21|ZCRB3A	protein_coding	Q9BWF3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8672
3.62186216666979e-69	0.390020158013733	0.672	0.502	6.56933359790567e-65	SAT2	Malignant cells	GSE139386	ENSG00000141504	112483	spermidine/spermine N1-acetyltransferase family member 2	SSAT2	protein_coding	Q96F10	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8673
4.39586897165119e-69	-0.330513498621009	0.621	0.791	7.97322714078092e-65	OXLD1	Malignant cells	GSE139386	ENSG00000204237	339229	oxidoreductase like domain containing 1	C17orf90|MGC104712	protein_coding	Q5BKU9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8674
4.40221643685856e-69	-0.30604227797601	0.208	0.396	7.98474017317405e-65	CMTM7	Malignant cells	GSE139386	ENSG00000153551	112616	CKLF like MARVEL transmembrane domain containing 7	CKLFSF7|FLJ30992	protein_coding	Q96FZ5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8675
4.41641999846354e-69	0.346758847303621	0.441	0.241	8.01050259321317e-65	SERINC1	Malignant cells	GSE139386	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8676
4.67443309970246e-69	0.379177522159379	0.879	0.81	8.47848675624033e-65	IER2	Malignant cells	GSE139386	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8677
5.05174071772657e-69	-0.326600363437002	0.368	0.564	9.16284731381245e-65	NAPA	Malignant cells	GSE139386	ENSG00000105402	8775	NSF attachment protein alpha	NA	protein_coding	P54920	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8678
5.71028179572983e-69	0.258992810760892	1	1	1.03573091210948e-64	B2M	Malignant cells	GSE139386	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8679
6.02489941660979e-69	-0.277383666995937	0.21	0.402	1.09279625618468e-64	TMTC3	Malignant cells	GSE139386	ENSG00000139324	160418	transmembrane O-mannosyltransferase targeting cadherins 3	FLJ90492|SMILE	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8680
6.25197357572577e-69	-0.327586460052568	0.368	0.56	1.13398296716514e-64	TSN	Malignant cells	GSE139386	ENSG00000211460	7247	translin	BCLF-1|REHF-1|TRSLN	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8681
6.59476822792588e-69	-0.300194649504496	0.309	0.513	1.1961590611812e-64	GNG12	Malignant cells	GSE139386	ENSG00000172380	55970	G protein subunit gamma 12	NA	protein_coding	Q9UBI6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8682
7.06096441252208e-69	-0.280307487490185	0.232	0.429	1.28071772514325e-64	PIGC	Malignant cells	GSE139386	ENSG00000135845	5279	phosphatidylinositol glycan anchor biosynthesis class C	NA	protein_coding	Q92535	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8683
7.47392456804114e-69	-0.303008316761986	0.286	0.485	1.3556204381513e-64	DPH7	Malignant cells	GSE139386	ENSG00000148399	92715	diphthamide biosynthesis 7	C9orf112|FLJ90634|RRT2|WDR85	protein_coding	Q9BTV6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8684
7.69615994812697e-69	0.284384045924263	0.28	0.1	1.39592949139127e-64	RP11-403I13.8	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8685
9.28780055318492e-69	-0.258125846972456	0.15	0.328	1.68462126433668e-64	HHLA3	Malignant cells	GSE139386	ENSG00000197568	11147	HERV-H LTR-associating 3	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8686
9.88792513217041e-69	0.293565293845495	0.318	0.129	1.79347186047307e-64	KDM6B	Malignant cells	GSE139386	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8687
1.00219445670514e-68	-0.389075362290574	0.648	0.8	1.81778030557178e-64	GSTO1	Malignant cells	GSE139386	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8688
1.85196967952219e-68	-0.330900090161037	0.32	0.513	3.35910260471734e-64	OXCT1	Malignant cells	GSE139386	ENSG00000083720	5019	3-oxoacid CoA-transferase 1	OXCT|SCOT	protein_coding	P55809	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8689
1.97563102451929e-68	-0.258794805801534	0.17	0.352	3.58339955227309e-64	KLHL42	Malignant cells	GSE139386	ENSG00000087448	57542	kelch like family member 42	Ctb9|KIAA1340|KLHDC5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8690
2.17901632627458e-68	-0.260300125816537	0.188	0.376	3.95229981259683e-64	GTPBP6	Malignant cells	GSE139386	ENSG00000178605	8225	GTP binding protein 6 (putative)	FLJ20977|PGPL	protein_coding	O43824	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8691
2.66745038189091e-68	0.337116500945116	0.932	0.89	4.83822150267373e-64	GHITM	Malignant cells	GSE139386	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8692
3.05580231180974e-68	-0.322995420247923	0.591	0.769	5.54261423316051e-64	ANAPC5	Malignant cells	GSE139386	ENSG00000089053	51433	anaphase promoting complex subunit 5	APC5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8693
3.11986695107295e-68	-0.365982604601402	0.963	0.981	5.65881467585612e-64	IER3	Malignant cells	GSE139386	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8694
3.2419802058726e-68	-0.328887771832383	0.902	0.971	5.88030369741172e-64	H2AFY	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8695
3.30878228099492e-68	0.384657372704712	0.763	0.637	6.00146930126858e-64	ORMDL1	Malignant cells	GSE139386	ENSG00000128699	94101	ORMDL sphingolipid biosynthesis regulator 1	NA	protein_coding	Q9P0S3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8696
3.37961582517828e-68	-0.269553684401706	0.197	0.386	6.12994718370836e-64	TRMT61B	Malignant cells	GSE139386	ENSG00000171103	55006	tRNA methyltransferase 61B	FLJ20628	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8697
3.57320896009969e-68	-0.315966657204071	0.399	0.598	6.48108641182882e-64	MAPK1	Malignant cells	GSE139386	ENSG00000100030	5594	mitogen-activated protein kinase 1	ERK|ERK2|MAPK2|p41mapk|PRKM1|PRKM2	protein_coding	P28482	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8698
3.67651474912539e-68	-0.518547234323414	0.276	0.453	6.66846245196362e-64	SOX2	Malignant cells	GSE139386	ENSG00000181449	6657	SRY-box transcription factor 2	NA	protein_coding	P48431	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8699
4.22635094150965e-68	0.334320886217668	0.389	0.195	7.66575533771021e-64	IBTK	Malignant cells	GSE139386	ENSG00000283068	25998	inhibitor of Bruton tyrosine kinase	BTBD26|BTKI|DKFZP564B116	protein_coding	Q9P2D0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8700
4.49114536007422e-68	0.355407378208081	0.839	0.751	8.14603945410262e-64	CLPP	Malignant cells	GSE139386	ENSG00000125656	8192	caseinolytic mitochondrial matrix peptidase proteolytic subunit	NA	protein_coding	Q16740	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8701
5.07264976355794e-68	0.320821060959701	0.399	0.198	9.20077214114139e-64	TNFAIP8	Malignant cells	GSE139386	ENSG00000145779	25816	TNF alpha induced protein 8	GG2-1|MDC-3.13|SCC-S2	protein_coding	O95379	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8702
6.45663299553211e-68	-0.310206216093434	0.4	0.602	1.17110409272961e-63	MBD4	Malignant cells	GSE139386	ENSG00000129071	8930	methyl-CpG binding domain 4, DNA glycosylase	MED1	protein_coding	O95243	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8703
6.53047969526876e-68	-0.260829093739116	0.191	0.379	1.18449840712785e-63	ARMC8	Malignant cells	GSE139386	ENSG00000114098	25852	armadillo repeat containing 8	DKFZP434A043|GID5|HSPC056|VID28	protein_coding	Q8IUR7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8704
6.64390100805939e-68	0.288372279821891	0.305	0.121	1.20507076484181e-63	HSPA13	Malignant cells	GSE139386	ENSG00000155304	6782	heat shock protein family A (Hsp70) member 13	STCH	protein_coding	P48723	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8705
6.89299158152998e-68	-0.303333406896747	0.277	0.474	1.25025081305791e-63	TTLL12	Malignant cells	GSE139386	ENSG00000100304	23170	tubulin tyrosine ligase like 12	KIAA0153	protein_coding	Q14166	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8706
1.21292610213236e-67	-0.349238600870446	0.485	0.667	2.20000536404767e-63	GPATCH4	Malignant cells	GSE139386	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8707
1.3088714842642e-67	0.335093133028514	0.349	0.159	2.37403109815841e-63	IER5L	Malignant cells	GSE139386	ENSG00000188483	389792	immediate early response 5 like	bA247A12.2	protein_coding	Q5T953	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8708
1.31593744126821e-67	-0.283447784809112	0.226	0.418	2.38684733097228e-63	CTPS1	Malignant cells	GSE139386	ENSG00000171793	1503	CTP synthase 1	CTPS|GATD5A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8709
1.36033041212101e-67	-0.298931033208777	0.382	0.584	2.46736730150508e-63	PRPF38A	Malignant cells	GSE139386	ENSG00000134748	84950	pre-mRNA processing factor 38A	FLJ14936|Prp38	protein_coding	Q8NAV1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8710
1.43524667094796e-67	-0.272262665928073	0.204	0.392	2.60325041176542e-63	DDX23	Malignant cells	GSE139386	ENSG00000174243	9416	DEAD-box helicase 23	prp28|PRPF28|SNRNP100|U5-100KD	protein_coding	Q9BUQ8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8711
1.78443229371103e-67	-0.288375485036607	0.273	0.474	3.23660329433307e-63	NUMA1	Malignant cells	GSE139386	ENSG00000137497	4926	nuclear mitotic apparatus protein 1	NUMA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8712
1.99442619504825e-67	-0.286632320440241	0.305	0.508	3.61749023257851e-63	C17orf62	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8713
2.41507411718661e-67	0.385566876231655	0.51	0.314	4.38046143375307e-63	SKAP2	Malignant cells	GSE139386	ENSG00000005020	8935	src kinase associated phosphoprotein 2	RA70|SAPS|SCAP2|SKAP-HOM|SKAP55R	protein_coding	O75563	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8714
2.88186706957588e-67	-0.28599774988813	0.255	0.452	5.22713049079672e-63	SPIN1	Malignant cells	GSE139386	ENSG00000106723	10927	spindlin 1	SPIN|TDRD24	protein_coding	Q9Y657	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8715
5.81943007929587e-67	-0.299944122257701	0.289	0.484	1.05552822778269e-62	AIDA	Malignant cells	GSE139386	ENSG00000186063	64853	axin interactor, dorsalization associated	C1orf80|FLJ12806	protein_coding	Q96BJ3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8716
6.73868274101242e-67	0.31678672587126	0.38	0.186	1.22226227556483e-62	TBC1D20	Malignant cells	GSE139386	ENSG00000125875	128637	TBC1 domain family member 20	C20orf140|dJ852M4.2	protein_coding	Q96BZ9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8717
8.83545752148935e-67	-0.28000169526448	0.25	0.448	1.60257528524774e-62	FBRSL1	Malignant cells	GSE139386	ENSG00000112787	57666	fibrosin like 1	KIAA1545	protein_coding	Q9HCM7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8718
1.01415265438229e-66	-0.287573313463763	0.25	0.443	1.83947008451861e-62	CNOT4	Malignant cells	GSE139386	ENSG00000080802	4850	CCR4-NOT transcription complex subunit 4	CLONE243|NOT4|NOT4H	protein_coding	O95628	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8719
1.14561121078688e-66	0.516986114776074	0.814	0.712	2.07790961412524e-62	HES4	Malignant cells	GSE139386	ENSG00000188290	57801	hes family bHLH transcription factor 4	bHLHb42	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8720
1.17860943452392e-66	-0.294355168942268	0.978	0.988	2.13776179233949e-62	SPCS1	Malignant cells	GSE139386	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8721
1.20526005902975e-66	-0.315239653941485	0.394	0.589	2.18610069506816e-62	C8orf82	Malignant cells	GSE139386	ENSG00000213563	414919	chromosome 8 open reading frame 82	MGC70857	protein_coding	Q6P1X6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8722
1.22214184319193e-66	-0.304495186214587	0.383	0.583	2.21672087518153e-62	CSNK1G2	Malignant cells	GSE139386	ENSG00000133275	1455	casein kinase 1 gamma 2	CK1g2	protein_coding	P78368	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8723
1.56211779964488e-66	-0.34719631303234	0.804	0.908	2.83336926499588e-62	NDUFB6	Malignant cells	GSE139386	ENSG00000165264	4712	NADH:ubiquinone oxidoreductase subunit B6	B17|CI	protein_coding	O95139	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8724
1.58501582349781e-66	-0.330624817147656	0.536	0.71	2.87490170066032e-62	BRD9	Malignant cells	GSE139386	ENSG00000028310	65980	bromodomain containing 9	FLJ13441|SMARCI2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8725
1.61164981499483e-66	-0.288516508293907	0.285	0.481	2.92321043443762e-62	SENP2	Malignant cells	GSE139386	ENSG00000163904	59343	SUMO specific peptidase 2	AXAM2|DKFZp762A2316|KIAA1331|SMT3IP2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8726
2.0706925442192e-66	-0.294515038936505	0.339	0.541	3.75582213670478e-62	COX11	Malignant cells	GSE139386	ENSG00000166260	1353	cytochrome c oxidase copper chaperone COX11	COX11P	protein_coding	Q9Y6N1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8727
2.07290558297016e-66	-0.335983406471648	0.33	0.52	3.75983614639128e-62	UBL3	Malignant cells	GSE139386	ENSG00000122042	5412	ubiquitin like 3	DKFZP434K151|FLJ32018|HCG-1|PNSC1	protein_coding	O95164	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8728
2.31322136232035e-66	0.296352403532942	0.977	0.959	4.19572090697664e-62	CHMP2A	Malignant cells	GSE139386	ENSG00000130724	27243	charged multivesicular body protein 2A	BC-2|CHMP2|VPS2|VPS2A	protein_coding	O43633	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8729
2.36506647505785e-66	-0.391329536830152	0.965	0.979	4.28975757245992e-62	PSMB6	Malignant cells	GSE139386	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8730
2.53537340603369e-66	0.393667781898461	0.638	0.467	4.59866028386391e-62	DFFA	Malignant cells	GSE139386	ENSG00000160049	1676	DNA fragmentation factor subunit alpha	DFF-45|DFF1|DFF45|ICAD	protein_coding	O00273	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8731
5.31606097867138e-66	0.308134440505091	0.963	0.944	9.64227140311414e-62	HNRNPDL	Malignant cells	GSE139386	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8732
5.38822114432779e-66	-0.319724453443967	0.846	0.926	9.77315551158175e-62	FAM162A	Malignant cells	GSE139386	ENSG00000114023	26355	family with sequence similarity 162 member A	C3orf28|E2IG5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8733
5.66066091350465e-66	-0.298035780154424	0.279	0.476	1.02673067649147e-61	JARID2	Malignant cells	GSE139386	ENSG00000008083	3720	jumonji and AT-rich interaction domain containing 2	JMJ	protein_coding	Q92833	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8734
5.77106063650348e-66	-0.307051125427776	0.283	0.475	1.046754978249e-61	SLC27A5	Malignant cells	GSE139386	ENSG00000083807	10998	solute carrier family 27 member 5	ACSB|ACSVL6|FACVL3|FATP5|FLJ22987|VLACSR|VLCS-H2|VLCSH2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8735
6.44087851823897e-66	-0.276135957159023	0.198	0.381	1.16824654563818e-61	ABCF2	Malignant cells	GSE139386	ENSG00000033050	10061	ATP binding cassette subfamily F member 2	ABC28|EST133090|HUSSY-18|M-ABC1	protein_coding	Q9UG63	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8736
6.83547094154972e-66	0.372344971206853	0.523	0.324	1.23981771937829e-61	LGMN	Malignant cells	GSE139386	ENSG00000100600	5641	legumain	LGMN1|PRSC1	protein_coding	Q99538	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8737
7.61991029719839e-66	-0.311361217254608	0.462	0.665	1.38209932970584e-61	C6orf1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8738
8.09447321236306e-66	-0.336305316636838	0.731	0.86	1.46817555125841e-61	PSENEN	Malignant cells	GSE139386	ENSG00000205155	55851	presenilin enhancer, gamma-secretase subunit	PEN2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8739
8.18490908369637e-66	0.351053791091935	0.471	0.269	1.48457880960085e-61	JUND	Malignant cells	GSE139386	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8740
8.3937420960025e-66	-0.303366023210423	0.924	0.975	1.52245694137293e-61	STARD10	Malignant cells	GSE139386	ENSG00000214530	10809	StAR related lipid transfer domain containing 10	CGI-52|NY-CO-28|PCTP2|SDCCAG28	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8741
8.83211648501082e-66	-0.274333296935364	0.246	0.442	1.60196928805126e-61	PKP4	Malignant cells	GSE139386	ENSG00000144283	8502	plakophilin 4	p0071	protein_coding	Q99569	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8742
8.92082335055785e-66	-0.295325930945097	0.298	0.492	1.61805893932418e-61	EIF1AD	Malignant cells	GSE139386	ENSG00000175376	84285	eukaryotic translation initiation factor 1A domain containing	haponin|MGC11102	protein_coding	Q8N9N8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8743
9.02104873830065e-66	-0.308566243023821	0.417	0.609	1.63623782015297e-61	KIAA1191	Malignant cells	GSE139386	ENSG00000122203	57179	KIAA1191	FLJ21022|p33MONOX|p60MONOX	protein_coding	Q96A73	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8744
9.41492375872095e-66	-0.279087116350985	0.27	0.466	1.70767887135681e-61	TMBIM1	Malignant cells	GSE139386	ENSG00000135926	64114	transmembrane BAX inhibitor motif containing 1	LFG3|PP1201|RECS1	protein_coding	Q969X1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8745
1.31856682232268e-65	0.387511594789453	0.745	0.61	2.39161650232887e-61	LSR	Malignant cells	GSE139386	ENSG00000105699	51599	lipolysis stimulated lipoprotein receptor	ILDR3|LISCH7	protein_coding	Q86X29	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8746
1.36712044370254e-65	-0.315268664562014	0.683	0.838	2.47968306078766e-61	SNAP29	Malignant cells	GSE139386	ENSG00000099940	9342	synaptosome associated protein 29	CEDNIK|SNAP-29	protein_coding	O95721	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8747
1.54675370445931e-65	-0.288086302523345	0.271	0.468	2.80550186914829e-61	TTF1	Malignant cells	GSE139386	ENSG00000125482	7270	transcription termination factor 1	NA	protein_coding	Q15361	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8748
2.01857016286629e-65	-0.269938748864959	0.207	0.392	3.66128256140687e-61	PDDC1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8749
2.17136995928219e-65	-0.290776255267943	0.237	0.425	3.93843083214604e-61	SMYD3	Malignant cells	GSE139386	ENSG00000185420	64754	SET and MYND domain containing 3	KMT3E|ZMYND1|ZNFN3A1	protein_coding	Q9H7B4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8750
2.36290537177871e-65	-0.255754211087072	0.203	0.39	4.28583776333223e-61	ZZZ3	Malignant cells	GSE139386	ENSG00000036549	26009	zinc finger ZZ-type containing 3	ATAC1|DKFZP564I052	protein_coding	Q8IYH5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8751
2.5484007245299e-65	-0.331401419166388	0.808	0.917	4.62228923415233e-61	BCAP31	Malignant cells	GSE139386	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8752
2.64367843773529e-65	-0.299626152882235	0.325	0.517	4.79510395036426e-61	SFXN4	Malignant cells	GSE139386	ENSG00000183605	119559	sideroflexin 4	SLC56A4	protein_coding	Q6P4A7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8753
2.65618194844616e-65	0.37154201802103	0.599	0.413	4.81778281809164e-61	PPIC	Malignant cells	GSE139386	ENSG00000168938	5480	peptidylprolyl isomerase C	CYPC	protein_coding	P45877	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8754
3.32106634507277e-65	-0.325630000548322	0.477	0.662	6.02375013669299e-61	DHX29	Malignant cells	GSE139386	ENSG00000067248	54505	DExH-box helicase 29	DDX29	protein_coding	Q7Z478	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8755
4.2363332339565e-65	-0.316509191423229	0.548	0.722	7.6838612197503e-61	COMMD5	Malignant cells	GSE139386	ENSG00000170619	28991	COMM domain containing 5	FLJ13008|HCaRG|HT002	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8756
4.31487153706523e-65	0.322036205165336	0.375	0.181	7.82631399392891e-61	CLDN1	Malignant cells	GSE139386	ENSG00000163347	9076	claudin 1	ILVASC|SEMP1	protein_coding	O95832	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8757
4.41248357089585e-65	0.368002808722899	0.617	0.443	8.00336270089089e-61	ZNF259	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8758
4.78600366196981e-65	0.37374252613827	0.809	0.691	8.68085344208085e-61	DNAJC10	Malignant cells	GSE139386	ENSG00000077232	54431	DnaJ heat shock protein family (Hsp40) member C10	ERdj5|PDIA19	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8759
5.22880888206437e-65	0.366540116946717	0.584	0.404	9.48401355028835e-61	ZKSCAN1	Malignant cells	GSE139386	ENSG00000106261	7586	zinc finger with KRAB and SCAN domains 1	KOX18|PHZ-37|ZNF139|ZNF36|ZSCAN33	protein_coding	P17029	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8760
5.33889442199781e-65	0.308303353410788	0.378	0.185	9.68368670261963e-61	MTMR4	Malignant cells	GSE139386	ENSG00000108389	9110	myotubularin related protein 4	KIAA0647|ZFYVE11	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8761
6.17296288200047e-65	-0.296823779713946	0.402	0.602	1.11965200753724e-60	KHSRP	Malignant cells	GSE139386	ENSG00000088247	8570	KH-type splicing regulatory protein	FBP2|FUBP2|KSRP	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8762
6.72946780032699e-65	-0.291472954442345	0.326	0.522	1.22059086962331e-60	PDCD7	Malignant cells	GSE139386	ENSG00000090470	10081	programmed cell death 7	59K|ES18|HES18	protein_coding	Q8N8D1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8763
7.36384171130692e-65	-0.309778585759966	0.532	0.707	1.33565360959685e-60	MTA1	Malignant cells	GSE139386	ENSG00000182979	9112	metastasis associated 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8764
8.6402540114967e-65	0.315440860273824	0.387	0.195	1.56716927260527e-60	ATXN1	Malignant cells	GSE139386	ENSG00000124788	6310	ataxin 1	ATX1|D6S504E|SCA1	protein_coding	P54253	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8765
8.88288877255104e-65	-0.31376898271836	0.353	0.544	1.61117836556531e-60	EIF2B1	Malignant cells	GSE139386	ENSG00000111361	1967	eukaryotic translation initiation factor 2B subunit alpha	EIF-2B|EIF-2Balpha|EIF2B|EIF2BA|EIF2Balpha	protein_coding	Q14232	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8766
1.02832171674523e-64	-0.253495475297671	0.156	0.328	1.8651699298325e-60	CETN3	Malignant cells	GSE139386	ENSG00000153140	1070	centrin 3	CEN3	protein_coding	O15182	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8767
1.03969931949629e-64	0.271547023003862	0.257	0.088	1.88580662570237e-60	IQCD	Malignant cells	GSE139386	ENSG00000166578	115811	IQ motif containing D	CFAP84|DRC10	protein_coding	Q96DY2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8768
1.14049047177228e-64	-0.334945315423818	0.467	0.654	2.06862161770056e-60	PSMB8	Malignant cells	GSE139386	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8769
1.34477251681024e-64	-0.258018197053105	0.203	0.389	2.43914839099041e-60	JMJD4	Malignant cells	GSE139386	ENSG00000081692	65094	jumonji domain containing 4	FLJ12517	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8770
1.47732289803012e-64	-0.304459691837858	0.484	0.672	2.67956827244704e-60	PTEN	Malignant cells	GSE139386	ENSG00000284792	5728	phosphatase and tensin homolog	BZS|MHAM|MMAC1|PTEN1|TEP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8771
1.66079161284748e-64	-0.266688750160853	0.202	0.385	3.01234382738276e-60	NUPL2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8772
1.78321057710598e-64	-0.291807518633835	0.304	0.501	3.23438734475483e-60	KDM2A	Malignant cells	GSE139386	ENSG00000173120	22992	lysine demethylase 2A	CXXC8|DKFZP434M1735|FBL11|FBL7|FBXL11|FLJ00115|JHDM1A|KIAA1004|LILINA	protein_coding	Q9Y2K7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8773
2.1577635765335e-64	-0.263883266271403	0.159	0.331	3.91375157511647e-60	BAG3	Malignant cells	GSE139386	ENSG00000151929	9531	BAG cochaperone 3	NA	protein_coding	O95817	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8774
2.47688872240242e-64	-0.255910458893329	0.17	0.345	4.49258076469351e-60	STAU2	Malignant cells	GSE139386	ENSG00000040341	27067	staufen double-stranded RNA binding protein 2	39K2	protein_coding	Q9NUL3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8775
2.72735238733854e-64	-0.289290048919825	0.861	0.951	4.94687176015465e-60	C1orf122	Malignant cells	GSE139386	ENSG00000197982	127687	chromosome 1 open reading frame 122	FLJ45459	protein_coding	Q6ZSJ8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8776
2.83813162954291e-64	0.399175930587987	0.576	0.402	5.14780314966493e-60	MBP	Malignant cells	GSE139386	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8777
2.93366973528851e-64	0.383927698803914	0.76	0.651	5.3210901658663e-60	TCEA2	Malignant cells	GSE139386	ENSG00000171703	6919	transcription elongation factor A2	TFIIS	protein_coding	Q15560	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8778
3.03877420433412e-64	0.251353062185242	0.259	0.089	5.51172865182122e-60	BTBD3	Malignant cells	GSE139386	ENSG00000132640	22903	BTB domain containing 3	dJ742J24.1|KIAA0952	protein_coding	Q9Y2F9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8779
3.9613462916704e-64	0.422457676149549	0.664	0.508	7.18508990383178e-60	RAC2	Malignant cells	GSE139386	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8780
4.25049011067197e-64	-0.271230441749828	0.245	0.436	7.70953896273683e-60	FAM92A1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8781
4.50111076152157e-64	-0.362259100514837	0.62	0.756	8.16411469924783e-60	SMIM19	Malignant cells	GSE139386	ENSG00000176209	114926	small integral membrane protein 19	C8orf40	protein_coding	Q96E16	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8782
4.67235592322909e-64	-0.285576742114113	0.3	0.493	8.47471917355292e-60	ZCCHC10	Malignant cells	GSE139386	ENSG00000155329	54819	zinc finger CCHC-type containing 10	FLJ20094	protein_coding	Q8TBK6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8783
5.21333339781123e-64	-0.250141593744144	0.184	0.368	9.45594411695001e-60	RFC3	Malignant cells	GSE139386	ENSG00000133119	5983	replication factor C subunit 3	MGC5276|RFC38	protein_coding	P40938	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8784
6.77885020977574e-64	-0.292636538764905	0.396	0.596	1.22954785104912e-59	TARDBP	Malignant cells	GSE139386	ENSG00000120948	23435	TAR DNA binding protein	ALS10|TDP-43	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8785
7.53886908859303e-64	-0.282199768509314	0.218	0.4	1.367400075289e-59	DHCR7	Malignant cells	GSE139386	ENSG00000172893	1717	7-dehydrocholesterol reductase	SLOS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8786
1.13631521187724e-63	-0.298260458780468	0.405	0.596	2.06104853130294e-59	LYRM7	Malignant cells	GSE139386	ENSG00000186687	90624	LYR motif containing 7	C5orf31|FLJ20796|MZM1L	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8787
1.18322767972849e-63	-0.284607510553961	0.354	0.552	2.14613836549154e-59	FAF2	Malignant cells	GSE139386	ENSG00000113194	23197	Fas associated factor family member 2	ETEA|KIAA0887|UBXD8|UBXN3B	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8788
1.50805865346722e-63	-0.260454989754141	0.218	0.407	2.73531678565885e-59	ASNSD1	Malignant cells	GSE139386	ENSG00000138381	54529	asparagine synthetase domain containing 1	FLJ20752|NBLA00058|NS3TP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8789
1.74171505100318e-63	-0.268522761574517	0.205	0.387	3.15912275950957e-59	FAM189B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8790
1.78907391765621e-63	-0.306963167327629	0.434	0.624	3.24502227184484e-59	GSTK1	Malignant cells	GSE139386	ENSG00000197448	373156	glutathione S-transferase kappa 1	GST13	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8791
1.810738953512e-63	0.369117553164013	0.571	0.387	3.28431831388006e-59	FARP1	Malignant cells	GSE139386	ENSG00000152767	10160	FERM, ARH/RhoGEF and pleckstrin domain protein 1	CDEP|GLCC1|MGC87400|PLEKHC2|PPP1R75	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8792
1.96689897847609e-63	-0.273390352015778	0.21	0.392	3.56756136715993e-59	RELB	Malignant cells	GSE139386	ENSG00000104856	5971	RELB proto-oncogene, NF-kB subunit	REL-B	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8793
2.03707933136458e-63	-0.293972737572913	0.468	0.662	3.69485449122907e-59	KATNBL1	Malignant cells	GSE139386	ENSG00000134152	79768	katanin regulatory subunit B1 like 1	C15orf29|FLJ22557	protein_coding	Q9H079	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8794
2.55457086960176e-63	-0.253903759978228	0.177	0.354	4.63348064328368e-59	IL17RC	Malignant cells	GSE139386	ENSG00000163702	84818	interleukin 17 receptor C	IL17-RL	protein_coding	Q8NAC3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8795
3.27839784391561e-63	-0.277136195483958	0.217	0.399	5.94635800929414e-59	ACAA2	Malignant cells	GSE139386	ENSG00000167315	10449	acetyl-CoA acyltransferase 2	DSAEC	protein_coding	P42765	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8796
3.84530241931233e-63	-0.27005779684104	0.254	0.444	6.9746095281487e-59	TEX261	Malignant cells	GSE139386	ENSG00000144043	113419	testis expressed 261	MGC32043|TEG-261	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8797
5.04092325201288e-63	-0.319538894637826	0.625	0.782	9.14322659450097e-59	KNOP1	Malignant cells	GSE139386	ENSG00000103550	400506	lysine rich nucleolar protein 1	101F10.1|C16orf88|FAM191A|TSG118	protein_coding	Q1ED39	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8798
5.36382043974629e-63	-0.286842880747879	0.437	0.634	9.72889751361183e-59	B4GALT7	Malignant cells	GSE139386	ENSG00000027847	11285	beta-1,4-galactosyltransferase 7	beta4Gal-T7|XGALT-1	protein_coding	Q9UBV7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8799
6.72793687458389e-63	0.476777256048793	0.53	0.36	1.22031319031203e-58	ARHGDIB	Malignant cells	GSE139386	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8800
8.71564362764644e-63	-0.29527879337394	0.386	0.581	1.58084344118251e-58	SFXN1	Malignant cells	GSE139386	ENSG00000164466	94081	sideroflexin 1	FLJ12876|SLC56A1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8801
8.97383878242159e-63	-0.291699156303286	0.372	0.568	1.62767487835563e-58	CEBPZ-AS1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8802
9.51335943563439e-63	-0.262315122693167	0.192	0.37	1.72553313443536e-58	RNF40	Malignant cells	GSE139386	ENSG00000103549	9810	ring finger protein 40	BRE1B|KIAA0661|RBP95|STARING	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8803
1.43105657252741e-62	-0.307942527246366	0.353	0.548	2.59565041125022e-58	ADH5	Malignant cells	GSE139386	ENSG00000197894	128	alcohol dehydrogenase 5 (class III), chi polypeptide	ADH-3|ADHX|FDH|GSNOR	protein_coding	P11766	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8804
1.53873245216234e-62	0.281684682830192	0.954	0.922	2.79095292173206e-58	PHB2	Malignant cells	GSE139386	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8805
1.54089569926095e-62	-0.277442839349561	0.26	0.451	2.79487661931951e-58	RAB18	Malignant cells	GSE139386	ENSG00000099246	22931	RAB18, member RAS oncogene family	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8806
1.61426109244402e-62	-0.301958854245501	0.914	0.964	2.92794676947496e-58	NDUFA6	Malignant cells	GSE139386	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8807
2.00255331692283e-62	-0.251483196496827	0.136	0.299	3.63223120623463e-58	RP1-313I6.12	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8808
2.20997500132071e-62	-0.263723456478558	0.207	0.387	4.00845265739551e-58	C6orf47	Malignant cells	GSE139386	ENSG00000228177	57827	chromosome 6 open reading frame 47	D6S53E|G4	protein_coding	O95873	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8809
2.33637950780305e-62	-0.314537765541581	0.613	0.78	4.23772515125317e-58	GAMT	Malignant cells	GSE139386	ENSG00000130005	2593	guanidinoacetate N-methyltransferase	PIG2|TP53I2	protein_coding	Q14353	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8810
2.79194099553203e-62	0.317019698933236	0.427	0.235	5.06402257769599e-58	ETV5	Malignant cells	GSE139386	ENSG00000244405	2119	ETS variant transcription factor 5	ERM	protein_coding	P41161	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8811
3.24641427565949e-62	0.266088843862875	0.272	0.102	5.88834621319119e-58	SYVN1	Malignant cells	GSE139386	ENSG00000162298	84447	synoviolin 1	DER3|HRD1	protein_coding	Q86TM6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8812
3.34757410431942e-62	0.366202744868096	0.626	0.46	6.07182991041457e-58	RHBDD2	Malignant cells	GSE139386	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8813
3.7793337418324e-62	0.289959674175367	0.356	0.17	6.85495554093561e-58	TMEM39A	Malignant cells	GSE139386	ENSG00000176142	55254	transmembrane protein 39A	FLJ10902|SUSR2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8814
5.22670534605322e-62	-0.336688687542888	0.47	0.648	9.48019815667132e-58	RBM47	Malignant cells	GSE139386	ENSG00000163694	54502	RNA binding motif protein 47	FLJ20273|NET18	protein_coding	A0AV96	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8815
5.63262656403705e-62	0.377609880760443	0.549	0.371	1.02164580618504e-57	NBL1	Malignant cells	GSE139386	ENSG00000158747	4681	NBL1, DAN family BMP antagonist	D1S1733E|DAN|DAND1|NB|NO3	protein_coding	P41271	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8816
5.91087898469935e-62	0.350596815605004	0.559	0.373	1.07211523024477e-57	TANC2	Malignant cells	GSE139386	ENSG00000170921	26115	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2	DKFZP564D166|FLJ10215|FLJ11824|KIAA1148|KIAA1636|rols|ROLSA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8817
6.17003409436419e-62	-0.295038158857727	0.558	0.736	1.11912078403578e-57	HMG20B	Malignant cells	GSE139386	ENSG00000064961	10362	high mobility group 20B	BRAF25|BRAF35|HMGX2|HMGXB2|SMARCE1r|SOXL	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8818
7.32379005260978e-62	-0.256419467992856	0.187	0.363	1.32838903974236e-57	NIP7	Malignant cells	GSE139386	ENSG00000132603	51388	nucleolar pre-rRNA processing protein NIP7	CGI-37|FLJ10296|HSPC031|KD93	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8819
7.75149553184886e-62	-0.264738255774432	0.198	0.374	1.40596625956675e-57	NELFA	Malignant cells	GSE139386	ENSG00000185049	7469	negative elongation factor complex member A	NELF-A|WHSC2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8820
8.42432483992913e-62	-0.3457596603797	0.728	0.848	1.52800403946635e-57	SBDS	Malignant cells	GSE139386	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8821
8.62380319650573e-62	0.639336879996086	0.437	0.269	1.56418542378221e-57	AKAP12	Malignant cells	GSE139386	ENSG00000131016	9590	A-kinase anchoring protein 12	AKAP250|SSeCKS	protein_coding	Q02952	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8822
1.08964922068969e-61	-0.325143062921665	0.302	0.489	1.97640575648696e-57	TSFM	Malignant cells	GSE139386	ENSG00000123297	10102	Ts translation elongation factor, mitochondrial	EF-TS|EF-Tsmt	protein_coding	P43897	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8823
1.11865430474799e-61	-0.281415708609335	0.3	0.49	2.02901517795191e-57	IVNS1ABP	Malignant cells	GSE139386	ENSG00000116679	10625	influenza virus NS1A binding protein	ARA3|HSPC068|KIAA0850|KLHL39|ND1|NS-1|NS1-BP	protein_coding	Q9Y6Y0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8824
1.11972325755225e-61	-0.314642484562349	0.372	0.555	2.03095404454827e-57	SNRNP40	Malignant cells	GSE139386	ENSG00000060688	9410	small nuclear ribonucleoprotein U5 subunit 40	HPRP8BP|PRP8BP|PRPF8BP|SPF38|WDR57	protein_coding	Q96DI7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8825
1.2284690208536e-61	-0.298858873225631	0.819	0.919	2.22819711002426e-57	GFER	Malignant cells	GSE139386	ENSG00000127554	2671	growth factor, augmenter of liver regeneration	ALR|ERV1|HERV1|HPO1|HPO2|HSS	protein_coding	P55789	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8826
1.2561453544364e-61	0.349979493227401	0.527	0.343	2.27839644387674e-57	CPSF3L	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8827
1.33968710387846e-61	0.339263161584216	0.523	0.335	2.42992446901475e-57	MRPL45	Malignant cells	GSE139386	ENSG00000277936	84311	mitochondrial ribosomal protein L45	Mba1|MGC11321	protein_coding	Q9BRJ2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8828
1.43517008572316e-61	-0.276234592615168	0.255	0.441	2.60311150148467e-57	SEC22C	Malignant cells	GSE139386	ENSG00000093183	9117	SEC22 homolog C, vesicle trafficking protein	MGC13261|MGC5373|SEC22L3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8829
1.47452793449828e-61	-0.31673215742656	0.741	0.864	2.67449876759298e-57	NINJ1	Malignant cells	GSE139386	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8830
1.49161538064434e-61	-0.271393396480611	0.256	0.444	2.70549197741271e-57	PEF1	Malignant cells	GSE139386	ENSG00000162517	553115	penta-EF-hand domain containing 1	PEF1A	protein_coding	Q9UBV8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8831
1.73128059646331e-61	-0.278488912584402	0.32	0.517	3.14019674586515e-57	TUBG1	Malignant cells	GSE139386	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8832
1.99700935216662e-61	-0.260371102707803	0.213	0.394	3.62217556295982e-57	POM121	Malignant cells	GSE139386	ENSG00000196313	9883	POM121 transmembrane nucleoporin	DKFZP586G1822|DKFZP586P2220|KIAA0618|POM121A	protein_coding	Q96HA1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8833
2.22042771104129e-61	-0.300656578074118	0.402	0.59	4.0274117822867e-57	LRRFIP2	Malignant cells	GSE139386	ENSG00000093167	9209	LRR binding FLII interacting protein 2	HUFI-2	protein_coding	Q9Y608	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8834
2.33727387572758e-61	0.343600813610498	0.49	0.299	4.23934735579468e-57	STXBP2	Malignant cells	GSE139386	ENSG00000076944	6813	syntaxin binding protein 2	Hunc18b|MUNC18-2|Unc18-2|UNC18B	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8835
2.89976255287155e-61	-0.306568587090769	0.526	0.701	5.25958931839842e-57	MRPL50	Malignant cells	GSE139386	ENSG00000136897	54534	mitochondrial ribosomal protein L50	FLJ20493|MRP-L50	protein_coding	Q8N5N7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8836
3.60451835239485e-61	-0.329464328286154	0.773	0.89	6.53787538757379e-57	C9orf89	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8837
5.63640864651858e-61	0.284484729523747	0.316	0.139	1.02233180030554e-56	FDXR	Malignant cells	GSE139386	ENSG00000161513	2232	ferredoxin reductase	ADR|ADXR	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8838
5.92855917249822e-61	0.347734301107426	0.67	0.504	1.07532206270773e-56	UGP2	Malignant cells	GSE139386	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8839
9.8381679063965e-61	0.271471869180106	0.28	0.11	1.7844468948622e-56	VPS13C	Malignant cells	GSE139386	ENSG00000129003	54832	vacuolar protein sorting 13 homolog C	BLTP5C|FLJ10381|FLJ20136|KIAA1421	protein_coding	Q709C8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8840
1.11949771589587e-60	-0.28300693294544	0.272	0.458	2.03054495709193e-56	MAP2K1	Malignant cells	GSE139386	ENSG00000169032	5604	mitogen-activated protein kinase kinase 1	MAPKK1|MEK1|PRKMK1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8841
1.14543248620756e-60	-0.286938181930664	0.359	0.549	2.07758544348327e-56	RBM23	Malignant cells	GSE139386	ENSG00000100461	55147	RNA binding motif protein 23	CAPERbeta|FLJ10482|RNPC4	protein_coding	Q86U06	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8842
1.18720689687154e-60	-0.289308064189925	0.284	0.469	2.15335586954561e-56	BCL9L	Malignant cells	GSE139386	ENSG00000186174	283149	BCL9 like	B9L|Bcl9-2|DLNB11	protein_coding	Q86UU0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8843
1.19088170164371e-60	-0.251191872722595	0.178	0.349	2.16002123044136e-56	MDFI	Malignant cells	GSE139386	ENSG00000112559	4188	MyoD family inhibitor	I-mfa	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8844
1.302336182814e-60	-0.290732532886161	0.428	0.621	2.36217736838804e-56	SRSF4	Malignant cells	GSE139386	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8845
1.32900754253942e-60	-0.259235639034233	0.221	0.401	2.410553880658e-56	SPECC1	Malignant cells	GSE139386	ENSG00000128487	92521	sperm antigen with calponin homology and coiled-coil domains 1	CYTSB|FLJ36955|HCMOGT-1|NSP	protein_coding	Q5M775	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8846
1.45568972786074e-60	0.315539980429084	0.411	0.225	2.64033002839381e-56	CLDN12	Malignant cells	GSE139386	ENSG00000157224	9069	claudin 12	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8847
1.91249643580403e-60	0.280556569725587	0.318	0.142	3.46888603526136e-56	AL592183.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8848
2.11969347077948e-60	-0.297474242018883	0.359	0.548	3.84470001729982e-56	MYCBP2	Malignant cells	GSE139386	ENSG00000005810	23077	MYC binding protein 2	FLJ10106|KIAA0916|PAM|PHR1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8849
2.26212858867245e-60	-0.283748731628249	0.41	0.603	4.10304883413408e-56	ATP5SL	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8850
2.60119922076108e-60	-0.276576626873376	0.234	0.414	4.71805514661645e-56	NOP9	Malignant cells	GSE139386	ENSG00000285326	161424	NOP9 nucleolar protein	C14orf21	protein_coding	Q86U38	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8851
2.96380733075597e-60	0.354178394221805	0.617	0.449	5.37575373652517e-56	SERINC3	Malignant cells	GSE139386	ENSG00000132824	10955	serine incorporator 3	AIGP1|DIFF33|SBBI99|TDE|TDE1|TMS-1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8852
3.30366646850149e-60	-0.308743591187835	0.718	0.862	5.99219024056801e-56	LARP1	Malignant cells	GSE139386	ENSG00000155506	23367	La ribonucleoprotein 1, translational regulator	KIAA0731|Lar1|LARP|Lhp1|MGC19556	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8853
3.36570229604847e-60	-0.309851126857989	0.656	0.804	6.10471082457271e-56	UROS	Malignant cells	GSE139386	ENSG00000188690	7390	uroporphyrinogen III synthase	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8854
5.24476385994349e-60	0.257317919935462	0.262	0.098	9.5129526891655e-56	WDR25	Malignant cells	GSE139386	ENSG00000176473	79446	WD repeat domain 25	C14orf67|MGC4645	protein_coding	Q64LD2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8855
5.50620144783151e-60	-0.271575074685991	0.241	0.423	9.98714818607679e-56	AGGF1	Malignant cells	GSE139386	ENSG00000164252	55109	angiogenic factor with G-patch and FHA domains 1	FLJ10283|GPATC7|GPATCH7|HSU84971|VG5Q	protein_coding	Q8N302	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8856
5.98420686376499e-60	-0.253447204834606	0.248	0.435	1.08541544094969e-55	AVEN	Malignant cells	GSE139386	ENSG00000169857	57099	apoptosis and caspase activation inhibitor	PDCD12	protein_coding	Q9NQS1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8857
6.00631150962912e-60	-0.298526922040421	0.641	0.798	1.08942478161653e-55	CDKN2AIPNL	Malignant cells	GSE139386	ENSG00000237190	91368	CDKN2A interacting protein N-terminal like	C2AIL|MGC13017	protein_coding	Q96HQ2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8858
6.4315387641209e-60	-0.30606463494304	0.637	0.785	1.16655250103625e-55	MOB1A	Malignant cells	GSE139386	ENSG00000114978	55233	MOB kinase activator 1A	C2orf6|FLJ10788|FLJ11595|Mats1|MOB1|Mob4B|MOBK1B|MOBKL1B	protein_coding	Q9H8S9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8859
7.10333522449389e-60	0.307163631809216	0.391	0.208	1.2884029430187e-55	PPAPDC1B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8860
9.97324192447373e-60	-0.281170771619645	0.344	0.536	1.80894662026105e-55	DDX27	Malignant cells	GSE139386	ENSG00000124228	55661	DEAD-box helicase 27	dJ686N3.1|DRS1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8861
1.26974459236749e-59	-0.265341309142924	0.306	0.497	2.30306274163615e-55	ARL8B	Malignant cells	GSE139386	ENSG00000134108	55207	ADP ribosylation factor like GTPase 8B	ARL10C|FLJ10702|Gie1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8862
1.7095926162529e-59	-0.254378205630243	0.26	0.449	3.10085908735951e-55	CHD8	Malignant cells	GSE139386	ENSG00000100888	57680	chromodomain helicase DNA binding protein 8	DUPLIN|HELSNF1|KIAA1564	protein_coding	Q9HCK8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8863
2.26156508826627e-59	-0.255105985146452	0.186	0.357	4.10202675709735e-55	DGCR8	Malignant cells	GSE139386	ENSG00000128191	54487	DGCR8 microprocessor complex subunit	C22orf12|DGCRK6|Gy1|pasha	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8864
2.35339195939413e-59	0.297743168701682	0.358	0.177	4.26858233594906e-55	ALG2	Malignant cells	GSE139386	ENSG00000119523	85365	ALG2 alpha-1,3/1,6-mannosyltransferase	CDG1I|CDGIi|FLJ14511|hALPG2|NET38	protein_coding	Q9H553	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8865
2.47767174666898e-59	0.347331799807314	0.68	0.525	4.49400101410819e-55	GRB2	Malignant cells	GSE139386	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8866
2.57291379176853e-59	0.392726503258505	0.72	0.583	4.66675103550976e-55	SELM	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8867
3.25950379016296e-59	-0.266242526460983	0.246	0.429	5.91208797459757e-55	XPO6	Malignant cells	GSE139386	ENSG00000169180	23214	exportin 6	FLJ22519|KIAA0370|RANBP20	protein_coding	Q96QU8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8868
3.28529523464274e-59	0.369051928679057	0.573	0.406	5.95886849659499e-55	INTS3	Malignant cells	GSE139386	ENSG00000262826	65123	integrator complex subunit 3	C1orf60|FLJ21919|INT3|SOSS-A	protein_coding	Q68E01	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8869
3.5276768424195e-59	-0.30584410700347	0.568	0.734	6.39850025678049e-55	YTHDF2	Malignant cells	GSE139386	ENSG00000198492	51441	YTH N6-methyladenosine RNA binding protein 2	CAHL|HGRG8|NY-REN-2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8870
4.04290518628867e-59	0.342413063311553	0.82	0.704	7.3330214268904e-55	FXYD5	Malignant cells	GSE139386	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8871
4.2308404378202e-59	-0.261096383472561	0.227	0.406	7.67389838611829e-55	PCYT2	Malignant cells	GSE139386	ENSG00000185813	5833	phosphate cytidylyltransferase 2, ethanolamine	ET	protein_coding	Q99447	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8872
4.63351915489609e-59	-0.290010896140456	0.376	0.563	8.40427704315054e-55	FUOM	Malignant cells	GSE139386	ENSG00000148803	282969	fucose mutarotase	C10orf125|FLJ26016|FucM|FucU	protein_coding	A2VDF0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8873
5.62028765970169e-59	0.297184255209827	0.366	0.187	1.01940777571669e-54	SLC35E2B	Malignant cells	GSE139386	ENSG00000189339	728661	solute carrier family 35 member E2B	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8874
6.40508914595357e-59	0.332554713789315	0.434	0.252	1.16175506929306e-54	IRF7	Malignant cells	GSE139386	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8875
6.41265153042062e-59	-0.268173120119698	0.268	0.452	1.16312673458769e-54	DNAL4	Malignant cells	GSE139386	ENSG00000100246	10126	dynein axonemal light chain 4	dJ327J16|PIG27	protein_coding	O96015	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8876
6.75797037670688e-59	-0.305203785100074	0.476	0.651	1.22576066692709e-54	CRK	Malignant cells	GSE139386	ENSG00000167193	1398	CRK proto-oncogene, adaptor protein	NA	protein_coding	P46108	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8877
7.32871409340766e-59	0.287464065814144	0.367	0.185	1.32928216226228e-54	PAX9	Malignant cells	GSE139386	ENSG00000198807	5083	paired box 9	NA	protein_coding	P55771	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8878
7.36882632569614e-59	-0.27383615570915	0.294	0.479	1.33655771895477e-54	DTD2	Malignant cells	GSE139386	ENSG00000129480	112487	D-aminoacyl-tRNA deacylase 2	C14orf126|MGC9912	protein_coding	Q96FN9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8879
8.03910514556198e-59	-0.261897481546331	0.268	0.456	1.45813289130203e-54	NETO2	Malignant cells	GSE139386	ENSG00000171208	81831	neuropilin and tolloid like 2	FLJ10430|NEOT2	protein_coding	Q8NC67	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8880
8.64977678337672e-59	-0.269668625897331	0.314	0.504	1.56889651296887e-54	UBTF	Malignant cells	GSE139386	ENSG00000108312	7343	upstream binding transcription factor	NOR-90|UBF|UBF1|UBF2	protein_coding	P17480	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8881
1.32716420886061e-58	-0.284686549389495	0.509	0.69	2.40721044203137e-54	PPP2R4	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8882
1.39526433698119e-58	-0.262183962135773	0.241	0.421	2.53073045441648e-54	FAM3A	Malignant cells	GSE139386	ENSG00000071889	60343	FAM3 metabolism regulating signaling molecule A	2-19|DXS560S|XAP-7	protein_coding	P98173	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8883
1.96585115960743e-58	-0.276083204017177	0.316	0.5	3.56566083329596e-54	FBXW2	Malignant cells	GSE139386	ENSG00000119402	26190	F-box and WD repeat domain containing 2	FBW2|Fwd2|Md6	protein_coding	Q9UKT8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8884
2.45706160373979e-58	0.327375050138643	0.448	0.265	4.45661833686323e-54	SLC35D2	Malignant cells	GSE139386	ENSG00000130958	11046	solute carrier family 35 member D2	SQV7L|UGTrel8	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8885
2.46743312996304e-58	-0.325330487783509	0.417	0.603	4.47543021112697e-54	TOR1AIP2	Malignant cells	GSE139386	ENSG00000169905	163590	torsin 1A interacting protein 2	IFRG15|LULL1|NET9	protein_coding	Q8NFQ8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8886
2.50509285152129e-58	-0.303290504389184	0.575	0.748	4.54373741408931e-54	NARF	Malignant cells	GSE139386	ENSG00000141562	26502	nuclear prelamin A recognition factor	DKFZp434G0420|FLJ10067|IOP2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8887
2.89094030302272e-58	-0.270120889694797	0.19	0.357	5.24358752162261e-54	ZFP36	Malignant cells	GSE139386	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8888
4.03705185468777e-58	0.371788585328225	0.599	0.426	7.32240465403267e-54	PXDN	Malignant cells	GSE139386	ENSG00000130508	7837	peroxidasin	D2S448|D2S448E|KIAA0230|MG50|PRG2|PXN	protein_coding	Q92626	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8889
6.11011562156613e-58	0.260181899601881	0.973	0.963	1.10825277143966e-53	WDR83OS	Malignant cells	GSE139386	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8890
6.45363952410454e-58	-0.33065185708647	0.665	0.816	1.17056113688208e-53	MAGOH	Malignant cells	GSE139386	ENSG00000162385	4116	mago homolog, exon junction complex subunit	MAGOH1|MAGOHA	protein_coding	P61326	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8891
6.53612182791598e-58	-0.26367809871339	0.937	0.975	1.1855217771474e-53	MRPS7	Malignant cells	GSE139386	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8892
7.59578671535715e-58	0.328762238771658	0.558	0.376	1.37772379443148e-53	PFKL	Malignant cells	GSE139386	ENSG00000141959	5211	phosphofructokinase, liver type	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8893
8.72965302243291e-58	-0.258138607312513	0.258	0.44	1.58338446520888e-53	UCK1	Malignant cells	GSE139386	ENSG00000130717	83549	uridine-cytidine kinase 1	FLJ12255|URK1	protein_coding	Q9HA47	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8894
1.06381178776159e-57	-0.280180781250742	0.237	0.414	1.92954182064197e-53	DDX39A	Malignant cells	GSE139386	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8895
1.09745598514363e-57	-0.258113757993035	0.963	0.985	1.99056566585352e-53	RHOA	Malignant cells	GSE139386	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8896
1.34702371263132e-57	-0.264663884349349	0.272	0.455	2.4432316099707e-53	KLC2	Malignant cells	GSE139386	ENSG00000174996	64837	kinesin light chain 2	FLJ12387	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8897
1.39567994774e-57	-0.298637838194787	0.512	0.688	2.53148428921081e-53	MPV17	Malignant cells	GSE139386	ENSG00000115204	4358	mitochondrial inner membrane protein MPV17	SYM1	protein_coding	P39210	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8898
1.52217732767081e-57	-0.281560849231637	0.36	0.549	2.76092523692932e-53	ABHD2	Malignant cells	GSE139386	ENSG00000140526	11057	abhydrolase domain containing 2, acylglycerol lipase	LABH2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8899
1.54441176914548e-57	-0.292978150701786	0.334	0.517	2.80125406687607e-53	GLOD4	Malignant cells	GSE139386	ENSG00000167699	51031	glyoxalase domain containing 4	C17orf25|CGI-150|HC71	protein_coding	Q9HC38	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8900
1.83557249935572e-57	-0.278475604264798	0.318	0.504	3.3293613993314e-53	ELOVL1	Malignant cells	GSE139386	ENSG00000066322	64834	ELOVL fatty acid elongase 1	Ssc1	protein_coding	Q9BW60	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8901
1.84638345703072e-57	0.366886701325363	0.691	0.552	3.34897031436231e-53	LPP	Malignant cells	GSE139386	ENSG00000145012	4026	LIM domain containing preferred translocation partner in lipoma	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8902
2.12533596923968e-57	0.332768992580711	0.521	0.344	3.85493438100693e-53	RARS2	Malignant cells	GSE139386	ENSG00000146282	57038	arginyl-tRNA synthetase 2, mitochondrial	DALRD2|dJ382I10.6|MGC14993|MGC23778|PRO1992|RARSL	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8903
2.16239348575084e-57	-0.275904865594083	0.292	0.475	3.92214930445487e-53	PPCDC	Malignant cells	GSE139386	ENSG00000138621	60490	phosphopantothenoylcysteine decarboxylase	FLJ14585|MDS018	protein_coding	Q96CD2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8904
2.58885429879473e-57	0.345943586968682	0.833	0.763	4.69566392715389e-53	AHCYL1	Malignant cells	GSE139386	ENSG00000168710	10768	adenosylhomocysteinase like 1	IRBIT|PPP1R78|XPVKONA	protein_coding	O43865	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8905
3.02506299100027e-57	0.345104494902072	0.842	0.789	5.48685925307629e-53	SLC38A1	Malignant cells	GSE139386	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8906
3.05753547550943e-57	0.336731797908037	0.523	0.346	5.54575784547901e-53	INO80B	Malignant cells	GSE139386	ENSG00000115274	83444	INO80 complex subunit B	hIes2|HMGA1L4|HMGIYL4|IES2|PAP-1BP|PAPA-1|ZNHIT4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8907
3.18856073726718e-57	-0.30853055103043	0.388	0.566	5.78341146525521e-53	PNO1	Malignant cells	GSE139386	ENSG00000115946	56902	partner of NOB1 homolog	KHRBP1|RRP20	protein_coding	Q9NRX1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8908
3.50016376431232e-57	-0.308128015975365	0.543	0.708	6.34859703570968e-53	SPATS2	Malignant cells	GSE139386	ENSG00000123352	65244	spermatogenesis associated serine rich 2	FLJ13117|SCR59|SPATA10	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8909
3.52982643300335e-57	-0.278714906695639	0.536	0.705	6.40239918418148e-53	DCTD	Malignant cells	GSE139386	ENSG00000129187	1635	dCMP deaminase	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8910
5.77308794678523e-57	-0.350752651558149	0.976	0.99	1.04712269178791e-52	CALM1	Malignant cells	GSE139386	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8911
6.02267854915562e-57	0.337619543899914	0.508	0.335	1.09239343524585e-52	NAT9	Malignant cells	GSE139386	ENSG00000109065	26151	N-acetyltransferase 9 (putative)	DKFZP564C103	protein_coding	Q9BTE0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8912
6.21041701542224e-57	0.34619886695427	0.396	0.222	1.12644543825729e-52	ASRGL1	Malignant cells	GSE139386	ENSG00000162174	80150	asparaginase and isoaspartyl peptidase 1	ALP|ALP1|FLJ22316	protein_coding	Q7L266	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8913
7.69421744372984e-57	-0.260337786623062	0.225	0.402	1.39557715994372e-52	RIT1	Malignant cells	GSE139386	ENSG00000143622	6016	Ras like without CAAX 1	MGC125864|MGC125865|RIBB|RIT|ROC1	protein_coding	Q92963	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8914
8.37084593785945e-57	-0.264013555635111	0.296	0.48	1.51830403620895e-52	TMEM55B	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8915
8.61173268923365e-57	-0.286945542401609	0.596	0.755	1.5619960751732e-52	PTPMT1	Malignant cells	GSE139386	ENSG00000285206	114971	protein tyrosine phosphatase mitochondrial 1	DUSP23|MOSP|PLIP	protein_coding	Q8WUK0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8916
1.0290102280402e-56	-0.274403615548688	0.258	0.437	1.86641875161932e-52	NIPAL3	Malignant cells	GSE139386	ENSG00000001461	57185	NIPA like domain containing 3	DJ462O23.2|NPAL3|SLC57A5	protein_coding	Q6P499	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8917
1.17614031282806e-56	0.337063300269046	0.701	0.556	2.13328329940753e-52	HADHA	Malignant cells	GSE139386	ENSG00000084754	3030	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha	GBP|LCEH|LCHAD|MTPA	protein_coding	P40939	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8918
1.27913161336053e-56	-0.303115541172057	0.493	0.657	2.32008892031334e-52	WBP4	Malignant cells	GSE139386	ENSG00000120688	11193	WW domain binding protein 4	FBP21|MGC117310	protein_coding	O75554	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8919
1.41465559083058e-56	-0.252240594717151	0.212	0.385	2.5659023106485e-52	GALNT3	Malignant cells	GSE139386	ENSG00000115339	2591	polypeptide N-acetylgalactosaminyltransferase 3	GalNAc-T3|HFTC|HHS	protein_coding	Q14435	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8920
1.5258395946818e-56	-0.256531509446741	0.256	0.433	2.76756785683384e-52	PCGF2	Malignant cells	GSE139386	ENSG00000278644	7703	polycomb group ring finger 2	MEL-18|RNF110|ZNF144	protein_coding	P35227	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8921
1.60067932932093e-56	-0.283760889085353	0.569	0.741	2.9033121675223e-52	RNF126	Malignant cells	GSE139386	ENSG00000070423	55658	ring finger protein 126	FLJ20552	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8922
1.87280968453604e-56	-0.252024291179208	0.199	0.367	3.39690220581146e-52	CHKA	Malignant cells	GSE139386	ENSG00000110721	1119	choline kinase alpha	CHK|CKI	protein_coding	P35790	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8923
1.89093850236248e-56	-0.279743697302708	0.354	0.536	3.42978425558506e-52	THAP11	Malignant cells	GSE139386	ENSG00000168286	57215	THAP domain containing 11	CTG-B43a|CTG-B45d|HRIHFB2206|RONIN	protein_coding	Q96EK4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8924
1.99629229952964e-56	-0.269879827022632	0.901	0.97	3.62087497288687e-52	ATRAID	Malignant cells	GSE139386	ENSG00000138085	51374	all-trans retinoic acid induced differentiation factor	APR3|C2orf28|HSPC013|p18	protein_coding	Q6UW56	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8925
2.12330967971494e-56	0.323078825478221	0.834	0.746	3.85125909706696e-52	MMADHC	Malignant cells	GSE139386	ENSG00000168288	27249	metabolism of cobalamin associated D	C2orf25|cblD|CL25022	protein_coding	Q9H3L0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8926
2.21609243655622e-56	-0.295811329705797	0.597	0.757	4.01954846142566e-52	WDR1	Malignant cells	GSE139386	ENSG00000071127	9948	WD repeat domain 1	AIP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8927
2.25858183217469e-56	-0.265181041820994	0.234	0.406	4.09661572719846e-52	DSCR3	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8928
2.87670716494177e-56	-0.27394856252415	0.276	0.454	5.21777145577139e-52	RXRA	Malignant cells	GSE139386	ENSG00000186350	6256	retinoid X receptor alpha	NR2B1|RXR-alpha|RXRalpha	protein_coding	P19793	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8929
3.28113421504304e-56	-0.315056599191626	0.504	0.665	5.95132123924506e-52	COPS5	Malignant cells	GSE139386	ENSG00000121022	10987	COP9 signalosome subunit 5	CSN5|JAB1|MOV-34|SGN5	protein_coding	Q92905	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8930
3.89773308597731e-56	-0.293562231115539	0.877	0.955	7.06970827134565e-52	MGLL	Malignant cells	GSE139386	ENSG00000074416	11343	monoglyceride lipase	HU-K5|MAGL|MGL	protein_coding	Q99685	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8931
4.22009102372089e-56	0.339850798929668	0.632	0.469	7.65440109882495e-52	PTRH1	Malignant cells	GSE139386	ENSG00000187024	138428	peptidyl-tRNA hydrolase 1 homolog	C9orf115|PTH1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8932
4.56883102175148e-56	-0.25742686028649	0.223	0.395	8.28694570725284e-52	TBC1D9B	Malignant cells	GSE139386	ENSG00000284400	23061	TBC1 domain family member 9B	GRAMD9B|KIAA0676	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8933
4.87937628762895e-56	-0.263509268851061	0.206	0.376	8.85021271050138e-52	COL6A1	Malignant cells	GSE139386	ENSG00000142156	1291	collagen type VI alpha 1 chain	NA	protein_coding	P12109	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8934
4.95654706329326e-56	0.340091123571002	0.652	0.493	8.99018506340132e-52	TWF2	Malignant cells	GSE139386	ENSG00000247596	11344	twinfilin actin binding protein 2	A6r|A6RP|PTK9L	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8935
5.74564892834929e-56	-0.256236579690952	0.235	0.408	1.04214580262399e-51	TANK	Malignant cells	GSE139386	ENSG00000136560	10010	TRAF family member associated NFKB activator	I-TRAF|TRAF2	protein_coding	Q92844	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8936
6.54515018427593e-56	0.321845686118471	0.466	0.29	1.18715934042397e-51	ARCN1	Malignant cells	GSE139386	ENSG00000095139	372	archain 1	COPD	protein_coding	P48444	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8937
7.68460238870014e-56	0.345480063475044	0.728	0.597	1.39383318126243e-51	CTSZ	Malignant cells	GSE139386	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8938
9.49141954697699e-56	-0.25177299348837	0.262	0.443	1.72155367743069e-51	ATP6V1A	Malignant cells	GSE139386	ENSG00000114573	523	ATPase H+ transporting V1 subunit A	ATP6A1|ATP6V1A1|VA68|Vma1|VPP2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8939
1.004824419666e-55	-0.274272222320401	0.341	0.525	1.8225505323902e-51	TRIM8	Malignant cells	GSE139386	ENSG00000171206	81603	tripartite motif containing 8	GERP|RNF27	protein_coding	Q9BZR9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8940
1.11281334298557e-55	-0.276203537907271	0.278	0.453	2.01842084150723e-51	CDC27	Malignant cells	GSE139386	ENSG00000004897	996	cell division cycle 27	ANAPC3|APC3|D0S1430E|D17S978E|NUC2	protein_coding	P30260	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8941
1.55184852600425e-55	-0.298632291286439	0.406	0.585	2.81474285646652e-51	PSMD11	Malignant cells	GSE139386	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8942
1.80147337814376e-55	0.277225754048681	0.331	0.159	3.26751241327715e-51	EFCAB4A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8943
2.41409835827714e-55	0.261468442111724	0.319	0.148	4.37869160224308e-51	KLF13	Malignant cells	GSE139386	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8944
3.04283049355172e-55	0.322389436814785	0.852	0.773	5.51908594920411e-51	KDELR1	Malignant cells	GSE139386	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8945
3.63314245420041e-55	0.334127449345435	0.682	0.534	6.5897937834287e-51	PRKAR1A	Malignant cells	GSE139386	ENSG00000108946	5573	protein kinase cAMP-dependent type I regulatory subunit alpha	CNC1|PRKAR1|TSE1	protein_coding	P10644	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8946
4.85724996312931e-55	-0.278672371391618	0.909	0.959	8.81007998312393e-51	CUTA	Malignant cells	GSE139386	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8947
5.2694347322705e-55	-0.291773358498439	0.44	0.614	9.55770071739223e-51	DIAPH1	Malignant cells	GSE139386	ENSG00000131504	1729	diaphanous related formin 1	DFNA1|hDIA1|LFHL1|mDia1	protein_coding	O60610	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8948
5.460248188622e-55	-0.256748940377382	0.228	0.399	9.90379816452258e-51	FBXO45	Malignant cells	GSE139386	ENSG00000174013	200933	F-box protein 45	Fbx45	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8949
5.50140901635163e-55	-0.260107817909044	0.901	0.962	9.97845567385859e-51	APH1A	Malignant cells	GSE139386	ENSG00000117362	51107	aph-1 homolog A, gamma-secretase subunit	APH-1A|CGI-78	protein_coding	Q96BI3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8950
6.62369244155562e-55	-0.288516508293907	0.593	0.751	1.20140533504936e-50	BCKDK	Malignant cells	GSE139386	ENSG00000103507	10295	branched chain keto acid dehydrogenase kinase	NA	protein_coding	O14874	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8951
7.49242720613952e-55	0.365583812553258	0.857	0.83	1.35897644664959e-50	RNF145	Malignant cells	GSE139386	ENSG00000145860	153830	ring finger protein 145	FLJ31951	protein_coding	Q96MT1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8952
7.72143564276723e-55	-0.278811223311797	0.35	0.532	1.40051399688512e-50	MAPKAPK2	Malignant cells	GSE139386	ENSG00000162889	9261	MAPK activated protein kinase 2	MK2	protein_coding	P49137	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8953
8.32312486631307e-55	-0.282043663775206	0.595	0.756	1.50964838825186e-50	RBM27	Malignant cells	GSE139386	ENSG00000091009	54439	RNA binding motif protein 27	ARRS1|KIAA1311|Psc1|ZC3H20	protein_coding	Q9P2N5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8954
8.80486817704058e-55	-0.290002029207437	0.56	0.715	1.59702698995162e-50	ATP6V1E1	Malignant cells	GSE139386	ENSG00000131100	529	ATPase H+ transporting V1 subunit E1	ATP6E|ATP6E2|ATP6V1E|P31|Vma4	protein_coding	P36543	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8955
1.27438248457642e-54	-0.300194248999926	0.576	0.735	2.31147495052472e-50	PSMG4	Malignant cells	GSE139386	ENSG00000180822	389362	proteasome assembly chaperone 4	C6orf86|PAC4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8956
1.29154345922847e-54	-0.281844252936507	0.468	0.637	2.34260152634861e-50	COA5	Malignant cells	GSE139386	ENSG00000183513	493753	cytochrome c oxidase assembly factor 5	C2orf64|FLJ27524|MGC52110|Pet191	protein_coding	Q86WW8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8957
1.31551641298747e-54	0.322612387922003	0.464	0.288	2.38608366987667e-50	SP100	Malignant cells	GSE139386	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8958
1.32671225141629e-54	-0.291475332012066	0.811	0.901	2.40639068161887e-50	SURF2	Malignant cells	GSE139386	ENSG00000281024	6835	surfeit 2	NA	protein_coding	Q15527	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8959
1.35107386240916e-54	0.266842635868513	0.974	0.968	2.45057777163774e-50	ROMO1	Malignant cells	GSE139386	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8960
1.55053023001724e-54	-0.250919501021272	0.217	0.386	2.81235173120527e-50	WDR36	Malignant cells	GSE139386	ENSG00000134987	134430	WD repeat domain 36	GLC1G|TA-WDRP|UTP21	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8961
1.70119505795122e-54	0.323083799785683	0.511	0.335	3.08562759611193e-50	PNPLA2	Malignant cells	GSE139386	ENSG00000177666	57104	patatin like phospholipase domain containing 2	ATGL|desnutrin|FP17548|iPLA2zeta|TTS-2.2	protein_coding	Q96AD5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8962
2.29454354620488e-54	-0.285010330552126	0.637	0.778	4.16184308410641e-50	ATG12	Malignant cells	GSE139386	ENSG00000145782	9140	autophagy related 12	APG12|APG12L	protein_coding	O94817	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8963
2.41119867502673e-54	0.267737888588514	0.949	0.905	4.37343215676348e-50	UQCRC1	Malignant cells	GSE139386	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8964
2.48414957712423e-54	-0.277985174663199	0.292	0.467	4.50575050298794e-50	TRNAU1AP	Malignant cells	GSE139386	ENSG00000180098	54952	tRNA selenocysteine 1 associated protein 1	FLJ20503|SECP43|TRSPAP1	protein_coding	Q9NX07	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8965
2.64901528753624e-54	-0.278026011794447	0.339	0.517	4.80478392853323e-50	C11orf24	Malignant cells	GSE139386	ENSG00000171067	53838	chromosome 11 open reading frame 24	DM4E3	protein_coding	Q96F05	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8966
2.7025687842362e-54	0.257944405989858	0.979	0.975	4.90191926084763e-50	C19orf43	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8967
3.08329011113079e-54	-0.26344141133469	0.36	0.541	5.59247160356903e-50	HERC2	Malignant cells	GSE139386	ENSG00000277278	8924	HECT and RLD domain containing E3 ubiquitin protein ligase 2	D15F37S1|jdf2|p528	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8968
3.68453349296246e-54	-0.251212320346044	0.286	0.467	6.68300684953531e-50	TRIM33	Malignant cells	GSE139386	ENSG00000197323	51592	tripartite motif containing 33	FLJ11429|KIAA1113|PTC7|RFG7|TF1G|TIF1G|TIF1GAMMA|TIFGAMMA	protein_coding	Q9UPN9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8969
4.34569318425017e-54	0.349526647107439	0.711	0.583	7.88221829759297e-50	DNAJC4	Malignant cells	GSE139386	ENSG00000110011	3338	DnaJ heat shock protein family (Hsp40) member C4	HSPF2|MCG18	protein_coding	Q9NNZ3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8970
5.24694749258576e-54	0.263754778834589	0.344	0.171	9.51691336205205e-50	REEP6	Malignant cells	GSE139386	ENSG00000115255	92840	receptor accessory protein 6	C19orf32|DP1L1|FLJ25383|Yip2f	protein_coding	Q96HR9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8971
6.92454700787399e-54	0.266250284299198	0.342	0.172	1.25597433628818e-49	SLC41A3	Malignant cells	GSE139386	ENSG00000114544	54946	solute carrier family 41 member 3	FLJ20473	protein_coding	Q96GZ6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8972
7.79201420479328e-54	-0.256484336615965	0.298	0.478	1.4133155364654e-49	SDHAF1	Malignant cells	GSE139386	ENSG00000205138	644096	succinate dehydrogenase complex assembly factor 1	LYRM8	protein_coding	A6NFY7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8973
7.88535248553785e-54	0.346694021156379	0.674	0.535	1.43024523382686e-49	CANT1	Malignant cells	GSE139386	ENSG00000171302	124583	calcium activated nucleotidase 1	SCAN-1|SHAPY	protein_coding	Q8WVQ1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8974
9.87875506923301e-54	-0.276615282397827	0.247	0.416	1.79180859445748e-49	SVIL	Malignant cells	GSE139386	ENSG00000197321	6840	supervillin	NA	protein_coding	O95425	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8975
1.30862699618435e-53	-0.302102082570481	0.548	0.711	2.37358764567917e-49	RBM25	Malignant cells	GSE139386	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8976
1.39209730292678e-53	-0.253026490809675	0.243	0.414	2.52498608804859e-49	TSR1	Malignant cells	GSE139386	ENSG00000167721	55720	TSR1 ribosome maturation factor	FLJ10534	protein_coding	Q2NL82	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8977
1.46235508713824e-53	0.306929521880291	0.398	0.223	2.65241965705134e-49	IRF1	Malignant cells	GSE139386	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8978
1.63616803100472e-53	0.352436599670534	0.668	0.52	2.96768157463636e-49	ARL6IP5	Malignant cells	GSE139386	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8979
1.68764971695245e-53	0.315391710689966	0.444	0.271	3.06105905660835e-49	TPGS1	Malignant cells	GSE139386	ENSG00000141933	91978	tubulin polyglutamylase complex subunit 1	C19orf20|GTRGEO22|PGs1	protein_coding	Q6ZTW0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8980
2.13461002500869e-53	0.354473203092759	0.527	0.362	3.87175566336076e-49	ASAH1	Malignant cells	GSE139386	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8981
2.81005279246364e-53	0.317990816513427	0.497	0.321	5.09687375497055e-49	DYNC1LI2	Malignant cells	GSE139386	ENSG00000135720	1783	dynein cytoplasmic 1 light intermediate chain 2	DNCLI2	protein_coding	O43237	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8982
3.11390403119207e-53	-0.274406052631326	0.299	0.472	5.64799913177617e-49	FAM127A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8983
3.31593542741693e-53	0.251096209155544	0.284	0.124	6.01444367824882e-49	TMEM51	Malignant cells	GSE139386	ENSG00000171729	55092	transmembrane protein 51	C1orf72|FLJ10199	protein_coding	Q9NW97	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8984
3.35203305019228e-53	-0.268988533068132	0.334	0.511	6.07991754643876e-49	MAGT1	Malignant cells	GSE139386	ENSG00000102158	84061	magnesium transporter 1	DKFZp564K142|IAP|MRX95|OST3B|SLC58A1	protein_coding	Q9H0U3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8985
3.9409977349654e-53	-0.272874634334559	0.815	0.912	7.14818169168025e-49	PIN1	Malignant cells	GSE139386	ENSG00000127445	5300	peptidylprolyl cis/trans isomerase, NIMA-interacting 1	dod	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8986
5.27143527481336e-53	-0.278300642811064	0.344	0.514	9.56132930145647e-49	RABEPK	Malignant cells	GSE139386	ENSG00000136933	10244	Rab9 effector protein with kelch motifs	bA65N13.1|RAB9P40	protein_coding	Q7Z6M1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8987
6.94750941841814e-53	-0.261522656816417	0.405	0.589	1.26013925831268e-48	NPEPPS	Malignant cells	GSE139386	ENSG00000141279	9520	aminopeptidase puromycin sensitive	MP100|PSA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8988
7.13342797919266e-53	0.343158127299932	0.593	0.438	1.29386116686596e-48	MRPL10	Malignant cells	GSE139386	ENSG00000159111	124995	mitochondrial ribosomal protein L10	L10MT|MGC17973|MRP-L10|MRP-L8|MRPL8|RPML8	protein_coding	Q7Z7H8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8989
7.23344460352312e-53	0.330583774306757	0.483	0.311	1.31200218218702e-48	PHGDH	Malignant cells	GSE139386	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8990
7.36252342493499e-53	-0.272835396391652	0.463	0.638	1.33541449881471e-48	PRPF38B	Malignant cells	GSE139386	ENSG00000134186	55119	pre-mRNA processing factor 38B	FLJ10330|NET1	protein_coding	Q5VTL8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8991
7.6884336728359e-53	-0.273111204010833	0.424	0.594	1.39452809957898e-48	IER3IP1.1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8992
7.8826455563915e-53	-0.264126722615798	0.303	0.48	1.42975425101829e-48	FUBP1	Malignant cells	GSE139386	ENSG00000162613	8880	far upstream element binding protein 1	FBP|FUBP	protein_coding	Q96AE4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8993
8.60009046537689e-53	-0.271213702069933	0.332	0.503	1.55988440861006e-48	CEP290	Malignant cells	GSE139386	ENSG00000198707	80184	centrosomal protein 290	3H11Ag|BBS14|CT87|FLJ13615|JBTS5|KIAA0373|LCA10|MKS4|NPHP6|POC3|rd16|SLSN6	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8994
9.86723987879049e-53	0.269310616639737	0.368	0.197	1.78971996921502e-48	ALG12	Malignant cells	GSE139386	ENSG00000182858	79087	ALG12 alpha-1,6-mannosyltransferase	CDG1G|ECM39	protein_coding	Q9BV10	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8995
1.3212880068029e-52	0.331456617432077	0.647	0.495	2.39655218673909e-48	MARK3	Malignant cells	GSE139386	ENSG00000075413	4140	microtubule affinity regulating kinase 3	CTAK1|KP78|PAR-1A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8996
1.45194874750623e-52	-0.261676199980143	0.315	0.494	2.6335446382268e-48	LYPLAL1	Malignant cells	GSE139386	ENSG00000143353	127018	lysophospholipase like 1	Q96AV0	protein_coding	Q5VWZ2	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8997
1.58287322090632e-52	-0.288346068659576	0.516	0.683	2.87101544807989e-48	USP22	Malignant cells	GSE139386	ENSG00000124422	23326	ubiquitin specific peptidase 22	KIAA1063|USP3L	protein_coding	Q9UPT9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8998
1.58515434570896e-52	0.312039958138458	0.893	0.866	2.87515295224692e-48	MPG	Malignant cells	GSE139386	ENSG00000103152	4350	N-methylpurine DNA glycosylase	MDG	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	8999
1.708486035618e-52	0.339076237380597	0.794	0.69	3.09885197140394e-48	VAMP2	Malignant cells	GSE139386	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9000
1.7730571061181e-52	0.312601106615928	0.439	0.268	3.21597097907701e-48	MYO6	Malignant cells	GSE139386	ENSG00000196586	4646	myosin VI	DFNA22|DFNB37|KIAA0389	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9001
2.05566552256113e-52	-0.273970905952213	0.358	0.538	3.72856612482137e-48	RBBP7	Malignant cells	GSE139386	ENSG00000102054	5931	RB binding protein 7, chromatin remodeling factor	RbAp46	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9002
2.33677528846678e-52	-0.264022478491326	0.29	0.462	4.23844301822105e-48	GPN1	Malignant cells	GSE139386	ENSG00000198522	11321	GPN-loop GTPase 1	ATPBD1A|MBDIN|NTPBP|RPAP4|XAB1	protein_coding	Q9HCN4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9003
2.94108433730443e-52	0.332059729317436	0.569	0.405	5.33453877100278e-48	PPP1R7	Malignant cells	GSE139386	ENSG00000115685	5510	protein phosphatase 1 regulatory subunit 7	sds22	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9004
2.98221937111757e-52	-0.271496593356563	0.722	0.868	5.40914949533304e-48	RTF1	Malignant cells	GSE139386	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9005
3.28424129471066e-52	-0.263434457382137	0.37	0.548	5.9569568603462e-48	RGS19	Malignant cells	GSE139386	ENSG00000171700	10287	regulator of G protein signaling 19	GAIP|RGSGAIP	protein_coding	P49795	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9006
3.31614563549753e-52	0.266125247095674	0.325	0.16	6.01482495366542e-48	ST6GALNAC4	Malignant cells	GSE139386	ENSG00000136840	27090	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	SIAT3C|SIAT7D|ST6GALNACIV	protein_coding	Q9H4F1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9007
4.88384126657702e-52	-0.25583338938857	0.274	0.446	8.85831128931741e-48	C1orf131	Malignant cells	GSE139386	ENSG00000143633	128061	chromosome 1 open reading frame 131	DKFZp547B1713	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9008
5.07869947680727e-52	-0.273681161764387	0.394	0.567	9.21174511103302e-48	HOMER3	Malignant cells	GSE139386	ENSG00000051128	9454	homer scaffold protein 3	HOMER-3	protein_coding	Q9NSC5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9009
5.50377641089851e-52	-0.260399298657542	0.951	0.982	9.98274965408772e-48	FBL	Malignant cells	GSE139386	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9010
7.7809606314962e-52	-0.288359156608464	0.739	0.86	1.41131063934078e-47	AK1	Malignant cells	GSE139386	ENSG00000106992	203	adenylate kinase 1	NA	protein_coding	P00568	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9011
8.3265388231002e-52	-0.269130409757286	0.511	0.681	1.51026761173391e-47	NMT1	Malignant cells	GSE139386	ENSG00000136448	4836	N-myristoyltransferase 1	NMT	protein_coding	P30419	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9012
9.63930876939515e-52	0.316448458946955	0.555	0.387	1.74837782459289e-47	HEXB	Malignant cells	GSE139386	ENSG00000049860	3074	hexosaminidase subunit beta	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9013
1.01621003912065e-51	0.344585144894788	0.627	0.482	1.84320176895703e-47	CYB561	Malignant cells	GSE139386	ENSG00000008283	1534	cytochrome b561	CYB561A1|FRRS2	protein_coding	P49447	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9014
1.04240779132279e-51	-0.270982576661459	0.748	0.873	1.89071925190128e-47	BRD2	Malignant cells	GSE139386	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9015
1.1834267299769e-51	-0.294228704761417	0.364	0.533	2.1464994028321e-47	HTATSF1	Malignant cells	GSE139386	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9016
1.58889180264708e-51	-0.253010281407167	0.317	0.491	2.88193195164128e-47	MEF2BNB	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9017
1.67559707552153e-51	-0.298474810618153	0.755	0.87	3.03919797558095e-47	NTMT1	Malignant cells	GSE139386	ENSG00000148335	28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1	AD-003|C9orf32|HOMT1A|METTL11A|NRMT|NRMT1	protein_coding	Q9BV86	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9018
2.06112912906198e-51	-0.298569521410185	0.74	0.856	3.73847601429261e-47	ECHS1	Malignant cells	GSE139386	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9019
2.28753615604466e-51	-0.277055296665422	0.713	0.844	4.14913307983381e-47	RPL7L1	Malignant cells	GSE139386	ENSG00000146223	285855	ribosomal protein L7 like 1	dJ475N16.4	protein_coding	Q6DKI1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9020
2.30489153088053e-51	-0.264921017950763	0.297	0.47	4.18061225871111e-47	MPP6	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9021
2.57561172006846e-51	-0.266698950823654	0.428	0.602	4.67164453786018e-47	FYTTD1	Malignant cells	GSE139386	ENSG00000122068	84248	forty-two-three domain containing 1	DKFZp761B1514|UIF	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9022
3.61793735455858e-51	0.343773306535438	0.706	0.584	6.56221477369835e-47	HOOK2	Malignant cells	GSE139386	ENSG00000095066	29911	hook microtubule tethering protein 2	HK2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9023
3.6482330011018e-51	0.326880053193682	0.794	0.701	6.61716501739844e-47	ACADVL	Malignant cells	GSE139386	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9024
3.84896233230531e-51	0.253251428669367	0.277	0.122	6.98124787833538e-47	ODF3B	Malignant cells	GSE139386	ENSG00000177989	440836	outer dense fiber of sperm tails 3B	FAP123	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9025
4.43980310993713e-51	-0.274145997459812	0.486	0.664	8.05291488080396e-47	MIR4458HG	Malignant cells	GSE139386	ENSG00000247516	100505738	MIR4458 host gene	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9026
4.91686606737932e-51	-0.265057152516223	0.442	0.621	8.91821167301261e-47	CRIP1	Malignant cells	GSE139386	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9027
5.02927407230298e-51	-0.257924956967949	0.273	0.442	9.12209731234315e-47	MYO1B	Malignant cells	GSE139386	ENSG00000128641	4430	myosin IB	myr1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9028
5.19104973485121e-51	0.319562005819255	0.378	0.212	9.41552600907313e-47	KCNQ1OT1	Malignant cells	GSE139386	ENSG00000269821	10984	KCNQ1 opposite strand/antisense transcript 1	KCNQ1-AS2|KvDMR1|KvLQT1-AS|LIT1|NCRNA00012	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9029
5.24954764332512e-51	0.343914464004205	0.826	0.755	9.5216295154631e-47	LAMA5	Malignant cells	GSE139386	ENSG00000130702	3911	laminin subunit alpha 5	NA	protein_coding	O15230	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9030
7.1782188957556e-51	0.364582475749377	0.766	0.673	1.30198534331215e-46	NAMPT	Malignant cells	GSE139386	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9031
7.89177791009576e-51	0.314084079644189	0.484	0.313	1.43141067733317e-46	CIR1	Malignant cells	GSE139386	ENSG00000138433	9541	corepressor interacting with RBPJ, CIR1	CIR	protein_coding	Q86X95	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9032
8.14504242061796e-51	0.268765514824701	0.33	0.167	1.47734779425169e-46	RERE	Malignant cells	GSE139386	ENSG00000142599	473	arginine-glutamic acid dipeptide repeats	ARG|ARP|ATN1L|ATN2|DNB1|KIAA0458	protein_coding	Q9P2R6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9033
1.07719860006143e-50	-0.286822863013667	0.303	0.474	1.95382282079142e-46	RQCD1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9034
1.17904874952347e-50	-0.299959260699397	0.56	0.709	2.13855862188567e-46	DKC1	Malignant cells	GSE139386	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9035
1.26703971238061e-50	-0.254408083519669	0.206	0.365	2.29815663031596e-46	PBDC1	Malignant cells	GSE139386	ENSG00000102390	51260	polysaccharide biosynthesis domain containing 1	CXorf26|MGC874	protein_coding	Q9BVG4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9036
1.26980600297961e-50	0.285462208982997	0.431	0.258	2.30317412820442e-46	CDC40	Malignant cells	GSE139386	ENSG00000168438	51362	cell division cycle 40	EHB3|FLJ10564|PRP17|PRPF17	protein_coding	O60508	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9037
1.28699443405725e-50	0.278419632972869	0.329	0.166	2.33435050449305e-46	TMEM159	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9038
1.38307303218616e-50	-0.264759869455434	0.406	0.58	2.50861786577926e-46	TNPO1	Malignant cells	GSE139386	ENSG00000083312	3842	transportin 1	IPO2|KPNB2|MIP|MIP1|TRN	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9039
1.59119052344892e-50	0.259905457206855	0.344	0.178	2.88610137143166e-46	ATF6	Malignant cells	GSE139386	ENSG00000118217	22926	activating transcription factor 6	ATF6A	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9040
1.82336245898606e-50	-0.279697780266877	0.558	0.72	3.30721482810892e-46	SDR39U1	Malignant cells	GSE139386	ENSG00000100445	56948	short chain dehydrogenase/reductase family 39U member 1	C14orf124|HCDI	protein_coding	Q9NRG7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9041
1.82950507821303e-50	-0.272500306172203	0.68	0.816	3.31835631086279e-46	PTP4A1	Malignant cells	GSE139386	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9042
2.18982272134345e-50	-0.269818111899486	0.427	0.601	3.97190045197275e-46	FNTA	Malignant cells	GSE139386	ENSG00000168522	2339	farnesyltransferase, CAAX box, alpha	FPTA|PGGT1A|PTAR2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9043
2.34474575148636e-50	0.256520736201813	0.318	0.157	4.25289984404595e-46	STX1A	Malignant cells	GSE139386	ENSG00000106089	6804	syntaxin 1A	HPC-1|p35-1|STX1	protein_coding	Q16623	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9044
3.79248601855461e-50	-0.271872633740517	0.51	0.673	6.87881114045435e-46	EXOSC3	Malignant cells	GSE139386	ENSG00000107371	51010	exosome component 3	CGI-102|hRrp-40|hRrp40p|p10|RRP40|Rrp40p	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9045
3.97570082076311e-50	0.307920796750233	0.584	0.421	7.21112614870013e-46	VEZF1	Malignant cells	GSE139386	ENSG00000136451	7716	vascular endothelial zinc finger 1	DB1|ZNF161	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9046
4.5310914861216e-50	-0.277010087019877	0.671	0.813	8.21849373752736e-46	EMC10	Malignant cells	GSE139386	ENSG00000161671	284361	ER membrane protein complex subunit 10	C19orf63|HSM1|HSS1|INM02	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9047
7.80930312856102e-50	0.286695631652866	0.926	0.879	1.4164514014584e-45	AK2	Malignant cells	GSE139386	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9048
8.8569903969698e-50	0.319416115883748	0.855	0.805	1.60648091820238e-45	TTC3	Malignant cells	GSE139386	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9049
9.14013592574433e-50	0.321592198766786	0.848	0.796	1.65783785421151e-45	ZFAND1	Malignant cells	GSE139386	ENSG00000104231	79752	zinc finger AN1-type containing 1	FLJ14007	protein_coding	Q8TCF1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9050
1.00963384360935e-49	0.314322516122257	0.622	0.473	1.83127386553865e-45	GLUD1	Malignant cells	GSE139386	ENSG00000148672	2746	glutamate dehydrogenase 1	GDH|GDH1|GLUD|hGDH1	protein_coding	P00367	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9051
1.1662065304636e-49	-0.277212995646357	0.53	0.692	2.11526540495488e-45	PGRMC1	Malignant cells	GSE139386	ENSG00000101856	10857	progesterone receptor membrane component 1	HPR6.6	protein_coding	O00264	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9052
1.37529938482867e-49	0.32470605097149	0.52	0.358	2.49451802420224e-45	NT5C2	Malignant cells	GSE139386	ENSG00000076685	22978	5'-nucleotidase, cytosolic II	cN-II|GMP|NT5B|PNT5|SPG45|SPG65	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9053
1.60308405958428e-49	-0.284917898809012	0.575	0.724	2.90767386727397e-45	MYO1C	Malignant cells	GSE139386	ENSG00000197879	4641	myosin IC	MyoIC|myr2|NMI	protein_coding	O00159	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9054
1.77143527921348e-49	-0.275558550698572	0.618	0.761	3.21302930943741e-45	TBL1XR1	Malignant cells	GSE139386	ENSG00000177565	79718	TBL1X/Y related 1	C21|DC42|FLJ12894|IRA1|TBLR1	protein_coding	Q9BZK7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9055
2.24870683536013e-49	-0.265038407020066	0.754	0.875	4.0787044579762e-45	PPP1R11	Malignant cells	GSE139386	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9056
2.92893021596067e-49	-0.25472427429488	0.382	0.557	5.31249362570947e-45	NUDT16	Malignant cells	GSE139386	ENSG00000198585	131870	nudix hydrolase 16	FLJ31265	protein_coding	Q96DE0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9057
3.97590584165592e-49	0.258982185736671	0.949	0.923	7.21149801559551e-45	RER1	Malignant cells	GSE139386	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9058
7.31865036434578e-49	0.260710281829868	0.982	0.947	1.32745680308504e-44	ATP6V0B	Malignant cells	GSE139386	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9059
7.45508089932324e-49	-0.254446674265452	0.323	0.493	1.35220257351925e-44	SPRYD7	Malignant cells	GSE139386	ENSG00000123178	57213	SPRY domain containing 7	C13orf1|CLLD6	protein_coding	Q5W111	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9060
7.50006725609616e-49	0.251755543716905	0.317	0.158	1.36036219891072e-44	ZC3H6	Malignant cells	GSE139386	ENSG00000188177	376940	zinc finger CCCH-type containing 6	FLJ41410|FLJ45877|KIAA2035|ZC3HDC6	protein_coding	P61129	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9061
8.42320988273017e-49	-0.255240213475553	0.372	0.547	1.5278018085296e-44	UBE2Z	Malignant cells	GSE139386	ENSG00000159202	65264	ubiquitin conjugating enzyme E2 Z	FLJ13855|USE1	protein_coding	Q9H832	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9062
1.03067983036782e-48	-0.274361378065168	0.477	0.642	1.86944707632115e-44	RPUSD3	Malignant cells	GSE139386	ENSG00000156990	285367	RNA pseudouridine synthase D3	MGC29784	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9063
1.38100076909267e-48	-0.263036060967927	0.887	0.948	2.50485919498029e-44	SSSCA1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9064
1.80688396149484e-48	-0.25618303769385	0.725	0.856	3.27732612935934e-44	MRPL34	Malignant cells	GSE139386	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9065
1.98694447033026e-48	0.299505457427207	0.842	0.788	3.60391988028503e-44	TMEM50A	Malignant cells	GSE139386	ENSG00000183726	23585	transmembrane protein 50A	SMP1	protein_coding	O95807	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9066
2.185801370708e-48	-0.262961714535514	0.336	0.504	3.96460652619017e-44	PRKAR2A	Malignant cells	GSE139386	ENSG00000114302	5576	protein kinase cAMP-dependent type II regulatory subunit alpha	PRKAR2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9067
2.29565441971322e-48	0.310831217108106	0.58	0.426	4.16385798647583e-44	RFXANK	Malignant cells	GSE139386	ENSG00000064490	8625	regulatory factor X associated ankyrin containing protein	ANKRA1|BLS|F14150_1|MGC138628|RFX-B	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9068
2.58662814797003e-48	-0.268380540871813	0.522	0.68	4.69162613478804e-44	RRP36	Malignant cells	GSE139386	ENSG00000124541	88745	ribosomal RNA processing 36	C6orf153|dJ20C7.4	protein_coding	Q96EU6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9069
2.98533962917167e-48	0.289960447137276	0.865	0.807	5.41480901939157e-44	UXT	Malignant cells	GSE139386	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9070
5.86482192348896e-48	0.307632949195209	0.486	0.324	1.06376140048243e-43	AKIRIN2	Malignant cells	GSE139386	ENSG00000135334	55122	akirin 2	C6orf166|dJ486L4.2|FLJ10342	protein_coding	Q53H80	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9071
6.96277852956391e-48	0.30677656879511	0.9	0.897	1.2629087696923e-43	KHDRBS1	Malignant cells	GSE139386	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9072
9.97258977344012e-48	0.297878423036669	0.833	0.765	1.80882833310657e-43	GRHPR	Malignant cells	GSE139386	ENSG00000137106	9380	glyoxylate and hydroxypyruvate reductase	GLXR|PH2	protein_coding	Q9UBQ7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9073
1.12998866904665e-47	0.314545389891814	0.873	0.809	2.04957344791682e-43	SETD5-AS1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9074
1.32005859314243e-47	0.299132932496329	0.88	0.827	2.39432227624174e-43	TARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9075
1.39491778279202e-47	-0.290889651868319	0.694	0.833	2.53010187442817e-43	SFPQ	Malignant cells	GSE139386	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9076
1.44513495092383e-47	-0.268351118810939	0.538	0.692	2.62118577398565e-43	IRF2BP2	Malignant cells	GSE139386	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9077
1.91107768773108e-47	-0.253256409361315	0.355	0.522	3.46631271000663e-43	DDX3X	Malignant cells	GSE139386	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9078
2.96082394516922e-47	-0.254322825028944	0.669	0.816	5.37034247174793e-43	TOMM5	Malignant cells	GSE139386	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9079
2.98938768662147e-47	0.310025740652363	0.821	0.73	5.42215138599403e-43	AIMP1	Malignant cells	GSE139386	ENSG00000164022	9255	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	EMAP-2|EMAPII|p43|SCYE1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9080
3.64339284574995e-47	0.331009310000512	0.747	0.649	6.60838594362126e-43	SMAD3	Malignant cells	GSE139386	ENSG00000166949	4088	SMAD family member 3	HsT17436|JV15-2|MADH3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9081
3.85762241888278e-47	0.340941702967289	0.685	0.551	6.99695554336958e-43	PYCARD	Malignant cells	GSE139386	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9082
3.90749697297383e-47	-0.262224246080453	0.481	0.649	7.08741800957993e-43	ABHD11	Malignant cells	GSE139386	ENSG00000106077	83451	abhydrolase domain containing 11	PP1226|WBSCR21	protein_coding	Q8NFV4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9083
3.98512261098764e-47	-0.269095436973466	0.615	0.762	7.22821539180938e-43	FAM133B	Malignant cells	GSE139386	ENSG00000234545	257415	family with sequence similarity 133 member B	MGC40405	protein_coding	Q5BKY9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9084
4.51130822046319e-47	-0.282386322266922	0.753	0.868	8.18261085027613e-43	WBSCR22	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9085
4.68746519142044e-47	-0.286451660785362	0.684	0.828	8.5021243641984e-43	MARCH6	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9086
5.85296099762238e-47	-0.253032211179916	0.756	0.87	1.06161006574875e-42	POLDIP2	Malignant cells	GSE139386	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9087
6.17451055257831e-47	0.303932662102843	0.595	0.439	1.11993272402665e-42	TM9SF2	Malignant cells	GSE139386	ENSG00000125304	9375	transmembrane 9 superfamily member 2	P76	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9088
8.08846057186488e-47	0.262729008313436	0.965	0.953	1.46708497852485e-42	HEBP2	Malignant cells	GSE139386	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9089
8.8868564124646e-47	-0.250195080395702	0.457	0.622	1.61189801609283e-42	NR1H2	Malignant cells	GSE139386	ENSG00000131408	7376	nuclear receptor subfamily 1 group H member 2	LXR-b|LXRb|NER|NER-I|RIP15|UNR	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9090
9.41465638081578e-47	0.277443028676998	0.42	0.255	1.70763037435237e-42	SRPR	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9091
9.89819764224495e-47	0.275107415484659	0.425	0.261	1.79533508835039e-42	CLCN3	Malignant cells	GSE139386	ENSG00000109572	1182	chloride voltage-gated channel 3	ClC-3|CLC3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9092
1.27345307206092e-46	0.291141885090607	0.863	0.815	2.3097891821041e-42	PPFIA1	Malignant cells	GSE139386	ENSG00000288198	8500	PTPRF interacting protein alpha 1	LIP.1|LIPRIN	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9093
4.43002948125643e-46	0.345045767760187	0.756	0.657	8.03518747310291e-42	HPCAL1	Malignant cells	GSE139386	ENSG00000115756	3241	hippocalcin like 1	BDR1|HLP2|VILIP-3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9094
4.50186031363776e-46	-0.273603268299766	0.722	0.85	8.16547423687616e-42	C14orf119	Malignant cells	GSE139386	ENSG00000179933	55017	chromosome 14 open reading frame 119	FLJ20671	protein_coding	Q9NWQ9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9095
4.96655101952175e-46	-0.276602168120961	0.479	0.626	9.00833023920856e-42	YTHDF1	Malignant cells	GSE139386	ENSG00000149658	54915	YTH N6-methyladenosine RNA binding protein 1	C20orf21|FLJ20391	protein_coding	Q9BYJ9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9096
6.05794143228157e-46	-0.279855344092098	0.547	0.684	1.09878941698723e-41	DNAJC2	Malignant cells	GSE139386	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9097
6.19929818347745e-46	0.262378728473522	0.391	0.226	1.12442870451914e-41	COPB1	Malignant cells	GSE139386	ENSG00000129083	1315	COPI coat complex subunit beta 1	COPB	protein_coding	P53618	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9098
8.52443159970823e-46	-0.317855565194276	0.398	0.547	1.54616140355508e-41	ACTN1	Malignant cells	GSE139386	ENSG00000072110	87	actinin alpha 1	NA	protein_coding	P12814	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9099
1.07734086141965e-45	0.285417349525917	0.438	0.278	1.95408085444296e-41	THG1L	Malignant cells	GSE139386	ENSG00000113272	54974	tRNA-histidine guanylyltransferase 1 like	FLJ11601|FLJ20546|hTHG1|ICF45|IHG-1	protein_coding	Q9NWX6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9100
1.16204805872583e-45	-0.349344361193214	0.69	0.806	2.10772276891692e-41	SSB	Malignant cells	GSE139386	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9101
1.26491296929386e-45	0.316127963059324	0.635	0.5	2.2942991437052e-41	IDH3G	Malignant cells	GSE139386	ENSG00000067829	3421	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma	NA	protein_coding	P51553	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9102
2.79802017570473e-45	0.29068381947178	0.494	0.334	5.07504899469324e-41	ATP6AP1	Malignant cells	GSE139386	ENSG00000071553	537	ATPase H+ transporting accessory protein 1	16A|Ac45|ATP6IP1|ATP6S1|CF2|ORF|VATPS1|XAP-3|XAP3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9103
3.18584531389227e-45	0.278082874661462	0.436	0.274	5.77848623033781e-41	BLVRA	Malignant cells	GSE139386	ENSG00000106605	644	biliverdin reductase A	BLVR	protein_coding	P53004	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9104
3.24225617984803e-45	0.358856552143274	0.645	0.533	5.88080425900835e-41	AGRN	Malignant cells	GSE139386	ENSG00000188157	375790	agrin	AGRIN	protein_coding	O00468	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9105
3.79288842669972e-45	-0.277273065712477	0.386	0.543	6.87954102834794e-41	GNPNAT1	Malignant cells	GSE139386	ENSG00000100522	64841	glucosamine-phosphate N-acetyltransferase 1	FLJ10607|Gpnat1	protein_coding	Q96EK6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9106
5.62711650667208e-45	0.285116809095757	0.45	0.292	1.02064639198018e-40	TTC17	Malignant cells	GSE139386	ENSG00000052841	55761	tetratricopeptide repeat domain 17	FLJ10890	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9107
5.71870249447285e-45	0.311064447986325	0.287	0.141	1.03725825844749e-40	FAM211A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9108
1.13381416603944e-44	-0.256373169360543	0.381	0.535	2.05651213436234e-40	RAB8A	Malignant cells	GSE139386	ENSG00000167461	4218	RAB8A, member RAS oncogene family	MEL|RAB8	protein_coding	P61006	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9109
1.40532850718352e-44	0.292152606643111	0.802	0.718	2.54898484632946e-40	DHX36	Malignant cells	GSE139386	ENSG00000281763	170506	DEAH-box helicase 36	DDX36|KIAA1488|MLEL1|RHAU	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9110
1.41144290867304e-44	0.293693522775721	0.537	0.382	2.56007514775116e-40	SLC39A6	Malignant cells	GSE139386	ENSG00000141424	25800	solute carrier family 39 member 6	LIV-1	protein_coding	Q13433	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9111
1.76179367329949e-44	0.345355794798563	0.715	0.624	3.19554136463062e-40	TYMP	Malignant cells	GSE139386	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9112
2.02105545737604e-44	0.297363220700258	0.596	0.448	3.66579038858867e-40	MARS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9113
2.33541328194646e-44	0.330254548280965	0.88	0.857	4.23597261079448e-40	RHOF	Malignant cells	GSE139386	ENSG00000139725	54509	ras homolog family member F, filopodia associated	ARHF|FLJ20247|RIF	protein_coding	Q9HBH0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9114
2.38951397147931e-44	-0.26445063498061	0.474	0.632	4.33410044146917e-40	COMMD3	Malignant cells	GSE139386	ENSG00000148444	23412	COMM domain containing 3	BUP|C10orf8	protein_coding	Q9UBI1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9115
2.65352572516441e-44	0.314099733437558	0.534	0.382	4.8129649603032e-40	SEC14L1	Malignant cells	GSE139386	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9116
2.71951785483566e-44	0.349182471905694	0.784	0.717	4.93266148510092e-40	TSPAN4	Malignant cells	GSE139386	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9117
3.26259286039883e-44	0.323582039516854	0.722	0.632	5.9176909301914e-40	CCNC	Malignant cells	GSE139386	ENSG00000112237	892	cyclin C	CycC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9118
4.04090350623218e-44	0.28747798115128	0.743	0.626	7.32939077960392e-40	OCIAD1	Malignant cells	GSE139386	ENSG00000109180	54940	OCIA domain containing 1	Asrij|FLJ20455|OCIA|TPA018	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9119
4.23397836162551e-44	0.270844114458133	0.301	0.154	7.67958995231635e-40	P4HA1	Malignant cells	GSE139386	ENSG00000122884	5033	prolyl 4-hydroxylase subunit alpha 1	C-P4Halpha(I)|P4HA	protein_coding	P13674	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9120
5.05623356843817e-44	0.296428394293059	0.734	0.625	9.17099644643316e-40	MRPS35	Malignant cells	GSE139386	ENSG00000061794	60488	mitochondrial ribosomal protein S35	MDS023|MRPS28	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9121
5.84154520083899e-44	-0.259984738323245	0.79	0.892	1.05953946852818e-39	MRPL37	Malignant cells	GSE139386	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9122
6.27270672224296e-44	-0.251905002374781	0.577	0.725	1.13774354528043e-39	CAPRIN1	Malignant cells	GSE139386	ENSG00000135387	4076	cell cycle associated protein 1	caprin-1|GPIAP1|M11S1|RNG105	protein_coding	Q14444	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9123
8.88186936299547e-44	0.250117664487837	0.371	0.214	1.61099346506012e-39	IRF2BPL	Malignant cells	GSE139386	ENSG00000119669	64207	interferon regulatory factor 2 binding protein like	C14orf4|EAP1|KIAA1865	protein_coding	Q9H1B7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9124
1.46644803474301e-43	0.305554847610333	0.503	0.349	2.65984344541687e-39	GOLGB1	Malignant cells	GSE139386	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9125
1.50441992930086e-43	0.320289365806487	0.651	0.53	2.7287168677659e-39	SLC25A36	Malignant cells	GSE139386	ENSG00000114120	55186	solute carrier family 25 member 36	FLJ10618|PNC2	protein_coding	Q96CQ1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9126
1.78157021080754e-43	0.304039809360427	0.654	0.519	3.23141204836272e-39	VPS37B	Malignant cells	GSE139386	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9127
2.39917762343006e-43	0.309406581450062	0.69	0.568	4.35162837337745e-39	CDC34	Malignant cells	GSE139386	ENSG00000099804	997	cell division cycle 34, ubiqiutin conjugating enzyme	E2-CDC34|UBC3|UBE2R1	protein_coding	P49427	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9128
4.16130654379959e-43	0.283501896006282	0.463	0.31	7.54777780914369e-39	SCARB2	Malignant cells	GSE139386	ENSG00000138760	950	scavenger receptor class B member 2	CD36L2|HLGP85|LIMP-2|LIMPII|SR-BII	protein_coding	Q14108	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9129
7.51858544103365e-43	0.287863292160738	0.822	0.763	1.36372102729468e-38	TMED3	Malignant cells	GSE139386	ENSG00000166557	23423	transmembrane p24 trafficking protein 3	C15orf22|p24B|p24g4|p24gamma4	protein_coding	Q9Y3Q3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9130
8.89096741657901e-43	-0.268919523436039	0.6	0.733	1.6126436700191e-38	YTHDC1	Malignant cells	GSE139386	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9131
1.04010161598926e-42	-0.262484953562939	0.372	0.523	1.88653631108131e-38	EVA1B	Malignant cells	GSE139386	ENSG00000142694	55194	eva-1 homolog B	C1orf78|FAM176B|FLJ10647	protein_coding	Q9NVM1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9132
1.04791188377289e-42	-0.252061451679424	0.74	0.861	1.90070257478726e-38	FAM173A	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9133
1.05936365357656e-42	0.253136481300251	0.404	0.248	1.92147379485716e-38	PTPRA	Malignant cells	GSE139386	ENSG00000132670	5786	protein tyrosine phosphatase receptor type A	HLPR|HPTPA|LRP|PTPA|PTPRL2|RPTPA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9134
2.38004992839318e-42	0.275362516856888	0.463	0.308	4.31693456011954e-38	RIOK3	Malignant cells	GSE139386	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9135
4.16766307234629e-42	-0.255220293351081	0.305	0.458	7.5593072806217e-38	NSMCE2	Malignant cells	GSE139386	ENSG00000156831	286053	NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase	C8orf36|FLJ32440|MMS21|NSE2|ZMIZ7	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9136
4.28436447788625e-42	0.271215583643449	0.549	0.388	7.77098028999007e-38	NDUFS2	Malignant cells	GSE139386	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9137
4.61405552123362e-42	0.283641884911881	0.493	0.34	8.36897390441353e-38	SRPRB	Malignant cells	GSE139386	ENSG00000144867	58477	SRP receptor subunit beta	APMCF1|SR-beta	protein_coding	Q9Y5M8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9138
4.83562721018712e-42	0.291122954730881	0.607	0.47	8.77086063383741e-38	CTNND1	Malignant cells	GSE139386	ENSG00000198561	1500	catenin delta 1	CTNND|KIAA0384|p120|p120cas|p120ctn	protein_coding	O60716	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9139
7.98123791698128e-42	0.286310425935605	0.452	0.301	1.44763693338206e-37	NMD3	Malignant cells	GSE139386	ENSG00000169251	51068	NMD3 ribosome export adaptor	CGI-07	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9140
1.02008814858309e-41	-0.263815498255696	0.679	0.797	1.85023588390002e-37	EWSR1	Malignant cells	GSE139386	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9141
1.3604222040391e-41	-0.30896960866461	0.809	0.898	2.46753379368612e-37	NUDC	Malignant cells	GSE139386	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9142
1.59269073209948e-41	-0.257432262666044	0.88	0.934	2.88882244988204e-37	LRRC59	Malignant cells	GSE139386	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9143
1.83736964468062e-41	0.253952586805982	0.396	0.242	3.33262106152171e-37	H2AFY2	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9144
2.53263309371584e-41	-0.269566841254334	0.759	0.87	4.59368990538179e-37	COPZ1	Malignant cells	GSE139386	ENSG00000111481	22818	COPI coat complex subunit zeta 1	CGI-120|COPZ	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9145
2.84930628029462e-41	0.304390892322807	0.699	0.583	5.16807173119839e-37	SMARCA4	Malignant cells	GSE139386	ENSG00000127616	6597	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	BAF190|BRG1|FLJ39786|hSNF2b|SNF2|SNF2-BETA|SNF2L4|SNF2LB|SWI2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9146
2.91107331295133e-41	0.30136907403878	0.664	0.547	5.28010477503112e-37	PPP1R2	Malignant cells	GSE139386	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9147
7.22239981916203e-41	-0.261935098933761	0.686	0.814	1.30999887919961e-36	PRDX4	Malignant cells	GSE139386	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9148
8.15475636361208e-41	0.292544417292246	0.632	0.504	1.47910970923196e-36	SIGMAR1	Malignant cells	GSE139386	ENSG00000147955	10280	sigma non-opioid intracellular receptor 1	OPRS1|SR-BP1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9149
1.13014096322403e-40	-0.2544325242781	0.54	0.675	2.04984967909574e-36	EIF1B	Malignant cells	GSE139386	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9150
1.20670680539081e-40	0.268579184065394	0.473	0.319	2.18872480361786e-36	CERS6	Malignant cells	GSE139386	ENSG00000172292	253782	ceramide synthase 6	LASS6	protein_coding	Q6ZMG9	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9151
1.67000727293101e-40	0.287853779386061	0.609	0.478	3.02905919164226e-36	ZFPL1	Malignant cells	GSE139386	ENSG00000162300	7542	zinc finger protein like 1	D11S750|MCG4	protein_coding	O95159	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9152
2.41530062407295e-40	-0.267197044210904	0.456	0.617	4.38087227194352e-36	MCM7	Malignant cells	GSE139386	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9153
2.71067145659675e-40	0.266594960833618	0.481	0.329	4.91661588797518e-36	CCNH	Malignant cells	GSE139386	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9154
2.73249705960578e-40	0.270792189802999	0.481	0.33	4.95620316671297e-36	LHPP	Malignant cells	GSE139386	ENSG00000107902	64077	phospholysine phosphohistidine inorganic pyrophosphate phosphatase	HDHD2B	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9155
3.34003828484301e-40	0.299328152524074	0.577	0.448	6.05816144104825e-36	GOLT1B	Malignant cells	GSE139386	ENSG00000111711	51026	golgi transport 1B	CGI-141|GOT1|YMR292W	protein_coding	Q9Y3E0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9156
3.4849115205709e-40	-0.255778558902351	0.595	0.728	6.32093251601149e-36	CHMP2B	Malignant cells	GSE139386	ENSG00000083937	25978	charged multivesicular body protein 2B	CHMP2.5|DKFZP564O123|VPS2B	protein_coding	Q9UQN3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9157
4.16984325130542e-40	0.288087019109905	0.709	0.597	7.56326168921776e-36	XRN2	Malignant cells	GSE139386	ENSG00000088930	22803	5'-3' exoribonuclease 2	NA	protein_coding	Q9H0D6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9158
4.62181840547716e-40	-0.279810248965288	0.921	0.954	8.38305422385447e-36	PSMD8	Malignant cells	GSE139386	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9159
6.60475048790448e-40	0.27998893014613	0.723	0.605	1.19796964349612e-35	OSBPL8	Malignant cells	GSE139386	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9160
6.68229946840957e-40	0.335399323778617	0.694	0.583	1.21203547758013e-35	SAV1	Malignant cells	GSE139386	ENSG00000151748	60485	salvador family WW domain containing protein 1	salvador|WW45|WWP4	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9161
8.05657880470566e-40	0.279419011639695	0.516	0.372	1.46130226359751e-35	NUS1	Malignant cells	GSE139386	ENSG00000153989	116150	NUS1 dehydrodolichyl diphosphate synthase subunit	C6orf68|MGC7199|NgBR|TANGO14	protein_coding	Q96E22	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9162
1.11079426276643e-39	0.28218678212925	0.788	0.7	2.01475863380575e-35	MPHOSPH8	Malignant cells	GSE139386	ENSG00000196199	54737	M-phase phosphoprotein 8	HSMPP8|mpp8	protein_coding	Q99549	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9163
1.15324721653661e-39	0.289223088523581	0.621	0.488	2.0917598013541e-35	MTX2	Malignant cells	GSE139386	ENSG00000128654	10651	metaxin 2	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9164
1.76471085195165e-39	-0.255349582575753	0.773	0.872	3.2008325432699e-35	TRAF4	Malignant cells	GSE139386	ENSG00000076604	9618	TNF receptor associated factor 4	CART1|MLN62|RNF83	protein_coding	Q9BUZ4	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9165
2.67640020169131e-39	-0.285424431084937	0.784	0.882	4.8544546858277e-35	APEX1	Malignant cells	GSE139386	ENSG00000100823	328	apurinic/apyrimidinic endodeoxyribonuclease 1	APE|APE-1|APEN|APEX|APX|HAP1|REF-1|REF1	protein_coding	P27695	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9166
2.87951517247397e-39	0.277246311263265	0.507	0.364	5.22286461983328e-35	FADS3	Malignant cells	GSE139386	ENSG00000221968	3995	fatty acid desaturase 3	CYB5RP|LLCDL3	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9167
3.92843195525518e-39	0.287941986057323	0.654	0.523	7.12538988044185e-35	GSDMD	Malignant cells	GSE139386	ENSG00000278718	79792	gasdermin D	DF5L|FLJ12150|GSDMDC1	protein_coding	P57764	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9168
4.82492682234329e-39	-0.254335791660223	0.556	0.699	8.75145227036626e-35	ATP1A1	Malignant cells	GSE139386	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9169
5.11401852526641e-39	0.296797383764473	0.675	0.566	9.27580680112822e-35	GRN	Malignant cells	GSE139386	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9170
7.38365072238676e-39	0.289326762147935	0.463	0.319	1.33924656802651e-34	NBPF10	Malignant cells	GSE139386	ENSG00000271425	100132406	NBPF member 10	AG1	protein_coding	Q6P3W6	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9171
1.17283997339739e-38	0.276856317992832	0.565	0.425	2.12729714374819e-34	TMED7	Malignant cells	GSE139386	ENSG00000134970	51014	transmembrane p24 trafficking protein 7	CGI-109|FLJ90481|p24g3|p24gamma3	protein_coding	Q9Y3B3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9172
1.84334720938629e-38	0.373633763210952	0.448	0.316	3.34346316838485e-34	CTSC	Malignant cells	GSE139386	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9173
2.61248652593529e-38	0.308742088392578	0.647	0.525	4.73852806074144e-34	KLF5	Malignant cells	GSE139386	ENSG00000102554	688	KLF transcription factor 5	BTEB2|CKLF|IKLF	protein_coding	Q13887	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9174
3.17902824188682e-38	0.276215474182781	0.771	0.677	5.76612142513431e-34	TAF7	Malignant cells	GSE139386	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9175
4.89073069217832e-38	0.328835159959792	0.799	0.723	8.87080732947305e-34	HES1	Malignant cells	GSE139386	ENSG00000114315	3280	hes family bHLH transcription factor 1	bHLHb39|FLJ20408|HES-1|HRY	protein_coding	Q14469	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9176
4.9296509880188e-38	0.276894092909747	0.657	0.535	8.9414009620685e-34	ESD	Malignant cells	GSE139386	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9177
1.01133650064814e-37	0.298624848318679	0.618	0.505	1.83436214487559e-33	CD320	Malignant cells	GSE139386	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9178
1.10111025231564e-37	-0.289422311917626	0.624	0.753	1.9971937756501e-33	HNRNPM	Malignant cells	GSE139386	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9179
1.2589298497993e-37	0.283290475966955	0.788	0.722	2.28344696156598e-33	AP2B1	Malignant cells	GSE139386	ENSG00000006125	163	adaptor related protein complex 2 subunit beta 1	ADTB2|CLAPB1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9180
1.41169558712569e-37	0.266193544193461	0.784	0.703	2.56053345592858e-33	TMCO1	Malignant cells	GSE139386	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9181
2.76998942846778e-37	0.251684013473155	0.89	0.872	5.02420682535485e-33	IFT20	Malignant cells	GSE139386	ENSG00000109083	90410	intraflagellar transport 20	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9182
4.1979295087777e-37	0.272064671479867	0.564	0.426	7.61420454302099e-33	XIAP	Malignant cells	GSE139386	ENSG00000101966	331	X-linked inhibitor of apoptosis	API3|BIRC4|hILP|ILP-1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9183
7.19359647643604e-37	0.278196765488966	0.566	0.435	1.30477452889597e-32	TRIM44	Malignant cells	GSE139386	ENSG00000166326	54765	tripartite motif containing 44	DIPB|MC7	protein_coding	Q96DX7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9184
1.67507556145411e-36	-0.401573775513526	0.664	0.796	3.03825205336547e-32	RBP1	Malignant cells	GSE139386	ENSG00000114115	5947	retinol binding protein 1	CRABP-I|CRBP|CRBP1|CRBPI|RBPC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9185
2.54990749901867e-36	0.266900956041708	0.517	0.379	4.62502222172006e-32	HLA-E	Malignant cells	GSE139386	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9186
4.31507274874974e-36	0.30511174072861	0.933	0.9	7.82667895168228e-32	JUNB	Malignant cells	GSE139386	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9187
1.23093547913773e-35	0.27551798644994	0.727	0.638	2.23267077206001e-31	LCMT1	Malignant cells	GSE139386	ENSG00000205629	51451	leucine carboxyl methyltransferase 1	CGI-68|PPMT1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9188
1.50547799548963e-35	0.273654910473604	0.652	0.532	2.73063598821909e-31	ITPA	Malignant cells	GSE139386	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9189
1.88698886801352e-35	0.25504198471488	0.86	0.828	3.42262040880293e-31	UBE2R2	Malignant cells	GSE139386	ENSG00000107341	54926	ubiquitin conjugating enzyme E2 R2	CDC34B|FLJ20419|MGC10481|UBC3B	protein_coding	Q712K3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9190
3.19008567295709e-35	0.282004575230179	0.613	0.5	5.78617739360957e-31	PTPLAD1	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9191
5.224388388938e-35	0.281925922722204	0.477	0.345	9.47599565985575e-31	BTG3	Malignant cells	GSE139386	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9192
7.27645485214159e-35	0.292972470704841	0.499	0.368	1.31980338108144e-30	SLC35F6	Malignant cells	GSE139386	ENSG00000213699	54978	solute carrier family 35 member F6	ANT2BP|C2orf18|FLJ20555|TANGO9	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9193
8.15141195531012e-35	-0.285148522852699	0.701	0.788	1.47850310045415e-30	GADD45A	Malignant cells	GSE139386	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9194
1.26175061313197e-34	0.251363113626155	0.479	0.342	2.28856326209877e-30	MPC1	Malignant cells	GSE139386	ENSG00000060762	51660	mitochondrial pyruvate carrier 1	BRP44L|CGI-129|dJ68L15.3|SLC54A1	protein_coding	Q9Y5U8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9195
3.02879170320475e-34	-0.296440449947039	0.876	0.918	5.49362239127277e-30	MARCKSL1	Malignant cells	GSE139386	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9196
1.34432578140522e-33	0.257061812912614	0.624	0.504	2.43833810231279e-29	RAB3IP	Malignant cells	GSE139386	ENSG00000127328	117177	RAB3A interacting protein	FLJ22548|RABIN3|RABIN8	protein_coding	Q96QF0	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9197
1.68025891401863e-33	0.275010959477231	0.79	0.732	3.047653618247e-29	MRPS26	Malignant cells	GSE139386	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9198
2.74822169820327e-33	0.25268273817664	0.484	0.35	4.9847245162011e-29	F11R	Malignant cells	GSE139386	ENSG00000158769	50848	F11 receptor	CD321|JAM-1|JAM-A|JAM1|JAMA|JCAM|PAM-1	protein_coding	Q9Y624	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9199
3.22945435253514e-33	0.260539685124332	0.592	0.478	5.85758430462823e-29	EXOC7	Malignant cells	GSE139386	ENSG00000182473	23265	exocyst complex component 7	BLOM4|EXO70|Exo70p|KIAA1067|YJL085W	protein_coding	Q9UPT5	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9200
5.98014216962784e-33	0.277477457134333	0.658	0.551	1.0846781867271e-28	WDR74	Malignant cells	GSE139386	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9201
7.03072398330883e-33	0.255001859531737	0.602	0.475	1.27523271609255e-28	EPRS	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9202
3.19716005335239e-32	0.272206488996831	0.784	0.714	5.79900890477057e-28	EIF2A	Malignant cells	GSE139386	ENSG00000144895	83939	eukaryotic translation initiation factor 2A	EIF-2A	protein_coding	Q9BY44	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9203
6.00941934238624e-32	0.294247587855002	0.72	0.657	1.08998848032202e-27	HAGH	Malignant cells	GSE139386	ENSG00000063854	3029	hydroxyacylglutathione hydrolase	GLO2|GLXII|HAGH1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9204
6.68991571384128e-32	0.255287091397078	0.86	0.846	1.21341691217653e-27	CNN2	Malignant cells	GSE139386	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9205
1.01549244932239e-31	0.256792209790874	0.567	0.439	1.84190020458095e-27	DNTTIP1	Malignant cells	GSE139386	ENSG00000101457	116092	deoxynucleotidyltransferase terminal interacting protein 1	C20orf167|dJ447F3.4|Tdif1	protein_coding	Q9H147	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9206
2.48117584981983e-31	-0.301455211294167	0.993	0.992	4.5003567564032e-27	MYL12B	Malignant cells	GSE139386	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9207
4.34408569560441e-31	0.257305324678541	0.621	0.513	7.87930263468729e-27	ZFAND3	Malignant cells	GSE139386	ENSG00000156639	60685	zinc finger AN1-type containing 3	FLJ13222|TEX27	protein_coding	Q9H8U3	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9208
5.84981088403276e-31	0.260820039456449	0.725	0.638	1.06103869814586e-26	CCDC104	Malignant cells	GSE139386	NA	NA	NA	NA	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9209
6.26562968195504e-31	0.274176509824525	0.663	0.563	1.13645991171301e-26	ERV3-1	Malignant cells	GSE139386	ENSG00000213462	2086	endogenous retrovirus group 3 member 1, envelope	envR|ERV-R|ERV3|H-PLK|HERV-R	protein_coding	Q14264	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9210
7.12858874427667e-31	-0.455867623752946	0.716	0.783	1.2929834264369e-26	ID1	Malignant cells	GSE139386	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9211
3.31146196670141e-30	0.26089211541274	0.679	0.583	6.00632971520301e-26	PTBP3	Malignant cells	GSE139386	ENSG00000119314	9991	polypyrimidine tract binding protein 3	DKFZp781I1117|ROD1	protein_coding	O95758	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9212
7.71992452749423e-30	0.27760766920193	0.383	0.261	1.4002399107969e-25	IFITM3	Malignant cells	GSE139386	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9213
1.08003604189546e-29	0.259956926474164	0.633	0.525	1.95896937278998e-25	CRB3	Malignant cells	GSE139386	ENSG00000130545	92359	crumbs cell polarity complex component 3	MGC17303	protein_coding	Q9BUF7	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9214
2.49837810087963e-29	0.275419458909486	0.502	0.388	4.53155819937547e-25	UBE2L6	Malignant cells	GSE139386	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9215
4.90263243702347e-29	0.257166887877218	0.568	0.455	8.89239471427316e-25	TBPL1	Malignant cells	GSE139386	ENSG00000028839	9519	TATA-box binding protein like 1	STUD|TLF|TLP|TRF2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9216
5.30784155949125e-29	0.256950707026201	0.711	0.629	9.62736302060522e-25	ATP2A2	Malignant cells	GSE139386	ENSG00000174437	488	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2	ATP2B|DAR|SERCA2	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9217
5.76357947939217e-28	0.259854888398399	0.696	0.622	1.04539804597215e-23	SDF4	Malignant cells	GSE139386	ENSG00000078808	51150	stromal cell derived factor 4	Cab45	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9218
8.63587204616987e-28	0.258306325281228	0.827	0.782	1.56637447173429e-23	CDC42	Malignant cells	GSE139386	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9219
8.116979390068e-27	-0.255846278454113	0.999	0.997	1.47225772177053e-22	NEAT1	Malignant cells	GSE139386	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9220
9.43831480641535e-27	0.252005148434232	0.72	0.646	1.71192153958762e-22	IFNGR2	Malignant cells	GSE139386	ENSG00000262795	3460	interferon gamma receptor 2	AF-1|IFNGT1	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9221
6.65939207704703e-26	0.255268628940139	0.553	0.449	1.20788053493479e-21	LUZP1	Malignant cells	GSE139386	ENSG00000169641	7798	leucine zipper protein 1	LUZP	protein_coding	Q86V48	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9222
1.44191207717633e-24	0.310946216368592	0.319	0.215	2.61534012558242e-20	PTPRS	Malignant cells	GSE139386	ENSG00000105426	5802	protein tyrosine phosphatase receptor type S	NA	protein_coding	Q13332	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9223
2.05868369823297e-24	0.306410665015094	0.605	0.528	3.73404049185495e-20	RAMP1	Malignant cells	GSE139386	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9224
4.25018304564544e-24	-0.272238666151928	0.952	0.975	7.7089820081917e-20	CKB	Malignant cells	GSE139386	ENSG00000166165	1152	creatine kinase B	CKBB	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9225
5.15139911831664e-24	-0.338933665745226	0.888	0.918	9.34360772080272e-20	FKBP3	Malignant cells	GSE139386	ENSG00000100442	2287	FKBP prolyl isomerase 3	FKBP-25|FKBP25	protein_coding	Q00688	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9226
2.88896796695743e-22	0.252453670769945	0.734	0.685	5.24001009846738e-18	BIK	Malignant cells	GSE139386	ENSG00000100290	638	BCL2 interacting killer	NBK	protein_coding	Q13323	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9227
2.44831677008538e-21	-0.269575221423138	0.648	0.729	4.44075695758087e-17	CD9	Malignant cells	GSE139386	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9228
2.2031282537762e-20	0.256838268359197	0.679	0.615	3.99603402669927e-16	SLC2A1	Malignant cells	GSE139386	ENSG00000117394	6513	solute carrier family 2 member 1	CSE|DYT18|DYT9|GLUT|GLUT-1|GLUT1|HTLVR	protein_coding	P11166	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9229
1.73678734555646e-19	0.280684614986224	0.439	0.353	3.1501848873703e-15	GCLC	Malignant cells	GSE139386	ENSG00000001084	2729	glutamate-cysteine ligase catalytic subunit	GCS|GLCL|GLCLC	protein_coding	NA	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9230
1.10789395135932e-18	-0.331942534370891	0.379	0.482	2.00949804897553e-14	CXCL2	Malignant cells	GSE139386	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9231
2.09919800998296e-11	-0.256881439471746	0.874	0.913	3.8075253505071e-07	PSMA3	Malignant cells	GSE139386	ENSG00000100567	5684	proteasome 20S subunit alpha 3	HC8	protein_coding	P25788	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9232
3.00120956948681e-08	0.474411697041119	0.996	1	0.000544359391713517	MT2A	Malignant cells	GSE139386	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE139386	GSE139386	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	NA	ceritinib	Homo sapiens	H3122 cell line	Cell line	resistant 1, sensitive 1	2	6986	Public on Sep 20, 2022	35999456	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA321747	10x genomics	CellRanger	Lung_cancer	Targeted_therapy	9233
8.35169590120375e-45	3.45657187033018	1	0.993	2.33555175877163e-40	SRI	Malignant cells	GSE140440	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9234
2.49060866937957e-43	3.28566226880709	1	0.746	6.96498714391997e-39	TFPI	Malignant cells	GSE140440	ENSG00000003436	7035	tissue factor pathway inhibitor	EPI|LACI|TFI|TFPI1	protein_coding	P10646	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9235
1.07002212006696e-42	1.85731495070105	1	1	2.99231685876726e-38	GNAS	Malignant cells	GSE140440	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9236
2.44975711657776e-41	8.00071729096411	0.887	0.075	6.85074577650971e-37	ABCB1	Malignant cells	GSE140440	ENSG00000085563	5243	ATP binding cassette subfamily B member 1	ABC20|CD243|CLCS|GP170|MDR1|p-170|P-gp|PGY1	protein_coding	P08183	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9237
2.73212838805395e-41	2.55282834230681	1	0.97	7.64039703719286e-37	TM4SF1	Malignant cells	GSE140440	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9238
2.0454145092914e-37	3.77184162172458	0.92	0.231	5.72000167523339e-33	NOG	Malignant cells	GSE140440	ENSG00000183691	9241	noggin	SYM1|SYNS1	protein_coding	Q13253	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9239
8.25557242085527e-36	-1.10319829897234	1	1	2.30867082749218e-31	HSPD1	Malignant cells	GSE140440	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9240
8.63400180160783e-36	2.38867003805073	0.993	0.664	2.41449860381963e-31	DBNDD2	Malignant cells	GSE140440	ENSG00000244274	55861	dysbindin domain containing 2	C20orf35|HSMNP1	protein_coding	Q9BQY9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9241
1.35635613484287e-35	1.37955012386788	1	0.948	3.79304993108809e-31	NDUFS4	Malignant cells	GSE140440	ENSG00000164258	4724	NADH:ubiquinone oxidoreductase subunit S4	AQDQ|CI-18	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9242
1.08971522304737e-34	2.96715751464627	0.967	0.44	3.04738862125198e-30	CDK14	Malignant cells	GSE140440	ENSG00000058091	5218	cyclin dependent kinase 14	PFTAIRE1|PFTK1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9243
2.52221307661107e-34	1.12893356606554	1	1	7.05336886874284e-30	MYL12A	Malignant cells	GSE140440	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9244
7.82240792114732e-34	1.78646032627508	1	0.933	2.18753637514885e-29	RAI14	Malignant cells	GSE140440	ENSG00000039560	26064	retinoic acid induced 14	DKFZp564G013|KIAA1334|NORPEG|RAI13	protein_coding	Q9P0K7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9245
1.54598753278576e-33	2.7484526336839	0.993	0.843	4.32335413543539e-29	SCD	Malignant cells	GSE140440	ENSG00000099194	6319	stearoyl-CoA desaturase	FADS5|SCD1|SCDOS	protein_coding	O00767	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9246
3.22928370508739e-33	-1.31947235776112	1	1	9.03069188127688e-29	SYNGR2	Malignant cells	GSE140440	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9247
3.40188090876299e-33	-1.45391826953005	1	1	9.5133599613557e-29	POLR2L	Malignant cells	GSE140440	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9248
1.02693196910505e-32	7.29409158013681	0.767	0.06	2.87181525160226e-28	STC1	Malignant cells	GSE140440	ENSG00000159167	6781	stanniocalcin 1	STC	protein_coding	P52823	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9249
1.63718539374784e-32	2.06873152947371	1	0.746	4.57838895361582e-28	TP53TG1	Malignant cells	GSE140440	ENSG00000182165	NA	NA	H_RG012D21.9|LINC00096|TP53AP1|TP53LC12	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9250
5.32970555584357e-32	2.13811003375124	1	0.754	1.49045215869165e-27	SC5D	Malignant cells	GSE140440	ENSG00000109929	6309	sterol-C5-desaturase	SC5DL	protein_coding	O75845	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9251
5.58864810288228e-32	-6.40895967745809	0.113	0.784	1.56286544197103e-27	ACTG2	Malignant cells	GSE140440	ENSG00000163017	72	actin gamma 2, smooth muscle	ACTA3|ACTL3|ACTSG	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9252
1.41771113156284e-31	1.60097260645099	1	0.993	3.96462917941549e-27	EMP3	Malignant cells	GSE140440	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9253
3.31774701097489e-31	-1.22069370720851	1	1	9.27807951619129e-27	HN1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9254
5.34539691782918e-31	6.01738904047674	0.74	0.06	1.49484024807093e-26	RTN1	Malignant cells	GSE140440	ENSG00000139970	6252	reticulon 1	NSP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9255
7.90695728840456e-31	1.91775285444638	1	0.918	2.21118060570233e-26	IFT27	Malignant cells	GSE140440	ENSG00000100360	11020	intraflagellar transport 27	BBS19|FAP156|RABL4|RAYL	protein_coding	Q9BW83	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9256
9.13485393068734e-31	-1.18365185708538	1	1	2.55456190171671e-26	HSP90AA1	Malignant cells	GSE140440	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9257
9.48892512414225e-30	1.01229669877587	1	1	2.65357791096638e-25	RABAC1	Malignant cells	GSE140440	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9258
1.53229200628065e-29	1.18281420741907	1	0.993	4.28505459556383e-25	TMEM230	Malignant cells	GSE140440	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9259
4.23283281707956e-29	1.02202992063294	1	0.985	1.1837116972963e-24	TMEM14A	Malignant cells	GSE140440	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9260
6.04599123546445e-29	2.82721411374792	0.993	0.739	1.69076144899763e-24	ITGA2	Malignant cells	GSE140440	ENSG00000164171	3673	integrin subunit alpha 2	CD49B	protein_coding	P17301	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9261
6.57686970579278e-29	-0.759301155282161	1	1	1.83922161322495e-24	CHCHD2	Malignant cells	GSE140440	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9262
7.35779346266388e-29	1.77754325869764	1	0.828	2.05760694183395e-24	YPEL5	Malignant cells	GSE140440	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9263
7.7380887581573e-29	1.58234957453867	1	1	2.16395652121869e-24	PIGT	Malignant cells	GSE140440	ENSG00000124155	51604	phosphatidylinositol glycan anchor biosynthesis class T	NA	protein_coding	Q969N2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9264
1.07144382435919e-28	1.36742475643208	1	0.873	2.99629265482046e-24	MOCS2	Malignant cells	GSE140440	ENSG00000164172	4338	molybdenum cofactor synthesis 2	MOCO1|MOCS2A|MOCS2B	protein_coding	O96033	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9265
1.5297232038904e-28	3.76171009926132	0.907	0.47	4.2778709396795e-24	ERAP2	Malignant cells	GSE140440	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9266
1.68637801082282e-28	2.62903630758116	0.967	0.627	4.715956107266e-24	PLEK2	Malignant cells	GSE140440	ENSG00000100558	26499	pleckstrin 2	NA	protein_coding	Q9NYT0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9267
2.86559889188456e-28	2.19176575805433	1	0.963	8.01364730115516e-24	DNTTIP1	Malignant cells	GSE140440	ENSG00000101457	116092	deoxynucleotidyltransferase terminal interacting protein 1	C20orf167|dJ447F3.4|Tdif1	protein_coding	Q9H147	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9268
1.71624196762694e-27	2.71256554893874	1	0.813	4.79947066246874e-23	ISG20	Malignant cells	GSE140440	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9269
3.31881202606729e-27	2.30424735458907	0.96	0.701	9.28105783089718e-23	TMEM158	Malignant cells	GSE140440	ENSG00000249992	25907	transmembrane protein 158	p40BBp|RIS1	protein_coding	Q8WZ71	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9270
7.0950921519903e-27	4.1145790367778	0.7	0.097	1.98414252030409e-22	WFDC3	Malignant cells	GSE140440	ENSG00000124116	140686	WAP four-disulfide core domain 3	dJ447F3.3|WAP14	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9271
1.29116970569102e-26	0.831839644318451	1	1	3.61075608196493e-22	NDUFB8	Malignant cells	GSE140440	ENSG00000166136	4714	NADH:ubiquinone oxidoreductase subunit B8	ASHI|CI-ASHI	protein_coding	O95169	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9272
1.80732055511956e-26	-0.883078690077873	1	1	5.05417193239185e-22	NME1	Malignant cells	GSE140440	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9273
2.03138596086168e-26	-1.25320542829269	1	1	5.6807708395497e-22	TXNRD1	Malignant cells	GSE140440	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9274
2.6855556911847e-26	3.81923915016521	0.88	0.366	7.51015649039802e-22	SOCS2	Malignant cells	GSE140440	ENSG00000120833	8835	suppressor of cytokine signaling 2	CIS2|Cish2|SOCS-2|SSI-2|SSI2|STATI2	protein_coding	O14508	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9275
3.46060469755352e-26	1.0057888942595	1	0.985	9.67758103670842e-22	TRAPPC1	Malignant cells	GSE140440	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9276
5.29763226307486e-26	1.4382331901811	1	1	1.48148286236888e-21	CAPN2	Malignant cells	GSE140440	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9277
7.20298369537615e-26	1.33342280808285	1	0.993	2.01431439041194e-21	CTSA	Malignant cells	GSE140440	ENSG00000064601	5476	cathepsin A	GSL|PPGB	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9278
9.00138155266791e-26	1.02053884324042	1	1	2.51723635120358e-21	TMSB10	Malignant cells	GSE140440	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9279
9.35545344019272e-26	1.80810419415055	1	0.896	2.6162525545499e-21	CDCP1	Malignant cells	GSE140440	ENSG00000163814	64866	CUB domain containing protein 1	CD318|SIMA135	protein_coding	Q9H5V8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9280
1.4325629515052e-25	-1.26575649843924	0.973	1	4.0061622938843e-21	ALYREF	Malignant cells	GSE140440	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9281
1.47867066648689e-25	1.32956487143634	1	0.97	4.13510251883058e-21	MPV17	Malignant cells	GSE140440	ENSG00000115204	4358	mitochondrial inner membrane protein MPV17	SYM1	protein_coding	P39210	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9282
1.64629820797502e-25	-1.24405256877384	1	1	4.60387293860214e-21	TUBB	Malignant cells	GSE140440	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9283
2.5784639121077e-25	-0.865628473825559	1	1	7.21067433020918e-21	PSMD12	Malignant cells	GSE140440	ENSG00000197170	5718	proteasome 26S subunit, non-ATPase 12	p55|Rpn5	protein_coding	O00232	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9284
3.07445342807478e-25	4.61566727514219	0.687	0.09	8.59770901161112e-21	IGF2	Malignant cells	GSE140440	ENSG00000167244	3481	insulin like growth factor 2	C11orf43|FLJ44734|IGF-II	protein_coding	P01344	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9285
3.33958013442937e-25	3.28325273074663	0.833	0.291	9.33913584593175e-21	RGS17	Malignant cells	GSE140440	ENSG00000091844	26575	regulator of G protein signaling 17	RGS-17|RGSZ2	protein_coding	Q9UGC6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9286
5.20781090752657e-25	-1.50641211390655	0.973	1	1.45636432028981e-20	YME1L1	Malignant cells	GSE140440	ENSG00000136758	10730	YME1 like 1 ATPase	YME1L	protein_coding	Q96TA2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9287
5.56106153895621e-25	1.39959080640137	0.993	0.776	1.5551508593691e-20	TMEM218	Malignant cells	GSE140440	ENSG00000150433	219854	transmembrane protein 218	NA	protein_coding	A2RU14	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9288
5.86798817179769e-25	1.45239343952088	1	0.94	1.64098289224323e-20	PERP	Malignant cells	GSE140440	ENSG00000112378	64065	p53 apoptosis effector related to PMP22	dJ496H19.1|KCP1|KRTCAP1|PIGPC1|THW	protein_coding	Q96FX8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9289
7.00979853694035e-25	3.78810580354873	0.987	0.873	1.96029016085537e-20	LPIN2	Malignant cells	GSE140440	ENSG00000101577	9663	lipin 2	KIAA0249	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9290
7.78415457760808e-25	5.08183181695498	0.693	0.112	2.1768388276281e-20	CALB2	Malignant cells	GSE140440	ENSG00000282830	794	calbindin 2	CAL2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9291
1.111998883567e-24	-1.12324492288076	0.987	0.993	3.10970487789511e-20	C17orf89	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9292
1.24137723729533e-24	1.555102225727	0.993	0.828	3.4715114440964e-20	CD58	Malignant cells	GSE140440	ENSG00000116815	965	CD58 molecule	LFA3	protein_coding	P19256	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9293
1.30251933479635e-24	2.52756045736184	0.947	0.582	3.642495319758e-20	INSIG1	Malignant cells	GSE140440	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9294
1.56513936212533e-24	1.80229600503209	1	0.918	4.37691222618349e-20	PLAUR	Malignant cells	GSE140440	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9295
1.69202237725244e-24	-0.711674821941552	1	1	4.73174057798644e-20	FAU	Malignant cells	GSE140440	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9296
1.94962948199308e-24	0.843980686640613	1	1	5.45213884639365e-20	RNASEK	Malignant cells	GSE140440	ENSG00000219200	440400	ribonuclease K	MGC71993	protein_coding	Q6P5S7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9297
2.17810308966895e-24	1.98212209447392	0.98	0.739	6.09106529025923e-20	OBFC1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9298
2.76683249316333e-24	3.0715747295415	0.807	0.231	7.73744706713127e-20	VAV1	Malignant cells	GSE140440	ENSG00000141968	7409	vav guanine nucleotide exchange factor 1	VAV	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9299
4.22244361691652e-24	0.691310048603249	1	1	1.1808063574707e-19	ANXA5	Malignant cells	GSE140440	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9300
4.44429016691109e-24	-1.13263464488978	1	1	1.24284574517669e-19	RPLP2	Malignant cells	GSE140440	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9301
4.72395090079944e-24	2.4541758931858	0.933	0.418	1.32105286940856e-19	SYTL2	Malignant cells	GSE140440	ENSG00000137501	54843	synaptotagmin like 2	CHR11SYT|exophilin-4|FLJ20163|FLJ21219|KIAA1597|MGC102768|PPP1R151|SGA72M|SLP2	protein_coding	Q9HCH5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9302
5.11574481493649e-24	0.926844933287605	1	0.993	1.43061803749699e-19	ATRAID	Malignant cells	GSE140440	ENSG00000138085	51374	all-trans retinoic acid induced differentiation factor	APR3|C2orf28|HSPC013|p18	protein_coding	Q6UW56	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9303
9.0891344480941e-24	-0.712402790220208	1	1	2.54177644840952e-19	HSP90AB1	Malignant cells	GSE140440	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9304
1.34081273824286e-23	-1.48057890943575	0.92	1	3.74958282249617e-19	TK1	Malignant cells	GSE140440	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9305
1.73803836490767e-23	1.31782352077992	0.993	0.963	4.86042428746431e-19	TCEAL8	Malignant cells	GSE140440	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9306
2.69683765567376e-23	1.09468047262123	0.993	0.993	7.54170650409168e-19	WBP5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9307
2.93245644362063e-23	-1.65915760656371	0.927	1	8.20061444458508e-19	RRM1	Malignant cells	GSE140440	ENSG00000167325	6240	ribonucleotide reductase catalytic subunit M1	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9308
3.94380897547786e-23	2.68678730351827	0.84	0.321	1.10288617999238e-18	NUDT11	Malignant cells	GSE140440	ENSG00000196368	55190	nudix hydrolase 11	DIPP3b|FLJ10628|hDIPP3beta	protein_coding	Q96G61	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9309
4.20371695675135e-23	5.17117123651533	0.633	0.075	1.17556944695552e-18	MPZL2	Malignant cells	GSE140440	ENSG00000149573	10205	myelin protein zero like 2	EVA|EVA1	protein_coding	O60487	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9310
4.33089588935929e-23	1.92799256229511	1	0.925	1.21113503545933e-18	SYNJ2	Malignant cells	GSE140440	ENSG00000078269	8871	synaptojanin 2	INPP5H	protein_coding	O15056	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9311
4.57978074984216e-23	0.88438543482761	1	0.985	1.28073568669336e-18	DYNLT1	Malignant cells	GSE140440	ENSG00000146425	6993	dynein light chain Tctex-type 1	TCTEL1|Tctex-1|TCTEX1	protein_coding	P63172	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9312
4.81320778324558e-23	-1.40645334367046	0.987	1	1.34601355658463e-18	MRTO4	Malignant cells	GSE140440	ENSG00000053372	51154	MRT4 homolog, ribosome maturation factor	C1orf33|dJ657E11.4|MRT4	protein_coding	Q9UKD2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9313
4.85369151566802e-23	1.03586314652215	1	0.993	1.35733483235656e-18	HSBP1	Malignant cells	GSE140440	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9314
4.92394978153418e-23	-0.869822315196238	1	1	1.37698255640603e-18	PEBP1	Malignant cells	GSE140440	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9315
5.84591565273716e-23	2.4039321839401	0.907	0.493	1.63481031228795e-18	MID1IP1	Malignant cells	GSE140440	ENSG00000165175	58526	MID1 interacting protein 1	FLJ10386|G12-like|MIG12|STRAIT11499|THRSPL	protein_coding	Q9NPA3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9316
5.89883309481039e-23	0.879975369933868	1	1	1.64960867496373e-18	APLP2	Malignant cells	GSE140440	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9317
5.9233266095772e-23	1.85081452587234	0.973	0.813	1.65645828636826e-18	TMEM243	Malignant cells	GSE140440	ENSG00000135185	79161	transmembrane protein 243	C7orf23|MGC4175|MM-TRAG	protein_coding	Q9BU79	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9318
6.71221652280109e-23	3.7301216423011	0.733	0.179	1.87707135060133e-18	IL31RA	Malignant cells	GSE140440	ENSG00000164509	133396	interleukin 31 receptor A	CRL|CRL3|GLM-R|Glmr|IL-31RA	protein_coding	Q8NI17	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9319
1.31726767362514e-22	-0.962128969779229	1	0.993	3.68373904929272e-18	STRA13	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9320
1.34633169321191e-22	1.37151536125375	1	0.985	3.76501658006711e-18	RAB22A	Malignant cells	GSE140440	ENSG00000124209	57403	RAB22A, member RAS oncogene family	NA	protein_coding	Q9UL26	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9321
1.46321306184586e-22	6.39882662100494	0.587	0.045	4.09187532745195e-18	BCL2A1	Malignant cells	GSE140440	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9322
2.52118206840236e-22	-1.17120269323354	1	0.993	7.0504856542872e-18	DNMT1	Malignant cells	GSE140440	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9323
2.84230570394019e-22	2.05172530038967	0.727	0.164	7.94850790106873e-18	RPS6KA2	Malignant cells	GSE140440	ENSG00000071242	6196	ribosomal protein S6 kinase A2	HU-2|RSK3	protein_coding	Q15349	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9324
2.86287247772269e-22	-1.17054348732107	1	1	8.00602288395151e-18	SRRM1	Malignant cells	GSE140440	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9325
3.20841489135436e-22	1.27646392039931	0.993	0.985	8.97233224367248e-18	LEPROT	Malignant cells	GSE140440	ENSG00000213625	54741	leptin receptor overlapping transcript	FLJ90360|OB-RGRP|OBRGRP|VPS55	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9326
3.30375546898259e-22	1.49782623601149	1	0.896	9.23895216900982e-18	L3HYPDH	Malignant cells	GSE140440	ENSG00000126790	112849	trans-L-3-hydroxyproline dehydratase	C14orf149|FLJ25436	protein_coding	Q96EM0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9327
3.36189800358067e-22	3.05052096518844	0.92	0.493	9.40154776701335e-18	ENPP1	Malignant cells	GSE140440	ENSG00000197594	5167	ectonucleotide pyrophosphatase/phosphodiesterase 1	M6S1|NPPS|PC-1|PCA1|PDNP1	protein_coding	P22413	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9328
3.62246015961798e-22	1.54356980006293	0.993	0.903	1.01302098363717e-17	PAM	Malignant cells	GSE140440	ENSG00000145730	5066	peptidylglycine alpha-amidating monooxygenase	PAL|PHM	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9329
4.76172190779792e-22	1.02682620916879	0.993	0.985	1.33161553151569e-17	GTF2H5	Malignant cells	GSE140440	ENSG00000272047	404672	general transcription factor IIH subunit 5	bA120J8.2|C6orf175|FLJ30544|TFB5|TFIIH|TTD|TTD-A|TTDA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9330
6.68950489240798e-22	1.16277078143784	1	0.993	1.87072004316189e-17	OCIAD2	Malignant cells	GSE140440	ENSG00000145247	132299	OCIA domain containing 2	MGC45416	protein_coding	Q56VL3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9331
7.09029572288772e-22	-1.75434378271103	0.833	0.985	1.98280119890555e-17	CCDC34	Malignant cells	GSE140440	ENSG00000109881	91057	coiled-coil domain containing 34	L15|NY-REN-41|RAMA3	protein_coding	Q96HJ3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9332
8.26237279621571e-22	1.14875117528336	1	1	2.31057255246172e-17	SERINC3	Malignant cells	GSE140440	ENSG00000132824	10955	serine incorporator 3	AIGP1|DIFF33|SBBI99|TDE|TDE1|TMS-1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9333
1.19672450521573e-21	0.861426391173032	1	0.993	3.34664007883579e-17	FIBP	Malignant cells	GSE140440	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9334
1.57567859775134e-21	2.62983518367026	0.813	0.321	4.40638519861162e-17	SMPDL3A	Malignant cells	GSE140440	ENSG00000172594	10924	sphingomyelin phosphodiesterase acid like 3A	ASM3A|ASML3a|FLJ20177|yR36GH4.1	protein_coding	Q92484	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9335
1.85472862725577e-21	3.74047968188114	0.833	0.425	5.18674860612077e-17	ADAM22	Malignant cells	GSE140440	ENSG00000008277	53616	ADAM metallopeptidase domain 22	MDC2	protein_coding	Q9P0K1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9336
1.89238106243141e-21	-1.71656210331509	0.333	0.836	5.29204364108944e-17	RP3-407E4.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9337
2.38162839547956e-21	4.47298862029294	0.62	0.09	6.66022380795858e-17	GBP2	Malignant cells	GSE140440	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9338
2.58361976414429e-21	1.54457824516917	0.98	0.963	7.22509267042951e-17	DYNC2LI1	Malignant cells	GSE140440	ENSG00000138036	51626	dynein cytoplasmic 2 light intermediate chain 1	CGI-60|D2LIC|DKFZP564A033|LIC3	protein_coding	Q8TCX1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9339
2.87726075007403e-21	0.760553541390182	1	1	8.04625968758201e-17	PSMD7	Malignant cells	GSE140440	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9340
3.05993303266203e-21	1.78923508958256	0.96	0.724	8.55710272583937e-17	ATP2B4	Malignant cells	GSE140440	ENSG00000058668	493	ATPase plasma membrane Ca2+ transporting 4	ATP2B2|MXRA1|PMCA4	protein_coding	P23634	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9341
4.40000087604275e-21	1.12244798470169	1	0.91	1.23046024498536e-16	NME7	Malignant cells	GSE140440	ENSG00000143156	29922	NME/NM23 family member 7	CFAP67|FLJ37194|NM23-H7	protein_coding	Q9Y5B8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9342
4.56075185560432e-21	1.66946485183533	1	0.843	1.27541425641975e-16	MBNL2	Malignant cells	GSE140440	ENSG00000139793	10150	muscleblind like splicing regulator 2	MBLL|MBLL39	protein_coding	Q5VZF2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9343
4.86409344189086e-21	2.13589603668741	0.96	0.739	1.36024373102478e-16	SEMA4B	Malignant cells	GSE140440	ENSG00000185033	10509	semaphorin 4B	KIAA1745|MGC131831|SEMAC|SemC	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9344
1.08757513217773e-20	10.7766392323019	0.547	0.045	3.04140385713502e-16	TCN1	Malignant cells	GSE140440	ENSG00000134827	6947	transcobalamin 1	TC1|TCI	protein_coding	P20061	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9345
1.20497714235286e-20	1.23565222356091	0.993	0.813	3.36971857858976e-16	DNAJC4	Malignant cells	GSE140440	ENSG00000110011	3338	DnaJ heat shock protein family (Hsp40) member C4	HSPF2|MCG18	protein_coding	Q9NNZ3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9346
1.24295161810018e-20	-0.915608237045429	1	1	3.47591420001714e-16	HDGF	Malignant cells	GSE140440	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9347
1.42088571565269e-20	1.34434605981083	0.993	0.955	3.97350690382274e-16	PLEKHA1	Malignant cells	GSE140440	ENSG00000107679	59338	pleckstrin homology domain containing A1	TAPP1	protein_coding	Q9HB21	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9348
1.48400992119806e-20	-1.43500246867644	1	1	4.15003374463037e-16	GTPBP4	Malignant cells	GSE140440	ENSG00000107937	23560	GTP binding protein 4	CRFG|FLJ10686|FLJ10690|NGB|NOG1	protein_coding	Q9BZE4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9349
1.77014624804576e-20	-1.01854804946022	1	1	4.95021398265996e-16	DDX24	Malignant cells	GSE140440	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9350
2.30449201710218e-20	8.74773961811719	0.54	0.045	6.44451192582625e-16	KRT75	Malignant cells	GSE140440	ENSG00000170454	9119	keratin 75	K6HF	protein_coding	O95678	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9351
2.30804303093511e-20	2.09121049574806	0.927	0.552	6.45444233601005e-16	NT5E	Malignant cells	GSE140440	ENSG00000135318	4907	5'-nucleotidase ecto	CALJA|CD73|eN|eNT|NT5	protein_coding	P21589	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9352
2.40261967834802e-20	-0.998917186209807	0.993	1	6.71892593050024e-16	KIF5B	Malignant cells	GSE140440	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9353
3.15610439918957e-20	7.09105160317381	0.54	0.045	8.82604595233362e-16	CCND2	Malignant cells	GSE140440	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9354
3.37225436421155e-20	1.28277211218371	0.993	0.91	9.43050932951761e-16	UQCC1	Malignant cells	GSE140440	ENSG00000101019	55245	ubiquinol-cytochrome c reductase complex assembly factor 1	BFZB|C20orf44|CBP3|FLJ10850|UQCC	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9355
3.84751725297093e-20	1.53813186396576	0.993	0.888	1.07595819979332e-15	PKIG	Malignant cells	GSE140440	ENSG00000168734	11142	cAMP-dependent protein kinase inhibitor gamma	NA	protein_coding	Q9Y2B9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9356
4.71360540122122e-20	1.09626827240915	1	1	1.31815975045151e-15	PDCD6	Malignant cells	GSE140440	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9357
4.90140775232871e-20	-1.55894330824771	1	0.993	1.37067867793872e-15	RBM17	Malignant cells	GSE140440	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9358
5.53643082231125e-20	0.782084366608716	1	0.978	1.54826287945934e-15	GABARAPL2	Malignant cells	GSE140440	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9359
5.66717789360646e-20	1.28184814261506	1	0.828	1.58482629794705e-15	PNRC1	Malignant cells	GSE140440	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9360
5.94920399356745e-20	-1.55805356568097	0.947	1	1.66369489680114e-15	PUM3	Malignant cells	GSE140440	ENSG00000080608	9933	pumilio RNA binding family member 3	HA-8|hPUF-A|KIAA0020|PEN|Puf-A|PUF6|XTP5	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9361
6.06381816620913e-20	1.36253827358789	0.987	0.866	1.69574675018038e-15	SH3KBP1	Malignant cells	GSE140440	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9362
6.1853853262131e-20	2.32405260674414	0.913	0.59	1.72974300647549e-15	KIAA1324L	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9363
7.11449583377906e-20	0.952621548395804	0.993	0.881	1.98956875991631e-15	MORN2	Malignant cells	GSE140440	ENSG00000188010	729967	MORN repeat containing 2	MOPT	protein_coding	Q502X0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9364
7.89489701594298e-20	2.26443283485662	0.927	0.657	2.20780795050845e-15	CCDC92	Malignant cells	GSE140440	ENSG00000275035	80212	coiled-coil domain containing 92	FLJ22471	protein_coding	Q53HC0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9365
9.44694342316277e-20	-0.751578787643833	1	1	2.64183772828747e-15	SLIRP	Malignant cells	GSE140440	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9366
1.01623183952769e-19	-0.937330870505934	0.993	0.985	2.84189233923919e-15	MRPL12	Malignant cells	GSE140440	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9367
1.05069479744911e-19	1.53924950004208	0.96	0.694	2.93826800106642e-15	PSMB8	Malignant cells	GSE140440	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9368
1.07856083824069e-19	1.01459880667092	1	0.963	3.01619538414008e-15	WDR54	Malignant cells	GSE140440	ENSG00000005448	84058	WD repeat domain 54	FLJ12953	protein_coding	Q9H977	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9369
1.08091489993456e-19	1.93340801837117	0.807	0.343	3.02277851766699e-15	BEX2	Malignant cells	GSE140440	ENSG00000133134	84707	brain expressed X-linked 2	DJ79P11.1	protein_coding	Q9BXY8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9370
1.20736455824118e-19	0.850514315953404	1	0.993	3.37639498712147e-15	MRGBP	Malignant cells	GSE140440	ENSG00000101189	55257	MRG domain binding protein	C20orf20|Eaf7|FLJ10914|MRG15BP	protein_coding	Q9NV56	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9371
1.222427494663e-19	2.01650787432103	0.927	0.47	3.41851848882507e-15	CASP4	Malignant cells	GSE140440	ENSG00000196954	837	caspase 4	ICE(rel)II|ICH-2|TX	protein_coding	P49662	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9372
1.25010529931279e-19	6.26574087356307	0.54	0.06	3.49591946952822e-15	DNAJC15	Malignant cells	GSE140440	ENSG00000120675	29103	DnaJ heat shock protein family (Hsp40) member C15	DNAJD1|MCJ	protein_coding	Q9Y5T4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9373
1.31545094616556e-19	1.60446925463032	0.933	0.687	3.67865857095198e-15	MACROD1	Malignant cells	GSE140440	ENSG00000133315	28992	mono-ADP ribosylhydrolase 1	LRP16	protein_coding	Q9BQ69	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9374
1.38922427041397e-19	1.05130345166082	1	0.993	3.88496567221266e-15	RDH11	Malignant cells	GSE140440	ENSG00000072042	51109	retinol dehydrogenase 11	ARSDR1|MDT1|SDR7C1	protein_coding	Q8TC12	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9375
1.95844099543181e-19	1.1915371677032	1	0.985	5.47678024372505e-15	MRPS6	Malignant cells	GSE140440	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9376
2.06186175604651e-19	1.59855577332351	0.993	0.955	5.76599640078406e-15	TUBA1A	Malignant cells	GSE140440	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9377
2.13573719355333e-19	0.589965585315056	1	1	5.9725890617719e-15	ANXA2	Malignant cells	GSE140440	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9378
2.23545393764725e-19	0.923867676069218	1	1	6.25144693663054e-15	MXRA7	Malignant cells	GSE140440	ENSG00000182534	439921	matrix remodeling associated 7	FLJ46603|PS1TP1|TMAP1	protein_coding	P84157	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9379
2.37205014673046e-19	-0.594207380796338	1	1	6.63343823533174e-15	SNRPC	Malignant cells	GSE140440	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9380
2.40140471345726e-19	3.40078796710515	0.993	0.888	6.71552828118323e-15	PLAU	Malignant cells	GSE140440	ENSG00000122861	5328	plasminogen activator, urokinase	UPA|URK	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9381
2.8410518901497e-19	1.24471156030617	0.993	0.918	7.94500161080364e-15	VAPB	Malignant cells	GSE140440	ENSG00000124164	9217	VAMP associated protein B and C	ALS8|VAP-B|VAP-C	protein_coding	O95292	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9382
3.07128323862835e-19	-3.68044465967975	0.067	0.53	8.58884357682417e-15	PPP1R14A	Malignant cells	GSE140440	ENSG00000167641	94274	protein phosphatase 1 regulatory inhibitor subunit 14A	CPI-17|PPP1INL	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9383
4.76054400843351e-19	0.824665676782618	1	0.993	1.33128613195843e-14	C4orf48	Malignant cells	GSE140440	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9384
4.81119420181366e-19	1.50699876698639	0.987	0.769	1.34545045853719e-14	VEGFA	Malignant cells	GSE140440	ENSG00000112715	7422	vascular endothelial growth factor A	VEGF|VEGF-A|VPF	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9385
5.45443425715087e-19	1.52854588157413	1	1	1.52533254001224e-14	SLC35F2	Malignant cells	GSE140440	ENSG00000110660	54733	solute carrier family 35 member F2	FLJ13018	protein_coding	Q8IXU6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9386
5.82422082906954e-19	8.27466048393616	0.533	0.052	1.6287433548493e-14	IL1RL1	Malignant cells	GSE140440	ENSG00000115602	9173	interleukin 1 receptor like 1	DER4|FIT-1|IL33R|ST2|ST2L|ST2V|T1	protein_coding	Q01638	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9387
5.92429964994993e-19	0.89897141204503	1	0.933	1.6567303971085e-14	LINC00998	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9388
6.54741518539519e-19	-0.720327360455761	1	1	1.83098465659577e-14	CCT6A	Malignant cells	GSE140440	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9389
7.20344949807297e-19	2.03807147645092	0.713	0.201	2.01444465213611e-14	RP3-460G2.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9390
8.111419230353e-19	-0.98852873053484	1	1	2.26835838776822e-14	AHSA1	Malignant cells	GSE140440	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9391
8.42039788080784e-19	-4.74325765856823	0.333	0.739	2.35476426736791e-14	BRDT	Malignant cells	GSE140440	ENSG00000137948	676	bromodomain testis associated	BRD6|CT9	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9392
9.98642761662074e-19	4.84355158495688	0.627	0.157	2.79270448298799e-14	CRMP1	Malignant cells	GSE140440	ENSG00000072832	1400	collapsin response mediator protein 1	DPYSL1|DRP-1	protein_coding	Q14194	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9393
1.05276630841601e-18	1.65569391513551	0.96	0.851	2.94406098148537e-14	CYB5D2	Malignant cells	GSE140440	ENSG00000167740	124936	cytochrome b5 domain containing 2	MGC32124	protein_coding	Q8WUJ1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9394
1.23526296009156e-18	1.25054135182336	1	0.888	3.45441286789606e-14	CUEDC2	Malignant cells	GSE140440	ENSG00000107874	79004	CUE domain containing 2	C10orf66|MGC2491	protein_coding	Q9H467	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9395
1.23784703834207e-18	1.61869920399613	0.987	0.619	3.46163924272361e-14	ETS1	Malignant cells	GSE140440	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9396
1.26787590726762e-18	-0.841369275109598	1	0.993	3.5456149746739e-14	SUPT16H	Malignant cells	GSE140440	ENSG00000092201	11198	SPT16 homolog, facilitates chromatin remodeling subunit	CDC68|FACT|FACTP140|FLJ10857|FLJ14010|SPT16/CDC68	protein_coding	Q9Y5B9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9397
1.42153860046026e-18	0.89317173967425	1	0.985	3.97533269618712e-14	TRPT1	Malignant cells	GSE140440	ENSG00000149743	83707	tRNA phosphotransferase 1	MGC11134	protein_coding	Q86TN4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9398
1.54809472257666e-18	1.3001598068658	1	0.985	4.32924689168562e-14	CD9	Malignant cells	GSE140440	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9399
1.59056084901433e-18	6.76119620823089	0.533	0.067	4.44800341426856e-14	ARHGDIB	Malignant cells	GSE140440	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9400
1.60882536490395e-18	-0.814514758520959	1	0.993	4.4990801329539e-14	PA2G4	Malignant cells	GSE140440	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9401
1.62313455947423e-18	1.45728530348476	0.973	0.522	4.53909579556968e-14	BCAT1	Malignant cells	GSE140440	ENSG00000060982	586	branched chain amino acid transaminase 1	BCATc|BCT1	protein_coding	P54687	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9402
1.64548072355381e-18	1.53937151124542	1	0.91	4.60158684341824e-14	GNG11	Malignant cells	GSE140440	ENSG00000127920	2791	G protein subunit gamma 11	GNGT11	protein_coding	P61952	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9403
1.68643404825484e-18	1.15764162637705	0.98	0.799	4.71611281594465e-14	VAMP2	Malignant cells	GSE140440	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9404
1.70105278755383e-18	2.46030571441738	0.853	0.44	4.75699412039429e-14	CLMN	Malignant cells	GSE140440	ENSG00000165959	79789	calmin	FLJ12383|KIAA0500|KIAA1188	protein_coding	Q96JQ2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9405
1.75387084848351e-18	1.59881509066856	0.953	0.776	4.90469982778413e-14	ACYP2	Malignant cells	GSE140440	ENSG00000170634	98	acylphosphatase 2	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9406
1.85410068033437e-18	0.646795834770369	1	1	5.18499255255506e-14	PRDX5	Malignant cells	GSE140440	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9407
1.96413773507888e-18	-1.26576663701495	1	1	5.49271117614808e-14	TUBB4B	Malignant cells	GSE140440	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9408
2.02829410716833e-18	1.0904956508677	1	1	5.67212447069623e-14	ACTR10	Malignant cells	GSE140440	ENSG00000131966	55860	actin related protein 10	ACTR11|Arp10|Arp11|HARP11	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9409
2.13732472254875e-18	4.40399706238389	0.667	0.231	5.97702858660757e-14	ARG2	Malignant cells	GSE140440	ENSG00000081181	384	arginase 2	NA	protein_coding	P78540	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9410
2.33584339457472e-18	0.507139980711004	1	1	6.53218605292822e-14	RPL15	Malignant cells	GSE140440	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9411
2.42007657442291e-18	2.17067775290113	0.92	0.545	6.76774414037367e-14	AIM1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9412
2.66862228588027e-18	1.05660045230252	1	0.955	7.46280222246416e-14	MYH9	Malignant cells	GSE140440	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9413
2.79333383666989e-18	5.58137144689912	0.533	0.075	7.81155807424735e-14	ABCG1	Malignant cells	GSE140440	ENSG00000160179	9619	ATP binding cassette subfamily G member 1	ABC8	protein_coding	P45844	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9414
2.82408258901832e-18	2.50549263329027	0.807	0.358	7.89754696018974e-14	PLCB1	Malignant cells	GSE140440	ENSG00000182621	23236	phospholipase C beta 1	KIAA0581|PLC-I|PLC154	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9415
3.41866019635282e-18	-4.53293622121112	0.6	0.828	9.56028323910067e-14	ZNF91	Malignant cells	GSE140440	ENSG00000167232	7644	zinc finger protein 91	HPF7|HTF10	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9416
3.77024086244424e-18	-0.838392421883295	0.993	1	1.05434785718253e-13	NOP58	Malignant cells	GSE140440	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9417
3.97435141416057e-18	1.73345809396337	0.927	0.657	1.11142737297e-13	SRR	Malignant cells	GSE140440	ENSG00000167720	63826	serine racemase	ILV1|ISO1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9418
4.30242958320035e-18	1.23751447538967	1	0.94	1.20317443294198e-13	HLA-B	Malignant cells	GSE140440	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9419
4.33534937163021e-18	-0.819043469754115	1	1	1.21238045177639e-13	MRPS23	Malignant cells	GSE140440	ENSG00000181610	51649	mitochondrial ribosomal protein S23	CGI-138|HSPC329|MRP-S23	protein_coding	Q9Y3D9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9420
4.59118878728132e-18	0.807283797342212	1	1	1.28392594436322e-13	CHURC1	Malignant cells	GSE140440	ENSG00000258289	91612	churchill domain containing 1	C14orf52|FLJ33064|My015	protein_coding	Q8WUH1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9421
4.84174082872058e-18	-5.31021711236067	0.06	0.507	1.35399282275171e-13	RBP4	Malignant cells	GSE140440	ENSG00000138207	5950	retinol binding protein 4	NA	protein_coding	P02753	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9422
5.34800800231974e-18	0.549618301067099	1	1	1.49557043784871e-13	SRP9	Malignant cells	GSE140440	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9423
6.42534160848702e-18	5.75574061446529	0.527	0.075	1.7968467808134e-13	TRBC2	Malignant cells	GSE140440	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9424
7.20305456279079e-18	-2.3222077140453	0.26	0.731	2.01433420848444e-13	RP11-255H23.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9425
7.26284544643624e-18	1.46569935410779	0.907	0.41	2.03105472909589e-13	STARD4	Malignant cells	GSE140440	ENSG00000164211	134429	StAR related lipid transfer domain containing 4	NA	protein_coding	Q96DR4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9426
7.42497503315226e-18	2.94297379634412	0.707	0.224	2.07639426802103e-13	PTGFRN	Malignant cells	GSE140440	ENSG00000134247	5738	prostaglandin F2 receptor inhibitor	CD315|CD9P-1|EWI-F|FLJ11001|FPRP|KIAA1436|SMAP-6	protein_coding	Q9P2B2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9427
7.43287750148378e-18	6.04348888021366	0.527	0.075	2.07860419328994e-13	SERPINA1	Malignant cells	GSE140440	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9428
7.4745311590891e-18	0.964388079842232	1	0.993	2.09025263863927e-13	ECH1	Malignant cells	GSE140440	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9429
7.61774868871369e-18	-0.985616768091361	1	1	2.13030342079878e-13	HSPA4	Malignant cells	GSE140440	ENSG00000170606	3308	heat shock protein family A (Hsp70) member 4	HS24/P52|HSPH2	protein_coding	P34932	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9430
7.98203487645163e-18	1.508781575761	0.953	0.604	2.2321760531997e-13	SREBF2	Malignant cells	GSE140440	ENSG00000198911	6721	sterol regulatory element binding transcription factor 2	bHLHd2|SREBP2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9431
8.20044439632174e-18	2.63721129265167	0.973	0.642	2.29325427543137e-13	IGFBP3	Malignant cells	GSE140440	ENSG00000146674	3486	insulin like growth factor binding protein 3	BP-53|IBP3	protein_coding	P17936	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9432
8.97670132092952e-18	-0.77439789306664	1	1	2.51033452439794e-13	PTMA	Malignant cells	GSE140440	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9433
9.01597246584572e-18	-2.21931302840448	0.853	0.97	2.52131670007375e-13	SNHG25	Malignant cells	GSE140440	ENSG00000266402	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9434
9.27291106931638e-18	1.82442762506144	0.987	0.896	2.59316958053432e-13	SMAGP	Malignant cells	GSE140440	ENSG00000170545	57228	small cell adhesion glycoprotein	hSMAGP|MGC149453|MGC149454	protein_coding	Q0VAQ4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9435
9.6264511990805e-18	-2.11925418694454	0.393	0.813	2.69203707782286e-13	SLC25A10	Malignant cells	GSE140440	ENSG00000183048	1468	solute carrier family 25 member 10	DIC	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9436
1.00797342287953e-17	1.03446350167556	0.98	0.836	2.81879767708261e-13	IFT20	Malignant cells	GSE140440	ENSG00000109083	90410	intraflagellar transport 20	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9437
1.03072766930133e-17	-0.862148450222024	1	1	2.88242992720116e-13	PSMD13	Malignant cells	GSE140440	ENSG00000185627	5719	proteasome 26S subunit, non-ATPase 13	p40.5|Rpn9	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9438
1.07960464531954e-17	1.63039128192324	0.953	0.754	3.01911439063609e-13	TMEM161B-AS1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9439
1.16155736683996e-17	-1.01637697222386	1	1	3.24829517636795e-13	CLTC	Malignant cells	GSE140440	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9440
1.28474012039721e-17	6.79970157521738	0.533	0.082	3.59277574669079e-13	GJB2	Malignant cells	GSE140440	ENSG00000165474	2706	gap junction protein beta 2	CX26|DFNA3|DFNB1|NSRD1	protein_coding	P29033	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9441
1.50093063307593e-17	0.464402454926987	1	1	4.19735251539685e-13	ATP5O	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9442
1.51695266415672e-17	5.77647053166296	0.533	0.082	4.24215812531425e-13	SIGLEC15	Malignant cells	GSE140440	ENSG00000197046	284266	sialic acid binding Ig like lectin 15	CD33L3|HsT1361	protein_coding	Q6ZMC9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9443
1.6811092057962e-17	4.54133660050893	0.653	0.246	4.70122189400909e-13	RGCC	Malignant cells	GSE140440	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9444
1.92296156360626e-17	0.78695214565106	1	0.933	5.3775620126249e-13	ITGAE	Malignant cells	GSE140440	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9445
2.06355176920522e-17	-0.747481197678093	1	1	5.77072252258241e-13	HSPE1	Malignant cells	GSE140440	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9446
2.12371655966244e-17	1.144702366741	1	0.993	5.93897335909602e-13	AC027612.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9447
2.13555576351019e-17	-2.41392308338824	0.22	0.687	5.97208169265624e-13	NPW	Malignant cells	GSE140440	ENSG00000183971	283869	neuropeptide W	PPL8	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9448
2.27700526934687e-17	1.11481494189974	1	0.97	6.36764523572853e-13	SH3GLB1	Malignant cells	GSE140440	ENSG00000097033	51100	SH3 domain containing GRB2 like, endophilin B1	Bif-1|CGI-61|KIAA0491|PPP1R70	protein_coding	Q9Y371	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9449
2.30288792898662e-17	2.67649411996348	0.713	0.276	6.44002609341109e-13	FZD1	Malignant cells	GSE140440	ENSG00000157240	8321	frizzled class receptor 1	DKFZp564G072	protein_coding	Q9UP38	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9450
2.30539144196919e-17	1.58788705432418	0.98	0.955	6.44702716746684e-13	DYNLT3	Malignant cells	GSE140440	ENSG00000165169	6990	dynein light chain Tctex-type 3	TCTE1L|TCTEX1L	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9451
2.48773326518884e-17	-0.82981438434776	1	1	6.95694607610059e-13	SAR1A	Malignant cells	GSE140440	ENSG00000079332	56681	secretion associated Ras related GTPase 1A	SAR1|Sara|SARA1	protein_coding	Q9NR31	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9452
2.49654659147188e-17	1.58740804591957	1	0.918	6.9815925430511e-13	SLCO4A1	Malignant cells	GSE140440	ENSG00000101187	28231	solute carrier organic anion transporter family member 4A1	OATP-E|OATP4A1|SLC21A12	protein_coding	Q96BD0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9453
2.53336959535614e-17	3.96804006525156	0.587	0.127	7.08456807341344e-13	NTSR1	Malignant cells	GSE140440	ENSG00000101188	4923	neurotensin receptor 1	NTR	protein_coding	P30989	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9454
2.74653359827671e-17	-0.991284074531426	1	1	7.68068120758081e-13	UBE2S	Malignant cells	GSE140440	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9455
2.93548722587757e-17	1.00854656956439	0.993	0.836	8.20909002716664e-13	STX8	Malignant cells	GSE140440	ENSG00000170310	9482	syntaxin 8	CARB	protein_coding	Q9UNK0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9456
3.10208106925653e-17	-1.47879776553852	0.913	0.985	8.67496971017589e-13	RRM2	Malignant cells	GSE140440	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9457
3.24667822671731e-17	0.97260081754145	1	1	9.07933566101496e-13	RPL23A	Malignant cells	GSE140440	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9458
3.41204014866757e-17	1.05600327543448	1	0.993	9.54177027574887e-13	MAP1LC3B	Malignant cells	GSE140440	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9459
3.70240489670474e-17	2.33283465548247	0.82	0.381	1.03537752936348e-12	CCNJL	Malignant cells	GSE140440	ENSG00000135083	79616	cyclin J like	FLJ14166	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9460
3.74556965812409e-17	5.67820401399427	0.52	0.082	1.0474485548944e-12	BEX4	Malignant cells	GSE140440	ENSG00000102409	56271	brain expressed X-linked 4	BEXL1|FLJ10097	protein_coding	Q9NWD9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9461
3.87213367217606e-17	2.66167325756621	0.747	0.291	1.08284218142403e-12	ZBTB20	Malignant cells	GSE140440	ENSG00000181722	26137	zinc finger and BTB domain containing 20	DKFZp566F123|DPZF|ODA-8S|ZNF288	protein_coding	Q9HC78	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9462
3.90715370915303e-17	1.00830379861786	0.993	1	1.09263553476464e-12	RBFOX2	Malignant cells	GSE140440	ENSG00000277564	23543	RNA binding fox-1 homolog 2	FOX-2|HNRBP2|HRNBP2|RBM9	protein_coding	O43251	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9463
4.04763291774676e-17	1.28670520961589	0.987	0.896	1.13192054544788e-12	SNX9	Malignant cells	GSE140440	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9464
4.29424740452607e-17	1.44108374484284	0.94	0.799	1.20088628667572e-12	DLGAP1-AS2	Malignant cells	GSE140440	ENSG00000262001	NA	NA	MGC11082	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9465
4.31369364624183e-17	-5.58984493625297	0.06	0.493	1.20632442817153e-12	IL33	Malignant cells	GSE140440	ENSG00000137033	90865	interleukin 33	C9orf26|DKFZp586H0523|DVS27|IL1F11|NF-HEV	protein_coding	O95760	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9466
4.46864687162009e-17	1.23990297834995	0.96	0.724	1.24965709764856e-12	SNHG11	Malignant cells	GSE140440	ENSG00000174365	128439	small nucleolar RNA host gene 11	C20orf198|LINC00101	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9467
4.47518758591535e-17	-0.815440014467381	1	1	1.25148620840123e-12	TXNL4A	Malignant cells	GSE140440	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9468
4.47732624962122e-17	-0.606003596127263	1	1	1.25208428570657e-12	ATP5G1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9469
5.72201340765118e-17	1.86114574938012	0.993	0.843	1.60016104944965e-12	MLLT4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9470
5.77992045219793e-17	1.00512237017217	1	0.933	1.61635475445715e-12	PTRHD1	Malignant cells	GSE140440	ENSG00000184924	391356	peptidyl-tRNA hydrolase domain containing 1	C2orf79|LOC391356	protein_coding	Q6GMV3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9471
5.90779897741673e-17	-0.972008327753335	1	1	1.65211598403459e-12	UBE2M	Malignant cells	GSE140440	ENSG00000130725	9040	ubiquitin conjugating enzyme E2 M	hUbc12|UBC12	protein_coding	P61081	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9472
6.51009985630517e-17	1.04744526461373	1	1	1.82054942481574e-12	FKBP1A	Malignant cells	GSE140440	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9473
6.96820995356943e-17	1.53474878888781	0.96	0.701	1.94865991351569e-12	CDK6	Malignant cells	GSE140440	ENSG00000105810	1021	cyclin dependent kinase 6	PLSTIRE	protein_coding	Q00534	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9474
7.1410117057923e-17	-1.02898959792324	1	0.993	1.99698392352482e-12	NAA50	Malignant cells	GSE140440	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9475
7.25648982561597e-17	1.86677604152164	0.873	0.5	2.02927737973351e-12	NMRK1	Malignant cells	GSE140440	ENSG00000106733	54981	nicotinamide riboside kinase 1	bA235O14.2|C9orf95|FLJ20559|NRK1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9476
7.39446384144404e-17	1.26738331970283	0.96	0.754	2.06786181325983e-12	CCS	Malignant cells	GSE140440	ENSG00000173992	9973	copper chaperone for superoxide dismutase	NA	protein_coding	O14618	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9477
7.87595954179026e-17	-0.77479685559765	1	1	2.20251208586165e-12	EIF3M	Malignant cells	GSE140440	ENSG00000149100	10480	eukaryotic translation initiation factor 3 subunit M	FLJ29030|GA17|hfl-B5|PCID1|TANGO7	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9478
7.92408274851725e-17	-1.29348103817869	0.847	0.963	2.21596974062285e-12	CLSPN	Malignant cells	GSE140440	ENSG00000092853	63967	claspin	NA	protein_coding	Q9HAW4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9479
8.21182531633395e-17	0.982857294186528	1	1	2.29643694971279e-12	MANBAL	Malignant cells	GSE140440	ENSG00000101363	63905	mannosidase beta like	dJ1141E15.2	protein_coding	Q9NQG1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9480
8.34592945803411e-17	1.68914325338328	0.927	0.694	2.33393917293924e-12	HMGCL	Malignant cells	GSE140440	ENSG00000117305	3155	3-hydroxy-3-methylglutaryl-CoA lyase	HL	protein_coding	P35914	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9481
9.39301708219368e-17	1.26566230218368	1	0.843	2.62675722703546e-12	TCEA2	Malignant cells	GSE140440	ENSG00000171703	6919	transcription elongation factor A2	TFIIS	protein_coding	Q15560	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9482
9.40251010769935e-17	0.757807024175612	1	1	2.62941195161812e-12	ERGIC3	Malignant cells	GSE140440	ENSG00000125991	51614	ERGIC and golgi 3	C20orf47|CGI-54|Erv46|NY-BR-84|PRO0989|SDBCAG84	protein_coding	Q9Y282	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9483
9.69435034184573e-17	-0.601924262256082	1	1	2.71102507309716e-12	PSMB5	Malignant cells	GSE140440	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9484
9.92464886499195e-17	1.11473170827032	1	0.978	2.775428055095e-12	TAPBP	Malignant cells	GSE140440	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9485
1.00757684953724e-16	2.21182397218949	0.873	0.627	2.8176886597309e-12	ELOVL6	Malignant cells	GSE140440	ENSG00000170522	79071	ELOVL fatty acid elongase 6	FLJ23378|LCE|MGC5487	protein_coding	Q9H5J4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9486
1.0363275688603e-16	0.936998622661479	1	0.903	2.89809004631782e-12	SMDT1	Malignant cells	GSE140440	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9487
1.03665347254252e-16	-0.564283110897396	1	1	2.89900143596516e-12	CCT2	Malignant cells	GSE140440	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9488
1.0615312867651e-16	5.37882059758901	0.56	0.142	2.96857224343861e-12	SULF2	Malignant cells	GSE140440	ENSG00000196562	55959	sulfatase 2	HSULF-2|KIAA1247|SULF-2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9489
1.19210810069302e-16	-4.07168256210352	0.12	0.56	3.33373030358802e-12	CREB3L1	Malignant cells	GSE140440	ENSG00000157613	90993	cAMP responsive element binding protein 3 like 1	OASIS	protein_coding	Q96BA8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9490
1.21409228827157e-16	-0.693903610722611	1	1	3.39520908415144e-12	EIF4A3	Malignant cells	GSE140440	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9491
1.38676861130619e-16	0.655811710991201	1	1	3.87809842151776e-12	FKBP2	Malignant cells	GSE140440	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9492
1.42969197575966e-16	0.496024447868471	1	1	3.9981336102119e-12	TMEM258	Malignant cells	GSE140440	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9493
1.44823883740479e-16	-0.514199820978199	1	1	4.04999990880248e-12	NCL	Malignant cells	GSE140440	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9494
1.47290988537627e-16	0.784940820069768	1	0.963	4.11899249445473e-12	NSMCE1	Malignant cells	GSE140440	ENSG00000169189	197370	NSE1 homolog, SMC5-SMC6 complex component	NSE1	protein_coding	Q8WV22	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9495
1.67691855709498e-16	2.47816966761147	0.933	0.761	4.68950274491611e-12	KLHL24	Malignant cells	GSE140440	ENSG00000114796	54800	kelch like family member 24	DRE1|FLJ20059	protein_coding	Q6TFL4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9496
1.68414967357288e-16	-1.6948210873672	0.82	0.985	4.70972456214655e-12	CDC20	Malignant cells	GSE140440	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9497
1.88732534766231e-16	1.58868989484075	0.993	0.724	5.27790533473765e-12	RGMB	Malignant cells	GSE140440	ENSG00000174136	285704	repulsive guidance molecule BMP co-receptor b	DRAGON|FLJ90406	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9498
1.95894403995413e-16	-1.17478971690192	0.98	0.993	5.47818700773172e-12	CKAP5	Malignant cells	GSE140440	ENSG00000175216	9793	cytoskeleton associated protein 5	ch-TOG|KIAA0097|TOG|TOGp	protein_coding	Q14008	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9499
1.9747537619057e-16	2.27461500192372	0.78	0.41	5.52239889516929e-12	RP11-356J5.12	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9500
2.16761444051445e-16	-3.26628569186471	0.1	0.522	6.06173378289867e-12	KRBOX1	Malignant cells	GSE140440	ENSG00000240747	100506243	KRAB box domain containing 1	NA	protein_coding	C9JBD0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9501
2.2117364501784e-16	3.05235812067511	0.62	0.179	6.18512098292389e-12	FEZ1	Malignant cells	GSE140440	ENSG00000149557	9638	fasciculation and elongation protein zeta 1	UNC-76	protein_coding	Q99689	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9502
2.2847342827061e-16	-5.57626340872657	0.113	0.552	6.38925942158762e-12	LXN	Malignant cells	GSE140440	ENSG00000079257	56925	latexin	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9503
2.30366625337556e-16	0.992712773073603	1	0.866	6.44220267756475e-12	CKLF	Malignant cells	GSE140440	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9504
2.36922434434797e-16	2.10795301649196	0.92	0.567	6.62553587896909e-12	LINC00648	Malignant cells	GSE140440	ENSG00000259129	100506433	long intergenic non-protein coding RNA 648	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9505
2.39105789473224e-16	2.10738944271417	0.893	0.687	6.6865934026187e-12	IFI6	Malignant cells	GSE140440	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9506
2.47750306562797e-16	1.01286473157734	1	0.97	6.92833732302862e-12	UFM1	Malignant cells	GSE140440	ENSG00000120686	51569	ubiquitin fold modifier 1	bA131P10.1|C13orf20	protein_coding	P61960	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9507
2.51910364144979e-16	1.63464692675815	0.96	0.821	7.04467333331434e-12	RASA1	Malignant cells	GSE140440	ENSG00000145715	5921	RAS p21 protein activator 1	CM-AVM|GAP|p120|p120GAP|p120RASGAP|RASA	protein_coding	P20936	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9508
2.71139317509749e-16	-0.915080384173114	0.987	1	7.58241101416013e-12	GPN3	Malignant cells	GSE140440	ENSG00000111231	51184	GPN-loop GTPase 3	ATPBD1C|MGC14560	protein_coding	Q9UHW5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9509
2.71155482873276e-16	1.2410240900034	0.987	0.791	7.58286307855115e-12	PCIF1	Malignant cells	GSE140440	ENSG00000100982	63935	phosphorylated CTD interacting factor 1	bA465L10.1|C20orf67|CAPAM|PPP1R121	protein_coding	Q9H4Z3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9510
2.82318773189603e-16	0.898900739448155	0.993	0.903	7.89504449224725e-12	AES	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9511
2.8273739277331e-16	-1.12593233463291	0.953	1	7.90675118890561e-12	SMC4	Malignant cells	GSE140440	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9512
2.84602448368222e-16	0.62424172111648	1	1	7.95890746861733e-12	ATP5G2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9513
2.94532182736556e-16	2.85388180633994	0.687	0.276	8.23659249022779e-12	MAOA	Malignant cells	GSE140440	ENSG00000189221	4128	monoamine oxidase A	NA	protein_coding	P21397	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9514
3.076765734025e-16	-0.789607463860444	1	1	8.60417537520091e-12	PSMC3	Malignant cells	GSE140440	ENSG00000165916	5702	proteasome 26S subunit, ATPase 3	RPT5|TBP-1|TBP1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9515
3.09653878488551e-16	-3.04129137258813	0.187	0.619	8.65947071193233e-12	ZNF880	Malignant cells	GSE140440	ENSG00000221923	400713	zinc finger protein 880	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9516
3.60446961893663e-16	-4.96869118679585	0.073	0.493	1.00798992893563e-11	TNNC1	Malignant cells	GSE140440	ENSG00000114854	7134	troponin C1, slow skeletal and cardiac type	TNNC	protein_coding	P63316	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9517
3.77237734631767e-16	2.20039356806162	0.84	0.463	1.05494532489774e-11	TGFBI	Malignant cells	GSE140440	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9518
3.95671294515307e-16	0.804183111784168	1	0.985	1.10649477511206e-11	SERPINB6	Malignant cells	GSE140440	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9519
5.07201281993251e-16	1.32059696499576	0.993	0.948	1.41838838509413e-11	THOC3	Malignant cells	GSE140440	ENSG00000051596	84321	THO complex subunit 3	MGC5469|TEX1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9520
5.29873997243222e-16	1.47280141677821	0.98	0.784	1.48179263329067e-11	PHGDH	Malignant cells	GSE140440	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9521
5.33512620957555e-16	1.76868136253735	0.9	0.649	1.4919680445078e-11	STC2	Malignant cells	GSE140440	ENSG00000113739	8614	stanniocalcin 2	STC-2	protein_coding	O76061	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9522
5.52269301730613e-16	-3.33494922924414	0.167	0.612	1.54442110228966e-11	PLCH1	Malignant cells	GSE140440	ENSG00000114805	23007	phospholipase C eta 1	DKFZp434C1372|KIAA1069|MGC117152|PLCeta1|PLCL3	protein_coding	Q4KWH8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9523
5.52480076528655e-16	0.612328319950359	1	0.993	1.54501053401238e-11	CPNE1	Malignant cells	GSE140440	ENSG00000214078	8904	copine 1	CPN1	protein_coding	Q99829	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9524
5.58891417240335e-16	-0.863124581028135	0.98	1	1.5629398483126e-11	TFAM	Malignant cells	GSE140440	ENSG00000108064	7019	transcription factor A, mitochondrial	TCF6|TCF6L2	protein_coding	Q00059	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9525
5.82890363997787e-16	0.763605773288038	1	1	1.63005290291981e-11	GNG12	Malignant cells	GSE140440	ENSG00000172380	55970	G protein subunit gamma 12	NA	protein_coding	Q9UBI6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9526
5.94162197778788e-16	1.72812399180042	0.74	0.291	1.66157458608838e-11	ULBP2	Malignant cells	GSE140440	ENSG00000131015	80328	UL16 binding protein 2	RAET1H	protein_coding	Q9BZM5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9527
5.94465320555703e-16	1.08357089003588	0.993	0.91	1.66242226893402e-11	UBE2E2	Malignant cells	GSE140440	ENSG00000182247	7325	ubiquitin conjugating enzyme E2 E2	FLJ25157|UbcH8	protein_coding	Q96LR5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9528
6.00411376303614e-16	2.23516839184025	0.727	0.269	1.67905041383306e-11	ADAM12	Malignant cells	GSE140440	ENSG00000148848	8038	ADAM metallopeptidase domain 12	MCMPMltna|MLTN	protein_coding	O43184	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9529
6.07856239127148e-16	0.607673666622009	1	1	1.69986997271907e-11	B2M	Malignant cells	GSE140440	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9530
7.20285656302005e-16	-1.31903381407914	0.933	1	2.01427883784856e-11	ZWINT	Malignant cells	GSE140440	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9531
7.26140631263063e-16	0.487187584504298	1	1	2.03065227532715e-11	COX4I1	Malignant cells	GSE140440	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9532
7.43602018064493e-16	-0.870906703745593	1	1	2.07948304351735e-11	EIF4G2	Malignant cells	GSE140440	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9533
7.46161308994074e-16	-0.813257409522315	0.987	1	2.08664010060193e-11	PSMC1	Malignant cells	GSE140440	ENSG00000100764	5700	proteasome 26S subunit, ATPase 1	p56|RPT2|S4	protein_coding	P62191	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9534
7.64993461538155e-16	-1.00887564284633	1	0.993	2.13930421519145e-11	DNAJC2	Malignant cells	GSE140440	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9535
7.69037220597041e-16	1.30607159484018	1	0.985	2.15061258739963e-11	ODF2L	Malignant cells	GSE140440	ENSG00000122417	57489	outer dense fiber of sperm tails 2 like	KIAA1229	protein_coding	Q9ULJ1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9536
7.90606097258152e-16	1.9441470500801	0.827	0.418	2.21092995098242e-11	PCED1A	Malignant cells	GSE140440	ENSG00000132635	64773	PC-esterase domain containing 1A	bA12M19.1|C20orf81|FAM113A|FLJ22376	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9537
8.01608524337846e-16	2.72904315858259	0.6	0.179	2.24169823831079e-11	GPSM3	Malignant cells	GSE140440	ENSG00000233490	63940	G protein signaling modulator 3	AGS4|C6orf9|G18|G18.1a|G18.1b|G18.2|NG1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9538
8.31119622111336e-16	1.67494104644697	0.793	0.358	2.32422602323435e-11	TNFRSF6B	Malignant cells	GSE140440	ENSG00000243509	8771	TNF receptor superfamily member 6b	DcR3|M68|TR6	protein_coding	O95407	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9539
8.36471931489188e-16	-1.13144171008557	0.98	1	2.33919375640951e-11	RRP1B	Malignant cells	GSE140440	ENSG00000160208	23076	ribosomal RNA processing 1B	KIAA0179|Nnp1|PPP1R136|RRP1	protein_coding	Q14684	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9540
8.50391714902877e-16	1.56449557658814	0.96	0.739	2.3781204307259e-11	CLDN12	Malignant cells	GSE140440	ENSG00000157224	9069	claudin 12	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9541
8.92382054159849e-16	0.934129192182461	0.993	0.896	2.49554641445802e-11	PDE6D	Malignant cells	GSE140440	ENSG00000156973	5147	phosphodiesterase 6D	JBTS22	protein_coding	O43924	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9542
9.14158761327095e-16	-1.19634787465517	0.98	1	2.55644497605122e-11	PDXK	Malignant cells	GSE140440	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9543
9.14527860176133e-16	-0.707361522699646	1	1	2.55747716098256e-11	HSPA9	Malignant cells	GSE140440	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9544
9.6910817660155e-16	0.959588302131059	0.98	0.851	2.71011101586624e-11	IFT52	Malignant cells	GSE140440	ENSG00000101052	51098	intraflagellar transport 52	C20orf9|CGI-53|dJ1028D15.1|NGD2|NGD5	protein_coding	Q9Y366	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9545
9.89292675692134e-16	-1.13062058848289	0.88	1	2.76655696757305e-11	BIRC5	Malignant cells	GSE140440	ENSG00000089685	332	baculoviral IAP repeat containing 5	API4|EPR-1|survivin	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9546
9.93061980548279e-16	0.712732716666398	1	0.985	2.77709782860326e-11	NELFCD	Malignant cells	GSE140440	ENSG00000101158	51497	negative elongation factor complex member C/D	HSPC130|NELF-C|NELF-D|TH1|TH1L	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9547
9.9815670715978e-16	0.609383199467792	1	1	2.79134523157232e-11	PFDN4	Malignant cells	GSE140440	ENSG00000101132	5203	prefoldin subunit 4	C-1|C1|PFD4	protein_coding	Q9NQP4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9548
1.01025633758246e-15	-0.817785306804067	0.96	0.993	2.82518184804936e-11	NASP	Malignant cells	GSE140440	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9549
1.17839507652249e-15	3.5682786388317	0.707	0.321	3.29538183149513e-11	SAMD5	Malignant cells	GSE140440	ENSG00000203727	389432	sterile alpha motif domain containing 5	dJ875H10.1	protein_coding	Q5TGI4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9550
1.27833015094454e-15	-1.66709271117693	0.787	0.963	3.5748502671164e-11	TUBA4A	Malignant cells	GSE140440	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9551
1.31938042256231e-15	4.73481705960132	0.54	0.134	3.6896473516955e-11	CLEC2B	Malignant cells	GSE140440	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9552
1.3725582185023e-15	-0.628378003974181	1	1	3.83835905804167e-11	MRPS7	Malignant cells	GSE140440	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9553
1.45582391669114e-15	-1.00368582546185	0.707	0.918	4.07121158302679e-11	HSP90AA2P	Malignant cells	GSE140440	ENSG00000224411	NA	NA	HSP90AA2|HSP90ALPHA|HSPCA|HSPCAL3	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9554
1.60487929094991e-15	-1.0121296548792	0.953	0.978	4.48804493714143e-11	DNAJC9	Malignant cells	GSE140440	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9555
1.65944932937387e-15	1.89610299174548	0.727	0.306	4.64065004959403e-11	DLX4	Malignant cells	GSE140440	ENSG00000108813	1748	distal-less homeobox 4	BP1|DLX7|DLX8|DLX9	protein_coding	Q92988	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9556
1.6712651437765e-15	3.29829420451492	0.6	0.172	4.67369297457098e-11	ZNF467	Malignant cells	GSE140440	ENSG00000181444	168544	zinc finger protein 467	EZI|Zfp467	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9557
1.80311975603287e-15	-0.66825753326486	0.42	0.858	5.04242439774593e-11	CTD-3162L10.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9558
2.03972280265883e-15	1.46428340946338	0.967	0.836	5.70408481763543e-11	WDR45	Malignant cells	GSE140440	ENSG00000196998	11152	WD repeat domain 45	JM5|NBIA5|WDRX1|WIPI4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9559
2.06800122491362e-15	1.54171111767922	0.92	0.597	5.78316542547093e-11	JAM3	Malignant cells	GSE140440	ENSG00000166086	83700	junctional adhesion molecule 3	JAM-3|JAM-C|JAMC	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9560
2.10641315882015e-15	-4.55799872955688	0.127	0.522	5.89058439864056e-11	ZNF826P	Malignant cells	GSE140440	ENSG00000231205	NA	NA	FLJ44894|ZNF826	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9561
2.16527231377242e-15	0.871042467320979	1	0.97	6.05518402546456e-11	IFNGR2	Malignant cells	GSE140440	ENSG00000262795	3460	interferon gamma receptor 2	AF-1|IFNGT1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9562
2.21474333063319e-15	0.66096886642547	1	1	6.19352972411571e-11	ZFAS1	Malignant cells	GSE140440	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9563
2.22564802652341e-15	1.88289575293151	0.907	0.649	6.22402470617272e-11	ACSS2	Malignant cells	GSE140440	ENSG00000131069	55902	acyl-CoA synthetase short chain family member 2	ACAS2|AceCS|ACS|ACSA|dJ1161H23.1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9564
2.36344782026302e-15	-1.02669182645677	0.993	1	6.60938182936554e-11	MT-TL1	Malignant cells	GSE140440	ENSG00000209082	NA	NA	MTTL1|TRNL1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9565
2.37659176189186e-15	1.16978429718927	1	0.985	6.64613886213059e-11	ATP13A3	Malignant cells	GSE140440	ENSG00000133657	79572	ATPase 13A3	AFURS1	protein_coding	Q9H7F0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9566
2.62345874275628e-15	1.89974622008039	1	0.985	7.33650237411793e-11	CYP51A1	Malignant cells	GSE140440	ENSG00000001630	1595	cytochrome P450 family 51 subfamily A member 1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9567
2.86316672132424e-15	1.4220235219433	1	0.828	8.00684573618324e-11	EDIL3	Malignant cells	GSE140440	ENSG00000164176	10085	EGF like repeats and discoidin domains 3	DEL1	protein_coding	O43854	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9568
2.92235995626418e-15	-4.59252162823553	0.347	0.672	8.17237961769277e-11	IFITM3	Malignant cells	GSE140440	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9569
2.95612408469532e-15	4.24184237787611	0.507	0.09	8.26680100285047e-11	LINC00326	Malignant cells	GSE140440	ENSG00000231023	285735	long intergenic non-protein coding RNA 326	NCRNA00326	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9570
3.05242477583557e-15	-1.34377142786522	0.993	1	8.53610588562418e-11	TUBA1B	Malignant cells	GSE140440	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9571
3.08264987949547e-15	5.58146101157367	0.5	0.097	8.62063038800908e-11	SLC7A8	Malignant cells	GSE140440	ENSG00000092068	23428	solute carrier family 7 member 8	LAT2|LPI-PC1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9572
3.69009286455171e-15	0.961927685668879	1	0.948	1.03193446957189e-10	TMEM219	Malignant cells	GSE140440	ENSG00000149932	124446	transmembrane protein 219	IGFBP-3R	protein_coding	Q86XT9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9573
3.73748790462146e-15	-0.506127942824779	1	1	1.04518849252739e-10	RPL38	Malignant cells	GSE140440	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9574
3.75933699948308e-15	-0.642772104220084	1	1	1.05129859190544e-10	PAICS	Malignant cells	GSE140440	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9575
3.88437443769629e-15	-2.55970228355496	0.32	0.746	1.08626531150177e-10	C11orf86	Malignant cells	GSE140440	ENSG00000173237	254439	chromosome 11 open reading frame 86	FLJ22675	protein_coding	A6NJI1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9576
4.12933219910544e-15	2.39380459235653	0.693	0.239	1.15476774947984e-10	TRIM9	Malignant cells	GSE140440	ENSG00000100505	114088	tripartite motif containing 9	RNF91|SPRING	protein_coding	Q9C026	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9577
4.39253886340976e-15	0.774678862794049	1	0.985	1.22837349315254e-10	ATP6V1D	Malignant cells	GSE140440	ENSG00000100554	51382	ATPase H+ transporting V1 subunit D	ATP6M|VATD|VMA8	protein_coding	Q9Y5K8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9578
4.55200198184948e-15	-2.34661197812594	0.38	0.776	1.27296735422421e-10	ZNF675	Malignant cells	GSE140440	ENSG00000197372	171392	zinc finger protein 675	TBZF|TIZ	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9579
4.70036012304959e-15	-0.492577258221709	0.433	0.866	1.31445570841082e-10	POTEKP	Malignant cells	GSE140440	ENSG00000204434	NA	NA	ACTBL3|FKSG30|POTE2delta|POTEK	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9580
4.73412870440215e-15	0.619807830185136	1	0.985	1.32389909218606e-10	DPM1	Malignant cells	GSE140440	ENSG00000000419	8813	dolichyl-phosphate mannosyltransferase subunit 1, catalytic	CDGIE|MPDS	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9581
4.97254253241204e-15	1.16181677454454	0.987	0.933	1.39057151918903e-10	PDCD4	Malignant cells	GSE140440	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9582
5.46274185359371e-15	0.793359000298465	0.913	0.485	1.52765575935748e-10	GLIDR	Malignant cells	GSE140440	ENSG00000278175	389741	glioblastoma down-regulated RNA	FAM88A|LINC01172|MGC21881|TCONS_00015562	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9583
5.62530274366887e-15	2.61168875191765	0.92	0.776	1.573115912267e-10	CROT	Malignant cells	GSE140440	ENSG00000005469	54677	carnitine O-octanoyltransferase	COT	protein_coding	Q9UKG9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9584
5.88441357345894e-15	1.38060755347295	1	0.978	1.64557625581779e-10	MAGED2	Malignant cells	GSE140440	ENSG00000102316	10916	MAGE family member D2	11B6|BCG1|HCA10|JCL-1|MAGE-D2|MAGED|MGC8386	protein_coding	Q9UNF1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9585
6.33770583102861e-15	-2.16810267213696	0.327	0.739	1.77233943564715e-10	ZNF736	Malignant cells	GSE140440	ENSG00000234444	728927	zinc finger protein 736	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9586
6.59766079936778e-15	1.05925780953774	1	0.873	1.8450358425432e-10	ITFG1	Malignant cells	GSE140440	ENSG00000129636	81533	integrin alpha FG-GAP repeat containing 1	CDA08|LNKN-1|TIP	protein_coding	Q8TB96	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9587
6.6798818655441e-15	0.66534401629608	1	0.955	1.86802896369941e-10	TMEM179B	Malignant cells	GSE140440	ENSG00000185475	374395	transmembrane protein 179B	NA	protein_coding	Q7Z7N9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9588
6.78438233021603e-15	0.914120951875217	0.793	0.425	1.89725251864491e-10	DDIT4	Malignant cells	GSE140440	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9589
6.83394703944092e-15	1.20773042947935	0.98	0.776	1.91111328957965e-10	STEAP1	Malignant cells	GSE140440	ENSG00000164647	26872	STEAP family member 1	PRSS24|STEAP	protein_coding	Q9UHE8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9590
7.15717164370827e-15	-3.07513710061419	0.287	0.664	2.00150305016302e-10	LGSN	Malignant cells	GSE140440	ENSG00000146166	51557	lengsin, lens protein with glutamine synthetase domain	GLULD1|LGS	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9591
7.26488018013058e-15	0.977364987599958	0.98	0.888	2.03162374237352e-10	C1GALT1C1	Malignant cells	GSE140440	ENSG00000288368	29071	C1GALT1 specific chaperone 1	C1GALT2|COSMC	protein_coding	Q96EU7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9592
7.27063202282108e-15	-2.34397593860453	0.693	0.888	2.03323224518191e-10	RP11-15H20.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9593
7.37316752003756e-15	2.18540210972946	0.667	0.269	2.0619062969785e-10	RP11-390P2.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9594
7.39804213847259e-15	1.21513299157772	1	0.903	2.06886248402386e-10	TBC1D17	Malignant cells	GSE140440	ENSG00000104946	79735	TBC1 domain family member 17	FLJ12168	protein_coding	Q9HA65	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9595
8.07139616220728e-15	-0.907309928097449	1	0.993	2.25716593676127e-10	NOL11	Malignant cells	GSE140440	ENSG00000130935	25926	nucleolar protein 11	DKFZP586L0724	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9596
8.11874272795979e-15	-1.35043027005735	0.713	0.97	2.27040640387396e-10	HSBP1L1	Malignant cells	GSE140440	ENSG00000226742	440498	heat shock factor binding protein 1 like 1	FLJ10967|MGC189743	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9597
8.20900389219814e-15	0.979660566491059	1	1	2.29564793845321e-10	FADS1	Malignant cells	GSE140440	ENSG00000149485	3992	fatty acid desaturase 1	D5D|FADS6|FADSD5|LLCDL1|TU12	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9598
8.30127577663494e-15	1.11091217562407	0.94	0.754	2.32145177093596e-10	PCMTD2	Malignant cells	GSE140440	ENSG00000280663	55251	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	C20orf36|FLJ10883	protein_coding	Q9NV79	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9599
8.54340113483939e-15	-1.17547454863951	0.98	0.993	2.38916212735784e-10	DDX46	Malignant cells	GSE140440	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9600
8.82415144275212e-15	1.42592662435772	0.94	0.791	2.46767395096563e-10	MYO6	Malignant cells	GSE140440	ENSG00000196586	4646	myosin VI	DFNA22|DFNB37|KIAA0389	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9601
9.04414132606813e-15	-0.784736738520196	1	1	2.52919412183495e-10	NAP1L4	Malignant cells	GSE140440	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9602
9.45317016538259e-15	-3.61135147186545	0.147	0.567	2.64357903674924e-10	TLL1	Malignant cells	GSE140440	ENSG00000038295	7092	tolloid like 1	NA	protein_coding	O43897	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9603
9.45789291890449e-15	0.918500633130055	1	0.963	2.64489975477164e-10	HLA-C	Malignant cells	GSE140440	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9604
9.96977637098559e-15	1.5586313134037	0.933	0.806	2.78804796214612e-10	SFXN3	Malignant cells	GSE140440	ENSG00000107819	81855	sideroflexin 3	SFX3|SLC56A3	protein_coding	Q9BWM7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9605
1.00598335403091e-14	-2.2313644033642	0.387	0.799	2.81323244954744e-10	LPAR3	Malignant cells	GSE140440	ENSG00000171517	23566	lysophosphatidic acid receptor 3	Edg-7|EDG7|HOFNH30|LP-A3|LPA3|RP4-678I3	protein_coding	Q9UBY5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9606
1.20354159845276e-14	-2.72738550771918	0.173	0.619	3.36570408007315e-10	ZNF85	Malignant cells	GSE140440	ENSG00000278091	7639	zinc finger protein 85	HPF4|HTF1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9607
1.2053262192413e-14	2.06583748338521	0.78	0.351	3.37069477210831e-10	DSP	Malignant cells	GSE140440	ENSG00000096696	1832	desmoplakin	DPI|DPII|KPPS2|PPKS2	protein_coding	P15924	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9608
1.23814861298187e-14	1.07832874938753	0.993	0.925	3.46248259620381e-10	SLC25A23	Malignant cells	GSE140440	ENSG00000125648	79085	solute carrier family 25 member 23	APC2|FLJ30339|MGC2615	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9609
1.27928004563757e-14	1.09231575735918	0.993	0.888	3.57750664762548e-10	SLK	Malignant cells	GSE140440	ENSG00000065613	9748	STE20 like kinase	KIAA0204|se20-9|STK2	protein_coding	Q9H2G2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9610
1.28523258515134e-14	-0.708596192313374	1	1	3.59415292437572e-10	C11orf31	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9611
1.29285528012346e-14	-1.14293379222083	0.96	0.985	3.61546979086526e-10	NUP85	Malignant cells	GSE140440	ENSG00000125450	79902	nucleoporin 85	FLJ12549|NUP75	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9612
1.31617804806598e-14	-1.28519854223468	1	1	3.68069191141652e-10	MLEC	Malignant cells	GSE140440	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9613
1.35420616408133e-14	-0.702057844645491	1	1	3.78703753785344e-10	RPS13	Malignant cells	GSE140440	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9614
1.36799655701409e-14	1.00951270445922	1	0.888	3.8256023716899e-10	BTG1	Malignant cells	GSE140440	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9615
1.36862835937094e-14	-0.863169218179201	0.447	0.813	3.82736920698082e-10	TUBBP1	Malignant cells	GSE140440	ENSG00000127589	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9616
1.48282750517298e-14	-0.601498630051443	1	1	4.14672711821625e-10	DNAJA1	Malignant cells	GSE140440	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9617
1.57628496642761e-14	3.16479647010618	0.62	0.224	4.40808090861481e-10	TNIK	Malignant cells	GSE140440	ENSG00000154310	23043	TRAF2 and NCK interacting kinase	KIAA0551	protein_coding	Q9UKE5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9618
1.58749859462659e-14	3.54391582781722	0.733	0.425	4.43943981987325e-10	ADGRG1	Malignant cells	GSE140440	ENSG00000205336	9289	adhesion G protein-coupled receptor G1	GPR56|TM7LN4|TM7XN1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9619
1.62995222734699e-14	2.12468138113352	0.787	0.396	4.55816140377586e-10	SDC2	Malignant cells	GSE140440	ENSG00000169439	6383	syndecan 2	CD362|fibroglycan|HSPG|HSPG1|SYND2	protein_coding	P34741	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9620
1.64738114638728e-14	4.28607265056039	0.56	0.187	4.60690137587203e-10	INHBA	Malignant cells	GSE140440	ENSG00000122641	3624	inhibin subunit beta A	NA	protein_coding	P08476	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9621
1.67802950825541e-14	-1.74620698257268	0.233	0.672	4.69260951983625e-10	NR0B1	Malignant cells	GSE140440	ENSG00000169297	190	nuclear receptor subfamily 0 group B member 1	AHC|AHCH|DAX1|DSS	protein_coding	P51843	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9622
1.78893265053368e-14	1.58829329303448	0.76	0.328	5.00275015721743e-10	AC108488.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9623
1.79659213478719e-14	1.94003786330652	0.767	0.373	5.02416990493238e-10	TSC22D3	Malignant cells	GSE140440	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9624
1.83993190180355e-14	3.09491164702547	0.807	0.53	5.14536956339364e-10	ARFGEF3	Malignant cells	GSE140440	ENSG00000112379	57221	ARFGEF family member 3	BIG3|C6orf92|dJ171N11.1|KIAA1244|PPP1R33	protein_coding	Q5TH69	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9625
1.87486214275473e-14	1.12177417419527	1	0.955	5.24305198221361e-10	GTPBP10	Malignant cells	GSE140440	ENSG00000105793	85865	GTP binding protein 10	DKFZP686A10121|FLJ38242|OBGH2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9626
1.91179500715459e-14	-0.710148889451633	1	1	5.34633473750781e-10	ACTG1	Malignant cells	GSE140440	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9627
1.92223260668658e-14	0.835125707565117	1	1	5.37552348459903e-10	RTFDC1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9628
2.02012391928562e-14	1.23602779503165	0.96	0.806	5.64927654028223e-10	MED7	Malignant cells	GSE140440	ENSG00000155868	9443	mediator complex subunit 7	CRSP33|CRSP9	protein_coding	O43513	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9629
2.126419940353e-14	-1.17198034989565	0.88	0.985	5.94653336319716e-10	C12orf45	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9630
2.14159574335452e-14	-2.44589126026123	0.173	0.604	5.98897249629092e-10	STK31	Malignant cells	GSE140440	ENSG00000196335	56164	serine/threonine kinase 31	SgK396|TDRD8	protein_coding	Q9BXU1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9631
2.15330857419725e-14	1.18112578888723	0.993	0.836	6.0217274277426e-10	OARD1	Malignant cells	GSE140440	ENSG00000124596	221443	O-acyl-ADP-ribose deacylase 1	C6orf130|dJ34B21.3|MGC19570|TARG1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9632
2.18189411794607e-14	1.28071456677053	0.993	0.925	6.10166690083618e-10	IMPACT	Malignant cells	GSE140440	ENSG00000154059	55364	impact RWD domain protein	RWDD5	protein_coding	Q9P2X3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9633
2.38418631032535e-14	1.3228805381351	0.913	0.664	6.66737701682485e-10	CCDC28A	Malignant cells	GSE140440	ENSG00000024862	25901	coiled-coil domain containing 28A	C6orf80|CCRL1AP|DKFZp586D0623	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9634
2.48951983681765e-14	0.77751018724104	1	0.813	6.96194222366056e-10	C17orf49	Malignant cells	GSE140440	ENSG00000258315	124944	chromosome 17 open reading frame 49	BAP18|HEPIS|MGC49942	protein_coding	Q8IXM2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9635
2.96093815286861e-14	1.21039046358198	0.993	0.97	8.28026354449707e-10	TSC22D1	Malignant cells	GSE140440	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9636
3.0170867309613e-14	2.39044070356628	0.64	0.239	8.43728304313327e-10	SRPX	Malignant cells	GSE140440	ENSG00000101955	8406	sushi repeat containing protein X-linked	ETX1|SRPX1	protein_coding	P78539	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9637
3.46217964669107e-14	0.64529802413297	1	1	9.68198538197158e-10	SPCS2	Malignant cells	GSE140440	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9638
3.5202903670632e-14	1.48866215614842	0.887	0.552	9.84449201149223e-10	DFNA5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9639
3.63719698472504e-14	0.981898388200498	1	0.993	1.01714213677836e-09	RBCK1	Malignant cells	GSE140440	ENSG00000125826	10616	RANBP2-type and C3HC4-type zinc finger containing 1	C20orf18|HOIL1|RBCK2|RNF54|UBCE7IP3|XAP4|ZRANB4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9640
4.33625801246064e-14	1.39382749124797	0.787	0.41	1.21263455318462e-09	B4GALT6	Malignant cells	GSE140440	ENSG00000118276	9331	beta-1,4-galactosyltransferase 6	beta4GalT-VI	protein_coding	Q9UBX8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9641
4.47077981041887e-14	-1.31852949937464	0.92	0.993	1.25025357398364e-09	BOP1	Malignant cells	GSE140440	ENSG00000285301	23246	BOP1 ribosomal biogenesis factor	KIAA0124	protein_coding	Q14137	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9642
4.54681150909373e-14	-0.726672324550417	1	1	1.27151583851806e-09	TCEB1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9643
4.67424847471383e-14	0.96615602008138	0.993	0.97	1.30715358595372e-09	NDRG3	Malignant cells	GSE140440	ENSG00000101079	57446	NDRG family member 3	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9644
4.7772748683998e-14	0.763320780096938	1	0.97	1.335964916948e-09	THYN1	Malignant cells	GSE140440	ENSG00000151500	29087	thymocyte nuclear protein 1	THY28	protein_coding	Q9P016	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9645
4.87744327853389e-14	-1.2167915813719	0.573	0.955	1.363977012842e-09	ASPM	Malignant cells	GSE140440	ENSG00000066279	259266	assembly factor for spindle microtubules	ASP|Calmbp1|FLJ10517|FLJ10549|MCPH5	protein_coding	Q8IZT6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9646
4.94691020012302e-14	1.00122983456781	0.987	0.799	1.3834034374644e-09	ZNF22	Malignant cells	GSE140440	ENSG00000165512	7570	zinc finger protein 22	HKR-T1|KOX15|Zfp422|ZNF422	protein_coding	P17026	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9647
4.97100806367557e-14	-0.684033976953545	1	1	1.39014240500687e-09	HSPA8	Malignant cells	GSE140440	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9648
5.17755851151144e-14	-2.07017778211497	0.467	0.821	1.44790423774417e-09	EPS8L2	Malignant cells	GSE140440	ENSG00000177106	64787	EPS8 like 2	FLJ21935|FLJ22171|MGC3088	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9649
5.28446047300522e-14	1.32532375247227	0.973	0.881	1.47779937127591e-09	SLC26A2	Malignant cells	GSE140440	ENSG00000155850	1836	solute carrier family 26 member 2	DTD|DTDST	protein_coding	P50443	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9650
5.46732035636115e-14	1.09597471695906	0.96	0.858	1.5289361376564e-09	TCEAL1	Malignant cells	GSE140440	ENSG00000172465	9338	transcription elongation factor A like 1	p21|pp21|SIIR|WEX9	protein_coding	Q15170	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9651
5.70342182931448e-14	-1.96571129040262	0.373	0.731	1.5949619145678e-09	JMJD1C-AS1	Malignant cells	GSE140440	ENSG00000272767	84989	JMJD1C antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9652
5.71846404884071e-14	-1.29810036796293	0.26	0.761	1.5991684712583e-09	MISP	Malignant cells	GSE140440	ENSG00000099812	126353	mitotic spindle positioning	C19orf21|Caprice|DKFZp686H18209|MISP1	protein_coding	Q8IVT2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9653
6.09204482824248e-14	0.960589705668845	1	0.955	1.70364033621801e-09	AIG1	Malignant cells	GSE140440	ENSG00000146416	51390	androgen induced 1	AIG-1|dJ95L4.1|FLJ10485	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9654
6.54768585212222e-14	-2.17702158760714	0.36	0.776	1.83106034854598e-09	DUSP13	Malignant cells	GSE140440	ENSG00000079393	51207	dual specificity phosphatase 13	BEDP|DUSP13A|DUSP13B|FLJ32450|MDSP|TMDP	protein_coding	Q9UII6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9655
6.77369071410407e-14	-0.766040597572225	1	1	1.8942626081992e-09	PWP1	Malignant cells	GSE140440	ENSG00000136045	11137	PWP1 homolog, endonuclein	IEF-SSP-9502	protein_coding	Q13610	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9656
6.84763779265523e-14	-1.11796870035981	0.993	0.993	1.91494190871603e-09	NUP107	Malignant cells	GSE140440	ENSG00000111581	57122	nucleoporin 107	NUP84	protein_coding	P57740	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9657
6.90341783842128e-14	0.977742969427039	0.987	0.955	1.93054079851451e-09	TMEM189	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9658
7.07857527303846e-14	-1.82146734242659	0.54	0.873	1.97952357510521e-09	MCM10	Malignant cells	GSE140440	ENSG00000065328	55388	minichromosome maintenance 10 replication initiation factor	CNA43|DNA43|PRO2249	protein_coding	Q7L590	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9659
7.22906958071481e-14	1.95158883303894	0.767	0.321	2.0216093082469e-09	ALDOC	Malignant cells	GSE140440	ENSG00000109107	230	aldolase, fructose-bisphosphate C	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9660
7.23997758852836e-14	2.17854768676927	0.727	0.328	2.02465973263196e-09	ICA1	Malignant cells	GSE140440	ENSG00000003147	3382	islet cell autoantigen 1	ICA69|ICAp69	protein_coding	Q05084	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9661
7.27670043877048e-14	-3.85067751234355	0.067	0.44	2.03492927770217e-09	RSPO3	Malignant cells	GSE140440	ENSG00000146374	84870	R-spondin 3	FLJ14440|THSD2	protein_coding	Q9BXY4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9662
7.54039775729088e-14	1.16442149135371	0.993	0.918	2.10867223282639e-09	ACP6	Malignant cells	GSE140440	ENSG00000162836	51205	acid phosphatase 6, lysophosphatidic	ACPL1|LPAP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9663
7.60078831151743e-14	-1.96440627788832	0.553	0.851	2.12556045131585e-09	ATAD3B	Malignant cells	GSE140440	ENSG00000160072	83858	ATPase family AAA domain containing 3B	KIAA1273|TOB3	protein_coding	Q5T9A4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9664
7.93910291350514e-14	3.7998589009738	0.507	0.134	2.22017012976171e-09	EPHB6	Malignant cells	GSE140440	ENSG00000275482	2051	EPH receptor B6	HEP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9665
8.04009496759926e-14	2.45335266943217	0.793	0.537	2.24841255768913e-09	YPEL3	Malignant cells	GSE140440	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9666
8.63699214436374e-14	-2.70813843203658	0.313	0.701	2.41533485317132e-09	SUSD2	Malignant cells	GSE140440	ENSG00000099994	56241	sushi domain containing 2	BK65A6.2|FLJ22778|W5C5	protein_coding	Q9UGT4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9667
8.81737020234627e-14	1.88242413238916	0.867	0.642	2.46577757708614e-09	C10orf11	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9668
9.31613413928796e-14	-1.63773692492986	0.347	0.754	2.60525691205188e-09	TRIML2	Malignant cells	GSE140440	ENSG00000179046	205860	tripartite motif family like 2	FLJ25801|SPRYD6	protein_coding	Q8N7C3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9669
9.42155683665943e-14	0.954711145388581	1	1	2.63473836937181e-09	RHOC	Malignant cells	GSE140440	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9670
9.471827494052e-14	-0.769322168985514	0.993	1	2.64879655871164e-09	TIMM10	Malignant cells	GSE140440	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9671
9.83794027645404e-14	0.829406049767077	1	0.97	2.75117999831037e-09	CCDC90B	Malignant cells	GSE140440	ENSG00000137500	60492	coiled-coil domain containing 90B	MDS011|MDS025	protein_coding	Q9GZT6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9672
1.00777593256779e-13	-1.17731703626115	0.387	0.761	2.81824539542581e-09	DNAH17-AS1	Malignant cells	GSE140440	ENSG00000267432	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9673
1.03596888003669e-13	-1.38178882920254	0.913	1	2.89708697302262e-09	CENPF	Malignant cells	GSE140440	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9674
1.07123119825458e-13	0.922979959671514	0.98	0.836	2.99569804591893e-09	SDF2	Malignant cells	GSE140440	ENSG00000132581	6388	stromal cell derived factor 2	NA	protein_coding	Q99470	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9675
1.07952284412026e-13	1.89916718945119	0.967	0.925	3.01888563358231e-09	CPM	Malignant cells	GSE140440	ENSG00000135678	1368	carboxypeptidase M	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9676
1.08786742175524e-13	5.16643310435255	0.473	0.097	3.04222124493854e-09	NTNG1	Malignant cells	GSE140440	ENSG00000162631	22854	netrin G1	KIAA0976|Lmnt1	protein_coding	Q9Y2I2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9677
1.0923629538186e-13	0.573738014174138	1	1	3.05479300035372e-09	EIF6	Malignant cells	GSE140440	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9678
1.11595054126148e-13	0.884927848582234	1	0.97	3.12075568863772e-09	QKI	Malignant cells	GSE140440	ENSG00000112531	9444	QKI, KH domain containing RNA binding	QK3	protein_coding	Q96PU8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9679
1.1280895020021e-13	-1.10093166330612	0.86	0.978	3.15470229234888e-09	KIAA0101	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9680
1.26543646624773e-13	1.08743887027703	0.987	0.896	3.53879307786177e-09	RICTOR	Malignant cells	GSE140440	ENSG00000164327	253260	RPTOR independent companion of MTOR complex 2	AVO3|KIAA1999|MGC39830|PIA	protein_coding	Q6R327	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9681
1.26590272572822e-13	0.633204505886686	1	0.985	3.54009697249896e-09	SNX2	Malignant cells	GSE140440	ENSG00000205302	6643	sorting nexin 2	NA	protein_coding	O60749	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9682
1.37154070591258e-13	0.967581420524246	1	0.918	3.83551358408452e-09	COMT	Malignant cells	GSE140440	ENSG00000093010	1312	catechol-O-methyltransferase	NA	protein_coding	P21964	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9683
1.45075253632709e-13	3.18050210805748	0.6	0.209	4.05702946783871e-09	TTLL1	Malignant cells	GSE140440	ENSG00000100271	25809	TTL family tubulin polyglutamylase complex subunit L1	C22orf7|PGs3|TPGS3	protein_coding	O95922	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9684
1.45869344916425e-13	-0.482524694953652	1	1	4.07923623058782e-09	VDAC2	Malignant cells	GSE140440	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9685
1.46620632292521e-13	-0.920140874151319	1	1	4.10024598206035e-09	TIMM21	Malignant cells	GSE140440	ENSG00000075336	29090	translocase of inner mitochondrial membrane 21	C18orf55|HSPC154|TIM21	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9686
1.49805671589668e-13	0.748177159311775	1	0.985	4.18931560600508e-09	CETN3	Malignant cells	GSE140440	ENSG00000153140	1070	centrin 3	CEN3	protein_coding	O15182	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9687
1.5402763576247e-13	-0.837176688224549	1	0.993	4.30738283409749e-09	IMPDH2	Malignant cells	GSE140440	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9688
1.56581039732441e-13	2.48867993088939	0.553	0.142	4.37878877611771e-09	C10orf10	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9689
1.57714952373473e-13	1.61402371524999	0.92	0.806	4.41049864312418e-09	TMEM136	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9690
1.73798802209467e-13	3.44452962945854	0.54	0.157	4.86028350378775e-09	AGR2	Malignant cells	GSE140440	ENSG00000106541	10551	anterior gradient 2, protein disulphide isomerase family member	AG2|HAG-2|PDIA17|XAG-2	protein_coding	O95994	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9691
1.73929201263177e-13	0.370866944398214	0.987	0.955	4.86393011332474e-09	S100A2	Malignant cells	GSE140440	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9692
1.76202653813079e-13	1.10356701440831	1	0.978	4.92750721388274e-09	HEBP2	Malignant cells	GSE140440	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9693
1.85364413064205e-13	-1.83241344167444	0.66	0.933	5.18371581134049e-09	ZNF430	Malignant cells	GSE140440	ENSG00000278780	80264	zinc finger protein 430	FLJ13659	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9694
1.9337865694261e-13	0.708971071838782	1	1	5.4078341414001e-09	PHF20	Malignant cells	GSE140440	ENSG00000025293	51230	PHD finger protein 20	C20orf104|dJ1121G12.1|TDRD20A	protein_coding	Q9BVI0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9695
2.06755993271406e-13	-2.14783062365877	0.34	0.746	5.78193135183486e-09	NPTX2	Malignant cells	GSE140440	ENSG00000106236	4885	neuronal pentraxin 2	NA	protein_coding	P47972	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9696
2.07231116791692e-13	1.00761230313012	1	0.948	5.79521818107966e-09	PTPRA	Malignant cells	GSE140440	ENSG00000132670	5786	protein tyrosine phosphatase receptor type A	HLPR|HPTPA|LRP|PTPA|PTPRL2|RPTPA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9697
2.08419649294386e-13	0.830128158731185	1	0.978	5.8284554925175e-09	CCDC127	Malignant cells	GSE140440	ENSG00000164366	133957	coiled-coil domain containing 127	FLJ25701	protein_coding	Q96BQ5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9698
2.10645669874172e-13	0.554708209783719	1	0.985	5.89070615803121e-09	FAM96B	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9699
2.10797463778167e-13	-1.46672903854865	0.54	0.873	5.89495107455643e-09	SIRT7	Malignant cells	GSE140440	ENSG00000187531	51547	sirtuin 7	NA	protein_coding	Q9NRC8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9700
2.27040563815888e-13	0.769530689469185	1	0.978	6.34918936711131e-09	NUDT22	Malignant cells	GSE140440	ENSG00000149761	84304	nudix hydrolase 22	MGC13045	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9701
2.35494049784592e-13	1.60928249623556	0.967	0.746	6.58559110222611e-09	SMAD1	Malignant cells	GSE140440	ENSG00000170365	4086	SMAD family member 1	JV4-1|MADH1|MADR1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9702
2.41038922431974e-13	-1.43343006122863	0.78	0.948	6.74065346581016e-09	BUB1	Malignant cells	GSE140440	ENSG00000169679	699	BUB1 mitotic checkpoint serine/threonine kinase	BUB1A|BUB1L|hBUB1	protein_coding	O43683	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9703
2.44729230437779e-13	-1.94065565991989	0.227	0.634	6.84385292919249e-09	TDRP	Malignant cells	GSE140440	ENSG00000180190	157695	testis development related protein	C8orf42|INM01|TDRP1|TDRP2	protein_coding	Q86YL5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9704
2.45633005918448e-13	5.71898299271131	0.467	0.097	6.86912701050941e-09	ADGRL2	Malignant cells	GSE140440	ENSG00000117114	23266	adhesion G protein-coupled receptor L2	CIRL2|KIAA0786|LEC1|LPHH1|LPHN2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9705
2.57924271991539e-13	0.951237869768864	0.993	0.94	7.2128522662434e-09	SKAP2	Malignant cells	GSE140440	ENSG00000005020	8935	src kinase associated phosphoprotein 2	RA70|SAPS|SCAP2|SKAP-HOM|SKAP55R	protein_coding	O75563	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9706
2.58857043441045e-13	0.549034478986746	1	1	7.23893721982882e-09	NDUFA8	Malignant cells	GSE140440	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9707
2.78074376217839e-13	1.47246593029941	0.973	0.836	7.77634993093187e-09	LOXL2	Malignant cells	GSE140440	ENSG00000134013	4017	lysyl oxidase like 2	LOR|WS9-14	protein_coding	Q9Y4K0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9708
2.85125141849359e-13	-0.589401699800356	0.38	0.806	7.97352459181733e-09	KRT8P3	Malignant cells	GSE140440	ENSG00000254285	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9709
2.9856971066153e-13	1.75823984332491	0.873	0.649	8.34950195864968e-09	ACOX2	Malignant cells	GSE140440	ENSG00000168306	8309	acyl-CoA oxidase 2	BRCACOX|BRCOX|THCCox	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9710
3.01613949051706e-13	1.61559980903011	0.86	0.575	8.43463408523096e-09	GSN	Malignant cells	GSE140440	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9711
3.03662205556814e-13	-0.745862330202182	0.387	0.799	8.49191357839631e-09	PARD6G-AS1	Malignant cells	GSE140440	ENSG00000267270	100130522	PARD6G antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9712
3.04283813942456e-13	0.804786779593059	1	0.993	8.50929685690077e-09	GSS	Malignant cells	GSE140440	ENSG00000100983	2937	glutathione synthetase	NA	protein_coding	P48637	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9713
3.0805295109571e-13	0.95092115304843	0.993	0.91	8.61470077739153e-09	NSRP1	Malignant cells	GSE140440	ENSG00000126653	84081	nuclear speckle splicing regulatory protein 1	CCDC55|DKFZP434K1421|NSrp70	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9714
3.38526572630631e-13	0.84520874852703	1	0.873	9.46689560361561e-09	UNC50	Malignant cells	GSE140440	ENSG00000115446	25972	unc-50 inner nuclear membrane RNA binding protein	GMH1|UNCL|URP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9715
3.40809796640405e-13	1.03395383877848	0.96	0.731	9.53074596304892e-09	TVP23C	Malignant cells	GSE140440	ENSG00000175106	201158	trans-golgi network vesicle protein 23 homolog C	FAM18B2|MGC8763	protein_coding	Q96ET8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9716
3.77648667505851e-13	0.735136249261486	0.967	0.754	1.05609449868011e-08	OFD1	Malignant cells	GSE140440	ENSG00000046651	8481	OFD1 centriole and centriolar satellite protein	71-7A|CXorf5|JBTS10|RP23	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9717
3.85124838277192e-13	-1.51730235805306	0.34	0.709	1.07700161024217e-08	SOD3	Malignant cells	GSE140440	ENSG00000109610	6649	superoxide dismutase 3	EC-SOD	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9718
3.89945532277246e-13	-0.791339885662096	0.38	0.799	1.09048268101332e-08	CFHR1	Malignant cells	GSE140440	ENSG00000244414	3078	complement factor H related 1	CFHL|CFHL1|CFHL1P|CFHR1P|FHR1|H36-1|H36-2|HFL1|HFL2	protein_coding	Q03591	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9719
3.95425461364007e-13	-1.51106642344645	0.88	0.97	1.10580730270445e-08	TOP2A	Malignant cells	GSE140440	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9720
3.99330843211749e-13	-1.35171366280299	0.967	0.985	1.11672870304166e-08	MT-TV	Malignant cells	GSE140440	ENSG00000210077	NA	NA	MTTV|trnV	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9721
4.15832974835021e-13	-0.63548249717324	0.233	0.642	1.16287691412614e-08	RCN1P2	Malignant cells	GSE140440	ENSG00000214455	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9722
4.20112262094849e-13	-0.773599593350916	1	0.993	1.17484394094825e-08	ARHGDIA	Malignant cells	GSE140440	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9723
4.22030466394999e-13	0.569741291656163	1	1	1.18020819927361e-08	RTN4	Malignant cells	GSE140440	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9724
4.34449976344037e-13	-1.0021904938059	0.973	0.993	1.2149393588461e-08	CCDC137	Malignant cells	GSE140440	ENSG00000185298	339230	coiled-coil domain containing 137	MGC16597	protein_coding	Q6PK04	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9725
4.35598001812627e-13	-0.530462956723449	1	1	1.21814981206901e-08	CDC37	Malignant cells	GSE140440	ENSG00000105401	11140	cell division cycle 37, HSP90 cochaperone	P50CDC37	protein_coding	Q16543	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9726
4.42490470708562e-13	-0.787098679037118	0.993	1	1.23742460133649e-08	HNRNPAB	Malignant cells	GSE140440	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9727
4.47913479887131e-13	1.15559185536852	0.92	0.463	1.25259004650436e-08	CADM1	Malignant cells	GSE140440	ENSG00000182985	23705	cell adhesion molecule 1	BL2|IGSF4|IGSF4A|Necl-2|NECL2|RA175|ST17|SYNCAM|SYNCAM1|TSLC1	protein_coding	Q9BY67	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9728
4.48099016835135e-13	1.93640661800492	0.74	0.373	1.25310890057945e-08	MT1F	Malignant cells	GSE140440	ENSG00000198417	4494	metallothionein 1F	MT1	protein_coding	P04733	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9729
4.48228600875614e-13	1.56472859149207	0.827	0.5	1.25347128234865e-08	LZTFL1	Malignant cells	GSE140440	ENSG00000163818	54585	leucine zipper transcription factor like 1	BBS17	protein_coding	Q9NQ48	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9730
4.57208217685243e-13	0.81564172149203	1	1	1.27858278075678e-08	LARS	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9731
4.60530325061915e-13	-3.44673511178172	0.253	0.634	1.28787305403564e-08	SLCO3A1	Malignant cells	GSE140440	ENSG00000176463	28232	solute carrier organic anion transporter family member 3A1	OATP-D|OATP3A1|SLC21A11	protein_coding	Q9UIG8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9732
4.81485817786462e-13	-1.05325787987617	0.833	0.978	1.34647508943984e-08	ATAD2	Malignant cells	GSE140440	ENSG00000156802	29028	ATPase family AAA domain containing 2	ANCCA|CT137|DKFZp667N1320|MGC29843|MGC5254|PRO2000	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9733
4.92695014064747e-13	0.349358434244641	1	1	1.37782160683207e-08	EEF1A1	Malignant cells	GSE140440	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9734
5.10013402276528e-13	-0.499254971138429	0.513	0.888	1.42625247946631e-08	ACTBP9	Malignant cells	GSE140440	ENSG00000266920	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9735
5.24620039214846e-13	4.28373005780969	0.64	0.328	1.46709993966432e-08	FBXO32	Malignant cells	GSE140440	ENSG00000156804	114907	F-box protein 32	ATROGIN1|Fbx32|MAFbx	protein_coding	Q969P5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9736
5.3639974964901e-13	0.698699030547857	1	0.993	1.50004189989346e-08	CHMP2A	Malignant cells	GSE140440	ENSG00000130724	27243	charged multivesicular body protein 2A	BC-2|CHMP2|VPS2|VPS2A	protein_coding	O43633	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9737
5.50917034506257e-13	-1.0182927278382	0.987	1	1.54063948699675e-08	KPNA2	Malignant cells	GSE140440	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9738
5.50923580032524e-13	-3.61280432841715	0.327	0.731	1.54065779156095e-08	SDPR	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9739
5.53442966801701e-13	-1.01676392184251	0.987	0.993	1.54770325666096e-08	SMIM4	Malignant cells	GSE140440	ENSG00000168273	440957	small integral membrane protein 4	C3orf78	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9740
5.57267442880493e-13	4.41731272050042	0.52	0.157	1.5583984040153e-08	AFAP1-AS1	Malignant cells	GSE140440	ENSG00000272620	84740	AFAP1 antisense RNA 1	AFAP1-AS|AFAP1AS|MGC10981	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9741
5.69074411740905e-13	-1.93946713629726	0.333	0.746	1.59141659243344e-08	ICAM1	Malignant cells	GSE140440	ENSG00000090339	3383	intercellular adhesion molecule 1	BB2|CD54	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9742
5.87103310417658e-13	-0.548073823539623	1	1	1.64183440758298e-08	PSMC6	Malignant cells	GSE140440	ENSG00000100519	5706	proteasome 26S subunit, ATPase 6	p42|RPT5	protein_coding	P62333	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9743
6.52156595311368e-13	-1.47862235301898	0.433	0.828	1.82375591878824e-08	RP11-498C9.15	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9744
6.52604298239471e-13	-0.857848373250096	0.973	1	1.82500792002668e-08	CCND1	Malignant cells	GSE140440	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9745
6.56265758423255e-13	2.86715516310751	0.66	0.291	1.83524719343063e-08	VWA5A	Malignant cells	GSE140440	ENSG00000110002	4013	von Willebrand factor A domain containing 5A	BCSC-1|LOH11CR2A	protein_coding	O00534	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9746
7.06888395737906e-13	-4.19694117845956	0.14	0.522	1.97681339868105e-08	PTGFR	Malignant cells	GSE140440	ENSG00000122420	5737	prostaglandin F receptor	FP	protein_coding	P43088	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9747
7.4781621046008e-13	1.33191201714788	0.96	0.925	2.09126803255161e-08	OPN3	Malignant cells	GSE140440	ENSG00000054277	23596	opsin 3	ECPN|encephalopsin|ERO|NMO-1|PPP1R116	protein_coding	Q9H1Y3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9748
7.54896900073967e-13	0.984369312619552	0.973	0.836	2.11106918105685e-08	GNPTG	Malignant cells	GSE140440	ENSG00000090581	84572	N-acetylglucosamine-1-phosphate transferase subunit gamma	C16orf27|c316G12.3|CAB56184|GNPTAG	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9749
7.56068679194045e-13	2.31621380478166	0.847	0.694	2.11434606136615e-08	DAB2	Malignant cells	GSE140440	ENSG00000153071	1601	DAB adaptor protein 2	DOC-2	protein_coding	P98082	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9750
7.59593147993012e-13	-1.28571917578549	0.913	1	2.12420223836246e-08	ZNF544	Malignant cells	GSE140440	ENSG00000198131	27300	zinc finger protein 544	AF020591	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9751
7.86696969697885e-13	-1.49235135053628	0.96	1	2.19999807576014e-08	ISG20L2	Malignant cells	GSE140440	ENSG00000143319	81875	interferon stimulated exonuclease gene 20 like 2	FLJ12671	protein_coding	Q9H9L3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9752
7.91204395137237e-13	-2.20620981895102	0.22	0.627	2.21260309100128e-08	CORO1A	Malignant cells	GSE140440	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9753
8.2354285254325e-13	0.729058313709401	1	0.993	2.3030375871372e-08	STAU1	Malignant cells	GSE140440	ENSG00000124214	6780	staufen double-stranded RNA binding protein 1	PPP1R150|STAU	protein_coding	O95793	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9754
8.8498527378148e-13	1.76048006129662	0.773	0.418	2.47486131812991e-08	PDK3	Malignant cells	GSE140440	ENSG00000067992	5165	pyruvate dehydrogenase kinase 3	NA	protein_coding	Q15120	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9755
8.85716468809479e-13	3.82961299610685	0.507	0.134	2.47690610502571e-08	ITGB3	Malignant cells	GSE140440	ENSG00000259207	3690	integrin subunit beta 3	CD61|GP3A|GPIIIa	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9756
8.99730210093015e-13	-0.465090226077972	0.287	0.701	2.51609553252512e-08	ACTG1P12	Malignant cells	GSE140440	ENSG00000226642	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9757
9.23420222611836e-13	1.46155613049408	0.713	0.336	2.582344652534e-08	CREB5	Malignant cells	GSE140440	ENSG00000146592	9586	cAMP responsive element binding protein 5	CRE-BPA|H_GS165L15.1	protein_coding	Q02930	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9758
9.93313556813916e-13	0.853910598023896	0.993	0.955	2.77780136163011e-08	PRKCA	Malignant cells	GSE140440	ENSG00000154229	5578	protein kinase C alpha	PKCA|PKCalpha	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9759
1.03596780899646e-12	-2.21751698026828	0.767	0.94	2.89708397785859e-08	CRIP2	Malignant cells	GSE140440	ENSG00000182809	1397	cysteine rich protein 2	CRP2|ESP1	protein_coding	P52943	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9760
1.06025186798253e-12	-3.46014850135377	0.387	0.709	2.96499434881314e-08	ZNF681	Malignant cells	GSE140440	ENSG00000196172	148213	zinc finger protein 681	FLJ31526	protein_coding	Q96N22	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9761
1.08270362395358e-12	2.19738178873714	0.707	0.343	3.02778068438617e-08	AC004980.9	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9762
1.14114126829441e-12	5.57618436591762	0.493	0.127	3.19120155678533e-08	LAMA4	Malignant cells	GSE140440	ENSG00000112769	3910	laminin subunit alpha 4	LAMA3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9763
1.15574727686451e-12	-3.11186218571866	0.34	0.746	3.2320472597516e-08	BMP5	Malignant cells	GSE140440	ENSG00000112175	653	bone morphogenetic protein 5	NA	protein_coding	P22003	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9764
1.16299483064094e-12	4.13649784304783	0.493	0.142	3.25231504388739e-08	HSD17B8	Malignant cells	GSE140440	ENSG00000228357	7923	hydroxysteroid 17-beta dehydrogenase 8	D6S2245E|FABGL|H2-KE6|HKE6|KE6|RING2|SDR30C1	protein_coding	Q92506	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9765
1.19137963122188e-12	1.0582196849235	0.993	0.918	3.331693138712e-08	COMMD7	Malignant cells	GSE140440	ENSG00000149600	149951	COMM domain containing 7	C20orf92|dJ1085F17.3	protein_coding	Q86VX2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9766
1.22099088087679e-12	-3.52462400224312	0.313	0.649	3.41450099837194e-08	CRISPLD1	Malignant cells	GSE140440	ENSG00000121005	83690	cysteine rich secretory protein LCCL domain containing 1	Cocoacrisp|DKFZp762F133|LCRISP1	protein_coding	Q9H336	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9767
1.24165766099877e-12	2.37105926831753	0.74	0.455	3.47229564898306e-08	PKIA	Malignant cells	GSE140440	ENSG00000171033	5569	cAMP-dependent protein kinase inhibitor alpha	PRKACN1	protein_coding	P61925	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9768
1.26103427264039e-12	-1.00471319552804	0.98	0.993	3.52648234343884e-08	ZMPSTE24	Malignant cells	GSE140440	ENSG00000084073	10269	zinc metallopeptidase STE24	FACE-1|HGPS|PRO1|STE24|Ste24p	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9769
1.32196961479053e-12	-1.20106838502166	1	1	3.6968880277617e-08	RBM25	Malignant cells	GSE140440	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9770
1.38823419404198e-12	0.916290997721394	1	0.918	3.8821969236384e-08	PPIC	Malignant cells	GSE140440	ENSG00000168938	5480	peptidylprolyl isomerase C	CYPC	protein_coding	P45877	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9771
1.41910440224324e-12	-1.45046703756739	0.647	0.933	3.96852546087321e-08	PARPBP	Malignant cells	GSE140440	ENSG00000185480	55010	PARP1 binding protein	C12orf48|FLJ20641|PARI	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9772
1.49800647933839e-12	0.385796453980458	1	1	4.18917511946982e-08	TCEB2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9773
1.50990583463481e-12	3.64966944281203	0.553	0.194	4.22245166655623e-08	AOX1	Malignant cells	GSE140440	ENSG00000138356	316	aldehyde oxidase 1	AO|AOH1	protein_coding	Q06278	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9774
1.52731139352874e-12	1.40097500305903	0.993	0.925	4.27112631200311e-08	ACAT2	Malignant cells	GSE140440	ENSG00000120437	39	acetyl-CoA acetyltransferase 2	NA	protein_coding	Q9BWD1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9775
1.55188993234928e-12	1.31627529924224	0.92	0.769	4.33986019581476e-08	MPC1	Malignant cells	GSE140440	ENSG00000060762	51660	mitochondrial pyruvate carrier 1	BRP44L|CGI-129|dJ68L15.3|SLC54A1	protein_coding	Q9Y5U8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9776
1.57342549360369e-12	-1.79701971312283	0.633	0.828	4.40008439286271e-08	SLC16A3	Malignant cells	GSE140440	ENSG00000141526	9123	solute carrier family 16 member 3	MCT3|MCT4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9777
1.70725220460367e-12	-0.420824906903022	1	1	4.77433079017417e-08	XRCC5	Malignant cells	GSE140440	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9778
1.74660468633792e-12	3.09976457976667	0.553	0.179	4.88438000534399e-08	ZNF385D	Malignant cells	GSE140440	ENSG00000151789	79750	zinc finger protein 385D	FLJ22419|ZNF659	protein_coding	Q9H6B1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9779
1.75513809596974e-12	-3.8154366073951	0.187	0.567	4.90824368537937e-08	TFF1	Malignant cells	GSE140440	ENSG00000160182	7031	trefoil factor 1	BCEI|D21S21|HP1.A|HPS2|pNR-2|pS2	protein_coding	P04155	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9780
1.75580936615977e-12	1.10990528186791	0.987	0.881	4.91012089246581e-08	DHX32	Malignant cells	GSE140440	ENSG00000089876	55760	DEAH-box helicase 32 (putative)	DDX32|DHLP1|FLJ10694|FLJ10889	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9781
1.774474637628e-12	1.66271998945664	0.927	0.709	4.9623183241267e-08	CNTNAP3B	Malignant cells	GSE140440	ENSG00000154529	728577	contactin associated protein family member 3B	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9782
1.81075888156614e-12	1.58242478765508	0.74	0.366	5.06378721229972e-08	MTMR11	Malignant cells	GSE140440	ENSG00000014914	10903	myotubularin related protein 11	CRA	protein_coding	A4FU01	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9783
1.85745288801961e-12	-2.78007517461007	0.393	0.701	5.19436700134683e-08	IPO5P1	Malignant cells	GSE140440	ENSG00000269837	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9784
1.86526194546338e-12	-2.74286480495928	0.173	0.56	5.21620503048835e-08	NAV2	Malignant cells	GSE140440	ENSG00000166833	89797	neuron navigator 2	FLJ10633|FLJ11030|FLJ23707|HELAD1|KIAA1419|POMFIL2|RAINB1	protein_coding	Q8IVL1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9785
1.88566137662571e-12	-4.04119482711865	0.147	0.5	5.27325203973379e-08	SELENBP1	Malignant cells	GSE140440	ENSG00000143416	8991	selenium binding protein 1	hSBP|hSP56|LPSB	protein_coding	Q13228	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9786
1.97944099385466e-12	-1.27671632988656	0.4	0.739	5.53550673931455e-08	HIST1H4J	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9787
2.0146288348974e-12	0.744124621969658	1	0.993	5.63390953679059e-08	NTPCR	Malignant cells	GSE140440	ENSG00000135778	84284	nucleoside-triphosphatase, cancer-related	C1orf57|HCR-NTPase|MGC13186|THEP1	protein_coding	Q9BSD7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9788
2.01601324919838e-12	-0.546094981822183	0.993	1	5.63778105138327e-08	PPA1	Malignant cells	GSE140440	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9789
2.06672498265787e-12	-1.57937427063021	0.567	0.903	5.77959641400274e-08	DTL	Malignant cells	GSE140440	ENSG00000143476	51514	denticleless E3 ubiquitin protein ligase homolog	CDT2|DCAF2|L2DTL|RAMP	protein_coding	Q9NZJ0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9790
2.16007942070582e-12	5.12504301464451	0.647	0.351	6.04066210000383e-08	C14orf37	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9791
2.1909212178462e-12	1.09620491004021	0.98	0.903	6.1269111857069e-08	CNN3	Malignant cells	GSE140440	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9792
2.19496424774616e-12	0.909855783800936	1	0.985	6.13821751882214e-08	BORCS7	Malignant cells	GSE140440	ENSG00000166275	119032	BLOC-1 related complex subunit 7	C10orf32|FLJ40752	protein_coding	Q96B45	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9793
2.1957158524149e-12	0.85924047412184	0.973	0.94	6.14031938127826e-08	PPCS	Malignant cells	GSE140440	ENSG00000127125	79717	phosphopantothenoylcysteine synthetase	FLJ11838	protein_coding	Q9HAB8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9794
2.25341702916529e-12	-0.96619823476296	0.92	0.94	6.30168072206074e-08	MT-TF	Malignant cells	GSE140440	ENSG00000210049	NA	NA	MTTF|trnF	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9795
2.2712385928419e-12	1.8618808112997	0.993	0.993	6.35151872488237e-08	DAP	Malignant cells	GSE140440	ENSG00000112977	1611	death associated protein	DAP1	protein_coding	P51397	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9796
2.28574280660827e-12	2.8999092892922	0.633	0.299	6.39207975868003e-08	KCNG1	Malignant cells	GSE140440	ENSG00000026559	3755	potassium voltage-gated channel modifier subfamily G member 1	K13|KCNG|kH2|Kv6.1	protein_coding	Q9UIX4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9797
2.30275795374273e-12	-1.09486336805002	0.88	0.985	6.43966261764153e-08	PRC1	Malignant cells	GSE140440	ENSG00000198901	9055	protein regulator of cytokinesis 1	ASE1	protein_coding	O43663	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9798
2.33287563577974e-12	-1.68668305314285	0.44	0.828	6.52388671545805e-08	CIT	Malignant cells	GSE140440	ENSG00000122966	11113	citron rho-interacting serine/threonine kinase	CITK|CRIK|KIAA0949|STK21	protein_coding	O14578	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9799
2.39886531991714e-12	4.4976257969134	0.533	0.216	6.70842686714828e-08	CDH11	Malignant cells	GSE140440	ENSG00000140937	1009	cadherin 11	CAD11|OB	protein_coding	P55287	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9800
2.5089096082921e-12	3.71398256453441	0.6	0.254	7.01616571958885e-08	AC137932.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9801
2.67633353691409e-12	-4.74015832807386	0.207	0.552	7.48436673598027e-08	TTC3P1	Malignant cells	GSE140440	ENSG00000215105	NA	NA	RNF105L|TTC3L	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9802
2.70985266582357e-12	0.914485862680545	0.993	0.918	7.5781029799756e-08	GOSR1	Malignant cells	GSE140440	ENSG00000108587	9527	golgi SNAP receptor complex member 1	GOLIM2|GOS-28|GOS28|GS28|P28	protein_coding	O95249	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9803
2.75295314282915e-12	1.83727049996189	0.793	0.418	7.69863346392171e-08	NCK2	Malignant cells	GSE140440	ENSG00000071051	8440	NCK adaptor protein 2	NCKbeta	protein_coding	O43639	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9804
2.7569517879977e-12	-1.62613002087835	0.32	0.672	7.70981567513557e-08	PGM5P3-AS1	Malignant cells	GSE140440	ENSG00000277631	101929127	PGM5P3 antisense RNA 1	FAM233B	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9805
2.81271264242766e-12	1.94760628968766	0.867	0.53	7.86575090454894e-08	SPRY2	Malignant cells	GSE140440	ENSG00000136158	10253	sprouty RTK signaling antagonist 2	hSPRY2	protein_coding	O43597	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9806
2.91878542264482e-12	1.08037174622284	0.993	0.918	8.16238343442623e-08	C14orf1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9807
2.96126766072524e-12	1.0393974297963	0.933	0.724	8.28118501321813e-08	DLL3	Malignant cells	GSE140440	ENSG00000090932	10683	delta like canonical Notch ligand 3	SCDO1	protein_coding	Q9NYJ7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9808
3.07999080570298e-12	0.750464181990942	1	0.993	8.61319428814839e-08	SERINC1	Malignant cells	GSE140440	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9809
3.22279662672163e-12	-1.50863645785991	0.173	0.56	9.01255076662703e-08	SAA1	Malignant cells	GSE140440	ENSG00000288411	6288	serum amyloid A1	PIG4|SAA|TP53I4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9810
3.24546537139687e-12	0.958684085680859	0.933	0.813	9.07594391111136e-08	MED11	Malignant cells	GSE140440	ENSG00000161920	400569	mediator complex subunit 11	HSPC296|MGC88387	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9811
3.36088132201867e-12	1.23130805300498	0.967	0.858	9.39870461702522e-08	DHCR7	Malignant cells	GSE140440	ENSG00000172893	1717	7-dehydrocholesterol reductase	SLOS	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9812
3.37999416381834e-12	-0.652272435680582	0.427	0.821	9.452153679118e-08	GTF2H2B	Malignant cells	GSE140440	ENSG00000226259	NA	NA	DKFZP686M0199	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9813
3.41653751839883e-12	1.17647946074533	0.94	0.761	9.55434717020233e-08	IFT46	Malignant cells	GSE140440	ENSG00000118096	56912	intraflagellar transport 46	C11orf2|C11orf60|CFAP32|FLJ21827	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9814
3.43581049240711e-12	1.62204928562223	0.887	0.679	9.6082440420165e-08	SH3YL1	Malignant cells	GSE140440	ENSG00000035115	26751	SH3 and SYLF domain containing 1	DKFZP586F1318|Ray	protein_coding	Q96HL8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9815
3.54980970890157e-12	1.25658165310458	0.98	0.896	9.92704285094324e-08	ACOT8	Malignant cells	GSE140440	ENSG00000101473	10005	acyl-CoA thioesterase 8	hACTE-III|hTE|NAP1|PTE-2|PTE1	protein_coding	O14734	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9816
3.71129960794844e-12	-1.82152788158743	0.587	0.821	1.03786493536278e-07	ZNF726	Malignant cells	GSE140440	ENSG00000213967	730087	zinc finger protein 726	ZNF92P3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9817
3.72484494838915e-12	-0.769987120733877	1	1	1.04165288981703e-07	ANAPC5	Malignant cells	GSE140440	ENSG00000089053	51433	anaphase promoting complex subunit 5	APC5	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9818
3.86740263072703e-12	3.75353128716495	0.52	0.164	1.08151914568281e-07	APOBEC3G	Malignant cells	GSE140440	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9819
3.91974357446314e-12	-0.819537566829103	1	1	1.09615629059862e-07	ILF3	Malignant cells	GSE140440	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9820
4.02223205946935e-12	4.35022922930322	0.493	0.149	1.12481719543061e-07	PTN	Malignant cells	GSE140440	ENSG00000105894	5764	pleiotrophin	HBGF8|HBNF|NEGF1	protein_coding	P21246	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9821
4.23397849821843e-12	-0.767991160994139	1	1	1.18403208702678e-07	PRDX6	Malignant cells	GSE140440	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9822
4.36641923747071e-12	2.50190703997233	0.627	0.291	1.22106913975869e-07	KCNK15	Malignant cells	GSE140440	ENSG00000124249	60598	potassium two pore domain channel subfamily K member 15	dJ781B1.1|K2p15.1|KCNK11|KCNK14|KIAA0237|KT3.3|TASK-5|TASK5	protein_coding	Q9H427	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9823
4.38230576635172e-12	2.87327317474687	0.54	0.194	1.22551180756026e-07	HCLS1	Malignant cells	GSE140440	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9824
4.39794405018534e-12	1.16720454573676	0.987	0.978	1.22988505363433e-07	GGPS1	Malignant cells	GSE140440	ENSG00000152904	9453	geranylgeranyl diphosphate synthase 1	GGPPS1	protein_coding	O95749	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9825
4.42957569515353e-12	0.609586498526225	1	0.993	1.23873084314969e-07	ATP5D	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9826
4.76519593144333e-12	2.30526238027371	0.587	0.224	1.33258704222813e-07	IFI16	Malignant cells	GSE140440	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9827
4.76933041292611e-12	-1.27448054057393	0.827	0.993	1.33374324997479e-07	DDX54	Malignant cells	GSE140440	ENSG00000123064	79039	DEAD-box helicase 54	APR-5|DP97|MGC2835	protein_coding	Q8TDD1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9828
4.80934246571575e-12	1.05039702534349	1	0.978	1.34493262053741e-07	DHRS7	Malignant cells	GSE140440	ENSG00000100612	51635	dehydrogenase/reductase 7	retDSR4|SDR34C1	protein_coding	Q9Y394	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9829
4.89461583971825e-12	1.73213829054992	0.847	0.709	1.36877931957721e-07	FBXO4	Malignant cells	GSE140440	ENSG00000151876	26272	F-box protein 4	FBX4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9830
5.0870771030834e-12	0.534184085672154	1	1	1.42260111187727e-07	SDHD	Malignant cells	GSE140440	ENSG00000204370	6392	succinate dehydrogenase complex subunit D	cybS|PGL|PGL1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9831
5.12471556344906e-12	1.3735779160924	0.787	0.463	1.43312670731853e-07	TJP2	Malignant cells	GSE140440	ENSG00000119139	9414	tight junction protein 2	DFNA51|X104|ZO-2|ZO2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9832
5.23951990967061e-12	1.91395270518203	0.96	0.978	1.46523174273939e-07	FUT8	Malignant cells	GSE140440	ENSG00000033170	2530	fucosyltransferase 8	NA	protein_coding	Q9BYC5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9833
5.32025807898859e-12	1.47876039414772	0.78	0.381	1.48781017178916e-07	IGFBP2	Malignant cells	GSE140440	ENSG00000115457	3485	insulin like growth factor binding protein 2	IBP2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9834
5.73482561391292e-12	0.825830154345447	1	0.91	1.60374398293075e-07	UROS	Malignant cells	GSE140440	ENSG00000188690	7390	uroporphyrinogen III synthase	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9835
5.73929722518796e-12	-1.25602668293606	0.953	0.993	1.60499446902381e-07	SNHG3	Malignant cells	GSE140440	ENSG00000242125	8420	small nucleolar RNA host gene 3	NCRNA00014|RNU17C|RNU17D|U17HG|U17HG-A	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9836
5.9757567249718e-12	0.947353124047202	0.967	0.881	1.67112036813836e-07	RP11-452F19.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9837
6.00382245904586e-12	1.89932559104518	0.833	0.507	1.67896895067217e-07	IL1RAP	Malignant cells	GSE140440	ENSG00000196083	3556	interleukin 1 receptor accessory protein	C3orf13|IL-1RAcP|IL1R3	protein_coding	Q9NPH3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9838
6.1405083811868e-12	-0.938214396145321	0.993	1	1.71719316879889e-07	PNN	Malignant cells	GSE140440	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9839
6.33390487171374e-12	-3.01837997913649	0.44	0.701	1.77127649737475e-07	ZFP42	Malignant cells	GSE140440	ENSG00000179059	132625	ZFP42 zinc finger protein	REX1|ZNF754	protein_coding	Q96MM3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9840
6.37928345373413e-12	1.13931541111322	0.867	0.515	1.78396661783675e-07	CDKN1C	Malignant cells	GSE140440	ENSG00000273707	1028	cyclin dependent kinase inhibitor 1C	BWCR|BWS|KIP2|P57	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9841
6.44873917753178e-12	1.21437709616682	0.807	0.537	1.80338991099676e-07	ATXN1	Malignant cells	GSE140440	ENSG00000124788	6310	ataxin 1	ATX1|D6S504E|SCA1	protein_coding	P54253	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9842
6.5049128254374e-12	2.08036621083594	0.887	0.776	1.81909887163357e-07	TFPI2	Malignant cells	GSE140440	ENSG00000105825	7980	tissue factor pathway inhibitor 2	PP5|REF1|TFPI-2	protein_coding	P48307	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9843
6.59135249879865e-12	0.526766857397042	1	0.993	1.84327172628904e-07	PTS	Malignant cells	GSE140440	ENSG00000150787	5805	6-pyruvoyltetrahydropterin synthase	PTPS	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9844
6.64510226772601e-12	1.60482071097402	0.967	0.836	1.85830284916958e-07	CDC42EP3	Malignant cells	GSE140440	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9845
6.72733563747959e-12	-1.20883575709293	0.873	0.978	1.88129941102117e-07	UTP20	Malignant cells	GSE140440	ENSG00000120800	27340	UTP20 small subunit processome component	1A6/DRIM|DRIM	protein_coding	O75691	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9846
6.77217785869334e-12	1.06473744196213	0.98	0.933	1.89383953818359e-07	POLR3GL	Malignant cells	GSE140440	ENSG00000121851	84265	RNA polymerase III subunit GL	flj32422|MGC3200	protein_coding	Q9BT43	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9847
6.80838319901438e-12	-1.07074273778857	0.913	0.993	1.90396436160437e-07	MCM7	Malignant cells	GSE140440	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9848
6.86211020695401e-12	-1.07161216898955	1	0.993	1.91898911937469e-07	CBX1	Malignant cells	GSE140440	ENSG00000108468	10951	chromobox 1	CBX|HP1-BETA|HP1Hs-beta|M31|MOD1	protein_coding	P83916	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9849
6.9370007489521e-12	1.36876776169201	1	1	1.93993225944445e-07	TMSB4X	Malignant cells	GSE140440	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9850
6.97099726851411e-12	0.785825308323448	1	0.97	1.94943938613997e-07	ADAM9	Malignant cells	GSE140440	ENSG00000282230	8754	ADAM metallopeptidase domain 9	CORD9|KIAA0021|MCMP|MDC9|Mltng	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9851
7.17628019270934e-12	-3.93888694204858	0.267	0.627	2.00684675589117e-07	LRRC38	Malignant cells	GSE140440	ENSG00000162494	126755	leucine rich repeat containing 38	NA	protein_coding	Q5VT99	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9852
7.40054488643187e-12	-1.0327229208705	0.773	0.97	2.06956237749067e-07	DHFR	Malignant cells	GSE140440	ENSG00000228716	1719	dihydrofolate reductase	NA	protein_coding	P00374	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9853
7.60460022245967e-12	0.819956012449504	0.993	0.985	2.12662645221085e-07	RPL23AP82	Malignant cells	GSE140440	ENSG00000184319	NA	NA	MGC70863	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9854
7.64710597997551e-12	-0.761497800284295	0.22	0.612	2.13851318730015e-07	CH17-360D5.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9855
7.70143690391294e-12	0.917494011340881	1	0.925	2.15370683017925e-07	MIB1	Malignant cells	GSE140440	ENSG00000101752	57534	MIB E3 ubiquitin protein ligase 1	DIP-1|KIAA1323|MIB|ZZANK2|ZZZ6	protein_coding	Q86YT6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9856
7.72924530858432e-12	3.83592908188209	0.487	0.142	2.16148345054561e-07	NOV	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9857
7.90324959299528e-12	-0.86476597736046	0.947	0.993	2.21014374868113e-07	WDR75	Malignant cells	GSE140440	ENSG00000115368	84128	WD repeat domain 75	FLJ12519|NET16|UTP17	protein_coding	Q8IWA0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9858
7.94524199468248e-12	-0.421972326709528	0.533	0.851	2.22188692381296e-07	HSPD1P1	Malignant cells	GSE140440	ENSG00000213430	NA	NA	HSPD1-2P	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9859
8.36923378377755e-12	1.84097891184242	0.687	0.306	2.34045622763339e-07	PLEKHB1	Malignant cells	GSE140440	ENSG00000021300	58473	pleckstrin homology domain containing B1	KPL1|PHR1|PHRET1	protein_coding	Q9UF11	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9860
8.52691954409091e-12	2.51669526394964	0.633	0.276	2.38455305050502e-07	CYFIP2	Malignant cells	GSE140440	ENSG00000055163	26999	cytoplasmic FMR1 interacting protein 2	PIR121	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9861
8.70472136906134e-12	0.835292565115372	1	0.985	2.434275330858e-07	HDDC2	Malignant cells	GSE140440	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9862
8.80863959451691e-12	-1.23998894815648	0.96	0.993	2.46333606260665e-07	FUS	Malignant cells	GSE140440	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9863
8.82159332769824e-12	0.921277155528267	1	0.91	2.46695857409081e-07	CD44	Malignant cells	GSE140440	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9864
8.88053215169403e-12	-0.882610788005906	0.967	1	2.48344081622124e-07	TCEB3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9865
8.95238147523608e-12	1.38669288408558	0.88	0.664	2.50353347954977e-07	NREP	Malignant cells	GSE140440	ENSG00000134986	9315	neuronal regeneration related protein	C5orf13|D4S114|P311|PRO1873|PTZ17|SEZ17	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9866
9.72877103738313e-12	-0.593845207330526	0.373	0.799	2.72065082060419e-07	KIF4B	Malignant cells	GSE140440	ENSG00000226650	285643	kinesin family member 4B	NA	protein_coding	Q2VIQ3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9867
9.80371683932367e-12	1.87376243514609	0.76	0.403	2.74160941411686e-07	PRKAR2B	Malignant cells	GSE140440	ENSG00000284096	5577	protein kinase cAMP-dependent type II regulatory subunit beta	PRKAR2	protein_coding	P31323	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9868
1.0308744542191e-11	-1.54732761935601	0.713	0.918	2.8828404112237e-07	TOR3A	Malignant cells	GSE140440	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9869
1.04284579268195e-11	0.73380666140197	1	0.978	2.91631825923507e-07	ARL3	Malignant cells	GSE140440	ENSG00000138175	403	ADP ribosylation factor like GTPase 3	ARFL3	protein_coding	P36405	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9870
1.05256082463478e-11	-1.88932660472326	0.2	0.597	2.94348634609115e-07	KAZN	Malignant cells	GSE140440	ENSG00000189337	23254	kazrin, periplakin interacting protein	C1orf196|FLJ43806|KAZRIN|KIAA1026	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9871
1.07094833024107e-11	0.961377278412741	0.987	0.843	2.99490700551914e-07	C11orf54	Malignant cells	GSE140440	ENSG00000182919	28970	chromosome 11 open reading frame 54	PTD012	protein_coding	Q9H0W9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9872
1.10220393076122e-11	-0.611020561070205	1	1	3.08231329237375e-07	MRPL52	Malignant cells	GSE140440	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9873
1.12943469747858e-11	0.879730152402097	0.987	0.948	3.15846413149884e-07	KIF2A	Malignant cells	GSE140440	ENSG00000068796	3796	kinesin family member 2A	HK2|KIF2	protein_coding	O00139	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9874
1.27840935752699e-11	-1.52381387305508	0.687	0.918	3.57507176832422e-07	CDR2L	Malignant cells	GSE140440	ENSG00000109089	30850	cerebellar degeneration related protein 2 like	HUMPPA	protein_coding	Q86X02	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9875
1.31231344554624e-11	-1.5335085083128	0.58	0.866	3.66988455047005e-07	NLE1	Malignant cells	GSE140440	ENSG00000073536	54475	notchless homolog 1	FLJ10458|NLE	protein_coding	Q9NVX2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9876
1.31912711420218e-11	0.779331793919336	0.993	0.933	3.68893897486639e-07	RAB32	Malignant cells	GSE140440	ENSG00000118508	10981	RAB32, member RAS oncogene family	NA	protein_coding	Q13637	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9877
1.32074154886492e-11	2.03835792454015	0.773	0.433	3.69345374140075e-07	LIMCH1	Malignant cells	GSE140440	ENSG00000064042	22998	LIM and calponin homology domains 1	DKFZP686A01247|LIMCH1A|LMO7B	protein_coding	Q9UPQ0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9878
1.37352236226764e-11	-0.789768720950607	1	1	3.84105528608146e-07	GRB2	Malignant cells	GSE140440	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9879
1.37985632259811e-11	1.99247399569744	0.6	0.246	3.85876820614561e-07	KCNQ2	Malignant cells	GSE140440	ENSG00000281151	3785	potassium voltage-gated channel subfamily Q member 2	BFNC|EBN|EBN1|ENB1|HNSPC|KCNA11|Kv7.2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9880
1.40082714152989e-11	-1.10380605842903	0.96	1	3.91741310128833e-07	ERP29	Malignant cells	GSE140440	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9881
1.40934426573674e-11	0.658269740740796	1	0.993	3.94123123913279e-07	YIF1A	Malignant cells	GSE140440	ENSG00000174851	10897	Yip1 interacting factor homolog A, membrane trafficking protein	54TM|FinGER7|YIF1|YIF1P	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9882
1.43649558156692e-11	-3.30495157269057	0.12	0.463	4.0171598938519e-07	ANKRD2	Malignant cells	GSE140440	ENSG00000165887	26287	ankyrin repeat domain 2	ARPP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9883
1.44488929047311e-11	0.645308230279499	0.993	1	4.04063290080805e-07	SPOP	Malignant cells	GSE140440	ENSG00000121067	8405	speckle type BTB/POZ protein	BTBD32|TEF2	protein_coding	O43791	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9884
1.45397117496017e-11	-0.981818851758042	0.92	0.978	4.0660303907761e-07	NDC1	Malignant cells	GSE140440	ENSG00000058804	55706	NDC1 transmembrane nucleoporin	FLJ10407|NET3|TMEM48	protein_coding	Q9BTX1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9885
1.48882696070705e-11	-1.09973970683443	1	1	4.16350459561726e-07	GDI2	Malignant cells	GSE140440	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9886
1.5094356511467e-11	0.90122011566081	0.993	0.978	4.22113679843176e-07	AAMDC	Malignant cells	GSE140440	ENSG00000087884	28971	adipogenesis associated Mth938 domain containing	C11orf67|CK067|FLJ21035|PTD015	protein_coding	Q9H7C9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9887
1.54863436840116e-11	-4.71253052536582	0.327	0.575	4.33075601123385e-07	INHBB	Malignant cells	GSE140440	ENSG00000163083	3625	inhibin subunit beta B	NA	protein_coding	P09529	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9888
1.57583088455825e-11	3.43143016046023	0.493	0.149	4.40681106866714e-07	ARMCX2	Malignant cells	GSE140440	ENSG00000184867	9823	armadillo repeat containing X-linked 2	ALEX2|GASP9|KIAA0512	protein_coding	Q7L311	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9889
1.61987536110105e-11	1.22400421431251	0.86	0.47	4.52998144731909e-07	EGFL7	Malignant cells	GSE140440	ENSG00000172889	51162	EGF like domain multiple 7	ZNEU1	protein_coding	Q9UHF1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9890
1.64125898523745e-11	-1.23251321751929	0.8	0.948	4.58978075221654e-07	EZH2	Malignant cells	GSE140440	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9891
1.67359366548825e-11	-1.011217623319	0.887	0.993	4.68020468553789e-07	CCNB1	Malignant cells	GSE140440	ENSG00000134057	891	cyclin B1	CCNB	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9892
1.67668780719609e-11	0.719248269302421	0.987	0.955	4.68885745282386e-07	SFT2D1	Malignant cells	GSE140440	ENSG00000198818	113402	SFT2 domain containing 1	C6orf83|MGC19825|pRGR1	protein_coding	Q8WV19	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9893
1.75767311133209e-11	-1.73086737811791	0.407	0.716	4.91533285584018e-07	SLC6A11	Malignant cells	GSE140440	ENSG00000132164	6538	solute carrier family 6 member 11	GAT3	protein_coding	P48066	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9894
1.76548646491306e-11	3.82446389425193	0.473	0.134	4.93718289912938e-07	PLA2G7	Malignant cells	GSE140440	ENSG00000146070	7941	phospholipase A2 group VII	LDL-PLA2|PAFAH	protein_coding	Q13093	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9895
1.76804791229262e-11	1.7655520101626	0.66	0.291	4.94434598672632e-07	MECOM	Malignant cells	GSE140440	ENSG00000085276	2122	MDS1 and EVI1 complex locus	EVI1|KMT8E|MDS1|MDS1-EVI1|PRDM3	protein_coding	Q03112	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9896
1.78810413200713e-11	1.4875561410156	0.58	0.231	5.00043320515793e-07	AC007319.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9897
1.79493129041485e-11	-0.528096856190368	0.48	0.821	5.01952535364514e-07	MT-TW	Malignant cells	GSE140440	ENSG00000210117	NA	NA	MTTW|trnW	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9898
1.79878771579633e-11	0.456518564920149	1	1	5.03030984722445e-07	DBI	Malignant cells	GSE140440	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9899
1.83252103906967e-11	-2.45367264021393	0.3	0.657	5.12464508575832e-07	TCEA3	Malignant cells	GSE140440	ENSG00000282941	6920	transcription elongation factor A3	TFIIS.H	protein_coding	O75764	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9900
1.89614444062803e-11	-1.17900066921259	0.607	0.858	5.3025679282163e-07	EMC3-AS1	Malignant cells	GSE140440	ENSG00000180385	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9901
1.90444099325682e-11	1.05617517134003	0.953	0.799	5.32576923764269e-07	CMTM3	Malignant cells	GSE140440	ENSG00000140931	123920	CKLF like MARVEL transmembrane domain containing 3	BNAS2|CKLFSF3|FLJ31762	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9902
1.91211226889449e-11	3.24182828236365	0.56	0.254	5.34722195996343e-07	SEMA3A	Malignant cells	GSE140440	ENSG00000075213	10371	semaphorin 3A	coll-1|Hsema-I|SEMA1|SEMAD|SemD	protein_coding	Q14563	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9903
1.9379802962732e-11	0.617803329023721	1	1	5.41956189852801e-07	CIB1	Malignant cells	GSE140440	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9904
2.05177287814249e-11	1.40148549738757	0.767	0.343	5.73778285372547e-07	NEO1	Malignant cells	GSE140440	ENSG00000067141	4756	neogenin 1	HsT17534|IGDCC2|NGN|NTN1R2	protein_coding	Q92859	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9905
2.05708365317571e-11	-0.507005473695918	1	1	5.75263443610589e-07	HMGN2	Malignant cells	GSE140440	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9906
2.11376165142254e-11	0.80081931057109	0.973	0.94	5.91113445820315e-07	MPHOSPH6	Malignant cells	GSE140440	ENSG00000135698	10200	M-phase phosphoprotein 6	MPP6	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9907
2.13036644940011e-11	0.932442882950243	0.993	0.851	5.95756977574741e-07	TANK	Malignant cells	GSE140440	ENSG00000136560	10010	TRAF family member associated NFKB activator	I-TRAF|TRAF2	protein_coding	Q92844	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9908
2.18183931680714e-11	0.578422368156066	1	1	6.10151364945117e-07	LAMTOR1	Malignant cells	GSE140440	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9909
2.21560102569322e-11	0.566523658920662	1	0.993	6.19592826835108e-07	JKAMP	Malignant cells	GSE140440	ENSG00000050130	51528	JNK1/MAPK8 associated membrane protein	C14orf100|CDA06|HSPC213|HSPC327|JAMP	protein_coding	Q9P055	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9910
2.29552870397688e-11	1.1287756742755	0.833	0.567	6.41944602067134e-07	CTD-2270L9.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9911
2.33155880491158e-11	-0.778280320592688	0.38	0.791	6.52020419793525e-07	RP11-290D2.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9912
2.54555150256291e-11	0.942925883845716	0.967	0.843	7.11863477691716e-07	RCAN1	Malignant cells	GSE140440	ENSG00000159200	1827	regulator of calcineurin 1	DSCR1	protein_coding	P53805	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9913
2.56750755004004e-11	1.46687055711584	0.9	0.612	7.18003486368697e-07	SDCBP2-AS1	Malignant cells	GSE140440	ENSG00000234684	100507495	SDCBP2 antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9914
2.56771259364461e-11	-0.918206800317683	0.987	0.985	7.18060826812714e-07	POP5	Malignant cells	GSE140440	ENSG00000167272	51367	POP5 homolog, ribonuclease P/MRP subunit	NA	protein_coding	Q969H6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9915
2.59082769677985e-11	0.670494801321984	1	0.918	7.24524965404486e-07	OSER1	Malignant cells	GSE140440	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9916
2.64520076514155e-11	4.2531450347464	0.5	0.164	7.39730393971835e-07	AC002456.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9917
2.69952658719078e-11	3.10023532970438	0.573	0.216	7.54922610107902e-07	WSCD1	Malignant cells	GSE140440	ENSG00000179314	23302	WSC domain containing 1	KIAA0523	protein_coding	Q658N2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9918
2.75158617417885e-11	1.29127504621486	0.867	0.612	7.69481073609114e-07	ELF1	Malignant cells	GSE140440	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9919
2.7697122891622e-11	-4.31615780879476	0.513	0.739	7.74550041664209e-07	LINC00632	Malignant cells	GSE140440	ENSG00000203930	286411	long intergenic non-protein coding RNA 632	ARST|ASINC	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9920
2.8317829884109e-11	-1.03036296281404	0.82	0.985	7.91908112709108e-07	DLGAP5	Malignant cells	GSE140440	ENSG00000126787	9787	DLG associated protein 5	DLG1|DLG7|HURP|KIAA0008	protein_coding	Q15398	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9921
2.85538298092723e-11	5.3418057717549	0.473	0.149	7.98507850616301e-07	RARB	Malignant cells	GSE140440	ENSG00000077092	5915	retinoic acid receptor beta	HAP|NR1B2|RAR-beta|RARbeta|RRB2	protein_coding	P10826	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9922
2.86690885563067e-11	0.943500826086814	0.953	0.701	8.01731061477118e-07	HLA-L	Malignant cells	GSE140440	ENSG00000239618	NA	NA	HLA-92|HLA92|HLAL	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9923
2.88460057047641e-11	-1.09724976450273	0.753	0.97	8.06678549533728e-07	PBK	Malignant cells	GSE140440	ENSG00000168078	55872	PDZ binding kinase	CT84|FLJ14385|Nori-3|SPK|TOPK	protein_coding	Q96KB5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9924
2.89900897538956e-11	0.980122334739985	0.993	0.933	8.10707859967691e-07	TSPAN15	Malignant cells	GSE140440	ENSG00000099282	23555	tetraspanin 15	NET-7|TM4SF15	protein_coding	O95858	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9925
2.91226983103018e-11	-0.407591092996009	0.887	0.993	8.14416258247591e-07	FANCI	Malignant cells	GSE140440	ENSG00000140525	55215	FA complementation group I	FLJ10719|KIAA1794	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9926
2.92778375398693e-11	0.986714503855762	0.993	0.933	8.18754726802444e-07	RIPK2	Malignant cells	GSE140440	ENSG00000104312	8767	receptor interacting serine/threonine kinase 2	CARD3|CARDIAK|RICK|RIP2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9927
2.95212034935938e-11	0.748067596299232	0.98	0.784	8.25560455698351e-07	DAAM1	Malignant cells	GSE140440	ENSG00000100592	23002	dishevelled associated activator of morphogenesis 1	KIAA0666	protein_coding	Q9Y4D1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9928
2.95753069977426e-11	3.22307077801564	0.5	0.164	8.27073460191873e-07	TRABD2A	Malignant cells	GSE140440	ENSG00000186854	129293	TraB domain containing 2A	C2orf89|TIKI1	protein_coding	Q86V40	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9929
2.97927769106428e-11	-1.24996533406742	0.733	0.955	8.33155006306125e-07	SHCBP1	Malignant cells	GSE140440	ENSG00000171241	79801	SHC binding and spindle associated 1	FLJ22009|PAL	protein_coding	Q8NEM2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9930
2.98682607365932e-11	-2.27289996696981	0.327	0.694	8.35265911498829e-07	COL5A2	Malignant cells	GSE140440	ENSG00000204262	1290	collagen type V alpha 2 chain	NA	protein_coding	P05997	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9931
2.99966935215408e-11	2.53230573504271	0.707	0.47	8.38857534329888e-07	ABLIM3	Malignant cells	GSE140440	ENSG00000173210	22885	actin binding LIM protein family member 3	KIAA0843	protein_coding	O94929	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9932
3.01566006259426e-11	1.41633886696261	0.947	0.799	8.43329336504484e-07	TTLL7	Malignant cells	GSE140440	ENSG00000137941	79739	tubulin tyrosine ligase like 7	FLJ23033	protein_coding	Q6ZT98	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9933
3.06966653801119e-11	-1.18520432072173	0.84	0.94	8.58432247354829e-07	DUS1L	Malignant cells	GSE140440	ENSG00000169718	64118	dihydrouridine synthase 1 like	DUS1|PP3111	protein_coding	Q6P1R4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9934
3.17290480269581e-11	0.792395092965619	1	0.963	8.87302828073882e-07	SLC39A10	Malignant cells	GSE140440	ENSG00000196950	57181	solute carrier family 39 member 10	DKFZp564L2123|FLJ90515|KIAA1265	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9935
3.21020963986599e-11	0.881752227945901	0.973	0.769	8.97735125788523e-07	SNX10	Malignant cells	GSE140440	ENSG00000086300	29887	sorting nexin 10	NA	protein_coding	Q9Y5X0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9936
3.23355567926099e-11	0.944019365951791	1	0.925	9.04263845705335e-07	RAB34	Malignant cells	GSE140440	ENSG00000109113	83871	RAB34, member RAS oncogene family	NARR|RAB39|RAH	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9937
3.29806619729134e-11	1.45108786335523	0.833	0.582	9.22304212072523e-07	HTRA1	Malignant cells	GSE140440	ENSG00000166033	5654	HtrA serine peptidase 1	ARMD7|HtrA|IGFBP5-protease|PRSS11	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9938
3.30076545733212e-11	1.16864824042025	0.953	0.836	9.23059060142928e-07	TAOK1	Malignant cells	GSE140440	ENSG00000160551	57551	TAO kinase 1	FLJ14314|hKFC-B|hTAOK1|KIAA1361|MAP3K16|MARKK|PSK2|TAO1	protein_coding	Q7L7X3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9939
3.40098258080296e-11	-1.66160162992246	0.433	0.813	9.51084778721549e-07	MASTL	Malignant cells	GSE140440	ENSG00000120539	84930	microtubule associated serine/threonine kinase like	FLJ14813|Gwl|THC2	protein_coding	Q96GX5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9940
3.41560096062151e-11	-0.487717124302341	1	1	9.55172808637805e-07	UBA52	Malignant cells	GSE140440	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9941
3.48748987469462e-11	5.74130738534473	0.54	0.246	9.75276543458352e-07	IL1B	Malignant cells	GSE140440	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9942
3.57034832496286e-11	0.583672598680378	1	1	9.98447909075864e-07	ITM2B	Malignant cells	GSE140440	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9943
3.62177824521226e-11	1.27837978103261	0.933	0.769	1.01283028627361e-06	TMEM65	Malignant cells	GSE140440	ENSG00000164983	157378	transmembrane protein 65	NA	protein_coding	Q6PI78	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9944
3.63839166695198e-11	1.45284920520141	0.927	0.761	1.01747622966312e-06	ANKH	Malignant cells	GSE140440	ENSG00000154122	56172	ANKH inorganic pyrophosphate transport regulator	ANK|CCAL2|CMDJ|CPPDD|HANK|SLC62A1	protein_coding	Q9HCJ1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9945
3.67606330527098e-11	3.72628792644719	0.5	0.164	1.02801110331903e-06	RFTN1	Malignant cells	GSE140440	ENSG00000131378	23180	raftlin, lipid raft linker 1	FLJ23866|KIAA0084|MIG2|Raftlin	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9946
3.71284544396979e-11	-0.570732018432992	1	1	1.03829722840615e-06	NEDD8	Malignant cells	GSE140440	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9947
3.81853063291068e-11	2.40846545083764	0.52	0.179	1.06785209149347e-06	HOXB9	Malignant cells	GSE140440	ENSG00000170689	3219	homeobox B9	HOX2|HOX2E	protein_coding	P17482	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9948
3.97194691247678e-11	3.1262056221991	0.507	0.157	1.11075495407413e-06	LINC00261	Malignant cells	GSE140440	ENSG00000259974	140828	long intergenic non-protein coding RNA 261	ALIEN|bA216C10.1|C20orf56|DEANR1|FALCOR|HCCDR1|LCAL62|NCRNA00261|onco-lncRNA-17|TCONS_00027846	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9949
4.01054856241657e-11	1.14351697261698	0.94	0.784	1.12154990547979e-06	RP11-783K16.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9950
4.01374948240645e-11	-1.47275127419142	0.96	0.993	1.12244504275496e-06	PARD3	Malignant cells	GSE140440	ENSG00000148498	56288	par-3 family cell polarity regulator	ASIP|Baz|Bazooka|PAR3|PARD3A|PPP1R118	protein_coding	Q8TEW0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9951
4.10293168676525e-11	-0.709388112582625	0.927	0.978	1.1473848462039e-06	PTMAP5	Malignant cells	GSE140440	ENSG00000214182	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9952
4.14923742930637e-11	-1.60624040059563	0.82	0.985	1.16033424710553e-06	HMGN5	Malignant cells	GSE140440	ENSG00000198157	79366	high mobility group nucleosome binding domain 5	NSBP1	protein_coding	P82970	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9953
4.29216612776864e-11	-1.38399547584328	0.887	0.97	1.2003042576305e-06	RCC1	Malignant cells	GSE140440	ENSG00000180198	1104	regulator of chromosome condensation 1	CHC1	protein_coding	P18754	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9954
4.37362122077633e-11	2.37892483925384	0.767	0.522	1.2230831743901e-06	OSER1-AS1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9955
4.51372455043433e-11	-2.03516285785758	0.153	0.53	1.26226307052896e-06	ZNF485	Malignant cells	GSE140440	ENSG00000198298	220992	zinc finger protein 485	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9956
4.77987800693739e-11	1.03357028547215	0.98	0.888	1.33669288464004e-06	CUL4B	Malignant cells	GSE140440	ENSG00000158290	8450	cullin 4B	NA	protein_coding	Q13620	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9957
4.81932262253317e-11	-4.08471386072926	0.267	0.567	1.3477235713914e-06	RP11-488P3.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9958
4.92131220164311e-11	-1.49118399729335	0.2	0.582	1.3762449571895e-06	NEFM	Malignant cells	GSE140440	ENSG00000104722	4741	neurofilament medium chain	NEF3|NF-M|NFM	protein_coding	P07197	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9959
4.92279964219899e-11	0.873805961968719	1	0.925	1.37666091994095e-06	S100A16	Malignant cells	GSE140440	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9960
4.95004634676563e-11	1.54350166416392	0.847	0.522	1.38428046087301e-06	MFI2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9961
4.95749392723795e-11	-1.57406683047436	0.36	0.687	1.38636317675209e-06	PCDHB2	Malignant cells	GSE140440	ENSG00000112852	56133	protocadherin beta 2	PCDH-BETA2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9962
4.96747946832556e-11	-1.08439154256951	0.813	0.978	1.38915563331724e-06	SPC24	Malignant cells	GSE140440	ENSG00000161888	147841	SPC24 component of NDC80 kinetochore complex	FLJ90806|SPBC24	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9963
4.99853103508643e-11	1.54964906190242	0.927	0.843	1.39783920396192e-06	GUSB	Malignant cells	GSE140440	ENSG00000169919	2990	glucuronidase beta	NA	protein_coding	P08236	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9964
4.99969732596072e-11	1.23491220419543	0.927	0.821	1.39816535720492e-06	RP11-465B22.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9965
5.20478378029557e-11	2.77947187077951	0.647	0.306	1.45551778415966e-06	PAQR8	Malignant cells	GSE140440	ENSG00000170915	85315	progestin and adipoQ receptor family member 8	C6orf33|LMPB1|MPRB	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9966
5.2071989544461e-11	-0.695764208715404	0.467	0.821	1.45619318761085e-06	RP11-271K21.12	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9967
5.30095027020645e-11	-1.0283838380574	0.92	0.985	1.48241074306323e-06	FANCD2	Malignant cells	GSE140440	ENSG00000144554	2177	FA complementation group D2	FA-D2|FACD|FAD|FANCD	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9968
5.30408694897318e-11	-1.08741986374752	0.547	0.888	1.48328791528035e-06	NUF2	Malignant cells	GSE140440	ENSG00000143228	83540	NUF2 component of NDC80 kinetochore complex	CDCA1|CT106|NUF2R	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9969
5.32563317110548e-11	-1.38150160569586	0.14	0.485	1.48931331629965e-06	DMRT3	Malignant cells	GSE140440	ENSG00000064218	58524	doublesex and mab-3 related transcription factor 3	DMRTA3	protein_coding	Q9NQL9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9970
5.34176220473953e-11	-1.96903785328602	0.313	0.672	1.49382380055541e-06	LIN7A	Malignant cells	GSE140440	ENSG00000111052	8825	lin-7 homolog A, crumbs cell polarity complex component	LIN-7A|MALS-1|TIP-33|VELI1	protein_coding	O14910	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9971
5.34256071469685e-11	-0.946825972883121	0.913	0.933	1.49404710386498e-06	YRDC	Malignant cells	GSE140440	ENSG00000196449	79693	yrdC N6-threonylcarbamoyltransferase domain containing	FLJ23476|IRIP|SUA5	protein_coding	Q86U90	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9972
5.3627299553203e-11	0.83335620869006	0.94	0.634	1.49968743200532e-06	LINC00857	Malignant cells	GSE140440	ENSG00000237523	439990	long intergenic non-protein coding RNA 857	HUMT	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9973
5.38623206698427e-11	2.31747016546858	0.6	0.276	1.50625979753215e-06	SH3BP5	Malignant cells	GSE140440	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9974
5.54664175815273e-11	2.9004892777214	0.58	0.284	1.55111836766741e-06	C2orf82	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9975
5.57845992689673e-11	1.24052437197992	0.887	0.56	1.56001631855667e-06	CDKN1A	Malignant cells	GSE140440	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9976
5.6940379470278e-11	-0.915871838360932	0.28	0.701	1.59233771188633e-06	SCARNA13	Malignant cells	GSE140440	ENSG00000252481	677768	small Cajal body-specific RNA 13	U93	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9977
5.71811042390239e-11	1.15085943825834	0.94	0.642	1.5990695800443e-06	USP53	Malignant cells	GSE140440	ENSG00000145390	54532	ubiquitin specific peptidase 53	KIAA1350	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9978
5.92982739879527e-11	-1.4170775627565	0.373	0.746	1.6582762320731e-06	RP5-1186N24.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9979
6.23760104948676e-11	-1.41805696327614	0.52	0.813	1.74434513348897e-06	KIF4A	Malignant cells	GSE140440	ENSG00000090889	24137	kinesin family member 4A	FLJ12530|FLJ12655|FLJ14204|FLJ20631|HSA271784|KIF4|KIF4-G1|MRX100	protein_coding	O95239	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9980
6.38130161840796e-11	1.73581251427995	0.667	0.313	1.78453099758779e-06	CALCOCO1	Malignant cells	GSE140440	ENSG00000012822	57658	calcium binding and coiled-coil domain 1	calphoglin|Cocoa|KIAA1536	protein_coding	Q9P1Z2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9981
6.46384112910051e-11	0.411472102704508	1	1	1.80761317175296e-06	RPS25	Malignant cells	GSE140440	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9982
6.69733021200734e-11	0.587653381947844	1	0.97	1.87290839378785e-06	GABARAP	Malignant cells	GSE140440	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9983
6.72011635204271e-11	4.29982146044337	0.46	0.142	1.87928053784874e-06	KRT32	Malignant cells	GSE140440	ENSG00000108759	3882	keratin 32	Ha-2|KRTHA2	protein_coding	Q14532	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9984
6.76395691079584e-11	-1.46201979124574	0.7	0.888	1.89154055010406e-06	TMEM238	Malignant cells	GSE140440	ENSG00000233493	388564	transmembrane protein 238	NA	protein_coding	C9JI98	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9985
6.80321309604445e-11	0.853421335692877	0.98	0.963	1.90251854230883e-06	SYNGR1	Malignant cells	GSE140440	ENSG00000100321	9145	synaptogyrin 1	NA	protein_coding	O43759	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9986
6.90198471792252e-11	1.06998361681882	0.953	0.888	1.93014002636703e-06	C6orf1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9987
6.92851171908279e-11	0.805824623353236	0.987	0.873	1.9375583022415e-06	TTC32	Malignant cells	GSE140440	ENSG00000183891	130502	tetratricopeptide repeat domain 32	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9988
6.9583728145588e-11	-1.66565623189325	0.313	0.672	1.94590895759137e-06	RP11-800A18.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9989
6.96572805951189e-11	-1.23333679948537	0.847	0.97	1.9479658518425e-06	NAT10	Malignant cells	GSE140440	ENSG00000135372	55226	N-acetyltransferase 10	FLJ10774|FLJ12179|hALP|KIAA1709|Kre33|NET43	protein_coding	Q9H0A0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9990
6.98244038238347e-11	0.431738172155203	1	1	1.95263945293354e-06	TSPO	Malignant cells	GSE140440	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9991
6.9920246074345e-11	1.08931302232248	0.907	0.724	1.95531968146906e-06	TDRKH	Malignant cells	GSE140440	ENSG00000182134	11022	tudor and KH domain containing	TDRD2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9992
7.0111113634716e-11	3.77965515560563	0.52	0.201	1.96065729279483e-06	RP11-59D5--B.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9993
7.02706067321589e-11	-1.28234036247456	0.707	0.963	1.96511751726482e-06	INF2	Malignant cells	GSE140440	ENSG00000203485	64423	inverted formin 2	C14orf151|C14orf173|MGC13251	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9994
7.1881410250811e-11	0.705490809614199	1	0.993	2.01016363766393e-06	GSTO1	Malignant cells	GSE140440	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9995
7.36171814039803e-11	1.26339544500565	1	1	2.05870447796231e-06	NF2	Malignant cells	GSE140440	ENSG00000186575	4771	NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor	ACN|BANF|merlin|merlin-1|SCH	protein_coding	P35240	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9996
7.53131501051739e-11	0.340100816925881	0.96	0.821	2.10613224269119e-06	RP11-670E13.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9997
7.59130998090173e-11	1.33586207626129	0.927	0.769	2.12290983615917e-06	TYMP	Malignant cells	GSE140440	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9998
7.63459031867925e-11	-1.57042268798881	0.613	0.873	2.13501318261865e-06	RAD54B	Malignant cells	GSE140440	ENSG00000197275	25788	RAD54 homolog B	RDH54	protein_coding	Q9Y620	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	9999
7.71026939293575e-11	0.890618344278562	0.94	0.754	2.15617683573448e-06	CMC4	Malignant cells	GSE140440	ENSG00000182712	100272147	C-X9-C motif containing 4	MTCP1|MTCP1NB|p8|P8MTCP1	protein_coding	P56277	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10000
7.74400130442747e-11	0.823434037447548	0.993	0.851	2.16560996478314e-06	SMIM19	Malignant cells	GSE140440	ENSG00000176209	114926	small integral membrane protein 19	C8orf40	protein_coding	Q96E16	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10001
7.77972998946631e-11	1.41654661104213	0.787	0.47	2.17560149155425e-06	KIF3C	Malignant cells	GSE140440	ENSG00000084731	3797	kinesin family member 3C	NA	protein_coding	O14782	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10002
7.80162310463568e-11	-0.626624179143464	1	1	2.18172390121137e-06	PRPF40A	Malignant cells	GSE140440	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10003
7.83562484170821e-11	-1.28729973181742	0.433	0.806	2.1912324869837e-06	NCAPH	Malignant cells	GSE140440	ENSG00000121152	23397	non-SMC condensin I complex subunit H	BRRN1|CAP-H|hCAP-H	protein_coding	Q15003	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10004
7.85326599309576e-11	-2.36617660595426	0.513	0.784	2.19616583496923e-06	RP11-159D12.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10005
7.88206658938599e-11	-1.21060353840622	0.42	0.821	2.20421992172179e-06	KIF15	Malignant cells	GSE140440	ENSG00000280610	56992	kinesin family member 15	HKLP2|KNSL7|NY-BR-62	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10006
8.03909911827431e-11	1.4320711930083	0.78	0.388	2.24813406842541e-06	OLFM2	Malignant cells	GSE140440	ENSG00000105088	93145	olfactomedin 2	NOE2|OlfC	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10007
8.2343897459471e-11	-1.79435120195257	0.347	0.687	2.30274709245411e-06	KIFC1	Malignant cells	GSE140440	ENSG00000233450	3833	kinesin family member C1	HSET|KNSL2	protein_coding	Q9BW19	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10008
8.38034959829675e-11	-3.5363777113728	0.327	0.672	2.34356476516369e-06	SLITRK4	Malignant cells	GSE140440	ENSG00000179542	139065	SLIT and NTRK like family member 4	DKFZp547M2010	protein_coding	Q8IW52	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10009
8.50712796184461e-11	0.58467322033426	1	1	2.37901833452984e-06	RDX	Malignant cells	GSE140440	ENSG00000137710	5962	radixin	DFNB24	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10010
8.51518039643048e-11	-0.909217868322821	0.287	0.694	2.38127019786178e-06	ZNF296	Malignant cells	GSE140440	ENSG00000170684	162979	zinc finger protein 296	ZNF342	protein_coding	Q8WUU4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10011
8.59183513403241e-11	-0.610903390324697	0.407	0.791	2.40270669523216e-06	CTD-2267D19.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10012
8.62584594036474e-11	-1.52148322059656	0.913	0.955	2.412217817223e-06	MTPAP	Malignant cells	GSE140440	ENSG00000107951	55149	mitochondrial poly(A) polymerase	FLJ10486|PAPD1|SPAX4|TENT6	protein_coding	Q9NVV4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10013
8.6692687090611e-11	0.71240906168657	0.98	0.754	2.42436099448894e-06	CCDC186	Malignant cells	GSE140440	ENSG00000165813	55088	coiled-coil domain containing 186	C10orf118|CCCP-1|FLJ10188|FLJ35301|golgin104	protein_coding	Q7Z3E2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10014
8.90164633461722e-11	-0.858363967680773	0.373	0.746	2.48934539747571e-06	VASN	Malignant cells	GSE140440	ENSG00000274334	114990	vasorin	SLITL2	protein_coding	Q6EMK4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10015
8.99681704736815e-11	0.887922335673329	0.953	0.687	2.5159598872965e-06	RILP	Malignant cells	GSE140440	ENSG00000274145	83547	Rab interacting lysosomal protein	FLJ31193	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10016
9.0010858251526e-11	-1.03542932067208	0.873	0.978	2.51715365100392e-06	RFC5	Malignant cells	GSE140440	ENSG00000111445	5985	replication factor C subunit 5	RFC36	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10017
9.01161206962183e-11	-0.85682583243177	1	1	2.52009731526974e-06	DDX21	Malignant cells	GSE140440	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10018
9.10752501237489e-11	1.77865077453549	0.833	0.619	2.54691936971064e-06	PTPRE	Malignant cells	GSE140440	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10019
9.38901350303398e-11	-2.26059956435161	0.333	0.687	2.62563762612345e-06	PABPC5	Malignant cells	GSE140440	ENSG00000174740	140886	poly(A) binding protein cytoplasmic 5	PABP5	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10020
9.96572544029674e-11	0.657745789480112	1	0.985	2.78691511937898e-06	DARS	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10021
1.01082237542723e-10	-0.819954365278846	0.98	0.985	2.82676477288224e-06	NUDCD1	Malignant cells	GSE140440	ENSG00000120526	84955	NudC domain containing 1	CML66|FLJ14991	protein_coding	Q96RS6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10022
1.02241415023749e-10	0.84518908687965	0.987	0.806	2.85918117113914e-06	POPDC3	Malignant cells	GSE140440	ENSG00000132429	64208	popeye domain containing 3	bA355M14.1|MGC22671|POP3	protein_coding	Q9HBV1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10023
1.02543212057849e-10	-0.784205984244622	0.993	1	2.86762092519774e-06	RAD51C	Malignant cells	GSE140440	ENSG00000108384	5889	RAD51 paralog C	FANCO|RAD51L2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10024
1.0354106142846e-10	-1.04703603514105	0.847	0.97	2.89552578284689e-06	PRR11	Malignant cells	GSE140440	ENSG00000068489	55771	proline rich 11	FLJ11029	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10025
1.0391393573552e-10	-0.679127714276193	0.4	0.776	2.90595321284381e-06	RASD1	Malignant cells	GSE140440	ENSG00000108551	51655	ras related dexamethasone induced 1	AGS1|DEXRAS1	protein_coding	Q9Y272	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10026
1.05973862036161e-10	1.04405574352834	0.993	0.948	2.96355905184123e-06	ANXA4	Malignant cells	GSE140440	ENSG00000196975	307	annexin A4	ANX4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10027
1.06758314043789e-10	-0.769002507004677	0.26	0.627	2.98549625223457e-06	BAIAP2L2	Malignant cells	GSE140440	ENSG00000128298	80115	BAR/IMD domain containing adaptor protein 2 like 2	FLJ22582|pinkbar	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10028
1.06907156592544e-10	3.71313419994979	0.48	0.157	2.98965863411048e-06	SNHG18	Malignant cells	GSE140440	ENSG00000250786	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10029
1.06979211309555e-10	-1.19638292423785	0.82	0.97	2.9916736442717e-06	HAUS6	Malignant cells	GSE140440	ENSG00000147874	54801	HAUS augmin like complex subunit 6	dgt6|FAM29A|FLJ20060|KIAA1574	protein_coding	Q7Z4H7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10030
1.07061654014481e-10	-2.68432993976183	0.253	0.634	2.99397915451495e-06	NAPSA	Malignant cells	GSE140440	ENSG00000131400	9476	napsin A aspartic peptidase	KAP|Kdap|NAP1|NAPA	protein_coding	O96009	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10031
1.07458307792591e-10	-0.615633231141347	0.987	1	3.0050715774198e-06	PGP	Malignant cells	GSE140440	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10032
1.10079967960789e-10	-1.48034460205439	0.373	0.746	3.07838630402348e-06	TM4SF20	Malignant cells	GSE140440	ENSG00000168955	79853	transmembrane 4 L six family member 20	FLJ22800|TCCE518	protein_coding	Q53R12	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10033
1.1070749814539e-10	-0.950852275395945	0.987	1	3.09593518563582e-06	PPP1CC	Malignant cells	GSE140440	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10034
1.11239120787812e-10	0.86836426906346	0.9	0.694	3.11080201283117e-06	TMSB4XP4	Malignant cells	GSE140440	ENSG00000223551	NA	NA	TMSL4	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10035
1.15342742995438e-10	-1.10956378962523	0.933	0.985	3.22555980786742e-06	TMX3	Malignant cells	GSE140440	ENSG00000166479	54495	thioredoxin related transmembrane protein 3	FLJ20793|KIAA1830|PDIA13|TXNDC10	protein_coding	Q96JJ7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10036
1.16324097881981e-10	-0.927404845682819	0.887	0.993	3.2530033972696e-06	MAD2L1	Malignant cells	GSE140440	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10037
1.1659069801492e-10	1.31894139346083	0.993	0.963	3.26045886998724e-06	SQLE	Malignant cells	GSE140440	ENSG00000104549	6713	squalene epoxidase	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10038
1.20306590388631e-10	1.3783403987286	0.88	0.552	3.36437380021807e-06	TKFC	Malignant cells	GSE140440	ENSG00000149476	26007	triokinase and FMN cyclase	DAK|DKFZP586B1621|NET45	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10039
1.20888652101935e-10	-1.48166837338116	0.66	0.903	3.38065115603061e-06	SGOL2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10040
1.2265058547839e-10	-1.01258734853556	0.867	0.97	3.42992362290319e-06	RPL22L1	Malignant cells	GSE140440	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10041
1.23257733089614e-10	3.31356631538001	0.5	0.179	3.44690250585105e-06	SMOC1	Malignant cells	GSE140440	ENSG00000198732	64093	SPARC related modular calcium binding 1	NA	protein_coding	Q9H4F8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10042
1.24290579575682e-10	1.39698293363325	0.973	0.918	3.47578605783394e-06	ARSK	Malignant cells	GSE140440	ENSG00000164291	153642	arylsulfatase family member K	DKFZp313G1735|TSULF	protein_coding	Q6UWY0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10043
1.29921975139416e-10	4.2906594080231	0.487	0.164	3.63326803477377e-06	DNER	Malignant cells	GSE140440	ENSG00000187957	92737	delta/notch like EGF repeat containing	bet|UNQ26	protein_coding	Q8NFT8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10044
1.31439329851659e-10	-0.601275583548343	1	1	3.67570085930164e-06	ATP5C1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10045
1.33969310932847e-10	0.350481712772179	1	1	3.74645178023705e-06	ATP5L	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10046
1.34361492450158e-10	-1.19816092327201	0.507	0.851	3.75741913636868e-06	CDCA5	Malignant cells	GSE140440	ENSG00000146670	113130	cell division cycle associated 5	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10047
1.34379694435797e-10	0.756080109105526	1	0.955	3.75792815489708e-06	SP100	Malignant cells	GSE140440	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10048
1.38432355837311e-10	1.57093292560521	0.84	0.59	3.8712608309904e-06	ASB9	Malignant cells	GSE140440	ENSG00000102048	140462	ankyrin repeat and SOCS box containing 9	DKFZP564L0862|FLJ20636|MGC4954	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10049
1.39732358955872e-10	-1.44848883595262	0.673	0.955	3.90761541820096e-06	CENPE	Malignant cells	GSE140440	ENSG00000138778	1062	centromere protein E	KIF10|PPP1R61	protein_coding	Q02224	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10050
1.42354976062251e-10	-0.98557292936472	0.413	0.746	3.98095690558086e-06	RP11-159D12.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10051
1.4455381435199e-10	-0.536932735786134	1	1	4.0424474183534e-06	PARP1	Malignant cells	GSE140440	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10052
1.44783036637353e-10	2.99595088064759	0.74	0.604	4.04885761956358e-06	STX1A	Malignant cells	GSE140440	ENSG00000106089	6804	syntaxin 1A	HPC-1|p35-1|STX1	protein_coding	Q16623	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10053
1.45235269399663e-10	-1.15185832098623	0.993	1	4.06150430876157e-06	CCDC47	Malignant cells	GSE140440	ENSG00000108588	57003	coiled-coil domain containing 47	GK001	protein_coding	Q96A33	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10054
1.46619721239549e-10	-0.444694814736662	1	1	4.10022050446399e-06	AP2M1	Malignant cells	GSE140440	ENSG00000161203	1173	adaptor related protein complex 2 subunit mu 1	AP50|CLAPM1|mu2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10055
1.47174550049037e-10	-1.16192322484524	1	1	4.11573629212132e-06	RBM28	Malignant cells	GSE140440	ENSG00000106344	55131	RNA binding motif protein 28	FLJ10377	protein_coding	Q9NW13	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10056
1.48671872769255e-10	-1.11010753772997	0.673	0.918	4.15760892199221e-06	GINS1	Malignant cells	GSE140440	ENSG00000101003	9837	GINS complex subunit 1	KIAA0186|PSF1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10057
1.48683650770579e-10	-1.55960429343112	0.467	0.784	4.15793829379925e-06	ABCA7	Malignant cells	GSE140440	ENSG00000064687	10347	ATP binding cassette subfamily A member 7	ABCX	protein_coding	Q8IZY2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10058
1.52303409827522e-10	1.70746189415269	0.533	0.179	4.25916485582665e-06	SAMD9	Malignant cells	GSE140440	ENSG00000205413	54809	sterile alpha motif domain containing 9	C7orf5|FLJ20073|KIAA2004	protein_coding	Q5K651	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10059
1.54583526853367e-10	-3.157275069946	0.213	0.522	4.32292832845441e-06	SSTR5-AS1	Malignant cells	GSE140440	ENSG00000261713	146336	SSTR5 antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10060
1.57634955431909e-10	-2.03184969815881	0.28	0.664	4.40826152865334e-06	CFH	Malignant cells	GSE140440	ENSG00000000971	3075	complement factor H	ARMD4|ARMS1|FHL1|HF|HF1|HF2|HUS	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10061
1.6374205316275e-10	1.50632715243172	0.893	0.784	4.57904651669629e-06	AHNAK2	Malignant cells	GSE140440	ENSG00000185567	113146	AHNAK nucleoprotein 2	C14orf78	protein_coding	Q8IVF2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10062
1.64611276812465e-10	0.546767694830898	0.98	0.97	4.60335435606058e-06	TMEM134	Malignant cells	GSE140440	ENSG00000172663	80194	transmembrane protein 134	FLJ21749	protein_coding	Q9H6X4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10063
1.68293045359676e-10	-0.432650291457142	0.367	0.746	4.70631501348333e-06	IGF2BP1	Malignant cells	GSE140440	ENSG00000159217	10642	insulin like growth factor 2 mRNA binding protein 1	IMP-1	protein_coding	Q9NZI8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10064
1.69239767587552e-10	1.63707312594891	0.62	0.254	4.73279010058589e-06	CCNG2	Malignant cells	GSE140440	ENSG00000138764	901	cyclin G2	NA	protein_coding	Q16589	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10065
1.69273731351382e-10	-1.91329839600414	0.36	0.731	4.7337398972414e-06	HHIPL2	Malignant cells	GSE140440	ENSG00000143512	79802	HHIP like 2	FLJ13840|KIAA1822L	protein_coding	Q6UWX4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10066
1.72048556482715e-10	3.61120733985305	0.553	0.269	4.81133788203912e-06	SERPIND1	Malignant cells	GSE140440	ENSG00000099937	3053	serpin family D member 1	D22S673|HC-II|HC2|HCF2|HLS2	protein_coding	P05546	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10067
1.7338977945331e-10	-3.09032899247874	0.547	0.754	4.84884518241181e-06	ZNF43	Malignant cells	GSE140440	ENSG00000279566	7594	zinc finger protein 43	HTF6|KOX27|ZNF39L1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10068
1.7542904624067e-10	-1.16444852918506	0.727	0.963	4.90587327812033e-06	TSEN54	Malignant cells	GSE140440	ENSG00000182173	283989	tRNA splicing endonuclease subunit 54	SEN54|SEN54L	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10069
1.75466069287091e-10	-0.441360760922921	0.467	0.828	4.90690862761349e-06	AC073055.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10070
1.77988857511717e-10	0.563783350110155	1	0.97	4.97745840031517e-06	ELP5	Malignant cells	GSE140440	ENSG00000288485	23587	elongator acetyltransferase complex subunit 5	C17orf81|DERP6	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10071
1.7900303999194e-10	2.75305548699027	0.567	0.269	5.00582001337459e-06	HLA-DMA	Malignant cells	GSE140440	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10072
1.79499117763148e-10	1.0940119375161	0.927	0.672	5.01969282824642e-06	LAMB3	Malignant cells	GSE140440	ENSG00000196878	3914	laminin subunit beta 3	BM600-125kDa|kalinin-140kDa|LAMNB1|nicein-125kDa	protein_coding	Q13751	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10073
1.83408551389346e-10	-1.24299784360257	0.973	0.993	5.12902013960307e-06	C1orf35	Malignant cells	GSE140440	ENSG00000143793	79169	chromosome 1 open reading frame 35	MGC4174|MMTAG2	protein_coding	Q9BU76	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10074
1.84192797173199e-10	3.14380196618484	0.553	0.254	5.1509515729485e-06	PRKG1	Malignant cells	GSE140440	ENSG00000185532	5592	protein kinase cGMP-dependent 1	PGK|PKG|PKG1|PRKG1B|PRKGR1B	protein_coding	Q13976	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10075
1.84836476206484e-10	0.649897691989505	1	0.978	5.16895205711433e-06	ACADM	Malignant cells	GSE140440	ENSG00000117054	34	acyl-CoA dehydrogenase medium chain	ACAD1|MCAD|MCADH	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10076
1.8637818579694e-10	2.07329264044171	0.64	0.299	5.21206596581143e-06	FIBCD1	Malignant cells	GSE140440	ENSG00000130720	84929	fibrinogen C domain containing 1	FLJ14810	protein_coding	Q8N539	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10077
1.88093175385238e-10	-0.8820870295491	0.92	0.97	5.26002564964819e-06	BCL2L12	Malignant cells	GSE140440	ENSG00000126453	83596	BCL2 like 12	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10078
1.91043373023138e-10	-1.49976448731568	0.453	0.791	5.34252792659205e-06	DGKZ	Malignant cells	GSE140440	ENSG00000149091	8525	diacylglycerol kinase zeta	DAGK5|DAGK6|DGK-ZETA|hDGKzeta	protein_coding	Q13574	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10079
1.94735381555e-10	0.443343673864197	1	1	5.44577494518558e-06	NDUFS6	Malignant cells	GSE140440	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10080
1.94766059993012e-10	0.629554249059664	1	1	5.44663286770459e-06	YWHAE	Malignant cells	GSE140440	ENSG00000274474	7531	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon	FLJ45465	protein_coding	P62258	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10081
1.9608177993437e-10	-0.425763905871902	0.473	0.806	5.48342697586465e-06	PRR27	Malignant cells	GSE140440	ENSG00000282868	401137	proline rich 27	C4orf40	protein_coding	Q6MZM9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10082
1.97648870206921e-10	-1.2495152364035	0.287	0.672	5.52725065533655e-06	PKMYT1	Malignant cells	GSE140440	ENSG00000127564	9088	protein kinase, membrane associated tyrosine/threonine 1	MYT1|PPP1R126	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10083
1.98375861443585e-10	4.56474755315058	0.433	0.119	5.54758096526985e-06	SCEL	Malignant cells	GSE140440	ENSG00000136155	8796	sciellin	FLJ21667|MGC22531	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10084
1.99279724899222e-10	-1.37262421427833	0.527	0.754	5.57285750680674e-06	ZNF486	Malignant cells	GSE140440	ENSG00000256229	90649	zinc finger protein 486	KRBO2|MGC2396	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10085
2.01079505241564e-10	0.774591192277922	0.98	0.888	5.62318836408032e-06	TVP23B	Malignant cells	GSE140440	ENSG00000171928	51030	trans-golgi network vesicle protein 23 homolog B	CGI-148|FAM18B|FAM18B1|YDR084C	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10086
2.05140385668547e-10	1.46016464819851	0.967	0.881	5.73675088522092e-06	KRIT1	Malignant cells	GSE140440	ENSG00000001631	889	KRIT1 ankyrin repeat containing	CAM|CCM1	protein_coding	O00522	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10087
2.07272210884993e-10	1.84109001136586	0.673	0.336	5.79636737739884e-06	EIF4E3	Malignant cells	GSE140440	ENSG00000163412	317649	eukaryotic translation initiation factor 4E family member 3	MGC39820	protein_coding	Q8N5X7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10088
2.08555131212618e-10	-1.36009766798473	0.887	0.955	5.83224424436087e-06	FTSJ3	Malignant cells	GSE140440	ENSG00000108592	117246	FtsJ RNA 2'-O-methyltransferase 3	SPB1	protein_coding	Q8IY81	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10089
2.12007355365977e-10	0.437935774563316	1	1	5.92878569280955e-06	RPN2	Malignant cells	GSE140440	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10090
2.1596729023386e-10	-0.611514388033878	1	1	6.03952527138989e-06	SNHG16	Malignant cells	GSE140440	ENSG00000163597	100507246	small nucleolar RNA host gene 16	Nbla10727|Nbla12061|ncRAN	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10091
2.20065524582853e-10	1.02047342306592	0.967	0.925	6.15413239495949e-06	FER	Malignant cells	GSE140440	ENSG00000151422	2241	FER tyrosine kinase	PPP1R74|TYK3	protein_coding	P16591	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10092
2.23785385343469e-10	0.723817510777885	0.953	0.694	6.25815830113012e-06	CPD	Malignant cells	GSE140440	ENSG00000108582	1362	carboxypeptidase D	GP180	protein_coding	O75976	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10093
2.26727022449359e-10	1.70723721186329	0.82	0.507	6.34042118279632e-06	ARL15	Malignant cells	GSE140440	ENSG00000185305	54622	ADP ribosylation factor like GTPase 15	ARFRP2|FLJ20051	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10094
2.28176986148202e-10	1.08792218724586	0.833	0.597	6.38096941763447e-06	CBY1	Malignant cells	GSE140440	ENSG00000100211	25776	chibby family member 1, beta catenin antagonist	C22orf2|Cby|Chibby|Chibby1|PGEA1|PIGEA-14|PIGEA14	protein_coding	Q9Y3M2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10095
2.31561909232238e-10	-0.675088251802425	0.6	0.843	6.47562879167952e-06	TUBAP2	Malignant cells	GSE140440	ENSG00000284997	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10096
2.38944472457972e-10	0.881519934912318	0.96	0.761	6.68208217228719e-06	TCAIM	Malignant cells	GSE140440	ENSG00000179152	285343	T cell activation inhibitor, mitochondrial	C3orf23|DKFZp313N0621|TOAG-1	protein_coding	Q8N3R3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10097
2.44534495236323e-10	1.01584668900585	0.827	0.493	6.83840715928378e-06	COL4A5	Malignant cells	GSE140440	ENSG00000188153	1287	collagen type IV alpha 5 chain	ASLN|ATS	protein_coding	P29400	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10098
2.45123813331262e-10	0.451965372130561	1	1	6.85488743980875e-06	TECR	Malignant cells	GSE140440	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10099
2.45310669032878e-10	1.06915336321808	0.907	0.672	6.86011285950443e-06	KRCC1	Malignant cells	GSE140440	ENSG00000172086	51315	lysine rich coiled-coil 1	FLJ22333	protein_coding	Q9NPI7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10100
2.49302948891233e-10	0.839929846412382	0.973	0.739	6.97175696574334e-06	SLC25A4	Malignant cells	GSE140440	ENSG00000151729	291	solute carrier family 25 member 4	AAC1|ANT1|PEO2|PEO3|T1	protein_coding	P12235	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10101
2.50518561410924e-10	-1.06412791201085	0.94	0.978	7.00575156985649e-06	PHF19	Malignant cells	GSE140440	ENSG00000119403	26147	PHD finger protein 19	DKFZP727G051|MTF2L1|PCL3|TDRD19B	protein_coding	Q5T6S3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10102
2.53407851265138e-10	-0.498941931829304	1	1	7.0865505606296e-06	USP14	Malignant cells	GSE140440	ENSG00000101557	9097	ubiquitin specific peptidase 14	TGT|Ubp6	protein_coding	P54578	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10103
2.58959794946434e-10	-1.64933539376603	0.473	0.806	7.24181066567704e-06	ZNF695	Malignant cells	GSE140440	ENSG00000197472	57116	zinc finger protein 695	SBZF3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10104
2.59407274122407e-10	-0.641937158525131	1	1	7.2543244208331e-06	PAPOLA	Malignant cells	GSE140440	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10105
2.65364844049372e-10	1.28087715143751	0.693	0.358	7.42092786384069e-06	LINC00869	Malignant cells	GSE140440	ENSG00000277147	NA	NA	KIAA0493	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10106
2.66703933351352e-10	-1.84017654624793	0.607	0.836	7.45837549617055e-06	VAMP8	Malignant cells	GSE140440	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10107
2.69309006289737e-10	-0.410096200687693	1	1	7.53122636089251e-06	PSMC5	Malignant cells	GSE140440	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10108
2.70845656149761e-10	-1.44709804755078	0.413	0.731	7.57419877422808e-06	ALDH3B1	Malignant cells	GSE140440	ENSG00000006534	221	aldehyde dehydrogenase 3 family member B1	ALDH7	protein_coding	P43353	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10109
2.74680485719913e-10	0.907953735576883	0.98	0.903	7.68143978315738e-06	MORN4	Malignant cells	GSE140440	ENSG00000171160	118812	MORN repeat containing 4	bA548K23.4|C10orf83|FLJ25925|rtp	protein_coding	Q8NDC4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10110
2.75669846238166e-10	-0.458439145132322	1	1	7.70910725005032e-06	C11orf58	Malignant cells	GSE140440	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10111
2.79570566390857e-10	-0.686447809470598	1	1	7.81819088912031e-06	DEGS1	Malignant cells	GSE140440	ENSG00000143753	8560	delta 4-desaturase, sphingolipid 1	DEGS-1|Des-1|DES1|FADS7|MLD	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10112
2.82193906839031e-10	-0.61658044863894	0.993	1	7.8915526047535e-06	TXNL1	Malignant cells	GSE140440	ENSG00000091164	9352	thioredoxin like 1	TRP32|Txl|TXNL	protein_coding	O43396	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10113
2.9161911682275e-10	0.496401787593902	1	1	8.15512860194821e-06	BZW1	Malignant cells	GSE140440	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10114
2.93089268867412e-10	-1.39212106204427	0.347	0.687	8.19624140387719e-06	JPH2	Malignant cells	GSE140440	ENSG00000149596	57158	junctophilin 2	JP-2	protein_coding	Q9BR39	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10115
2.97626831232269e-10	1.16872244356852	0.953	0.716	8.3231343354104e-06	PSD3	Malignant cells	GSE140440	ENSG00000156011	23362	pleckstrin and Sec7 domain containing 3	DKFZp761K1423|EFA6D|EFA6R|HCA67|KIAA0942	protein_coding	Q9NYI0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10116
3.04065780196766e-10	0.520418253077999	1	1	8.50319954320255e-06	PRELID3B	Malignant cells	GSE140440	ENSG00000101166	51012	PRELI domain containing 3B	C20orf45|dJ543J19.5|SLMO2	protein_coding	Q9Y3B1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10117
3.06437577108331e-10	-1.36494403943693	0.4	0.754	8.56952684383448e-06	LINC01224	Malignant cells	GSE140440	ENSG00000269416	104472717	long intergenic non-protein coding RNA 1224	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10118
3.06678497089398e-10	0.643873986313971	1	0.963	8.57626417110502e-06	FXYD5	Malignant cells	GSE140440	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10119
3.0691986289662e-10	1.09790478660482	1	0.993	8.58301396590397e-06	STK17A	Malignant cells	GSE140440	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10120
3.12670184312902e-10	-0.43950411645247	1	1	8.74382170431031e-06	SRSF9	Malignant cells	GSE140440	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10121
3.21566790205813e-10	0.611792153455411	1	0.993	8.99261528810556e-06	MAPRE1	Malignant cells	GSE140440	ENSG00000101367	22919	microtubule associated protein RP/EB family member 1	EB1	protein_coding	Q15691	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10122
3.22437178722598e-10	-0.401041476460671	0.367	0.731	9.01695570297745e-06	DNAJA1P3	Malignant cells	GSE140440	ENSG00000215007	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10123
3.22930093937316e-10	0.706622875511769	1	0.963	9.03074007695704e-06	RPAIN	Malignant cells	GSE140440	ENSG00000129197	84268	RPA interacting protein	hRIP|MGC4189|RIP	protein_coding	Q86UA6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10124
3.23824284454937e-10	-1.71773719610359	0.533	0.828	9.05574611478231e-06	SAPCD2	Malignant cells	GSE140440	ENSG00000186193	89958	suppressor APC domain containing 2	C9orf140|p42.3	protein_coding	Q86UD0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10125
3.24586779836222e-10	-1.53401024226018	0.46	0.769	9.07706929811995e-06	ZNF600	Malignant cells	GSE140440	ENSG00000189190	162966	zinc finger protein 600	DKFZp686F06123|KR-ZNF1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10126
3.30654318061345e-10	0.614280373656575	0.993	0.978	9.24674800458551e-06	MED10	Malignant cells	GSE140440	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10127
3.30766417870571e-10	-0.910759477400454	1	1	9.24988287575051e-06	ITGB1	Malignant cells	GSE140440	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10128
3.31609594901874e-10	-2.20140996820217	0.253	0.59	9.2734623214309e-06	SEMA3F	Malignant cells	GSE140440	ENSG00000001617	6405	semaphorin 3F	Sema4|SEMAK	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10129
3.33302910272902e-10	1.69738612708595	0.8	0.515	9.32081588578171e-06	PARP3	Malignant cells	GSE140440	ENSG00000041880	10039	poly(ADP-ribose) polymerase family member 3	ADPRT3|ADPRTL3|ARTD3|hPARP-3|IRT1|pADPRT-3	protein_coding	Q9Y6F1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10130
3.33305077543587e-10	1.06158252520501	0.913	0.873	9.32087649350642e-06	THG1L	Malignant cells	GSE140440	ENSG00000113272	54974	tRNA-histidine guanylyltransferase 1 like	FLJ11601|FLJ20546|hTHG1|ICF45|IHG-1	protein_coding	Q9NWX6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10131
3.39610450856734e-10	-1.81000670931621	0.86	0.91	9.49720625820858e-06	MARC1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10132
3.44925317378259e-10	0.427153730806657	1	1	9.64583650048302e-06	MT-ND4	Malignant cells	GSE140440	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10133
3.46338729814902e-10	0.838502185041925	0.98	0.866	9.68536257927373e-06	CD109	Malignant cells	GSE140440	ENSG00000156535	135228	CD109 molecule	CPAMD7|DKFZp762L1111|FLJ38569	protein_coding	Q6YHK3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10134
3.47619505644875e-10	-1.6387758325263	0.527	0.806	9.72117947535892e-06	STIL	Malignant cells	GSE140440	ENSG00000123473	6491	STIL centriolar assembly protein	MCPH7|SIL	protein_coding	Q15468	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10135
3.50801409180779e-10	-1.71927986804903	0.273	0.582	9.81016140774048e-06	ZNF429	Malignant cells	GSE140440	ENSG00000197013	353088	zinc finger protein 429	NA	protein_coding	Q86V71	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10136
3.53009693335221e-10	-2.21088031375315	0.273	0.627	9.87191607411944e-06	MX1	Malignant cells	GSE140440	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10137
3.54951314576706e-10	-1.65224245791327	0.287	0.672	9.92621351213759e-06	GYLTL1B	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10138
3.55652063725141e-10	1.65684508603776	0.607	0.284	9.94580996207357e-06	BATF3	Malignant cells	GSE140440	ENSG00000123685	55509	basic leucine zipper ATF-like transcription factor 3	JDP1|JUNDM1|SNFT	protein_coding	Q9NR55	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10139
3.56871687138942e-10	0.994778117486128	0.98	0.888	9.97991673084051e-06	FAM89B	Malignant cells	GSE140440	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10140
3.59711860847951e-10	-1.05909900068679	0.487	0.843	1.00593421886129e-05	KIF2C	Malignant cells	GSE140440	ENSG00000142945	11004	kinesin family member 2C	CT139|KNSL6|MCAK	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10141
3.60528826092504e-10	-1.10303617032711	0.76	0.948	1.00821886216769e-05	KNSTRN	Malignant cells	GSE140440	ENSG00000128944	90417	kinetochore localized astrin (SPAG5) binding protein	C15orf23|FLJ14502|kinastrin|SKAP|TRAF4AF1	protein_coding	Q9Y448	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10142
3.61617737563285e-10	-2.78368575734908	0.153	0.485	1.01126400309573e-05	DPP4	Malignant cells	GSE140440	ENSG00000197635	1803	dipeptidyl peptidase 4	ADCP2|CD26|DPPIV	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10143
3.63945399864823e-10	1.58777398686297	0.887	0.664	1.01777331072198e-05	MVD	Malignant cells	GSE140440	ENSG00000167508	4597	mevalonate diphosphate decarboxylase	MPD	protein_coding	P53602	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10144
3.63955514315912e-10	1.17333398156252	0.96	0.731	1.01780159578445e-05	FGFR1	Malignant cells	GSE140440	ENSG00000077782	2260	fibroblast growth factor receptor 1	BFGFR|CD331|CEK|FLG|FLT2|H2|H3|H4|H5|KAL2|N-SAM	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10145
3.68042476676271e-10	-0.589910643129619	1	1	1.02923078602519e-05	TALDO1	Malignant cells	GSE140440	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10146
3.69119093008244e-10	2.20694746584086	0.647	0.299	1.03224154359755e-05	TP53I11	Malignant cells	GSE140440	ENSG00000175274	9537	tumor protein p53 inducible protein 11	PIG11	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10147
3.72427567956201e-10	2.03470005273137	0.64	0.291	1.04149369378952e-05	C10orf55	Malignant cells	GSE140440	ENSG00000222047	414236	chromosome 10 putative open reading frame 55	bA417O11.3	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10148
3.72429302169296e-10	0.666142571148942	1	0.918	1.04149854351644e-05	DGCR6L	Malignant cells	GSE140440	ENSG00000128185	85359	DiGeorge syndrome critical region gene 6 like	FLJ10666	protein_coding	Q9BY27	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10149
3.90949374198861e-10	-0.66567584968001	1	1	1.09328992494712e-05	RAB18	Malignant cells	GSE140440	ENSG00000099246	22931	RAB18, member RAS oncogene family	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10150
3.9619677088104e-10	1.09534039673558	0.9	0.754	1.10796426976883e-05	CHIC2	Malignant cells	GSE140440	ENSG00000109220	26511	cysteine rich hydrophobic domain 2	BTL	protein_coding	Q9UKJ5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10151
3.99729061740955e-10	-1.52475237856631	0.52	0.851	1.11784232115858e-05	CDCA8	Malignant cells	GSE140440	ENSG00000134690	55143	cell division cycle associated 8	BOR|DasraB|FLJ12042|MESRGP	protein_coding	Q53HL2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10152
4.01240582555458e-10	1.62422004796281	0.913	0.866	1.12206928911634e-05	RNF24	Malignant cells	GSE140440	ENSG00000101236	11237	ring finger protein 24	G1L	protein_coding	Q9Y225	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10153
4.01922870066759e-10	0.898479557883508	1	0.993	1.12397730614169e-05	ROCK2	Malignant cells	GSE140440	ENSG00000134318	9475	Rho associated coiled-coil containing protein kinase 2	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10154
4.08672105386314e-10	3.87685113097367	0.46	0.149	1.14285154271283e-05	CTC-529P8.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10155
4.10321114985026e-10	4.32581870822357	0.473	0.164	1.14746299805562e-05	KIAA0040	Malignant cells	GSE140440	ENSG00000235750	9674	KIAA0040	NA	protein_coding	Q15053	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10156
4.13097345676524e-10	0.774345434647619	0.98	0.978	1.1552267271844e-05	SLC25A1	Malignant cells	GSE140440	ENSG00000100075	6576	solute carrier family 25 member 1	CTP|SLC20A3	protein_coding	P53007	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10157
4.14609572560129e-10	0.898850766678932	0.967	0.963	1.1594556696644e-05	C11orf1	Malignant cells	GSE140440	ENSG00000137720	64776	chromosome 11 open reading frame 1	FLJ23499	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10158
4.15917240340108e-10	2.01658783299783	0.733	0.507	1.16311256261111e-05	ST3GAL6	Malignant cells	GSE140440	ENSG00000064225	10402	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	SIAT10|ST3GALVI	protein_coding	Q9Y274	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10159
4.18285376407273e-10	0.965299447216119	0.98	0.858	1.16973505512294e-05	ELK3	Malignant cells	GSE140440	ENSG00000111145	2004	ETS transcription factor ELK3	ERP|NET|SAP2	protein_coding	P41970	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10160
4.23453582737119e-10	0.998995194105459	0.96	0.851	1.18418794412435e-05	FMNL2	Malignant cells	GSE140440	ENSG00000157827	114793	formin like 2	FHOD2|KIAA1902	protein_coding	Q96PY5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10161
4.24177602062352e-10	0.933479422110016	0.98	0.94	1.18621266416737e-05	C11orf68	Malignant cells	GSE140440	ENSG00000175573	83638	chromosome 11 open reading frame 68	BLES03|P5326	protein_coding	Q9H3H3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10162
4.27870610349219e-10	3.16494578890041	0.493	0.179	1.19654016184159e-05	SLC1A3	Malignant cells	GSE140440	ENSG00000079215	6507	solute carrier family 1 member 3	EA6|EAAT1|GLAST|GLAST-1|GLAST1	protein_coding	P43003	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10163
4.30827652778094e-10	-0.778046909177942	0.987	0.993	1.20480953099394e-05	DNAJB1	Malignant cells	GSE140440	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10164
4.35667744441347e-10	1.41755975953701	0.927	0.694	1.21834484733023e-05	PMEPA1	Malignant cells	GSE140440	ENSG00000124225	56937	prostate transmembrane protein, androgen induced 1	STAG1|TMEPAI	protein_coding	Q969W9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10165
4.45121923184628e-10	-0.485652959001317	1	1	1.24478345818581e-05	RPLP0	Malignant cells	GSE140440	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10166
4.52875259339833e-10	-0.814468212668993	0.893	0.955	1.26646566274384e-05	CCNB2	Malignant cells	GSE140440	ENSG00000157456	9133	cyclin B2	HsT17299	protein_coding	O95067	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10167
4.74771986399191e-10	0.41048323790524	1	0.993	1.32769985996534e-05	NDUFV2P1	Malignant cells	GSE140440	ENSG00000267809	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10168
4.76203418639332e-10	1.54318206314188	0.86	0.619	1.33170286022489e-05	C16orf45	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10169
4.82699078234623e-10	1.01500284949953	0.94	0.806	1.34986797228312e-05	TBC1D5	Malignant cells	GSE140440	ENSG00000131374	9779	TBC1 domain family member 5	KIAA0210	protein_coding	Q92609	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10170
4.85530020844962e-10	-0.998675546150905	0.52	0.828	1.35778470329294e-05	GTSE1	Malignant cells	GSE140440	ENSG00000075218	51512	G2 and S-phase expressed 1	B99|GTSE-1|Lnc_bc060912	protein_coding	Q9NYZ3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10171
4.90498457014613e-10	0.531756621090997	1	1	1.37167893504136e-05	PSMB1	Malignant cells	GSE140440	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10172
5.08437691067373e-10	3.9590227216956	0.447	0.157	1.42184600306991e-05	TSPAN19	Malignant cells	GSE140440	ENSG00000231738	144448	tetraspanin 19	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10173
5.09087801554868e-10	0.642035684962569	0.993	0.896	1.42366403704819e-05	VAMP4	Malignant cells	GSE140440	ENSG00000117533	8674	vesicle associated membrane protein 4	NA	protein_coding	O75379	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10174
5.15967367720059e-10	-0.606841075905827	0.993	1	1.44290274382914e-05	GMPS	Malignant cells	GSE140440	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10175
5.22261894493742e-10	-1.11761857217544	0.807	0.94	1.46050538795175e-05	CASC5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10176
5.25380581632137e-10	0.889911979703121	0.94	0.791	1.46922679653427e-05	AC007246.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10177
5.35503626871139e-10	1.23101291510903	0.88	0.664	1.49753589254514e-05	FAM129A	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10178
5.41191200543225e-10	-1.027799919952	0.353	0.694	1.51344119231913e-05	AC015849.19	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10179
5.50233870260015e-10	0.572524256764112	0.967	0.866	1.53872901818213e-05	RWDD3	Malignant cells	GSE140440	ENSG00000122481	25950	RWD domain containing 3	DKFZP566K023|RSUME	protein_coding	Q9Y3V2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10180
5.52302497053318e-10	1.11253890372951	0.967	0.881	1.5445139330096e-05	ITSN1	Malignant cells	GSE140440	ENSG00000205726	6453	intersectin 1	ITSN|MGC134948|MGC134949|SH3D1A|SH3P17	protein_coding	Q15811	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10181
5.53455352273573e-10	-1.83499679906253	0.427	0.776	1.54773789263305e-05	SUPT16HP1	Malignant cells	GSE140440	ENSG00000256238	NA	NA	bcm670|SUPT16HP	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10182
5.54538512826472e-10	0.841820263249617	0.94	0.97	1.55076695111923e-05	HHLA3	Malignant cells	GSE140440	ENSG00000197568	11147	HERV-H LTR-associating 3	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10183
5.56678047993688e-10	1.78878886036672	0.88	0.59	1.55675016121435e-05	ERAP1	Malignant cells	GSE140440	ENSG00000164307	51752	endoplasmic reticulum aminopeptidase 1	A-LAP|ARTS-1|ERAAP1|KIAA0525|PILS-AP	protein_coding	Q9NZ08	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10184
5.66486102099579e-10	-2.28745001584728	0.193	0.537	1.58417838452147e-05	TBX2	Malignant cells	GSE140440	ENSG00000121068	6909	T-box transcription factor 2	NA	protein_coding	Q13207	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10185
5.74918111387567e-10	-1.08205710064091	0.98	0.993	1.60775849849533e-05	DDX55	Malignant cells	GSE140440	ENSG00000111364	57696	DEAD-box helicase 55	KIAA1595	protein_coding	Q8NHQ9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10186
5.7780311812309e-10	2.6918529186276	0.473	0.164	1.61582641983122e-05	KLF9	Malignant cells	GSE140440	ENSG00000119138	687	KLF transcription factor 9	BTEB1	protein_coding	Q13886	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10187
5.90095221083135e-10	-1.10944607613982	0.32	0.672	1.65020128575899e-05	HPDL	Malignant cells	GSE140440	ENSG00000186603	84842	4-hydroxyphenylpyruvate dioxygenase like	4-HPPD-L|GLOXD1|MGC15668	protein_coding	Q96IR7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10188
5.92318845073127e-10	-0.689976502902977	0.253	0.619	1.656419650247e-05	RP11-15B17.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10189
5.96262080706136e-10	-1.72705393099568	0.713	0.896	1.66744690869471e-05	CCNA2	Malignant cells	GSE140440	ENSG00000145386	890	cyclin A2	CCN1|CCNA	protein_coding	P20248	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10190
6.0025147998232e-10	-0.93563424675222	0.987	0.993	1.67860326377056e-05	RNH1	Malignant cells	GSE140440	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10191
6.09740628578721e-10	0.83098423711446	0.713	0.493	1.70513966782039e-05	GEM	Malignant cells	GSE140440	ENSG00000164949	2669	GTP binding protein overexpressed in skeletal muscle	KIR	protein_coding	P55040	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10192
6.13303589910587e-10	0.799583086095974	0.987	0.873	1.71510348918496e-05	TMEM242	Malignant cells	GSE140440	ENSG00000215712	729515	transmembrane protein 242	BM033|C6orf35	protein_coding	Q9NWH2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10193
6.20198458406068e-10	-0.36836159482698	0.52	0.843	1.73438498893257e-05	RPLP0P6	Malignant cells	GSE140440	ENSG00000213553	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10194
6.28287576338668e-10	0.784173626082336	0.98	0.888	1.75700620723108e-05	DCTN6	Malignant cells	GSE140440	ENSG00000104671	10671	dynactin subunit 6	WS-3	protein_coding	O00399	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10195
6.31351861415181e-10	0.683510288258475	1	0.993	1.76557548044755e-05	VPS28	Malignant cells	GSE140440	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10196
6.45059671301945e-10	1.04754771639876	0.933	0.754	1.80390937079589e-05	MXI1	Malignant cells	GSE140440	ENSG00000119950	4601	MAX interactor 1, dimerization protein	bHLHc11|MAD2|MXD2|MXI	protein_coding	P50539	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10197
6.52227839139287e-10	-1.21118276806518	0.327	0.672	1.82395515215302e-05	DTX4	Malignant cells	GSE140440	ENSG00000110042	23220	deltex E3 ubiquitin ligase 4	KIAA0937|RNF155	protein_coding	Q9Y2E6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10198
6.57367518354236e-10	1.08342296154638	0.913	0.716	1.83832826507762e-05	RBPMS	Malignant cells	GSE140440	ENSG00000157110	11030	RNA binding protein, mRNA processing factor	HERMES	protein_coding	Q93062	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10199
6.59895840314309e-10	-0.381469526915223	0.5	0.806	1.84539871743897e-05	HSPD1P6	Malignant cells	GSE140440	ENSG00000230067	NA	NA	HSPD1-6P|HSPDP6	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10200
6.63057804932124e-10	-1.70477643140559	0.527	0.821	1.85424115149268e-05	PDSS1	Malignant cells	GSE140440	ENSG00000148459	23590	decaprenyl diphosphate synthase subunit 1	COQ1|COQ1A|TPRT|TPT	protein_coding	Q5T2R2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10201
6.9033444109515e-10	0.940255397555202	0.973	0.821	1.93052026452259e-05	LPIN1	Malignant cells	GSE140440	ENSG00000134324	23175	lipin 1	KIAA0188	protein_coding	Q14693	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10202
6.98439905991824e-10	0.529411780154064	1	0.985	1.95318719710613e-05	NDUFA5	Malignant cells	GSE140440	ENSG00000128609	4698	NADH:ubiquinone oxidoreductase subunit A5	B13|CI-13kB|CI-13KD-B|NUFM|UQOR13	protein_coding	Q16718	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10203
7.06029194069781e-10	0.84762128664936	0.947	0.776	1.97441064121614e-05	HSDL1	Malignant cells	GSE140440	ENSG00000103160	83693	hydroxysteroid dehydrogenase like 1	SDR12C3	protein_coding	Q3SXM5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10204
7.07630900104644e-10	-1.31456042389755	0.22	0.597	1.97888981214264e-05	CEP131	Malignant cells	GSE140440	ENSG00000141577	22994	centrosomal protein 131	AZ1|AZI1|KIAA1118	protein_coding	Q9UPN4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10205
7.1518825048712e-10	-1.408527663719	0.887	0.993	2.00002394248723e-05	HSPA1B	Malignant cells	GSE140440	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10206
7.18840113137013e-10	-2.51342317915208	0.327	0.649	2.01023637638766e-05	PLPPR5	Malignant cells	GSE140440	ENSG00000117598	163404	phospholipid phosphatase related 5	LPPR5|PAP2|PAP2D|PRG5	protein_coding	Q32ZL2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10207
7.25188013012669e-10	0.882506845452784	0.987	0.948	2.02798827838993e-05	DMTF1	Malignant cells	GSE140440	ENSG00000135164	9988	cyclin D binding myb like transcription factor 1	DMP1|DMTF|hDMP1|MRUL	protein_coding	Q9Y222	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10208
7.25909760485706e-10	1.05113965259829	0.9	0.679	2.03000664519828e-05	DHRS7B	Malignant cells	GSE140440	ENSG00000109016	25979	dehydrogenase/reductase 7B	CGI-93|DKFZp566O084|MGC8916|SDR32C1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10209
7.332574325451e-10	0.979829368271163	0.987	0.873	2.05055441011237e-05	RHBDD2	Malignant cells	GSE140440	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10210
7.43678384249128e-10	0.402832563495221	1	1	2.07969660155269e-05	ATP5EP2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10211
7.46241989199789e-10	-2.49605234952558	0.393	0.731	2.08686572279721e-05	ZNF93	Malignant cells	GSE140440	ENSG00000184635	81931	zinc finger protein 93	FLJ12488|HPF34|TF34|ZNF505	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10212
7.54554592642122e-10	0.751970831706569	1	1	2.1101119183237e-05	IDS	Malignant cells	GSE140440	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10213
7.54919207379215e-10	-0.582867947107747	1	1	2.11113156343597e-05	HNRNPM	Malignant cells	GSE140440	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10214
7.56544453749128e-10	2.09748438673331	0.54	0.239	2.11567656490944e-05	CYGB	Malignant cells	GSE140440	ENSG00000161544	114757	cytoglobin	HGB|STAP	protein_coding	Q8WWM9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10215
7.58526114789345e-10	1.3256824952254	0.667	0.313	2.1212182800084e-05	SNX18	Malignant cells	GSE140440	ENSG00000178996	112574	sorting nexin 18	SH3PX2|SH3PXD3B|SNAG1	protein_coding	Q96RF0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10216
7.60610158963129e-10	-1.49653169521376	0.36	0.716	2.12704630954039e-05	RP11-521C22.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10217
7.68358499944997e-10	0.964334882347484	0.913	0.769	2.14871454509618e-05	ENTPD3-AS1	Malignant cells	GSE140440	ENSG00000223797	285266	ENTPD3 antisense RNA 1	FLJ36665	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10218
7.75826919067513e-10	0.595697231354752	1	0.978	2.1695999791723e-05	EIF4B	Malignant cells	GSE140440	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10219
7.81614274350098e-10	1.32526668674427	0.94	0.769	2.18578431822005e-05	JUN	Malignant cells	GSE140440	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10220
7.86597319105766e-10	0.717781672252195	1	0.993	2.19971940287927e-05	RCN1	Malignant cells	GSE140440	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10221
7.9083970996695e-10	-0.611190000854402	0.213	0.567	2.21158324892257e-05	RP11-148K1.10	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10222
8.12209155764099e-10	-0.564064445038699	1	1	2.2713429040943e-05	PSMD1	Malignant cells	GSE140440	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10223
8.28777144526323e-10	1.04137405123974	0.947	0.821	2.31767528466786e-05	PEMT	Malignant cells	GSE140440	ENSG00000133027	10400	phosphatidylethanolamine N-methyltransferase	PEMPT|PEMT2	protein_coding	Q9UBM1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10224
8.54621255304077e-10	-1.76539400249272	0.353	0.701	2.38994834045785e-05	RP11-754B17.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10225
8.56745436926719e-10	3.27312647074829	0.513	0.201	2.39588861436557e-05	SHANK2	Malignant cells	GSE140440	ENSG00000162105	22941	SH3 and multiple ankyrin repeat domains 2	CORTBP1|CTTNBP1|ProSAP1|SHANK|SPANK-3	protein_coding	Q9UPX8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10226
8.62757023147163e-10	-1.57147434429534	0.687	0.925	2.41270001523104e-05	MELK	Malignant cells	GSE140440	ENSG00000165304	9833	maternal embryonic leucine zipper kinase	KIAA0175	protein_coding	Q14680	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10227
8.65650735272139e-10	-0.774759554549528	1	1	2.42079228118854e-05	EBNA1BP2	Malignant cells	GSE140440	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10228
8.68694406310386e-10	-1.07431900290633	0.98	0.993	2.42930390724699e-05	TOMM40	Malignant cells	GSE140440	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10229
8.89274375885835e-10	-0.455429688079802	1	1	2.48685579216474e-05	ANAPC11	Malignant cells	GSE140440	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10230
8.95558644176774e-10	2.49698064093745	0.553	0.261	2.50442974844035e-05	TMSB15A	Malignant cells	GSE140440	ENSG00000158164	11013	thymosin beta 15A	TMSL8|TMSNB	protein_coding	P0CG34	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10231
9.01445960010508e-10	-1.81261049899807	0.267	0.642	2.52089362716939e-05	KIAA0922	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10232
9.01757853127691e-10	-0.724253087794436	0.373	0.746	2.52176583627159e-05	NFE2	Malignant cells	GSE140440	ENSG00000123405	4778	nuclear factor, erythroid 2	NF-E2	protein_coding	Q16621	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10233
9.02060115899275e-10	-0.822141949919146	0.387	0.746	2.52261111411232e-05	KIFC2	Malignant cells	GSE140440	ENSG00000167702	90990	kinesin family member C2	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10234
9.03110235681047e-10	2.4563346529977	0.627	0.291	2.52554777408205e-05	MAML2	Malignant cells	GSE140440	ENSG00000184384	84441	mastermind like transcriptional coactivator 2	KIAA1819|MAM3	protein_coding	Q8IZL2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10235
9.26726053918982e-10	0.413607679509981	1	1	2.59158940978443e-05	TMEM59	Malignant cells	GSE140440	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10236
9.26819336508448e-10	-0.757861176678283	1	1	2.59185027454587e-05	TFRC	Malignant cells	GSE140440	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10237
9.28862826484894e-10	0.922513319675028	0.987	0.918	2.59756489426501e-05	SURF1	Malignant cells	GSE140440	ENSG00000280627	6834	SURF1 cytochrome c oxidase assembly factor	SHY1	protein_coding	Q15526	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10238
9.30506402121756e-10	3.15646535429528	0.533	0.231	2.60216115353349e-05	GPM6B	Malignant cells	GSE140440	ENSG00000046653	2824	glycoprotein M6B	M6B|MGC17150|MGC54284	protein_coding	Q13491	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10239
9.32807181291145e-10	2.96473268170258	0.527	0.209	2.60859528248069e-05	ABCA10	Malignant cells	GSE140440	ENSG00000154263	10349	ATP binding cassette subfamily A member 10	EST698739	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10240
9.36861001141509e-10	-3.46465799843286	0.813	0.843	2.61993178969223e-05	ZNF347	Malignant cells	GSE140440	ENSG00000197937	84671	zinc finger protein 347	ZNF1111	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10241
9.39229825570373e-10	3.77901367342833	0.473	0.179	2.62655620720755e-05	RRAGD	Malignant cells	GSE140440	ENSG00000025039	58528	Ras related GTP binding D	bA11D8.2.1|DKFZP761H171	protein_coding	Q9NQL2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10242
9.46336192777752e-10	1.99778565752042	0.687	0.381	2.64642916310298e-05	GLIS3	Malignant cells	GSE140440	ENSG00000107249	169792	GLIS family zinc finger 3	MGC33662|ZNF515	protein_coding	Q8NEA6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10243
9.48699933144856e-10	3.70685739649829	0.54	0.254	2.65303936303959e-05	COL8A1	Malignant cells	GSE140440	ENSG00000144810	1295	collagen type VIII alpha 1 chain	C3orf7|MGC9568	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10244
9.5868855260254e-10	-2.04674453854273	0.407	0.701	2.680972537353e-05	TBX3	Malignant cells	GSE140440	ENSG00000135111	6926	T-box transcription factor 3	TBX3-ISO|UMS|XHL	protein_coding	O15119	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10245
9.63484024819447e-10	-1.03948551888343	0.66	0.918	2.69438307540758e-05	KIF23	Malignant cells	GSE140440	ENSG00000137807	9493	kinesin family member 23	KNSL5|MKLP-1|MKLP1	protein_coding	Q02241	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10246
9.70969358071333e-10	-3.66120433636882	0.2	0.485	2.71531580984648e-05	STEAP1B	Malignant cells	GSE140440	ENSG00000105889	256227	STEAP family member 1B	NA	protein_coding	Q6NZ63	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10247
9.80612477884433e-10	-1.72961888775922	0.293	0.634	2.74228279440382e-05	ZNF239	Malignant cells	GSE140440	ENSG00000196793	8187	zinc finger protein 239	HOK-2|MOK2	protein_coding	Q16600	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10248
9.82407894732564e-10	-1.26003817384331	0.76	0.97	2.74730367761961e-05	NUP205	Malignant cells	GSE140440	ENSG00000155561	23165	nucleoporin 205	C7orf14|KIAA0225	protein_coding	Q92621	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10249
9.8761562450203e-10	1.01493052493473	0.907	0.739	2.76186709391993e-05	CTBS	Malignant cells	GSE140440	ENSG00000117151	1486	chitobiase	CTB	protein_coding	Q01459	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10250
1.01907895245745e-09	-0.645310910031167	0.993	1	2.84985429054725e-05	MRPL17	Malignant cells	GSE140440	ENSG00000158042	63875	mitochondrial ribosomal protein L17	MRP-L26|RPML26	protein_coding	Q9NRX2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10251
1.02263791124206e-09	1.59233472718724	0.593	0.246	2.85980691878842e-05	PPP4R1L	Malignant cells	GSE140440	ENSG00000124224	NA	NA	bA196N14.4|bA196N14.5|C20orf192|PPP4R1P1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10252
1.02365860883407e-09	-1.42052725750576	0.347	0.701	2.86266129960448e-05	RP11-797A18.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10253
1.02374696162074e-09	1.1815157713047	0.907	0.716	2.86290837817239e-05	CD24	Malignant cells	GSE140440	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10254
1.02836182955344e-09	0.431908926741134	1	1	2.87581385634621e-05	CWC15	Malignant cells	GSE140440	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10255
1.02926340011902e-09	-0.633238771081274	0.94	1	2.87833509843284e-05	MKI67	Malignant cells	GSE140440	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10256
1.03144840219553e-09	-1.31360312847864	0.833	0.918	2.88444545673979e-05	ZNF714	Malignant cells	GSE140440	ENSG00000160352	148206	zinc finger protein 714	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10257
1.04269909493105e-09	-0.586872364807459	1	1	2.91590801897467e-05	CCAR1	Malignant cells	GSE140440	ENSG00000060339	55749	cell division cycle and apoptosis regulator 1	CARP-1|CARP1|FLJ10590	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10258
1.04866917659587e-09	1.25296124581784	0.86	0.754	2.93260335235036e-05	SRP14-AS1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10259
1.06186389824205e-09	-0.552410536691271	1	1	2.96950239143388e-05	DDX3X	Malignant cells	GSE140440	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10260
1.10346341045261e-09	1.24156097218736	0.933	0.821	3.08583542733072e-05	TMEM159	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10261
1.1253389658641e-09	0.862534885109934	1	1	3.14701041803896e-05	TMEM106B	Malignant cells	GSE140440	ENSG00000106460	54664	transmembrane protein 106B	FLJ11273|MGC33727	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10262
1.13092202925588e-09	0.702192312522938	1	0.985	3.16262345481407e-05	JAK1	Malignant cells	GSE140440	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10263
1.14954219689631e-09	2.78998441355397	0.513	0.201	3.21469475362054e-05	BHLHE41	Malignant cells	GSE140440	ENSG00000123095	79365	basic helix-loop-helix family member e41	BHLHB3|DEC2|SHARP-1|SHARP1	protein_coding	Q9C0J9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10264
1.15871060360394e-09	-0.961358496670203	0.88	0.993	3.24033420297841e-05	ABCF2	Malignant cells	GSE140440	ENSG00000033050	10061	ATP binding cassette subfamily F member 2	ABC28|EST133090|HUSSY-18|M-ABC1	protein_coding	Q9UG63	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10265
1.17016123524878e-09	3.67639898754779	0.54	0.299	3.2723558943732e-05	EPB41L3	Malignant cells	GSE140440	ENSG00000082397	23136	erythrocyte membrane protein band 4.1 like 3	4.1B|DAL1|KIAA0987	protein_coding	Q9Y2J2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10266
1.17813706267433e-09	2.25581012762401	0.567	0.261	3.29466029576877e-05	SNAI2	Malignant cells	GSE140440	ENSG00000019549	6591	snail family transcriptional repressor 2	SLUG|SLUGH|SLUGH1|SNAIL2	protein_coding	O43623	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10267
1.18114116525788e-09	3.07975506887012	0.527	0.209	3.30306126864366e-05	GS1-358P8.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10268
1.18551115681919e-09	-1.05469004510746	0.36	0.709	3.31528195004485e-05	HIST2H2AC	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10269
1.1882580119485e-09	-1.75831074756041	0.373	0.701	3.32296353041397e-05	RPP25	Malignant cells	GSE140440	ENSG00000178718	54913	ribonuclease P and MRP subunit p25	FLJ20374	protein_coding	Q9BUL9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10270
1.21694699629637e-09	-1.82040745268015	0.4	0.746	3.40319227514281e-05	CHST11	Malignant cells	GSE140440	ENSG00000171310	50515	carbohydrate sulfotransferase 11	C4ST|C4St-1|C4ST1|HSA269537	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10271
1.2399217916623e-09	0.846793274080398	0.793	0.612	3.46744129038363e-05	FKBP1C	Malignant cells	GSE140440	ENSG00000198225	642489	FKBP prolyl isomerase family member 1C	bA184C23.2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10272
1.26470236770861e-09	-1.59388666468023	0.647	0.813	3.53674017129712e-05	AGAP3	Malignant cells	GSE140440	ENSG00000133612	116988	ArfGAP with GTPase domain, ankyrin repeat and PH domain 3	CENTG3	protein_coding	Q96P47	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10273
1.26847257454174e-09	-4.62027954678707	0.347	0.687	3.54728355470598e-05	SPARC	Malignant cells	GSE140440	ENSG00000113140	6678	secreted protein acidic and cysteine rich	BM-40|ON|ONT	protein_coding	P09486	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10274
1.27726105893869e-09	2.60541085152941	0.593	0.313	3.57186055132204e-05	WBSCR27	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10275
1.28544365708369e-09	-0.621154972084454	0.84	0.978	3.59474318703453e-05	HMGB2	Malignant cells	GSE140440	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10276
1.2867847965998e-09	-2.66365842475395	0.227	0.53	3.59849368369135e-05	SPDEF	Malignant cells	GSE140440	ENSG00000124664	25803	SAM pointed domain containing ETS transcription factor	bA375E1.3|PDEF	protein_coding	O95238	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10277
1.29127522843349e-09	-1.70089778928032	0.233	0.575	3.61105117631425e-05	CDR1	Malignant cells	GSE140440	ENSG00000288642	NA	NA	CDR|CDR34|CDR62A	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10278
1.33778602335172e-09	-0.280670757409525	0.393	0.754	3.74111861430308e-05	RP11-253M7.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10279
1.34574919513279e-09	4.83661505719886	0.44	0.142	3.76338762418886e-05	FLRT3	Malignant cells	GSE140440	ENSG00000125848	23767	fibronectin leucine rich transmembrane protein 3	NA	protein_coding	Q9NZU0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10280
1.35976665777215e-09	0.752101331361211	0.993	0.948	3.80258745845982e-05	SNAP23	Malignant cells	GSE140440	ENSG00000092531	8773	synaptosome associated protein 23	HsT17016|SNAP23A|SNAP23B	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10281
1.36067503706931e-09	0.85745279250936	0.78	0.418	3.80512774116432e-05	FAM89A	Malignant cells	GSE140440	ENSG00000182118	375061	family with sequence similarity 89 member A	C1orf153|MGC15887	protein_coding	Q96GI7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10282
1.37945914772603e-09	-0.547821488852662	1	1	3.85765750661584e-05	CDKN3	Malignant cells	GSE140440	ENSG00000100526	1033	cyclin dependent kinase inhibitor 3	CDI1|KAP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10283
1.38155179711818e-09	1.02072781608369	0.933	0.799	3.86350960064098e-05	DBNDD1	Malignant cells	GSE140440	ENSG00000003249	79007	dysbindin domain containing 1	FLJ12582|MGC3101	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10284
1.38742883148643e-09	-0.994226145023669	0.807	0.978	3.8799447272518e-05	TROAP	Malignant cells	GSE140440	ENSG00000135451	10024	trophinin associated protein	TASTIN	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10285
1.39902849859013e-09	2.32129807247501	0.927	0.888	3.91238319630731e-05	MED24	Malignant cells	GSE140440	ENSG00000008838	9862	mediator complex subunit 24	CRSP100|CRSP4|DRIP100|KIAA0130|MED5|THRAP4|TRAP100	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10286
1.41544632498459e-09	0.877666360228388	0.987	0.888	3.9582956478194e-05	MLST8	Malignant cells	GSE140440	ENSG00000167965	64223	MTOR associated protein, LST8 homolog	GbetaL|GBL|Lst8|Pop3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10287
1.45582353384996e-09	0.52841065997807	1	0.985	4.07121051241142e-05	UQCRC2	Malignant cells	GSE140440	ENSG00000140740	7385	ubiquinol-cytochrome c reductase core protein 2	QCR2|UQCR2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10288
1.46802743626201e-09	-0.627348336824123	0.967	1	4.10533872550672e-05	COMMD4	Malignant cells	GSE140440	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10289
1.46952966883197e-09	0.857686013352208	0.96	0.657	4.1095397188886e-05	GCA	Malignant cells	GSE140440	ENSG00000115271	25801	grancalcin	GCL	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10290
1.50909753247782e-09	4.82287528811274	0.453	0.164	4.22019124957424e-05	PLD5	Malignant cells	GSE140440	ENSG00000180287	200150	phospholipase D family member 5	FLJ40773	protein_coding	Q8N7P1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10291
1.51123512587577e-09	-1.68765441797343	0.273	0.642	4.2261690295116e-05	EVPL	Malignant cells	GSE140440	ENSG00000167880	2125	envoplakin	EVPK	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10292
1.52550815963401e-09	1.00701187064714	0.813	0.634	4.26608356841652e-05	LINC00339	Malignant cells	GSE140440	ENSG00000218510	29092	long intergenic non-protein coding RNA 339	HSPC157|NCRNA00339	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10293
1.53450709042174e-09	-0.628048753759775	0.407	0.769	4.2912490783644e-05	HMGA1P4	Malignant cells	GSE140440	ENSG00000234705	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10294
1.5522630674449e-09	-1.68911717457381	0.267	0.597	4.34090366810968e-05	NPM2	Malignant cells	GSE140440	ENSG00000158806	10361	nucleophosmin/nucleoplasmin 2	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10295
1.5766285394344e-09	-1.42023373331968	0.633	0.851	4.40904171052829e-05	EXO1	Malignant cells	GSE140440	ENSG00000174371	9156	exonuclease 1	HEX1|hExoI	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10296
1.59983079111585e-09	1.12563420729683	0.793	0.44	4.47392680735546e-05	WIPI1	Malignant cells	GSE140440	ENSG00000070540	55062	WD repeat domain, phosphoinositide interacting 1	ATG18|ATG18A|FLJ10055|WIPI49	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10297
1.61623689963693e-09	1.42917663493562	0.707	0.47	4.51980648983467e-05	FOXD3-AS1	Malignant cells	GSE140440	ENSG00000230798	100996301	FOXD3 antisense RNA 1	FAST|pasFOXD3	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10298
1.62063631907812e-09	0.715206472441416	1	0.963	4.53210946630197e-05	FHL2	Malignant cells	GSE140440	ENSG00000115641	2274	four and a half LIM domains 2	DRAL|SLIM3	protein_coding	Q14192	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10299
1.66545853239321e-09	-0.578122216639326	1	1	4.65745478583762e-05	RPS8	Malignant cells	GSE140440	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10300
1.71376026352704e-09	-2.36974382021564	0.18	0.507	4.79253057695336e-05	FAM84A	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10301
1.72347604449904e-09	0.462037926600765	1	0.985	4.81970075844157e-05	ALKBH7	Malignant cells	GSE140440	ENSG00000125652	84266	alkB homolog 7	MGC10974|SPATA11	protein_coding	Q9BT30	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10302
1.73921405969767e-09	1.49239285219596	0.76	0.44	4.86371211794453e-05	HOXB7	Malignant cells	GSE140440	ENSG00000260027	3217	homeobox B7	HOX2|HOX2C	protein_coding	P09629	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10303
1.74697203299201e-09	3.51580711599525	0.487	0.187	4.88540729026216e-05	RUNDC3B	Malignant cells	GSE140440	ENSG00000105784	154661	RUN domain containing 3B	RPIB9|RPIP9	protein_coding	Q96NL0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10304
1.75706268904534e-09	-1.05001553770712	0.38	0.731	4.91362580991529e-05	RP11-20I20.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10305
1.76933928146713e-09	1.10001140665097	0.86	0.59	4.94795730062282e-05	TMEM42	Malignant cells	GSE140440	ENSG00000280516	131616	transmembrane protein 42	MGC29956	protein_coding	Q69YG0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10306
1.78827124187257e-09	0.402527330943053	1	0.993	5.00090052789664e-05	AP2S1	Malignant cells	GSE140440	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10307
1.79688163896412e-09	0.314444962416518	1	1	5.02497950336316e-05	SF3B6	Malignant cells	GSE140440	ENSG00000115128	51639	splicing factor 3b subunit 6	CGI-110|Ht006|P14|SAP14a|SF3B14a	protein_coding	Q9Y3B4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10308
1.80161074745963e-09	-0.377742391008959	0.367	0.709	5.03820445527086e-05	RN7SKP23	Malignant cells	GSE140440	ENSG00000280039	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10309
1.84667806576916e-09	0.474511586147478	0.973	0.91	5.16423521092346e-05	ITGA3	Malignant cells	GSE140440	ENSG00000005884	3675	integrin subunit alpha 3	CD49c|GAP-B3|MSK18|VCA-2|VLA3a	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10310
1.86582192804261e-09	-1.03963436906616	0.213	0.56	5.21777102177115e-05	ENPP2	Malignant cells	GSE140440	ENSG00000136960	5168	ectonucleotide pyrophosphatase/phosphodiesterase 2	ATX|PD-IALPHA|PDNP2	protein_coding	Q13822	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10311
1.88223560343997e-09	-0.514573172829758	0.3	0.649	5.26367186501987e-05	DDX12P	Malignant cells	GSE140440	ENSG00000214826	NA	NA	CHLR2|DDX12	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10312
1.88901458940709e-09	-0.655794614021659	1	0.993	5.28262929927694e-05	PDAP1	Malignant cells	GSE140440	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10313
1.902723057136e-09	0.736946683785044	0.96	0.918	5.32096502928083e-05	MMAB	Malignant cells	GSE140440	ENSG00000139428	326625	metabolism of cobalamin associated B	cblB|CFAP23	protein_coding	Q96EY8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10314
1.92921858490084e-09	-0.625595524407567	0.587	0.791	5.39505977267519e-05	PTMAP2	Malignant cells	GSE140440	ENSG00000197744	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10315
1.94237666555627e-09	-0.815170144087426	0.653	0.903	5.43185634522812e-05	BUB1B	Malignant cells	GSE140440	ENSG00000156970	701	BUB1 mitotic checkpoint serine/threonine kinase B	Bub1A|BUBR1|MAD3L|SSK1	protein_coding	O60566	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10316
1.94250429662217e-09	-3.19760981639739	0.44	0.649	5.4322132655039e-05	ADGRF1	Malignant cells	GSE140440	ENSG00000153292	266977	adhesion G protein-coupled receptor F1	GPR110|hGPCR36|PGR19	protein_coding	Q5T601	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10317
1.94869030656235e-09	0.556095498589674	0.993	0.687	5.4495124423016e-05	IFI27L2	Malignant cells	GSE140440	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10318
1.96342359417861e-09	0.741428348092189	1	0.978	5.49071408112047e-05	PIGP	Malignant cells	GSE140440	ENSG00000185808	51227	phosphatidylinositol glycan anchor biosynthesis class P	DCRC|DSCR5|DSRC	protein_coding	P57054	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10319
1.96826914062886e-09	2.58236244162695	0.653	0.388	5.50426465176861e-05	LPXN	Malignant cells	GSE140440	ENSG00000110031	9404	leupaxin	LDPL	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10320
1.99931630491231e-09	1.67511065586531	1	0.985	5.59108804668728e-05	MAP4K4	Malignant cells	GSE140440	ENSG00000071054	9448	mitogen-activated protein kinase kinase kinase kinase 4	FLH21957|HGK|NIK	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10321
2.00372335233576e-09	1.1993166298072	0.713	0.425	5.60341235480695e-05	FAM228B	Malignant cells	GSE140440	ENSG00000219626	375190	family with sequence similarity 228 member B	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10322
2.03580803332048e-09	0.552742810223002	1	1	5.69313716518071e-05	MRPS10	Malignant cells	GSE140440	ENSG00000048544	55173	mitochondrial ribosomal protein S10	FLJ10567	protein_coding	P82664	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10323
2.03773450805709e-09	-0.353060712142258	0.487	0.843	5.69852455178166e-05	HSPA8P9	Malignant cells	GSE140440	ENSG00000241478	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10324
2.04804375026095e-09	2.02715549471905	0.533	0.224	5.72735434760476e-05	SYNGR3	Malignant cells	GSE140440	ENSG00000127561	9143	synaptogyrin 3	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10325
2.05356412123341e-09	1.25781237463554	0.76	0.425	5.74279206502923e-05	ENHO	Malignant cells	GSE140440	ENSG00000168913	375704	energy homeostasis associated	C9orf165|UNQ470	protein_coding	Q6UWT2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10326
2.09235456163083e-09	-0.908207246260839	0.833	0.955	5.85126953160063e-05	ASF1B	Malignant cells	GSE140440	ENSG00000288210	55723	anti-silencing function 1B histone chaperone	FLJ10604	protein_coding	Q9NVP2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10327
2.13016425977228e-09	1.23620606780841	0.833	0.619	5.95700435245318e-05	PITPNC1	Malignant cells	GSE140440	ENSG00000154217	26207	phosphatidylinositol transfer protein cytoplasmic 1	RDGB-BETA|RDGBB|RDGBB1	protein_coding	Q9UKF7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10328
2.14759124166128e-09	0.503263869575699	1	0.985	6.00573890730578e-05	ZFAND6	Malignant cells	GSE140440	ENSG00000086666	54469	zinc finger AN1-type containing 6	AWP1|ZA20D3|ZFAND5B	protein_coding	Q6FIF0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10329
2.14795340799181e-09	0.405481098142603	1	1	6.0067517054491e-05	YWHAQ	Malignant cells	GSE140440	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10330
2.16260478821079e-09	0.686377164753224	1	0.993	6.04772429023148e-05	TMBIM4	Malignant cells	GSE140440	ENSG00000155957	51643	transmembrane BAX inhibitor motif containing 4	CGI-119|GAAP|LFG4|S1R|ZPRO	protein_coding	Q9HC24	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10331
2.17565400366699e-09	0.28580915128923	1	1	6.08421642125473e-05	RPL18A	Malignant cells	GSE140440	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10332
2.19757645080559e-09	0.796666286799938	0.987	0.858	6.14552254467783e-05	ARFGEF2	Malignant cells	GSE140440	ENSG00000124198	10564	ADP ribosylation factor guanine nucleotide exchange factor 2	BIG2	protein_coding	Q9Y6D5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10333
2.21246801983417e-09	1.0825048039127	0.9	0.724	6.18716681746624e-05	BBS2	Malignant cells	GSE140440	ENSG00000125124	583	Bardet-Biedl syndrome 2	BBS	protein_coding	Q9BXC9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10334
2.22434871104317e-09	1.23108267894472	1	0.985	6.22039117043224e-05	ARL2	Malignant cells	GSE140440	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10335
2.24549498038191e-09	0.315090942390995	1	1	6.27952671263801e-05	RPS14	Malignant cells	GSE140440	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10336
2.25400226499823e-09	4.37338821387579	0.513	0.224	6.30331733406755e-05	HPGD	Malignant cells	GSE140440	ENSG00000164120	3248	15-hydroxyprostaglandin dehydrogenase	SDR36C1	protein_coding	P15428	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10337
2.30780761496628e-09	0.957596569188022	0.893	0.664	6.45378399525322e-05	HS2ST1	Malignant cells	GSE140440	ENSG00000153936	9653	heparan sulfate 2-O-sulfotransferase 1	KIAA0448	protein_coding	Q7LGA3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10338
2.35735990480092e-09	0.893348187190756	0.94	0.91	6.59235697377576e-05	SLC35C2	Malignant cells	GSE140440	ENSG00000080189	51006	solute carrier family 35 member C2	bA394O2.1|C20orf5|CGI-15|OVCOV1	protein_coding	Q9NQQ7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10339
2.37174418263714e-09	-1.056387704333	0.313	0.687	6.63258260674476e-05	LBX2-AS1	Malignant cells	GSE140440	ENSG00000257702	151534	LBX2 antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10340
2.41016760820113e-09	1.27781394555191	0.887	0.746	6.74003371633447e-05	HBP1	Malignant cells	GSE140440	ENSG00000283847	26959	HMG-box transcription factor 1	NA	protein_coding	O60381	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10341
2.41052767445348e-09	-1.13090119990709	0.867	0.97	6.74104064160916e-05	PEG10	Malignant cells	GSE140440	ENSG00000242265	23089	paternally expressed 10	HB-1|KIAA1051|Mar2|Mart2|MEF3L|RGAG3|RTL2|SIRH1	protein_coding	Q86TG7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10342
2.4384905054174e-09	-1.46200851592227	0.6	0.866	6.81923869839976e-05	KIF20A	Malignant cells	GSE140440	ENSG00000112984	10112	kinesin family member 20A	MKLP2|RAB6KIFL	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10343
2.47487194107601e-09	-1.09516524396733	1	0.985	6.92097938321907e-05	EIF5B	Malignant cells	GSE140440	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10344
2.49704089913656e-09	0.497186075079695	1	0.993	6.9829748744354e-05	MRPL16	Malignant cells	GSE140440	ENSG00000166902	54948	mitochondrial ribosomal protein L16	FLJ20484|PNAS-111	protein_coding	Q9NX20	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10345
2.50562547230181e-09	-1.16594621272165	0.353	0.701	7.00698163329201e-05	PROB1	Malignant cells	GSE140440	ENSG00000228672	389333	proline rich basic protein 1	C5orf65	protein_coding	E7EW31	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10346
2.53111544130118e-09	1.10759267553088	0.807	0.575	7.07826433159875e-05	SNX21	Malignant cells	GSE140440	ENSG00000124104	90203	sorting nexin family member 21	C20orf161|dJ337O18.4|SNX-L	protein_coding	Q969T3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10347
2.54049445356402e-09	0.672106931689731	0.987	0.918	7.10449273939178e-05	TAX1BP3	Malignant cells	GSE140440	ENSG00000213977	30851	Tax1 binding protein 3	TIP-1	protein_coding	O14907	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10348
2.54919762806546e-09	0.618044294597246	0.98	0.828	7.12883116688506e-05	R3HDM2	Malignant cells	GSE140440	ENSG00000179912	22864	R3H domain containing 2	KIAA1002	protein_coding	Q9Y2K5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10349
2.58723410342233e-09	-0.646058366875488	0.98	1	7.23520017022056e-05	PPIF	Malignant cells	GSE140440	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10350
2.59416307815343e-09	0.928090049817658	0.92	0.724	7.25457704805606e-05	GSTA4	Malignant cells	GSE140440	ENSG00000170899	2941	glutathione S-transferase alpha 4	NA	protein_coding	O15217	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10351
2.59926918542795e-09	1.30287012731409	0.933	0.836	7.26885627704925e-05	MYO10	Malignant cells	GSE140440	ENSG00000145555	4651	myosin X	KIAA0799|MyoX	protein_coding	Q9HD67	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10352
2.60499388210431e-09	-1.62929729995703	0.36	0.687	7.28486539130471e-05	SLC19A3	Malignant cells	GSE140440	ENSG00000135917	80704	solute carrier family 19 member 3	THTR2	protein_coding	Q9BZV2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10353
2.6218275559153e-09	1.0940543894779	0.847	0.59	7.33194076011714e-05	DUSP22	Malignant cells	GSE140440	ENSG00000112679	56940	dual specificity phosphatase 22	JKAP|JSP1|MKPX|VHX	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10354
2.63306706957427e-09	0.364319790743435	1	1	7.36337206006446e-05	SEC61B	Malignant cells	GSE140440	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10355
2.64412315258972e-09	-1.92538980271416	0.74	0.918	7.39429039621716e-05	IPP	Malignant cells	GSE140440	ENSG00000197429	3652	intracisternal A particle-promoted polypeptide	KLHL27	protein_coding	Q9Y573	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10356
2.64758203825822e-09	-0.788126865158503	0.433	0.784	7.40396316998912e-05	RP11-247L20.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10357
2.66450766059316e-09	-1.17502876498855	0.333	0.701	7.45129567284878e-05	RP11-398C13.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10358
2.71364682047609e-09	-1.61710789094912	0.227	0.56	7.58871333346138e-05	CTD-3105H18.11	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10359
2.74658258721503e-09	0.865048773176286	0.973	0.955	7.68081820514683e-05	MGAT4B	Malignant cells	GSE140440	ENSG00000284501	11282	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GnT-Ivb	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10360
2.76785996396036e-09	0.757806321769561	0.967	0.806	7.74032038921515e-05	NTAN1	Malignant cells	GSE140440	ENSG00000275779	123803	N-terminal asparagine amidase	NA	protein_coding	Q96AB6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10361
2.79693021994488e-09	-0.942070045926116	0.387	0.739	7.82161536007586e-05	PON3	Malignant cells	GSE140440	ENSG00000105852	5446	paraoxonase 3	NA	protein_coding	Q15166	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10362
2.81274319082102e-09	-0.637233559880799	1	0.993	7.86583633313098e-05	MRPL38	Malignant cells	GSE140440	ENSG00000204316	64978	mitochondrial ribosomal protein L38	HSPC262|MGC4810|MRP-L3|RPML3	protein_coding	Q96DV4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10363
2.83855695250407e-09	1.2865381189984	0.853	0.642	7.93802451767763e-05	THSD4	Malignant cells	GSE140440	ENSG00000187720	79875	thrombospondin type 1 domain containing 4	ADAMTSL6|FLJ13710|FVSY9334|PRO34005	protein_coding	Q6ZMP0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10364
2.91733224656653e-09	-0.900538673972623	0.993	0.993	8.15831962752329e-05	DDA1	Malignant cells	GSE140440	ENSG00000130311	79016	DET1 and DDB1 associated 1	C19orf58|MGC2594|PCIA1	protein_coding	Q9BW61	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10365
2.93578134557536e-09	-0.793134971520432	0.333	0.679	8.2099125329015e-05	SNX25P1	Malignant cells	GSE140440	ENSG00000236809	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10366
3.05147644430191e-09	1.14712576254868	0.64	0.276	8.5334538764903e-05	GALNT12	Malignant cells	GSE140440	ENSG00000119514	79695	polypeptide N-acetylgalactosaminyltransferase 12	GalNAc-T12	protein_coding	Q8IXK2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10367
3.08470678212919e-09	0.727525888165742	0.993	0.978	8.62638251622429e-05	USP22	Malignant cells	GSE140440	ENSG00000124422	23326	ubiquitin specific peptidase 22	KIAA1063|USP3L	protein_coding	Q9UPT9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10368
3.08755048170794e-09	-0.477682034438972	1	1	8.63433492209627e-05	EIF3I	Malignant cells	GSE140440	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10369
3.13446278065e-09	4.6123501385343	0.433	0.134	8.76552516608774e-05	MMP1	Malignant cells	GSE140440	ENSG00000196611	4312	matrix metallopeptidase 1	CLG	protein_coding	P03956	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10370
3.15446288019088e-09	-1.66823582131317	0.647	0.873	8.82145544445379e-05	BLM	Malignant cells	GSE140440	ENSG00000197299	641	BLM RecQ like helicase	BS|RECQ2|RECQL3	protein_coding	P54132	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10371
3.16895673831953e-09	0.97981455176093	0.973	0.903	8.86198751871057e-05	GLUL	Malignant cells	GSE140440	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10372
3.19455369938191e-09	2.67824697883907	0.487	0.194	8.93356942032151e-05	FCMR	Malignant cells	GSE140440	ENSG00000162894	9214	Fc mu receptor	FAIM3|FcmuR|TOSO	protein_coding	O60667	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10373
3.20247334373889e-09	-0.270485680393991	0.493	0.836	8.95571670576581e-05	FTH1P4	Malignant cells	GSE140440	ENSG00000242992	NA	NA	FTHL4	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10374
3.20891328238749e-09	1.6922131610468	0.84	0.582	8.97372599419663e-05	SYT1	Malignant cells	GSE140440	ENSG00000067715	6857	synaptotagmin 1	P65|SVP65|SYT	protein_coding	P21579	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10375
3.21594776490412e-09	0.849627899631982	0.953	0.836	8.99339792455436e-05	OAF	Malignant cells	GSE140440	ENSG00000184232	220323	out at first homolog	MGC52117	protein_coding	Q86UD1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10376
3.25601746610165e-09	-0.538238635130315	0.227	0.56	9.10545284395327e-05	CITF22-62D4.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10377
3.31166276678496e-09	0.682678364379376	0.987	0.963	9.26106492731415e-05	AKR1A1	Malignant cells	GSE140440	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10378
3.32943327921147e-09	1.8162713078684	0.86	0.664	9.31076016531487e-05	ADRB2	Malignant cells	GSE140440	ENSG00000169252	154	adrenoceptor beta 2	ADRB2R|ADRBR|B2AR|BAR	protein_coding	P07550	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10379
3.3386790391896e-09	0.772606991180857	0.993	0.933	9.33661593309372e-05	SPAG7	Malignant cells	GSE140440	ENSG00000091640	9552	sperm associated antigen 7	ACRP|FSA-1|MGC20134	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10380
3.36094197319066e-09	-0.388389635208467	0.213	0.567	9.39887422802768e-05	RNU6-850P	Malignant cells	GSE140440	ENSG00000252743	NA	NA	RNU6-1030P	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10381
3.44594835647215e-09	0.825580968129418	0.933	0.709	9.63659457887438e-05	RNASET2	Malignant cells	GSE140440	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10382
3.4704162155952e-09	1.21856569328505	0.98	0.948	9.70501894691198e-05	CD2AP	Malignant cells	GSE140440	ENSG00000198087	23607	CD2 associated protein	CMS	protein_coding	Q9Y5K6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10383
3.55314638748217e-09	0.688592328106862	0.947	0.896	9.93637387259389e-05	LCMT1	Malignant cells	GSE140440	ENSG00000205629	51451	leucine carboxyl methyltransferase 1	CGI-68|PPMT1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10384
3.58309744903745e-09	0.698602901320001	1	0.978	0.000100201320162332	RAB3IP	Malignant cells	GSE140440	ENSG00000127328	117177	RAB3A interacting protein	FLJ22548|RABIN3|RABIN8	protein_coding	Q96QF0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10385
3.65703004312375e-09	-0.282524012572823	0.287	0.634	0.000102268845155956	RP11-166B2.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10386
3.66790252640965e-09	1.22945954988108	0.9	0.664	0.000102572894151046	HMGCS1	Malignant cells	GSE140440	ENSG00000112972	3157	3-hydroxy-3-methylglutaryl-CoA synthase 1	HMGCS	protein_coding	Q01581	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10387
3.67867339847114e-09	0.998960210012897	0.88	0.597	0.000102874101588246	FAHD2B	Malignant cells	GSE140440	ENSG00000144199	151313	fumarylacetoacetate hydrolase domain containing 2B	DKFZp434N062	protein_coding	Q6P2I3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10388
3.68161815612374e-09	-1.74202325067257	0.247	0.597	0.000102956451736	OSR2	Malignant cells	GSE140440	ENSG00000164920	116039	odd-skipped related transciption factor 2	FLJ90037	protein_coding	Q8N2R0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10389
3.7957635524708e-09	0.53671125127202	1	0.993	0.000106148527744846	BNIP3L	Malignant cells	GSE140440	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10390
3.93275947215495e-09	-2.09424976215534	0.267	0.582	0.000109979618638813	AC091492.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10391
3.97812839184402e-09	0.58435865939881	0.993	0.955	0.000111248360477918	COA5	Malignant cells	GSE140440	ENSG00000183513	493753	cytochrome c oxidase assembly factor 5	C2orf64|FLJ27524|MGC52110|Pet191	protein_coding	Q86WW8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10392
4.0291048512815e-09	0.638124818012607	0.973	0.821	0.000112673917166087	ABHD14A	Malignant cells	GSE140440	ENSG00000248487	25864	abhydrolase domain containing 14A	DKFZP564O243|DORZ1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10393
4.06990414938502e-09	0.597000138064755	0.993	0.985	0.000113814869537552	BLVRA	Malignant cells	GSE140440	ENSG00000106605	644	biliverdin reductase A	BLVR	protein_coding	P53004	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10394
4.15121835801214e-09	-1.42633425379034	0.367	0.709	0.000116088821381809	CLN6	Malignant cells	GSE140440	ENSG00000128973	54982	CLN6 transmembrane ER protein	FLJ20561|HsT18960|nclf	protein_coding	Q9NWW5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10395
4.18996430326214e-09	-0.701521819326339	0.347	0.679	0.000117172351740726	RP1-150O5.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10396
4.2156168375675e-09	-0.540831637517005	0.993	1	0.000117889724862575	SIVA1	Malignant cells	GSE140440	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10397
4.24014757982031e-09	1.27940257531769	0.913	0.746	0.000118575727069675	UBASH3B	Malignant cells	GSE140440	ENSG00000154127	84959	ubiquitin associated and SH3 domain containing B	KIAA1959|STS-1|TULA-2|TULA2	protein_coding	Q8TF42	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10398
4.3089490478883e-09	-0.529732496243732	1	1	0.000120499760124196	ACTL6A	Malignant cells	GSE140440	ENSG00000136518	86	actin like 6A	Actl6|Arp4|BAF53A|INO80K|SMARCN1	protein_coding	O96019	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10399
4.35747324485025e-09	1.07428989729374	0.813	0.59	0.000121856739292237	GLIPR2	Malignant cells	GSE140440	ENSG00000122694	152007	GLI pathogenesis related 2	C9orf19|GAPR-1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10400
4.38472628068625e-09	0.319159298958049	1	1	0.000122618870439391	SRSF5	Malignant cells	GSE140440	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10401
4.39551467424233e-09	1.74510095101443	0.84	0.619	0.000122920567865187	SORL1	Malignant cells	GSE140440	ENSG00000137642	6653	sortilin related receptor 1	C11orf32|gp250|LR11|LRP9|SorLA|SorLA-1	protein_coding	Q92673	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10402
4.43567393008473e-09	0.618077908094283	1	0.978	0.000124043621454819	MTIF3	Malignant cells	GSE140440	ENSG00000122033	219402	mitochondrial translational initiation factor 3	IF-3mt|IF3(mt)	protein_coding	Q9H2K0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10403
4.43923045459675e-09	0.674116549501388	1	0.94	0.000124143079662798	NIPSNAP1	Malignant cells	GSE140440	ENSG00000184117	8508	nipsnap homolog 1	NA	protein_coding	Q9BPW8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10404
4.46466799935894e-09	-1.94242039320215	0.313	0.612	0.000124854440602073	ZNF433	Malignant cells	GSE140440	ENSG00000197647	163059	zinc finger protein 433	FLJ40981	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10405
4.47224710824747e-09	-0.495464349882054	0.54	0.813	0.00012506639038214	RP11-516A11.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10406
4.52659746281883e-09	0.730318258945487	0.953	0.836	0.000126586298047728	WDR11	Malignant cells	GSE140440	ENSG00000120008	55717	WD repeat domain 11	BRWD2|DR11|FLJ10506|HH14|KIAA1351|SRI1|WDR15	protein_coding	Q9BZH6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10407
4.53146329535387e-09	-1.8626845230492	0.46	0.746	0.000126722371054571	CYP4F11	Malignant cells	GSE140440	ENSG00000171903	57834	cytochrome P450 family 4 subfamily F member 11	NA	protein_coding	Q9HBI6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10408
4.54110203106591e-09	0.696931675513819	1	0.97	0.000126991918298758	FRG1HP	Malignant cells	GSE140440	ENSG00000276291	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10409
4.6085864036187e-09	-0.62320997007812	0.387	0.731	0.000128879118777197	HLA-K	Malignant cells	GSE140440	ENSG00000232331	NA	NA	HLA-70|HLA70|HLAK	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10410
4.63009523030729e-09	1.51878537672391	0.787	0.53	0.000129480613115543	FAM69A	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10411
4.64846930033976e-09	-0.77619232372767	1	1	0.000129994443984001	Metazoa-SRP	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10412
4.72678835074063e-09	-2.87103161171753	0.893	0.963	0.000132184636228462	CCND3	Malignant cells	GSE140440	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10413
4.77687041684324e-09	0.994895314588285	0.947	0.791	0.000133585181207021	FAM229B	Malignant cells	GSE140440	ENSG00000203778	619208	family with sequence similarity 229 member B	C6orf225|DKFZp586F0922|LOC619208	protein_coding	Q4G0N7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10414
4.79958174325718e-09	0.832247577731011	0.993	0.948	0.000134220303450187	ARHGEF12	Malignant cells	GSE140440	ENSG00000196914	23365	Rho guanine nucleotide exchange factor 12	KIAA0382|LARG	protein_coding	Q9NZN5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10415
4.82447575971958e-09	-0.880370300740859	0.347	0.694	0.000134916464620558	DAPK1	Malignant cells	GSE140440	ENSG00000196730	1612	death associated protein kinase 1	DAPK	protein_coding	P53355	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10416
4.82512611457503e-09	-0.858102332016577	1	1	0.000134934651794091	PHLDA2	Malignant cells	GSE140440	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10417
4.8399897094555e-09	1.183356125455	0.953	0.94	0.000135350312224923	CMB9-22P13.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10418
4.95016585476493e-09	-1.4745570049565	0.133	0.44	0.000138431388128501	RP11-774D14.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10419
4.95390496977573e-09	0.414033588973473	1	1	0.000138535952479778	VAPA	Malignant cells	GSE140440	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10420
4.97324836979776e-09	2.44120557679443	0.587	0.284	0.000139076890661394	SIPA1L2	Malignant cells	GSE140440	ENSG00000116991	57568	signal induced proliferation associated 1 like 2	KIAA1389|SPAR2	protein_coding	Q9P2F8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10421
5.01078335990099e-09	0.80724801686244	0.96	0.776	0.000140126556659631	MDP1	Malignant cells	GSE140440	ENSG00000285200	145553	magnesium dependent phosphatase 1	FN6Pase|MGC5987	protein_coding	Q86V88	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10422
5.09214428776126e-09	1.43626192008945	0.713	0.47	0.000142401815007244	LINC00511	Malignant cells	GSE140440	ENSG00000227036	400619	long intergenic non-protein coding RNA 511	onco-lncRNA-12	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10423
5.14426979732829e-09	-0.61018847700933	0.393	0.761	0.000143859504882286	RP4-800M22.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10424
5.15337694683563e-09	-1.28127863319799	0.607	0.843	0.000144114186318258	CDC6	Malignant cells	GSE140440	ENSG00000094804	990	cell division cycle 6	CDC18L	protein_coding	Q99741	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10425
5.16332198498951e-09	-0.970139026544515	0.833	0.955	0.000144392299310232	TOPBP1	Malignant cells	GSE140440	ENSG00000163781	11073	DNA topoisomerase II binding protein 1	Dpb11|KIAA0259|TOP2BP1	protein_coding	Q92547	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10426
5.17076438644496e-09	-0.866293094879995	0.973	1	0.000144600426066933	POLR2D	Malignant cells	GSE140440	ENSG00000144231	5433	RNA polymerase II subunit D	RPB4	protein_coding	O15514	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10427
5.17767761559138e-09	0.912635898797801	0.993	0.896	0.000144793754520013	PPM1A	Malignant cells	GSE140440	ENSG00000100614	5494	protein phosphatase, Mg2+/Mn2+ dependent 1A	MGC9201|PP2CA|PP2Calpha	protein_coding	P35813	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10428
5.19475765230417e-09	-0.618620974295228	1	1	0.000145271397746686	SNRPF	Malignant cells	GSE140440	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10429
5.20424517400745e-09	-0.852488190770874	0.54	0.746	0.000145536716291118	CTC-260E6.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10430
5.22578260377067e-09	-1.88900922311446	0.453	0.657	0.000146139010514447	ZNF100	Malignant cells	GSE140440	ENSG00000274746	163227	zinc finger protein 100	NA	protein_coding	Q8IYN0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10431
5.26470447878355e-09	-0.5688083056985	1	1	0.000147227460749182	CKS1B	Malignant cells	GSE140440	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10432
5.26494607502464e-09	-0.423436967500896	1	1	0.000147234216988064	H2AFZ	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10433
5.29950757353668e-09	0.81630318159368	0.967	0.769	0.000148200729293953	URB1-AS1	Malignant cells	GSE140440	ENSG00000256073	84996	URB1 antisense RNA 1 (head to head)	C21orf119|MGC14136|PRED84	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10434
5.30589638548535e-09	-0.567509093951513	0.54	0.843	0.000148379392420098	MT1G	Malignant cells	GSE140440	ENSG00000125144	4495	metallothionein 1G	MT1|MT1K	protein_coding	P13640	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10435
5.30850851935361e-09	-1.38930062101107	0.267	0.59	0.000148452440743724	ANKRD30A	Malignant cells	GSE140440	ENSG00000148513	91074	ankyrin repeat domain 30A	NY-BR-1	protein_coding	Q9BXX3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10436
5.33167392516431e-09	2.1897006832466	0.5	0.209	0.00014910026131722	LRRIQ1	Malignant cells	GSE140440	ENSG00000133640	84125	leucine rich repeats and IQ motif containing 1	FLJ12303|KIAA1801	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10437
5.35910338807169e-09	-2.69490108675147	0.307	0.59	0.000149867326247425	C1R	Malignant cells	GSE140440	ENSG00000288512	715	complement C1r	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10438
5.36494318614487e-09	-0.913766803792007	0.953	0.985	0.000150030636200541	SAC3D1	Malignant cells	GSE140440	ENSG00000168061	29901	SAC3 domain containing 1	HSU79266|SHD1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10439
5.39109155090107e-09	-2.46504855098694	0.227	0.56	0.000150761875220948	ALDH3A1	Malignant cells	GSE140440	ENSG00000108602	218	aldehyde dehydrogenase 3 family member A1	ALDH3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10440
5.47295747580319e-09	-0.824495616200261	1	0.993	0.000153051255810836	TUBA1C	Malignant cells	GSE140440	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10441
5.47448641854235e-09	2.09407295208417	0.56	0.276	0.000153094012694537	NXPH4	Malignant cells	GSE140440	ENSG00000182379	11247	neurexophilin 4	NPH4	protein_coding	O95158	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10442
5.49785798469778e-09	0.563632270052516	1	0.993	0.000153747598542073	EI24	Malignant cells	GSE140440	ENSG00000149547	9538	EI24 autophagy associated transmembrane protein	EPG4|PIG8|TP53I8	protein_coding	O14681	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10443
5.54550201858282e-09	-0.512522239412725	1	1	0.000155079963949669	C14orf2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10444
5.56873565381426e-09	-0.696588881745308	0.993	0.993	0.000155729692558916	BMS1	Malignant cells	GSE140440	ENSG00000165733	9790	BMS1 ribosome biogenesis factor	BMS1L|KIAA0187	protein_coding	Q14692	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10445
5.57137481590723e-09	0.992491070104515	0.953	0.888	0.000155803496726846	LIPA	Malignant cells	GSE140440	ENSG00000107798	3988	lipase A, lysosomal acid type	CESD|LAL	protein_coding	P38571	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10446
5.65777089373341e-09	-0.279094256729893	0.387	0.746	0.000158219563043255	TUBB8P7	Malignant cells	GSE140440	ENSG00000261812	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10447
5.66679111233361e-09	-0.567194381577027	1	0.993	0.000158471813456409	SRPK1	Malignant cells	GSE140440	ENSG00000096063	6732	SRSF protein kinase 1	SFRSK1	protein_coding	Q96SB4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10448
5.68096660443752e-09	1.01221280907016	0.967	0.91	0.000158868231093095	BCL10	Malignant cells	GSE140440	ENSG00000142867	8915	BCL10 immune signaling adaptor	c-E10|CARMEN|CIPER|CLAP|mE10	protein_coding	O95999	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10449
5.70436493321819e-09	2.34502240693564	0.607	0.306	0.000159522565357447	RP11-53O19.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10450
5.76697235963504e-09	0.523294383728176	1	1	0.000161273382037194	COTL1	Malignant cells	GSE140440	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10451
5.83452056560937e-09	1.47153184731085	0.647	0.373	0.000163162367617266	IDNK	Malignant cells	GSE140440	ENSG00000148057	414328	IDNK gluconokinase	bA522I20.2|C9orf103|hGntK	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10452
5.9775299146308e-09	0.559115378841758	1	0.978	0.00016716162406265	BLOC1S1	Malignant cells	GSE140440	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10453
5.99345873843803e-09	4.7114569304977	0.427	0.149	0.000167607073620419	TAGLN3	Malignant cells	GSE140440	ENSG00000144834	29114	transgelin 3	NP22|NP25	protein_coding	Q9UI15	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10454
5.99435878073905e-09	0.621688131428204	1	0.985	0.000167632243303368	TXN2	Malignant cells	GSE140440	ENSG00000100348	25828	thioredoxin 2	MT-TRX	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10455
6.23424909704003e-09	0.68396116921548	0.96	0.881	0.000174340775998724	HIAT1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10456
6.2865561167211e-09	-0.917151388893444	1	1	0.000175803541804106	HYPK	Malignant cells	GSE140440	ENSG00000242028	25764	huntingtin interacting protein K	C15orf63|FLJ20431|HSPC136	protein_coding	Q9NX55	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10457
6.34017465469407e-09	-0.767481065685587	0.967	1	0.00017730298421852	UCHL5	Malignant cells	GSE140440	ENSG00000116750	51377	ubiquitin C-terminal hydrolase L5	CGI-70|INO80R|UCH37	protein_coding	Q9Y5K5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10458
6.35409734475893e-09	1.59520651651434	0.733	0.44	0.000177692332246184	TRAM2-AS1	Malignant cells	GSE140440	ENSG00000225791	401264	TRAM2 antisense RNA 1 (head to head)	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10459
6.4119975965682e-09	1.66217220507297	0.627	0.328	0.00017931151278803	CLYBL	Malignant cells	GSE140440	ENSG00000125246	171425	citramalyl-CoA lyase	CLB	protein_coding	Q8N0X4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10460
6.42547569606373e-09	-0.519251217521457	1	1	0.000179688427840422	SLC25A5	Malignant cells	GSE140440	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10461
6.59274314225625e-09	0.920660555215743	0.927	0.821	0.000184366061973196	RNFT1	Malignant cells	GSE140440	ENSG00000189050	51136	ring finger protein, transmembrane 1	PTD016	protein_coding	Q5M7Z0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10462
6.63903947128655e-09	-1.01382097761375	0.807	0.94	0.000185660738814528	TMUB1	Malignant cells	GSE140440	ENSG00000164897	83590	transmembrane and ubiquitin like domain containing 1	C7orf21|HOPS|SB144	protein_coding	Q9BVT8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10463
6.75152044041519e-09	0.977154872837829	0.907	0.769	0.000188806269116211	HSD17B7	Malignant cells	GSE140440	ENSG00000132196	51478	hydroxysteroid 17-beta dehydrogenase 7	PRAP|SDR37C1	protein_coding	P56937	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10464
6.76802968554855e-09	-0.926610897246166	0.853	0.955	0.000189267950156365	MIS18A	Malignant cells	GSE140440	ENSG00000159055	54069	MIS18 kinetochore protein A	B28|C21orf45|C21orf46|FASP1|hMis18alpha	protein_coding	Q9NYP9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10465
6.89933795107707e-09	-0.478756993485787	0.287	0.627	0.00019293998580187	PRDX3P2	Malignant cells	GSE140440	ENSG00000231468	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10466
6.96129860714108e-09	1.99248471802876	0.567	0.284	0.0001946727155487	PPM1N	Malignant cells	GSE140440	ENSG00000213889	147699	protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)	FLJ40125	protein_coding	Q8N819	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10467
7.01864174595202e-09	1.1081000530818	0.94	0.94	0.000196276316425548	ZSWIM7	Malignant cells	GSE140440	ENSG00000214941	125150	zinc finger SWIM-type containing 7	SWS1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10468
7.16718212405432e-09	4.21984360399422	0.44	0.164	0.000200430248099179	ZMAT4	Malignant cells	GSE140440	ENSG00000165061	79698	zinc finger matrin-type 4	FLJ13842	protein_coding	Q9H898	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10469
7.32220566816329e-09	-2.67271223032301	0.147	0.455	0.000204765481510186	ZNF540	Malignant cells	GSE140440	ENSG00000171817	163255	zinc finger protein 540	DKFZp547B0714	protein_coding	Q8NDQ6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10470
7.35717768125666e-09	-0.783803036132269	0.66	0.896	0.000205743473856343	AURKB	Malignant cells	GSE140440	ENSG00000178999	9212	aurora kinase B	Aik2|AIM-1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5	protein_coding	Q96GD4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10471
7.38352181036755e-09	-1.31665857170115	0.373	0.716	0.000206480187426929	RP11-572O17.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10472
7.61436879966898e-09	4.3234868678466	0.74	0.575	0.000212935823482743	LINC01234	Malignant cells	GSE140440	ENSG00000249550	100506465	long intergenic non-protein coding RNA 1234	onco-lncRNA-32	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10473
7.68106318856765e-09	0.967882577379378	0.947	0.948	0.000214800932068294	SPA17	Malignant cells	GSE140440	ENSG00000064199	53340	sperm autoantigenic protein 17	CT22|SP17	protein_coding	Q15506	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10474
7.68552859098584e-09	0.641343335882143	0.927	0.769	0.000214925807046919	R3HDM4	Malignant cells	GSE140440	ENSG00000198858	91300	R3H domain containing 4	C19orf22|MGC16353	protein_coding	Q96D70	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10475
7.88456677964796e-09	-0.896314832487139	0.933	1	0.000220491909992855	SMPD4	Malignant cells	GSE140440	ENSG00000136699	55627	sphingomyelin phosphodiesterase 4	FLJ20297|FLJ20756|KIAA1418|NET13|nSMase-3|NSMASE3	protein_coding	Q9NXE4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10476
8.03734265208879e-09	1.76976266604817	1	1	0.000224764287265663	TOMM34	Malignant cells	GSE140440	ENSG00000025772	10953	translocase of outer mitochondrial membrane 34	HTOM34P|TOM34	protein_coding	Q15785	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10477
8.03883602589604e-09	-0.28409768130222	0.387	0.761	0.000224806049464183	RP11-872J21.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10478
8.07582665121905e-09	0.698142264846856	0.987	0.888	0.000225840492301341	FAM200B	Malignant cells	GSE140440	ENSG00000237765	285550	family with sequence similarity 200 member B	C4orf53	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10479
8.14680167889054e-09	-1.17370061785911	0.347	0.679	0.000227825308950174	ASPN	Malignant cells	GSE140440	ENSG00000106819	54829	asporin	FLJ20129|PLAP-1|SLRR1C	protein_coding	Q9BXN1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10480
8.20041224680051e-09	1.12921980642078	0.86	0.672	0.000229324528481776	EPS8	Malignant cells	GSE140440	ENSG00000151491	2059	epidermal growth factor receptor pathway substrate 8	NA	protein_coding	Q12929	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10481
8.21615465702356e-09	-2.40167651967581	0.2	0.515	0.000229764764983664	C1S	Malignant cells	GSE140440	ENSG00000182326	716	complement C1s	NA	protein_coding	P09871	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10482
8.42836003833297e-09	-1.0379066383013	0.907	0.978	0.000235699088471981	AQR	Malignant cells	GSE140440	ENSG00000021776	9716	aquarius intron-binding spliceosomal factor	fSAP164|IBP160|KIAA0560	protein_coding	O60306	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10483
8.55178008284482e-09	1.19655815771692	0.827	0.597	0.000239150530016755	KLF13	Malignant cells	GSE140440	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10484
8.78667236944622e-09	-1.23801762734235	0.627	0.806	0.000245719292811564	C21orf58	Malignant cells	GSE140440	ENSG00000160298	54058	chromosome 21 open reading frame 58	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10485
8.85425290517078e-09	-0.63132724406748	0.427	0.761	0.000247609182493101	ZNF66	Malignant cells	GSE140440	ENSG00000275050	7617	zinc finger protein 66	FLJ16537|ZNF66P	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10486
8.89996197623618e-09	0.642709830651582	1	0.985	0.000248887436665445	C16orf13	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10487
8.90372954894872e-09	-1.19220719319854	0.967	0.985	0.000248992796836351	IPO7	Malignant cells	GSE140440	ENSG00000205339	10527	importin 7	Imp7|RANBP7	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10488
8.92512990569842e-09	-0.831733059341365	0.933	0.985	0.000249591257812856	H2AFX	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10489
8.95459919996938e-09	1.98315491396202	0.593	0.321	0.000250415366627144	CLIP2	Malignant cells	GSE140440	ENSG00000106665	7461	CAP-Gly domain containing linker protein 2	CLIP|CLIP-115|CYLN2|KIAA0291|WBSCR3|WBSCR4|WSCR3|WSCR4	protein_coding	Q9UDT6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10490
9.16417737483783e-09	-0.99671954859918	0.26	0.604	0.00025627622028734	PRKCQ	Malignant cells	GSE140440	ENSG00000065675	5588	protein kinase C theta	NA	protein_coding	Q04759	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10491
9.26869105673281e-09	0.947505568085711	0.967	0.948	0.000259198945401533	GSK3B	Malignant cells	GSE140440	ENSG00000082701	2932	glycogen synthase kinase 3 beta	NA	protein_coding	P49841	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10492
9.28873463292859e-09	2.10397122299345	0.567	0.261	0.000259759464009848	DNAH5	Malignant cells	GSE140440	ENSG00000039139	1767	dynein axonemal heavy chain 5	CILD3|Dnahc5|HL1|KTGNR|PCD	protein_coding	Q8TE73	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10493
9.3265466802649e-09	-0.800557240879522	0.453	0.754	0.000260816877913608	MT1L	Malignant cells	GSE140440	ENSG00000260549	NA	NA	MT1|MT1R|MTF	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10494
9.35832676371237e-09	-1.62530538808031	0.42	0.724	0.000261705607947216	ZNF737	Malignant cells	GSE140440	ENSG00000237440	100129842	zinc finger protein 737	ZNF102	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10495
9.38196864856062e-09	-0.991391290522913	0.887	0.978	0.000262366753256998	WDHD1	Malignant cells	GSE140440	ENSG00000198554	11169	WD repeat and HMG-box DNA binding protein 1	AND-1|CHTF4|CTF4	protein_coding	O75717	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10496
9.40422092671972e-09	-1.04108205244148	0.673	0.828	0.000262989038215717	GP6	Malignant cells	GSE140440	ENSG00000278670	51206	glycoprotein VI platelet	GPVI	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10497
9.41595864755408e-09	3.02771427751227	0.513	0.254	0.00026331728357885	TENM4	Malignant cells	GSE140440	ENSG00000149256	26011	teneurin transmembrane protein 4	DOC4|KIAA1302|ODZ4|Ten-M4|TEN4	protein_coding	Q6N022	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10498
9.60316753025858e-09	0.79691276234575	0.773	0.47	0.000268552579983681	MCC	Malignant cells	GSE140440	ENSG00000171444	4163	MCC regulator of WNT signaling pathway	NA	protein_coding	P23508	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10499
9.61232669868561e-09	-1.21110412245412	0.713	0.91	0.000268808716128743	WDR76	Malignant cells	GSE140440	ENSG00000092470	79968	WD repeat domain 76	FLJ12973	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10500
9.81827434221448e-09	0.50864775250052	0.993	0.955	0.000274568041980028	CRIPT	Malignant cells	GSE140440	ENSG00000119878	9419	CXXC repeat containing interactor of PDZ3 domain	HSPC139	protein_coding	Q9P021	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10501
9.86625843418007e-09	-0.60919145206233	0.22	0.56	0.000275909917111846	RP11-318E3.9	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10502
9.86953851279701e-09	-0.677427504072901	1	1	0.000276001644510368	SNRPE	Malignant cells	GSE140440	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10503
9.87745596993955e-09	3.50992580846625	0.447	0.172	0.00027622305619936	SUSD4	Malignant cells	GSE140440	ENSG00000143502	55061	sushi domain containing 4	FLJ10052	protein_coding	Q5VX71	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10504
9.90529624739416e-09	-0.737379626323127	0.327	0.687	0.000277001609558378	NOTCH3	Malignant cells	GSE140440	ENSG00000074181	4854	notch receptor 3	CADASIL|CASIL	protein_coding	Q9UM47	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10505
9.95519903503616e-09	0.425134324065924	1	1	0.000278397141014786	TIMMDC1	Malignant cells	GSE140440	ENSG00000113845	51300	translocase of inner mitochondrial membrane domain containing 1	C3orf1|FLJ22597	protein_coding	Q9NPL8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10506
1.02407134581588e-08	0.751195215018959	0.893	0.507	0.000286381551857411	C1QL1	Malignant cells	GSE140440	ENSG00000131094	10882	complement C1q like 1	C1QRF|C1QTNF14|CRF|CTRP14	protein_coding	O75973	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10507
1.03730354285698e-08	0.999731982219084	0.94	0.873	0.000290081935759955	SDC4	Malignant cells	GSE140440	ENSG00000124145	6385	syndecan 4	amphiglycan|ryudocan|SYND4	protein_coding	P31431	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10508
1.03828932218945e-08	-1.4266103095576	0.353	0.694	0.00029035760895028	HOTTIP	Malignant cells	GSE140440	ENSG00000243766	NA	NA	HOXA-AS6|HOXA13-AS1|NCRNA00213|RP1-170O19.3	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10509
1.04369648830088e-08	-1.34351549411219	0.34	0.642	0.00029186972295334	ZNF682	Malignant cells	GSE140440	ENSG00000197124	91120	zinc finger protein 682	BC39498_3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10510
1.05727110571097e-08	0.933198674352732	0.947	0.739	0.000295665864712072	LITAF	Malignant cells	GSE140440	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10511
1.07740204246919e-08	0.753560412442856	0.987	0.933	0.00030129548117651	TMEM50B	Malignant cells	GSE140440	ENSG00000263160	757	transmembrane protein 50B	C21orf4	protein_coding	P56557	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10512
1.07957849570899e-08	-0.406302263726047	1	1	0.000301904126325018	PSMD2	Malignant cells	GSE140440	ENSG00000175166	5708	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	MGC14274|P97|Rpn1|S2|TRAP2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10513
1.0821374297138e-08	0.672199287573194	0.967	0.94	0.000302619732219465	TUG1	Malignant cells	GSE140440	ENSG00000253352	55000	taurine up-regulated 1	FLJ20618|LINC00080|NCRNA00080	protein_coding	A0A6I8PU40	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10514
1.09462277288274e-08	-3.78699943155483	0.22	0.53	0.000306111258436657	LINC00707	Malignant cells	GSE140440	ENSG00000238266	100507127	long intergenic non-protein coding RNA 707	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10515
1.09509851124356e-08	-0.752179391751579	0.413	0.761	0.000306244298669262	CEBPA	Malignant cells	GSE140440	ENSG00000245848	1050	CCAAT enhancer binding protein alpha	C/EBP-alpha|CEBP	protein_coding	P49715	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10516
1.10034183740284e-08	-0.996507159166647	0.92	0.925	0.000307710594829704	GCHFR	Malignant cells	GSE140440	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10517
1.10079643255393e-08	-0.757765722772374	0.36	0.701	0.000307837722363707	PRDM13	Malignant cells	GSE140440	ENSG00000112238	59336	PR/SET domain 13	PFM10	protein_coding	Q9H4Q3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10518
1.13076817627093e-08	1.09566862990632	0.807	0.612	0.000316219320494165	RP11-166P13.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10519
1.13990821169515e-08	0.8200885377537	0.887	0.694	0.000318775331400549	FBXL15	Malignant cells	GSE140440	ENSG00000107872	79176	F-box and leucine rich repeat protein 15	Fbl15|FBXO37|MGC11279	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10520
1.14000902236118e-08	-1.2365009322609	0.647	0.843	0.000318803523103305	NCAPG	Malignant cells	GSE140440	ENSG00000109805	64151	non-SMC condensin I complex subunit G	CAP-G|FLJ12450|hCAP-G|YCG1	protein_coding	Q9BPX3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10521
1.15231870555371e-08	-1.73020457403042	0.107	0.388	0.000322245926008095	FOLH1	Malignant cells	GSE140440	ENSG00000086205	2346	folate hydrolase 1	FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA	protein_coding	Q04609	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10522
1.15466975921875e-08	0.668091732975202	0.993	0.978	0.000322903398165524	ERCC1	Malignant cells	GSE140440	ENSG00000012061	2067	ERCC excision repair 1, endonuclease non-catalytic subunit	RAD10	protein_coding	P07992	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10523
1.16220425446169e-08	-2.23264000447974	0.6	0.769	0.000325010419760211	ZNF724P	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10524
1.17228783540819e-08	-0.4386864046647	0.38	0.724	0.000327830293171901	TGFB2-AS1	Malignant cells	GSE140440	ENSG00000232480	NA	NA	NR_046268	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10525
1.17315595167177e-08	1.65992455840238	0.56	0.269	0.00032807306188501	DENND2D	Malignant cells	GSE140440	ENSG00000162777	79961	DENN domain containing 2D	FLJ22457|RP5-1180E21.2	protein_coding	Q9H6A0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10526
1.17442787388947e-08	0.781589738982347	0.993	0.873	0.00032842875493319	BRE	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10527
1.18462307920642e-08	0.714225119137518	0.987	0.858	0.000331279844100077	UBN1	Malignant cells	GSE140440	ENSG00000118900	29855	ubinuclein 1	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10528
1.18807057210996e-08	-0.592194069952232	0.26	0.59	0.000332243935490551	RP11-347E10.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10529
1.19107919626728e-08	-0.872981070113967	0.907	0.963	0.000333085297236144	TIPIN	Malignant cells	GSE140440	ENSG00000075131	54962	TIMELESS interacting protein	FLJ20516	protein_coding	Q9BVW5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10530
1.19276940566278e-08	-1.03093663911018	0.673	0.896	0.000333557964293598	SKA1	Malignant cells	GSE140440	ENSG00000262634	220134	spindle and kinetochore associated complex subunit 1	C18orf24|MGC10200	protein_coding	Q96BD8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10531
1.20959077544836e-08	-1.49816929906682	0.973	0.978	0.000338262060354135	PDDC1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10532
1.21556745990344e-08	-0.784882560067681	0.247	0.582	0.000339933440161997	HIST4H4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10533
1.21947591776116e-08	-0.963634832754457	0.48	0.91	0.000341026440401909	SDHAF3	Malignant cells	GSE140440	ENSG00000196636	57001	succinate dehydrogenase complex assembly factor 3	ACN9|DC11|LYRM10|Sdh7	protein_coding	Q9NRP4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10534
1.22162338397981e-08	-1.07546863488197	0.487	0.836	0.000341626979329953	DSCC1	Malignant cells	GSE140440	ENSG00000136982	79075	DNA replication and sister chromatid cohesion 1	DCC1|hDCC1|MGC5528	protein_coding	Q9BVC3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10535
1.22632791615798e-08	2.1856447198799	0.793	0.619	0.000342942601753579	HAS3	Malignant cells	GSE140440	ENSG00000103044	3038	hyaluronan synthase 3	NA	protein_coding	O00219	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10536
1.24169401323705e-08	0.798399134948057	0.907	0.59	0.000347239730801742	RAMP1	Malignant cells	GSE140440	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10537
1.2580026293e-08	-0.761061772146126	0.993	1	0.000351800435283744	ABCE1	Malignant cells	GSE140440	ENSG00000164163	6059	ATP binding cassette subfamily E member 1	OABP|RLI|RLI1|RNASEL1|RNASELI|RNS4I	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10538
1.30335108677832e-08	1.55264775689909	0.6	0.306	0.000364482131417557	SEPT5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10539
1.30500426704233e-08	0.396542638162921	1	0.993	0.000364944443278388	NDUFV2	Malignant cells	GSE140440	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10540
1.30551081161551e-08	-1.43087718458951	0.367	0.694	0.000365086098468277	PLEKHA7	Malignant cells	GSE140440	ENSG00000166689	144100	pleckstrin homology domain containing A7	DKFZp686M22243	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10541
1.32202653386114e-08	-1.16266709298539	0.987	0.985	0.000369704720194268	NBPF1	Malignant cells	GSE140440	ENSG00000219481	55672	NBPF member 1	FLJ20719|KIAA1693	protein_coding	Q3BBV0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10542
1.35291569744336e-08	1.39136941700226	0.913	0.873	0.000378342874790035	STYXL1	Malignant cells	GSE140440	ENSG00000127952	51657	serine/threonine/tyrosine interacting like 1	DUSP24|MK-STYX	protein_coding	Q9Y6J8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10543
1.36600176769527e-08	0.793215319883956	0.853	0.597	0.000382002394335982	AC009502.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10544
1.3730925859747e-08	0.644157293182695	0.94	0.761	0.000383985341667825	HSD17B7P2	Malignant cells	GSE140440	ENSG00000288374	NA	NA	bA291L22.1|HSD17B7	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10545
1.37368602854e-08	-1.7425669685814	0.36	0.709	0.000384151297881211	AKR1C2	Malignant cells	GSE140440	ENSG00000151632	1646	aldo-keto reductase family 1 member C2	BABP|DD|DD2|DDH2|HAKRD|MCDR2|TDD	protein_coding	P52895	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10546
1.38227832115074e-08	1.7399059254526	0.747	0.515	0.000386554132509805	UGT8	Malignant cells	GSE140440	ENSG00000174607	7368	UDP glycosyltransferase 8	CGT	protein_coding	Q16880	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10547
1.38806843951259e-08	-0.332049471049709	0.467	0.806	0.000388173339109696	TSSC2	Malignant cells	GSE140440	ENSG00000223756	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10548
1.39776113831248e-08	-0.965448216778479	0.98	0.993	0.000390883902329084	PABPN1	Malignant cells	GSE140440	ENSG00000100836	8106	poly(A) binding protein nuclear 1	OPMD|PAB2|PABP2	protein_coding	Q86U42	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10549
1.40222117920467e-08	-1.02986870078501	0.94	0.993	0.000392131152764586	GCN1	Malignant cells	GSE140440	ENSG00000089154	10985	GCN1 activator of EIF2AK4	GCN1L|GCN1L1|KIAA0219	protein_coding	Q92616	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10550
1.41083905009836e-08	-0.488465855053775	0.587	0.813	0.000394541140360007	BMP7	Malignant cells	GSE140440	ENSG00000101144	655	bone morphogenetic protein 7	OP-1	protein_coding	P18075	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10551
1.41358504671783e-08	0.91762389692892	0.84	0.739	0.000395309058314641	SOCS2-AS1	Malignant cells	GSE140440	ENSG00000246985	144481	SOCS2 antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10552
1.41390517748911e-08	-0.979807761620038	0.78	0.918	0.00039539858288483	MSH5	Malignant cells	GSE140440	ENSG00000230293	4439	mutS homolog 5	G7	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10553
1.41661285316156e-08	1.43113922435663	0.82	0.53	0.000396155784386631	ABR	Malignant cells	GSE140440	ENSG00000276016	29	ABR activator of RhoGEF and GTPase	MDB	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10554
1.4300928039937e-08	-0.34082434906291	0.933	1	0.000399925452636838	TPX2	Malignant cells	GSE140440	ENSG00000088325	22974	TPX2 microtubule nucleation factor	C20orf1|C20orf2|DIL-2|FLS353|HCA519|p100	protein_coding	Q9ULW0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10555
1.4417401171311e-08	1.37598580568896	0.733	0.433	0.000403182623755713	ZNF134	Malignant cells	GSE140440	ENSG00000213762	7693	zinc finger protein 134	pHZ-15	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10556
1.44819636454107e-08	-0.375723223372307	0.28	0.627	0.00040498811334391	RP11-703I16.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10557
1.44855970096121e-08	-0.811629671328505	0.667	0.918	0.000405089720373801	KIF14	Malignant cells	GSE140440	ENSG00000118193	9928	kinesin family member 14	KIAA0042	protein_coding	Q15058	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10558
1.45261642933263e-08	-1.07990775320644	0.887	0.963	0.00040622418446287	PLIN2	Malignant cells	GSE140440	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10559
1.45619604142106e-08	0.708607774695799	0.687	0.366	0.000407225222983399	GABARAPL1	Malignant cells	GSE140440	ENSG00000139112	23710	GABA type A receptor associated protein like 1	APG8L|ATG8B|ATG8L|gec1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10560
1.47108488517016e-08	-1.05108337456722	0.653	0.896	0.000411388888137834	NEK2	Malignant cells	GSE140440	ENSG00000117650	4751	NIMA related kinase 2	NEK2A|NLK1|PPP1R111|RP67	protein_coding	P51955	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10561
1.47456709155873e-08	-0.893053528519945	0.987	1	0.0004123626871544	ZNF593	Malignant cells	GSE140440	ENSG00000142684	51042	zinc finger protein 593	ZT86	protein_coding	O00488	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10562
1.47739584450567e-08	0.763630108763955	1	1	0.00041315374791601	SLC38A2	Malignant cells	GSE140440	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10563
1.52384490387941e-08	0.597477350336757	0.967	0.701	0.000426143227369878	C2orf74	Malignant cells	GSE140440	ENSG00000237651	339804	chromosome 2 open reading frame 74	LOC339804	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10564
1.53991067928545e-08	-0.614193569598532	0.753	0.94	0.000430636021462175	NDC80	Malignant cells	GSE140440	ENSG00000080986	10403	NDC80 kinetochore complex component	HEC|HEC1|hsNDC80|KNTC2|TID3	protein_coding	O14777	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10565
1.54731001955679e-08	-1.39623537822666	0.34	0.701	0.000432705246969057	CDC25A	Malignant cells	GSE140440	ENSG00000164045	993	cell division cycle 25A	NA	protein_coding	P30304	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10566
1.57255867038664e-08	1.60781998102095	0.62	0.358	0.000439766032173624	ORAI3	Malignant cells	GSE140440	ENSG00000175938	93129	ORAI calcium release-activated calcium modulator 3	MGC13024|TMEM142C	protein_coding	Q9BRQ5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10567
1.57362648384863e-08	-0.660115160933985	0.993	0.993	0.000440064646208271	FARSB	Malignant cells	GSE140440	ENSG00000116120	10056	phenylalanyl-tRNA synthetase subunit beta	FARSLB|FRSB|PheHB	protein_coding	Q9NSD9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10568
1.58393245085208e-08	-0.752534086997854	0.947	0.963	0.000442946709880783	NGDN	Malignant cells	GSE140440	ENSG00000129460	25983	neuroguidin	C14orf120|CANu1|DKFZP564O092|LCP5|lpd-2|NGD	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10569
1.60758097768679e-08	-0.333428687193064	0.347	0.687	0.000449560020410109	RORB-AS1	Malignant cells	GSE140440	ENSG00000224825	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10570
1.60980549648271e-08	0.523330215835416	0.98	0.821	0.000450182107091389	FAM45A	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10571
1.6137525223598e-08	0.807621487693804	0.893	0.746	0.000451285892877917	RP11-545E17.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10572
1.62115225309913e-08	-0.686716173739391	0.82	0.873	0.000453355227579172	HSP90AB3P	Malignant cells	GSE140440	ENSG00000183199	NA	NA	HSPCP1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10573
1.62569759853536e-08	0.993667778930733	0.953	0.828	0.000454626333430413	PTPN12	Malignant cells	GSE140440	ENSG00000127947	5782	protein tyrosine phosphatase non-receptor type 12	PTP-PEST|PTPG1	protein_coding	Q05209	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10574
1.62741886792174e-08	0.584602733635858	0.993	0.978	0.000455107686414316	SLU7	Malignant cells	GSE140440	ENSG00000164609	10569	SLU7 homolog, splicing factor	9G8	protein_coding	O95391	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10575
1.62752386761578e-08	0.250120610529411	1	0.993	0.000455137049578752	RBX1	Malignant cells	GSE140440	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10576
1.6392989293651e-08	-0.633842923723041	0.407	0.746	0.000458429945596949	AC004471.9	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10577
1.63965548869599e-08	-1.25391809882814	0.973	0.985	0.000458529657413834	ZNF37A	Malignant cells	GSE140440	ENSG00000075407	7587	zinc finger protein 37A	KOX21|ZNF37	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10578
1.64103068343966e-08	-0.960336229980522	1	0.993	0.000458914230623901	DHX36	Malignant cells	GSE140440	ENSG00000281763	170506	DEAH-box helicase 36	DDX36|KIAA1488|MLEL1|RHAU	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10579
1.64693341853547e-08	-2.44397539537172	0.207	0.507	0.000460564930493444	RP11-8L18.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10580
1.65413461199192e-08	0.40281265716876	1	1	0.00046257874424354	SCAND1	Malignant cells	GSE140440	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10581
1.65544919814999e-08	1.03496007755224	0.867	0.649	0.000462946368262645	MBP	Malignant cells	GSE140440	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10582
1.67107942233339e-08	3.11916154564706	0.48	0.201	0.000467317360455532	LINC00659	Malignant cells	GSE140440	ENSG00000228705	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10583
1.67389437090583e-08	-1.70072113454708	0.527	0.709	0.000468104560823816	ANKRD16	Malignant cells	GSE140440	ENSG00000134461	54522	ankyrin repeat domain 16	DKFZP434N1511	protein_coding	Q6P6B7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10584
1.69117057651459e-08	-2.81042775610723	0.273	0.545	0.000472935851722305	C1orf106	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10585
1.73295579312254e-08	0.508396144643132	1	1	0.000484621087546719	ATOX1	Malignant cells	GSE140440	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10586
1.7471730381813e-08	-1.40712935920329	0.92	0.97	0.0004885969401274	MYCBP2	Malignant cells	GSE140440	ENSG00000005810	23077	MYC binding protein 2	FLJ10106|KIAA0916|PAM|PHR1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10587
1.74966676800142e-08	-0.801787744800175	0.353	0.672	0.000489294311671596	SYNGR4	Malignant cells	GSE140440	ENSG00000105467	23546	synaptogyrin 4	NA	protein_coding	O95473	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10588
1.75559875481628e-08	0.803542114814539	0.88	0.679	0.000490953191784372	ASB3	Malignant cells	GSE140440	ENSG00000115239	51130	ankyrin repeat and SOCS box containing 3	ASB-3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10589
1.76699123263215e-08	-0.344567823023921	0.327	0.664	0.000494139098205581	RP11-297L17.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10590
1.77638761279085e-08	-0.500752971028652	0.987	1	0.000496766795916962	MRPL4	Malignant cells	GSE140440	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10591
1.78253445113122e-08	-0.384244636433635	0.287	0.627	0.000498485759258846	RP11-415J8.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10592
1.78994480782312e-08	0.728756825893877	0.987	0.925	0.000500558065507736	YIPF3	Malignant cells	GSE140440	ENSG00000137207	25844	Yip1 domain family member 3	C6orf109|dJ337H4.3|DKFZp566C243|FinGER3|KLIP1	protein_coding	Q9GZM5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10593
1.80782556257519e-08	-0.624297716233865	0.993	1	0.000505558418574151	NOP16	Malignant cells	GSE140440	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10594
1.80817695891516e-08	-0.7786962542909	0.887	1	0.000505656686560623	TEAD1	Malignant cells	GSE140440	ENSG00000187079	7003	TEA domain transcription factor 1	AA|TCF13|TEF-1	protein_coding	P28347	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10595
1.81408130636593e-08	-0.542633462187962	0.46	0.776	0.000507307837325233	ZNF578	Malignant cells	GSE140440	ENSG00000258405	147660	zinc finger protein 578	FLJ31384	protein_coding	Q96N58	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10596
1.81522085247453e-08	-1.10999616278158	0.767	0.948	0.000507626511394501	RFC3	Malignant cells	GSE140440	ENSG00000133119	5983	replication factor C subunit 3	MGC5276|RFC38	protein_coding	P40938	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10597
1.81551862358346e-08	-0.412662845831212	1	1	0.000507709783085115	RBM8A	Malignant cells	GSE140440	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10598
1.81574854890477e-08	2.11809853921268	0.553	0.246	0.000507774081701219	IGIP	Malignant cells	GSE140440	ENSG00000182700	492311	IgA inducing protein	C5orf53|LOC492311	protein_coding	A6NJ69	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10599
1.83159728890153e-08	-0.487032402113374	0.387	0.724	0.000512206181841314	ZNF571-AS1	Malignant cells	GSE140440	ENSG00000267470	100507433	ZNF571 antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10600
1.8378782941217e-08	0.695336629094675	1	0.985	0.000513962664951133	MRPL48	Malignant cells	GSE140440	ENSG00000175581	51642	mitochondrial ribosomal protein L48	CGI-118	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10601
1.84223733291994e-08	-0.360668877650017	0.527	0.821	0.000515181670151061	AC005562.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10602
1.87877924308808e-08	-1.66511831928707	0.253	0.59	0.000525400615329583	ZNF563	Malignant cells	GSE140440	ENSG00000188868	147837	zinc finger protein 563	FLJ34797	protein_coding	Q8TA94	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10603
1.89514184504811e-08	-1.72763434841801	0.113	0.396	0.000529976416967705	ABCA8	Malignant cells	GSE140440	ENSG00000141338	10351	ATP binding cassette subfamily A member 8	KIAA0822	protein_coding	O94911	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10604
1.899285705278e-08	0.579731073049039	0.993	0.94	0.000531135247480993	MRFAP1L1	Malignant cells	GSE140440	ENSG00000178988	114932	Morf4 family associated protein 1 like 1	MGC9651	protein_coding	Q96HT8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10605
1.92012367392864e-08	-0.579186276402286	0.407	0.724	0.000536962585414144	RP11-452L6.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10606
1.95475956286172e-08	1.10580288828824	0.9	0.731	0.00054664851175428	PEX1	Malignant cells	GSE140440	ENSG00000127980	5189	peroxisomal biogenesis factor 1	ZWS|ZWS1	protein_coding	O43933	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10607
1.98202890895955e-08	0.444115336437218	1	0.985	0.000554274384390537	VAMP3	Malignant cells	GSE140440	ENSG00000049245	9341	vesicle associated membrane protein 3	CEB	protein_coding	Q15836	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10608
1.98460288610603e-08	-0.909963429658141	0.44	0.754	0.000554994197099551	RP11-697E22.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10609
1.98865885536356e-08	2.7044791332161	0.48	0.209	0.000556128448902418	LINC00704	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10610
2.00009612344187e-08	2.42105191585172	0.507	0.231	0.00055932688092052	AF127936.9	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10611
2.00176722255895e-08	-0.810563801657886	0.52	0.784	0.00055979420378861	PLK1	Malignant cells	GSE140440	ENSG00000166851	5347	polo like kinase 1	PLK	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10612
2.01050015002309e-08	-0.434932221145498	0.22	0.53	0.000562236366953957	LINC00671	Malignant cells	GSE140440	ENSG00000213373	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10613
2.03776153924274e-08	1.09960446995735	0.767	0.493	0.000569860014449233	ZSCAN5A	Malignant cells	GSE140440	ENSG00000131848	79149	zinc finger and SCAN domain containing 5A	MGC4161|ZNF495|ZSCAN5	protein_coding	Q9BUG6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10614
2.05176418929498e-08	-1.02003544973104	0.467	0.791	0.00057377585553634	PLK4	Malignant cells	GSE140440	ENSG00000142731	10733	polo like kinase 4	Sak|STK18	protein_coding	O00444	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10615
2.06796988014365e-08	0.526341404023786	1	0.925	0.000578307776982172	ERCC4	Malignant cells	GSE140440	ENSG00000175595	2072	ERCC excision repair 4, endonuclease catalytic subunit	FANCQ|RAD1|XPF	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10616
2.10938610626995e-08	1.20220098250357	0.913	0.843	0.000589889824618391	STEAP2	Malignant cells	GSE140440	ENSG00000157214	261729	STEAP2 metalloreductase	IPCA-1|PCANAP1|STAMP1|STMP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10617
2.11666535834115e-08	1.52507585170057	0.58	0.261	0.000591925467460103	FAM134B	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10618
2.12535577723164e-08	-1.31797986363739	0.707	0.888	0.000594355743102829	BRIP1	Malignant cells	GSE140440	ENSG00000136492	83990	BRCA1 interacting helicase 1	BACH1|FANCJ|OF	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10619
2.13474428440817e-08	0.609522848714141	0.993	0.963	0.000596981239134746	ZCCHC9	Malignant cells	GSE140440	ENSG00000131732	84240	zinc finger CCHC-type containing 9	DKFZp761J139|PPP1R41	protein_coding	Q8N567	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10620
2.16127568791728e-08	1.82557486973253	0.653	0.403	0.000604400746126068	CREBRF	Malignant cells	GSE140440	ENSG00000164463	153222	CREB3 regulatory factor	C5orf41|LRF	protein_coding	Q8IUR6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10621
2.16407991871342e-08	-0.822201745546526	0.993	0.993	0.000605184949268207	LRPPRC	Malignant cells	GSE140440	ENSG00000138095	10128	leucine rich pentatricopeptide repeat containing	GP130|LRP130|LSFC	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10622
2.18975018019777e-08	-0.742585110326176	0.487	0.806	0.000612363637892306	PDE6B	Malignant cells	GSE140440	ENSG00000133256	5158	phosphodiesterase 6B	CSNB3|CSNBAD2|PDEB|rd1|RP40	protein_coding	P35913	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10623
2.19555558007128e-08	-0.524637032894116	0.5	0.791	0.000613987117966933	PNPLA1	Malignant cells	GSE140440	ENSG00000180316	285848	patatin like phospholipase domain containing 1	dJ50J22.1|FLJ38755	protein_coding	Q8N8W4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10624
2.23134908038832e-08	0.49149223498416	0.993	0.918	0.000623996770330593	SRSF8	Malignant cells	GSE140440	ENSG00000263465	10929	serine and arginine rich splicing factor 8	SFRS2B|SRP46	protein_coding	Q9BRL6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10625
2.24305106720084e-08	1.6485558205883	0.827	0.59	0.000627269230942715	PLD1	Malignant cells	GSE140440	ENSG00000075651	5337	phospholipase D1	NA	protein_coding	Q13393	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10626
2.30793252445723e-08	-1.51464691328012	0.353	0.649	0.000645413330464464	IFI44L	Malignant cells	GSE140440	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10627
2.31245131810019e-08	4.72943380982386	0.487	0.224	0.000646677011106717	AF127936.7	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10628
2.31616410168354e-08	-1.53049909051705	0.347	0.679	0.000647715291035803	CNTN1	Malignant cells	GSE140440	ENSG00000018236	1272	contactin 1	F3|GP135	protein_coding	Q12860	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10629
2.33246767942443e-08	-0.929806411209491	0.367	0.724	0.000652274586551043	SCARNA16	Malignant cells	GSE140440	ENSG00000275143	677781	small Cajal body-specific RNA 16	ACA47	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10630
2.34898382489161e-08	-1.24812099126875	0.22	0.537	0.000656893326630939	LPAR5	Malignant cells	GSE140440	ENSG00000184574	57121	lysophosphatidic acid receptor 5	GPR92|GPR93|KPG_010|LPA5	protein_coding	Q9H1C0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10631
2.35041297512376e-08	0.804791476142201	0.913	0.799	0.000657292988493359	STARD10	Malignant cells	GSE140440	ENSG00000214530	10809	StAR related lipid transfer domain containing 10	CGI-52|NY-CO-28|PCTP2|SDCCAG28	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10632
2.35903167599833e-08	0.681168106085059	0.993	0.925	0.000659703208192933	UBE2H	Malignant cells	GSE140440	ENSG00000186591	7328	ubiquitin conjugating enzyme E2 H	GID3|UBC8|UBCH	protein_coding	P62256	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10633
2.36872873632885e-08	-0.922608303251317	0.8	0.888	0.000662414991114362	PPAN	Malignant cells	GSE140440	ENSG00000130810	56342	peter pan homolog	BXDC3|SSF|SSF1|SSF2	protein_coding	Q9NQ55	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10634
2.3687528544458e-08	1.28826361946355	0.973	0.955	0.000662421735745769	FDFT1	Malignant cells	GSE140440	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10635
2.40156932150617e-08	0.347162902078606	1	1	0.0006715988607592	NDUFS8	Malignant cells	GSE140440	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10636
2.41175407572745e-08	-0.457854088433493	1	1	0.00067444702727718	SRM	Malignant cells	GSE140440	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10637
2.41458647388913e-08	0.800325150482571	0.893	0.649	0.000675239107423094	TRIM38	Malignant cells	GSE140440	ENSG00000112343	10475	tripartite motif containing 38	RNF15|RORET	protein_coding	O00635	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10638
2.41733851830224e-08	-1.06913066488545	0.853	0.948	0.000676008716643221	RAD18	Malignant cells	GSE140440	ENSG00000070950	56852	RAD18 E3 ubiquitin protein ligase	RNF73	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10639
2.45485571292515e-08	-1.02098974393819	0.667	0.91	0.000686500400119518	KIF11	Malignant cells	GSE140440	ENSG00000138160	3832	kinesin family member 11	Eg5|HKSP|KNSL1|TRIP5	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10640
2.46705548491735e-08	-1.4322070574443	0.5	0.731	0.000689912066357136	E2F2	Malignant cells	GSE140440	ENSG00000282899	1870	E2F transcription factor 2	E2F-2	protein_coding	Q14209	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10641
2.47221250332717e-08	-0.566303599114244	1	1	0.000691354226555442	COX11	Malignant cells	GSE140440	ENSG00000166260	1353	cytochrome c oxidase copper chaperone COX11	COX11P	protein_coding	Q9Y6N1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10642
2.48438625622932e-08	-1.01118302791065	0.34	0.672	0.000694758616554529	RP11-175P13.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10643
2.49217140115012e-08	0.619065052870889	1	0.955	0.000696935732331632	TMEM54	Malignant cells	GSE140440	ENSG00000121900	113452	transmembrane protein 54	BCLP|CAC-1	protein_coding	Q969K7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10644
2.49239154701298e-08	1.17663178987877	0.64	0.306	0.000696997296122181	C6orf141	Malignant cells	GSE140440	ENSG00000197261	135398	chromosome 6 open reading frame 141	MGC46457	protein_coding	Q5SZD1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10645
2.51043074559611e-08	-1.78352007989489	0.293	0.582	0.000702041958005952	ZNF253	Malignant cells	GSE140440	ENSG00000256771	56242	zinc finger protein 253	BMZF-1|FLJ90391|ZNF411	protein_coding	O75346	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10646
2.51576392167123e-08	-0.799804033278555	0.36	0.679	0.000703533380695359	CCDC96	Malignant cells	GSE140440	ENSG00000173013	257236	coiled-coil domain containing 96	FLJ90575	protein_coding	Q2M329	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10647
2.52449188915271e-08	0.773114043886093	1	0.993	0.000705974156801556	NRIP1	Malignant cells	GSE140440	ENSG00000180530	8204	nuclear receptor interacting protein 1	RIP140	protein_coding	P48552	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10648
2.54644550037594e-08	-2.06843445626318	0.42	0.687	0.000712113484180132	PHRF1	Malignant cells	GSE140440	ENSG00000274780	57661	PHD and ring finger domains 1	KIAA1542|PPP1R125|RNF221	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10649
2.56121154458994e-08	0.602131318783746	0.953	0.776	0.000716242808444576	RP11-43F13.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10650
2.59949597866675e-08	0.838358915736555	0.947	0.701	0.000726949050434157	TMEM135	Malignant cells	GSE140440	ENSG00000166575	65084	transmembrane protein 135	FLJ22104	protein_coding	Q86UB9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10651
2.63035983579907e-08	-0.862131681247831	0.38	0.709	0.000735580128081211	DUSP2	Malignant cells	GSE140440	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10652
2.64201732972757e-08	-0.676856567413376	0.993	1	0.000738840146258314	ELP2	Malignant cells	GSE140440	ENSG00000134759	55250	elongator acetyltransferase complex subunit 2	FLJ10879|STATIP1|StIP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10653
2.64600008951149e-08	-0.515126280037724	0.327	0.664	0.000739953925031889	RN7SKP269	Malignant cells	GSE140440	ENSG00000202415	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10654
2.64786539546249e-08	-0.323884291852689	0.447	0.769	0.000740475557841085	RP11-447H19.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10655
2.65235870421096e-08	-0.975097052391112	1	0.985	0.000741732111632596	PPP4R2	Malignant cells	GSE140440	ENSG00000163605	151987	protein phosphatase 4 regulatory subunit 2	NA	protein_coding	Q9NY27	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10656
2.66411862631939e-08	0.876610536771309	1	0.985	0.000745020773850217	SMIM14	Malignant cells	GSE140440	ENSG00000163683	201895	small integral membrane protein 14	C4orf34|FLJ13289	protein_coding	Q96QK8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10657
2.67563850708627e-08	-0.494777483441318	1	0.993	0.000748242308506676	P4HB	Malignant cells	GSE140440	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10658
2.70620246111248e-08	3.90757351903565	0.413	0.164	0.000756789518250106	LY96	Malignant cells	GSE140440	ENSG00000154589	23643	lymphocyte antigen 96	MD-2	protein_coding	Q9Y6Y9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10659
2.70948213290761e-08	0.740179210578356	1	0.985	0.000757706678467614	ANXA1	Malignant cells	GSE140440	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10660
2.71162350197064e-08	2.43288024488256	0.58	0.343	0.00075830551232609	RTN4RL2	Malignant cells	GSE140440	ENSG00000186907	349667	reticulon 4 receptor like 2	NgR2|NGRH1	protein_coding	Q86UN3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10661
2.75549473292176e-08	-0.955933933752679	0.073	0.328	0.00077057410206157	HMX1	Malignant cells	GSE140440	ENSG00000215612	3166	H6 family homeobox 1	H6|NKX5-3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10662
2.76549133199136e-08	-0.777343323943092	0.967	0.993	0.000773369650991385	ASUN	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10663
2.80686676490796e-08	1.23932527908987	0.593	0.321	0.000784940290806512	C14orf28	Malignant cells	GSE140440	ENSG00000179476	122525	chromosome 14 open reading frame 28	DRIP-1|DRIP1	protein_coding	Q4W4Y0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10664
2.80930383218151e-08	-1.31032741436316	0.287	0.597	0.000785621816669559	MIR137HG	Malignant cells	GSE140440	ENSG00000225206	400765	MIR137 host gene	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10665
2.83230876850841e-08	-0.34220605684421	1	1	0.000792055147113376	ATP5J2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10666
2.92892772281847e-08	0.537573439938837	0.807	0.604	0.000819074637686184	CD70	Malignant cells	GSE140440	ENSG00000125726	970	CD70 molecule	CD27L|CD27LG|TNFSF7	protein_coding	P32970	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10667
2.93169473369785e-08	0.741154499610245	0.947	0.933	0.000819848432278603	PRKAG1	Malignant cells	GSE140440	ENSG00000181929	5571	protein kinase AMP-activated non-catalytic subunit gamma 1	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10668
2.94860246587937e-08	-0.390535417560921	0.427	0.761	0.000824576679583165	SNORD27	Malignant cells	GSE140440	ENSG00000275996	9301	small nucleolar RNA, C/D box 27	RNU27|U27	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10669
2.96256209211985e-08	-0.831158823276579	0.38	0.694	0.000828480489061315	KRT8P39	Malignant cells	GSE140440	ENSG00000233560	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10670
2.98245133049911e-08	-0.329935000126829	0.227	0.567	0.000834042514574076	NEBL-AS1	Malignant cells	GSE140440	ENSG00000231920	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10671
3.00888407119343e-08	0.839180089970522	0.98	0.873	0.000841434430509244	PCSK1N	Malignant cells	GSE140440	ENSG00000102109	27344	proprotein convertase subtilisin/kexin type 1 inhibitor	BigLEN|PEN|proSAAS|SAAS|SCG8|SgVIII	protein_coding	Q9UHG2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10672
3.01717969552073e-08	-0.931403953931653	0.393	0.716	0.000843754301852373	PLXND1	Malignant cells	GSE140440	ENSG00000004399	23129	plexin D1	KIAA0620	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10673
3.03852968022633e-08	-0.608604403239545	0.373	0.709	0.000849724825075292	RP11-366M4.11	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10674
3.09146467420551e-08	0.624869995360125	1	0.993	0.00086452809614157	ATP1A1	Malignant cells	GSE140440	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10675
3.09275690312411e-08	0.45305732064511	0.993	0.993	0.000864889467958659	COPZ1	Malignant cells	GSE140440	ENSG00000111481	22818	COPI coat complex subunit zeta 1	CGI-120|COPZ	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10676
3.11576078021134e-08	0.716725518824144	1	0.97	0.000871322502186102	DSG2	Malignant cells	GSE140440	ENSG00000046604	1829	desmoglein 2	CDHF5	protein_coding	Q14126	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10677
3.136963619866e-08	-1.68571233183195	0.28	0.597	0.000877251876295526	RP11-342D11.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10678
3.14219782216971e-08	-1.22417791787458	0.54	0.799	0.000878715620969759	DDIAS	Malignant cells	GSE140440	ENSG00000165490	220042	DNA damage induced apoptosis suppressor	C11orf82|FLJ25416|FLJ38838|noxin	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10679
3.14255287920978e-08	1.5738921448975	0.8	0.604	0.000878814912671016	DOCK4	Malignant cells	GSE140440	ENSG00000128512	9732	dedicator of cytokinesis 4	FLJ34238|KIAA0716	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10680
3.14347106458517e-08	0.826299382140888	0.693	0.44	0.000879071683211244	BEX1	Malignant cells	GSE140440	ENSG00000133169	55859	brain expressed X-linked 1	NA	protein_coding	Q9HBH7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10681
3.14761319268851e-08	-0.485754284481048	0.533	0.791	0.000880230029335343	RN7SL455P	Malignant cells	GSE140440	ENSG00000264047	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10682
3.17206315123016e-08	-1.26828199955474	0.46	0.799	0.000887067460241515	ERCC6L	Malignant cells	GSE140440	ENSG00000186871	54821	ERCC excision repair 6 like, spindle assembly checkpoint helicase	FLJ20105|PICH|RAD26L	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10683
3.1787551514749e-08	-1.00017648725215	0.127	0.41	0.000888938878109955	C7orf61	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10684
3.18305790120835e-08	0.461537993532963	1	0.993	0.000890142142072914	DDX17	Malignant cells	GSE140440	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10685
3.18357067416511e-08	0.391473812970265	1	1	0.000890285539030274	NCBP2	Malignant cells	GSE140440	ENSG00000114503	22916	nuclear cap binding protein subunit 2	Cbc2|CBP20|NIP1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10686
3.19312053909674e-08	-1.09468411261501	0.387	0.724	0.000892956158758404	CTB-119C2.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10687
3.19624650518656e-08	-0.289841417941448	0.513	0.821	0.000893830335175421	EIF4A1P10	Malignant cells	GSE140440	ENSG00000229132	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10688
3.2249084700045e-08	-0.910459652017946	0.74	0.933	0.000901845653636758	NCAPG2	Malignant cells	GSE140440	ENSG00000146918	54892	non-SMC condensin II complex subunit G2	CAP-G2|FLJ20311|hCAP-G2|LUZP5|MTB	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10689
3.27569563095542e-08	3.23617464288628	0.533	0.276	0.000916048283196684	SIRPB1	Malignant cells	GSE140440	ENSG00000101307	10326	signal regulatory protein beta 1	CD172b|SIRP-BETA-1	protein_coding	O00241	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10690
3.32689761769887e-08	-0.544036142004403	0.367	0.709	0.00093036691878949	RP11-137H2.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10691
3.34784498185552e-08	5.43428477579503	0.427	0.164	0.000936224849175896	RCAN2	Malignant cells	GSE140440	ENSG00000172348	10231	regulator of calcineurin 2	DSCR1L1|ZAKI-4	protein_coding	Q14206	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10692
3.35222117935492e-08	-0.685908069180359	0.92	0.985	0.000937448652806603	UBE2T	Malignant cells	GSE140440	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10693
3.3724808149804e-08	-0.834655143238118	0.987	1	0.000943114259909268	DHX9	Malignant cells	GSE140440	ENSG00000135829	1660	DExH-box helicase 9	DDX9|LKP|RHA	protein_coding	Q08211	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10694
3.40843146544935e-08	-0.856857000566599	0.413	0.679	0.000953167859312912	ZNF114	Malignant cells	GSE140440	ENSG00000178150	163071	zinc finger protein 114	MGC17986	protein_coding	Q8NC26	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10695
3.41908608843992e-08	0.880369458264063	0.867	0.701	0.000956147424632223	ING4	Malignant cells	GSE140440	ENSG00000111653	51147	inhibitor of growth family member 4	my036|p29ING4	protein_coding	Q9UNL4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10696
3.44225266043092e-08	0.6111861703763	1	0.993	0.000962625956489507	C4orf3	Malignant cells	GSE140440	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10697
3.4754333219308e-08	-1.4054309037749	0.453	0.724	0.000971904928477947	MESTIT1	Malignant cells	GSE140440	ENSG00000272701	317751	MEST intronic transcript 1, antisense RNA	MEST-AS1|MEST-IT1|NCRNA00040	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10698
3.50533073042375e-08	-0.359921367249414	0.32	0.634	0.000980265738763002	RP11-767I20.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10699
3.51479470993914e-08	-0.363023839065624	1	1	0.00098291234063448	RPL8	Malignant cells	GSE140440	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10700
3.51914832353553e-08	-0.974034007944358	0.38	0.716	0.00098412982867671	PCDHB5	Malignant cells	GSE140440	ENSG00000113209	26167	protocadherin beta 5	DKFZp586B0217|PCDH-BETA5	protein_coding	Q9Y5E4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10701
3.53119783762194e-08	1.10290726642598	0.947	0.888	0.000987499475290976	RBM23	Malignant cells	GSE140440	ENSG00000100461	55147	RNA binding motif protein 23	CAPERbeta|FLJ10482|RNPC4	protein_coding	Q86U06	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10702
3.58752270387045e-08	-0.735501132456097	1	1	0.00100325072413737	WDR43	Malignant cells	GSE140440	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10703
3.65667735873309e-08	1.22479968389161	0.713	0.418	0.00102258982336971	CYP2R1	Malignant cells	GSE140440	ENSG00000186104	120227	cytochrome P450 family 2 subfamily R member 1	NA	protein_coding	Q6VVX0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10704
3.67628824767339e-08	0.71336781408411	1	0.993	0.00102807400846186	UFC1	Malignant cells	GSE140440	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10705
3.67639292234383e-08	-0.42679110067563	0.48	0.776	0.00102810328073345	MS4A7	Malignant cells	GSE140440	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10706
3.68747376500707e-08	-0.473931188332412	0.367	0.687	0.00103120203838423	LCAT	Malignant cells	GSE140440	ENSG00000213398	3931	lecithin-cholesterol acyltransferase	NA	protein_coding	P04180	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10707
3.71206876172386e-08	-0.892021166318893	0.687	0.858	0.00103808002921608	AC098823.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10708
3.73530763739009e-08	-1.15746619408937	0.687	0.903	0.00104457878079614	CCDC18	Malignant cells	GSE140440	ENSG00000122483	343099	coiled-coil domain containing 18	NY-SAR-41	protein_coding	Q5T9S5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10709
3.74647579147649e-08	-3.10088735064411	0.267	0.522	0.0010477019550864	SHISA3	Malignant cells	GSE140440	ENSG00000178343	152573	shisa family member 3	hShisa3	protein_coding	A0PJX4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10710
3.74654901591356e-08	-1.15431726022191	0.147	0.425	0.00104772243230023	ZNF582-AS1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10711
3.76333563943948e-08	0.607876235872291	0.98	0.94	0.00105241681156925	BET1	Malignant cells	GSE140440	ENSG00000105829	10282	Bet1 golgi vesicular membrane trafficking protein	hbet1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10712
3.78134917959943e-08	-0.804835907862874	0.713	0.948	0.00105745429807498	SGOL1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10713
3.81022334024457e-08	1.04733887163377	0.88	0.679	0.00106552895709939	SAYSD1	Malignant cells	GSE140440	ENSG00000112167	55776	SAYSVFN motif domain containing 1	C6orf64|FLJ11101	protein_coding	Q9NPB0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10714
3.91066504545557e-08	-0.706339600420689	1	1	0.00109361747996165	CACYBP	Malignant cells	GSE140440	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10715
3.92177585327401e-08	-1.57531134759064	0.473	0.709	0.00109672461736808	NACC1	Malignant cells	GSE140440	ENSG00000160877	112939	nucleus accumbens associated 1	BEND8|BTBD14B|BTBD30|NAC-1|NAC1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10716
3.95035749704356e-08	-0.400785037670451	0.233	0.537	0.00110471747404823	MYO7B	Malignant cells	GSE140440	ENSG00000169994	4648	myosin VIIB	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10717
3.95348201841628e-08	-1.58115663256857	0.533	0.776	0.00110559124645011	RBFA	Malignant cells	GSE140440	ENSG00000101546	79863	ribosome binding factor A	C18orf22|FLJ21172|HsT169	protein_coding	Q8N0V3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10718
3.95656115865206e-08	2.03459646310629	0.56	0.261	0.00110645232801705	LYPD3	Malignant cells	GSE140440	ENSG00000124466	27076	LY6/PLAUR domain containing 3	C4.4A	protein_coding	O95274	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10719
3.98616143474569e-08	-0.951647173839036	0.26	0.604	0.00111473004522663	GPER1	Malignant cells	GSE140440	ENSG00000164850	2852	G protein-coupled estrogen receptor 1	CEPR|CMKRL2|DRY12|FEG-1|GPCR-Br|GPER|GPR30|LERGU|LERGU2|LyGPR	protein_coding	Q99527	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10720
4.00005223703855e-08	1.04890627996434	0.947	0.896	0.00111861460808783	OLMALINC	Malignant cells	GSE140440	ENSG00000235823	90271	oligodendrocyte maturation-associated long intergenic non-coding RNA	bA34D15.5|C10orf75|FLJ12974|HI-LNC80|LINC00263|NCRNA00263	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10721
4.05484651823179e-08	0.517578484525179	1	0.955	0.00113393782882352	RRAS	Malignant cells	GSE140440	ENSG00000126458	6237	RAS related	R-Ras	protein_coding	P10301	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10722
4.06719311452707e-08	1.41499026080191	0.713	0.485	0.00113739055447749	TRAPPC6A	Malignant cells	GSE140440	ENSG00000007255	79090	trafficking protein particle complex subunit 6A	HSPC289|MGC2650|TRS33	protein_coding	O75865	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10723
4.11532033196663e-08	0.773055362143969	0.72	0.373	0.00115084933083447	RAPGEF5	Malignant cells	GSE140440	ENSG00000136237	9771	Rap guanine nucleotide exchange factor 5	GFR|KIAA0277|MR-GEF	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10724
4.22817889391084e-08	0.68982157728227	0.847	0.612	0.00118241022768217	MKL2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10725
4.23411243568111e-08	0.755059025268532	0.947	0.821	0.00118406954263822	KIF3B	Malignant cells	GSE140440	ENSG00000101350	9371	kinesin family member 3B	FLA8|KIAA0359|KLP-11	protein_coding	O15066	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10726
4.2375476778091e-08	2.30480181480677	0.54	0.261	0.00118503020809932	SH3BGRL2	Malignant cells	GSE140440	ENSG00000198478	83699	SH3 domain binding glutamate rich protein like 2	NA	protein_coding	Q9UJC5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10727
4.24741714449659e-08	4.0491587945079	0.62	0.425	0.00118779020445847	PECAM1	Malignant cells	GSE140440	ENSG00000261371	5175	platelet and endothelial cell adhesion molecule 1	CD31	protein_coding	P16284	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10728
4.26135122291338e-08	0.351610270256831	1	1	0.00119168686948773	EIF2S2	Malignant cells	GSE140440	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10729
4.27529359666116e-08	0.592963535945977	1	0.94	0.00119558585430629	HINT2	Malignant cells	GSE140440	ENSG00000137133	84681	histidine triad nucleotide binding protein 2	NA	protein_coding	Q9BX68	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10730
4.32649206445519e-08	4.15510267121798	0.433	0.187	0.0012099035058249	SATB1	Malignant cells	GSE140440	ENSG00000182568	6304	SATB homeobox 1	NA	protein_coding	Q01826	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10731
4.33154188711452e-08	0.891760150683079	0.9	0.701	0.00121131568873158	B9D1	Malignant cells	GSE140440	ENSG00000108641	27077	B9 domain containing 1	B9|EPPB9|MKS9|MKSR-1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10732
4.38145791502283e-08	-0.817353248997104	0.96	1	0.00122527470593613	NAA15	Malignant cells	GSE140440	ENSG00000164134	80155	N-alpha-acetyltransferase 15, NatA auxiliary subunit	FLJ13340|NARG1|NATH|TBDN100	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10733
4.38424410373902e-08	0.468552278503839	1	0.985	0.00122605386361062	ST13	Malignant cells	GSE140440	ENSG00000100380	6767	ST13 Hsp70 interacting protein	FAM10A1|HIP|HSPABP1|P48|SNC6	protein_coding	P50502	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10734
4.38678525395666e-08	-1.01548270212478	0.76	0.903	0.00122676449626898	MT-TI	Malignant cells	GSE140440	ENSG00000210100	NA	NA	MTTI|trnI	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10735
4.39076760663994e-08	1.41956121223222	0.78	0.545	0.00122787816119686	PCMTD1	Malignant cells	GSE140440	ENSG00000168300	115294	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1	FLJ10883	protein_coding	Q96MG8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10736
4.40245325293643e-08	0.693440180339659	0.887	0.657	0.00123114605218367	CYLD	Malignant cells	GSE140440	ENSG00000083799	1540	CYLD lysine 63 deubiquitinase	CYLD1|KIAA0849|USPL2	protein_coding	Q9NQC7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10737
4.44155058062611e-08	2.42616184823651	0.467	0.201	0.00124207961987209	NGF	Malignant cells	GSE140440	ENSG00000134259	4803	nerve growth factor	NGFB	protein_coding	P01138	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10738
4.45320848386976e-08	-0.540367027511758	0.493	0.769	0.00124533975251418	AC097382.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10739
4.49333594699484e-08	-0.49631705709055	0.987	0.985	0.00125656139757711	DTYMK	Malignant cells	GSE140440	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10740
4.51730701477869e-08	-0.722491446634122	0.333	0.657	0.00126326490668286	ATP6V0E2-AS1	Malignant cells	GSE140440	ENSG00000204934	401431	ATP6V0E2 antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10741
4.52373708828317e-08	0.835132698517313	0.947	0.843	0.00126506307673839	TMEM216	Malignant cells	GSE140440	ENSG00000187049	51259	transmembrane protein 216	CORS2|HSPC244|JBTS2|MGC13379|MKS2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10742
4.54029312922034e-08	2.71671060944608	0.5	0.224	0.00126969297358647	MOXD1	Malignant cells	GSE140440	ENSG00000079931	26002	monooxygenase DBH like 1	dJ248E1.1|DKFZP564G202|MOX	protein_coding	Q6UVY6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10743
4.56720101170788e-08	0.365197928663257	1	1	0.00127721776292411	NUDCD2	Malignant cells	GSE140440	ENSG00000170584	134492	NudC domain containing 2	DKFZp686E10109|NudCL2	protein_coding	Q8WVJ2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10744
4.58237308603154e-08	1.02500416894483	0.993	0.925	0.00128146063350872	CHD3	Malignant cells	GSE140440	ENSG00000170004	1107	chromodomain helicase DNA binding protein 3	Mi-2a|Mi2-ALPHA|ZFH	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10745
4.5848414530724e-08	-0.713808914912879	0.98	0.993	0.0012821509123517	WBP11	Malignant cells	GSE140440	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10746
4.6226954413146e-08	1.51634833043194	0.633	0.328	0.00129273678016363	CTA-445C9.14	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10747
4.63550445389001e-08	-1.10199196673446	0.88	0.985	0.00129631882053034	SART3	Malignant cells	GSE140440	ENSG00000075856	9733	spliceosome associated factor 3, U4/U6 recycling protein	KIAA0156|p110|RP11-13G14|TIP110	protein_coding	Q15020	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10748
4.64835831197434e-08	-0.938264131989563	0.56	0.858	0.00129991340194362	SKA3	Malignant cells	GSE140440	ENSG00000165480	221150	spindle and kinetochore associated complex subunit 3	C13orf3|MGC4832|RAMA1	protein_coding	Q8IX90	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10749
4.65844027087095e-08	3.76004778098587	0.467	0.201	0.00130273282174906	PLXNA2	Malignant cells	GSE140440	ENSG00000076356	5362	plexin A2	FLJ11751|FLJ30634|KIAA0463|OCT|PLXN2	protein_coding	O75051	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10750
4.75661062628016e-08	0.600240232025184	1	0.978	0.00133018616163925	VAT1	Malignant cells	GSE140440	ENSG00000108828	10493	vesicle amine transport 1	FLJ20230|VATI	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10751
4.76255369434911e-08	-1.52735323819079	0.327	0.619	0.00133184814062473	RP11-767N6.7	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10752
4.80163820861398e-08	1.98040182339387	0.62	0.328	0.0013427781250389	SESN3	Malignant cells	GSE140440	ENSG00000149212	143686	sestrin 3	MGC29667|SEST3	protein_coding	P58005	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10753
4.85182890957434e-08	-1.07578358703899	0.313	0.627	0.00135681395456246	CTC-479C5.12	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10754
4.85334923583003e-08	0.562060422888517	1	0.94	0.00135723911379987	ECI1	Malignant cells	GSE140440	ENSG00000167969	1632	enoyl-CoA delta isomerase 1	DCI	protein_coding	P42126	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10755
4.87506145323859e-08	0.510059525002974	0.993	0.985	0.00136331093539817	SYNJ2BP	Malignant cells	GSE140440	ENSG00000213463	55333	synaptojanin 2 binding protein	Arip2	protein_coding	P57105	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10756
4.93464963166324e-08	-0.67524352144315	0.973	0.993	0.00137997476949462	G3BP2	Malignant cells	GSE140440	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10757
4.9517134832522e-08	1.84666919796414	0.52	0.261	0.00138474667559148	TUBB2B	Malignant cells	GSE140440	ENSG00000137285	347733	tubulin beta 2B class IIb	bA506K6.1|DKFZp566F223|MGC8685	protein_coding	Q9BVA1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10758
4.98591801388146e-08	-1.24442350135567	0.72	0.881	0.00139431197258195	TOE1	Malignant cells	GSE140440	ENSG00000132773	114034	target of EGR1, exonuclease	hCaf1z|TOE-1	protein_coding	Q96GM8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10759
4.98817637278371e-08	-0.570462198693719	0.413	0.754	0.00139494352264896	RP5-1158E12.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10760
4.98966192800169e-08	1.4981201411077	0.92	0.918	0.00139535895816567	SASH1	Malignant cells	GSE140440	ENSG00000111961	23328	SAM and SH3 domain containing 1	dJ323M4.1|KIAA0790|SH3D6A	protein_coding	O94885	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10761
4.99686974113481e-08	0.501891687439425	1	1	0.00139737462310835	GPX4	Malignant cells	GSE140440	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10762
5.03859010789454e-08	-0.409566678344101	0.353	0.672	0.00140904172367271	SNORD19B	Malignant cells	GSE140440	ENSG00000238862	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10763
5.07456087740259e-08	-0.480301189881335	0.207	0.522	0.00141910094936563	HNRNPA1P33	Malignant cells	GSE140440	ENSG00000213412	728643	heterogeneous nuclear ribonucleoprotein A1 pseudogene 33	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10764
5.07835607319928e-08	0.785033230803855	1	1	0.00142016227587018	LINC00657	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10765
5.12632485141174e-08	-0.33606110292367	0.413	0.754	0.00143357674469729	PCDHA6	Malignant cells	GSE140440	ENSG00000081842	56142	protocadherin alpha 6	CNR2|CNRS2|CRNR2|PCDH-ALPHA6	protein_coding	Q9UN73	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10766
5.15232119458905e-08	0.741861631456993	0.933	0.739	0.00144084662206683	CTTNBP2NL	Malignant cells	GSE140440	ENSG00000143079	55917	CTTNBP2 N-terminal like	DKFZp547A023	protein_coding	Q9P2B4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10767
5.15736942785095e-08	1.96354476703452	0.667	0.418	0.00144225836049852	CEP162	Malignant cells	GSE140440	ENSG00000135315	22832	centrosomal protein 162	C6orf84|KIAA1009|QN1	protein_coding	Q5TB80	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10768
5.16851750899272e-08	0.250521379766721	0.353	0.716	0.00144537592138981	PPM1E	Malignant cells	GSE140440	ENSG00000175175	22843	protein phosphatase, Mg2+/Mn2+ dependent 1E	CaMKP-N|KIAA1072|POPX1|PP2CH	protein_coding	Q8WY54	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10769
5.18116065065777e-08	-0.442019099918378	0.96	1	0.00144891157595644	TNPO1	Malignant cells	GSE140440	ENSG00000083312	3842	transportin 1	IPO2|KPNB2|MIP|MIP1|TRN	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10770
5.21957007695389e-08	1.34618880992843	0.62	0.328	0.00145965277202015	KLF4	Malignant cells	GSE140440	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10771
5.22830598172067e-08	1.92131039510753	0.567	0.284	0.00146209576778819	CACNA2D1	Malignant cells	GSE140440	ENSG00000153956	781	calcium voltage-gated channel auxiliary subunit alpha2delta 1	alpha2delta-1|CACNA2|CACNL2A|LINC01112|lncRNA-N3|MHS3	protein_coding	P54289	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10772
5.24653505777403e-08	-0.546115590493056	0.987	0.993	0.00146719352890651	TYMS	Malignant cells	GSE140440	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10773
5.29984304407007e-08	0.853765321300914	0.98	0.94	0.0014821011072742	MPG	Malignant cells	GSE140440	ENSG00000103152	4350	N-methylpurine DNA glycosylase	MDG	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10774
5.3102425675794e-08	0.550023424857343	0.993	0.993	0.00148500933402358	NAPG	Malignant cells	GSE140440	ENSG00000134265	8774	NSF attachment protein gamma	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10775
5.33307337366974e-08	0.395365209878054	1	1	0.00149139396894674	MORF4L2	Malignant cells	GSE140440	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10776
5.34234714366226e-08	-0.278206717458044	0.207	0.53	0.00149398737872515	XXbac-BPG181B23.7	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10777
5.35546507787043e-08	3.03344350031007	0.587	0.328	0.00149765580902647	SHISA2	Malignant cells	GSE140440	ENSG00000180730	387914	shisa family member 2	bA398O19.2|C13orf13|hShisa|PRO28631|TMEM46|WGAR9166	protein_coding	Q6UWI4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10778
5.35708379980459e-08	2.29381485932778	0.527	0.254	0.00149810848461535	PDLIM3	Malignant cells	GSE140440	ENSG00000154553	27295	PDZ and LIM domain 3	ALP	protein_coding	Q53GG5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10779
5.36670923262843e-08	-0.787535208968903	0.66	0.918	0.00150080023690454	KLF5	Malignant cells	GSE140440	ENSG00000102554	688	KLF transcription factor 5	BTEB2|CKLF|IKLF	protein_coding	Q13887	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10780
5.51041904818383e-08	-3.5620518880978	0.193	0.448	0.00154098868682461	ABCC2	Malignant cells	GSE140440	ENSG00000023839	1244	ATP binding cassette subfamily C member 2	CMOAT|cMRP|DJS|MRP2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10781
5.51950871126685e-08	-0.551426607138172	0.38	0.716	0.00154353061110578	CTC-459F4.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10782
5.57552551937744e-08	0.603295559550592	1	0.985	0.0015591957114939	SDHA	Malignant cells	GSE140440	ENSG00000073578	6389	succinate dehydrogenase complex flavoprotein subunit A	FP|SDH2|SDHF	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10783
5.73469082599853e-08	-0.702976243069832	1	1	0.00160370628949049	NAA10	Malignant cells	GSE140440	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10784
5.77163522414342e-08	0.500563443354785	0.98	0.925	0.00161403779043171	C1orf123	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10785
5.83248693311276e-08	0.729406356517054	0.993	0.813	0.00163105497084498	COMMD8	Malignant cells	GSE140440	ENSG00000169019	54951	COMM domain containing 8	FLJ20502	protein_coding	Q9NX08	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10786
5.85596729714315e-08	1.509709306001	0.813	0.53	0.00163762125464608	ATRN	Malignant cells	GSE140440	ENSG00000088812	8455	attractin	DPPT-L|MGCA	protein_coding	O75882	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10787
5.90965427167202e-08	-1.36528976171534	0.373	0.657	0.00165263481707308	ZNF107	Malignant cells	GSE140440	ENSG00000196247	51427	zinc finger protein 107	smap-7|ZFD25|ZNF588	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10788
6.00084347551846e-08	1.89955477821623	0.907	0.784	0.00167813587792874	COL6A1	Malignant cells	GSE140440	ENSG00000142156	1291	collagen type VI alpha 1 chain	NA	protein_coding	P12109	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10789
6.00356134560414e-08	-1.62447014750374	0.333	0.649	0.0016788959302982	ZNF680	Malignant cells	GSE140440	ENSG00000173041	340252	zinc finger protein 680	FLJ90430	protein_coding	Q8NEM1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10790
6.05293650737518e-08	-0.865387043429019	0.367	0.701	0.00169270369428747	RPSAP6	Malignant cells	GSE140440	ENSG00000214629	NA	NA	AC022026.3|LAMR1P6	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10791
6.05684988928344e-08	-0.797625263948964	0.36	0.709	0.00169379807153812	RP11-474G23.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10792
6.1652431557327e-08	-0.789228204234385	0.98	0.993	0.00172411024850065	SLC52A2	Malignant cells	GSE140440	ENSG00000285112	79581	solute carrier family 52 member 2	D15Ertd747e|FLJ11856|GPCR41|GPR172A|hRFT3|PAR1|RFVT2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10793
6.24319191245556e-08	-0.732818724277734	0.293	0.619	0.0017459086183182	CCDC40	Malignant cells	GSE140440	ENSG00000141519	55036	coiled-coil domain containing 40	CFAP172|CILD15|FAP172|FLJ20753|FLJ32021|KIAA1640	protein_coding	Q4G0X9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10794
6.25455553370688e-08	-0.35110254175679	0.213	0.537	0.00174908645500113	TMTC2	Malignant cells	GSE140440	ENSG00000179104	160335	transmembrane O-mannosyltransferase targeting cadherins 2	DKFZp762A217	protein_coding	Q8N394	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10795
6.28795707463766e-08	-0.295623770535454	0.4	0.754	0.00175842719592242	FAM66B	Malignant cells	GSE140440	ENSG00000280677	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10796
6.30778613866122e-08	0.877109964607541	0.98	0.94	0.00176397239367661	INO80C	Malignant cells	GSE140440	ENSG00000153391	125476	INO80 complex subunit C	C18orf37|FLJ38183|hIes6|IES6	protein_coding	Q6PI98	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10797
6.32710312385677e-08	0.744470673104718	0.833	0.604	0.00176937438858654	COL4A1	Malignant cells	GSE140440	ENSG00000187498	1282	collagen type IV alpha 1 chain	NA	protein_coding	P02462	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10798
6.35945027590289e-08	-0.46319723241916	0.36	0.709	0.00177842026965624	ENOX1	Malignant cells	GSE140440	ENSG00000120658	55068	ecto-NOX disulfide-thiol exchanger 1	cCNOX|CNOX|FLJ10094|PIG38	protein_coding	Q8TC92	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10799
6.47644254555878e-08	0.446942112212104	1	0.993	0.00181113715786551	DCTN2	Malignant cells	GSE140440	ENSG00000175203	10540	dynactin subunit 2	DCTN-50|RBP50	protein_coding	Q13561	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10800
6.48282111380232e-08	0.765904728689132	0.98	0.963	0.00181292092447482	NFS1	Malignant cells	GSE140440	ENSG00000244005	9054	NFS1 cysteine desulfurase	IscS|NifS	protein_coding	Q9Y697	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10801
6.58109210488187e-08	-0.56428376995333	0.227	0.545	0.00184040240713021	NT5DC4	Malignant cells	GSE140440	ENSG00000144130	284958	5'-nucleotidase domain containing 4	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10802
6.58632094422812e-08	-1.25418565626861	0.147	0.425	0.00184186465205339	ANO9	Malignant cells	GSE140440	ENSG00000185101	338440	anoctamin 9	PIG5|TMEM16J|TP53I5	protein_coding	A1A5B4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10803
6.63205006557332e-08	-1.25116746470569	0.3	0.604	0.00185465280083758	AC009005.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10804
6.66056142608038e-08	-0.496879046795719	0.873	0.963	0.00186262600280338	CDK1	Malignant cells	GSE140440	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10805
6.69859688426937e-08	1.17281590853556	0.72	0.455	0.00187326261868593	SCAMP1-AS1	Malignant cells	GSE140440	ENSG00000245556	728769	SCAMP1 antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10806
6.72562859323197e-08	-1.26652491241041	0.373	0.694	0.00188082203609732	ADRA1D	Malignant cells	GSE140440	ENSG00000171873	146	adrenoceptor alpha 1D	ADRA1|ADRA1A|ADRA1R	protein_coding	P25100	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10807
6.74936369542739e-08	2.05889054421081	0.713	0.373	0.00188745955742627	TP53INP2	Malignant cells	GSE140440	ENSG00000078804	58476	tumor protein p53 inducible nuclear protein 2	C20orf110|dJ1181N3.1|DKFZp434B2411|DKFZp434O0827|DOR|FLJ21759|FLJ23500|PINH	protein_coding	Q8IXH6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10808
6.7544622664641e-08	-0.373374261391726	0.46	0.776	0.00188888537281669	MT-TL2	Malignant cells	GSE140440	ENSG00000210191	NA	NA	MTTL2|TRNL2	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10809
6.81946674781433e-08	-0.429162482333767	0.133	0.425	0.00190706387602628	FAM83A-AS1	Malignant cells	GSE140440	ENSG00000204949	100131726	FAM83A antisense RNA 1	HCCC11	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10810
6.83978617197242e-08	1.18823807025124	0.827	0.575	0.00191274620299209	MIPEP	Malignant cells	GSE140440	ENSG00000027001	4285	mitochondrial intermediate peptidase	MIP	protein_coding	Q99797	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10811
6.85252268657455e-08	-0.974883412103766	0.513	0.828	0.00191630796930057	CCDC138	Malignant cells	GSE140440	ENSG00000163006	165055	coiled-coil domain containing 138	FLJ32745	protein_coding	Q96M89	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10812
6.85529133304295e-08	-0.840801405150746	0.067	0.306	0.00191708222128546	CTD-2139B15.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10813
6.91313314042376e-08	-0.678494490400238	0.393	0.709	0.0019332576827195	CTD-3035K23.7	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10814
7.05656929066642e-08	-1.09495836912843	0.34	0.649	0.00197336960213486	CNNM1	Malignant cells	GSE140440	ENSG00000119946	26507	cyclin and CBS domain divalent metal cation transport mediator 1	ACDP1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10815
7.09285173993419e-08	1.85047546861509	0.553	0.276	0.0019835159890726	DNAJC12	Malignant cells	GSE140440	ENSG00000108176	56521	DnaJ heat shock protein family (Hsp40) member C12	JDP1	protein_coding	Q9UKB3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10816
7.1493632871724e-08	2.60778865383912	0.473	0.209	0.00199931944325776	SEPT3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10817
7.15545501208908e-08	-1.59871540383714	0.44	0.724	0.00200102299413071	CCNE2	Malignant cells	GSE140440	ENSG00000175305	9134	cyclin E2	CYCE2	protein_coding	O96020	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10818
7.1905475571395e-08	-0.375723223372307	0.42	0.784	0.00201083662435406	RP11-417L19.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10819
7.24603447374724e-08	0.783950801182601	1	1	0.00202635354058342	LRP10	Malignant cells	GSE140440	ENSG00000197324	26020	LDL receptor related protein 10	DKFZP564C1940|LRP9|MGC8675|MST087|MSTP087	protein_coding	Q7Z4F1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10820
7.3510028743048e-08	-0.815732783059986	0.427	0.761	0.00205570795379934	RP11-15E18.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10821
7.39502332854344e-08	0.896600102423339	0.927	0.791	0.00206801827382717	ADAL	Malignant cells	GSE140440	ENSG00000168803	161823	adenosine deaminase like	NA	protein_coding	Q6DHV7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10822
7.40989302652647e-08	0.5127717374003	1	0.993	0.00207217658486813	FKBP8	Malignant cells	GSE140440	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10823
7.42576629328455e-08	-1.01131870673107	0.78	0.903	0.00207661554391703	SVIL-AS1	Malignant cells	GSE140440	ENSG00000224597	NA	NA	RP11-534G20.3	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10824
7.45692437201853e-08	-0.535836318851034	0.38	0.709	0.00208532890063498	AC005592.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10825
7.47901656214796e-08	1.57484341682319	0.627	0.358	0.00209150698160468	GPR137B	Malignant cells	GSE140440	ENSG00000077585	7107	G protein-coupled receptor 137B	TM7SF1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10826
7.51216973460245e-08	-0.603116730490081	0.893	0.993	0.00210077826628157	FEN1	Malignant cells	GSE140440	ENSG00000168496	2237	flap structure-specific endonuclease 1	FEN-1|MF1|RAD2	protein_coding	P39748	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10827
7.54248224073049e-08	-1.75609224515646	0.46	0.761	0.00210925515862028	ASS1	Malignant cells	GSE140440	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10828
7.54641547463615e-08	-0.923466608089655	0.9	0.94	0.002110355087482	HSPA14	Malignant cells	GSE140440	ENSG00000187522	51182	heat shock protein family A (Hsp70) member 14	HSP70-4|HSP70L1	protein_coding	Q0VDF9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10829
7.66925202663693e-08	-0.901448065308066	0.387	0.724	0.00214470632924902	RP11-120D5.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10830
7.68192184626359e-08	-1.31607631307229	0.94	0.963	0.00214824944430761	DIAPH1	Malignant cells	GSE140440	ENSG00000131504	1729	diaphanous related formin 1	DFNA1|hDIA1|LFHL1|mDia1	protein_coding	O60610	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10831
7.69652781232674e-08	-2.47179230014599	0.387	0.575	0.00215233400271717	IGFBP5	Malignant cells	GSE140440	ENSG00000115461	3488	insulin like growth factor binding protein 5	NA	protein_coding	P24593	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10832
7.70529392479792e-08	0.923316997502904	0.693	0.373	0.00215478544606974	TIAM1	Malignant cells	GSE140440	ENSG00000156299	7074	TIAM Rac1 associated GEF 1	NA	protein_coding	Q13009	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10833
7.72737148147227e-08	-0.360808464031133	0.313	0.627	0.00216095943479372	CRIP3	Malignant cells	GSE140440	ENSG00000146215	401262	cysteine rich protein 3	bA480N24.2|TLP|TLP-A	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10834
7.84674744495401e-08	-0.425763905871902	0.553	0.806	0.00219434292298139	HSP90AB2P	Malignant cells	GSE140440	ENSG00000205940	NA	NA	HSP90BB	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10835
7.94169420253249e-08	-1.0519300506748	0.9	0.97	0.00222089478373821	SLC39A4	Malignant cells	GSE140440	ENSG00000285243	55630	solute carrier family 39 member 4	AEZ|AWMS2|ZIP4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10836
7.94377625693882e-08	-1.14845610536032	0.76	0.918	0.00222147703025294	LARP4B	Malignant cells	GSE140440	ENSG00000107929	23185	La ribonucleoprotein 4B	KIAA0217|LARP5	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10837
7.94881917009587e-08	-0.793045450731015	0.92	0.955	0.00222288728091731	PPIH	Malignant cells	GSE140440	ENSG00000171960	10465	peptidylprolyl isomerase H	CYP-20|CYPH|MGC5016|SnuCyp-20|USA-CYP	protein_coding	O43447	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10838
7.95832132591931e-08	-0.703297881400812	0.387	0.716	0.00222554455879333	SEPT7P1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10839
7.97126008183848e-08	0.659421915533612	0.973	0.888	0.00222916288188613	SAT2	Malignant cells	GSE140440	ENSG00000141504	112483	spermidine/spermine N1-acetyltransferase family member 2	SSAT2	protein_coding	Q96F10	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10840
7.97572707899091e-08	-0.606349064483044	1	0.993	0.00223041207763981	PNKD	Malignant cells	GSE140440	ENSG00000127838	25953	PNKD metallo-beta-lactamase domain containing	BRP17|DKFZp564N1362|DYT8|FKSG19|FPD1|KIAA1184|KIPP1184|MGC31943|MR-1|MR-1S|PDC|PKND1|TAHCCP2	protein_coding	Q8N490	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10841
7.99017160940244e-08	-1.49232225697654	0.36	0.664	0.00223445149056939	ARMC3	Malignant cells	GSE140440	ENSG00000165309	219681	armadillo repeat containing 3	CT81|FLJ32827	protein_coding	Q5W041	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10842
8.01142289500562e-08	2.70458898428218	0.793	0.627	0.00224039441258832	IRS2	Malignant cells	GSE140440	ENSG00000185950	8660	insulin receptor substrate 2	NA	protein_coding	Q9Y4H2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10843
8.11407433363597e-08	1.02318408839839	0.887	0.694	0.0022691008874013	GNAL	Malignant cells	GSE140440	ENSG00000141404	2774	G protein subunit alpha L	NA	protein_coding	P38405	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10844
8.14718465548237e-08	-0.59214555612814	0.587	0.858	0.00227836018890564	SPC25	Malignant cells	GSE140440	ENSG00000277909	57405	SPC25 component of NDC80 kinetochore complex	AD024|MGC22228|SPBC25	protein_coding	Q9HBM1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10845
8.15536015916369e-08	-0.600850612429993	0.207	0.507	0.00228064646851013	SPG20-AS1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10846
8.20326611298877e-08	2.50886008527607	0.487	0.254	0.00229404336849731	SNCB	Malignant cells	GSE140440	ENSG00000074317	6620	synuclein beta	NA	protein_coding	Q16143	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10847
8.20929646086801e-08	-0.635047650209998	0.98	0.993	0.00229572975528174	GPATCH4	Malignant cells	GSE140440	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10848
8.2380756213711e-08	0.711765743955141	0.967	0.896	0.00230377784751643	PRRC1	Malignant cells	GSE140440	ENSG00000164244	133619	proline rich coiled-coil 1	FLJ32875	protein_coding	Q96M27	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10849
8.24673010919365e-08	0.796063537261669	0.86	0.507	0.002306198075036	LYST	Malignant cells	GSE140440	ENSG00000143669	1130	lysosomal trafficking regulator	CHS|CHS1|Mauve	protein_coding	Q99698	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10850
8.28677228455467e-08	0.835833552591217	0.893	0.642	0.00231739586937571	PQLC3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10851
8.30010340601749e-08	1.39002338803854	0.76	0.545	0.00232112391749279	ST6GALNAC4	Malignant cells	GSE140440	ENSG00000136840	27090	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	SIAT3C|SIAT7D|ST6GALNACIV	protein_coding	Q9H4F1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10852
8.3338538576686e-08	0.772601072404164	0.973	0.963	0.00233056223129702	FCGRT	Malignant cells	GSE140440	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10853
8.39039574167828e-08	0.786470290010155	0.813	0.552	0.00234637416916033	ZSWIM6	Malignant cells	GSE140440	ENSG00000130449	57688	zinc finger SWIM-type containing 6	KIAA1577	protein_coding	Q9HCJ5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10854
8.40943329489529e-08	-0.63803727506227	1	1	0.00235169802091747	MRPL55	Malignant cells	GSE140440	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10855
8.4437035225648e-08	2.63216863108028	0.6	0.351	0.00236128169008525	GK	Malignant cells	GSE140440	ENSG00000198814	2710	glycerol kinase	GK1|GKD	protein_coding	P32189	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10856
8.45978316850017e-08	1.44267578131347	0.793	0.515	0.00236577836307107	GFPT2	Malignant cells	GSE140440	ENSG00000131459	9945	glutamine-fructose-6-phosphate transaminase 2	GFAT2	protein_coding	O94808	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10857
8.51818604979204e-08	-0.421365441974385	0.167	0.463	0.00238211072882434	CCDC183-AS1	Malignant cells	GSE140440	ENSG00000228544	100131193	CCDC183 antisense RNA 1	KIAA1984-AS1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10858
8.56815582260391e-08	-0.345593557187919	0.387	0.724	0.00239608477579118	RP11-124N14.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10859
8.62061552903686e-08	0.650793067026722	0.953	0.858	0.00241075513269516	VEGFB	Malignant cells	GSE140440	ENSG00000173511	7423	vascular endothelial growth factor B	VEGFL|VRF	protein_coding	P49765	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10860
8.6503920813341e-08	-0.288737384950214	0.58	0.858	0.00241908214554508	RPL7P6	Malignant cells	GSE140440	ENSG00000227525	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10861
8.68891936097494e-08	1.37129408037324	0.68	0.448	0.00242985629929664	DNAAF3	Malignant cells	GSE140440	ENSG00000167646	352909	dynein axonemal assembly factor 3	C19orf51|CILD2|FLJ36139|FLJ40069|PCD|PF22	protein_coding	Q8N9W5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10862
8.77504843799395e-08	-0.882222795377209	0.653	0.828	0.00245394229568501	HJURP	Malignant cells	GSE140440	ENSG00000123485	55355	Holliday junction recognition protein	DKFZp762E1312|FAKTS|hFLEG1|URLC9	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10863
8.78982202519738e-08	-0.721117128397469	0.573	0.791	0.00245807372934645	MYLK3	Malignant cells	GSE140440	ENSG00000140795	91807	myosin light chain kinase 3	caMLCK|MLCK	protein_coding	Q32MK0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10864
9.00748500593784e-08	0.738280704840616	0.927	0.813	0.00251894318191052	EFHC1	Malignant cells	GSE140440	ENSG00000096093	114327	EF-hand domain containing 1	EJM|EJM1|FLJ10466|POC9|RIB72	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10865
9.04629699483666e-08	1.35098624091821	0.8	0.597	0.00252979695460607	LAMA3	Malignant cells	GSE140440	ENSG00000053747	3909	laminin subunit alpha 3	BM600-150kDa|epiligrin|kalinin-165kDa|LAMNA|nicein-150kDa	protein_coding	Q16787	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10866
9.04635779701957e-08	-0.513760386869731	0.513	0.776	0.00252981395793652	RP11-556N4.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10867
9.31305237856911e-08	-0.671172979933322	0.827	0.97	0.00260439509766685	MYBL2	Malignant cells	GSE140440	ENSG00000101057	4605	MYB proto-oncogene like 2	B-MYB|BMYB	protein_coding	P10244	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10868
9.34698604694574e-08	-0.405919094475031	0.447	0.739	0.00261388464802838	RP11-162A12.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10869
9.40321734154695e-08	-1.34607501724274	0.807	0.948	0.00262960972956361	NR2F6	Malignant cells	GSE140440	ENSG00000160113	2063	nuclear receptor subfamily 2 group F member 6	EAR-2|EAR2|ERBAL2	protein_coding	P10588	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10870
9.40809442354013e-08	-0.561278876528383	0.413	0.746	0.002630973605543	RP3-323P24.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10871
9.42319383560712e-08	-0.355374577980505	0.56	0.873	0.00263519615612753	FTH1P2	Malignant cells	GSE140440	ENSG00000285319	NA	NA	FTHL2	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10872
9.46681785410865e-08	-0.377386272594951	0.233	0.537	0.00264739561290148	WDR45BP1	Malignant cells	GSE140440	ENSG00000265574	NA	NA	WDR45LP1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10873
9.51807802650762e-08	-0.515864560391045	0.387	0.724	0.00266173052011286	RP11-981P6.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10874
9.5473511370261e-08	-1.01326860115551	0.56	0.784	0.00266991674546935	PTAFR	Malignant cells	GSE140440	ENSG00000169403	5724	platelet activating factor receptor	NA	protein_coding	P25105	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10875
9.56148995319402e-08	-1.13327661425114	0.693	0.851	0.00267387066541071	C14orf80	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10876
9.59609989827868e-08	-0.351659162481516	0.507	0.828	0.00268354933655363	HSPA8P5	Malignant cells	GSE140440	ENSG00000256356	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10877
9.63478070089535e-08	-0.658685642944208	0.993	1	0.00269436642300539	GCLM	Malignant cells	GSE140440	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10878
9.67980499201482e-08	-1.97669093640359	0.56	0.761	0.00270695746601694	SAP30L-AS1	Malignant cells	GSE140440	ENSG00000245275	386627	SAP30L antisense RNA 1 (head to head)	FLJ38109|GALNT10-AS1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10879
9.71209021524507e-08	1.81639177028598	0.533	0.224	0.00271598602869328	TRIM36	Malignant cells	GSE140440	ENSG00000152503	55521	tripartite motif containing 36	HAPRIN|RBCC728|RNF98	protein_coding	Q9NQ86	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10880
9.77491758962027e-08	0.75052806496146	0.533	0.231	0.00273355570393731	NFATC2	Malignant cells	GSE140440	ENSG00000101096	4773	nuclear factor of activated T cells 2	NF-ATP|NFAT1|NFATp	protein_coding	Q13469	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10881
9.78202114453459e-08	1.54737475396053	0.56	0.291	0.0027355422130691	HOXC8	Malignant cells	GSE140440	ENSG00000037965	3224	homeobox C8	HOX3|HOX3A	protein_coding	P31273	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10882
9.78504494672603e-08	1.00503412603035	0.993	0.993	0.00273638781935193	SNTB2	Malignant cells	GSE140440	ENSG00000260873	6645	syntrophin beta 2	D16S2531E|EST25263|SNT2B2|SNT3|SNTL	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10883
9.81279332757136e-08	0.611369169166561	0.993	0.925	0.00274414765405533	SMARCB1	Malignant cells	GSE140440	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10884
9.86285152074867e-08	-2.90887452097871	0.467	0.59	0.00275814642777737	PGM5P4-AS1	Malignant cells	GSE140440	ENSG00000231943	103344932	PGM5P4 antisense RNA 1	FAM233C	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10885
9.86292199234606e-08	-0.309570888367379	0.073	0.328	0.00275816613515958	ANXA8L1	Malignant cells	GSE140440	ENSG00000264230	728113	annexin A8 like 1	ANXA8L2|bA145E20.2|bA301J7.3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10886
9.89739608134553e-08	-0.654582596367783	0.2	0.493	0.00276780681414828	SH2D6	Malignant cells	GSE140440	ENSG00000152292	284948	SH2 domain containing 6	FLJ35993|SLNK	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10887
9.9974536359421e-08	-1.48934167384829	0.333	0.612	0.00279578790929121	POMK	Malignant cells	GSE140440	ENSG00000185900	84197	protein O-mannose kinase	FLJ23356|SgK196	protein_coding	Q9H5K3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10888
1.00007662755144e-07	-2.44882951578984	0.453	0.679	0.00279671428894761	RHBDL2	Malignant cells	GSE140440	ENSG00000158315	54933	rhomboid like 2	FLJ20435	protein_coding	Q9NX52	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10889
1.00620065412378e-07	0.509578133367182	1	0.985	0.00281384012925716	RNF130	Malignant cells	GSE140440	ENSG00000113269	55819	ring finger protein 130	G1RZFP|GOLIATH|GP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10890
1.01413298252589e-07	0.983461928764805	0.927	0.716	0.00283602288563365	MID1	Malignant cells	GSE140440	ENSG00000101871	4281	midline 1	FXY|OS|RNF59|TRIM18	protein_coding	O15344	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10891
1.01476196841662e-07	-0.346211128442814	1	1	0.00283778184467707	BTF3	Malignant cells	GSE140440	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10892
1.02152686563129e-07	-0.270023513210017	0.42	0.754	0.0028566998797379	SMG1P4	Malignant cells	GSE140440	ENSG00000185710	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10893
1.03665658736922e-07	-0.311592885952591	0.52	0.799	0.00289901014657802	HSP90AA4P	Malignant cells	GSE140440	ENSG00000281610	NA	NA	HSPCAL2	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10894
1.04178520146782e-07	0.596891461827681	0.987	0.925	0.00291335231590475	ABRACL	Malignant cells	GSE140440	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10895
1.04749540004183e-07	-0.459992345806391	1	1	0.00292932088621698	SSB	Malignant cells	GSE140440	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10896
1.0475764822888e-07	-0.360344453752892	0.987	1	0.00292954763272063	RPL12P38	Malignant cells	GSE140440	ENSG00000213228	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10897
1.04981810713524e-07	3.88217585073636	0.66	0.47	0.00293581633660369	KCNN3	Malignant cells	GSE140440	ENSG00000143603	3782	potassium calcium-activated channel subfamily N member 3	hSK3|KCa2.3|SKCA3	protein_coding	Q9UGI6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10898
1.05165975755346e-07	1.60053161039675	0.773	0.448	0.00294096651199826	FAM102B	Malignant cells	GSE140440	ENSG00000162636	284611	family with sequence similarity 102 member B	DKFZp779B126|SYM-3B	protein_coding	Q5T8I3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10899
1.06012479494224e-07	0.446969542991864	1	1	0.00296463898905598	ZCRB1	Malignant cells	GSE140440	ENSG00000139168	85437	zinc finger CCHC-type and RNA binding motif containing 1	MADP-1|MADP1|RBM36|SNRNP31|ZCCHC19	protein_coding	Q8TBF4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10900
1.06244794341044e-07	0.576206800176173	1	0.903	0.0029711356737473	PPP1R11	Malignant cells	GSE140440	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10901
1.06270722636518e-07	-0.983044475133103	0.5	0.813	0.00297186075853021	TTK	Malignant cells	GSE140440	ENSG00000112742	7272	TTK protein kinase	CT96|MPH1|MPS1|MPS1L1	protein_coding	P33981	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10902
1.06317418075244e-07	0.799973747594157	0.86	0.709	0.00297316659647419	OCEL1	Malignant cells	GSE140440	ENSG00000099330	79629	occludin/ELL domain containing 1	FLJ22709	protein_coding	Q9H607	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10903
1.06536755394295e-07	-0.507457464298608	0.44	0.754	0.00297930036460146	SNORA68	Malignant cells	GSE140440	ENSG00000207166	26780	small nucleolar RNA, H/ACA box 68	RNU68|SNORA68A|U68	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10904
1.06728324694906e-07	-0.377935380781287	0.48	0.769	0.00298465760009305	ADH1B	Malignant cells	GSE140440	ENSG00000196616	125	alcohol dehydrogenase 1B (class I), beta polypeptide	ADH2	protein_coding	P00325	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10905
1.06762778370451e-07	0.684546239273188	0.887	0.679	0.00298562109712966	PIGUP1	Malignant cells	GSE140440	ENSG00000224437	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10906
1.08274027397449e-07	1.16934169667822	0.86	0.634	0.00302788317616965	CNTNAP3	Malignant cells	GSE140440	ENSG00000106714	79937	contactin associated protein family member 3	CASPR3|CNTNAP3A|FLJ14195|KIAA1714	protein_coding	Q9BZ76	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10907
1.08795111502828e-07	0.907255390610753	0.86	0.746	0.00304245529317659	SCRN3	Malignant cells	GSE140440	ENSG00000144306	79634	secernin 3	FLJ23142	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10908
1.09781466825751e-07	-1.04848638139629	0.633	0.851	0.00307003871978213	CEP55	Malignant cells	GSE140440	ENSG00000138180	55165	centrosomal protein 55	C10orf3|CT111|FLJ10540	protein_coding	Q53EZ4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10909
1.12006496398405e-07	-1.25807737662559	0.073	0.313	0.00313226167178139	CTB-176F20.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10910
1.12148590293098e-07	1.28720260700113	0.84	0.731	0.00313623532754649	ADD3	Malignant cells	GSE140440	ENSG00000148700	120	adducin 3	ADDL	protein_coding	Q9UEY8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10911
1.13322966213752e-07	1.00099665749043	0.933	0.813	0.00316907675016756	PXK	Malignant cells	GSE140440	ENSG00000168297	54899	PX domain containing serine/threonine kinase like	FLJ20335|Slob	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10912
1.13356605259051e-07	0.883491575673946	0.94	0.739	0.00317001746606937	RAD17	Malignant cells	GSE140440	ENSG00000276618	5884	RAD17 checkpoint clamp loader component	CCYC|RAD17Sp|Rad24	protein_coding	O75943	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10913
1.14587826598592e-07	-0.320270777024588	0.367	0.687	0.00320444857082962	PRLHR	Malignant cells	GSE140440	ENSG00000119973	2834	prolactin releasing hormone receptor	GPR10|PrRPR	protein_coding	P49683	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10914
1.14626214094612e-07	0.854108658244797	0.987	0.97	0.00320552207715583	FAM126A	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10915
1.15146517630961e-07	0.552616052024343	0.973	0.731	0.00322007236554982	GPS2P1	Malignant cells	GSE140440	ENSG00000236496	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10916
1.15827244192739e-07	-1.16658182553372	0.147	0.425	0.00323910888384996	MSC-AS1	Malignant cells	GSE140440	ENSG00000235531	100132891	MSC antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10917
1.16977049181975e-07	-0.895794238770597	0.913	0.963	0.00327126318037393	WDR46	Malignant cells	GSE140440	ENSG00000226916	9277	WD repeat domain 46	BING4|C6orf11|UTP7	protein_coding	O15213	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10918
1.17490365513268e-07	-0.435923772092124	0.453	0.806	0.00328561807157853	CH507-42P11.8	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10919
1.17827612812368e-07	3.05820848153417	0.913	0.806	0.00329504919229788	SLC25A40	Malignant cells	GSE140440	ENSG00000075303	55972	solute carrier family 25 member 40	MCFP	protein_coding	Q8TBP6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10920
1.17862768008818e-07	-0.854925224084292	0.2	0.5	0.00329603230736661	GDI2P2	Malignant cells	GSE140440	ENSG00000233994	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10921
1.17868902353932e-07	0.947920838756704	0.787	0.515	0.00329620385432771	ROBO3	Malignant cells	GSE140440	ENSG00000154134	64221	roundabout guidance receptor 3	FLJ21044|HGPPS|HGPS|RBIG1	protein_coding	Q96MS0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10922
1.18671130514074e-07	3.95402274622389	0.527	0.276	0.00331863816482608	CNTNAP2	Malignant cells	GSE140440	ENSG00000278728	26047	contactin associated protein 2	Caspr2|KIAA0868|NRXN4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10923
1.19391368165428e-07	2.01144764767223	0.993	0.985	0.00333877961074619	CMTM7	Malignant cells	GSE140440	ENSG00000153551	112616	CKLF like MARVEL transmembrane domain containing 7	CKLFSF7|FLJ30992	protein_coding	Q96FZ5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10924
1.19391821167611e-07	0.794701780513341	1	1	0.00333879227895223	DYNLRB1	Malignant cells	GSE140440	ENSG00000125971	83658	dynein light chain roadblock-type 1	DNCL2A|DNLC2A|ROBLD1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10925
1.20910712232778e-07	0.494550603469477	0.98	0.851	0.00338126806758964	STX5	Malignant cells	GSE140440	ENSG00000162236	6811	syntaxin 5	SED5|STX5A	protein_coding	Q13190	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10926
1.20970929817359e-07	2.68723159339736	0.473	0.201	0.00338295205234245	AADACP1	Malignant cells	GSE140440	ENSG00000240602	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10927
1.21414696700672e-07	-0.781166705310353	0.413	0.724	0.0033953619932343	MIR663AHG	Malignant cells	GSE140440	ENSG00000227195	284801	MIR663A host gene	RP3-410C9.1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10928
1.21924203596637e-07	-0.441883571235179	0.54	0.799	0.00340961035357996	SLC30A2	Malignant cells	GSE140440	ENSG00000158014	7780	solute carrier family 30 member 2	ZNT2	protein_coding	Q9BRI3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10929
1.2338123541577e-07	1.15093407438252	0.887	0.664	0.00345035624840202	C16orf52	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10930
1.23426005769468e-07	0.68620121722053	0.967	0.896	0.00345160825134318	RMND5A	Malignant cells	GSE140440	ENSG00000153561	64795	required for meiotic nuclear division 5 homolog A	FLJ13910|GID2|GID2A|p44CTLH|RMD5	protein_coding	Q9H871	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10931
1.2426560549304e-07	-0.339468187071143	0.353	0.679	0.00347508765761286	RP11-73K9.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10932
1.24554378850597e-07	0.625225031268503	0.893	0.522	0.00348316320455694	LRRCC1	Malignant cells	GSE140440	ENSG00000133739	85444	leucine rich repeat and coiled-coil centrosomal protein 1	CLERC|KIAA1764|VFL1	protein_coding	Q9C099	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10933
1.24725034415549e-07	0.539912113232807	1	0.993	0.00348793558743081	ATF4	Malignant cells	GSE140440	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10934
1.24740716663884e-07	0.481939246807316	0.773	0.485	0.00348837414150551	RP11-262H14.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10935
1.25170388243828e-07	-0.638097068411438	1	1	0.00350038990723864	ABCF1	Malignant cells	GSE140440	ENSG00000225989	23	ATP binding cassette subfamily F member 1	ABC50|EST123147	protein_coding	Q8NE71	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10936
1.25194897994085e-07	1.03722206865662	0.953	0.806	0.00350107532240459	ZNF33B	Malignant cells	GSE140440	ENSG00000196693	7582	zinc finger protein 33B	KOX2|KOX31|ZNF11B	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10937
1.26813690856136e-07	1.00164453249027	0.833	0.672	0.00354634486479183	RP11-660L16.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10938
1.27178146552613e-07	0.50649097596639	1	0.993	0.00355653686834383	RALY	Malignant cells	GSE140440	ENSG00000125970	22913	RALY heterogeneous nuclear ribonucleoprotein	HNRPCL2|P542	protein_coding	Q9UKM9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10939
1.27296711268937e-07	-1.04187510516372	0.207	0.515	0.00355985253063583	RP11-613D13.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10940
1.27582454903803e-07	-0.546058139589614	0.327	0.634	0.00356784335138485	RP11-628M2.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10941
1.28420232596152e-07	-1.03645323171143	0.34	0.627	0.00359127180455139	RP11-273G15.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10942
1.28541466431203e-07	-0.488773703397703	0.427	0.761	0.0035946621087486	RPGRIP1	Malignant cells	GSE140440	ENSG00000092200	57096	RPGR interacting protein 1	CORD13|LCA6|RGI1|RPGRIP	protein_coding	Q96KN7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10943
1.28890033229919e-07	-0.347872246768674	0.547	0.821	0.00360440977927468	RP11-383M4.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10944
1.29241905201066e-07	-0.477116709323777	1	1	0.0036142498789478	MTCH2	Malignant cells	GSE140440	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10945
1.29933684649506e-07	-1.24622949571178	0.127	0.396	0.00363359549122345	FAM155A-IT1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10946
1.3140904829475e-07	-0.504895066505657	0.413	0.724	0.00367485403556268	RAPGEFL1	Malignant cells	GSE140440	ENSG00000108352	51195	Rap guanine nucleotide exchange factor like 1	Link-GEFII	protein_coding	Q9UHV5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10947
1.31739710596721e-07	0.654527002591612	1	0.993	0.0036841010068373	CARD19	Malignant cells	GSE140440	ENSG00000165233	84270	caspase recruitment domain family member 19	bA370F5.1|BinCARD|C9orf89|MGC11115	protein_coding	Q96LW7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10948
1.31828623643524e-07	0.426338482878235	1	1	0.00368658746019114	YWHAB	Malignant cells	GSE140440	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10949
1.32663490967823e-07	1.43673257037816	0.567	0.306	0.00370993452491517	TCF7L1	Malignant cells	GSE140440	ENSG00000152284	83439	transcription factor 7 like 1	TCF3	protein_coding	Q9HCS4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10950
1.32721666068612e-07	0.62870647127152	0.993	0.933	0.00371156139160872	CH17-13I23.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10951
1.34381385077447e-07	0.446803174799864	0.993	0.985	0.00375797543369081	CFAP36	Malignant cells	GSE140440	ENSG00000163001	112942	cilia and flagella associated protein 36	BARTL1|CCDC104|MGC15407	protein_coding	Q96G28	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10952
1.34448171861994e-07	-0.419038712464694	1	1	0.00375984312612067	FKBP3	Malignant cells	GSE140440	ENSG00000100442	2287	FKBP prolyl isomerase 3	FKBP-25|FKBP25	protein_coding	Q00688	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10953
1.34536910577322e-07	-1.0086520783552	0.4	0.694	0.0037623247042948	RP13-516M14.8	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10954
1.35057535423083e-07	1.09256594752284	0.867	0.806	0.00377688397810651	AC093673.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10955
1.35264394660689e-07	-0.862040201525085	0.553	0.754	0.00378266879668617	RP4-675C20.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10956
1.35807670762912e-07	1.05057619108645	0.88	0.679	0.00379786151288485	BTRC	Malignant cells	GSE140440	ENSG00000166167	8945	beta-transducin repeat containing E3 ubiquitin protein ligase	beta-TrCP1|betaTrCP|bTrCP|bTrCP1|FBXW1A|Fwd1	protein_coding	Q9Y297	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10957
1.36263784064638e-07	-0.529645049698781	0.267	0.582	0.00381061672136759	PODNL1	Malignant cells	GSE140440	ENSG00000288195	79883	podocan like 1	FLJ23447|SLRR5B	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10958
1.36560383902336e-07	-1.2086906713446	0.333	0.664	0.00381891113582881	MND1	Malignant cells	GSE140440	ENSG00000121211	84057	meiotic nuclear divisions 1	GAJ	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10959
1.37080972822013e-07	-2.18317100829733	0.633	0.776	0.0038334694049676	TONSL	Malignant cells	GSE140440	ENSG00000160949	4796	tonsoku like, DNA repair protein	IKBR|NFKBIL2	protein_coding	Q96HA7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10960
1.37700802104049e-07	4.19667330026792	0.433	0.194	0.00385080293083974	PELI2	Malignant cells	GSE140440	ENSG00000139946	57161	pellino E3 ubiquitin protein ligase family member 2	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10961
1.37908418895687e-07	-0.749629805000757	0.313	0.642	0.00385660893441787	ADAM11	Malignant cells	GSE140440	ENSG00000073670	4185	ADAM metallopeptidase domain 11	MDC	protein_coding	O75078	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10962
1.38209441185773e-07	-0.457421441071219	1	1	0.00386502702276014	RPS27A	Malignant cells	GSE140440	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10963
1.38661244355966e-07	-0.709937078763846	0.447	0.769	0.00387766169841458	RP11-582J16.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10964
1.38672830743706e-07	-0.844302701460567	1	1	0.00387798571174773	NSA2	Malignant cells	GSE140440	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10965
1.38781693853057e-07	0.927635256395459	0.967	0.888	0.00388103006860073	CORO1B	Malignant cells	GSE140440	ENSG00000172725	57175	coronin 1B	coronin-2	protein_coding	Q9BR76	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10966
1.39840322640028e-07	-1.42680895846442	0.873	0.91	0.00391063462262839	CTC-425O23.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10967
1.39915304680021e-07	-0.915732951940086	0.9	0.955	0.00391273149537679	VSTM4	Malignant cells	GSE140440	ENSG00000165633	196740	V-set and transmembrane domain containing 4	C10orf72|FLJ31737	protein_coding	Q8IW00	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10968
1.40181458305351e-07	-1.03402961348865	0.607	0.866	0.00392017448150915	ZNF28	Malignant cells	GSE140440	ENSG00000198538	7576	zinc finger protein 28	DKFZp781D0275|KOX24	protein_coding	P17035	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10969
1.40555884008145e-07	0.567356250270905	0.98	0.963	0.00393064529628778	GATAD1	Malignant cells	GSE140440	ENSG00000157259	57798	GATA zinc finger domain containing 1	FLJ22489|ODAG|RG083M05.2	protein_coding	Q8WUU5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10970
1.40883030057872e-07	-0.759151116134329	0.313	0.627	0.00393979393556838	CTD-2135D7.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10971
1.41169106723318e-07	-1.03719861795425	0.367	0.694	0.00394779406951759	HSPA1L	Malignant cells	GSE140440	ENSG00000236251	3305	heat shock protein family A (Hsp70) member 1 like	HSP70-HOM|hum70t	protein_coding	P34931	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10972
1.4145346163669e-07	-0.849942059007215	0.427	0.739	0.00395574605467003	PLEKHN1	Malignant cells	GSE140440	ENSG00000187583	84069	pleckstrin homology domain containing N1	DKFZP434H2010	protein_coding	Q494U1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10973
1.43025621325923e-07	1.23159980019521	0.8	0.56	0.00399971150037944	RP11-395G23.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10974
1.4339746389032e-07	1.24912955547684	0.5	0.231	0.00401011007769279	FSIP2	Malignant cells	GSE140440	ENSG00000188738	401024	fibrous sheath interacting protein 2	FLJ34780	protein_coding	Q5CZC0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10975
1.44566514509083e-07	1.40705129717296	0.727	0.41	0.0040428025782465	SLC9A8	Malignant cells	GSE140440	ENSG00000197818	23315	solute carrier family 9 member A8	KIAA0939|NHE8	protein_coding	Q9Y2E8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10976
1.4638337215963e-07	0.606838943891201	1	0.903	0.00409361100244405	KDELR3	Malignant cells	GSE140440	ENSG00000100196	11015	KDEL endoplasmic reticulum protein retention receptor 3	NA	protein_coding	O43731	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10977
1.46857655696008e-07	-0.348596045349442	0.133	0.403	0.00410687434153886	CLDN10	Malignant cells	GSE140440	ENSG00000134873	9071	claudin 10	CPETRL3|OSP-L	protein_coding	P78369	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10978
1.4691688996682e-07	0.800976427393744	0.98	0.896	0.00410853082792213	LETMD1	Malignant cells	GSE140440	ENSG00000050426	25875	LETM1 domain containing 1	HCCR|HCCR-1|HCCR-2|HCCR1|HCCR2|SLC55A3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10979
1.46981304034611e-07	-0.521810593342937	0.553	0.776	0.0041103321673279	RP11-170K4.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10980
1.46994346169601e-07	-0.335922215314332	0.3	0.604	0.00411069689063291	AC091038.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10981
1.475405361096e-07	-0.339365186623462	1	1	0.00412597109230496	NME2	Malignant cells	GSE140440	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10982
1.48135452439145e-07	1.26305397231069	0.72	0.418	0.0041426079274607	ATP10D	Malignant cells	GSE140440	ENSG00000145246	57205	ATPase phospholipid transporting 10D (putative)	ATPVD|KIAA1487	protein_coding	Q9P241	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10983
1.48886194505712e-07	-0.516366454652809	0.513	0.761	0.00416360242935224	RP11-166B2.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10984
1.49641634963728e-07	-0.987895698212173	0.133	0.403	0.00418472832176064	AC139100.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10985
1.5048069111491e-07	0.300266112342942	0.58	0.291	0.00420819252702846	CXCL8	Malignant cells	GSE140440	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10986
1.53044329999508e-07	-0.385887886373111	0.14	0.418	0.00427988468843624	ANKRD7	Malignant cells	GSE140440	ENSG00000106013	56311	ankyrin repeat domain 7	TSA806	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10987
1.53112195100339e-07	2.3147253694899	0.547	0.291	0.00428178253598097	DOCK3	Malignant cells	GSE140440	ENSG00000088538	1795	dedicator of cytokinesis 3	KIAA0299|MOCA|PBP	protein_coding	Q8IZD9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10988
1.54175672712185e-07	1.52653724366261	0.6	0.321	0.00431152268739626	CYB5R2	Malignant cells	GSE140440	ENSG00000166394	51700	cytochrome b5 reductase 2	NA	protein_coding	Q6BCY4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10989
1.54648803582437e-07	-0.437523619334376	0.367	0.694	0.00432475379218284	PFN1P8	Malignant cells	GSE140440	ENSG00000244371	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10990
1.56043266695895e-07	-1.36420535287937	0.48	0.716	0.0043637499531507	ZNF787	Malignant cells	GSE140440	ENSG00000142409	126208	zinc finger protein 787	NA	protein_coding	Q6DD87	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10991
1.58019024017265e-07	0.565638679934637	0.973	0.821	0.00441900200664281	MPP6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10992
1.58429897387616e-07	0.746816465082744	0.993	0.97	0.00443049208044467	PHF14	Malignant cells	GSE140440	ENSG00000106443	9678	PHD finger protein 14	KIAA0783	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10993
1.60446693457389e-07	-0.740785306226538	0.973	0.993	0.00448689178253589	API5	Malignant cells	GSE140440	ENSG00000166181	8539	apoptosis inhibitor 5	AAC-11|AAC11|API5L1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10994
1.61691661227476e-07	-0.57133500007242	0.533	0.776	0.00452170730622637	CLNK	Malignant cells	GSE140440	ENSG00000109684	116449	cytokine dependent hematopoietic cell linker	MIST	protein_coding	Q7Z7G1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10995
1.63022075657844e-07	4.39399534895147	0.393	0.149	0.0045589123457716	HSD17B2	Malignant cells	GSE140440	ENSG00000086696	3294	hydroxysteroid 17-beta dehydrogenase 2	HSD17|SDR9C2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10996
1.6354624816633e-07	0.780351396085372	0.993	0.97	0.00457357082997143	PPFIBP1	Malignant cells	GSE140440	ENSG00000110841	8496	PPFIA binding protein 1	hSGT2|hSgt2p|L2|SGT2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10997
1.64286444325161e-07	-1.4169067184149	0.373	0.694	0.00459427041555313	RECQL4	Malignant cells	GSE140440	ENSG00000160957	9401	RecQ like helicase 4	RecQ4	protein_coding	O94761	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10998
1.66206154876008e-07	-0.544221376194798	1	0.993	0.00464795512110756	DDX18	Malignant cells	GSE140440	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	10999
1.66273539613859e-07	-1.15598266759752	0.333	0.642	0.00464983953530156	KLHL3	Malignant cells	GSE140440	ENSG00000146021	26249	kelch like family member 3	KIAA1129	protein_coding	Q9UH77	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11000
1.66427810097493e-07	-2.06876869695512	0.433	0.664	0.00465415370937639	ATF5	Malignant cells	GSE140440	ENSG00000169136	22809	activating transcription factor 5	NA	protein_coding	Q9Y2D1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11001
1.66867121968172e-07	0.693313182846116	0.933	0.828	0.00466643906583993	LINC00476	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11002
1.68156022364628e-07	0.467976672780454	0.993	0.97	0.00470248316542683	POLD4	Malignant cells	GSE140440	ENSG00000175482	57804	DNA polymerase delta 4, accessory subunit	p12|POLDS	protein_coding	Q9HCU8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11003
1.68247963282024e-07	-1.9788112265163	0.413	0.694	0.00470505429318179	RP4-814D15.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11004
1.72177392264998e-07	-0.527837892044024	1	0.993	0.00481494077469067	ZC3H15	Malignant cells	GSE140440	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11005
1.72217544986909e-07	0.582149340289925	1	1	0.00481606364555891	S100A10	Malignant cells	GSE140440	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11006
1.72630030562725e-07	-0.364060305846727	0.367	0.679	0.0048275988046866	RBBP4P1	Malignant cells	GSE140440	ENSG00000249485	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11007
1.72838245702268e-07	1.21264092803175	1	1	0.00483342154106391	ACER3	Malignant cells	GSE140440	ENSG00000078124	55331	alkaline ceramidase 3	APHC|FLJ11238|PHCA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11008
1.72883108802351e-07	-1.42917710145249	0.687	0.799	0.00483467613765774	RP11-676J12.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11009
1.7300520735128e-07	-0.826347645593045	1	0.993	0.00483809062357855	AAK1	Malignant cells	GSE140440	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11010
1.73398826737003e-07	-0.726497778490141	0.247	0.56	0.00484909818970029	GRB14	Malignant cells	GSE140440	ENSG00000115290	2888	growth factor receptor bound protein 14	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11011
1.73647824030726e-07	1.76108991480353	0.607	0.373	0.00485606139901925	AC005076.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11012
1.75195610542028e-07	1.4974873067633	0.607	0.343	0.00489934524880781	KLF7	Malignant cells	GSE140440	ENSG00000118263	8609	KLF transcription factor 7	UKLF	protein_coding	O75840	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11013
1.75315914340569e-07	-1.11474831971649	0.713	0.918	0.004902709544534	KNTC1	Malignant cells	GSE140440	ENSG00000184445	9735	kinetochore associated 1	KIAA0166|ROD	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11014
1.7561061759934e-07	-0.598079454739209	0.473	0.724	0.00491095092116554	KIF6	Malignant cells	GSE140440	ENSG00000164627	221458	kinesin family member 6	C6orf102|dJ1043E3.1|dJ137F1.4|dJ188D3.1|DKFZp451I2418|MGC33317	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11015
1.78957474138252e-07	-0.862605775469095	0.7	0.888	0.00500454576427621	HAUS8	Malignant cells	GSE140440	ENSG00000131351	93323	HAUS augmin like complex subunit 8	HICE1|MGC20533|NY-SAR-48	protein_coding	Q9BT25	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11016
1.79050211318793e-07	-1.07058797262947	0.647	0.843	0.00500713915953006	CDCA3	Malignant cells	GSE140440	ENSG00000111665	83461	cell division cycle associated 3	GRCC8|TOME-1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11017
1.7957881880481e-07	0.817930298431531	0.88	0.701	0.00502192166787651	UBXN6	Malignant cells	GSE140440	ENSG00000167671	80700	UBX domain protein 6	UBXD1|UBXDC2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11018
1.805790819868e-07	-0.840041639461751	0.927	0.955	0.00504989402776086	PRPF3	Malignant cells	GSE140440	ENSG00000117360	9129	pre-mRNA processing factor 3	hPrp3|Prp3|RP18|SNRNP90	protein_coding	O43395	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11019
1.80791639232287e-07	-5.09625753105139	0.38	0.634	0.00505583819113092	MFAP5	Malignant cells	GSE140440	ENSG00000197614	8076	microfibril associated protein 5	MAGP2|MP25	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11020
1.81855863841204e-07	-0.587227328566019	0.54	0.761	0.00508559923231927	RP5-1181K21.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11021
1.82274268968526e-07	0.939218707588197	0.927	0.858	0.00509729993170484	TMEM53	Malignant cells	GSE140440	ENSG00000126106	79639	transmembrane protein 53	FLJ22353|NET4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11022
1.83002133949835e-07	-0.859337356588174	0.32	0.627	0.00511765467590714	RP11-473O4.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11023
1.8370410519679e-07	-0.314732593483158	0.247	0.552	0.00513728530182822	CTC-575D19.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11024
1.84236159114963e-07	-0.26964470395462	0.253	0.59	0.00515216418964993	DCLRE1CP1	Malignant cells	GSE140440	ENSG00000237470	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11025
1.86322839497802e-07	-0.936848092621781	0.467	0.754	0.00521051820655603	RP11-226M10.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11026
1.87729134009805e-07	0.771521771563475	0.887	0.687	0.00524984523258419	FAM174A	Malignant cells	GSE140440	ENSG00000174132	345757	family with sequence similarity 174 member A	NS5ATP6|TMEM157|UNQ1912	protein_coding	Q8TBP5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11027
1.88910935618478e-07	-0.873486065240367	0.947	1	0.00528289431457075	SAFB2	Malignant cells	GSE140440	ENSG00000130254	9667	scaffold attachment factor B2	KIAA0138	protein_coding	Q14151	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11028
1.90162221667814e-07	2.71712513325801	0.607	0.41	0.00531788652894042	C11orf63	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11029
1.93612003897051e-07	0.461505418891374	1	1	0.00541435968898102	BUB3	Malignant cells	GSE140440	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11030
1.94211861576061e-07	-0.735914832982911	0.547	0.769	0.00543113470897455	RP11-680B3.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11031
1.94490158106788e-07	-0.566085194269317	0.16	0.44	0.00543891727145633	ELDR	Malignant cells	GSE140440	ENSG00000280890	NA	NA	Fabl|LINC01156	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11032
1.95346335934221e-07	-0.933585297120057	0.96	0.985	0.0054628602844005	UHRF1	Malignant cells	GSE140440	ENSG00000276043	29128	ubiquitin like with PHD and ring finger domains 1	FLJ21925|ICBP90|Np95|RNF106|TDRD22	protein_coding	Q96T88	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11033
1.96511028309491e-07	0.630107696496183	0.993	0.94	0.0054954309066749	EFR3A	Malignant cells	GSE140440	ENSG00000132294	23167	EFR3 homolog A	KIAA0143	protein_coding	Q14156	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11034
1.9737636561649e-07	-0.648442722444355	0.987	1	0.00551963006446515	DCTPP1	Malignant cells	GSE140440	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11035
1.9921906944784e-07	-0.551391583892655	0.34	0.649	0.00557116127710886	CTD-2561B21.8	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11036
2.00038080460778e-07	0.81484807549386	0.987	0.963	0.00559406492008567	CEP250	Malignant cells	GSE140440	ENSG00000126001	11190	centrosomal protein 250	C-NAP1|CEP2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11037
2.00284751182682e-07	-1.15170247788908	0.247	0.545	0.0056009630668237	RP11-277B15.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11038
2.00480442451453e-07	0.801645364991121	1	0.963	0.00560643557315487	ITGA6	Malignant cells	GSE140440	ENSG00000091409	3655	integrin subunit alpha 6	CD49f	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11039
2.02170220893724e-07	-1.06168966584198	0.373	0.701	0.005653690227293	IFITM10	Malignant cells	GSE140440	ENSG00000281618	402778	interferon induced transmembrane protein 10	DSPA3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11040
2.03451173487929e-07	-0.307846207897919	0.493	0.746	0.00568951206658995	LRRC19	Malignant cells	GSE140440	ENSG00000184434	64922	leucine rich repeat containing 19	FLJ21302	protein_coding	Q9H756	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11041
2.07486383032537e-07	0.641124583026979	0.98	0.881	0.0058023567015049	ADD1	Malignant cells	GSE140440	ENSG00000087274	118	adducin 1	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11042
2.09705113197087e-07	0.897268375827165	0.76	0.448	0.00586440349055654	ZBED8	Malignant cells	GSE140440	ENSG00000221886	63920	zinc finger BED-type containing 8	Buster3|C5orf54	protein_coding	Q8IZ13	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11043
2.09720321297167e-07	-0.506031245718038	0.473	0.813	0.00586482878507527	PWP2	Malignant cells	GSE140440	ENSG00000241945	5822	PWP2 small subunit processome component	EHOC-17|PWP2H|UTP1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11044
2.11775293865031e-07	-1.96817286416158	0.3	0.552	0.00592229609293559	ZNF699	Malignant cells	GSE140440	ENSG00000196110	374879	zinc finger protein 699	FLJ38144|hang	protein_coding	Q32M78	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11045
2.11951633072181e-07	-0.602429053551221	0.52	0.776	0.00592722741886354	RP11-570L14.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11046
2.12379209324055e-07	-0.413861816815611	0.553	0.784	0.00593918458874721	CNTN4	Malignant cells	GSE140440	ENSG00000144619	152330	contactin 4	BIG-2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11047
2.12635202575103e-07	2.76866668596287	0.487	0.231	0.00594634344001276	LHX1	Malignant cells	GSE140440	ENSG00000274577	3975	LIM homeobox 1	LIM-1|LIM1	protein_coding	P48742	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11048
2.13071231304168e-07	2.28356796207944	0.72	0.59	0.00595853698342105	ANTXR2	Malignant cells	GSE140440	ENSG00000163297	118429	ANTXR cell adhesion molecule 2	CMG-2|CMG2|FLJ31074	protein_coding	P58335	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11049
2.13552479681279e-07	1.24305219425728	0.907	0.888	0.00597199509428696	CCDC113	Malignant cells	GSE140440	ENSG00000103021	29070	coiled-coil domain containing 113	DKFZp434N1418|HSPC065	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11050
2.14618122258119e-07	-0.328886687793019	0.38	0.687	0.00600179578894829	AC008984.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11051
2.1479955839066e-07	0.295416690630833	0.573	0.306	0.0060068696503948	AC093818.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11052
2.15178382672985e-07	-0.314130089803118	0.3	0.634	0.00601746347145004	LY6G5C	Malignant cells	GSE140440	ENSG00000231325	80741	lymphocyte antigen 6 family member G5C	C6orf20|G5c|NG33	protein_coding	Q5SRR4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11053
2.15187136524024e-07	-0.370837695368309	0.5	0.761	0.00601770827289432	KDM5C-IT1	Malignant cells	GSE140440	ENSG00000235262	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11054
2.15192911041666e-07	-1.66391967608225	0.647	0.836	0.0060178697572802	XRCC2	Malignant cells	GSE140440	ENSG00000196584	7516	X-ray repair cross complementing 2	FANCU	protein_coding	O43543	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11055
2.15694510688937e-07	1.2800290467634	0.667	0.396	0.00603189699141612	DNAL4	Malignant cells	GSE140440	ENSG00000100246	10126	dynein axonemal light chain 4	dJ327J16|PIG27	protein_coding	O96015	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11056
2.16617314022941e-07	-1.10190430734207	0.513	0.754	0.00605770318665155	RP11-648O15.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11057
2.16776295416237e-07	-0.798096954196508	0.493	0.761	0.00606214910131506	RP11-715J22.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11058
2.18458543998713e-07	-0.679422724742236	0.687	0.828	0.00610919318292401	HDGFP1	Malignant cells	GSE140440	ENSG00000227183	NA	NA	HDGFP	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11059
2.19255444759478e-07	0.791975408795675	0.947	0.672	0.00613147851269879	FAM101B	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11060
2.20111374034854e-07	-0.326918131931276	0.447	0.739	0.00615541457488471	ZDHHC15	Malignant cells	GSE140440	ENSG00000102383	158866	zinc finger DHHC-type palmitoyltransferase 15	DHHC15|FLJ31812|MRX91	protein_coding	Q96MV8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11061
2.21082296258406e-07	2.30239323067704	0.513	0.254	0.00618256641486632	ELOVL2	Malignant cells	GSE140440	ENSG00000197977	54898	ELOVL fatty acid elongase 2	Ssc2	protein_coding	Q9NXB9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11062
2.21351176241593e-07	-1.50947595777697	0.373	0.672	0.00619008564359615	TMEM139	Malignant cells	GSE140440	ENSG00000178826	135932	transmembrane protein 139	FLJ90586	protein_coding	Q8IV31	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11063
2.24263376471526e-07	2.45658028964977	0.6	0.358	0.00627152532302622	HDAC9	Malignant cells	GSE140440	ENSG00000048052	9734	histone deacetylase 9	HD7|HDAC|HDAC7B|KIAA0744|MITR	protein_coding	Q9UKV0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11064
2.25735944160606e-07	-0.383374259088289	0.5	0.791	0.00631270567845135	RP11-352D13.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11065
2.25803574762029e-07	-0.361897701561838	0.393	0.709	0.00631459696822014	RP11-699L21.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11066
2.26546350971993e-07	-0.975270868811048	0.26	0.575	0.00633536870493177	RP11-16E18.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11067
2.27091190098254e-07	0.939252180486324	0.827	0.582	0.00635060513109766	LAMC2	Malignant cells	GSE140440	ENSG00000058085	3918	laminin subunit gamma 2	BM600-100kDa|EBR2|EBR2A|kalinin-105kDa|LAMB2T|LAMNB2|nicein-100kDa	protein_coding	Q13753	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11068
2.2716425100425e-07	-1.51471482878165	0.2	0.5	0.00635264827933386	NRCAM	Malignant cells	GSE140440	ENSG00000091129	4897	neuronal cell adhesion molecule	Bravo|KIAA0343	protein_coding	Q92823	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11069
2.27194015348805e-07	2.01354545453368	0.56	0.291	0.00635348063922933	MARCH3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11070
2.27428995028637e-07	0.492272463621064	0.987	0.94	0.00636005184597584	UCHL3	Malignant cells	GSE140440	ENSG00000118939	7347	ubiquitin C-terminal hydrolase L3	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11071
2.2761206616608e-07	0.989187501842668	0.9	0.716	0.00636517143033441	OSTF1	Malignant cells	GSE140440	ENSG00000134996	26578	osteoclast stimulating factor 1	bA235O14.1|OSF|SH3P2	protein_coding	Q92882	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11072
2.28083829838735e-07	0.539204961138236	0.933	0.828	0.00637836430144023	CCDC91	Malignant cells	GSE140440	ENSG00000123106	55297	coiled-coil domain containing 91	DKFZp779L1558|FLJ11088|p56	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11073
2.28394134442947e-07	2.7903494525744	0.46	0.246	0.00638704196969701	CTD-2066L21.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11074
2.29855778766402e-07	1.03190998144735	0.767	0.545	0.00642791685320244	SPAG4	Malignant cells	GSE140440	ENSG00000061656	6676	sperm associated antigen 4	CT127|SUN4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11075
2.30333540341999e-07	0.72871195079212	0.973	0.94	0.006441277455664	TBC1D20	Malignant cells	GSE140440	ENSG00000125875	128637	TBC1 domain family member 20	C20orf140|dJ852M4.2	protein_coding	Q96BZ9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11076
2.30969520779356e-07	-1.10298741634622	0.253	0.575	0.0064590626485947	OSBPL5	Malignant cells	GSE140440	ENSG00000021762	114879	oxysterol binding protein like 5	KIAA1534|OBPH1|ORP5	protein_coding	Q9H0X9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11077
2.3417240876055e-07	-0.489991039228512	0.407	0.694	0.00654863141098878	CTA-286B10.8	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11078
2.35052947582539e-07	1.51885892196346	0.653	0.396	0.0065732556791457	ADAM19	Malignant cells	GSE140440	ENSG00000135074	8728	ADAM metallopeptidase domain 19	MLTNB	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11079
2.356908303372e-07	-0.631983118137564	0.413	0.716	0.00659109407037979	PCDHA12	Malignant cells	GSE140440	ENSG00000251664	56137	protocadherin alpha 12	PCDH-ALPHA12	protein_coding	Q9UN75	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11080
2.37893163639187e-07	-1.58622857806515	0.293	0.597	0.00665268232116987	PABPC4L	Malignant cells	GSE140440	ENSG00000254535	132430	poly(A) binding protein cytoplasmic 4 like	NA	protein_coding	P0CB38	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11081
2.40887403297212e-07	-0.283527644009246	0.52	0.799	0.00673641623320653	FTH1P5	Malignant cells	GSE140440	ENSG00000230204	NA	NA	FTHL5|FTHP1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11082
2.42206693752942e-07	-0.888103626302043	0.847	0.955	0.00677331019080101	PUS7	Malignant cells	GSE140440	ENSG00000091127	54517	pseudouridine synthase 7	FLJ20485	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11083
2.45300696217694e-07	-0.616908656505233	1	1	0.00685983396972781	HP1BP3	Malignant cells	GSE140440	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11084
2.46084001601001e-07	0.826061936051064	0.787	0.493	0.00688173910477198	TLE2	Malignant cells	GSE140440	ENSG00000065717	7089	TLE family member 2, transcriptional corepressor	ESG|ESG2|FLJ41188|GRG2	protein_coding	Q04725	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11085
2.4647553089172e-07	0.902578497959175	0.667	0.373	0.00689268822138695	KAT2B	Malignant cells	GSE140440	ENSG00000114166	8850	lysine acetyltransferase 2B	GCN5|GCN5L|P/CAF|PCAF	protein_coding	Q92831	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11086
2.47184993006279e-07	0.719659040987967	1	1	0.0069125283294206	SNF8	Malignant cells	GSE140440	ENSG00000159210	11267	SNF8 subunit of ESCRT-II	Dot3|EAP30|VPS22	protein_coding	Q96H20	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11087
2.49146924362899e-07	0.837394097738013	0.947	0.873	0.00696739373980847	TMEM107	Malignant cells	GSE140440	ENSG00000179029	84314	transmembrane protein 107	JBTS29|MGC10744|MKS13	protein_coding	Q6UX40	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11088
2.50729596355529e-07	-0.873222882843123	0.18	0.463	0.00701165316208235	RIC3	Malignant cells	GSE140440	ENSG00000166405	79608	RIC3 acetylcholine receptor chaperone	AYST720|FLJ11608|PRO1385	protein_coding	Q7Z5B4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11089
2.50805533568911e-07	-0.314038823313074	0.373	0.679	0.00701377674625459	RP11-152F13.10	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11090
2.5102102607523e-07	0.474004972773082	0.967	0.478	0.0070198029941938	CRNDE	Malignant cells	GSE140440	ENSG00000245694	101927480	uncharacterized LOC101927480	CRNDEP|LINC00180|LOC643911	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11091
2.51039101308307e-07	0.369664646697911	1	1	0.0070203084680868	HM13	Malignant cells	GSE140440	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11092
2.54830956099454e-07	0.542263704389819	0.993	0.97	0.00712634768732122	TNRC6B	Malignant cells	GSE140440	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11093
2.58912888227615e-07	0.537125916220942	0.987	0.993	0.00724049891928525	RNF13	Malignant cells	GSE140440	ENSG00000082996	11342	ring finger protein 13	RZF	protein_coding	O43567	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11094
2.5989993741079e-07	0.341616361107945	1	1	0.00726810174969275	MRPL40	Malignant cells	GSE140440	ENSG00000185608	64976	mitochondrial ribosomal protein L40	MRP-L22|NLVCF	protein_coding	Q9NQ50	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11095
2.63123735900446e-07	-0.981926034740229	0.153	0.433	0.00735825527445596	VSTM1	Malignant cells	GSE140440	ENSG00000276066	284415	V-set and transmembrane domain containing 1	UNQ3033	protein_coding	Q6UX27	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11096
2.63769001080413e-07	0.912156572237983	0.94	0.799	0.00737630011521374	NPC1	Malignant cells	GSE140440	ENSG00000141458	4864	NPC intracellular cholesterol transporter 1	SLC65A1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11097
2.6455050726291e-07	0.580772046597345	0.993	0.948	0.00739815493560729	HCFC1R1	Malignant cells	GSE140440	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11098
2.65231290176905e-07	-0.525299579422816	0.24	0.552	0.00741719302979715	TERT	Malignant cells	GSE140440	ENSG00000164362	7015	telomerase reverse transcriptase	EST2|hEST2|TCS1|TP2|TRT	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11099
2.68149535272796e-07	-1.7930299565953	0.287	0.567	0.00749880175390374	RP11-157P1.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11100
2.6826280602335e-07	-1.41661171577278	0.507	0.791	0.00750196937044298	RP11-479G22.8	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11101
2.68491667073853e-07	-0.669689488757992	0.453	0.769	0.00750836946972031	CH507-254M2.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11102
2.68505133285194e-07	0.890959982315006	0.907	0.776	0.00750874605232045	RBL2	Malignant cells	GSE140440	ENSG00000103479	5934	RB transcriptional corepressor like 2	p130|Rb2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11103
2.6850521512417e-07	-1.01837236455285	0.553	0.836	0.0075087483409474	DIAPH3	Malignant cells	GSE140440	ENSG00000139734	81624	diaphanous related formin 3	AN|AUNA1|DRF3|FLJ34705|NSDAN	protein_coding	Q9NSV4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11104
2.70524806146335e-07	1.20302766503643	0.827	0.709	0.00756522620388226	FAM105A	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11105
2.70986660569307e-07	0.984861192447798	0.847	0.731	0.00757814196282066	MTERF1	Malignant cells	GSE140440	ENSG00000127989	7978	mitochondrial transcription termination factor 1	MTERF	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11106
2.71995225857563e-07	1.14701060949431	0.813	0.619	0.00760634649110674	SLC30A1	Malignant cells	GSE140440	ENSG00000170385	7779	solute carrier family 30 member 1	ZNT1|ZRC1	protein_coding	Q9Y6M5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11107
2.72141645166547e-07	-2.25980709246083	0.667	0.784	0.00761044110708249	ZNF585B	Malignant cells	GSE140440	ENSG00000245680	92285	zinc finger protein 585B	FLJ14928|SZFP41|Zfp27	protein_coding	Q52M93	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11108
2.72815790994281e-07	-0.872549687478063	0.753	0.925	0.00762929359515507	CDKN2C	Malignant cells	GSE140440	ENSG00000123080	1031	cyclin dependent kinase inhibitor 2C	INK4C|p18	protein_coding	P42773	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11109
2.72923534160508e-07	0.612149606554156	1	0.903	0.00763230663279859	DPM2	Malignant cells	GSE140440	ENSG00000136908	8818	dolichyl-phosphate mannosyltransferase subunit 2, regulatory	MGC111193|MGC21559	protein_coding	O94777	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11110
2.73784233274172e-07	-0.774712214692973	0.42	0.746	0.00765637608351223	CTA-390C10.10	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11111
2.74205788437646e-07	-0.453665977165032	1	1	0.00766816487365877	EEF1D	Malignant cells	GSE140440	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11112
2.7501260436542e-07	-0.458295324127556	0.927	0.955	0.00769072748107897	HMGN2P4	Malignant cells	GSE140440	ENSG00000249014	NA	NA	HMGN2L4	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11113
2.76427004034735e-07	-1.03052564102103	0.38	0.687	0.00773028116783137	NDNF	Malignant cells	GSE140440	ENSG00000173376	79625	neuron derived neurotrophic factor	C4orf31|FLJ23191	protein_coding	Q8TB73	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11114
2.77520197639779e-07	0.463457973246118	1	0.985	0.00776085232699643	PAIP1	Malignant cells	GSE140440	ENSG00000172239	10605	poly(A) binding protein interacting protein 1	NA	protein_coding	Q9H074	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11115
2.77750094096054e-07	-0.394055046144564	0.353	0.657	0.00776728138139616	RP1-71H24.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11116
2.81113770492609e-07	0.98068394501801	0.907	0.731	0.00786134659182581	BACH1	Malignant cells	GSE140440	ENSG00000156273	571	BTB domain and CNC homolog 1	BACH-1|BTBD24	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11117
2.82728084135067e-07	-1.00196005291718	0.88	0.993	0.00790649087283716	DIS3L	Malignant cells	GSE140440	ENSG00000166938	115752	DIS3 like exosome 3'-5' exoribonuclease	DIS3L1|FLJ38088|KIAA1955|MGC4562	protein_coding	Q8TF46	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11118
2.84974376963492e-07	-0.769387071858583	0.527	0.761	0.00796930845178406	RP11-94C24.13	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11119
2.85788802334348e-07	-0.558721494057795	0.753	0.948	0.00799208385728005	ORC6	Malignant cells	GSE140440	ENSG00000091651	23594	origin recognition complex subunit 6	ORC6L	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11120
2.86152444997174e-07	-0.896599928027552	1	1	0.00800225312434596	ECT2	Malignant cells	GSE140440	ENSG00000114346	1894	epithelial cell transforming 2	ARHGEF31	protein_coding	Q9H8V3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11121
2.86938834249642e-07	-3.31918670123514	0.78	0.843	0.00802424449979124	CAMK2N1	Malignant cells	GSE140440	ENSG00000162545	55450	calcium/calmodulin dependent protein kinase II inhibitor 1	CaMKIINalpha	protein_coding	Q7Z7J9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11122
2.89530476755541e-07	-0.746229938416972	1	1	0.0080967197824687	SF3A3	Malignant cells	GSE140440	ENSG00000183431	10946	splicing factor 3a subunit 3	PRP9|PRPF9|SAP61|SF3a60	protein_coding	Q12874	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11123
2.90846903810456e-07	-0.726158839209623	0.287	0.604	0.0081335336650594	RP11-295P9.13	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11124
2.91147481920946e-07	-0.61690539322391	0.487	0.709	0.00814193933191925	RP11-462G12.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11125
2.93447979155266e-07	0.356806078314576	0.96	0.806	0.008206272737077	XPA	Malignant cells	GSE140440	ENSG00000136936	7507	XPA, DNA damage recognition and repair factor	XP1|XPAC	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11126
2.93830702194843e-07	-0.646739141396072	0.407	0.754	0.00821697558687879	RP11-489E7.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11127
2.96014023882105e-07	-0.541241123291839	0.413	0.761	0.00827803217786305	CYYR1-AS1	Malignant cells	GSE140440	ENSG00000197934	100996571	CYYR1 antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11128
2.97137882980806e-07	-0.536704342695066	0.52	0.746	0.00830946089755825	CTD-2013N17.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11129
2.98295586197141e-07	-1.46063203835415	0.627	0.843	0.00834183606800305	ADNP2	Malignant cells	GSE140440	ENSG00000101544	22850	ADNP homeobox 2	KIAA0863|ZNF508	protein_coding	Q6IQ32	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11130
2.99506418111106e-07	-1.4560884427287	0.247	0.545	0.00837569698247709	PRODH	Malignant cells	GSE140440	ENSG00000277196	5625	proline dehydrogenase 1	HSPOX2|PIG6|PRODH1|PRODH2|TP53I6	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11131
2.99709037320945e-07	-0.637545811118358	0.993	1	0.00838136322868022	STARD7	Malignant cells	GSE140440	ENSG00000084090	56910	StAR related lipid transfer domain containing 7	GTT1	protein_coding	Q9NQZ5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11132
3.01228801488383e-07	-0.282028428410453	0.507	0.806	0.00842386343362264	NPM1P22	Malignant cells	GSE140440	ENSG00000227969	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11133
3.02035451909265e-07	0.41196048000244	1	0.978	0.0084464214126426	HEXB	Malignant cells	GSE140440	ENSG00000049860	3074	hexosaminidase subunit beta	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11134
3.02138627728826e-07	-0.518445908381755	0.307	0.634	0.00844930672443662	TFAP2A-AS1	Malignant cells	GSE140440	ENSG00000229950	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11135
3.03793816734178e-07	0.627074298851737	0.893	0.828	0.00849559408497128	TNIP1	Malignant cells	GSE140440	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11136
3.04977223571408e-07	-1.09151270149547	0.32	0.634	0.00852868805717441	AC092881.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11137
3.05127242444381e-07	-0.338456787546954	0.28	0.575	0.0085328833349571	ITPRIPL1	Malignant cells	GSE140440	ENSG00000198885	150771	ITPRIP like 1	KIAA1754L	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11138
3.06723515361016e-07	0.587337957551615	0.98	0.896	0.00857752310707082	DCTN4	Malignant cells	GSE140440	ENSG00000132912	51164	dynactin subunit 4	Dyn4|p62	protein_coding	Q9UJW0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11139
3.06791856161968e-07	-0.632214783339329	0.507	0.791	0.00857943425756944	RP11-288H12.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11140
3.06852482525288e-07	-1.47955672323261	0.387	0.687	0.00858112967381969	RP11-271C24.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11141
3.12690614364456e-07	0.691073766519324	0.927	0.784	0.00874439303070202	MOSPD1	Malignant cells	GSE140440	ENSG00000101928	56180	motile sperm domain containing 1	dJ473B4	protein_coding	Q9UJG1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11142
3.12714444272596e-07	1.1645796341087	0.953	0.888	0.00874505943408314	TGFBR2	Malignant cells	GSE140440	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11143
3.13952798140257e-07	-0.441771782072295	0.407	0.709	0.00877968999999229	PLEKHG6	Malignant cells	GSE140440	ENSG00000008323	55200	pleckstrin homology and RhoGEF domain containing G6	FLJ10665|MYOGEF	protein_coding	Q3KR16	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11144
3.14487166169835e-07	-2.01255060885344	0.2	0.478	0.00879463360193943	ANPEP	Malignant cells	GSE140440	ENSG00000166825	290	alanyl aminopeptidase, membrane	AP-N|CD13|gp150|hAPN|LAP1|p150|PEPN	protein_coding	P15144	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11145
3.15064491524835e-07	-0.540899489162308	0.993	1	0.008810778505492	TKT	Malignant cells	GSE140440	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11146
3.18352752491721e-07	-0.313705398679431	0.387	0.687	0.00890273472343098	ITPK1-AS1	Malignant cells	GSE140440	ENSG00000280802	319085	ITPK1 antisense RNA 1	C14orf85|ITPK1-AS|ITPK1AS|NCRNA00203	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11147
3.18967059593336e-07	-1.35087884587125	0.687	0.843	0.00891991382152763	ATAD3A	Malignant cells	GSE140440	ENSG00000197785	55210	ATPase family AAA domain containing 3A	FLJ10709	protein_coding	Q9NVI7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11148
3.19516429601168e-07	-0.384266484029073	0.487	0.769	0.00893527695379666	RP4-547N15.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11149
3.26001359940292e-07	-0.458037361705956	0.38	0.709	0.00911662803073026	MB	Malignant cells	GSE140440	ENSG00000198125	4151	myoglobin	PVALB	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11150
3.26194436678495e-07	-0.694367592336486	0.353	0.664	0.00912202742171412	FLJ42393	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11151
3.26552379333913e-07	-1.35999980537101	0.887	0.97	0.00913203728807286	SPATA5	Malignant cells	GSE140440	ENSG00000145375	166378	spermatogenesis associated 5	AFG2|SPAF	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11152
3.26926398196103e-07	-1.687985754635	0.453	0.716	0.00914249672555402	CTD-2233K9.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11153
3.27081085232634e-07	-0.436788374558039	0.28	0.597	0.00914682254853062	RP11-276H7.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11154
3.273400593391e-07	1.21121869180736	0.833	0.657	0.00915406475941794	NFIL3	Malignant cells	GSE140440	ENSG00000165030	4783	nuclear factor, interleukin 3 regulated	E4BP4|IL3BP1|NF-IL3A|NFIL3A	protein_coding	Q16649	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11155
3.28853923179023e-07	3.76142899889593	0.447	0.209	0.00919639996170139	ITGA10	Malignant cells	GSE140440	ENSG00000143127	8515	integrin subunit alpha 10	NA	protein_coding	O75578	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11156
3.2899237124314e-07	0.697716776329885	0.98	0.799	0.0092002716618144	ISOC1	Malignant cells	GSE140440	ENSG00000066583	51015	isochorismatase domain containing 1	CGI-111	protein_coding	Q96CN7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11157
3.2932436129657e-07	-0.980101889655776	0.973	0.985	0.00920955576365859	ACIN1	Malignant cells	GSE140440	ENSG00000100813	22985	apoptotic chromatin condensation inducer 1	ACINUS|fSAP152|KIAA0670	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11158
3.29687984571731e-07	0.525297787011374	1	0.963	0.00921972448854846	TM2D1	Malignant cells	GSE140440	ENSG00000162604	83941	TM2 domain containing 1	BBP	protein_coding	Q9BX74	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11159
3.34789134336344e-07	0.624614339853193	0.967	0.836	0.00936237814171587	GTF2B	Malignant cells	GSE140440	ENSG00000137947	2959	general transcription factor IIB	TFIIB	protein_coding	Q00403	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11160
3.34910439450509e-07	-0.918194642959541	0.94	0.985	0.00936577043923348	ALDH2	Malignant cells	GSE140440	ENSG00000111275	217	aldehyde dehydrogenase 2 family member	NA	protein_coding	P05091	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11161
3.37322899771142e-07	-0.963739796493662	0.8	0.843	0.00943323489209997	MT-TK	Malignant cells	GSE140440	ENSG00000210156	NA	NA	MERRF|MTTK|trnK	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11162
3.40028196605247e-07	-0.854535984615896	1	0.985	0.00950888851806573	PRPF4B	Malignant cells	GSE140440	ENSG00000112739	8899	pre-mRNA processing factor 4B	KIAA0536|PR4H|Prp4	protein_coding	Q13523	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11163
3.40146284153973e-07	-1.21329878191627	0.333	0.627	0.00951219083636585	C16orf59	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11164
3.41419738053512e-07	-0.653249972910688	1	0.985	0.00954780297466645	FARSA	Malignant cells	GSE140440	ENSG00000179115	2193	phenylalanyl-tRNA synthetase subunit alpha	CML33|FARSL|FARSLA	protein_coding	Q9Y285	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11165
3.4314251179307e-07	-0.602163447264392	0.48	0.955	0.00959598034229322	HTATIP2	Malignant cells	GSE140440	ENSG00000109854	10553	HIV-1 Tat interactive protein 2	CC3|FLJ26963|SDR44U1|TIP30	protein_coding	Q9BUP3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11166
3.47846673335607e-07	-0.97416559890753	0.993	1	0.00972753221983025	WAC	Malignant cells	GSE140440	ENSG00000095787	51322	WW domain containing adaptor with coiled-coil	BM-016|FLJ31290|MGC10753|PRO1741|Wwp4	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11167
3.49666565522296e-07	-0.31346093624711	0.48	0.761	0.009778425504831	RP11-329B9.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11168
3.5178630525542e-07	-2.37781375679468	0.387	0.701	0.00983770402646783	HSPA6	Malignant cells	GSE140440	ENSG00000173110	3310	heat shock protein family A (Hsp70) member 6	HSP70B'	protein_coding	P17066	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11169
3.53631558480515e-07	-1.28940130352654	0.053	0.269	0.00988930653290759	VENTXP1	Malignant cells	GSE140440	ENSG00000259849	139538	VENT homeobox pseudogene 1	CT18|NA88A	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11170
3.53956076045894e-07	1.02976562259458	0.853	0.657	0.00989838166662343	ERMARD	Malignant cells	GSE140440	ENSG00000276187	55780	ER membrane associated RNA degradation	C6orf70|dJ266L20.3|FLJ11152	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11171
3.54778288006592e-07	-1.24812099126875	0.207	0.493	0.00992137482410435	RP11-964E11.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11172
3.58379638369072e-07	0.909908814791643	0.8	0.634	0.0100220865869911	PLPP1	Malignant cells	GSE140440	ENSG00000067113	8611	phospholipid phosphatase 1	LPP1|PAP-2a|PPAP2A	protein_coding	O14494	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11173
3.58739364954543e-07	0.350670625116825	1	1	0.0100321463409538	DPY30	Malignant cells	GSE140440	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11174
3.64684918436259e-07	-0.867570009527217	0.913	0.978	0.01019841374407	FNBP4	Malignant cells	GSE140440	ENSG00000285182	23360	formin binding protein 4	KIAA1014	protein_coding	Q8N3X1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11175
3.64839841039135e-07	-0.943309869864575	0.273	0.582	0.0102027461546594	RP11-661A12.8	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11176
3.68451635805073e-07	0.846815861188166	1	0.955	0.0103037499952889	NBPF14	Malignant cells	GSE140440	ENSG00000270629	25832	NBPF member 14	DJ328E19.C1.1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11177
3.69339151663773e-07	-1.81809201452863	0.707	0.866	0.0103285693762774	GALNT10	Malignant cells	GSE140440	ENSG00000164574	55568	polypeptide N-acetylgalactosaminyltransferase 10	GalNAc-T10	protein_coding	Q86SR1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11178
3.69751195055875e-07	-0.297795744268769	0.393	0.709	0.0103400921697375	CTB-178M22.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11179
3.71383987642578e-07	-0.550887690437255	1	1	0.0103857532144247	PSMD11	Malignant cells	GSE140440	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11180
3.71736350198652e-07	-0.413496566004232	0.333	0.672	0.0103956070333053	RP11-203M5.8	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11181
3.73143010056574e-07	-0.477185239866096	0.54	0.776	0.0104349442762321	NCCRP1	Malignant cells	GSE140440	ENSG00000188505	342897	NCCRP1, F-box associated domain containing	FBXO50|LOC342897|NCCRP-1	protein_coding	Q6ZVX7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11182
3.73912468473023e-07	0.995491852218352	0.987	0.836	0.0104564621808481	NDEL1	Malignant cells	GSE140440	ENSG00000166579	81565	nudE neurodevelopment protein 1 like 1	MITAP1|NDE1L1|NDE2|NUDEL	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11183
3.75195694338318e-07	2.01810983009692	0.513	0.246	0.0104923475921711	CHST2	Malignant cells	GSE140440	ENSG00000175040	9435	carbohydrate sulfotransferase 2	C6ST	protein_coding	Q9Y4C5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11184
3.75675152198932e-07	-0.512292167491808	1	1	0.0105057556312431	ILF2	Malignant cells	GSE140440	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11185
3.76011285203695e-07	-0.814225752014965	0.173	0.455	0.0105151555907213	TGM1	Malignant cells	GSE140440	ENSG00000285348	7051	transglutaminase 1	ICR2|LI|LI1|TGASE|TGK	protein_coding	P22735	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11186
3.76301357883921e-07	1.30593244465273	0.953	0.888	0.0105232674732238	ARHGAP26	Malignant cells	GSE140440	ENSG00000145819	23092	Rho GTPase activating protein 26	GRAF|KIAA0621|OPHN1L|OPHN1L1	protein_coding	Q9UNA1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11187
3.76492149695005e-07	-1.25000332130247	0.493	0.746	0.0105286029662208	PFKFB3	Malignant cells	GSE140440	ENSG00000170525	5209	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	NA	protein_coding	Q16875	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11188
3.78403696640743e-07	-0.911009191830364	0.84	0.955	0.0105820593765584	CEP78	Malignant cells	GSE140440	ENSG00000148019	84131	centrosomal protein 78	C9orf81|FLJ12643	protein_coding	Q5JTW2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11189
3.8154378036261e-07	0.782661011068063	0.933	0.881	0.0106698718178404	ARFGAP3	Malignant cells	GSE140440	ENSG00000242247	26286	ADP ribosylation factor GTPase activating protein 3	ARFGAP1	protein_coding	Q9NP61	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11190
3.83518867079154e-07	-0.745145318648918	0.36	0.679	0.0107251051178686	DNAH7	Malignant cells	GSE140440	ENSG00000118997	56171	dynein axonemal heavy chain 7	KIAA0944	protein_coding	Q8WXX0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11191
3.86923775187724e-07	-1.37519313746513	0.367	0.672	0.0108203233731247	ROR1	Malignant cells	GSE140440	ENSG00000185483	4919	receptor tyrosine kinase like orphan receptor 1	NTRKR1	protein_coding	Q01973	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11192
3.87377052549907e-07	-1.09718922501304	0.413	0.679	0.0108329992745581	RP11-1379J22.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11193
3.8991506402537e-07	0.837844402392408	0.967	0.851	0.0109039747654695	PARD6B	Malignant cells	GSE140440	ENSG00000124171	84612	par-6 family cell polarity regulator beta	PAR-6B	protein_coding	Q9BYG5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11194
3.91861536281355e-07	0.867952824815279	0.813	0.567	0.0109584078621081	KIAA0430	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11195
3.9200954199428e-07	-0.562764835977706	0.367	0.701	0.01096254684187	ABTB2	Malignant cells	GSE140440	ENSG00000166016	25841	ankyrin repeat and BTB domain containing 2	ABTB2A|BTBD22|DKFZP586C1619	protein_coding	Q8N961	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11196
3.94066285985905e-07	-1.7937043985161	0.42	0.664	0.0110200636875958	MEX3A	Malignant cells	GSE140440	ENSG00000254726	92312	mex-3 RNA binding family member A	RKHD4|RNF162	protein_coding	A1L020	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11197
3.94596228479598e-07	1.06063731294305	0.867	0.649	0.0110348835294319	SFR1	Malignant cells	GSE140440	ENSG00000156384	119392	SWI5 dependent homologous recombination repair protein 1	bA373N18.1|C10orf78|FLJ41960|MEI5|MEIR5	protein_coding	Q86XK3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11198
3.94958546360574e-07	-1.53917422459893	0.84	0.896	0.0110450157489735	ATP9B	Malignant cells	GSE140440	ENSG00000274273	374868	ATPase phospholipid transporting 9B (putative)	ATPIIB	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11199
3.96655746616291e-07	-0.333091218614341	0.373	0.687	0.0110924779541246	LHX9	Malignant cells	GSE140440	ENSG00000143355	56956	LIM homeobox 9	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11200
3.99958730979969e-07	-0.749808941771366	0.167	0.448	0.0111848459118548	RP11-391L3.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11201
4.00596550702817e-07	-1.43599303818879	0.527	0.776	0.0112026825404043	AP001505.10	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11202
4.01141384802447e-07	-0.818639755226587	0.36	0.642	0.0112179188260004	EEF1B2P3	Malignant cells	GSE140440	ENSG00000232472	NA	NA	EEF1B4	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11203
4.0422565051686e-07	-0.79128655342995	0.527	0.784	0.011304170316704	POC1A	Malignant cells	GSE140440	ENSG00000164087	25886	POC1 centriolar protein A	DKFZP434C245|WDR51A	protein_coding	Q8NBT0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11204
4.08854124235052e-07	0.68899436123554	0.88	0.731	0.0114336055842332	TMEM186	Malignant cells	GSE140440	ENSG00000184857	25880	transmembrane protein 186	C16orf51|DKFZP564K2062	protein_coding	Q96B77	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11205
4.13770781912802e-07	-0.334554034395902	0.36	0.679	0.0115710999161915	RP11-829H16.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11206
4.14654474285787e-07	0.347282399736489	1	1	0.011595812373402	C7orf73	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11207
4.19840458813672e-07	-0.879314697480897	0.887	0.933	0.0117408384307243	PITRM1	Malignant cells	GSE140440	ENSG00000107959	10531	pitrilysin metallopeptidase 1	hMP1|KIAA1104|MP1|PreP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11208
4.20983693399009e-07	0.311796864272141	1	1	0.0117728089859033	TMEM14C	Malignant cells	GSE140440	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11209
4.21052820481557e-07	-6.33597471694083	0.387	0.687	0.0117747421247667	MMP13	Malignant cells	GSE140440	ENSG00000137745	4322	matrix metallopeptidase 13	CLG3	protein_coding	P45452	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11210
4.22607422787382e-07	-1.33446261682035	0.54	0.761	0.0118182165782491	ZNF670-ZNF695	Malignant cells	GSE140440	ENSG00000135747	NA	NA	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11211
4.26346685032965e-07	2.11760450556158	0.607	0.321	0.0119227850469469	RASSF4	Malignant cells	GSE140440	ENSG00000107551	83937	Ras association domain family member 4	AD037|MGC44914	protein_coding	Q9H2L5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11212
4.26952861018131e-07	2.39095154283734	0.507	0.231	0.011939736758372	DUSP10	Malignant cells	GSE140440	ENSG00000143507	11221	dual specificity phosphatase 10	MKP-5|MKP5	protein_coding	Q9Y6W6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11213
4.28671343676585e-07	-0.333348271650505	0.473	0.739	0.0119877941259157	RN7SL73P	Malignant cells	GSE140440	ENSG00000265882	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11214
4.29574018992543e-07	-0.963944950056104	0.74	0.91	0.0120130374411265	TIMM8A	Malignant cells	GSE140440	ENSG00000126953	1678	translocase of inner mitochondrial membrane 8A	DDP|DFN1|MTS	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11215
4.30312092118374e-07	-0.767516979115514	0.433	0.739	0.0120336776560903	RPS2P45	Malignant cells	GSE140440	ENSG00000244378	NA	NA	FLJ12331	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11216
4.30495957447281e-07	0.498123614975563	0.933	0.769	0.0120388194500132	SHPRH	Malignant cells	GSE140440	ENSG00000146414	257218	SNF2 histone linker PHD RING helicase	bA545I5.2|FLJ90837|KIAA2023	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11217
4.31434185159796e-07	1.27162314253786	0.3	0.627	0.0120650569879937	S100P	Malignant cells	GSE140440	ENSG00000163993	6286	S100 calcium binding protein P	NA	protein_coding	P25815	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11218
4.31599094145246e-07	0.884872265361101	0.907	0.739	0.0120696686677718	STX3	Malignant cells	GSE140440	ENSG00000166900	6809	syntaxin 3	STX3A	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11219
4.34224918468468e-07	0.907798538527231	0.967	0.843	0.0121430998449707	VPS36	Malignant cells	GSE140440	ENSG00000136100	51028	vacuolar protein sorting 36 homolog	C13orf9|CGI-145|Eap45	protein_coding	Q86VN1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11220
4.37293021299802e-07	-0.6715035364203	0.98	0.993	0.012228899340649	KRT7	Malignant cells	GSE140440	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11221
4.38672555260006e-07	0.494319600131656	0.98	0.851	0.0122674780078461	SUCLG2	Malignant cells	GSE140440	ENSG00000172340	8801	succinate-CoA ligase GDP-forming subunit beta	NA	protein_coding	Q96I99	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11222
4.39008392962414e-07	-0.412088968974825	0.24	0.537	0.0122768697091939	C8orf48	Malignant cells	GSE140440	ENSG00000164743	157773	chromosome 8 open reading frame 48	FLJ25402	protein_coding	Q96LL4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11223
4.40180048649119e-07	0.340421652040435	0.933	0.813	0.0123096350604726	B4GALT5	Malignant cells	GSE140440	ENSG00000158470	9334	beta-1,4-galactosyltransferase 5	beta4GalT-V	protein_coding	O43286	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11224
4.41281260036836e-07	-0.948329869455191	0.367	0.649	0.0123404304369301	HR	Malignant cells	GSE140440	ENSG00000168453	55806	HR lysine demethylase and nuclear receptor corepressor	ALUNC|AU	protein_coding	O43593	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11225
4.4313830490151e-07	1.03592037138106	0.747	0.485	0.0123923626965707	ARSA	Malignant cells	GSE140440	ENSG00000100299	410	arylsulfatase A	ASA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11226
4.43824640601456e-07	0.644239496966502	0.88	0.709	0.0124115560744197	YIPF2	Malignant cells	GSE140440	ENSG00000130733	78992	Yip1 domain family member 2	FinGER2|MGC3262	protein_coding	Q9BWQ6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11227
4.4441851446341e-07	-1.30759517343741	0.547	0.754	0.0124281637569693	ADCY3	Malignant cells	GSE140440	ENSG00000138031	109	adenylate cyclase 3	AC3	protein_coding	O60266	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11228
4.48347833284801e-07	-1.70805836211337	0.34	0.619	0.0125380471578095	LPAR2	Malignant cells	GSE140440	ENSG00000064547	9170	lysophosphatidic acid receptor 2	EDG-4|EDG4|LPA2	protein_coding	Q9HBW0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11229
4.490158494077e-07	0.934304248485277	0.827	0.604	0.0125567282286863	TST	Malignant cells	GSE140440	ENSG00000128311	7263	thiosulfate sulfurtransferase	RDS	protein_coding	Q16762	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11230
4.55235613703189e-07	1.89639047637235	0.533	0.276	0.0127306639372097	IGSF3	Malignant cells	GSE140440	ENSG00000143061	3321	immunoglobulin superfamily member 3	EWI-3|MGC117164|V8	protein_coding	O75054	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11231
4.55857514215511e-07	-0.69673638597239	0.967	1	0.0127480553850368	NOLC1	Malignant cells	GSE140440	ENSG00000166197	9221	nucleolar and coiled-body phosphoprotein 1	KIAA0035|NOPP130|NOPP140|P130|Srp40	protein_coding	Q14978	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11232
4.56059289508839e-07	-0.956567094269758	0.807	0.955	0.0127536980311147	SOGA1	Malignant cells	GSE140440	ENSG00000149639	140710	suppressor of glucose, autophagy associated 1	C20orf117|dJ132F21.1|FLJ44670|KIAA0889|SOGA	protein_coding	O94964	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11233
4.58589352029857e-07	-0.713385878721944	0.367	0.694	0.0128244512295149	RP11-395N3.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11234
4.59443624069171e-07	-0.568912201430811	0.433	0.731	0.0128483409470944	VGLL3	Malignant cells	GSE140440	ENSG00000206538	389136	vestigial like family member 3	VGL-3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11235
4.59754386299402e-07	-0.459995540691202	0.46	0.739	0.0128570314128628	HNRNPCP7	Malignant cells	GSE140440	ENSG00000228653	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11236
4.61645516944266e-07	-0.46438519989921	0.293	0.597	0.0129099168813464	PFN1P6	Malignant cells	GSE140440	ENSG00000227212	NA	NA	PFN1P7	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11237
4.6756346600186e-07	1.50955076726477	0.62	0.396	0.013075412326742	GS1-124K5.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11238
4.68639240754706e-07	-0.336597370949876	0.34	0.634	0.0131054963677053	RSAD2	Malignant cells	GSE140440	ENSG00000134321	91543	radical S-adenosyl methionine domain containing 2	cig5|vig1|Viperin	protein_coding	Q8WXG1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11239
4.70227159373886e-07	0.948497660611803	0.66	0.358	0.0131499025118907	CYBRD1	Malignant cells	GSE140440	ENSG00000071967	79901	cytochrome b reductase 1	CYB561A2|DCYTB|FLJ23462|FRRS3	protein_coding	Q53TN4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11240
4.76928167494824e-07	-1.43159635117406	0.347	0.642	0.0133372962039928	CTD-2123J17.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11241
4.78429529251609e-07	0.851362019481109	1	0.978	0.0133792817855212	ARNTL2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11242
4.83854881112176e-07	-0.573356538990923	0.973	0.985	0.013531001750302	RRP7A	Malignant cells	GSE140440	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11243
4.85814006427287e-07	-0.580194656181606	0.993	0.993	0.0135857886897391	MRPS18C	Malignant cells	GSE140440	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11244
4.87123032201617e-07	-0.36880166768819	0.5	0.791	0.0136223955955182	RP11-1144P22.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11245
4.91726965956259e-07	0.947816954325272	0.68	0.373	0.0137511446029668	RP4-665J23.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11246
4.91870790937141e-07	-0.994073917983362	0.353	0.649	0.0137551666685572	RP11-85I17.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11247
4.92333126133921e-07	-0.74479098493581	0.913	0.978	0.0137680958723351	BAG5	Malignant cells	GSE140440	ENSG00000166170	9529	BAG cochaperone 5	NA	protein_coding	Q9UL15	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11248
4.92798465115627e-07	0.817706081538998	0.993	0.925	0.0137811090769585	TRNP1	Malignant cells	GSE140440	ENSG00000253368	388610	TMF1 regulated nuclear protein 1	C1orf225|TRNP	protein_coding	Q6NT89	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11249
4.93737834919412e-07	-0.976417158560964	0.213	0.5	0.0138073785535214	ZNF613	Malignant cells	GSE140440	ENSG00000176024	79898	zinc finger protein 613	FLJ13590	protein_coding	Q6PF04	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11250
4.98088330126114e-07	-0.943612210734521	0.333	0.627	0.0139290401519768	RP11-333E13.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11251
5.04420509686106e-07	-0.446122993506481	0.547	0.761	0.014106119553372	LAMB4	Malignant cells	GSE140440	ENSG00000091128	22798	laminin subunit beta 4	NA	protein_coding	A4D0S4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11252
5.04792507534787e-07	-0.538528261281467	1	0.993	0.0141165224732103	CMPK1	Malignant cells	GSE140440	ENSG00000162368	51727	cytidine/uridine monophosphate kinase 1	CMPK|UMP-CMPK	protein_coding	P30085	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11253
5.04827123777012e-07	-0.558759373207629	0.993	1	0.0141174905164241	RPA2	Malignant cells	GSE140440	ENSG00000117748	6118	replication protein A2	NA	protein_coding	P15927	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11254
5.05706949081168e-07	1.60105022477016	0.66	0.47	0.0141420948310549	LETM2	Malignant cells	GSE140440	ENSG00000165046	137994	leucine zipper and EF-hand containing transmembrane protein 2	FLJ25409|SLC55A2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11255
5.07219478096393e-07	-0.459404802993559	0.393	0.679	0.0141843927049656	CTD-2017F17.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11256
5.10388680770767e-07	-1.94652095032503	0.287	0.545	0.0142730194577545	PEX5L	Malignant cells	GSE140440	ENSG00000114757	51555	peroxisomal biogenesis factor 5 like	PEX5R|PXR2|TRIP8b	protein_coding	Q8IYB4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11257
5.1125230036933e-07	-0.985220131213161	0.24	0.53	0.0142971705798283	DDR2	Malignant cells	GSE140440	ENSG00000162733	4921	discoidin domain receptor tyrosine kinase 2	NTRKR3|TKT|TYRO10	protein_coding	Q16832	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11258
5.11429746571307e-07	2.5547969193448	0.527	0.291	0.0143021328628666	SLC2A10	Malignant cells	GSE140440	ENSG00000197496	81031	solute carrier family 2 member 10	GLUT-10|GLUT10	protein_coding	O95528	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11259
5.12912368877877e-07	-0.378615957515146	0.56	0.791	0.0143435943956698	SLC2A5	Malignant cells	GSE140440	ENSG00000142583	6518	solute carrier family 2 member 5	GLUT5	protein_coding	P22732	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11260
5.13536349621303e-07	-0.355374577980505	0.273	0.582	0.0143610440171597	RP1-140A9.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11261
5.15091547875913e-07	-1.25185539051109	0.567	0.754	0.0144045351363499	RP11-583F2.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11262
5.15992806025692e-07	-0.317279275593505	0.413	0.731	0.0144297388205085	RP11-156E8.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11263
5.20288107944549e-07	-0.456292703672109	0.26	0.567	0.0145498569386693	RP11-424M22.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11264
5.20822685151871e-07	0.887256022246372	0.98	0.97	0.0145648063902721	LRRC37BP1	Malignant cells	GSE140440	ENSG00000250462	NA	NA	DKFZp667M2411|LRRC37B2	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11265
5.2093912704027e-07	-0.322509944074878	0.433	0.709	0.0145680626876811	ASB16	Malignant cells	GSE140440	ENSG00000161664	92591	ankyrin repeat and SOCS box containing 16	FLJ30165	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11266
5.22124988461833e-07	-1.0559941496456	0.36	0.664	0.0146012253023352	IL20RB	Malignant cells	GSE140440	ENSG00000174564	53833	interleukin 20 receptor subunit beta	DIRS1|FNDC6|IL-20R2|MGC34923	protein_coding	Q6UXL0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11267
5.22285955453386e-07	0.588906125664971	1	1	0.0146057267442539	SLC38A1	Malignant cells	GSE140440	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11268
5.24708839465362e-07	-0.264131532246322	0.16	0.433	0.0146734826956489	ADPGK-AS1	Malignant cells	GSE140440	ENSG00000260898	100287559	ADPGK antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11269
5.25102041468038e-07	-0.616369838540699	0.507	0.784	0.0146844785896537	CLEC7A	Malignant cells	GSE140440	ENSG00000172243	64581	C-type lectin domain containing 7A	CD369|CLECSF12|DECTIN-1|hDectin-1|SCARE2	protein_coding	Q9BXN2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11270
5.2610271924927e-07	-0.55797184982884	1	0.993	0.0147124625438058	H2AFY	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11271
5.29912044557554e-07	0.483589171992268	1	0.948	0.014818990326052	TOP2B	Malignant cells	GSE140440	ENSG00000077097	7155	DNA topoisomerase II beta	top2beta|TOPIIB	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11272
5.30853976832456e-07	-0.906713879823946	0.647	0.881	0.0148453314621196	POLR1E	Malignant cells	GSE140440	ENSG00000137054	64425	RNA polymerase I subunit E	FLJ13390|FLJ13970|PAF53|PRAF1|RPA49	protein_coding	Q9GZS1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11273
5.31253251038968e-07	1.7005516486872	0.667	0.433	0.0148564971653047	SATB2	Malignant cells	GSE140440	ENSG00000119042	23314	SATB homeobox 2	FLJ21474|KIAA1034	protein_coding	Q9UPW6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11274
5.33533018730649e-07	0.681729709032906	0.973	0.94	0.0149202508688026	PEX2	Malignant cells	GSE140440	ENSG00000164751	5828	peroxisomal biogenesis factor 2	PAF-1|PMP35|PXMP3|RNF72|ZWS3	protein_coding	P28328	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11275
5.33675527063314e-07	-1.40420776250545	0.293	0.612	0.0149242361143256	NRARP	Malignant cells	GSE140440	ENSG00000198435	441478	NOTCH regulated ankyrin repeat protein	MGC61598	protein_coding	Q7Z6K4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11276
5.35548178331124e-07	-0.453676651592308	0.52	0.791	0.0149766048070299	C9orf106	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11277
5.35720971214809e-07	-0.532128917812933	0.44	0.746	0.0149814369600221	CTD-3035D6.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11278
5.3991339832113e-07	-1.91219411435596	0.34	0.59	0.0150986781840504	ZNF215	Malignant cells	GSE140440	ENSG00000149054	7762	zinc finger protein 215	ZKSCAN11|ZSCAN43	protein_coding	Q9UL58	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11279
5.40195909909098e-07	-0.291531271065156	0.407	0.724	0.0151065786206079	KCNQ5-IT1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11280
5.43437035004723e-07	-0.351763324428126	0.52	0.806	0.0151972166839071	RN7SL317P	Malignant cells	GSE140440	ENSG00000242668	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11281
5.4685037123549e-07	0.990506693901584	0.727	0.5	0.0152926706316005	ZCCHC14	Malignant cells	GSE140440	ENSG00000140948	23174	zinc finger CCHC-type containing 14	BDG29|MGC14139	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11282
5.48298284542018e-07	-0.909073426520176	0.347	0.642	0.0153331615272175	KCNG3	Malignant cells	GSE140440	ENSG00000171126	170850	potassium voltage-gated channel modifier subfamily G member 3	Kv6.3	protein_coding	Q8TAE7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11283
5.49006420861367e-07	1.10408593954355	0.787	0.552	0.0153529645593881	SLFN5	Malignant cells	GSE140440	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11284
5.57017055736393e-07	0.819826037826959	0.947	0.896	0.0155769819636682	SYS1	Malignant cells	GSE140440	ENSG00000204070	90196	SYS1 golgi trafficking protein	C20orf169|dJ453C12.4	protein_coding	Q8N2H4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11285
5.57998615713999e-07	1.59271501746896	0.847	0.657	0.015604431288442	C11orf80	Malignant cells	GSE140440	ENSG00000173715	79703	chromosome 11 open reading frame 80	FLJ22531|TOPOVIBL	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11286
5.62658548229992e-07	-1.70115594275071	0.513	0.761	0.0157347463012517	AREG	Malignant cells	GSE140440	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11287
5.69835757269861e-07	-0.296354064168304	0.487	0.776	0.0159354569520517	RP11-79L9.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11288
5.7440387647038e-07	-1.02057113800152	0.373	0.679	0.0160632044054942	RPSAP13	Malignant cells	GSE140440	ENSG00000233924	NA	NA	LAMR1P13|LAMRL3|LAMRP3	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11289
5.86752070245122e-07	-0.555447952097524	1	0.993	0.0164085216444048	U2SURP	Malignant cells	GSE140440	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11290
5.90092288058596e-07	0.664534236076576	0.96	0.858	0.0165019308355586	C5orf28	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11291
5.90150535271942e-07	-0.440541961243182	0.193	0.485	0.0165035597188799	RP11-157J24.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11292
5.90576088259403e-07	0.581883375172644	0.98	0.799	0.0165154603081742	SIPA1L1	Malignant cells	GSE140440	ENSG00000197555	26037	signal induced proliferation associated 1 like 1	E6TP1|KIAA0440|SPAR1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11293
5.93247446620787e-07	-0.545199136860521	0.533	0.761	0.0165901648447503	LINC00330	Malignant cells	GSE140440	ENSG00000235097	144817	long intergenic non-protein coding RNA 330	NCRNA00330	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11294
5.94771061235678e-07	1.07536671588856	0.987	0.955	0.0166327727274557	MSMO1	Malignant cells	GSE140440	ENSG00000052802	6307	methylsterol monooxygenase 1	DESP4|ERG25|SC4MOL	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11295
5.97747030190006e-07	0.558215992395764	0.993	0.985	0.0167159956992635	SGCB	Malignant cells	GSE140440	ENSG00000163069	6443	sarcoglycan beta	A3b|LGMD2E|SGC	protein_coding	Q16585	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11296
6.060272021923e-07	0.545545648311492	0.967	0.836	0.0169475507093077	RGS19	Malignant cells	GSE140440	ENSG00000171700	10287	regulator of G protein signaling 19	GAIP|RGSGAIP	protein_coding	P49795	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11297
6.08657485293582e-07	-0.469911009556285	0.487	0.769	0.017021106576235	FFAR4	Malignant cells	GSE140440	ENSG00000186188	338557	free fatty acid receptor 4	GPR120|GPR129|O3FAR1|PGR4	protein_coding	Q5NUL3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11298
6.09827937794209e-07	-0.976782717631436	0.747	0.985	0.0170538382804151	IGFBP4	Malignant cells	GSE140440	ENSG00000141753	3487	insulin like growth factor binding protein 4	BP-4|HT29-IGFBP|IBP4|IGFBP-4	protein_coding	P22692	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11299
6.10672061455847e-07	-0.352989300433748	0.387	0.701	0.0170774441986128	RP11-295P9.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11300
6.11672369908354e-07	-0.503766417873175	0.573	0.806	0.0171054178244871	RP11-442O1.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11301
6.14535154578643e-07	-1.11003149796569	0.48	0.769	0.0171854755977918	POLD1	Malignant cells	GSE140440	ENSG00000062822	5424	DNA polymerase delta 1, catalytic subunit	CDC2|POLD	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11302
6.14555808704806e-07	-0.350492356600758	0.547	0.821	0.0171860531904299	ZNF454	Malignant cells	GSE140440	ENSG00000178187	285676	zinc finger protein 454	FLJ37444	protein_coding	Q8N9F8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11303
6.14690536412739e-07	-1.0448625271589	0.847	0.888	0.0171898208507823	DLEU2	Malignant cells	GSE140440	ENSG00000231607	8847	deleted in lymphocytic leukemia 2	BCMSUN|DLB2|LEU2|LINC00022|MIR15AHG|NCRNA00022|RFP2OS|TRIM13OS	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11304
6.14892922280842e-07	-0.747692000759265	0.5	0.791	0.0171954805715838	AP000692.9	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11305
6.1779351961359e-07	-0.513114040974699	0.467	0.701	0.017276595775994	RP11-266O8.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11306
6.18081298178635e-07	0.553913988731453	0.993	0.97	0.0172846435035655	FAM208A	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11307
6.1816689388252e-07	0.681762756882689	0.993	0.963	0.0172870371874247	PIGH	Malignant cells	GSE140440	ENSG00000100564	5283	phosphatidylinositol glycan anchor biosynthesis class H	GPI-H	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11308
6.28655855812262e-07	-0.593541811077323	0.413	0.634	0.0175803610077899	RP4-714D9.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11309
6.30070932487587e-07	-0.346396785703815	1	1	0.0176199336270154	PSMC2	Malignant cells	GSE140440	ENSG00000161057	5701	proteasome 26S subunit, ATPase 2	MSS1|Nbla10058|RPT1|S7	protein_coding	P35998	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11310
6.33850122536256e-07	-1.03742653546383	0.493	0.799	0.0177256186767264	DNA2	Malignant cells	GSE140440	ENSG00000138346	1763	DNA replication helicase/nuclease 2	DNA2L|KIAA0083	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11311
6.36168257543782e-07	0.69474408908868	0.88	0.724	0.0177904453222119	REEP6	Malignant cells	GSE140440	ENSG00000115255	92840	receptor accessory protein 6	C19orf32|DP1L1|FLJ25383|Yip2f	protein_coding	Q96HR9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11312
6.41340408900144e-07	-0.368103337484711	0.333	0.642	0.0179350845348925	RP11-107M16.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11313
6.41931607810287e-07	0.280004653155634	1	1	0.0179516174124147	SPCS1	Malignant cells	GSE140440	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11314
6.42820273839304e-07	-0.412707753046456	0.52	0.806	0.0179764689579161	RP11-630A13.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11315
6.43868455893899e-07	-0.936218258394096	0.76	0.94	0.0180057813690729	SETD8	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11316
6.45799331943849e-07	-1.76716186495749	0.287	0.575	0.0180597783178097	HOXA13	Malignant cells	GSE140440	ENSG00000106031	3209	homeobox A13	HOX1|HOX1J	protein_coding	P31271	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11317
6.47000007746963e-07	-0.324192922732225	0.473	0.761	0.0180933552166438	RP11-417O18.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11318
6.4723035930317e-07	0.778486195434916	0.907	0.761	0.0180997969979131	STEAP3	Malignant cells	GSE140440	ENSG00000115107	55240	STEAP3 metalloreductase	dudlin-2|STMP3|TSAP6	protein_coding	Q658P3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11319
6.48350382842116e-07	-0.341515729420117	0.4	0.709	0.0181311184561798	CEP83-AS1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11320
6.50802079315566e-07	-0.734635847933818	0.373	0.679	0.0181996801480598	CH507-9B2.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11321
6.50832204184035e-07	1.19302898808787	0.747	0.552	0.0182005225900065	TMEM51	Malignant cells	GSE140440	ENSG00000171729	55092	transmembrane protein 51	C1orf72|FLJ10199	protein_coding	Q9NW97	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11322
6.51636289771292e-07	1.64394054422791	0.5	0.254	0.0182230088434542	TM4SF1-AS1	Malignant cells	GSE140440	ENSG00000240541	100874091	TM4SF1 antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11323
6.60726766581777e-07	-0.855589930322025	0.627	0.881	0.0184772240274594	BRCA1	Malignant cells	GSE140440	ENSG00000012048	672	BRCA1 DNA repair associated	BRCC1|FANCS|PPP1R53|RNF53	protein_coding	P38398	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11324
6.61797741460998e-07	-0.456790801492527	0.5	0.754	0.0185071738399568	CTD-2371O3.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11325
6.63790473209985e-07	-0.721412675960416	0.527	0.776	0.0185629005833172	CTD-2542C24.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11326
6.67409136105994e-07	0.89981439480809	0.927	0.873	0.0186640964912041	YEATS4	Malignant cells	GSE140440	ENSG00000127337	8089	YEATS domain containing 4	GAS41|NuBI-1|YAF9	protein_coding	O95619	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11327
6.68221334030552e-07	-0.804407665231867	0.973	0.993	0.0186868096061644	NPLOC4	Malignant cells	GSE140440	ENSG00000182446	55666	NPL4 homolog, ubiquitin recognition factor	FLJ20657|KIAA1499|NPL4	protein_coding	Q8TAT6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11328
6.68773932397403e-07	-0.330211325552092	0.247	0.56	0.0187022630194934	GLB1L2	Malignant cells	GSE140440	ENSG00000149328	89944	galactosidase beta 1 like 2	NA	protein_coding	Q8IW92	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11329
6.70663341248294e-07	0.926162702472519	0.733	0.485	0.0187551003380085	MTHFSD	Malignant cells	GSE140440	ENSG00000103248	64779	methenyltetrahydrofolate synthetase domain containing	FLJ12998	protein_coding	Q2M296	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11330
6.71606831802284e-07	0.735347018172011	0.907	0.821	0.0187814850513509	EIF3J-AS1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11331
6.74835635426426e-07	0.891718283984268	0.827	0.709	0.0188717785447	RNF214	Malignant cells	GSE140440	ENSG00000167257	257160	ring finger protein 214	DKFZp547C195	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11332
6.77515835624121e-07	0.414233118584994	0.947	0.672	0.0189467303432286	SMAP1	Malignant cells	GSE140440	ENSG00000112305	60682	small ArfGAP 1	FLJ13159|SMAP-1	protein_coding	Q8IYB5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11333
6.79930332047165e-07	-2.03364654712021	0.353	0.59	0.019014251735699	IRF7	Malignant cells	GSE140440	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11334
6.82103365072204e-07	1.39924359208477	0.667	0.373	0.0190750206042442	PARP8	Malignant cells	GSE140440	ENSG00000151883	79668	poly(ADP-ribose) polymerase family member 8	ARTD16|FLJ21308|pART16	protein_coding	Q8N3A8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11335
6.82871605079841e-07	-0.628871340264958	0.493	0.716	0.0190965044360577	FHDC1	Malignant cells	GSE140440	ENSG00000137460	85462	FH2 domain containing 1	INF1|KIAA1727	protein_coding	Q9C0D6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11336
6.8333587118822e-07	-0.444393724711744	0.153	0.425	0.0191094876377786	MEGF6	Malignant cells	GSE140440	ENSG00000162591	1953	multiple EGF like domains 6	EGFL3	protein_coding	O75095	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11337
6.83651943209386e-07	-0.339833727084726	0.527	0.799	0.0191183265918505	AC004824.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11338
6.85870856596287e-07	0.375781474756085	1	0.985	0.0191803785047152	HIGD2A	Malignant cells	GSE140440	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11339
6.87145674460633e-07	-1.91507032009123	0.06	0.276	0.0192160287862916	NIPAL4	Malignant cells	GSE140440	ENSG00000172548	348938	NIPA like domain containing 4	ICHYN|SLC57A6	protein_coding	Q0D2K0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11340
6.89387215051252e-07	-0.61194411463504	0.193	0.47	0.0192787134689083	RHBDL1	Malignant cells	GSE140440	ENSG00000103269	9028	rhomboid like 1	RHBDL|RRP	protein_coding	O75783	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11341
6.92463836344575e-07	-1.0315410595977	0.547	0.784	0.019364751183376	FAM111B	Malignant cells	GSE140440	ENSG00000189057	374393	FAM111 trypsin like peptidase B	CANP	protein_coding	Q6SJ93	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11342
6.94210821816655e-07	-0.836323300031594	0.413	0.701	0.0194136056321028	RP11-551L14.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11343
6.94871905603414e-07	-0.302552469691002	0.487	0.754	0.0194320928401995	RP11-473I1.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11344
6.94927571780198e-07	0.657559098079482	1	0.97	0.0194336495448332	FLYWCH2	Malignant cells	GSE140440	ENSG00000162076	114984	FLYWCH family member 2	NA	protein_coding	Q96CP2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11345
7.02568884987178e-07	-0.423069796702639	0.567	0.806	0.0196473388686664	CD209	Malignant cells	GSE140440	ENSG00000090659	30835	CD209 molecule	CDSIGN|CLEC4L|DC-SIGN|DC-SIGN1|hDC-SIGN	protein_coding	Q9NNX6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11346
7.03216171841791e-07	-0.398107562969037	0.54	0.731	0.0196654402455557	ACTA1	Malignant cells	GSE140440	ENSG00000143632	58	actin alpha 1, skeletal muscle	ACTA|NEM3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11347
7.09542543457562e-07	-1.20560905496674	0.693	0.858	0.0198423572277907	PLAA	Malignant cells	GSE140440	ENSG00000137055	9373	phospholipase A2 activating protein	DOA1|FLJ11281|FLJ12699|PLA2P|PLAP	protein_coding	Q9Y263	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11348
7.18013863545527e-07	-0.690373429274031	1	1	0.0200792576940507	CCT3	Malignant cells	GSE140440	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11349
7.20318853725672e-07	0.518709583592374	0.98	0.963	0.0201437167444384	CASC4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11350
7.23487561515504e-07	-2.76642856334085	0.34	0.642	0.0202323296577811	CSF2	Malignant cells	GSE140440	ENSG00000164400	1437	colony stimulating factor 2	GM-CSF|GMCSF	protein_coding	P04141	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11351
7.28479276887956e-07	0.648038671517899	1	0.955	0.0203719229781717	FAM3C	Malignant cells	GSE140440	ENSG00000196937	10447	FAM3 metabolism regulating signaling molecule C	GS3876|ILEI	protein_coding	Q92520	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11352
7.34167159862395e-07	0.847113170234161	1	1	0.0205309846255519	CLU	Malignant cells	GSE140440	ENSG00000120885	1191	clusterin	APOJ|CLI|CLU1|CLU2|KUB1|SGP-2|SP-40|TRPM-2	protein_coding	P10909	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11353
7.34982294482254e-07	0.858947460971257	0.76	0.634	0.0205537798651962	C6orf203	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11354
7.36261589612282e-07	-1.66022915950893	0.287	0.582	0.0205895553535075	PRR26	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11355
7.44904205506302e-07	0.543839219949968	0.973	0.978	0.0208312461069837	HMOX2	Malignant cells	GSE140440	ENSG00000277424	3163	heme oxygenase 2	HO-2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11356
7.46077747669021e-07	0.777572615808642	0.867	0.672	0.0208640642135642	SUPT3H	Malignant cells	GSE140440	ENSG00000196284	8464	SPT3 homolog, SAGA and STAGA complex component	SPT3|SPT3L	protein_coding	O75486	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11357
7.48478673657034e-07	-0.331000982627907	0.287	0.567	0.020931206108819	RP11-756P10.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11358
7.51263230789752e-07	1.28204208604262	0.627	0.373	0.0210090762490354	GMPR	Malignant cells	GSE140440	ENSG00000137198	2766	guanosine monophosphate reductase	NA	protein_coding	P36959	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11359
7.58230677533247e-07	-0.321066527205209	0.473	0.769	0.0212039208972173	KCNH6	Malignant cells	GSE140440	ENSG00000173826	81033	potassium voltage-gated channel subfamily H member 6	erg2|HERG2|Kv11.2	protein_coding	Q9H252	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11360
7.60490394436237e-07	-0.867986234476976	0.393	0.679	0.0212671138804094	PLIN4	Malignant cells	GSE140440	ENSG00000167676	729359	perilipin 4	KIAA1881|S3-12	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11361
7.74232808131568e-07	-1.92025031338647	0.353	0.672	0.0216514204793993	SYT14	Malignant cells	GSE140440	ENSG00000143469	255928	synaptotagmin 14	FLJ34198|sytXIV	protein_coding	Q8NB59	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11362
7.78571637264888e-07	-0.445901551442978	0.547	0.776	0.0217727558361126	HIF3A	Malignant cells	GSE140440	ENSG00000124440	64344	hypoxia inducible factor 3 subunit alpha	bHLHe17|IPAS|MOP7|PASD7	protein_coding	Q9Y2N7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11363
7.79037794151881e-07	0.64543070747314	1	0.963	0.0217857919134573	ZNF24	Malignant cells	GSE140440	ENSG00000172466	7572	zinc finger protein 24	KOX17|Zfp191|ZNF191|ZSCAN3	protein_coding	P17028	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11364
7.79151564324475e-07	0.46014513351127	1	0.985	0.0217889734963339	PDHB	Malignant cells	GSE140440	ENSG00000168291	5162	pyruvate dehydrogenase E1 subunit beta	E1beta|PDHE1B	protein_coding	P11177	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11365
7.79185180925364e-07	-0.426317773909476	1	1	0.0217899135845778	VPS29	Malignant cells	GSE140440	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11366
7.81493620765078e-07	0.512464457005055	0.967	0.963	0.0218544691046954	OXR1	Malignant cells	GSE140440	ENSG00000164830	55074	oxidation resistance 1	TLDC3	protein_coding	Q8N573	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11367
7.85946432814586e-07	0.661663455863271	0.94	0.836	0.0219789919936599	LYRM1	Malignant cells	GSE140440	ENSG00000102897	57149	LYR motif containing 1	A211C6.1	protein_coding	O43325	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11368
7.91185297363898e-07	0.584456985773746	0.713	0.433	0.0221254968407814	CFL1P1	Malignant cells	GSE140440	ENSG00000282866	NA	NA	CFLP1|MGC35136	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11369
7.92342581835989e-07	-0.326077567077168	0.487	0.739	0.0221578603010434	RP11-378A13.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11370
8.00045103640592e-07	-0.988399319475795	0.36	0.672	0.0223732613233092	FAM110B	Malignant cells	GSE140440	ENSG00000169122	90362	family with sequence similarity 110 member B	C8orf72|MGC39325	protein_coding	Q8TC76	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11371
8.01981372428379e-07	-1.22194451735513	0.747	0.888	0.0224274090799596	MDN1	Malignant cells	GSE140440	ENSG00000288121	23195	midasin AAA ATPase 1	KIAA0301|Rea1	protein_coding	Q9NU22	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11372
8.04050234124461e-07	-0.553519453070275	0.347	0.649	0.0224852647972906	SNORD17	Malignant cells	GSE140440	ENSG00000212232	692086	small nucleolar RNA, C/D box 17	HBI-43	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11373
8.1126092937012e-07	-0.30618229011923	0.453	0.724	0.0226869118898354	POTEF	Malignant cells	GSE140440	ENSG00000196604	728378	POTE ankyrin domain family member F	A26C1B|POTE2alpha|POTEACTIN	protein_coding	A5A3E0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11374
8.14068341695507e-07	0.438801559189796	0.973	0.776	0.0227654211755149	PLGRKT	Malignant cells	GSE140440	ENSG00000107020	55848	plasminogen receptor with a C-terminal lysine	AD025|C9orf46|FLJ14688|MDS030|Plg-RKT	protein_coding	Q9HBL7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11375
8.14198830654666e-07	-0.734765937248865	0.86	0.978	0.0227690702992577	PBDC1	Malignant cells	GSE140440	ENSG00000102390	51260	polysaccharide biosynthesis domain containing 1	CXorf26|MGC874	protein_coding	Q9BVG4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11376
8.14533123427324e-07	0.371986466655436	0.887	0.701	0.0227784187966451	LINC01116	Malignant cells	GSE140440	ENSG00000163364	NA	NA	TALNEC2	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11377
8.22959716249494e-07	1.05682458688277	0.787	0.567	0.0230140684649171	PORCN	Malignant cells	GSE140440	ENSG00000102312	64840	porcupine O-acyltransferase	DHOF|MG61|por|PORC|PPN	protein_coding	Q9H237	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11378
8.25798038199075e-07	-0.85724708654848	0.427	0.731	0.0230934421382371	ZXDA	Malignant cells	GSE140440	ENSG00000198205	7789	zinc finger X-linked duplicated A	ZNF896	protein_coding	P98168	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11379
8.25986562756307e-07	-0.370171579908585	0.173	0.463	0.0230987142274801	UCHL1-AS1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11380
8.27479088843221e-07	0.596839052028183	0.993	0.97	0.0231404527195007	TGFB1	Malignant cells	GSE140440	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11381
8.28825557641079e-07	-0.576288070391039	0.32	0.619	0.0231781067194328	RP5-968P14.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11382
8.32335947307856e-07	-1.71233005786779	0.38	0.672	0.0232762747664642	CA9	Malignant cells	GSE140440	ENSG00000107159	768	carbonic anhydrase 9	CAIX|MN	protein_coding	Q16790	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11383
8.33970092144994e-07	0.624811909520935	0.993	0.843	0.0233219736268348	COQ9	Malignant cells	GSE140440	ENSG00000088682	57017	coenzyme Q9	C16orf49|DKFZP434K046	protein_coding	O75208	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11384
8.36419334667762e-07	-1.30738774286999	0.453	0.679	0.023390466693984	LINC01521	Malignant cells	GSE140440	ENSG00000213888	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11385
8.37137156840829e-07	-1.52807013802811	0.493	0.754	0.0234105405910538	ZNF254	Malignant cells	GSE140440	ENSG00000213096	9534	zinc finger protein 254	BMZF-5|HD-ZNF1|ZNF539|ZNF91L	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11386
8.3891069842775e-07	-0.834646730790552	0.96	0.993	0.023460137681532	DDX56	Malignant cells	GSE140440	ENSG00000136271	54606	DEAD-box helicase 56	NOH61	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11387
8.41212891777512e-07	-0.329935000126829	0.52	0.784	0.0235245185185581	RP11-466A19.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11388
8.53839768324578e-07	-1.01182393045039	0.287	0.582	0.0238776291211968	RADIL	Malignant cells	GSE140440	ENSG00000157927	55698	Rap associating with DIL domain	FLJ10324|KIAA1849|RASIP2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11389
8.58820749422079e-07	-0.524347933582975	0.347	0.664	0.0240169222575884	FAM212A	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11390
8.60759981703335e-07	-0.587756713315252	0.98	0.97	0.0240711528883338	SRP68	Malignant cells	GSE140440	ENSG00000167881	6730	signal recognition particle 68	NA	protein_coding	Q9UHB9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11391
8.73813603795352e-07	-0.467343009623302	0.513	0.799	0.024436197430137	LA16c-380H5.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11392
8.78227617774799e-07	1.1976652543488	0.607	0.366	0.0245596353310723	MYLIP	Malignant cells	GSE140440	ENSG00000007944	29116	myosin regulatory light chain interacting protein	IDOL|MIR	protein_coding	Q8WY64	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11393
8.86329826751788e-07	0.84985425478817	0.86	0.657	0.0247862136051137	ZER1	Malignant cells	GSE140440	ENSG00000160445	10444	zyg-11 related cell cycle regulator	C9orf60|Hzyg|ZYG|ZYG11BL	protein_coding	Q7Z7L7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11394
8.87078600681206e-07	-0.448455988392862	1	1	0.0248071530680499	LDHA	Malignant cells	GSE140440	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11395
8.88828444485459e-07	-1.05052826459033	0.667	0.896	0.0248560874500358	RAB27A	Malignant cells	GSE140440	ENSG00000069974	5873	RAB27A, member RAS oncogene family	GS2|HsT18676|RAB27|RAM	protein_coding	P51159	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11396
8.97036973034126e-07	-0.291531271065156	0.54	0.821	0.0250856389508993	RP11-536P6.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11397
8.97047314539323e-07	2.58503578604191	0.613	0.448	0.0250859281510922	FAR2	Malignant cells	GSE140440	ENSG00000064763	55711	fatty acyl-CoA reductase 2	FLJ10462|MLSTD1|SDR10E2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11398
8.99565032312628e-07	-1.90089185498708	0.693	0.813	0.0251563361286226	AGMAT	Malignant cells	GSE140440	ENSG00000116771	79814	agmatinase	FLJ23384	protein_coding	Q9BSE5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11399
9.00090500230586e-07	0.488195460617055	1	0.993	0.0251710308389483	ZNF706	Malignant cells	GSE140440	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11400
9.00376604224823e-07	0.745161765314996	0.933	0.784	0.0251790317371472	DPH6	Malignant cells	GSE140440	ENSG00000134146	89978	diphthamine biosynthesis 6	ATPBD4|MGC14798	protein_coding	Q7L8W6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11401
9.0338989840828e-07	0.71094647106832	0.993	0.985	0.0252632985089876	DNAJC21	Malignant cells	GSE140440	ENSG00000168724	134218	DnaJ heat shock protein family (Hsp40) member C21	DNAJA5|GS3|JJJ1	protein_coding	Q5F1R6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11402
9.13104254835923e-07	0.722076694115151	0.94	0.776	0.0255349604864866	LMBRD1	Malignant cells	GSE140440	ENSG00000168216	55788	LMBR1 domain containing 1	bA810I22.1|C6orf209|cblF|FLJ11240	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11403
9.16794437754686e-07	-0.417858707786556	0.533	0.799	0.0256381564518098	FAM9C	Malignant cells	GSE140440	ENSG00000187268	171484	family with sequence similarity 9 member C	TEX39C	protein_coding	Q8IZT9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11404
9.18212858470597e-07	0.706929306728432	0.753	0.56	0.0256778225871302	PSTK	Malignant cells	GSE140440	ENSG00000179988	118672	phosphoseryl-tRNA kinase	C10orf89|MGC35392	protein_coding	Q8IV42	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11405
9.20297651774647e-07	-0.588878754412381	0.993	1	0.025736123831878	HACD3	Malignant cells	GSE140440	ENSG00000074696	51495	3-hydroxyacyl-CoA dehydratase 3	B-ind1|HSPC121|PTPLAD1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11406
9.23850332683878e-07	3.13105563050355	0.48	0.291	0.0258354745535046	RSPH9	Malignant cells	GSE140440	ENSG00000172426	221421	radial spoke head component 9	C6orf206|CILD12|FLJ30845|MRPS18AL1	protein_coding	Q9H1X1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11407
9.24434024682963e-07	0.699231023618007	0.967	0.925	0.0258517975002591	MXD4	Malignant cells	GSE140440	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11408
9.24541209925226e-07	-0.952054168307982	0.547	0.776	0.025854794935559	ZNF813	Malignant cells	GSE140440	ENSG00000198346	126017	zinc finger protein 813	FLJ16542	protein_coding	Q6ZN06	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11409
9.34789619546269e-07	-0.381264445705042	0.173	0.448	0.0261413917106114	TMED6	Malignant cells	GSE140440	ENSG00000157315	146456	transmembrane p24 trafficking protein 6	MGC23911|p24g5|p24gamma5	protein_coding	Q8WW62	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11410
9.35895043187136e-07	-0.563827808359078	0.407	0.709	0.0261723048827283	LINC01186	Malignant cells	GSE140440	ENSG00000236751	NA	NA	ZNF674-1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11411
9.41121963202745e-07	-0.585759790070483	0.413	0.701	0.0263184757009648	CTC-499B15.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11412
9.43352056262878e-07	-0.631761888957681	0.373	0.672	0.0263808402533914	ENG	Malignant cells	GSE140440	ENSG00000106991	2022	endoglin	CD105|END|HHT1|ORW|ORW1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11413
9.50796617404387e-07	-1.10666343761735	0.2	0.485	0.0265890274057137	RP11-295H24.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11414
9.51070915188739e-07	-0.385121921374557	0.4	0.694	0.0265966981432531	RP11-446E9.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11415
9.55106572975732e-07	-0.885902985956305	0.613	0.866	0.0267095553132663	FCHO1	Malignant cells	GSE140440	ENSG00000130475	23149	FCH and mu domain containing endocytic adaptor 1	KIAA0290	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11416
9.55973219444408e-07	-0.840056018907924	0.44	0.739	0.0267337910817629	RP11-496H1.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11417
9.56023493140546e-07	-0.71361637225595	0.387	0.687	0.0267351969856754	RP11-318A15.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11418
9.58358596598921e-07	0.556530550252427	0.993	0.993	0.0268004981538888	CLINT1	Malignant cells	GSE140440	ENSG00000113282	9685	clathrin interactor 1	CLINT|ENTH|EPNR|KIAA0171	protein_coding	Q14677	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11419
9.60020941580232e-07	-2.23678212581879	0.253	0.515	0.0268469856312912	WNK4	Malignant cells	GSE140440	ENSG00000126562	65266	WNK lysine deficient protein kinase 4	PRKWNK4	protein_coding	Q96J92	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11420
9.61557172149866e-07	-0.673863588901096	0.553	0.746	0.026889946319171	RP11-354K4.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11421
9.65383535172224e-07	-1.20061862414282	0.407	0.716	0.0269969505610913	PWAR5	Malignant cells	GSE140440	ENSG00000279192	NA	NA	PAR-5|PAR5	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11422
9.83109971798583e-07	1.82960206300443	0.867	0.836	0.0274926703613474	IGFBP6	Malignant cells	GSE140440	ENSG00000167779	3489	insulin like growth factor binding protein 6	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11423
9.85724908464861e-07	-0.306031978070658	0.453	0.791	0.0275657970652198	AC016700.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11424
9.8772509640756e-07	-1.16103917173591	0.267	0.567	0.0276217323210374	CTD-2510F5.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11425
9.88110743902878e-07	-0.826703447881037	0.853	0.933	0.027632516953244	SMARCD2	Malignant cells	GSE140440	ENSG00000108604	6603	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2	BAF60B|CRACD2|PRO2451|Rsc6p	protein_coding	Q92925	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11426
9.89069726512156e-07	0.969984422307132	0.713	0.5	0.0276593349019125	RPARP-AS1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11427
9.9253011155712e-07	0.651696239566258	0.947	0.851	0.0277561045696949	ATF1	Malignant cells	GSE140440	ENSG00000123268	466	activating transcription factor 1	TREB36	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11428
9.94620450149085e-07	-0.460410048678793	0.413	0.739	0.0278145608884192	FAM86B1	Malignant cells	GSE140440	ENSG00000186523	85002	family with sequence similarity 86 member B1	MGC16279	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11429
9.96641628809535e-07	-0.260466301733906	0.287	0.582	0.0278710831496587	P3H2-AS1	Malignant cells	GSE140440	ENSG00000225764	NA	NA	LEPREL1-AS1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11430
1.00433263225031e-06	-0.863962912512591	0.547	0.799	0.02808616206088	CDCA2	Malignant cells	GSE140440	ENSG00000184661	157313	cell division cycle associated 2	PPP1R81|Repo-Man	protein_coding	Q69YH5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11431
1.0049551926802e-06	-0.315307257916524	0.407	0.724	0.0281035719633017	PERM1	Malignant cells	GSE140440	ENSG00000187642	84808	PPARGC1 and ESRR induced regulator, muscle 1	C1orf170|MGC13275|RP11-54O7.8	protein_coding	Q5SV97	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11432
1.00828752321411e-06	0.700202047096101	0.933	0.858	0.0281967605866825	CBL	Malignant cells	GSE140440	ENSG00000110395	867	Cbl proto-oncogene	c-Cbl|CBL2|RNF55	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11433
1.00918204390489e-06	-0.299859317001629	0.36	0.657	0.0282217758578003	RP11-173M1.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11434
1.0098636187559e-06	-1.76526085376083	0.287	0.56	0.0282408360985086	ARHGAP11B	Malignant cells	GSE140440	ENSG00000274734	89839	Rho GTPase activating protein 11B	B'-T|FAM7B1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11435
1.01114620126552e-06	-0.320731334104602	0.42	0.694	0.0282767035183904	RP11-326K13.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11436
1.02611574815511e-06	0.802472338547585	0.987	0.955	0.0286953268971577	RAB5B	Malignant cells	GSE140440	ENSG00000111540	5869	RAB5B, member RAS oncogene family	NA	protein_coding	P61020	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11437
1.02739018263398e-06	0.408236443770774	0.987	0.978	0.0287309664573593	FUNDC2	Malignant cells	GSE140440	ENSG00000165775	65991	FUN14 domain containing 2	DC44|HCBP6	protein_coding	Q9BWH2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11438
1.03175669218137e-06	-1.08190297048451	0.773	0.881	0.028853075896852	CHAF1A	Malignant cells	GSE140440	ENSG00000167670	10036	chromatin assembly factor 1 subunit A	CAF-1|CAF1|CAF1B|CAF1P150|MGC71229|P150	protein_coding	Q13111	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11439
1.03188432145106e-06	-0.468759968045262	0.513	0.746	0.028856645049379	RP11-147L13.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11440
1.03231387292097e-06	0.58020849635366	0.993	0.881	0.0288686574562349	STXBP3	Malignant cells	GSE140440	ENSG00000116266	6814	syntaxin binding protein 3	UNC-18C	protein_coding	O00186	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11441
1.03555504515298e-06	-0.365642913434332	0.527	0.784	0.0289592968377031	RP11-375O18.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11442
1.0384691122555e-06	1.10838653909365	0.547	0.276	0.0290407887242251	REEP1	Malignant cells	GSE140440	ENSG00000068615	65055	receptor accessory protein 1	C2orf23|FLJ13110|SPG31|Yip2a	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11443
1.04485979817173e-06	-0.276764743284138	0.507	0.784	0.0292195042558725	RP5-882O7.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11444
1.04630867206808e-06	0.564147276504515	0.94	0.799	0.0292600220143839	ADIPOR2	Malignant cells	GSE140440	ENSG00000285070	79602	adiponectin receptor 2	ACDCR2|PAQR2	protein_coding	Q86V24	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11445
1.05514225246326e-06	-0.451133560785935	0.42	0.724	0.0295070530901349	RP11-314A20.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11446
1.06073035883716e-06	-0.767298845975915	0.987	0.985	0.0296633244848811	UPF2	Malignant cells	GSE140440	ENSG00000151461	26019	UPF2 regulator of nonsense mediated mRNA decay	DKFZP434D222|KIAA1408|RENT2|smg-3	protein_coding	Q9HAU5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11447
1.06365674144633e-06	0.893729609800229	0.853	0.687	0.0297451607745467	CEP19	Malignant cells	GSE140440	ENSG00000174007	84984	centrosomal protein 19	C3orf34|MGC14126	protein_coding	Q96LK0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11448
1.07102717674716e-06	1.01969726976456	0.707	0.47	0.0299512749977344	NMU	Malignant cells	GSE140440	ENSG00000109255	10874	neuromedin U	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11449
1.07793108135967e-06	0.550324508972146	1	0.97	0.0301443426902231	ALDH3A2	Malignant cells	GSE140440	ENSG00000072210	224	aldehyde dehydrogenase 3 family member A2	ALDH10|FALDH|SLS	protein_coding	P51648	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11450
1.08203017537338e-06	-0.868037615357845	0.82	0.963	0.0302589738543165	MIS18BP1	Malignant cells	GSE140440	ENSG00000129534	55320	MIS18 binding protein 1	C14orf106|FLJ11186|KIAA1903|KNL2|M18BP1	protein_coding	Q6P0N0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11451
1.08582990019068e-06	0.824265448929211	0.987	0.985	0.0303652331588325	CCNH	Malignant cells	GSE140440	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11452
1.09718845377387e-06	-0.318465312359488	0.273	0.56	0.0306828751097864	KRT18P17	Malignant cells	GSE140440	ENSG00000213943	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11453
1.09768039418637e-06	-0.284408056626361	0.567	0.843	0.030696632223422	MORF4	Malignant cells	GSE140440	ENSG00000234801	NA	NA	SEN|SEN1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11454
1.09974351559641e-06	0.971867870134473	0.86	0.694	0.0307543274136535	COG6	Malignant cells	GSE140440	ENSG00000133103	57511	component of oligomeric golgi complex 6	COD2|KIAA1134	protein_coding	Q9Y2V7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11455
1.10015167688674e-06	2.20435063124163	0.46	0.224	0.0307657416441376	ARHGEF40	Malignant cells	GSE140440	ENSG00000165801	55701	Rho guanine nucleotide exchange factor 40	FLJ10357|solo	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11456
1.10188706535907e-06	0.531353149306447	0.973	0.776	0.0308142717827663	PWWP2A	Malignant cells	GSE140440	ENSG00000170234	114825	PWWP domain containing 2A	KIAA1935	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11457
1.10338359603516e-06	-0.628684820626719	0.387	0.694	0.0308561222631233	OGN	Malignant cells	GSE140440	ENSG00000106809	4969	osteoglycin	mimecan|OIF|SLRR3A	protein_coding	P20774	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11458
1.10590432757009e-06	1.14838060740546	0.767	0.552	0.0309266145204975	B3GLCT	Malignant cells	GSE140440	ENSG00000187676	145173	beta 3-glucosyltransferase	B3GALTL|B3Glc-T|B3GTL	protein_coding	Q6Y288	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11459
1.11004681750155e-06	-0.765793807134575	0.453	0.754	0.0310424592514309	RP11-22B23.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11460
1.11069099782301e-06	-0.292364780454704	0.527	0.799	0.0310604737541205	ABT1P1	Malignant cells	GSE140440	ENSG00000250496	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11461
1.11845675930757e-06	-0.341603458207904	0.54	0.791	0.0312776432740362	SHC1P2	Malignant cells	GSE140440	ENSG00000267691	NA	NA	SHCL1	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11462
1.13052340950914e-06	0.727246758582887	0.9	0.776	0.031615087146923	INSIG2	Malignant cells	GSE140440	ENSG00000125629	51141	insulin induced gene 2	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11463
1.13483402904556e-06	0.526000106341863	0.82	0.575	0.031735633622259	TMEM45A	Malignant cells	GSE140440	ENSG00000181458	55076	transmembrane protein 45A	DERP7|FLJ10134	protein_coding	Q9NWC5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11464
1.14307830204677e-06	0.272836839886569	1	1	0.0319661847167379	POLR2G	Malignant cells	GSE140440	ENSG00000168002	5436	RNA polymerase II subunit G	hRPB19|hsRPB7|RPB7	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11465
1.14394681013753e-06	3.26558793944123	0.42	0.224	0.0319904725454961	RP11-18B16.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11466
1.14652267021469e-06	4.52285440671162	0.4	0.187	0.0320625064725537	S100A9	Malignant cells	GSE140440	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11467
1.14875112819053e-06	2.63296721683512	0.44	0.224	0.0321248252998482	PIEZO2	Malignant cells	GSE140440	ENSG00000154864	63895	piezo type mechanosensitive ion channel component 2	C18orf30|C18orf58|FAM38B|FAM38B2|FLJ23144|FLJ23403|FLJ34907|HsT748|HsT771	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11468
1.15933401678485e-06	4.32859358341239	0.547	0.328	0.0324207757793884	CDH6	Malignant cells	GSE140440	ENSG00000113361	1004	cadherin 6	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11469
1.17276074416264e-06	-0.619107794697852	0.4	0.687	0.0327962542105081	BRSK2	Malignant cells	GSE140440	ENSG00000174672	9024	BR serine/threonine kinase 2	C11orf7|PEN11B|SAD-A|STK29	protein_coding	Q8IWQ3	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11470
1.17438668647487e-06	-0.435747994444525	0.5	0.791	0.0328417236872698	RP5-1024G6.7	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11471
1.18136841575721e-06	-0.655458283824647	0.387	0.679	0.0330369677466503	RAB5CP1	Malignant cells	GSE140440	ENSG00000213731	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11472
1.18154363035737e-06	-1.07232826784222	0.733	0.881	0.0330418676229439	REEP4	Malignant cells	GSE140440	ENSG00000168476	80346	receptor accessory protein 4	C8orf20|FLJ22246|FLJ22277|PP432|Yip2c	protein_coding	Q9H6H4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11473
1.18560786751936e-06	-1.18929922044201	0.52	0.746	0.0331555240151789	PCDHB13	Malignant cells	GSE140440	ENSG00000187372	56123	protocadherin beta 13	PCDH-BETA13	protein_coding	Q9Y5F0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11474
1.18597717606792e-06	-0.361633568452187	0.453	0.716	0.0331658517287393	RP5-1142A6.8	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11475
1.19061130011067e-06	-0.303020841159663	0.467	0.739	0.0332954450075949	RP11-713P17.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11476
1.20095462663587e-06	1.29270317935105	0.92	0.858	0.0335846961338721	CHRNB1	Malignant cells	GSE140440	ENSG00000283946	1140	cholinergic receptor nicotinic beta 1 subunit	CHRNB	protein_coding	P11230	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11477
1.20832403395453e-06	-0.955633265798172	0.32	0.619	0.0337907816095385	RP11-169K17.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11478
1.21165183253899e-06	-0.561719058085082	0.273	0.575	0.0338838434969528	FAM109B	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11479
1.21600114397481e-06	0.598937768171365	1	0.97	0.0340054719912555	EMC2	Malignant cells	GSE140440	ENSG00000104412	9694	ER membrane protein complex subunit 2	KIAA0103|TTC35	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11480
1.2220519851196e-06	-0.332654501480421	0.313	0.59	0.0341746837638697	RP11-114M1.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11481
1.23917194471081e-06	-1.12217608149069	0.847	0.866	0.0346534434338379	ZNF124	Malignant cells	GSE140440	ENSG00000196418	7678	zinc finger protein 124	HZF-16|HZF16	protein_coding	Q15973	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11482
1.26145871585758e-06	-0.739016066029031	0.967	1	0.0352766929889571	TUBG1	Malignant cells	GSE140440	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11483
1.26609774713302e-06	-0.666014334026512	0.993	1	0.0354064234985749	UBAP2L	Malignant cells	GSE140440	ENSG00000143569	9898	ubiquitin associated protein 2 like	KIAA0144|NICE-4	protein_coding	Q14157	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11484
1.28481431267932e-06	-0.376361699554236	1	1	0.0359298322540771	COPS6	Malignant cells	GSE140440	ENSG00000168090	10980	COP9 signalosome subunit 6	CSN6|MOV34-34KD	protein_coding	Q7L5N1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11485
1.29542794796443e-06	-0.520514516857439	0.573	0.784	0.0362266425648253	SV2B	Malignant cells	GSE140440	ENSG00000185518	9899	synaptic vesicle glycoprotein 2B	HsT19680|KIAA0735	protein_coding	Q7L1I2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11486
1.29685254909987e-06	0.749832398331163	0.84	0.619	0.0362664815355777	ITGA5	Malignant cells	GSE140440	ENSG00000161638	3678	integrin subunit alpha 5	CD49e|FNRA	protein_coding	P08648	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11487
1.29913962455791e-06	-0.933081262698861	0.573	0.739	0.0363304396007621	SLC12A8	Malignant cells	GSE140440	ENSG00000221955	84561	solute carrier family 12 member 8	CCC9	protein_coding	A0AV02	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11488
1.30107891477388e-06	1.33233999717214	0.64	0.403	0.0363846718516515	FRG1CP	Malignant cells	GSE140440	ENSG00000282826	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11489
1.30342958082336e-06	-0.385121921374557	0.24	0.53	0.0364504082277253	CTA-384D8.36	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11490
1.30829751954419e-06	0.303245076594846	1	1	0.0365865401340534	REXO2	Malignant cells	GSE140440	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11491
1.30951527364576e-06	0.545890102429337	0.94	0.851	0.0366205946275037	CLK1	Malignant cells	GSE140440	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11492
1.31796553482196e-06	0.398402955374387	1	1	0.0368569061812961	CD46	Malignant cells	GSE140440	ENSG00000117335	4179	CD46 molecule	MCP|MGC26544|MIC10|TLX|TRA2.10	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11493
1.32591331710223e-06	-0.556326475043441	0.48	0.746	0.0370791659127638	RP11-485G7.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11494
1.32593667753295e-06	-1.16858222628355	0.48	0.761	0.0370798191872089	ZNF20	Malignant cells	GSE140440	ENSG00000132010	7568	zinc finger protein 20	KOX13	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11495
1.33133018283173e-06	-0.297659080124217	0.587	0.836	0.0372306485628894	PRDX1P1	Malignant cells	GSE140440	ENSG00000214121	NA	NA	PAGB|TDPX2	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11496
1.3347300830367e-06	-0.333325054613984	0.473	0.769	0.0373257267721214	FLJ35934	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11497
1.33612526745957e-06	0.528703477394777	0.993	1	0.0373647431045069	CSTF1	Malignant cells	GSE140440	ENSG00000101138	1477	cleavage stimulation factor subunit 1	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11498
1.33933926285811e-06	1.15455766514174	0.553	0.284	0.037454622485827	B3GALT1	Malignant cells	GSE140440	ENSG00000172318	8708	beta-1,3-galactosyltransferase 1	beta3Gal-T1	protein_coding	Q9Y5Z6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11499
1.34543405907204e-06	1.33321320829209	0.867	0.791	0.0376250634619495	GRPEL2	Malignant cells	GSE140440	ENSG00000164284	134266	GrpE like 2, mitochondrial	DKFZp451C205|FLJ23713|Mt-GrpE#2	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11500
1.35208916489886e-06	0.320776774696716	1	1	0.0378111734963967	MT-RNR2	Malignant cells	GSE140440	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11501
1.35657377672637e-06	-0.748300384471778	1	0.993	0.037936585666153	SFT2D2	Malignant cells	GSE140440	ENSG00000213064	375035	SFT2 domain containing 2	dJ747L4.C1.2|UNQ512	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11502
1.36252008572164e-06	3.27138386551082	0.407	0.187	0.0381028741972057	IL18R1	Malignant cells	GSE140440	ENSG00000115604	8809	interleukin 18 receptor 1	CD218a|IL-1Rrp|IL1RRP	protein_coding	Q13478	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11503
1.37229868435736e-06	1.14519812668065	0.627	0.351	0.0383763327080537	GLTSCR1L	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11504
1.37320313693183e-06	-0.422664667213016	0.473	0.769	0.0384016257242986	RP13-216E22.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11505
1.37616363646906e-06	0.436695734679893	1	0.955	0.0384844160938573	SEC11C	Malignant cells	GSE140440	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11506
1.38453478561845e-06	-1.21939184481799	0.947	0.94	0.0387185152798201	NOC2L	Malignant cells	GSE140440	ENSG00000188976	26155	NOC2 like nucleolar associated transcriptional repressor	DKFZP564C186|NET15|NET7|NIR|PPP1R112	protein_coding	Q9Y3T9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11507
1.38463866209956e-06	-0.581628162121118	0.507	0.761	0.0387214201856141	APOLD1	Malignant cells	GSE140440	ENSG00000178878	81575	apolipoprotein L domain containing 1	DKFZP434F0318|FLJ25138	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11508
1.38837903893286e-06	-1.44782764153789	0.493	0.754	0.0388260198237575	SPHK1	Malignant cells	GSE140440	ENSG00000176170	8877	sphingosine kinase 1	SPHK	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11509
1.39443427694919e-06	0.973051059684323	0.827	0.672	0.0389953545548841	FAM168A	Malignant cells	GSE140440	ENSG00000054965	23201	family with sequence similarity 168 member A	KIAA0280|TCRP1	protein_coding	Q92567	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11510
1.39777570128281e-06	-0.554915722272792	0.907	0.978	0.0390887974863739	VRK1	Malignant cells	GSE140440	ENSG00000100749	7443	VRK serine/threonine kinase 1	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11511
1.40137553379888e-06	0.895995513346774	0.453	0.201	0.0391894668026857	LINC00920	Malignant cells	GSE140440	ENSG00000246898	NA	NA	CALIC|LINRIS	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11512
1.40905889619343e-06	-0.476976857843847	0.44	0.724	0.0394043320320493	C19orf35	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11513
1.41425126291648e-06	-0.41601592932034	0.493	0.769	0.0395495365674594	RP11-429J17.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11514
1.42017169896353e-06	-0.8696242403165	0.4	0.672	0.0397151015615151	FOXP1-AS1	Malignant cells	GSE140440	ENSG00000244203	104502416	FOXP1 antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11515
1.43133788092501e-06	-0.330362689972431	0.453	0.694	0.0400273638400678	VAC14-AS1	Malignant cells	GSE140440	ENSG00000214353	100130894	VAC14 antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11516
1.43505279226088e-06	-0.820127836885996	0.307	0.612	0.0401312513355755	RP11-689C9.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11517
1.43789999900812e-06	0.511096052898512	1	0.985	0.0402108734722621	METTL9	Malignant cells	GSE140440	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11518
1.4442003383541e-06	1.67425960664862	0.653	0.478	0.0403870624620724	AP000783.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11519
1.44484163322825e-06	0.803909186717635	0.827	0.664	0.040404996273228	C2orf76	Malignant cells	GSE140440	ENSG00000186132	130355	chromosome 2 open reading frame 76	AIM29|LOC130355|MGC104437	protein_coding	Q3KRA6	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11520
1.44772978038626e-06	1.92421826241169	0.807	0.724	0.0404857633085018	MAST4	Malignant cells	GSE140440	ENSG00000069020	375449	microtubule associated serine/threonine kinase family member 4	KIAA0303	protein_coding	O15021	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11521
1.44980347181001e-06	-0.664451057800262	0.413	0.716	0.040543754089167	ATP5G1P4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11522
1.45246407749479e-06	0.928358637200018	0.9	0.739	0.0406181579271417	ENPP4	Malignant cells	GSE140440	ENSG00000001561	22875	ectonucleotide pyrophosphatase/phosphodiesterase 4	AP3Aase|KIAA0879|NPP4	protein_coding	Q9Y6X5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11523
1.45329732417536e-06	-0.999812535331958	0.693	0.851	0.0406414596705639	CDCA7	Malignant cells	GSE140440	ENSG00000144354	83879	cell division cycle associated 7	FLJ14736|JPO1	protein_coding	Q9BWT1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11524
1.45400478612834e-06	-0.428319610775659	0.527	0.791	0.040661243844079	ACTG1P9	Malignant cells	GSE140440	ENSG00000229349	NA	NA	ACTGP9	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11525
1.45786259750588e-06	-0.391656051551638	0.4	0.701	0.0407691275392519	SLC7A2	Malignant cells	GSE140440	ENSG00000003989	6542	solute carrier family 7 member 2	ATRC2|CAT-2|HCAT2	protein_coding	P52569	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11526
1.47029723324849e-06	-0.323850489646975	0.387	0.679	0.041116862127794	NRG4	Malignant cells	GSE140440	ENSG00000169752	145957	neuregulin 4	HRG4	protein_coding	Q8WWG1	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11527
1.47087754465428e-06	-0.64212624511333	0.36	0.672	0.0411330905362569	SPTBN4	Malignant cells	GSE140440	ENSG00000160460	57731	spectrin beta, non-erythrocytic 4	KIAA1642|SPTBN3	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11528
1.47103117729177e-06	-0.518666487090369	0.313	0.604	0.0411373868729642	RP11-219B4.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11529
1.47888926247129e-06	-0.672403873455028	0.16	0.418	0.0413571382250096	KCNK5	Malignant cells	GSE140440	ENSG00000164626	8645	potassium two pore domain channel subfamily K member 5	K2p5.1|TASK-2|TASK2	protein_coding	O95279	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11530
1.49628799004317e-06	-0.618904932527006	0.893	0.978	0.0418436936415574	ZWILCH	Malignant cells	GSE140440	ENSG00000174442	55055	zwilch kinetochore protein	FLJ10036|KNTC1AP	protein_coding	Q9H900	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11531
1.49637184108549e-06	0.473830013401599	0.993	0.978	0.0418460385359557	ILK	Malignant cells	GSE140440	ENSG00000166333	3611	integrin linked kinase	NA	protein_coding	Q13418	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11532
1.49811392175811e-06	0.988843130912062	0.967	0.784	0.0418947558219655	PSMD5-AS1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11533
1.51220360085428e-06	0.808200575505571	0.933	0.881	0.0422887736978901	RBM48	Malignant cells	GSE140440	ENSG00000127993	84060	RNA binding motif protein 48	C7orf64|DKFZp564O0523|HSPC304	protein_coding	Q5RL73	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11534
1.51965530968459e-06	0.651815206703956	0.8	0.455	0.0424971607353295	TGFB1I1	Malignant cells	GSE140440	ENSG00000140682	7041	transforming growth factor beta 1 induced transcript 1	ARA55|Hic-5|TSC-5	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11535
1.52026877739227e-06	-0.567632622183239	0.347	0.634	0.0425143163597749	KBTBD11-OT1	Malignant cells	GSE140440	ENSG00000253696	104266957	KBTBD11 overlapping transcript 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11536
1.52498622424589e-06	-0.867815583035565	0.84	0.97	0.0426462397610364	TSPAN4	Malignant cells	GSE140440	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11537
1.52628117839817e-06	0.526089778481875	0.98	0.91	0.0426824531539047	CCNDBP1	Malignant cells	GSE140440	ENSG00000166946	23582	cyclin D1 binding protein 1	DIP1|GCIP|HHM	protein_coding	O95273	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11538
1.52731319515474e-06	-0.80603598699007	0.327	0.604	0.0427113135025023	RP4-604K5.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11539
1.53782187804677e-06	0.709909116468705	0.973	0.799	0.0430051888195781	EXOC3	Malignant cells	GSE140440	ENSG00000180104	11336	exocyst complex component 3	Sec6|SEC6L1	protein_coding	O60645	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11540
1.53799677016788e-06	-1.02621641608338	0.96	1	0.0430100796777447	HSPA4L	Malignant cells	GSE140440	ENSG00000164070	22824	heat shock protein family A (Hsp70) member 4 like	APG-1|HSPH3|Osp94	protein_coding	O95757	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11541
1.55101743337224e-06	0.543988800654229	1	0.993	0.0433742025242547	SPATS2	Malignant cells	GSE140440	ENSG00000123352	65244	spermatogenesis associated serine rich 2	FLJ13117|SCR59|SPATA10	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11542
1.55109207591865e-06	0.702489673519443	0.973	0.828	0.0433762899030651	TMEM141	Malignant cells	GSE140440	ENSG00000244187	85014	transmembrane protein 141	MGC14141	protein_coding	Q96I45	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11543
1.55116033424008e-06	-1.1282199696115	0.453	0.731	0.0433781987470238	TRMT61A	Malignant cells	GSE140440	ENSG00000166166	115708	tRNA methyltransferase 61A	C14orf172|FLJ40452|GCD14|Gcd14p|hTRM61	protein_coding	Q96FX7	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11544
1.56904896813273e-06	-0.631683892793912	0.487	0.754	0.0438784543938319	RP11-486A14.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11545
1.57357463419609e-06	-1.19197979688094	0.487	0.724	0.0440050146452936	NEIL3	Malignant cells	GSE140440	ENSG00000109674	55247	nei like DNA glycosylase 3	FLJ10858|FPG2|hFPG2|hNEI3|ZGRF3	protein_coding	Q8TAT5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11546
1.57859578951574e-06	-0.450655081413613	0.5	0.784	0.0441454312538076	RP11-568J23.2	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11547
1.57953411935904e-06	-0.295623770535454	0.467	0.746	0.0441716716478755	CTD-2313F11.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11548
1.58580385868824e-06	-0.375458824023837	0.36	0.649	0.0443470049082167	APOBEC3B-AS1	Malignant cells	GSE140440	ENSG00000262679	100874530	APOBEC3B antisense RNA 1	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11549
1.59343000815701e-06	-0.849148405344035	0.587	0.784	0.0445602701781108	RAD51	Malignant cells	GSE140440	ENSG00000051180	5888	RAD51 recombinase	BRCC5|FANCR|HsRad51|HsT16930|RAD51A|RECA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11550
1.59563446272351e-06	-0.347154071175536	0.453	0.701	0.044621917750063	CTD-2561B21.5	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11551
1.60080240332807e-06	-1.16715885983218	0.687	0.858	0.0447664392090696	IPO4	Malignant cells	GSE140440	ENSG00000285248	79711	importin 4	FLJ23338|Imp4	protein_coding	Q8TEX9	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11552
1.62601183201804e-06	-0.751648607211152	1	1	0.0454714208823845	PPIG	Malignant cells	GSE140440	ENSG00000138398	9360	peptidylprolyl isomerase G	CARS-Cyp|SCAF10|SRCyp	protein_coding	Q13427	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11553
1.62808602948736e-06	0.932775090045475	0.96	0.813	0.0455294258146141	B3GNT5	Malignant cells	GSE140440	ENSG00000176597	84002	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	B3GN-T5|beta3Gn-T5	protein_coding	Q9BYG0	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11554
1.63815175800581e-06	1.26572730146593	1	1	0.0458109139126324	TIMP1	Malignant cells	GSE140440	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11555
1.63816491017214e-06	-0.464265806094293	0.42	0.724	0.0458112817129638	RP11-29H23.4	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11556
1.64649208277474e-06	-0.889711005631693	0.38	0.679	0.0460441510947957	RP11-20I23.8	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11557
1.6483847150324e-06	-0.417986555280183	0.46	0.769	0.0460970785558811	WISP3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11558
1.65237753639647e-06	0.657434424356713	0.653	0.388	0.0462087378053272	CH17-340M24.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11559
1.65496148955213e-06	1.01939406793008	0.733	0.53	0.0462809980553253	LHFP	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11560
1.65654562879393e-06	-0.405784573611061	0.293	0.597	0.0463252985092223	HIST1H2BH	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11561
1.65751251083222e-06	-0.444336011908324	0.533	0.731	0.046352337365423	RN7SL605P	Malignant cells	GSE140440	ENSG00000265566	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11562
1.66177791052023e-06	0.792080962448054	1	0.978	0.0464716192676982	GRN	Malignant cells	GSE140440	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11563
1.66177901051003e-06	-0.561070710444639	0.493	0.769	0.0464716500289129	C14orf132	Malignant cells	GSE140440	ENSG00000227051	56967	chromosome 14 open reading frame 132	C14orf88	protein_coding	Q9NPU4	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11564
1.66609366105156e-06	0.490103531070645	0.98	0.963	0.0465923092313069	YWHAG	Malignant cells	GSE140440	ENSG00000170027	7532	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma	14-3-3GAMMA|PPP1R170	protein_coding	P61981	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11565
1.67498685911959e-06	0.865345451574609	0.827	0.582	0.0468410075152793	ACAD8	Malignant cells	GSE140440	ENSG00000151498	27034	acyl-CoA dehydrogenase family member 8	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11566
1.67721127220838e-06	-3.11466488684536	0.487	0.672	0.0469032132273072	SLITRK5	Malignant cells	GSE140440	ENSG00000165300	26050	SLIT and NTRK like family member 5	bA364G4.2|KIAA0918|LRRC11	protein_coding	O94991	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11567
1.67920645222249e-06	-0.313509452213718	0.513	0.776	0.0469590084364019	AC079776.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11568
1.69179010437691e-06	-0.50403661078358	0.553	0.776	0.0473109102689004	GABRG3	Malignant cells	GSE140440	ENSG00000182256	2567	gamma-aminobutyric acid type A receptor subunit gamma3	NA	protein_coding	Q99928	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11569
1.70100685134515e-06	0.955175816200514	0.873	0.739	0.0475686565978673	NUDT12	Malignant cells	GSE140440	ENSG00000112874	83594	nudix hydrolase 12	DKFZP761I172	protein_coding	Q9BQG2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11570
1.7022080525267e-06	-0.695523762880891	0.98	0.993	0.0476022481889091	H2AFJ	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11571
1.70486121671301e-06	-0.368478165254685	0.553	0.821	0.0476764439253793	AP001992.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11572
1.70831376593476e-06	-0.68041304785825	0.473	0.716	0.0477729944643657	RP11-20I23.6	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11573
1.73062502841374e-06	-0.996704751347548	0.873	0.933	0.0483969289195904	KIAA2013	Malignant cells	GSE140440	ENSG00000116685	90231	KIAA2013	MGC33867|RP5-1077B9.1	protein_coding	Q8IYS2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11574
1.73088861704995e-06	-0.57162770634407	0.66	0.881	0.0484043001758018	HMMR	Malignant cells	GSE140440	ENSG00000072571	3161	hyaluronan mediated motility receptor	CD168|RHAMM	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11575
1.74131962636865e-06	0.446800194611024	1	1	0.0486960033513994	AUP1	Malignant cells	GSE140440	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11576
1.74231425519556e-06	-0.313351363084798	0.373	0.649	0.0487238181465438	RP11-145E17.3	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11577
1.74544882400959e-06	-1.25274753616664	0.913	0.94	0.0488114763634281	SNHG1	Malignant cells	GSE140440	ENSG00000255717	23642	small nucleolar RNA host gene 1	LINC00057|lncRNA16|NCRNA00057|UHG	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11578
1.75560190887073e-06	1.03453134346517	0.88	0.709	0.0490954073815698	ABHD17C	Malignant cells	GSE140440	ENSG00000136379	58489	abhydrolase domain containing 17C, depalmitoylase	FAM108C1	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11579
1.75985831662197e-06	1.06680695535623	0.687	0.507	0.0492144378243333	C17orf67	Malignant cells	GSE140440	ENSG00000214226	339210	chromosome 17 open reading frame 67	NA	protein_coding	Q0P5P2	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11580
1.76007400242627e-06	1.35764929447286	0.56	0.336	0.0492204694778507	PSORS1C1	Malignant cells	GSE140440	ENSG00000231094	170679	psoriasis susceptibility 1 candidate 1	C6orf16|SEEK1	protein_coding	Q9UIG5	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11581
1.76282510127556e-06	-0.468665562157569	0.18	0.448	0.0492974039571711	ZNF763	Malignant cells	GSE140440	ENSG00000197054	284390	zinc finger protein 763	ZNF440L	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11582
1.77360430492987e-06	-0.368820109045456	0.513	0.791	0.0495988443873639	RP11-42F12.1	Malignant cells	GSE140440	NA	NA	NA	NA	NA	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11583
1.77869948649235e-06	0.607365395719954	1	0.993	0.0497413311397586	FKBP14	Malignant cells	GSE140440	ENSG00000106080	55033	FKBP prolyl isomerase 14	FKBP22|FLJ20731	protein_coding	Q9NWM8	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11584
1.78023763477423e-06	-1.275437332931	0.347	0.612	0.0497843454564612	PKP3	Malignant cells	GSE140440	ENSG00000184363	11187	plakophilin 3	NA	protein_coding	NA	GSE140440	GSE140440	Prostate cancer	Prostate cancer	Chemotherapy	NA	docetaxel	Homo sapiens	DU145 and PC cell lines	Cell line	resistant 2, sensitive 2	4	284	Public on Sep 01, 2020	32513898	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA589746	SMART-seq v4	NA	Prostate_cancer	Chemotherapy	11585
8.61776111414923e-230	1.27788943574576	0.671	0.016	1.40124795716067e-225	RPL21	Malignant cells	GSE149214	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11586
9.5360181678369e-193	1.01328561649467	0.583	0.008	1.55055655409028e-188	RPL7	Malignant cells	GSE149214	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11587
6.80440667224613e-176	1.09699459877735	0.847	0.418	1.10639652490722e-171	EEF1A1	Malignant cells	GSE149214	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11588
3.03719548462455e-157	1.12254156908571	0.637	0.113	4.93847985799951e-153	CCDC80	Malignant cells	GSE149214	ENSG00000091986	151887	coiled-coil domain containing 80	CL2|DRO1|LINC01279|SSG1|TCONS_00006930|URB	protein_coding	Q76M96	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11589
3.40914099217674e-141	0.921294573619267	0.613	0.122	5.54326325327938e-137	RPS27	Malignant cells	GSE149214	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11590
4.15530502277928e-141	-1.10276522635155	0.22	0.671	6.7565259670391e-137	HMGA1	Malignant cells	GSE149214	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11591
5.80464067948492e-139	0.851930180799181	0.999	0.997	9.43834574484247e-135	MT-RNR2	Malignant cells	GSE149214	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11592
1.62525131538497e-137	1.08575276304008	0.85	0.524	2.64265863881597e-133	TPM1	Malignant cells	GSE149214	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11593
2.46062642837554e-137	-0.886789197205082	0.602	0.924	4.00097857253863e-133	PFN1	Malignant cells	GSE149214	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11594
1.91404737921698e-136	-1.08994733859885	0.91	0.977	3.1122410386068e-132	HSP90AA1	Malignant cells	GSE149214	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11595
9.99431961921348e-117	0.76013717324118	0.548	0.101	1.62507637008411e-112	RPS3A	Malignant cells	GSE149214	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11596
2.71601638929639e-115	0.994035443545048	0.723	0.327	4.41624264899594e-111	CALD1	Malignant cells	GSE149214	ENSG00000122786	800	caldesmon 1	CDM|H-CAD|h-CD|L-CAD	protein_coding	Q05682	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11597
6.81471194787493e-114	-0.892610958204752	0.828	0.989	1.10807216272446e-109	S100A6	Malignant cells	GSE149214	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11598
3.20068728477583e-111	0.720985893443857	0.52	0.095	5.2043175250455e-107	RPL9	Malignant cells	GSE149214	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11599
6.3808235256431e-108	-1.03900319971161	0.07	0.454	1.03752190526957e-103	S100A4	Malignant cells	GSE149214	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11600
6.97941595010077e-106	0.754090166046419	0.973	0.86	1.13485303348639e-101	PTMA	Malignant cells	GSE149214	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11601
1.32819011012234e-99	-0.795634057184322	0.436	0.796	2.15963711905892e-95	NPC2	Malignant cells	GSE149214	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11602
3.78852420342167e-97	0.735780027148674	0.774	0.467	6.16014035476363e-93	RPS28	Malignant cells	GSE149214	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11603
4.69252532835304e-90	0.648309147851971	0.888	0.725	7.63004618390205e-86	RPL6	Malignant cells	GSE149214	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11604
1.85045590148781e-89	-0.513037823567991	0.036	0.353	3.00884129581918e-85	RP11-36C20.1	Malignant cells	GSE149214	NA	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11605
7.27301002096896e-81	-0.59115674377684	0.063	0.374	1.18259142940955e-76	EMP1	Malignant cells	GSE149214	ENSG00000134531	2012	epithelial membrane protein 1	CL-20|TMP	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11606
9.52606318141698e-81	0.840149684464351	0.561	0.188	1.5489378732984e-76	NEAT1	Malignant cells	GSE149214	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11607
2.1354750067906e-77	0.681465196621204	0.401	0.075	3.47228236104152e-73	SERPINE1	Malignant cells	GSE149214	ENSG00000106366	5054	serpin family E member 1	PAI|PAI1|PLANH1	protein_coding	P05121	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11608
2.39882264036209e-76	-0.601727809630009	0.643	0.896	3.90048561322876e-72	RPL39	Malignant cells	GSE149214	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11609
5.28467606977109e-75	0.489551441526263	0.282	0.009	8.5928832894478e-71	NUPR1	Malignant cells	GSE149214	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11610
1.25049863841829e-74	-0.631971977111458	0.567	0.843	2.03331078606813e-70	RPL28	Malignant cells	GSE149214	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11611
1.57088947924291e-73	-0.593823180920729	0.642	0.878	2.55426629324897e-69	ALDOA	Malignant cells	GSE149214	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11612
5.4686008986656e-72	0.705639858428253	0.385	0.073	8.89194506123027e-68	KRT17	Malignant cells	GSE149214	ENSG00000128422	3872	keratin 17	PCHC1	protein_coding	Q04695	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11613
1.77905274172906e-69	0.683045024582266	0.403	0.091	2.89273975805145e-65	INHBA	Malignant cells	GSE149214	ENSG00000122641	3624	inhibin subunit beta A	NA	protein_coding	P08476	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11614
3.16468244250169e-67	0.766775563959166	0.558	0.225	5.14577365150774e-63	IGFBP3	Malignant cells	GSE149214	ENSG00000146674	3486	insulin like growth factor binding protein 3	BP-53|IBP3	protein_coding	P17936	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11615
2.75403304251728e-66	0.490164566650251	0.999	0.995	4.47805772713309e-62	FTL	Malignant cells	GSE149214	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11616
4.54883602249824e-66	-0.388777769105201	0.026	0.269	7.39640737258213e-62	RPL30P4	Malignant cells	GSE149214	ENSG00000237676	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11617
1.71328874738879e-62	0.879668200534693	0.992	0.973	2.78580750325417e-58	MALAT1	Malignant cells	GSE149214	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11618
3.61400694326089e-60	-0.441949452728203	0.058	0.31	5.87637528974221e-56	ITGA6	Malignant cells	GSE149214	ENSG00000091409	3655	integrin subunit alpha 6	CD49f	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11619
3.93592916470854e-60	0.511357641246544	0.917	0.769	6.39982082181609e-56	MYL6	Malignant cells	GSE149214	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11620
4.43836818038863e-58	-0.424296018488912	0.068	0.32	7.21678666131191e-54	AC016739.2	Malignant cells	GSE149214	NA	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11621
2.88168754856702e-56	0.719510305628322	0.548	0.256	4.68562395396998e-52	TACSTD2	Malignant cells	GSE149214	ENSG00000184292	4070	tumor associated calcium signal transducer 2	EGP-1|GA733-1|M1S1|TROP2	protein_coding	P09758	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11622
2.23912017287116e-54	0.41355105726838	0.993	0.979	3.64080940108851e-50	GSTP1	Malignant cells	GSE149214	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11623
3.05700257826951e-53	0.539523183256243	0.537	0.236	4.97068619226622e-49	PSAP	Malignant cells	GSE149214	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11624
2.53395847819374e-52	0.544057355312725	0.848	0.716	4.12021648554302e-48	B2M	Malignant cells	GSE149214	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11625
4.26893290544552e-52	-0.519684965891246	0.831	0.964	6.94128490425441e-48	RPS29	Malignant cells	GSE149214	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11626
4.45930306388163e-51	0.469595539501634	0.395	0.125	7.25082678187153e-47	CST6	Malignant cells	GSE149214	ENSG00000175315	1474	cystatin E/M	NA	protein_coding	Q15828	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11627
1.05694546687631e-50	-0.512669816082166	0.101	0.347	1.71859332914088e-46	S100A2	Malignant cells	GSE149214	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11628
1.38875289894008e-50	0.384677264803846	0.333	0.08	2.25811221367657e-46	RPL18A	Malignant cells	GSE149214	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11629
1.65598808703459e-50	-0.342492597442829	0.053	0.274	2.69263662951824e-46	RPL3P4	Malignant cells	GSE149214	ENSG00000232573	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11630
2.99058750382597e-49	0.387529760134092	0.317	0.075	4.86269528122102e-45	FSTL1	Malignant cells	GSE149214	ENSG00000163430	11167	follistatin like 1	FRP|FSL1|OCC-1|OCC1|tsc36	protein_coding	Q12841	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11631
7.35599532972266e-49	0.547470073191349	0.439	0.167	1.1960848406129e-44	SOX4	Malignant cells	GSE149214	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11632
1.84363384413526e-48	0.503621570169209	0.963	0.889	2.99774863056394e-44	CAV1	Malignant cells	GSE149214	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11633
1.31334672342772e-47	-0.552977721594049	0.192	0.444	2.13550177229347e-43	ANXA1	Malignant cells	GSE149214	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11634
7.74268615982969e-47	0.436417121964283	0.888	0.777	1.25896076958831e-42	RPL3	Malignant cells	GSE149214	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11635
7.07334053370001e-46	0.479870319051053	0.505	0.23	1.15012517077962e-41	SLC3A2	Malignant cells	GSE149214	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11636
1.0580953384883e-44	0.408929776411929	0.988	0.969	1.72046302038197e-40	RPL13A	Malignant cells	GSE149214	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11637
1.81332821293832e-44	-0.462711094633297	0.804	0.939	2.9484716742377e-40	RPL26	Malignant cells	GSE149214	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11638
1.68496928725777e-43	-0.500611966106348	0.163	0.397	2.73976006108114e-39	MTRNR2L1	Malignant cells	GSE149214	NA	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11639
6.13089705608494e-43	0.394561111298384	0.37	0.125	9.96883861319412e-39	PDLIM1	Malignant cells	GSE149214	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11640
8.43357731260042e-43	-0.526126244880035	0.439	0.668	1.37129967102883e-38	SLIRP	Malignant cells	GSE149214	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11641
3.79579003294601e-42	-0.447677929403848	0.785	0.932	6.17195459357021e-38	HNRNPA2B1	Malignant cells	GSE149214	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11642
1.54702917080145e-41	0.409363232664182	0.419	0.169	2.51546943172315e-37	RHOBTB3	Malignant cells	GSE149214	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11643
3.70069915516934e-41	0.477445348761863	0.451	0.2	6.01733682630534e-37	GPRC5A	Malignant cells	GSE149214	ENSG00000013588	9052	G protein-coupled receptor class C group 5 member A	PEIG-1|RAI3|RAIG1|TIG1	protein_coding	Q8NFJ5	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11644
6.14940655583348e-41	0.436933460782367	0.486	0.222	9.99893505978523e-37	PTRF	Malignant cells	GSE149214	NA	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11645
2.90101664580782e-40	0.438692085953769	0.381	0.143	4.71705306608351e-36	CYR61	Malignant cells	GSE149214	NA	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11646
3.04467657228101e-40	-0.364008751314212	0.09	0.3	4.95064410652893e-36	PPP1R14B	Malignant cells	GSE149214	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11647
3.13817273555657e-40	-0.328216001817901	0.066	0.26	5.10266886801499e-36	AC004453.8	Malignant cells	GSE149214	NA	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11648
1.383910928758e-39	0.471192224075219	0.521	0.27	2.2502391701605e-35	PRSS23	Malignant cells	GSE149214	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11649
1.647694405267e-39	0.420455306911426	0.312	0.092	2.67915110296415e-35	FILIP1L	Malignant cells	GSE149214	ENSG00000168386	11259	filamin A interacting protein 1 like	DOC-1|GIP130	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11650
7.15367438446979e-39	0.433135663111176	0.437	0.192	1.16318745491479e-34	IGFBP7	Malignant cells	GSE149214	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11651
1.59196612599235e-38	0.441647289595855	0.46	0.216	2.58853692086356e-34	NGFRAP1	Malignant cells	GSE149214	NA	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11652
2.12709671332131e-38	0.530031749692165	0.436	0.198	3.45865925586045e-34	MT2A	Malignant cells	GSE149214	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11653
6.48771357102861e-37	-0.429512185460335	0.591	0.787	1.05490222664925e-32	HSPD1	Malignant cells	GSE149214	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11654
5.28097822868411e-35	-0.370133605340689	0.767	0.919	8.58687059984036e-31	ENO1	Malignant cells	GSE149214	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11655
9.55872488266601e-35	0.379348498549912	0.863	0.787	1.55424866592149e-30	RPS7	Malignant cells	GSE149214	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11656
4.18364553259849e-34	0.366220915904381	0.41	0.183	6.80260763600515e-30	HNRNPA3	Malignant cells	GSE149214	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11657
9.7281746661405e-34	-0.366949894113234	0.723	0.892	1.58180120071445e-29	CHCHD2	Malignant cells	GSE149214	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11658
3.35049490960352e-33	-0.393586026663133	0.186	0.392	5.44790472301532e-29	KLK6	Malignant cells	GSE149214	ENSG00000167755	5653	kallikrein related peptidase 6	Bssp|Klk7|neurosin|PRSS18|PRSS9	protein_coding	Q92876	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11659
5.27084511715846e-33	0.349343991627558	0.375	0.155	8.57039416049966e-29	TCF25	Malignant cells	GSE149214	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11660
6.73073235810174e-33	0.419683809504521	0.551	0.325	1.09441708142734e-28	SQSTM1	Malignant cells	GSE149214	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11661
7.8398653923431e-33	-0.403334166442512	0.552	0.747	1.27476211279499e-28	CCT6A	Malignant cells	GSE149214	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11662
2.16581046044897e-32	-0.501384853402689	0.408	0.583	3.52160780869002e-28	S100A11	Malignant cells	GSE149214	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11663
3.31804604845309e-32	0.357896242126834	0.317	0.122	5.39514287478473e-28	GSTM3	Malignant cells	GSE149214	ENSG00000134202	2947	glutathione S-transferase mu 3	GST5	protein_coding	P21266	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11664
6.48517954837318e-32	0.463461159347307	0.512	0.293	1.05449019456548e-27	MT-ATP8	Malignant cells	GSE149214	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11665
1.0989165001444e-31	0.296620609029134	0.41	0.185	1.7868382292348e-27	GADD45A	Malignant cells	GSE149214	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11666
3.43477728181152e-31	0.421044689429296	0.548	0.325	5.58494786022553e-27	MT-RNR1	Malignant cells	GSE149214	ENSG00000211459	NA	NA	12S|MOTS-c|MTRNR1	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11667
4.04010532550415e-31	0.556645669672868	0.855	0.791	6.56921125926975e-27	MT-ND5	Malignant cells	GSE149214	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11668
8.98452034565736e-31	-0.410101882038015	0.848	0.938	1.46088300820389e-26	RPS5	Malignant cells	GSE149214	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11669
1.31987832279086e-30	0.354412933237665	0.424	0.205	2.14612215285794e-26	PALLD	Malignant cells	GSE149214	ENSG00000129116	23022	palladin, cytoskeletal associated protein	CGI-151|KIAA0992|SIH002	protein_coding	Q8WX93	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11670
1.4106348101603e-30	-0.328896763419906	0.093	0.272	2.29369220132065e-26	KRT13	Malignant cells	GSE149214	ENSG00000171401	3860	keratin 13	CK13|K13|MGC161462|MGC3781	protein_coding	P13646	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11671
5.10383210160871e-30	0.287744323607033	0.282	0.096	8.29883099721577e-26	NCF2	Malignant cells	GSE149214	ENSG00000116701	4688	neutrophil cytosolic factor 2	NOXA2|p67phox	protein_coding	P19878	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11672
1.07668729831579e-29	0.331751796573917	0.289	0.104	1.75069354706148e-25	CD24	Malignant cells	GSE149214	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11673
2.7915071836826e-29	0.350680065008603	0.902	0.799	4.5389906806679e-25	KTN1	Malignant cells	GSE149214	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11674
9.13761534368698e-29	-0.436080785994095	0.402	0.576	1.4857762548835e-24	PKM	Malignant cells	GSE149214	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11675
1.53797529150714e-28	0.353243907296188	0.317	0.131	2.5007478239906e-24	THBS1	Malignant cells	GSE149214	ENSG00000137801	7057	thrombospondin 1	THBS|THBS-1|TSP|TSP-1|TSP1	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11676
1.78173709168211e-28	0.329223414166182	0.994	0.986	2.89710451107511e-24	MT-CO1	Malignant cells	GSE149214	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11677
1.30387881146286e-27	0.339235789917523	0.399	0.194	2.12010694743861e-23	PAWR	Malignant cells	GSE149214	ENSG00000177425	5074	pro-apoptotic WT1 regulator	par-4|PAR4	protein_coding	Q96IZ0	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11678
2.91438203271466e-27	0.316111371388567	0.413	0.208	4.73878518519404e-23	PTTG1IP	Malignant cells	GSE149214	ENSG00000183255	754	PTTG1 interacting protein	C21orf1|C21orf3|PBF|PTTG1IP1	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11679
7.84833659279169e-27	0.341932777785912	0.429	0.226	1.27613952998793e-22	RDX	Malignant cells	GSE149214	ENSG00000137710	5962	radixin	DFNB24	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11680
1.5062409327576e-26	0.282832251410048	0.318	0.132	2.44914775666385e-22	RPS27L	Malignant cells	GSE149214	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11681
2.57112589665386e-26	0.30417189431992	0.998	0.997	4.18065070795918e-22	FTH1	Malignant cells	GSE149214	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11682
3.13104128506495e-26	0.352705407085633	0.381	0.193	5.09107312951561e-22	ALDH1A3	Malignant cells	GSE149214	ENSG00000184254	220	aldehyde dehydrogenase 1 family member A3	ALDH6|RALDH3	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11683
4.69718853836613e-26	-0.28278742454229	0.122	0.293	7.63762856338333e-22	BRI3	Malignant cells	GSE149214	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11684
1.2262542078482e-25	0.335976505481452	0.509	0.303	1.99388934196118e-21	CSDE1	Malignant cells	GSE149214	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11685
1.61143330208354e-25	-0.291907096424553	0.968	0.987	2.62019054918783e-21	TPT1	Malignant cells	GSE149214	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11686
3.5494801737078e-25	0.278692332832742	0.996	0.981	5.77145476244889e-21	RPS27A	Malignant cells	GSE149214	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11687
7.03710034611508e-25	-0.33624534659556	0.175	0.347	1.14423251627831e-20	AHSA1	Malignant cells	GSE149214	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11688
1.62509500488647e-24	0.26320594613933	0.261	0.099	2.64240447794541e-20	RP11-622K12.1	Malignant cells	GSE149214	NA	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11689
2.30545279313446e-24	0.295647379707049	0.332	0.152	3.74866624163663e-20	SKIL	Malignant cells	GSE149214	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11690
1.23344594756384e-23	0.35412423493154	0.569	0.379	2.0055831107388e-19	RPSA	Malignant cells	GSE149214	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11691
2.18974292839267e-23	-0.277519283769006	0.151	0.316	3.56052200156648e-19	ATP5J2	Malignant cells	GSE149214	NA	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11692
3.0480459502036e-23	-0.28464052500768	0.149	0.312	4.95612271503105e-19	MIF	Malignant cells	GSE149214	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11693
3.14760138575812e-23	0.265475525071197	0.999	0.982	5.1179998532427e-19	TMSB4X	Malignant cells	GSE149214	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11694
5.94043127436139e-23	0.288520321681319	0.383	0.195	9.65914125211163e-19	RSF1	Malignant cells	GSE149214	ENSG00000048649	51773	remodeling and spacing factor 1	HBXAP|p325|RSF-1|XAP8	protein_coding	Q96T23	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11695
6.73819570197131e-23	-0.351168809802356	0.256	0.427	1.09563062114053e-18	TMSB4XP8	Malignant cells	GSE149214	ENSG00000187653	NA	NA	TMSL3	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11696
4.56528277504177e-22	0.293207258873118	0.371	0.193	7.42314979221792e-18	APLP2	Malignant cells	GSE149214	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11697
6.81298509638216e-22	0.265274469800791	0.3	0.137	1.10779137667174e-17	GSTK1	Malignant cells	GSE149214	ENSG00000197448	373156	glutathione S-transferase kappa 1	GST13	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11698
8.07482210171368e-21	-0.380582769406203	0.395	0.532	1.31296607373864e-16	DBI	Malignant cells	GSE149214	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11699
9.23877303818773e-21	-0.315518242264013	0.234	0.401	1.50222449600933e-16	ANXA5	Malignant cells	GSE149214	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11700
1.04057525942942e-20	-0.270955377389102	0.952	0.985	1.69197537183224e-16	RPL11	Malignant cells	GSE149214	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11701
1.79281420217162e-20	0.259217405157907	0.477	0.282	2.91511589273106e-16	HDLBP	Malignant cells	GSE149214	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11702
1.87092328798838e-20	0.295431287466624	0.378	0.206	3.04212126626911e-16	SLC7A11	Malignant cells	GSE149214	ENSG00000151012	23657	solute carrier family 7 member 11	xCT	protein_coding	Q9UPY5	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11703
6.52055384831114e-20	0.281080263213403	0.764	0.666	1.06024205573539e-15	GNAS	Malignant cells	GSE149214	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11704
1.22693703323423e-19	-0.303213464641323	0.254	0.411	1.99499961603886e-15	RP11-742N3.1	Malignant cells	GSE149214	NA	NA	NA	NA	NA	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11705
1.73098286233798e-19	0.277019767410729	0.373	0.207	2.81457813416156e-15	RTF1	Malignant cells	GSE149214	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11706
2.69979084392481e-19	0.286053198334363	0.424	0.256	4.38985991222174e-15	TES	Malignant cells	GSE149214	ENSG00000135269	26136	testin LIM domain protein	DKFZP586B2022|TESS-2|TESTIN	protein_coding	Q9UGI8	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11707
5.52441462518034e-19	-0.304828342999382	0.172	0.318	8.98269818054323e-15	TNFRSF12A	Malignant cells	GSE149214	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11708
5.97842047774473e-19	0.27352449464845	0.456	0.285	9.72091169681292e-15	PRDX6	Malignant cells	GSE149214	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11709
6.72595631559835e-19	-0.283015270724487	0.924	0.972	1.09364049691629e-14	RPL18	Malignant cells	GSE149214	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11710
1.15946039347548e-18	-0.265594295089479	0.777	0.897	1.88528259979113e-14	CFL1	Malignant cells	GSE149214	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11711
1.20357236878592e-18	0.267508465781118	0.424	0.252	1.95700867164591e-14	TALDO1	Malignant cells	GSE149214	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11712
1.22308310798252e-18	0.273684222809332	0.434	0.267	1.98873313357958e-14	CCNI	Malignant cells	GSE149214	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11713
1.48667867110012e-18	0.252724054305878	0.431	0.258	2.41733951920879e-14	CAV2	Malignant cells	GSE149214	ENSG00000105971	858	caveolin 2	CAV	protein_coding	P51636	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11714
1.65047106030527e-18	0.328578586337527	0.514	0.341	2.68366594405637e-14	MAP1B	Malignant cells	GSE149214	ENSG00000131711	4131	microtubule associated protein 1B	MAP5|PPP1R102	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11715
2.00308477599948e-18	-0.32115617107954	0.227	0.374	3.25701584577515e-14	S100A14	Malignant cells	GSE149214	ENSG00000189334	57402	S100 calcium binding protein A14	BCMP84|S100A15	protein_coding	Q9HCY8	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11716
1.0796988654524e-17	-0.255639136123087	0.151	0.286	1.7555903552256e-13	SRSF9	Malignant cells	GSE149214	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11717
1.95297028101316e-17	-0.262347461418671	0.867	0.958	3.1755296769274e-13	RPL38	Malignant cells	GSE149214	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11718
2.62205650257509e-17	0.257636037486211	0.996	0.99	4.26346387318709e-13	MT-CO3	Malignant cells	GSE149214	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11719
3.09058962050889e-17	-0.277891688344956	0.199	0.347	5.02529872294746e-13	SFN	Malignant cells	GSE149214	ENSG00000175793	2810	stratifin	YWHAS	protein_coding	P31947	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11720
3.17352930688742e-17	-0.291426342816162	0.232	0.373	5.16015865299895e-13	EIF5A	Malignant cells	GSE149214	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11721
3.7952231842226e-17	0.305479292265006	0.502	0.34	6.17103289754595e-13	PTGR1	Malignant cells	GSE149214	ENSG00000106853	22949	prostaglandin reductase 1	LTB4DH|ZADH3	protein_coding	Q14914	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11722
4.06479419461017e-17	0.297417811760969	0.751	0.689	6.60935536043614e-13	YBX1	Malignant cells	GSE149214	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11723
7.68746123221379e-17	0.253584293028982	0.395	0.233	1.24998119635796e-12	GOLGB1	Malignant cells	GSE149214	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11724
9.90260665261483e-17	-0.266033027505657	0.586	0.752	1.61016384171517e-12	LGALS1	Malignant cells	GSE149214	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11725
4.48962685462271e-16	-0.258759779751431	0.245	0.389	7.30013326561652e-12	SNRPB	Malignant cells	GSE149214	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11726
7.22942673761097e-16	0.263155869079991	0.421	0.27	1.17550478753554e-11	UBXN4	Malignant cells	GSE149214	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11727
1.00009222296845e-15	-0.286732836572237	0.162	0.292	1.62614995454669e-11	S100P	Malignant cells	GSE149214	ENSG00000163993	6286	S100 calcium binding protein P	NA	protein_coding	P25815	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11728
1.79901272750959e-15	-0.317109373745418	0.226	0.364	2.9251946949306e-11	ALDH3A1	Malignant cells	GSE149214	ENSG00000108602	218	aldehyde dehydrogenase 3 family member A1	ALDH3	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11729
1.86616078490854e-15	-0.324329642351839	0.346	0.475	3.03437743626129e-11	PRDX5	Malignant cells	GSE149214	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11730
1.97412817021735e-15	0.263770120818761	0.495	0.334	3.20993240477341e-11	LUC7L3	Malignant cells	GSE149214	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11731
3.09395797023205e-15	-0.323823245949205	0.332	0.462	5.03077565959732e-11	CSTB	Malignant cells	GSE149214	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11732
4.44278676581874e-15	-0.258911180585884	0.218	0.352	7.22397128122127e-11	LMNA	Malignant cells	GSE149214	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11733
4.72827161059099e-15	0.250432439150375	0.976	0.959	7.68816963882094e-11	KRT7	Malignant cells	GSE149214	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11734
6.53459843088309e-15	-0.270318184355547	0.216	0.346	1.06252570486159e-10	CAPNS1	Malignant cells	GSE149214	ENSG00000126247	826	calpain small subunit 1	30K|CANP|CANPS|CAPN4|CDPS	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11735
1.26079418673475e-14	-0.278502628046586	0.151	0.271	2.05005134763071e-10	HSPH1	Malignant cells	GSE149214	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11736
4.88128779481959e-14	0.263098017121401	0.431	0.288	7.93697395437666e-10	ACTN1	Malignant cells	GSE149214	ENSG00000072110	87	actinin alpha 1	NA	protein_coding	P12814	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11737
8.73321563377088e-14	-0.253080031166679	0.741	0.857	1.42002086205115e-09	MT-ND3	Malignant cells	GSE149214	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11738
1.67181912809686e-13	0.274035393415854	0.804	0.752	2.71837790228549e-09	DEK	Malignant cells	GSE149214	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11739
5.72830516276318e-13	-0.255982957465977	0.785	0.9	9.31422419465292e-09	MT-ND2	Malignant cells	GSE149214	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11740
5.96355752771374e-13	-0.272322580615666	0.221	0.333	9.69674454006254e-09	GPX2	Malignant cells	GSE149214	ENSG00000176153	2877	glutathione peroxidase 2	GSHPX-GI	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11741
1.00436757377556e-12	0.266384616346053	0.937	0.934	1.63310167495906e-08	PRDX1	Malignant cells	GSE149214	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11742
7.76813708024473e-12	-0.275496173035392	0.891	0.947	1.26309908924779e-07	MT-CYB	Malignant cells	GSE149214	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11743
8.37294225661708e-12	-0.261766965950041	0.215	0.325	1.36144041092594e-07	CYCS	Malignant cells	GSE149214	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11744
1.29540586493012e-11	-0.302040152876616	0.441	0.534	2.10632993637638e-07	AKR1B1	Malignant cells	GSE149214	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11745
1.75657595240495e-11	-0.264473711661265	0.381	0.489	2.85619249861044e-07	HSPE1	Malignant cells	GSE149214	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11746
2.46560188462679e-11	0.252894173407648	0.952	0.933	4.00906866440316e-07	KRT18	Malignant cells	GSE149214	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11747
4.11514150304649e-11	-0.294492645863946	0.397	0.499	6.69122008395359e-07	CCT5	Malignant cells	GSE149214	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11748
6.96833857831588e-09	-0.26438983475159	0.48	0.552	0.000113305185283416	LDHA	Malignant cells	GSE149214	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE149214	GSE149214	Lung cancer	EGFR-mutated non-small cell lung cancer (NSCLC)	Targeted therapy	NA	erlotinib	Homo sapiens	PC9 cell line	Cell line	resistant 1, sensitive 1	2	2393	Public on Dec 19, 2020	33712615	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA627676	DropSeq 	Casava1.7	Lung_cancer	Targeted_therapy	11749
0	0.725594747364118	0.435	0.053	0	JUN	Malignant cells	GSE152469	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11750
0	0.922646301285252	0.47	0.001	0	RGS1	Malignant cells	GSE152469	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11751
0	1.27029978609413	0.559	0.011	0	RGS2	Malignant cells	GSE152469	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11752
0	1.94913018633559	0.957	0.456	0	CXCR4	Malignant cells	GSE152469	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11753
0	0.705540340609834	0.398	0.008	0	DUSP1	Malignant cells	GSE152469	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11754
0	1.61716199766645	0.896	0.243	0	TSC22D3	Malignant cells	GSE152469	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11755
0	1.05937979890286	0.637	0.146	0	KLF6	Malignant cells	GSE152469	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11756
0	1.19103470991776	0.724	0.182	0	CD69	Malignant cells	GSE152469	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11757
0	-0.801935082680978	0.782	0.959	0	TCL1A	Malignant cells	GSE152469	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11758
0	1.06487765227744	0.999	0.957	0	EIF1	Malignant cells	GSE152469	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11759
0	0.779362469923501	0.983	0.937	0	H3F3B	Malignant cells	GSE152469	NA	NA	NA	NA	NA	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11760
0	1.14166757794681	0.706	0.2	0	PMAIP1	Malignant cells	GSE152469	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11761
0	0.73574057344079	0.864	0.599	0	CIRBP	Malignant cells	GSE152469	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11762
0	0.851358342488873	0.61	0.226	0	KLF2	Malignant cells	GSE152469	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11763
0	0.662678834447777	0.532	0.139	0	JUND	Malignant cells	GSE152469	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11764
0	0.607865352776018	0.662	0.251	0	RPS4Y1	Malignant cells	GSE152469	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11765
3.72464540645307e-300	0.675645314783448	0.811	0.52	5.3024052006266e-296	UBC	Malignant cells	GSE152469	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11766
4.1078546342938e-297	-0.56970177668352	0.121	0.471	5.84794185738066e-293	RP5-1171I10.5	Malignant cells	GSE152469	NA	NA	NA	NA	NA	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11767
7.20247797939426e-294	0.631405147879899	0.543	0.178	1.02534476514657e-289	BCL2	Malignant cells	GSE152469	ENSG00000171791	596	BCL2 apoptosis regulator	Bcl-2|PPP1R50	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11768
7.37573432927743e-274	0.595530980711077	0.492	0.15	1.05000953911594e-269	YPEL5	Malignant cells	GSE152469	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11769
3.14560557813213e-259	0.286774903555469	1	1	4.47808410102891e-255	RPL13	Malignant cells	GSE152469	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11770
1.05192939898059e-245	-0.61724855150911	0.332	0.65	1.49752669238877e-241	DYNLL1	Malignant cells	GSE152469	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11771
2.67221735811459e-200	0.501304128683487	0.946	0.85	3.80416863101193e-196	DDX5	Malignant cells	GSE152469	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11772
9.60562086750597e-196	0.375034852696403	0.306	0.057	1.36745618669815e-191	CNOT1	Malignant cells	GSE152469	ENSG00000125107	23019	CCR4-NOT transcription complex subunit 1	AD-005|CDC39|KIAA1007|NOT1|NOT1H	protein_coding	A5YKK6	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11773
4.69002944818027e-192	-0.318911664789771	1	1	6.67672592242943e-188	RPS12	Malignant cells	GSE152469	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11774
6.36388773765046e-181	0.403378390974823	0.371	0.111	9.0596305833192e-177	SBDS	Malignant cells	GSE152469	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11775
2.62149447529613e-174	-0.494220364408329	0.58	0.797	3.73195953503157e-170	SEC62	Malignant cells	GSE152469	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11776
1.07911619255458e-173	0.488256447500154	0.705	0.446	1.5362298117207e-169	HNRNPDL	Malignant cells	GSE152469	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11777
1.03608283713997e-168	0.514404358540362	0.382	0.132	1.47496752695247e-164	WDR74	Malignant cells	GSE152469	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11778
3.03916891787813e-151	-0.386600818711754	0.185	0.434	4.32656087149131e-147	KIAA0226L	Malignant cells	GSE152469	NA	NA	NA	NA	NA	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11779
2.10095357896205e-149	0.390964871151505	0.458	0.204	2.99091751501037e-145	SNHG9	Malignant cells	GSE152469	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11780
3.04426314541791e-147	0.37177817871457	0.329	0.103	4.33381301381694e-143	IQGAP1	Malignant cells	GSE152469	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11781
9.99188164205726e-147	0.426897767530745	0.549	0.297	1.42244427056327e-142	RBM3	Malignant cells	GSE152469	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11782
5.22468807978622e-144	-0.40587004881327	0.281	0.533	7.43786595038367e-140	HSPA8	Malignant cells	GSE152469	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11783
1.02516056021426e-143	0.46342316013073	0.352	0.127	1.45941857352102e-139	JUNB	Malignant cells	GSE152469	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11784
5.80929854087089e-143	0.479710142654861	0.449	0.189	8.27011740278379e-139	JCHAIN	Malignant cells	GSE152469	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11785
2.09083045351574e-142	-0.296265947648623	0.301	0.586	2.97650623362501e-138	ID3	Malignant cells	GSE152469	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11786
4.40367044023473e-140	0.338018126770705	0.327	0.106	6.26906523871816e-136	MED30	Malignant cells	GSE152469	ENSG00000164758	90390	mediator complex subunit 30	THRAP6|TRAP25	protein_coding	Q96HR3	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11787
5.08216845827275e-139	0.321115277762584	0.26	0.061	7.23497501719708e-135	PPP1R15A	Malignant cells	GSE152469	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11788
3.06670313534195e-138	0.385436932012464	0.367	0.139	4.3657585834728e-134	UBALD2	Malignant cells	GSE152469	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11789
3.85291428088825e-137	0.429862619897942	0.606	0.375	5.48500877027251e-133	TRA2B	Malignant cells	GSE152469	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11790
5.79296000457498e-132	0.381016494804669	0.439	0.205	8.24685786251294e-128	CYCS	Malignant cells	GSE152469	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11791
1.21768568071903e-131	-0.409566053422644	0.556	0.767	1.73349733507162e-127	CALM2	Malignant cells	GSE152469	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11792
1.44515141480437e-127	0.46765658953018	0.95	0.906	2.05731755411551e-123	BTG1	Malignant cells	GSE152469	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11793
6.84966523991837e-122	-0.298063548625056	0.999	1	9.75118343554779e-118	RPL7	Malignant cells	GSE152469	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11794
1.00209563665274e-117	-0.401561651408129	0.292	0.513	1.42658334833884e-113	TRAC	Malignant cells	GSE152469	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11795
2.79436070815862e-117	0.358811168946494	0.441	0.22	3.97805190413461e-113	MAP1LC3B	Malignant cells	GSE152469	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11796
2.82688010118799e-117	0.34117998915336	0.314	0.115	4.02434651205123e-113	TAGAP	Malignant cells	GSE152469	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11797
2.14993268874951e-113	-0.370467120082239	0.294	0.518	3.06064417570381e-109	IGHA1	Malignant cells	GSE152469	ENSG00000282633	NA	NA	AL928768.3	IG_C_gene	P01876	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11798
1.16386427315715e-109	0.549998929931883	0.45	0.244	1.65687717926651e-105	RP11-386I14.4	Malignant cells	GSE152469	NA	NA	NA	NA	NA	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11799
7.4670442723865e-109	0.324049741740706	0.335	0.138	1.06300842261694e-104	CD44	Malignant cells	GSE152469	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11800
7.67620677865933e-107	0.404060620590777	0.3	0.115	1.09278479700994e-102	RGCC	Malignant cells	GSE152469	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11801
3.82857330719764e-106	0.343942997838934	0.941	0.876	5.45035696012657e-102	COX4I1	Malignant cells	GSE152469	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11802
8.37303792786097e-106	0.292679791092612	0.999	0.996	1.19198567941029e-101	MT-ND2	Malignant cells	GSE152469	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11803
1.53414443334451e-105	0.376373236965558	0.444	0.236	2.18400801530924e-101	SAT1	Malignant cells	GSE152469	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11804
5.58982790201311e-103	-0.309232519457447	0.229	0.44	7.95767900130586e-99	LUC7L3	Malignant cells	GSE152469	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11805
4.5892804945703e-101	0.309994376394781	0.404	0.2	6.53329971207028e-97	EPC1	Malignant cells	GSE152469	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11806
2.02281025402994e-98	-0.349149763743826	0.954	0.989	2.87967267763702e-94	IGHM	Malignant cells	GSE152469	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11807
1.41872345719522e-96	-0.314433032034671	0.303	0.51	2.01969471366312e-92	NOP10	Malignant cells	GSE152469	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11808
5.81700900621924e-94	-0.370425370855546	0.478	0.665	8.28109402125372e-90	FCMR	Malignant cells	GSE152469	ENSG00000162894	9214	Fc mu receptor	FAIM3|FcmuR|TOSO	protein_coding	O60667	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11809
1.0739572534419e-90	0.274503426141563	0.326	0.145	1.52888554599989e-86	CCNL1	Malignant cells	GSE152469	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11810
3.29931517590452e-89	0.354342741410706	0.696	0.534	4.69690508441768e-85	SLC25A6	Malignant cells	GSE152469	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11811
2.53842502042948e-81	0.280006476581579	0.4	0.219	3.61370185908341e-77	MRPL54	Malignant cells	GSE152469	ENSG00000183617	116541	mitochondrial ribosomal protein L54	NA	protein_coding	Q6P161	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11812
3.55209070940154e-81	-0.311630328727767	0.404	0.587	5.05675633390403e-77	RAN	Malignant cells	GSE152469	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11813
6.44633484261381e-79	-0.287465991770032	0.296	0.482	9.17700228194502e-75	THUMPD3-AS1	Malignant cells	GSE152469	ENSG00000206573	440944	THUMPD3 antisense RNA 1	SETD5-AS1	NA	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11814
3.42890946775638e-78	-0.252338000458341	0.161	0.328	4.88139551829799e-74	SIT1	Malignant cells	GSE152469	ENSG00000137078	27240	signaling threshold regulating transmembrane adaptor 1	SIT	protein_coding	Q9Y3P8	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11815
2.30324294446113e-75	-0.261434846193157	0.228	0.403	3.27889665573486e-71	STX7	Malignant cells	GSE152469	ENSG00000079950	8417	syntaxin 7	NA	protein_coding	O15400	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11816
2.62383723382027e-74	-0.275316249039641	0.253	0.429	3.73529468606654e-70	LSM10	Malignant cells	GSE152469	ENSG00000181817	84967	LSM10, U7 small nuclear RNA associated	MGC15749	protein_coding	Q969L4	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11817
8.6258394025469e-73	-0.259712574783781	0.208	0.376	1.22797449734658e-68	HVCN1	Malignant cells	GSE152469	ENSG00000122986	84329	hydrogen voltage gated channel 1	Hv1|MGC15619|VSOP	protein_coding	Q96D96	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11818
3.55739514396275e-72	-0.284596805103725	0.825	0.909	5.06430772694538e-68	H3F3A	Malignant cells	GSE152469	NA	NA	NA	NA	NA	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11819
2.81434315808312e-71	-0.271945354589937	0.279	0.453	4.00649891984712e-67	ZNF706	Malignant cells	GSE152469	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11820
4.84015823032045e-69	0.317782431720402	0.483	0.312	6.8904492566842e-65	TAGLN2	Malignant cells	GSE152469	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11821
1.17252537423904e-67	0.309152175276397	0.681	0.534	1.6692071227667e-63	CDC42	Malignant cells	GSE152469	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11822
3.67216800444152e-65	-0.280980471273427	0.321	0.493	5.22769837112294e-61	TUBA1B	Malignant cells	GSE152469	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11823
6.46738552406057e-64	0.318744605594679	0.66	0.523	9.20697003205263e-60	YBX3	Malignant cells	GSE152469	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11824
2.35234350851275e-63	-0.269776581558434	0.376	0.542	3.34879621871874e-59	ARHGAP24	Malignant cells	GSE152469	ENSG00000138639	83478	Rho GTPase activating protein 24	DKFZP564B1162|FilGAP|FLJ33877	protein_coding	Q8N264	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11825
3.05980459004295e-62	-0.261286343553619	0.488	0.648	4.35593781438514e-58	TRMT112	Malignant cells	GSE152469	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11826
6.68666810239352e-62	0.301476945688659	0.86	0.761	9.51914071056742e-58	HLA-DQB1	Malignant cells	GSE152469	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11827
8.73412140166432e-62	0.266824968579003	0.353	0.201	1.24338952274093e-57	GSTP1	Malignant cells	GSE152469	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11828
2.95274916356723e-61	-0.322145819782571	0.62	0.744	4.20353370925431e-57	ACTG1	Malignant cells	GSE152469	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11829
9.05230605885725e-59	0.252084508549868	0.464	0.306	1.28868629053892e-54	TCF25	Malignant cells	GSE152469	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11830
2.58385921357754e-57	-0.253733469164853	0.459	0.607	3.67838197644899e-53	ATP6V0E1	Malignant cells	GSE152469	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11831
1.04213615328041e-50	0.262410545207288	0.779	0.668	1.48358502780999e-46	PEBP1	Malignant cells	GSE152469	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11832
2.79890894862591e-50	0.264554751406994	0.298	0.171	3.98452677926385e-46	ZFP36L2	Malignant cells	GSE152469	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11833
4.06554585304134e-49	0.25071182999925	0.671	0.539	5.78771107638965e-45	SRSF5	Malignant cells	GSE152469	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11834
4.31176237854932e-48	1.82511639429855	0.883	0.141	6.13822492210282e-44	CXCR4	CD8+ T cells	GSE152469	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11835
4.27103851781091e-32	1.05893663641851	1	0.917	6.08025043395561e-28	EIF1	CD8+ T cells	GSE152469	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11836
2.83332916541164e-30	-1.03769474919935	0.283	0.878	4.03352739988001e-26	GIMAP7	CD8+ T cells	GSE152469	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11837
8.16211948399306e-27	1.00273941904802	0.738	0.205	1.16195932974125e-22	TSC22D3	CD8+ T cells	GSE152469	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11838
9.84173725612226e-25	1.1890027767677	0.697	0.195	1.40106971578157e-20	JUNB	CD8+ T cells	GSE152469	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11839
2.46371519096157e-23	0.827840631251701	0.579	0.093	3.50734494585289e-19	CD69	CD8+ T cells	GSE152469	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11840
4.02762310651731e-22	0.675648237914419	0.421	0.015	5.73372425443805e-18	DUSP1	CD8+ T cells	GSE152469	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11841
2.03951305257116e-16	0.805850193722712	0.531	0.137	2.90345078164031e-12	DUSP2	CD8+ T cells	GSE152469	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11842
6.91533878275366e-16	0.564276698878327	0.414	0.063	9.84467629112811e-12	TNFAIP3	CD8+ T cells	GSE152469	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11843
1.1240258375751e-15	0.954832986378854	0.897	0.741	1.60016318237192e-11	H3F3B	CD8+ T cells	GSE152469	NA	NA	NA	NA	NA	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11844
1.92450827790178e-15	0.531703630431321	0.434	0.078	2.73972998442097e-11	YPEL5	CD8+ T cells	GSE152469	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11845
4.8653849556362e-15	0.63650665484662	0.483	0.117	6.92636202284369e-11	NFKBIA	CD8+ T cells	GSE152469	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11846
5.13583348387385e-15	-0.614644559365513	0.186	0.595	7.31137254764281e-11	GIMAP4	CD8+ T cells	GSE152469	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11847
1.72581516865791e-13	0.464972347966545	0.31	0.029	2.4568704741014e-09	PMAIP1	CD8+ T cells	GSE152469	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11848
1.37906304924072e-12	0.593898392038665	0.345	0.054	1.96323415689909e-08	RGS1	CD8+ T cells	GSE152469	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11849
1.58931023427537e-11	-0.68338067224804	0.262	0.595	2.26254204951442e-07	S100A11	CD8+ T cells	GSE152469	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11850
3.07866707735601e-11	0.425913967765203	0.352	0.073	4.38279045132401e-07	JUND	CD8+ T cells	GSE152469	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11851
1.44645640745218e-10	0.685865972040596	0.772	0.541	2.05917534164892e-06	SRGN	CD8+ T cells	GSE152469	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11852
1.8533109041315e-10	0.533404604566387	0.641	0.332	2.6383734031216e-06	HNRNPDL	CD8+ T cells	GSE152469	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11853
2.39172271940642e-10	-0.787249649207648	0.531	0.834	3.40485646334697e-06	LTB	CD8+ T cells	GSE152469	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11854
5.78198987971894e-10	-0.482050461194634	0.083	0.371	8.23124079276789e-06	RP5-1171I10.5	CD8+ T cells	GSE152469	NA	NA	NA	NA	NA	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11855
1.9883953300183e-09	0.565804707890598	0.634	0.346	2.83067959181405e-05	ZFP36L2	CD8+ T cells	GSE152469	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11856
4.77322479188056e-09	-0.555805747545862	0.421	0.683	6.79516281372117e-05	TXNIP	CD8+ T cells	GSE152469	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11857
1.12522041423822e-08	0.34102507017869	0.303	0.073	0.000160186378170954	RP11-51J9.5	CD8+ T cells	GSE152469	NA	NA	NA	NA	NA	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11858
3.75963218580589e-08	0.380234104965784	1	0.976	0.000535221237971326	MT-ND2	CD8+ T cells	GSE152469	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11859
3.9919582699951e-08	0.611629516682983	0.848	0.702	0.000568295179316503	BTG1	CD8+ T cells	GSE152469	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11860
4.07219590109626e-08	0.475802843557562	0.628	0.371	0.000579717808480064	CIRBP	CD8+ T cells	GSE152469	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11861
5.63143495850275e-08	0.470773745183077	0.469	0.22	0.000801691080692452	CYCS	CD8+ T cells	GSE152469	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11862
8.70216175303557e-08	0.342029732504031	0.366	0.127	0.00123883974716214	SBDS	CD8+ T cells	GSE152469	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11863
1.20221644675166e-07	-0.387954261251076	0.297	0.58	0.00171147533359566	TRAF3IP3	CD8+ T cells	GSE152469	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11864
1.67328636203604e-07	0.351320050906569	0.49	0.229	0.0023820904649945	TRA2B	CD8+ T cells	GSE152469	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11865
2.84252712536168e-07	0.302534162430958	0.372	0.137	0.00404662161566488	SNHG9	CD8+ T cells	GSE152469	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11866
4.50185769364961e-07	-0.27030920714843	0.076	0.298	0.00640884461267958	GIMAP2	CD8+ T cells	GSE152469	ENSG00000106560	26157	GTPase, IMAP family member 2	DKFZp586D0824|HIMAP2|IAN12|IMAP2	protein_coding	Q9UG22	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11867
4.94055269547673e-07	0.272800147643489	0.255	0.063	0.00703337081728068	IQGAP1	CD8+ T cells	GSE152469	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11868
8.11241475872875e-07	0.420213217877228	0.738	0.576	0.0115488336505262	SRSF5	CD8+ T cells	GSE152469	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11869
1.00988801282079e-06	0.429362007209109	0.779	0.62	0.0143767657505167	UBC	CD8+ T cells	GSE152469	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11870
1.25387405623999e-06	0.341779763684054	0.255	0.073	0.0178501510646325	DDIT4	CD8+ T cells	GSE152469	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11871
1.68631365922956e-06	-0.36763010796159	0.303	0.546	0.0240063612527921	DYNLL1	CD8+ T cells	GSE152469	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11872
2.08028202710673e-06	0.592989706420618	0.69	0.459	0.0296148949378914	NKG7	CD8+ T cells	GSE152469	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11873
2.12755152591371e-06	-0.369089564933975	0.697	0.883	0.0302878235229076	ACTG1	CD8+ T cells	GSE152469	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11874
3.49808057199314e-06	0.438816978411415	0.979	0.907	0.0497986750228944	FTH1	CD8+ T cells	GSE152469	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11875
7.43400062595491e-15	1.65244354471975	0.845	0.188	1.05830432911094e-10	CXCR4	NK cells	GSE152469	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11876
1.97821848870888e-14	-1.07863762435198	0.194	0.812	2.81619184052596e-10	GIMAP7	NK cells	GSE152469	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11877
3.18235946301667e-12	0.894921615832689	1	0.938	4.53040693155054e-08	EIF1	NK cells	GSE152469	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11878
7.67139336248464e-10	-0.643687443644245	0.107	0.562	1.09209955908331e-05	GIMAP4	NK cells	GSE152469	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11879
5.4391991095722e-08	0.815268038011539	0.65	0.208	0.000774324385238698	TSC22D3	NK cells	GSE152469	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11880
6.16617780783577e-07	-0.657931374986447	0.282	0.667	0.008778170727235	DYNLL1	NK cells	GSE152469	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11881
1.34274952840975e-06	-0.44393022390914	0.087	0.417	0.0191153822864412	DDX17	NK cells	GSE152469	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE152469	GSE152469	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	NA	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	9269	Public on Dec 15, 2020	33298182	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA639502	10x genomics	CellRanger 3.0.2	Chronic_lymphocytic_leukemia	Targeted_therapy	11882
2.83289740107398e-16	0.421396814504371	0.3	0.018	4.54453401080288e-12	POLA2	Mono/Macro	GSE153697	ENSG00000014138	23649	DNA polymerase alpha 2, accessory subunit	FLJ21662	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11883
1.08131203384324e-12	-1.62202110751077	0.867	1	1.73464076469133e-08	TSC22D3	Mono/Macro	GSE153697	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11884
9.70154494412566e-11	0.4614268098843	0.267	0.027	1.55632183993664e-06	TMEM106C	Mono/Macro	GSE153697	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11885
1.00036816683158e-10	-1.68919769748985	0.767	0.975	1.60479061323123e-06	TXNIP	Mono/Macro	GSE153697	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11886
5.12784008986827e-10	-1.40401479768206	0.333	0.809	8.22608107216668e-06	UPP1	Mono/Macro	GSE153697	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11887
4.54835235212739e-09	-1.61250934530961	0.367	0.84	7.29646684328275e-05	DDIT4	Mono/Macro	GSE153697	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11888
4.63058853594297e-09	0.377245175440826	0.367	0.064	7.42839012935972e-05	EBNA1BP2	Mono/Macro	GSE153697	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11889
6.87397783615325e-09	0.438884241233212	0.333	0.055	0.00011027235244757	NNT	Mono/Macro	GSE153697	ENSG00000112992	23530	nicotinamide nucleotide transhydrogenase	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11890
1.04674057311858e-08	0.375774197378573	0.267	0.035	0.000167918122739682	HIRIP3	Mono/Macro	GSE153697	ENSG00000149929	8479	HIRA interacting protein 3	NA	protein_coding	Q9BW71	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11891
2.64001880524557e-08	-1.43089318135821	0.267	0.73	0.000423511816737494	ARL4A	Mono/Macro	GSE153697	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11892
6.087644685846e-08	0.397543445852312	0.367	0.074	0.000976579960503416	APAF1	Mono/Macro	GSE153697	ENSG00000120868	317	apoptotic peptidase activating factor 1	APAF-1|CED4	protein_coding	O14727	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11893
1.80223802535175e-07	1.23841086504734	1	0.959	0.00289115024026927	SRGN	Mono/Macro	GSE153697	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11894
1.81850928825287e-07	0.673904270897409	0.267	0.043	0.00291725260021525	AZU1	Mono/Macro	GSE153697	ENSG00000278624	566	azurocidin 1	AZAMP|AZU|CAP37|HBP|HUMAZUR|NAZC	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11895
2.24728564130734e-07	0.304583149521621	0.333	0.064	0.00360509562578524	LMNB1	Mono/Macro	GSE153697	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11896
2.72102311281775e-07	-1.73747521833375	0.5	0.799	0.00436506527758223	TNFAIP3	Mono/Macro	GSE153697	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11897
4.71060655900896e-07	-0.857631434481137	0.633	0.957	0.00755675504196218	ZEB2	Mono/Macro	GSE153697	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11898
5.67103945506332e-07	0.298021705393362	0.3	0.057	0.00909748149381258	ASRGL1	Mono/Macro	GSE153697	ENSG00000162174	80150	asparaginase and isoaspartyl peptidase 1	ALP|ALP1|FLJ22316	protein_coding	Q7L266	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11899
6.73183158438727e-07	-0.582985336707772	1	1	0.0107992042276741	RPS9	Mono/Macro	GSE153697	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11900
6.82336069158479e-07	0.417667755323516	0.4	0.1	0.0109460352214403	SUCO	Mono/Macro	GSE153697	ENSG00000094975	51430	SUN domain containing ossification factor	C1orf9|CH1|OPT|SLP1	protein_coding	Q9UBS9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11901
1.00343901467295e-06	0.861801033941641	1	0.857	0.0160971686733834	PKM	Mono/Macro	GSE153697	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11902
1.07307914125953e-06	0.436215054457227	0.367	0.088	0.0172143355840853	ACOT8	Mono/Macro	GSE153697	ENSG00000101473	10005	acyl-CoA thioesterase 8	hACTE-III|hTE|NAP1|PTE-2|PTE1	protein_coding	O14734	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11903
1.25547361113836e-06	0.382741163195678	0.3	0.061	0.0201403076698815	HERC2	Mono/Macro	GSE153697	ENSG00000277278	8924	HECT and RLD domain containing E3 ubiquitin protein ligase 2	D15F37S1|jdf2|p528	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11904
1.33028118408853e-06	-0.83198718546651	1	1	0.0213403707551482	NEAT1	Mono/Macro	GSE153697	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11905
1.52308018481542e-06	1.04353507687648	0.867	0.564	0.0244332523248089	MNDA	Mono/Macro	GSE153697	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11906
1.87037389987918e-06	-0.808967262882842	1	1	0.0300045381018619	SAT1	Mono/Macro	GSE153697	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11907
1.98445184229771e-06	0.651613565218939	0.6	0.242	0.0318345764541398	MRPL51	Mono/Macro	GSE153697	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11908
2.45949154417272e-06	0.441444481551775	0.4	0.109	0.0394551633516188	NOLC1	Mono/Macro	GSE153697	ENSG00000166197	9221	nucleolar and coiled-body phosphoprotein 1	KIAA0035|NOPP130|NOPP140|P130|Srp40	protein_coding	Q14978	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11909
2.62625610437271e-06	-0.924827871125217	0.533	0.9	0.042130400426347	CXCR4	Mono/Macro	GSE153697	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11910
2.8224129805547e-06	-1.00168835015277	0.233	0.668	0.0452771490340585	PER1	Mono/Macro	GSE153697	ENSG00000179094	5187	period circadian regulator 1	PER|RIGUI	protein_coding	O15534	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11911
3.08549776107868e-06	0.621387308754994	0.433	0.127	0.0494975550832242	TUBA1C	Mono/Macro	GSE153697	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11912
5.49118858279067e-257	-2.92078498822294	0.738	0.998	8.80896472451279e-253	TSC22D3	Malignant cells	GSE153697	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11913
1.19042042577535e-205	-2.32222479491876	0.761	0.991	1.90967244702882e-201	PMAIP1	Malignant cells	GSE153697	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11914
6.99713253522495e-190	-1.9352724129545	0.775	0.994	1.12248000130079e-185	KLF6	Malignant cells	GSE153697	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11915
8.63125500189212e-165	-1.89113769168033	0.366	0.9	1.38462592740353e-160	AC103591.3	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11916
7.20265871782028e-163	-1.84574536880381	0.983	0.997	1.15545051151273e-158	VIM	Malignant cells	GSE153697	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11917
1.79075702507005e-160	-1.11875787653336	1	1	2.87273241961738e-156	EIF1	Malignant cells	GSE153697	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11918
1.07878144170911e-158	-2.01662111008014	0.811	0.993	1.73058118878975e-154	AC007952.4	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11919
4.35447616854451e-157	-1.88355911780262	0.723	0.965	6.9854506695791e-153	WDR74	Malignant cells	GSE153697	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11920
2.18256822941809e-156	-1.07556621245091	0.969	0.999	3.5012759536325e-152	CDC42	Malignant cells	GSE153697	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11921
1.17795382967403e-155	1.25646474493246	0.918	0.476	1.88967353356307e-151	DYNLL1	Malignant cells	GSE153697	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11922
1.10145699484347e-149	-2.25471904722714	0.801	0.987	1.76695731112789e-145	AC245014.3	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11923
3.600740684001e-143	-0.976036612454058	1	1	5.77630820527441e-139	UBC	Malignant cells	GSE153697	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11924
1.80074290356816e-139	-1.27301199927819	0.507	0.941	2.88875176590404e-135	NEAT1	Malignant cells	GSE153697	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11925
1.29575557501157e-138	-1.3688390892628	0.5	0.917	2.07865109343356e-134	ZFP36L2	Malignant cells	GSE153697	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11926
2.66126721094871e-137	-2.42932945232507	0.438	0.868	4.26920485980392e-133	S100A10	Malignant cells	GSE153697	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11927
1.66542636617434e-136	1.20223479796309	0.876	0.407	2.67167697661687e-132	VPREB1	Malignant cells	GSE153697	ENSG00000169575	7441	V-set pre-B cell surrogate light chain 1	CD179A|VpreB	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11928
6.59116772299069e-134	-1.27244318545743	0.577	0.948	1.05735512612217e-129	YPEL5	Malignant cells	GSE153697	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11929
5.09024133943263e-133	-1.16791247023383	0.818	0.979	8.16576515671783e-129	CCNL1	Malignant cells	GSE153697	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11930
5.07904479046214e-132	-1.95608098412442	0.499	0.899	8.14780365285936e-128	TXNIP	Malignant cells	GSE153697	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11931
2.37565064971634e-129	0.987918924410778	0.973	0.747	3.81101877227495e-125	CALM2	Malignant cells	GSE153697	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11932
3.64585805069296e-128	-1.50015175774562	0.489	0.877	5.84868548492165e-124	RHOB	Malignant cells	GSE153697	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11933
1.25068603582361e-127	-1.20693302013656	0.694	0.948	2.00635053866824e-123	EZR	Malignant cells	GSE153697	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11934
1.76629377903424e-127	1.07556504648978	0.918	0.542	2.83348848032672e-123	ERH	Malignant cells	GSE153697	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11935
2.52916896128937e-125	1.1529637469669	0.985	0.899	4.0572928477004e-121	CD164	Malignant cells	GSE153697	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11936
1.28806103951849e-123	-1.6754932042537	0.297	0.794	2.06630751959557e-119	AC091271.1	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11937
7.06215953262087e-122	-1.2629469151878	0.613	0.937	1.13291163222304e-117	AKAP13	Malignant cells	GSE153697	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11938
7.92770765750643e-119	-1.2533097665867	0.579	0.918	1.27176286241718e-114	CLEC2B	Malignant cells	GSE153697	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11939
4.07950065019442e-117	-1.96200084097513	0.48	0.875	6.54433494304189e-113	Z93241.1	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11940
1.22332346131212e-115	1.2613963077149	0.875	0.416	1.9624554966369e-111	UHRF1	Malignant cells	GSE153697	ENSG00000276043	29128	ubiquitin like with PHD and ring finger domains 1	FLJ21925|ICBP90|Np95|RNF106|TDRD22	protein_coding	Q96T88	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11941
4.9275628360308e-115	1.04379213540916	0.835	0.405	7.90479630156061e-111	HNRNPF	Malignant cells	GSE153697	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11942
8.51482360850067e-115	1.33169825616747	0.994	0.941	1.36594800327568e-110	STMN1	Malignant cells	GSE153697	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11943
7.17987041684179e-111	0.867904386684814	0.746	0.27	1.15179481226976e-106	MRPL20	Malignant cells	GSE153697	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11944
7.73038096663795e-109	-1.3310797463488	0.192	0.697	1.24010771466806e-104	EMP3	Malignant cells	GSE153697	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11945
2.50716267884868e-108	0.874194985178404	0.71	0.235	4.02199036940906e-104	ABRACL	Malignant cells	GSE153697	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11946
1.37998261505847e-102	-0.999770021824464	0.431	0.85	2.21376811107679e-98	AKIRIN2	Malignant cells	GSE153697	ENSG00000135334	55122	akirin 2	C6orf166|dJ486L4.2|FLJ10342	protein_coding	Q53H80	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11947
6.2281114679061e-101	-1.29067010325889	0.908	0.986	9.99113641681497e-97	ZFP36	Malignant cells	GSE153697	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11948
8.12426516294472e-101	0.813153664622063	0.777	0.325	1.30329461743959e-96	PRDX3	Malignant cells	GSE153697	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11949
1.75274201851592e-99	0.960894619946602	0.999	0.979	2.81174874610324e-95	PRDX1	Malignant cells	GSE153697	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11950
4.73779024879706e-99	-0.971641668872622	0.537	0.884	7.60036311712024e-95	IQGAP1	Malignant cells	GSE153697	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11951
3.10068031383507e-98	-1.34062753076984	0.086	0.582	4.97411135945422e-94	AHNAK	Malignant cells	GSE153697	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11952
1.78016520096374e-97	1.43435650713815	0.92	0.622	2.85574101538604e-93	IGLL1	Malignant cells	GSE153697	ENSG00000128322	3543	immunoglobulin lambda like polypeptide 1	14.1|CD179B|IGL5|IGLL|IGVPB	protein_coding	P15814	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11953
2.17357607113131e-97	-0.990848578348074	0.963	0.996	3.48685073330885e-93	LAPTM5	Malignant cells	GSE153697	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11954
7.44449148855217e-97	1.29595211030664	0.908	0.596	1.19424532459354e-92	VPREB3	Malignant cells	GSE153697	ENSG00000128218	29802	V-set pre-B cell surrogate light chain 3	8HS20	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11955
2.08272258532126e-96	-0.848247289609414	0.958	0.994	3.34110357137236e-92	RBM39	Malignant cells	GSE153697	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11956
5.52420923972245e-96	-0.932861639494934	0.508	0.87	8.86193646236275e-92	CLK1	Malignant cells	GSE153697	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11957
2.24524335043444e-95	0.796625331102198	0.907	0.556	3.60181938276694e-91	UQCR10	Malignant cells	GSE153697	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11958
1.10254190155313e-94	-0.944692562428673	0.127	0.616	1.76869771847153e-90	KLF2	Malignant cells	GSE153697	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11959
2.77113663046305e-94	-0.859471354997409	0.976	0.999	4.44545738258882e-90	PPP1R15A	Malignant cells	GSE153697	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11960
1.41446343213403e-93	1.11521767567323	0.994	0.955	2.26908223782941e-89	TUBB	Malignant cells	GSE153697	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11961
6.36367905319474e-93	1.1098491116879	0.983	0.878	1.0208613937135e-88	TCL1A	Malignant cells	GSE153697	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11962
1.04694895914376e-92	-1.04319594420494	0.213	0.678	1.67951552025842e-88	AC087239.1	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11963
1.48384455432087e-90	-0.923225368820006	0.851	0.969	2.38038343404154e-86	ELF1	Malignant cells	GSE153697	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11964
3.51559639132547e-90	-1.53625633689168	0.549	0.866	5.63971973096432e-86	S100A4	Malignant cells	GSE153697	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11965
1.29159003217368e-89	0.698584402624281	0.621	0.186	2.07196872961303e-85	ATP6V0E1	Malignant cells	GSE153697	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11966
1.9105518837593e-88	0.790774253985117	0.876	0.537	3.06490733192666e-84	SRP9	Malignant cells	GSE153697	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11967
1.04933455090642e-86	0.816516689906128	0.827	0.429	1.68334248656408e-82	CCT5	Malignant cells	GSE153697	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11968
2.69428936262907e-86	-1.59405458340039	0.756	0.939	4.32217899552956e-82	C12orf57	Malignant cells	GSE153697	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11969
1.11301333200956e-84	-0.929145077222325	0.437	0.804	1.78549598720974e-80	AFF4	Malignant cells	GSE153697	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11970
6.82264072242688e-84	0.748514147784833	0.662	0.245	1.09448802469172e-79	RGS19	Malignant cells	GSE153697	ENSG00000171700	10287	regulator of G protein signaling 19	GAIP|RGSGAIP	protein_coding	P49795	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11971
3.91522946267956e-83	0.842286238233306	0.986	0.916	6.28081110403055e-79	RAN	Malignant cells	GSE153697	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11972
7.46558619664326e-83	1.08536977792045	0.946	0.773	1.19762933766551e-78	HSPA8	Malignant cells	GSE153697	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11973
1.91677471990057e-82	0.811235595495303	0.866	0.552	3.0748900056645e-78	PDIA6	Malignant cells	GSE153697	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11974
2.7480178068342e-82	-1.13485902807526	0.625	0.884	4.40837016572342e-78	CD44	Malignant cells	GSE153697	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11975
9.10388520545611e-82	-0.800504389390134	1	1	1.46044526465927e-77	MALAT1	Malignant cells	GSE153697	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11976
9.40769204279907e-82	0.678727228785449	0.652	0.233	1.50918195750583e-77	NDUFB3	Malignant cells	GSE153697	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11977
6.26651493877559e-81	-0.994891002102408	0.723	0.911	1.00527432647838e-76	BTG1	Malignant cells	GSE153697	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11978
6.92957693074798e-80	-1.27226791656476	0.968	0.971	1.11164273123059e-75	TAGLN2	Malignant cells	GSE153697	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11979
9.20944858750465e-80	-1.15810248816223	0.475	0.819	1.4773797424075e-75	DDIT4	Malignant cells	GSE153697	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11980
6.07147007625174e-79	0.811517581092595	0.989	0.905	9.73985229632304e-75	IFITM2	Malignant cells	GSE153697	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11981
2.22619756640922e-78	-1.30504313131969	0.376	0.747	3.57126613603368e-74	TMEM107	Malignant cells	GSE153697	ENSG00000179029	84314	transmembrane protein 107	JBTS29|MGC10744|MKS13	protein_coding	Q6UX40	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11982
5.94415078173887e-77	-0.686429087254023	0.976	0.993	9.5356066840655e-73	YWHAZ	Malignant cells	GSE153697	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11983
7.63330109171593e-77	0.58480249461653	0.561	0.165	1.22453416113307e-72	MRPL14	Malignant cells	GSE153697	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11984
1.43671329563609e-76	-1.04076334774563	0.993	1	2.30477546885942e-72	FTH1	Malignant cells	GSE153697	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11985
6.1216152610879e-75	-1.32938282613339	0.059	0.46	9.82029520183721e-71	LMNA	Malignant cells	GSE153697	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11986
1.21051093995788e-74	-0.728906210941046	1	0.998	1.94190164988043e-70	SH3BGRL3	Malignant cells	GSE153697	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11987
1.529796651863e-74	-0.906175842784919	0.441	0.761	2.45409978891862e-70	SBDS	Malignant cells	GSE153697	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11988
2.39542247064239e-74	-1.17368517416144	0.908	0.987	3.84273672740452e-70	JUN	Malignant cells	GSE153697	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11989
2.48886632337839e-73	0.664103513845693	0.862	0.543	3.99263935596362e-69	SEM1	Malignant cells	GSE153697	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11990
3.53968900699094e-73	0.939267619729354	0.91	0.639	5.67836910501486e-69	HSPD1	Malignant cells	GSE153697	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11991
3.56691451521872e-73	-0.798134889400495	0.485	0.811	5.72204426531387e-69	YBX3	Malignant cells	GSE153697	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11992
1.00878657135891e-72	0.713376548864836	0.696	0.33	1.61829541777396e-68	SLIRP	Malignant cells	GSE153697	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11993
1.51461873924494e-72	-1.20815384149454	0.366	0.729	2.42975138149673e-68	PTCH2	Malignant cells	GSE153697	ENSG00000117425	8643	patched 2	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11994
4.2491158443565e-72	0.618758979396756	1	0.992	6.8164316375167e-68	MT-ND5	Malignant cells	GSE153697	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11995
7.76719655017785e-72	-0.946403194064541	0.213	0.617	1.24601367057953e-67	ADGRE5	Malignant cells	GSE153697	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11996
1.64628920151213e-71	-0.732345568135406	0.659	0.896	2.64097713706577e-67	EPC1	Malignant cells	GSE153697	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11997
4.70871138181743e-71	0.722090954495506	0.938	0.674	7.55371479871152e-67	BLNK	Malignant cells	GSE153697	ENSG00000095585	29760	B cell linker	BASH|bca|BLNK-s|Ly57|SLP-65|SLP65	protein_coding	Q8WV28	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11998
1.65164939626097e-70	0.665579760195152	0.789	0.424	2.64957596148185e-66	OSTC	Malignant cells	GSE153697	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	11999
1.66524476335696e-70	0.711929827027194	0.828	0.513	2.67138564937724e-66	SNRPD1	Malignant cells	GSE153697	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12000
1.40342604021843e-69	0.696876531161978	0.851	0.559	2.2513760537184e-65	SNRPE	Malignant cells	GSE153697	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12001
2.57635395117062e-69	0.586350904520074	0.952	0.754	4.13298700846792e-65	SELENOH	Malignant cells	GSE153697	ENSG00000211450	280636	selenoprotein H	C11orf31|SELH	protein_coding	Q8IZQ5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12002
2.74069165712472e-69	0.760094005808657	0.886	0.605	4.39661755635948e-65	MSH6	Malignant cells	GSE153697	ENSG00000116062	2956	mutS homolog 6	GTBP|MSH-6	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12003
3.60177383996881e-69	0.596334485283446	0.593	0.211	5.77796559407797e-65	MAT2B	Malignant cells	GSE153697	ENSG00000038274	27430	methionine adenosyltransferase 2B	MATIIbeta|SDR23E1	protein_coding	Q9NZL9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12004
7.52138462057155e-69	0.695061634489873	0.646	0.277	1.20658052083209e-64	DKC1	Malignant cells	GSE153697	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12005
1.08496880126124e-68	0.672358584125702	0.883	0.631	1.74050695098328e-64	SNRPD3	Malignant cells	GSE153697	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12006
1.18718117388751e-68	-1.07824731429799	0.297	0.684	1.90447603915034e-64	CD99	Malignant cells	GSE153697	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12007
1.38893310570231e-68	0.645303398014147	0.979	0.881	2.22812648816765e-64	RBBP4	Malignant cells	GSE153697	ENSG00000162521	5928	RB binding protein 4, chromatin remodeling factor	lin-53|NURF55|RbAp48	protein_coding	Q09028	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12008
2.0405263643247e-68	0.588358464413927	0.541	0.167	3.27341239364969e-64	SLC1A5	Malignant cells	GSE153697	ENSG00000105281	6510	solute carrier family 1 member 5	AAAT|ASCT2|M7V1|RDRC	protein_coding	Q15758	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12009
4.79092089181997e-68	0.675502434565103	0.793	0.44	7.68559529465759e-64	RBX1	Malignant cells	GSE153697	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12010
1.41256113122265e-67	0.499350506862697	0.435	0.093	2.26603056670737e-63	POLR3K	Malignant cells	GSE153697	ENSG00000161980	51728	RNA polymerase III subunit K	C11|RPC11	protein_coding	Q9Y2Y1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12011
3.01905261464334e-67	-0.86518253267527	0.085	0.472	4.84316420441084e-63	SMIM3	Malignant cells	GSE153697	ENSG00000256235	85027	small integral membrane protein 3	C5orf62|MSTP150|NID67	protein_coding	Q9BZL3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12012
4.02326881972523e-67	0.573274535645678	0.631	0.249	6.45412784060322e-63	FAM96A	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12013
1.66831556787954e-66	0.394763056566365	0.318	0.034	2.67631183399235e-62	C14orf119	Malignant cells	GSE153697	ENSG00000179933	55017	chromosome 14 open reading frame 119	FLJ20671	protein_coding	Q9NWQ9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12014
2.44761694080745e-66	-0.862391081977905	0.52	0.805	3.9264670964433e-62	IGHM	Malignant cells	GSE153697	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12015
3.55870081852103e-66	0.652048277211021	0.855	0.539	5.70886785307144e-62	SASH3	Malignant cells	GSE153697	ENSG00000122122	54440	SAM and SH3 domain containing 3	753P9|CXorf9|HACS2|SH3D6C|SLY	protein_coding	O75995	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12016
7.50248730862587e-66	-0.809808348623155	0.372	0.717	1.20354901404976e-61	GGNBP2	Malignant cells	GSE153697	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12017
8.35099156825583e-66	-0.948772319927904	0.542	0.843	1.3396660673796e-61	HIST1H1C	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12018
5.63133262817373e-65	0.554497896582591	0.579	0.207	9.0337838021163e-61	TMX1	Malignant cells	GSE153697	ENSG00000139921	81542	thioredoxin related transmembrane protein 1	PDIA11|TMX|TXNDC|TXNDC1	protein_coding	Q9H3N1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12019
9.09073963962003e-65	0.521546252976894	0.545	0.173	1.45833645298784e-60	TIMM8B	Malignant cells	GSE153697	ENSG00000150779	26521	translocase of inner mitochondrial membrane 8 homolog B	DDP2|FLJ21744|MGC102866|MGC117373|TIM8B	protein_coding	Q9Y5J9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12020
1.29157977876721e-64	0.524858633253471	0.559	0.19	2.07195228109836e-60	LSM6	Malignant cells	GSE153697	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12021
2.69381153348562e-64	0.618082966078719	0.704	0.337	4.32141246201763e-60	PSMA5	Malignant cells	GSE153697	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12022
3.36565976650849e-64	0.721279097159976	0.668	0.311	5.39919139743293e-60	CDK4	Malignant cells	GSE153697	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12023
7.2379349576853e-64	0.622235928755094	0.962	0.793	1.16110952591188e-59	PTGES3	Malignant cells	GSE153697	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12024
7.80806536922037e-64	-0.444594339403308	1	1	1.25256984653033e-59	HLA-B	Malignant cells	GSE153697	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12025
9.61801979446473e-64	0.782674223064634	0.711	0.372	1.54292273542803e-59	HSPE1	Malignant cells	GSE153697	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12026
1.67294304154361e-63	-0.835768148894248	0.725	0.908	2.68373522724426e-59	DUSP1	Malignant cells	GSE153697	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12027
2.85590393471888e-63	-0.886503884685811	0.266	0.658	4.58144109207603e-59	BTG2	Malignant cells	GSE153697	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12028
3.85121922236638e-63	0.861231836801464	0.951	0.788	6.17812587652015e-59	NASP	Malignant cells	GSE153697	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12029
4.93457055943751e-63	-0.928696194205743	0.382	0.703	7.91603809144965e-59	ELOA	Malignant cells	GSE153697	ENSG00000011007	6924	elongin A	SIII|TCEB3|TCEB3A	protein_coding	Q14241	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12030
5.50913592103927e-63	0.710117529599181	0.665	0.296	8.8377558445312e-59	NREP	Malignant cells	GSE153697	ENSG00000134986	9315	neuronal regeneration related protein	C5orf13|D4S114|P311|PRO1873|PTZ17|SEZ17	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12031
1.41051073661734e-62	0.734423399603753	0.683	0.323	2.26274132368153e-58	PAICS	Malignant cells	GSE153697	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12032
1.92638743993407e-62	0.574204370104066	0.982	0.851	3.09031073114224e-58	PARP1	Malignant cells	GSE153697	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12033
2.02437589473488e-62	0.600148931367003	0.938	0.747	3.24750381033369e-58	ANP32A	Malignant cells	GSE153697	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12034
4.83344968865016e-62	0.660562769687798	0.934	0.718	7.75381999053259e-58	LAT2	Malignant cells	GSE153697	ENSG00000086730	7462	linker for activation of T cells family member 2	HSPC046|LAB|NTAL|WBSCR15|WBSCR5|WSCR5	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12035
7.23343037826118e-62	0.76639457017067	0.977	0.868	1.16038690128066e-57	DNTT	Malignant cells	GSE153697	ENSG00000107447	1791	DNA nucleotidylexotransferase	TDT	protein_coding	P04053	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12036
7.37191723274387e-62	0.530486297330108	0.587	0.219	1.18260296247677e-57	FARSA	Malignant cells	GSE153697	ENSG00000179115	2193	phenylalanyl-tRNA synthetase subunit alpha	CML33|FARSL|FARSLA	protein_coding	Q9Y285	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12037
9.62202473830547e-62	0.588291018417871	0.411	0.095	1.54356520851896e-57	LINC00511	Malignant cells	GSE153697	ENSG00000227036	400619	long intergenic non-protein coding RNA 511	onco-lncRNA-12	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12038
9.687507212407e-62	0.615799869220399	0.982	0.922	1.55406990701433e-57	LDHB	Malignant cells	GSE153697	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12039
1.02426990456348e-61	-0.759024264248631	0.72	0.927	1.64313378090073e-57	HIST1H1D	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12040
1.11623467400735e-61	-0.726227855709155	0.662	0.899	1.79066366404258e-57	ANKRD10	Malignant cells	GSE153697	ENSG00000088448	55608	ankyrin repeat domain 10	FLJ20093	protein_coding	Q9NXR5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12041
1.66026691877458e-61	0.644302424221899	0.861	0.543	2.66340019109818e-57	BANF1	Malignant cells	GSE153697	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12042
1.75578274141491e-61	0.424529689103421	0.308	0.037	2.8166266737778e-57	AC008060.1	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12043
2.70777122852279e-61	0.488482283371075	0.303	0.035	4.34380660479626e-57	UBE2T	Malignant cells	GSE153697	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12044
3.92122106527972e-61	0.47070436253685	0.411	0.094	6.29042283292173e-57	NEXN	Malignant cells	GSE153697	ENSG00000162614	91624	nexilin F-actin binding protein	NELIN|nexilin	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12045
6.55561273007745e-61	0.490689749289015	0.459	0.125	1.05165139415902e-56	MRPS18C	Malignant cells	GSE153697	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12046
6.66169001290638e-61	0.52139037862734	0.534	0.181	1.06866831187044e-56	COA4	Malignant cells	GSE153697	ENSG00000181924	51287	cytochrome c oxidase assembly factor 4 homolog	CHCHD8|CMC3|E2IG2	protein_coding	Q9NYJ1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12047
7.56654928451721e-61	0.593808996377704	0.756	0.426	1.21382583622225e-56	LSM2	Malignant cells	GSE153697	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12048
1.07300165018519e-60	-0.701395661811594	0.313	0.68	1.72130924722708e-56	RELL1	Malignant cells	GSE153697	ENSG00000181826	768211	RELT like 1	NA	protein_coding	Q8IUW5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12049
1.15803669283045e-60	-0.493785261917482	0.994	0.997	1.85772246263861e-56	RHOA	Malignant cells	GSE153697	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12050
1.77029541812318e-60	0.614503957512326	0.976	0.821	2.83990790975321e-56	PSMA6	Malignant cells	GSE153697	ENSG00000100902	5687	proteasome 20S subunit alpha 6	IOTA|MGC22756|MGC2333|MGC23846|p27K|PROS27	protein_coding	P60900	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12051
2.73205500673632e-60	0.553155298392968	0.997	0.997	4.38276264180641e-56	NPM1	Malignant cells	GSE153697	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12052
2.89017294029348e-60	-0.937081411869251	0.515	0.803	4.63641543081881e-56	SERPINB1	Malignant cells	GSE153697	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12053
3.45692373762971e-60	0.573437799351495	0.994	0.939	5.54559705990558e-56	SERBP1	Malignant cells	GSE153697	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12054
3.75414076118262e-60	-0.703466918578366	1	1	6.02239260908916e-56	H3F3B	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12055
4.50825297843948e-60	0.757127569786372	0.942	0.757	7.23213942801261e-56	CALR	Malignant cells	GSE153697	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12056
1.93208558493755e-59	-0.540603652569034	1	1	3.09945169535681e-55	TMSB10	Malignant cells	GSE153697	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12057
2.8630976634397e-59	0.63569767637176	0.648	0.298	4.59298127168997e-55	GNL3	Malignant cells	GSE153697	ENSG00000163938	26354	G protein nucleolar 3	C77032|E2IG3|MGC800|NS	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12058
3.75715410625029e-59	0.544601027617699	0.986	0.863	6.02722661724672e-55	CNBP	Malignant cells	GSE153697	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12059
5.59371797914443e-59	-1.04568968632262	0.67	0.932	8.97344238214349e-55	HIST1H1E	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12060
6.77919204974595e-59	0.512979551981967	0.994	0.957	1.08751798862024e-54	SUMO2	Malignant cells	GSE153697	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12061
1.57935837119971e-58	-0.834252447748795	0.328	0.66	2.53360669907858e-54	AFF1	Malignant cells	GSE153697	ENSG00000172493	4299	ALF transcription elongation factor 1	AF-4|AF4|FEL|MLLT2|PBM1	protein_coding	P51825	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12062
3.11766418082982e-58	0.546449761385255	0.561	0.215	5.00135687888721e-54	UBE2V2	Malignant cells	GSE153697	ENSG00000169139	7336	ubiquitin conjugating enzyme E2 V2	DDVit-1|DDVIT1|EDAF-1|EDPF-1|EDPF1|MMS2|UEV-2|UEV2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12063
8.64759399952676e-58	0.67449670016097	0.813	0.548	1.38724702940408e-53	SNRPG	Malignant cells	GSE153697	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12064
9.56548652137858e-58	0.470060592250205	0.466	0.138	1.53449534775955e-53	MESD	Malignant cells	GSE153697	ENSG00000117899	23184	mesoderm development LRP chaperone	BOCA|KIAA0081|MESDC2	protein_coding	Q14696	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12065
1.92891706781426e-57	0.540309017614694	0.945	0.78	3.09436876018764e-53	UBE2I	Malignant cells	GSE153697	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12066
2.61860970972447e-57	-1.07514047011728	0.544	0.798	4.20077369634e-53	ID2	Malignant cells	GSE153697	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12067
7.11451972328416e-57	0.44926357021956	0.42	0.106	1.14131125400925e-52	IMP3	Malignant cells	GSE153697	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12068
9.56196079805671e-57	0.601876671302444	0.706	0.372	1.53392975122426e-52	SNRNP40	Malignant cells	GSE153697	ENSG00000060688	9410	small nuclear ribonucleoprotein U5 subunit 40	HPRP8BP|PRP8BP|PRPF8BP|SPF38|WDR57	protein_coding	Q96DI7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12069
1.61782276718914e-56	0.592085608950395	0.748	0.422	2.59531128312482e-52	NDUFAB1	Malignant cells	GSE153697	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12070
1.92708706898872e-56	-0.755571750505339	0.383	0.697	3.09143307607171e-52	ISG20	Malignant cells	GSE153697	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12071
1.93730742305979e-56	0.587539857406902	0.434	0.119	3.10782856807251e-52	MCM6	Malignant cells	GSE153697	ENSG00000076003	4175	minichromosome maintenance complex component 6	Mis5	protein_coding	Q14566	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12072
1.97643423457794e-56	0.659932855499166	0.354	0.071	3.17059579910993e-52	GINS2	Malignant cells	GSE153697	ENSG00000131153	51659	GINS complex subunit 2	Pfs2|PSF2	protein_coding	Q9Y248	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12073
5.97532399467455e-56	0.450786955846159	0.446	0.126	9.58561475225691e-52	ACTL6A	Malignant cells	GSE153697	ENSG00000136518	86	actin like 6A	Actl6|Arp4|BAF53A|INO80K|SMARCN1	protein_coding	O96019	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12074
9.23291889913997e-56	0.679603205136609	0.782	0.482	1.48114484980003e-51	RRP7A	Malignant cells	GSE153697	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12075
2.23260757886739e-55	-1.05812988425125	0.045	0.366	3.58154907801907e-51	AREG	Malignant cells	GSE153697	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12076
3.77778972372312e-55	0.588381658469475	0.861	0.585	6.06033027479663e-51	TRMT112	Malignant cells	GSE153697	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12077
4.7476336132186e-55	0.379448155149708	0.342	0.065	7.61615384232528e-51	ASF1A	Malignant cells	GSE153697	ENSG00000111875	25842	anti-silencing function 1A histone chaperone	CIA|DKFZP547E2110	protein_coding	Q9Y294	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12078
6.81259809920091e-55	0.722315623643765	0.92	0.709	1.09287698707381e-50	CD79B	Malignant cells	GSE153697	ENSG00000007312	974	CD79b molecule	B29|Ig-beta|IGB|Igbeta	protein_coding	P40259	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12079
3.41245155884962e-54	0.608441745749038	0.883	0.66	5.47425479070657e-50	PSMB2	Malignant cells	GSE153697	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12080
4.06126128510987e-54	0.462611491339562	0.449	0.136	6.51507535357326e-50	MRPS12	Malignant cells	GSE153697	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12081
4.56574158575389e-54	1.15281468955925	0.983	0.935	7.32436265186639e-50	TUBA1B	Malignant cells	GSE153697	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12082
6.71551108047113e-54	-0.66283680115911	0.13	0.47	1.07730228752918e-49	PER1	Malignant cells	GSE153697	ENSG00000179094	5187	period circadian regulator 1	PER|RIGUI	protein_coding	O15534	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12083
6.82026973033224e-54	0.416957351699694	0.413	0.109	1.0941076701399e-49	ZNF146	Malignant cells	GSE153697	ENSG00000167635	7705	zinc finger protein 146	OZF	protein_coding	Q15072	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12084
9.88944356826818e-54	-0.635278941144783	0.366	0.702	1.58646453722158e-49	CD19	Malignant cells	GSE153697	ENSG00000177455	930	CD19 molecule	NA	protein_coding	P15391	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12085
1.00126233685428e-53	0.585339278093225	0.783	0.48	1.60622504078164e-49	SOD1	Malignant cells	GSE153697	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12086
1.0782104918185e-53	0.597719875137863	0.621	0.289	1.72966527097524e-49	BCL11A	Malignant cells	GSE153697	ENSG00000119866	53335	BAF chromatin remodeling complex subunit BCL11A	BCL11A-L|BCL11A-S|BCL11A-XL|CTIP1|EVI9|HBFQTL5|SMARCM1|ZNF856	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12087
1.18130332173011e-53	0.586915770287744	0.892	0.662	1.89504678871945e-49	CCT6A	Malignant cells	GSE153697	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12088
2.26221748264933e-53	0.513796491558858	0.565	0.223	3.62904928566605e-49	EXOSC5	Malignant cells	GSE153697	ENSG00000077348	56915	exosome component 5	hRrp46p|MGC12901|p12B|RRP41B|RRP46|Rrp46p	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12089
2.27283788149348e-53	0.566513902888669	0.752	0.439	3.64608652949184e-49	TAP1	Malignant cells	GSE153697	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12090
2.47828489119586e-53	0.513517974276786	0.366	0.083	3.9756646224564e-49	RAG1	Malignant cells	GSE153697	ENSG00000166349	5896	recombination activating 1	MGC43321|RNF74	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12091
2.58440164554942e-53	0.542027642106727	0.915	0.685	4.14589711979038e-49	SELENOF	Malignant cells	GSE153697	ENSG00000183291	9403	selenoprotein F	SEP15	protein_coding	O60613	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12092
3.31089361363275e-53	0.567094796061809	0.908	0.694	5.31133553498965e-49	XRCC5	Malignant cells	GSE153697	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12093
3.58310803197396e-53	-0.694634191769232	0.718	0.909	5.74802190489262e-49	JMJD1C	Malignant cells	GSE153697	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12094
4.35747269414568e-53	-0.551199082673734	0.997	1	6.9902576959485e-49	DDX5	Malignant cells	GSE153697	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12095
2.02358558045544e-52	0.396968568346002	0.4	0.104	3.24623598816662e-48	COA3	Malignant cells	GSE153697	ENSG00000183978	28958	cytochrome c oxidase assembly factor 3	CCDC56|COX25|hCOA3|HSPC009|MITRAC12	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12096
3.14553341366814e-52	-0.988243790715904	0.756	0.861	5.04606470220644e-48	ANXA2	Malignant cells	GSE153697	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12097
3.63830006687901e-52	1.11510195638845	0.862	0.673	5.83656096728731e-48	H2AFZ	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12098
3.70715658375319e-52	-0.487731560611117	0.985	0.995	5.94702059165686e-48	CCNI	Malignant cells	GSE153697	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12099
4.08656540912672e-52	0.463052412161503	0.999	0.958	6.55566822932109e-48	OAZ1	Malignant cells	GSE153697	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12100
4.61437509704862e-52	0.477824875547576	0.487	0.172	7.4023805306854e-48	MPLKIP	Malignant cells	GSE153697	ENSG00000168303	136647	M-phase specific PLK1 interacting protein	C7orf11|ORF20|TTDN1	protein_coding	Q8TAP9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12101
5.06440193629728e-52	0.394107936143744	0.389	0.098	8.1243135862081e-48	KEAP1	Malignant cells	GSE153697	ENSG00000079999	9817	kelch like ECH associated protein 1	INrf2|KIAA0132|KLHL19|MGC10630|MGC1114|MGC20887|MGC4407|MGC9454	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12102
5.85137520118212e-52	0.559577737082931	0.879	0.618	9.38677609773636e-48	PSMB9	Malignant cells	GSE153697	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12103
6.73085037980666e-52	0.507356422491553	0.569	0.239	1.07976301792858e-47	MRPL51	Malignant cells	GSE153697	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12104
9.31783420861394e-52	-1.10917892448851	0.451	0.719	1.49476696374585e-47	LSP1	Malignant cells	GSE153697	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12105
1.53462535265217e-51	0.543968475071235	0.917	0.724	2.4618459907246e-47	ATP5MF	Malignant cells	GSE153697	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12106
1.68231492058283e-51	0.766040074076674	0.483	0.179	2.69876959559897e-47	PCNA	Malignant cells	GSE153697	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12107
2.24844315733453e-51	0.593128383781125	0.944	0.778	3.60695251299605e-47	SRSF7	Malignant cells	GSE153697	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12108
4.8669001871193e-51	0.804100109530112	0.739	0.465	7.80748128017678e-47	FABP5	Malignant cells	GSE153697	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12109
4.8936132057786e-51	0.650398135644483	0.892	0.683	7.85033430471003e-47	PA2G4	Malignant cells	GSE153697	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12110
5.65182190162492e-51	0.575576530111422	0.561	0.242	9.06665269458669e-47	RPA2	Malignant cells	GSE153697	ENSG00000117748	6118	replication protein A2	NA	protein_coding	P15927	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12111
8.19796089427155e-51	-0.883215269434661	0.707	0.879	1.31511688665904e-46	SLC2A3	Malignant cells	GSE153697	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12112
1.02798793415883e-50	0.426315799303233	0.394	0.108	1.64909824397759e-46	TNFRSF1A	Malignant cells	GSE153697	ENSG00000067182	7132	TNF receptor superfamily member 1A	CD120a|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR60	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12113
1.1644443020568e-50	0.528332294619065	0.544	0.221	1.86800154935952e-46	MRTO4	Malignant cells	GSE153697	ENSG00000053372	51154	MRT4 homolog, ribosome maturation factor	C1orf33|dJ657E11.4|MRT4	protein_coding	Q9UKD2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12114
1.31896985368492e-50	-0.787106347497415	0.187	0.52	2.11589143928135e-46	CDKN1A	Malignant cells	GSE153697	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12115
1.98663166507919e-50	-0.640541906734632	0.686	0.857	3.18695451712003e-46	EIF1B	Malignant cells	GSE153697	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12116
3.33499397422799e-50	-0.578634231268181	0.944	0.986	5.34999733345654e-46	SRSF5	Malignant cells	GSE153697	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12117
3.7936886697156e-50	-0.895215316089266	0.42	0.676	6.08583536395777e-46	GUSB	Malignant cells	GSE153697	ENSG00000169919	2990	glucuronidase beta	NA	protein_coding	P08236	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12118
3.9802028848901e-50	-0.708852588397248	0.173	0.512	6.38504146794069e-46	CD9	Malignant cells	GSE153697	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12119
6.54566545865002e-50	-0.541353860554254	0.88	0.957	1.05005565287664e-45	DAZAP2	Malignant cells	GSE153697	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12120
1.09224578178988e-49	0.595234084840893	0.787	0.497	1.75218068314733e-45	GLRX	Malignant cells	GSE153697	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12121
1.26283613920066e-49	0.301013820817157	1	1	2.0258417345057e-45	MT-ND4L	Malignant cells	GSE153697	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12122
1.42421644669381e-49	0.838562864234849	0.527	0.232	2.28472802378621e-45	MCM3	Malignant cells	GSE153697	ENSG00000112118	4172	minichromosome maintenance complex component 3	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12123
1.61887974628167e-49	0.369428093728553	0.359	0.085	2.59700688898505e-45	CISD1	Malignant cells	GSE153697	ENSG00000122873	55847	CDGSH iron sulfur domain 1	C10orf70|MDS029|mitoNEET|ZCD1	protein_coding	Q9NZ45	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12124
2.65079374303335e-49	-0.739266030028322	0.41	0.684	4.2524033225741e-45	LBR	Malignant cells	GSE153697	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12125
5.813639702536e-49	0.703155716575949	0.99	0.925	9.32624081080825e-45	CD24	Malignant cells	GSE153697	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12126
5.98452038438704e-49	0.346583283236829	0.3	0.054	9.60036760063368e-45	SH2D3C	Malignant cells	GSE153697	ENSG00000095370	10044	SH2 domain containing 3C	NSP3	protein_coding	Q8N5H7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12127
6.22251205068217e-49	0.536973969525914	0.541	0.22	9.98215383170434e-45	DCTPP1	Malignant cells	GSE153697	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12128
6.25203624600519e-49	0.508107044972854	0.999	0.998	1.00295165458415e-44	MT-ND2	Malignant cells	GSE153697	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12129
1.12550527360899e-48	0.482151428387787	0.452	0.154	1.80553555992354e-44	RFC2	Malignant cells	GSE153697	ENSG00000049541	5982	replication factor C subunit 2	A1|RFC40	protein_coding	P35250	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12130
1.37574885556107e-48	0.528143275719956	0.69	0.368	2.20697631409108e-44	TRAF3IP2	Malignant cells	GSE153697	ENSG00000056972	10758	TRAF3 interacting protein 2	ACT1|C6orf2|C6orf4|C6orf5|C6orf6|CIKS|DKFZP586G0522	protein_coding	O43734	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12131
2.97872920681774e-48	0.474498086757328	0.551	0.23	4.77847739357702e-44	ELOVL1	Malignant cells	GSE153697	ENSG00000066322	64834	ELOVL fatty acid elongase 1	Ssc1	protein_coding	Q9BW60	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12132
3.76128936968876e-48	-0.593079565751534	0.314	0.638	6.03386040685471e-44	UBE2J1	Malignant cells	GSE153697	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12133
9.63171932069894e-48	0.521722675482878	0.937	0.77	1.54512041342652e-43	APEX1	Malignant cells	GSE153697	ENSG00000100823	328	apurinic/apyrimidinic endodeoxyribonuclease 1	APE|APE-1|APEN|APEX|APX|HAP1|REF-1|REF1	protein_coding	P27695	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12134
1.30073234714426e-47	0.515423173484199	0.583	0.276	2.08663483128882e-43	MRPL3	Malignant cells	GSE153697	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12135
1.5142426081745e-47	-0.842584059120325	0.339	0.637	2.42914799203354e-43	S100A6	Malignant cells	GSE153697	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12136
1.56019859227975e-47	0.431795860675327	0.376	0.101	2.50287058173518e-43	NOP16	Malignant cells	GSE153697	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12137
2.03176385288674e-47	0.512144661340599	0.914	0.732	3.25935557280091e-43	XRCC6	Malignant cells	GSE153697	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12138
4.23643635227949e-47	0.344470603910694	0.331	0.074	6.79609119632675e-43	TFAP4	Malignant cells	GSE153697	ENSG00000090447	7023	transcription factor AP-4	AP-4|bHLHc41	protein_coding	Q01664	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12139
4.5459015332417e-47	-0.608271696582804	0.261	0.586	7.29253523962634e-43	DUSP10	Malignant cells	GSE153697	ENSG00000143507	11221	dual specificity phosphatase 10	MKP-5|MKP5	protein_coding	Q9Y6W6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12140
6.38540503524683e-47	0.419924870458929	0.441	0.147	1.0243466757543e-42	AK6	Malignant cells	GSE153697	ENSG00000279247	102157402	adenylate kinase 6	CINAP	protein_coding	Q9Y3D8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12141
6.55912217901966e-47	0.45722052109072	0.486	0.188	1.05221437995833e-42	MRPS23	Malignant cells	GSE153697	ENSG00000181610	51649	mitochondrial ribosomal protein S23	CGI-138|HSPC329|MRP-S23	protein_coding	Q9Y3D9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12142
7.69462633209554e-47	0.524210783873439	0.811	0.565	1.23437195619477e-42	SSBP1	Malignant cells	GSE153697	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12143
1.66553907682416e-46	0.566553605757098	0.713	0.419	2.67185778704133e-42	BUB3	Malignant cells	GSE153697	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12144
3.09244004756489e-46	0.320339161531074	0.28	0.048	4.9608923243036e-42	TEX30	Malignant cells	GSE153697	ENSG00000151287	93081	testis expressed 30	C13orf27	protein_coding	Q5JUR7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12145
4.38810754861917e-46	0.458836621813685	0.465	0.169	7.03940212949488e-42	GPATCH4	Malignant cells	GSE153697	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12146
5.89244064638562e-46	-0.711709393536082	0.161	0.469	9.45265328493181e-42	AC007384.1	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12147
6.46373138527148e-46	-0.659201321709427	0.28	0.583	1.03691178882525e-41	OSER1	Malignant cells	GSE153697	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12148
7.00037089719034e-46	0.458562373137248	0.528	0.224	1.12299949932727e-41	ZNF706	Malignant cells	GSE153697	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12149
7.18953907187885e-46	-0.596043959355047	0.637	0.839	1.1533458579108e-41	TRA2A	Malignant cells	GSE153697	ENSG00000164548	29896	transformer 2 alpha homolog	AWMS1|htra-2-alpha	protein_coding	Q13595	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12150
7.37740794601906e-46	-0.518917610026197	0.037	0.312	1.18348378270038e-41	MCAM	Malignant cells	GSE153697	ENSG00000076706	4162	melanoma cell adhesion molecule	CD146|HEMCAM|MelCAM|METCAM|MUC18	protein_coding	P43121	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12151
9.54067349542626e-46	0.427289150208036	0.503	0.196	1.53051484213628e-41	WDR77	Malignant cells	GSE153697	ENSG00000116455	79084	WD repeat domain 77	MEP50|p44	protein_coding	Q9BQA1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12152
1.23130127454111e-45	0.600849783159543	0.845	0.634	1.97525350461885e-41	TPM4	Malignant cells	GSE153697	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12153
1.68971670921489e-45	0.470261190842133	0.549	0.24	2.71064354492253e-41	MRPS34	Malignant cells	GSE153697	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12154
1.89444360985737e-45	0.449570674193544	0.513	0.211	3.03906643893319e-41	SFT2D1	Malignant cells	GSE153697	ENSG00000198818	113402	SFT2 domain containing 1	C6orf83|MGC19825|pRGR1	protein_coding	Q8WV19	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12155
1.93783777100352e-45	0.692315124441549	0.908	0.772	3.10867935224385e-41	MT-ND6	Malignant cells	GSE153697	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12156
1.98355641991901e-45	0.419152512410869	0.483	0.179	3.18202120883408e-41	MRPL34	Malignant cells	GSE153697	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12157
2.28568001950045e-45	-0.532547168913006	0.928	0.982	3.66668788728262e-41	PNISR	Malignant cells	GSE153697	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12158
2.31903809442181e-45	0.46199445015495	0.306	0.066	3.72020091107147e-41	MAD2L1	Malignant cells	GSE153697	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12159
2.36818634120696e-45	0.425021808221796	0.466	0.172	3.7990445285642e-41	MRPS18B	Malignant cells	GSE153697	ENSG00000233813	28973	mitochondrial ribosomal protein S18B	C6orf14|HSPC183|MRPS18-2|PTD017	protein_coding	Q9Y676	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12160
4.28665774577657e-45	0.421440738383362	0.504	0.2	6.87665635577478e-41	PDHB	Malignant cells	GSE153697	ENSG00000168291	5162	pyruvate dehydrogenase E1 subunit beta	E1beta|PDHE1B	protein_coding	P11177	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12161
4.89775622217722e-45	0.4657061902497	0.568	0.257	7.85698053161669e-41	GGCT	Malignant cells	GSE153697	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12162
6.15709760975653e-45	0.49456918669585	0.72	0.406	9.87721598557143e-41	NDUFS6	Malignant cells	GSE153697	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12163
1.2800495507836e-44	0.698268363041112	0.562	0.272	2.05345548936705e-40	C12orf75	Malignant cells	GSE153697	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12164
1.52638525547005e-44	0.500975962115576	0.644	0.345	2.44862722682505e-40	PSMA3	Malignant cells	GSE153697	ENSG00000100567	5684	proteasome 20S subunit alpha 3	HC8	protein_coding	P25788	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12165
1.88594967832414e-44	0.5449573967642	0.986	0.957	3.02544047396758e-40	PDLIM1	Malignant cells	GSE153697	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12166
2.13704399329551e-44	0.893765143636902	0.552	0.274	3.42824597404466e-40	MCM7	Malignant cells	GSE153697	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12167
2.38588904122709e-44	0.447114723277601	0.508	0.208	3.8274431999365e-40	RNF5	Malignant cells	GSE153697	ENSG00000223767	6048	ring finger protein 5	G16|NG2|RING5|RMA1	protein_coding	Q99942	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12168
2.57454810277e-44	0.444610889670095	0.561	0.249	4.13009006646363e-40	POLR2F	Malignant cells	GSE153697	ENSG00000100142	5435	RNA polymerase II, I and III subunit F	HRBP14.4|RPB6	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12169
2.74538498765299e-44	-0.526769659405873	0.17	0.483	4.40414659719292e-40	FNIP1	Malignant cells	GSE153697	ENSG00000217128	96459	folliculin interacting protein 1	KIAA1961	protein_coding	Q8TF40	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12170
4.09070391829658e-44	0.40139759583306	0.442	0.152	6.56230722573137e-40	CYB5B	Malignant cells	GSE153697	ENSG00000103018	80777	cytochrome b5 type B	CYB5-M	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12171
4.32954905153691e-44	0.524087887707619	0.655	0.354	6.94546258847551e-40	SUPT4H1	Malignant cells	GSE153697	ENSG00000213246	6827	SPT4 homolog, DSIF elongation factor subunit	Spt4|SPT4H|Supt4a|SUPT4H	protein_coding	P63272	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12172
4.74823288262337e-44	0.456007182821526	0.544	0.244	7.61711519030441e-40	EIF2S1	Malignant cells	GSE153697	ENSG00000134001	1965	eukaryotic translation initiation factor 2 subunit alpha	EIF-2alpha|EIF2|EIF2A	protein_coding	P05198	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12173
7.66517375048229e-44	-0.582135742554963	0.049	0.327	1.22964717305237e-39	CREB5	Malignant cells	GSE153697	ENSG00000146592	9586	cAMP responsive element binding protein 5	CRE-BPA|H_GS165L15.1	protein_coding	Q02930	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12174
7.89092178543169e-44	0.47237319816077	0.72	0.415	1.26586167281895e-39	MDH1	Malignant cells	GSE153697	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12175
8.92673621724104e-44	-0.610509705933371	0.115	0.404	1.43202702396981e-39	AL031733.2	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12176
1.07154268533692e-43	0.399462635842462	0.997	0.982	1.71896877581749e-39	ATP5MC2	Malignant cells	GSE153697	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12177
1.32091351580928e-43	0.465152665370578	0.531	0.231	2.11900946206125e-39	AHSA1	Malignant cells	GSE153697	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12178
1.36906840451507e-43	0.573084699857032	0.877	0.668	2.19625953452308e-39	MEF2C	Malignant cells	GSE153697	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12179
1.81786578168532e-43	-0.568703995998522	0.98	0.995	2.91622028697959e-39	TPM3	Malignant cells	GSE153697	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12180
1.82495892706018e-43	0.411212338832917	0.454	0.164	2.92759911078994e-39	TRIM27	Malignant cells	GSE153697	ENSG00000234495	5987	tripartite motif containing 27	RFP|RNF76	protein_coding	P14373	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12181
2.22550723127542e-43	0.378585272938897	1	0.998	3.57015870041203e-39	PABPC1	Malignant cells	GSE153697	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12182
2.39063099085215e-43	0.304076726395156	0.287	0.057	3.83505023552502e-39	BET1	Malignant cells	GSE153697	ENSG00000105829	10282	Bet1 golgi vesicular membrane trafficking protein	hbet1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12183
3.38614018799271e-43	0.40005398362043	0.431	0.148	5.43204608957791e-39	MSH2	Malignant cells	GSE153697	ENSG00000095002	4436	mutS homolog 2	COCA1|HNPCC|HNPCC1|MSH-2	protein_coding	P43246	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12184
3.51651719288711e-43	0.520192245330918	0.768	0.525	5.6411968808295e-39	RNASEH2B	Malignant cells	GSE153697	ENSG00000136104	79621	ribonuclease H2 subunit B	AGS2|DLEU8|FLJ11712	protein_coding	Q5TBB1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12185
4.25177781784567e-43	0.407103596405085	0.444	0.157	6.82070197538803e-39	MRPS6	Malignant cells	GSE153697	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12186
6.45834094292861e-43	-0.705185362504241	0.261	0.554	1.03604705406461e-38	MAP1LC3B	Malignant cells	GSE153697	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12187
6.84897168578611e-43	0.536656523850165	0.752	0.479	1.09871203783381e-38	SPCS2	Malignant cells	GSE153697	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12188
9.55644959811015e-43	-0.621695933568905	0.563	0.8	1.53304564452883e-38	STK17B	Malignant cells	GSE153697	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12189
9.71084419070328e-43	0.472970303211892	0.6	0.297	1.55781362507262e-38	STIP1	Malignant cells	GSE153697	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12190
1.1825970521083e-42	0.353722500077061	0.379	0.113	1.89712219099213e-38	SMIM12	Malignant cells	GSE153697	ENSG00000163866	113444	small integral membrane protein 12	C1orf212|FLJ90372	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12191
2.31311838129709e-42	0.439780073148281	0.507	0.213	3.71070450727679e-38	MFSD1	Malignant cells	GSE153697	ENSG00000118855	64747	major facilitator superfamily domain containing 1	FLJ14153|Minerva|UG0581B09	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12192
2.67253433186001e-42	-0.49154795069278	0.104	0.393	4.28727957516983e-38	MTMR10	Malignant cells	GSE153697	ENSG00000277086	54893	myotubularin related protein 10	FLJ20313	protein_coding	Q9NXD2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12193
2.81034519838094e-42	0.450012383144555	0.551	0.247	4.50835576724271e-38	G3BP1	Malignant cells	GSE153697	ENSG00000145907	10146	G3BP stress granule assembly factor 1	G3BP|HDH-VIII	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12194
3.40852139253758e-42	0.53758300483205	0.866	0.651	5.46795001790879e-38	PSME2	Malignant cells	GSE153697	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12195
4.36393677909389e-42	0.31978089702149	0.306	0.07	7.00062738102241e-38	OSBPL1A	Malignant cells	GSE153697	ENSG00000141447	114876	oxysterol binding protein like 1A	ORP-1|ORP1|OSBPL1B	protein_coding	Q9BXW6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12196
4.37127973978652e-42	-0.96767238783469	0.62	0.776	7.01240695856553e-38	UCP2	Malignant cells	GSE153697	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12197
5.04160114721308e-42	-0.446253796400782	0.975	0.998	8.08773656035922e-38	UBB	Malignant cells	GSE153697	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12198
5.97792020014363e-42	0.420110573418252	0.489	0.198	9.58977958507042e-38	MRPL18	Malignant cells	GSE153697	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12199
7.23145916144339e-42	0.33974333881221	0.299	0.067	1.16007067867875e-37	MTFP1	Malignant cells	GSE153697	ENSG00000242114	51537	mitochondrial fission process 1	HSPC242|MTP18	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12200
1.07263420551537e-41	0.4520515014822	1	0.999	1.72071979248776e-37	PPIA	Malignant cells	GSE153697	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12201
1.43001247587917e-41	0.416119365092005	0.517	0.213	2.29402601380537e-37	MRPS26	Malignant cells	GSE153697	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12202
1.50945910321088e-41	0.394064599309203	0.462	0.174	2.4214742933709e-37	CD320	Malignant cells	GSE153697	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12203
1.77113246639181e-41	0.400400285470265	0.303	0.071	2.84125070258574e-37	GMNN	Malignant cells	GSE153697	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12204
1.83181472987995e-41	0.507709297432795	0.397	0.136	2.93859718967342e-37	RRM1	Malignant cells	GSE153697	ENSG00000167325	6240	ribonucleotide reductase catalytic subunit M1	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12205
2.94884365081073e-41	0.386148341433698	0.47	0.185	4.73053498463057e-37	VPS72	Malignant cells	GSE153697	ENSG00000163159	6944	vacuolar protein sorting 72 homolog	Swc2|TCFL1|YL-1|YL1	protein_coding	Q15906	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12206
3.1432826848998e-41	0.42647325578807	0.541	0.243	5.04245408311625e-37	MRPS7	Malignant cells	GSE153697	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12207
3.77247734858228e-41	0.331088734272262	0.356	0.1	6.0518081625957e-37	LEO1	Malignant cells	GSE153697	ENSG00000166477	123169	LEO1 homolog, Paf1/RNA polymerase II complex component	NA	protein_coding	Q8WVC0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12208
4.28711861461457e-41	0.633901686345212	0.972	0.874	6.87739568156469e-37	TCL1B	Malignant cells	GSE153697	ENSG00000213231	9623	TCL1 family AKT coactivator B	TML1	protein_coding	O95988	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12209
4.96661908606201e-41	0.577198792844554	0.29	0.065	7.96745033786068e-37	CLSPN	Malignant cells	GSE153697	ENSG00000092853	63967	claspin	NA	protein_coding	Q9HAW4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12210
5.91174465138599e-41	0.474151009330305	0.915	0.726	9.48362076975341e-37	PRMT1	Malignant cells	GSE153697	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12211
6.59147342530568e-41	0.416707556003305	0.534	0.24	1.05740416688754e-36	DNAJC19	Malignant cells	GSE153697	ENSG00000205981	131118	DnaJ heat shock protein family (Hsp40) member C19	Pam18|Tim14|TIMM14	protein_coding	Q96DA6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12212
9.76665813659561e-41	0.414409066902144	0.441	0.163	1.56676729827267e-36	CDK2AP2	Malignant cells	GSE153697	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12213
1.38443144588156e-40	0.597453444904353	0.779	0.523	2.2209049254832e-36	PRKDC	Malignant cells	GSE153697	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12214
1.41956608183442e-40	0.482278421237813	0.866	0.659	2.27726790847878e-36	TOP1	Malignant cells	GSE153697	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12215
1.73705524182485e-40	-0.683920063188622	0.583	0.804	2.78658401893543e-36	SAT1	Malignant cells	GSE153697	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12216
1.7870380017486e-40	0.349372615837906	0.318	0.082	2.8667663624051e-36	POP7	Malignant cells	GSE153697	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12217
2.30649528337401e-40	-0.538493635191567	0.827	0.933	3.70007973358859e-36	PNN	Malignant cells	GSE153697	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12218
2.7970367591629e-40	0.312590513844571	0.341	0.093	4.48700636904912e-36	ISCA2	Malignant cells	GSE153697	ENSG00000165898	122961	iron-sulfur cluster assembly 2	HBLD1|ISA2	protein_coding	Q86U28	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12219
3.93041244071536e-40	0.499661835845368	0.689	0.406	6.30516763739559e-36	NDUFAF3	Malignant cells	GSE153697	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12220
4.06600386813158e-40	0.477222907738049	0.575	0.288	6.52268340525668e-36	FLI1	Malignant cells	GSE153697	ENSG00000151702	2313	Fli-1 proto-oncogene, ETS transcription factor	EWSR2|FLI-1|SIC-1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12221
4.22322856579577e-40	-0.383962403603866	1	0.999	6.77490326524958e-36	HLA-C	Malignant cells	GSE153697	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12222
4.49732552424109e-40	0.330770907281937	0.331	0.09	7.21460960598756e-36	JPT2	Malignant cells	GSE153697	ENSG00000206053	90861	Jupiter microtubule associated homolog 2	C16orf34|FLJ13092|HN1L|KIAA1426|L11	protein_coding	Q9H910	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12223
8.62412309933119e-40	0.435259391986322	0.597	0.304	1.38348182759471e-35	TMCO1	Malignant cells	GSE153697	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12224
1.05825408113395e-39	0.559221686864335	0.808	0.596	1.69765119695508e-35	H2AFY	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12225
1.08642352678718e-39	-0.478263405306241	0.056	0.312	1.74284062167199e-35	TP53INP1	Malignant cells	GSE153697	ENSG00000164938	94241	tumor protein p53 inducible nuclear protein 1	DKFZp434M1317|FLJ22139|P53DINP1|SIP|Teap|TP53INP1A|TP53INP1B	protein_coding	Q96A56	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12226
1.30068619813352e-39	-0.513765958569427	0.693	0.849	2.0865607990458e-35	SYF2	Malignant cells	GSE153697	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12227
1.91573342101137e-39	0.436850737505976	0.548	0.259	3.07321955398644e-35	PFDN6	Malignant cells	GSE153697	ENSG00000235692	10471	prefoldin subunit 6	H2-KE2|HKE2|KE-2|PFD6	protein_coding	O15212	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12228
2.68056327094303e-39	0.392013440335539	0.479	0.197	4.30015959924681e-35	FARSB	Malignant cells	GSE153697	ENSG00000116120	10056	phenylalanyl-tRNA synthetase subunit beta	FARSLB|FRSB|PheHB	protein_coding	Q9NSD9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12229
2.8205365674066e-39	0.388959790255602	0.469	0.189	4.52470476143366e-35	ZCCHC17	Malignant cells	GSE153697	ENSG00000121766	51538	zinc finger CCHC-type containing 17	HSPC251|pNO40|PS1D	protein_coding	Q9NP64	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12230
3.30948295561997e-39	0.371936350637812	0.435	0.164	5.30907255740556e-35	LSM10	Malignant cells	GSE153697	ENSG00000181817	84967	LSM10, U7 small nuclear RNA associated	MGC15749	protein_coding	Q969L4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12231
4.35922932658724e-39	-0.696527845753363	0.324	0.592	6.99307568571125e-35	ARHGEF7	Malignant cells	GSE153697	ENSG00000102606	8874	Rho guanine nucleotide exchange factor 7	BETA-PIX|COOL1|DKFZp686C12170|DKFZp761K1021|KIAA0142|Nbla10314|P50|P50BP|P85|P85COOL1|P85SPR|PAK3|PIXB	protein_coding	Q14155	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12232
4.76009022233377e-39	0.386065560660266	0.434	0.163	7.63613673466783e-35	HLTF	Malignant cells	GSE153697	ENSG00000071794	6596	helicase like transcription factor	HIP116A|HLTF1|RNF80|SMARCA3|SNF2L3	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12233
5.00313776757287e-39	0.448423048460595	0.518	0.238	8.0260336067404e-35	NIFK	Malignant cells	GSE153697	ENSG00000155438	84365	nucleolar protein interacting with the FHA domain of MKI67	hNIFK|MKI67IP|Nopp34	protein_coding	Q9BYG3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12234
6.93286335245443e-39	0.495634420352944	0.742	0.497	1.11216993900074e-34	NDUFB2	Malignant cells	GSE153697	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12235
7.12822214487612e-39	0.352429005102442	0.365	0.116	1.14350939648103e-34	ERGIC2	Malignant cells	GSE153697	ENSG00000087502	51290	ERGIC and golgi 2	Erv41|PTX1	protein_coding	Q96RQ1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12236
8.19909483950516e-39	0.495120729543	0.831	0.606	1.31529879415342e-34	CCT3	Malignant cells	GSE153697	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12237
1.01591272756105e-38	-0.492851806160665	0.924	0.961	1.62972719755343e-34	WASF2	Malignant cells	GSE153697	ENSG00000158195	10163	WASP family member 2	SCAR2|WAVE2	protein_coding	Q9Y6W5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12238
1.09847950029722e-38	0.43126350789132	0.913	0.723	1.7621808143768e-34	C11orf58	Malignant cells	GSE153697	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12239
1.35924582292626e-38	0.987580111089184	0.697	0.464	2.1805021491383e-34	DUT	Malignant cells	GSE153697	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12240
1.61070935689751e-38	0.423250997765149	0.558	0.27	2.58389995033498e-34	GART	Malignant cells	GSE153697	ENSG00000262473	2618	phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase	GARS-AIRS-GART|PGFT|PRGS	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12241
1.6229291385362e-38	0.437610552843348	0.59	0.3	2.60350292403977e-34	SATB1	Malignant cells	GSE153697	ENSG00000182568	6304	SATB homeobox 1	NA	protein_coding	Q01826	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12242
1.64465575678557e-38	0.388670051571687	0.313	0.083	2.63835676503541e-34	NRN1	Malignant cells	GSE153697	ENSG00000124785	51299	neuritin 1	NRN	protein_coding	Q9NPD7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12243
1.98573050818447e-38	0.505946539471013	0.749	0.492	3.18550888122952e-34	AK2	Malignant cells	GSE153697	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12244
2.65421718385084e-38	0.297362776114458	0.303	0.077	4.25789520633351e-34	MALSU1	Malignant cells	GSE153697	ENSG00000156928	115416	mitochondrial assembly of ribosomal large subunit 1	C7orf30|mtRsfA	protein_coding	Q96EH3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12245
2.67215247620643e-38	0.371376317390798	0.48	0.2	4.28666700233036e-34	AASDHPPT	Malignant cells	GSE153697	ENSG00000149313	60496	aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase	AASD-PPT|ACPS|CGI-80|LYS5	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12246
2.70403494217278e-38	0.282857599376057	0.259	0.052	4.33781285423358e-34	SLC25A19	Malignant cells	GSE153697	ENSG00000125454	60386	solute carrier family 25 member 19	DNC|MCPHA|MUP1|TPC	protein_coding	Q9HC21	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12247
2.90771757056045e-38	0.400626236361197	0.532	0.25	4.66456052669308e-34	NAA20	Malignant cells	GSE153697	ENSG00000173418	51126	N-alpha-acetyltransferase 20, NatB catalytic subunit	dJ1002M8.1|NAT3|NAT5	protein_coding	P61599	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12248
3.13555038758659e-38	0.458339782416791	0.541	0.264	5.03004993176641e-34	HPRT1	Malignant cells	GSE153697	ENSG00000165704	3251	hypoxanthine phosphoribosyltransferase 1	HGPRT|HPRT	protein_coding	P00492	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12249
3.56710365345507e-38	0.595232062303067	0.608	0.339	5.72234768087262e-34	RANBP1	Malignant cells	GSE153697	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12250
3.90099041207973e-38	0.366441961436247	0.455	0.179	6.2579688190583e-34	VTA1	Malignant cells	GSE153697	ENSG00000009844	51534	vesicle trafficking 1	C6orf55|HSPC228|My012	protein_coding	Q9NP79	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12251
4.03720978696782e-38	-0.601759469444918	0.423	0.679	6.47649194025377e-34	CYTIP	Malignant cells	GSE153697	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12252
4.63535086437762e-38	0.46988278687391	0.3	0.08	7.43602985663458e-34	FEN1	Malignant cells	GSE153697	ENSG00000168496	2237	flap structure-specific endonuclease 1	FEN-1|MF1|RAD2	protein_coding	P39748	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12253
4.69384497263925e-38	0.490160758720121	0.982	0.94	7.52986610510789e-34	ENO1	Malignant cells	GSE153697	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12254
5.13272678796595e-38	0.438940975375856	0.661	0.382	8.23392031325498e-34	MRPL57	Malignant cells	GSE153697	ENSG00000173141	78988	mitochondrial ribosomal protein L57	MRP63	protein_coding	Q9BQC6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12255
6.90385743437421e-38	0.35911327712741	0.407	0.145	1.10751680962231e-33	FAM216A	Malignant cells	GSE153697	ENSG00000204856	29902	family with sequence similarity 216 member A	C12orf24|HSU79274	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12256
7.9293565556057e-38	0.472286460910918	0.679	0.398	1.27202737865027e-33	NAP1L4	Malignant cells	GSE153697	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12257
8.05868972736835e-38	0.476293493436075	0.873	0.664	1.29277500606443e-33	IFI16	Malignant cells	GSE153697	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12258
9.20728846930057e-38	0.319268532716408	0.325	0.092	1.4770332162452e-33	MGST2	Malignant cells	GSE153697	ENSG00000085871	4258	microsomal glutathione S-transferase 2	MGST-II	protein_coding	Q99735	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12259
1.08867398558784e-37	-0.71603351575633	0.661	0.807	1.74645080768001e-33	CLINT1	Malignant cells	GSE153697	ENSG00000113282	9685	clathrin interactor 1	CLINT|ENTH|EPNR|KIAA0171	protein_coding	Q14677	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12260
1.2108617777247e-37	0.437626243443024	0.927	0.762	1.94246446382597e-33	PARK7	Malignant cells	GSE153697	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12261
1.33912599610524e-37	0.354318660926534	0.375	0.126	2.14822592295203e-33	RAD51C	Malignant cells	GSE153697	ENSG00000108384	5889	RAD51 paralog C	FANCO|RAD51L2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12262
1.73419209392834e-37	0.255294924628742	1	1	2.78199095707984e-33	MT-CO2	Malignant cells	GSE153697	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12263
2.40277788091755e-37	0.464370606793518	0.844	0.607	3.85453627656793e-33	RPL36AL	Malignant cells	GSE153697	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12264
2.6321620113802e-37	0.43962385080235	0.692	0.407	4.22251429865612e-33	PDCD6	Malignant cells	GSE153697	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12265
3.40636031354878e-37	0.442030002367425	0.876	0.675	5.46448321499495e-33	CCT8	Malignant cells	GSE153697	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12266
3.96211691201752e-37	0.510288203177754	0.71	0.464	6.3560279502585e-33	ATP5MC1	Malignant cells	GSE153697	ENSG00000159199	516	ATP synthase membrane subunit c locus 1	ATP5G|ATP5G1	protein_coding	P05496	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12267
4.57793243741946e-37	0.477404703292644	0.741	0.488	7.34391921610829e-33	TIMM13	Malignant cells	GSE153697	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12268
4.84141288090042e-37	0.490791714462385	0.827	0.595	7.76659454354046e-33	NUDC	Malignant cells	GSE153697	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12269
4.96836280399876e-37	0.494746193633179	0.692	0.443	7.97024761017481e-33	EIF5B	Malignant cells	GSE153697	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12270
6.63018433899544e-37	0.352005132411245	0.4	0.144	1.06361417166165e-32	LYAR	Malignant cells	GSE153697	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12271
7.83264100194745e-37	0.436143674977833	0.623	0.344	1.25651226953241e-32	GPX7	Malignant cells	GSE153697	ENSG00000116157	2882	glutathione peroxidase 7	FLJ14777|GPX6|NPGPx	protein_coding	Q96SL4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12272
8.55506702963346e-37	0.361891205358312	0.477	0.203	1.3724038528938e-32	CLTA	Malignant cells	GSE153697	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12273
8.80061927222652e-37	-0.586901359154024	0.668	0.841	1.41179534365058e-32	RHOH	Malignant cells	GSE153697	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12274
8.82937737097495e-37	0.453547239524912	0.852	0.63	1.4164087178518e-32	VDAC1	Malignant cells	GSE153697	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12275
1.08421115911179e-36	0.439384514852467	0.438	0.179	1.73929154144713e-32	MTHFD1	Malignant cells	GSE153697	ENSG00000100714	4522	methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1	MTHFC|MTHFD	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12276
1.15029984236562e-36	0.476353634397394	0.297	0.079	1.84531100712292e-32	ZWINT	Malignant cells	GSE153697	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12277
1.26882898911988e-36	0.429387619705198	0.976	0.904	2.03545546434611e-32	COX7C	Malignant cells	GSE153697	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12278
1.35017669346895e-36	-0.525265718646829	0.323	0.594	2.1659534516629e-32	RLF	Malignant cells	GSE153697	ENSG00000117000	6018	RLF zinc finger	Zn-15L|ZNF292L	protein_coding	Q13129	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12279
1.51257585918592e-36	0.309960264095767	0.311	0.087	2.42647419330605e-32	MFAP1	Malignant cells	GSE153697	ENSG00000140259	4236	microfibril associated protein 1	AMP	protein_coding	P55081	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12280
1.55083266622488e-36	0.339742233027195	0.38	0.132	2.48784576315795e-32	NDUFAF4	Malignant cells	GSE153697	ENSG00000123545	29078	NADH:ubiquinone oxidoreductase complex assembly factor 4	bA22L21.1|C6orf66|HRPAP20|HSPC125|My013	protein_coding	Q9P032	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12281
1.64223149753024e-36	-0.620937998878986	0.294	0.549	2.63446776833801e-32	ANKRD28	Malignant cells	GSE153697	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12282
1.69067657666281e-36	0.280538153473099	0.258	0.055	2.71218336428247e-32	RNF219	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12283
2.13852779988841e-36	-0.617380160227661	0.265	0.528	3.43062629658098e-32	IRS2	Malignant cells	GSE153697	ENSG00000185950	8660	insulin receptor substrate 2	NA	protein_coding	Q9Y4H2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12284
2.22235554867861e-36	0.397267850522822	0.534	0.256	3.56510277119022e-32	GRK2	Malignant cells	GSE153697	ENSG00000173020	156	G protein-coupled receptor kinase 2	ADRBK1|BARK1	protein_coding	P25098	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12285
2.23237669915278e-36	0.425061281797323	0.525	0.252	3.58117870078089e-32	PDIA4	Malignant cells	GSE153697	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12286
2.5523668873781e-36	0.473200299780772	0.687	0.419	4.09450696073194e-32	EIF2S2	Malignant cells	GSE153697	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12287
2.65119222421555e-36	0.440978084066789	0.599	0.322	4.25304256608658e-32	TXNDC12	Malignant cells	GSE153697	ENSG00000117862	51060	thioredoxin domain containing 12	AGR1|ERP18|ERP19|hAG-1|PDIA16|TLP19	protein_coding	O95881	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12288
2.6729281036519e-36	-0.480516860912183	0.258	0.536	4.28791126387837e-32	JUND	Malignant cells	GSE153697	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12289
4.24451028350396e-36	-0.65455995039066	0.192	0.467	6.80904339679706e-32	AC016831.7	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12290
4.37398455534522e-36	0.41486896481844	0.475	0.21	7.0167460236848e-32	DCK	Malignant cells	GSE153697	ENSG00000156136	1633	deoxycytidine kinase	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12291
5.18708711402218e-36	0.442531678471199	0.421	0.166	8.32112514831438e-32	IGHV5-78	Malignant cells	GSE153697	ENSG00000276708	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12292
5.38853706271881e-36	0.637771929482445	0.554	0.3	8.64429115601351e-32	USP1	Malignant cells	GSE153697	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12293
6.05864957879333e-36	0.365576174532884	0.406	0.153	9.71928565430026e-32	POLR2H	Malignant cells	GSE153697	ENSG00000163882	5437	RNA polymerase II, I and III subunit H	RPB8	protein_coding	P52434	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12294
6.83617565662792e-36	0.350954753740246	0.399	0.147	1.09665929883625e-31	GRWD1	Malignant cells	GSE153697	ENSG00000105447	83743	glutamate rich WD repeat containing 1	GRWD|RRB1|WDR28	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12295
8.38599584606345e-36	0.288496714927698	0.261	0.059	1.3452814536255e-31	MIS18A	Malignant cells	GSE153697	ENSG00000159055	54069	MIS18 kinetochore protein A	B28|C21orf45|C21orf46|FASP1|hMis18alpha	protein_coding	Q9NYP9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12296
9.35025770900999e-36	0.409561641546386	0.461	0.202	1.49996834167938e-31	PSMB5	Malignant cells	GSE153697	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12297
1.29362681510408e-35	-0.552017322709648	0.224	0.491	2.07523613678996e-31	STAG3	Malignant cells	GSE153697	ENSG00000066923	10734	stromal antigen 3	NA	protein_coding	Q9UJ98	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12298
1.49820724594187e-35	0.337275291717347	0.438	0.174	2.40342406393994e-31	MAEA	Malignant cells	GSE153697	ENSG00000090316	10296	macrophage erythroblast attacher, E3 ubiquitin ligase	EMP|GID9|HLC-10|p44EMLP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12299
1.55026441818224e-35	0.314877343850996	0.255	0.056	2.48693417964795e-31	SLC29A1	Malignant cells	GSE153697	ENSG00000112759	2030	solute carrier family 29 member 1 (Augustine blood group)	ENT1	protein_coding	Q99808	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12300
1.68440191699747e-35	-0.517530557038271	0.444	0.673	2.70211755524735e-31	ITGAE	Malignant cells	GSE153697	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12301
1.7260186437451e-35	0.377549425608466	0.466	0.201	2.76887910829588e-31	C5orf15	Malignant cells	GSE153697	ENSG00000113583	56951	chromosome 5 open reading frame 15	HTGN29|KCT2	protein_coding	Q8NC54	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12302
2.02006988039739e-35	0.330020782575727	0.4	0.148	3.24059610213349e-31	TIMM9	Malignant cells	GSE153697	ENSG00000100575	26520	translocase of inner mitochondrial membrane 9	TIM9A	protein_coding	Q9Y5J7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12303
2.18643877659725e-35	-0.545950935541221	0.169	0.433	3.50748508541731e-31	RTP5	Malignant cells	GSE153697	ENSG00000277949	285093	receptor transporter protein 5 (putative)	C2orf85|CXXC11|FLJ33590|Z3CXXC5	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12304
2.49028223510505e-35	0.313017574548359	1	1	3.99491076155553e-31	PTMA	Malignant cells	GSE153697	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12305
2.77838327610109e-35	0.337723045358026	0.397	0.149	4.45708245152136e-31	MRPL36	Malignant cells	GSE153697	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12306
2.8092607038246e-35	-0.456806548576222	0.034	0.258	4.50661602107542e-31	MTSS1	Malignant cells	GSE153697	ENSG00000170873	9788	MTSS I-BAR domain containing 1	KIAA0429|MIM|MIMA|MIMB	protein_coding	O43312	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12307
3.24528719306213e-35	0.329590305709597	0.397	0.143	5.20608971511028e-31	TRMT10C	Malignant cells	GSE153697	ENSG00000174173	54931	tRNA methyltransferase 10C, mitochondrial RNase P subunit	FLJ20432|MRPP1|RG9MTD1	protein_coding	Q7L0Y3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12308
3.66360550074701e-35	-0.498395690853196	0.631	0.804	5.87715594429836e-31	RSRC2	Malignant cells	GSE153697	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12309
3.93097599075138e-35	0.439651636081339	0.872	0.646	6.30607168436336e-31	ATP5PF	Malignant cells	GSE153697	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12310
4.71597642811981e-35	0.284663088494454	0.283	0.072	7.56536938598981e-31	TTC9C	Malignant cells	GSE153697	ENSG00000162222	283237	tetratricopeptide repeat domain 9C	MGC29649	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12311
4.73618180459285e-35	-0.515212297033224	0.111	0.363	7.59778285092785e-31	CD109	Malignant cells	GSE153697	ENSG00000156535	135228	CD109 molecule	CPAMD7|DKFZp762L1111|FLJ38569	protein_coding	Q6YHK3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12312
4.84954419524776e-35	-0.637271341274578	0.313	0.59	7.77963879801645e-31	ATF3	Malignant cells	GSE153697	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12313
4.96513607786416e-35	0.439666045956046	0.641	0.374	7.96507129610968e-31	RAB8A	Malignant cells	GSE153697	ENSG00000167461	4218	RAB8A, member RAS oncogene family	MEL|RAB8	protein_coding	P61006	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12314
5.03301509190247e-35	0.339007725383314	0.313	0.092	8.07396281042995e-31	RFC4	Malignant cells	GSE153697	ENSG00000163918	5984	replication factor C subunit 4	A1|RFC37	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12315
5.3859195492433e-35	0.402023463387967	0.565	0.29	8.6400921408961e-31	M6PR	Malignant cells	GSE153697	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12316
5.99103093080458e-35	0.399687910103794	0.728	0.442	9.61081181919671e-31	HSBP1	Malignant cells	GSE153697	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12317
6.09528285920251e-35	0.388425196456935	0.387	0.144	9.77805276273266e-31	RNASEH2A	Malignant cells	GSE153697	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12318
6.4190348400149e-35	0.481137062364324	0.738	0.498	1.02974156903519e-30	DAD1	Malignant cells	GSE153697	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12319
7.70603167314687e-35	0.378717358085687	0.461	0.2	1.23620160100622e-30	TOMM5	Malignant cells	GSE153697	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12320
8.07279741480963e-35	0.324165085873357	0.386	0.138	1.29503816128376e-30	VPS25	Malignant cells	GSE153697	ENSG00000131475	84313	vacuolar protein sorting 25 homolog	DERP9|EAP20|MGC10540	protein_coding	Q9BRG1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12321
8.32762551542937e-35	0.4192799092835	0.689	0.41	1.33591768518518e-30	GTF2A2	Malignant cells	GSE153697	ENSG00000140307	2958	general transcription factor IIA subunit 2	HsT18745|TFIIA	protein_coding	P52657	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12322
8.40374547835528e-35	0.273934474183413	0.285	0.073	1.34812884963775e-30	MRFAP1L1	Malignant cells	GSE153697	ENSG00000178988	114932	Morf4 family associated protein 1 like 1	MGC9651	protein_coding	Q96HT8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12323
8.75590810153281e-35	0.291964889118591	0.28	0.071	1.40462277764789e-30	NRBF2	Malignant cells	GSE153697	ENSG00000148572	29982	nuclear receptor binding factor 2	COPR1|COPR2|DKFZp564C1664|FLJ30395	protein_coding	Q96F24	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12324
1.21520238532403e-34	0.470678116980034	0.683	0.42	1.94942766653682e-30	SUPT16H	Malignant cells	GSE153697	ENSG00000092201	11198	SPT16 homolog, facilitates chromatin remodeling subunit	CDC68|FACT|FACTP140|FLJ10857|FLJ14010|SPT16/CDC68	protein_coding	Q9Y5B9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12325
1.3698995397868e-34	0.617460654294654	0.53	0.282	2.19759284172598e-30	MCM5	Malignant cells	GSE153697	ENSG00000100297	4174	minichromosome maintenance complex component 5	CDC46	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12326
1.73779680877412e-34	0.308581190654902	0.341	0.11	2.78777364063544e-30	MRPS14	Malignant cells	GSE153697	ENSG00000120333	63931	mitochondrial ribosomal protein S14	HSMRPS14	protein_coding	O60783	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12327
1.96162653858526e-34	0.501534327170592	0.651	0.389	3.14684129319848e-30	PPA1	Malignant cells	GSE153697	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12328
2.17807771904427e-34	0.497048164325285	0.624	0.368	3.49407227689081e-30	CD58	Malignant cells	GSE153697	ENSG00000116815	965	CD58 molecule	LFA3	protein_coding	P19256	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12329
2.24532754215568e-34	0.716136975234259	0.439	0.185	3.60195444312614e-30	LTB	Malignant cells	GSE153697	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12330
2.30536359881109e-34	0.423414961122314	0.992	0.988	3.69826428521276e-30	NCL	Malignant cells	GSE153697	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12331
2.32659103888989e-34	0.486164502874392	0.377	0.14	3.73231734458717e-30	MCM4	Malignant cells	GSE153697	ENSG00000104738	4173	minichromosome maintenance complex component 4	CDC21|CDC54|hCdc21|MGC33310|P1-Cdc21	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12332
2.3571657969846e-34	0.437211528200242	0.786	0.561	3.7813653715227e-30	NDUFA3	Malignant cells	GSE153697	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12333
2.4931710411878e-34	0.389828394549747	0.573	0.294	3.99954498427347e-30	PCMT1	Malignant cells	GSE153697	ENSG00000120265	5110	protein-L-isoaspartate (D-aspartate) O-methyltransferase	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12334
2.89606291223665e-34	0.318089870397419	0.334	0.107	4.64586412381003e-30	NDUFA8	Malignant cells	GSE153697	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12335
3.06962931090765e-34	0.46448572178228	0.641	0.382	4.92429934055806e-30	PPIH	Malignant cells	GSE153697	ENSG00000171960	10465	peptidylprolyl isomerase H	CYP-20|CYPH|MGC5016|SnuCyp-20|USA-CYP	protein_coding	O43447	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12336
3.17570428198754e-34	0.41709044164821	0.558	0.287	5.09446480916442e-30	JPT1	Malignant cells	GSE153697	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12337
3.23883365664887e-34	-0.581785534580953	0.282	0.545	5.19573695199612e-30	PLP2	Malignant cells	GSE153697	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12338
3.29187591544013e-34	0.366730887606457	0.555	0.275	5.28082734354906e-30	METTL5	Malignant cells	GSE153697	ENSG00000138382	29081	methyltransferase 5, N6-adenosine	HSPC133	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12339
3.54845393888556e-34	0.387849314656693	0.497	0.231	5.69242980876021e-30	TMEM109	Malignant cells	GSE153697	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12340
3.74898675659292e-34	0.320630644518405	0.325	0.101	6.01412455492636e-30	CSE1L	Malignant cells	GSE153697	ENSG00000124207	1434	chromosome segregation 1 like	CAS|CSE1|XPO2	protein_coding	P55060	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12341
3.88217409213536e-34	0.388553088269252	0.397	0.156	6.22778367860355e-30	SNRNP25	Malignant cells	GSE153697	ENSG00000161981	79622	small nuclear ribonucleoprotein U11/U12 subunit 25	C16orf33|U11/U12-25K	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12342
3.88833835479344e-34	-0.495288185886366	0.238	0.507	6.23767238875963e-30	NLRP1	Malignant cells	GSE153697	ENSG00000091592	22861	NLR family pyrin domain containing 1	CARD7|CLR17.1|DEFCAP|DKFZp586O1822|KIAA0926|NAC|NALP1|SLEV1|VAMAS1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12343
5.37924940912348e-34	-0.427170264844615	0.106	0.355	8.62939190211589e-30	KLF7	Malignant cells	GSE153697	ENSG00000118263	8609	KLF transcription factor 7	UKLF	protein_coding	O75840	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12344
5.43900799194122e-34	0.342790854616582	0.42	0.168	8.72525662067211e-30	CHCHD1	Malignant cells	GSE153697	ENSG00000172586	118487	coiled-coil-helix-coiled-coil-helix domain containing 1	C10orf34|FLJ25854	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12345
7.71399526943377e-34	0.395899885998765	0.98	0.933	1.23747912112256e-29	UQCRH	Malignant cells	GSE153697	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12346
1.14662576704653e-33	0.310033271052817	0.335	0.109	1.83941705549604e-29	PREB	Malignant cells	GSE153697	ENSG00000138073	10113	prolactin regulatory element binding	SEC12	protein_coding	Q9HCU5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12347
1.42951003495733e-33	0.448329903756123	0.799	0.576	2.29321999807855e-29	HDAC2	Malignant cells	GSE153697	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12348
1.46623300507795e-33	0.404919935503465	0.685	0.427	2.35213098674604e-29	CDC123	Malignant cells	GSE153697	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12349
1.56510357750242e-33	0.388341443007614	0.968	0.894	2.51073915902938e-29	LSM7	Malignant cells	GSE153697	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12350
1.57451140111034e-33	0.388611838480411	0.93	0.754	2.52583118966121e-29	THRAP3	Malignant cells	GSE153697	ENSG00000054118	9967	thyroid hormone receptor associated protein 3	BCLAF2|TRAP150	protein_coding	Q9Y2W1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12351
1.75985513581e-33	0.792890725900063	0.99	0.972	2.8231596088664e-29	HMGN2	Malignant cells	GSE153697	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12352
2.2367461557356e-33	-0.563958884691983	0.83	0.912	3.58818818303104e-29	WSB1	Malignant cells	GSE153697	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12353
2.74742143667993e-33	-0.569847519321593	0.223	0.473	4.40741346872194e-29	COQ7	Malignant cells	GSE153697	ENSG00000167186	10229	coenzyme Q7, hydroxylase	CAT5|CLK-1	protein_coding	Q99807	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12354
2.84804041793115e-33	0.415719205590677	0.57	0.3	4.56882643844515e-29	ATIC	Malignant cells	GSE153697	ENSG00000138363	471	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	AICARFT|IMPCHASE|PURH	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12355
3.16749035012827e-33	0.315561681600286	1	1	5.08128801967578e-29	MT-ATP6	Malignant cells	GSE153697	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12356
3.18185052459786e-33	0.359939864827757	0.442	0.191	5.10432461155988e-29	UTP11	Malignant cells	GSE153697	ENSG00000183520	51118	UTP11 small subunit processome component	CGI-94|UTP11L	protein_coding	Q9Y3A2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12357
3.30261361080414e-33	0.290749880873009	0.349	0.118	5.298052754452e-29	TMEM126B	Malignant cells	GSE153697	ENSG00000171204	55863	transmembrane protein 126B	HT007	protein_coding	Q8IUX1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12358
3.34572573528711e-33	-0.548358450574434	0.373	0.614	5.36721322454758e-29	PRDM2	Malignant cells	GSE153697	ENSG00000116731	7799	PR/SET domain 2	HUMHOXY1|KMT8|KMT8A|MTB-ZF|RIZ|RIZ1|RIZ2	protein_coding	Q13029	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12359
3.7816954978933e-33	0.336635571782004	1	1	6.06659591772044e-29	ACTG1	Malignant cells	GSE153697	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12360
4.70682294846647e-33	0.373903347956795	0.956	0.846	7.55068537392991e-29	UBL5	Malignant cells	GSE153697	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12361
4.84605730693104e-33	0.486631374901287	0.418	0.175	7.77404513177877e-29	LMNB1	Malignant cells	GSE153697	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12362
5.66122978886913e-33	0.409321056921247	0.848	0.656	9.08174482730386e-29	NDUFB4	Malignant cells	GSE153697	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12363
6.07055906140576e-33	0.375890886891933	0.535	0.271	9.73839084630712e-29	DCAF13	Malignant cells	GSE153697	ENSG00000164934	25879	DDB1 and CUL4 associated factor 13	DKFZP564O0463|Gm83|HSPC064|Sof1|WDSOF1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12364
6.50490918210989e-33	0.486537569544723	0.832	0.658	1.04351753099407e-28	KPNB1	Malignant cells	GSE153697	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12365
7.02130863481393e-33	0.542441477288243	0.286	0.084	1.12635833119685e-28	DHFR	Malignant cells	GSE153697	ENSG00000228716	1719	dihydrofolate reductase	NA	protein_coding	P00374	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12366
7.39081552928546e-33	0.309317379695739	0.337	0.112	1.18563462720797e-28	BOLA3	Malignant cells	GSE153697	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12367
8.39266247920289e-33	0.300652735713863	0.308	0.094	1.34635091491373e-28	GPN3	Malignant cells	GSE153697	ENSG00000111231	51184	GPN-loop GTPase 3	ATPBD1C|MGC14560	protein_coding	Q9UHW5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12368
1.20109750008642e-32	0.315525074566304	0.328	0.109	1.92680060963864e-28	MPHOSPH6	Malignant cells	GSE153697	ENSG00000135698	10200	M-phase phosphoprotein 6	MPP6	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12369
1.21986163454921e-32	0.417855153498585	0.835	0.668	1.95690203414385e-28	MAGOH	Malignant cells	GSE153697	ENSG00000162385	4116	mago homolog, exon junction complex subunit	MAGOH1|MAGOHA	protein_coding	P61326	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12370
1.28257202878831e-32	-0.467105468231553	0.669	0.843	2.0575020485822e-28	PNRC1	Malignant cells	GSE153697	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12371
1.30828322044594e-32	0.440671745279659	0.58	0.32	2.09874794223938e-28	NAA38	Malignant cells	GSE153697	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12372
1.45533767333097e-32	0.378626548814471	0.568	0.3	2.33465269555754e-28	VDAC3	Malignant cells	GSE153697	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12373
1.55019215121154e-32	0.469711406392742	0.955	0.846	2.48681824897355e-28	ITGA4	Malignant cells	GSE153697	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12374
1.6395272401226e-32	0.393500362053902	0.545	0.284	2.63012959860468e-28	NFYC	Malignant cells	GSE153697	ENSG00000066136	4802	nuclear transcription factor Y subunit gamma	CBF-C|NF-YC	protein_coding	Q13952	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12375
1.96550885460461e-32	0.38849189875046	0.52	0.259	3.15306930455671e-28	ZKSCAN1	Malignant cells	GSE153697	ENSG00000106261	7586	zinc finger with KRAB and SCAN domains 1	KOX18|PHZ-37|ZNF139|ZNF36|ZSCAN33	protein_coding	P17029	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12376
2.16051770433177e-32	0.271139455470849	0.265	0.069	3.46590250128902e-28	MRM2	Malignant cells	GSE153697	ENSG00000122687	29960	mitochondrial rRNA methyltransferase 2	FJH1|FTSJ2|RRMJ2	protein_coding	Q9UI43	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12377
2.2304646602679e-32	0.263351370208232	0.289	0.082	3.57811140800176e-28	MRPS18A	Malignant cells	GSE153697	ENSG00000096080	55168	mitochondrial ribosomal protein S18A	FLJ10548|MRPS18-3	protein_coding	Q9NVS2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12378
2.37796765927625e-32	-0.473505223953361	0.872	0.943	3.81473571901096e-28	TRA2B	Malignant cells	GSE153697	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12379
2.40293688979207e-32	-0.452171902494796	0.158	0.408	3.85479135860444e-28	CA5B	Malignant cells	GSE153697	ENSG00000169239	11238	carbonic anhydrase 5B	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12380
2.59842546589262e-32	0.28605633077777	0.282	0.078	4.16839413238495e-28	ARL11	Malignant cells	GSE153697	ENSG00000152213	115761	ADP ribosylation factor like GTPase 11	ARLTS1|FLJ33930	protein_coding	Q969Q4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12381
3.46694117862671e-32	0.37268673950266	0.928	0.769	5.56166703875296e-28	ATP5MPL	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12382
3.52834165389249e-32	0.300083267114319	0.323	0.105	5.66016568117433e-28	MAGOHB	Malignant cells	GSE153697	ENSG00000111196	55110	mago homolog B, exon junction complex subunit	FLJ10292|MGN2	protein_coding	Q96A72	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12383
4.52175212136907e-32	0.410821819815996	0.538	0.286	7.25379475310026e-28	SSR3	Malignant cells	GSE153697	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12384
5.08693153551134e-32	0.418645701852464	0.862	0.683	8.16045556926728e-28	TMEM258	Malignant cells	GSE153697	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12385
5.28796508330554e-32	0.30701036483429	0.301	0.094	8.48295358663875e-28	BCL2L12	Malignant cells	GSE153697	ENSG00000126453	83596	BCL2 like 12	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12386
5.49707413194218e-32	0.303111845209129	0.377	0.141	8.81840632246165e-28	ANAPC13	Malignant cells	GSE153697	ENSG00000129055	25847	anaphase promoting complex subunit 13	APC13|DKFZP566D193|SWM1	protein_coding	Q9BS18	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12387
6.23231129603707e-32	0.444389184648008	0.713	0.468	9.99787378110267e-28	ADA	Malignant cells	GSE153697	ENSG00000196839	100	adenosine deaminase	ADA1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12388
6.26761434981284e-32	0.392826924488427	0.534	0.273	1.00545069399698e-27	CLNS1A	Malignant cells	GSE153697	ENSG00000074201	1207	chloride nucleotide-sensitive channel 1A	CLCI|ICln	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12389
7.33409867208835e-32	0.33319411490553	0.415	0.173	1.17653610897641e-27	YEATS4	Malignant cells	GSE153697	ENSG00000127337	8089	YEATS domain containing 4	GAS41|NuBI-1|YAF9	protein_coding	O95619	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12390
7.46587056528241e-32	0.436017130884713	0.918	0.795	1.1976749560826e-27	HNRNPR	Malignant cells	GSE153697	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12391
8.96726525134548e-32	-0.538474946477882	0.341	0.575	1.43852869162084e-27	SSH2	Malignant cells	GSE153697	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12392
1.02796522389498e-31	-0.358451038364084	0.055	0.272	1.64906181217232e-27	AL353708.3	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12393
1.04649498332315e-31	0.418893075914541	0.645	0.385	1.67878725224699e-27	RUVBL2	Malignant cells	GSE153697	ENSG00000183207	10856	RuvB like AAA ATPase 2	ECP51|INO80J|Reptin52|RVB2|TIH2|TIP48|TIP49b	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12394
1.06714391440359e-31	0.336690352218896	0.432	0.185	1.71191226748623e-27	LDOC1	Malignant cells	GSE153697	ENSG00000182195	23641	LDOC1 regulator of NFKB signaling	BCUR1|Mar7|Mart7|RTL7|SIRH7	protein_coding	O95751	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12395
1.12013342046891e-31	0.341436978417044	0.434	0.19	1.79691803311623e-27	ISOC2	Malignant cells	GSE153697	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12396
1.18688521662596e-31	0.37619850597482	0.496	0.241	1.90400126451136e-27	STT3A	Malignant cells	GSE153697	ENSG00000134910	3703	STT3 oligosaccharyltransferase complex catalytic subunit A	ITM1|MGC9042|STT3-A|TMC	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12397
1.25850973024211e-31	0.263260162041263	0.262	0.069	2.01890130925439e-27	NUDCD1	Malignant cells	GSE153697	ENSG00000120526	84955	NudC domain containing 1	CML66|FLJ14991	protein_coding	Q96RS6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12398
1.26872568482446e-31	0.414258433370305	0.745	0.497	2.03528974359541e-27	SF3A3	Malignant cells	GSE153697	ENSG00000183431	10946	splicing factor 3a subunit 3	PRP9|PRPF9|SAP61|SF3a60	protein_coding	Q12874	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12399
1.27044079073737e-31	0.48672440527119	0.437	0.197	2.03804111650088e-27	SMC4	Malignant cells	GSE153697	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12400
1.43772390202439e-31	-0.459648599424133	0.983	0.986	2.30639668362753e-27	TKT	Malignant cells	GSE153697	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12401
1.46314946110704e-31	0.474164990582941	0.401	0.167	2.34718436550791e-27	PHGDH	Malignant cells	GSE153697	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12402
1.46639477434565e-31	0.32996071219621	0.415	0.173	2.35239049700529e-27	NDUFB6	Malignant cells	GSE153697	ENSG00000165264	4712	NADH:ubiquinone oxidoreductase subunit B6	B17|CI	protein_coding	O95139	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12403
1.57433066863458e-31	0.264934683149442	0.296	0.088	2.5255412586236e-27	PEX11B	Malignant cells	GSE153697	ENSG00000131779	8799	peroxisomal biogenesis factor 11 beta	PEX11beta	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12404
1.64902000368178e-31	0.460197825775857	0.577	0.316	2.64535788990632e-27	TMPO	Malignant cells	GSE153697	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12405
1.84859075386764e-31	0.286718009028274	0.318	0.103	2.96550928735447e-27	GMCL1	Malignant cells	GSE153697	ENSG00000087338	64395	germ cell-less 1, spermatogenesis associated	BTBD13|FLJ13057|GCL1|SPATA29	protein_coding	Q96IK5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12406
1.85066026868613e-31	0.362959017704201	0.548	0.28	2.96882920302629e-27	MRPL43	Malignant cells	GSE153697	ENSG00000055950	84545	mitochondrial ribosomal protein L43	bMRP36a	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12407
1.89247241132899e-31	0.307680828931749	0.376	0.142	3.03590424225397e-27	GTF2H5	Malignant cells	GSE153697	ENSG00000272047	404672	general transcription factor IIH subunit 5	bA120J8.2|C6orf175|FLJ30544|TFB5|TFIIH|TTD|TTD-A|TTDA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12408
2.14640610459413e-31	-0.959639429421541	0.189	0.428	3.44326467298991e-27	CD83	Malignant cells	GSE153697	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12409
2.1529920867887e-31	0.473630399706394	0.807	0.632	3.45382990562643e-27	RPN2	Malignant cells	GSE153697	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12410
2.23816513767373e-31	-0.471392192054348	0.185	0.43	3.5904645138562e-27	ERLIN2	Malignant cells	GSE153697	ENSG00000147475	11160	ER lipid raft associated 2	C8orf2|Erlin-2|NET32|SPFH2|SPG18	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12411
2.26989870343213e-31	0.384733698778412	0.601	0.34	3.64137150004582e-27	ADH5	Malignant cells	GSE153697	ENSG00000197894	128	alcohol dehydrogenase 5 (class III), chi polypeptide	ADH-3|ADHX|FDH|GSNOR	protein_coding	P11766	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12412
2.44669481757546e-31	-0.434029690952973	0.048	0.259	3.92498782635456e-27	CRIP1	Malignant cells	GSE153697	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12413
2.45078198839498e-31	0.32729454723785	0.407	0.168	3.93154446578322e-27	MRPL24	Malignant cells	GSE153697	ENSG00000143314	79590	mitochondrial ribosomal protein L24	MRP-L18	protein_coding	Q96A35	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12414
3.13176641471157e-31	0.338259038851968	0.425	0.18	5.02397968248031e-27	PRDX4	Malignant cells	GSE153697	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12415
3.36968006734182e-31	0.325972397182909	0.393	0.156	5.40564076402974e-27	LRIF1	Malignant cells	GSE153697	ENSG00000121931	55791	ligand dependent nuclear receptor interacting factor 1	C1orf103|FLJ11269|RIF1	protein_coding	Q5T3J3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12416
3.553278512092e-31	-0.433982886525728	0.956	0.974	5.70016938909798e-27	SON	Malignant cells	GSE153697	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12417
3.70667705587641e-31	0.346791025301687	0.424	0.179	5.94625133303693e-27	CMSS1	Malignant cells	GSE153697	ENSG00000184220	84319	cms1 ribosomal small subunit homolog	C3orf26|MGC4308	protein_coding	Q9BQ75	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12418
3.98930976944732e-31	0.280335897053184	0.306	0.097	6.39965073214739e-27	UQCC3	Malignant cells	GSE153697	ENSG00000204922	790955	ubiquinol-cytochrome c reductase complex assembly factor 3	C11orf83|UNQ655	protein_coding	Q6UW78	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12419
4.08081652707307e-31	0.319098000004139	0.323	0.107	6.54644587273062e-27	ELK3	Malignant cells	GSE153697	ENSG00000111145	2004	ETS transcription factor ELK3	ERP|NET|SAP2	protein_coding	P41970	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12420
5.22198386520475e-31	0.534721641724627	0.865	0.723	8.37710651656146e-27	PPIB	Malignant cells	GSE153697	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12421
5.4487392533221e-31	0.461452264752785	0.356	0.136	8.74086751017931e-27	UNG	Malignant cells	GSE153697	ENSG00000076248	7374	uracil DNA glycosylase	DGU|HIGM4|UDG|UNG1|UNG2	protein_coding	P13051	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12422
6.52776377832572e-31	0.318136152832889	0.4	0.165	1.04718386531901e-26	MRPL13	Malignant cells	GSE153697	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12423
7.94275685192828e-31	0.478284826713347	0.403	0.172	1.27417705418633e-26	VNN1	Malignant cells	GSE153697	ENSG00000112299	8876	vanin 1	Tiff66	protein_coding	O95497	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12424
7.98906342543662e-31	0.286555659760824	0.315	0.105	1.28160555470854e-26	ARL1	Malignant cells	GSE153697	ENSG00000120805	400	ADP ribosylation factor like GTPase 1	ARFL1	protein_coding	P40616	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12425
8.38719785310962e-31	-0.878973991210596	0.896	0.924	1.34547427959584e-26	GADD45B	Malignant cells	GSE153697	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12426
8.68761992865016e-31	0.277846836417767	0.32	0.105	1.39366798895406e-26	ATF1	Malignant cells	GSE153697	ENSG00000123268	466	activating transcription factor 1	TREB36	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12427
8.89588411481442e-31	0.271644904738995	0.296	0.092	1.42707772969853e-26	MRPL46	Malignant cells	GSE153697	ENSG00000259494	26589	mitochondrial ribosomal protein L46	C15orf4|LIECG2|P2ECSL	protein_coding	Q9H2W6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12428
9.05107239685441e-31	0.517294188698041	0.462	0.232	1.45197303390338e-26	CENPX	Malignant cells	GSE153697	ENSG00000169689	201254	centromere protein X	CENP-X|FAAP10|MGC14480|MHF2|STRA13	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12429
1.10625595402167e-30	0.393838187061445	0.587	0.332	1.77465580144157e-26	GTF3C6	Malignant cells	GSE153697	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12430
1.13706743838929e-30	0.277260696340956	0.279	0.081	1.8240835846641e-26	SLC2A5	Malignant cells	GSE153697	ENSG00000142583	6518	solute carrier family 2 member 5	GLUT5	protein_coding	P22732	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12431
1.17568611530824e-30	0.292673414970625	0.321	0.109	1.88603566617748e-26	RRP1	Malignant cells	GSE153697	ENSG00000160214	8568	ribosomal RNA processing 1	D21S2056E|NNP-1|Nop52|RRP1A	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12432
1.18366792695892e-30	0.363526940807583	0.414	0.184	1.8988400884275e-26	TMEM69	Malignant cells	GSE153697	ENSG00000159596	51249	transmembrane protein 69	C1orf154|FLJ21029	protein_coding	Q5SWH9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12433
1.24588999894501e-30	0.385304049861475	0.558	0.306	1.99865673630758e-26	RPL7L1	Malignant cells	GSE153697	ENSG00000146223	285855	ribosomal protein L7 like 1	dJ475N16.4	protein_coding	Q6DKI1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12434
1.27659896495381e-30	-0.355418877743318	0.054	0.265	2.0479200595789e-26	CYGB	Malignant cells	GSE153697	ENSG00000161544	114757	cytoglobin	HGB|STAP	protein_coding	Q8WWM9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12435
1.47564500676972e-30	-0.393883398886899	0.982	0.99	2.36722971985999e-26	SRRM1	Malignant cells	GSE153697	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12436
1.58845553130523e-30	0.404392457749574	0.585	0.327	2.54820036331984e-26	SYNGR1	Malignant cells	GSE153697	ENSG00000100321	9145	synaptogyrin 1	NA	protein_coding	O43759	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12437
1.7604221758786e-30	0.372796661325087	0.541	0.288	2.82406925454445e-26	MTCH2	Malignant cells	GSE153697	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12438
2.03392081342067e-30	0.420360709143796	0.946	0.833	3.26281576888943e-26	HNRNPA3	Malignant cells	GSE153697	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12439
2.15266712579771e-30	-0.48666341102157	0.204	0.446	3.45330860320469e-26	H1FX	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12440
2.15580102624989e-30	0.386716081118546	0.517	0.267	3.45833600631008e-26	TXNRD1	Malignant cells	GSE153697	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12441
2.43646811496679e-30	0.28711527967004	0.337	0.118	3.90858215002972e-26	WDR12	Malignant cells	GSE153697	ENSG00000138442	55759	WD repeat domain 12	FLJ10881|YTM1	protein_coding	Q9GZL7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12442
2.57684212585176e-30	-0.479241889649038	0.111	0.338	4.13377013829139e-26	C11orf24	Malignant cells	GSE153697	ENSG00000171067	53838	chromosome 11 open reading frame 24	DM4E3	protein_coding	Q96F05	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12443
2.68145912728058e-30	0.305328141646676	0.39	0.156	4.30159673198351e-26	ZNF770	Malignant cells	GSE153697	ENSG00000198146	54989	zinc finger protein 770	FLJ20582|PRO1914	protein_coding	Q6IQ21	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12444
3.58692255796971e-30	0.293746017223643	0.276	0.081	5.75414116749501e-26	KTI12	Malignant cells	GSE153697	ENSG00000198841	112970	KTI12 chromatin associated homolog	MGC20419|SBBI81|TOT4	protein_coding	Q96EK9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12445
3.64710521006516e-30	0.405370562998706	0.725	0.485	5.85068617798654e-26	PRPF38A	Malignant cells	GSE153697	ENSG00000134748	84950	pre-mRNA processing factor 38A	FLJ14936|Prp38	protein_coding	Q8NAV1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12446
3.93684017957883e-30	0.476298958438427	0.879	0.723	6.31547901608036e-26	RCSD1	Malignant cells	GSE153697	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12447
3.98785367759545e-30	0.357953069481771	0.366	0.141	6.39731486959861e-26	MCM2	Malignant cells	GSE153697	ENSG00000073111	4171	minichromosome maintenance complex component 2	BM28|CCNL1|cdc19|CDCL1|D3S3194|DFNA70|KIAA0030	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12448
4.10865123372029e-30	0.362114317018776	0.292	0.092	6.59109830913408e-26	VNN2	Malignant cells	GSE153697	ENSG00000112303	8875	vanin 2	FOAP-4|GPI-80	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12449
4.28638033526406e-30	-0.453449740893212	0.59	0.79	6.87621133383061e-26	CHD2	Malignant cells	GSE153697	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12450
4.47989799904171e-30	0.303337046386701	0.396	0.161	7.1866523700627e-26	IRF2	Malignant cells	GSE153697	ENSG00000168310	3660	interferon regulatory factor 2	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12451
5.74706602961543e-30	-0.524390031189965	0.176	0.408	9.21944332470908e-26	SEC14L1	Malignant cells	GSE153697	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12452
5.88167958326753e-30	-0.329994592314856	0.061	0.275	9.43539038747777e-26	GAS7	Malignant cells	GSE153697	ENSG00000007237	8522	growth arrest specific 7	KIAA0394|MGC1348	protein_coding	O60861	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12453
6.54632926057002e-30	0.457545253048043	0.685	0.452	1.05016213998064e-25	NOLC1	Malignant cells	GSE153697	ENSG00000166197	9221	nucleolar and coiled-body phosphoprotein 1	KIAA0035|NOPP130|NOPP140|P130|Srp40	protein_coding	Q14978	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12454
7.45448226398872e-30	0.271204885301056	0.299	0.096	1.19584804478907e-25	ADPRHL2	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12455
8.07800559894713e-30	0.471014075884821	0.811	0.594	1.2958736581831e-25	TOP2B	Malignant cells	GSE153697	ENSG00000077097	7155	DNA topoisomerase II beta	top2beta|TOPIIB	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12456
8.98883030840981e-30	0.342476114809833	0.4	0.173	1.4419881580751e-25	CCDC86	Malignant cells	GSE153697	ENSG00000110104	79080	coiled-coil domain containing 86	cyclon|MGC2574	protein_coding	Q9H6F5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12457
9.03619681302669e-30	-0.371930131853182	0.999	1	1.44958669274574e-25	HSP90AA1	Malignant cells	GSE153697	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12458
9.81540637163001e-30	0.364107412238227	0.68	0.419	1.57458749013689e-25	ETFA	Malignant cells	GSE153697	ENSG00000140374	2108	electron transfer flavoprotein subunit alpha	EMA|GA2|MADD	protein_coding	P13804	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12459
9.89730353145788e-30	-0.465552969195711	0.289	0.539	1.58772543251647e-25	CREBRF	Malignant cells	GSE153697	ENSG00000164463	153222	CREB3 regulatory factor	C5orf41|LRF	protein_coding	Q8IUR6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12460
1.00914566364991e-29	0.332662389092275	0.4	0.168	1.61887147362719e-25	POLR2D	Malignant cells	GSE153697	ENSG00000144231	5433	RNA polymerase II subunit D	RPB4	protein_coding	O15514	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12461
1.00964616719006e-29	0.337586180460008	0.542	0.284	1.6196743814063e-25	ZNRD1	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12462
1.09636998483929e-29	0.335557688378399	0.454	0.209	1.7587967296792e-25	EXOSC8	Malignant cells	GSE153697	ENSG00000120699	11340	exosome component 8	bA421P11.3|CIP3|EAP2|OIP2|p9|RRP43|Rrp43p	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12463
1.21627637064283e-29	0.34688538669116	0.514	0.264	1.95115055378523e-25	PDHA1	Malignant cells	GSE153697	ENSG00000131828	5160	pyruvate dehydrogenase E1 subunit alpha 1	E1alpha|PDHA	protein_coding	P08559	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12464
1.22973109886031e-29	0.428665334008757	0.407	0.179	1.97273462879171e-25	MTHFD2	Malignant cells	GSE153697	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12465
1.34421863219737e-29	0.332914237541121	0.413	0.178	2.15639552977103e-25	SCMH1	Malignant cells	GSE153697	ENSG00000010803	22955	Scm polycomb group protein homolog 1	Scml3	protein_coding	Q96GD3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12466
1.42756575174296e-29	0.459020218348271	0.349	0.134	2.29010097894606e-25	HELLS	Malignant cells	GSE153697	ENSG00000119969	3070	helicase, lymphoid specific	LSH|Nbla10143|PASG|SMARCA6	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12467
1.57719995697991e-29	-0.488537965543304	0.385	0.611	2.53014417098718e-25	ATP6V0C	Malignant cells	GSE153697	ENSG00000185883	527	ATPase H+ transporting V0 subunit c	ATP6C|ATP6L|ATPL|VATL|Vma3	protein_coding	P27449	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12468
1.62760198143034e-29	0.326129425784444	0.511	0.255	2.61099909861056e-25	TGS1	Malignant cells	GSE153697	ENSG00000137574	96764	trimethylguanosine synthase 1	NCOA6IP|PIMT	protein_coding	Q96RS0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12469
1.70074108087137e-29	0.360896137360386	0.507	0.259	2.72832884193385e-25	NDUFC1	Malignant cells	GSE153697	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12470
1.78214090236349e-29	0.596120736851187	0.496	0.267	2.8589104355715e-25	CDCA7	Malignant cells	GSE153697	ENSG00000144354	83879	cell division cycle associated 7	FLJ14736|JPO1	protein_coding	Q9BWT1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12471
1.81779345309064e-29	0.295903296940024	0.335	0.122	2.91610425744801e-25	HPF1	Malignant cells	GSE153697	ENSG00000056050	54969	histone PARylation factor 1	C4orf27|FLJ20534	protein_coding	Q9NWY4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12472
1.87248934125559e-29	0.338322063286902	0.451	0.211	3.00384740124222e-25	PPA2	Malignant cells	GSE153697	ENSG00000138777	27068	inorganic pyrophosphatase 2	FLJ20459	protein_coding	Q9H2U2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12473
1.89177584917054e-29	-0.493240210733636	0.33	0.582	3.03478681723938e-25	MDM4	Malignant cells	GSE153697	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12474
1.99903184908482e-29	0.285992583565207	0.299	0.098	3.20684689230186e-25	SDHAF3	Malignant cells	GSE153697	ENSG00000196636	57001	succinate dehydrogenase complex assembly factor 3	ACN9|DC11|LYRM10|Sdh7	protein_coding	Q9NRP4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12475
2.26600167516929e-29	0.378942745005364	0.542	0.293	3.63511988730657e-25	PPCS	Malignant cells	GSE153697	ENSG00000127125	79717	phosphopantothenoylcysteine synthetase	FLJ11838	protein_coding	Q9HAB8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12476
2.4874692591932e-29	0.292955952375747	0.258	0.071	3.99039818559773e-25	SMC2	Malignant cells	GSE153697	ENSG00000136824	10592	structural maintenance of chromosomes 2	CAP-E|hCAP-E|SMC2L1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12477
2.59901786973222e-29	0.349850008213471	0.527	0.277	4.16934446662443e-25	TDG	Malignant cells	GSE153697	ENSG00000139372	6996	thymine DNA glycosylase	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12478
3.42937019822753e-29	0.335480206173036	0.335	0.124	5.5013956719966e-25	PTTG1	Malignant cells	GSE153697	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12479
3.60258707839678e-29	-0.453892002218188	0.256	0.498	5.77927019116412e-25	COG3	Malignant cells	GSE153697	ENSG00000136152	83548	component of oligomeric golgi complex 3	SEC34	protein_coding	Q96JB2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12480
4.02358595695389e-29	0.376587651245766	0.821	0.599	6.45463659214543e-25	TBCA	Malignant cells	GSE153697	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12481
4.06441990687292e-29	0.356473766781459	0.489	0.246	6.52014241460554e-25	SDAD1	Malignant cells	GSE153697	ENSG00000198301	55153	SDA1 domain containing 1	FLJ10498	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12482
5.72505611345571e-29	0.3175323609553	0.365	0.146	9.18413501720564e-25	FOPNL	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12483
5.89554389877913e-29	0.266792404939394	0.314	0.107	9.45763152242149e-25	CCDC137	Malignant cells	GSE153697	ENSG00000185298	339230	coiled-coil domain containing 137	MGC16597	protein_coding	Q6PK04	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12484
6.80692257152359e-29	0.362926105592469	0.745	0.495	1.09196651892381e-24	ESD	Malignant cells	GSE153697	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12485
6.85766027948674e-29	0.294273034149726	0.324	0.116	1.10010586203526e-24	CASP2	Malignant cells	GSE153697	ENSG00000106144	835	caspase 2	ICH1|MGC2181|NEDD2|PPP1R57	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12486
6.94415694864572e-29	0.322106724412629	0.414	0.186	1.11398165770175e-24	COX17	Malignant cells	GSE153697	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12487
7.19081962426626e-29	0.408240134598585	0.734	0.497	1.15355128412479e-24	ARPC5	Malignant cells	GSE153697	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12488
8.40774806625332e-29	0.444712388298243	0.617	0.38	1.34877094478836e-24	EIF4EBP1	Malignant cells	GSE153697	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12489
9.32532880708803e-29	0.275599103661549	0.33	0.119	1.49596924723306e-24	KNOP1	Malignant cells	GSE153697	ENSG00000103550	400506	lysine rich nucleolar protein 1	101F10.1|C16orf88|FAM191A|TSG118	protein_coding	Q1ED39	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12490
9.55264090158594e-29	0.412959865995848	0.675	0.433	1.53243465343242e-24	PTBP1	Malignant cells	GSE153697	ENSG00000011304	5725	polypyrimidine tract binding protein 1	HNRNP-I|HNRPI|pPTB|PTB|PTB-1|PTB2|PTB3|PTB4	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12491
9.85162272612973e-29	0.372457253127141	0.885	0.723	1.58039731772573e-24	SNU13	Malignant cells	GSE153697	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12492
1.03657095782907e-28	0.372195195584143	0.485	0.245	1.66286713054939e-24	MARCH7	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12493
1.14965135623364e-28	0.390385109529903	0.583	0.343	1.84427070567e-24	POLD2	Malignant cells	GSE153697	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12494
1.19105414222883e-28	-0.417501691351976	0.19	0.425	1.91068905496348e-24	JMJD6	Malignant cells	GSE153697	ENSG00000070495	23210	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	KIAA0585|PTDSR|PTDSR1	protein_coding	Q6NYC1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12495
1.22353357340776e-28	0.315651227171742	0.414	0.182	1.96279255846073e-24	GSTO1	Malignant cells	GSE153697	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12496
1.35484801555048e-28	0.407818817506917	0.527	0.287	2.17344718654607e-24	EBNA1BP2	Malignant cells	GSE153697	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12497
1.96546051263676e-28	0.349580605904635	0.49	0.252	3.1529917543719e-24	COPB2	Malignant cells	GSE153697	ENSG00000184432	9276	COPI coat complex subunit beta 2	beta'-COP|betaprime-COP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12498
2.10862238549455e-28	0.388944857765749	0.579	0.338	3.38265203081036e-24	SRPRA	Malignant cells	GSE153697	ENSG00000182934	6734	SRP receptor subunit alpha	SR-alpha|Sralpha|SRP-alpha|SRPR	protein_coding	P08240	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12499
2.12013419302628e-28	0.351388228580206	0.583	0.332	3.40111927245275e-24	AAMP	Malignant cells	GSE153697	ENSG00000127837	14	angio associated migratory cell protein	NA	protein_coding	Q13685	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12500
2.17982233447366e-28	0.384179141390533	0.548	0.307	3.49687098896265e-24	ABCE1	Malignant cells	GSE153697	ENSG00000164163	6059	ATP binding cassette subfamily E member 1	OABP|RLI|RLI1|RNASEL1|RNASELI|RNS4I	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12501
2.19113229214071e-28	0.273390352807831	0.304	0.104	3.51501442305212e-24	COQ5	Malignant cells	GSE153697	ENSG00000110871	84274	coenzyme Q5, methyltransferase	MGC4767	protein_coding	Q5HYK3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12502
2.20472194518551e-28	0.34252037975594	0.521	0.272	3.53681494446659e-24	ADSS	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12503
2.70588097189764e-28	0.318966697613349	0.421	0.19	4.34077425511819e-24	SCOC	Malignant cells	GSE153697	ENSG00000153130	60592	short coiled-coil protein	HRIHFB2072|SCOCO|UNC-69	protein_coding	Q9UIL1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12504
2.85445526512697e-28	0.285694733771451	0.359	0.14	4.57911713631668e-24	MRPL27	Malignant cells	GSE153697	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12505
2.90395623680939e-28	0.330470642325644	0.441	0.207	4.65852659508963e-24	CCDC47	Malignant cells	GSE153697	ENSG00000108588	57003	coiled-coil domain containing 47	GK001	protein_coding	Q96A33	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12506
3.01387615113204e-28	0.2753722636062	0.342	0.128	4.83486012164602e-24	GEMIN7	Malignant cells	GSE153697	ENSG00000142252	79760	gem nuclear organelle associated protein 7	FLJ13956	protein_coding	Q9H840	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12507
3.05786002052332e-28	0.338141225138473	0.568	0.313	4.90541904492352e-24	COPS5	Malignant cells	GSE153697	ENSG00000121022	10987	COP9 signalosome subunit 5	CSN5|JAB1|MOV-34|SGN5	protein_coding	Q92905	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12508
3.24964955856926e-28	0.338977708945873	0.468	0.229	5.2130878218568e-24	IARS	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12509
3.88489748440239e-28	0.388400387463951	0.651	0.418	6.23215254447832e-24	NDUFA12	Malignant cells	GSE153697	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12510
4.10559349794256e-28	0.291711897461437	0.349	0.134	6.58619308939945e-24	GCA	Malignant cells	GSE153697	ENSG00000115271	25801	grancalcin	GCL	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12511
4.36904617003631e-28	0.365650326621597	0.661	0.417	7.00882386597225e-24	SF3B4	Malignant cells	GSE153697	ENSG00000143368	10262	splicing factor 3b subunit 4	Hsh49|SAP49|SF3b49	protein_coding	Q15427	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12512
4.4671989031889e-28	0.402399426980883	0.562	0.324	7.16628048049563e-24	GTPBP4	Malignant cells	GSE153697	ENSG00000107937	23560	GTP binding protein 4	CRFG|FLJ10686|FLJ10690|NGB|NOG1	protein_coding	Q9BZE4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12513
4.63730479144615e-28	0.448907129194674	0.43	0.202	7.43916434643791e-24	SERHL2	Malignant cells	GSE153697	ENSG00000183569	253190	serine hydrolase like 2	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12514
4.70291962400557e-28	0.438728562097476	0.689	0.444	7.54442366082973e-24	MRPL16	Malignant cells	GSE153697	ENSG00000166902	54948	mitochondrial ribosomal protein L16	FLJ20484|PNAS-111	protein_coding	Q9NX20	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12515
4.7627091256759e-28	0.334025978213898	0.456	0.224	7.64033797940927e-24	SNAPIN	Malignant cells	GSE153697	ENSG00000143553	23557	SNAP associated protein	BLOC1S7|BORCS3|SNAPAP	protein_coding	O95295	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12516
4.95387416359041e-28	0.422250619959583	0.527	0.299	7.94700493323173e-24	HSPB11	Malignant cells	GSE153697	ENSG00000081870	51668	heat shock protein family B (small) member 11	C1orf41|FAP232|HSPCO34|IFT25|PP25	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12517
5.58429524766383e-28	0.27077146795683	0.299	0.101	8.95832643630232e-24	SFXN4	Malignant cells	GSE153697	ENSG00000183605	119559	sideroflexin 4	SLC56A4	protein_coding	Q6P4A7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12518
5.7709882887964e-28	0.47201434738081	0.735	0.503	9.25781941288718e-24	ERG	Malignant cells	GSE153697	ENSG00000157554	2078	ETS transcription factor ERG	erg-3|p55	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12519
5.93208536309613e-28	0.345890516411819	0.925	0.773	9.51625133947882e-24	ATP5F1C	Malignant cells	GSE153697	ENSG00000165629	509	ATP synthase F1 subunit gamma	ATP5C|ATP5C1|ATP5CL1	protein_coding	P36542	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12520
6.25876476499944e-28	0.305449489058197	0.256	0.076	1.00403104360121e-23	WDR76	Malignant cells	GSE153697	ENSG00000092470	79968	WD repeat domain 76	FLJ12973	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12521
7.03704803580814e-28	0.43897277801762	0.662	0.446	1.12888324590434e-23	CALM3	Malignant cells	GSE153697	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12522
7.39245320861039e-28	0.381459568212956	0.656	0.411	1.18589734372528e-23	C20orf27	Malignant cells	GSE153697	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12523
7.45390720488893e-28	0.368525371662871	0.694	0.445	1.19575579380828e-23	DCAF7	Malignant cells	GSE153697	ENSG00000136485	10238	DDB1 and CUL4 associated factor 7	HAN11|SWAN-1|WDR68	protein_coding	P61962	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12524
7.47047810289711e-28	0.404916876538537	0.635	0.389	1.19841409726675e-23	SMS	Malignant cells	GSE153697	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12525
8.30931570404485e-28	-0.348624151158593	0.073	0.279	1.33298042524287e-23	CEMIP2	Malignant cells	GSE153697	ENSG00000135048	23670	cell migration inducing hyaluronidase 2	TMEM2	protein_coding	Q9UHN6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12526
9.0272915329879e-28	0.360915100420689	0.558	0.31	1.44815810772192e-23	CTPS1	Malignant cells	GSE153697	ENSG00000171793	1503	CTP synthase 1	CTPS|GATD5A	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12527
9.25505878811731e-28	0.305239036019028	0.365	0.151	1.48469653078978e-23	DNPH1	Malignant cells	GSE153697	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12528
9.57914535369478e-28	0.320633559050897	0.463	0.224	1.53668649763972e-23	MPHOSPH10	Malignant cells	GSE153697	ENSG00000124383	10199	M-phase phosphoprotein 10	CT90|MPP10|MPP10P|PPP1R106	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12529
9.97605618928237e-28	0.275766333873964	0.339	0.129	1.60035893388468e-23	AIMP2	Malignant cells	GSE153697	ENSG00000106305	7965	aminoacyl tRNA synthetase complex interacting multifunctional protein 2	JTV-1|JTV1|p38|PRO0992	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12530
1.5032830392207e-27	0.321180137970445	0.392	0.173	2.41156665151785e-23	FH	Malignant cells	GSE153697	ENSG00000091483	2271	fumarate hydratase	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12531
1.54754220664767e-27	0.411214496942296	0.768	0.568	2.48256720790419e-23	SYNCRIP	Malignant cells	GSE153697	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12532
1.63806025671329e-27	0.434528932141695	0.977	0.906	2.62777626381946e-23	FAM129C	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12533
1.67892531780188e-27	0.334033553070354	0.58	0.325	2.69333199481777e-23	NDUFB1	Malignant cells	GSE153697	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12534
1.71802527385663e-27	-0.414865309144261	0.161	0.389	2.75605614432081e-23	ZBTB10	Malignant cells	GSE153697	ENSG00000205189	65986	zinc finger and BTB domain containing 10	FLJ12752|RINZF	protein_coding	Q96DT7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12535
2.00394237657703e-27	0.307170454107758	0.39	0.168	3.21472436050487e-23	GAR1	Malignant cells	GSE153697	ENSG00000109534	54433	GAR1 ribonucleoprotein	NOLA1	protein_coding	Q9NY12	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12536
2.14782423430244e-27	0.388615563289816	0.561	0.324	3.44553963666797e-23	PRPF19	Malignant cells	GSE153697	ENSG00000110107	27339	pre-mRNA processing factor 19	hPSO4|NMP200|PRP19|PSO4|SNEV|UBOX4	protein_coding	Q9UMS4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12537
2.44783715193663e-27	0.297553130388502	0.294	0.1	3.92682035913675e-23	CENPH	Malignant cells	GSE153697	ENSG00000153044	64946	centromere protein H	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12538
2.646615968622e-27	0.254317963256909	0.256	0.077	4.24570133686341e-23	RHNO1	Malignant cells	GSE153697	ENSG00000171792	83695	RAD9-HUS1-RAD1 interacting nuclear orphan 1	C12orf32|HKMT1188|MGC13204|RHINO	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12539
2.75546237289369e-27	0.410280493537734	0.832	0.697	4.42031273859606e-23	SNRPF	Malignant cells	GSE153697	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12540
3.00832479526611e-27	0.357461037791428	0.779	0.556	4.82595463656589e-23	LAPTM4A	Malignant cells	GSE153697	ENSG00000068697	9741	lysosomal protein transmembrane 4 alpha	HUMORF13|KIAA0108|LAPTM4|MBNT|Mtrp	protein_coding	Q15012	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12541
3.0486520499665e-27	0.313297064225344	0.413	0.187	4.89064761855626e-23	ALG3	Malignant cells	GSE153697	ENSG00000214160	10195	ALG3 alpha-1,3- mannosyltransferase	CDGS4|D16Ertd36e|Not56|NOT56L	protein_coding	Q92685	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12542
3.15634677111707e-27	0.293814581898773	0.401	0.177	5.063411490226e-23	DDX56	Malignant cells	GSE153697	ENSG00000136271	54606	DEAD-box helicase 56	NOH61	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12543
3.28539575941835e-27	0.26717977061808	0.282	0.092	5.27043187725891e-23	TIMM10	Malignant cells	GSE153697	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12544
4.32459961157434e-27	0.296582284669117	0.428	0.196	6.93752269688755e-23	PIN4	Malignant cells	GSE153697	ENSG00000102309	5303	peptidylprolyl cis/trans isomerase, NIMA-interacting 4	EPVH|PAR14|PAR17	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12545
4.60954329247735e-27	0.32997614916477	0.452	0.22	7.39462934979217e-23	NBN	Malignant cells	GSE153697	ENSG00000104320	4683	nibrin	AT-V1|AT-V2|ATV|NBS|NBS1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12546
4.9651206662042e-27	0.389726958980948	0.865	0.707	7.96504657272478e-23	NHP2	Malignant cells	GSE153697	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12547
4.99716349106315e-27	0.264464224933673	0.311	0.112	8.01644967236351e-23	PIGF	Malignant cells	GSE153697	ENSG00000151665	5281	phosphatidylinositol glycan anchor biosynthesis class F	NA	protein_coding	Q07326	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12548
7.0370353187553e-27	0.298917859384506	0.396	0.174	1.12888120583473e-22	CCDC28B	Malignant cells	GSE153697	ENSG00000160050	79140	coiled-coil domain containing 28B	MGC1203|RP4-622L5.5	protein_coding	Q9BUN5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12549
7.82883177383096e-27	0.336893215322638	0.548	0.302	1.25590119315796e-22	LYPLA2	Malignant cells	GSE153697	ENSG00000011009	11313	lysophospholipase 2	APT-2	protein_coding	O95372	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12550
8.50086783801205e-27	0.292699481099013	0.449	0.211	1.36370921857389e-22	SPOP	Malignant cells	GSE153697	ENSG00000121067	8405	speckle type BTB/POZ protein	BTBD32|TEF2	protein_coding	O43791	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12551
9.73006272817098e-27	0.350209842609792	0.52	0.28	1.56089666285319e-22	RAB10	Malignant cells	GSE153697	ENSG00000084733	10890	RAB10, member RAS oncogene family	NA	protein_coding	P61026	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12552
1.03095284915039e-26	0.279580506547203	0.354	0.142	1.65385456060706e-22	ARMC1	Malignant cells	GSE153697	ENSG00000104442	55156	armadillo repeat containing 1	Arcp|FLJ10511	protein_coding	Q9NVT9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12553
1.03672534852171e-26	0.324765451001909	0.451	0.219	1.66311480409853e-22	NOL11	Malignant cells	GSE153697	ENSG00000130935	25926	nucleolar protein 11	DKFZP586L0724	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12554
1.05364302490999e-26	-0.462334081659829	0.396	0.609	1.6902541405606e-22	RIOK3	Malignant cells	GSE153697	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12555
1.17143847651608e-26	-0.440550408534184	0.113	0.328	1.87922160402709e-22	TBX3	Malignant cells	GSE153697	ENSG00000135111	6926	T-box transcription factor 3	TBX3-ISO|UMS|XHL	protein_coding	O15119	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12556
1.20649849355203e-26	0.31536512574676	0.993	0.969	1.93546488335617e-22	ATP5F1B	Malignant cells	GSE153697	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12557
1.35349833491641e-26	-0.429822709034543	0.497	0.699	2.1712820288729e-22	PPP1R2	Malignant cells	GSE153697	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12558
1.62321897616274e-26	0.358474290417845	0.534	0.294	2.60396788156027e-22	CKS2	Malignant cells	GSE153697	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12559
1.92162972163105e-26	0.381412059723801	0.794	0.618	3.08267839944053e-22	CBX3	Malignant cells	GSE153697	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12560
2.0258761102525e-26	0.394942797576578	0.779	0.581	3.24991045606706e-22	PSMA4	Malignant cells	GSE153697	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12561
2.26209963579415e-26	0.366809605109731	0.773	0.551	3.62886023574097e-22	ZNF22	Malignant cells	GSE153697	ENSG00000165512	7570	zinc finger protein 22	HKR-T1|KOX15|Zfp422|ZNF422	protein_coding	P17026	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12562
2.39869873543992e-26	0.354206512578413	0.561	0.322	3.84799251139271e-22	CEBPZ	Malignant cells	GSE153697	ENSG00000115816	10153	CCAAT enhancer binding protein zeta	CBF2|CTF2	protein_coding	Q03701	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12563
2.65259706252767e-26	0.33369367008979	0.573	0.331	4.25529620770689e-22	EMC4	Malignant cells	GSE153697	ENSG00000128463	51234	ER membrane protein complex subunit 4	FLJ90746|MGC24415|PIG17|TMEM85	protein_coding	Q5J8M3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12564
2.95393188726295e-26	0.251510347627293	0.265	0.084	4.73869753354722e-22	PPAT	Malignant cells	GSE153697	ENSG00000128059	5471	phosphoribosyl pyrophosphate amidotransferase	GPAT|PRAT	protein_coding	Q06203	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12565
5.06656526095051e-26	0.271643762053242	0.324	0.124	8.12778399161681e-22	GPR174	Malignant cells	GSE153697	ENSG00000147138	84636	G protein-coupled receptor 174	FKSG79	protein_coding	Q9BXC1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12566
5.58668113293774e-26	0.262125204115886	0.303	0.11	8.96215387345873e-22	SPTSSA	Malignant cells	GSE153697	ENSG00000165389	171546	serine palmitoyltransferase small subunit A	C14orf147|ssSPTa	protein_coding	Q969W0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12567
5.84237187188133e-26	0.375925615731652	0.975	0.901	9.37233295687203e-22	SEPT9	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12568
6.16042400597011e-26	0.270133942881111	0.356	0.145	9.88255219037724e-22	NAT10	Malignant cells	GSE153697	ENSG00000135372	55226	N-acetyltransferase 10	FLJ10774|FLJ12179|hALP|KIAA1709|Kre33|NET43	protein_coding	Q9H0A0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12569
6.71374764438165e-26	-0.521362338492397	0.282	0.494	1.0770193971117e-21	DSTN	Malignant cells	GSE153697	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12570
6.72080467040265e-26	0.382174125896765	0.82	0.621	1.07815148522599e-21	ATP5MD	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12571
6.86952308388425e-26	0.251999716194009	0.263	0.085	1.10200889311671e-21	ASNSD1	Malignant cells	GSE153697	ENSG00000138381	54529	asparagine synthetase domain containing 1	FLJ20752|NBLA00058|NS3TP1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12572
7.08750445424284e-26	0.391524978154442	0.766	0.58	1.13697746454964e-21	RPN1	Malignant cells	GSE153697	ENSG00000163902	6184	ribophorin I	OST1	protein_coding	P04843	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12573
7.22779304243759e-26	0.278608126374699	0.346	0.143	1.15948255986784e-21	HMOX2	Malignant cells	GSE153697	ENSG00000277424	3163	heme oxygenase 2	HO-2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12574
7.42489587618939e-26	0.29072315730056	0.359	0.153	1.1911017964583e-21	PNPT1	Malignant cells	GSE153697	ENSG00000138035	87178	polyribonucleotide nucleotidyltransferase 1	DFNB70|old-35|OLD35|PNPase	protein_coding	Q8TCS8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12575
7.53421337532272e-26	0.274133619995907	0.254	0.078	1.20863850966927e-21	CHEK1	Malignant cells	GSE153697	ENSG00000149554	1111	checkpoint kinase 1	CHK1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12576
7.57301125670709e-26	0.251948635589939	0.272	0.09	1.21486246580095e-21	MED8	Malignant cells	GSE153697	ENSG00000159479	112950	mediator complex subunit 8	ARC32|MGC17544|MGC19641	protein_coding	Q96G25	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12577
8.08439820617055e-26	0.360410318565257	0.504	0.275	1.29689916023388e-21	SPN	Malignant cells	GSE153697	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12578
8.33531230586824e-26	0.33408292273123	0.463	0.229	1.33715080010738e-21	CFAP20	Malignant cells	GSE153697	ENSG00000070761	29105	cilia and flagella associated protein 20	C16orf80|fSAP23|GTL3	protein_coding	Q9Y6A4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12579
8.36019845120353e-26	0.348469166859097	0.645	0.407	1.34114303554207e-21	SDHC	Malignant cells	GSE153697	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12580
8.37696824679828e-26	0.319570327834551	0.345	0.142	1.34383324615138e-21	ENG	Malignant cells	GSE153697	ENSG00000106991	2022	endoglin	CD105|END|HHT1|ORW|ORW1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12581
8.41251171609871e-26	0.342811501267281	0.57	0.332	1.34953512949655e-21	KRTCAP2	Malignant cells	GSE153697	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12582
8.56695107018644e-26	0.284798538663376	0.392	0.174	1.37431029067931e-21	ARMC6	Malignant cells	GSE153697	ENSG00000105676	93436	armadillo repeat containing 6	MGC19595	protein_coding	Q6NXE6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12583
8.96705812929471e-26	0.360076152442691	0.676	0.454	1.43849546510146e-21	NDUFS3	Malignant cells	GSE153697	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12584
9.59943512936477e-26	0.343725860973041	0.469	0.245	1.5399413834527e-21	TXNDC17	Malignant cells	GSE153697	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12585
1.01702216235386e-25	-0.472482550332527	0.356	0.562	1.63150695284806e-21	SECISBP2L	Malignant cells	GSE153697	ENSG00000138593	9728	SECIS binding protein 2 like	KIAA0256	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12586
1.04628381617333e-25	0.367094906783969	0.434	0.219	1.67844849790526e-21	ICAM2	Malignant cells	GSE153697	ENSG00000108622	3384	intercellular adhesion molecule 2	CD102	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12587
1.17291324472444e-25	0.404510207700396	0.603	0.378	1.88158742718695e-21	P4HB	Malignant cells	GSE153697	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12588
1.1835522744392e-25	0.34705876979605	0.485	0.261	1.89865455865537e-21	HACD3	Malignant cells	GSE153697	ENSG00000074696	51495	3-hydroxyacyl-CoA dehydratase 3	B-ind1|HSPC121|PTPLAD1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12589
1.25902320943228e-25	-0.389434296608504	0.237	0.46	2.01972503257127e-21	PTP4A2	Malignant cells	GSE153697	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12590
1.26561670306792e-25	0.320654022955477	0.449	0.227	2.03030231506156e-21	BCAT2	Malignant cells	GSE153697	ENSG00000105552	587	branched chain amino acid transaminase 2	BCAM|BCATm|BCT2	protein_coding	O15382	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12591
1.28841512972702e-25	0.404543181325997	0.303	0.113	2.06687555110809e-21	CENPF	Malignant cells	GSE153697	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12592
1.41619663055541e-25	0.349855065756643	0.786	0.6	2.27186263473699e-21	NDUFV2	Malignant cells	GSE153697	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12593
1.41996864115216e-25	0.364607337946145	0.686	0.457	2.2779136941363e-21	SRSF1	Malignant cells	GSE153697	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12594
1.42842249399233e-25	-0.434224426529743	0.496	0.702	2.29147536486249e-21	GNAS	Malignant cells	GSE153697	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12595
1.54675178888842e-25	0.344709948242517	0.454	0.23	2.4812992197348e-21	POLE3	Malignant cells	GSE153697	ENSG00000148229	54107	DNA polymerase epsilon 3, accessory subunit	CHARAC17|CHRAC17|CHRAC2|p17|Ybl1	protein_coding	Q9NRF9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12596
1.99069474921678e-25	0.2695016754817	0.325	0.127	3.19347251669356e-21	RSPRY1	Malignant cells	GSE153697	ENSG00000159579	89970	ring finger and SPRY domain containing 1	KIAA1972	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12597
1.99079887851882e-25	0.343333280208995	0.57	0.347	3.1936395609199e-21	TIMM17B	Malignant cells	GSE153697	ENSG00000126768	10245	translocase of inner mitochondrial membrane 17B	DXS9822|JM3	protein_coding	O60830	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12598
1.99092307519108e-25	-0.356210961579614	0.063	0.251	3.19383879722153e-21	SNX9	Malignant cells	GSE153697	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12599
2.08741802200504e-25	0.334454598392767	0.348	0.144	3.34863599090048e-21	PLD4	Malignant cells	GSE153697	ENSG00000166428	122618	phospholipase D family member 4	C14orf175	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12600
2.14741756677927e-25	0.399646497912317	0.825	0.651	3.44488726062731e-21	UQCRQ	Malignant cells	GSE153697	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12601
2.19599020258915e-25	0.318398638704244	0.375	0.165	3.52280748299351e-21	CASP8AP2	Malignant cells	GSE153697	ENSG00000288475	9994	caspase 8 associated protein 2	CED-4|FLASH|FLJ11208|KIAA1315|RIP25	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12602
2.2784507633514e-25	0.321232936559295	0.411	0.195	3.65509071456831e-21	HNRNPAB	Malignant cells	GSE153697	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12603
2.41584184191508e-25	0.345948043119387	0.59	0.364	3.87549348280017e-21	RER1	Malignant cells	GSE153697	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12604
2.6430478927822e-25	0.316654114723218	0.494	0.259	4.23997742960121e-21	TYW3	Malignant cells	GSE153697	ENSG00000162623	127253	tRNA-yW synthesizing protein 3 homolog	C1orf171|FLJ40918	protein_coding	Q6IPR3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12605
3.48202180339203e-25	0.297938534323501	0.396	0.184	5.5858593770015e-21	DCUN1D5	Malignant cells	GSE153697	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12606
3.68282533525694e-25	0.499043201754843	0.69	0.509	5.90798840281918e-21	DEK	Malignant cells	GSE153697	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12607
3.76897909117377e-25	0.258847591859739	0.308	0.117	6.04619625806096e-21	PSMD10	Malignant cells	GSE153697	ENSG00000101843	5716	proteasome 26S subunit, non-ATPase 10	p28	protein_coding	O75832	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12608
4.09554847419485e-25	-0.708499615200109	0.589	0.775	6.57007886230338e-21	CD37	Malignant cells	GSE153697	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12609
4.3207248650708e-25	0.328573711130214	0.455	0.235	6.93130682854658e-21	HAUS1	Malignant cells	GSE153697	ENSG00000152240	115106	HAUS augmin like complex subunit 1	CCDC5|FLJ40084|HEI-C|HsT1461	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12610
4.3557320386831e-25	0.371227286344657	0.627	0.4	6.98746533645543e-21	AKR1B1	Malignant cells	GSE153697	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12611
4.68603916334688e-25	0.290206979729666	0.383	0.173	7.51734402584107e-21	YDJC	Malignant cells	GSE153697	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12612
4.71055152762957e-25	-0.341682707904991	1	1	7.55666676062335e-21	TPT1	Malignant cells	GSE153697	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12613
4.96243558930968e-25	0.326313892276081	0.527	0.293	7.96073917237058e-21	NOB1	Malignant cells	GSE153697	ENSG00000141101	28987	NIN1 (RPN12) binding protein 1 homolog	ART-4|MST158|NOB1P|PSMD8BP1	protein_coding	Q9ULX3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12614
4.97169750605578e-25	0.306931401749467	0.342	0.145	7.97559713921468e-21	TIPIN	Malignant cells	GSE153697	ENSG00000075131	54962	TIMELESS interacting protein	FLJ20516	protein_coding	Q9BVW5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12615
4.98872361803057e-25	0.39383236303806	0.396	0.185	8.00291042804464e-21	TMEM106C	Malignant cells	GSE153697	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12616
5.20968270725244e-25	0.293759984141385	0.389	0.178	8.35737299897436e-21	MRPL15	Malignant cells	GSE153697	ENSG00000137547	29088	mitochondrial ribosomal protein L15	HSPC145|L15mt|MRP-L15|MRP-L7|RPML7	protein_coding	Q9P015	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12617
5.6150878315561e-25	-0.352196678793712	0.154	0.369	9.0077238993823e-21	ZFAND2A	Malignant cells	GSE153697	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12618
5.75783546475022e-25	-0.493939750932268	0.231	0.446	9.2367196525523e-21	PCGF5	Malignant cells	GSE153697	ENSG00000180628	84333	polycomb group ring finger 5	MGC16202|RNF159	protein_coding	Q86SE9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12619
5.8342185240437e-25	0.338167869962843	0.999	1	9.35925335627091e-21	MT-ATP8	Malignant cells	GSE153697	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12620
6.14024468848584e-25	0.299371558588198	0.463	0.236	9.85018052926899e-21	NAA50	Malignant cells	GSE153697	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12621
6.30159121324214e-25	0.297873344141807	0.435	0.213	1.0109012624283e-20	GOPC	Malignant cells	GSE153697	ENSG00000047932	57120	golgi associated PDZ and coiled-coil motif containing	CAL|dJ94G16.2|FIG|GOPC1|PIST	protein_coding	Q9HD26	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12622
6.53739409483633e-25	0.28383507864701	0.332	0.135	1.04872876069364e-20	PSMG1	Malignant cells	GSE153697	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12623
7.61476210050584e-25	0.348292704277757	0.668	0.426	1.22156013616315e-20	TSC22D4	Malignant cells	GSE153697	ENSG00000166925	81628	TSC22 domain family member 4	THG-1|TILZ2	protein_coding	Q9Y3Q8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12624
7.88974900800557e-25	0.409936112460184	0.81	0.63	1.26567353586425e-20	VAMP8	Malignant cells	GSE153697	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12625
8.88269524160385e-25	0.379881223720758	0.683	0.457	1.42496197065809e-20	BZW2	Malignant cells	GSE153697	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12626
9.18234210413184e-25	0.394102679144168	0.777	0.607	1.47303132034483e-20	PHB	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12627
9.85344118841214e-25	0.296839965802199	0.4	0.185	1.58068903544507e-20	DDX10	Malignant cells	GSE153697	ENSG00000178105	1662	DEAD-box helicase 10	Dbp4|HRH-J8	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12628
1.03781624426051e-24	-0.382461139346774	0.193	0.411	1.66486481904271e-20	TACC1	Malignant cells	GSE153697	ENSG00000147526	6867	transforming acidic coiled-coil containing protein 1	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12629
1.29737686194753e-24	0.257546510846869	0.354	0.148	2.08125196193623e-20	CISD2	Malignant cells	GSE153697	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12630
1.42095913313806e-24	0.279747852143619	0.446	0.22	2.27950264138008e-20	ZBTB8OS	Malignant cells	GSE153697	ENSG00000176261	339487	zinc finger and BTB domain containing 8 opposite strand	ARCH	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12631
1.51821281909067e-24	-0.367356102302992	0.08	0.272	2.43551700438525e-20	AC016831.1	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12632
1.5436797211507e-24	0.397275917098951	0.555	0.334	2.47637100866995e-20	CACYBP	Malignant cells	GSE153697	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12633
1.61081110313448e-24	-0.458910031180339	0.241	0.455	2.58406317164833e-20	MYLIP	Malignant cells	GSE153697	ENSG00000007944	29116	myosin regulatory light chain interacting protein	IDOL|MIR	protein_coding	Q8WY64	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12634
1.68550168520747e-24	0.339991579622006	0.658	0.426	2.70388180340982e-20	VPS35	Malignant cells	GSE153697	ENSG00000069329	55737	VPS35 retromer complex component	FLJ10752|MEM3|PARK17	protein_coding	Q96QK1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12635
1.72083133381661e-24	0.387053497342459	0.703	0.498	2.7605576257086e-20	PDCD5	Malignant cells	GSE153697	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12636
1.87821956231328e-24	0.418684165104454	0.693	0.478	3.01303982186297e-20	HMGA1	Malignant cells	GSE153697	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12637
1.88469699529653e-24	0.338507643296085	0.861	0.663	3.02343091985469e-20	BRK1	Malignant cells	GSE153697	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12638
2.02578255165588e-24	0.371283171182877	0.572	0.354	3.24976036936636e-20	SERINC3	Malignant cells	GSE153697	ENSG00000132824	10955	serine incorporator 3	AIGP1|DIFF33|SBBI99|TDE|TDE1|TMS-1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12639
2.17026774592579e-24	0.347904223812019	0.663	0.436	3.48154351801415e-20	DDX18	Malignant cells	GSE153697	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12640
2.18834839887624e-24	0.319018838059938	0.506	0.278	3.51054850147726e-20	NARS	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12641
2.27975811884664e-24	0.352009908606137	0.765	0.548	3.65718797425378e-20	NUTF2	Malignant cells	GSE153697	ENSG00000102898	10204	nuclear transport factor 2	NTF2|PP15	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12642
2.29457328180292e-24	0.265193212234749	0.369	0.162	3.68095445866824e-20	CRIPT	Malignant cells	GSE153697	ENSG00000119878	9419	CXXC repeat containing interactor of PDZ3 domain	HSPC139	protein_coding	Q9P021	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12643
2.46575842825658e-24	0.251174213872429	0.28	0.1	3.95556967060921e-20	GON7	Malignant cells	GSE153697	ENSG00000275619	84520	GON7 subunit of KEOPS complex	C14orf142	protein_coding	Q9BXV9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12644
2.85706483412952e-24	0.252838638727905	0.349	0.147	4.58330340691057e-20	BDH1	Malignant cells	GSE153697	ENSG00000275544	622	3-hydroxybutyrate dehydrogenase 1	BDH|SDR9C1	protein_coding	Q02338	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12645
2.89337001462869e-24	0.282607049668317	0.423	0.204	4.64154417746735e-20	RBM28	Malignant cells	GSE153697	ENSG00000106344	55131	RNA binding motif protein 28	FLJ10377	protein_coding	Q9NW13	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12646
3.44864348009378e-24	0.329367387687089	0.534	0.312	5.53231387076644e-20	TTC1	Malignant cells	GSE153697	ENSG00000113312	7265	tetratricopeptide repeat domain 1	TPR1	protein_coding	Q99614	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12647
3.73194773924669e-24	0.276914954933033	0.435	0.214	5.98679056329954e-20	DDX23	Malignant cells	GSE153697	ENSG00000174243	9416	DEAD-box helicase 23	prp28|PRPF28|SNRNP100|U5-100KD	protein_coding	Q9BUQ8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12648
3.90702157473782e-24	0.307364168271957	0.486	0.264	6.26764401019442e-20	MCTS1	Malignant cells	GSE153697	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12649
4.5740729234466e-24	-0.362890507763636	0.097	0.292	7.33772778379303e-20	GRASP	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12650
4.74342278019742e-24	0.37875139933372	0.579	0.363	7.6093988239927e-20	CDCA7L	Malignant cells	GSE153697	ENSG00000164649	55536	cell division cycle associated 7 like	JPO2|R1|RAM2	protein_coding	Q96GN5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12651
5.25459623739522e-24	0.379044489940663	0.53	0.318	8.42942328402942e-20	MYD88	Malignant cells	GSE153697	ENSG00000172936	4615	MYD88 innate immune signal transduction adaptor	NA	protein_coding	Q99836	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12652
5.36797142232557e-24	0.300037132372679	0.499	0.272	8.61129975569468e-20	POLR2K	Malignant cells	GSE153697	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12653
5.4735732959502e-24	0.380920827013638	0.454	0.241	8.78070628136331e-20	ITGA6	Malignant cells	GSE153697	ENSG00000091409	3655	integrin subunit alpha 6	CD49f	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12654
5.85279474253483e-24	0.372278072963312	0.811	0.628	9.38905332597438e-20	FBL	Malignant cells	GSE153697	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12655
6.29448463896308e-24	0.281433125611532	0.42	0.204	1.00976122578246e-19	MRPS25	Malignant cells	GSE153697	ENSG00000131368	64432	mitochondrial ribosomal protein S25	DKFZp313H0817|FLJ00023|MRP-S25|RPMS25	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12656
6.69842134562693e-24	0.418014013153831	0.804	0.626	1.07456075226547e-19	NUCKS1	Malignant cells	GSE153697	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12657
6.74593840319453e-24	0.327459200860591	0.477	0.263	1.08218343864047e-19	SF3B3	Malignant cells	GSE153697	ENSG00000189091	23450	splicing factor 3b subunit 3	KIAA0017|RSE1|SAP130|SF3b130	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12658
7.50205207787345e-24	0.302535488698064	0.642	0.398	1.20347919433246e-19	PYURF	Malignant cells	GSE153697	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12659
8.11158907647984e-24	0.342077963057074	0.952	0.886	1.3012611196489e-19	ATP5MC3	Malignant cells	GSE153697	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12660
8.29742789125664e-24	-0.623939855740367	0.194	0.397	1.33107338231539e-19	AL133415.1	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12661
8.87770332039519e-24	0.31573671583605	0.486	0.266	1.4241611666578e-19	ECHDC1	Malignant cells	GSE153697	ENSG00000093144	55862	ethylmalonyl-CoA decarboxylase 1	dJ351K20.2	protein_coding	Q9NTX5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12662
9.22381133560472e-24	0.272540853141987	1	1	1.47968381445771e-19	B2M	Malignant cells	GSE153697	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12663
9.94052160913107e-24	0.308984841000139	0.499	0.277	1.59465847653681e-19	CNIH1	Malignant cells	GSE153697	ENSG00000100528	10175	cornichon family AMPA receptor auxiliary protein 1	CNIH|CNIL|TGAM77	protein_coding	O95406	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12664
1.08058390037737e-23	0.33725254446742	0.739	0.523	1.73347269298538e-19	SEC13	Malignant cells	GSE153697	ENSG00000157020	6396	SEC13 homolog, nuclear pore and COPII coat complex component	D3S1231E|npp-20|SEC13L1|SEC13R	protein_coding	P55735	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12665
1.11387833511765e-23	0.280717437062355	0.42	0.204	1.78688362519573e-19	BFAR	Malignant cells	GSE153697	ENSG00000275618	51283	bifunctional apoptosis regulator	BAR|RNF47	protein_coding	Q9NZS9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12666
1.22330062447513e-23	0.338759100597532	0.341	0.146	1.962418861783e-19	LIG1	Malignant cells	GSE153697	ENSG00000105486	3978	DNA ligase 1	hLig1|LIGI	protein_coding	P18858	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12667
1.27507764940356e-23	0.323170328134204	0.315	0.129	2.0454795651732e-19	CENPW	Malignant cells	GSE153697	ENSG00000203760	387103	centromere protein W	C6orf173|CUG2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12668
1.28018835839451e-23	0.344803961576128	0.783	0.602	2.05367816453648e-19	AURKAIP1	Malignant cells	GSE153697	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12669
1.28318129987541e-23	-0.387051542477919	0.087	0.274	2.05847944126013e-19	ARL4C	Malignant cells	GSE153697	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12670
1.50635701659144e-23	0.299335748927224	0.465	0.243	2.41649792601598e-19	NUP107	Malignant cells	GSE153697	ENSG00000111581	57122	nucleoporin 107	NUP84	protein_coding	P57740	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12671
1.71917539345988e-23	0.26989090927359	0.331	0.139	2.75790116618834e-19	AARS	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12672
1.81606760214308e-23	0.275537472414732	0.397	0.187	2.91333564735793e-19	SEC22B	Malignant cells	GSE153697	ENSG00000265808	9554	SEC22 homolog B, vesicle trafficking protein	ERS-24|SEC22L1	protein_coding	O75396	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12673
1.83090809343135e-23	0.250305952053683	0.272	0.097	2.93714276348257e-19	CXXC5	Malignant cells	GSE153697	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12674
2.03458740125284e-23	0.355733654855768	0.765	0.581	3.2638851090898e-19	TMED9	Malignant cells	GSE153697	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12675
2.0745171780609e-23	0.315751044563035	0.468	0.249	3.3279404570453e-19	ACAT1	Malignant cells	GSE153697	ENSG00000075239	38	acetyl-CoA acetyltransferase 1	ACAT|THIL	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12676
2.09881059994772e-23	0.29440695195627	0.441	0.227	3.36691196443614e-19	NSL1	Malignant cells	GSE153697	ENSG00000117697	25936	NSL1 component of MIS12 kinetochore complex	C1orf48|DC8|DKFZP566O1646|MIS14	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12677
2.32382691757226e-23	0.336342558603427	0.525	0.306	3.72788314116941e-19	LSM5	Malignant cells	GSE153697	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12678
2.34277101529606e-23	0.25654632226021	0.332	0.14	3.75827326273793e-19	EXOSC7	Malignant cells	GSE153697	ENSG00000075914	23016	exosome component 7	EAP1|hRrp42p|KIAA0116|p8|RRP42|Rrp42p	protein_coding	Q15024	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12679
2.36000368360822e-23	0.292564177700056	0.355	0.158	3.7859179092443e-19	KRCC1	Malignant cells	GSE153697	ENSG00000172086	51315	lysine rich coiled-coil 1	FLJ22333	protein_coding	Q9NPI7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12680
2.36573602043575e-23	0.280184595073856	0.43	0.212	3.79511372398304e-19	FGFR1OP2	Malignant cells	GSE153697	ENSG00000111790	26127	FGFR1 oncogene partner 2	DKFZp564O1863	protein_coding	Q9NVK5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12681
2.63266446081513e-23	0.26791054514535	0.355	0.158	4.22332032803964e-19	MINOS1	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12682
2.79757623215163e-23	-0.37236035745003	0.137	0.336	4.48787179161765e-19	TFEB	Malignant cells	GSE153697	ENSG00000112561	7942	transcription factor EB	bHLHe35|TCFEB	protein_coding	P19484	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12683
2.80193715813016e-23	-0.397181094529329	0.801	0.911	4.49486758907241e-19	CD69	Malignant cells	GSE153697	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12684
2.86221102772416e-23	0.326091410245082	0.515	0.295	4.5915589306751e-19	LAP3	Malignant cells	GSE153697	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12685
3.08387272356214e-23	0.344806951955437	0.261	0.092	4.94714862313838e-19	CENPU	Malignant cells	GSE153697	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12686
3.20632167141213e-23	-0.503949597605377	0.459	0.635	5.14358122527933e-19	AES	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12687
3.20771841022075e-23	0.378720216377934	0.879	0.721	5.14582187367612e-19	CANX	Malignant cells	GSE153697	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12688
3.47781617475739e-23	0.275755890013502	0.369	0.168	5.57911270754581e-19	SNUPN	Malignant cells	GSE153697	ENSG00000169371	10073	snurportin 1	RNUT1|SNURPORTIN-1|Snurportin1	protein_coding	O95149	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12689
3.60755968646555e-23	0.367469762906736	0.53	0.308	5.78724724902803e-19	UBASH3B	Malignant cells	GSE153697	ENSG00000154127	84959	ubiquitin associated and SH3 domain containing B	KIAA1959|STS-1|TULA-2|TULA2	protein_coding	Q8TF42	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12690
3.8726886830979e-23	0.278901207335805	0.406	0.197	6.21256718542565e-19	DNAJC11	Malignant cells	GSE153697	ENSG00000007923	55735	DnaJ heat shock protein family (Hsp40) member C11	FLJ10737	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12691
3.92020712663577e-23	0.342465902616301	0.554	0.328	6.2887962725491e-19	PIK3CD	Malignant cells	GSE153697	ENSG00000171608	5293	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta	p110D	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12692
4.12702699075575e-23	-0.368545398794611	0.907	0.952	6.62057669857037e-19	SARAF	Malignant cells	GSE153697	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12693
4.38697460459938e-23	0.256969682334694	0.263	0.094	7.03758466069833e-19	SKA2	Malignant cells	GSE153697	ENSG00000182628	348235	spindle and kinetochore associated complex subunit 2	FAM33A|FLJ12758	protein_coding	Q8WVK7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12694
4.8508615196199e-23	0.313287852083941	0.41	0.202	7.78175204977424e-19	NRM	Malignant cells	GSE153697	ENSG00000236843	11270	nurim	NRM29	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12695
5.18675776718328e-23	0.357856169139799	0.762	0.57	8.32059681011541e-19	STAG2	Malignant cells	GSE153697	ENSG00000101972	10735	stromal antigen 2	SA-2|SA2|SCC3B	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12696
5.78631820687258e-23	-0.439858587743393	0.731	0.821	9.282411667465e-19	WIPF1	Malignant cells	GSE153697	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12697
7.85412486976589e-23	-0.390693217570802	0.141	0.338	1.25995871160784e-18	PATL2	Malignant cells	GSE153697	ENSG00000282077	197135	PAT1 homolog 2	Pat1a	protein_coding	C9JE40	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12698
7.90447887891334e-23	0.319819052756268	0.935	0.817	1.26803650175528e-18	COX5B	Malignant cells	GSE153697	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12699
8.01695153436932e-23	0.441274366830019	0.673	0.497	1.28607936514353e-18	DNMT1	Malignant cells	GSE153697	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12700
1.04772649060123e-22	-0.393516218993467	0.214	0.422	1.6807628362225e-18	HIST2H2BE	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12701
1.33217785602292e-22	0.251882141645314	0.328	0.139	2.13707971663197e-18	JKAMP	Malignant cells	GSE153697	ENSG00000050130	51528	JNK1/MAPK8 associated membrane protein	C14orf100|CDA06|HSPC213|HSPC327|JAMP	protein_coding	Q9P055	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12702
1.36734980451569e-22	0.275969856205264	0.356	0.161	2.19350255640407e-18	NOL8	Malignant cells	GSE153697	ENSG00000198000	55035	nucleolar protein 8	C9orf34|FLJ20736|Nop132	protein_coding	Q76FK4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12703
1.50521847396031e-22	0.368193485350988	0.807	0.659	2.41467147592714e-18	AKR1A1	Malignant cells	GSE153697	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12704
1.5915502443634e-22	0.306754481638768	0.524	0.308	2.55316490200776e-18	NUDCD2	Malignant cells	GSE153697	ENSG00000170584	134492	NudC domain containing 2	DKFZp686E10109|NudCL2	protein_coding	Q8WVJ2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12705
1.62978073561012e-22	0.343979921296658	0.461	0.253	2.61449425606575e-18	IPO7	Malignant cells	GSE153697	ENSG00000205339	10527	importin 7	Imp7|RANBP7	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12706
1.83468766161438e-22	0.327874305176759	0.715	0.509	2.94320594676178e-18	NDUFS8	Malignant cells	GSE153697	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12707
1.84578154328265e-22	0.401557588822211	0.724	0.544	2.96100275173402e-18	MAD2L2	Malignant cells	GSE153697	ENSG00000116670	10459	mitotic arrest deficient 2 like 2	FANCV|MAD2B|POLZ2|REV7	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12708
1.92757331976697e-22	0.260240957064359	0.318	0.134	3.09221311957017e-18	MRPS33	Malignant cells	GSE153697	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12709
1.95575764486389e-22	0.280712087410363	0.451	0.239	3.13742641389065e-18	UTP18	Malignant cells	GSE153697	ENSG00000011260	51096	UTP18 small subunit processome component	CGI-48|WDR50	protein_coding	Q9Y5J1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12710
2.00023335070933e-22	0.35831816979731	0.775	0.582	3.20877434120791e-18	TCP1	Malignant cells	GSE153697	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12711
2.16027760272798e-22	0.431099272744242	0.73	0.55	3.46551733029622e-18	HSH2D	Malignant cells	GSE153697	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12712
2.27388416157408e-22	0.314859164080958	0.601	0.376	3.64776497199715e-18	TRAPPC2L	Malignant cells	GSE153697	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12713
2.2925148399625e-22	0.384524108958115	0.306	0.129	3.67765230626784e-18	CKS1B	Malignant cells	GSE153697	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12714
2.30580678298889e-22	0.29378732189063	0.52	0.298	3.69897524127078e-18	ADSL	Malignant cells	GSE153697	ENSG00000239900	158	adenylosuccinate lyase	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12715
2.31193554613312e-22	0.268702852474544	0.276	0.105	3.70880700310676e-18	CCM2	Malignant cells	GSE153697	ENSG00000136280	83605	CCM2 scaffold protein	C7orf22|MGC4607|OSM	protein_coding	Q9BSQ5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12716
2.3791557026866e-22	-0.408622930301345	0.218	0.42	3.81664157824984e-18	CRY1	Malignant cells	GSE153697	ENSG00000008405	1407	cryptochrome circadian regulator 1	PHLL1	protein_coding	Q16526	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12717
2.53945537226954e-22	0.291839284743833	0.399	0.198	4.07379430819479e-18	ZNF24	Malignant cells	GSE153697	ENSG00000172466	7572	zinc finger protein 24	KOX17|Zfp191|ZNF191|ZSCAN3	protein_coding	P17028	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12718
2.55555530929064e-22	-0.319573844838999	0.976	0.989	4.09962182716405e-18	FXYD5	Malignant cells	GSE153697	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12719
2.63642835033318e-22	0.313278282749519	0.424	0.218	4.22935835960449e-18	HSPH1	Malignant cells	GSE153697	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12720
2.6510949907365e-22	0.250820946275003	0.334	0.145	4.25288658413949e-18	ERG28	Malignant cells	GSE153697	ENSG00000133935	11161	ergosterol biosynthesis 28 homolog	C14orf1|NET51	protein_coding	Q9UKR5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12721
2.85209676716448e-22	0.302905966501553	0.292	0.116	4.57533363388525e-18	CLEC2D	Malignant cells	GSE153697	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12722
3.07073612687666e-22	0.322987294062402	0.71	0.492	4.92607489473554e-18	BCAP31	Malignant cells	GSE153697	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12723
3.08361318781538e-22	0.250404727239815	0.327	0.139	4.94673227589343e-18	VTI1B	Malignant cells	GSE153697	ENSG00000100568	10490	vesicle transport through interaction with t-SNAREs 1B	VTI2	protein_coding	Q9UEU0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12724
3.15706931421582e-22	0.283386515782129	0.342	0.153	5.06457059386503e-18	RPA3	Malignant cells	GSE153697	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12725
3.21697425662617e-22	-0.427454131920262	0.338	0.543	5.1606701024797e-18	HIST1H2AE	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12726
3.3173247926265e-22	0.25232880157585	0.349	0.156	5.32165243233143e-18	CMC1	Malignant cells	GSE153697	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12727
3.33897071288924e-22	0.289876018052435	0.508	0.288	5.35637681761692e-18	PHF5A	Malignant cells	GSE153697	ENSG00000100410	84844	PHD finger protein 5A	bK223H9.2|INI|MGC1346|Rds3|SAP14b|SF3b14b|SF3B7	protein_coding	Q7RTV0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12728
3.41672519642226e-22	0.27940707145445	0.356	0.165	5.48111056010059e-18	CERS2	Malignant cells	GSE153697	ENSG00000143418	29956	ceramide synthase 2	FLJ10243|LASS2|SP260	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12729
3.73292437385071e-22	0.297646575670972	0.468	0.257	5.98835728053132e-18	PDE6D	Malignant cells	GSE153697	ENSG00000156973	5147	phosphodiesterase 6D	JBTS22	protein_coding	O43924	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12730
3.7620081888496e-22	0.303278125784813	0.468	0.255	6.03501353655253e-18	HADH	Malignant cells	GSE153697	ENSG00000138796	3033	hydroxyacyl-CoA dehydrogenase	HADH1|HADHSC|SCHAD	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12731
4.05378969920773e-22	-0.384233615954962	0.794	0.872	6.50308943546904e-18	BZW1	Malignant cells	GSE153697	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12732
4.20731543712088e-22	0.30005726647546	0.456	0.245	6.74937542422931e-18	BRIX1	Malignant cells	GSE153697	ENSG00000113460	55299	biogenesis of ribosomes BRX1	BRIX|BXDC2|FLJ11100	protein_coding	Q8TDN6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12733
4.2452844678272e-22	0.296191417784584	0.428	0.221	6.8102853432884e-18	IWS1	Malignant cells	GSE153697	ENSG00000163166	55677	interacts with SUPT6H, CTD assembly factor 1	DKFZp761G0123|FLJ10006|FLJ14655|FLJ32319	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12734
4.25124775152339e-22	0.255070419276361	0.324	0.139	6.81985164299382e-18	DNAJA3	Malignant cells	GSE153697	ENSG00000276726	9093	DnaJ heat shock protein family (Hsp40) member A3	hTid-1|TID1	protein_coding	Q96EY1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12735
4.30244096833331e-22	0.38313279854975	0.662	0.463	6.90197580140029e-18	PGAM1	Malignant cells	GSE153697	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12736
4.3775313400944e-22	0.287559414488801	0.458	0.247	7.02243577577944e-18	PPP5C	Malignant cells	GSE153697	ENSG00000011485	5536	protein phosphatase 5 catalytic subunit	PP5|PPP5	protein_coding	P53041	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12737
4.59522873767416e-22	0.280165772999743	0.366	0.173	7.37166594097689e-18	IFRD2	Malignant cells	GSE153697	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12738
5.1754857799385e-22	0.294019426392018	0.477	0.265	8.30251428817735e-18	PSME3	Malignant cells	GSE153697	ENSG00000131467	10197	proteasome activator subunit 3	Ki|PA28-gamma|PA28G|REG-GAMMA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12739
5.5423620916089e-22	0.253141063457978	0.346	0.154	8.891057267359e-18	SART3	Malignant cells	GSE153697	ENSG00000075856	9733	spliceosome associated factor 3, U4/U6 recycling protein	KIAA0156|p110|RP11-13G14|TIP110	protein_coding	Q15020	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12740
5.73871530194838e-22	0.316630253662572	0.559	0.34	9.2060470873856e-18	NCBP2	Malignant cells	GSE153697	ENSG00000114503	22916	nuclear cap binding protein subunit 2	Cbc2|CBP20|NIP1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12741
6.35628655458075e-22	0.261623045871894	0.32	0.138	1.01967548908584e-17	GRPEL1	Malignant cells	GSE153697	ENSG00000109519	80273	GrpE like 1, mitochondrial	FLJ25609|GrpE|hMGE	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12742
7.12878098573436e-22	0.337776407906627	0.5	0.281	1.14359904573151e-17	REXO2	Malignant cells	GSE153697	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12743
7.52244508434807e-22	0.303544204421616	0.559	0.347	1.20675064043112e-17	OSGEP	Malignant cells	GSE153697	ENSG00000092094	55644	O-sialoglycoprotein endopeptidase	GCPL1|KAE1|OSGEP1|PRSMG1|TCS3	protein_coding	Q9NPF4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12744
7.92797429319347e-22	0.316851446422474	0.634	0.42	1.2718056361141e-17	THOC7	Malignant cells	GSE153697	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12745
8.90613807464389e-22	-0.339281822456695	0.107	0.293	1.42872266993437e-17	RNF11	Malignant cells	GSE153697	ENSG00000123091	26994	ring finger protein 11	CGI-123|MGC51169|Sid1669p	protein_coding	Q9Y3C5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12746
1.14361961664528e-21	0.284554319187028	0.448	0.233	1.83459458902236e-17	MYC	Malignant cells	GSE153697	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12747
1.53390860028742e-21	0.432621119307976	0.483	0.292	2.46069617658109e-17	C19orf48	Malignant cells	GSE153697	ENSG00000167747	84798	multidrug resistance-related protein	BC006151|MGC13170	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12748
1.73649726661154e-21	0.340194623539446	0.661	0.452	2.78568891509823e-17	MTF2	Malignant cells	GSE153697	ENSG00000143033	22823	metal response element binding transcription factor 2	M96|PCL2|TDRD19A	protein_coding	Q9Y483	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12749
1.89014790966985e-21	0.288021372261964	0.334	0.151	3.03217527669238e-17	CD200	Malignant cells	GSE153697	ENSG00000091972	4345	CD200 molecule	MOX1|MOX2|MRC|OX-2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12750
1.94502215386632e-21	0.278416746196346	0.376	0.182	3.12020453923235e-17	BID	Malignant cells	GSE153697	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12751
2.06591439325655e-21	0.275681880701507	0.476	0.263	3.31413986966216e-17	RPUSD3	Malignant cells	GSE153697	ENSG00000156990	285367	RNA pseudouridine synthase D3	MGC29784	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12752
2.07100965176476e-21	0.336256251076614	0.541	0.327	3.32231368336103e-17	SMC1A	Malignant cells	GSE153697	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12753
2.07462147327442e-21	-0.373715374965668	0.22	0.416	3.32810776742682e-17	VPS37B	Malignant cells	GSE153697	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12754
2.09302202604035e-21	-0.611926301377381	0.658	0.775	3.35762593417393e-17	JUNB	Malignant cells	GSE153697	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12755
2.20722027238601e-21	0.308447680526553	0.562	0.351	3.54082276096164e-17	GLRX3	Malignant cells	GSE153697	ENSG00000108010	10539	glutaredoxin 3	bA500G10.4|GLRX4|GRX3|GRX4|PICOT|TXNL2	protein_coding	O76003	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12756
2.20995041791467e-21	0.304763409592683	0.401	0.205	3.54520246041872e-17	GALNT7	Malignant cells	GSE153697	ENSG00000109586	51809	polypeptide N-acetylgalactosaminyltransferase 7	GALNAC-T7	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12757
2.35183073324064e-21	0.256714485594348	0.377	0.182	3.77280686226464e-17	TEX264	Malignant cells	GSE153697	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12758
2.53423895145933e-21	0.318167922168237	0.97	0.905	4.06542612593106e-17	YWHAB	Malignant cells	GSE153697	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12759
2.94117749134163e-21	0.368829635280452	0.715	0.517	4.71823693161024e-17	CAPRIN1	Malignant cells	GSE153697	ENSG00000135387	4076	cell cycle associated protein 1	caprin-1|GPIAP1|M11S1|RNG105	protein_coding	Q14444	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12760
3.06569669559483e-21	-0.413466418778196	0.215	0.408	4.91799063907322e-17	P2RX1	Malignant cells	GSE153697	ENSG00000108405	5023	purinergic receptor P2X 1	P2X1	protein_coding	P51575	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12761
3.07079772267729e-21	0.274907585295278	0.4	0.202	4.9261737067189e-17	MRPL19	Malignant cells	GSE153697	ENSG00000115364	9801	mitochondrial ribosomal protein L19	KIAA0104|MRP-L15|RLX1|RPML15	protein_coding	P49406	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12762
3.32170216508361e-21	0.343893889509971	0.79	0.605	5.32867461322712e-17	HM13	Malignant cells	GSE153697	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12763
3.45055442516466e-21	0.312588233289596	0.835	0.654	5.53537940884914e-17	ATP5PB	Malignant cells	GSE153697	ENSG00000116459	515	ATP synthase peripheral stalk-membrane subunit b	ATP5F1	protein_coding	P24539	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12764
3.60753157491228e-21	0.346864474855575	0.732	0.528	5.78720215247428e-17	IMPDH2	Malignant cells	GSE153697	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12765
3.65400490059793e-21	0.299424151116764	0.528	0.317	5.8617546615392e-17	VBP1	Malignant cells	GSE153697	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12766
3.88027431589506e-21	-0.332871034775098	0.168	0.362	6.22473605755885e-17	TCTA	Malignant cells	GSE153697	ENSG00000145022	6988	T cell leukemia translocation altered	NA	protein_coding	P57738	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12767
3.89069596196509e-21	0.310758417693192	0.793	0.611	6.2414544621844e-17	MEAF6	Malignant cells	GSE153697	ENSG00000163875	64769	MYST/Esa1 associated factor 6	C1orf149|CENP-28|Eaf6|FLJ11730|NY-SAR-91	protein_coding	Q9HAF1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12768
4.03173042469784e-21	0.26532153646608	0.4	0.2	6.46770194730027e-17	YIPF4	Malignant cells	GSE153697	ENSG00000119820	84272	Yip1 domain family member 4	FinGER4|MGC11061	protein_coding	Q9BSR8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12769
4.05826274373144e-21	0.307025048379654	0.518	0.314	6.51026509349397e-17	NDUFB5	Malignant cells	GSE153697	ENSG00000136521	4711	NADH:ubiquinone oxidoreductase subunit B5	CI-SGDH|MGC12314|SGDH	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12770
4.15554106971583e-21	0.326880270258565	0.67	0.477	6.66631898403813e-17	NDUFB7	Malignant cells	GSE153697	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12771
4.26767970944899e-21	-0.465940414847238	0.361	0.542	6.84621178989807e-17	LUZP1	Malignant cells	GSE153697	ENSG00000169641	7798	leucine zipper protein 1	LUZP	protein_coding	Q86V48	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12772
4.39040318591796e-21	-0.397921833697263	0.499	0.665	7.04308479084959e-17	DDX6	Malignant cells	GSE153697	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12773
4.95451925923398e-21	0.288925938965818	0.562	0.339	7.94803979566315e-17	TSPAN3	Malignant cells	GSE153697	ENSG00000140391	10099	tetraspanin 3	TM4-A|TM4SF8|TSPAN-3	protein_coding	O60637	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12774
5.00269662387135e-21	0.32549398490925	0.637	0.421	8.02532592401441e-17	POLR2I	Malignant cells	GSE153697	ENSG00000105258	5438	RNA polymerase II subunit I	hRPB14.5|RPB9	protein_coding	P36954	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12775
5.0367146777494e-21	0.345046929780622	0.597	0.4	8.07989768604559e-17	NDUFA6	Malignant cells	GSE153697	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12776
5.87781845804569e-21	-0.359944318676868	0.508	0.688	9.4291963703969e-17	MAPRE1	Malignant cells	GSE153697	ENSG00000101367	22919	microtubule associated protein RP/EB family member 1	EB1	protein_coding	Q15691	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12777
5.91406201404162e-21	0.356180159764599	0.731	0.541	9.48733828292556e-17	CCT7	Malignant cells	GSE153697	ENSG00000135624	10574	chaperonin containing TCP1 subunit 7	Ccth|Nip7-1	protein_coding	Q99832	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12778
5.96079263791609e-21	0.309906307187922	0.358	0.173	9.56230354974498e-17	RBBP8	Malignant cells	GSE153697	ENSG00000101773	5932	RB binding protein 8, endonuclease	COM1|CtIP|RIM|SCKL2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12779
6.15524814274251e-21	0.275326396540469	0.382	0.19	9.87424907058754e-17	UCHL5	Malignant cells	GSE153697	ENSG00000116750	51377	ubiquitin C-terminal hydrolase L5	CGI-70|INO80R|UCH37	protein_coding	Q9Y5K5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12780
6.33190935926581e-21	0.292844734983905	0.514	0.304	1.01576489941342e-16	DPF2	Malignant cells	GSE153697	ENSG00000133884	5977	double PHD fingers 2	BAF45d|REQ|SMARCG2|ubi-d4	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12781
6.44800215164585e-21	-0.418350395649615	0.627	0.765	1.03438850516703e-16	TMEM243	Malignant cells	GSE153697	ENSG00000135185	79161	transmembrane protein 243	C7orf23|MGC4175|MM-TRAG	protein_coding	Q9BU79	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12782
7.47002835749319e-21	0.308454222513361	0.969	0.913	1.19834194910906e-16	COX6C	Malignant cells	GSE153697	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12783
7.8595306652073e-21	-0.389421476726458	0.213	0.413	1.26082590931255e-16	TFPI	Malignant cells	GSE153697	ENSG00000003436	7035	tissue factor pathway inhibitor	EPI|LACI|TFI|TFPI1	protein_coding	P10646	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12784
8.85492571448064e-21	0.292734603101442	0.562	0.344	1.42050718311698e-16	HDDC2	Malignant cells	GSE153697	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12785
9.84511871149673e-21	0.350672003795823	0.904	0.795	1.5793539436983e-16	HSP90B1	Malignant cells	GSE153697	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12786
1.03822998992173e-20	0.354051453174516	0.659	0.463	1.66552854983244e-16	SSRP1	Malignant cells	GSE153697	ENSG00000149136	6749	structure specific recognition protein 1	FACT80	protein_coding	Q08945	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12787
1.16037979963965e-20	0.28694706262145	0.424	0.223	1.86148127458193e-16	RPA1	Malignant cells	GSE153697	ENSG00000132383	6117	replication protein A1	HSSB|REPA1|RF-A|RP-A|RPA70	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12788
1.1850085159492e-20	0.312273841809553	0.927	0.806	1.9009906612857e-16	PSMA7	Malignant cells	GSE153697	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12789
1.19667913948669e-20	-0.314557989250352	0.087	0.26	1.91971267556455e-16	WDR49	Malignant cells	GSE153697	ENSG00000174776	151790	WD repeat domain 49	FLJ33620	protein_coding	Q8IV35	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12790
1.23193256453023e-20	0.288465069244728	0.466	0.256	1.97626622001939e-16	GNG7	Malignant cells	GSE153697	ENSG00000176533	2788	G protein subunit gamma 7	FLJ00058	protein_coding	O60262	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12791
1.26187481215161e-20	0.25759439398602	0.393	0.196	2.02429957365361e-16	BLCAP	Malignant cells	GSE153697	ENSG00000166619	10904	BLCAP apoptosis inducing factor	BC10	protein_coding	P62952	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12792
1.30706068525616e-20	0.339553841177189	0.8	0.638	2.09678675128793e-16	SSB	Malignant cells	GSE153697	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12793
1.43669970993354e-20	0.259466326199343	0.439	0.235	2.30475367467538e-16	ZC3H14	Malignant cells	GSE153697	ENSG00000100722	79882	zinc finger CCCH-type containing 14	FLJ11806|NY-REN-37|UKp68	protein_coding	Q6PJT7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12794
1.51328483473056e-20	0.261820782173675	0.418	0.219	2.42761153187477e-16	MRPL2	Malignant cells	GSE153697	ENSG00000112651	51069	mitochondrial ribosomal protein L2	CGI-22|MRP-L14|RPML14	protein_coding	Q5T653	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12795
1.6453932497062e-20	0.320867378094176	0.693	0.485	2.63953985117868e-16	CAT	Malignant cells	GSE153697	ENSG00000121691	847	catalase	NA	protein_coding	P04040	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12796
1.65959091412866e-20	0.337940021438776	0.877	0.769	2.6623157444452e-16	PSMB8	Malignant cells	GSE153697	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12797
1.70179034550815e-20	0.262829142257878	0.335	0.155	2.73001207226417e-16	RPTOR	Malignant cells	GSE153697	ENSG00000141564	57521	regulatory associated protein of MTOR complex 1	KIAA1303|KOG1|Mip1|raptor	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12798
1.7508876274187e-20	0.264504439341092	0.373	0.182	2.80877393190507e-16	ACTR6	Malignant cells	GSE153697	ENSG00000075089	64431	actin related protein 6	ARP6|FLJ13433	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12799
1.80785740542506e-20	0.264837294448693	0.396	0.2	2.90016484978289e-16	DPY30	Malignant cells	GSE153697	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12800
1.95902287232941e-20	0.277335721434755	0.413	0.216	3.14266449179085e-16	PHF6	Malignant cells	GSE153697	ENSG00000156531	84295	PHD finger protein 6	BFLS|BORJ|CENP-31|KIAA1823|MGC14797	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12801
2.25546297370707e-20	0.284719448310203	0.575	0.357	3.61821370242089e-16	SSU72	Malignant cells	GSE153697	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12802
2.26877171004138e-20	-0.368665601484994	0.645	0.783	3.63956357724838e-16	TAPBP	Malignant cells	GSE153697	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12803
2.28339481017792e-20	0.366176308433445	0.614	0.425	3.66302195448742e-16	NOP56	Malignant cells	GSE153697	ENSG00000101361	10528	NOP56 ribonucleoprotein	NOL5A|SCA36	protein_coding	O00567	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12804
2.37237402914534e-20	0.365517363435045	0.73	0.57	3.80576241755496e-16	IDH2	Malignant cells	GSE153697	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12805
2.46506136581524e-20	0.300601884598398	0.628	0.406	3.95445144304081e-16	DHX15	Malignant cells	GSE153697	ENSG00000109606	1665	DEAH-box helicase 15	DBP1|DDX15|HRH2|PRP43|PRPF43|PrPp43p	protein_coding	O43143	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12806
2.51426881129585e-20	0.294913561625826	0.58	0.374	4.0333900270808e-16	TRAPPC3	Malignant cells	GSE153697	ENSG00000054116	27095	trafficking protein particle complex subunit 3	BET3	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12807
2.55267414265717e-20	0.254170299957871	0.465	0.255	4.09499985965063e-16	CIAPIN1	Malignant cells	GSE153697	ENSG00000005194	57019	cytokine induced apoptosis inhibitor 1	CIAE2	protein_coding	Q6FI81	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12808
2.55666377951283e-20	0.276026136272379	0.466	0.259	4.10140003509449e-16	WDR61	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12809
2.71387664294889e-20	0.304804818265782	0.561	0.359	4.35360091061862e-16	MED28	Malignant cells	GSE153697	ENSG00000118579	80306	mediator complex subunit 28	DKFZP434N185|EG1|magicin	protein_coding	Q9H204	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12810
2.7381644635522e-20	0.315813034039832	0.897	0.773	4.39256343243044e-16	PAIP2	Malignant cells	GSE153697	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12811
2.82217346122231e-20	0.332201427525956	0.532	0.334	4.52733066649284e-16	AHCY	Malignant cells	GSE153697	ENSG00000101444	191	adenosylhomocysteinase	AdoHcyase|SAHH	protein_coding	P23526	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12812
2.84203731579615e-20	-0.426126014875099	0.327	0.51	4.55919626200018e-16	PRNP	Malignant cells	GSE153697	ENSG00000171867	5621	prion protein	AltPrP|CD230|CJD|GSS|PRIP|PRP	protein_coding	P04156	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12813
2.94365129456044e-20	0.31677950232228	0.3	0.13	4.72220540673386e-16	CENPK	Malignant cells	GSE153697	ENSG00000123219	64105	centromere protein K	CENP-K|FKSG14|SOLT	protein_coding	Q9BS16	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12814
3.43132042072079e-20	-0.263725998511491	0.999	0.997	5.50452421892029e-16	EEF2	Malignant cells	GSE153697	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12815
4.02289235311253e-20	0.311149636253592	0.621	0.408	6.45352391286311e-16	SDHA	Malignant cells	GSE153697	ENSG00000073578	6389	succinate dehydrogenase complex flavoprotein subunit A	FP|SDH2|SDHF	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12816
4.13559206939329e-20	0.312170626474829	0.604	0.402	6.63431679772072e-16	LMAN2	Malignant cells	GSE153697	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12817
5.32452520473496e-20	0.269761941764374	0.311	0.141	8.54160333343582e-16	UQCC2	Malignant cells	GSE153697	ENSG00000137288	84300	ubiquinol-cytochrome c reductase complex assembly factor 2	bA6B20.2|C6orf125|Cbp6|M19|MGC14833|MNF1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12818
6.08609499181673e-20	0.348691144479383	0.472	0.275	9.7633135858724e-16	PRSS57	Malignant cells	GSE153697	ENSG00000185198	400668	serine protease 57	PRSSL1|UNQ782	protein_coding	Q6UWY2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12819
6.80251508170201e-20	0.275538435196994	0.356	0.174	1.09125946940664e-15	ITGB3BP	Malignant cells	GSE153697	ENSG00000142856	23421	integrin subunit beta 3 binding protein	CENPR|HSU37139|NRIF3|TAP20	protein_coding	Q13352	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12820
7.03715166088474e-20	0.313269255598661	0.452	0.259	1.12889986943913e-15	GMPS	Malignant cells	GSE153697	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12821
9.32377035681582e-20	0.299487511462995	0.606	0.401	1.49571924064039e-15	CNOT7	Malignant cells	GSE153697	ENSG00000198791	29883	CCR4-NOT transcription complex subunit 7	CAF1	protein_coding	Q9UIV1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12822
9.34761165047456e-20	0.396571338049367	0.563	0.372	1.49954386096913e-15	PTPRE	Malignant cells	GSE153697	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12823
9.73106934218273e-20	-0.344759211990994	0.277	0.47	1.56105814387295e-15	MCL1	Malignant cells	GSE153697	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12824
1.15058120781357e-19	0.333988586805071	0.693	0.496	1.84576237357452e-15	DNAJA1	Malignant cells	GSE153697	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12825
1.20171839754721e-19	-0.418053189871307	0.666	0.77	1.92779665334523e-15	HNRNPUL1	Malignant cells	GSE153697	ENSG00000105323	11100	heterogeneous nuclear ribonucleoprotein U like 1	E1B-AP5|E1BAP5|FLJ12944|HNRPUL1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12826
1.24685605353146e-19	0.278379399455331	0.432	0.236	2.00020648107517e-15	VRK1	Malignant cells	GSE153697	ENSG00000100749	7443	VRK serine/threonine kinase 1	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12827
1.37012161016974e-19	0.29744250174292	0.886	0.785	2.1979490870343e-15	NDUFB11	Malignant cells	GSE153697	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12828
1.37755188714147e-19	-0.354465029747653	0.413	0.588	2.20986873735234e-15	CCDC59	Malignant cells	GSE153697	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12829
1.56723450690449e-19	0.272830058337835	0.511	0.304	2.51415759597618e-15	CHCHD7	Malignant cells	GSE153697	ENSG00000170791	79145	coiled-coil-helix-coiled-coil-helix domain containing 7	COX23|MGC2217	protein_coding	Q9BUK0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12830
1.62450079069567e-19	0.352088867369306	0.506	0.321	2.60602416843399e-15	XBP1	Malignant cells	GSE153697	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12831
1.64931752568801e-19	0.32590328442279	1	1	2.64583517470871e-15	GAPDH	Malignant cells	GSE153697	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12832
1.72002228516912e-19	0.36313778520178	0.755	0.585	2.75925974986831e-15	NUCB2	Malignant cells	GSE153697	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12833
1.74293078199952e-19	0.3009869894994	0.587	0.379	2.79600956048364e-15	COPZ1	Malignant cells	GSE153697	ENSG00000111481	22818	COPI coat complex subunit zeta 1	CGI-120|COPZ	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12834
1.87950012294302e-19	0.259184275512714	0.413	0.219	3.01509409722519e-15	SRP54	Malignant cells	GSE153697	ENSG00000100883	6729	signal recognition particle 54	NA	protein_coding	P61011	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12835
2.28239074657991e-19	0.305764129761272	0.618	0.417	3.6614112356635e-15	TFAM	Malignant cells	GSE153697	ENSG00000108064	7019	transcription factor A, mitochondrial	TCF6|TCF6L2	protein_coding	Q00059	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12836
2.55980347766445e-19	-0.377984787136965	0.762	0.845	4.10643673886931e-15	ARHGDIA	Malignant cells	GSE153697	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12837
2.58266196412395e-19	0.290101096260449	0.525	0.325	4.14310632284763e-15	FAM162A	Malignant cells	GSE153697	ENSG00000114023	26355	family with sequence similarity 162 member A	C3orf28|E2IG5	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12838
2.69768575126813e-19	0.287000404102796	0.546	0.338	4.32762748218434e-15	LAMTOR1	Malignant cells	GSE153697	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12839
2.85696811257714e-19	0.318763456270064	0.717	0.54	4.58314824619625e-15	C1orf43	Malignant cells	GSE153697	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12840
2.86658906382602e-19	0.361647017277743	0.63	0.446	4.59858217618971e-15	GBP4	Malignant cells	GSE153697	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12841
3.0506561525541e-19	0.285387553134494	0.694	0.495	4.89386259992728e-15	PEF1	Malignant cells	GSE153697	ENSG00000162517	553115	penta-EF-hand domain containing 1	PEF1A	protein_coding	Q9UBV8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12842
3.39333653594068e-19	0.254231303455534	0.396	0.207	5.44359047095603e-15	ELP6	Malignant cells	GSE153697	ENSG00000163832	54859	elongator acetyltransferase complex subunit 6	C3orf75|FLJ20211|TMEM103	protein_coding	Q0PNE2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12843
3.44546624338728e-19	0.307097392132816	0.508	0.311	5.52721694764187e-15	MPZL1	Malignant cells	GSE153697	ENSG00000197965	9019	myelin protein zero like 1	FLJ21047|PZR	protein_coding	O95297	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12844
3.50555108966309e-19	0.308283143956003	0.706	0.507	5.62360505803753e-15	PPP1R18	Malignant cells	GSE153697	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12845
3.6753905252543e-19	-0.358247046754204	0.749	0.818	5.89606148061295e-15	ZC3H15	Malignant cells	GSE153697	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12846
3.89343882584851e-19	-0.366396997498961	0.511	0.689	6.24585456442618e-15	DDAH2	Malignant cells	GSE153697	ENSG00000226634	23564	dimethylarginine dimethylaminohydrolase 2	G6A	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12847
4.08977753764647e-19	0.251603858020287	0.351	0.173	6.56082112589246e-15	SS18L2	Malignant cells	GSE153697	ENSG00000008324	51188	SS18 like 2	KIAA-iso	protein_coding	Q9UHA2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12848
4.29480730810907e-19	0.285478894743369	0.497	0.294	6.88972988366857e-15	REST	Malignant cells	GSE153697	ENSG00000084093	5978	RE1 silencing transcription factor	DFNA27|NRSF|XBR	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12849
5.64704904582658e-19	0.333662336784525	0.366	0.189	9.05899607931499e-15	DNAJC9	Malignant cells	GSE153697	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12850
5.65205471958306e-19	0.275809184133647	0.518	0.315	9.06702618115515e-15	MRPL42	Malignant cells	GSE153697	ENSG00000198015	28977	mitochondrial ribosomal protein L42	HSPC204|MRP-L31|MRPL31|MRPS32|PTD007|RPML31	protein_coding	Q9Y6G3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12851
6.33520514927147e-19	0.288995520593985	0.508	0.315	1.01629361004613e-14	COX14	Malignant cells	GSE153697	ENSG00000178449	84987	cytochrome c oxidase assembly factor COX14	C12orf62|MGC14288	protein_coding	Q96I36	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12852
6.83937457871638e-19	0.320983802250298	0.928	0.879	1.09717246991768e-14	PGK1	Malignant cells	GSE153697	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12853
7.26677109063453e-19	-0.342994701127118	0.244	0.433	1.16573541835959e-14	RNF19A	Malignant cells	GSE153697	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12854
7.37641576718412e-19	0.257839105213964	0.413	0.224	1.18332461737168e-14	GORASP2	Malignant cells	GSE153697	ENSG00000115806	26003	golgi reassembly stacking protein 2	GOLPH6|GRASP55|GRS2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12855
7.66422102137107e-19	-0.50144339038159	0.896	0.896	1.22949433624835e-14	DBI	Malignant cells	GSE153697	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12856
8.13070543307197e-19	0.287985591387263	0.692	0.485	1.3043277655734e-14	SDHB	Malignant cells	GSE153697	ENSG00000117118	6390	succinate dehydrogenase complex iron sulfur subunit B	SDH|SDH1	protein_coding	P21912	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12857
8.70279496655325e-19	0.27533193311256	0.415	0.227	1.39610236853447e-14	PES1	Malignant cells	GSE153697	ENSG00000100029	23481	pescadillo ribosomal biogenesis factor 1	NOP7|PES	protein_coding	O00541	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12858
8.76589052972216e-19	0.312373765150973	0.493	0.298	1.40622415877803e-14	CBX5	Malignant cells	GSE153697	ENSG00000094916	23468	chromobox 5	HP1|HP1-ALPHA|HP1Hs-alpha	protein_coding	P45973	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12859
9.193120722442e-19	0.379995523947064	0.501	0.321	1.47476042629415e-14	SAE1	Malignant cells	GSE153697	ENSG00000142230	10055	SUMO1 activating enzyme subunit 1	AOS1|FLJ3091|Sua1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12860
9.27810835018223e-19	0.275636679226824	0.413	0.224	1.48839414153623e-14	ESF1	Malignant cells	GSE153697	ENSG00000089048	51575	ESF1 nucleolar pre-rRNA processing protein homolog	bA526K24.1|C20orf6	protein_coding	Q9H501	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12861
1.02720288679763e-18	0.27464681953436	0.893	0.737	1.64783887100076e-14	RTRAF	Malignant cells	GSE153697	ENSG00000087302	51637	RNA transcription, translation and transport factor	C14orf166|CGI-99|CLE|CLE7|hCLE1|LCRP369|RLLM1	protein_coding	Q9Y224	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12862
1.08024860138522e-18	0.301124494728506	0.48	0.288	1.73293480634217e-14	RCC1	Malignant cells	GSE153697	ENSG00000180198	1104	regulator of chromosome condensation 1	CHC1	protein_coding	P18754	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12863
1.14832293259657e-18	0.395579247842286	0.628	0.452	1.84213964847141e-14	NRIP1	Malignant cells	GSE153697	ENSG00000180530	8204	nuclear receptor interacting protein 1	RIP140	protein_coding	P48552	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12864
1.23062562189571e-18	0.25020854341189	0.337	0.164	1.9741696226451e-14	ADIPOR2	Malignant cells	GSE153697	ENSG00000285070	79602	adiponectin receptor 2	ACDCR2|PAQR2	protein_coding	Q86V24	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12865
1.25208589018229e-18	0.294303831885152	0.625	0.422	2.00859618503043e-14	TMEM14B	Malignant cells	GSE153697	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12866
1.25704562274152e-18	0.256691411518731	0.396	0.213	2.01655258800195e-14	TMEM167A	Malignant cells	GSE153697	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12867
1.28399286820593e-18	0.257367305202159	0.461	0.264	2.05978135917595e-14	MRPS27	Malignant cells	GSE153697	ENSG00000113048	23107	mitochondrial ribosomal protein S27	KIAA0264	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12868
1.30952530358871e-18	-0.439916112881329	0.442	0.626	2.10074049201701e-14	HIST1H2AC	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12869
1.35217617920754e-18	0.347318854390737	0.706	0.537	2.16916102668474e-14	MRPL37	Malignant cells	GSE153697	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12870
1.45686215113242e-18	0.297558658728829	0.482	0.291	2.33709826284663e-14	MEA1	Malignant cells	GSE153697	ENSG00000124733	4201	male-enhanced antigen 1	MEA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12871
1.56804125885331e-18	0.291547913703695	0.506	0.31	2.51545178745248e-14	H2AFX	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12872
1.65890577907206e-18	0.294913561625826	0.558	0.364	2.6612166507874e-14	EIF3J	Malignant cells	GSE153697	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12873
1.7290740395493e-18	-0.343520294496748	0.296	0.481	2.77378057424498e-14	UBQLN1	Malignant cells	GSE153697	ENSG00000135018	29979	ubiquilin 1	DA41|DSK2|PLIC-1|XDRP1	protein_coding	Q9UMX0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12874
1.78501596552945e-18	0.311963638691752	0.635	0.434	2.86352261190235e-14	LMAN1	Malignant cells	GSE153697	ENSG00000074695	3998	lectin, mannose binding 1	ERGIC-53|ERGIC53|F5F8D|FMFD1|gp58|MCFD1|MR60	protein_coding	P49257	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12875
1.83440190587234e-18	-0.328531421705358	0.665	0.776	2.9427475374004e-14	KIF5B	Malignant cells	GSE153697	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12876
1.83707417967517e-18	-0.451400623618275	0.261	0.447	2.94703439903491e-14	PTGER4	Malignant cells	GSE153697	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12877
1.98976585963002e-18	0.268223708439369	0.48	0.287	3.19198239201847e-14	TPRKB	Malignant cells	GSE153697	ENSG00000144034	51002	TP53RK binding protein	CGI-121|CGI121	protein_coding	Q9Y3C4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12878
2.09206093405163e-18	0.278840812444664	0.383	0.202	3.35608415040563e-14	ETS2	Malignant cells	GSE153697	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12879
2.17957247414633e-18	0.29690844359553	0.501	0.303	3.49647016302553e-14	PYCARD	Malignant cells	GSE153697	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12880
2.22354857824934e-18	0.306870466089712	0.728	0.564	3.56701662922759e-14	TOMM22	Malignant cells	GSE153697	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12881
2.30399362014727e-18	0.292600543530897	0.894	0.745	3.69606656544025e-14	DNAJC8	Malignant cells	GSE153697	ENSG00000285317	22826	DnaJ heat shock protein family (Hsp40) member C8	SPF31	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12882
2.36334577089219e-18	0.379680861303476	0.475	0.291	3.79127928566525e-14	RRP12	Malignant cells	GSE153697	ENSG00000052749	23223	ribosomal RNA processing 12 homolog	KIAA0690	protein_coding	Q5JTH9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12883
2.41828323424094e-18	0.289250700532269	0.628	0.434	3.87940996436932e-14	FAM96B	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12884
2.50914630452229e-18	0.271755481356999	0.976	0.953	4.02517250171465e-14	HNRNPA1	Malignant cells	GSE153697	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12885
2.61571745693046e-18	-0.588328258213666	0.248	0.426	4.19613394440785e-14	AL355075.4	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12886
2.77759746422537e-18	0.291859104331537	0.704	0.503	4.45582185211034e-14	FDFT1	Malignant cells	GSE153697	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12887
2.79721433607758e-18	0.278672581799964	0.48	0.283	4.48729123793565e-14	LSM4	Malignant cells	GSE153697	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12888
2.82677667764214e-18	0.252865284001957	0.449	0.256	4.53471514627352e-14	PCID2	Malignant cells	GSE153697	ENSG00000126226	55795	PCI domain containing 2	FLJ11305	protein_coding	Q5JVF3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12889
2.84236812668503e-18	0.26679424695483	0.513	0.315	4.55972694882813e-14	DRG1	Malignant cells	GSE153697	ENSG00000185721	4733	developmentally regulated GTP binding protein 1	NEDD3	protein_coding	Q9Y295	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12890
3.46744416085466e-18	-0.445080578650577	0.261	0.44	5.56247392284304e-14	HIST2H2BF	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12891
3.66694043402735e-18	0.394805020078054	0.615	0.443	5.88250584426667e-14	SIVA1	Malignant cells	GSE153697	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12892
3.80693781987002e-18	0.305816268141173	0.835	0.719	6.10708965063548e-14	DDOST	Malignant cells	GSE153697	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12893
4.06852072865829e-18	-0.446591453462105	0.527	0.673	6.52672095291363e-14	PPP1R10	Malignant cells	GSE153697	ENSG00000230995	5514	protein phosphatase 1 regulatory subunit 10	CAT53|FB19|p99|PNUTS	protein_coding	Q96QC0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12894
4.08639458553388e-18	0.293547868364359	0.813	0.644	6.55539419411345e-14	TMEM50A	Malignant cells	GSE153697	ENSG00000183726	23585	transmembrane protein 50A	SMP1	protein_coding	O95807	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12895
4.10465950207563e-18	0.298547784565418	0.782	0.603	6.58469477322972e-14	GHITM	Malignant cells	GSE153697	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12896
4.95068298535188e-18	-0.366936192885972	0.931	0.955	7.94188564510148e-14	SF1	Malignant cells	GSE153697	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12897
5.40806544570093e-18	0.300350017948719	0.569	0.377	8.67561858799343e-14	MRPL11	Malignant cells	GSE153697	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12898
6.24662321756052e-18	-0.360924557486662	0.638	0.765	1.00208329656106e-13	SLC38A2	Malignant cells	GSE153697	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12899
6.42817254038846e-18	0.282602095228389	0.954	0.84	1.03120743892912e-13	NDUFS5	Malignant cells	GSE153697	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12900
7.38478896738275e-18	0.272081003504983	0.554	0.358	1.18466784614754e-13	ERI3	Malignant cells	GSE153697	ENSG00000117419	79033	ERI1 exoribonuclease family member 3	FLJ22943|PINT1|PRNPIP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12901
7.76995608324555e-18	0.303545600757603	0.487	0.306	1.24645635487425e-13	EIF1AY	Malignant cells	GSE153697	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12902
7.96916907562692e-18	-0.301166049364833	0.168	0.347	1.27841410311207e-13	EIF2AK3	Malignant cells	GSE153697	ENSG00000172071	9451	eukaryotic translation initiation factor 2 alpha kinase 3	PEK|PERK	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12903
8.48015159607674e-18	0.274720826877785	0.662	0.459	1.36038591904263e-13	MMADHC	Malignant cells	GSE153697	ENSG00000168288	27249	metabolism of cobalamin associated D	C2orf25|cblD|CL25022	protein_coding	Q9H3L0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12904
9.31951540144838e-18	-0.357589034065437	0.621	0.746	1.49503666070035e-13	ITM2B	Malignant cells	GSE153697	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12905
9.8816942308091e-18	0.27034632537949	0.969	0.909	1.5852213885064e-13	SRSF3	Malignant cells	GSE153697	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12906
1.18018683605534e-17	-0.281789922476413	0.118	0.284	1.89325572239998e-13	ARAP2	Malignant cells	GSE153697	ENSG00000047365	116984	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	CENTD1|PARX	protein_coding	Q8WZ64	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12907
1.38559547506048e-17	0.271343699994982	0.986	0.957	2.22277226109202e-13	CD34	Malignant cells	GSE153697	ENSG00000174059	947	CD34 molecule	NA	protein_coding	P28906	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12908
1.40543784844807e-17	0.269267041138079	0.441	0.259	2.25460339648039e-13	RPS27L	Malignant cells	GSE153697	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12909
1.4670688636628e-17	-0.3777348090705	0.6	0.719	2.35347187108787e-13	PIAS1	Malignant cells	GSE153697	ENSG00000033800	8554	protein inhibitor of activated STAT 1	DDXBP1|GBP|GU/RH-II|ZMIZ3	protein_coding	O75925	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12910
1.55165853842156e-17	0.285462901494092	0.773	0.584	2.48917062733587e-13	ATXN10	Malignant cells	GSE153697	ENSG00000130638	25814	ataxin 10	ATX10|E46L|FLJ37990|SCA10	protein_coding	Q9UBB4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12911
1.69823127558365e-17	-0.356716203401071	0.706	0.815	2.72430261229129e-13	JUP	Malignant cells	GSE153697	ENSG00000173801	3728	junction plakoglobin	CTNNG|DP3|DPIII|PDGB|PG|PKGB	protein_coding	P14923	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12912
1.70416631371262e-17	0.265171732211211	0.493	0.302	2.73382360045778e-13	HAX1	Malignant cells	GSE153697	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12913
1.71766137397565e-17	0.252799780376344	0.965	0.947	2.75547237613174e-13	SNRPD2	Malignant cells	GSE153697	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12914
1.77707960930069e-17	0.291511533453885	0.937	0.853	2.85079110924017e-13	EIF3E	Malignant cells	GSE153697	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12915
1.80372494543492e-17	0.261206207886808	0.506	0.31	2.8935355574667e-13	PCCB	Malignant cells	GSE153697	ENSG00000114054	5096	propionyl-CoA carboxylase subunit beta	NA	protein_coding	P05166	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12916
1.80653080244683e-17	0.252659120897662	0.437	0.247	2.89803671328521e-13	EAF2	Malignant cells	GSE153697	ENSG00000145088	55840	ELL associated factor 2	BM040|TRAITS|U19	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12917
2.23267506593756e-17	-0.412055408535621	0.858	0.916	3.58165734077703e-13	RSRP1	Malignant cells	GSE153697	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12918
2.24851233946962e-17	0.323772616653109	0.725	0.539	3.60706349497716e-13	EBF1	Malignant cells	GSE153697	ENSG00000164330	1879	EBF transcription factor 1	COE1|EBF|OLF1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12919
2.33716760816689e-17	0.298053424335263	0.732	0.571	3.74928427702132e-13	ACP1	Malignant cells	GSE153697	ENSG00000143727	52	acid phosphatase 1	HAAP|LMW-PTP|LMWPTP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12920
2.34983222428813e-17	0.310048035745573	0.646	0.466	3.76960085420302e-13	PRPF6	Malignant cells	GSE153697	ENSG00000101161	24148	pre-mRNA processing factor 6	ANT-1|bB152O15.1|C20orf14|hPrp6|Prp6|RP60|SNRNP102|TOM|U5-102K	protein_coding	O94906	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12921
2.86276135762732e-17	0.299630585578169	0.734	0.537	4.59244176990575e-13	EID1	Malignant cells	GSE153697	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12922
2.99554806422968e-17	-0.355189471911193	0.539	0.673	4.80545820463725e-13	CAMTA1	Malignant cells	GSE153697	ENSG00000171735	23261	calmodulin binding transcription activator 1	KIAA0833	protein_coding	Q9Y6Y1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12923
3.02382125149276e-17	0.347562340888177	0.693	0.52	4.85081405164469e-13	C1QBP	Malignant cells	GSE153697	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12924
3.04216193009176e-17	0.443543740975621	0.569	0.389	4.8802361682532e-13	CYBB	Malignant cells	GSE153697	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12925
3.21601952712929e-17	0.308710894323347	0.623	0.448	5.1591385254208e-13	LSM3	Malignant cells	GSE153697	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12926
3.58963744310468e-17	0.278761278912911	0.449	0.272	5.75849638622853e-13	DLD	Malignant cells	GSE153697	ENSG00000091140	1738	dihydrolipoamide dehydrogenase	DLDH|E3|GCSL|LAD|OGDC-E3	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12927
3.70027476748287e-17	0.252865284001957	0.437	0.253	5.93598078199602e-13	NIPA2	Malignant cells	GSE153697	ENSG00000140157	81614	NIPA magnesium transporter 2	SLC57A2	protein_coding	Q8N8Q9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12928
3.71706766815254e-17	-0.338747361637269	0.214	0.387	5.9629199532503e-13	EIF2AK4	Malignant cells	GSE153697	ENSG00000128829	440275	eukaryotic translation initiation factor 2 alpha kinase 4	GCN2|KIAA1338	protein_coding	Q9P2K8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12929
3.77595594921279e-17	0.278866432497068	0.456	0.278	6.05738853372716e-13	RUVBL1	Malignant cells	GSE153697	ENSG00000284901	8607	RuvB like AAA ATPase 1	ECP54|INO80H|NMP238|Pontin52|RVB1|TIH1|TIP49|TIP49a	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12930
3.79194324132279e-17	0.255842660367115	0.496	0.304	6.08303534773001e-13	NDUFA2	Malignant cells	GSE153697	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12931
3.91838482522445e-17	0.2983986915861	0.665	0.469	6.28587293662506e-13	NGLY1	Malignant cells	GSE153697	ENSG00000151092	55768	N-glycanase 1	FLJ11005|PNG-1|PNG1	protein_coding	Q96IV0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12932
3.93289036486673e-17	0.303050353712728	0.452	0.269	6.3091427233192e-13	MYO18A	Malignant cells	GSE153697	ENSG00000196535	399687	myosin XVIIIA	KIAA0216|MysPDZ|TIAF1	protein_coding	Q92614	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12933
4.32156130433556e-17	0.292119287883615	0.406	0.229	6.93264864441511e-13	P2RY8	Malignant cells	GSE153697	ENSG00000182162	286530	P2Y receptor family member 8	P2Y8	protein_coding	Q86VZ1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12934
4.37805772467907e-17	0.253759018370533	0.459	0.271	7.02328020193016e-13	MRPS16	Malignant cells	GSE153697	ENSG00000182180	51021	mitochondrial ribosomal protein S16	CGI-132	protein_coding	Q9Y3D3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12935
4.55540446700906e-17	0.277295362538767	0.992	0.991	7.30777984597594e-13	RPL38	Malignant cells	GSE153697	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12936
4.81489506421546e-17	0.300087413450993	0.323	0.162	7.72405466201445e-13	KIF22	Malignant cells	GSE153697	ENSG00000079616	3835	kinesin family member 22	Kid|KNSL4|OBP-1|OBP-2	protein_coding	Q14807	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12937
5.12916874836387e-17	0.279488538991815	0.617	0.425	8.22821250612532e-13	C8orf59	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12938
5.48043532117371e-17	0.2677136877545	0.834	0.707	8.79171434222687e-13	NDUFB10	Malignant cells	GSE153697	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12939
5.78394114681035e-17	-0.330647796639344	0.252	0.424	9.27859838771316e-13	UBL3	Malignant cells	GSE153697	ENSG00000122042	5412	ubiquitin like 3	DKFZP434K151|FLJ32018|HCG-1|PNSC1	protein_coding	O95164	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12940
6.43899840748246e-17	0.275589558587161	0.723	0.526	1.03294412452834e-12	PPT1	Malignant cells	GSE153697	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12941
7.03778909415386e-17	-0.312000937487599	0.92	0.946	1.12900212648416e-12	SF3B1	Malignant cells	GSE153697	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12942
8.00632992700981e-17	-0.388830473553613	0.858	0.89	1.28437544689091e-12	SFPQ	Malignant cells	GSE153697	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12943
8.26345544042118e-17	-0.431474819350722	0.57	0.685	1.32562352175237e-12	DNAJB6	Malignant cells	GSE153697	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12944
8.59359533179739e-17	0.334193465604695	0.558	0.384	1.37858456312694e-12	ANP32E	Malignant cells	GSE153697	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12945
8.71221726904153e-17	-0.2891190277186	0.113	0.269	1.39761389429964e-12	WFS1	Malignant cells	GSE153697	ENSG00000109501	7466	wolframin ER transmembrane glycoprotein	DFNA14|DFNA38|DFNA6|DIDMOAD|WFS	protein_coding	O76024	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12946
9.00884908952595e-17	0.280738680965379	0.645	0.461	1.44519957094175e-12	SNX17	Malignant cells	GSE153697	ENSG00000115234	9784	sorting nexin 17	KIAA0064	protein_coding	Q15036	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12947
9.67695466555418e-17	0.295790499100184	0.624	0.436	1.5523770674482e-12	DARS	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12948
1.01988697458859e-16	0.301005446427852	0.497	0.311	1.63610268463501e-12	SERINC5	Malignant cells	GSE153697	ENSG00000164300	256987	serine incorporator 5	C5orf12|TPO1	protein_coding	Q86VE9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12949
1.0431147263011e-16	0.269495982681514	0.437	0.259	1.67336464393223e-12	BTN3A2	Malignant cells	GSE153697	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12950
1.12957956711426e-16	0.254570228662738	0.568	0.379	1.8120715415647e-12	SCAMP3	Malignant cells	GSE153697	ENSG00000263290	10067	secretory carrier membrane protein 3	C1orf3	protein_coding	O14828	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12951
1.25550691302254e-16	-0.376118781907528	0.725	0.823	2.01408418987077e-12	EIF5	Malignant cells	GSE153697	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12952
1.41554308883045e-16	0.274560126794395	0.914	0.814	2.27081422310181e-12	LDHA	Malignant cells	GSE153697	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12953
1.46333635050235e-16	-0.412194953328163	0.214	0.385	2.34748417347586e-12	HIST1H3H	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12954
1.49297429615878e-16	0.293754318318698	0.362	0.199	2.39502936589792e-12	DTYMK	Malignant cells	GSE153697	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12955
1.63457702183842e-16	-0.371998659532401	0.151	0.311	2.62218845843319e-12	FLNA	Malignant cells	GSE153697	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12956
1.7396703566499e-16	0.289029614366738	0.625	0.43	2.79077918613777e-12	KIF2A	Malignant cells	GSE153697	ENSG00000068796	3796	kinesin family member 2A	HK2|KIF2	protein_coding	O00139	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12957
1.97274161067053e-16	0.257469725289585	0.589	0.389	3.16467209183766e-12	ACADM	Malignant cells	GSE153697	ENSG00000117054	34	acyl-CoA dehydrogenase medium chain	ACAD1|MCAD|MCADH	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12958
2.57599252908539e-16	0.272845043874109	0.487	0.304	4.13240721515878e-12	RNASEH2C	Malignant cells	GSE153697	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12959
2.7710478833919e-16	0.27913475351721	0.507	0.329	4.44531501453729e-12	CTNNBL1	Malignant cells	GSE153697	ENSG00000132792	56259	catenin beta like 1	C20orf33|FLJ21108|NAP|NYD-SP19|P14|P14L	protein_coding	Q8WYA6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12960
2.89356201825617e-16	-0.291672500043064	0.88	0.908	4.64185218968654e-12	EIF4H	Malignant cells	GSE153697	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12961
3.06887074406307e-16	-0.388424259156494	0.27	0.432	4.92308244762598e-12	MIDN	Malignant cells	GSE153697	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12962
3.24410878236513e-16	0.292791944700331	0.589	0.402	5.20419930867015e-12	PLAC8	Malignant cells	GSE153697	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12963
3.29838307430004e-16	0.256245240171155	0.634	0.445	5.29126612779212e-12	RPS19BP1	Malignant cells	GSE153697	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12964
3.54247279206906e-16	0.26640355358614	0.556	0.362	5.68283485303719e-12	NDUFS2	Malignant cells	GSE153697	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12965
3.71131409521878e-16	0.273842597702117	0.894	0.777	5.95369007154997e-12	CCT2	Malignant cells	GSE153697	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12966
3.85895033200667e-16	0.275972103275381	0.607	0.424	6.1905281226051e-12	ATP5PD	Malignant cells	GSE153697	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12967
3.91676719674058e-16	0.298613260208071	0.696	0.514	6.28327793701124e-12	GTF2I	Malignant cells	GSE153697	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12968
4.25427327540821e-16	0.281770823399326	0.575	0.39	6.82470518840984e-12	USP10	Malignant cells	GSE153697	ENSG00000103194	9100	ubiquitin specific peptidase 10	KIAA0190|UBPO	protein_coding	Q14694	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12969
4.40978970584491e-16	0.283473671304233	0.986	0.972	7.0741846461164e-12	GSTP1	Malignant cells	GSE153697	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12970
4.41592459683806e-16	0.294270128023269	0.794	0.652	7.08402623824762e-12	RAD23A	Malignant cells	GSE153697	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12971
4.73538578917656e-16	0.256889615678256	0.662	0.466	7.59650588299703e-12	PSMD3	Malignant cells	GSE153697	ENSG00000108344	5709	proteasome 26S subunit, non-ATPase 3	P58|Rpn3|S3|TSTA2	protein_coding	O43242	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12972
5.75708913409028e-16	0.257964386728262	0.487	0.307	9.23552238890762e-12	MED4	Malignant cells	GSE153697	ENSG00000136146	29079	mediator complex subunit 4	DRIP36|HSPC126|TRAP36|VDRIP	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12973
6.93602886233029e-16	0.258885771862588	0.768	0.615	1.11267775009502e-11	RAB11A	Malignant cells	GSE153697	ENSG00000103769	8766	RAB11A, member RAS oncogene family	YL8	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12974
7.71440719777738e-16	-0.336863910121181	0.889	0.916	1.23754520266745e-11	BCLAF1	Malignant cells	GSE153697	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12975
8.24965323594497e-16	0.264107145633008	0.554	0.369	1.32340937211029e-11	DHPS	Malignant cells	GSE153697	ENSG00000095059	1725	deoxyhypusine synthase	MIG13	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12976
8.36123492243233e-16	-0.349935718115481	0.365	0.537	1.34130930625659e-11	LRRFIP1	Malignant cells	GSE153697	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12977
8.44069092685812e-16	0.255200693947729	0.903	0.801	1.35405563848658e-11	PSMB1	Malignant cells	GSE153697	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12978
8.47254340381788e-16	0.299431246320829	0.642	0.473	1.35916541284046e-11	PPP1CC	Malignant cells	GSE153697	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12979
8.49930050598408e-16	0.350663173795243	0.982	0.969	1.36345778716997e-11	MIF	Malignant cells	GSE153697	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12980
8.85655986440563e-16	0.25152653508515	0.625	0.43	1.42076933344795e-11	SND1	Malignant cells	GSE153697	ENSG00000197157	27044	staphylococcal nuclease and tudor domain containing 1	p100|TDRD11	protein_coding	Q7KZF4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12981
9.72124731821581e-16	0.257133714510407	0.586	0.392	1.55948249478818e-11	SSR1	Malignant cells	GSE153697	ENSG00000124783	6745	signal sequence receptor subunit 1	TRAPA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12982
1.00221467030565e-15	0.338984852389231	1	1	1.60775277410433e-11	HMGB1	Malignant cells	GSE153697	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12983
1.05833928174944e-15	0.316659800008068	0.78	0.646	1.69778787578245e-11	POLR2L	Malignant cells	GSE153697	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12984
1.12825805129691e-15	0.256116835112026	0.731	0.549	1.80995156589051e-11	UBE2L6	Malignant cells	GSE153697	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12985
1.31467090251895e-15	0.463532189004085	0.476	0.309	2.1089950618209e-11	SELL	Malignant cells	GSE153697	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12986
1.56362745993289e-15	0.269025313995731	0.82	0.701	2.50837117122434e-11	COX7B	Malignant cells	GSE153697	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12987
1.59541092158568e-15	0.269242886437616	0.427	0.253	2.55935820040775e-11	AIF1	Malignant cells	GSE153697	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12988
1.82709204234188e-15	-0.322687262789007	0.172	0.327	2.93102105432484e-11	ZFHX3	Malignant cells	GSE153697	ENSG00000140836	463	zinc finger homeobox 3	ATBF1|C16orf47|FLJ26184|ZNF927	protein_coding	Q15911	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12989
1.88766685272541e-15	0.271341833017422	0.576	0.395	3.0281951651421e-11	CEP57	Malignant cells	GSE153697	ENSG00000166037	9702	centrosomal protein 57	KIAA0092|Translokin|TSP57	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12990
1.9770298817517e-15	0.256890841308641	0.496	0.321	3.17155133630608e-11	UBL7	Malignant cells	GSE153697	ENSG00000288408	84993	ubiquitin like 7	BMSC-UbP|MGC14421	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12991
2.31772868035352e-15	0.281451829906987	0.83	0.743	3.71810034902311e-11	SNRPC	Malignant cells	GSE153697	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12992
2.34730378283702e-15	0.284838290906724	0.496	0.322	3.76554472842715e-11	ANAPC11	Malignant cells	GSE153697	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12993
2.40322425449342e-15	0.31241980139645	0.801	0.686	3.85525234905834e-11	GPX4	Malignant cells	GSE153697	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12994
3.18133993714196e-15	0.25273450764556	0.593	0.406	5.10350552716314e-11	RFC1	Malignant cells	GSE153697	ENSG00000035928	5981	replication factor C subunit 1	A1|MHCBFB|PO-GA|RFC140	protein_coding	P35251	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12995
3.30847079007933e-15	0.281997386612565	0.886	0.764	5.30744884144527e-11	RAP1B	Malignant cells	GSE153697	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12996
4.64452230712147e-15	-0.351999877631229	0.852	0.906	7.45074268508427e-11	HIF1A	Malignant cells	GSE153697	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12997
4.70063245764777e-15	-0.339084887897719	0.268	0.439	7.54075458855855e-11	HCST	Malignant cells	GSE153697	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12998
5.05003197055669e-15	0.267579727661467	0.577	0.407	8.10126128716704e-11	MRPL4	Malignant cells	GSE153697	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	12999
5.08449837350571e-15	-0.322390893777507	0.642	0.756	8.15655229077785e-11	SZRD1	Malignant cells	GSE153697	ENSG00000055070	26099	SUZ RNA binding domain containing 1	C1orf144|DKFZp566C0424	protein_coding	Q7Z422	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13000
5.37382770054692e-15	-0.267158897324366	0.211	0.375	8.62069439721736e-11	DCTN4	Malignant cells	GSE153697	ENSG00000132912	51164	dynactin subunit 4	Dyn4|p62	protein_coding	Q9UJW0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13001
6.01635678503387e-15	0.260638596035394	0.575	0.401	9.65143955455134e-11	PTDSS1	Malignant cells	GSE153697	ENSG00000156471	9791	phosphatidylserine synthase 1	KIAA0024|PSS1|PSSA	protein_coding	P48651	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13002
6.49500702778179e-15	-0.303253803540119	0.392	0.552	1.04192902739675e-10	BSDC1	Malignant cells	GSE153697	ENSG00000160058	55108	BSD domain containing 1	FLJ10276|RP4-811H24.7	protein_coding	Q9NW68	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13003
6.50423202389246e-15	-0.352401222197607	0.706	0.805	1.04340890127283e-10	ARID4B	Malignant cells	GSE153697	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13004
6.69078873724281e-15	-0.294390805116803	0.835	0.894	1.07333632922849e-10	PSAP	Malignant cells	GSE153697	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13005
6.69517496151916e-15	-0.517546483346462	0.452	0.578	1.0740399673269e-10	MYADM	Malignant cells	GSE153697	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13006
7.1947542107805e-15	-0.364664617480339	0.393	0.542	1.15418247049341e-10	ILF3-DT	Malignant cells	GSE153697	ENSG00000267100	147727	ILF3 divergent transcript	ILF3-AS1	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13007
7.20916800926913e-15	0.256486361885664	0.611	0.436	1.15649473204695e-10	SMARCA4	Malignant cells	GSE153697	ENSG00000127616	6597	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	BAF190|BRG1|FLJ39786|hSNF2b|SNF2|SNF2-BETA|SNF2L4|SNF2LB|SWI2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13008
7.4612497509618e-15	0.254708711131624	0.593	0.412	1.19693368504929e-10	HDLBP	Malignant cells	GSE153697	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13009
8.19449424808797e-15	0.282270427094336	0.663	0.5	1.31456076727827e-10	PDAP1	Malignant cells	GSE153697	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13010
8.44980051250785e-15	0.26729273268531	0.506	0.335	1.35551699821651e-10	DNMT3A	Malignant cells	GSE153697	ENSG00000119772	1788	DNA methyltransferase 3 alpha	NA	protein_coding	Q9Y6K1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13011
8.46367336922297e-15	-0.590377863181049	0.869	0.884	1.35774248189075e-10	ZFP36L1	Malignant cells	GSE153697	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13012
8.72887327047985e-15	0.251384352044523	0.332	0.181	1.40028585005038e-10	HMGB3	Malignant cells	GSE153697	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13013
8.91093696236188e-15	-0.317340825391711	0.332	0.509	1.42949250750209e-10	HERC1	Malignant cells	GSE153697	ENSG00000103657	8925	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	p532|p619	protein_coding	Q15751	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13014
1.08409579672672e-14	0.257150722264695	0.518	0.341	1.739106477109e-10	TAOK3	Malignant cells	GSE153697	ENSG00000135090	51347	TAO kinase 3	DPK|JIK|MAP3K18	protein_coding	Q9H2K8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13015
1.23396484833484e-14	0.295647082922235	0.649	0.492	1.97952640969876e-10	EIF1AX	Malignant cells	GSE153697	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13016
1.24082902182827e-14	0.251329862915719	0.489	0.325	1.99053791681691e-10	TSN	Malignant cells	GSE153697	ENSG00000211460	7247	translin	BCLF-1|REHF-1|TRSLN	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13017
1.25928384618824e-14	-0.32380128034431	0.965	0.965	2.02014314605517e-10	SRSF2	Malignant cells	GSE153697	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13018
1.27262420685454e-14	-0.281429481917242	0.854	0.914	2.04154375263605e-10	MBNL1	Malignant cells	GSE153697	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13019
1.63941893942842e-14	-0.37199214947439	0.568	0.704	2.62995586263107e-10	KDM5B	Malignant cells	GSE153697	ENSG00000117139	10765	lysine demethylase 5B	CT31|JARID1B|PLU-1|PPP1R98|RBBP2H1A	protein_coding	Q9UGL1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13020
1.7313831251495e-14	0.305306058622041	0.949	0.904	2.77748480936482e-10	PKM	Malignant cells	GSE153697	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13021
1.7805967080053e-14	0.270728387958911	0.43	0.269	2.8564332389821e-10	RIF1	Malignant cells	GSE153697	ENSG00000080345	55183	replication timing regulatory factor 1	FLJ10599|FLJ12870	protein_coding	Q5UIP0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13022
1.84735906815305e-14	-0.391474544745076	0.475	0.6	2.96353341713112e-10	ATF7IP2	Malignant cells	GSE153697	ENSG00000166669	80063	activating transcription factor 7 interacting protein 2	FLJ12668	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13023
1.88345011236527e-14	-0.331957854708831	0.697	0.781	3.02143067025636e-10	CELF2	Malignant cells	GSE153697	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13024
2.00786758684539e-14	0.26034790882853	0.83	0.696	3.22102118281737e-10	RSL1D1	Malignant cells	GSE153697	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13025
2.02471762899601e-14	-0.28946912454822	0.135	0.281	3.2480520204354e-10	OSER1-DT	Malignant cells	GSE153697	ENSG00000223891	100505783	OSER1 divergent transcript	OSER1-AS1	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13026
2.08518844456126e-14	0.252888712311059	0.859	0.734	3.34505930276517e-10	EIF3A	Malignant cells	GSE153697	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13027
2.46210094757595e-14	0.258230153294526	0.444	0.281	3.94970234010134e-10	VGLL4	Malignant cells	GSE153697	ENSG00000144560	9686	vestigial like family member 4	KIAA0121	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13028
2.55678746418073e-14	0.256507767775698	0.456	0.294	4.10159845003873e-10	LRPPRC	Malignant cells	GSE153697	ENSG00000138095	10128	leucine rich pentatricopeptide repeat containing	GP130|LRP130|LSFC	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13029
2.57092512606635e-14	0.285945731408317	0.906	0.818	4.12427808723564e-10	APRT	Malignant cells	GSE153697	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13030
2.60864838147098e-14	0.295176814782526	0.997	0.991	4.18479373355574e-10	CHCHD2	Malignant cells	GSE153697	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13031
2.6122811164482e-14	-0.381627360730178	0.435	0.575	4.1906213670062e-10	ARPC5L	Malignant cells	GSE153697	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13032
2.69709343456119e-14	0.273378361900232	0.638	0.471	4.32667728772307e-10	PSMC3	Malignant cells	GSE153697	ENSG00000165916	5702	proteasome 26S subunit, ATPase 3	RPT5|TBP-1|TBP1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13033
3.08390144073379e-14	-0.291612618623577	0.303	0.465	4.94719469122514e-10	UTY	Malignant cells	GSE153697	ENSG00000183878	7404	ubiquitously transcribed tetratricopeptide repeat containing, Y-linked	KDM6AL|KDM6C	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13034
3.29469720008145e-14	-0.311173466836358	0.2	0.353	5.28535324837066e-10	RAB11FIP1	Malignant cells	GSE153697	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13035
4.48999951552534e-14	0.255976961825228	0.604	0.438	7.20285722280576e-10	EIF6	Malignant cells	GSE153697	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13036
5.65091929207869e-14	0.269752915199887	0.735	0.573	9.06520472835263e-10	APBB1IP	Malignant cells	GSE153697	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13037
7.67228406189131e-14	0.260511098793396	0.565	0.393	1.2307878092086e-09	CCND2	Malignant cells	GSE153697	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13038
9.63811075624005e-14	-0.29794372598581	0.497	0.627	1.54614572751603e-09	MED30	Malignant cells	GSE153697	ENSG00000164758	90390	mediator complex subunit 30	THRAP6|TRAP25	protein_coding	Q96HR3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13039
1.00177680664823e-13	-0.29518674153732	0.428	0.573	1.60705035322509e-09	TGOLN2	Malignant cells	GSE153697	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13040
1.02925120214626e-13	0.264654344887715	0.585	0.418	1.65112477848304e-09	BAZ1A	Malignant cells	GSE153697	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13041
1.13276208526001e-13	-0.327011817006847	0.286	0.437	1.8171769371741e-09	SPTY2D1	Malignant cells	GSE153697	ENSG00000179119	144108	SPT2 chromatin protein domain containing 1	DKFZp686I068|FLJ39441|Spt2	protein_coding	Q68D10	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13042
1.15826075990146e-13	-0.432170129954527	0.99	0.986	1.85808191103392e-09	CD52	Malignant cells	GSE153697	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13043
1.17092706524148e-13	-0.253545964848119	0.141	0.286	1.87840119806039e-09	KMT2E-AS1	Malignant cells	GSE153697	ENSG00000239569	NA	NA	LOC100216545	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13044
1.20837313631408e-13	0.271775408332616	0.723	0.579	1.93847218527504e-09	SNRPA	Malignant cells	GSE153697	ENSG00000077312	6626	small nuclear ribonucleoprotein polypeptide A	Mud1|U1-A|U1A	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13045
1.40543528516146e-13	-0.35244483942748	0.256	0.403	2.25459928445602e-09	CD55	Malignant cells	GSE153697	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13046
1.51572625431643e-13	-0.263561095669019	0.173	0.321	2.43152805717442e-09	NDRG1	Malignant cells	GSE153697	ENSG00000104419	10397	N-myc downstream regulated 1	CAP43|DRG1|NDR1|RTP|TDD5	protein_coding	Q92597	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13047
1.5468141790955e-13	0.287329031128021	0.661	0.507	2.481399306105e-09	CARHSP1	Malignant cells	GSE153697	ENSG00000153048	23589	calcium regulated heat stable protein 1	CRHSP-24|CSDC1	protein_coding	Q9Y2V2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13048
1.55031709998446e-13	-0.265600160360662	0.945	0.947	2.48701869179507e-09	SAP18	Malignant cells	GSE153697	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13049
1.68484064730211e-13	-0.300347495249642	0.437	0.581	2.70282136640205e-09	TBRG1	Malignant cells	GSE153697	ENSG00000154144	84897	transforming growth factor beta regulator 1	FLJ14621|NIAM|TB-5	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13050
1.76532317037814e-13	0.25909275918674	0.603	0.435	2.83193142992061e-09	BTF3L4	Malignant cells	GSE153697	ENSG00000134717	91408	basic transcription factor 3 like 4	MGC23908	protein_coding	Q96K17	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13051
1.77409377003169e-13	-0.317849797862309	0.697	0.775	2.84600122588483e-09	MTPN	Malignant cells	GSE153697	ENSG00000105887	136319	myotrophin	GCDP|MYOTROPHIN|V-1	protein_coding	P58546	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13052
2.42013557202302e-13	0.264012784305413	0.939	0.869	3.88238148463933e-09	NAP1L1	Malignant cells	GSE153697	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13053
2.46696952460886e-13	0.272556541852409	0.848	0.749	3.95751251137754e-09	EIF4B	Malignant cells	GSE153697	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13054
2.58457526004376e-13	-0.280043174822348	0.569	0.694	4.1461756321622e-09	BNIP2	Malignant cells	GSE153697	ENSG00000140299	663	BCL2 interacting protein 2	BNIP-2|Nip2	protein_coding	Q12982	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13055
2.63502528909354e-13	0.263226541015152	0.493	0.33	4.22710756876386e-09	POLR2B	Malignant cells	GSE153697	ENSG00000047315	5431	RNA polymerase II subunit B	RPB2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13056
2.83699736208843e-13	0.271583703369937	0.592	0.435	4.55111116826227e-09	SRPK1	Malignant cells	GSE153697	ENSG00000096063	6732	SRSF protein kinase 1	SFRSK1	protein_coding	Q96SB4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13057
2.90294970572391e-13	0.250624807407375	0.473	0.316	4.6569119179223e-09	ZMIZ1	Malignant cells	GSE153697	ENSG00000108175	57178	zinc finger MIZ-type containing 1	FLJ13541|hZIMP10|KIAA1224|MIZ|RAI17|RP11-519K18.1|Zimp10	protein_coding	Q9ULJ6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13058
2.94799541993855e-13	-0.256529112563142	0.914	0.952	4.72917425266542e-09	UBE2D3	Malignant cells	GSE153697	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13059
3.16474431252347e-13	-0.30313690129999	0.442	0.578	5.07688282615015e-09	PCF11	Malignant cells	GSE153697	ENSG00000165494	51585	PCF11 cleavage and polyadenylation factor subunit	KIAA0824	protein_coding	O94913	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13060
3.90026684955067e-13	0.273082348554051	0.834	0.727	6.25680808004919e-09	COX5A	Malignant cells	GSE153697	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13061
4.09259659632528e-13	-0.273489417900382	0.269	0.424	6.56534345982501e-09	FRMD4B	Malignant cells	GSE153697	ENSG00000114541	23150	FERM domain containing 4B	GRSP1|KIAA1013	protein_coding	Q9Y2L6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13062
5.06656914323599e-13	0.257710572453861	0.546	0.391	8.12779021957918e-09	SHMT2	Malignant cells	GSE153697	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13063
5.25338148439524e-13	-0.30844486552374	0.246	0.408	8.42747457726684e-09	NFKBIZ	Malignant cells	GSE153697	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13064
5.26467897089825e-13	-0.313030137815735	0.315	0.455	8.44559800511497e-09	CAST	Malignant cells	GSE153697	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13065
5.59152067850904e-13	-0.392322324994197	0.446	0.565	8.9699174724642e-09	CD63	Malignant cells	GSE153697	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13066
5.69621764239245e-13	-0.331263493192746	0.889	0.928	9.13787234192596e-09	CLIC1	Malignant cells	GSE153697	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13067
6.6277829994269e-13	-0.335293985897646	0.489	0.615	1.06322894876806e-08	REL	Malignant cells	GSE153697	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13068
8.98622612636096e-13	0.266611473729374	0.945	0.935	1.44157039519082e-08	SLC25A5	Malignant cells	GSE153697	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13069
1.24747612966669e-12	0.259593451116392	0.746	0.593	2.00120120721131e-08	PNRC2	Malignant cells	GSE153697	ENSG00000189266	55629	proline rich nuclear receptor coactivator 2	NA	protein_coding	Q9NPJ4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13070
1.36732024667618e-12	-0.313884520239275	0.575	0.674	2.19345513971793e-08	RBBP6	Malignant cells	GSE153697	ENSG00000122257	5930	RB binding protein 6, ubiquitin ligase	P2P-R|PACT|SNAMA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13071
1.39473793139798e-12	-0.286916845906245	0.118	0.25	2.23743858954863e-08	HIST1H2BB	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13072
1.48366403078899e-12	0.250247634247791	0.651	0.497	2.3800938381917e-08	PLIN3	Malignant cells	GSE153697	ENSG00000105355	10226	perilipin 3	M6PRBP1|PP17|TIP47	protein_coding	O60664	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13073
1.50330259082424e-12	-0.356322854825777	0.57	0.696	2.41159801620025e-08	PCDH9	Malignant cells	GSE153697	ENSG00000184226	5101	protocadherin 9	NA	protein_coding	Q9HC56	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13074
1.53818870920408e-12	0.257585201186078	0.556	0.406	2.46756232730518e-08	SCCPDH	Malignant cells	GSE153697	ENSG00000143653	51097	saccharopine dehydrogenase (putative)	CGI-49|NET11	protein_coding	Q8NBX0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13075
1.56401673472174e-12	-0.29353811833622	0.904	0.924	2.50899564584062e-08	EIF4G2	Malignant cells	GSE153697	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13076
1.66299223442257e-12	-0.576468440318755	0.494	0.588	2.66777214246068e-08	RASD1	Malignant cells	GSE153697	ENSG00000108551	51655	ras related dexamethasone induced 1	AGS1|DEXRAS1	protein_coding	Q9Y272	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13077
1.69102836744243e-12	-0.272756431881974	0.263	0.412	2.71274770705115e-08	CDKN1B	Malignant cells	GSE153697	ENSG00000111276	1027	cyclin dependent kinase inhibitor 1B	KIP1|P27KIP1	protein_coding	P46527	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13078
1.85126585713894e-12	-0.282052157316694	0.906	0.916	2.96980068802228e-08	SEPT7	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13079
1.86451374556228e-12	-0.27200286955568	0.339	0.481	2.99105295063101e-08	NCBP3	Malignant cells	GSE153697	ENSG00000074356	55421	nuclear cap binding subunit 3	C17orf85|ELG|HSA277841	protein_coding	Q53F19	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13080
1.93993877367426e-12	0.292901978824223	0.604	0.46	3.11204978072825e-08	EGFL7	Malignant cells	GSE153697	ENSG00000172889	51162	EGF like domain multiple 7	ZNEU1	protein_coding	Q9UHF1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13081
2.8945388851723e-12	-0.27802472306718	0.666	0.762	4.64341927959341e-08	ZNF207	Malignant cells	GSE153697	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13082
3.04449971743942e-12	-0.285991856820261	0.263	0.413	4.88398644671632e-08	RIPOR2	Malignant cells	GSE153697	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13083
3.66300774131772e-12	-0.312586717201418	0.337	0.474	5.87619701862189e-08	SMCHD1	Malignant cells	GSE153697	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13084
3.7173809568635e-12	0.265296658899777	0.663	0.531	5.96342253100043e-08	SINHCAF	Malignant cells	GSE153697	ENSG00000276371	58516	SIN3-HDAC complex associated factor	C12orf14|FAM60A|TERA	protein_coding	Q9NP50	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13085
3.90092981335901e-12	-0.277989756095796	0.917	0.934	6.25787160659053e-08	PRRC2C	Malignant cells	GSE153697	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13086
4.05858816514088e-12	-0.311306867862503	0.194	0.329	6.510787134519e-08	LINC01215	Malignant cells	GSE153697	ENSG00000271856	101929623	long intergenic non-protein coding RNA 1215	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13087
4.08272998152954e-12	-0.404202545403091	0.465	0.585	6.54951543636968e-08	SOD2	Malignant cells	GSE153697	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13088
4.50088627257258e-12	-0.285589689071807	0.321	0.458	7.22032175846093e-08	CNST	Malignant cells	GSE153697	ENSG00000162852	163882	consortin, connexin sorting protein	C1orf71|FLJ32001|PPP1R64	protein_coding	Q6PJW8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13089
4.57874524215482e-12	0.258075724092351	0.827	0.715	7.34522311746477e-08	RAC2	Malignant cells	GSE153697	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13090
4.81881763863866e-12	0.330358861295316	0.341	0.209	7.73034725590414e-08	ATAD2	Malignant cells	GSE153697	ENSG00000156802	29028	ATPase family AAA domain containing 2	ANCCA|CT137|DKFZp667N1320|MGC29843|MGC5254|PRO2000	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13091
6.12385522911855e-12	0.584676280099071	0.741	0.66	9.82388855855198e-08	HMGB2	Malignant cells	GSE153697	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13092
6.32120952709727e-12	-0.260170506468244	0.189	0.323	1.01404843233694e-07	SLC2A1	Malignant cells	GSE153697	ENSG00000117394	6513	solute carrier family 2 member 1	CSE|DYT18|DYT9|GLUT|GLUT-1|GLUT1|HTLVR	protein_coding	P11166	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13093
6.60961975580933e-12	-0.28169006689841	0.365	0.503	1.06031520122693e-07	RBM33	Malignant cells	GSE153697	ENSG00000184863	155435	RNA binding motif protein 33	DKFZp434D1319|DKFZp686F102|MGC20460|PRR8	protein_coding	Q96EV2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13094
7.01290220940491e-12	-0.258266660665097	0.227	0.37	1.12500977243274e-07	AC025159.1	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13095
7.75772408227212e-12	-0.250679264988162	0.946	0.976	1.24449409727809e-07	SRSF10	Malignant cells	GSE153697	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13096
9.39542134224093e-12	-0.264121663086309	0.132	0.261	1.50721349172229e-07	HIST1H2BG	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13097
1.00478777557413e-11	0.25014041842265	0.735	0.615	1.61188054957602e-07	POLR2E	Malignant cells	GSE153697	ENSG00000099817	5434	RNA polymerase II, I and III subunit E	hRPB25|hsRPB5|RPABC1|RPB5|XAP4	protein_coding	P19388	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13098
1.62724598691737e-11	-0.292903887636872	0.52	0.643	2.61042801221284e-07	USP15	Malignant cells	GSE153697	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13099
1.93231124253647e-11	-0.303751228661271	0.496	0.598	3.099813695277e-07	WBP11	Malignant cells	GSE153697	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13100
2.36864999711053e-11	-0.449581601531838	1	1	3.79978832536471e-07	MTRNR2L12	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13101
2.38893825570953e-11	0.262092316846031	0.28	0.159	3.83233474980922e-07	ABHD4	Malignant cells	GSE153697	ENSG00000100439	63874	abhydrolase domain containing 4, N-acyl phospholipase B	FLJ12816	protein_coding	Q8TB40	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13102
2.45173647303822e-11	0.250810373504671	0.83	0.71	3.93307565004792e-07	PDIA3	Malignant cells	GSE153697	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13103
3.06329487939013e-11	-0.258031916914919	0.193	0.327	4.91413764551765e-07	TAGAP	Malignant cells	GSE153697	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13104
3.7355115800097e-11	-0.296690501448486	0.28	0.413	5.99250767665156e-07	PNPLA8	Malignant cells	GSE153697	ENSG00000135241	50640	patatin like phospholipase domain containing 8	IPLA2-2|IPLA2G|iPLA2gamma	protein_coding	Q9NP80	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13105
4.03491925743585e-11	-0.301687110935503	0.79	0.852	6.47281747277859e-07	MIR181A1HG	Malignant cells	GSE153697	ENSG00000229989	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13106
4.95417844980756e-11	-0.419701159739017	0.193	0.327	7.94749306918129e-07	LYZ	Malignant cells	GSE153697	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13107
5.00043423322781e-11	-0.261196114599097	0.189	0.321	8.02169659694405e-07	BANP	Malignant cells	GSE153697	ENSG00000172530	54971	BTG3 associated nuclear protein	BEND1|DKFZp761H172|FLJ10177|FLJ20538|SMAR1|SMARBP1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13108
7.6801610595787e-11	0.254257675123139	0.454	0.322	1.23205143717761e-06	STK38	Malignant cells	GSE153697	ENSG00000112079	11329	serine/threonine kinase 38	NDR|NDR1	protein_coding	Q15208	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13109
9.42827043183321e-11	-0.293134334028832	0.739	0.81	1.51248314267468e-06	AMD1	Malignant cells	GSE153697	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13110
1.33526001249445e-10	-0.377949641187608	0.266	0.387	2.1420241120436e-06	TSPYL2	Malignant cells	GSE153697	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13111
1.40740589685424e-10	-0.333064395291959	0.366	0.481	2.25776053973356e-06	PTPN6	Malignant cells	GSE153697	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13112
1.53522477752919e-10	0.274011945208006	0.852	0.781	2.46280758811233e-06	AFF3	Malignant cells	GSE153697	ENSG00000144218	3899	ALF transcription elongation factor 3	LAF4|MLLT2-like	protein_coding	P51826	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13113
1.544035824344e-10	-0.449281235602261	0.906	0.925	2.47694226941264e-06	IER2	Malignant cells	GSE153697	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13114
1.55871934575747e-10	-0.356308005041916	0.418	0.528	2.50049757446413e-06	LRMP	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13115
1.66305011447835e-10	-0.2501203518837	0.911	0.935	2.66786499364617e-06	ARGLU1	Malignant cells	GSE153697	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13116
2.16605223709809e-10	-0.268482668441402	0.486	0.6	3.47478099875275e-06	ARRB2	Malignant cells	GSE153697	ENSG00000141480	409	arrestin beta 2	ARR2|BARR2|DKFZp686L0365	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13117
2.23023798397433e-10	-0.313127602941883	0.501	0.603	3.57774777389162e-06	CTNNB1	Malignant cells	GSE153697	ENSG00000168036	1499	catenin beta 1	armadillo|beta-catenin|CTNNB	protein_coding	P35222	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13118
2.48875817809459e-10	-0.270783862266519	0.449	0.575	3.99246586929934e-06	BAZ2A	Malignant cells	GSE153697	ENSG00000076108	11176	bromodomain adjacent to zinc finger domain 2A	KIAA0314|TIP5|WALp3	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13119
3.66270562067038e-10	0.297765066854025	0.334	0.205	5.87571235667942e-06	NR4A2	Malignant cells	GSE153697	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13120
3.67571504438935e-10	-0.283612785793933	0.379	0.495	5.89658207420939e-06	DCP1A	Malignant cells	GSE153697	ENSG00000272886	55802	decapping mRNA 1A	HSA275986|SMAD4IP1|SMIF	protein_coding	Q9NPI6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13121
4.09474993667956e-10	-0.289324534683642	0.661	0.736	6.56879784842135e-06	ITM2C	Malignant cells	GSE153697	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13122
4.36448381474034e-10	-0.270752158561969	0.444	0.555	7.00150493560646e-06	IKZF1	Malignant cells	GSE153697	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13123
4.59061885614614e-10	0.261574244898565	0.675	0.57	7.36427076902965e-06	SMC3	Malignant cells	GSE153697	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13124
4.74396003995509e-10	-0.25497733009452	0.237	0.359	7.61026069609595e-06	PTP4A1	Malignant cells	GSE153697	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13125
6.47196314593986e-10	-0.317372112331378	0.299	0.415	1.03823232787167e-05	IDS	Malignant cells	GSE153697	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13126
8.73262935024406e-10	-0.27023232929555	0.473	0.577	1.40088840036615e-05	ASAH1	Malignant cells	GSE153697	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13127
9.82478407118444e-10	-0.296488679091212	0.411	0.525	1.57609186069941e-05	SQSTM1	Malignant cells	GSE153697	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13128
1.01027947124205e-09	-0.259191482586342	0.335	0.459	1.6206903277665e-05	RHOG	Malignant cells	GSE153697	ENSG00000177105	391	ras homolog family member G	ARHG|MGC125835|MGC125836	protein_coding	P84095	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13129
1.22522104883548e-09	-0.343008207294562	0.168	0.276	1.96549960654187e-05	SGK1	Malignant cells	GSE153697	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13130
1.60780041866412e-09	-0.261041014059228	0.492	0.589	2.57923343162098e-05	COPS2	Malignant cells	GSE153697	ENSG00000166200	9318	COP9 signalosome subunit 2	ALIEN|CSN2|TRIP15	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13131
1.6840855962775e-09	-0.278532554007863	0.301	0.419	2.70161011354836e-05	PBXIP1	Malignant cells	GSE153697	ENSG00000163346	57326	PBX homeobox interacting protein 1	HPIP	protein_coding	Q96AQ6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13132
1.85509033095883e-09	-0.253946375519709	0.359	0.488	2.97593590892416e-05	HIST1H2BC	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13133
2.39758885232784e-09	0.292643513704252	0.839	0.763	3.84621203690431e-05	SSBP2	Malignant cells	GSE153697	ENSG00000145687	23635	single stranded DNA binding protein 2	HSPC116	protein_coding	P81877	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13134
2.49691189243144e-09	-0.277253130242883	0.272	0.385	4.00554605783851e-05	LDLRAD4	Malignant cells	GSE153697	ENSG00000168675	753	low density lipoprotein receptor class A domain containing 4	C18orf1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13135
2.54092140237479e-09	-0.300670755330431	0.434	0.537	4.07614611368964e-05	RTN4	Malignant cells	GSE153697	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13136
2.57534683714579e-09	-0.269408093602813	0.386	0.501	4.13137139614927e-05	NR3C1	Malignant cells	GSE153697	ENSG00000113580	2908	nuclear receptor subfamily 3 group C member 1	GR|GRL	protein_coding	P04150	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13137
3.51606552516127e-09	-0.39912150325668	1	1	5.64047231546371e-05	MTRNR2L8	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13138
3.7560242143839e-09	-0.27690583108308	0.442	0.549	6.02541404471465e-05	SDE2	Malignant cells	GSE153697	ENSG00000143751	163859	SDE2 telomere maintenance homolog	C1orf55|FLJ35382	protein_coding	Q6IQ49	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13139
7.22511445864048e-09	-0.369718003063497	0.3	0.418	0.000115905286145511	HIST1H2BF	Malignant cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13140
1.36475112131111e-08	-0.254497760465249	0.286	0.401	0.000218933374880728	SMAD1	Malignant cells	GSE153697	ENSG00000170365	4086	SMAD family member 1	JV4-1|MADH1|MADR1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13141
1.70843211957107e-08	-0.279939129479443	0.487	0.594	0.000274066680621591	OGT	Malignant cells	GSE153697	ENSG00000147162	8473	O-linked N-acetylglucosamine (GlcNAc) transferase	FLJ23071|HRNT1|MGC22921|O-GLCNAC|OGT1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13142
3.22955710557489e-08	-0.271270351113495	0.255	0.369	0.000518085550876323	BHLHE40	Malignant cells	GSE153697	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13143
3.54547939424009e-08	-0.539680728694409	0.889	0.894	0.000568765804423995	HSPB1	Malignant cells	GSE153697	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13144
3.72696176374241e-08	-0.260008898710043	0.682	0.739	0.000597879206139557	GLUL	Malignant cells	GSE153697	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13145
3.72802943991271e-08	-0.260902649285527	0.432	0.526	0.000598050482750796	BCAS2	Malignant cells	GSE153697	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13146
5.35194431032106e-08	-0.252212503795673	0.413	0.515	0.000858558906261704	CNOT1	Malignant cells	GSE153697	ENSG00000125107	23019	CCR4-NOT transcription complex subunit 1	AD-005|CDC39|KIAA1007|NOT1|NOT1H	protein_coding	A5YKK6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13147
2.46522880909959e-07	-0.278205478323397	0.863	0.861	0.00395472005555756	BRD2	Malignant cells	GSE153697	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13148
4.43045187247716e-07	0.267288920801659	0.987	0.966	0.00710733089382785	CLTC	Malignant cells	GSE153697	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13149
6.41936252888041e-07	-0.276065657486761	0.792	0.789	0.01029794136883	HMGN3	Malignant cells	GSE153697	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13150
9.85783995287411e-07	-0.327712302141968	0.348	0.423	0.0158139468524007	TMEM156	Malignant cells	GSE153697	ENSG00000121895	80008	transmembrane protein 156	FLJ23235	protein_coding	Q8N614	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13151
5.38556299811645e-29	-0.485426827170242	0	0.3	8.63952016157841e-25	LINC01126	Physiology B cells	GSE153697	ENSG00000279873	100129726	long intergenic non-protein coding RNA 1126	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13152
6.13598704996092e-22	-0.581490308814351	0.002	0.3	9.8433504255473e-18	ANK2	Physiology B cells	GSE153697	ENSG00000145362	287	ankyrin 2	CFAP87|FAP87|LQT4	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13153
1.50218976664909e-20	-0.889612604176683	0.048	0.8	2.40981282365847e-16	AL031733.2	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13154
2.66752466780836e-19	-0.571123593256092	0.01	0.4	4.27924307209817e-15	AC004854.2	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13155
3.06813614548688e-18	-0.557416173835494	0.019	0.5	4.92190400459005e-14	AC087623.3	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13156
1.21653893781568e-17	-0.57802645351078	0.005	0.3	1.95157176404392e-13	LDLRAD3	Physiology B cells	GSE153697	ENSG00000179241	143458	low density lipoprotein receptor class A domain containing 3	LRAD3	protein_coding	Q86YD5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13157
1.37158518712841e-17	-0.371575576043353	0.005	0.3	2.2002969571914e-13	DNM1P35	Physiology B cells	GSE153697	ENSG00000246877	NA	NA	DNM1DN8-2|DNM1DN8@	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13158
1.4586745734482e-17	-0.475035221323646	0.005	0.3	2.3400057507256e-13	TRDV2	Physiology B cells	GSE153697	ENSG00000211821	NA	NA	hDV102S1|MGC117421	TR_V_gene	A0JD36	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13159
4.27206878654774e-17	-0.468148835738406	0.012	0.4	6.85325274737988e-13	TRAC	Physiology B cells	GSE153697	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13160
3.43989468802561e-15	-0.447684733178691	0.014	0.4	5.51827905853069e-11	IL10RA	Physiology B cells	GSE153697	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13161
1.00060287418089e-14	-0.368120017407134	0.007	0.3	1.60516713076098e-10	GAL3ST2	Physiology B cells	GSE153697	ENSG00000276126	64090	galactose-3-O-sulfotransferase 2	GP3ST	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13162
1.00060287418089e-14	-0.368120017407134	0.007	0.3	1.60516713076098e-10	CD40	Physiology B cells	GSE153697	ENSG00000101017	958	CD40 molecule	Bp50|p50|TNFRSF5	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13163
5.21655311483403e-14	-0.461295164697343	0.017	0.4	8.36839450681674e-10	AFDN	Physiology B cells	GSE153697	ENSG00000130396	4301	afadin, adherens junction formation factor	AF-6|AF6|MLLT4	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13164
8.4606812414331e-14	-0.812395310049363	0.063	0.7	1.3572624847507e-09	HIST1H4A	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13165
6.84552825081481e-13	-0.550610995930379	0.019	0.4	1.09815964199571e-08	TBX3	Physiology B cells	GSE153697	ENSG00000135111	6926	T-box transcription factor 3	TBX3-ISO|UMS|XHL	protein_coding	O15119	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13166
1.07714809219915e-12	-0.468148835738406	0.01	0.3	1.72796096950588e-08	CAPN10-DT	Physiology B cells	GSE153697	ENSG00000260942	NA	NA	CAPN10-AS1|locus959	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13167
4.49653558452615e-12	-2.80380391373728	0.152	0.9	7.21334238469684e-08	AC091271.1	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13168
3.90341931800843e-11	-0.361233631821894	0.012	0.3	6.26186526994912e-07	SIAE	Physiology B cells	GSE153697	ENSG00000110013	54414	sialic acid acetylesterase	CSE-C|LSE|MGC87009|YSG2	protein_coding	Q9HAT2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13169
1.33049219160979e-10	-0.851477475289912	0.043	0.5	2.13437557378042e-06	AL021453.1	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13170
2.04242680674316e-10	-0.547220406729605	0.027	0.4	3.27646108337737e-06	TFEB	Physiology B cells	GSE153697	ENSG00000112561	7942	transcription factor EB	bHLHe35|TCFEB	protein_coding	P19484	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13171
3.09172201548663e-10	-0.688538904163706	0.106	0.8	4.95974045724365e-06	IL3RA	Physiology B cells	GSE153697	ENSG00000185291	3563	interleukin 3 receptor subunit alpha	CD123	protein_coding	P26951	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13172
6.20858859663133e-10	-0.357802726421621	0.014	0.3	9.95981782671598e-06	ZNF831	Physiology B cells	GSE153697	ENSG00000124203	128611	zinc finger protein 831	C20orf174|dJ492J12.1	protein_coding	Q5JPB2	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13173
9.31448526194069e-10	-1.52379686528832	0.048	0.5	1.49422972572053e-05	LGALS1	Physiology B cells	GSE153697	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13174
4.40303461473889e-09	-0.440927367003382	0.031	0.4	7.06334812896413e-05	PAN3-AS1	Physiology B cells	GSE153697	ENSG00000261485	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13175
5.70805061676664e-09	-0.354379960780832	0.017	0.3	9.15685479941704e-05	EGR1	Physiology B cells	GSE153697	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13176
5.70805061676664e-09	-0.354379960780832	0.017	0.3	9.15685479941704e-05	SYT1	Physiology B cells	GSE153697	ENSG00000067715	6857	synaptotagmin 1	P65|SVP65|SYT	protein_coding	P21579	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13177
8.08238564717497e-09	-0.764985949662938	0.075	0.6	0.000129657630551981	AHNAK	Physiology B cells	GSE153697	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13178
9.13676002105345e-09	-0.545316696260866	0.072	0.6	0.000146571904257739	METTL15	Physiology B cells	GSE153697	ENSG00000169519	196074	methyltransferase like 15	FLJ33979|METT5D1	protein_coding	A6NJ78	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13179
1.16427183201895e-08	-0.694317947820338	0.034	0.4	0.000186772487292479	AL627171.1	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13180
1.47951390893914e-08	-0.694317947820338	0.034	0.4	0.000237343621272017	ID1	Physiology B cells	GSE153697	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13181
1.83303862468549e-08	-0.424171138677804	0.034	0.4	0.000294056056172046	JMY	Physiology B cells	GSE153697	ENSG00000152409	133746	junction mediating and regulatory protein, p53 cofactor	FLJ37870|WHAMM2	protein_coding	Q8N9B5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13182
3.08141491274297e-08	-0.45447389884133	0.019	0.3	0.000494320580302227	PIK3IP1	Physiology B cells	GSE153697	ENSG00000100100	113791	phosphoinositide-3-kinase interacting protein 1	HGFL|MGC17330|TrIP	protein_coding	Q96FE7	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13183
3.3721752653701e-08	-1.10900253735161	0.087	0.6	0.000540964356070672	IGLV3-6	Physiology B cells	GSE153697	ENSG00000253448	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13184
3.52072599517299e-08	-0.350965296368067	0.019	0.3	0.000564794864145651	ATP11A	Physiology B cells	GSE153697	ENSG00000068650	23250	ATPase phospholipid transporting 11A	ATPIH|ATPIS|KIAA1021	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13185
3.6257813792945e-08	-0.447684733178691	0.019	0.3	0.000581647848866424	ADPRHL1	Physiology B cells	GSE153697	ENSG00000153531	113622	ADP-ribosylhydrolase like 1	ARH2	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13186
3.8199156528342e-08	-0.347558694924818	0.019	0.3	0.000612790869027662	SRD5A1	Physiology B cells	GSE153697	ENSG00000145545	6715	steroid 5 alpha-reductase 1	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13187
4.1429491704675e-08	-0.344160118462953	0.019	0.3	0.000664611905926397	AC092803.2	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13188
8.11226672104704e-08	-0.896067626313982	0.039	0.4	0.00130136982739037	LMNA	Physiology B cells	GSE153697	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13189
1.25994120760437e-07	-0.620151929183456	0.041	0.4	0.00202119768523894	IQGAP3	Physiology B cells	GSE153697	ENSG00000183856	128239	IQ motif containing GTPase activating protein 3	NA	protein_coding	Q86VI3	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13190
1.59155182057384e-07	-1.10373740952953	0.164	0.8	0.00255316743056455	HIST1H2BN	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13191
1.60915489707786e-07	-0.347558694924818	0.022	0.3	0.0025814062858923	FAM117A	Physiology B cells	GSE153697	ENSG00000121104	81558	family with sequence similarity 117 member A	NA	protein_coding	Q9C073	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13192
1.73379332717053e-07	-0.340769529262179	0.022	0.3	0.00278135125544697	DHRS3	Physiology B cells	GSE153697	ENSG00000162496	9249	dehydrogenase/reductase 3	RDH17|retSDR1|Rsdr1|SDR1|SDR16C1	protein_coding	O75911	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13193
1.8093310377167e-07	-2.06460697529739	0.308	0.9	0.00290252885070513	TMEM107	Physiology B cells	GSE153697	ENSG00000179029	84314	transmembrane protein 107	JBTS29|MGC10744|MKS13	protein_coding	Q6UX40	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13194
1.87105604504864e-07	-0.523706812228718	0.041	0.4	0.00300154810746703	AL359513.1	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13195
2.1641665299012e-07	-0.33401216308687	0.022	0.3	0.0034717559472675	LAX1	Physiology B cells	GSE153697	ENSG00000122188	54900	lymphocyte transmembrane adaptor 1	FLJ20340|LAX	protein_coding	Q8IWV1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13196
2.72325199934203e-07	-0.734223695892251	0.092	0.6	0.00436864085734448	ERLIN2	Physiology B cells	GSE153697	ENSG00000147475	11160	ER lipid raft associated 2	C8orf2|Erlin-2|NET32|SPFH2|SPG18	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13197
3.06213237687117e-07	-2.0314975233535	0.154	0.7	0.00491227275897673	PTCH2	Physiology B cells	GSE153697	ENSG00000117425	8643	patched 2	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13198
3.34279282795665e-07	-0.57413953142662	0.041	0.4	0.00536250825460805	MTSS1	Physiology B cells	GSE153697	ENSG00000170873	9788	MTSS I-BAR domain containing 1	KIAA0429|MIM|MIMA|MIMB	protein_coding	O43312	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13199
4.14649647731849e-07	-0.570908410163607	0.067	0.5	0.00665180964891432	CYP2R1	Physiology B cells	GSE153697	ENSG00000186104	120227	cytochrome P450 family 2 subfamily R member 1	NA	protein_coding	Q6VVX0	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13200
4.98881525398086e-07	-0.447684733178691	0.024	0.3	0.00800305743043609	APLF	Physiology B cells	GSE153697	ENSG00000169621	200558	aprataxin and PNKP like factor	C2orf13|MGC47799|Xip1|ZCCHH1	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13201
5.56115057946468e-07	-0.754453020895047	0.092	0.6	0.00892119775957724	HCST	Physiology B cells	GSE153697	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13202
6.69640150180927e-07	-0.337386889867527	0.024	0.3	0.0107423672892024	SIPA1	Physiology B cells	GSE153697	ENSG00000213445	6494	signal-induced proliferation-associated 1	SPA1	protein_coding	Q96FS4	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13203
7.36186536264753e-07	-0.407607293803355	0.043	0.4	0.0118099044147592	SETD9	Physiology B cells	GSE153697	ENSG00000155542	133383	SET domain containing 9	C5orf35|MGC33648	protein_coding	Q8NE22	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13204
1.0473714196533e-06	-0.576805899257869	0.099	0.6	0.0168019323140782	DTX3L	Physiology B cells	GSE153697	ENSG00000163840	151636	deltex E3 ubiquitin ligase 3L	BBAP|RNF143	protein_coding	Q8TDB6	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13205
1.29778802837993e-06	-1.09181486579005	0.352	1	0.0208191155512709	CHD2	Physiology B cells	GSE153697	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13206
1.40112024904728e-06	-0.490767138400425	0.046	0.4	0.0224767710352164	CHD7	Physiology B cells	GSE153697	ENSG00000171316	55636	chromodomain helicase DNA binding protein 7	CRG|FLJ20357|FLJ20361|KIAA1416	protein_coding	Q9P2D1	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13207
1.40269156804795e-06	-0.447684733178691	0.027	0.3	0.0225019781346252	AL360012.1	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13208
1.88263698542611e-06	-0.337386889867527	0.027	0.3	0.0302012625202056	C1orf122	Physiology B cells	GSE153697	ENSG00000197982	127687	chromosome 1 open reading frame 122	FLJ45459	protein_coding	Q6ZSJ8	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13209
1.88263698542611e-06	-0.337386889867527	0.027	0.3	0.0302012625202056	ADCY7	Physiology B cells	GSE153697	ENSG00000121281	113	adenylate cyclase 7	AC7|KIAA0037	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13210
1.88263698542611e-06	-0.337386889867527	0.027	0.3	0.0302012625202056	LINC00528	Physiology B cells	GSE153697	ENSG00000269220	200298	long intergenic non-protein coding RNA 528	C22orf37|FLJ40542	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13211
2.10394385714418e-06	-1.21046766439882	0.118	0.6	0.0337514673563069	HIST1H3G	Physiology B cells	GSE153697	NA	NA	NA	NA	NA	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13212
2.51765426614055e-06	-0.790076930625769	0.113	0.6	0.0403882097374267	NAPG	Physiology B cells	GSE153697	ENSG00000134265	8774	NSF attachment protein gamma	NA	protein_coding	NA	GSE153697	GSE153697	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	NA	anti-CD19 CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	2919	Public on Dec 11, 2020	33558546	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA643723	10x genomics	CellRanger 3.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	13213
0	-0.73449514278101	0.281	0.526	0	AC012181.2	Malignant cells	GSE161195_pre	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13214
0	-0.609693531995341	0.176	0.461	0	DERL3	Malignant cells	GSE161195_pre	ENSG00000274437	91319	derlin 3	C22orf14|derlin-3|FLJ43842|IZP6|MGC71803	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13215
0	-1.94974505887521	0.468	0.72	0	IGHG1	Malignant cells	GSE161195_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13216
0	-1.5676376942908	0.18	0.557	0	IGHG2	Malignant cells	GSE161195_pre	ENSG00000274497	NA	NA	NA	IG_C_gene	P01859	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13217
0	-1.51334527077148	0.296	0.662	0	IGHG3	Malignant cells	GSE161195_pre	ENSG00000282184	NA	NA	NA	IG_C_gene	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13218
0	-2.4725466320873	0.168	0.547	0	IGHG4	Malignant cells	GSE161195_pre	ENSG00000277016	NA	NA	NA	IG_C_gene	P01861	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13219
0	0.985105898922789	0.368	0.147	0	ITGB7	Malignant cells	GSE161195_pre	ENSG00000139626	3695	integrin subunit beta 7	NA	protein_coding	P26010	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13220
0	0.564977771078857	0.272	0.035	0	LILRB4	Malignant cells	GSE161195_pre	ENSG00000278555	11006	leukocyte immunoglobulin like receptor B4	CD85k|HM18|ILT3|LIR-5|LIR5	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13221
0	0.504297078319706	0.999	0.998	0	MT-CO1	Malignant cells	GSE161195_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13222
0	0.546375209513564	1	0.998	0	MT-CO2	Malignant cells	GSE161195_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13223
0	0.896265416123859	1	0.998	0	MT-CO3	Malignant cells	GSE161195_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13224
0	-0.546310627082143	0.883	0.974	0	SSR4	Malignant cells	GSE161195_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13225
0	0.738956023983382	0.37	0.153	0	TUBA1B	Malignant cells	GSE161195_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13226
0	-2.11312108708975	0.448	0.707	0	IGHGP	Malignant cells	GSE161195_pre	ENSG00000282094	NA	NA	IGHGP1	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13227
1.08348655535958e-297	-0.531860047607613	0.337	0.58	2.00184975968236e-293	HLA-E	Malignant cells	GSE161195_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13228
2.63931547581028e-297	0.35880399618331	1	0.999	4.87639927310708e-293	MT-ND4	Malignant cells	GSE161195_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13229
1.79730314294953e-294	-0.554388694959515	0.975	0.97	3.32069728691355e-290	SNORA31	Malignant cells	GSE161195_pre	ENSG00000199477	677814	small nucleolar RNA, H/ACA box 31	ACA31|SNORA31A	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13230
3.37546704135899e-292	0.508740561300218	0.866	0.756	6.23651290561488e-288	MT-TG	Malignant cells	GSE161195_pre	ENSG00000210164	NA	NA	MTTG|trnG	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13231
2.03207543328484e-286	-0.506678359294948	0.24	0.479	3.75446257053707e-282	SEC62	Malignant cells	GSE161195_pre	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13232
8.15506189125656e-286	-0.441354127806547	0.053	0.254	1.50672923502856e-281	FCRLA	Malignant cells	GSE161195_pre	ENSG00000132185	84824	Fc receptor like A	FCRL|FCRLb|FCRLc1|FCRLc2|FCRLd|FCRLe|FCRLM1|FCRLX|FREB|MGC4595	protein_coding	Q7L513	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13233
7.71144148446679e-282	-1.33598975876113	0.108	0.32	1.42476592867009e-277	IGHM	Malignant cells	GSE161195_pre	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13234
1.75462257152089e-259	-0.436942763148816	0.127	0.337	3.24184066314199e-255	SEL1L3	Malignant cells	GSE161195_pre	ENSG00000091490	23231	SEL1L family member 3	KIAA0746	protein_coding	Q68CR1	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13235
1.72458551799024e-256	-0.616537067330675	0.605	0.76	3.18634420303877e-252	XBP1	Malignant cells	GSE161195_pre	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13236
1.16824602612627e-254	0.471663917164632	0.455	0.26	2.1584513578709e-250	COX6C	Malignant cells	GSE161195_pre	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13237
3.86315701536016e-248	-0.485538510790986	0.792	0.854	7.13756890157943e-244	TPT1	Malignant cells	GSE161195_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13238
5.0093981960481e-232	0.554543994740719	0.505	0.33	9.25536410701848e-228	PPIA	Malignant cells	GSE161195_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13239
4.71731886059836e-231	0.517809782122779	0.688	0.529	8.71571832684154e-227	TMSB10	Malignant cells	GSE161195_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13240
8.88213668413879e-231	-0.532689430557498	0.269	0.48	1.64106357376148e-226	ITM2B	Malignant cells	GSE161195_pre	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13241
3.13595659459123e-223	-0.438808004012965	0.122	0.311	5.79399340416675e-219	MTRNR2L1	Malignant cells	GSE161195_pre	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13242
2.74767524069797e-220	0.38848336902211	0.357	0.184	5.07660477471357e-216	RAN	Malignant cells	GSE161195_pre	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13243
1.45497376658754e-219	-0.42925511325126	0.243	0.453	2.68820953114715e-215	SLAMF7	Malignant cells	GSE161195_pre	ENSG00000026751	57823	SLAM family member 7	19A|CD319|CRACC|CS1	protein_coding	Q9NQ25	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13244
2.75270287421888e-215	-0.306924897167386	0.078	0.252	5.08589383040681e-211	ADA2	Malignant cells	GSE161195_pre	ENSG00000093072	51816	adenosine deaminase 2	ADGF|CECR1|IDGFL	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13245
3.41665090595765e-215	0.403334239623095	0.376	0.201	6.31260421384736e-211	LDHA	Malignant cells	GSE161195_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13246
3.76815035133554e-214	0.339327915678832	0.938	0.865	6.96203458912754e-210	RPLP0	Malignant cells	GSE161195_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13247
5.1355490565957e-210	-1.94839149001035	0.485	0.6	9.48844043696622e-206	IGLC3	Malignant cells	GSE161195_pre	ENSG00000211679	NA	NA	IGLC	IG_C_gene	P0DOY3	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13248
2.72763911793066e-208	-0.447409321659393	0.61	0.752	5.03958603428869e-204	CD74	Malignant cells	GSE161195_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13249
5.59312189201914e-205	-0.413388893561982	0.171	0.363	1.03338520076946e-200	BTG2	Malignant cells	GSE161195_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13250
3.27396770422985e-197	-0.373826981965669	0.153	0.336	6.04898273033507e-193	HERPUD1	Malignant cells	GSE161195_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13251
4.2394991347988e-193	0.493640851354941	0.531	0.376	7.83289860145427e-189	GAPDH	Malignant cells	GSE161195_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13252
9.57703354377276e-193	0.28026548724361	0.322	0.163	1.76945271754746e-188	IGHA2	Malignant cells	GSE161195_pre	ENSG00000276173	NA	NA	NA	IG_C_gene	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13253
1.1648319696002e-190	-0.351868937086479	0.336	0.534	2.15214354703333e-186	AC034236.1	Malignant cells	GSE161195_pre	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13254
1.06231111409768e-181	-1.34699561326697	0.628	0.696	1.96272601440687e-177	IGLC2	Malignant cells	GSE161195_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13255
2.92660371073089e-176	-0.393485512049005	0.689	0.777	5.40719301594639e-172	RPL3P4	Malignant cells	GSE161195_pre	ENSG00000232573	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13256
3.38876693702608e-173	0.354527471103028	0.893	0.805	6.26108579284938e-169	RPL38	Malignant cells	GSE161195_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13257
5.39407380260014e-172	-0.285404452768691	0.108	0.27	9.96609075768402e-168	ST6GAL1	Malignant cells	GSE161195_pre	ENSG00000073849	6480	ST6 beta-galactoside alpha-2,6-sialyltransferase 1	CDw75|SIAT1	protein_coding	P15907	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13258
4.11577603923534e-168	-0.356318760083812	0.342	0.529	7.60430781009122e-164	PSAP	Malignant cells	GSE161195_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13259
1.16428341869201e-166	-0.945480457708012	0.182	0.33	2.15113004437536e-162	IGLJ2	Malignant cells	GSE161195_pre	ENSG00000211676	NA	NA	NA	IG_J_gene	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13260
1.96331994363653e-166	-0.678379067538379	0.176	0.333	3.62742992786285e-162	CCND1	Malignant cells	GSE161195_pre	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13261
1.97465353368093e-162	-0.299714078190314	0.099	0.259	3.64836986882888e-158	LINC01781	Malignant cells	GSE161195_pre	ENSG00000234184	101927412	long intergenic non-protein coding RNA 1781	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13262
2.53191609151722e-162	0.297747259415305	0.303	0.16	4.67796817068721e-158	RPS24P8	Malignant cells	GSE161195_pre	ENSG00000224094	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13263
2.80915785457035e-159	0.365777308939243	0.293	0.155	5.19020005210418e-155	H2AFZ	Malignant cells	GSE161195_pre	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13264
1.65350823854329e-156	-0.255148353590814	0.878	0.957	3.05502182153259e-152	BLOC1S5-TXNDC5	Malignant cells	GSE161195_pre	ENSG00000259040	NA	NA	MUTED-TXNDC5	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13265
1.81182771799903e-156	-0.295038567541348	0.127	0.285	3.34753289177501e-152	PECAM1	Malignant cells	GSE161195_pre	ENSG00000261371	5175	platelet and endothelial cell adhesion molecule 1	CD31	protein_coding	P16284	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13266
2.82987148469952e-156	0.750632412802101	0.291	0.163	5.22847055513083e-152	HIST1H4C	Malignant cells	GSE161195_pre	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13267
2.75229069286378e-152	0.335115006908602	0.91	0.843	5.08513228413511e-148	RPL27	Malignant cells	GSE161195_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13268
9.6535333478653e-145	-0.308888944729796	0.189	0.352	1.78358682135159e-140	DNAJB9	Malignant cells	GSE161195_pre	ENSG00000128590	4189	DnaJ heat shock protein family (Hsp40) member B9	MDG1	protein_coding	Q9UBS3	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13269
3.75251206770384e-137	0.287451335130876	0.251	0.129	6.93314129628961e-133	ENO1	Malignant cells	GSE161195_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13270
9.03101134939571e-136	0.282287168534363	0.271	0.145	1.66856965691435e-131	NDUFB9	Malignant cells	GSE161195_pre	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13271
2.39691397226525e-132	-0.311968015554253	0.167	0.312	4.42853825515727e-128	NOP53	Malignant cells	GSE161195_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13272
1.48036855662085e-128	-0.328897487255835	0.804	0.853	2.73512894521267e-124	RPS25	Malignant cells	GSE161195_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13273
1.60080823593523e-127	0.250750660929041	0.996	0.993	2.95765329671393e-123	MT-ND1	Malignant cells	GSE161195_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13274
1.29228458053683e-124	-0.260601584053408	0.169	0.312	2.38762499099985e-120	POU2AF1	Malignant cells	GSE161195_pre	ENSG00000110777	5450	POU class 2 homeobox associating factor 1	BOB1|OBF1|OCA-B	protein_coding	Q16633	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13275
1.96585851453384e-123	0.329896322117088	0.436	0.304	3.63212019145272e-119	YBX1	Malignant cells	GSE161195_pre	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13276
1.80128194017169e-119	-0.335906969638033	0.889	0.977	3.32804851266122e-115	HLA-B	Malignant cells	GSE161195_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13277
3.15563805473642e-113	0.304796621112863	0.653	0.545	5.83035686993101e-109	MTCO1P12	Malignant cells	GSE161195_pre	ENSG00000237973	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13278
2.71582330484879e-112	-0.273952931787109	0.207	0.352	5.01775513803863e-108	AC134669.2	Malignant cells	GSE161195_pre	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13279
3.41029830938764e-111	-0.4125476824286	0.922	0.919	6.3008671564246e-107	RPS14	Malignant cells	GSE161195_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13280
3.88347518954193e-111	-0.288656867240393	0.231	0.375	7.17510876019767e-107	HDLBP	Malignant cells	GSE161195_pre	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13281
1.64515026736277e-107	0.288403073111462	0.301	0.186	3.03957963397946e-103	ATP5J2	Malignant cells	GSE161195_pre	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13282
2.99279007531494e-106	-0.253998909925986	0.3	0.457	5.52947894315188e-102	FAM46C	Malignant cells	GSE161195_pre	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13283
1.81632843236684e-98	0.29807018975818	0.754	0.674	3.35584841164098e-94	HLA-A	Malignant cells	GSE161195_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13284
4.00359901395897e-97	-0.324491689878907	0.446	0.574	7.39704953819059e-93	FKBP11	Malignant cells	GSE161195_pre	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13285
8.94413124532042e-96	0.311067966710391	0.711	0.628	1.6525176888854e-91	MTCO2P12	Malignant cells	GSE161195_pre	ENSG00000229344	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13286
1.31985181016828e-93	-0.250724629279099	0.29	0.432	2.43855820446692e-89	NUCB2	Malignant cells	GSE161195_pre	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13287
6.25807146113543e-89	0.28989995527375	0.63	0.531	1.15624128315938e-84	ATP5E	Malignant cells	GSE161195_pre	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13288
2.59999452779744e-88	-0.28228604266397	0.425	0.549	4.80374988955854e-84	RPL36AL	Malignant cells	GSE161195_pre	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13289
9.85978885995257e-85	0.320969729464067	0.512	0.402	1.82169458976484e-80	ACTG1	Malignant cells	GSE161195_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13290
1.12269663062946e-84	0.505871825534546	0.901	0.871	2.07429429475099e-80	FTL	Malignant cells	GSE161195_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13291
5.27313474469877e-84	-0.289274710753863	0.319	0.443	9.74264375430545e-80	SEL1L	Malignant cells	GSE161195_pre	ENSG00000071537	6400	SEL1L adaptor subunit of ERAD E3 ubiquitin ligase	Hrd3|IBD2|SEL1L1	protein_coding	Q9UBV2	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13292
1.00412101222567e-83	-0.32184206261395	0.186	0.312	1.85521398218814e-79	FRZB	Malignant cells	GSE161195_pre	ENSG00000162998	2487	frizzled related protein	FRE|FRITZ|FRP-3|FRZB-1|FRZB-PEN|FRZB1|FZRB|hFIZ|SFRP3|SRFP3	protein_coding	Q92765	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13293
5.77419686908919e-79	0.577441536908225	0.346	0.256	1.06684061353292e-74	TMSB4X	Malignant cells	GSE161195_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13294
3.36761526224162e-78	0.270793395766896	0.345	0.246	6.22200595851761e-74	CHCHD2	Malignant cells	GSE161195_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13295
7.61987854490318e-77	0.285626460410944	0.749	0.694	1.40784875995631e-72	SUB1	Malignant cells	GSE161195_pre	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13296
8.04200697537243e-76	-0.605314117077952	0.819	0.866	1.48584120876981e-71	IGLC1	Malignant cells	GSE161195_pre	ENSG00000211675	NA	NA	IGLC	IG_C_gene	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13297
2.15579090331175e-75	-0.29950581802555	0.331	0.444	3.98303927295879e-71	SNORD35A	Malignant cells	GSE161195_pre	ENSG00000200259	26816	small nucleolar RNA, C/D box 35A	RNU35|RNU35A|U35	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13298
9.88478889446897e-74	0.259248991625884	0.531	0.432	1.82631359614209e-69	NME2	Malignant cells	GSE161195_pre	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13299
3.82051792312801e-61	0.318901878336396	0.365	0.279	7.0587889147713e-57	HSP90AA1	Malignant cells	GSE161195_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13300
3.20154650397219e-60	0.304546744837268	0.54	0.47	5.91517732073902e-56	PTMA	Malignant cells	GSE161195_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13301
5.85957269511094e-60	0.254007561848988	0.322	0.236	1.0826146511487e-55	CALM2	Malignant cells	GSE161195_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13302
1.36105267621198e-59	-0.267095080043565	0.35	0.459	2.51468092456926e-55	CYBA	Malignant cells	GSE161195_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13303
1.61583629762512e-55	0.274301683916779	0.498	0.429	2.98541914349218e-51	OAZ1	Malignant cells	GSE161195_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13304
3.79329317999502e-48	0.272573199819648	0.899	0.877	7.0084884793588e-44	RPS29	Malignant cells	GSE161195_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13305
1.04032801381206e-46	0.253407834626064	0.517	0.456	1.92211003831915e-42	MIF	Malignant cells	GSE161195_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13306
3.51874757197403e-33	0.399787727723353	0.357	0.316	6.50123801397922e-29	MYDGF	Malignant cells	GSE161195_pre	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13307
4.17379316247653e-32	-0.342671380035554	0.92	0.936	7.71150024699163e-28	HSP90B1	Malignant cells	GSE161195_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13308
4.56691669861458e-32	-0.286093469368471	0.641	0.659	8.4378352923603e-28	RPS2	Malignant cells	GSE161195_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13309
6.95707720891745e-24	-0.30437561934934	0.565	0.619	1.28538958511959e-19	HSPA5	Malignant cells	GSE161195_pre	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	13310
0	-0.737716250337199	0.371	0.706	0	SDF4	Malignant cells	GSE161801_IMiD_post	ENSG00000078808	51150	stromal cell derived factor 4	Cab45	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13311
0	-0.471488990701107	0.645	0.784	0	PARK7	Malignant cells	GSE161801_IMiD_post	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13312
0	-0.498618006431222	0.475	0.702	0	ENO1	Malignant cells	GSE161801_IMiD_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13313
0	-0.517622981554065	0.608	0.825	0	DDOST	Malignant cells	GSE161801_IMiD_post	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13314
0	-0.448386749164707	0.362	0.608	0	PSMB2	Malignant cells	GSE161801_IMiD_post	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13315
0	0.468421339248624	1	0.998	0	RPS8	Malignant cells	GSE161801_IMiD_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13316
0	-0.423090897579936	0.231	0.501	0	SARS	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13317
0	-0.515697474591592	0.199	0.527	0	PSMA5	Malignant cells	GSE161801_IMiD_post	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13318
0	0.52747421670671	0.613	0.265	0	MRPS21	Malignant cells	GSE161801_IMiD_post	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13319
0	-0.536451086037923	0.584	0.763	0	HAX1	Malignant cells	GSE161801_IMiD_post	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13320
0	-0.4246311794905	0.158	0.441	0	SLC50A1	Malignant cells	GSE161801_IMiD_post	ENSG00000169241	55974	solute carrier family 50 member 1	HsSWEET1|RAG1AP1|RP11-540D14.5|RZPDo834D038D|SCP|slv|SWEET1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13321
0	-0.603967379594219	0.855	0.96	0	KRTCAP2	Malignant cells	GSE161801_IMiD_post	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13322
0	-0.857223782748472	0.878	0.951	0	SSR2	Malignant cells	GSE161801_IMiD_post	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13323
0	0.993469675030514	0.682	0.151	0	FCRL5	Malignant cells	GSE161801_IMiD_post	ENSG00000143297	83416	Fc receptor like 5	BXMAS1|CD307e|FCRH5|IRTA2	protein_coding	Q96RD9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13324
0	0.728192531443595	0.432	0.03	0	FCGR2B	Malignant cells	GSE161801_IMiD_post	ENSG00000072694	2213	Fc gamma receptor IIb	CD32|CD32B|FCG2|FcgammaRIIb|FCGR2|FcGRIIB	protein_coding	P31994	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13325
0	1.93600020051758	0.644	0.036	0	FCRLA	Malignant cells	GSE161801_IMiD_post	ENSG00000132185	84824	Fc receptor like A	FCRL|FCRLb|FCRLc1|FCRLc2|FCRLd|FCRLe|FCRLM1|FCRLX|FREB|MGC4595	protein_coding	Q7L513	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13326
0	-0.341893524105177	0.161	0.403	0	TSEN15	Malignant cells	GSE161801_IMiD_post	ENSG00000198860	116461	tRNA splicing endonuclease subunit 15	C1orf19	protein_coding	Q8WW01	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13327
0	0.634163851725719	0.772	0.526	0	BTG2	Malignant cells	GSE161801_IMiD_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13328
0	-1.30796753346291	0.084	0.395	0	ATF3	Malignant cells	GSE161801_IMiD_post	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13329
0	0.521900758989818	0.968	0.907	0	H3F3A	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13330
0	-0.879393953629211	0.886	0.954	0	PDIA6	Malignant cells	GSE161801_IMiD_post	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13331
0	-1.4800462298507	0.571	0.792	0	SDC1	Malignant cells	GSE161801_IMiD_post	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13332
0	-0.509725158845501	0.618	0.863	0	ATRAID	Malignant cells	GSE161801_IMiD_post	ENSG00000138085	51374	all-trans retinoic acid induced differentiation factor	APR3|C2orf28|HSPC013|p18	protein_coding	Q6UW56	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13333
0	-0.548478985083337	0.185	0.488	0	MTHFD2	Malignant cells	GSE161801_IMiD_post	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13334
0	-0.786201901220854	0.952	1	0	TMSB10	Malignant cells	GSE161801_IMiD_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13335
0	-0.386556000792352	0.37	0.686	0	CYTOR	Malignant cells	GSE161801_IMiD_post	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13336
0	0.849759049278298	0.996	0.948	0	RPL31	Malignant cells	GSE161801_IMiD_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13337
0	1.69514811014804	0.929	0.462	0	FRZB	Malignant cells	GSE161801_IMiD_post	ENSG00000162998	2487	frizzled related protein	FRE|FRITZ|FRP-3|FRZB-1|FRZB-PEN|FRZB1|FZRB|hFIZ|SFRP3|SRFP3	protein_coding	Q92765	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13338
0	-0.841273307084036	0.359	0.625	0	HSPD1	Malignant cells	GSE161801_IMiD_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13339
0	-0.303365917354357	0.056	0.261	0	SPATS2L	Malignant cells	GSE161801_IMiD_post	ENSG00000196141	26010	spermatogenesis associated serine rich 2 like	DNAPTP6|SGNP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13340
0	1.09882019267532	0.365	0.023	0	IL5RA	Malignant cells	GSE161801_IMiD_post	ENSG00000091181	3568	interleukin 5 receptor subunit alpha	CD125|CDw125|IL5R	protein_coding	Q01344	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13341
0	-0.565677190639335	0.758	0.897	0	MANF	Malignant cells	GSE161801_IMiD_post	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13342
0	0.542312771615177	0.379	0.021	0	LSAMP	Malignant cells	GSE161801_IMiD_post	ENSG00000185565	4045	limbic system associated membrane protein	IGLON3|LAMP	protein_coding	Q13449	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13343
0	1.0689521174068	0.945	0.703	0	SEC62	Malignant cells	GSE161801_IMiD_post	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13344
0	0.532785445514758	0.474	0.152	0	GPR160	Malignant cells	GSE161801_IMiD_post	ENSG00000173890	26996	G protein-coupled receptor 160	GPCR1|GPCR150	protein_coding	Q9UJ42	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13345
0	-1.07351910007291	0.477	0.831	0	LRPAP1	Malignant cells	GSE161801_IMiD_post	ENSG00000163956	4043	LDL receptor related protein associated protein 1	A2MRAP|HBP44|RAP	protein_coding	P30533	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13346
0	0.54423419750467	0.53	0.284	0	CD38	Malignant cells	GSE161801_IMiD_post	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13347
0	-1.3060353913391	0.176	0.524	0	UCHL1	Malignant cells	GSE161801_IMiD_post	ENSG00000154277	7345	ubiquitin C-terminal hydrolase L1	PARK5|PGP9.5|Uch-L1|UCHL-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13348
0	0.509481620558514	0.345	0.083	0	PLAC8	Malignant cells	GSE161801_IMiD_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13349
0	-0.439235595210216	0.662	0.824	0	OSTC	Malignant cells	GSE161801_IMiD_post	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13350
0	0.566658247847815	0.589	0.341	0	FBXW7	Malignant cells	GSE161801_IMiD_post	ENSG00000109670	55294	F-box and WD repeat domain containing 7	AGO|CDC4|FBW7|FBX30|FBXW6|FLJ11071|SEL-10|SEL10	protein_coding	Q969H0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13351
0	-0.517202843470678	0.177	0.532	0	AGA	Malignant cells	GSE161801_IMiD_post	ENSG00000038002	175	aspartylglucosaminidase	ASRG	protein_coding	P20933	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13352
0	-0.692267260812761	0.159	0.401	0	ANKRD37	Malignant cells	GSE161801_IMiD_post	ENSG00000186352	353322	ankyrin repeat domain 37	Lrp2bp	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13353
0	0.48129467454945	0.996	0.997	0	RPL37	Malignant cells	GSE161801_IMiD_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13354
0	0.765763728074556	0.998	0.996	0	RPS23	Malignant cells	GSE161801_IMiD_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13355
0	-0.545084202673621	0.803	0.934	0	HINT1	Malignant cells	GSE161801_IMiD_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13356
0	-0.502985572393333	0.291	0.581	0	HSPA9	Malignant cells	GSE161801_IMiD_post	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13357
0	-1.45496828916864	0.9	0.998	0	CD74	Malignant cells	GSE161801_IMiD_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13358
0	-0.564850897820994	0.478	0.663	0	ATOX1	Malignant cells	GSE161801_IMiD_post	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13359
0	0.462579216103331	0.798	0.629	0	ATP6V0E1	Malignant cells	GSE161801_IMiD_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13360
0	-0.507046770871909	0.804	0.934	0	LMAN2	Malignant cells	GSE161801_IMiD_post	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13361
0	-0.716669883467299	0.822	0.951	0	TMED9	Malignant cells	GSE161801_IMiD_post	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13362
0	-0.41154998349565	0.599	0.788	0	CANX	Malignant cells	GSE161801_IMiD_post	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13363
0	-0.698478614437828	0.548	0.76	0	SQSTM1	Malignant cells	GSE161801_IMiD_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13364
0	-1.19797700231371	0.772	0.987	0	HLA-A	Malignant cells	GSE161801_IMiD_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13365
0	-0.726444459629652	0.92	0.995	0	HLA-B	Malignant cells	GSE161801_IMiD_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13366
0	-0.397326257825771	0.76	0.916	0	CLIC1	Malignant cells	GSE161801_IMiD_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13367
0	-1.17029025637364	0.048	0.393	0	HLA-DRB1	Malignant cells	GSE161801_IMiD_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13368
0	0.497294585133306	0.439	0.136	0	HLA-DOB	Malignant cells	GSE161801_IMiD_post	ENSG00000243612	3112	major histocompatibility complex, class II, DO beta	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13369
0	-0.652174885643415	0.519	0.771	0	TAPBP	Malignant cells	GSE161801_IMiD_post	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13370
0	-0.627042295727707	0.739	0.837	0	HSP90AB1	Malignant cells	GSE161801_IMiD_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13371
0	-0.479868343993544	0.92	0.968	0	COX7A2	Malignant cells	GSE161801_IMiD_post	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13372
0	-0.441874513591006	0.491	0.738	0	HMGN3	Malignant cells	GSE161801_IMiD_post	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13373
0	-0.540024373187039	0.881	0.931	0	CHCHD2	Malignant cells	GSE161801_IMiD_post	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13374
0	-0.540821540162626	0.418	0.709	0	BUD23	Malignant cells	GSE161801_IMiD_post	ENSG00000071462	114049	BUD23 rRNA methyltransferase and ribosome maturation factor	MERM1|MGC19709|MGC2022|MGC5140|PP3381|WBMT|WBSCR22	protein_coding	O43709	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13375
0	-0.344231838514085	0.117	0.344	0	ASNS	Malignant cells	GSE161801_IMiD_post	ENSG00000070669	440	asparagine synthetase (glutamine-hydrolyzing)	NA	protein_coding	P08243	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13376
0	-0.387099275551104	0.231	0.497	0	BUD31	Malignant cells	GSE161801_IMiD_post	ENSG00000106245	8896	BUD31 homolog	Cwc14|EDG-2|EDG2|fSAP17|G10|YCR063W	protein_coding	P41223	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13377
0	1.02359247232579	0.532	0.238	0	AZGP1	Malignant cells	GSE161801_IMiD_post	ENSG00000160862	563	alpha-2-glycoprotein 1, zinc-binding	ZA2G|ZAG	protein_coding	P25311	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13378
0	-0.370415387241376	0.13	0.358	0	PLOD3	Malignant cells	GSE161801_IMiD_post	ENSG00000106397	8985	procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	LH3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13379
0	0.379164814170565	0.322	0.093	0	CAV1	Malignant cells	GSE161801_IMiD_post	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13380
0	-0.882110826243265	0.663	0.871	0	PDIA4	Malignant cells	GSE161801_IMiD_post	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13381
0	-0.845249414369679	0.089	0.294	0	INSIG1	Malignant cells	GSE161801_IMiD_post	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13382
0	0.803797650720306	0.999	0.997	0	RPL39	Malignant cells	GSE161801_IMiD_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13383
0	-0.569696628632108	0.546	0.813	0	SARAF	Malignant cells	GSE161801_IMiD_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13384
0	0.702241873263487	0.476	0.214	0	MYC	Malignant cells	GSE161801_IMiD_post	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13385
0	-1.07921681191958	0.339	0.805	0	LY6E	Malignant cells	GSE161801_IMiD_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13386
0	0.626550583601628	1	0.992	0	RPS6	Malignant cells	GSE161801_IMiD_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13387
0	-0.679831430792463	0.128	0.492	0	PSAT1	Malignant cells	GSE161801_IMiD_post	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13388
0	-1.05093287761081	0.876	0.919	0	HSPA5	Malignant cells	GSE161801_IMiD_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13389
0	-0.695221405036362	0.012	0.381	0	ASS1	Malignant cells	GSE161801_IMiD_post	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13390
0	-0.91440943884335	0.254	0.706	0	CTSD	Malignant cells	GSE161801_IMiD_post	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13391
0	-0.562999057211361	0.155	0.479	0	RCN1	Malignant cells	GSE161801_IMiD_post	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13392
0	-1.19784500368149	0.966	0.999	0	FTH1	Malignant cells	GSE161801_IMiD_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13393
0	-0.50458409655166	0.459	0.707	0	SLC3A2	Malignant cells	GSE161801_IMiD_post	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13394
0	-0.476794712485802	0.237	0.528	0	RTN3	Malignant cells	GSE161801_IMiD_post	ENSG00000133318	10313	reticulon 3	ASYIP|HAP|NSPL2|NSPLII|RTN3-A1	protein_coding	O95197	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13395
0	-0.445171515603435	0.844	0.93	0	TRMT112	Malignant cells	GSE161801_IMiD_post	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13396
0	1.25473083989213	0.999	0.992	0	MALAT1	Malignant cells	GSE161801_IMiD_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13397
0	-0.544318806088705	0.108	0.341	0	CADM1	Malignant cells	GSE161801_IMiD_post	ENSG00000182985	23705	cell adhesion molecule 1	BL2|IGSF4|IGSF4A|Necl-2|NECL2|RA175|ST17|SYNCAM|SYNCAM1|TSLC1	protein_coding	Q9BY67	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13398
0	-0.371848049731789	0.906	0.981	0	ATP5MG	Malignant cells	GSE161801_IMiD_post	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13399
0	-0.412842365362359	0.165	0.437	0	HYOU1	Malignant cells	GSE161801_IMiD_post	ENSG00000280682	10525	hypoxia up-regulated 1	Grp170|HSP12A|ORP150	protein_coding	Q9Y4L1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13400
0	0.381680759747715	0.345	0.101	0	ARID5B	Malignant cells	GSE161801_IMiD_post	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13401
0	0.53243034428888	0.492	0.208	0	PPA1	Malignant cells	GSE161801_IMiD_post	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13402
0	0.688630774019492	0.996	0.94	0	RPS24	Malignant cells	GSE161801_IMiD_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13403
0	-0.771850373512209	0.931	0.94	0	GAPDH	Malignant cells	GSE161801_IMiD_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13404
0	0.677014150083621	0.39	0.062	0	CLECL1	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13405
0	-0.713436301343545	0.489	0.729	0	TUBA1B	Malignant cells	GSE161801_IMiD_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13406
0	0.490723357825515	0.978	0.939	0	RPS26	Malignant cells	GSE161801_IMiD_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13407
0	-0.402435380255683	0.889	0.963	0	MYL6	Malignant cells	GSE161801_IMiD_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13408
0	-0.581355781373218	0.116	0.48	0	SHMT2	Malignant cells	GSE161801_IMiD_post	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13409
0	-0.709815594076484	0.442	0.741	0	OS9	Malignant cells	GSE161801_IMiD_post	ENSG00000135506	10956	OS9 endoplasmic reticulum lectin	ERLEC2|OS-9	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13410
0	-2.26754030082937	0.953	0.986	0	HSP90B1	Malignant cells	GSE161801_IMiD_post	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13411
0	-0.519912610856218	0.684	0.866	0	ISCU	Malignant cells	GSE161801_IMiD_post	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13412
0	-0.699553993282993	0.788	0.958	0	ERP29	Malignant cells	GSE161801_IMiD_post	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13413
0	-0.63316111690548	0.561	0.799	0	PEBP1	Malignant cells	GSE161801_IMiD_post	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13414
0	-0.690860768430016	0.99	0.999	0	UBC	Malignant cells	GSE161801_IMiD_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13415
0	0.634557642040763	0.301	0.045	0	RGCC	Malignant cells	GSE161801_IMiD_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13416
0	-0.846329724199607	0.392	0.667	0	NFKBIA	Malignant cells	GSE161801_IMiD_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13417
0	-0.716366504569412	0.097	0.514	0	IFI27L1	Malignant cells	GSE161801_IMiD_post	ENSG00000276880	122509	interferon alpha inducible protein 27 like 1	FAM14B	protein_coding	Q96BM0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13418
0	-2.52747544125519	0.163	0.513	0	IFI27	Malignant cells	GSE161801_IMiD_post	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13419
0	-0.513235247491032	0.331	0.613	0	IFI27L2	Malignant cells	GSE161801_IMiD_post	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13420
0	-0.966610206272316	0.104	0.546	0	WARS	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13421
0	-0.967670798099287	0.554	0.793	0	HSP90AA1	Malignant cells	GSE161801_IMiD_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13422
0	-0.869025741819465	0.631	0.871	0	PDIA3	Malignant cells	GSE161801_IMiD_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13423
0	0.357382252204512	1	0.998	0	SERF2	Malignant cells	GSE161801_IMiD_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13424
0	-0.764358903453756	0.527	0.761	0	CCPG1	Malignant cells	GSE161801_IMiD_post	ENSG00000260916	9236	cell cycle progression 1	CPR8|KIAA1254	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13425
0	-0.94070105128834	0.971	0.984	0	PPIB	Malignant cells	GSE161801_IMiD_post	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13426
0	-0.979606670769283	0.257	0.668	0	HEXA	Malignant cells	GSE161801_IMiD_post	ENSG00000213614	3073	hexosaminidase subunit alpha	NA	protein_coding	P06865	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13427
0	0.365857899544602	0.291	0.045	0	SCAMP5	Malignant cells	GSE161801_IMiD_post	ENSG00000198794	192683	secretory carrier membrane protein 5	MGC24969	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13428
0	-0.481386209999084	0.399	0.705	0	SEC11A	Malignant cells	GSE161801_IMiD_post	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13429
0	-0.669941811223283	0.686	0.907	0	SELENOS	Malignant cells	GSE161801_IMiD_post	ENSG00000131871	55829	selenoprotein S	AD-015|MGC2553|SBBI8|SELS|SEPS1|VIMP	protein_coding	Q9BQE4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13430
0	-0.397529555389574	0.101	0.319	0	LMF1	Malignant cells	GSE161801_IMiD_post	ENSG00000103227	64788	lipase maturation factor 1	C16orf26|FLJ12681|FLJ22302|JFP11|TMEM112|TMEM112A	protein_coding	Q96S06	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13431
0	-0.827076382853443	0.113	0.468	0	NTHL1	Malignant cells	GSE161801_IMiD_post	ENSG00000065057	4913	nth like DNA glycosylase 1	NTH1|OCTS3	protein_coding	P78549	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13432
0	-0.662307512257043	0.4	0.795	0	EIF5A	Malignant cells	GSE161801_IMiD_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13433
0	0.439894180420405	0.502	0.226	0	TMEM256	Malignant cells	GSE161801_IMiD_post	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13434
0	0.441903421661145	0.524	0.232	0	NAA38	Malignant cells	GSE161801_IMiD_post	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13435
0	0.451268559587475	0.56	0.305	0	VAMP2	Malignant cells	GSE161801_IMiD_post	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13436
0	0.90191450625781	0.992	0.958	0	RPL26	Malignant cells	GSE161801_IMiD_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13437
0	-0.781209166242449	0.823	0.956	0	UBB	Malignant cells	GSE161801_IMiD_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13438
0	0.483570275314234	0.999	0.994	0	RPL23A	Malignant cells	GSE161801_IMiD_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13439
0	0.573030351362245	0.642	0.364	0	EVI2B	Malignant cells	GSE161801_IMiD_post	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13440
0	-0.703591123545929	0.999	1	0	EIF1	Malignant cells	GSE161801_IMiD_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13441
0	-0.360190052311306	0.129	0.358	0	TUBG1	Malignant cells	GSE161801_IMiD_post	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13442
0	-0.729709621332481	0.089	0.49	0	SCPEP1	Malignant cells	GSE161801_IMiD_post	ENSG00000121064	59342	serine carboxypeptidase 1	RISC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13443
0	-0.703670796448075	0.182	0.49	0	ERN1	Malignant cells	GSE161801_IMiD_post	ENSG00000178607	2081	endoplasmic reticulum to nucleus signaling 1	IRE1|IRE1P	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13444
0	-0.911983355719398	0.454	0.718	0	SYNGR2	Malignant cells	GSE161801_IMiD_post	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13445
0	-1.07695608534305	0.82	0.929	0	P4HB	Malignant cells	GSE161801_IMiD_post	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13446
0	-0.689796974473752	0.223	0.576	0	PMAIP1	Malignant cells	GSE161801_IMiD_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13447
0	-0.324471607096021	0.153	0.393	0	PSMF1	Malignant cells	GSE161801_IMiD_post	ENSG00000125818	9491	proteasome inhibitor subunit 1	PI31	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13448
0	-0.743900096377586	0.344	0.714	0	RRBP1	Malignant cells	GSE161801_IMiD_post	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13449
0	-0.731086160086652	0.627	0.87	0	HM13	Malignant cells	GSE161801_IMiD_post	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13450
0	-1.26315922850168	0.728	0.936	0	RPN2	Malignant cells	GSE161801_IMiD_post	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13451
0	-0.693986281641514	0.259	0.633	0	PIGT	Malignant cells	GSE161801_IMiD_post	ENSG00000124155	51604	phosphatidylinositol glycan anchor biosynthesis class T	NA	protein_coding	Q969N2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13452
0	-0.355097925584577	0.119	0.372	0	CTSA	Malignant cells	GSE161801_IMiD_post	ENSG00000064601	5476	cathepsin A	GSL|PPGB	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13453
0	-0.523197188807288	0.245	0.503	0	CEBPB	Malignant cells	GSE161801_IMiD_post	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13454
0	-0.493433502692743	0.609	0.82	0	PSMA7	Malignant cells	GSE161801_IMiD_post	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13455
0	-0.621790999587925	0.754	0.928	0	PPDPF	Malignant cells	GSE161801_IMiD_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13456
0	-0.502868769946246	0.681	0.874	0	BSG	Malignant cells	GSE161801_IMiD_post	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13457
0	0.448927852311809	1	1	0	RPS15	Malignant cells	GSE161801_IMiD_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13458
0	-0.74067316216483	0.886	0.973	0	MYDGF	Malignant cells	GSE161801_IMiD_post	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13459
0	0.449510852993634	0.999	0.999	0	RPL36	Malignant cells	GSE161801_IMiD_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13460
0	-0.516500045774642	0.324	0.569	0	CD320	Malignant cells	GSE161801_IMiD_post	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13461
0	0.562633702892916	1	0.999	0	RPS28	Malignant cells	GSE161801_IMiD_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13462
0	-0.549453682625769	0.739	0.86	0	CALR	Malignant cells	GSE161801_IMiD_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13463
0	-0.566518268269496	0.618	0.791	0	BST2	Malignant cells	GSE161801_IMiD_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13464
0	0.589250793424112	1	0.998	0	RPL18A	Malignant cells	GSE161801_IMiD_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13465
0	-1.09978877006033	0.67	0.957	0	FXYD5	Malignant cells	GSE161801_IMiD_post	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13466
0	0.481324132682659	0.382	0.086	0	POU2F2	Malignant cells	GSE161801_IMiD_post	ENSG00000028277	5452	POU class 2 homeobox 2	OCT2|OTF2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13467
0	-0.658871124511238	0.263	0.624	0	SLC1A5	Malignant cells	GSE161801_IMiD_post	ENSG00000105281	6510	solute carrier family 1 member 5	AAAT|ASCT2|M7V1|RDRC	protein_coding	Q15758	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13468
0	0.363288924602259	1	1	0	RPL13A	Malignant cells	GSE161801_IMiD_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13469
0	0.362148559473503	0.998	0.984	0	RPS11	Malignant cells	GSE161801_IMiD_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13470
0	-0.49337675105237	0.423	0.666	0	PRMT1	Malignant cells	GSE161801_IMiD_post	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13471
0	0.688433881702275	0.309	0.003	0	LILRB4	Malignant cells	GSE161801_IMiD_post	ENSG00000278555	11006	leukocyte immunoglobulin like receptor B4	CD85k|HM18|ILT3|LIR-5|LIR5	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13472
0	0.736622088498285	0.762	0.43	0	CHCHD10	Malignant cells	GSE161801_IMiD_post	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13473
0	1.15002368954057	0.965	0.858	0	XBP1	Malignant cells	GSE161801_IMiD_post	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13474
0	0.395386551530971	1	1	0	RPL3	Malignant cells	GSE161801_IMiD_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13475
0	-0.709038587068102	0.521	0.809	0	SOD1	Malignant cells	GSE161801_IMiD_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13476
0	-1.06300997427214	0.173	0.427	0	LAPTM5	Malignant cells	GSE161801_IMiD_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13477
0	-0.349612351835437	0.17	0.422	0	PIGK	Malignant cells	GSE161801_IMiD_post	ENSG00000142892	10026	phosphatidylinositol glycan anchor biosynthesis class K	GPI8|hGPI8	protein_coding	Q92643	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13478
0	-0.613815561890222	0.119	0.417	0	WNT10A	Malignant cells	GSE161801_IMiD_post	ENSG00000135925	80326	Wnt family member 10A	NA	protein_coding	Q9GZT5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13479
0	-0.638178418269897	0.053	0.391	0	FGFR3	Malignant cells	GSE161801_IMiD_post	ENSG00000068078	2261	fibroblast growth factor receptor 3	ACH|CD333|CEK2|JTK4	protein_coding	P22607	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13480
0	-1.08654188262607	0.115	0.504	0	NSD2	Malignant cells	GSE161801_IMiD_post	ENSG00000109685	7468	nuclear receptor binding SET domain protein 2	KMT3G|MMSET|WHSC1	protein_coding	O96028	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13481
0	-0.481397328216711	0.087	0.338	0	LINC02362	Malignant cells	GSE161801_IMiD_post	ENSG00000249096	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13482
0	-1.38689043321642	0.36	0.715	0	HLA-DRA	Malignant cells	GSE161801_IMiD_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13483
0	-0.250419672023843	0.196	0.589	0	CTHRC1	Malignant cells	GSE161801_IMiD_post	ENSG00000164932	115908	collagen triple helix repeat containing 1	NA	protein_coding	Q96CG8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13484
0	0.970805889477255	0.365	0.052	0	MS4A1	Malignant cells	GSE161801_IMiD_post	ENSG00000156738	931	membrane spanning 4-domains A1	B1|Bp35|CD20|FMC7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13485
0	0.629086332118446	0.274	0.06	0	BIRC3	Malignant cells	GSE161801_IMiD_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13486
0	-0.774381260808967	0.109	0.418	0	TMEM132D-AS1	Malignant cells	GSE161801_IMiD_post	ENSG00000249196	283352	TMEM132D antisense RNA 1	LOC283352|RP11-669N7.2	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13487
0	-0.872310487151425	0.048	0.409	0	DPEP1	Malignant cells	GSE161801_IMiD_post	ENSG00000015413	1800	dipeptidase 1	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13488
0	-0.341260456091266	0.088	0.298	0	NFE2L1	Malignant cells	GSE161801_IMiD_post	ENSG00000082641	4779	NFE2 like bZIP transcription factor 1	FLJ00380|LCR-F1|NRF-1|NRF1|TCF11	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13489
0	-0.615509860430097	0.042	0.431	0	TMC6	Malignant cells	GSE161801_IMiD_post	ENSG00000141524	11322	transmembrane channel like 6	EVER1|EVIN1|LAK-4P|TNRC6C-AS1	protein_coding	Q7Z403	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13490
0	0.958456377814881	0.351	0.083	0	VPREB3	Malignant cells	GSE161801_IMiD_post	ENSG00000128218	29802	V-set pre-B cell surrogate light chain 3	8HS20	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13491
0	-0.581283394325403	0.059	0.407	0	APP	Malignant cells	GSE161801_IMiD_post	ENSG00000142192	351	amyloid beta precursor protein	AD1|alpha-sAPP	protein_coding	P05067	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13492
0	-1.78743393865922	0.038	0.787	0	EDNRB	Malignant cells	GSE161801_IMiD_post	ENSG00000136160	1910	endothelin receptor type B	ETB|HSCR|HSCR2	protein_coding	P24530	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13493
0	0.522038883125918	0.258	0.012	0	RPS4Y1	Malignant cells	GSE161801_IMiD_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13494
0	0.428264104253838	0.252	0.003	0	EIF1AY	Malignant cells	GSE161801_IMiD_post	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13495
5.48894038461559e-307	-0.446561957101218	0.322	0.556	1.18489756082697e-302	NUCB1	Malignant cells	GSE161801_IMiD_post	ENSG00000104805	4924	nucleobindin 1	Calnuc|NUC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13496
4.262857772991e-304	0.295696469368308	1	1	9.20223107455567e-300	RPL41	Malignant cells	GSE161801_IMiD_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13497
1.72256584798869e-298	-0.372377546098117	0.255	0.503	3.71850289605319e-294	NME3	Malignant cells	GSE161801_IMiD_post	ENSG00000103024	4832	NME/NM23 nucleoside diphosphate kinase 3	DR-nm23|NDPKC|NM23-H3	protein_coding	Q13232	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13498
3.38620229035625e-297	-0.38661714514608	0.336	0.578	7.30979488419204e-293	EIF3I	Malignant cells	GSE161801_IMiD_post	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13499
4.04929918895222e-297	-0.311754948171724	0.145	0.378	8.74122215919116e-293	LAMP1	Malignant cells	GSE161801_IMiD_post	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13500
5.28186889037483e-297	-0.401209412876921	0.566	0.763	1.14019703736521e-292	TMEM230	Malignant cells	GSE161801_IMiD_post	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13501
1.26995883070073e-296	-0.410193104047181	0.489	0.717	2.74146012783367e-292	PTGES3	Malignant cells	GSE161801_IMiD_post	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13502
3.96196400179314e-296	-0.408964853950661	0.39	0.646	8.55269169067084e-292	PABPC4	Malignant cells	GSE161801_IMiD_post	ENSG00000090621	8761	poly(A) binding protein cytoplasmic 4	APP-1|iPABP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13503
8.12124791412616e-294	0.482177562949469	0.98	0.85	1.75313378722241e-289	ACTB	Malignant cells	GSE161801_IMiD_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13504
3.13725532742831e-293	-0.513855506508591	0.542	0.713	6.7723930753195e-289	DBI	Malignant cells	GSE161801_IMiD_post	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13505
3.66010328425644e-291	-0.412173477892206	0.308	0.547	7.90106495972437e-287	CKAP4	Malignant cells	GSE161801_IMiD_post	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13506
5.40071208086017e-289	-0.394149984969255	0.223	0.458	1.16585171689528e-284	TRADD	Malignant cells	GSE161801_IMiD_post	ENSG00000102871	8717	TNFRSF1A associated via death domain	Hs.89862	protein_coding	Q15628	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13507
1.3539489661252e-287	-0.380755642194772	0.296	0.534	2.92276963317446e-283	FAM96B	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13508
1.06826566533745e-286	-0.35779082580174	0.214	0.456	2.30606509176395e-282	CCDC167	Malignant cells	GSE161801_IMiD_post	ENSG00000198937	154467	coiled-coil domain containing 167	C6orf129|dJ153P14.2	protein_coding	Q9P0B6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13509
1.08387672735816e-286	-0.326234702789129	0.149	0.376	2.33976469134806e-282	RBCK1	Malignant cells	GSE161801_IMiD_post	ENSG00000125826	10616	RANBP2-type and C3HC4-type zinc finger containing 1	C20orf18|HOIL1|RBCK2|RNF54|UBCE7IP3|XAP4|ZRANB4	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13510
4.52290244311002e-285	-1.08191703123295	0.664	0.867	9.7635895039416e-281	ITM2C	Malignant cells	GSE161801_IMiD_post	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13511
2.25017515583802e-283	-0.341535021480588	0.156	0.379	4.85745310890754e-279	AARS	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13512
2.09748457521342e-282	0.630889406081447	0.46	0.209	4.52783995251321e-278	SAT1	Malignant cells	GSE161801_IMiD_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13513
1.09908382252802e-281	0.482098572169896	0.497	0.261	2.37259224769124e-277	IFI16	Malignant cells	GSE161801_IMiD_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13514
2.16251284059692e-281	-0.375915109224035	0.173	0.395	4.66821646899658e-277	IGSF8	Malignant cells	GSE161801_IMiD_post	ENSG00000162729	93185	immunoglobulin superfamily member 8	CD316|CD81P3|EWI2|PGRL	protein_coding	Q969P0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13515
1.79985945459959e-280	-0.417397294042391	0.331	0.562	3.88535660464414e-276	CHPF	Malignant cells	GSE161801_IMiD_post	ENSG00000123989	79586	chondroitin polymerizing factor	CHSY2|CSS2	protein_coding	Q8IZ52	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13516
6.91732833280018e-280	-0.388022913182911	0.322	0.557	1.49324366720157e-275	SRP72	Malignant cells	GSE161801_IMiD_post	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13517
7.35659329837615e-280	-0.362859132580793	0.336	0.58	1.58806779532046e-275	MIEN1	Malignant cells	GSE161801_IMiD_post	ENSG00000141741	84299	migration and invasion enhancer 1	C17orf37|C35|MGC14832|ORB3|Rdx12|XTP4	protein_coding	Q9BRT3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13518
1.36913251137532e-279	-0.366935331576752	0.416	0.652	2.9555463523059e-275	COX7A2L	Malignant cells	GSE161801_IMiD_post	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13519
8.67862842662806e-279	0.329633870185739	0.303	0.089	1.8734555184562e-274	ST6GAL1	Malignant cells	GSE161801_IMiD_post	ENSG00000073849	6480	ST6 beta-galactoside alpha-2,6-sialyltransferase 1	CDw75|SIAT1	protein_coding	P15907	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13520
1.452609621465e-277	0.47041260976723	0.587	0.361	3.1357483898565e-273	LY96	Malignant cells	GSE161801_IMiD_post	ENSG00000154589	23643	lymphocyte antigen 96	MD-2	protein_coding	Q9Y6Y9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13521
9.81084552068568e-277	-0.37215152610672	0.144	0.362	2.11786722255042e-272	HLA-F	Malignant cells	GSE161801_IMiD_post	ENSG00000234487	3134	major histocompatibility complex, class I, F	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13522
1.50819047805571e-274	-0.37017750435013	0.365	0.607	3.25573078497885e-270	PRKCSH	Malignant cells	GSE161801_IMiD_post	ENSG00000130175	5589	protein kinase C substrate 80K-H	G19P1|GIIB|PCLD|PLD1|VASAP-60	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13523
5.21867636486738e-271	-0.303591641837182	0.125	0.334	1.12655566688392e-266	ECI2	Malignant cells	GSE161801_IMiD_post	ENSG00000198721	10455	enoyl-CoA delta isomerase 2	ACBD2|DRS1|HCA88|PECI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13524
5.89371736449297e-271	-0.36035531043775	0.59	0.78	1.2722767674731e-266	ARPC3	Malignant cells	GSE161801_IMiD_post	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13525
1.04051603804855e-270	0.567281828043091	0.82	0.634	2.24616197133541e-266	RPL36A	Malignant cells	GSE161801_IMiD_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13526
3.09204763701573e-270	-0.739486722552721	0.138	0.332	6.67480323402585e-266	HLA-DMA	Malignant cells	GSE161801_IMiD_post	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13527
1.02002606873743e-269	-0.364653192452148	0.31	0.544	2.20193027458349e-265	SLC25A39	Malignant cells	GSE161801_IMiD_post	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13528
1.12644290644291e-269	0.365422561017301	0.441	0.193	2.43165230213831e-265	GLCCI1	Malignant cells	GSE161801_IMiD_post	ENSG00000106415	113263	glucocorticoid induced 1	FAM117C|GIG18|TSSN1	protein_coding	Q86VQ1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13529
5.60947525617441e-269	-0.338894389091205	0.289	0.532	1.21091742355037e-264	DDRGK1	Malignant cells	GSE161801_IMiD_post	ENSG00000198171	65992	DDRGK domain containing 1	C20orf116|dJ1187M17.3|UFBP1	protein_coding	Q96HY6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13530
4.43949187763109e-268	-0.382269787833255	0.336	0.564	9.58353111624224e-264	ADI1	Malignant cells	GSE161801_IMiD_post	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13531
1.69679414883868e-267	-0.542283420869298	0.85	0.92	3.66286952909807e-263	PRDX4	Malignant cells	GSE161801_IMiD_post	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13532
3.3415776151115e-266	0.395411272055606	0.401	0.173	7.2134635977412e-262	UCP2	Malignant cells	GSE161801_IMiD_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13533
1.26628121541871e-265	0.354087028040542	0.346	0.126	2.73352125972437e-261	BHLHE41	Malignant cells	GSE161801_IMiD_post	ENSG00000123095	79365	basic helix-loop-helix family member e41	BHLHB3|DEC2|SHARP-1|SHARP1	protein_coding	Q9C0J9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13534
1.51396759052494e-264	0.334462921291187	0.997	0.992	3.26820183766619e-260	RPS13	Malignant cells	GSE161801_IMiD_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13535
2.36992990720567e-264	0.483737347173721	1	1	5.11596769068487e-260	B2M	Malignant cells	GSE161801_IMiD_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13536
1.38797561868846e-262	-0.28126236940869	0.094	0.287	2.99622296806278e-258	MYEOV	Malignant cells	GSE161801_IMiD_post	ENSG00000172927	26579	myeloma overexpressed	OCIM	protein_coding	Q96EZ4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13537
4.6063017257669e-262	-0.265182046522233	0.07	0.25	9.94362353541301e-258	AC084033.3	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13538
1.4028259632922e-261	0.353319279240808	1	1	3.02828040695886e-257	RPS18	Malignant cells	GSE161801_IMiD_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13539
1.67264571659427e-261	-0.372175234379373	0.698	0.973	3.61074030841206e-257	GSTP1	Malignant cells	GSE161801_IMiD_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13540
8.17025386064253e-261	-0.890435105150767	0.172	0.37	1.7637127008969e-256	DUSP4	Malignant cells	GSE161801_IMiD_post	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13541
5.054794622885e-259	-0.346978367142595	0.23	0.46	1.09117851524219e-254	ARPC5	Malignant cells	GSE161801_IMiD_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13542
5.11946330293044e-259	0.367118000880699	0.357	0.138	1.10513854320359e-254	EVI2A	Malignant cells	GSE161801_IMiD_post	ENSG00000126860	2123	ecotropic viral integration site 2A	EVDA|EVI2	protein_coding	P22794	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13543
1.17084119466907e-258	-0.516916140031266	0.651	0.829	2.52749488693211e-254	ISG20	Malignant cells	GSE161801_IMiD_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13544
3.37559734463104e-258	-0.314084046999331	0.149	0.376	7.28690198785503e-254	CCND2	Malignant cells	GSE161801_IMiD_post	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13545
1.72296050988195e-257	-0.330251684979173	0.212	0.441	3.71935485268217e-253	TPM3	Malignant cells	GSE161801_IMiD_post	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13546
2.65521354934941e-256	-0.569127800015665	0.494	0.676	5.73180948898057e-252	CD48	Malignant cells	GSE161801_IMiD_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13547
3.30238946922495e-255	-0.265035604323775	0.092	0.286	7.1288681472159e-251	TRAF3IP3	Malignant cells	GSE161801_IMiD_post	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13548
4.37629842135471e-253	-0.394755850343833	0.739	0.887	9.4471154021784e-249	TMED10	Malignant cells	GSE161801_IMiD_post	ENSG00000170348	10972	transmembrane p24 trafficking protein 10	p23|P24(DELTA)|p24d1|p24delta1|TMP21	protein_coding	P49755	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13549
7.0104733218548e-253	0.449404124083846	0.478	0.255	1.5133508759888e-248	IGLL5	Malignant cells	GSE161801_IMiD_post	ENSG00000254709	100423062	immunoglobulin lambda like polypeptide 5	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13550
1.21041387946474e-251	-0.522982355593739	0.501	0.665	2.61292044160054e-247	ANXA2	Malignant cells	GSE161801_IMiD_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13551
4.20836496025704e-250	-0.327637657079006	0.221	0.446	9.08459743970687e-246	DNASE2	Malignant cells	GSE161801_IMiD_post	ENSG00000105612	1777	deoxyribonuclease 2, lysosomal	DNL|DNL2	protein_coding	O00115	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13552
9.71652338834038e-250	-0.318766376607992	0.927	0.97	2.09750590384104e-245	SEC61G	Malignant cells	GSE161801_IMiD_post	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13553
4.47850358787633e-249	-0.340104055391832	0.81	0.931	9.66774569514863e-245	UBE2J1	Malignant cells	GSE161801_IMiD_post	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13554
1.20995231384734e-245	-0.316098119819363	0.188	0.403	2.61192405990226e-241	ISOC2	Malignant cells	GSE161801_IMiD_post	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13555
2.11197629576872e-244	-0.353763537012258	0.263	0.481	4.55912322967593e-240	PSMD7	Malignant cells	GSE161801_IMiD_post	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13556
2.7416718446016e-243	-0.362174219919366	0.384	0.594	5.91844701094147e-239	C1orf43	Malignant cells	GSE161801_IMiD_post	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13557
1.13040921999293e-242	-0.350860351617844	0.965	0.993	2.44021438319873e-238	SPCS1	Malignant cells	GSE161801_IMiD_post	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13558
5.80615789866588e-242	0.471807957147759	0.998	0.999	1.253375305585e-237	RPL34	Malignant cells	GSE161801_IMiD_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13559
4.10554857143327e-240	0.879588288914669	0.686	0.497	8.86264770115299e-236	S100A6	Malignant cells	GSE161801_IMiD_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13560
4.52496303274921e-240	-0.388669058620788	0.34	0.561	9.76803769879573e-236	SIVA1	Malignant cells	GSE161801_IMiD_post	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13561
3.43513651213214e-239	-0.285715315361485	0.93	0.952	7.41542918873965e-235	EDF1	Malignant cells	GSE161801_IMiD_post	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13562
4.11008720626234e-239	-0.418450786670507	0.164	0.371	8.87244525215851e-235	CKS1B	Malignant cells	GSE161801_IMiD_post	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13563
3.55087567270424e-237	1.06531360548634	0.302	0.11	7.66527531466664e-233	DKK1	Malignant cells	GSE161801_IMiD_post	ENSG00000107984	22943	dickkopf WNT signaling pathway inhibitor 1	DKK-1|SK	protein_coding	O94907	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13564
2.8729831075239e-236	-0.351635088662198	0.55	0.735	6.20190863421184e-232	PSMB3	Malignant cells	GSE161801_IMiD_post	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13565
4.93597396570593e-236	-0.371992527753564	0.425	0.624	1.06552869997694e-231	MRPS34	Malignant cells	GSE161801_IMiD_post	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13566
1.79149471491615e-235	-0.313687305101977	0.316	0.553	3.8672996410895e-231	YWHAB	Malignant cells	GSE161801_IMiD_post	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13567
1.673114191609e-234	-0.336755473474384	0.545	0.75	3.61175160542636e-230	ERLEC1	Malignant cells	GSE161801_IMiD_post	ENSG00000068912	27248	endoplasmic reticulum lectin 1	C2orf30|CL25084|ERLECTIN|XTP3-B|XTP3TPB	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13568
2.25016428351823e-233	-0.358940866616262	0.43	0.633	4.8574296388308e-229	PSMA1	Malignant cells	GSE161801_IMiD_post	ENSG00000129084	5682	proteasome 20S subunit alpha 1	HC2|MGC14542|MGC14575|MGC14751|MGC1667|MGC21459|MGC22853|MGC23915|NU|PROS30	protein_coding	P25786	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13569
3.44480009814639e-232	0.442920503669485	0.373	0.173	7.43628997186861e-228	FAM174A	Malignant cells	GSE161801_IMiD_post	ENSG00000174132	345757	family with sequence similarity 174 member A	NS5ATP6|TMEM157|UNQ1912	protein_coding	Q8TBP5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13570
2.79753348376459e-231	-0.337454322878736	0.225	0.442	6.03903553140263e-227	ARPC1B	Malignant cells	GSE161801_IMiD_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13571
2.82083755007306e-231	-0.293347785708	0.21	0.425	6.08934201934272e-227	AAMP	Malignant cells	GSE161801_IMiD_post	ENSG00000127837	14	angio associated migratory cell protein	NA	protein_coding	Q13685	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13572
6.32887718928574e-230	-0.400244134610201	0.429	0.623	1.36621471885111e-225	B4GALT3	Malignant cells	GSE161801_IMiD_post	ENSG00000158850	8703	beta-1,4-galactosyltransferase 3	beta4Gal-T3	protein_coding	O60512	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13573
1.31501686711464e-229	-0.397815371199248	0.264	0.482	2.83872691104038e-225	AQP3	Malignant cells	GSE161801_IMiD_post	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13574
1.44956824140187e-229	0.341108364196046	0.299	0.106	3.12918296271421e-225	PNOC	Malignant cells	GSE161801_IMiD_post	ENSG00000168081	5368	prepronociceptin	N/OFQ|NOP|PPNOC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13575
3.15864736391602e-229	-0.297941634901639	0.155	0.354	6.81857206448552e-225	TNIP1	Malignant cells	GSE161801_IMiD_post	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13576
6.34588564770953e-229	0.544134445727839	0.577	0.367	1.36988633477106e-224	TXNIP	Malignant cells	GSE161801_IMiD_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13577
5.71841313494772e-228	0.377114793719001	0.503	0.286	1.23443384344117e-223	CD47	Malignant cells	GSE161801_IMiD_post	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13578
6.83605748886767e-228	-0.25851750270104	0.086	0.259	1.47569973012186e-223	BTN3A2	Malignant cells	GSE161801_IMiD_post	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13579
1.02670620262152e-227	0.461494004323743	0.999	1	2.21635067959908e-223	RPL32	Malignant cells	GSE161801_IMiD_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13580
1.79527238398643e-226	-0.432731986702142	0.557	0.761	3.8754544953115e-222	ATP5ME	Malignant cells	GSE161801_IMiD_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13581
2.93906515927043e-225	-0.332554626848282	0.35	0.581	6.34455995931707e-221	PSMB9	Malignant cells	GSE161801_IMiD_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13582
2.37722542818841e-224	-0.278905714800448	0.112	0.294	5.13171653183031e-220	QSOX1	Malignant cells	GSE161801_IMiD_post	ENSG00000116260	5768	quiescin sulfhydryl oxidase 1	QSCN6	protein_coding	O00391	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13583
3.76192558288807e-223	-0.328660850235294	0.336	0.557	8.12086875578048e-219	PSMB4	Malignant cells	GSE161801_IMiD_post	ENSG00000159377	5692	proteasome 20S subunit beta 4	HN3|PROS26	protein_coding	P28070	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13584
5.28411666185014e-223	-0.291601435536261	0.222	0.434	1.14068226379359e-218	PSMD3	Malignant cells	GSE161801_IMiD_post	ENSG00000108344	5709	proteasome 26S subunit, non-ATPase 3	P58|Rpn3|S3|TSTA2	protein_coding	O43242	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13585
6.69407243691236e-222	-0.318000775512424	0.345	0.567	1.44504941695627e-217	DYNLRB1	Malignant cells	GSE161801_IMiD_post	ENSG00000125971	83658	dynein light chain roadblock-type 1	DNCL2A|DNLC2A|ROBLD1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13586
2.48154787045462e-221	0.813385409000724	0.734	0.564	5.35691738795038e-217	JUNB	Malignant cells	GSE161801_IMiD_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13587
2.98968554228751e-221	0.515015600745334	0.997	0.999	6.45383418013604e-217	RPS12	Malignant cells	GSE161801_IMiD_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13588
3.39615366672902e-221	-0.283969147622716	0.843	0.935	7.33127692036793e-217	TMED2	Malignant cells	GSE161801_IMiD_post	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13589
5.39007256260341e-220	0.344884271152371	0.475	0.267	1.1635549640892e-215	ERGIC2	Malignant cells	GSE161801_IMiD_post	ENSG00000087502	51290	ERGIC and golgi 2	Erv41|PTX1	protein_coding	Q96RQ1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13590
1.49457647239306e-219	-0.406676164244217	0.511	0.691	3.2263422309549e-215	NCL	Malignant cells	GSE161801_IMiD_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13591
1.04698391238788e-218	-0.356808476889521	0.31	0.534	2.26012417167172e-214	NUCKS1	Malignant cells	GSE161801_IMiD_post	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13592
3.29386365323038e-218	-0.313098478131483	0.313	0.528	7.11046346822843e-214	NUDC	Malignant cells	GSE161801_IMiD_post	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13593
2.21682365391877e-217	-0.296636805386967	0.229	0.44	4.78545722171445e-213	TIMM10	Malignant cells	GSE161801_IMiD_post	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13594
2.39197897740271e-217	-0.271422444044449	0.1	0.276	5.16356501851924e-213	IL27RA	Malignant cells	GSE161801_IMiD_post	ENSG00000288185	9466	interleukin 27 receptor subunit alpha	CRL1|IL-27R|TCCR|WSX-1|WSX1|zcytor1	protein_coding	Q6UWB1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13595
1.23128126097703e-214	-0.326665779205738	0.296	0.509	2.65796685807112e-210	ASAH1	Malignant cells	GSE161801_IMiD_post	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13596
1.4334144813075e-213	0.347055603485939	0.912	0.837	3.0943118407985e-209	BTF3	Malignant cells	GSE161801_IMiD_post	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13597
3.90494897122698e-213	-0.255274960574436	0.131	0.316	8.42961334418768e-209	MAN1B1	Malignant cells	GSE161801_IMiD_post	ENSG00000177239	11253	mannosidase alpha class 1B member 1	ERMan1|ERManI|MANA-ER|MRT15	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13598
4.13354678611027e-213	-0.563547842909424	0.441	0.601	8.92308744717623e-209	TOR3A	Malignant cells	GSE161801_IMiD_post	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13599
2.54042074109914e-212	-0.335384093490983	0.522	0.702	5.48400625381072e-208	SSR1	Malignant cells	GSE161801_IMiD_post	ENSG00000124783	6745	signal sequence receptor subunit 1	TRAPA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13600
1.72011042324153e-211	-0.373452138697649	0.453	0.631	3.71320237065148e-207	UBXN4	Malignant cells	GSE161801_IMiD_post	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13601
1.9809620880029e-210	-0.312445244945039	0.302	0.517	4.27630285937186e-206	PYCR1	Malignant cells	GSE161801_IMiD_post	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13602
4.80565391288281e-210	-0.293335534805127	0.224	0.428	1.03739651017401e-205	NARS	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13603
4.762452148864e-209	-0.259157651846308	0.182	0.4	1.02807054537527e-204	JSRP1	Malignant cells	GSE161801_IMiD_post	ENSG00000167476	126306	junctional sarcoplasmic reticulum protein 1	FLJ32416|JP-45	protein_coding	Q96MG2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13604
7.67308707574742e-208	0.28130435237654	0.999	1	1.6563893070416e-203	RPS16	Malignant cells	GSE161801_IMiD_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13605
5.90955526638632e-206	-0.309349978137181	0.462	0.69	1.27569569535482e-201	CSTB	Malignant cells	GSE161801_IMiD_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13606
7.86983778686085e-206	-0.443750635193634	0.276	0.492	1.69886188304965e-201	HMGB2	Malignant cells	GSE161801_IMiD_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13607
1.21582264138171e-204	0.40877127130687	0.959	0.931	2.6245963359507e-200	RPS17	Malignant cells	GSE161801_IMiD_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13608
1.29680248377074e-202	-0.329973180649495	0.471	0.663	2.7994075217159e-198	EIF2S2	Malignant cells	GSE161801_IMiD_post	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13609
1.48291390123799e-202	0.412360929801017	1	1	3.20116623860245e-198	RPS19	Malignant cells	GSE161801_IMiD_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13610
1.26146568864574e-201	-0.515807675781039	0.556	0.656	2.72312598207955e-197	LMAN1	Malignant cells	GSE161801_IMiD_post	ENSG00000074695	3998	lectin, mannose binding 1	ERGIC-53|ERGIC53|F5F8D|FMFD1|gp58|MCFD1|MR60	protein_coding	P49257	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13611
3.03290079377057e-201	0.391725468509871	0.998	0.997	6.54712294351254e-197	RPL21	Malignant cells	GSE161801_IMiD_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13612
2.95396264466121e-200	-0.294811584522471	0.227	0.428	6.37671916103015e-196	RBBP4	Malignant cells	GSE161801_IMiD_post	ENSG00000162521	5928	RB binding protein 4, chromatin remodeling factor	lin-53|NURF55|RbAp48	protein_coding	Q09028	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13613
1.04674518664507e-199	-0.283774845310087	0.133	0.314	2.25960883441072e-195	LGALS3BP	Malignant cells	GSE161801_IMiD_post	ENSG00000108679	3959	galectin 3 binding protein	90K|BTBD17B|CyCAP|gp90|M2BP|MAC-2-BP|TANGO10B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13614
6.03352239959675e-198	0.447825306573557	0.27	0.096	1.30245648040095e-193	OTUD1	Malignant cells	GSE161801_IMiD_post	ENSG00000165312	220213	OTU deubiquitinase 1	DUBA7|OTDC1	protein_coding	Q5VV17	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13615
1.2465255687052e-197	0.446570113065794	0.968	0.977	2.69087474516392e-193	RPL24	Malignant cells	GSE161801_IMiD_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13616
3.54334227534556e-196	0.371768031364511	0.352	0.167	7.64901296978846e-192	CD37	Malignant cells	GSE161801_IMiD_post	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13617
4.41069102941746e-196	-0.301481741165669	0.815	0.89	9.52135872520348e-192	ELOB	Malignant cells	GSE161801_IMiD_post	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13618
1.52595015678025e-195	-0.274942589184265	0.158	0.343	3.29406860344153e-191	NCF1	Malignant cells	GSE161801_IMiD_post	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13619
3.58145451550903e-195	-0.322206489771851	0.438	0.623	7.73128586262935e-191	PSMD4	Malignant cells	GSE161801_IMiD_post	ENSG00000159352	5710	proteasome 26S subunit ubiquitin receptor, non-ATPase 4	AF|AF-1|Rpn10|S5A	protein_coding	P55036	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13620
3.79773441034375e-195	-0.291906150043295	0.289	0.496	8.19816927160904e-191	COX14	Malignant cells	GSE161801_IMiD_post	ENSG00000178449	84987	cytochrome c oxidase assembly factor COX14	C12orf62|MGC14288	protein_coding	Q96I36	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13621
1.28941781091531e-194	0.353848355260347	0.516	0.329	2.78346622842287e-190	MRPL34	Malignant cells	GSE161801_IMiD_post	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13622
2.68389032527765e-194	-0.268132987306804	0.194	0.387	5.79371404517685e-190	GNB2	Malignant cells	GSE161801_IMiD_post	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13623
4.86536581529597e-194	0.262419776024689	0.32	0.133	1.05028651854794e-189	NSA2	Malignant cells	GSE161801_IMiD_post	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13624
7.80494852449866e-194	0.295012490418054	0.48	0.27	1.68485423798353e-189	NDUFA6	Malignant cells	GSE161801_IMiD_post	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13625
2.41275968367553e-193	-0.29239708058581	0.439	0.643	5.20842432915038e-189	VPS28	Malignant cells	GSE161801_IMiD_post	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13626
2.62392924026375e-193	-0.277701857314193	0.22	0.417	5.66427605095735e-189	STT3A	Malignant cells	GSE161801_IMiD_post	ENSG00000134910	3703	STT3 oligosaccharyltransferase complex catalytic subunit A	ITM1|MGC9042|STT3-A|TMC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13627
1.36780539093054e-192	0.452213103355487	0.658	0.538	2.95268149740176e-188	LDHB	Malignant cells	GSE161801_IMiD_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13628
1.88615306049766e-192	-0.293176627047999	0.221	0.416	4.07163861169629e-188	GRINA	Malignant cells	GSE161801_IMiD_post	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13629
3.83666053114653e-192	-0.305849763995796	0.4	0.596	8.28219908858601e-188	COPZ1	Malignant cells	GSE161801_IMiD_post	ENSG00000111481	22818	COPI coat complex subunit zeta 1	CGI-120|COPZ	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13630
1.935304390981e-189	-0.269564087450005	0.138	0.317	4.17774158881068e-185	RHOH	Malignant cells	GSE161801_IMiD_post	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13631
6.64578894987141e-188	0.444594234806063	0.913	0.877	1.43462646060874e-183	RPS27L	Malignant cells	GSE161801_IMiD_post	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13632
2.0721574946454e-187	-0.362065509703059	0.826	0.879	4.47316638369103e-183	COX4I1	Malignant cells	GSE161801_IMiD_post	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13633
1.80113487144593e-186	-0.281552057444451	0.31	0.51	3.88810984699033e-182	TMEM14B	Malignant cells	GSE161801_IMiD_post	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13634
2.12189226185702e-186	-0.262186248767978	0.246	0.447	4.58052882567076e-182	APH1A	Malignant cells	GSE161801_IMiD_post	ENSG00000117362	51107	aph-1 homolog A, gamma-secretase subunit	APH-1A|CGI-78	protein_coding	Q96BI3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13635
2.23878189555032e-186	-0.291992240901901	0.199	0.387	4.83285847792447e-182	IFI35	Malignant cells	GSE161801_IMiD_post	ENSG00000068079	3430	interferon induced protein 35	IFP35	protein_coding	P80217	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13636
1.74536466101235e-185	0.291816683327969	0.356	0.163	3.76771869372736e-181	PDE4B	Malignant cells	GSE161801_IMiD_post	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13637
3.68415495795566e-185	0.342084773214773	0.894	0.896	7.95298530773889e-181	NDUFA4	Malignant cells	GSE161801_IMiD_post	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13638
7.63569610433235e-185	0.32926418662461	0.828	0.725	1.64831771804222e-180	UQCRB	Malignant cells	GSE161801_IMiD_post	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13639
1.04778930544898e-184	-0.310442556192434	0.71	0.829	2.26186277367271e-180	PRDX5	Malignant cells	GSE161801_IMiD_post	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13640
1.07202356671593e-184	-0.286089432214171	0.379	0.593	2.31417727346969e-180	GUSB	Malignant cells	GSE161801_IMiD_post	ENSG00000169919	2990	glucuronidase beta	NA	protein_coding	P08236	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13641
1.20613483594243e-184	-0.313301687592261	0.555	0.715	2.60368327034892e-180	SEM1	Malignant cells	GSE161801_IMiD_post	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13642
3.32257509036793e-184	-0.300466995287347	0.412	0.616	7.17244284757726e-180	MINOS1	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13643
6.00644731395773e-184	-0.273525742384123	0.227	0.418	1.29661178166405e-179	NBDY	Malignant cells	GSE161801_IMiD_post	ENSG00000204272	550643	negative regulator of P-body association	LINC01420|NoBody	protein_coding	A0A0U1RRE5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13644
8.60879241870887e-184	-0.279078169684983	0.233	0.427	1.85838001942668e-179	GARS	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13645
2.96065236649344e-183	0.345607560783136	0.752	0.664	6.3911602635494e-179	ATP5MC3	Malignant cells	GSE161801_IMiD_post	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13646
3.89371028616098e-183	-0.25177059298846	0.19	0.375	8.40535239473571e-179	EIF4H	Malignant cells	GSE161801_IMiD_post	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13647
6.42124288654406e-182	-0.344739381152686	0.548	0.722	1.38615370191827e-177	CHID1	Malignant cells	GSE161801_IMiD_post	ENSG00000177830	66005	chitinase domain containing 1	FLJ42707|MGC3234|SI-CLP	protein_coding	Q9BWS9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13648
1.78355458449609e-181	-0.302933914692293	0.554	0.715	3.85015928155171e-177	NDUFB10	Malignant cells	GSE161801_IMiD_post	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13649
3.15185419960343e-181	-0.377567412812528	0.657	0.782	6.80390766068393e-177	RAN	Malignant cells	GSE161801_IMiD_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13650
6.22147162621702e-180	0.572979283021763	0.525	0.372	1.34302907995147e-175	TPM4	Malignant cells	GSE161801_IMiD_post	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13651
2.69699202651141e-178	-0.677518305703676	0.999	1	5.82199668763019e-174	SSR4	Malignant cells	GSE161801_IMiD_post	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13652
3.13961405691968e-177	-0.359311535170666	0.525	0.657	6.77748486467252e-173	MESD	Malignant cells	GSE161801_IMiD_post	ENSG00000117899	23184	mesoderm development LRP chaperone	BOCA|KIAA0081|MESDC2	protein_coding	Q14696	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13653
3.51534795140367e-177	1.05659351565916	0.524	0.415	7.5885816226951e-173	LINC01781	Malignant cells	GSE161801_IMiD_post	ENSG00000234184	101927412	long intergenic non-protein coding RNA 1781	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13654
3.83980577407712e-177	-0.332618219342974	0.444	0.61	8.28898872450027e-173	MLEC	Malignant cells	GSE161801_IMiD_post	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13655
5.56808904939504e-176	-0.271679128646597	0.275	0.463	1.20198338309291e-171	MRPS15	Malignant cells	GSE161801_IMiD_post	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13656
8.60357146036081e-176	-0.27869358278253	0.137	0.309	1.85725297114809e-171	C16orf54	Malignant cells	GSE161801_IMiD_post	ENSG00000185905	283897	chromosome 16 open reading frame 54	FLJ35681	protein_coding	Q6UWD8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13657
2.4091577429555e-175	0.391942876730247	0.656	0.5	5.20064881971803e-171	SELENOM	Malignant cells	GSE161801_IMiD_post	ENSG00000198832	140606	selenoprotein M	SELM|SEPM	protein_coding	Q8WWX9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13658
2.87858417738253e-175	-0.284297737587289	0.536	0.717	6.21399966371566e-171	UBE2D2	Malignant cells	GSE161801_IMiD_post	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13659
3.68305211943648e-175	0.30262456995363	0.417	0.226	7.95060461022752e-171	RPL22L1	Malignant cells	GSE161801_IMiD_post	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13660
8.62181096829064e-174	0.269308664600265	0.328	0.15	1.8611903337249e-169	BLVRB	Malignant cells	GSE161801_IMiD_post	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13661
1.75453682658223e-173	-0.443395345219731	0.229	0.409	3.78751864754306e-169	GADD45B	Malignant cells	GSE161801_IMiD_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13662
1.77758144844846e-173	0.313043089327815	0.287	0.122	3.83726507276569e-169	NEB	Malignant cells	GSE161801_IMiD_post	ENSG00000183091	4703	nebulin	NEB177D|NEM2	protein_coding	P20929	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13663
8.41488100837063e-173	0.355985835193003	0.837	0.818	1.81652036327697e-168	ATP5F1D	Malignant cells	GSE161801_IMiD_post	ENSG00000099624	513	ATP synthase F1 subunit delta	ATP5D	protein_coding	P30049	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13664
5.28160902226784e-172	-0.520910240366733	0.679	0.791	1.14014093963696e-167	HSPA8	Malignant cells	GSE161801_IMiD_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13665
5.62651369989377e-172	-0.282576200935504	0.293	0.481	1.21459551239607e-167	TMEM14C	Malignant cells	GSE161801_IMiD_post	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13666
6.66301643511179e-172	-0.324986902903619	0.395	0.575	1.43834535784758e-167	SRPRA	Malignant cells	GSE161801_IMiD_post	ENSG00000182934	6734	SRP receptor subunit alpha	SR-alpha|Sralpha|SRP-alpha|SRPR	protein_coding	P08240	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13667
1.03225721352503e-171	-0.416616159146353	0.577	0.698	2.22833364683649e-167	ARF4	Malignant cells	GSE161801_IMiD_post	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13668
1.3621802571443e-171	-0.449541961098176	0.551	0.709	2.94053852109741e-167	BCAP31	Malignant cells	GSE161801_IMiD_post	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13669
3.00055166580395e-170	-0.257433194129833	0.315	0.514	6.47729088097099e-166	PAPOLA	Malignant cells	GSE161801_IMiD_post	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13670
6.21146682720537e-170	-0.253451281796107	0.225	0.413	1.34086934398882e-165	FKBP1A	Malignant cells	GSE161801_IMiD_post	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13671
3.32974809052079e-169	0.419868994834813	0.63	0.48	7.18792720300724e-165	EAF2	Malignant cells	GSE161801_IMiD_post	ENSG00000145088	55840	ELL associated factor 2	BM040|TRAITS|U19	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13672
5.42812515568642e-169	-0.259013100659473	0.302	0.496	1.17176937735803e-164	DPM2	Malignant cells	GSE161801_IMiD_post	ENSG00000136908	8818	dolichyl-phosphate mannosyltransferase subunit 2, regulatory	MGC111193|MGC21559	protein_coding	O94777	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13673
6.96363375504304e-169	-0.301757830862914	0.538	0.729	1.50323961870114e-164	HMGN1	Malignant cells	GSE161801_IMiD_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13674
7.02626283735771e-169	0.31288981059062	0.338	0.165	1.51675935870041e-164	FCGRT	Malignant cells	GSE161801_IMiD_post	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13675
3.25473800977066e-168	-0.354111377277926	0.998	0.999	7.02600294169192e-164	PTMA	Malignant cells	GSE161801_IMiD_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13676
3.90610547196892e-168	-0.272127270096991	0.428	0.631	8.43210988233931e-164	PPP1CA	Malignant cells	GSE161801_IMiD_post	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13677
6.02528745488757e-168	0.386778644068177	0.352	0.174	1.30067880288658e-163	NR4A1	Malignant cells	GSE161801_IMiD_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13678
7.34500718632268e-168	-0.294641482493702	0.412	0.597	1.58556670131148e-163	POMP	Malignant cells	GSE161801_IMiD_post	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13679
2.88669965911623e-167	-0.260850571624273	0.212	0.389	6.2315185541342e-163	PSMD14	Malignant cells	GSE161801_IMiD_post	ENSG00000115233	10213	proteasome 26S subunit, non-ATPase 14	pad1|POH1|Rpn11	protein_coding	O00487	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13680
3.41145725002498e-167	-0.28179240522571	0.37	0.563	7.36431276562892e-163	TAF7	Malignant cells	GSE161801_IMiD_post	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13681
1.28390181405256e-166	-0.447203296339085	0.499	0.679	2.77155884599525e-162	PPP1R15A	Malignant cells	GSE161801_IMiD_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13682
5.00366949942494e-166	-0.266948709513477	0.425	0.644	1.08014213484086e-161	RNASET2	Malignant cells	GSE161801_IMiD_post	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13683
5.78948737724887e-165	0.31949234264953	0.76	0.624	1.24977664012671e-160	NOP53	Malignant cells	GSE161801_IMiD_post	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13684
6.70317271536126e-164	-0.267619672093329	0.113	0.264	1.44701389406504e-159	ADTRP	Malignant cells	GSE161801_IMiD_post	ENSG00000111863	84830	androgen dependent TFPI regulating protein	AIG1L|C6orf105|dJ413H6.1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13685
1.49991661075693e-163	-0.257460707742132	0.97	0.989	3.23786998764099e-159	RPSA	Malignant cells	GSE161801_IMiD_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13686
3.55269028118972e-163	0.25325032083496	0.309	0.139	7.66919251000424e-159	PAIP2B	Malignant cells	GSE161801_IMiD_post	ENSG00000124374	400961	poly(A) binding protein interacting protein 2B	KIAA1155	protein_coding	Q9ULR5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13687
3.03055268796003e-162	-0.370042215161176	0.525	0.638	6.54205408749931e-158	PSMB6	Malignant cells	GSE161801_IMiD_post	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13688
5.63910312481686e-162	0.381704626344905	0.644	0.532	1.21731319155422e-157	TECR	Malignant cells	GSE161801_IMiD_post	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13689
1.00969521208899e-161	-0.271276566927446	0.304	0.486	2.1796290543365e-157	DSTN	Malignant cells	GSE161801_IMiD_post	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13690
2.62035259679438e-160	-0.26914135594543	0.394	0.59	5.65655515070004e-156	SF3B5	Malignant cells	GSE161801_IMiD_post	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13691
3.7350472099504e-160	-0.26928333067825	0.307	0.493	8.06284641211992e-156	IER3IP1	Malignant cells	GSE161801_IMiD_post	ENSG00000134049	51124	immediate early response 3 interacting protein 1	NA	protein_coding	Q9Y5U9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13692
3.82933250277536e-160	0.278198371837752	0.276	0.118	8.26638007374117e-156	RALGPS2	Malignant cells	GSE161801_IMiD_post	ENSG00000116191	55103	Ral GEF with PH domain and SH3 binding motif 2	FLJ10244|FLJ25604|KIAA0351	protein_coding	Q86X27	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13693
5.73183494013358e-160	-0.279936354475424	0.649	0.797	1.23733120852664e-155	ATP6V0B	Malignant cells	GSE161801_IMiD_post	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13694
1.50410581419944e-159	0.256881278124651	0.326	0.157	3.24691322111234e-155	SAT2	Malignant cells	GSE161801_IMiD_post	ENSG00000141504	112483	spermidine/spermine N1-acetyltransferase family member 2	SSAT2	protein_coding	Q96F10	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13695
1.59596533372964e-159	0.318033564831202	0.399	0.216	3.44521036592218e-155	ARHGDIB	Malignant cells	GSE161801_IMiD_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13696
7.55164795325299e-159	-0.374289067450516	0.201	0.375	1.63017424366872e-154	CDKN1A	Malignant cells	GSE161801_IMiD_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13697
2.24231553909091e-158	-0.271796022849087	0.278	0.458	4.84048655423554e-154	ST6GALNAC4	Malignant cells	GSE161801_IMiD_post	ENSG00000136840	27090	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	SIAT3C|SIAT7D|ST6GALNACIV	protein_coding	Q9H4F1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13698
6.03460501422479e-158	-0.285049694844825	0.941	0.975	1.30269018442071e-153	FKBP2	Malignant cells	GSE161801_IMiD_post	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13699
1.17047365206018e-157	-0.33186537700301	0.36	0.541	2.52670147270232e-153	CDC42	Malignant cells	GSE161801_IMiD_post	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13700
1.61931136048893e-157	0.258347186146763	0.331	0.158	3.49560743388746e-153	PDCD4	Malignant cells	GSE161801_IMiD_post	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13701
2.44946188548818e-157	-0.28854348693543	0.469	0.649	5.28765337220333e-153	SKP1	Malignant cells	GSE161801_IMiD_post	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13702
3.22493156950224e-157	0.27474241539466	0.999	0.998	6.96165977908448e-153	RPL35A	Malignant cells	GSE161801_IMiD_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13703
5.5759200588543e-157	-0.252328148677061	0.26	0.451	1.20367386310488e-152	ANXA6	Malignant cells	GSE161801_IMiD_post	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13704
9.83254270463157e-157	0.272623015756595	0.937	0.932	2.12255099364882e-152	RPL36AL	Malignant cells	GSE161801_IMiD_post	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13705
4.6653635681175e-155	0.865328657946608	0.381	0.226	1.00711203344952e-150	S100A4	Malignant cells	GSE161801_IMiD_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13706
5.75188449806513e-155	0.343613791829842	0.651	0.541	1.24165930659732e-150	HIGD2A	Malignant cells	GSE161801_IMiD_post	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13707
1.29224799639934e-154	0.324869936805224	0.666	0.51	2.78957574982725e-150	PRDX2	Malignant cells	GSE161801_IMiD_post	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13708
1.52331124830859e-154	-0.27924894192411	0.334	0.516	3.28837199172375e-150	VDAC1	Malignant cells	GSE161801_IMiD_post	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13709
1.79195454235585e-154	-0.264250707856939	0.399	0.577	3.86829227058357e-150	ADRM1	Malignant cells	GSE161801_IMiD_post	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13710
1.51931868087157e-153	0.301970657838243	0.999	0.997	3.27975323639745e-149	RPS3A	Malignant cells	GSE161801_IMiD_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13711
1.24016593931511e-151	-0.487876394038273	0.551	0.71	2.67714621319952e-147	KLF6	Malignant cells	GSE161801_IMiD_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13712
3.2983612408196e-151	0.288835868039027	0.442	0.267	7.12017241055726e-147	CREB3L2	Malignant cells	GSE161801_IMiD_post	ENSG00000182158	64764	cAMP responsive element binding protein 3 like 2	BBF2H7|TCAG_1951439	protein_coding	Q70SY1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13713
1.22735053972174e-150	-0.251724293409354	0.29	0.47	2.64948161009732e-146	HAGH	Malignant cells	GSE161801_IMiD_post	ENSG00000063854	3029	hydroxyacylglutathione hydrolase	GLO2|GLXII|HAGH1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13714
2.18861372229697e-150	-0.293507562671022	0.633	0.768	4.72456044232246e-146	ATP5IF1	Malignant cells	GSE161801_IMiD_post	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13715
6.18048814256039e-150	0.378407087518059	0.34	0.173	1.33418197533451e-145	AC245014.3	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13716
1.37523388269281e-149	0.309441960336871	0.352	0.189	2.96871738256896e-145	TNFRSF13B	Malignant cells	GSE161801_IMiD_post	ENSG00000240505	23495	TNF receptor superfamily member 13B	CD267|IGAD2|TACI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13717
1.54567796567427e-149	-0.260082833962668	0.333	0.51	3.33665502450105e-145	GORASP2	Malignant cells	GSE161801_IMiD_post	ENSG00000115806	26003	golgi reassembly stacking protein 2	GOLPH6|GRASP55|GRS2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13718
2.66732046397648e-149	-0.477481734985584	0.82	0.893	5.75794468558604e-145	ACTG1	Malignant cells	GSE161801_IMiD_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13719
1.26051011063683e-148	0.330907046701673	0.264	0.114	2.72106317583174e-144	Z93241.1	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13720
3.90501564355279e-148	-0.397498998243656	0.982	0.984	8.4297572697374e-144	MT-ND1	Malignant cells	GSE161801_IMiD_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13721
2.3983129157411e-147	0.357955245647714	0.312	0.154	5.17723809121032e-143	FCER2	Malignant cells	GSE161801_IMiD_post	ENSG00000104921	2208	Fc epsilon receptor II	CD23|CD23A|CLEC4J|FCE2|FcepsilonRII|FCErII	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13722
2.76145580947073e-146	-0.259898855774248	0.352	0.53	5.96115465590447e-142	PMVK	Malignant cells	GSE161801_IMiD_post	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13723
3.74670262705414e-146	0.26191884039862	0.303	0.146	8.08800696102177e-142	MAPKAPK2	Malignant cells	GSE161801_IMiD_post	ENSG00000162889	9261	MAPK activated protein kinase 2	MK2	protein_coding	P49137	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13724
2.37845631669866e-145	-0.404559905568769	0.136	0.28	5.13437365085739e-141	MDK	Malignant cells	GSE161801_IMiD_post	ENSG00000110492	4192	midkine	FLJ27379|MK|NEGF2	protein_coding	P21741	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13725
1.73226275636817e-144	-0.27203863783604	0.485	0.656	3.73943561217196e-140	CYC1	Malignant cells	GSE161801_IMiD_post	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13726
6.73177469986107e-144	-0.298530876240506	0.439	0.603	1.45318820445901e-139	RHOA	Malignant cells	GSE161801_IMiD_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13727
1.79201241005096e-143	-0.340023561373712	0.325	0.472	3.86841718957702e-139	DNPH1	Malignant cells	GSE161801_IMiD_post	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13728
1.21828195673272e-142	-0.268521676756617	0.573	0.754	2.62990525999891e-138	SRSF5	Malignant cells	GSE161801_IMiD_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13729
1.40408061977431e-142	0.352226866491789	0.564	0.428	3.0309888339068e-138	MRPL41	Malignant cells	GSE161801_IMiD_post	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13730
2.07414950779103e-142	-0.26527568342683	0.416	0.597	4.47746654246849e-138	BRK1	Malignant cells	GSE161801_IMiD_post	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13731
3.57830819652218e-142	-0.252429655426006	0.159	0.309	7.72449390383243e-138	CRNDE	Malignant cells	GSE161801_IMiD_post	ENSG00000245694	101927480	uncharacterized LOC101927480	CRNDEP|LINC00180|LOC643911	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13732
4.73212436638198e-142	-0.309674153789955	0.356	0.514	1.02152368697088e-137	FDPS	Malignant cells	GSE161801_IMiD_post	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13733
5.9072724655701e-142	-0.321007407713937	0.541	0.693	1.27520290714262e-137	SRSF2	Malignant cells	GSE161801_IMiD_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13734
1.50783427251148e-141	0.585393084647478	0.852	0.816	3.25496184407052e-137	TMEM59	Malignant cells	GSE161801_IMiD_post	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13735
1.60884026288904e-141	0.271850456593596	0.514	0.344	3.47300347549858e-137	TMEM167A	Malignant cells	GSE161801_IMiD_post	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13736
7.65240358982317e-141	-0.254896950053343	0.218	0.379	1.65192436293513e-136	SNRPA1	Malignant cells	GSE161801_IMiD_post	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13737
3.23661496328187e-140	-0.288347572316558	0.47	0.628	6.98688072123658e-136	KDELR1	Malignant cells	GSE161801_IMiD_post	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13738
9.37485696794261e-140	-0.250875818385416	0.371	0.543	2.02375037366977e-135	PHB	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13739
2.36795181203392e-139	-0.26275301548191	0.217	0.379	5.11169757663763e-135	C6orf48	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13740
1.26036252352327e-138	-0.269973574570173	0.274	0.433	2.72074457952969e-134	TIMM17A	Malignant cells	GSE161801_IMiD_post	ENSG00000134375	10440	translocase of inner mitochondrial membrane 17A	TIM17|TIM17A	protein_coding	Q99595	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13741
3.04717567947392e-136	-0.264829563810614	0.465	0.63	6.57793813928034e-132	RHEB	Malignant cells	GSE161801_IMiD_post	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13742
4.77213548334398e-136	-0.28502992751175	0.502	0.632	1.03016088678946e-131	SSBP1	Malignant cells	GSE161801_IMiD_post	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13743
2.60355394347309e-135	-0.25862729740697	0.479	0.654	5.62029189777535e-131	NAP1L1	Malignant cells	GSE161801_IMiD_post	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13744
3.8959838893291e-135	-0.2763162760997	0.215	0.37	8.41026042189474e-131	MAP1LC3B	Malignant cells	GSE161801_IMiD_post	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13745
4.87013819458184e-135	-0.266870234123875	0.277	0.44	1.05131673206438e-130	CACYBP	Malignant cells	GSE161801_IMiD_post	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13746
6.78398631027092e-135	-0.253460675852294	0.346	0.514	1.46445912479818e-130	ILF2	Malignant cells	GSE161801_IMiD_post	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13747
1.43225660386414e-134	0.387845973694564	0.389	0.243	3.09181233076152e-130	GLRX	Malignant cells	GSE161801_IMiD_post	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13748
9.45193633353982e-133	-0.27110351210766	0.572	0.717	2.04038949632124e-128	RPN1	Malignant cells	GSE161801_IMiD_post	ENSG00000163902	6184	ribophorin I	OST1	protein_coding	P04843	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13749
8.44385403611877e-132	-0.261438025387412	0.585	0.748	1.82277477077696e-127	CRELD2	Malignant cells	GSE161801_IMiD_post	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13750
1.48128307678671e-129	-0.285439408538441	0.531	0.655	3.19764577785948e-125	UFC1	Malignant cells	GSE161801_IMiD_post	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13751
1.4658287157099e-128	-0.290306137558229	0.518	0.639	3.16428444860296e-124	NDUFAF3	Malignant cells	GSE161801_IMiD_post	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13752
3.15027408641502e-128	-0.258977144148866	0.651	0.799	6.80049667034411e-124	COX8A	Malignant cells	GSE161801_IMiD_post	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13753
2.25459583675967e-127	0.270398572095436	0.293	0.148	4.86699603281309e-123	PELI1	Malignant cells	GSE161801_IMiD_post	ENSG00000197329	57162	pellino E3 ubiquitin protein ligase 1	NA	protein_coding	Q96FA3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13754
2.94115037025728e-127	0.929677604479643	0.347	0.213	6.3490613042744e-123	ADM	Malignant cells	GSE161801_IMiD_post	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13755
1.61025531286258e-126	-0.297790780252742	0.814	0.882	3.47605814387646e-122	TXN	Malignant cells	GSE161801_IMiD_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13756
5.30180514872458e-126	-0.371991322986635	0.699	0.733	1.14450067745517e-121	TPI1	Malignant cells	GSE161801_IMiD_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13757
1.0667131205978e-123	-0.301788683781332	0.164	0.301	2.30271361343447e-119	MIR4435-2HG	Malignant cells	GSE161801_IMiD_post	ENSG00000172965	541471	MIR4435-2 host gene	AGD2|AK001796|LINC00978|lncRNA-AWPPH|MIR4435-1HG|MORRBID	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13758
7.2780289594628e-123	0.287138334790602	0.42	0.261	1.57110811147923e-118	TYMP	Malignant cells	GSE161801_IMiD_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13759
9.08509905947267e-123	-0.251920752541577	0.486	0.63	1.96120033396836e-118	PSMB7	Malignant cells	GSE161801_IMiD_post	ENSG00000136930	5695	proteasome 20S subunit beta 7	Z	protein_coding	Q99436	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13760
2.44969788034232e-120	0.312303266145858	0.43	0.287	5.28816281429496e-116	STT3B	Malignant cells	GSE161801_IMiD_post	ENSG00000163527	201595	STT3 oligosaccharyltransferase complex catalytic subunit B	FLJ90106|SIMP|STT3-B	protein_coding	Q8TCJ2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13761
6.34791726041366e-120	0.294594179513079	0.684	0.558	1.3703248990055e-115	GYPC	Malignant cells	GSE161801_IMiD_post	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13762
3.60742477811669e-118	-0.461012293800593	0.351	0.512	7.78734786852051e-114	RHOB	Malignant cells	GSE161801_IMiD_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13763
6.11264975093797e-118	0.574285339981993	0.722	0.63	1.31953770173498e-113	HIST1H1C	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13764
1.67482616496207e-113	-0.251094398740007	0.266	0.417	3.61544724230363e-109	CKLF	Malignant cells	GSE161801_IMiD_post	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13765
4.85532982554518e-113	0.371727228184574	0.85	0.75	1.04812004944044e-108	H1FX	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13766
6.21993418448463e-111	-0.371382883492785	0.753	0.844	1.3426971924047e-106	HLA-E	Malignant cells	GSE161801_IMiD_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13767
1.24556876800703e-110	0.317250537887234	0.71	0.649	2.68880929949678e-106	ZNF706	Malignant cells	GSE161801_IMiD_post	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13768
6.35786491055434e-109	-0.259981987848861	0.45	0.602	1.37247229824137e-104	PLP2	Malignant cells	GSE161801_IMiD_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13769
6.3411736610155e-108	0.276413593004577	0.324	0.193	1.36886915820342e-103	C11orf24	Malignant cells	GSE161801_IMiD_post	ENSG00000171067	53838	chromosome 11 open reading frame 24	DM4E3	protein_coding	Q96F05	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13770
3.19886933358452e-105	-0.252203353117036	0.321	0.472	6.90539923040891e-101	IDS	Malignant cells	GSE161801_IMiD_post	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13771
3.21334447760675e-105	-0.260796993988386	0.445	0.572	6.9366467238097e-101	CCT3	Malignant cells	GSE161801_IMiD_post	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13772
7.89709157856496e-105	-0.255115897416112	0.922	0.953	1.70474515906482e-100	FKBP11	Malignant cells	GSE161801_IMiD_post	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13773
1.77602800300027e-104	0.269391405894043	0.54	0.403	3.83391165007668e-100	CDV3	Malignant cells	GSE161801_IMiD_post	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13774
3.29977618985242e-102	-0.324790783861935	0.235	0.368	7.12322686103442e-98	GGH	Malignant cells	GSE161801_IMiD_post	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13775
1.73500903884735e-101	-0.273142407128684	0.51	0.631	3.74536401215978e-97	PSMA4	Malignant cells	GSE161801_IMiD_post	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13776
1.14331773991752e-100	-0.283979943321191	0.56	0.638	2.46808000515996e-96	KRT10	Malignant cells	GSE161801_IMiD_post	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13777
5.06693942549043e-99	0.38270833519853	0.496	0.355	1.09380021378062e-94	HIST1H2AC	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13778
1.35569399774053e-97	-0.478773674542143	0.57	0.651	2.92653663292249e-93	HSPE1	Malignant cells	GSE161801_IMiD_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13779
2.23516348682066e-97	0.355205377881266	1	1	4.82504741899975e-93	RPS27	Malignant cells	GSE161801_IMiD_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13780
1.07262313438348e-95	-0.351641000212937	0.558	0.705	2.31547156019362e-91	HMGN2	Malignant cells	GSE161801_IMiD_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13781
1.3565256519614e-94	-0.324325117792009	0.529	0.653	2.92833192488907e-90	LDHA	Malignant cells	GSE161801_IMiD_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13782
3.92634482831664e-94	0.285079786992042	0.443	0.321	8.47580058088714e-90	KLF13	Malignant cells	GSE161801_IMiD_post	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13783
1.47753183616129e-92	-0.270317499608258	0.239	0.356	3.18954797472137e-88	QPRT	Malignant cells	GSE161801_IMiD_post	ENSG00000103485	23475	quinolinate phosphoribosyltransferase	QPRTase	protein_coding	Q15274	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13784
5.36120089185233e-92	0.48779175975843	0.539	0.425	1.15732243652416e-87	DUSP5	Malignant cells	GSE161801_IMiD_post	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13785
5.50606114513478e-91	-0.490278438768594	0.811	0.822	1.18859341940025e-86	TSC22D3	Malignant cells	GSE161801_IMiD_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13786
1.14816284055052e-90	0.295302408478559	0.374	0.257	2.47853912389641e-86	TSPAN13	Malignant cells	GSE161801_IMiD_post	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13787
1.98883561423007e-89	-0.264174395213806	0.337	0.453	4.29329944043844e-85	TAPBPL	Malignant cells	GSE161801_IMiD_post	ENSG00000139192	55080	TAP binding protein like	FLJ10143|TAPBP-R|TAPBPR	protein_coding	Q9BX59	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13788
1.99682426528582e-84	-0.27085788689022	0.613	0.725	4.31054454147249e-80	ANAPC16	Malignant cells	GSE161801_IMiD_post	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13789
9.39460700973364e-84	-0.692133514437476	0.348	0.483	2.0280138151912e-79	CCL3	Malignant cells	GSE161801_IMiD_post	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13790
2.24726250025297e-83	0.334979968271093	0.722	0.69	4.85116555929608e-79	EIF4A2	Malignant cells	GSE161801_IMiD_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13791
1.63753411718657e-82	-0.393841212855215	0.781	0.894	3.53494489877065e-78	ITM2B	Malignant cells	GSE161801_IMiD_post	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13792
4.52245032312136e-82	0.583866275718226	0.982	0.991	9.76261351252209e-78	H3F3B	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13793
6.64636681714238e-82	0.363465644545523	0.65	0.536	1.43475120481653e-77	CXCR4	Malignant cells	GSE161801_IMiD_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13794
3.05314707751039e-80	-0.251772774359027	0.996	0.99	6.59082859622169e-76	MT-ND2	Malignant cells	GSE161801_IMiD_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13795
2.03507371851547e-77	-0.468386477322282	0.988	0.99	4.39311363615935e-73	MZB1	Malignant cells	GSE161801_IMiD_post	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13796
4.93533685891828e-77	-0.563998634912519	0.578	0.666	1.06539116773469e-72	YPEL5	Malignant cells	GSE161801_IMiD_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13797
4.99738254499363e-75	-0.452608641115332	0.188	0.291	1.07878496998777e-70	DNAJB1	Malignant cells	GSE161801_IMiD_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13798
6.11433563095962e-75	0.261312844194607	0.789	0.774	1.31990163265525e-70	SELENOT	Malignant cells	GSE161801_IMiD_post	ENSG00000198843	51714	selenoprotein T	SELT	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13799
2.15281302357375e-74	0.419357959989533	0.457	0.334	4.64727747398866e-70	GADD45A	Malignant cells	GSE161801_IMiD_post	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13800
1.50199994967777e-73	0.273286975843508	0.992	0.991	3.24236729136941e-69	RPL10A	Malignant cells	GSE161801_IMiD_post	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13801
2.91323689504456e-67	-0.282195501154339	0.535	0.632	6.2888044853327e-63	CFLAR	Malignant cells	GSE161801_IMiD_post	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13802
1.45306086275129e-66	0.34398377263523	0.67	0.648	3.13672248442122e-62	EID1	Malignant cells	GSE161801_IMiD_post	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13803
3.77666978983058e-65	-0.259189249238644	0.166	0.257	8.15269707530727e-61	KLF10	Malignant cells	GSE161801_IMiD_post	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13804
2.36700838099978e-62	-0.334941963894387	0.638	0.752	5.10966099206422e-58	H2AFZ	Malignant cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13805
9.6972358102118e-61	-0.330587975324495	0.409	0.509	2.09334229435042e-56	TUBB	Malignant cells	GSE161801_IMiD_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13806
4.74289902422391e-60	-0.603908064575968	0.368	0.426	1.02384961235922e-55	IFITM1	Malignant cells	GSE161801_IMiD_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13807
3.14558350072806e-57	-0.286843599481996	0.568	0.62	6.79037110302165e-53	IDH2	Malignant cells	GSE161801_IMiD_post	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13808
2.54857778065653e-56	0.291116009261536	0.559	0.463	5.50161485510325e-52	ISG15	Malignant cells	GSE161801_IMiD_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13809
7.28092511542755e-53	0.254545835346104	0.994	0.993	1.57173330466735e-48	RPL7A	Malignant cells	GSE161801_IMiD_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13810
1.97335790678207e-52	0.401286812464833	0.581	0.49	4.25988771337045e-48	CCND1	Malignant cells	GSE161801_IMiD_post	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13811
4.92989322772374e-51	-0.282528651172189	0.948	0.96	1.06421605106872e-46	HERPUD1	Malignant cells	GSE161801_IMiD_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13812
1.79166558931166e-50	0.273270828246398	0.48	0.381	3.86766850764708e-46	EMP3	Malignant cells	GSE161801_IMiD_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13813
1.19221795810795e-45	0.321954593242619	0.983	0.994	2.57364090616762e-41	RPS2	Malignant cells	GSE161801_IMiD_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13814
8.30769363672376e-42	0.254452687206244	1	1	1.79338182535956e-37	RPL10	Malignant cells	GSE161801_IMiD_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13815
2.06054314738063e-41	-0.47871351393513	0.28	0.354	4.44809449225057e-37	DDIT4	Malignant cells	GSE161801_IMiD_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13816
8.61349973212254e-29	-0.252042814073958	0.201	0.265	1.85939618717329e-24	CD27	Malignant cells	GSE161801_IMiD_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13817
4.74778761051712e-27	0.280459529819973	0.73	0.774	1.02490491148233e-22	NPC2	Malignant cells	GSE161801_IMiD_post	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13818
4.21930679388526e-22	0.373357039092292	0.471	0.459	9.10821757596011e-18	KLF2	Malignant cells	GSE161801_IMiD_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13819
6.27988373393868e-19	0.280261618054405	0.384	0.528	1.35563850164534e-14	QPCT	Malignant cells	GSE161801_IMiD_post	ENSG00000115828	25797	glutaminyl-peptide cyclotransferase	GCT|QC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13820
8.5812764076082e-07	-0.498022483060887	0.565	0.526	0.0185244013811038	RGS2	Malignant cells	GSE161801_IMiD_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13821
0	-1.31611916193464	0.572	0.914	0	DUSP1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13822
0	1.27774999231932	0.98	0.916	0	RPS26	CD8+ T cells	GSE161801_IMiD_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13823
0	-0.861272063435823	0.182	0.572	0	PPP1R15A	CD8+ T cells	GSE161801_IMiD_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13824
5.71239606063519e-288	-0.379873836848785	0.045	0.289	1.23313493760932e-283	CXCL8	CD8+ T cells	GSE161801_IMiD_post	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13825
9.5664484613004e-263	-0.509473806222554	0.069	0.333	2.06510922934092e-258	AC020916.1	CD8+ T cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13826
2.46840874677756e-255	-0.805312269568662	0.351	0.691	5.32855396166871e-251	KLF6	CD8+ T cells	GSE161801_IMiD_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13827
3.42288616177362e-252	0.931625850495268	0.534	0.108	7.38898435742071e-248	RPS4Y1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13828
5.23899648676063e-225	-0.786496897316651	0.578	0.81	1.13094217159702e-220	TSC22D3	CD8+ T cells	GSE161801_IMiD_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13829
1.9382510325584e-209	-0.853228550448024	0.354	0.655	4.18410250398383e-205	FOS	CD8+ T cells	GSE161801_IMiD_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13830
4.89919434491509e-195	-0.564487612187351	0.131	0.395	1.05758908323682e-190	PMAIP1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13831
7.35288116032876e-177	-0.403449644380165	0.118	0.366	1.58726645608017e-172	XIST	CD8+ T cells	GSE161801_IMiD_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13832
3.57386060533259e-173	-0.745620139654547	0.412	0.703	7.71489288873146e-169	JUN	CD8+ T cells	GSE161801_IMiD_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13833
3.19601130073796e-156	-0.485166988577582	0.98	0.993	6.89922959490303e-152	MT-ATP6	CD8+ T cells	GSE161801_IMiD_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13834
7.76836166088447e-154	-0.38127378825039	1	1	1.67695623173513e-149	MT-CO2	CD8+ T cells	GSE161801_IMiD_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13835
6.11122631204455e-152	-0.432067853883702	0.967	0.994	1.31923042398106e-147	UBC	CD8+ T cells	GSE161801_IMiD_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13836
2.36268857976074e-146	0.745756584069078	0.534	0.249	5.1003358371295e-142	KLF2	CD8+ T cells	GSE161801_IMiD_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13837
1.94720982743006e-142	-0.987902577487718	0.452	0.709	4.20344185447327e-138	GNLY	CD8+ T cells	GSE161801_IMiD_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13838
1.62531877680292e-139	-0.496783981515955	0.494	0.746	3.50857564348445e-135	CD69	CD8+ T cells	GSE161801_IMiD_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13839
1.14167310878967e-133	-0.558134864933937	0.212	0.454	2.46452973994426e-129	NFKBIA	CD8+ T cells	GSE161801_IMiD_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13840
1.26817120129346e-133	-0.310704531853904	1	1	2.7376011722322e-129	RPS4X	CD8+ T cells	GSE161801_IMiD_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13841
6.72739644132996e-129	-0.334915576165913	0.998	0.999	1.4522430697899e-124	EIF1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13842
1.73222559365518e-123	-0.336098678062315	0.999	0.999	3.73935538902344e-119	PTMA	CD8+ T cells	GSE161801_IMiD_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13843
5.42186018068996e-114	-0.316474659899502	0.092	0.268	1.17041695720554e-109	MYADM	CD8+ T cells	GSE161801_IMiD_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13844
1.64450066599088e-104	-0.370923114380244	0.156	0.354	3.54998358767451e-100	JUND	CD8+ T cells	GSE161801_IMiD_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13845
9.22096790026906e-104	0.494449312049486	0.502	0.268	1.99053034063108e-99	GIMAP7	CD8+ T cells	GSE161801_IMiD_post	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13846
2.42455665993315e-103	0.744960473422369	0.51	0.317	5.23389046179768e-99	HBB	CD8+ T cells	GSE161801_IMiD_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13847
1.65427201644703e-99	-0.50674318506086	0.775	0.873	3.5710770019042e-95	CXCR4	CD8+ T cells	GSE161801_IMiD_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13848
7.7006998608392e-97	-0.396005609715831	0.86	0.926	1.66235007895936e-92	BTG1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13849
2.25152492806912e-95	-0.265560900403237	1	1	4.8603668622228e-91	MT-CO1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13850
7.72082497777633e-92	0.270238937220337	1	1	1.66669448795258e-87	RPLP1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13851
5.08974100064225e-88	-0.394493128428171	0.268	0.47	1.09872238980864e-83	YPEL5	CD8+ T cells	GSE161801_IMiD_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13852
6.27286938622023e-87	-0.352859796454291	0.93	0.956	1.35412431440336e-82	DDX5	CD8+ T cells	GSE161801_IMiD_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13853
2.10485993978729e-83	0.429468646774813	0.452	0.243	4.54376115201883e-79	GIMAP4	CD8+ T cells	GSE161801_IMiD_post	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13854
8.09769695013835e-83	-0.525756071139277	0.322	0.53	1.74804984062637e-78	RGS1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13855
3.8744446411908e-81	-0.301033764197389	0.991	0.995	8.36376364693858e-77	MT-ND2	CD8+ T cells	GSE161801_IMiD_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13856
1.55898753264917e-79	-0.320581309099846	0.951	0.973	3.36538638672975e-75	SRGN	CD8+ T cells	GSE161801_IMiD_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13857
1.02638300115589e-78	0.252757300264387	1	1	2.21565298459522e-74	RPS29	CD8+ T cells	GSE161801_IMiD_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13858
9.35748756087811e-76	-0.402695046494305	0.492	0.665	2.02000083976676e-71	PNRC1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13859
3.0500837416999e-75	0.407807714851998	0.529	0.323	6.58421577320758e-71	PTP4A2	CD8+ T cells	GSE161801_IMiD_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13860
4.70617095124968e-74	0.500072671010105	0.828	0.705	1.01592112324627e-69	TRAC	CD8+ T cells	GSE161801_IMiD_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13861
3.20870814044148e-70	-0.341680502585591	0.928	0.945	6.92663826277103e-66	RPS10	CD8+ T cells	GSE161801_IMiD_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13862
3.99666065602312e-70	-0.274705412253549	0.998	1	8.62759135815711e-66	MT-ND4	CD8+ T cells	GSE161801_IMiD_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13863
9.978190319947e-70	0.540962289887944	0.421	0.222	2.15399194436696e-65	H1FX	CD8+ T cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13864
3.4501385716766e-69	0.44963727992622	0.268	0.096	7.44781413467827e-65	HBA2	CD8+ T cells	GSE161801_IMiD_post	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13865
7.54003687628619e-69	0.757790936765364	0.687	0.61	1.6276677604839e-64	GZMB	CD8+ T cells	GSE161801_IMiD_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13866
4.73830240092746e-66	0.750200227511216	0.704	0.567	1.02285733928821e-61	CCL4	CD8+ T cells	GSE161801_IMiD_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13867
4.8059272593811e-66	-0.406185059946503	0.801	0.879	1.0374555174826e-61	GZMH	CD8+ T cells	GSE161801_IMiD_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13868
5.85787731064525e-66	-0.313742495009317	0.916	0.941	1.26453997504899e-61	MT-ND1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13869
2.04642126283123e-65	-0.296552607526133	0.943	0.97	4.41760958007378e-61	HLA-E	CD8+ T cells	GSE161801_IMiD_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13870
2.47448254243188e-64	0.344369975998372	0.335	0.157	5.3416654643477e-60	YPEL3	CD8+ T cells	GSE161801_IMiD_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13871
2.52774870693886e-64	0.356055069210163	0.455	0.261	5.45665113366891e-60	SRSF9	CD8+ T cells	GSE161801_IMiD_post	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13872
2.19528534067823e-54	0.270988017319586	0.999	0.998	4.7389624649221e-50	RPL9	CD8+ T cells	GSE161801_IMiD_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13873
8.0416530043486e-54	0.341764996362832	0.619	0.428	1.73595163404873e-49	S100A11	CD8+ T cells	GSE161801_IMiD_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13874
2.16075036153139e-52	-0.292989448041339	1	1	4.66441180543781e-48	ACTB	CD8+ T cells	GSE161801_IMiD_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13875
3.20113665229745e-52	0.328199107442418	0.837	0.747	6.9102936913145e-48	PTPRC	CD8+ T cells	GSE161801_IMiD_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13876
2.4100268725362e-51	0.307430779467321	0.356	0.193	5.2025250097439e-47	TAP1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13877
3.45637239409171e-50	0.30436329276923	0.927	0.845	7.46127108712577e-46	RPL36A	CD8+ T cells	GSE161801_IMiD_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13878
2.65572864026228e-48	0.32884841428714	0.479	0.323	5.73292141573419e-44	CTSC	CD8+ T cells	GSE161801_IMiD_post	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13879
4.14228979606323e-46	0.372802239237412	0.286	0.143	8.94196098276168e-42	HBA1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13880
3.78139806515983e-45	-0.327631864191913	0.407	0.531	8.16290400326053e-41	CYCS	CD8+ T cells	GSE161801_IMiD_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13881
1.21068009723859e-44	-0.293936584226605	0.275	0.421	2.61349512590894e-40	DNAJB1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13882
2.92381725113234e-44	-0.277049146778167	0.735	0.798	6.31164430001939e-40	CIRBP	CD8+ T cells	GSE161801_IMiD_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13883
7.7388219418946e-41	-0.318941874040467	0.686	0.764	1.67057949259679e-36	ANXA1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13884
7.83431661496906e-41	-0.269992601683848	0.655	0.749	1.69119392767337e-36	HNRNPDL	CD8+ T cells	GSE161801_IMiD_post	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13885
2.23772601429546e-40	-0.314012216367223	0.46	0.606	4.83057914705962e-36	ITGB1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13886
2.78903717231447e-39	-0.291089341479589	0.535	0.642	6.02069454387524e-35	RBM3	CD8+ T cells	GSE161801_IMiD_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13887
3.70412582896956e-38	0.27592011173156	0.412	0.276	7.9960964269966e-34	HNRNPF	CD8+ T cells	GSE161801_IMiD_post	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13888
5.49567571364551e-38	-0.270873841308765	0.155	0.264	1.18635151630466e-33	RGS2	CD8+ T cells	GSE161801_IMiD_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13889
1.25383272234899e-37	0.264106130911561	0.343	0.207	2.70664869773477e-33	IFI16	CD8+ T cells	GSE161801_IMiD_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13890
6.61243255831509e-36	-0.260984011488944	0.365	0.489	1.42742581636348e-31	SCAND1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13891
8.61069005538115e-36	0.305010753676428	0.411	0.278	1.85878966225513e-31	ITM2A	CD8+ T cells	GSE161801_IMiD_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13892
5.61519375064845e-35	-0.318886500417189	0.487	0.596	1.21215187495248e-30	ZFP36	CD8+ T cells	GSE161801_IMiD_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13893
1.21826880050769e-33	-0.287002235553367	0.575	0.683	2.62987685965594e-29	PPP2R5C	CD8+ T cells	GSE161801_IMiD_post	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13894
1.47607412992983e-32	0.382774721123053	0.48	0.341	3.18640122427953e-28	GZMK	CD8+ T cells	GSE161801_IMiD_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13895
2.91610685028551e-31	0.306509033898143	0.809	0.756	6.29499985771133e-27	ID2	CD8+ T cells	GSE161801_IMiD_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13896
4.58916071236542e-31	-0.297073702437832	0.405	0.503	9.90662122978323e-27	HSPA5	CD8+ T cells	GSE161801_IMiD_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13897
1.13770981530321e-29	0.264932671973449	0.351	0.237	2.45597417829504e-25	EFHD2	CD8+ T cells	GSE161801_IMiD_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13898
1.39583329568959e-29	0.4144481754941	0.597	0.488	3.01318533540512e-25	CMC1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13899
1.43815708347265e-28	0.255188756788877	0.752	0.679	3.10454969609242e-24	PSMB9	CD8+ T cells	GSE161801_IMiD_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13900
1.51632697993483e-28	0.268544264768462	0.655	0.575	3.27329505158531e-24	CD2	CD8+ T cells	GSE161801_IMiD_post	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13901
8.78217281323608e-28	0.340662514736399	0.647	0.574	1.89580764519327e-23	PRF1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13902
3.21873565999914e-26	-0.263820426765552	0.155	0.253	6.94828466924015e-22	TRDC	CD8+ T cells	GSE161801_IMiD_post	ENSG00000211829	NA	NA	NA	TR_C_gene	B7Z8K6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13903
1.06536133518919e-22	0.326293114100559	0.4	0.306	2.29979551427289e-18	CDC42SE1	CD8+ T cells	GSE161801_IMiD_post	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13904
2.08937539791413e-22	-0.457377249517532	0.237	0.318	4.51033467147722e-18	TYROBP	CD8+ T cells	GSE161801_IMiD_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13905
8.76806096688996e-22	0.315053895291502	0.382	0.285	1.89276132092254e-17	C1orf56	CD8+ T cells	GSE161801_IMiD_post	ENSG00000143443	54964	chromosome 1 open reading frame 56	FLJ20519|MENT	protein_coding	Q9BUN1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13906
9.74324524001393e-43	1.41054627131535	0.982	0.884	2.10327434996181e-38	RPS26	CD4+ T cells	GSE161801_IMiD_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13907
3.60743664652983e-28	-0.504557694180834	0.094	0.395	7.78737348886394e-24	GNLY	CD4+ T cells	GSE161801_IMiD_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13908
6.64123138917033e-28	-0.598561843343771	0.993	1	1.4336426199802e-23	HLA-C	CD4+ T cells	GSE161801_IMiD_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13909
1.4849733679809e-26	0.375019537894243	1	1	3.20561200946037e-22	RPS27	CD4+ T cells	GSE161801_IMiD_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13910
7.70748926073796e-25	0.561480919199851	1	1	1.6638157067155e-20	RPS3A	CD4+ T cells	GSE161801_IMiD_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13911
5.00562869928123e-24	1.10788313085043	0.726	0.395	1.08056506731384e-19	KLF2	CD4+ T cells	GSE161801_IMiD_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13912
2.54317421405777e-23	-0.596327820925985	0.927	1	5.48995017588651e-19	UBC	CD4+ T cells	GSE161801_IMiD_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13913
1.51712101081289e-21	1.04105876031402	0.61	0.177	3.27500912604178e-17	RPS4Y1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13914
2.07648670237749e-21	-0.856177611315789	0.657	0.918	4.48251184442229e-17	DUSP1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13915
4.84332076526096e-21	0.424286035706549	1	1	1.04552765359688e-16	RPS29	CD4+ T cells	GSE161801_IMiD_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13916
4.181235558285e-19	-0.368447752476559	1	1	9.02603319966984e-15	B2M	CD4+ T cells	GSE161801_IMiD_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13917
1.5675864064699e-18	-0.423803799756865	0.14	0.415	3.38394877564658e-14	XIST	CD4+ T cells	GSE161801_IMiD_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13918
1.03140590789942e-17	0.344591766731039	1	1	2.22649593338248e-13	RPL39	CD4+ T cells	GSE161801_IMiD_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13919
1.49801944095189e-16	0.560400281899843	0.98	0.932	3.23377456718285e-12	RPL36A	CD4+ T cells	GSE161801_IMiD_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13920
2.44147186062754e-16	-0.654064222350749	0.346	0.633	5.27040530553667e-12	PPP1R15A	CD4+ T cells	GSE161801_IMiD_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13921
3.57056171802581e-16	-0.509759747086656	0.896	0.98	7.70777158070231e-12	DDX5	CD4+ T cells	GSE161801_IMiD_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13922
1.91494134351731e-15	-0.461555826110169	0.314	0.612	4.13378387825081e-11	EIF5A	CD4+ T cells	GSE161801_IMiD_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13923
7.02443237697136e-15	0.317588022677681	1	1	1.51636421721681e-10	RPS3	CD4+ T cells	GSE161801_IMiD_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13924
2.20706913426807e-14	0.314965401857449	0.999	1	4.76440014014448e-10	RPL21	CD4+ T cells	GSE161801_IMiD_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13925
4.76337131943867e-14	-0.585305311638554	0.745	0.925	1.02826896672723e-09	TSC22D3	CD4+ T cells	GSE161801_IMiD_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13926
1.05256069916928e-13	-0.271844294535635	0.126	0.354	2.27216278129673e-09	CXCL8	CD4+ T cells	GSE161801_IMiD_post	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13927
4.33481063464073e-13	-0.296100280003669	0.156	0.401	9.35755571699894e-09	PMAIP1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13928
6.90834891406894e-13	0.346745987092361	1	1	1.49130528008006e-08	RPS8	CD4+ T cells	GSE161801_IMiD_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13929
9.45691690801506e-13	-0.639049701381037	0.347	0.605	2.04146465293321e-08	NFKBIA	CD4+ T cells	GSE161801_IMiD_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13930
1.38091634183364e-12	-0.460481378208896	0.174	0.408	2.98098410711629e-08	LMNA	CD4+ T cells	GSE161801_IMiD_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13931
1.46059966429756e-12	-0.452426768805701	0.963	1	3.15299649531914e-08	MT-ATP6	CD4+ T cells	GSE161801_IMiD_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13932
2.49444147226873e-12	-0.504695376566332	0.515	0.741	5.3847508061865e-08	ITGB2	CD4+ T cells	GSE161801_IMiD_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13933
3.68354864904452e-12	-0.468825963501483	0.266	0.503	7.9516764686924e-08	HLA-DPB1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13934
3.8426705391972e-12	0.273564840307063	1	1	8.295172892965e-08	RPL13	CD4+ T cells	GSE161801_IMiD_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13935
7.53155676973463e-12	0.280438624399864	1	1	1.62583715988262e-07	RPL3	CD4+ T cells	GSE161801_IMiD_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13936
8.25807867647821e-12	-0.480237073816507	0.946	0.98	1.78267144389135e-07	SH3BGRL3	CD4+ T cells	GSE161801_IMiD_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13937
1.26032326203699e-11	-0.356197055677591	1	1	2.72065982575925e-07	MT-CO1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13938
1.28570518832072e-11	-0.31621370771588	0.992	1	2.77545179002794e-07	HLA-A	CD4+ T cells	GSE161801_IMiD_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13939
2.10617056826772e-11	-0.370954879130136	0.258	0.524	4.54659040571953e-07	HLA-DRB1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13940
2.26610467063607e-11	-0.319576291886587	1	1	4.89184015250208e-07	TMSB10	CD4+ T cells	GSE161801_IMiD_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13941
2.71131634297942e-11	0.25175834341208	1	1	5.85291858958967e-07	RPS14	CD4+ T cells	GSE161801_IMiD_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13942
5.12654088926134e-11	-0.43850716115928	0.306	0.544	1.10666638176485e-06	EML4	CD4+ T cells	GSE161801_IMiD_post	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13943
6.32061237045232e-11	0.281055146518681	1	1	1.36443059240954e-06	RPLP1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13944
8.04377752580645e-11	0.306775721999112	0.997	0.993	1.73641025449584e-06	RPS21	CD4+ T cells	GSE161801_IMiD_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13945
1.16026346715515e-10	-0.373881193676777	0.275	0.537	2.50466074654781e-06	RGS1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13946
1.39752722989172e-10	-0.443658311518774	0.999	1	3.01684203116725e-06	ACTB	CD4+ T cells	GSE161801_IMiD_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13947
1.65277354176027e-10	-0.544285236228678	0.5	0.735	3.5678422445979e-06	ITGB1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13948
2.24392404664011e-10	-0.451555654991239	0.942	1	4.843958839482e-06	IL32	CD4+ T cells	GSE161801_IMiD_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13949
3.24154209190828e-10	0.269619510235949	1	1	6.99751691380241e-06	RPL31	CD4+ T cells	GSE161801_IMiD_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13950
3.54514857672209e-10	0.29776610796657	0.989	0.986	7.65291223256998e-06	RPS17	CD4+ T cells	GSE161801_IMiD_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13951
5.36787865145839e-10	-0.325326824953964	0.998	1	1.15876396449032e-05	MT-CO2	CD4+ T cells	GSE161801_IMiD_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13952
5.75848851265253e-10	0.25570048352109	1	1	1.2430849152263e-05	RPL36	CD4+ T cells	GSE161801_IMiD_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13953
1.06192570918138e-09	-0.306538752869301	0.169	0.367	2.29237902840985e-05	SNHG15	CD4+ T cells	GSE161801_IMiD_post	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13954
1.2291836075417e-09	-0.587511691215616	0.464	0.667	2.65343865360027e-05	KLF6	CD4+ T cells	GSE161801_IMiD_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13955
1.38798441603976e-09	0.274345594588421	1	1	2.99624195890504e-05	RPS12	CD4+ T cells	GSE161801_IMiD_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13956
1.95876890380801e-09	0.761512144682691	0.505	0.299	4.22839443265036e-05	H1FX	CD4+ T cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13957
2.06068212681983e-09	-0.47243224528793	0.945	0.986	4.44839450716597e-05	S100A4	CD4+ T cells	GSE161801_IMiD_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13958
2.36299928329614e-09	-0.531893143305106	0.724	0.857	5.10100655285139e-05	S100A10	CD4+ T cells	GSE161801_IMiD_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13959
2.56378417854968e-09	0.311578151965029	0.999	1	5.5344409062352e-05	RPS20	CD4+ T cells	GSE161801_IMiD_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13960
3.06135788820461e-09	-0.353379195726457	0.256	0.476	6.60855327326729e-05	NR4A2	CD4+ T cells	GSE161801_IMiD_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13961
4.12859314335793e-09	-0.263630376116312	0.144	0.327	8.91239401856676e-05	CAPG	CD4+ T cells	GSE161801_IMiD_post	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13962
4.36528061002749e-09	-0.291455811239075	0.207	0.415	9.42333125286633e-05	SLC3A2	CD4+ T cells	GSE161801_IMiD_post	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13963
4.77214837036859e-09	-0.408469737698152	0.474	0.667	0.000103016366871147	PPP2R5C	CD4+ T cells	GSE161801_IMiD_post	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13964
5.42826617632205e-09	-0.297226139146119	0.999	1	0.000117179981948264	HLA-B	CD4+ T cells	GSE161801_IMiD_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13965
1.64471350961227e-08	-0.350893613479599	0.892	0.966	0.000355044305320001	HLA-E	CD4+ T cells	GSE161801_IMiD_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13966
1.71243149992071e-08	-0.387924667706051	0.656	0.81	0.000369662587887885	HNRNPDL	CD4+ T cells	GSE161801_IMiD_post	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13967
3.7409861053488e-08	-0.408102189454641	0.742	0.857	0.000807566670561646	CALM1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13968
4.73906571307831e-08	-0.354754600925643	0.437	0.646	0.00102302211548221	LDHA	CD4+ T cells	GSE161801_IMiD_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13969
5.17761545752052e-08	-0.424066215589699	0.742	0.898	0.00111769184881496	IFITM1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13970
5.26227121178389e-08	-0.357232237692035	0.324	0.544	0.00113596648648779	ANXA2	CD4+ T cells	GSE161801_IMiD_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13971
5.64492402264388e-08	-0.382720638561456	0.987	1	0.00121856974876813	CD52	CD4+ T cells	GSE161801_IMiD_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13972
5.98645399107291e-08	-0.548788372938747	0.959	0.973	0.00129229582305291	LTB	CD4+ T cells	GSE161801_IMiD_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13973
7.49632023141159e-08	-0.56647549374231	0.705	0.803	0.00161823064835482	ANXA1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13974
7.6515452127995e-08	0.256213747409385	1	1	0.00165173906508703	RPS13	CD4+ T cells	GSE161801_IMiD_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13975
7.75330566213177e-08	-0.349594448698671	0.257	0.449	0.00167370609328438	FLNA	CD4+ T cells	GSE161801_IMiD_post	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13976
9.86142132650822e-08	-0.326756388476138	0.136	0.299	0.00212878502175333	KLRB1	CD4+ T cells	GSE161801_IMiD_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13977
1.44779190298324e-07	-0.458071660124995	0.47	0.707	0.00312534838096992	JUN	CD4+ T cells	GSE161801_IMiD_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13978
2.39799012461674e-07	-0.40580684939534	0.727	0.878	0.00517654128201017	CD74	CD4+ T cells	GSE161801_IMiD_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13979
2.78839670592092e-07	-0.446848971678107	0.577	0.789	0.0060193119690715	FOS	CD4+ T cells	GSE161801_IMiD_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13980
2.87887797680851e-07	-0.389134198126277	0.426	0.633	0.00621463388853653	ZFP36	CD4+ T cells	GSE161801_IMiD_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13981
2.89385335382715e-07	-0.270827718398353	0.131	0.279	0.00624696123490668	CNOT6L	CD4+ T cells	GSE161801_IMiD_post	ENSG00000138767	246175	CCR4-NOT transcription complex subunit 6 like	Ccr4b|DKFZp434K098	protein_coding	Q96LI5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13982
3.22017921882781e-07	-0.262333365759242	0.385	0.605	0.0069514008796836	CYCS	CD4+ T cells	GSE161801_IMiD_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13983
9.19535354191703e-07	0.326521461506125	0.987	0.986	0.0198500096909363	MT-ND3	CD4+ T cells	GSE161801_IMiD_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13984
1.11609275746972e-06	0.308929660564268	0.291	0.102	0.0240930943554989	YPEL3	CD4+ T cells	GSE161801_IMiD_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13985
1.33536506161684e-06	-0.308016671770161	0.357	0.551	0.0288265255851227	YWHAQ	CD4+ T cells	GSE161801_IMiD_post	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13986
2.18025113660208e-06	-0.341907909485469	0.685	0.81	0.0470650812858292	MYL12B	CD4+ T cells	GSE161801_IMiD_post	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13987
2.71814961169613e-280	-1.80697442531119	0.36	0.793	5.86766956676845e-276	CXCL8	Mono/Macro	GSE161801_IMiD_post	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13988
1.38678471767512e-261	0.859283181152029	0.982	0.861	2.99365217004529e-257	RPS26	Mono/Macro	GSE161801_IMiD_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13989
2.53161992528114e-246	1.01501110632737	0.496	0.005	5.46500793270439e-242	HLA-DRB5	Mono/Macro	GSE161801_IMiD_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13990
2.21954349254679e-211	-1.16953342763125	0.628	0.873	4.79132853736076e-207	NFKBIA	Mono/Macro	GSE161801_IMiD_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13991
1.6759832349896e-210	-0.931175209735625	0.224	0.596	3.61794500937204e-206	IL1B	Mono/Macro	GSE161801_IMiD_post	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13992
9.35781810311878e-209	-0.857953614848996	0.97	0.99	2.02007219392025e-204	DUSP1	Mono/Macro	GSE161801_IMiD_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13993
3.9521064053658e-181	-0.437406479464155	0.079	0.328	8.53141209726316e-177	FOLR3	Mono/Macro	GSE161801_IMiD_post	ENSG00000110203	2352	folate receptor gamma	FR-G|FRgamma	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13994
5.42821000543995e-161	-0.69027059231152	0.492	0.825	1.17178769387432e-156	KLF6	Mono/Macro	GSE161801_IMiD_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13995
5.40883213615707e-153	-0.462725429296922	0.142	0.426	1.16760459323223e-148	XIST	Mono/Macro	GSE161801_IMiD_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13996
2.69773245719085e-146	-0.46054455827022	0.151	0.429	5.82359505533788e-142	GNLY	Mono/Macro	GSE161801_IMiD_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13997
3.6792813918476e-136	0.692856725321968	0.528	0.158	7.94246474058142e-132	RPS4Y1	Mono/Macro	GSE161801_IMiD_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13998
4.125780802371e-118	-0.622160854065859	0.64	0.861	8.90632301807828e-114	ZFP36	Mono/Macro	GSE161801_IMiD_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	13999
9.47231792184775e-112	-0.52812933802053	0.365	0.659	2.04478926978927e-107	PPP1R15A	Mono/Macro	GSE161801_IMiD_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14000
2.34740284198158e-88	-0.362842115974135	0.131	0.333	5.06733851498563e-84	AC020916.1	Mono/Macro	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14001
6.92566506481332e-85	-0.68176723527087	0.25	0.471	1.49504331754125e-80	GPR183	Mono/Macro	GSE161801_IMiD_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14002
6.12941757826298e-82	-0.449077724978817	0.348	0.596	1.32315737261963e-77	ATP2B1-AS1	Mono/Macro	GSE161801_IMiD_post	ENSG00000271614	NA	NA	LINC00936	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14003
1.0602294013338e-81	-0.547665210093917	0.59	0.885	2.28871720865928e-77	AC020656.1	Mono/Macro	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14004
5.72429951969129e-81	-0.398914392211964	0.918	0.981	1.23570453731576e-76	UBC	Mono/Macro	GSE161801_IMiD_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14005
1.51240341116528e-78	0.441575635366724	0.251	0.031	3.26482524368248e-74	TMEM176B	Mono/Macro	GSE161801_IMiD_post	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14006
1.35447920665253e-73	-0.455239298096021	0.459	0.678	2.92391426340082e-69	JUND	Mono/Macro	GSE161801_IMiD_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14007
1.63340513657822e-73	-0.465221275058338	0.203	0.406	3.5260316683314e-69	PTGS2	Mono/Macro	GSE161801_IMiD_post	ENSG00000073756	5743	prostaglandin-endoperoxide synthase 2	COX2	protein_coding	P35354	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14008
3.02095896973438e-72	-0.672418026626973	0.277	0.491	6.52134412796562e-68	G0S2	Mono/Macro	GSE161801_IMiD_post	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14009
1.41178567469161e-71	-0.474869244490745	0.691	0.847	3.04762173595677e-67	NAMPT	Mono/Macro	GSE161801_IMiD_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14010
1.02609033881997e-70	0.349507675277934	1	1	2.21502121441068e-66	RPS3A	Mono/Macro	GSE161801_IMiD_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14011
1.78081524469774e-69	-0.288602248930958	0.108	0.272	3.84424586872901e-65	AC103591.3	Mono/Macro	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14012
2.88039062780238e-68	-0.305779345260471	0.125	0.301	6.217899248237e-64	ANKRD28	Mono/Macro	GSE161801_IMiD_post	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14013
2.55301627319647e-66	0.328543018000274	0.997	0.996	5.51119622894921e-62	MT-ND3	Mono/Macro	GSE161801_IMiD_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14014
7.63683028772486e-66	-0.536658265051768	0.194	0.395	1.64856255421116e-61	CXCL2	Mono/Macro	GSE161801_IMiD_post	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14015
2.01766848408975e-64	-0.322170910302802	0.252	0.467	4.35554095660454e-60	NKG7	Mono/Macro	GSE161801_IMiD_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14016
3.63102731200491e-63	-0.464773107176545	0.837	0.939	7.83829865842499e-59	CD52	Mono/Macro	GSE161801_IMiD_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14017
4.53006345865386e-63	0.279703988865553	1	1	9.77904798819608e-59	RPLP1	Mono/Macro	GSE161801_IMiD_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14018
5.85808308855572e-60	-0.454715396587496	0.834	0.837	1.26458439632652e-55	ITGB2	Mono/Macro	GSE161801_IMiD_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14019
3.79649833493912e-58	-0.414891506206876	0.309	0.503	8.19550095563307e-54	DUSP6	Mono/Macro	GSE161801_IMiD_post	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14020
8.51299893694614e-58	-0.287953693339571	0.193	0.377	1.83770108051856e-53	CD83	Mono/Macro	GSE161801_IMiD_post	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14021
8.34846559501327e-57	0.465257218493973	0.674	0.508	1.80218326799551e-52	CEBPD	Mono/Macro	GSE161801_IMiD_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14022
4.17918113970978e-56	-0.316922821579943	0.198	0.37	9.0215983262915e-52	AC245128.3	Mono/Macro	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14023
8.57834787370949e-55	0.268094113886224	0.998	0.995	1.85180795549767e-50	OAZ1	Mono/Macro	GSE161801_IMiD_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14024
5.07614989597076e-54	-0.317399879198983	0.999	0.999	1.09578847804321e-49	SRGN	Mono/Macro	GSE161801_IMiD_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14025
7.04727414440897e-53	-0.280495412950075	0.976	0.993	1.52129506955356e-48	HLA-C	Mono/Macro	GSE161801_IMiD_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14026
3.0096335020209e-52	-0.382914765259687	0.464	0.64	6.49689584081252e-48	NFKBIZ	Mono/Macro	GSE161801_IMiD_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14027
5.31783199185859e-52	0.412815491424198	0.607	0.442	1.14796039208251e-47	BRI3	Mono/Macro	GSE161801_IMiD_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14028
5.63805035377806e-52	-0.311551905621178	0.868	0.929	1.21708592987007e-47	DDX5	Mono/Macro	GSE161801_IMiD_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14029
1.11626340652998e-51	0.516506988067977	0.626	0.435	2.40967781567628e-47	LGALS2	Mono/Macro	GSE161801_IMiD_post	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14030
9.30884878581081e-50	0.390666547179889	0.36	0.169	2.00950118739298e-45	KLF2	Mono/Macro	GSE161801_IMiD_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14031
2.36231280927648e-49	-0.379713830197547	0.269	0.437	5.09952466138513e-45	CLEC4E	Mono/Macro	GSE161801_IMiD_post	ENSG00000166523	26253	C-type lectin domain family 4 member E	CLECSF9|MINCLE	protein_coding	Q9ULY5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14032
2.685127926454e-45	-0.378108988953885	0.952	0.976	5.79638565483624e-41	SAT1	Mono/Macro	GSE161801_IMiD_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14033
3.43733962708703e-45	-0.390246125926642	0.678	0.785	7.42018505299277e-41	CTSD	Mono/Macro	GSE161801_IMiD_post	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14034
1.60380089075375e-44	-0.339904442263058	0.607	0.752	3.46212498287012e-40	PNRC1	Mono/Macro	GSE161801_IMiD_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14035
2.20021035104699e-44	-0.25980226920268	0.156	0.303	4.74959408480513e-40	TNFAIP3	Mono/Macro	GSE161801_IMiD_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14036
4.92970742153959e-43	-0.271404425337478	0.168	0.316	1.06417594108775e-38	OTUD1	Mono/Macro	GSE161801_IMiD_post	ENSG00000165312	220213	OTU deubiquitinase 1	DUBA7|OTDC1	protein_coding	Q5VV17	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14037
7.6868503649331e-42	0.271503277929178	0.999	0.998	1.65936038827811e-37	RPS13	Mono/Macro	GSE161801_IMiD_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14038
8.41550127432992e-42	-0.383332663799843	0.522	0.688	1.8166542600896e-37	HLA-DQB1	Mono/Macro	GSE161801_IMiD_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14039
7.52225045068688e-41	0.401201076459372	0.966	0.945	1.62382820478978e-36	JUNB	Mono/Macro	GSE161801_IMiD_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14040
2.05676483558987e-40	-0.284851774665456	0.179	0.325	4.43993825058785e-36	PHACTR1	Mono/Macro	GSE161801_IMiD_post	ENSG00000112137	221692	phosphatase and actin regulator 1	dJ257A7.2|KIAA1733|RPEL1	protein_coding	Q9C0D0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14041
4.09164463637336e-40	-0.350805297786696	0.597	0.731	8.83263327653916e-36	GLUL	Mono/Macro	GSE161801_IMiD_post	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14042
2.14043266219504e-38	-0.309826153672769	0.515	0.665	4.62055198788044e-34	STK17B	Mono/Macro	GSE161801_IMiD_post	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14043
4.0449881110135e-37	-0.264911813463191	0.292	0.448	8.73191583524484e-33	SULT1A1	Mono/Macro	GSE161801_IMiD_post	ENSG00000196502	6817	sulfotransferase family 1A member 1	P-PST|STP|STP1	protein_coding	P50225	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14044
1.58239084911465e-35	0.322181098083299	0.503	0.356	3.4159071259838e-31	SRSF9	Mono/Macro	GSE161801_IMiD_post	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14045
1.80324241695773e-35	-0.289664670015451	0.538	0.669	3.89265940548664e-31	HNRNPDL	Mono/Macro	GSE161801_IMiD_post	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14046
2.54683184666403e-34	0.280137932323243	0.996	0.995	5.49784590739363e-30	RPL9	Mono/Macro	GSE161801_IMiD_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14047
3.94663801070473e-34	0.384834477928787	0.713	0.617	8.5196074737083e-30	CEBPB	Mono/Macro	GSE161801_IMiD_post	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14048
1.52370285427002e-33	-0.468302266872012	0.343	0.468	3.28921735151269e-29	HSPA5	Mono/Macro	GSE161801_IMiD_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14049
1.89936319755562e-32	0.324465313155321	0.911	0.872	4.10015533456331e-28	MNDA	Mono/Macro	GSE161801_IMiD_post	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14050
4.55172250658091e-32	0.264676379123359	0.315	0.169	9.82580337495622e-28	YPEL3	Mono/Macro	GSE161801_IMiD_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14051
4.9180135935562e-31	-0.366839789315663	0.161	0.279	1.06165159444098e-26	EREG	Mono/Macro	GSE161801_IMiD_post	ENSG00000124882	2069	epiregulin	ER	protein_coding	O14944	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14052
1.83260686716355e-30	-0.259643325141703	0.423	0.569	3.95604844414596e-26	CCNL1	Mono/Macro	GSE161801_IMiD_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14053
3.53105018223473e-30	-0.278929244155443	0.575	0.7	7.62247802839011e-26	LRRFIP1	Mono/Macro	GSE161801_IMiD_post	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14054
2.08717257064012e-29	0.258886110480351	0.369	0.226	4.50557942824082e-25	GIMAP4	Mono/Macro	GSE161801_IMiD_post	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14055
8.12251510505014e-29	-0.252972984035073	0.334	0.469	1.75340733572717e-24	CHMP1B	Mono/Macro	GSE161801_IMiD_post	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14056
9.59424661457964e-27	-0.254793972029863	0.697	0.795	2.07111001668931e-22	CD44	Mono/Macro	GSE161801_IMiD_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14057
1.82042162943999e-26	-0.263917133343199	0.535	0.653	3.92974417147211e-22	CAPG	Mono/Macro	GSE161801_IMiD_post	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14058
1.06395156741374e-25	-0.281947681032749	0.354	0.485	2.29675224857604e-21	MAFB	Mono/Macro	GSE161801_IMiD_post	ENSG00000204103	9935	MAF bZIP transcription factor B	KRML	protein_coding	Q9Y5Q3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14059
8.28698746989657e-24	0.265227161289773	0.582	0.47	1.78891198512657e-19	DYNLL1	Mono/Macro	GSE161801_IMiD_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14060
7.02078327599044e-23	-0.418653390194886	0.758	0.785	1.51557648578806e-18	SSR4	Mono/Macro	GSE161801_IMiD_post	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14061
6.77604472548966e-20	-0.253359221209838	0.88	0.911	1.46274477489145e-15	RPS10	Mono/Macro	GSE161801_IMiD_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14062
1.02312209880256e-19	0.267787719411483	0.485	0.365	2.20861367468509e-15	SMIM25	Mono/Macro	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14063
1.97626007579067e-17	0.259344884006925	0.767	0.702	4.26615262560932e-13	CFD	Mono/Macro	GSE161801_IMiD_post	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14064
4.96562506169213e-16	0.325937746461137	0.366	0.264	1.07192948206748e-11	RETN	Mono/Macro	GSE161801_IMiD_post	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14065
2.43802299482336e-15	0.331410223811395	0.52	0.431	5.26296023892519e-11	H1FX	Mono/Macro	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14066
4.73046268359314e-15	-0.286387271074894	0.643	0.71	1.02116497950725e-10	NCF1	Mono/Macro	GSE161801_IMiD_post	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14067
2.72977975057837e-14	0.363807951321667	0.793	0.798	5.89277554757353e-10	CSTA	Mono/Macro	GSE161801_IMiD_post	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14068
3.87073793306976e-09	-0.335660650294845	0.545	0.603	8.35576197611769e-05	CRIP1	Mono/Macro	GSE161801_IMiD_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14069
8.1640621075826e-25	2.27881787731793	0.826	0.017	1.76237608716386e-20	HLA-DRB5	cDCs	GSE161801_IMiD_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14070
2.00521088549661e-11	0.889162650375852	0.979	0.776	4.32864873852153e-07	RPS26	cDCs	GSE161801_IMiD_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14071
2.25632163622842e-10	1.45347228036962	0.468	0.017	4.8707215161263e-06	HLA-DQA2	cDCs	GSE161801_IMiD_post	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14072
1.56256845169762e-07	-0.871625638021805	0.762	0.897	0.00337311651667964	GPR183	cDCs	GSE161801_IMiD_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14073
2.05528225145363e-07	0.428552305753325	0.332	0	0.00443673779621295	AC004556.1	cDCs	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14074
2.312573613986e-07	-0.508974674689733	0.412	0.724	0.00499215266051157	EIF5A	cDCs	GSE161801_IMiD_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14075
1.08570194170458e-06	-0.899478173361282	0.212	0.5	0.0234370478155768	CXCL8	cDCs	GSE161801_IMiD_post	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14076
1.9679471250164e-06	-0.411337057648061	0.247	0.534	0.0424820745877291	INSIG1	cDCs	GSE161801_IMiD_post	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14077
9.06235438938558e-78	0.890028272455817	0.995	0.955	1.95629044203667e-73	RPS26	NK cells	GSE161801_IMiD_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14078
8.47311957679519e-76	-1.07217401633058	0.671	0.934	1.82909232304278e-71	DUSP1	NK cells	GSE161801_IMiD_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14079
1.31548379118802e-44	-0.428343439688969	1	1	2.83973486003758e-40	HLA-C	NK cells	GSE161801_IMiD_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14080
3.93195722515385e-41	1.18002870886143	0.581	0.284	8.48791606193962e-37	HBB	NK cells	GSE161801_IMiD_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14081
1.02266708460843e-40	-0.597437387251081	0.894	0.979	2.20763143554421e-36	CCL5	NK cells	GSE161801_IMiD_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14082
1.38804610362479e-34	-0.584360805644552	0.096	0.331	2.99637512389484e-30	AC020916.1	NK cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14083
5.46860685281886e-34	-0.437066264838546	0.952	0.994	1.18050816131801e-29	UBC	NK cells	GSE161801_IMiD_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14084
7.89387774603546e-34	1.12000763594664	0.338	0.07	1.70405138903668e-29	S100B	NK cells	GSE161801_IMiD_post	ENSG00000160307	6285	S100 calcium binding protein B	S100beta	protein_coding	P04271	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14085
1.13718984070426e-33	-0.595023326160106	0.327	0.608	2.45485170912829e-29	KLF6	NK cells	GSE161801_IMiD_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14086
3.12453372841131e-33	-0.69305015442109	0.415	0.684	6.74493095952148e-29	JUN	NK cells	GSE161801_IMiD_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14087
1.85288713299967e-32	-0.645259296027525	0.448	0.699	3.99982745400638e-28	FOS	NK cells	GSE161801_IMiD_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14088
2.54305089764271e-32	0.567874090292495	0.521	0.183	5.48968397274132e-28	RPS4Y1	NK cells	GSE161801_IMiD_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14089
9.03091313283843e-30	-0.598815496675828	0.219	0.469	1.94950321798583e-25	PPP1R15A	NK cells	GSE161801_IMiD_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14090
5.07727583357147e-29	0.918431728109347	0.871	0.849	1.09603153419307e-24	GZMB	NK cells	GSE161801_IMiD_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14091
8.96038311013659e-29	-0.525408902082227	0.439	0.685	1.93427790198519e-24	CD69	NK cells	GSE161801_IMiD_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14092
8.0890332799693e-27	-0.552499856686709	0.401	0.631	1.74617961414697e-22	HLA-DPB1	NK cells	GSE161801_IMiD_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14093
2.81908207758085e-26	-0.627320947511053	0.597	0.742	6.08555248087377e-22	TSC22D3	NK cells	GSE161801_IMiD_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14094
8.07816488121639e-26	-0.49652795788807	0.149	0.369	1.74383345290818e-21	PMAIP1	NK cells	GSE161801_IMiD_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14095
1.42949170922512e-25	-0.633174194616087	0.257	0.512	3.08584375270427e-21	CD3D	NK cells	GSE161801_IMiD_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14096
2.66612349464883e-24	0.324988510895674	1	1	5.75536078789843e-20	RPLP1	NK cells	GSE161801_IMiD_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14097
1.98649881245348e-23	-0.490810667176983	0.14	0.347	4.28825498644333e-19	RGS1	NK cells	GSE161801_IMiD_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14098
2.25727683736331e-23	0.47154768331546	0.676	0.411	4.87278350881617e-19	S100A11	NK cells	GSE161801_IMiD_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14099
3.99957817769176e-23	-0.383361929602457	0.927	0.968	8.63388941218321e-19	DDX5	NK cells	GSE161801_IMiD_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14100
6.80157148935442e-23	0.574351216467334	0.314	0.094	1.46825523740694e-18	HBA2	NK cells	GSE161801_IMiD_post	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14101
1.65163639439794e-22	-0.505456667352281	0.293	0.512	3.56538748458683e-18	LYAR	NK cells	GSE161801_IMiD_post	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14102
1.36175451461918e-20	0.508995943918251	0.516	0.284	2.93961947070842e-16	BST2	NK cells	GSE161801_IMiD_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14103
2.17948560614555e-20	0.504597445239553	0.282	0.087	4.70485557798641e-16	XCL1	NK cells	GSE161801_IMiD_post	ENSG00000143184	6375	X-C motif chemokine ligand 1	ATAC|LPTN|LTN|SCM-1|SCM-1a|SCYC1	protein_coding	P47992	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14104
2.1853818632774e-20	-0.4549858265437	0.585	0.761	4.71758382825693e-16	CXCR4	NK cells	GSE161801_IMiD_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14105
8.12305657186962e-20	0.511785089712754	0.697	0.492	1.75352422216949e-15	FCER1G	NK cells	GSE161801_IMiD_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14106
1.58268729984545e-19	-0.342743775569032	0.116	0.294	3.41654707417637e-15	CD3G	NK cells	GSE161801_IMiD_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14107
1.58740778553096e-18	0.353542563897663	0.996	0.987	3.42673718662569e-14	MT-ND3	NK cells	GSE161801_IMiD_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14108
1.59657789468667e-18	-0.277523321266044	0.998	1	3.44653270126012e-14	PTMA	NK cells	GSE161801_IMiD_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14109
2.82734453371444e-18	-0.486250526111114	0.476	0.64	6.10338864492937e-14	PPP2R5C	NK cells	GSE161801_IMiD_post	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14110
2.59127281483194e-16	0.498360174549619	0.438	0.243	5.59378062537772e-12	SELL	NK cells	GSE161801_IMiD_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14111
4.58545998445061e-16	-0.263142468566859	0.115	0.275	9.89863246843353e-12	XIST	NK cells	GSE161801_IMiD_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14112
5.01836878613706e-16	0.479538875453817	0.452	0.252	1.08331526986341e-11	KLRC1	NK cells	GSE161801_IMiD_post	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14113
9.59112806985938e-16	0.460036090933694	0.743	0.589	2.07043681644054e-11	CD7	NK cells	GSE161801_IMiD_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14114
3.85687115678983e-15	0.488598844153348	0.67	0.488	8.32582776616221e-11	S100A8	NK cells	GSE161801_IMiD_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14115
8.47992835309057e-15	0.485910638841966	0.469	0.29	1.83056213358166e-10	KLF2	NK cells	GSE161801_IMiD_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14116
8.18179424577394e-14	-0.277540826069524	0.139	0.288	1.76620392383522e-09	HLA-DQB1	NK cells	GSE161801_IMiD_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14117
1.16915534451411e-13	-0.392523731890736	0.644	0.793	2.52385564220261e-09	GZMH	NK cells	GSE161801_IMiD_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14118
4.77433765870785e-13	-0.357683511172883	0.496	0.621	1.03063627038526e-08	PNRC1	NK cells	GSE161801_IMiD_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14119
5.2322232612534e-13	-0.421233192325672	0.427	0.573	1.12948003540677e-08	HLA-DRB1	NK cells	GSE161801_IMiD_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14120
6.58830891527815e-13	0.305774085845409	0.329	0.162	1.4222182455411e-08	HBA1	NK cells	GSE161801_IMiD_post	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14121
4.15062884142884e-12	-0.298987633984942	0.306	0.467	8.95996247999243e-08	EIF5A	NK cells	GSE161801_IMiD_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14122
4.6429229958927e-12	0.43118579766824	0.755	0.653	1.00226778712336e-07	LY6E	NK cells	GSE161801_IMiD_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14123
1.23335586677002e-11	0.284322092072209	0.299	0.147	2.66244530959645e-07	YPEL3	NK cells	GSE161801_IMiD_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14124
2.89467296749028e-11	0.589673627982833	0.368	0.228	6.24873053492127e-07	IFI6	NK cells	GSE161801_IMiD_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14125
5.13915427242255e-11	-0.368386932954935	0.894	0.917	1.10938923278786e-06	SSR4	NK cells	GSE161801_IMiD_post	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14126
5.46057549005024e-11	-0.262353914524639	0.99	0.996	1.17877443103715e-06	MT-ATP6	NK cells	GSE161801_IMiD_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14127
7.30131668748092e-11	-0.273923856871578	0.17	0.301	1.57613523332651e-06	AC114760.2	NK cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14128
1.4165051448203e-10	0.25126691903142	0.911	0.78	3.05780965612358e-06	RPL36A	NK cells	GSE161801_IMiD_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14129
1.48300060301346e-10	0.410287575972127	0.707	0.535	3.20135340172516e-06	CMC1	NK cells	GSE161801_IMiD_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14130
1.90018800853153e-10	-0.435450227048025	0.258	0.392	4.10193585401702e-06	TRGC2	NK cells	GSE161801_IMiD_post	ENSG00000227191	NA	NA	TCRGC2|TRGC2(2X)|TRGC2(3X)	TR_C_gene	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14131
2.3005816785892e-10	0.282227404775916	0.41	0.256	4.9662656695705e-06	CST3	NK cells	GSE161801_IMiD_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14132
2.3690880088431e-10	0.27794316891025	0.258	0.122	5.1141502846896e-06	TYMP	NK cells	GSE161801_IMiD_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14133
3.10968231397539e-10	-0.273636768812523	0.989	0.994	6.71287121117867e-06	MT-CYB	NK cells	GSE161801_IMiD_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14134
3.18271732357161e-10	-0.255442635825935	1	1	6.87053188639403e-06	ACTB	NK cells	GSE161801_IMiD_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14135
3.33136017185483e-10	0.323050883241026	0.277	0.143	7.19140720298301e-06	IGFBP7	NK cells	GSE161801_IMiD_post	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14136
3.42653774330619e-10	-0.29598307476962	0.387	0.518	7.39686702647507e-06	CYCS	NK cells	GSE161801_IMiD_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14137
4.58199797249753e-10	0.321021522922319	0.508	0.365	9.89115902323042e-06	IL2RB	NK cells	GSE161801_IMiD_post	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14138
6.16836519422687e-10	0.291504969745643	0.454	0.299	1.33156499447775e-05	PSMA4	NK cells	GSE161801_IMiD_post	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14139
1.64520120236912e-09	0.265415189348098	0.396	0.25	3.55149583555421e-05	GIMAP7	NK cells	GSE161801_IMiD_post	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14140
2.17968562971622e-09	0.303808159823532	0.286	0.151	4.7052873688684e-05	AC245014.3	NK cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14141
5.37064232014927e-09	-0.251892299262829	0.879	0.911	0.000115936055765062	BTG1	NK cells	GSE161801_IMiD_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14142
5.8461327128537e-09	0.283926735252577	0.498	0.341	0.000126200466872373	MTRNR2L8	NK cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14143
6.03403859390045e-09	0.251589404626289	0.35	0.209	0.000130256791126529	IFITM3	NK cells	GSE161801_IMiD_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14144
7.67756427308906e-09	0.341221433445005	0.693	0.574	0.000165735579963173	S100A9	NK cells	GSE161801_IMiD_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14145
1.21592567577213e-08	0.269264655346975	0.857	0.795	0.00026248187562893	TYROBP	NK cells	GSE161801_IMiD_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14146
1.38947923768504e-08	0.252602518825327	0.613	0.461	0.00029994688303907	XBP1	NK cells	GSE161801_IMiD_post	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14147
1.49150187925507e-08	0.250141486752704	0.372	0.241	0.000321970510674791	CD300A	NK cells	GSE161801_IMiD_post	ENSG00000167851	11314	CD300a molecule	CMRF-35-H9|CMRF35H|IGSF12|IRC1|IRC2|Irp60	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14148
1.88612815550723e-08	-0.278800076410646	0.248	0.365	0.000407158484929346	YPEL5	NK cells	GSE161801_IMiD_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14149
1.91788776983095e-08	0.487370529626959	0.395	0.279	0.000414014432873407	XCL2	NK cells	GSE161801_IMiD_post	ENSG00000143185	6846	X-C motif chemokine ligand 2	SCM-1b|SCYC2	protein_coding	Q9UBD3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14150
2.29207758450988e-08	0.312745096099538	0.407	0.269	0.000494790788168147	DDIT4	NK cells	GSE161801_IMiD_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14151
3.57440168723479e-08	0.34055433692229	0.843	0.789	0.000771606092223374	PRF1	NK cells	GSE161801_IMiD_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14152
4.99522940288083e-08	-0.265435892015367	0.526	0.65	0.00107832017119988	LITAF	NK cells	GSE161801_IMiD_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14153
5.73610487076816e-08	-0.257703162568809	0.235	0.348	0.00123825295845272	GADD45B	NK cells	GSE161801_IMiD_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14154
5.80006379596071e-08	0.344780469460475	0.316	0.194	0.00125205977163404	LTB	NK cells	GSE161801_IMiD_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14155
5.94311589744588e-08	-0.286336308706884	0.566	0.718	0.00128294042878164	IL32	NK cells	GSE161801_IMiD_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14156
9.47709109820844e-08	-0.257430797238609	0.512	0.627	0.00204581965537026	C12orf75	NK cells	GSE161801_IMiD_post	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14157
1.11222491364649e-07	-0.300346244153699	0.421	0.525	0.00240095992108868	ITGB1	NK cells	GSE161801_IMiD_post	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14158
1.13157106554707e-07	0.299190402865695	0.512	0.369	0.00244272245919645	ISG20	NK cells	GSE161801_IMiD_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14159
1.55072110513578e-07	0.367523057550851	0.365	0.241	0.0033475416496566	H1FX	NK cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14160
1.91226656959425e-07	0.439378726050461	0.441	0.33	0.0041280098437831	ISG15	NK cells	GSE161801_IMiD_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14161
2.34859493308849e-07	0.327308315966919	0.479	0.356	0.00506991188205812	CLIC3	NK cells	GSE161801_IMiD_post	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14162
2.94281511221869e-07	0.316729068880117	0.385	0.264	0.00635265498274649	ALOX5AP	NK cells	GSE161801_IMiD_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14163
5.07058809333748e-07	0.321294687451203	0.371	0.252	0.0109458785170876	GZMK	NK cells	GSE161801_IMiD_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14164
9.06993858144693e-07	0.289568009838834	0.819	0.768	0.0195792764157695	ID2	NK cells	GSE161801_IMiD_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14165
1.02396477198768e-06	-0.337191774595361	0.529	0.586	0.0221043275328981	HLA-DRA	NK cells	GSE161801_IMiD_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14166
8.18885311625024e-10	-0.44049284614704	0.056	0.37	1.76772772220494e-05	HES6	Progenitors	GSE161801_IMiD_post	ENSG00000144485	55502	hes family bHLH transcription factor 6	bHLHb41	protein_coding	Q96HZ4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14167
8.44393598880009e-10	-0.851717292314684	0.282	0.852	1.82279246190228e-05	BLVRB	Progenitors	GSE161801_IMiD_post	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14168
2.0476083987563e-09	-0.370008753390553	0.058	0.37	4.42017225039521e-05	ALAD	Progenitors	GSE161801_IMiD_post	ENSG00000148218	210	aminolevulinate dehydratase	ALADH|PBGS	protein_coding	P13716	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14169
1.97591817255699e-08	0.827344744939909	1	1	0.000426541455909877	RPL39	Progenitors	GSE161801_IMiD_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14170
3.64392832467702e-08	-0.48173706802118	0.095	0.444	0.000786614807448028	APOE	Progenitors	GSE161801_IMiD_post	ENSG00000130203	348	apolipoprotein E	AD2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14171
3.65486686135925e-08	-0.389446121154849	0.068	0.37	0.000788976109361622	SMIM10	Progenitors	GSE161801_IMiD_post	ENSG00000184785	644538	small integral membrane protein 10	CXorf69	protein_coding	Q96HG1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14172
1.34890231599305e-07	-0.346999978562622	0.048	0.296	0.0029118754295342	HSD17B8	Progenitors	GSE161801_IMiD_post	ENSG00000228357	7923	hydroxysteroid 17-beta dehydrogenase 8	D6S2245E|FABGL|H2-KE6|HKE6|KE6|RING2|SDR30C1	protein_coding	Q92506	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14173
2.69200025948502e-07	-0.341472404594189	0.05	0.296	0.00581122096015031	DUS1L	Progenitors	GSE161801_IMiD_post	ENSG00000169718	64118	dihydrouridine synthase 1 like	DUS1|PP3111	protein_coding	Q6P1R4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14174
4.30868220571403e-07	-0.48078979612839	0.115	0.444	0.00930115227747487	UBAC1	Progenitors	GSE161801_IMiD_post	ENSG00000130560	10422	UBA domain containing 1	GBDR1|KPC2|UBADC1	protein_coding	Q9BSL1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14175
5.51532252665781e-07	1.07762815412153	0.757	0.296	0.0119059267382962	AIF1	Progenitors	GSE161801_IMiD_post	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14176
7.90144574032413e-07	-0.658373403488735	0.968	1	0.0170568509196377	MT-ND1	Progenitors	GSE161801_IMiD_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14177
8.28202206633244e-07	-0.370657269015588	0.066	0.333	0.0178784010345918	STXBP6	Progenitors	GSE161801_IMiD_post	ENSG00000168952	29091	syntaxin binding protein 6	amisyn|HSPC156	protein_coding	Q8NFX7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14178
1.09886540382188e-06	-0.363495446431878	0.115	0.444	0.0237212074723029	HMBS	Progenitors	GSE161801_IMiD_post	ENSG00000256269	3145	hydroxymethylbilane synthase	PBGD|PORC|UPS	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14179
1.24288977164904e-06	-1.11992662826085	0.199	0.593	0.0268302615005879	APOC1	Progenitors	GSE161801_IMiD_post	ENSG00000130208	341	apolipoprotein C1	NA	protein_coding	P02654	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14180
1.61533764403237e-06	-0.472998444837546	0.105	0.407	0.0348702937217267	SMIM1	Progenitors	GSE161801_IMiD_post	ENSG00000235169	388588	small integral membrane protein 1 (Vel blood group)	Vel	protein_coding	B2RUZ4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14181
1.68385066222821e-06	-0.311906827985903	0.044	0.259	0.0363492842455203	ZNF394	Progenitors	GSE161801_IMiD_post	ENSG00000160908	84124	zinc finger protein 394	FLJ12298|ZKSCAN14|ZSCAN46	protein_coding	Q53GI3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14182
1.8327101704456e-06	-0.454980609778785	0.125	0.444	0.0395627144494092	PSMC4	Progenitors	GSE161801_IMiD_post	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14183
8.13041041285494e-20	-1.78669046395314	0.256	0.737	1.755111695823e-15	SSR4	Erythrocytes	GSE161801_IMiD_post	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14184
7.96560007946938e-15	0.838136968746556	1	0.982	1.71953408915506e-10	RPL39	Erythrocytes	GSE161801_IMiD_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14185
9.51717346467312e-15	0.61012309479085	1	1	2.05447223581899e-10	RPL21	Erythrocytes	GSE161801_IMiD_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14186
9.19409976378928e-14	-0.761513483093216	0.941	0.965	1.98473031600919e-09	MT-ND1	Erythrocytes	GSE161801_IMiD_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14187
2.89315413550383e-13	0.659982689600047	1	1	6.24545183231211e-09	RPL34	Erythrocytes	GSE161801_IMiD_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14188
2.51011107588271e-10	-0.792695457245316	0.702	0.912	5.41857677950801e-06	EIF5A	Erythrocytes	GSE161801_IMiD_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14189
4.11730285268426e-10	-0.306676145509326	0.076	0.333	8.88802166808952e-06	RANGAP1	Erythrocytes	GSE161801_IMiD_post	ENSG00000100401	5905	Ran GTPase activating protein 1	Fug1|KIAA1835|SD	protein_coding	P46060	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14190
9.21377582024478e-10	0.473238241389859	1	1	1.98897778631624e-05	RPS26	Erythrocytes	GSE161801_IMiD_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14191
1.44176678229128e-09	0.547435872634247	1	1	3.11234195293219e-05	RPS27	Erythrocytes	GSE161801_IMiD_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14192
3.63636932277483e-09	0.620845177876549	0.919	0.667	7.84983045707403e-05	UQCRB	Erythrocytes	GSE161801_IMiD_post	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14193
8.84007460937683e-09	0.482937166598423	1	1	0.000190830690592618	RPL26	Erythrocytes	GSE161801_IMiD_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14194
1.74391543584525e-08	-0.690962877290364	0.326	0.684	0.000376459025135913	UBC	Erythrocytes	GSE161801_IMiD_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14195
2.13220717593695e-08	-0.481928429250308	0.181	0.474	0.00046027956306951	PRRC2C	Erythrocytes	GSE161801_IMiD_post	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14196
3.00322768248253e-08	0.550765615496567	1	1	0.000648306759817505	RPL9	Erythrocytes	GSE161801_IMiD_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14197
3.88347080845327e-08	0.506561000967424	0.973	0.754	0.000838324843420808	ATP5MPL	Erythrocytes	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14198
4.4614280566717e-08	-0.502345720962995	0.498	0.807	0.000963088474593721	RRP7A	Erythrocytes	GSE161801_IMiD_post	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14199
5.40757470939593e-08	-0.839213835874306	0.284	0.561	0.0011673331525173	GSTP1	Erythrocytes	GSE161801_IMiD_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14200
1.02370750891101e-07	0.501639117827158	1	1	0.00220987739948621	RPL7	Erythrocytes	GSE161801_IMiD_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14201
1.1398583378057e-07	0.286317046209553	1	1	0.00246061219382116	RPS27A	Erythrocytes	GSE161801_IMiD_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14202
1.71340252445945e-07	-0.498969071700802	0.958	1	0.00369872202955061	MT-CYB	Erythrocytes	GSE161801_IMiD_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14203
2.443437176852e-07	0.541193075469902	0.991	0.965	0.00527464783367042	S100A4	Erythrocytes	GSE161801_IMiD_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14204
3.26741744816008e-07	0.455474979118199	1	0.947	0.00705337404534316	S100A6	Erythrocytes	GSE161801_IMiD_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14205
3.71114996156195e-07	-0.515868555174665	0.612	0.807	0.00801125942202378	CENPX	Erythrocytes	GSE161801_IMiD_post	ENSG00000169689	201254	centromere protein X	CENP-X|FAAP10|MGC14480|MHF2|STRA13	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14206
4.84683290417798e-07	0.391696876628032	1	1	0.010462858190249	RPS28	Erythrocytes	GSE161801_IMiD_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14207
5.60870188305863e-07	-0.516423143029474	0.598	0.789	0.0121075047549587	HNRNPDL	Erythrocytes	GSE161801_IMiD_post	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14208
5.69126314526616e-07	0.259237096410119	1	1	0.0122857297516861	RPLP1	Erythrocytes	GSE161801_IMiD_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14209
6.87103647962118e-07	0.442484414224523	0.977	0.912	0.0148325064485582	ATP5IF1	Erythrocytes	GSE161801_IMiD_post	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14210
1.14534835298178e-06	0.250283337777732	1	1	0.0247246348958177	RPL41	Erythrocytes	GSE161801_IMiD_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14211
1.54859272274571e-06	-0.443257836032198	0.226	0.491	0.0334294711059116	ACTN4	Erythrocytes	GSE161801_IMiD_post	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14212
8.21579558030732e-33	1.03774334891001	0.556	0.012	1.77354379192094e-28	HLA-DRB5	B cells	GSE161801_IMiD_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14213
7.86806432329042e-32	-0.787281071983328	0.977	1	1.6984790454687e-27	HLA-C	B cells	GSE161801_IMiD_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14214
1.42486394131877e-21	1.06198055588789	0.731	0.389	3.07585379012483e-17	S100A8	B cells	GSE161801_IMiD_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14215
5.06171798711974e-19	0.400797368641041	1	1	1.09267306187954e-14	RPS3A	B cells	GSE161801_IMiD_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14216
1.74994575394964e-16	-0.541263957790472	0.228	0.543	3.7776078990511e-12	EIF5A	B cells	GSE161801_IMiD_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14217
2.47592806309698e-16	-0.641439265597436	0.791	0.938	5.34478590980745e-12	RPL17	B cells	GSE161801_IMiD_post	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14218
5.01736094474411e-16	0.926855747946104	0.728	0.506	1.08309770714191e-11	S100A9	B cells	GSE161801_IMiD_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14219
1.961116537959e-15	-0.55927516938622	0.973	0.994	4.23346227049209e-11	RPS10	B cells	GSE161801_IMiD_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14220
9.85713932973709e-12	-0.45535948931089	0.092	0.29	2.12786066711035e-07	GNLY	B cells	GSE161801_IMiD_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14221
1.03210850500858e-11	-0.36386900916815	1	1	2.22801262976203e-07	PTMA	B cells	GSE161801_IMiD_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14222
2.09184940694833e-11	-0.433071422109105	0.982	0.994	4.51567531477936e-07	HLA-A	B cells	GSE161801_IMiD_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14223
8.22623221308685e-11	0.285304859401961	1	1	1.77579674783906e-06	RPLP1	B cells	GSE161801_IMiD_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14224
8.40689645927866e-11	-0.29871504948285	1	1	1.81479673866448e-06	RPL28	B cells	GSE161801_IMiD_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14225
5.70498188407595e-10	-0.581675939092291	0.799	0.833	1.23153443931548e-05	SSR4	B cells	GSE161801_IMiD_post	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14226
7.30128451033527e-10	-0.352192092159543	0.94	0.988	1.57612828724608e-05	UBC	B cells	GSE161801_IMiD_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14227
5.06297722171438e-09	-0.801548751151656	0.288	0.5	0.000109294489285148	CRIP1	B cells	GSE161801_IMiD_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14228
8.57990644122178e-09	-0.396713558384765	1	1	0.000185214440346655	MT-CO1	B cells	GSE161801_IMiD_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14229
1.48431577356752e-08	-0.545638115991669	0.811	0.907	0.00032041924604002	TSC22D3	B cells	GSE161801_IMiD_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14230
1.54429664588148e-08	0.422516414187729	0.999	0.914	0.000333367316946435	RPS26	B cells	GSE161801_IMiD_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14231
3.25252330703435e-08	0.62429503445152	0.633	0.475	0.000702122206289505	KLF2	B cells	GSE161801_IMiD_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14232
6.50325918213178e-08	-0.424429917925906	0.978	0.988	0.00140385855964679	RPS17	B cells	GSE161801_IMiD_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14233
7.63623690699302e-08	-0.494602359030684	0.428	0.642	0.00164843446111258	KLF6	B cells	GSE161801_IMiD_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14234
2.51963356753306e-07	-0.428945072641939	0.519	0.698	0.00543913298223362	RBM3	B cells	GSE161801_IMiD_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14235
2.79900829986147e-07	0.331271017995842	0.64	0.37	0.00604221921691095	RPS4Y1	B cells	GSE161801_IMiD_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14236
3.52183288399285e-07	-0.449035373403693	0.806	0.963	0.00760258064667537	DUSP1	B cells	GSE161801_IMiD_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14237
3.62517161779817e-07	-0.255417141845963	1	1	0.00782565797134091	RPS18	B cells	GSE161801_IMiD_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14238
3.64988554230224e-07	-0.317923738805713	0.447	0.673	0.00787900792016784	HMGB2	B cells	GSE161801_IMiD_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14239
9.83617572886237e-07	-0.355466705190634	0.772	0.889	0.0212333525458952	LAPTM5	B cells	GSE161801_IMiD_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14240
1.67022399864953e-06	-0.34316023729958	0.317	0.506	0.0360551254588473	SMDT1	B cells	GSE161801_IMiD_post	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14241
1.87324286023755e-06	-0.296381168147041	0.897	0.963	0.0404376936239479	DDX5	B cells	GSE161801_IMiD_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14242
1.88272193017202e-06	0.638413236828369	0.421	0.247	0.0406423183066235	H1FX	B cells	GSE161801_IMiD_post	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14243
0	-0.442554588531125	0.064	0.338	0	MARCKSL1	Malignant cells	GSE161801_IMiD_pre	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14244
0	-0.560999700977115	0.937	0.973	0	YBX1	Malignant cells	GSE161801_IMiD_pre	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14245
0	1.09343746439995	0.973	0.786	0	TMEM59	Malignant cells	GSE161801_IMiD_pre	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14246
0	1.53962383882383	0.912	0.63	0	JUN	Malignant cells	GSE161801_IMiD_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14247
0	1.28237155409362	0.707	0.396	0	GADD45A	Malignant cells	GSE161801_IMiD_pre	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14248
0	-0.404933339461139	0.313	0.623	0	PSMA5	Malignant cells	GSE161801_IMiD_pre	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14249
0	0.788002042056186	0.487	0.192	0	HIST2H2BE	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14250
0	0.978651210181533	0.836	0.549	0	MCL1	Malignant cells	GSE161801_IMiD_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14251
0	0.616001527692631	0.38	0.066	0	S100A10	Malignant cells	GSE161801_IMiD_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14252
0	1.51669212521519	0.8	0.531	0	S100A6	Malignant cells	GSE161801_IMiD_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14253
0	-0.444670735826779	0.229	0.567	0	SEMA4A	Malignant cells	GSE161801_IMiD_pre	ENSG00000196189	64218	semaphorin 4A	CORD10|FLJ12287|SEMAB|SemB	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14254
0	1.60947778791087	0.834	0.405	0	BTG2	Malignant cells	GSE161801_IMiD_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14255
0	1.00087778811221	0.325	0.006	0	HIST3H2A	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14256
0	-0.538294018019341	0.993	0.998	0	RPS7	Malignant cells	GSE161801_IMiD_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14257
0	-0.461665882889192	0.948	0.989	0	PDIA6	Malignant cells	GSE161801_IMiD_pre	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14258
0	-0.784109840098957	0.807	0.962	0	SDC1	Malignant cells	GSE161801_IMiD_pre	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14259
0	1.62785834255777	0.873	0.539	0	YPEL5	Malignant cells	GSE161801_IMiD_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14260
0	2.29365463146117	0.778	0.382	0	QPCT	Malignant cells	GSE161801_IMiD_pre	ENSG00000115828	25797	glutaminyl-peptide cyclotransferase	GCT|QC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14261
0	1.26340297984043	0.891	0.537	0	FRZB	Malignant cells	GSE161801_IMiD_pre	ENSG00000162998	2487	frizzled related protein	FRE|FRITZ|FRP-3|FRZB-1|FRZB-PEN|FRZB1|FZRB|hFIZ|SFRP3|SRFP3	protein_coding	Q92765	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14262
0	-0.576722745023748	0.351	0.646	0	HSPD1	Malignant cells	GSE161801_IMiD_pre	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14263
0	-0.615334928720269	0.995	0.999	0	PTMA	Malignant cells	GSE161801_IMiD_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14264
0	2.10331915694969	0.579	0.039	0	IL5RA	Malignant cells	GSE161801_IMiD_pre	ENSG00000091181	3568	interleukin 5 receptor subunit alpha	CD125|CDw125|IL5R	protein_coding	Q01344	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14265
0	-0.534381308456391	0.999	1	0	RPL15	Malignant cells	GSE161801_IMiD_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14266
0	-0.74285201818376	0.955	0.996	0	RPSA	Malignant cells	GSE161801_IMiD_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14267
0	-0.462371671735043	0.978	0.996	0	RPL14	Malignant cells	GSE161801_IMiD_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14268
0	0.494674166679769	0.272	0.013	0	CHST2	Malignant cells	GSE161801_IMiD_pre	ENSG00000175040	9435	carbohydrate sulfotransferase 2	C6ST	protein_coding	Q9Y4C5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14269
0	0.989816364244961	0.821	0.419	0	CD38	Malignant cells	GSE161801_IMiD_pre	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14270
0	1.36438247265749	0.541	0.219	0	AREG	Malignant cells	GSE161801_IMiD_pre	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14271
0	0.620621398955589	0.938	0.891	0	SPCS3	Malignant cells	GSE161801_IMiD_pre	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14272
0	-0.98974978339004	0.943	0.999	0	CD74	Malignant cells	GSE161801_IMiD_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14273
0	0.813410647459133	0.893	0.693	0	DUSP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14274
0	0.491073345979966	0.792	0.536	0	ATP6V0E1	Malignant cells	GSE161801_IMiD_pre	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14275
0	1.04294661424896	0.856	0.535	0	HIST1H1C	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14276
0	-0.940226355680764	0.826	0.988	0	HLA-A	Malignant cells	GSE161801_IMiD_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14277
0	0.716857265436326	0.994	1	0	HLA-C	Malignant cells	GSE161801_IMiD_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14278
0	-0.524867966470584	0.512	0.829	0	TAPBP	Malignant cells	GSE161801_IMiD_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14279
0	-0.480928220552748	0.472	0.761	0	HMGN3	Malignant cells	GSE161801_IMiD_pre	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14280
0	-0.79906045706793	0.997	1	0	RPS12	Malignant cells	GSE161801_IMiD_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14281
0	0.743544700400684	0.992	0.889	0	ACTB	Malignant cells	GSE161801_IMiD_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14282
0	1.25161883191911	0.487	0.111	0	AZGP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000160862	563	alpha-2-glycoprotein 1, zinc-binding	ZA2G|ZAG	protein_coding	P25311	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14283
0	-0.749012673973944	0.684	0.911	0	PDIA4	Malignant cells	GSE161801_IMiD_pre	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14284
0	1.1553866050405	0.599	0.208	0	SAT1	Malignant cells	GSE161801_IMiD_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14285
0	1.4616611135783	0.706	0.368	0	TIMP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14286
0	-0.915268195241278	0.998	0.999	0	RPS4X	Malignant cells	GSE161801_IMiD_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14287
0	-0.584844820347369	0.03	0.343	0	XIST	Malignant cells	GSE161801_IMiD_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14288
0	-0.383128712542822	1	1	0	RPL10	Malignant cells	GSE161801_IMiD_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14289
0	-0.494310861205787	0.99	0.998	0	RPS20	Malignant cells	GSE161801_IMiD_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14290
0	0.937622419013304	0.943	0.907	0	MTDH	Malignant cells	GSE161801_IMiD_pre	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14291
0	-0.486670348991237	0.989	0.998	0	RPL30	Malignant cells	GSE161801_IMiD_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14292
0	0.836696346761632	0.654	0.364	0	TRIB1	Malignant cells	GSE161801_IMiD_pre	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14293
0	-0.740456824468445	0.233	0.672	0	LY6E	Malignant cells	GSE161801_IMiD_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14294
0	-0.504754495931599	0.999	1	0	RPL8	Malignant cells	GSE161801_IMiD_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14295
0	-0.730696111295255	0.313	0.701	0	AQP3	Malignant cells	GSE161801_IMiD_pre	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14296
0	-0.956385058235463	0.904	0.974	0	HSPA5	Malignant cells	GSE161801_IMiD_pre	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14297
0	-0.70947210461035	0.992	0.997	0	RPL12	Malignant cells	GSE161801_IMiD_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14298
0	0.812193469617454	0.999	0.997	0	MALAT1	Malignant cells	GSE161801_IMiD_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14299
0	-0.829812974219093	0.773	0.987	0	GSTP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14300
0	0.621553239355779	0.433	0.122	0	RAB30	Malignant cells	GSE161801_IMiD_pre	ENSG00000137502	27314	RAB30, member RAS oncogene family	NA	protein_coding	Q15771	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14301
0	-0.482995963334853	0.955	0.999	0	RPS25	Malignant cells	GSE161801_IMiD_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14302
0	0.77254141088772	0.4	0.108	0	OTUD1	Malignant cells	GSE161801_IMiD_pre	ENSG00000165312	220213	OTU deubiquitinase 1	DUBA7|OTDC1	protein_coding	Q5VV17	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14303
0	-0.464455337594768	0.986	0.997	0	RPS24	Malignant cells	GSE161801_IMiD_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14304
0	0.914126106821879	0.494	0.09	0	CLECL1	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14305
0	0.615966780220621	0.834	0.68	0	LDHB	Malignant cells	GSE161801_IMiD_pre	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14306
0	1.17423972882459	0.488	0.045	0	NR4A1	Malignant cells	GSE161801_IMiD_pre	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14307
0	-0.545027347246403	0.863	0.961	0	HNRNPA1	Malignant cells	GSE161801_IMiD_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14308
0	-0.386286973407631	0.11	0.374	0	SHMT2	Malignant cells	GSE161801_IMiD_pre	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14309
0	-1.11286452879322	0.989	1	0	HSP90B1	Malignant cells	GSE161801_IMiD_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14310
0	-0.401888817457689	0.051	0.295	0	C12orf75	Malignant cells	GSE161801_IMiD_pre	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14311
0	-0.501980145580106	0.993	0.999	0	RPL6	Malignant cells	GSE161801_IMiD_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14312
0	-0.516584349462156	0.634	0.878	0	PEBP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14313
0	-0.744062817355393	0.031	0.422	0	ALOX5AP	Malignant cells	GSE161801_IMiD_pre	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14314
0	1.27549715853247	0.743	0.299	0	FOS	Malignant cells	GSE161801_IMiD_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14315
0	-0.463646454261534	0.175	0.467	0	IFI27L1	Malignant cells	GSE161801_IMiD_pre	ENSG00000276880	122509	interferon alpha inducible protein 27 like 1	FAM14B	protein_coding	Q96BM0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14316
0	-1.90936501514917	0.125	0.5	0	IFI27	Malignant cells	GSE161801_IMiD_pre	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14317
0	-0.459699912511866	0.076	0.335	0	WARS	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14318
0	0.499503754705944	0.603	0.316	0	MORF4L1	Malignant cells	GSE161801_IMiD_pre	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14319
0	-0.482194955001644	0.37	0.692	0	MRPS34	Malignant cells	GSE161801_IMiD_pre	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14320
0	-0.610583793695492	0.958	0.996	0	RPS2	Malignant cells	GSE161801_IMiD_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14321
0	0.989031070564323	0.961	0.916	0	TNFRSF17	Malignant cells	GSE161801_IMiD_pre	ENSG00000048462	608	TNF receptor superfamily member 17	BCM|BCMA|CD269|TNFRSF13A	protein_coding	Q02223	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14322
0	-0.443915341282445	0.997	0.999	0	RPS15A	Malignant cells	GSE161801_IMiD_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14323
0	0.617805163993055	0.999	0.993	0	CYBA	Malignant cells	GSE161801_IMiD_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14324
0	-1.04697818490187	0.545	0.928	0	EIF5A	Malignant cells	GSE161801_IMiD_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14325
0	-0.44888744769583	1	1	0	RPL19	Malignant cells	GSE161801_IMiD_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14326
0	0.64051931326569	0.501	0.165	0	PECAM1	Malignant cells	GSE161801_IMiD_pre	ENSG00000261371	5175	platelet and endothelial cell adhesion molecule 1	CD31	protein_coding	P16284	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14327
0	-0.638570236242214	0.451	0.697	0	SYNGR2	Malignant cells	GSE161801_IMiD_pre	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14328
0	0.86842570911564	0.366	0.075	0	TIMP2	Malignant cells	GSE161801_IMiD_pre	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14329
0	-0.532358523880347	0.882	0.977	0	P4HB	Malignant cells	GSE161801_IMiD_pre	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14330
0	0.985463712782392	0.987	0.987	0	SEC11C	Malignant cells	GSE161801_IMiD_pre	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14331
0	-0.636346278593716	0.134	0.415	0	PMAIP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14332
0	-0.374230086769155	0.222	0.52	0	FKBP1A	Malignant cells	GSE161801_IMiD_pre	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14333
0	-0.597381146067625	0.829	0.964	0	PPDPF	Malignant cells	GSE161801_IMiD_pre	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14334
0	1.17414626828543	0.835	0.514	0	JUNB	Malignant cells	GSE161801_IMiD_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14335
0	0.57519240692126	0.798	0.625	0	TECR	Malignant cells	GSE161801_IMiD_pre	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14336
0	0.877583245768496	0.756	0.435	0	TPM4	Malignant cells	GSE161801_IMiD_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14337
0	0.878288404323821	0.603	0.309	0	JUND	Malignant cells	GSE161801_IMiD_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14338
0	-0.90598851881113	0.712	0.952	0	FXYD5	Malignant cells	GSE161801_IMiD_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14339
0	0.86591847678463	0.708	0.403	0	ZFP36	Malignant cells	GSE161801_IMiD_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14340
0	0.571497237965747	1	0.999	0	FTL	Malignant cells	GSE161801_IMiD_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14341
0	0.920135668047094	0.452	0.011	0	LILRB4	Malignant cells	GSE161801_IMiD_pre	ENSG00000278555	11006	leukocyte immunoglobulin like receptor B4	CD85k|HM18|ILT3|LIR-5|LIR5	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14342
0	0.576026488260686	0.759	0.555	0	CHCHD10	Malignant cells	GSE161801_IMiD_pre	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14343
0	0.950625824887414	0.995	0.943	0	XBP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14344
0	-0.522385059636328	0.6	0.877	0	SOD1	Malignant cells	GSE161801_IMiD_pre	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14345
0	-1.00731296089858	0.984	0.991	0	MT-ND1	Malignant cells	GSE161801_IMiD_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14346
0	-1.27640934140732	0.995	0.998	0	MT-ND2	Malignant cells	GSE161801_IMiD_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14347
0	-0.760010354428616	0.998	1	0	MT-CO2	Malignant cells	GSE161801_IMiD_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14348
0	-0.940788582594191	0.934	0.984	0	MT-ATP6	Malignant cells	GSE161801_IMiD_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14349
0	-0.693340958473335	0.994	0.998	0	MT-CO3	Malignant cells	GSE161801_IMiD_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14350
0	-0.78850658319448	0.803	0.938	0	MT-ND3	Malignant cells	GSE161801_IMiD_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14351
0	-0.946507328609711	0.99	0.995	0	MT-ND4	Malignant cells	GSE161801_IMiD_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14352
0	-1.06478510055112	0.855	0.963	0	MT-ND5	Malignant cells	GSE161801_IMiD_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14353
0	-0.897190786478379	0.978	0.994	0	MT-CYB	Malignant cells	GSE161801_IMiD_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14354
0	-1.37297711375019	0.033	0.34	0	LAPTM5	Malignant cells	GSE161801_IMiD_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14355
0	-0.750218061858967	0.153	0.477	0	LINC01781	Malignant cells	GSE161801_IMiD_pre	ENSG00000234184	101927412	long intergenic non-protein coding RNA 1781	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14356
0	1.05935876375179	0.375	0.036	0	EGR1	Malignant cells	GSE161801_IMiD_pre	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14357
0	-2.06047931285043	0.272	0.702	0	HLA-DRA	Malignant cells	GSE161801_IMiD_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14358
0	-0.950240128268283	0.058	0.297	0	HLA-DMA	Malignant cells	GSE161801_IMiD_pre	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14359
0	-0.655003921323703	0.004	0.286	0	TMEM176B	Malignant cells	GSE161801_IMiD_pre	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14360
0	-0.46191562768749	0.023	0.343	0	PTPRN2	Malignant cells	GSE161801_IMiD_pre	ENSG00000282185	5799	protein tyrosine phosphatase receptor type N2	IA-2beta|ICAAR|KIAA0387|phogrin	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14361
0	0.783408467525039	0.478	0.195	0	ABCB9	Malignant cells	GSE161801_IMiD_pre	ENSG00000150967	23457	ATP binding cassette subfamily B member 9	EST122234	protein_coding	Q9NP78	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14362
0	1.72062702663214	0.485	0.075	0	DNAAF1	Malignant cells	GSE161801_IMiD_pre	ENSG00000154099	123872	dynein axonemal assembly factor 1	CILD13|DAU1|FLJ25330|LRRC50|ODA7|swt	protein_coding	Q8NEP3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14363
0	-0.923521061924527	0.132	0.535	0	DPEP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000015413	1800	dipeptidase 1	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14364
0	-0.627790612533423	0.019	0.445	0	TMC6	Malignant cells	GSE161801_IMiD_pre	ENSG00000141524	11322	transmembrane channel like 6	EVER1|EVIN1|LAK-4P|TNRC6C-AS1	protein_coding	Q7Z403	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14365
0	1.24114608642354	0.696	0.452	0	CST3	Malignant cells	GSE161801_IMiD_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14366
0	-0.465474546052905	0.042	0.282	0	CD70	Malignant cells	GSE161801_IMiD_pre	ENSG00000125726	970	CD70 molecule	CD27L|CD27LG|TNFSF7	protein_coding	P32970	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14367
0	0.556292984489237	0.315	0.003	0	TRPM4	Malignant cells	GSE161801_IMiD_pre	ENSG00000130529	54795	transient receptor potential cation channel subfamily M member 4	FLJ20041	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14368
0	-0.549788713724758	0.057	0.324	0	DENND6B	Malignant cells	GSE161801_IMiD_pre	ENSG00000205593	414918	DENN domain containing 6B	AFI1B|FAM116B|MGC33692	protein_coding	Q8NEG7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14369
0	-1.61802267158383	0.018	0.741	0	EDNRB	Malignant cells	GSE161801_IMiD_pre	ENSG00000136160	1910	endothelin receptor type B	ETB|HSCR|HSCR2	protein_coding	P24530	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14370
0	0.463352750182231	0.285	0	0	RAMP2	Malignant cells	GSE161801_IMiD_pre	ENSG00000131477	10266	receptor activity modifying protein 2	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14371
0	0.816663580660328	0.347	0.002	0	WFDC2	Malignant cells	GSE161801_IMiD_pre	ENSG00000101443	10406	WAP four-disulfide core domain 2	dJ461P17.6|EDDM4|HE4|WAP5	protein_coding	Q14508	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14372
1.67709489464354e-304	0.505067751955934	0.435	0.147	3.62034474906701e-300	MAPKAPK2	Malignant cells	GSE161801_IMiD_pre	ENSG00000162889	9261	MAPK activated protein kinase 2	MK2	protein_coding	P49137	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14373
2.05330698297443e-304	0.614126258512904	0.758	0.49	4.43247378414689e-300	SELENOM	Malignant cells	GSE161801_IMiD_pre	ENSG00000198832	140606	selenoprotein M	SELM|SEPM	protein_coding	Q8WWX9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14374
4.95558625953913e-304	-0.452229381277946	0.995	0.999	1.06976240584671e-299	RPL7	Malignant cells	GSE161801_IMiD_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14375
1.28694428482138e-303	-0.460388838857806	0.266	0.551	2.77812662764392e-299	SLC1A5	Malignant cells	GSE161801_IMiD_pre	ENSG00000105281	6510	solute carrier family 1 member 5	AAAT|ASCT2|M7V1|RDRC	protein_coding	Q15758	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14376
8.49873478608056e-301	0.683030706842863	0.971	0.909	1.83462187827121e-296	CD63	Malignant cells	GSE161801_IMiD_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14377
9.47579629089994e-301	0.78925800448897	0.739	0.523	2.04554014531657e-296	ANKRD28	Malignant cells	GSE161801_IMiD_pre	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14378
2.44119602958034e-300	-0.668423472881989	0.61	0.815	5.26980986905508e-296	HSP90AA1	Malignant cells	GSE161801_IMiD_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14379
7.43938006119069e-299	0.919117385265715	0.551	0.265	1.60593897380923e-294	FOSB	Malignant cells	GSE161801_IMiD_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14380
1.21919531763025e-298	0.369182242281255	0.263	0.02	2.63187693216843e-294	KDELR3	Malignant cells	GSE161801_IMiD_pre	ENSG00000100196	11015	KDEL endoplasmic reticulum protein retention receptor 3	NA	protein_coding	O43731	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14381
2.44018733602701e-296	-0.418024790907115	0.336	0.639	5.26763240228151e-292	CSTB	Malignant cells	GSE161801_IMiD_pre	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14382
2.07777148779657e-294	-0.333473320431813	0.159	0.427	4.48528531070645e-290	UQCRC2	Malignant cells	GSE161801_IMiD_pre	ENSG00000140740	7385	ubiquinol-cytochrome c reductase core protein 2	QCR2|UQCR2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14383
2.40311534459367e-293	-0.468025191831942	0.751	0.925	5.18760509437435e-289	CALR	Malignant cells	GSE161801_IMiD_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14384
2.59801856878921e-293	-0.365159242975373	0.979	0.993	5.60834268444527e-289	NACA	Malignant cells	GSE161801_IMiD_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14385
3.88249756547393e-290	0.702212192167891	0.556	0.27	8.38114749458858e-286	HIST1H2AC	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14386
2.16401491703182e-289	-0.421386224965019	0.213	0.495	4.6714590013966e-285	MARCKS	Malignant cells	GSE161801_IMiD_pre	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14387
7.50974384608134e-288	0.793034966046441	0.648	0.446	1.62112840405358e-283	CCR10	Malignant cells	GSE161801_IMiD_pre	ENSG00000184451	2826	C-C motif chemokine receptor 10	GPR2	protein_coding	P46092	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14388
5.98704930895223e-287	-0.481201968552399	0.486	0.725	1.29242433432352e-282	NAP1L1	Malignant cells	GSE161801_IMiD_pre	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14389
7.82516835109433e-286	-0.457877562911057	0.995	0.996	1.68921909195073e-281	RPL37A	Malignant cells	GSE161801_IMiD_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14390
2.45499450733646e-284	0.431025157300222	0.958	0.935	5.29959664298722e-280	NDUFA4	Malignant cells	GSE161801_IMiD_pre	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14391
1.36510693923985e-282	-0.72921607457991	0.971	0.978	2.94685634973707e-278	GAPDH	Malignant cells	GSE161801_IMiD_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14392
2.39565732295315e-282	-0.360654151293651	0.889	0.988	5.17150546305897e-278	RPL24	Malignant cells	GSE161801_IMiD_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14393
2.49263293414242e-279	-0.905257836926859	0.128	0.361	5.38084671493324e-275	IFITM1	Malignant cells	GSE161801_IMiD_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14394
3.60387508037655e-278	-0.44610390556637	0.143	0.386	7.77968513600887e-274	PSAT1	Malignant cells	GSE161801_IMiD_pre	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14395
2.42859811408154e-277	-0.367569787318817	0.992	0.999	5.24261474886782e-273	RPL29	Malignant cells	GSE161801_IMiD_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14396
1.37966488946765e-276	-0.582572639865798	0.079	0.283	2.97828259689381e-272	HLA-DRB1	Malignant cells	GSE161801_IMiD_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14397
2.76293201377278e-274	-0.338306759054566	0.989	0.999	5.9643413381313e-270	RPL18	Malignant cells	GSE161801_IMiD_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14398
6.89432712939875e-274	-0.349462080608172	0.193	0.46	1.48827839742331e-269	GRINA	Malignant cells	GSE161801_IMiD_pre	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14399
1.06838983027376e-269	0.534491065480489	0.545	0.282	2.30633312661196e-265	RASGRP3	Malignant cells	GSE161801_IMiD_pre	ENSG00000152689	25780	RAS guanyl releasing protein 3	CalDAG-GEFIII|GRP3|KIAA0846	protein_coding	Q8IV61	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14400
8.47355195201173e-269	0.668987964474029	0.841	0.789	1.82918565988077e-264	TMEM147	Malignant cells	GSE161801_IMiD_pre	ENSG00000105677	10430	transmembrane protein 147	MGC1936|NIFIE14	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14401
1.62760866027466e-268	0.579001329852585	0.97	0.792	3.5135188149349e-264	VIM	Malignant cells	GSE161801_IMiD_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14402
1.97020590369329e-266	-0.30885894748751	1	1	4.2530834843027e-262	RPS27A	Malignant cells	GSE161801_IMiD_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14403
9.35596206584085e-266	-0.550150230803519	0.164	0.41	2.01967153115307e-261	CKS1B	Malignant cells	GSE161801_IMiD_pre	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14404
1.33824194421288e-265	-0.369130110004955	0.334	0.623	2.88886288497234e-261	SNX3	Malignant cells	GSE161801_IMiD_pre	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14405
1.6167441119523e-265	0.466266455866213	0.579	0.313	3.49006551447144e-261	NDUFA6	Malignant cells	GSE161801_IMiD_pre	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14406
7.49837988693038e-264	0.55219774239086	0.441	0.172	1.61867526619166e-259	PELI1	Malignant cells	GSE161801_IMiD_pre	ENSG00000197329	57162	pellino E3 ubiquitin protein ligase 1	NA	protein_coding	Q96FA3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14407
9.72327843803569e-262	-0.385384786241035	0.541	0.795	2.09896411641876e-257	TMEM230	Malignant cells	GSE161801_IMiD_pre	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14408
2.23564840546906e-261	-0.396934118180016	0.9	0.962	4.82609421288607e-257	RPL38	Malignant cells	GSE161801_IMiD_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14409
2.89176757699486e-261	-0.410043992936068	0.999	1	6.24245866845881e-257	RPS3A	Malignant cells	GSE161801_IMiD_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14410
8.91907181509104e-261	-0.496523694397393	0.679	0.851	1.9253600327237e-256	RAN	Malignant cells	GSE161801_IMiD_pre	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14411
1.11877617124968e-257	0.80599075320829	0.655	0.434	2.41510212087668e-253	DUSP5	Malignant cells	GSE161801_IMiD_pre	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14412
6.49883236388808e-257	0.630950987626409	0.707	0.561	1.40290294239252e-252	CLPTM1L	Malignant cells	GSE161801_IMiD_pre	ENSG00000274811	81037	CLPTM1 like	CRR9|FLJ14400	protein_coding	Q96KA5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14413
3.38533578833301e-255	0.589643198548857	0.999	0.997	7.30792436627447e-251	UBC	Malignant cells	GSE161801_IMiD_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14414
3.23726592776795e-254	-0.370042746965675	0.803	0.921	6.98828595827266e-250	ATP5MC2	Malignant cells	GSE161801_IMiD_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14415
8.6496842993012e-254	-0.421150083842449	0.538	0.77	1.86720734969015e-249	SLC25A3	Malignant cells	GSE161801_IMiD_pre	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14416
5.46311363445504e-253	-0.279034791271903	0.076	0.274	1.17932234026981e-248	ANG	Malignant cells	GSE161801_IMiD_pre	ENSG00000214274	283	angiogenin	RAA1|RNASE5	protein_coding	P03950	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14417
4.61558904779461e-251	0.496649685647257	0.52	0.263	9.96367207747423e-247	FAM174A	Malignant cells	GSE161801_IMiD_pre	ENSG00000174132	345757	family with sequence similarity 174 member A	NS5ATP6|TMEM157|UNQ1912	protein_coding	Q8TBP5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14418
1.34892657276781e-250	-0.585557065162194	0.936	0.948	2.91192779263387e-246	SLC25A6	Malignant cells	GSE161801_IMiD_pre	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14419
1.12819628995647e-248	-0.281893749677864	0.087	0.291	2.43543733112903e-244	FAM27C	Malignant cells	GSE161801_IMiD_pre	ENSG00000231527	105379444	uncharacterized LOC105379444	bA374M1.5|bA7G23.5|FAM27A|FAM27A1|FAM27A3	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14420
1.31035965618586e-248	0.425361160895836	0.421	0.157	2.82867338980842e-244	GLCCI1	Malignant cells	GSE161801_IMiD_pre	ENSG00000106415	113263	glucocorticoid induced 1	FAM117C|GIG18|TSSN1	protein_coding	Q86VQ1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14421
3.25067852941424e-248	-0.43428541221296	0.289	0.545	7.01723974144652e-244	PNISR	Malignant cells	GSE161801_IMiD_pre	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14422
9.7796996199162e-247	0.803204553547522	0.26	0.041	2.11114375695131e-242	DUSP2	Malignant cells	GSE161801_IMiD_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14423
1.50356696486978e-245	-0.296548717754678	0.958	0.989	3.24575000706439e-241	RPL37	Malignant cells	GSE161801_IMiD_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14424
1.71159977721971e-244	-0.371916270382729	0.923	0.981	3.69483043908418e-240	CHCHD2	Malignant cells	GSE161801_IMiD_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14425
1.41364521331624e-243	0.468881642688879	0.406	0.153	3.05163592198578e-239	SIAH2	Malignant cells	GSE161801_IMiD_pre	ENSG00000181788	6478	siah E3 ubiquitin protein ligase 2	NA	protein_coding	O43255	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14426
4.76819402982286e-243	-0.392740740948871	0.086	0.282	1.02931004521786e-238	FABP5	Malignant cells	GSE161801_IMiD_pre	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14427
8.78602555256377e-243	-0.375081868303332	1	1	1.89663933603194e-238	RPL11	Malignant cells	GSE161801_IMiD_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14428
1.46538889494621e-242	-0.356870413105928	0.642	0.851	3.16333500752039e-238	ATP5MPL	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14429
9.66015621486436e-242	0.647187640007133	0.339	0.099	2.08533792210277e-237	FCRLA	Malignant cells	GSE161801_IMiD_pre	ENSG00000132185	84824	Fc receptor like A	FCRL|FCRLb|FCRLc1|FCRLc2|FCRLd|FCRLe|FCRLM1|FCRLX|FREB|MGC4595	protein_coding	Q7L513	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14430
7.05373436437265e-240	0.511418545119657	0.879	0.89	1.52268963723712e-235	ERGIC3	Malignant cells	GSE161801_IMiD_pre	ENSG00000125991	51614	ERGIC and golgi 3	C20orf47|CGI-54|Erv46|NY-BR-84|PRO0989|SDBCAG84	protein_coding	Q9Y282	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14431
6.70039169935658e-239	0.547408814682542	0.512	0.262	1.44641355614011e-234	HLA-DOB	Malignant cells	GSE161801_IMiD_pre	ENSG00000243612	3112	major histocompatibility complex, class II, DO beta	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14432
5.99713701003202e-238	0.377796216997414	0.346	0.1	1.29460196635561e-233	PLPP2	Malignant cells	GSE161801_IMiD_pre	ENSG00000141934	8612	phospholipid phosphatase 2	LPP2|PAP-2c|PPAP2C	protein_coding	O43688	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14433
1.46437876850419e-237	-0.38262383084302	0.405	0.666	3.16115444757e-233	CCNI	Malignant cells	GSE161801_IMiD_pre	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14434
4.73871173490163e-235	-0.407668717900567	0.302	0.566	1.02294570221321e-230	CORO1A	Malignant cells	GSE161801_IMiD_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14435
5.9807905799506e-235	-0.364522837534969	0.537	0.778	1.29107326249394e-230	GHITM	Malignant cells	GSE161801_IMiD_pre	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14436
4.70405768524083e-233	0.448045853828735	0.537	0.287	1.01546493251294e-228	MRPS21	Malignant cells	GSE161801_IMiD_pre	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14437
9.27875052461548e-233	0.482295513300302	0.649	0.446	2.00300387574874e-228	IFNAR2	Malignant cells	GSE161801_IMiD_pre	ENSG00000159110	3455	interferon alpha and beta receptor subunit 2	IFNABR	protein_coding	P48551	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14438
4.2293993863668e-231	-0.381190454437626	0.482	0.732	9.13000445535001e-227	PTGES3	Malignant cells	GSE161801_IMiD_pre	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14439
3.0185327426842e-230	0.477177760073475	0.403	0.159	6.51610663163237e-226	NEB	Malignant cells	GSE161801_IMiD_pre	ENSG00000183091	4703	nebulin	NEB177D|NEM2	protein_coding	P20929	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14440
4.70966636564737e-230	-0.344558461866777	0.789	0.91	1.0166756783523e-225	ELOB	Malignant cells	GSE161801_IMiD_pre	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14441
1.60945990431891e-228	-0.397196857006814	0.999	1	3.47434109545324e-224	RPS8	Malignant cells	GSE161801_IMiD_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14442
6.57356660794665e-228	-0.340730427677422	0.927	0.981	1.41903582365744e-223	SSR2	Malignant cells	GSE161801_IMiD_pre	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14443
7.5210070605936e-228	0.924094007973074	0.588	0.339	1.62355979417034e-223	RGS2	Malignant cells	GSE161801_IMiD_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14444
1.39658412042124e-227	-0.350371962455075	0.242	0.489	3.01480614075332e-223	PYCR1	Malignant cells	GSE161801_IMiD_pre	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14445
4.72692812649018e-226	-0.34962644600685	0.927	0.974	1.02040197466544e-221	RPS21	Malignant cells	GSE161801_IMiD_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14446
3.81618342336976e-225	-0.391522721398885	0.421	0.656	8.23799515602831e-221	CCT3	Malignant cells	GSE161801_IMiD_pre	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14447
6.41892098705089e-224	0.544061543901502	0.558	0.325	1.38565247347468e-219	UBALD2	Malignant cells	GSE161801_IMiD_pre	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14448
1.38808471295206e-223	-0.463007680669449	0.999	0.999	2.99645846984962e-219	RPL28	Malignant cells	GSE161801_IMiD_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14449
4.02626005134938e-222	-0.377806993443026	0.881	0.968	8.69148757284791e-218	EEF2	Malignant cells	GSE161801_IMiD_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14450
1.28677076911515e-221	-0.332995871841458	0.193	0.429	2.77775205928886e-217	ARPC1B	Malignant cells	GSE161801_IMiD_pre	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14451
8.14483842120425e-221	0.710294582477593	0.937	0.858	1.75822626998536e-216	DERL3	Malignant cells	GSE161801_IMiD_pre	ENSG00000274437	91319	derlin 3	C22orf14|derlin-3|FLJ43842|IZP6|MGC71803	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14452
2.08534348573275e-220	-0.32460304156658	0.236	0.48	4.50163098265129e-216	ISOC2	Malignant cells	GSE161801_IMiD_pre	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14453
3.0913785830462e-220	0.381781733747985	0.337	0.098	6.67335894722182e-216	FAM92B	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14454
5.520165001469e-220	0.456327501333834	0.524	0.284	1.19163801886711e-215	PDK1	Malignant cells	GSE161801_IMiD_pre	ENSG00000152256	5163	pyruvate dehydrogenase kinase 1	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14455
2.90118048233372e-217	0.552367881983442	0.302	0.083	6.2627783072138e-213	AC020916.1	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14456
4.59583996888121e-217	-0.328114903181129	0.987	0.997	9.92103974082387e-213	RPL27	Malignant cells	GSE161801_IMiD_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14457
2.53237448600365e-214	-0.451608891569818	0.612	0.799	5.46663680293609e-210	SLC25A5	Malignant cells	GSE161801_IMiD_pre	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14458
4.08935211235309e-213	0.403900812782509	0.349	0.118	8.82768440493661e-209	BTBD3	Malignant cells	GSE161801_IMiD_pre	ENSG00000132640	22903	BTB domain containing 3	dJ742J24.1|KIAA0952	protein_coding	Q9Y2F9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14459
1.24388272625009e-212	-0.345076157598631	0.467	0.706	2.68516964115606e-208	COX7A2L	Malignant cells	GSE161801_IMiD_pre	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14460
3.47212110028274e-212	-0.472979179884891	0.665	0.851	7.49526781918036e-208	PDIA3	Malignant cells	GSE161801_IMiD_pre	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14461
5.26047054669769e-212	-0.367876844201118	0.999	0.999	1.13557777691563e-207	RPL27A	Malignant cells	GSE161801_IMiD_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14462
6.47546939379711e-212	-0.332752932443696	0.424	0.677	1.39785957803898e-207	SSBP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14463
1.31235793760273e-211	-0.379676356446903	1	1	2.83298707990301e-207	RPLP0	Malignant cells	GSE161801_IMiD_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14464
1.01787741519195e-209	0.560937254103879	0.687	0.505	2.19729197617486e-205	PPP1R15A	Malignant cells	GSE161801_IMiD_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14465
1.24870095164617e-209	-0.378978055212744	0.706	0.887	2.69557074431859e-205	SARAF	Malignant cells	GSE161801_IMiD_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14466
2.28630937784768e-207	-0.329175086587869	0.353	0.61	4.93545605395979e-203	CD164	Malignant cells	GSE161801_IMiD_pre	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14467
2.58266598031975e-207	-0.31563483957063	0.981	0.999	5.57520105171624e-203	RPL7A	Malignant cells	GSE161801_IMiD_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14468
1.23730520341431e-206	-0.390319290957632	0.171	0.385	2.67097074261047e-202	TMEM106C	Malignant cells	GSE161801_IMiD_pre	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14469
2.4155974824896e-206	-0.3909015492106	0.917	0.953	5.21455028545031e-202	TXN	Malignant cells	GSE161801_IMiD_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14470
1.04718635996501e-205	0.434607487387929	0.719	0.558	2.26056119525646e-201	DERL1	Malignant cells	GSE161801_IMiD_pre	ENSG00000136986	79139	derlin 1	DER-1|DER1|derlin-1|FLJ13784|MGC3067|PRO2577	protein_coding	Q9BUN8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14471
5.85774672653805e-205	-0.433529120213906	0.216	0.437	1.26451178585777e-200	LMF1	Malignant cells	GSE161801_IMiD_pre	ENSG00000103227	64788	lipase maturation factor 1	C16orf26|FLJ12681|FLJ22302|JFP11|TMEM112|TMEM112A	protein_coding	Q96S06	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14472
1.03767797282593e-204	0.367796752018644	0.96	0.865	2.24003543993933e-200	DDX5	Malignant cells	GSE161801_IMiD_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14473
2.50163173890172e-204	-0.303189560565471	0.156	0.367	5.40027243476715e-200	SCPEP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000121064	59342	serine carboxypeptidase 1	RISC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14474
6.2303190879091e-204	0.413429982218543	0.747	0.538	1.34493898150694e-199	ATF4	Malignant cells	GSE161801_IMiD_pre	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14475
7.23306380774098e-204	-0.303416678484644	0.264	0.508	1.56140148417705e-199	UBE2I	Malignant cells	GSE161801_IMiD_pre	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14476
2.65240774030645e-203	0.710194681304162	0.776	0.676	5.72575258899953e-199	KLF6	Malignant cells	GSE161801_IMiD_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14477
4.35180008869856e-203	-0.268750724714241	0.133	0.338	9.39423085147359e-199	FUCA2	Malignant cells	GSE161801_IMiD_pre	ENSG00000001036	2519	alpha-L-fucosidase 2	dJ20N2.5|MGC1314	protein_coding	Q9BTY2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14478
2.00727852275734e-202	-0.264479532906409	0.096	0.28	4.33311214707628e-198	BTN3A2	Malignant cells	GSE161801_IMiD_pre	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14479
3.17657020648332e-202	-0.408159073626116	0.423	0.634	6.85726210473554e-198	IFI27L2	Malignant cells	GSE161801_IMiD_pre	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14480
1.19661615781754e-201	0.444143876945732	0.536	0.312	2.58313529988071e-197	CD47	Malignant cells	GSE161801_IMiD_pre	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14481
2.36382461591927e-201	0.401507110001165	0.383	0.157	5.10278819838492e-197	DST	Malignant cells	GSE161801_IMiD_pre	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14482
5.47668950842557e-201	-0.296310369792314	0.229	0.462	1.18225296418383e-196	MPG	Malignant cells	GSE161801_IMiD_pre	ENSG00000103152	4350	N-methylpurine DNA glycosylase	MDG	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14483
3.81216118020914e-200	-0.287738223150697	0.885	0.97	8.22931233971748e-196	EDF1	Malignant cells	GSE161801_IMiD_pre	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14484
1.31556603049371e-199	-0.319724631414447	0.462	0.705	2.83991239002677e-195	SDF4	Malignant cells	GSE161801_IMiD_pre	ENSG00000078808	51150	stromal cell derived factor 4	Cab45	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14485
1.35423699004142e-199	-0.515125569252387	0.813	0.926	2.92339139040241e-195	HSPA8	Malignant cells	GSE161801_IMiD_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14486
1.95920126146264e-198	-0.327657255415306	0.872	0.945	4.2293277631194e-194	PABPC1	Malignant cells	GSE161801_IMiD_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14487
4.24698014632009e-198	-0.349214631846275	0.333	0.571	9.16795604186119e-194	SNRPB	Malignant cells	GSE161801_IMiD_pre	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14488
1.92274577679066e-196	-0.325752583220149	0.185	0.4	4.15063130835799e-192	EDEM1	Malignant cells	GSE161801_IMiD_pre	ENSG00000134109	9695	ER degradation enhancing alpha-mannosidase like protein 1	EDEM|KIAA0212	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14489
1.0113423443767e-193	0.739904591034373	0.369	0.154	2.18318471880598e-189	PHLDA1	Malignant cells	GSE161801_IMiD_pre	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14490
6.19755666623358e-193	-0.302462192688838	0.992	0.999	1.33786655753984e-188	RPL34	Malignant cells	GSE161801_IMiD_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14491
1.01900458686906e-192	-0.391961404298574	0.943	0.96	2.19972520167424e-188	RPL23	Malignant cells	GSE161801_IMiD_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14492
3.35337833882056e-192	0.410775430326346	0.437	0.213	7.23893782001195e-188	PRKD3	Malignant cells	GSE161801_IMiD_pre	ENSG00000115825	23683	protein kinase D3	EPK2|PRKCN	protein_coding	O94806	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14493
5.00375723788067e-192	-0.328691324507885	0.453	0.688	1.0801610749413e-187	PSMB2	Malignant cells	GSE161801_IMiD_pre	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14494
7.95214653060765e-191	0.380632283914817	0.898	0.721	1.71662987156227e-186	SEC62	Malignant cells	GSE161801_IMiD_pre	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14495
1.15835842283567e-190	0.37910741552764	0.448	0.217	2.50054832737536e-186	FCGRT	Malignant cells	GSE161801_IMiD_pre	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14496
5.9797243369281e-190	-0.504879771255234	0.972	0.969	1.29084309261267e-185	RPL26	Malignant cells	GSE161801_IMiD_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14497
1.03092795529117e-188	0.502714044300109	0.586	0.383	2.22546417708706e-184	ZBP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000124256	81030	Z-DNA binding protein 1	C20orf183|DAI|dJ718J7.3|DLM-1|DLM1	protein_coding	Q9H171	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14498
5.18791224305405e-188	-0.330351634087924	0.407	0.637	1.11991461590808e-183	ILF2	Malignant cells	GSE161801_IMiD_pre	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14499
1.2920081716799e-187	-0.270097410291324	0.181	0.395	2.7890580402054e-183	EIF4H	Malignant cells	GSE161801_IMiD_pre	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14500
1.45994382852672e-187	-0.281183408478005	0.187	0.401	3.15158074264063e-183	RCN1	Malignant cells	GSE161801_IMiD_pre	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14501
5.23174905632895e-187	-0.33162416159464	0.222	0.444	1.12937766878973e-182	HOMER3	Malignant cells	GSE161801_IMiD_pre	ENSG00000051128	9454	homer scaffold protein 3	HOMER-3	protein_coding	Q9NSC5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14502
5.94028194066599e-186	0.385860902873152	0.556	0.339	1.28232866253157e-181	ERGIC2	Malignant cells	GSE161801_IMiD_pre	ENSG00000087502	51290	ERGIC and golgi 2	Erv41|PTX1	protein_coding	Q96RQ1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14503
1.14414836557984e-185	0.41278481425989	0.276	0.078	2.4698730767772e-181	NR4A2	Malignant cells	GSE161801_IMiD_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14504
2.59310983763132e-185	-0.3534550936458	0.406	0.632	5.59774620649474e-181	GTF3A	Malignant cells	GSE161801_IMiD_pre	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14505
2.69356370009267e-185	-0.344374707764769	0.362	0.593	5.81459595939004e-181	CKLF	Malignant cells	GSE161801_IMiD_pre	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14506
3.96708650208661e-185	0.29305089426637	0.267	0.071	8.56374963205438e-181	ELP5	Malignant cells	GSE161801_IMiD_pre	ENSG00000288485	23587	elongator acetyltransferase complex subunit 5	C17orf81|DERP6	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14507
8.11549208290402e-185	-0.264953591715041	0.898	0.986	1.75189127593649e-180	ATP5MG	Malignant cells	GSE161801_IMiD_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14508
5.27508968555561e-184	-0.305432786453288	0.401	0.634	1.13873361042089e-179	MDH2	Malignant cells	GSE161801_IMiD_pre	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14509
1.40519664542166e-183	-0.431147151152464	0.336	0.543	3.03339799847174e-179	CKAP4	Malignant cells	GSE161801_IMiD_pre	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14510
3.19694385908467e-183	-0.333864603090361	0.492	0.706	6.90124270860607e-179	PSMA1	Malignant cells	GSE161801_IMiD_pre	ENSG00000129084	5682	proteasome 20S subunit alpha 1	HC2|MGC14542|MGC14575|MGC14751|MGC1667|MGC21459|MGC22853|MGC23915|NU|PROS30	protein_coding	P25786	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14511
4.30330543422743e-183	-0.305327005018959	0.741	0.892	9.28954544086676e-179	PARK7	Malignant cells	GSE161801_IMiD_pre	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14512
1.10534432307298e-182	-0.305631110560498	0.411	0.646	2.38610679021765e-178	PGAM1	Malignant cells	GSE161801_IMiD_pre	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14513
1.43681276852152e-181	-0.287297955560847	0.389	0.634	3.10164772340741e-177	SSU72	Malignant cells	GSE161801_IMiD_pre	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14514
4.86725995841717e-179	-1.29195839286491	0.168	0.335	1.05069540722351e-174	CCND1	Malignant cells	GSE161801_IMiD_pre	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14515
8.07522873714072e-179	0.322389553186874	0.33	0.116	1.74319962748657e-174	TNFRSF13B	Malignant cells	GSE161801_IMiD_pre	ENSG00000240505	23495	TNF receptor superfamily member 13B	CD267|IGAD2|TACI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14516
1.45756337898519e-178	-0.396892396474402	0.406	0.637	3.14644206621532e-174	NFKBIA	Malignant cells	GSE161801_IMiD_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14517
3.73735383075909e-178	-0.301829898017325	0.247	0.465	8.06782571445964e-174	C8orf59	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14518
6.08130012944884e-178	-0.395241853562437	0.322	0.547	1.31277025894412e-173	NUCKS1	Malignant cells	GSE161801_IMiD_pre	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14519
4.72135338068952e-177	-0.361567861242305	0.563	0.778	1.01919855428945e-172	BST2	Malignant cells	GSE161801_IMiD_pre	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14520
1.13066636572713e-176	-0.274454054656959	0.177	0.381	2.44076948369515e-172	VDAC3	Malignant cells	GSE161801_IMiD_pre	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14521
1.731344021913e-176	-0.393178753697565	0.234	0.439	3.73745234010358e-172	MTHFD2	Malignant cells	GSE161801_IMiD_pre	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14522
1.25311518400863e-175	-0.391096271789847	0.275	0.531	2.70509974771943e-171	FGFR3	Malignant cells	GSE161801_IMiD_pre	ENSG00000068078	2261	fibroblast growth factor receptor 3	ACH|CD333|CEK2|JTK4	protein_coding	P22607	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14523
1.50043739049325e-175	-0.33224444997916	0.091	0.254	3.23899419485778e-171	CDKN2C	Malignant cells	GSE161801_IMiD_pre	ENSG00000123080	1031	cyclin dependent kinase inhibitor 2C	INK4C|p18	protein_coding	P42773	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14524
6.56694422703482e-174	0.385893981708333	0.288	0.095	1.41760625029001e-169	HIST1H2BC	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14525
1.00267081184735e-172	-0.267210650698695	0.995	0.998	2.16446548153488e-168	RPL21	Malignant cells	GSE161801_IMiD_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14526
2.43053318855147e-172	0.350851148187782	0.929	0.896	5.24679199412607e-168	TRAM1	Malignant cells	GSE161801_IMiD_pre	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14527
2.47119685004924e-172	0.396839585214282	0.33	0.13	5.3345726402013e-168	NAMPT	Malignant cells	GSE161801_IMiD_pre	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14528
2.50525346985378e-172	0.382190225046206	0.52	0.305	5.40809066537335e-168	FBXW7	Malignant cells	GSE161801_IMiD_pre	ENSG00000109670	55294	F-box and WD repeat domain containing 7	AGO|CDC4|FBW7|FBX30|FBXW6|FLJ11071|SEL-10|SEL10	protein_coding	Q969H0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14529
6.3970758869943e-172	0.311231418363589	0.304	0.106	1.38093677172546e-167	RUBCN	Malignant cells	GSE161801_IMiD_pre	ENSG00000145016	9711	rubicon autophagy regulator	KIAA0226|rubicon|rundataxin	protein_coding	Q92622	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14530
1.94301548917125e-171	-0.305323384572995	0.604	0.808	4.19438753647399e-167	LRPAP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000163956	4043	LDL receptor related protein associated protein 1	A2MRAP|HBP44|RAP	protein_coding	P30533	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14531
6.32526837747844e-171	-0.261904489467097	0.133	0.317	1.36543568464627e-166	CCNG1	Malignant cells	GSE161801_IMiD_pre	ENSG00000113328	900	cyclin G1	CCNG	protein_coding	P51959	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14532
1.64251343048904e-170	-0.303223572592409	0.63	0.843	3.5456937423967e-166	ANAPC16	Malignant cells	GSE161801_IMiD_pre	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14533
2.69289500758463e-170	-0.681131912234573	0.221	0.429	5.81315245287294e-166	STMN1	Malignant cells	GSE161801_IMiD_pre	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14534
1.5005306946187e-169	0.368621779849839	0.517	0.303	3.23919561047339e-165	MEI1	Malignant cells	GSE161801_IMiD_pre	ENSG00000167077	150365	meiotic double-stranded break formation protein 1	MGC40042|SPATA38	protein_coding	Q5TIA1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14535
7.83149158912395e-169	-0.275391503773065	0.203	0.409	1.69058408934419e-164	PIGK	Malignant cells	GSE161801_IMiD_pre	ENSG00000142892	10026	phosphatidylinositol glycan anchor biosynthesis class K	GPI8|hGPI8	protein_coding	Q92643	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14536
1.51104715390948e-168	-0.442168839992172	0.798	0.908	3.26189749114439e-164	MANF	Malignant cells	GSE161801_IMiD_pre	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14537
2.01914635994161e-168	-0.286241792645729	0.957	0.984	4.35873124720595e-164	RPL22	Malignant cells	GSE161801_IMiD_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14538
2.04338112918314e-168	0.354191783008251	0.475	0.261	4.41104684356764e-164	ELL2	Malignant cells	GSE161801_IMiD_pre	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14539
2.92981494882716e-168	-0.328989353758583	0.29	0.504	6.32459153003319e-164	SIVA1	Malignant cells	GSE161801_IMiD_pre	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14540
3.67939412394623e-168	0.500267486750288	0.257	0.076	7.94270809536274e-164	CTSH	Malignant cells	GSE161801_IMiD_pre	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14541
6.9500828408744e-167	0.342970700459643	0.307	0.111	1.50031438285956e-162	ARID5B	Malignant cells	GSE161801_IMiD_pre	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14542
4.65097884255108e-164	-0.262051654263224	0.29	0.524	1.0040068027415e-159	CCNC	Malignant cells	GSE161801_IMiD_pre	ENSG00000112237	892	cyclin C	CycC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14543
5.66816433169642e-164	0.326959278846572	0.911	0.847	1.22358663428331e-159	MIF	Malignant cells	GSE161801_IMiD_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14544
6.1261806147e-164	-0.314681408288684	0.884	0.941	1.32245860929529e-159	PPIA	Malignant cells	GSE161801_IMiD_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14545
8.86719551892563e-164	0.40082752511115	0.363	0.166	1.91416149667048e-159	BHLHE41	Malignant cells	GSE161801_IMiD_pre	ENSG00000123095	79365	basic helix-loop-helix family member e41	BHLHB3|DEC2|SHARP-1|SHARP1	protein_coding	Q9C0J9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14546
7.53936318038203e-163	0.368726543601992	0.925	0.873	1.62752232974907e-158	RABAC1	Malignant cells	GSE161801_IMiD_pre	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14547
2.32209837242468e-162	0.447037130254856	0.541	0.333	5.01271375655315e-158	GLRX	Malignant cells	GSE161801_IMiD_pre	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14548
5.60340635527888e-162	0.425634737705435	0.546	0.362	1.20960732991405e-157	LSR	Malignant cells	GSE161801_IMiD_pre	ENSG00000105699	51599	lipolysis stimulated lipoprotein receptor	ILDR3|LISCH7	protein_coding	Q86X29	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14549
5.37734470935127e-161	0.328029081777929	0.298	0.108	1.16080740240766e-156	HIST1H2BD	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14550
7.84614605086413e-161	0.458560013707513	0.355	0.161	1.69374754800004e-156	CYP20A1	Malignant cells	GSE161801_IMiD_pre	ENSG00000119004	57404	cytochrome P450 family 20 subfamily A member 1	CYP-M	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14551
3.14539226757456e-160	-0.307478586304344	0.435	0.647	6.7899582880132e-156	ADI1	Malignant cells	GSE161801_IMiD_pre	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14552
7.30393080820997e-160	0.428889781827734	0.564	0.381	1.57669954356829e-155	CDV3	Malignant cells	GSE161801_IMiD_pre	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14553
3.65144297013152e-158	0.391135232907414	0.397	0.199	7.88236993962291e-154	GPRC5D	Malignant cells	GSE161801_IMiD_pre	ENSG00000111291	55507	G protein-coupled receptor class C group 5 member D	NA	protein_coding	Q9NZD1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14554
4.2125632646432e-158	-0.25410802751124	0.236	0.446	9.09366031938528e-154	ARPC1A	Malignant cells	GSE161801_IMiD_pre	ENSG00000241685	10552	actin related protein 2/3 complex subunit 1A	Arc40|SOP2Hs|SOP2L	protein_coding	Q92747	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14555
5.76875110248729e-158	0.376065301197036	0.491	0.296	1.24530030049393e-153	STT3B	Malignant cells	GSE161801_IMiD_pre	ENSG00000163527	201595	STT3 oligosaccharyltransferase complex catalytic subunit B	FLJ90106|SIMP|STT3-B	protein_coding	Q8TCJ2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14556
7.28730246585751e-158	-0.347829719584182	0.355	0.57	1.57310998330466e-153	CALM3	Malignant cells	GSE161801_IMiD_pre	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14557
1.03496023176755e-157	-0.366639685359457	0.894	0.961	2.23416865231661e-153	RPN2	Malignant cells	GSE161801_IMiD_pre	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14558
3.53790488561466e-156	-0.29013856625994	0.694	0.851	7.63727527657637e-152	ATP5MD	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14559
4.51875812728193e-156	-0.285338943549744	0.546	0.751	9.75464316936349e-152	NDUFB10	Malignant cells	GSE161801_IMiD_pre	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14560
7.05114524266708e-156	-0.271202368876153	0.296	0.515	1.52213072353454e-151	SEC63	Malignant cells	GSE161801_IMiD_pre	ENSG00000025796	11231	SEC63 homolog, protein translocation regulator	DNAJC23|ERdj2|PRO2507|SEC63L	protein_coding	Q9UGP8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14561
3.82707252841565e-155	-0.302888553494078	0.999	0.999	8.26150146709087e-151	RPS5	Malignant cells	GSE161801_IMiD_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14562
1.49885602743202e-154	0.637535902915739	0.573	0.381	3.23558050641749e-150	S100A4	Malignant cells	GSE161801_IMiD_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14563
2.70029000623049e-153	-0.358444165675287	1	0.999	5.82911603644976e-149	RPL13	Malignant cells	GSE161801_IMiD_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14564
5.12740545440925e-153	-0.254731287118697	0.294	0.512	1.10685301544333e-148	ANAPC5	Malignant cells	GSE161801_IMiD_pre	ENSG00000089053	51433	anaphase promoting complex subunit 5	APC5	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14565
1.04490766982933e-152	0.373215458218379	0.739	0.606	2.25564218686057e-148	TMEM205	Malignant cells	GSE161801_IMiD_pre	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14566
1.74092758882134e-152	-0.275739722004171	0.818	0.954	3.75814038598863e-148	UBE2J1	Malignant cells	GSE161801_IMiD_pre	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14567
8.62617546948826e-152	-0.267076079230698	0.245	0.45	1.86213249859843e-147	SH3BGRL	Malignant cells	GSE161801_IMiD_pre	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14568
7.81316228447104e-151	0.357566529204925	0.355	0.165	1.68662734234876e-146	BRSK1	Malignant cells	GSE161801_IMiD_pre	ENSG00000160469	84446	BR serine/threonine kinase 1	KIAA1811|SAD-B	protein_coding	Q8TDC3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14569
1.0998090844445e-150	-0.270291003091328	0.253	0.465	2.37415787059035e-146	NME4	Malignant cells	GSE161801_IMiD_pre	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14570
1.26212591629388e-147	-0.328454493789825	0.236	0.421	2.7245512155036e-143	BMI1	Malignant cells	GSE161801_IMiD_pre	ENSG00000168283	648	BMI1 proto-oncogene, polycomb ring finger	PCGF4|RNF51	protein_coding	P35226	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14571
6.98934472990588e-146	0.475231489423662	0.869	0.743	1.50878984684478e-141	H1FX	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14572
8.58489564222791e-146	-0.345199171403638	0.198	0.379	1.85322142228774e-141	LSP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14573
1.27952057811719e-145	-0.330139189889196	0.862	0.947	2.76210107198157e-141	NPM1	Malignant cells	GSE161801_IMiD_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14574
1.2798876537631e-145	0.433989459312938	0.336	0.154	2.7628934781784e-141	PLAC8	Malignant cells	GSE161801_IMiD_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14575
4.17465178736912e-145	-0.255360724911707	0.303	0.512	9.01182081339372e-141	MRPS33	Malignant cells	GSE161801_IMiD_pre	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14576
7.5590999496075e-145	0.298658794290886	0.406	0.207	1.63178290612177e-140	CHST12	Malignant cells	GSE161801_IMiD_pre	ENSG00000136213	55501	carbohydrate sulfotransferase 12	C4S-2|C4ST2	protein_coding	Q9NRB3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14577
1.42060402675021e-144	-0.374406631045644	0.408	0.577	3.06665791254568e-140	DNPH1	Malignant cells	GSE161801_IMiD_pre	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14578
6.76646950558509e-144	-0.273230342099416	1	1	1.46067777217065e-139	RPL13A	Malignant cells	GSE161801_IMiD_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14579
6.67392612606383e-143	0.372412604195986	0.488	0.3	1.4407004328334e-138	KLF13	Malignant cells	GSE161801_IMiD_pre	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14580
1.20896156567618e-142	-0.572280525903368	0.582	0.747	2.60978533182517e-138	HMGN2	Malignant cells	GSE161801_IMiD_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14581
1.25792896046173e-142	0.50305320406122	0.686	0.543	2.71549124694874e-138	S100A11	Malignant cells	GSE161801_IMiD_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14582
2.79679742669062e-142	0.990082907305201	0.434	0.252	6.03744660499704e-138	RGS1	Malignant cells	GSE161801_IMiD_pre	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14583
1.14534789808668e-139	-0.252969740100152	0.378	0.592	2.47246250759972e-135	C1orf43	Malignant cells	GSE161801_IMiD_pre	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14584
3.30063567630276e-139	-0.258111690164315	0.344	0.552	7.12508223443477e-135	ANXA7	Malignant cells	GSE161801_IMiD_pre	ENSG00000138279	310	annexin A7	ANX7	protein_coding	P20073	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14585
7.02414946700047e-139	0.336504425826306	0.836	0.8	1.51630314544139e-134	ATP5MC3	Malignant cells	GSE161801_IMiD_pre	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14586
2.26920816249495e-138	-0.279566510286192	0.282	0.48	4.89853966037786e-134	ARPC5	Malignant cells	GSE161801_IMiD_pre	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14587
3.8798312366384e-138	-0.25916008963851	0.599	0.792	8.37539169053131e-134	COX7B	Malignant cells	GSE161801_IMiD_pre	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14588
5.00548816924945e-138	-0.250626845472823	0.245	0.439	1.08053473109588e-133	PCNP	Malignant cells	GSE161801_IMiD_pre	ENSG00000081154	57092	PEST proteolytic signal containing nuclear protein	NA	protein_coding	Q8WW12	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14589
5.44106725465457e-138	0.517283705331316	0.365	0.181	1.17456318826228e-133	DUSP4	Malignant cells	GSE161801_IMiD_pre	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14590
2.12871591728193e-137	0.296928131135691	0.395	0.205	4.59525905063651e-133	FNDC3B	Malignant cells	GSE161801_IMiD_pre	ENSG00000075420	64778	fibronectin type III domain containing 3B	DKFZp762K137|FAD104|FLJ23399|PRO4979|YVTM2421	protein_coding	Q53EP0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14591
4.4856793003766e-137	0.437402588832092	0.524	0.362	9.68323590572298e-133	PTP4A1	Malignant cells	GSE161801_IMiD_pre	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14592
4.94158520483479e-137	-0.258673312101602	0.463	0.684	1.06673999816769e-132	ATP5ME	Malignant cells	GSE161801_IMiD_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14593
3.47469888883666e-136	0.304823972350876	0.33	0.151	7.5008324913317e-132	ATF6	Malignant cells	GSE161801_IMiD_pre	ENSG00000118217	22926	activating transcription factor 6	ATF6A	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14594
7.47080088807934e-136	0.661267742445875	0.406	0.222	1.61272178770969e-131	ADM	Malignant cells	GSE161801_IMiD_pre	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14595
8.31448828558752e-136	0.405854742691802	0.589	0.416	1.79484858620978e-131	CALM1	Malignant cells	GSE161801_IMiD_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14596
1.45383723222227e-135	-0.362758777918196	0.962	0.959	3.13839843319821e-131	HINT1	Malignant cells	GSE161801_IMiD_pre	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14597
1.11005644637992e-134	-0.617231720465206	0.165	0.338	2.39627885080033e-130	CD79A	Malignant cells	GSE161801_IMiD_pre	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14598
1.14370484185292e-134	-0.250412383904179	0.408	0.624	2.46891564210789e-130	HNRNPC	Malignant cells	GSE161801_IMiD_pre	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14599
1.58082775177098e-134	-0.256233468927502	0.406	0.621	3.41253286774801e-130	YWHAB	Malignant cells	GSE161801_IMiD_pre	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14600
1.33881135624821e-132	0.343158752514026	0.483	0.295	2.890092074733e-128	LMNA	Malignant cells	GSE161801_IMiD_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14601
1.42214672610423e-132	-0.252547726745928	0.235	0.422	3.06998813764119e-128	SARS	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14602
5.09178542465444e-132	-0.262040933242777	0.482	0.683	1.09916371962015e-127	EIF3H	Malignant cells	GSE161801_IMiD_pre	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14603
6.03103078867736e-132	0.302272867667672	0.4	0.215	1.30191861635178e-127	ZNF791	Malignant cells	GSE161801_IMiD_pre	ENSG00000173875	163049	zinc finger protein 791	FLJ90396	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14604
1.66866578158725e-131	0.257567803903737	0.304	0.125	3.60214882271239e-127	CCDC88A	Malignant cells	GSE161801_IMiD_pre	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14605
1.59685357626158e-130	-0.267860116058644	0.217	0.394	3.44712781507588e-126	DNAJC15	Malignant cells	GSE161801_IMiD_pre	ENSG00000120675	29103	DnaJ heat shock protein family (Hsp40) member C15	DNAJD1|MCJ	protein_coding	Q9Y5T4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14606
2.74845877114458e-130	-0.255740636111228	0.468	0.674	5.93309794926981e-126	SEM1	Malignant cells	GSE161801_IMiD_pre	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14607
3.01523223486206e-129	0.311917897121071	0.353	0.176	6.50898182539674e-125	CD55	Malignant cells	GSE161801_IMiD_pre	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14608
5.24078531387002e-129	-0.261702614665795	0.203	0.38	1.13132832570512e-124	KCNN3	Malignant cells	GSE161801_IMiD_pre	ENSG00000143603	3782	potassium calcium-activated channel subfamily N member 3	hSK3|KCa2.3|SKCA3	protein_coding	Q9UGI6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14609
8.51960900083038e-129	0.349332276351912	0.548	0.368	1.83912799500925e-124	VPS37B	Malignant cells	GSE161801_IMiD_pre	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14610
8.79166756356515e-129	-0.28553087400326	0.372	0.565	1.89785727694681e-124	CD79B	Malignant cells	GSE161801_IMiD_pre	ENSG00000007312	974	CD79b molecule	B29|Ig-beta|IGB|Igbeta	protein_coding	P40259	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14611
3.5120756790427e-128	-0.309589320642107	0.606	0.776	7.58151776834949e-124	PABPC4	Malignant cells	GSE161801_IMiD_pre	ENSG00000090621	8761	poly(A) binding protein cytoplasmic 4	APP-1|iPABP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14612
1.5699451489494e-127	0.25414414346815	0.293	0.122	3.38904059303708e-123	NCF4	Malignant cells	GSE161801_IMiD_pre	ENSG00000275990	4689	neutrophil cytosolic factor 4	p40phox|SH3PXD4	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14613
1.36686289138416e-126	-0.364249943333207	1	1	2.95064692363098e-122	EEF1A1	Malignant cells	GSE161801_IMiD_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14614
3.67789848934295e-126	0.385015829696036	0.814	0.702	7.93947946894462e-122	NPC2	Malignant cells	GSE161801_IMiD_pre	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14615
5.20845675858288e-126	-0.27258591026029	0.776	0.914	1.12434956047529e-121	BSG	Malignant cells	GSE161801_IMiD_pre	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14616
3.74576052629462e-125	0.559414443594377	0.695	0.629	8.08597324811219e-121	NENF	Malignant cells	GSE161801_IMiD_pre	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14617
9.92937096929359e-125	-0.258637582700315	0.423	0.621	2.14345331114141e-120	SLC25A39	Malignant cells	GSE161801_IMiD_pre	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14618
2.04409187123366e-124	-0.259484352680281	0.384	0.58	4.41258112243211e-120	PMVK	Malignant cells	GSE161801_IMiD_pre	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14619
2.70045579890107e-124	-0.26725476871935	0.493	0.682	5.82947393308774e-120	PCBP2	Malignant cells	GSE161801_IMiD_pre	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14620
1.05866906010277e-123	0.327819148492754	0.363	0.192	2.28534890004385e-119	THUMPD3-AS1	Malignant cells	GSE161801_IMiD_pre	ENSG00000206573	440944	THUMPD3 antisense RNA 1	SETD5-AS1	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14621
3.31570087650942e-123	0.341818530664795	0.355	0.186	7.15760348212088e-119	BCL2L11	Malignant cells	GSE161801_IMiD_pre	ENSG00000153094	10018	BCL2 like 11	BIM|BimEL|BimL|BimS|BOD	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14622
6.17635599860232e-123	-0.289777476205429	0.994	0.996	1.33328996941828e-118	MT-CO1	Malignant cells	GSE161801_IMiD_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14623
6.76354450980651e-123	0.300162678564745	0.445	0.262	1.46004635333193e-118	RAC1	Malignant cells	GSE161801_IMiD_pre	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14624
1.06212365523773e-121	-0.259390673329046	0.317	0.503	2.29280633456169e-117	CACYBP	Malignant cells	GSE161801_IMiD_pre	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14625
1.09278561358347e-121	-0.522749374256474	0.904	0.957	2.35899630404263e-117	ACTG1	Malignant cells	GSE161801_IMiD_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14626
4.6529534579349e-121	-0.262419165080522	0.314	0.502	1.00443306296441e-116	CTSD	Malignant cells	GSE161801_IMiD_pre	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14627
1.56263071114428e-120	0.355643814565653	0.491	0.326	3.37325091614716e-116	RTN4	Malignant cells	GSE161801_IMiD_pre	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14628
2.49167508585009e-120	0.263883114582714	0.348	0.174	5.3787790078246e-116	CIB1	Malignant cells	GSE161801_IMiD_pre	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14629
2.5058688559693e-120	0.325647151785855	0.424	0.246	5.40941909938094e-116	PDE4B	Malignant cells	GSE161801_IMiD_pre	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14630
2.12734413666404e-117	0.271883247704865	0.962	0.952	4.59229778781665e-113	COX7C	Malignant cells	GSE161801_IMiD_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14631
1.02488426613641e-116	-0.253135074389105	0.423	0.611	2.21241766530867e-112	SRP72	Malignant cells	GSE161801_IMiD_pre	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14632
5.55459979620408e-116	0.549576357169414	0.94	0.938	1.19907145800658e-111	ITM2C	Malignant cells	GSE161801_IMiD_pre	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14633
6.1239122571309e-116	0.302717486477873	0.489	0.317	1.32196893894685e-111	VOPP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14634
8.68434739508791e-115	0.668414976592909	0.525	0.376	1.87469007217763e-110	HNRNPH1	Malignant cells	GSE161801_IMiD_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14635
3.63018778897641e-114	0.305488699506464	0.329	0.166	7.83648638006338e-110	YWHAH	Malignant cells	GSE161801_IMiD_pre	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14636
3.43813309390035e-113	-0.442334818189705	0.612	0.723	7.42189790980268e-109	HMGB1	Malignant cells	GSE161801_IMiD_pre	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14637
1.76258230645937e-112	0.316103022129021	0.548	0.399	3.80488642495385e-108	NDUFAF8	Malignant cells	GSE161801_IMiD_pre	ENSG00000224877	284184	NADH:ubiquinone oxidoreductase complex assembly factor 8	C17orf89	protein_coding	A1L188	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14638
2.40847554342842e-111	0.326068418531496	0.357	0.196	5.19917615559892e-107	TP53INP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000164938	94241	tumor protein p53 inducible nuclear protein 1	DKFZp434M1317|FLJ22139|P53DINP1|SIP|Teap|TP53INP1A|TP53INP1B	protein_coding	Q96A56	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14639
1.76060393086021e-110	0.279426857863897	0.472	0.303	3.80061570554794e-106	MRPL40	Malignant cells	GSE161801_IMiD_pre	ENSG00000185608	64976	mitochondrial ribosomal protein L40	MRP-L22|NLVCF	protein_coding	Q9NQ50	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14640
2.94617335704417e-110	-0.730991886232586	0.399	0.561	6.35990442585126e-106	TUBB	Malignant cells	GSE161801_IMiD_pre	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14641
8.58993001754446e-110	-0.293499456662208	0.26	0.43	1.85430819288732e-105	IL16	Malignant cells	GSE161801_IMiD_pre	ENSG00000172349	3603	interleukin 16	FLJ16806|FLJ42735|HsT19289|IL-16|LCF|prIL-16	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14642
1.10931905665748e-109	0.321552183523994	0.434	0.266	2.39468704760651e-105	ARRDC3	Malignant cells	GSE161801_IMiD_pre	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14643
3.65659879747506e-109	0.281222754613988	0.801	0.669	7.89349982410941e-105	DNAJB9	Malignant cells	GSE161801_IMiD_pre	ENSG00000128590	4189	DnaJ heat shock protein family (Hsp40) member B9	MDG1	protein_coding	Q9UBS3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14644
1.84559332915922e-108	-0.258493850349304	0.713	0.839	3.98408231965601e-104	ATP5F1B	Malignant cells	GSE161801_IMiD_pre	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14645
5.52389325583016e-108	0.334982597534414	0.89	0.887	1.19244283713606e-103	GUK1	Malignant cells	GSE161801_IMiD_pre	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14646
1.14082921085253e-107	-0.274110650909885	0.447	0.622	2.46270801746736e-103	RHOA	Malignant cells	GSE161801_IMiD_pre	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14647
6.78730915268675e-107	0.313328736354471	0.643	0.52	1.46517642679049e-102	UQCR10	Malignant cells	GSE161801_IMiD_pre	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14648
6.85775229910235e-105	-0.357504533212042	0.883	0.929	1.48038298880722e-100	KRTCAP2	Malignant cells	GSE161801_IMiD_pre	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14649
2.94566212238223e-104	0.288347869211796	0.585	0.43	6.35880082358652e-100	RBX1	Malignant cells	GSE161801_IMiD_pre	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14650
2.09573597919376e-102	-0.294897856723709	0.53	0.687	4.52406525828558e-98	SRSF5	Malignant cells	GSE161801_IMiD_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14651
7.0639504878667e-100	-0.275297947677044	0.849	0.912	1.52489499181579e-95	HSP90AB1	Malignant cells	GSE161801_IMiD_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14652
2.88675091097428e-98	0.270992795390516	0.46	0.305	6.23162919152019e-94	TXNDC17	Malignant cells	GSE161801_IMiD_pre	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14653
3.02667815719721e-98	0.318999680030223	0.496	0.36	6.53369013794162e-94	EMC3	Malignant cells	GSE161801_IMiD_pre	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14654
3.38432604581493e-98	-0.394192276067676	0.463	0.589	7.30574463510069e-94	NSD2	Malignant cells	GSE161801_IMiD_pre	ENSG00000109685	7468	nuclear receptor binding SET domain protein 2	KMT3G|MMSET|WHSC1	protein_coding	O96028	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14655
3.86735801173413e-95	-0.280327884669895	0.749	0.837	8.34846573993046e-91	TPI1	Malignant cells	GSE161801_IMiD_pre	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14656
5.79828750829844e-95	0.266295112131964	0.441	0.285	1.25167632441638e-90	GPBP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000062194	65056	GC-rich promoter binding protein 1	DKFZp761C169	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14657
1.64526435703661e-94	0.258314537726412	0.646	0.491	3.55163216753493e-90	GRN	Malignant cells	GSE161801_IMiD_pre	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14658
2.78693189428291e-93	-0.724320976808473	0.693	0.817	6.01614988018851e-89	TUBA1B	Malignant cells	GSE161801_IMiD_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14659
5.20884516767734e-93	0.284540549293981	0.671	0.579	1.12443340634651e-88	GADD45GIP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14660
6.72777806817246e-92	0.258435482053802	0.308	0.165	1.45232545157639e-87	EHD4	Malignant cells	GSE161801_IMiD_pre	ENSG00000103966	30844	EH domain containing 4	PAST4	protein_coding	Q9H223	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14661
1.45847424046117e-91	0.291821288650595	0.368	0.222	3.14840834288352e-87	SERPINI1	Malignant cells	GSE161801_IMiD_pre	ENSG00000163536	5274	serpin family I member 1	PI12	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14662
1.78832045801459e-91	-0.288464306222658	0.838	0.923	3.8604473727161e-87	ERP29	Malignant cells	GSE161801_IMiD_pre	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14663
2.6826089130118e-91	0.258719718555548	0.278	0.139	5.79094786051857e-87	MIR29B2CHG	Malignant cells	GSE161801_IMiD_pre	ENSG00000203709	NA	NA	C1orf132|FLJ35650	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14664
3.03642965537827e-90	0.307472085820302	0.582	0.456	6.55474069706506e-86	CCNL1	Malignant cells	GSE161801_IMiD_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14665
3.37563221512974e-89	0.413209382656505	0.769	0.733	7.28697726280057e-85	ERLEC1	Malignant cells	GSE161801_IMiD_pre	ENSG00000068912	27248	endoplasmic reticulum lectin 1	C2orf30|CL25084|ERLECTIN|XTP3-B|XTP3TPB	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14666
1.32731057389544e-88	-0.32418822127468	0.148	0.273	2.86526533586808e-84	MDK	Malignant cells	GSE161801_IMiD_pre	ENSG00000110492	4192	midkine	FLJ27379|MK|NEGF2	protein_coding	P21741	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14667
1.47523071234663e-88	-0.372508837636574	0.999	1	3.18458053874267e-84	MZB1	Malignant cells	GSE161801_IMiD_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14668
6.00826331427591e-88	-0.4099692335505	0.765	0.884	1.29700380165274e-83	H2AFZ	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14669
8.6574122626479e-88	0.461658020318035	0.371	0.243	1.8688755851378e-83	PHACTR1	Malignant cells	GSE161801_IMiD_pre	ENSG00000112137	221692	phosphatase and actin regulator 1	dJ257A7.2|KIAA1733|RPEL1	protein_coding	Q9C0D0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14670
6.03054872497109e-86	0.276934331645186	0.674	0.595	1.30181455325951e-81	TMEM208	Malignant cells	GSE161801_IMiD_pre	ENSG00000168701	29100	transmembrane protein 208	hSND2|HSPC171	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14671
3.21614162590223e-85	0.299665154050336	0.408	0.276	6.94268492783514e-81	TMEM9	Malignant cells	GSE161801_IMiD_pre	ENSG00000116857	252839	transmembrane protein 9	TMEM9A	protein_coding	Q9P0T7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14672
3.38025361357805e-85	0.260409843860642	0.869	0.784	7.29695347563094e-81	CALM2	Malignant cells	GSE161801_IMiD_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14673
5.57260772394964e-85	0.498235122377837	0.406	0.263	1.20295882936901e-80	ISG15	Malignant cells	GSE161801_IMiD_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14674
1.02129083980651e-84	0.356646698656505	0.993	0.987	2.20466053589032e-80	HLA-B	Malignant cells	GSE161801_IMiD_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14675
1.42160845143811e-84	0.260088520645238	0.476	0.334	3.06882616411945e-80	UNC93B1	Malignant cells	GSE161801_IMiD_pre	ENSG00000110057	81622	unc-93 homolog B1, TLR signaling regulator	UNC93	protein_coding	Q9H1C4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14676
4.03256510482503e-83	-0.293714269986065	0.2	0.333	8.70509829178579e-79	LINC02362	Malignant cells	GSE161801_IMiD_pre	ENSG00000249096	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14677
6.50233753350493e-82	0.393915164886176	0.574	0.462	1.40365960335771e-77	SPAG4	Malignant cells	GSE161801_IMiD_pre	ENSG00000061656	6676	sperm associated antigen 4	CT127|SUN4	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14678
2.98679348215917e-80	0.272743560995226	0.695	0.633	6.44759108993701e-76	C19orf70	Malignant cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14679
4.27654062215555e-80	0.271447462422123	0.391	0.257	9.23176824104719e-76	GPR160	Malignant cells	GSE161801_IMiD_pre	ENSG00000173890	26996	G protein-coupled receptor 160	GPCR1|GPCR150	protein_coding	Q9UJ42	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14680
1.1126596417712e-79	0.276593623215577	0.284	0.155	2.40189836869149e-75	APOBEC3C	Malignant cells	GSE161801_IMiD_pre	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14681
9.96432004852964e-79	0.269765515386208	0.414	0.279	2.15099776887609e-74	UCP2	Malignant cells	GSE161801_IMiD_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14682
1.10027406181761e-77	0.665256001015202	0.587	0.536	2.37516161724567e-73	IER2	Malignant cells	GSE161801_IMiD_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14683
2.11528156891392e-77	0.293430368226053	0.464	0.342	4.56625832281448e-73	MRPL41	Malignant cells	GSE161801_IMiD_pre	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14684
1.05707413496334e-76	0.381121693027969	0.373	0.246	2.28190593514536e-72	MDM4	Malignant cells	GSE161801_IMiD_pre	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14685
6.42115314528965e-76	0.262485311629031	0.68	0.568	1.38613432947368e-71	C12orf57	Malignant cells	GSE161801_IMiD_pre	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14686
2.61518580011419e-75	0.259349968607684	0.593	0.48	5.6454015867065e-71	ZBTB38	Malignant cells	GSE161801_IMiD_pre	ENSG00000177311	253461	zinc finger and BTB domain containing 38	CIBZ|FLJ35036|PPP1R171|ZNF921	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14687
1.01603113556234e-72	0.257764459146847	0.279	0.155	2.19330641233842e-68	TOB1	Malignant cells	GSE161801_IMiD_pre	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14688
1.42806580469063e-72	0.261649865819552	0.588	0.483	3.08276565258566e-68	DDT	Malignant cells	GSE161801_IMiD_pre	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14689
1.85476487965981e-72	0.29273478439356	0.422	0.302	4.00388094572163e-68	IGF1	Malignant cells	GSE161801_IMiD_pre	ENSG00000017427	3479	insulin like growth factor 1	IGF|IGF-I|IGF1A|IGFI	protein_coding	P05019	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14690
1.31755392310774e-70	0.296791684874009	0.729	0.669	2.84420365381269e-66	ANXA2	Malignant cells	GSE161801_IMiD_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14691
1.64384207672946e-70	0.330202262632207	0.448	0.322	3.54856189103588e-66	PRDM1	Malignant cells	GSE161801_IMiD_pre	ENSG00000057657	639	PR/SET domain 1	BLIMP1|PRDI-BF1	protein_coding	O75626	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14692
2.21758930315228e-70	0.291692731261083	0.638	0.54	4.78711002871484e-66	VAMP2	Malignant cells	GSE161801_IMiD_pre	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14693
2.43805873191452e-69	-0.273696378816705	0.663	0.784	5.26303738458387e-65	NDUFC2	Malignant cells	GSE161801_IMiD_pre	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14694
3.13063542850744e-67	0.358247182244133	0.815	0.765	6.75810269951901e-63	NEAT1	Malignant cells	GSE161801_IMiD_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14695
7.28873746205167e-67	0.255857960984452	0.608	0.522	1.57341975593309e-62	AUP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14696
1.07713909305678e-66	-0.335998911641254	0.427	0.559	2.32522016018168e-62	GGH	Malignant cells	GSE161801_IMiD_pre	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14697
5.92873247764185e-65	0.423370508893759	0.641	0.541	1.27983547994855e-60	CXCR4	Malignant cells	GSE161801_IMiD_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14698
5.18115658911747e-64	-0.250087708983207	0.686	0.784	1.11845627289279e-59	DAD1	Malignant cells	GSE161801_IMiD_pre	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14699
1.51547043532561e-63	0.26091695019799	0.372	0.251	3.2714460287374e-59	TYMP	Malignant cells	GSE161801_IMiD_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14700
1.85541139876066e-62	-1.00650402177981	0.362	0.433	4.00527658650463e-58	TMSB4X	Malignant cells	GSE161801_IMiD_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14701
3.35664784275331e-62	0.275209010552577	0.335	0.215	7.24599569815157e-58	SPINT2	Malignant cells	GSE161801_IMiD_pre	ENSG00000167642	10653	serine peptidase inhibitor, Kunitz type 2	HAI-2|HAI2|Kop	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14702
4.35146376444551e-62	0.492433575720117	0.871	0.912	9.39350482830852e-58	LGALS1	Malignant cells	GSE161801_IMiD_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14703
3.34423970101522e-58	0.257959410907064	0.596	0.529	7.21921024258155e-54	HIGD2A	Malignant cells	GSE161801_IMiD_pre	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14704
5.85997910813904e-56	-0.358527432043645	0.955	0.989	1.26499369007397e-51	TPT1	Malignant cells	GSE161801_IMiD_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14705
1.30356935763718e-53	0.504106811396535	0.645	0.603	2.81401517233139e-49	UAP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000117143	6675	UDP-N-acetylglucosamine pyrophosphorylase 1	AgX|AGX1|SPAG2	protein_coding	Q16222	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14706
4.91798780119726e-52	-0.31000844204102	0.955	0.967	1.06164602664445e-47	FKBP2	Malignant cells	GSE161801_IMiD_pre	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14707
1.11799534666396e-49	0.33176639773619	0.65	0.636	2.41341655484349e-45	IFI6	Malignant cells	GSE161801_IMiD_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14708
9.24864142160754e-45	0.254634833085425	0.538	0.473	1.99650422368242e-40	YWHAZ	Malignant cells	GSE161801_IMiD_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14709
1.82987494848496e-44	-0.327315028184181	0.632	0.723	3.95015105129449e-40	TXNIP	Malignant cells	GSE161801_IMiD_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14710
2.46537098816999e-44	0.316390428348769	0.569	0.491	5.32199635216256e-40	ZFP36L2	Malignant cells	GSE161801_IMiD_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14711
1.11573995745302e-43	-0.463883245817792	0.214	0.281	2.40854784615383e-39	CADM1	Malignant cells	GSE161801_IMiD_pre	ENSG00000182985	23705	cell adhesion molecule 1	BL2|IGSF4|IGSF4A|Necl-2|NECL2|RA175|ST17|SYNCAM|SYNCAM1|TSLC1	protein_coding	Q9BY67	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14712
2.56337439926197e-43	0.268292407238674	0.7	0.656	5.53355631568681e-39	EMP3	Malignant cells	GSE161801_IMiD_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14713
3.78293042109675e-40	0.297192323783815	0.579	0.517	8.16621190002155e-36	CDC42	Malignant cells	GSE161801_IMiD_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14714
4.10915474288162e-40	0.259088822035977	0.25	0.162	8.87043234345855e-36	MX1	Malignant cells	GSE161801_IMiD_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14715
8.86629266352472e-38	0.261625965158527	0.334	0.251	1.91396659727508e-33	C16orf54	Malignant cells	GSE161801_IMiD_pre	ENSG00000185905	283897	chromosome 16 open reading frame 54	FLJ35681	protein_coding	Q6UWD8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14716
1.11556185870126e-34	0.36742999805401	0.785	0.784	2.40816338437842e-30	ISG20	Malignant cells	GSE161801_IMiD_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14717
2.72274603836463e-34	-0.79353386865736	0.291	0.376	5.87759187301772e-30	CCL3	Malignant cells	GSE161801_IMiD_pre	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14718
9.02249360193539e-34	0.253659431958424	0.803	0.782	1.94768569384979e-29	NUCB2	Malignant cells	GSE161801_IMiD_pre	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14719
3.4284216808181e-33	0.304470131887792	0.336	0.275	7.40093388238202e-29	BASP1	Malignant cells	GSE161801_IMiD_pre	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14720
2.85085108759968e-32	-0.453509954088767	0.729	0.73	6.15413224280143e-28	COMMD3	Malignant cells	GSE161801_IMiD_pre	ENSG00000148444	23412	COMM domain containing 3	BUP|C10orf8	protein_coding	Q9UBI1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14721
4.18450290858344e-32	-0.382524642646701	0.404	0.441	9.03308642875908e-28	SEL1L3	Malignant cells	GSE161801_IMiD_pre	ENSG00000091490	23231	SEL1L family member 3	KIAA0746	protein_coding	Q68CR1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14722
6.01179427131224e-31	0.311607271178348	0.691	0.65	1.29776602934817e-26	ICAM3	Malignant cells	GSE161801_IMiD_pre	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14723
2.82700517332499e-30	0.323011484536525	0.547	0.506	6.10265606765665e-26	KLF2	Malignant cells	GSE161801_IMiD_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14724
4.09365171135743e-20	0.440132364353661	0.576	0.637	8.83696594930729e-16	CYTOR	Malignant cells	GSE161801_IMiD_pre	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14725
7.19526592735182e-17	0.310043867193278	0.715	0.807	1.55324205573744e-12	IL2RG	Malignant cells	GSE161801_IMiD_pre	ENSG00000147168	3561	interleukin 2 receptor subunit gamma	CD132|CIDX|IMD4|SCIDX1	protein_coding	P31785	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14726
1.12377229953454e-16	-0.316409534635318	0.415	0.465	2.4258872630052e-12	DDIT4	Malignant cells	GSE161801_IMiD_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14727
2.12037331161966e-12	-0.362200315644406	0.438	0.477	4.57724986779336e-08	HMGB2	Malignant cells	GSE161801_IMiD_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14728
1.92045179204974e-07	-0.265613785917788	0.621	0.612	0.00414567928349778	BCAP31	Malignant cells	GSE161801_IMiD_pre	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14729
2.40118713205825e-214	0.643122288466119	1	1	5.18344266197414e-210	RPS29	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14730
9.42179735764254e-191	-0.575649381694718	1	1	2.03388339559429e-186	EEF1A1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14731
8.561045695494e-167	-0.641408258661305	0.999	1	1.84807293428629e-162	TPT1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14732
3.85802772100424e-160	-0.51683324570171	0.999	1	8.32832444133186e-156	HLA-C	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14733
1.18987159238134e-152	-0.586076448992878	0.941	0.988	2.56857580647361e-148	MT-ND1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14734
1.69089751648576e-108	-0.763285062804383	0.069	0.299	3.65014046883781e-104	HSPA1A	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14735
4.17299867917843e-104	-0.47822179900833	0.993	0.997	9.00825224874248e-100	MT-CYB	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14736
9.40221854046997e-104	0.296939135779279	1	1	2.02965691633125e-99	RPS27	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14737
1.88161097296885e-103	-0.661124382691396	0.704	0.906	4.06183360734787e-99	MT-ND5	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14738
2.86872661300918e-94	-0.917456603415401	0.629	0.834	6.19272013950292e-90	JUN	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14739
1.4211627243621e-92	-0.541908537420761	0.512	0.761	3.06786397308046e-88	VIM	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14740
1.18276528509425e-91	-0.44665428032047	0.998	0.998	2.55323542093296e-87	MT-ND2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14741
1.9943756080386e-89	-0.306261736471329	1	1	4.30525862507292e-85	RPS23	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14742
4.81019562414403e-88	0.555195571121912	0.923	0.846	1.03837692938397e-83	RPL36A	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14743
2.91630517201292e-87	-0.332274735915342	1	1	6.2954279748243e-83	RPL30	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14744
5.6320004242577e-86	-0.510016116379635	0.618	0.834	1.21577993158451e-81	S100A10	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14745
3.39909342112267e-84	-0.308302461800091	1	1	7.33762296817751e-80	RPS12	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14746
3.28854257033847e-78	-0.512242692230205	0.33	0.575	7.09897684658966e-74	HOPX	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14747
6.05767638022244e-73	-0.366797700899149	0.344	0.645	1.30767060019862e-68	EIF5A	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14748
9.0706623180379e-72	-0.64012154199701	0.147	0.36	1.95808387459484e-67	HSPA1B	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14749
2.90502572400299e-69	-0.309131389725509	1	1	6.27107903040525e-65	RPS20	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14750
1.47488048361323e-61	0.256392751999155	1	1	3.18382449997589e-57	MALAT1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14751
3.27909265610508e-61	-0.25848345087238	1	1	7.07857731673404e-57	RPS24	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14752
3.16506631992589e-55	0.373131899425516	0.964	0.92	6.83242866482403e-51	RPS17	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14753
6.11710876896012e-55	-0.310081575797132	0.947	0.978	1.32050026995542e-50	NACA	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14754
3.15819602931646e-54	0.27786555275515	1	1	6.81759776848543e-50	RPL34	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14755
6.02013266435196e-54	-0.347149367002447	0.767	0.904	1.29956603825366e-49	EEF1B2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14756
2.69823666374389e-53	0.530040149427401	0.423	0.245	5.82468348602394e-49	HBB	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14757
2.90062322767899e-52	-0.267879864949391	0.994	0.998	6.26157536159063e-48	RPL7A	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14758
1.62384659628456e-51	-0.300754156052439	0.275	0.495	3.50539764739948e-47	TUBA1B	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14759
1.2806047123567e-50	0.483052748110819	0.401	0.221	2.7644413925644e-46	LYZ	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14760
8.48740717667523e-49	-0.33215602686276	0.376	0.599	1.83217658722888e-44	YWHAQ	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14761
1.50267099414993e-48	-0.394193427596503	0.429	0.62	3.24381587507144e-44	CD48	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14762
1.33622265547785e-46	-0.343650136430834	0.549	0.741	2.88450384638003e-42	LAPTM5	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14763
2.38568380006911e-46	-0.612802737309341	0.342	0.456	5.14997561920918e-42	MZB1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14764
6.14419301137278e-46	-0.378936733335938	0.592	0.771	1.32634694536504e-41	HSPA8	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14765
2.34756371761317e-45	-0.264368219419694	0.986	0.997	5.06768579721156e-41	MT-ATP6	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14766
4.43912374569177e-45	-0.413170287647412	0.716	0.867	9.58273642982482e-41	HSP90AA1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14767
7.42717967733698e-45	-0.641481182197247	0.547	0.697	1.60330527694673e-40	GNLY	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14768
1.85927035379014e-44	-0.253388571840617	0.124	0.28	4.01360691272677e-40	BTN3A2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14769
1.98251764758118e-44	-0.321664271893511	0.437	0.649	4.2796608458335e-40	RAC2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14770
6.36595898162854e-44	-0.252854684212994	0.991	0.998	1.37421956536415e-39	RPSA	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14771
8.44821174420858e-43	-0.314948261202887	0.378	0.571	1.82371546922231e-38	HLA-F	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000234487	3134	major histocompatibility complex, class I, F	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14772
1.03270020954775e-41	-0.628623961600736	0.256	0.433	2.22928994235072e-37	NFKBIA	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14773
1.76531593604019e-41	-0.261467793955853	0.384	0.607	3.81078751112995e-37	LDHA	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14774
1.29216068296134e-39	-0.298983214259673	0.387	0.594	2.78938726630864e-35	TAGLN2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14775
2.32062543239437e-39	-0.532122718224829	0.69	0.765	5.00953412090972e-35	GZMH	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14776
2.70029683576097e-39	-0.340981706663472	0.396	0.58	5.8291307793572e-35	HSP90B1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14777
5.7067662912957e-39	0.463545493119222	0.378	0.227	1.231919639302e-34	S100A8	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14778
2.61730576524223e-37	-0.293343732982879	0.899	0.96	5.64997795542841e-33	IL32	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14779
9.6140062047979e-37	0.34868767834085	0.731	0.65	2.07537551942972e-32	UQCR11	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14780
1.72746171213043e-36	-0.280608318743605	0.396	0.573	3.72907159797597e-32	MYO1F	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14781
4.28005645808026e-36	0.291267242224492	0.974	0.966	9.23935787605787e-32	CYBA	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14782
1.78380967629884e-35	-0.279841528080857	0.502	0.691	3.8507099482263e-31	CD37	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14783
2.0257188435361e-35	-0.256895732191623	0.245	0.417	4.37291926754139e-31	SBDS	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14784
1.3317394330404e-34	0.31512004624157	0.986	0.98	2.87482591410432e-30	MT-ND3	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14785
6.27184373678335e-34	-0.277850857231617	0.727	0.833	1.35390290745942e-29	PPIA	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14786
6.2923225460655e-34	-0.256746722623745	0.4	0.592	1.35832366801916e-29	RHOA	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14787
1.05541196540104e-33	-0.263491284883433	0.32	0.499	2.27831780971122e-29	ANXA6	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14788
1.06368314793048e-33	-0.31784085126939	0.334	0.509	2.29617281143753e-29	TUBA4A	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14789
1.71416470265622e-33	-0.256025627471586	0.371	0.558	3.70036734362399e-29	HNRNPA0	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14790
2.3683588887173e-33	0.310933138593485	0.744	0.682	5.11257633307403e-29	ATP5MPL	CD8+ T cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14791
2.9819006999454e-33	-0.283779555585014	0.376	0.549	6.43702904097213e-29	IRF1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14792
1.78232824368609e-32	-0.379122132691085	0.268	0.43	3.84751197964516e-28	PPP1R15A	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14793
2.27986983486084e-32	-0.518605731634395	0.429	0.561	4.92155501251411e-28	FGFBP2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14794
6.88379447019237e-32	-0.260846514763179	0.44	0.623	1.48600471228043e-27	CCNI	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14795
7.29127702907088e-32	-0.252942793984129	0.319	0.5	1.57396797226553e-27	UCP2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14796
1.03662788966386e-31	-0.253473538422657	0.13	0.26	2.23776862541738e-27	MYADM	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14797
4.82205506607301e-31	0.489692608700622	0.485	0.368	1.04093702711318e-26	HNRNPH1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14798
7.65391410540111e-30	-0.265774799747065	0.618	0.8	1.65225043793294e-25	IFITM2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14799
8.65172844493974e-30	-0.26881214807279	0.491	0.665	1.86764861940914e-25	HSP90AB1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14800
1.82248205364002e-29	-0.293976436019338	0.483	0.654	3.9341920091927e-25	HSPE1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14801
7.26866589014466e-29	-0.466230790097555	0.17	0.296	1.56908690570553e-24	AC020916.1	CD8+ T cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14802
1.08152916626937e-28	0.344505859597808	0.565	0.467	2.33469701122569e-24	ATP5ME	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14803
1.29389499763309e-28	-0.253012115644948	0.682	0.795	2.79313113139055e-24	NOP53	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14804
7.6261654760015e-28	-0.30051316929943	0.138	0.259	1.64626034130444e-23	IFRD1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14805
3.85758430976809e-27	-0.298472365042565	0.527	0.652	8.32736724949639e-23	CD2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14806
6.76693529746231e-27	-0.283864019381046	0.431	0.594	1.46077832266319e-22	DNAJB1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14807
6.90055321846594e-26	-0.261311967983277	0.135	0.25	1.48962242327024e-21	SPON2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14808
1.68057676523585e-25	0.392626707855822	0.421	0.314	3.62786106311463e-21	S100A9	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14809
3.41738966389223e-23	0.423319038471162	0.383	0.268	7.37711906744417e-19	C1orf56	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000143443	54964	chromosome 1 open reading frame 56	FLJ20519|MENT	protein_coding	Q9BUN1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14810
9.13003347880189e-23	-0.331260634360951	0.597	0.71	1.97090032706896e-18	ID2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14811
1.03714497890909e-22	-0.360101226180782	0.345	0.477	2.23888486597106e-18	YPEL5	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14812
3.02686564854032e-22	0.395785251812425	0.706	0.69	6.53409487550398e-18	HMGB2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14813
6.04557002478079e-21	-0.42963356219809	0.497	0.611	1.30505720124943e-16	KLF6	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14814
7.71245407722853e-20	0.288799059690528	0.378	0.273	1.66488746165132e-15	VMP1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14815
5.81628826499858e-19	0.288802139499951	0.394	0.298	1.25556214776524e-14	PET100	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14816
2.08016195356811e-18	-0.309332926339109	0.447	0.55	4.49044560916748e-14	PRF1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14817
8.11140104741638e-18	0.289077384190453	0.77	0.771	1.75100814410577e-13	VAMP2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14818
9.78750250181636e-18	-0.261992636303149	0.747	0.83	2.1128281650671e-13	ACTG1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14819
1.25743113422782e-17	0.266168717423456	0.439	0.356	2.7144165894576e-13	NDUFA13	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14820
4.52719101711669e-15	0.423005885913579	0.582	0.513	9.7728472486498e-11	CCL4	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14821
4.61400921102392e-15	-0.442764005218446	0.535	0.654	9.96026168383733e-11	ZFP36	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14822
6.73892863316127e-14	-0.253676493057507	0.234	0.327	1.45473252404052e-09	PMAIP1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14823
8.02574965921275e-14	0.353685381769901	0.556	0.48	1.73251857893426e-09	GZMB	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14824
1.40420425452031e-11	0.263749204244429	0.445	0.369	3.031255724233e-07	LINC01871	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000235576	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14825
1.82512601492993e-11	0.271237127062457	0.461	0.388	3.93989952842925e-07	PIK3R1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14826
7.08911503468951e-11	-0.548226090527526	0.831	0.846	1.53032726253843e-06	DUSP1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14827
2.14741159889404e-10	-0.26999827627093	0.757	0.839	4.63561741853256e-06	TSC22D3	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14828
3.32448783685795e-10	0.254115373395979	0.321	0.26	7.17657189342527e-06	PFDN2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14829
1.77750205528507e-08	0.283643498139825	0.366	0.315	0.000383709368674388	CDC42SE1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14830
2.66518222546412e-08	-0.287201289792868	0.716	0.794	0.000575332887010941	IER2	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14831
4.57187987058209e-07	0.362004823107885	0.49	0.458	0.00986931707662556	CMC1	CD8+ T cells	GSE161801_IMiD_pre	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14832
2.27005961626082e-162	-0.761895982129614	0.165	0.506	4.90037769362224e-158	MZB1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14833
1.92931702843728e-161	0.584805601996544	0.998	0.992	4.16481666928757e-157	RPS29	Mono/Macro	GSE161801_IMiD_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14834
1.25816672224703e-120	0.367816775914458	1	1	2.71600450331466e-116	RPS27	Mono/Macro	GSE161801_IMiD_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14835
3.87991999115131e-114	-0.570661427075105	0.982	0.994	8.37558328489833e-110	MT-ND1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14836
2.82350510103326e-112	0.484891532789923	0.999	0.996	6.09510046160051e-108	MT-ND3	Mono/Macro	GSE161801_IMiD_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14837
1.43124263677223e-106	-1.32348170035185	0.609	0.841	3.08962348000021e-102	AC020656.1	Mono/Macro	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14838
7.43638694882125e-99	-0.454422096076526	1	1	1.60529285064204e-94	EEF1A1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14839
2.39957333803628e-92	0.612162139866489	0.285	0.002	5.17995896481892e-88	HLA-DQA2	Mono/Macro	GSE161801_IMiD_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14840
1.9156148773603e-91	0.592082383663439	0.82	0.62	4.13523783575769e-87	ITGB2	Mono/Macro	GSE161801_IMiD_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14841
5.24950359345464e-78	-0.350241448968274	0.996	0.999	1.13321034071905e-73	EIF1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14842
1.14482583386784e-76	0.495834926950379	0.926	0.831	2.47133552757052e-72	RPL36A	Mono/Macro	GSE161801_IMiD_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14843
1.89304235123349e-74	-1.03757184343735	0.562	0.733	4.08651052360774e-70	NFKBIA	Mono/Macro	GSE161801_IMiD_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14844
1.45182900652783e-66	-0.657273727055224	0.678	0.799	3.13406327639163e-62	ZFP36	Mono/Macro	GSE161801_IMiD_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14845
3.59079507777714e-65	-0.325243137886292	0.999	1	7.75144933439751e-61	RPS23	Mono/Macro	GSE161801_IMiD_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14846
1.88730362874615e-63	-0.638418583982643	0.281	0.508	4.07412234337431e-59	JUN	Mono/Macro	GSE161801_IMiD_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14847
9.63027344234758e-63	-0.428439670514233	0.943	0.98	2.07888712799957e-58	NACA	Mono/Macro	GSE161801_IMiD_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14848
1.5540203254802e-62	-0.492935409962796	0.961	0.977	3.35466367661411e-58	DUSP1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14849
1.36904846441702e-59	-0.357791544733429	0.996	0.997	2.95536492013701e-55	RPL30	Mono/Macro	GSE161801_IMiD_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14850
3.90212407970582e-57	-0.394850818334091	0.357	0.598	8.42351525086094e-53	EIF5A	Mono/Macro	GSE161801_IMiD_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14851
4.10968746765924e-54	0.29024215615726	1	1	8.87158233643601e-50	MT-CO1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14852
2.27603041144357e-52	0.604086753644859	0.463	0.256	4.91326684918324e-48	HBB	Mono/Macro	GSE161801_IMiD_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14853
2.70601835525146e-52	-0.398414295139363	0.997	0.998	5.84148182348133e-48	RPL9	Mono/Macro	GSE161801_IMiD_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14854
5.49427481679487e-52	-0.308381084831199	0.988	0.993	1.18604910470151e-47	RPL6	Mono/Macro	GSE161801_IMiD_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14855
6.2632684328811e-51	-0.555302332564821	0.534	0.7	1.35205175660604e-46	KLF6	Mono/Macro	GSE161801_IMiD_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14856
2.52092739013124e-49	-0.330635754410132	0.983	0.993	5.44192595707631e-45	RPS20	Mono/Macro	GSE161801_IMiD_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14857
2.03925948439771e-46	-0.368543775558728	0.684	0.812	4.40214944896934e-42	EEF1B2	Mono/Macro	GSE161801_IMiD_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14858
2.52912489864311e-45	-1.04932389990402	0.23	0.412	5.45962191870088e-41	CCL3	Mono/Macro	GSE161801_IMiD_pre	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14859
1.05815506054123e-42	-0.519785059798175	0.273	0.446	2.28423932919034e-38	DUSP6	Mono/Macro	GSE161801_IMiD_pre	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14860
9.23457772380591e-41	-0.410094436249514	0.857	0.931	1.99346829323798e-36	CD52	Mono/Macro	GSE161801_IMiD_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14861
4.79332788645391e-39	-0.416556605179415	0.998	0.998	1.03473569084881e-34	TPT1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14862
8.47012975997643e-37	-0.470631902570391	0.659	0.776	1.82844691128611e-32	HSP90AA1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14863
2.62923651930904e-36	0.32489853820393	0.914	0.837	5.67573287423243e-32	RPS17	Mono/Macro	GSE161801_IMiD_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14864
8.70502355326392e-36	-0.299072745639887	0.715	0.829	1.87915343444308e-31	CHCHD2	Mono/Macro	GSE161801_IMiD_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14865
7.17742771497779e-35	-0.396665510304908	0.926	0.968	1.54939132083226e-30	VIM	Mono/Macro	GSE161801_IMiD_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14866
9.60788899530793e-34	-0.300789931546846	0.897	0.946	2.07405499741712e-29	ARPC3	Mono/Macro	GSE161801_IMiD_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14867
1.68959853675406e-32	-0.364589732136354	0.183	0.33	3.64733636129099e-28	AC020916.1	Mono/Macro	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14868
2.94012793233485e-32	-0.280152819034176	0.132	0.266	6.34685416753124e-28	LAIR1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000276163	3903	leukocyte associated immunoglobulin like receptor 1	CD305|LAIR-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14869
5.43286077753777e-32	-0.285031691050668	0.999	1	1.17279165604708e-27	RPS13	Mono/Macro	GSE161801_IMiD_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14870
5.81623224049001e-32	0.329603692033474	0.75	0.602	1.25555005375458e-27	HMGB2	Mono/Macro	GSE161801_IMiD_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14871
5.34653232162647e-31	0.291496523336833	0.863	0.798	1.15415593226951e-26	UQCR11	Mono/Macro	GSE161801_IMiD_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14872
7.37756150973626e-31	-0.537833380943735	0.145	0.272	1.59259420310677e-26	HSPA1A	Mono/Macro	GSE161801_IMiD_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14873
1.64781687274408e-30	0.32037003800981	0.787	0.657	3.55714228319265e-26	MTRNR2L8	Mono/Macro	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14874
3.3072427643485e-30	-0.63472946033548	0.145	0.269	7.1393449553991e-26	IL1B	Mono/Macro	GSE161801_IMiD_pre	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14875
1.16436682196552e-29	-0.357790384332517	0.485	0.631	2.51351865857698e-25	LGALS3	Mono/Macro	GSE161801_IMiD_pre	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14876
9.23189442020833e-29	0.385172104279929	0.719	0.557	1.99288904849037e-24	MT2A	Mono/Macro	GSE161801_IMiD_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14877
1.06285539699544e-27	-0.343012953057467	0.333	0.481	2.29438594549405e-23	PPP1R15A	Mono/Macro	GSE161801_IMiD_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14878
2.36356084836254e-27	-0.253754630439177	0.963	0.987	5.10221880336022e-23	FCER1G	Mono/Macro	GSE161801_IMiD_pre	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14879
9.30511312916695e-27	-0.281065182936156	0.878	0.921	2.00869477119327e-22	ACTG1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14880
1.55323877213223e-26	0.290537470564033	0.474	0.316	3.35297653740184e-22	WSB1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14881
1.16592267184173e-25	0.282374233286417	0.535	0.382	2.51687727170475e-21	PET100	Mono/Macro	GSE161801_IMiD_pre	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14882
2.71924548773761e-25	-0.254920200715987	0.195	0.328	5.87003523437919e-21	CD83	Mono/Macro	GSE161801_IMiD_pre	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14883
2.29250668326806e-24	-0.369407740685157	0.515	0.664	4.94883417717076e-20	HLA-DQB1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14884
5.78511849379443e-24	0.300073903421045	0.711	0.599	1.2488335292554e-19	VMP1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14885
2.59329914166988e-23	-0.278887699598485	0.716	0.815	5.59815485712278e-19	CD44	Mono/Macro	GSE161801_IMiD_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14886
1.02684800906635e-22	-0.963068951705933	0.231	0.353	2.21665679717153e-18	CXCL8	Mono/Macro	GSE161801_IMiD_pre	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14887
3.61567056824947e-22	-0.35167504822867	0.225	0.349	7.80514805568014e-18	SGK1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14888
5.39772547148766e-22	-0.292373392110103	0.67	0.772	1.16520699753004e-17	STXBP2	Mono/Macro	GSE161801_IMiD_pre	ENSG00000076944	6813	syntaxin binding protein 2	Hunc18b|MUNC18-2|Unc18-2|UNC18B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14889
1.11821151701884e-21	0.332868892088356	0.299	0.167	2.41388320178856e-17	AC245014.3	Mono/Macro	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14890
2.77091281220946e-21	-0.275480423553314	0.701	0.773	5.98156948771655e-17	COMMD6	Mono/Macro	GSE161801_IMiD_pre	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14891
3.06378116876803e-21	-0.289757050185995	0.914	0.945	6.61378440901955e-17	COTL1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14892
5.00494369087867e-21	0.286294500518101	0.575	0.404	1.08041719454998e-16	LGALS2	Mono/Macro	GSE161801_IMiD_pre	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14893
7.01131822692652e-21	-0.381231968664639	0.969	0.984	1.51353326564663e-16	HLA-DRA	Mono/Macro	GSE161801_IMiD_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14894
8.27026324482098e-21	0.258191487867795	0.689	0.557	1.78530172665951e-16	NDUFB1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14895
9.12919055153492e-21	0.292293491287301	0.929	0.936	1.97071836435984e-16	TYMP	Mono/Macro	GSE161801_IMiD_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14896
3.93826920647808e-19	-0.360434689133453	0.825	0.855	8.50154173602423e-15	CSTA	Mono/Macro	GSE161801_IMiD_pre	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14897
4.06320333775462e-19	0.253288676133512	0.288	0.167	8.7712370452109e-15	NR4A2	Mono/Macro	GSE161801_IMiD_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14898
6.55088683287966e-19	-0.4082126147386	0.575	0.67	1.41413994061373e-14	ID2	Mono/Macro	GSE161801_IMiD_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14899
1.50817609219881e-18	-0.261826060917651	0.351	0.474	3.25569973022957e-14	ATP2B1-AS1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000271614	NA	NA	LINC00936	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14900
1.69725772018789e-18	0.269322640488899	0.732	0.622	3.66387024056961e-14	CTSD	Mono/Macro	GSE161801_IMiD_pre	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14901
9.43517542867958e-18	0.258913866547161	0.641	0.54	2.03677131978906e-13	CYBB	Mono/Macro	GSE161801_IMiD_pre	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14902
1.21781285720502e-16	-0.369835342808011	0.708	0.771	2.62889261484848e-12	HLA-DPA1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14903
1.48494353465495e-16	0.251832507019789	0.278	0.167	3.20554760825963e-12	IFI44L	Mono/Macro	GSE161801_IMiD_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14904
1.52951678529954e-16	0.30970335771797	0.85	0.831	3.30176788442612e-12	MNDA	Mono/Macro	GSE161801_IMiD_pre	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14905
4.27239522576137e-16	0.266473303764973	0.498	0.394	9.22281957385106e-12	CLEC12A	Mono/Macro	GSE161801_IMiD_pre	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14906
5.17634188166188e-16	0.263410724553115	0.701	0.617	1.11741692199435e-11	IFI30	Mono/Macro	GSE161801_IMiD_pre	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14907
6.68496273851752e-16	0.307640108110873	0.658	0.565	1.44308290636378e-11	PLAUR	Mono/Macro	GSE161801_IMiD_pre	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14908
1.51218151756844e-15	0.295733439507908	0.473	0.369	3.26434624197499e-11	HNRNPH1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14909
8.12931594122865e-15	-0.396697497749711	0.746	0.791	1.75487543223303e-10	HLA-DPB1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14910
1.36611865065468e-14	0.354092041379321	0.554	0.461	2.94904033116826e-10	IFI6	Mono/Macro	GSE161801_IMiD_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14911
2.83200890128456e-12	-0.278857077593477	0.573	0.629	6.11345761520297e-08	ARF6	Mono/Macro	GSE161801_IMiD_pre	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14912
9.06537692577426e-12	0.271892654191458	0.556	0.458	1.95694291696689e-07	NCF1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14913
1.12000169033031e-11	-0.281766577568673	0.971	0.98	2.41774764891604e-07	SAT1	Mono/Macro	GSE161801_IMiD_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14914
1.16004005921733e-157	-0.754194792672915	1	1	2.50417847583244e-153	HLA-C	NK cells	GSE161801_IMiD_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14915
6.74925521177363e-156	-1.66484646821602	0.366	0.789	1.45696172256557e-151	JUN	NK cells	GSE161801_IMiD_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14916
3.75589368218348e-109	-0.607985489094105	1	1	8.10784769172948e-105	EEF1A1	NK cells	GSE161801_IMiD_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14917
5.53606842307062e-98	-0.677778352027379	0.048	0.309	1.19507109048826e-93	CD3G	NK cells	GSE161801_IMiD_pre	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14918
3.09165964444793e-96	-0.635736738546766	0.273	0.671	6.67396567446974e-92	EIF5A	NK cells	GSE161801_IMiD_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14919
1.00856507767757e-77	-0.58131670152393	0.997	0.999	2.17718943318258e-73	TPT1	NK cells	GSE161801_IMiD_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14920
3.41889127116215e-73	-0.94216530904451	0.131	0.408	7.38036058705773e-69	CD3D	NK cells	GSE161801_IMiD_pre	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14921
1.52749951377005e-70	0.798576115792335	0.557	0.256	3.29741320037542e-66	S100A8	NK cells	GSE161801_IMiD_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14922
4.06192077213345e-67	-0.666313496922593	0.297	0.597	8.76846837080449e-63	HLA-DPB1	NK cells	GSE161801_IMiD_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14923
1.35459932130721e-66	-0.428311947641998	1	0.999	2.92417355490587e-62	RPL30	NK cells	GSE161801_IMiD_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14924
4.20047300764793e-65	-0.934246240148211	0.513	0.758	9.0675610816096e-61	GZMH	NK cells	GSE161801_IMiD_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14925
1.80212626370724e-62	-0.345774399915269	1	1	3.89024996546481e-58	RPL28	NK cells	GSE161801_IMiD_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14926
4.75764124565632e-59	0.507877421199426	0.992	0.996	1.02703201569983e-54	MT-ND3	NK cells	GSE161801_IMiD_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14927
4.85262604154856e-59	-0.776921411562129	0.613	0.792	1.04753638358909e-54	FGFBP2	NK cells	GSE161801_IMiD_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14928
3.21466092554438e-56	-0.416873414328819	0.146	0.388	6.93948853997266e-52	FCRL6	NK cells	GSE161801_IMiD_pre	ENSG00000181036	343413	Fc receptor like 6	FcRH6|FLJ16056|IFGP6	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14929
1.46372631009145e-55	-0.432486049444631	0.965	0.988	3.15974598559441e-51	UBC	NK cells	GSE161801_IMiD_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14930
9.1354142265123e-53	-0.372896082323507	0.996	1	1.97206186907721e-48	RPL9	NK cells	GSE161801_IMiD_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14931
7.99546231333939e-51	0.433208954497027	1	0.999	1.72598044958057e-46	RPS29	NK cells	GSE161801_IMiD_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14932
1.16365412627492e-48	-0.956006587860179	0.19	0.402	2.51198016238967e-44	MYOM2	NK cells	GSE161801_IMiD_pre	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14933
3.6371529094674e-47	-0.354217810972016	1	1	7.85152198566728e-43	RPS12	NK cells	GSE161801_IMiD_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14934
8.64315475777248e-47	0.665535040819916	0.571	0.372	1.86579781756034e-42	S100A9	NK cells	GSE161801_IMiD_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14935
1.54888189295388e-46	-0.534302626952635	0.614	0.821	3.34357134231954e-42	HSP90AA1	NK cells	GSE161801_IMiD_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14936
3.73218134072587e-46	0.536322378341062	0.852	0.622	8.05665986022493e-42	FCER1G	NK cells	GSE161801_IMiD_pre	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14937
3.97617379734777e-46	-0.375992503876579	0.995	0.999	8.58336637633463e-42	RPS20	NK cells	GSE161801_IMiD_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14938
1.28429903938399e-44	-0.33206890394142	0.998	0.999	2.77241633631823e-40	EIF1	NK cells	GSE161801_IMiD_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14939
1.3308306990459e-44	-0.715916414489069	0.531	0.697	2.87286423003038e-40	FCGR3A	NK cells	GSE161801_IMiD_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14940
1.11772496157944e-43	-0.378846910781307	0.113	0.315	2.41283287456155e-39	DNAJB1	NK cells	GSE161801_IMiD_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14941
5.16134417719141e-43	-0.471543330370157	0.322	0.578	1.11417936753031e-38	HSPE1	NK cells	GSE161801_IMiD_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14942
9.37630339189513e-41	-0.386827552264434	0.913	0.962	2.0240626132084e-36	DDX5	NK cells	GSE161801_IMiD_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14943
1.35781436115228e-40	-0.36724837174794	0.168	0.373	2.93111386141943e-36	LAIR1	NK cells	GSE161801_IMiD_pre	ENSG00000276163	3903	leukocyte associated immunoglobulin like receptor 1	CD305|LAIR-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14944
6.49564092767605e-39	-0.375083624715518	0.958	0.983	1.40221400705743e-34	MT-ND1	NK cells	GSE161801_IMiD_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14945
1.03584468143571e-38	-0.350493988122544	0.939	0.98	2.23607791381526e-34	HLA-E	NK cells	GSE161801_IMiD_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14946
3.24864646957377e-38	0.584627700489425	0.471	0.262	7.01285313386889e-34	LYZ	NK cells	GSE161801_IMiD_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14947
6.84069057300723e-38	-0.410160417037275	0.343	0.596	1.47669987399507e-33	CD48	NK cells	GSE161801_IMiD_pre	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14948
1.24890381166375e-37	-0.497475933794225	0.497	0.685	2.69600865823854e-33	VIM	NK cells	GSE161801_IMiD_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14949
2.31559843873711e-37	-0.326095915768363	0.118	0.3	4.9986823497018e-33	LINC02384	NK cells	GSE161801_IMiD_pre	ENSG00000251301	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14950
3.30119494205531e-36	-0.369367855418488	0.195	0.392	7.1262895214148e-32	PRSS23	NK cells	GSE161801_IMiD_pre	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14951
2.13544672227839e-35	-0.293805312335819	0.129	0.315	4.60978883938237e-31	THEMIS2	NK cells	GSE161801_IMiD_pre	ENSG00000130775	9473	thymocyte selection associated family member 2	C1orf38|ICB-1	protein_coding	Q5TEJ8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14952
4.47731507631058e-35	-0.586837162977869	0.297	0.52	9.66518005523166e-31	NFKBIA	NK cells	GSE161801_IMiD_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14953
4.73365828158523e-35	-0.454065875186298	0.879	0.926	1.0218548132458e-30	CCL5	NK cells	GSE161801_IMiD_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14954
3.21720884620748e-34	-0.377543367057945	0.257	0.481	6.94498873630808e-30	HLA-DPA1	NK cells	GSE161801_IMiD_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14955
8.47571718417238e-34	-0.630086328594164	0.741	0.871	1.82965306854729e-29	IER2	NK cells	GSE161801_IMiD_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14956
3.02973712106273e-33	-0.379735892736701	0.396	0.613	6.54029352323812e-29	HLA-F	NK cells	GSE161801_IMiD_pre	ENSG00000234487	3134	major histocompatibility complex, class I, F	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14957
1.04639998619532e-32	-0.418907023260037	0.526	0.716	2.25886365019985e-28	HSPA8	NK cells	GSE161801_IMiD_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14958
4.02495177037782e-31	0.483367373204897	0.827	0.755	8.6886633867146e-27	RPL36A	NK cells	GSE161801_IMiD_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14959
4.37293290101882e-31	-0.352627096624032	0.506	0.726	9.43985025342932e-27	LAPTM5	NK cells	GSE161801_IMiD_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14960
1.13383896045541e-30	-0.394659700150253	0.329	0.535	2.4476181639351e-26	CD2	NK cells	GSE161801_IMiD_pre	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14961
4.05043269362201e-30	-0.438693932796	0.523	0.706	8.74366905572184e-26	TRBC1	NK cells	GSE161801_IMiD_pre	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14962
4.05056485761495e-30	-0.278382762293895	0.148	0.325	8.74395435813339e-26	BTN3A2	NK cells	GSE161801_IMiD_pre	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14963
6.75232268385887e-30	0.453533743685121	0.495	0.266	1.45762389776462e-25	KLRC1	NK cells	GSE161801_IMiD_pre	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14964
9.75310635383507e-30	-0.356919521587563	0.265	0.47	2.10540306860238e-25	LYAR	NK cells	GSE161801_IMiD_pre	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14965
1.74514973206271e-29	-0.407624704162952	0.165	0.347	3.76725472660377e-25	BTG2	NK cells	GSE161801_IMiD_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14966
2.07597435315368e-29	-0.26603597852497	1	1	4.48140583615286e-25	RPS23	NK cells	GSE161801_IMiD_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14967
3.62890425876085e-29	0.50418133347006	0.941	0.92	7.83371562338705e-25	GZMB	NK cells	GSE161801_IMiD_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14968
6.87813921835955e-29	-0.461825780488144	0.284	0.479	1.48478391306728e-24	HLA-DRB1	NK cells	GSE161801_IMiD_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14969
1.27392949687338e-28	-0.330333724494623	0.587	0.779	2.75003160490056e-24	LITAF	NK cells	GSE161801_IMiD_pre	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14970
1.35324451057665e-28	-0.391977369668732	0.101	0.254	2.92124892498182e-24	TRAC	NK cells	GSE161801_IMiD_pre	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14971
3.00957960417385e-28	-0.480899348115721	0.169	0.337	6.4967794915301e-24	PPP1R15A	NK cells	GSE161801_IMiD_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14972
6.98209175396904e-28	-0.397324058849334	0.73	0.849	1.5072241469293e-23	CD247	NK cells	GSE161801_IMiD_pre	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14973
8.68740749883541e-28	-0.281378896431921	0.989	0.994	1.8753506567736e-23	RPL7A	NK cells	GSE161801_IMiD_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14974
9.40681213906886e-28	-0.331199723306193	0.48	0.689	2.0306485364608e-23	C12orf75	NK cells	GSE161801_IMiD_pre	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14975
1.59820141969499e-27	-0.333021733443133	0.697	0.844	3.45003740469556e-23	MYL12B	NK cells	GSE161801_IMiD_pre	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14976
2.42311037263941e-27	-0.256803192738504	0.159	0.334	5.23076836141669e-23	SBDS	NK cells	GSE161801_IMiD_pre	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14977
4.5830222703996e-26	-0.285788603068472	0.98	0.992	9.89337017511162e-22	RPSA	NK cells	GSE161801_IMiD_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14978
5.55364342344639e-26	0.358455075871035	0.933	0.889	1.19886500581937e-21	RPS17	NK cells	GSE161801_IMiD_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14979
2.7946528412502e-25	-0.629356743159995	0.31	0.484	6.0328170884068e-21	KLF6	NK cells	GSE161801_IMiD_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14980
1.75790699865966e-24	-0.265036568033644	0.187	0.358	3.79479383800661e-20	TUBA4A	NK cells	GSE161801_IMiD_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14981
2.54128392554491e-24	-0.270911571821043	0.236	0.426	5.48586961007381e-20	GADD45B	NK cells	GSE161801_IMiD_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14982
5.07523494093389e-24	-0.40885466381454	0.761	0.874	1.0955909666994e-19	CD52	NK cells	GSE161801_IMiD_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14983
5.23129892966218e-24	-0.296979043703776	0.374	0.561	1.12928049994618e-19	LCK	NK cells	GSE161801_IMiD_pre	ENSG00000182866	3932	LCK proto-oncogene, Src family tyrosine kinase	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14984
8.03797822078159e-24	-0.40424962866672	0.814	0.915	1.73515835852012e-19	JUNB	NK cells	GSE161801_IMiD_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14985
1.06483222346839e-23	0.376166449269067	0.363	0.192	2.29865332080122e-19	CST3	NK cells	GSE161801_IMiD_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14986
1.4817723860428e-23	-0.297851236846293	0.744	0.889	3.1987020497506e-19	CALM1	NK cells	GSE161801_IMiD_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14987
2.14922532147294e-23	-0.276388940856671	0.549	0.771	4.63953270146362e-19	SARAF	NK cells	GSE161801_IMiD_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14988
3.82636659925654e-23	-0.330641466141388	0.275	0.444	8.2599775778151e-19	CLEC2D	NK cells	GSE161801_IMiD_pre	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14989
4.93831744586778e-23	-0.301172885517329	0.397	0.603	1.06603458703948e-18	HSP90AB1	NK cells	GSE161801_IMiD_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14990
1.39031545939801e-22	-0.254096782125979	0.118	0.254	3.00127398220249e-18	CD160	NK cells	GSE161801_IMiD_pre	ENSG00000117281	11126	CD160 molecule	BY55|NK1|NK28	protein_coding	O95971	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14991
1.75514463668137e-22	-0.252612283744579	0.24	0.427	3.78883072720408e-18	C12orf57	NK cells	GSE161801_IMiD_pre	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14992
1.86201105382879e-22	-0.768761969598373	0.153	0.282	4.0195232619002e-18	RGS1	NK cells	GSE161801_IMiD_pre	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14993
2.60318356089631e-22	0.402483713854158	0.813	0.752	5.61949235290686e-18	NEAT1	NK cells	GSE161801_IMiD_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14994
3.02763427478509e-22	-1.09331695569471	0.744	0.798	6.53575410897857e-18	DUSP1	NK cells	GSE161801_IMiD_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14995
1.15456514100832e-21	-0.259851677847197	0.327	0.512	2.49235976989466e-17	DHRS7	NK cells	GSE161801_IMiD_pre	ENSG00000100612	51635	dehydrogenase/reductase 7	retDSR4|SDR34C1	protein_coding	Q9Y394	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14996
2.29323734198987e-21	-0.253679740119165	0.944	0.978	4.95041145015354e-17	NACA	NK cells	GSE161801_IMiD_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14997
2.33709293780729e-21	-0.272589881197871	0.756	0.876	5.04508252484459e-17	EEF1B2	NK cells	GSE161801_IMiD_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14998
3.04065430020309e-21	-0.254285855822553	0.361	0.569	6.56386043784841e-17	CNBP	NK cells	GSE161801_IMiD_pre	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	14999
3.25251280589607e-21	0.354233462978051	0.751	0.671	7.02119939408785e-17	UQCR11	NK cells	GSE161801_IMiD_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15000
1.51464633738732e-20	-0.311087563378944	0.444	0.645	3.26966704851801e-16	CALR	NK cells	GSE161801_IMiD_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15001
1.8136954843251e-20	-0.268512206344189	0.232	0.394	3.9152244420126e-16	IDI1	NK cells	GSE161801_IMiD_pre	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15002
2.44764447031134e-20	0.282584336267566	0.928	0.863	5.28373011806109e-16	TYROBP	NK cells	GSE161801_IMiD_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15003
4.56616315424806e-20	0.481522226137911	0.391	0.229	9.8569764010753e-16	AREG	NK cells	GSE161801_IMiD_pre	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15004
1.26843637564458e-19	-0.261081044587957	0.508	0.703	2.73817360410395e-15	PDIA3	NK cells	GSE161801_IMiD_pre	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15005
1.60508892848322e-19	-0.325010539035531	0.467	0.633	3.46490546991673e-15	KLF2	NK cells	GSE161801_IMiD_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15006
2.50472380477735e-19	0.317560270602758	0.756	0.711	5.40694727737287e-15	ATP5MPL	NK cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15007
3.84047820246519e-19	-0.287872082425701	0.395	0.56	8.29044029566161e-15	APMAP	NK cells	GSE161801_IMiD_pre	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15008
1.42820313694357e-18	-0.314236560266742	0.761	0.887	3.08306211172009e-14	MT-ND5	NK cells	GSE161801_IMiD_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15009
1.48294993532735e-18	-0.263831843308845	0.415	0.598	3.20124402539115e-14	CCNI	NK cells	GSE161801_IMiD_pre	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15010
1.73562628761561e-18	-0.285841969821819	0.202	0.351	3.74669646707582e-14	YPEL5	NK cells	GSE161801_IMiD_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15011
2.28100048326046e-18	-1.05608974399846	0.495	0.608	4.92399574321436e-14	CD69	NK cells	GSE161801_IMiD_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15012
2.54330147533777e-18	-0.263177290297089	0.566	0.733	5.49022489481164e-14	MYO1F	NK cells	GSE161801_IMiD_pre	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15013
2.84478434431291e-18	-0.257854723503283	0.383	0.564	6.14103596406828e-14	HSPA5	NK cells	GSE161801_IMiD_pre	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15014
2.85382667035489e-18	-0.253493620315104	0.375	0.566	6.1605556332951e-14	LDHA	NK cells	GSE161801_IMiD_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15015
1.57238805119699e-17	-0.288735196445396	0.476	0.656	3.39431408611895e-13	IRF1	NK cells	GSE161801_IMiD_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15016
1.9559474882646e-17	-0.315035300278929	0.587	0.754	4.22230384291678e-13	ANXA1	NK cells	GSE161801_IMiD_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15017
5.37564341867834e-17	0.330751151421029	0.686	0.616	1.16044014479009e-12	POLR2L	NK cells	GSE161801_IMiD_pre	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15018
8.81678111132792e-17	-0.259931602718882	0.796	0.864	1.90327853850236e-12	PPIA	NK cells	GSE161801_IMiD_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15019
1.27718910351782e-16	-0.266636472069785	0.568	0.721	2.75706811776392e-12	NOP53	NK cells	GSE161801_IMiD_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15020
4.91944409991732e-16	-0.396475457747935	0.526	0.675	1.06196039784915e-11	IL32	NK cells	GSE161801_IMiD_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15021
4.93507371473725e-16	-0.296175677563858	0.551	0.701	1.06533436280033e-11	SPON2	NK cells	GSE161801_IMiD_pre	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15022
4.92323108537551e-15	-0.25231640527455	0.406	0.581	1.06277789440001e-10	CYCS	NK cells	GSE161801_IMiD_pre	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15023
9.74236533274998e-15	0.331332909145482	0.585	0.515	2.10308440438074e-10	ATP5ME	NK cells	GSE161801_IMiD_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15024
1.78041930726477e-14	-0.261160663856486	0.611	0.746	3.84339115859247e-10	RAC2	NK cells	GSE161801_IMiD_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15025
1.88386569652717e-13	-0.332394659228015	0.148	0.251	4.06670087909319e-09	PMAIP1	NK cells	GSE161801_IMiD_pre	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15026
2.64015390867724e-13	-0.53880292868446	0.157	0.256	5.69930024266156e-09	HIST1H1C	NK cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15027
4.71223727987137e-12	-0.282473972619304	0.649	0.772	1.01723066160583e-07	CXCR4	NK cells	GSE161801_IMiD_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15028
6.57230402349567e-12	-0.350707222869306	0.589	0.745	1.41876326955201e-07	ZFP36	NK cells	GSE161801_IMiD_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15029
2.0305932264339e-11	0.41390252300594	0.406	0.301	4.38344159790285e-07	SELL	NK cells	GSE161801_IMiD_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15030
5.24762505879845e-10	0.301527352345564	0.594	0.549	1.13280482144282e-05	S100A11	NK cells	GSE161801_IMiD_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15031
1.20464034217556e-09	-0.640181596259731	0.998	0.999	2.60045710665437e-05	H3F3B	NK cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15032
5.22954909988962e-09	0.279445285315362	0.325	0.234	0.000112890276419317	IFITM3	NK cells	GSE161801_IMiD_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15033
1.59941584057787e-08	0.29440305773453	0.389	0.31	0.000345265897505546	ISG15	NK cells	GSE161801_IMiD_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15034
1.86995375061675e-07	-0.261682340987206	0.652	0.743	0.00403666916145638	TSC22D3	NK cells	GSE161801_IMiD_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15035
2.15617822738448e-07	0.346360137908274	0.47	0.411	0.00465454193945487	CDC42SE1	NK cells	GSE161801_IMiD_pre	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15036
3.25299711731549e-25	0.745030327603762	1	1	7.02224487714895e-21	RPS29	cDCs	GSE161801_IMiD_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15037
1.72814716650651e-23	-0.597327765886972	0.012	0.333	3.73055128833761e-19	MZB1	cDCs	GSE161801_IMiD_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15038
1.11338738837443e-22	-0.826098028289944	0.37	0.885	2.40346935528389e-18	EIF5A	cDCs	GSE161801_IMiD_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15039
3.91818653943912e-22	0.530659297267003	1	1	8.45818928268723e-18	RPS27	cDCs	GSE161801_IMiD_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15040
2.59758092272005e-19	0.774258825614352	0.985	0.854	5.60739793787577e-15	RPL36A	cDCs	GSE161801_IMiD_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15041
3.15319349631852e-19	1.79987970115378	0.545	0.01	6.80679880050278e-15	HLA-DQA2	cDCs	GSE161801_IMiD_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15042
6.18440163848573e-18	0.719934662677101	0.982	0.885	1.33502678169991e-13	RPS17	cDCs	GSE161801_IMiD_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15043
2.25035668329842e-17	0.472510939284956	1	1	4.8578449722363e-13	RPL34	cDCs	GSE161801_IMiD_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15044
8.28165457121831e-17	0.393123569879957	1	1	1.7877607722889e-12	RPL39	cDCs	GSE161801_IMiD_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15045
1.89140101110169e-16	0.405835474310896	1	1	4.08296736266523e-12	RPL36	cDCs	GSE161801_IMiD_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15046
2.37811008579643e-14	0.549155877199427	1	1	5.13362624220875e-10	MT-ND3	cDCs	GSE161801_IMiD_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15047
1.39824320858593e-13	-0.537626349017496	0.985	1	3.01838761437445e-09	MT-ND1	cDCs	GSE161801_IMiD_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15048
3.83920146432329e-13	0.562240173612803	0.9	0.729	8.28768420103468e-09	UQCR11	cDCs	GSE161801_IMiD_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15049
1.59517489891007e-11	-1.11829797625116	0.545	0.875	3.44350405427716e-07	AC020656.1	cDCs	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15050
1.63456303853818e-11	0.676845644910558	0.488	0.115	3.52853123129236e-07	HBB	cDCs	GSE161801_IMiD_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15051
3.47222222701678e-11	0.280731611636708	1	1	7.49548612146113e-07	RPL21	cDCs	GSE161801_IMiD_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15052
2.7190968606391e-10	-0.638809835866213	0.994	1	5.86971439306161e-06	HLA-DQB1	cDCs	GSE161801_IMiD_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15053
3.27434956381802e-10	-0.545987941300837	1	0.99	7.06833840341397e-06	TPT1	cDCs	GSE161801_IMiD_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15054
5.75026645877047e-10	0.425912340413142	0.982	0.969	1.24131002045478e-05	ATP5MPL	cDCs	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15055
7.01593029537967e-10	-0.523036614342958	1	1	1.51452887286361e-05	HLA-DRB1	cDCs	GSE161801_IMiD_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15056
8.72910909490304e-10	-0.509763294187442	0.748	0.906	1.88435278031672e-05	HSP90AA1	cDCs	GSE161801_IMiD_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15057
9.47402198917524e-10	-0.364267385468178	1	1	2.04515712680326e-05	EIF1	cDCs	GSE161801_IMiD_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15058
1.77986906132025e-09	-0.565109696531834	0.57	0.823	3.84220334267202e-05	UCP2	cDCs	GSE161801_IMiD_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15059
1.9941371496612e-09	-0.64098367870869	1	1	4.30474386497364e-05	HLA-DPB1	cDCs	GSE161801_IMiD_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15060
2.0976043175752e-09	0.494186130504843	0.833	0.594	4.52809844034959e-05	ATP5ME	cDCs	GSE161801_IMiD_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15061
2.26108188106873e-09	-0.790799409410965	0.815	0.927	4.88099745666308e-05	ZFP36	cDCs	GSE161801_IMiD_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15062
2.62911778016817e-09	-0.347600174287607	1	1	5.67547655204904e-05	EEF1A1	cDCs	GSE161801_IMiD_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15063
3.94040476331463e-09	-0.428562482250017	1	1	8.50615176256729e-05	HLA-DRA	cDCs	GSE161801_IMiD_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15064
4.08226225993677e-09	0.509541485742078	0.697	0.406	8.81237954052551e-05	NDUFA13	cDCs	GSE161801_IMiD_pre	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15065
4.87450254126412e-09	-0.390325256629373	0.973	0.99	0.000105225886358269	HLA-C	cDCs	GSE161801_IMiD_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15066
6.2203275174895e-09	0.477215044118434	0.673	0.365	0.000134278210120046	PSMA2	cDCs	GSE161801_IMiD_pre	ENSG00000106588	5683	proteasome 20S subunit alpha 2	HC3|MU|PMSA2	protein_coding	P25787	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15067
6.25500096310312e-09	-0.981289473205625	0.882	0.938	0.000135026705790507	HLA-DQA1	cDCs	GSE161801_IMiD_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15068
6.3912711914085e-09	-0.42799911080064	0.909	0.99	0.000137968371208935	EEF1B2	cDCs	GSE161801_IMiD_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15069
8.68938604275306e-09	0.370271503377311	0.291	0.01	0.00018757777650491	AC004556.1	cDCs	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15070
9.70537460294422e-09	-0.694850720269985	0.106	0.333	0.000209509921553757	HSPA1B	cDCs	GSE161801_IMiD_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15071
1.16839541932486e-08	0.290478248930556	1	1	0.000252221519169657	RPS28	cDCs	GSE161801_IMiD_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15072
1.42048686280588e-08	-0.430862466440527	0.864	0.958	0.000306640499073905	HLA-DMB	cDCs	GSE161801_IMiD_pre	ENSG00000242386	3109	major histocompatibility complex, class II, DM beta	D6S221E|RING7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15073
2.26551570351027e-08	0.314050344471358	0.997	1	0.000489056874916762	RPS21	cDCs	GSE161801_IMiD_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15074
5.28793765487518e-08	-1.0933037198394	0.358	0.594	0.0011415071015579	NFKBIA	cDCs	GSE161801_IMiD_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15075
5.93861199530819e-08	0.434296376315912	0.655	0.354	0.00128196817142718	NDUFA3	cDCs	GSE161801_IMiD_pre	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15076
8.76739080247696e-08	-0.423574696705328	0.155	0.396	0.0018926166525307	BHLHE40	cDCs	GSE161801_IMiD_pre	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15077
9.0825275672618e-08	0.546827371834385	0.624	0.354	0.0019606452259448	VMP1	cDCs	GSE161801_IMiD_pre	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15078
9.58478741216022e-08	-0.336210300746624	0.991	0.979	0.00206906805866303	NACA	cDCs	GSE161801_IMiD_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15079
1.00390643626821e-07	-0.367210846883021	0.994	1	0.00216713282397218	COTL1	cDCs	GSE161801_IMiD_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15080
2.0360773644864e-07	0.451839462768371	0.467	0.188	0.00439528020671679	PET100	cDCs	GSE161801_IMiD_pre	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15081
2.13656691714546e-07	0.311069869111893	1	0.99	0.00461220700404191	CYBA	cDCs	GSE161801_IMiD_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15082
2.28983293113381e-07	0.343053016950513	1	1	0.00494306234843856	MT-CO2	cDCs	GSE161801_IMiD_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15083
2.39714189282615e-07	-0.355089288553586	1	1	0.00517471020404381	CD74	cDCs	GSE161801_IMiD_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15084
2.66785251919036e-07	-0.460169758863627	0.985	0.99	0.00575909323317624	ACTG1	cDCs	GSE161801_IMiD_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15085
2.94580280685615e-07	-0.323638752373506	1	1	0.00635910451916036	RPL30	cDCs	GSE161801_IMiD_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15086
3.87727851728009e-07	0.327496588002733	0.912	0.771	0.00836988113525252	MTRNR2L8	cDCs	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15087
4.2267695412002e-07	-0.378988626081976	0.118	0.333	0.00912432740858887	RGCC	cDCs	GSE161801_IMiD_pre	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15088
4.88528856790678e-07	-0.60597142976987	0.294	0.531	0.0105458724315404	SGK1	cDCs	GSE161801_IMiD_pre	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15089
6.47070851815885e-07	0.373045870135695	0.585	0.281	0.0139683184781495	AC004687.1	cDCs	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15090
7.56512961197965e-07	-0.632496327610177	0.236	0.49	0.0163308452933805	JUN	cDCs	GSE161801_IMiD_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15091
9.25368467377077e-07	0.31720412095893	0.264	0.031	0.0199759291052689	HBA2	cDCs	GSE161801_IMiD_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15092
1.14343216578435e-06	-0.367819562632318	0.939	1	0.0246832701627868	HLA-A	cDCs	GSE161801_IMiD_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15093
1.37361508784353e-06	-0.93512541566897	0.579	0.75	0.0296522289012784	ID2	cDCs	GSE161801_IMiD_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15094
1.96056063966817e-06	-0.287432288957127	0.994	1	0.0423226225285167	RPS20	cDCs	GSE161801_IMiD_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15095
1.03231905608653e-09	-1.11987047250424	0.493	0.966	2.22846714637399e-05	EIF5A	Progenitors	GSE161801_IMiD_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15096
2.01811988011956e-09	-0.682445604991747	0.057	0.379	4.35651538521409e-05	HSPA1A	Progenitors	GSE161801_IMiD_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15097
3.00334356682547e-09	0.619682490555133	1	1	6.48331775770615e-05	RPS27	Progenitors	GSE161801_IMiD_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15098
1.49732032469264e-08	0.758831848735113	1	1	0.0003232265384914	RPS29	Progenitors	GSE161801_IMiD_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15099
1.66067014247826e-07	-0.434386007786971	0.186	0.621	0.00358488863656781	MCM2	Progenitors	GSE161801_IMiD_pre	ENSG00000073111	4171	minichromosome maintenance complex component 2	BM28|CCNL1|cdc19|CDCL1|D3S3194|DFNA70|KIAA0030	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15100
7.14343321186931e-07	-0.611735027085118	0.541	0.862	0.0154205292744623	SRSF7	Progenitors	GSE161801_IMiD_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15101
8.31360201760457e-07	-0.796411355494083	0.99	0.966	0.017946572675403	MT-ND1	Progenitors	GSE161801_IMiD_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15102
9.14461686016765e-07	-0.562310565209743	0.287	0.69	0.0197404844160439	C8orf59	Progenitors	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15103
1.23499882953757e-06	-0.566531597488705	0.838	1	0.0266599197332276	RAN	Progenitors	GSE161801_IMiD_pre	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15104
1.5758198797097e-06	0.402706712771898	1	1	0.0340172237432932	RPL21	Progenitors	GSE161801_IMiD_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15105
1.73982889986901e-06	-0.309381037012345	0.057	0.31	0.0375576864614723	MED24	Progenitors	GSE161801_IMiD_pre	ENSG00000008838	9862	mediator complex subunit 24	CRSP100|CRSP4|DRIP100|KIAA0130|MED5|THRAP4|TRAP100	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15106
1.79467037067151e-06	-0.338010110694815	0.084	0.379	0.0387415492916858	EIF4G1	Progenitors	GSE161801_IMiD_pre	ENSG00000114867	1981	eukaryotic translation initiation factor 4 gamma 1	EIF4F|EIF4G|p220|PARK18	protein_coding	Q04637	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15107
2.13741926175162e-06	-0.470327187729415	0.196	0.586	0.0461404696034322	MCM4	Progenitors	GSE161801_IMiD_pre	ENSG00000104738	4173	minichromosome maintenance complex component 4	CDC21|CDC54|hCdc21|MGC33310|P1-Cdc21	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15108
1.79717614489163e-18	-0.987171163752614	0.725	0.971	3.87956414397756e-14	EIF5A	Erythrocytes	GSE161801_IMiD_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15109
2.17113380560191e-16	-0.9790536847752	0.179	0.638	4.68682654615285e-12	NMU	Erythrocytes	GSE161801_IMiD_pre	ENSG00000109255	10874	neuromedin U	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15110
8.7897967935471e-14	-1.08410732976455	0.629	0.913	1.89745343382301e-09	GLRX	Erythrocytes	GSE161801_IMiD_pre	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15111
4.17176901588076e-13	-1.03195676677166	0.77	0.942	9.00559777458181e-09	HSPA8	Erythrocytes	GSE161801_IMiD_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15112
2.10211373335234e-12	-0.328082642898408	0.027	0.275	4.53783291618769e-08	GTSF1	Erythrocytes	GSE161801_IMiD_pre	ENSG00000170627	121355	gametocyte specific factor 1	Cue110|FAM112B|FLJ32942	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15113
2.69662823876339e-11	0.634892889300066	0.997	1	5.82121137901854e-07	RPS29	Erythrocytes	GSE161801_IMiD_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15114
3.49274327720583e-11	-0.595519195891692	0.79	0.913	7.53978491250422e-07	MPC2	Erythrocytes	GSE161801_IMiD_pre	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15115
6.96643764829431e-11	-0.578662206673323	0.419	0.812	1.50384489513729e-06	RRP7A	Erythrocytes	GSE161801_IMiD_pre	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15116
1.03667996260914e-10	-0.497991120233206	0.416	0.812	2.23788103528436e-06	RNH1	Erythrocytes	GSE161801_IMiD_pre	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15117
2.48245359581524e-10	-0.552788930073102	0.646	0.913	5.35887257728635e-06	SRSF7	Erythrocytes	GSE161801_IMiD_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15118
3.15453942113758e-10	0.658787354985085	0.983	1	6.8097042484097e-06	RPS17	Erythrocytes	GSE161801_IMiD_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15119
3.42237311532815e-10	-0.521762034452477	0.268	0.638	7.38787684405887e-06	TSC22D4	Erythrocytes	GSE161801_IMiD_pre	ENSG00000166925	81628	TSC22 domain family member 4	THG-1|TILZ2	protein_coding	Q9Y3Q8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15120
7.10874874063374e-10	-0.631999580648714	0.959	0.986	1.53456559064061e-05	MT-ND1	Erythrocytes	GSE161801_IMiD_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15121
7.25092177442104e-10	0.432132884743681	1	1	1.56525648344427e-05	RPS27	Erythrocytes	GSE161801_IMiD_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15122
8.84709898064071e-10	-0.522320244960849	0.055	0.304	1.90982325695091e-05	HSPA1A	Erythrocytes	GSE161801_IMiD_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15123
2.03854447961204e-09	-0.359999860530286	1	1	4.4006059681385e-05	PTMA	Erythrocytes	GSE161801_IMiD_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15124
3.11370680919024e-09	-0.749444297129936	0.859	0.942	6.72155888899898e-05	MT-ND5	Erythrocytes	GSE161801_IMiD_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15125
3.35112799336655e-09	-0.608017148752123	0.959	0.971	7.23407999928036e-05	MT-CYB	Erythrocytes	GSE161801_IMiD_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15126
3.77502679846547e-09	-0.591939683810609	0.57	0.855	8.1491503498474e-05	FKBP4	Erythrocytes	GSE161801_IMiD_pre	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15127
6.91726746179942e-09	0.636665331686288	0.973	0.957	0.000149323052697864	RPL36A	Erythrocytes	GSE161801_IMiD_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15128
8.33645277707752e-09	-0.493908377387474	0.643	0.913	0.000179959006098773	ILF2	Erythrocytes	GSE161801_IMiD_pre	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15129
2.08566208884197e-08	-0.325923032157346	0.103	0.377	0.000450231875118317	APOL4	Erythrocytes	GSE161801_IMiD_pre	ENSG00000100336	80832	apolipoprotein L4	APOLIV	protein_coding	Q9BPW4	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15130
4.410349302484e-08	-0.397521461944736	0.282	0.623	0.00095206210392722	DDX24	Erythrocytes	GSE161801_IMiD_pre	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15131
6.97603488538029e-08	-0.440119715098449	0.34	0.652	0.00150591665070704	NOP16	Erythrocytes	GSE161801_IMiD_pre	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15132
8.66163446204302e-08	-0.43249469635539	0.732	0.928	0.00186978703132123	H2AFV	Erythrocytes	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15133
1.87346049142287e-07	0.334949640016218	1	1	0.00404423916283456	RPS21	Erythrocytes	GSE161801_IMiD_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15134
2.55113370283025e-07	-0.397236947717651	0.629	0.884	0.00550713232429966	EIF3I	Erythrocytes	GSE161801_IMiD_pre	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15135
2.87863001956644e-07	-0.428136829182821	0.254	0.565	0.00621409862323807	HPS1	Erythrocytes	GSE161801_IMiD_pre	ENSG00000107521	3257	HPS1 biogenesis of lysosomal organelles complex 3 subunit 1	BLOC3S1|HPS	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15136
2.96741452615468e-07	-0.434485994174481	0.227	0.507	0.00640575773761011	GSTM3	Erythrocytes	GSE161801_IMiD_pre	ENSG00000134202	2947	glutathione S-transferase mu 3	GST5	protein_coding	P21266	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15137
3.19918303871074e-07	-0.418516452597663	0.852	0.957	0.00690607642566488	TMEM14C	Erythrocytes	GSE161801_IMiD_pre	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15138
3.39420621551803e-07	-0.495975654904611	0.818	0.957	0.00732707295743878	HMGA1	Erythrocytes	GSE161801_IMiD_pre	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15139
3.58098898034744e-07	-0.419424789889026	0.649	0.841	0.00773028091187601	CDK4	Erythrocytes	GSE161801_IMiD_pre	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15140
3.86237056342347e-07	-0.510004063576306	0.251	0.551	0.00833769933526224	ATF7IP2	Erythrocytes	GSE161801_IMiD_pre	ENSG00000166669	80063	activating transcription factor 7 interacting protein 2	FLJ12668	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15141
7.62809217331213e-07	0.282317755572266	1	1	0.0164667625745289	RPS28	Erythrocytes	GSE161801_IMiD_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15142
8.22950981170859e-07	-0.523024050897632	0.732	0.913	0.0177650428305353	KLF1	Erythrocytes	GSE161801_IMiD_pre	ENSG00000105610	10661	KLF transcription factor 1	EKLF	protein_coding	Q13351	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15143
8.3045186133992e-07	-0.40819444988256	0.498	0.754	0.0179269643307448	PSMB5	Erythrocytes	GSE161801_IMiD_pre	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15144
9.57817674741915e-07	-0.516274756683389	0.973	0.986	0.0206764101446537	MT-ND2	Erythrocytes	GSE161801_IMiD_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15145
1.27725989326106e-06	-0.415936156979493	0.471	0.71	0.0275722093158266	PNN	Erythrocytes	GSE161801_IMiD_pre	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15146
1.54580142334467e-06	-0.407465901863868	0.34	0.623	0.0333692153257414	LMO2	Erythrocytes	GSE161801_IMiD_pre	ENSG00000135363	4005	LIM domain only 2	RBTN2|RBTNL1|RHOM2|TTG2	protein_coding	P25791	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15147
2.31141813008859e-06	-0.38727998206822	0.495	0.768	0.0498965831742225	DDX21	Erythrocytes	GSE161801_IMiD_pre	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15148
5.84176428835081e-56	0.554845797946681	1	1	1.26106165692629e-51	RPS29	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15149
1.34017894202132e-43	-0.422167955436338	1	1	2.89304428214143e-39	EEF1A1	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15150
7.68301879757742e-37	0.62046576191953	0.973	0.94	1.65853326783304e-32	RPL36A	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15151
1.70031827901654e-36	-0.544869290063415	1	1	3.67047706891301e-32	TPT1	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15152
4.64479082375257e-34	-0.331229938467711	1	1	1.00267099512347e-29	RPL30	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15153
5.19938207780116e-33	0.578114882452312	0.994	0.974	1.12239060913494e-28	MT-ND3	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15154
3.25145489648123e-32	0.254662587831293	1	1	7.01891568503403e-28	RPS27	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15155
7.01635097195013e-31	-0.499849869989123	0.99	0.998	1.51461968431487e-26	HLA-C	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15156
1.35211625791003e-28	0.552190187413269	0.488	0.188	2.91881336595039e-24	S100A8	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15157
2.19840920741449e-27	-0.734228755246387	0.141	0.391	4.74570595604565e-23	MZB1	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15158
2.44739666545551e-26	-0.469284144869932	0.941	0.991	5.2831951817188e-22	MT-ND1	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15159
3.57897155675214e-25	-0.370986060392251	0.976	0.987	7.72592589956085e-21	NACA	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15160
6.00333949742471e-24	0.415012918042446	0.982	0.945	1.29594089730907e-19	RPS17	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15161
1.32259755723287e-23	-0.299131951712181	1	1	2.85509134679859e-19	RPS20	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15162
1.77220082768942e-22	0.256403866582424	1	1	3.82564992673314e-18	RPL34	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15163
1.07372591330309e-19	-0.631934285594486	0.064	0.25	2.31785212904738e-15	HSPA1A	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15164
3.07197099305785e-19	-0.260645715491568	1	1	6.63146378271399e-15	RPL9	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15165
5.81317424383191e-19	0.4647471165365	0.413	0.186	1.25488992401599e-14	LYZ	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15166
6.51895651385258e-19	-0.516152035099025	0.102	0.305	1.40724714264536e-14	HSPA1B	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15167
2.05849171895757e-18	-0.702327400700292	0.486	0.686	4.44366607371371e-14	JUN	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15168
2.99486262453237e-17	-0.309554370178915	0.368	0.641	6.46500994757802e-13	EIF5A	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15169
9.79212724777213e-17	0.557290129907331	0.442	0.241	2.11382650897657e-12	HBB	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15170
1.86603736635089e-15	0.449017815951288	0.507	0.316	4.02821486274167e-11	S100A9	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15171
5.80786949358667e-15	0.250498002806762	1	1	1.25374478758055e-10	TMSB4X	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15172
1.78726214595524e-12	0.300923245378566	0.398	0.212	3.85816279447357e-08	PET100	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15173
8.39598105955955e-12	-0.291808491127191	0.23	0.425	1.81244043132712e-07	SOCS3	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15174
9.58040289874143e-12	0.262529293737846	1	1	2.06812157375131e-07	MT-CO1	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15175
1.81572630235562e-11	-0.324955726989134	0.918	0.966	3.91960836889508e-07	UBC	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15176
3.01975826412867e-11	0.309719473133923	0.77	0.65	6.51875216477455e-07	ATP5MPL	CD4+ T cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15177
3.8663673708442e-11	0.464084986282567	0.6	0.43	8.34632724344137e-07	MT2A	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15178
5.48549656862513e-11	0.33656580826783	0.582	0.425	1.18415414426911e-06	ATP5ME	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15179
6.89227466599525e-11	-0.579122278928963	0.344	0.494	1.48783533214839e-06	KLF6	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15180
7.58507037374135e-11	-0.275295070046734	0.93	0.974	1.63738914157954e-06	EEF1B2	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15181
9.91908586847561e-11	-0.583668637151886	0.594	0.718	2.14123306642783e-06	CD69	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15182
1.01428374935322e-10	-0.277801451809566	0.368	0.545	2.1895343297288e-06	SMDT1	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15183
3.08146131312843e-10	0.301937910417017	0.742	0.62	6.65195053665035e-06	UQCR11	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15184
5.54914941385451e-10	-0.376576504299466	0.256	0.41	1.19789488396877e-05	PPP1R15A	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15185
3.24271369587523e-09	0.387511378632685	0.682	0.571	7.00004605528585e-05	HMGB2	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15186
3.28270689937004e-09	-0.282553423474096	0.934	0.964	7.08637938367011e-05	BTG1	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15187
3.89896918892353e-09	-0.373396833959829	0.774	0.844	8.41670478812922e-05	VIM	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15188
4.35098464543418e-09	-0.638582730920832	0.738	0.791	9.39247055409875e-05	DUSP1	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15189
5.88160280269422e-09	-0.30478854367635	0.408	0.564	0.00012696615970176	DNAJB1	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15190
7.52878001492817e-09	0.38905843269801	0.434	0.288	0.000162523774182254	C1orf56	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000143443	54964	chromosome 1 open reading frame 56	FLJ20519|MENT	protein_coding	Q9BUN1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15191
8.9599973563538e-09	-0.263470463945062	0.864	0.945	0.000193419462931609	GAPDH	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15192
1.6005235373611e-08	0.257994676945324	0.451	0.301	0.000345505016010141	NDUFB1	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15193
7.27135543864311e-08	0.25384828181349	0.434	0.295	0.00156966749853989	CAPZA1	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15194
1.06868178736806e-07	-0.587926467173367	0.406	0.526	0.00230696337439143	ZFP36	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15195
1.50122352441686e-07	-0.264323279837596	0.258	0.395	0.00324069122215869	BTG2	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15196
1.53141624657933e-07	-0.27039779424728	0.752	0.827	0.0033058682514908	HSPA8	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15197
4.5968183727115e-07	0.259602246694269	0.411	0.289	0.00992315182117233	PSMA4	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15198
1.31303503907173e-06	0.348289867699056	0.973	0.976	0.0283444873884414	LTB	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15199
1.50718037560533e-06	0.279521429565285	0.366	0.242	0.0325355027681924	ISG15	CD4+ T cells	GSE161801_IMiD_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15200
8.23662195227071e-172	0.736127389997277	1	1	1.77803958083668e-167	RPS29	B cells	GSE161801_IMiD_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15201
2.01116470262564e-150	-1.30119503821092	0.367	0.78	4.34150124355798e-146	CD83	B cells	GSE161801_IMiD_pre	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15202
6.75714303094536e-140	-0.821534864141669	0.946	0.996	1.45866446609017e-135	MT-ND1	B cells	GSE161801_IMiD_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15203
4.81843674224537e-135	-0.8211775971675	0.999	1	1.04015593954851e-130	EIF1	B cells	GSE161801_IMiD_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15204
2.22171169401914e-124	-1.43438149707243	0.42	0.783	4.79600903387911e-120	CD69	B cells	GSE161801_IMiD_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15205
2.51368850032305e-108	0.327024820380752	1	1	5.42629936564738e-104	RPS27	B cells	GSE161801_IMiD_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15206
1.32483834730417e-97	0.823889876765327	0.419	0.02	2.85992854032552e-93	HLA-DQA2	B cells	GSE161801_IMiD_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15207
1.49950729825868e-97	-0.968944282774946	0.345	0.707	3.236986404751e-93	NFKBIA	B cells	GSE161801_IMiD_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15208
1.73900593429232e-83	-0.36515086827452	1	1	3.75399211035684e-79	RPL28	B cells	GSE161801_IMiD_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15209
4.96940672496236e-82	-0.39673845117395	1	1	1.07274582971763e-77	EEF1A1	B cells	GSE161801_IMiD_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15210
1.47852152654497e-81	-0.727471577160057	0.329	0.679	3.19168441935263e-77	EIF5A	B cells	GSE161801_IMiD_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15211
3.30693892981215e-76	-0.468198055262745	1	1	7.13868906778549e-72	MT-CO3	B cells	GSE161801_IMiD_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15212
4.9439542196618e-74	-0.410348585223582	1	1	1.06725139739839e-69	RPS20	B cells	GSE161801_IMiD_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15213
9.93945232254596e-73	-0.831397696655755	0.475	0.761	2.145629572868e-68	JUN	B cells	GSE161801_IMiD_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15214
1.96330577475473e-71	-0.543316803676316	0.954	0.992	4.23818817596303e-67	HLA-DPB1	B cells	GSE161801_IMiD_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15215
5.29589813583384e-71	-0.386115782127538	1	1	1.14322553058245e-66	HLA-DRA	B cells	GSE161801_IMiD_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15216
7.50982467248291e-71	0.851260951625785	0.523	0.184	1.62114585204889e-66	S100A8	B cells	GSE161801_IMiD_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15217
3.18222965382807e-70	-0.762208722304736	0.597	0.82	6.86947915371866e-66	HLA-DQA1	B cells	GSE161801_IMiD_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15218
1.09571406428917e-69	0.652806117320209	0.934	0.832	2.36531795058102e-65	RPL36A	B cells	GSE161801_IMiD_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15219
1.73608322411547e-67	-0.452413110320238	0.121	0.39	3.74768285589806e-63	NFKBID	B cells	GSE161801_IMiD_pre	ENSG00000167604	84807	NFKB inhibitor delta	IkappaBNS|IkBNS|TA-NFKBH	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15220
2.53280635633363e-67	-0.672571761413351	0.176	0.466	5.4675690814174e-63	PPP1R15A	B cells	GSE161801_IMiD_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15221
3.1657118127026e-67	0.834443228614034	0.571	0.252	6.83382209008111e-63	S100A9	B cells	GSE161801_IMiD_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15222
2.12651106180934e-66	0.600179749532823	0.801	0.463	4.59049942912783e-62	TCL1A	B cells	GSE161801_IMiD_pre	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15223
1.32368834567623e-65	0.535097953362853	0.98	0.947	2.85744603181128e-61	RPS17	B cells	GSE161801_IMiD_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15224
1.33553100261846e-64	-0.504741464274125	0.997	1	2.88301077535247e-60	MT-ND2	B cells	GSE161801_IMiD_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15225
2.43825362781847e-64	-0.760107703955055	0.267	0.564	5.26345810637173e-60	KLF6	B cells	GSE161801_IMiD_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15226
1.5863170837675e-63	-0.524227153111223	0.996	1	3.42438268872891e-59	TPT1	B cells	GSE161801_IMiD_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15227
1.71581433496447e-60	-0.341943831315947	1	1	3.70392840488781e-56	RPL8	B cells	GSE161801_IMiD_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15228
5.11153208571466e-59	0.290555285964885	1	1	1.10342643134322e-54	RPL34	B cells	GSE161801_IMiD_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15229
3.33787995966239e-58	0.730968366094834	0.487	0.181	7.2054814689232e-54	LYZ	B cells	GSE161801_IMiD_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15230
5.27013723667045e-55	-0.456892596651125	0.977	0.993	1.13766452528005e-50	HLA-DRB1	B cells	GSE161801_IMiD_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15231
8.6123142599234e-52	-0.313531482242643	1	1	1.85914027928966e-47	RPL30	B cells	GSE161801_IMiD_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15232
3.39389562822459e-51	-0.266347706290749	1	1	7.32640249264842e-47	RPS23	B cells	GSE161801_IMiD_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15233
9.46141213006631e-50	0.531314309823946	0.858	0.618	2.04243503651741e-45	CD79B	B cells	GSE161801_IMiD_pre	ENSG00000007312	974	CD79b molecule	B29|Ig-beta|IGB|Igbeta	protein_coding	P40259	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15234
6.32242609000367e-49	-0.391856725942268	1	1	1.36482212004909e-44	MT-CO2	B cells	GSE161801_IMiD_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15235
1.44970533478746e-48	-0.391829091601477	0.995	1	3.12947890620569e-44	MT-CYB	B cells	GSE161801_IMiD_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15236
1.92833227130622e-48	0.659945366791	0.818	0.599	4.16269087406873e-44	TXNIP	B cells	GSE161801_IMiD_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15237
2.3300765325981e-47	-0.279671365504249	1	1	5.02993621091952e-43	RPS18	B cells	GSE161801_IMiD_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15238
4.35552800437607e-45	-0.604791878085767	0.533	0.699	9.40227830304663e-41	MZB1	B cells	GSE161801_IMiD_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15239
2.04038148217608e-44	-0.525427352494051	0.656	0.848	4.4045715055735e-40	MT-ND5	B cells	GSE161801_IMiD_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15240
3.776344418518e-42	0.291287520505334	1	1	8.15199469625481e-38	TMSB10	B cells	GSE161801_IMiD_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15241
1.69573036283092e-41	-0.544359808069935	0.423	0.655	3.66057313424311e-37	HSP90AA1	B cells	GSE161801_IMiD_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15242
1.10980555555832e-38	-0.442835594691497	0.977	0.988	2.39573725278374e-34	UBC	B cells	GSE161801_IMiD_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15243
1.35223576229802e-36	-0.445824858888227	0.291	0.513	2.91907134007274e-32	REL	B cells	GSE161801_IMiD_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15244
6.62730973907201e-36	-0.420240459887908	0.194	0.402	1.43063735337348e-31	DDX21	B cells	GSE161801_IMiD_pre	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15245
8.2254853677974e-33	-0.332005667565412	0.994	1	1.77563552634642e-28	HLA-C	B cells	GSE161801_IMiD_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15246
3.41469496777331e-32	-0.506906673471873	0.303	0.503	7.37130202693225e-28	CYCS	B cells	GSE161801_IMiD_pre	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15247
4.9669885366304e-32	-0.418052342135201	0.275	0.479	1.0722238154024e-27	EIF1B	B cells	GSE161801_IMiD_pre	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15248
4.23013582061267e-31	0.445889077930559	0.419	0.204	9.13159419595658e-27	ARRDC3	B cells	GSE161801_IMiD_pre	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15249
4.99066768228043e-31	0.538703113677042	0.663	0.475	1.07733543257388e-26	ZFP36L2	B cells	GSE161801_IMiD_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15250
7.23216231510695e-31	-0.448487354870052	0.325	0.531	1.56120687896214e-26	HSP90B1	B cells	GSE161801_IMiD_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15251
1.24930864343476e-30	0.412893311604774	0.255	0.067	2.69688256858262e-26	AIF1	B cells	GSE161801_IMiD_pre	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15252
5.90624073929495e-30	0.418434937160822	0.817	0.645	1.2749801883916e-25	RPL17	B cells	GSE161801_IMiD_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15253
8.38801613996012e-30	-0.450401061057988	0.498	0.687	1.81072104413319e-25	HSP90AB1	B cells	GSE161801_IMiD_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15254
2.28348045388624e-29	-0.373943291053533	0.875	0.948	4.92934925580423e-25	LAPTM5	B cells	GSE161801_IMiD_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15255
2.86392714611718e-29	0.425739859882503	0.264	0.08	6.18235953032316e-25	TYROBP	B cells	GSE161801_IMiD_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15256
3.11113432031459e-29	0.344706176145443	0.996	0.999	6.7160056572631e-25	MT-ND3	B cells	GSE161801_IMiD_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15257
1.21768575684564e-28	-0.339130811232427	0.891	0.954	2.62861824330267e-24	EEF1B2	B cells	GSE161801_IMiD_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15258
1.4553881682189e-26	0.298707804512197	0.988	0.974	3.14174643873414e-22	CYBA	B cells	GSE161801_IMiD_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15259
8.48992726324871e-26	-0.2953148244564	0.988	0.999	1.8327205983175e-21	MT-ATP6	B cells	GSE161801_IMiD_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15260
2.14853282163002e-25	-0.2649074786034	0.99	0.998	4.63803780205272e-21	HLA-A	B cells	GSE161801_IMiD_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15261
2.96126249723288e-25	0.388300097866961	0.898	0.784	6.39247735277662e-21	LTB	B cells	GSE161801_IMiD_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15262
2.44777547753774e-24	-0.332895140435916	0.882	0.962	5.28401292336073e-20	UBB	B cells	GSE161801_IMiD_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15263
4.46146710556457e-24	-0.265880397280804	1	1	9.63096904078224e-20	MT-ND4	B cells	GSE161801_IMiD_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15264
6.25033269615418e-24	0.35019949207183	0.798	0.729	1.3492593191188e-19	S100A4	B cells	GSE161801_IMiD_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15265
1.54571500182148e-23	-0.279426891107221	0.112	0.251	3.33673497443202e-19	PIM3	B cells	GSE161801_IMiD_pre	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15266
5.37292555641172e-23	-0.318540458217493	0.891	0.951	1.1598534398626e-18	HLA-DQB1	B cells	GSE161801_IMiD_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15267
1.28616915979849e-22	-0.400315500286087	0.211	0.37	2.776453365257e-18	HIST1H1C	B cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15268
1.32365277581456e-22	-0.557239773192437	0.523	0.658	2.85736924715089e-18	EMP3	B cells	GSE161801_IMiD_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15269
2.13991668946397e-22	-0.314489917372506	0.188	0.346	4.61943815754587e-18	SBDS	B cells	GSE161801_IMiD_pre	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15270
1.65706314406699e-21	0.335421732949631	0.969	0.916	3.57710220909741e-17	CXCR4	B cells	GSE161801_IMiD_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15271
2.19915419569318e-21	0.354134749347928	0.637	0.485	4.74731416224286e-17	ATP5MPL	B cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15272
4.01149463369156e-21	-0.265972538597996	0.15	0.294	8.65961346574997e-17	IFRD1	B cells	GSE161801_IMiD_pre	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15273
6.48306313239328e-21	-0.316553368472992	0.396	0.573	1.39949883838974e-16	EZR	B cells	GSE161801_IMiD_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15274
8.72744174425626e-21	0.36979692605173	0.546	0.39	1.8839928493326e-16	UQCR11	B cells	GSE161801_IMiD_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15275
9.91216125603716e-21	0.260176705739369	0.993	0.975	2.13973825034074e-16	CD52	B cells	GSE161801_IMiD_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15276
6.13443009369753e-20	-0.282754530587874	0.19	0.339	1.32423942432649e-15	RHOG	B cells	GSE161801_IMiD_pre	ENSG00000177105	391	ras homolog family member G	ARHG|MGC125835|MGC125836	protein_coding	P84095	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15277
9.84268068651026e-20	-0.255484928256295	0.951	0.972	2.12473947979697e-15	HLA-DPA1	B cells	GSE161801_IMiD_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15278
1.97316100682828e-19	0.485760627874145	0.45	0.294	4.2594626654402e-15	HNRNPH1	B cells	GSE161801_IMiD_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15279
1.32266871262808e-18	0.295049512683393	0.835	0.777	2.85524494995023e-14	S100A6	B cells	GSE161801_IMiD_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15280
1.40160221604112e-18	0.363164640509424	0.537	0.377	3.02563870376796e-14	SEC62	B cells	GSE161801_IMiD_pre	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15281
1.43754728292785e-18	0.323406971383076	0.739	0.639	3.10323331965635e-14	CALM2	B cells	GSE161801_IMiD_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15282
2.50043354655708e-18	-0.252320556979468	0.235	0.387	5.39768589695277e-14	ADAM28	B cells	GSE161801_IMiD_pre	ENSG00000042980	10863	ADAM metallopeptidase domain 28	ADAM23|eMDCII|MDC-Lm|MDC-Ls	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15283
3.30903886381711e-18	0.334373723590581	0.437	0.248	7.14322219532199e-14	RPS4Y1	B cells	GSE161801_IMiD_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15284
1.82633694557455e-17	0.349414237768933	0.306	0.161	3.94251356441178e-13	CST3	B cells	GSE161801_IMiD_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15285
1.96095392040987e-17	0.275336322031612	0.297	0.146	4.23311122798878e-13	S1PR4	B cells	GSE161801_IMiD_pre	ENSG00000125910	8698	sphingosine-1-phosphate receptor 4	EDG6	protein_coding	O95977	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15286
2.99019743098614e-17	-0.294287538329293	0.329	0.484	6.45493919426979e-13	CD48	B cells	GSE161801_IMiD_pre	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15287
5.85591903727663e-17	0.349241793388926	0.314	0.168	1.26411724257691e-12	B4GALT1	B cells	GSE161801_IMiD_pre	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15288
6.53614297250828e-17	-0.292052538747717	0.779	0.868	1.41095718347536e-12	HINT1	B cells	GSE161801_IMiD_pre	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15289
2.71374999988957e-16	-0.271973204323996	0.188	0.318	5.85817212476162e-12	GGNBP2	B cells	GSE161801_IMiD_pre	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15290
4.98173470765256e-16	-0.268562119622104	0.21	0.343	1.07540707134096e-11	EIF4A1	B cells	GSE161801_IMiD_pre	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15291
5.30568532637509e-16	-0.308047377341202	0.356	0.497	1.14533829140459e-11	SEC61B	B cells	GSE161801_IMiD_pre	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15292
1.33228848606226e-15	-0.265948692596047	0.4	0.553	2.87601115486261e-11	HNRNPA0	B cells	GSE161801_IMiD_pre	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15293
1.56877117693031e-15	0.31874371249248	0.586	0.439	3.38650633963947e-11	UCP2	B cells	GSE161801_IMiD_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15294
1.69432773276927e-15	-0.267763138335715	0.287	0.433	3.65754527672902e-11	TCOF1	B cells	GSE161801_IMiD_pre	ENSG00000070814	6949	treacle ribosome biogenesis factor 1	TCS|treacle	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15295
2.08457142175698e-15	0.270550630706758	0.288	0.154	4.4999643281468e-11	CXXC5	B cells	GSE161801_IMiD_pre	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15296
4.8207655093317e-15	-0.253445304738225	0.869	0.917	1.04065865049943e-10	DDX5	B cells	GSE161801_IMiD_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15297
5.01416868534932e-15	0.322641314688514	0.708	0.609	1.08240859410636e-10	ISG20	B cells	GSE161801_IMiD_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15298
8.07163272176348e-15	0.283604038123286	0.303	0.173	1.74242335564708e-10	ITGB2	B cells	GSE161801_IMiD_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15299
9.25929465395307e-15	-0.269162264387346	0.541	0.671	1.99880393694885e-10	ZFAS1	B cells	GSE161801_IMiD_pre	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15300
1.26152396234213e-14	0.372860924899984	0.542	0.42	2.72325177750795e-10	LY6E	B cells	GSE161801_IMiD_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15301
1.36502075531766e-14	0.40235455135924	0.859	0.842	2.94667030450424e-10	JUNB	B cells	GSE161801_IMiD_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15302
5.78475341702562e-14	-0.272927019160224	0.598	0.719	1.24875472013332e-09	CHCHD2	B cells	GSE161801_IMiD_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15303
6.24415698324357e-14	0.287264876352908	0.275	0.149	1.34792616797279e-09	LST1	B cells	GSE161801_IMiD_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15304
7.87243509993757e-14	-0.29387376084459	0.427	0.575	1.69942256502352e-09	VIM	B cells	GSE161801_IMiD_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15305
2.17562136683674e-13	-0.269279842403766	0.564	0.695	4.69651384459048e-09	RBM3	B cells	GSE161801_IMiD_pre	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15306
2.26207482229703e-13	0.299630663790452	0.447	0.322	4.88314091889259e-09	ATP5ME	B cells	GSE161801_IMiD_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15307
2.50691024860625e-13	-0.268405738391569	0.26	0.387	5.41166715366632e-09	SELENOK	B cells	GSE161801_IMiD_pre	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15308
2.94482998947015e-13	0.254417887734814	0.377	0.241	6.35700449826922e-09	TNFAIP8	B cells	GSE161801_IMiD_pre	ENSG00000145779	25816	TNF alpha induced protein 8	GG2-1|MDC-3.13|SCC-S2	protein_coding	O95379	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15309
6.11499326027879e-12	0.305652324908146	0.602	0.486	1.32004359509638e-07	MEF2C	B cells	GSE161801_IMiD_pre	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15310
8.68236551935769e-12	0.308494137708383	0.615	0.544	1.87426224466374e-07	HMGB2	B cells	GSE161801_IMiD_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15311
2.51464438343584e-11	-0.259007334111974	0.172	0.271	5.42836283052294e-07	MYC	B cells	GSE161801_IMiD_pre	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15312
4.93405108354923e-11	0.26775899368473	0.622	0.507	1.06511360740577e-06	BIRC3	B cells	GSE161801_IMiD_pre	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15313
9.4819165369901e-11	-0.257898760410027	0.341	0.461	2.04686132284005e-06	IRF1	B cells	GSE161801_IMiD_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15314
2.0162158612016e-10	0.313804244639986	0.268	0.164	4.35240517957589e-06	ISG15	B cells	GSE161801_IMiD_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15315
1.78846950572558e-09	0.262822752076769	0.583	0.504	3.86076912200982e-05	GMFG	B cells	GSE161801_IMiD_pre	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15316
1.06176403967248e-07	0.273965780397105	0.416	0.324	0.00229203003244097	MDM4	B cells	GSE161801_IMiD_pre	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15317
2.61941203920692e-07	0.255418570726282	0.289	0.202	0.00565452476903598	RGS2	B cells	GSE161801_IMiD_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15318
3.55257166622148e-07	0.286886211291675	0.347	0.262	0.0076689364558723	H1FX	B cells	GSE161801_IMiD_pre	NA	NA	NA	NA	NA	NA	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15319
1.89924484921428e-06	0.85698673673109	1	1	0.0409989985599886	RPS29	pDCs	GSE161801_IMiD_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_IMiD	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 6, sensitive 2); post (resistant 6, sensitive 3)	17	85449	Public on Aug 18, 2021	34845188	This dataset has 9 patients, 8 of whom have both pre- and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15320
1.0187082304363e-156	-1.62240704705431	0.205	0.945	1.86932960285062e-152	IGLL5	Malignant cells	GSE161801_PI_post	ENSG00000254709	100423062	immunoglobulin lambda like polypeptide 5	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15321
1.55714988244113e-151	-1.0109630497562	0.065	0.677	2.85737003427948e-147	CADM1	Malignant cells	GSE161801_PI_post	ENSG00000182985	23705	cell adhesion molecule 1	BL2|IGSF4|IGSF4A|Necl-2|NECL2|RA175|ST17|SYNCAM|SYNCAM1|TSLC1	protein_coding	Q9BY67	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15322
2.99417809255828e-128	-0.53879231928823	0	0.339	5.49431679984444e-124	RGS13	Malignant cells	GSE161801_PI_post	ENSG00000127074	6003	regulator of G protein signaling 13	NA	protein_coding	O14921	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15323
1.61261041818623e-125	-0.598724183830035	0.005	0.366	2.95914011737172e-121	C12orf75	Malignant cells	GSE161801_PI_post	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15324
4.59140448033213e-113	-0.807313911353879	0.013	0.378	8.42522722140946e-109	TIMD4	Malignant cells	GSE161801_PI_post	ENSG00000145850	91937	T cell immunoglobulin and mucin domain containing 4	TIM4	protein_coding	Q96H15	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15325
2.80548571232838e-109	-0.849843945689234	0.074	0.583	5.14806628212259e-105	COX11	Malignant cells	GSE161801_PI_post	ENSG00000166260	1353	cytochrome c oxidase copper chaperone COX11	COX11P	protein_coding	Q9Y6N1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15326
3.89002325833021e-108	-1.47249081127851	0.731	0.984	7.13819267903593e-104	RPL17	Malignant cells	GSE161801_PI_post	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15327
2.1247551074654e-104	-1.131625011107	0.861	1	3.89892562219902e-100	COX7C	Malignant cells	GSE161801_PI_post	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15328
3.03873094749513e-94	-1.18360387676237	0.993	1	5.57607128865356e-90	RPL39	Malignant cells	GSE161801_PI_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15329
4.12750491404537e-94	-1.09065423291593	0.999	1	7.57397151727325e-90	RPS27	Malignant cells	GSE161801_PI_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15330
4.16217515583418e-92	-1.39679519865002	0.132	0.642	7.63759141095571e-88	TIMP1	Malignant cells	GSE161801_PI_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15331
2.29305471909401e-87	-1.29569252668932	0.98	1	4.2077554095375e-83	HLA-C	Malignant cells	GSE161801_PI_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15332
3.57846165706473e-87	-0.814056590551054	0.14	0.661	6.56647714071378e-83	TNFRSF13B	Malignant cells	GSE161801_PI_post	ENSG00000240505	23495	TNF receptor superfamily member 13B	CD267|IGAD2|TACI	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15333
1.13647507898138e-84	1.66992387096349	0.811	0.106	2.08543176993083e-80	LINC01781	Malignant cells	GSE161801_PI_post	ENSG00000234184	101927412	long intergenic non-protein coding RNA 1781	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15334
2.68897548962356e-83	-1.10856683485689	0.718	0.98	4.93427002345924e-79	TOMM7	Malignant cells	GSE161801_PI_post	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15335
2.18696865479876e-82	-0.966672942152304	0.988	1	4.01308748155573e-78	RPL37	Malignant cells	GSE161801_PI_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15336
4.78797556537385e-79	-1.07448503802636	0.97	1	8.78593516246101e-75	SUB1	Malignant cells	GSE161801_PI_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15337
3.52111007019706e-77	-0.976265429008116	0.561	0.957	6.46123697881161e-73	CIRBP	Malignant cells	GSE161801_PI_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15338
4.00898575407679e-76	-0.92383523851261	0.99	1	7.35648885873091e-72	RPS23	Malignant cells	GSE161801_PI_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15339
9.47525463545742e-76	-0.918873746654526	0.989	1	1.73870922560644e-71	SSR4	Malignant cells	GSE161801_PI_post	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15340
3.4017008651593e-72	-0.957873522580638	0.244	0.803	6.24212108756731e-68	VIM	Malignant cells	GSE161801_PI_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15341
1.0438968644631e-71	-0.596712771550503	0.042	0.378	1.91555074628979e-67	HBD	Malignant cells	GSE161801_PI_post	ENSG00000223609	3045	hemoglobin subunit delta	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15342
1.16660658586691e-70	-0.885365079619094	0.998	1	2.14072308506578e-66	RPS28	Malignant cells	GSE161801_PI_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15343
2.35543771081714e-70	-0.625912035843718	0.101	0.528	4.32222819934944e-66	MGST3	Malignant cells	GSE161801_PI_post	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15344
8.03096318809146e-70	-0.921478412216968	0.999	1	1.47368174501478e-65	RPS14	Malignant cells	GSE161801_PI_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15345
8.78364489691642e-68	-1.04322263527766	0.942	1	1.61179883858416e-63	RPL36A	Malignant cells	GSE161801_PI_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15346
8.39557561214958e-67	-0.767847643198964	0.263	0.756	1.54058812482945e-62	NDUFA2	Malignant cells	GSE161801_PI_post	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15347
1.32549062048268e-65	1.96513643316983	0.651	0.031	2.43227528858572e-61	EDNRB	Malignant cells	GSE161801_PI_post	ENSG00000136160	1910	endothelin receptor type B	ETB|HSCR|HSCR2	protein_coding	P24530	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15348
1.63476518420645e-65	-0.613525555318637	0.121	0.555	2.99979411301883e-61	COX20	Malignant cells	GSE161801_PI_post	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15349
2.10444564937331e-65	1.24460836834536	0.829	0.346	3.86165776660003e-61	IFITM1	Malignant cells	GSE161801_PI_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15350
4.69717073006585e-65	-0.789702091520427	1	1	8.61930828967083e-61	RPL10	Malignant cells	GSE161801_PI_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15351
9.16241401222614e-65	-0.720139637645201	0.162	0.618	1.6813029712435e-60	CKLF	Malignant cells	GSE161801_PI_post	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15352
1.16594749142641e-63	1.60623684602411	0.621	0	2.13951364676746e-59	FBP1	Malignant cells	GSE161801_PI_post	ENSG00000165140	2203	fructose-bisphosphatase 1	FBP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15353
1.75829784054099e-62	-0.779924096035212	0.286	0.78	3.22647653739271e-58	TSTD1	Malignant cells	GSE161801_PI_post	ENSG00000215845	100131187	thiosulfate sulfurtransferase like domain containing 1	KAT	protein_coding	Q8NFU3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15354
5.8579411970771e-62	-0.481359788899132	0.051	0.374	1.07493220966365e-57	BEX2	Malignant cells	GSE161801_PI_post	ENSG00000133134	84707	brain expressed X-linked 2	DJ79P11.1	protein_coding	Q9BXY8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15355
2.90108036088722e-61	-0.823625794629166	0.369	0.819	5.32348246222804e-57	SLC25A5	Malignant cells	GSE161801_PI_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15356
5.67756893707988e-61	0.751911429370208	0.997	1	1.04183389995416e-56	RPL19	Malignant cells	GSE161801_PI_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15357
3.94193287460981e-60	-0.90476364592428	0.248	0.768	7.23344682490901e-56	LAMP5	Malignant cells	GSE161801_PI_post	ENSG00000125869	24141	lysosomal associated membrane protein family member 5	BAD-LAMP|C20orf103|dJ1119D9.3|UNC-46	protein_coding	Q9UJQ1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15358
4.49717854609745e-60	-0.653990723433452	0.98	1	8.25232263208881e-56	UBA52	Malignant cells	GSE161801_PI_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15359
5.43765533941443e-60	-0.924011293642805	0.957	0.996	9.97809754782547e-56	RPL24	Malignant cells	GSE161801_PI_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15360
1.37005403086006e-59	-0.835943434371232	0.998	1	2.51404914662821e-55	RPL32	Malignant cells	GSE161801_PI_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15361
5.13880500114977e-59	-0.709906133203676	0.275	0.748	9.42970717710983e-55	CD47	Malignant cells	GSE161801_PI_post	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15362
6.59388680093965e-59	-0.590262814037994	0.14	0.559	1.20997822797243e-54	FAM133A	Malignant cells	GSE161801_PI_post	ENSG00000179083	286499	family with sequence similarity 133 member A	CT115|FLJ37659|RP1-32F7.2	protein_coding	Q8N9E0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15363
8.33511602910806e-59	-0.844991723139331	0.722	0.937	1.52949379134133e-54	NDUFA4	Malignant cells	GSE161801_PI_post	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15364
2.24505388728636e-58	-0.723562637997114	0.687	0.969	4.11967388317047e-54	UQCR11	Malignant cells	GSE161801_PI_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15365
3.61534068893252e-58	-0.89985355552945	0.78	0.969	6.63415016419117e-54	SEC61G	Malignant cells	GSE161801_PI_post	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15366
1.50291355423988e-57	-0.760749399293261	0.999	1	2.75784637203019e-53	RPL15	Malignant cells	GSE161801_PI_post	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15367
1.77811549036469e-57	-1.02283512138788	0.855	0.992	3.26284192481921e-53	SPCS1	Malignant cells	GSE161801_PI_post	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15368
3.10601836255369e-57	-0.873256370240497	0.692	0.949	5.69954369528602e-53	H3F3A	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15369
1.52261035241385e-56	-0.723565306104532	0.957	1	2.79398999667942e-52	RPL38	Malignant cells	GSE161801_PI_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15370
2.98051564049199e-56	1.06193131860668	0.979	0.677	5.46924620030281e-52	HLA-A	Malignant cells	GSE161801_PI_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15371
2.41826647745504e-55	-0.961271853748663	0.202	0.654	4.43751898612999e-51	CCR10	Malignant cells	GSE161801_PI_post	ENSG00000184451	2826	C-C motif chemokine receptor 10	GPR2	protein_coding	P46092	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15372
2.45741838876734e-55	0.884198788982552	0.993	0.811	4.50936274338807e-51	EIF1	Malignant cells	GSE161801_PI_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15373
2.96967902084113e-55	1.26308489473267	0.874	0.461	5.44936100324347e-51	IFI6	Malignant cells	GSE161801_PI_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15374
2.75495463714955e-54	-0.771642438157477	0.52	0.937	5.05534175916941e-50	TXN	Malignant cells	GSE161801_PI_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15375
2.34277639695033e-53	-0.506125819838078	0.053	0.35	4.29899468840386e-49	RAD51C	Malignant cells	GSE161801_PI_post	ENSG00000108384	5889	RAD51 paralog C	FANCO|RAD51L2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15376
2.87009285658023e-52	-0.615754301103114	0.145	0.535	5.26662039182473e-48	MSI2	Malignant cells	GSE161801_PI_post	ENSG00000153944	124540	musashi RNA binding protein 2	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15377
1.03125996941042e-51	1.93698847946545	0.577	0.047	1.89236204386811e-47	CXCR4	Malignant cells	GSE161801_PI_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15378
2.00714817292148e-51	-0.716741884038685	0.542	0.909	3.68311689731091e-47	ATP5MF	Malignant cells	GSE161801_PI_post	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15379
3.4021417211001e-51	-0.758009467633934	0.991	1	6.24293005821868e-47	RPL35A	Malignant cells	GSE161801_PI_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15380
2.64206275104326e-50	-0.393655188948455	0.049	0.331	4.84818514816438e-46	CMTM6	Malignant cells	GSE161801_PI_post	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15381
3.33615858795736e-50	1.22516513697104	1	1	6.12185100890176e-46	B2M	Malignant cells	GSE161801_PI_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15382
4.69899476152911e-50	-0.576234352392716	0.086	0.413	8.62265538740592e-46	FHL1	Malignant cells	GSE161801_PI_post	ENSG00000022267	2273	four and a half LIM domains 1	bA535K18.1|FHL1B|FLH1A|KYO-T|MGC111107|SLIM1|XMPMA	protein_coding	Q13642	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15383
5.31332391469381e-50	1.03321727365626	0.812	0.441	9.74994938346314e-46	PRDX4	Malignant cells	GSE161801_PI_post	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15384
6.4222861189633e-50	-1.20642467489567	0.766	0.949	1.17848950282977e-45	ACTB	Malignant cells	GSE161801_PI_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15385
2.66462592506918e-49	-0.685013191270725	0.617	0.917	4.88958857250195e-45	NDUFA1	Malignant cells	GSE161801_PI_post	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15386
6.16829007872673e-49	1.0681407238899	0.813	0.472	1.13188122944635e-44	TXNDC11	Malignant cells	GSE161801_PI_post	ENSG00000153066	51061	thioredoxin domain containing 11	EFP1	protein_coding	Q6PKC3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15387
6.70634585217065e-49	1.01748952573323	0.584	0.071	1.23061446387331e-44	IGF1	Malignant cells	GSE161801_PI_post	ENSG00000017427	3479	insulin like growth factor 1	IGF|IGF-I|IGF1A|IGFI	protein_coding	P05019	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15388
6.82803328063251e-49	-0.42791013904368	0.087	0.425	1.25294410699607e-44	ENAM	Malignant cells	GSE161801_PI_post	ENSG00000132464	10117	enamelin	AIH2	protein_coding	Q9NRM1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15389
4.79620182810073e-48	1.0582593979724	0.513	0	8.80103035456484e-44	VPREB3	Malignant cells	GSE161801_PI_post	ENSG00000128218	29802	V-set pre-B cell surrogate light chain 3	8HS20	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15390
1.2187227567216e-47	-0.611993919105015	0.194	0.591	2.23635625858413e-43	SUPT4H1	Malignant cells	GSE161801_PI_post	ENSG00000213246	6827	SPT4 homolog, DSIF elongation factor subunit	Spt4|SPT4H|Supt4a|SUPT4H	protein_coding	P63272	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15391
6.52422103209119e-47	2.57685340057641	0.563	0.047	1.19719455938873e-42	CCL3	Malignant cells	GSE161801_PI_post	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15392
3.0785278278681e-46	-0.641294365922645	0.286	0.701	5.64909856413797e-42	HIGD2A	Malignant cells	GSE161801_PI_post	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15393
1.17813705096152e-45	2.04934128152698	0.637	0.181	2.1618814885144e-41	FOS	Malignant cells	GSE161801_PI_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15394
1.94764664117522e-45	-0.940650255380694	0.961	0.976	3.57393158655654e-41	RPL26	Malignant cells	GSE161801_PI_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15395
3.32253522397779e-45	0.687891055917274	0.989	0.965	6.09685213599925e-41	TPT1	Malignant cells	GSE161801_PI_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15396
5.96193485088635e-45	-0.617122189622696	0.457	0.839	1.09401504513765e-40	NDUFB4	Malignant cells	GSE161801_PI_post	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15397
1.4814625486216e-44	-0.632967309894038	0.226	0.626	2.71848377672064e-40	ARRDC3	Malignant cells	GSE161801_PI_post	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15398
1.83987738138375e-44	-0.739057561994095	0.599	0.949	3.37617499483918e-40	UBL5	Malignant cells	GSE161801_PI_post	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15399
2.72828143873028e-43	-0.585829672741854	0.155	0.512	5.00639644007007e-39	CHMP4B	Malignant cells	GSE161801_PI_post	ENSG00000101421	128866	charged multivesicular body protein 4B	C20orf178|dJ553F4.4|Shax1|SNF7-2|VPS32B	protein_coding	Q9H444	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15400
4.09850894106804e-43	-0.336337316024605	0.042	0.283	7.52076390685986e-39	SERPINI1	Malignant cells	GSE161801_PI_post	ENSG00000163536	5274	serpin family I member 1	PI12	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15401
6.35059622737727e-43	-0.727575416720901	0.335	0.709	1.16533440772373e-38	SVIP	Malignant cells	GSE161801_PI_post	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15402
1.06943848542058e-42	0.754125494593971	0.897	0.657	1.96241962074677e-38	TMBIM6	Malignant cells	GSE161801_PI_post	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15403
1.18315155491722e-42	-0.522166511859869	0.143	0.488	2.1710831032731e-38	MRPS23	Malignant cells	GSE161801_PI_post	ENSG00000181610	51649	mitochondrial ribosomal protein S23	CGI-138|HSPC329|MRP-S23	protein_coding	Q9Y3D9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15404
2.75282809965361e-42	-0.389158105075702	0.069	0.35	5.05143956286438e-38	CAV1	Malignant cells	GSE161801_PI_post	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15405
2.95437298204183e-42	-0.49421877788482	0.147	0.5	5.42127442204676e-38	NSA2	Malignant cells	GSE161801_PI_post	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15406
3.91018629433461e-42	1.15713305428392	0.572	0.098	7.17519185010401e-38	KLF2	Malignant cells	GSE161801_PI_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15407
4.8963780950003e-42	-0.775123931582552	0.518	0.87	8.98485380432554e-38	CALM2	Malignant cells	GSE161801_PI_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15408
1.85804923052608e-41	1.03284693185611	0.49	0.024	3.40952033801536e-37	LAPTM5	Malignant cells	GSE161801_PI_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15409
2.99476704595833e-41	1.69539308557154	0.636	0.213	5.49539752933353e-37	DUSP1	Malignant cells	GSE161801_PI_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15410
3.14967268653047e-41	-0.543581851596666	0.159	0.508	5.7796493797834e-37	GAS6	Malignant cells	GSE161801_PI_post	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15411
3.32440749773769e-41	0.99335247280742	0.506	0.043	6.10028775834865e-37	TMEM156	Malignant cells	GSE161801_PI_post	ENSG00000121895	80008	transmembrane protein 156	FLJ23235	protein_coding	Q8N614	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15412
9.68078241292358e-41	-0.294804566009729	0.036	0.26	1.77642357277148e-36	RNFT1	Malignant cells	GSE161801_PI_post	ENSG00000189050	51136	ring finger protein, transmembrane 1	PTD016	protein_coding	Q5M7Z0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15413
3.38129264149361e-40	-0.674430541960071	0.437	0.819	6.20467199714077e-36	MEF2C	Malignant cells	GSE161801_PI_post	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15414
1.47996530295813e-39	-0.680805764688614	0.751	0.941	2.71573633092818e-35	MT-ND5	Malignant cells	GSE161801_PI_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15415
2.4601031034471e-39	-0.53017483212669	0.317	0.72	4.51428919482543e-35	SRP9	Malignant cells	GSE161801_PI_post	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15416
2.47038926323535e-39	-0.918268408711779	0.978	0.984	4.53316429803687e-35	HLA-B	Malignant cells	GSE161801_PI_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15417
2.52992387340214e-39	-0.706421587065885	0.979	0.996	4.64241030769292e-35	MT-CO2	Malignant cells	GSE161801_PI_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15418
7.87501838702523e-39	0.769101799022542	0.611	0.169	1.44506587401913e-34	CYTIP	Malignant cells	GSE161801_PI_post	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15419
1.16496737507993e-38	-0.588756055058519	0.8	0.961	2.13771513327167e-34	TMA7	Malignant cells	GSE161801_PI_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15420
1.17736816046137e-38	-0.499502488793783	0.117	0.425	2.16047057444661e-34	VMP1	Malignant cells	GSE161801_PI_post	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15421
1.44282320188392e-38	-0.577282425509773	0.317	0.709	2.647580575457e-34	SELENOM	Malignant cells	GSE161801_PI_post	ENSG00000198832	140606	selenoprotein M	SELM|SEPM	protein_coding	Q8WWX9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15422
1.83104900424632e-38	-0.504400297809016	0.132	0.453	3.359974922792e-34	GOSR2	Malignant cells	GSE161801_PI_post	ENSG00000108433	9570	golgi SNAP receptor complex member 2	Bos1|GS27	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15423
2.30487530495014e-38	1.83339636238352	0.606	0.213	4.2294461845835e-34	NFKBIA	Malignant cells	GSE161801_PI_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15424
2.39519992871059e-38	-0.574948095550076	0.838	0.953	4.39519186918393e-34	HINT1	Malignant cells	GSE161801_PI_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15425
3.26712592071283e-38	-0.495174634646908	0.216	0.583	5.99517606450803e-34	NDUFA5	Malignant cells	GSE161801_PI_post	ENSG00000128609	4698	NADH:ubiquinone oxidoreductase subunit A5	B13|CI-13kB|CI-13KD-B|NUFM|UQOR13	protein_coding	Q16718	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15426
3.82401249005803e-38	-0.609955355546945	0.417	0.776	7.01706291925649e-34	COX17	Malignant cells	GSE161801_PI_post	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15427
7.9775302924387e-38	-0.49771324810093	0.125	0.437	1.4638768086625e-33	ARPC5	Malignant cells	GSE161801_PI_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15428
1.40157640180012e-37	1.91253808812928	0.681	0.343	2.57189269730322e-33	JUNB	Malignant cells	GSE161801_PI_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15429
2.43700558919951e-37	-0.523786440636004	0.327	0.724	4.4719052561811e-33	C19orf70	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15430
3.15162987787489e-37	-0.51336705969804	0.07	0.327	5.78324082590043e-33	TEX14	Malignant cells	GSE161801_PI_post	ENSG00000121101	56155	testis expressed 14, intercellular bridge forming factor	CT113	protein_coding	Q8IWB6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15431
6.33697622267721e-37	1.54544757231229	0.452	0.024	1.16283513686127e-32	IFI27	Malignant cells	GSE161801_PI_post	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15432
8.58399379982658e-37	-0.560560396920034	0.314	0.669	1.57516286226818e-32	ALKBH7	Malignant cells	GSE161801_PI_post	ENSG00000125652	84266	alkB homolog 7	MGC10974|SPATA11	protein_coding	Q9BT30	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15433
2.81161351552587e-36	-0.497941773925266	0.189	0.535	5.15931080098998e-32	CLECL1	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15434
3.88823063261394e-36	-0.33530602976733	0.061	0.307	7.13490321084658e-32	ZMAT2	Malignant cells	GSE161801_PI_post	ENSG00000146007	153527	zinc finger matrin-type 2	FLJ31121|hSNU23|Snu23	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15435
4.68920830426778e-36	-0.453307895030784	0.139	0.457	8.60469723833138e-32	ALDOA	Malignant cells	GSE161801_PI_post	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15436
6.83682665488056e-36	1.14650756057792	0.518	0.098	1.25455769117058e-31	FOSB	Malignant cells	GSE161801_PI_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15437
7.3763217205076e-36	0.900544173922683	0.79	0.516	1.35355503571314e-31	UBB	Malignant cells	GSE161801_PI_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15438
1.1002391789151e-35	0.617475314239647	0.41	0	2.01893889330921e-31	FAM30A	Malignant cells	GSE161801_PI_post	ENSG00000277059	9834	family with sequence similarity 30 member A	C14orf110|HSPC053|KIAA0125	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15439
1.28708661773127e-35	-0.427402812266349	0.128	0.433	2.36180394353688e-31	TMEM45A	Malignant cells	GSE161801_PI_post	ENSG00000181458	55076	transmembrane protein 45A	DERP7|FLJ10134	protein_coding	Q9NWC5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15440
1.3771646519298e-35	0.700068621535437	0.631	0.224	2.52709713629119e-31	PLPP5	Malignant cells	GSE161801_PI_post	ENSG00000147535	84513	phospholipid phosphatase 5	DPPL1|HTPAP|PPAPDC1B	protein_coding	Q8NEB5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15441
1.43114351203613e-35	-0.555415519053751	0.364	0.736	2.6261483445863e-31	POLR2K	Malignant cells	GSE161801_PI_post	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15442
1.44639922617585e-35	-0.586126706102369	0.194	0.528	2.65414258003269e-31	FCRLA	Malignant cells	GSE161801_PI_post	ENSG00000132185	84824	Fc receptor like A	FCRL|FCRLb|FCRLc1|FCRLc2|FCRLd|FCRLe|FCRLM1|FCRLX|FREB|MGC4595	protein_coding	Q7L513	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15443
4.9767447747751e-35	-0.507077397931633	0.081	0.343	9.13232666171231e-31	AC004687.1	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15444
6.29037356308646e-35	-0.610683358520236	0.997	1	1.15428354882637e-30	RPL13	Malignant cells	GSE161801_PI_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15445
6.37281295555424e-35	0.645678491333853	0.879	0.732	1.1694111773442e-30	PABPC1	Malignant cells	GSE161801_PI_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15446
7.97238654230642e-35	-0.525793440969711	0.906	0.992	1.46293293051323e-30	ATP5F1E	Malignant cells	GSE161801_PI_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15447
1.18824157075933e-34	-0.383004486861689	0.101	0.382	2.18042328234337e-30	SMIM30	Malignant cells	GSE161801_PI_post	ENSG00000214194	401397	small integral membrane protein 30	LINC00998	protein_coding	A4D0T7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15448
1.67992650933809e-34	-0.553271653112653	0.519	0.846	3.0826651446354e-30	NDUFA3	Malignant cells	GSE161801_PI_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15449
1.94600945029691e-34	1.02842791111456	0.616	0.232	3.57092734129483e-30	BTG1	Malignant cells	GSE161801_PI_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15450
3.22817482662046e-34	-0.444444868788944	0.165	0.492	5.92370080684854e-30	MRPL55	Malignant cells	GSE161801_PI_post	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15451
8.39935360510592e-34	0.744044560460665	0.988	0.996	1.54128138653694e-29	RPLP0	Malignant cells	GSE161801_PI_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15452
1.04043743273395e-33	0.613264333269587	0.418	0.02	1.90920268906679e-29	DENND6B	Malignant cells	GSE161801_PI_post	ENSG00000205593	414918	DENN domain containing 6B	AFI1B|FAM116B|MGC33692	protein_coding	Q8NEG7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15453
2.01766018341825e-33	1.30029154361671	0.599	0.165	3.70240643657249e-29	TMSB4X	Malignant cells	GSE161801_PI_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15454
2.10918815808834e-33	0.942320451336765	0.4	0.004	3.8703602700921e-29	HIST1H2BG	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15455
2.42652999933187e-33	0.678189629844174	0.913	0.74	4.45268254877398e-29	TMEM59	Malignant cells	GSE161801_PI_post	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15456
3.28725843505189e-33	1.1464354481807	0.505	0.098	6.03211922832023e-29	PPP1R15A	Malignant cells	GSE161801_PI_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15457
3.43605517048258e-33	-0.542696773744146	0.762	0.937	6.30516123783554e-29	POLR2L	Malignant cells	GSE161801_PI_post	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15458
3.69147202847607e-33	0.994569470283118	0.542	0.134	6.77385117225359e-29	RHOB	Malignant cells	GSE161801_PI_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15459
4.05182472227473e-33	-0.3500429630188	0.085	0.346	7.43509836537414e-29	TCEAL4	Malignant cells	GSE161801_PI_post	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15460
4.07371871002667e-33	0.649287578269188	0.907	0.827	7.47527383289894e-29	SPCS3	Malignant cells	GSE161801_PI_post	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15461
4.17051782577378e-33	0.790167884681511	0.651	0.283	7.65290021029489e-29	PABPC4	Malignant cells	GSE161801_PI_post	ENSG00000090621	8761	poly(A) binding protein cytoplasmic 4	APP-1|iPABP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15462
4.90261784078078e-33	-0.329632154562818	0.071	0.315	8.99630373783273e-29	PTRH2	Malignant cells	GSE161801_PI_post	ENSG00000141378	51651	peptidyl-tRNA hydrolase 2	BIT1|CFAP37|CGI-147|PTH2	protein_coding	Q9Y3E5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15463
5.99165367302187e-33	-0.571953182810115	0.365	0.705	1.09946844899951e-28	LSM5	Malignant cells	GSE161801_PI_post	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15464
9.38776884345815e-33	0.650394253192647	0.386	0	1.72265558277457e-28	FCER2	Malignant cells	GSE161801_PI_post	ENSG00000104921	2208	Fc epsilon receptor II	CD23|CD23A|CLEC4J|FCE2|FcepsilonRII|FCErII	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15465
1.56276506628293e-32	-0.629789431880866	0.947	1	2.86767389662917e-28	FTH1	Malignant cells	GSE161801_PI_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15466
8.44428110789579e-32	0.857226552060782	0.844	0.673	1.54952558329888e-27	HSPA8	Malignant cells	GSE161801_PI_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15467
1.70674600902478e-31	-0.665496542263237	0.845	0.969	3.13187892656047e-27	MT-ND3	Malignant cells	GSE161801_PI_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15468
2.45488900580304e-31	-0.570304000705135	0.776	0.929	4.50472132564858e-27	NPM1	Malignant cells	GSE161801_PI_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15469
2.4702284942029e-31	-0.588957525757342	0.637	0.941	4.53286928686233e-27	NPC2	Malignant cells	GSE161801_PI_post	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15470
8.74935175961926e-31	-0.54560504364593	0.316	0.657	1.60550604789014e-26	RAN	Malignant cells	GSE161801_PI_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15471
1.96288106264467e-30	0.844523349407136	0.959	0.819	3.60188674995297e-26	UBC	Malignant cells	GSE161801_PI_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15472
2.03694101742684e-30	2.33748064330036	0.673	0.457	3.73778676697825e-26	JUN	Malignant cells	GSE161801_PI_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15473
2.08823480027858e-30	-0.642581006114208	0.849	0.961	3.8319108585112e-26	MT-ATP6	Malignant cells	GSE161801_PI_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15474
4.25394570986782e-30	-0.328475930354086	0.063	0.283	7.80599037760745e-26	CLTC	Malignant cells	GSE161801_PI_post	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15475
6.75427077167759e-30	-0.285382462547026	0.051	0.256	1.23940868660284e-25	COIL	Malignant cells	GSE161801_PI_post	ENSG00000121058	8161	coilin	CLN80|p80-coilin	protein_coding	P38432	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15476
1.22890534089046e-29	0.806910213228256	0.41	0.039	2.255041300534e-25	LY6E	Malignant cells	GSE161801_PI_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15477
2.98250889222841e-29	-0.519109953426531	0.658	0.902	5.47290381723914e-25	UQCRQ	Malignant cells	GSE161801_PI_post	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15478
3.33586592511905e-29	-0.419200797253577	0.998	1	6.12131397259347e-25	RPS25	Malignant cells	GSE161801_PI_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15479
4.17306771756511e-29	-0.466540102133233	0.845	0.965	7.65757926173197e-25	BTF3	Malignant cells	GSE161801_PI_post	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15480
5.02518605614934e-29	-0.467741562336126	0.288	0.61	9.22121641303403e-25	UFC1	Malignant cells	GSE161801_PI_post	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15481
6.71833235497821e-29	1.53098189627377	0.661	0.476	1.2328139871385e-24	FRZB	Malignant cells	GSE161801_PI_post	ENSG00000162998	2487	frizzled related protein	FRE|FRITZ|FRP-3|FRZB-1|FRZB-PEN|FRZB1|FZRB|hFIZ|SFRP3|SRFP3	protein_coding	Q92765	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15482
9.90885426879483e-29	1.70037673673451	0.676	0.37	1.81827475832385e-24	IER2	Malignant cells	GSE161801_PI_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15483
1.08629361286937e-28	-0.627146568235797	0.97	0.984	1.9933487796153e-24	MT-ND4	Malignant cells	GSE161801_PI_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15484
1.21161264227263e-28	0.648942163217166	0.521	0.157	2.22330919857027e-24	CDV3	Malignant cells	GSE161801_PI_post	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15485
1.95272094036406e-28	-0.416590173735569	0.994	1	3.58324292556804e-24	RPS15A	Malignant cells	GSE161801_PI_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15486
2.13051210213867e-28	0.695305747187084	0.795	0.571	3.90948970742445e-24	PDIA3	Malignant cells	GSE161801_PI_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15487
2.45306803481889e-28	0.596367263993406	0.353	0.004	4.50137984389266e-24	PLAC8	Malignant cells	GSE161801_PI_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15488
2.55022608954724e-28	-0.470244241210399	0.318	0.646	4.67966487431918e-24	REX1BD	Malignant cells	GSE161801_PI_post	ENSG00000006015	55049	required for excision 1-B domain containing	C19orf60|FLJ20850|FLJ30108|FLJ34606|FLJ37391	protein_coding	Q96EN9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15489
3.5320100736631e-28	-0.495215815981402	0.321	0.646	6.48123848517179e-24	TMEM167A	Malignant cells	GSE161801_PI_post	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15490
3.88033465053588e-28	-0.467450992528552	0.64	0.913	7.12041408373334e-24	COX4I1	Malignant cells	GSE161801_PI_post	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15491
8.37335672761568e-28	-0.388135582700497	0.156	0.441	1.53651095951748e-23	VBP1	Malignant cells	GSE161801_PI_post	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15492
1.58457271415056e-27	-0.433878758100199	0.999	1	2.90769093046627e-23	RPS15	Malignant cells	GSE161801_PI_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15493
1.63707801023118e-27	-0.523931799629314	0.555	0.839	3.00403814877422e-23	ELOB	Malignant cells	GSE161801_PI_post	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15494
2.66528202533518e-27	1.27556742623711	0.672	0.472	4.89079251649006e-23	CD79A	Malignant cells	GSE161801_PI_post	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15495
2.69794541711554e-27	-0.386433115479774	0.994	1	4.95072984040702e-23	RPL8	Malignant cells	GSE161801_PI_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15496
3.24360810337996e-27	0.596505184993949	0.994	0.996	5.95202086970223e-23	SERF2	Malignant cells	GSE161801_PI_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15497
3.91673245289883e-27	-0.450330336835389	0.244	0.551	7.18720405106935e-23	RBM8A	Malignant cells	GSE161801_PI_post	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15498
8.35564725579212e-27	-0.348049106272164	0.997	1	1.53326127143785e-22	FAU	Malignant cells	GSE161801_PI_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15499
9.38271639389074e-27	-0.493984922143518	0.306	0.622	1.72172845827895e-22	RHEB	Malignant cells	GSE161801_PI_post	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15500
1.11360357398624e-26	0.565605010222719	0.569	0.217	2.04346255826475e-22	SELENOF	Malignant cells	GSE161801_PI_post	ENSG00000183291	9403	selenoprotein F	SEP15	protein_coding	O60613	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15501
1.12088294991666e-26	-0.53067192459573	0.595	0.858	2.05682021309708e-22	COX6C	Malignant cells	GSE161801_PI_post	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15502
1.16949941261676e-26	-0.559751937923876	0.719	0.913	2.14603142215176e-22	GSTP1	Malignant cells	GSE161801_PI_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15503
1.20111984501396e-26	0.579303482824878	0.991	0.984	2.20405491560062e-22	RPL4	Malignant cells	GSE161801_PI_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15504
1.20643990278773e-26	-0.386915341061661	0.183	0.472	2.21381722161549e-22	QTRT1	Malignant cells	GSE161801_PI_post	ENSG00000213339	81890	queuine tRNA-ribosyltransferase catalytic subunit 1	TGT	protein_coding	Q9BXR0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15505
1.2773263494465e-26	-0.478904166417817	0.536	0.823	2.34389385123432e-22	NDUFA11	Malignant cells	GSE161801_PI_post	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15506
2.19746648832121e-26	-0.382414112769329	0.138	0.402	4.03235100606941e-22	TCEAL8	Malignant cells	GSE161801_PI_post	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15507
2.35722600409344e-26	0.764383636137857	0.515	0.177	4.32550971751146e-22	IL16	Malignant cells	GSE161801_PI_post	ENSG00000172349	3603	interleukin 16	FLJ16806|FLJ42735|HsT19289|IL-16|LCF|prIL-16	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15508
3.46659319542765e-26	0.739389098024912	0.495	0.154	6.36119851360974e-22	PRDM1	Malignant cells	GSE161801_PI_post	ENSG00000057657	639	PR/SET domain 1	BLIMP1|PRDI-BF1	protein_coding	O75626	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15509
4.05736919110707e-26	-0.487765825098149	0.368	0.673	7.44527246568147e-22	TMEM205	Malignant cells	GSE161801_PI_post	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15510
4.13742991515181e-26	-0.458355922347434	0.222	0.512	7.59218389430357e-22	SRI	Malignant cells	GSE161801_PI_post	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15511
4.5372991634083e-26	-0.480485424624341	0.438	0.74	8.32594396485423e-22	PSMA2	Malignant cells	GSE161801_PI_post	ENSG00000106588	5683	proteasome 20S subunit alpha 2	HC3|MU|PMSA2	protein_coding	P25787	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15512
8.51961010855224e-26	0.507567171654328	0.332	0.008	1.56334845491934e-21	KRT18	Malignant cells	GSE161801_PI_post	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15513
9.88629225433968e-26	0.963919738517068	0.651	0.358	1.81413462867133e-21	NEAT1	Malignant cells	GSE161801_PI_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15514
1.92955679321675e-25	-0.352599616396983	0.145	0.413	3.54073671555273e-21	MAP3K13	Malignant cells	GSE161801_PI_post	ENSG00000073803	9175	mitogen-activated protein kinase kinase kinase 13	LZK|MEKK13	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15515
2.26951235451596e-25	0.77315931412332	0.573	0.272	4.16455517053679e-21	RASGRP3	Malignant cells	GSE161801_PI_post	ENSG00000152689	25780	RAS guanyl releasing protein 3	CalDAG-GEFIII|GRP3|KIAA0846	protein_coding	Q8IV61	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15516
2.38137496898888e-25	0.591943511839256	0.385	0.051	4.3698230680946e-21	GABPB1-AS1	Malignant cells	GSE161801_PI_post	ENSG00000244879	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15517
2.54902189866242e-25	-0.490858032352161	0.388	0.697	4.67745518404554e-21	ROMO1	Malignant cells	GSE161801_PI_post	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15518
4.97257617385117e-25	-0.441265970631602	0.314	0.622	9.1246772790169e-21	GPX4	Malignant cells	GSE161801_PI_post	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15519
5.06796780933824e-25	-0.616224202251643	0.432	0.705	9.29972093013566e-21	CD48	Malignant cells	GSE161801_PI_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15520
5.93322911896652e-25	-0.511465197388545	0.28	0.567	1.08874754333036e-20	MLLT3	Malignant cells	GSE161801_PI_post	ENSG00000171843	4300	MLLT3 super elongation complex subunit	AF-9|AF9|YEATS3	protein_coding	P42568	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15521
7.0542853715741e-25	-0.426363445538255	0.356	0.681	1.29446136568385e-20	TBCA	Malignant cells	GSE161801_PI_post	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15522
1.00464862147698e-24	1.10662039944524	0.42	0.091	1.84353022041027e-20	SAT1	Malignant cells	GSE161801_PI_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15523
1.63552870346442e-24	-0.460918965238277	0.474	0.768	3.00119517085721e-20	NDUFB1	Malignant cells	GSE161801_PI_post	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15524
2.08946160946368e-24	0.575776169220159	0.836	0.744	3.83416205336586e-20	COX5A	Malignant cells	GSE161801_PI_post	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15525
2.99148615839695e-24	0.614034112767204	0.78	0.591	5.48937710065841e-20	PSAP	Malignant cells	GSE161801_PI_post	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15526
5.28952268097516e-24	0.617951512395699	0.995	1	9.70627411958942e-20	RPS12	Malignant cells	GSE161801_PI_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15527
5.85928812676475e-24	-0.463054630561827	0.761	0.945	1.07517937126133e-19	KRTCAP2	Malignant cells	GSE161801_PI_post	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15528
9.18603483708424e-24	-0.499491413106402	0.734	0.902	1.68563739260496e-19	EIF3E	Malignant cells	GSE161801_PI_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15529
1.13614275727761e-23	-0.343123415033606	0.065	0.256	2.08482195960441e-19	FMNL1	Malignant cells	GSE161801_PI_post	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15530
1.29157311529627e-23	-0.252594978857775	0.062	0.252	2.37003666656865e-19	TCEAL9	Malignant cells	GSE161801_PI_post	ENSG00000185222	51186	transcription elongation factor A like 9	DKFZp313K1940|WBP5|WEX6	protein_coding	Q9UHQ7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15531
1.79430184392944e-23	0.608825380056689	0.383	0.063	3.29254388361051e-19	NSMCE3	Malignant cells	GSE161801_PI_post	ENSG00000282130	56160	NSE3 homolog, SMC5-SMC6 complex component	HCA4|MAGEG1|MAGEL3|NDNL2|NSE3	protein_coding	Q96MG7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15532
3.01217522789504e-23	0.486350670204308	0.456	0.118	5.5273415431874e-19	KRT10	Malignant cells	GSE161801_PI_post	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15533
5.73998116234155e-23	0.500789604011174	0.506	0.177	1.05328654328967e-18	STT3B	Malignant cells	GSE161801_PI_post	ENSG00000163527	201595	STT3 oligosaccharyltransferase complex catalytic subunit B	FLJ90106|SIMP|STT3-B	protein_coding	Q8TCJ2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15534
5.95088592153886e-23	1.12515264943195	0.966	0.98	1.09198756660238e-18	MALAT1	Malignant cells	GSE161801_PI_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15535
6.07249978786172e-23	-0.579181418336355	0.92	0.984	1.11430371107263e-18	XBP1	Malignant cells	GSE161801_PI_post	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15536
7.99680148937259e-23	0.522496473835838	0.487	0.161	1.46741307329987e-18	TENT5C	Malignant cells	GSE161801_PI_post	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15537
9.3277944799325e-23	0.719282946603633	0.36	0.051	1.71165028706761e-18	GADD45B	Malignant cells	GSE161801_PI_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15538
9.93233947474329e-23	1.03624883424973	0.468	0.161	1.82258429361539e-18	ZFP36	Malignant cells	GSE161801_PI_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15539
9.97917342234748e-23	-0.583341917000013	0.49	0.76	1.83117832300076e-18	H2AFZ	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15540
1.02513932135705e-22	-0.54861675449535	0.227	0.484	1.88113065469018e-18	ITGB7	Malignant cells	GSE161801_PI_post	ENSG00000139626	3695	integrin subunit beta 7	NA	protein_coding	P26010	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15541
1.20815480912631e-22	-0.340620353966898	0.134	0.374	2.21696407474679e-18	UBE2A	Malignant cells	GSE161801_PI_post	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15542
1.61238461863821e-22	-0.335398000254142	0.156	0.413	2.95872577520111e-18	PSMB10	Malignant cells	GSE161801_PI_post	ENSG00000205220	5699	proteasome 20S subunit beta 10	beta2i|LMP10|MECL1|MGC1665	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15543
1.76096506474463e-22	-0.374984588887345	0.21	0.484	3.2313708938064e-18	PDCD6	Malignant cells	GSE161801_PI_post	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15544
2.63443202156931e-22	0.765530908596639	0.364	0.063	4.83418275957968e-18	ZFP36L2	Malignant cells	GSE161801_PI_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15545
3.50703430814892e-22	-0.465476954764984	0.612	0.843	6.43540795545327e-18	COX6B1	Malignant cells	GSE161801_PI_post	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15546
3.7029055716092e-22	-0.352205283748689	0.107	0.327	6.79483172390288e-18	KLF10	Malignant cells	GSE161801_PI_post	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15547
3.74087301268835e-22	-0.397248632175409	0.37	0.689	6.86450197828313e-18	APRT	Malignant cells	GSE161801_PI_post	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15548
4.54267980741682e-22	-0.427039331060647	0.393	0.693	8.33581744660986e-18	PET100	Malignant cells	GSE161801_PI_post	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15549
4.94024711288401e-22	-0.340620353966898	0.134	0.37	9.06535345214217e-18	HNRNPH2	Malignant cells	GSE161801_PI_post	ENSG00000126945	3188	heterogeneous nuclear ribonucleoprotein H2	FTP3|hnRNPH'|HNRPH'|HNRPH2	protein_coding	P55795	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15550
5.35621845001917e-22	0.456947510526722	1	1	9.82866085578517e-18	RPL3	Malignant cells	GSE161801_PI_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15551
8.69049438246537e-22	0.520212090410683	0.668	0.37	1.5947057191824e-17	HM13	Malignant cells	GSE161801_PI_post	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15552
1.04419606833842e-21	-0.403280472534965	0.22	0.484	1.916099785401e-17	NDUFAF3	Malignant cells	GSE161801_PI_post	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15553
1.61441061053169e-21	-0.37920782129813	0.267	0.547	2.96244347032565e-17	TOMM20	Malignant cells	GSE161801_PI_post	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15554
2.54215666817246e-21	-0.450820552238222	0.984	1	4.66485748609646e-17	RPL14	Malignant cells	GSE161801_PI_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15555
3.17115645164534e-21	-0.408927035676108	0.338	0.622	5.8190720887692e-17	TECR	Malignant cells	GSE161801_PI_post	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15556
3.51335425934407e-21	-0.458095957104411	0.438	0.709	6.44700506589636e-17	SKP1	Malignant cells	GSE161801_PI_post	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15557
3.67521351219915e-21	0.496415888079469	0.343	0.051	6.74401679488543e-17	SCAPER	Malignant cells	GSE161801_PI_post	ENSG00000140386	49855	S-phase cyclin A associated protein in the ER	Zfp291|ZNF291	protein_coding	Q9BY12	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15558
3.98307789141522e-21	-0.326044203359594	0.164	0.417	7.30894793074693e-17	NAA38	Malignant cells	GSE161801_PI_post	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15559
4.79928820957903e-21	0.50467780792478	0.715	0.457	8.80669386457751e-17	DNAJC1	Malignant cells	GSE161801_PI_post	ENSG00000136770	64215	DnaJ heat shock protein family (Hsp40) member C1	DNAJL1|ERdj1|MTJ1	protein_coding	Q96KC8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15560
5.10866969670354e-21	1.07608372947513	0.278	0.004	9.374408893451e-17	JSRP1	Malignant cells	GSE161801_PI_post	ENSG00000167476	126306	junctional sarcoplasmic reticulum protein 1	FLJ32416|JP-45	protein_coding	Q96MG2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15561
6.17322955891205e-21	-0.302011831759596	0.15	0.394	1.13278762406036e-16	RNF13	Malignant cells	GSE161801_PI_post	ENSG00000082996	11342	ring finger protein 13	RZF	protein_coding	O43567	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15562
7.36287987795005e-21	0.593899008402656	0.716	0.504	1.35108845760383e-16	SNHG8	Malignant cells	GSE161801_PI_post	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15563
7.61045975200952e-21	-0.423736188917413	0.381	0.661	1.39651936449375e-16	ATOX1	Malignant cells	GSE161801_PI_post	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15564
8.79876573902146e-21	0.866180202458261	0.408	0.11	1.61457351311044e-16	CITED2	Malignant cells	GSE161801_PI_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15565
1.15263594714664e-20	0.469549319691216	0.469	0.165	2.11508696301409e-16	OS9	Malignant cells	GSE161801_PI_post	ENSG00000135506	10956	OS9 endoplasmic reticulum lectin	ERLEC2|OS-9	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15566
1.21980204979915e-20	-0.390994099207136	0.346	0.642	2.23833676138144e-16	NDUFS6	Malignant cells	GSE161801_PI_post	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15567
1.37448334003932e-20	0.501627788479805	0.554	0.252	2.52217692897215e-16	GYPC	Malignant cells	GSE161801_PI_post	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15568
1.39750898868011e-20	-0.388236188067074	0.516	0.791	2.564428994228e-16	C19orf53	Malignant cells	GSE161801_PI_post	ENSG00000104979	28974	chromosome 19 open reading frame 53	HSPC023|LYDG10	protein_coding	Q9UNZ5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15569
1.55249403531479e-20	0.502821397492489	0.794	0.646	2.84882655480264e-16	P4HB	Malignant cells	GSE161801_PI_post	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15570
1.66985883791059e-20	1.15478729109061	0.81	0.661	3.06419096756594e-16	HSPA5	Malignant cells	GSE161801_PI_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15571
1.77606203257201e-20	-0.285652922791278	0.077	0.264	3.25907382976964e-16	MORC1	Malignant cells	GSE161801_PI_post	ENSG00000114487	27136	MORC family CW-type zinc finger 1	CT33|MORC|ZCW6	protein_coding	Q86VD1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15572
2.2543624398649e-20	0.420263687621969	0.351	0.063	4.1367550771521e-16	UBL7	Malignant cells	GSE161801_PI_post	ENSG00000288408	84993	ubiquitin like 7	BMSC-UbP|MGC14421	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15573
2.60370891447799e-20	0.472027477863673	0.263	0	4.77780585806711e-16	HIST1H2AE	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15574
2.66243094859532e-20	-0.361269919959196	0.302	0.591	4.88556079067242e-16	LSM7	Malignant cells	GSE161801_PI_post	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15575
2.97511727992635e-20	-0.281261390022608	0.081	0.272	5.45934020866486e-16	BEX5	Malignant cells	GSE161801_PI_post	ENSG00000184515	340542	brain expressed X-linked 5	NGFRAP1L1	protein_coding	Q5H9J7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15576
3.1911095154357e-20	-0.357117833640151	0.22	0.48	5.85568596082451e-16	AC104699.1	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15577
3.6141845089191e-20	0.722047150187071	0.546	0.268	6.63202857386654e-16	CYTOR	Malignant cells	GSE161801_PI_post	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15578
5.00973788220195e-20	-0.300852947416705	0.154	0.394	9.19286901384057e-16	LAGE3	Malignant cells	GSE161801_PI_post	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15579
5.72378193868584e-20	-0.410546121246378	0.317	0.587	1.05031398574885e-15	LY96	Malignant cells	GSE161801_PI_post	ENSG00000154589	23643	lymphocyte antigen 96	MD-2	protein_coding	Q9Y6Y9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15580
6.87610406167516e-20	0.680889172548164	0.546	0.264	1.26176509531739e-15	NUCB2	Malignant cells	GSE161801_PI_post	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15581
7.41528873706806e-20	-0.40901636940417	0.324	0.602	1.36070548325199e-15	SOD1	Malignant cells	GSE161801_PI_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15582
1.06387480343961e-19	-0.350403689947744	0.999	1	1.95221026431168e-15	RPL37A	Malignant cells	GSE161801_PI_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15583
1.18626608048134e-19	-0.266995375191276	0.089	0.283	2.17679825768327e-15	CYSTM1	Malignant cells	GSE161801_PI_post	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15584
1.21102973221761e-19	0.424378025482817	0.335	0.055	2.22223955861931e-15	OAS1	Malignant cells	GSE161801_PI_post	ENSG00000089127	4938	2'-5'-oligoadenylate synthetase 1	IFI-4|OIAS|OIASI	protein_coding	P00973	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15585
1.7986221551201e-19	-0.375810928862341	0.192	0.433	3.30047165464539e-15	HGF	Malignant cells	GSE161801_PI_post	ENSG00000019991	3082	hepatocyte growth factor	DFNB39|F-TCF|HGFB|HPTA|SF	protein_coding	P14210	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15586
2.26746657605767e-19	-0.393244455768659	0.35	0.622	4.16080116706582e-15	NDUFS5	Malignant cells	GSE161801_PI_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15587
2.61958251390034e-19	0.546419385587038	0.771	0.614	4.80693391300712e-15	RPN2	Malignant cells	GSE161801_PI_post	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15588
3.37031709462364e-19	0.43669496081413	0.463	0.165	6.18453186863438e-15	TMEM123	Malignant cells	GSE161801_PI_post	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15589
3.643886855569e-19	-0.329262823239909	0.937	0.992	6.68653237996911e-15	RPS10	Malignant cells	GSE161801_PI_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15590
4.29010591839363e-19	-0.322483868560853	0.172	0.413	7.8723443602523e-15	VAMP2	Malignant cells	GSE161801_PI_post	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15591
5.00181823395389e-19	0.47108948313164	0.375	0.094	9.17833645930539e-15	IFITM2	Malignant cells	GSE161801_PI_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15592
5.00607514731542e-19	-0.397292736158572	0.222	0.472	9.1861478953238e-15	RPA3	Malignant cells	GSE161801_PI_post	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15593
5.17546073190378e-19	0.811967000508281	0.255	0.004	9.49697044304344e-15	ASS1	Malignant cells	GSE161801_PI_post	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15594
6.37190684098541e-19	0.480275741671325	0.288	0.028	1.16924490532082e-14	ANKRD37	Malignant cells	GSE161801_PI_post	ENSG00000186352	353322	ankyrin repeat domain 37	Lrp2bp	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15595
6.63241596634059e-19	-0.417494884203307	0.484	0.74	1.2170483298235e-14	MTRNR2L8	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15596
7.91119327802015e-19	0.641881923245774	0.259	0.008	1.4517039665167e-14	OTUD1	Malignant cells	GSE161801_PI_post	ENSG00000165312	220213	OTU deubiquitinase 1	DUBA7|OTDC1	protein_coding	Q5VV17	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15597
9.18990669022506e-19	-0.400465456927911	0.368	0.634	1.6863478776563e-14	SNRPE	Malignant cells	GSE161801_PI_post	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15598
1.07969496446215e-18	-0.283121043035166	0.114	0.319	1.98124025978804e-14	TRAPPC2L	Malignant cells	GSE161801_PI_post	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15599
3.54353016441339e-18	0.544939025186403	0.257	0.012	6.50237785169857e-14	EIF4EBP1	Malignant cells	GSE161801_PI_post	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15600
4.60321003357631e-18	0.460319840090717	0.267	0.02	8.44689041161252e-14	AL031777.3	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15601
5.15617068586672e-18	0.41273572306538	0.458	0.177	9.46157320856544e-14	SFT2D1	Malignant cells	GSE161801_PI_post	ENSG00000198818	113402	SFT2 domain containing 1	C6orf83|MGC19825|pRGR1	protein_coding	Q8WV19	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15602
5.3678565758625e-18	-0.41533514047768	0.327	0.602	9.8500168167077e-14	MYL12A	Malignant cells	GSE161801_PI_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15603
6.83978838147851e-18	0.44356451088465	0.814	0.657	1.25510116800131e-13	UQCRH	Malignant cells	GSE161801_PI_post	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15604
8.74234883533472e-18	0.89232080637158	0.283	0.035	1.60422101128392e-13	CST3	Malignant cells	GSE161801_PI_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15605
1.06776326867265e-17	0.844850108688657	0.438	0.165	1.95934559801431e-13	KLF6	Malignant cells	GSE161801_PI_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15606
1.10320037153894e-17	0.330404925954844	0.257	0.016	2.02437268177395e-13	APP	Malignant cells	GSE161801_PI_post	ENSG00000142192	351	amyloid beta precursor protein	AD1|alpha-sAPP	protein_coding	P05067	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15607
1.25527954894748e-17	0.414102137878908	1	1	2.30343797231863e-13	RPLP1	Malignant cells	GSE161801_PI_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15608
1.50086330401077e-17	-0.263365903860112	0.107	0.299	2.75408416285976e-13	TMEM14A	Malignant cells	GSE161801_PI_post	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15609
1.8035201010103e-17	-0.336472473410897	0.311	0.575	3.3094593853539e-13	MRPL41	Malignant cells	GSE161801_PI_post	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15610
2.1844610242161e-17	-0.376478423334299	0.951	0.984	4.00848597943654e-13	RPSA	Malignant cells	GSE161801_PI_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15611
2.66720423171693e-17	0.458513771767192	0.426	0.157	4.89431976520057e-13	HDLBP	Malignant cells	GSE161801_PI_post	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15612
2.94879537499442e-17	0.657196387701118	0.257	0.02	5.41103951311477e-13	HSPA1B	Malignant cells	GSE161801_PI_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15613
3.17894545422389e-17	0.434997506286813	0.408	0.142	5.83336490850085e-13	CCDC32	Malignant cells	GSE161801_PI_post	ENSG00000128891	90416	coiled-coil domain containing 32	C15orf57|MGC20481	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15614
4.01117845299216e-17	0.46291661283321	0.565	0.287	7.36051246124062e-13	RNASET2	Malignant cells	GSE161801_PI_post	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15615
4.01313223989008e-17	-0.380731573382324	0.142	0.343	7.3640976601983e-13	PTP4A1	Malignant cells	GSE161801_PI_post	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15616
4.35338878347113e-17	-0.356262613761949	0.947	0.988	7.98846841766953e-13	PTMA	Malignant cells	GSE161801_PI_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15617
4.66529114918881e-17	-0.331794379294794	0.317	0.587	8.56080925876146e-13	NDUFB2	Malignant cells	GSE161801_PI_post	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15618
6.35866726538669e-17	0.382247959326062	0.31	0.059	1.16681544319846e-12	ADAM10	Malignant cells	GSE161801_PI_post	ENSG00000137845	102	ADAM metallopeptidase domain 10	CD156C|HsT18717|kuz|MADM	protein_coding	O14672	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15619
7.41260799424795e-17	0.353179993038095	0.266	0.028	1.3602135669445e-12	SCYL2	Malignant cells	GSE161801_PI_post	ENSG00000136021	55681	SCY1 like pseudokinase 2	CVAK104|KIAA1360	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15620
9.0786224157652e-17	-0.334003418182389	0.416	0.705	1.66592721329291e-12	NDUFB7	Malignant cells	GSE161801_PI_post	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15621
9.13390794255252e-17	-0.28673344351746	0.212	0.453	1.67607210745839e-12	MRPS36	Malignant cells	GSE161801_PI_post	ENSG00000278461	92259	mitochondrial ribosomal protein S36	DC47|MRP-S36	protein_coding	P82909	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15622
9.91973301950318e-17	0.380570512617024	0.271	0.031	1.82027100907883e-12	RNF187	Malignant cells	GSE161801_PI_post	ENSG00000285426	149603	ring finger protein 187	RACO-1|RACO1	protein_coding	Q5TA31	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15623
1.05050669843981e-16	0.839452080482954	0.532	0.311	1.92767979163706e-12	BTG2	Malignant cells	GSE161801_PI_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15624
1.15432636009085e-16	-0.315769003959849	0.98	0.984	2.1181888707667e-12	SPCS2	Malignant cells	GSE161801_PI_post	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15625
1.17809530222891e-16	0.324542280802591	0.996	1	2.16180487959005e-12	RPS13	Malignant cells	GSE161801_PI_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15626
1.32682557433884e-16	-0.323445631185341	0.101	0.283	2.43472492891177e-12	S100A11	Malignant cells	GSE161801_PI_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15627
1.35490380870398e-16	0.444014044338437	0.488	0.228	2.4862484889718e-12	DNAJC4	Malignant cells	GSE161801_PI_post	ENSG00000110011	3338	DnaJ heat shock protein family (Hsp40) member C4	HSPF2|MCG18	protein_coding	Q9NNZ3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15628
1.68410252321872e-16	-0.361480316615133	0.489	0.748	3.09032813010635e-12	CYCS	Malignant cells	GSE161801_PI_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15629
1.87194603816553e-16	0.331086641051931	0.287	0.043	3.43502098003374e-12	C2orf88	Malignant cells	GSE161801_PI_post	ENSG00000187699	84281	chromosome 2 open reading frame 88	MGC13057|smAKAP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15630
2.1226404737109e-16	-0.335618882906475	0.283	0.531	3.8950452692595e-12	RAD23A	Malignant cells	GSE161801_PI_post	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15631
2.28153398619879e-16	-0.339031908368762	0.347	0.598	4.18661486467478e-12	PPP1R2	Malignant cells	GSE161801_PI_post	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15632
2.3838034665199e-16	-0.396032677508362	0.445	0.681	4.37427936106401e-12	MRPS21	Malignant cells	GSE161801_PI_post	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15633
2.43492661086362e-16	0.419336876144477	0.319	0.071	4.46809033093475e-12	SHMT2	Malignant cells	GSE161801_PI_post	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15634
2.61358500241195e-16	-0.321097737916711	0.219	0.449	4.79592847942593e-12	HEXB	Malignant cells	GSE161801_PI_post	ENSG00000049860	3074	hexosaminidase subunit beta	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15635
2.77457544722365e-16	0.412650503512094	0.64	0.409	5.09134594565539e-12	ATP5F1A	Malignant cells	GSE161801_PI_post	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15636
3.4400696643089e-16	-0.337308312703166	0.362	0.61	6.31252783400684e-12	SSBP1	Malignant cells	GSE161801_PI_post	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15637
3.4982052756488e-16	-0.315060112211885	0.219	0.449	6.41920668081555e-12	GABARAPL2	Malignant cells	GSE161801_PI_post	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15638
3.52112200270924e-16	-0.334054500196577	0.989	1	6.46125887497145e-12	RPL7	Malignant cells	GSE161801_PI_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15639
4.07621189584496e-16	0.454254920070003	0.514	0.264	7.4798488288755e-12	SRM	Malignant cells	GSE161801_PI_post	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15640
4.30536397137532e-16	0.398121484120413	0.336	0.087	7.90034288747372e-12	PPCDC	Malignant cells	GSE161801_PI_post	ENSG00000138621	60490	phosphopantothenoylcysteine decarboxylase	FLJ14585|MDS018	protein_coding	Q96CD2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15641
5.20606578825807e-16	-0.288881692675978	0.096	0.268	9.55313072145356e-12	TMEM11	Malignant cells	GSE161801_PI_post	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15642
5.79977939138294e-16	-0.276300575656771	0.198	0.449	1.06425951831877e-11	TMEM132D-AS1	Malignant cells	GSE161801_PI_post	ENSG00000249196	283352	TMEM132D antisense RNA 1	LOC283352|RP11-669N7.2	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15643
6.11714661052165e-16	0.429940599505759	0.437	0.185	1.12249640303072e-11	HSPD1	Malignant cells	GSE161801_PI_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15644
6.71777982822605e-16	0.36351669580298	0.973	0.933	1.23271259847948e-11	RPL27	Malignant cells	GSE161801_PI_post	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15645
6.79140158804486e-16	-0.365845579084399	0.659	0.854	1.24622219140623e-11	ATP6V0E1	Malignant cells	GSE161801_PI_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15646
7.46000198365696e-16	-0.301672414032847	0.181	0.398	1.36891036400105e-11	LSM6	Malignant cells	GSE161801_PI_post	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15647
7.68512343095231e-16	0.346991811021491	0.255	0.028	1.41022014957975e-11	CD200	Malignant cells	GSE161801_PI_post	ENSG00000091972	4345	CD200 molecule	MOX1|MOX2|MRC|OX-2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15648
7.83029696712773e-16	-0.308334666152279	0.17	0.386	1.43685949346794e-11	SEPT7	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15649
1.10549934968702e-15	0.581493987511875	0.336	0.098	2.02859130667568e-11	PHGDH	Malignant cells	GSE161801_PI_post	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15650
1.11202769262616e-15	0.508450673709325	0.269	0.039	2.040570815969e-11	CDKN1A	Malignant cells	GSE161801_PI_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15651
1.15370072164158e-15	-0.483264754479808	0.384	0.579	2.11704082421229e-11	KLF13	Malignant cells	GSE161801_PI_post	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15652
1.16542916297415e-15	0.619022469653716	0.969	0.949	2.13856251405756e-11	MT-CO3	Malignant cells	GSE161801_PI_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15653
1.37784202325131e-15	-0.313913920815887	0.283	0.528	2.52834011266615e-11	LAMTOR4	Malignant cells	GSE161801_PI_post	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15654
1.44823207835626e-15	-0.310260999576771	0.29	0.539	2.65750586378373e-11	POLR2J	Malignant cells	GSE161801_PI_post	ENSG00000005075	5439	RNA polymerase II subunit J	hRPB14|POLR2J1|RPB11|RPB11A|RPB11m	protein_coding	P52435	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15655
1.50438216362284e-15	0.531873975292275	0.33	0.091	2.76054127024792e-11	PMAIP1	Malignant cells	GSE161801_PI_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15656
1.57009765240118e-15	-0.354851708074838	0.628	0.811	2.88112919215617e-11	EIF3K	Malignant cells	GSE161801_PI_post	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15657
1.60108486862684e-15	-0.312046257283116	0.231	0.461	2.93799073393025e-11	RALY	Malignant cells	GSE161801_PI_post	ENSG00000125970	22913	RALY heterogeneous nuclear ribonucleoprotein	HNRPCL2|P542	protein_coding	Q9UKM9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15658
1.69068359017487e-15	0.960467798047024	0.609	0.417	3.10240438797089e-11	HSP90AA1	Malignant cells	GSE161801_PI_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15659
1.98929089227639e-15	0.3567488210821	0.359	0.11	3.65034878732718e-11	MZT2A	Malignant cells	GSE161801_PI_post	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15660
2.0271188951704e-15	0.348819284564942	0.284	0.051	3.71976317263768e-11	LMF1	Malignant cells	GSE161801_PI_post	ENSG00000103227	64788	lipase maturation factor 1	C16orf26|FLJ12681|FLJ22302|JFP11|TMEM112|TMEM112A	protein_coding	Q96S06	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15661
2.02861995396084e-15	0.48724974407017	0.764	0.642	3.72251761551815e-11	UQCRB	Malignant cells	GSE161801_PI_post	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15662
2.11966224553631e-15	-0.349112844272551	0.419	0.654	3.88958022055912e-11	GADD45GIP1	Malignant cells	GSE161801_PI_post	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15663
2.12669681372941e-15	0.362471474729943	0.994	0.965	3.90248865319347e-11	RPS5	Malignant cells	GSE161801_PI_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15664
2.16079504816734e-15	0.392178326568161	0.471	0.217	3.96505891338706e-11	NIPA2	Malignant cells	GSE161801_PI_post	ENSG00000140157	81614	NIPA magnesium transporter 2	SLC57A2	protein_coding	Q8N8Q9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15665
2.26564454610202e-15	0.370279897533473	0.317	0.079	4.15745774209721e-11	ABCB9	Malignant cells	GSE161801_PI_post	ENSG00000150967	23457	ATP binding cassette subfamily B member 9	EST122234	protein_coding	Q9NP78	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15666
2.29844945217466e-15	-0.255769372922468	0.147	0.346	4.2176547447405e-11	NME2	Malignant cells	GSE161801_PI_post	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15667
2.61924349193398e-15	0.335167393456783	0.276	0.047	4.80631180769884e-11	CERCAM	Malignant cells	GSE161801_PI_post	ENSG00000167123	51148	cerebral endothelial cell adhesion molecule	CEECAM1|GLT25D3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15668
2.64639090916842e-15	0.413775850714933	0.611	0.366	4.85612731832405e-11	CCPG1	Malignant cells	GSE161801_PI_post	ENSG00000260916	9236	cell cycle progression 1	CPR8|KIAA1254	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15669
3.15053999131187e-15	0.48507090865331	0.269	0.043	5.78124088405729e-11	NR4A1	Malignant cells	GSE161801_PI_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15670
3.17377559168965e-15	0.318431373463299	0.27	0.043	5.8238782107505e-11	SLC38A5	Malignant cells	GSE161801_PI_post	ENSG00000017483	92745	solute carrier family 38 member 5	JM24|SN2	protein_coding	Q8WUX1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15671
4.27860992946293e-15	-0.314482120961635	0.22	0.437	7.85124922056448e-11	NAA10	Malignant cells	GSE161801_PI_post	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15672
4.36630382050708e-15	-0.394014733444997	0.484	0.693	8.01216751063048e-11	BCAP31	Malignant cells	GSE161801_PI_post	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15673
4.58316716976574e-15	-0.306138842690053	0.282	0.52	8.41011175652014e-11	VOPP1	Malignant cells	GSE161801_PI_post	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15674
4.73290219479069e-15	-0.262077571966052	0.103	0.276	8.68487552744092e-11	ANP32E	Malignant cells	GSE161801_PI_post	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15675
5.19760008500438e-15	-0.362787129364941	0.971	0.992	9.53759615598303e-11	RPS24	Malignant cells	GSE161801_PI_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15676
5.21516057419181e-15	-0.39218636233269	0.272	0.484	9.56981965364197e-11	FCRL5	Malignant cells	GSE161801_PI_post	ENSG00000143297	83416	Fc receptor like 5	BXMAS1|CD307e|FCRH5|IRTA2	protein_coding	Q96RD9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15677
6.20140994640707e-15	0.395349807465001	0.317	0.083	1.1379587251657e-10	ARID5B	Malignant cells	GSE161801_PI_post	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15678
6.87817650254799e-15	0.492962878874045	0.553	0.343	1.26214538821756e-10	SNRPN	Malignant cells	GSE161801_PI_post	ENSG00000128739	6638	small nuclear ribonucleoprotein polypeptide N	HCERN3|PWCR|RT-LI|SM-D|SMN|SNRNP-N|SNURF-SNRPN	protein_coding	P63162	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15679
8.64891232148738e-15	-0.296382450207055	0.269	0.508	1.58707541099293e-10	SRP19	Malignant cells	GSE161801_PI_post	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15680
8.73064041150266e-15	0.969625643797574	0.39	0.161	1.60207251551074e-10	RGS2	Malignant cells	GSE161801_PI_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15681
1.02969421537667e-14	-0.297733156940818	0.178	0.394	1.88948888521619e-10	HMGB2	Malignant cells	GSE161801_PI_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15682
1.62715657934401e-14	-0.391491018608439	0.393	0.626	2.98583232309626e-10	HMGN1	Malignant cells	GSE161801_PI_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15683
1.6933557255909e-14	-0.352396841889204	0.993	1	3.10730775645929e-10	RPL36	Malignant cells	GSE161801_PI_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15684
1.77327530114015e-14	-0.275743707617873	0.879	0.976	3.25396017759218e-10	PFDN5	Malignant cells	GSE161801_PI_post	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15685
2.09141755981352e-14	0.348924706364965	0.364	0.126	3.8377512222578e-10	SRP72	Malignant cells	GSE161801_PI_post	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15686
2.40825388785703e-14	0.395570291956677	0.485	0.244	4.41914588421765e-10	SRSF9	Malignant cells	GSE161801_PI_post	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15687
2.72684614435605e-14	-0.35133291349661	0.389	0.606	5.00376267489335e-10	HAX1	Malignant cells	GSE161801_PI_post	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15688
3.16637006605493e-14	0.382687732674664	0.44	0.197	5.8102890712108e-10	SERBP1	Malignant cells	GSE161801_PI_post	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15689
3.21044887791188e-14	0.640436660686922	0.883	0.89	5.89117369096831e-10	FKBP2	Malignant cells	GSE161801_PI_post	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15690
3.39777013636065e-14	-0.261506511406802	0.125	0.303	6.23490820022179e-10	MRPL36	Malignant cells	GSE161801_PI_post	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15691
3.63544239442167e-14	-0.276753320880508	0.226	0.453	6.67103679376377e-10	FAM174A	Malignant cells	GSE161801_PI_post	ENSG00000174132	345757	family with sequence similarity 174 member A	NS5ATP6|TMEM157|UNQ1912	protein_coding	Q8TBP5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15692
4.13416446493887e-14	0.400496266722726	0.819	0.701	7.58619179316283e-10	SELENOS	Malignant cells	GSE161801_PI_post	ENSG00000131871	55829	selenoprotein S	AD-015|MGC2553|SBBI8|SELS|SEPS1|VIMP	protein_coding	Q9BQE4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15693
4.39907180672378e-14	-0.321417972718407	0.734	0.894	8.07229676533814e-10	SRGN	Malignant cells	GSE161801_PI_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15694
4.84574929768043e-14	0.501626228793472	0.405	0.169	8.89194996124359e-10	ZBTB20	Malignant cells	GSE161801_PI_post	ENSG00000181722	26137	zinc finger and BTB domain containing 20	DKFZp566F123|DPZF|ODA-8S|ZNF288	protein_coding	Q9HC78	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15695
5.00368210559132e-14	-0.295660999607207	0.219	0.433	9.18175666376008e-10	CAPZA2	Malignant cells	GSE161801_PI_post	ENSG00000198898	830	capping actin protein of muscle Z-line subunit alpha 2	CAPPA2|CAPZ	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15696
6.42087053351546e-14	-0.310227818496323	0.747	0.89	1.17822974290009e-09	ATP5MPL	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15697
7.97286163842432e-14	-0.35000856890417	0.77	0.909	1.46302011065086e-09	SSR2	Malignant cells	GSE161801_PI_post	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15698
8.82167920076096e-14	-0.299847949621642	0.739	0.913	1.61877813333964e-09	ATP5MC2	Malignant cells	GSE161801_PI_post	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15699
9.07764615115652e-14	0.359854674612292	0.405	0.165	1.66574806873722e-09	SLC25A3	Malignant cells	GSE161801_PI_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15700
1.19033164154974e-13	0.441496608273382	0.574	0.354	2.18425856224377e-09	SEL1L3	Malignant cells	GSE161801_PI_post	ENSG00000091490	23231	SEL1L family member 3	KIAA0746	protein_coding	Q68CR1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15701
1.21023209755565e-13	0.436038829323835	0.783	0.614	2.22077589901461e-09	ISG20	Malignant cells	GSE161801_PI_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15702
1.25875341384532e-13	-0.364845582024977	0.418	0.634	2.30981251440617e-09	C4orf48	Malignant cells	GSE161801_PI_post	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15703
1.53132488129216e-13	0.356977442887993	0.485	0.248	2.80998115717112e-09	MRPS31	Malignant cells	GSE161801_PI_post	ENSG00000102738	10240	mitochondrial ribosomal protein S31	IMOGN38	protein_coding	Q92665	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15704
1.67349668047196e-13	0.4384012151746	0.644	0.453	3.07086640866604e-09	BST2	Malignant cells	GSE161801_PI_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15705
1.71195599995657e-13	-0.380719026886267	0.99	0.996	3.14143925992031e-09	CYBA	Malignant cells	GSE161801_PI_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15706
2.0628193253393e-13	0.387132094164373	0.719	0.52	3.78527346199762e-09	FXYD5	Malignant cells	GSE161801_PI_post	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15707
2.08909791957941e-13	-0.300051937938802	0.999	1	3.83349468242822e-09	RPL18A	Malignant cells	GSE161801_PI_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15708
2.22243682051065e-13	0.338492391521474	0.364	0.134	4.07817156563704e-09	C8orf59	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15709
2.37018840055923e-13	0.312257203785284	0.321	0.098	4.34929571502618e-09	RCN1	Malignant cells	GSE161801_PI_post	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15710
2.50611743657679e-13	-0.281338363546269	0.316	0.551	4.5987254961184e-09	TMEM208	Malignant cells	GSE161801_PI_post	ENSG00000168701	29100	transmembrane protein 208	hSND2|HSPC171	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15711
2.5665454676088e-13	-0.294678386816484	0.424	0.677	4.70961093306215e-09	ATP5IF1	Malignant cells	GSE161801_PI_post	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15712
2.92694228607124e-13	0.613303338556312	0.321	0.094	5.37093909494073e-09	RGS1	Malignant cells	GSE161801_PI_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15713
3.0110811861339e-13	0.326116361040706	0.386	0.154	5.5253339765557e-09	CKAP4	Malignant cells	GSE161801_PI_post	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15714
3.10297693481802e-13	0.554121458866968	0.263	0.059	5.69396267539107e-09	DNAJB1	Malignant cells	GSE161801_PI_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15715
3.10498468016927e-13	-0.251253499933709	0.156	0.343	5.69764688811062e-09	MPC2	Malignant cells	GSE161801_PI_post	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15716
3.53223998743703e-13	-0.44850571645652	0.776	0.862	6.48166037694694e-09	ITM2C	Malignant cells	GSE161801_PI_post	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15717
3.78308175854563e-13	-0.291263101997974	0.121	0.287	6.94195502693124e-09	SRSF1	Malignant cells	GSE161801_PI_post	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15718
4.19283336104603e-13	-0.302011831759596	0.37	0.594	7.69384921751946e-09	SEM1	Malignant cells	GSE161801_PI_post	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15719
4.70295863187657e-13	0.343980102359121	0.269	0.063	8.62992908949351e-09	YPEL3	Malignant cells	GSE161801_PI_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15720
6.21373393652751e-13	0.372988047104881	0.546	0.331	1.1402201773528e-08	MZT2B	Malignant cells	GSE161801_PI_post	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15721
6.72622230701933e-13	0.40237366278016	0.915	0.906	1.23426179333805e-08	MTDH	Malignant cells	GSE161801_PI_post	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15722
7.03786122651994e-13	-0.31083422377037	0.125	0.287	1.29144753506641e-08	HSH2D	Malignant cells	GSE161801_PI_post	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15723
7.80027772551163e-13	0.321497973899048	0.361	0.138	1.43135096263138e-08	SDF4	Malignant cells	GSE161801_PI_post	ENSG00000078808	51150	stromal cell derived factor 4	Cab45	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15724
7.90581697482583e-13	-0.391494141328358	0.421	0.622	1.45071741488054e-08	SRSF5	Malignant cells	GSE161801_PI_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15725
8.1458236789615e-13	-0.265890335686714	0.187	0.378	1.49475864508944e-08	DNAJC19	Malignant cells	GSE161801_PI_post	ENSG00000205981	131118	DnaJ heat shock protein family (Hsp40) member C19	Pam18|Tim14|TIMM14	protein_coding	Q96DA6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15726
8.18889612873558e-13	0.307658385327211	0.283	0.075	1.50266243962298e-08	PNOC	Malignant cells	GSE161801_PI_post	ENSG00000168081	5368	prepronociceptin	N/OFQ|NOP|PPNOC	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15727
8.3233368101943e-13	0.29362314835764	0.275	0.067	1.52733230467065e-08	ST6GALNAC4	Malignant cells	GSE161801_PI_post	ENSG00000136840	27090	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	SIAT3C|SIAT7D|ST6GALNACIV	protein_coding	Q9H4F1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15728
1.00612495860848e-12	0.328355182005227	0.255	0.055	1.84623929904656e-08	FOXO3	Malignant cells	GSE161801_PI_post	ENSG00000118689	2309	forkhead box O3	AF6q21|FKHRL1|FOXO2|FOXO3A	protein_coding	O43524	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15729
1.12595247870192e-12	0.317484238514698	0.292	0.083	2.06612279841802e-08	AIM2	Malignant cells	GSE161801_PI_post	ENSG00000163568	9447	absent in melanoma 2	PYHIN4	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15730
1.15339122145312e-12	0.363248436063899	0.44	0.213	2.11647289136648e-08	SARAF	Malignant cells	GSE161801_PI_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15731
1.29277763995574e-12	-0.33662363539785	0.161	0.339	2.37224696931879e-08	STK17B	Malignant cells	GSE161801_PI_post	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15732
1.35619975076027e-12	0.734351125700462	0.518	0.327	2.4886265426451e-08	HSPE1	Malignant cells	GSE161801_PI_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15733
1.57896921822004e-12	-0.320337933435124	0.541	0.768	2.89740851543377e-08	COX8A	Malignant cells	GSE161801_PI_post	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15734
1.98842127307659e-12	0.342113743701821	0.406	0.169	3.64875303609554e-08	ENO1	Malignant cells	GSE161801_PI_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15735
2.09495412792439e-12	-0.326769273637155	0.719	0.878	3.84424082474125e-08	RABAC1	Malignant cells	GSE161801_PI_post	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15736
2.18918248759796e-12	0.702798585617644	0.3	0.098	4.01714986474225e-08	MYC	Malignant cells	GSE161801_PI_post	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15737
2.28056898461717e-12	-0.34740767812033	0.995	0.996	4.18484408677251e-08	RPS16	Malignant cells	GSE161801_PI_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15738
3.65360980352453e-12	0.305357499583854	0.347	0.13	6.70437398946751e-08	PLA2G16	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15739
4.22179263313026e-12	0.337293349838489	0.451	0.232	7.74698948179404e-08	SRPRA	Malignant cells	GSE161801_PI_post	ENSG00000182934	6734	SRP receptor subunit alpha	SR-alpha|Sralpha|SRP-alpha|SRPR	protein_coding	P08240	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15740
5.07288563656797e-12	0.447763266964875	0.567	0.386	9.30874514310222e-08	CCDC85B	Malignant cells	GSE161801_PI_post	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15741
5.54831689015621e-12	-0.409123494455044	0.57	0.732	1.01811614934366e-07	CLIC1	Malignant cells	GSE161801_PI_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15742
5.57078408008869e-12	0.357972405024594	0.547	0.343	1.02223887869627e-07	EMC4	Malignant cells	GSE161801_PI_post	ENSG00000128463	51234	ER membrane protein complex subunit 4	FLJ90746|MGC24415|PIG17|TMEM85	protein_coding	Q5J8M3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15743
5.66905001960612e-12	-0.303959141455136	0.346	0.551	1.04027067859772e-07	NHP2	Malignant cells	GSE161801_PI_post	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15744
6.39191261809265e-12	0.819396450637764	0.893	0.846	1.17291596542e-07	HSP90B1	Malignant cells	GSE161801_PI_post	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15745
6.78592381506993e-12	0.296075083053498	0.296	0.091	1.24521702006533e-07	SP100	Malignant cells	GSE161801_PI_post	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15746
6.80417028578519e-12	0.337826997481634	0.326	0.118	1.24856524744158e-07	UBE2G1	Malignant cells	GSE161801_PI_post	ENSG00000132388	7326	ubiquitin conjugating enzyme E2 G1	UBC7|UBE2G	protein_coding	P62253	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15747
8.08742217470001e-12	0.365091459988456	0.349	0.142	1.48404196905745e-07	ERN1	Malignant cells	GSE161801_PI_post	ENSG00000178607	2081	endoplasmic reticulum to nucleus signaling 1	IRE1|IRE1P	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15748
8.26159666552969e-12	0.349645513295217	0.284	0.087	1.5160029881247e-07	EPHX2	Malignant cells	GSE161801_PI_post	ENSG00000120915	2053	epoxide hydrolase 2	ABHD20|sEH	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15749
8.52565736996491e-12	-0.286086804998392	0.157	0.331	1.56445812738856e-07	H2AFV	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15750
1.01709763940177e-11	-0.288305292273882	0.244	0.441	1.86637416830225e-07	SRSF6	Malignant cells	GSE161801_PI_post	ENSG00000124193	6431	serine and arginine rich splicing factor 6	B52|SFRS6|SRP55	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15751
1.05919698092267e-11	0.295802928907342	0.28	0.083	1.9436264599931e-07	CD40	Malignant cells	GSE161801_PI_post	ENSG00000101017	958	CD40 molecule	Bp50|p50|TNFRSF5	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15752
1.13796226339144e-11	0.372005830421617	0.607	0.429	2.08816075332329e-07	EMC7	Malignant cells	GSE161801_PI_post	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15753
1.23491205235971e-11	0.341313136000427	0.322	0.11	2.26606361608006e-07	BASP1	Malignant cells	GSE161801_PI_post	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15754
1.2827235200889e-11	0.347081006381276	0.321	0.118	2.35379765936314e-07	ACADVL	Malignant cells	GSE161801_PI_post	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15755
1.92149985876267e-11	-0.287315121728981	0.686	0.866	3.5259522408295e-07	COPE	Malignant cells	GSE161801_PI_post	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15756
1.9468344556714e-11	-0.284201386452807	0.407	0.626	3.57244122615703e-07	HMGN3	Malignant cells	GSE161801_PI_post	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15757
2.18505840021612e-11	0.35671063535274	0.747	0.65	4.00958216439658e-07	ATF4	Malignant cells	GSE161801_PI_post	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15758
2.71477275141251e-11	-0.303429488041432	0.929	0.988	4.98160799884195e-07	OAZ1	Malignant cells	GSE161801_PI_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15759
2.94908746604873e-11	0.256925205418268	0.26	0.071	5.41157550019941e-07	LSM1	Malignant cells	GSE161801_PI_post	ENSG00000175324	27257	LSM1 homolog, mRNA degradation associated	CASM|YJL124C	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15760
3.32051786291749e-11	0.340312657733211	0.891	0.843	6.09315027845359e-07	SRP14	Malignant cells	GSE161801_PI_post	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15761
3.63776214132394e-11	0.300984952166547	0.998	0.996	6.67529352932943e-07	RPS9	Malignant cells	GSE161801_PI_post	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15762
4.18770801434525e-11	0.392055915208859	0.378	0.177	7.68444420632354e-07	SLC1A5	Malignant cells	GSE161801_PI_post	ENSG00000105281	6510	solute carrier family 1 member 5	AAAT|ASCT2|M7V1|RDRC	protein_coding	Q15758	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15763
4.40214550304224e-11	0.284235920753369	0.319	0.118	8.0779369980825e-07	SARS	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15764
4.70887328136438e-11	0.363075372489335	0.737	0.618	8.64078247130364e-07	NOP10	Malignant cells	GSE161801_PI_post	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15765
4.85521015528641e-11	-0.353850763279213	0.348	0.539	8.90931063495057e-07	HMGN2	Malignant cells	GSE161801_PI_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15766
5.07510176202425e-11	0.530558833114932	0.53	0.346	9.31281173331451e-07	TRIB1	Malignant cells	GSE161801_PI_post	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15767
5.15596484780526e-11	0.388282093613625	0.269	0.083	9.46119549572265e-07	HIST2H2BE	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15768
5.43268841986113e-11	-0.252435637932811	0.99	1	9.96898325044517e-07	RPS21	Malignant cells	GSE161801_PI_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15769
5.89407645735019e-11	0.266509668738498	0.272	0.083	1.08156302992376e-06	PDXK	Malignant cells	GSE161801_PI_post	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15770
6.53947872392871e-11	-0.372057693479379	0.992	1	1.19999434584092e-06	RPL29	Malignant cells	GSE161801_PI_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15771
6.62470362345555e-11	-0.263353353589342	0.662	0.831	1.21563311490409e-06	SELENOT	Malignant cells	GSE161801_PI_post	ENSG00000198843	51714	selenoprotein T	SELT	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15772
6.99184805475934e-11	0.292998498601708	0.388	0.181	1.28300411804834e-06	WIPI1	Malignant cells	GSE161801_PI_post	ENSG00000070540	55062	WD repeat domain, phosphoinositide interacting 1	ATG18|ATG18A|FLJ10055|WIPI49	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15773
1.01734181379821e-10	-0.306271838803331	0.231	0.409	1.86682222831972e-06	PSMB9	Malignant cells	GSE161801_PI_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15774
1.04545457001734e-10	0.271794447850479	0.289	0.098	1.91840913598182e-06	TMEM165	Malignant cells	GSE161801_PI_post	ENSG00000134851	55858	transmembrane protein 165	GDT1|SLC64A1|TMPT27|TPARL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15775
1.07337108742267e-10	0.272490897316522	0.313	0.118	1.9696359454206e-06	STX5	Malignant cells	GSE161801_PI_post	ENSG00000162236	6811	syntaxin 5	SED5|STX5A	protein_coding	Q13190	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15776
1.18521058941385e-10	0.292947210072395	0.296	0.106	2.17486143157442e-06	SNHG7	Malignant cells	GSE161801_PI_post	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15777
1.19863727991098e-10	-0.326664763955655	0.213	0.382	2.19949940863664e-06	YWHAZ	Malignant cells	GSE161801_PI_post	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15778
1.25012892383357e-10	-0.285679260637634	0.334	0.524	2.2939865752346e-06	ATP5PD	Malignant cells	GSE161801_PI_post	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15779
1.31406352141056e-10	-0.285092918406077	0.387	0.583	2.41130656178838e-06	SLIRP	Malignant cells	GSE161801_PI_post	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15780
1.62670613054449e-10	0.373106220172479	0.287	0.098	2.98500574954915e-06	MX1	Malignant cells	GSE161801_PI_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15781
1.67132202468345e-10	0.266050353209235	0.364	0.15	3.06687591529413e-06	EZR	Malignant cells	GSE161801_PI_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15782
1.74404325623408e-10	0.273232397776049	0.269	0.087	3.20031937518954e-06	CCDC57	Malignant cells	GSE161801_PI_post	ENSG00000176155	284001	coiled-coil domain containing 57	FLJ00130|FLJ23754	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15783
1.99454157682393e-10	0.635766081640119	0.333	0.157	3.65998379347191e-06	PSAT1	Malignant cells	GSE161801_PI_post	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15784
2.04507616226345e-10	-0.302947600259702	0.996	1	3.75271475775343e-06	RPS8	Malignant cells	GSE161801_PI_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15785
2.0868694876892e-10	0.271218866338401	0.269	0.087	3.82940550990968e-06	TNIP1	Malignant cells	GSE161801_PI_post	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15786
2.1953006311881e-10	-0.279682467757331	0.998	1	4.02837665823016e-06	RPS3	Malignant cells	GSE161801_PI_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15787
2.33782847310933e-10	0.284504676174744	0.297	0.11	4.28991524815563e-06	HIST1H2BD	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15788
2.43976428872412e-10	0.274306574552309	0.278	0.094	4.47696746980876e-06	NDUFV3	Malignant cells	GSE161801_PI_post	ENSG00000160194	4731	NADH:ubiquinone oxidoreductase subunit V3	CI-10k	protein_coding	P56181	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15789
2.52583877455968e-10	-0.310993373088842	0.998	1	4.63491415131701e-06	RPL35	Malignant cells	GSE161801_PI_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15790
2.56704305877357e-10	-0.355310432517634	0.552	0.709	4.7105240128495e-06	EVI2B	Malignant cells	GSE161801_PI_post	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15791
2.65061755510876e-10	0.364299208842825	0.391	0.193	4.86388321362457e-06	DNAJA1	Malignant cells	GSE161801_PI_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15792
2.7442294369994e-10	-0.271182439982945	0.52	0.728	5.0356610168939e-06	COX5B	Malignant cells	GSE161801_PI_post	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15793
3.21762681687063e-10	-0.255933822061812	0.221	0.394	5.9043452089576e-06	PFDN2	Malignant cells	GSE161801_PI_post	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15794
3.54366601497094e-10	0.442739637409192	0.255	0.079	6.50262713747168e-06	WARS	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15795
4.01209079775925e-10	0.256293500729753	0.28	0.098	7.36218661388823e-06	MYL6B	Malignant cells	GSE161801_PI_post	ENSG00000196465	140465	myosin light chain 6B	MLC1SA	protein_coding	P14649	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15796
4.24831945572876e-10	0.272076031737562	0.286	0.102	7.79566620126228e-06	LAP3	Malignant cells	GSE161801_PI_post	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15797
4.81486517577752e-10	-0.391071200919042	0.723	0.819	8.83527759755175e-06	RPS27L	Malignant cells	GSE161801_PI_post	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15798
5.94990545754416e-10	0.306015829159424	0.325	0.138	1.09180765145935e-05	WDR74	Malignant cells	GSE161801_PI_post	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15799
5.99618986987756e-10	0.386610098474051	0.763	0.661	1.10030084112253e-05	CALR	Malignant cells	GSE161801_PI_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15800
6.17740786834995e-10	-0.285884958705286	0.512	0.693	1.13355434384222e-05	PRDX1	Malignant cells	GSE161801_PI_post	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15801
8.1321603348827e-10	0.287055901522726	0.307	0.122	1.49225142145098e-05	ARMC2	Malignant cells	GSE161801_PI_post	ENSG00000118690	84071	armadillo repeat containing 2	bA787I22.1|DKFZp434P0714	protein_coding	Q8NEN0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15802
1.06835880335307e-09	0.460198085319943	0.81	0.803	1.96043840415288e-05	TRMT112	Malignant cells	GSE161801_PI_post	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15803
1.12625662953059e-09	-0.257100009098837	0.996	1	2.06668091518862e-05	RPL21	Malignant cells	GSE161801_PI_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15804
1.14819616006293e-09	0.33919392186478	0.31	0.13	2.10693995371547e-05	PDE4B	Malignant cells	GSE161801_PI_post	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15805
1.30678489591823e-09	0.276199626970481	0.341	0.157	2.39795028400995e-05	RAB2A	Malignant cells	GSE161801_PI_post	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15806
1.5097235132246e-09	0.282950668961561	0.358	0.173	2.77034264676715e-05	PLD3	Malignant cells	GSE161801_PI_post	ENSG00000105223	23646	phospholipase D family member 3	HU-K4	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15807
1.8247172423434e-09	0.27419894014189	0.381	0.189	3.34835613970014e-05	FAM96A	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15808
1.92549313016207e-09	-0.254097898152294	0.394	0.591	3.53327989384739e-05	UQCR10	Malignant cells	GSE161801_PI_post	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15809
2.05416970990117e-09	0.287705138862048	0.343	0.161	3.76940141766864e-05	MEI1	Malignant cells	GSE161801_PI_post	ENSG00000167077	150365	meiotic double-stranded break formation protein 1	MGC40042|SPATA38	protein_coding	Q5TIA1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15810
2.11254267409107e-09	0.268087385899749	0.283	0.106	3.87651580695711e-05	SNRPB	Malignant cells	GSE161801_PI_post	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15811
2.37783535189551e-09	-0.298493156979934	0.527	0.673	4.36332787072826e-05	KDELR2	Malignant cells	GSE161801_PI_post	ENSG00000136240	11014	KDEL endoplasmic reticulum protein retention receptor 2	ELP-1|ERD2.2	protein_coding	P33947	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15812
2.52109177587761e-09	-0.282107837205731	0.426	0.642	4.62620340873542e-05	QPCT	Malignant cells	GSE161801_PI_post	ENSG00000115828	25797	glutaminyl-peptide cyclotransferase	GCT|QC	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15813
2.58757524374255e-09	0.28211583954306	0.418	0.228	4.74820057226758e-05	SURF4	Malignant cells	GSE161801_PI_post	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15814
2.77232268729809e-09	0.256815801211427	0.364	0.177	5.08721213119199e-05	SND1	Malignant cells	GSE161801_PI_post	ENSG00000197157	27044	staphylococcal nuclease and tudor domain containing 1	p100|TDRD11	protein_coding	Q7KZF4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15815
3.06493347849638e-09	0.286387022410491	0.341	0.161	5.62415293304085e-05	TIFA	Malignant cells	GSE161801_PI_post	ENSG00000145365	92610	TRAF interacting protein with forkhead associated domain	MGC20791|T2BP|T6BP|TIFAA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15816
4.37111255471989e-09	0.584909403909137	0.505	0.343	8.020991537911e-05	SQSTM1	Malignant cells	GSE161801_PI_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15817
4.72809080669829e-09	-0.25552479551852	0.867	0.965	8.67604663029136e-05	HNRNPA1	Malignant cells	GSE161801_PI_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15818
5.42244454922369e-09	0.284062195775014	0.404	0.217	9.95018574782548e-05	DUSP22	Malignant cells	GSE161801_PI_post	ENSG00000112679	56940	dual specificity phosphatase 22	JKAP|JSP1|MKPX|VHX	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15819
6.46539638529772e-09	0.297544529368836	0.427	0.248	0.000118640023670213	EIF3J	Malignant cells	GSE161801_PI_post	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15820
7.56871281388664e-09	1.02681462247837	0.447	0.311	0.00013888588013482	CCND1	Malignant cells	GSE161801_PI_post	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15821
8.61560480641879e-09	0.30597474253915	0.538	0.378	0.000158096348197785	ATP5F1B	Malignant cells	GSE161801_PI_post	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15822
8.70575644503224e-09	0.318388388456379	0.396	0.228	0.000159750630766342	C6orf48	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15823
8.73151725700914e-09	-0.254756813459884	0.281	0.449	0.000160223341666118	IDH2	Malignant cells	GSE161801_PI_post	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15824
8.77039644793166e-09	0.356494251126362	0.36	0.193	0.000160936774819546	DPM2	Malignant cells	GSE161801_PI_post	ENSG00000136908	8818	dolichyl-phosphate mannosyltransferase subunit 2, regulatory	MGC111193|MGC21559	protein_coding	O94777	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15825
1.03448808817048e-08	-0.258562953451831	0.34	0.512	0.000189828564179283	PAIP2	Malignant cells	GSE161801_PI_post	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15826
1.18761382647267e-08	0.339867471932457	0.718	0.61	0.000217927137157736	EIF4A2	Malignant cells	GSE161801_PI_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15827
1.21792990172599e-08	0.250645575857345	0.307	0.138	0.000223490136966719	SCAMP2	Malignant cells	GSE161801_PI_post	ENSG00000140497	10066	secretory carrier membrane protein 2	NA	protein_coding	O15127	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15828
1.42269528897366e-08	0.263831069540062	0.258	0.098	0.000261064585526666	VPS37B	Malignant cells	GSE161801_PI_post	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15829
3.13314805964261e-08	0.776477480581808	0.846	0.957	0.000574932668944418	CD74	Malignant cells	GSE161801_PI_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15830
3.60315623286551e-08	-0.266801954185795	0.567	0.748	0.000661179168730821	PSME2	Malignant cells	GSE161801_PI_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15831
4.0866704883309e-08	0.293374049825706	0.513	0.339	0.00074990403460872	HNRNPC	Malignant cells	GSE161801_PI_post	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15832
4.42895129376079e-08	-0.27033672020568	0.703	0.862	0.000812712562405105	DDX5	Malignant cells	GSE161801_PI_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15833
4.48469372975201e-08	0.283379213459258	0.32	0.157	0.000822941299409495	IRF7	Malignant cells	GSE161801_PI_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15834
5.16503801636784e-08	0.303206997260732	0.312	0.15	0.000947784476003498	RNGTT	Malignant cells	GSE161801_PI_post	ENSG00000111880	8732	RNA guanylyltransferase and 5'-phosphatase	hCAP|HCE|HCE1	protein_coding	O60942	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15835
5.4194455930445e-08	0.288099211114093	0.997	1	0.000994468266323666	RPS3A	Malignant cells	GSE161801_PI_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15836
5.59315910249858e-08	0.27837819797175	0.483	0.319	0.00102634469530849	SF3B2	Malignant cells	GSE161801_PI_post	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15837
5.59606688810697e-08	0.251567131328405	0.386	0.217	0.00102687827396763	YIPF3	Malignant cells	GSE161801_PI_post	ENSG00000137207	25844	Yip1 domain family member 3	C6orf109|dJ337H4.3|DKFZp566C243|FinGER3|KLIP1	protein_coding	Q9GZM5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15838
6.0033264657024e-08	0.256398893900745	0.305	0.146	0.00110161040645639	CTSD	Malignant cells	GSE161801_PI_post	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15839
6.18011191128971e-08	-0.303792057850352	0.383	0.539	0.00113405053572166	LSP1	Malignant cells	GSE161801_PI_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15840
8.10319060742442e-08	0.285052843130895	0.371	0.205	0.00148693547646238	RTN3	Malignant cells	GSE161801_PI_post	ENSG00000133318	10313	reticulon 3	ASYIP|HAP|NSPL2|NSPLII|RTN3-A1	protein_coding	O95197	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15841
1.31513905666264e-07	0.322908319258156	0.589	0.457	0.00241328016897594	SNU13	Malignant cells	GSE161801_PI_post	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15842
1.82138196248933e-07	0.254964698760559	0.543	0.394	0.00334223590116793	TUFM	Malignant cells	GSE161801_PI_post	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15843
2.24016798839312e-07	0.427240956320695	0.856	0.843	0.00411070825870137	SEC11C	Malignant cells	GSE161801_PI_post	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15844
3.37770910535924e-07	0.349328250066288	0.905	0.862	0.00619809620833421	HERPUD1	Malignant cells	GSE161801_PI_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15845
3.98698671527549e-07	0.27767766234228	0.883	0.87	0.00731612062253053	SEC62	Malignant cells	GSE161801_PI_post	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15846
4.25965095412008e-07	0.305921453326746	0.571	0.449	0.00781645950081034	CRELD2	Malignant cells	GSE161801_PI_post	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15847
4.35537778796122e-07	-0.263578000724857	0.375	0.52	0.00799211824090884	RHOA	Malignant cells	GSE161801_PI_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15848
4.92990193016902e-07	0.581801150858741	0.426	0.276	0.00904637004186016	ISG15	Malignant cells	GSE161801_PI_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15849
5.26268382415281e-07	0.339066119118808	0.837	0.799	0.00965702481732041	PDIA6	Malignant cells	GSE161801_PI_post	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15850
5.40292499845436e-07	0.513471700404797	0.557	0.425	0.00991436737216376	H1FX	Malignant cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15851
7.81383819622038e-07	0.256297749667783	0.378	0.232	0.0143383930900644	VCP	Malignant cells	GSE161801_PI_post	ENSG00000165280	7415	valosin containing protein	CDC48|IBMPFD|p97|TERA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15852
1.46829567441656e-06	0.267930584612651	0.384	0.248	0.0269432256255439	CCNDBP1	Malignant cells	GSE161801_PI_post	ENSG00000166946	23582	cyclin D1 binding protein 1	DIP1|GCIP|HHM	protein_coding	O95273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15853
1.6673948355622e-06	0.265726490358799	0.739	0.701	0.0305966952325664	ERP29	Malignant cells	GSE161801_PI_post	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15854
2.05390064670558e-06	0.286755350490587	0.376	0.244	0.0376890768670473	ZFAS1	Malignant cells	GSE161801_PI_post	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15855
2.25073876523076e-06	0.272717575774194	0.737	0.626	0.0413010563419845	ITM2B	Malignant cells	GSE161801_PI_post	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15856
2.51652541468209e-06	0.264106698765281	0.306	0.169	0.0461782413594163	MTHFD2	Malignant cells	GSE161801_PI_post	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15857
1.01920642030853e-295	0.923551031854651	1	0.952	1.87024378126615e-291	RPS29	Mono/Macro	GSE161801_PI_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15858
5.51772515041564e-284	1.56930021541226	0.926	0.57	1.01250256510127e-279	DUSP1	Mono/Macro	GSE161801_PI_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15859
1.25044400658548e-250	-0.909840520654883	0.022	0.562	2.29456475208435e-246	HLA-DQA2	Mono/Macro	GSE161801_PI_post	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15860
7.06361116335654e-238	0.980768393677473	0.939	0.642	1.29617264847593e-233	RPL36A	Mono/Macro	GSE161801_PI_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15861
1.12695524169112e-212	-0.790471107590465	0.982	0.998	2.06796286850321e-208	MT-ND2	Mono/Macro	GSE161801_PI_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15862
5.07443962872386e-211	1.00688157141205	0.96	0.823	9.31159671870828e-207	JUNB	Mono/Macro	GSE161801_PI_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15863
4.01404369585003e-203	-0.623089255215583	0.999	1	7.36577018188481e-199	EEF1A1	Mono/Macro	GSE161801_PI_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15864
5.5901109858161e-189	1.53102451067962	0.771	0.415	1.02578536589725e-184	FOS	Mono/Macro	GSE161801_PI_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15865
2.09496158013605e-185	-0.94095137777735	0.718	0.961	3.84425449954965e-181	VIM	Mono/Macro	GSE161801_PI_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15866
8.00539241831203e-182	-0.742024460056808	0.957	0.997	1.46898950876026e-177	MT-CYB	Mono/Macro	GSE161801_PI_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15867
4.93623874289351e-161	0.598689483832668	0.321	0	9.0579980932096e-157	RPS4Y1	Mono/Macro	GSE161801_PI_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15868
3.94725386811462e-154	-0.495471429439371	0.999	1	7.24321084799033e-150	RPS2	Mono/Macro	GSE161801_PI_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15869
2.32853690170372e-151	-0.607565283835697	0.149	0.582	4.27286521462632e-147	XIST	Mono/Macro	GSE161801_PI_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15870
6.50005519676307e-146	-0.654424060151913	0.379	0.786	1.19276012860602e-141	CLEC12A	Mono/Macro	GSE161801_PI_post	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15871
6.44207311172093e-144	-0.597658398145843	0.996	1	1.18212041600079e-139	MT-ND4	Mono/Macro	GSE161801_PI_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15872
8.97961162918946e-142	-0.540130846443271	0.999	1	1.64775873395627e-137	HLA-B	Mono/Macro	GSE161801_PI_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15873
7.62199335077358e-141	-0.6225567878031	0.913	0.996	1.39863577986695e-136	CTSS	Mono/Macro	GSE161801_PI_post	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15874
3.17076239457192e-140	-0.650072877863454	0.887	0.988	5.81834899403948e-136	MT-ND1	Mono/Macro	GSE161801_PI_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15875
6.83576005714553e-136	0.896303570567362	0.693	0.339	1.2543619704862e-131	IFI6	Mono/Macro	GSE161801_PI_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15876
2.46080158582574e-134	-0.528195461570582	0.993	0.999	4.51557090999024e-130	RPS3A	Mono/Macro	GSE161801_PI_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15877
4.77541052062318e-134	-1.21935433653254	0.241	0.672	8.76287830534354e-130	AC020656.1	Mono/Macro	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15878
1.37865931145546e-128	-0.494626507684961	0.994	0.999	2.52983983652077e-124	RPS12	Mono/Macro	GSE161801_PI_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15879
3.37963146063382e-125	-0.509918097726553	1	1	6.20162373026305e-121	MT-CO1	Mono/Macro	GSE161801_PI_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15880
3.46050836739586e-123	0.753457559433772	0.511	0.166	6.35003285417141e-119	GNLY	Mono/Macro	GSE161801_PI_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15881
2.27587034843646e-121	-0.444550685271316	0.999	0.999	4.17622208938091e-117	RPS15A	Mono/Macro	GSE161801_PI_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15882
3.9578092459893e-119	-0.404097952204213	0.999	1	7.26257996639037e-115	RPL10	Mono/Macro	GSE161801_PI_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15883
3.5431720666875e-115	0.387022646725231	1	1	6.50172074237156e-111	RPS27	Mono/Macro	GSE161801_PI_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15884
1.64302080559274e-114	-0.580156520881023	0.035	0.345	3.01494317826268e-110	FOLR3	Mono/Macro	GSE161801_PI_post	ENSG00000110203	2352	folate receptor gamma	FR-G|FRgamma	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15885
8.50794543811551e-114	0.783770324790268	0.291	0.025	1.5612079878942e-109	JUN	Mono/Macro	GSE161801_PI_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15886
1.57952846757115e-110	-0.449640640783461	0.996	0.998	2.89843473799306e-106	RPS4X	Mono/Macro	GSE161801_PI_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15887
1.76162960091962e-107	0.745288024811818	0.539	0.219	3.2325903176875e-103	RHOB	Mono/Macro	GSE161801_PI_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15888
3.6202177806382e-107	1.3239495773466	0.281	0.026	6.6430996274711e-103	CXCL8	Mono/Macro	GSE161801_PI_post	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15889
1.30714154771307e-104	0.698845912915398	0.572	0.26	2.39860474005348e-100	AC114760.2	Mono/Macro	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15890
1.0195137698031e-94	-0.458043325817753	0.967	0.998	1.87080776758868e-90	MT-ATP6	Mono/Macro	GSE161801_PI_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15891
7.59818950210253e-94	0.989785498962551	0.691	0.457	1.39426777363581e-89	ISG15	Mono/Macro	GSE161801_PI_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15892
3.92162755872042e-90	-0.659041475296885	0.272	0.595	7.19618657025197e-86	HLA-DQA1	Mono/Macro	GSE161801_PI_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15893
3.61761097538161e-89	-0.491323982180499	0.976	0.992	6.63831613982525e-85	TPT1	Mono/Macro	GSE161801_PI_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15894
4.29986078019095e-88	-0.508956671774466	0.565	0.849	7.8902445316504e-84	TKT	Mono/Macro	GSE161801_PI_post	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15895
2.78456789795328e-87	-0.454472853098511	0.856	0.967	5.10968209274427e-83	RPL7A	Mono/Macro	GSE161801_PI_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15896
4.82907227918254e-87	-0.418347804743998	0.94	0.987	8.86134763229996e-83	RPL14	Mono/Macro	GSE161801_PI_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15897
1.09810741237992e-86	-0.569510586940285	0.892	0.978	2.01502710171716e-82	GAPDH	Mono/Macro	GSE161801_PI_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15898
2.2246657820361e-78	-0.366924518763506	0.98	0.997	4.08226171003625e-74	H3F3A	Mono/Macro	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15899
2.62297622780607e-77	0.441704971797774	0.273	0.051	4.81316137802413e-73	IFITM1	Mono/Macro	GSE161801_PI_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15900
7.03687009011819e-76	0.396728168658681	0.308	0.073	1.29126566153669e-71	CCL5	Mono/Macro	GSE161801_PI_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15901
9.59895630986726e-76	-0.375993430498356	0.997	0.999	1.76140848286064e-71	RPS24	Mono/Macro	GSE161801_PI_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15902
9.67627677910534e-76	0.4438632101242	0.305	0.073	1.77559678896583e-71	CXCR4	Mono/Macro	GSE161801_PI_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15903
1.05375661051459e-75	0.629799183395605	0.96	0.941	1.93364338029428e-71	SAT1	Mono/Macro	GSE161801_PI_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15904
1.68751552445636e-73	-0.394337083170358	0.959	0.99	3.09659098737742e-69	RPL9	Mono/Macro	GSE161801_PI_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15905
2.19147399173466e-73	-0.536851125168078	0.809	0.959	4.0213547748331e-69	S100A10	Mono/Macro	GSE161801_PI_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15906
4.89430347467217e-73	-0.399868551291777	0.922	0.974	8.98104687602343e-69	RACK1	Mono/Macro	GSE161801_PI_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15907
5.0875749958459e-73	0.726330728441845	0.623	0.4	9.33570011737723e-69	IER2	Mono/Macro	GSE161801_PI_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15908
1.27262121378645e-72	0.500881367893967	0.81	0.637	2.33525992729814e-68	RPS17	Mono/Macro	GSE161801_PI_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15909
4.01589794995061e-71	-0.489681090103714	0.582	0.841	7.36917273815937e-67	TXNIP	Mono/Macro	GSE161801_PI_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15910
4.53667175158878e-69	-0.363010735031802	0.992	0.998	8.32479266416542e-65	RPL7	Mono/Macro	GSE161801_PI_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15911
1.2940121440655e-68	-0.368886563983691	0.254	0.555	2.37451228436019e-64	CTSH	Mono/Macro	GSE161801_PI_post	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15912
4.54383828976206e-68	0.419906432400403	0.408	0.153	8.33794326171337e-64	NKG7	Mono/Macro	GSE161801_PI_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15913
1.00537746216056e-66	-0.327309496632076	0.115	0.37	1.84486764306463e-62	HHEX	Mono/Macro	GSE161801_PI_post	ENSG00000152804	3087	hematopoietically expressed homeobox	HEX|HOX11L-PEN|PRHX	protein_coding	Q03014	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15914
2.88039788807207e-65	-0.444510908069803	0.405	0.681	5.28553012461225e-61	LTA4H	Mono/Macro	GSE161801_PI_post	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15915
4.77972023484976e-65	-0.352975226346258	0.997	0.999	8.77078663094931e-61	MT-CO3	Mono/Macro	GSE161801_PI_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15916
9.37148301691722e-65	-0.377276993849665	0.305	0.601	1.71966713360431e-60	CSF3R	Mono/Macro	GSE161801_PI_post	ENSG00000119535	1441	colony stimulating factor 3 receptor	CD114|GCSFR	protein_coding	Q99062	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15917
1.93136825615127e-64	-0.40483198526126	0.632	0.879	3.54406075003759e-60	MT-ND5	Mono/Macro	GSE161801_PI_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15918
3.72857857075079e-64	0.520273721951806	0.676	0.475	6.8419416773277e-60	ATP5ME	Mono/Macro	GSE161801_PI_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15919
1.66783774769689e-63	-0.386823777328285	0.351	0.63	3.06048226702379e-59	SEC11A	Mono/Macro	GSE161801_PI_post	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15920
1.69967896771386e-63	-0.438802005470951	1	1	3.11891090575493e-59	RPLP1	Mono/Macro	GSE161801_PI_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15921
7.26402984300424e-61	-0.393846659942896	0.761	0.94	1.33294947619128e-56	SLC25A6	Mono/Macro	GSE161801_PI_post	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15922
1.76659705847309e-60	-0.399288284261219	0.816	0.952	3.24170560229812e-56	ARPC3	Mono/Macro	GSE161801_PI_post	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15923
2.46090564749289e-60	-0.4146972219396	0.602	0.828	4.51576186314946e-56	CD37	Mono/Macro	GSE161801_PI_post	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15924
2.60016084068437e-60	-0.347592278434043	0.321	0.605	4.77129514265583e-56	NCF2	Mono/Macro	GSE161801_PI_post	ENSG00000116701	4688	neutrophil cytosolic factor 2	NOXA2|p67phox	protein_coding	P19878	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15925
2.9116017884977e-60	0.599854890109216	0.772	0.655	5.34278928189328e-56	LY6E	Mono/Macro	GSE161801_PI_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15926
3.4226379749477e-60	-0.399794604125777	0.795	0.953	6.28054068402903e-56	NPC2	Mono/Macro	GSE161801_PI_post	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15927
4.95440526785085e-60	-0.335116257216151	0.976	0.993	9.0913336665063e-56	RPL29	Mono/Macro	GSE161801_PI_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15928
3.62390891504303e-59	-0.398012506170169	0.67	0.885	6.64987285910396e-55	BTF3	Mono/Macro	GSE161801_PI_post	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15929
3.83372699451614e-59	-0.305117089713712	0.973	0.994	7.03488903493711e-55	RPS16	Mono/Macro	GSE161801_PI_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15930
7.21374789406498e-59	-0.263995790314579	0.994	1	1.32372273856092e-54	TYROBP	Mono/Macro	GSE161801_PI_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15931
2.33032507127137e-58	0.410567566541869	0.374	0.149	4.27614650578297e-54	IFI44L	Mono/Macro	GSE161801_PI_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15932
3.2488454028373e-58	0.445592694573834	0.541	0.312	5.96163131420644e-54	PET100	Mono/Macro	GSE161801_PI_post	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15933
6.59767050851702e-58	-0.494875770092861	0.216	0.466	1.21067253831287e-53	AC007952.4	Mono/Macro	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15934
1.27737878588242e-57	0.532200883632764	0.681	0.474	2.34399007209425e-53	NAMPT	Mono/Macro	GSE161801_PI_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15935
6.47862058999636e-56	-0.277510941066423	0.991	0.997	1.18882687826433e-51	RPL8	Mono/Macro	GSE161801_PI_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15936
1.14954697670864e-55	-0.42627992604156	0.764	0.913	2.10941870226035e-51	ACTG1	Mono/Macro	GSE161801_PI_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15937
3.36721147220001e-55	-0.419158421163233	0.611	0.823	6.17883305148702e-51	CD68	Mono/Macro	GSE161801_PI_post	ENSG00000129226	968	CD68 molecule	DKFZp686M18236|GP110|LAMP4|SCARD1	protein_coding	P34810	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15938
2.36906141275011e-53	-0.316927644887165	0.166	0.406	4.34722769239644e-49	CDKN2D	Mono/Macro	GSE161801_PI_post	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15939
5.45334733602662e-53	-0.372535540519275	0.393	0.651	1.00068923616088e-48	LGALS3	Mono/Macro	GSE161801_PI_post	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15940
8.37512701988635e-53	-0.367562910148273	0.754	0.917	1.53683580814915e-48	ARPC2	Mono/Macro	GSE161801_PI_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15941
2.0034857253204e-52	-0.317902626411196	0.94	0.984	3.67639630596294e-48	RPS7	Mono/Macro	GSE161801_PI_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15942
1.12834988462566e-51	-0.418415369036262	0.889	0.968	2.07052203828808e-47	HLA-DRB1	Mono/Macro	GSE161801_PI_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15943
2.45156618724673e-51	-0.343814581165674	0.778	0.921	4.49862395359774e-47	RPL5	Mono/Macro	GSE161801_PI_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15944
1.67856918421561e-50	-0.31908481422703	0.236	0.483	3.08017445303564e-46	HLA-F	Mono/Macro	GSE161801_PI_post	ENSG00000234487	3134	major histocompatibility complex, class I, F	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15945
2.05515492247983e-49	-0.361122855524971	0.83	0.951	3.77120928275048e-45	TSPO	Mono/Macro	GSE161801_PI_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15946
2.37509138260635e-49	-0.301654907871907	0.317	0.572	4.35829268708265e-45	PPT1	Mono/Macro	GSE161801_PI_post	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15947
2.7759369132694e-49	-0.298514539774981	0.326	0.593	5.09384423584935e-45	AGTRAP	Mono/Macro	GSE161801_PI_post	ENSG00000177674	57085	angiotensin II receptor associated protein	ATRAP	protein_coding	Q6RW13	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15948
1.1948834085632e-48	-0.305407042733014	0.183	0.414	2.19261105471347e-44	KLF10	Mono/Macro	GSE161801_PI_post	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15949
1.03828621922886e-47	-0.368846365740669	0.3	0.531	1.90525521228496e-43	ICAM3	Mono/Macro	GSE161801_PI_post	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15950
3.97647241330392e-47	-0.270609599830681	0.132	0.343	7.2968268784127e-43	NCF4	Mono/Macro	GSE161801_PI_post	ENSG00000275990	4689	neutrophil cytosolic factor 4	p40phox|SH3PXD4	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15951
4.88204119889552e-47	-0.354594786290033	0.68	0.896	8.95854559997328e-43	GSTP1	Mono/Macro	GSE161801_PI_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15952
7.25580259184682e-47	-0.331726687691081	0.351	0.595	1.33143977560389e-42	EEF1B2	Mono/Macro	GSE161801_PI_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15953
7.67137594326143e-46	-0.259681901007902	0.994	1	1.40769748558847e-41	RPL19	Mono/Macro	GSE161801_PI_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15954
1.99889444823775e-45	-0.262855307616467	0.988	0.999	3.66797131251626e-41	CST3	Mono/Macro	GSE161801_PI_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15955
2.1482503521436e-45	-0.578336049385373	0.717	0.861	3.94203939618351e-41	HLA-DPA1	Mono/Macro	GSE161801_PI_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15956
4.63233222867896e-45	-0.639065200420203	0.877	0.994	8.5003296396259e-41	S100A9	Mono/Macro	GSE161801_PI_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15957
1.21977093710502e-44	-0.314500095946524	0.864	0.96	2.23827966958771e-40	NACA	Mono/Macro	GSE161801_PI_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15958
1.28502592239158e-44	-0.308973517413342	0.906	0.997	2.35802256758854e-40	FCN1	Mono/Macro	GSE161801_PI_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15959
1.69636143506677e-44	-0.328779479651579	0.489	0.722	3.11282323334751e-40	TALDO1	Mono/Macro	GSE161801_PI_post	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15960
2.58647682379913e-44	-0.315987198879271	0.349	0.587	4.7461849716714e-40	SLC7A7	Mono/Macro	GSE161801_PI_post	ENSG00000155465	9056	solute carrier family 7 member 7	LPI|y+LAT-1	protein_coding	Q9UM01	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15961
1.93000454882612e-43	0.399475236398632	0.928	0.824	3.54155834709593e-39	UBC	Mono/Macro	GSE161801_PI_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15962
1.3298667460051e-42	0.600463897219307	0.763	0.668	2.44030547891935e-38	MT2A	Mono/Macro	GSE161801_PI_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15963
4.12164474294032e-42	-0.26740360953159	0.138	0.335	7.56321810329549e-38	VSTM1	Mono/Macro	GSE161801_PI_post	ENSG00000276066	284415	V-set and transmembrane domain containing 1	UNQ3033	protein_coding	Q6UX27	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15964
4.44726212011839e-42	0.463273232339477	0.789	0.63	8.16072599041725e-38	IFITM3	Mono/Macro	GSE161801_PI_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15965
1.71337771429892e-41	-0.259438358371454	0.97	0.99	3.14404810573852e-37	RPL30	Mono/Macro	GSE161801_PI_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15966
3.29361210889124e-41	0.383682408515367	0.279	0.11	6.04377821981542e-37	ATP2B1-AS1	Mono/Macro	GSE161801_PI_post	ENSG00000271614	NA	NA	LINC00936	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15967
7.74871817635935e-41	-0.300060469346153	0.556	0.775	1.42188978536194e-36	FCGRT	Mono/Macro	GSE161801_PI_post	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15968
1.34314513948485e-40	-0.332604761067301	0.591	0.785	2.4646713309547e-36	EVI2B	Mono/Macro	GSE161801_PI_post	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15969
3.62543071491835e-40	0.349394593904059	0.304	0.132	6.65266536187517e-36	PPP1R15A	Mono/Macro	GSE161801_PI_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15970
8.11170924329667e-40	-0.306263195682575	0.741	0.906	1.48849864614494e-35	PABPC1	Mono/Macro	GSE161801_PI_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15971
8.26536102134455e-40	-0.266274546693467	0.378	0.613	1.51669374741672e-35	PGLS	Mono/Macro	GSE161801_PI_post	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15972
1.10557026406053e-38	-0.284833180496381	0.806	0.922	2.02872143455108e-34	RPL4	Mono/Macro	GSE161801_PI_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15973
1.52235132826136e-38	0.292146404426409	0.999	0.986	2.79351468735959e-34	HLA-A	Mono/Macro	GSE161801_PI_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15974
4.01697576133762e-38	0.353195151392543	0.94	0.902	7.37115052205452e-34	RPS21	Mono/Macro	GSE161801_PI_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15975
1.0109115205911e-37	0.263584793352734	0.997	0.991	1.85502264028467e-33	RPL36	Mono/Macro	GSE161801_PI_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15976
3.98216471438002e-37	-0.290896741693572	0.382	0.597	7.30727225088734e-33	EIF3H	Mono/Macro	GSE161801_PI_post	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15977
8.59811785985178e-37	-0.250081706955546	0.309	0.532	1.5777546272828e-32	SNX10	Mono/Macro	GSE161801_PI_post	ENSG00000086300	29887	sorting nexin 10	NA	protein_coding	Q9Y5X0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15978
1.00067421665009e-36	-0.292362277732262	0.484	0.704	1.83623718755292e-32	PKM	Mono/Macro	GSE161801_PI_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15979
1.08676198394384e-36	-0.32628691811324	0.395	0.632	1.99420824053694e-32	NCF1	Mono/Macro	GSE161801_PI_post	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15980
2.80048860237727e-36	-0.27785553495341	0.493	0.721	5.1388965853623e-32	EIF3E	Mono/Macro	GSE161801_PI_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15981
3.45637522040614e-36	-0.252191912538761	0.254	0.466	6.34244852944527e-32	EIF3L	Mono/Macro	GSE161801_PI_post	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15982
3.74689966797093e-36	-0.258343736598576	0.289	0.509	6.87556089072666e-32	SMDT1	Mono/Macro	GSE161801_PI_post	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15983
4.57436581571275e-36	-0.283269929724339	0.354	0.571	8.3939612718329e-32	SLC25A5	Mono/Macro	GSE161801_PI_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15984
6.16023184572325e-36	-0.257769348767158	0.266	0.474	1.13040254369022e-31	GLIPR2	Mono/Macro	GSE161801_PI_post	ENSG00000122694	152007	GLI pathogenesis related 2	C9orf19|GAPR-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15985
6.30074079975072e-36	-0.430195472842068	0.72	0.877	1.15618593675426e-31	HLA-DPB1	Mono/Macro	GSE161801_PI_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15986
7.66342902081334e-36	-0.273990244317547	0.465	0.687	1.40623922531925e-31	SARAF	Mono/Macro	GSE161801_PI_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15987
8.62700993595119e-36	-0.262073182877627	0.335	0.552	1.58305632324704e-31	LAMTOR1	Mono/Macro	GSE161801_PI_post	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15988
1.2154946674411e-35	-0.271779354243631	0.199	0.394	2.23043271475442e-31	GBP2	Mono/Macro	GSE161801_PI_post	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15989
2.90240469259951e-35	-0.305348233313321	0.391	0.602	5.3259126109201e-31	VASP	Mono/Macro	GSE161801_PI_post	ENSG00000125753	7408	vasodilator stimulated phosphoprotein	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15990
3.49601962202496e-35	-0.292145540629456	0.446	0.658	6.4151960064158e-31	SH3BGRL	Mono/Macro	GSE161801_PI_post	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15991
1.21014227631706e-34	0.33886836746045	0.821	0.78	2.2206110770418e-30	UQCR11	Mono/Macro	GSE161801_PI_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15992
1.75056360162821e-34	-0.282102528756415	0.393	0.609	3.21228420898776e-30	CPVL	Mono/Macro	GSE161801_PI_post	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15993
4.48240647175791e-34	-0.306775098375626	0.277	0.474	8.22521587567577e-30	LILRA1	Mono/Macro	GSE161801_PI_post	ENSG00000274935	11024	leukocyte immunoglobulin like receptor A1	CD85i|LIR-6|LIR6	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15994
7.65146527106036e-34	-0.274966689586049	0.417	0.634	1.40404387723958e-29	PILRA	Mono/Macro	GSE161801_PI_post	ENSG00000085514	29992	paired immunoglobin like type 2 receptor alpha	FDF03	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15995
1.18848894830792e-33	-0.252845302254486	0.428	0.661	2.18087722014503e-29	NOP53	Mono/Macro	GSE161801_PI_post	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15996
3.04143233746552e-33	0.35245395315741	0.59	0.448	5.58102833924922e-29	NDUFA13	Mono/Macro	GSE161801_PI_post	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15997
3.85595278168332e-33	0.352848526102327	0.547	0.386	7.07567335438889e-29	NDUFA3	Mono/Macro	GSE161801_PI_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15998
9.88952974717905e-33	-0.293849505383106	0.453	0.664	1.81472870860736e-28	HLA-DMA	Mono/Macro	GSE161801_PI_post	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	15999
1.23085836948818e-32	-0.263144298900757	0.524	0.749	2.25862510801081e-28	GPSM3	Mono/Macro	GSE161801_PI_post	ENSG00000233490	63940	G protein signaling modulator 3	AGS4|C6orf9|G18|G18.1a|G18.1b|G18.2|NG1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16000
4.00520717938643e-32	-0.253159365380169	0.414	0.62	7.34955517417409e-28	BRK1	Mono/Macro	GSE161801_PI_post	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16001
4.40012897046553e-32	-0.34041745862928	0.447	0.642	8.07423666080425e-28	TAGLN2	Mono/Macro	GSE161801_PI_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16002
7.03755737062721e-32	-0.351927873082652	0.862	0.955	1.29139177751009e-27	COTL1	Mono/Macro	GSE161801_PI_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16003
8.31052012262742e-32	-0.269434984892534	0.639	0.819	1.52498044250213e-27	VSIR	Mono/Macro	GSE161801_PI_post	ENSG00000107738	64115	V-set immunoregulatory receptor	B7-H5|B7H5|C10orf54|Dies1|GI24|PD-1H|SISP1|VISTA	protein_coding	Q9H7M9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16004
1.04346098630223e-31	0.326161479472179	1	1	1.91475090986459e-27	MALAT1	Mono/Macro	GSE161801_PI_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16005
3.08352002333942e-31	-0.267150295839712	0.507	0.711	5.65825924282783e-27	CD44	Mono/Macro	GSE161801_PI_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16006
1.8311908579635e-30	-0.282296481742526	0.213	0.391	3.36023522436303e-26	MGST1	Mono/Macro	GSE161801_PI_post	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16007
2.06402396072316e-30	-0.25966900614567	0.897	0.969	3.787483967927e-26	ITM2B	Mono/Macro	GSE161801_PI_post	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16008
4.64317599817507e-30	-0.259573701119901	0.93	0.988	8.52022795665125e-26	TYMP	Mono/Macro	GSE161801_PI_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16009
4.68825670962407e-30	-0.291807678963362	0.931	0.988	8.60295106216017e-26	HLA-DRA	Mono/Macro	GSE161801_PI_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16010
5.51018099723877e-30	-0.28826405765986	0.129	0.284	1.01111821299332e-25	TPPP3	Mono/Macro	GSE161801_PI_post	ENSG00000159713	51673	tubulin polymerization promoting protein family member 3	CGI-38|p20|p25gamma	protein_coding	Q9BW30	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16011
6.7855675971919e-30	-0.253333346158291	0.516	0.731	1.24515165408471e-25	PSME1	Mono/Macro	GSE161801_PI_post	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16012
7.95474161567103e-29	-0.302199061405423	0.777	0.904	1.45969508647563e-24	YBX1	Mono/Macro	GSE161801_PI_post	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16013
1.81588906366579e-28	0.490979675915253	0.543	0.437	3.33215643182673e-24	ZFP36	Mono/Macro	GSE161801_PI_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16014
2.74827668846106e-28	-0.250248099210576	0.321	0.506	5.04308772332604e-24	PLP2	Mono/Macro	GSE161801_PI_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16015
7.05953101931709e-28	0.31147591291428	0.541	0.398	1.29542394204469e-23	EFHD2	Mono/Macro	GSE161801_PI_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16016
8.8037237410734e-28	-0.284014455581774	0.478	0.658	1.61548330648697e-23	VAMP5	Mono/Macro	GSE161801_PI_post	ENSG00000168899	10791	vesicle associated membrane protein 5	NA	protein_coding	O95183	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16017
2.98664123508119e-27	-0.257545367861469	0.644	0.815	5.48048666637398e-23	GRN	Mono/Macro	GSE161801_PI_post	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16018
3.16449733538821e-27	0.314733150578166	0.777	0.712	5.80685261043737e-23	TMA7	Mono/Macro	GSE161801_PI_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16019
4.71052893247042e-27	0.327664992845584	0.715	0.655	8.64382059108321e-23	UBL5	Mono/Macro	GSE161801_PI_post	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16020
5.84088944676437e-27	-0.522100700421346	0.445	0.606	1.07180321348126e-22	S100A12	Mono/Macro	GSE161801_PI_post	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16021
9.25748781740548e-27	-0.255689319397014	0.419	0.603	1.69874901449391e-22	BLVRB	Mono/Macro	GSE161801_PI_post	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16022
2.42890182056e-26	0.311164724791803	0.621	0.488	4.45703484072761e-22	NDUFB1	Mono/Macro	GSE161801_PI_post	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16023
3.39359564332324e-26	-0.257164451493559	0.215	0.379	6.22724800549814e-22	PLBD1	Mono/Macro	GSE161801_PI_post	ENSG00000121316	79887	phospholipase B domain containing 1	FLJ22662	protein_coding	Q6P4A8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16024
4.49868393933611e-26	0.434980889735339	0.352	0.218	8.25508502868177e-22	KLF6	Mono/Macro	GSE161801_PI_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16025
6.92237486293238e-25	0.328303243542713	0.437	0.299	1.27025578734809e-20	NFKBIZ	Mono/Macro	GSE161801_PI_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16026
2.97541393275649e-24	0.442136148102316	0.491	0.362	5.45988456660817e-20	APOBEC3A	Mono/Macro	GSE161801_PI_post	ENSG00000262156	200315	apolipoprotein B mRNA editing enzyme catalytic subunit 3A	ARP3|PHRBN	protein_coding	P31941	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16027
3.7319703449352e-22	0.276434843799889	0.381	0.249	6.8481655829561e-18	JUND	Mono/Macro	GSE161801_PI_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16028
3.87631914778756e-22	-0.384029979515267	0.94	0.992	7.11304563619017e-18	LYZ	Mono/Macro	GSE161801_PI_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16029
5.83369357348075e-22	0.312891466861455	0.918	0.923	1.07048277073372e-17	EMP3	Mono/Macro	GSE161801_PI_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16030
5.91735568083597e-22	-0.283787481287044	0.486	0.651	1.0858347674334e-17	MS4A6A	Mono/Macro	GSE161801_PI_post	ENSG00000110077	64231	membrane spanning 4-domains A6A	CD20L3|MS4A6	protein_coding	Q9H2W1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16031
1.02711143210309e-21	-0.277367852645668	0.81	0.955	1.88474947790916e-17	S100A8	Mono/Macro	GSE161801_PI_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16032
6.51130966326142e-21	-0.380127723060747	0.156	0.295	1.19482532320847e-16	C1QA	Mono/Macro	GSE161801_PI_post	ENSG00000173372	712	complement C1q A chain	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16033
2.24725999354298e-20	0.50684211670441	0.257	0.145	4.12372208815136e-16	G0S2	Mono/Macro	GSE161801_PI_post	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16034
5.84670732875672e-20	0.299786639201334	0.747	0.687	1.07287079482686e-15	BTG1	Mono/Macro	GSE161801_PI_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16035
4.08234274193599e-19	0.302529257481461	0.268	0.16	7.49109893145254e-15	KLF2	Mono/Macro	GSE161801_PI_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16036
1.17866546640066e-18	0.254212520107836	0.376	0.255	2.1628511308452e-14	COX17	Mono/Macro	GSE161801_PI_post	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16037
5.40622421565172e-18	0.308192391671025	0.546	0.453	9.9204214357209e-14	MCL1	Mono/Macro	GSE161801_PI_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16038
9.06939451692214e-18	0.281248380106087	0.678	0.624	1.66423389385521e-13	PTP4A2	Mono/Macro	GSE161801_PI_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16039
6.60855830016224e-17	-0.365476825545511	0.494	0.604	1.21267044807977e-12	VCAN	Mono/Macro	GSE161801_PI_post	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16040
2.13533214046928e-16	0.254454892471951	0.621	0.561	3.91833447776113e-12	ATP5MD	Mono/Macro	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16041
4.54680276357204e-16	0.321928464972069	0.969	0.983	8.3433830711547e-12	SRGN	Mono/Macro	GSE161801_PI_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16042
7.01172449322532e-16	0.270682590764692	0.614	0.551	1.28665144450685e-11	NDUFA1	Mono/Macro	GSE161801_PI_post	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16043
1.43629502666016e-14	-0.257304874596999	0.602	0.714	2.6356013739214e-10	NAP1L1	Mono/Macro	GSE161801_PI_post	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16044
6.63554045919367e-14	0.302428168003838	0.425	0.342	1.21762167426204e-09	HERPUD1	Mono/Macro	GSE161801_PI_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16045
2.61252987986529e-13	0.305576620811056	0.515	0.429	4.7939923295528e-09	PLAC8	Mono/Macro	GSE161801_PI_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16046
3.51134419981131e-13	0.256483587150436	0.339	0.246	6.44331660665376e-09	H1FX	Mono/Macro	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16047
4.18433762086184e-13	-0.27155641761603	0.306	0.417	7.67825953428148e-09	RHOC	Mono/Macro	GSE161801_PI_post	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16048
1.2427348991873e-12	0.258387385947694	0.339	0.248	2.28041854000869e-08	CDC42SE1	Mono/Macro	GSE161801_PI_post	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16049
8.40401045663901e-10	0.303200968894061	0.677	0.673	1.54213591879326e-05	CEBPB	Mono/Macro	GSE161801_PI_post	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16050
1.41253391377367e-09	0.294596024397569	0.667	0.66	2.59199973177469e-05	HLA-DRB5	Mono/Macro	GSE161801_PI_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16051
8.90229015894823e-08	-0.323204136701587	0.431	0.483	0.001633570244167	FCGR3A	Mono/Macro	GSE161801_PI_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16052
7.99401424049506e-07	0.256479597144669	0.525	0.502	0.0146690161313084	PLAUR	Mono/Macro	GSE161801_PI_post	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16053
0	0.846704219654687	1	0.998	0	RPS29	CD8+ T cells	GSE161801_PI_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16054
0	-0.71170480882831	0.999	1	0	MT-CO1	CD8+ T cells	GSE161801_PI_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16055
0	-1.03903542751337	0.193	0.748	0	S100A9	CD8+ T cells	GSE161801_PI_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16056
2.73526681680425e-306	-0.801974436015119	0.2	0.669	5.01921460883581e-302	S100A8	CD8+ T cells	GSE161801_PI_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16057
6.64325594772089e-299	-0.745276666840227	0.178	0.636	1.21903746640678e-294	LYZ	CD8+ T cells	GSE161801_PI_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16058
3.89698035979815e-286	-0.628914899542839	0.096	0.482	7.1509589602296e-282	XIST	CD8+ T cells	GSE161801_PI_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16059
1.47957273753794e-275	-0.842848952366748	0.945	0.995	2.71501597338212e-271	MT-ND2	CD8+ T cells	GSE161801_PI_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16060
1.10193416049243e-256	0.812832475969903	0.936	0.744	2.02204918450362e-252	RPL36A	CD8+ T cells	GSE161801_PI_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16061
2.94914861181828e-254	-0.672399559451466	0.977	0.998	5.41168770268655e-250	MT-ND4	CD8+ T cells	GSE161801_PI_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16062
2.56927174881268e-241	-0.706435089899307	0.909	0.988	4.71461365907127e-237	MT-ATP6	CD8+ T cells	GSE161801_PI_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16063
4.1522678057349e-236	0.470409288830653	1	1	7.61941142352355e-232	RPS27	CD8+ T cells	GSE161801_PI_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16064
1.48680543487006e-232	-0.733093118601302	0.945	0.995	2.72828797298656e-228	MT-CYB	CD8+ T cells	GSE161801_PI_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16065
2.75607186328006e-220	-0.603492021031909	0.975	0.993	5.0573918691189e-216	TPT1	CD8+ T cells	GSE161801_PI_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16066
2.04004598549123e-213	-0.56686452508047	0.993	1	3.74348438337641e-209	MT-CO3	CD8+ T cells	GSE161801_PI_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16067
2.79854725431999e-211	-0.505240941928156	1	1	5.13533421167717e-207	EEF1A1	CD8+ T cells	GSE161801_PI_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16068
4.95160634472326e-208	-0.698661077170884	0.687	0.925	9.08619764256718e-204	MT-ND1	CD8+ T cells	GSE161801_PI_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16069
5.51897594978961e-202	0.84363532958936	0.385	0	1.01273208678639e-197	RPS4Y1	CD8+ T cells	GSE161801_PI_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16070
5.50512095258572e-188	-0.480740268106139	0.992	0.998	1.01018969479948e-183	RPS24	CD8+ T cells	GSE161801_PI_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16071
1.62468010461246e-184	-0.446845313830637	1	1	2.98128799196387e-180	RPS4X	CD8+ T cells	GSE161801_PI_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16072
1.01520488304601e-172	-0.48584290873791	0.994	0.999	1.86290096038943e-168	MT-CO2	CD8+ T cells	GSE161801_PI_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16073
1.00367325713132e-160	-0.538223908240473	0.183	0.499	1.84174042683598e-156	PIK3R1	CD8+ T cells	GSE161801_PI_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16074
6.89630010629501e-146	1.44994536664262	0.409	0.091	1.26547106950514e-141	JUN	CD8+ T cells	GSE161801_PI_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16075
1.10159571188292e-132	-0.345292959417541	0.072	0.296	2.02142813130516e-128	NCR3	CD8+ T cells	GSE161801_PI_post	ENSG00000206430	259197	natural cytotoxicity triggering receptor 3	1C7|CD337|LY117|NKp30	protein_coding	O14931	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16076
1.17600846971245e-130	-0.573434310921	0.471	0.779	2.15797554192235e-126	MT-ND5	CD8+ T cells	GSE161801_PI_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16077
2.10141617536388e-122	-0.346013728051693	0.992	1	3.85609868179272e-118	HLA-B	CD8+ T cells	GSE161801_PI_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16078
2.50228860525784e-121	-0.393767447821383	0.986	0.997	4.59169959064813e-117	RPL14	CD8+ T cells	GSE161801_PI_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16079
1.45570610127355e-120	0.516278285215408	0.919	0.812	2.67122069583696e-116	RPS17	CD8+ T cells	GSE161801_PI_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16080
2.05366422900337e-119	-0.289676197268779	0.062	0.267	3.76847386022118e-115	FCN1	CD8+ T cells	GSE161801_PI_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16081
1.07895623002483e-114	-0.324089271748496	0.091	0.312	1.97988468209557e-110	ATG2A	CD8+ T cells	GSE161801_PI_post	ENSG00000110046	23130	autophagy related 2A	BLTP4A|KIAA0404	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16082
1.94138201321996e-110	-0.513627436901662	0.377	0.669	3.56243599425862e-106	FLNA	CD8+ T cells	GSE161801_PI_post	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16083
2.61096440135057e-107	-0.327112150360156	0.999	1	4.79111967647829e-103	RPL28	CD8+ T cells	GSE161801_PI_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16084
1.27197176820258e-106	-0.298970882994649	0.122	0.367	2.33406819465174e-102	CST3	CD8+ T cells	GSE161801_PI_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16085
6.31757321119295e-106	-0.316496403570527	0.107	0.335	1.15927468425391e-101	LST1	CD8+ T cells	GSE161801_PI_post	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16086
4.20426482065852e-101	-0.654908477515627	0.635	0.83	7.71482594590838e-97	ZFP36L2	CD8+ T cells	GSE161801_PI_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16087
3.36734072674502e-99	-0.503453164801074	0.434	0.728	6.17907023357712e-95	HMGB2	CD8+ T cells	GSE161801_PI_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16088
8.44617216576241e-99	-0.343734004074656	0.15	0.384	1.5498725924174e-94	IDI1	CD8+ T cells	GSE161801_PI_post	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16089
4.92695582613733e-96	-0.364709339282949	0.127	0.345	9.040963940962e-92	MAP3K8	CD8+ T cells	GSE161801_PI_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16090
2.36414584406265e-94	-0.286335713969799	1	1	4.33820762385496e-90	RPS15A	CD8+ T cells	GSE161801_PI_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16091
6.4660457835195e-92	-0.318331609784254	0.131	0.346	1.18651940127583e-87	KLF3	CD8+ T cells	GSE161801_PI_post	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16092
2.63818677408241e-91	1.04667331970607	0.455	0.222	4.84107273044122e-87	DUSP1	CD8+ T cells	GSE161801_PI_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16093
8.21828821821611e-91	-0.293390812501648	0.105	0.313	1.50805588804266e-86	AIF1	CD8+ T cells	GSE161801_PI_post	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16094
2.07520087601747e-90	-0.323236508450719	1	1	3.80799360749205e-86	RPLP1	CD8+ T cells	GSE161801_PI_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16095
7.16216157116475e-90	-0.350310656173155	0.94	0.979	1.31425664830873e-85	RPL7A	CD8+ T cells	GSE161801_PI_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16096
2.77640957610906e-86	-0.287943281447087	0.999	1	5.09471157216013e-82	RPL19	CD8+ T cells	GSE161801_PI_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16097
3.66625150901858e-85	-0.293745880888074	0.128	0.334	6.72757151904909e-81	EML4	CD8+ T cells	GSE161801_PI_post	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16098
1.64225617080379e-84	0.316904517661567	0.989	0.999	3.01354007342495e-80	HLA-C	CD8+ T cells	GSE161801_PI_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16099
2.36492398952592e-82	-0.277738116476674	0.998	0.999	4.33963552078006e-78	RPS3A	CD8+ T cells	GSE161801_PI_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16100
3.11036996545782e-79	-0.251985218050553	0.105	0.292	5.70752888661509e-75	NSA2	CD8+ T cells	GSE161801_PI_post	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16101
3.44041990599435e-79	-0.271062912781348	1	1	6.31317052749964e-75	RPL13	CD8+ T cells	GSE161801_PI_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16102
3.70220883285835e-79	-0.319946331967297	0.226	0.469	6.79355320829507e-75	MTRNR2L8	CD8+ T cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16103
1.06830560606245e-78	-0.483030353868547	0.475	0.72	1.9603407871246e-74	NEAT1	CD8+ T cells	GSE161801_PI_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16104
4.0325666487545e-78	-0.338360391000319	0.277	0.527	7.3997598004645e-74	TSPO	CD8+ T cells	GSE161801_PI_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16105
2.58914352020913e-77	-0.309281766007306	0.982	0.995	4.75107835958376e-73	RPL29	CD8+ T cells	GSE161801_PI_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16106
8.26647875429313e-77	-0.401204802168798	0.506	0.755	1.51689885141279e-72	NOP53	CD8+ T cells	GSE161801_PI_post	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16107
8.31813790643797e-76	-0.374434814645303	0.266	0.529	1.52637830583137e-71	TYROBP	CD8+ T cells	GSE161801_PI_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16108
1.46900610342408e-75	-0.259773440086398	0.101	0.278	2.69562619978318e-71	REL	CD8+ T cells	GSE161801_PI_post	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16109
1.58540737906552e-75	-0.262859885605938	0.133	0.329	2.90922254058523e-71	CASP8	CD8+ T cells	GSE161801_PI_post	ENSG00000064012	841	caspase 8	Casp-8|FLICE|MACH|MCH5	protein_coding	Q14790	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16110
1.24490466381383e-74	-0.280234216788464	0.144	0.342	2.28440005809837e-70	POLR1D	CD8+ T cells	GSE161801_PI_post	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16111
1.48952814487365e-74	0.463496924331849	0.954	0.917	2.73328414584315e-70	UBC	CD8+ T cells	GSE161801_PI_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16112
1.60103703661029e-74	-0.321757224618551	0.218	0.441	2.93790296217988e-70	SYNE2	CD8+ T cells	GSE161801_PI_post	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16113
2.56886030724811e-74	0.2717953807363	0.993	1	4.71385866380028e-70	HLA-A	CD8+ T cells	GSE161801_PI_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16114
3.18170686383795e-71	0.496244210305554	0.631	0.465	5.83843209514263e-67	IFITM1	CD8+ T cells	GSE161801_PI_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16115
1.75630067550751e-70	-0.365515650573127	0.327	0.57	3.22281173955628e-66	HOPX	CD8+ T cells	GSE161801_PI_post	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16116
4.74816547850054e-69	-0.400010851761131	0.351	0.601	8.71288365304849e-65	COTL1	CD8+ T cells	GSE161801_PI_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16117
9.97794226712153e-69	-0.273938696444665	0.213	0.432	1.8309524060168e-64	SMDT1	CD8+ T cells	GSE161801_PI_post	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16118
1.81367499285814e-68	-0.334137821918741	0.143	0.329	3.32809361189469e-64	NR4A2	CD8+ T cells	GSE161801_PI_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16119
9.85204474826953e-68	-0.307104395531273	0.924	0.969	1.80785021130746e-63	RPL5	CD8+ T cells	GSE161801_PI_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16120
6.33765163128752e-67	-0.311500596174015	0.981	0.993	1.16295907434126e-62	RPL9	CD8+ T cells	GSE161801_PI_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16121
4.15129037685835e-66	0.775392813914046	0.272	0.084	7.61761784153507e-62	FOS	CD8+ T cells	GSE161801_PI_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16122
2.33975562854397e-65	-0.655988970692197	0.154	0.333	4.29345157837818e-61	TRDC	CD8+ T cells	GSE161801_PI_post	ENSG00000211829	NA	NA	NA	TR_C_gene	B7Z8K6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16123
2.37001752736027e-65	-0.307063012681863	0.257	0.476	4.34898216270609e-61	MBP	CD8+ T cells	GSE161801_PI_post	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16124
2.82115944324912e-64	-0.346959669007859	0.566	0.805	5.17682757836213e-60	HINT1	CD8+ T cells	GSE161801_PI_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16125
2.94469541888508e-64	-0.270022980862691	0.155	0.343	5.40351609365411e-60	CCDC167	CD8+ T cells	GSE161801_PI_post	ENSG00000198937	154467	coiled-coil domain containing 167	C6orf129|dJ153P14.2	protein_coding	Q9P0B6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16126
1.77008129897623e-62	-0.35482661405322	0.476	0.705	3.24809918362139e-58	LYAR	CD8+ T cells	GSE161801_PI_post	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16127
1.99916972726609e-62	-0.362014373938448	0.561	0.785	3.66847644953328e-58	ITGB2	CD8+ T cells	GSE161801_PI_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16128
3.83862724950587e-61	0.600997199703173	0.555	0.374	7.04388100284326e-57	CCL4	CD8+ T cells	GSE161801_PI_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16129
1.20010320611995e-59	-0.577985826870981	0.233	0.428	2.20218938323011e-55	LTB	CD8+ T cells	GSE161801_PI_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16130
1.93451037856778e-59	-0.265548643713758	1	1	3.54982654467187e-55	RPS12	CD8+ T cells	GSE161801_PI_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16131
1.90007216645362e-58	-0.31175027445668	0.936	0.972	3.48663242544239e-54	RPSA	CD8+ T cells	GSE161801_PI_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16132
4.74828832074975e-58	-0.267346585045142	0.139	0.313	8.71310906857579e-54	SELL	CD8+ T cells	GSE161801_PI_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16133
1.75921362544423e-55	-0.252618614686861	0.995	0.998	3.22815700269016e-51	RPL30	CD8+ T cells	GSE161801_PI_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16134
4.25671067107956e-55	-0.335787516061393	0.757	0.903	7.81106408143099e-51	ARPC2	CD8+ T cells	GSE161801_PI_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16135
4.55915811255125e-54	-0.296383254687005	0.472	0.698	8.36605513653154e-50	SARAF	CD8+ T cells	GSE161801_PI_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16136
2.41573692327415e-53	-0.282051893125903	0.91	0.965	4.43287725420807e-49	RPL24	CD8+ T cells	GSE161801_PI_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16137
3.41034896589213e-53	0.482162975495349	0.749	0.671	6.25799035241206e-49	TRAC	CD8+ T cells	GSE161801_PI_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16138
4.19384093459675e-52	-0.28203539184011	0.297	0.498	7.69569811498504e-48	PCSK7	CD8+ T cells	GSE161801_PI_post	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16139
8.96413584535923e-51	-0.406489826177986	0.586	0.777	1.64491892762342e-46	DUSP2	CD8+ T cells	GSE161801_PI_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16140
1.16004117886102e-50	-0.256320769619174	0.269	0.468	2.12867556320997e-46	DDX6	CD8+ T cells	GSE161801_PI_post	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16141
1.97255042563921e-50	-0.27417306512501	0.327	0.534	3.61963003104795e-46	NAP1L1	CD8+ T cells	GSE161801_PI_post	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16142
1.40277836118387e-49	-0.302287137048835	0.465	0.67	2.57409829277241e-45	C12orf75	CD8+ T cells	GSE161801_PI_post	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16143
4.40507357501138e-48	-0.254123916465992	0.333	0.543	8.08331001014589e-44	PNISR	CD8+ T cells	GSE161801_PI_post	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16144
3.27622370123701e-47	-0.300391815490699	0.394	0.599	6.01187049176991e-43	IRF1	CD8+ T cells	GSE161801_PI_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16145
4.77528835529209e-47	-0.25761885252732	0.306	0.499	8.76265413196099e-43	RNF213	CD8+ T cells	GSE161801_PI_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16146
2.75020964436013e-45	-0.313148362936197	0.697	0.854	5.04663469740083e-41	CTSW	CD8+ T cells	GSE161801_PI_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16147
1.75699424740848e-44	-0.269886043013717	0.324	0.519	3.22408444399456e-40	LDHA	CD8+ T cells	GSE161801_PI_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16148
8.99613340742883e-42	-0.257341084624908	0.391	0.583	1.65079048026319e-37	CCNI	CD8+ T cells	GSE161801_PI_post	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16149
5.94952419926012e-40	-0.282333262922422	0.127	0.258	1.09173769056423e-35	ZNF683	CD8+ T cells	GSE161801_PI_post	ENSG00000176083	257101	zinc finger protein 683	Hobit|MGC33414	protein_coding	Q8IZ20	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16150
7.42986948892328e-40	-0.266715046602916	0.252	0.421	1.36338105121742e-35	SLC25A5	CD8+ T cells	GSE161801_PI_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16151
7.01586560305168e-39	0.354275628530116	0.395	0.244	1.28741133815998e-34	AC114760.2	CD8+ T cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16152
2.93893503479759e-36	-0.256909372967171	0.594	0.775	5.39294578885358e-32	VAMP2	CD8+ T cells	GSE161801_PI_post	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16153
4.99309885097395e-36	0.267952423922222	0.932	0.924	9.1623363915372e-32	MYL12A	CD8+ T cells	GSE161801_PI_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16154
8.30200966756087e-36	0.472656808325373	0.345	0.21	1.52341877399742e-31	KLF6	CD8+ T cells	GSE161801_PI_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16155
4.18796336091844e-35	0.362133977523439	0.472	0.34	7.68491276728533e-31	LINC01871	CD8+ T cells	GSE161801_PI_post	ENSG00000235576	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16156
4.43732944598561e-35	-0.325366336334649	0.867	0.918	8.14249953338359e-31	GAPDH	CD8+ T cells	GSE161801_PI_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16157
2.0261127172946e-34	0.462803549703964	0.672	0.642	3.71791683623559e-30	IER2	CD8+ T cells	GSE161801_PI_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16158
3.88430903616141e-34	-0.268286378153612	0.592	0.786	7.12770708135619e-30	S100A10	CD8+ T cells	GSE161801_PI_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16159
8.29134865060249e-34	-0.250525632480401	0.511	0.705	1.52146247738556e-29	HLA-DRB1	CD8+ T cells	GSE161801_PI_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16160
4.52434423351413e-30	0.419422273962765	0.626	0.542	8.30217166849844e-26	LGALS1	CD8+ T cells	GSE161801_PI_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16161
4.47638952648153e-29	0.385610668961669	0.621	0.563	8.21417478109361e-25	KLRD1	CD8+ T cells	GSE161801_PI_post	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16162
6.06201912805151e-28	0.303102587995793	0.275	0.157	1.11238050999745e-23	IFI6	CD8+ T cells	GSE161801_PI_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16163
3.99608860801851e-27	0.657441113817507	0.705	0.682	7.33282259571397e-23	GNLY	CD8+ T cells	GSE161801_PI_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16164
7.96679937431461e-26	0.296426242760783	0.54	0.45	1.46190768518673e-21	PTP4A2	CD8+ T cells	GSE161801_PI_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16165
2.56071147073348e-24	0.393247944125885	0.539	0.433	4.69890554879594e-20	GZMB	CD8+ T cells	GSE161801_PI_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16166
3.36786186281246e-24	0.323121334619578	0.607	0.53	6.18002651826087e-20	PRF1	CD8+ T cells	GSE161801_PI_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16167
1.41477353355639e-23	-0.357977618656063	0.743	0.847	2.59610943407598e-19	ACTG1	CD8+ T cells	GSE161801_PI_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16168
1.94777707452744e-23	0.254825240531742	0.81	0.722	3.57417093175785e-19	GZMH	CD8+ T cells	GSE161801_PI_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16169
4.20577151411621e-23	0.270905671754704	0.765	0.765	7.71759072840325e-19	EMP3	CD8+ T cells	GSE161801_PI_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16170
4.53150843607042e-23	0.402915637262202	0.406	0.317	8.31531798018922e-19	TSC22D3	CD8+ T cells	GSE161801_PI_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16171
4.43248219142666e-19	0.277997291852782	0.749	0.723	8.13360482126793e-15	ID2	CD8+ T cells	GSE161801_PI_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16172
6.36544249235008e-18	0.337004035323584	0.347	0.263	1.16805869734624e-13	H1FX	CD8+ T cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16173
4.36739141981645e-08	0.259649464179429	0.6	0.633	0.000801416325536319	HSPA8	CD8+ T cells	GSE161801_PI_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16174
3.83319899304175e-44	-1.20206267523225	0.035	0.789	7.03392015223162e-40	HLA-DQA2	B cells	GSE161801_PI_post	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16175
2.29728420679977e-21	-0.778553780582548	0.101	0.711	4.21551651947758e-17	XIST	B cells	GSE161801_PI_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16176
2.39151877159305e-21	-1.0544884427897	0.182	0.895	4.38843694587324e-17	S100A9	B cells	GSE161801_PI_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16177
1.0820278041139e-12	-0.493168329867347	0.022	0.289	1.985521020549e-08	CD27	B cells	GSE161801_PI_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16178
4.32161358848131e-12	-0.684697214207985	1	1	7.9301609348632e-08	RPS4X	B cells	GSE161801_PI_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16179
4.62094526669684e-11	1.09058564143889	0.921	0.632	8.47943456438869e-07	RPL36A	B cells	GSE161801_PI_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16180
1.10587996573415e-10	-0.391996460121785	0.053	0.368	2.02928973712217e-06	ITGB2-AS1	B cells	GSE161801_PI_post	ENSG00000227039	100505746	ITGB2 antisense RNA 1	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16181
1.1202077581567e-10	-0.342489417369679	0.038	0.316	2.05558123621755e-06	NBPF14	B cells	GSE161801_PI_post	ENSG00000270629	25832	NBPF member 14	DJ328E19.C1.1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16182
1.4399570949511e-10	-0.824027069066894	0.877	1	2.64232126923526e-06	HLA-DRB1	B cells	GSE161801_PI_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16183
1.60538150293415e-10	-0.642998528622135	0.17	0.658	2.94587505788417e-06	S100A8	B cells	GSE161801_PI_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16184
1.67738574478997e-10	-0.618891046941302	0.151	0.579	3.07800284168959e-06	ANXA4	B cells	GSE161801_PI_post	ENSG00000196975	307	annexin A4	ANX4	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16185
1.66317007496818e-09	-0.816261149191843	0.783	1	3.05191708756661e-05	MT-ND1	B cells	GSE161801_PI_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16186
1.89369244970214e-09	-0.459412063697161	0.097	0.447	3.47492564520343e-05	SND1	B cells	GSE161801_PI_post	ENSG00000197157	27044	staphylococcal nuclease and tudor domain containing 1	p100|TDRD11	protein_coding	Q7KZF4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16187
2.13808037975847e-09	-0.385214716367514	0.072	0.395	3.92337749685679e-05	PBXIP1	B cells	GSE161801_PI_post	ENSG00000163346	57326	PBX homeobox interacting protein 1	HPIP	protein_coding	Q96AQ6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16188
5.95055962248473e-09	-0.621200433632967	0.994	1	0.000109192769072595	RPS11	B cells	GSE161801_PI_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16189
1.06936044535712e-08	1.30238311273654	0.83	0.5	0.000196227641723032	CXCR4	B cells	GSE161801_PI_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16190
1.28241949578013e-08	-0.463782713938355	0.107	0.447	0.000235323977475653	SRPK2	B cells	GSE161801_PI_post	ENSG00000135250	6733	SRSF protein kinase 2	SFRSK2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16191
1.31469913944364e-08	-0.425227137688722	0.069	0.368	0.000241247292087908	MAP3K8	B cells	GSE161801_PI_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16192
1.34598313058951e-08	-0.476221187230405	1	1	0.000246987904463176	RPS7	B cells	GSE161801_PI_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16193
1.78824007340815e-08	-0.536797081924807	1	1	0.000328142053470396	RPS24	B cells	GSE161801_PI_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16194
2.69151631238818e-08	-0.538587595030462	0.167	0.553	0.000493893243323231	NSA2	B cells	GSE161801_PI_post	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16195
4.54666291342142e-08	-0.313343071710162	0.038	0.263	0.000834312644612831	FUOM	B cells	GSE161801_PI_post	ENSG00000148803	282969	fucose mutarotase	C10orf125|FLJ26016|FucM|FucU	protein_coding	A2VDF0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16196
4.96178916390658e-08	-0.351767230957689	0.066	0.342	0.000910488311576857	TOR3A	B cells	GSE161801_PI_post	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16197
5.55911358332718e-08	0.571906299714136	1	1	0.00102009734254054	MALAT1	B cells	GSE161801_PI_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16198
1.27539349106894e-07	-0.325107339141442	0.05	0.289	0.0023403470561115	EXOC1	B cells	GSE161801_PI_post	ENSG00000090989	55763	exocyst complex component 1	BM-102|FLJ10893|SEC3|SEC3L1|Sec3p	protein_coding	Q9NV70	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16199
1.61894091961492e-07	-0.274878511215001	0.041	0.263	0.00297075658749338	LILRB1	B cells	GSE161801_PI_post	ENSG00000276452	10859	leukocyte immunoglobulin like receptor B1	CD85|CD85j|ILT2|LIR-1|LIR1|MIR-7|PIR-B|PIRB	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16200
1.64957519059414e-07	-0.679862345829922	0.862	0.974	0.00302697047474025	HLA-DPA1	B cells	GSE161801_PI_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16201
1.67856562623342e-07	0.669339432071765	1	1	0.00308016792413832	RPS29	B cells	GSE161801_PI_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16202
1.8155211101757e-07	-0.645485696246666	1	1	0.00333148123717241	MT-CO1	B cells	GSE161801_PI_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16203
2.16316643937841e-07	-0.581707364202494	0.236	0.605	0.00396941041625939	BLK	B cells	GSE161801_PI_post	ENSG00000285369	640	BLK proto-oncogene, Src family tyrosine kinase	MGC10442	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16204
2.26774959568273e-07	-0.393665434634114	1	1	0.00416132050807782	RPS15A	B cells	GSE161801_PI_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16205
3.41344862711557e-07	-0.291648000610843	0.053	0.289	0.00626367823075707	STMN3	B cells	GSE161801_PI_post	ENSG00000197457	50861	stathmin 3	SCLIP	protein_coding	Q9NZ72	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16206
3.4253370882425e-07	-0.414029678741255	0.113	0.421	0.00628549355692498	KIAA0040	B cells	GSE161801_PI_post	ENSG00000235750	9674	KIAA0040	NA	protein_coding	Q15053	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16207
3.55183920956547e-07	-0.677874667428157	0.975	1	0.00651762494955264	MT-ND2	B cells	GSE161801_PI_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16208
3.84889488778845e-07	-0.378209203162299	0.138	0.474	0.00706272211909181	CYTH1	B cells	GSE161801_PI_post	ENSG00000108669	9267	cytohesin 1	B2-1|cytohesin-1|D17S811E|PSCD1	protein_coding	Q15438	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16209
4.08462295528083e-07	-0.399725601273478	0.192	0.605	0.00749528312294032	LYZ	B cells	GSE161801_PI_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16210
4.61938173047336e-07	-0.578289718037169	0.994	1	0.00847656547541862	TPT1	B cells	GSE161801_PI_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16211
4.88378613676308e-07	0.771152309928767	0.931	0.842	0.00896174756096025	RPS17	B cells	GSE161801_PI_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16212
4.93405869485932e-07	-0.34333039380905	0.053	0.289	0.00905399770506685	FCN1	B cells	GSE161801_PI_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16213
4.95074088608586e-07	0.956243723865062	0.437	0	0.00908460952596755	RPS4Y1	B cells	GSE161801_PI_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16214
6.5911469489923e-07	-0.421099252066045	0.094	0.368	0.0120947546514009	TNFRSF13B	B cells	GSE161801_PI_post	ENSG00000240505	23495	TNF receptor superfamily member 13B	CD267|IGAD2|TACI	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16215
6.93901166193586e-07	-0.340062679975139	0.101	0.395	0.0127330863996523	NIN	B cells	GSE161801_PI_post	ENSG00000100503	51199	ninein	NA	protein_coding	Q8N4C6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16216
7.3776741580591e-07	-0.527207579540446	0.39	0.816	0.0135380320800384	ARPC5	B cells	GSE161801_PI_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16217
7.37779763243227e-07	-0.287347863177218	0.057	0.289	0.0135382586555132	BZW2	B cells	GSE161801_PI_post	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16218
7.53626251390631e-07	-0.290959116729597	0.066	0.316	0.0138290417130181	CLTB	B cells	GSE161801_PI_post	ENSG00000175416	1212	clathrin light chain B	Lcb	protein_coding	P09497	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16219
7.71471181259908e-07	-0.30793219533331	0.057	0.289	0.0141564961761193	TLE1	B cells	GSE161801_PI_post	ENSG00000196781	7088	TLE family member 1, transcriptional corepressor	ESG|ESG1|GRG1|TLE-1	protein_coding	Q04724	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16220
8.32563180913924e-07	-0.411686927728705	0.082	0.342	0.0152775343697705	ARID3A	B cells	GSE161801_PI_post	ENSG00000116017	1820	AT-rich interaction domain 3A	BRIGHT|DRIL1	protein_coding	Q99856	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16221
9.04424037230195e-07	-0.714769086911894	0.264	0.605	0.0165961810831741	COTL1	B cells	GSE161801_PI_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16222
1.01939524590579e-06	-0.572097784734048	1	1	0.0187059027623712	EEF1A1	B cells	GSE161801_PI_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16223
1.07291567689931e-06	0.874356631460126	0.56	0.132	0.0196880026711024	GNLY	B cells	GSE161801_PI_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16224
1.2334217862078e-06	-0.444369031388892	0.142	0.447	0.0226332897769132	R3HDM4	B cells	GSE161801_PI_post	ENSG00000198858	91300	R3H domain containing 4	C19orf22|MGC16353	protein_coding	Q96D70	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16225
1.31509201312015e-06	-0.461675286297516	1	1	0.0241319384407548	RPS3A	B cells	GSE161801_PI_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16226
1.32139438765898e-06	-0.502476955270993	0.997	1	0.0242475870135422	HLA-B	B cells	GSE161801_PI_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16227
1.3275586115817e-06	-0.441046660879097	0.167	0.526	0.0243607005225242	S100A11	B cells	GSE161801_PI_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16228
1.36250649886213e-06	-0.661917743652336	0.167	0.5	0.0250019942541201	TXN	B cells	GSE161801_PI_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16229
1.38044614526921e-06	-0.462979830743405	0.981	1	0.02533118676569	UBA52	B cells	GSE161801_PI_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16230
1.55620129601959e-06	0.655984728399361	0.535	0.105	0.0285562937819594	NKG7	B cells	GSE161801_PI_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16231
1.69844094878696e-06	-0.360253696845518	0.05	0.263	0.0311663914102408	KLF10	B cells	GSE161801_PI_post	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16232
2.23961462510681e-06	-0.452608296968727	1	1	0.0410969283707099	RPS12	B cells	GSE161801_PI_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16233
2.63410981754952e-06	-0.566330339745326	0.965	1	0.0483359151520337	RPSA	B cells	GSE161801_PI_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16234
2.6757632695692e-06	-0.427962238359398	0.129	0.421	0.0491002559965948	MKNK2	B cells	GSE161801_PI_post	ENSG00000099875	2872	MAPK interacting serine/threonine kinase 2	GPRK7|MNK2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16235
5.21258023402323e-16	-0.474779582970733	0.117	0.438	9.56508472943263e-12	XIST	CD4+ T cells	GSE161801_PI_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16236
4.02740130609245e-14	-0.534098418075314	0.24	0.613	7.39028139667965e-10	PIK3R1	CD4+ T cells	GSE161801_PI_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16237
8.82382867106899e-14	-0.498929061193702	0.199	0.562	1.61917256114116e-09	C12orf75	CD4+ T cells	GSE161801_PI_post	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16238
2.69822369799441e-13	0.975752453753323	0.433	0	4.95124048581973e-09	RPS4Y1	CD4+ T cells	GSE161801_PI_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16239
4.14095593937942e-13	0.661697810148759	0.978	0.863	7.59865414876123e-09	RPL36A	CD4+ T cells	GSE161801_PI_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16240
5.06127382322603e-12	-0.654527195814516	0.185	0.488	9.28743746561977e-08	S100A9	CD4+ T cells	GSE161801_PI_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16241
6.11840585128212e-12	-0.482515231750338	0.997	1	1.12272747371027e-07	RPS24	CD4+ T cells	GSE161801_PI_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16242
1.54717763738328e-10	-0.514174583231729	0.416	0.775	2.83907096459832e-06	HMGB2	CD4+ T cells	GSE161801_PI_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16243
3.45102558510353e-10	-0.495279264607054	0.883	1	6.33263194866498e-06	MT-ATP6	CD4+ T cells	GSE161801_PI_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16244
6.11418269214266e-10	-0.375121096647948	1	1	1.12195252400818e-05	HLA-B	CD4+ T cells	GSE161801_PI_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16245
8.0415817370101e-10	-0.681727593468987	0.471	0.775	1.47563024874135e-05	DUSP2	CD4+ T cells	GSE161801_PI_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16246
1.09875163238936e-09	1.29807683426633	0.412	0.075	2.01620924543447e-05	FOS	CD4+ T cells	GSE161801_PI_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16247
1.51240209147703e-09	-0.444300350016134	0.207	0.488	2.77525783786036e-05	EML4	CD4+ T cells	GSE161801_PI_post	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16248
1.52685838300102e-09	0.401126604504021	1	1	2.80178513280687e-05	RPS29	CD4+ T cells	GSE161801_PI_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16249
3.00451080837601e-09	-0.341314519344657	0.09	0.3	5.51327733336998e-05	NPDC1	CD4+ T cells	GSE161801_PI_post	ENSG00000107281	56654	neural proliferation, differentiation and control 1	CAB-|CAB1|DKFZp586J0523	protein_coding	Q9NQX5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16250
3.18159085507468e-09	-0.318277282210761	0.999	1	5.83821921906203e-05	RPL28	CD4+ T cells	GSE161801_PI_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16251
1.87750278065827e-08	-0.433156644960587	0.174	0.425	0.000344521760250793	LYZ	CD4+ T cells	GSE161801_PI_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16252
1.95567052149117e-08	-0.561246431747349	0.323	0.6	0.00035886554069363	LYAR	CD4+ T cells	GSE161801_PI_post	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16253
1.95744131622417e-08	-0.612059796598577	0.512	0.725	0.000359190481527136	MT-ND5	CD4+ T cells	GSE161801_PI_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16254
3.69239510277715e-08	-0.313770052066074	0.127	0.35	0.000677554501359607	CASP8	CD4+ T cells	GSE161801_PI_post	ENSG00000064012	841	caspase 8	Casp-8|FLICE|MACH|MCH5	protein_coding	Q14790	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16255
9.23746090545248e-08	0.685239011259959	0.952	0.925	0.00169507407615053	JUNB	CD4+ T cells	GSE161801_PI_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16256
1.11836724131247e-07	0.378557550185112	0.999	1	0.00205220388780838	HLA-A	CD4+ T cells	GSE161801_PI_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16257
1.7429387725552e-07	-0.425182056684386	0.964	1	0.00319829264763879	MT-ND2	CD4+ T cells	GSE161801_PI_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16258
2.11456674404392e-07	-0.324894051039237	0.997	1	0.00388022997532059	MT-CO1	CD4+ T cells	GSE161801_PI_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16259
3.64269104542669e-07	-0.440417240718653	0.189	0.412	0.00668433806835798	CCDC167	CD4+ T cells	GSE161801_PI_post	ENSG00000198937	154467	coiled-coil domain containing 167	C6orf129|dJ153P14.2	protein_coding	Q9P0B6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16260
3.67878314144146e-07	-0.336574870851764	0.997	1	0.00675056706454507	MT-CO2	CD4+ T cells	GSE161801_PI_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16261
4.72577064041211e-07	1.1064287174572	0.48	0.225	0.00867178912515622	DUSP1	CD4+ T cells	GSE161801_PI_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16262
5.04556892527911e-07	0.486120597340326	0.289	0.025	0.00925861897788717	IFI44L	CD4+ T cells	GSE161801_PI_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16263
5.66799030762566e-07	-0.731913079075296	0.634	0.812	0.0104007622144931	CCL5	CD4+ T cells	GSE161801_PI_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16264
6.36367710860231e-07	-0.337753062049045	0.2	0.438	0.0116773474942852	POLR1D	CD4+ T cells	GSE161801_PI_post	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16265
1.45298854877024e-06	-0.381565926309026	0.977	0.988	0.0266623398699338	MT-ND4	CD4+ T cells	GSE161801_PI_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16266
1.94338764569488e-06	-0.34334809944719	0.131	0.325	0.035661163298501	HOPX	CD4+ T cells	GSE161801_PI_post	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16267
3.08271466744364e-137	-1.11462325503803	0.2	0.79	5.65678141475907e-133	S100A9	NK cells	GSE161801_PI_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16268
3.56263431972144e-111	-0.921466138805775	0.207	0.758	6.53743397668885e-107	S100A8	NK cells	GSE161801_PI_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16269
5.14156659457581e-103	-0.897508579628199	0.961	1	9.4347747010466e-99	MT-ND2	NK cells	GSE161801_PI_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16270
7.03870548125976e-103	0.778180461057198	1	0.994	1.29160245581117e-98	RPS29	NK cells	GSE161801_PI_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16271
1.34196875669861e-98	-0.820260129375357	0.196	0.71	2.46251266854194e-94	LYZ	NK cells	GSE161801_PI_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16272
4.49895261784517e-93	-0.885128884459704	0.967	0.994	8.25557805374589e-89	TPT1	NK cells	GSE161801_PI_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16273
3.32387831587828e-89	-0.737591280319225	1	1	6.09931670963665e-85	EEF1A1	NK cells	GSE161801_PI_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16274
1.85346547891824e-82	-0.554057246453487	0.089	0.487	3.40110915381498e-78	XIST	NK cells	GSE161801_PI_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16275
2.4404915076668e-70	-0.533304763251843	0.999	1	4.47830191656857e-66	MT-CO1	NK cells	GSE161801_PI_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16276
6.97221214495985e-67	-0.552227057184887	0.128	0.523	1.27940092860013e-62	CST3	NK cells	GSE161801_PI_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16277
1.66787559861225e-60	-0.552279307402054	0.988	0.998	3.06055172345348e-56	RPS24	NK cells	GSE161801_PI_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16278
3.36811976871127e-59	-0.521619907698726	0.999	1	6.18049977558519e-55	RPS4X	NK cells	GSE161801_PI_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16279
2.29934833362132e-58	-0.44605978421997	1	1	4.21930419219512e-54	HLA-B	NK cells	GSE161801_PI_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16280
7.69372982923013e-58	-0.639161902612734	0.153	0.504	1.41179942366373e-53	MAP3K8	NK cells	GSE161801_PI_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16281
6.46284464578256e-56	-0.397236860058788	0.065	0.355	1.1859319925011e-51	FCN1	NK cells	GSE161801_PI_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16282
1.25387902319974e-53	-0.717516274300898	0.712	0.92	2.30086800757151e-49	MT-ND1	NK cells	GSE161801_PI_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16283
5.32673489718372e-53	-0.544385571906581	0.145	0.481	9.77455853633213e-49	PIK3R1	NK cells	GSE161801_PI_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16284
8.4559480877131e-53	-0.835893847245475	0.243	0.624	1.55166647409535e-48	SELL	NK cells	GSE161801_PI_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16285
3.43948132025503e-52	0.78169940465483	0.363	0	6.31144822266798e-48	RPS4Y1	NK cells	GSE161801_PI_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16286
1.78222437034838e-51	0.999352605674067	0.742	0.439	3.27038171958928e-47	GZMH	NK cells	GSE161801_PI_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16287
2.61586841695238e-51	-0.786667800550674	0.511	0.872	4.80011854510761e-47	CMC1	NK cells	GSE161801_PI_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16288
1.96049409535736e-50	-0.881575498529727	0.194	0.534	3.59750666498076e-46	GZMK	NK cells	GSE161801_PI_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16289
2.45730693384989e-50	-0.822777708769052	0.545	0.872	4.50915822361455e-46	ZFP36L2	NK cells	GSE161801_PI_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16290
7.53884671739042e-50	-0.511440553421623	0.978	0.996	1.38337837264114e-45	MT-ND4	NK cells	GSE161801_PI_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16291
6.01085084446915e-49	0.674854509643167	0.886	0.702	1.10299112996009e-44	RPL36A	NK cells	GSE161801_PI_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16292
1.44753574936732e-47	-0.865494788271917	0.626	0.887	2.65622810008903e-43	KLRB1	NK cells	GSE161801_PI_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16293
1.50586811079135e-46	-0.636964664309081	0.468	0.826	2.76326798330213e-42	MT-ND5	NK cells	GSE161801_PI_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16294
2.72912026094646e-46	-0.382670775905611	0.091	0.376	5.00793567883676e-42	LST1	NK cells	GSE161801_PI_post	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16295
9.21671896262472e-45	-0.545784640180901	0.925	0.994	1.69126792964164e-40	MT-ATP6	NK cells	GSE161801_PI_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16296
4.51726308112759e-44	-0.626969643089579	0.231	0.576	8.28917775386912e-40	KLRC1	NK cells	GSE161801_PI_post	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16297
6.90746077875354e-43	-0.470092831180967	0.982	0.998	1.26751905290128e-38	RPL9	NK cells	GSE161801_PI_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16298
7.38378231296554e-43	-0.591077367160983	0.52	0.845	1.35492405442918e-38	HOPX	NK cells	GSE161801_PI_post	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16299
2.63697120978099e-42	-0.455306998041773	0.995	1	4.83884216994812e-38	MT-CO3	NK cells	GSE161801_PI_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16300
1.01211650931324e-41	-0.361820198895405	0.095	0.37	1.85723379458979e-37	AIF1	NK cells	GSE161801_PI_post	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16301
1.05084915901673e-41	-0.44621531796162	0.997	1	1.92830820679571e-37	RPS3A	NK cells	GSE161801_PI_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16302
1.01058376224919e-38	-0.391250017813914	0.999	1	1.85442120372727e-34	RPL13	NK cells	GSE161801_PI_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16303
1.83707748053436e-38	-0.472319972104307	0.928	0.983	3.37103717678056e-34	RPL7A	NK cells	GSE161801_PI_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16304
2.35180758662184e-38	-0.472034938859052	0.959	0.994	4.31556692145108e-34	MT-CYB	NK cells	GSE161801_PI_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16305
8.76538380080764e-38	-0.304232350424328	0.053	0.258	1.6084479274482e-33	IL18RAP	NK cells	GSE161801_PI_post	ENSG00000115607	8807	interleukin 18 receptor accessory protein	AcPL|CD218b	protein_coding	O95256	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16306
1.11227724653158e-37	0.384102989916178	1	1	2.04102874738544e-33	HLA-C	NK cells	GSE161801_PI_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16307
1.16763131459067e-37	1.31930798811536	0.641	0.351	2.14260346227387e-33	CCL4	NK cells	GSE161801_PI_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16308
7.48078828700119e-37	-0.429017471438565	0.995	1	1.37272465066472e-32	H3F3B	NK cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16309
1.8820905270002e-36	-0.522964508130713	0.543	0.912	3.45363611704537e-32	FCER1G	NK cells	GSE161801_PI_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16310
2.27017049565906e-36	-0.596354655943339	0.666	0.895	4.16576285953438e-32	CD7	NK cells	GSE161801_PI_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16311
4.20539507972038e-36	-0.50702911447299	0.352	0.672	7.7168999712869e-32	IL2RB	NK cells	GSE161801_PI_post	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16312
2.94716807279245e-35	-0.416207285097172	0.984	0.996	5.40805341357414e-31	RPL14	NK cells	GSE161801_PI_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16313
8.77621011850758e-34	-0.378219161128432	0.996	1	1.61043455674614e-29	RPL7	NK cells	GSE161801_PI_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16314
2.13248239753299e-33	-0.434741234459157	0.197	0.479	3.91310519947304e-29	C1orf162	NK cells	GSE161801_PI_post	ENSG00000143110	128346	chromosome 1 open reading frame 162	MGC24133	protein_coding	Q8NEQ5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16315
2.21002509731498e-33	0.976373697187327	0.318	0.048	4.05539605357298e-29	JUN	NK cells	GSE161801_PI_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16316
9.13030750259216e-33	-0.465786570944219	0.487	0.807	1.67541142672566e-28	HINT1	NK cells	GSE161801_PI_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16317
9.37485301540671e-32	0.535743956704513	0.894	0.758	1.72028552832713e-27	RPS17	NK cells	GSE161801_PI_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16318
1.31850457638487e-31	-0.344810103483705	1	1	2.41945589766623e-27	RPS15A	NK cells	GSE161801_PI_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16319
6.53511650196222e-31	-0.478042375550974	0.441	0.733	1.19919387811007e-26	NOP53	NK cells	GSE161801_PI_post	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16320
9.21986770350648e-31	-0.335055573695097	0.1	0.326	1.69184572359344e-26	XCL1	NK cells	GSE161801_PI_post	ENSG00000143184	6375	X-C motif chemokine ligand 1	ATAC|LPTN|LTN|SCM-1|SCM-1a|SCYC1	protein_coding	P47992	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16321
3.49312150721448e-30	-0.345448724171345	0.992	0.996	6.40987796573857e-26	FAU	NK cells	GSE161801_PI_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16322
5.19407487928952e-30	0.308168007373264	1	1	9.53112740349627e-26	RPS27	NK cells	GSE161801_PI_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16323
6.25950074760807e-30	-0.363515371228689	0.995	1	1.14861838718608e-25	RPS23	NK cells	GSE161801_PI_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16324
9.67693644263246e-30	-0.37544245367857	0.999	1	1.77571783722306e-25	RPS12	NK cells	GSE161801_PI_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16325
3.01877215961787e-29	-0.346978173792463	1	1	5.53944691289878e-25	RPL13A	NK cells	GSE161801_PI_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16326
5.36598175515833e-29	-0.376633189763167	0.161	0.397	9.84657652071553e-25	TXK	NK cells	GSE161801_PI_post	ENSG00000074966	7294	TXK tyrosine kinase	BTKL|PSCTK5|PTK4|RLK|TKL	protein_coding	P42681	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16327
1.1831965131864e-28	-0.396424896262374	0.18	0.437	2.17116560169705e-24	COTL1	NK cells	GSE161801_PI_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16328
1.37742827645063e-28	-0.474838682817111	0.472	0.752	2.5275808872869e-24	EEF1B2	NK cells	GSE161801_PI_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16329
1.76816052362188e-28	0.256470218526057	1	1	3.24457456084615e-24	TMSB4X	NK cells	GSE161801_PI_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16330
1.01447610279427e-27	-0.358655005577669	0.982	0.994	1.86156364862749e-23	RPL29	NK cells	GSE161801_PI_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16331
1.24012610708092e-27	-0.350980015720626	1	1	2.27563140649349e-23	RPLP1	NK cells	GSE161801_PI_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16332
1.56977801510678e-27	-0.41606814968142	0.895	0.96	2.88054265772093e-23	RPL5	NK cells	GSE161801_PI_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16333
3.5783332213651e-27	-0.32560255194826	0.997	0.994	6.56624146120496e-23	RPL19	NK cells	GSE161801_PI_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16334
1.05166946550652e-26	-0.31162313031107	0.995	1	1.92981346920447e-22	MT-CO2	NK cells	GSE161801_PI_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16335
1.32305417114554e-26	-0.30172025027947	1	1	2.42780440405206e-22	RPLP2	NK cells	GSE161801_PI_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16336
6.99744722770335e-26	-0.318825087911634	0.974	0.989	1.28403156628356e-21	RPS16	NK cells	GSE161801_PI_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16337
3.3009190041801e-25	-0.341752716144906	0.999	1	6.05718637267048e-21	RPS2	NK cells	GSE161801_PI_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16338
3.55229630194427e-25	-0.312974183166685	0.198	0.45	6.51846371406773e-21	SMDT1	NK cells	GSE161801_PI_post	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16339
5.16575976683214e-25	-0.308185514398597	1	0.998	9.47916917213697e-21	RPL23A	NK cells	GSE161801_PI_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16340
1.10604401469905e-24	-0.43797844962493	0.608	0.872	2.02959076697276e-20	TXNIP	NK cells	GSE161801_PI_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16341
1.27366927051295e-24	-0.333345007630883	0.177	0.401	2.33718311139125e-20	HSH2D	NK cells	GSE161801_PI_post	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16342
2.85420664320165e-24	-0.34149533299408	0.991	0.998	5.23746919027502e-20	RPL30	NK cells	GSE161801_PI_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16343
3.56901604099242e-24	-0.328809458191552	0.985	0.996	6.5491444352211e-20	RPS7	NK cells	GSE161801_PI_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16344
4.49551705857182e-24	0.799450814581204	0.682	0.54	8.24927380247929e-20	LGALS1	NK cells	GSE161801_PI_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16345
5.04554159508165e-24	-0.298007713955795	0.999	0.998	9.25856882697482e-20	RPL28	NK cells	GSE161801_PI_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16346
5.81203557907835e-24	-0.356545816413847	0.328	0.601	1.06650852876088e-19	TSPO	NK cells	GSE161801_PI_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16347
6.08529617550703e-24	-0.408309770233372	0.906	0.971	1.11665184820554e-19	RPSA	NK cells	GSE161801_PI_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16348
7.88327026805409e-24	-0.345874750850136	0.982	0.994	1.44658009418792e-19	RPL18	NK cells	GSE161801_PI_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16349
1.12007871752834e-23	-0.339248209421654	0.23	0.492	2.05534444666451e-19	NFKBIA	NK cells	GSE161801_PI_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16350
1.62370758076289e-23	0.480446820832466	1	1	2.97950341069991e-19	ACTB	NK cells	GSE161801_PI_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16351
3.13898221907445e-23	-0.315433233754732	0.228	0.481	5.76003237200161e-19	CTSS	NK cells	GSE161801_PI_post	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16352
3.25853460758784e-23	-0.414179310868962	0.425	0.695	5.97941100492369e-19	IRF1	NK cells	GSE161801_PI_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16353
1.06957108307488e-22	-0.343816153446943	0.355	0.637	1.9626629374424e-18	CCNI	NK cells	GSE161801_PI_post	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16354
1.25283349434935e-22	0.467119505920421	0.943	0.849	2.29894946213107e-18	UBC	NK cells	GSE161801_PI_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16355
1.99853102913597e-22	0.389860041871825	0.952	0.945	3.66730443846451e-18	MYL12A	NK cells	GSE161801_PI_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16356
3.75130779791706e-22	-0.254530315624311	0.121	0.315	6.88364980917781e-18	RNF125	NK cells	GSE161801_PI_post	ENSG00000101695	54941	ring finger protein 125	FLJ20456	protein_coding	Q96EQ8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16357
4.3382291416253e-22	-0.314917416526183	0.974	0.992	7.96065047488243e-18	RPL27	NK cells	GSE161801_PI_post	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16358
4.58419680435492e-22	-0.252464756164957	1	1	8.41200113599129e-18	RPL10	NK cells	GSE161801_PI_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16359
5.95791560277653e-22	-0.39989272771971	0.4	0.658	1.09327751310949e-17	EIF3G	NK cells	GSE161801_PI_post	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16360
1.36176443288608e-21	-0.293083447091078	0.104	0.279	2.49883773434596e-17	CHST2	NK cells	GSE161801_PI_post	ENSG00000175040	9435	carbohydrate sulfotransferase 2	C6ST	protein_coding	Q9Y4C5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16361
1.88062609824211e-21	-0.352635101326989	0.384	0.649	3.45094889027427e-17	HMGB2	NK cells	GSE161801_PI_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16362
3.25829127851961e-21	0.732869924717438	0.322	0.111	5.97896449608349e-17	CD3D	NK cells	GSE161801_PI_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16363
4.61631513259525e-21	0.502519878785007	0.721	0.624	8.47093826831228e-17	IFITM1	NK cells	GSE161801_PI_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16364
5.06230355614362e-21	-0.279595179707067	1	1	9.28932702552355e-17	RPS3	NK cells	GSE161801_PI_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16365
7.37370935060755e-21	-0.259603068533681	0.999	0.998	1.35307566583648e-16	RPL26	NK cells	GSE161801_PI_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16366
2.66397212514502e-20	0.546394909054915	0.641	0.437	4.88838884964111e-16	FGFBP2	NK cells	GSE161801_PI_post	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16367
2.91644453143753e-20	-0.310590497652691	0.978	0.989	5.35167571518787e-16	RPL8	NK cells	GSE161801_PI_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16368
3.3338714451694e-20	-0.347248247003919	0.871	0.964	6.11765410188584e-16	TYROBP	NK cells	GSE161801_PI_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16369
4.75532354378125e-20	-0.273137380216429	0.998	1	8.7260187028386e-16	RPL27A	NK cells	GSE161801_PI_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16370
5.61604856064188e-20	-0.315977099609829	0.421	0.702	1.03054491087778e-15	SARAF	NK cells	GSE161801_PI_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16371
9.05832561126605e-20	0.498594911026137	0.87	0.836	1.66220274966732e-15	PRF1	NK cells	GSE161801_PI_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16372
1.56252285022709e-19	0.25235935152176	0.999	1	2.86722943016671e-15	HLA-A	NK cells	GSE161801_PI_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16373
8.58216960706118e-19	0.267088353537737	1	1	1.57482812289573e-14	MALAT1	NK cells	GSE161801_PI_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16374
1.15939861101232e-18	-0.33323363167199	0.247	0.462	2.12749645120761e-14	CD44	NK cells	GSE161801_PI_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16375
2.19383241716683e-18	0.538401075245164	0.608	0.429	4.02568248550113e-14	TRBC1	NK cells	GSE161801_PI_post	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16376
4.84043504613029e-18	-0.324046274747333	0.37	0.618	8.88219830964907e-14	PNRC1	NK cells	GSE161801_PI_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16377
1.02614963861934e-17	-0.313873244519132	0.898	0.956	1.88298458686649e-13	RPL24	NK cells	GSE161801_PI_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16378
1.3936752783795e-17	-0.371643397874881	0.436	0.683	2.55739413582638e-13	DUSP2	NK cells	GSE161801_PI_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16379
6.96112488027247e-17	-0.273005382036639	0.308	0.534	1.27736641553e-12	ICAM3	NK cells	GSE161801_PI_post	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16380
7.96230284978288e-17	-0.262290318381503	0.179	0.363	1.46108257293516e-12	SEPT6	NK cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16381
8.57686133311596e-17	0.795968649827781	0.454	0.277	1.57385405462678e-12	DUSP1	NK cells	GSE161801_PI_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16382
9.50755977526528e-17	0.934072107634589	0.327	0.141	1.74463721876118e-12	CCL3	NK cells	GSE161801_PI_post	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16383
1.44038744357167e-16	-0.283985389480822	0.327	0.544	2.64311095895401e-12	MBP	NK cells	GSE161801_PI_post	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16384
1.66433253084876e-16	-0.279489831370487	0.337	0.571	3.05405019410748e-12	PNISR	NK cells	GSE161801_PI_post	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16385
2.03942851275484e-16	-0.268002706375703	0.386	0.634	3.74235132090513e-12	ATP6V1G1	NK cells	GSE161801_PI_post	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16386
2.82268721976005e-16	-0.258909891982608	0.157	0.336	5.1796310482597e-12	IFITM3	NK cells	GSE161801_PI_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16387
5.82326573299458e-16	-0.27803352636163	0.308	0.532	1.06856926200451e-11	LYAR	NK cells	GSE161801_PI_post	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16388
1.1330099392832e-15	0.42640597912252	0.877	0.836	2.07907323858467e-11	S100A6	NK cells	GSE161801_PI_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16389
1.51209093792085e-15	-0.28585790871715	0.951	0.977	2.77468687108476e-11	SRGN	NK cells	GSE161801_PI_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16390
2.0592511152664e-15	0.308869271083847	0.984	0.979	3.77872579651385e-11	CYBA	NK cells	GSE161801_PI_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16391
2.1631894529499e-15	-0.276323687772755	0.561	0.811	3.96945264616306e-11	VAMP2	NK cells	GSE161801_PI_post	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16392
2.21192912191495e-15	-0.258464868799783	0.238	0.437	4.05888993871393e-11	MTRNR2L8	NK cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16393
3.19792391967001e-15	0.831328596087449	0.298	0.137	5.86819039259447e-11	FOS	NK cells	GSE161801_PI_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16394
4.02372326132666e-15	-0.298678586602211	0.595	0.828	7.38353218453443e-11	CIRBP	NK cells	GSE161801_PI_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16395
4.48147927126602e-15	-0.264585671272349	0.211	0.387	8.22351446277314e-11	CDKN2D	NK cells	GSE161801_PI_post	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16396
1.02854061604141e-14	-0.310965344043117	0.878	0.968	1.88737203043598e-10	CTSW	NK cells	GSE161801_PI_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16397
2.48624103945573e-14	-0.256405774593656	0.385	0.618	4.56225230740126e-10	RBM3	NK cells	GSE161801_PI_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16398
5.57432733349354e-14	0.451097399053319	0.93	0.929	1.02288906569606e-09	S100A4	NK cells	GSE161801_PI_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16399
6.98482483694855e-14	-0.265537498160093	0.944	0.964	1.28171535758006e-09	RACK1	NK cells	GSE161801_PI_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16400
7.59039410007842e-14	-0.276097293885921	0.95	0.952	1.39283731736439e-09	RPS5	NK cells	GSE161801_PI_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16401
2.16423804709584e-13	0.491188325627293	0.636	0.555	3.97137681642087e-09	MT2A	NK cells	GSE161801_PI_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16402
2.86563472309198e-13	-0.259803839582697	0.904	0.943	5.25843971687378e-09	CD74	NK cells	GSE161801_PI_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16403
3.01299255438498e-13	-0.291717792218902	0.847	0.918	5.52884133729643e-09	RPL23	NK cells	GSE161801_PI_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16404
1.55870103221203e-12	0.321368700210772	0.845	0.807	2.86021639410908e-08	TMA7	NK cells	GSE161801_PI_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16405
3.89043867698808e-12	-0.279172607042284	0.86	0.92	7.13895497227312e-08	RPL4	NK cells	GSE161801_PI_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16406
3.93128234687363e-12	-0.279931826964116	0.772	0.893	7.21390310651311e-08	HNRNPA1	NK cells	GSE161801_PI_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16407
5.01085044764499e-12	-0.274975578012618	0.526	0.746	9.19491057142855e-08	S100A10	NK cells	GSE161801_PI_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16408
7.38058391685989e-12	0.312463375551242	0.316	0.162	1.35433714874379e-07	ABI3	NK cells	GSE161801_PI_post	ENSG00000108798	51225	ABI family member 3	NESH|SSH3BP3	protein_coding	Q9P2A4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16409
1.4244533359366e-11	-0.285549229232188	0.813	0.926	2.61387187144366e-07	BTG1	NK cells	GSE161801_PI_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16410
2.16829924344767e-11	-0.298598362447508	0.821	0.889	3.97882911172647e-07	RPLP0	NK cells	GSE161801_PI_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16411
2.41632220857932e-11	0.334585503883154	0.309	0.164	4.43395125274305e-07	DDIT4	NK cells	GSE161801_PI_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16412
2.83923343139903e-11	-0.319713794488453	0.466	0.639	5.20999334661723e-07	TAGLN2	NK cells	GSE161801_PI_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16413
3.893738153397e-11	0.276463780967909	0.977	0.973	7.1450095114835e-07	CFL1	NK cells	GSE161801_PI_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16414
4.85194117284466e-11	0.393777620428647	0.454	0.33	8.90331205216996e-07	TRBC2	NK cells	GSE161801_PI_post	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16415
1.09431256573235e-10	0.343464871511879	0.751	0.714	2.00806355811887e-06	EMP3	NK cells	GSE161801_PI_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16416
1.32602497728813e-10	0.420485983010091	0.323	0.193	2.43325583332371e-06	H1FX	NK cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16417
2.10646965347831e-10	0.389849522745345	0.447	0.334	3.86537181413269e-06	KLF2	NK cells	GSE161801_PI_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16418
4.89153513347221e-10	0.276781366334918	0.972	0.975	8.9759669699215e-06	SH3BGRL3	NK cells	GSE161801_PI_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16419
1.88026936161856e-08	0.315410576555457	0.524	0.443	0.000345029427857006	ATP5ME	NK cells	GSE161801_PI_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16420
2.15802558568309e-08	0.324347079656849	0.571	0.496	0.000395997694972846	EFHD2	NK cells	GSE161801_PI_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16421
5.20711454997275e-08	0.30813140014654	0.398	0.29	0.000955505519920001	CRIP1	NK cells	GSE161801_PI_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16422
1.05884553246081e-07	0.30449283225075	0.364	0.267	0.00194298155206558	PET100	NK cells	GSE161801_PI_post	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16423
1.23534512659307e-07	0.311566740973635	0.937	0.91	0.00226685830729828	CD52	NK cells	GSE161801_PI_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16424
1.68816143850588e-07	0.332245365428638	0.343	0.239	0.00309777623965828	LINC01871	NK cells	GSE161801_PI_post	ENSG00000235576	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16425
1.83933209464438e-07	-0.267255750823121	0.161	0.265	0.00337517439367244	LTB	NK cells	GSE161801_PI_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16426
1.87018144932016e-07	0.314044550192597	0.594	0.563	0.00343178295950249	CD99	NK cells	GSE161801_PI_post	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16427
4.30837770329928e-07	0.292034962435293	0.414	0.328	0.00790587308555417	NDUFA13	NK cells	GSE161801_PI_post	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16428
4.31520610618385e-07	0.273904377779066	0.745	0.767	0.00791840320484736	PPDPF	NK cells	GSE161801_PI_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16429
4.74931623794522e-07	0.328770920964289	0.441	0.317	0.00871499529662947	SPON2	NK cells	GSE161801_PI_post	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16430
6.03754299212563e-07	0.274162261046935	0.737	0.609	0.0110788913905505	IL32	NK cells	GSE161801_PI_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16431
8.04714420782792e-07	0.251964625129295	0.306	0.204	0.0147665096213642	ADGRG1	NK cells	GSE161801_PI_post	ENSG00000205336	9289	adhesion G protein-coupled receptor G1	GPR56|TM7LN4|TM7XN1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16432
8.32970014280511e-07	0.287577344992114	0.47	0.401	0.0152849997620474	PTP4A2	NK cells	GSE161801_PI_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16433
2.1967058222206e-06	0.281813641169124	0.333	0.239	0.040309551837748	AC114760.2	NK cells	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16434
7.11899255803745e-27	-2.15270864652346	0.056	0.946	1.30633513439987e-22	HLA-DQA2	cDCs	GSE161801_PI_post	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16435
8.96813930561428e-19	2.0652280731675	0.944	0.429	1.64565356258022e-14	FOS	cDCs	GSE161801_PI_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16436
6.22332225676325e-17	1.8794309933949	0.798	0.054	1.14197963411606e-12	DUSP1	cDCs	GSE161801_PI_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16437
3.3936473311757e-16	1.20498805256019	0.978	0.714	6.22734285270742e-12	RPL36A	cDCs	GSE161801_PI_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16438
1.54934182318964e-14	-0.848084531143691	0.079	0.696	2.84304224555299e-10	XIST	cDCs	GSE161801_PI_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16439
8.57232710381112e-14	-1.00124746660681	0.876	0.982	1.57302202354934e-09	MT-ND1	cDCs	GSE161801_PI_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16440
1.92867815817312e-13	-0.659522157948286	1	1	3.53912442024767e-09	RPS3A	cDCs	GSE161801_PI_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16441
2.38693020529443e-13	-0.641193679582563	1	1	4.38001692671528e-09	RPS12	cDCs	GSE161801_PI_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16442
2.58325114298439e-13	-1.02430291451941	0.944	1	4.74026584737636e-09	MT-ND2	cDCs	GSE161801_PI_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16443
4.19105593414797e-13	0.819781558815426	1	0.982	7.69058763916152e-09	RPS29	cDCs	GSE161801_PI_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16444
1.53174129141009e-12	-0.837427291046377	0.989	1	2.81074526973752e-08	MT-ND4	cDCs	GSE161801_PI_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16445
2.11352351312236e-12	-0.656004440496901	1	1	3.87831564657953e-08	EEF1A1	cDCs	GSE161801_PI_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16446
2.89771389302761e-12	-0.628514048030854	1	1	5.31730499370566e-08	RPL9	cDCs	GSE161801_PI_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16447
2.97870968090802e-12	0.813937943271065	0.978	0.946	5.46593226446622e-08	HLA-DRB5	cDCs	GSE161801_PI_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16448
5.35882276850204e-12	-0.77615760209716	0.966	1	9.83343978020125e-08	TPT1	cDCs	GSE161801_PI_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16449
1.41620907569786e-10	0.840635138579064	0.697	0.161	2.59874365390557e-06	AC114760.2	cDCs	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16450
2.7443646841831e-10	0.460955711920435	1	1	5.035909195476e-06	RPS27	cDCs	GSE161801_PI_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16451
3.46529119573788e-10	-0.551812171427835	1	1	6.358809344179e-06	RPS4X	cDCs	GSE161801_PI_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16452
6.6032558050468e-10	1.047413062153	0.978	0.768	1.21169744022609e-05	JUNB	cDCs	GSE161801_PI_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16453
6.90406359156946e-10	1.00808234629786	0.494	0	1.266895669053e-05	RPS4Y1	cDCs	GSE161801_PI_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16454
7.32980194813691e-10	-0.443071724309867	1	1	1.34501865748312e-05	RPS2	cDCs	GSE161801_PI_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16455
1.03617191927085e-09	-0.723344968126722	0.955	1	1.90137547186201e-05	MT-ATP6	cDCs	GSE161801_PI_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16456
1.055986551717e-09	-1.08341600818764	0.169	0.661	1.93773532240069e-05	AC020656.1	cDCs	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16457
3.86848912190064e-09	0.759483030727634	0.921	0.786	7.09867753868767e-05	RPS17	cDCs	GSE161801_PI_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16458
6.28235446230778e-09	-0.564415279505898	0.989	1	0.000115281204383348	HLA-B	cDCs	GSE161801_PI_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16459
7.25841217992148e-09	-0.722640102695268	0.989	1	0.000133191863501559	MT-CYB	cDCs	GSE161801_PI_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16460
7.42515910391236e-09	-0.426017671339749	1	1	0.000136251669556792	RPS15A	cDCs	GSE161801_PI_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16461
9.58395492724755e-09	-0.648016893314837	1	1	0.000175865572914993	MT-CO1	cDCs	GSE161801_PI_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16462
1.12897133967094e-08	0.74665899037005	0.64	0.161	0.000207166240829617	H1FX	cDCs	GSE161801_PI_post	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16463
1.26719823675314e-08	0.670710137136751	0.944	0.714	0.000232530876444201	TMA7	cDCs	GSE161801_PI_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16464
1.70477172295118e-08	-0.407038401614875	1	1	0.000312825611161541	RPS24	cDCs	GSE161801_PI_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16465
2.5311562768272e-08	-0.89958938704707	0.978	0.982	0.000464467176797791	VIM	cDCs	GSE161801_PI_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16466
6.0039819534998e-08	-0.373947518757869	1	1	0.00110173068846721	RPL10	cDCs	GSE161801_PI_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16467
7.09423850170625e-08	0.525794038780196	0.483	0.054	0.0013017927650631	GABARAP	cDCs	GSE161801_PI_post	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16468
1.01748666330794e-07	-0.450573357067997	0.978	1	0.00186708802717008	RPL14	cDCs	GSE161801_PI_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16469
2.31250944681258e-07	-0.422568281677762	1	1	0.00424345483490108	RPL7	cDCs	GSE161801_PI_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16470
2.34527689716377e-07	-0.456695730726942	0.989	1	0.00430358310629551	RPL7A	cDCs	GSE161801_PI_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16471
2.78244159878539e-07	0.527172300209013	0.517	0.089	0.00510578033377119	PET100	cDCs	GSE161801_PI_post	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16472
3.48800699219587e-07	-0.378222760075911	1	1	0.00640049283067942	RPS3	cDCs	GSE161801_PI_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16473
3.9627003028658e-07	0.589773675545254	0.708	0.286	0.00727155505575874	NDUFA13	cDCs	GSE161801_PI_post	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16474
4.02889431329257e-07	0.564165529703278	1	0.964	0.00739302106489187	HLA-A	cDCs	GSE161801_PI_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16475
4.08529070016366e-07	0.676067022539996	0.82	0.482	0.00749650843480032	ATP5ME	cDCs	GSE161801_PI_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16476
7.29037131812524e-07	-0.606222032846224	0.573	0.893	0.0133778313687598	MT-ND5	cDCs	GSE161801_PI_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16477
8.22171511963436e-07	-0.453210414340258	0.944	1	0.015086847244529	NACA	cDCs	GSE161801_PI_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16478
8.25369136955452e-07	0.744403016429682	0.708	0.339	0.0151455236631325	LY6E	cDCs	GSE161801_PI_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16479
8.75635332168934e-07	0.916583991812362	0.348	0	0.0160679083452999	JUN	cDCs	GSE161801_PI_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16480
9.66327123502269e-07	0.934731338522622	0.708	0.393	0.0177321027162666	ZFP36	cDCs	GSE161801_PI_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16481
1.02069610100171e-06	1.15302418763444	0.629	0.232	0.0187297734533814	GPR183	cDCs	GSE161801_PI_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16482
1.61589596277471e-06	0.776859228145749	0.539	0.161	0.029651690916916	CXCR4	cDCs	GSE161801_PI_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16483
1.79962421969128e-06	0.663465054843651	0.371	0.018	0.033023104431335	GNLY	cDCs	GSE161801_PI_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16484
1.86637588179749e-06	0.598725561234047	0.416	0.054	0.0342479974309839	KLF6	cDCs	GSE161801_PI_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16485
1.86921668820651e-06	0.618903443171677	0.416	0.054	0.0343001262285895	IFI44L	cDCs	GSE161801_PI_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16486
1.88411607963598e-06	0.613034426239855	0.539	0.161	0.0345735300613203	TRA2B	cDCs	GSE161801_PI_post	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16487
6.26475219603917e-261	-2.27933312712895	0.102	0.987	1.14958202797319e-256	LAMP5	Malignant cells	GSE161801_PI_pre	ENSG00000125869	24141	lysosomal associated membrane protein family member 5	BAD-LAMP|C20orf103|dJ1119D9.3|UNC-46	protein_coding	Q9UJQ1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16488
2.52678583794724e-200	1.53784764262601	0.995	0.839	4.63665201263318e-196	EIF1	Malignant cells	GSE161801_PI_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16489
9.10063887720992e-194	-1.25393176364851	0.808	0.987	1.66996723396802e-189	TOMM7	Malignant cells	GSE161801_PI_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16490
2.85159198312572e-189	1.82306095719719	0.795	0.004	5.2326712890357e-185	LINC01781	Malignant cells	GSE161801_PI_pre	ENSG00000234184	101927412	long intergenic non-protein coding RNA 1781	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16491
1.04935874545588e-184	-2.37578573785569	0.616	0.982	1.92557329791154e-180	DUSP1	Malignant cells	GSE161801_PI_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16492
3.91672900402291e-177	-1.46837103117138	0.959	0.99	7.18719772238204e-173	RPL24	Malignant cells	GSE161801_PI_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16493
5.55775755765304e-167	-1.35964240209738	0.987	1	1.01984851182933e-162	RPS23	Malignant cells	GSE161801_PI_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16494
5.11107823180559e-161	-1.12569413585343	0.137	0.815	9.37882855536326e-157	LGALS3BP	Malignant cells	GSE161801_PI_pre	ENSG00000108679	3959	galectin 3 binding protein	90K|BTBD17B|CyCAP|gp90|M2BP|MAC-2-BP|TANGO10B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16495
5.97116091465512e-160	-1.32473476923164	0.725	0.966	1.09570802783921e-155	NPM1	Malignant cells	GSE161801_PI_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16496
1.39858484765871e-159	-1.13410982431486	0.214	0.883	2.56640319545373e-155	LAG3	Malignant cells	GSE161801_PI_pre	ENSG00000089692	3902	lymphocyte activating 3	CD223	protein_coding	P18627	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16497
1.98156004916207e-157	-1.71328861283654	0.62	0.981	3.63616269021241e-153	TSC22D3	Malignant cells	GSE161801_PI_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16498
3.13704363084522e-155	1.12313656894391	0.999	0.945	5.75647506260098e-151	SERF2	Malignant cells	GSE161801_PI_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16499
2.68330012721989e-154	-1.13268884711846	0.864	0.996	4.9238557334485e-150	EEF2	Malignant cells	GSE161801_PI_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16500
3.2005486493233e-150	-1.02726742113058	0.871	0.991	5.87300677150826e-146	RPSA	Malignant cells	GSE161801_PI_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16501
3.38895742713292e-147	-1.73216523829804	0.068	0.685	6.21873687878891e-143	EGR1	Malignant cells	GSE161801_PI_pre	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16502
4.2520811675929e-147	2.89162891020926	0.727	0.071	7.80256894253298e-143	TMSB4X	Malignant cells	GSE161801_PI_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16503
2.6040467195354e-145	-1.07119645756257	0.27	0.876	4.77842573034746e-141	TNFRSF13B	Malignant cells	GSE161801_PI_pre	ENSG00000240505	23495	TNF receptor superfamily member 13B	CD267|IGAD2|TACI	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16504
4.846523405729e-145	0.96708945010153	1	1	8.89337044951272e-141	B2M	Malignant cells	GSE161801_PI_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16505
3.70588830179566e-144	-1.09043251090848	0.394	0.904	6.80030503379503e-140	KLF13	Malignant cells	GSE161801_PI_pre	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16506
1.29189105708081e-142	-1.72489202852654	0.493	0.941	2.37062008974328e-138	FOS	Malignant cells	GSE161801_PI_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16507
3.28058706581509e-142	-0.78239996862243	0.008	0.589	6.0198772657707e-138	LSAMP	Malignant cells	GSE161801_PI_pre	ENSG00000185565	4045	limbic system associated membrane protein	IGLON3|LAMP	protein_coding	Q13449	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16508
4.04627956697323e-141	-0.927466852328581	0.083	0.706	7.42492300539587e-137	CADM1	Malignant cells	GSE161801_PI_pre	ENSG00000182985	23705	cell adhesion molecule 1	BL2|IGSF4|IGSF4A|Necl-2|NECL2|RA175|ST17|SYNCAM|SYNCAM1|TSLC1	protein_coding	Q9BY67	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16509
9.3615999810374e-140	-1.11497929949822	1	1	1.71785359652036e-135	RPS14	Malignant cells	GSE161801_PI_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16510
3.12220173705462e-138	-0.869695404942679	0.993	0.999	5.72924018749523e-134	RPS16	Malignant cells	GSE161801_PI_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16511
1.06562974037507e-137	-1.16929488356655	0.972	0.99	1.95543057358826e-133	RPL26	Malignant cells	GSE161801_PI_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16512
1.60719736302077e-136	-0.925928374403473	0.867	0.985	2.94920716114311e-132	COX7C	Malignant cells	GSE161801_PI_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16513
1.41358080626804e-133	-0.769818709042727	0.979	0.999	2.59392077950186e-129	UBA52	Malignant cells	GSE161801_PI_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16514
1.89784441782052e-131	-1.02680602057044	0.29	0.855	3.48254450670065e-127	ITGB7	Malignant cells	GSE161801_PI_pre	ENSG00000139626	3695	integrin subunit beta 7	NA	protein_coding	P26010	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16515
1.15811292984394e-130	-0.853061900498257	1	1	2.12513722626363e-126	EEF1A1	Malignant cells	GSE161801_PI_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16516
8.3208991830073e-129	1.16273331390246	0.989	0.838	1.52688500008184e-124	TMSB10	Malignant cells	GSE161801_PI_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16517
3.70881786207028e-127	-0.798305444177395	0.108	0.699	6.80568077689897e-123	VSIR	Malignant cells	GSE161801_PI_pre	ENSG00000107738	64115	V-set immunoregulatory receptor	B7-H5|B7H5|C10orf54|Dies1|GI24|PD-1H|SISP1|VISTA	protein_coding	Q9H7M9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16518
2.92946250069826e-126	0.903497581130712	0.999	0.972	5.37556368878131e-122	RPS29	Malignant cells	GSE161801_PI_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16519
5.79977380081778e-126	-1.12646286391899	0.845	0.997	1.06425849245006e-121	ITM2C	Malignant cells	GSE161801_PI_pre	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16520
1.28278470173499e-124	-1.0216523486001	0.994	0.985	2.3539099276837e-120	RPL37	Malignant cells	GSE161801_PI_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16521
1.49857292334215e-124	-1.04291116143361	0.7	0.972	2.74988131433284e-120	NOP53	Malignant cells	GSE161801_PI_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16522
1.97423235164812e-123	-0.827633509105644	0.994	1	3.6227163652743e-119	RPL18	Malignant cells	GSE161801_PI_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16523
1.94819364496496e-121	-1.22783500813362	0.946	1	3.57493533851071e-117	MT-ND2	Malignant cells	GSE161801_PI_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16524
7.38688341927199e-121	-0.744297424202071	0.993	0.999	1.35549310743641e-116	RPL7A	Malignant cells	GSE161801_PI_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16525
9.75558811845971e-121	-0.844654633515496	0.969	0.997	1.79015041973736e-116	RACK1	Malignant cells	GSE161801_PI_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16526
1.11473487982066e-120	-0.963627720118759	0.373	0.879	2.0455385044709e-116	GAS6	Malignant cells	GSE161801_PI_pre	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16527
3.45244566686597e-120	-0.581115888604398	0.998	1	6.33523779869905e-116	RPL8	Malignant cells	GSE161801_PI_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16528
4.11897116598753e-120	1.07187511055831	0.9	0.594	7.55831208958712e-116	SPCS3	Malignant cells	GSE161801_PI_pre	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16529
2.08887295575935e-118	-0.827800165981874	0.998	1	3.8330818738184e-114	RPL15	Malignant cells	GSE161801_PI_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16530
3.14480383767943e-118	1.38935350815199	0.616	0.038	5.77071504214175e-114	S100A6	Malignant cells	GSE161801_PI_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16531
7.83191154516315e-117	1.45129076715394	0.965	0.731	1.43715576853744e-112	HLA-A	Malignant cells	GSE161801_PI_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16532
4.64503229423681e-115	1.46205972200604	0.843	0.489	8.52363425992455e-111	PRDX4	Malignant cells	GSE161801_PI_pre	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16533
5.28249741930684e-115	1.01947897798272	0.716	0.152	9.69338276442805e-111	SARAF	Malignant cells	GSE161801_PI_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16534
7.15597450555934e-114	-0.886405881669405	1	0.997	1.31312132177014e-109	RPL32	Malignant cells	GSE161801_PI_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16535
1.51672130427944e-113	-0.902304804394928	0.957	0.991	2.78318359335277e-109	RPL14	Malignant cells	GSE161801_PI_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16536
1.99000623434787e-113	-0.832850253718278	0.8	0.997	3.65166144002833e-109	CIRBP	Malignant cells	GSE161801_PI_pre	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16537
2.83522195909958e-113	-1.41419966354266	0.746	0.979	5.20263229494773e-109	JUN	Malignant cells	GSE161801_PI_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16538
7.74930322677222e-112	-0.81505180290095	0.994	0.999	1.4219971421127e-107	RPS3	Malignant cells	GSE161801_PI_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16539
9.38436118528312e-112	-0.880020764410708	0.998	0.996	1.72203027749945e-107	RPL29	Malignant cells	GSE161801_PI_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16540
2.34430137332851e-111	0.874469117916141	0.538	0	4.30179302005781e-107	FCER2	Malignant cells	GSE161801_PI_pre	ENSG00000104921	2208	Fc epsilon receptor II	CD23|CD23A|CLEC4J|FCE2|FcepsilonRII|FCErII	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16541
2.53760582915415e-109	0.985734207460173	0.919	0.718	4.65650669649787e-105	MIF	Malignant cells	GSE161801_PI_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16542
1.23704841363789e-108	-0.681010110617479	1	1	2.26998383902553e-104	RPLP2	Malignant cells	GSE161801_PI_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16543
2.38305016243617e-107	-0.87544436260227	0.731	0.978	4.37289704807037e-103	TMED9	Malignant cells	GSE161801_PI_pre	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16544
9.54940467447153e-106	-0.8289660364656	0.996	0.996	1.75231575776553e-101	RPL35A	Malignant cells	GSE161801_PI_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16545
1.66414861157663e-104	-0.817675877624404	0.276	0.796	3.05371270224312e-100	IDH2	Malignant cells	GSE161801_PI_pre	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16546
1.30846690498177e-103	-0.760270575978398	0.362	0.852	2.40103677064155e-99	SLC25A5	Malignant cells	GSE161801_PI_pre	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16547
2.74726915401838e-103	1.05502000665868	0.901	0.753	5.04123889762373e-99	TMBIM6	Malignant cells	GSE161801_PI_pre	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16548
1.16367819371848e-102	-0.868297075810599	0.312	0.809	2.1353494854734e-98	MLLT3	Malignant cells	GSE161801_PI_pre	ENSG00000171843	4300	MLLT3 super elongation complex subunit	AF-9|AF9|YEATS3	protein_coding	P42568	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16549
1.52328882255808e-102	-0.727590046662982	0.602	0.942	2.79523498939408e-98	EIF3K	Malignant cells	GSE161801_PI_pre	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16550
2.44924293382973e-102	0.840415912153659	0.999	0.957	4.49436078357756e-98	RPL19	Malignant cells	GSE161801_PI_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16551
2.65081066466153e-102	1.3656333926688	0.511	0.003	4.86423756965391e-98	FBP1	Malignant cells	GSE161801_PI_pre	ENSG00000165140	2203	fructose-bisphosphatase 1	FBP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16552
3.89587424962418e-102	-0.725767666466253	0.055	0.544	7.14892924806038e-98	C1R	Malignant cells	GSE161801_PI_pre	ENSG00000288512	715	complement C1r	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16553
7.81655715217376e-102	0.728727345022213	0.502	0.001	1.43433823742388e-97	KRT10	Malignant cells	GSE161801_PI_pre	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16554
1.94777983238757e-101	0.860858991394211	0.961	0.889	3.57417599243118e-97	TMEM258	Malignant cells	GSE161801_PI_pre	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16555
2.52237813382426e-100	-0.708031919693397	1	1	4.62856387556752e-96	RPL13	Malignant cells	GSE161801_PI_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16556
3.17171814926837e-97	0.940060902006586	0.887	0.6	5.82010280390746e-93	SELENOS	Malignant cells	GSE161801_PI_pre	ENSG00000131871	55829	selenoprotein S	AD-015|MGC2553|SBBI8|SELS|SEPS1|VIMP	protein_coding	Q9BQE4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16557
1.26988413583212e-95	0.861693509942612	0.566	0.058	2.33023738925193e-91	EZR	Malignant cells	GSE161801_PI_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16558
2.76110890269492e-95	0.987691658969988	0.762	0.318	5.06663483644518e-91	PLPP5	Malignant cells	GSE161801_PI_pre	ENSG00000147535	84513	phospholipid phosphatase 5	DPPL1|HTPAP|PPAPDC1B	protein_coding	Q8NEB5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16559
2.93966754862986e-95	-0.679620900071148	0.148	0.654	5.39428995173579e-91	NSA2	Malignant cells	GSE161801_PI_pre	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16560
8.56195526021378e-95	-0.648447639807264	0.109	0.603	1.57111879024923e-90	COX11	Malignant cells	GSE161801_PI_pre	ENSG00000166260	1353	cytochrome c oxidase copper chaperone COX11	COX11P	protein_coding	Q9Y6N1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16561
6.43888560901421e-94	1.51908789707253	0.77	0.309	1.18153550925411e-89	CD79A	Malignant cells	GSE161801_PI_pre	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16562
1.4942555608287e-93	-0.7070146669034	0.097	0.579	2.74195895412067e-89	TBCEL	Malignant cells	GSE161801_PI_pre	ENSG00000154114	219899	tubulin folding cofactor E like	LRRC35|MGC10233	protein_coding	Q5QJ74	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16563
1.75639174688234e-93	-0.653651021752862	1	1	3.2229788555291e-89	RPS6	Malignant cells	GSE161801_PI_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16564
1.77064215005666e-93	-0.651276115939686	0.991	0.99	3.24912834535397e-89	RPL9	Malignant cells	GSE161801_PI_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16565
3.41414153683891e-93	-0.691593541737224	0.182	0.685	6.2649497200994e-89	PRKD2	Malignant cells	GSE161801_PI_pre	ENSG00000105287	25865	protein kinase D2	DKFZP586E0820|HSPC187|PKD2	protein_coding	Q9BZL6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16566
4.06616261844023e-93	-0.700489471854263	0.937	0.985	7.46140840483782e-89	RPS24	Malignant cells	GSE161801_PI_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16567
1.33539519345432e-92	0.949519894031636	0.698	0.222	2.45045017998868e-88	ATP5ME	Malignant cells	GSE161801_PI_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16568
1.61028331677464e-90	-1.07796008552743	0.386	0.826	2.95486988628146e-86	FOSB	Malignant cells	GSE161801_PI_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16569
1.96489062322354e-90	-0.944539129947434	0.583	0.885	3.60557429361519e-86	EVI2B	Malignant cells	GSE161801_PI_pre	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16570
2.01316057549342e-90	0.807904158215891	0.678	0.185	3.69414965603043e-86	SELENOF	Malignant cells	GSE161801_PI_pre	ENSG00000183291	9403	selenoprotein F	SEP15	protein_coding	O60613	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16571
9.57577640750156e-90	-0.669599923267133	0.127	0.612	1.75715497077654e-85	SCPEP1	Malignant cells	GSE161801_PI_pre	ENSG00000121064	59342	serine carboxypeptidase 1	RISC	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16572
1.06320945501948e-89	2.09486057760568	0.474	0.013	1.95098934996075e-85	CST3	Malignant cells	GSE161801_PI_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16573
1.67367729330809e-89	-0.506250150239716	0.998	1	3.07119783322035e-85	FAU	Malignant cells	GSE161801_PI_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16574
8.227556337472e-89	-0.66303083919875	0.986	0.991	1.50975658792611e-84	RPS11	Malignant cells	GSE161801_PI_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16575
9.27584955535001e-89	-0.888612568809706	0.616	0.945	1.70211839340673e-84	ACTG1	Malignant cells	GSE161801_PI_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16576
2.27375306215949e-88	-0.83137702012847	0.858	0.994	4.17233686906267e-84	MT-ND1	Malignant cells	GSE161801_PI_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16577
3.22205910200895e-88	0.720874120734096	0.939	0.796	5.91247845218642e-84	SEC62	Malignant cells	GSE161801_PI_pre	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16578
1.9955282795415e-87	-0.71083254894468	0.912	0.972	3.66179439295864e-83	EEF1B2	Malignant cells	GSE161801_PI_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16579
2.76521299375358e-87	-0.753337830753932	0.142	0.61	5.07416584353782e-83	HGF	Malignant cells	GSE161801_PI_pre	ENSG00000019991	3082	hepatocyte growth factor	DFNB39|F-TCF|HGFB|HPTA|SF	protein_coding	P14210	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16580
5.94812076927691e-87	-0.737240791996396	0.999	0.999	1.09148016116231e-82	RPL39	Malignant cells	GSE161801_PI_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16581
3.73585591133295e-86	2.3161593430649	0.442	0	6.85529559729597e-82	JSRP1	Malignant cells	GSE161801_PI_pre	ENSG00000167476	126306	junctional sarcoplasmic reticulum protein 1	FLJ32416|JP-45	protein_coding	Q96MG2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16582
6.56854976533954e-86	0.654425096548413	0.441	0.001	1.20532888193981e-81	FAM30A	Malignant cells	GSE161801_PI_pre	ENSG00000277059	9834	family with sequence similarity 30 member A	C14orf110|HSPC053|KIAA0125	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16583
1.00115829901282e-85	1.06857090532238	0.991	0.963	1.83712547868853e-81	RPS17	Malignant cells	GSE161801_PI_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16584
1.56007537871864e-85	-0.660776610966202	0.411	0.858	2.86273831994871e-81	ALKBH7	Malignant cells	GSE161801_PI_pre	ENSG00000125652	84266	alkB homolog 7	MGC10974|SPATA11	protein_coding	Q9BT30	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16585
6.13988892205866e-84	-0.639871508085911	0.224	0.713	1.12666961719776e-79	SUPT4H1	Malignant cells	GSE161801_PI_pre	ENSG00000213246	6827	SPT4 homolog, DSIF elongation factor subunit	Spt4|SPT4H|Supt4a|SUPT4H	protein_coding	P63272	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16586
1.40477346011387e-83	-1.5533996341674	0.292	0.731	2.57775929930895e-79	HSPA1B	Malignant cells	GSE161801_PI_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16587
1.59364244720235e-83	-0.546020276843576	1	0.999	2.92433389061632e-79	RPL35	Malignant cells	GSE161801_PI_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16588
5.53453502684533e-83	-0.926058795374248	0.913	0.991	1.01558717742612e-78	ACTB	Malignant cells	GSE161801_PI_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16589
6.16467662552689e-82	-0.609008916875521	0.134	0.594	1.13121816078418e-77	MSI2	Malignant cells	GSE161801_PI_pre	ENSG00000153944	124540	musashi RNA binding protein 2	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16590
7.78226468785296e-81	2.62860384414764	0.42	0	1.42804557022102e-76	PLD4	Malignant cells	GSE161801_PI_pre	ENSG00000166428	122618	phospholipase D family member 4	C14orf175	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16591
3.91949302251516e-80	-0.698152417637951	0.154	0.604	7.19226969631533e-76	PRPS1	Malignant cells	GSE161801_PI_pre	ENSG00000147224	5631	phosphoribosyl pyrophosphate synthetase 1	CMTX5|DFN2|DFNX1|PPRibP|PRS-I	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16592
1.24273987702964e-79	-0.594093649830723	1	1	2.2804276743494e-75	RPL10	Malignant cells	GSE161801_PI_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16593
1.89119632097306e-78	-0.648263412869627	0.319	0.774	3.47034524898557e-74	HIGD2A	Malignant cells	GSE161801_PI_pre	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16594
8.76695269630403e-78	0.906191161008775	0.719	0.315	1.60873581977179e-73	RNASET2	Malignant cells	GSE161801_PI_pre	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16595
1.11476226706513e-77	0.824554664527857	0.447	0.025	2.04558876006451e-73	PMAIP1	Malignant cells	GSE161801_PI_pre	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16596
1.22347736828409e-76	1.20914599789842	0.893	0.795	2.2450809708013e-72	SEC11C	Malignant cells	GSE161801_PI_pre	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16597
1.34921776069412e-76	0.733503055531453	0.457	0.032	2.47581459087371e-72	ANXA2	Malignant cells	GSE161801_PI_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16598
3.62780822662899e-76	-0.492556899845308	1	1	6.6570280958642e-72	RPL11	Malignant cells	GSE161801_PI_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16599
3.70386021679964e-76	0.690226833172498	0.552	0.105	6.79658349782734e-72	SRSF9	Malignant cells	GSE161801_PI_pre	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16600
7.53014047418813e-76	-0.553899349244411	0.231	0.708	1.38178077701352e-71	TOMM20	Malignant cells	GSE161801_PI_pre	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16601
1.49539393204734e-74	-0.844712362587624	0.926	0.993	2.74404786530686e-70	XBP1	Malignant cells	GSE161801_PI_pre	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16602
1.6997783082309e-74	0.870119127189805	0.414	0.013	3.1190931956037e-70	TMEM156	Malignant cells	GSE161801_PI_pre	ENSG00000121895	80008	transmembrane protein 156	FLJ23235	protein_coding	Q8N614	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16603
5.11501594232286e-74	0.660174522465758	0.92	0.814	9.38605425416244e-70	SRP14	Malignant cells	GSE161801_PI_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16604
6.38952713900757e-74	-0.910084447697976	0.417	0.821	1.17247823000789e-69	HIST1H2AC	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16605
1.5401017189151e-73	0.774330067993822	0.606	0.154	2.8260866542092e-69	PFN1	Malignant cells	GSE161801_PI_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16606
1.72507769281876e-73	0.920711408146374	0.995	0.994	3.16551756632242e-69	FTL	Malignant cells	GSE161801_PI_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16607
2.28456734820919e-73	0.839862186882416	0.833	0.538	4.19218108396386e-69	PPDPF	Malignant cells	GSE161801_PI_pre	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16608
2.42545346438193e-73	0.769138974229777	0.519	0.09	4.45070710714085e-69	TXNDC5	Malignant cells	GSE161801_PI_pre	ENSG00000239264	81567	thioredoxin domain containing 5	EndoPDI|ERp46|FLJ21353|FLJ90810|Hcc-2|MGC3178|PDIA15	protein_coding	Q8NBS9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16609
4.29177404084487e-73	0.823699504505142	0.491	0.062	7.87540536495033e-69	LY6E	Malignant cells	GSE161801_PI_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16610
7.4411425108051e-73	0.825717623887302	0.829	0.551	1.36544965073274e-68	ITM2B	Malignant cells	GSE161801_PI_pre	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16611
2.94448811304625e-71	1.17389666537482	0.397	0.012	5.40313568743987e-67	ASS1	Malignant cells	GSE161801_PI_pre	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16612
6.37699398314961e-71	0.990656637669803	0.377	0	1.17017839590795e-66	UCHL1	Malignant cells	GSE161801_PI_pre	ENSG00000154277	7345	ubiquitin C-terminal hydrolase L1	PARK5|PGP9.5|Uch-L1|UCHL-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16613
9.50370568082446e-71	-0.994906069922449	0.641	0.905	1.74392999243129e-66	PIM2	Malignant cells	GSE161801_PI_pre	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16614
2.12230151081239e-70	-0.544147214739711	0.202	0.643	3.89442327234074e-66	FBL	Malignant cells	GSE161801_PI_pre	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16615
2.65952554360878e-70	-0.72022118275638	0.1	0.501	4.88022937252212e-66	TNFSF10	Malignant cells	GSE161801_PI_pre	ENSG00000121858	8743	TNF superfamily member 10	Apo-2L|CD253|TL2|TRAIL	protein_coding	P50591	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16616
4.28092217676215e-70	1.06503235436954	0.39	0.01	7.85549219435854e-66	SLC22A31	Malignant cells	GSE161801_PI_pre	ENSG00000259803	146429	solute carrier family 22 member 31	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16617
1.4332138119393e-69	0.566224535235791	0.45	0.046	2.62994734490861e-65	SFT2D1	Malignant cells	GSE161801_PI_pre	ENSG00000198818	113402	SFT2 domain containing 1	C6orf83|MGC19825|pRGR1	protein_coding	Q8WV19	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16618
1.0362515856275e-68	0.726769827060318	0.366	0	1.90152165962646e-64	VPREB3	Malignant cells	GSE161801_PI_pre	ENSG00000128218	29802	V-set pre-B cell surrogate light chain 3	8HS20	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16619
1.37192951788103e-68	0.872620693523772	0.366	0	2.51749066531169e-64	EIF1AY	Malignant cells	GSE161801_PI_pre	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16620
5.10190531737599e-68	0.756309842786815	0.552	0.131	9.36199625738493e-64	CD44	Malignant cells	GSE161801_PI_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16621
5.4184099438681e-68	0.993756696070139	0.901	0.88	9.94278224699796e-64	FKBP2	Malignant cells	GSE161801_PI_pre	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16622
8.63217189310824e-66	-0.540140459303066	0.122	0.521	1.58400354238536e-61	CLINT1	Malignant cells	GSE161801_PI_pre	ENSG00000113282	9685	clathrin interactor 1	CLINT|ENTH|EPNR|KIAA0171	protein_coding	Q14677	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16623
2.52201124177018e-65	0.657607802552922	0.351	0	4.62789062864829e-61	RBP1	Malignant cells	GSE161801_PI_pre	ENSG00000114115	5947	retinol binding protein 1	CRABP-I|CRBP|CRBP1|CRBPI|RBPC	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16624
1.4132954290679e-64	0.673406282637737	0.914	0.855	2.5933971123396e-60	OST4	Malignant cells	GSE161801_PI_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16625
5.08082207945782e-64	1.44455532389184	0.908	0.833	9.32330851580509e-60	HSP90B1	Malignant cells	GSE161801_PI_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16626
5.3506012212397e-64	-0.520500608298843	0.15	0.551	9.81835324097485e-60	BEX2	Malignant cells	GSE161801_PI_pre	ENSG00000133134	84707	brain expressed X-linked 2	DJ79P11.1	protein_coding	Q9BXY8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16627
1.51636824612511e-63	-0.480407401437307	0.081	0.451	2.78253573163958e-59	GTF2F2	Malignant cells	GSE161801_PI_pre	ENSG00000188342	2963	general transcription factor IIF subunit 2	BTF4|RAP30|TFIIF	protein_coding	P13984	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16628
3.51503369805762e-63	-0.616745625837057	0.272	0.688	6.45008683593573e-59	ARRDC3	Malignant cells	GSE161801_PI_pre	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16629
7.77190853028811e-63	-0.525607641829815	0.504	0.874	1.42614521530787e-58	CNBP	Malignant cells	GSE161801_PI_pre	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16630
9.32844455629724e-63	-0.572994292883122	0.994	0.999	1.71176957608054e-58	RPS25	Malignant cells	GSE161801_PI_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16631
1.56479080060445e-62	1.09855024067794	0.758	0.527	2.87139111910916e-58	UBB	Malignant cells	GSE161801_PI_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16632
3.66285891439928e-62	-0.569354729901897	0.209	0.62	6.72134610792268e-58	TNFRSF14	Malignant cells	GSE161801_PI_pre	ENSG00000273936	8764	TNF receptor superfamily member 14	ATAR|CD270|HVEA|HVEM|LIGHTR|TR2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16633
7.2067670315789e-62	0.963058501478288	0.793	0.513	1.32244175029473e-57	IFI6	Malignant cells	GSE161801_PI_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16634
8.78841837777826e-62	0.546370163791923	0.454	0.071	1.61267477232231e-57	SNX3	Malignant cells	GSE161801_PI_pre	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16635
9.97457982923015e-62	2.04276869225027	0.398	0.037	1.83033539866373e-57	CCL3	Malignant cells	GSE161801_PI_pre	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16636
4.85933049177454e-60	0.678388869795901	0.781	0.498	8.91687145240627e-56	OSTC	Malignant cells	GSE161801_PI_pre	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16637
1.08736887869702e-59	1.34926384536543	0.815	0.669	1.99532189240904e-55	DERL3	Malignant cells	GSE161801_PI_pre	ENSG00000274437	91319	derlin 3	C22orf14|derlin-3|FLJ43842|IZP6|MGC71803	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16638
3.12224075354328e-59	0.627234153509403	0.323	0	5.72931178275191e-55	RPS4Y1	Malignant cells	GSE161801_PI_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16639
4.21946678715787e-59	-0.499425042388908	0.113	0.479	7.74272155443469e-55	PIP5K1B	Malignant cells	GSE161801_PI_pre	ENSG00000107242	8395	phosphatidylinositol-4-phosphate 5-kinase type 1 beta	MSS4|STM7	protein_coding	O14986	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16640
5.15972227498568e-59	0.609586287689979	0.322	0	9.46809037459872e-55	WFDC2	Malignant cells	GSE161801_PI_pre	ENSG00000101443	10406	WAP four-disulfide core domain 2	dJ461P17.6|EDDM4|HE4|WAP5	protein_coding	Q14508	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16641
5.86253790507716e-59	-0.477187383137217	0.162	0.552	1.07577570558166e-54	GOSR2	Malignant cells	GSE161801_PI_pre	ENSG00000108433	9570	golgi SNAP receptor complex member 2	Bos1|GS27	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16642
9.06100396611018e-59	-0.46960795267519	0.127	0.504	1.66269422778122e-54	ATP6AP1	Malignant cells	GSE161801_PI_pre	ENSG00000071553	537	ATPase H+ transporting accessory protein 1	16A|Ac45|ATP6IP1|ATP6S1|CF2|ORF|VATPS1|XAP-3|XAP3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16643
1.33216195363604e-58	0.881993923572844	0.351	0.018	2.44451718492213e-54	LAPTM5	Malignant cells	GSE161801_PI_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16644
3.64539644073503e-58	0.685176221913555	0.326	0.004	6.68930246874879e-54	CTHRC1	Malignant cells	GSE161801_PI_pre	ENSG00000164932	115908	collagen triple helix repeat containing 1	NA	protein_coding	Q96CG8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16645
7.31261233370326e-58	0.724129437037665	0.364	0.027	1.34186436323455e-53	ATF5	Malignant cells	GSE161801_PI_pre	ENSG00000169136	22809	activating transcription factor 5	NA	protein_coding	Q9Y2D1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16646
1.51468249884863e-57	0.582702993539031	0.315	0	2.77944238538724e-53	DPEP1	Malignant cells	GSE161801_PI_pre	ENSG00000015413	1800	dipeptidase 1	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16647
2.37250842783878e-57	0.887266901733216	0.927	0.697	4.35355296508417e-53	MT-CO1	Malignant cells	GSE161801_PI_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16648
2.5222469966319e-57	0.646106657234963	0.522	0.137	4.62832323881954e-53	GPRC5D	Malignant cells	GSE161801_PI_pre	ENSG00000111291	55507	G protein-coupled receptor class C group 5 member D	NA	protein_coding	Q9NZD1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16649
6.49433017986768e-57	0.695086281816354	0.781	0.489	1.19170958800572e-52	MYL6	Malignant cells	GSE161801_PI_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16650
1.70721912692719e-56	0.66224489252879	0.378	0.035	3.1327470979114e-52	S100A4	Malignant cells	GSE161801_PI_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16651
1.73320349515616e-56	0.594566366701372	0.883	0.742	3.18042841361156e-52	COX7A2	Malignant cells	GSE161801_PI_pre	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16652
2.28634419571961e-56	-0.529268845901251	0.344	0.737	4.19544159914549e-52	MGAT1	Malignant cells	GSE161801_PI_pre	ENSG00000131446	4245	alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GLCNAC-TI|GLYT1|GNT-1|GnTI|MGAT	protein_coding	P26572	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16653
4.65763690120763e-56	-0.699457232138113	0.406	0.743	8.54676371371601e-52	CFLAR	Malignant cells	GSE161801_PI_pre	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16654
5.35321370695013e-56	0.647942270900815	0.654	0.297	9.82314715225349e-52	CISD2	Malignant cells	GSE161801_PI_pre	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16655
1.94323220090176e-55	-0.492162268844088	0.219	0.612	3.56583108865473e-51	SUMF2	Malignant cells	GSE161801_PI_pre	ENSG00000129103	25870	sulfatase modifying factor 2	DKFZp566I1024	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16656
3.01554850085468e-55	-0.689302418800915	0.897	0.999	5.53353149906834e-51	HLA-C	Malignant cells	GSE161801_PI_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16657
3.91857669296857e-55	1.37455469716625	0.829	0.773	7.19058823159733e-51	KRTCAP2	Malignant cells	GSE161801_PI_pre	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16658
4.32311734828204e-55	0.636012865392653	0.729	0.402	7.93292033409754e-51	TMCO1	Malignant cells	GSE161801_PI_pre	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16659
1.94818237250528e-54	-0.726492869148485	0.465	0.815	3.57491465354719e-50	MCL1	Malignant cells	GSE161801_PI_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16660
2.45123151358431e-54	-0.588716361096922	0.509	0.854	4.4980098274272e-50	SDC1	Malignant cells	GSE161801_PI_pre	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16661
2.94380161985385e-54	-0.628279495672369	0.236	0.609	5.40187597243182e-50	VMP1	Malignant cells	GSE161801_PI_pre	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16662
4.27653109341925e-54	-0.462401288295435	0.981	0.993	7.84743455642432e-50	RPL30	Malignant cells	GSE161801_PI_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16663
6.42693121203753e-54	0.568834702897312	0.473	0.112	1.17934187740889e-49	PSMB3	Malignant cells	GSE161801_PI_pre	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16664
1.4647697446464e-53	-0.768409138788055	0.148	0.502	2.68785248142614e-49	ADM	Malignant cells	GSE161801_PI_pre	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16665
2.62850818807678e-53	0.419122006595491	0.315	0.01	4.82331252512089e-49	PARM1	Malignant cells	GSE161801_PI_pre	ENSG00000169116	25849	prostate androgen-regulated mucin-like protein 1	Cipar1|DKFZP564O0823|WSC4	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16666
3.78070478281783e-53	0.922779412591754	0.45	0.111	6.93759327647072e-49	EMP3	Malignant cells	GSE161801_PI_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16667
6.40142311707168e-53	-0.467295134413216	0.115	0.464	1.17466114198265e-48	EVI2A	Malignant cells	GSE161801_PI_pre	ENSG00000126860	2123	ecotropic viral integration site 2A	EVDA|EVI2	protein_coding	P22794	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16668
1.16966411074557e-52	0.447317489481316	0.309	0.009	2.14633364321812e-48	MARCKS	Malignant cells	GSE161801_PI_pre	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16669
3.67455176370629e-52	0.698152331095719	0.594	0.257	6.74280248640104e-48	PSMB1	Malignant cells	GSE161801_PI_pre	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16670
3.75521423307552e-52	-0.472312240659496	1	0.999	6.89081811769358e-48	RPS28	Malignant cells	GSE161801_PI_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16671
4.34566477920418e-52	0.771246718871201	0.927	0.833	7.97429486983968e-48	TNFRSF17	Malignant cells	GSE161801_PI_pre	ENSG00000048462	608	TNF receptor superfamily member 17	BCM|BCMA|CD269|TNFRSF13A	protein_coding	Q02223	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16672
3.0590397788669e-51	-0.81010097158419	0.809	0.981	5.61333799422075e-47	MT-ND3	Malignant cells	GSE161801_PI_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16673
3.46860228887018e-51	-0.39138158703389	0.027	0.303	6.36488520007677e-47	TSC22D1	Malignant cells	GSE161801_PI_pre	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16674
6.43536178152572e-51	0.81264849839412	0.478	0.146	1.18088888690997e-46	PLP2	Malignant cells	GSE161801_PI_pre	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16675
3.31093328470757e-50	-0.54954322871838	0.452	0.781	6.0755625774384e-46	LSP1	Malignant cells	GSE161801_PI_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16676
5.87008862527027e-50	0.613083742984162	0.703	0.39	1.07716126273709e-45	NOP10	Malignant cells	GSE161801_PI_pre	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16677
6.4504833611429e-50	-0.545565945680751	0.533	0.854	1.18366369676972e-45	POU2AF1	Malignant cells	GSE161801_PI_pre	ENSG00000110777	5450	POU class 2 homeobox associating factor 1	BOB1|OBF1|OCA-B	protein_coding	Q16633	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16678
1.36606052453204e-49	0.527304259301356	0.289	0.006	2.50672106251629e-45	BASP1	Malignant cells	GSE161801_PI_pre	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16679
1.84354735789973e-49	-0.379024284034624	1	0.996	3.382909401746e-45	RPL37A	Malignant cells	GSE161801_PI_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16680
2.49040021230893e-49	1.37381702669981	0.57	0.254	4.56988438958688e-45	BTG1	Malignant cells	GSE161801_PI_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16681
3.31410382180077e-49	0.500311050555636	0.978	0.91	6.08138051300441e-45	RPL27	Malignant cells	GSE161801_PI_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16682
1.51432206004806e-48	-0.348357077852862	0.011	0.254	2.77878098018819e-44	CCR2	Malignant cells	GSE161801_PI_pre	ENSG00000121807	729230	C-C motif chemokine receptor 2	CC-CKR-2|CD192|CKR2|CMKBR2|FLJ78302|MCP-1-R	protein_coding	P41597	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16683
3.66477367075941e-48	-0.563721177968795	0.398	0.728	6.72485968584352e-44	GPR160	Malignant cells	GSE161801_PI_pre	ENSG00000173890	26996	G protein-coupled receptor 160	GPCR1|GPCR150	protein_coding	Q9UJ42	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16684
4.64989525607969e-48	-0.371797316514519	0.04	0.316	8.53255779490623e-44	ERAP2	Malignant cells	GSE161801_PI_pre	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16685
6.90852625743813e-48	-0.42226081833063	0.113	0.439	1.2677145682399e-43	CCNG1	Malignant cells	GSE161801_PI_pre	ENSG00000113328	900	cyclin G1	CCNG	protein_coding	P51959	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16686
3.01789294029424e-47	-0.509795943359703	0.539	0.863	5.53783354543992e-43	ICAM3	Malignant cells	GSE161801_PI_pre	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16687
2.54757302897529e-46	0.436886601367238	0.312	0.027	4.67479650816966e-42	DENND6B	Malignant cells	GSE161801_PI_pre	ENSG00000205593	414918	DENN domain containing 6B	AFI1B|FAM116B|MGC33692	protein_coding	Q8NEG7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16688
4.12390346191818e-46	0.640463356224062	0.67	0.396	7.56736285261987e-42	ATP5MD	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16689
4.64698585716289e-46	-0.487610842709762	0.501	0.824	8.5272190478939e-42	CANX	Malignant cells	GSE161801_PI_pre	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16690
2.0061040694317e-45	0.454257968740372	0.364	0.061	3.68120096740716e-41	SRP72	Malignant cells	GSE161801_PI_pre	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16691
2.43398429960157e-45	-0.442366297572437	0.331	0.679	4.46636118976887e-41	EIF2A	Malignant cells	GSE161801_PI_pre	ENSG00000144895	83939	eukaryotic translation initiation factor 2A	EIF-2A	protein_coding	Q9BY44	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16692
6.13364595649173e-45	-0.444808797729445	0.919	0.993	1.12552403301623e-40	UBE2J1	Malignant cells	GSE161801_PI_pre	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16693
6.87225297232274e-45	-0.430800353457055	0.204	0.56	1.26105842042122e-40	TUBB	Malignant cells	GSE161801_PI_pre	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16694
7.50013204158227e-45	-0.343312225553557	0.015	0.25	1.37627422963035e-40	TIMD4	Malignant cells	GSE161801_PI_pre	ENSG00000145850	91937	T cell immunoglobulin and mucin domain containing 4	TIM4	protein_coding	Q96H15	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16695
1.13165848151479e-44	0.42390006798864	0.251	0	2.07659331357963e-40	TNFRSF18	Malignant cells	GSE161801_PI_pre	ENSG00000186891	8784	TNF receptor superfamily member 18	AITR|CD357|GITR	protein_coding	Q9Y5U5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16696
2.34346417237633e-44	0.447666581573313	0.269	0.009	4.30025675631056e-40	PLAC8	Malignant cells	GSE161801_PI_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16697
6.17776548040382e-44	-0.446316935089152	0.836	0.981	1.1336199656541e-39	HNRNPA1	Malignant cells	GSE161801_PI_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16698
1.53693955298058e-43	0.553043230974735	0.532	0.214	2.82028407971936e-39	NENF	Malignant cells	GSE161801_PI_pre	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16699
2.14016091893537e-43	-0.454368470282982	0.986	0.975	3.9271952862464e-39	TPT1	Malignant cells	GSE161801_PI_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16700
2.16603216772241e-43	0.421142076863768	0.319	0.038	3.97466902777062e-39	CBWD5	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16701
3.16196121969846e-43	-0.363233170083948	0.061	0.334	5.80219883814667e-39	SKA2	Malignant cells	GSE161801_PI_pre	ENSG00000182628	348235	spindle and kinetochore associated complex subunit 2	FAM33A|FLJ12758	protein_coding	Q8WVK7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16702
3.81982202901758e-43	-0.402904547143261	0.175	0.502	7.00937342324727e-39	DAP	Malignant cells	GSE161801_PI_pre	ENSG00000112977	1611	death associated protein	DAP1	protein_coding	P51397	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16703
4.77437569603423e-43	0.506375910504737	0.844	0.778	8.76097940222282e-39	CUTA	Malignant cells	GSE161801_PI_pre	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16704
4.77668732700922e-43	-0.336635519466509	0.027	0.267	8.76522124506192e-39	SULF2	Malignant cells	GSE161801_PI_pre	ENSG00000196562	55959	sulfatase 2	HSULF-2|KIAA1247|SULF-2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16705
6.34341548595889e-43	-1.13271656192445	0.684	0.849	1.16401674167346e-38	JUNB	Malignant cells	GSE161801_PI_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16706
1.54893831181076e-42	0.492711485291727	0.597	0.273	2.84230180217274e-38	LAPTM4A	Malignant cells	GSE161801_PI_pre	ENSG00000068697	9741	lysosomal protein transmembrane 4 alpha	HUMORF13|KIAA0108|LAPTM4|MBNT|Mtrp	protein_coding	Q15012	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16707
5.25508147991008e-42	0.446925606863447	0.326	0.047	9.643074515635e-38	YPEL3	Malignant cells	GSE161801_PI_pre	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16708
6.89047053988252e-42	0.472992083486932	0.451	0.136	1.26440134406844e-37	STT3B	Malignant cells	GSE161801_PI_pre	ENSG00000163527	201595	STT3 oligosaccharyltransferase complex catalytic subunit B	FLJ90106|SIMP|STT3-B	protein_coding	Q8TCJ2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16709
8.30284342761937e-42	-0.399601661152645	0.232	0.575	1.52357176896815e-37	RNASEH2C	Malignant cells	GSE161801_PI_pre	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16710
1.14063507345316e-41	-0.438689816184128	0.428	0.778	2.09306535978654e-37	TAPBP	Malignant cells	GSE161801_PI_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16711
1.21118273371369e-41	-0.556627397459133	0.165	0.47	2.22252031636462e-37	CCDC144A	Malignant cells	GSE161801_PI_pre	ENSG00000170160	9720	coiled-coil domain containing 144A	FLJ43983|KIAA0565	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16712
2.32142788426434e-41	-0.357803487990307	0.09	0.375	4.25982016762506e-37	ZMAT2	Malignant cells	GSE161801_PI_pre	ENSG00000146007	153527	zinc finger matrin-type 2	FLJ31121|hSNU23|Snu23	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16713
2.81846526297363e-41	-0.50946242505023	0.079	0.353	5.17188375755662e-37	H1F0	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16714
3.15558227967911e-41	-0.373332085358805	0.311	0.722	5.79049348321117e-37	IGLL5	Malignant cells	GSE161801_PI_pre	ENSG00000254709	100423062	immunoglobulin lambda like polypeptide 5	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16715
3.23976624361096e-41	-0.561455847610337	0.25	0.591	5.94497105702611e-37	TXNIP	Malignant cells	GSE161801_PI_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16716
3.97936653644609e-41	0.490752721806749	0.401	0.103	7.30213759437858e-37	DPM3	Malignant cells	GSE161801_PI_pre	ENSG00000179085	54344	dolichyl-phosphate mannosyltransferase subunit 3, regulatory	MGC125904|MGC125905|MGC34275	protein_coding	Q9P2X0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16717
6.16910322821649e-41	-0.438479368010643	0.832	0.953	1.13203044237773e-36	BTF3	Malignant cells	GSE161801_PI_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16718
6.75600950051625e-41	0.487189721274388	0.482	0.165	1.23972774334473e-36	SF3B5	Malignant cells	GSE161801_PI_pre	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16719
7.10434153229408e-41	0.398581102388122	0.277	0.022	1.30364667117596e-36	STX11	Malignant cells	GSE161801_PI_pre	ENSG00000135604	8676	syntaxin 11	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16720
1.23585295248833e-40	-0.338174352942295	0.043	0.29	2.26779016781608e-36	KCNMB2-AS1	Malignant cells	GSE161801_PI_pre	ENSG00000237978	NA	NA	RP11-385J1.2	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16721
1.88967961583135e-40	0.475925309997649	0.427	0.121	3.46756209505053e-36	CDC42	Malignant cells	GSE161801_PI_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16722
1.89181134840861e-40	-0.623174329922774	0.324	0.638	3.4714738243298e-36	IRF1	Malignant cells	GSE161801_PI_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16723
4.0327320733117e-40	-0.407795965905549	0.376	0.715	7.40006335452697e-36	NDUFS6	Malignant cells	GSE161801_PI_pre	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16724
4.29461438444115e-40	-0.409183476581817	0.444	0.768	7.88061739544951e-36	EIF3G	Malignant cells	GSE161801_PI_pre	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16725
4.93370112415866e-40	0.78117506256207	0.343	0.069	9.05334156283115e-36	WARS	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16726
5.59130889089264e-40	-0.354834095448776	0.987	0.999	1.0260051814788e-35	RPL10A	Malignant cells	GSE161801_PI_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16727
1.24831487321212e-39	0.787329658204413	0.473	0.183	2.29065779234423e-35	LMNA	Malignant cells	GSE161801_PI_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16728
4.85364622815739e-39	-0.37918126813855	0.2	0.523	8.9064408286688e-35	FUNDC2	Malignant cells	GSE161801_PI_pre	ENSG00000165775	65991	FUN14 domain containing 2	DC44|HCBP6	protein_coding	Q9BWH2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16729
5.99148334904488e-39	-0.386605064734668	0.992	0.993	1.09943719454974e-34	RPL7	Malignant cells	GSE161801_PI_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16730
1.21928828476045e-38	-0.388115148558427	0.163	0.467	2.23739400253542e-34	CD320	Malignant cells	GSE161801_PI_pre	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16731
1.35867695215417e-38	-0.325169553653344	0.039	0.272	2.4931722072029e-34	NDRG1	Malignant cells	GSE161801_PI_pre	ENSG00000104419	10397	N-myc downstream regulated 1	CAP43|DRG1|NDR1|RTP|TDD5	protein_coding	Q92597	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16732
1.4898744401397e-38	0.425813052578588	0.394	0.102	2.73391959765636e-34	IL2RG	Malignant cells	GSE161801_PI_pre	ENSG00000147168	3561	interleukin 2 receptor subunit gamma	CD132|CIDX|IMD4|SCIDX1	protein_coding	P31785	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16733
1.82721992328776e-38	1.20556816203902	0.62	0.434	3.35294855923305e-34	NUCB2	Malignant cells	GSE161801_PI_pre	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16734
1.90031286236051e-38	0.684721392051901	0.501	0.211	3.48707410243154e-34	DBI	Malignant cells	GSE161801_PI_pre	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16735
1.94281406520156e-38	-0.395523899429084	0.359	0.696	3.56506380964486e-34	NDUFA2	Malignant cells	GSE161801_PI_pre	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16736
3.71978592115753e-38	0.459469702707296	0.934	0.948	6.82580716532408e-34	TMEM59	Malignant cells	GSE161801_PI_pre	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16737
4.26450061682584e-38	-0.370986727764899	0.144	0.437	7.82535863187542e-34	MRPS23	Malignant cells	GSE161801_PI_pre	ENSG00000181610	51649	mitochondrial ribosomal protein S23	CGI-138|HSPC329|MRP-S23	protein_coding	Q9Y3D9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16738
4.80467457953212e-38	0.445283676363244	0.426	0.133	8.81657785344145e-34	GNG5	Malignant cells	GSE161801_PI_pre	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16739
6.16733389622011e-38	-0.382476419376766	0.127	0.415	1.13170576995639e-33	TUBA4A	Malignant cells	GSE161801_PI_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16740
8.40844480499728e-38	0.645867983730606	0.853	0.693	1.542949621717e-33	GAPDH	Malignant cells	GSE161801_PI_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16741
1.21140323709047e-37	-0.376551832435102	0.11	0.386	2.22292494006102e-33	RRAGD	Malignant cells	GSE161801_PI_pre	ENSG00000025039	58528	Ras related GTP binding D	bA11D8.2.1|DKFZP761H171	protein_coding	Q9NQL2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16742
1.22671247884724e-37	0.765074292451593	0.689	0.409	2.25101739868468e-33	NFKBIA	Malignant cells	GSE161801_PI_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16743
2.07097499500249e-37	-0.412521925773913	0.435	0.778	3.80023911582956e-33	PNRC1	Malignant cells	GSE161801_PI_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16744
2.19062597578309e-37	0.447648797506904	0.254	0.019	4.01979866556197e-33	SLC7A5	Malignant cells	GSE161801_PI_pre	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16745
2.44609561142951e-37	0.56499876471685	0.565	0.281	4.48858544697314e-33	GNAS	Malignant cells	GSE161801_PI_pre	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16746
2.81553844209511e-37	0.387842975970368	0.357	0.081	5.16651304124453e-33	AGA	Malignant cells	GSE161801_PI_pre	ENSG00000038002	175	aspartylglucosaminidase	ASRG	protein_coding	P20933	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16747
4.87880584602483e-37	-0.423547797397761	0.999	1	8.95260872745557e-33	RPL13A	Malignant cells	GSE161801_PI_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16748
5.03282338160991e-37	-0.325376907281487	0.074	0.328	9.23523090525419e-33	BEX4	Malignant cells	GSE161801_PI_pre	ENSG00000102409	56271	brain expressed X-linked 4	BEXL1|FLJ10097	protein_coding	Q9NWD9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16749
5.39736122696317e-37	0.460512830625078	0.835	0.722	9.90415785147741e-33	TRMT112	Malignant cells	GSE161801_PI_pre	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16750
6.80728548069494e-37	0.340891251303816	0.257	0.022	1.24913688570752e-32	CCDC57	Malignant cells	GSE161801_PI_pre	ENSG00000176155	284001	coiled-coil domain containing 57	FLJ00130|FLJ23754	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16751
7.57279146504102e-37	-0.604447157317847	0.39	0.702	1.38960723383503e-32	BTG2	Malignant cells	GSE161801_PI_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16752
7.97077400220885e-37	0.471939037160652	0.582	0.292	1.46263702940532e-32	ATP6V0B	Malignant cells	GSE161801_PI_pre	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16753
8.0902918118493e-37	-0.436618199059414	0.55	0.839	1.48456854747435e-32	SLAMF7	Malignant cells	GSE161801_PI_pre	ENSG00000026751	57823	SLAM family member 7	19A|CD319|CRACC|CS1	protein_coding	Q9NQ25	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16754
9.21881867027834e-37	-0.359484776750537	0.14	0.425	1.69165322599608e-32	TCEAL4	Malignant cells	GSE161801_PI_pre	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16755
1.08525849480467e-36	-0.378198507879888	0.249	0.57	1.99144933796657e-32	C7orf50	Malignant cells	GSE161801_PI_pre	ENSG00000146540	84310	chromosome 7 open reading frame 50	MGC11257|YCR016W	protein_coding	Q9BRJ6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16756
1.66869436114482e-36	0.557762137609433	0.825	0.778	3.06205415270075e-32	TMED2	Malignant cells	GSE161801_PI_pre	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16757
2.30224468591857e-36	-0.299312509757716	0.052	0.288	4.22461899866058e-32	FAM133A	Malignant cells	GSE161801_PI_pre	ENSG00000179083	286499	family with sequence similarity 133 member A	CT115|FLJ37659|RP1-32F7.2	protein_coding	Q8N9E0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16758
2.35631428283396e-36	0.45584407162361	0.459	0.168	4.32383670900033e-32	PAPOLA	Malignant cells	GSE161801_PI_pre	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16759
2.91578416150744e-36	0.382145439483618	0.317	0.059	5.35046393636616e-32	PNOC	Malignant cells	GSE161801_PI_pre	ENSG00000168081	5368	prepronociceptin	N/OFQ|NOP|PPNOC	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16760
4.90887494823927e-36	-0.529007426273953	0.718	0.947	9.00778553001907e-32	HSPA8	Malignant cells	GSE161801_PI_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16761
6.19152400427214e-36	-0.476734793086184	0.088	0.343	1.13614465478394e-31	DDIT4	Malignant cells	GSE161801_PI_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16762
6.24578909295536e-36	0.442597247971875	0.405	0.126	1.14610229855731e-31	MRPL52	Malignant cells	GSE161801_PI_pre	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16763
7.20194537041915e-36	-0.403605040199865	0.959	0.997	1.32155697547191e-31	RPL4	Malignant cells	GSE161801_PI_pre	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16764
7.31268493744349e-36	-0.369426396731969	0.16	0.458	1.34187768602088e-31	ARL6IP5	Malignant cells	GSE161801_PI_pre	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16765
8.08139337632985e-36	-0.350424804719747	0.155	0.446	1.48293568455653e-31	EIF4H	Malignant cells	GSE161801_PI_pre	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16766
1.12300349209079e-35	0.484798995406306	0.52	0.222	2.0607114079866e-31	LMO4	Malignant cells	GSE161801_PI_pre	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16767
1.83316517337368e-35	-0.351167460849066	0.255	0.579	3.36385809314071e-31	NDUFA5	Malignant cells	GSE161801_PI_pre	ENSG00000128609	4698	NADH:ubiquinone oxidoreductase subunit A5	B13|CI-13kB|CI-13KD-B|NUFM|UQOR13	protein_coding	Q16718	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16768
1.92553335158005e-35	-0.391429596678568	0.561	0.843	3.53335370014939e-31	PRELID1	Malignant cells	GSE161801_PI_pre	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16769
2.31806701573074e-35	0.492966806073485	0.62	0.36	4.2536529738659e-31	MZT2B	Malignant cells	GSE161801_PI_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16770
2.33504405037743e-35	-0.344886368407382	0.142	0.424	4.28480583244258e-31	NDUFS4	Malignant cells	GSE161801_PI_pre	ENSG00000164258	4724	NADH:ubiquinone oxidoreductase subunit S4	AQDQ|CI-18	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16771
2.84461589642293e-35	0.540043664076531	0.403	0.129	5.21987016993608e-31	PRDM1	Malignant cells	GSE161801_PI_pre	ENSG00000057657	639	PR/SET domain 1	BLIMP1|PRDI-BF1	protein_coding	O75626	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16772
2.9985514709899e-35	-0.397132042599475	0.376	0.687	5.50234194926647e-31	UNC93B1	Malignant cells	GSE161801_PI_pre	ENSG00000110057	81622	unc-93 homolog B1, TLR signaling regulator	UNC93	protein_coding	Q9H1C4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16773
3.63326143372629e-35	0.393908135350817	0.41	0.127	6.66703473088775e-31	MZT2A	Malignant cells	GSE161801_PI_pre	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16774
4.57755062362624e-35	-0.417620931452482	0.495	0.786	8.39980539435415e-31	MEF2C	Malignant cells	GSE161801_PI_pre	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16775
8.94311609102307e-35	0.33061828443369	0.273	0.037	1.64106180270273e-30	FUCA2	Malignant cells	GSE161801_PI_pre	ENSG00000001036	2519	alpha-L-fucosidase 2	dJ20N2.5|MGC1314	protein_coding	Q9BTY2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16776
1.205590573112e-34	0.62924689481976	0.435	0.165	2.21225870166052e-30	PHGDH	Malignant cells	GSE161801_PI_pre	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16777
2.90260193294713e-34	-0.316281804790469	0.996	0.99	5.32627454695799e-30	RPS15A	Malignant cells	GSE161801_PI_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16778
3.20978934787811e-34	0.446581471455082	0.575	0.294	5.88996345335633e-30	GYPC	Malignant cells	GSE161801_PI_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16779
7.6535871799485e-34	0.370792861055013	0.27	0.038	1.40443324752055e-29	HSD17B11	Malignant cells	GSE161801_PI_pre	ENSG00000198189	51170	hydroxysteroid 17-beta dehydrogenase 11	17-BETA-HSD11|17-BETA-HSDXI|DHRS8|PAN1B|RetSDR2|SDR16C2	protein_coding	Q8NBQ5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16780
7.7746563689989e-34	0.485173399490481	0.901	0.826	1.4266494437113e-29	RPL23	Malignant cells	GSE161801_PI_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16781
9.09871290944406e-34	0.350443972770843	0.283	0.046	1.66961381888299e-29	NDUFA12	Malignant cells	GSE161801_PI_pre	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16782
1.120806193725e-33	-0.315071278063432	0.12	0.386	2.05667936548538e-29	TMEM11	Malignant cells	GSE161801_PI_pre	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16783
1.49144867574235e-33	0.530090112677138	0.657	0.419	2.7368083199872e-29	DYNLL1	Malignant cells	GSE161801_PI_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16784
1.75024279154492e-33	0.629103423228201	0.798	0.74	3.21169552248492e-29	TRAM1	Malignant cells	GSE161801_PI_pre	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16785
1.93589546823677e-33	-0.318136916790742	0.123	0.388	3.55236818421448e-29	CYSTM1	Malignant cells	GSE161801_PI_pre	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16786
4.10918247550733e-33	-0.411395900843706	0.2	0.487	7.54034984255595e-29	KLF10	Malignant cells	GSE161801_PI_pre	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16787
5.17700057407086e-33	0.506787950641034	0.592	0.347	9.49979605342003e-29	NDUFA13	Malignant cells	GSE161801_PI_pre	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16788
5.32335742915072e-33	1.60348595042648	0.54	0.357	9.76836088249158e-29	CCND1	Malignant cells	GSE161801_PI_pre	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16789
7.23332389971391e-33	-0.562899306273025	0.464	0.753	1.3273149355975e-28	ZFP36	Malignant cells	GSE161801_PI_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16790
9.29794127423129e-33	0.338624808856862	0.257	0.034	1.70617222382144e-28	IFI27L1	Malignant cells	GSE161801_PI_pre	ENSG00000276880	122509	interferon alpha inducible protein 27 like 1	FAM14B	protein_coding	Q96BM0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16791
1.07757813986535e-32	-0.37051684554137	0.243	0.547	1.97735588665291e-28	NCF1	Malignant cells	GSE161801_PI_pre	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16792
1.237777563193e-32	0.490962862743739	0.616	0.366	2.27132182845915e-28	PET100	Malignant cells	GSE161801_PI_pre	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16793
1.30413555065956e-32	-0.427029557093856	0.207	0.483	2.3930887354603e-28	CYSLTR1	Malignant cells	GSE161801_PI_pre	ENSG00000173198	10800	cysteinyl leukotriene receptor 1	CysLT(1)|CysLT1|CYSLT1R	protein_coding	Q9Y271	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16794
1.54513852414294e-32	0.526034221175517	0.743	0.629	2.83532919180229e-28	DAD1	Malignant cells	GSE161801_PI_pre	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16795
1.61350876603409e-32	-0.383556869824493	0.998	1	2.96078858567256e-28	RPL27A	Malignant cells	GSE161801_PI_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16796
1.61717927122977e-32	-0.355446199423451	0.959	0.963	2.96752396270662e-28	RPL38	Malignant cells	GSE161801_PI_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16797
1.97417578126889e-32	0.590795670588609	0.536	0.279	3.62261255862841e-28	UBALD2	Malignant cells	GSE161801_PI_pre	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16798
2.14757996870104e-32	0.333148783485638	0.319	0.072	3.94080924256641e-28	SEPT10	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16799
2.15475773374549e-32	-0.351366545351118	0.535	0.812	3.95398044142298e-28	C19orf53	Malignant cells	GSE161801_PI_pre	ENSG00000104979	28974	chromosome 19 open reading frame 53	HSPC023|LYDG10	protein_coding	Q9UNZ5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16800
2.42244867213542e-32	-0.299457259650634	0.06	0.282	4.44519331336849e-28	ACY3	Malignant cells	GSE161801_PI_pre	ENSG00000132744	91703	aminoacylase 3	ACY-3|HCBP1|MGC9740	protein_coding	Q96HD9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16801
4.87534657943875e-32	1.11545851582029	0.377	0.129	8.9462609732701e-28	SAT1	Malignant cells	GSE161801_PI_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16802
5.38164453479031e-32	0.566067314388911	0.893	0.848	9.87531772134021e-28	MTDH	Malignant cells	GSE161801_PI_pre	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16803
1.21656774144616e-31	-0.348480815482676	0.272	0.566	2.23240180555369e-27	HINT2	Malignant cells	GSE161801_PI_pre	ENSG00000137133	84681	histidine triad nucleotide binding protein 2	NA	protein_coding	Q9BX68	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16804
1.2832534658287e-31	0.561987759350108	0.319	0.083	2.35477010979566e-27	MYADM	Malignant cells	GSE161801_PI_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16805
1.59860839501679e-31	0.370540619592548	0.337	0.089	2.93344640485581e-27	SLC25A3	Malignant cells	GSE161801_PI_pre	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16806
2.19518078227204e-31	0.371265484003507	0.353	0.1	4.02815673546919e-27	ST6GALNAC4	Malignant cells	GSE161801_PI_pre	ENSG00000136840	27090	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	SIAT3C|SIAT7D|ST6GALNACIV	protein_coding	Q9H4F1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16807
2.55886569425608e-31	-0.334458736327899	0.208	0.489	4.69551854895991e-27	QTRT1	Malignant cells	GSE161801_PI_pre	ENSG00000213339	81890	queuine tRNA-ribosyltransferase catalytic subunit 1	TGT	protein_coding	Q9BXR0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16808
3.4471007858154e-31	-0.346029674032436	0.985	0.987	6.32542994197127e-27	RPS21	Malignant cells	GSE161801_PI_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16809
9.47460995718474e-31	0.356024478495515	0.345	0.096	1.7385909271434e-26	SEC63	Malignant cells	GSE161801_PI_pre	ENSG00000025796	11231	SEC63 homolog, protein translocation regulator	DNAJC23|ERdj2|PRO2507|SEC63L	protein_coding	Q9UGP8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16810
1.04206325020379e-30	0.403707483527748	0.311	0.072	1.91218606412396e-26	SH3BGRL3	Malignant cells	GSE161801_PI_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16811
1.07644917621149e-30	0.331267416071588	0.266	0.046	1.97528423834809e-26	HEBP2	Malignant cells	GSE161801_PI_pre	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16812
1.34775944048104e-30	0.313302486856147	0.259	0.041	2.47313857328271e-26	TMEM165	Malignant cells	GSE161801_PI_pre	ENSG00000134851	55858	transmembrane protein 165	GDT1|SLC64A1|TMPT27|TPARL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16813
1.52421032589654e-30	0.54247136625727	0.501	0.25	2.79692594802015e-26	CYTIP	Malignant cells	GSE161801_PI_pre	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16814
1.55481306151017e-30	0.367997120161592	0.339	0.093	2.85308196787117e-26	PCGF5	Malignant cells	GSE161801_PI_pre	ENSG00000180628	84333	polycomb group ring finger 5	MGC16202|RNF159	protein_coding	Q86SE9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16815
1.63092035257018e-30	-0.326798797238002	0.311	0.619	2.99273884696628e-26	PPA1	Malignant cells	GSE161801_PI_pre	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16816
1.66641195980543e-30	-0.281287930001477	0.996	0.997	3.05786594624297e-26	RPS27A	Malignant cells	GSE161801_PI_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16817
2.15689963292223e-30	-0.328863224342528	0.178	0.448	3.95791082641229e-26	LY9	Malignant cells	GSE161801_PI_pre	ENSG00000122224	4063	lymphocyte antigen 9	CD229|hly9|mLY9|SLAMF3	protein_coding	Q9HBG7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16818
2.16228739434617e-30	-0.361444940044893	0.39	0.693	3.96779736862522e-26	LDHA	Malignant cells	GSE161801_PI_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16819
2.16288099809937e-30	0.339072057740585	0.289	0.061	3.96888663151234e-26	ATF6	Malignant cells	GSE161801_PI_pre	ENSG00000118217	22926	activating transcription factor 6	ATF6A	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16820
2.73566260498109e-30	0.434360909035691	0.628	0.377	5.01994088014029e-26	GUK1	Malignant cells	GSE161801_PI_pre	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16821
2.97363187005476e-30	-0.374501919194257	0.121	0.363	5.45661448155049e-26	FMNL1	Malignant cells	GSE161801_PI_pre	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16822
3.42105235289559e-30	-0.32340622301945	0.204	0.482	6.27763106756341e-26	TAF9	Malignant cells	GSE161801_PI_pre	ENSG00000276463	6880	TATA-box binding protein associated factor 9	AD-004|CGI-137|MGC1603|MGC3647|MGC5067|TAF2G|TAFII31|TAFII32|TAFIID32	protein_coding	Q16594	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16823
4.33042153644108e-30	-0.352914082560537	0.1	0.334	7.94632351936939e-26	PBXIP1	Malignant cells	GSE161801_PI_pre	ENSG00000163346	57326	PBX homeobox interacting protein 1	HPIP	protein_coding	Q96AQ6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16824
4.62168986898825e-30	0.509696575079862	0.689	0.508	8.48080090959343e-26	YBX1	Malignant cells	GSE161801_PI_pre	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16825
5.09307960068415e-30	0.435137460787894	0.721	0.549	9.34580106725541e-26	NDUFB11	Malignant cells	GSE161801_PI_pre	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16826
5.25264667518029e-30	-0.293145851211354	0.979	0.981	9.63860664895584e-26	RPS7	Malignant cells	GSE161801_PI_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16827
6.50753992738706e-30	-0.322138768225997	0.215	0.496	1.19413357667553e-25	NDUFB5	Malignant cells	GSE161801_PI_pre	ENSG00000136521	4711	NADH:ubiquinone oxidoreductase subunit B5	CI-SGDH|MGC12314|SGDH	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16828
6.72747500982658e-30	0.44166384422504	0.798	0.62	1.23449166430318e-25	CFL1	Malignant cells	GSE161801_PI_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16829
1.26924639528018e-29	0.370808526771992	0.445	0.183	2.32906713533914e-25	TMEM179B	Malignant cells	GSE161801_PI_pre	ENSG00000185475	374395	transmembrane protein 179B	NA	protein_coding	Q7Z7N9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16830
1.8621174893032e-29	0.332816203167074	0.32	0.084	3.41698559287137e-25	CBWD1	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16831
2.07555794070571e-29	-0.302343683903579	0.15	0.408	3.80864882119498e-25	ZCCHC7	Malignant cells	GSE161801_PI_pre	ENSG00000147905	84186	zinc finger CCHC-type containing 7	AIR1|FLJ22611	protein_coding	Q8N3Z6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16832
2.45289708188976e-29	0.690971478698874	0.657	0.483	4.5010661452677e-25	CRELD2	Malignant cells	GSE161801_PI_pre	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16833
4.86154672236944e-29	-0.413283383009613	0.839	0.966	8.92093823554791e-25	ISG20	Malignant cells	GSE161801_PI_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16834
5.29721251945619e-29	-0.343064917764613	0.978	0.987	9.7203849732021e-25	RPL31	Malignant cells	GSE161801_PI_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16835
5.30051332480564e-29	0.412324571186697	0.874	0.823	9.72644195101835e-25	TMA7	Malignant cells	GSE161801_PI_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16836
6.20067038120621e-29	0.38417839213351	0.359	0.117	1.13782301495134e-24	FAM96A	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16837
6.52331292519041e-29	-0.318387143067463	0.137	0.384	1.19702792177244e-24	SDHA	Malignant cells	GSE161801_PI_pre	ENSG00000073578	6389	succinate dehydrogenase complex flavoprotein subunit A	FP|SDH2|SDHF	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16838
1.005133171925e-28	0.327528247565795	0.31	0.08	1.84441937048238e-24	FAAP20	Malignant cells	GSE161801_PI_pre	ENSG00000162585	199990	FA core complex associated protein 20	C1orf86|FLJ31031	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16839
1.29104607894263e-28	0.66096042800799	0.567	0.328	2.36906955485972e-24	IFITM1	Malignant cells	GSE161801_PI_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16840
1.35472723579693e-28	-0.294624163740784	0.109	0.341	2.48592447768737e-24	CREB3	Malignant cells	GSE161801_PI_pre	ENSG00000107175	10488	cAMP responsive element binding protein 3	Luman|LZIP|sLZIP	protein_coding	O43889	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16841
1.95697665064081e-28	0.394851381570026	0.459	0.201	3.59105215392589e-24	CD164	Malignant cells	GSE161801_PI_pre	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16842
2.24315584461958e-28	-0.289515094077713	0.093	0.318	4.11619097487694e-24	SRSF1	Malignant cells	GSE161801_PI_pre	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16843
3.03280016960049e-28	0.335150850558816	0.33	0.096	5.56518831121691e-24	TMED5	Malignant cells	GSE161801_PI_pre	ENSG00000117500	50999	transmembrane p24 trafficking protein 5	CGI-100|p24g2|p24gamma2	protein_coding	Q9Y3A6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16844
3.19642563154786e-28	-0.310553666054899	0.187	0.451	5.86544103389032e-24	LSM4	Malignant cells	GSE161801_PI_pre	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16845
3.70792531593404e-28	0.400071431641549	0.552	0.294	6.80404295473896e-24	PCBP2	Malignant cells	GSE161801_PI_pre	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16846
4.29974438274746e-28	0.457839028506363	0.709	0.548	7.8900309423416e-24	ISCU	Malignant cells	GSE161801_PI_pre	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16847
4.48126175286413e-28	0.351901422066484	0.338	0.103	8.22311531650568e-24	EDEM2	Malignant cells	GSE161801_PI_pre	ENSG00000088298	55741	ER degradation enhancing alpha-mannosidase like protein 2	bA4204.1|C20orf31|C20orf49|FLJ10783	protein_coding	Q9BV94	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16848
5.8152871436535e-28	-0.333040263142252	0.225	0.496	1.06710519086042e-23	TMEM109	Malignant cells	GSE161801_PI_pre	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16849
6.38973566790653e-28	0.506354122629679	0.322	0.096	1.17251649506085e-23	NSMCE3	Malignant cells	GSE161801_PI_pre	ENSG00000282130	56160	NSE3 homolog, SMC5-SMC6 complex component	HCA4|MAGEG1|MAGEL3|NDNL2|NSE3	protein_coding	Q96MG7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16850
6.9212603229685e-28	0.369188937693963	0.322	0.092	1.27005126926472e-23	CD37	Malignant cells	GSE161801_PI_pre	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16851
6.96231370086609e-28	0.497973002453353	0.783	0.728	1.27758456410893e-23	TMED10	Malignant cells	GSE161801_PI_pre	ENSG00000170348	10972	transmembrane p24 trafficking protein 10	p23|P24(DELTA)|p24d1|p24delta1|TMP21	protein_coding	P49755	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16852
1.22382149330556e-27	0.339725365037602	0.309	0.084	2.2457124402157e-23	CERCAM	Malignant cells	GSE161801_PI_pre	ENSG00000167123	51148	cerebral endothelial cell adhesion molecule	CEECAM1|GLT25D3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16853
1.22542151336343e-27	-0.326675154534436	0.275	0.552	2.2486484770219e-23	ZBP1	Malignant cells	GSE161801_PI_pre	ENSG00000124256	81030	Z-DNA binding protein 1	C20orf183|DAI|dJ718J7.3|DLM-1|DLM1	protein_coding	Q9H171	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16854
1.26770990746918e-27	0.33137214512255	0.289	0.071	2.32624768020594e-23	UBL7	Malignant cells	GSE161801_PI_pre	ENSG00000288408	84993	ubiquitin like 7	BMSC-UbP|MGC14421	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16855
1.69400261814213e-27	-0.367492587083096	0.36	0.634	3.10849480429081e-23	MEI1	Malignant cells	GSE161801_PI_pre	ENSG00000167077	150365	meiotic double-stranded break formation protein 1	MGC40042|SPATA38	protein_coding	Q5TIA1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16856
2.28752856951497e-27	0.327071300839071	0.324	0.095	4.19761492505997e-23	RAB2A	Malignant cells	GSE161801_PI_pre	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16857
2.83952094096663e-27	-0.302610017770326	0.15	0.396	5.21052092667376e-23	PDCD4	Malignant cells	GSE161801_PI_pre	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16858
3.76729454644915e-27	0.315917244943917	0.31	0.086	6.91298549273419e-23	ARL1	Malignant cells	GSE161801_PI_pre	ENSG00000120805	400	ADP ribosylation factor like GTPase 1	ARFL1	protein_coding	P40616	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16859
5.54316220550824e-27	-0.327011615946801	0.827	0.942	1.01717026471076e-22	HINT1	Malignant cells	GSE161801_PI_pre	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16860
5.88232953222091e-27	0.379825620619267	0.376	0.136	1.07940746916254e-22	RTN4	Malignant cells	GSE161801_PI_pre	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16861
6.93463055950545e-27	-0.305153225281588	0.96	0.972	1.27250470766925e-22	RPL36A	Malignant cells	GSE161801_PI_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16862
1.13649892270797e-26	0.350025162474753	0.309	0.087	2.08547552316913e-22	PTPN6	Malignant cells	GSE161801_PI_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16863
1.19321537552208e-26	-0.288984114043105	1	1	2.18955021408301e-22	RPS18	Malignant cells	GSE161801_PI_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16864
1.64345795423932e-26	-0.31575605278182	0.325	0.6	3.01574534602915e-22	NHP2	Malignant cells	GSE161801_PI_pre	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16865
2.14848846076805e-26	0.669876538847269	0.454	0.21	3.94247632550937e-22	IFI27	Malignant cells	GSE161801_PI_pre	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16866
3.78394143298161e-26	-0.349715431709603	0.262	0.52	6.94353252952126e-22	CTSD	Malignant cells	GSE161801_PI_pre	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16867
4.25128824592603e-26	0.439105501862455	0.755	0.679	7.80111393127427e-22	ATP6V1G1	Malignant cells	GSE161801_PI_pre	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16868
5.03808717054618e-26	0.489732510618485	0.414	0.189	9.24488995795223e-22	ACADVL	Malignant cells	GSE161801_PI_pre	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16869
5.93313984822556e-26	-0.409296591450678	0.894	0.999	1.08873116214939e-21	MT-ND4	Malignant cells	GSE161801_PI_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16870
6.03858705200686e-26	-0.347531470684495	0.316	0.588	1.10808072404326e-21	VAMP2	Malignant cells	GSE161801_PI_pre	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16871
6.74975045076136e-26	-0.306655009597778	0.209	0.461	1.23857920771471e-21	VPS51	Malignant cells	GSE161801_PI_pre	ENSG00000149823	738	VPS51 subunit of GARP complex	ANG2|ANG3|C11orf2|C11orf3|FFR	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16872
8.15195411708751e-26	0.397802547268799	0.702	0.532	1.49588358048556e-21	TMBIM4	Malignant cells	GSE161801_PI_pre	ENSG00000155957	51643	transmembrane BAX inhibitor motif containing 4	CGI-119|GAAP|LFG4|S1R|ZPRO	protein_coding	Q9HC24	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16873
8.19406035463459e-26	0.304711669488991	0.57	0.267	1.50361007507545e-21	IER2	Malignant cells	GSE161801_PI_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16874
1.01318147833867e-25	-0.330297601353314	0.198	0.439	1.85918801275146e-21	FAM174A	Malignant cells	GSE161801_PI_pre	ENSG00000174132	345757	family with sequence similarity 174 member A	NS5ATP6|TMEM157|UNQ1912	protein_coding	Q8TBP5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16875
1.40406487767833e-25	-0.272485818070929	0.097	0.31	2.57645905053973e-21	PPT1	Malignant cells	GSE161801_PI_pre	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16876
1.41738906823847e-25	-0.327980904923564	0.326	0.588	2.6009089402176e-21	VOPP1	Malignant cells	GSE161801_PI_pre	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16877
1.821617014678e-25	0.378001131746372	0.55	0.313	3.34266722193413e-21	HNRNPC	Malignant cells	GSE161801_PI_pre	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16878
1.98624245914366e-25	0.323376817281329	0.313	0.096	3.64475491252863e-21	KTN1	Malignant cells	GSE161801_PI_pre	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16879
2.33888481223548e-25	0.480991627109764	0.505	0.287	4.2918536304521e-21	LY96	Malignant cells	GSE161801_PI_pre	ENSG00000154589	23643	lymphocyte antigen 96	MD-2	protein_coding	Q9Y6Y9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16880
2.35258140481775e-25	-0.275679104753239	0.079	0.276	4.31698687784058e-21	ARHGAP27	Malignant cells	GSE161801_PI_pre	ENSG00000276836	201176	Rho GTPase activating protein 27	CAMGAP1|FLJ43547|SH3D20|SH3P20	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16881
2.5091084601555e-25	0.346374308461796	0.367	0.137	4.60421402438535e-21	AIG1	Malignant cells	GSE161801_PI_pre	ENSG00000146416	51390	androgen induced 1	AIG-1|dJ95L4.1|FLJ10485	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16882
2.66572706659801e-25	-0.315036366383046	0.115	0.329	4.89160916720735e-21	CD180	Malignant cells	GSE161801_PI_pre	ENSG00000134061	4064	CD180 molecule	LY64|Ly78|RP105	protein_coding	Q99467	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16883
2.76560345212802e-25	0.489016555510704	0.687	0.566	5.07488233465492e-21	ATRAID	Malignant cells	GSE161801_PI_pre	ENSG00000138085	51374	all-trans retinoic acid induced differentiation factor	APR3|C2orf28|HSPC013|p18	protein_coding	Q6UW56	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16884
3.07288862907416e-25	0.393102616538433	0.38	0.154	5.63875063435108e-21	MDH1	Malignant cells	GSE161801_PI_pre	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16885
6.83461144023822e-25	1.74945816210963	0.418	0.241	1.25415119928371e-20	CXCR4	Malignant cells	GSE161801_PI_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16886
7.97153632826368e-25	0.282569128373115	0.271	0.066	1.46277691623639e-20	TYMP	Malignant cells	GSE161801_PI_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16887
9.2574966185992e-25	-0.272618363896819	0.131	0.355	1.69875062951295e-20	HNRNPH2	Malignant cells	GSE161801_PI_pre	ENSG00000126945	3188	heterogeneous nuclear ribonucleoprotein H2	FTP3|hnRNPH'|HNRPH'|HNRPH2	protein_coding	P55795	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16888
1.31807612214334e-24	0.353429065995747	0.421	0.185	2.41866968413303e-20	CALM1	Malignant cells	GSE161801_PI_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16889
1.3317523333347e-24	0.299190109374468	0.31	0.096	2.44376553166918e-20	PTPMT1	Malignant cells	GSE161801_PI_pre	ENSG00000285206	114971	protein tyrosine phosphatase mitochondrial 1	DUSP23|MOSP|PLIP	protein_coding	Q8WUK0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16890
1.43303778823318e-24	-0.279892208767884	0.211	0.461	2.62962434140789e-20	MCTS1	Malignant cells	GSE161801_PI_pre	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16891
1.5316245738847e-24	0.28462907497965	0.278	0.074	2.81053109307842e-20	ALDOA	Malignant cells	GSE161801_PI_pre	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16892
2.11581711743993e-24	-0.312818002807118	0.075	0.266	3.88252441050227e-20	CHST2	Malignant cells	GSE161801_PI_pre	ENSG00000175040	9435	carbohydrate sulfotransferase 2	C6ST	protein_coding	Q9Y4C5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16893
2.20529703773125e-24	-0.288665581287406	0.323	0.595	4.04672006423684e-20	C19orf70	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16894
2.43541507851262e-24	0.518050153615221	0.52	0.307	4.46898666907065e-20	RASGRP3	Malignant cells	GSE161801_PI_pre	ENSG00000152689	25780	RAS guanyl releasing protein 3	CalDAG-GEFIII|GRP3|KIAA0846	protein_coding	Q8IV61	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16895
2.46187031953293e-24	0.341368895634542	0.396	0.164	4.51753203634292e-20	LMF1	Malignant cells	GSE161801_PI_pre	ENSG00000103227	64788	lipase maturation factor 1	C16orf26|FLJ12681|FLJ22302|JFP11|TMEM112|TMEM112A	protein_coding	Q96S06	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16896
2.50070094621743e-24	0.293869986749268	0.265	0.066	4.58878623630899e-20	PTP4A2	Malignant cells	GSE161801_PI_pre	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16897
3.47237062949296e-24	0.518909511000264	0.467	0.254	6.37180010511957e-20	CHPF	Malignant cells	GSE161801_PI_pre	ENSG00000123989	79586	chondroitin polymerizing factor	CHSY2|CSS2	protein_coding	Q8IZ52	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16898
3.58059418050074e-24	-0.257744441859081	0.948	0.976	6.57039032121885e-20	RPL22	Malignant cells	GSE161801_PI_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16899
3.74024662491714e-24	-0.274542590740504	0.373	0.669	6.86335255672295e-20	EIF5A	Malignant cells	GSE161801_PI_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16900
4.68888314153201e-24	-0.269717927723531	0.135	0.356	8.60410056471124e-20	BRMS1	Malignant cells	GSE161801_PI_pre	ENSG00000174744	25855	BRMS1 transcriptional repressor and anoikis regulator	DKFZP564A063	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16901
5.17312031197066e-24	-0.396625559266508	0.52	0.758	9.49267577246617e-20	TRIB1	Malignant cells	GSE161801_PI_pre	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16902
8.42132123892735e-24	-0.30429143931019	0.256	0.507	1.54531244734317e-19	METTL7A	Malignant cells	GSE161801_PI_pre	ENSG00000185432	25840	methyltransferase like 7A	DKFZP586A0522	protein_coding	Q9H8H3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16903
8.65628631947945e-24	0.28280917968433	0.257	0.062	1.58842853962448e-19	TSPO	Malignant cells	GSE161801_PI_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16904
9.25031618418906e-24	0.282890073179593	0.262	0.066	1.69743301979869e-19	SH3GLB1	Malignant cells	GSE161801_PI_pre	ENSG00000097033	51100	SH3 domain containing GRB2 like, endophilin B1	Bif-1|CGI-61|KIAA0491|PPP1R70	protein_coding	Q9Y371	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16905
9.73984570709349e-24	-0.2699024957034	0.116	0.325	1.78726168725166e-19	EMD	Malignant cells	GSE161801_PI_pre	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16906
1.58365536678681e-23	0.427715688619481	0.822	0.767	2.9060075980538e-19	SELENOK	Malignant cells	GSE161801_PI_pre	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16907
2.37496942268196e-23	-0.264800559675967	0.112	0.316	4.35806889062139e-19	AC012368.1	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16908
2.55294975720664e-23	0.535035872485694	0.492	0.282	4.68466280447419e-19	IGF1	Malignant cells	GSE161801_PI_pre	ENSG00000017427	3479	insulin like growth factor 1	IGF|IGF-I|IGF1A|IGFI	protein_coding	P05019	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16909
3.00448163092842e-23	0.282177595985554	0.3	0.095	5.51322379275365e-19	C15orf61	Malignant cells	GSE161801_PI_pre	ENSG00000189227	145853	chromosome 15 open reading frame 61	LOC145853	protein_coding	A6NNL5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16910
3.4283234180108e-23	-0.278399370490792	0.313	0.572	6.29097347204982e-19	SSBP1	Malignant cells	GSE161801_PI_pre	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16911
3.80495231768091e-23	0.37689073498486	0.444	0.216	6.98208750294448e-19	ARPC2	Malignant cells	GSE161801_PI_pre	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16912
4.31657859556187e-23	0.445761181533915	0.366	0.148	7.92092172285603e-19	ZFP36L2	Malignant cells	GSE161801_PI_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16913
4.96058325834368e-23	0.601831949165278	0.926	0.941	9.10267027906065e-19	SEC61B	Malignant cells	GSE161801_PI_pre	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16914
5.98738390317826e-23	-0.317634884109214	0.295	0.53	1.09868494623321e-18	FCRL5	Malignant cells	GSE161801_PI_pre	ENSG00000143297	83416	Fc receptor like 5	BXMAS1|CD307e|FCRH5|IRTA2	protein_coding	Q96RD9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16915
1.47064750053859e-22	-0.294157880077406	0.306	0.561	2.69863816348831e-18	SBDS	Malignant cells	GSE161801_PI_pre	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16916
1.70400536497505e-22	1.20247378369023	0.762	0.814	3.12684984472921e-18	CD63	Malignant cells	GSE161801_PI_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16917
1.78310026872869e-22	0.318412905360956	0.39	0.165	3.27198899311715e-18	SUMO1	Malignant cells	GSE161801_PI_pre	ENSG00000116030	7341	small ubiquitin like modifier 1	GMP1|OFC10|PIC1|SMT3C|SMT3H3|SUMO-1|UBL1	protein_coding	P63165	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16918
1.95199334128862e-22	0.293798133146337	0.284	0.087	3.58190778126462e-18	ARMC2	Malignant cells	GSE161801_PI_pre	ENSG00000118690	84071	armadillo repeat containing 2	bA787I22.1|DKFZp434P0714	protein_coding	Q8NEN0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16919
2.68086418442776e-22	-0.258324410320622	0.127	0.334	4.91938577842494e-18	SAT2	Malignant cells	GSE161801_PI_pre	ENSG00000141504	112483	spermidine/spermine N1-acetyltransferase family member 2	SSAT2	protein_coding	Q96F10	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16920
3.32108985908626e-22	0.271015306207733	0.262	0.072	6.09419989142328e-18	RNF187	Malignant cells	GSE161801_PI_pre	ENSG00000285426	149603	ring finger protein 187	RACO-1|RACO1	protein_coding	Q5TA31	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16921
3.44730423347582e-22	-0.261599398826195	0.155	0.371	6.32580326842814e-18	USE1	Malignant cells	GSE161801_PI_pre	ENSG00000053501	55850	unconventional SNARE in the ER 1	D12|MDS032|p31|SLT1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16922
3.52521999313304e-22	-0.29543405266407	0.45	0.718	6.46877868739912e-18	CD38	Malignant cells	GSE161801_PI_pre	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16923
4.13294560544231e-22	-0.271736802203696	0.114	0.313	7.58395518598665e-18	TAP2	Malignant cells	GSE161801_PI_pre	ENSG00000232326	6891	transporter 2, ATP binding cassette subfamily B member	ABCB3|D6S217E|PSF2|RING11	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16924
5.50469824034397e-22	0.309407982107849	0.317	0.114	1.01011212710312e-17	YWHAZ	Malignant cells	GSE161801_PI_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16925
8.62752951580951e-22	-0.259584618565299	0.165	0.384	1.58315166615105e-17	MRPL34	Malignant cells	GSE161801_PI_pre	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16926
8.79741640505608e-22	0.356887535144472	0.881	0.818	1.61432591032779e-17	RPS27L	Malignant cells	GSE161801_PI_pre	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16927
1.01991502514292e-21	-0.265562494851525	0.141	0.349	1.87154407113725e-17	CASP4	Malignant cells	GSE161801_PI_pre	ENSG00000196954	837	caspase 4	ICE(rel)II|ICH-2|TX	protein_coding	P49662	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16928
1.02717161625959e-21	0.473322237158833	0.742	0.716	1.88485991583635e-17	CLIC1	Malignant cells	GSE161801_PI_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16929
1.04147877532206e-21	-0.267148748824916	0.163	0.391	1.91111355271598e-17	ATF3	Malignant cells	GSE161801_PI_pre	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16930
1.20239938134664e-21	-0.427587909320757	0.731	0.913	2.20640286477109e-17	MT-ATP6	Malignant cells	GSE161801_PI_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16931
1.33184748502284e-21	-0.27547413443494	0.396	0.657	2.44394013501691e-17	REX1BD	Malignant cells	GSE161801_PI_pre	ENSG00000006015	55049	required for excision 1-B domain containing	C19orf60|FLJ20850|FLJ30108|FLJ34606|FLJ37391	protein_coding	Q96EN9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16932
1.36641103544799e-21	0.290657292542179	0.302	0.103	2.50736425004706e-17	TXNDC12	Malignant cells	GSE161801_PI_pre	ENSG00000117862	51060	thioredoxin domain containing 12	AGR1|ERP18|ERP19|hAG-1|PDIA16|TLP19	protein_coding	O95881	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16933
1.3810673669235e-21	-0.288006314240943	0.498	0.746	2.53425861830462e-17	CYCS	Malignant cells	GSE161801_PI_pre	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16934
1.38898382960103e-21	0.311167233540959	0.311	0.111	2.54878532731789e-17	SHMT2	Malignant cells	GSE161801_PI_pre	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16935
1.55462363345245e-21	-0.253777710865386	0.134	0.338	2.85273436738524e-17	TCEAL8	Malignant cells	GSE161801_PI_pre	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16936
2.36269775823165e-21	-0.265129979711852	0.993	0.994	4.33555038635508e-17	RPL23A	Malignant cells	GSE161801_PI_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16937
2.52222287840752e-21	1.18084217902639	0.474	0.331	4.6282789818778e-17	LGALS1	Malignant cells	GSE161801_PI_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16938
2.62629158669146e-21	0.833826315637872	0.775	0.719	4.81924506157882e-17	MANF	Malignant cells	GSE161801_PI_pre	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16939
2.74052668380827e-21	-0.274722965314156	0.196	0.417	5.02886646478817e-17	DNASE2	Malignant cells	GSE161801_PI_pre	ENSG00000105612	1777	deoxyribonuclease 2, lysosomal	DNL|DNL2	protein_coding	O00115	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16940
3.15283218543843e-21	-0.25069344066673	0.141	0.349	5.78544706027951e-17	FLI1	Malignant cells	GSE161801_PI_pre	ENSG00000151702	2313	Fli-1 proto-oncogene, ETS transcription factor	EWSR2|FLI-1|SIC-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16941
4.24794460113482e-21	0.3451742293346	0.523	0.312	7.7949783430824e-17	AUP1	Malignant cells	GSE161801_PI_pre	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16942
4.81017981538012e-21	0.392709093040995	0.535	0.335	8.82667996122252e-17	CDV3	Malignant cells	GSE161801_PI_pre	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16943
8.38866799196303e-21	-0.262276195693362	0.208	0.43	1.53932057652522e-16	UBE2E1	Malignant cells	GSE161801_PI_pre	ENSG00000170142	7324	ubiquitin conjugating enzyme E2 E1	UbcH6	protein_coding	P51965	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16944
1.01303058623632e-20	0.292943807730234	0.353	0.148	1.85891112574364e-16	TMEM19	Malignant cells	GSE161801_PI_pre	ENSG00000139291	55266	transmembrane protein 19	FLJ10936	protein_coding	Q96HH6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16945
1.15654014017265e-20	-0.32780368054635	0.268	0.483	2.12225115721682e-16	TAF7	Malignant cells	GSE161801_PI_pre	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16946
1.26365335342985e-20	0.31208432119713	0.34	0.139	2.31880390354377e-16	CAPZA1	Malignant cells	GSE161801_PI_pre	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16947
1.34267576093894e-20	0.266273964632177	0.273	0.087	2.46381002132296e-16	C2orf88	Malignant cells	GSE161801_PI_pre	ENSG00000187699	84281	chromosome 2 open reading frame 88	MGC13057|smAKAP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16948
1.82530297183514e-20	-0.289402798172828	0.224	0.443	3.34943095331748e-16	PDK1	Malignant cells	GSE161801_PI_pre	ENSG00000152256	5163	pyruvate dehydrogenase kinase 1	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16949
2.14069263525596e-20	0.333768477156031	0.406	0.198	3.92817098569468e-16	ANXA5	Malignant cells	GSE161801_PI_pre	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16950
3.148875981806e-20	0.609824450884772	0.992	0.987	5.77818742661401e-16	RPS12	Malignant cells	GSE161801_PI_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16951
3.33939289109248e-20	0.312706595696401	0.268	0.087	6.12778595515469e-16	SCAPER	Malignant cells	GSE161801_PI_pre	ENSG00000140386	49855	S-phase cyclin A associated protein in the ER	Zfp291|ZNF291	protein_coding	Q9BY12	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16952
3.37369132588594e-20	0.274298603942512	0.297	0.106	6.1907235830007e-16	NDUFA7	Malignant cells	GSE161801_PI_pre	ENSG00000267855	4701	NADH:ubiquinone oxidoreductase subunit A7	B14.5a	protein_coding	O95182	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16953
3.40818235083715e-20	-0.27195301105778	0.224	0.443	6.25401461378618e-16	TBXAS1	Malignant cells	GSE161801_PI_pre	ENSG00000059377	6916	thromboxane A synthase 1	CYP5|CYP5A1|THAS|TS|TXAS|TXS	protein_coding	P24557	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16954
6.39170002577233e-20	-0.261548497723597	0.323	0.567	1.17287695472922e-15	CD79B	Malignant cells	GSE161801_PI_pre	ENSG00000007312	974	CD79b molecule	B29|Ig-beta|IGB|Igbeta	protein_coding	P40259	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16955
7.86148195379059e-20	0.365768884756448	0.398	0.199	1.44258193852057e-15	IFI27L2	Malignant cells	GSE161801_PI_pre	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16956
1.0259675995329e-19	-0.25213721866152	0.219	0.446	1.88265054514288e-15	UBE2L6	Malignant cells	GSE161801_PI_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16957
1.09532234823894e-19	0.272773836579175	0.313	0.121	2.00991650901846e-15	PDXK	Malignant cells	GSE161801_PI_pre	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16958
1.72247357916947e-19	0.281646705440137	0.3	0.112	3.16073901777598e-15	EIF4E	Malignant cells	GSE161801_PI_pre	ENSG00000151247	1977	eukaryotic translation initiation factor 4E	EIF4E1|EIF4EL1|EIF4F	protein_coding	P06730	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16959
1.98450307102171e-19	-0.254657605561571	1	1	3.64156313532484e-15	RPS15	Malignant cells	GSE161801_PI_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16960
2.03799945252249e-19	0.39010921143186	0.566	0.377	3.73972899537876e-15	DNAJC3	Malignant cells	GSE161801_PI_pre	ENSG00000102580	5611	DnaJ heat shock protein family (Hsp40) member C3	ERdj6|HP58|P58|p58(IPK)|P58IPK|PRKRI	protein_coding	Q13217	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16961
2.16661075491361e-19	-0.250062568246644	0.496	0.737	3.97573073526648e-15	SKP1	Malignant cells	GSE161801_PI_pre	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16962
3.29009729886781e-19	0.373492267406736	0.452	0.257	6.03732854342244e-15	RCN2	Malignant cells	GSE161801_PI_pre	ENSG00000117906	5955	reticulocalbin 2	E6BP|ERC-55|ERC55|TCBP49	protein_coding	Q14257	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16963
3.32422078283178e-19	0.468648266887399	0.717	0.644	6.09994513649631e-15	HM13	Malignant cells	GSE161801_PI_pre	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16964
3.37382565542371e-19	-0.253256242048196	0.257	0.482	6.19097007770251e-15	SRP19	Malignant cells	GSE161801_PI_pre	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16965
3.56101130915001e-19	0.530357760552862	0.987	0.997	6.53445575229027e-15	RPLP0	Malignant cells	GSE161801_PI_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16966
3.60496465659387e-19	0.34181534057826	0.419	0.22	6.61511014484974e-15	PYURF	Malignant cells	GSE161801_PI_pre	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16967
4.29280185368094e-19	0.307522183003164	0.273	0.096	7.87729140150452e-15	TMC6	Malignant cells	GSE161801_PI_pre	ENSG00000141524	11322	transmembrane channel like 6	EVER1|EVIN1|LAK-4P|TNRC6C-AS1	protein_coding	Q7Z403	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16968
4.49013382481806e-19	0.38690408954165	0.277	0.1	8.23939556854114e-15	C16orf54	Malignant cells	GSE161801_PI_pre	ENSG00000185905	283897	chromosome 16 open reading frame 54	FLJ35681	protein_coding	Q6UWD8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16969
7.01255232596155e-19	0.450487064027272	0.596	0.425	1.28680335181394e-14	CYTOR	Malignant cells	GSE161801_PI_pre	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16970
7.08520161715045e-19	-0.290300974819673	0.347	0.567	1.30013449674711e-14	CREB3L2	Malignant cells	GSE161801_PI_pre	ENSG00000182158	64764	cAMP responsive element binding protein 3 like 2	BBF2H7|TCAG_1951439	protein_coding	Q70SY1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16971
8.08263724919624e-19	0.255834263682448	0.282	0.1	1.48316393522751e-14	RBBP4	Malignant cells	GSE161801_PI_pre	ENSG00000162521	5928	RB binding protein 4, chromatin remodeling factor	lin-53|NURF55|RbAp48	protein_coding	Q09028	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16972
8.20640987072845e-19	0.353798982533663	0.755	0.668	1.50587621127867e-14	FXYD5	Malignant cells	GSE161801_PI_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16973
8.72214239516838e-19	0.280072508909917	0.346	0.152	1.6005131295134e-14	TXNL4A	Malignant cells	GSE161801_PI_pre	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16974
8.97407499050813e-19	0.288801061297077	0.377	0.177	1.64674276075824e-14	MLEC	Malignant cells	GSE161801_PI_pre	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16975
9.49010144412566e-19	0.300109767529982	0.381	0.183	1.74143361499706e-14	CKAP4	Malignant cells	GSE161801_PI_pre	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16976
9.86756661821752e-19	-0.263391583259933	0.205	0.409	1.81069847444292e-14	IDUA	Malignant cells	GSE161801_PI_pre	ENSG00000127415	3425	alpha-L-iduronidase	MPS1|MPSI	protein_coding	P35475	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16977
1.15780986550798e-18	0.53134069167628	0.668	0.619	2.12458110320715e-14	DDOST	Malignant cells	GSE161801_PI_pre	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16978
1.2215317289729e-18	0.434971591723148	0.756	0.716	2.24151072266527e-14	RPN2	Malignant cells	GSE161801_PI_pre	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16979
1.47480795546308e-18	0.34215362552583	0.386	0.196	2.70627259827475e-14	RTN3	Malignant cells	GSE161801_PI_pre	ENSG00000133318	10313	reticulon 3	ASYIP|HAP|NSPL2|NSPLII|RTN3-A1	protein_coding	O95197	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16980
1.61259396043744e-18	0.48738494102246	0.965	0.985	2.95910991740271e-14	FTH1	Malignant cells	GSE161801_PI_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16981
1.94260857506912e-18	0.338634887097029	0.279	0.102	3.56468673525184e-14	NR4A1	Malignant cells	GSE161801_PI_pre	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16982
3.02991442199468e-18	-0.252816807865804	0.387	0.62	5.55989296436023e-14	TBCA	Malignant cells	GSE161801_PI_pre	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16983
3.88613958630543e-18	-0.2633754062843	0.237	0.449	7.13106614087047e-14	HSPA9	Malignant cells	GSE161801_PI_pre	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16984
4.46586666958139e-18	0.729437409914433	0.534	0.428	8.19486533868186e-14	EDNRB	Malignant cells	GSE161801_PI_pre	ENSG00000136160	1910	endothelin receptor type B	ETB|HSCR|HSCR2	protein_coding	P24530	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16985
5.25475126055877e-18	-0.272803907597273	0.665	0.885	9.64246856312534e-14	EIF4A2	Malignant cells	GSE161801_PI_pre	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16986
5.71004719401125e-18	-0.287255768334204	0.865	0.979	1.04779366010106e-13	PSAP	Malignant cells	GSE161801_PI_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16987
5.95151697726153e-18	0.3183599322922	0.745	0.662	1.09210336532749e-13	PRDX5	Malignant cells	GSE161801_PI_pre	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16988
6.28168933608686e-18	0.290614419013293	0.344	0.154	1.15268999317194e-13	ERN1	Malignant cells	GSE161801_PI_pre	ENSG00000178607	2081	endoplasmic reticulum to nucleus signaling 1	IRE1|IRE1P	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16989
1.12994092121483e-17	-0.318058418947431	0.881	0.981	2.07344159042922e-13	MT-CYB	Malignant cells	GSE161801_PI_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16990
1.22985379260636e-17	-0.427733401811888	0.95	0.999	2.25678170943268e-13	MT-CO2	Malignant cells	GSE161801_PI_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16991
1.44658669916375e-17	0.319398786160064	0.35	0.161	2.65448659296549e-13	IFITM2	Malignant cells	GSE161801_PI_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16992
1.72708713672014e-17	0.310391666949695	0.39	0.198	3.16920489588145e-13	TIFA	Malignant cells	GSE161801_PI_pre	ENSG00000145365	92610	TRAF interacting protein with forkhead associated domain	MGC20791|T2BP|T6BP|TIFAA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16993
1.96308621211558e-17	0.325000657669229	0.988	0.942	3.6022631992321e-13	RPS26	Malignant cells	GSE161801_PI_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16994
1.98267152424225e-17	0.294207794824021	0.352	0.165	3.63820224698453e-13	EIF5B	Malignant cells	GSE161801_PI_pre	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16995
2.5752874390195e-17	0.285673139285643	0.379	0.189	4.72565245060079e-13	RBX1	Malignant cells	GSE161801_PI_pre	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16996
2.69483475814396e-17	0.300398879661409	0.812	0.743	4.94502178119416e-13	ATP5MPL	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16997
2.75634947437088e-17	-0.256990973644665	0.543	0.767	5.05790128547056e-13	SRPRB	Malignant cells	GSE161801_PI_pre	ENSG00000144867	58477	SRP receptor subunit beta	APMCF1|SR-beta	protein_coding	Q9Y5M8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16998
2.88529577690969e-17	0.32541468982615	0.39	0.199	5.29451775062928e-13	ARF6	Malignant cells	GSE161801_PI_pre	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	16999
2.9012442780875e-17	-0.269266681253697	1	1	5.32378325029055e-13	RPS19	Malignant cells	GSE161801_PI_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17000
3.40202609961125e-17	0.292172702922492	0.387	0.198	6.24271789278665e-13	PGRMC2	Malignant cells	GSE161801_PI_pre	ENSG00000164040	10424	progesterone receptor membrane component 2	DG6|PMBP	protein_coding	O15173	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17001
3.40441320517407e-17	0.304053013984491	0.519	0.325	6.24709823149442e-13	DRAP1	Malignant cells	GSE161801_PI_pre	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17002
3.58370485868024e-17	0.286723545747612	0.394	0.204	6.57609841567824e-13	SDF4	Malignant cells	GSE161801_PI_pre	ENSG00000078808	51150	stromal cell derived factor 4	Cab45	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17003
3.66727154191306e-17	0.342550755940697	0.621	0.484	6.72944327941047e-13	ATP5PF	Malignant cells	GSE161801_PI_pre	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17004
5.97121567448349e-17	-0.2740996768943	0.365	0.578	1.09571807626772e-12	ARPC5L	Malignant cells	GSE161801_PI_pre	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17005
6.09148206729064e-17	0.687321835203756	0.579	0.492	1.11778695934783e-12	JUND	Malignant cells	GSE161801_PI_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17006
6.93703646053838e-17	0.332323727534103	0.596	0.442	1.27294619050879e-12	NDUFC2	Malignant cells	GSE161801_PI_pre	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17007
9.21883685115328e-17	-0.253767748027704	0.265	0.464	1.69165656218663e-12	ST3GAL6	Malignant cells	GSE161801_PI_pre	ENSG00000064225	10402	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	SIAT10|ST3GALVI	protein_coding	Q9Y274	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17008
1.0751480373014e-16	-0.26452951761835	0.403	0.609	1.97289664844808e-12	SRPRA	Malignant cells	GSE161801_PI_pre	ENSG00000182934	6734	SRP receptor subunit alpha	SR-alpha|Sralpha|SRP-alpha|SRPR	protein_coding	P08240	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17009
1.14445857438685e-16	0.30639487049315	0.527	0.343	2.10008148399987e-12	MRPS21	Malignant cells	GSE161801_PI_pre	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17010
1.20006593997725e-16	0.383572926416045	0.816	0.821	2.20212099985825e-12	COX5A	Malignant cells	GSE161801_PI_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17011
1.26608764417724e-16	0.276911444506104	0.394	0.207	2.32327082706524e-12	MINOS1	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17012
1.32559709497783e-16	0.263912148269823	0.298	0.126	2.43247066928431e-12	TCEA1	Malignant cells	GSE161801_PI_pre	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17013
1.69854897209125e-16	-0.353900768868139	0.472	0.688	3.11683736378744e-12	TPM4	Malignant cells	GSE161801_PI_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17014
2.13047773863785e-16	-0.269322405607958	0.958	0.999	3.90942665040046e-12	RPS2	Malignant cells	GSE161801_PI_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17015
2.29572964620365e-16	0.361991628868848	0.282	0.117	4.2126639007837e-12	UBE2G1	Malignant cells	GSE161801_PI_pre	ENSG00000132388	7326	ubiquitin conjugating enzyme E2 G1	UBC7|UBE2G	protein_coding	P62253	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17016
2.4075411256115e-16	0.432847951340156	0.935	0.928	4.4178379654971e-12	MT-CO3	Malignant cells	GSE161801_PI_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17017
2.48875396926001e-16	0.307791846142745	0.487	0.301	4.56686353359212e-12	SYNGR2	Malignant cells	GSE161801_PI_pre	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17018
4.10469481198314e-16	0.361206915745945	0.647	0.517	7.53211497998905e-12	CALM2	Malignant cells	GSE161801_PI_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17019
5.54646741037026e-16	1.10646246065975	0.322	0.167	1.01777676980294e-11	RGS2	Malignant cells	GSE161801_PI_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17020
7.04657113917297e-16	0.322513171729348	0.62	0.486	1.29304580403824e-11	SNU13	Malignant cells	GSE161801_PI_pre	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17021
7.22193953001156e-16	0.315388365760909	0.627	0.486	1.32522590375712e-11	UBE2D3	Malignant cells	GSE161801_PI_pre	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17022
8.00607436013784e-16	-0.346772917112939	0.978	1	1.46911464508529e-11	RPL21	Malignant cells	GSE161801_PI_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17023
8.21314264025958e-16	0.312099037919809	0.546	0.371	1.50711167448763e-11	TUFM	Malignant cells	GSE161801_PI_pre	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17024
9.92854096540934e-16	-0.26376238151173	0.596	0.79	1.82188726715261e-11	PSME2	Malignant cells	GSE161801_PI_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17025
1.12117407968065e-15	0.369113232756834	0.457	0.285	2.057354436214e-11	TENT5C	Malignant cells	GSE161801_PI_pre	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17026
1.12155575544128e-15	0.283853223903738	0.403	0.22	2.05805481123476e-11	ASAH1	Malignant cells	GSE161801_PI_pre	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17027
1.14160531691643e-15	0.269070607344077	0.38	0.201	2.09484575654165e-11	DERL2	Malignant cells	GSE161801_PI_pre	ENSG00000072849	51009	derlin 2	CGI-101|derlin-2|F-LAN-1|F-LANa|FLANa	protein_coding	Q9GZP9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17028
1.33430467759198e-15	0.297226659132708	0.634	0.489	2.44844908338128e-11	ARL6IP4	Malignant cells	GSE161801_PI_pre	ENSG00000182196	51329	ADP ribosylation factor like GTPase 6 interacting protein 4	SFRS20|SR-25|SRp25|SRrp37	protein_coding	Q66PJ3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17029
2.18126146248222e-15	0.280956637939363	0.437	0.256	4.00261478365488e-11	HMGN3	Malignant cells	GSE161801_PI_pre	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17030
2.52236912764713e-15	0.399262121885967	0.567	0.428	4.62854734923249e-11	LMAN1	Malignant cells	GSE161801_PI_pre	ENSG00000074695	3998	lectin, mannose binding 1	ERGIC-53|ERGIC53|F5F8D|FMFD1|gp58|MCFD1|MR60	protein_coding	P49257	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17031
2.91095626769978e-15	0.386267035585309	0.523	0.378	5.34160475122909e-11	SNRPN	Malignant cells	GSE161801_PI_pre	ENSG00000128739	6638	small nuclear ribonucleoprotein polypeptide N	HCERN3|PWCR|RT-LI|SM-D|SMN|SNRNP-N|SNURF-SNRPN	protein_coding	P63162	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17032
3.52529442109671e-15	0.293657470744351	0.418	0.242	6.46891526271247e-11	UBXN4	Malignant cells	GSE161801_PI_pre	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17033
4.09279697858598e-15	0.254491164272395	0.325	0.157	7.51028245570527e-11	TMEM50A	Malignant cells	GSE161801_PI_pre	ENSG00000183726	23585	transmembrane protein 50A	SMP1	protein_coding	O95807	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17034
6.13955266715602e-15	0.302293239997679	0.755	0.696	1.12660791442313e-10	TXNDC11	Malignant cells	GSE161801_PI_pre	ENSG00000153066	51061	thioredoxin domain containing 11	EFP1	protein_coding	Q6PKC3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17035
7.55576156529594e-15	0.314622633075364	0.52	0.357	1.3864822472318e-10	COX7B	Malignant cells	GSE161801_PI_pre	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17036
1.02268350762168e-14	0.262898963516695	0.336	0.168	1.87662423648579e-10	CSTB	Malignant cells	GSE161801_PI_pre	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17037
1.52091764427143e-14	-0.253901996810681	0.293	0.486	2.79088387723807e-10	ODC1	Malignant cells	GSE161801_PI_pre	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17038
1.69269415664081e-14	0.281992081902918	0.894	0.861	3.10609377743589e-10	RPL17	Malignant cells	GSE161801_PI_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17039
1.83063293028136e-14	0.279222693945974	0.501	0.331	3.3592114270663e-10	NEDD8	Malignant cells	GSE161801_PI_pre	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17040
4.16089126618097e-14	0.30421609151707	0.319	0.155	7.63523547344208e-10	OTUD1	Malignant cells	GSE161801_PI_pre	ENSG00000165312	220213	OTU deubiquitinase 1	DUBA7|OTDC1	protein_coding	Q5VV17	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17041
4.9789184365505e-14	0.425031252336794	0.622	0.502	9.13631533107016e-10	H2AFZ	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17042
7.77472821006052e-14	0.419500146363566	0.401	0.244	1.42666262654611e-09	PSAT1	Malignant cells	GSE161801_PI_pre	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17043
1.21328126050828e-13	0.343444977423125	0.95	0.953	2.2263711130327e-09	OAZ1	Malignant cells	GSE161801_PI_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17044
1.42492344291817e-13	0.486464080363346	0.607	0.552	2.61473451775485e-09	GNG7	Malignant cells	GSE161801_PI_pre	ENSG00000176533	2788	G protein subunit gamma 7	FLJ00058	protein_coding	O60262	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17045
1.66641117887379e-13	0.261756364963954	0.404	0.238	3.05786451323341e-09	RNF181	Malignant cells	GSE161801_PI_pre	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17046
1.89450864870526e-13	0.321843136238212	0.67	0.579	3.47642337037415e-09	PPIA	Malignant cells	GSE161801_PI_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17047
2.07913341006099e-13	0.286604849376581	0.453	0.294	3.81520980746192e-09	NDUFC1	Malignant cells	GSE161801_PI_pre	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17048
2.63760771946947e-13	0.316767846376473	0.677	0.581	4.84001016522648e-09	CCPG1	Malignant cells	GSE161801_PI_pre	ENSG00000260916	9236	cell cycle progression 1	CPR8|KIAA1254	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17049
2.68955713204211e-13	0.268196677196131	0.329	0.173	4.93533733729728e-09	RAP1B	Malignant cells	GSE161801_PI_pre	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17050
4.06205078851018e-13	0.659067780344059	0.372	0.22	7.45386319691618e-09	CDKN1A	Malignant cells	GSE161801_PI_pre	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17051
1.75219968154378e-12	0.277549556193742	0.408	0.257	3.21528641563285e-08	DUSP22	Malignant cells	GSE161801_PI_pre	ENSG00000112679	56940	dual specificity phosphatase 22	JKAP|JSP1|MKPX|VHX	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17052
2.6782804272022e-12	0.274638554862882	0.504	0.357	4.91464458391604e-08	ERH	Malignant cells	GSE161801_PI_pre	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17053
3.69452004997331e-12	0.300341346692306	0.574	0.453	6.77944429170102e-08	NDUFB1	Malignant cells	GSE161801_PI_pre	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17054
4.37066361625188e-12	0.260251334386421	0.359	0.208	8.02016773582221e-08	EIF3J	Malignant cells	GSE161801_PI_pre	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17055
9.408978555036e-12	-0.303043327191537	0.708	0.88	1.72654756484911e-07	HLA-E	Malignant cells	GSE161801_PI_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17056
9.86151513996345e-12	0.285636208918753	0.39	0.248	1.80958802818329e-07	DNAJC4	Malignant cells	GSE161801_PI_pre	ENSG00000110011	3338	DnaJ heat shock protein family (Hsp40) member C4	HSPF2|MCG18	protein_coding	Q9NNZ3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17057
1.09997398255369e-11	0.258669182635603	0.543	0.406	2.01845225798603e-07	PARK7	Malignant cells	GSE161801_PI_pre	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17058
1.19239864027168e-11	0.303332357926871	0.842	0.824	2.18805150489853e-07	PABPC1	Malignant cells	GSE161801_PI_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17059
1.19748267137603e-11	0.888827130780028	0.817	0.88	2.19738070197501e-07	FKBP11	Malignant cells	GSE161801_PI_pre	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17060
1.45237119488363e-11	0.494332189848897	0.643	0.632	2.66510114261147e-07	ERLEC1	Malignant cells	GSE161801_PI_pre	ENSG00000068912	27248	endoplasmic reticulum lectin 1	C2orf30|CL25084|ERLECTIN|XTP3-B|XTP3TPB	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17061
2.1081853093369e-11	0.419877692399716	0.597	0.513	3.8685200426332e-07	YPEL5	Malignant cells	GSE161801_PI_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17062
5.76575181232341e-11	-0.276750523805039	0.452	0.635	1.05801545756135e-06	MTRNR2L8	Malignant cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17063
8.90279734322704e-11	0.271761247687704	0.474	0.343	1.63366331248216e-06	SRM	Malignant cells	GSE161801_PI_pre	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17064
2.18360985761609e-10	0.295575708928279	0.428	0.312	4.00692408872553e-06	SURF1	Malignant cells	GSE161801_PI_pre	ENSG00000280627	6834	SURF1 cytochrome c oxidase assembly factor	SHY1	protein_coding	Q15526	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17065
2.29303879511325e-10	0.27045387459717	0.56	0.452	4.20772618903281e-06	SSR1	Malignant cells	GSE161801_PI_pre	ENSG00000124783	6745	signal sequence receptor subunit 1	TRAPA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17066
2.8592405846059e-10	0.270903560247632	0.599	0.501	5.24670647275182e-06	RPN1	Malignant cells	GSE161801_PI_pre	ENSG00000163902	6184	ribophorin I	OST1	protein_coding	P04843	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17067
3.03132075712255e-10	0.360510409147114	1	1	5.56247358931987e-06	RPLP1	Malignant cells	GSE161801_PI_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17068
6.48333090193018e-10	0.504837636411972	0.761	0.812	1.18969122050419e-05	SDF2L1	Malignant cells	GSE161801_PI_pre	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17069
1.95597761597907e-09	-0.331697596650842	0.234	0.365	3.58921892532159e-05	DNAJB1	Malignant cells	GSE161801_PI_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17070
1.97713517333433e-09	-0.293013887171062	0.775	0.874	3.6280430430685e-05	DNAJB9	Malignant cells	GSE161801_PI_pre	ENSG00000128590	4189	DnaJ heat shock protein family (Hsp40) member B9	MDG1	protein_coding	Q9UBS3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17071
2.49601000006388e-09	0.260731734258391	0.744	0.731	4.58017835011721e-05	UQCRH	Malignant cells	GSE161801_PI_pre	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17072
4.55694477778647e-09	0.305641608396094	0.878	0.939	8.36199366723818e-05	MYDGF	Malignant cells	GSE161801_PI_pre	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17073
8.21294624928032e-09	0.283443052735339	0.455	0.325	0.000150707563674294	GADD45B	Malignant cells	GSE161801_PI_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17074
1.54532763550922e-08	0.252760200535033	0.475	0.365	0.000283567621115941	MORF4L1	Malignant cells	GSE161801_PI_pre	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17075
2.57357712267605e-08	0.281558650322868	0.504	0.421	0.000472251402011056	ROMO1	Malignant cells	GSE161801_PI_pre	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17076
3.36171018083615e-08	0.393545512490823	0.487	0.399	0.000616873818183433	KLF2	Malignant cells	GSE161801_PI_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17077
5.21440283714152e-08	0.337715225869626	0.569	0.554	0.000956842920615468	PRDX1	Malignant cells	GSE161801_PI_pre	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17078
1.3247535947058e-07	0.398606664771234	0.897	0.957	0.00243092284628514	HERPUD1	Malignant cells	GSE161801_PI_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17079
1.78177460905928e-07	0.250774738173759	0.741	0.774	0.00326955640762378	COX6A1	Malignant cells	GSE161801_PI_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17080
0	1.13142094401731	0.564	0	0	RPS4Y1	CD8+ T cells	GSE161801_PI_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17081
4.19917101217921e-263	-0.940776675316118	0.242	0.648	7.70547880734885e-259	HSPA1B	CD8+ T cells	GSE161801_PI_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17082
9.32232199452718e-257	-0.730816602849028	0.836	0.959	1.71064608599574e-252	IL32	CD8+ T cells	GSE161801_PI_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17083
2.10518490502563e-198	-0.477596822698565	0.079	0.38	3.86301430072203e-194	XIST	CD8+ T cells	GSE161801_PI_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17084
1.24163205063066e-187	-0.773764291834872	0.682	0.863	2.27839481290727e-183	ZFP36L2	CD8+ T cells	GSE161801_PI_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17085
2.92384254446791e-185	0.423836216599264	1	1	5.36525106909862e-181	MALAT1	CD8+ T cells	GSE161801_PI_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17086
4.95122679116493e-182	0.529323431986759	0.459	0.137	9.08550116178765e-178	RBM38	CD8+ T cells	GSE161801_PI_pre	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17087
6.39275935693731e-177	-0.374051162998613	1	1	1.173071341998e-172	RPS19	CD8+ T cells	GSE161801_PI_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17088
3.7057681969313e-170	1.11993271840535	0.548	0.259	6.80008464136894e-166	H1FX	CD8+ T cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17089
1.80757203098515e-169	-0.402439820617281	0.997	1	3.31689467685776e-165	RPS4X	CD8+ T cells	GSE161801_PI_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17090
9.17942444502211e-168	-0.864464094032438	0.152	0.438	1.68442438566156e-163	LTB	CD8+ T cells	GSE161801_PI_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17091
9.5149856525695e-166	0.503548531960542	0.996	0.993	1.7459998672465e-161	TPT1	CD8+ T cells	GSE161801_PI_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17092
9.59833210645227e-163	0.396302550131353	0.996	0.997	1.76129394153399e-158	HLA-C	CD8+ T cells	GSE161801_PI_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17093
1.96261996733707e-159	-0.392107504583849	0.768	0.942	3.60140764006352e-155	DUSP1	CD8+ T cells	GSE161801_PI_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17094
5.24075066730322e-159	-0.414175998895867	0.996	0.998	9.61677747450141e-155	RPL36	CD8+ T cells	GSE161801_PI_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17095
2.20374146009165e-152	0.533461526757693	0.514	0.213	4.04386557926817e-148	EFHD2	CD8+ T cells	GSE161801_PI_pre	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17096
1.1304081655171e-147	-0.362738777240978	1	1	2.07429898372389e-143	RPL34	CD8+ T cells	GSE161801_PI_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17097
7.94130050030311e-143	1.46924081346416	0.387	0.111	1.45722864180562e-138	CCL3	CD8+ T cells	GSE161801_PI_pre	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17098
1.20040001437146e-139	0.769943800212485	0.659	0.444	2.20273402637163e-135	YPEL5	CD8+ T cells	GSE161801_PI_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17099
1.93524752930782e-137	-0.570668788304241	0.77	0.922	3.55117921627984e-133	JUNB	CD8+ T cells	GSE161801_PI_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17100
5.6207276765594e-130	0.988318657968026	0.559	0.326	1.03140352864865e-125	AC020916.1	CD8+ T cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17101
4.60952761525352e-128	-0.480798318642638	0.928	0.984	8.45848317399021e-124	CD52	CD8+ T cells	GSE161801_PI_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17102
1.07362110341494e-127	-0.333923080114695	0.998	0.999	1.97009472476641e-123	TMSB10	CD8+ T cells	GSE161801_PI_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17103
2.19040922061334e-121	-0.464260994425453	0.143	0.383	4.01940091982548e-117	IL7R	CD8+ T cells	GSE161801_PI_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17104
4.8070792285317e-120	-0.321628135262509	1	1	8.82099038435567e-116	RPS2	CD8+ T cells	GSE161801_PI_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17105
1.23827515652735e-119	0.389477682237817	0.398	0.144	2.27223491222768e-115	YPEL3	CD8+ T cells	GSE161801_PI_pre	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17106
1.48363966349456e-119	-0.287633120356468	1	1	2.72247878251252e-115	RPS15	CD8+ T cells	GSE161801_PI_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17107
2.73340255966613e-118	-0.308160283706481	1	1	5.01579369698736e-114	RPL13	CD8+ T cells	GSE161801_PI_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17108
7.89831040277177e-118	0.353152323080908	0.998	0.998	1.44933995890862e-113	EIF1	CD8+ T cells	GSE161801_PI_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17109
1.81236161122761e-110	-0.403456183669719	0.986	0.995	3.32568355660266e-106	MT-ND4	CD8+ T cells	GSE161801_PI_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17110
9.38743202020332e-110	-0.280444278062071	0.998	0.999	1.72259377570731e-105	HLA-B	CD8+ T cells	GSE161801_PI_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17111
1.32060815561572e-109	0.790155165873511	0.632	0.394	2.42331596555485e-105	RGS1	CD8+ T cells	GSE161801_PI_pre	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17112
4.76496974173653e-108	0.33572142957072	0.269	0.062	8.74371947608653e-104	SKIL	CD8+ T cells	GSE161801_PI_pre	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17113
1.01551756343743e-107	0.337718839864268	0.291	0.076	1.86347472890768e-103	UBE2S	CD8+ T cells	GSE161801_PI_pre	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17114
2.64294565020119e-106	-0.282310187079611	1	1	4.84980526811918e-102	RPS18	CD8+ T cells	GSE161801_PI_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17115
1.21707085879242e-103	0.458761946670074	0.345	0.123	2.23332502588409e-99	IER5	CD8+ T cells	GSE161801_PI_pre	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17116
1.34872645658098e-98	0.590316915220439	0.696	0.483	2.47491304782609e-94	FGFBP2	CD8+ T cells	GSE161801_PI_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17117
4.72822051387676e-98	0.396053325425451	0.514	0.273	8.67628464296386e-94	TGFB1	CD8+ T cells	GSE161801_PI_pre	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17118
1.7020254702506e-96	-0.30936787281913	1	1	3.12321673790985e-92	MT-CO1	CD8+ T cells	GSE161801_PI_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17119
1.88451692048506e-96	-0.334769847508796	0.979	0.991	3.45808854909009e-92	RPL8	CD8+ T cells	GSE161801_PI_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17120
1.53799666325302e-88	-0.437515521086009	0.493	0.695	2.82222387706929e-84	TXNIP	CD8+ T cells	GSE161801_PI_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17121
9.20396266774383e-87	0.580820449428572	0.587	0.392	1.68892714953099e-82	KLF2	CD8+ T cells	GSE161801_PI_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17122
4.6222709878857e-84	-0.315248182641404	0.103	0.283	8.48186726277027e-80	LST1	CD8+ T cells	GSE161801_PI_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17123
3.9897078793181e-83	0.411348792744317	0.632	0.437	7.32111395854871e-79	DNAJB6	CD8+ T cells	GSE161801_PI_pre	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17124
7.25743851407621e-83	-0.269864675896251	0.997	0.999	1.33173996733298e-78	RPL35	CD8+ T cells	GSE161801_PI_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17125
2.16964108676923e-82	0.264898757061572	0.998	0.998	3.98129139422154e-78	HLA-A	CD8+ T cells	GSE161801_PI_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17126
1.41749924731382e-81	0.331142012727804	0.961	0.933	2.60111111882087e-77	RPS17	CD8+ T cells	GSE161801_PI_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17127
5.60958620522844e-78	0.334620554312072	0.917	0.836	1.02935906865942e-73	UQCRB	CD8+ T cells	GSE161801_PI_pre	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17128
5.95468020864743e-77	0.40488890663326	0.43	0.229	1.0926838182868e-72	BHLHE40	CD8+ T cells	GSE161801_PI_pre	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17129
8.16960012007034e-74	0.323120442532938	0.981	0.971	1.49912162203291e-69	NKG7	CD8+ T cells	GSE161801_PI_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17130
4.33066061887285e-72	-0.317503693495094	0.984	0.997	7.94676223563167e-68	MT-ND2	CD8+ T cells	GSE161801_PI_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17131
1.68444838342642e-71	0.353626363478738	0.985	0.976	3.09096278358748e-67	CCL5	CD8+ T cells	GSE161801_PI_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17132
3.42953618290575e-71	-0.305002187221626	0.595	0.783	6.29319889563205e-67	DNAJB1	CD8+ T cells	GSE161801_PI_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17133
6.78548675592313e-69	0.315141258700887	0.378	0.189	1.24513681971189e-64	RAB5IF	CD8+ T cells	GSE161801_PI_pre	ENSG00000101084	55969	RAB5 interacting factor	C20orf24|PNAS-11|RCAF1|RIP5	protein_coding	Q9BUV8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17134
3.172293325172e-68	0.330554377672647	0.96	0.937	5.82115825169062e-64	SRGN	CD8+ T cells	GSE161801_PI_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17135
6.10378509731672e-67	0.255980067209868	1	1	1.12004456535762e-62	EEF1A1	CD8+ T cells	GSE161801_PI_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17136
4.28343838137531e-63	0.489084846701993	0.67	0.524	7.8601094298237e-59	TNFAIP3	CD8+ T cells	GSE161801_PI_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17137
1.89828270056275e-62	0.452532714545176	0.624	0.466	3.48334875553265e-58	TUBA4A	CD8+ T cells	GSE161801_PI_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17138
3.16945401669678e-61	-0.272023552656899	0.208	0.385	5.81594812063859e-57	SMDT1	CD8+ T cells	GSE161801_PI_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17139
2.62617690529469e-59	0.295485234458208	0.928	0.865	4.81903462121575e-55	RPS10	CD8+ T cells	GSE161801_PI_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17140
6.18310153383401e-59	-0.36497354087839	0.39	0.556	1.13459913145854e-54	PIK3R1	CD8+ T cells	GSE161801_PI_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17141
5.04506219563522e-58	-0.32243950100386	0.712	0.87	9.25768912899064e-54	CD3D	CD8+ T cells	GSE161801_PI_pre	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17142
3.63103742461262e-57	0.935809619833577	0.614	0.492	6.66295367416416e-53	NFKBIA	CD8+ T cells	GSE161801_PI_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17143
5.40205695459943e-57	0.541526488076126	0.781	0.71	9.91277451168996e-53	GZMB	CD8+ T cells	GSE161801_PI_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17144
6.03740504134089e-57	0.535174325371496	0.625	0.476	1.10786382508605e-52	HSPA5	CD8+ T cells	GSE161801_PI_pre	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17145
6.82047196289511e-55	-0.353495364547226	0.57	0.722	1.25155660519125e-50	KLF6	CD8+ T cells	GSE161801_PI_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17146
2.20160360211326e-54	-0.314978390642509	0.724	0.832	4.03994260987783e-50	ANXA1	CD8+ T cells	GSE161801_PI_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17147
1.41387046173088e-53	-0.285409095780465	0.872	0.927	2.59445229727617e-49	MYL12A	CD8+ T cells	GSE161801_PI_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17148
1.4922217500249e-53	-0.267942271092291	0.288	0.464	2.73822691129569e-49	TSPO	CD8+ T cells	GSE161801_PI_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17149
1.4923777859532e-51	0.376871127051573	0.509	0.356	2.73851323722413e-47	JUND	CD8+ T cells	GSE161801_PI_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17150
5.6215865034611e-51	0.274010403476766	0.539	0.367	1.03156112338511e-46	PTP4A2	CD8+ T cells	GSE161801_PI_pre	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17151
1.48378981485851e-50	0.251617192721703	0.933	0.88	2.72275431026537e-46	NACA	CD8+ T cells	GSE161801_PI_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17152
1.01565139098926e-48	-0.35451481576012	0.47	0.607	1.86372030246529e-44	ITGB1	CD8+ T cells	GSE161801_PI_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17153
6.3938060964549e-48	0.25567686599629	0.441	0.277	1.17326341869947e-43	EPC1	CD8+ T cells	GSE161801_PI_pre	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17154
1.18486561346998e-47	-0.269615940822082	0.971	0.984	2.17422840071741e-43	MT-CYB	CD8+ T cells	GSE161801_PI_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17155
6.75082063248378e-46	0.286927231157813	0.866	0.725	1.23877558606077e-41	GZMH	CD8+ T cells	GSE161801_PI_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17156
2.92731836218603e-45	-0.281111222747033	0.375	0.524	5.37162919461137e-41	CCND3	CD8+ T cells	GSE161801_PI_pre	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17157
5.49999040942746e-45	0.263773359151218	0.472	0.311	1.00924824012994e-40	SET	CD8+ T cells	GSE161801_PI_pre	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17158
5.50922371334582e-45	-0.260674675604736	0.129	0.261	1.01094255139896e-40	SELL	CD8+ T cells	GSE161801_PI_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17159
1.60541735440949e-44	-0.410731039034755	0.653	0.74	2.94594084534142e-40	ID2	CD8+ T cells	GSE161801_PI_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17160
2.56757918589407e-44	0.313299388480635	0.611	0.475	4.71150780611561e-40	LDHA	CD8+ T cells	GSE161801_PI_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17161
6.37122613721678e-44	-0.287882509622007	0.97	0.987	1.16911999617928e-39	S100A4	CD8+ T cells	GSE161801_PI_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17162
9.93610218522989e-43	0.349513718497425	0.374	0.229	1.82327475098968e-38	SPON2	CD8+ T cells	GSE161801_PI_pre	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17163
2.10177492511542e-42	-0.351414388050757	0.431	0.587	3.8567569875868e-38	TRGC2	CD8+ T cells	GSE161801_PI_pre	ENSG00000227191	NA	NA	TCRGC2|TRGC2(2X)|TRGC2(3X)	TR_C_gene	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17164
9.58630379228104e-42	-0.271029757160591	0.35	0.502	1.75908674588357e-37	S100A11	CD8+ T cells	GSE161801_PI_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17165
1.71467616375484e-40	0.259038734408266	0.916	0.872	3.14643076049013e-36	GAPDH	CD8+ T cells	GSE161801_PI_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17166
2.11495211291188e-39	0.286897452879684	0.627	0.51	3.88093712719329e-35	SRSF2	CD8+ T cells	GSE161801_PI_pre	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17167
1.50905952528051e-38	0.254602163359243	0.482	0.336	2.76912422888974e-34	SNHG8	CD8+ T cells	GSE161801_PI_pre	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17168
1.87890993647317e-37	-0.252212342740609	0.761	0.865	3.44779973342827e-33	CTSW	CD8+ T cells	GSE161801_PI_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17169
4.40015704820802e-37	0.519599717820833	0.834	0.868	8.07428818346171e-33	GNLY	CD8+ T cells	GSE161801_PI_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17170
5.48971252281322e-36	0.263884829917544	0.406	0.271	1.00736224793623e-31	CHMP1B	CD8+ T cells	GSE161801_PI_pre	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17171
8.79878238837981e-34	0.261194323891936	0.485	0.353	1.6145765682677e-29	DSTN	CD8+ T cells	GSE161801_PI_pre	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17172
9.52402137526615e-32	-0.288223642115123	0.617	0.728	1.74765792236134e-27	NEAT1	CD8+ T cells	GSE161801_PI_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17173
1.98435376917396e-29	0.254495284168376	0.899	0.848	3.64128916643423e-25	CST7	CD8+ T cells	GSE161801_PI_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17174
4.42900590528525e-29	0.262375818245676	0.325	0.21	8.12722583619844e-25	ZC3HAV1	CD8+ T cells	GSE161801_PI_pre	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17175
4.0128108589652e-27	0.279927690041373	0.591	0.482	7.36350792620115e-23	VIM	CD8+ T cells	GSE161801_PI_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17176
7.79711748584798e-27	-0.291829256372743	0.624	0.689	1.4307710586531e-22	TRBC2	CD8+ T cells	GSE161801_PI_pre	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17177
1.61895524378873e-25	0.786924905661626	0.645	0.517	2.97078287235233e-21	CCL4	CD8+ T cells	GSE161801_PI_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17178
1.55209446849207e-23	0.291906702784378	0.503	0.417	2.84809334968295e-19	CD247	CD8+ T cells	GSE161801_PI_pre	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17179
4.46499297594151e-23	0.309924764631458	0.275	0.178	8.19326211085267e-19	RGCC	CD8+ T cells	GSE161801_PI_pre	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17180
8.39988579122189e-20	0.28308911352456	0.732	0.881	1.54137904268922e-15	JUN	CD8+ T cells	GSE161801_PI_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17181
6.48551507359484e-18	0.264604587163974	0.995	0.996	1.19009201600465e-13	H3F3B	CD8+ T cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17182
3.09296513627198e-16	0.251321159090076	0.908	0.894	5.67559102505909e-12	CXCR4	CD8+ T cells	GSE161801_PI_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17183
1.81700279983532e-11	0.391143304649924	0.471	0.406	3.33420013769781e-07	PMAIP1	CD8+ T cells	GSE161801_PI_pre	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17184
9.35951656203146e-09	0.27170836821184	0.268	0.213	0.000171747128913277	IFNG	CD8+ T cells	GSE161801_PI_pre	ENSG00000111537	3458	interferon gamma	NA	protein_coding	P01579	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17185
3.18935083598914e-168	-0.945693529511557	0.015	0.577	5.85245878404007e-164	HLA-DQA2	Mono/Macro	GSE161801_PI_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17186
1.07642009022361e-111	-0.699350701066439	0.991	0.997	1.97523086556033e-107	CST3	Mono/Macro	GSE161801_PI_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17187
2.92929479259442e-108	0.686371580145333	0.994	0.948	5.37525594441076e-104	HLA-A	Mono/Macro	GSE161801_PI_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17188
3.73849582867136e-98	0.839558974697664	0.915	0.772	6.86013984561194e-94	CSTA	Mono/Macro	GSE161801_PI_pre	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17189
1.85948566440053e-95	0.624074791980411	0.355	0	3.41215619417497e-91	RPS4Y1	Mono/Macro	GSE161801_PI_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17190
8.98869159984856e-89	0.571483423180875	0.999	0.978	1.64942490857221e-84	RPS13	Mono/Macro	GSE161801_PI_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17191
2.76521626949374e-84	-0.733458664784904	0.675	0.934	5.07417185452102e-80	MNDA	Mono/Macro	GSE161801_PI_pre	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17192
2.78342181866947e-84	-0.679451030907976	0.255	0.658	5.10757903725847e-80	CLEC12A	Mono/Macro	GSE161801_PI_pre	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17193
5.02535651834168e-84	-0.585391387182784	0.172	0.59	9.22152921115699e-80	XIST	Mono/Macro	GSE161801_PI_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17194
1.47231846587376e-82	-0.95411401124709	0.581	0.908	2.70170438487834e-78	FOS	Mono/Macro	GSE161801_PI_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17195
3.37889162565819e-72	-0.355593364143187	1	1	6.20026613308278e-68	TMSB10	Mono/Macro	GSE161801_PI_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17196
1.66034241119978e-71	0.727888269841809	1	1	3.0467283245516e-67	MALAT1	Mono/Macro	GSE161801_PI_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17197
5.08763334881158e-67	0.545686387299102	0.997	0.984	9.33580719506924e-63	EIF1	Mono/Macro	GSE161801_PI_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17198
5.75033295876186e-66	2.00139763261729	0.591	0.323	1.0551860979328e-61	IL1B	Mono/Macro	GSE161801_PI_pre	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17199
1.05203346999496e-61	-0.582974268258597	0.826	0.96	1.93048141744075e-57	CALM2	Mono/Macro	GSE161801_PI_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17200
8.23380486569941e-57	1.4649108317294	0.834	0.757	1.51090319285584e-52	NFKBIA	Mono/Macro	GSE161801_PI_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17201
1.28709878819304e-54	0.836255790157625	0.367	0.087	2.36182627633423e-50	C15orf48	Mono/Macro	GSE161801_PI_pre	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17202
3.37411019593316e-54	0.419617661942938	0.995	0.969	6.19149220953734e-50	RPL30	Mono/Macro	GSE161801_PI_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17203
4.48528120478808e-52	0.61344833006807	0.467	0.172	8.23049101078613e-48	BASP1	Mono/Macro	GSE161801_PI_pre	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17204
2.17915891742489e-51	-0.383876739878262	0.988	0.999	3.99875661347468e-47	RPL8	Mono/Macro	GSE161801_PI_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17205
2.98846067565185e-51	-0.443994419589936	0.988	0.994	5.48382533982115e-47	SH3BGRL3	Mono/Macro	GSE161801_PI_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17206
5.63212164010075e-49	0.475635763459363	0.997	0.991	1.03349432095849e-44	TPT1	Mono/Macro	GSE161801_PI_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17207
1.84118652161197e-48	-0.509489703905722	0.929	0.987	3.37857726715796e-44	LST1	Mono/Macro	GSE161801_PI_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17208
2.00811544217784e-48	0.614663950075399	0.973	0.946	3.68489183639634e-44	MT-ND1	Mono/Macro	GSE161801_PI_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17209
8.53177869470535e-48	-0.446980169558637	0.327	0.633	1.56558139047843e-43	PPT1	Mono/Macro	GSE161801_PI_pre	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17210
2.16312856473524e-47	-0.37068132238983	0.998	0.999	3.96934091628917e-43	RPS2	Mono/Macro	GSE161801_PI_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17211
2.63948636798844e-47	-0.471961528159131	0.999	1	4.84345748525879e-43	RPS19	Mono/Macro	GSE161801_PI_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17212
5.98881082873099e-47	1.03540814144189	0.385	0.12	1.09894678707214e-42	CCL4	Mono/Macro	GSE161801_PI_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17213
5.9444108079174e-46	-0.339139887333635	1	1	1.09079938325284e-41	RPL10	Mono/Macro	GSE161801_PI_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17214
3.46705721636738e-45	0.873565640050741	0.56	0.303	6.36204999203415e-41	H1FX	Mono/Macro	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17215
1.78479416059465e-44	0.860466039566088	0.434	0.167	3.27509728469119e-40	EREG	Mono/Macro	GSE161801_PI_pre	ENSG00000124882	2069	epiregulin	ER	protein_coding	O14944	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17216
3.4162639985063e-43	0.584036674473294	0.503	0.233	6.26884443725906e-39	TNFAIP3	Mono/Macro	GSE161801_PI_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17217
4.66153870224508e-43	0.423020218866426	0.999	0.996	8.55392351861972e-39	SRGN	Mono/Macro	GSE161801_PI_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17218
6.11432852311118e-43	-0.48740122518845	0.884	0.971	1.1219792839909e-38	JUNB	Mono/Macro	GSE161801_PI_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17219
7.16240886220207e-42	1.39954250865042	0.576	0.33	1.31430202621408e-37	CCL3	Mono/Macro	GSE161801_PI_pre	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17220
7.16277446766684e-42	-0.337461611886116	0.984	0.998	1.31436911481686e-37	SERF2	Mono/Macro	GSE161801_PI_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17221
1.45840776704437e-41	0.598351807567684	0.974	0.979	2.67617825252643e-37	SAT1	Mono/Macro	GSE161801_PI_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17222
5.08894660495923e-41	-0.530014343955787	0.267	0.547	9.33821702010019e-37	TXNIP	Mono/Macro	GSE161801_PI_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17223
5.31794161323647e-41	-0.387379210304771	0.987	0.993	9.75842286028892e-37	LGALS1	Mono/Macro	GSE161801_PI_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17224
6.11075239476388e-40	0.63318347713805	0.452	0.196	1.12132306443917e-35	IER3	Mono/Macro	GSE161801_PI_pre	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17225
7.06397873702752e-40	0.47166138537015	0.814	0.659	1.29624009824455e-35	MTRNR2L8	Mono/Macro	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17226
3.64839456493606e-39	-0.40640083151789	0.922	0.983	6.69480402665766e-35	TYMP	Mono/Macro	GSE161801_PI_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17227
6.74508590418273e-39	-0.361383878346962	0.048	0.25	1.23772326341753e-34	FOLR3	Mono/Macro	GSE161801_PI_pre	ENSG00000110203	2352	folate receptor gamma	FR-G|FRgamma	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17228
3.07130924788239e-38	-0.310791936915106	1	1	5.63585246986418e-34	ACTB	Mono/Macro	GSE161801_PI_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17229
7.74085718173064e-38	-0.305583355255226	0.998	0.997	1.42044729284757e-33	S100A6	Mono/Macro	GSE161801_PI_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17230
2.14973304101339e-37	0.447436807472482	0.932	0.821	3.94476013025958e-33	RPL36A	Mono/Macro	GSE161801_PI_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17231
7.90384761535609e-37	-0.369554849189266	0.256	0.522	1.45035603741784e-32	GCA	Mono/Macro	GSE161801_PI_pre	ENSG00000115271	25801	grancalcin	GCL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17232
9.75105868174061e-36	0.367473166953105	0.381	0.146	1.7893192680994e-31	MTRNR2L12	Mono/Macro	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17233
1.25567003795186e-35	0.348206723996169	0.998	0.983	2.30415451964166e-31	RPS29	Mono/Macro	GSE161801_PI_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17234
5.89160499315414e-35	0.416094622665251	0.283	0.078	1.08110951624379e-30	THBD	Mono/Macro	GSE161801_PI_pre	ENSG00000178726	7056	thrombomodulin	BDCA-3|CD141|THRM	protein_coding	P07204	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17235
1.05537487274242e-34	-0.440260656339657	0.266	0.528	1.93661289148233e-30	RHOB	Mono/Macro	GSE161801_PI_pre	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17236
1.55249691714916e-33	0.672045549683676	0.495	0.25	2.8488318429687e-29	G0S2	Mono/Macro	GSE161801_PI_pre	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17237
2.18225749186397e-32	-0.294979781998002	0.982	0.993	4.00444249757038e-28	RPS4X	Mono/Macro	GSE161801_PI_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17238
5.97844079732733e-32	-0.369495838477574	0.525	0.749	1.09704388630956e-27	ITGB2	Mono/Macro	GSE161801_PI_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17239
1.87812911474683e-31	0.32549693104273	0.975	0.936	3.44636692556042e-27	RPS20	Mono/Macro	GSE161801_PI_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17240
3.78464533999453e-31	-0.397953870416298	0.212	0.447	6.94482419888996e-27	MARCO	Mono/Macro	GSE161801_PI_pre	ENSG00000019169	8685	macrophage receptor with collagenous structure	SCARA2|SR-A6	protein_coding	Q9UEW3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17241
1.71975226648624e-30	0.429156668546093	1	1	3.15574540900226e-26	MT-CO3	Mono/Macro	GSE161801_PI_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17242
2.73061630894378e-30	1.11526510701373	0.486	0.271	5.01068092691183e-26	CXCL2	Mono/Macro	GSE161801_PI_pre	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17243
1.57136546572724e-29	-0.250031654759115	1	1	2.88345562960948e-25	RPL34	Mono/Macro	GSE161801_PI_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17244
2.63519613982167e-29	-0.271471600389898	1	1	4.83558491657276e-25	RPLP1	Mono/Macro	GSE161801_PI_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17245
2.39559994879488e-28	-0.575230173173429	0.796	0.887	4.3959259060386e-24	CD52	Mono/Macro	GSE161801_PI_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17246
4.07735540905764e-28	0.474963505518337	0.421	0.216	7.48194717562078e-24	DUSP6	Mono/Macro	GSE161801_PI_pre	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17247
1.10782196707492e-27	0.383050421302521	0.29	0.105	2.03285330958247e-23	AC015912.3	Mono/Macro	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17248
2.04926945330145e-27	-0.405999230610572	0.725	0.858	3.76040944680817e-23	CFD	Mono/Macro	GSE161801_PI_pre	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17249
2.37594292996996e-27	-0.269741136752163	0.128	0.331	4.35985527649487e-23	GIMAP4	Mono/Macro	GSE161801_PI_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17250
2.44394049857147e-27	0.543377716864065	0.649	0.498	4.48463081487865e-23	SOD2	Mono/Macro	GSE161801_PI_pre	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17251
4.37765005429382e-27	0.458280259618606	0.866	0.782	8.03298784962917e-23	BTG1	Mono/Macro	GSE161801_PI_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17252
1.19008924023491e-26	0.489597031443017	0.757	0.654	2.18381375583106e-22	HLA-DRB5	Mono/Macro	GSE161801_PI_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17253
2.17041393863334e-26	-0.266724401344965	0.183	0.399	3.98270957739218e-22	UBE2D1	Mono/Macro	GSE161801_PI_pre	ENSG00000072401	7321	ubiquitin conjugating enzyme E2 D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UbcH5A	protein_coding	P51668	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17254
2.80263440288638e-26	0.300440955369233	0.999	1	5.14283412929651e-22	FTH1	Mono/Macro	GSE161801_PI_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17255
3.75274456044513e-26	-0.316627680674819	0.62	0.806	6.88628626841682e-22	VSIR	Mono/Macro	GSE161801_PI_pre	ENSG00000107738	64115	V-set immunoregulatory receptor	B7-H5|B7H5|C10orf54|Dies1|GI24|PD-1H|SISP1|VISTA	protein_coding	Q9H7M9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17256
5.42410404213114e-26	0.816164965418488	0.371	0.166	9.95323091731064e-22	CXCL3	Mono/Macro	GSE161801_PI_pre	ENSG00000163734	2921	C-X-C motif chemokine ligand 3	CINC-2b|GRO3|GROg|MIP-2b|SCYB3	protein_coding	P19876	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17257
7.95670732390222e-26	-0.305395310670669	0.377	0.609	1.46005579393606e-21	CAPZA2	Mono/Macro	GSE161801_PI_pre	ENSG00000198898	830	capping actin protein of muscle Z-line subunit alpha 2	CAPPA2|CAPZ	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17258
1.43491920032719e-25	-0.317155740386836	0.316	0.533	2.63307673260039e-21	WSB1	Mono/Macro	GSE161801_PI_pre	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17259
1.73012454908929e-25	0.274086754608793	1	1	3.17477854757885e-21	EEF1A1	Mono/Macro	GSE161801_PI_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17260
2.6839041687937e-25	0.336596905636683	0.92	0.838	4.92496414973644e-21	NACA	Mono/Macro	GSE161801_PI_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17261
4.71800302697295e-25	-0.371503299664667	0.718	0.848	8.65753555449537e-21	AP1S2	Mono/Macro	GSE161801_PI_pre	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17262
5.88767276427151e-25	-0.259724600667382	0.149	0.347	1.08038795224382e-20	MARCH1	Mono/Macro	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17263
8.06574368877401e-25	0.440545886820284	0.548	0.372	1.48006396689003e-20	CD83	Mono/Macro	GSE161801_PI_pre	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17264
2.42371087570487e-24	0.43958281110155	0.667	0.501	4.44750945691844e-20	BCL2A1	Mono/Macro	GSE161801_PI_pre	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17265
3.04076070018008e-24	-0.311863443514618	0.63	0.803	5.57979588483044e-20	CORO1A	Mono/Macro	GSE161801_PI_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17266
3.2163752942681e-24	-0.318765008790113	0.441	0.641	5.90204866498196e-20	VAMP2	Mono/Macro	GSE161801_PI_pre	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17267
5.62678984014323e-24	-0.279899924295334	0.245	0.457	1.03251593566628e-19	SMDT1	Mono/Macro	GSE161801_PI_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17268
1.51571538388015e-23	-0.392264300301007	0.574	0.754	2.78133772942008e-19	IFI30	Mono/Macro	GSE161801_PI_pre	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17269
3.02574576327803e-23	-0.33059442749473	0.793	0.912	5.55224347561519e-19	GSTP1	Mono/Macro	GSE161801_PI_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17270
7.92627809277939e-23	-0.359919043113092	0.105	0.27	1.45447203002502e-18	CYP1B1	Mono/Macro	GSE161801_PI_pre	ENSG00000138061	1545	cytochrome P450 family 1 subfamily B member 1	CP1B|GLC3A	protein_coding	Q16678	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17271
9.70966157557636e-23	0.318755758732311	0.339	0.16	1.78172289911826e-18	RASGEF1B	Mono/Macro	GSE161801_PI_pre	ENSG00000138670	153020	RasGEF domain family member 1B	FLJ31695|GPIG4	protein_coding	Q0VAM2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17272
2.43462609186543e-22	0.329277201894302	0.521	0.342	4.46753887857306e-18	EFHD2	Mono/Macro	GSE161801_PI_pre	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17273
2.77021738815072e-22	0.398926929259619	0.865	0.835	5.08334890725657e-18	NAMPT	Mono/Macro	GSE161801_PI_pre	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17274
3.97518505547847e-22	0.303004739461893	0.379	0.196	7.29446457680299e-18	C8orf59	Mono/Macro	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17275
8.72306117453997e-22	-0.27859660314339	0.306	0.507	1.60068172552808e-17	CTSH	Mono/Macro	GSE161801_PI_pre	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17276
9.7121587423852e-22	-0.272815036749584	0.153	0.33	1.78218112922768e-17	ABI3	Mono/Macro	GSE161801_PI_pre	ENSG00000108798	51225	ABI family member 3	NESH|SSH3BP3	protein_coding	Q9P2A4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17277
1.17649722211503e-21	-0.275067404401217	0.276	0.485	2.15887240258108e-17	N4BP2L2	Mono/Macro	GSE161801_PI_pre	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17278
1.28520616942041e-21	-0.266803455293909	0.134	0.306	2.35835332088646e-17	LPAR6	Mono/Macro	GSE161801_PI_pre	ENSG00000139679	10161	lysophosphatidic acid receptor 6	P2RY5|P2Y5	protein_coding	P43657	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17279
1.65809137192372e-21	-0.286301716928664	0.211	0.407	3.04259766748003e-17	RHOC	Mono/Macro	GSE161801_PI_pre	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17280
7.33582187283129e-21	0.446758724773596	0.992	0.996	1.34612331366454e-16	LYZ	Mono/Macro	GSE161801_PI_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17281
8.27908246039156e-21	0.418523277481629	0.828	0.741	1.51921163148185e-16	PLAUR	Mono/Macro	GSE161801_PI_pre	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17282
9.31887300332574e-21	-0.275478289969069	0.295	0.488	1.71001319611027e-16	ABRACL	Mono/Macro	GSE161801_PI_pre	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17283
1.07563874715659e-20	0.301418596126198	0.895	0.844	1.97379710103234e-16	PABPC1	Mono/Macro	GSE161801_PI_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17284
1.38349954536619e-20	-0.322637365883431	0.963	0.984	2.53872166574695e-16	AIF1	Mono/Macro	GSE161801_PI_pre	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17285
1.86418492144571e-20	0.415345316010521	0.536	0.391	3.42077933085289e-16	ATP2B1	Mono/Macro	GSE161801_PI_pre	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17286
2.12660277575049e-20	-0.250434510712558	0.952	0.985	3.90231609350214e-16	RPL14	Mono/Macro	GSE161801_PI_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17287
2.19348133094322e-20	0.251864200880104	0.996	0.987	4.02503824228081e-16	RPS23	Mono/Macro	GSE161801_PI_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17288
4.00255898005395e-20	-0.263543700581501	0.323	0.521	7.344695728399e-16	SAMHD1	Mono/Macro	GSE161801_PI_pre	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17289
6.16691125862123e-20	-0.252299707020195	0.176	0.348	1.131628215957e-15	CD300LF	Mono/Macro	GSE161801_PI_pre	ENSG00000186074	146722	CD300 molecule like family member f	CD300f|CLM1|IGSF13|IREM1|NKIR	protein_coding	Q8TDQ1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17290
7.93132938402919e-20	-0.318316606795258	0.623	0.774	1.45539894196936e-15	PRELID1	Mono/Macro	GSE161801_PI_pre	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17291
1.4850802558846e-19	-0.268076706331092	0.754	0.867	2.72512226954825e-15	FKBP1A	Mono/Macro	GSE161801_PI_pre	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17292
1.98965455778947e-19	0.415137128128821	0.604	0.464	3.65101611354368e-15	NFKBIZ	Mono/Macro	GSE161801_PI_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17293
4.26132642148e-19	0.272191147768778	0.473	0.296	7.8195339834158e-15	SRSF9	Mono/Macro	GSE161801_PI_pre	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17294
4.62452893678018e-19	-0.299512136752817	0.381	0.576	8.48601059899164e-15	TSC22D3	Mono/Macro	GSE161801_PI_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17295
5.88040260911711e-19	-0.267107681577283	0.998	1	1.07905387877299e-14	MT-ND4	Mono/Macro	GSE161801_PI_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17296
6.11495725612725e-19	0.308021659935572	0.264	0.114	1.12209465649935e-14	RGCC	Mono/Macro	GSE161801_PI_pre	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17297
6.50913448691756e-19	-0.324421500755203	0.611	0.756	1.19442617834937e-14	CD68	Mono/Macro	GSE161801_PI_pre	ENSG00000129226	968	CD68 molecule	DKFZp686M18236|GP110|LAMP4|SCARD1	protein_coding	P34810	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17298
7.3621709531384e-19	0.276347676374227	0.934	0.902	1.3509583699009e-14	UQCRB	Mono/Macro	GSE161801_PI_pre	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17299
8.8469703661502e-19	0.289121350660143	0.354	0.189	1.62341906218856e-14	NLRP3	Mono/Macro	GSE161801_PI_pre	ENSG00000162711	114548	NLR family pyrin domain containing 3	AGTAVPRL|AII|AVP|C1orf7|CIAS1|CLR1.1|DFNA34|FCAS|FCU|MWS|NALP3|PYPAF1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17300
1.04339684397188e-18	0.479371676030974	0.661	0.527	1.91463320868841e-14	APOBEC3A	Mono/Macro	GSE161801_PI_pre	ENSG00000262156	200315	apolipoprotein B mRNA editing enzyme catalytic subunit 3A	ARP3|PHRBN	protein_coding	P31941	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17301
1.43282221704124e-18	-0.261316534708634	0.524	0.693	2.62922876827067e-14	SNX3	Mono/Macro	GSE161801_PI_pre	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17302
1.86596709398989e-18	-0.263228768403084	0.531	0.706	3.42404961747144e-14	POLR2L	Mono/Macro	GSE161801_PI_pre	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17303
2.21958097362979e-18	-0.279238434442676	0.919	0.961	4.07293108661066e-14	ITM2B	Mono/Macro	GSE161801_PI_pre	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17304
6.93895161138447e-18	0.661542883044523	0.515	0.38	1.27329762068905e-13	HSPA5	Mono/Macro	GSE161801_PI_pre	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17305
7.70735692117236e-18	-0.255201902929925	0.226	0.395	1.41429999503513e-13	SLC16A3	Mono/Macro	GSE161801_PI_pre	ENSG00000141526	9123	solute carrier family 16 member 3	MCT3|MCT4	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17306
1.16489260970062e-17	-0.469648851887152	0.259	0.423	2.13757793880065e-13	JUN	Mono/Macro	GSE161801_PI_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17307
2.83834649530779e-17	-0.261432990511512	0.831	0.917	5.20836581888979e-13	TSPO	Mono/Macro	GSE161801_PI_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17308
5.02027566627961e-17	-0.276174196407435	0.351	0.517	9.21220584762308e-13	NAAA	Mono/Macro	GSE161801_PI_pre	ENSG00000138744	27163	N-acylethanolamine acid amidase	ASAHL	protein_coding	Q02083	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17309
6.7230517183033e-17	-0.277634638979797	0.954	0.995	1.23367999030866e-12	CTSS	Mono/Macro	GSE161801_PI_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17310
7.57111035890517e-17	-0.292659023291828	0.251	0.42	1.3892987508591e-12	UTRN	Mono/Macro	GSE161801_PI_pre	ENSG00000152818	7402	utrophin	DMDL|DRP|DRP1	protein_coding	P46939	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17311
7.8634188380616e-17	-0.294169636752998	0.605	0.74	1.4429373567843e-12	CSTB	Mono/Macro	GSE161801_PI_pre	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17312
2.29231506896699e-16	-0.253979834831678	0.556	0.708	4.20639815155442e-12	ARPC5	Mono/Macro	GSE161801_PI_pre	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17313
5.09802131225666e-16	0.444268820865436	0.714	0.676	9.35486910799097e-12	PNRC1	Mono/Macro	GSE161801_PI_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17314
1.33011304994843e-15	-0.253170946841327	0.434	0.601	2.44075744665537e-11	CAP1	Mono/Macro	GSE161801_PI_pre	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17315
1.94275885381396e-15	-0.284327913546196	0.528	0.708	3.56496249674862e-11	RGS2	Mono/Macro	GSE161801_PI_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17316
3.46257233217635e-15	0.281771409625865	0.433	0.286	6.3538202295436e-11	IER5	Mono/Macro	GSE161801_PI_pre	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17317
4.70208153897817e-15	-0.255249616879326	0.577	0.722	8.62831962402494e-11	LSP1	Mono/Macro	GSE161801_PI_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17318
6.32464834157342e-15	0.46929092073193	0.398	0.265	1.16057297067872e-10	PTGS2	Mono/Macro	GSE161801_PI_pre	ENSG00000073756	5743	prostaglandin-endoperoxide synthase 2	COX2	protein_coding	P35354	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17319
1.07468608164344e-14	0.284279696369293	0.797	0.711	1.97204895981571e-10	RPS10	Mono/Macro	GSE161801_PI_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17320
1.08248233956457e-14	-0.295522409930308	0.632	0.778	1.98635509310098e-10	MS4A6A	Mono/Macro	GSE161801_PI_pre	ENSG00000110077	64231	membrane spanning 4-domains A6A	CD20L3|MS4A6	protein_coding	Q9H2W1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17321
2.90144038494758e-14	-0.263890772982227	0.622	0.751	5.32414310637882e-10	VAMP8	Mono/Macro	GSE161801_PI_pre	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17322
3.79518200287001e-13	0.293597850482795	0.758	0.685	6.96415897526647e-09	MCL1	Mono/Macro	GSE161801_PI_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17323
6.44722264285529e-13	0.295074000949934	0.4	0.271	1.18306535496395e-08	AC245128.3	Mono/Macro	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17324
7.076269639123e-13	0.378950015644296	0.821	0.792	1.29849547877907e-08	ZFP36	Mono/Macro	GSE161801_PI_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17325
1.19698894465821e-12	0.318436222036272	0.547	0.431	2.19647471344782e-08	CD300E	Mono/Macro	GSE161801_PI_pre	ENSG00000186407	342510	CD300e molecule	CD300LE|CLM2|IREM2	protein_coding	Q496F6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17326
1.81210951985469e-12	0.25931663253336	0.453	0.322	3.32522096893336e-08	IRF2BP2	Mono/Macro	GSE161801_PI_pre	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17327
1.76750375607355e-11	0.254167319685572	0.478	0.354	3.24336939239496e-07	SELENOK	Mono/Macro	GSE161801_PI_pre	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17328
2.13319507947474e-11	0.25205554320572	0.602	0.509	3.91441297083615e-07	BRI3	Mono/Macro	GSE161801_PI_pre	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17329
4.30226448886825e-11	-0.398662845564302	0.591	0.696	7.89465533707323e-07	IER2	Mono/Macro	GSE161801_PI_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17330
6.33552918428131e-11	0.474081623758333	0.599	0.541	1.16256960531562e-06	IFI6	Mono/Macro	GSE161801_PI_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17331
1.86369690772932e-09	0.307177896362897	0.628	0.569	3.4198838256833e-05	PPP1R15A	Mono/Macro	GSE161801_PI_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17332
3.01615990992982e-09	0.553181469641958	0.852	0.887	5.53465343472121e-05	TIMP1	Mono/Macro	GSE161801_PI_pre	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17333
3.54496539151876e-09	0.258003019805809	0.94	0.933	6.50501149343692e-05	VIM	Mono/Macro	GSE161801_PI_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17334
3.63055718680424e-09	0.29492301112617	0.486	0.405	6.66207243778578e-05	MARCKS	Mono/Macro	GSE161801_PI_pre	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17335
3.95741801043009e-09	0.339560253693627	0.557	0.5	7.26186204913921e-05	ATP2B1-AS1	Mono/Macro	GSE161801_PI_pre	ENSG00000271614	NA	NA	LINC00936	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17336
8.32396240566093e-09	0.25153974173702	0.494	0.406	0.000152744710143878	NINJ1	Mono/Macro	GSE161801_PI_pre	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17337
1.63853250171045e-08	-0.269791344368009	0.566	0.66	0.000300670714063868	CRIP1	Mono/Macro	GSE161801_PI_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17338
2.8677810735144e-08	0.295563750986454	0.681	0.629	0.000526237826989893	ZEB2	Mono/Macro	GSE161801_PI_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17339
1.99323852501135e-06	0.521220737268548	0.408	0.329	0.0365759269339583	CCL3L1	Mono/Macro	GSE161801_PI_pre	ENSG00000277796	6349	C-C motif chemokine ligand 3 like 1	D17S1718|G0S19-2|LD78BETA|SCYA3L|SCYA3L1|MGC12815	protein_coding	P16619	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17340
2.58639245634827e-24	0.935357994306607	1	1	4.74603015739908e-20	MALAT1	CD4+ T cells	GSE161801_PI_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17341
9.76289888595852e-14	-1.09884875169219	0.629	0.922	1.79149194557339e-09	DUSP1	CD4+ T cells	GSE161801_PI_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17342
2.04269689512057e-13	0.761825240521731	0.995	0.909	3.74834880254625e-09	RPS10	CD4+ T cells	GSE161801_PI_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17343
3.19631818294574e-13	0.511485477994256	1	1	5.86524386570543e-09	RPS29	CD4+ T cells	GSE161801_PI_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17344
3.8702803390683e-13	-0.759031665705299	0.234	0.662	7.10196442219032e-09	PPP1R15A	CD4+ T cells	GSE161801_PI_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17345
6.63377208613941e-12	-1.0605927318122	0.868	0.974	1.21729717780658e-07	IL32	CD4+ T cells	GSE161801_PI_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17346
4.44862770507479e-11	0.650793928132987	0.985	0.948	8.16323183881224e-07	RPS17	CD4+ T cells	GSE161801_PI_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17347
8.97379172398123e-11	-0.876097442062915	0.127	0.468	1.64669078135055e-06	HOPX	CD4+ T cells	GSE161801_PI_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17348
1.1433783742755e-10	0.624926240158345	0.995	0.922	2.09809931679554e-06	RPL36A	CD4+ T cells	GSE161801_PI_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17349
1.83771032390417e-09	-0.72768314410253	0.31	0.675	3.37219844436415e-05	KLF6	CD4+ T cells	GSE161801_PI_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17350
4.88952962878556e-09	-0.810682239556158	0.127	0.429	8.97228686882151e-05	HSPA1B	CD4+ T cells	GSE161801_PI_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17351
6.01300179500135e-09	-0.439657466051847	1	1	0.000110338582938275	MT-CO1	CD4+ T cells	GSE161801_PI_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17352
6.61250366635361e-09	-0.459686827680374	1	1	0.000121339442277589	RPS19	CD4+ T cells	GSE161801_PI_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17353
7.1557726506116e-09	-0.393400407648246	0.122	0.442	0.000131308428138723	DNAJB9	CD4+ T cells	GSE161801_PI_pre	ENSG00000128590	4189	DnaJ heat shock protein family (Hsp40) member B9	MDG1	protein_coding	Q9UBS3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17354
2.40286020076819e-08	-0.608818631584384	0.665	0.922	0.000440924846840962	IER2	CD4+ T cells	GSE161801_PI_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17355
3.05720454451632e-08	0.763325894196975	0.848	0.727	0.000560997033918745	IFITM1	CD4+ T cells	GSE161801_PI_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17356
5.60549907337157e-08	-0.80831610397705	0.497	0.766	0.00102860907996368	JUN	CD4+ T cells	GSE161801_PI_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17357
6.22517412761579e-08	-0.997838502652726	0.442	0.727	0.0011423194524175	FOS	CD4+ T cells	GSE161801_PI_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17358
7.06434609630064e-08	-0.529010151360591	0.954	1	0.00129630750867117	MT-ND2	CD4+ T cells	GSE161801_PI_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17359
7.24983810642516e-08	-0.575953393885674	0.178	0.481	0.00133034529252902	CTSW	CD4+ T cells	GSE161801_PI_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17360
7.40065565444163e-08	-1.16428581005649	0.411	0.701	0.00135802031259004	LGALS1	CD4+ T cells	GSE161801_PI_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17361
1.45859619983499e-07	-0.747582701540235	0.213	0.545	0.0026765240266972	GNLY	CD4+ T cells	GSE161801_PI_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17362
1.81232445574236e-07	-0.76150582980316	0.954	0.987	0.00332561537628723	LTB	CD4+ T cells	GSE161801_PI_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17363
1.82946066993523e-07	-0.409713062783851	0.046	0.26	0.00335706032933115	TRGC2	CD4+ T cells	GSE161801_PI_pre	ENSG00000227191	NA	NA	TCRGC2|TRGC2(2X)|TRGC2(3X)	TR_C_gene	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17364
2.17453137177729e-07	-0.519417454872641	1	1	0.00399026506721133	TMSB10	CD4+ T cells	GSE161801_PI_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17365
2.91578550160352e-07	-0.348476113098836	0.081	0.325	0.00535046639544246	FOSB	CD4+ T cells	GSE161801_PI_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17366
4.12849873069035e-07	0.629493430875246	0.99	0.922	0.0075757951708168	JUNB	CD4+ T cells	GSE161801_PI_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17367
4.77405806933729e-07	-0.750558842741904	0.949	0.987	0.00876039655723393	S100A4	CD4+ T cells	GSE161801_PI_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17368
5.24726744027357e-07	-0.372271704067165	0.228	0.545	0.00962873575290199	NDUFA12	CD4+ T cells	GSE161801_PI_pre	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17369
1.00042386080526e-06	-0.429052585751336	1	1	0.0183577778457765	MT-CO2	CD4+ T cells	GSE161801_PI_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17370
1.070137628112e-06	-0.425968270104676	0.081	0.312	0.0196370254758552	AIF1	CD4+ T cells	GSE161801_PI_pre	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17371
1.14971870450555e-06	-0.361606805635302	0.137	0.403	0.0210973382276768	ZFP36L1	CD4+ T cells	GSE161801_PI_pre	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17372
1.1669034172446e-06	-0.379927332995744	1	1	0.0214126777064384	HLA-B	CD4+ T cells	GSE161801_PI_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17373
1.25501441551634e-06	0.285287808983012	1	1	0.0230295145247248	RPS27	CD4+ T cells	GSE161801_PI_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17374
1.69597678360567e-06	-0.405018313958574	0.142	0.403	0.031121173979164	AC016831.5	CD4+ T cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17375
2.20396317191621e-06	-0.716424409338476	0.528	0.753	0.0404427242046625	DNAJB1	CD4+ T cells	GSE161801_PI_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17376
2.36844158864917e-06	0.313475301611778	1	1	0.0434609031517123	RPL21	CD4+ T cells	GSE161801_PI_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17377
4.58140838986838e-22	-2.16946693030308	0.064	0.98	8.40688439540848e-18	HLA-DQA2	cDCs	GSE161801_PI_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17378
1.58873300078212e-14	1.01044583341338	1	0.898	2.9153250564352e-10	HLA-A	cDCs	GSE161801_PI_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17379
2.21175261564907e-12	0.663904668803935	1	1	4.05856604971604e-08	MALAT1	cDCs	GSE161801_PI_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17380
3.31496569718735e-12	0.659730269123128	1	1	6.08296205433878e-08	RPS29	cDCs	GSE161801_PI_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17381
1.63375596291213e-11	0.627161585161464	1	0.949	2.99794219194375e-07	RPS17	cDCs	GSE161801_PI_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17382
4.03741886930545e-11	0.884644245312722	1	0.959	7.40866362517551e-07	HLA-DRB5	cDCs	GSE161801_PI_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17383
7.88992704030528e-11	0.854802084460064	0.383	0	1.44780161189602e-06	RPS4Y1	cDCs	GSE161801_PI_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17384
6.19452925118015e-09	-0.693842678080532	0.957	1	0.000113669611759156	S100A6	cDCs	GSE161801_PI_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17385
8.28516463868405e-09	0.435557788419731	1	1	0.000152032771119852	RPS13	cDCs	GSE161801_PI_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17386
1.10944923143929e-08	0.62773624959483	1	0.898	0.000203583933969109	RPS10	cDCs	GSE161801_PI_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17387
3.89325772231731e-08	-0.676844601728636	0.809	0.959	0.000714412792045226	LST1	cDCs	GSE161801_PI_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17388
4.77470045228963e-08	0.6144038750693	0.979	0.878	0.000876157532995147	RPL36A	cDCs	GSE161801_PI_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17389
5.9365699253751e-08	0.47251860984371	1	0.99	0.00108936058130633	RPL30	cDCs	GSE161801_PI_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17390
6.92520930759031e-08	0.550974273415155	1	0.99	0.00127077590794282	RPS20	cDCs	GSE161801_PI_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17391
7.29146855398425e-08	-0.60890577307206	0.064	0.531	0.00133798447965611	LTA4H	cDCs	GSE161801_PI_pre	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17392
2.16421527276246e-07	-0.854990109975916	0.617	0.898	0.00397133502551911	MNDA	cDCs	GSE161801_PI_pre	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17393
2.25940447880121e-07	0.490018250894473	1	1	0.00414600721860022	RPS23	cDCs	GSE161801_PI_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17394
2.59398948090451e-07	0.477862700644793	1	1	0.00475997069745978	EIF1	cDCs	GSE161801_PI_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17395
5.17946593480995e-07	-0.310597326061814	1	1	0.00950431999037625	TMSB10	cDCs	GSE161801_PI_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17396
1.01373082243809e-06	-0.653708102930701	0.83	0.949	0.018601960591739	TYMP	cDCs	GSE161801_PI_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17397
1.52438230149988e-06	0.84510810146672	0.617	0.286	0.0279724152325229	BASP1	cDCs	GSE161801_PI_pre	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17398
1.55379956731334e-06	-1.50232997701304	0.553	0.816	0.0285122220601999	S100A9	cDCs	GSE161801_PI_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17399
1.69997671839876e-06	0.653211374042127	0.553	0.194	0.0311945727826173	MARCKSL1	cDCs	GSE161801_PI_pre	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17400
1.91399816565075e-06	0.475158491716415	0.489	0.133	0.0351218663396912	SNHG8	cDCs	GSE161801_PI_pre	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17401
1.92893065698839e-06	0.308800105294295	0.255	0.01	0.035395877555737	TNFAIP3	cDCs	GSE161801_PI_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17402
2.64146100770887e-22	-0.626703514022233	0.004	0.444	4.84708094914578e-18	RASD1	B cells	GSE161801_PI_pre	ENSG00000108551	51655	ras related dexamethasone induced 1	AGS1|DEXRAS1	protein_coding	Q9Y272	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17403
2.6864539579143e-21	-0.415037499278844	0	0.333	4.92964301277274e-17	MAP1LC3A	B cells	GSE161801_PI_pre	ENSG00000101460	84557	microtubule associated protein 1 light chain 3 alpha	ATG8E|LC3|LC3A|MAP1ALC3|MAP1BLC3	protein_coding	Q9H492	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17404
1.37212667333298e-18	-0.514454865802681	0.007	0.444	2.51785244556601e-14	LILRB4	B cells	GSE161801_PI_pre	ENSG00000278555	11006	leukocyte immunoglobulin like receptor B4	CD85k|HM18|ILT3|LIR-5|LIR5	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17405
5.06643297540992e-16	-0.885594947305273	0.022	0.556	9.29690450987721e-12	LGMN	B cells	GSE161801_PI_pre	ENSG00000100600	5641	legumain	LGMN1|PRSC1	protein_coding	Q99538	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17406
1.43742748086934e-14	-1.32570125798942	0.09	0.889	2.63767942739524e-10	TXN	B cells	GSE161801_PI_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17407
1.52217665965442e-14	-1.33450906178637	0.119	1	2.79319417046586e-10	HLA-DQA2	B cells	GSE161801_PI_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17408
1.94434062845193e-14	-0.600231302661042	0.026	0.556	3.56786505320929e-10	BORCS8	B cells	GSE161801_PI_pre	ENSG00000254901	729991	BLOC-1 related complex subunit 8	MEF2BNB	protein_coding	Q96FH0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17409
4.44760083506115e-14	-0.509141065906213	0.015	0.444	8.16134753233721e-10	RPS6KA4	B cells	GSE161801_PI_pre	ENSG00000162302	8986	ribosomal protein S6 kinase A4	MSK2|RSK-B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17410
4.44760083506115e-14	-0.509141065906213	0.015	0.444	8.16134753233721e-10	SFXN4	B cells	GSE161801_PI_pre	ENSG00000183605	119559	sideroflexin 4	SLC56A4	protein_coding	Q6P4A7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17411
4.44760083506115e-14	-0.509141065906213	0.015	0.444	8.16134753233721e-10	TNNI2	B cells	GSE161801_PI_pre	ENSG00000288219	7136	troponin I2, fast skeletal type	AMCD2B|DA2B|FSSV	protein_coding	P48788	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17412
7.15266368955679e-14	-0.818720103590112	0.063	0.778	1.31251378703367e-09	POLDIP2	B cells	GSE161801_PI_pre	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17413
5.24827574053742e-13	-0.519788310105721	0.007	0.333	9.63058598388617e-09	AL627171.1	B cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17414
5.24827574053742e-13	-0.726239187573148	0.007	0.333	9.63058598388617e-09	SCT	B cells	GSE161801_PI_pre	ENSG00000274473	6343	secretin	NA	protein_coding	P09683	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17415
5.24827574053742e-13	-0.519788310105721	0.007	0.333	9.63058598388617e-09	LILRA4	B cells	GSE161801_PI_pre	ENSG00000276798	23547	leukocyte immunoglobulin like receptor A4	CD85g|ILT7	protein_coding	P59901	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17416
5.61813669788247e-13	-0.621370069719193	0.007	0.333	1.03092808406143e-08	TPM2	B cells	GSE161801_PI_pre	ENSG00000198467	7169	tropomyosin 2	AMCD1|DA1|NEM4	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17417
5.99670877779157e-13	-0.404311092685785	0.007	0.333	1.10039606072475e-08	CXCR3	B cells	GSE161801_PI_pre	ENSG00000186810	2833	C-X-C motif chemokine receptor 3	CD183|CKR-L2|CMKAR3|GPR9|IP10-R|MigR	protein_coding	P49682	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17418
7.34531071621353e-13	-0.388369548816764	0.007	0.333	1.34786451642518e-08	HSPA1B	B cells	GSE161801_PI_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17419
2.79264562077628e-12	-0.663503432225185	0.052	0.667	5.12450471412447e-08	MRPS18C	B cells	GSE161801_PI_pre	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17420
1.35605659426116e-11	-0.653307665119296	0.056	0.667	2.48836385046922e-07	HIGD1A	B cells	GSE161801_PI_pre	ENSG00000181061	25994	HIG1 hypoxia inducible domain family member 1A	DKFZP564K247|HIG1|RCF1A	protein_coding	Q9Y241	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17421
1.92052778519144e-11	-0.579397799243877	0.037	0.556	3.5241684858263e-07	GYG1	B cells	GSE161801_PI_pre	ENSG00000163754	2992	glycogenin 1	GYG	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17422
2.08824647481858e-11	-0.658396541792096	0.037	0.556	3.83193228129209e-07	IRF4	B cells	GSE161801_PI_pre	ENSG00000137265	3662	interferon regulatory factor 4	LSIRF|MUM1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17423
2.13209527055498e-11	-0.705022701663452	0.022	0.444	3.91239482146839e-07	CTSC	B cells	GSE161801_PI_pre	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17424
2.77943123772675e-11	-0.498571824196026	0.022	0.444	5.10025632122859e-07	POLR3K	B cells	GSE161801_PI_pre	ENSG00000161980	51728	RNA polymerase III subunit K	C11|RPC11	protein_coding	Q9Y2Y1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17425
6.37182138531605e-11	-0.514454865802681	0.011	0.333	1.16922922420549e-06	FAM213A	B cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17426
6.37182138531605e-11	-0.514454865802681	0.011	0.333	1.16922922420549e-06	MAP2K6	B cells	GSE161801_PI_pre	ENSG00000108984	5608	mitogen-activated protein kinase kinase 6	MAPKK6|MEK6|MKK6|PRKMK6|SAPKK3	protein_coding	P52564	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17427
7.52532255364227e-11	-0.398977648382745	0.011	0.333	1.38089668859336e-06	HIPK2	B cells	GSE161801_PI_pre	ENSG00000064393	28996	homeodomain interacting protein kinase 2	NA	protein_coding	Q9H2X6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17428
7.52532255364227e-11	-0.398977648382745	0.011	0.333	1.38089668859336e-06	ASPH	B cells	GSE161801_PI_pre	ENSG00000198363	444	aspartate beta-hydroxylase	BAH|CASQ2BP1|HAAH|JCTN	protein_coding	Q12797	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17429
7.52532255364227e-11	-0.398977648382745	0.011	0.333	1.38089668859336e-06	BIK	B cells	GSE161801_PI_pre	ENSG00000100290	638	BCL2 interacting killer	NBK	protein_coding	Q13323	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17430
7.52532255364227e-11	-0.398977648382745	0.011	0.333	1.38089668859336e-06	GNAQ	B cells	GSE161801_PI_pre	ENSG00000156052	2776	G protein subunit alpha q	G-ALPHA-q|GAQ	protein_coding	P50148	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17431
8.53046938320295e-11	-0.579397799243877	0.041	0.556	1.56534113181774e-06	EP400	B cells	GSE161801_PI_pre	ENSG00000183495	57634	E1A binding protein p400	CAGH32|DKFZP434I225|KIAA1498|KIAA1818|P400|TNRC12	protein_coding	Q96L91	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17432
6.39918275056669e-10	-2.05340393082666	0.116	0.778	1.17425003472899e-05	S100A10	B cells	GSE161801_PI_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17433
1.93421114023616e-09	-0.558860868241182	0.049	0.556	3.54927744233336e-05	OSBPL8	B cells	GSE161801_PI_pre	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17434
2.0646806764821e-09	-0.488079450378383	0.03	0.444	3.78868904134464e-05	TSEN34	B cells	GSE161801_PI_pre	ENSG00000274078	79042	tRNA splicing endonuclease subunit 34	LENG5|SEN34|SEN34L	protein_coding	Q9BSV6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17435
2.39895238610721e-09	-0.482861741107364	0.03	0.444	4.40207762850674e-05	IQGAP2	B cells	GSE161801_PI_pre	ENSG00000145703	10788	IQ motif containing GTPase activating protein 2	NA	protein_coding	Q13576	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17436
2.40148294644363e-09	-0.393663848486277	0.015	0.333	4.40672120672406e-05	MAD2L1BP	B cells	GSE161801_PI_pre	ENSG00000124688	9587	MAD2L1 binding protein	CMT2|dJ261G23.1|KIAA0110	protein_coding	Q15013	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17437
2.40148294644363e-09	-0.393663848486277	0.015	0.333	4.40672120672406e-05	CEP164	B cells	GSE161801_PI_pre	ENSG00000110274	22897	centrosomal protein 164	KIAA1052|NPHP15	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17438
2.40148294644363e-09	-0.393663848486277	0.015	0.333	4.40672120672406e-05	GAS6	B cells	GSE161801_PI_pre	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17439
2.40148294644363e-09	-0.393663848486277	0.015	0.333	4.40672120672406e-05	HAGHL	B cells	GSE161801_PI_pre	ENSG00000103253	84264	hydroxyacylglutathione hydrolase like	MGC2605	protein_coding	Q6PII5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17440
2.40148294644363e-09	-0.393663848486277	0.015	0.333	4.40672120672406e-05	THOP1	B cells	GSE161801_PI_pre	ENSG00000172009	7064	thimet oligopeptidase 1	NA	protein_coding	P52888	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17441
2.40148294644363e-09	-0.393663848486277	0.015	0.333	4.40672120672406e-05	LATS1	B cells	GSE161801_PI_pre	ENSG00000131023	9113	large tumor suppressor kinase 1	WARTS	protein_coding	O95835	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17442
2.7842794646275e-09	-0.477662834433045	0.03	0.444	5.10915281759146e-05	ADA	B cells	GSE161801_PI_pre	ENSG00000196839	100	adenosine deaminase	ADA1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17443
5.35715604091719e-09	-0.558860868241182	0.052	0.556	9.83038133508304e-05	POLR2F	B cells	GSE161801_PI_pre	ENSG00000100142	5435	RNA polymerase II, I and III subunit F	HRBP14.4|RPB6	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17444
1.1136195942413e-08	-0.528593428572385	0.052	0.556	0.000204349195543278	MRPL13	B cells	GSE161801_PI_pre	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17445
1.24899743133985e-08	-0.477662834433045	0.034	0.444	0.000229191028650862	SUPT5H	B cells	GSE161801_PI_pre	ENSG00000196235	6829	SPT5 homolog, DSIF elongation factor subunit	FLJ34157|SPT5|SPT5H	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17446
1.27037762174523e-08	-0.818161677014187	0.119	0.778	0.00023311429359025	ARHGAP45	B cells	GSE161801_PI_pre	ENSG00000180448	23526	Rho GTPase activating protein 45	HA-1|HMHA1|KIAA0223	protein_coding	Q92619	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17447
1.3405266873378e-08	-0.558860868241182	0.056	0.556	0.000245986647126486	PHB	B cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17448
1.43284039222728e-08	-0.472482595327365	0.034	0.444	0.000262926211973706	DCPS	B cells	GSE161801_PI_pre	ENSG00000110063	28960	decapping enzyme, scavenger	HINT-5|HINT5|HSL1|HSPC015	protein_coding	Q96C86	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17449
1.43284039222728e-08	-0.472482595327365	0.034	0.444	0.000262926211973706	UBE2Q2	B cells	GSE161801_PI_pre	ENSG00000140367	92912	ubiquitin conjugating enzyme E2 Q2	DKFZp762C143	protein_coding	Q8WVN8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17450
2.41374144970906e-08	-0.864685957542292	0.037	0.444	0.000442921556021613	KYNU	B cells	GSE161801_PI_pre	ENSG00000115919	8942	kynureninase	NA	protein_coding	Q16719	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17451
3.2517481399761e-08	-0.388369548816764	0.019	0.333	0.000596695783685615	STX18	B cells	GSE161801_PI_pre	ENSG00000168818	53407	syntaxin 18	Ufe1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17452
3.2517481399761e-08	-0.388369548816764	0.019	0.333	0.000596695783685615	SLAIN2	B cells	GSE161801_PI_pre	ENSG00000109171	57606	SLAIN motif family member 2	FLJ21611|KIAA1458	protein_coding	Q9P270	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17453
3.2517481399761e-08	-0.388369548816764	0.019	0.333	0.000596695783685615	NDRG1	B cells	GSE161801_PI_pre	ENSG00000104419	10397	N-myc downstream regulated 1	CAP43|DRG1|NDR1|RTP|TDD5	protein_coding	Q92597	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17454
3.2517481399761e-08	-0.388369548816764	0.019	0.333	0.000596695783685615	ZNF628	B cells	GSE161801_PI_pre	ENSG00000197483	89887	zinc finger protein 628	ZEC|Zfp628	protein_coding	Q5EBL2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17455
3.2517481399761e-08	-0.388369548816764	0.019	0.333	0.000596695783685615	TANGO2	B cells	GSE161801_PI_pre	ENSG00000183597	128989	transport and golgi organization 2 homolog	C22orf25|DKFZp761P1121	protein_coding	Q6ICL3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17456
3.40213882048857e-08	-0.594994654294895	0.019	0.333	0.000624292473559652	JAML	B cells	GSE161801_PI_pre	ENSG00000160593	120425	junction adhesion molecule like	AMICA|AMICA1|Gm638	protein_coding	Q86YT9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17457
3.68796960715096e-08	-0.38309460677609	0.019	0.333	0.000676742422912202	JOSD2	B cells	GSE161801_PI_pre	ENSG00000161677	126119	Josephin domain containing 2	SBBI54	protein_coding	Q8TAC2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17458
3.68796960715096e-08	-0.38309460677609	0.019	0.333	0.000676742422912202	HACD4	B cells	GSE161801_PI_pre	ENSG00000188921	401494	3-hydroxyacyl-CoA dehydratase 4	Em:AL662879.1|OTTHUMG00000021016|PTPLAD2	protein_coding	Q5VWC8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17459
4.15789519745937e-08	-1.56524731090084	0.157	0.778	0.000762973768733794	CCDC50	B cells	GSE161801_PI_pre	ENSG00000152492	152137	coiled-coil domain containing 50	C3orf6|DFNA44|Ymer	protein_coding	Q8IVM0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17460
4.53061645256169e-08	-0.477662834433045	0.037	0.444	0.00083136811904507	LAGE3	B cells	GSE161801_PI_pre	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17461
4.53061645256169e-08	-0.477662834433045	0.037	0.444	0.00083136811904507	CHFR	B cells	GSE161801_PI_pre	ENSG00000072609	55743	checkpoint with forkhead and ring finger domains	FLJ10796|RNF196	protein_coding	Q96EP1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17462
5.15072302458452e-08	-0.472482595327365	0.037	0.444	0.000945157675011259	HEXB	B cells	GSE161801_PI_pre	ENSG00000049860	3074	hexosaminidase subunit beta	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17463
5.27095586982197e-08	-0.533594109630752	0.06	0.556	0.000967220402112331	IFI35	B cells	GSE161801_PI_pre	ENSG00000068079	3430	interferon induced protein 35	IFP35	protein_coding	P80217	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17464
9.66149211842408e-08	-0.543647774294675	0.063	0.556	0.00177288380373082	DAAM1	B cells	GSE161801_PI_pre	ENSG00000100592	23002	dishevelled associated activator of morphogenesis 1	KIAA0666	protein_coding	Q9Y4D1	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17465
1.13461308153351e-07	-0.579397799243877	0.041	0.444	0.00208201500461399	FUT8	B cells	GSE161801_PI_pre	ENSG00000033170	2530	fucosyltransferase 8	NA	protein_coding	Q9BYC5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17466
1.48536552484293e-07	-0.946204871515056	0.172	0.889	0.00272564573808678	SLC25A3	B cells	GSE161801_PI_pre	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17467
1.56380769985543e-07	-0.472482595327365	0.041	0.444	0.00286958712923472	TOMM40	B cells	GSE161801_PI_pre	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17468
1.60351554814635e-07	-0.51864376816478	0.063	0.556	0.00294245103084855	NASP	B cells	GSE161801_PI_pre	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17469
1.76241247043101e-07	-0.467320890211586	0.041	0.444	0.00323402688324089	PARL	B cells	GSE161801_PI_pre	ENSG00000175193	55486	presenilin associated rhomboid like	PRO2207|PSARL|PSARL1|RHBDS1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17470
1.76241247043101e-07	-0.467320890211586	0.041	0.444	0.00323402688324089	MTCH2	B cells	GSE161801_PI_pre	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17471
1.76241247043101e-07	-0.467320890211586	0.041	0.444	0.00323402688324089	RETREG2	B cells	GSE161801_PI_pre	ENSG00000144567	79137	reticulophagy regulator family member 2	C2orf17|FAM134A|MAG-2|MGC3035	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17472
1.78652818057259e-07	-0.600231302661042	0.022	0.333	0.0032782792113507	CORO1B	B cells	GSE161801_PI_pre	ENSG00000172725	57175	coronin 1B	coronin-2	protein_coding	Q9BR76	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17473
1.79362761065531e-07	-0.6281291021233	0.067	0.556	0.0032913066655525	MRPS6	B cells	GSE161801_PI_pre	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17474
2.48374275521349e-07	-0.38309460677609	0.022	0.333	0.00455766795581675	MRPL37	B cells	GSE161801_PI_pre	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17475
2.48374275521349e-07	-0.38309460677609	0.022	0.333	0.00455766795581675	FEM1C	B cells	GSE161801_PI_pre	ENSG00000145780	56929	fem-1 homolog C	EUROIMAGE686608|EUROIMAGE783647|FEM1A|KIAA1785	protein_coding	Q96JP0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17476
2.48374275521349e-07	-0.38309460677609	0.022	0.333	0.00455766795581675	MSRB2	B cells	GSE161801_PI_pre	ENSG00000148450	22921	methionine sulfoxide reductase B2	CBS-1|CBS1|CGI-131|MSRB|PILB	protein_coding	Q9Y3D2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17477
2.48374275521349e-07	-0.38309460677609	0.022	0.333	0.00455766795581675	SAMM50	B cells	GSE161801_PI_pre	ENSG00000100347	25813	SAMM50 sorting and assembly machinery component	CGI-51|OMP85|SAM50|TOB55|TRG-3|YNL026W	protein_coding	Q9Y512	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17478
2.48374275521349e-07	-0.38309460677609	0.022	0.333	0.00455766795581675	HNRNPUL2	B cells	GSE161801_PI_pre	ENSG00000214753	221092	heterogeneous nuclear ribonucleoprotein U like 2	DKFZp762N1910|HNRPUL2	protein_coding	Q1KMD3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17479
2.61236679179813e-07	-0.583886264161817	0.097	0.667	0.00479369306294957	ELOF1	B cells	GSE161801_PI_pre	ENSG00000130165	84337	elongation factor 1	ELF1|MGC4549	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17480
2.77702952273051e-07	-0.372602232958447	0.022	0.333	0.00509584917421049	PTMS	B cells	GSE161801_PI_pre	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17481
4.29777520414437e-07	-0.558860868241182	0.045	0.444	0.00788641749960493	PPP1R14B	B cells	GSE161801_PI_pre	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17482
4.63239375787799e-07	-0.467320890211586	0.045	0.444	0.0085004425457061	PRDX3	B cells	GSE161801_PI_pre	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17483
5.02334624465944e-07	-0.528593428572385	0.071	0.556	0.00921784035895008	GPAA1	B cells	GSE161801_PI_pre	ENSG00000197858	8733	glycosylphosphatidylinositol anchor attachment 1	GAA1|hGAA1	protein_coding	O43292	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17484
5.18100590507816e-07	-0.462177586935626	0.045	0.444	0.00950714583581842	NDUFA8	B cells	GSE161801_PI_pre	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17485
6.61749581062906e-07	-0.574236094128098	0.104	0.667	0.0121431048125043	EIF4A3	B cells	GSE161801_PI_pre	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17486
7.2844721149815e-07	-0.555127271180393	0.101	0.667	0.0133670063309911	RAP1A	B cells	GSE161801_PI_pre	ENSG00000116473	5906	RAP1A, member of RAS oncogene family	KREV-1|SMGP21	protein_coding	P62834	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17487
7.31814059404447e-07	-1.56378173649093	0.526	1	0.0134287879900716	SUB1	B cells	GSE161801_PI_pre	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17488
8.34086084787589e-07	-0.606145342082842	0.142	0.778	0.0153054796558523	PSMB6	B cells	GSE161801_PI_pre	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17489
1.00861483577433e-06	-0.49331609874453	0.026	0.333	0.0185080822364589	RBM14	B cells	GSE161801_PI_pre	ENSG00000239306	10432	RNA binding motif protein 14	COAA|DKFZp779J0927|SIP|SYTIP1	protein_coding	Q96PK6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17490
1.0741424355162e-06	-1.60338243978761	0.187	0.778	0.0197105136917222	IRF7	B cells	GSE161801_PI_pre	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17491
1.23287256910674e-06	-0.482861741107364	0.026	0.333	0.0226232116431087	RUBCNL	B cells	GSE161801_PI_pre	ENSG00000102445	80183	rubicon like autophagy enhancer	C13orf18|FLJ21562|KIAA0226L|PACER	protein_coding	Q9H714	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17492
1.26980713488392e-06	-0.377838881324594	0.026	0.333	0.0233009609251199	RANBP2	B cells	GSE161801_PI_pre	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17493
1.26980713488392e-06	-0.377838881324594	0.026	0.333	0.0233009609251199	PBX2	B cells	GSE161801_PI_pre	ENSG00000236353	5089	PBX homeobox 2	G17|HOX12|PBX2MHC	protein_coding	P40425	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17494
1.26980713488392e-06	-0.377838881324594	0.026	0.333	0.0233009609251199	FOXK1	B cells	GSE161801_PI_pre	ENSG00000164916	221937	forkhead box K1	IMAGE:5164497	protein_coding	P85037	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17495
1.26980713488392e-06	-0.377838881324594	0.026	0.333	0.0233009609251199	CDK5	B cells	GSE161801_PI_pre	ENSG00000164885	1020	cyclin dependent kinase 5	PSSALRE	protein_coding	Q00535	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17496
1.26980713488392e-06	-0.377838881324594	0.026	0.333	0.0233009609251199	DPYSL2	B cells	GSE161801_PI_pre	ENSG00000092964	1808	dihydropyrimidinase like 2	CRMP2|DHPRP2|DRP-2|DRP2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17497
1.34390578238637e-06	-0.457052554757759	0.049	0.444	0.0246606711067899	UBA1	B cells	GSE161801_PI_pre	ENSG00000130985	7317	ubiquitin like modifier activating enzyme 1	A1S9T|CFAP124|GXP1|POC20|UBE1|UBE1X	protein_coding	P22314	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17498
1.40362638974351e-06	-0.372602232958447	0.026	0.333	0.0257565442517935	WARS	B cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17499
1.49555942106681e-06	-0.603382439787614	0.078	0.556	0.027443515376576	DDX39A	B cells	GSE161801_PI_pre	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17500
2.24217076586285e-06	-0.558860868241182	0.052	0.444	0.0411438335535832	BAK1	B cells	GSE161801_PI_pre	ENSG00000030110	578	BCL2 antagonist/killer 1	BAK|BCL2L7|CDN1	protein_coding	Q16611	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17501
2.33194624389978e-06	-0.726239187573148	0.16	0.778	0.0427912135755609	PSMA2	B cells	GSE161801_PI_pre	ENSG00000106588	5683	proteasome 20S subunit alpha 2	HC3|MU|PMSA2	protein_coding	P25787	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17502
2.6688829140331e-06	-0.638147857948291	0.052	0.444	0.0489740014725074	SAMHD1	B cells	GSE161801_PI_pre	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17503
1.57611370472181e-67	1.13947213168216	1	1	2.89216864816453e-63	MALAT1	NK cells	GSE161801_PI_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17504
3.60683179074254e-61	-1.76342571754177	0.878	0.992	6.61853633601255e-57	GNLY	NK cells	GSE161801_PI_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17505
3.87050353555949e-55	-1.63566759476519	0.037	0.641	7.10237398775167e-51	XCL1	NK cells	GSE161801_PI_pre	ENSG00000143184	6375	X-C motif chemokine ligand 1	ATAC|LPTN|LTN|SCM-1|SCM-1a|SCYC1	protein_coding	P47992	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17506
3.00230160798425e-51	-1.54401610116833	0.22	0.827	5.50922345065109e-47	FOS	NK cells	GSE161801_PI_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17507
6.22442514577211e-49	-1.4520295409669	0.113	0.702	1.14218201424918e-44	SELL	NK cells	GSE161801_PI_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17508
2.4270423348689e-45	-1.65374818319007	0.293	0.806	4.45362268448443e-41	NFKBIA	NK cells	GSE161801_PI_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17509
3.08082123085394e-45	-1.35499267266981	0.552	0.94	5.65330695861698e-41	DUSP1	NK cells	GSE161801_PI_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17510
2.03391442763222e-42	-1.4610711920875	0.634	0.927	3.73223297470512e-38	CMC1	NK cells	GSE161801_PI_pre	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17511
3.80996842030745e-41	-0.736675096524413	1	1	6.99129205126416e-37	RPL34	NK cells	GSE161801_PI_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17512
4.37064375747902e-41	-1.09974605516279	0.695	0.952	8.020131294974e-37	CTSW	NK cells	GSE161801_PI_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17513
1.40012493622317e-40	-0.647202675409746	1	1	2.56922925796951e-36	RPL13	NK cells	GSE161801_PI_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17514
6.58377474094953e-37	-1.19377958956999	0.253	0.766	1.20812266496424e-32	JUN	NK cells	GSE161801_PI_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17515
9.10990921782937e-37	-0.563361216475991	1	1	1.67166834147169e-32	RPL13A	NK cells	GSE161801_PI_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17516
1.08447053629238e-34	-0.905015548257803	0.165	0.653	1.99000343409653e-30	PPP1R15A	NK cells	GSE161801_PI_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17517
1.59179220865734e-34	-0.594663874268259	1	1	2.92093870288622e-30	RPS28	NK cells	GSE161801_PI_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17518
1.75845179716987e-34	1.09779890564922	0.97	0.762	3.22675904780672e-30	CCL5	NK cells	GSE161801_PI_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17519
5.64054729960621e-33	-0.762483069049171	0.988	0.984	1.03504042947774e-28	MT-ND2	NK cells	GSE161801_PI_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17520
7.16062435949132e-31	-1.01416437243917	0.168	0.633	1.31397456996666e-26	GZMK	NK cells	GSE161801_PI_pre	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17521
3.50087021186714e-30	-0.879128952796844	0.122	0.569	6.42409683877621e-26	KLRC1	NK cells	GSE161801_PI_pre	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17522
2.73623774051539e-29	-0.549769406161827	1	1	5.02099625384575e-25	RPS3A	NK cells	GSE161801_PI_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17523
6.65837637929109e-29	-0.566555797150495	1	1	1.22181206559992e-24	RPS2	NK cells	GSE161801_PI_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17524
8.45180337646347e-29	-0.559150366838633	1	1	1.55090591958105e-24	RPS12	NK cells	GSE161801_PI_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17525
1.35834585825308e-28	-0.874806502415319	0.183	0.637	2.49256464989441e-24	XCL2	NK cells	GSE161801_PI_pre	ENSG00000143185	6846	X-C motif chemokine ligand 2	SCM-1b|SCYC2	protein_coding	Q9UBD3	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17526
2.81476443636943e-28	-0.505509365852755	1	1	5.1650927407379e-24	RPL32	NK cells	GSE161801_PI_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17527
1.21109501961325e-27	-0.571702876815718	1	1	2.22235936099032e-23	RPS18	NK cells	GSE161801_PI_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17528
2.15066310422405e-27	-0.557932731340085	0.021	0.363	3.94646679625114e-23	RAMP1	NK cells	GSE161801_PI_pre	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17529
1.51814907764738e-26	-0.649410646049856	0.945	0.988	2.78580355748294e-22	MT-ND3	NK cells	GSE161801_PI_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17530
1.63600441933975e-26	-0.735064809911156	0.207	0.641	3.00206810948844e-22	CD44	NK cells	GSE161801_PI_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17531
6.32171785700125e-26	-0.472697123009247	1	1	1.16003522675973e-21	RPLP2	NK cells	GSE161801_PI_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17532
1.85838004978058e-25	-0.530674524295661	0.994	1	3.41012739134736e-21	RPS24	NK cells	GSE161801_PI_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17533
8.03192727786709e-25	0.412269934909671	1	1	1.47385865548861e-20	TMSB4X	NK cells	GSE161801_PI_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17534
6.15708777164346e-24	-0.604121274097567	0.963	0.988	1.12982560609657e-19	RPL8	NK cells	GSE161801_PI_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17535
1.930320459788e-23	-0.477432898615805	1	1	3.54213804371099e-19	RPS19	NK cells	GSE161801_PI_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17536
2.21850104326468e-23	-0.453607672902376	1	1	4.07094941439068e-19	RPS15	NK cells	GSE161801_PI_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17537
4.32300036551333e-23	-0.454673348047479	1	1	7.93270567071696e-19	RPS15A	NK cells	GSE161801_PI_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17538
4.45623791043238e-23	-0.915805695167997	0.131	0.5	8.17719656564341e-19	AREG	NK cells	GSE161801_PI_pre	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17539
2.10478954658022e-22	-0.463953754446498	1	1	3.8622888179747e-18	RPS6	NK cells	GSE161801_PI_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17540
2.10700311925338e-22	-0.543152378685538	0.982	1	3.86635072382996e-18	RPL18	NK cells	GSE161801_PI_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17541
6.14408522461107e-22	-0.544514697236394	0.997	1	1.12743963871613e-17	RPS8	NK cells	GSE161801_PI_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17542
1.68708396532516e-21	0.329524678343931	1	1	3.09579907637168e-17	B2M	NK cells	GSE161801_PI_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17543
2.47068379651179e-21	0.452471326746166	1	1	4.53370476659913e-17	HLA-A	NK cells	GSE161801_PI_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17544
3.70045866939593e-21	-0.420383147471351	1	1	6.79034165834154e-17	RPS3	NK cells	GSE161801_PI_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17545
9.17785772926512e-21	-0.45532904415468	0.997	1	1.68413689332015e-16	RPL28	NK cells	GSE161801_PI_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17546
2.73445461845773e-20	-0.673127180544198	0.686	0.923	5.01772422486994e-16	IER2	NK cells	GSE161801_PI_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17547
1.03462268575805e-19	0.879951106628846	0.698	0.331	1.89853262836602e-15	CCL4	NK cells	GSE161801_PI_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17548
1.04526939436022e-19	-0.49855747758393	0.994	0.992	1.91806933865101e-15	RPL35	NK cells	GSE161801_PI_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17549
4.03936680347107e-19	-0.518832911651145	0.146	0.492	7.41223808436941e-15	CD300A	NK cells	GSE161801_PI_pre	ENSG00000167851	11314	CD300a molecule	CMRF-35-H9|CMRF35H|IGSF12|IRC1|IRC2|Irp60	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17550
4.82809328090357e-19	-0.533416234795582	0.064	0.367	8.85955117045805e-15	AC020916.1	NK cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17551
6.82443326720264e-19	-0.402084783820825	1	1	1.25228350453168e-14	RPS14	NK cells	GSE161801_PI_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17552
8.88008155785498e-19	-0.673884636611927	0.293	0.637	1.62949496586639e-14	IL2RB	NK cells	GSE161801_PI_pre	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17553
1.4969116750626e-18	-0.534329247974313	0.988	0.996	2.74683292373986e-14	TPT1	NK cells	GSE161801_PI_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17554
1.74756400392693e-18	-0.381644091355741	1	1	3.20677994720591e-14	RPL10	NK cells	GSE161801_PI_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17555
3.86070660399637e-18	0.98597168594174	0.579	0.262	7.08439661833333e-14	FGFBP2	NK cells	GSE161801_PI_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17556
6.38839454193928e-18	-0.475248612712994	0.966	1	1.17227039844586e-13	RPL27	NK cells	GSE161801_PI_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17557
1.5533307126553e-17	-0.708841375962558	0.43	0.798	2.85036185772247e-13	TSC22D3	NK cells	GSE161801_PI_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17558
1.82268398975172e-17	-0.432699655813353	0.997	0.996	3.3446251211944e-13	RPL31	NK cells	GSE161801_PI_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17559
4.50504893191594e-17	0.802805456346824	0.534	0.234	8.26676479006576e-13	FCGR3A	NK cells	GSE161801_PI_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17560
6.73034273168594e-17	-0.614462308021142	0.47	0.802	1.23501789126437e-12	HOPX	NK cells	GSE161801_PI_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17561
7.07982076398302e-17	-0.326776297559482	1	1	1.29914711019088e-12	RPL21	NK cells	GSE161801_PI_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17562
8.76016579080241e-17	-0.355334179368265	0.024	0.254	1.60749042261224e-12	GSN	NK cells	GSE161801_PI_pre	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17563
1.02241374682565e-16	-0.518097780404212	0.896	0.976	1.87612922542507e-12	RPSA	NK cells	GSE161801_PI_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17564
1.08528768395597e-16	0.650537313763994	0.738	0.419	1.99150290005921e-12	GZMH	NK cells	GSE161801_PI_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17565
1.40365098500107e-16	-0.432666533938094	0.982	1	2.57569955747695e-12	RPL10A	NK cells	GSE161801_PI_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17566
3.65128457093565e-16	-0.479853831705252	0.162	0.476	6.70010718766692e-12	HSH2D	NK cells	GSE161801_PI_pre	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17567
2.12750477992734e-15	-0.522085889446232	0.232	0.556	3.90397127116666e-11	ADGRE5	NK cells	GSE161801_PI_pre	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17568
2.21219352427897e-15	-0.396540287332668	1	1	4.05937511705192e-11	RPL35A	NK cells	GSE161801_PI_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17569
3.3903283803994e-15	-0.642646640141024	0.549	0.806	6.2212525780329e-11	CD7	NK cells	GSE161801_PI_pre	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17570
4.4599479362662e-15	-0.387949193454234	1	1	8.18400446304848e-11	RPL3	NK cells	GSE161801_PI_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17571
4.88696234472308e-15	-0.424704042352825	0.985	0.988	8.96757590256685e-11	RPS16	NK cells	GSE161801_PI_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17572
5.91867872727328e-15	-0.362699024992824	0.994	1	1.08607754645465e-10	RPL11	NK cells	GSE161801_PI_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17573
7.37921574797397e-15	-0.418152696159289	0.125	0.415	1.35408608975322e-10	BHLHE40	NK cells	GSE161801_PI_pre	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17574
9.11603960141341e-15	0.563229628472471	0.902	0.706	1.67279326685936e-10	S100A6	NK cells	GSE161801_PI_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17575
1.18386317083217e-14	-0.383177812293579	0.985	0.988	2.17238891847704e-10	RPL14	NK cells	GSE161801_PI_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17576
1.24715750048914e-14	0.589031121658916	0.79	0.653	2.28853401339758e-10	ARPC2	NK cells	GSE161801_PI_pre	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17577
1.54320295300517e-14	-0.404690904915028	0.988	1	2.83177741876448e-10	RPL37A	NK cells	GSE161801_PI_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17578
1.84197988421325e-14	-0.374459548596753	0.058	0.294	3.38003308753131e-10	MAFF	NK cells	GSE161801_PI_pre	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17579
2.10139782591719e-14	-0.403355694231208	0.104	0.367	3.85606501055804e-10	CD55	NK cells	GSE161801_PI_pre	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17580
2.23720781546623e-14	-0.475879768493719	0.909	0.968	4.10527634138053e-10	RPS5	NK cells	GSE161801_PI_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17581
2.43969383259267e-14	-0.421343324162787	0.948	0.996	4.47683818280755e-10	RPS11	NK cells	GSE161801_PI_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17582
3.42071037349973e-14	-0.308342579370988	1	1	6.277003535372e-10	RPL23A	NK cells	GSE161801_PI_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17583
3.94217640304346e-14	0.670923731727348	0.61	0.375	7.23389369958474e-10	HLA-DPB1	NK cells	GSE161801_PI_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17584
4.60140031940951e-14	-0.421518272016482	0.878	0.956	8.44356958611644e-10	RPL24	NK cells	GSE161801_PI_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17585
5.97172650599449e-14	-0.360030506105526	1	1	1.09581181384999e-09	EEF1A1	NK cells	GSE161801_PI_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17586
7.51369920102827e-14	-0.568252126480441	0.274	0.577	1.37876380338869e-09	KLF6	NK cells	GSE161801_PI_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17587
3.84921490803032e-13	-0.357087208144786	1	1	7.06330935623564e-09	MT-CO1	NK cells	GSE161801_PI_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17588
4.81522760930771e-13	-0.485039491824917	0.18	0.452	8.83594266307964e-09	IGFBP7	NK cells	GSE161801_PI_pre	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17589
5.50383604456583e-13	-0.298614861549033	0.073	0.306	1.00995391417783e-08	NFE2L2	NK cells	GSE161801_PI_pre	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17590
6.56163606142392e-13	-0.424174165738763	0.854	0.94	1.20406021727129e-08	RPL4	NK cells	GSE161801_PI_pre	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17591
1.06779095669848e-12	-0.340710757242212	0.073	0.294	1.95939640554171e-08	IL18RAP	NK cells	GSE161801_PI_pre	ENSG00000115607	8807	interleukin 18 receptor accessory protein	AcPL|CD218b	protein_coding	O95256	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17592
1.18389568301563e-12	-0.368995840776524	0.994	1	2.17244857833367e-08	RPS25	NK cells	GSE161801_PI_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17593
1.19163918193085e-12	-0.583223498921099	0.518	0.774	2.18665789884311e-08	KLRF1	NK cells	GSE161801_PI_pre	ENSG00000150045	51348	killer cell lectin like receptor F1	CLEC5C|NKp80	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17594
1.27444298903611e-12	0.496187386466535	0.979	0.871	2.33860288488126e-08	S100A4	NK cells	GSE161801_PI_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17595
1.32286371462016e-12	-0.401751808528619	0.988	0.992	2.42745491632799e-08	RPL9	NK cells	GSE161801_PI_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17596
1.43154073257275e-12	-0.347395764336141	0.994	1	2.626877244271e-08	RPL36	NK cells	GSE161801_PI_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17597
1.85663531646573e-12	-0.425637141607215	0.329	0.641	3.40692580571461e-08	EIF3G	NK cells	GSE161801_PI_pre	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17598
1.89828165253833e-12	-0.360286972339323	0.119	0.363	3.48334683240784e-08	MVD	NK cells	GSE161801_PI_pre	ENSG00000167508	4597	mevalonate diphosphate decarboxylase	MPD	protein_coding	P53602	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17599
1.95199344516055e-12	-0.619350344369506	0.588	0.843	3.58190797186961e-08	DUSP2	NK cells	GSE161801_PI_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17600
2.55250952315611e-12	-0.379596875916499	1	1	4.68385497499146e-08	RPLP1	NK cells	GSE161801_PI_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17601
2.63480353045267e-12	-0.308735159765602	1	1	4.83486447838065e-08	RPL27A	NK cells	GSE161801_PI_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17602
3.36085715819848e-12	-0.502018329909254	0.387	0.677	6.16717288529421e-08	PNRC1	NK cells	GSE161801_PI_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17603
3.44334513807972e-12	-0.347707664681294	0.082	0.315	6.31853832837629e-08	LST1	NK cells	GSE161801_PI_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17604
5.20426795581845e-12	-0.324060374015599	1	1	9.54983169892685e-08	RPL19	NK cells	GSE161801_PI_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17605
5.33044754567146e-12	-0.385610144041254	0.146	0.415	9.78137124630713e-08	CST3	NK cells	GSE161801_PI_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17606
6.59374103771704e-12	-0.545799959251414	0.183	0.435	1.20995148042108e-07	PMAIP1	NK cells	GSE161801_PI_pre	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17607
6.82838169194653e-12	-0.428698542345672	0.14	0.387	1.25300804047219e-07	IFITM3	NK cells	GSE161801_PI_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17608
9.75094423186715e-12	-0.283418828620573	0.061	0.266	1.78929826654762e-07	TCF7	NK cells	GSE161801_PI_pre	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17609
1.20017244183422e-11	-0.443784120140216	0.375	0.706	2.20231643076579e-07	NOP53	NK cells	GSE161801_PI_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17610
1.61753355478019e-11	-0.345818528037308	0.988	0.988	2.96817407302165e-07	RPS9	NK cells	GSE161801_PI_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17611
1.84850607285292e-11	-0.327711852418034	0.997	1	3.39200864368511e-07	RPS23	NK cells	GSE161801_PI_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17612
2.15405170135946e-11	-0.343160912312462	0.162	0.431	3.95268487199462e-07	JUND	NK cells	GSE161801_PI_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17613
2.37444544377942e-11	-0.341250192288983	0.076	0.282	4.35710738933523e-07	PBXIP1	NK cells	GSE161801_PI_pre	ENSG00000163346	57326	PBX homeobox interacting protein 1	HPIP	protein_coding	Q96AQ6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17614
2.38792028953753e-11	-0.450661409009565	0.354	0.641	4.38183373130137e-07	ARL4C	NK cells	GSE161801_PI_pre	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17615
2.48551351961725e-11	-0.472618356668322	0.649	0.867	4.56091730849766e-07	ZFP36L2	NK cells	GSE161801_PI_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17616
2.75102602697237e-11	-0.365194699237617	0.299	0.605	5.0481327594943e-07	HSP90AB1	NK cells	GSE161801_PI_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17617
2.8325785653718e-11	-0.469470128034141	0.686	0.867	5.19778166745725e-07	MT-ND1	NK cells	GSE161801_PI_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17618
2.86120122923147e-11	-0.309469185031879	0.991	0.996	5.25030425563975e-07	RPS26	NK cells	GSE161801_PI_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17619
4.71333709624546e-11	0.454555132610516	0.866	0.77	8.64897357161042e-07	ARHGDIB	NK cells	GSE161801_PI_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17620
5.19292178942191e-11	-0.304951990170214	0.091	0.306	9.52901148358921e-07	CMTM6	NK cells	GSE161801_PI_pre	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17621
8.29390215074416e-11	-0.455782542828195	0.726	0.903	1.52193104466155e-06	TYROBP	NK cells	GSE161801_PI_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17622
8.38305569946377e-11	-0.324745859534842	0.146	0.391	1.5382907208516e-06	NDUFS8	NK cells	GSE161801_PI_pre	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17623
8.51131118079298e-11	-0.588975786498486	0.524	0.786	1.56182560167551e-06	ZFP36	NK cells	GSE161801_PI_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17624
9.58751201543289e-11	-0.331119877583497	0.21	0.476	1.75930845483194e-06	RUNX3	NK cells	GSE161801_PI_pre	ENSG00000020633	864	RUNX family transcription factor 3	AML2|CBFA3|PEBP2A3	protein_coding	Q13761	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17625
1.07096396832103e-10	-0.349992468632483	0.076	0.274	1.96521888186908e-06	TMEM173	NK cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17626
1.30311286727696e-10	-0.371455609764921	0.311	0.601	2.39121211145323e-06	HLA-F	NK cells	GSE161801_PI_pre	ENSG00000234487	3134	major histocompatibility complex, class I, F	NA	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17627
1.31028434905497e-10	-0.316896854982959	0.988	0.996	2.40437178051586e-06	RPL29	NK cells	GSE161801_PI_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17628
1.43564756248684e-10	-0.297987063670833	1	1	2.63441327716336e-06	RPL26	NK cells	GSE161801_PI_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17629
2.69948007929615e-10	-0.278549238494928	0.076	0.274	4.95354594550843e-06	CD320	NK cells	GSE161801_PI_pre	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17630
3.2140181011542e-10	-0.322303891708461	0.204	0.46	5.89772321561795e-06	FMNL1	NK cells	GSE161801_PI_pre	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17631
3.25468400710541e-10	-0.257970196730314	1	1	5.97234515303843e-06	RPS27A	NK cells	GSE161801_PI_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17632
3.74252769822232e-10	-0.336414535259342	0.152	0.383	6.86753832623795e-06	SH2D1A	NK cells	GSE161801_PI_pre	ENSG00000183918	4068	SH2 domain containing 1A	DSHP|EBVS|IMD5|LYP|MTCP1|SAP|XLP|XLPD	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17633
4.25223131435637e-10	-0.260951562322004	1	1	7.80284446184393e-06	RPL18A	NK cells	GSE161801_PI_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17634
5.54815969667695e-10	-0.42139986970097	0.521	0.806	1.01808730434022e-05	FCER1G	NK cells	GSE161801_PI_pre	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17635
5.76705381489814e-10	-0.290786550847512	0.168	0.419	1.05825437503381e-05	SMDT1	NK cells	GSE161801_PI_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17636
6.24899950610995e-10	0.369770926217303	0.976	0.907	1.14669140937118e-05	CYBA	NK cells	GSE161801_PI_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17637
7.37485309024071e-10	-0.256656632646086	0.07	0.258	1.35328554205917e-05	NFKBIZ	NK cells	GSE161801_PI_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17638
7.423427506689e-10	-0.323628501760474	0.107	0.31	1.36219894747743e-05	RPL22L1	NK cells	GSE161801_PI_pre	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17639
7.66004184052557e-10	0.35754264201105	0.287	0.081	1.40561767773644e-05	ADGRG1	NK cells	GSE161801_PI_pre	ENSG00000205336	9289	adhesion G protein-coupled receptor G1	GPR56|TM7LN4|TM7XN1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17640
8.14552169444997e-10	-0.303020964973969	0.131	0.355	1.49470323093157e-05	ATF4	NK cells	GSE161801_PI_pre	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17641
9.05392836660042e-10	-0.270430481544697	0.155	0.399	1.66139585527118e-05	DNAJA1	NK cells	GSE161801_PI_pre	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17642
1.07713525233156e-09	-0.332621182693975	0.171	0.407	1.97654318802841e-05	TMEM123	NK cells	GSE161801_PI_pre	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17643
1.66654475808305e-09	-0.277471253748107	0.098	0.298	3.05810963108239e-05	CNN2	NK cells	GSE161801_PI_pre	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17644
2.63658143631063e-09	-0.291570629012578	0.994	1	4.83812693563001e-05	RPL12	NK cells	GSE161801_PI_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17645
3.03095193499456e-09	-0.342298409040353	0.899	0.964	5.56179680071502e-05	RPL5	NK cells	GSE161801_PI_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17646
4.25975052596581e-09	-0.287031576263977	0.183	0.423	7.81664221514726e-05	BTG2	NK cells	GSE161801_PI_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17647
4.4056274788772e-09	-0.304366599599841	0.107	0.302	8.08432642373966e-05	AC245014.3	NK cells	GSE161801_PI_pre	NA	NA	NA	NA	NA	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17648
1.45449750439944e-08	-0.355721122592324	0.875	0.944	0.000266900292057298	RPL23	NK cells	GSE161801_PI_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17649
1.62200199417821e-08	-0.295102803579185	0.18	0.403	0.000297637365931702	ACAP1	NK cells	GSE161801_PI_pre	ENSG00000288169	9744	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	CENTB1|KIAA0050	protein_coding	Q15027	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17650
2.2028431517311e-08	-0.293999381372065	0.927	0.98	0.000404221718342657	RPL7A	NK cells	GSE161801_PI_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17651
2.60346861105853e-08	-0.301383721129931	0.101	0.286	0.000477736490129241	LTB	NK cells	GSE161801_PI_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17652
3.49680513354856e-08	-0.381950330627937	0.5	0.754	0.000641663742006161	EEF1B2	NK cells	GSE161801_PI_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17653
4.32246501905672e-08	0.310526286821957	0.985	0.944	0.000793172330996908	FTL	NK cells	GSE161801_PI_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17654
4.87825585905122e-08	-0.371262064521355	0.299	0.524	0.000895159950135899	TNFAIP3	NK cells	GSE161801_PI_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17655
5.44304943394322e-08	0.366875201806856	0.851	0.871	0.000998799571128581	CST7	NK cells	GSE161801_PI_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17656
5.64030316555939e-08	-0.320214458930963	0.671	0.919	0.00103499563088015	COX4I1	NK cells	GSE161801_PI_pre	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17657
6.21219393660837e-08	-0.261999844985667	0.104	0.278	0.00113993758736764	PIM3	NK cells	GSE161801_PI_pre	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17658
6.57419581728722e-08	-0.296440490314696	1	1	0.00120636493247221	RPL7	NK cells	GSE161801_PI_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17659
7.16556118608898e-08	-0.303597913830361	0.268	0.496	0.00131488047764733	ICAM3	NK cells	GSE161801_PI_pre	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17660
7.99859488999042e-08	-0.460169764858309	0.506	0.702	0.00146774216231324	CD69	NK cells	GSE161801_PI_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17661
8.49720964202626e-08	0.450988319089625	0.771	0.734	0.00155923796931182	CALM1	NK cells	GSE161801_PI_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17662
9.5575928033982e-08	-0.279572474433617	0.253	0.488	0.00175381827942357	NDUFS5	NK cells	GSE161801_PI_pre	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17663
9.61860661339846e-08	-0.257849147811737	1	1	0.00176501431355862	RPL15	NK cells	GSE161801_PI_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17664
1.09759712145745e-07	-0.269546654039015	0.21	0.431	0.00201409071787441	EIF3L	NK cells	GSE161801_PI_pre	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17665
1.11156585523018e-07	-0.32279021292754	0.436	0.694	0.00203972334434737	FXYD5	NK cells	GSE161801_PI_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17666
1.40758227791904e-07	-0.48528253158183	0.427	0.633	0.00258291347998144	TAGLN2	NK cells	GSE161801_PI_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17667
1.45108631834156e-07	0.275346936637734	1	0.996	0.00266274339415677	HLA-C	NK cells	GSE161801_PI_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17668
2.47941554020773e-07	-0.257584554497673	0.143	0.323	0.00454972751628118	TXK	NK cells	GSE161801_PI_pre	ENSG00000074966	7294	TXK tyrosine kinase	BTKL|PSCTK5|PTK4|RLK|TKL	protein_coding	P42681	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17669
2.69799492684605e-07	0.463251305911962	0.436	0.246	0.0049508206907625	SPON2	NK cells	GSE161801_PI_pre	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17670
2.86026254548618e-07	-0.336768847383712	0.674	0.867	0.00524858177096714	ID2	NK cells	GSE161801_PI_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17671
2.94733496479147e-07	-0.290084995274873	0.314	0.54	0.00540835966039235	WDR83OS	NK cells	GSE161801_PI_pre	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17672
3.5460351220457e-07	0.329312964395485	1	1	0.00650697444895386	ACTB	NK cells	GSE161801_PI_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17673
4.18339456199412e-07	-0.285457440765866	0.305	0.544	0.0076765290212592	XBP1	NK cells	GSE161801_PI_pre	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17674
4.8134618840505e-07	-0.362504456699789	0.576	0.778	0.00883270255723267	CIRBP	NK cells	GSE161801_PI_pre	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17675
9.2584867072467e-07	-0.520954085675291	0.689	0.831	0.0169893231077977	KLRB1	NK cells	GSE161801_PI_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17676
1.06211852570859e-06	-0.317735268677925	0.835	0.887	0.0194898749467526	RPLP0	NK cells	GSE161801_PI_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17677
1.19569385390654e-06	-0.269127302514135	0.296	0.508	0.0219409822191851	DAZAP2	NK cells	GSE161801_PI_pre	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17678
1.32135164160488e-06	0.408404406946397	0.399	0.234	0.0242468026234496	ZEB2	NK cells	GSE161801_PI_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17679
1.4721441335661e-06	-0.271778436080427	0.213	0.395	0.027013844850938	POLR2K	NK cells	GSE161801_PI_pre	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17680
1.99860757491896e-06	0.450039975368175	0.427	0.278	0.036674448999763	DDX6	NK cells	GSE161801_PI_pre	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17681
2.04902342336515e-06	-0.321886205395602	0.744	0.895	0.0375995798187505	IFITM2	NK cells	GSE161801_PI_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17682
2.32736326652647e-06	0.286449172347446	0.997	1	0.0427071159407608	PFN1	NK cells	GSE161801_PI_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE161801_PI	GSE161801	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pre	carfilzomib + dexamethasone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 2, sensitive 1); post (resistant 2, sensitive 1)	6	27674	Public on Aug 18, 2021	34845188	This dataset has 3 patients with both pre -and post-treatment samples.	EGAD00001006903	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	17683
0	0.743673441568479	1	1	0	RPL22	Malignant cells	GSE163836	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17684
0	-0.960951101129703	1	1	0	YBX1	Malignant cells	GSE163836	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17685
0	-1.56981175939516	0.886	0.992	0	EBNA1BP2	Malignant cells	GSE163836	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17686
0	0.789354263332879	1	1	0	RPS8	Malignant cells	GSE163836	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17687
0	-0.812491923746403	0.86	0.986	0	ENSA	Malignant cells	GSE163836	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17688
0	-0.87624548111427	0.85	0.981	0	PSMD4	Malignant cells	GSE163836	ENSG00000159352	5710	proteasome 26S subunit ubiquitin receptor, non-ATPase 4	AF|AF-1|Rpn10|S5A	protein_coding	P55036	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17689
0	-0.89069958243633	0.991	1	0	JTB	Malignant cells	GSE163836	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17690
0	-0.84089924423026	0.73	0.966	0	PMVK	Malignant cells	GSE163836	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17691
0	-0.79967604015903	0.861	0.987	0	APOA1BP	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17692
0	-0.855128674166842	0.448	0.864	0	MRPL24	Malignant cells	GSE163836	ENSG00000143314	79590	mitochondrial ribosomal protein L24	MRP-L18	protein_coding	Q96A35	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17693
0	-0.857848273587081	0.606	0.918	0	SDHC	Malignant cells	GSE163836	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17694
0	-0.840609091720851	0.397	0.855	0	MRPS14	Malignant cells	GSE163836	ENSG00000120333	63931	mitochondrial ribosomal protein S14	HSMRPS14	protein_coding	O60783	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17695
0	1.63723177371374	0.874	0.307	0	ATF3	Malignant cells	GSE163836	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17696
0	-0.999960544565665	0.992	0.998	0	GUK1	Malignant cells	GSE163836	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17697
0	0.830440759608687	0.994	0.915	0	TOMM20	Malignant cells	GSE163836	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17698
0	-0.900308677850011	0.556	0.895	0	ITGB1BP1	Malignant cells	GSE163836	ENSG00000119185	9270	integrin subunit beta 1 binding protein 1	ICAP-1A|ICAP-1alpha|ICAP-1B|ICAP1|ICAP1A|ICAP1B	protein_coding	O14713	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17699
0	-0.871672608080154	0.946	0.996	0	YWHAQ	Malignant cells	GSE163836	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17700
0	-0.746923889197849	0.987	0.999	0	SF3B14	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17701
0	-1.49647897328466	1	1	0	RPL31	Malignant cells	GSE163836	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17702
0	1.74154474670442	0.936	0.261	0	NBEAL1	Malignant cells	GSE163836	ENSG00000144426	65065	neurobeachin like 1	ALS2CR16|ALS2CR17|MGC164581	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17703
0	0.479084158131361	1	1	0	RPL37A	Malignant cells	GSE163836	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17704
0	1.111632078693	0.647	0.047	0	MTRNR2L12	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17705
0	-0.775617711388244	0.273	0.721	0	PPA2	Malignant cells	GSE163836	ENSG00000138777	27068	inorganic pyrophosphatase 2	FLJ20459	protein_coding	Q9H2U2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17706
0	0.930552570223888	0.956	0.698	0	SORBS2	Malignant cells	GSE163836	ENSG00000154556	8470	sorbin and SH3 domain containing 2	ARGBP2|KIAA0777	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17707
0	1.06373826241801	1	1	0	RPL37	Malignant cells	GSE163836	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17708
0	-0.962152470952462	0.715	0.975	0	HNRNPA0	Malignant cells	GSE163836	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17709
0	-0.848051374481264	0.983	0.998	0	NHP2	Malignant cells	GSE163836	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17710
0	2.45185427296729	0.996	0.59	0	IER3	Malignant cells	GSE163836	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17711
0	-0.88075438820227	0.902	0.987	0	CLIC1	Malignant cells	GSE163836	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17712
0	-0.627889688809524	1	1	0	RPS18	Malignant cells	GSE163836	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17713
0	-0.624206374470759	1	1	0	RPL10A	Malignant cells	GSE163836	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17714
0	0.539484793143184	1	1	0	EEF1A1	Malignant cells	GSE163836	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17715
0	1.00175003263819	0.918	0.652	0	MARCKS	Malignant cells	GSE163836	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17716
0	0.613981172805652	1	1	0	RPS12	Malignant cells	GSE163836	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17717
0	-0.569115070636534	1	1	0	RAC1	Malignant cells	GSE163836	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17718
0	-0.931847062326837	0.939	0.99	0	CYCS	Malignant cells	GSE163836	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17719
0	-0.747548448753184	1	1	0	CHCHD2	Malignant cells	GSE163836	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17720
0	-0.810823250089965	0.695	0.96	0	GNB2	Malignant cells	GSE163836	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17721
0	-0.76524463240462	0.37	0.798	0	CHCHD3	Malignant cells	GSE163836	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17722
0	-1.42207481728035	0.995	0.999	0	TMSB4X	Malignant cells	GSE163836	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17723
0	-1.30803903490114	0.599	0.947	0	HSD17B10	Malignant cells	GSE163836	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17724
0	-1.1442426684692	0.983	1	0	SLC25A5	Malignant cells	GSE163836	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17725
0	-0.992711458708675	0.579	0.913	0	HMGB3	Malignant cells	GSE163836	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17726
0	-0.989090215332715	0.895	0.99	0	LAGE3	Malignant cells	GSE163836	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17727
0	-1.47660291179926	1	1	0	RPS20	Malignant cells	GSE163836	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17728
0	-1.12108661648053	1	1	0	RPL7	Malignant cells	GSE163836	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17729
0	0.56409597968841	1	1	0	RPL30	Malignant cells	GSE163836	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17730
0	-0.79402646664464	1	1	0	PABPC1	Malignant cells	GSE163836	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17731
0	0.902339543487846	0.999	0.974	0	YWHAZ	Malignant cells	GSE163836	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17732
0	-1.12039049957669	0.996	1	0	NDUFB9	Malignant cells	GSE163836	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17733
0	-0.938231520248448	0.999	1	0	LY6E	Malignant cells	GSE163836	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17734
0	-0.460569919349945	1	1	0	EEF1D	Malignant cells	GSE163836	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17735
0	-1.19237846335067	0.981	0.999	0	CYC1	Malignant cells	GSE163836	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17736
0	-0.319407125243291	1	1	0	RPL8	Malignant cells	GSE163836	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17737
0	-0.825422329456919	0.999	0.999	0	TXN	Malignant cells	GSE163836	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17738
0	-0.876079150958612	0.581	0.928	0	NDUFA8	Malignant cells	GSE163836	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17739
0	-0.926119161753007	0.842	0.986	0	PSMB7	Malignant cells	GSE163836	ENSG00000136930	5695	proteasome 20S subunit beta 7	Z	protein_coding	Q99436	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17740
0	0.570276310552523	1	1	0	RPL12	Malignant cells	GSE163836	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17741
0	-1.02729317464645	0.47	0.903	0	AK1	Malignant cells	GSE163836	ENSG00000106992	203	adenylate kinase 1	NA	protein_coding	P00568	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17742
0	-0.858894399204906	0.66	0.928	0	ZDHHC12	Malignant cells	GSE163836	ENSG00000160446	84885	zinc finger DHHC-type palmitoyltransferase 12	FLJ14524|ZNF400	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17743
0	0.418050926601944	1	1	0	RPL7A	Malignant cells	GSE163836	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17744
0	1.33793862935268	0.813	0.257	0	NRARP	Malignant cells	GSE163836	ENSG00000198435	441478	NOTCH regulated ankyrin repeat protein	MGC61598	protein_coding	Q7Z6K4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17745
0	0.56043734937976	1	1	0	RPS24	Malignant cells	GSE163836	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17746
0	-0.859483400010704	0.555	0.903	0	NPM3	Malignant cells	GSE163836	ENSG00000107833	10360	nucleophosmin/nucleoplasmin 3	NA	protein_coding	O75607	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17747
0	-1.48927591341751	1	1	0	RPL27A	Malignant cells	GSE163836	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17748
0	1.56321175405194	0.928	0.387	0	SAA1	Malignant cells	GSE163836	ENSG00000288411	6288	serum amyloid A1	PIG4|SAA|TP53I4	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17749
0	-1.07813967024501	0.73	0.974	0	C11orf48	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17750
0	-0.770747617542908	0.926	0.994	0	TRMT112	Malignant cells	GSE163836	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17751
0	1.17692546034457	0.996	0.885	0	NEAT1	Malignant cells	GSE163836	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17752
0	-0.896342507955449	0.889	0.992	0	PPP1CA	Malignant cells	GSE163836	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17753
0	-1.52211506968008	0.953	0.995	0	GAL	Malignant cells	GSE163836	ENSG00000069482	51083	galanin and GMAP prepropeptide	GAL-GMAP|GALN|GLNN|GMAP	protein_coding	P22466	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17754
0	-0.812427597304273	0.804	0.979	0	LAMTOR1	Malignant cells	GSE163836	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17755
0	-0.903505087234667	0.996	0.999	0	TPI1	Malignant cells	GSE163836	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17756
0	2.95278918932904	0.986	0.511	0	MGP	Malignant cells	GSE163836	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17757
0	-0.795950010150849	0.981	0.999	0	HNRNPA1	Malignant cells	GSE163836	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17758
0	-0.863118637757096	0.639	0.93	0	CDK4	Malignant cells	GSE163836	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17759
0	-0.410886611147395	1	0.999	0	RPLP0	Malignant cells	GSE163836	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17760
0	-0.785370429510756	0.786	0.966	0	SRSF9	Malignant cells	GSE163836	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17761
0	-0.978654680230553	0.485	0.912	0	TMED2	Malignant cells	GSE163836	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17762
0	-0.615790395359353	1	0.999	0	RPL21	Malignant cells	GSE163836	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17763
0	-0.622425982975543	1	0.998	0	GTF3A	Malignant cells	GSE163836	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17764
0	1.31243707075652	1	0.989	0	TPT1	Malignant cells	GSE163836	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17765
0	1.10867517288957	0.931	0.69	0	FOS	Malignant cells	GSE163836	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17766
0	-0.752523357822823	0.288	0.751	0	OAZ2	Malignant cells	GSE163836	ENSG00000180304	4947	ornithine decarboxylase antizyme 2	NA	protein_coding	O95190	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17767
0	-0.789846991982269	0.979	0.995	0	PKM	Malignant cells	GSE163836	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17768
0	-0.88973399322147	0.671	0.924	0	IDH2	Malignant cells	GSE163836	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17769
0	-0.691289316409113	1	1	0	RPS2	Malignant cells	GSE163836	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17770
0	-0.876938475549534	0.245	0.741	0	THOC6	Malignant cells	GSE163836	ENSG00000131652	79228	THO complex subunit 6	fSAP35|MGC2655|WDR58	protein_coding	Q86W42	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17771
0	-0.838331114707792	0.998	1	0	ALDOA	Malignant cells	GSE163836	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17772
0	-1.09565458684828	0.463	0.926	0	NUTF2	Malignant cells	GSE163836	ENSG00000102898	10204	nuclear transport factor 2	NTF2|PP15	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17773
0	-1.05406729502575	0.786	0.97	0	PSMB6	Malignant cells	GSE163836	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17774
0	-1.91923819074612	0.997	0.999	0	PFN1	Malignant cells	GSE163836	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17775
0	-0.96132231732613	0.502	0.902	0	CENPV	Malignant cells	GSE163836	ENSG00000166582	201161	centromere protein V	CENP-V|p30|PRR6	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17776
0	-1.00704651999558	0.991	0.999	0	UBB	Malignant cells	GSE163836	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17777
0	-0.719251663048412	0.241	0.692	0	ALKBH5	Malignant cells	GSE163836	ENSG00000091542	54890	alkB homolog 5, RNA demethylase	FLJ20308|OFOXD1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17778
0	-0.794807408396794	0.363	0.8	0	TMEM11	Malignant cells	GSE163836	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17779
0	-0.650996670450222	1	1	0	RPL23A	Malignant cells	GSE163836	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17780
0	-1.13315485768933	0.394	0.86	0	KRT14	Malignant cells	GSE163836	ENSG00000186847	3861	keratin 14	EBS3|EBS4	protein_coding	P02533	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17781
0	-1.61379521547638	0.889	0.978	0	KRT16	Malignant cells	GSE163836	ENSG00000186832	3868	keratin 16	NEPPK	protein_coding	P08779	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17782
0	-0.398254879068495	1	1	0	RPL27	Malignant cells	GSE163836	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17783
0	0.954764413231535	1	0.982	0	ACTG1	Malignant cells	GSE163836	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17784
0	-0.85939143907721	0.769	0.976	0	FKBP1A	Malignant cells	GSE163836	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17785
0	-0.699963581681765	0.97	0.996	0	SNRPB	Malignant cells	GSE163836	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17786
0	-1.02780786846601	0.61	0.94	0	C20orf27	Malignant cells	GSE163836	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17787
0	-1.2225808956031	0.253	0.88	0	CHMP4B	Malignant cells	GSE163836	ENSG00000101421	128866	charged multivesicular body protein 4B	C20orf178|dJ553F4.4|Shax1|SNF7-2|VPS32B	protein_coding	Q9H444	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17788
0	-0.837709078180519	0.667	0.946	0	RALY	Malignant cells	GSE163836	ENSG00000125970	22913	RALY heterogeneous nuclear ribonucleoprotein	HNRPCL2|P542	protein_coding	Q9UKM9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17789
0	1.5823693745383	1	0.848	0	GNAS	Malignant cells	GSE163836	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17790
0	-0.956165110266387	1	1	0	PSMA7	Malignant cells	GSE163836	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17791
0	-0.790302997284295	0.843	0.98	0	ADRM1	Malignant cells	GSE163836	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17792
0	0.759093336181702	1	1	0	RPS21	Malignant cells	GSE163836	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17793
0	-0.864195065255748	0.034	0.448	0	EEF1A2	Malignant cells	GSE163836	ENSG00000101210	1917	eukaryotic translation elongation factor 1 alpha 2	EEF1AL|HS1|STN|STNL	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17794
0	-0.903542714467581	0.997	0.998	0	PPDPF	Malignant cells	GSE163836	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17795
0	-0.941591660773683	0.999	1	0	OAZ1	Malignant cells	GSE163836	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17796
0	0.63246522953637	1	1	0	RPS28	Malignant cells	GSE163836	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17797
0	-0.691545308793115	0.998	1	0	PRDX2	Malignant cells	GSE163836	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17798
0	-1.06812146713223	0.992	0.999	0	RAD23A	Malignant cells	GSE163836	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17799
0	-0.856745809708625	0.998	1	0	GADD45GIP1	Malignant cells	GSE163836	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17800
0	-0.827242356933274	0.895	0.99	0	GIPC1	Malignant cells	GSE163836	ENSG00000123159	10755	GIPC PDZ domain containing family member 1	C19orf3|GIPC|GLUT1CBP|Hs.6454|NIP|RGS19IP1|SEMCAP|SYNECTIN|TIP-2	protein_coding	O14908	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17801
0	-0.529527082366061	1	0.999	0	NDUFB7	Malignant cells	GSE163836	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17802
0	2.0955626200938	0.992	0.475	0	JUND	Malignant cells	GSE163836	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17803
0	-1.10113984966646	0.043	0.554	0	SBSN	Malignant cells	GSE163836	ENSG00000189001	374897	suprabasin	HLAR698|UNQ698	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17804
0	-1.04750977129619	0.955	0.996	0	TMEM147	Malignant cells	GSE163836	ENSG00000105677	10430	transmembrane protein 147	MGC1936|NIFIE14	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17805
0	-0.440329032858676	1	1	0	RPS19	Malignant cells	GSE163836	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17806
0	-1.14555051889129	0.168	0.614	0	IGSF23	Malignant cells	GSE163836	ENSG00000216588	147710	immunoglobulin superfamily member 23	NA	protein_coding	A1L1A6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17807
0	-0.978273917427015	0.692	0.957	0	TOMM40	Malignant cells	GSE163836	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17808
0	-1.50066988637071	1	1	0	RPL13A	Malignant cells	GSE163836	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17809
0	-1.12443722685695	0.676	0.933	0	KLK5	Malignant cells	GSE163836	ENSG00000167754	25818	kallikrein related peptidase 5	KLK-L2|SCTE	protein_coding	Q9Y337	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17810
0	1.90057694093482	0.914	0.14	0	TMEM238	Malignant cells	GSE163836	ENSG00000233493	388564	transmembrane protein 238	NA	protein_coding	C9JI98	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17811
0	0.500047630023344	1	1	0	RPL28	Malignant cells	GSE163836	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17812
0	-0.833951618534715	0.944	0.988	0	RANBP1	Malignant cells	GSE163836	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17813
0	-0.914707341767695	0.985	0.998	0	POLR2F	Malignant cells	GSE163836	ENSG00000100142	5435	RNA polymerase II, I and III subunit F	HRBP14.4|RPB6	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17814
0	-0.463906867921902	1	1	0	RPL3	Malignant cells	GSE163836	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17815
0	-0.751099419936208	0.981	0.997	0	SOD1	Malignant cells	GSE163836	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17816
0	1.27250175343379	1	0.995	0	MT-ND1	Malignant cells	GSE163836	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17817
0	0.800260206281408	1	0.997	0	MT-CO1	Malignant cells	GSE163836	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17818
0	1.82034600527216	1	0.996	0	MT-CO2	Malignant cells	GSE163836	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17819
0	2.88793260349272	1	0.995	0	MT-ATP6	Malignant cells	GSE163836	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17820
0	1.82291369052228	1	0.996	0	MT-CO3	Malignant cells	GSE163836	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17821
0	3.78901643969351	1	0.982	0	MT-ND3	Malignant cells	GSE163836	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17822
0	1.34222146077479	0.978	0.698	0	MT-ND4L	Malignant cells	GSE163836	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17823
0	1.7393744655714	1	0.996	0	MT-ND4	Malignant cells	GSE163836	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17824
0	1.06871795413253	1	0.987	0	MT-ND5	Malignant cells	GSE163836	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17825
0	1.90183249440851	1	0.995	0	MT-CYB	Malignant cells	GSE163836	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17826
1.11361790832963e-306	-0.696670592049651	0.896	0.986	1.90506615577949e-302	AP2M1	Malignant cells	GSE163836	ENSG00000161203	1173	adaptor related protein complex 2 subunit mu 1	AP50|CLAPM1|mu2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17827
1.43283631652043e-306	0.372923247424894	1	1	2.45115308667151e-302	RPL36	Malignant cells	GSE163836	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17828
1.93709802148179e-306	-0.699998653811654	0.923	0.991	3.3137935853489e-302	ERH	Malignant cells	GSE163836	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17829
4.74886010595434e-305	0.407070067375286	1	0.999	8.1238749832561e-301	RPS15A	Malignant cells	GSE163836	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17830
3.70997439281826e-304	-0.380619965891008	1	1	6.3466531937942e-300	RPS3	Malignant cells	GSE163836	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17831
7.10596254911795e-303	-0.441191622017296	1	1	1.21561701327761e-298	RPS6	Malignant cells	GSE163836	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17832
1.86414936765195e-302	-0.341067128035784	1	1	3.18900032324218e-298	RPS16	Malignant cells	GSE163836	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17833
3.09867723749234e-301	-0.779415147448333	0.6	0.922	5.30090715017814e-297	PPP4C	Malignant cells	GSE163836	ENSG00000149923	5531	protein phosphatase 4 catalytic subunit	PP4|PPX	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17834
1.05956704729477e-300	-0.344469272959055	1	1	1.81260134780716e-296	RPL13	Malignant cells	GSE163836	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17835
1.38814709067247e-300	-0.642996219899065	0.956	0.987	2.37470322801339e-296	BRK1	Malignant cells	GSE163836	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17836
1.96303484870396e-297	-0.907912997634063	0.688	0.933	3.35816371567786e-293	TMEM123	Malignant cells	GSE163836	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17837
2.08370557614037e-295	-0.85035291558009	0.57	0.91	3.56459512910334e-291	TMED9	Malignant cells	GSE163836	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17838
2.32044697770657e-294	-0.323784455447209	1	1	3.96958864476262e-290	RPS14	Malignant cells	GSE163836	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17839
3.23414011765328e-294	-0.721491632125007	0.937	0.99	5.53264349926946e-290	LSM4	Malignant cells	GSE163836	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17840
1.35617925940147e-293	-0.458670639075084	1	1	2.3200158590581e-289	NDUFA4	Malignant cells	GSE163836	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17841
2.59645339424155e-293	-0.748002712075205	0.375	0.794	4.44175282152903e-289	FLYWCH2	Malignant cells	GSE163836	ENSG00000162076	114984	FLYWCH family member 2	NA	protein_coding	Q96CP2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17842
3.24198506704402e-293	-0.718925747658059	0.941	0.995	5.5460638541922e-289	ARF1	Malignant cells	GSE163836	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17843
1.1348104572573e-292	-0.657958606744141	0.993	0.997	1.94132024923007e-288	PRELID1	Malignant cells	GSE163836	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17844
1.61422248893706e-291	-0.749771729890609	0.847	0.975	2.76145041182462e-287	DRAP1	Malignant cells	GSE163836	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17845
6.5673921847679e-290	-0.715730986892177	0.87	0.985	1.12348378104824e-285	TBCB	Malignant cells	GSE163836	ENSG00000105254	1155	tubulin folding cofactor B	CG22|CKAP1|CKAPI	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17846
1.17848559402829e-289	-1.07285579613842	0.997	0.999	2.01603530570419e-285	MALAT1	Malignant cells	GSE163836	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17847
1.18015156628318e-288	-0.698891472355604	0.874	0.986	2.01888528444064e-284	TSTA3	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17848
3.03549715530439e-286	-0.761435906820725	0.433	0.827	5.19282498357922e-282	GLRX3	Malignant cells	GSE163836	ENSG00000108010	10539	glutaredoxin 3	bA500G10.4|GLRX4|GRX3|GRX4|PICOT|TXNL2	protein_coding	O76003	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17849
9.79518054201776e-286	0.979947258926842	0.529	0.057	1.67566153532298e-281	CXCL2	Malignant cells	GSE163836	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17850
7.44662238540777e-285	-0.66393569523953	0.192	0.606	1.27389369147171e-280	HMCES	Malignant cells	GSE163836	ENSG00000183624	56941	5-hydroxymethylcytosine binding, ES cell specific	C3orf37|DC12|SRAPD1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17851
1.36241471795059e-284	-1.23787412756527	0.654	0.909	2.33068285799808e-280	H1F0	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17852
1.67679035961966e-283	0.391245525038109	1	1	2.86848526820135e-279	RPL34	Malignant cells	GSE163836	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17853
1.85138238034064e-281	-0.65632753671235	0.975	0.996	3.16715983804874e-277	MRPL51	Malignant cells	GSE163836	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17854
4.70595332840402e-281	-0.735116449942417	0.556	0.898	8.05047435890075e-277	TRAPPC1	Malignant cells	GSE163836	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17855
3.39925471590409e-278	-0.771765820525813	0.52	0.889	5.81510504249714e-274	ETFB	Malignant cells	GSE163836	ENSG00000105379	2109	electron transfer flavoprotein subunit beta	NA	protein_coding	P38117	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17856
3.70221975785829e-278	-0.755815382281624	0.563	0.89	6.33338733976817e-274	POLR2E	Malignant cells	GSE163836	ENSG00000099817	5434	RNA polymerase II, I and III subunit E	hRPB25|hsRPB5|RPABC1|RPB5|XAP4	protein_coding	P19388	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17857
7.00753881675802e-277	1.20844657483829	0.894	0.49	1.19877966538279e-272	LTF	Malignant cells	GSE163836	ENSG00000012223	4057	lactotransferrin	HLF2	protein_coding	P02788	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17858
9.81154190429066e-276	-0.758654127252454	0.492	0.855	1.678460473567e-271	UFD1L	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17859
1.10756219078362e-275	-0.396792533636201	1	1	1.89470663977355e-271	GSTP1	Malignant cells	GSE163836	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17860
1.81498692976606e-274	0.806657921100895	0.982	0.858	3.1048981407508e-270	CYP1B1	Malignant cells	GSE163836	ENSG00000138061	1545	cytochrome P450 family 1 subfamily B member 1	CP1B|GLC3A	protein_coding	Q16678	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17861
4.73132442958141e-274	-0.72945287664294	0.851	0.975	8.09387670168492e-270	C1QBP	Malignant cells	GSE163836	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17862
2.66042223048416e-273	1.17469876319246	0.71	0.291	4.55118430968925e-269	IGFBP3	Malignant cells	GSE163836	ENSG00000146674	3486	insulin like growth factor binding protein 3	BP-53|IBP3	protein_coding	P17936	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17863
3.17646827242048e-272	-0.693316045048573	0.98	0.995	5.43398427362972e-268	SLC25A6	Malignant cells	GSE163836	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17864
1.06601076770183e-271	-0.67167816816951	0.299	0.718	1.82362462030752e-267	SLC25A11	Malignant cells	GSE163836	ENSG00000108528	8402	solute carrier family 25 member 11	OGC|SLC20A4	protein_coding	Q02978	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17865
1.17860871535674e-271	-0.59009404863203	0.996	0.999	2.01624592936077e-267	MYL6	Malignant cells	GSE163836	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17866
2.56094786025149e-271	-0.735470290271464	0.846	0.967	4.38101350453223e-267	CLDN7	Malignant cells	GSE163836	ENSG00000288292	1366	claudin 7	CEPTRL2|CPETRL2|Hs.84359	protein_coding	O95471	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17867
4.38816601187803e-270	-0.742634538001556	0.434	0.832	7.50683559651974e-266	ACADVL	Malignant cells	GSE163836	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17868
6.72311096209011e-270	0.665474448803171	0.997	0.95	1.15012259228476e-265	ZFAS1	Malignant cells	GSE163836	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17869
2.59299442957872e-269	-0.73871399689534	0.728	0.952	4.43583557068031e-265	ADI1	Malignant cells	GSE163836	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17870
7.60034866961388e-269	-0.578526030191423	0.146	0.535	1.30019164691085e-264	TAX1BP3	Malignant cells	GSE163836	ENSG00000213977	30851	Tax1 binding protein 3	TIP-1	protein_coding	O14907	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17871
8.33695500551823e-269	-0.656846833714752	0.991	0.996	1.426202892794e-264	CDKN2A	Malignant cells	GSE163836	ENSG00000147889	1029	cyclin dependent kinase inhibitor 2A	ARF|CDK4I|CDKN2|CMM2|INK4|INK4a|MLM|MTS1|p14|p14ARF|p16|P16-INK4A|p16INK4a|p19|p19Arf	protein_coding	P42771	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17872
3.96744768374542e-268	-0.68880718489114	0.8	0.963	6.78711275258329e-264	MPC2	Malignant cells	GSE163836	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17873
7.00317164944663e-268	-0.572559215355219	0.152	0.541	1.19803257407084e-263	SLC35B2	Malignant cells	GSE163836	ENSG00000157593	347734	solute carrier family 35 member B2	UGTrel4	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17874
4.85041619973266e-265	-0.757222527062428	0.487	0.858	8.29760699288266e-261	WBSCR22	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17875
1.10944436608919e-264	-0.554063811072862	0.996	0.999	1.89792647706877e-260	HMGN1	Malignant cells	GSE163836	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17876
3.76535206858781e-264	-0.88229762415389	0.967	0.991	6.44138778373316e-260	LDHA	Malignant cells	GSE163836	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17877
5.10981721937671e-264	-0.694902641757385	0.999	0.999	8.74136431718774e-260	SH3BGRL3	Malignant cells	GSE163836	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17878
1.10135431245645e-263	-0.755685868336418	0.597	0.896	1.88408682231925e-259	LSR	Malignant cells	GSE163836	ENSG00000105699	51599	lipolysis stimulated lipoprotein receptor	ILDR3|LISCH7	protein_coding	Q86X29	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17879
2.09584465476536e-261	-0.696084469109949	0.387	0.788	3.58536145090711e-257	ADIPOR1	Malignant cells	GSE163836	ENSG00000159346	51094	adiponectin receptor 1	ACDCR1|PAQR1	protein_coding	Q96A54	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17880
1.92772206026045e-260	-0.69777002530009	0.838	0.976	3.29775412848755e-256	ASNA1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17881
1.50359262169383e-257	-0.738979424120585	0.331	0.74	2.57219589793164e-253	C6orf48	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17882
6.45243386912529e-257	-0.694633649510028	0.864	0.971	1.10381786199126e-252	NAA10	Malignant cells	GSE163836	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17883
1.28833521811165e-256	-0.731976891641796	0.53	0.865	2.20395505762359e-252	COPS6	Malignant cells	GSE163836	ENSG00000168090	10980	COP9 signalosome subunit 6	CSN6|MOV34-34KD	protein_coding	Q7L5N1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17884
2.07508359716381e-256	0.754072384464353	0.481	0.043	3.54984550966812e-252	ABCB1	Malignant cells	GSE163836	ENSG00000085563	5243	ATP binding cassette subfamily B member 1	ABC20|CD243|CLCS|GP170|MDR1|p-170|P-gp|PGY1	protein_coding	P08183	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17885
3.8493502098539e-255	-0.684253607910225	0.414	0.81	6.58508340399707e-251	OSTF1	Malignant cells	GSE163836	ENSG00000134996	26578	osteoclast stimulating factor 1	bA235O14.1|OSF|SH3P2	protein_coding	Q92882	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17886
8.07361112093963e-255	0.475876367338518	1	0.999	1.38115265445914e-250	UQCRB	Malignant cells	GSE163836	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17887
1.17061614823535e-254	-0.682716564601499	0.83	0.967	2.00257304478621e-250	SLC25A39	Malignant cells	GSE163836	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17888
9.12508432730009e-254	-0.687777317802608	0.764	0.954	1.56102817587123e-249	UBE2I	Malignant cells	GSE163836	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17889
3.35918073835505e-252	0.536074331620588	1	0.996	5.74655048910398e-248	S100A13	Malignant cells	GSE163836	ENSG00000189171	6284	S100 calcium binding protein A13	NA	protein_coding	Q99584	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17890
1.02549176928249e-251	-0.665051707028998	0.316	0.722	1.75430876971155e-247	SLC25A4	Malignant cells	GSE163836	ENSG00000151729	291	solute carrier family 25 member 4	AAC1|ANT1|PEO2|PEO3|T1	protein_coding	P12235	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17891
3.04729215167427e-251	-0.554066419536403	0.157	0.536	5.21300268386917e-247	CRLS1	Malignant cells	GSE163836	ENSG00000088766	54675	cardiolipin synthase 1	C20orf155|CLS1|dJ967N21.6|GCD10	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17892
1.2069834624888e-250	0.838866257437405	0.878	0.619	2.0647866092796e-246	RAB11FIP1	Malignant cells	GSE163836	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17893
2.27157030370709e-250	-0.707194738918524	0.488	0.846	3.88597531855172e-246	EMC4	Malignant cells	GSE163836	ENSG00000128463	51234	ER membrane protein complex subunit 4	FLJ90746|MGC24415|PIG17|TMEM85	protein_coding	Q5J8M3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17894
4.53486522506651e-250	-0.566134968068581	0.962	0.995	7.75779394052128e-246	COX8A	Malignant cells	GSE163836	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17895
8.06451865868763e-250	-0.567041554506086	0.168	0.55	1.37959720694169e-245	TRPT1	Malignant cells	GSE163836	ENSG00000149743	83707	tRNA phosphotransferase 1	MGC11134	protein_coding	Q86TN4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17896
8.37450580357841e-250	-0.609676754126978	0.204	0.594	1.43262670781816e-245	RABEPK	Malignant cells	GSE163836	ENSG00000136933	10244	Rab9 effector protein with kelch motifs	bA65N13.1|RAB9P40	protein_coding	Q7Z6M1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17897
1.39575145249082e-249	-0.693611474431249	0.303	0.701	2.38771200977605e-245	RAB30-AS1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17898
7.73080962696919e-247	0.744568447809304	0.975	0.841	1.32250960288562e-242	RDH10	Malignant cells	GSE163836	ENSG00000121039	157506	retinol dehydrogenase 10	SDR16C4	protein_coding	Q8IZV5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17899
1.29907954504912e-246	-0.595079404150204	0.992	0.996	2.22233537771553e-242	METTL5	Malignant cells	GSE163836	ENSG00000138382	29081	methyltransferase 5, N6-adenosine	HSPC133	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17900
7.30131626824823e-246	-0.487978362939041	0.998	0.999	1.24903617400922e-241	COX4I1	Malignant cells	GSE163836	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17901
1.117971455673e-245	-0.561236513213514	0.181	0.568	1.9125137692198e-241	NFU1	Malignant cells	GSE163836	ENSG00000169599	27247	NFU1 iron-sulfur cluster scaffold	CGI-33|HIRIP5|NifU|NIFUC	protein_coding	Q9UMS0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17902
1.17117670384125e-245	-0.685952945552351	0.434	0.815	2.00353198726122e-241	C11orf73	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17903
3.1749345676817e-245	-0.788460851735417	0.672	0.921	5.43136056493308e-241	MORF4L2	Malignant cells	GSE163836	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17904
1.20648258686491e-244	-0.687018818885439	0.404	0.795	2.06392976134981e-240	EMD	Malignant cells	GSE163836	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17905
1.38914366603224e-244	-0.622329235621066	0.248	0.645	2.37640806948136e-240	NXT1	Malignant cells	GSE163836	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17906
1.60754773210074e-243	-0.490954464251531	0.999	0.999	2.75003190530473e-239	APRT	Malignant cells	GSE163836	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17907
1.24865576082727e-242	0.492100160113619	1	0.997	2.13607541004722e-238	TOMM7	Malignant cells	GSE163836	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17908
1.07658144610203e-241	-0.617820668585156	0.261	0.661	1.84170787984673e-237	NSFL1C	Malignant cells	GSE163836	ENSG00000088833	55968	NSFL1 cofactor	dJ776F14.1|p47|UBX1|UBXD10|UBXN2C	protein_coding	Q9UNZ2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17909
1.40695838894162e-241	-0.693147200473167	0.469	0.823	2.40688371596243e-237	FDX1	Malignant cells	GSE163836	ENSG00000137714	2230	ferredoxin 1	ADX|FDX	protein_coding	P10109	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17910
1.47994662655254e-241	-0.687906815355273	0.872	0.971	2.53174469404343e-237	HMGA1	Malignant cells	GSE163836	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17911
2.44331876048501e-241	0.40792638450802	1	1	4.17978540356171e-237	RPL5	Malignant cells	GSE163836	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17912
1.451644011296e-240	-0.506280973683205	0.999	0.998	2.48332741012407e-236	POMP	Malignant cells	GSE163836	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17913
2.78120005597135e-238	-0.525509635318479	0.133	0.489	4.7577989357502e-234	RNASET2	Malignant cells	GSE163836	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17914
3.06985910159484e-238	-0.7999118117899	0.72	0.915	5.2516079650983e-234	NGFRAP1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17915
4.73384288800745e-238	-0.296836350748388	1	0.998	8.09818502851435e-234	RPL15	Malignant cells	GSE163836	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17916
3.97485846505723e-237	-0.676110901114483	0.824	0.965	6.7997903761734e-233	U2AF1	Malignant cells	GSE163836	ENSG00000160201	7307	U2 small nuclear RNA auxiliary factor 1	RN|RNU2AF1|U2AF35|U2AFBP	protein_coding	Q01081	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17917
8.18107255228792e-237	-0.663910451217091	0.424	0.804	1.39953608151989e-232	NCOR1	Malignant cells	GSE163836	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17918
9.66761358275639e-236	0.446010668296264	1	1	1.65383865560214e-231	S100A6	Malignant cells	GSE163836	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17919
1.33708881182552e-235	0.782285639353188	0.899	0.669	2.28735783038991e-231	DBF4	Malignant cells	GSE163836	ENSG00000006634	10926	DBF4 zinc finger	ASK|chif|DBF4A|ZDBF1	protein_coding	Q9UBU7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17920
1.07711081503689e-233	-0.322849062198473	1	1	1.8426134712836e-229	RPS5	Malignant cells	GSE163836	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17921
1.18878958775308e-233	-0.867787691667358	0.63	0.902	2.03366234776919e-229	TNFRSF12A	Malignant cells	GSE163836	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17922
1.85228253480293e-233	0.86055367287965	0.723	0.368	3.16869973228737e-229	FOSB	Malignant cells	GSE163836	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17923
3.46304354840888e-233	0.700146510630439	0.964	0.836	5.92422859826306e-229	SNHG8	Malignant cells	GSE163836	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17924
1.43035002778004e-232	-0.530886884493045	0.99	0.997	2.44689979252331e-228	CSTB	Malignant cells	GSE163836	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17925
1.88510268879419e-232	-0.68726284273	0.593	0.895	3.22484516972022e-228	MRPL9	Malignant cells	GSE163836	ENSG00000143436	65005	mitochondrial ribosomal protein L9	NA	protein_coding	Q9BYD2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17926
2.26100796004052e-231	-0.634522350649666	0.859	0.97	3.86790631724132e-227	MLF2	Malignant cells	GSE163836	ENSG00000089693	8079	myeloid leukemia factor 2	NTN4	protein_coding	Q15773	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17927
2.35049536445727e-231	-0.573893453747254	0.191	0.567	4.02099241997706e-227	TEX30	Malignant cells	GSE163836	ENSG00000151287	93081	testis expressed 30	C13orf27	protein_coding	Q5JUR7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17928
1.22284674972047e-230	-1.14583662268492	0.034	0.289	2.0919239347468e-226	IFI27	Malignant cells	GSE163836	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17929
3.25546196414189e-229	0.786914315345355	0.946	0.798	5.56911878205754e-225	CEBPD	Malignant cells	GSE163836	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17930
9.98973337607671e-229	-0.662458723785097	0.749	0.948	1.70894368864544e-224	POLD2	Malignant cells	GSE163836	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17931
2.16709786606459e-228	-0.634704526000622	0.788	0.963	3.7072543194767e-224	UQCRFS1	Malignant cells	GSE163836	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17932
1.05604988242371e-227	0.793105381729929	0.576	0.169	1.80658453386224e-223	DHRS3	Malignant cells	GSE163836	ENSG00000162496	9249	dehydrogenase/reductase 3	RDH17|retSDR1|Rsdr1|SDR1|SDR16C1	protein_coding	O75911	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17933
2.50657142928689e-227	1.05703584998078	0.638	0.238	4.28799174408109e-223	DEFB1	Malignant cells	GSE163836	ENSG00000164825	1672	defensin beta 1	BD1|DEFB-1|DEFB101|HBD-1|HBD1|MGC51822	protein_coding	P60022	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17934
4.45115378273282e-227	-0.66101112726229	0.879	0.973	7.61458877612103e-223	CACYBP	Malignant cells	GSE163836	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17935
4.7877188728725e-227	-0.792308381196777	0.982	0.994	8.19035067582298e-223	ENO1	Malignant cells	GSE163836	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17936
9.16948356959443e-227	-0.588553951941836	0.253	0.633	1.56862355425052e-222	CECR5	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17937
3.06631699347859e-226	-0.655487690606738	0.356	0.736	5.24554848074383e-222	NOP16	Malignant cells	GSE163836	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17938
3.84813414320338e-226	-0.591367321819456	0.26	0.644	6.58300307877802e-222	DTD1	Malignant cells	GSE163836	ENSG00000125821	92675	D-aminoacyl-tRNA deacylase 1	bA379J5.3|bA555E18.1|C20orf88|DUEB|HARS2|MGC119131|MGC41905|pqn-68	protein_coding	Q8TEA8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17939
2.03329901201614e-225	-0.565919915302006	0.222	0.599	3.47836461985601e-221	ACTR1B	Malignant cells	GSE163836	ENSG00000115073	10120	actin related protein 1B	Arp1B|CTRN2	protein_coding	P42025	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17940
6.88660176414303e-225	-0.670131404551142	0.581	0.886	1.17809096379195e-220	LSM1	Malignant cells	GSE163836	ENSG00000175324	27257	LSM1 homolog, mRNA degradation associated	CASM|YJL124C	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17941
1.13386130714658e-224	0.696586654857358	0.916	0.75	1.93969653813565e-220	CDK6	Malignant cells	GSE163836	ENSG00000105810	1021	cyclin dependent kinase 6	PLSTIRE	protein_coding	Q00534	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17942
5.01404913011387e-224	-0.490931594370535	0.088	0.403	8.57753384688581e-220	C6orf15	Malignant cells	GSE163836	ENSG00000206461	29113	chromosome 6 open reading frame 15	STG	protein_coding	Q6UXA7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17943
2.42323059005261e-223	0.904168799755001	0.482	0.079	4.14542057040301e-219	FMO2	Malignant cells	GSE163836	ENSG00000094963	2327	flavin containing dimethylaniline monoxygenase 2	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17944
6.52785681262076e-223	-0.503966550357979	0.144	0.494	1.11672046493503e-218	FADD	Malignant cells	GSE163836	ENSG00000168040	8772	Fas associated via death domain	GIG3|MORT1	protein_coding	Q13158	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17945
4.78802539048747e-222	-0.529386449812223	0.185	0.551	8.19087503550692e-218	QTRT1	Malignant cells	GSE163836	ENSG00000213339	81890	queuine tRNA-ribosyltransferase catalytic subunit 1	TGT	protein_coding	Q9BXR0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17946
6.13637845228068e-222	-0.655423580640299	0.852	0.973	1.04975026183166e-217	BSG	Malignant cells	GSE163836	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17947
6.9573225501231e-222	-0.63630244958372	0.893	0.971	1.19018916864956e-217	PARP1	Malignant cells	GSE163836	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17948
9.61621316760136e-222	-0.625623111758654	0.807	0.954	1.64504558658156e-217	MRPL55	Malignant cells	GSE163836	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17949
4.90068064864708e-221	-0.628456696793895	0.817	0.96	8.38359438564057e-217	MRPL21	Malignant cells	GSE163836	ENSG00000197345	219927	mitochondrial ribosomal protein L21	NA	protein_coding	Q7Z2W9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17950
5.12502368702488e-221	0.356026442445458	1	1	8.76737802139346e-217	UBA52	Malignant cells	GSE163836	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17951
7.51480090560696e-221	-0.861287996459442	0.923	0.968	1.28555699092218e-216	CKS1B	Malignant cells	GSE163836	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17952
2.42813616961837e-220	-0.665498137602371	0.599	0.891	4.15381254536614e-216	MRPS26	Malignant cells	GSE163836	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17953
1.69954915788885e-219	-0.623348300030831	0.46	0.825	2.90741874440046e-215	MEA1	Malignant cells	GSE163836	ENSG00000124733	4201	male-enhanced antigen 1	MEA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17954
2.02791434306622e-219	0.726289208262334	0.882	0.711	3.46915306668339e-215	YWHAG	Malignant cells	GSE163836	ENSG00000170027	7532	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma	14-3-3GAMMA|PPP1R170	protein_coding	P61981	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17955
2.11574810814052e-218	-0.578062439020511	0.891	0.984	3.61941028859598e-214	ATP5O	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17956
6.27591231064074e-218	-0.680938812599849	0.657	0.906	1.07362031898131e-213	CLTB	Malignant cells	GSE163836	ENSG00000175416	1212	clathrin light chain B	Lcb	protein_coding	P09497	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17957
9.75892392442154e-218	-0.463748193951972	0.12	0.453	1.66945911575079e-213	TOR3A	Malignant cells	GSE163836	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17958
1.77587262937355e-217	-0.671682965205695	0.599	0.888	3.03798530706933e-213	TOMM22	Malignant cells	GSE163836	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17959
2.20884249526266e-217	-0.565935935346302	0.901	0.99	3.77866685664583e-213	C1orf43	Malignant cells	GSE163836	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17960
9.41372041375694e-217	0.704334948427438	0.882	0.679	1.6104051511814e-212	LITAF	Malignant cells	GSE163836	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17961
1.07934000552123e-216	-0.635096095047478	0.414	0.782	1.84642694744517e-212	SDHB	Malignant cells	GSE163836	ENSG00000117118	6390	succinate dehydrogenase complex iron sulfur subunit B	SDH|SDH1	protein_coding	P21912	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17962
1.72229022991054e-215	-0.650435677753357	0.687	0.926	2.94632189630796e-211	OCIAD2	Malignant cells	GSE163836	ENSG00000145247	132299	OCIA domain containing 2	MGC45416	protein_coding	Q56VL3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17963
2.46533783001208e-214	-0.503369632895748	0.144	0.483	4.21745342580167e-210	FAM104B	Malignant cells	GSE163836	ENSG00000182518	90736	family with sequence similarity 104 member B	CXorf44|FLJ20434	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17964
6.04657061789877e-214	-0.630948933576116	0.591	0.896	1.03438683560394e-209	APH1A	Malignant cells	GSE163836	ENSG00000117362	51107	aph-1 homolog A, gamma-secretase subunit	APH-1A|CGI-78	protein_coding	Q96BI3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17965
3.80407364518639e-213	0.589542461706655	0.993	0.95	6.50762878482035e-209	ATP5I	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17966
1.65219670589255e-212	-0.703763883327252	0.715	0.927	2.82641290477039e-208	PLP2	Malignant cells	GSE163836	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17967
2.75938668176711e-212	-0.558629961443948	0.92	0.985	4.72048279649899e-208	SPINT2	Malignant cells	GSE163836	ENSG00000167642	10653	serine peptidase inhibitor, Kunitz type 2	HAI-2|HAI2|Kop	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17968
9.9957631890348e-212	-0.658264189412521	0.492	0.821	1.70997520874818e-207	C20orf24	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17969
1.65065463505651e-211	-0.558544012259664	0.305	0.685	2.82377488419117e-207	RNF167	Malignant cells	GSE163836	ENSG00000108523	26001	ring finger protein 167	DKFZP566H073	protein_coding	Q9H6Y7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17970
4.18912124958596e-211	-0.558668679364984	0.909	0.989	7.1663297216667e-207	NDUFAB1	Malignant cells	GSE163836	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17971
6.91053207514857e-211	-0.648587285717684	0.47	0.81	1.18218472209567e-206	MKKS	Malignant cells	GSE163836	ENSG00000125863	8195	MKKS centrosomal shuttling protein	BBS6|HMCS|KMS|MKS	protein_coding	Q9NPJ1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17972
8.10783142627582e-211	-0.507082704788645	0.172	0.524	1.387006722093e-206	RPIA	Malignant cells	GSE163836	ENSG00000153574	22934	ribose 5-phosphate isomerase A	NA	protein_coding	P49247	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17973
3.43744802656646e-209	0.321125987138661	1	1	5.88044233904724e-205	RPL39	Malignant cells	GSE163836	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17974
4.55013505992536e-209	0.463857572070507	1	0.999	7.78391604701431e-205	EIF1	Malignant cells	GSE163836	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17975
7.31644847604516e-209	-0.460470987788368	0.105	0.418	1.25162484079705e-204	PRADC1	Malignant cells	GSE163836	ENSG00000135617	84279	protease associated domain containing 1	C2orf7|hPAP21|MGC13004|PAP21	protein_coding	Q9BSG0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17976
2.02421235514806e-208	-0.469223436177669	0.148	0.488	3.46282007595178e-204	RABEP1	Malignant cells	GSE163836	ENSG00000029725	9135	rabaptin, RAB GTPase binding effector protein 1	neurocrescin|RAB5EP|rabaptin-5|RABPT5	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17977
5.32941732975007e-208	-0.604440622817335	0.363	0.725	9.11703422600344e-204	ISCU	Malignant cells	GSE163836	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17978
1.86687692658289e-207	0.758471949265814	0.929	0.763	3.19366635830536e-203	UBC	Malignant cells	GSE163836	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17979
3.12471401781437e-207	-0.531954271449283	0.975	0.995	5.34544827027504e-203	MDH2	Malignant cells	GSE163836	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17980
3.31660798012884e-207	0.799947404876644	0.673	0.32	5.67372127160641e-203	TRIB1	Malignant cells	GSE163836	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17981
3.41199220238808e-206	-0.507003206888037	0.998	0.999	5.8368950606253e-202	CFL1	Malignant cells	GSE163836	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17982
8.7808657496682e-206	-0.626077143807333	0.691	0.922	1.50214270379574e-201	JOSD2	Malignant cells	GSE163836	ENSG00000161677	126119	Josephin domain containing 2	SBBI54	protein_coding	Q8TAC2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17983
1.69606224145733e-202	-0.642585984845175	0.714	0.929	2.90145367646106e-198	TSEN34	Malignant cells	GSE163836	ENSG00000274078	79042	tRNA splicing endonuclease subunit 34	LENG5|SEN34|SEN34L	protein_coding	Q9BSV6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17984
1.44435762942919e-201	-0.561781230543478	0.824	0.972	2.47086259666451e-197	COX7A2L	Malignant cells	GSE163836	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17985
4.31130702783741e-200	-0.577704172987215	0.263	0.619	7.37535293252146e-196	FAM58A	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17986
8.77741591725847e-200	-0.501345846263871	0.99	0.997	1.50155254096541e-195	TIMM13	Malignant cells	GSE163836	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17987
7.85306945097099e-199	-0.651919129175452	0.619	0.885	1.34342459097761e-194	BOLA3	Malignant cells	GSE163836	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17988
1.61942928685164e-198	-0.600962078695297	0.411	0.769	2.7703576810171e-194	MRPL32	Malignant cells	GSE163836	ENSG00000106591	64983	mitochondrial ribosomal protein L32	bMRP-59b|HSPC283|L32mt|MRP-L32	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17989
3.51147851461932e-198	0.722498490521601	0.768	0.421	6.00708629495928e-194	TPM2	Malignant cells	GSE163836	ENSG00000198467	7169	tropomyosin 2	AMCD1|DA1|NEM4	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17990
7.60006026044958e-198	-0.551561820180691	0.866	0.975	1.30014230875511e-193	MTCH2	Malignant cells	GSE163836	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17991
1.22123613092807e-197	-0.577737294659138	0.357	0.718	2.08916864917865e-193	FAM96A	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17992
5.50644881726372e-197	-0.642920512220943	0.476	0.809	9.41988199169304e-193	RNASEH2C	Malignant cells	GSE163836	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17993
1.58601215851881e-196	-0.614568295495624	0.646	0.902	2.71319099957813e-192	PYURF	Malignant cells	GSE163836	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17994
5.21688806080164e-196	-0.618941304162234	0.628	0.891	8.92453040561337e-192	RPS6KB2	Malignant cells	GSE163836	ENSG00000175634	6199	ribosomal protein S6 kinase B2	KLS|P70-BETA|p70S6Kb|S6KB|S6Kbeta|STK14B	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17995
5.73920757374701e-196	-0.568286566863174	0.904	0.976	9.81806239640901e-192	C7orf50	Malignant cells	GSE163836	ENSG00000146540	84310	chromosome 7 open reading frame 50	MGC11257|YCR016W	protein_coding	Q9BRJ6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17996
6.48383115230229e-196	-0.486911207907371	0.164	0.495	1.10918899522435e-191	CHCHD6	Malignant cells	GSE163836	ENSG00000159685	84303	coiled-coil-helix-coiled-coil-helix domain containing 6	CHCM1|MGC13016|Mic25|MICOS25|PPP1R23	protein_coding	Q9BRQ6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17997
2.17250545718899e-195	-0.369872616423086	0.043	0.287	3.7165050856132e-191	PLEKHO1	Malignant cells	GSE163836	ENSG00000023902	51177	pleckstrin homology domain containing O1	CKIP-1|OC120	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17998
1.17313773426223e-194	-0.536713444755671	0.978	0.996	2.0068867220024e-190	SSR4	Malignant cells	GSE163836	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	17999
1.23844318486366e-194	-0.593695602151665	0.509	0.836	2.11860475634626e-190	LMAN2	Malignant cells	GSE163836	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18000
8.67571733884512e-194	-0.616759583924177	1	0.999	1.48415496515624e-189	S100A10	Malignant cells	GSE163836	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18001
9.51429851898748e-194	-0.454446820028751	0.134	0.452	1.62761104764319e-189	TSC22D4	Malignant cells	GSE163836	ENSG00000166925	81628	TSC22 domain family member 4	THG-1|TILZ2	protein_coding	Q9Y3Q8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18002
1.52206287395445e-193	-0.614227266208782	0.407	0.751	2.60379295847387e-189	RAD23B	Malignant cells	GSE163836	ENSG00000119318	5887	RAD23 homolog B, nucleotide excision repair protein	HHR23B|HR23B|P58	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18003
2.58194305053379e-193	-0.59219687978739	0.942	0.979	4.41692997654815e-189	H2AFV	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18004
1.11366757807503e-192	-0.618790122206691	0.553	0.857	1.90515112581295e-188	PRR13	Malignant cells	GSE163836	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18005
1.1558604430794e-192	-0.595712210817092	0.344	0.691	1.97733045997594e-188	PRPF19	Malignant cells	GSE163836	ENSG00000110107	27339	pre-mRNA processing factor 19	hPSO4|NMP200|PRP19|PSO4|SNEV|UBOX4	protein_coding	Q9UMS4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18006
5.70189527218253e-192	-0.630201666052216	0.576	0.87	9.75423224212265e-188	DAP3	Malignant cells	GSE163836	ENSG00000132676	7818	death associated protein 3	bMRP-10|DAP-3|DKFZp686G12159|MGC126058|MGC126059|MRP-S29|MRPS29	protein_coding	P51398	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18007
6.61373350216506e-192	0.708511624260297	0.871	0.664	1.13141139021538e-187	CD44	Malignant cells	GSE163836	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18008
7.25447953784151e-192	0.821656654883334	0.825	0.561	1.24102381453855e-187	LCN2	Malignant cells	GSE163836	ENSG00000148346	3934	lipocalin 2	24p3|NGAL	protein_coding	P80188	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18009
2.25477613824223e-191	-0.535129758505863	0.97	0.992	3.85724553969099e-187	PDCD5	Malignant cells	GSE163836	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18010
3.64960304852413e-191	-0.559218515645358	0.296	0.651	6.24337593511023e-187	HPCAL1	Malignant cells	GSE163836	ENSG00000115756	3241	hippocalcin like 1	BDR1|HLP2|VILIP-3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18011
5.91213796588112e-191	0.716477934611715	0.845	0.612	1.01138944182328e-186	LMO4	Malignant cells	GSE163836	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18012
6.34736518588286e-191	-0.3288130467731	1	1	1.08584376234898e-186	RPL23	Malignant cells	GSE163836	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18013
6.56852015112628e-191	0.504201088213286	1	0.989	1.12367674225317e-186	EIF3E	Malignant cells	GSE163836	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18014
1.21722769832973e-190	-0.595158131288778	0.451	0.793	2.08231142353268e-186	MRPL16	Malignant cells	GSE163836	ENSG00000166902	54948	mitochondrial ribosomal protein L16	FLJ20484|PNAS-111	protein_coding	Q9NX20	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18015
1.76093010699127e-190	-0.501398347574409	0.198	0.538	3.01242313402996e-186	PREB	Malignant cells	GSE163836	ENSG00000138073	10113	prolactin regulatory element binding	SEC12	protein_coding	Q9HCU5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18016
6.12115238871338e-190	0.588549923231448	0.969	0.892	1.0471455391372e-185	VPS28	Malignant cells	GSE163836	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18017
1.52687805705731e-189	-0.466870780948487	0.98	0.995	2.61203029220794e-185	SEC61B	Malignant cells	GSE163836	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18018
3.14339352853875e-189	-0.484193289383075	0.169	0.496	5.37740330927125e-185	CCDC109B	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18019
3.44287037023558e-189	-0.572857096974212	0.355	0.703	5.88971834236201e-185	PDZD11	Malignant cells	GSE163836	ENSG00000120509	51248	PDZ domain containing 11	PDZK11	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18020
3.73587104194469e-189	-0.490525708920233	0.212	0.557	6.39095459145478e-185	TSSC1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18021
5.06654329361942e-189	0.688464646998908	0.854	0.65	8.66733561239474e-185	TRPS1	Malignant cells	GSE163836	ENSG00000104447	7227	transcriptional repressor GATA binding 1	GC79|LGCR	protein_coding	Q9UHF7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18022
6.64880856108422e-189	0.642571669879457	0.91	0.746	1.13741168054468e-184	ATPIF1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18023
1.18190033113829e-188	-0.580407241600947	0.502	0.83	2.02187689647827e-184	RPL26L1	Malignant cells	GSE163836	ENSG00000037241	51121	ribosomal protein L26 like 1	RPL26P1	protein_coding	Q9UNX3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18024
2.40306391729044e-188	-0.548115871880309	0.855	0.971	4.11092144330876e-184	H2AFY	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18025
2.45336439602005e-188	-0.450438412713157	0.08	0.353	4.1969704722715e-184	KLK7	Malignant cells	GSE163836	ENSG00000169035	5650	kallikrein related peptidase 7	PRSS6|SCCE	protein_coding	P49862	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18026
2.55217060102186e-187	-0.575929370395714	0.42	0.761	4.36599824716809e-183	CDC26	Malignant cells	GSE163836	ENSG00000176386	246184	cell division cycle 26	ANAPC12|APC12|C9orf17	protein_coding	Q8NHZ8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18027
3.16680269440023e-187	0.7176868186737	0.756	0.439	5.41744936931047e-183	NTRK2	Malignant cells	GSE163836	ENSG00000148053	4915	neurotrophic receptor tyrosine kinase 2	TRKB	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18028
2.30212804758819e-186	-0.646598463176845	0.558	0.848	3.93825045100912e-182	BCL2L12	Malignant cells	GSE163836	ENSG00000126453	83596	BCL2 like 12	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18029
2.40067463797713e-186	-0.538869794237221	0.27	0.617	4.10683410318748e-182	H2AFY2	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18030
3.94447472852082e-186	-0.531665398268679	0.075	0.34	6.74781291808057e-182	OSR2	Malignant cells	GSE163836	ENSG00000164920	116039	odd-skipped related transciption factor 2	FLJ90037	protein_coding	Q8N2R0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18031
4.98728273657788e-186	-0.353114706534449	0.06	0.317	8.53174457746378e-182	ITM2C	Malignant cells	GSE163836	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18032
9.17631685525566e-186	-0.583321824712043	0.406	0.744	1.56979252442859e-181	TPRKB	Malignant cells	GSE163836	ENSG00000144034	51002	TP53RK binding protein	CGI-121|CGI121	protein_coding	Q9Y3C4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18033
2.62083504505209e-185	-0.463954743698558	0.156	0.478	4.48346251157061e-181	ASF1A	Malignant cells	GSE163836	ENSG00000111875	25842	anti-silencing function 1A histone chaperone	CIA|DKFZP547E2110	protein_coding	Q9Y294	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18034
4.74701223799969e-185	0.476580705939624	0.997	0.989	8.12071383554606e-181	COX7C	Malignant cells	GSE163836	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18035
1.31281374660276e-184	-0.522490343934033	0.23	0.569	2.24583047631334e-180	CYTH2	Malignant cells	GSE163836	ENSG00000105443	9266	cytohesin 2	ARNO|CTS18.1|cytohesin-2|PSCD2|PSCD2L|Sec7p-L|Sec7p-like	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18036
1.3224500302134e-184	-0.586785077960872	0.761	0.94	2.26231526668606e-180	POLE4	Malignant cells	GSE163836	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18037
1.5612116531582e-184	-0.53142421080268	0.985	0.996	2.67076477505773e-180	PFDN2	Malignant cells	GSE163836	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18038
1.63666680192319e-184	-0.523106883585847	0.309	0.664	2.79984589805e-180	CMC1	Malignant cells	GSE163836	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18039
7.4460104603132e-184	-0.498880827238339	0.186	0.514	1.27378900944578e-179	LAMP1	Malignant cells	GSE163836	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18040
7.56851854326601e-184	-0.589984056767052	0.609	0.885	1.29474646719652e-179	COMT	Malignant cells	GSE163836	ENSG00000093010	1312	catechol-O-methyltransferase	NA	protein_coding	P21964	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18041
7.70289256426087e-184	-0.571790488995063	0.372	0.716	1.31773383096811e-179	DESI1	Malignant cells	GSE163836	ENSG00000100418	27351	desumoylating isopeptidase 1	D15Wsu75e|DESI-1|FAM152B|POST|PPPDE2	protein_coding	Q6ICB0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18042
9.03570045189631e-184	-0.57952503394947	0.506	0.826	1.5457372763059e-179	PIN1	Malignant cells	GSE163836	ENSG00000127445	5300	peptidylprolyl cis/trans isomerase, NIMA-interacting 1	dod	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18043
2.67216003274923e-183	-0.670025644141903	0.441	0.768	4.5712641680241e-179	CDC42EP1	Malignant cells	GSE163836	ENSG00000128283	11135	CDC42 effector protein 1	Borg5|CEP1|MSE55	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18044
1.77093318954882e-182	-0.586239134623622	0.691	0.919	3.02953540736117e-178	FAM96B	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18045
1.89593947575781e-182	-0.582911048097599	0.693	0.917	3.24338366117888e-178	RNPS1	Malignant cells	GSE163836	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18046
3.84667220010497e-182	-0.84454877048428	0.355	0.673	6.58050213271957e-178	HIST1H2BK	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18047
4.1511734118513e-182	-0.522540082068013	0.898	0.971	7.10141235565402e-178	MRPL23	Malignant cells	GSE163836	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18048
5.39431857140803e-182	-0.492473347165822	0.21	0.544	9.22806078010771e-178	POP1	Malignant cells	GSE163836	ENSG00000104356	10940	POP1 homolog, ribonuclease P/MRP subunit	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18049
7.43476122307946e-182	-0.530517001334706	0.315	0.667	1.2718646024322e-177	NR1H2	Malignant cells	GSE163836	ENSG00000131408	7376	nuclear receptor subfamily 1 group H member 2	LXR-b|LXRb|NER|NER-I|RIP15|UNR	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18050
1.07688240788943e-181	-0.540455554277829	0.288	0.632	1.84222273517644e-177	EWSR1	Malignant cells	GSE163836	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18051
1.21537492707451e-181	-0.471928637938237	0.195	0.528	2.07914188774637e-177	SEC11C	Malignant cells	GSE163836	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18052
1.6686280490866e-180	-0.619701351998766	0.649	0.879	2.85452200357244e-176	PPP1R14A	Malignant cells	GSE163836	ENSG00000167641	94274	protein phosphatase 1 regulatory inhibitor subunit 14A	CPI-17|PPP1INL	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18053
1.72314967127822e-180	-0.548359936696485	0.314	0.654	2.94779214265566e-176	DEF8	Malignant cells	GSE163836	ENSG00000140995	54849	differentially expressed in FDCP 8 homolog	FLJ20186	protein_coding	Q6ZN54	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18054
5.12103811673577e-180	-0.581467662743651	0.43	0.766	8.76055990629989e-176	TIMM50	Malignant cells	GSE163836	ENSG00000105197	92609	translocase of inner mitochondrial membrane 50	TIM50|TIM50L	protein_coding	Q3ZCQ8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18055
8.61626006569226e-180	-0.381605721578883	0.08	0.347	1.47398360943797e-175	IFT27	Malignant cells	GSE163836	ENSG00000100360	11020	intraflagellar transport 27	BBS19|FAP156|RABL4|RAYL	protein_coding	Q9BW83	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18056
3.13263888425381e-179	0.578179766259888	0.982	0.883	5.35900533929299e-175	RBP7	Malignant cells	GSE163836	ENSG00000162444	116362	retinol binding protein 7	CRBPIV	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18057
1.4521441125235e-178	-0.460440617746267	0.992	0.997	2.48418293329394e-174	SNRPE	Malignant cells	GSE163836	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18058
2.21637740963973e-178	-0.4728030165685	0.975	0.996	3.79155683467068e-174	TCEB1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18059
2.37382819900363e-178	-0.572815302549277	0.688	0.911	4.06090790003551e-174	TXNDC17	Malignant cells	GSE163836	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18060
3.6250974893007e-178	-0.447849094286109	0.158	0.474	6.20145427494671e-174	DERA	Malignant cells	GSE163836	ENSG00000023697	51071	deoxyribose-phosphate aldolase	CGI-26|DEOC	protein_coding	Q9Y315	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18061
3.83211663209559e-178	0.371226285783488	1	1	6.55560192252592e-174	H3F3A	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18062
4.90832658353846e-178	-0.574687706214838	0.385	0.721	8.39667428645924e-174	UBE2N	Malignant cells	GSE163836	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18063
1.75525224596444e-177	-0.756934567312871	0.971	0.98	3.00271001717137e-173	PHLDA2	Malignant cells	GSE163836	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18064
3.92787355172647e-177	-0.35837947792677	0.067	0.321	6.71941328493847e-173	CCDC71	Malignant cells	GSE163836	ENSG00000177352	64925	coiled-coil domain containing 71	FLJ12800	protein_coding	Q8IV32	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18065
5.63855237934274e-177	-0.512588871623695	0.996	0.995	9.64587155534163e-173	KRT18	Malignant cells	GSE163836	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18066
5.98137497175598e-177	-0.451438125131186	0.991	0.999	1.0232338164183e-172	EIF3H	Malignant cells	GSE163836	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18067
8.11770790650586e-177	-0.47778342302772	0.983	0.996	1.38869629156596e-172	AURKAIP1	Malignant cells	GSE163836	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18068
1.11176159283857e-176	0.496549398250184	0.998	0.98	1.90189055686894e-172	USMG5	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18069
4.6519858375546e-176	-0.583008743212553	0.898	0.975	7.95815217230465e-172	SRM	Malignant cells	GSE163836	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18070
5.64602564270279e-176	-0.526544872304136	0.958	0.985	9.65865606697167e-172	NME4	Malignant cells	GSE163836	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18071
2.69929779997314e-175	-0.592176125436482	0.563	0.856	4.61768874641406e-171	CALM3	Malignant cells	GSE163836	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18072
3.4904329909205e-175	-0.36772282507606	0.067	0.32	5.97108371756769e-171	TMEM98	Malignant cells	GSE163836	ENSG00000006042	26022	transmembrane protein 98	DKFZP564K1964	protein_coding	Q9Y2Y6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18073
8.65900901277405e-175	-0.579532086131833	0.615	0.881	1.48129667181526e-170	UBE2L3	Malignant cells	GSE163836	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18074
9.56515971471911e-175	-0.590584051742954	0.355	0.684	1.636311872397e-170	PSMC2	Malignant cells	GSE163836	ENSG00000161057	5701	proteasome 26S subunit, ATPase 2	MSS1|Nbla10058|RPT1|S7	protein_coding	P35998	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18075
1.67007921380651e-174	-0.54309942023579	0.308	0.644	2.85700451105879e-170	DBNL	Malignant cells	GSE163836	ENSG00000136279	28988	drebrin like	ABP1|HIP-55|SH3P7	protein_coding	Q9UJU6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18076
2.56085042262568e-174	-0.6011603597679	0.625	0.876	4.38084681798575e-170	CD320	Malignant cells	GSE163836	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18077
4.97754548837807e-174	-0.535377167637428	0.402	0.738	8.51508706696836e-170	POLDIP2	Malignant cells	GSE163836	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18078
5.18442026465328e-174	-0.510275734212994	0.299	0.641	8.86898774674237e-170	MAPKAP1	Malignant cells	GSE163836	ENSG00000119487	79109	MAPK associated protein 1	MGC2745|MIP1|SIN1	protein_coding	Q9BPZ7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18079
1.30200023808578e-173	-0.555995104228316	0.378	0.717	2.22733180729334e-169	SMARCB1	Malignant cells	GSE163836	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18080
1.44245470316325e-173	-0.640182025307855	0.337	0.664	2.46760726070137e-169	SMC1A	Malignant cells	GSE163836	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18081
1.69213483509188e-173	-0.550103303112849	0.508	0.826	2.89473506239168e-169	EMC6	Malignant cells	GSE163836	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18082
3.97805171403656e-173	-0.454938536549533	0.169	0.483	6.80525306720235e-169	TSR2	Malignant cells	GSE163836	ENSG00000158526	90121	TSR2 ribosome maturation factor	DT1P1A10|RP1-112K5.2|WGG1	protein_coding	Q969E8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18083
7.56218091633525e-173	-0.520748961447273	0.901	0.978	1.29366228935747e-168	ATP6V1F	Malignant cells	GSE163836	ENSG00000128524	9296	ATPase H+ transporting V1 subunit F	ATP6S14|VATF|Vma7	protein_coding	Q16864	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18084
8.19149367678444e-173	0.539217844988697	0.993	0.961	1.40131882328751e-168	PRKDC	Malignant cells	GSE163836	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18085
2.117648827366e-172	0.688145389330036	0.648	0.337	3.62266184897502e-168	IQGAP1	Malignant cells	GSE163836	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18086
3.6381529675419e-172	0.477522495305873	0.997	0.979	6.22378828157393e-168	SLC25A3	Malignant cells	GSE163836	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18087
1.69143578466654e-171	-0.591088713155343	0.721	0.921	2.89353919682905e-167	C19orf10	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18088
2.20147127992055e-171	-0.528372869047232	0.268	0.602	3.76605691856008e-167	CCDC58	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18089
6.80341403325807e-171	-0.596802502296178	0.884	0.969	1.16386003866946e-166	ATP5B	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18090
6.8732536664619e-171	-0.451369149173676	0.195	0.517	1.17580750472164e-166	ANKRD39	Malignant cells	GSE163836	ENSG00000213337	51239	ankyrin repeat domain 39	MGC41816	protein_coding	Q53RE8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18091
7.99851132024459e-171	0.700417987505155	0.568	0.236	1.36830533155424e-166	NR4A2	Malignant cells	GSE163836	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18092
1.65550903067578e-170	-0.299430637008898	1	0.999	2.83207929877706e-166	RPL6	Malignant cells	GSE163836	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18093
6.87838529448018e-170	-0.451527543648856	0.148	0.448	1.17668537232672e-165	MSRB1	Malignant cells	GSE163836	ENSG00000198736	51734	methionine sulfoxide reductase B1	SELENOR|SELENOX|SelR|SelX|SepR|SEPX1	protein_coding	Q9NZV6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18094
1.9003986935673e-169	-0.466290513215453	0.203	0.528	3.25101204508558e-165	POLR2C	Malignant cells	GSE163836	ENSG00000102978	5432	RNA polymerase II subunit C	RPB3	protein_coding	P19387	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18095
2.22149756650421e-169	-0.496481631262833	0.307	0.644	3.80031588701876e-165	SFT2D1	Malignant cells	GSE163836	ENSG00000198818	113402	SFT2 domain containing 1	C6orf83|MGC19825|pRGR1	protein_coding	Q8WV19	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18096
2.32416203744637e-169	-0.604861256935025	0.514	0.808	3.9759439974595e-165	SSSCA1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18097
2.80902916701981e-169	-0.364550991798318	0.082	0.343	4.80540619602079e-165	SMKR1	Malignant cells	GSE163836	ENSG00000240204	100287482	small lysine rich protein 1	NA	protein_coding	H3BMG3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18098
4.55882652039951e-169	-0.660237315146966	0.274	0.594	7.79878452844744e-165	RGCC	Malignant cells	GSE163836	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18099
1.89127279045624e-168	-0.554671130986024	0.457	0.772	3.23540036263349e-164	BID	Malignant cells	GSE163836	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18100
2.54718635840306e-168	-0.516545728760894	0.317	0.65	4.35747170332011e-164	HSPBP1	Malignant cells	GSE163836	ENSG00000133265	23640	HSPA (Hsp70) binding protein 1	FES1	protein_coding	Q9NZL4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18101
4.06023971997463e-168	-0.573531188376681	0.398	0.721	6.9458520889606e-164	NAA20	Malignant cells	GSE163836	ENSG00000173418	51126	N-alpha-acetyltransferase 20, NatB catalytic subunit	dJ1002M8.1|NAT3|NAT5	protein_coding	P61599	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18102
4.43243247640627e-168	-0.68172348387964	0.538	0.809	7.5825622373882e-164	KHDRBS3	Malignant cells	GSE163836	ENSG00000131773	10656	KH RNA binding domain containing, signal transduction associated 3	Etle|etoile|SALP|SLM-2|SLM2|T-STAR	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18103
5.36114202098451e-168	-0.57677617969636	0.662	0.9	9.1713056552982e-164	SLC52A2	Malignant cells	GSE163836	ENSG00000285112	79581	solute carrier family 52 member 2	D15Ertd747e|FLJ11856|GPCR41|GPR172A|hRFT3|PAR1|RFVT2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18104
1.44561569055971e-167	-0.603253490249932	0.416	0.729	2.4730147618405e-163	TMEM106C	Malignant cells	GSE163836	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18105
1.65767290638787e-167	-0.406151339985045	0.116	0.399	2.83578104095773e-163	MPDU1	Malignant cells	GSE163836	ENSG00000129255	9526	mannose-P-dolichol utilization defect 1	CDGIf|Lec35|PQLC5|SL15|SLC66A5	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18106
5.70518450600245e-167	-0.493449392373738	0.264	0.598	9.75985913441839e-163	CERS2	Malignant cells	GSE163836	ENSG00000143418	29956	ceramide synthase 2	FLJ10243|LASS2|SP260	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18107
1.60902770518156e-166	-0.52166181469337	0.352	0.683	2.7525636952541e-162	ELOF1	Malignant cells	GSE163836	ENSG00000130165	84337	elongation factor 1	ELF1|MGC4549	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18108
1.30761005778192e-165	-0.485350884444464	0.302	0.637	2.23692852584753e-161	GID8	Malignant cells	GSE163836	ENSG00000101193	54994	GID complex subunit 8 homolog	bA305P22.1|C20orf11|FLJ20602|TWA1	protein_coding	Q9NWU2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18109
1.35270138350081e-165	0.596083205851694	0.881	0.717	2.31406625675484e-161	EIF3J	Malignant cells	GSE163836	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18110
1.77411925531995e-165	0.349370761657818	1	1	3.03498581007585e-161	SERF2	Malignant cells	GSE163836	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18111
2.32892492217343e-165	-0.523692855479742	0.306	0.634	3.98409186436209e-161	UBE2A	Malignant cells	GSE163836	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18112
2.7216263371387e-165	-0.271402339764865	1	1	4.65588617494317e-161	RPS7	Malignant cells	GSE163836	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18113
4.43093314746411e-165	-0.460841738116711	0.215	0.536	7.57999733536685e-161	KLHDC3	Malignant cells	GSE163836	ENSG00000124702	116138	kelch domain containing 3	dJ20C7.3|hPeas|PEAS	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18114
5.09707223269034e-165	-0.479709158375522	0.244	0.569	8.71956146846337e-161	RSU1	Malignant cells	GSE163836	ENSG00000148484	6251	Ras suppressor protein 1	FLJ31034|RSP-1	protein_coding	Q15404	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18115
7.25852820406475e-165	0.662159792834364	0.799	0.609	1.24171641986936e-160	AHNAK	Malignant cells	GSE163836	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18116
7.73714381312834e-165	0.713347022723041	0.651	0.345	1.32359319211187e-160	STAU2	Malignant cells	GSE163836	ENSG00000040341	27067	staufen double-stranded RNA binding protein 2	39K2	protein_coding	Q9NUL3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18117
8.04911701605811e-165	-0.494595951099811	0.298	0.629	1.37696244793706e-160	SNAPIN	Malignant cells	GSE163836	ENSG00000143553	23557	SNAP associated protein	BLOC1S7|BORCS3|SNAPAP	protein_coding	O95295	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18118
2.44015861625748e-164	-0.55928426468797	0.52	0.816	4.17437934483167e-160	SNRNP25	Malignant cells	GSE163836	ENSG00000161981	79622	small nuclear ribonucleoprotein U11/U12 subunit 25	C16orf33|U11/U12-25K	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18119
2.27689836525652e-163	-0.519527984398648	0.489	0.812	3.89509003344433e-159	METTL9	Malignant cells	GSE163836	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18120
3.4335381907886e-163	-0.574151377543506	0.793	0.944	5.87375378298205e-159	SSNA1	Malignant cells	GSE163836	ENSG00000176101	8636	SS nuclear autoantigen 1	N14|NA14	protein_coding	O43805	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18121
1.24594412435616e-162	-0.478671498103189	0.245	0.57	2.13143661353609e-158	RHBDD2	Malignant cells	GSE163836	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18122
3.6008605550766e-162	-0.467609220651527	0.2	0.51	6.15999215156953e-158	PTRH1	Malignant cells	GSE163836	ENSG00000187024	138428	peptidyl-tRNA hydrolase 1 homolog	C9orf115|PTH1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18123
4.54310475341762e-162	-0.530114467122297	0.565	0.849	7.77188930167152e-158	COX16	Malignant cells	GSE163836	ENSG00000133983	51241	cytochrome c oxidase assembly factor COX16	C14orf112|HSPC203	protein_coding	Q9P0S2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18124
1.56641126714926e-161	-0.529594985294391	0.431	0.752	2.67965975471225e-157	PPP2R1A	Malignant cells	GSE163836	ENSG00000105568	5518	protein phosphatase 2 scaffold subunit Aalpha	PP2A-Aalpha|PP2AA|PR65A	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18125
1.6018262049304e-161	-0.466200319577295	0.247	0.572	2.74024408877443e-157	SLC39A3	Malignant cells	GSE163836	ENSG00000141873	29985	solute carrier family 39 member 3	ZIP3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18126
2.2189482266512e-161	-0.522757452735591	0.387	0.71	3.79595473133221e-157	TMEM14A	Malignant cells	GSE163836	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18127
5.72310813305851e-161	0.654869993410896	0.984	0.871	9.79052108322319e-157	SOX4	Malignant cells	GSE163836	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18128
8.27556210836077e-161	-0.438203882782866	0.174	0.476	1.41570040987728e-156	ZDHHC24	Malignant cells	GSE163836	ENSG00000174165	254359	zinc finger DHHC-type containing 24	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18129
8.58049345145644e-161	0.585627966029907	0.883	0.759	1.46786501474065e-156	MAZ	Malignant cells	GSE163836	ENSG00000103495	4150	MYC associated zinc finger protein	Pur-1|ZF87|Zif87|ZNF801	protein_coding	P56270	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18130
9.48083843256775e-161	-0.550078824978964	0.507	0.803	1.62188703065937e-156	DAZAP1	Malignant cells	GSE163836	ENSG00000071626	26528	DAZ associated protein 1	MGC19907	protein_coding	Q96EP5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18131
3.3203725783997e-160	-0.554966806898371	0.494	0.789	5.68016136986837e-156	AGPAT2	Malignant cells	GSE163836	ENSG00000169692	10555	1-acylglycerol-3-phosphate O-acyltransferase 2	BSCL|LPAAT-beta|LPLAT2	protein_coding	O15120	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18132
4.20205437372826e-160	-0.524364686540774	0.402	0.724	7.18845441713693e-156	TMEM230	Malignant cells	GSE163836	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18133
7.66254763875547e-160	-0.356814749844218	0.069	0.308	1.3108320245619e-155	CNIH2	Malignant cells	GSE163836	ENSG00000174871	254263	cornichon family AMPA receptor auxiliary protein 2	CNIH-2|Cnil|MGC50896	protein_coding	Q6PI25	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18134
1.26790550762467e-159	-0.470373717405319	0.258	0.584	2.16900595189352e-155	LINC00998	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18135
3.08695863839956e-159	0.255184117924609	1	1	5.28086014271013e-155	RPS27	Malignant cells	GSE163836	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18136
1.53452479738765e-158	-0.460662845908641	0.279	0.605	2.62511157089105e-154	BCKDK	Malignant cells	GSE163836	ENSG00000103507	10295	branched chain keto acid dehydrogenase kinase	NA	protein_coding	O14874	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18137
1.75496475793872e-158	0.653801250963225	0.81	0.558	3.00221821140577e-154	NUPR1	Malignant cells	GSE163836	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18138
2.37647724639683e-158	-0.47177144882339	0.995	0.994	4.06543962541105e-154	EIF4EBP1	Malignant cells	GSE163836	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18139
2.38282888567331e-158	0.626693713829173	0.862	0.688	4.07630537472133e-154	MESP1	Malignant cells	GSE163836	ENSG00000166823	55897	mesoderm posterior bHLH transcription factor 1	bHLHc5|MGC10676	protein_coding	Q9BRJ9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18140
5.61907754480073e-158	-0.553630782353914	0.649	0.884	9.6125559558906e-154	POP7	Malignant cells	GSE163836	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18141
1.47662341957851e-157	-0.433854785812894	0.986	0.996	2.52605968387295e-153	ATP5J	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18142
2.84449496056995e-157	-0.422940074559025	0.134	0.414	4.86607752904702e-153	EFNA3	Malignant cells	GSE163836	ENSG00000143590	1944	ephrin A3	Ehk1-L|EPLG3|LERK3	protein_coding	P52797	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18143
3.85132463820094e-157	-0.443343773361146	0.183	0.486	6.58846105857035e-153	DPP3	Malignant cells	GSE163836	ENSG00000254986	10072	dipeptidyl peptidase 3	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18144
4.48602859289869e-157	0.591506053704457	0.988	0.883	7.67424911387179e-153	AZGP1	Malignant cells	GSE163836	ENSG00000160862	563	alpha-2-glycoprotein 1, zinc-binding	ZA2G|ZAG	protein_coding	P25311	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18145
5.86441615190255e-157	-0.543942451705489	0.677	0.904	1.00322567110597e-152	SF3B5	Malignant cells	GSE163836	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18146
1.02870812855172e-156	-0.53800821422612	0.443	0.758	1.75981099551343e-152	ARF6	Malignant cells	GSE163836	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18147
1.49540878091203e-156	-0.466511330450431	0.946	0.987	2.55819580150621e-152	ARPC2	Malignant cells	GSE163836	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18148
1.5336947451624e-156	-0.5195087023067	0.485	0.793	2.62369160054932e-152	SPG21	Malignant cells	GSE163836	ENSG00000090487	51324	SPG21 abhydrolase domain containing, maspardin	ABHD21|ACP33|BM-019|GL010|MAST	protein_coding	Q9NZD8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18149
1.74615270082515e-156	-0.529083274995146	0.751	0.931	2.98714342530159e-152	UQCRC1	Malignant cells	GSE163836	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18150
1.2573939944323e-155	-0.513426698697753	0.394	0.714	2.15102390627534e-151	EBPL	Malignant cells	GSE163836	ENSG00000123179	84650	EBP like	EBRP	protein_coding	Q9BY08	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18151
2.55960488439653e-155	-0.494447591112434	0.824	0.956	4.37871607573714e-151	ACP1	Malignant cells	GSE163836	ENSG00000143727	52	acid phosphatase 1	HAAP|LMW-PTP|LMWPTP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18152
2.59316965310036e-155	-0.429300161390379	0.193	0.496	4.43613532555878e-151	CHST12	Malignant cells	GSE163836	ENSG00000136213	55501	carbohydrate sulfotransferase 12	C4S-2|C4ST2	protein_coding	Q9NRB3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18153
7.23334220216251e-155	-0.46517133438158	0.23	0.54	1.23740785052394e-150	CRB3	Malignant cells	GSE163836	ENSG00000130545	92359	crumbs cell polarity complex component 3	MGC17303	protein_coding	Q9BUF7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18154
1.70570025584727e-154	-0.384650660181328	0.132	0.412	2.91794142767793e-150	ATPAF2	Malignant cells	GSE163836	ENSG00000171953	91647	ATP synthase mitochondrial F1 complex assembly factor 2	ATP12|Atp12p|LP3663|MGC29736	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18155
5.00262784586539e-154	-0.533237045641334	0.407	0.724	8.55799545592192e-150	EGFL7	Malignant cells	GSE163836	ENSG00000172889	51162	EGF like domain multiple 7	ZNEU1	protein_coding	Q9UHF1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18156
7.41037814529821e-154	-0.456314922225413	0.145	0.425	1.26769338931616e-149	MALL	Malignant cells	GSE163836	ENSG00000144063	7851	mal, T cell differentiation protein like	BENE	protein_coding	Q13021	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18157
1.16055702920231e-153	-0.493324141298081	0.845	0.96	1.98536490985639e-149	MRPL14	Malignant cells	GSE163836	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18158
1.29589447254424e-153	0.559449436096938	0.995	0.979	2.21688667418143e-149	HSP90AB1	Malignant cells	GSE163836	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18159
1.95020691593708e-153	-0.468351227458692	0.268	0.584	3.33621897109356e-149	EXOSC3	Malignant cells	GSE163836	ENSG00000107371	51010	exosome component 3	CGI-102|hRrp-40|hRrp40p|p10|RRP40|Rrp40p	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18160
3.16969197560177e-153	-0.417726424548166	0.172	0.468	5.42239206266195e-149	MTERFD1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18161
6.89025066590064e-153	0.816998173469397	0.893	0.71	1.17871518141562e-148	CALD1	Malignant cells	GSE163836	ENSG00000122786	800	caldesmon 1	CDM|H-CAD|h-CD|L-CAD	protein_coding	Q05682	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18162
1.58644841981831e-152	-0.478225293503218	0.347	0.672	2.71393731178318e-148	UCHL3	Malignant cells	GSE163836	ENSG00000118939	7347	ubiquitin C-terminal hydrolase L3	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18163
1.64282431931411e-152	-0.424049590638064	0.186	0.484	2.81037956305065e-148	TMEM216	Malignant cells	GSE163836	ENSG00000187049	51259	transmembrane protein 216	CORS2|HSPC244|JBTS2|MGC13379|MKS2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18164
2.63707161020422e-152	-0.286720756187671	1	1	4.51123840357636e-148	GAPDH	Malignant cells	GSE163836	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18165
3.56318953372155e-152	-0.519368266957232	0.769	0.938	6.09554833533745e-148	FIBP	Malignant cells	GSE163836	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18166
4.65252126615672e-152	-0.392436561027949	0.16	0.452	7.95906813001431e-148	ABT1	Malignant cells	GSE163836	ENSG00000146109	29777	activator of basal transcription 1	Esf2	protein_coding	Q9ULW3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18167
5.381475149311e-152	-0.524277531815782	0.489	0.788	9.20608953792632e-148	PCNP	Malignant cells	GSE163836	ENSG00000081154	57092	PEST proteolytic signal containing nuclear protein	NA	protein_coding	Q8WW12	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18168
1.23250079396474e-151	-0.418615580741694	0.977	0.997	2.10843910823549e-147	NDUFV2	Malignant cells	GSE163836	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18169
1.23860490789073e-151	-0.432411815247625	0.228	0.541	2.11888141592867e-147	HDAC3	Malignant cells	GSE163836	ENSG00000171720	8841	histone deacetylase 3	HD3|KDAC3|RPD3|RPD3-2	protein_coding	O15379	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18170
2.56276560291956e-151	-0.545678873407879	0.558	0.836	4.38412311691449e-147	CBR1	Malignant cells	GSE163836	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18171
3.3223263467038e-151	-0.523422350941941	0.383	0.696	5.68350368130619e-147	RRP7A	Malignant cells	GSE163836	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18172
4.38910990090425e-151	-0.459017498872494	0.936	0.991	7.5084503074769e-147	LAPTM4B	Malignant cells	GSE163836	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18173
4.61188189041645e-151	-0.413693217102738	0.157	0.442	7.88954634993542e-147	BNIP3	Malignant cells	GSE163836	ENSG00000176171	664	BCL2 interacting protein 3	HABON|Nip3	protein_coding	Q12983	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18174
2.12575721741808e-150	-0.57567354274564	0.594	0.845	3.63653287183711e-146	C19orf48	Malignant cells	GSE163836	ENSG00000167747	84798	multidrug resistance-related protein	BC006151|MGC13170	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18175
3.2609055568016e-150	-0.490337808594744	0.314	0.628	5.57843113602049e-146	CREM	Malignant cells	GSE163836	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18176
4.17346551116153e-150	-0.535079695275661	0.525	0.804	7.13954744994403e-146	COPS3	Malignant cells	GSE163836	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18177
5.33423737218167e-150	-0.49964339763295	0.776	0.937	9.12527987259118e-146	FKBP8	Malignant cells	GSE163836	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18178
7.78934224518676e-150	-0.508366571863037	0.428	0.74	1.3325227778841e-145	TSR3	Malignant cells	GSE163836	ENSG00000007520	115939	TSR3 ribosome maturation factor	C16orf42|MGC24381	protein_coding	Q9UJK0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18179
1.59866582175039e-149	-0.462860351272547	0.278	0.59	2.7348376212684e-145	TMEM9B	Malignant cells	GSE163836	ENSG00000175348	56674	TMEM9 domain family member B	C11orf15	protein_coding	Q9NQ34	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18180
3.37525453972194e-149	-0.4831981863752	0.32	0.638	5.77404794110232e-145	DGCR6L	Malignant cells	GSE163836	ENSG00000128185	85359	DiGeorge syndrome critical region gene 6 like	FLJ10666	protein_coding	Q9BY27	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18181
9.6569986241511e-149	-0.544823376599403	0.364	0.669	1.65202275463353e-144	DNAJC9	Malignant cells	GSE163836	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18182
1.93598706796201e-148	-0.335878318889913	0.089	0.335	3.31189307716261e-144	CXorf40B	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18183
2.41292919783853e-148	-0.496595576611341	0.901	0.969	4.12779797874238e-144	NENF	Malignant cells	GSE163836	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18184
3.80489834244997e-148	-0.59458540893312	0.98	0.987	6.50903959442916e-144	HMGN2	Malignant cells	GSE163836	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18185
4.7408694315781e-148	-0.695438190557389	0.69	0.894	8.11020533660066e-144	NPC2	Malignant cells	GSE163836	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18186
5.20679723395289e-148	-0.535765252298563	0.669	0.883	8.9072680281232e-144	STX10	Malignant cells	GSE163836	ENSG00000104915	8677	syntaxin 10	hsyn10|SYN10	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18187
1.01298556168985e-147	-0.488270021334615	0.311	0.617	1.73291440038282e-143	TFDP1	Malignant cells	GSE163836	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18188
1.24356244935333e-147	-0.516788375274412	0.305	0.618	2.12736228210875e-143	FH	Malignant cells	GSE163836	ENSG00000091483	2271	fumarate hydratase	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18189
1.60753652683766e-147	-0.430025833045391	0.142	0.416	2.75001273646118e-143	C12orf75	Malignant cells	GSE163836	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18190
2.07744317445323e-147	-0.456132909038326	0.281	0.593	3.55388203853715e-143	SRSF1	Malignant cells	GSE163836	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18191
4.71456280931773e-147	-0.417187534195238	0.196	0.494	8.06520259789985e-143	ALDH3A2	Malignant cells	GSE163836	ENSG00000072210	224	aldehyde dehydrogenase 3 family member A2	ALDH10|FALDH|SLS	protein_coding	P51648	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18192
9.33685223808421e-147	0.644109139705369	0.703	0.453	1.59725531236907e-142	LYN	Malignant cells	GSE163836	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18193
1.00625936962934e-146	-0.428797925016814	0.202	0.499	1.72140790362491e-142	YKT6	Malignant cells	GSE163836	ENSG00000106636	10652	YKT6 v-SNARE homolog	NA	protein_coding	O15498	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18194
1.09933017921569e-146	-0.527317198116234	0.438	0.739	1.88062413758427e-142	EFNA4	Malignant cells	GSE163836	ENSG00000243364	1945	ephrin A4	EPLG4|LERK4	protein_coding	P52798	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18195
2.25473544396059e-146	-0.471040873413944	0.304	0.619	3.85717592398339e-142	SPAG7	Malignant cells	GSE163836	ENSG00000091640	9552	sperm associated antigen 7	ACRP|FSA-1|MGC20134	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18196
3.40818045485977e-146	-0.522475237090487	0.771	0.93	5.83037430412861e-142	UBXN4	Malignant cells	GSE163836	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18197
3.76155713626472e-146	-0.49503550332195	0.993	0.997	6.43489579300805e-142	KRT8	Malignant cells	GSE163836	ENSG00000170421	3856	keratin 8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	protein_coding	P05787	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18198
4.33249369099498e-146	0.626536897855706	0.488	0.172	7.41159695718511e-142	ALDH1A3	Malignant cells	GSE163836	ENSG00000184254	220	aldehyde dehydrogenase 1 family member A3	ALDH6|RALDH3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18199
4.88254158474753e-146	-0.480935265351705	0.863	0.961	8.35256388902761e-142	MAF1	Malignant cells	GSE163836	ENSG00000179632	84232	MAF1 homolog, negative regulator of RNA polymerase III	DKFZp586G1123	protein_coding	Q9H063	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18200
5.11976221005565e-146	0.349979016875306	1	0.999	8.7583772127422e-142	ATP5E	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18201
9.07302766391601e-146	-0.549472255256033	0.349	0.658	1.55212284246611e-141	SDF2L1	Malignant cells	GSE163836	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18202
1.09381246416122e-145	-0.472309566233855	0.267	0.574	1.8711849824406e-141	ASRGL1	Malignant cells	GSE163836	ENSG00000162174	80150	asparaginase and isoaspartyl peptidase 1	ALP|ALP1|FLJ22316	protein_coding	Q7L266	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18203
1.5016712252157e-145	-0.485975909368588	0.362	0.681	2.5689089649765e-141	PACSIN3	Malignant cells	GSE163836	ENSG00000165912	29763	protein kinase C and casein kinase substrate in neurons 3	SDPIII	protein_coding	Q9UKS6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18204
1.88399299846594e-145	-0.46919719617859	0.349	0.664	3.22294682247569e-141	NABP2	Malignant cells	GSE163836	ENSG00000139579	79035	nucleic acid binding protein 2	hSSB1|MGC2731|OBFC2B|SOSS-B1|SSB1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18205
2.00069334042289e-145	-0.480117811083314	0.322	0.632	3.42258609746144e-141	ITGAE	Malignant cells	GSE163836	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18206
2.31409052988063e-145	-0.416430405682134	0.18	0.471	3.95871466946679e-141	PEPD	Malignant cells	GSE163836	ENSG00000124299	5184	peptidase D	NA	protein_coding	P12955	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18207
1.2367418528876e-144	-0.413199499031603	0.18	0.469	2.11569428773482e-140	DGAT2	Malignant cells	GSE163836	ENSG00000062282	84649	diacylglycerol O-acyltransferase 2	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18208
1.28947027388817e-144	-0.346203660755839	0.083	0.319	2.2058967975405e-140	PXN-AS1	Malignant cells	GSE163836	ENSG00000255857	NA	NA	EyeLinc4	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18209
1.36287095475273e-144	-0.49939639281315	0.426	0.734	2.3314633422955e-140	NAA50	Malignant cells	GSE163836	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18210
1.70059228441531e-144	0.502138335117745	0.967	0.885	2.90920322094926e-140	TSTD1	Malignant cells	GSE163836	ENSG00000215845	100131187	thiosulfate sulfurtransferase like domain containing 1	KAT	protein_coding	Q8NFU3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18211
1.88470662673303e-144	-0.338108751191668	0.103	0.356	3.22416762635219e-140	RHBDD3	Malignant cells	GSE163836	ENSG00000100263	25807	rhomboid domain containing 3	C22orf3|PTAG	protein_coding	Q9Y3P4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18212
5.1294223943031e-144	0.533768674533147	0.406	0.099	8.77490288993431e-140	MTRNR2L8	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18213
8.60082850876955e-144	-0.491789168507206	0.375	0.687	1.47134373299521e-139	FUOM	Malignant cells	GSE163836	ENSG00000148803	282969	fucose mutarotase	C10orf125|FLJ26016|FucM|FucU	protein_coding	A2VDF0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18214
3.29367654718109e-143	-0.516389820712386	0.392	0.698	5.63449246926269e-139	EMG1	Malignant cells	GSE163836	ENSG00000126749	10436	EMG1 N1-specific pseudouridine methyltransferase	C2F|Grcc2f|NEP1	protein_coding	Q92979	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18215
3.70109308078452e-143	-0.468719764113005	0.968	0.99	6.33145993329808e-139	KDELR2	Malignant cells	GSE163836	ENSG00000136240	11014	KDEL endoplasmic reticulum protein retention receptor 2	ELP-1|ERD2.2	protein_coding	P33947	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18216
5.25917873894488e-143	0.667810813510196	0.791	0.502	8.99687706871301e-139	VIM	Malignant cells	GSE163836	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18217
8.13010706097983e-143	-0.401271031479786	0.195	0.49	1.39081741492182e-138	POLR3H	Malignant cells	GSE163836	ENSG00000100413	171568	RNA polymerase III subunit H	C25|KIAA1665|RPC8	protein_coding	Q9Y535	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18218
1.19955183445691e-142	-0.42460446923476	0.217	0.515	2.05207332320544e-138	CREG1	Malignant cells	GSE163836	ENSG00000143162	8804	cellular repressor of E1A stimulated genes 1	CREG	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18219
3.14337218483235e-142	-0.648401105101527	0.429	0.726	5.37736679659269e-138	KLK6	Malignant cells	GSE163836	ENSG00000167755	5653	kallikrein related peptidase 6	Bssp|Klk7|neurosin|PRSS18|PRSS9	protein_coding	Q92876	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18220
3.27143079083302e-142	-0.429225238892777	0.222	0.522	5.59643665387804e-138	C16orf80	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18221
3.62067649910458e-142	-0.532186700854824	0.567	0.823	6.19389128701821e-138	TMEM134	Malignant cells	GSE163836	ENSG00000172663	80194	transmembrane protein 134	FLJ21749	protein_coding	Q9H6X4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18222
3.65001701801478e-142	-0.419967741058959	0.228	0.53	6.24408411271788e-138	DEXI	Malignant cells	GSE163836	ENSG00000182108	28955	Dexi homolog	MYLE	protein_coding	O95424	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18223
4.60973621021881e-142	-0.434233933780206	0.243	0.544	7.88587573482132e-138	BCL7B	Malignant cells	GSE163836	ENSG00000106635	9275	BAF chromatin remodeling complex subunit BCL7B	SMARCJ2	protein_coding	Q9BQE9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18224
6.56615120031344e-142	-0.49654431867864	0.892	0.964	1.12327148583762e-137	YIF1A	Malignant cells	GSE163836	ENSG00000174851	10897	Yip1 interacting factor homolog A, membrane trafficking protein	54TM|FinGER7|YIF1|YIF1P	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18225
6.94499683111933e-142	-0.497749322633088	0.761	0.941	1.18808060789958e-137	VAMP8	Malignant cells	GSE163836	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18226
1.73175710161811e-141	0.636992607363521	0.662	0.39	2.9625168737381e-137	FOXC1	Malignant cells	GSE163836	ENSG00000054598	2296	forkhead box C1	ARA|FKHL7|FREAC3|IGDA|IHG1|IRID1	protein_coding	Q12948	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18227
2.68663163196979e-141	-0.321486111982969	1	1	4.59602073281072e-137	RPL4	Malignant cells	GSE163836	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18228
4.00256619052447e-141	-0.459257553790021	0.316	0.627	6.8471899821302e-137	OSBPL8	Malignant cells	GSE163836	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18229
4.70391431111096e-141	-0.396015960617512	0.211	0.512	8.04698621201751e-137	UBL7	Malignant cells	GSE163836	ENSG00000288408	84993	ubiquitin like 7	BMSC-UbP|MGC14421	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18230
1.05037145479314e-140	-0.417731265262518	0.233	0.533	1.79687044771462e-136	PEMT	Malignant cells	GSE163836	ENSG00000133027	10400	phosphatidylethanolamine N-methyltransferase	PEMPT|PEMT2	protein_coding	Q9UBM1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18231
3.59779653885038e-140	-0.501949176074604	0.917	0.977	6.15475053901134e-136	CD63	Malignant cells	GSE163836	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18232
7.23803420779198e-140	-0.520117935554628	0.823	0.935	1.23821051192697e-135	TMEM160	Malignant cells	GSE163836	ENSG00000130748	54958	transmembrane protein 160	FLJ20512	protein_coding	Q9NX00	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18233
9.17967380934021e-140	0.512075073829061	0.95	0.856	1.57036679856383e-135	C12orf57	Malignant cells	GSE163836	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18234
1.15226270845747e-139	0.643406501371977	0.873	0.722	1.9711758153582e-135	DSP	Malignant cells	GSE163836	ENSG00000096696	1832	desmoplakin	DPI|DPII|KPPS2|PPKS2	protein_coding	P15924	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18235
1.61208441794199e-138	-0.491542850754024	0.759	0.935	2.75779281377337e-134	TMEM179B	Malignant cells	GSE163836	ENSG00000185475	374395	transmembrane protein 179B	NA	protein_coding	Q7Z7N9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18236
1.82791158101014e-138	-0.61940345325286	0.686	0.902	3.12700834163405e-134	DDX39A	Malignant cells	GSE163836	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18237
2.137669746361e-138	-0.500147275051243	0.509	0.79	3.65691163509976e-134	FAM32A	Malignant cells	GSE163836	ENSG00000105058	26017	family with sequence similarity 32 member A	DKFZP586O0120|OTAG-12	protein_coding	Q9Y421	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18238
3.33388611878626e-138	-0.438872714639095	0.251	0.551	5.70327898340766e-134	STX5	Malignant cells	GSE163836	ENSG00000162236	6811	syntaxin 5	SED5|STX5A	protein_coding	Q13190	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18239
4.74605739619099e-138	-0.372205236745917	0.165	0.443	8.11908038766393e-134	TMEM251	Malignant cells	GSE163836	ENSG00000275947	26175	transmembrane protein 251	C14orf109|DKFZP564F1123	protein_coding	Q8N6I4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18240
4.82957027716485e-138	-0.507709555337432	0.655	0.876	8.26194587314591e-134	TMEM14B	Malignant cells	GSE163836	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18241
8.21697574051588e-138	-0.443761227356033	0.283	0.585	1.40567803993005e-133	PLA2G12A	Malignant cells	GSE163836	ENSG00000123739	81579	phospholipase A2 group XIIA	PLA2G12	protein_coding	Q9BZM1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18242
9.15478080898371e-138	-0.436379104001216	0.196	0.478	1.56610835299284e-133	AAMP	Malignant cells	GSE163836	ENSG00000127837	14	angio associated migratory cell protein	NA	protein_coding	Q13685	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18243
1.77733382609585e-137	-0.416443811125175	0.209	0.5	3.04048497630216e-133	MPV17	Malignant cells	GSE163836	ENSG00000115204	4358	mitochondrial inner membrane protein MPV17	SYM1	protein_coding	P39210	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18244
1.90846357071285e-137	-0.291971132353302	1	1	3.26480863041847e-133	HINT1	Malignant cells	GSE163836	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18245
1.97424377625981e-137	0.591186805610726	0.734	0.517	3.37733882804766e-133	AP2B1	Malignant cells	GSE163836	ENSG00000006125	163	adaptor related protein complex 2 subunit beta 1	ADTB2|CLAPB1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18246
2.63973352666274e-137	-0.464076344010588	0.388	0.696	4.51579214406194e-133	MRPL19	Malignant cells	GSE163836	ENSG00000115364	9801	mitochondrial ribosomal protein L19	KIAA0104|MRP-L15|RLX1|RPML15	protein_coding	P49406	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18247
3.31491986289213e-137	-0.454213901982372	0.272	0.572	5.67083340944957e-133	IDH3B	Malignant cells	GSE163836	ENSG00000101365	3420	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta	RP46	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18248
4.33042803736048e-137	-0.480790542132506	0.893	0.968	7.40806324351258e-133	HNRNPDL	Malignant cells	GSE163836	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18249
6.67395020444812e-137	-0.663138258538766	0.346	0.616	1.14171266147494e-132	ASF1B	Malignant cells	GSE163836	ENSG00000288210	55723	anti-silencing function 1B histone chaperone	FLJ10604	protein_coding	Q9NVP2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18250
8.89188938079666e-137	-0.296668432886374	0.062	0.273	1.52113551637288e-132	CNTNAP2	Malignant cells	GSE163836	ENSG00000278728	26047	contactin associated protein 2	Caspr2|KIAA0868|NRXN4	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18251
1.17275757841686e-136	-0.455760395793464	0.264	0.561	2.00623638939773e-132	BRMS1	Malignant cells	GSE163836	ENSG00000174744	25855	BRMS1 transcriptional repressor and anoikis regulator	DKFZP564A063	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18252
1.50719712758693e-136	-0.470232830450654	0.466	0.769	2.57836212616296e-132	BABAM1	Malignant cells	GSE163836	ENSG00000105393	29086	BRISC and BRCA1 A complex member 1	C19orf62|FLJ20571|HSPC142|MERIT40|NBA1	protein_coding	Q9NWV8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18253
1.89648226987772e-136	0.495796176404283	0.375	0.081	3.24431221907981e-132	MT-ATP8	Malignant cells	GSE163836	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18254
3.13882527113842e-136	-0.405220766799526	0.987	0.998	5.36958839133649e-132	ATP5G3	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18255
3.40929744754227e-136	-0.504636101868399	0.174	0.456	5.83228514351056e-132	IFI6	Malignant cells	GSE163836	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18256
4.55764315802192e-136	-0.490475680572372	0.427	0.725	7.79676015042809e-132	EIF4H	Malignant cells	GSE163836	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18257
4.91109262783723e-136	-0.478660783072487	0.914	0.978	8.40140615844115e-132	MARCKSL1	Malignant cells	GSE163836	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18258
5.59447721881343e-136	-0.488001577168138	0.736	0.92	9.57047217822413e-132	NDUFAF3	Malignant cells	GSE163836	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18259
6.21284856358779e-136	-0.399083594968749	0.99	0.992	1.06283200377296e-131	MIF	Malignant cells	GSE163836	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18260
6.86477207004547e-136	-0.389184097072982	0.178	0.459	1.17435655802268e-131	RITA1	Malignant cells	GSE163836	ENSG00000139405	84934	RBPJ interacting and tubulin associated 1	C12orf52|FLJ14827|RITA	protein_coding	Q96K30	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18261
9.54392270127054e-136	-0.400086326069448	0.98	0.988	1.63267885650635e-131	PAFAH1B3	Malignant cells	GSE163836	ENSG00000079462	5050	platelet activating factor acetylhydrolase 1b catalytic subunit 3	NA	protein_coding	Q15102	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18262
1.5439604222376e-135	-0.591492029009273	0.462	0.743	2.64125309432186e-131	MANF	Malignant cells	GSE163836	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18263
1.64599303661963e-135	0.337363842952168	1	1	2.8158002877452e-131	COX6C	Malignant cells	GSE163836	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18264
3.13549328309527e-135	-0.41353298416487	0.967	0.99	5.36388835939108e-131	ZNF706	Malignant cells	GSE163836	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18265
4.12515633347847e-135	0.465115618439877	0.977	0.934	7.05690493968162e-131	C14orf2	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18266
4.36241966243075e-135	-0.43761617181241	0.243	0.538	7.46279131652028e-131	CRELD2	Malignant cells	GSE163836	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18267
5.92087327210369e-135	-0.501378900387714	0.892	0.97	1.01288379065878e-130	RHEB	Malignant cells	GSE163836	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18268
1.05991895562137e-134	-0.469484225475456	0.368	0.673	1.81320335738148e-130	NUDT22	Malignant cells	GSE163836	ENSG00000149761	84304	nudix hydrolase 22	MGC13045	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18269
1.15168114954265e-134	-0.608875072814056	0.566	0.812	1.9701809425226e-130	PSMC4	Malignant cells	GSE163836	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18270
1.33243186981378e-134	-0.458107524219707	0.916	0.978	2.27939119969043e-130	MRPS12	Malignant cells	GSE163836	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18271
2.02452414953597e-134	-0.460030483635538	0.315	0.616	3.46335346261118e-130	MAPRE1	Malignant cells	GSE163836	ENSG00000101367	22919	microtubule associated protein RP/EB family member 1	EB1	protein_coding	Q15691	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18272
5.48995451869722e-134	-0.494298598481779	0.414	0.708	9.39166519513534e-130	NCBP2-AS2	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18273
7.02026253080964e-134	-0.496981562565986	0.395	0.689	1.2009563111456e-129	TMEM205	Malignant cells	GSE163836	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18274
9.1980219423798e-134	-0.487622706315747	0.604	0.863	1.57350561368291e-129	RAB10	Malignant cells	GSE163836	ENSG00000084733	10890	RAB10, member RAS oncogene family	NA	protein_coding	P61026	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18275
1.33788008865291e-133	-0.509210061631899	0.959	0.973	2.28871146765853e-129	SIVA1	Malignant cells	GSE163836	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18276
1.40942260634237e-133	0.66328364359531	0.795	0.626	2.4110992526699e-129	NASP	Malignant cells	GSE163836	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18277
1.55399691159077e-133	-0.48202486908383	0.63	0.878	2.65842251665833e-129	RAB5C	Malignant cells	GSE163836	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18278
1.71504377650228e-133	-0.387467197902747	0.163	0.432	2.93392538846246e-129	LOXL1	Malignant cells	GSE163836	ENSG00000129038	4016	lysyl oxidase like 1	LOL|LOXL	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18279
2.21994179021065e-133	0.531616478571831	0.92	0.813	3.79765442051336e-129	KDELR1	Malignant cells	GSE163836	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18280
2.2181034662121e-132	-0.549445079420322	0.399	0.68	3.79450959964904e-128	DCUN1D5	Malignant cells	GSE163836	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18281
2.39488455961475e-132	-0.480489593613824	0.263	0.547	4.09692901613294e-128	CDCA4	Malignant cells	GSE163836	ENSG00000170779	55038	cell division cycle associated 4	FLJ20764|Hepp	protein_coding	Q9BXL8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18282
2.47405096938649e-132	-0.504804692362088	0.432	0.721	4.23235899332946e-128	RHOD	Malignant cells	GSE163836	ENSG00000173156	29984	ras homolog family member D	ARHD|Rho|RhoHP1	protein_coding	O00212	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18283
3.68173795565123e-132	-0.356301680100338	0.148	0.411	6.29834912073256e-128	TMEM38B	Malignant cells	GSE163836	ENSG00000095209	55151	transmembrane protein 38B	bA219P18.1|C9orf87|D4Ertd89e|FLJ10493|TRIC-B	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18284
4.24107948284837e-132	-0.464690224481438	0.808	0.948	7.2552146713087e-128	PHF14	Malignant cells	GSE163836	ENSG00000106443	9678	PHD finger protein 14	KIAA0783	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18285
4.82420418303117e-132	-0.483502149095178	0.759	0.926	8.25276609591143e-128	DPY30	Malignant cells	GSE163836	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18286
7.50763779775656e-132	-0.477046775573156	0.947	0.987	1.28433159806222e-127	PSMB3	Malignant cells	GSE163836	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18287
9.25712511654802e-132	0.665178711562214	0.626	0.36	1.58361639368787e-127	RCAN1	Malignant cells	GSE163836	ENSG00000159200	1827	regulator of calcineurin 1	DSCR1	protein_coding	P53805	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18288
1.72052978336934e-131	-0.462358119971159	0.269	0.559	2.94331030040992e-127	DPM1	Malignant cells	GSE163836	ENSG00000000419	8813	dolichyl-phosphate mannosyltransferase subunit 1, catalytic	CDGIE|MPDS	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18289
1.79181377895696e-131	-0.513358131488912	0.847	0.95	3.06525583166168e-127	COTL1	Malignant cells	GSE163836	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18290
2.02554690291754e-131	-0.384836053187233	0.176	0.45	3.46510308682104e-127	MOSPD3	Malignant cells	GSE163836	ENSG00000106330	64598	motile sperm domain containing 3	CDS3|NET30	protein_coding	O75425	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18291
2.32702940896723e-131	-0.499738380077148	0.275	0.557	3.98084920992024e-127	GGH	Malignant cells	GSE163836	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18292
3.81547779034591e-131	-0.456685873903423	0.336	0.636	6.52713785594475e-127	TRMT1	Malignant cells	GSE163836	ENSG00000104907	55621	tRNA methyltransferase 1	FLJ20244|TRM1	protein_coding	Q9NXH9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18293
6.53412257918678e-131	-0.489204031683372	0.56	0.825	1.11779234962148e-126	CNPY2	Malignant cells	GSE163836	ENSG00000257727	10330	canopy FGF signaling regulator 2	HP10390|TMEM4|ZSIG9	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18294
2.0704661943878e-130	-0.452195428774848	0.379	0.681	3.54194651873921e-126	ATG3	Malignant cells	GSE163836	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18295
3.91121453088637e-130	-0.334865878638887	0.101	0.336	6.69091469798731e-126	AKR1B1	Malignant cells	GSE163836	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18296
4.6001595787443e-130	-0.321011573775839	0.082	0.304	7.86949299135788e-126	ARID5A	Malignant cells	GSE163836	ENSG00000196843	10865	AT-rich interaction domain 5A	MRF-1|RP11-363D14	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18297
5.62523078194068e-130	-0.471155320895135	0.788	0.93	9.62308229866593e-126	ARPC1A	Malignant cells	GSE163836	ENSG00000241685	10552	actin related protein 2/3 complex subunit 1A	Arc40|SOP2Hs|SOP2L	protein_coding	Q92747	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18298
2.09994346770609e-129	-0.338666221437511	0.11	0.35	3.59237329020481e-125	UXS1	Malignant cells	GSE163836	ENSG00000115652	80146	UDP-glucuronate decarboxylase 1	FLJ23591|SDR6E1|UGD	protein_coding	Q8NBZ7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18299
2.22634245740295e-129	-0.417218947784552	0.259	0.549	3.80860404187922e-125	KEAP1	Malignant cells	GSE163836	ENSG00000079999	9817	kelch like ECH associated protein 1	INrf2|KIAA0132|KLHL19|MGC10630|MGC1114|MGC20887|MGC4407|MGC9454	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18300
1.11848229477946e-128	-0.563929856656832	0.585	0.809	1.91338766167922e-124	IMPA2	Malignant cells	GSE163836	ENSG00000141401	3613	inositol monophosphatase 2	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18301
1.7456396722115e-128	-0.436885500397759	0.285	0.575	2.98626578725221e-124	WDR5	Malignant cells	GSE163836	ENSG00000196363	11091	WD repeat domain 5	CFAP89|SWD3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18302
1.76353962831771e-128	-0.55591298641221	0.782	0.92	3.01688724216311e-124	PDIA6	Malignant cells	GSE163836	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18303
1.7863494379185e-128	-0.516064247209139	0.471	0.749	3.05590798344717e-124	PKP3	Malignant cells	GSE163836	ENSG00000184363	11187	plakophilin 3	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18304
2.8554670125655e-128	-0.428912780767622	0.245	0.528	4.8848474183958e-124	BARX2	Malignant cells	GSE163836	ENSG00000043039	8538	BARX homeobox 2	NA	protein_coding	Q9UMQ3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18305
4.16369483256311e-128	-0.373017424937195	0.169	0.435	7.12283275006572e-124	PUS1	Malignant cells	GSE163836	ENSG00000177192	80324	pseudouridine synthase 1	MLASA1	protein_coding	Q9Y606	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18306
5.19625621324678e-128	-0.456784541753731	0.683	0.91	8.88923550400126e-124	DGUOK	Malignant cells	GSE163836	ENSG00000114956	1716	deoxyguanosine kinase	dGK	protein_coding	Q16854	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18307
1.1853655121511e-127	-0.455950598382271	0.343	0.633	2.02780478163688e-123	PIGC	Malignant cells	GSE163836	ENSG00000135845	5279	phosphatidylinositol glycan anchor biosynthesis class C	NA	protein_coding	Q92535	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18308
1.87962873665042e-127	-0.452817755584518	0.852	0.969	3.21548087978788e-123	COPE	Malignant cells	GSE163836	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18309
2.12093722990598e-127	-0.475865309088078	0.944	0.981	3.62828731920016e-123	PSMB1	Malignant cells	GSE163836	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18310
2.56500632558733e-127	-0.306506731831987	0.074	0.286	4.38795632118224e-123	APMAP	Malignant cells	GSE163836	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18311
2.93777101785017e-127	-0.407224016280705	0.233	0.518	5.02564488023628e-123	FAM210B	Malignant cells	GSE163836	ENSG00000124098	116151	family with sequence similarity 210 member B	C20orf108|dJ1167H4.1|DKFZP434A1114	protein_coding	Q96KR6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18312
3.26303305397016e-127	-0.391156838714952	0.246	0.539	5.58207064542676e-123	MCRS1	Malignant cells	GSE163836	ENSG00000187778	10445	microspherule protein 1	ICP22BP|INO80Q|MCRS2|MSP58|P78	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18313
4.03354633218749e-127	-0.447159698299544	0.351	0.647	6.90018771047314e-123	NELFCD	Malignant cells	GSE163836	ENSG00000101158	51497	negative elongation factor complex member C/D	HSPC130|NELF-C|NELF-D|TH1|TH1L	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18314
2.02729144862692e-126	-0.49612763536246	0.623	0.866	3.46808748116606e-122	NOSIP	Malignant cells	GSE163836	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18315
2.03795955174008e-126	-0.389182444007206	0.199	0.474	3.48633740516176e-122	CXCL16	Malignant cells	GSE163836	ENSG00000161921	58191	C-X-C motif chemokine ligand 16	CXCLG16|SR-PSOX|SRPSOX	protein_coding	Q9H2A7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18316
2.14031102887493e-126	-0.567433152784299	0.319	0.597	3.66143007709634e-122	FEN1	Malignant cells	GSE163836	ENSG00000168496	2237	flap structure-specific endonuclease 1	FEN-1|MF1|RAD2	protein_coding	P39748	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18317
3.67162300983361e-126	-0.37021036630375	0.151	0.409	6.28104548292236e-122	SLC10A3	Malignant cells	GSE163836	ENSG00000126903	8273	solute carrier family 10 member 3	DXS253E|P3	protein_coding	P09131	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18318
9.1193470214456e-126	-0.498515314932581	0.634	0.851	1.5600466949587e-121	C9orf142	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18319
1.37418541686201e-125	-0.323404983650478	0.109	0.343	2.35081899262585e-121	FTSJ1	Malignant cells	GSE163836	ENSG00000068438	24140	FtsJ RNA 2'-O-methyltransferase 1	CDLIV|JM23|MRX44|MRX9|SPB1|TRM7|TRMT7	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18320
1.83685151926669e-125	-0.457012547492245	0.666	0.883	3.14230189400952e-121	TMEM183A	Malignant cells	GSE163836	ENSG00000163444	92703	transmembrane protein 183A	C1orf37	protein_coding	Q8IXX5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18321
2.24831078430481e-125	-0.444056891465233	0.418	0.714	3.84618525871024e-121	RNF130	Malignant cells	GSE163836	ENSG00000113269	55819	ring finger protein 130	G1RZFP|GOLIATH|GP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18322
3.45846790753907e-125	-0.469606778834389	0.412	0.7	5.91640104942708e-121	PRCC	Malignant cells	GSE163836	ENSG00000143294	5546	proline rich mitotic checkpoint control factor	RCCP1	protein_coding	Q92733	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18323
3.63567109436226e-125	-0.402970949724088	0.205	0.478	6.21954254112552e-121	PRR14	Malignant cells	GSE163836	ENSG00000156858	78994	proline rich 14	MGC3121	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18324
4.04192547089309e-125	-0.448070998591195	0.323	0.609	6.91452190305681e-121	CAPN2	Malignant cells	GSE163836	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18325
4.54369058903411e-125	-0.492414345198162	0.605	0.847	7.77289149066065e-121	DUSP23	Malignant cells	GSE163836	ENSG00000158716	54935	dual specificity phosphatase 23	DUSP25|FLJ20442	protein_coding	Q9BVJ7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18326
4.70374586271788e-125	0.479688856493731	0.939	0.857	8.04669804735148e-121	C8orf59	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18327
1.06330493206306e-124	-0.513993668705088	0.518	0.775	1.81899574728028e-120	PGP	Malignant cells	GSE163836	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18328
2.94314151414073e-124	-0.397676801450013	0.209	0.48	5.03483218824054e-120	RNF5	Malignant cells	GSE163836	ENSG00000223767	6048	ring finger protein 5	G16|NG2|RING5|RMA1	protein_coding	Q99942	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18329
6.3400784677023e-124	0.523792983961429	0.919	0.808	1.08459722346983e-119	SQSTM1	Malignant cells	GSE163836	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18330
7.32927424071816e-124	0.556020550952102	0.728	0.519	1.25381894435966e-119	NR2F6	Malignant cells	GSE163836	ENSG00000160113	2063	nuclear receptor subfamily 2 group F member 6	EAR-2|EAR2|ERBAL2	protein_coding	P10588	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18331
8.73344924801341e-124	0.285707598355015	1	0.999	1.49403116285765e-119	SAT1	Malignant cells	GSE163836	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18332
9.36476433130773e-124	-0.485131017647347	0.585	0.832	1.60203023415681e-119	WHSC1L1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18333
3.03801578602979e-123	-0.401782433730817	0.184	0.447	5.19713360516117e-119	PDIA4	Malignant cells	GSE163836	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18334
3.92373371989447e-123	-0.467755210401627	0.638	0.874	6.71233127462346e-119	PIH1D1	Malignant cells	GSE163836	ENSG00000104872	55011	PIH1 domain containing 1	DNAAF14|FLJ20643|MOT48|NOP17|Pih1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18335
1.10980827854914e-122	-0.428955998235981	0.305	0.592	1.89854902211402e-118	MAP2K3	Malignant cells	GSE163836	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18336
1.76057479213745e-122	-0.468250362580352	0.594	0.835	3.01181529690953e-118	ATRAID	Malignant cells	GSE163836	ENSG00000138085	51374	all-trans retinoic acid induced differentiation factor	APR3|C2orf28|HSPC013|p18	protein_coding	Q6UW56	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18337
1.93788317390703e-122	-0.429412042076489	0.393	0.696	3.31513674560276e-118	AKT1S1	Malignant cells	GSE163836	ENSG00000204673	84335	AKT1 substrate 1	Lobe|MGC2865|PRAS40	protein_coding	Q96B36	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18338
2.39601397593521e-122	-0.391947015716414	0.272	0.563	4.09886110863237e-118	NTPCR	Malignant cells	GSE163836	ENSG00000135778	84284	nucleoside-triphosphatase, cancer-related	C1orf57|HCR-NTPase|MGC13186|THEP1	protein_coding	Q9BSD7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18339
2.86082764450691e-122	-0.391408274526775	0.15	0.4	4.89401785145796e-118	HAND2	Malignant cells	GSE163836	ENSG00000164107	9464	heart and neural crest derivatives expressed 2	bHLHa26|dHand|Hed|Thing2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18340
7.60349861729395e-122	-0.461182065411299	0.522	0.789	1.30073050846048e-117	POLR3K	Malignant cells	GSE163836	ENSG00000161980	51728	RNA polymerase III subunit K	C11|RPC11	protein_coding	Q9Y2Y1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18341
7.7312611259744e-122	-0.627916414956984	0.625	0.832	1.32258684082044e-117	OBP2B	Malignant cells	GSE163836	ENSG00000280584	29989	odorant binding protein 2B	hOBPIIb|LCN14	protein_coding	Q9NPH6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18342
1.05221415055794e-121	-0.468131443942813	0.699	0.9	1.80002274735947e-117	CCDC124	Malignant cells	GSE163836	ENSG00000007080	115098	coiled-coil domain containing 124	Lso2|oxs1	protein_coding	Q96CT7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18343
1.15169006849412e-121	-0.455143748411929	0.413	0.696	1.97019620017289e-117	MRPS25	Malignant cells	GSE163836	ENSG00000131368	64432	mitochondrial ribosomal protein S25	DKFZp313H0817|FLJ00023|MRP-S25|RPMS25	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18344
1.4732566107177e-121	-0.445297281816145	0.451	0.741	2.52030008395476e-117	LSM6	Malignant cells	GSE163836	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18345
1.72913713328365e-121	-0.454277811710263	0.477	0.762	2.95803489390835e-117	LSM14A	Malignant cells	GSE163836	ENSG00000262860	26065	LSM14A mRNA processing body assembly factor	C19orf13|DKFZP434D1335|FAM61A|RAP55|RAP55A	protein_coding	Q8ND56	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18346
1.8469974431629e-121	-0.418465271864148	0.977	0.99	3.15965852601877e-117	YBX3	Malignant cells	GSE163836	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18347
1.89806491189909e-121	-0.451196323731859	0.522	0.803	3.24701964478578e-117	PAIP2	Malignant cells	GSE163836	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18348
3.28497505329281e-121	0.738590284382405	0.422	0.134	5.61960682366802e-117	RARRES3	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18349
4.34048633102095e-121	-0.459561028573913	0.519	0.786	7.42526996647754e-117	RAB1A	Malignant cells	GSE163836	ENSG00000138069	5861	RAB1A, member RAS oncogene family	RAB1|YPT1	protein_coding	P62820	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18350
5.5499463883653e-121	-0.389826336786705	0.087	0.3	9.49429328657651e-117	CTSV	Malignant cells	GSE163836	ENSG00000136943	1515	cathepsin V	CTSL2|CTSU	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18351
5.87982174726923e-121	-0.408432745852621	0.28	0.565	1.00586110630535e-116	ACN9	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18352
6.99385571691138e-121	-0.413140826111123	0.3	0.586	1.19643889749203e-116	EMC8	Malignant cells	GSE163836	ENSG00000131148	10328	ER membrane protein complex subunit 8	C16orf2|C16orf4|COX4NB|FAM158B|NOC4	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18353
1.02490686914612e-120	-0.422480340155612	0.333	0.622	1.75330818104827e-116	B4GALT3	Malignant cells	GSE163836	ENSG00000158850	8703	beta-1,4-galactosyltransferase 3	beta4Gal-T3	protein_coding	O60512	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18354
1.21089003449404e-120	-0.428897378655092	0.302	0.588	2.07146958200896e-116	LUZP1	Malignant cells	GSE163836	ENSG00000169641	7798	leucine zipper protein 1	LUZP	protein_coding	Q86V48	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18355
3.32263287376933e-120	-0.345628147018366	0.149	0.399	5.6840280571572e-116	B9D1	Malignant cells	GSE163836	ENSG00000108641	27077	B9 domain containing 1	B9|EPPB9|MKS9|MKSR-1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18356
4.37819964255016e-120	-0.362130502872776	0.193	0.459	7.48978612851057e-116	KLHL7	Malignant cells	GSE163836	ENSG00000122550	55975	kelch like family member 7	KLHL6|RP42|SBBI26	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18357
5.21756972615506e-120	-0.371866444958747	0.191	0.456	8.92569653053345e-116	ROGDI	Malignant cells	GSE163836	ENSG00000067836	79641	rogdi atypical leucine zipper	FLJ22386|RAV2|ROGD1	protein_coding	Q9GZN7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18358
5.56797582912894e-120	-0.470096817131136	0.78	0.932	9.52513625089087e-116	ARPC5L	Malignant cells	GSE163836	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18359
7.96435153852699e-120	-0.433812171125618	0.869	0.947	1.36246161769581e-115	GPAA1	Malignant cells	GSE163836	ENSG00000197858	8733	glycosylphosphatidylinositol anchor attachment 1	GAA1|hGAA1	protein_coding	O43292	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18360
9.72809602237054e-120	-0.306012339795791	0.107	0.336	1.66418538654693e-115	SNX12	Malignant cells	GSE163836	ENSG00000147164	29934	sorting nexin 12	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18361
1.33022232938633e-119	-0.321600575605109	0.133	0.376	2.2756113388812e-115	USB1	Malignant cells	GSE163836	ENSG00000103005	79650	U6 snRNA biogenesis phosphodiesterase 1	C16orf57|FLJ13154|HVSL1|Mpn1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18362
2.20911425154719e-119	-0.530045448403035	0.616	0.831	3.77913175012178e-115	RPL39L	Malignant cells	GSE163836	ENSG00000163923	116832	ribosomal protein L39 like	RPL39L1	protein_coding	Q96EH5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18363
3.20356434076587e-119	-0.397824890596426	0.265	0.547	5.48033751774818e-115	SMIM20	Malignant cells	GSE163836	ENSG00000250317	389203	small integral membrane protein 20	C4orf52|MITRAC7|PNX	protein_coding	Q8N5G0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18364
7.05200904439288e-119	-0.470602268159134	0.55	0.808	1.20638718722429e-114	MRPL18	Malignant cells	GSE163836	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18365
1.11257693625891e-118	-0.340885434490888	0.168	0.426	1.90328536485811e-114	ACOT8	Malignant cells	GSE163836	ENSG00000101473	10005	acyl-CoA thioesterase 8	hACTE-III|hTE|NAP1|PTE-2|PTE1	protein_coding	O14734	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18366
1.30543105941072e-118	-0.462116188969731	0.662	0.877	2.23320091333393e-114	ERGIC3	Malignant cells	GSE163836	ENSG00000125991	51614	ERGIC and golgi 3	C20orf47|CGI-54|Erv46|NY-BR-84|PRO0989|SDBCAG84	protein_coding	Q9Y282	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18367
1.97619317034784e-118	-0.484890077362491	0.438	0.708	3.38067365651406e-114	PPT1	Malignant cells	GSE163836	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18368
2.12486394413487e-118	0.495793271920992	0.397	0.122	3.63500474923151e-114	NFIL3	Malignant cells	GSE163836	ENSG00000165030	4783	nuclear factor, interleukin 3 regulated	E4BP4|IL3BP1|NF-IL3A|NFIL3A	protein_coding	Q16649	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18369
2.44520486153703e-118	-0.416831847618746	0.29	0.569	4.18301195663139e-114	CYB561A3	Malignant cells	GSE163836	ENSG00000162144	220002	cytochrome b561 family member A3	CYBASC3	protein_coding	Q8NBI2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18370
3.12930905446333e-118	0.624411102419471	0.637	0.39	5.35330899947042e-114	DUSP1	Malignant cells	GSE163836	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18371
3.96812655947817e-118	-0.493587048468243	0.996	0.998	6.78827410529931e-114	CALM2	Malignant cells	GSE163836	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18372
4.04306099104389e-118	-0.369904644995162	0.198	0.464	6.91646443737879e-114	TOB2	Malignant cells	GSE163836	ENSG00000183864	10766	transducer of ERBB2, 2	APRO5|bK223H9|TOB4|TOBL|TROB2	protein_coding	Q14106	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18373
5.91819799808643e-118	-0.354828223946674	0.173	0.432	1.01242613153265e-113	CYB561D2	Malignant cells	GSE163836	ENSG00000114395	11068	cytochrome b561 family member D2	101F6|TSP10	protein_coding	O14569	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18374
6.17384187626402e-118	-0.428472656771689	0.322	0.602	1.05615912977249e-113	BLOC1S2	Malignant cells	GSE163836	ENSG00000196072	282991	biogenesis of lysosomal organelles complex 1 subunit 2	BLOS2|BORCS2|FLJ30135|MGC10120	protein_coding	Q6QNY1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18375
8.06694370897116e-118	-0.49868222680172	0.668	0.881	1.3800120602937e-113	STRAP	Malignant cells	GSE163836	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18376
1.2267832456723e-117	-0.409907522367216	0.356	0.644	2.0986580983716e-113	PAIP1	Malignant cells	GSE163836	ENSG00000172239	10605	poly(A) binding protein interacting protein 1	NA	protein_coding	Q9H074	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18377
2.14418119796089e-117	0.486524135487344	0.886	0.756	3.66805077535169e-113	DYNC1I2	Malignant cells	GSE163836	ENSG00000077380	1781	dynein cytoplasmic 1 intermediate chain 2	DIC74|DNCI2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18378
3.53685423944392e-117	-0.453615076526224	0.407	0.684	6.05049654741671e-113	FUNDC2	Malignant cells	GSE163836	ENSG00000165775	65991	FUN14 domain containing 2	DC44|HCBP6	protein_coding	Q9BWH2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18379
4.19267061639001e-117	-0.437019338715131	0.39	0.67	7.17240162345839e-113	COA1	Malignant cells	GSE163836	ENSG00000106603	55744	cytochrome c oxidase assembly factor 1	C7orf44|FLJ10803|MITRAC15	protein_coding	Q9GZY4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18380
5.06554944005309e-117	-0.455268389195148	0.532	0.797	8.66563542709883e-113	MRPL17	Malignant cells	GSE163836	ENSG00000158042	63875	mitochondrial ribosomal protein L17	MRP-L26|RPML26	protein_coding	Q9NRX2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18381
6.72774199763504e-117	-0.359176676214385	0.208	0.48	1.15091482353543e-112	GCDH	Malignant cells	GSE163836	ENSG00000105607	2639	glutaryl-CoA dehydrogenase	ACAD5|GCD	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18382
1.24186895852155e-116	-0.33455312476617	0.151	0.398	2.12446522734282e-112	MAP2K1	Malignant cells	GSE163836	ENSG00000169032	5604	mitogen-activated protein kinase kinase 1	MAPKK1|MEK1|PRKMK1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18383
1.75914600068685e-116	-0.435744242225576	0.331	0.61	3.009371063375e-112	NQO2	Malignant cells	GSE163836	ENSG00000124588	4835	N-ribosyldihydronicotinamide:quinone reductase 2	DHQV|DIA6|NMOR2|QR2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18384
2.19909226098024e-116	-0.393914600562439	0.244	0.516	3.76198713085889e-112	HTATSF1	Malignant cells	GSE163836	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18385
2.77819179254535e-116	-0.304083895033488	0.103	0.324	4.75265269950734e-112	REEP6	Malignant cells	GSE163836	ENSG00000115255	92840	receptor accessory protein 6	C19orf32|DP1L1|FLJ25383|Yip2f	protein_coding	Q96HR9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18386
4.30215372058726e-116	-0.31161110970337	1	0.999	7.35969436980863e-112	C19orf53	Malignant cells	GSE163836	ENSG00000104979	28974	chromosome 19 open reading frame 53	HSPC023|LYDG10	protein_coding	Q9UNZ5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18387
4.77536564521906e-116	-0.300130798236543	0.094	0.309	8.16921800927625e-112	CCNG1	Malignant cells	GSE163836	ENSG00000113328	900	cyclin G1	CCNG	protein_coding	P51959	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18388
7.28321353470849e-116	-0.303903906770331	0.104	0.326	1.24593933938258e-111	ITSN2	Malignant cells	GSE163836	ENSG00000198399	50618	intersectin 2	KIAA1256|PRO2015|SH3D1B|SH3P18|SWA|SWAP	protein_coding	Q9NZM3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18389
7.28593340141317e-116	-0.439558918098995	0.369	0.654	1.24640462697975e-111	CD3EAP	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18390
1.13568255862784e-115	-0.448629789880391	0.907	0.963	1.94281215304465e-111	PRDX4	Malignant cells	GSE163836	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18391
1.80872495917328e-115	-0.422255411183655	0.345	0.624	3.09418578765773e-111	MED30	Malignant cells	GSE163836	ENSG00000164758	90390	mediator complex subunit 30	THRAP6|TRAP25	protein_coding	Q96HR3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18392
3.037042669093e-115	-0.405153317494812	0.347	0.633	5.1954688940174e-111	CLPTM1	Malignant cells	GSE163836	ENSG00000104853	1209	CLPTM1 regulator of GABA type A receptor forward trafficking	NA	protein_coding	O96005	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18393
3.62789102512503e-115	-0.39907354694006	0.296	0.58	6.20623317668138e-111	ZNF326	Malignant cells	GSE163836	ENSG00000162664	284695	zinc finger protein 326	FLJ20403|ZAN75|Zfp326|ZIRD	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18394
4.48953771154811e-115	-0.426636707262898	0.346	0.626	7.68025216314535e-111	TP53RK	Malignant cells	GSE163836	ENSG00000172315	112858	TP53 regulating kinase	BUD32|C20orf64|dJ101A2.2|Nori-2p|prpk|TPRKB	protein_coding	Q96S44	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18395
6.26163164441285e-115	-0.37865500569478	0.229	0.499	1.07117732540971e-110	TSFM	Malignant cells	GSE163836	ENSG00000123297	10102	Ts translation elongation factor, mitochondrial	EF-TS|EF-Tsmt	protein_coding	P43897	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18396
7.25192579305436e-115	-0.334895496359141	0.142	0.383	1.24058694541781e-110	KAT5	Malignant cells	GSE163836	ENSG00000172977	10524	lysine acetyltransferase 5	cPLA2|ESA1|HTATIP|HTATIP1|PLIP|TIP60|ZC2HC5	protein_coding	Q92993	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18397
7.79741644003516e-115	-0.406235407466241	0.89	0.972	1.33390403039682e-110	SUMO1	Malignant cells	GSE163836	ENSG00000116030	7341	small ubiquitin like modifier 1	GMP1|OFC10|PIC1|SMT3C|SMT3H3|SUMO-1|UBL1	protein_coding	P63165	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18398
7.93529128517057e-115	-0.382722147841869	0.21	0.471	1.35749028015413e-110	HTRA2	Malignant cells	GSE163836	ENSG00000115317	27429	HtrA serine peptidase 2	OMI|PARK13|PRSS25	protein_coding	O43464	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18399
9.78745171708058e-115	-0.396588130304227	0.239	0.508	1.67433936524098e-110	CCM2	Malignant cells	GSE163836	ENSG00000136280	83605	CCM2 scaffold protein	C7orf22|MGC4607|OSM	protein_coding	Q9BSQ5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18400
1.11229808476739e-114	-0.416210612754786	0.337	0.619	1.90280833361157e-110	SMYD2	Malignant cells	GSE163836	ENSG00000143499	56950	SET and MYND domain containing 2	HSKM-B|KMT3C|ZMYND14	protein_coding	Q9NRG4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18401
1.38647353996189e-114	-0.453559694113373	0.525	0.785	2.3718402848128e-110	SELK	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18402
1.52014439336111e-114	-0.433355248025851	0.499	0.769	2.60051101372285e-110	STAU1	Malignant cells	GSE163836	ENSG00000124214	6780	staufen double-stranded RNA binding protein 1	PPP1R150|STAU	protein_coding	O95793	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18403
3.39589525655277e-114	-0.450198633448734	0.277	0.543	5.80935801538483e-110	CST3	Malignant cells	GSE163836	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18404
4.45362559804907e-114	0.56494196300113	0.804	0.643	7.61881731058254e-110	ARHGDIB	Malignant cells	GSE163836	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18405
4.68965673219469e-114	-0.466795072717539	0.737	0.905	8.02259577176546e-110	VKORC1	Malignant cells	GSE163836	ENSG00000167397	79001	vitamin K epoxide reductase complex subunit 1	VKCFD2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18406
6.35955144350251e-114	0.525474499639691	0.813	0.653	1.08792846543998e-109	ARL4C	Malignant cells	GSE163836	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18407
7.38194754155433e-114	-0.391274402554075	0.298	0.582	1.2628297659337e-109	RPUSD3	Malignant cells	GSE163836	ENSG00000156990	285367	RNA pseudouridine synthase D3	MGC29784	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18408
1.23458382160445e-113	0.504176662144781	0.917	0.783	2.11200254361873e-109	ELF3	Malignant cells	GSE163836	ENSG00000163435	1999	E74 like ETS transcription factor 3	EPR-1|ERT|ESE-1|ESX	protein_coding	P78545	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18409
2.0531686653488e-113	-0.413824690045818	0.272	0.541	3.51235563581219e-109	TIMM8A	Malignant cells	GSE163836	ENSG00000126953	1678	translocase of inner mitochondrial membrane 8A	DDP|DFN1|MTS	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18410
2.13198175541288e-113	-0.362883510822238	0.198	0.458	3.64718118898481e-109	COMMD1	Malignant cells	GSE163836	ENSG00000173163	150684	copper metabolism domain containing 1	C2orf5|MGC27155|MURR1	protein_coding	Q8N668	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18411
3.12653474186913e-113	-0.391878356853944	0.253	0.522	5.34856298291552e-109	FEZ2	Malignant cells	GSE163836	ENSG00000171055	9637	fasciculation and elongation protein zeta 2	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18412
6.62295443173566e-113	-0.42970282302634	0.344	0.628	1.13298881463702e-108	PTTG1IP	Malignant cells	GSE163836	ENSG00000183255	754	PTTG1 interacting protein	C21orf1|C21orf3|PBF|PTTG1IP1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18413
6.66085808192655e-113	-0.38491298524542	0.235	0.499	1.13947299207518e-108	MRPS18A	Malignant cells	GSE163836	ENSG00000096080	55168	mitochondrial ribosomal protein S18A	FLJ10548|MRPS18-3	protein_coding	Q9NVS2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18414
7.25857050242062e-113	0.376618139293357	1	0.993	1.2417236558491e-108	KRT7	Malignant cells	GSE163836	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18415
8.90201218242113e-113	-0.407959054823236	0.303	0.576	1.52286722404678e-108	CLN6	Malignant cells	GSE163836	ENSG00000128973	54982	CLN6 transmembrane ER protein	FLJ20561|HsT18960|nclf	protein_coding	Q9NWW5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18416
9.26552382544481e-113	-0.419597917447505	0.904	0.97	1.58505316081884e-108	ANAPC11	Malignant cells	GSE163836	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18417
2.09156498286082e-112	-0.388931986503754	0.27	0.544	3.57804021618e-108	TMEM70	Malignant cells	GSE163836	ENSG00000175606	54968	transmembrane protein 70	FLJ20533	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18418
2.56192902597858e-112	-0.41153742738075	0.878	0.962	4.38269198474156e-108	ARPC3	Malignant cells	GSE163836	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18419
3.54663008046079e-112	-0.423048834350859	0.424	0.709	6.06722007864427e-108	WDR18	Malignant cells	GSE163836	ENSG00000065268	57418	WD repeat domain 18	Ipi3	protein_coding	Q9BV38	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18420
4.07837747068201e-112	0.563114141892864	0.675	0.459	6.97688033909571e-108	SOX9	Malignant cells	GSE163836	ENSG00000125398	6662	SRY-box transcription factor 9	CMD1|CMPD1|SRA1	protein_coding	P48436	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18421
5.51633466741186e-112	-0.803301660246462	0.466	0.708	9.43679371554148e-108	CDKN3	Malignant cells	GSE163836	ENSG00000100526	1033	cyclin dependent kinase inhibitor 3	CDI1|KAP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18422
6.15617917087737e-112	0.577043342929959	0.89	0.769	1.05313757076199e-107	TUBA1C	Malignant cells	GSE163836	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18423
6.86303390201165e-112	-0.396691391601402	0.252	0.521	1.17405920961713e-107	TSPAN15	Malignant cells	GSE163836	ENSG00000099282	23555	tetraspanin 15	NET-7|TM4SF15	protein_coding	O95858	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18424
2.08047509978514e-111	-0.429946553798334	0.362	0.634	3.55906875320244e-107	C9orf89	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18425
3.4754079780053e-111	-0.371738607083764	0.217	0.477	5.94538042797367e-107	ACAT1	Malignant cells	GSE163836	ENSG00000075239	38	acetyl-CoA acetyltransferase 1	ACAT|THIL	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18426
4.6730372514132e-111	-0.425444390449265	0.441	0.722	7.99416482599256e-107	SBDS	Malignant cells	GSE163836	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18427
6.27667575709514e-111	-0.36711998931277	0.252	0.523	1.07375092176626e-106	RPP25L	Malignant cells	GSE163836	ENSG00000164967	138716	ribonuclease P/MRP subunit p25 like	bA296L22.5|C9orf23|MGC29635	protein_coding	Q8N5L8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18428
1.02447006592936e-110	-0.422435018617044	0.831	0.945	1.75256094178536e-106	EXOSC4	Malignant cells	GSE163836	ENSG00000178896	54512	exosome component 4	FLJ20591|hRrp41p|p12A|RRP41|RRP41A|Rrp41p|SKI6|Ski6p	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18429
1.6246531014981e-110	-0.453033696825049	0.566	0.806	2.7792940607328e-106	RAB7A	Malignant cells	GSE163836	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18430
2.12708037547021e-110	0.493804086520099	0.809	0.665	3.63879639831689e-106	SEC11A	Malignant cells	GSE163836	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18431
2.79792489298777e-110	-0.350032376125961	0.19	0.444	4.78641011443418e-106	TPRA1	Malignant cells	GSE163836	ENSG00000163870	131601	transmembrane protein adipocyte associated 1	FLJ32197|GPR175|TMEM227|TPRA40	protein_coding	Q86W33	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18432
4.17607792459395e-110	-0.339363850339273	0.151	0.389	7.14401650560286e-106	OSGEP	Malignant cells	GSE163836	ENSG00000092094	55644	O-sialoglycoprotein endopeptidase	GCPL1|KAE1|OSGEP1|PRSMG1|TCS3	protein_coding	Q9NPF4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18433
4.29714463208299e-110	-0.318757290948595	0.124	0.35	7.35112532210438e-106	PHF23	Malignant cells	GSE163836	ENSG00000040633	79142	PHD finger protein 23	FLJ16355|MGC2941	protein_coding	Q9BUL5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18434
6.51636644837767e-110	-0.372858954944653	0.277	0.552	1.11475480832397e-105	HYAL2	Malignant cells	GSE163836	ENSG00000068001	8692	hyaluronidase 2	LuCa-2|LUCA2	protein_coding	Q12891	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18435
8.0935948852307e-110	-0.452810925347615	0.537	0.787	1.38457127701642e-105	SLC39A1	Malignant cells	GSE163836	ENSG00000143570	27173	solute carrier family 39 member 1	ZIP1|ZIRTL	protein_coding	Q9NY26	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18436
1.41413651091083e-109	-0.438905071008104	0.625	0.858	2.41916332921516e-105	YWHAE	Malignant cells	GSE163836	ENSG00000274474	7531	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon	FLJ45465	protein_coding	P62258	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18437
1.45806612517426e-109	-0.27382464757397	0.075	0.269	2.4943137203356e-105	B4GALNT1	Malignant cells	GSE163836	ENSG00000135454	2583	beta-1,4-N-acetyl-galactosaminyltransferase 1	beta1-4GalNAc-T|GALGT|SPG26	protein_coding	Q00973	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18438
1.69077327946386e-109	-0.353133704363254	0.214	0.477	2.89240584917883e-105	DNAAF2	Malignant cells	GSE163836	ENSG00000165506	55172	dynein axonemal assembly factor 2	C14orf104|CILD10|FLJ10563|KTU|PF13	protein_coding	Q9NVR5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18439
1.91462555682364e-109	-0.370674344342246	0.255	0.525	3.2753499400582e-105	PPP1R11	Malignant cells	GSE163836	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18440
2.65445117499356e-109	-0.28630062605776	0.098	0.309	4.54096962506148e-105	GNB1L	Malignant cells	GSE163836	ENSG00000185838	54584	G protein subunit beta 1 like	GY2|WDR14	protein_coding	Q9BYB4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18441
3.08762157568594e-109	-0.443986143127913	0.513	0.777	5.28199422952593e-105	MRPL28	Malignant cells	GSE163836	ENSG00000086504	10573	mitochondrial ribosomal protein L28	MAAT1|p15	protein_coding	Q13084	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18442
3.35668082171994e-109	-0.443696524287555	0.582	0.821	5.74227388171631e-105	MRPS5	Malignant cells	GSE163836	ENSG00000144029	64969	mitochondrial ribosomal protein S5	MRP-S5|S5mt	protein_coding	P82675	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18443
3.43743937243489e-109	-0.33937390134684	0.161	0.402	5.88042753442436e-105	DAPK3	Malignant cells	GSE163836	ENSG00000167657	1613	death associated protein kinase 3	ZIP|ZIPK	protein_coding	O43293	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18444
3.75342457049077e-109	-0.420504328091966	0.327	0.593	6.42098341273856e-105	KARS	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18445
4.1811982779807e-109	0.273507371807722	1	1	7.15277589414159e-105	UQCRH	Malignant cells	GSE163836	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18446
4.64541256544772e-109	-0.389681610212361	0.999	0.999	7.94690727571141e-105	FABP5	Malignant cells	GSE163836	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18447
5.11844787095738e-109	-0.354376823339352	0.173	0.418	8.75612877284678e-105	DPH2	Malignant cells	GSE163836	ENSG00000132768	1802	diphthamide biosynthesis 2	DPH2L2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18448
1.20102980318373e-108	-0.387824783591687	0.275	0.545	2.0546016843064e-104	NDUFAF4	Malignant cells	GSE163836	ENSG00000123545	29078	NADH:ubiquinone oxidoreductase complex assembly factor 4	bA22L21.1|C6orf66|HRPAP20|HSPC125|My013	protein_coding	Q9P032	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18449
1.31939564500388e-108	-0.367893626826056	0.986	0.993	2.25709012990813e-104	SNRPG	Malignant cells	GSE163836	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18450
1.96647718803201e-108	-0.370293194127914	0.235	0.498	3.36405252556636e-104	ARRDC1	Malignant cells	GSE163836	ENSG00000197070	92714	arrestin domain containing 1	MGC40555	protein_coding	Q8N5I2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18451
2.31771022889317e-108	-0.312686664129283	0.131	0.358	3.96490688856755e-104	ECHDC3	Malignant cells	GSE163836	ENSG00000134463	79746	enoyl-CoA hydratase domain containing 3	FLJ20909	protein_coding	Q96DC8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18452
2.36100691411853e-108	-0.3992043337758	0.327	0.602	4.03897452798257e-104	FAM189B	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18453
2.66192697591596e-108	-0.428415637594516	0.942	0.978	4.55375847769943e-104	PSMD8	Malignant cells	GSE163836	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18454
2.88774446255183e-108	-0.323188521834774	0.135	0.363	4.94006445208742e-104	FAM92A1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18455
3.42201498683452e-108	-0.349372609667702	0.191	0.44	5.85404103797782e-104	VPS4A	Malignant cells	GSE163836	ENSG00000132612	27183	vacuolar protein sorting 4 homolog A	FLJ22197|SKD1|SKD1A|SKD2|VPS4|VPS4-1	protein_coding	Q9UN37	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18456
3.56536475508909e-108	-0.382960235612269	0.275	0.546	6.09926948653091e-104	LINC00667	Malignant cells	GSE163836	ENSG00000263753	339290	long intergenic non-protein coding RNA 667	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18457
5.98473314400865e-108	-0.387565965399591	0.26	0.521	1.02380829894556e-103	TMEM243	Malignant cells	GSE163836	ENSG00000135185	79161	transmembrane protein 243	C7orf23|MGC4175|MM-TRAG	protein_coding	Q9BU79	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18458
6.026278740961e-108	-0.328473798759894	0.135	0.362	1.0309155042162e-103	MRPL39	Malignant cells	GSE163836	ENSG00000154719	54148	mitochondrial ribosomal protein L39	C21orf92|FLJ20451|L39mt|MGC104174|MGC3400|MRP-L5|MSTP003|PRED22|PRED66|RPML5	protein_coding	Q9NYK5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18459
7.2683030781853e-108	-0.404875892984435	0.945	0.981	1.24338860758516e-103	TPM4	Malignant cells	GSE163836	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18460
1.44493976997165e-107	-0.36407090632734	0.247	0.511	2.4718584644905e-103	UBL4A	Malignant cells	GSE163836	ENSG00000102178	8266	ubiquitin like 4A	DXS254E|GDX|GET5|MDY2|TMA24|UBL4	protein_coding	P11441	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18461
2.86259322098921e-107	0.487660640299273	0.448	0.186	4.89703822314623e-103	FAM84B	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18462
3.629605158587e-107	-0.4248493756805	0.44	0.704	6.20916554479479e-103	VTI1B	Malignant cells	GSE163836	ENSG00000100568	10490	vesicle transport through interaction with t-SNAREs 1B	VTI2	protein_coding	Q9UEU0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18463
4.00683721717027e-107	0.434932102677265	0.925	0.831	6.85449642741318e-103	DDT	Malignant cells	GSE163836	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18464
4.54072275983552e-107	-0.255176502745637	0.07	0.259	7.76781442525062e-103	MPV17L2	Malignant cells	GSE163836	ENSG00000254858	84769	MPV17 mitochondrial inner membrane protein like 2	FKSG24|MGC12972	protein_coding	Q567V2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18465
4.7074584069696e-107	-0.397515327749177	0.289	0.551	8.05304909680289e-103	ATP6V0E2	Malignant cells	GSE163836	ENSG00000171130	155066	ATPase H+ transporting V0 subunit e2	ATP6V0E2L|C7orf32	protein_coding	Q8NHE4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18466
5.91985355249774e-107	-0.392826384607957	0.934	0.979	1.01270934722579e-102	SERP1	Malignant cells	GSE163836	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18467
7.08520636438872e-107	-0.384768370694202	0.279	0.548	1.21206625275598e-102	PIGX	Malignant cells	GSE163836	ENSG00000163964	54965	phosphatidylinositol glycan anchor biosynthesis class X	FLJ20522	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18468
7.22293030171229e-107	-0.419733648555139	0.418	0.684	1.23562668671392e-102	LYRM4	Malignant cells	GSE163836	ENSG00000214113	57128	LYR motif containing 4	C6orf149|CGI-203|ISD11	protein_coding	Q9HD34	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18469
9.2386165073735e-107	-0.40129013801423	0.227	0.479	1.58045012591638e-102	RRP9	Malignant cells	GSE163836	ENSG00000114767	9136	ribosomal RNA processing 9, U3 small nucleolar RNA binding protein	RNU3IP2|U3-55K	protein_coding	O43818	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18470
1.22981478779554e-106	-0.420861171929161	0.457	0.727	2.10384415748183e-102	SELT	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18471
1.48304525102033e-106	-0.436305783452502	0.517	0.781	2.53704551092048e-102	SRSF5	Malignant cells	GSE163836	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18472
1.60176966817847e-106	-0.33299745631847	0.173	0.415	2.74014737135291e-102	THOC3	Malignant cells	GSE163836	ENSG00000051596	84321	THO complex subunit 3	MGC5469|TEX1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18473
2.29273068326726e-106	-0.471720069946532	0.549	0.797	3.9221743798653e-102	CNN3	Malignant cells	GSE163836	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18474
2.4184725815629e-106	-0.374537835282928	0.269	0.534	4.13728104527965e-102	EGLN2	Malignant cells	GSE163836	ENSG00000269858	112398	egl-9 family hypoxia inducible factor 2	HIFPH1|PHD1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18475
9.71222925052022e-106	-0.419919875982772	0.357	0.624	1.66147105788649e-101	ACOT7	Malignant cells	GSE163836	ENSG00000097021	11332	acyl-CoA thioesterase 7	ACH1|ACT|BACH|CTE-II|hBACH|LACH1|MGC1126	protein_coding	O00154	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18476
1.5383404375074e-105	-0.395617468193407	0.379	0.651	2.63163898644391e-101	STARD7	Malignant cells	GSE163836	ENSG00000084090	56910	StAR related lipid transfer domain containing 7	GTT1	protein_coding	Q9NQZ5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18477
1.74795206710361e-105	-0.427020013496503	0.774	0.923	2.99022160119414e-101	COX20	Malignant cells	GSE163836	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18478
2.40109985105638e-105	0.509899673139686	0.773	0.606	4.10756151520215e-101	MGMT	Malignant cells	GSE163836	ENSG00000170430	4255	O-6-methylguanine-DNA methyltransferase	NA	protein_coding	P16455	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18479
3.20033964307121e-105	-0.378656483809893	0.252	0.511	5.47482102740191e-101	LDOC1	Malignant cells	GSE163836	ENSG00000182195	23641	LDOC1 regulator of NFKB signaling	BCUR1|Mar7|Mart7|RTL7|SIRH7	protein_coding	O95751	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18480
3.99155373423927e-105	-0.425406084942356	0.662	0.872	6.82835097316312e-101	RBM17	Malignant cells	GSE163836	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18481
4.10587474315937e-105	-0.449320343823709	0.57	0.795	7.02391992312273e-101	GAMT	Malignant cells	GSE163836	ENSG00000130005	2593	guanidinoacetate N-methyltransferase	PIG2|TP53I2	protein_coding	Q14353	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18482
4.24701604511525e-105	-0.455803760477754	0.527	0.784	7.26537034837866e-101	PQBP1	Malignant cells	GSE163836	ENSG00000102103	10084	polyglutamine binding protein 1	MRX2|MRX55|MRXS3|MRXS8|RENS1|SHS	protein_coding	O60828	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18483
5.38142959646189e-105	-0.415476104412482	0.551	0.792	9.20601161066735e-101	ELP5	Malignant cells	GSE163836	ENSG00000288485	23587	elongator acetyltransferase complex subunit 5	C17orf81|DERP6	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18484
7.64054749122396e-105	-0.416905570480109	0.697	0.896	1.30706845932368e-100	RBM39	Malignant cells	GSE163836	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18485
1.43282472704012e-104	-0.335805778125277	0.187	0.433	2.45113326054753e-100	ZDHHC16	Malignant cells	GSE163836	ENSG00000171307	84287	zinc finger DHHC-type palmitoyltransferase 16	APH2	protein_coding	Q969W1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18486
1.67221598440673e-104	-0.379096212806715	0.29	0.553	2.86065988452459e-100	PIGT	Malignant cells	GSE163836	ENSG00000124155	51604	phosphatidylinositol glycan anchor biosynthesis class T	NA	protein_coding	Q969N2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18487
1.68538852977637e-104	-0.408919764945297	0.461	0.732	2.88319415788843e-100	RALA	Malignant cells	GSE163836	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18488
1.76447234669852e-104	-0.262875796508971	0.075	0.264	3.01848284349715e-100	KATNB1	Malignant cells	GSE163836	ENSG00000140854	10300	katanin regulatory subunit B1	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18489
2.0859292863246e-104	-0.362396085875765	0.241	0.497	3.5683992301155e-100	TEAD4	Malignant cells	GSE163836	ENSG00000197905	7004	TEA domain transcription factor 4	EFTR-2|RTEF-1|TCF13L1|TEF-3|TEFR-1	protein_coding	Q15561	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18490
2.18747985292547e-104	-0.440282058720365	0.586	0.821	3.7421217843996e-100	FAM162A	Malignant cells	GSE163836	ENSG00000114023	26355	family with sequence similarity 162 member A	C3orf28|E2IG5	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18491
2.65623198943251e-104	-0.385460792121307	0.315	0.583	4.5440160643222e-100	FTSJ2	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18492
2.69858347415302e-104	-0.406196635079958	0.813	0.946	4.61646674923357e-100	NDUFV1	Malignant cells	GSE163836	ENSG00000167792	4723	NADH:ubiquinone oxidoreductase core subunit V1	CI-51K	protein_coding	P49821	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18493
3.08468553094296e-104	-0.429194572230064	0.543	0.792	5.27697153778412e-100	ABHD11	Malignant cells	GSE163836	ENSG00000106077	83451	abhydrolase domain containing 11	PP1226|WBSCR21	protein_coding	Q8NFV4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18494
3.92873013591373e-104	-0.365306025936981	0.299	0.572	6.72087864350762e-100	PARL	Malignant cells	GSE163836	ENSG00000175193	55486	presenilin associated rhomboid like	PRO2207|PSARL|PSARL1|RHBDS1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18495
3.99911287596808e-104	-0.430027119237848	0.367	0.635	6.84128239691859e-100	TAF7	Malignant cells	GSE163836	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18496
6.14083166378484e-104	-0.372526113641366	0.356	0.632	1.05051207272367e-99	MOB1A	Malignant cells	GSE163836	ENSG00000114978	55233	MOB kinase activator 1A	C2orf6|FLJ10788|FLJ11595|Mats1|MOB1|Mob4B|MOBK1B|MOBKL1B	protein_coding	Q9H8S9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18497
1.44478825134335e-103	-0.298786953785883	0.113	0.327	2.47159926157307e-99	MRPL49	Malignant cells	GSE163836	ENSG00000149792	740	mitochondrial ribosomal protein L49	C11orf4|L49mt|NOF|NOF1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18498
1.71677504086207e-103	-0.256928286531564	0.072	0.259	2.93688706240275e-99	HDGFRP3	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18499
5.31270473169609e-103	-0.596495066020649	0.259	0.502	9.0884439845125e-99	HIST1H1C	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18500
7.12102856245602e-103	-0.330376521874143	0.144	0.371	1.21819435617935e-98	ERP44	Malignant cells	GSE163836	ENSG00000023318	23071	endoplasmic reticulum protein 44	KIAA0573|PDIA10|TXNDC4	protein_coding	Q9BS26	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18501
7.91058231238927e-103	-0.446008105320258	0.358	0.619	1.35326331618043e-98	ELOVL6	Malignant cells	GSE163836	ENSG00000170522	79071	ELOVL fatty acid elongase 6	FLJ23378|LCE|MGC5487	protein_coding	Q9H5J4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18502
7.97368636501632e-103	-0.400906107582746	0.933	0.97	1.36405852646334e-98	MRPL41	Malignant cells	GSE163836	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18503
1.04255440063206e-102	-0.349355799275362	0.266	0.53	1.78349781316127e-98	NDUFS4	Malignant cells	GSE163836	ENSG00000164258	4724	NADH:ubiquinone oxidoreductase subunit S4	AQDQ|CI-18	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18504
1.14879185921154e-102	-0.564401703292019	0.89	0.937	1.96523823355318e-98	TACSTD2	Malignant cells	GSE163836	ENSG00000184292	4070	tumor associated calcium signal transducer 2	EGP-1|GA733-1|M1S1|TROP2	protein_coding	P09758	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18505
1.28561427747186e-102	-0.297470226113875	0.126	0.346	2.19930034447112e-98	ZNF672	Malignant cells	GSE163836	ENSG00000171161	79894	zinc finger protein 672	FLJ22301	protein_coding	Q499Z4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18506
1.34420227087914e-102	-0.410886282635525	0.803	0.931	2.29952682479294e-98	PTRHD1	Malignant cells	GSE163836	ENSG00000184924	391356	peptidyl-tRNA hydrolase domain containing 1	C2orf79|LOC391356	protein_coding	Q6GMV3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18507
1.5893014427419e-102	-0.39156725711674	0.257	0.512	2.71881797809857e-98	WDR77	Malignant cells	GSE163836	ENSG00000116455	79084	WD repeat domain 77	MEP50|p44	protein_coding	Q9BQA1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18508
1.79369081038845e-102	-0.404469786461057	0.361	0.629	3.06846686933152e-98	WIZ	Malignant cells	GSE163836	ENSG00000011451	58525	WIZ zinc finger	ZNF803	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18509
1.93072451547952e-102	-0.391711312537249	0.336	0.6	3.30289042863082e-98	REST	Malignant cells	GSE163836	ENSG00000084093	5978	RE1 silencing transcription factor	DFNA27|NRSF|XBR	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18510
2.12917507906502e-102	0.416360118439271	0.343	0.097	3.64237980775652e-98	RP11-54O7.17	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18511
2.44404386888266e-102	-0.264523627949785	0.078	0.267	4.18102584649757e-98	PHTF1	Malignant cells	GSE163836	ENSG00000116793	10745	putative homeodomain transcription factor 1	PHTF	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18512
3.1877130690729e-102	-0.383499282862044	0.308	0.571	5.45322074726301e-98	GEMIN7	Malignant cells	GSE163836	ENSG00000142252	79760	gem nuclear organelle associated protein 7	FLJ13956	protein_coding	Q9H840	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18513
3.43698582982234e-102	-0.315774143539829	0.146	0.372	5.87965165907707e-98	CBY1	Malignant cells	GSE163836	ENSG00000100211	25776	chibby family member 1, beta catenin antagonist	C22orf2|Cby|Chibby|Chibby1|PGEA1|PIGEA-14|PIGEA14	protein_coding	Q9Y3M2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18514
3.6371246817094e-102	-0.425042217702859	0.317	0.574	6.22202919300026e-98	RRS1	Malignant cells	GSE163836	ENSG00000179041	23212	ribosome biogenesis regulator 1 homolog	KIAA0112	protein_coding	Q15050	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18515
4.63614388368329e-102	-0.275616055870249	0.073	0.257	7.931051341817e-98	FAM64A	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18516
5.82796704722341e-102	0.522166888574084	0.667	0.472	9.96990322768509e-98	AHCYL1	Malignant cells	GSE163836	ENSG00000168710	10768	adenosylhomocysteinase like 1	IRBIT|PPP1R78|XPVKONA	protein_coding	O43865	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18517
1.14827259124615e-101	-0.385851501090021	0.439	0.714	1.96434992184479e-97	MLST8	Malignant cells	GSE163836	ENSG00000167965	64223	MTOR associated protein, LST8 homolog	GbetaL|GBL|Lst8|Pop3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18518
1.21187866370028e-101	0.376126405940296	0.997	0.976	2.07316082999207e-97	C9orf16	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18519
1.73130004264313e-101	0.499328790942357	0.99	0.954	2.9617349829496e-97	S100A4	Malignant cells	GSE163836	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18520
2.04342666130794e-101	-0.438140611250254	0.515	0.772	3.49568998949948e-97	PSMD14	Malignant cells	GSE163836	ENSG00000115233	10213	proteasome 26S subunit, non-ATPase 14	pad1|POH1|Rpn11	protein_coding	O00487	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18521
2.10655970425262e-101	-0.376396280447273	0.329	0.596	3.60369168606496e-97	TUSC2	Malignant cells	GSE163836	ENSG00000114383	11334	tumor suppressor 2, mitochondrial calcium regulator	C3orf11|FUS1|PAP|PDAP2	protein_coding	O75896	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18522
2.95804389404358e-101	-0.387655005534219	0.3	0.561	5.06032568954036e-97	GLRX2	Malignant cells	GSE163836	ENSG00000023572	51022	glutaredoxin 2	bA101E13.1|GRX2	protein_coding	Q9NS18	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18523
3.02399920642459e-101	-0.331635416338623	0.184	0.425	5.17315544243055e-97	C1orf210	Malignant cells	GSE163836	ENSG00000253313	149466	chromosome 1 open reading frame 210	MGC52423|TEMP	protein_coding	Q8IVY1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18524
3.59776666375737e-101	-0.423368746154982	0.465	0.729	6.15469943168973e-97	C1orf35	Malignant cells	GSE163836	ENSG00000143793	79169	chromosome 1 open reading frame 35	MGC4174|MMTAG2	protein_coding	Q9BU76	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18525
4.33390639826848e-101	-0.345860026974382	0.178	0.413	7.41401367551788e-97	KRCC1	Malignant cells	GSE163836	ENSG00000172086	51315	lysine rich coiled-coil 1	FLJ22333	protein_coding	Q9NPI7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18526
4.54447590680323e-101	-0.414477981555754	0.493	0.754	7.77423493376828e-97	ZNF511	Malignant cells	GSE163836	ENSG00000198546	118472	zinc finger protein 511	MGC30006|Zfp511	protein_coding	Q8NB15	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18527
4.67538073377238e-101	0.483780946698071	0.879	0.763	7.99817382126441e-97	ATP1B1	Malignant cells	GSE163836	ENSG00000143153	481	ATPase Na+/K+ transporting subunit beta 1	ATP1B	protein_coding	P05026	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18528
5.24166875763198e-101	-0.415932627707685	0.435	0.695	8.96692274368103e-97	UCK2	Malignant cells	GSE163836	ENSG00000143179	7371	uridine-cytidine kinase 2	UMPK	protein_coding	Q9BZX2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18529
5.68862691652327e-101	-0.314238250263992	0.16	0.391	9.73153406609636e-97	GCFC2	Malignant cells	GSE163836	ENSG00000005436	6936	GC-rich sequence DNA-binding factor 2	C2orf3|DNABF|GCF|TCF9	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18530
6.06243790344237e-101	-0.393373935140447	0.875	0.965	1.03710125214189e-96	PHB	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18531
8.68535529353626e-101	-0.374551302618352	0.321	0.593	1.48580373006525e-96	CIAO1	Malignant cells	GSE163836	ENSG00000144021	9391	cytosolic iron-sulfur assembly component 1	CIA1|WDR39	protein_coding	O76071	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18532
8.71416297754983e-101	-0.39007654916151	0.91	0.97	1.49073186056945e-96	TTC3	Malignant cells	GSE163836	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18533
1.19600377983849e-100	-0.401031169572945	0.328	0.585	2.04600366616971e-96	URM1	Malignant cells	GSE163836	ENSG00000167118	81605	ubiquitin related modifier 1	C9orf74|MGC2668	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18534
1.25126441468508e-100	-0.299466413915475	0.136	0.358	2.14053803420176e-96	HIBADH	Malignant cells	GSE163836	ENSG00000106049	11112	3-hydroxyisobutyrate dehydrogenase	NS5ATP1	protein_coding	P31937	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18535
2.41235480620317e-100	-0.298455603176895	0.14	0.362	4.12681536697177e-96	TEX261	Malignant cells	GSE163836	ENSG00000144043	113419	testis expressed 261	MGC32043|TEG-261	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18536
2.70925197397873e-100	-0.359778082812787	0.274	0.535	4.63471735188541e-96	SHKBP1	Malignant cells	GSE163836	ENSG00000160410	92799	SH3KBP1 binding protein 1	PP203|Sb1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18537
3.1282755762693e-100	-0.555652919623423	0.74	0.886	5.35154102832389e-96	ID4	Malignant cells	GSE163836	ENSG00000172201	3400	inhibitor of DNA binding 4	bHLHb27	protein_coding	P47928	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18538
5.90923298403323e-100	-0.370413070502723	0.35	0.616	1.01089248657856e-95	TRAF7	Malignant cells	GSE163836	ENSG00000131653	84231	TNF receptor associated factor 7	DKFZp586I021|MGC7807|RFWD1|RNF119	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18539
7.28474375350834e-100	-0.425161260721514	0.575	0.807	1.24620111391267e-95	AP1S1	Malignant cells	GSE163836	ENSG00000106367	1174	adaptor related protein complex 1 subunit sigma 1	AP19|CLAPS1|EKV3|SIGMA1A|WUGSC:H_DJ0747G18.2	protein_coding	P61966	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18540
7.66725265158509e-100	-0.373426514464367	0.284	0.546	1.31163691110666e-95	DNTTIP1	Malignant cells	GSE163836	ENSG00000101457	116092	deoxynucleotidyltransferase terminal interacting protein 1	C20orf167|dJ447F3.4|Tdif1	protein_coding	Q9H147	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18541
1.25241631751612e-99	-0.41956550761799	0.648	0.858	2.14250859437483e-95	PAPOLA	Malignant cells	GSE163836	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18542
1.49161218873405e-99	-0.404607523034721	0.465	0.73	2.55170097126734e-95	TRAPPC3	Malignant cells	GSE163836	ENSG00000054116	27095	trafficking protein particle complex subunit 3	BET3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18543
1.52898195781982e-99	-0.31878055289088	0.996	0.998	2.61562943524237e-95	SNRPD2	Malignant cells	GSE163836	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18544
1.56909304182973e-99	0.579427895941354	0.525	0.278	2.68424746665812e-95	SGK1	Malignant cells	GSE163836	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18545
1.7014974925099e-99	-0.335646334592425	0.207	0.454	2.91075176043669e-95	AIFM2	Malignant cells	GSE163836	ENSG00000042286	84883	apoptosis inducing factor mitochondria associated 2	AMID|FLJ14497|FSP1|PRG3	protein_coding	Q9BRQ8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18546
1.7776998688317e-99	-0.416040857318934	0.558	0.795	3.04111116561039e-95	FLAD1	Malignant cells	GSE163836	ENSG00000160688	80308	flavin adenine dinucleotide synthetase 1	FAD1|PP591	protein_coding	Q8NFF5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18547
1.85457564697611e-99	-0.471343718685687	0.819	0.927	3.17262255928203e-95	SRSF7	Malignant cells	GSE163836	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18548
1.90062704241856e-99	-0.406046296139654	0.43	0.695	3.25140268146542e-95	MPZL1	Malignant cells	GSE163836	ENSG00000197965	9019	myelin protein zero like 1	FLJ21047|PZR	protein_coding	O95297	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18549
2.30101804343292e-99	-0.404932817057481	0.55	0.797	3.9363515669007e-95	CAPZB	Malignant cells	GSE163836	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18550
3.18822185040848e-99	-0.317386640607731	0.205	0.452	5.45409111949378e-95	MEF2BNB	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18551
3.35349226674588e-99	-0.401130908778112	0.426	0.69	5.73681922072218e-95	SEPHS2	Malignant cells	GSE163836	ENSG00000179918	22928	selenophosphate synthetase 2	SPS2|SPS2b	protein_coding	Q99611	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18552
3.56789621846403e-99	-0.311599270833767	0.162	0.393	6.10360006092642e-95	HRASLS	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18553
4.06586296574116e-99	-0.323278998172841	0.193	0.434	6.95547177549339e-95	ATG4D	Malignant cells	GSE163836	ENSG00000130734	84971	autophagy related 4D cysteine peptidase	APG4-D|APG4D|AUTL4	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18554
4.79749719396175e-99	0.462295898598364	0.641	0.343	8.20707844971036e-95	NPW	Malignant cells	GSE163836	ENSG00000183971	283869	neuropeptide W	PPL8	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18555
7.81072008992338e-99	-0.351616318996919	0.315	0.584	1.33617988578319e-94	CCZ1	Malignant cells	GSE163836	ENSG00000122674	51622	CCZ1 homolog, vacuolar protein trafficking and biogenesis associated	C7orf28A|CCZ1A|CGI-43	protein_coding	P86791	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18556
1.20103670587484e-98	-0.268556863904208	0.074	0.255	2.05461349274009e-94	ROPN1	Malignant cells	GSE163836	ENSG00000065371	54763	rhophilin associated tail protein 1	CT91|ODF6|ROPN1A|ropporin	protein_coding	Q9HAT0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18557
1.59336904420153e-98	-0.333939255510378	0.168	0.396	2.72577642391555e-94	ACD	Malignant cells	GSE163836	ENSG00000102977	65057	ACD shelterin complex subunit and telomerase recruitment factor	Pip1|Ptop|Tint1|Tpp1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18558
4.05972432736128e-98	-0.360747097301228	0.924	0.973	6.94497040681695e-94	BAX	Malignant cells	GSE163836	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18559
4.10641755616783e-98	-0.406735450568331	0.768	0.92	7.02484851333631e-94	UBE2D2	Malignant cells	GSE163836	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18560
5.06254554072937e-98	-0.335723596958555	0.991	0.996	8.66049665652573e-94	SNRPD1	Malignant cells	GSE163836	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18561
5.34699691093487e-98	-0.41232174317967	0.97	0.985	9.14710761553629e-94	RBM8A	Malignant cells	GSE163836	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18562
6.1406684664018e-98	-0.346875753955021	0.263	0.519	1.05048415454736e-93	MTX2	Malignant cells	GSE163836	ENSG00000128654	10651	metaxin 2	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18563
6.60383822510371e-98	-0.438476408137275	0.504	0.745	1.12971860516849e-93	PSIP1	Malignant cells	GSE163836	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18564
7.75792552276883e-98	-0.366547692869652	0.281	0.537	1.32714831918006e-93	GRK6	Malignant cells	GSE163836	ENSG00000198055	2870	G protein-coupled receptor kinase 6	GPRK6	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18565
8.97894241292909e-98	0.397358128785786	0.995	0.995	1.53602767857978e-93	PRDX1	Malignant cells	GSE163836	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18566
9.2518783589948e-98	-0.367006689486967	0.998	0.998	1.58271883087324e-93	DYNLL1	Malignant cells	GSE163836	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18567
9.54046190173902e-98	-0.35870850384942	0.173	0.402	1.63208681753049e-93	CCDC86	Malignant cells	GSE163836	ENSG00000110104	79080	coiled-coil domain containing 86	cyclon|MGC2574	protein_coding	Q9H6F5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18568
1.51049733788455e-97	-0.33643825269571	0.224	0.471	2.5840077959191e-93	RFWD2	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18569
1.58010121182615e-97	-0.326396790683303	0.205	0.446	2.70307914307099e-93	PDCD2L	Malignant cells	GSE163836	ENSG00000126249	84306	programmed cell death 2 like	MGC13096	protein_coding	Q9BRP1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18570
1.86430772517719e-97	-0.398870629368649	0.292	0.548	3.18927122546062e-93	TNNT1	Malignant cells	GSE163836	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18571
1.9854170787667e-97	0.529188382730243	0.46	0.218	3.3964529966462e-93	CASC8	Malignant cells	GSE163836	ENSG00000246228	727677	cancer susceptibility 8	CARLo-1|LINC00860	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18572
2.05819142318024e-97	-0.368722335970677	0.986	0.995	3.52094806763444e-93	TECR	Malignant cells	GSE163836	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18573
2.28834129792967e-97	-0.334207974271438	0.213	0.457	3.91466545836829e-93	FLII	Malignant cells	GSE163836	ENSG00000284571	2314	FLII actin remodeling protein	FLI|Fli1|FLIL|MGC39265	protein_coding	Q13045	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18574
2.55115993132137e-97	-0.286505541874645	0.099	0.295	4.36426929451147e-93	LGMN	Malignant cells	GSE163836	ENSG00000100600	5641	legumain	LGMN1|PRSC1	protein_coding	Q99538	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18575
3.88916968783474e-97	-0.410188921539043	0.465	0.724	6.6532025849789e-93	MRPL22	Malignant cells	GSE163836	ENSG00000082515	29093	mitochondrial ribosomal protein L22	HSPC158|MRP-L25|RPML25	protein_coding	Q9NWU5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18576
4.41365070493575e-97	-0.440921506352075	0.941	0.969	7.55043226093359e-93	S100A16	Malignant cells	GSE163836	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18577
6.50920272519185e-97	-0.389960285880189	0.871	0.956	1.11352931019857e-92	FBL	Malignant cells	GSE163836	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18578
8.10972357378116e-97	0.334630415789159	1	0.982	1.38733041176674e-92	HSPB1	Malignant cells	GSE163836	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18579
1.0364201312975e-96	-0.390180195342978	0.33	0.586	1.77300391861063e-92	SUCLG1	Malignant cells	GSE163836	ENSG00000163541	8802	succinate-CoA ligase GDP/ADP-forming subunit alpha	NA	protein_coding	P53597	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18580
3.01561057902778e-96	-0.386924520705602	0.465	0.724	5.15880501754282e-92	COMMD7	Malignant cells	GSE163836	ENSG00000149600	149951	COMM domain containing 7	C20orf92|dJ1085F17.3	protein_coding	Q86VX2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18581
5.29634453193499e-96	-0.376367989640185	0.306	0.562	9.06045659078119e-92	WDR83	Malignant cells	GSE163836	ENSG00000123154	84292	WD repeat domain 83	MORG1	protein_coding	Q9BRX9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18582
5.45567293448577e-96	-0.280264222057603	0.116	0.322	9.33301968902481e-92	STX4	Malignant cells	GSE163836	ENSG00000103496	6810	syntaxin 4	p35-2|STX4A	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18583
5.62022054169085e-96	-0.402713415730255	0.377	0.632	9.61451128067053e-92	PPP4R2	Malignant cells	GSE163836	ENSG00000163605	151987	protein phosphatase 4 regulatory subunit 2	NA	protein_coding	Q9NY27	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18584
7.06227914533431e-96	-0.476942918658385	0.762	0.902	1.20814409339234e-91	CCT7	Malignant cells	GSE163836	ENSG00000135624	10574	chaperonin containing TCP1 subunit 7	Ccth|Nip7-1	protein_coding	Q99832	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18585
8.28833468768837e-96	-0.386716326779289	0.858	0.953	1.41788541502285e-91	STOML2	Malignant cells	GSE163836	ENSG00000165283	30968	stomatin like 2	HSPC108|SLP-2	protein_coding	Q9UJZ1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18586
1.07370448295981e-95	-0.312170228531096	0.172	0.401	1.83678625899934e-91	FBXO7	Malignant cells	GSE163836	ENSG00000100225	25793	F-box protein 7	Fbx|FBX7|PARK15	protein_coding	Q9Y3I1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18587
1.20004027623765e-95	-0.367270701721609	0.316	0.572	2.05290890055975e-91	SURF4	Malignant cells	GSE163836	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18588
1.49436899238759e-95	-0.381010510047655	0.452	0.723	2.55641703527745e-91	BAD	Malignant cells	GSE163836	ENSG00000002330	572	BCL2 associated agonist of cell death	BBC2|BCL2L8	protein_coding	Q92934	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18589
1.58285394849429e-95	-0.342594125057567	0.268	0.521	2.70778824968919e-91	MTA1	Malignant cells	GSE163836	ENSG00000182979	9112	metastasis associated 1	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18590
1.7549850653503e-95	-0.307873508378223	0.158	0.38	3.00225295129476e-91	SMUG1	Malignant cells	GSE163836	ENSG00000123415	23583	single-strand-selective monofunctional uracil-DNA glycosylase 1	FDG|HMUDG|UNG3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18591
6.21669658370632e-95	-0.357198277506239	0.272	0.52	1.06349028457464e-90	FXN	Malignant cells	GSE163836	ENSG00000165060	2395	frataxin	CyaY|FA|FARR|FRDA|X25	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18592
6.94942878600287e-95	0.429968251977212	0.43	0.179	1.18883878242151e-90	SNORA76	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18593
7.51279596793291e-95	-0.28788020686992	0.125	0.333	1.28521400623428e-90	FSD1	Malignant cells	GSE163836	ENSG00000105255	79187	fibronectin type III and SPRY domain containing 1	MGC3213|MIR1	protein_coding	Q9BTV5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18594
1.20641710643906e-94	-0.375791426620995	0.853	0.954	2.06381774398529e-90	MRPL11	Malignant cells	GSE163836	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18595
1.66773853911547e-94	-0.673792827194863	0.789	0.895	2.85300031886484e-90	CRABP2	Malignant cells	GSE163836	ENSG00000143320	1382	cellular retinoic acid binding protein 2	CRABP-II	protein_coding	P29373	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18596
1.71222643476453e-94	-0.403707757870763	0.485	0.738	2.92910576195168e-90	C11orf31	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18597
1.99406322955579e-94	-0.28609407723993	0.134	0.346	3.41124396680108e-90	SDHD	Malignant cells	GSE163836	ENSG00000204370	6392	succinate dehydrogenase complex subunit D	cybS|PGL|PGL1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18598
2.56272474915682e-94	-0.341801030533966	0.271	0.523	4.38405322838258e-90	CDIPT	Malignant cells	GSE163836	ENSG00000103502	10423	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	PIS|PIS1	protein_coding	O14735	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18599
2.62218062210637e-94	-0.417000292225996	0.593	0.811	4.48576439023737e-90	FAM136A	Malignant cells	GSE163836	ENSG00000035141	84908	family with sequence similarity 136 member A	FLJ14668	protein_coding	Q96C01	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18600
3.19074868762149e-94	-0.331369836211366	0.219	0.459	5.45841377991409e-90	NETO2	Malignant cells	GSE163836	ENSG00000171208	81831	neuropilin and tolloid like 2	FLJ10430|NEOT2	protein_coding	Q8NC67	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18601
3.36120741907525e-94	-0.342131037961363	0.225	0.466	5.75001753181202e-90	SCCPDH	Malignant cells	GSE163836	ENSG00000143653	51097	saccharopine dehydrogenase (putative)	CGI-49|NET11	protein_coding	Q8NBX0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18602
3.45782763371473e-94	-0.269734290786647	0.092	0.28	5.91530573299579e-90	PLGRKT	Malignant cells	GSE163836	ENSG00000107020	55848	plasminogen receptor with a C-terminal lysine	AD025|C9orf46|FLJ14688|MDS030|Plg-RKT	protein_coding	Q9HBL7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18603
4.07925977401858e-94	-0.294198234717828	0.176	0.408	6.97838969541359e-90	GOLGA7	Malignant cells	GSE163836	ENSG00000147533	51125	golgin A7	GCP16|GOLGA3AP1|GOLGA7A|HSPC041	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18604
5.5968817477802e-94	-0.334554360440636	0.215	0.452	9.5745856059276e-90	COMMD9	Malignant cells	GSE163836	ENSG00000110442	29099	COMM domain containing 9	FLJ31106|HSPC166	protein_coding	Q9P000	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18605
6.01835161266265e-94	-0.410695784932662	0.507	0.761	1.0295594103782e-89	AHSA1	Malignant cells	GSE163836	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18606
6.89592388402651e-94	0.363791175372729	0.981	0.958	1.17968569884042e-89	RPS10	Malignant cells	GSE163836	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18607
6.98720906630773e-94	-0.401730058561048	0.679	0.869	1.19530185497326e-89	MRPS16	Malignant cells	GSE163836	ENSG00000182180	51021	mitochondrial ribosomal protein S16	CGI-132	protein_coding	Q9Y3D3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18608
7.82498299936142e-94	-0.351489810687301	0.299	0.552	1.33861984170076e-89	PAFAH1B1	Malignant cells	GSE163836	ENSG00000007168	5048	platelet activating factor acetylhydrolase 1b regulatory subunit 1	LIS1|MDCR|MDS|NudF|PAFAH	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18609
9.40069517593524e-94	-0.391830926111892	0.833	0.95	1.60817692374724e-89	DYNLT1	Malignant cells	GSE163836	ENSG00000146425	6993	dynein light chain Tctex-type 1	TCTEL1|Tctex-1|TCTEX1	protein_coding	P63172	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18610
1.06870357603613e-93	-0.378578050814291	0.215	0.448	1.828231207525e-89	GINS2	Malignant cells	GSE163836	ENSG00000131153	51659	GINS complex subunit 2	Pfs2|PSF2	protein_coding	Q9Y248	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18611
1.80152848490642e-93	-0.272513236315377	0.115	0.317	3.08187477912942e-89	PDLIM7	Malignant cells	GSE163836	ENSG00000196923	9260	PDZ and LIM domain 7	ENIGMA	protein_coding	Q9NR12	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18612
2.22392867662363e-93	0.375997253906938	0.992	0.969	3.80447478710004e-89	ATP5J2	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18613
2.81621703870071e-93	-0.352049432388981	0.303	0.558	4.81770248810531e-89	C16orf91	Malignant cells	GSE163836	ENSG00000174109	283951	chromosome 16 open reading frame 91	CCSMST1|gs103|URLC5	protein_coding	Q4G0I0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18614
3.65484341955282e-93	-0.400070279758684	0.585	0.81	6.25234063782901e-89	MPG	Malignant cells	GSE163836	ENSG00000103152	4350	N-methylpurine DNA glycosylase	MDG	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18615
4.2600351454132e-93	-0.425208455301777	0.668	0.863	7.28764212325837e-89	MRPL47	Malignant cells	GSE163836	ENSG00000136522	57129	mitochondrial ribosomal protein L47	CGI-204|NCM1	protein_coding	Q9HD33	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18616
5.91156520589306e-93	-0.363398792554124	0.31	0.562	1.01129145977213e-88	CMAS	Malignant cells	GSE163836	ENSG00000111726	55907	cytidine monophosphate N-acetylneuraminic acid synthetase	NA	protein_coding	Q8NFW8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18617
6.84885383832762e-93	0.342349787867733	0.993	0.987	1.17163342612271e-88	SUMO2	Malignant cells	GSE163836	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18618
7.69375798668703e-93	-0.382822256254509	0.41	0.665	1.31617117878255e-88	RNASEH1	Malignant cells	GSE163836	ENSG00000171865	246243	ribonuclease H1	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18619
1.43523940766076e-92	0.498065539125357	0.957	0.829	2.45526405468526e-88	RARRES1	Malignant cells	GSE163836	ENSG00000118849	5918	retinoic acid receptor responder 1	LXNL|TIG1	protein_coding	P49788	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18620
1.59055997388043e-92	-0.40426097228763	0.762	0.92	2.72097094731725e-88	DCTPP1	Malignant cells	GSE163836	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18621
1.68381090558783e-92	0.409662304277247	0.928	0.837	2.8804953161891e-88	SIGIRR	Malignant cells	GSE163836	ENSG00000185187	59307	single Ig and TIR domain containing	IL-1R8|TIR8	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18622
2.04431824348283e-92	-0.350256618036128	0.278	0.525	3.49721521912607e-88	DNPEP	Malignant cells	GSE163836	ENSG00000123992	23549	aspartyl aminopeptidase	ASPEP|DAP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18623
2.23617065636286e-92	-0.380782065513113	0.313	0.563	3.82541714183994e-88	DNAJB11	Malignant cells	GSE163836	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18624
2.36442698747339e-92	-0.387114786097508	0.48	0.728	4.04482524747072e-88	NUBP2	Malignant cells	GSE163836	ENSG00000095906	10101	NUBP iron-sulfur cluster assembly factor 2, cytosolic	CFD1|CIAO6	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18625
3.80483183770937e-92	-0.384616126114474	0.437	0.691	6.50892582476943e-88	HDDC2	Malignant cells	GSE163836	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18626
4.74022880581236e-92	-0.388761636839117	0.622	0.839	8.10910941810321e-88	ALG3	Malignant cells	GSE163836	ENSG00000214160	10195	ALG3 alpha-1,3- mannosyltransferase	CDGS4|D16Ertd36e|Not56|NOT56L	protein_coding	Q92685	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18627
5.00780276336676e-92	-0.385619027670972	0.441	0.698	8.56684818729152e-88	AP3S1	Malignant cells	GSE163836	ENSG00000177879	1176	adaptor related protein complex 3 subunit sigma 1	CLAPS3	protein_coding	Q92572	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18628
5.54242847899632e-92	-0.41066342217113	0.733	0.893	9.481432399019e-88	ATP5A1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18629
5.63592768369667e-92	0.451424477430366	0.435	0.19	9.64138148849989e-88	LIMCH1	Malignant cells	GSE163836	ENSG00000064042	22998	LIM and calponin homology domains 1	DKFZP686A01247|LIMCH1A|LMO7B	protein_coding	Q9UPQ0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18630
5.74927379955259e-92	0.497416233082904	0.65	0.463	9.83528268889461e-88	COPA	Malignant cells	GSE163836	ENSG00000122218	1314	COPI coat complex subunit alpha	HEP-COP	protein_coding	P53621	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18631
7.20927340567583e-92	-0.394174030480191	0.397	0.645	1.23329040150896e-87	IMPDH1	Malignant cells	GSE163836	ENSG00000106348	3614	inosine monophosphate dehydrogenase 1	LCA11|RP10|sWSS2608	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18632
7.54070416216048e-92	-0.306457848237738	0.178	0.404	1.28998826102079e-87	SIRT2	Malignant cells	GSE163836	ENSG00000283100	22933	sirtuin 2	SIR2L	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18633
9.68091359424787e-92	-0.335872726460595	0.226	0.463	1.65611388856798e-87	DPCD	Malignant cells	GSE163836	ENSG00000166171	25911	deleted in primary ciliary dyskinesia homolog (mouse)	DKFZP566F084|RP11-529I10.4	protein_coding	Q9BVM2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18634
1.42062153264599e-91	-0.37897510620959	0.458	0.714	2.43025725589749e-87	ARF5	Malignant cells	GSE163836	ENSG00000004059	381	ADP ribosylation factor 5	NA	protein_coding	P84085	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18635
1.47446992835416e-91	-0.364024981699669	0.327	0.584	2.52237570643546e-87	SAE1	Malignant cells	GSE163836	ENSG00000142230	10055	SUMO1 activating enzyme subunit 1	AOS1|FLJ3091|Sua1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18636
1.57772622818387e-91	-0.39955522001638	1	0.999	2.69901625855414e-87	HEBP2	Malignant cells	GSE163836	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18637
3.542301597197e-91	-0.421725892453752	0.634	0.843	6.05981534232491e-87	PSMD11	Malignant cells	GSE163836	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18638
4.01429573106804e-91	-0.345808731810189	0.292	0.541	6.8672557071381e-87	ZNF576	Malignant cells	GSE163836	ENSG00000124444	79177	zinc finger protein 576	MGC2508	protein_coding	Q9H609	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18639
5.82114337931687e-91	-0.362890501415799	0.34	0.594	9.95822997899736e-87	PTPMT1	Malignant cells	GSE163836	ENSG00000285206	114971	protein tyrosine phosphatase mitochondrial 1	DUSP23|MOSP|PLIP	protein_coding	Q8WUK0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18640
6.34801864079184e-91	-0.412700390845748	0.164	0.378	1.08595554888026e-86	HIST2H2AC	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18641
6.99259406930391e-91	-0.475478373003591	0.181	0.394	1.19622306743582e-86	AURKB	Malignant cells	GSE163836	ENSG00000178999	9212	aurora kinase B	Aik2|AIM-1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5	protein_coding	Q96GD4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18642
7.38002075720312e-91	-0.378936983828976	0.425	0.675	1.26250015093474e-86	UROS	Malignant cells	GSE163836	ENSG00000188690	7390	uroporphyrinogen III synthase	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18643
7.65059383636488e-91	-0.267819263632583	0.117	0.316	1.30878708758694e-86	INTS12	Malignant cells	GSE163836	ENSG00000138785	57117	integrator complex subunit 12	INT12|PHF22|SBBI22	protein_coding	Q96CB8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18644
8.9343542581165e-91	-0.358094404495526	0.318	0.57	1.52839998293599e-86	MFAP2	Malignant cells	GSE163836	ENSG00000117122	4237	microfibril associated protein 2	MAGP|MAGP-1	protein_coding	P55001	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18645
1.07765275390304e-90	-0.479215457846898	0.283	0.51	1.84354056610193e-86	E2F1	Malignant cells	GSE163836	ENSG00000101412	1869	E2F transcription factor 1	RBBP3|RBP3	protein_coding	Q01094	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18646
1.08638072505616e-90	-0.355977954408726	0.278	0.523	1.85847150635356e-86	DOHH	Malignant cells	GSE163836	ENSG00000129932	83475	deoxyhypusine hydroxylase	HLRC1|MGC4293	protein_coding	Q9BU89	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18647
2.01094342649424e-90	-0.284893088290952	0.13	0.336	3.4401209197037e-86	LENG1	Malignant cells	GSE163836	ENSG00000276628	79165	leukocyte receptor cluster member 1	NA	protein_coding	Q96BZ8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18648
2.22853703242117e-90	-0.397889615245327	0.587	0.809	3.8123583013629e-86	MLEC	Malignant cells	GSE163836	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18649
3.36086349801085e-90	-0.370801522456435	0.395	0.65	5.74942918604716e-86	FAM127B	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18650
4.01027337964519e-90	-0.460687583444104	0.667	0.85	6.86037467055903e-86	FARSA	Malignant cells	GSE163836	ENSG00000179115	2193	phenylalanyl-tRNA synthetase subunit alpha	CML33|FARSL|FARSLA	protein_coding	Q9Y285	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18651
7.29627032540892e-90	-0.363162240090677	0.294	0.54	1.2481729645677e-85	CEBPG	Malignant cells	GSE163836	ENSG00000153879	1054	CCAAT enhancer binding protein gamma	GPE1BP|IG/EBP-1	protein_coding	P53567	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18652
8.25831211557401e-90	-0.408714073480214	0.69	0.872	1.41274945361125e-85	TCP1	Malignant cells	GSE163836	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18653
9.51017371861202e-90	-0.318874271699973	0.156	0.37	1.62690541804296e-85	MAGED2	Malignant cells	GSE163836	ENSG00000102316	10916	MAGE family member D2	11B6|BCG1|HCA10|JCL-1|MAGE-D2|MAGED|MGC8386	protein_coding	Q9UNF1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18654
1.0779420114179e-89	-0.259139175547448	0.096	0.282	1.84403539893261e-85	RFT1	Malignant cells	GSE163836	ENSG00000163933	91869	RFT1 homolog	CDG1N	protein_coding	Q96AA3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18655
1.35599475247979e-89	-0.308388750571018	0.204	0.436	2.31970022306718e-85	SMIM15	Malignant cells	GSE163836	ENSG00000188725	643155	small integral membrane protein 15	C5orf43|DKFZP686E2158	protein_coding	Q7Z3B0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18656
1.93837842877545e-89	-0.283787521159505	0.129	0.331	3.31598397810616e-85	SHMT1	Malignant cells	GSE163836	ENSG00000284320	6470	serine hydroxymethyltransferase 1	cSHMT|MGC15229|MGC24556|SHMT	protein_coding	P34896	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18657
1.96669789673952e-89	-0.390561614839924	0.304	0.546	3.36443009195229e-85	ILVBL	Malignant cells	GSE163836	ENSG00000105135	10994	ilvB acetolactate synthase like	209L8|AHAS|FLJ39061|HACL1L|ILV2H|MGC1269|MGC19535	protein_coding	A1L0T0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18658
3.16763051449442e-89	0.501912247127051	0.655	0.466	5.41886552114561e-85	FXR1	Malignant cells	GSE163836	ENSG00000114416	8087	FMR1 autosomal homolog 1	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18659
3.34420621625832e-89	-0.412153928987374	0.407	0.651	5.72093357415311e-85	RBM42	Malignant cells	GSE163836	ENSG00000126254	79171	RNA binding motif protein 42	MGC10433	protein_coding	Q9BTD8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18660
3.37182661971596e-89	-0.324819548078278	0.294	0.547	5.7681837983481e-85	SDF4	Malignant cells	GSE163836	ENSG00000078808	51150	stromal cell derived factor 4	Cab45	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18661
3.93781592969631e-89	-0.338487105487629	0.257	0.496	6.73642171093148e-85	POP4	Malignant cells	GSE163836	ENSG00000105171	10775	POP4 homolog, ribonuclease P/MRP subunit	RPP29	protein_coding	O95707	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18662
4.56647705685797e-89	-0.319167867991968	0.216	0.45	7.81187230116693e-85	STXBP2	Malignant cells	GSE163836	ENSG00000076944	6813	syntaxin binding protein 2	Hunc18b|MUNC18-2|Unc18-2|UNC18B	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18663
5.8597140422884e-89	-0.266746277353735	0.136	0.344	1.00242128121428e-84	EGLN1	Malignant cells	GSE163836	ENSG00000135766	54583	egl-9 family hypoxia inducible factor 1	C1orf12|HIFPH2|PHD2|SM-20|ZMYND6	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18664
6.0032565883508e-89	-0.325387877445872	0.149	0.357	1.02697710456917e-84	CENPU	Malignant cells	GSE163836	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18665
6.23583649475898e-89	-0.284241760196743	0.14	0.347	1.06676454915842e-84	TM7SF3	Malignant cells	GSE163836	ENSG00000064115	51768	transmembrane 7 superfamily member 3	NA	protein_coding	Q9NS93	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18666
6.8752483278226e-89	-0.365598465523369	0.412	0.663	1.17614873144061e-84	NT5C3B	Malignant cells	GSE163836	ENSG00000141698	115024	5'-nucleotidase, cytosolic IIIB	cN-IIIB|MGC20781|NT5C3L	protein_coding	Q969T7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18667
1.09177986417404e-88	-0.260640580050511	0.094	0.278	1.86770781364253e-84	RNF26	Malignant cells	GSE163836	ENSG00000173456	79102	ring finger protein 26	MGC2642	protein_coding	Q9BY78	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18668
1.18852487338997e-88	-0.364409070946534	0.445	0.7	2.03320950090823e-84	ERI3	Malignant cells	GSE163836	ENSG00000117419	79033	ERI1 exoribonuclease family member 3	FLJ22943|PINT1|PRNPIP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18669
1.25371869268747e-88	-0.374479957954732	0.42	0.668	2.14473656758046e-84	PSMG1	Malignant cells	GSE163836	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18670
1.28175665924791e-88	-0.348235856959906	0.362	0.618	2.19270111697541e-84	EMC10	Malignant cells	GSE163836	ENSG00000161671	284361	ER membrane protein complex subunit 10	C19orf63|HSM1|HSS1|INM02	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18671
1.54516044456801e-88	-0.373645041874111	0.507	0.752	2.64330597252249e-84	EI24	Malignant cells	GSE163836	ENSG00000149547	9538	EI24 autophagy associated transmembrane protein	EPG4|PIG8|TP53I8	protein_coding	O14681	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18672
1.69229963602039e-88	-0.356714704482649	0.448	0.714	2.89501698734008e-84	RP11-345J4.5	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18673
2.11128111067941e-88	-0.433586234215127	0.781	0.912	3.61176859603926e-84	WDR34	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18674
2.42899435678581e-88	-0.461068521814861	0.684	0.845	4.15528064615348e-84	EIF3I	Malignant cells	GSE163836	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18675
4.29502794791137e-88	-0.363893996174393	0.41	0.658	7.34750431049199e-84	PRKRA	Malignant cells	GSE163836	ENSG00000180228	8575	protein activator of interferon induced protein kinase EIF2AK2	DYT16|HSD14|PACT|RAX	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18676
4.6140152931741e-88	-0.341363556626682	0.28	0.524	7.89319596203293e-84	SMC6	Malignant cells	GSE163836	ENSG00000163029	79677	structural maintenance of chromosomes 6	FLJ22116|SMC6L1	protein_coding	Q96SB8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18677
5.36926369686141e-88	-0.386973429948034	0.831	0.941	9.18519940622081e-84	LSM3	Malignant cells	GSE163836	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18678
5.70440419735271e-88	-0.334237036360979	0.262	0.502	9.75852426041128e-84	SIAH2	Malignant cells	GSE163836	ENSG00000181788	6478	siah E3 ubiquitin protein ligase 2	NA	protein_coding	O43255	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18679
6.4924883178561e-88	-0.271399358674971	0.124	0.323	1.11066997653564e-83	BLCAP	Malignant cells	GSE163836	ENSG00000166619	10904	BLCAP apoptosis inducing factor	BC10	protein_coding	P62952	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18680
8.25183332456259e-88	-0.263322302272413	0.118	0.315	1.41164112683292e-83	ASCC2	Malignant cells	GSE163836	ENSG00000100325	84164	activating signal cointegrator 1 complex subunit 2	ASC1p100|DKFZp586O0223|FLJ21588	protein_coding	Q9H1I8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18681
1.00176942398358e-87	-0.392647118150834	0.561	0.787	1.71372695360872e-83	IMP4	Malignant cells	GSE163836	ENSG00000136718	92856	IMP U3 small nucleolar ribonucleoprotein 4	BXDC4|MGC19606	protein_coding	Q96G21	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18682
1.17684687690712e-87	-0.271149193216865	0.117	0.312	2.013231952325e-83	MUS81	Malignant cells	GSE163836	ENSG00000172732	80198	MUS81 structure-specific endonuclease subunit	FLJ44872|SLX3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18683
1.34472695275572e-87	-0.472668091877399	0.746	0.891	2.30042439807921e-83	RNASEH2A	Malignant cells	GSE163836	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18684
1.60546297240598e-87	-0.313195372241562	0.225	0.462	2.7464655068949e-83	HORMAD1	Malignant cells	GSE163836	ENSG00000143452	84072	HORMA domain containing 1	CT46|DKFZP434A1315	protein_coding	Q86X24	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18685
1.66414670288746e-87	-0.320948106095105	0.152	0.361	2.84685576462958e-83	CCNE1	Malignant cells	GSE163836	ENSG00000105173	898	cyclin E1	CCNE	protein_coding	P24864	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18686
1.73860833422466e-87	-0.370303490736712	0.358	0.602	2.97423727735812e-83	HN1L	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18687
2.03872117118616e-87	-0.454677777032594	0.731	0.88	3.48764030754816e-83	PSMA5	Malignant cells	GSE163836	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18688
2.192901784306e-87	-0.360374436659128	0.245	0.48	3.75139708241227e-83	PNO1	Malignant cells	GSE163836	ENSG00000115946	56902	partner of NOB1 homolog	KHRBP1|RRP20	protein_coding	Q9NRX1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18689
2.32992097493083e-87	-0.286483173850766	0.145	0.351	3.98579581181418e-83	ELAC2	Malignant cells	GSE163836	ENSG00000006744	60528	elaC ribonuclease Z 2	FLJ10530|HPC2	protein_coding	Q9BQ52	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18690
2.56084540965976e-87	-0.443005212012437	0.531	0.755	4.38083824230495e-83	GPATCH4	Malignant cells	GSE163836	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18691
2.80517996411618e-87	-0.397249012292528	0.432	0.672	4.79882136461354e-83	NDUFA9	Malignant cells	GSE163836	ENSG00000139180	4704	NADH:ubiquinone oxidoreductase subunit A9	CI-39k|COQ11|NDUFS2L|SDR22E1	protein_coding	Q16795	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18692
4.49651275091655e-87	-0.396832027681477	0.422	0.67	7.69218436299294e-83	DNASE2	Malignant cells	GSE163836	ENSG00000105612	1777	deoxyribonuclease 2, lysosomal	DNL|DNL2	protein_coding	O00115	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18693
5.0091877548681e-87	-0.264728549031793	0.137	0.344	8.56921749225286e-83	LPHN1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18694
6.07081100807532e-87	-0.275355781383345	0.116	0.309	1.03853363915144e-82	RNF113A	Malignant cells	GSE163836	ENSG00000125352	7737	ring finger protein 113A	Cwc24|RNF113|ZNF183	protein_coding	O15541	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18695
6.47505158241338e-87	-0.341787927409467	0.294	0.537	1.10768707420346e-82	NR2C2AP	Malignant cells	GSE163836	ENSG00000184162	126382	nuclear receptor 2C2 associated protein	TRA16	protein_coding	Q86WQ0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18696
7.0273007791917e-87	-0.291438561669416	0.184	0.407	1.20216034429632e-82	TRMT6	Malignant cells	GSE163836	ENSG00000089195	51605	tRNA methyltransferase 6 non-catalytic subunit	CGI-09|GCD10|Gcd10p|MGC5029	protein_coding	Q9UJA5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18697
1.14920419394496e-86	-0.301053300146949	0.19	0.412	1.96594361458164e-82	TMX1	Malignant cells	GSE163836	ENSG00000139921	81542	thioredoxin related transmembrane protein 1	PDIA11|TMX|TXNDC|TXNDC1	protein_coding	Q9H3N1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18698
1.16147514746698e-86	-0.335234710840414	0.293	0.536	1.98693553477176e-82	SLC35B1	Malignant cells	GSE163836	ENSG00000121073	10237	solute carrier family 35 member B1	AXER|UGTREL1	protein_coding	P78383	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18699
1.170165733689e-86	-0.312534044028848	0.199	0.427	2.00180252062178e-82	PVRL4	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18700
1.20633881063226e-86	-0.368508052664674	0.391	0.64	2.06368380334862e-82	CTDNEP1	Malignant cells	GSE163836	ENSG00000288307	23399	CTD nuclear envelope phosphatase 1	DULLARD|HSA011916|NET56	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18701
1.26818220143288e-86	-0.31002177079532	0.997	0.997	2.16947929199122e-82	OST4	Malignant cells	GSE163836	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18702
1.62546302468161e-86	-0.356489649778081	0.386	0.637	2.78067959632283e-82	DFFA	Malignant cells	GSE163836	ENSG00000160049	1676	DNA fragmentation factor subunit alpha	DFF-45|DFF1|DFF45|ICAD	protein_coding	O00273	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18703
1.73837874379612e-86	-0.288483535844088	0.19	0.416	2.97384451701202e-82	HCCS	Malignant cells	GSE163836	ENSG00000004961	3052	holocytochrome c synthase	CCHL|MLS	protein_coding	P53701	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18704
1.82667694532694e-86	-0.301086611057878	0.196	0.421	3.12489625037079e-82	UBE2D4	Malignant cells	GSE163836	ENSG00000078967	51619	ubiquitin conjugating enzyme E2 D4 (putative)	HBUCE1	protein_coding	Q9Y2X8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18705
2.06359745151012e-86	-0.304910206898845	0.207	0.437	3.53019616029836e-82	MTIF2	Malignant cells	GSE163836	ENSG00000085760	4528	mitochondrial translational initiation factor 2	IF-2mt	protein_coding	P46199	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18706
2.07305583692683e-86	-0.339207726903408	0.293	0.538	3.54637662023073e-82	TMEM203	Malignant cells	GSE163836	ENSG00000187713	94107	transmembrane protein 203	HBEBP1|MGC14327	protein_coding	Q969S6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18707
2.10234511779854e-86	-0.30172563267105	0.191	0.414	3.59648179301796e-82	SPNS1	Malignant cells	GSE163836	ENSG00000169682	83985	sphingolipid transporter 1 (putative)	HSpin1|LAT|nrs|PP2030|SLC63A1|SPIN1|SPINL	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18708
2.71168084677655e-86	-0.319176861997325	0.227	0.458	4.63887242458064e-82	RTKN	Malignant cells	GSE163836	ENSG00000114993	6242	rhotekin	B5	protein_coding	Q9BST9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18709
3.84814837126241e-86	0.608019397949649	0.799	0.605	6.5830274187186e-82	SLPI	Malignant cells	GSE163836	ENSG00000124107	6590	secretory leukocyte peptidase inhibitor	ALK1|ALP|BLPI|HUSI|HUSI-I|WAP4|WFDC4	protein_coding	P03973	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18710
4.44038565534384e-86	-0.376588595915782	0.383	0.629	7.59616774059671e-82	CHPT1	Malignant cells	GSE163836	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18711
4.49589606150186e-86	-0.291410692734427	0.164	0.377	7.69112939241123e-82	MRI1	Malignant cells	GSE163836	ENSG00000037757	84245	methylthioribose-1-phosphate isomerase 1	MGC3207|MRDI|mtnA|Ypr118w	protein_coding	Q9BV20	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18712
4.6227298107522e-86	-0.384905838897635	0.867	0.95	7.90810388725379e-82	ATP5C1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18713
6.22695639564719e-86	-0.398591816062382	0.975	0.985	1.06524543060336e-81	MGST3	Malignant cells	GSE163836	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18714
7.83995943127026e-86	-0.356545016578844	0.214	0.439	1.3411818599074e-81	EHF	Malignant cells	GSE163836	ENSG00000135373	26298	ETS homologous factor	ESE3|ESEJ	protein_coding	Q9NZC4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18715
8.01444019828915e-86	-0.486342037296112	0.562	0.762	1.37103028472132e-81	UBE2T	Malignant cells	GSE163836	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18716
8.50318052102328e-86	-0.360847326778653	0.384	0.633	1.45463909173145e-81	BET1	Malignant cells	GSE163836	ENSG00000105829	10282	Bet1 golgi vesicular membrane trafficking protein	hbet1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18717
9.08482941354528e-86	-0.320599351157098	0.257	0.495	1.55414176777519e-81	DRG1	Malignant cells	GSE163836	ENSG00000185721	4733	developmentally regulated GTP binding protein 1	NEDD3	protein_coding	Q9Y295	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18718
1.19437386414056e-85	-0.320037357579022	0.214	0.44	2.04321536938525e-81	RCC1	Malignant cells	GSE163836	ENSG00000180198	1104	regulator of chromosome condensation 1	CHC1	protein_coding	P18754	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18719
1.61955175195229e-85	-0.361333135299895	0.386	0.637	2.77056718206478e-81	MPHOSPH10	Malignant cells	GSE163836	ENSG00000124383	10199	M-phase phosphoprotein 10	CT90|MPP10|MPP10P|PPP1R106	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18720
1.7341286311214e-85	-0.366939608624935	0.453	0.699	2.96657384925938e-81	C9orf78	Malignant cells	GSE163836	ENSG00000136819	51759	chromosome 9 open reading frame 78	CSU2|HCA59|HSPC220	protein_coding	Q9NZ63	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18721
2.04909645525085e-85	-0.880370689701057	0.638	0.763	3.50538930599764e-81	HMGB2	Malignant cells	GSE163836	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18722
2.13160967291101e-85	-0.388581148880015	0.477	0.719	3.64654466744887e-81	RNF181	Malignant cells	GSE163836	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18723
2.44891782223479e-85	-0.259350188424947	0.133	0.335	4.18936371849706e-81	SLC30A9	Malignant cells	GSE163836	ENSG00000014824	10463	solute carrier family 30 member 9	C4orf1|GAC63|HUEL|ZNT9	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18724
4.60931850216401e-85	-0.373892830031733	0.416	0.654	7.88516116165198e-81	TIMM17B	Malignant cells	GSE163836	ENSG00000126768	10245	translocase of inner mitochondrial membrane 17B	DXS9822|JM3	protein_coding	O60830	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18725
5.86751585826235e-85	-0.305650744456101	0.99	0.997	1.00375593787294e-80	AP2S1	Malignant cells	GSE163836	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18726
5.93843089553511e-85	-0.328280489421843	0.128	0.321	1.01588737329919e-80	HRCT1	Malignant cells	GSE163836	ENSG00000196196	646962	histidine rich carboxyl terminus 1	LGLL338|PRO537|UNQ338	protein_coding	Q6UXD1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18727
9.14067566858131e-85	-0.338438092703836	0.299	0.539	1.5636953866242e-80	CAPZA2	Malignant cells	GSE163836	ENSG00000198898	830	capping actin protein of muscle Z-line subunit alpha 2	CAPPA2|CAPZ	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18728
1.20666157668467e-84	-0.381407270622306	0.292	0.528	2.06423595923446e-80	MSH6	Malignant cells	GSE163836	ENSG00000116062	2956	mutS homolog 6	GTBP|MSH-6	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18729
1.58192553927293e-84	-0.370167724816902	0.429	0.668	2.7062000200342e-80	TRABD	Malignant cells	GSE163836	ENSG00000170638	80305	TraB domain containing	PP2447	protein_coding	Q9H4I3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18730
2.00240096205405e-84	-0.268153206158834	0.151	0.36	3.42550732578586e-80	ARL2BP	Malignant cells	GSE163836	ENSG00000102931	23568	ADP ribosylation factor like GTPase 2 binding protein	BART|BART1|RP66	protein_coding	Q9Y2Y0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18731
2.05776142379106e-84	-0.352037504064666	0.404	0.654	3.52021246767936e-80	PDCL3	Malignant cells	GSE163836	ENSG00000115539	79031	phosducin like 3	VIAF1	protein_coding	Q9H2J4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18732
2.16335605816045e-84	-0.394596169707578	0.462	0.703	3.70085320869509e-80	CTSD	Malignant cells	GSE163836	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18733
2.60070964102573e-84	-0.274155377312861	0.143	0.347	4.44903398290272e-80	CYB5R1	Malignant cells	GSE163836	ENSG00000159348	51706	cytochrome b5 reductase 1	humb5R2|NQO3A2	protein_coding	Q9UHQ9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18734
2.67413192769078e-84	-0.279144889719586	0.137	0.337	4.57463748870061e-80	MAP7D1	Malignant cells	GSE163836	ENSG00000116871	55700	MAP7 domain containing 1	FLJ10350|FLJ39022|PARCC1|RPRC1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18735
3.49910635184279e-84	-0.346745251754963	0.171	0.379	5.98592123609746e-80	TIMP1	Malignant cells	GSE163836	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18736
4.81952000465088e-84	-0.275272998234895	0.133	0.329	8.24475287195625e-80	E2F4	Malignant cells	GSE163836	ENSG00000205250	1874	E2F transcription factor 4	E2F-4	protein_coding	Q16254	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18737
5.21703734507101e-84	-0.385464183733206	0.637	0.833	8.92478578621298e-80	GHITM	Malignant cells	GSE163836	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18738
6.10007728699304e-84	-0.383075595055421	0.936	0.972	1.0435402214859e-79	MAGOH	Malignant cells	GSE163836	ENSG00000162385	4116	mago homolog, exon junction complex subunit	MAGOH1|MAGOHA	protein_coding	P61326	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18739
6.4763148781754e-84	-0.32526813456365	0.252	0.486	1.10790318620947e-79	M6PR	Malignant cells	GSE163836	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18740
6.54547679473319e-84	0.399509617309432	0.928	0.867	1.11973471527501e-79	CD81	Malignant cells	GSE163836	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18741
7.01768233094063e-84	-0.311933322158968	0.208	0.432	1.20051491635401e-79	TMEM138	Malignant cells	GSE163836	ENSG00000149483	51524	transmembrane protein 138	HSPC196|JBTS16	protein_coding	Q9NPI0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18742
7.65866430703823e-84	-0.343784148027135	0.964	0.981	1.31016770300503e-79	ANP32B	Malignant cells	GSE163836	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18743
8.39192959633448e-84	-0.257638266548848	0.122	0.314	1.43560739604494e-79	UCK1	Malignant cells	GSE163836	ENSG00000130717	83549	uridine-cytidine kinase 1	FLJ12255|URK1	protein_coding	Q9HA47	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18744
9.29292188691015e-84	-0.391499605649723	0.649	0.85	1.58974014719372e-79	MRPL37	Malignant cells	GSE163836	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18745
9.88553232365681e-84	-0.276066877285799	0.118	0.307	1.69111801460797e-79	SIRT6	Malignant cells	GSE163836	ENSG00000077463	51548	sirtuin 6	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18746
1.0673038250698e-83	-0.368932892168213	0.489	0.731	1.8258366535469e-79	MRPL42	Malignant cells	GSE163836	ENSG00000198015	28977	mitochondrial ribosomal protein L42	HSPC204|MRP-L31|MRPL31|MRPS32|PTD007|RPML31	protein_coding	Q9Y6G3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18747
1.12162188903255e-83	-0.359721445444836	0.344	0.587	1.91875856556798e-79	RFC2	Malignant cells	GSE163836	ENSG00000049541	5982	replication factor C subunit 2	A1|RFC40	protein_coding	P35250	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18748
1.96675407083057e-83	-0.417358399428671	0.555	0.761	3.36452618896985e-79	HBS1L	Malignant cells	GSE163836	ENSG00000112339	10767	HBS1 like translational GTPase	DKFZp434g247|EF-1a|eRF3c|ERFS|HBS1|HSPC276|KIAA1038	protein_coding	Q9Y450	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18749
2.37420834269856e-83	-0.273754656947996	0.139	0.337	4.06155821185443e-79	HMBS	Malignant cells	GSE163836	ENSG00000256269	3145	hydroxymethylbilane synthase	PBGD|PORC|UPS	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18750
2.67484012543693e-83	-0.407273739461147	0.535	0.764	4.57584900258496e-79	GSTM3	Malignant cells	GSE163836	ENSG00000134202	2947	glutathione S-transferase mu 3	GST5	protein_coding	P21266	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18751
2.76566828768354e-83	-0.349402176178284	0.378	0.622	4.73122873974023e-79	UBE2J2	Malignant cells	GSE163836	ENSG00000160087	118424	ubiquitin conjugating enzyme E2 J2	NCUBE2|Ubc6p	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18752
4.02871878668812e-83	-0.351450733012082	0.461	0.698	6.89192922838736e-79	CWC15	Malignant cells	GSE163836	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18753
4.55528549202215e-83	-0.392670501452234	0.532	0.762	7.79272689120229e-79	RUVBL2	Malignant cells	GSE163836	ENSG00000183207	10856	RuvB like AAA ATPase 2	ECP51|INO80J|Reptin52|RVB2|TIH2|TIP48|TIP49b	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18754
4.84298619127524e-83	-0.274664479406561	0.152	0.357	8.28489647741455e-79	TRADD	Malignant cells	GSE163836	ENSG00000102871	8717	TNFRSF1A associated via death domain	Hs.89862	protein_coding	Q15628	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18755
5.0002308850191e-83	-0.316806604398937	0.26	0.496	8.55389497500217e-79	MTFR1L	Malignant cells	GSE163836	ENSG00000117640	56181	mitochondrial fission regulator 1 like	FAM54B	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18756
5.68793126757892e-83	-0.309056248478709	1	1	9.73034401944725e-79	ANXA2	Malignant cells	GSE163836	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18757
5.84102060016984e-83	0.45841481199124	0.721	0.583	9.99223394071054e-79	DPM3	Malignant cells	GSE163836	ENSG00000179085	54344	dolichyl-phosphate mannosyltransferase subunit 3, regulatory	MGC125904|MGC125905|MGC34275	protein_coding	Q9P2X0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18758
6.58919961179274e-83	-0.335670190787391	0.323	0.565	1.12721437758938e-78	RPL17	Malignant cells	GSE163836	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18759
7.94850924327465e-83	-0.391044418775461	0.505	0.746	1.35975147624699e-78	RNF187	Malignant cells	GSE163836	ENSG00000285426	149603	ring finger protein 187	RACO-1|RACO1	protein_coding	Q5TA31	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18760
9.6818454435107e-83	-0.366565226504284	0.495	0.743	1.65627330002138e-78	PTS	Malignant cells	GSE163836	ENSG00000150787	5805	6-pyruvoyltetrahydropterin synthase	PTPS	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18761
1.12808222046984e-82	-0.25748135651493	0.106	0.289	1.92981025455775e-78	PRPS1	Malignant cells	GSE163836	ENSG00000147224	5631	phosphoribosyl pyrophosphate synthetase 1	CMTX5|DFN2|DFNX1|PPRibP|PRS-I	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18762
1.23896520106446e-82	-0.344851764301577	0.419	0.67	2.11949776946097e-78	COA6	Malignant cells	GSE163836	ENSG00000168275	388753	cytochrome c oxidase assembly factor 6	C1orf31	protein_coding	Q5JTJ3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18763
1.53139345128607e-82	-0.332801223136992	0.347	0.589	2.61975477711508e-78	TOP1MT	Malignant cells	GSE163836	ENSG00000184428	116447	DNA topoisomerase I mitochondrial	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18764
1.77314120604869e-82	-0.25150007654475	0.107	0.29	3.03331266118749e-78	EIF2B1	Malignant cells	GSE163836	ENSG00000111361	1967	eukaryotic translation initiation factor 2B subunit alpha	EIF-2B|EIF-2Balpha|EIF2B|EIF2BA|EIF2Balpha	protein_coding	Q14232	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18765
2.11304615305983e-82	-0.300456646244861	0.166	0.374	3.61478805403944e-78	LAS1L	Malignant cells	GSE163836	ENSG00000001497	81887	LAS1 like ribosome biogenesis factor	FLJ12525|Las1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18766
2.30743404296105e-82	-0.34837288112294	0.63	0.85	3.94732741729347e-78	SNF8	Malignant cells	GSE163836	ENSG00000159210	11267	SNF8 subunit of ESCRT-II	Dot3|EAP30|VPS22	protein_coding	Q96H20	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18767
2.76754901667775e-82	0.407031440700053	0.983	0.942	4.73444610283062e-78	BTG1	Malignant cells	GSE163836	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18768
3.31973829097467e-82	-0.298412669131729	0.23	0.459	5.67907629437037e-78	TCEB3	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18769
3.98718561512998e-82	-0.279460905238074	0.147	0.349	6.82087843180286e-78	CHIC2	Malignant cells	GSE163836	ENSG00000109220	26511	cysteine rich hydrophobic domain 2	BTL	protein_coding	Q9UKJ5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18770
5.46401406746386e-82	-0.329018846993677	0.269	0.501	9.34728886521043e-78	PPAN	Malignant cells	GSE163836	ENSG00000130810	56342	peter pan homolog	BXDC3|SSF|SSF1|SSF2	protein_coding	Q9NQ55	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18771
7.22535536832302e-82	0.423226068668641	0.968	0.896	1.23604154285902e-77	ANXA1	Malignant cells	GSE163836	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18772
1.07153729812879e-81	-0.403117103740992	0.859	0.937	1.83307885590893e-77	FSCN1	Malignant cells	GSE163836	ENSG00000075618	6624	fascin actin-bundling protein 1	FLJ38511|p55|SNL	protein_coding	Q16658	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18773
1.07669279811964e-81	-0.520759709922576	0.771	0.879	1.84189836974326e-77	PGK1	Malignant cells	GSE163836	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18774
1.16857171271938e-81	-0.337625043620537	0.338	0.581	1.99907562894905e-77	COMMD5	Malignant cells	GSE163836	ENSG00000170619	28991	COMM domain containing 5	FLJ13008|HCaRG|HT002	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18775
1.26946003796827e-81	-0.38598129162959	0.444	0.684	2.17166528695232e-77	PSAP	Malignant cells	GSE163836	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18776
1.49244587767455e-81	-0.359570949813093	0.269	0.495	2.55312716293786e-77	CENPN	Malignant cells	GSE163836	ENSG00000166451	55839	centromere protein N	BM039|C16orf60|FLJ13607|FLJ22660	protein_coding	Q96H22	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18777
2.01368908189892e-81	-0.311535353001092	0.253	0.485	3.44481791240449e-77	NUDT21	Malignant cells	GSE163836	ENSG00000167005	11051	nudix hydrolase 21	CFIM25|CPSF5	protein_coding	O43809	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18778
2.55581587517968e-81	-0.330856275194109	0.283	0.521	4.37223421766987e-77	DLL3	Malignant cells	GSE163836	ENSG00000090932	10683	delta like canonical Notch ligand 3	SCDO1	protein_coding	Q9NYJ7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18779
2.56607739866252e-81	-0.332337791144071	0.261	0.488	4.38978860589198e-77	SPATS2	Malignant cells	GSE163836	ENSG00000123352	65244	spermatogenesis associated serine rich 2	FLJ13117|SCR59|SPATA10	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18780
2.74303553021328e-81	-0.291660774343366	0.165	0.37	4.69251088153586e-77	PES1	Malignant cells	GSE163836	ENSG00000100029	23481	pescadillo ribosomal biogenesis factor 1	NOP7|PES	protein_coding	O00541	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18781
5.83204965349839e-81	-0.306990693809432	0.218	0.439	9.97688734223969e-77	AIF1L	Malignant cells	GSE163836	ENSG00000126878	83543	allograft inflammatory factor 1 like	C9orf58|FLJ12783|IBA2	protein_coding	Q9BQI0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18782
6.30371953145729e-81	0.432610269813126	0.479	0.246	1.0783773002464e-76	GCHFR	Malignant cells	GSE163836	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18783
6.59320673773455e-81	-0.31773777459367	0.255	0.482	1.12789987662425e-76	LRPAP1	Malignant cells	GSE163836	ENSG00000163956	4043	LDL receptor related protein associated protein 1	A2MRAP|HBP44|RAP	protein_coding	P30533	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18784
6.6944180933662e-81	-0.309000688134041	0.273	0.509	1.14521410323216e-76	DCTD	Malignant cells	GSE163836	ENSG00000129187	1635	dCMP deaminase	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18785
8.41451131852049e-81	-0.266614899621556	0.126	0.317	1.4394704512593e-76	TMEM139	Malignant cells	GSE163836	ENSG00000178826	135932	transmembrane protein 139	FLJ90586	protein_coding	Q8IV31	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18786
8.68226438618112e-81	-0.281174179855144	0.163	0.368	1.485274968544e-76	TOMM34	Malignant cells	GSE163836	ENSG00000025772	10953	translocase of outer mitochondrial membrane 34	HTOM34P|TOM34	protein_coding	Q15785	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18787
1.24759947200556e-80	-0.270966718512916	0.154	0.357	2.13426841675991e-76	TMEM189	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18788
1.26728860093461e-80	-0.280281673232662	0.162	0.367	2.16795060961884e-76	KIF1C	Malignant cells	GSE163836	ENSG00000129250	10749	kinesin family member 1C	SAX2|SPAX2|SPG58	protein_coding	O43896	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18789
1.26947448232072e-80	-0.277886901086496	0.168	0.377	2.17168999690605e-76	MCMBP	Malignant cells	GSE163836	ENSG00000197771	79892	minichromosome maintenance complex binding protein	C10orf119|FLJ13081|MCM-BP	protein_coding	Q9BTE3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18790
1.38401037549593e-80	-0.343366923293836	0.334	0.568	2.36762654936088e-76	GOLM1	Malignant cells	GSE163836	ENSG00000135052	51280	golgi membrane protein 1	bA379P1.3|C9orf155|FLJ23608|GOLPH2|GP73	protein_coding	Q8NBJ4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18791
1.6475408627521e-80	-0.360627907180543	0.848	0.946	2.81844815391002e-76	HAX1	Malignant cells	GSE163836	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18792
2.09368308830423e-80	-0.353486901764876	0.349	0.587	3.58166365916204e-76	BSPRY	Malignant cells	GSE163836	ENSG00000119411	54836	B-box and SPRY domain containing	FLJ20150	protein_coding	Q5W0U4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18793
4.09146403163373e-80	-0.368097145323271	0.358	0.588	6.99926751891582e-76	TMEM109	Malignant cells	GSE163836	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18794
4.15512904429732e-80	-0.355967266877552	0.353	0.594	7.10817925607943e-76	NMB	Malignant cells	GSE163836	ENSG00000197696	4828	neuromedin B	MGC17211|MGC2277|MGC3936	protein_coding	P08949	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18795
4.27742360170278e-80	-0.448096498988168	0.759	0.882	7.31738855543295e-76	IMPDH2	Malignant cells	GSE163836	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18796
4.79681695531646e-80	-0.284409733811827	0.172	0.38	8.20591476545987e-76	MECR	Malignant cells	GSE163836	ENSG00000116353	51102	mitochondrial trans-2-enoyl-CoA reductase	CGI-63|ETR1|FASN2B|NRBF1	protein_coding	Q9BV79	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18797
5.85519778434927e-80	-0.411717336779534	0.543	0.755	1.00164868496863e-75	AIMP2	Malignant cells	GSE163836	ENSG00000106305	7965	aminoacyl tRNA synthetase complex interacting multifunctional protein 2	JTV-1|JTV1|p38|PRO0992	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18798
9.24123564592822e-80	-0.287620247119722	0.214	0.437	1.58089818194894e-75	MORN2	Malignant cells	GSE163836	ENSG00000188010	729967	MORN repeat containing 2	MOPT	protein_coding	Q502X0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18799
9.61807631257819e-80	-0.376898980504098	0.47	0.697	1.64536431479275e-75	TBPL1	Malignant cells	GSE163836	ENSG00000028839	9519	TATA-box binding protein like 1	STUD|TLF|TLP|TRF2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18800
9.91910411606423e-80	-0.296111169737105	0.191	0.402	1.69686114113511e-75	JPX	Malignant cells	GSE163836	ENSG00000225470	554203	JPX transcript, XIST activator	DCBALD06|ENOX|LINC00183|NCRNA00183	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18801
1.31700454202669e-79	-0.313408959552896	0.234	0.457	2.25299967004507e-75	NKAP	Malignant cells	GSE163836	ENSG00000101882	79576	NFKB activating protein	FLJ22626	protein_coding	Q8N5F7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18802
1.39109380535419e-79	-0.380044788581106	0.442	0.672	2.37974417281942e-75	IRAK1	Malignant cells	GSE163836	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18803
1.82156931349041e-79	-0.333822420827552	0.971	0.985	3.11615862458804e-75	NME1	Malignant cells	GSE163836	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18804
2.15455040043088e-79	-0.295674850858964	0.2	0.415	3.6857893700171e-75	ST6GALNAC4	Malignant cells	GSE163836	ENSG00000136840	27090	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	SIAT3C|SIAT7D|ST6GALNACIV	protein_coding	Q9H4F1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18805
3.11387588810556e-79	-0.305894790484467	0.237	0.463	5.32690748178218e-75	ICMT	Malignant cells	GSE163836	ENSG00000116237	23463	isoprenylcysteine carboxyl methyltransferase	HSTE14|PCCMT|PPMT	protein_coding	O60725	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18806
3.54755770353894e-79	-0.352787400911366	0.416	0.651	6.06880696344406e-75	TPGS2	Malignant cells	GSE163836	ENSG00000134779	25941	tubulin polyglutamylase complex subunit 2	C18orf10|DKFZP586M1523|HsT3006|PGs2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18807
3.67560128140537e-79	-0.346440185084874	0.278	0.501	6.28785111210017e-75	YEATS4	Malignant cells	GSE163836	ENSG00000127337	8089	YEATS domain containing 4	GAS41|NuBI-1|YAF9	protein_coding	O95619	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18808
4.72101255773784e-79	-0.339503951995173	0.353	0.591	8.07623618252213e-75	PFDN6	Malignant cells	GSE163836	ENSG00000235692	10471	prefoldin subunit 6	H2-KE2|HKE2|KE-2|PFD6	protein_coding	O15212	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18809
5.55187744828438e-79	-0.290868821856556	0.207	0.423	9.49759675078009e-75	ZDHHC6	Malignant cells	GSE163836	ENSG00000023041	64429	zinc finger DHHC-type palmitoyltransferase 6	FLJ21952|ZNF376	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18810
6.91868450876167e-79	-0.322980424690295	0.312	0.547	1.18357935891386e-74	TMEM248	Malignant cells	GSE163836	ENSG00000106609	55069	transmembrane protein 248	C7orf42|FLJ10099|FLJ13090	protein_coding	Q9NWD8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18811
9.48691319232635e-79	-0.259432883822259	0.141	0.336	1.62292623981127e-74	POLR2D	Malignant cells	GSE163836	ENSG00000144231	5433	RNA polymerase II subunit D	RPB4	protein_coding	O15514	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18812
9.60040160958893e-79	-0.305240742628392	0.245	0.472	1.64234070335238e-74	BOLA1	Malignant cells	GSE163836	ENSG00000178096	51027	bolA family member 1	CGI-143	protein_coding	Q9Y3E2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18813
1.07968235405395e-78	-0.353343246871909	0.668	0.861	1.84701260308009e-74	ATP5H	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18814
1.20218933527434e-78	-0.366469394915587	0.627	0.834	2.05658529585382e-74	NDUFS3	Malignant cells	GSE163836	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18815
1.24288235895959e-78	-0.383362566225106	0.629	0.836	2.12619885147218e-74	IFRD2	Malignant cells	GSE163836	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18816
1.60085741770072e-78	-0.393409744245372	0.301	0.525	2.73858678446062e-74	SDC2	Malignant cells	GSE163836	ENSG00000169439	6383	syndecan 2	CD362|fibroglycan|HSPG|HSPG1|SYND2	protein_coding	P34741	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18817
1.74004707406296e-78	0.358386716763757	0.954	0.901	2.9766985295995e-74	BRI3	Malignant cells	GSE163836	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18818
1.81954700640351e-78	-0.261197045260209	0.122	0.306	3.11269906385449e-74	CHAMP1	Malignant cells	GSE163836	ENSG00000198824	283489	chromosome alignment maintaining phosphoprotein 1	C13orf8|CAMP|CHAMP|ZNF828	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18819
2.15014660523674e-78	-0.277602885893497	0.17	0.375	3.67825579757849e-74	CRK	Malignant cells	GSE163836	ENSG00000167193	1398	CRK proto-oncogene, adaptor protein	NA	protein_coding	P46108	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18820
2.16182741635e-78	-0.351111845808096	0.602	0.82	3.69823816114994e-74	NDUFA6	Malignant cells	GSE163836	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18821
2.1727346414544e-78	-0.289085137180489	0.214	0.433	3.71689715113604e-74	DRG2	Malignant cells	GSE163836	ENSG00000108591	1819	developmentally regulated GTP binding protein 2	NA	protein_coding	P55039	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18822
2.22084664721209e-78	-0.373623087757097	0.717	0.888	3.79920235938573e-74	SUMO3	Malignant cells	GSE163836	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18823
2.42258764013519e-78	-0.264280197011627	0.152	0.351	4.14432067597927e-74	DHX29	Malignant cells	GSE163836	ENSG00000067248	54505	DExH-box helicase 29	DDX29	protein_coding	Q7Z478	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18824
3.18558502531933e-78	-0.331844791377442	0.411	0.655	5.44958030281377e-74	SLMO2	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18825
4.52344125611354e-78	-0.30506072032887	0.195	0.404	7.73825095683343e-74	TMEM237	Malignant cells	GSE163836	ENSG00000155755	65062	transmembrane protein 237	ALS2CR4|JBTS14	protein_coding	Q96Q45	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18826
4.85083937256799e-78	0.434408185205408	0.471	0.255	8.29833091465206e-74	CLTC	Malignant cells	GSE163836	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18827
4.86622332584601e-78	0.275478595075	0.999	0.986	8.32464824352477e-74	TM4SF1	Malignant cells	GSE163836	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18828
5.2969987158624e-78	-0.440572576929974	0.551	0.751	9.0615757032258e-74	PDIA3	Malignant cells	GSE163836	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18829
6.00066356269722e-78	-0.34304475260909	0.473	0.714	1.02653351567061e-73	TSSC4	Malignant cells	GSE163836	ENSG00000184281	10078	tumor suppressing subtransferable candidate 4	NA	protein_coding	Q9Y5U2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18830
6.38409926006328e-78	-0.331730203083025	0.333	0.568	1.09212786041903e-73	C21orf59	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18831
7.44424390395199e-78	-0.344906693770672	0.348	0.581	1.27348680464907e-73	UCP2	Malignant cells	GSE163836	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18832
1.08133779844438e-77	-0.287224370018462	0.182	0.389	1.8498445717988e-73	NUCB2	Malignant cells	GSE163836	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18833
1.31709224155138e-77	-0.267589700569758	0.172	0.378	2.25314969762195e-73	TIMM23	Malignant cells	GSE163836	ENSG00000265354	100287932	translocase of inner mitochondrial membrane 23	TIM23	protein_coding	O14925	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18834
1.47844101492472e-77	-0.304416217235105	0.268	0.495	2.52916904423172e-73	NOL12	Malignant cells	GSE163836	ENSG00000273899	79159	nucleolar protein 12	MGC3731|Nop25|RRP17	protein_coding	Q9UGY1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18835
1.59457423527924e-77	-0.319969801621733	0.283	0.51	2.7278381442922e-73	CC2D1A	Malignant cells	GSE163836	ENSG00000288293	54862	coiled-coil and C2 domain containing 1A	Aki-1|FLJ20241|Freud-1|Lgd2|MRT3|TAPE	protein_coding	Q6P1N0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18836
1.61688646541305e-77	-0.37039554111433	0.458	0.686	2.76600767638211e-73	RAB8A	Malignant cells	GSE163836	ENSG00000167461	4218	RAB8A, member RAS oncogene family	MEL|RAB8	protein_coding	P61006	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18837
1.92998885545187e-77	-0.28413226957096	0.216	0.436	3.30163193502152e-73	RBM18	Malignant cells	GSE163836	ENSG00000119446	92400	RNA binding motif protein 18	MGC2734	protein_coding	Q96H35	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18838
1.93602667799374e-77	-0.305726854159387	0.232	0.45	3.31196083804389e-73	ATP5SL	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18839
3.06037954723388e-77	-0.369978105151377	0.598	0.797	5.235391291453e-73	CISD2	Malignant cells	GSE163836	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18840
3.70470700880796e-77	-0.277672002107302	0.136	0.326	6.33764227996778e-73	DUSP2	Malignant cells	GSE163836	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18841
7.33935276533921e-77	-0.307889036337928	0.272	0.5	1.25554307756658e-72	NOL3	Malignant cells	GSE163836	ENSG00000140939	8996	nucleolar protein 3	ARC|CARD2|MYP|NOP30	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18842
8.63364359048079e-77	-0.293386272010346	0.247	0.472	1.47695740902355e-72	ERLEC1	Malignant cells	GSE163836	ENSG00000068912	27248	endoplasmic reticulum lectin 1	C2orf30|CL25084|ERLECTIN|XTP3-B|XTP3TPB	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18843
9.49978896087999e-77	-0.303607007027018	0.252	0.474	1.62512889753774e-72	TMED1	Malignant cells	GSE163836	ENSG00000099203	11018	transmembrane p24 trafficking protein 1	Il1rl1l|IL1RL1LG|MGC1270|p24g1|p24gamma1|ST2L	protein_coding	Q13445	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18844
1.46268765993819e-76	-0.323821016962424	0.346	0.581	2.50221977985626e-72	KIF1A	Malignant cells	GSE163836	ENSG00000130294	547	kinesin family member 1A	ATSV|C2orf20|SPG30|UNC104	protein_coding	Q12756	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18845
2.29416615222698e-76	-0.278308744828385	0.175	0.377	3.9246300366147e-72	ADA	Malignant cells	GSE163836	ENSG00000196839	100	adenosine deaminase	ADA1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18846
2.72694347427787e-76	-0.314364683014156	0.164	0.36	4.66498220144716e-72	MLLT11	Malignant cells	GSE163836	ENSG00000213190	10962	MLLT11 transcription factor 7 cofactor	AF1Q	protein_coding	Q13015	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18847
3.27507916505595e-76	-0.26305264384745	0.146	0.338	5.60267792766121e-72	MAPKAPK3	Malignant cells	GSE163836	ENSG00000114738	7867	MAPK activated protein kinase 3	3pK|MAPKAP3|MK-3|MK3	protein_coding	Q16644	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18848
4.60853598850594e-76	-0.354427004196514	0.764	0.902	7.88382251553712e-72	MRPS15	Malignant cells	GSE163836	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18849
4.85785178486328e-76	-0.270246561594423	0.157	0.355	8.31032704836562e-72	STX3	Malignant cells	GSE163836	ENSG00000166900	6809	syntaxin 3	STX3A	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18850
1.86010637138083e-75	-0.368186354532562	0.296	0.514	3.18208396952119e-71	SERPINH1	Malignant cells	GSE163836	ENSG00000149257	871	serpin family H member 1	CBP1|CBP2|HSP47|SERPINH2	protein_coding	P50454	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18851
2.00913161077144e-75	0.428830992441323	0.732	0.604	3.4370214465467e-71	NSA2	Malignant cells	GSE163836	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18852
3.18626861044713e-75	-0.319111118671415	0.291	0.517	5.4507497118919e-71	TPD52L2	Malignant cells	GSE163836	ENSG00000101150	7165	TPD52 like 2	D54|hD54|TPD54	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18853
3.56919419340842e-75	-0.322833945403322	0.888	0.964	6.10582050666378e-71	HSBP1	Malignant cells	GSE163836	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18854
4.68207090817561e-75	-0.265620434893501	0.156	0.351	8.00961870261602e-71	PRPSAP2	Malignant cells	GSE163836	ENSG00000141127	5636	phosphoribosyl pyrophosphate synthetase associated protein 2	PAP41	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18855
6.52356400403624e-75	-0.35895003232445	0.7	0.88	1.11598609417048e-70	HSF1	Malignant cells	GSE163836	ENSG00000284774	3297	heat shock transcription factor 1	HSTF1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18856
9.90326936640018e-75	-0.296693981470229	0.274	0.499	1.69415229051008e-70	RHOT2	Malignant cells	GSE163836	ENSG00000140983	89941	ras homolog family member T2	ARHT2|C16orf39|MIRO-2|MIRO2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18857
1.06312632081869e-74	-0.289328119294536	0.306	0.539	1.81869019702453e-70	STRBP	Malignant cells	GSE163836	ENSG00000165209	55342	spermatid perinuclear RNA binding protein	FLJ11307|ILF3L|SPNR	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18858
1.33868802815317e-74	-0.324219715064567	0.319	0.547	2.29009360976163e-70	ORAI1	Malignant cells	GSE163836	ENSG00000276045	84876	ORAI calcium release-activated calcium modulator 1	CRACM1|FLJ14466|TMEM142A	protein_coding	Q96D31	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18859
1.60641013338839e-74	-0.343008860770209	0.398	0.631	2.74808581518752e-70	REXO2	Malignant cells	GSE163836	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18860
1.77686041497104e-74	-0.268035150785164	0.146	0.336	3.03967511189096e-70	PRR16	Malignant cells	GSE163836	ENSG00000184838	51334	proline rich 16	DSC54	protein_coding	Q569H4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18861
1.87695643140214e-74	0.371748999864425	0.855	0.76	3.21090936719963e-70	RHOV	Malignant cells	GSE163836	ENSG00000104140	171177	ras homolog family member V	ARHV|Chp|WRCH2	protein_coding	Q96L33	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18862
2.01631282414826e-74	0.442550279493897	0.728	0.592	3.44930634827042e-70	VMP1	Malignant cells	GSE163836	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18863
2.03381186231432e-74	0.365341332946583	0.34	0.131	3.47924195286111e-70	SEZ6L2	Malignant cells	GSE163836	ENSG00000174938	26470	seizure related 6 homolog like 2	FLJ90517|PSK-1	protein_coding	Q6UXD5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18864
2.21813104904396e-74	-0.269737045417173	0.159	0.354	3.79455678559951e-70	SNAP29	Malignant cells	GSE163836	ENSG00000099940	9342	synaptosome associated protein 29	CEDNIK|SNAP-29	protein_coding	O95721	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18865
2.29104056099804e-74	-0.322085216111851	0.331	0.559	3.91928308769935e-70	TMEM256	Malignant cells	GSE163836	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18866
2.33212468261426e-74	-0.301640763169741	0.205	0.413	3.98956569454821e-70	PIR	Malignant cells	GSE163836	ENSG00000087842	8544	pirin	NA	protein_coding	O00625	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18867
2.45339318844504e-74	-0.382123426030852	0.674	0.845	4.19701972747293e-70	CISD3	Malignant cells	GSE163836	ENSG00000274768	284106	CDGSH iron sulfur domain 3	Miner2|MiNT	protein_coding	P0C7P0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18868
2.82875632014883e-74	-0.344131080473197	0.353	0.577	4.83915343687861e-70	VBP1	Malignant cells	GSE163836	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18869
3.27072859626061e-74	-0.351529523491127	0.396	0.624	5.59523540962302e-70	LYAR	Malignant cells	GSE163836	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18870
3.50006157165941e-74	-0.350890055742397	0.446	0.67	5.98755533063775e-70	VPS72	Malignant cells	GSE163836	ENSG00000163159	6944	vacuolar protein sorting 72 homolog	Swc2|TCFL1|YL-1|YL1	protein_coding	Q15906	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18871
4.46123063252053e-74	-0.307765584415699	0.257	0.474	7.63182724305286e-70	GEMIN6	Malignant cells	GSE163836	ENSG00000152147	79833	gem nuclear organelle associated protein 6	FLJ23459	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18872
5.3010262278446e-74	-0.274787329657656	0.999	0.999	9.06846556797376e-70	C19orf43	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18873
6.32136725782759e-74	-0.326611781875916	0.322	0.545	1.08139629679657e-69	ADSL	Malignant cells	GSE163836	ENSG00000239900	158	adenylosuccinate lyase	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18874
6.47348258128067e-74	-0.327290120168872	0.338	0.565	1.10741866517968e-69	BRD3	Malignant cells	GSE163836	ENSG00000169925	8019	bromodomain containing 3	KIAA0043|ORFX|RING3L	protein_coding	Q15059	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18875
6.8812613495194e-74	0.467570766142508	0.569	0.371	1.17717737906228e-69	HSPA1A	Malignant cells	GSE163836	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18876
7.29924347529663e-74	-0.29666574852343	0.96	0.987	1.24868158131899e-69	ATP5L	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18877
1.00299176173748e-73	0.390387064406936	0.329	0.125	1.71581800680431e-69	IER5L	Malignant cells	GSE163836	ENSG00000188483	389792	immediate early response 5 like	bA247A12.2	protein_coding	Q5T953	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18878
1.09166868470458e-73	-0.32059491154324	0.328	0.554	1.86751761892412e-69	FAM120AOS	Malignant cells	GSE163836	ENSG00000188938	158293	family with sequence similarity 120A opposite strand	C9orf10OS	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18879
1.17001392933092e-73	-0.321857361565095	1	1	2.0015428289064e-69	ACTB	Malignant cells	GSE163836	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18880
2.04607724168315e-73	-0.33331449696906	0.41	0.64	3.50022433734736e-69	LAD1	Malignant cells	GSE163836	ENSG00000159166	3898	ladinin 1	NA	protein_coding	O00515	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18881
2.06304950648053e-73	0.462801755181399	0.686	0.544	3.52925879073624e-69	NUDT8	Malignant cells	GSE163836	ENSG00000167799	254552	nudix hydrolase 8	FLJ41567	protein_coding	Q8WV74	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18882
2.11581341089019e-73	-0.355698215267589	0.663	0.857	3.61952200200985e-69	BUD31	Malignant cells	GSE163836	ENSG00000106245	8896	BUD31 homolog	Cwc14|EDG-2|EDG2|fSAP17|G10|YCR063W	protein_coding	P41223	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18883
2.35397269276642e-73	-0.345930270453333	0.778	0.921	4.02694108551551e-69	ECHS1	Malignant cells	GSE163836	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18884
2.51331630513505e-73	-0.274248799471569	0.177	0.375	4.29953020319454e-69	PIGF	Malignant cells	GSE163836	ENSG00000151665	5281	phosphatidylinositol glycan anchor biosynthesis class F	NA	protein_coding	Q07326	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18885
2.53769216678445e-73	0.484408599180478	0.392	0.18	4.34122998971815e-69	FAM211A	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18886
3.3513075950099e-73	-0.305139996440065	0.267	0.485	5.73308190278343e-69	TCEA2	Malignant cells	GSE163836	ENSG00000171703	6919	transcription elongation factor A2	TFIIS	protein_coding	Q15560	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18887
4.82710457487366e-73	-0.316161759797061	0.922	0.968	8.25772779623637e-69	BRD4	Malignant cells	GSE163836	ENSG00000141867	23476	bromodomain containing 4	CAP|HUNK1|HUNKI|MCAP	protein_coding	O60885	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18888
5.11598565195711e-73	-0.254322843559115	0.165	0.362	8.75191665480303e-69	SAYSD1	Malignant cells	GSE163836	ENSG00000112167	55776	SAYSVFN motif domain containing 1	C6orf64|FLJ11101	protein_coding	Q9NPB0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18889
6.05384971546644e-73	-0.254807070512192	0.139	0.324	1.03563207082484e-68	UBE2G1	Malignant cells	GSE163836	ENSG00000132388	7326	ubiquitin conjugating enzyme E2 G1	UBC7|UBE2G	protein_coding	P62253	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18890
6.19618865718165e-73	-0.27990458877011	0.221	0.432	1.05998199358407e-68	ABHD12	Malignant cells	GSE163836	ENSG00000100997	26090	abhydrolase domain containing 12, lysophospholipase	ABHD12A|BEM46L2|C20orf22|dJ965G21.2|DKFZP434P106	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18891
8.08253824012098e-73	-0.276658142727757	0.184	0.385	1.3826798167375e-68	FAHD1	Malignant cells	GSE163836	ENSG00000180185	81889	fumarylacetoacetate hydrolase domain containing 1	C16orf36|DKFZP566J2046	protein_coding	Q6P587	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18892
1.16261454365624e-72	-0.33100377667155	0.378	0.607	1.98888469983273e-68	C14orf1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18893
1.16510498787187e-72	-0.352332812276218	0.801	0.928	1.99314510275241e-68	SCAND1	Malignant cells	GSE163836	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18894
1.22274316253527e-72	0.353218386012528	0.969	0.912	2.09174672814909e-68	C4orf48	Malignant cells	GSE163836	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18895
1.23559431303127e-72	-0.275983229864432	0.172	0.367	2.1137311913026e-68	TMEM51	Malignant cells	GSE163836	ENSG00000171729	55092	transmembrane protein 51	C1orf72|FLJ10199	protein_coding	Q9NW97	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18896
1.90479004474535e-72	-0.263506964053679	0.204	0.415	3.25852432954586e-68	ATPAF1	Malignant cells	GSE163836	ENSG00000123472	64756	ATP synthase mitochondrial F1 complex assembly factor 1	ATP11|Atp11p|FLJ22351	protein_coding	Q5TC12	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18897
2.02643189668202e-72	-0.30621877391907	0.276	0.494	3.46661704565394e-68	PSMF1	Malignant cells	GSE163836	ENSG00000125818	9491	proteasome inhibitor subunit 1	PI31	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18898
2.47963841331747e-72	-0.321595202044081	0.328	0.551	4.2419174336622e-68	MANBAL	Malignant cells	GSE163836	ENSG00000101363	63905	mannosidase beta like	dJ1141E15.2	protein_coding	Q9NQG1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18899
2.98024518602017e-72	-0.26643605908421	0.18	0.38	5.09830543972471e-68	PPP1R8	Malignant cells	GSE163836	ENSG00000117751	5511	protein phosphatase 1 regulatory subunit 8	ard-1|ARD1|NIPP-1|NIPP1|PRO2047	protein_coding	Q12972	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18900
3.65341404706668e-72	-0.290575734365446	0.223	0.431	6.24989541031697e-68	CD2BP2	Malignant cells	GSE163836	ENSG00000169217	10421	CD2 cytoplasmic tail binding protein 2	LIN1|PPP1R59|Snu40|U5-52K	protein_coding	O95400	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18901
3.74109798128039e-72	-0.32897382593199	0.76	0.903	6.39989631657636e-68	NDUFS7	Malignant cells	GSE163836	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18902
5.05673233626183e-72	-0.258503360519243	0.161	0.354	8.65055200764312e-68	NUS1	Malignant cells	GSE163836	ENSG00000153989	116150	NUS1 dehydrodolichyl diphosphate synthase subunit	C6orf68|MGC7199|NgBR|TANGO14	protein_coding	Q96E22	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18903
6.60316704920731e-72	-0.377030208311836	0.878	0.944	1.12960378710789e-67	PSMB2	Malignant cells	GSE163836	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18904
1.10486545011355e-71	-0.264478745957087	0.161	0.353	1.89009332550925e-67	ZNF259	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18905
1.2251092671563e-71	-0.415308834481006	0.829	0.932	2.09579442332429e-67	ID2	Malignant cells	GSE163836	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18906
1.34024910782275e-71	-0.34785900971205	0.425	0.648	2.29276414875238e-67	USP1	Malignant cells	GSE163836	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18907
1.37377784655339e-71	-0.300766434496748	0.951	0.985	2.35012176209888e-67	NDUFS8	Malignant cells	GSE163836	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18908
1.55315424403233e-71	0.430803143061806	0.448	0.235	2.65698096526611e-67	GADD45B	Malignant cells	GSE163836	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18909
2.34819314860528e-71	-0.270766523075419	0.202	0.406	4.01705401931905e-67	FAM3A	Malignant cells	GSE163836	ENSG00000071889	60343	FAM3 metabolism regulating signaling molecule A	2-19|DXS560S|XAP-7	protein_coding	P98173	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18910
2.51201130401838e-71	-0.34233068891191	0.427	0.654	4.29729773778425e-67	RABGGTB	Malignant cells	GSE163836	ENSG00000137955	5876	Rab geranylgeranyltransferase subunit beta	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18911
3.51158570721888e-71	-0.292714052008027	0.283	0.506	6.00726966933933e-67	EMC7	Malignant cells	GSE163836	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18912
3.54244692892261e-71	-0.31023750384706	0.329	0.555	6.06006396130791e-67	PTDSS1	Malignant cells	GSE163836	ENSG00000156471	9791	phosphatidylserine synthase 1	KIAA0024|PSS1|PSSA	protein_coding	P48651	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18913
4.13863867367578e-71	-0.26479365362567	0.195	0.399	7.07996917905716e-67	NOL10	Malignant cells	GSE163836	ENSG00000115761	79954	nucleolar protein 10	FLJ14075|PQBP5	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18914
5.51951419347205e-71	-0.258487027080912	0.168	0.362	9.44223293077264e-67	TM2D2	Malignant cells	GSE163836	ENSG00000169490	83877	TM2 domain containing 2	BLP1	protein_coding	Q9BX73	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18915
5.96704940487393e-71	-0.278653616181012	0.243	0.459	1.02078314169178e-66	FAF1	Malignant cells	GSE163836	ENSG00000185104	11124	Fas associated factor 1	CGI-03|hFAF1|HFAF1s|UBXD12|UBXN3A	protein_coding	Q9UNN5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18916
7.04052756430253e-71	-0.360574382013844	0.67	0.847	1.20442305042523e-66	FAM195A	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18917
7.37213034995512e-71	-0.256809841764825	0.168	0.361	1.26115033896682e-66	RAF1	Malignant cells	GSE163836	ENSG00000132155	5894	Raf-1 proto-oncogene, serine/threonine kinase	c-Raf|CRAF|Raf-1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18918
9.33649422586864e-71	-0.329746207656566	0.451	0.681	1.59719406721935e-66	PRPF31	Malignant cells	GSE163836	ENSG00000274651	26121	pre-mRNA processing factor 31	hPrp31|NY-BR-99|PRP31|RP11|SNRNP61	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18919
1.12083225501563e-70	-0.325739232790456	0.317	0.537	1.91740773865525e-66	CCDC64B	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18920
1.24534598737513e-70	-0.32215960897039	0.407	0.632	2.13041338060264e-66	SPTSSA	Malignant cells	GSE163836	ENSG00000165389	171546	serine palmitoyltransferase small subunit A	C14orf147|ssSPTa	protein_coding	Q969W0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18921
1.33672668494448e-70	-0.355235368405387	0.575	0.787	2.28673833993452e-66	SMC3	Malignant cells	GSE163836	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18922
1.64689179546345e-70	-0.343312455799296	0.904	0.965	2.81733779449933e-66	CNBP	Malignant cells	GSE163836	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18923
1.99959576161526e-70	-0.333949019051718	0.33	0.545	3.42070846939523e-66	PXMP2	Malignant cells	GSE163836	ENSG00000176894	5827	peroxisomal membrane protein 2	MPV17L3|PMP22	protein_coding	Q9NR77	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18924
2.05051789466878e-70	0.443807398204218	0.284	0.089	3.50782096240987e-66	SAA2	Malignant cells	GSE163836	ENSG00000134339	6289	serum amyloid A2	NA	protein_coding	P0DJI9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18925
2.32593713427364e-70	-0.304680740536395	0.243	0.457	3.97898065560191e-66	VSNL1	Malignant cells	GSE163836	ENSG00000163032	7447	visinin like 1	HLP3|HPCAL3|HUVISL1|VILIP|VILIP-1	protein_coding	P62760	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18926
2.41708117155284e-70	-0.287512338994288	0.277	0.496	4.13490076017544e-66	MTHFD2L	Malignant cells	GSE163836	ENSG00000163738	441024	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like	MGC72244	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18927
2.90137583100484e-70	-0.315999727956825	0.338	0.555	4.96338363409998e-66	POP5	Malignant cells	GSE163836	ENSG00000167272	51367	POP5 homolog, ribonuclease P/MRP subunit	NA	protein_coding	Q969H6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18928
3.23918776095739e-70	0.314780525777825	0.996	0.981	5.54127850266981e-66	NDUFS6	Malignant cells	GSE163836	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18929
3.64423157595116e-70	-0.285418368199909	0.266	0.482	6.23418695697965e-66	EML4	Malignant cells	GSE163836	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18930
4.29137177282034e-70	-0.364371579267887	0.647	0.836	7.34124969176376e-66	AUP1	Malignant cells	GSE163836	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18931
4.75401169760853e-70	-0.338210746538647	0.738	0.903	8.13268781109891e-66	EIF2AK1	Malignant cells	GSE163836	ENSG00000086232	27102	eukaryotic translation initiation factor 2 alpha kinase 1	HCR|hHRI|HRI|KIAA1369	protein_coding	Q9BQI3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18932
4.95231789343841e-70	-0.304942865160573	0.324	0.547	8.47193022030508e-66	RABIF	Malignant cells	GSE163836	ENSG00000183155	5877	RAB interacting factor	mss4|RASGRF3	protein_coding	P47224	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18933
5.26688783095366e-70	-0.256990798670864	0.185	0.383	9.01006501241243e-66	BCL2L13	Malignant cells	GSE163836	ENSG00000099968	23786	BCL2 like 13	BCL-RAMBO|MIL1	protein_coding	Q9BXK5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18934
7.18499047036272e-70	-0.269905750409922	0.215	0.421	1.22913631976495e-65	GDI1	Malignant cells	GSE163836	ENSG00000203879	2664	GDP dissociation inhibitor 1	FLJ41411|GDIL|MRX41|MRX48|OPHN2|RABGDIA|XAP-4	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18935
7.77203521481945e-70	0.437544568594301	0.63	0.459	1.32956206419916e-65	MBNL1	Malignant cells	GSE163836	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18936
7.91901223232559e-70	-0.262304444222525	0.189	0.388	1.35470542258394e-65	SLMAP	Malignant cells	GSE163836	ENSG00000163681	7871	sarcolemma associated protein	KIAA1601|SLAP	protein_coding	Q14BN4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18937
9.70286386446177e-70	0.389197782371273	0.369	0.162	1.65986892129347e-65	PDE4B	Malignant cells	GSE163836	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18938
1.17878562394782e-69	-0.309009292069793	0.343	0.568	2.01654856688753e-65	C12orf44	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18939
1.72928264562142e-69	-0.281471835616242	0.229	0.438	2.95828382186456e-65	TOR1A	Malignant cells	GSE163836	ENSG00000136827	1861	torsin family 1 member A	DQ2|DYT1	protein_coding	O14656	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18940
2.60491351636603e-69	-0.298391418178592	0.345	0.574	4.45622555244737e-65	ZCCHC17	Malignant cells	GSE163836	ENSG00000121766	51538	zinc finger CCHC-type containing 17	HSPC251|pNO40|PS1D	protein_coding	Q9NP64	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18941
2.62659432989016e-69	-0.27453122596443	0.11	0.274	4.4933149201431e-65	KRT12	Malignant cells	GSE163836	ENSG00000263243	3859	keratin 12	K12	protein_coding	Q99456	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18942
3.09202494425845e-69	-0.269391172688413	0.205	0.407	5.28952707214293e-65	MAP3K11	Malignant cells	GSE163836	ENSG00000173327	4296	mitogen-activated protein kinase kinase kinase 11	MEKK11|MLK3|PTK1|SPRK	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18943
3.39171620026022e-69	0.305261550355706	1	0.998	5.80220890378515e-65	KRT19	Malignant cells	GSE163836	ENSG00000171345	3880	keratin 19	CK19|K19|K1CS|MGC15366	protein_coding	P08727	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18944
3.49461388261288e-69	-0.388245978290186	0.276	0.479	5.97823596898585e-65	CLSPN	Malignant cells	GSE163836	ENSG00000092853	63967	claspin	NA	protein_coding	Q9HAW4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18945
3.93644428920037e-69	-0.264593605639556	0.208	0.412	6.73407524553506e-65	PLEKHA1	Malignant cells	GSE163836	ENSG00000107679	59338	pleckstrin homology domain containing A1	TAPP1	protein_coding	Q9HB21	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18946
4.44019354250917e-69	0.3891685286576	0.837	0.76	7.59583909317044e-65	ECI1	Malignant cells	GSE163836	ENSG00000167969	1632	enoyl-CoA delta isomerase 1	DCI	protein_coding	P42126	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18947
4.63484859095091e-69	0.377908278417458	0.369	0.167	7.92883548453973e-65	TLE4	Malignant cells	GSE163836	ENSG00000106829	7091	TLE family member 4, transcriptional corepressor	E(spl)|ESG|GRG4	protein_coding	Q04727	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18948
5.50407197360583e-69	-0.320009359222276	0.358	0.579	9.4158159252475e-65	TLE1	Malignant cells	GSE163836	ENSG00000196781	7088	TLE family member 1, transcriptional corepressor	ESG|ESG1|GRG1|TLE-1	protein_coding	Q04724	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18949
5.57041725706403e-69	0.3669423124993	0.373	0.169	9.52931280165944e-65	CTDSPL	Malignant cells	GSE163836	ENSG00000144677	10217	CTD small phosphatase like	C3orf8|HYA22|PSR1|RBSP3|SCP3	protein_coding	O15194	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18950
5.66105748303081e-69	-0.263678130857141	0.204	0.407	9.6843710362208e-65	FARP1	Malignant cells	GSE163836	ENSG00000152767	10160	FERM, ARH/RhoGEF and pleckstrin domain protein 1	CDEP|GLCC1|MGC87400|PLEKHC2|PPP1R75	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18951
6.13873529978645e-69	0.334858683760231	0.936	0.894	1.05015344773447e-64	LAMTOR4	Malignant cells	GSE163836	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18952
6.42562873516024e-69	-0.333767658339532	0.464	0.689	1.09923230772386e-64	KXD1	Malignant cells	GSE163836	ENSG00000105700	79036	KxDL motif containing 1	BORCS4|C19orf50|FLJ25480|KXDL|MGC2749	protein_coding	Q9BQD3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18953
6.57066867571492e-69	0.357402847410181	0.37	0.168	1.12404429035455e-64	ARHGAP21	Malignant cells	GSE163836	ENSG00000107863	57584	Rho GTPase activating protein 21	ARHGAP10|KIAA1424	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18954
6.7493651730462e-69	-0.5089270988323	0.532	0.7	1.15461390015301e-64	SMC4	Malignant cells	GSE163836	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18955
7.0800055453852e-69	-0.352564615551485	0.704	0.871	1.21117654864905e-64	SNX3	Malignant cells	GSE163836	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18956
7.23645808063658e-69	-0.324996313798519	0.332	0.556	1.2379408838545e-64	TM7SF2	Malignant cells	GSE163836	ENSG00000149809	7108	transmembrane 7 superfamily member 2	ANG1|DHCR14A|NET47	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18957
7.58092910792273e-69	-0.256860115643446	0.175	0.369	1.29686954249234e-64	NGDN	Malignant cells	GSE163836	ENSG00000129460	25983	neuroguidin	C14orf120|CANu1|DKFZP564O092|LCP5|lpd-2|NGD	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18958
1.14479841422726e-68	-0.280358158949696	0.278	0.495	1.95840664721857e-64	ECSIT	Malignant cells	GSE163836	ENSG00000130159	51295	ECSIT signaling integrator	SITPEC	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18959
1.38481128872586e-68	-0.319550555380771	0.45	0.679	2.36899667162333e-64	CRIPT	Malignant cells	GSE163836	ENSG00000119878	9419	CXXC repeat containing interactor of PDZ3 domain	HSPC139	protein_coding	Q9P021	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18960
1.76008235297011e-68	-0.333524967272774	0.64	0.844	3.01097288122597e-64	DNAJC19	Malignant cells	GSE163836	ENSG00000205981	131118	DnaJ heat shock protein family (Hsp40) member C19	Pam18|Tim14|TIMM14	protein_coding	Q96DA6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18961
2.27857057607069e-68	-0.273955368757691	0.225	0.429	3.89795068448413e-64	G6PD	Malignant cells	GSE163836	ENSG00000160211	2539	glucose-6-phosphate dehydrogenase	G6PD1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18962
2.59682851889084e-68	-0.378172701627263	0.985	0.998	4.44239454726656e-64	SSB	Malignant cells	GSE163836	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18963
2.80368207620476e-68	-0.268802351035426	0.209	0.411	4.79625892776349e-64	UBE2D1	Malignant cells	GSE163836	ENSG00000072401	7321	ubiquitin conjugating enzyme E2 D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UbcH5A	protein_coding	P51668	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18964
2.85252917334527e-68	0.412402815429711	0.877	0.801	4.87982165684175e-64	RAD21	Malignant cells	GSE163836	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18965
3.58822096965231e-68	-0.316033661400519	0.5	0.723	6.13836961278421e-64	APOPT1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18966
3.92094074999217e-68	-0.287884225230205	0.152	0.332	6.70755334101161e-64	CDCA5	Malignant cells	GSE163836	ENSG00000146670	113130	cell division cycle associated 5	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18967
4.49197908415706e-68	-0.404517494936479	0.642	0.816	7.68442861926748e-64	SF3B2	Malignant cells	GSE163836	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18968
4.55038723042937e-68	-0.255034777214712	0.164	0.352	7.78434743509552e-64	RBM4B	Malignant cells	GSE163836	ENSG00000173914	83759	RNA binding motif protein 4B	MGC10871|RBM30|RBM4L|ZCCHC15|ZCCHC21B|ZCRB3B	protein_coding	Q9BQ04	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18969
4.5680100525607e-68	-0.310991798837843	0.491	0.717	7.81449479691559e-64	ANAPC5	Malignant cells	GSE163836	ENSG00000089053	51433	anaphase promoting complex subunit 5	APC5	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18970
4.60129057109648e-68	-0.279971149775583	0.212	0.412	7.87142777997475e-64	EFHD2	Malignant cells	GSE163836	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18971
5.18292215350027e-68	0.400050945145886	0.452	0.234	8.8664249279929e-64	EDN1	Malignant cells	GSE163836	ENSG00000078401	1906	endothelin 1	ET1	protein_coding	P05305	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18972
5.86445954654745e-68	-0.264917575925867	0.197	0.394	1.00323309462787e-63	FAM86A	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18973
5.94018625115762e-68	-0.264569235996717	0.203	0.404	1.01618766198553e-63	ALKBH3	Malignant cells	GSE163836	ENSG00000166199	221120	alkB homolog 3, alpha-ketoglutarate dependent dioxygenase	DEPC-1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18974
7.93902435213523e-68	0.400377137403594	0.761	0.627	1.35812889591977e-63	TRAPPC6A	Malignant cells	GSE163836	ENSG00000007255	79090	trafficking protein particle complex subunit 6A	HSPC289|MGC2650|TRS33	protein_coding	O75865	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18975
8.49847468306543e-68	-0.349580599433808	0.636	0.83	1.453834064032e-63	MTCH1	Malignant cells	GSE163836	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18976
9.43253191761849e-68	-0.254960316649349	0.186	0.381	1.613623235147e-63	AC010642.1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18977
1.20471508858508e-67	-0.336768677709025	0.516	0.745	2.06090610204249e-63	NOL7	Malignant cells	GSE163836	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18978
1.23664743806824e-67	-0.267401168381065	0.196	0.392	2.11553277230333e-63	DHRS7B	Malignant cells	GSE163836	ENSG00000109016	25979	dehydrogenase/reductase 7B	CGI-93|DKFZp566O084|MGC8916|SDR32C1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18979
1.38238791795837e-67	-0.262217544474786	0.995	0.999	2.36485101125139e-63	WDR83OS	Malignant cells	GSE163836	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18980
1.5007445737832e-67	0.397682569153502	0.538	0.318	2.56732374237091e-63	TUBB2B	Malignant cells	GSE163836	ENSG00000137285	347733	tubulin beta 2B class IIb	bA506K6.1|DKFZp566F223|MGC8685	protein_coding	Q9BVA1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18981
1.87648250862616e-67	-0.338581501473852	0.565	0.769	3.21009862750678e-63	NTMT1	Malignant cells	GSE163836	ENSG00000148335	28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1	AD-003|C9orf32|HOMT1A|METTL11A|NRMT|NRMT1	protein_coding	Q9BV86	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18982
2.18141506817337e-67	-0.303665643691216	0.295	0.505	3.73174675712419e-63	FADS2	Malignant cells	GSE163836	ENSG00000134824	9415	fatty acid desaturase 2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	protein_coding	O95864	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18983
2.51663329073473e-67	-0.437008766980916	0.508	0.699	4.3052045704599e-63	MYBL2	Malignant cells	GSE163836	ENSG00000101057	4605	MYB proto-oncogene like 2	B-MYB|BMYB	protein_coding	P10244	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18984
3.87673555022986e-67	-0.323789025513014	0.876	0.948	6.63193150577822e-63	CIRBP	Malignant cells	GSE163836	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18985
4.20932090867761e-67	-0.359549417474924	0.442	0.659	7.20088527847478e-63	WDR74	Malignant cells	GSE163836	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18986
5.14524796988653e-67	0.429440854771233	0.583	0.401	8.80197570208488e-63	PBX1	Malignant cells	GSE163836	ENSG00000185630	5087	PBX homeobox 1	NA	protein_coding	P40424	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18987
7.53784452516414e-67	-0.321234863245398	0.966	0.981	1.28949906291983e-62	SRSF3	Malignant cells	GSE163836	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18988
7.65999791005772e-67	-0.300325194759504	0.322	0.539	1.31039584247357e-62	CDC73	Malignant cells	GSE163836	ENSG00000134371	79577	cell division cycle 73	C1orf28|FIHP|HRPT1|HRPT2|parafibromin	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18989
8.07016952497328e-67	-0.328552892624711	0.372	0.588	1.38056390063718e-62	ECE2	Malignant cells	GSE163836	ENSG00000145194	9718	endothelin converting enzyme 2	KIAA0604|MGC2408	protein_coding	P0DPD6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18990
9.40183070204672e-67	-0.287954564591278	0.378	0.61	1.60837117819913e-62	ASPH	Malignant cells	GSE163836	ENSG00000198363	444	aspartate beta-hydroxylase	BAH|CASQ2BP1|HAAH|JCTN	protein_coding	Q12797	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18991
1.12045681779207e-66	-0.310655160257161	0.435	0.657	1.91676547819689e-62	HAGH	Malignant cells	GSE163836	ENSG00000063854	3029	hydroxyacylglutathione hydrolase	GLO2|GLXII|HAGH1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18992
1.1800567266693e-66	-0.29986259611322	0.31	0.523	2.01872304231317e-62	HADH	Malignant cells	GSE163836	ENSG00000138796	3033	hydroxyacyl-CoA dehydrogenase	HADH1|HADHSC|SCHAD	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18993
1.29761863292369e-66	-0.360850083918082	0.909	0.961	2.21983619534256e-62	C11orf83	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18994
1.37140352342011e-66	-0.267004164913771	0.205	0.402	2.34606000751478e-62	C1orf85	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18995
1.64116867250353e-66	-0.31036994670698	0.438	0.663	2.8075472480518e-62	SNX17	Malignant cells	GSE163836	ENSG00000115234	9784	sorting nexin 17	KIAA0064	protein_coding	Q15036	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18996
1.78074684700597e-66	-0.271485789999123	0.206	0.401	3.04632363117311e-62	HAUS1	Malignant cells	GSE163836	ENSG00000152240	115106	HAUS augmin like complex subunit 1	CCDC5|FLJ40084|HEI-C|HsT1461	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18997
1.93623518177717e-66	-0.32442746355219	0.994	0.998	3.3123175254662e-62	RAN	Malignant cells	GSE163836	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18998
2.28413516899003e-66	-0.27379195450739	0.25	0.458	3.90747003359125e-62	PCBP4	Malignant cells	GSE163836	ENSG00000090097	57060	poly(rC) binding protein 4	LIP4|MCG10	protein_coding	P57723	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	18999
2.43198733609219e-66	-0.33250334740935	0.35	0.559	4.1604007358529e-62	GNL2	Malignant cells	GSE163836	ENSG00000134697	29889	G protein nucleolar 2	HUMAUANTIG|Ngp-1|Nog2|Nug2	protein_coding	Q13823	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19000
2.45226903532733e-66	-0.261448503377799	0.145	0.322	4.19509663873447e-62	TROAP	Malignant cells	GSE163836	ENSG00000135451	10024	trophinin associated protein	TASTIN	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19001
2.50773554106926e-66	-0.327198137399183	0.713	0.89	4.28998319010718e-62	GTF3C6	Malignant cells	GSE163836	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19002
2.78429368006151e-66	-0.337960711845025	0.68	0.863	4.76309119848123e-62	PTGES2	Malignant cells	GSE163836	ENSG00000148334	80142	prostaglandin E synthase 2	C9orf15|FLJ14038	protein_coding	Q9H7Z7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19003
2.99429038630177e-66	-0.303757743327902	0.449	0.673	5.12233256384644e-62	ZCRB1	Malignant cells	GSE163836	ENSG00000139168	85437	zinc finger CCHC-type and RNA binding motif containing 1	MADP-1|MADP1|RBM36|SNRNP31|ZCCHC19	protein_coding	Q8TBF4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19004
3.02459915443407e-66	-0.398599301585342	0.86	0.928	5.17418177349036e-62	CALML5	Malignant cells	GSE163836	ENSG00000178372	51806	calmodulin like 5	CLSP	protein_coding	Q9NZT1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19005
3.09047976401737e-66	-0.294760041620956	0.397	0.623	5.28688373230451e-62	ARMC10	Malignant cells	GSE163836	ENSG00000282813	83787	armadillo repeat containing 10	MGC3195|SVH	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19006
3.447201305026e-66	-0.275785841479455	0.248	0.456	5.89712727250797e-62	RASSF7	Malignant cells	GSE163836	ENSG00000273859	8045	Ras association domain family member 7	C11orf13|CFAP88|FAP88|HRAS1|HRC1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19007
3.56677071193253e-66	-0.314374913754711	0.413	0.629	6.10167465690298e-62	MRPS35	Malignant cells	GSE163836	ENSG00000061794	60488	mitochondrial ribosomal protein S35	MDS023|MRPS28	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19008
4.0057028484328e-66	-0.360650109399282	0.496	0.703	6.85255586281399e-62	CDK2AP2	Malignant cells	GSE163836	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19009
4.06190964975313e-66	-0.293271661572264	0.253	0.459	6.94870883783268e-62	PDHB	Malignant cells	GSE163836	ENSG00000168291	5162	pyruvate dehydrogenase E1 subunit beta	E1beta|PDHE1B	protein_coding	P11177	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19010
7.35035994712677e-66	-0.304737896252455	0.333	0.549	1.25742607615498e-61	HPRT1	Malignant cells	GSE163836	ENSG00000165704	3251	hypoxanthine phosphoribosyltransferase 1	HGPRT|HPRT	protein_coding	P00492	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19011
9.26720159776959e-66	-0.300549302805005	0.288	0.499	1.58534017733044e-61	LRRCC1	Malignant cells	GSE163836	ENSG00000133739	85444	leucine rich repeat and coiled-coil centrosomal protein 1	CLERC|KIAA1764|VFL1	protein_coding	Q9C099	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19012
9.68755328173802e-66	-0.482282567349606	0.958	0.972	1.65724973990692e-61	EIF4A1	Malignant cells	GSE163836	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19013
1.28942625162133e-65	-0.295614722953105	0.34	0.553	2.20582148864861e-61	YIF1B	Malignant cells	GSE163836	ENSG00000167645	90522	Yip1 interacting factor homolog B, membrane trafficking protein	FinGER8	protein_coding	Q5BJH7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19014
1.45073649377609e-65	-0.324057519649787	0.776	0.906	2.48177491990276e-61	UBXN1	Malignant cells	GSE163836	ENSG00000162191	51035	UBX domain protein 1	2B28|LOC51035|SAKS1|UBXD10	protein_coding	Q04323	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19015
1.51183512512231e-65	-0.297243143704586	0.287	0.494	2.58629634854673e-61	BCAT2	Malignant cells	GSE163836	ENSG00000105552	587	branched chain amino acid transaminase 2	BCAM|BCATm|BCT2	protein_coding	O15382	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19016
1.78705481388697e-65	-0.293774282597924	0.295	0.505	3.05711467011644e-61	NSMCE1	Malignant cells	GSE163836	ENSG00000169189	197370	NSE1 homolog, SMC5-SMC6 complex component	NSE1	protein_coding	Q8WV22	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19017
1.91749250043841e-65	-0.311008189273141	0.469	0.694	3.2802544205e-61	RTFDC1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19018
1.94405237516922e-65	-0.275877217438563	0.27	0.479	3.32569039820199e-61	ATP6V1D	Malignant cells	GSE163836	ENSG00000100554	51382	ATPase H+ transporting V1 subunit D	ATP6M|VATD|VMA8	protein_coding	Q9Y5K8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19019
2.04437101279528e-65	-0.357263900290655	0.629	0.809	3.49730549158888e-61	HOMER3	Malignant cells	GSE163836	ENSG00000051128	9454	homer scaffold protein 3	HOMER-3	protein_coding	Q9NSC5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19020
2.35438895809841e-65	-0.346514481177206	0.495	0.698	4.02765319061895e-61	PYCR2	Malignant cells	GSE163836	ENSG00000143811	29920	pyrroline-5-carboxylate reductase 2	P5CR2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19021
2.85654556497918e-65	-0.300613603670619	0.322	0.536	4.88669249800989e-61	RPUSD1	Malignant cells	GSE163836	ENSG00000007376	113000	RNA pseudouridine synthase domain containing 1	C16orf40|MGC19600|RLUCL	protein_coding	Q9UJJ7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19022
2.92460344108297e-65	-0.294651922990977	0.33	0.543	5.00311910666064e-61	TRUB2	Malignant cells	GSE163836	ENSG00000167112	26995	TruB pseudouridine synthase family member 2	CLONE24922	protein_coding	O95900	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19023
4.05612479833975e-65	-0.318360221603825	0.347	0.56	6.93881269251981e-61	SERPINB6	Malignant cells	GSE163836	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19024
4.08519226845002e-65	-0.284059031303818	0.248	0.45	6.98853841363744e-61	CREB3L4	Malignant cells	GSE163836	ENSG00000143578	148327	cAMP responsive element binding protein 3 like 4	AIbZIP|ATCE1|CREB3|CREB4|hJAL	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19025
4.61667753371526e-65	-0.327046670121008	0.868	0.943	7.8977502569267e-61	CHCHD10	Malignant cells	GSE163836	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19026
6.18183394575624e-65	-0.259612578354285	0.232	0.435	1.05752633310052e-60	ACO2	Malignant cells	GSE163836	ENSG00000100412	50	aconitase 2	ACONM	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19027
9.50864597810515e-65	-0.313927084673574	0.437	0.658	1.62664406747445e-60	OTUB1	Malignant cells	GSE163836	ENSG00000167770	55611	OTU deubiquitinase, ubiquitin aldehyde binding 1	FLJ20113|FLJ40710	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19028
9.6764553595334e-65	0.403397812898011	0.47	0.276	1.65535121835538e-60	NFIB	Malignant cells	GSE163836	ENSG00000147862	4781	nuclear factor I B	NFI-RED|NFIB2|NFIB3	protein_coding	O00712	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19029
1.75356355609549e-64	-0.314419088997809	0.491	0.716	2.99982117541255e-60	BAZ1A	Malignant cells	GSE163836	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19030
2.15941506180885e-64	-0.277042255673559	0.229	0.425	3.69411134623641e-60	PYCRL	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19031
2.50651983315697e-64	-0.250763535239003	0.195	0.387	4.28790347858163e-60	RAB22A	Malignant cells	GSE163836	ENSG00000124209	57403	RAB22A, member RAS oncogene family	NA	protein_coding	Q9UL26	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19032
2.54280564282924e-64	-0.258259576698749	0.224	0.424	4.34997761318798e-60	SNAP47	Malignant cells	GSE163836	ENSG00000143740	116841	synaptosome associated protein 47	C1orf142|SNAP-47|SVAP1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19033
2.74375374246546e-64	0.407342457768909	0.612	0.451	4.69373952723567e-60	TCF25	Malignant cells	GSE163836	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19034
2.78191038155834e-64	-0.284634414750869	0.32	0.533	4.75901408973185e-60	MKRN1	Malignant cells	GSE163836	ENSG00000133606	23608	makorin ring finger protein 1	RNF61	protein_coding	Q9UHC7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19035
3.47539822773873e-64	-0.306090228759359	0.478	0.701	5.94536374819264e-60	EXOSC5	Malignant cells	GSE163836	ENSG00000077348	56915	exosome component 5	hRrp46p|MGC12901|p12B|RRP41B|RRP46|Rrp46p	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19036
5.02869010941984e-64	-0.371378425255532	0.993	0.994	8.60258017018453e-60	NUCKS1	Malignant cells	GSE163836	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19037
6.23935208831014e-64	-0.255742751403137	0.192	0.381	1.06736596174722e-59	C1orf172	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19038
7.54388079254081e-64	-0.3008581919109	0.389	0.606	1.29053168717996e-59	UBE2E1	Malignant cells	GSE163836	ENSG00000170142	7324	ubiquitin conjugating enzyme E2 E1	UbcH6	protein_coding	P51965	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19039
8.25061014746431e-64	-0.292624409392842	0.38	0.6	1.41143187792672e-59	YIPF4	Malignant cells	GSE163836	ENSG00000119820	84272	Yip1 domain family member 4	FinGER4|MGC11061	protein_coding	Q9BSR8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19040
8.38093687387883e-64	0.415727313713856	0.671	0.536	1.43372687101445e-59	MATR3	Malignant cells	GSE163836	ENSG00000015479	9782	matrin 3	ALS21|MPD2|VCPDM|KIAA0723|MGC9105	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19041
1.0053442503755e-63	-0.298369823819451	0.406	0.62	1.71984240911738e-59	MAPK1IP1L	Malignant cells	GSE163836	ENSG00000168175	93487	mitogen-activated protein kinase 1 interacting protein 1 like	C14orf32	protein_coding	Q8NDC0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19042
1.07104526132939e-63	0.355136539840088	0.895	0.829	1.83223712855619e-59	SNRPD3	Malignant cells	GSE163836	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19043
1.12033211278392e-63	-0.401320290093724	0.901	0.945	1.91655214533945e-59	KRT5	Malignant cells	GSE163836	ENSG00000186081	3852	keratin 5	CK-5|EBS2|KRT5A	protein_coding	P13647	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19044
1.61891275938244e-63	0.451840067741145	0.448	0.257	2.76947405747554e-59	RP3-395M20.12	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19045
1.85484117857469e-63	-0.306220175819509	0.441	0.659	3.17307680418772e-59	PSENEN	Malignant cells	GSE163836	ENSG00000205155	55851	presenilin enhancer, gamma-secretase subunit	PEN2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19046
1.90328362836507e-63	-0.305802575815605	0.443	0.659	3.25594730304413e-59	RNF126	Malignant cells	GSE163836	ENSG00000070423	55658	ring finger protein 126	FLJ20552	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19047
1.99069646407403e-63	-0.26542993196703	0.151	0.325	3.40548444109145e-59	PYCARD	Malignant cells	GSE163836	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19048
2.7976010379041e-63	-0.267987220712348	0.22	0.416	4.78585609554255e-59	UTP14A	Malignant cells	GSE163836	ENSG00000156697	10813	UTP14A small subunit processome component	NY-CO-16|SDCCAG16|Utp14	protein_coding	Q9BVJ6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19049
3.1249971752291e-63	-0.302410280002799	0.316	0.528	5.34593266766443e-59	SH3KBP1	Malignant cells	GSE163836	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19050
3.15538544573908e-63	-0.298516925645016	0.957	0.978	5.39791788202585e-59	SSR2	Malignant cells	GSE163836	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19051
4.18697961406288e-63	-0.280993122435728	0.372	0.597	7.16266602577737e-59	GBAS	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19052
5.38504808209288e-63	-0.301186974906488	0.356	0.569	9.21220175403628e-59	OSER1	Malignant cells	GSE163836	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19053
6.3676046677162e-63	0.405265420487057	0.519	0.337	1.08930613050621e-58	SEC31A	Malignant cells	GSE163836	ENSG00000138674	22872	SEC31 homolog A, COPII coat complex component	ABP125|ABP130|KIAA0905|SEC31L1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19054
8.43021983840497e-63	-0.277327291496028	0.223	0.416	1.44215770775594e-58	ST3GAL4	Malignant cells	GSE163836	ENSG00000110080	6484	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	CGS23|FLJ11867|NANTA3|SAT3|SIAT4|SIAT4C|STZ	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19055
9.3458997873547e-63	0.373941898219725	0.834	0.738	1.59880307662277e-58	DDX5	Malignant cells	GSE163836	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19056
1.00387545936105e-62	-0.276473345787082	0.324	0.538	1.71732974832895e-58	SNRNP40	Malignant cells	GSE163836	ENSG00000060688	9410	small nuclear ribonucleoprotein U5 subunit 40	HPRP8BP|PRP8BP|PRPF8BP|SPF38|WDR57	protein_coding	Q96DI7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19057
1.23110747227303e-62	-0.260167319286052	0.227	0.424	2.10605555281747e-58	GALE	Malignant cells	GSE163836	ENSG00000117308	2582	UDP-galactose-4-epimerase	SDR1E1	protein_coding	Q14376	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19058
1.39887818433229e-62	-0.368044786753095	0.383	0.582	2.39306090993726e-58	SMC2	Malignant cells	GSE163836	ENSG00000136824	10592	structural maintenance of chromosomes 2	CAP-E|hCAP-E|SMC2L1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19059
1.56611690320665e-62	-0.323074950751445	0.793	0.907	2.67915618631561e-58	LSM2	Malignant cells	GSE163836	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19060
1.60264719085765e-62	-0.386016472598906	0.98	0.981	2.74164854940018e-58	CCND1	Malignant cells	GSE163836	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19061
1.84386686943799e-62	-0.257562625378287	0.997	0.996	3.15430305354757e-58	MZT2B	Malignant cells	GSE163836	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19062
1.96288035134326e-62	-0.316003979261401	0.412	0.623	3.35789941704291e-58	GLO1	Malignant cells	GSE163836	ENSG00000124767	2739	glyoxalase I	GLOD1	protein_coding	Q04760	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19063
2.00476201195896e-62	-0.251190741314829	0.221	0.417	3.42954637385819e-58	GNPAT	Malignant cells	GSE163836	ENSG00000116906	8443	glyceronephosphate O-acyltransferase	DAP-AT|DAPAT|DHAPAT	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19064
2.6914837642851e-62	-0.282332186211808	0.335	0.551	4.60432127556251e-58	CCNC	Malignant cells	GSE163836	ENSG00000112237	892	cyclin C	CycC	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19065
2.77790587731077e-62	-0.285361230267105	0.326	0.536	4.75216358431553e-58	SPCS3	Malignant cells	GSE163836	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19066
4.77880630420881e-62	-0.329109162660346	0.809	0.92	8.17510394461002e-58	HOOK2	Malignant cells	GSE163836	ENSG00000095066	29911	hook microtubule tethering protein 2	HK2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19067
5.58618446276492e-62	0.412133418551657	0.457	0.269	9.55628576045196e-58	UGCG	Malignant cells	GSE163836	ENSG00000148154	7357	UDP-glucose ceramide glucosyltransferase	GCS	protein_coding	Q16739	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19068
5.86326111081249e-62	-0.306585460054018	0.424	0.637	1.00302807822669e-57	GOPC	Malignant cells	GSE163836	ENSG00000047932	57120	golgi associated PDZ and coiled-coil motif containing	CAL|dJ94G16.2|FIG|GOPC1|PIST	protein_coding	Q9HD26	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19069
5.90646616400496e-62	-0.300330862867558	0.336	0.549	1.01041916667633e-57	RNF114	Malignant cells	GSE163836	ENSG00000124226	55905	ring finger protein 114	PSORS12|ZNF313	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19070
7.36865437273824e-62	-0.27374358845622	0.23	0.425	1.26055570354433e-57	THOP1	Malignant cells	GSE163836	ENSG00000172009	7064	thimet oligopeptidase 1	NA	protein_coding	P52888	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19071
7.59107661665579e-62	0.325618820929818	0.981	0.945	1.29860547681131e-57	H2AFJ	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19072
8.83479330144639e-62	-0.282345770733216	0.338	0.554	1.51136809007843e-57	BOD1	Malignant cells	GSE163836	ENSG00000145919	91272	biorientation of chromosomes in cell division 1	FAM44B	protein_coding	Q96IK1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19073
1.17203745518268e-61	-0.266015641987435	0.227	0.422	2.005004474581e-57	CLEC11A	Malignant cells	GSE163836	ENSG00000105472	6320	C-type lectin domain containing 11A	CLECSF3|LSLCL|P47|SCGF	protein_coding	Q9Y240	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19074
1.26811845893668e-61	-0.285103004431646	0.372	0.59	2.16937024770298e-57	CCDC90B	Malignant cells	GSE163836	ENSG00000137500	60492	coiled-coil domain containing 90B	MDS011|MDS025	protein_coding	Q9GZT6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19075
1.45308709487008e-61	-0.264901617777169	0.269	0.472	2.48579609319425e-57	HPS1	Malignant cells	GSE163836	ENSG00000107521	3257	HPS1 biogenesis of lysosomal organelles complex 3 subunit 1	BLOC3S1|HPS	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19076
1.99273439119932e-61	0.350021725387021	0.896	0.805	3.40897072302467e-57	ZFP36L1	Malignant cells	GSE163836	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19077
2.44814616767805e-61	-0.619667448763322	0.435	0.602	4.18804364904685e-57	MKI67	Malignant cells	GSE163836	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19078
2.66540033741658e-61	-0.285407436076662	0.382	0.599	4.55970035721854e-57	TTC19	Malignant cells	GSE163836	ENSG00000011295	54902	tetratricopeptide repeat domain 19	FLJ20343|MGC19520	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19079
2.71759768602704e-61	-0.297538577802313	0.307	0.51	4.64899436148646e-57	WDR61	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19080
2.89132893275968e-61	-0.280001247466103	0.27	0.468	4.94619640527198e-57	SMC5	Malignant cells	GSE163836	ENSG00000198887	23137	structural maintenance of chromosomes 5	KIAA0594|SMC5L1	protein_coding	Q8IY18	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19081
3.23925377281301e-61	-0.260877428000229	0.276	0.48	5.54139142915121e-57	WDR13	Malignant cells	GSE163836	ENSG00000101940	64743	WD repeat domain 13	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19082
3.69854549520947e-61	-0.285667826512386	0.397	0.615	6.32710177865484e-57	PDCD2	Malignant cells	GSE163836	ENSG00000071994	5134	programmed cell death 2	RP8|ZMYND7	protein_coding	Q16342	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19083
4.43285787392792e-61	-0.286715579545229	0.397	0.615	7.58328996492849e-57	TROVE2	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19084
4.88278768989515e-61	-0.315155612077141	0.481	0.694	8.35298490110363e-57	ANAPC15	Malignant cells	GSE163836	ENSG00000110200	25906	anaphase promoting complex subunit 15	APC15|C11orf51|DKFZP564M082|HSPC020	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19085
4.99133966152261e-61	-0.305289734070826	0.143	0.308	8.53868475896673e-57	SPC25	Malignant cells	GSE163836	ENSG00000277909	57405	SPC25 component of NDC80 kinetochore complex	AD024|MGC22228|SPBC25	protein_coding	Q9HBM1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19086
5.00931207876516e-61	-0.36242698395947	0.109	0.259	8.56943017314356e-57	HIST1H1A	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19087
6.12110641327221e-61	-0.254644016858671	0.182	0.363	1.04713767411848e-56	ADCK3	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19088
6.42339253565106e-61	-0.414423800219152	0.865	0.932	1.09884976107383e-56	CLDN4	Malignant cells	GSE163836	ENSG00000189143	1364	claudin 4	CPE-R|CPETR|CPETR1|hCPE-R|WBSCR8	protein_coding	O14493	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19089
7.54261095198044e-61	0.430046879661221	0.628	0.477	1.29031445555529e-56	NR2F2	Malignant cells	GSE163836	ENSG00000185551	7026	nuclear receptor subfamily 2 group F member 2	ARP1|COUP-TFII|COUPTF2|COUPTFB|NF-E3|SVP40|TFCOUP2	protein_coding	P24468	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19090
1.34190952235652e-60	-0.301515550046125	0.41	0.617	2.29560461989529e-56	IER3IP1.1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19091
2.11340486054084e-60	-0.298147711714643	0.44	0.655	3.61540169492722e-56	EBP	Malignant cells	GSE163836	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19092
3.01868095914729e-60	-0.302423273276248	0.51	0.72	5.16405751681326e-56	CHTOP	Malignant cells	GSE163836	ENSG00000160679	26097	chromatin target of PRMT1	C1orf77|DKFZP547E1010|FOP|SRAG	protein_coding	Q9Y3Y2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19093
3.17384633189821e-60	0.332510767138729	0.986	0.973	5.42949891997827e-56	TPM3	Malignant cells	GSE163836	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19094
4.09295842325314e-60	-0.259027882247934	0.249	0.446	7.00182397465914e-56	FAM210A	Malignant cells	GSE163836	ENSG00000177150	125228	family with sequence similarity 210 member A	C18orf19|HsT2329|MGC24180	protein_coding	Q96ND0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19095
4.69061170256001e-60	-0.297207216380968	0.525	0.737	8.0242294395694e-56	TMEM208	Malignant cells	GSE163836	ENSG00000168701	29100	transmembrane protein 208	hSND2|HSPC171	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19096
4.80750579865722e-60	-0.258571297153622	0.233	0.428	8.22420016976291e-56	MAST1	Malignant cells	GSE163836	ENSG00000105613	22983	microtubule associated serine/threonine kinase 1	KIAA0973|SAST	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19097
5.76217716278592e-60	0.381755044967663	0.483	0.3	9.85735647237788e-56	FASN	Malignant cells	GSE163836	ENSG00000169710	2194	fatty acid synthase	FAS|SDR27X1	protein_coding	P49327	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19098
5.92858255976792e-60	0.401466065113197	0.623	0.475	1.0142026184995e-55	IRF2BP2	Malignant cells	GSE163836	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19099
6.11590048989829e-60	-0.28050546473083	0.248	0.441	1.0462470968069e-55	UPF3B	Malignant cells	GSE163836	ENSG00000125351	65109	UPF3B regulator of nonsense mediated mRNA decay	HUPF3B|MRX62|MRX82|RENT3B|UPF3BP1|UPF3BP2|UPF3BP3|UPF3X	protein_coding	Q9BZI7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19100
7.71597672054721e-60	0.380599159453695	0.455	0.268	1.31997213758401e-55	ABCA7	Malignant cells	GSE163836	ENSG00000064687	10347	ATP binding cassette subfamily A member 7	ABCX	protein_coding	Q8IZY2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19101
9.69815331573805e-60	-0.256654565611684	0.232	0.426	1.65906308772331e-55	CGREF1	Malignant cells	GSE163836	ENSG00000138028	10669	cell growth regulator with EF-hand domain 1	CGR11	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19102
9.83075755750957e-60	0.328248667764853	0.999	1	1.68174769536316e-55	HSP90AA1	Malignant cells	GSE163836	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19103
1.09686245930738e-59	-0.412414248870611	0.205	0.381	1.87640260913714e-55	GNG11	Malignant cells	GSE163836	ENSG00000127920	2791	G protein subunit gamma 11	GNGT11	protein_coding	P61952	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19104
1.1880776547601e-59	-0.341581249627373	0.637	0.81	2.0324444439981e-55	PMF1	Malignant cells	GSE163836	ENSG00000160783	11243	polyamine modulated factor 1	NA	protein_coding	Q6P1K2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19105
1.24913126279098e-59	-0.344813427013393	0.577	0.77	2.13688885125653e-55	PPIE	Malignant cells	GSE163836	ENSG00000084072	10450	peptidylprolyl isomerase E	CyP-33|MGC111222|MGC3736	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19106
1.80774413463133e-59	-0.282055143998557	0.303	0.506	3.09250789111382e-55	MRPL2	Malignant cells	GSE163836	ENSG00000112651	51069	mitochondrial ribosomal protein L2	CGI-22|MRP-L14|RPML14	protein_coding	Q5T653	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19107
2.19939431762465e-59	-0.254471334504605	0.232	0.424	3.76250385916048e-55	TSEN15	Malignant cells	GSE163836	ENSG00000198860	116461	tRNA splicing endonuclease subunit 15	C1orf19	protein_coding	Q8WW01	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19108
2.30381545860998e-59	0.334073785969772	0.983	0.961	3.94113710504409e-55	TKT	Malignant cells	GSE163836	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19109
2.40820698601734e-59	-0.357394939738162	0.873	0.937	4.11971969097986e-55	RSL1D1	Malignant cells	GSE163836	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19110
3.45278305993324e-59	-0.313514908850832	0.455	0.656	5.9066759806278e-55	TUBG1	Malignant cells	GSE163836	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19111
3.82381071591358e-59	-0.264710589735459	0.266	0.462	6.54139299171337e-55	UBN1	Malignant cells	GSE163836	ENSG00000118900	29855	ubinuclein 1	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19112
5.1694185319752e-59	-0.255404396520552	0.231	0.424	8.84332428264998e-55	STK25	Malignant cells	GSE163836	ENSG00000115694	10494	serine/threonine kinase 25	SOK1|YSK1	protein_coding	O00506	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19113
5.74779964381089e-59	-0.26549427957968	0.287	0.488	9.8327608506673e-55	FKBP10	Malignant cells	GSE163836	ENSG00000141756	60681	FKBP prolyl isomerase 10	FKBP6|FKBP65|FLJ20683|FLJ22041|FLJ23833|hFKBP65	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19114
7.26668351698511e-59	-0.332569592736872	0.778	0.908	1.24311154925064e-54	GSPT1	Malignant cells	GSE163836	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19115
7.48677122565487e-59	-0.340624485496024	0.654	0.816	1.28076195357278e-54	SURF2	Malignant cells	GSE163836	ENSG00000281024	6835	surfeit 2	NA	protein_coding	Q15527	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19116
7.53792811372863e-59	-0.255306364515089	0.189	0.369	1.28951336241556e-54	CREB3	Malignant cells	GSE163836	ENSG00000107175	10488	cAMP responsive element binding protein 3	Luman|LZIP|sLZIP	protein_coding	O43889	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19117
7.58483699479033e-59	0.37126273027369	0.764	0.679	1.29753806469878e-54	CAPNS1	Malignant cells	GSE163836	ENSG00000126247	826	calpain small subunit 1	30K|CANP|CANPS|CAPN4|CDPS	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19118
7.6048505152167e-59	-0.299421552844968	0.399	0.606	1.30096177763812e-54	ANXA7	Malignant cells	GSE163836	ENSG00000138279	310	annexin A7	ANX7	protein_coding	P20073	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19119
8.78022470191809e-59	-0.270988259282834	0.36	0.568	1.50203303975713e-54	RPAIN	Malignant cells	GSE163836	ENSG00000129197	84268	RPA interacting protein	hRIP|MGC4189|RIP	protein_coding	Q86UA6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19120
9.8674920179148e-59	-0.263004703408095	0.279	0.476	1.68803185950469e-54	ALKBH2	Malignant cells	GSE163836	ENSG00000189046	121642	alkB homolog 2, alpha-ketoglutarate dependent dioxygenase	ABH2|MGC90512	protein_coding	Q6NS38	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19121
1.02885881214391e-58	0.369346566734349	0.854	0.797	1.76006876993458e-54	EIF3A	Malignant cells	GSE163836	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19122
1.20426829484802e-58	-0.319295930337974	0.587	0.775	2.0601417719965e-54	MRP63	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19123
1.95719490867106e-58	-0.326177468139234	0.582	0.762	3.34817333026358e-54	PGAM1	Malignant cells	GSE163836	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19124
2.04858694020728e-58	-0.250229609620028	0.219	0.407	3.50451767861259e-54	LACTB2	Malignant cells	GSE163836	ENSG00000147592	51110	lactamase beta 2	CGI-83	protein_coding	Q53H82	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19125
2.57237785461216e-58	-0.274684348678204	0.304	0.508	4.40056679588503e-54	VAMP2	Malignant cells	GSE163836	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19126
4.06168258653735e-58	0.391346110578429	0.757	0.673	6.94832040078944e-54	CIB1	Malignant cells	GSE163836	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19127
5.17249865005451e-58	-0.288161625671511	0.52	0.731	8.84859344064824e-54	MRPL34	Malignant cells	GSE163836	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19128
5.23489473189383e-58	-0.313762493420671	1	0.999	8.95533441785078e-54	H2AFZ	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19129
5.67474460736639e-58	-0.260502056953297	0.32	0.528	9.70778559982169e-54	SDHAF2	Malignant cells	GSE163836	ENSG00000167985	54949	succinate dehydrogenase complex assembly factor 2	C11orf79|FLJ20487|PGL2|SDH5	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19130
1.00913609215407e-57	-0.304922277064851	0.813	0.908	1.72632911284796e-53	POLR2J	Malignant cells	GSE163836	ENSG00000005075	5439	RNA polymerase II subunit J	hRPB14|POLR2J1|RPB11|RPB11A|RPB11m	protein_coding	P52435	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19131
1.04976748310215e-57	-0.32963509170639	0.6	0.785	1.79583723334285e-53	FAM89B	Malignant cells	GSE163836	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19132
1.16327375433661e-57	-0.314874500466668	0.548	0.736	1.99001241154363e-53	FAM207A	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19133
1.29050056435785e-57	-0.255370453313564	0.217	0.4	2.20765931544697e-53	UNC50	Malignant cells	GSE163836	ENSG00000115446	25972	unc-50 inner nuclear membrane RNA binding protein	GMH1|UNCL|URP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19134
1.67586808041695e-57	-0.271695018984446	0.313	0.514	2.86690752516928e-53	TOR1AIP2	Malignant cells	GSE163836	ENSG00000169905	163590	torsin 1A interacting protein 2	IFRG15|LULL1|NET9	protein_coding	Q8NFQ8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19135
2.01288052984006e-57	0.379343313802292	0.394	0.208	3.44343472239738e-53	IRF1	Malignant cells	GSE163836	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19136
2.2200739926844e-57	0.279123567002216	0.267	0.097	3.79788057928521e-53	MAML2	Malignant cells	GSE163836	ENSG00000184384	84441	mastermind like transcriptional coactivator 2	KIAA1819|MAM3	protein_coding	Q8IZL2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19137
2.98680710014096e-57	0.396680884145888	0.58	0.42	5.10953090621113e-53	COMTD1	Malignant cells	GSE163836	ENSG00000165644	118881	catechol-O-methyltransferase domain containing 1	FLJ23841	protein_coding	Q86VU5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19138
4.68352933998249e-57	-0.255151128280615	0.375	0.594	8.01211364190804e-53	ACBD6	Malignant cells	GSE163836	ENSG00000230124	84320	acyl-CoA binding domain containing 6	MGC2404	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19139
5.36154666018991e-57	-0.295938614086149	0.53	0.728	9.17199787158688e-53	TRAPPC2L	Malignant cells	GSE163836	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19140
5.66545357094328e-57	-0.300914221739248	0.489	0.688	9.69189142381266e-53	UBE2Q1	Malignant cells	GSE163836	ENSG00000160714	55585	ubiquitin conjugating enzyme E2 Q1	NICE-5|PRO3094|UBE2Q	protein_coding	Q7Z7E8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19141
6.00981418662537e-57	0.334886124269675	0.867	0.799	1.028098912906e-52	RSL24D1	Malignant cells	GSE163836	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19142
8.16454448040322e-57	0.307165808266754	0.972	0.961	1.39670862426258e-52	PRRC2C	Malignant cells	GSE163836	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19143
9.75951876152634e-57	-0.311685073908164	0.584	0.78	1.66956087453431e-52	PFN2	Malignant cells	GSE163836	ENSG00000070087	5217	profilin 2	NA	protein_coding	P35080	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19144
1.01956240623441e-56	-0.267971708032338	0.298	0.495	1.74416540834521e-52	RP11-1094M14.11	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19145
1.37557052823295e-56	-0.280891700248143	0.918	0.964	2.3531885026481e-52	SRP9	Malignant cells	GSE163836	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19146
2.29149839482466e-56	-0.322299315378803	0.722	0.878	3.92006630402655e-52	TMEM59	Malignant cells	GSE163836	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19147
2.38665060758485e-56	-0.318475429754107	0.726	0.87	4.0828431943954e-52	BCAP31	Malignant cells	GSE163836	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19148
3.94885315407992e-56	-0.394856948917029	0.193	0.357	6.75530309068452e-52	CDCA3	Malignant cells	GSE163836	ENSG00000111665	83461	cell division cycle associated 3	GRCC8|TOME-1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19149
4.51417124484576e-56	-0.285983935662392	0.409	0.608	7.72239274855764e-52	ETFA	Malignant cells	GSE163836	ENSG00000140374	2108	electron transfer flavoprotein subunit alpha	EMA|GA2|MADD	protein_coding	P13804	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19150
5.692259351431e-56	-0.299863205113316	0.588	0.777	9.73774807249301e-52	RCN2	Malignant cells	GSE163836	ENSG00000117906	5955	reticulocalbin 2	E6BP|ERC-55|ERC55|TCBP49	protein_coding	Q14257	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19151
6.78973318206909e-56	-0.344877143824475	0.951	0.981	1.16151965545656e-51	EPCAM	Malignant cells	GSE163836	ENSG00000119888	4072	epithelial cell adhesion molecule	17-1A|323/A3|Ber-Ep4|BerEp4|CD326|CO-17A|EGP-2|EGP34|EGP40|Ep-CAM|ESA|GA733-2|HEA125|KS1/4|KSA|Ly74|M4S1|MH99|MIC18|MK-1|MOC-31|MOC31|TACST-1|TACSTD1|TROP1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19152
1.37331025207554e-55	-0.997047372347653	0.659	0.781	2.34932184822563e-51	CDC20	Malignant cells	GSE163836	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19153
1.84127421339374e-55	-0.279845367609673	0.395	0.593	3.14986779685267e-51	MRPS11	Malignant cells	GSE163836	ENSG00000181991	64963	mitochondrial ribosomal protein S11	FLJ22512|FLJ23406|HCC-2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19154
2.87087325699126e-55	-0.327587470727514	0.686	0.839	4.91120288073495e-51	ISOC2	Malignant cells	GSE163836	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19155
3.02480758695892e-55	0.382572357158576	0.463	0.285	5.17453833901062e-51	COPB1	Malignant cells	GSE163836	ENSG00000129083	1315	COPI coat complex subunit beta 1	COPB	protein_coding	P53618	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19156
3.03424424686603e-55	-0.308914219990094	0.583	0.774	5.19068163311372e-51	MMP24-AS1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19157
3.35486241091354e-55	-0.255212285063707	0.301	0.499	5.7391631263498e-51	FBXO9	Malignant cells	GSE163836	ENSG00000112146	26268	F-box protein 9	FBX9|NY-REN-57	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19158
3.76920259989735e-55	-0.285505191351746	0.486	0.697	6.4479748876444e-51	FBXW5	Malignant cells	GSE163836	ENSG00000159069	54461	F-box and WD repeat domain containing 5	DKFZP434B205|Fbw5|MGC20962	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19159
5.426627963196e-55	-0.282011926267568	0.409	0.612	9.2833324566394e-51	NAE1	Malignant cells	GSE163836	ENSG00000159593	8883	NEDD8 activating enzyme E1 subunit 1	APP-BP1|APPBP1|ula-1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19160
6.25319399936171e-55	-0.252117056234439	0.303	0.506	1.06973389747081e-50	CNOT11	Malignant cells	GSE163836	ENSG00000158435	55571	CCR4-NOT transcription complex subunit 11	C2orf29|C40	protein_coding	Q9UKZ1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19161
7.23999564555449e-55	-0.276524398618438	0.367	0.57	1.23854605508501e-50	RRP1	Malignant cells	GSE163836	ENSG00000160214	8568	ribosomal RNA processing 1	D21S2056E|NNP-1|Nop52|RRP1A	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19162
8.51138497966487e-55	-0.255504699244876	0.223	0.404	1.45604262847127e-50	CNP	Malignant cells	GSE163836	ENSG00000173786	1267	2',3'-cyclic nucleotide 3' phosphodiesterase	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19163
9.92725265445677e-55	-0.266794637054531	0.35	0.554	1.69825511159792e-50	MAGEF1	Malignant cells	GSE163836	ENSG00000177383	64110	MAGE family member F1	NA	protein_coding	Q9HAY2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19164
1.00264559051263e-54	-0.300641007581985	0.373	0.574	1.71522581168995e-50	PSAT1	Malignant cells	GSE163836	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19165
1.02135966355403e-54	-0.257317118217725	0.355	0.56	1.74723997644188e-50	ZNF146	Malignant cells	GSE163836	ENSG00000167635	7705	zinc finger protein 146	OZF	protein_coding	Q15072	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19166
1.09229965697726e-54	0.313595228852686	0.338	0.16	1.868597023191e-50	EGFR	Malignant cells	GSE163836	ENSG00000146648	1956	epidermal growth factor receptor	ERBB|ERBB1|ERRP	protein_coding	P00533	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19167
1.30300465891504e-54	0.383476338186097	0.939	0.813	2.22905007000596e-50	MT2A	Malignant cells	GSE163836	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19168
1.43745954661142e-54	-0.297893748799859	0.488	0.689	2.45906204638815e-50	HMOX2	Malignant cells	GSE163836	ENSG00000277424	3163	heme oxygenase 2	HO-2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19169
1.53897285262101e-54	-0.314201670277327	0.675	0.834	2.63272085897876e-50	NDUFB8.1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19170
1.83073503222712e-54	-0.270239952386467	0.339	0.536	3.13183841963093e-50	LYPLA2	Malignant cells	GSE163836	ENSG00000011009	11313	lysophospholipase 2	APT-2	protein_coding	O95372	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19171
1.85002377896736e-54	-0.285393768302754	0.338	0.533	3.16483567867947e-50	EZH2	Malignant cells	GSE163836	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19172
1.88886822446532e-54	-0.257744526900974	0.316	0.513	3.23128687159282e-50	MAX	Malignant cells	GSE163836	ENSG00000125952	4149	MYC associated factor X	bHLHd4|bHLHd5|bHLHd6|bHLHd7|bHLHd8	protein_coding	P61244	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19173
2.07912797817229e-54	-0.253847055094929	0.304	0.501	3.55676423225934e-50	MFF	Malignant cells	GSE163836	ENSG00000168958	56947	mitochondrial fission factor	C2orf33|GL004	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19174
2.40145864879681e-54	-0.287251554995266	0.143	0.297	4.10817531049671e-50	NMU	Malignant cells	GSE163836	ENSG00000109255	10874	neuromedin U	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19175
3.59712083690886e-54	-0.317948572874728	0.643	0.812	6.15359461569998e-50	DNMT1	Malignant cells	GSE163836	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19176
3.65133121467095e-54	-0.293653032201066	0.486	0.693	6.24633230893759e-50	FAM213A	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19177
4.68324809466255e-54	-0.292603133213814	0.453	0.648	8.01163251553922e-50	MAD2L2	Malignant cells	GSE163836	ENSG00000116670	10459	mitotic arrest deficient 2 like 2	FANCV|MAD2B|POLZ2|REV7	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19178
4.72570166154601e-54	-0.273781494467524	0.533	0.738	8.08425783240675e-50	PTOV1	Malignant cells	GSE163836	ENSG00000104960	53635	PTOV1 extended AT-hook containing adaptor protein	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19179
5.47574645297451e-54	-0.269102130530762	0.214	0.39	9.3673594571035e-50	H2AFX	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19180
6.77723591444143e-54	-0.334588261581293	0.614	0.786	1.1593817478835e-49	CDC123	Malignant cells	GSE163836	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19181
8.8060546419591e-54	-0.308543438479596	0.559	0.759	1.50645176759994e-49	TAX1BP1	Malignant cells	GSE163836	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19182
9.5227699104963e-54	-0.300862917630804	0.772	0.902	1.6290602485886e-49	GTF2A2	Malignant cells	GSE163836	ENSG00000140307	2958	general transcription factor IIA subunit 2	HsT18745|TFIIA	protein_coding	P52657	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19183
1.00390668098933e-53	-0.260124540472538	0.249	0.433	1.71738315916845e-49	MRPS22	Malignant cells	GSE163836	ENSG00000175110	56945	mitochondrial ribosomal protein S22	C3orf5|GIBT|GK002|MRP-S22	protein_coding	P82650	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19184
1.0437570172419e-53	-0.289176745410263	0.476	0.678	1.78555512939572e-49	SCNM1	Malignant cells	GSE163836	ENSG00000163156	79005	sodium channel modifier 1	MGC3180	protein_coding	Q9BWG6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19185
1.35702065708567e-53	-0.28598469638511	0.422	0.619	2.32145523807645e-49	DDRGK1	Malignant cells	GSE163836	ENSG00000198171	65992	DDRGK domain containing 1	C20orf116|dJ1187M17.3|UFBP1	protein_coding	Q96HY6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19186
1.45207657088401e-53	-0.275796853409972	0.395	0.595	2.48406738981127e-49	RBBP7	Malignant cells	GSE163836	ENSG00000102054	5931	RB binding protein 7, chromatin remodeling factor	RbAp46	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19187
1.45876880489213e-53	-0.27163430582198	0.417	0.617	2.49551579452897e-49	ORMDL1	Malignant cells	GSE163836	ENSG00000128699	94101	ORMDL sphingolipid biosynthesis regulator 1	NA	protein_coding	Q9P0S3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19188
1.64218129380897e-53	0.370434368713559	0.704	0.581	2.809279539319e-49	HEY2	Malignant cells	GSE163836	ENSG00000135547	23493	hes related family bHLH transcription factor with YRPW motif 2	bHLHb32|HERP1|HESR2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19189
1.68564539682587e-53	-0.292172892644824	0.539	0.731	2.88363358035002e-49	CISD1	Malignant cells	GSE163836	ENSG00000122873	55847	CDGSH iron sulfur domain 1	C10orf70|MDS029|mitoNEET|ZCD1	protein_coding	Q9NZ45	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19190
1.83389391151362e-53	-0.277830192237536	0.214	0.388	3.13724231442635e-49	SAPCD2	Malignant cells	GSE163836	ENSG00000186193	89958	suppressor APC domain containing 2	C9orf140|p42.3	protein_coding	Q86UD0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19191
2.01549920689256e-53	0.309864773468202	0.941	0.904	3.44791449323111e-49	RGS10	Malignant cells	GSE163836	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19192
2.75646708247715e-53	-0.278216487407945	0.418	0.612	4.71548823799367e-49	FASTK	Malignant cells	GSE163836	ENSG00000164896	10922	Fas activated serine/threonine kinase	FAST	protein_coding	Q14296	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19193
2.8425474409831e-53	0.331217836888791	0.369	0.192	4.86274590728979e-49	TOB1	Malignant cells	GSE163836	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19194
3.20769814374251e-53	0.387161599007689	0.462	0.286	5.48740921450031e-49	TM4SF18	Malignant cells	GSE163836	ENSG00000163762	116441	transmembrane 4 L six family member 18	L6D	protein_coding	Q96CE8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19195
5.34194327076088e-53	-0.262124757225523	0.477	0.687	9.13846235329064e-49	NCBP2	Malignant cells	GSE163836	ENSG00000114503	22916	nuclear cap binding protein subunit 2	Cbc2|CBP20|NIP1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19196
6.11903140971267e-53	-0.292359670463867	0.443	0.642	1.04678270325955e-48	PDHA1	Malignant cells	GSE163836	ENSG00000131828	5160	pyruvate dehydrogenase E1 subunit alpha 1	E1alpha|PDHA	protein_coding	P08559	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19197
6.32600654482128e-53	-0.251340078133789	0.961	0.985	1.08218993962258e-48	LAMTOR5	Malignant cells	GSE163836	ENSG00000134248	10542	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	HBXIP|MGC71071|XIP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19198
7.85491749769703e-53	-0.251153773634005	0.337	0.539	1.34374073633103e-48	HDHD3	Malignant cells	GSE163836	ENSG00000119431	81932	haloacid dehalogenase like hydrolase domain containing 3	C9orf158|MGC12904	protein_coding	Q9BSH5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19199
7.88658249171816e-53	0.357438722122692	0.831	0.776	1.34915766685823e-48	EPRS	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19200
1.31343487063475e-52	0.373500457493498	0.665	0.541	2.24689303319486e-48	NFE2L2	Malignant cells	GSE163836	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19201
1.51451341999734e-52	-0.268455504311394	0.417	0.617	2.59087810758945e-48	VMA21	Malignant cells	GSE163836	ENSG00000160131	203547	vacuolar ATPase assembly factor VMA21	MEAX|XMEA	protein_coding	Q3ZAQ7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19202
2.02560317214754e-52	-0.337587459576132	0.397	0.59	3.46519934659279e-48	PCNA	Malignant cells	GSE163836	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19203
2.37523116217685e-52	-0.311601851512586	0.674	0.836	4.06330794913594e-48	NIT2	Malignant cells	GSE163836	ENSG00000114021	56954	nitrilase family member 2	NA	protein_coding	Q9NQR4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19204
2.40603989204928e-52	-0.27832329525933	0.419	0.613	4.1160124433287e-48	MRPL50	Malignant cells	GSE163836	ENSG00000136897	54534	mitochondrial ribosomal protein L50	FLJ20493|MRP-L50	protein_coding	Q8N5N7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19205
2.8975678272598e-52	-0.268893941030096	0.502	0.709	4.95686928209334e-48	DDA1	Malignant cells	GSE163836	ENSG00000130311	79016	DET1 and DDB1 associated 1	C19orf58|MGC2594|PCIA1	protein_coding	Q9BW61	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19206
4.33782979689642e-52	0.354488990046046	0.749	0.652	7.42072543355071e-48	CALU	Malignant cells	GSE163836	ENSG00000128595	813	calumenin	NA	protein_coding	O43852	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19207
4.55954914347929e-52	-0.285405379547882	0.626	0.817	7.80002071975003e-48	MRPS33	Malignant cells	GSE163836	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19208
4.90539810559568e-52	-0.296033743004488	0.438	0.63	8.39166453924254e-48	EIF2S1	Malignant cells	GSE163836	ENSG00000134001	1965	eukaryotic translation initiation factor 2 subunit alpha	EIF-2alpha|EIF2|EIF2A	protein_coding	P05198	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19209
5.03294533476617e-52	-0.316122734843042	0.647	0.809	8.60985958418449e-48	NDUFB6	Malignant cells	GSE163836	ENSG00000165264	4712	NADH:ubiquinone oxidoreductase subunit B6	B17|CI	protein_coding	O95139	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19210
6.37128305082927e-52	0.341253862838599	0.393	0.22	1.08993539150536e-47	JAG1	Malignant cells	GSE163836	ENSG00000101384	182	jagged canonical Notch ligand 1	AGS|AHD|AWS|CD339|HJ1|JAGL1	protein_coding	P78504	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19211
6.75277212337853e-52	-0.250945926690445	0.305	0.497	1.15519672714636e-47	RNPEP	Malignant cells	GSE163836	ENSG00000176393	6051	arginyl aminopeptidase	APB	protein_coding	Q9H4A4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19212
7.81235078832116e-52	-0.250358724997477	0.328	0.522	1.3364588493581e-47	SCAMP3	Malignant cells	GSE163836	ENSG00000263290	10067	secretory carrier membrane protein 3	C1orf3	protein_coding	O14828	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19213
1.02528113282218e-51	-0.295433810222331	0.425	0.611	1.7539484339189e-47	HILPDA	Malignant cells	GSE163836	ENSG00000135245	29923	hypoxia inducible lipid droplet associated	C7orf68|FLJ21076|HIG-2|HIG2	protein_coding	Q9Y5L2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19214
1.1773023830062e-51	-0.298502052602049	0.647	0.814	2.01401118660871e-47	MRPL4	Malignant cells	GSE163836	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19215
1.3975029834763e-51	-0.273312306720775	0.522	0.716	2.39070835383291e-47	CMPK1	Malignant cells	GSE163836	ENSG00000162368	51727	cytidine/uridine monophosphate kinase 1	CMPK|UMP-CMPK	protein_coding	P30085	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19216
1.67997357150935e-51	-0.314569009297445	0.508	0.692	2.87393078878105e-47	TRAP1	Malignant cells	GSE163836	ENSG00000126602	10131	TNF receptor associated protein 1	HSP75|HSP90L	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19217
1.78287996646995e-51	0.267936190993098	0.258	0.098	3.04997275864015e-47	ABCC3	Malignant cells	GSE163836	ENSG00000108846	8714	ATP binding cassette subfamily C member 3	cMOAT2|EST90757|MLP2|MOAT-D|MRP3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19218
2.15679717214856e-51	-0.271900109362651	0.507	0.711	3.68963292239453e-47	CYB5A	Malignant cells	GSE163836	ENSG00000166347	1528	cytochrome b5 type A	CYB5	protein_coding	P00167	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19219
2.27351169924379e-51	-0.313340659089213	0.449	0.64	3.88929646389635e-47	AKIRIN2	Malignant cells	GSE163836	ENSG00000135334	55122	akirin 2	C6orf166|dJ486L4.2|FLJ10342	protein_coding	Q53H80	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19220
2.66352745105122e-51	-0.256925160253517	0.346	0.54	4.55649641051332e-47	QARS	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19221
2.80263578676682e-51	-0.279091420859796	0.471	0.67	4.79446904042199e-47	TMEM167A	Malignant cells	GSE163836	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19222
4.11283857684203e-51	-0.283166720904212	0.514	0.716	7.03583295340367e-47	PITX1	Malignant cells	GSE163836	ENSG00000069011	5307	paired like homeodomain 1	BFT|POTX|PTX1	protein_coding	P78337	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19223
4.20393307952342e-51	-0.347372925607033	0.796	0.878	7.19166831914072e-47	STRA13	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19224
4.32009919614279e-51	0.316318665398985	0.846	0.784	7.39039369484147e-47	PTPRF	Malignant cells	GSE163836	ENSG00000142949	5792	protein tyrosine phosphatase receptor type F	LAR	protein_coding	P10586	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19225
9.91741605003162e-51	-0.29380220592618	0.674	0.835	1.69657236367891e-46	C4orf3	Malignant cells	GSE163836	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19226
9.98849314357628e-51	-0.265524578516257	0.423	0.623	1.70873152207159e-46	TCEAL4	Malignant cells	GSE163836	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19227
1.00787202526545e-50	-0.292013203672819	0.71	0.868	1.72416667362161e-46	ARL2	Malignant cells	GSE163836	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19228
1.15142843447899e-50	-0.251352496753834	0.32	0.507	1.9697486228632e-46	CLPTM1L	Malignant cells	GSE163836	ENSG00000274811	81037	CLPTM1 like	CRR9|FLJ14400	protein_coding	Q96KA5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19229
1.26440799478568e-50	-0.281937811784827	0.563	0.758	2.16302275667987e-46	SWI5	Malignant cells	GSE163836	ENSG00000175854	375757	SWI5 homologous recombination repair protein	bA395P17.9|C9orf119|SAE3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19230
1.31722411270815e-50	-0.303195406495823	0.638	0.804	2.25337528960983e-46	MTHFD2	Malignant cells	GSE163836	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19231
1.74044914993219e-50	-0.269647123540011	0.329	0.518	2.97738636078899e-46	GMNN	Malignant cells	GSE163836	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19232
1.96275430604316e-50	-0.272229174987892	0.394	0.586	3.35768379134804e-46	LSM10	Malignant cells	GSE163836	ENSG00000181817	84967	LSM10, U7 small nuclear RNA associated	MGC15749	protein_coding	Q969L4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19233
2.49045642343909e-50	-0.293947013861289	0.605	0.786	4.26042380357725e-46	NANS	Malignant cells	GSE163836	ENSG00000095380	54187	N-acetylneuraminate synthase	SAS	protein_coding	Q9NR45	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19234
2.59573116494419e-50	-0.322199414467546	0.727	0.869	4.44051730387002e-46	CNIH4	Malignant cells	GSE163836	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19235
3.55927944333642e-50	-0.301053230860842	0.225	0.39	6.08885934371561e-46	SGOL1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19236
3.7471993836922e-50	-0.267081102638059	0.934	0.973	6.41033398568224e-46	SLIRP	Malignant cells	GSE163836	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19237
4.35046136050107e-50	0.309712037076362	0.328	0.162	7.44233424940918e-46	SLCO3A1	Malignant cells	GSE163836	ENSG00000176463	28232	solute carrier organic anion transporter family member 3A1	OATP-D|OATP3A1|SLC21A11	protein_coding	Q9UIG8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19238
6.04495737161453e-50	-0.260200312668884	0.376	0.568	1.0341108575621e-45	PWP1	Malignant cells	GSE163836	ENSG00000136045	11137	PWP1 homolog, endonuclein	IEF-SSP-9502	protein_coding	Q13610	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19239
8.66515229393689e-50	-0.266049704838031	0.519	0.71	1.48234760292378e-45	URI1	Malignant cells	GSE163836	ENSG00000105176	8725	URI1 prefoldin like chaperone	C19orf2|FLJ10575|NNX3|PPP1R19|RMP|URI	protein_coding	O94763	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19240
1.04052429194478e-49	-0.29125577771634	0.506	0.696	1.78002490622993e-45	HSPB11	Malignant cells	GSE163836	ENSG00000081870	51668	heat shock protein family B (small) member 11	C1orf41|FAP232|HSPCO34|IFT25|PP25	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19241
1.19096796042202e-49	-0.306010991757441	0.616	0.785	2.03738888989394e-45	CCDC23	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19242
1.20411107339913e-49	0.366547567194947	0.548	0.399	2.0598728132639e-45	SFT2D2	Malignant cells	GSE163836	ENSG00000213064	375035	SFT2 domain containing 2	dJ747L4.C1.2|UNQ512	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19243
1.66730745319581e-49	-0.27366261017852	0.785	0.902	2.85226286018207e-45	TPD52	Malignant cells	GSE163836	ENSG00000076554	7163	tumor protein D52	D52|hD52|N8L	protein_coding	P55327	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19244
2.31538793972078e-49	-0.265142377870585	0.438	0.636	3.96093414848033e-45	IRF3	Malignant cells	GSE163836	ENSG00000126456	3661	interferon regulatory factor 3	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19245
2.37552951496252e-49	0.36294568108741	0.532	0.375	4.06381834124639e-45	FAM114A1	Malignant cells	GSE163836	ENSG00000197712	92689	family with sequence similarity 114 member A1	Noxp20	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19246
2.43744637168189e-49	-0.374634532983338	0.502	0.674	4.16973950803622e-45	MFGE8	Malignant cells	GSE163836	ENSG00000140545	4240	milk fat globule EGF and factor V/VIII domain containing	BA46|EDIL1|hP47|HsT19888|MFG-E8|OAcGD3S|SED1|SPAG10	protein_coding	Q08431	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19247
2.71045137524055e-49	-0.308703822385445	0.636	0.789	4.636769167624e-45	SNRPC	Malignant cells	GSE163836	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19248
2.92961911063555e-49	0.30468927290731	0.885	0.779	5.01169941256423e-45	TYMP	Malignant cells	GSE163836	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19249
2.95178345540188e-49	-0.254809622768959	0.372	0.566	5.049615957156e-45	THAP7	Malignant cells	GSE163836	ENSG00000184436	80764	THAP domain containing 7	MGC10963	protein_coding	Q9BT49	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19250
5.48567875352558e-49	-0.273332277893373	0.362	0.552	9.38435064365622e-45	ACAT2	Malignant cells	GSE163836	ENSG00000120437	39	acetyl-CoA acetyltransferase 2	NA	protein_coding	Q9BWD1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19251
8.08373299561837e-49	-0.251721249953978	0.291	0.472	1.38288420356043e-44	GNPDA1	Malignant cells	GSE163836	ENSG00000113552	10007	glucosamine-6-phosphate deaminase 1	GNPDA|GNPI|GPI|HLN|KIAA0060	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19252
8.09548470625503e-49	0.340100021422472	0.438	0.271	1.38489456869905e-44	ACTR6	Malignant cells	GSE163836	ENSG00000075089	64431	actin related protein 6	ARP6|FLJ13433	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19253
1.04453259703203e-48	-0.259121725455935	0.288	0.469	1.78688191374269e-44	DHFR	Malignant cells	GSE163836	ENSG00000228716	1719	dihydrofolate reductase	NA	protein_coding	P00374	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19254
1.2153468262556e-48	-0.271343006275777	0.373	0.552	2.07909381567546e-44	WDR33	Malignant cells	GSE163836	ENSG00000136709	55339	WD repeat domain 33	FLJ11294|NET14|WDC146	protein_coding	Q9C0J8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19255
1.44662472632082e-48	-0.25238281934487	0.272	0.45	2.47474091931703e-44	SAT2	Malignant cells	GSE163836	ENSG00000141504	112483	spermidine/spermine N1-acetyltransferase family member 2	SSAT2	protein_coding	Q96F10	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19256
1.81394550278455e-48	-0.256740904127269	0.33	0.514	3.10311657161353e-44	CMC2	Malignant cells	GSE163836	ENSG00000103121	56942	C-X9-C motif containing 2	C16orf61|DC13|MGC45036	protein_coding	Q9NRP2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19257
2.11348620051526e-48	-0.274115518780416	0.385	0.572	3.61554084322145e-44	NOC2L	Malignant cells	GSE163836	ENSG00000188976	26155	NOC2 like nucleolar associated transcriptional repressor	DKFZP564C186|NET15|NET7|NIR|PPP1R112	protein_coding	Q9Y3T9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19258
2.78761694934895e-48	0.31268648809054	0.496	0.319	4.76877631525125e-44	SMIM22	Malignant cells	GSE163836	ENSG00000267795	440335	small integral membrane protein 22	CASIMO1	protein_coding	K7EJ46	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19259
3.11258628747983e-48	-0.263099201020029	0.441	0.627	5.32470136199175e-44	LINC00116	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19260
3.23840790524296e-48	-0.282515473100747	0.963	0.969	5.53994440349913e-44	PSMB5	Malignant cells	GSE163836	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19261
3.79923538465665e-48	-0.276254508657342	0.93	0.962	6.49935197253212e-44	GGCT	Malignant cells	GSE163836	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19262
3.97126347643627e-48	0.291606333819716	0.356	0.185	6.79364042913954e-44	RP11-485G4.2	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19263
7.0349069961794e-48	-0.250557847645096	0.4	0.597	1.20346153983641e-43	NAPA	Malignant cells	GSE163836	ENSG00000105402	8775	NSF attachment protein alpha	NA	protein_coding	P54920	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19264
8.18581427886411e-48	-0.359589510284702	0.999	0.997	1.40034724868528e-43	TUBA1B	Malignant cells	GSE163836	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19265
8.76782396981148e-48	-0.282906805761961	0.691	0.838	1.49991164651565e-43	RER1	Malignant cells	GSE163836	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19266
1.24366930068226e-47	-0.350198522620609	0.946	0.965	2.12754507267714e-43	LGALS3	Malignant cells	GSE163836	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19267
1.44326707171212e-47	0.316040440524844	0.955	0.914	2.46899697957792e-43	HNRNPAB	Malignant cells	GSE163836	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19268
1.52304824989228e-47	-0.269388175589633	0.622	0.797	2.60547864109073e-43	ILF3	Malignant cells	GSE163836	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19269
1.87700882915967e-47	-0.252456070069775	0.463	0.655	3.21099900404345e-43	DNAJC2	Malignant cells	GSE163836	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19270
1.88502665472657e-47	-0.286423434529972	0.456	0.642	3.22471509824074e-43	DTYMK	Malignant cells	GSE163836	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19271
1.92945689394679e-47	-0.456955632840007	0.961	0.959	3.30072190847477e-43	ID3	Malignant cells	GSE163836	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19272
2.46894098262111e-47	0.361742560805064	0.668	0.551	4.22361733896993e-43	KIF22	Malignant cells	GSE163836	ENSG00000079616	3835	kinesin family member 22	Kid|KNSL4|OBP-1|OBP-2	protein_coding	Q14807	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19273
2.51689040866481e-47	-0.277546895232599	0.773	0.901	4.30564442210289e-43	ARPC5	Malignant cells	GSE163836	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19274
2.54858246730484e-47	0.29628716054342	0.969	0.944	4.35986002681839e-43	CALR	Malignant cells	GSE163836	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19275
3.19482953358823e-47	-0.278601558459113	0.58	0.755	5.46539488310939e-43	CLPP	Malignant cells	GSE163836	ENSG00000125656	8192	caseinolytic mitochondrial matrix peptidase proteolytic subunit	NA	protein_coding	Q16740	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19276
1.07589734813807e-46	0.349956186561986	0.69	0.595	1.8405375934598e-42	ENAH	Malignant cells	GSE163836	ENSG00000154380	55740	ENAH actin regulator	FLJ10773|MENA|NDPP1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19277
1.15502965919231e-46	-0.251630959136788	0.395	0.582	1.97590923798028e-42	C1orf50	Malignant cells	GSE163836	ENSG00000164008	79078	chromosome 1 open reading frame 50	MGC955	protein_coding	Q9BV19	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19278
2.04616470711475e-46	-0.334204447055716	0.742	0.862	3.5003739644612e-42	CCT4	Malignant cells	GSE163836	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19279
2.48876624460638e-46	-0.30130220289392	0.665	0.815	4.25753241464813e-42	BCL7C	Malignant cells	GSE163836	ENSG00000099385	9274	BAF chromatin remodeling complex subunit BCL7C	SMARCJ3	protein_coding	Q8WUZ0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19280
3.49768744570631e-46	-0.279726226213537	0.509	0.693	5.98349391336978e-42	SVIP	Malignant cells	GSE163836	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19281
7.11468327179077e-46	0.329961506715262	0.459	0.302	1.21710886730525e-41	PUM1	Malignant cells	GSE163836	ENSG00000134644	9698	pumilio RNA binding family member 1	KIAA0099|PUMH1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19282
7.74208238891249e-46	0.305962660906418	0.899	0.828	1.32443803427126e-41	GUCY1A3	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19283
9.04369754007167e-46	-0.327877829747403	0.792	0.881	1.54710533818006e-41	PCSK1N	Malignant cells	GSE163836	ENSG00000102109	27344	proprotein convertase subtilisin/kexin type 1 inhibitor	BigLEN|PEN|proSAAS|SAAS|SCG8|SgVIII	protein_coding	Q9UHG2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19284
1.02791984054481e-45	-0.279564236895247	0.37	0.558	1.75846247122001e-41	GAS1	Malignant cells	GSE163836	ENSG00000180447	2619	growth arrest specific 1	NA	protein_coding	P54826	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19285
1.05113532036333e-45	-0.27167212427383	0.359	0.532	1.79817719254555e-41	C10orf35	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19286
1.65819978215725e-45	-0.280971280997441	0.635	0.801	2.83668236733641e-41	RUVBL1	Malignant cells	GSE163836	ENSG00000284901	8607	RuvB like AAA ATPase 1	ECP54|INO80H|NMP238|Pontin52|RVB1|TIH1|TIP49|TIP49a	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19287
2.37926029491803e-45	-0.266719798690423	0.777	0.894	4.07020058651627e-41	DDX46	Malignant cells	GSE163836	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19288
2.45421703030007e-45	-0.254082932157423	0.391	0.571	4.19842907373432e-41	SEC13	Malignant cells	GSE163836	ENSG00000157020	6396	SEC13 homolog, nuclear pore and COPII coat complex component	D3S1231E|npp-20|SEC13L1|SEC13R	protein_coding	P55735	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19289
2.75071056512241e-45	0.258518224965516	0.975	0.952	4.70564056375491e-41	PPA1	Malignant cells	GSE163836	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19290
2.88000439454585e-45	-0.279966648419169	0.602	0.766	4.92682351774959e-41	IMP3	Malignant cells	GSE163836	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19291
3.55245325920364e-45	-0.269470845679245	0.558	0.734	6.07718179051966e-41	DCTN3	Malignant cells	GSE163836	ENSG00000137100	11258	dynactin subunit 3	DCTN-22	protein_coding	O75935	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19292
5.56787173785669e-45	-0.254944807173237	0.478	0.668	9.52495818195145e-41	NUDCD2	Malignant cells	GSE163836	ENSG00000170584	134492	NudC domain containing 2	DKFZp686E10109|NudCL2	protein_coding	Q8WVJ2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19293
7.51825313475054e-45	-0.53943809570708	0.968	0.974	1.28614756376178e-40	UBE2S	Malignant cells	GSE163836	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19294
9.75368637146791e-45	0.33438490807646	0.851	0.781	1.66856312756701e-40	TUBB4B	Malignant cells	GSE163836	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19295
1.12790040095972e-44	-0.311714511759753	0.922	0.963	1.92949921592179e-40	CRYAB	Malignant cells	GSE163836	ENSG00000109846	1410	crystallin alpha B	CRYA2|HSPB5	protein_coding	P02511	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19296
2.2256298694776e-44	-0.261979373991767	0.481	0.657	3.80738501771534e-40	ITPA	Malignant cells	GSE163836	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19297
2.70224621781684e-44	-0.274426027685505	0.782	0.908	4.62273260481926e-40	UBE2D3	Malignant cells	GSE163836	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19298
2.72203027445593e-44	0.333638022001348	0.535	0.388	4.65657719051176e-40	CNFN	Malignant cells	GSE163836	ENSG00000105427	84518	cornifelin	PLAC8L2	protein_coding	Q9BYD5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19299
3.25741610179779e-44	-0.253632668058033	0.352	0.528	5.57246172534549e-40	PSMD6	Malignant cells	GSE163836	ENSG00000163636	9861	proteasome 26S subunit, non-ATPase 6	KIAA0107|p44S10|Rpn7|S10	protein_coding	Q15008	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19300
4.94286633004995e-44	-0.340432582562452	0.487	0.642	8.45576143081644e-40	FBXO2	Malignant cells	GSE163836	ENSG00000116661	26232	F-box protein 2	Fbg1|Fbs1|FBX2|Nfb42|OCP1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19301
7.55944326672073e-44	0.284707899467421	0.369	0.206	1.29319395963792e-39	TACC2	Malignant cells	GSE163836	ENSG00000138162	10579	transforming acidic coiled-coil containing protein 2	AZU-1|ECTACC	protein_coding	O95359	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19302
1.04613930593978e-43	0.298998625951627	0.28	0.131	1.78963051067119e-39	ANKRD37	Malignant cells	GSE163836	ENSG00000186352	353322	ankyrin repeat domain 37	Lrp2bp	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19303
1.19532430176857e-43	-0.274273069133735	0.493	0.676	2.04484128303549e-39	SF3B4	Malignant cells	GSE163836	ENSG00000143368	10262	splicing factor 3b subunit 4	Hsh49|SAP49|SF3b49	protein_coding	Q15427	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19304
1.40016971800942e-43	0.252283154866189	0.993	0.989	2.39527033659871e-39	SERBP1	Malignant cells	GSE163836	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19305
4.01114132410514e-43	0.369013314838923	0.55	0.411	6.86185946314666e-39	ELF5	Malignant cells	GSE163836	ENSG00000135374	2001	E74 like ETS transcription factor 5	NA	protein_coding	Q9UKW6	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19306
5.43528274286579e-43	0.318843769318754	0.787	0.722	9.29813818822051e-39	DDX21	Malignant cells	GSE163836	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19307
6.21964196393034e-43	-0.250803930857588	0.57	0.751	1.06399415076956e-38	PPP1CC	Malignant cells	GSE163836	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19308
6.36512143059054e-43	-0.284032108432051	0.88	0.953	1.08888132313112e-38	HNRNPA3	Malignant cells	GSE163836	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19309
8.32656167325065e-43	0.344363931037157	0.738	0.646	1.42442490544299e-38	HSPA2	Malignant cells	GSE163836	ENSG00000126803	3306	heat shock protein family A (Hsp70) member 2	NA	protein_coding	P54652	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19310
8.50841629165205e-43	0.337673957871815	0.537	0.4	1.45553477501292e-38	ESRP1	Malignant cells	GSE163836	ENSG00000104413	54845	epithelial splicing regulatory protein 1	FLJ20171|RBM35A	protein_coding	Q6NXG1	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19311
8.93975612919362e-43	-0.268844886901059	0.556	0.729	1.52932408102115e-38	UQCRC2	Malignant cells	GSE163836	ENSG00000140740	7385	ubiquinol-cytochrome c reductase core protein 2	QCR2|UQCR2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19312
1.01780579505151e-42	-0.279875063344381	0.536	0.706	1.74116037359462e-38	CMTM7	Malignant cells	GSE163836	ENSG00000153551	112616	CKLF like MARVEL transmembrane domain containing 7	CKLFSF7|FLJ30992	protein_coding	Q96FZ5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19313
1.05560798170363e-42	-0.276082808093846	0.372	0.54	1.80582857430039e-38	SVIL	Malignant cells	GSE163836	ENSG00000197321	6840	supervillin	NA	protein_coding	O95425	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19314
1.14150625492169e-42	-0.269419972872726	0.403	0.58	1.95277475029454e-38	EIF4A3	Malignant cells	GSE163836	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19315
1.68092431734963e-42	-0.277580351744109	0.53	0.707	2.87555722969002e-38	BUB3	Malignant cells	GSE163836	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19316
1.72256864043395e-42	0.326658807034397	0.459	0.309	2.94679817319036e-38	PLEC	Malignant cells	GSE163836	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19317
2.31375463256374e-42	0.347468259650823	0.981	0.936	3.95814004992679e-38	TPM1	Malignant cells	GSE163836	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19318
6.69692311434513e-42	0.324637226718403	0.783	0.727	1.14564263717102e-37	SFPQ	Malignant cells	GSE163836	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19319
7.31388448223005e-42	0.36514322194238	0.579	0.456	1.25118621837509e-37	GPRC5A	Malignant cells	GSE163836	ENSG00000013588	9052	G protein-coupled receptor class C group 5 member A	PEIG-1|RAI3|RAIG1|TIG1	protein_coding	Q8NFJ5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19320
7.93055684123675e-42	-0.272520387018557	0.728	0.856	1.35668035883037e-37	PSMG3	Malignant cells	GSE163836	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19321
8.24602279380575e-42	0.260190577064605	0.97	0.944	1.41064711933635e-37	CBX3	Malignant cells	GSE163836	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19322
1.2566408957755e-41	0.298341938053468	0.285	0.139	2.14973558040315e-37	SNHG12	Malignant cells	GSE163836	ENSG00000197989	85028	small nucleolar RNA host gene 12	ASLNC04080|C1orf79|LINC00100|PNAS-123	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19323
1.31281316632538e-41	-0.256010206097449	0.419	0.593	2.24582948363282e-37	CORO1B	Malignant cells	GSE163836	ENSG00000172725	57175	coronin 1B	coronin-2	protein_coding	Q9BR76	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19324
2.05266953056029e-41	0.268676754179829	0.351	0.197	3.51150176592949e-37	BTBD2	Malignant cells	GSE163836	ENSG00000133243	55643	BTB domain containing 2	NA	protein_coding	Q9BX70	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19325
2.73280529649328e-41	-0.254124443666334	0.729	0.871	4.67501002071105e-37	NDUFB3	Malignant cells	GSE163836	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19326
4.49657007598298e-41	-0.270078531332668	0.704	0.847	7.69228242898409e-37	FKBP2	Malignant cells	GSE163836	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19327
4.91885734516954e-41	0.312141922402015	0.773	0.715	8.41468926038153e-37	ACTN4	Malignant cells	GSE163836	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19328
5.08383726983268e-41	0.267668227642954	0.945	0.902	8.69692041750277e-37	PTGES3	Malignant cells	GSE163836	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19329
5.4862395998871e-41	-0.272636525653186	0.479	0.657	9.38531008352687e-37	HMG20B	Malignant cells	GSE163836	ENSG00000064961	10362	high mobility group 20B	BRAF25|BRAF35|HMGX2|HMGXB2|SMARCE1r|SOXL	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19330
1.12949135750977e-40	0.269629715463674	0.327	0.173	1.93222086529196e-36	PHLDA1	Malignant cells	GSE163836	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19331
2.37650878870862e-40	-0.259258782166725	0.426	0.598	4.06549358484383e-36	PEA15	Malignant cells	GSE163836	ENSG00000162734	8682	proliferation and apoptosis adaptor protein 15	HMAT1|HUMMAT1H|MAT1|MAT1H|PEA-15|PED|PED-PEA15|PED/PEA15	protein_coding	Q15121	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19332
2.74270200954686e-40	0.258618006331861	0.334	0.17	4.69194032773181e-36	IL32	Malignant cells	GSE163836	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19333
2.87371451439559e-40	-0.252069740459301	0.836	0.924	4.91606341977654e-36	C14orf166	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19334
2.87904267746924e-40	-0.254319728133453	0.882	0.945	4.92517830834663e-36	TUFM	Malignant cells	GSE163836	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19335
2.91792638874386e-40	0.309151949770616	0.422	0.261	4.99169667322412e-36	CCL28	Malignant cells	GSE163836	ENSG00000151882	56477	C-C motif chemokine ligand 28	CCK1|MEC|SCYA28	protein_coding	Q9NRJ3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19336
3.19203961054825e-40	0.276276277391253	0.696	0.556	5.4606221617649e-36	ID1	Malignant cells	GSE163836	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19337
3.22694423085839e-40	-0.340216565557656	0.744	0.84	5.52033349572944e-36	GABRP	Malignant cells	GSE163836	ENSG00000094755	2568	gamma-aminobutyric acid type A receptor subunit pi	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19338
4.6004033942147e-40	-0.252242567098415	0.702	0.843	7.86991008648309e-36	MALSU1	Malignant cells	GSE163836	ENSG00000156928	115416	mitochondrial assembly of ribosomal large subunit 1	C7orf30|mtRsfA	protein_coding	Q96EH3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19339
2.19997299284938e-39	0.341193998894981	0.543	0.418	3.76349379886744e-35	GNAQ	Malignant cells	GSE163836	ENSG00000156052	2776	G protein subunit alpha q	G-ALPHA-q|GAQ	protein_coding	P50148	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19340
2.59792053034799e-39	1.28714098754874	0.252	0.119	4.44426265126631e-35	KRT81	Malignant cells	GSE163836	ENSG00000205426	3887	keratin 81	Hb-1|KRTHB1	protein_coding	Q14533	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19341
2.90681000225457e-39	0.298423866618768	0.439	0.296	4.9726798708569e-35	ZNF580	Malignant cells	GSE163836	ENSG00000213015	51157	zinc finger protein 580	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19342
3.34042146933632e-39	-0.291712118009062	0.615	0.766	5.71445900759364e-35	PSMC1	Malignant cells	GSE163836	ENSG00000100764	5700	proteasome 26S subunit, ATPase 1	p56|RPT2|S4	protein_coding	P62191	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19343
4.33381246054922e-39	-0.271091654387584	0.429	0.6	7.41385297626155e-35	CENPW	Malignant cells	GSE163836	ENSG00000203760	387103	centromere protein W	C6orf173|CUG2	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19344
5.70582705843099e-39	-0.260326071537359	0.928	0.965	9.76095834885789e-35	PPIB	Malignant cells	GSE163836	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19345
9.51543764095213e-39	-0.250993026161731	0.372	0.534	1.62780591723768e-34	GRPEL1	Malignant cells	GSE163836	ENSG00000109519	80273	GrpE like 1, mitochondrial	FLJ25609|GrpE|hMGE	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19346
9.76404856405602e-39	0.316360404409756	0.639	0.539	1.67033578785306e-34	METAP2	Malignant cells	GSE163836	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19347
1.76788676323619e-38	-0.267185902114898	0.847	0.928	3.02432388586815e-34	NAPRT1	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19348
2.14812359868256e-38	-0.254122223588514	0.49	0.663	3.67479504026626e-34	PSMD3	Malignant cells	GSE163836	ENSG00000108344	5709	proteasome 26S subunit, non-ATPase 3	P58|Rpn3|S3|TSTA2	protein_coding	O43242	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19349
5.53724945366348e-38	-0.256616895154642	0.569	0.724	9.47257264038212e-34	HM13	Malignant cells	GSE163836	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19350
5.96252701552355e-38	0.2979871437895	0.726	0.65	1.02000949654561e-33	TMEM50A	Malignant cells	GSE163836	ENSG00000183726	23585	transmembrane protein 50A	SMP1	protein_coding	O95807	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19351
6.75262360592171e-38	-0.256766416049356	0.853	0.925	1.15517132026503e-33	PSMB4	Malignant cells	GSE163836	ENSG00000159377	5692	proteasome 20S subunit beta 4	HN3|PROS26	protein_coding	P28070	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19352
1.25016331944436e-37	0.251888183685797	0.935	0.894	2.13865439057346e-33	GNG5	Malignant cells	GSE163836	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19353
1.27184829813489e-37	-0.25797255179452	0.522	0.682	2.17575088361935e-33	SAC3D1	Malignant cells	GSE163836	ENSG00000168061	29901	SAC3 domain containing 1	HSU79266|SHD1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19354
1.36920717115472e-37	0.275653733002849	0.999	0.994	2.34230270769438e-33	STMN1	Malignant cells	GSE163836	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19355
1.95746901534585e-37	0.257634326730664	0.89	0.859	3.34864224455215e-33	PGLS	Malignant cells	GSE163836	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19356
2.0304980356584e-37	-0.268054996732579	0.551	0.71	3.47357298960083e-33	SLBP	Malignant cells	GSE163836	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19357
5.2647890253852e-37	-0.289317311116336	0.788	0.886	9.00647458572647e-33	EIF6	Malignant cells	GSE163836	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19358
2.10804250099381e-36	-0.255268674480779	0.501	0.659	3.60622830645011e-32	PCMT1	Malignant cells	GSE163836	ENSG00000120265	5110	protein-L-isoaspartate (D-aspartate) O-methyltransferase	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19359
2.14636023415537e-36	0.292352835522715	0.409	0.266	3.67177845256959e-32	SAMD1	Malignant cells	GSE163836	ENSG00000288488	90378	sterile alpha motif domain containing 1	NA	protein_coding	Q6SPF0	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19360
4.57049669588408e-36	-0.258548319638574	0.633	0.783	7.81874869764889e-32	LRRC59	Malignant cells	GSE163836	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19361
4.97549245050357e-36	0.272236212699634	0.849	0.789	8.51157493507646e-32	SPCS2	Malignant cells	GSE163836	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19362
5.33011213856099e-36	0.304638109869076	0.526	0.404	9.11822283543628e-32	PET100	Malignant cells	GSE163836	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19363
6.4694836081562e-36	0.295596814716225	0.713	0.639	1.10673456084728e-31	NCKAP1	Malignant cells	GSE163836	ENSG00000061676	10787	NCK associated protein 1	HEM2|Nap1|NAP125	protein_coding	Q9Y2A7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19364
7.00529363496186e-36	0.295781818844373	0.423	0.284	1.19839558213293e-31	EMC2	Malignant cells	GSE163836	ENSG00000104412	9694	ER membrane protein complex subunit 2	KIAA0103|TTC35	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19365
8.0433279586441e-36	0.284189770926404	0.787	0.722	1.37597211388525e-31	KHDRBS1	Malignant cells	GSE163836	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19366
1.01421362821574e-35	-0.278308039342324	0.305	0.458	1.73501525378867e-31	KRT15	Malignant cells	GSE163836	ENSG00000171346	3866	keratin 15	CK15|K15|K1CO	protein_coding	P19012	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19367
1.26317369433403e-35	-0.254469227074467	0.481	0.64	2.16091123889723e-31	RTN3	Malignant cells	GSE163836	ENSG00000133318	10313	reticulon 3	ASYIP|HAP|NSPL2|NSPLII|RTN3-A1	protein_coding	O95197	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19368
2.17149729955875e-35	0.276143568506908	0.88	0.849	3.71478043035516e-31	HMGN3	Malignant cells	GSE163836	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19369
3.01043945069896e-35	0.294661293253929	0.461	0.329	5.14995876831071e-31	TBL1XR1	Malignant cells	GSE163836	ENSG00000177565	79718	TBL1X/Y related 1	C21|DC42|FLJ12894|IRA1|TBLR1	protein_coding	Q9BZK7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19370
4.04621731008264e-35	-0.265466795519459	0.593	0.743	6.92186395235836e-31	HSPA9	Malignant cells	GSE163836	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19371
5.80971788170817e-35	0.304382330076983	0.478	0.352	9.93868438023817e-31	SNHG9	Malignant cells	GSE163836	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19372
8.28665345082193e-35	0.280552425214319	0.347	0.212	1.41759780583211e-30	RNF19A	Malignant cells	GSE163836	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19373
1.22979425829897e-34	0.300521852225248	0.391	0.255	2.10380903767206e-30	DST	Malignant cells	GSE163836	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19374
1.3722515673023e-34	0.285685639481606	0.768	0.741	2.34751075618405e-30	NOTCH2	Malignant cells	GSE163836	ENSG00000134250	4853	notch receptor 2	NA	protein_coding	Q04721	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19375
3.66887315023791e-34	-0.300205463892928	0.955	0.962	6.27634129811199e-30	JUN	Malignant cells	GSE163836	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19376
4.22943121873183e-34	0.262872445401711	0.401	0.258	7.23528798588455e-30	NR4A1	Malignant cells	GSE163836	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19377
4.71265578265918e-34	0.2866328161924	0.76	0.727	8.06194024739505e-30	HP1BP3	Malignant cells	GSE163836	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19378
4.93563314971169e-34	-0.254551408396547	0.705	0.824	8.44338762921179e-30	MRPL3	Malignant cells	GSE163836	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19379
5.23772659383421e-34	-0.256502407462748	0.793	0.883	8.96017888407218e-30	NT5DC2	Malignant cells	GSE163836	ENSG00000168268	64943	5'-nucleotidase domain containing 2	FLJ12442	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19380
8.7151043778531e-34	0.283649752615121	0.477	0.343	1.49089290591933e-29	WWTR1	Malignant cells	GSE163836	ENSG00000018408	25937	WW domain containing transcription regulator 1	DKFZp586I1419|TAZ	protein_coding	Q9GZV5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19381
1.24225358317893e-33	0.304044243385777	0.576	0.467	2.12512320474419e-29	DDX17	Malignant cells	GSE163836	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19382
2.72867386677709e-33	0.270360978671651	0.41	0.276	4.66794238389557e-29	LPP	Malignant cells	GSE163836	ENSG00000145012	4026	LIM domain containing preferred translocation partner in lipoma	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19383
2.99895216897146e-33	0.369298503857195	0.409	0.278	5.13030747545948e-29	KLK10	Malignant cells	GSE163836	ENSG00000129451	5655	kallikrein related peptidase 10	NES1|PRSSL1	protein_coding	O43240	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19384
5.78634566076936e-33	-0.317961389209445	0.28	0.41	9.89870152187814e-29	CBX6	Malignant cells	GSE163836	ENSG00000183741	23466	chromobox 6	NA	protein_coding	O95503	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19385
1.26161330172492e-32	0.289657204162757	0.52	0.402	2.15824187526082e-28	PGD	Malignant cells	GSE163836	ENSG00000142657	5226	phosphogluconate dehydrogenase	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19386
1.29947342319703e-32	0.302246093811115	0.521	0.414	2.22300918506316e-28	YME1L1	Malignant cells	GSE163836	ENSG00000136758	10730	YME1 like 1 ATPase	YME1L	protein_coding	Q96TA2	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19387
2.15498570151673e-32	0.281271827784419	0.381	0.25	3.68653403958467e-28	ZNF217	Malignant cells	GSE163836	ENSG00000171940	7764	zinc finger protein 217	ZABC1	protein_coding	O75362	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19388
2.94197165562274e-32	-0.256917234943398	0.457	0.606	5.03283091127382e-28	TK1	Malignant cells	GSE163836	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19389
5.54514570601466e-32	0.261093820427228	0.397	0.265	9.48608075927928e-28	CCNB1IP1	Malignant cells	GSE163836	ENSG00000100814	57820	cyclin B1 interacting protein 1	C14orf18|HEI10	protein_coding	Q9NPC3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19390
8.64787286422203e-32	0.30561779719097	0.379	0.244	1.47939161088246e-27	SLC26A2	Malignant cells	GSE163836	ENSG00000155850	1836	solute carrier family 26 member 2	DTD|DTDST	protein_coding	P50443	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19391
9.19988706197109e-32	0.266911498480783	0.73	0.627	1.57382467969139e-27	CRIP1	Malignant cells	GSE163836	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19392
2.29021052653052e-31	-0.317365259294847	0.398	0.528	3.91786314773576e-27	RRM2	Malignant cells	GSE163836	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19393
5.66785989850667e-31	-0.300629566541898	0.77	0.863	9.69600792837535e-27	CCT2	Malignant cells	GSE163836	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19394
2.35597781965981e-30	0.250091007025445	0.361	0.234	4.03037125609203e-26	QKI	Malignant cells	GSE163836	ENSG00000112531	9444	QKI, KH domain containing RNA binding	QK3	protein_coding	Q96PU8	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19395
2.57678478666091e-30	-0.250415788425266	0.719	0.836	4.40810573454082e-26	RBM3	Malignant cells	GSE163836	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19396
3.15453186992591e-30	0.25163837926837	0.497	0.369	5.39645766988225e-26	GPNMB	Malignant cells	GSE163836	ENSG00000136235	10457	glycoprotein nmb	HGFIN|NMB	protein_coding	Q14956	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19397
3.17355284825678e-30	0.250048406722098	0.425	0.296	5.42899685751287e-26	SPTAN1	Malignant cells	GSE163836	ENSG00000197694	6709	spectrin alpha, non-erythrocytic 1	NA	protein_coding	Q13813	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19398
3.44252265527679e-30	0.250876507766169	0.38	0.252	5.88912350638201e-26	DHX15	Malignant cells	GSE163836	ENSG00000109606	1665	DEAH-box helicase 15	DBP1|DDX15|HRH2|PRP43|PRPF43|PrPp43p	protein_coding	O43143	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19399
5.24925542883885e-30	0.28312921111768	0.914	0.868	8.97990126211463e-26	DUT	Malignant cells	GSE163836	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19400
2.49680086537519e-29	0.283863521563297	0.662	0.585	4.27127724039733e-25	AKR7A2	Malignant cells	GSE163836	ENSG00000053371	8574	aldo-keto reductase family 7 member A2	AFAR	protein_coding	O43488	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19401
4.82564670045227e-29	0.287429712822892	0.591	0.498	8.2552338104637e-25	ACBD3	Malignant cells	GSE163836	ENSG00000182827	64746	acyl-CoA binding domain containing 3	GCP60|GOCAP1|GOLPH1|PAP7	protein_coding	Q9H3P7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19402
4.99901856212158e-29	0.263271626072451	0.764	0.716	8.55182105422138e-25	PSME1	Malignant cells	GSE163836	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19403
1.14103613151277e-28	0.297980460623379	0.6	0.509	1.95197051017889e-24	SF3B1	Malignant cells	GSE163836	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19404
1.41492315139819e-28	0.269574304099256	0.7	0.638	2.42050903509689e-24	NOTCH3	Malignant cells	GSE163836	ENSG00000074181	4854	notch receptor 3	CADASIL|CASIL	protein_coding	Q9UM47	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19405
2.32259801973084e-28	0.261479831466397	0.355	0.232	3.97326843235354e-24	SLC34A2	Malignant cells	GSE163836	ENSG00000157765	10568	solute carrier family 34 member 2	NAPI-3B	protein_coding	O95436	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19406
2.37916823390958e-28	0.258331197734603	0.443	0.323	4.07004309774912e-24	COPS2	Malignant cells	GSE163836	ENSG00000166200	9318	COP9 signalosome subunit 2	ALIEN|CSN2|TRIP15	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19407
2.57388675051142e-28	-0.367773909091661	0.246	0.366	4.40314806409989e-24	CENPA	Malignant cells	GSE163836	ENSG00000115163	1058	centromere protein A	CenH3|CENP-A	protein_coding	P49450	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19408
4.36327923866451e-28	0.254374667082644	0.75	0.707	7.46426179358338e-24	HADHA	Malignant cells	GSE163836	ENSG00000084754	3030	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha	GBP|LCEH|LCHAD|MTPA	protein_coding	P40939	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19409
6.669474157916e-28	0.251518761286709	0.423	0.301	1.14094694419469e-23	NUFIP2	Malignant cells	GSE163836	ENSG00000108256	57532	nuclear FMR1 interacting protein 2	182-FIP|82-FIP|FIP-82|KIAA1321|MGC117262|NUFP2|PIG1	protein_coding	Q7Z417	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19410
8.81578426149805e-28	0.267247394671897	0.642	0.57	1.50811621361447e-23	ITGB1	Malignant cells	GSE163836	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19411
1.01590670500458e-27	0.254003029834617	0.446	0.326	1.73791160025134e-23	SERINC2	Malignant cells	GSE163836	ENSG00000168528	347735	serine incorporator 2	FKSG84|PRO0899|TDE2|TDE2L	protein_coding	Q96SA4	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19412
1.5232969527875e-27	-0.316747291703599	0.532	0.652	2.60590409713358e-23	CITED2	Malignant cells	GSE163836	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19413
2.52976561510832e-27	0.280975750015997	0.7	0.629	4.3276700377658e-23	RND3	Malignant cells	GSE163836	ENSG00000115963	390	Rho family GTPase 3	ARHE|Rho8|RhoE	protein_coding	P61587	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19414
3.06804144368191e-27	-0.282303606369691	0.744	0.854	5.24849849770665e-23	EIF5	Malignant cells	GSE163836	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19415
3.38284940709486e-27	0.272895007980675	0.5	0.388	5.78704048071718e-23	ESD	Malignant cells	GSE163836	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19416
5.55104710085362e-27	0.271806699850738	0.535	0.434	9.49617627543028e-23	HAGHL	Malignant cells	GSE163836	ENSG00000103253	84264	hydroxyacylglutathione hydrolase like	MGC2605	protein_coding	Q6PII5	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19417
5.64193381809927e-27	0.250464172921824	0.385	0.267	9.65165618262241e-23	KAZN	Malignant cells	GSE163836	ENSG00000189337	23254	kazrin, periplakin interacting protein	C1orf196|FLJ43806|KAZRIN|KIAA1026	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19418
1.00999036778541e-26	0.251514459755809	0.452	0.333	1.72779052217051e-22	ABL2	Malignant cells	GSE163836	ENSG00000143322	27	ABL proto-oncogene 2, non-receptor tyrosine kinase	ABLL|ARG	protein_coding	P42684	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19419
1.1454780388765e-26	0.290274330434944	0.517	0.423	1.95956928110603e-22	SKA2	Malignant cells	GSE163836	ENSG00000182628	348235	spindle and kinetochore associated complex subunit 2	FAM33A|FLJ12758	protein_coding	Q8WVK7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19420
1.21401403935042e-26	-0.280246817066327	0.575	0.699	2.07681381711676e-22	CTSB	Malignant cells	GSE163836	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19421
1.2412402125152e-26	0.257240048325758	0.433	0.317	2.12338963154975e-22	LRPPRC	Malignant cells	GSE163836	ENSG00000138095	10128	leucine rich pentatricopeptide repeat containing	GP130|LRP130|LSFC	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19422
8.40682725915527e-26	0.256160739157154	0.531	0.433	1.43815593922369e-21	MGAT4B	Malignant cells	GSE163836	ENSG00000284501	11282	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GnT-Ivb	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19423
2.16445968240562e-25	0.254222410484583	0.669	0.6	3.70274117869129e-21	EIF4B	Malignant cells	GSE163836	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19424
3.35640618144221e-25	0.280926234503969	0.936	0.925	5.74180405459319e-21	NCL	Malignant cells	GSE163836	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19425
3.37704649195199e-25	0.254442890449665	0.62	0.54	5.77711343378228e-21	PLSCR1	Malignant cells	GSE163836	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19426
6.42674317606152e-24	-0.285136746735414	0.913	0.915	1.09942295512885e-19	MIR4435-1HG	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19427
2.39363362789024e-23	-0.425722226065288	0.554	0.651	4.09478904723183e-19	PTTG1	Malignant cells	GSE163836	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19428
2.48172976220628e-23	0.253949648911593	0.492	0.393	4.24549510420628e-19	CA8	Malignant cells	GSE163836	ENSG00000178538	767	carbonic anhydrase 8	CALS|CARP	protein_coding	P35219	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19429
3.89010929120606e-23	0.257181659568577	0.559	0.481	6.65480996446621e-19	SNX6	Malignant cells	GSE163836	ENSG00000129515	58533	sorting nexin 6	NA	protein_coding	Q9UNH7	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19430
1.18739447019709e-22	-0.257571654850595	0.337	0.468	2.03127572016616e-18	RGS5	Malignant cells	GSE163836	ENSG00000143248	8490	regulator of G protein signaling 5	MST092|MST106|MST129|MSTP032|MSTP092|MSTP106|MSTP129	protein_coding	O15539	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19431
4.94292723305816e-22	-0.325509245864054	0.339	0.444	8.45586561759259e-18	NUF2	Malignant cells	GSE163836	ENSG00000143228	83540	NUF2 component of NDC80 kinetochore complex	CDCA1|CT106|NUF2R	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19432
7.35229060923778e-22	-0.551923270622796	0.885	0.881	1.25775635452231e-17	MMP7	Malignant cells	GSE163836	ENSG00000137673	4316	matrix metallopeptidase 7	MPSL1|PUMP-1	protein_coding	P09237	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19433
8.8841692233239e-22	0.260119869406417	0.443	0.339	1.51981482903402e-17	PLK2	Malignant cells	GSE163836	ENSG00000145632	10769	polo like kinase 2	SNK	protein_coding	Q9NYY3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19434
4.97711625026936e-21	-0.281015474483649	0.56	0.672	8.51435276933579e-17	HSP90B1	Malignant cells	GSE163836	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19435
8.33102109141378e-20	0.344778289054989	0.472	0.389	1.42518777810816e-15	KLF2	Malignant cells	GSE163836	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19436
2.77686218437672e-15	-0.302052419054089	0.231	0.314	4.75037813881326e-11	AURKA	Malignant cells	GSE163836	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19437
1.3802941428894e-13	0.267334239718408	0.399	0.329	2.3612691902409e-09	PRC1	Malignant cells	GSE163836	ENSG00000198901	9055	protein regulator of cytokinesis 1	ASE1	protein_coding	O43663	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19438
1.438609664721e-13	-0.63101104180032	0.908	0.862	2.46102955343821e-09	HIST1H4C	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19439
1.77039006146601e-12	-0.307420872726701	0.928	0.926	3.0286062781499e-08	CKS2	Malignant cells	GSE163836	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19440
9.36550743203433e-11	-0.258556334098151	0.987	0.955	1.60215735639811e-06	AARD	Malignant cells	GSE163836	ENSG00000205002	441376	alanine and arginine rich domain containing protein	C8orf85|LOC441376	protein_coding	Q4LEZ3	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19441
2.16537102315275e-08	0.34774207404809	0.406	0.369	0.00037043002093074	TOP2A	Malignant cells	GSE163836	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19442
2.39772472668653e-08	-0.278243016023196	0.763	0.745	0.000410178768994264	KIAA0101	Malignant cells	GSE163836	NA	NA	NA	NA	NA	NA	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19443
4.94919718154078e-07	-0.313617848003518	0.636	0.655	0.00846659161846181	CTTN	Malignant cells	GSE163836	ENSG00000288401	2017	cortactin	EMS1	protein_coding	Q14247	GSE163836	GSE163836	Breast cancer	Inflammatory breast cancer	Chemotherapy	NA	paclitaxel	Homo sapiens	FCIBC02 cell line	Cell line	resistant 1, sensitive 1	2	7358	Public on Nov 02, 2022	36409824	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA685991	10x genomics	CellRanger	Breast_cancer	Chemotherapy	19444
0	-1.62156243083164	0.925	1	0	RPS26	CD8+ T cells	GSE164237_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19445
1.30904766550024e-212	-0.692020629941559	0.494	0.724	2.1570487432113e-208	DUSP2	CD8+ T cells	GSE164237_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19446
3.38584346922308e-178	-0.429952598154042	0.131	0.335	5.57919286858578e-174	HLA-DQB1	CD8+ T cells	GSE164237_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19447
5.34726500062808e-154	0.262158349254724	1	1	8.81122326803495e-150	RPS9	CD8+ T cells	GSE164237_post	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19448
1.05526822944948e-149	-0.669689911827393	0.701	0.807	1.73887098848686e-145	NKG7	CD8+ T cells	GSE164237_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19449
3.52767062280098e-132	0.465716610683258	0.911	0.843	5.81289565225146e-128	VIM	CD8+ T cells	GSE164237_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19450
7.79973271690627e-131	-0.640159976442045	0.418	0.603	1.28523995709182e-126	GZMH	CD8+ T cells	GSE164237_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19451
1.54221131373246e-126	-0.423835101653147	0.249	0.439	2.54125580276834e-122	HLA-DRB1	CD8+ T cells	GSE164237_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19452
9.66925135346659e-124	-0.308958353970629	0.891	0.942	1.59329923802422e-119	PPDPF	CD8+ T cells	GSE164237_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19453
1.06094253468533e-117	-0.37689831011431	0.599	0.742	1.74822110865448e-113	KLF2	CD8+ T cells	GSE164237_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19454
1.4366879797584e-112	-0.395871001632552	0.757	0.848	2.3673744530459e-108	CTSW	CD8+ T cells	GSE164237_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19455
1.86838154431e-112	0.258317114428317	0.999	0.997	3.07871910871402e-108	RPS5	CD8+ T cells	GSE164237_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19456
6.07722809884987e-112	-0.360745421696219	0.998	1	1.00140564612848e-107	HLA-C	CD8+ T cells	GSE164237_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19457
6.32186409575936e-110	0.299871893639301	1	1	1.04171676569923e-105	TPT1	CD8+ T cells	GSE164237_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19458
1.7462041949352e-100	-0.540490720128791	0.242	0.408	2.87739527241422e-96	FGFBP2	CD8+ T cells	GSE164237_post	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19459
2.86400060535659e-99	-0.345632430581409	0.147	0.298	4.71930019750658e-95	ADGRG1	CD8+ T cells	GSE164237_post	ENSG00000205336	9289	adhesion G protein-coupled receptor G1	GPR56|TM7LN4|TM7XN1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19460
5.18172607603545e-99	-0.440274104367491	0.597	0.733	8.53844822809122e-95	CST7	CD8+ T cells	GSE164237_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19461
2.93935534930928e-96	-0.481281329111712	0.228	0.395	4.84346974459183e-92	GZMB	CD8+ T cells	GSE164237_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19462
1.00652855705206e-95	-0.427101137673173	0.234	0.418	1.65855775631038e-91	KLRB1	CD8+ T cells	GSE164237_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19463
2.43961507451345e-93	-0.452686155144849	0.164	0.307	4.01999771978326e-89	SPON2	CD8+ T cells	GSE164237_post	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19464
8.59666847438294e-93	0.324799456260155	0.687	0.543	1.41655903120882e-88	SNHG8	CD8+ T cells	GSE164237_post	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19465
7.95608216649014e-89	-0.309958749019325	0.213	0.366	1.31100321939425e-84	FCRL6	CD8+ T cells	GSE164237_post	ENSG00000181036	343413	Fc receptor like 6	FcRH6|FLJ16056|IFGP6	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19466
2.94704663886812e-84	0.373609664164701	0.455	0.279	4.85614345152688e-80	RPS4Y1	CD8+ T cells	GSE164237_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19467
3.41533165426029e-81	-0.323267911678886	0.252	0.4	5.6277834998901e-77	ZEB2	CD8+ T cells	GSE164237_post	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19468
3.96878828643272e-81	0.541814844095775	0.667	0.53	6.53976933838383e-77	LTB	CD8+ T cells	GSE164237_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19469
3.9139628369963e-80	-0.281052117825151	0.555	0.682	6.4494279628025e-76	ZFP36	CD8+ T cells	GSE164237_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19470
8.12146539741835e-80	-0.427580523492223	0.333	0.491	1.3382550681866e-75	CCL4	CD8+ T cells	GSE164237_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19471
1.58188021491375e-78	0.266047270678374	0.98	0.968	2.60662221813487e-74	PABPC1	CD8+ T cells	GSE164237_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19472
6.55567950261152e-78	-0.377734368392739	0.38	0.531	1.08024486844033e-73	PRF1	CD8+ T cells	GSE164237_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19473
1.8029030236695e-75	-0.305962691000479	0.286	0.433	2.9708236024026e-71	PLEK	CD8+ T cells	GSE164237_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19474
5.22344946090303e-71	-0.343328598654149	0.546	0.653	8.60720002167602e-67	UCP2	CD8+ T cells	GSE164237_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19475
8.87580958746156e-71	-0.429280077621274	0.545	0.637	1.46255590382192e-66	FLNA	CD8+ T cells	GSE164237_post	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19476
1.43843494237966e-69	0.318508460917012	0.505	0.375	2.37025309805321e-65	PIM1	CD8+ T cells	GSE164237_post	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19477
3.84905218632953e-66	-0.26756177861626	0.558	0.727	6.3424681926338e-62	GZMA	CD8+ T cells	GSE164237_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19478
1.16663028494736e-65	0.398908240498854	0.63	0.5	1.92237338353625e-61	IL7R	CD8+ T cells	GSE164237_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19479
2.0582567695731e-57	-0.261578436350072	0.214	0.338	3.39159550490256e-53	TRGC2	CD8+ T cells	GSE164237_post	ENSG00000227191	NA	NA	TCRGC2|TRGC2(2X)|TRGC2(3X)	TR_C_gene	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19480
6.56625587717514e-57	0.404484800038719	0.709	0.632	1.08198764344092e-52	EEF1G	CD8+ T cells	GSE164237_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19481
9.16914023143218e-56	0.288501404659793	0.989	0.986	1.51089092733539e-51	RPL17	CD8+ T cells	GSE164237_post	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19482
1.37101831749668e-53	-0.287491777333585	0.673	0.763	2.25916398357103e-49	TRBC2	CD8+ T cells	GSE164237_post	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19483
3.50654707447995e-53	-0.294087426006148	0.692	0.77	5.77808826932807e-49	ITGB2	CD8+ T cells	GSE164237_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19484
4.28114499100643e-51	0.256795713634085	0.312	0.201	7.05447071618039e-47	IFI6	CD8+ T cells	GSE164237_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19485
2.29992365961399e-49	-0.299308048256307	0.79	0.837	3.78981420631193e-45	CD8A	CD8+ T cells	GSE164237_post	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19486
3.02608039697129e-48	0.270766110963923	0.962	0.944	4.98637527812929e-44	BTG1	CD8+ T cells	GSE164237_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19487
5.89426657851536e-48	-0.352131728591183	0.34	0.467	9.71257246807761e-44	GNLY	CD8+ T cells	GSE164237_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19488
1.18478566507903e-46	-0.426772744210461	0.848	0.878	1.95228981891723e-42	JUNB	CD8+ T cells	GSE164237_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19489
1.93187589880604e-46	-0.272428797305846	0.576	0.673	3.18334510605259e-42	ID2	CD8+ T cells	GSE164237_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19490
8.74776139864446e-37	-0.280926964036154	0.946	0.952	1.44145612326863e-32	SH3BGRL3	CD8+ T cells	GSE164237_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19491
2.61421933236148e-32	0.289903333535485	0.988	0.987	4.30771061586524e-28	MT-ND4	CD8+ T cells	GSE164237_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19492
2.05217536006439e-26	0.275478423432008	0.383	0.308	3.3815745583141e-22	STAT1	CD8+ T cells	GSE164237_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19493
0	-1.21511808531293	0.967	1	0	RPS26	CD8+ T cells	GSE164237_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19494
0	0.668897916991641	1	0.994	0	RPL41	CD8+ T cells	GSE164237_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19495
0	0.770781249753887	0.998	0.974	0	MT-ND4	CD8+ T cells	GSE164237_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19496
3.16799787908121e-296	-0.630398823659353	0.104	0.416	5.22022690515001e-292	HLA-DQB1	CD8+ T cells	GSE164237_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19497
3.54163098287215e-287	0.661001048840411	0.995	0.916	5.83589953357673e-283	RPL27A	CD8+ T cells	GSE164237_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19498
2.01124003538517e-264	0.60690724658158	0.99	0.877	3.31412133030768e-260	RPS20	CD8+ T cells	GSE164237_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19499
4.06498309412016e-249	0.438016575620182	0.999	0.984	6.6982791424912e-245	RPL38	CD8+ T cells	GSE164237_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19500
2.9866793090737e-245	0.541512405750749	1	0.994	4.92145016549163e-241	RPL13A	CD8+ T cells	GSE164237_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19501
2.01147285926502e-233	0.520147858516319	0.998	0.979	3.3145049774969e-229	MT-ND2	CD8+ T cells	GSE164237_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19502
5.23693244910002e-233	0.406935745584037	1	0.997	8.62941728962701e-229	RPS2	CD8+ T cells	GSE164237_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19503
3.79156032441452e-217	0.520486283480162	1	1	6.24773310257024e-213	MALAT1	CD8+ T cells	GSE164237_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19504
3.87915499628631e-208	0.415151641793415	0.998	0.957	6.39207160288058e-204	RPL36A	CD8+ T cells	GSE164237_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19505
1.8561748093657e-204	0.37402301016315	0.999	0.995	3.0586048508728e-200	RPL35	CD8+ T cells	GSE164237_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19506
3.71566220547914e-203	-0.536989534017473	0.086	0.322	6.12266818218852e-199	CX3CR1	CD8+ T cells	GSE164237_pre	ENSG00000168329	1524	C-X3-C motif chemokine receptor 1	CCRL1|CMKBRL1|CMKDR1|GPR13|V28	protein_coding	P49238	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19507
3.05456509550858e-199	0.37277749731676	1	0.999	5.03331236437904e-195	RPL21	CD8+ T cells	GSE164237_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19508
3.32089839287948e-197	0.46206262592514	0.997	0.985	5.4721763717868e-193	RPL31	CD8+ T cells	GSE164237_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19509
4.75928922121479e-193	-0.609218714889294	0.282	0.57	7.84235677871773e-189	PTPRCAP	CD8+ T cells	GSE164237_pre	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19510
1.41346450133796e-189	-0.726663115751599	0.215	0.466	2.32910680530469e-185	HLA-DRB1	CD8+ T cells	GSE164237_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19511
1.20023327475544e-185	0.516375083536562	0.55	0.238	1.97774439014202e-181	RPS4Y1	CD8+ T cells	GSE164237_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19512
6.80066999634773e-180	-0.630873878466689	0.396	0.609	1.12061440199818e-175	SLC9A3R1	CD8+ T cells	GSE164237_pre	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19513
3.06024965112734e-179	-1.02985085336525	0.709	0.801	5.04267937512763e-175	CD74	CD8+ T cells	GSE164237_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19514
1.32783317840023e-176	0.435229031300114	0.96	0.863	2.1880035113679e-172	RPL23	CD8+ T cells	GSE164237_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19515
1.01695898671507e-174	0.330143792476129	1	0.999	1.67574501830909e-170	RPS29	CD8+ T cells	GSE164237_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19516
2.81181395489653e-171	0.378360827694501	1	1	4.6333070348785e-167	TMSB4X	CD8+ T cells	GSE164237_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19517
7.09525057199478e-171	-0.401561852433382	0.105	0.326	1.1691553892533e-166	AC116366.3	CD8+ T cells	GSE164237_pre	NA	NA	NA	NA	NA	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19518
2.03356070537737e-168	0.313096534556529	1	1	3.35090133032083e-164	RPS6	CD8+ T cells	GSE164237_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19519
6.86561763628098e-167	0.393452133117381	0.991	0.971	1.13131647410638e-162	RPS11	CD8+ T cells	GSE164237_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19520
2.1954404791666e-166	-0.560645256323129	0.509	0.734	3.61764682157072e-162	CRIP1	CD8+ T cells	GSE164237_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19521
4.42958659196061e-165	0.350060452265028	0.997	0.967	7.2990727862327e-161	RPL7	CD8+ T cells	GSE164237_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19522
9.45462830686035e-165	-0.527123085426736	0.295	0.528	1.55793365240445e-160	PSMB10	CD8+ T cells	GSE164237_pre	ENSG00000205220	5699	proteasome 20S subunit beta 10	beta2i|LMP10|MECL1|MGC1665	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19523
2.99651573305246e-164	0.305740736095019	1	0.997	4.93765862492384e-160	RPS9	CD8+ T cells	GSE164237_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19524
6.05796841866181e-164	-0.43011583512361	0.119	0.349	9.98232036027092e-160	HLA-DRB5	CD8+ T cells	GSE164237_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19525
4.36363706049045e-163	-0.431987451732251	0.21	0.451	7.19040114827616e-159	RNASEK	CD8+ T cells	GSE164237_pre	ENSG00000219200	440400	ribonuclease K	MGC71993	protein_coding	Q6P5S7	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19526
1.99153569914766e-156	0.327660705491005	1	0.999	3.28165252505552e-152	RPL23A	CD8+ T cells	GSE164237_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19527
3.45670596425526e-156	0.297190906700135	1	0.999	5.69596008789982e-152	RPS18	CD8+ T cells	GSE164237_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19528
6.8413301957695e-155	-0.643665676524386	0.965	0.958	1.1273143896589e-150	SH3BGRL3	CD8+ T cells	GSE164237_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19529
1.79560624429098e-153	-0.383912314512695	0.232	0.469	2.95879996934267e-149	ARF5	CD8+ T cells	GSE164237_pre	ENSG00000004059	381	ADP ribosylation factor 5	NA	protein_coding	P84085	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19530
3.24811566870019e-151	0.272896702290924	1	1	5.35224499888417e-147	RPLP2	CD8+ T cells	GSE164237_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19531
1.72537361962474e-149	-0.41220617738912	1	1	2.84307065041764e-145	HLA-C	CD8+ T cells	GSE164237_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19532
2.32075969993187e-148	-0.440619816020537	0.213	0.434	3.82414783354773e-144	SASH3	CD8+ T cells	GSE164237_pre	ENSG00000122122	54440	SAM and SH3 domain containing 3	753P9|CXorf9|HACS2|SH3D6C|SLY	protein_coding	O75995	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19533
3.17425292622996e-147	-0.661817443560869	0.537	0.725	5.23053397184173e-143	IFITM1	CD8+ T cells	GSE164237_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19534
1.27397939970736e-144	-0.547418830277933	0.384	0.599	2.09926325483779e-140	HLA-DPA1	CD8+ T cells	GSE164237_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19535
2.37982385799344e-142	0.326529779149196	0.999	0.989	3.92147375320159e-138	RPL27	CD8+ T cells	GSE164237_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19536
1.20615873023209e-138	-0.521643111768047	0.732	0.835	1.98750835567644e-134	LIMD2	CD8+ T cells	GSE164237_pre	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19537
1.41428945445783e-137	-0.606309144372204	0.989	0.979	2.33046616305562e-133	PFN1	CD8+ T cells	GSE164237_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19538
4.10580742136675e-135	-0.475641341599095	0.627	0.777	6.76554946892814e-131	LITAF	CD8+ T cells	GSE164237_pre	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19539
1.9005354210043e-134	-0.430545129095891	0.365	0.58	3.13170226673089e-130	GABARAP	CD8+ T cells	GSE164237_pre	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19540
5.58325044086738e-129	0.398490643999546	0.946	0.841	9.20008007646126e-125	RPS17	CD8+ T cells	GSE164237_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19541
4.5971569283863e-128	-0.471022435118722	0.699	0.804	7.57519518659495e-124	LSP1	CD8+ T cells	GSE164237_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19542
6.86082725593832e-128	-0.391387795889321	0.086	0.267	1.13052711523352e-123	HLA-DRA	CD8+ T cells	GSE164237_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19543
4.53753022117529e-126	-0.411742207353851	0.743	0.843	7.47694229845265e-122	PCBP2	CD8+ T cells	GSE164237_pre	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19544
1.19102146552698e-125	-0.32251046002323	0.165	0.37	1.96256517089535e-121	ATP6V0C	CD8+ T cells	GSE164237_pre	ENSG00000185883	527	ATPase H+ transporting V0 subunit c	ATP6C|ATP6L|ATPL|VATL|Vma3	protein_coding	P27449	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19545
8.82002112045772e-125	-0.585631475682751	0.535	0.697	1.45336308022902e-120	FLNA	CD8+ T cells	GSE164237_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19546
4.70369422169653e-124	-0.444811836517871	0.644	0.776	7.75074733851154e-120	RHOA	CD8+ T cells	GSE164237_pre	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19547
1.55440518094969e-123	-0.338990921987484	0.103	0.283	2.56134885716889e-119	XIST	CD8+ T cells	GSE164237_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19548
4.03991251871197e-122	0.271263650270834	1	0.995	6.65696784833358e-118	RPL9	CD8+ T cells	GSE164237_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19549
1.91963560807647e-121	0.271159478300937	0.995	0.965	3.16317555498841e-117	RPL17	CD8+ T cells	GSE164237_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19550
8.26319263320815e-119	-0.509435015965368	0.95	0.959	1.36160888210004e-114	GAPDH	CD8+ T cells	GSE164237_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19551
3.86465294636962e-118	-0.357706560748885	0.172	0.369	6.36817512502787e-114	LIME1	CD8+ T cells	GSE164237_pre	ENSG00000203896	54923	Lck interacting transmembrane adaptor 1	dJ583P15.4|FLJ20406|LIME	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19552
2.96867338698302e-117	0.250420882457525	1	0.999	4.89178000707062e-113	RPL37A	CD8+ T cells	GSE164237_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19553
1.34843600018043e-114	-0.351998985510281	0.312	0.526	2.22195284109732e-110	ALDOA	CD8+ T cells	GSE164237_pre	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19554
2.57214555239593e-114	-0.537328025943975	0.809	0.835	4.23838144123801e-110	CD8A	CD8+ T cells	GSE164237_pre	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19555
2.75356435813791e-113	-0.390950674670284	0.388	0.586	4.53732334933965e-109	ZAP70	CD8+ T cells	GSE164237_pre	ENSG00000115085	7535	zeta chain of T cell receptor associated protein kinase 70	SRK|STD|ZAP-70	protein_coding	P43403	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19556
3.50510330723165e-113	-0.413947062421422	0.249	0.447	5.77570922965632e-109	FCRL6	CD8+ T cells	GSE164237_pre	ENSG00000181036	343413	Fc receptor like 6	FcRH6|FLJ16056|IFGP6	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19557
2.09538599615613e-112	-0.630824625003985	0.497	0.647	3.45277704446608e-108	UCP2	CD8+ T cells	GSE164237_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19558
2.17793657823037e-112	-0.45626720040555	0.187	0.373	3.58880389360801e-108	ADGRG1	CD8+ T cells	GSE164237_pre	ENSG00000205336	9289	adhesion G protein-coupled receptor G1	GPR56|TM7LN4|TM7XN1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19559
4.69346587914044e-112	-0.586895992594065	0.357	0.541	7.73389307564761e-108	PRF1	CD8+ T cells	GSE164237_pre	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19560
1.80933131313241e-111	-0.343333518506656	0.151	0.334	2.98141613777958e-107	NFATC2	CD8+ T cells	GSE164237_pre	ENSG00000101096	4773	nuclear factor of activated T cells 2	NF-ATP|NFAT1|NFATp	protein_coding	Q13469	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19561
1.39429473123709e-110	-0.355696324567998	0.216	0.408	2.29751885813248e-106	KCNAB2	CD8+ T cells	GSE164237_pre	ENSG00000069424	8514	potassium voltage-gated channel subfamily A regulatory beta subunit 2	AKR6A5|HKvbeta2.1|HKvbeta2.2|KCNA2B	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19562
4.55108032072216e-109	-0.344674729011637	0.167	0.35	7.49927015248598e-105	TBX21	CD8+ T cells	GSE164237_pre	ENSG00000073861	30009	T-box transcription factor 21	T-bet|TBLYM	protein_coding	Q9UL17	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19563
5.39111434976483e-107	-0.472827120941983	0.624	0.749	8.88347822554249e-103	RARRES3	CD8+ T cells	GSE164237_pre	NA	NA	NA	NA	NA	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19564
3.0610113373476e-106	-0.340993626654873	0.476	0.679	5.04393448168138e-102	GYPC	CD8+ T cells	GSE164237_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19565
3.91638820677341e-106	0.260895648945415	0.966	0.857	6.45342448712123e-102	RPS10	CD8+ T cells	GSE164237_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19566
1.30458442673143e-105	0.263456647415484	1	1	2.14969421836806e-101	MT-ND3	CD8+ T cells	GSE164237_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19567
2.2294140533712e-105	-0.315743408714309	0.192	0.38	3.67362847714507e-101	PXN	CD8+ T cells	GSE164237_pre	ENSG00000089159	5829	paxillin	NA	protein_coding	P49023	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19568
2.32904245846048e-105	-0.369141826468625	0.32	0.516	3.83779616305118e-101	GNG2	CD8+ T cells	GSE164237_pre	ENSG00000186469	54331	G protein subunit gamma 2	NA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19569
1.56092977195726e-104	-0.323758698540147	0.146	0.32	2.57210007823117e-100	SH2D2A	CD8+ T cells	GSE164237_pre	ENSG00000027869	9047	SH2 domain containing 2A	F2771|TSAd	protein_coding	Q9NP31	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19570
5.45069642045919e-101	-0.381029684259177	0.113	0.277	8.98165756163265e-97	FCGR3A	CD8+ T cells	GSE164237_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19571
6.7052948938488e-101	-0.270882997944037	0.142	0.315	1.10489849260841e-96	RAB1B	CD8+ T cells	GSE164237_pre	ENSG00000174903	81876	RAB1B, member RAS oncogene family	NA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19572
6.93192167102842e-100	-0.352733885520861	0.479	0.667	1.14224205295206e-95	ARHGEF1	CD8+ T cells	GSE164237_pre	ENSG00000076928	9138	Rho guanine nucleotide exchange factor 1	LBCL2|P115-RHOGEF|SUB1.5	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19573
1.29137450777311e-98	-0.438516234062914	0.582	0.72	2.12792691390853e-94	PSMB9	CD8+ T cells	GSE164237_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19574
3.09678479773004e-98	-0.556804026647348	0.314	0.505	5.10288198969956e-94	FGFBP2	CD8+ T cells	GSE164237_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19575
7.36722881113504e-98	-0.263790866216189	0.101	0.257	1.21397196349883e-93	CD300A	CD8+ T cells	GSE164237_pre	ENSG00000167851	11314	CD300a molecule	CMRF-35-H9|CMRF35H|IGSF12|IRC1|IRC2|Irp60	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19576
1.5427940209146e-97	-0.417261419457816	0.318	0.499	2.54221598766308e-93	PLEK	CD8+ T cells	GSE164237_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19577
2.97361826898001e-96	-0.373266684446064	0.697	0.808	4.89992818362526e-92	SRGN	CD8+ T cells	GSE164237_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19578
6.09570753726389e-96	-0.426971483514454	0.496	0.668	1.00445068799034e-91	TAGLN2	CD8+ T cells	GSE164237_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19579
3.82199527546567e-95	-0.364167971051285	0.334	0.515	6.29788381491234e-91	CD6	CD8+ T cells	GSE164237_pre	ENSG00000013725	923	CD6 molecule	Tp120	protein_coding	P30203	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19580
4.47639913475903e-95	-0.302153205460578	0.133	0.297	7.37621049425593e-91	CEP78	CD8+ T cells	GSE164237_pre	ENSG00000148019	84131	centrosomal protein 78	C9orf81|FLJ12643	protein_coding	Q5JTW2	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19581
2.69733789638368e-94	-0.329628401623024	0.339	0.523	4.44467338566103e-90	HNRNPF	CD8+ T cells	GSE164237_pre	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19582
9.7173597000832e-94	-0.403959318227707	0.314	0.489	1.60122653137971e-89	TAP1	CD8+ T cells	GSE164237_pre	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19583
1.01964005872431e-93	-0.310992425275479	1	1	1.68016288876591e-89	HLA-B	CD8+ T cells	GSE164237_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19584
1.28851101955103e-92	-0.337784814473982	0.284	0.462	2.12320845801619e-88	TNFRSF14	CD8+ T cells	GSE164237_pre	ENSG00000273936	8764	TNF receptor superfamily member 14	ATAR|CD270|HVEA|HVEM|LIGHTR|TR2	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19585
1.50649716029537e-92	-0.397397336406255	0.958	0.968	2.48240602073471e-88	IL32	CD8+ T cells	GSE164237_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19586
1.75742002919134e-92	-0.324945097919642	0.174	0.344	2.89587672410149e-88	TGFBR3	CD8+ T cells	GSE164237_pre	ENSG00000069702	7049	transforming growth factor beta receptor 3	betaglycan|BGCAN	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19587
2.24796729585692e-92	-0.300548807943765	0.207	0.382	3.70420051011304e-88	CD5	CD8+ T cells	GSE164237_pre	ENSG00000110448	921	CD5 molecule	LEU1|T1	protein_coding	P06127	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19588
2.5696530360854e-92	-0.355718302458881	0.696	0.804	4.23427427286152e-88	YWHAZ	CD8+ T cells	GSE164237_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19589
2.30764726752683e-91	-0.478800863038086	0.762	0.792	3.80254116743071e-87	RAC2	CD8+ T cells	GSE164237_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19590
5.12506887744008e-91	-0.384403171450301	0.149	0.309	8.44508849624576e-87	CLIC3	CD8+ T cells	GSE164237_pre	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19591
1.86974809369754e-90	-0.374712439202331	0.364	0.532	3.08097090879481e-86	PPP1R18	CD8+ T cells	GSE164237_pre	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19592
5.62626183081459e-90	-0.59650316075609	0.841	0.846	9.27095424481628e-86	NKG7	CD8+ T cells	GSE164237_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19593
1.65100444227323e-88	-0.436709703520068	0.717	0.784	2.72052511997783e-84	ITGB2	CD8+ T cells	GSE164237_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19594
2.16993577981507e-85	-0.304477685141737	0.32	0.497	3.57562017797928e-81	WAS	CD8+ T cells	GSE164237_pre	ENSG00000015285	7454	WASP actin nucleation promoting factor	IMD2|THC|WASP|WASPA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19595
2.50931333464956e-85	-0.313749694091126	0.638	0.783	4.13484651283555e-81	SUB1	CD8+ T cells	GSE164237_pre	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19596
9.34825901104766e-85	-0.307277262627478	0.25	0.42	1.54040611984043e-80	CSK	CD8+ T cells	GSE164237_pre	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19597
8.55350408530528e-84	-0.250247804532783	0.182	0.346	1.4094464031766e-79	PSMA6	CD8+ T cells	GSE164237_pre	ENSG00000100902	5687	proteasome 20S subunit alpha 6	IOTA|MGC22756|MGC2333|MGC23846|p27K|PROS27	protein_coding	P60900	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19598
5.11680882275118e-83	-0.26842443654095	0.235	0.405	8.43147757812939e-79	OTUB1	CD8+ T cells	GSE164237_pre	ENSG00000167770	55611	OTU deubiquitinase, ubiquitin aldehyde binding 1	FLJ20113|FLJ40710	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19599
5.86955040761656e-83	-0.263984150539	0.195	0.362	9.67184516167057e-79	UBE2V1	CD8+ T cells	GSE164237_pre	ENSG00000244687	7335	ubiquitin conjugating enzyme E2 V1	CROC-1|CROC1|UBE2V|UEV-1|UEV1A	protein_coding	Q13404	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19600
3.13101626019375e-82	-0.301966353931745	0.57	0.733	5.15928859354726e-78	DAZAP2	CD8+ T cells	GSE164237_pre	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19601
4.48569546745563e-82	-0.344238983698476	0.278	0.454	7.39152899127338e-78	TNFAIP3	CD8+ T cells	GSE164237_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19602
7.49214164033556e-82	-0.279865402640861	0.264	0.438	1.23455509949449e-77	VCP	CD8+ T cells	GSE164237_pre	ENSG00000165280	7415	valosin containing protein	CDC48|IBMPFD|p97|TERA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19603
7.67961364965762e-81	-0.341495375652092	0.363	0.525	1.26544673719058e-76	WDR1	CD8+ T cells	GSE164237_pre	ENSG00000071127	9948	WD repeat domain 1	AIP1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19604
8.22182869370552e-81	-0.25560162916862	0.116	0.26	1.35479293214879e-76	TTC38	CD8+ T cells	GSE164237_pre	ENSG00000075234	55020	tetratricopeptide repeat domain 38	FLJ20699	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19605
1.23786228392497e-80	-0.379646898878779	0.328	0.509	2.03974947145156e-76	COTL1	CD8+ T cells	GSE164237_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19606
2.12426108365725e-80	-0.338733867880404	0.29	0.469	3.50035741365042e-76	ZEB2	CD8+ T cells	GSE164237_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19607
3.18056115499991e-80	-0.450825477069861	0.636	0.75	5.24092867120886e-76	LY6E	CD8+ T cells	GSE164237_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19608
2.52790683253709e-79	-0.271859217084552	0.534	0.725	4.16548487865462e-75	MIF	CD8+ T cells	GSE164237_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19609
2.54600867088478e-79	-0.27804865136994	0.286	0.459	4.19531308788394e-75	SHISA5	CD8+ T cells	GSE164237_pre	ENSG00000164054	51246	shisa family member 5	hShisa5|SCOTIN	protein_coding	Q8N114	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19610
1.13984822638629e-78	-0.300660660418886	0.924	0.938	1.87824190743933e-74	CD3E	CD8+ T cells	GSE164237_pre	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19611
2.1649353513672e-78	-0.283367041785977	0.854	0.917	3.56738047198288e-74	PPDPF	CD8+ T cells	GSE164237_pre	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19612
2.55540474143634e-77	-0.539761027329879	0.191	0.338	4.2107959329388e-73	SPON2	CD8+ T cells	GSE164237_pre	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19613
3.83218663285039e-77	-0.380148180347033	0.239	0.397	6.31467713361087e-73	GBP5	CD8+ T cells	GSE164237_pre	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19614
4.94270877916495e-77	-0.336322219069694	0.444	0.598	8.14459552630801e-73	PSMB8	CD8+ T cells	GSE164237_pre	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19615
5.28005883563717e-77	-0.317260631804409	0.638	0.761	8.70048094936293e-73	YWHAB	CD8+ T cells	GSE164237_pre	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19616
8.83122865632591e-77	-0.297931709175784	0.342	0.51	1.45520985798938e-72	ARRB2	CD8+ T cells	GSE164237_pre	ENSG00000141480	409	arrestin beta 2	ARR2|BARR2|DKFZp686L0365	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19617
4.6673506435186e-76	-0.252642317171335	0.354	0.555	7.69086039038996e-72	MT-ND6	CD8+ T cells	GSE164237_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19618
1.16360455768604e-75	-0.265277028461274	0.304	0.472	1.91738759015505e-71	GNG5	CD8+ T cells	GSE164237_pre	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19619
1.29118666944488e-75	-0.306553482130515	0.491	0.655	2.12761739391128e-71	PAXX	CD8+ T cells	GSE164237_pre	ENSG00000148362	286257	PAXX non-homologous end joining factor	C9orf142|XLS	protein_coding	Q9BUH6	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19620
1.5057210563016e-75	-0.319989604360338	0.741	0.823	2.48112715657378e-71	ARPC3	CD8+ T cells	GSE164237_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19621
2.34067536060364e-75	-0.656430074655268	0.964	0.965	3.85696485920267e-71	ACTG1	CD8+ T cells	GSE164237_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19622
3.32913210629621e-75	-0.37043367264472	0.397	0.543	5.4857438847549e-71	GIMAP4	CD8+ T cells	GSE164237_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19623
3.35300560928054e-75	-0.322350360659695	0.353	0.521	5.52508264297248e-71	SAMHD1	CD8+ T cells	GSE164237_pre	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19624
6.07747053833123e-74	-0.281586141299384	0.898	0.922	1.00144559530622e-69	H3F3A	CD8+ T cells	GSE164237_pre	NA	NA	NA	NA	NA	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19625
1.04139836233141e-73	-0.281809104595965	0.218	0.375	1.7160162214497e-69	STK38	CD8+ T cells	GSE164237_pre	ENSG00000112079	11329	serine/threonine kinase 38	NDR|NDR1	protein_coding	Q15208	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19626
7.97638380411025e-73	-0.25943342579644	0.285	0.454	1.31434852324129e-68	BRD2	CD8+ T cells	GSE164237_pre	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19627
1.79111215704758e-72	-0.29070886349154	0.285	0.446	2.951394612383e-68	CDC25B	CD8+ T cells	GSE164237_pre	ENSG00000101224	994	cell division cycle 25B	NA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19628
7.95100607997434e-72	0.292661431858512	0.899	0.757	1.31016678185817e-67	VIM	CD8+ T cells	GSE164237_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19629
1.21134284952315e-71	-0.291718195100067	0.205	0.354	1.99605074744424e-67	DIP2A	CD8+ T cells	GSE164237_pre	ENSG00000160305	23181	disco interacting protein 2 homolog A	C21orf106|Dip2|KIAA0184	protein_coding	Q14689	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19630
1.22008491010884e-71	-0.268047506397748	0.295	0.456	2.01045591487735e-67	GNB2	CD8+ T cells	GSE164237_pre	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19631
1.23592347668187e-71	-0.286103360030312	0.442	0.616	2.03655470487639e-67	CLEC2B	CD8+ T cells	GSE164237_pre	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19632
1.54064799281841e-71	-0.261433631952842	0.173	0.322	2.53867976256618e-67	FGR	CD8+ T cells	GSE164237_pre	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19633
1.92037241001085e-71	-0.457153721551918	0.745	0.767	3.16438965721589e-67	CST7	CD8+ T cells	GSE164237_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19634
5.26387356827164e-71	-0.261877727431311	0.158	0.301	8.67381086579801e-67	CEMIP2	CD8+ T cells	GSE164237_pre	ENSG00000135048	23670	cell migration inducing hyaluronidase 2	TMEM2	protein_coding	Q9UHN6	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19635
1.9173192709362e-70	-0.315160210198321	0.258	0.406	3.15935869464868e-66	UBE2L6	CD8+ T cells	GSE164237_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19636
2.70924102343482e-70	-0.289204161595148	0.459	0.622	4.46428735841589e-66	WIPF1	CD8+ T cells	GSE164237_pre	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19637
3.42859593965847e-70	-0.344002203230324	0.44	0.593	5.64964038936923e-66	CNN2	CD8+ T cells	GSE164237_pre	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19638
4.30477367834164e-70	-0.276228609450849	0.198	0.347	7.09340606717135e-66	CDK2AP2	CD8+ T cells	GSE164237_pre	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19639
5.03321349728503e-70	-0.257944689450157	0.267	0.428	8.29372920082627e-66	IDH2	CD8+ T cells	GSE164237_pre	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19640
5.54276624305583e-70	-0.280346925102048	0.911	0.934	9.13337021530739e-66	MYL6	CD8+ T cells	GSE164237_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19641
8.30032978910642e-70	-0.273246831628805	0.325	0.491	1.36772834264896e-65	KLF3	CD8+ T cells	GSE164237_pre	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19642
9.11756713543934e-70	-0.294183717400873	0.325	0.484	1.50239271257769e-65	CTSC	CD8+ T cells	GSE164237_pre	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19643
2.1240602298191e-69	-0.338627999593287	0.53	0.66	3.50002644669591e-65	PPP1CA	CD8+ T cells	GSE164237_pre	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19644
2.95801063638681e-69	-0.301154545243811	0.247	0.399	4.87420992663818e-65	DYNLL1	CD8+ T cells	GSE164237_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19645
3.44142740847928e-67	-0.311381167445538	0.489	0.635	5.67078408369216e-63	LAT	CD8+ T cells	GSE164237_pre	ENSG00000213658	27040	linker for activation of T cells	LAT1	protein_coding	O43561	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19646
8.16730204704499e-67	-0.270433385150093	0.312	0.47	1.34580803131207e-62	LCP2	CD8+ T cells	GSE164237_pre	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19647
1.49885670050877e-66	-0.309484835986026	0.96	0.953	2.46981607109836e-62	ARHGDIB	CD8+ T cells	GSE164237_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19648
7.88927461240066e-66	-0.258945431198433	0.288	0.442	1.29999467063138e-61	CASP4	CD8+ T cells	GSE164237_pre	ENSG00000196954	837	caspase 4	ICE(rel)II|ICH-2|TX	protein_coding	P49662	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19649
1.09117641475456e-65	-0.283468821337883	0.255	0.404	1.79804049623257e-61	ZYX	CD8+ T cells	GSE164237_pre	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19650
1.94651281514898e-65	-0.304718183718722	0.47	0.622	3.20746381680249e-61	MSN	CD8+ T cells	GSE164237_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19651
3.10757188569958e-65	-0.278957740486664	0.477	0.634	5.12065695325577e-61	SEPT9	CD8+ T cells	GSE164237_pre	NA	NA	NA	NA	NA	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19652
1.57432924914374e-64	-0.286992084690698	0.471	0.618	2.59417973673905e-60	TBC1D10C	CD8+ T cells	GSE164237_pre	ENSG00000175463	374403	TBC1 domain family member 10C	Carabin|EPI64C|FLJ00332	protein_coding	Q8IV04	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19653
1.70301395736152e-64	-0.535841069376992	0.998	0.998	2.80622639894031e-60	ACTB	CD8+ T cells	GSE164237_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19654
1.76852081052325e-64	-0.287679022224044	0.483	0.631	2.91416859158022e-60	HCLS1	CD8+ T cells	GSE164237_pre	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19655
2.88222700886662e-64	-0.269212055110875	0.242	0.388	4.74933366521042e-60	DENND2D	CD8+ T cells	GSE164237_pre	ENSG00000162777	79961	DENN domain containing 2D	FLJ22457|RP5-1180E21.2	protein_coding	Q9H6A0	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19656
3.19945145748457e-64	-0.25807146891938	0.396	0.553	5.27205611164307e-60	ATP5MC3	CD8+ T cells	GSE164237_pre	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19657
5.4857525738281e-64	-0.256134587127137	0.74	0.842	9.03942309115394e-60	AES	CD8+ T cells	GSE164237_pre	NA	NA	NA	NA	NA	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19658
9.01085789779829e-64	-0.264354855820941	0.316	0.475	1.4848091643992e-59	GADD45B	CD8+ T cells	GSE164237_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19659
2.94503545205645e-63	-0.286021571203713	0.556	0.696	4.85282941789863e-59	BIN2	CD8+ T cells	GSE164237_pre	ENSG00000110934	51411	bridging integrator 2	BRAP-1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19660
4.11799446796559e-63	-0.265766970534396	0.37	0.527	6.78563128431371e-59	PRKCH	CD8+ T cells	GSE164237_pre	ENSG00000027075	5583	protein kinase C eta	PKC-L|PKCL|PRKCL	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19661
1.43943739926979e-62	-0.260540631210086	0.385	0.542	2.37190494651676e-58	CD247	CD8+ T cells	GSE164237_pre	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19662
2.02631414139212e-62	-0.273920059320432	0.175	0.312	3.33896044218594e-58	TPM4	CD8+ T cells	GSE164237_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19663
6.96613704972022e-62	-0.293874206062622	0.5	0.64	1.1478800630529e-57	HLA-DPB1	CD8+ T cells	GSE164237_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19664
1.14292537365175e-60	-0.330017221195785	0.463	0.605	1.88331243070335e-56	MYH9	CD8+ T cells	GSE164237_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19665
2.08305268137966e-59	-0.500131162763166	0.876	0.861	3.43245420837741e-55	MT-ND4L	CD8+ T cells	GSE164237_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19666
1.11068106155371e-58	-0.257136041956715	0.372	0.519	1.83018025322821e-54	ATP5F1B	CD8+ T cells	GSE164237_pre	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19667
1.16521908863203e-58	-0.26120842306279	0.31	0.455	1.92004801424785e-54	P2RY8	CD8+ T cells	GSE164237_pre	ENSG00000182162	286530	P2Y receptor family member 8	P2Y8	protein_coding	Q86VZ1	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19668
8.2768072349061e-58	-0.402072424690119	0.529	0.66	1.36385229616783e-53	MT2A	CD8+ T cells	GSE164237_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19669
1.72158929525976e-57	0.294846832152804	0.557	0.42	2.83683484072904e-53	CXCR4	CD8+ T cells	GSE164237_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19670
4.48675530062098e-56	-0.326104943204102	0.724	0.779	7.39327538436324e-52	ARPC1B	CD8+ T cells	GSE164237_pre	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19671
5.56186677443749e-56	-0.261190126572012	0.407	0.552	9.16484407091809e-52	YWHAQ	CD8+ T cells	GSE164237_pre	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19672
6.86810347612656e-56	-0.311960120087259	0.149	0.265	1.13172609079613e-51	GBP1	CD8+ T cells	GSE164237_pre	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19673
7.5100086464325e-56	-0.270298041555933	0.748	0.819	1.23749922475915e-51	CD99	CD8+ T cells	GSE164237_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19674
1.58989759734306e-55	-0.263792655908998	0.613	0.745	2.6198332609019e-51	IER2	CD8+ T cells	GSE164237_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19675
2.91644859294768e-55	-0.28308194587225	0.45	0.59	4.80572399145918e-51	ANXA6	CD8+ T cells	GSE164237_pre	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19676
1.13192382185907e-54	-0.252996668283245	0.374	0.524	1.86518407365937e-50	CALM3	CD8+ T cells	GSE164237_pre	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19677
1.38713357192437e-54	-0.293801919211018	0.394	0.531	2.28571869981697e-50	SLC25A5	CD8+ T cells	GSE164237_pre	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19678
9.52072420080799e-53	-0.253669153441906	0.177	0.299	1.56882493380914e-48	AOAH	CD8+ T cells	GSE164237_pre	ENSG00000136250	313	acyloxyacyl hydrolase	NA	protein_coding	P28039	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19679
1.09382786485666e-52	-0.468237419167842	0.611	0.669	1.80240955571081e-48	GZMH	CD8+ T cells	GSE164237_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19680
1.10183896539078e-52	-0.256982204691713	0.333	0.474	1.81561024717092e-48	ITGAL	CD8+ T cells	GSE164237_pre	ENSG00000005844	3683	integrin subunit alpha L	CD11A|LFA-1|LFA1A	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19681
1.0666085546991e-50	-0.287538602967245	0.833	0.862	1.75755757643318e-46	HSPA8	CD8+ T cells	GSE164237_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19682
3.82283499861357e-49	-0.268236285461043	0.615	0.737	6.29926751071545e-45	PPIB	CD8+ T cells	GSE164237_pre	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19683
1.22760165302805e-48	-0.291661974804499	0.572	0.692	2.02284200385962e-44	IRF1	CD8+ T cells	GSE164237_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19684
1.70084112995455e-48	-0.251197187075816	0.255	0.378	2.8026460139391e-44	PTPN6	CD8+ T cells	GSE164237_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19685
4.44706059415446e-47	-0.282487450563847	0.512	0.629	7.32786644704771e-43	CAP1	CD8+ T cells	GSE164237_pre	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19686
8.23404193187703e-47	-0.263585292190186	0.78	0.826	1.3568054295347e-42	EVL	CD8+ T cells	GSE164237_pre	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19687
1.12929623632431e-46	-0.255697662331108	0.891	0.907	1.8608543382152e-42	ARPC2	CD8+ T cells	GSE164237_pre	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19688
1.92247336127377e-46	-0.327831722231205	0.408	0.534	3.16785160470692e-42	HMGB2	CD8+ T cells	GSE164237_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19689
5.38900717583944e-46	0.318138583400928	0.619	0.546	8.88000602434822e-42	TRAC	CD8+ T cells	GSE164237_pre	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19690
1.80287178753309e-45	-0.317989808296371	0.49	0.603	2.97077213149702e-41	PSME2	CD8+ T cells	GSE164237_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19691
6.79454600155951e-45	-0.260259533878682	0.266	0.387	1.11960529013698e-40	TAGAP	CD8+ T cells	GSE164237_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19692
2.20395297231493e-44	-0.269875915289346	0.436	0.554	3.63167370778054e-40	ACTR3	CD8+ T cells	GSE164237_pre	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19693
2.76652944541227e-43	-0.258226575197548	0.515	0.648	4.55868722015033e-39	AHNAK	CD8+ T cells	GSE164237_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19694
1.11649732407175e-41	-0.269811289560973	0.839	0.853	1.83976429060543e-37	PSME1	CD8+ T cells	GSE164237_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19695
7.33595602336304e-41	-0.264532643010453	0.902	0.898	1.20881883352976e-36	PPIA	CD8+ T cells	GSE164237_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19696
1.36973759250856e-40	-0.449569859492231	0.311	0.426	2.2570536049356e-36	GZMB	CD8+ T cells	GSE164237_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19697
3.24743275127281e-40	0.269184389386027	0.596	0.519	5.35111968754733e-36	SNHG8	CD8+ T cells	GSE164237_pre	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19698
3.25911648003376e-40	-0.250870853896707	0.59	0.695	5.37037213579963e-36	DUSP2	CD8+ T cells	GSE164237_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19699
2.45066479020763e-39	-0.253984615395809	0.833	0.855	4.03820544130413e-35	CTSW	CD8+ T cells	GSE164237_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19700
3.07716727465918e-39	-0.320972504939336	0.926	0.902	5.0705562351834e-35	CORO1A	CD8+ T cells	GSE164237_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19701
1.23083884155356e-38	-0.287848050606086	0.675	0.737	2.02817624311195e-34	CLIC1	CD8+ T cells	GSE164237_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19702
1.08309035243754e-36	0.52252424028793	0.46	0.383	1.78471628274658e-32	CMC1	CD8+ T cells	GSE164237_pre	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19703
1.91343854346816e-36	-0.369656949988545	0.718	0.742	3.15296403192683e-32	GZMA	CD8+ T cells	GSE164237_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19704
3.63985649096445e-35	0.271670813780425	0.514	0.412	5.99775552581123e-31	IL7R	CD8+ T cells	GSE164237_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19705
1.05611470760493e-33	-0.280849343425898	0.247	0.346	1.74026581519141e-29	STAT1	CD8+ T cells	GSE164237_pre	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19706
3.10194972449294e-33	-0.282284278766811	0.614	0.726	5.11139275601947e-29	HMGN2	CD8+ T cells	GSE164237_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19707
7.390413059113e-31	-0.273254912511354	0.865	0.885	1.21779226388064e-26	CCL5	CD8+ T cells	GSE164237_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19708
3.81604231881011e-30	-0.35362502797273	0.358	0.459	6.2880745329353e-26	CCL4	CD8+ T cells	GSE164237_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19709
5.70333170775467e-29	-0.266480939035707	0.697	0.744	9.39794998803815e-25	LCP1	CD8+ T cells	GSE164237_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19710
3.04103051000499e-27	-0.30490099338844	0.676	0.729	5.01101007438622e-23	RNF213	CD8+ T cells	GSE164237_pre	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19711
4.71712741541123e-27	0.337361021518289	0.546	0.436	7.77288255511463e-23	GNLY	CD8+ T cells	GSE164237_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19712
8.72347678877451e-27	0.373892480355112	0.444	0.375	1.43745450525426e-22	NFKBIA	CD8+ T cells	GSE164237_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19713
4.43711924765008e-18	-0.363326545119199	0.993	0.993	7.3114850962778e-14	H3F3B	CD8+ T cells	GSE164237_pre	NA	NA	NA	NA	NA	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19714
1.00539667322312e-08	-0.261772681693586	0.31	0.357	0.000165669263813705	H1FX	CD8+ T cells	GSE164237_pre	NA	NA	NA	NA	NA	NA	GSE164237	GSE164237	Melanoma	Advanced stages of melanoma 	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 4); post (resistant 4, sensitive 4)	16	23276	Public on Feb 18, 2022	34911739	This dataset has 8 patients with both pre -and post-treatment samples.	PRJNA689600	10x genomics	CellRanger 3.1.0	Melanoma	Immunotherapy	19715
5.00973106473061e-49	-1.88940318141472	0.464	0.84	7.89683907733486e-45	S100A4	CD4+ T cells	GSE164551	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19716
9.23311483088934e-46	1.17397686568108	0.481	0.022	1.45541589079309e-41	IGLC3	CD4+ T cells	GSE164551	ENSG00000211679	NA	NA	IGLC	IG_C_gene	P0DOY3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19717
2.43925213900068e-41	-0.827952871647108	0.082	0.381	3.84499314670678e-37	AC103591.3	CD4+ T cells	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19718
1.45837625939147e-36	-0.795329518135035	0.113	0.406	2.29883849767878e-32	RGS1	CD4+ T cells	GSE164551	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19719
1.4379351960682e-35	-1.03030869023385	0.508	0.767	2.26661724956231e-31	TSC22D3	CD4+ T cells	GSE164551	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19720
1.80447969251171e-34	-0.486254456683329	0.051	0.286	2.84440133930622e-30	S100A11	CD4+ T cells	GSE164551	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19721
1.52482561717199e-32	-0.91917088004553	0.652	0.909	2.4035826203482e-28	VIM	CD4+ T cells	GSE164551	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19722
9.93678206319901e-32	0.399637864402505	0.868	0.579	1.56633495662206e-27	HBA2	CD4+ T cells	GSE164551	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19723
5.04472575056931e-31	-0.987521845561855	0.259	0.557	7.95200120062241e-27	JUN	CD4+ T cells	GSE164551	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19724
7.3195635774524e-31	-0.801960925244405	0.091	0.346	1.15378280671382e-26	HLA-DRB1	CD4+ T cells	GSE164551	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19725
3.82936829255135e-29	-1.08797426152155	0.745	0.915	6.03623323954869e-25	TXNIP	CD4+ T cells	GSE164551	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19726
1.76728132364039e-28	-1.34307157901288	0.934	0.984	2.78576555045434e-24	TMSB10	CD4+ T cells	GSE164551	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19727
4.03632527147747e-27	-0.605163527292385	0.124	0.368	6.36245952542993e-23	CORO1B	CD4+ T cells	GSE164551	ENSG00000172725	57175	coronin 1B	coronin-2	protein_coding	Q9BR76	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19728
2.77027240405594e-25	-0.558149406592267	0.114	0.355	4.36678039051338e-21	HLA-DRA	CD4+ T cells	GSE164551	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19729
2.05449858819018e-24	-0.601471122693027	0.169	0.415	3.23850612456417e-20	CLIC1	CD4+ T cells	GSE164551	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19730
1.72476633385875e-23	0.612705945717966	0.763	0.531	2.71874917206154e-19	LIMD2	CD4+ T cells	GSE164551	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19731
8.87411065281345e-23	-0.396682704117756	0.065	0.255	1.39882606220298e-18	PRDX2	CD4+ T cells	GSE164551	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19732
4.10081018052783e-22	-0.727231054425413	0.72	0.903	6.46410708756602e-18	SH3BGRL3	CD4+ T cells	GSE164551	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19733
1.0087855681781e-21	-1.01464504144296	0.099	0.305	1.59014869111913e-17	LGALS1	CD4+ T cells	GSE164551	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19734
2.04754118593083e-21	0.617761553269039	0.982	0.943	3.22753917138276e-17	PABPC1	CD4+ T cells	GSE164551	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19735
2.58187262396021e-21	-0.893739087665433	0.671	0.871	4.06980581714847e-17	ACTG1	CD4+ T cells	GSE164551	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19736
1.13753597120907e-20	-0.516112396768577	0.272	0.535	1.79309795141685e-16	OAZ1	CD4+ T cells	GSE164551	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19737
3.093594647413e-20	-0.620622436590839	0.353	0.601	4.87643324271712e-16	CYBA	CD4+ T cells	GSE164551	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19738
3.78348967241379e-20	0.621556517484222	0.745	0.497	5.96391477062586e-16	EML4	CD4+ T cells	GSE164551	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19739
4.24361935779148e-20	-0.628322995865983	0.324	0.547	6.6892171936867e-16	CD3E	CD4+ T cells	GSE164551	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19740
4.89630743189314e-20	-0.478377404475207	0.124	0.333	7.71804940489315e-16	ITGB2	CD4+ T cells	GSE164551	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19741
7.47912927719416e-20	-0.4419827550548	0.087	0.28	1.17893514796411e-15	CXCL8	CD4+ T cells	GSE164551	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19742
2.06970092310053e-19	-0.344644304811079	0.091	0.283	3.26246956508336e-15	FKBP1A	CD4+ T cells	GSE164551	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19743
2.19052343228749e-19	0.512066077741577	0.736	0.484	3.45292208631477e-15	CDC42SE2	CD4+ T cells	GSE164551	ENSG00000158985	56990	CDC42 small effector 2	FLJ21967|SPEC2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19744
4.00588531553396e-19	-1.03606377379586	0.423	0.591	6.31447702287618e-15	CD52	CD4+ T cells	GSE164551	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19745
4.29959473532131e-19	-0.672535113789294	0.43	0.682	6.77745118128699e-15	CD74	CD4+ T cells	GSE164551	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19746
4.61538273889421e-19	1.55601017148623	0.833	0.777	7.27522781131894e-15	MT2A	CD4+ T cells	GSE164551	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19747
7.45084586726293e-19	-0.530431092190095	0.081	0.258	1.17447683405666e-14	HLA-DPA1	CD4+ T cells	GSE164551	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19748
1.02561179716801e-18	-0.452466865333062	0.283	0.55	1.61667187587593e-14	ZFP36L1	CD4+ T cells	GSE164551	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19749
4.16289226694981e-18	0.505992063228	0.445	0.182	6.56196708039299e-14	NFKB2	CD4+ T cells	GSE164551	ENSG00000077150	4791	nuclear factor kappa B subunit 2	LYT-10|NF-kB2|p105|p49/p100|p52	protein_coding	Q00653	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19750
5.24278020780452e-18	-0.432407773700115	0.084	0.258	8.26419444156227e-14	ARPC1B	CD4+ T cells	GSE164551	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19751
4.54434011485298e-17	-0.931180103916215	0.739	0.868	7.16324332304275e-13	GAPDH	CD4+ T cells	GSE164551	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19752
6.39687771643222e-17	-0.606730641647106	0.291	0.519	1.00833983444121e-12	COTL1	CD4+ T cells	GSE164551	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19753
4.3562658458755e-16	-0.535640557669163	0.675	0.881	6.86678185285356e-12	SERF2	CD4+ T cells	GSE164551	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19754
4.91821306142558e-16	-0.456271353975983	0.561	0.786	7.75257924872514e-12	LAPTM5	CD4+ T cells	GSE164551	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19755
5.55069276295309e-16	-0.716066288101246	0.389	0.61	8.74955700224295e-12	CFL1	CD4+ T cells	GSE164551	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19756
7.11739226238765e-16	0.539764977832434	0.57	0.34	1.12191454232017e-11	DDX21	CD4+ T cells	GSE164551	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19757
1.15148171347586e-15	-0.348347006067326	0.102	0.274	1.81508062495199e-11	TSPO	CD4+ T cells	GSE164551	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19758
1.22727263691965e-15	-0.485985873411421	0.18	0.381	1.93454985757644e-11	TIPARP	CD4+ T cells	GSE164551	ENSG00000163659	25976	TCDD inducible poly(ADP-ribose) polymerase	ARTD14|DDF1|DKFZP434J214|DKFZp686N0351|PARP-1|PARP-7|PARP7|pART14|RM1	protein_coding	Q7Z3E1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19759
3.47826631887078e-15	-0.658042890623819	0.487	0.72	5.48279119843602e-11	S100A10	CD4+ T cells	GSE164551	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19760
3.48508921137289e-15	-0.807732473126327	0.469	0.67	5.49354612388708e-11	PFN1	CD4+ T cells	GSE164551	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19761
1.00102308010774e-14	1.11497373810743	0.852	0.648	1.57791268117383e-10	HBB	CD4+ T cells	GSE164551	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19762
1.15690152052795e-14	-0.894250694547357	0.644	0.83	1.82362386680821e-10	S100A6	CD4+ T cells	GSE164551	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19763
1.40944458601233e-14	-0.555019731284856	0.396	0.623	2.22170750093124e-10	H1FX	CD4+ T cells	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19764
1.66310405634287e-14	0.490906913612277	0.573	0.355	2.62155092401326e-10	EIF5A	CD4+ T cells	GSE164551	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19765
2.58608447048066e-14	0.481188015464989	0.861	0.701	4.07644495081867e-10	ANKRD12	CD4+ T cells	GSE164551	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19766
2.60183268018194e-14	-0.332228655281071	0.099	0.267	4.10126885377079e-10	MAP3K8	CD4+ T cells	GSE164551	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19767
4.22064368472896e-14	1.06479435185744	0.37	0.17	6.65300064023826e-10	MT1X	CD4+ T cells	GSE164551	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19768
6.83210952090719e-14	-0.359819903989795	0.133	0.308	1.0769454237806e-09	IL2RG	CD4+ T cells	GSE164551	ENSG00000147168	3561	interleukin 2 receptor subunit gamma	CD132|CIDX|IMD4|SCIDX1	protein_coding	P31785	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19769
9.17694528600816e-14	-0.400928603876197	0.228	0.431	1.44656188543347e-09	S100A9	CD4+ T cells	GSE164551	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19770
1.04769321101197e-13	-0.343437916984768	0.098	0.255	1.65147880851817e-09	PLK3	CD4+ T cells	GSE164551	ENSG00000173846	1263	polo like kinase 3	CNK|FNK|PRK	protein_coding	Q9H4B4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19771
1.23064608951296e-13	-0.260715213885522	0.102	0.261	1.93986743089927e-09	NDUFA11	CD4+ T cells	GSE164551	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19772
1.39955421747479e-13	-0.578758744309658	0.315	0.491	2.20611731300551e-09	ARPC3	CD4+ T cells	GSE164551	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19773
1.54723359534585e-13	0.412958819174872	0.468	0.23	2.43890431634367e-09	TCF7	CD4+ T cells	GSE164551	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19774
1.6725130997225e-13	-0.519784499751103	0.349	0.525	2.63638239909258e-09	PPP1R2	CD4+ T cells	GSE164551	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19775
2.060344676318e-13	0.436581013652119	0.591	0.349	3.24772131328007e-09	IL7R	CD4+ T cells	GSE164551	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19776
8.30727924540381e-13	-0.416255667564354	0.12	0.28	1.309476427453e-08	DUSP4	CD4+ T cells	GSE164551	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19777
1.56199543422153e-12	-0.590025326423825	0.348	0.506	2.4621734029634e-08	CD3D	CD4+ T cells	GSE164551	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19778
1.65438128717758e-12	-0.441922528968864	0.162	0.336	2.60780122297802e-08	THBS1	CD4+ T cells	GSE164551	ENSG00000137801	7057	thrombospondin 1	THBS|THBS-1|TSP|TSP-1|TSP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19779
2.51125640014119e-12	-0.364995484283186	0.227	0.412	3.95849346354255e-08	LYZ	CD4+ T cells	GSE164551	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19780
3.44014679637364e-12	-0.714849966655992	0.514	0.711	5.42270339512376e-08	MYL6	CD4+ T cells	GSE164551	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19781
3.71332019694035e-12	-1.14681097494956	0.903	0.965	5.85330662643707e-08	ACTB	CD4+ T cells	GSE164551	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19782
4.84189444767609e-12	0.395839474203782	0.551	0.33	7.63227821787182e-08	CHD1	CD4+ T cells	GSE164551	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19783
5.02998352967691e-12	-0.297781676772904	0.108	0.255	7.92876303782972e-08	POLR2L	CD4+ T cells	GSE164551	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19784
6.4062841588933e-12	-0.332257611844043	0.199	0.371	1.00982257196635e-07	ANAPC16	CD4+ T cells	GSE164551	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19785
6.51477209730958e-12	-0.404320292535388	0.198	0.362	1.02692352569891e-07	CD3G	CD4+ T cells	GSE164551	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19786
1.63617959131479e-11	-0.277155026182946	0.115	0.264	2.57910988978951e-07	GNG5	CD4+ T cells	GSE164551	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19787
2.27713889773384e-11	-0.381885296926819	0.216	0.387	3.58945404449785e-07	MYH9	CD4+ T cells	GSE164551	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19788
2.34013517106746e-11	0.383846834384001	0.399	0.208	3.68875507015364e-07	TECR	CD4+ T cells	GSE164551	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19789
2.87609970018286e-11	0.340124881720064	0.398	0.192	4.53359595739824e-07	ZEB1	CD4+ T cells	GSE164551	ENSG00000148516	6935	zinc finger E-box binding homeobox 1	AREB6|BZP|FECD6|NIL-2-A|PPCD3|TCF8|ZEB|Zfhep|Zfhx1a	protein_coding	P37275	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19790
2.97510538933985e-11	-0.256983902086876	0.181	0.355	4.68965862521641e-07	CTSS	CD4+ T cells	GSE164551	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19791
3.34515900229432e-11	-0.320328412187963	0.197	0.365	5.27297413531653e-07	HLA-F	CD4+ T cells	GSE164551	ENSG00000234487	3134	major histocompatibility complex, class I, F	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19792
4.55491606217036e-11	0.417831617672743	0.445	0.245	7.17991418879914e-07	CLEC2D	CD4+ T cells	GSE164551	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19793
7.74979756969542e-11	-0.747353336251731	0.997	0.991	1.22160059091109e-06	B2M	CD4+ T cells	GSE164551	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19794
1.03088837482926e-10	-0.565158941672282	0.723	0.874	1.62498934524337e-06	ATP5F1E	CD4+ T cells	GSE164551	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19795
1.37959965200435e-10	-0.343873529488018	0.116	0.258	2.17466293145446e-06	PMAIP1	CD4+ T cells	GSE164551	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19796
1.64344437032268e-10	-0.298861113945122	0.208	0.377	2.59056136093964e-06	RAC1	CD4+ T cells	GSE164551	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19797
1.70289188027065e-10	0.366634964422717	0.36	0.179	2.68426847087062e-06	GIMAP7	CD4+ T cells	GSE164551	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19798
1.88076953433382e-10	0.344818244430802	0.255	0.088	2.9646570169704e-06	SOCS3	CD4+ T cells	GSE164551	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19799
2.27156809308065e-10	-0.451684445248133	0.163	0.308	3.58067278512302e-06	LSP1	CD4+ T cells	GSE164551	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19800
2.45880909214891e-10	-0.399180094341008	0.327	0.494	3.87582077195432e-06	TGFB1	CD4+ T cells	GSE164551	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19801
2.73058527022247e-10	-0.379604337284105	0.59	0.755	4.30422156145167e-06	CCNL1	CD4+ T cells	GSE164551	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19802
2.97257912931789e-10	-0.535288356886949	0.297	0.434	4.68567648154379e-06	HCST	CD4+ T cells	GSE164551	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19803
3.00027903798246e-10	-0.380906221071872	0.906	0.962	4.72933984757176e-06	BTG1	CD4+ T cells	GSE164551	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19804
3.26532517675262e-10	-0.41465547487639	0.166	0.311	5.14713207611515e-06	TXN	CD4+ T cells	GSE164551	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19805
4.02181299824113e-10	0.363171216426626	0.662	0.472	6.33958382912749e-06	FOXP1	CD4+ T cells	GSE164551	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19806
4.71210094950372e-10	0.289245709880351	0.256	0.094	7.42768472670271e-06	GOLGA7	CD4+ T cells	GSE164551	ENSG00000147533	51125	golgin A7	GCP16|GOLGA3AP1|GOLGA7A|HSPC041	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19807
6.73930838236819e-10	-0.456904809547472	0.251	0.409	1.0623171803127e-05	CD99	CD4+ T cells	GSE164551	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19808
1.21034147644674e-09	0.318584341440111	0.455	0.261	1.907861269323e-05	USP16	CD4+ T cells	GSE164551	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19809
1.59275807491362e-09	-0.33145235398321	0.18	0.333	2.51066455348635e-05	TIMP1	CD4+ T cells	GSE164551	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19810
1.62424088386216e-09	0.438037303670601	0.995	0.997	2.56029090523193e-05	EEF1A1	CD4+ T cells	GSE164551	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19811
1.63992898928524e-09	0.335328885457554	0.366	0.192	2.58502006581033e-05	PHF1	CD4+ T cells	GSE164551	ENSG00000225553	5252	PHD finger protein 1	MTF2L2|PCL1|TDRD19C	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19812
1.76771195580733e-09	0.358220904601661	0.719	0.566	2.7864443559391e-05	SF1	CD4+ T cells	GSE164551	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19813
2.44983296328836e-09	0.318586129112035	0.331	0.16	3.86167170003145e-05	SPTBN1	CD4+ T cells	GSE164551	ENSG00000115306	6711	spectrin beta, non-erythrocytic 1	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19814
2.61985655092264e-09	-0.444757614846327	0.161	0.296	4.12967988121936e-05	ATP1B3	CD4+ T cells	GSE164551	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19815
3.58143660063282e-09	-0.358702585137791	0.228	0.371	5.64541851357751e-05	CACYBP	CD4+ T cells	GSE164551	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19816
3.98770471273781e-09	0.355214545497442	0.328	0.16	6.28581893868861e-05	CCR7	CD4+ T cells	GSE164551	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19817
4.59661571748414e-09	-0.331970910612037	0.145	0.274	7.24564535547025e-05	CALM3	CD4+ T cells	GSE164551	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19818
5.63187857856662e-09	-0.444800387434866	0.539	0.66	8.87753020339456e-05	TNFAIP3	CD4+ T cells	GSE164551	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19819
5.9010561570425e-09	-0.376901333229748	0.205	0.34	9.3018348203461e-05	LY6E	CD4+ T cells	GSE164551	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19820
6.54264268813456e-09	-0.322811913960189	0.145	0.28	0.000103131676693065	ITGB1	CD4+ T cells	GSE164551	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19821
7.03381070853675e-09	0.301450634683594	0.294	0.132	0.000110873958198665	SATB1	CD4+ T cells	GSE164551	ENSG00000182568	6304	SATB homeobox 1	NA	protein_coding	Q01826	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19822
7.5258447633605e-09	0.365385805255996	0.56	0.387	0.000118629891004852	CNOT6L	CD4+ T cells	GSE164551	ENSG00000138767	246175	CCR4-NOT transcription complex subunit 6 like	Ccr4b|DKFZp434K098	protein_coding	Q96LI5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19823
7.71236892728066e-09	0.38433254733079	0.289	0.135	0.000121570071400725	PASK	CD4+ T cells	GSE164551	ENSG00000115687	23178	PAS domain containing serine/threonine kinase	KIAA0135|PASKIN|STK37	protein_coding	Q96RG2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19824
8.13981973615801e-09	0.264563864233216	0.303	0.138	0.000128307978501059	RAB8B	CD4+ T cells	GSE164551	ENSG00000166128	51762	RAB8B, member RAS oncogene family	NA	protein_coding	Q92930	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19825
9.18095306889363e-09	-0.362995906636838	0.217	0.355	0.00014471936322497	PDE4B	CD4+ T cells	GSE164551	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19826
1.17814310431476e-08	0.340686610504671	0.338	0.173	0.000185710697533135	TNRC6B	CD4+ T cells	GSE164551	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19827
1.26119215025972e-08	0.250446321198158	0.264	0.11	0.00019880171864544	SGTB	CD4+ T cells	GSE164551	ENSG00000197860	54557	small glutamine rich tetratricopeptide repeat co-chaperone beta	FLJ39002|Sgt2	protein_coding	Q96EQ0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19828
1.27633136334393e-08	-0.340378740724822	0.192	0.327	0.000201188112803904	RAC2	CD4+ T cells	GSE164551	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19829
1.31751154738594e-08	-0.417286481027331	0.286	0.428	0.000207679345214446	COX8A	CD4+ T cells	GSE164551	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19830
1.56182725756405e-08	0.298676462786081	0.344	0.179	0.000246190830609822	BRAF	CD4+ T cells	GSE164551	ENSG00000157764	673	B-Raf proto-oncogene, serine/threonine kinase	BRAF-1|BRAF1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19831
1.64826994750046e-08	-0.385129605432471	0.191	0.321	0.000259816791824497	ATP5IF1	CD4+ T cells	GSE164551	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19832
2.53952010121343e-08	-0.34295598656276	0.285	0.434	0.000400304553554272	HERPUD1	CD4+ T cells	GSE164551	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19833
3.90701680156444e-08	-0.543221731969474	0.52	0.616	0.000615863058430603	ARHGDIB	CD4+ T cells	GSE164551	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19834
3.99727499140606e-08	-0.372471680871534	0.922	0.969	0.000630090456895337	DDX5	CD4+ T cells	GSE164551	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19835
5.10553349281247e-08	0.301594854123055	0.402	0.242	0.000804785244472029	SDCBP	CD4+ T cells	GSE164551	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19836
5.57060644795851e-08	0.260424530673655	0.289	0.138	0.0008780946943917	PDE3B	CD4+ T cells	GSE164551	ENSG00000152270	5140	phosphodiesterase 3B	HcGIP1	protein_coding	Q13370	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19837
1.00764790906422e-07	0.301217436215298	0.364	0.211	0.00158835539905793	NOP58	CD4+ T cells	GSE164551	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19838
1.01122238985814e-07	0.388023948381364	0.667	0.569	0.00159398985313339	LEPROTL1	CD4+ T cells	GSE164551	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19839
1.13975591120298e-07	0.312493413534032	0.579	0.409	0.00179659724282926	ARID4B	CD4+ T cells	GSE164551	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19840
1.29534991098619e-07	0.309564778928817	0.815	0.726	0.00204186006468754	PRRC2C	CD4+ T cells	GSE164551	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19841
1.51729274237364e-07	0.300870676198994	0.396	0.239	0.00239170854980356	BAZ1A	CD4+ T cells	GSE164551	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19842
1.73003420498929e-07	0.306895034478583	0.676	0.528	0.00272705291732462	STK4	CD4+ T cells	GSE164551	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19843
2.09423834170941e-07	-0.331954839507253	0.369	0.519	0.00330114789803655	CEMIP2	CD4+ T cells	GSE164551	ENSG00000135048	23670	cell migration inducing hyaluronidase 2	TMEM2	protein_coding	Q9UHN6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19844
2.43450092389641e-07	-0.358723338385643	0.64	0.774	0.00383750380633792	ATP5MG	CD4+ T cells	GSE164551	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19845
3.05025683954891e-07	-0.428932632867191	0.368	0.491	0.00480811985618095	ZFP36	CD4+ T cells	GSE164551	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19846
3.0613167143538e-07	0.429751359166683	0.958	0.962	0.0048255535368359	RPS6	CD4+ T cells	GSE164551	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19847
3.18039852488832e-07	-0.376992952111252	0.371	0.497	0.00501326219478147	RGS10	CD4+ T cells	GSE164551	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19848
3.22735078711035e-07	-0.355251029481553	0.254	0.381	0.00508727304572205	RNF213	CD4+ T cells	GSE164551	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19849
3.3957041569445e-07	-1.29458005973615	0.463	0.528	0.00535264846259162	IL32	CD4+ T cells	GSE164551	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19850
5.9406214256574e-07	0.314833898169294	0.903	0.909	0.00936420155326376	RPL4	CD4+ T cells	GSE164551	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19851
5.95027042378569e-07	0.331782657025067	0.853	0.899	0.00937941126901338	COX4I1	CD4+ T cells	GSE164551	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19852
6.78799309411839e-07	-0.304974581328372	0.26	0.39	0.0106999135142588	NDFIP1	CD4+ T cells	GSE164551	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19853
8.62806461083961e-07	0.315893035497165	0.523	0.377	0.0136004182460665	SFXN1	CD4+ T cells	GSE164551	ENSG00000164466	94081	sideroflexin 1	FLJ12876|SLC56A1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19854
9.36072142467287e-07	0.262643731541325	0.467	0.305	0.0147553051817118	EIF5	CD4+ T cells	GSE164551	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19855
1.4633349336853e-06	0.295335402144107	0.551	0.403	0.0230665485596813	MBNL1	CD4+ T cells	GSE164551	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19856
1.67793935324697e-06	-0.478136461469669	0.353	0.456	0.026449358025232	DDIT4	CD4+ T cells	GSE164551	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19857
1.95665176365305e-06	-0.382827946060401	0.924	0.981	0.0308427017504631	UBC	CD4+ T cells	GSE164551	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19858
2.11106799974144e-06	0.25846830630009	0.313	0.182	0.0332767648799244	SQSTM1	CD4+ T cells	GSE164551	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19859
2.16043943704471e-06	-0.279478566398968	0.238	0.358	0.0340550068461358	IDI1	CD4+ T cells	GSE164551	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19860
2.23199816867102e-06	0.254034843186917	0.344	0.204	0.0351829871327612	NUCKS1	CD4+ T cells	GSE164551	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19861
2.36155972696982e-06	0.359313252092898	0.988	0.994	0.0372252659762253	RPS18	CD4+ T cells	GSE164551	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19862
3.16244451880849e-06	-0.278906507569477	0.171	0.274	0.0498496129499782	ATP5MF	CD4+ T cells	GSE164551	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19863
1.14287480626059e-138	0.815865348184868	0.995	0.933	1.80151355710857e-134	HBA2	Erythrocytes	GSE164551	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19864
2.0772526143648e-109	0.629084874160013	0.997	0.955	3.27437329602324e-105	HBA1	Erythrocytes	GSE164551	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19865
1.55703161816153e-91	0.915953404336274	0.346	0.004	2.45434893970802e-87	IGLC3	Erythrocytes	GSE164551	ENSG00000211679	NA	NA	IGLC	IG_C_gene	P0DOY3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19866
1.50961374426679e-78	-0.978023338470005	0.443	0.882	2.37960414508774e-74	B2M	Erythrocytes	GSE164551	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19867
4.74704153740837e-71	-1.43777018562095	0.309	0.718	7.48276157541682e-67	CA2	Erythrocytes	GSE164551	ENSG00000104267	760	carbonic anhydrase 2	CA-II|CAII|Car2	protein_coding	P00918	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19868
5.73848133552698e-66	-0.87511379848787	0.938	0.955	9.04556812919119e-62	AHSP	Erythrocytes	GSE164551	ENSG00000169877	51327	alpha hemoglobin stabilizing protein	EDRF|ERAF	protein_coding	Q9NZD4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19869
6.938555403233e-64	-0.849310979312016	0.41	0.845	1.09372448821162e-59	TFRC	Erythrocytes	GSE164551	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19870
1.40552622690154e-62	-0.791021540727262	0.866	0.92	2.21553099146489e-58	BLVRB	Erythrocytes	GSE164551	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19871
1.83899975557478e-61	-0.943290548874888	0.523	0.863	2.89881531471253e-57	H3F3A	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19872
5.69671182740568e-60	-1.34548313528725	0.588	0.906	8.97972685353957e-56	MT-ND3	Erythrocytes	GSE164551	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19873
1.17186761518339e-58	-1.52511311926246	0.212	0.598	1.84721492181358e-54	HMGB1	Erythrocytes	GSE164551	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19874
6.88580602115001e-55	0.687088998426657	0.539	0.178	1.08540960311388e-50	KRT1	Erythrocytes	GSE164551	ENSG00000167768	3848	keratin 1	EHK1|KRT1A	protein_coding	P04264	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19875
1.51840395063183e-53	-0.977516893798826	0.949	0.994	2.39346014738095e-49	MT-CO1	Erythrocytes	GSE164551	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19876
5.36881107244335e-51	-0.997804994014115	0.41	0.754	8.46285689349245e-47	GYPA	Erythrocytes	GSE164551	ENSG00000170180	2993	glycophorin A (MNS blood group)	CD235a|GPA|MN|MNS	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19877
2.33483319190507e-50	-1.12308543889543	0.275	0.652	3.68039756039996e-46	RPS27A	Erythrocytes	GSE164551	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19878
2.8424191292757e-50	-1.63025281802817	0.155	0.506	4.48050527347728e-46	HSP90AA1	Erythrocytes	GSE164551	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19879
3.56316716079546e-50	-0.796480987382692	0.668	0.983	5.61662039556189e-46	MALAT1	Erythrocytes	GSE164551	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19880
2.08788397232507e-49	0.600827094130756	0.779	0.443	3.29113150557601e-45	GABARAPL2	Erythrocytes	GSE164551	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19881
4.16992475407876e-49	-0.712769947618301	0.374	0.745	6.57305238985435e-45	DDX5	Erythrocytes	GSE164551	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19882
1.17698936048348e-48	-0.700005535748416	0.387	0.75	1.85528832893011e-44	RHAG	Erythrocytes	GSE164551	ENSG00000112077	6005	Rh associated glycoprotein	CD241|RH50A|SLC42A1	protein_coding	Q02094	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19883
1.80112968140824e-48	0.719753271969678	0.801	0.449	2.83912071680381e-44	BPGM	Erythrocytes	GSE164551	ENSG00000172331	669	bisphosphoglycerate mutase	NA	protein_coding	P07738	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19884
8.06558304295152e-48	-0.633806824809736	0.077	0.407	1.27137785506045e-43	PER1	Erythrocytes	GSE164551	ENSG00000179094	5187	period circadian regulator 1	PER|RIGUI	protein_coding	O15534	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19885
9.04160155617712e-48	-0.942057235706342	0.265	0.649	1.4252276533002e-43	RPS27	Erythrocytes	GSE164551	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19886
2.02003710548621e-47	-1.2374561149514	0.206	0.558	3.18418448937791e-43	RPL35	Erythrocytes	GSE164551	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19887
4.24589119989e-47	-1.14332282715569	0.863	0.978	6.6927982983866e-43	MT-CO3	Erythrocytes	GSE164551	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19888
8.60329119805515e-47	-0.894792476304743	0.234	0.578	1.35613679154943e-42	HNRNPA2B1	Erythrocytes	GSE164551	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19889
2.38339087444142e-46	-1.09725964328503	0.253	0.614	3.75693903538201e-42	RPS29	Erythrocytes	GSE164551	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19890
6.5283948140248e-46	-1.17351870453153	0.299	0.646	1.02907087453473e-41	RPS24	Erythrocytes	GSE164551	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19891
1.50313151807518e-45	-1.7316262680329	0.212	0.551	2.36938621194191e-41	PTMA	Erythrocytes	GSE164551	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19892
2.03596641101317e-45	-1.40268404869639	0.132	0.471	3.20929385368007e-41	TUBA1B	Erythrocytes	GSE164551	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19893
4.66189900387416e-45	-1.03805085256406	0.243	0.607	7.34855139980684e-41	RPL34	Erythrocytes	GSE164551	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19894
4.90012724216899e-45	-1.10396917005525	0.768	0.942	7.72407057183098e-41	MT-ATP6	Erythrocytes	GSE164551	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19895
6.99957190599147e-45	-0.698842633479607	0.208	0.545	1.10334251954144e-40	RPL36AL	Erythrocytes	GSE164551	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19896
1.12592836135615e-44	-0.874782232568659	0.208	0.55	1.77480087600569e-40	RPL38	Erythrocytes	GSE164551	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19897
1.18035883862619e-44	-0.866858376256124	0.242	0.604	1.86059963732646e-40	RPL24	Erythrocytes	GSE164551	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19898
1.67802561979074e-44	-1.17867682935416	0.129	0.475	2.64507178447614e-40	HMGB2	Erythrocytes	GSE164551	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19899
5.46709194610236e-44	-0.992998241140232	0.426	0.733	8.61777703464114e-40	MT-ND5	Erythrocytes	GSE164551	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19900
1.26993497501733e-43	-1.20374579465489	0.515	0.774	2.00179850111982e-39	RPL21	Erythrocytes	GSE164551	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19901
1.79410468793801e-43	0.543613698243899	0.997	0.973	2.82804721959668e-39	HBB	Erythrocytes	GSE164551	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19902
2.01964569635866e-43	-0.844682507317009	0.315	0.666	3.18356751117015e-39	RPL30	Erythrocytes	GSE164551	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19903
3.32255214264756e-43	-0.853600156790571	0.111	0.427	5.23733894245535e-39	HMGN2	Erythrocytes	GSE164551	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19904
4.84712274970486e-43	-1.12608090459319	0.284	0.631	7.64051959035976e-39	RPL32	Erythrocytes	GSE164551	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19905
3.210946047105e-42	-0.756663077802609	0.134	0.457	5.06141425405162e-38	MGST3	Erythrocytes	GSE164551	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19906
3.39344162722047e-42	-0.841187343734409	0.343	0.677	5.34908203698763e-38	FAU	Erythrocytes	GSE164551	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19907
3.46932959837907e-42	-1.12028866583189	0.304	0.64	5.46870424592493e-38	RPS28	Erythrocytes	GSE164551	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19908
6.89476698140851e-42	-1.17251927132169	0.417	0.746	1.08682211927942e-37	RPLP1	Erythrocytes	GSE164551	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19909
8.98206610604229e-42	-1.03887936998789	0.706	0.915	1.41584308029545e-37	MT-CYB	Erythrocytes	GSE164551	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19910
9.40666517353009e-42	-0.851881316021416	0.248	0.594	1.48277263130355e-37	RPS26	Erythrocytes	GSE164551	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19911
1.07680075455276e-41	-0.887847366482154	0.933	0.954	1.69736102940152e-37	CA1	Erythrocytes	GSE164551	ENSG00000133742	759	carbonic anhydrase 1	Car1	protein_coding	P00915	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19912
1.10598500341844e-41	-0.719099967718563	0.288	0.626	1.74336416088849e-37	SPTA1	Erythrocytes	GSE164551	ENSG00000163554	6708	spectrin alpha, erythrocytic 1	EL2	protein_coding	P02549	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19913
1.68436601247174e-41	-1.08766183641485	0.288	0.631	2.6550661454592e-37	RPL37	Erythrocytes	GSE164551	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19914
2.49468096726216e-41	-0.935902769011796	0.495	0.822	3.93236560869535e-37	MT-ND2	Erythrocytes	GSE164551	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19915
3.00018926052923e-41	-0.825699695039388	0.237	0.562	4.72919833137223e-37	H1FX	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19916
4.98240350414596e-41	-0.555184013596704	0.458	0.797	7.85376264358528e-37	UBC	Erythrocytes	GSE164551	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19917
5.92208271194115e-41	-0.923930286767601	0.315	0.646	9.33497897883284e-37	RPL28	Erythrocytes	GSE164551	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19918
2.62888237877259e-40	-1.00932962092825	0.325	0.652	4.14390729365923e-36	RPS15	Erythrocytes	GSE164551	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19919
2.66083407048772e-40	-1.04808745283925	0.105	0.414	4.1942727453098e-36	TUBB	Erythrocytes	GSE164551	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19920
3.31939798847807e-40	-1.17020866707584	0.261	0.581	5.23236704923799e-36	RPL8	Erythrocytes	GSE164551	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19921
3.4687880881809e-40	-1.20395950796453	0.235	0.56	5.46785066339955e-36	RPL37A	Erythrocytes	GSE164551	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19922
3.70721180312735e-40	-1.2138542587615	0.606	0.837	5.84367796526964e-36	RPL41	Erythrocytes	GSE164551	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19923
3.80504480494773e-40	-0.984937417642289	0.222	0.566	5.9978921260391e-36	RPL19	Erythrocytes	GSE164551	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19924
5.9690887035203e-40	-1.13161951059507	0.688	0.883	9.40907452335905e-36	MT-ND4	Erythrocytes	GSE164551	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19925
6.64983288443095e-40	-1.10762043524141	0.224	0.553	1.04821315757285e-35	RPL29	Erythrocytes	GSE164551	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19926
7.94779183719273e-40	2.44122447248316	0.49	0.213	1.25281042729669e-35	HBG2	Erythrocytes	GSE164551	ENSG00000196565	3048	hemoglobin subunit gamma 2	HBG-T1	protein_coding	P69892	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19927
1.04025612588372e-39	-1.1179209540376	0.317	0.641	1.63975573123051e-35	EEF1A1	Erythrocytes	GSE164551	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19928
1.26388620313567e-39	-0.634984737417257	0.178	0.495	1.99226382200276e-35	UQCRB	Erythrocytes	GSE164551	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19929
1.72703887306298e-39	-1.00966216833922	0.623	0.873	2.72233137560918e-35	MT-ND1	Erythrocytes	GSE164551	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19930
4.15443498557761e-39	-0.985257980923441	0.093	0.381	6.54863586776598e-35	ATP5IF1	Erythrocytes	GSE164551	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19931
9.8564413091416e-39	-1.00299719025992	0.258	0.586	1.55367084355999e-34	RPS14	Erythrocytes	GSE164551	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19932
1.18001767409047e-37	-0.626420620415062	0.181	0.482	1.8600618596688e-33	SUB1	Erythrocytes	GSE164551	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19933
1.2913118553646e-37	-1.01440432658296	0.399	0.668	2.03549487761123e-33	RPLP2	Erythrocytes	GSE164551	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19934
1.34185746070159e-37	-0.620671989399948	0.18	0.476	2.11516991530391e-33	ATP5MF	Erythrocytes	GSE164551	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19935
1.88973633681726e-37	-0.921695298455329	0.096	0.38	2.97879138772505e-33	H2AFZ	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19936
2.18056410411872e-37	-1.0431536467526	0.27	0.585	3.43722319732234e-33	RPL11	Erythrocytes	GSE164551	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19937
4.87734064900488e-37	-1.33399989532527	0.109	0.393	7.68815206502639e-33	S100A6	Erythrocytes	GSE164551	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19938
5.21072258024754e-37	-0.829260704877246	0.562	0.774	8.2136620032442e-33	HEMGN	Erythrocytes	GSE164551	ENSG00000136929	55363	hemogen	CT155|EDAG|NDR	protein_coding	Q9BXL5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19939
5.51872121936978e-37	-1.01719557632354	0.229	0.54	8.69916025809259e-33	RPL18	Erythrocytes	GSE164551	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19940
6.37032171858702e-37	-0.555199098527733	0.482	0.785	1.00415381250087e-32	H3F3B	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19941
7.03346452826013e-37	-0.927135382925933	0.291	0.607	1.10868501358964e-32	RPS15A	Erythrocytes	GSE164551	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19942
7.51425513566092e-37	-1.17065071663758	0.242	0.556	1.18447203703423e-32	RPS8	Erythrocytes	GSE164551	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19943
7.69349513630643e-37	-1.08828686451245	0.31	0.614	1.21272563833598e-32	RPL12	Erythrocytes	GSE164551	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19944
2.03262982942114e-36	-1.04802346670653	0.822	0.946	3.20403440011655e-32	MT-CO2	Erythrocytes	GSE164551	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19945
2.29629582736475e-36	-0.584830478882901	0.641	0.85	3.61965111267505e-32	EIF1	Erythrocytes	GSE164551	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19946
2.60740463104464e-36	-1.12104230481842	0.212	0.526	4.11005191991567e-32	RPL14	Erythrocytes	GSE164551	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19947
3.35885686026261e-36	-1.16561137444778	0.281	0.589	5.29456606883195e-32	RPS6	Erythrocytes	GSE164551	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19948
3.77896021988457e-36	-0.838759669376149	0.188	0.488	5.95677499460406e-32	RPL27A	Erythrocytes	GSE164551	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19949
5.24446569151611e-36	-0.563131748928627	0.505	0.813	8.26685126953685e-32	CAT	Erythrocytes	GSE164551	ENSG00000121691	847	catalase	NA	protein_coding	P04040	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19950
5.30563159221769e-36	-0.868787471125775	0.229	0.541	8.36326707881274e-32	RPS25	Erythrocytes	GSE164551	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19951
1.43798068673942e-35	-0.566236234315626	0.418	0.686	2.26668895650734e-31	HNRNPK	Erythrocytes	GSE164551	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19952
2.21713080492877e-35	-1.06630610877671	0.196	0.502	3.49486328780923e-31	RPL26	Erythrocytes	GSE164551	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19953
2.86480076456937e-35	-1.15936037742017	0.188	0.489	4.51578544519069e-31	RPS21	Erythrocytes	GSE164551	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19954
3.2182124062278e-35	-0.959836851202721	0.296	0.613	5.07286821593689e-31	RPL13	Erythrocytes	GSE164551	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19955
3.80625144279591e-35	-0.573467602171093	0.312	0.629	5.99979414927919e-31	RBM39	Erythrocytes	GSE164551	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19956
3.97629045331792e-35	-0.527003323177089	0.361	0.692	6.26782664156503e-31	PABPC1	Erythrocytes	GSE164551	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19957
6.65780037179837e-35	-1.18455768176982	0.261	0.571	1.04946907260658e-30	RPS3A	Erythrocytes	GSE164551	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19958
6.702722718959e-35	-0.623095638319246	0.109	0.386	1.05655018218951e-30	SRSF3	Erythrocytes	GSE164551	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19959
9.2261309659326e-35	-0.572071690352973	0.18	0.48	1.45431502415996e-30	HNRNPH1	Erythrocytes	GSE164551	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19960
2.28951981584289e-34	-0.838633067204958	0.556	0.732	3.60897008571315e-30	YBX1	Erythrocytes	GSE164551	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19961
2.72871524467272e-34	-0.555825044820712	0.129	0.409	4.30127384017761e-30	HNRNPU	Erythrocytes	GSE164551	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19962
2.90840481114503e-34	-0.553390663606352	0.092	0.361	4.58451850380791e-30	COX6C	Erythrocytes	GSE164551	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19963
3.04280623665814e-34	-0.592036330574566	0.448	0.738	4.79637547084422e-30	ANK1	Erythrocytes	GSE164551	ENSG00000029534	286	ankyrin 1	ANK|SPH1	protein_coding	P16157	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19964
3.05105531461567e-34	-0.893386325231647	0.42	0.702	4.80937849242869e-30	RPL35A	Erythrocytes	GSE164551	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19965
3.67262944364565e-34	-0.896299727193198	0.237	0.549	5.78916579201864e-30	RPL39	Erythrocytes	GSE164551	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19966
3.73164250387915e-34	-0.738308455343014	0.155	0.447	5.88218807886471e-30	RPS20	Erythrocytes	GSE164551	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19967
5.8657466005184e-34	-0.579032303901974	0.637	0.872	9.24617636639716e-30	JUND	Erythrocytes	GSE164551	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19968
7.98910147244672e-34	-0.790140267739362	0.27	0.555	1.25932206510178e-29	RPS11	Erythrocytes	GSE164551	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19969
1.15445052661048e-33	-1.32143123766454	0.225	0.518	1.8197603650961e-29	RPS23	Erythrocytes	GSE164551	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19970
1.16114230346748e-33	-1.00820391258952	0.193	0.482	1.83030861295579e-29	RPS9	Erythrocytes	GSE164551	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19971
1.168454742822e-33	-0.693763777556055	0.176	0.456	1.84183521111032e-29	COX7C	Erythrocytes	GSE164551	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19972
1.42439555408638e-33	-0.958877972223551	0.26	0.557	2.24527471190636e-29	RPS7	Erythrocytes	GSE164551	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19973
1.55587437365226e-33	-0.611055352704285	0.19	0.478	2.45252477518806e-29	TMA7	Erythrocytes	GSE164551	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19974
2.09926362851047e-33	-1.16411610713576	0.092	0.36	3.30906925762105e-29	HIST1H4C	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19975
2.19155940606494e-33	-0.521536754281968	0.209	0.499	3.45455509178017e-29	PCBP2	Erythrocytes	GSE164551	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19976
2.22537795417e-33	-0.993072560307027	0.217	0.514	3.50786326915817e-29	RPL15	Erythrocytes	GSE164551	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19977
3.39807985206235e-33	-0.523072688714232	0.322	0.597	5.35639327080588e-29	ATP5MG	Erythrocytes	GSE164551	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19978
3.59660136574241e-33	-0.628415359814612	0.113	0.372	5.66932273281976e-29	ATP5ME	Erythrocytes	GSE164551	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19979
4.32761566340555e-33	-0.880524271940056	0.245	0.544	6.82162057022616e-29	RPL9	Erythrocytes	GSE164551	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19980
4.57920806516954e-33	-1.1677900472371	0.275	0.566	7.21820567312674e-29	RPS3	Erythrocytes	GSE164551	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19981
5.80262147624665e-33	-0.551326349334676	0.134	0.402	9.1466722330076e-29	UQCR10	Erythrocytes	GSE164551	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19982
6.63208304659975e-33	-0.942659815733463	0.217	0.499	1.04541525063552e-28	RPL22	Erythrocytes	GSE164551	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19983
7.17733691990703e-33	-0.562251238175798	0.193	0.467	1.13136361868495e-28	PCBP1	Erythrocytes	GSE164551	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19984
9.18104887975351e-33	-0.850526206423559	0.19	0.488	1.44720873491555e-28	RPS13	Erythrocytes	GSE164551	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19985
1.20433557382271e-32	-0.535841689518899	0.139	0.409	1.89839416501674e-28	POMP	Erythrocytes	GSE164551	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19986
1.28694178568544e-32	-0.717196758014814	0.654	0.818	2.02860633677595e-28	TPT1	Erythrocytes	GSE164551	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19987
1.75114353730462e-32	-0.72451924793751	0.454	0.675	2.76032755785328e-28	ANP32B	Erythrocytes	GSE164551	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19988
2.19817175499942e-32	-0.64149230297679	0.333	0.607	3.46497813740559e-28	TMEM14B	Erythrocytes	GSE164551	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19989
2.34483545380328e-32	-0.636314456089506	0.036	0.264	3.69616412583012e-28	HNRNPAB	Erythrocytes	GSE164551	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19990
2.77205592722386e-32	-0.752836561647428	0.163	0.431	4.36959175808297e-28	TUBB4B	Erythrocytes	GSE164551	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19991
2.93298467827507e-32	-0.571136187826332	0.158	0.427	4.62326374836499e-28	NDUFA4	Erythrocytes	GSE164551	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19992
5.99378181519925e-32	-0.368132156763238	0.029	0.256	9.44799827529858e-28	TSPO	Erythrocytes	GSE164551	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19993
7.29887839868318e-32	-0.898252142324826	0.294	0.589	1.15052220198443e-27	RPL6	Erythrocytes	GSE164551	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19994
7.41549744781591e-32	-0.926364291869872	0.199	0.483	1.16890486269922e-27	RPS16	Erythrocytes	GSE164551	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19995
8.41252052869701e-32	-0.446070671291187	0.088	0.341	1.32606561093851e-27	COX6A1	Erythrocytes	GSE164551	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19996
8.99217707104334e-32	-1.05165432875578	0.222	0.514	1.41743687170856e-27	RPS4X	Erythrocytes	GSE164551	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19997
9.30201653873203e-32	-0.848730189361236	0.199	0.492	1.46627686700033e-27	RPL23A	Erythrocytes	GSE164551	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19998
9.32503181884675e-32	-0.493771219679053	0.077	0.323	1.46990476560481e-27	CBX3	Erythrocytes	GSE164551	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	19999
1.20156315989677e-31	-0.556064555909648	0.234	0.532	1.89402400894528e-27	CD36	Erythrocytes	GSE164551	ENSG00000135218	948	CD36 molecule	FAT|GP3B|GP4|GPIV|SCARB3	protein_coding	P16671	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20000
1.35840304489185e-31	-1.18583724040805	0.211	0.499	2.14125071966302e-27	RPS18	Erythrocytes	GSE164551	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20001
1.63667497731018e-31	-0.596192069642473	0.188	0.473	2.57989076673403e-27	MT-ND4L	Erythrocytes	GSE164551	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20002
1.7350976495152e-31	-0.923942236657505	0.25	0.521	2.73503442493081e-27	RPL7	Erythrocytes	GSE164551	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20003
1.8134814600958e-31	-0.915028588184459	0.136	0.402	2.85859082554901e-27	GAPDH	Erythrocytes	GSE164551	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20004
2.94036672758177e-31	-0.560731977234345	0.193	0.457	4.63490007268715e-27	TSPO2	Erythrocytes	GSE164551	ENSG00000112212	222642	translocator protein 2	BZRPL1|dJ34B21.2	protein_coding	Q5TGU0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20005
3.04445380167186e-31	-0.566874453764606	0.144	0.404	4.79897252757535e-27	CALM2	Erythrocytes	GSE164551	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20006
3.08622626762426e-31	-0.563675963639485	0.139	0.402	4.86481846565613e-27	HNRNPA3	Erythrocytes	GSE164551	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20007
4.21846361286902e-31	-0.526991611554634	0.07	0.308	6.64956419296544e-27	PSMA7	Erythrocytes	GSE164551	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20008
7.0501541576239e-31	-0.754105656801156	0.848	0.909	1.11131579986626e-26	FTH1	Erythrocytes	GSE164551	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20009
1.50551196781775e-30	-0.523373869608853	0.155	0.419	2.37313851487112e-26	SFPQ	Erythrocytes	GSE164551	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20010
1.65685276184502e-30	0.462492929901297	0.926	0.762	2.61169700849631e-26	SNCA	Erythrocytes	GSE164551	ENSG00000145335	6622	synuclein alpha	NACP|PARK1|PARK4|PD1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20011
1.88709598352128e-30	-0.552112407437529	0.181	0.443	2.9746293988246e-26	TXN	Erythrocytes	GSE164551	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20012
1.94577624433798e-30	-0.455192212428343	0.065	0.303	3.06712709394996e-26	SEC61B	Erythrocytes	GSE164551	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20013
2.18956750621215e-30	-0.651470114172366	0.093	0.36	3.45141526004221e-26	CENPF	Erythrocytes	GSE164551	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20014
2.45924065687533e-30	-0.628472108793337	0.291	0.584	3.87650104743259e-26	H1F0	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20015
3.60721965314485e-30	-0.53880932185014	0.33	0.597	5.68606033925223e-26	UROD	Erythrocytes	GSE164551	ENSG00000126088	7389	uroporphyrinogen decarboxylase	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20016
4.41345949076699e-30	-1.06619743235363	0.173	0.434	6.956936195296e-26	RPLP0	Erythrocytes	GSE164551	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20017
4.54470363150477e-30	-0.429082603954922	0.108	0.368	7.16381633434096e-26	SRRM2	Erythrocytes	GSE164551	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20018
5.83310023400264e-30	-0.571817266578926	0.044	0.263	9.19471589885836e-26	METAP2	Erythrocytes	GSE164551	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20019
6.51588782211177e-30	-1.04107227704504	0.165	0.411	1.02709939739948e-25	HSP90AB1	Erythrocytes	GSE164551	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20020
6.87897915440798e-30	-1.15014646373977	0.224	0.496	1.08433348410933e-25	RPL7A	Erythrocytes	GSE164551	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20021
8.08098452223238e-30	-1.04251958699027	0.203	0.487	1.27380559023949e-25	RPL10	Erythrocytes	GSE164551	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20022
9.86244066015483e-30	-0.899460915109395	0.234	0.516	1.55461652126021e-25	RPL18A	Erythrocytes	GSE164551	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20023
1.02519380593363e-29	-0.712559407394701	0.712	0.847	1.61601299629317e-25	SLC4A1	Erythrocytes	GSE164551	ENSG00000004939	6521	solute carrier family 4 member 1 (Diego blood group)	AE1|CD233|DI|EPB3|FR|RTA1A|SW|WD|WR	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20024
1.09790778479057e-29	-0.450988869840909	0.162	0.429	1.73063204116538e-25	PET100	Erythrocytes	GSE164551	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20025
1.47826483424587e-29	-1.15558201294246	0.217	0.486	2.33018885822176e-25	RPL36	Erythrocytes	GSE164551	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20026
1.8254839716991e-29	-0.934299182980944	0.078	0.308	2.87751038458929e-25	PPIA	Erythrocytes	GSE164551	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20027
2.67901541177279e-29	-0.845357570391745	0.158	0.421	4.22293199357744e-25	RACK1	Erythrocytes	GSE164551	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20028
4.443511853914e-29	-0.575161561345645	0.088	0.323	7.00430773532463e-25	SUMO2	Erythrocytes	GSE164551	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20029
7.04750043303066e-29	-0.494880631400132	0.136	0.385	1.11089749325862e-24	SLC25A3	Erythrocytes	GSE164551	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20030
9.26530456198084e-29	-0.476244333435583	0.085	0.324	1.46048995810504e-24	SRSF2	Erythrocytes	GSE164551	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20031
9.47442259270676e-29	-0.509388337424166	0.065	0.288	1.49345323328837e-24	UQCRQ	Erythrocytes	GSE164551	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20032
1.04692510704585e-28	-0.447992222233581	0.09	0.324	1.65026804623638e-24	HNRNPM	Erythrocytes	GSE164551	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20033
1.10036675214896e-28	-0.400907829549716	0.075	0.308	1.7345081114124e-24	GNG5	Erythrocytes	GSE164551	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20034
1.13645978840252e-28	0.299256152320805	0.355	0.125	1.79140156445889e-24	RAP1GAP	Erythrocytes	GSE164551	ENSG00000076864	5909	RAP1 GTPase activating protein	KIAA0474|RAP1GA1|RAP1GAP1|RAP1GAPII	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20035
1.17997852561556e-28	-0.79980713797513	0.087	0.314	1.8600001499278e-24	RAN	Erythrocytes	GSE164551	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20036
1.46133833503446e-28	-0.436306015967985	0.051	0.268	2.30350761751483e-24	RPS27L	Erythrocytes	GSE164551	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20037
1.56806750269209e-28	-0.945357080530935	0.217	0.49	2.47174480449354e-24	RPS19	Erythrocytes	GSE164551	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20038
2.08432757319662e-28	-0.641142267575214	0.088	0.317	3.28552555362983e-24	ATP5MPL	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20039
2.58669292641549e-28	-0.430758208139667	0.121	0.37	4.07740405990873e-24	PSMB1	Erythrocytes	GSE164551	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20040
3.63249229362702e-28	0.546518206409184	0.302	0.092	5.72589760244427e-24	HBG1	Erythrocytes	GSE164551	ENSG00000213934	3047	hemoglobin subunit gamma 1	HBG-T2	protein_coding	P69891	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20041
5.92665841316594e-28	-0.480294802267504	0.087	0.315	9.34219165667347e-24	POLR2L	Erythrocytes	GSE164551	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20042
7.52227721947273e-28	-0.401557404657017	0.052	0.268	1.18573655810549e-23	ATP5PO	Erythrocytes	GSE164551	ENSG00000241837	539	ATP synthase peripheral stalk subunit OSCP	ATP5O|ATPO|OSCP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20043
7.60796672739438e-28	0.364395664261399	0.747	0.44	1.19924379523918e-23	ADIPOR1	Erythrocytes	GSE164551	ENSG00000159346	51094	adiponectin receptor 1	ACDCR1|PAQR1	protein_coding	Q96A54	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20044
8.3315365661413e-28	0.36901083400614	0.897	0.682	1.31330010892085e-23	FKBP8	Erythrocytes	GSE164551	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20045
9.84000159803639e-28	-0.534742889869466	0.335	0.585	1.55107945189848e-23	HDGF	Erythrocytes	GSE164551	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20046
1.13702060531404e-27	-0.551460967760514	0.118	0.36	1.79228558015652e-23	RPL31	Erythrocytes	GSE164551	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20047
1.58757168839492e-27	-0.788069909169359	0.203	0.468	2.50248925241691e-23	RPL13A	Erythrocytes	GSE164551	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20048
1.78027318805861e-27	-0.870565426415209	0.095	0.324	2.80624462633679e-23	S100A4	Erythrocytes	GSE164551	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20049
2.16395505242162e-27	-0.518577860942105	0.145	0.384	3.4110423491322e-23	PTGES3	Erythrocytes	GSE164551	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20050
2.49693021370339e-27	-0.982493534490257	0.201	0.462	3.93591109586065e-23	RPL3	Erythrocytes	GSE164551	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20051
2.74142671067615e-27	-1.10308136468453	0.158	0.401	4.32131092403882e-23	RPS5	Erythrocytes	GSE164551	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20052
3.18080826670751e-27	-0.366393305173355	0.054	0.267	5.01390807081106e-23	NDUFB9	Erythrocytes	GSE164551	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20053
3.25046732949649e-27	-0.532201876109826	0.19	0.432	5.12371165148532e-23	COX7B	Erythrocytes	GSE164551	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20054
5.90983428029875e-27	-0.481872062414889	0.178	0.427	9.31567177603491e-23	PTP4A2	Erythrocytes	GSE164551	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20055
7.77711518569897e-27	-0.339670441468561	0.07	0.294	1.22590666672173e-22	NUDT1	Erythrocytes	GSE164551	ENSG00000106268	4521	nudix hydrolase 1	MTH1	protein_coding	P36639	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20056
9.80839394100193e-27	-0.550124681886429	0.096	0.331	1.54609713692013e-22	SMC4	Erythrocytes	GSE164551	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20057
1.00762599708051e-26	-0.894173902106543	0.172	0.422	1.58832085919801e-22	RPSA	Erythrocytes	GSE164551	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20058
1.13699785992856e-26	-0.768790393544098	0.337	0.585	1.79224972660539e-22	NACA	Erythrocytes	GSE164551	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20059
1.33464463728265e-26	-0.416039632702072	0.064	0.281	2.10380034174864e-22	DNAJC9	Erythrocytes	GSE164551	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20060
1.45837144532885e-26	-0.390641143847122	0.07	0.287	2.29883090927186e-22	SEC61G	Erythrocytes	GSE164551	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20061
1.96909788811959e-26	-0.512833818950837	0.103	0.333	3.10388900104291e-22	DEK	Erythrocytes	GSE164551	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20062
2.00554744116145e-26	-0.803879647795422	0.083	0.296	3.16134443150279e-22	NCL	Erythrocytes	GSE164551	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20063
2.27858749197774e-26	-0.592249446734631	0.181	0.422	3.59173746360452e-22	SRP14	Erythrocytes	GSE164551	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20064
2.47194801230205e-26	-0.440096488260259	0.065	0.289	3.89653165179171e-22	TMPO	Erythrocytes	GSE164551	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20065
2.58261583897151e-26	-0.342458524267161	0.057	0.268	4.07097734697078e-22	NDUFB1	Erythrocytes	GSE164551	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20066
2.81869230941832e-26	-0.536070819176613	0.279	0.522	4.44310468733609e-22	PFDN5	Erythrocytes	GSE164551	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20067
2.8783298558928e-26	-0.438464979020109	0.126	0.361	4.53711135184382e-22	H2AFV	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20068
3.03328528114594e-26	-0.538777433993716	0.25	0.48	4.78136758867034e-22	SOD1	Erythrocytes	GSE164551	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20069
3.99212810884863e-26	-0.731203880677269	0.183	0.427	6.2927915379781e-22	RPL27	Erythrocytes	GSE164551	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20070
4.39963204674006e-26	-0.598693266015468	0.056	0.261	6.93513999527636e-22	HSPA8	Erythrocytes	GSE164551	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20071
5.8001288058963e-26	-0.441448243618363	0.105	0.335	9.14274303673434e-22	CALR	Erythrocytes	GSE164551	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20072
6.41745490163939e-26	-0.394562179410691	0.552	0.851	1.01158341614542e-21	HMBS	Erythrocytes	GSE164551	ENSG00000256269	3145	hydroxymethylbilane synthase	PBGD|PORC|UPS	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20073
6.51919843726059e-26	-0.453935565628455	0.059	0.275	1.02762124966539e-21	NUSAP1	Erythrocytes	GSE164551	ENSG00000137804	51203	nucleolar and spindle associated protein 1	ANKT|BM037|FLJ13421|LNP|PRO0310p1|Q0310|SAPL	protein_coding	Q9BXS6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20074
6.94885764028594e-26	-0.452666045674519	0.064	0.274	1.09534842983827e-21	CKS2	Erythrocytes	GSE164551	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20075
7.72648076841352e-26	-0.444043375567452	0.203	0.46	1.21792516352502e-21	ABCB10	Erythrocytes	GSE164551	ENSG00000135776	23456	ATP binding cassette subfamily B member 10	EST20237|M-ABC2|MTABC2	protein_coding	Q9NRK6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20076
9.00451513684009e-26	-0.746941611598481	0.183	0.424	1.4193817210201e-21	RPL4	Erythrocytes	GSE164551	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20077
1.13662215587331e-25	-0.343748919845064	0.064	0.277	1.7916575043031e-21	DDT	Erythrocytes	GSE164551	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20078
1.22024981839655e-25	-0.482801453353882	0.149	0.393	1.92347978873847e-21	COX4I1	Erythrocytes	GSE164551	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20079
1.30695869574043e-25	-1.04722428535777	0.232	0.478	2.06015899209564e-21	RPL5	Erythrocytes	GSE164551	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20080
1.44893125352351e-25	-0.630376622188754	0.103	0.321	2.28395033492911e-21	UQCRH	Erythrocytes	GSE164551	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20081
1.4904684497447e-25	-0.425716727760861	0.067	0.276	2.34942541733257e-21	TUBG1	Erythrocytes	GSE164551	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20082
1.66493801055473e-25	-0.472001476697902	0.196	0.449	2.62444178603742e-21	CYTOR	Erythrocytes	GSE164551	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20083
1.77467713090352e-25	-0.382363887055428	0.203	0.461	2.79742356144322e-21	LEPROT	Erythrocytes	GSE164551	ENSG00000213625	54741	leptin receptor overlapping transcript	FLJ90360|OB-RGRP|OBRGRP|VPS55	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20084
1.85155737798331e-25	0.475311185607122	0.626	0.395	2.91860989491509e-21	GSPT1	Erythrocytes	GSE164551	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20085
1.88480158067633e-25	-0.782651401693006	0.167	0.401	2.97101273162009e-21	RPL23	Erythrocytes	GSE164551	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20086
1.96582008502158e-25	-0.445641057117408	0.075	0.291	3.09872220001952e-21	NUCKS1	Erythrocytes	GSE164551	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20087
2.56264015430129e-25	-0.491685315016306	0.167	0.409	4.03948967522513e-21	XIST	Erythrocytes	GSE164551	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20088
3.59213138336594e-25	-0.443399702353551	0.096	0.311	5.66227669959973e-21	CCT2	Erythrocytes	GSE164551	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20089
3.90504287819134e-25	-0.672135783411419	0.105	0.317	6.155519088893e-21	TMEM14C	Erythrocytes	GSE164551	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20090
4.27587258746524e-25	-0.409301799210957	0.137	0.372	6.74005795962146e-21	AMD1	Erythrocytes	GSE164551	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20091
4.35980788968201e-25	-0.383297403850387	0.09	0.306	6.87236517650575e-21	RAC1	Erythrocytes	GSE164551	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20092
4.92621614794531e-25	-0.354189560559587	0.121	0.353	7.76519451400619e-21	PSMD7	Erythrocytes	GSE164551	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20093
4.93410526941907e-25	-0.495897124541363	0.057	0.258	7.77763013618528e-21	HSP90B1	Erythrocytes	GSE164551	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20094
5.49181902178553e-25	-0.313432991280783	0.049	0.25	8.65675432404053e-21	YWHAH	Erythrocytes	GSE164551	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20095
5.83995485628135e-25	-0.393051280735045	0.059	0.26	9.2055208399563e-21	NDUFB11	Erythrocytes	GSE164551	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20096
6.52813465648621e-25	-0.608280625931925	0.126	0.343	1.02902986590192e-20	SERBP1	Erythrocytes	GSE164551	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20097
8.142606948119e-25	-0.879646333056232	0.539	0.738	1.283519133232e-20	ACTB	Erythrocytes	GSE164551	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20098
8.15748955249632e-25	-0.413606736477804	0.103	0.333	1.28586507815999e-20	SRSF10	Erythrocytes	GSE164551	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20099
9.16584236655355e-25	-0.361638417024247	0.069	0.276	1.44481173223984e-20	EIF5B	Erythrocytes	GSE164551	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20100
9.84022069700177e-25	-0.395667003210567	0.074	0.282	1.55111398846839e-20	MTDH	Erythrocytes	GSE164551	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20101
1.03515499517912e-24	-0.499831153753199	0.098	0.311	1.63171481890084e-20	MPC2	Erythrocytes	GSE164551	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20102
1.06327802432538e-24	-0.477170556342027	0.266	0.53	1.6760451497441e-20	TXNIP	Erythrocytes	GSE164551	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20103
1.37306028829721e-24	-0.481550111517828	0.067	0.272	2.16435493244289e-20	SET	Erythrocytes	GSE164551	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20104
1.81664290731857e-24	-0.333541395432267	0.054	0.251	2.86357421480626e-20	EDF1	Erythrocytes	GSE164551	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20105
1.87845426071383e-24	0.448828862214196	0.621	0.36	2.96100745116321e-20	DCAF12	Erythrocytes	GSE164551	ENSG00000198876	25853	DDB1 and CUL4 associated factor 12	CT102|DKFZP434O125|KIAA1892|MGC1058|TCC52|WDR40A	protein_coding	Q5T6F0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20106
1.97975871737101e-24	-0.433278087371603	0.064	0.262	3.12069366619193e-20	ATP5PF	Erythrocytes	GSE164551	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20107
2.09044317598458e-24	-0.387471439844701	0.096	0.307	3.2951655783045e-20	TRMT112	Erythrocytes	GSE164551	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20108
2.11485066565582e-24	-0.350757391346821	0.057	0.256	3.33363910427326e-20	NDUFC2	Erythrocytes	GSE164551	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20109
2.29566545006665e-24	-0.450991129363553	0.127	0.348	3.61865744894006e-20	COX7A2	Erythrocytes	GSE164551	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20110
2.74008240989877e-24	-0.574088571985042	0.065	0.262	4.31919190272343e-20	NDUFS5	Erythrocytes	GSE164551	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20111
2.76559736709755e-24	-0.331115222165644	0.057	0.257	4.35941112975587e-20	PABPN1	Erythrocytes	GSE164551	ENSG00000100836	8106	poly(A) binding protein nuclear 1	OPMD|PAB2|PABP2	protein_coding	Q86U42	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20112
3.00926381351042e-24	-0.391816753561884	0.114	0.338	4.74350254923648e-20	ITGB1	Erythrocytes	GSE164551	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20113
3.39272445376654e-24	-0.424588961666752	0.072	0.274	5.34795155647219e-20	ATP5MD	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20114
3.50582366875486e-24	-0.409866852656073	0.266	0.506	5.52622984905829e-20	CDC42	Erythrocytes	GSE164551	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20115
3.95332059380196e-24	-0.335295381741308	0.07	0.275	6.23161925201002e-20	NDUFC1	Erythrocytes	GSE164551	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20116
4.07338031417341e-24	-0.364187972028792	0.087	0.298	6.42086938923154e-20	SF3B6	Erythrocytes	GSE164551	ENSG00000115128	51639	splicing factor 3b subunit 6	CGI-110|Ht006|P14|SAP14a|SF3B14a	protein_coding	Q9Y3B4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20117
4.27620185067731e-24	-0.500632428442438	0.095	0.308	6.74057697722265e-20	CFL1	Erythrocytes	GSE164551	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20118
4.3692970172932e-24	-0.354531600604226	0.069	0.271	6.88732288835927e-20	ATP5F1D	Erythrocytes	GSE164551	ENSG00000099624	513	ATP synthase F1 subunit delta	ATP5D	protein_coding	P30049	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20119
5.15544943532003e-24	-0.391646203451201	0.149	0.373	8.12653494489497e-20	SAP18	Erythrocytes	GSE164551	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20120
6.24370430478498e-24	-0.483206363030908	0.436	0.643	9.84195109563257e-20	RBX1	Erythrocytes	GSE164551	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20121
8.33431022981554e-24	-0.416130096927867	0.121	0.335	1.31373732152582e-19	COX5B	Erythrocytes	GSE164551	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20122
8.98043857894414e-24	-0.484937674146862	0.141	0.362	1.41558653319896e-19	BCLAF1	Erythrocytes	GSE164551	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20123
9.77459719267288e-24	0.344387371811664	0.636	0.38	1.54076975548103e-19	STRADB	Erythrocytes	GSE164551	ENSG00000082146	55437	STE20 related adaptor beta	ALS2CR2|CALS-21|ILPIP|ILPIPA|PAPK	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20124
9.79618279251688e-24	-0.997021430239279	0.129	0.347	1.54417229358443e-19	EEF1B2	Erythrocytes	GSE164551	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20125
1.29870344172936e-23	-0.432598163786901	0.096	0.305	2.04714623519799e-19	SRRM1	Erythrocytes	GSE164551	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20126
1.44908611079024e-23	-0.416039632702072	0.072	0.272	2.28419443643865e-19	HNRNPDL	Erythrocytes	GSE164551	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20127
1.67228694958099e-23	-0.350493212707669	0.062	0.259	2.63602591862452e-19	NDUFB4	Erythrocytes	GSE164551	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20128
1.71099079000221e-23	-0.427906226950576	0.062	0.255	2.69703478228048e-19	TUBA1C	Erythrocytes	GSE164551	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20129
2.15535450981849e-23	-0.557852106722924	0.324	0.534	3.39748531382688e-19	GYPB	Erythrocytes	GSE164551	ENSG00000250361	2994	glycophorin B (MNS blood group)	CD235b|GPB|MNS|SS	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20130
3.14146340234029e-23	-0.543941156845748	0.27	0.482	4.951888761109e-19	UBAC1	Erythrocytes	GSE164551	ENSG00000130560	10422	UBA domain containing 1	GBDR1|KPC2|UBADC1	protein_coding	Q9BSL1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20131
3.19745882909765e-23	-1.07418472504096	0.703	0.824	5.04015435230663e-19	RPS12	Erythrocytes	GSE164551	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20132
3.49142212177897e-23	-0.434929115303642	0.139	0.366	5.5035286905602e-19	RAD21	Erythrocytes	GSE164551	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20133
4.08139763713858e-23	-0.345929777085736	0.075	0.276	6.43350709542154e-19	RHOA	Erythrocytes	GSE164551	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20134
4.96776187934069e-23	-0.399064511662681	0.075	0.271	7.83068305040474e-19	SSB	Erythrocytes	GSE164551	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20135
5.20693376192601e-23	-0.516271878826561	0.505	0.733	8.20768968892397e-19	CPEB4	Erythrocytes	GSE164551	ENSG00000113742	80315	cytoplasmic polyadenylation element binding protein 4	KIAA1673	protein_coding	Q17RY0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20136
6.07312134816304e-23	-0.346203272864879	0.092	0.299	9.57306118110939e-19	EIF1AX	Erythrocytes	GSE164551	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20137
7.48452742108126e-23	-0.354321822393649	0.072	0.268	1.17978605738504e-18	U2SURP	Erythrocytes	GSE164551	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20138
7.5494641993298e-23	-0.445105901696331	0.106	0.315	1.19002204174036e-18	PFN1	Erythrocytes	GSE164551	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20139
8.36525160794746e-23	-0.417016398015026	0.072	0.265	1.31861461096076e-18	YWHAE	Erythrocytes	GSE164551	ENSG00000274474	7531	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon	FLJ45465	protein_coding	P62258	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20140
8.38544991988381e-23	-0.343072291798038	0.121	0.339	1.32179847087129e-18	MORF4L1	Erythrocytes	GSE164551	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20141
1.011172481694e-22	-0.36979339180494	0.108	0.321	1.59391118289425e-18	SLC38A2	Erythrocytes	GSE164551	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20142
1.16278431953102e-22	-0.506624315408035	0.078	0.272	1.83289692287675e-18	SLIRP	Erythrocytes	GSE164551	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20143
1.21348593289331e-22	-0.406172046538954	0.165	0.397	1.91281787601972e-18	EEF1D	Erythrocytes	GSE164551	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20144
1.39291590212769e-22	-0.51889717374468	0.288	0.503	2.19565333652388e-18	CHCHD2	Erythrocytes	GSE164551	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20145
1.49630052501079e-22	-0.436107964345185	0.181	0.404	2.35861851757452e-18	SUCO	Erythrocytes	GSE164551	ENSG00000094975	51430	SUN domain containing ossification factor	C1orf9|CH1|OPT|SLP1	protein_coding	Q9UBS9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20146
1.79116178025353e-22	-0.396232692271203	0.162	0.389	2.82340831421364e-18	PCM1	Erythrocytes	GSE164551	ENSG00000078674	5108	pericentriolar material 1	PTC4	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20147
2.94565396830421e-22	-0.45531791661068	0.167	0.38	4.64323435023793e-18	HNRNPC	Erythrocytes	GSE164551	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20148
3.0998407059611e-22	-0.35023164215147	0.111	0.325	4.88627890480648e-18	MAZ	Erythrocytes	GSE164551	ENSG00000103495	4150	MYC associated zinc finger protein	Pur-1|ZF87|Zif87|ZNF801	protein_coding	P56270	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20149
3.41604017633286e-22	-0.361940796634305	0.15	0.372	5.38470412995348e-18	EIF4G2	Erythrocytes	GSE164551	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20150
3.43249259459465e-22	-0.316030248481266	0.183	0.424	5.41063807685955e-18	HLA-C	Erythrocytes	GSE164551	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20151
4.99550342620181e-22	-0.329044584628733	0.078	0.273	7.87441205072192e-18	ENY2	Erythrocytes	GSE164551	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20152
5.21017615352077e-22	-0.368019077178528	0.072	0.262	8.21280067079479e-18	SNRPB	Erythrocytes	GSE164551	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20153
6.05261863585602e-22	-0.475129511624438	0.123	0.335	9.54074275569984e-18	LBR	Erythrocytes	GSE164551	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20154
6.39823617529527e-22	-0.302804826142266	0.085	0.282	1.00855396831179e-17	NDUFA3	Erythrocytes	GSE164551	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20155
7.2205650670574e-22	-0.420953618197648	0.119	0.323	1.13817767152026e-17	HNRNPD	Erythrocytes	GSE164551	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20156
8.27480909131578e-22	-0.434984322193045	0.219	0.427	1.30435815706411e-17	UBL5	Erythrocytes	GSE164551	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20157
1.39165453466591e-21	-0.444269621378871	0.333	0.555	2.19366504299388e-17	PA2G4	Erythrocytes	GSE164551	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20158
1.86823512933141e-21	-0.450708026291786	0.085	0.275	2.9448990343651e-17	EIF3A	Erythrocytes	GSE164551	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20159
1.92960825358527e-21	-0.40794905274572	0.154	0.366	3.04164149012646e-17	RBM25	Erythrocytes	GSE164551	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20160
2.54602826925839e-21	-0.367625215428965	0.144	0.365	4.01330436083199e-17	SRSF11	Erythrocytes	GSE164551	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20161
2.59349930821046e-21	-0.36109154315522	0.193	0.422	4.08813295953215e-17	CLTC	Erythrocytes	GSE164551	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20162
2.81357398905888e-21	-0.380879915442574	0.265	0.495	4.43503667895352e-17	TRA2B	Erythrocytes	GSE164551	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20163
3.20144450470204e-21	-0.460155380243771	0.1	0.311	5.04643697276183e-17	MKI67	Erythrocytes	GSE164551	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20164
3.91682320574354e-21	-0.296719076759734	0.075	0.262	6.17408841921354e-17	PSMB6	Erythrocytes	GSE164551	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20165
4.32538502357453e-21	-0.497609913836521	0.106	0.307	6.81810441266053e-17	UBE2S	Erythrocytes	GSE164551	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20166
4.58862779769891e-21	-0.370295895345768	0.103	0.301	7.23305399751279e-17	SREK1	Erythrocytes	GSE164551	ENSG00000153914	140890	splicing regulatory glutamic acid and lysine rich protein 1	DKFZp564B176|SFRS12|SRrp508|SRrp86	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20167
7.40142938832766e-21	-0.328169534537681	0.07	0.253	1.16668731448209e-16	TCP1	Erythrocytes	GSE164551	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20168
9.08788144668356e-21	-0.366260778405134	0.069	0.252	1.43252275244073e-16	H2AFY	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20169
1.00480422529615e-20	-0.373518716468071	0.332	0.562	1.58387290033433e-16	SON	Erythrocytes	GSE164551	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20170
1.07679975720825e-20	-0.60316918329887	0.147	0.344	1.69735945728737e-16	HNRNPA1	Erythrocytes	GSE164551	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20171
1.21437634020249e-20	-0.433275384470586	0.458	0.701	1.91422142506119e-16	TOP1	Erythrocytes	GSE164551	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20172
1.26182323898452e-20	-0.78019543812491	0.155	0.364	1.9890119716113e-16	RPL10A	Erythrocytes	GSE164551	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20173
1.26468651128297e-20	-0.336717945466972	0.175	0.412	1.99352534773535e-16	HLA-B	Erythrocytes	GSE164551	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20174
1.34068005021079e-20	-0.363094816961459	0.178	0.392	2.11331396314727e-16	SF3B1	Erythrocytes	GSE164551	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20175
1.39595956497316e-20	-0.379766666837611	0.255	0.476	2.20045106226719e-16	TMBIM6	Erythrocytes	GSE164551	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20176
1.71733194508454e-20	-0.412470194148387	0.144	0.337	2.70703034503676e-16	SMIM1	Erythrocytes	GSE164551	ENSG00000235169	388588	small integral membrane protein 1 (Vel blood group)	Vel	protein_coding	B2RUZ4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20177
2.97694662711353e-20	-0.324346626968986	0.108	0.304	4.69256096831906e-16	GCLM	Erythrocytes	GSE164551	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20178
4.1750273960501e-20	-0.315216766808526	0.075	0.261	6.58109568439377e-16	MIS18BP1	Erythrocytes	GSE164551	ENSG00000129534	55320	MIS18 binding protein 1	C14orf106|FLJ11186|KIAA1903|KNL2|M18BP1	protein_coding	Q6P0N0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20179
4.66604493022743e-20	-0.318120237933176	0.082	0.265	7.3550866235175e-16	COX8A	Erythrocytes	GSE164551	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20180
4.82906967390934e-20	-0.282491960143037	0.08	0.262	7.61206252698329e-16	SNW1	Erythrocytes	GSE164551	ENSG00000100603	22938	SNW domain containing 1	Bx42|FUN20|NCoA-62|Prp45|PRPF45|SKIIP|SKIP|SKIP1	protein_coding	Q13573	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20181
5.15300988531683e-20	-0.364860155593711	0.082	0.264	8.12268948222493e-16	SLC25A6	Erythrocytes	GSE164551	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20182
7.25643638836808e-20	-0.448234596940018	0.307	0.517	1.14383206789846e-15	EIF1B	Erythrocytes	GSE164551	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20183
7.29459169167123e-20	-0.384015632886786	0.224	0.454	1.14984648835814e-15	HLA-A	Erythrocytes	GSE164551	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20184
8.31299954444149e-20	-0.288304682754917	0.077	0.26	1.31037811819031e-15	PRPF40A	Erythrocytes	GSE164551	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20185
8.38595679237513e-20	-0.285828199849065	0.074	0.251	1.32187836918209e-15	NEDD8	Erythrocytes	GSE164551	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20186
9.01572784460598e-20	-0.426796296316892	0.116	0.313	1.42114918014524e-15	PTTG1	Erythrocytes	GSE164551	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20187
9.68332470555585e-20	0.361866922964425	0.944	0.835	1.52638247333677e-15	ALAS2	Erythrocytes	GSE164551	ENSG00000158578	212	5'-aminolevulinate synthase 2	ALAS-E|ASB	protein_coding	P22557	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20188
1.2070912522769e-19	-0.306414850777261	0.428	0.683	1.90273794096407e-15	ZNF451	Erythrocytes	GSE164551	ENSG00000112200	26036	zinc finger protein 451	COASTER|dJ417I1.1|KIAA0576|KIAA1702|ZATT	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20189
1.28503871075392e-19	-0.747899104294704	0.814	0.829	2.0256065197614e-15	PRDX2	Erythrocytes	GSE164551	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20190
2.18248606818094e-19	-0.353564429857293	0.147	0.354	3.44025278927361e-15	HNRNPH3	Erythrocytes	GSE164551	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20191
2.39695465257477e-19	-1.28925220611035	0.358	0.555	3.77831961885362e-15	RPS2	Erythrocytes	GSE164551	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20192
2.47143881354003e-19	-0.321892330864116	0.082	0.262	3.89572900178314e-15	WSB1	Erythrocytes	GSE164551	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20193
3.30815054095882e-19	-0.364287608936924	0.208	0.409	5.21463769771339e-15	AP2S1	Erythrocytes	GSE164551	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20194
3.70369152444784e-19	-0.352353843415003	0.209	0.416	5.83812894998713e-15	TCEA1	Erythrocytes	GSE164551	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20195
4.07490421494754e-19	-0.373453867983643	0.142	0.342	6.42327151402181e-15	KLF13	Erythrocytes	GSE164551	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20196
4.47785852544473e-19	-0.54807107502725	0.1	0.282	7.05844839365853e-15	HINT1	Erythrocytes	GSE164551	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20197
4.90786009647433e-19	-0.328309367376557	0.085	0.263	7.73625987007248e-15	ARGLU1	Erythrocytes	GSE164551	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20198
5.38424550952212e-19	-0.392467490075261	0.216	0.421	8.48718619665971e-15	MBOAT2	Erythrocytes	GSE164551	ENSG00000143797	129642	membrane bound O-acyltransferase domain containing 2	FLJ14415|FLJ90298|LPLAT13|OACT2	protein_coding	Q6ZWT7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20199
8.25747343348644e-19	-0.533113204891961	0.211	0.396	1.30162553732047e-14	EIF5A	Erythrocytes	GSE164551	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20200
9.6657940838271e-19	-0.280441220578274	0.078	0.253	1.52361912143367e-14	EID1	Erythrocytes	GSE164551	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20201
1.10220502139676e-18	-0.307064478184123	0.09	0.267	1.73740577522771e-14	TOMM20	Erythrocytes	GSE164551	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20202
1.1523504472107e-18	-0.312979217061382	0.113	0.301	1.81645000993823e-14	NDUFA1	Erythrocytes	GSE164551	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20203
1.22557657941205e-18	-0.35274834049078	0.092	0.265	1.93187636212722e-14	BOLA3	Erythrocytes	GSE164551	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20204
1.43139098256086e-18	-0.45170198287892	0.113	0.289	2.25630160581069e-14	NME4	Erythrocytes	GSE164551	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20205
1.64757743798476e-18	-0.292886962880081	0.093	0.27	2.59707631549538e-14	C11orf58	Erythrocytes	GSE164551	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20206
1.65084579298656e-18	-0.441960290010739	0.448	0.649	2.60222822348471e-14	STOM	Erythrocytes	GSE164551	ENSG00000148175	2040	stomatin	BND7|EPB7|EPB72	protein_coding	P27105	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20207
1.86561968851102e-18	-0.450526673006782	0.645	0.787	2.94077631499993e-14	SEC62	Erythrocytes	GSE164551	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20208
2.20865159299822e-18	-0.307067281703042	0.101	0.283	3.4814975060431e-14	USP14	Erythrocytes	GSE164551	ENSG00000101557	9097	ubiquitin specific peptidase 14	TGT|Ubp6	protein_coding	P54578	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20209
2.62149668413739e-18	-0.400036538257608	0.131	0.323	4.13226522320577e-14	FUS	Erythrocytes	GSE164551	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20210
2.79537258777797e-18	-0.311808837507167	0.157	0.35	4.40634581011441e-14	SLC38A5	Erythrocytes	GSE164551	ENSG00000017483	92745	solute carrier family 38 member 5	JM24|SN2	protein_coding	Q8WUX1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20211
3.1057794818717e-18	-0.322539359512199	0.103	0.281	4.89564019727436e-14	EIF2S2	Erythrocytes	GSE164551	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20212
3.22805402990215e-18	-0.365224049729316	0.361	0.59	5.08838156733476e-14	GADD45A	Erythrocytes	GSE164551	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20213
3.36945448586117e-18	0.279488453316645	0.513	0.301	5.31127110606296e-14	GMPR	Erythrocytes	GSE164551	ENSG00000137198	2766	guanosine monophosphate reductase	NA	protein_coding	P36959	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20214
3.66420994443435e-18	-0.320049956565873	0.103	0.285	5.77589413541187e-14	RBM3	Erythrocytes	GSE164551	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20215
4.16671266272619e-18	-0.419779031891426	0.168	0.36	6.56798917025529e-14	EEF2	Erythrocytes	GSE164551	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20216
5.42327682578166e-18	-0.365480709607125	0.132	0.314	8.54871126047963e-14	PRDX1	Erythrocytes	GSE164551	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20217
5.45031753393116e-18	-0.368884636390257	0.286	0.508	8.59133552873568e-14	ABHD5	Erythrocytes	GSE164551	ENSG00000011198	51099	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	CGI-58|NCIE2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20218
6.12556376383566e-18	-0.369878413759816	0.181	0.383	9.65572616093415e-14	CCNL1	Erythrocytes	GSE164551	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20219
6.4758836000447e-18	0.289589055870875	0.69	0.443	1.02079353187505e-13	RNF10	Erythrocytes	GSE164551	ENSG00000022840	9921	ring finger protein 10	KIAA0262|RIE2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20220
6.71210357896251e-18	0.347751190673279	0.9	0.64	1.05802888715186e-13	BNIP3L	Erythrocytes	GSE164551	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20221
8.11139812835157e-18	-0.357760595519409	0.208	0.399	1.27859968697206e-13	COX6B1	Erythrocytes	GSE164551	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20222
1.57031479826164e-17	-0.339026530639583	0.147	0.335	2.47528721649982e-13	PNISR	Erythrocytes	GSE164551	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20223
1.97066684873838e-17	-0.330094974383126	0.165	0.358	3.10636215366631e-13	SRSF5	Erythrocytes	GSE164551	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20224
2.11482832336049e-17	-0.322050706098901	0.137	0.317	3.33360388611314e-13	PSMD6	Erythrocytes	GSE164551	ENSG00000163636	9861	proteasome 26S subunit, non-ATPase 6	KIAA0107|p44S10|Rpn7|S10	protein_coding	Q15008	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20225
2.30633954124632e-17	-0.33416489710148	0.181	0.377	3.63548301886657e-13	VAPA	Erythrocytes	GSE164551	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20226
2.65539230431339e-17	-0.358647782843793	0.144	0.329	4.18569488928919e-13	DNAJB6	Erythrocytes	GSE164551	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20227
2.70082284336226e-17	-0.374053786544051	0.155	0.34	4.25730704799193e-13	DNAJA4	Erythrocytes	GSE164551	ENSG00000140403	55466	DnaJ heat shock protein family (Hsp40) member A4	PRO1472	protein_coding	Q8WW22	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20228
3.96145174158525e-17	-0.319364596184455	0.515	0.763	6.24443638026083e-13	SLC2A1	Erythrocytes	GSE164551	ENSG00000117394	6513	solute carrier family 2 member 1	CSE|DYT18|DYT9|GLUT|GLUT-1|GLUT1|HTLVR	protein_coding	P11166	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20229
4.50378363545121e-17	-0.336794010033172	0.123	0.296	7.09931414456174e-13	UGCG	Erythrocytes	GSE164551	ENSG00000148154	7357	UDP-glucose ceramide glucosyltransferase	GCS	protein_coding	Q16739	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20230
6.17877803904142e-17	-0.306835722862737	0.132	0.31	9.73960782294098e-13	ARPC3	Erythrocytes	GSE164551	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20231
7.97812473294154e-17	-0.300850119026803	0.214	0.416	1.25759180165357e-12	E2F4	Erythrocytes	GSE164551	ENSG00000205250	1874	E2F transcription factor 4	E2F-4	protein_coding	Q16254	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20232
9.05687416309256e-17	-0.376064728128682	0.225	0.423	1.42763507432828e-12	RAP2B	Erythrocytes	GSE164551	ENSG00000181467	5912	RAP2B, member of RAS oncogene family	NA	protein_coding	P61225	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20233
9.81576306754443e-17	-0.529164647711366	0.15	0.339	1.54725873233703e-12	TMSB10	Erythrocytes	GSE164551	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20234
1.09556597808478e-16	-0.284009515381897	0.095	0.266	1.72694065125504e-12	PPIG	Erythrocytes	GSE164551	ENSG00000138398	9360	peptidylprolyl isomerase G	CARS-Cyp|SCAF10|SRCyp	protein_coding	Q13427	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20235
1.24786183464111e-16	-0.297366725467408	0.108	0.277	1.96700460994479e-12	RBM8A	Erythrocytes	GSE164551	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20236
1.24939459470458e-16	0.282336264396956	0.43	0.23	1.96942069963284e-12	LYL1	Erythrocytes	GSE164551	ENSG00000104903	4066	LYL1 basic helix-loop-helix family member	bHLHa18	protein_coding	P12980	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20237
1.35588093494397e-16	-0.272440938593409	0.105	0.277	2.13727511775219e-12	CAPZA2	Erythrocytes	GSE164551	ENSG00000198898	830	capping actin protein of muscle Z-line subunit alpha 2	CAPPA2|CAPZ	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20238
1.39631585773849e-16	-0.326220087638633	0.113	0.288	2.20101268655318e-12	ANP32E	Erythrocytes	GSE164551	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20239
1.45391513846559e-16	-0.312097847291752	0.201	0.386	2.29180643276331e-12	AP2M1	Erythrocytes	GSE164551	ENSG00000161203	1173	adaptor related protein complex 2 subunit mu 1	AP50|CLAPM1|mu2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20240
1.50026991075089e-16	-0.47054648877427	0.982	0.899	2.36487546031662e-12	SLC25A37	Erythrocytes	GSE164551	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20241
1.52501518804313e-16	-0.339085579085282	0.219	0.42	2.40388144091239e-12	SERINC1	Erythrocytes	GSE164551	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20242
1.55011986690251e-16	-0.329203695837771	0.124	0.299	2.44345394619842e-12	ATP6V0A1	Erythrocytes	GSE164551	ENSG00000033627	535	ATPase H+ transporting V0 subunit a1	a1|ATP6N1|ATP6N1A|Stv1|Vph1|VPP1	protein_coding	Q93050	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20243
1.78396699219939e-16	-0.420604462602624	0.131	0.307	2.81206716980391e-12	RPS10	Erythrocytes	GSE164551	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20244
2.00160174534454e-16	-0.364925855126321	0.381	0.555	3.1551248311866e-12	SKP1	Erythrocytes	GSE164551	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20245
2.11644507809739e-16	-0.379029613563323	0.178	0.349	3.33615237660491e-12	ATP5F1B	Erythrocytes	GSE164551	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20246
2.12264324475697e-16	-0.26500575157071	0.105	0.277	3.3459225467104e-12	EWSR1	Erythrocytes	GSE164551	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20247
2.20379564845088e-16	-0.287820750943872	0.137	0.316	3.47384308065312e-12	NDFIP1	Erythrocytes	GSE164551	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20248
3.28438724030346e-16	-0.296631055130512	0.092	0.253	5.17717960689035e-12	PLIN2	Erythrocytes	GSE164551	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20249
3.46675268626827e-16	-0.355441244418024	0.176	0.357	5.46464225936468e-12	PIGQ	Erythrocytes	GSE164551	ENSG00000007541	9091	phosphatidylinositol glycan anchor biosynthesis class Q	GPI1|hGPI1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20250
3.65172118966107e-16	-0.354309274928104	0.154	0.335	5.75620811126274e-12	CALM3	Erythrocytes	GSE164551	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20251
3.65419713368048e-16	-0.330355240264984	0.245	0.433	5.76011094182053e-12	TFDP2	Erythrocytes	GSE164551	ENSG00000114126	7029	transcription factor Dp-2	Dp-2	protein_coding	Q14188	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20252
3.98407773468014e-16	-0.362549566014915	0.168	0.348	6.2801017331763e-12	PRPF4B	Erythrocytes	GSE164551	ENSG00000112739	8899	pre-mRNA processing factor 4B	KIAA0536|PR4H|Prp4	protein_coding	Q13523	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20253
4.08177713448201e-16	-0.284818262782349	0.096	0.262	6.43410529708399e-12	EIF3B	Erythrocytes	GSE164551	ENSG00000106263	8662	eukaryotic translation initiation factor 3 subunit B	EIF3S9|PRT1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20254
4.1895794564438e-16	-0.346517115155802	0.431	0.631	6.60403409719236e-12	USP15	Erythrocytes	GSE164551	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20255
4.5686936634423e-16	-0.286785589924524	0.19	0.376	7.2016318216841e-12	MYL12B	Erythrocytes	GSE164551	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20256
5.87341178483329e-16	-0.289243002134116	0.173	0.356	9.25825899643272e-12	MBNL1	Erythrocytes	GSE164551	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20257
7.40506636407371e-16	-0.341367256671787	0.154	0.332	1.16726061096894e-11	IRF2BP2	Erythrocytes	GSE164551	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20258
8.90355155444338e-16	-0.303047563422308	0.212	0.398	1.40346683152691e-11	NAP1L4	Erythrocytes	GSE164551	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20259
9.95783087141181e-16	-0.3216811282541	0.137	0.312	1.56965288026064e-11	CD47	Erythrocytes	GSE164551	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20260
1.07328341006069e-15	-0.265119895334117	0.1	0.262	1.69181663927866e-11	ATG3	Erythrocytes	GSE164551	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20261
1.15366377696716e-15	-0.284442120154513	0.101	0.262	1.81852021163334e-11	DHX9	Erythrocytes	GSE164551	ENSG00000135829	1660	DExH-box helicase 9	DDX9|LKP|RHA	protein_coding	Q08211	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20262
1.43814392305637e-15	-0.387980871268253	0.281	0.46	2.26694626591375e-11	TFDP1	Erythrocytes	GSE164551	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20263
1.78222898525057e-15	-0.574793211434421	0.219	0.394	2.80932754945048e-11	ARL6IP1	Erythrocytes	GSE164551	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20264
2.05652740159966e-15	-0.303187894212357	0.154	0.327	3.24170414314154e-11	TFR2	Erythrocytes	GSE164551	ENSG00000106327	7036	transferrin receptor 2	HFE3|TFRC2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20265
2.33202505671192e-15	-0.343738206283846	0.391	0.603	3.675971096895e-11	RB1CC1	Erythrocytes	GSE164551	ENSG00000023287	9821	RB1 inducible coiled-coil 1	ATG17|Cc1|DRAGOU14|FIP200|KIAA0203|PPP1R131	protein_coding	Q8TDY2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20266
2.74914126022865e-15	-0.278790836584032	0.121	0.287	4.33347136849842e-11	PRKAR2B	Erythrocytes	GSE164551	ENSG00000284096	5577	protein kinase cAMP-dependent type II regulatory subunit beta	PRKAR2	protein_coding	P31323	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20267
3.27683674240618e-15	-0.364850603148585	0.119	0.281	5.16527775705487e-11	RPL36A	Erythrocytes	GSE164551	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20268
4.4304791185468e-15	-0.398798131815782	0.338	0.509	6.98376423456533e-11	MTRNR2L12	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20269
7.13914850089259e-15	-0.287731818213964	0.098	0.25	1.1253439781957e-10	ILF3	Erythrocytes	GSE164551	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20270
8.29122920803088e-15	-0.318695402522302	0.108	0.267	1.30694646006191e-10	SUZ12	Erythrocytes	GSE164551	ENSG00000178691	23512	SUZ12 polycomb repressive complex 2 subunit	CHET9|JJAZ1|KIAA0160	protein_coding	Q15022	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20271
8.68496365404627e-15	-0.280929594549586	0.139	0.308	1.36901082078731e-10	ZNF207	Erythrocytes	GSE164551	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20272
1.46082596715842e-14	-0.268541760433727	0.118	0.275	2.30269997203181e-10	PAPOLA	Erythrocytes	GSE164551	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20273
1.76555410757698e-14	-0.256450169054426	0.114	0.271	2.78304293977359e-10	NDUFA2	Erythrocytes	GSE164551	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20274
1.83507766430204e-14	0.285059266083779	0.812	0.687	2.8926329222393e-10	OAZ1	Erythrocytes	GSE164551	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20275
2.45878222349241e-14	-0.265250747061807	0.144	0.311	3.87577841889108e-10	AMMECR1	Erythrocytes	GSE164551	ENSG00000101935	9949	AMMECR nuclear protein 1	NA	protein_coding	Q9Y4X0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20276
3.12232570968584e-14	-0.321713456226604	0.234	0.411	4.92172201617779e-10	SOX6	Erythrocytes	GSE164551	ENSG00000110693	55553	SRY-box transcription factor 6	NA	protein_coding	P35712	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20277
3.59457373521298e-14	-0.42233230069107	0.832	0.844	5.66612657881622e-10	ATP5F1E	Erythrocytes	GSE164551	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20278
3.64673414803786e-14	-0.334253969957282	0.25	0.43	5.74834703755208e-10	FRYL	Erythrocytes	GSE164551	ENSG00000075539	285527	FRY like transcription coactivator	AF4p12|DKFZp686E205|KIAA0826|MOR2	protein_coding	O94915	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20279
4.22365523088158e-14	-0.296038757954531	0.127	0.282	6.65774774043864e-10	EIF3K	Erythrocytes	GSE164551	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20280
5.48218715949858e-14	-0.311857515534701	0.17	0.334	8.64157161951762e-10	HIPK1	Erythrocytes	GSE164551	ENSG00000163349	204851	homeodomain interacting protein kinase 1	KIAA0630|MGC26642|MGC33446|MGC33548|Myak|Nbak2	protein_coding	Q86Z02	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20281
8.7685211725862e-14	-0.257143567941761	0.225	0.403	1.38218199243476e-09	ARF1	Erythrocytes	GSE164551	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20282
1.00681017355011e-13	-0.4183012682566	0.25	0.407	1.58703487656704e-09	OST4	Erythrocytes	GSE164551	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20283
1.13401930260976e-13	-0.270954138378456	0.209	0.38	1.78755462670377e-09	CSDE1	Erythrocytes	GSE164551	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20284
1.18082729380787e-13	-0.308366236491926	0.217	0.389	1.86133806322934e-09	RHCE	Erythrocytes	GSE164551	ENSG00000188672	6006	Rh blood group CcEe antigens	CD240CE|RH	protein_coding	P18577	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20285
1.26728567549791e-13	-0.276362194699873	0.137	0.293	1.99762241028735e-09	ALAD	Erythrocytes	GSE164551	ENSG00000148218	210	aminolevulinate dehydratase	ALADH|PBGS	protein_coding	P13716	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20286
3.32693427940427e-13	0.271899858573684	0.73	0.528	5.24424650462494e-09	BCL2L1	Erythrocytes	GSE164551	ENSG00000171552	598	BCL2 like 1	Bcl-X|bcl-xL|bcl-xS|BCL2L|BCLX|PPP1R52	protein_coding	Q07817	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20287
3.88452176564961e-13	-0.264686825007903	0.162	0.323	6.12317165919348e-09	PPDPF	Erythrocytes	GSE164551	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20288
1.17240115282281e-12	-0.265847092529627	0.33	0.511	1.8480559371946e-08	AC100835.2	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20289
1.43965569858581e-12	-0.279697060622562	0.194	0.351	2.26932927768081e-08	ODC1	Erythrocytes	GSE164551	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20290
1.73765105898058e-12	-0.260413852779632	0.167	0.327	2.73905936427109e-08	PHIP	Erythrocytes	GSE164551	ENSG00000146247	55023	pleckstrin homology domain interacting protein	BRWD2|DCAF14|FLJ20705|ndrp|WDR11	protein_coding	Q8WWQ0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20291
2.35339978065697e-12	-0.263566110208839	0.369	0.537	3.70966407424958e-08	ITM2B	Erythrocytes	GSE164551	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20292
2.40203609872562e-12	-0.305804845412443	0.243	0.408	3.78632950242119e-08	BSDC1	Erythrocytes	GSE164551	ENSG00000160058	55108	BSD domain containing 1	FLJ10276|RP4-811H24.7	protein_coding	Q9NW68	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20293
2.76184798764329e-12	-0.250357537145626	0.384	0.578	4.35350098292212e-08	KLF3	Erythrocytes	GSE164551	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20294
3.23869699578996e-12	-0.30682399900105	0.188	0.343	5.10515807446372e-08	CLK1	Erythrocytes	GSE164551	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20295
6.36248227032251e-12	-0.263681492404823	0.247	0.415	1.00291808027094e-07	DDX6	Erythrocytes	GSE164551	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20296
7.26432159850077e-12	-0.287784580028603	0.56	0.697	1.14507501357168e-07	RAD23A	Erythrocytes	GSE164551	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20297
7.3948665182824e-12	-0.305927289376446	0.265	0.411	1.16565280927685e-07	ST13	Erythrocytes	GSE164551	ENSG00000100380	6767	ST13 Hsp70 interacting protein	FAM10A1|HIP|HSPABP1|P48|SNC6	protein_coding	P50502	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20298
1.37968636309869e-11	-0.256884423361085	0.243	0.409	2.17479961415246e-07	DDX3X	Erythrocytes	GSE164551	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20299
1.41739665899322e-11	-0.279441085327899	0.243	0.398	2.23424235357101e-07	SPECC1	Erythrocytes	GSE164551	ENSG00000128487	92521	sperm antigen with calponin homology and coiled-coil domains 1	CYTSB|FLJ36955|HCMOGT-1|NSP	protein_coding	Q5M775	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20300
1.94677230053704e-11	-0.260258206111064	0.157	0.301	3.06869717733653e-07	PTMS	Erythrocytes	GSE164551	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20301
2.0190512496687e-11	-0.262272284822468	0.132	0.269	3.18263048485278e-07	EHBP1L1	Erythrocytes	GSE164551	ENSG00000173442	254102	EH domain binding protein 1 like 1	DKFZp762C186|TANGERIN	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20302
2.2354940570599e-11	-0.272361659129417	0.292	0.44	3.52380928214352e-07	TMEM59	Erythrocytes	GSE164551	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20303
2.34163521340853e-11	-0.271012463257318	0.165	0.309	3.69111958689586e-07	PSAP	Erythrocytes	GSE164551	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20304
2.69175657439017e-11	-0.294220762788361	0.186	0.335	4.24301588821122e-07	HSPA5	Erythrocytes	GSE164551	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20305
3.19809550085118e-11	-0.29597605266687	0.288	0.445	5.04115793799171e-07	SLC7A5	Erythrocytes	GSE164551	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20306
3.22337856135168e-11	-0.252765863336542	0.342	0.506	5.08101162625865e-07	NARF	Erythrocytes	GSE164551	ENSG00000141562	26502	nuclear prelamin A recognition factor	DKFZp434G0420|FLJ10067|IOP2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20307
8.28414962527655e-11	-0.27039856233899	0.188	0.337	1.30583050543234e-06	CTSL	Erythrocytes	GSE164551	ENSG00000135047	1514	cathepsin L	CTSL1|FLJ31037	protein_coding	P07711	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20308
9.04641022819526e-11	-0.282086509415745	0.508	0.641	1.42598564427042e-06	PRDX6	Erythrocytes	GSE164551	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20309
9.19076409276735e-11	-0.266739140969012	0.201	0.349	1.44874014394292e-06	CD44	Erythrocytes	GSE164551	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20310
1.10267670452074e-10	-0.260112518098888	0.237	0.383	1.73814928933605e-06	UQCR11	Erythrocytes	GSE164551	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20311
1.46632188439049e-10	-0.302338361825366	0.448	0.549	2.31136318636473e-06	ELOB	Erythrocytes	GSE164551	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20312
4.59031987298157e-10	-0.262791956452349	0.188	0.321	7.23572121578085e-06	MZT2B	Erythrocytes	GSE164551	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20313
9.99152973062341e-10	-0.25641508704436	0.268	0.415	1.57496483143817e-05	XPO7	Erythrocytes	GSE164551	ENSG00000130227	23039	exportin 7	EXP7|KIAA0745|RANBP16	protein_coding	Q9UIA9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20314
1.90328951417226e-09	-0.254191010711788	0.134	0.25	3.00015526118973e-05	KIAA1551	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20315
2.29951539999199e-09	-0.259070160585847	0.168	0.295	3.62472612500738e-05	YPEL5	Erythrocytes	GSE164551	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20316
3.80964072820001e-09	-0.309637076873629	0.299	0.441	6.00513667986168e-05	GPCPD1	Erythrocytes	GSE164551	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20317
6.47681555688856e-09	-0.256506711700607	0.279	0.414	0.000102094043623234	TRAK2	Erythrocytes	GSE164551	ENSG00000115993	66008	trafficking kinesin protein 2	ALS2CR3|CALS-C|GRIF-1|KIAA0549|MILT2|OIP98	protein_coding	O60296	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20318
7.45028130386065e-09	-0.274505069246746	0.541	0.636	0.000117438784192755	SNX3	Erythrocytes	GSE164551	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20319
1.19286994611293e-08	-0.251365220806858	0.229	0.354	0.000188032089605781	TMEM56	Erythrocytes	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20320
1.31486965380007e-08	-0.287442140512388	0.25	0.372	0.000207262903528505	REXO2	Erythrocytes	GSE164551	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20321
1.43500214885571e-08	-0.283142536956619	0.895	0.872	0.000226199388724126	UBA52	Erythrocytes	GSE164551	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20322
2.78853509296563e-08	-0.322011768504012	0.796	0.787	0.000439556786704172	SERF2	Erythrocytes	GSE164551	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20323
7.59589027403189e-08	-0.250514551362544	0.382	0.524	0.00119734018389565	EP300	Erythrocytes	GSE164551	ENSG00000100393	2033	E1A binding protein p300	KAT3B|p300	protein_coding	Q09472	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20324
1.37936979567241e-07	-0.252437214269054	0.209	0.323	0.00217430060891842	GOLGA4	Erythrocytes	GSE164551	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20325
1.91541119170013e-07	-0.250872775642038	0.703	0.75	0.00301926266147691	MYL6	Erythrocytes	GSE164551	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20326
2.26753177835608e-07	-0.282927224638502	0.373	0.478	0.00357431034222269	EMC3	Erythrocytes	GSE164551	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20327
3.17090002584862e-07	-0.597518484572185	0.828	0.781	0.00499828971074519	HBM	Erythrocytes	GSE164551	ENSG00000206177	3042	hemoglobin subunit mu	HBAP2|HBK	protein_coding	Q6B0K9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20328
6.17569893237018e-07	-0.333864320458723	0.936	0.909	0.00973475422709511	HBD	Erythrocytes	GSE164551	ENSG00000223609	3045	hemoglobin subunit delta	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20329
1.59191448606117e-06	-0.288431060314039	0.513	0.584	0.0250933480437822	TUBB2A	Erythrocytes	GSE164551	ENSG00000137267	7280	tubulin beta 2A class IIa	dJ40E16.7|TUBB|TUBB2	protein_coding	Q13885	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20330
1.58558667847569e-50	2.66365092861052	0.714	0.176	2.49936028128123e-46	GNLY	CD8+ T cells	GSE164551	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20331
1.19296609696181e-44	0.798469067167773	0.496	0.031	1.8804724586409e-40	IGLC3	CD8+ T cells	GSE164551	ENSG00000211679	NA	NA	IGLC	IG_C_gene	P0DOY3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20332
5.1218378874934e-39	-1.53949479535077	0.268	0.738	8.07355306205584e-35	VIM	CD8+ T cells	GSE164551	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20333
2.68927257125317e-35	1.66306089970825	0.54	0.12	4.23910035406637e-31	MT1X	CD8+ T cells	GSE164551	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20334
2.96431295256424e-35	1.03834551270134	0.598	0.132	4.67264650712702e-31	GZMB	CD8+ T cells	GSE164551	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20335
7.96468698318969e-33	-1.32577865455453	0.348	0.718	1.25547360916019e-28	ZFP36	CD8+ T cells	GSE164551	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20336
1.47298366733416e-32	-1.25540254308813	0.083	0.514	2.32186415481884e-28	IFRD1	CD8+ T cells	GSE164551	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20337
1.8840252217592e-31	0.998676470898829	0.522	0.112	2.96978895705903e-27	FGFBP2	CD8+ T cells	GSE164551	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20338
2.74946505088036e-31	0.750906865953235	0.986	0.947	4.33398175970272e-27	RPL23A	CD8+ T cells	GSE164551	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20339
1.37781691850348e-30	-0.749672582039278	1	1	2.17185280863703e-26	MT-ND3	CD8+ T cells	GSE164551	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20340
3.13674493381427e-28	0.66708785939543	1	1	4.94445103917143e-24	RPL10	CD8+ T cells	GSE164551	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20341
4.31409561980936e-28	0.701704403457279	0.457	0.087	6.80030892550549e-24	CDKN2D	CD8+ T cells	GSE164551	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20342
9.69534876040675e-28	-1.33052170876199	0.714	0.84	1.52827782510292e-23	ZFP36L2	CD8+ T cells	GSE164551	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20343
2.05266238156453e-27	-1.19683287490583	0.493	0.751	3.23561171206017e-23	TSC22D3	CD8+ T cells	GSE164551	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20344
1.27096603786624e-25	-1.03826468706035	0.207	0.552	2.00342376548856e-21	DDIT4	CD8+ T cells	GSE164551	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20345
1.72104209389745e-24	-0.860116000016922	0.087	0.443	2.71287865261056e-20	SLC7A5	CD8+ T cells	GSE164551	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20346
2.47397683369594e-24	0.523375851954919	0.38	0.064	3.89972968295491e-20	GIMAP7	CD8+ T cells	GSE164551	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20347
2.63078941899247e-24	-1.3006226894298	0.112	0.463	4.14691336115783e-20	AC103591.3	CD8+ T cells	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20348
4.94990780599751e-24	0.5897021310318	1	0.992	7.80253967459388e-20	RPS27A	CD8+ T cells	GSE164551	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20349
8.64387427037386e-24	0.806039568955891	0.851	0.601	1.36253390123903e-19	HBA2	CD8+ T cells	GSE164551	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20350
6.67093269407513e-23	0.63980721805229	0.996	0.954	1.05153912056706e-18	RPL26	CD8+ T cells	GSE164551	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20351
1.05185661801856e-22	-1.12085974210515	0.116	0.455	1.65804158698266e-18	RGS1	CD8+ T cells	GSE164551	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20352
1.8993511069963e-22	0.948854523863765	0.355	0.064	2.99394714995828e-18	MT1E	CD8+ T cells	GSE164551	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20353
4.60070702546854e-22	0.564181129122922	1	0.997	7.25209448424607e-18	RPL41	CD8+ T cells	GSE164551	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20354
9.84421256752966e-22	-0.698247149849763	0.04	0.356	1.5517432270197e-17	LYZ	CD8+ T cells	GSE164551	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20355
1.07533497431939e-21	0.755977414584036	0.949	0.712	1.69505052001965e-17	NKG7	CD8+ T cells	GSE164551	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20356
3.52074541559746e-21	0.726383421563139	0.899	0.59	5.54975099860628e-17	PIK3R1	CD8+ T cells	GSE164551	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20357
6.29012491585278e-21	0.695295710818216	0.87	0.532	9.91512390485874e-17	RPS10	CD8+ T cells	GSE164551	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20358
3.14348255871339e-20	-0.988258195292961	0.04	0.328	4.95507155729992e-16	RGCC	CD8+ T cells	GSE164551	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20359
3.57702633606527e-20	0.687935117267062	0.493	0.163	5.63846661353969e-16	LYAR	CD8+ T cells	GSE164551	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20360
4.5441517009484e-20	-0.882234030832461	0.098	0.397	7.16294632620497e-16	MAFF	CD8+ T cells	GSE164551	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20361
6.20134970618048e-20	-1.26748401020161	0.261	0.562	9.7751875418523e-16	JUN	CD8+ T cells	GSE164551	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20362
8.56327555849973e-20	0.541922254712736	0.996	0.959	1.34982912628631e-15	HLA-C	CD8+ T cells	GSE164551	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20363
7.51466140214805e-19	0.526039337917881	1	0.975	1.1845360768206e-14	RPL7A	CD8+ T cells	GSE164551	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20364
1.00132539031775e-18	0.51616378613342	0.989	0.962	1.57838921275787e-14	RPS7	CD8+ T cells	GSE164551	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20365
4.15397337052026e-18	0.565697019276536	0.996	0.985	6.54790822395108e-14	RPS4X	CD8+ T cells	GSE164551	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20366
8.38586379056304e-18	0.499444429535099	0.993	0.972	1.32186370930645e-13	RPL3	CD8+ T cells	GSE164551	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20367
8.41071735365185e-18	0.417711198850229	0.475	0.15	1.32578137645614e-13	MGAT4A	CD8+ T cells	GSE164551	ENSG00000071073	11320	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GnT-4a|GnT-Iva	protein_coding	Q9UM21	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20368
1.09095522891254e-17	0.520084601772274	0.989	0.98	1.71967272733484e-13	RPS3A	CD8+ T cells	GSE164551	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20369
2.8161125655644e-17	-0.956224059388799	0.558	0.735	4.43903823709916e-13	TNFAIP3	CD8+ T cells	GSE164551	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20370
4.63751018058229e-17	0.605795642539705	0.768	0.425	7.31010729765187e-13	CLEC2B	CD8+ T cells	GSE164551	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20371
7.48834306137761e-17	0.47797020727523	0.993	0.997	1.18038751676495e-12	RPS24	CD8+ T cells	GSE164551	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20372
7.58106241231909e-17	-0.851637115405676	0.127	0.42	1.19500286805386e-12	GZMK	CD8+ T cells	GSE164551	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20373
9.02974775107568e-17	-0.848032546694797	0.087	0.356	1.42335913800206e-12	KDM6B	CD8+ T cells	GSE164551	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20374
1.13818209160647e-16	-0.82746714270067	0.312	0.562	1.79411643099928e-12	TUBA4A	CD8+ T cells	GSE164551	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20375
2.38825034420916e-16	0.504297397074819	1	0.997	3.76459901757689e-12	RPS15A	CD8+ T cells	GSE164551	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20376
2.6951765559314e-16	0.509861045480437	0.931	0.784	4.24840680511467e-12	COX4I1	CD8+ T cells	GSE164551	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20377
3.08047014546779e-16	-0.612898847883195	0.072	0.346	4.85574509030087e-12	S100A9	CD8+ T cells	GSE164551	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20378
3.72172668734083e-16	-0.537120322389879	0.033	0.277	5.86655777725534e-12	THBS1	CD8+ T cells	GSE164551	ENSG00000137801	7057	thrombospondin 1	THBS|THBS-1|TSP|TSP-1|TSP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20379
3.83715677292583e-16	0.50560216403812	0.931	0.679	6.04851022116299e-12	HLA-E	CD8+ T cells	GSE164551	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20380
3.99145561003948e-16	0.454949972164078	0.986	0.913	6.29173147810523e-12	NACA	CD8+ T cells	GSE164551	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20381
4.09574212293859e-16	-0.906807539377335	0.312	0.575	6.4561183083881e-12	NR4A2	CD8+ T cells	GSE164551	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20382
6.69373007766985e-16	-0.639318374398264	0.188	0.463	1.0551326721431e-11	PDE4B	CD8+ T cells	GSE164551	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20383
7.24714437103335e-16	0.363728540159888	0.355	0.102	1.14236736720599e-11	PYHIN1	CD8+ T cells	GSE164551	ENSG00000163564	149628	pyrin and HIN domain family member 1	IFIX|MGC23885	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20384
1.00729641182922e-15	0.512832612011728	0.395	0.12	1.5878013339664e-11	ATP2B1	CD8+ T cells	GSE164551	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20385
1.26915453836116e-15	0.55331415291803	0.797	0.466	2.0005682988187e-11	LIMD2	CD8+ T cells	GSE164551	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20386
1.72612173587701e-15	0.547284585150123	0.714	0.402	2.72088569226293e-11	ATP6V1G1	CD8+ T cells	GSE164551	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20387
2.70096388655699e-15	0.528029168179362	0.804	0.476	4.25752937437979e-11	STK4	CD8+ T cells	GSE164551	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20388
3.19517570733925e-15	0.378947557417242	0.25	0.043	5.03655546747886e-11	MT1F	CD8+ T cells	GSE164551	ENSG00000198417	4494	metallothionein 1F	MT1	protein_coding	P04733	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20389
5.24817295515815e-15	0.456874232950079	0.996	1	8.27269502921578e-11	EEF1A1	CD8+ T cells	GSE164551	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20390
6.49668066427601e-15	-0.906346997506344	0.373	0.585	1.02407177310983e-10	YPEL5	CD8+ T cells	GSE164551	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20391
8.0853935313144e-15	0.537185631992672	0.457	0.176	1.27450058234109e-10	SDCBP	CD8+ T cells	GSE164551	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20392
9.0298587606131e-15	0.452294995497168	0.996	0.969	1.42337663643544e-10	RPL35A	CD8+ T cells	GSE164551	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20393
1.11609537480349e-14	-0.612016781554766	0.094	0.364	1.75930113930274e-10	S100A8	CD8+ T cells	GSE164551	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20394
1.32553599981504e-14	0.469082293192224	0.996	0.982	2.08944239650845e-10	RPS3	CD8+ T cells	GSE164551	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20395
2.31671608702023e-14	0.433390219620371	0.478	0.186	3.65183956796998e-10	EAPP	CD8+ T cells	GSE164551	ENSG00000129518	55837	E2F associated phosphoprotein	BM036|C14orf11|FLJ20578	protein_coding	Q56P03	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20396
3.49389013021451e-14	0.478763214174183	0.989	0.977	5.50741901225713e-10	RPS8	CD8+ T cells	GSE164551	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20397
4.66102880986366e-14	0.443838192844188	0.949	0.858	7.34717971298808e-10	RPL27	CD8+ T cells	GSE164551	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20398
8.03435015862826e-14	0.536963189535613	0.739	0.427	1.26645461550457e-09	SEPT7	CD8+ T cells	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20399
8.08538797699318e-14	0.330585021885284	0.326	0.089	1.27449970681343e-09	ADH5	CD8+ T cells	GSE164551	ENSG00000197894	128	alcohol dehydrogenase 5 (class III), chi polypeptide	ADH-3|ADHX|FDH|GSNOR	protein_coding	P11766	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20400
9.02197844133076e-14	0.540846291057296	0.678	0.354	1.42213446170697e-09	MYL12A	CD8+ T cells	GSE164551	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20401
1.22259173970123e-13	-0.640184861441879	0.964	0.975	1.92717135929106e-09	MT-ND5	CD8+ T cells	GSE164551	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20402
1.29449343257901e-13	-0.422323570291991	0.058	0.285	2.04050999777429e-09	FAM102A	CD8+ T cells	GSE164551	ENSG00000167106	399665	family with sequence similarity 102 member A	bA203J24.7|C9orf132|Eeig1|SYM-3A	protein_coding	Q5T9C2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20403
1.48272543605056e-13	0.51259083823601	0.822	0.641	2.3372201048465e-09	HBB	CD8+ T cells	GSE164551	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20404
3.03702497498739e-13	-0.893367151508773	0.326	0.527	4.78726246807262e-09	ADGRE5	CD8+ T cells	GSE164551	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20405
3.15278559130509e-13	0.533768584967037	0.71	0.405	4.96973592757421e-09	CDC42SE2	CD8+ T cells	GSE164551	ENSG00000158985	56990	CDC42 small effector 2	FLJ21967|SPEC2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20406
3.28555436604643e-13	0.387672472939298	1	0.962	5.17901934719899e-09	RPL15	CD8+ T cells	GSE164551	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20407
3.44237296237126e-13	0.392264814155599	0.428	0.16	5.42621250058581e-09	RBX1	CD8+ T cells	GSE164551	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20408
3.52697611075837e-13	-0.562168640792216	0.051	0.262	5.55957244338842e-09	PLP2	CD8+ T cells	GSE164551	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20409
3.65407741616904e-13	-0.782855128190438	0.373	0.557	5.75992223110726e-09	LDHA	CD8+ T cells	GSE164551	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20410
3.65516635153365e-13	0.456118822074099	0.5	0.211	5.76163871992249e-09	GZMH	CD8+ T cells	GSE164551	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20411
3.75959768033437e-13	-0.616953715873779	0.656	0.796	5.92625382351106e-09	MT-ND4L	CD8+ T cells	GSE164551	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20412
5.51664486962094e-13	0.414102062675007	0.649	0.333	8.69588730798348e-09	WIPF1	CD8+ T cells	GSE164551	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20413
7.67716108460682e-13	-0.653438479146835	0.264	0.483	1.21015090176657e-08	NFKB1	CD8+ T cells	GSE164551	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20414
7.90642014561905e-13	0.397108060740533	0.993	0.995	1.24628900755393e-08	RPS15	CD8+ T cells	GSE164551	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20415
8.8981737045434e-13	-0.604466888806236	0.895	0.964	1.40261912104718e-08	BTG1	CD8+ T cells	GSE164551	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20416
1.25881659955921e-12	0.414641041537445	1	1	1.98427260588518e-08	RPL30	CD8+ T cells	GSE164551	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20417
1.30356557594107e-12	-0.545812552208721	0.083	0.303	2.05481041735591e-08	CCND2	CD8+ T cells	GSE164551	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20418
1.30509360780604e-12	0.449600520662963	0.62	0.326	2.05721905398466e-08	RORA	CD8+ T cells	GSE164551	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20419
1.78029833129184e-12	0.357434075894529	1	0.99	2.80628425961532e-08	HLA-B	CD8+ T cells	GSE164551	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20420
1.78873505352162e-12	-0.614229302244207	0.152	0.382	2.81958306486614e-08	OTULIN	CD8+ T cells	GSE164551	ENSG00000154124	90268	OTU deubiquitinase with linear linkage specificity	FAM105B|FLJ34884	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20421
2.15012188289671e-12	0.439499408206998	0.982	0.941	3.38923712401009e-08	RPL5	CD8+ T cells	GSE164551	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20422
2.16421563334219e-12	-0.526822166273667	0.996	1	3.41145310283729e-08	PTMA	CD8+ T cells	GSE164551	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20423
2.35102591663433e-12	0.389826254292021	0.996	1	3.7059221523907e-08	RPS14	CD8+ T cells	GSE164551	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20424
5.70127150674354e-12	0.36577182289935	0.413	0.163	8.98691427607985e-08	RSF1	CD8+ T cells	GSE164551	ENSG00000048649	51773	remodeling and spacing factor 1	HBXAP|p325|RSF-1|XAP8	protein_coding	Q96T23	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20425
7.5857223495587e-12	0.404349924439608	0.514	0.249	1.19573741396094e-07	EPB41L4A-AS1	CD8+ T cells	GSE164551	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20426
8.29660561589388e-12	0.393586475761477	0.996	0.99	1.30779394323335e-07	RPL19	CD8+ T cells	GSE164551	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20427
9.49562179958097e-12	0.348358960701103	0.413	0.165	1.49679486426795e-07	DCTN3	CD8+ T cells	GSE164551	ENSG00000137100	11258	dynactin subunit 3	DCTN-22	protein_coding	O75935	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20428
1.01846805553234e-11	0.358522941694955	0.366	0.13	1.60541119593562e-07	HNRNPR	CD8+ T cells	GSE164551	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20429
1.08081621536273e-11	0.410613954985551	1	0.995	1.70369060027627e-07	RPS12	CD8+ T cells	GSE164551	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20430
1.17392749429233e-11	0.395007426531801	0.996	0.997	1.85046190925301e-07	RPS2	CD8+ T cells	GSE164551	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20431
1.57575613178035e-11	0.284616883660423	0.25	0.066	2.48386439052536e-07	PTPN4	CD8+ T cells	GSE164551	ENSG00000088179	5775	protein tyrosine phosphatase non-receptor type 4	PTPMEG	protein_coding	P29074	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20432
1.96941654901287e-11	0.409297078913154	0.982	0.972	3.10439130620899e-07	RPL6	CD8+ T cells	GSE164551	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20433
1.97550313142418e-11	-0.380699349187504	0.08	0.293	3.11398558606393e-07	CXCR3	CD8+ T cells	GSE164551	ENSG00000186810	2833	C-X-C motif chemokine receptor 3	CD183|CKR-L2|CMKAR3|GPR9|IP10-R|MigR	protein_coding	P49682	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20434
2.51077296663398e-11	0.394797979072643	1	0.987	3.95773142730514e-07	RPS26	CD8+ T cells	GSE164551	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20435
3.13533063689831e-11	0.379377949408275	0.333	0.127	4.9422216829428e-07	SAMD3	CD8+ T cells	GSE164551	ENSG00000164483	154075	sterile alpha motif domain containing 3	bA73O6.2|FLJ34032	protein_coding	Q8N6K7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20436
3.29511550175751e-11	0.395528370001442	0.986	0.975	5.19409056542037e-07	RPL21	CD8+ T cells	GSE164551	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20437
3.97492579838359e-11	0.456223081878364	0.862	0.672	6.26567553599205e-07	CIRBP	CD8+ T cells	GSE164551	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20438
4.00419892077503e-11	-0.390770559656399	0.101	0.316	6.31181875881769e-07	APOBEC3G	CD8+ T cells	GSE164551	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20439
4.59447170034355e-11	0.420311876981632	0.967	0.936	7.24226574125153e-07	RPS25	CD8+ T cells	GSE164551	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20440
5.99798066397209e-11	0.316770759992188	0.322	0.109	9.4546169206192e-07	VPS26A	CD8+ T cells	GSE164551	ENSG00000122958	9559	VPS26 retromer complex component A	Hbeta58|PEP8A|VPS26	protein_coding	O75436	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20441
6.07384488356672e-11	0.382233527304724	0.583	0.295	9.57420168996622e-07	VAMP2	CD8+ T cells	GSE164551	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20442
6.07680975459151e-11	0.337126510451301	0.42	0.176	9.5788752161626e-07	STRAP	CD8+ T cells	GSE164551	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20443
6.57943329655704e-11	-0.56793623214523	0.243	0.448	1.03711607053629e-06	PIK3IP1	CD8+ T cells	GSE164551	ENSG00000100100	113791	phosphoinositide-3-kinase interacting protein 1	HGFL|MGC17330|TrIP	protein_coding	Q96FE7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20444
6.64924858633724e-11	0.408459013272224	0.576	0.308	1.04812105466434e-06	EIF5A	CD8+ T cells	GSE164551	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20445
6.72099757476101e-11	-0.580676500933165	0.185	0.417	1.05943084770958e-06	HLA-DRA	CD8+ T cells	GSE164551	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20446
6.92319661923528e-11	0.384330163396578	0.982	0.944	1.09130348309006e-06	RPS13	CD8+ T cells	GSE164551	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20447
7.85105066930902e-11	0.386779561337897	0.989	0.957	1.23756111700318e-06	RPL14	CD8+ T cells	GSE164551	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20448
8.73578360069226e-11	0.335063968870966	0.344	0.122	1.37702156897712e-06	BAZ2A	CD8+ T cells	GSE164551	ENSG00000076108	11176	bromodomain adjacent to zinc finger domain 2A	KIAA0314|TIP5|WALp3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20449
9.35655720968488e-11	0.341589562890639	0.438	0.188	1.47487411296263e-06	KLF3	CD8+ T cells	GSE164551	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20450
9.76803627701724e-11	0.368174395005538	0.319	0.12	1.53973555834623e-06	PRF1	CD8+ T cells	GSE164551	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20451
1.03879792892135e-10	0.398920608657273	0.565	0.298	1.63745717535872e-06	CALM2	CD8+ T cells	GSE164551	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20452
1.23236299381255e-10	0.422153658922132	0.906	0.743	1.94257378714672e-06	RPS5	CD8+ T cells	GSE164551	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20453
1.38196192927057e-10	0.324799663456092	0.428	0.183	2.17838658910921e-06	SSBP1	CD8+ T cells	GSE164551	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20454
1.50236465381007e-10	0.371096975524586	0.63	0.349	2.36817740380081e-06	EIF3F	CD8+ T cells	GSE164551	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20455
1.77001408502014e-10	0.286468488893614	0.337	0.122	2.79007320221724e-06	SMC3	CD8+ T cells	GSE164551	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20456
1.84081974946865e-10	-0.637456768096453	0.576	0.707	2.90168417108743e-06	LAPTM5	CD8+ T cells	GSE164551	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20457
2.35990429227804e-10	-0.700002701332019	0.225	0.43	3.71991713591788e-06	ZFP36L1	CD8+ T cells	GSE164551	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20458
2.88114234167781e-10	0.465672963602646	0.797	0.573	4.54154467318673e-06	HINT1	CD8+ T cells	GSE164551	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20459
2.9033333190389e-10	0.269780624740289	0.254	0.079	4.57652431080103e-06	TGFBR3	CD8+ T cells	GSE164551	ENSG00000069702	7049	transforming growth factor beta receptor 3	betaglycan|BGCAN	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20460
2.92672716273668e-10	0.283646913191581	0.254	0.074	4.61340002662183e-06	PLAC8	CD8+ T cells	GSE164551	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20461
2.98723345622204e-10	-0.566923394878475	0.681	0.728	4.70877609704281e-06	TGFB1	CD8+ T cells	GSE164551	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20462
3.03248494688519e-10	0.696972557739426	0.504	0.277	4.78010602177512e-06	KLRB1	CD8+ T cells	GSE164551	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20463
3.066296846758e-10	-0.678740356652332	0.96	0.99	4.83340371954463e-06	TMSB10	CD8+ T cells	GSE164551	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20464
3.36285208634497e-10	0.417938556039398	0.656	0.374	5.30086374370558e-06	CST7	CD8+ T cells	GSE164551	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20465
3.56645990357609e-10	0.311694739823879	0.486	0.221	5.62181074600699e-06	COPE	CD8+ T cells	GSE164551	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20466
3.67242144994632e-10	0.331523804221925	0.583	0.295	5.78883793155039e-06	COX7B	CD8+ T cells	GSE164551	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20467
4.06211744126349e-10	0.402335359390879	0.975	0.972	6.40311572266364e-06	RPS6	CD8+ T cells	GSE164551	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20468
4.77024002989136e-10	0.312755065754848	0.388	0.163	7.51932935911776e-06	PARK7	CD8+ T cells	GSE164551	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20469
5.50180964959952e-10	0.382070111656254	0.681	0.407	8.67250255066372e-06	POMP	CD8+ T cells	GSE164551	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20470
5.76980061919014e-10	-0.292130691810074	0.083	0.28	9.09493671602942e-06	SLC25A37	CD8+ T cells	GSE164551	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20471
5.82489501117319e-10	0.353945177344754	0.996	0.962	9.18178200611229e-06	RPL12	CD8+ T cells	GSE164551	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20472
5.82622265320848e-10	0.357359820711908	0.975	0.954	9.18387476825252e-06	UBA52	CD8+ T cells	GSE164551	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20473
6.46744826254192e-10	0.31715105291494	0.996	0.972	1.01946386962448e-05	RPL13A	CD8+ T cells	GSE164551	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20474
7.22184628997242e-10	0.404867300281991	0.942	0.873	1.13837963068835e-05	RPSA	CD8+ T cells	GSE164551	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20475
8.71576978723285e-10	0.292423506086754	0.254	0.079	1.37386679156151e-05	GOLGA7	CD8+ T cells	GSE164551	ENSG00000147533	51125	golgin A7	GCP16|GOLGA3AP1|GOLGA7A|HSPC041	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20476
8.96450819772611e-10	0.321061596046811	0.996	0.99	1.41307542720757e-05	FAU	CD8+ T cells	GSE164551	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20477
9.25112105292454e-10	0.334774338922346	0.417	0.186	1.4582542115725e-05	YPEL3	CD8+ T cells	GSE164551	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20478
1.01449405595853e-09	0.334774338922346	0.656	0.351	1.59914698040743e-05	MYL12B	CD8+ T cells	GSE164551	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20479
1.07636073923215e-09	0.289118361363082	0.272	0.094	1.69666743325164e-05	KLRG1	CD8+ T cells	GSE164551	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20480
1.07904648830035e-09	0.295122196687425	0.341	0.137	1.70090097950784e-05	PSMB8	CD8+ T cells	GSE164551	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20481
1.24554447295992e-09	0.372669085286597	0.322	0.13	1.96335175272672e-05	CBLB	CD8+ T cells	GSE164551	ENSG00000114423	868	Cbl proto-oncogene B	Cbl-b|RNF56	protein_coding	Q13191	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20482
1.25684228052459e-09	0.280163823520756	0.315	0.117	1.98116048679092e-05	PTPRJ	CD8+ T cells	GSE164551	ENSG00000149177	5795	protein tyrosine phosphatase receptor type J	CD148|DEP1|HPTPeta	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20483
1.39159506653075e-09	-0.650925333714005	0.964	0.959	2.19357130337242e-05	JUND	CD8+ T cells	GSE164551	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20484
1.39460515478226e-09	0.3703557743411	1	1	2.19831610548328e-05	B2M	CD8+ T cells	GSE164551	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20485
1.47809631213038e-09	0.395592476959656	0.638	0.369	2.32992321681111e-05	GZMM	CD8+ T cells	GSE164551	ENSG00000197540	3004	granzyme M	LMET1|MET1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20486
1.51910610608712e-09	0.403220850150517	0.942	0.865	2.39456695502513e-05	RPL7	CD8+ T cells	GSE164551	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20487
1.57952942263519e-09	0.264190682496052	0.326	0.122	2.48981222889985e-05	CD47	CD8+ T cells	GSE164551	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20488
1.77196694012461e-09	0.355320572563544	0.942	0.827	2.79315148771843e-05	RPL36AL	CD8+ T cells	GSE164551	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20489
1.97077104365024e-09	0.372006884946448	0.732	0.455	3.10652639610587e-05	AES	CD8+ T cells	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20490
2.30944973291857e-09	0.297359373665637	0.435	0.196	3.64038561399955e-05	C11orf58	CD8+ T cells	GSE164551	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20491
2.65254703716806e-09	0.274276617931665	0.42	0.188	4.18120989468802e-05	HSPA8	CD8+ T cells	GSE164551	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20492
2.83310836858592e-09	-0.692902569107078	0.239	0.435	4.46582872140198e-05	DUSP1	CD8+ T cells	GSE164551	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20493
3.07044174192039e-09	0.345741665719331	0.587	0.323	4.83993731778911e-05	COX5B	CD8+ T cells	GSE164551	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20494
3.16033276511737e-09	-0.390945597980787	0.091	0.262	4.9816325376545e-05	ST3GAL5	CD8+ T cells	GSE164551	ENSG00000115525	8869	ST3 beta-galactoside alpha-2,3-sialyltransferase 5	SIAT9|SIATGM3S|ST3GalV	protein_coding	Q9UNP4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20495
3.68698125530692e-09	0.357560519802422	0.428	0.206	5.8117885527403e-05	NDUFB2	CD8+ T cells	GSE164551	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20496
3.72522190791759e-09	0.336768764959442	0.409	0.193	5.8720672934505e-05	SH2D1A	CD8+ T cells	GSE164551	ENSG00000183918	4068	SH2 domain containing 1A	DSHP|EBVS|IMD5|LYP|MTCP1|SAP|XLP|XLPD	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20497
3.96277306536702e-09	-0.386167026103784	1	1	6.24651918293804e-05	MT-CYB	CD8+ T cells	GSE164551	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20498
4.38606797047524e-09	0.396886335263672	0.529	0.282	6.91375894186012e-05	KLRD1	CD8+ T cells	GSE164551	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20499
4.63224912952932e-09	0.271701308285673	0.293	0.107	7.30181430287706e-05	SIRT2	CD8+ T cells	GSE164551	ENSG00000283100	22933	sirtuin 2	SIR2L	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20500
4.71424644044856e-09	0.280900573741173	0.341	0.142	7.43106666407906e-05	MAX	CD8+ T cells	GSE164551	ENSG00000125952	4149	MYC associated factor X	bHLHd4|bHLHd5|bHLHd6|bHLHd7|bHLHd8	protein_coding	P61244	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20501
4.95882861285255e-09	0.265935462594348	0.435	0.198	7.81660154243947e-05	ACTR2	CD8+ T cells	GSE164551	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20502
5.01179732445341e-09	0.330621367761585	0.957	0.814	7.90009612253591e-05	TMA7	CD8+ T cells	GSE164551	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20503
6.38666051808604e-09	0.298356940286726	0.384	0.17	0.00010067292974659	EIF3D	CD8+ T cells	GSE164551	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20504
6.44942417788711e-09	-0.567692098804731	0.453	0.593	0.000101662273316034	CCNL1	CD8+ T cells	GSE164551	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20505
6.57319134901991e-09	0.325562095401114	0.989	0.936	0.000103613215234601	RPL24	CD8+ T cells	GSE164551	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20506
6.8841820981286e-09	0.314041719742898	0.406	0.191	0.000108515362412801	RAB5IF	CD8+ T cells	GSE164551	ENSG00000101084	55969	RAB5 interacting factor	C20orf24|PNAS-11|RCAF1|RIP5	protein_coding	Q9BUV8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20507
8.60971680781013e-09	0.26255099193966	0.254	0.089	0.000135714966041511	C1orf43	CD8+ T cells	GSE164551	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20508
8.76331518479801e-09	0.410939492247163	0.96	0.763	0.000138136137257971	CCL5	CD8+ T cells	GSE164551	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20509
8.94398839349577e-09	0.304090845091403	0.366	0.165	0.000140984089046674	RPS19BP1	CD8+ T cells	GSE164551	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20510
9.96375683802188e-09	0.320635488079189	0.525	0.28	0.000157058699037739	NDUFA1	CD8+ T cells	GSE164551	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20511
1.10529373911263e-08	0.310212579800279	0.319	0.135	0.000174227452096323	CTSC	CD8+ T cells	GSE164551	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20512
1.11209450821065e-08	0.403449429342925	0.576	0.336	0.000175299457329245	SET	CD8+ T cells	GSE164551	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20513
1.12592256878034e-08	0.426203116433528	0.431	0.221	0.000177479174516845	FYB1	CD8+ T cells	GSE164551	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20514
1.13529049749124e-08	0.295337512828461	0.489	0.244	0.000178955841119544	EIF3H	CD8+ T cells	GSE164551	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20515
1.28182141330542e-08	-0.481150171292308	0.12	0.295	0.000202053509379334	HOPX	CD8+ T cells	GSE164551	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20516
1.42726307810489e-08	0.352373147276348	0.957	0.858	0.000224979479001675	RPL10A	CD8+ T cells	GSE164551	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20517
1.48770574344706e-08	0.32839511809809	0.986	0.98	0.00023450705633956	RPL29	CD8+ T cells	GSE164551	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20518
1.50385300695564e-08	-0.553907366518417	0.522	0.603	0.000237052349486418	RNMT	CD8+ T cells	GSE164551	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20519
1.54947543826689e-08	0.423871903767471	0.67	0.44	0.00024424381333401	ITM2B	CD8+ T cells	GSE164551	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20520
1.62579050581922e-08	0.308109504548832	0.514	0.265	0.000256273357432283	UQCRH	CD8+ T cells	GSE164551	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20521
1.67976388606014e-08	0.25056904133246	0.286	0.107	0.00026478118135966	TECR	CD8+ T cells	GSE164551	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20522
1.75037429064879e-08	0.295237598442547	0.283	0.107	0.000275911499434969	IL10RA	CD8+ T cells	GSE164551	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20523
1.96699926043341e-08	0.258603807422997	0.359	0.16	0.000310058093422119	EMC7	CD8+ T cells	GSE164551	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20524
2.03714126944294e-08	0.341960879515615	0.685	0.412	0.000321114578302291	ARPC5L	CD8+ T cells	GSE164551	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20525
2.18676087858341e-08	-0.462917485784538	0.138	0.305	0.000344699117291103	CSRNP1	CD8+ T cells	GSE164551	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20526
2.34514388141262e-08	0.271456306155358	0.678	0.374	0.000369665030027071	ATP5MPL	CD8+ T cells	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20527
2.34725143945147e-08	0.292164136965542	1	0.995	0.000369997244400736	TMSB4X	CD8+ T cells	GSE164551	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20528
2.42257727891369e-08	0.270062347540374	0.449	0.221	0.000381870856475166	HSPA9	CD8+ T cells	GSE164551	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20529
2.99004538612131e-08	0.25988279247209	0.337	0.148	0.000471320854214303	ATP5PB	CD8+ T cells	GSE164551	ENSG00000116459	515	ATP synthase peripheral stalk-membrane subunit b	ATP5F1	protein_coding	P24539	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20530
3.30027376450376e-08	0.300013877463103	0.268	0.102	0.000520222153498728	CMIP	CD8+ T cells	GSE164551	ENSG00000153815	80790	c-Maf inducing protein	NA	protein_coding	Q8IY22	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20531
3.37462666961122e-08	-0.557427084315363	0.272	0.427	0.000531942401930817	PPP1R2	CD8+ T cells	GSE164551	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20532
3.5574088949017e-08	0.276855435087256	0.399	0.188	0.000560754364103355	NSD3	CD8+ T cells	GSE164551	ENSG00000147548	54904	nuclear receptor binding SET domain protein 3	FLJ20353|KMT3F|WHISTLE|WHSC1L1	protein_coding	Q9BZ95	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20533
3.5620577906183e-08	0.350234710832362	0.772	0.601	0.000561487169535163	YBX1	CD8+ T cells	GSE164551	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20534
4.17784707390006e-08	0.326882302131521	0.587	0.333	0.000658554034258867	COX7A2	CD8+ T cells	GSE164551	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20535
4.7597087803832e-08	0.257439828703377	0.5	0.26	0.000750272895051803	ATG2A	CD8+ T cells	GSE164551	ENSG00000110046	23130	autophagy related 2A	BLTP4A|KIAA0404	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20536
4.79628800703248e-08	-0.319368246792604	1	1	0.00075603887854853	MT-ATP6	CD8+ T cells	GSE164551	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20537
5.16032448483701e-08	0.25910496942508	0.598	0.326	0.000813421948544858	ELOB	CD8+ T cells	GSE164551	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20538
5.45432139078094e-08	0.30454541475019	0.996	1	0.0008597646808288	RPL32	CD8+ T cells	GSE164551	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20539
5.95095487811275e-08	-0.524170583094354	0.214	0.389	0.000938049017436912	COTL1	CD8+ T cells	GSE164551	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20540
6.89810526371424e-08	0.270904779269541	0.333	0.145	0.00108734833271928	TNRC6B	CD8+ T cells	GSE164551	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20541
7.45709384653525e-08	0.255736121236341	0.29	0.125	0.00117546170302935	F2R	CD8+ T cells	GSE164551	ENSG00000181104	2149	coagulation factor II thrombin receptor	CF2R|PAR-1|PAR1|TR	protein_coding	P25116	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20542
7.46467145085456e-08	0.34125273212887	0.859	0.774	0.0011766561607982	EEF1B2	CD8+ T cells	GSE164551	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20543
7.80917930361996e-08	0.264116520230041	1	1	0.00123096093362961	RPL13	CD8+ T cells	GSE164551	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20544
7.97069578549411e-08	0.309514730171247	0.862	0.692	0.00125642077666744	RPL31	CD8+ T cells	GSE164551	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20545
9.09584547630484e-08	0.295508577977695	0.366	0.176	0.00143377812242993	NDUFA6	CD8+ T cells	GSE164551	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20546
9.24200457733654e-08	0.316131265741387	0.989	0.992	0.00145681718152556	RPS23	CD8+ T cells	GSE164551	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20547
9.90207426393166e-08	-0.336957880316856	1	1	0.00156086396622355	MT-CO3	CD8+ T cells	GSE164551	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20548
1.00920649815779e-07	0.258603807422997	0.337	0.153	0.00159081220304613	ARL6IP5	CD8+ T cells	GSE164551	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20549
1.09279160563632e-07	0.425796780691963	0.598	0.369	0.00172256740796453	CD247	CD8+ T cells	GSE164551	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20550
1.35720420779773e-07	0.298215005607986	0.42	0.216	0.00213936099275157	SNRPD2	CD8+ T cells	GSE164551	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20551
1.4161661104831e-07	0.335039869690296	0.583	0.341	0.00223230263995451	TAX1BP1	CD8+ T cells	GSE164551	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20552
1.49271311878495e-07	0.280475420723023	0.384	0.188	0.00235296368914071	ATP5MC3	CD8+ T cells	GSE164551	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20553
1.78508853897767e-07	-0.366515008265545	1	1	0.00281383506399051	MT-ND1	CD8+ T cells	GSE164551	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20554
1.83506069779282e-07	0.25227518417839	0.641	0.379	0.00289260617793082	OST4	CD8+ T cells	GSE164551	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20555
1.87371334265526e-07	0.28746862414399	0.366	0.173	0.00295353434202748	DDHD1	CD8+ T cells	GSE164551	ENSG00000100523	80821	DDHD domain containing 1	iPLA1alpha|KIAA1705|PA-PLA1|PAPLA1|SPG28	protein_coding	Q8NEL9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20556
2.17226621400459e-07	-0.50215591929478	0.511	0.59	0.00342414323313544	STK17B	CD8+ T cells	GSE164551	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20557
2.33697079689772e-07	0.323009931313016	0.786	0.567	0.00368376706714987	ANKRD12	CD8+ T cells	GSE164551	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20558
2.41960892200002e-07	-0.481647493625923	0.355	0.504	0.00381402954374863	RNF125	CD8+ T cells	GSE164551	ENSG00000101695	54941	ring finger protein 125	FLJ20456	protein_coding	Q96EQ8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20559
2.44999123796065e-07	0.279347781947598	0.656	0.397	0.00386192118839738	ATP5MC2	CD8+ T cells	GSE164551	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20560
2.73591534021618e-07	-0.31474287435879	1	1	0.00431262335078276	MT-ND4	CD8+ T cells	GSE164551	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20561
2.78052729101611e-07	0.377354127661185	0.308	0.145	0.00438294516882869	CLEC2D	CD8+ T cells	GSE164551	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20562
3.18699637518248e-07	0.289796678612202	0.391	0.204	0.00502366238620014	UXT	CD8+ T cells	GSE164551	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20563
3.24588180869203e-07	1.106097731111	0.866	0.802	0.00511648349504124	MT2A	CD8+ T cells	GSE164551	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20564
3.30924454447367e-07	-0.472436952786104	0.207	0.372	0.00521636217545385	IRF2BP2	CD8+ T cells	GSE164551	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20565
3.43389471930445e-07	0.263881803826374	0.435	0.226	0.0054128482460396	UQCR10	CD8+ T cells	GSE164551	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20566
3.45171638687059e-07	0.267991249644686	0.511	0.285	0.00544094054062412	UBE2D2	CD8+ T cells	GSE164551	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20567
3.52413151064316e-07	0.253413415072444	0.667	0.399	0.00555508850022681	ETS1	CD8+ T cells	GSE164551	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20568
3.56072941382157e-07	0.300669393238308	0.562	0.323	0.00561277777500694	CNOT6L	CD8+ T cells	GSE164551	ENSG00000138767	246175	CCR4-NOT transcription complex subunit 6 like	Ccr4b|DKFZp434K098	protein_coding	Q96LI5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20569
3.88215487042649e-07	-0.488320813080584	0.29	0.438	0.00611944072225327	IKZF1	CD8+ T cells	GSE164551	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20570
3.90857689701519e-07	0.311350718039473	0.554	0.331	0.00616108976276505	RAP1B	CD8+ T cells	GSE164551	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20571
4.07328015248734e-07	0.32656844383293	0.522	0.31	0.00642071150436579	PPDPF	CD8+ T cells	GSE164551	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20572
4.58924620546215e-07	-0.445354780533895	0.707	0.753	0.00723402879366998	CXCR4	CD8+ T cells	GSE164551	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20573
4.72825816309953e-07	0.308523091406663	0.761	0.504	0.00745315334249379	TOMM7	CD8+ T cells	GSE164551	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20574
5.15290532726126e-07	0.299027829230566	0.906	0.791	0.00812252466736193	RPL4	CD8+ T cells	GSE164551	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20575
5.232532371975e-07	0.281108459364549	0.583	0.338	0.0082480407779442	SLC25A3	CD8+ T cells	GSE164551	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20576
5.81815613081371e-07	0.268032144679579	0.721	0.461	0.00917115950900165	LITAF	CD8+ T cells	GSE164551	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20577
6.25236367480163e-07	0.276573983040695	0.453	0.244	0.00985560086058981	MECP2	CD8+ T cells	GSE164551	ENSG00000169057	4204	methyl-CpG binding protein 2	MRX16|MRX79|RTT	protein_coding	P51608	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20578
6.63016249039087e-07	-0.557402181424241	0.384	0.491	0.0104511251336031	MXD4	CD8+ T cells	GSE164551	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20579
6.6561186535522e-07	0.273960439065042	0.645	0.41	0.0104920398335943	SUMO2	CD8+ T cells	GSE164551	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20580
6.76760449544194e-07	0.286694022761146	0.504	0.29	0.0106677749661651	SERBP1	CD8+ T cells	GSE164551	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20581
7.53315391946498e-07	0.257924348529974	0.373	0.186	0.0118745105232527	ERH	CD8+ T cells	GSE164551	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20582
8.09893308099803e-07	0.276810892536459	0.761	0.547	0.0127663482155772	RPL36A	CD8+ T cells	GSE164551	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20583
8.82448374386382e-07	-0.380355491604342	0.928	0.936	0.0139100337254525	HMGB1	CD8+ T cells	GSE164551	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20584
8.96276275728653e-07	0.278308624858514	0.417	0.229	0.0141280029343108	ATP5MD	CD8+ T cells	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20585
8.96551754384394e-07	0.251595883794515	0.464	0.257	0.0141323453043612	PCSK7	CD8+ T cells	GSE164551	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20586
9.07322009884839e-07	-0.520909674636544	0.562	0.677	0.0143021168418147	DUSP2	CD8+ T cells	GSE164551	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20587
1.20040463217732e-06	0.298557802805795	0.623	0.407	0.0189219782170111	NDUFA4	CD8+ T cells	GSE164551	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20588
1.22044315633645e-06	0.271478893263127	0.986	0.977	0.0192378454733315	RPS21	CD8+ T cells	GSE164551	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20589
1.24417507798145e-06	-0.431162235047227	0.207	0.359	0.0196119317542215	ZNF331	CD8+ T cells	GSE164551	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20590
1.30796662307217e-06	-0.545394066509783	0.257	0.412	0.0206174778794866	SLC2A3	CD8+ T cells	GSE164551	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20591
1.39623100554212e-06	-0.415481756949354	0.185	0.331	0.0220087893403604	KLF13	CD8+ T cells	GSE164551	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20592
1.63801954811386e-06	0.266199429927847	1	0.997	0.0258201021369188	RPL37	CD8+ T cells	GSE164551	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20593
2.02095987055555e-06	-0.657980641461386	0.395	0.491	0.0318563904395672	LRRFIP1	CD8+ T cells	GSE164551	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20594
2.10711718821416e-06	0.289633208257313	0.641	0.427	0.0332144882378199	GUK1	CD8+ T cells	GSE164551	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20595
2.14301624218842e-06	0.261972531700053	1	0.997	0.0337803650256161	RPL34	CD8+ T cells	GSE164551	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20596
2.16832253389514e-06	0.288229338657206	0.938	0.807	0.0341792681017892	EEF1D	CD8+ T cells	GSE164551	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20597
2.17839910945016e-06	0.28528457139194	0.931	0.865	0.0343381051622629	RACK1	CD8+ T cells	GSE164551	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20598
2.23251732892724e-06	-0.436415378655002	0.591	0.735	0.03519117065588	CD74	CD8+ T cells	GSE164551	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20599
2.32527441575886e-06	0.305847153458844	0.529	0.326	0.0366533006156069	SSR2	CD8+ T cells	GSE164551	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20600
2.362394172279e-06	-0.651827805862111	0.351	0.504	0.0372384193376338	H1FX	CD8+ T cells	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20601
2.3825928986547e-06	0.270594805579593	0.482	0.285	0.037556811861494	RAB8B	CD8+ T cells	GSE164551	ENSG00000166128	51762	RAB8B, member RAS oncogene family	NA	protein_coding	Q92930	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20602
2.54882161929664e-06	0.278627469860794	0.565	0.346	0.040177075184973	TPM3	CD8+ T cells	GSE164551	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20603
2.70328391296539e-06	-0.373624945793137	0.181	0.328	0.0426118643200735	SKIL	CD8+ T cells	GSE164551	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20604
2.71394580167206e-06	0.270007009745797	0.424	0.234	0.0427799276717566	EIF3G	CD8+ T cells	GSE164551	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20605
2.72117066956204e-06	0.254603990238363	0.533	0.323	0.0428938132643064	CD48	CD8+ T cells	GSE164551	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20606
2.41253777118375e-167	0.98139247253697	0.414	0.025	3.80288328871694e-163	IGLC3	Mono/Macro	GSE164551	ENSG00000211679	NA	NA	IGLC	IG_C_gene	P0DOY3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20607
2.20365922269338e-162	-1.85367908400452	0.336	0.892	3.47362803273157e-158	IER3	Mono/Macro	GSE164551	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20608
8.51049366667378e-158	-2.24704522904477	0.528	0.909	1.34150911667779e-153	HMOX1	Mono/Macro	GSE164551	ENSG00000100292	3162	heme oxygenase 1	bK286B10|HO-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20609
5.60131760873285e-154	-1.8578852043388	0.164	0.821	8.82935694664559e-150	THBD	Mono/Macro	GSE164551	ENSG00000178726	7056	thrombomodulin	BDCA-3|CD141|THRM	protein_coding	P07204	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20610
1.16005750434518e-149	1.97179334671818	0.387	0.027	1.82859864409931e-145	MT1G	Mono/Macro	GSE164551	ENSG00000125144	4495	metallothionein 1G	MT1|MT1K	protein_coding	P13640	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20611
2.01368592552686e-143	-1.48981552658573	0.504	0.902	3.17417312440799e-139	MAP3K8	Mono/Macro	GSE164551	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20612
8.24090059665279e-137	-1.65482708908737	0.61	0.935	1.29901316105038e-132	ANXA1	Mono/Macro	GSE164551	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20613
5.63912541415138e-126	1.54239471971369	0.907	0.466	8.88895339032682e-122	HBA2	Mono/Macro	GSE164551	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20614
4.36690647840794e-122	-1.23787598408746	0.093	0.677	6.88355468191444e-118	CD163	Mono/Macro	GSE164551	ENSG00000177575	9332	CD163 molecule	M130|MM130|SCARI1	protein_coding	Q86VB7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20615
2.28159513653527e-117	-1.30342767789949	0.861	0.957	3.59647841372055e-113	S100A6	Mono/Macro	GSE164551	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20616
2.87203362412305e-114	-1.37005803909599	0.171	0.729	4.52718660170517e-110	FOSB	Mono/Macro	GSE164551	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20617
2.65604084719543e-113	-1.15126058528144	0.27	0.802	4.18671718743415e-109	TIPARP	Mono/Macro	GSE164551	ENSG00000163659	25976	TCDD inducible poly(ADP-ribose) polymerase	ARTD14|DDF1|DKFZP434J214|DKFZp686N0351|PARP-1|PARP-7|PARP7|pART14|RM1	protein_coding	Q7Z3E1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20618
3.71704968211149e-109	-1.25124027996461	0.204	0.734	5.85918541391234e-105	GADD45B	Mono/Macro	GSE164551	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20619
1.11623928136006e-108	-0.990119106448111	0.292	0.795	1.75952797920786e-104	RUNX1	Mono/Macro	GSE164551	ENSG00000159216	861	RUNX family transcription factor 1	AML1|AMLCR1|CBFA2|PEBP2A2	protein_coding	Q01196	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20620
1.09587955760525e-103	-1.16521904694339	0.104	0.645	1.72743494665315e-99	RGCC	Mono/Macro	GSE164551	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20621
2.59014002203276e-102	-1.03273270224483	0.753	0.949	4.08283771673024e-98	CEBPB	Mono/Macro	GSE164551	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20622
9.22564557422312e-98	-1.09328779628111	0.32	0.805	1.45423851186479e-93	SLC11A1	Mono/Macro	GSE164551	ENSG00000018280	6556	solute carrier family 11 member 1	LSH|NRAMP|NRAMP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20623
3.48923129314557e-97	1.58743731456789	0.911	0.526	5.50007528738537e-93	HBB	Mono/Macro	GSE164551	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20624
3.21757472274986e-96	-1.10593071279892	0.753	0.93	5.0718630354706e-92	S100A10	Mono/Macro	GSE164551	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20625
3.35685436956471e-93	-0.887890365403676	0.091	0.605	5.29140954274485e-89	RASGEF1B	Mono/Macro	GSE164551	ENSG00000138670	153020	RasGEF domain family member 1B	FLJ31695|GPIG4	protein_coding	Q0VAM2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20626
7.8782595199555e-93	-1.11383316720948	0.602	0.896	1.24185004813059e-88	S100A11	Mono/Macro	GSE164551	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20627
2.50189867625203e-92	-0.929459424151752	0.61	0.898	3.94374288337608e-88	IRF2BP2	Mono/Macro	GSE164551	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20628
5.92362174696914e-91	-1.61108903632912	0.809	0.949	9.33740495974746e-87	S100A8	Mono/Macro	GSE164551	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20629
1.97192273539965e-90	-0.992009192561946	0.136	0.626	3.10834180781047e-86	RNASE2	Mono/Macro	GSE164551	ENSG00000169385	6036	ribonuclease A family member 2	EDN|RAF3|RNS2	protein_coding	P10153	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20630
4.62227876239198e-89	-0.938069176808129	0.141	0.617	7.28609801315848e-85	CDKN1A	Mono/Macro	GSE164551	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20631
1.10100604756181e-88	-0.949897842630825	0.957	0.98	1.73551583277169e-84	ACTB	Mono/Macro	GSE164551	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20632
2.31037957870062e-88	-0.870556152839281	0.18	0.665	3.64185132990579e-84	ITGA5	Mono/Macro	GSE164551	ENSG00000161638	3678	integrin subunit alpha 5	CD49e|FNRA	protein_coding	P08648	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20633
1.96002256251977e-87	-0.963289577555654	0.11	0.599	3.08958356529991e-83	VEGFA	Mono/Macro	GSE164551	ENSG00000112715	7422	vascular endothelial growth factor A	VEGF|VEGF-A|VPF	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20634
2.8281488721925e-87	-1.05951505732086	0.45	0.861	4.45801106723704e-83	MAFB	Mono/Macro	GSE164551	ENSG00000204103	9935	MAF bZIP transcription factor B	KRML	protein_coding	Q9Y5Q3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20635
6.99894519765846e-86	-0.926662725658975	0.866	0.946	1.1032437315069e-81	UBC	Mono/Macro	GSE164551	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20636
2.25757506223722e-85	1.95496244052407	0.539	0.183	3.55861557060453e-81	G0S2	Mono/Macro	GSE164551	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20637
2.60772993441188e-83	-0.871162143011713	0.478	0.853	4.11056469561344e-79	MIDN	Mono/Macro	GSE164551	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20638
6.03289949689355e-80	2.84766744370867	0.515	0.188	9.5096594769533e-76	MT1X	Mono/Macro	GSE164551	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20639
5.06877461061829e-79	-0.868335329075921	0.905	0.979	7.98990941871761e-75	VIM	Mono/Macro	GSE164551	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20640
2.96963475688468e-78	-1.45389878633842	0.812	0.943	4.68103526727732e-74	S100A9	Mono/Macro	GSE164551	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20641
2.55412148620715e-77	-1.18209298640984	0.545	0.819	4.02606169870833e-73	H1FX	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20642
1.17999924709716e-76	-0.845213614833373	0.264	0.697	1.86003281319925e-72	GABARAPL1	Mono/Macro	GSE164551	ENSG00000139112	23710	GABA type A receptor associated protein like 1	APG8L|ATG8B|ATG8L|gec1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20643
2.49941423665919e-76	-0.866632723721084	0.284	0.718	3.93982666124587e-72	ARRDC3	Mono/Macro	GSE164551	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20644
5.8218073705191e-76	-0.924882309826768	0.9	0.96	9.17691495814926e-72	TMSB10	Mono/Macro	GSE164551	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20645
4.83592312269408e-75	-0.856601282680782	0.639	0.898	7.62286561830268e-71	MCL1	Mono/Macro	GSE164551	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20646
1.81798464748264e-74	-1.00036320066431	0.335	0.735	2.86568919982688e-70	SLC16A6	Mono/Macro	GSE164551	ENSG00000108932	9120	solute carrier family 16 member 6	MCT6|MCT7	protein_coding	O15403	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20647
3.42406525593143e-74	-0.964373933666125	0.097	0.542	5.39735406292471e-70	RETN	Mono/Macro	GSE164551	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20648
5.04361524583974e-74	-0.778920485540153	0.201	0.645	7.95025071201718e-70	ETS2	Mono/Macro	GSE164551	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20649
9.10169974013727e-74	-0.805818175491382	0.444	0.822	1.43470093003784e-69	GPCPD1	Mono/Macro	GSE164551	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20650
3.16210402987635e-71	-0.937393760429548	0.128	0.575	4.9844245822941e-67	CTSL	Mono/Macro	GSE164551	ENSG00000135047	1514	cathepsin L	CTSL1|FLJ31037	protein_coding	P07711	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20651
1.3763747240624e-70	-0.796997874257851	0.184	0.612	2.16957947753955e-66	MAFF	Mono/Macro	GSE164551	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20652
1.53744995493387e-70	-1.39664236218325	0.506	0.818	2.42348236396226e-66	S100A12	Mono/Macro	GSE164551	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20653
7.3162801916576e-69	-0.747719079354552	0.771	0.936	1.15326524661099e-64	LAPTM5	Mono/Macro	GSE164551	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20654
7.87571685746995e-69	-0.785243075266976	0.32	0.735	1.24144924824299e-64	LMNA	Mono/Macro	GSE164551	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20655
5.11951107292268e-68	-0.769172319837866	0.253	0.656	8.06988530424802e-64	ITGB1	Mono/Macro	GSE164551	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20656
8.4923061599253e-68	-0.708755781091123	0.212	0.634	1.33864221998902e-63	BHLHE40	Mono/Macro	GSE164551	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20657
1.15498368114839e-66	-0.734577449886165	0.318	0.72	1.82060077659421e-62	TPM4	Mono/Macro	GSE164551	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20658
2.99318152964761e-66	0.758491171742923	0.593	0.253	4.71815204518353e-62	ZNF292	Mono/Macro	GSE164551	ENSG00000188994	23036	zinc finger protein 292	bA393I2.3|KIAA0530|ZFP292|Zn-15|Zn-16	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20659
4.90879390101964e-66	-0.784585910729572	0.786	0.901	7.73773182617726e-62	SERF2	Mono/Macro	GSE164551	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20660
3.82382349036197e-65	-0.716060628160642	0.283	0.688	6.02749296785757e-61	PLEC	Mono/Macro	GSE164551	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20661
4.48193333215439e-64	-0.741432304848046	0.303	0.707	7.06487151147497e-60	DSE	Mono/Macro	GSE164551	ENSG00000111817	29940	dermatan sulfate epimerase	DS-Epi1|DSEPI|SART2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20662
4.94932608682672e-64	-0.858930263599093	0.768	0.914	7.80162271066496e-60	CTSS	Mono/Macro	GSE164551	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20663
9.31281533580154e-64	0.831239646577527	0.284	0.052	1.4679790813824e-59	MT1E	Mono/Macro	GSE164551	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20664
2.70131716898996e-63	-0.834427390587176	0.186	0.588	4.25808625347887e-59	TSC22D3	Mono/Macro	GSE164551	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20665
3.39453485030488e-62	-0.744119228256701	0.4	0.752	5.35080528453559e-58	ANXA2	Mono/Macro	GSE164551	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20666
3.44786079531945e-62	-1.20258879192598	0.201	0.607	5.43486297166204e-58	EREG	Mono/Macro	GSE164551	ENSG00000124882	2069	epiregulin	ER	protein_coding	O14944	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20667
3.99551696669356e-62	-0.892142127668595	0.461	0.815	6.29813339459906e-58	DUSP1	Mono/Macro	GSE164551	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20668
1.90257858332707e-61	-0.744115101088326	0.864	0.941	2.99903462089847e-57	SH3BGRL3	Mono/Macro	GSE164551	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20669
2.31155564529585e-61	-0.926960268246246	0.217	0.633	3.64370516367985e-57	DUSP6	Mono/Macro	GSE164551	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20670
2.44228410131235e-61	-0.820222255067707	0.184	0.588	3.84977242889866e-57	IFITM3	Mono/Macro	GSE164551	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20671
3.29346914945442e-61	-0.721758839382385	0.615	0.886	5.19149542028499e-57	GRN	Mono/Macro	GSE164551	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20672
1.72787618587344e-59	-0.679347526153901	0.136	0.516	2.7236512317923e-55	KLF9	Mono/Macro	GSE164551	ENSG00000119138	687	KLF transcription factor 9	BTEB1	protein_coding	Q13886	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20673
1.83451821454697e-59	-0.585166992891225	0.024	0.392	2.89175106159039e-55	PNP	Mono/Macro	GSE164551	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20674
4.52677980774606e-59	-0.680749674786304	0.37	0.729	7.13556301095012e-55	ANXA5	Mono/Macro	GSE164551	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20675
7.76598000864444e-59	-0.787691388586859	0.572	0.873	1.22415142876262e-54	AC245128.3	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20676
1.3734338708899e-57	-0.686646084596073	0.519	0.845	2.16494381068375e-53	ANPEP	Mono/Macro	GSE164551	ENSG00000166825	290	alanyl aminopeptidase, membrane	AP-N|CD13|gp150|hAPN|LAP1|p150|PEPN	protein_coding	P15144	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20677
1.94800042544918e-57	-0.678757608048532	0.164	0.553	3.07063307063555e-53	KLF4	Mono/Macro	GSE164551	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20678
2.14312394302802e-57	0.727307519799572	0.55	0.251	3.37820627139507e-53	MAP3K1	Mono/Macro	GSE164551	ENSG00000095015	4214	mitogen-activated protein kinase kinase kinase 1	MAPKKK1|MEKK|MEKK1	protein_coding	Q13233	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20679
1.33889540077529e-56	-0.694929356340012	0.178	0.567	2.1105008202421e-52	SLC20A1	Mono/Macro	GSE164551	ENSG00000144136	6574	solute carrier family 20 member 1	Glvr-1|GLVR1|PiT-1|PiT1	protein_coding	Q8WUM9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20680
1.98981727819373e-56	-0.671550414544998	0.318	0.694	3.13654897561677e-52	PLAUR	Mono/Macro	GSE164551	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20681
2.57597241647689e-56	-0.665765363617268	0.27	0.637	4.06050532009252e-52	ALDH2	Mono/Macro	GSE164551	ENSG00000111275	217	aldehyde dehydrogenase 2 family member	NA	protein_coding	P05091	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20682
2.73228666718064e-56	-0.630616918800272	0.046	0.411	4.30690347347685e-52	CES1	Mono/Macro	GSE164551	ENSG00000262243	1066	carboxylesterase 1	CEH|CES1A1|CES1A2|CES2|HMSE|HMSE1|SES1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20683
9.05751957420205e-56	-0.881007515655868	0.154	0.53	1.42773681048147e-51	C5AR2	Mono/Macro	GSE164551	ENSG00000134830	27202	complement C5a receptor 2	C5L2|GPR77	protein_coding	Q9P296	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20684
4.61573024804707e-55	-0.734787036148986	0.437	0.758	7.27577558999659e-51	RAB31	Mono/Macro	GSE164551	ENSG00000168461	11031	RAB31, member RAS oncogene family	Rab22B	protein_coding	Q13636	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20685
1.20930438201157e-53	-0.874622983687138	0.351	0.734	1.90622649736484e-49	CYP1B1	Mono/Macro	GSE164551	ENSG00000138061	1545	cytochrome P450 family 1 subfamily B member 1	CP1B|GLC3A	protein_coding	Q16678	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20686
1.48875356528229e-53	-0.634240981376483	0.563	0.858	2.34672224495447e-49	UPP1	Mono/Macro	GSE164551	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20687
4.00283813557742e-53	-0.60698863586768	0.149	0.52	6.30967375311069e-49	HBEGF	Mono/Macro	GSE164551	ENSG00000113070	1839	heparin binding EGF like growth factor	DTR|DTS|HEGFL	protein_coding	Q99075	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20688
4.28504770391916e-52	-0.573035068764659	0.006	0.331	6.75452069568777e-48	TPST1	Mono/Macro	GSE164551	ENSG00000169902	8460	tyrosylprotein sulfotransferase 1	TANGO13A	protein_coding	O60507	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20689
7.12732942507556e-52	-0.740673827036377	0.271	0.616	1.12348093727466e-47	PLBD1	Mono/Macro	GSE164551	ENSG00000121316	79887	phospholipase B domain containing 1	FLJ22662	protein_coding	Q6P4A8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20690
1.81613668825327e-51	-0.554353479082265	0.043	0.381	2.86277626169364e-47	GRASP	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20691
4.13046668993265e-51	-0.649039799617375	0.894	0.966	6.51085464334084e-47	H3F3B	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20692
5.95360315310971e-51	-0.573314936803389	0.13	0.488	9.38466465024684e-47	HAVCR2	Mono/Macro	GSE164551	ENSG00000135077	84868	hepatitis A virus cellular receptor 2	CD366|FLJ14428|Tim-3|TIM3|TIMD3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20693
1.65942560642492e-50	-0.572838363220372	0.007	0.326	2.6157525834076e-46	IL10	Mono/Macro	GSE164551	ENSG00000136634	3586	interleukin 10	CSIF|IL-10|IL10A|TGIF	protein_coding	P22301	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20694
9.19535604587388e-50	-0.815745111376382	0.199	0.55	1.4494639735111e-45	AC103591.3	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20695
1.14464727534534e-49	0.531443778569825	0.422	0.156	1.80430750012686e-45	CDC42SE2	Mono/Macro	GSE164551	ENSG00000158985	56990	CDC42 small effector 2	FLJ21967|SPEC2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20696
1.24694345203921e-49	-0.613838606335393	0.316	0.672	1.9655569634494e-45	MAP1LC3B	Mono/Macro	GSE164551	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20697
3.19104560767018e-49	-0.532462845986457	0.009	0.324	5.03004519137051e-45	OLR1	Mono/Macro	GSE164551	ENSG00000173391	4973	oxidized low density lipoprotein receptor 1	CLEC8A|LOX-1|SCARE1	protein_coding	P78380	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20698
5.29637927442428e-49	0.631679337478489	0.483	0.21	8.34868265027499e-45	YIPF4	Mono/Macro	GSE164551	ENSG00000119820	84272	Yip1 domain family member 4	FinGER4|MGC11061	protein_coding	Q9BSR8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20699
5.4123469344011e-49	-0.697657143445652	0.494	0.79	8.53148247269645e-45	FCER1G	Mono/Macro	GSE164551	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20700
6.32546111626024e-49	-0.663161554185869	0.322	0.678	9.97082435756101e-45	JMJD1C	Mono/Macro	GSE164551	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20701
1.18669345357603e-48	-0.533819230343144	0.167	0.527	1.87058489087189e-44	SKIL	Mono/Macro	GSE164551	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20702
3.23605081517274e-48	-0.612216853744398	0.374	0.691	5.10098689995678e-44	ARF6	Mono/Macro	GSE164551	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20703
3.60127987068539e-48	-0.582928324559657	0.219	0.559	5.67669746016137e-44	STK24	Mono/Macro	GSE164551	ENSG00000102572	8428	serine/threonine kinase 24	MST-3|MST3|MST3B|STE20|STK3	protein_coding	Q9Y6E0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20704
2.02973314453974e-47	-0.64645954640911	0.727	0.861	3.19946835573799e-43	MYL6	Mono/Macro	GSE164551	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20705
2.7485462993662e-47	-0.608350181457041	0.738	0.889	4.33253353169094e-43	OAZ1	Mono/Macro	GSE164551	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20706
3.14868094556534e-47	-0.720821770543078	0.422	0.745	4.96326577449465e-43	GPR183	Mono/Macro	GSE164551	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20707
5.29245256121678e-47	-0.653792412241558	0.576	0.863	8.34249297224601e-43	JARID2	Mono/Macro	GSE164551	ENSG00000008083	3720	jumonji and AT-rich interaction domain containing 2	JMJ	protein_coding	Q92833	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20708
1.75509926343938e-46	-0.61418156132764	0.201	0.542	2.76656296895949e-42	PPIF	Mono/Macro	GSE164551	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20709
1.99542987685844e-46	-0.742542540000934	0.022	0.332	3.14539611489195e-42	RGS1	Mono/Macro	GSE164551	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20710
6.70872487479974e-46	-0.5976414437039	0.576	0.831	1.05749630201468e-41	RAC1	Mono/Macro	GSE164551	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20711
6.04007690095712e-45	-0.552525525532953	0.184	0.516	9.52097321897871e-41	CSRNP1	Mono/Macro	GSE164551	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20712
1.2198001697416e-44	-0.490956014297308	0.019	0.313	1.92277100756368e-40	SKI	Mono/Macro	GSE164551	ENSG00000157933	6497	SKI proto-oncogene	NA	protein_coding	P12755	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20713
2.29161869365744e-44	-0.667366847755605	0.48	0.79	3.61227854681223e-40	ATP13A3	Mono/Macro	GSE164551	ENSG00000133657	79572	ATPase 13A3	AFURS1	protein_coding	Q9H7F0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20714
2.34091848101445e-44	-0.536000010663558	0.022	0.317	3.68998980162308e-40	ZNF331	Mono/Macro	GSE164551	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20715
5.55611133093405e-44	-0.602331584522341	0.216	0.556	8.75809829095134e-40	EHD1	Mono/Macro	GSE164551	ENSG00000110047	10938	EH domain containing 1	FLJ42622|FLJ44618|H-PAST|HPAST1|PAST1	protein_coding	Q9H4M9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20716
1.38653583210007e-43	-0.832781187716501	0.255	0.569	2.18559643213934e-39	INSIG1	Mono/Macro	GSE164551	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20717
2.46399076124843e-43	0.709218447929985	0.792	0.648	3.88398863695589e-39	PTPRC	Mono/Macro	GSE164551	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20718
3.07113287168844e-43	-0.928320857090356	0.342	0.687	4.84102674564248e-39	SERPINB2	Mono/Macro	GSE164551	ENSG00000197632	5055	serpin family B member 2	HsT1201|PAI-2|PAI2|PLANH2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20719
5.89579865386432e-43	-0.613550461124711	0.327	0.63	9.29354741808633e-39	CSTB	Mono/Macro	GSE164551	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20720
6.07688260859285e-43	-0.577760841834581	0.474	0.766	9.57899005592492e-39	ARHGDIB	Mono/Macro	GSE164551	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20721
1.15485114515441e-42	-0.719984585945398	0.236	0.573	1.82039186010689e-38	JUN	Mono/Macro	GSE164551	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20722
2.65815840107193e-42	-0.541695313292935	0.584	0.826	4.19005508760968e-38	YWHAZ	Mono/Macro	GSE164551	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20723
3.16351253621803e-42	1.00192288614137	0.673	0.387	4.98664481084048e-38	HBA1	Mono/Macro	GSE164551	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20724
5.68502276858469e-42	-0.570180620414711	0.998	1	8.96130139012005e-38	MALAT1	Mono/Macro	GSE164551	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20725
1.41706565296565e-41	-0.64284580067935	0.892	0.951	2.23372058876976e-37	TMSB4X	Mono/Macro	GSE164551	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20726
1.63964185148484e-41	-0.664930653693354	0.017	0.295	2.58456745049555e-37	RNASE1	Mono/Macro	GSE164551	ENSG00000129538	6035	ribonuclease A family member 1, pancreatic	RAC1|RNS1	protein_coding	P07998	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20727
4.55678266624001e-41	-0.543225478648386	0.327	0.639	7.18285651679412e-37	UBALD2	Mono/Macro	GSE164551	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20728
5.53374241522263e-41	-0.532456021993494	0.266	0.585	8.72283816911544e-37	CALR	Mono/Macro	GSE164551	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20729
3.71374059149625e-40	-0.498492157246584	0.19	0.508	5.85396929437554e-36	TREM1	Mono/Macro	GSE164551	ENSG00000124731	54210	triggering receptor expressed on myeloid cells 1	CD354|TREM-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20730
5.39715744598893e-40	-0.477625311343721	0.112	0.413	8.50753928211235e-36	MAP1S	Mono/Macro	GSE164551	ENSG00000130479	55201	microtubule associated protein 1S	BPY2IP1|C19orf5|FLJ10669|MAP8|VCY2IP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20731
6.20667130242213e-40	0.477316912522634	0.392	0.155	9.78357597400801e-36	CACUL1	Mono/Macro	GSE164551	ENSG00000151893	143384	CDK2 associated cullin domain 1	C10orf46|CAC1|FLJ40409|MGC33215	protein_coding	Q86Y37	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20732
6.627913851227e-40	-0.451971249978507	0.074	0.369	1.04475806036891e-35	IRF2BPL	Mono/Macro	GSE164551	ENSG00000119669	64207	interferon regulatory factor 2 binding protein like	C14orf4|EAP1|KIAA1865	protein_coding	Q9H1B7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20733
6.6992333165272e-40	-0.497144311416885	0.158	0.479	1.05600014768418e-35	NDRG1	Mono/Macro	GSE164551	ENSG00000104419	10397	N-myc downstream regulated 1	CAP43|DRG1|NDR1|RTP|TDD5	protein_coding	Q92597	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20734
8.62036115877794e-40	-0.514984804057965	0.022	0.294	1.35882752945817e-35	OSM	Mono/Macro	GSE164551	ENSG00000099985	5008	oncostatin M	MGC20461	protein_coding	P13725	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20735
2.12023705580855e-39	-0.644502422003041	0.907	0.96	3.34212967107102e-35	LYZ	Mono/Macro	GSE164551	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20736
2.42791653979786e-39	0.751089038288145	0.37	0.145	3.82712484168337e-35	EGR1	Mono/Macro	GSE164551	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20737
4.02606842002225e-39	-0.485170053759063	0.006	0.265	6.34629165048107e-35	VSIG4	Mono/Macro	GSE164551	ENSG00000155659	11326	V-set and immunoglobulin domain containing 4	CRIg|Z39IG	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20738
5.81020306512964e-39	-0.487002976768998	0.05	0.329	9.15862309156385e-35	EMP1	Mono/Macro	GSE164551	ENSG00000134531	2012	epithelial membrane protein 1	CL-20|TMP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20739
1.26735086365362e-38	-0.61364175837681	0.859	0.974	1.9977251663772e-34	THBS1	Mono/Macro	GSE164551	ENSG00000137801	7057	thrombospondin 1	THBS|THBS-1|TSP|TSP-1|TSP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20740
3.2325774789584e-38	-0.510076936198643	0.177	0.479	5.09551188008212e-34	CD36	Mono/Macro	GSE164551	ENSG00000135218	948	CD36 molecule	FAT|GP3B|GP4|GPIV|SCARB3	protein_coding	P16671	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20741
5.23389424562983e-38	-0.569933018270216	0.236	0.542	8.25018749938631e-34	HSP90B1	Mono/Macro	GSE164551	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20742
6.07370040411907e-38	-0.590908996818127	0.26	0.58	9.57397394701288e-34	C5AR1	Mono/Macro	GSE164551	ENSG00000197405	728	complement C5a receptor 1	C5A|C5AR|C5R1|CD88	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20743
8.33536498090743e-38	0.78219782240425	1	1	1.31390358194044e-33	MT-CYB	Mono/Macro	GSE164551	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20744
1.13965591223233e-37	0.369649320363625	0.31	0.102	1.79643961445182e-33	BBX	Mono/Macro	GSE164551	ENSG00000114439	56987	BBX high mobility group box domain containing	HBP2|HSPC339|MDS001	protein_coding	Q8WY36	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20745
1.45575803139668e-37	-0.489027029978501	0.212	0.51	2.29471138489059e-33	HCLS1	Mono/Macro	GSE164551	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20746
1.87023970255715e-37	-0.545820417833876	0.182	0.481	2.94805884314084e-33	IER5L	Mono/Macro	GSE164551	ENSG00000188483	389792	immediate early response 5 like	bA247A12.2	protein_coding	Q5T953	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20747
3.00097805773375e-37	-0.527201101095983	0.242	0.547	4.73044171240571e-33	ZMIZ1	Mono/Macro	GSE164551	ENSG00000108175	57178	zinc finger MIZ-type containing 1	FLJ13541|hZIMP10|KIAA1224|MIZ|RAI17|RP11-519K18.1|Zimp10	protein_coding	Q9ULJ6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20748
5.02613909799191e-37	-0.526070217481796	0.504	0.811	7.92270306016465e-33	CD14	Mono/Macro	GSE164551	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20749
5.34002480842399e-37	-0.601227682523795	0.413	0.685	8.41748110551873e-33	AHNAK	Mono/Macro	GSE164551	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20750
8.70159507628506e-37	-0.49174106626228	0.217	0.525	1.37163243187481e-32	MTSS1	Mono/Macro	GSE164551	ENSG00000170873	9788	MTSS I-BAR domain containing 1	KIAA0429|MIM|MIMA|MIMB	protein_coding	O43312	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20751
9.46253815446883e-37	-0.513084241679477	0.18	0.475	1.49157988928892e-32	CYTOR	Mono/Macro	GSE164551	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20752
9.88637769319531e-37	-0.430064219002294	0.167	0.469	1.55838971577838e-32	GLIPR2	Mono/Macro	GSE164551	ENSG00000122694	152007	GLI pathogenesis related 2	C9orf19|GAPR-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20753
1.03457235188792e-36	0.58817874533459	0.556	0.318	1.63079639828093e-32	FAR1	Mono/Macro	GSE164551	ENSG00000197601	84188	fatty acyl-CoA reductase 1	FLJ22728|MLSTD2|SDR10E1	protein_coding	Q8WVX9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20754
1.05825131354355e-36	-0.467209184135597	0.249	0.558	1.6681215455387e-32	TGFB1	Mono/Macro	GSE164551	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20755
1.15939993239753e-36	-0.485075489287887	0.123	0.416	1.82756211343822e-32	ARL4A	Mono/Macro	GSE164551	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20756
1.1715958572087e-36	-0.443538947025941	0.072	0.347	1.84678654971807e-32	RFX2	Mono/Macro	GSE164551	ENSG00000087903	5990	regulatory factor X2	FLJ14226	protein_coding	P48378	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20757
1.44657406579268e-36	-0.51959635297742	0.779	0.918	2.28023469990901e-32	CST3	Mono/Macro	GSE164551	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20758
1.46718706911481e-36	-0.45709908931705	0.095	0.381	2.31272697704567e-32	ELL2	Mono/Macro	GSE164551	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20759
7.028654821299e-36	-0.549996781453049	0.504	0.761	1.10792685948136e-31	NINJ1	Mono/Macro	GSE164551	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20760
8.12938154858653e-36	-0.641746763844677	0.736	0.899	1.2814344135037e-31	TIMP1	Mono/Macro	GSE164551	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20761
9.10036966181001e-36	-0.50117263780824	0.331	0.612	1.43449126979111e-31	TXN	Mono/Macro	GSE164551	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20762
9.67511048887516e-36	-0.472835687195903	0.106	0.389	1.52508766636139e-31	SLC7A5	Mono/Macro	GSE164551	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20763
1.85914764708705e-35	-0.635730938503913	0.825	0.924	2.93057443610332e-31	S100A4	Mono/Macro	GSE164551	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20764
2.28497494889142e-35	-0.468190265381367	0.173	0.461	3.60180601193754e-31	SNHG15	Mono/Macro	GSE164551	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20765
6.15938295054338e-35	-0.455469141694724	0.191	0.483	9.70903534494153e-31	NFIL3	Mono/Macro	GSE164551	ENSG00000165030	4783	nuclear factor, interleukin 3 regulated	E4BP4|IL3BP1|NF-IL3A|NFIL3A	protein_coding	Q16649	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20766
7.93495476995818e-35	-0.462886128094686	0.336	0.625	1.25078692038851e-30	GSTO1	Mono/Macro	GSE164551	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20767
9.63236811856547e-35	-0.637766993383666	0.217	0.501	1.51835018652947e-30	ID2	Mono/Macro	GSE164551	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20768
1.21558045748443e-34	-0.469243405316507	0.701	0.894	1.9161194751327e-30	H2AFY	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20769
1.81063339251673e-34	-0.507145741000704	0.405	0.693	2.85410141662413e-30	CTNNB1	Mono/Macro	GSE164551	ENSG00000168036	1499	catenin beta 1	armadillo|beta-catenin|CTNNB	protein_coding	P35222	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20770
2.29701619311039e-34	0.52359987312466	0.481	0.249	3.6207866251999e-30	STK4	Mono/Macro	GSE164551	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20771
2.46278519143211e-34	-0.542548228902372	0.546	0.804	3.88208829725444e-30	TSPO	Mono/Macro	GSE164551	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20772
6.32717761832172e-34	-0.656983318306499	0.312	0.594	9.97353007976053e-30	HSPA5	Mono/Macro	GSE164551	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20773
8.99533906800584e-34	0.79223046597013	1	1	1.41793529728976e-29	MT-ND1	Mono/Macro	GSE164551	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20774
1.25226786350779e-33	-0.494429883670306	0.385	0.675	1.97394983324734e-29	CD68	Mono/Macro	GSE164551	ENSG00000129226	968	CD68 molecule	DKFZp686M18236|GP110|LAMP4|SCARD1	protein_coding	P34810	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20775
1.45032720233443e-33	-0.46985990340222	0.318	0.621	2.28615076903976e-29	FOXO3	Mono/Macro	GSE164551	ENSG00000118689	2309	forkhead box O3	AF6q21|FKHRL1|FOXO2|FOXO3A	protein_coding	O43524	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20776
3.76077579686126e-33	-0.440647226883908	0.204	0.489	5.92811088859241e-29	EAF1	Mono/Macro	GSE164551	ENSG00000144597	85403	ELL associated factor 1	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20777
4.06327230070444e-33	-0.422295775063799	0.039	0.284	6.40493612760041e-29	LHFPL2	Mono/Macro	GSE164551	ENSG00000145685	10184	LHFPL tetraspan subfamily member 2	KIAA0206	protein_coding	Q6ZUX7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20778
8.78909103916524e-33	0.368597123977385	0.327	0.125	1.38542442050362e-28	DDHD1	Mono/Macro	GSE164551	ENSG00000100523	80821	DDHD domain containing 1	iPLA1alpha|KIAA1705|PA-PLA1|PAPLA1|SPG28	protein_coding	Q8NEL9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20779
8.99334271925259e-33	-0.415464718344827	0.152	0.432	1.41762061283578e-28	SNHG25	Mono/Macro	GSE164551	ENSG00000266402	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20780
1.06141074353663e-32	-0.436727654999688	0.119	0.389	1.67310175503678e-28	BIN1	Mono/Macro	GSE164551	ENSG00000136717	274	bridging integrator 1	AMPH2|AMPHL|SH3P9	protein_coding	O00499	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20781
1.83387367701316e-32	2.34498663492524	0.807	0.648	2.89073507707585e-28	MT2A	Mono/Macro	GSE164551	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20782
2.10040772666574e-32	-0.500954217632755	0.271	0.558	3.3108726995432e-28	PIK3R1	Mono/Macro	GSE164551	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20783
2.24873446554184e-32	-0.406811214804866	0.115	0.382	3.54468013803361e-28	BLVRB	Mono/Macro	GSE164551	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20784
3.06897294957274e-32	-0.415524584535057	0.112	0.37	4.83762206041151e-28	MAP2K1	Mono/Macro	GSE164551	ENSG00000169032	5604	mitogen-activated protein kinase kinase 1	MAPKK1|MEK1|PRKMK1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20785
3.84476353218082e-32	-0.497967072145122	0.857	0.948	6.06050075577663e-28	PSAP	Mono/Macro	GSE164551	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20786
4.49015694350265e-32	-0.438727148196577	0.048	0.289	7.07783439004322e-28	IL1R1	Mono/Macro	GSE164551	ENSG00000115594	3554	interleukin 1 receptor type 1	CD121A|D2S1473|IL1R|IL1RA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20787
1.30522625667093e-31	-0.510952699741708	0.732	0.857	2.05742814839039e-27	BTG1	Mono/Macro	GSE164551	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20788
1.32897089954413e-31	-0.394554534549617	0.097	0.353	2.09485682895141e-27	TRMT6	Mono/Macro	GSE164551	ENSG00000089195	51605	tRNA methyltransferase 6 non-catalytic subunit	CGI-09|GCD10|Gcd10p|MGC5029	protein_coding	Q9UJA5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20789
4.00169698492737e-31	-0.482039964992065	0.58	0.849	6.30787495734102e-27	CEBPD	Mono/Macro	GSE164551	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20790
7.06373044212202e-31	-0.465343424163703	0.136	0.396	1.11345582959169e-26	H1F0	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20791
8.25344865383269e-31	-0.572538368065754	0.747	0.89	1.30099111130365e-26	ZFP36L1	Mono/Macro	GSE164551	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20792
1.03291633502884e-30	0.525047662479016	0.546	0.326	1.62818601890596e-26	SF1	Mono/Macro	GSE164551	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20793
1.72514903038609e-30	-0.465768396739121	0.388	0.636	2.7193524165976e-26	ARPC1B	Mono/Macro	GSE164551	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20794
2.06773159846916e-30	-0.382030668439226	0.375	0.669	3.25936531866693e-26	MXD1	Mono/Macro	GSE164551	ENSG00000059728	4084	MAX dimerization protein 1	bHLHc58|MAD|MAD1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20795
2.40548715117613e-30	-0.470127422599533	0.123	0.388	3.79176939639893e-26	ANKRD28	Mono/Macro	GSE164551	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20796
5.17341692800719e-30	-0.431682582346636	0.182	0.451	8.15485710361774e-26	ZCCHC2	Mono/Macro	GSE164551	ENSG00000141664	54877	zinc finger CCHC-type containing 2	C18orf49|FLJ20222|FLJ20281|KIAA1744	protein_coding	Q9C0B9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20797
5.43292688385985e-30	-0.402037081977788	0.173	0.436	8.56392264702828e-26	HMGA1	Mono/Macro	GSE164551	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20798
5.59800531405023e-30	-0.435537609334013	0.39	0.651	8.82413577653738e-26	FKBP1A	Mono/Macro	GSE164551	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20799
7.2797270459159e-30	-0.428958242885473	0.115	0.376	1.14750337424772e-25	NR4A2	Mono/Macro	GSE164551	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20800
8.57192193344097e-30	0.435531565917445	0.444	0.233	1.3511920543683e-25	LRRC25	Mono/Macro	GSE164551	ENSG00000175489	126364	leucine rich repeat containing 25	FLJ38116|MAPA	protein_coding	Q8N386	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20801
1.27161379409777e-29	-0.398099446049955	0.104	0.354	2.00444482363631e-25	SERPINB9	Mono/Macro	GSE164551	ENSG00000170542	5272	serpin family B member 9	CAP3|PI9	protein_coding	P50453	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20802
4.25766107190786e-29	-0.357517527168285	0.082	0.327	6.71135114764835e-25	CD109	Mono/Macro	GSE164551	ENSG00000156535	135228	CD109 molecule	CPAMD7|DKFZp762L1111|FLJ38569	protein_coding	Q6YHK3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20803
5.13103178725998e-29	-0.434971970329783	0.245	0.506	8.08804540625791e-25	EHD4	Mono/Macro	GSE164551	ENSG00000103966	30844	EH domain containing 4	PAST4	protein_coding	Q9H223	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20804
6.83040191089502e-29	-0.421641639917299	0.193	0.459	1.07667625321438e-24	STAB1	Mono/Macro	GSE164551	ENSG00000010327	23166	stabilin 1	CLEVER-1|FEEL-1|FELE-1|FEX1|KIAA0246|SCARH2|STAB-1	protein_coding	Q9NY15	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20805
1.06294472414181e-28	-0.66826828922948	0.078	0.312	1.67551976866473e-24	PTGS2	Mono/Macro	GSE164551	ENSG00000073756	5743	prostaglandin-endoperoxide synthase 2	COX2	protein_coding	P35354	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20806
1.12159513642201e-28	0.525817792338786	0.396	0.199	1.76797041354201e-24	TUBA1A	Mono/Macro	GSE164551	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20807
1.12692410831408e-28	-0.419060048764129	0.379	0.639	1.77637047193548e-24	CTSZ	Mono/Macro	GSE164551	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20808
1.14417029872792e-28	-0.405421287458969	0.125	0.373	1.80355564188482e-24	ATF3	Mono/Macro	GSE164551	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20809
2.02631850460267e-28	-0.47396542946228	0.623	0.844	3.19408585880519e-24	CD63	Mono/Macro	GSE164551	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20810
2.49462783037877e-28	-0.510996879357086	0.532	0.784	3.93228184902605e-24	SEMA6B	Mono/Macro	GSE164551	ENSG00000167680	10501	semaphorin 6B	SEM-SEMA-Z|SEMA-VIB|SEMAN|semaZ	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20811
2.90778411839025e-28	-0.394527446104358	0.468	0.733	4.58354010581855e-24	TMBIM6	Mono/Macro	GSE164551	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20812
3.67466780043742e-28	-0.450874761616112	0.4	0.66	5.79237885382951e-24	BCL2A1	Mono/Macro	GSE164551	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20813
3.91540401223171e-28	-0.458282702790891	0.164	0.418	6.17185134448085e-24	LUCAT1	Mono/Macro	GSE164551	ENSG00000248323	NA	NA	SCAL1|SCAT5	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20814
4.17039910581731e-28	-0.374216634443641	0.128	0.374	6.57380011049983e-24	B3GNT5	Mono/Macro	GSE164551	ENSG00000176597	84002	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	B3GN-T5|beta3Gn-T5	protein_coding	Q9BYG0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20815
5.96210187356377e-28	-0.470199027744749	0.708	0.878	9.39806118329857e-24	CD44	Mono/Macro	GSE164551	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20816
7.86083402254939e-28	-0.471851509114679	0.401	0.681	1.23910326697446e-23	AC020656.1	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20817
1.13222168237916e-27	-0.346306277471997	0.039	0.252	1.78472103793427e-23	ALAS1	Mono/Macro	GSE164551	ENSG00000023330	211	5'-aminolevulinate synthase 1	ALAS|ALAS-H|ALAS3	protein_coding	P13196	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20818
1.16374305736089e-27	-0.450385639514557	0.26	0.533	1.83440818131798e-23	PHLDA1	Mono/Macro	GSE164551	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20819
1.94629536646041e-27	-0.34457460207405	0.097	0.333	3.06794538615154e-23	PLXDC2	Mono/Macro	GSE164551	ENSG00000120594	84898	plexin domain containing 2	FLJ14623|TEM7R	protein_coding	Q6UX71	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20820
2.01725005170707e-27	0.496512703309495	0.513	0.3	3.17979125650586e-23	RICTOR	Mono/Macro	GSE164551	ENSG00000164327	253260	RPTOR independent companion of MTOR complex 2	AVO3|KIAA1999|MGC39830|PIA	protein_coding	Q6R327	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20821
2.25298141464094e-27	-0.362119462489213	0.052	0.271	3.55137460389851e-23	ITGAV	Mono/Macro	GSE164551	ENSG00000138448	3685	integrin subunit alpha V	CD51|MSK8|VNRA|VTNR	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20822
2.45194770149215e-27	0.417463599217346	0.455	0.247	3.86500516186207e-23	TANK	Mono/Macro	GSE164551	ENSG00000136560	10010	TRAF family member associated NFKB activator	I-TRAF|TRAF2	protein_coding	Q92844	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20823
2.74420736372425e-27	-0.399369417085393	0.651	0.873	4.32569406743853e-23	CLEC7A	Mono/Macro	GSE164551	ENSG00000172243	64581	C-type lectin domain containing 7A	CD369|CLECSF12|DECTIN-1|hDectin-1|SCARE2	protein_coding	Q9BXN2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20824
3.14878285238439e-27	-0.423308084349512	0.474	0.738	4.96342641021352e-23	ZBTB43	Mono/Macro	GSE164551	ENSG00000169155	23099	zinc finger and BTB domain containing 43	FLJ22470|KIAA0414|ZBTB22B|ZNF-X|ZNF297B	protein_coding	O43298	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20825
3.88223925474034e-27	-0.388095546051911	0.186	0.442	6.1195737372472e-23	PLK3	Mono/Macro	GSE164551	ENSG00000173846	1263	polo like kinase 3	CNK|FNK|PRK	protein_coding	Q9H4B4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20826
1.05088291490473e-26	-0.473092991300184	0.223	0.462	1.65650673876432e-22	DBI	Mono/Macro	GSE164551	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20827
1.81466366846458e-26	-0.255979422986156	0.743	0.938	2.86045434060072e-22	SLC2A3	Mono/Macro	GSE164551	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20828
3.67153843906912e-26	-0.372797238624744	0.169	0.411	5.78744604150466e-22	RALGDS	Mono/Macro	GSE164551	ENSG00000160271	5900	ral guanine nucleotide dissociation stimulator	RalGEF|RGDS|RGF	protein_coding	Q12967	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20829
3.95130645606041e-26	-0.348593342600711	0.232	0.494	6.22844436668803e-22	CD53	Mono/Macro	GSE164551	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20830
4.22765108772307e-26	-0.418637835667745	0.335	0.577	6.66404640957788e-22	YPEL5	Mono/Macro	GSE164551	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20831
5.83908504817617e-26	-0.384458948474107	0.203	0.447	9.20414976144009e-22	MPP1	Mono/Macro	GSE164551	ENSG00000130830	4354	MAGUK p55 scaffold protein 1	DXS552E|PEMP	protein_coding	Q00013	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20832
9.93358654231872e-26	0.357798759785012	0.283	0.114	1.5658312466657e-21	POU2F2	Mono/Macro	GSE164551	ENSG00000028277	5452	POU class 2 homeobox 2	OCT2|OTF2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20833
1.16942251394903e-25	-0.325757205369103	0.641	0.847	1.84336070873786e-21	HLA-DRB1	Mono/Macro	GSE164551	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20834
1.88304234899864e-25	-0.43147757763347	0.307	0.561	2.96823965472655e-21	SOCS3	Mono/Macro	GSE164551	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20835
2.24600936369945e-25	-0.379541817964597	0.104	0.329	3.54038455999944e-21	UBAC2	Mono/Macro	GSE164551	ENSG00000134882	337867	UBA domain containing 2	FLJ30548|PHGDHL1|RP11-178C10.1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20836
3.82735847757328e-25	-0.513680398589225	0.623	0.837	6.03306516819876e-21	LGALS1	Mono/Macro	GSE164551	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20837
4.35503888003037e-25	-0.356476593250843	0.136	0.368	6.86484778659188e-21	TRIB1	Mono/Macro	GSE164551	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20838
5.23327542179878e-25	-0.424434363261837	0.333	0.572	8.24921204738142e-21	TGFBI	Mono/Macro	GSE164551	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20839
5.7622546088187e-25	-0.356196366024953	0.201	0.44	9.08304193988091e-21	CAPG	Mono/Macro	GSE164551	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20840
6.76022863351844e-25	0.409824836696958	0.398	0.208	1.06561483950151e-20	ARID4A	Mono/Macro	GSE164551	ENSG00000032219	5926	AT-rich interaction domain 4A	RBBP1|RBP-1|RBP1	protein_coding	P29374	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20841
8.1905076976681e-25	-0.386065217721049	0.154	0.389	1.29106972838342e-20	PRDM1	Mono/Macro	GSE164551	ENSG00000057657	639	PR/SET domain 1	BLIMP1|PRDI-BF1	protein_coding	O75626	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20842
1.76732217165008e-24	-0.398977056549604	0.428	0.669	2.78582993917203e-20	RAP2B	Mono/Macro	GSE164551	ENSG00000181467	5912	RAP2B, member of RAS oncogene family	NA	protein_coding	P61225	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20843
1.97625857156279e-24	-0.345965010154678	0.188	0.427	3.11517638635443e-20	BSG	Mono/Macro	GSE164551	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20844
2.20351382072041e-24	-0.368362348847608	0.141	0.368	3.47339883560158e-20	SMOX	Mono/Macro	GSE164551	ENSG00000088826	54498	spermine oxidase	C20orf16|dJ779E11.1|FLJ20746|MGC1010|PAO|PAOh1|SMO	protein_coding	Q9NWM0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20845
2.21435910513048e-24	-0.449071810757637	0.368	0.615	3.49049425741717e-20	CD300E	Mono/Macro	GSE164551	ENSG00000186407	342510	CD300e molecule	CD300LE|CLM2|IREM2	protein_coding	Q496F6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20846
2.48456321491368e-24	-0.541262414606372	0.45	0.687	3.91641699566844e-20	ARL4C	Mono/Macro	GSE164551	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20847
2.49947443371647e-24	-0.590867830476058	0.528	0.741	3.93992154986727e-20	AIF1	Mono/Macro	GSE164551	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20848
2.75759175682255e-24	-0.320264619542217	0.134	0.361	4.34679188627938e-20	NDUFA3	Mono/Macro	GSE164551	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20849
4.33437278573068e-24	-0.375080208647324	0.225	0.478	6.83227182214726e-20	CD93	Mono/Macro	GSE164551	ENSG00000125810	22918	CD93 molecule	C1qR(P)|C1QR1|C1qRP|CDw93|dJ737E23.1|ECSM3|MXRA4	protein_coding	Q9NPY3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20850
4.69578445498859e-24	-0.385985119170609	0.42	0.682	7.40196503639852e-20	COX6B1	Mono/Macro	GSE164551	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20851
5.44972294776778e-24	-0.365793100990483	0.234	0.469	8.59039828256635e-20	ATP5MF	Mono/Macro	GSE164551	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20852
6.04323950427784e-24	-0.359058354409813	0.307	0.564	9.52595843059316e-20	AKAP13	Mono/Macro	GSE164551	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20853
6.16201355362628e-24	-0.343565748465028	0.275	0.523	9.71318196458111e-20	GNA15	Mono/Macro	GSE164551	ENSG00000060558	2769	G protein subunit alpha 15	GNA16	protein_coding	P30679	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20854
7.47782666854735e-24	-0.406315991372923	0.762	0.893	1.17872981776312e-19	CYBA	Mono/Macro	GSE164551	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20855
7.73800115659602e-24	-0.320516274345464	0.091	0.302	1.21974112231423e-19	EIF4E	Mono/Macro	GSE164551	ENSG00000151247	1977	eukaryotic translation initiation factor 4E	EIF4E1|EIF4EL1|EIF4F	protein_coding	P06730	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20856
8.6987546851292e-24	-0.360689067633991	0.063	0.262	1.37118470101692e-19	MARCO	Mono/Macro	GSE164551	ENSG00000019169	8685	macrophage receptor with collagenous structure	SCARA2|SR-A6	protein_coding	Q9UEW3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20857
9.86849437649607e-24	-0.387786101194953	0.74	0.894	1.55557076856708e-19	EMP3	Mono/Macro	GSE164551	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20858
1.15767138292535e-23	-0.491120830477776	0.318	0.542	1.82483740090522e-19	SELL	Mono/Macro	GSE164551	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20859
1.20622990902377e-23	0.28978886214177	0.27	0.109	1.90138020559417e-19	OAZ2	Mono/Macro	GSE164551	ENSG00000180304	4947	ornithine decarboxylase antizyme 2	NA	protein_coding	O95190	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20860
1.29789906121796e-23	0.731870390393909	1	1	2.04587829019787e-19	MT-CO3	Mono/Macro	GSE164551	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20861
1.51997029386076e-23	-0.377885146170287	0.452	0.68	2.39592917421272e-19	MSN	Mono/Macro	GSE164551	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20862
1.54073218012823e-23	-0.35418984430246	0.141	0.362	2.42865613553613e-19	SYAP1	Mono/Macro	GSE164551	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20863
1.65816430107887e-23	-0.360134529991676	0.678	0.857	2.61376438779062e-19	PFN1	Mono/Macro	GSE164551	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20864
2.30324634606716e-23	-0.381231034477343	0.892	0.946	3.63060721530566e-19	H3F3A	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20865
2.41022737849063e-23	-0.35276269105898	0.128	0.34	3.79924141671477e-19	RNASE6	Mono/Macro	GSE164551	ENSG00000169413	6039	ribonuclease A family member k6	RAD1|RNaseK6|RNS6	protein_coding	Q93091	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20866
2.61243357942969e-23	-0.350766977216465	0.312	0.548	4.11797905125502e-19	SH3BGRL	Mono/Macro	GSE164551	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20867
2.85632283704498e-23	-0.329043839596192	0.056	0.252	4.50242168803401e-19	ANKH	Mono/Macro	GSE164551	ENSG00000154122	56172	ANKH inorganic pyrophosphate transport regulator	ANK|CCAL2|CMDJ|CPPDD|HANK|SLC62A1	protein_coding	Q9HCJ1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20868
3.0955682554857e-23	0.419596543167758	0.455	0.268	4.87954424112211e-19	LCOR	Mono/Macro	GSE164551	ENSG00000196233	84458	ligand dependent nuclear receptor corepressor	C10orf12|DKFZP564P1916|FLJ13022|FLJ38026|KIAA1795|MLR2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20869
3.10223055930755e-23	-0.325284180213239	0.139	0.357	4.89004603063649e-19	UQCRC1	Mono/Macro	GSE164551	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20870
3.65111733509744e-23	0.508583406854252	0.656	0.56	5.7552562553141e-19	LSP1	Mono/Macro	GSE164551	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20871
3.85611217979211e-23	-0.367773222965535	0.39	0.623	6.0783896290063e-19	DNAJB6	Mono/Macro	GSE164551	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20872
4.68887342968167e-23	0.305885469287267	0.253	0.1	7.39107118720722e-19	ORAI2	Mono/Macro	GSE164551	ENSG00000160991	80228	ORAI calcium release-activated calcium modulator 2	C7orf19|CBCIP2|FLJ12474|FLJ14733|H_NH0514P08.8|TMEM142B	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20873
5.43029206064397e-23	-0.376928087453884	0.245	0.482	8.5597693751931e-19	NLRP3	Mono/Macro	GSE164551	ENSG00000162711	114548	NLR family pyrin domain containing 3	AGTAVPRL|AII|AVP|C1orf7|CIAS1|CLR1.1|DFNA34|FCAS|FCU|MWS|NALP3|PYPAF1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20874
5.63651367071101e-23	0.299922314809305	0.323	0.149	8.88483649914177e-19	SPOPL	Mono/Macro	GSE164551	ENSG00000144228	339745	speckle type BTB/POZ protein like	BTBD33	protein_coding	Q6IQ16	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20875
6.32778288950987e-23	-0.345415125998815	0.152	0.372	9.97448416873441e-19	SSH1	Mono/Macro	GSE164551	ENSG00000084112	54434	slingshot protein phosphatase 1	KIAA1298|SSH1L	protein_coding	Q8WYL5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20876
7.54120003091503e-23	-0.382153766182409	0.413	0.665	1.18871936087314e-18	IFITM2	Mono/Macro	GSE164551	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20877
7.60634632946639e-23	-0.380692243752123	0.6	0.813	1.19898837191379e-18	ITGB2	Mono/Macro	GSE164551	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20878
7.7277506349652e-23	0.277410729863145	0.275	0.115	1.21812533258956e-18	GIT2	Mono/Macro	GSE164551	ENSG00000139436	9815	GIT ArfGAP 2	KIAA0148|PKL	protein_coding	Q14161	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20879
1.24366364176306e-22	0.443118889534465	0.448	0.27	1.9603869985111e-18	GRK2	Mono/Macro	GSE164551	ENSG00000173020	156	G protein-coupled receptor kinase 2	ADRBK1|BARK1	protein_coding	P25098	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20880
1.47986482673101e-22	-0.408945719449354	0.952	0.976	2.33271092637608e-18	FTL	Mono/Macro	GSE164551	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20881
1.88693927370533e-22	-0.348753176501913	0.448	0.681	2.97438237714172e-18	ARF1	Mono/Macro	GSE164551	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20882
1.91394962194004e-22	-0.385545610762716	0.671	0.879	3.01695878906408e-18	FCN1	Mono/Macro	GSE164551	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20883
1.91820365514982e-22	-0.360961331389716	0.493	0.717	3.02366442161266e-18	FLNA	Mono/Macro	GSE164551	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20884
1.93116174121598e-22	-0.415570059153233	0.68	0.909	3.04409025267875e-18	VCAN	Mono/Macro	GSE164551	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20885
2.08641969019364e-22	-0.381627706827125	0.48	0.713	3.28882335765223e-18	CTSB	Mono/Macro	GSE164551	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20886
2.65494456671085e-22	-0.32649610747796	0.736	0.892	4.18498912050632e-18	HLA-DRA	Mono/Macro	GSE164551	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20887
4.34085702331461e-22	-0.360706798618443	0.074	0.265	6.84249292585082e-18	F13A1	Mono/Macro	GSE164551	ENSG00000124491	2162	coagulation factor XIII A chain	F13A	protein_coding	P00488	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20888
5.53489067324711e-22	-0.332903705735509	0.346	0.588	8.72464816823942e-18	ANXA11	Mono/Macro	GSE164551	ENSG00000122359	311	annexin A11	ANX11	protein_coding	P50995	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20889
5.61360112988501e-22	0.427162059959052	0.392	0.213	8.84871946103775e-18	NFKBIZ	Mono/Macro	GSE164551	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20890
6.55607651315789e-22	-0.296813996960642	0.069	0.264	1.03343434076908e-17	ALOX5AP	Mono/Macro	GSE164551	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20891
7.20824039977421e-22	0.384791726669245	0.465	0.278	1.13623493421641e-17	TET2	Mono/Macro	GSE164551	ENSG00000168769	54790	tet methylcytosine dioxygenase 2	FLJ20032|KIAA1546	protein_coding	Q6N021	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20892
7.42541236645739e-22	-0.377607450957224	0.435	0.673	1.17046775132468e-17	ATP5ME	Mono/Macro	GSE164551	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20893
8.81697434263318e-22	-0.320083517830533	0.136	0.352	1.38981966562927e-17	SH3BP5	Mono/Macro	GSE164551	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20894
9.58387545406564e-22	-0.335511002152946	0.136	0.347	1.51070628782437e-17	MS4A7	Mono/Macro	GSE164551	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20895
1.03227270810722e-21	-0.31217471961012	0.089	0.286	1.62717146978942e-17	TUBA1C	Mono/Macro	GSE164551	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20896
1.70264277164677e-21	-0.288596704176134	0.065	0.252	2.6838758009468e-17	MN1	Mono/Macro	GSE164551	ENSG00000169184	4330	MN1 proto-oncogene, transcriptional regulator	MGCR|MGCR1|MGCR1-PEN	protein_coding	Q10571	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20897
2.0842397238483e-21	-0.400341303845344	0.069	0.254	3.28538707670208e-17	IL1RN	Mono/Macro	GSE164551	ENSG00000136689	3557	interleukin 1 receptor antagonist	ICIL-1RA|IL-1RN|IL1F3|IL1RA|IRAP|MGC10430	protein_coding	P18510	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20898
2.09891904329226e-21	0.255331487502554	0.255	0.104	3.30852608794159e-17	MKLN1	Mono/Macro	GSE164551	ENSG00000128585	4289	muskelin 1	TWA2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20899
2.13342005791981e-21	-0.336948189738914	0.184	0.403	3.362910037299e-17	CTDSP1	Mono/Macro	GSE164551	ENSG00000144579	58190	CTD small phosphatase 1	NLIIF|SCP1	protein_coding	Q9GZU7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20900
2.32115409550462e-21	-0.330988871136705	0.225	0.443	3.65883520074393e-17	NRGN	Mono/Macro	GSE164551	ENSG00000154146	4900	neurogranin	RC3	protein_coding	Q92686	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20901
2.34482286035036e-21	-0.372050248669382	0.827	0.946	3.69614427477027e-17	SAT1	Mono/Macro	GSE164551	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20902
2.45429386685631e-21	0.43254069565922	0.578	0.409	3.86870342232561e-17	KMT2C	Mono/Macro	GSE164551	ENSG00000055609	58508	lysine methyltransferase 2C	HALR|KIAA1506|MLL3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20903
2.50309463718903e-21	-0.338220920881021	0.132	0.337	3.94562807660108e-17	IRS2	Mono/Macro	GSE164551	ENSG00000185950	8660	insulin receptor substrate 2	NA	protein_coding	Q9Y4H2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20904
2.52898421005641e-21	-0.317116582364888	0.234	0.467	3.98643781031192e-17	RANBP2	Mono/Macro	GSE164551	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20905
2.56997912443707e-21	0.473449979784732	0.647	0.563	4.05105809385015e-17	LYN	Mono/Macro	GSE164551	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20906
3.38254943543307e-21	-0.352002345005325	0.881	0.963	5.33191267507315e-17	GAPDH	Mono/Macro	GSE164551	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20907
3.58284185034043e-21	0.487216893577714	0.61	0.45	5.64763360869161e-17	ANKRD12	Mono/Macro	GSE164551	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20908
4.06260929259899e-21	-0.362500511528437	0.344	0.571	6.40389102792379e-17	SLC43A2	Mono/Macro	GSE164551	ENSG00000278550	124935	solute carrier family 43 member 2	MGC34680	protein_coding	Q8N370	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20909
4.39239087212966e-21	-0.297943583475082	0.21	0.437	6.92372573173798e-17	ACTN1	Mono/Macro	GSE164551	ENSG00000072110	87	actinin alpha 1	NA	protein_coding	P12814	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20910
4.40682962953212e-21	-0.285692744594619	0.08	0.269	6.94648554503149e-17	IL13RA1	Mono/Macro	GSE164551	ENSG00000131724	3597	interleukin 13 receptor subunit alpha 1	CD213a1|IL-13Ra|NR4	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20911
4.53504950413336e-21	-0.396923272179081	0.877	0.93	7.14859853336541e-17	RPL37A	Mono/Macro	GSE164551	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20912
4.91592714312266e-21	-0.354030733762622	0.442	0.683	7.74897595570425e-17	PPP1R15A	Mono/Macro	GSE164551	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20913
5.09930335299333e-21	0.376466227345155	0.407	0.234	8.03803187532339e-17	ZNF106	Mono/Macro	GSE164551	ENSG00000103994	64397	zinc finger protein 106	SH3BP3|ZFP106|ZNF474	protein_coding	Q9H2Y7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20914
5.6114307431577e-21	-0.290842390524952	0.099	0.292	8.84529828043949e-17	ATP5IF1	Mono/Macro	GSE164551	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20915
6.61442146670434e-21	-0.343921428091252	0.264	0.484	1.0426312557966e-16	MAPK6	Mono/Macro	GSE164551	ENSG00000069956	5597	mitogen-activated protein kinase 6	ERK3|HsT17250|p97MAPK|PRKM6	protein_coding	Q16659	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20916
6.72684389752691e-21	0.66487928197278	1	1	1.06035240356717e-16	MT-CO2	Mono/Macro	GSE164551	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20917
8.73975255147102e-21	-0.356047431684428	0.325	0.55	1.37764719468838e-16	MYADM	Mono/Macro	GSE164551	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20918
9.47588746534929e-21	-0.334845676566127	0.266	0.497	1.49368414116301e-16	TLR2	Mono/Macro	GSE164551	ENSG00000137462	7097	toll like receptor 2	CD282|TIL4	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20919
1.17510943170422e-20	-0.422283051527682	0.604	0.815	1.85232499719536e-16	LGALS3	Mono/Macro	GSE164551	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20920
1.47330298657038e-20	-0.351530944387993	0.526	0.762	2.3223674977309e-16	FOSL2	Mono/Macro	GSE164551	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20921
2.09124154350716e-20	-0.495749425977958	0.465	0.691	3.29642404503034e-16	ZFP36	Mono/Macro	GSE164551	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20922
2.16060184152221e-20	-0.297002686789756	0.243	0.479	3.40575668279146e-16	SLA	Mono/Macro	GSE164551	ENSG00000155926	6503	Src like adaptor	hSLAP|SLA1|SLAP|SLAP-1	protein_coding	Q13239	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20923
2.20150326985541e-20	-0.336911708232648	0.364	0.587	3.47022960427308e-16	CAPNS1	Mono/Macro	GSE164551	ENSG00000126247	826	calpain small subunit 1	30K|CANP|CANPS|CAPN4|CDPS	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20924
2.41669083286195e-20	-0.296254156657397	0.091	0.283	3.8094297598403e-16	KBTBD8	Mono/Macro	GSE164551	ENSG00000163376	84541	kelch repeat and BTB domain containing 8	KIAA1842|TA-KRP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20925
2.47563768110981e-20	-0.310517640846189	0.21	0.425	3.90234767673339e-16	CAPN2	Mono/Macro	GSE164551	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20926
2.67237414645629e-20	-0.311749383000112	0.717	0.86	4.21246336705904e-16	HNRNPA2B1	Mono/Macro	GSE164551	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20927
3.31257348814953e-20	-0.32052615264318	0.151	0.353	5.2216095893701e-16	LIMS1	Mono/Macro	GSE164551	ENSG00000169756	3987	LIM zinc finger domain containing 1	PINCH|PINCH1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20928
5.18138755337664e-20	0.403494279077112	0.429	0.257	8.1674212003876e-16	BAZ2A	Mono/Macro	GSE164551	ENSG00000076108	11176	bromodomain adjacent to zinc finger domain 2A	KIAA0314|TIP5|WALp3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20929
7.23743650522165e-20	-0.323025759219274	0.197	0.405	1.14083711631809e-15	PNPLA8	Mono/Macro	GSE164551	ENSG00000135241	50640	patatin like phospholipase domain containing 8	IPLA2-2|IPLA2G|iPLA2gamma	protein_coding	Q9NP80	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20930
7.66636851532537e-20	-0.320154796146215	0.099	0.286	1.20844966907074e-15	FGL2	Mono/Macro	GSE164551	ENSG00000127951	10875	fibrinogen like 2	pT49|T49	protein_coding	Q14314	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20931
7.80403326729869e-20	0.251425276157365	0.29	0.134	1.23014976392429e-15	TSC22D4	Mono/Macro	GSE164551	ENSG00000166925	81628	TSC22 domain family member 4	THG-1|TILZ2	protein_coding	Q9Y3Q8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20932
1.00579878478557e-19	0.482637483240186	0.667	0.58	1.58544062445749e-15	MYO1F	Mono/Macro	GSE164551	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20933
1.09032466244154e-19	-0.314618162141238	0.121	0.314	1.7186787654066e-15	ACSL3	Mono/Macro	GSE164551	ENSG00000123983	2181	acyl-CoA synthetase long chain family member 3	ACS3|FACL3|PRO2194	protein_coding	O95573	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20934
1.10218825952434e-19	0.333772353728504	0.357	0.19	1.73737935348822e-15	KLHL24	Mono/Macro	GSE164551	ENSG00000114796	54800	kelch like family member 24	DRE1|FLJ20059	protein_coding	Q6TFL4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20935
1.20971523051192e-19	-0.293076346006333	0.136	0.335	1.90687411785594e-15	SELENOK	Mono/Macro	GSE164551	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20936
1.39505033093245e-19	-0.301840579076161	0.177	0.381	2.19901783664881e-15	ATP1A1	Mono/Macro	GSE164551	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20937
1.57482088590676e-19	-0.265564284964992	0.087	0.271	2.48239016245483e-15	TUBB6	Mono/Macro	GSE164551	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20938
1.68136086730235e-19	-0.282241405560543	0.119	0.318	2.6503291351287e-15	ADGRE5	Mono/Macro	GSE164551	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20939
2.11075069416625e-19	-0.324157882030119	0.411	0.625	3.32717631921425e-15	CFP	Mono/Macro	GSE164551	ENSG00000126759	5199	complement factor properdin	PFC	protein_coding	P27918	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20940
2.11342343177798e-19	0.295566112704031	0.309	0.15	3.33138935551162e-15	YPEL2	Mono/Macro	GSE164551	ENSG00000175155	388403	yippee like 2	FKSG4	protein_coding	Q96QA6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20941
2.21825854263779e-19	-0.276696644076744	0.519	0.749	3.49664094075994e-15	LST1	Mono/Macro	GSE164551	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20942
2.84615703523782e-19	0.495032913713046	0.634	0.531	4.48639733464538e-15	TNFRSF1B	Mono/Macro	GSE164551	ENSG00000028137	7133	TNF receptor superfamily member 1B	CD120b|p75|TNF-R-II|TNF-R75|TNFBR|TNFR2|TNFR80	protein_coding	P20333	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20943
3.34924580549465e-19	0.690462012943475	1	1	5.27941616320121e-15	MT-ND2	Mono/Macro	GSE164551	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20944
3.43472692847669e-19	-0.304262541966986	0.219	0.429	5.41416005735781e-15	FAM129B	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20945
3.56143004446223e-19	-0.321090341515649	0.513	0.725	5.61388217908582e-15	IQGAP1	Mono/Macro	GSE164551	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20946
3.91179763794241e-19	-0.359713890774097	0.539	0.734	6.16616661668862e-15	PPIA	Mono/Macro	GSE164551	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20947
6.30287621463779e-19	-0.293490592462253	0.154	0.35	9.93522377713354e-15	TGIF1	Mono/Macro	GSE164551	ENSG00000177426	7050	TGFB induced factor homeobox 1	HPE4|TGIF	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20948
6.90518225255782e-19	-0.329395406137822	0.227	0.434	1.08846387847069e-14	IRAK1	Mono/Macro	GSE164551	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20949
7.37982306531471e-19	-0.285930669553846	0.225	0.439	1.16328150978556e-14	BCL6	Mono/Macro	GSE164551	ENSG00000113916	604	BCL6 transcription repressor	BCL5|BCL6A|LAZ3|ZBTB27|ZNF51	protein_coding	P41182	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20950
9.94499634661311e-19	-0.273588132320894	0.796	0.909	1.56762977411662e-14	CD74	Mono/Macro	GSE164551	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20951
1.24715581497894e-18	-0.300362499484153	0.229	0.441	1.9658917111513e-14	LCP2	Mono/Macro	GSE164551	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20952
1.59525876222459e-18	-0.282542881530891	0.151	0.344	2.51460638689462e-14	DNTTIP2	Mono/Macro	GSE164551	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20953
1.64327340970456e-18	-0.294556178676578	0.125	0.31	2.59029187571729e-14	MGAT4A	Mono/Macro	GSE164551	ENSG00000071073	11320	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GnT-4a|GnT-Iva	protein_coding	Q9UM21	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20954
1.65426166018297e-18	-0.30057888708629	0.903	0.961	2.60761265494642e-14	DDX5	Mono/Macro	GSE164551	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20955
1.69298908931596e-18	-0.293703793271082	0.106	0.286	2.66865870148875e-14	SMIM3	Mono/Macro	GSE164551	ENSG00000256235	85027	small integral membrane protein 3	C5orf62|MSTP150|NID67	protein_coding	Q9BZL3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20956
1.94633278848264e-18	-0.357501619623108	0.52	0.739	3.06800437448519e-14	NPC2	Mono/Macro	GSE164551	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20957
2.06863974867085e-18	-0.367834256943095	0.929	0.968	3.26079683582986e-14	RPLP1	Mono/Macro	GSE164551	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20958
2.19774688455852e-18	-0.32438851151475	0.82	0.9	3.4643084141296e-14	RPL27A	Mono/Macro	GSE164551	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20959
2.21776030287734e-18	-0.277731748899941	0.097	0.275	3.49585556542555e-14	HIC1	Mono/Macro	GSE164551	ENSG00000177374	3090	HIC ZBTB transcriptional repressor 1	ZBTB29|ZNF901	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20960
2.22999743072341e-18	-0.275140983986317	0.169	0.367	3.51514495004931e-14	ENSA	Mono/Macro	GSE164551	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20961
2.32393854716969e-18	-0.292747227699501	0.223	0.431	3.66322433190359e-14	STX11	Mono/Macro	GSE164551	ENSG00000135604	8676	syntaxin 11	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20962
2.49246797584544e-18	-0.266210901617121	0.097	0.275	3.92887727032516e-14	LRRC8C	Mono/Macro	GSE164551	ENSG00000171488	84230	leucine rich repeat containing 8 VRAC subunit C	AD158	protein_coding	Q8TDW0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20963
2.61214073946738e-18	-0.317701471086796	0.322	0.529	4.11751744762244e-14	AP2S1	Mono/Macro	GSE164551	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20964
2.68187962411662e-18	-0.353816890018365	0.918	0.962	4.22744685149503e-14	RPL28	Mono/Macro	GSE164551	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20965
3.47972249923756e-18	-0.322414638516665	0.322	0.52	5.48508657554816e-14	PPT1	Mono/Macro	GSE164551	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20966
3.60522339460441e-18	-0.296341943932949	0.375	0.603	5.68291363691493e-14	IFNGR1	Mono/Macro	GSE164551	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20967
3.86280537164671e-18	-0.298969250325216	0.141	0.327	6.08894010732671e-14	TMEM189	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20968
4.02045242181737e-18	-0.32504086795704	0.454	0.658	6.33743915251073e-14	SEC61B	Mono/Macro	GSE164551	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20969
4.0677652466945e-18	-0.303250328902066	0.353	0.558	6.41201835836454e-14	COPE	Mono/Macro	GSE164551	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20970
4.64585495396668e-18	0.318631430440787	0.329	0.175	7.32326116393768e-14	ARID1A	Mono/Macro	GSE164551	ENSG00000117713	8289	AT-rich interaction domain 1A	B120|BAF250|BAF250a|C10rf4|C1orf4|P270|SMARCF1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20971
5.64579418218639e-18	0.535390572984443	0.416	0.259	8.89946536938041e-14	GCA	Mono/Macro	GSE164551	ENSG00000115271	25801	grancalcin	GCL	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20972
5.78483249380917e-18	0.250326699402472	0.294	0.143	9.1186314599914e-14	SWAP70	Mono/Macro	GSE164551	ENSG00000133789	23075	switching B cell complex subunit SWAP70	KIAA0640|SWAP-70	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20973
7.05781232782003e-18	-0.269407215590508	0.086	0.257	1.11252295723427e-13	IL1RAP	Mono/Macro	GSE164551	ENSG00000196083	3556	interleukin 1 receptor accessory protein	C3orf13|IL-1RAcP|IL1R3	protein_coding	Q9NPH3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20974
8.73167168020945e-18	-0.254535275890895	0.102	0.277	1.37637340695141e-13	DAD1	Mono/Macro	GSE164551	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20975
9.25075051409832e-18	-0.328369830651376	0.385	0.587	1.45819580353732e-13	CALM1	Mono/Macro	GSE164551	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20976
1.26148988727068e-17	-0.255192707307718	0.119	0.297	1.98848650930477e-13	PHPT1	Mono/Macro	GSE164551	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20977
1.36098550941817e-17	0.500380224312382	0.678	0.566	2.14532145849587e-13	CELF2	Mono/Macro	GSE164551	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20978
1.39462138617343e-17	-0.274614480915496	0.141	0.328	2.19834169102518e-13	ATXN1	Mono/Macro	GSE164551	ENSG00000124788	6310	ataxin 1	ATX1|D6S504E|SCA1	protein_coding	P54253	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20979
1.42970774283498e-17	-0.325016540217972	0.63	0.796	2.25364831503078e-13	SLC25A37	Mono/Macro	GSE164551	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20980
1.44045970164123e-17	0.27362775337956	0.292	0.144	2.27059662769707e-13	NFKB2	Mono/Macro	GSE164551	ENSG00000077150	4791	nuclear factor kappa B subunit 2	LYT-10|NF-kB2|p105|p49/p100|p52	protein_coding	Q00653	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20981
1.54601703399815e-17	-0.325409517767917	0.58	0.778	2.43698665069129e-13	VAPA	Mono/Macro	GSE164551	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20982
1.7875100360843e-17	-0.298527532270067	0.102	0.274	2.81765206987969e-13	LIPA	Mono/Macro	GSE164551	ENSG00000107798	3988	lipase A, lysosomal acid type	CESD|LAL	protein_coding	P38571	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20983
1.90285633054029e-17	-0.341811640287047	0.552	0.778	2.99947243383065e-13	ARPC3	Mono/Macro	GSE164551	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20984
1.94817684394858e-17	-0.319527918486366	0.284	0.48	3.07091115911615e-13	TNFRSF1A	Mono/Macro	GSE164551	ENSG00000067182	7132	TNF receptor superfamily member 1A	CD120a|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR60	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20985
2.03504419763834e-17	-0.252771091929375	0.271	0.486	3.20784016873732e-13	MYH9	Mono/Macro	GSE164551	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20986
2.09452505754154e-17	-0.330878227038004	0.322	0.517	3.30159984820272e-13	TALDO1	Mono/Macro	GSE164551	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20987
2.89569913209937e-17	-0.286848272364067	0.132	0.312	4.56449054192824e-13	TUBB4B	Mono/Macro	GSE164551	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20988
3.57680892609699e-17	-0.278315604674895	0.288	0.488	5.63812391020668e-13	RAB1A	Mono/Macro	GSE164551	ENSG00000138069	5861	RAB1A, member RAS oncogene family	RAB1|YPT1	protein_coding	P62820	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20989
4.53659355690759e-17	-0.323189053125607	0.753	0.87	7.15103242375344e-13	CFL1	Mono/Macro	GSE164551	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20990
5.57447161725652e-17	-0.288445090138027	0.162	0.344	8.78703961028145e-13	CEBPA	Mono/Macro	GSE164551	ENSG00000245848	1050	CCAAT enhancer binding protein alpha	C/EBP-alpha|CEBP	protein_coding	P49715	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20991
6.99556074999328e-17	-0.298934463957195	0.162	0.344	1.10271024102144e-12	MIR181A1HG	Mono/Macro	GSE164551	ENSG00000229989	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20992
8.81763355184467e-17	0.336930100783247	0.439	0.283	1.38992357677727e-12	FNIP1	Mono/Macro	GSE164551	ENSG00000217128	96459	folliculin interacting protein 1	KIAA1961	protein_coding	Q8TF40	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20993
8.91473995730573e-17	-0.290984211102933	0.262	0.457	1.4052304594701e-12	PYCARD	Mono/Macro	GSE164551	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20994
1.34249607383343e-16	0.395352335664553	0.323	0.178	2.11617656118363e-12	CREBRF	Mono/Macro	GSE164551	ENSG00000164463	153222	CREB3 regulatory factor	C5orf41|LRF	protein_coding	Q8IUR6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20995
1.34778569936215e-16	-0.30789998583963	0.151	0.324	2.12451459790456e-12	ENG	Mono/Macro	GSE164551	ENSG00000106991	2022	endoglin	CD105|END|HHT1|ORW|ORW1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20996
1.36586783480058e-16	-0.315713264213435	0.247	0.432	2.15301746799616e-12	ATP5MD	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20997
1.52656767534583e-16	0.342644560248419	0.27	0.134	2.40632862664763e-12	TENT5A	Mono/Macro	GSE164551	ENSG00000112773	55603	terminal nucleotidyltransferase 5A	C6orf37|FAM46A|FLJ20037	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20998
1.58193274551305e-16	-0.282384395306524	0.305	0.497	2.49360058675222e-12	PIK3R5	Mono/Macro	GSE164551	ENSG00000141506	23533	phosphoinositide-3-kinase regulatory subunit 5	p101|P101-PI3K	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	20999
1.79914297757214e-16	0.324611198171631	0.372	0.217	2.83598907554696e-12	HELZ	Mono/Macro	GSE164551	ENSG00000198265	9931	helicase with zinc finger	DHRC|HUMORF5|KIAA0054	protein_coding	P42694	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21000
2.07892040763301e-16	-0.295330988061952	0.223	0.415	3.27700223855192e-12	TSPAN14	Mono/Macro	GSE164551	ENSG00000108219	81619	tetraspanin 14	DC-TM4F2|MGC11352|TM4SF14	protein_coding	Q8NG11	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21001
2.21414258855555e-16	-0.334092543081015	0.79	0.872	3.49015296234011e-12	RPS21	Mono/Macro	GSE164551	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21002
2.30226888618916e-16	-0.287605093001698	0.19	0.374	3.62906644529997e-12	GGA2	Mono/Macro	GSE164551	ENSG00000103365	23062	golgi associated, gamma adaptin ear containing, ARF binding protein 2	KIAA1080|VEAR	protein_coding	Q9UJY4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21003
2.51963607743081e-16	-0.273388960037039	0.139	0.312	3.97170234885419e-12	NDUFB2	Mono/Macro	GSE164551	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21004
2.80748462956468e-16	-0.26080910956707	0.203	0.393	4.4254380215828e-12	TES	Mono/Macro	GSE164551	ENSG00000135269	26136	testin LIM domain protein	DKFZP586B2022|TESS-2|TESTIN	protein_coding	Q9UGI8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21005
2.95612325278884e-16	-0.253908603518962	0.113	0.281	4.65973708337105e-12	SDC4	Mono/Macro	GSE164551	ENSG00000124145	6385	syndecan 4	amphiglycan|ryudocan|SYND4	protein_coding	P31431	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21006
3.89235804460862e-16	-0.383611497762629	0.822	0.866	6.13552398571656e-12	RPS29	Mono/Macro	GSE164551	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21007
4.45457729996936e-16	-0.319167168283249	0.528	0.718	7.02175019794171e-12	RHOA	Mono/Macro	GSE164551	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21008
4.53769646165425e-16	-0.266970119229109	0.193	0.379	7.15277093250559e-12	PTP4A1	Mono/Macro	GSE164551	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21009
6.17459408397521e-16	-0.287710119394267	0.132	0.31	9.73301265457013e-12	TFRC	Mono/Macro	GSE164551	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21010
6.41236648956985e-16	0.504202025370216	0.786	0.706	1.0107813297509e-11	TXNIP	Mono/Macro	GSE164551	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21011
7.01771759496339e-16	-0.288990199679604	0.216	0.393	1.10620282449408e-11	NDUFB1	Mono/Macro	GSE164551	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21012
9.86934173345579e-16	-0.269047883192396	0.236	0.423	1.55570433744464e-11	CIB1	Mono/Macro	GSE164551	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21013
1.18946626502081e-15	-0.287247946065627	0.299	0.49	1.87495567355231e-11	CANX	Mono/Macro	GSE164551	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21014
1.38616494648731e-15	-0.305028212972996	0.286	0.47	2.18501180514794e-11	GLIPR1	Mono/Macro	GSE164551	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21015
1.58222992804626e-15	-0.264482455840624	0.442	0.638	2.49406903557933e-11	HNRNPA3	Mono/Macro	GSE164551	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21016
1.92539595620436e-15	-0.32579353034092	0.433	0.615	3.03500164576493e-11	POLR2L	Mono/Macro	GSE164551	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21017
1.97430323153152e-15	-0.329206493204986	0.355	0.537	3.11209418386313e-11	NRIP1	Mono/Macro	GSE164551	ENSG00000180530	8204	nuclear receptor interacting protein 1	RIP140	protein_coding	P48552	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21018
2.6172488628076e-15	-0.253601583109103	0.19	0.371	4.12556938244361e-11	CORO1C	Mono/Macro	GSE164551	ENSG00000110880	23603	coronin 1C	coronin-3|HCRNN4	protein_coding	Q9ULV4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21019
3.21041657745815e-15	0.468089809743389	0.392	0.257	5.06057965104729e-11	BTG2	Mono/Macro	GSE164551	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21020
3.29545627691671e-15	-0.293671613414155	0.446	0.643	5.19462772930381e-11	GMFG	Mono/Macro	GSE164551	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21021
3.53825698521337e-15	0.350250792833908	0.362	0.219	5.57735448579184e-11	PIAS1	Mono/Macro	GSE164551	ENSG00000033800	8554	protein inhibitor of activated STAT 1	DDXBP1|GBP|GU/RH-II|ZMIZ3	protein_coding	O75925	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21022
4.10411948998734e-15	-0.266487139411882	0.262	0.458	6.46932355206704e-11	PPIB	Mono/Macro	GSE164551	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21023
4.81843477227427e-15	-0.262122615968787	0.204	0.382	7.59529873153592e-11	NUCB1	Mono/Macro	GSE164551	ENSG00000104805	4924	nucleobindin 1	Calnuc|NUC	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21024
5.14591237586384e-15	-0.295251038458205	0.894	0.942	8.11150167807417e-11	RPS28	Mono/Macro	GSE164551	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21025
7.03865494207574e-15	-0.298919780172712	0.257	0.431	1.1095031785194e-10	C1orf162	Mono/Macro	GSE164551	ENSG00000143110	128346	chromosome 1 open reading frame 162	MGC24133	protein_coding	Q8NEQ5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21026
8.35200586062299e-15	0.436704759315959	0.71	0.673	1.31652668381e-10	CSF3R	Mono/Macro	GSE164551	ENSG00000119535	1441	colony stimulating factor 3 receptor	CD114|GCSFR	protein_coding	Q99062	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21027
8.55369092292309e-15	-0.266169521444744	0.485	0.7	1.34831830018037e-10	FCAR	Mono/Macro	GSE164551	ENSG00000276858	2204	Fc alpha receptor	CD89|FcalphaR|FcalphaRI	protein_coding	P24071	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21028
9.08684577326433e-15	-0.274814139613604	0.387	0.575	1.43235949923966e-10	P4HB	Mono/Macro	GSE164551	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21029
9.21590789483161e-15	0.446173818401352	0.489	0.354	1.45270356146231e-10	OGA	Mono/Macro	GSE164551	ENSG00000198408	10724	O-GlcNAcase	MEA5|MGEA5|NCOAT	protein_coding	O60502	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21030
1.04176790769142e-14	-0.253870118768938	0.214	0.39	1.64213875289399e-10	LAMTOR1	Mono/Macro	GSE164551	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21031
1.08014278315751e-14	-0.258040766316745	0.223	0.397	1.70262906909118e-10	TRAPPC1	Mono/Macro	GSE164551	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21032
1.16353162009745e-14	-0.289084552743603	0.42	0.626	1.83407489275961e-10	SERPINB1	Mono/Macro	GSE164551	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21033
1.3136280678582e-14	-0.286430430970239	0.859	0.912	2.07067192336488e-10	RPS11	Mono/Macro	GSE164551	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21034
1.43565463309882e-14	0.409751848153273	0.47	0.331	2.26302239815366e-10	WSB1	Mono/Macro	GSE164551	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21035
1.55563981517192e-14	-0.264620471705624	0.323	0.503	2.4521550406555e-10	EDF1	Mono/Macro	GSE164551	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21036
1.94409382557556e-14	-0.271874320551736	0.34	0.53	3.06447509725475e-10	MYL12A	Mono/Macro	GSE164551	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21037
2.31005765018422e-14	-0.292111564997435	0.556	0.717	3.64134387398538e-10	SRP14	Mono/Macro	GSE164551	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21038
2.43410869395522e-14	-0.261477518756192	0.271	0.449	3.83688553428162e-10	MOB3A	Mono/Macro	GSE164551	ENSG00000172081	126308	MOB kinase activator 3A	MOB-LAK|MOB1C|MOBKL2A|moblak	protein_coding	Q96BX8	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21039
3.21263505900272e-14	-0.313737642202164	0.476	0.658	5.06407664350599e-10	TAGLN2	Mono/Macro	GSE164551	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21040
3.2361605787068e-14	0.295330048704634	0.286	0.157	5.10115992021554e-10	MXI1	Mono/Macro	GSE164551	ENSG00000119950	4601	MAX interactor 1, dimerization protein	bHLHc11|MAD2|MXD2|MXI	protein_coding	P50539	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21041
3.32359752720423e-14	0.542205276024999	1	1	5.23898678213203e-10	MT-ATP6	Mono/Macro	GSE164551	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21042
3.44167836810655e-14	0.416822421679889	0.639	0.56	5.42511761164635e-10	REL	Mono/Macro	GSE164551	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21043
4.04330158364587e-14	-0.280057589140123	0.121	0.272	6.37345628630099e-10	IRF8	Mono/Macro	GSE164551	ENSG00000140968	3394	interferon regulatory factor 8	ICSBP|ICSBP1|IRF-8	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21044
4.36723465723899e-14	0.291600006481757	0.4	0.254	6.88407199020582e-10	SEC14L1	Mono/Macro	GSE164551	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21045
4.50577710847425e-14	0.364849241940214	0.483	0.356	7.10245645608797e-10	SQSTM1	Mono/Macro	GSE164551	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21046
4.76739716175221e-14	0.296935798206792	0.335	0.202	7.51484814607001e-10	FBXL5	Mono/Macro	GSE164551	ENSG00000118564	26234	F-box and leucine rich repeat protein 5	FBL4|FBL5|FLR1	protein_coding	Q9UKA1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21047
4.87792854312097e-14	0.309051357233377	0.441	0.297	7.68907876252159e-10	GGNBP2	Mono/Macro	GSE164551	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21048
5.67452309655645e-14	-0.252145948116866	0.169	0.332	8.94475075710194e-10	KAT6A	Mono/Macro	GSE164551	ENSG00000083168	7994	lysine acetyltransferase 6A	MOZ|MYST3|RUNXBP2|ZC2HC6A|ZNF220	protein_coding	Q92794	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21049
6.04229342668818e-14	0.287852240281645	0.398	0.249	9.52446712848857e-10	CBX6	Mono/Macro	GSE164551	ENSG00000183741	23466	chromobox 6	NA	protein_coding	O95503	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21050
6.35515980823975e-14	-0.292144937858872	0.53	0.734	1.00176384057283e-09	SERPINA1	Mono/Macro	GSE164551	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21051
6.66014101536713e-14	-0.258791164235256	0.257	0.428	1.04983802825232e-09	UBL5	Mono/Macro	GSE164551	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21052
6.8951586041831e-14	0.32357415153344	0.465	0.322	1.08688385077738e-09	WAC	Mono/Macro	GSE164551	ENSG00000095787	51322	WW domain containing adaptor with coiled-coil	BM-016|FLJ31290|MGC10753|PRO1741|Wwp4	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21053
7.04164616823543e-14	0.271222860272446	0.346	0.207	1.10997468549895e-09	PTBP3	Mono/Macro	GSE164551	ENSG00000119314	9991	polypyrimidine tract binding protein 3	DKFZp781I1117|ROD1	protein_coding	O95758	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21054
7.62797318506808e-14	-0.255415929341652	0.431	0.622	1.20239741316228e-09	RIOK3	Mono/Macro	GSE164551	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21055
9.26288518011015e-14	-0.269206407771732	0.467	0.647	1.46010859094076e-09	GPX4	Mono/Macro	GSE164551	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21056
9.42549615770194e-14	-0.271447064762983	0.818	0.882	1.48574095933856e-09	RPL35	Mono/Macro	GSE164551	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21057
1.13052345439174e-13	-0.254145431121308	0.188	0.354	1.78204412115771e-09	ADM	Mono/Macro	GSE164551	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21058
1.19614730200443e-13	-0.271635143962533	0.758	0.856	1.88548699214959e-09	RPL23	Mono/Macro	GSE164551	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21059
1.24401163392027e-13	-0.265569925534489	0.266	0.441	1.96093553854852e-09	PPP4R3A	Mono/Macro	GSE164551	ENSG00000100796	55671	protein phosphatase 4 regulatory subunit 3A	FLFL1|FLJ20707|KIAA2010|MSTP033|PP4R3|SMEK1|smk-1|smk1	protein_coding	Q6IN85	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21060
1.26976619155729e-13	-0.266973304552419	0.401	0.586	2.00153244775175e-09	CD99	Mono/Macro	GSE164551	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21061
1.27630513962581e-13	-0.331592457414793	0.188	0.343	2.01183979159217e-09	LPAR6	Mono/Macro	GSE164551	ENSG00000139679	10161	lysophosphatidic acid receptor 6	P2RY5|P2Y5	protein_coding	P43657	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21062
1.8308490103993e-13	-0.309991015225755	0.896	0.941	2.88596729509241e-09	PTMA	Mono/Macro	GSE164551	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21063
1.8679460140159e-13	-0.270442769159271	0.368	0.554	2.94444330189326e-09	COX6C	Mono/Macro	GSE164551	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21064
1.89009638556703e-13	-0.252539738427701	0.286	0.466	2.97935893256931e-09	KLF10	Mono/Macro	GSE164551	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21065
1.99497523891825e-13	0.28868882774544	0.452	0.305	3.14467946910684e-09	RAB11FIP1	Mono/Macro	GSE164551	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21066
2.33535326038476e-13	-0.269242528067102	0.574	0.78	3.6812173443445e-09	BRI3	Mono/Macro	GSE164551	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21067
2.57632131508821e-13	-0.328557454346066	0.914	0.948	4.06105528897354e-09	RPL39	Mono/Macro	GSE164551	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21068
2.81923736188969e-13	0.437611703785736	0.476	0.346	4.44396385354672e-09	MARCKS	Mono/Macro	GSE164551	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21069
3.71066711133214e-13	-0.277595854151158	0.18	0.344	5.84912456759285e-09	AC020916.1	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21070
3.90995451167908e-13	-0.26322154767218	0.342	0.513	6.16326129675974e-09	PET100	Mono/Macro	GSE164551	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21071
5.89946288322234e-13	-0.25640132873462	0.221	0.382	9.29932334282337e-09	NCOR2	Mono/Macro	GSE164551	ENSG00000196498	9612	nuclear receptor corepressor 2	CTG26|SMRT|SMRTE|TNRC14|TRAC-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21072
1.20484161643406e-12	-0.251490137957858	0.361	0.527	1.89919183998501e-08	COX5B	Mono/Macro	GSE164551	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21073
1.64973677060304e-12	0.539542572083489	0.381	0.258	2.60048007150158e-08	PLIN2	Mono/Macro	GSE164551	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21074
1.7209239455857e-12	-0.254250607767691	0.325	0.494	2.71269241542674e-08	NDUFS5	Mono/Macro	GSE164551	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21075
2.11259175544652e-12	0.334103970845975	0.448	0.313	3.33007838411035e-08	CYLD	Mono/Macro	GSE164551	ENSG00000083799	1540	CYLD lysine 63 deubiquitinase	CYLD1|KIAA0849|USPL2	protein_coding	Q9NQC7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21076
2.59170296472454e-12	0.429855273627234	1	1	4.08530138329529e-08	MT-ND4	Mono/Macro	GSE164551	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21077
3.28789901489644e-12	-0.255958851142124	0.654	0.863	5.18271521718127e-08	TYROBP	Mono/Macro	GSE164551	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21078
3.83618935280155e-12	0.271857070554828	0.353	0.226	6.04698527682108e-08	ETV6	Mono/Macro	GSE164551	ENSG00000139083	2120	ETS variant transcription factor 6	TEL	protein_coding	P41212	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21079
6.37844578148327e-12	0.365961492612072	0.612	0.535	1.00543440853521e-07	MED13L	Mono/Macro	GSE164551	ENSG00000123066	23389	mediator complex subunit 13L	KIAA1025|THRAP2|TRAP240L	protein_coding	Q71F56	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21080
8.54901724514972e-12	0.266546000040219	0.348	0.216	1.34758158835295e-07	ARID3A	Mono/Macro	GSE164551	ENSG00000116017	1820	AT-rich interaction domain 3A	BRIGHT|DRIL1	protein_coding	Q99856	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21081
9.96757320149114e-12	0.251217770235591	0.253	0.142	1.57118856375105e-07	TBL1XR1	Mono/Macro	GSE164551	ENSG00000177565	79718	TBL1X/Y related 1	C21|DC42|FLJ12894|IRA1|TBLR1	protein_coding	Q9BZK7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21082
1.64734598667954e-11	0.436942555925424	0.286	0.179	2.59671147880297e-07	MAPK14	Mono/Macro	GSE164551	ENSG00000112062	1432	mitogen-activated protein kinase 14	CSBP1|CSBP2|CSPB1|Mxi2|p38|PRKM14|PRKM15	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21083
1.72545900081722e-11	0.304839019918079	0.286	0.173	2.71984102298819e-07	CASP8	Mono/Macro	GSE164551	ENSG00000064012	841	caspase 8	Casp-8|FLICE|MACH|MCH5	protein_coding	Q14790	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21084
2.18510290379202e-11	-0.270655459914571	0.487	0.655	3.44437770724737e-07	PKM	Mono/Macro	GSE164551	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21085
2.32886672450092e-11	0.314926900430276	0.511	0.397	3.6709926178308e-07	TNFAIP2	Mono/Macro	GSE164551	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21086
3.89093110707723e-11	0.266532515448758	0.349	0.23	6.13327470408583e-07	FNBP1	Mono/Macro	GSE164551	ENSG00000187239	23048	formin binding protein 1	FBP17|KIAA0554	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21087
4.21071253260093e-11	0.41398100716311	0.42	0.304	6.63734616513884e-07	LBR	Mono/Macro	GSE164551	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21088
5.23619100538776e-11	0.292796764311166	0.435	0.316	8.25380788179272e-07	ZMYM2	Mono/Macro	GSE164551	ENSG00000121741	7750	zinc finger MYM-type containing 2	FIM|MYM|RAMP|ZNF198	protein_coding	Q9UBW7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21089
7.3535922375993e-11	0.300620696145284	0.52	0.413	1.15914674441278e-06	CIRBP	Mono/Macro	GSE164551	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21090
1.1943684459734e-10	-0.398403212511516	0.225	0.376	1.88268298138787e-06	IL1B	Mono/Macro	GSE164551	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21091
1.39474590444928e-10	-0.315679294014028	0.474	0.622	2.1985379691834e-06	HMGN2	Mono/Macro	GSE164551	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21092
2.04641399408474e-10	0.257957734941932	0.329	0.211	3.22576237887577e-06	POLR2J3.1	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21093
2.05140681484636e-10	0.270908806649505	0.414	0.298	3.23363256224232e-06	STK10	Mono/Macro	GSE164551	ENSG00000072786	6793	serine/threonine kinase 10	LOK|PRO2729	protein_coding	O94804	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21094
2.07847979114083e-10	0.254169372425849	0.374	0.256	3.2763076947753e-06	VAMP2	Mono/Macro	GSE164551	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21095
2.90170675205177e-10	0.312090418997125	0.439	0.324	4.57396035325921e-06	ACAP2	Mono/Macro	GSE164551	ENSG00000114331	23527	ArfGAP with coiled-coil, ankyrin repeat and PH domains 2	CENTB2|CNT-B2|KIAA0041	protein_coding	Q15057	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21096
2.91234351121587e-10	0.331656525370869	0.494	0.376	4.59072707672957e-06	NKTR	Mono/Macro	GSE164551	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21097
5.86541062940901e-10	0.322589026711662	0.686	0.64	9.24564677513742e-06	FMNL1	Mono/Macro	GSE164551	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21098
6.83768739338613e-10	0.260779057628746	0.292	0.184	1.07782466381946e-05	PCNX1	Mono/Macro	GSE164551	ENSG00000100731	22990	pecanex 1	KIAA0805|KIAA0995|PCNX|PCNXL1|pecanex	protein_coding	Q96RV3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21099
6.93165670351617e-10	0.361455768631092	0.948	0.971	1.09263704617525e-05	ZEB2	Mono/Macro	GSE164551	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21100
6.98806403733813e-10	-0.257274909135261	0.766	0.818	1.10152853420561e-05	ATP5F1E	Mono/Macro	GSE164551	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21101
1.32114265741386e-09	0.253990066781666	0.258	0.157	2.08251717088146e-05	PDK1	Mono/Macro	GSE164551	ENSG00000152256	5163	pyruvate dehydrogenase kinase 1	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21102
1.51605538461289e-09	0.452532553882541	0.459	0.364	2.38975810276529e-05	IFI30	Mono/Macro	GSE164551	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21103
1.78073359725676e-09	0.424082269295551	0.344	0.245	2.80697036935583e-05	NABP1	Mono/Macro	GSE164551	ENSG00000173559	64859	nucleic acid binding protein 1	DKFZp667M1322|FLJ13624|FLJ22833|hSSB2|MGC111163|NABP1-OT1|OBFC2A|SOSS-B2|SSB2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21104
1.94427612677165e-09	0.25760845639262	0.375	0.265	3.06476245863015e-05	COL4A3BP	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21105
2.28674504305776e-09	0.28791259475469	0.533	0.429	3.60459621137195e-05	MDM4	Mono/Macro	GSE164551	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21106
3.59433328234856e-09	0.311778956869627	0.338	0.232	5.66574755296604e-05	DYNC1LI2	Mono/Macro	GSE164551	ENSG00000135720	1783	dynein cytoplasmic 1 light intermediate chain 2	DNCLI2	protein_coding	O43237	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21107
5.51357786675519e-09	0.52083133478587	1	1	8.69105279136621e-05	MT-ND3	Mono/Macro	GSE164551	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21108
7.56556018028787e-09	-0.278837483318713	0.766	0.848	0.000119255925121878	JUNB	Mono/Macro	GSE164551	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21109
8.52804319155667e-09	0.351034317615063	0.771	0.716	0.000134427544828508	MTRNR2L12	Mono/Macro	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21110
1.59911079515633e-08	0.315558710581846	0.755	0.747	0.000252067834640493	RBPJ	Mono/Macro	GSE164551	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21111
2.27164780986137e-08	0.276479818218747	0.513	0.42	0.000358079844268448	EP300	Mono/Macro	GSE164551	ENSG00000100393	2033	E1A binding protein p300	KAT3B|p300	protein_coding	Q09472	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21112
2.29003608046658e-08	0.265306176942426	0.316	0.216	0.000360978387363947	ARID1B	Mono/Macro	GSE164551	ENSG00000049618	57492	AT-rich interaction domain 1B	6A3-5|BAF250b|DAN15|ELD/OSA1|KIAA1235|p250R|SMARCF2	protein_coding	Q8NFD5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21113
2.49158803623247e-08	0.33633491542476	0.491	0.42	0.000392749022151324	CHD2	Mono/Macro	GSE164551	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21114
2.56924522725536e-08	0.402541265212302	0.519	0.458	0.000404990125172263	ATP2B1-AS1	Mono/Macro	GSE164551	ENSG00000271614	NA	NA	LINC00936	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21115
3.27262922620246e-08	0.306884247606607	0.498	0.403	0.000515864544926293	TRIM38	Mono/Macro	GSE164551	ENSG00000112343	10475	tripartite motif containing 38	RNF15|RORET	protein_coding	O00635	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21116
3.44129239593483e-08	0.306427553760511	0.435	0.352	0.000542450920371208	LIMD2	Mono/Macro	GSE164551	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21117
5.92335058654317e-08	0.258651859932613	0.394	0.298	0.0009336977529568	RAF1	Mono/Macro	GSE164551	ENSG00000132155	5894	Raf-1 proto-oncogene, serine/threonine kinase	c-Raf|CRAF|Raf-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21118
1.1132964140189e-07	0.274101291522394	0.465	0.373	0.001754889137418	IL10RA	Mono/Macro	GSE164551	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21119
1.24246636197962e-07	0.279463067883361	0.283	0.195	0.00195849972638848	LILRB1	Mono/Macro	GSE164551	ENSG00000276452	10859	leukocyte immunoglobulin like receptor B1	CD85|CD85j|ILT2|LIR-1|LIR1|MIR-7|PIR-B|PIRB	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21120
1.9188044409468e-07	0.268632179017779	0.387	0.298	0.00302461144026444	FAM91A1	Mono/Macro	GSE164551	ENSG00000176853	157769	family with sequence similarity 91 member A1	FLJ23790	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21121
3.06446697194878e-07	0.297357407719458	0.379	0.294	0.00483051928788287	BRAF	Mono/Macro	GSE164551	ENSG00000157764	673	B-Raf proto-oncogene, serine/threonine kinase	BRAF-1|BRAF1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21122
3.39411945328115e-07	0.263360532627457	0.312	0.225	0.00535015049420708	ADAR	Mono/Macro	GSE164551	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21123
3.41737252086051e-07	0.288377190158173	0.519	0.44	0.00538680430463242	PHIP	Mono/Macro	GSE164551	ENSG00000146247	55023	pleckstrin homology domain interacting protein	BRWD2|DCAF14|FLJ20705|ndrp|WDR11	protein_coding	Q8WWQ0	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21124
6.48394750771449e-07	0.264697881178939	0.403	0.324	0.0102206464564103	RAB8B	Mono/Macro	GSE164551	ENSG00000166128	51762	RAB8B, member RAS oncogene family	NA	protein_coding	Q92930	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21125
6.65613188346503e-07	0.462619217232207	0.619	0.614	0.0104920606879059	ATP2B1	Mono/Macro	GSE164551	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21126
7.32214965551901e-07	0.296124115105485	0.413	0.323	0.0115419045019946	RGS2	Mono/Macro	GSE164551	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21127
7.39168101491894e-07	0.328427541523088	0.537	0.491	0.0116515067838167	BACH1	Mono/Macro	GSE164551	ENSG00000156273	571	BTB domain and CNC homolog 1	BACH-1|BTBD24	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21128
9.0176863434818e-07	-0.338759594672106	0.219	0.327	0.0142145789832304	CXCL2	Mono/Macro	GSE164551	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21129
1.68398736686256e-06	0.260456182207546	0.504	0.435	0.0265446928638545	PLEKHO1	Mono/Macro	GSE164551	ENSG00000023902	51177	pleckstrin homology domain containing O1	CKIP-1|OC120	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21130
2.05328608097952e-56	1.13074596835984	0.527	0.014	3.23659484944802e-52	IGLC3	NK cells	GSE164551	ENSG00000211679	NA	NA	IGLC	IG_C_gene	P0DOY3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21131
1.35964666830823e-26	0.483363213441407	0.295	0.016	2.14321104325427e-22	FLNB	NK cells	GSE164551	ENSG00000136068	2317	filamin B	ABP-278|FH1|FLN1L|LRS1|TABP|TAP	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21132
1.23288167837433e-20	0.854469437439897	0.509	0.139	1.94339138962145e-16	TCF7	NK cells	GSE164551	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21133
1.15555870893674e-19	0.543475872999459	0.286	0.032	1.82150719289698e-15	IL7R	NK cells	GSE164551	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21134
3.14373478825799e-17	-1.08374116877428	0.661	0.917	4.95546914673108e-13	SH3BGRL3	NK cells	GSE164551	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21135
5.14657443741718e-17	0.408067767251718	0.286	0.042	8.11254528570071e-13	CHPT1	NK cells	GSE164551	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21136
7.11772822350745e-17	0.992934677776325	0.607	0.252	1.12196749987148e-12	KLF2	NK cells	GSE164551	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21137
4.69084832225896e-16	-1.35743819170934	0.589	0.875	7.3941842103768e-12	S100A4	NK cells	GSE164551	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21138
4.81726899299333e-16	0.774428581517359	0.393	0.097	7.59346111365539e-12	MT1X	NK cells	GSE164551	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21139
2.22093521714158e-14	0.751826588581179	0.938	0.62	3.50086018278027e-10	HBA2	NK cells	GSE164551	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21140
7.79789030550753e-13	0.408253025042135	0.402	0.113	1.22918144885715e-08	IL10RA	NK cells	GSE164551	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21141
3.3820034902717e-12	-0.779403853368016	0.384	0.714	5.33105210171529e-08	VIM	NK cells	GSE164551	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21142
8.01916360895388e-12	0.878814699116849	0.473	0.187	1.2640607596794e-07	XCL1	NK cells	GSE164551	ENSG00000143184	6375	X-C motif chemokine ligand 1	ATAC|LPTN|LTN|SCM-1|SCM-1a|SCYC1	protein_coding	P47992	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21143
1.57235951386233e-11	0.611382728650966	0.643	0.322	2.47851030170119e-07	EIF5A	NK cells	GSE164551	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21144
1.70239471083074e-11	0.853416144671427	0.991	0.994	2.68348478268249e-07	EEF1A1	NK cells	GSE164551	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21145
2.27339064119542e-11	-0.881900235030439	0.607	0.839	3.58354566771634e-07	S100A6	NK cells	GSE164551	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21146
1.98339937422683e-10	-1.04734368572202	0.955	0.992	3.12643243359376e-06	TMSB10	NK cells	GSE164551	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21147
3.66066111737124e-10	-0.802182936686575	0.268	0.563	5.77030011931228e-06	IKZF1	NK cells	GSE164551	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21148
5.24549896787687e-10	-0.511414718896378	0	0.272	8.2684800230643e-06	SLC1A5	NK cells	GSE164551	ENSG00000105281	6510	solute carrier family 1 member 5	AAAT|ASCT2|M7V1|RDRC	protein_coding	Q15758	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21149
5.84594338664525e-10	0.785293414317467	0.982	0.863	9.21496056036891e-06	GNLY	NK cells	GSE164551	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21150
7.39080366209678e-10	1.1252394920533	0.911	0.692	1.16501238125631e-05	HBB	NK cells	GSE164551	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21151
1.3667615510147e-09	-0.850981772544937	0.188	0.477	2.15442623286448e-05	DDIT4	NK cells	GSE164551	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21152
3.20823309214766e-09	0.400549797967702	0.33	0.109	5.05713782315236e-05	KLF3	NK cells	GSE164551	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21153
3.40568019724233e-09	0.536832433290985	0.58	0.322	5.36837369491309e-05	CDC42SE2	NK cells	GSE164551	ENSG00000158985	56990	CDC42 small effector 2	FLJ21967|SPEC2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21154
4.26474726529046e-09	0.422440501038282	0.402	0.155	6.72252111427735e-05	FAM107B	NK cells	GSE164551	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21155
5.17456574966382e-09	0.702214771338612	0.973	0.988	8.15666799119508e-05	RPS27A	NK cells	GSE164551	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21156
5.91738160603058e-09	0.771991506038478	0.982	0.988	9.327568625586e-05	RPS18	NK cells	GSE164551	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21157
6.05137098409616e-09	-0.886650918996844	0.205	0.469	9.53877608223078e-05	GRASP	NK cells	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21158
9.18188678502836e-09	-0.704783980761395	0.098	0.368	0.000144734081392402	IFRD1	NK cells	GSE164551	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21159
1.0146635324176e-08	0.404558981474579	0.464	0.207	0.000159941412614986	RBX1	NK cells	GSE164551	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21160
1.21528682526371e-08	-1.02671207564876	0.277	0.541	0.000191565662266318	GZMA	NK cells	GSE164551	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21161
1.36030552704034e-08	0.699164869146179	0.973	0.968	0.000214424960227368	RPL3	NK cells	GSE164551	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21162
2.38052195764102e-08	-0.669621925579193	0.259	0.529	0.000375241676182955	MXD4	NK cells	GSE164551	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21163
2.68790916777506e-08	0.477162327238496	0.562	0.278	0.000423695122116382	ATG2A	NK cells	GSE164551	ENSG00000110046	23130	autophagy related 2A	BLTP4A|KIAA0404	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21164
2.99294239801549e-08	0.366912229661235	0.348	0.129	0.000471777510199181	CBLB	NK cells	GSE164551	ENSG00000114423	868	Cbl proto-oncogene B	Cbl-b|RNF56	protein_coding	Q13191	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21165
3.15855198584586e-08	0.649695245177577	0.973	0.96	0.000497882549528883	RPL9	NK cells	GSE164551	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21166
3.58927034258858e-08	0.947719278522621	0.518	0.288	0.000565776684102238	KLF6	NK cells	GSE164551	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21167
3.64741874944696e-08	-0.749151555837074	0.152	0.421	0.000574942617475324	AREG	NK cells	GSE164551	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21168
4.46419236753523e-08	0.387185482112426	0.527	0.254	0.000703690642894578	CNBP	NK cells	GSE164551	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21169
5.73138776741413e-08	0.306192960941931	0.25	0.074	0.00090343865377749	PHF1	NK cells	GSE164551	ENSG00000225553	5252	PHD finger protein 1	MTF2L2|PCL1|TDRD19C	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21170
5.95319098978873e-08	-0.43612659159214	0.054	0.298	0.000938401495720398	APOBEC3G	NK cells	GSE164551	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21171
7.4034833202424e-08	0.459364918295581	0.866	0.662	0.00116701107576981	FUS	NK cells	GSE164551	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21172
1.01972885882313e-07	0.582352850685547	0.973	0.978	0.00160739860016289	RPL30	NK cells	GSE164551	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21173
1.03035051527387e-07	0.500688838175216	0.955	0.952	0.0016241415172262	RPL24	NK cells	GSE164551	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21174
1.0719473247727e-07	-0.926635127213931	0.357	0.581	0.0016897105680392	GZMB	NK cells	GSE164551	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21175
1.07977952529343e-07	0.505451208995578	0.723	0.467	0.00170205646572004	LIMD2	NK cells	GSE164551	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21176
1.29315542128348e-07	0.596743942991168	1	0.988	0.00203840089056915	RPL37	NK cells	GSE164551	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21177
1.33758921127414e-07	-0.752743258827368	0.946	0.996	0.00210844187373143	PTMA	NK cells	GSE164551	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21178
1.39392709891184e-07	-0.587827834415546	0.411	0.636	0.00219724728601474	LAPTM5	NK cells	GSE164551	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21179
1.40368291911289e-07	0.630677347471829	0.982	0.986	0.00221262538539764	RPS12	NK cells	GSE164551	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21180
2.32609579292402e-07	-0.79263072767577	0.33	0.557	0.00366662479838614	ZFP36	NK cells	GSE164551	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21181
2.46263449475069e-07	0.443899873106747	0.357	0.153	0.00388185075407551	CDKN2D	NK cells	GSE164551	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21182
2.58481990635617e-07	0.633911662861712	0.973	0.966	0.00407445161838924	RPS6	NK cells	GSE164551	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21183
2.61903570223388e-07	0.281561366136242	0.268	0.089	0.00412838597743126	GON4L	NK cells	GSE164551	ENSG00000116580	54856	gon-4 like	FLJ20203|GON-4|GON4|YARP	protein_coding	Q3T8J9	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21184
2.63976981107941e-07	0.331515200137203	0.42	0.191	0.00416106915320447	ANP32A	NK cells	GSE164551	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21185
2.73831645479953e-07	0.497208269440254	0.723	0.483	0.0043164082277005	KMT2E	NK cells	GSE164551	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21186
3.21066579525271e-07	-0.50850538175414	0.089	0.328	0.00506097249305685	TUBA4A	NK cells	GSE164551	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21187
3.30174011859579e-07	0.562128750794171	0.964	0.988	0.00520453294894255	RPL32	NK cells	GSE164551	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21188
3.71095696962152e-07	-0.839483178118849	0.214	0.469	0.00584958147121441	LGALS1	NK cells	GSE164551	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21189
4.7144371080787e-07	0.557789225532012	1	0.998	0.00743136721346445	RPL13	NK cells	GSE164551	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21190
4.9621045795054e-07	0.499284284810242	0.804	0.584	0.00782176544867436	PIK3R1	NK cells	GSE164551	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21191
5.94853461356592e-07	0.508283387288279	0.991	0.99	0.00937667511136395	RPL19	NK cells	GSE164551	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21192
6.46815401378725e-07	0.565552317803869	0.598	0.378	0.0101957511719328	PNRC1	NK cells	GSE164551	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21193
7.82230458999547e-07	0.343749640044443	0.286	0.107	0.0123302987252099	NFKB2	NK cells	GSE164551	ENSG00000077150	4791	nuclear factor kappa B subunit 2	LYT-10|NF-kB2|p105|p49/p100|p52	protein_coding	Q00653	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21194
8.42331430148643e-07	-0.936826572131562	0.214	0.421	0.0132776703334331	AC103591.3	NK cells	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21195
8.67940887727731e-07	0.540294812392623	0.991	0.986	0.0136813522132522	RPS3A	NK cells	GSE164551	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21196
9.29513481021703e-07	0.527733136453712	0.982	0.976	0.0146519210013451	RPL37A	NK cells	GSE164551	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21197
9.34616111269235e-07	-0.645503545312442	0.188	0.427	0.0147323537619369	GZMH	NK cells	GSE164551	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21198
1.07769650384296e-06	0.497421859645824	0.964	0.946	0.0169877299900766	RPS25	NK cells	GSE164551	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21199
1.0878676877875e-06	-0.503478564679307	0.045	0.254	0.0171480583625944	ITGA5	NK cells	GSE164551	ENSG00000161638	3678	integrin subunit alpha 5	CD49e|FNRA	protein_coding	P08648	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21200
1.09709131443653e-06	0.645496987545181	0.991	0.996	0.017293450389463	TPT1	NK cells	GSE164551	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21201
1.12733726210649e-06	-0.694843473087285	0.259	0.463	0.0177702172625845	LDHA	NK cells	GSE164551	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21202
1.22745130319113e-06	0.446952118177669	1	0.97	0.0193483148922017	RPL13A	NK cells	GSE164551	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21203
1.2564847586061e-06	0.387325787975983	0.545	0.296	0.0198059692499079	MED23	NK cells	GSE164551	ENSG00000112282	9439	mediator complex subunit 23	CRSP130|CRSP3|DRIP130|MRT18|Sur2	protein_coding	Q9ULK4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21204
1.38849553664419e-06	0.317349346453701	0.402	0.187	0.0218868551441223	SQSTM1	NK cells	GSE164551	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21205
1.46081560976336e-06	0.341296903731772	0.429	0.223	0.0230268364566998	SAMD3	NK cells	GSE164551	ENSG00000164483	154075	sterile alpha motif domain containing 3	bA73O6.2|FLJ34032	protein_coding	Q8N6K7	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21206
2.63023174779354e-06	0.523271451072266	0.938	0.885	0.0414603430404695	RPL10A	NK cells	GSE164551	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21207
2.70916378833698e-06	-1.04218291622518	0.161	0.406	0.0427045487955558	CCL4	NK cells	GSE164551	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21208
2.82716383279001e-06	0.482253849793934	0.964	0.96	0.0445645834962689	RPL6	NK cells	GSE164551	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21209
2.94286577242068e-06	0.524906060196634	0.973	0.95	0.0463883931706672	RPL23A	NK cells	GSE164551	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21210
3.07977363737303e-06	0.263826095747493	0.295	0.121	0.0485464718459111	NDUFA13	NK cells	GSE164551	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21211
6.22747777412675e-19	-0.321928094887362	0	0.25	9.816373215356e-15	GPRC5A	Malignant cells	GSE164551	ENSG00000013588	9052	G protein-coupled receptor class C group 5 member A	PEIG-1|RAI3|RAIG1|TIG1	protein_coding	Q8NFJ5	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21212
1.19068997849832e-10	-0.553352894204334	0.016	0.375	1.8768846131069e-06	IER5L	Malignant cells	GSE164551	ENSG00000188483	389792	immediate early response 5 like	bA247A12.2	protein_coding	Q5T953	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21213
1.98940223078131e-09	-1.02423125556029	0.063	0.625	3.13589473638058e-05	S100A9	Malignant cells	GSE164551	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21214
4.56354316188469e-09	-0.749191896499465	0.041	0.5	7.19351308607883e-05	LAPTM5	Malignant cells	GSE164551	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21215
1.0160560611532e-08	-0.553352894204334	0.022	0.375	0.000160160916919579	GBP1	Malignant cells	GSE164551	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21216
5.55522978192101e-08	-1.1073835353736	0.009	0.25	0.000875670870524209	CCL4L2	Malignant cells	GSE164551	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21217
6.13703612644004e-08	-0.303780748177103	0.009	0.25	0.000967381004610743	CXCL8	Malignant cells	GSE164551	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21218
1.93663881901899e-07	-1.59482953018049	0.051	0.5	0.00305272377041963	CITED2	Malignant cells	GSE164551	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21219
7.68606596492973e-07	-0.915510158461044	0.092	0.625	0.0121155457805187	SAT1	Malignant cells	GSE164551	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21220
8.04164147586604e-07	-1.15177765473205	0.013	0.25	0.0126760394584076	EGR1	Malignant cells	GSE164551	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21221
9.49910028879741e-07	-0.303780748177103	0.013	0.25	0.0149734317852314	YJU2	Malignant cells	GSE164551	ENSG00000105248	55702	YJU2 splicing factor homolog	CCDC94|FLJ10374	protein_coding	Q9BW85	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21222
3.05580414041767e-06	-1.13808033259652	0.07	0.5	0.0481686406654037	AC007952.4	Malignant cells	GSE164551	NA	NA	NA	NA	NA	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21223
1.8096516220941e-09	-1.16240039640809	0.053	0.571	2.85255385190694e-05	TNFAIP3	B cells	GSE164551	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21224
2.50914897709979e-07	-0.60564865885171	0.053	0.5	0.0039551715326024	DDIT4	B cells	GSE164551	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21225
5.80257282995937e-07	-0.813515232134177	0.088	0.571	0.00914659555186495	NINJ1	B cells	GSE164551	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE164551	GSE164551	Multiple myeloma	Refractory multiple myeloma (MM)	Immunotherapy	NA	CAR-T	Homo sapiens	patients	Bone marrow aspirate	resistant 1, sensitive 1	2	7736	Public on Jan 11, 2021	33558511	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	https://doi.org/10.7910/DVN/1RKYQ8	10x genomics	CellRanger 3.1.0	Multiple_myeloma	Immunotherapy	21226
0	0.518182920436632	0.29	0	0	ABCC9	Malignant cells	GSE175716	ENSG00000069431	10060	ATP binding cassette subfamily C member 9	CMD1O|SUR2	protein_coding	O60706	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21227
0	1.69984136574905	0.961	0.602	0	AC010343.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21228
0	3.98750718528805	0.923	0.103	0	AKR1B1	Malignant cells	GSE175716	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21229
0	1.91963032922436	1	0.952	0	AKR1C2	Malignant cells	GSE175716	ENSG00000151632	1646	aldo-keto reductase family 1 member C2	BABP|DD|DD2|DDH2|HAKRD|MCDR2|TDD	protein_coding	P52895	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21230
0	0.645689293421854	0.305	0.006	0	AL035661.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21231
0	-2.69344177685908	0.484	0.934	0	ALDH1A1	Malignant cells	GSE175716	ENSG00000165092	216	aldehyde dehydrogenase 1 family member A1	ALDH1|PUMB1|RALDH1	protein_coding	P00352	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21232
0	0.699930824981659	0.34	0.015	0	AOC3	Malignant cells	GSE175716	ENSG00000131471	8639	amine oxidase copper containing 3	HPAO|VAP-1|VAP1	protein_coding	Q16853	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21233
0	0.912301835696161	0.423	0	0	AP000547.3	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21234
0	1.69084265430257	1	0.887	0	AP001324.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21235
0	2.10977064312763	0.913	0.46	0	APMAP	Malignant cells	GSE175716	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21236
0	-2.32813212841328	0.559	0.996	0	ATP1B1	Malignant cells	GSE175716	ENSG00000143153	481	ATPase Na+/K+ transporting subunit beta 1	ATP1B	protein_coding	P05026	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21237
0	0.515649976884296	0.281	0.006	0	ATP2A3	Malignant cells	GSE175716	ENSG00000074370	489	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3	SERCA3	protein_coding	Q93084	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21238
0	2.06335826468178	0.968	0.519	0	BRI3	Malignant cells	GSE175716	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21239
0	-2.01194165324474	0.6	0.98	0	C1S	Malignant cells	GSE175716	ENSG00000182326	716	complement C1s	NA	protein_coding	P09871	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21240
0	0.717923393710171	0.361	0.011	0	CCDC69	Malignant cells	GSE175716	ENSG00000198624	26112	coiled-coil domain containing 69	DKFZP434C171|FLJ13705	protein_coding	A6NI79	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21241
0	-2.18692384309345	0.481	0.975	0	CFH	Malignant cells	GSE175716	ENSG00000000971	3075	complement factor H	ARMD4|ARMS1|FHL1|HF|HF1|HF2|HUS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21242
0	5.27993888190394	0.999	0.293	0	CHI3L1	Malignant cells	GSE175716	ENSG00000133048	1116	chitinase 3 like 1	GP39|YK-40|YKL40	protein_coding	P36222	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21243
0	0.878901364092091	0.414	0.024	0	CLMP	Malignant cells	GSE175716	ENSG00000166250	79827	CXADR like membrane protein	ACAM|ASAM|FLJ22415	protein_coding	Q9H6B4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21244
0	-2.22185872930769	0.523	0.984	0	CLU	Malignant cells	GSE175716	ENSG00000120885	1191	clusterin	APOJ|CLI|CLU1|CLU2|KUB1|SGP-2|SP-40|TRPM-2	protein_coding	P10909	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21245
0	1.81079298157182	0.671	0	0	CPVL	Malignant cells	GSE175716	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21246
0	0.69230791040823	0.309	0	0	CXCR4	Malignant cells	GSE175716	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21247
0	1.07053274406935	0.493	0	0	CYBRD1	Malignant cells	GSE175716	ENSG00000071967	79901	cytochrome b reductase 1	CYB561A2|DCYTB|FLJ23462|FRRS3	protein_coding	Q53TN4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21248
0	1.46244036850964	0.553	0	0	DUSP9	Malignant cells	GSE175716	ENSG00000130829	1852	dual specificity phosphatase 9	MKP-4|MKP4	protein_coding	Q99956	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21249
0	1.66158761390373	1	0.999	0	EEF1A1	Malignant cells	GSE175716	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21250
0	-1.30008508923178	1	1	0	EIF1	Malignant cells	GSE175716	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21251
0	1.39229426151888	0.513	0.004	0	ELOVL3	Malignant cells	GSE175716	ENSG00000119915	83401	ELOVL fatty acid elongase 3	CIG-30	protein_coding	Q9HB03	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21252
0	1.06295788514148	0.485	0.033	0	ERV3-1	Malignant cells	GSE175716	ENSG00000213462	2086	endogenous retrovirus group 3 member 1, envelope	envR|ERV-R|ERV3|H-PLK|HERV-R	protein_coding	Q14264	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21253
0	0.63303909364215	0.326	0.003	0	FAR2	Malignant cells	GSE175716	ENSG00000064763	55711	fatty acyl-CoA reductase 2	FLJ10462|MLSTD1|SDR10E2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21254
0	-2.48002994551307	0.502	0.922	0	FGA	Malignant cells	GSE175716	ENSG00000171560	2243	fibrinogen alpha chain	NA	protein_coding	P02671	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21255
0	-3.50139665390398	0.564	0.991	0	FGG	Malignant cells	GSE175716	ENSG00000171557	2266	fibrinogen gamma chain	NA	protein_coding	P02679	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21256
0	0.771380052480975	0.344	0.002	0	FGR	Malignant cells	GSE175716	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21257
0	2.7956050894757	0.888	0.346	0	G0S2	Malignant cells	GSE175716	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21258
0	1.01755820698117	0.42	0.027	0	GJB6	Malignant cells	GSE175716	ENSG00000121742	10804	gap junction protein beta 6	CX30|DFNA3|ED2|EDH|HED	protein_coding	O95452	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21259
0	1.61068759538044	1	0.921	0	GNAS	Malignant cells	GSE175716	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21260
0	0.762916033668648	0.365	0.008	0	GPC3	Malignant cells	GSE175716	ENSG00000147257	2719	glypican 3	DGSX|OCI-5|SDYS|SGB|SGBS|SGBS1	protein_coding	P51654	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21261
0	1.03374753366801	0.493	0.042	0	HACD1	Malignant cells	GSE175716	ENSG00000165996	9200	3-hydroxyacyl-CoA dehydratase 1	CAP|PTPLA	protein_coding	B0YJ81	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21262
0	1.21862703502938	0.508	0.013	0	HCAR2	Malignant cells	GSE175716	ENSG00000182782	338442	hydroxycarboxylic acid receptor 2	GPR109A|HCA2|HM74A|NIACR1|Puma-g|PUMAG	protein_coding	Q8TDS4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21263
0	0.702121509880331	0.327	0.015	0	HSPA2	Malignant cells	GSE175716	ENSG00000126803	3306	heat shock protein family A (Hsp70) member 2	NA	protein_coding	P54652	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21264
0	-2.52237340870446	0.5	0.96	0	IFITM2	Malignant cells	GSE175716	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21265
0	-3.57252446282999	0.714	0.984	0	IFITM3	Malignant cells	GSE175716	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21266
0	2.65772613720709	0.833	0.015	0	LDHB	Malignant cells	GSE175716	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21267
0	0.935912477997431	0.449	0.001	0	LDHBP2	Malignant cells	GSE175716	ENSG00000213684	NA	NA	LDHBL2|LDHBP	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21268
0	-2.62056454329238	0.492	0.992	0	LGALS4	Malignant cells	GSE175716	ENSG00000282992	3960	galectin 4	GAL4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21269
0	1.18872069150364	0.467	0.001	0	LPL	Malignant cells	GSE175716	ENSG00000175445	4023	lipoprotein lipase	LIPD	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21270
0	0.807785127828166	0.377	0	0	MAGEA4	Malignant cells	GSE175716	ENSG00000147381	4103	MAGE family member A4	CT1.4|MAGE-41|MAGE-X2|MAGE4|MAGE4A|MAGE4B|MGC21336	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21271
0	2.03441161131517	0.749	0.27	0	MARC1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21272
0	0.975229207693035	0.45	0.013	0	MEIOB	Malignant cells	GSE175716	ENSG00000282650	254528	meiosis specific with OB-fold	C16orf73|MGC35212	protein_coding	Q8N635	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21273
0	1.20660146408005	0.368	0	0	MNDA	Malignant cells	GSE175716	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21274
0	1.45329694712302	1	1	0	MT-CO3	Malignant cells	GSE175716	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21275
0	2.41208651773976	0.775	0.227	0	MTND1P23	Malignant cells	GSE175716	ENSG00000225972	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21276
0	0.905885629109923	0.416	0.035	0	PALMD	Malignant cells	GSE175716	ENSG00000099260	54873	palmdelphin	C1orf11|FLJ20271|PALML	protein_coding	Q9NP74	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21277
0	2.22296641125702	0.878	0.313	0	PEG10	Malignant cells	GSE175716	ENSG00000242265	23089	paternally expressed 10	HB-1|KIAA1051|Mar2|Mart2|MEF3L|RGAG3|RTL2|SIRH1	protein_coding	Q86TG7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21278
0	0.570065118185622	0.289	0.008	0	PHGDH	Malignant cells	GSE175716	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21279
0	0.634604067355664	0.306	0.008	0	PHLDA3	Malignant cells	GSE175716	ENSG00000174307	23612	pleckstrin homology like domain family A member 3	TIH1	protein_coding	Q9Y5J5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21280
0	0.755447470870205	0.357	0.015	0	PLIN1	Malignant cells	GSE175716	ENSG00000166819	5346	perilipin 1	PLIN	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21281
0	3.31118029250184	1	0.945	0	PLIN2	Malignant cells	GSE175716	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21282
0	0.664051984919151	0.332	0.003	0	PLXDC2	Malignant cells	GSE175716	ENSG00000120594	84898	plexin domain containing 2	FLJ14623|TEM7R	protein_coding	Q6UX71	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21283
0	0.516078332111709	0.27	0	0	PPP1R1A	Malignant cells	GSE175716	ENSG00000135447	5502	protein phosphatase 1 regulatory inhibitor subunit 1A	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21284
0	1.99277356628807	0.672	0.086	0	PSAT1	Malignant cells	GSE175716	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21285
0	2.34190465831089	0.641	0.053	0	PTX3	Malignant cells	GSE175716	ENSG00000163661	5806	pentraxin 3	TNFAIP5|TSG-14	protein_coding	P26022	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21286
0	1.40767711474132	0.568	0.001	0	QPCT	Malignant cells	GSE175716	ENSG00000115828	25797	glutaminyl-peptide cyclotransferase	GCT|QC	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21287
0	0.451073673172028	0.264	0.003	0	RENBP	Malignant cells	GSE175716	ENSG00000102032	5973	renin binding protein	RBP|RNBP	protein_coding	P51606	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21288
0	0.809849255685133	0.433	0.042	0	RPL34P1	Malignant cells	GSE175716	ENSG00000237049	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21289
0	2.05292803122556	0.73	0.137	0	RPL34P26	Malignant cells	GSE175716	ENSG00000223676	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21290
0	2.38188925806137	0.958	0.424	0	RPL34P27	Malignant cells	GSE175716	ENSG00000232858	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21291
0	1.34755758630893	0.63	0.114	0	RPL34P31	Malignant cells	GSE175716	ENSG00000239223	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21292
0	1.64615940695065	0.961	0.541	0	RPS10	Malignant cells	GSE175716	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21293
0	1.66158938497929	1	0.906	0	RPS18	Malignant cells	GSE175716	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21294
0	0.980749660573947	1	1	0	RPS6	Malignant cells	GSE175716	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21295
0	2.62681922998449	0.951	0.306	0	S100A11	Malignant cells	GSE175716	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21296
0	1.00300874987234	0.265	0	0	S100A12	Malignant cells	GSE175716	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21297
0	6.13304384421987	0.98	0.073	0	S100A8	Malignant cells	GSE175716	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21298
0	4.84885275201044	0.996	0.39	0	S100A9	Malignant cells	GSE175716	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21299
0	2.45164261054126	0.581	0.101	0	SAA1	Malignant cells	GSE175716	ENSG00000288411	6288	serum amyloid A1	PIG4|SAA|TP53I4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21300
0	-3.97603830519461	0.706	1	0	SERPINA1	Malignant cells	GSE175716	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21301
0	-1.56315152284072	0.543	0.964	0	SLC9A3R1	Malignant cells	GSE175716	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21302
0	0.595518463084997	0.322	0.015	0	SMARCD3	Malignant cells	GSE175716	ENSG00000082014	6604	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3	BAF60C|CRACD3|Rsc6p	protein_coding	Q6STE5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21303
0	-3.41250397504846	0.568	0.987	0	SPINK1	Malignant cells	GSE175716	ENSG00000164266	6690	serine peptidase inhibitor Kazal type 1	PCTT|PSTI|Spink3|TATI	protein_coding	P00995	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21304
0	0.494294302905595	0.283	0.002	0	SPON1	Malignant cells	GSE175716	ENSG00000262655	10418	spondin 1	f-spondin|KIAA0762	protein_coding	Q9HCB6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21305
0	1.92846343946111	0.989	0.72	0	SRI	Malignant cells	GSE175716	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21306
0	1.0946755417863	0.419	0.013	0	STK31	Malignant cells	GSE175716	ENSG00000196335	56164	serine/threonine kinase 31	SgK396|TDRD8	protein_coding	Q9BXU1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21307
0	3.19403504961687	0.947	0.482	0	TF	Malignant cells	GSE175716	ENSG00000091513	7018	transferrin	PRO1557|PRO2086	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21308
0	-2.72367501131399	0.849	1	0	TM4SF1	Malignant cells	GSE175716	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21309
0	-1.99905309863816	0.453	0.938	0	TM4SF4	Malignant cells	GSE175716	ENSG00000169903	7104	transmembrane 4 L six family member 4	il-TMP	protein_coding	P48230	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21310
0	-2.25151183750008	0.82	0.996	0	TMSB4X	Malignant cells	GSE175716	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21311
0	1.40269825157693	1	0.999	0	TPT1	Malignant cells	GSE175716	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21312
0	1.78333042905427	0.544	0.001	0	VGLL2	Malignant cells	GSE175716	ENSG00000170162	245806	vestigial like family member 2	NA	protein_coding	Q8N8G2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21313
0	4.30409039844619	0.995	0.173	0	VIM	Malignant cells	GSE175716	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21314
0	1.76990741365877	0.602	0.002	0	WDR86-AS1	Malignant cells	GSE175716	ENSG00000243836	100131176	WDR86 antisense RNA 1	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21315
0	2.82172225830597	0.794	0.027	0	ZNF117	Malignant cells	GSE175716	ENSG00000152926	51351	zinc finger protein 117	H-plk|HPF9	protein_coding	Q03924	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21316
0	-2.96340645996002	0.477	0.934	0	FGL1	Malignant cells	GSE175716	ENSG00000104760	2267	fibrinogen like 1	HFREP-1|HPS	protein_coding	Q08830	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21317
0	-3.52662332735881	0.545	0.993	0	GPX2	Malignant cells	GSE175716	ENSG00000176153	2877	glutathione peroxidase 2	GSHPX-GI	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21318
0	-1.4210211772303	0.403	0.928	0	RPS4Y1	Malignant cells	GSE175716	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21319
0	-3.40159664889852	0.528	0.997	0	SPP1	Malignant cells	GSE175716	ENSG00000118785	6696	secreted phosphoprotein 1	BNSP|BSPI|ETA-1|OPN	protein_coding	P10451	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21320
0	-2.17056620087062	0.452	0.959	0	UBC	Malignant cells	GSE175716	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21321
0	-1.68714246479516	0.429	0.956	0	UQCR10	Malignant cells	GSE175716	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21322
0	-2.16927453143764	0.462	0.989	0	UQCRB	Malignant cells	GSE175716	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21323
0	-2.84449880380966	0.475	0.956	0	UQCRH	Malignant cells	GSE175716	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21324
0	-1.3687610945461	0.396	0.898	0	UQCRHL	Malignant cells	GSE175716	ENSG00000233954	440567	ubiquinol-cytochrome c reductase hinge protein like	NA	protein_coding	A0A096LP55	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21325
0	-2.22686213440298	0.459	0.962	0	UQCRQ	Malignant cells	GSE175716	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21326
2.80661813652158e-307	1.55091673670715	0.998	0.937	6.41452575102007e-303	RPL39	Malignant cells	GSE175716	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21327
1.15800418538311e-305	1.37201354339311	0.998	0.966	2.64661856569311e-301	ATP5G3	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21328
1.15477697230396e-302	-3.19287947165399	0.519	0.899	2.6392427702007e-298	FGB	Malignant cells	GSE175716	ENSG00000171564	2244	fibrinogen beta chain	NA	protein_coding	P02675	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21329
1.89012028903274e-297	1.31486083437626	1	0.974	4.31986992058434e-293	RPL7A	Malignant cells	GSE175716	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21330
1.81184833745783e-296	-1.48591639227442	0.478	0.931	4.14097937525987e-292	DAB2	Malignant cells	GSE175716	ENSG00000153071	1601	DAB adaptor protein 2	DOC-2	protein_coding	P98082	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21331
3.99263299372726e-294	1.09127101468131	1	0.999	9.12516270716365e-290	RPS12	Malignant cells	GSE175716	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21332
2.17035883641048e-292	1.53780097500682	0.653	0.184	4.96035512061615e-288	CKB	Malignant cells	GSE175716	ENSG00000166165	1152	creatine kinase B	CKBB	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21333
1.35406344862813e-287	0.898070603366278	0.261	0.007	3.09471201183959e-283	PPP1R1B	Malignant cells	GSE175716	ENSG00000131771	84152	protein phosphatase 1 regulatory inhibitor subunit 1B	DARPP-32|FLJ20940	protein_coding	Q9UD71	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21334
3.86800201070293e-286	-1.17040485001353	0.982	0.999	8.84031859546155e-282	TMBIM6	Malignant cells	GSE175716	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21335
1.09747518385599e-284	0.665136780843024	0.35	0.027	2.50827953270285e-280	AL031316.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21336
4.53782859600668e-284	1.74245460504949	0.995	0.673	1.03712072561733e-279	TRIB1	Malignant cells	GSE175716	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21337
1.5233682158012e-282	-1.42538839452872	0.395	0.872	3.48165805721365e-278	USMG5	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21338
2.07427793410605e-282	0.910878592902949	0.462	0.066	4.74076221839937e-278	CAPG	Malignant cells	GSE175716	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21339
2.62136327555841e-282	1.19563244496338	0.939	0.487	5.99112576628875e-278	RPL35P5	Malignant cells	GSE175716	ENSG00000225573	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21340
1.19170113413825e-277	-1.51228997753939	0.402	0.884	2.72363294207298e-273	TSPAN8	Malignant cells	GSE175716	ENSG00000127324	7103	tetraspanin 8	CO-029|TM4SF3	protein_coding	P19075	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21341
1.19043635648357e-276	1.54994695231386	0.997	0.957	2.7207422927432e-272	CSTB	Malignant cells	GSE175716	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21342
1.76277295186532e-275	0.778539748107484	0.38	0.039	4.0288175814882e-271	APOE	Malignant cells	GSE175716	ENSG00000130203	348	apolipoprotein E	AD2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21343
1.79756431680339e-275	-1.61891986778354	0.871	0.983	4.10833324605414e-271	TXNRD1	Malignant cells	GSE175716	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21344
7.24745731468953e-274	-1.50493796246912	0.394	0.87	1.65640636927229e-269	UGDH	Malignant cells	GSE175716	ENSG00000109814	7358	UDP-glucose 6-dehydrogenase	NA	protein_coding	O60701	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21345
4.37070379660592e-273	1.43977449804412	0.997	0.767	9.98924352714284e-269	RPS3A	Malignant cells	GSE175716	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21346
1.3835522550096e-271	-1.83946764919906	1	1	3.16210867882444e-267	ACTG1	Malignant cells	GSE175716	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21347
3.51502414599863e-271	1.8476346528179	0.736	0.317	8.03358768567987e-267	CMAS	Malignant cells	GSE175716	ENSG00000111726	55907	cytidine monophosphate N-acetylneuraminic acid synthetase	NA	protein_coding	Q8NFW8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21348
1.22425165563125e-270	-1.7467137965982	0.652	0.956	2.79802715894523e-266	ANXA4	Malignant cells	GSE175716	ENSG00000196975	307	annexin A4	ANX4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21349
2.20640160530631e-270	-1.43230135040002	1	1	5.04273086892756e-266	B2M	Malignant cells	GSE175716	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21350
2.37134178684449e-268	1.84220055643563	0.871	0.428	5.41970165383309e-264	EFNA1	Malignant cells	GSE175716	ENSG00000169242	1942	ephrin A1	ECKLG|EPLG1|GMAN|LERK1|TNFAIP4	protein_coding	P20827	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21351
2.26548189924728e-267	1.30623699348669	0.592	0.153	5.17775888072967e-263	RPS29P3	Malignant cells	GSE175716	ENSG00000225770	NA	NA	bcm2758	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21352
4.5963621080631e-267	1.51910102521536	0.898	0.523	1.05049855979782e-262	ECHDC1	Malignant cells	GSE175716	ENSG00000093144	55862	ethylmalonyl-CoA decarboxylase 1	dJ351K20.2	protein_coding	Q9NTX5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21353
1.44533396249793e-265	-1.49374793274113	0.381	0.85	3.30331077128903e-261	UBE2D3	Malignant cells	GSE175716	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21354
7.04063267928038e-264	-3.95662877117447	0.519	0.904	1.60913659884953e-259	CXCL1	Malignant cells	GSE175716	ENSG00000163739	2919	C-X-C motif chemokine ligand 1	FSP|GRO1|GROa|MGSA|MGSA-a|NAP-3|SCYB1	protein_coding	P09341	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21355
2.79038146719002e-262	-1.45377177255624	0.421	0.875	6.3774168432628e-258	CFI	Malignant cells	GSE175716	ENSG00000205403	3426	complement factor I	C3b-INA|FI|IF|KAF	protein_coding	P05156	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21356
7.93375123364616e-260	-2.7049257427656	0.461	0.905	1.81325884444983e-255	UBA52	Malignant cells	GSE175716	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21357
2.87191067436693e-258	1.74188124213157	0.69	0.236	6.56375184626562e-254	FOXQ1	Malignant cells	GSE175716	ENSG00000164379	94234	forkhead box Q1	HFH1	protein_coding	Q9C009	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21358
5.25948265520353e-258	0.554499691698895	0.31	0.022	1.20205476084677e-253	RPS10P3	Malignant cells	GSE175716	ENSG00000217716	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21359
3.03354549608721e-257	-1.29198109512876	0.376	0.842	6.93316823130732e-253	BACE2	Malignant cells	GSE175716	ENSG00000182240	25825	beta-secretase 2	AEPLC|ALP56|CEAP1|DRAP	protein_coding	Q9Y5Z0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21360
4.69475351984304e-255	1.27172421429455	0.932	0.537	1.07298591696013e-250	PUF60	Malignant cells	GSE175716	ENSG00000274081	22827	poly(U) binding splicing factor 60	FIR|RoBPI|SIAHBP1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21361
6.29594178703627e-254	1.2286218149214	0.485	0.093	1.43893749542714e-249	CLSTN3	Malignant cells	GSE175716	ENSG00000288427	9746	calsyntenin 3	CDHR14|CSTN3|KIAA0726	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21362
1.93065195780545e-250	-1.39197478681767	0.498	0.918	4.41250504956435e-246	PHLDA1	Malignant cells	GSE175716	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21363
2.21816163638506e-249	1.43711771287737	0.985	0.759	5.06960841995806e-245	MARCKS	Malignant cells	GSE175716	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21364
1.46442295939618e-247	1.14132936092442	0.926	0.524	3.34693867369998e-243	AC246787.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21365
4.92593983113059e-247	1.22571583597551	0.915	0.543	1.1258235484049e-242	NUDT5	Malignant cells	GSE175716	ENSG00000165609	11164	nudix hydrolase 5	hYSAH1|YSA1H	protein_coding	Q9UKK9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21366
5.12319243694047e-246	-2.04219181507866	1	1	1.17090563146274e-241	FTL	Malignant cells	GSE175716	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21367
3.07128941013241e-245	-1.26380801853796	0.368	0.834	7.01943194685761e-241	UBE2R2	Malignant cells	GSE175716	ENSG00000107341	54926	ubiquitin conjugating enzyme E2 R2	CDC34B|FLJ20419|MGC10481|UBC3B	protein_coding	Q712K3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21368
4.41846139855296e-245	1.43714405400783	0.983	0.783	1.00983935263928e-240	RPL37P2	Malignant cells	GSE175716	ENSG00000239559	NA	NA	PSANK1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21369
5.23250165724304e-245	0.946924626277865	0.455	0.078	1.1958882537629e-240	NDN	Malignant cells	GSE175716	ENSG00000288364	4692	necdin, MAGE family member	HsT16328|PWCR	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21370
1.88293864099925e-244	-1.27747711188975	0.991	0.999	4.30345626400379e-240	ANXA2	Malignant cells	GSE175716	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21371
8.24217024144914e-244	1.32297807502171	0.878	0.499	1.8837480086832e-239	RPL23AP2	Malignant cells	GSE175716	ENSG00000225067	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21372
1.89070966142344e-243	1.37223073567108	0.942	0.601	4.32121693118327e-239	CCT5	Malignant cells	GSE175716	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21373
2.01655260378046e-243	1.27043531875168	0.996	0.914	4.60883097594023e-239	EIF3E	Malignant cells	GSE175716	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21374
1.47227158037376e-242	-1.6724376946651	0.41	0.853	3.36487669694424e-238	NNMT	Malignant cells	GSE175716	ENSG00000166741	4837	nicotinamide N-methyltransferase	NA	protein_coding	P40261	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21375
7.41755133084914e-240	-1.09456185920431	0.962	0.996	1.69528135666557e-235	SUB1	Malignant cells	GSE175716	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21376
1.23844677000961e-239	1.46588953053511	0.923	0.57	2.83047009285697e-235	IRS2	Malignant cells	GSE175716	ENSG00000185950	8660	insulin receptor substrate 2	NA	protein_coding	Q9Y4H2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21377
6.79064996627857e-239	0.952963774390202	1	1	1.55200304979297e-234	MT-CO1	Malignant cells	GSE175716	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21378
1.02992401785439e-238	1.65275185919451	0.578	0.159	2.35389134280621e-234	AL138826.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21379
2.68088418484841e-238	-1.25463179897852	0.691	0.958	6.12716080447105e-234	SPTSSA	Malignant cells	GSE175716	ENSG00000165389	171546	serine palmitoyltransferase small subunit A	C14orf147|ssSPTa	protein_coding	Q969W0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21380
1.1672948556222e-236	1.12979396054351	0.582	0.157	2.66785239252455e-232	RHOBTB3	Malignant cells	GSE175716	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21381
2.05874899148134e-236	1.22025395973323	0.96	0.689	4.7052708200306e-232	RPL9	Malignant cells	GSE175716	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21382
1.29827745434165e-235	-1.3222301165372	0.99	0.998	2.96721312189785e-231	H3F3B	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21383
4.85008123044911e-235	1.38660416146376	1	0.879	1.10848606521914e-230	MT-ATP8	Malignant cells	GSE175716	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21384
5.45426291786907e-235	1.26945782444201	0.978	0.812	1.24657178987898e-230	GDI2	Malignant cells	GSE175716	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21385
1.55974121937824e-234	1.30972413632197	0.996	0.889	3.56478855688897e-230	NUCKS1	Malignant cells	GSE175716	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21386
2.43603002616208e-234	-1.19475412041558	0.613	0.938	5.56754662479344e-230	SARAF	Malignant cells	GSE175716	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21387
1.06917177810524e-232	0.612125220127783	0.302	0.026	2.44359209885952e-228	ISYNA1	Malignant cells	GSE175716	ENSG00000105655	51477	inositol-3-phosphate synthase 1	Ino1|INOS|IPS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21388
2.89517337911809e-232	1.15621207942481	0.993	0.883	6.61691875797439e-228	ATP5F1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21389
7.59655433919648e-232	-1.78301951171412	0.906	0.973	1.73619249422336e-227	NQO1	Malignant cells	GSE175716	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21390
9.34811531506732e-232	1.39864071808384	0.944	0.643	2.13651175525864e-227	AZGP1	Malignant cells	GSE175716	ENSG00000160862	563	alpha-2-glycoprotein 1, zinc-binding	ZA2G|ZAG	protein_coding	P25311	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21391
1.59748422058743e-231	-1.18733093703553	0.841	0.98	3.65105018615256e-227	CD59	Malignant cells	GSE175716	ENSG00000085063	966	CD59 molecule (CD59 blood group)	16.3A5|EJ16|EJ30|EL32|G344|MIC11|MIN1|MIN2|MIN3|MSK21|p18-20	protein_coding	P13987	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21392
5.42882927585857e-231	1.78161280930814	0.696	0.308	1.24075893099748e-226	MT-TP	Malignant cells	GSE175716	ENSG00000210196	NA	NA	MTTP|trnP	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21393
6.68766018465344e-230	1.20508173821578	0.999	0.951	1.52846473520254e-225	RPL26	Malignant cells	GSE175716	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21394
7.35907323213576e-230	1.18412175812035	0.599	0.178	1.68191618720463e-225	GLUL	Malignant cells	GSE175716	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21395
2.52973778112652e-229	-1.27994312380217	0.454	0.862	5.78171569876467e-225	MSN	Malignant cells	GSE175716	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21396
4.0016567297803e-229	-1.4233224471041	0.468	0.87	9.14578645591287e-225	C1R	Malignant cells	GSE175716	ENSG00000288512	715	complement C1r	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21397
8.18367389566402e-229	0.608078387065081	0.314	0.03	1.87037866885401e-224	TMEM170B	Malignant cells	GSE175716	ENSG00000205269	100113407	transmembrane protein 170B	NA	protein_coding	Q5T4T1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21398
1.75018990755977e-226	1.60390932990598	0.872	0.494	4.00005903372786e-222	CD36	Malignant cells	GSE175716	ENSG00000135218	948	CD36 molecule	FAT|GP3B|GP4|GPIV|SCARB3	protein_coding	P16671	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21399
1.03628975919858e-225	1.24116010707622	0.989	0.814	2.36844024464834e-221	FO393411.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21400
2.25908920779872e-225	-2.8919116006263	0.456	0.831	5.16314838442397e-221	APCS	Malignant cells	GSE175716	ENSG00000132703	325	amyloid P component, serum	MGC88159|PTX2|SAP	protein_coding	P02743	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21401
3.89623823176118e-225	1.14154545343643	1	0.891	8.90485247869017e-221	RPL8	Malignant cells	GSE175716	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21402
6.99595429269962e-224	1.16132427430115	0.999	0.98	1.5989253535965e-219	RPL12	Malignant cells	GSE175716	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21403
3.91532879188126e-223	-1.14692213735837	0.924	0.991	8.94848395384462e-219	MYL12A	Malignant cells	GSE175716	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21404
3.45980443066644e-221	-1.11892824614442	0.868	0.991	7.90738302628815e-217	HLA-A	Malignant cells	GSE175716	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21405
3.13695755818006e-218	-1.15924706812729	0.604	0.928	7.16951649922053e-214	CTSB	Malignant cells	GSE175716	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21406
4.03698865019424e-218	0.851843794295011	0.428	0.078	9.22653756001893e-214	IRF8	Malignant cells	GSE175716	ENSG00000140968	3394	interferon regulatory factor 8	ICSBP|ICSBP1|IRF-8	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21407
5.93743088142983e-217	-1.75757581847048	0.89	0.993	1.35699982795079e-212	FTLP3	Malignant cells	GSE175716	ENSG00000226608	NA	NA	dJ681N20.2|FTLL1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21408
1.46301417694486e-216	-1.39797533445526	0.374	0.803	3.34371890140748e-212	C12orf75	Malignant cells	GSE175716	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21409
2.95700617142079e-216	1.09930185715636	1	0.964	6.75823760478221e-212	PPIAP22	Malignant cells	GSE175716	ENSG00000198618	NA	NA	PPIA3L|PPIAL3	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21410
1.14103342249674e-213	0.747153821443597	0.426	0.079	2.60783188711629e-209	RPL34P34	Malignant cells	GSE175716	ENSG00000236312	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21411
1.76093476950548e-212	-1.74876719299443	0.602	0.906	4.02461641570477e-208	BIRC3	Malignant cells	GSE175716	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21412
3.00954886526926e-212	1.31984664999712	0.992	0.827	6.87832393157289e-208	HSPB1	Malignant cells	GSE175716	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21413
1.45935837428263e-211	1.1752766330295	0.857	0.483	3.33536356442295e-207	BZW2	Malignant cells	GSE175716	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21414
4.98424775972103e-211	0.870903355046474	0.487	0.114	1.13914982548424e-206	MTCO1P12	Malignant cells	GSE175716	ENSG00000237973	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21415
1.88591657208982e-210	1.21179454896341	0.982	0.844	4.31026232551129e-206	EEF1B2P6	Malignant cells	GSE175716	ENSG00000213261	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21416
4.41929440676037e-210	1.04190879541554	1	0.992	1.01002973666508e-205	PTMA	Malignant cells	GSE175716	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21417
1.17574626469253e-208	1.4310567037816	0.856	0.464	2.68716808795477e-204	CKS1B	Malignant cells	GSE175716	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21418
1.60193168045998e-208	1.0980514123656	0.992	0.956	3.66121485569129e-204	EEF1B2	Malignant cells	GSE175716	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21419
2.21182073094582e-208	1.38653834063611	0.659	0.273	5.05511628057667e-204	DHTKD1	Malignant cells	GSE175716	ENSG00000181192	55526	dehydrogenase E1 and transketolase domain containing 1	CMT2Q|DKFZP762M115|KIAA1630|MGC3090	protein_coding	Q96HY7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21420
3.71863858367068e-206	-0.969331336487663	0.336	0.79	8.49894848297935e-202	UBQLN1	Malignant cells	GSE175716	ENSG00000135018	29979	ubiquilin 1	DA41|DSK2|PLIC-1|XDRP1	protein_coding	Q9UMX0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21421
5.79987457377065e-206	-1.06517375379211	0.576	0.906	1.32556133383528e-201	EGLN1	Malignant cells	GSE175716	ENSG00000135766	54583	egl-9 family hypoxia inducible factor 1	C1orf12|HIFPH2|PHD2|SM-20|ZMYND6	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21422
5.91672307765739e-206	-0.968861112227157	0.336	0.788	1.3522670593986e-201	UBE2N	Malignant cells	GSE175716	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21423
2.31048680026596e-204	-1.96417446346357	0.422	0.808	5.28061758200784e-200	AGR2	Malignant cells	GSE175716	ENSG00000106541	10551	anterior gradient 2, protein disulphide isomerase family member	AG2|HAG-2|PDIA17|XAG-2	protein_coding	O95994	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21424
9.89260263735146e-204	-1.26663486653758	0.926	0.981	2.26095433276668e-199	PTGR1	Malignant cells	GSE175716	ENSG00000106853	22949	prostaglandin reductase 1	LTB4DH|ZADH3	protein_coding	Q14914	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21425
1.33600455299105e-203	-1.72585351525784	0.645	0.904	3.05343840586104e-199	CDKN1A	Malignant cells	GSE175716	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21426
2.36432118909703e-203	-1.34605485925176	0.387	0.802	5.40365607768127e-199	SLC39A14	Malignant cells	GSE175716	ENSG00000104635	23516	solute carrier family 39 member 14	KIAA0062|NET34|ZIP14	protein_coding	Q15043	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21427
1.03816451387634e-202	1.15185580526968	0.588	0.197	2.37272499646438e-198	GM2A	Malignant cells	GSE175716	ENSG00000196743	2760	ganglioside GM2 activator	GM2-AP|GM2AP|SAP-3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21428
1.60473743412254e-202	0.89063483193045	1	0.997	3.66762740568706e-198	NPM1	Malignant cells	GSE175716	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21429
6.34875073652388e-202	1.18343007066813	0.827	0.463	1.45100698083253e-197	PTPN12	Malignant cells	GSE175716	ENSG00000127947	5782	protein tyrosine phosphatase non-receptor type 12	PTP-PEST|PTPG1	protein_coding	Q05209	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21430
1.18144807093741e-201	0.77657186999125	0.427	0.085	2.70019956612746e-197	FMC1	Malignant cells	GSE175716	ENSG00000164898	154791	formation of mitochondrial complex V assembly factor 1 homolog	C7orf55|HSPC268	protein_coding	Q96HJ9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21431
4.79219935049e-200	0.510816483661814	0.278	0.027	1.09525716155449e-195	CASZ1	Malignant cells	GSE175716	ENSG00000130940	54897	castor zinc finger 1	castor|cst|FLJ20321|SRG|ZNF693	protein_coding	Q86V15	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21432
8.11157245934149e-200	-1.29204982312484	0.368	0.782	1.8538998855825e-195	RARRES1	Malignant cells	GSE175716	ENSG00000118849	5918	retinoic acid receptor responder 1	LXNL|TIG1	protein_coding	P49788	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21433
3.43730185430825e-198	-1.82741459571274	0.397	0.791	7.8559533880215e-194	UGCG	Malignant cells	GSE175716	ENSG00000148154	7357	UDP-glucose ceramide glucosyltransferase	GCS	protein_coding	Q16739	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21434
4.81168290101484e-197	1.04856214164587	0.989	0.923	1.09971012702694e-192	SERBP1	Malignant cells	GSE175716	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21435
8.12251214731517e-197	-1.15020216938736	0.77	0.944	1.85640015126888e-192	ODC1	Malignant cells	GSE175716	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21436
2.78505600376563e-196	-1.11534645577023	0.939	0.992	6.36524549660634e-192	MYL12B	Malignant cells	GSE175716	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21437
5.85821279667297e-196	-1.26728315698755	0.376	0.788	1.33889453467961e-191	SERPING1	Malignant cells	GSE175716	ENSG00000149131	710	serpin family G member 1	C1-INH|C1IN|C1INH|C1NH|HAE1|HAE2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21438
9.14771693096267e-196	-0.918204125571123	0.936	0.994	2.09071070457152e-191	CALM1	Malignant cells	GSE175716	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21439
1.15695337310481e-195	0.998710939943516	0.993	0.906	2.64421693423105e-191	CBX3	Malignant cells	GSE175716	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21440
1.64518413634187e-194	-1.03884919935535	0.337	0.77	3.76006834360935e-190	UHMK1	Malignant cells	GSE175716	ENSG00000152332	127933	U2AF homology motif kinase 1	KIS|Kist	protein_coding	Q8TAS1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21441
6.80436602833162e-194	-0.948954707198634	0.335	0.774	1.55513785577519e-189	UBE2I	Malignant cells	GSE175716	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21442
1.91389347661601e-193	1.17427313429625	0.562	0.185	4.37420354080589e-189	PEX11A	Malignant cells	GSE175716	ENSG00000166821	8800	peroxisomal biogenesis factor 11 alpha	MGC119947|MGC138534|PEX11alpha|PMP28	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21443
4.9149165732191e-192	-0.882337601369133	0.981	0.996	1.12330418280923e-187	TPI1	Malignant cells	GSE175716	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21444
1.77867335917141e-191	1.26166058191042	0.961	0.756	4.06515796238626e-187	NPC2	Malignant cells	GSE175716	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21445
2.86864963395953e-190	1.06966554342141	0.817	0.432	6.55629873841451e-186	EIF3B	Malignant cells	GSE175716	ENSG00000106263	8662	eukaryotic translation initiation factor 3 subunit B	EIF3S9|PRT1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21446
4.38065252363667e-190	-1.13973774986745	0.35	0.764	1.00119813427716e-185	UFC1	Malignant cells	GSE175716	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21447
3.01488991825783e-189	0.956346882257414	0.521	0.152	6.89053090817827e-185	RPS18P12	Malignant cells	GSE175716	ENSG00000230897	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21448
1.49674525166389e-187	-1.01541414925744	0.336	0.763	3.42081127267782e-183	UBE2K	Malignant cells	GSE175716	ENSG00000078140	3093	ubiquitin conjugating enzyme E2 K	HIP2|HYPG|UBC1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21449
9.66305730250562e-185	0.939746116894567	0.476	0.121	2.20849174648766e-180	SPTLC3	Malignant cells	GSE175716	ENSG00000172296	55304	serine palmitoyltransferase long chain base subunit 3	C20orf38|FLJ11112|hLCB2b|LCB2B|SPTLC2L	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21450
1.18849130593819e-184	-1.75727114427424	0.408	0.769	2.71629687972173e-180	C4BPB	Malignant cells	GSE175716	ENSG00000123843	725	complement component 4 binding protein beta	C4BP	protein_coding	P20851	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21451
9.98201992580501e-184	-1.52962981748168	0.443	0.807	2.28139065404273e-179	FN1	Malignant cells	GSE175716	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21452
1.42437931012558e-183	-1.53529945213372	0.383	0.756	3.25541891329201e-179	UBL5	Malignant cells	GSE175716	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21453
2.86014220032113e-183	1.3704802115618	0.689	0.347	6.53685499883395e-179	VKORC1L1	Malignant cells	GSE175716	ENSG00000196715	154807	vitamin K epoxide reductase complex subunit 1 like 1	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21454
3.01208832063587e-182	-1.63835851567078	0.517	0.84	6.88412785681327e-178	IL32	Malignant cells	GSE175716	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21455
5.37889527099599e-182	1.17994870312157	0.989	0.765	1.22934651418613e-177	CAV2	Malignant cells	GSE175716	ENSG00000105971	858	caveolin 2	CAV	protein_coding	P51636	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21456
6.49496514555045e-182	-0.791274904213207	0.987	0.999	1.48442428401556e-177	CFL1	Malignant cells	GSE175716	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21457
7.06465352320979e-182	-0.93532154513024	0.331	0.754	1.6146265627296e-177	UQCRC2	Malignant cells	GSE175716	ENSG00000140740	7385	ubiquinol-cytochrome c reductase core protein 2	QCR2|UQCR2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21458
1.12960301307426e-181	-0.962822705458117	0.876	0.972	2.58170768638122e-177	NOP10	Malignant cells	GSE175716	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21459
1.91238408681427e-181	0.592889616583748	0.323	0.048	4.37075383041402e-177	FANCE	Malignant cells	GSE175716	ENSG00000112039	2178	FA complementation group E	FACE|FAE	protein_coding	Q9HB96	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21460
3.25286014268144e-181	1.24498495113512	0.66	0.283	7.43441185609843e-177	AL161909.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21461
7.53787051352358e-181	-1.03854257561046	0.336	0.753	1.72278030586582e-176	UBE2Z	Malignant cells	GSE175716	ENSG00000159202	65264	ubiquitin conjugating enzyme E2 Z	FLJ13855|USE1	protein_coding	Q9H832	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21462
2.56212450958937e-180	0.737739578807517	1	1	5.85573556666651e-176	MT-ND6	Malignant cells	GSE175716	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21463
3.19103249144941e-180	-1.58617402119866	0.378	0.758	7.29310475920764e-176	UFM1	Malignant cells	GSE175716	ENSG00000120686	51569	ubiquitin fold modifier 1	bA131P10.1|C13orf20	protein_coding	P61960	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21464
1.30331460208226e-179	0.948411287215787	0.994	0.912	2.978725523059e-175	RPL10AP6	Malignant cells	GSE175716	ENSG00000226360	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21465
6.77805199242844e-178	1.30599701676349	0.987	0.816	1.54912378286952e-173	JUN	Malignant cells	GSE175716	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21466
1.78931044804271e-176	0.865827311477052	0.998	0.993	4.08946902900162e-172	RPS15A	Malignant cells	GSE175716	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21467
2.86765842407574e-176	0.674315847375687	0.251	0.025	6.5540333282251e-172	CDKN2B-AS1	Malignant cells	GSE175716	ENSG00000240498	100048912	CDKN2B antisense RNA 1	ANRIL|CDKN2B-AS|CDKN2BAS|NCRNA00089|p15AS|PCAT12|RP11-145E5.4	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21468
1.34300692101334e-175	-1.29132616638985	0.994	0.994	3.06944231797599e-171	S100A6	Malignant cells	GSE175716	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21469
4.60103509959017e-175	1.10395403097537	0.852	0.524	1.05156657201133e-170	ALDH2	Malignant cells	GSE175716	ENSG00000111275	217	aldehyde dehydrogenase 2 family member	NA	protein_coding	P05091	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21470
5.84833356002794e-175	1.02457292898941	0.991	0.949	1.33663663514439e-170	RPL34P18	Malignant cells	GSE175716	ENSG00000240509	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21471
2.2425788093273e-173	-0.953074652498416	0.323	0.743	5.12541386871755e-169	UBE2D2	Malignant cells	GSE175716	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21472
2.34473541737861e-173	-2.01193899086	0.419	0.766	5.35889279641882e-169	MUC13	Malignant cells	GSE175716	ENSG00000173702	56667	mucin 13, cell surface associated	DRCC1	protein_coding	Q9H3R2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21473
4.55290474974223e-173	-1.0994841258671	0.34	0.741	1.04056638055359e-168	UQCRFS1	Malignant cells	GSE175716	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21474
5.0095661662168e-173	0.915228948007075	0.55	0.184	1.14493634728885e-168	CHCHD10	Malignant cells	GSE175716	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21475
1.63874641143205e-172	1.20806813001325	0.596	0.235	3.74535492332795e-168	JUNB	Malignant cells	GSE175716	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21476
2.53561883643993e-172	-1.04980574827853	0.671	0.918	5.79515685068346e-168	LMAN1	Malignant cells	GSE175716	ENSG00000074695	3998	lectin, mannose binding 1	ERGIC-53|ERGIC53|F5F8D|FMFD1|gp58|MCFD1|MR60	protein_coding	P49257	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21477
2.54268930142247e-172	-0.957221534120867	0.325	0.741	5.81131639840106e-168	UAP1	Malignant cells	GSE175716	ENSG00000117143	6675	UDP-N-acetylglucosamine pyrophosphorylase 1	AgX|AGX1|SPAG2	protein_coding	Q16222	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21478
3.35716291180414e-172	0.611845507281879	1	1	7.67279583492836e-168	RPL37A	Malignant cells	GSE175716	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21479
8.70662755543054e-172	0.969543345071805	0.886	0.57	1.98989972779365e-167	RPS20P14	Malignant cells	GSE175716	ENSG00000223803	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21480
2.26932575211687e-170	-1.44536240743999	0.547	0.868	5.1865440064631e-166	LRG1	Malignant cells	GSE175716	ENSG00000171236	116844	leucine rich alpha-2-glycoprotein 1	LRG	protein_coding	P02750	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21481
2.73104812190652e-170	-1.01778011869544	0.336	0.737	6.24181048261735e-166	KCNK1	Malignant cells	GSE175716	ENSG00000135750	3775	potassium two pore domain channel subfamily K member 1	DPK|K2p1.1|TWIK-1	protein_coding	O00180	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21482
5.40892809374647e-170	1.00371145073765	0.567	0.206	1.23621051582576e-165	EBPL	Malignant cells	GSE175716	ENSG00000123179	84650	EBP like	EBRP	protein_coding	Q9BY08	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21483
7.27706082527847e-170	-2.19395611944775	0.723	0.93	1.66317225161739e-165	TRAM1	Malignant cells	GSE175716	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21484
5.81340326234853e-169	1.3078327170224	0.71	0.379	1.32865331560976e-164	TMEM56	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21485
1.2656068395455e-168	0.447437111909429	0.251	0.027	2.89254443178125e-164	CYFIP2	Malignant cells	GSE175716	ENSG00000055163	26999	cytoplasmic FMR1 interacting protein 2	PIR121	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21486
1.55929138908325e-168	-1.22838062126078	0.756	0.92	3.56376046974976e-164	PRDX4	Malignant cells	GSE175716	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21487
2.5159801216957e-167	-1.00065790658974	0.545	0.845	5.75027256813551e-163	MESD	Malignant cells	GSE175716	ENSG00000117899	23184	mesoderm development LRP chaperone	BOCA|KIAA0081|MESDC2	protein_coding	Q14696	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21488
4.73023351646552e-167	-1.45175941397669	0.715	0.908	1.0810948701882e-162	TNFRSF12A	Malignant cells	GSE175716	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21489
5.08140007805693e-167	-1.39030212863311	0.38	0.736	1.16135398783991e-162	ASGR2	Malignant cells	GSE175716	ENSG00000161944	433	asialoglycoprotein receptor 2	CLEC4H2	protein_coding	P07307	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21490
2.88368838113957e-165	-0.968754057840748	0.395	0.768	6.59066979509448e-161	GOLM1	Malignant cells	GSE175716	ENSG00000135052	51280	golgi membrane protein 1	bA379P1.3|C9orf155|FLJ23608|GOLPH2|GP73	protein_coding	Q8NBJ4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21491
3.67731528085294e-165	1.08940240434506	0.998	0.901	8.40450407438941e-161	S100P	Malignant cells	GSE175716	ENSG00000163993	6286	S100 calcium binding protein P	NA	protein_coding	P25815	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21492
3.54823469171115e-164	1.43332289213404	0.942	0.703	8.10949038790583e-160	DUSP1	Malignant cells	GSE175716	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21493
4.2663890572844e-164	0.773024986525813	0.385	0.082	9.75083219042349e-160	TIMP2	Malignant cells	GSE175716	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21494
4.96493340975781e-164	-0.83874540338913	0.453	0.809	1.13473553080015e-159	CNOT7	Malignant cells	GSE175716	ENSG00000198791	29883	CCR4-NOT transcription complex subunit 7	CAF1	protein_coding	Q9UIV1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21495
1.68069108198155e-161	-1.06156781206593	0.653	0.912	3.84121946786884e-157	C4orf3	Malignant cells	GSE175716	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21496
5.36838947563406e-161	-1.13450543158317	0.794	0.941	1.22694541465616e-156	PLP2	Malignant cells	GSE175716	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21497
1.5380119196844e-160	0.455781757969596	0.263	0.033	3.51512624243868e-156	KLHDC8B	Malignant cells	GSE175716	ENSG00000185909	200942	kelch domain containing 8B	MGC35097	protein_coding	Q8IXV7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21498
2.11422607622546e-160	0.963400267469666	0.818	0.432	4.8320636972133e-156	CDA	Malignant cells	GSE175716	ENSG00000158825	978	cytidine deaminase	CDD	protein_coding	P32320	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21499
5.24486411010057e-160	1.00864690442955	0.744	0.404	1.19871369236349e-155	RPS7P11	Malignant cells	GSE175716	ENSG00000282052	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21500
3.5171565837367e-159	1.02697996724656	0.941	0.73	8.03846137213022e-155	AL049873.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21501
5.17056702483958e-159	1.08909963863431	0.626	0.287	1.18173309352709e-154	PTMAP5	Malignant cells	GSE175716	ENSG00000214182	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21502
7.38154818653752e-159	0.958727663537472	0.866	0.546	1.68705283803315e-154	HSPE1P3	Malignant cells	GSE175716	ENSG00000259746	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21503
7.89962007281664e-159	-2.18960247669	0.41	0.764	1.80545816764224e-154	SOX9	Malignant cells	GSE175716	ENSG00000125398	6662	SRY-box transcription factor 9	CMD1|CMPD1|SRA1	protein_coding	P48436	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21504
9.8171915570608e-159	-1.29231699132051	0.428	0.771	2.24371913036624e-154	ADAM9	Malignant cells	GSE175716	ENSG00000282230	8754	ADAM metallopeptidase domain 9	CORD9|KIAA0021|MCMP|MDC9|Mltng	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21505
1.21941306219e-158	-0.736906135235822	0.927	0.991	2.78696855363525e-154	TMED10	Malignant cells	GSE175716	ENSG00000170348	10972	transmembrane p24 trafficking protein 10	p23|P24(DELTA)|p24d1|p24delta1|TMP21	protein_coding	P49755	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21506
2.36445081669246e-158	-1.06194248404848	0.684	0.922	5.40395234155063e-154	CHMP2B	Malignant cells	GSE175716	ENSG00000083937	25978	charged multivesicular body protein 2B	CHMP2.5|DKFZP564O123|VPS2B	protein_coding	Q9UQN3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21507
7.41889926391441e-158	-0.908204396937867	0.99	0.993	1.69558942676764e-153	HSP90B1	Malignant cells	GSE175716	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21508
1.01646042552359e-157	-1.02374522631767	0.612	0.876	2.32312030253416e-153	ANKRD12	Malignant cells	GSE175716	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21509
2.52092430362188e-157	0.753876852564083	0.397	0.093	5.7615724959278e-153	NPW	Malignant cells	GSE175716	ENSG00000183971	283869	neuropeptide W	PPL8	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21510
4.23703419450112e-157	-0.965593837780072	0.359	0.737	9.68374165153232e-153	PRSS23	Malignant cells	GSE175716	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21511
9.79242369026063e-157	-1.17358666016973	0.712	0.892	2.23805843440907e-152	TXNDC17	Malignant cells	GSE175716	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21512
1.38618989787727e-156	0.68273009676354	0.974	0.771	3.16813701159851e-152	RPS3AP26	Malignant cells	GSE175716	ENSG00000214389	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21513
2.00502591830111e-156	1.83254491667559	0.598	0.252	4.58248673627719e-152	PI3	Malignant cells	GSE175716	ENSG00000124102	5266	peptidase inhibitor 3	cementoin|ELAFIN|ESI|SKALP|WAP3|WFDC14	protein_coding	P19957	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21514
3.38843001319893e-156	-0.98581096347461	0.737	0.93	7.74425679516615e-152	GCLM	Malignant cells	GSE175716	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21515
2.36268140963861e-155	-1.03250943478785	0.829	0.944	5.39990836172904e-151	RPL36AL	Malignant cells	GSE175716	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21516
4.82088075550256e-155	0.631054631562272	0.278	0.041	1.10181229667011e-150	SNCG	Malignant cells	GSE175716	ENSG00000173267	6623	synuclein gamma	BCSG1|persyn|SR	protein_coding	O76070	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21517
5.62470461834318e-155	-1.05945315745515	0.949	0.977	1.28552624052233e-150	SSR2	Malignant cells	GSE175716	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21518
2.16057099848153e-154	0.907604649430841	1	0.949	4.93798501702954e-150	NDUFA4	Malignant cells	GSE175716	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21519
2.92453198295516e-153	0.91321675692426	0.825	0.485	6.68401784704401e-149	CDC123	Malignant cells	GSE175716	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21520
5.26714261396416e-153	0.938743670004953	0.984	0.875	1.20380544442151e-148	PSMB1	Malignant cells	GSE175716	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21521
2.38563810123868e-152	0.904657272636453	0.825	0.518	5.452375880381e-148	ATP5EP2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21522
6.59050718021644e-152	-1.12738579486152	0.418	0.75	1.50626041603847e-147	PON1	Malignant cells	GSE175716	ENSG00000005421	5444	paraoxonase 1	ESA|PON	protein_coding	P27169	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21523
2.07071977996031e-151	-0.814568495641184	0.683	0.901	4.7326300570993e-147	MRPL33	Malignant cells	GSE175716	ENSG00000243147	9553	mitochondrial ribosomal protein L33	C2orf1|RPL33L	protein_coding	O75394	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21524
8.18246115233442e-151	0.972044798482506	0.946	0.653	1.87010149636603e-146	ZNHIT1	Malignant cells	GSE175716	ENSG00000106400	10467	zinc finger HIT-type containing 1	CG1I|H_DJ0747G18.14|ZNFN4A1	protein_coding	O43257	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21525
5.09586262123613e-149	0.501134036195495	0.278	0.042	1.16465940208352e-144	PHOSPHO2	Malignant cells	GSE175716	ENSG00000144362	493911	phosphatase, orphan 2	MGC22679	protein_coding	Q8TCD6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21526
6.11950829622571e-149	0.881735056783906	0.948	0.618	1.39861362110239e-144	ASS1	Malignant cells	GSE175716	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21527
1.15079682174942e-148	-0.748212402325606	0.836	0.963	2.6301461361083e-144	BRK1	Malignant cells	GSE175716	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21528
1.98490633447595e-148	-1.03286597846796	0.341	0.719	4.53650342744478e-144	CA9	Malignant cells	GSE175716	ENSG00000107159	768	carbonic anhydrase 9	CAIX|MN	protein_coding	Q16790	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21529
2.54450919170823e-147	0.973606416452185	0.841	0.542	5.81547575764917e-143	SDC2	Malignant cells	GSE175716	ENSG00000169439	6383	syndecan 2	CD362|fibroglycan|HSPG|HSPG1|SYND2	protein_coding	P34741	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21530
3.52190410854431e-147	0.910178333937101	0.987	0.881	8.04931184007801e-143	ORM1	Malignant cells	GSE175716	ENSG00000229314	5004	orosomucoid 1	NA	protein_coding	P02763	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21531
7.09862284162608e-147	-1.18513904770013	0.532	0.812	1.62239025045364e-142	EPS8	Malignant cells	GSE175716	ENSG00000151491	2059	epidermal growth factor receptor pathway substrate 8	NA	protein_coding	Q12929	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21532
8.54275295157605e-146	1.0784444614559	0.637	0.312	1.95244618708271e-141	GRINA	Malignant cells	GSE175716	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21533
1.35717242195449e-145	0.713234871517921	0.412	0.11	3.10181757037698e-141	AL136968.2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21534
2.08183185595984e-145	-0.902447160536095	0.534	0.827	4.75802670679622e-141	PPP2CB	Malignant cells	GSE175716	ENSG00000104695	5516	protein phosphatase 2 catalytic subunit beta	PP2Abeta	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21535
1.12091868613223e-144	0.806154294736199	0.439	0.128	2.56185965715522e-140	SNTB1	Malignant cells	GSE175716	ENSG00000172164	6641	syntrophin beta 1	59-DAP|A1B|BSYN2|SNT2|SNT2B1|TIP-43	protein_coding	Q13884	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21536
2.43401552363453e-144	-0.970928953541466	0.467	0.783	5.56294247926672e-140	AL445524.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21537
3.05792410417004e-144	-0.887016517198139	0.613	0.862	6.98888554008063e-140	SELENOS	Malignant cells	GSE175716	ENSG00000131871	55829	selenoprotein S	AD-015|MGC2553|SBBI8|SELS|SEPS1|VIMP	protein_coding	Q9BQE4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21538
5.73977235861731e-144	-1.11361674126009	0.535	0.817	1.31182497256199e-139	FAM46A	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21539
6.08892751489333e-144	0.905236808844359	0.973	0.815	1.39162438352887e-139	RPS13P2	Malignant cells	GSE175716	ENSG00000228929	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21540
1.18582396920806e-143	0.963477077338019	0.968	0.803	2.71020068162502e-139	CYC1	Malignant cells	GSE175716	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21541
2.24864754633389e-143	-0.868806516598467	0.611	0.876	5.1392839671461e-139	POLR2K	Malignant cells	GSE175716	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21542
2.15692270772128e-142	1.07268391757214	0.935	0.638	4.92964684849698e-138	STMN1	Malignant cells	GSE175716	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21543
5.41634104492582e-142	-0.948363759474537	0.999	0.999	1.2379047458178e-137	TXN	Malignant cells	GSE175716	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21544
5.87056186396237e-142	-1.40127790712877	0.4	0.71	1.3417169140086e-137	CFHR1	Malignant cells	GSE175716	ENSG00000244414	3078	complement factor H related 1	CFHL|CFHL1|CFHL1P|CFHR1P|FHR1|H36-1|H36-2|HFL1|HFL2	protein_coding	Q03591	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21545
6.36033877398872e-142	-0.790225039099618	0.017	0.461	1.45365542679512e-137	TMEM98	Malignant cells	GSE175716	ENSG00000006042	26022	transmembrane protein 98	DKFZP564K1964	protein_coding	Q9Y2Y6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21546
8.29178172684883e-142	0.577933491737245	0.976	0.799	1.8950867136713e-137	RPS27AP16	Malignant cells	GSE175716	ENSG00000224631	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21547
3.1654152173009e-141	0.90850542160931	0.834	0.541	7.23455647914121e-137	ESD	Malignant cells	GSE175716	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21548
1.0326075343036e-140	0.983200649307461	0.838	0.481	2.36002451965087e-136	CITED2	Malignant cells	GSE175716	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21549
1.21628079805966e-140	0.624642442738406	0.36	0.081	2.77980976396535e-136	CADM1	Malignant cells	GSE175716	ENSG00000182985	23705	cell adhesion molecule 1	BL2|IGSF4|IGSF4A|Necl-2|NECL2|RA175|ST17|SYNCAM|SYNCAM1|TSLC1	protein_coding	Q9BY67	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21550
1.84786554277601e-140	1.16206117734355	0.939	0.79	4.22329669801457e-136	DHCR24	Malignant cells	GSE175716	ENSG00000116133	1718	24-dehydrocholesterol reductase	DCE|KIAA0018|seladin-1	protein_coding	Q15392	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21551
2.15207245749443e-140	0.904606334749714	0.952	0.657	4.91856160160353e-136	RPS15AP24	Malignant cells	GSE175716	ENSG00000241511	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21552
1.52806409969522e-139	0.788351977315496	0.997	0.945	3.49239049985343e-135	TOMM20	Malignant cells	GSE175716	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21553
1.57921947026999e-139	-1.44712616125218	0.751	0.88	3.60930609930206e-135	S100A16	Malignant cells	GSE175716	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21554
1.72192894991945e-139	0.420749833443473	0.256	0.037	3.93546861504091e-135	GLCCI1	Malignant cells	GSE175716	ENSG00000106415	113263	glucocorticoid induced 1	FAM117C|GIG18|TSSN1	protein_coding	Q86VQ1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21555
2.08178547959618e-139	-0.792193838283699	1	1	4.75792071361707e-135	RPS16	Malignant cells	GSE175716	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21556
3.73952540846191e-139	-1.23842278158327	0.707	0.913	8.54668532103969e-135	ATP5G1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21557
4.59831948308308e-139	0.90338255888492	1	1	1.05094591785864e-134	MT-RNR1	Malignant cells	GSE175716	ENSG00000211459	NA	NA	12S|MOTS-c|MTRNR1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21558
4.60764539346634e-139	-0.978024835612927	0.377	0.735	1.05307735467673e-134	MYADM	Malignant cells	GSE175716	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21559
1.73549766276672e-138	1.09021558987262	0.489	0.165	3.96647990825335e-134	HILPDA	Malignant cells	GSE175716	ENSG00000135245	29923	hypoxia inducible lipid droplet associated	C7orf68|FLJ21076|HIG-2|HIG2	protein_coding	Q9Y5L2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21560
2.34809952785537e-138	-0.799668841602486	0.305	0.687	5.36658147091344e-134	UBE2L3	Malignant cells	GSE175716	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21561
5.89753719397888e-138	0.820643376348135	0.998	0.979	1.34788212568387e-133	RPS3AP6	Malignant cells	GSE175716	ENSG00000234797	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21562
9.86080979200923e-138	-0.899727373564679	0.489	0.798	2.25368807796371e-133	HIF1A	Malignant cells	GSE175716	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21563
9.92111074997676e-138	-0.824365772429532	0.305	0.685	2.26746986190719e-133	UBA2	Malignant cells	GSE175716	ENSG00000126261	10054	ubiquitin like modifier activating enzyme 2	FLJ13058|HRIHFB2115|SAE2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21564
1.63319906789272e-137	-0.780826070161523	0.071	0.509	3.73267646966882e-133	UGP2	Malignant cells	GSE175716	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21565
3.29568816924522e-137	0.304787230251837	0.944	0.63	7.53229531080994e-133	FOS	Malignant cells	GSE175716	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21566
1.87915250298516e-136	-0.843371754753969	1	1	4.29480304557259e-132	MGST1	Malignant cells	GSE175716	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21567
4.18781323303309e-136	0.889059490117645	0.956	0.785	9.57124714409713e-132	CNIH4	Malignant cells	GSE175716	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21568
1.30060612403448e-135	0.520372426128942	1	1	2.97253529648081e-131	MT-ATP6	Malignant cells	GSE175716	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21569
1.73938061735889e-135	0.842594868752374	0.474	0.161	3.97535440097375e-131	GTF2F2	Malignant cells	GSE175716	ENSG00000188342	2963	general transcription factor IIF subunit 2	BTF4|RAP30|TFIIF	protein_coding	P13984	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21570
2.54401079758892e-135	0.484230317269373	0.287	0.051	5.81433667788947e-131	MPDZ	Malignant cells	GSE175716	ENSG00000107186	8777	multiple PDZ domain crumbs cell polarity complex component	MUPP1	protein_coding	O75970	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21571
7.71310741511489e-135	1.11939496539903	0.961	0.852	1.76283069972451e-130	ARL6IP1	Malignant cells	GSE175716	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21572
1.01969373737202e-134	-1.61235694719447	0.659	0.911	2.33051003676374e-130	NDRG1	Malignant cells	GSE175716	ENSG00000104419	10397	N-myc downstream regulated 1	CAP43|DRG1|NDR1|RTP|TDD5	protein_coding	Q92597	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21573
1.49007748034491e-134	-1.20049403264212	0.64	0.893	3.40557208132828e-130	TNFAIP2	Malignant cells	GSE175716	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21574
1.62887506146489e-134	0.682548849269127	1	0.999	3.72279395297801e-130	RPS29	Malignant cells	GSE175716	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21575
2.5844995712247e-134	0.924144480849773	0.82	0.528	5.90687377003406e-130	HDAC2	Malignant cells	GSE175716	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21576
3.58259360169129e-134	0.80067125548138	0.38	0.101	8.18801767666545e-130	CDKN2C	Malignant cells	GSE175716	ENSG00000123080	1031	cyclin dependent kinase inhibitor 2C	INK4C|p18	protein_coding	P42773	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21577
8.18054744097522e-134	0.657508346050104	0.999	0.999	1.86966411763489e-129	RPS27A	Malignant cells	GSE175716	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21578
7.76425920203121e-133	-0.749456538349403	0	0.421	1.77452144062423e-128	URM1	Malignant cells	GSE175716	ENSG00000167118	81605	ubiquitin related modifier 1	C9orf74|MGC2668	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21579
1.90621097697639e-131	-0.772128510153343	0.659	0.888	4.35664518787954e-127	IPO7	Malignant cells	GSE175716	ENSG00000205339	10527	importin 7	Imp7|RANBP7	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21580
2.91460969832366e-131	0.572345374731096	1	1	6.66134046551872e-127	MT-ND4	Malignant cells	GSE175716	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21581
5.51222282458049e-131	0.918994068657156	0.348	0.082	1.25981852655787e-126	PCK1	Malignant cells	GSE175716	ENSG00000124253	5105	phosphoenolpyruvate carboxykinase 1	PEPCK-C	protein_coding	P35558	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21582
5.57361195835589e-131	1.06911576535394	0.545	0.237	1.27384901308224e-126	MCCC1	Malignant cells	GSE175716	ENSG00000078070	56922	methylcrotonyl-CoA carboxylase subunit 1	MCCA|MCCCalpha	protein_coding	Q96RQ3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21583
7.45339817535149e-131	0.508386188627044	0.333	0.074	1.70347415297658e-126	MTCO2P12	Malignant cells	GSE175716	ENSG00000229344	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21584
8.91771667098579e-131	-0.727191601465336	0	0.417	2.0381441451538e-126	EIF1AY	Malignant cells	GSE175716	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21585
1.67427364059323e-130	0.92189006963983	0.883	0.655	3.82655240557583e-126	SUCLG1	Malignant cells	GSE175716	ENSG00000163541	8802	succinate-CoA ligase GDP/ADP-forming subunit alpha	NA	protein_coding	P53597	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21586
4.31622206520358e-130	-0.787006276665802	0	0.416	9.86472553002279e-126	USP8	Malignant cells	GSE175716	ENSG00000138592	9101	ubiquitin specific peptidase 8	HumORF8|KIAA0055|SPG59|UBPY	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21587
6.43762464435649e-130	0.758878206728525	1	0.999	1.47131911246767e-125	MTATP6P1	Malignant cells	GSE175716	ENSG00000248527	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21588
6.61102198945348e-130	-0.81412115544578	0	0.416	1.51094907568959e-125	WWC1	Malignant cells	GSE175716	ENSG00000113645	23286	WW and C2 domain containing 1	KIAA0869|KIBRA|PPP1R168	protein_coding	Q8IX03	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21589
7.40984942650222e-130	0.926609012794961	0.957	0.762	1.69352108642708e-125	NDUFS2	Malignant cells	GSE175716	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21590
9.51588809240481e-130	0.962117982564301	0.867	0.602	2.17485622351912e-125	METTL7A	Malignant cells	GSE175716	ENSG00000185432	25840	methyltransferase like 7A	DKFZP586A0522	protein_coding	Q9H8H3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21591
9.57673647828557e-130	-0.720787886511854	0	0.414	2.18876312211217e-125	UBB	Malignant cells	GSE175716	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21592
1.34129153415142e-129	-2.44796037862835	0.459	0.722	3.06552180130307e-125	VTN	Malignant cells	GSE175716	ENSG00000109072	7448	vitronectin	VN	protein_coding	P04004	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21593
2.2140679279423e-129	-0.918405654761617	0.326	0.675	5.06025224931213e-125	SERPINA6	Malignant cells	GSE175716	ENSG00000277405	866	serpin family A member 6	CBG	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21594
2.58353467633732e-129	-0.828081911167852	0.296	0.666	5.90466850276895e-125	UBXN4	Malignant cells	GSE175716	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21595
3.73016657866377e-129	-0.852014264132442	0.301	0.667	8.52529571553605e-125	UBE3A	Malignant cells	GSE175716	ENSG00000114062	7337	ubiquitin protein ligase E3A	ANCR|AS|E6-AP|EPVE6AP|FLJ26981|HPVE6A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21596
5.5052417065676e-129	-0.867842671510713	0.289	0.662	1.25822299203602e-124	UBE2B	Malignant cells	GSE175716	ENSG00000119048	7320	ubiquitin conjugating enzyme E2 B	HHR6B|RAD6B|UBC2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21597
5.63130728945625e-129	0.942512474248714	0.566	0.249	1.28703528100523e-124	PPDPF	Malignant cells	GSE175716	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21598
8.15626628909316e-129	0.850293400782346	0.804	0.501	1.86411466037224e-124	AL033519.2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21599
1.87934619999453e-128	0.525328528874616	1	1	4.29524574008751e-124	RPL23	Malignant cells	GSE175716	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21600
2.30318779945754e-128	-1.02540765919407	0.444	0.74	5.26393571566021e-124	KRT10	Malignant cells	GSE175716	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21601
2.90730960905174e-128	-0.827749375285967	0.015	0.429	6.64465611148776e-124	UQCC2	Malignant cells	GSE175716	ENSG00000137288	84300	ubiquinol-cytochrome c reductase complex assembly factor 2	bA6B20.2|C6orf125|Cbp6|M19|MGC14833|MNF1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21602
9.52340542339257e-128	-1.88184431601334	0.414	0.705	2.17657430951637e-123	AREG	Malignant cells	GSE175716	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21603
1.42858351851175e-127	0.953535631377998	0.98	0.869	3.26502763155861e-123	ORM2	Malignant cells	GSE175716	ENSG00000228278	5005	orosomucoid 2	AGP-B|AGP-B'|AGP2	protein_coding	P19652	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21604
1.47622677579334e-127	0.804695251865393	0.436	0.143	3.37391629607567e-123	MAPK9	Malignant cells	GSE175716	ENSG00000050748	5601	mitogen-activated protein kinase 9	JNK2|p54a|PRKM9|SAPK	protein_coding	P45984	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21605
8.72765336549523e-127	-1.26126080686953	0.562	0.777	1.99470517668394e-122	CD99	Malignant cells	GSE175716	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21606
3.51307838530731e-126	0.895285810954709	0.941	0.746	8.02914064961985e-122	CS	Malignant cells	GSE175716	ENSG00000062485	1431	citrate synthase	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21607
3.80752748611743e-126	-0.713488977367525	0.977	0.994	8.7021040695214e-122	RPL39P3	Malignant cells	GSE175716	ENSG00000235174	NA	NA	Em:AC019205.3	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21608
4.38897897165515e-126	0.89080560294392	0.793	0.514	1.00310114397178e-121	PGM1	Malignant cells	GSE175716	ENSG00000079739	5236	phosphoglucomutase 1	NA	protein_coding	P36871	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21609
6.64773039303879e-126	-0.743452189091725	0.109	0.522	1.51933878132901e-121	UBE2J1	Malignant cells	GSE175716	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21610
7.30252733114971e-126	-0.733865126573931	0.696	0.898	1.66899262153427e-121	SF3B4	Malignant cells	GSE175716	ENSG00000143368	10262	splicing factor 3b subunit 4	Hsh49|SAP49|SF3b49	protein_coding	Q15427	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21611
1.01839996484812e-125	-3.1806614694259	0.443	0.688	2.32755311966038e-121	NTS	Malignant cells	GSE175716	ENSG00000133636	4922	neurotensin	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21612
2.76801299129306e-125	0.856463892079147	0.947	0.76	6.32629369160029e-121	ETF1	Malignant cells	GSE175716	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21613
3.46390955660643e-125	-0.86634198239307	0.401	0.724	7.91676529162399e-121	MBP	Malignant cells	GSE175716	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21614
1.76143809437287e-124	0.831879179247229	0.9	0.553	4.02576676468919e-120	LBP	Malignant cells	GSE175716	ENSG00000129988	3929	lipopolysaccharide binding protein	BPIFD2	protein_coding	P18428	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21615
1.92574228994485e-124	0.980173373069225	0.572	0.267	4.40128400366896e-120	MSRB1	Malignant cells	GSE175716	ENSG00000198736	51734	methionine sulfoxide reductase B1	SELENOR|SELENOX|SelR|SelX|SepR|SEPX1	protein_coding	Q9NZV6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21616
2.27046721131254e-124	-0.789806719314087	0.002	0.406	5.18915281145482e-120	TMEM156	Malignant cells	GSE175716	ENSG00000121895	80008	transmembrane protein 156	FLJ23235	protein_coding	Q8N614	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21617
4.42060680258962e-124	-1.06551802181598	0.438	0.729	1.01032968473186e-119	TGM2	Malignant cells	GSE175716	ENSG00000198959	7052	transglutaminase 2	TGC	protein_coding	P21980	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21618
5.41435110404031e-124	-0.989433770292468	0.423	0.738	1.23744994482841e-119	HHEX	Malignant cells	GSE175716	ENSG00000152804	3087	hematopoietically expressed homeobox	HEX|HOX11L-PEN|PRHX	protein_coding	Q03014	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21619
6.63047533342466e-124	-0.798083229712689	0	0.402	1.51539513745421e-119	UBE2E3	Malignant cells	GSE175716	ENSG00000170035	10477	ubiquitin conjugating enzyme E2 E3	UbcH9	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21620
9.27166630537752e-124	0.948082205423889	0.866	0.611	2.11903933409403e-119	PCBD1	Malignant cells	GSE175716	ENSG00000166228	5092	pterin-4 alpha-carbinolamine dehydratase 1	DCOH|PCBD|PCD	protein_coding	P61457	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21621
1.64682880303233e-123	0.777785482656153	0.997	0.986	3.76382722933038e-119	HDGF	Malignant cells	GSE175716	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21622
1.89764221024188e-123	-0.840323707510261	0	0.402	4.33706127150781e-119	USP10	Malignant cells	GSE175716	ENSG00000103194	9100	ubiquitin specific peptidase 10	KIAA0190|UBPO	protein_coding	Q14694	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21623
3.91057641195785e-123	0.887601013171637	0.822	0.538	8.93762238952968e-119	TST	Malignant cells	GSE175716	ENSG00000128311	7263	thiosulfate sulfurtransferase	RDS	protein_coding	Q16762	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21624
7.19697758622527e-123	-0.821321066619118	0.457	0.768	1.64486922733178e-118	CD47	Malignant cells	GSE175716	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21625
1.02083691175584e-122	-0.802795584282313	0.669	0.869	2.33312276181797e-118	EMC7	Malignant cells	GSE175716	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21626
1.08820676609978e-122	-0.739039215553865	0.703	0.893	2.48709656392105e-118	COPZ1	Malignant cells	GSE175716	ENSG00000111481	22818	COPI coat complex subunit zeta 1	CGI-120|COPZ	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21627
1.27606363491456e-122	-0.784449471699543	0.347	0.691	2.91644343759723e-118	SEMA4B	Malignant cells	GSE175716	ENSG00000185033	10509	semaphorin 4B	KIAA1745|MGC131831|SEMAC|SemC	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21628
1.28208174512968e-122	-0.797817006923497	0.094	0.5	2.93019782849389e-118	UTP23	Malignant cells	GSE175716	ENSG00000147679	84294	UTP23 small subunit processome component	C8orf53|MGC14595	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21629
1.55729152190672e-122	-0.74828551958309	0	0.398	3.5591897733178e-118	URI1	Malignant cells	GSE175716	ENSG00000105176	8725	URI1 prefoldin like chaperone	C19orf2|FLJ10575|NNX3|PPP1R19|RMP|URI	protein_coding	O94763	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21630
8.35736923270678e-122	-0.802373642737389	0.022	0.426	1.91007673813513e-117	CYB561	Malignant cells	GSE175716	ENSG00000008283	1534	cytochrome b561	CYB561A1|FRRS2	protein_coding	P49447	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21631
1.4671074553145e-121	0.799573003803811	0.994	0.888	3.35307408912128e-117	ATP5C1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21632
5.64468817236296e-121	-1.09977490455131	0.69	0.89	1.29009348179355e-116	CA12	Malignant cells	GSE175716	ENSG00000074410	771	carbonic anhydrase 12	HsT18816	protein_coding	O43570	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21633
4.18397916367883e-120	0.811936560723743	0.453	0.163	9.56248437858796e-116	CAP2	Malignant cells	GSE175716	ENSG00000112186	10486	cyclase associated actin cytoskeleton regulatory protein 2	NA	protein_coding	P40123	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21634
4.33813711052909e-120	0.850042123330677	0.802	0.525	9.91481236611422e-116	OLA1	Malignant cells	GSE175716	ENSG00000138430	29789	Obg like ATPase 1	GTPBP9|PTD004	protein_coding	Q9NTK5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21635
5.99821650606884e-120	-0.720638624182727	0	0.392	1.37089238246203e-115	USP47	Malignant cells	GSE175716	ENSG00000170242	55031	ubiquitin specific peptidase 47	NA	protein_coding	Q96K76	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21636
1.63397035483989e-119	0.839677866700177	0.98	0.876	3.73443924598657e-115	MDH1	Malignant cells	GSE175716	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21637
2.78223440964462e-119	-1.07925145187945	0.413	0.722	6.35879674324277e-115	SGMS2	Malignant cells	GSE175716	ENSG00000164023	166929	sphingomyelin synthase 2	MGC26963|SMS2	protein_coding	Q8NHU3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21638
5.01147951749278e-119	-0.892007066707206	0.84	0.957	1.14537364372298e-114	EIF5	Malignant cells	GSE175716	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21639
5.55957478869964e-119	0.586939270430879	1	1	1.2706408179573e-114	HSP90AB1	Malignant cells	GSE175716	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21640
8.02655328396172e-119	-0.724768366272068	0.278	0.64	1.83446875304945e-114	UROD	Malignant cells	GSE175716	ENSG00000126088	7389	uroporphyrinogen decarboxylase	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21641
8.2860462804907e-119	-0.779513601600574	0.108	0.504	1.89377587740615e-114	DDX3Y	Malignant cells	GSE175716	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21642
9.53314785915291e-119	0.535101805303746	1	1	2.1788009432094e-114	RPS8	Malignant cells	GSE175716	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21643
6.56130999440104e-118	-0.733480429100019	0.578	0.83	1.49958739922036e-113	LAMP2	Malignant cells	GSE175716	ENSG00000005893	3920	lysosomal associated membrane protein 2	CD107b	protein_coding	P13473	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21644
1.7652803799223e-117	0.604701722658385	0.255	0.047	4.03454830831242e-113	RIMS2	Malignant cells	GSE175716	ENSG00000176406	9699	regulating synaptic membrane exocytosis 2	KIAA0751|OBOE|RAB3IP3|RIM2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21645
2.90276816822331e-117	0.853228952729111	0.759	0.484	6.63427664847438e-113	PPP2R5A	Malignant cells	GSE175716	ENSG00000066027	5525	protein phosphatase 2 regulatory subunit B'alpha	B56A|B56alpha|PR61A	protein_coding	Q15172	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21646
3.37989073213145e-117	-0.754766608344928	0.007	0.395	7.72474026828643e-113	PRNP	Malignant cells	GSE175716	ENSG00000171867	5621	prion protein	AltPrP|CD230|CJD|GSS|PRIP|PRP	protein_coding	P04156	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21647
3.94557710764798e-117	-1.21133238487569	0.331	0.653	9.01761647952946e-113	GPRC5A	Malignant cells	GSE175716	ENSG00000013588	9052	G protein-coupled receptor class C group 5 member A	PEIG-1|RAI3|RAIG1|TIG1	protein_coding	Q8NFJ5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21648
5.16575755045788e-117	-0.763503454562052	0.248	0.616	1.18063388815715e-112	UBE2Q1	Malignant cells	GSE175716	ENSG00000160714	55585	ubiquitin conjugating enzyme E2 Q1	NICE-5|PRO3094|UBE2Q	protein_coding	Q7Z7E8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21649
5.779756338262e-117	-0.681296835494687	0	0.384	1.32096331110978e-112	UBAP1	Malignant cells	GSE175716	ENSG00000165006	51271	ubiquitin associated protein 1	UBAP	protein_coding	Q9NZ09	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21650
1.3127233969626e-116	-0.908784432045594	0.048	0.442	3.00022932375803e-112	RNF128	Malignant cells	GSE175716	ENSG00000133135	79589	ring finger protein 128	FLJ23516|GRAIL	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21651
1.33631279836062e-116	-0.903067827797806	0.056	0.449	3.0541429006532e-112	PROX1	Malignant cells	GSE175716	ENSG00000117707	5629	prospero homeobox 1	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21652
1.48927445794038e-116	-0.710545053318123	0.192	0.575	3.40373677362275e-112	UBE2V2	Malignant cells	GSE175716	ENSG00000169139	7336	ubiquitin conjugating enzyme E2 V2	DDVit-1|DDVIT1|EDAF-1|EDPF-1|EDPF1|MMS2|UEV-2|UEV2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21653
1.96330735878134e-116	0.778109472925316	0.96	0.658	4.48713896849475e-112	ATP5O	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21654
2.05313788757475e-116	0.827238069279888	0.779	0.426	4.6924466420521e-112	HMGB2	Malignant cells	GSE175716	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21655
3.28515947108692e-116	0.984088601677952	0.772	0.513	7.50823197116916e-112	HACD2	Malignant cells	GSE175716	ENSG00000206527	201562	3-hydroxyacyl-CoA dehydratase 2	PTPLB	protein_coding	Q6Y1H2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21656
3.84529417483183e-116	1.07846686669611	0.52	0.224	8.78841983657814e-112	CSTA	Malignant cells	GSE175716	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21657
3.85763095950658e-116	-1.12666943405907	0.528	0.777	8.81661555795229e-112	AQP3	Malignant cells	GSE175716	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21658
1.09645877717663e-115	0.694348261426508	0.452	0.165	2.50595653523718e-111	RPS15AP38	Malignant cells	GSE175716	ENSG00000237668	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21659
1.13207361562359e-115	0.868714674830884	0.819	0.568	2.58735424850772e-111	PCMT1	Malignant cells	GSE175716	ENSG00000120265	5110	protein-L-isoaspartate (D-aspartate) O-methyltransferase	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21660
1.18283500110432e-115	-0.727296135233286	0.218	0.593	2.70336939502391e-111	U2AF2	Malignant cells	GSE175716	ENSG00000063244	11338	U2 small nuclear RNA auxiliary factor 2	U2AF65	protein_coding	P26368	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21661
1.69659890622192e-115	-1.00976224770219	0.49	0.737	3.87757680017019e-111	CBR1	Malignant cells	GSE175716	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21662
3.76095344538886e-115	-1.00613883111527	0.319	0.648	8.59565909943625e-111	GJA1	Malignant cells	GSE175716	ENSG00000152661	2697	gap junction protein alpha 1	CX43|GJAL|ODD|ODDD|ODOD|SDTY3	protein_coding	P17302	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21663
3.91589364377951e-115	-0.820722971332659	0.082	0.473	8.94977492285806e-111	SCNN1A	Malignant cells	GSE175716	ENSG00000111319	6337	sodium channel epithelial 1 subunit alpha	ENaCalpha|SCNN1	protein_coding	P37088	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21664
4.12698384405367e-115	-0.74276130185033	0.516	0.79	9.43222157558465e-111	TXNL1	Malignant cells	GSE175716	ENSG00000091164	9352	thioredoxin like 1	TRP32|Txl|TXNL	protein_coding	O43396	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21665
5.36806700958765e-115	-1.0331648124405	0.314	0.641	1.22687171504126e-110	UBL3	Malignant cells	GSE175716	ENSG00000122042	5412	ubiquitin like 3	DKFZP434K151|FLJ32018|HCG-1|PNSC1	protein_coding	O95164	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21666
8.67881906572585e-115	-0.719018682965097	0.542	0.818	1.98354409747164e-110	CNN3	Malignant cells	GSE175716	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21667
2.00028667533423e-114	-1.20446007606603	0.337	0.635	4.57165519647638e-110	UQCRC1	Malignant cells	GSE175716	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21668
2.4889847304838e-114	-0.90352300944313	0.311	0.641	5.68857460152073e-110	LAD1	Malignant cells	GSE175716	ENSG00000159166	3898	ladinin 1	NA	protein_coding	O00515	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21669
3.44317385365454e-114	-0.757136454317452	0.254	0.615	7.86937384252746e-110	UTP11	Malignant cells	GSE175716	ENSG00000183520	51118	UTP11 small subunit processome component	CGI-94|UTP11L	protein_coding	Q9Y3A2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21670
3.59035005086954e-114	0.735863900418288	0.508	0.207	8.20574504126234e-110	ECI1	Malignant cells	GSE175716	ENSG00000167969	1632	enoyl-CoA delta isomerase 1	DCI	protein_coding	P42126	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21671
3.63463125475399e-114	0.749773438921934	0.99	0.819	8.30694973274025e-110	PSMA7	Malignant cells	GSE175716	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21672
3.79073406416033e-114	0.481300480664958	0.285	0.061	8.66372270363844e-110	EPB41L4B	Malignant cells	GSE175716	ENSG00000095203	54566	erythrocyte membrane protein band 4.1 like 4B	EHM2|LULU2	protein_coding	Q9H329	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21673
4.08448141364144e-114	-0.937970004975279	0.991	0.991	9.33508227087751e-110	S100A10	Malignant cells	GSE175716	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21674
6.8792191401696e-114	-0.743458099942688	0.217	0.589	1.57224553448576e-109	USP7	Malignant cells	GSE175716	ENSG00000187555	7874	ubiquitin specific peptidase 7	HAUSP	protein_coding	Q93009	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21675
7.65980750300496e-114	-0.783581258851965	0.641	0.849	1.75064900481178e-109	MYH9	Malignant cells	GSE175716	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21676
1.12444963011121e-113	-0.664478960488658	0	0.376	2.56992962961917e-109	USP16	Malignant cells	GSE175716	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21677
1.21782961484786e-113	-0.71326144435097	0.948	0.986	2.78334958473478e-109	ATF4	Malignant cells	GSE175716	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21678
1.62132164858485e-113	0.841424505556134	0.98	0.892	3.70553062784068e-109	RPL12P4	Malignant cells	GSE175716	ENSG00000185834	NA	NA	dJ800C24.1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21679
1.75762337128396e-113	0.993505044116924	0.775	0.506	4.01704821506949e-109	PTMS	Malignant cells	GSE175716	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21680
5.92492445567494e-113	0.550046406078994	1	0.999	1.35414148434451e-108	RPL31	Malignant cells	GSE175716	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21681
6.35351129062106e-113	-0.84137826138328	0.623	0.846	1.45209500547144e-108	NEDD9	Malignant cells	GSE175716	ENSG00000111859	4739	neural precursor cell expressed, developmentally down-regulated 9	CAS-L|CASS2|HEF1	protein_coding	Q14511	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21682
8.82037436434156e-113	0.635747101217955	0.411	0.131	2.01589656097026e-108	MAGEA12	Malignant cells	GSE175716	ENSG00000213401	4111	MAGE family member A12	CT1.12|MAGE12	protein_coding	P43365	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21683
1.00210999412837e-112	-0.653417388970789	1	1	2.29032239158038e-108	RPS24	Malignant cells	GSE175716	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21684
1.24868308365973e-112	-1.00132223159636	0.327	0.645	2.85386518770432e-108	SDCBP2	Malignant cells	GSE175716	ENSG00000125775	27111	syndecan binding protein 2	SITAC18|ST-2	protein_coding	Q9H190	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21685
1.2895693512358e-112	-0.870505359617891	0.303	0.64	2.94731075224943e-108	TACC1	Malignant cells	GSE175716	ENSG00000147526	6867	transforming acidic coiled-coil containing protein 1	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21686
1.44778795670281e-112	-0.787457420261206	0.005	0.382	3.30891937504426e-108	MUC1	Malignant cells	GSE175716	ENSG00000185499	4582	mucin 1, cell surface associated	ADMCKD|ADMCKD1|Ca15-3|CD227|EMA|KL-6|MCD|MCKD|MCKD1|PEM|PUM	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21687
1.55914347640186e-112	-0.737825732457932	0.17	0.547	3.56342241531646e-108	UTP3	Malignant cells	GSE175716	ENSG00000132467	57050	UTP3 small subunit processome component	CRLZ1|DKFZp761F222|FLJ23256|SAS10	protein_coding	Q9NQZ2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21688
2.10220904152183e-112	0.794575364241686	0.906	0.7	4.80459876439813e-108	SNX5	Malignant cells	GSE175716	ENSG00000089006	27131	sorting nexin 5	NA	protein_coding	Q9Y5X3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21689
3.56577230623443e-112	-0.796787451894424	0.263	0.616	8.1495726058988e-108	U2SURP	Malignant cells	GSE175716	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21690
3.6714111949702e-112	0.804043935125028	0.436	0.157	8.3910102861044e-108	FABP5P7	Malignant cells	GSE175716	ENSG00000234964	NA	NA	FABP5L7	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21691
9.5267512838811e-112	-0.927867180930497	0.933	0.961	2.17733900593103e-107	RPSA	Malignant cells	GSE175716	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21692
1.43476604894196e-111	0.71001458897383	0.454	0.169	3.27915780485684e-107	DNAJC15	Malignant cells	GSE175716	ENSG00000120675	29103	DnaJ heat shock protein family (Hsp40) member C15	DNAJD1|MCJ	protein_coding	Q9Y5T4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21693
2.18418892569932e-111	0.584752029773682	1	0.999	4.99196378968579e-107	RPS20	Malignant cells	GSE175716	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21694
3.5241370751449e-111	-0.676687582242097	0	0.37	8.05441528524366e-107	UCHL5	Malignant cells	GSE175716	ENSG00000116750	51377	ubiquitin C-terminal hydrolase L5	CGI-70|INO80R|UCH37	protein_coding	Q9Y5K5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21695
4.03759037509697e-111	-0.761404995026737	0	0.371	9.22791280228412e-107	SHROOM3	Malignant cells	GSE175716	ENSG00000138771	57619	shroom family member 3	APXL3|KIAA1481|SHRM|ShrmL	protein_coding	Q8TF72	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21696
5.06554941648252e-111	-0.76092350329407	0.024	0.406	1.15773131913708e-106	RND1	Malignant cells	GSE175716	ENSG00000172602	27289	Rho family GTPase 1	ARHS|Rho6|RHOS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21697
1.13421020733655e-110	-1.27271285353318	0.375	0.649	2.59223742886769e-106	ANPEP	Malignant cells	GSE175716	ENSG00000166825	290	alanyl aminopeptidase, membrane	AP-N|CD13|gp150|hAPN|LAP1|p150|PEPN	protein_coding	P15144	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21698
1.17491803901568e-110	-0.912928425243693	0.767	0.918	2.68527517817035e-106	SAT1	Malignant cells	GSE175716	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21699
1.17986837602059e-110	-0.842353200005149	1	0.999	2.69658917339505e-106	RPS17	Malignant cells	GSE175716	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21700
3.34926052593768e-110	-1.11524192433069	0.32	0.636	7.65473493203056e-106	UBE2D1	Malignant cells	GSE175716	ENSG00000072401	7321	ubiquitin conjugating enzyme E2 D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UbcH5A	protein_coding	P51668	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21701
3.52456879855413e-110	-0.826103046965455	0	0.37	8.05540198909547e-106	MISP	Malignant cells	GSE175716	ENSG00000099812	126353	mitotic spindle positioning	C19orf21|Caprice|DKFZp686H18209|MISP1	protein_coding	Q8IVT2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21702
3.87730608536074e-110	0.616965031161961	0.998	0.981	8.86158305809198e-106	RPL9P9	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21703
4.4050860597802e-110	-1.27926221549639	0.358	0.662	1.00678241896276e-105	ITIH2	Malignant cells	GSE175716	ENSG00000151655	3698	inter-alpha-trypsin inhibitor heavy chain 2	H2P	protein_coding	P19823	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21704
5.81762995730125e-110	0.752600080977581	0.993	0.972	1.3296193267412e-105	AC114491.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21705
8.94259598066678e-110	-0.690483237854437	0.032	0.415	2.04383031138139e-105	GABARAPL1	Malignant cells	GSE175716	ENSG00000139112	23710	GABA type A receptor associated protein like 1	APG8L|ATG8B|ATG8L|gec1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21706
1.03449225243555e-109	0.427620422948809	0.257	0.051	2.36433204294145e-105	TMEM38A	Malignant cells	GSE175716	ENSG00000072954	79041	transmembrane protein 38A	MGC3169|TRIC-A	protein_coding	Q9H6F2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21707
1.30977209606862e-109	0.838440202757309	0.721	0.459	2.99348412556483e-105	PPT1	Malignant cells	GSE175716	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21708
2.6639854267683e-109	-1.04537176501057	0.469	0.734	6.08853869287894e-105	VNN1	Malignant cells	GSE175716	ENSG00000112299	8876	vanin 1	Tiff66	protein_coding	O95497	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21709
2.88141588404518e-109	-0.712716931164515	0.36	0.685	6.58547600298526e-105	PLPP5	Malignant cells	GSE175716	ENSG00000147535	84513	phospholipid phosphatase 5	DPPL1|HTPAP|PPAPDC1B	protein_coding	Q8NEB5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21710
3.26029668188563e-109	-0.673606545212276	0	0.366	7.4514080664496e-105	SMIM31	Malignant cells	GSE175716	ENSG00000248771	100505989	small integral membrane protein 31	h.EPR|LINC01207	protein_coding	A0A1B0GVY4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21711
3.75534266903538e-109	0.840918949540519	0.518	0.222	8.58283567008035e-105	SGCE	Malignant cells	GSE175716	ENSG00000127990	8910	sarcoglycan epsilon	DYT11	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21712
4.54887376758226e-109	-0.82339443635736	0.016	0.388	1.03964509958093e-104	TMEM99	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21713
6.3091955896099e-109	-0.750527084943248	0.239	0.594	1.44196665200534e-104	USP14	Malignant cells	GSE175716	ENSG00000101557	9097	ubiquitin specific peptidase 14	TGT|Ubp6	protein_coding	P54578	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21714
1.66053412276375e-108	-1.71552236910579	0.531	0.763	3.79515073757656e-104	CP	Malignant cells	GSE175716	ENSG00000047457	1356	ceruloplasmin	AB073614	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21715
1.68072247422641e-108	-0.814400937283346	0	0.365	3.84129121484446e-104	PAH	Malignant cells	GSE175716	ENSG00000171759	5053	phenylalanine hydroxylase	PH	protein_coding	P00439	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21716
1.82133947684994e-108	-1.76672964897099	0.406	0.654	4.16267137434053e-104	FADS1	Malignant cells	GSE175716	ENSG00000149485	3992	fatty acid desaturase 1	D5D|FADS6|FADSD5|LLCDL1|TU12	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21717
2.20511879709277e-108	-0.745399115324267	0.023	0.396	5.03979901075552e-104	MFHAS1	Malignant cells	GSE175716	ENSG00000147324	9258	multifunctional ROCO family signaling regulator 1	LRRC65|MASL1	protein_coding	Q9Y4C4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21718
2.4573230441629e-108	-0.691742216873052	0.668	0.867	5.61621181743432e-104	ARPP19	Malignant cells	GSE175716	ENSG00000128989	10776	cAMP regulated phosphoprotein 19	ARPP-16|ARPP-19|ARPP16|ENSAL	protein_coding	P56211	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21719
3.66889824842272e-108	0.830172042700188	0.479	0.199	8.38526694677014e-104	FPGS	Malignant cells	GSE175716	ENSG00000136877	2356	folylpolyglutamate synthase	NA	protein_coding	Q05932	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21720
5.3790021040592e-108	-0.802633143116534	0.004	0.371	1.22937093088273e-103	JUP	Malignant cells	GSE175716	ENSG00000173801	3728	junction plakoglobin	CTNNG|DP3|DPIII|PDGB|PG|PKGB	protein_coding	P14923	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21721
5.62594921435415e-108	-0.802885155965766	0	0.364	1.28581069294064e-103	UPP1	Malignant cells	GSE175716	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21722
6.51034217367792e-108	-0.760967479175368	0.705	0.884	1.48793870379409e-103	LPGAT1	Malignant cells	GSE175716	ENSG00000123684	9926	lysophosphatidylglycerol acyltransferase 1	FAM34A|FAM34A1|KIAA0205|LPLAT7|NET8	protein_coding	Q92604	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21723
1.63642209173153e-107	-0.672960049686748	0.028	0.401	3.74004269065241e-103	GMDS	Malignant cells	GSE175716	ENSG00000112699	2762	GDP-mannose 4,6-dehydratase	GMD|SDR3E1	protein_coding	O60547	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21724
1.74242431579134e-107	0.714951018097814	0.985	0.893	3.9823107737411e-103	RPL22	Malignant cells	GSE175716	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21725
1.88142410697051e-107	-0.702112195113665	0.023	0.398	4.29999479648111e-103	GLCE	Malignant cells	GSE175716	ENSG00000138604	26035	glucuronic acid epimerase	HSEPI|KIAA0836	protein_coding	O94923	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21726
3.1426235605249e-107	-0.689251488467418	0	0.36	7.18246614757967e-103	UBAP2L	Malignant cells	GSE175716	ENSG00000143569	9898	ubiquitin associated protein 2 like	KIAA0144|NICE-4	protein_coding	Q14157	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21727
4.63617197711481e-107	-0.679268406431532	0.003	0.365	1.05959710536959e-102	CHRDL2	Malignant cells	GSE175716	ENSG00000054938	25884	chordin like 2	BNF1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21728
5.46950096844234e-107	-0.733276235057273	0.206	0.566	1.2500544463375e-102	USP1	Malignant cells	GSE175716	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21729
1.41175262241451e-106	-0.721523994814808	0.683	0.889	3.22656061852835e-102	ARF6	Malignant cells	GSE175716	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21730
1.5737204183154e-106	0.481240796008001	0.329	0.088	3.59673801605985e-102	CHKA	Malignant cells	GSE175716	ENSG00000110721	1119	choline kinase alpha	CHK|CKI	protein_coding	P35790	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21731
1.70509069762458e-106	0.8270915563556	0.934	0.761	3.89698478942097e-102	GTPBP4	Malignant cells	GSE175716	ENSG00000107937	23560	GTP binding protein 4	CRFG|FLJ10686|FLJ10690|NGB|NOG1	protein_coding	Q9BZE4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21732
2.798493624748e-106	-0.64310999038971	0.716	0.906	6.39595717936156e-102	TMED9	Malignant cells	GSE175716	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21733
3.84958987127415e-106	-0.951367892812263	0.059	0.429	8.79823765079707e-102	DNAJC12	Malignant cells	GSE175716	ENSG00000108176	56521	DnaJ heat shock protein family (Hsp40) member C12	JDP1	protein_coding	Q9UKB3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21734
3.97875932252851e-106	-0.74269849412567	0.21	0.566	9.09345443163891e-102	UBE2A	Malignant cells	GSE175716	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21735
4.0436930513092e-106	-0.677610611730326	0	0.358	9.24186046876717e-102	UBA1	Malignant cells	GSE175716	ENSG00000130985	7317	ubiquitin like modifier activating enzyme 1	A1S9T|CFAP124|GXP1|POC20|UBE1|UBE1X	protein_coding	P22314	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21736
6.9387680998943e-106	-1.37287210497246	0.733	0.883	1.58585544923084e-101	EIF4A2	Malignant cells	GSE175716	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21737
7.12670813071318e-106	-0.805932700177469	0.075	0.448	1.6288091432745e-101	SLC7A11	Malignant cells	GSE175716	ENSG00000151012	23657	solute carrier family 7 member 11	xCT	protein_coding	Q9UPY5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21738
7.92567225538409e-106	-0.868238593225188	0.307	0.63	1.81141239396803e-101	C4BPA	Malignant cells	GSE175716	ENSG00000123838	722	complement component 4 binding protein alpha	C4BP	protein_coding	P04003	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21739
8.37396765526363e-106	-0.787433889683077	0	0.358	1.9138703076105e-101	CA2	Malignant cells	GSE175716	ENSG00000104267	760	carbonic anhydrase 2	CA-II|CAII|Car2	protein_coding	P00918	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21740
1.45734928929764e-105	-1.00143415026755	0.011	0.373	3.33077180068976e-101	TCIM	Malignant cells	GSE175716	ENSG00000176907	56892	transcriptional and immune response regulator	C8orf4|hTC-1|TC-1|TC1	protein_coding	Q9NR00	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21741
7.25877509790511e-105	-0.618915553186854	0	0.354	1.65899304862621e-100	UGGT1	Malignant cells	GSE175716	ENSG00000136731	56886	UDP-glucose glycoprotein glucosyltransferase 1	HUGT1|UGCGL1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21742
1.11313931492948e-104	-0.699941261490746	0.065	0.442	2.54407990427132e-100	EPDR1	Malignant cells	GSE175716	ENSG00000086289	54749	ependymin related 1	EPDR|MERP-1|MERP1|UCC1	protein_coding	Q9UM22	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21743
1.41870351345157e-104	0.564659349799158	0.396	0.132	3.24244687999357e-100	AL445189.2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21744
2.22756497320771e-104	-0.810937276406358	0.588	0.803	5.09109974626623e-100	HLA-E	Malignant cells	GSE175716	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21745
3.50684867079364e-104	-0.681742259851703	0.035	0.4	8.01490263709887e-100	FNDC4	Malignant cells	GSE175716	ENSG00000115226	64838	fibronectin type III domain containing 4	FLJ22362|FRCP1	protein_coding	Q9H6D8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21746
7.7952413845249e-104	-0.825974657644491	0.339	0.651	1.78160241843317e-99	GCNT3	Malignant cells	GSE175716	ENSG00000140297	9245	glucosaminyl (N-acetyl) transferase 3, mucin type	C2/4GnT|C2GnT-M|C2GnT2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21747
7.82803509422344e-104	-0.655251566742951	0.011	0.369	1.78909742078477e-99	SNX9	Malignant cells	GSE175716	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21748
9.61166912148307e-104	-0.869080287021388	0.477	0.74	2.19674697771495e-99	GNA13	Malignant cells	GSE175716	ENSG00000120063	10672	G protein subunit alpha 13	G13|MGC46138	protein_coding	Q14344	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21749
1.12482976915739e-103	-0.944013420277244	0.361	0.658	2.57079843740922e-99	ONECUT2	Malignant cells	GSE175716	ENSG00000119547	9480	one cut homeobox 2	OC-2	protein_coding	O95948	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21750
1.13086359989876e-103	-1.64429929903793	0.611	0.769	2.58458875756861e-99	ASAH1	Malignant cells	GSE175716	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21751
2.26332855768944e-103	-1.42574320532844	0.847	0.908	5.17283741859923e-99	KRT8	Malignant cells	GSE175716	ENSG00000170421	3856	keratin 8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	protein_coding	P05787	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21752
2.46961206366033e-103	-0.644566693656004	0.005	0.358	5.64429837149568e-99	LGALS9	Malignant cells	GSE175716	ENSG00000168961	3965	galectin 9	LGALS9A	protein_coding	O00182	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21753
3.24888413232988e-103	-0.931790559634507	0.581	0.803	7.42532468443995e-99	IL6ST	Malignant cells	GSE175716	ENSG00000134352	3572	interleukin 6 cytokine family signal transducer	CD130|GP130|IL-6RB|sGP130	protein_coding	P40189	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21754
5.34259852890665e-103	0.706078100957528	0.998	0.958	1.22105089378161e-98	RAC1	Malignant cells	GSE175716	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21755
5.79329761583017e-103	-0.834568138256855	0.796	0.916	1.32405817009799e-98	MRPL51	Malignant cells	GSE175716	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21756
7.427967804597e-103	-0.773700407976931	0.751	0.887	1.69766204174064e-98	ERP29	Malignant cells	GSE175716	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21757
9.62436743379816e-103	-0.606247486672358	0.998	0.999	2.19964917699457e-98	RPL14	Malignant cells	GSE175716	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21758
1.47355415097622e-102	-1.03427219259894	0.626	0.836	3.36780801205615e-98	AHR	Malignant cells	GSE175716	ENSG00000106546	196	aryl hydrocarbon receptor	bHLHe76	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21759
4.23620152700116e-102	-0.976985069569695	0.481	0.742	9.68183858996116e-98	DSP	Malignant cells	GSE175716	ENSG00000096696	1832	desmoplakin	DPI|DPII|KPPS2|PPKS2	protein_coding	P15924	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21760
1.26661779454319e-101	-1.15506034025611	0.482	0.727	2.89485496942846e-97	DSG2	Malignant cells	GSE175716	ENSG00000046604	1829	desmoglein 2	CDHF5	protein_coding	Q14126	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21761
1.59571232076901e-101	-0.760824433634239	0	0.347	3.64700050911756e-97	UBR5	Malignant cells	GSE175716	ENSG00000104517	51366	ubiquitin protein ligase E3 component n-recognin 5	DD5|EDD|EDD1|HYD|KIAA0896	protein_coding	O95071	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21762
3.68831800128261e-101	-0.85373181404065	0.041	0.402	8.42965079193141e-97	DDR1	Malignant cells	GSE175716	ENSG00000223680	780	discoidin domain receptor tyrosine kinase 1	CAK|CD167|EDDR1|NEP|NTRK4|PTK3A|RTK6	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21763
5.18532105241667e-101	0.745143063655238	0.935	0.738	1.18510512652983e-96	CDKN2A	Malignant cells	GSE175716	ENSG00000147889	1029	cyclin dependent kinase inhibitor 2A	ARF|CDK4I|CDKN2|CMM2|INK4|INK4a|MLM|MTS1|p14|p14ARF|p16|P16-INK4A|p16INK4a|p19|p19Arf	protein_coding	P42771	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21764
5.58534925721799e-101	-3.01103576650049	0.443	0.645	1.27653157273717e-96	TM4SF20	Malignant cells	GSE175716	ENSG00000168955	79853	transmembrane 4 L six family member 20	FLJ22800|TCCE518	protein_coding	Q53R12	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21765
5.90791370611278e-101	-0.623168615871058	0.703	0.893	1.35025367753208e-96	MAPK1IP1L	Malignant cells	GSE175716	ENSG00000168175	93487	mitogen-activated protein kinase 1 interacting protein 1 like	C14orf32	protein_coding	Q8NDC0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21766
1.17385965426602e-100	1.03146641353781	0.529	0.255	2.68285623982498e-96	PIM1	Malignant cells	GSE175716	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21767
2.47045251615931e-100	0.867271028760482	0.951	0.801	5.64621922568211e-96	IRF2BP2	Malignant cells	GSE175716	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21768
3.85654465704503e-100	-0.946846617147919	0.446	0.703	8.81413281367642e-96	HIST1H1C	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21769
4.57919587531573e-100	-0.664677621486631	0.035	0.392	1.04657521730341e-95	GJB1	Malignant cells	GSE175716	ENSG00000169562	2705	gap junction protein beta 1	CMTX|CMTX1|CX32	protein_coding	P08034	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21770
5.50544520329783e-100	-0.940281432575236	0.286	0.601	1.25826950121372e-95	FST	Malignant cells	GSE175716	ENSG00000134363	10468	follistatin	FS	protein_coding	P19883	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21771
1.12923016230879e-99	-0.594198265181995	0	0.341	2.58085553595674e-95	USO1	Malignant cells	GSE175716	ENSG00000138768	8615	USO1 vesicle transport factor	p115|TAP|VDP	protein_coding	O60763	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21772
1.17997335757349e-99	-0.6282541603658	0.064	0.432	2.69682910873421e-95	EMP1	Malignant cells	GSE175716	ENSG00000134531	2012	epithelial membrane protein 1	CL-20|TMP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21773
1.4434984891496e-99	0.763158732148186	0.967	0.833	3.29911579695141e-95	SDCBP	Malignant cells	GSE175716	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21774
1.70483452950415e-99	0.706975400901349	0.945	0.664	3.89639931718173e-95	RPL23P8	Malignant cells	GSE175716	ENSG00000219451	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21775
1.93667152922294e-99	-0.613035361366231	0.006	0.35	4.42626278003903e-95	MAP7	Malignant cells	GSE175716	ENSG00000135525	9053	microtubule associated protein 7	E-MAP-115	protein_coding	Q14244	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21776
2.26292130260259e-99	-0.63086250352712	0.669	0.868	5.17190663709823e-95	PRKAR1A	Malignant cells	GSE175716	ENSG00000108946	5573	protein kinase cAMP-dependent type I regulatory subunit alpha	CNC1|PRKAR1|TSE1	protein_coding	P10644	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21777
2.28907556893799e-99	0.695326897319799	0.987	0.96	5.23168221280777e-95	PSAP	Malignant cells	GSE175716	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21778
5.91542477453397e-99	-0.815465421950319	0.644	0.834	1.35197033221974e-94	ABHD2	Malignant cells	GSE175716	ENSG00000140526	11057	abhydrolase domain containing 2, acylglycerol lipase	LABH2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21779
6.8080702985031e-99	-0.72113326671774	0.186	0.533	1.55598446672288e-94	VIL1	Malignant cells	GSE175716	ENSG00000127831	7429	villin 1	D2S1471|VIL	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21780
6.89221119367998e-99	0.669058831142537	0.994	0.915	1.57521486831556e-94	ATP5J2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21781
7.33365802687278e-99	-0.620996325226873	0	0.339	1.67610754204177e-94	UPF2	Malignant cells	GSE175716	ENSG00000151461	26019	UPF2 regulator of nonsense mediated mRNA decay	DKFZP434D222|KIAA1408|RENT2|smg-3	protein_coding	Q9HAU5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21782
9.6582814125915e-99	1.36445191376362	0.526	0.263	2.20740021684779e-94	HMGCS2	Malignant cells	GSE175716	ENSG00000134240	3158	3-hydroxy-3-methylglutaryl-CoA synthase 2	NA	protein_coding	P54868	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21783
1.68457488332569e-98	-0.647148613082841	0	0.338	3.85009589584087e-94	UBXN1	Malignant cells	GSE175716	ENSG00000162191	51035	UBX domain protein 1	2B28|LOC51035|SAKS1|UBXD10	protein_coding	Q04323	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21784
1.76368174768809e-98	-1.21314379151104	0.531	0.77	4.03089463434112e-94	ERO1A	Malignant cells	GSE175716	ENSG00000197930	30001	endoplasmic reticulum oxidoreductase 1 alpha	ERO1-alpha|Ero1alpha|ERO1L	protein_coding	Q96HE7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21785
1.84065923912118e-98	0.627024385699452	0.42	0.159	4.20682669101146e-94	EEF1DP1	Malignant cells	GSE175716	ENSG00000288278	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21786
2.12717578310134e-98	-1.01400866819123	0.004	0.346	4.86166025227812e-94	AKAP12	Malignant cells	GSE175716	ENSG00000131016	9590	A-kinase anchoring protein 12	AKAP250|SSeCKS	protein_coding	Q02952	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21787
4.25166767918634e-98	0.659252299336183	0.372	0.125	9.71718648078038e-94	CEP78	Malignant cells	GSE175716	ENSG00000148019	84131	centrosomal protein 78	C9orf81|FLJ12643	protein_coding	Q5JTW2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21788
5.19600332198808e-98	-0.619075719164359	0	0.337	1.18754655924038e-93	UTP4	Malignant cells	GSE175716	ENSG00000262788	84916	UTP4 small subunit processome component	CIRH1A|CIRHIN|FLJ14728|KIAA1988|NAIC|TEX292	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21789
1.10693349821126e-97	-0.735473141276722	0.089	0.444	2.52989651016183e-93	GLA	Malignant cells	GSE175716	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21790
1.22200289497454e-97	-0.7386455805668	0.992	0.999	2.7928876164643e-93	COX6C	Malignant cells	GSE175716	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21791
1.23593156728064e-97	-0.933472606641861	0.492	0.739	2.82472159701991e-93	TMC5	Malignant cells	GSE175716	ENSG00000103534	79838	transmembrane channel like 5	FLJ13593	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21792
1.61108680010086e-97	-0.697600728345116	0.329	0.641	3.68213888163051e-93	LYN	Malignant cells	GSE175716	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21793
1.7169035987235e-97	-0.654069921987202	0.117	0.477	3.92398317488255e-93	DYNLT3	Malignant cells	GSE175716	ENSG00000165169	6990	dynein light chain Tctex-type 3	TCTE1L|TCTEX1L	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21794
2.03360128357137e-97	-0.780650890142986	0.857	0.937	4.64779573360236e-93	SNHG5	Malignant cells	GSE175716	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21795
3.32055486639474e-97	-0.623638950163041	0.707	0.873	7.58912814714517e-93	OSTC	Malignant cells	GSE175716	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21796
5.27378836906506e-97	-1.42855500557765	0.414	0.643	1.20532433174982e-92	HGD	Malignant cells	GSE175716	ENSG00000113924	3081	homogentisate 1,2-dioxygenase	AKU|HGO	protein_coding	Q93099	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21797
5.28708360571139e-97	-1.06313267485393	0.014	0.353	1.20836295808534e-92	KRT19	Malignant cells	GSE175716	ENSG00000171345	3880	keratin 19	CK19|K19|K1CS|MGC15366	protein_coding	P08727	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21798
6.09863739151156e-97	-0.606203989453084	0.032	0.382	1.39384357582997e-92	MYRF	Malignant cells	GSE175716	ENSG00000124920	745	myelin regulatory factor	C11orf9|MRF|Ndt80|pqn-47	protein_coding	Q9Y2G1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21799
9.72887526774838e-97	-0.643520635234045	0.077	0.44	2.22353444244389e-92	ACSL5	Malignant cells	GSE175716	ENSG00000197142	51703	acyl-CoA synthetase long chain family member 5	ACS2|ACS5|FACL5	protein_coding	Q9ULC5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21800
1.17446408049818e-96	-0.638603447228705	0.029	0.375	2.68423765597858e-92	IL13RA1	Malignant cells	GSE175716	ENSG00000131724	3597	interleukin 13 receptor subunit alpha 1	CD213a1|IL-13Ra|NR4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21801
1.43675102580188e-96	0.683921599188336	0.973	0.828	3.28369446947021e-92	EIF3K	Malignant cells	GSE175716	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21802
1.69686931833705e-96	0.758948339454129	0.485	0.218	3.87819482705933e-92	EMC2	Malignant cells	GSE175716	ENSG00000104412	9694	ER membrane protein complex subunit 2	KIAA0103|TTC35	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21803
2.26929154091197e-96	-0.594251623700066	0.825	0.951	5.18646581675432e-92	EID1	Malignant cells	GSE175716	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21804
2.80296695717668e-96	-0.833985149843378	0.724	0.852	6.40618098062729e-92	PSME1	Malignant cells	GSE175716	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21805
3.36377719857964e-96	-0.645323084673785	0.484	0.745	7.68791278735376e-92	SPPL2A	Malignant cells	GSE175716	ENSG00000138600	84888	signal peptide peptidase like 2A	IMP3|PSL2	protein_coding	Q8TCT8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21806
3.61110430443737e-96	-0.910256185103058	0.079	0.422	8.25317888779161e-92	UGT2B4	Malignant cells	GSE175716	ENSG00000156096	7363	UDP glucuronosyltransferase family 2 member B4	UGT2B11	protein_coding	P06133	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21807
6.02539145036985e-96	-0.993960773975242	0	0.334	1.37710321598203e-91	NFE4	Malignant cells	GSE175716	ENSG00000230257	58160	nuclear factor, erythroid 4	NF-E4	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21808
9.38151453830652e-96	-0.670735414717619	0.255	0.587	2.14414514772995e-91	SEL1L3	Malignant cells	GSE175716	ENSG00000091490	23231	SEL1L family member 3	KIAA0746	protein_coding	Q68CR1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21809
1.11949825967322e-95	0.710562500887913	0.955	0.814	2.55861327248314e-91	CLTA	Malignant cells	GSE175716	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21810
1.41506018460044e-95	-0.617447637670168	0.896	0.969	3.23412005190431e-91	DYNLL1	Malignant cells	GSE175716	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21811
1.67653279797929e-95	-0.676795622549562	0.826	0.953	3.83171570978166e-91	ZNF706	Malignant cells	GSE175716	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21812
1.85956087955389e-95	-0.649345929714355	0	0.331	4.25002639022041e-91	CNTN1	Malignant cells	GSE175716	ENSG00000018236	1272	contactin 1	F3|GP135	protein_coding	Q12860	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21813
2.10902533053112e-95	-0.805979547389861	0.023	0.364	4.82017739292887e-91	FXYD3	Malignant cells	GSE175716	ENSG00000089356	5349	FXYD domain containing ion transport regulator 3	MAT-8|PLML	protein_coding	Q14802	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21814
2.93167045355258e-95	0.64384094480543	0.996	0.978	6.70033282159443e-91	YBX1	Malignant cells	GSE175716	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21815
2.94359977163092e-95	-0.683951537302972	0.151	0.502	6.72759727806246e-91	HNF4A	Malignant cells	GSE175716	ENSG00000101076	3172	hepatocyte nuclear factor 4 alpha	HNF4|MODY|MODY1|NR2A1|TCF14	protein_coding	P41235	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21816
3.42576719334079e-95	-1.120162657249	0.998	1	7.82959092038038e-91	HSP90AA1	Malignant cells	GSE175716	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21817
3.99360023695237e-95	-0.884669853659666	0.783	0.879	9.12737334155464e-91	C3	Malignant cells	GSE175716	ENSG00000125730	718	complement C3	ARMD9|C3a|C3b|CPAMD1	protein_coding	P01024	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21818
4.56168942915873e-95	-0.625097791616307	1	0.999	1.04257411903423e-90	RPS3	Malignant cells	GSE175716	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21819
6.67260164399661e-95	0.681880075562018	0.982	0.78	1.52502310573543e-90	AC074033.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21820
8.7484018582312e-95	-0.615908220790532	0.552	0.784	1.99944724469874e-90	ATP6AP2	Malignant cells	GSE175716	ENSG00000182220	10159	ATPase H+ transporting accessory protein 2	APT6M8-9|ATP6IP2|ATP6M8-9|M8-9|PRR|RENR	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21821
1.07042745670633e-94	-0.708380221854958	0.227	0.562	2.44646195230233e-90	F2RL1	Malignant cells	GSE175716	ENSG00000164251	2150	F2R like trypsin receptor 1	GPR11|PAR2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21822
1.8229964284877e-94	-0.635561298795433	0.489	0.753	4.16645833730863e-90	F11R	Malignant cells	GSE175716	ENSG00000158769	50848	F11 receptor	CD321|JAM-1|JAM-A|JAM1|JAMA|JCAM|PAM-1	protein_coding	Q9Y624	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21823
2.53103664293894e-94	-0.969972847917244	0.535	0.766	5.78468424743695e-90	HIST1H2AC	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21824
2.53584312504159e-94	0.739920434901672	0.965	0.66	5.79566946228256e-90	PNRC1	Malignant cells	GSE175716	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21825
3.78920795040063e-94	-0.54632213805549	0	0.326	8.66023477064065e-90	UBE2E1	Malignant cells	GSE175716	ENSG00000170142	7324	ubiquitin conjugating enzyme E2 E1	UbcH6	protein_coding	P51965	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21826
4.87706919709138e-94	0.702869798648585	0.96	0.889	1.11465416499524e-89	ST13	Malignant cells	GSE175716	ENSG00000100380	6767	ST13 Hsp70 interacting protein	FAM10A1|HIP|HSPABP1|P48|SNC6	protein_coding	P50502	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21827
8.16378847075806e-94	-0.713587938254339	0.578	0.798	1.86583385499175e-89	PLS3	Malignant cells	GSE175716	ENSG00000102024	5358	plastin 3	T-plastin	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21828
8.21753965044371e-94	0.700670878069801	0.775	0.511	1.87811868710891e-89	EEF1A1P5	Malignant cells	GSE175716	ENSG00000196205	NA	NA	EEF1AL3	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21829
8.376965605703e-94	-0.732626690503658	0.704	0.871	1.91455548918342e-89	ATP2A2	Malignant cells	GSE175716	ENSG00000174437	488	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2	ATP2B|DAR|SERCA2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21830
1.65185977997846e-93	-0.577151908691183	0	0.325	3.77532552714076e-89	FMO3	Malignant cells	GSE175716	ENSG00000007933	2328	flavin containing dimethylaniline monoxygenase 3	FMOII	protein_coding	P31513	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21831
1.81664405897102e-93	0.476935154725199	0.289	0.076	4.15193999677827e-89	SLC39A4	Malignant cells	GSE175716	ENSG00000285243	55630	solute carrier family 39 member 4	AEZ|AWMS2|ZIP4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21832
2.57770448413679e-93	-0.90232310652243	0.001	0.328	5.89134359849462e-89	AL365226.2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21833
3.35558714435069e-93	-0.777444122932235	0.017	0.349	7.66919441841349e-89	EPS8L3	Malignant cells	GSE175716	ENSG00000198758	79574	EPS8 like 3	FLJ21522|MGC16817	protein_coding	Q8TE67	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21834
3.73089320506225e-93	-0.706287413463821	0.017	0.35	8.52695642016978e-89	TRIB2	Malignant cells	GSE175716	ENSG00000071575	28951	tribbles pseudokinase 2	GS3955|TRB2	protein_coding	Q92519	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21835
4.16751002248445e-93	-0.583795621116945	0.039	0.379	9.52484415638822e-89	ALG13	Malignant cells	GSE175716	ENSG00000101901	79868	ALG13 UDP-N-acetylglucosaminyltransferase subunit	CDG1S|CXorf45|FLJ23018|GLT28D1|MDS031|TDRD13|YGL047W	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21836
4.6491392022274e-93	-0.794159634600389	0.003	0.33	1.06256076466907e-88	DUSP4	Malignant cells	GSE175716	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21837
6.87114535832518e-93	-0.556727847723864	0	0.323	1.57040027164522e-88	UTP18	Malignant cells	GSE175716	ENSG00000011260	51096	UTP18 small subunit processome component	CGI-48|WDR50	protein_coding	Q9Y5J1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21838
1.01261972720917e-92	-0.684761148310331	0.081	0.432	2.31434238653656e-88	RBPMS	Malignant cells	GSE175716	ENSG00000157110	11030	RNA binding protein, mRNA processing factor	HERMES	protein_coding	Q93062	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21839
1.17316331443803e-92	-0.915028869998218	0.057	0.389	2.68126475514812e-88	ASPG	Malignant cells	GSE175716	ENSG00000166183	374569	asparaginase	C14orf76|hASNase1|LysoLP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21840
1.2547164109213e-92	-0.928140739786519	0.003	0.328	2.86765435716062e-88	CTHRC1	Malignant cells	GSE175716	ENSG00000164932	115908	collagen triple helix repeat containing 1	NA	protein_coding	Q96CG8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21841
1.4017078286248e-92	-2.7909802381796	0.428	0.627	3.20360324232198e-88	ALDOB	Malignant cells	GSE175716	ENSG00000136872	229	aldolase, fructose-bisphosphate B	NA	protein_coding	P05062	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21842
1.82705989832574e-92	-0.695484912547883	0.313	0.623	4.17574539762348e-88	TM2D2	Malignant cells	GSE175716	ENSG00000169490	83877	TM2 domain containing 2	BLP1	protein_coding	Q9BX73	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21843
1.88963562935841e-92	-0.739303668838158	0.506	0.754	4.31876223089865e-88	TMBIM1	Malignant cells	GSE175716	ENSG00000135926	64114	transmembrane BAX inhibitor motif containing 1	LFG3|PP1201|RECS1	protein_coding	Q969X1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21844
2.08183236097348e-92	-1.0436582415726	0.447	0.67	4.75802786100488e-88	AC113935.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21845
2.28866570013137e-92	-0.789257189421594	0.748	0.869	5.23074545765025e-88	RPS27	Malignant cells	GSE175716	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21846
4.02792395484311e-92	0.600993560181906	0.993	0.731	9.20582019879392e-88	JUND	Malignant cells	GSE175716	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21847
4.51565822915859e-92	-0.688198746366752	0.064	0.412	1.03205368827419e-87	ADO	Malignant cells	GSE175716	ENSG00000181915	84890	2-aminoethanethiol dioxygenase	C10orf22|FLJ14547	protein_coding	Q96SZ5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21848
5.81237347276504e-92	-0.750421891589226	0.348	0.642	1.32841795720045e-87	CHMP4C	Malignant cells	GSE175716	ENSG00000164695	92421	charged multivesicular body protein 4C	MGC22825|Shax3|VPS32C	protein_coding	Q96CF2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21849
6.73496465637813e-92	-0.910094322959635	0.272	0.576	1.53927617221522e-87	USP12	Malignant cells	GSE175716	ENSG00000152484	219333	ubiquitin specific peptidase 12	USP12L1	protein_coding	O75317	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21850
7.24732429863147e-92	-0.668400412629377	0.485	0.735	1.65637596845222e-87	SRPRA	Malignant cells	GSE175716	ENSG00000182934	6734	SRP receptor subunit alpha	SR-alpha|Sralpha|SRP-alpha|SRPR	protein_coding	P08240	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21851
7.94065778412551e-92	-0.988048463139619	0.76	0.869	1.81483733656189e-87	CD55	Malignant cells	GSE175716	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21852
1.01609545654591e-91	0.41050697655767	0.286	0.074	2.32228616593568e-87	MCTP1	Malignant cells	GSE175716	ENSG00000175471	79772	multiple C2 and transmembrane domain containing 1	FLJ22344	protein_coding	Q6DN14	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21853
1.46839672807167e-91	0.703898798094649	0.966	0.884	3.3560207220078e-87	CCT6A	Malignant cells	GSE175716	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21854
1.672020079159e-91	-0.92571309473466	0.074	0.404	3.82140189091789e-87	FADS2	Malignant cells	GSE175716	ENSG00000134824	9415	fatty acid desaturase 2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	protein_coding	O95864	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21855
1.78872093002488e-91	-0.593723527788361	0.007	0.33	4.08812168557186e-87	LINC00511	Malignant cells	GSE175716	ENSG00000227036	400619	long intergenic non-protein coding RNA 511	onco-lncRNA-12	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21856
2.23293708297404e-91	-0.968429543118961	0.36	0.627	5.10337770313718e-87	SMOX	Malignant cells	GSE175716	ENSG00000088826	54498	spermine oxidase	C20orf16|dJ779E11.1|FLJ20746|MGC1010|PAO|PAOh1|SMO	protein_coding	Q9NWM0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21857
2.28653804442958e-91	-0.611187134307576	0.628	0.829	5.22588270054381e-87	EIF1B	Malignant cells	GSE175716	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21858
2.68489697574685e-91	-1.09471639729727	0.764	0.86	6.13633203806942e-87	ETFA	Malignant cells	GSE175716	ENSG00000140374	2108	electron transfer flavoprotein subunit alpha	EMA|GA2|MADD	protein_coding	P13804	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21859
2.88080477391851e-91	-0.560402229300192	0	0.319	6.58407931079075e-87	UMPS	Malignant cells	GSE175716	ENSG00000114491	7372	uridine monophosphate synthetase	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21860
5.15780832759452e-91	-0.861853007099633	0.431	0.693	1.17881709327173e-86	ALCAM	Malignant cells	GSE175716	ENSG00000170017	214	activated leukocyte cell adhesion molecule	CD166|MEMD	protein_coding	Q13740	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21861
6.18668830633326e-91	-1.0517376497227	0.31	0.593	1.41396761241247e-86	BAAT	Malignant cells	GSE175716	ENSG00000276559	570	bile acid-CoA:amino acid N-acyltransferase	BAT	protein_coding	Q14032	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21862
6.76264679592259e-91	-0.700396470140063	0.075	0.419	1.54560292520811e-86	CPM	Malignant cells	GSE175716	ENSG00000135678	1368	carboxypeptidase M	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21863
7.10221497027125e-91	-3.15616650572045	0.5	0.655	1.6232112314555e-86	AMBP	Malignant cells	GSE175716	ENSG00000106927	259	alpha-1-microglobulin/bikunin precursor	EDC1|HCP|HI30|IATIL|ITI|ITIL|ITILC|UTI	protein_coding	P02760	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21864
8.37373188189247e-91	-0.649316137842603	0.82	0.912	1.91381642160652e-86	EIF3I	Malignant cells	GSE175716	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21865
9.99804374189884e-91	-0.61816438705166	0.026	0.356	2.28505289721098e-86	STEAP1	Malignant cells	GSE175716	ENSG00000164647	26872	STEAP family member 1	PRSS24|STEAP	protein_coding	Q9UHE8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21866
1.01973657646014e-90	-0.567225068785892	0	0.317	2.33060794549965e-86	UTP6	Malignant cells	GSE175716	ENSG00000108651	55813	UTP6 small subunit processome component	C17orf40|HCA66	protein_coding	Q9NYH9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21867
2.91147128957438e-90	-2.07817586487003	0.394	0.595	6.65416763232223e-86	C8G	Malignant cells	GSE175716	ENSG00000176919	733	complement C8 gamma chain	NA	protein_coding	P07360	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21868
4.49283536441779e-90	0.62199106895861	0.43	0.172	1.02683752253769e-85	WAC-AS1	Malignant cells	GSE175716	ENSG00000254635	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21869
5.28163672954149e-90	0.503392627173491	0.316	0.092	1.20711807453671e-85	TGFBR3	Malignant cells	GSE175716	ENSG00000069702	7049	transforming growth factor beta receptor 3	betaglycan|BGCAN	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21870
8.50050552648303e-90	-1.01590961537358	0.296	0.581	1.9427905380777e-85	UBE2H	Malignant cells	GSE175716	ENSG00000186591	7328	ubiquitin conjugating enzyme E2 H	GID3|UBC8|UBCH	protein_coding	P62256	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21871
9.10211257317872e-90	-0.609272908127334	0	0.315	2.0802878286e-85	PTHLH	Malignant cells	GSE175716	ENSG00000087494	5744	parathyroid hormone like hormone	HHM|PLP|PTHR|PTHRP	protein_coding	P12272	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21872
1.56361686946125e-89	0.652279654996872	0.849	0.594	3.57364635515368e-85	SSB	Malignant cells	GSE175716	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21873
1.72685737111814e-89	-0.90559449885697	0	0.316	3.94673252169051e-85	KIF25-AS1	Malignant cells	GSE175716	ENSG00000229921	100505879	KIF25 antisense RNA 1	C6orf54|HGC6.1.1|NCRNA00300	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21874
1.72805703938932e-89	-0.902144971569571	0.289	0.571	3.94947436352429e-85	UXT	Malignant cells	GSE175716	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21875
1.73995815074072e-89	-0.714641380148257	0.052	0.383	3.97667435351791e-85	MEA1	Malignant cells	GSE175716	ENSG00000124733	4201	male-enhanced antigen 1	MEA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21876
1.80986242701201e-89	0.780499411099334	0.508	0.249	4.13644057693596e-85	SOAT1	Malignant cells	GSE175716	ENSG00000057252	6646	sterol O-acyltransferase 1	ACAT|ACAT1|SOAT|STAT	protein_coding	P35610	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21877
1.87092017148607e-89	-0.580281221611338	0	0.314	4.27598805193141e-85	UFD1	Malignant cells	GSE175716	ENSG00000070010	7353	ubiquitin recognition factor in ER associated degradation 1	UFD1L	protein_coding	Q92890	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21878
2.42150951072036e-89	-1.01666399607045	0.434	0.661	5.53435998675139e-85	PON3	Malignant cells	GSE175716	ENSG00000105852	5446	paraoxonase 3	NA	protein_coding	Q15166	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21879
2.48405774482883e-89	-0.765605445859382	0.278	0.578	5.67731397580628e-85	C5	Malignant cells	GSE175716	ENSG00000106804	727	complement C5	C5a|C5b|CPAMD4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21880
2.52173953164461e-89	-0.635983401443058	0.299	0.61	5.76343569957376e-85	MYO1E	Malignant cells	GSE175716	ENSG00000157483	4643	myosin IE	HuncM-IC|MGC104638|MYO1C	protein_coding	Q12965	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21881
6.30898379018803e-89	-1.00769171764283	0.311	0.574	1.44191824524747e-84	UQCR11	Malignant cells	GSE175716	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21882
7.23450047050279e-89	0.764176469933026	0.852	0.63	1.65344508253341e-84	ANP32E	Malignant cells	GSE175716	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21883
7.55119669979964e-89	-0.811731601708495	0.493	0.733	1.72582600573921e-84	FOXP1	Malignant cells	GSE175716	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21884
9.16987059447377e-89	0.660245252100846	0.805	0.534	2.09577392436698e-84	ADH5	Malignant cells	GSE175716	ENSG00000197894	128	alcohol dehydrogenase 5 (class III), chi polypeptide	ADH-3|ADHX|FDH|GSNOR	protein_coding	P11766	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21885
1.04741417442171e-88	0.562316919185249	0.328	0.103	2.39386509564081e-84	MLXIPL	Malignant cells	GSE175716	ENSG00000009950	51085	MLX interacting protein like	bHLHd14|CHREBP|MIO|MONDOB|WBSCR14|WS-bHLH	protein_coding	Q9NP71	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21886
1.50480885712284e-88	-0.580466214616994	0.022	0.347	3.43924064295424e-84	SULT1C2	Malignant cells	GSE175716	ENSG00000198203	6819	sulfotransferase family 1C member 2	ST1C1|SULT1C1	protein_coding	O00338	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21887
1.53342827248043e-88	-0.983147290761671	0.057	0.381	3.50465031675403e-84	GATA6	Malignant cells	GSE175716	ENSG00000141448	2627	GATA binding protein 6	NA	protein_coding	Q92908	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21888
1.71048819045508e-88	-0.643373980930542	0	0.312	3.90932075928509e-84	USP38	Malignant cells	GSE175716	ENSG00000170185	84640	ubiquitin specific peptidase 38	HP43.8KD|KIAA1891	protein_coding	Q8NB14	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21889
1.7893800872524e-88	0.65534515110929	0.912	0.678	4.08962818941536e-84	EEF1B2P3	Malignant cells	GSE175716	ENSG00000232472	NA	NA	EEF1B4	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21890
1.9294303736379e-88	-0.627475865252374	0.173	0.515	4.40971311894943e-84	HNMT	Malignant cells	GSE175716	ENSG00000150540	3176	histamine N-methyltransferase	NA	protein_coding	P50135	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21891
2.83879244913774e-88	0.66983100882484	0.984	0.919	6.48806014250431e-84	HSPE1	Malignant cells	GSE175716	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21892
2.98312605395448e-88	-0.470215385439419	0.942	0.984	6.81793459631296e-84	CDC42	Malignant cells	GSE175716	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21893
3.04777942386235e-88	-0.527508954480949	0.808	0.946	6.9656998732374e-84	TMEM258	Malignant cells	GSE175716	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21894
3.09071027534086e-88	-0.47876374006169	0.998	0.999	7.06381833429153e-84	CD63	Malignant cells	GSE175716	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21895
3.30285459611329e-88	-0.887428220386962	0.3	0.594	7.54867417941692e-84	CAMK2N1	Malignant cells	GSE175716	ENSG00000162545	55450	calcium/calmodulin dependent protein kinase II inhibitor 1	CaMKIINalpha	protein_coding	Q7Z7J9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21896
4.04191609249416e-88	-0.655702687940606	0.031	0.361	9.23779922939541e-84	TMSB4XP8	Malignant cells	GSE175716	ENSG00000187653	NA	NA	TMSL3	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21897
6.13563889350534e-88	-0.732537774132218	0.057	0.389	1.40230026911064e-83	TNFRSF10D	Malignant cells	GSE175716	ENSG00000173530	8793	TNF receptor superfamily member 10d	CD264|DcR2|TRAILR4|TRUNDD	protein_coding	Q9UBN6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21898
9.5073527196096e-88	0.666338367747531	0.971	0.708	2.17290546406677e-83	SLPI	Malignant cells	GSE175716	ENSG00000124107	6590	secretory leukocyte peptidase inhibitor	ALK1|ALP|BLPI|HUSI|HUSI-I|WAP4|WFDC4	protein_coding	P03973	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21899
1.19507668446656e-87	-0.606259514531761	0.037	0.362	2.73134776234832e-83	LMO7	Malignant cells	GSE175716	ENSG00000136153	4008	LIM domain 7	FBX20|FBXO20|KIAA0858	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21900
2.07076730920391e-87	-0.72216111678072	0.004	0.316	4.73273868518553e-83	CDHR5	Malignant cells	GSE175716	ENSG00000273572	53841	cadherin related family member 5	FLJ20219|MU-PCDH|MUCDHL|MUPCDH	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21901
3.15059135579631e-87	-0.86122147493326	0.267	0.567	7.20067654367246e-83	CYP2C8	Malignant cells	GSE175716	ENSG00000138115	1558	cytochrome P450 family 2 subfamily C member 8	CPC8	protein_coding	P10632	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21902
4.86078751009581e-87	0.452938396740132	0.33	0.103	1.1109329854324e-82	AC016712.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21903
5.78674672413737e-87	-0.559734855613773	0	0.307	1.3225609638016e-82	USP15	Malignant cells	GSE175716	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21904
6.25644426410101e-87	0.655044388084678	0.438	0.183	1.42991033656029e-82	LAMA4	Malignant cells	GSE175716	ENSG00000112769	3910	laminin subunit alpha 4	LAMA3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21905
6.57662858165965e-87	-2.38052193365974	0.451	0.658	1.50308846233831e-82	CTGF	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21906
6.67664259225016e-87	0.584956314315267	0.356	0.122	1.52594666445877e-82	SNHG26	Malignant cells	GSE175716	ENSG00000228649	109729180	small nucleolar RNA host gene 26	AC005682.5	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21907
7.08782084588094e-87	0.36317308284912	0.256	0.063	1.61992145432609e-82	PEX3	Malignant cells	GSE175716	ENSG00000034693	8504	peroxisomal biogenesis factor 3	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21908
1.15139260189189e-86	0.395418014331805	0.285	0.079	2.6315077916239e-82	AC021074.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21909
1.39636814596366e-86	0.893407158298911	0.604	0.382	3.19139939759995e-82	RSU1	Malignant cells	GSE175716	ENSG00000148484	6251	Ras suppressor protein 1	FLJ31034|RSP-1	protein_coding	Q15404	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21910
1.56194909792403e-86	-0.543568754159981	0.04	0.366	3.56983466330537e-82	SMCO4	Malignant cells	GSE175716	ENSG00000166002	56935	single-pass membrane protein with coiled-coil domains 4	C11orf75|FN5	protein_coding	Q9NRQ5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21911
1.95278454063829e-86	0.658694441754816	0.874	0.655	4.46308906762881e-82	TCP1	Malignant cells	GSE175716	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21912
2.02631688905084e-86	-0.800615242669107	0.316	0.601	4.63114724992569e-82	MTUS1	Malignant cells	GSE175716	ENSG00000129422	57509	microtubule associated scaffold protein 1	ATBP|ATIP1|ATIP3|DKFZp586D1519|FLJ14295|ICIS|KIAA1288|MP44|MTSG1	protein_coding	Q9ULD2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21913
2.15109949284698e-86	-0.74628467071547	0.261	0.565	4.91633789090177e-82	ITGA2	Malignant cells	GSE175716	ENSG00000164171	3673	integrin subunit alpha 2	CD49B	protein_coding	P17301	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21914
2.31206407943887e-86	0.75148825949928	0.968	0.829	5.28422245355753e-82	RAD21	Malignant cells	GSE175716	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21915
3.04926397491882e-86	-0.808422431805739	0.391	0.658	6.96909281467696e-82	ARHGAP29	Malignant cells	GSE175716	ENSG00000137962	9411	Rho GTPase activating protein 29	PARG1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21916
3.21974250161403e-86	0.66922736678645	0.989	0.883	7.35872148743887e-82	NFKBIA	Malignant cells	GSE175716	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21917
3.50906818636689e-86	0.715335872634313	0.921	0.771	8.01997533994153e-82	RHEB	Malignant cells	GSE175716	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21918
4.01820539866676e-86	-0.572667167013449	0.01	0.32	9.18360843865287e-82	AC090204.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21919
6.45089536689474e-86	0.593585951333791	0.992	0.929	1.47435213610379e-81	ANP32B	Malignant cells	GSE175716	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21920
8.24560994528171e-86	-0.778424935979616	0.007	0.317	1.88453415299413e-81	IFI27	Malignant cells	GSE175716	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21921
1.02739059116476e-85	-0.749248984562889	0.41	0.677	2.34810119610706e-81	ZBTB38	Malignant cells	GSE175716	ENSG00000177311	253461	zinc finger and BTB domain containing 38	CIBZ|FLJ35036|PPP1R171|ZNF921	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21922
1.77006145134728e-85	0.583569500068853	0.835	0.535	4.04547544705421e-81	SNX10	Malignant cells	GSE175716	ENSG00000086300	29887	sorting nexin 10	NA	protein_coding	Q9Y5X0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21923
1.86011541795026e-85	0.473333617491203	0.325	0.102	4.25129378772532e-81	TBC1D4	Malignant cells	GSE175716	ENSG00000136111	9882	TBC1 domain family member 4	AS160|DKFZp779C0666|KIAA0603	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21924
2.06231894678899e-85	-0.654013626887896	0.703	0.854	4.71342995288624e-81	ACSL3	Malignant cells	GSE175716	ENSG00000123983	2181	acyl-CoA synthetase long chain family member 3	ACS3|FACL3|PRO2194	protein_coding	O95573	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21925
3.2191285738177e-85	0.791009168856202	0.879	0.702	7.35731835546035e-81	LAMP1	Malignant cells	GSE175716	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21926
3.22798051678277e-85	-0.651290865137095	0.562	0.781	7.37754947110702e-81	OSMR	Malignant cells	GSE175716	ENSG00000145623	9180	oncostatin M receptor	OSMRB|OSMRbeta	protein_coding	Q99650	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21927
3.38707565978648e-85	-0.616836530875345	0.035	0.356	7.741161420442e-81	EHD4	Malignant cells	GSE175716	ENSG00000103966	30844	EH domain containing 4	PAST4	protein_coding	Q9H223	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21928
8.75775630371746e-85	-0.666959949992413	0	0.302	2.00158520321462e-80	C6	Malignant cells	GSE175716	ENSG00000039537	729	complement C6	NA	protein_coding	P13671	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21929
1.11693267750103e-84	-0.552308229717382	0.076	0.412	2.5527496344286e-80	GSK3A	Malignant cells	GSE175716	ENSG00000105723	2931	glycogen synthase kinase 3 alpha	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21930
1.72264493366774e-84	-0.582233952434008	0.79	0.921	3.93710499589761e-80	KDELR1	Malignant cells	GSE175716	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21931
1.85081006516571e-84	0.728450690791533	0.478	0.231	4.23002640393623e-80	WIPI2	Malignant cells	GSE175716	ENSG00000157954	26100	WD repeat domain, phosphoinositide interacting 2	ATG18B|ATG21|CGI-50|DKFZP434J154|DKFZp686P02188|FLJ12979|FLJ14217|FLJ42984	protein_coding	Q9Y4P8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21932
2.04569289305671e-84	-0.853865936938085	0.268	0.565	4.67543110708111e-80	PALLD	Malignant cells	GSE175716	ENSG00000129116	23022	palladin, cytoskeletal associated protein	CGI-151|KIAA0992|SIH002	protein_coding	Q8WX93	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21933
2.652298556977e-84	-0.639699085564367	0.754	0.887	6.06182835197094e-80	BANF1	Malignant cells	GSE175716	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21934
2.81513322537536e-84	-1.94789150888582	0.381	0.584	6.43398698659538e-80	CPS1	Malignant cells	GSE175716	ENSG00000021826	1373	carbamoyl-phosphate synthase 1	GATD6	protein_coding	P31327	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21935
3.11698974927884e-84	-0.734078479511327	0.1	0.428	7.12388007197679e-80	MYO1B	Malignant cells	GSE175716	ENSG00000128641	4430	myosin IB	myr1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21936
3.38823352278569e-84	-0.549855064531953	0	0.299	7.74380771632669e-80	USP9X	Malignant cells	GSE175716	ENSG00000124486	8239	ubiquitin specific peptidase 9 X-linked	DFFRX|FAF|MRX99	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21937
3.71399567156141e-84	0.452195857219258	0.299	0.088	8.4883371073536e-80	MRPS31	Malignant cells	GSE175716	ENSG00000102738	10240	mitochondrial ribosomal protein S31	IMOGN38	protein_coding	Q92665	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21938
4.19945756706687e-84	-0.795215941333908	0.001	0.302	9.59786026953134e-80	TFF2	Malignant cells	GSE175716	ENSG00000160181	7032	trefoil factor 2	SML1	protein_coding	Q03403	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21939
4.56273119244728e-84	-0.672363977027925	0.006	0.309	1.04281221403383e-79	IRF7	Malignant cells	GSE175716	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21940
6.22163210852394e-84	-0.556045580115115	0.049	0.375	1.42195401840315e-79	ITGB5	Malignant cells	GSE175716	ENSG00000082781	3693	integrin subunit beta 5	NA	protein_coding	P18084	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21941
8.2307757173656e-84	-0.770908674329439	0.546	0.77	1.88114379020391e-79	WDR45B	Malignant cells	GSE175716	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21942
9.82859161423123e-84	-0.895403861521638	0.579	0.765	2.24632461343255e-79	ARHGAP5	Malignant cells	GSE175716	ENSG00000100852	394	Rho GTPase activating protein 5	GFI2|p190-B|p190BRhoGAP|RhoGAP5	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21943
1.35751772853701e-83	0.82603935028444	0.532	0.294	3.10260676857134e-79	PEX19	Malignant cells	GSE175716	ENSG00000162735	5824	peroxisomal biogenesis factor 19	D1S2223E|HK33|PMP1|PMPI|PXF|PXMP1	protein_coding	P40855	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21944
1.56034008953455e-83	-0.518773375879792	0	0.297	3.56615727463122e-79	USP48	Malignant cells	GSE175716	ENSG00000090686	84196	ubiquitin specific peptidase 48	FLJ11328|FLJ20103|FLJ23054|FLJ23277|MGC14879|USP31	protein_coding	Q86UV5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21945
3.06834406301111e-83	-0.672429242957909	0.063	0.385	7.01270035601188e-79	FAM102A	Malignant cells	GSE175716	ENSG00000167106	399665	family with sequence similarity 102 member A	bA203J24.7|C9orf132|Eeig1|SYM-3A	protein_coding	Q5T9C2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21946
3.07553112909695e-83	-0.618790258240814	0.834	0.933	7.02912639555107e-79	LGALS3BP	Malignant cells	GSE175716	ENSG00000108679	3959	galectin 3 binding protein	90K|BTBD17B|CyCAP|gp90|M2BP|MAC-2-BP|TANGO10B	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21947
3.18412893674089e-83	0.449314108769427	0.946	0.604	7.2773266849213e-79	ATF3	Malignant cells	GSE175716	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21948
3.88318221730399e-83	-0.855543895470478	0.931	0.957	8.87501295764827e-79	NDUFA1	Malignant cells	GSE175716	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21949
4.26454069286682e-83	-0.843068823058098	0	0.298	9.74660775354712e-79	DSC2	Malignant cells	GSE175716	ENSG00000134755	1824	desmocollin 2	CDHF2|DSC3	protein_coding	Q02487	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21950
5.96149970973101e-83	0.670879057704819	0.999	0.96	1.36250075865902e-78	AKR1C3	Malignant cells	GSE175716	ENSG00000196139	8644	aldo-keto reductase family 1 member C3	DDX|HAKRB|HSD17B5|KIAA0119|PGFS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21951
5.98378019721474e-83	-0.574457334922079	0.852	0.949	1.36759296407343e-78	SEC11A	Malignant cells	GSE175716	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21952
7.1248301217774e-83	-1.05909530826012	0.045	0.352	1.62837992433223e-78	DPYS	Malignant cells	GSE175716	ENSG00000147647	1807	dihydropyrimidinase	DHPase	protein_coding	Q14117	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21953
8.23135029221714e-83	-0.815880662256721	0.257	0.549	1.88127510928623e-78	GSN	Malignant cells	GSE175716	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21954
8.56369010994582e-83	-0.569255873526979	0.016	0.319	1.95723137462812e-78	GK	Malignant cells	GSE175716	ENSG00000198814	2710	glycerol kinase	GK1|GKD	protein_coding	P32189	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21955
1.13105699661708e-82	-0.702916351065386	0	0.296	2.58503076576833e-78	SRGN	Malignant cells	GSE175716	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21956
1.21770864907928e-82	0.709275807185778	0.916	0.78	2.78307311747069e-78	HMGN1	Malignant cells	GSE175716	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21957
1.63322589756644e-82	0.464382994069856	0.314	0.099	3.73273778888809e-78	RPL11P3	Malignant cells	GSE175716	ENSG00000283120	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21958
1.75857060890016e-82	-1.28573028711769	0.541	0.69	4.01921312664131e-78	FKBP2	Malignant cells	GSE175716	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21959
1.89493059004136e-82	-0.511151252234761	0.904	0.962	4.33086386353954e-78	TMCO1	Malignant cells	GSE175716	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21960
1.99937414508983e-82	-0.649032232161284	0	0.295	4.56956960860281e-78	USP53	Malignant cells	GSE175716	ENSG00000145390	54532	ubiquitin specific peptidase 53	KIAA1350	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21961
2.08066809286977e-82	-0.587472816747962	0.019	0.323	4.75536692625385e-78	PDZK1	Malignant cells	GSE175716	ENSG00000174827	5174	PDZ domain containing 1	NHERF3|PDZD1	protein_coding	Q5T2W1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21962
3.99958509338656e-82	-0.561261984585067	0.468	0.734	9.14105173093497e-78	SMIM15	Malignant cells	GSE175716	ENSG00000188725	643155	small integral membrane protein 15	C5orf43|DKFZP686E2158	protein_coding	Q7Z3B0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21963
5.05047511917235e-82	-0.545286696562159	0.077	0.401	1.15428608848684e-77	PLPBP	Malignant cells	GSE175716	ENSG00000147471	11212	pyridoxal phosphate binding protein	PROSC	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21964
5.31758138743972e-82	-0.628019678776504	0.081	0.41	1.21533322609935e-77	PLEKHA5	Malignant cells	GSE175716	ENSG00000052126	54477	pleckstrin homology domain containing A5	FLJ10667|KIAA1686|PEPP2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21965
6.50212376711417e-82	-0.481556179616813	0	0.292	1.48606038697394e-77	UBE3C	Malignant cells	GSE175716	ENSG00000009335	9690	ubiquitin protein ligase E3C	KIAA0010|KIAA10	protein_coding	Q15386	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21966
7.61046680032014e-82	0.547530067598694	0.357	0.13	1.73937218721317e-77	AL161787.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21967
7.94541587854577e-82	-0.723778356293055	0.383	0.644	1.81592479904164e-77	TMEM45B	Malignant cells	GSE175716	ENSG00000151715	120224	transmembrane protein 45B	BC016153|FLJ40787	protein_coding	Q96B21	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21968
8.08227884253589e-82	0.796400248604357	0.744	0.502	1.84720482946158e-77	PAPSS2	Malignant cells	GSE175716	ENSG00000198682	9060	3'-phosphoadenosine 5'-phosphosulfate synthase 2	ATPSK2	protein_coding	O95340	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21969
8.34351770981344e-82	-0.620793970969667	0.467	0.715	1.90691097257786e-77	NUCB2	Malignant cells	GSE175716	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21970
8.96317234055553e-82	-0.62243606434103	0.028	0.334	2.04853303843397e-77	HYAL1	Malignant cells	GSE175716	ENSG00000114378	3373	hyaluronidase 1	HYAL-1|LUCA1	protein_coding	Q12794	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21971
9.411206045564e-82	-0.626710836508143	0.443	0.697	2.15093114171365e-77	LRP10	Malignant cells	GSE175716	ENSG00000197324	26020	LDL receptor related protein 10	DKFZP564C1940|LRP9|MGC8675|MST087|MSTP087	protein_coding	Q7Z4F1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21972
1.14210141365364e-81	-0.814333081513274	0.008	0.306	2.6102727809054e-77	FAM84B	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21973
1.20275291296305e-81	-0.651831241780593	0.011	0.311	2.74889178257704e-77	AC090498.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21974
1.39246047242002e-81	-0.846040073071037	0.996	0.993	3.18246840971596e-77	COX7C	Malignant cells	GSE175716	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21975
1.67783377294526e-81	-0.583037422592988	0.039	0.348	3.83468908806639e-77	TGFBR2	Malignant cells	GSE175716	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21976
1.69556314573391e-81	0.388324586635404	1	1	3.87520956957486e-77	MT-CO2	Malignant cells	GSE175716	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21977
2.0259759303892e-81	-0.706164936624724	0.087	0.406	4.63036798890452e-77	TRIP11	Malignant cells	GSE175716	ENSG00000100815	9321	thyroid hormone receptor interactor 11	CEV14|GMAP-210|GMAP210|Trip230	protein_coding	Q15643	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21978
2.1028850476316e-81	0.60022774765466	0.886	0.576	4.80614377636203e-77	LAMTOR4	Malignant cells	GSE175716	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21979
2.11945048826747e-81	-0.911622116333607	0	0.293	4.84400409093529e-77	UGT3A1	Malignant cells	GSE175716	ENSG00000145626	133688	UDP glycosyltransferase family 3 member A1	FLJ34658	protein_coding	Q6NUS8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21980
2.50020504538281e-81	-0.626424198331969	0	0.292	5.71421863122241e-77	CDH17	Malignant cells	GSE175716	ENSG00000079112	1015	cadherin 17	cadherin|HPT-1	protein_coding	Q12864	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21981
2.63893433052827e-81	-0.601806122357592	0.022	0.325	6.03128441242236e-77	MACROD2	Malignant cells	GSE175716	ENSG00000172264	140733	mono-ADP ribosylhydrolase 2	C20orf133|dJ631M13.5	protein_coding	A1Z1Q3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21982
3.00818690975569e-81	-0.566993257634369	0.717	0.864	6.87521118224663e-77	PGRMC1	Malignant cells	GSE175716	ENSG00000101856	10857	progesterone receptor membrane component 1	HPR6.6	protein_coding	O00264	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21983
3.59412522164249e-81	-0.651840048308208	0.045	0.36	8.21437319406392e-77	SGK1	Malignant cells	GSE175716	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21984
4.95605979191191e-81	-0.512567048711956	0.004	0.298	1.13270746544147e-76	TMEM51	Malignant cells	GSE175716	ENSG00000171729	55092	transmembrane protein 51	C1orf72|FLJ10199	protein_coding	Q9NW97	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21985
5.14359884991026e-81	-0.630576618906269	0.516	0.74	1.17556951714699e-76	TNPO1	Malignant cells	GSE175716	ENSG00000083312	3842	transportin 1	IPO2|KPNB2|MIP|MIP1|TRN	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21986
7.31720766908966e-81	-0.566402940041223	0.093	0.421	1.67234781277044e-76	KIAA1522	Malignant cells	GSE175716	ENSG00000162522	57648	KIAA1522	NA	protein_coding	Q9P206	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21987
8.02286088992221e-81	-0.576543883187168	0.011	0.307	1.83362485639172e-76	SEZ6L2	Malignant cells	GSE175716	ENSG00000174938	26470	seizure related 6 homolog like 2	FLJ90517|PSK-1	protein_coding	Q6UXD5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21988
8.38352506836788e-81	-0.522426021709328	0.014	0.31	1.91605465437548e-76	ABHD17C	Malignant cells	GSE175716	ENSG00000136379	58489	abhydrolase domain containing 17C, depalmitoylase	FAM108C1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21989
8.91995390132708e-81	0.503313317184625	0.366	0.132	2.03865546414831e-76	DPP7	Malignant cells	GSE175716	ENSG00000176978	29952	dipeptidyl peptidase 7	DPP2|DPPII	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21990
1.02964574470148e-80	-0.644801526508562	0.065	0.382	2.35325534951523e-76	ZSWIM6	Malignant cells	GSE175716	ENSG00000130449	57688	zinc finger SWIM-type containing 6	KIAA1577	protein_coding	Q9HCJ5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21991
1.08538884358755e-80	0.700583893212323	0.81	0.581	2.48065620201934e-76	PDHA1	Malignant cells	GSE175716	ENSG00000131828	5160	pyruvate dehydrogenase E1 subunit alpha 1	E1alpha|PDHA	protein_coding	P08559	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21992
1.17339780057199e-80	-0.588683947783427	0.646	0.838	2.68180067320729e-76	IQGAP1	Malignant cells	GSE175716	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21993
1.28115048147547e-80	-0.540704209033779	0.04	0.347	2.92806942541218e-76	VPS37A	Malignant cells	GSE175716	ENSG00000155975	137492	VPS37A subunit of ESCRT-I	FLJ32642|HCRP1|PQBP2|SPG53	protein_coding	Q8NEZ2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21994
1.35719363790112e-80	0.615756168328698	0.813	0.535	3.10186605942301e-76	GPAA1	Malignant cells	GSE175716	ENSG00000197858	8733	glycosylphosphatidylinositol anchor attachment 1	GAA1|hGAA1	protein_coding	O43292	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21995
2.0272632471925e-80	-0.81390039449298	0.481	0.713	4.63331015145846e-76	GOLGB1	Malignant cells	GSE175716	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21996
2.23348525912541e-80	0.643515658428737	0.848	0.631	5.10463055973113e-76	PAICS	Malignant cells	GSE175716	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21997
2.43027771010347e-80	-0.554572870790607	0.011	0.307	5.55439970644149e-76	GPRC5B	Malignant cells	GSE175716	ENSG00000167191	51704	G protein-coupled receptor class C group 5 member B	RAIG-2	protein_coding	Q9NZH0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21998
2.57430602231433e-80	0.643231943435085	0.985	0.911	5.8835764139994e-76	HMGB1	Malignant cells	GSE175716	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	21999
5.4348190244279e-80	-0.525039600752897	0.764	0.914	1.242127888033e-75	HTATIP2	Malignant cells	GSE175716	ENSG00000109854	10553	HIV-1 Tat interactive protein 2	CC3|FLJ26963|SDR44U1|TIP30	protein_coding	Q9BUP3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22000
5.66377353017386e-80	-0.523743758721344	0	0.287	1.29445544032124e-75	USP33	Malignant cells	GSE175716	ENSG00000077254	23032	ubiquitin specific peptidase 33	KIAA1097|VDU1	protein_coding	Q8TEY7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22001
5.83640560831588e-80	-1.81330813268958	0.353	0.584	1.33391050178059e-75	MMP7	Malignant cells	GSE175716	ENSG00000137673	4316	matrix metallopeptidase 7	MPSL1|PUMP-1	protein_coding	P09237	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22002
8.16547063343177e-80	-0.694732974900381	0	0.288	1.86621831327083e-75	MS4A8	Malignant cells	GSE175716	ENSG00000166959	83661	membrane spanning 4-domains A8	CD20L5|MS4A4|MS4A8B	protein_coding	Q9BY19	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22003
9.0594241787706e-80	-2.70451172385723	0.528	0.649	2.07053139605802e-75	TM4SF5	Malignant cells	GSE175716	ENSG00000142484	9032	transmembrane 4 L six family member 5	NA	protein_coding	O14894	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22004
9.65389554923841e-80	-0.561736051228913	0	0.287	2.20639782777844e-75	UBE2M	Malignant cells	GSE175716	ENSG00000130725	9040	ubiquitin conjugating enzyme E2 M	hUbc12|UBC12	protein_coding	P61081	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22005
1.21840226611354e-79	-0.646520193148745	0	0.287	2.78465837920249e-75	DUOX2	Malignant cells	GSE175716	ENSG00000140279	50506	dual oxidase 2	LNOX2|P138(TOX)|P138-TOX|THOX2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22006
1.44239007803888e-79	0.667389941940367	0.872	0.665	3.29658252335785e-75	RBM17	Malignant cells	GSE175716	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22007
1.55970832446617e-79	-0.905069166109831	0	0.287	3.56471337556743e-75	AC117402.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22008
1.7731532791036e-79	-0.790706500609828	0.309	0.575	4.05254181939127e-75	HGF	Malignant cells	GSE175716	ENSG00000019991	3082	hepatocyte growth factor	DFNB39|F-TCF|HGFB|HPTA|SF	protein_coding	P14210	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22009
2.23921075263076e-79	-0.633916226812748	0.865	0.955	5.1177161751376e-75	TMEM123	Malignant cells	GSE175716	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22010
2.87883172211093e-79	-0.575058865000579	0.011	0.303	6.57956990088454e-75	NECTIN3	Malignant cells	GSE175716	ENSG00000177707	25945	nectin cell adhesion molecule 3	CD113|CDw113|DKFZP566B0846|nectin-3|PPR3|PVRL3|PVRR3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22011
3.33082109895019e-79	0.758325001215278	0.341	0.123	7.61259162165065e-75	TXNIP	Malignant cells	GSE175716	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22012
3.51873115029836e-79	-0.740481394867079	0.368	0.631	8.04206004400689e-75	ARFGAP3	Malignant cells	GSE175716	ENSG00000242247	26286	ADP ribosylation factor GTPase activating protein 3	ARFGAP1	protein_coding	Q9NP61	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22013
4.52402205376279e-79	-0.560981613417082	0.91	0.973	1.03396524038749e-74	LITAF	Malignant cells	GSE175716	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22014
4.8275243888115e-79	-0.691432248694954	0.595	0.782	1.10333069906287e-74	FDFT1	Malignant cells	GSE175716	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22015
5.91494021169882e-79	-0.550543047103805	0.767	0.889	1.35185958538377e-74	ATRAID	Malignant cells	GSE175716	ENSG00000138085	51374	all-trans retinoic acid induced differentiation factor	APR3|C2orf28|HSPC013|p18	protein_coding	Q6UW56	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22016
8.24825131351423e-79	-0.845941612969504	0.004	0.292	1.88513783770368e-74	LINC01419	Malignant cells	GSE175716	ENSG00000253898	103352670	long intergenic non-protein coding RNA 1419	PRLH1|TCONS_00014497	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22017
9.82092444694268e-79	-0.591588822841135	0	0.284	2.24457228234875e-74	MUC3A	Malignant cells	GSE175716	ENSG00000169894	4584	mucin 3A, cell surface associated	MUC3	protein_coding	Q02505	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22018
1.08791977015653e-78	-0.503064545988341	0	0.283	2.48644063469275e-74	PDE4D	Malignant cells	GSE175716	ENSG00000113448	5144	phosphodiesterase 4D	DPDE3	protein_coding	Q08499	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22019
1.26009572360361e-78	-0.890524125260912	0.269	0.545	2.87994877629605e-74	ADH1C	Malignant cells	GSE175716	ENSG00000248144	126	alcohol dehydrogenase 1C (class I), gamma polypeptide	ADH3	protein_coding	P00326	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22020
1.30596033611297e-78	-1.07234374821886	0.068	0.366	2.9847723481862e-74	DKK1	Malignant cells	GSE175716	ENSG00000107984	22943	dickkopf WNT signaling pathway inhibitor 1	DKK-1|SK	protein_coding	O94907	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22021
1.85290885459188e-78	-0.814083314117591	0.076	0.378	4.23482318716973e-74	ASRGL1	Malignant cells	GSE175716	ENSG00000162174	80150	asparaginase and isoaspartyl peptidase 1	ALP|ALP1|FLJ22316	protein_coding	Q7L266	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22022
3.9612408751205e-78	-0.682523486682105	0	0.283	9.0534160200879e-74	GAPLINC	Malignant cells	GSE175716	ENSG00000266835	NA	NA	LINC01540|lncRNA-uc002kmd.1|RP11-838N2.4|TCONS_00026238	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22023
5.94010571890229e-78	-0.714272907287555	0.183	0.485	1.35761116205512e-73	CSRP1	Malignant cells	GSE175716	ENSG00000159176	1465	cysteine and glycine rich protein 1	CSRP|CYRP|D1S181E	protein_coding	P21291	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22024
6.97715458312678e-78	-0.607462922052364	0.087	0.403	1.59462867997363e-73	TNFRSF10A	Malignant cells	GSE175716	ENSG00000104689	8797	TNF receptor superfamily member 10a	Apo2|CD261|DR4|TRAILR-1|TRAILR1	protein_coding	O00220	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22025
7.59460226898215e-78	-0.469170936412322	0	0.28	1.73574634857587e-73	UBE2W	Malignant cells	GSE175716	ENSG00000104343	55284	ubiquitin conjugating enzyme E2 W	FLJ11011|UBC-16	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22026
7.708136545928e-78	-0.562499000089814	0.078	0.39	1.76169460757184e-73	PBDC1	Malignant cells	GSE175716	ENSG00000102390	51260	polysaccharide biosynthesis domain containing 1	CXorf26|MGC874	protein_coding	Q9BVG4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22027
8.64338590934518e-78	-0.616920887660181	0.26	0.559	1.97544584958084e-73	NEDD4L	Malignant cells	GSE175716	ENSG00000049759	23327	NEDD4 like E3 ubiquitin protein ligase	KIAA0439|NEDD4-2|RSP5	protein_coding	Q96PU5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22028
1.10695815225662e-77	-0.769021828796628	0.045	0.342	2.5299528569825e-73	HOOK1	Malignant cells	GSE175716	ENSG00000134709	51361	hook microtubule tethering protein 1	HK1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22029
1.30312353925102e-77	-0.47979335554498	0	0.28	2.97828884895822e-73	UBXN8	Malignant cells	GSE175716	ENSG00000104691	7993	UBX domain protein 8	D8S2298E|REP8|UBXD6	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22030
1.373670103658e-77	-0.754871097995133	0.407	0.648	3.13952302191036e-73	CALR	Malignant cells	GSE175716	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22031
1.47960393666751e-77	-0.649176761832016	1	0.999	3.38163479725359e-73	RPL4	Malignant cells	GSE175716	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22032
1.57807399980314e-77	0.600589126801064	1	0.963	3.60668812655008e-73	AC024293.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22033
2.70584965176735e-77	-0.471656505642997	0	0.279	6.18421937911428e-73	UNC50	Malignant cells	GSE175716	ENSG00000115446	25972	unc-50 inner nuclear membrane RNA binding protein	GMH1|UNCL|URP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22034
3.52062618304142e-77	0.697048892234494	0.382	0.151	8.04639114134116e-73	MT-TL1	Malignant cells	GSE175716	ENSG00000209082	NA	NA	MTTL1|TRNL1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22035
3.62977586601743e-77	-0.545053474641327	0.006	0.289	8.29585274178284e-73	PGM2L1	Malignant cells	GSE175716	ENSG00000165434	283209	phosphoglucomutase 2 like 1	BM32A|FLJ32029	protein_coding	Q6PCE3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22036
3.89902929606326e-77	-0.905506368436112	0.302	0.562	8.91123145615257e-73	TIMP1	Malignant cells	GSE175716	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22037
4.53876573580745e-77	-0.514361384147273	0.01	0.297	1.03733490891879e-72	KLHL5	Malignant cells	GSE175716	ENSG00000109790	51088	kelch like family member 5	NA	protein_coding	Q96PQ7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22038
4.81516256553525e-77	-0.823235172148819	0.333	0.589	1.10050540435308e-72	HLA-DMA	Malignant cells	GSE175716	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22039
7.70594327786093e-77	-0.933788218194333	0.01	0.298	1.76119333615512e-72	ARL4C	Malignant cells	GSE175716	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22040
8.30303252040209e-77	-0.769719238663167	0.267	0.554	1.8976580825379e-72	TRNP1	Malignant cells	GSE175716	ENSG00000253368	388610	TMF1 regulated nuclear protein 1	C1orf225|TRNP	protein_coding	Q6NT89	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22041
9.84366649584043e-77	-0.742962927443078	0.079	0.387	2.24976997762433e-72	KAT6B	Malignant cells	GSE175716	ENSG00000281813	23522	lysine acetyltransferase 6B	Morf|MOZ2|MYST4|qkf|querkopf|ZC2HC6B	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22042
1.05963275475105e-76	-0.718995718528732	0	0.279	2.42179066098351e-72	UGT2B15	Malignant cells	GSE175716	ENSG00000277132	7366	UDP glucuronosyltransferase family 2 member B15	UGT2B8	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22043
1.09382253384031e-76	0.758098444677025	0.419	0.189	2.49993140109204e-72	ACSL1	Malignant cells	GSE175716	ENSG00000151726	2180	acyl-CoA synthetase long chain family member 1	ACS1|FACL1|FACL2|LACS|LACS1|LACS2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22044
1.18630935519022e-76	-0.670445346824873	0.061	0.364	2.71131003128726e-72	DYRK2	Malignant cells	GSE175716	ENSG00000127334	8445	dual specificity tyrosine phosphorylation regulated kinase 2	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22045
1.22186228072583e-76	0.562234646599486	0.387	0.157	2.79256624259889e-72	TARBP1	Malignant cells	GSE175716	ENSG00000059588	6894	TAR (HIV-1) RNA binding protein 1	TRM3|TRMT3|TRP-185	protein_coding	Q13395	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22046
1.46236925025267e-76	-0.710441638562651	0.263	0.553	3.34224492145248e-72	TPM1	Malignant cells	GSE175716	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22047
1.50139659424232e-76	-0.617021909650342	0.045	0.342	3.43144191614083e-72	SMURF2	Malignant cells	GSE175716	ENSG00000108854	64750	SMAD specific E3 ubiquitin protein ligase 2	NA	protein_coding	Q9HAU4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22048
1.82878301596331e-76	-0.896056718021752	0.99	0.987	4.17968358298414e-72	RPL13A	Malignant cells	GSE175716	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22049
1.9054291185839e-76	0.58153238679193	1	0.994	4.3548582505235e-72	PPIA	Malignant cells	GSE175716	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22050
2.02457428200221e-76	-0.900358371168909	0.737	0.848	4.62716452151606e-72	SCD	Malignant cells	GSE175716	ENSG00000099194	6319	stearoyl-CoA desaturase	FADS5|SCD1|SCDOS	protein_coding	O00767	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22051
2.10215104471812e-76	-0.674222965920917	0.014	0.299	4.80446621270325e-72	ELK3	Malignant cells	GSE175716	ENSG00000111145	2004	ETS transcription factor ELK3	ERP|NET|SAP2	protein_coding	P41970	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22052
2.21336980375751e-76	-0.491388385408959	0	0.277	5.05865668648778e-72	UGT2B7	Malignant cells	GSE175716	ENSG00000171234	7364	UDP glucuronosyltransferase family 2 member B7	UGT2B9	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22053
2.71884319739447e-76	-0.523138741339565	0.026	0.316	6.21391612764506e-72	LSR	Malignant cells	GSE175716	ENSG00000105699	51599	lipolysis stimulated lipoprotein receptor	ILDR3|LISCH7	protein_coding	Q86X29	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22054
4.21385865816332e-76	0.614033547179691	0.401	0.168	9.63077396323227e-72	PRKAG2-AS1	Malignant cells	GSE175716	ENSG00000239911	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22055
4.36180662954994e-76	-0.740924333001347	0.459	0.69	9.96890905183639e-72	TNFRSF10B	Malignant cells	GSE175716	ENSG00000120889	8795	TNF receptor superfamily member 10b	CD262|DR5|KILLER|TRAIL-R2|TRAILR2|TRICK2A|TRICKB	protein_coding	O14763	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22056
4.97496452217019e-76	-0.8353521140126	0.419	0.638	1.137028141542e-71	CXCL16	Malignant cells	GSE175716	ENSG00000161921	58191	C-X-C motif chemokine ligand 16	CXCLG16|SR-PSOX|SRPSOX	protein_coding	Q9H2A7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22057
5.1609230549933e-76	-0.469002487771681	0.002	0.279	1.17952896421872e-71	SMAGP	Malignant cells	GSE175716	ENSG00000170545	57228	small cell adhesion glycoprotein	hSMAGP|MGC149453|MGC149454	protein_coding	Q0VAQ4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22058
5.67453938164681e-76	-0.502250965939493	0.004	0.282	1.29691597567538e-71	LIMCH1	Malignant cells	GSE175716	ENSG00000064042	22998	LIM and calponin homology domains 1	DKFZP686A01247|LIMCH1A|LMO7B	protein_coding	Q9UPQ0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22059
5.87333839149929e-76	-0.500985962418866	0.011	0.293	1.34235148937716e-71	GBP3	Malignant cells	GSE175716	ENSG00000117226	2635	guanylate binding protein 3	FLJ10961	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22060
6.70115922877586e-76	0.503111733105362	0.359	0.136	1.53154994173672e-71	AL355338.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22061
6.92951715670664e-76	-0.489136244541122	0.013	0.296	1.5837411461653e-71	RAB11FIP1	Malignant cells	GSE175716	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22062
7.85909528168456e-76	-0.470208272324341	0.947	0.982	1.79619622662901e-71	PFDN5	Malignant cells	GSE175716	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22063
7.99950150668172e-76	-0.58233539937824	0.619	0.803	1.82828606935211e-71	TM9SF3	Malignant cells	GSE175716	ENSG00000077147	56889	transmembrane 9 superfamily member 3	SMBP	protein_coding	Q9HD45	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22064
8.94337277256518e-76	-0.552011501119339	0.1	0.415	2.04400784716977e-71	SMAD4	Malignant cells	GSE175716	ENSG00000141646	4089	SMAD family member 4	DPC4|MADH4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22065
9.49338907687778e-76	-0.549014675948226	0	0.275	2.16971407352042e-71	UBTD2	Malignant cells	GSE175716	ENSG00000168246	92181	ubiquitin domain containing 2	DC-UbP|MGC30022	protein_coding	Q8WUN7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22066
1.00275910315288e-75	-0.743435660512152	0.307	0.58	2.2918059302559e-71	NCEH1	Malignant cells	GSE175716	ENSG00000144959	57552	neutral cholesterol ester hydrolase 1	AADACL1|KIAA1363|NCEH	protein_coding	Q6PIU2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22067
1.02729310768147e-75	0.586155773329654	0.78	0.517	2.34787839760601e-71	TRIP6	Malignant cells	GSE175716	ENSG00000087077	7205	thyroid hormone receptor interactor 6	MGC10556|MGC10558|MGC29959|MGC3837|MGC4423|OIP1|ZRP-1	protein_coding	Q15654	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22068
1.03685409123451e-75	-0.531487152972504	0.066	0.368	2.36973002551648e-71	CASC4	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22069
1.18051627185226e-75	-0.45775348067806	0	0.274	2.69806993931834e-71	UBIAD1	Malignant cells	GSE175716	ENSG00000120942	29914	UbiA prenyltransferase domain containing 1	SCCD|TERE1	protein_coding	Q9Y5Z9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22070
1.41450683278234e-75	0.76586611937392	0.515	0.286	3.23285536632405e-71	HADH	Malignant cells	GSE175716	ENSG00000138796	3033	hydroxyacyl-CoA dehydrogenase	HADH1|HADHSC|SCHAD	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22071
1.7086466718741e-75	-0.708640319262603	0.006	0.285	3.90511196856826e-71	TNFSF10	Malignant cells	GSE175716	ENSG00000121858	8743	TNF superfamily member 10	Apo-2L|CD253|TL2|TRAIL	protein_coding	P50591	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22072
1.8847865284174e-75	-0.570525180308985	0.514	0.74	4.30767961069797e-71	VASP	Malignant cells	GSE175716	ENSG00000125753	7408	vasodilator stimulated phosphoprotein	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22073
2.05441594792117e-75	-0.578254168428788	0.43	0.679	4.69536764897383e-71	SVIP	Malignant cells	GSE175716	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22074
2.47702578244341e-75	-0.544051891817308	0.082	0.392	5.66124242577442e-71	MAP3K21	Malignant cells	GSE175716	ENSG00000143674	84451	mitogen-activated protein kinase kinase kinase 21	KIAA1804|MLK4	protein_coding	Q5TCX8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22075
3.32168641251755e-75	-0.535116417544858	0.018	0.303	7.59171429580886e-71	OAF	Malignant cells	GSE175716	ENSG00000184232	220323	out at first homolog	MGC52117	protein_coding	Q86UD1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22076
3.44451500079705e-75	-0.674377421554896	0	0.274	7.87243903432165e-71	UACA	Malignant cells	GSE175716	ENSG00000137831	55075	uveal autoantigen with coiled-coil domains and ankyrin repeats	FLJ10128|KIAA1561	protein_coding	Q9BZF9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22077
3.5348857181813e-75	-0.578501025991414	0.238	0.537	8.07898130890336e-71	ABCC2	Malignant cells	GSE175716	ENSG00000023839	1244	ATP binding cassette subfamily C member 2	CMOAT|cMRP|DJS|MRP2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22078
3.73619107692224e-75	0.47885996218869	1	0.995	8.53906470630577e-71	RPL10A	Malignant cells	GSE175716	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22079
4.1175125776556e-75	-1.18375356044756	0.403	0.6	9.41057499623187e-71	FURIN	Malignant cells	GSE175716	ENSG00000140564	5045	furin, paired basic amino acid cleaving enzyme	FUR|PACE|PCSK3|SPC1	protein_coding	P09958	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22080
4.55916784267756e-75	-0.62683854524968	0.104	0.415	1.04199781044396e-70	GOLIM4	Malignant cells	GSE175716	ENSG00000173905	27333	golgi integral membrane protein 4	GIMPC|GOLPH4|GPP130|P138	protein_coding	O00461	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22081
4.97421428170739e-75	-0.762752019986727	0.004	0.28	1.13685667408422e-70	CCDC71L	Malignant cells	GSE175716	ENSG00000253276	168455	coiled-coil domain containing 71 like	C7orf74|FLJ36031	protein_coding	Q8N9Z2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22082
5.87016405762821e-75	-0.653738777660766	0.033	0.327	1.34162599537093e-70	GDF15	Malignant cells	GSE175716	ENSG00000130513	9518	growth differentiation factor 15	MIC-1|MIC1|NAG-1|PDF|PLAB|PTGFB	protein_coding	Q99988	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22083
5.95600111399175e-75	0.778631057155354	0.936	0.806	1.36124405460281e-70	IDH1	Malignant cells	GSE175716	ENSG00000138413	3417	isocitrate dehydrogenase (NADP(+)) 1	NA	protein_coding	O75874	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22084
9.22609868601659e-75	-0.554384723012467	0	0.273	2.10862485468909e-70	CAVIN3	Malignant cells	GSE175716	ENSG00000170955	112464	caveolae associated protein 3	cavin-3|HSRBC|MGC20400|PRKCDBP|SRBC	protein_coding	Q969G5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22085
9.58710447190927e-75	-0.841285092217761	0	0.273	2.19113272705486e-70	VCAN	Malignant cells	GSE175716	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22086
9.64379490491733e-75	-1.35150707177054	0.335	0.547	2.20408932551886e-70	PCSK1	Malignant cells	GSE175716	ENSG00000175426	5122	proprotein convertase subtilisin/kexin type 1	NEC1|PC1|PC1/3|PC3|SPC3	protein_coding	P29120	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22087
9.74548935287748e-75	0.628866046309985	0.787	0.552	2.22733159160015e-70	HMGN3	Malignant cells	GSE175716	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22088
1.38793304057964e-74	0.677753164905303	0.758	0.506	3.17212096424476e-70	IER2	Malignant cells	GSE175716	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22089
1.67601743848375e-74	-0.912419837227321	0.799	0.891	3.83053785565462e-70	KTN1	Malignant cells	GSE175716	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22090
1.82113950437259e-74	-0.48243678456443	0	0.271	4.16221433724356e-70	IFITM1	Malignant cells	GSE175716	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22091
2.06949650220185e-74	-0.68420843091459	0	0.272	4.72983425578234e-70	CPLX2	Malignant cells	GSE175716	ENSG00000145920	10814	complexin 2	CPX-2|DKFZp547D155	protein_coding	Q6PUV4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22092
2.13044073037789e-74	-0.704728592535827	0	0.272	4.86912228927866e-70	SPTSSB	Malignant cells	GSE175716	ENSG00000196542	165679	serine palmitoyltransferase small subunit B	ADMP|C3orf57|ssSPTb	protein_coding	Q8NFR3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22093
2.17349264971983e-74	0.462462463032939	0.312	0.105	4.96751745093468e-70	ADD3	Malignant cells	GSE175716	ENSG00000148700	120	adducin 3	ADDL	protein_coding	Q9UEY8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22094
2.62048946238532e-74	-0.497812065078778	0.044	0.338	5.98912866628165e-70	GPAT4	Malignant cells	GSE175716	ENSG00000158669	137964	glycerol-3-phosphate acyltransferase 4	AGPAT6|DKFZp586M1819|LPAAT-zeta|TSARG7	protein_coding	Q86UL3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22095
3.28444004867126e-74	-0.583973192351702	0.003	0.276	7.50658773123816e-70	ABCB1	Malignant cells	GSE175716	ENSG00000085563	5243	ATP binding cassette subfamily B member 1	ABC20|CD243|CLCS|GP170|MDR1|p-170|P-gp|PGY1	protein_coding	P08183	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22096
4.13769753765941e-74	-0.635863838823263	0.005	0.278	9.45670772232059e-70	TMEM158	Malignant cells	GSE175716	ENSG00000249992	25907	transmembrane protein 158	p40BBp|RIS1	protein_coding	Q8WZ71	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22097
4.59649993868025e-74	-0.519258557352411	0.061	0.358	1.05053006098537e-69	INPP1	Malignant cells	GSE175716	ENSG00000151689	3628	inositol polyphosphate-1-phosphatase	NA	protein_coding	P49441	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22098
5.17374913783172e-74	0.617706257153793	0.921	0.675	1.18246036545144e-69	RGS2	Malignant cells	GSE175716	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22099
5.39154769556535e-74	-0.578336600787431	0.141	0.454	1.23223822582146e-69	KCTD9	Malignant cells	GSE175716	ENSG00000104756	54793	potassium channel tetramerization domain containing 9	BTBD27|FLJ20038	protein_coding	Q7L273	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22100
5.47525884249661e-74	-0.79297604859744	0.103	0.392	1.2513704084526e-69	FLYWCH2	Malignant cells	GSE175716	ENSG00000162076	114984	FLYWCH family member 2	NA	protein_coding	Q96CP2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22101
6.11846972415467e-74	0.469007669114407	0.359	0.138	1.39837625545555e-69	AC024619.4	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22102
7.68293445063131e-74	0.60196584976525	0.388	0.161	1.75593466869178e-69	MSH2	Malignant cells	GSE175716	ENSG00000095002	4436	mutS homolog 2	COCA1|HNPCC|HNPCC1|MSH-2	protein_coding	P43246	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22103
7.80554613300467e-74	-0.571740282920603	0.057	0.35	1.78395756869822e-69	SLC35C1	Malignant cells	GSE175716	ENSG00000181830	55343	solute carrier family 35 member C1	FLJ11320|FUCT1	protein_coding	Q96A29	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22104
9.70369727193673e-74	-0.690883390151947	0.006	0.279	2.21778001150114e-69	PFN2	Malignant cells	GSE175716	ENSG00000070087	5217	profilin 2	NA	protein_coding	P35080	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22105
1.21964763935727e-73	0.660997687170604	0.919	0.79	2.78750467975105e-69	SSU72	Malignant cells	GSE175716	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22106
1.87207906377641e-73	-0.826518860301693	0.635	0.773	4.27863670026099e-69	AKR1A1	Malignant cells	GSE175716	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22107
2.66318672734131e-73	0.572883710206178	0.803	0.538	6.08671326533856e-69	RPLP0P6	Malignant cells	GSE175716	ENSG00000213553	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22108
2.89718945118259e-73	0.620938977248039	0.957	0.783	6.62152649067781e-69	CAPZB	Malignant cells	GSE175716	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22109
3.01070273231685e-73	-0.708824718623768	0.86	0.92	6.88096109471017e-69	CD46	Malignant cells	GSE175716	ENSG00000117335	4179	CD46 molecule	MCP|MGC26544|MIC10|TLX|TRA2.10	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22110
3.13910014304668e-73	0.647884590598411	0.434	0.198	7.17441337693318e-69	KLHL23	Malignant cells	GSE175716	ENSG00000213160	151230	kelch like family member 23	FLJ37812|MGC22679|MGC2610	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22111
3.27245256469413e-73	-0.490717690106005	0.011	0.285	7.47919033660843e-69	ADGRG1	Malignant cells	GSE175716	ENSG00000205336	9289	adhesion G protein-coupled receptor G1	GPR56|TM7LN4|TM7XN1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22112
3.67319247528609e-73	0.520072209241384	0.998	0.994	8.39508140226636e-69	ATP5E	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22113
5.98270693075548e-73	-0.533916917996847	0.972	0.993	1.36734766902417e-68	CALM2	Malignant cells	GSE175716	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22114
7.81516434607401e-73	-4.51861108377081	0.539	0.629	1.78615581129521e-68	PLA2G2A	Malignant cells	GSE175716	ENSG00000188257	5320	phospholipase A2 group IIA	PLA2B|PLA2L	protein_coding	P14555	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22115
9.39238112548305e-73	-0.546827371834385	0	0.266	2.14662870622915e-68	UBE2D3P1	Malignant cells	GSE175716	ENSG00000225022	NA	NA	RP4-680N4|UBE2D3P|UBE2D5P	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22116
9.56553250360773e-73	-0.603556073637468	0.648	0.808	2.18620245369955e-68	MORF4L2	Malignant cells	GSE175716	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22117
9.83507775586271e-73	-0.649132197817642	0.385	0.633	2.24780702110242e-68	TNFAIP1	Malignant cells	GSE175716	ENSG00000109079	7126	TNF alpha induced protein 1	B12|B61|BTBD34|EDP1|MGC2317	protein_coding	Q13829	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22118
1.1349454402717e-72	-0.563565382148043	0.031	0.314	2.59391780374098e-68	SPAG1	Malignant cells	GSE175716	ENSG00000104450	6674	sperm associated antigen 1	CILD28|CT140|DNAAF13|FLJ32920|HSD-3.8|SP75|TPIS	protein_coding	Q07617	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22119
1.64763132270469e-72	-0.554803741864043	0.059	0.35	3.76566138804156e-68	TGFBR1	Malignant cells	GSE175716	ENSG00000106799	7046	transforming growth factor beta receptor 1	ACVRLK4|ALK-5|ALK5|ESS1|MSSE|TBR-i|TBRI	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22120
2.44839467861352e-72	1.26957812789865	0.399	0.172	5.59580603797121e-68	LCN2	Malignant cells	GSE175716	ENSG00000148346	3934	lipocalin 2	24p3|NGAL	protein_coding	P80188	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22121
2.48479579602368e-72	0.541182767837092	1	0.965	5.67900079181211e-68	ENO1	Malignant cells	GSE175716	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22122
3.78163322045546e-72	-0.56035733693076	0.108	0.411	8.64292272535096e-68	ABT1	Malignant cells	GSE175716	ENSG00000146109	29777	activator of basal transcription 1	Esf2	protein_coding	Q9ULW3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22123
3.90367025013667e-72	-1.10536341026251	0.313	0.545	8.92183835668737e-68	A2M	Malignant cells	GSE175716	ENSG00000175899	2	alpha-2-macroglobulin	CPAMD5|FWP007|S863-7	protein_coding	P01023	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22124
5.53302572316851e-72	-0.539483438919638	0.047	0.331	1.26457302903016e-67	CLDN12	Malignant cells	GSE175716	ENSG00000157224	9069	claudin 12	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22125
5.63234897087944e-72	-0.606315285089196	0.024	0.3	1.2872733572945e-67	ZC3H12C	Malignant cells	GSE175716	ENSG00000149289	85463	zinc finger CCCH-type containing 12C	KIAA1726|MCPIP3	protein_coding	Q9C0D7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22126
6.8827484782646e-72	-1.05510970269305	0.388	0.623	1.57305216470737e-67	ARL14	Malignant cells	GSE175716	ENSG00000179674	80117	ADP ribosylation factor like GTPase 14	ARF7|FLJ22595	protein_coding	Q8N4G2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22127
7.39863835331004e-72	0.633303805685349	0.885	0.61	1.69095879564901e-67	MAL2	Malignant cells	GSE175716	ENSG00000147676	114569	mal, T cell differentiation protein 2	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22128
8.90384533190825e-72	-0.777283740348694	0.004	0.27	2.03497385060763e-67	ACTL8	Malignant cells	GSE175716	ENSG00000117148	81569	actin like 8	CT57	protein_coding	Q9H568	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22129
1.1395883953718e-71	0.579321073704932	0.31	0.11	2.60452927762225e-67	SNHG11	Malignant cells	GSE175716	ENSG00000174365	128439	small nucleolar RNA host gene 11	C20orf198|LINC00101	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22130
1.40884989723643e-71	-0.672091801215883	0.403	0.646	3.21992644013386e-67	ARHGEF12	Malignant cells	GSE175716	ENSG00000196914	23365	Rho guanine nucleotide exchange factor 12	KIAA0382|LARG	protein_coding	Q9NZN5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22131
1.43091376886633e-71	0.725089479147798	0.256	0.076	3.27035341874401e-67	SAA2	Malignant cells	GSE175716	ENSG00000134339	6289	serum amyloid A2	NA	protein_coding	P0DJI9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22132
1.50881579892912e-71	-0.4705917860073	0	0.262	3.4483985084525e-67	UBAP2	Malignant cells	GSE175716	ENSG00000137073	55833	ubiquitin associated protein 2	bA176F3.5|FLJ22435|KIAA1491	protein_coding	Q5T6F2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22133
1.7210608085259e-71	-1.19690692698329	0.318	0.536	3.93348447788595e-67	IL13RA2	Malignant cells	GSE175716	ENSG00000123496	3598	interleukin 13 receptor subunit alpha 2	CD213a2|CT19|IL-13R|IL13BP	protein_coding	Q14627	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22134
1.89174569723674e-71	-0.677474739069822	0.505	0.716	4.32358479103457e-67	REEP3	Malignant cells	GSE175716	ENSG00000165476	221035	receptor accessory protein 3	C10orf74|Yip2b	protein_coding	Q6NUK4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22135
2.04883423674761e-71	-0.679754591854552	0.541	0.725	4.68261064808666e-67	DUSP23	Malignant cells	GSE175716	ENSG00000158716	54935	dual specificity phosphatase 23	DUSP25|FLJ20442	protein_coding	Q9BVJ7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22136
2.30627644322479e-71	-0.65263564240083	0	0.263	5.27099481099025e-67	RASSF8	Malignant cells	GSE175716	ENSG00000123094	11228	Ras association domain family member 8	C12orf2|HoJ-1	protein_coding	Q8NHQ8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22137
2.45113323026792e-71	-0.479980242560748	0.729	0.88	5.60206499777732e-67	MLF2	Malignant cells	GSE175716	ENSG00000089693	8079	myeloid leukemia factor 2	NTN4	protein_coding	Q15773	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22138
2.46735886777956e-71	-0.519784929762388	0.018	0.29	5.63914869231017e-67	IFT57	Malignant cells	GSE175716	ENSG00000114446	55081	intraflagellar transport 57	ESRRBL1|FLJ10147|HIPPI|MHS4R2	protein_coding	Q9NWB7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22139
2.63868737282052e-71	-0.912992957368533	0.335	0.581	6.0307199905813e-67	METTL7B	Malignant cells	GSE175716	ENSG00000170439	196410	methyltransferase like 7B	ALDI|MGC17301	protein_coding	Q6UX53	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22140
2.78270819794559e-71	-0.828663405776477	0.033	0.31	6.35987958640464e-67	KLF7	Malignant cells	GSE175716	ENSG00000118263	8609	KLF transcription factor 7	UKLF	protein_coding	O75840	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22141
4.44203618926758e-71	-0.702080272137963	0.586	0.769	1.01522737105711e-66	KPNA4	Malignant cells	GSE175716	ENSG00000186432	3840	karyopherin subunit alpha 4	IPOA3|MGC12217|MGC26703|QIP1|SRP3	protein_coding	O00629	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22142
4.69277651844881e-71	0.70049238642794	0.504	0.27	1.07253407329148e-66	MPST	Malignant cells	GSE175716	ENSG00000128309	4357	mercaptopyruvate sulfurtransferase	MST|TST2|TUM1	protein_coding	P25325	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22143
5.39138165060739e-71	0.545475050804162	0.82	0.549	1.23220027624632e-66	PKIB	Malignant cells	GSE175716	ENSG00000135549	5570	cAMP-dependent protein kinase inhibitor beta	PRKACN2	protein_coding	Q9C010	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22144
6.13713931490349e-71	-1.34869586954453	0.323	0.535	1.40264319042119e-66	MUC6	Malignant cells	GSE175716	ENSG00000277518	4588	mucin 6, oligomeric mucus/gel-forming	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22145
6.5483037481075e-71	0.415554412163847	1	1	1.49661482162997e-66	ACTB	Malignant cells	GSE175716	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22146
6.94550984370283e-71	-0.567839009537889	0.104	0.405	1.58739627477828e-66	ZNF148	Malignant cells	GSE175716	ENSG00000163848	7707	zinc finger protein 148	BERF-1|BFCOL1|HT-BETA|pHZ-52|ZBP-89|ZFP148	protein_coding	Q9UQR1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22147
7.31595326824494e-71	-0.638957725033696	0	0.261	1.67206111945738e-66	FRMD6	Malignant cells	GSE175716	ENSG00000139926	122786	FERM domain containing 6	C14orf31|EX1|MGC17921|willin	protein_coding	Q96NE9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22148
7.62062390813418e-71	0.576662756122789	0.883	0.684	1.74169359420407e-66	HNRNPD	Malignant cells	GSE175716	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22149
7.66368379269842e-71	-0.470059131380282	0	0.26	1.75153493082122e-66	UNG	Malignant cells	GSE175716	ENSG00000076248	7374	uracil DNA glycosylase	DGU|HIGM4|UDG|UNG1|UNG2	protein_coding	P13051	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22150
1.29100204373506e-70	-0.618144403702457	0.094	0.387	2.95058517095647e-66	MBIP	Malignant cells	GSE175716	ENSG00000151332	51562	MAP3K12 binding inhibitory protein 1	NA	protein_coding	Q9NS73	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22151
1.33075058620213e-70	-0.605153207662629	0.073	0.363	3.04143046476496e-66	NMB	Malignant cells	GSE175716	ENSG00000197696	4828	neuromedin B	MGC17211|MGC2277|MGC3936	protein_coding	P08949	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22152
1.34795337086878e-70	-0.74617111568485	0.175	0.456	3.0807474291206e-66	FHIT	Malignant cells	GSE175716	ENSG00000189283	2272	fragile histidine triad diadenosine triphosphatase	AP3Aase|FRA3B	protein_coding	P49789	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22153
1.55333371802513e-70	-0.563174130206318	0.023	0.295	3.55014421254644e-66	KITLG	Malignant cells	GSE175716	ENSG00000049130	4254	KIT ligand	DFNA69|FPH2|Kitl|KL-1|MGF|SCF|SF|SLF	protein_coding	P21583	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22154
1.74025167159445e-70	-0.459901147678158	0	0.259	3.97734519542911e-66	USP6NL	Malignant cells	GSE175716	ENSG00000148429	9712	USP6 N-terminal like	KIAA0019|RN-tre|RNTRE|TRE2NL|USP6NL-IT1	protein_coding	Q92738	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22155
2.10397878432365e-70	-0.525537776218915	0.462	0.703	4.80864351157171e-66	LEPROTL1	Malignant cells	GSE175716	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22156
2.51560538286795e-70	0.55045666322685	0.307	0.109	5.7494161025447e-66	SMYD3	Malignant cells	GSE175716	ENSG00000185420	64754	SET and MYND domain containing 3	KMT3E|ZMYND1|ZNFN3A1	protein_coding	Q9H7B4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22157
2.62339262623858e-70	-0.595040389292969	0.595	0.792	5.99576384726828e-66	ATP13A3	Malignant cells	GSE175716	ENSG00000133657	79572	ATPase 13A3	AFURS1	protein_coding	Q9H7F0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22158
5.52546914031238e-70	-0.443715169662953	0	0.257	1.26284597201839e-65	UBP1	Malignant cells	GSE175716	ENSG00000153560	7342	upstream binding protein 1	LBP-1a	protein_coding	Q9NZI7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22159
6.09743395237669e-70	0.415283504060903	0.288	0.094	1.39356852981569e-65	COBLL1	Malignant cells	GSE175716	ENSG00000082438	22837	cordon-bleu WH2 repeat protein like 1	KIAA0977	protein_coding	Q53SF7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22160
6.09920315426994e-70	-0.544565036589832	0.047	0.329	1.3939728809084e-65	SAMD8	Malignant cells	GSE175716	ENSG00000156671	142891	sterile alpha motif domain containing 8	FLJ25082|SMSr	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22161
7.72854695188028e-70	-2.98536474158539	0.629	0.738	1.76635940585224e-65	CXCL3	Malignant cells	GSE175716	ENSG00000163734	2921	C-X-C motif chemokine ligand 3	CINC-2b|GRO3|GROg|MIP-2b|SCYB3	protein_coding	P19876	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22162
8.17461867928426e-70	-1.5815662713528	0.666	0.737	1.86830909915042e-65	MYDGF	Malignant cells	GSE175716	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22163
9.57175603300423e-70	-0.680156844796356	0.003	0.263	2.18762484134312e-65	CDC42EP3	Malignant cells	GSE175716	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22164
1.0248613201851e-69	-0.505890896223567	0.055	0.339	2.34232054728304e-65	ZNF226	Malignant cells	GSE175716	ENSG00000167380	7769	zinc finger protein 226	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22165
1.18840996286265e-69	-0.715254869466834	0	0.258	2.71611097012259e-65	ADAM28	Malignant cells	GSE175716	ENSG00000042980	10863	ADAM metallopeptidase domain 28	ADAM23|eMDCII|MDC-Lm|MDC-Ls	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22166
1.39259809262978e-69	0.701406582022028	0.283	0.09	3.18278294070535e-65	TOP2A	Malignant cells	GSE175716	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22167
1.47418281676287e-69	-0.486620639186694	0.003	0.263	3.36924482771153e-65	SPECC1	Malignant cells	GSE175716	ENSG00000128487	92521	sperm antigen with calponin homology and coiled-coil domains 1	CYTSB|FLJ36955|HCMOGT-1|NSP	protein_coding	Q5M775	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22168
1.75309764902512e-69	-0.501154940669588	0.002	0.26	4.00670467684691e-65	MECOM	Malignant cells	GSE175716	ENSG00000085276	2122	MDS1 and EVI1 complex locus	EVI1|KMT8E|MDS1|MDS1-EVI1|PRDM3	protein_coding	Q03112	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22169
2.02655478875584e-69	-0.848334392517965	0.31	0.569	4.63169096970146e-65	CPE	Malignant cells	GSE175716	ENSG00000109472	1363	carboxypeptidase E	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22170
2.03170762844199e-69	-0.489852692699795	0.07	0.356	4.64346778480416e-65	AKAP17A	Malignant cells	GSE175716	ENSG00000197976	8227	A-kinase anchoring protein 17A	721P|CCDC133|CXYorf3|DXYS155E|MGC39904|SFRS17A|XE7|XE7Y	protein_coding	Q02040	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22171
2.11088619948451e-69	-0.426796668127615	0	0.256	4.82443040892184e-65	UPF3A	Malignant cells	GSE175716	ENSG00000169062	65110	UPF3A regulator of nonsense mediated mRNA decay	HUPF3A|RENT3A|UPF3	protein_coding	Q9H1J1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22172
2.40567364178732e-69	-0.646583335191142	0.016	0.282	5.49816710830493e-65	LYPD3	Malignant cells	GSE175716	ENSG00000124466	27076	LY6/PLAUR domain containing 3	C4.4A	protein_coding	O95274	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22173
2.41869864860331e-69	-0.628830932704114	0.305	0.565	5.52793576138286e-65	PPP1R11	Malignant cells	GSE175716	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22174
2.78378938362437e-69	-1.23658754194777	0.327	0.535	6.36235063627351e-65	VMO1	Malignant cells	GSE175716	ENSG00000182853	284013	vitelline membrane outer layer 1 homolog	NA	protein_coding	Q7Z5L0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22175
3.57125946917766e-69	-0.531041825674289	0.03	0.303	8.16211351680554e-65	ZNF830	Malignant cells	GSE175716	ENSG00000198783	91603	zinc finger protein 830	CCDC16|MGC20398|OMCG1	protein_coding	Q96NB3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22176
3.62342274968063e-69	-0.774981362493302	0	0.256	8.28133269439507e-65	ACE2	Malignant cells	GSE175716	ENSG00000130234	59272	angiotensin converting enzyme 2	ACEH	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22177
3.7930641602342e-69	-0.433187152085471	0	0.255	8.66904813821527e-65	UBLCP1	Malignant cells	GSE175716	ENSG00000164332	134510	ubiquitin like domain containing CTD phosphatase 1	CPUB1|MGC10067	protein_coding	Q8WVY7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22178
4.91686618843148e-69	-0.61682185111659	0.296	0.568	1.12374976736601e-64	SLC4A4	Malignant cells	GSE175716	ENSG00000080493	8671	solute carrier family 4 member 4	hhNMC|HNBC1|NBC1|NBC2|pNBC|SLC4A5	protein_coding	Q9Y6R1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22179
5.07389848110525e-69	-0.434279826998261	0	0.255	1.15963949785661e-64	UBA5	Malignant cells	GSE175716	ENSG00000081307	79876	ubiquitin like modifier activating enzyme 5	FLJ23251|UBE1DC1	protein_coding	Q9GZZ9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22180
5.61063297903145e-69	-0.54910066367899	0.387	0.641	1.28231016735764e-64	TMOD3	Malignant cells	GSE175716	ENSG00000138594	29766	tropomodulin 3	UTMOD	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22181
5.95416934187586e-69	-0.576402789076739	0.199	0.491	1.36082540308573e-64	VPS4B	Malignant cells	GSE175716	ENSG00000119541	9525	vacuolar protein sorting 4 homolog B	SKD1|SKD1B|VPS4-2	protein_coding	O75351	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22182
6.49412725143021e-69	-0.495465387803849	0.064	0.349	1.48423278331437e-64	SCML1	Malignant cells	GSE175716	ENSG00000047634	6322	Scm polycomb group protein like 1	NA	protein_coding	Q9UN30	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22183
6.90368414146247e-69	-0.968201077931674	0.479	0.666	1.57783701053125e-64	WWTR1	Malignant cells	GSE175716	ENSG00000018408	25937	WW domain containing transcription regulator 1	DKFZp586I1419|TAZ	protein_coding	Q9GZV5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22184
7.7402953318349e-69	-0.502847180299551	0.193	0.495	1.76904449809087e-64	RAB9A	Malignant cells	GSE175716	ENSG00000123595	9367	RAB9A, member RAS oncogene family	RAB9	protein_coding	P51151	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22185
8.11320827288154e-69	0.622029165419218	0.92	0.79	1.85427375076708e-64	HNRNPH1	Malignant cells	GSE175716	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22186
1.01906761608235e-68	-0.460545639058247	0.008	0.267	2.32907903655622e-64	PSD3	Malignant cells	GSE175716	ENSG00000156011	23362	pleckstrin and Sec7 domain containing 3	DKFZp761K1423|EFA6D|EFA6R|HCA67|KIAA0942	protein_coding	Q9NYI0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22187
1.34189346491044e-68	-0.458290697232728	0	0.254	3.06689751405281e-64	TXLNGY	Malignant cells	GSE175716	ENSG00000131002	NA	NA	CYorf15A|CYorf15B|TXLNG2P	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22188
1.52308320914269e-68	-0.792009643834355	0.073	0.357	3.48100667449562e-64	PPP1R3B	Malignant cells	GSE175716	ENSG00000173281	79660	protein phosphatase 1 regulatory subunit 3B	FLJ14005|GL|PPP1R4	protein_coding	Q86XI6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22189
1.59490591378075e-68	-0.600714827289163	0.042	0.313	3.64515746594589e-64	TIMM17B	Malignant cells	GSE175716	ENSG00000126768	10245	translocase of inner mitochondrial membrane 17B	DXS9822|JM3	protein_coding	O60830	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22190
1.87341656574837e-68	-0.480459183769129	0.109	0.409	4.28169356101791e-64	NIPA1	Malignant cells	GSE175716	ENSG00000288478	123606	NIPA magnesium transporter 1	MGC35570|SLC57A1|SPG6	protein_coding	Q7RTP0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22191
2.18850665781508e-68	-1.79450734607254	0.441	0.621	5.00183196643638e-64	FBXO32	Malignant cells	GSE175716	ENSG00000156804	114907	F-box protein 32	ATROGIN1|Fbx32|MAFbx	protein_coding	Q969P5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22192
2.23191675511159e-68	-0.455781973389481	0	0.253	5.10104574380755e-64	UBXN7	Malignant cells	GSE175716	ENSG00000163960	26043	UBX domain protein 7	KIAA0794|UBXD7	protein_coding	O94888	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22193
2.36661398898902e-68	-0.535850552215989	0.616	0.789	5.4088962718344e-64	NDUFS4	Malignant cells	GSE175716	ENSG00000164258	4724	NADH:ubiquinone oxidoreductase subunit S4	AQDQ|CI-18	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22194
2.83671423768421e-68	-0.464342671607998	0.006	0.263	6.48331039022725e-64	MLPH	Malignant cells	GSE175716	ENSG00000115648	79083	melanophilin	exophilin-3|l(1)-3Rk|l1Rk3|ln|Slac-2a	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22195
2.99770237792054e-68	-0.820375033918049	0.281	0.524	6.85124878473739e-64	CREB3L3	Malignant cells	GSE175716	ENSG00000060566	84699	cAMP responsive element binding protein 3 like 3	CREB-H|CREBH	protein_coding	Q68CJ9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22196
4.64011527223786e-68	-0.546194955652258	0.073	0.354	1.06049834546996e-63	AKR7A3	Malignant cells	GSE175716	ENSG00000162482	22977	aldo-keto reductase family 7 member A3	NA	protein_coding	O95154	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22197
4.77990251567594e-68	0.698725567870319	0.657	0.455	1.09244671995774e-63	FAM49B	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22198
5.3812670979864e-68	-0.455589149672689	0.019	0.282	1.22988859524479e-63	RALGPS2	Malignant cells	GSE175716	ENSG00000116191	55103	Ral GEF with PH domain and SH3 binding motif 2	FLJ10244|FLJ25604|KIAA0351	protein_coding	Q86X27	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22199
6.75952716982863e-68	0.556663930758305	0.889	0.666	1.54488993466433e-63	DCAF13	Malignant cells	GSE175716	ENSG00000164934	25879	DDB1 and CUL4 associated factor 13	DKFZP564O0463|Gm83|HSPC064|Sof1|WDSOF1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22200
7.09491904017975e-68	-0.529441816932536	0.065	0.349	1.62154374663308e-63	KIF1BP	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22201
7.1154962679552e-68	-0.741092214728738	0	0.252	1.62624667204116e-63	CD177	Malignant cells	GSE175716	ENSG00000204936	57126	CD177 molecule	HNA2A|NB1|PRV1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22202
8.37872110671173e-68	-1.12723711973956	0.351	0.543	1.91495670893897e-63	SCAND1	Malignant cells	GSE175716	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22203
8.41487077613577e-68	-0.445703224528102	0	0.251	1.92321871588583e-63	UHRF1BP1L	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22204
9.53408143093416e-68	0.671631466936232	0.809	0.597	2.17901431104e-63	RPA3	Malignant cells	GSE175716	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22205
9.73608611324224e-68	-0.53903848442655	0.024	0.29	2.22518248118151e-63	RARRES3	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22206
1.13723906491097e-67	-0.48263138795734	0.959	0.979	2.59915988285402e-63	DAD1	Malignant cells	GSE175716	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22207
1.17335340285782e-67	-0.562883773490461	0.703	0.832	2.68169920223155e-63	RAB11A	Malignant cells	GSE175716	ENSG00000103769	8766	RAB11A, member RAS oncogene family	YL8	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22208
1.38091475286635e-67	-0.740484119898042	0.684	0.832	3.15608066767605e-63	ATP2B1	Malignant cells	GSE175716	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22209
1.43243273405644e-67	0.582179933613615	0.733	0.497	3.273825013686e-63	LRPPRC	Malignant cells	GSE175716	ENSG00000138095	10128	leucine rich pentatricopeptide repeat containing	GP130|LRP130|LSFC	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22210
1.49379009051444e-67	-0.434279826998261	0	0.25	3.41405725187076e-63	LYPD1	Malignant cells	GSE175716	ENSG00000150551	116372	LY6/PLAUR domain containing 1	LYPDC1|MGC29643	protein_coding	Q8N2G4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22211
1.58633845706845e-67	0.623078686782697	0.429	0.207	3.62557654362994e-63	LYPLAL1	Malignant cells	GSE175716	ENSG00000143353	127018	lysophospholipase like 1	Q96AV0	protein_coding	Q5VWZ2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22212
1.77255067968734e-67	0.617623235622601	0.497	0.269	4.05116457842543e-63	NUDT16L1	Malignant cells	GSE175716	ENSG00000168101	84309	nudix hydrolase 16 like 1	SDOS|TIRR	protein_coding	Q9BRJ7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22213
1.79097467674755e-67	-0.570872845801036	0	0.251	4.09327262370652e-63	AC128657.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22214
1.8610377043394e-67	-0.516966728177213	0.735	0.856	4.2534016732677e-63	SSR3	Malignant cells	GSE175716	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22215
2.10341244145017e-67	-0.481908486099855	0	0.25	4.80734913493437e-63	PPP1R1C	Malignant cells	GSE175716	ENSG00000150722	151242	protein phosphatase 1 regulatory inhibitor subunit 1C	Inhibitor-1-like	protein_coding	Q8WVI7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22216
2.25529620513261e-67	-0.926298027879296	0.242	0.488	5.15447947683058e-63	TESC	Malignant cells	GSE175716	ENSG00000088992	54997	tescalcin	CHP3|FLJ20607|TSC	protein_coding	Q96BS2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22217
2.50335453846559e-67	0.575106000139798	0.966	0.894	5.7214167976631e-63	HSPA9	Malignant cells	GSE175716	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22218
2.6334952517104e-67	-0.592863843225546	0.05	0.322	6.01885339778413e-63	MICA	Malignant cells	GSE175716	ENSG00000231225	100507436	MHC class I polypeptide-related sequence A	PERB11.1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22219
2.85038592156007e-67	-0.796436825868092	0.261	0.513	6.51455702372554e-63	RASD1	Malignant cells	GSE175716	ENSG00000108551	51655	ras related dexamethasone induced 1	AGS1|DEXRAS1	protein_coding	Q9Y272	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22220
2.91682146146319e-67	-0.638336220746337	0.049	0.319	6.66639545017411e-63	RABAC1	Malignant cells	GSE175716	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22221
3.7495819601698e-67	-0.669964837218232	0.169	0.448	8.56966956996808e-63	ETHE1	Malignant cells	GSE175716	ENSG00000105755	23474	ETHE1 persulfide dioxygenase	HSCO|YF13H12	protein_coding	O95571	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22222
4.26763276020237e-67	-0.519885995393615	0.12	0.418	9.75367467344251e-63	MFAP1	Malignant cells	GSE175716	ENSG00000140259	4236	microfibril associated protein 1	AMP	protein_coding	P55081	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22223
4.71700579300816e-67	-0.492215065759804	0.97	0.981	1.07807167399201e-62	TPM3	Malignant cells	GSE175716	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22224
4.76280701505845e-67	-0.652878494367005	0.046	0.318	1.08853954329161e-62	INSIG2	Malignant cells	GSE175716	ENSG00000125629	51141	insulin induced gene 2	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22225
5.24136099571783e-67	-0.450064949344828	0.021	0.283	1.19791305557131e-62	CCDC68	Malignant cells	GSE175716	ENSG00000166510	80323	coiled-coil domain containing 68	SE57-1	protein_coding	Q9H2F9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22226
5.76196386068699e-67	-0.959354260754692	0.398	0.596	1.31689684036001e-62	F5	Malignant cells	GSE175716	ENSG00000198734	2153	coagulation factor V	NA	protein_coding	P12259	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22227
5.84946297621666e-67	-0.664868644016359	0.045	0.314	1.33689476321432e-62	PDGFC	Malignant cells	GSE175716	ENSG00000145431	56034	platelet derived growth factor C	fallotein|SCDGF	protein_coding	Q9NRA1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22228
6.50251811958829e-67	-0.700687063736755	0.221	0.495	1.4861505162319e-62	CDK6	Malignant cells	GSE175716	ENSG00000105810	1021	cyclin dependent kinase 6	PLSTIRE	protein_coding	Q00534	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22229
6.75711081516724e-67	-1.83059052265737	0.338	0.538	1.54433767680647e-62	GHRH	Malignant cells	GSE175716	ENSG00000118702	2691	growth hormone releasing hormone	GHRF	protein_coding	P01286	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22230
7.53179340798651e-67	0.865100538493884	0.994	0.97	1.72139138339532e-62	AKR1C1	Malignant cells	GSE175716	ENSG00000187134	1645	aldo-keto reductase family 1 member C1	DD1|DDH|DDH1|HAKRC|MBAB	protein_coding	Q04828	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22231
8.87965548421037e-67	-0.580987376427247	0.52	0.729	2.02944526091628e-62	MAP2K3	Malignant cells	GSE175716	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22232
9.20098470149568e-67	-0.786363392919486	0.657	0.796	2.10288505352684e-62	SFN	Malignant cells	GSE175716	ENSG00000175793	2810	stratifin	YWHAS	protein_coding	P31947	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22233
9.91766686006351e-67	-0.472818629493959	0.008	0.263	2.26668276086752e-62	FHL2	Malignant cells	GSE175716	ENSG00000115641	2274	four and a half LIM domains 2	DRAL|SLIM3	protein_coding	Q14192	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22234
1.03133184362506e-66	0.654011821351879	0.463	0.236	2.35710892860506e-62	GRB14	Malignant cells	GSE175716	ENSG00000115290	2888	growth factor receptor bound protein 14	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22235
1.33766913921789e-66	-1.24838597604012	0.661	0.766	3.0572428176825e-62	TOB1	Malignant cells	GSE175716	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22236
2.13028263443157e-66	-0.837193148635883	0.066	0.335	4.86876096099335e-62	SNHG14	Malignant cells	GSE175716	ENSG00000224078	NA	NA	NCRNA00214|UBE3A-AS|UBE3A-AS1|UBE3A-ATS	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22237
3.51331657062081e-66	-0.550842790052096	0.021	0.278	8.02968502215386e-62	ME1	Malignant cells	GSE175716	ENSG00000065833	4199	malic enzyme 1	NA	protein_coding	P48163	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22238
3.62415011830903e-66	-0.491049219567938	0.059	0.335	8.2829950953953e-62	KAT6A	Malignant cells	GSE175716	ENSG00000083168	7994	lysine acetyltransferase 6A	MOZ|MYST3|RUNXBP2|ZC2HC6A|ZNF220	protein_coding	Q92794	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22239
4.03381001051335e-66	-0.855604051330496	0.435	0.619	9.21927277902827e-62	NUCB1	Malignant cells	GSE175716	ENSG00000104805	4924	nucleobindin 1	Calnuc|NUC	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22240
4.11188287705543e-66	-0.585034982705873	0.119	0.41	9.39770831551018e-62	CCNT1	Malignant cells	GSE175716	ENSG00000129315	904	cyclin T1	CCNT|CYCT1|HIVE1	protein_coding	O60563	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22241
4.16331665754999e-66	0.593535236863132	0.758	0.543	9.51526022083049e-62	TSNAX	Malignant cells	GSE175716	ENSG00000116918	7257	translin associated factor X	C3PO|TRAX	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22242
4.17091240731845e-66	-0.444030427741308	0.014	0.267	9.53262030692631e-62	SEC24D	Malignant cells	GSE175716	ENSG00000150961	9871	SEC24 homolog D, COPII coat complex component	KIAA0755	protein_coding	O94855	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22243
4.35751141046554e-66	-0.561670149830343	0.697	0.839	9.95909232861899e-62	SUCLG2	Malignant cells	GSE175716	ENSG00000172340	8801	succinate-CoA ligase GDP-forming subunit beta	NA	protein_coding	Q96I99	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22244
4.69524504266155e-66	-0.501020033461136	0.065	0.342	1.0730982545003e-61	SLC37A4	Malignant cells	GSE175716	ENSG00000281500	2542	solute carrier family 37 member 4	G6PT|G6PT1|G6PT2|G6PT3|GSD1b|GSD1c|GSD1d|SPX4	protein_coding	O43826	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22245
5.16617819855857e-66	-0.551591316828996	0.429	0.658	1.18073002728056e-61	MAGT1	Malignant cells	GSE175716	ENSG00000102158	84061	magnesium transporter 1	DKFZp564K142|IAP|MRX95|OST3B|SLC58A1	protein_coding	Q9H0U3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22246
5.57413805492683e-66	0.74136170656473	0.854	0.697	1.27396925245353e-61	GRN	Malignant cells	GSE175716	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22247
6.22855425491731e-66	-0.80953836362796	0.665	0.769	1.42353607496135e-61	COX6A1P2	Malignant cells	GSE175716	ENSG00000226976	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22248
6.23438058742257e-66	-0.591063723819364	0.039	0.302	1.42486768325543e-61	RASSF7	Malignant cells	GSE175716	ENSG00000273859	8045	Ras association domain family member 7	C11orf13|CFAP88|FAP88|HRAS1|HRC1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22249
6.28366241460585e-66	-0.436440692555424	0.018	0.275	1.43613104485817e-61	RGS9	Malignant cells	GSE175716	ENSG00000108370	8787	regulator of G protein signaling 9	MGC111763|MGC26458|PERRS|RGS9L	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22250
7.65159018177807e-66	-0.461901194013377	0.021	0.278	1.74877093604538e-61	SLC17A3	Malignant cells	GSE175716	ENSG00000124564	10786	solute carrier family 17 member 3	NPT4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22251
9.18494657587764e-66	-0.538954605048233	0.633	0.798	2.09921953991684e-61	FAM177A1	Malignant cells	GSE175716	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22252
9.37229654799625e-66	-0.513054450523565	0.087	0.372	2.14203837604454e-61	MDM2	Malignant cells	GSE175716	ENSG00000135679	4193	MDM2 proto-oncogene	HDM2|MGC5370	protein_coding	Q00987	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22253
9.43918895518631e-66	-0.620177688490149	0.185	0.474	2.15732663570783e-61	CSRP2	Malignant cells	GSE175716	ENSG00000175183	1466	cysteine and glycine rich protein 2	CRP2|LMO5|SmLIM	protein_coding	Q16527	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22254
1.01172301228613e-65	-0.776383472360991	0.541	0.724	2.31229294457996e-61	BNIP3L	Malignant cells	GSE175716	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22255
1.28042074275251e-65	-0.747226301399414	0.063	0.337	2.92640160756087e-61	HBEGF	Malignant cells	GSE175716	ENSG00000113070	1839	heparin binding EGF like growth factor	DTR|DTS|HEGFL	protein_coding	Q99075	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22256
1.35130926930155e-65	-0.752108294405333	0.101	0.382	3.08841733498868e-61	CHORDC1	Malignant cells	GSE175716	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22257
1.35835338402577e-65	-0.610904030418664	0.077	0.353	3.10451665919089e-61	BCL2L1	Malignant cells	GSE175716	ENSG00000171552	598	BCL2 like 1	Bcl-X|bcl-xL|bcl-xS|BCL2L|BCLX|PPP1R52	protein_coding	Q07817	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22258
1.43849078536002e-65	-0.61812098514653	0.054	0.323	3.28767068994031e-61	APOM	Malignant cells	GSE175716	ENSG00000235754	55937	apolipoprotein M	Apo-M|G3a|NG20	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22259
1.74877722837858e-65	-0.636437999957046	0.152	0.436	3.99683035545924e-61	SP100	Malignant cells	GSE175716	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22260
1.79785642830153e-65	-0.604658705314166	0.014	0.266	4.10900086688315e-61	DCAF4L2	Malignant cells	GSE175716	ENSG00000176566	138009	DDB1 and CUL4 associated factor 4 like 2	WDR21C	protein_coding	Q8NA75	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22261
1.89417031877999e-65	-0.914177415970193	0.195	0.445	4.32912626357167e-61	AK8	Malignant cells	GSE175716	ENSG00000165695	158067	adenylate kinase 8	C9orf98|FLJ32704	protein_coding	Q96MA6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22262
2.94338524888837e-65	-0.652068115723622	0.177	0.463	6.72710698633436e-61	APOL1	Malignant cells	GSE175716	ENSG00000100342	8542	apolipoprotein L1	APOL	protein_coding	O14791	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22263
3.93854178167361e-65	-1.28724717969442	0.309	0.519	9.00153724201503e-61	SPANXB1	Malignant cells	GSE175716	ENSG00000227234	728695	SPANX family member B1	CT11.2|SPANXB2|SPANXF1|SPANXF2	protein_coding	Q9NS25	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22264
4.2681993138009e-65	0.62967791109534	0.481	0.254	9.75496953169197e-61	MRPL2	Malignant cells	GSE175716	ENSG00000112651	51069	mitochondrial ribosomal protein L2	CGI-22|MRP-L14|RPML14	protein_coding	Q5T653	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22265
4.36862166666908e-65	0.577151610228996	0.751	0.535	9.98448481917218e-61	METTL9	Malignant cells	GSE175716	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22266
5.60813392601523e-65	0.566152104720426	0.413	0.196	1.28173900879078e-60	LRP11	Malignant cells	GSE175716	ENSG00000120256	84918	LDL receptor related protein 11	bA350J20.3|MANSC3	protein_coding	Q86VZ4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22267
5.93196578075979e-65	-0.672841990839885	0.062	0.331	1.35575077919265e-60	DCPS	Malignant cells	GSE175716	ENSG00000110063	28960	decapping enzyme, scavenger	HINT-5|HINT5|HSL1|HSPC015	protein_coding	Q96C86	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22268
7.21407089844707e-65	-0.445514411863026	0.011	0.26	1.64877590384008e-60	TNFRSF11A	Malignant cells	GSE175716	ENSG00000141655	8792	TNF receptor superfamily member 11a	CD265|FEO|LOH18CR1|ODFR|PDB2|RANK|TRANCE-R	protein_coding	Q9Y6Q6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22269
7.53202977594718e-65	-0.563969037107681	0.118	0.404	1.72144540529273e-60	GAREM1	Malignant cells	GSE175716	ENSG00000141441	64762	GRB2 associated regulator of MAPK1 subtype 1	C18orf11|FAM59A|FLJ21610|GAREM	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22270
8.51348619366225e-65	-0.502269561899603	0.19	0.481	1.94575726956151e-60	PPP1R2	Malignant cells	GSE175716	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22271
9.60793142348009e-65	-0.584120599833388	0.452	0.678	2.19589272683637e-60	B3GNT5	Malignant cells	GSE175716	ENSG00000176597	84002	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	B3GN-T5|beta3Gn-T5	protein_coding	Q9BYG0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22272
1.15861157640262e-64	-0.441421057907107	0.041	0.305	2.6480067578682e-60	THAP1	Malignant cells	GSE175716	ENSG00000131931	55145	THAP domain containing 1	4833431A01Rik|DYT6|FLJ10477	protein_coding	Q9NVV9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22273
1.48883387425493e-64	-0.532584763316852	0.947	0.986	3.40272981960964e-60	SAP18	Malignant cells	GSE175716	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22274
1.61796190865823e-64	-0.490596288003253	0.513	0.72	3.69785194223839e-60	TMEM167A	Malignant cells	GSE175716	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22275
1.63506710056912e-64	0.544825787774395	0.401	0.184	3.73694585835072e-60	BTG3	Malignant cells	GSE175716	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22276
1.79664072875763e-64	-1.53734902012821	0.335	0.53	4.10622238557557e-60	ALPI	Malignant cells	GSE175716	ENSG00000163295	248	alkaline phosphatase, intestinal	IAP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22277
1.8228361420498e-64	0.619301574810666	0.715	0.505	4.16609200265481e-60	ATP1B3	Malignant cells	GSE175716	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22278
1.87807414559513e-64	-0.491850306554544	0.082	0.359	4.29233845975766e-60	TMEM214	Malignant cells	GSE175716	ENSG00000119777	54867	transmembrane protein 214	FLJ20254	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22279
1.9622060481408e-64	-1.19066009592381	0.329	0.529	4.4846219230258e-60	HULC	Malignant cells	GSE175716	ENSG00000285219	100506207	uncharacterized LOC100506207	HCCAT1|LINC00078|NCRNA00078	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22280
2.23644374714502e-64	-0.446637158553368	0.074	0.352	5.11139218409994e-60	MCU	Malignant cells	GSE175716	ENSG00000156026	90550	mitochondrial calcium uniporter	C10orf42|CCDC109A|FLJ46135	protein_coding	Q8NE86	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22281
2.8842839163074e-64	0.661170105790049	0.451	0.23	6.59203089072055e-60	DDX39A	Malignant cells	GSE175716	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22282
3.45325727968908e-64	-0.510353441171904	0.032	0.292	7.89241951272939e-60	AP002884.3	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22283
3.69878169834768e-64	-0.582428431624178	0.212	0.49	8.45356557157362e-60	SERPINB8	Malignant cells	GSE175716	ENSG00000166401	5271	serpin family B member 8	CAP2|PI8	protein_coding	P50452	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22284
5.11367731330152e-64	-0.645213993762872	0.449	0.664	1.16873094995506e-59	GFPT1	Malignant cells	GSE175716	ENSG00000198380	2673	glutamine--fructose-6-phosphate transaminase 1	GFA|GFAT|GFAT1|GFPT	protein_coding	Q06210	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22285
6.63268224772755e-64	0.562915723862209	0.779	0.554	1.51589952771813e-59	ANAPC5	Malignant cells	GSE175716	ENSG00000089053	51433	anaphase promoting complex subunit 5	APC5	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22286
6.69636715786781e-64	-0.927150712544933	0.222	0.463	1.53045471393069e-59	BEX3	Malignant cells	GSE175716	ENSG00000166681	27018	brain expressed X-linked 3	Bex|DXS6984E|HGR74|NADE|NGFRAP1	protein_coding	Q00994	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22287
9.03662696196803e-64	-0.598603318979929	0.022	0.273	2.06532109215779e-59	PLSCR4	Malignant cells	GSE175716	ENSG00000114698	57088	phospholipid scramblase 4	NA	protein_coding	Q9NRQ2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22288
1.65300511000561e-63	-0.465259220093163	0.038	0.294	3.77794317891782e-59	DOCK5	Malignant cells	GSE175716	ENSG00000147459	80005	dedicator of cytokinesis 5	FLJ21034	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22289
1.95833203440755e-63	-0.51214485671866	0.353	0.608	4.47576786463846e-59	GOLGA7	Malignant cells	GSE175716	ENSG00000147533	51125	golgin A7	GCP16|GOLGA3AP1|GOLGA7A|HSPC041	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22290
2.32621054755192e-63	0.458617837064434	0.318	0.123	5.31655420642991e-59	MTHFS	Malignant cells	GSE175716	ENSG00000136371	10588	methenyltetrahydrofolate synthetase	HsT19268	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22291
2.74276157896878e-63	-0.519563807815155	0.49	0.702	6.26858158873315e-59	ARCN1	Malignant cells	GSE175716	ENSG00000095139	372	archain 1	COPD	protein_coding	P48444	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22292
2.76819521198434e-63	-0.445146931466491	0.037	0.295	6.32671015699021e-59	NECTIN2	Malignant cells	GSE175716	ENSG00000130202	5819	nectin cell adhesion molecule 2	CD112|HVEB|Nectin-2|PRR2|PVRL2|PVRR2	protein_coding	Q92692	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22293
2.89021835675803e-63	-0.621789998243858	0.506	0.693	6.60559405437048e-59	CPT1A	Malignant cells	GSE175716	ENSG00000110090	1374	carnitine palmitoyltransferase 1A	CPT1|CPT1-L|L-CPT1	protein_coding	P50416	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22294
4.67970383161935e-63	-0.644479350889495	0.542	0.719	1.0695463107166e-58	TUBB2A	Malignant cells	GSE175716	ENSG00000137267	7280	tubulin beta 2A class IIa	dJ40E16.7|TUBB|TUBB2	protein_coding	Q13885	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22295
4.68005830333093e-63	-0.70309011301612	0.483	0.679	1.06962732522628e-58	KDSR	Malignant cells	GSE175716	ENSG00000119537	2531	3-ketodihydrosphingosine reductase	DHSR|FVT1|SDR35C1	protein_coding	Q06136	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22296
5.40557094494208e-63	-0.680125896983508	0.686	0.817	1.23544323946651e-58	GOLGA4	Malignant cells	GSE175716	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22297
5.64298429130168e-63	-0.363117931585178	0.994	0.999	1.289704059777e-58	BTF3	Malignant cells	GSE175716	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22298
6.67657064039979e-63	-0.479942601029323	0.014	0.258	1.52593021986337e-58	ANTXR2	Malignant cells	GSE175716	ENSG00000163297	118429	ANTXR cell adhesion molecule 2	CMG-2|CMG2|FLJ31074	protein_coding	P58335	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22299
6.67790822984438e-63	-0.622383932791611	0.425	0.638	1.52623592593093e-58	SDC1	Malignant cells	GSE175716	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22300
7.21708627470205e-63	0.429822724474521	0.305	0.111	1.64946506808315e-58	APBB1IP	Malignant cells	GSE175716	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22301
8.81321249407992e-63	-0.64034060634824	0.371	0.605	2.01425971552197e-58	PCM1	Malignant cells	GSE175716	ENSG00000078674	5108	pericentriolar material 1	PTC4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22302
9.42468348468903e-63	-0.511159585858756	0.018	0.263	2.15401141042568e-58	GPC1	Malignant cells	GSE175716	ENSG00000063660	2817	glypican 1	glypican	protein_coding	P35052	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22303
1.14049409107471e-62	-0.778564828869848	0.017	0.261	2.60659924515125e-58	EGR2	Malignant cells	GSE175716	ENSG00000122877	1959	early growth response 2	KROX20	protein_coding	P11161	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22304
1.22908956243304e-62	-0.434959706155001	0.034	0.29	2.8090841949407e-58	FAM102B	Malignant cells	GSE175716	ENSG00000162636	284611	family with sequence similarity 102 member B	DKFZp779B126|SYM-3B	protein_coding	Q5T8I3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22305
1.41000748249121e-62	-0.600939495290532	0.094	0.369	3.22257210123366e-58	ARFGEF1	Malignant cells	GSE175716	ENSG00000066777	10565	ADP ribosylation factor guanine nucleotide exchange factor 1	ARFGEP1|BIG1|DKFZP434L057|p200	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22306
1.44782860646414e-62	-0.551944269745959	0.776	0.884	3.30901228007379e-58	OST4	Malignant cells	GSE175716	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22307
2.38744985334181e-62	-0.507497791759395	0.145	0.435	5.4565166398127e-58	KDM5A	Malignant cells	GSE175716	ENSG00000073614	5927	lysine demethylase 5A	JARID1A|RBBP2	protein_coding	P29375	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22308
2.7632842496524e-62	-0.611178691584565	0.035	0.287	6.31548615258055e-58	MITF	Malignant cells	GSE175716	ENSG00000187098	4286	melanocyte inducing transcription factor	bHLHe32|MI|WS2|WS2A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22309
2.826513327764e-62	-1.0712185115992	0.394	0.567	6.45999621060463e-58	SELENOP	Malignant cells	GSE175716	ENSG00000250722	6414	selenoprotein P	SELP|SeP|SEPP|SEPP1	protein_coding	P49908	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22310
2.93899279893508e-62	-0.472133072023982	0.065	0.33	6.71706804196612e-58	ECE2	Malignant cells	GSE175716	ENSG00000145194	9718	endothelin converting enzyme 2	KIAA0604|MGC2408	protein_coding	P0DPD6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22311
3.28606624657996e-62	-0.478956868039082	0.055	0.32	7.51030440655849e-58	CSGALNACT2	Malignant cells	GSE175716	ENSG00000169826	55454	chondroitin sulfate N-acetylgalactosaminyltransferase 2	GALNACT-2|GALNACT2|MGC40204|PRO0082	protein_coding	Q8N6G5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22312
4.21330218197694e-62	0.634453530126376	0.69	0.478	9.6295021369083e-58	MAPKAPK2	Malignant cells	GSE175716	ENSG00000162889	9261	MAPK activated protein kinase 2	MK2	protein_coding	P49137	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22313
4.72653423054225e-62	-0.970719852151015	0.573	0.723	1.08024939839043e-57	TMEM141	Malignant cells	GSE175716	ENSG00000244187	85014	transmembrane protein 141	MGC14141	protein_coding	Q96I45	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22314
4.95235275066841e-62	0.371916108873917	0.277	0.096	1.13186022116527e-57	RPL37P6	Malignant cells	GSE175716	ENSG00000241431	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22315
5.21466160810499e-62	-0.565055551092661	0.223	0.498	1.19181091053239e-57	WWP1	Malignant cells	GSE175716	ENSG00000123124	11059	WW domain containing E3 ubiquitin protein ligase 1	AIP5|DKFZP434D2111	protein_coding	Q9H0M0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22316
5.65395262241171e-62	-0.933482041163267	0.347	0.577	1.2922108718522e-57	EDN1	Malignant cells	GSE175716	ENSG00000078401	1906	endothelin 1	ET1	protein_coding	P05305	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22317
6.09353413374244e-62	-0.535508308749076	0.925	0.957	1.39267722626684e-57	GAPDHP1	Malignant cells	GSE175716	ENSG00000228232	NA	NA	GAPDHL2|GAPDL2|GAPDP1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22318
6.28751348332863e-62	-0.889164835785411	0.354	0.557	1.43701120661476e-57	ASGR1	Malignant cells	GSE175716	ENSG00000141505	432	asialoglycoprotein receptor 1	CLEC4H1	protein_coding	P07306	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22319
7.89356853830578e-62	-0.463074114809089	0.076	0.344	1.80407508942979e-57	GTF2E2	Malignant cells	GSE175716	ENSG00000197265	2961	general transcription factor IIE subunit 2	FE|TF2E2|TFIIE-B	protein_coding	P29084	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22320
1.20987789721881e-61	0.587973118826166	0.476	0.257	2.76517593409359e-57	PPP1R14B	Malignant cells	GSE175716	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22321
1.30552901083627e-61	0.641571589118712	0.814	0.622	2.98378655426629e-57	CAPN2	Malignant cells	GSE175716	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22322
1.37798962408491e-61	0.629971343988384	0.506	0.3	3.14939528584605e-57	AC107075.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22323
1.45042336720355e-61	0.529543571344806	0.442	0.218	3.31494260574371e-57	PABPC1P3	Malignant cells	GSE175716	ENSG00000230673	NA	NA	PABP3|PABPCP3	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22324
1.49447509275655e-61	-0.461787263432748	0.751	0.872	3.41562282449509e-57	C11orf58	Malignant cells	GSE175716	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22325
1.5021553524134e-61	-0.466369654694052	0.116	0.4	3.43317605794083e-57	ATP6V1B2	Malignant cells	GSE175716	ENSG00000147416	526	ATPase H+ transporting V1 subunit B2	ATP6B2|HO57|VATB|Vma2|VPP3	protein_coding	P21281	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22326
1.8817035422706e-61	-0.712420047510939	0.324	0.561	4.30063344585947e-57	C11orf68	Malignant cells	GSE175716	ENSG00000175573	83638	chromosome 11 open reading frame 68	BLES03|P5326	protein_coding	Q9H3H3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22327
1.89283333425265e-61	-0.467030340504697	0.208	0.493	4.32607058543443e-57	RHOG	Malignant cells	GSE175716	ENSG00000177105	391	ras homolog family member G	ARHG|MGC125835|MGC125836	protein_coding	P84095	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22328
1.98843004887895e-61	0.652638734216997	0.483	0.272	4.54455687671283e-57	PSMG3	Malignant cells	GSE175716	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22329
2.00198924015455e-61	-0.492719883688312	0.682	0.835	4.57554640837322e-57	PSMD11	Malignant cells	GSE175716	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22330
2.93171409859219e-61	-0.535525415162561	0.541	0.748	6.70043257233244e-57	MAPK6	Malignant cells	GSE175716	ENSG00000069956	5597	mitogen-activated protein kinase 6	ERK3|HsT17250|p97MAPK|PRKM6	protein_coding	Q16659	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22331
3.46069041454209e-61	0.425932873081462	0.501	0.254	7.90940794243595e-57	HP	Malignant cells	GSE175716	ENSG00000257017	3240	haptoglobin	NA	protein_coding	P00738	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22332
3.71530308592177e-61	-0.442073774118492	0.085	0.355	8.49132520287421e-57	CCNDBP1	Malignant cells	GSE175716	ENSG00000166946	23582	cyclin D1 binding protein 1	DIP1|GCIP|HHM	protein_coding	O95273	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22333
4.1305134543371e-61	-0.547757543762064	0.827	0.931	9.44028849988744e-57	BRD2	Malignant cells	GSE175716	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22334
5.02965448659271e-61	-0.472830126743885	0.243	0.521	1.14952753291076e-56	SMAD2	Malignant cells	GSE175716	ENSG00000175387	4087	SMAD family member 2	JV18-1|MADH2|MADR2	protein_coding	Q15796	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22335
5.03106809336326e-61	-0.651656581778421	0.415	0.634	1.14985061273817e-56	BCL10	Malignant cells	GSE175716	ENSG00000142867	8915	BCL10 immune signaling adaptor	c-E10|CARMEN|CIPER|CLAP|mE10	protein_coding	O95999	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22336
5.35617048182534e-61	-0.470528570621451	0.046	0.301	1.22415276362118e-56	FAT1	Malignant cells	GSE175716	ENSG00000083857	2195	FAT atypical cadherin 1	CDHF7|CDHR8|FAT	protein_coding	Q14517	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22337
5.6206538422044e-61	-0.500364170110057	0.015	0.254	1.28460043563581e-56	SDSL	Malignant cells	GSE175716	ENSG00000139410	113675	serine dehydratase like	cSDH|SDS-RS1	protein_coding	Q96GA7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22338
5.99355708824892e-61	-0.611771599977897	0.105	0.379	1.36982747251929e-56	SPRED2	Malignant cells	GSE175716	ENSG00000198369	200734	sprouty related EVH1 domain containing 2	FLJ21897|FLJ31917|Spred-2	protein_coding	Q7Z698	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22339
6.01776247440665e-61	-0.526770969377854	0.043	0.295	1.37535961352564e-56	KLHL28	Malignant cells	GSE175716	ENSG00000179454	54813	kelch like family member 28	BTBD5|FLJ20081	protein_coding	Q9NXS3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22340
8.69172216320752e-61	-0.459267001111016	0.099	0.376	1.98649310040108e-56	TNKS1BP1	Malignant cells	GSE175716	ENSG00000149115	85456	tankyrase 1 binding protein 1	FLJ45975|KIAA1741|TAB182	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22341
9.25714361360542e-61	-0.471150274523123	0.117	0.393	2.11572017288952e-56	IMPAD1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22342
9.8771233583999e-61	-0.48999242133614	0.529	0.725	2.2574165435623e-56	DDOST	Malignant cells	GSE175716	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22343
1.66363288508219e-60	-0.447627931237273	0.017	0.255	3.80223295885534e-56	PAQR5	Malignant cells	GSE175716	ENSG00000137819	54852	progestin and adipoQ receptor family member 5	FLJ20190|MPRG	protein_coding	Q9NXK6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22344
1.82224833682499e-60	0.537764299831456	0.842	0.642	4.1647485738135e-56	AL358472.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22345
1.9688462009627e-60	-0.503483049231312	0.037	0.285	4.49979799230026e-56	CCDC198	Malignant cells	GSE175716	ENSG00000100557	55195	coiled-coil domain containing 198	C14orf105|FLJ10650	protein_coding	Q9NVL8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22346
2.04023151552645e-60	-0.441162107062434	0.032	0.28	4.6629491287357e-56	TMEM92	Malignant cells	GSE175716	ENSG00000167105	162461	transmembrane protein 92	FLJ33318	protein_coding	Q6UXU6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22347
2.28152172915699e-60	-0.561805079295437	0.067	0.327	5.21441791198829e-56	SPOPL	Malignant cells	GSE175716	ENSG00000144228	339745	speckle type BTB/POZ protein like	BTBD33	protein_coding	Q6IQ16	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22348
2.50960777081076e-60	0.682329829758678	0.543	0.336	5.73570856018799e-56	ALYREF	Malignant cells	GSE175716	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22349
2.90598577545561e-60	-0.577530339631729	0.058	0.309	6.64163048980379e-56	FKBP8	Malignant cells	GSE175716	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22350
3.24961500044092e-60	0.398136837136014	0.29	0.105	7.42699508350771e-56	MGAT4B	Malignant cells	GSE175716	ENSG00000284501	11282	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GnT-Ivb	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22351
3.50378517729702e-60	-0.826633389180453	0.677	0.795	8.00790102271234e-56	GMNN	Malignant cells	GSE175716	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22352
4.42635656061689e-60	-0.49308271520567	0.046	0.299	1.01164379192899e-55	SH3RF1	Malignant cells	GSE175716	ENSG00000154447	57630	SH3 domain containing ring finger 1	KIAA1494|POSH|RNF142|SH3MD2	protein_coding	Q7Z6J0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22353
4.45408195970959e-60	-0.524545735041224	0.401	0.631	1.01798043189163e-55	CLDND1	Malignant cells	GSE175716	ENSG00000080822	56650	claudin domain containing 1	C3orf4|Z38	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22354
4.75285701401232e-60	0.759744417520584	0.561	0.372	1.08626547055252e-55	MDK	Malignant cells	GSE175716	ENSG00000110492	4192	midkine	FLJ27379|MK|NEGF2	protein_coding	P21741	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22355
5.79546534200529e-60	-0.487490345259585	0.024	0.264	1.32455360391531e-55	TSPAN1	Malignant cells	GSE175716	ENSG00000117472	10103	tetraspanin 1	NET-1|TSPAN-1	protein_coding	O60635	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22356
5.85062985139075e-60	-0.47692305581395	0.101	0.375	1.33716145253536e-55	TMF1	Malignant cells	GSE175716	ENSG00000144747	7110	TATA element modulatory factor 1	ARA160|TMF	protein_coding	P82094	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22357
5.93737437844001e-60	-0.482906713871455	0.715	0.853	1.35698691419246e-55	TMEM50A	Malignant cells	GSE175716	ENSG00000183726	23585	transmembrane protein 50A	SMP1	protein_coding	O95807	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22358
6.56901865952622e-60	-0.532542387738873	0.064	0.321	1.50134921463472e-55	NCOA2	Malignant cells	GSE175716	ENSG00000140396	10499	nuclear receptor coactivator 2	bHLHe75|GRIP1|KAT13C|NCoA-2|TIF2	protein_coding	Q15596	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22359
6.68028050780375e-60	-0.478155291499368	0.193	0.475	1.52677811005855e-55	IMP3	Malignant cells	GSE175716	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22360
6.82967046913633e-60	-0.446905421401661	0.123	0.403	1.56092118572111e-55	VHL	Malignant cells	GSE175716	ENSG00000134086	7428	von Hippel-Lindau tumor suppressor	VHL1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22361
7.2227333790478e-60	0.508750295796582	0.693	0.423	1.65075571378138e-55	FTH1P11	Malignant cells	GSE175716	ENSG00000237264	NA	NA	FTHL11	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22362
7.80818036695005e-60	-0.516583908561667	0.019	0.258	1.78455962286643e-55	OSGIN1	Malignant cells	GSE175716	ENSG00000140961	29948	oxidative stress induced growth inhibitor 1	BDGI|OKL38	protein_coding	Q9UJX0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22363
8.99627431854654e-60	-0.545538358357538	0.793	0.905	2.05609849550381e-55	TFPI	Malignant cells	GSE175716	ENSG00000003436	7035	tissue factor pathway inhibitor	EPI|LACI|TFI|TFPI1	protein_coding	P10646	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22364
1.01751664939047e-59	-0.540827581807735	0.052	0.307	2.32553430218192e-55	PLAUR	Malignant cells	GSE175716	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22365
1.1475913155874e-59	-0.508845573347213	0.016	0.253	2.62281995177501e-55	KRT7	Malignant cells	GSE175716	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22366
1.17446990670352e-59	-0.580382883189663	0.622	0.782	2.6842509717709e-55	WIPF2	Malignant cells	GSE175716	ENSG00000171475	147179	WAS/WASL interacting protein family member 2	WICH|WIRE	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22367
1.29843239365287e-59	0.591125375047121	0.884	0.732	2.96756723569362e-55	CKAP4	Malignant cells	GSE175716	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22368
1.43834346354724e-59	-0.674734990697154	0.764	0.884	3.28733398593721e-55	TMEM97	Malignant cells	GSE175716	ENSG00000109084	27346	transmembrane protein 97	σ2R|MAC30	protein_coding	Q5BJF2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22369
1.76017539406952e-59	-0.691707539291091	0.546	0.714	4.02288086314588e-55	SCARB2	Malignant cells	GSE175716	ENSG00000138760	950	scavenger receptor class B member 2	CD36L2|HLGP85|LIMP-2|LIMPII|SR-BII	protein_coding	Q14108	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22370
2.50219827025794e-59	-1.58230797278894	0.437	0.568	5.71877414667452e-55	CYBA	Malignant cells	GSE175716	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22371
2.54046743508328e-59	-0.425588815289562	0.062	0.318	5.80623832288284e-55	CASK	Malignant cells	GSE175716	ENSG00000147044	8573	calcium/calmodulin dependent serine protein kinase	CAGH39|FGS4|LIN2|TNRC8	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22372
2.71383897054761e-59	0.545325459561168	0.419	0.207	6.20247896718655e-55	CTBP1	Malignant cells	GSE175716	ENSG00000159692	1487	C-terminal binding protein 1	BARS	protein_coding	Q13363	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22373
2.82689648161153e-59	-0.462545358924522	0.129	0.411	6.46087190872315e-55	FYTTD1	Malignant cells	GSE175716	ENSG00000122068	84248	forty-two-three domain containing 1	DKFZp761B1514|UIF	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22374
2.94186157144693e-59	-0.478326126772525	0.526	0.723	6.72362462154195e-55	RPL23A	Malignant cells	GSE175716	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22375
3.01522216267293e-59	0.634197058857587	0.711	0.476	6.89129025278899e-55	HMGB3	Malignant cells	GSE175716	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22376
3.28909013775869e-59	-0.601819096457994	0.887	0.926	7.51721550984749e-55	SPCS1	Malignant cells	GSE175716	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22377
3.46558368706901e-59	-0.455622619279016	0.058	0.312	7.92059151679621e-55	BET1L	Malignant cells	GSE175716	ENSG00000177951	51272	Bet1 golgi vesicular membrane trafficking protein like	GOLIM3|GS15	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22378
3.57313053846624e-59	0.368144789599611	0.276	0.098	8.16638984566459e-55	AGAP3	Malignant cells	GSE175716	ENSG00000133612	116988	ArfGAP with GTPase domain, ankyrin repeat and PH domain 3	CENTG3	protein_coding	Q96P47	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22379
3.97913901248682e-59	-0.691229305456268	0.334	0.563	9.09432221303864e-55	MBNL2	Malignant cells	GSE175716	ENSG00000139793	10150	muscleblind like splicing regulator 2	MBLL|MBLL39	protein_coding	Q5VZF2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22380
4.68651027062871e-59	0.439603137085263	0.318	0.129	1.07110192235219e-54	BCKDHB	Malignant cells	GSE175716	ENSG00000083123	594	branched chain keto acid dehydrogenase E1 subunit beta	NA	protein_coding	P21953	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22381
5.28603064625844e-59	-0.452305035950498	0.049	0.302	1.20812230420237e-54	FGD6	Malignant cells	GSE175716	ENSG00000180263	55785	FYVE, RhoGEF and PH domain containing 6	FLJ11183|ZFYVE24	protein_coding	Q6ZV73	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22382
7.00647140192718e-59	-0.491584915368545	0.249	0.519	1.60132903891046e-54	TM2D3	Malignant cells	GSE175716	ENSG00000184277	80213	TM2 domain containing 3	BLP2|FLJ22604	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22383
1.09713590180571e-58	-0.838607858120769	0.22	0.452	2.50750410357695e-54	HLA-DMB	Malignant cells	GSE175716	ENSG00000242386	3109	major histocompatibility complex, class II, DM beta	D6S221E|RING7	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22384
1.16308678825748e-58	-0.470931120215452	0.088	0.352	2.65823485456248e-54	SGPP1	Malignant cells	GSE175716	ENSG00000285281	81537	sphingosine-1-phosphate phosphatase 1	NA	protein_coding	Q9BX95	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22385
1.36079127812692e-58	-0.427032651636588	0.058	0.312	3.11008846615907e-54	TMEM127	Malignant cells	GSE175716	ENSG00000135956	55654	transmembrane protein 127	FLJ20507|FLJ22257	protein_coding	O75204	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22386
1.55676890931835e-58	-0.70630670969159	0.03	0.269	3.55799534224708e-54	FLRT3	Malignant cells	GSE175716	ENSG00000125848	23767	fibronectin leucine rich transmembrane protein 3	NA	protein_coding	Q9NZU0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22387
2.42455598933579e-58	-0.84659097299811	0.73	0.784	5.54132271362694e-54	RPS27L	Malignant cells	GSE175716	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22388
3.29535628643927e-58	0.535210792466064	0.851	0.657	7.53153679265696e-54	CSNK2B	Malignant cells	GSE175716	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22389
3.45862265125618e-58	-0.431949443529765	0.808	0.905	7.904682069446e-54	ELOC	Malignant cells	GSE175716	ENSG00000154582	6921	elongin C	SIII|TCEB1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22390
3.67205938683672e-58	-0.931189311432061	0.268	0.506	8.39249172861532e-54	IFI6	Malignant cells	GSE175716	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22391
3.98558024715305e-58	-0.515249469765276	0.565	0.743	9.10904365486829e-54	WNK1	Malignant cells	GSE175716	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22392
4.33753459170868e-58	-0.455726282010108	0.064	0.316	9.91343530935019e-54	TLNRD1	Malignant cells	GSE175716	ENSG00000140406	59274	talin rod domain containing 1	MESDC1|MGC99595	protein_coding	Q9H1K6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22393
4.50261923682799e-58	-0.705918403213625	0.317	0.536	1.02907362657704e-53	BST2	Malignant cells	GSE175716	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22394
5.10414816019238e-58	-0.471995060886727	0.171	0.447	1.16655306201197e-53	TPD52	Malignant cells	GSE175716	ENSG00000076554	7163	tumor protein D52	D52|hD52|N8L	protein_coding	P55327	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22395
5.8014776265272e-58	0.51343190840014	0.857	0.619	1.32592771154279e-53	FIS1	Malignant cells	GSE175716	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22396
6.08256154421653e-58	-0.573188757059699	0.095	0.352	1.39016944093069e-53	ANKRD28	Malignant cells	GSE175716	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22397
1.09587444198971e-57	-0.559085185784186	0.098	0.357	2.50462103716747e-53	DDX50	Malignant cells	GSE175716	ENSG00000107625	79009	DExD-box helicase 50	GU2|GUB|MGC3199|RH-II/GuB	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22398
1.39028235412378e-57	-1.07529350256914	0.244	0.463	3.1774903203499e-53	CREB5	Malignant cells	GSE175716	ENSG00000146592	9586	cAMP responsive element binding protein 5	CRE-BPA|H_GS165L15.1	protein_coding	Q02930	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22399
1.53440794672842e-57	-1.30963036311075	0.787	0.807	3.5068893622478e-53	KRT18	Malignant cells	GSE175716	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22400
1.6446412733978e-57	-1.07459174018738	0.293	0.494	3.75882763035068e-53	MUC5B	Malignant cells	GSE175716	ENSG00000117983	727897	mucin 5B, oligomeric mucus/gel-forming	MG1|MUC5	protein_coding	Q9HC84	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22401
2.08417425203193e-57	-0.569722954929411	0.16	0.431	4.76338025301897e-53	BOD1L1	Malignant cells	GSE175716	ENSG00000038219	259282	biorientation of chromosomes in cell division 1 like 1	BOD1L|FAM44A|FLJ33215|KIAA1327	protein_coding	Q8NFC6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22402
2.1137559567843e-57	-0.464758999118472	0.103	0.372	4.83098923923053e-53	GPAT3	Malignant cells	GSE175716	ENSG00000138678	84803	glycerol-3-phosphate acyltransferase 3	AGPAT10|AGPAT9|HMFN0839|LPAAT-theta|MAG1|MGC11324	protein_coding	Q53EU6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22403
2.14669877611735e-57	0.612786696643877	0.483	0.285	4.90628005281621e-53	ACOT2	Malignant cells	GSE175716	ENSG00000119673	10965	acyl-CoA thioesterase 2	Mte1|ZAP128	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22404
2.5252247101952e-57	0.48353217804917	0.851	0.643	5.77140107515113e-53	XRCC6	Malignant cells	GSE175716	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22405
2.56159448546966e-57	-0.767330905491301	0.138	0.386	5.85452419654092e-53	FBP1	Malignant cells	GSE175716	ENSG00000165140	2203	fructose-bisphosphatase 1	FBP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22406
2.86280255078261e-57	0.500984313144274	0.811	0.619	6.54293522981367e-53	SNRPEP2	Malignant cells	GSE175716	ENSG00000256968	NA	NA	bA390F4.4|SNRPEL1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22407
2.96920747039267e-57	-0.421833494863819	0.044	0.286	6.78612367358244e-53	RALB	Malignant cells	GSE175716	ENSG00000144118	5899	RAS like proto-oncogene B	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22408
3.11264958435525e-57	-0.455832591207918	0.021	0.252	7.11396062504391e-53	ZG16B	Malignant cells	GSE175716	ENSG00000283056	124220	zymogen granule protein 16B	HRPE773|JCLN2|PRO1567	protein_coding	Q96DA0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22409
3.27956695393225e-57	0.629632215537565	0.517	0.319	7.49545027321216e-53	HDDC2	Malignant cells	GSE175716	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22410
3.31701143675854e-57	-1.08866186271973	0.283	0.485	7.58102963871163e-53	ARHGAP36	Malignant cells	GSE175716	ENSG00000147256	158763	Rho GTPase activating protein 36	FLJ30058	protein_coding	Q6ZRI8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22411
3.87216010211657e-57	-0.619277598509906	0.26	0.508	8.84982191338742e-53	MAP4K5	Malignant cells	GSE175716	ENSG00000012983	11183	mitogen-activated protein kinase kinase kinase kinase 5	GCKR|KHS|KHS1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22412
3.97850741495587e-57	0.548818701251955	0.968	0.913	9.09287869688165e-53	ARPC5	Malignant cells	GSE175716	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22413
4.50255395105072e-57	0.374592175476085	0.263	0.092	1.02905870551264e-52	KIF22	Malignant cells	GSE175716	ENSG00000079616	3835	kinesin family member 22	Kid|KNSL4|OBP-1|OBP-2	protein_coding	Q14807	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22414
5.63825072986636e-57	0.393919858962527	0.263	0.093	1.28862220431096e-52	KANK1	Malignant cells	GSE175716	ENSG00000107104	23189	KN motif and ankyrin repeat domains 1	ANKRD15|KANK|KIAA0172	protein_coding	Q14678	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22415
6.5742442793244e-57	-0.429998760798175	0.859	0.946	1.50254353003959e-52	TMEM59	Malignant cells	GSE175716	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22416
6.82571348431127e-57	-0.530744154885414	0.74	0.862	1.56001681683934e-52	SON	Malignant cells	GSE175716	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22417
9.49464186918852e-57	-0.695086771407051	0.662	0.766	2.17000039920304e-52	RALA	Malignant cells	GSE175716	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22418
9.66635777202951e-57	-0.742662286804449	0.433	0.631	2.20924606879734e-52	HIST1H2BD	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22419
1.0632768152676e-56	-0.588762599803163	0.027	0.259	2.43011916129409e-52	STC2	Malignant cells	GSE175716	ENSG00000113739	8614	stanniocalcin 2	STC-2	protein_coding	O76061	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22420
1.14448010538905e-56	-0.503370674933888	0.538	0.717	2.61570928086666e-52	PSENEN	Malignant cells	GSE175716	ENSG00000205155	55851	presenilin enhancer, gamma-secretase subunit	PEN2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22421
1.19210571721021e-56	-0.463866627879465	0.104	0.368	2.72455761668394e-52	TJP1	Malignant cells	GSE175716	ENSG00000277401	7082	tight junction protein 1	DKFZp686M05161|MGC133289|ZO-1	protein_coding	Q07157	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22422
1.49035028402304e-56	0.538067980708622	0.313	0.127	3.40619557413467e-52	SPON2	Malignant cells	GSE175716	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22423
1.57662866612201e-56	-0.370645653536554	0.026	0.258	3.60338481642185e-52	KIAA1671	Malignant cells	GSE175716	ENSG00000197077	85379	KIAA1671	NA	protein_coding	Q9BY89	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22424
1.60622287462968e-56	-0.42644552217538	0.104	0.369	3.67102237996613e-52	ZDHHC9	Malignant cells	GSE175716	ENSG00000188706	51114	zinc finger DHHC-type palmitoyltransferase 9	CGI-89|CXorf11|DHHC9|ZDHHC10|ZNF379|ZNF380	protein_coding	Q9Y397	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22425
1.68883050518293e-56	0.586622762757419	0.703	0.488	3.85982211959559e-52	TAB2	Malignant cells	GSE175716	ENSG00000055208	23118	TGF-beta activated kinase 1 (MAP3K7) binding protein 2	KIAA0733|MAP3K7IP2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22426
1.71697130286659e-56	-0.517136167995225	0.062	0.307	3.92413791270158e-52	CYB561D2	Malignant cells	GSE175716	ENSG00000114395	11068	cytochrome b561 family member D2	101F6|TSP10	protein_coding	O14569	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22427
1.93605986055989e-56	-0.464572338989637	0.056	0.303	4.42486481130964e-52	SYVN1	Malignant cells	GSE175716	ENSG00000162298	84447	synoviolin 1	DER3|HRD1	protein_coding	Q86TM6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22428
2.01690834305412e-56	-0.624197467653531	0.544	0.715	4.60964401805019e-52	PPP2R2A	Malignant cells	GSE175716	ENSG00000221914	5520	protein phosphatase 2 regulatory subunit Balpha	B55A|B55alpha|PR52A|PR55A|PR55alpha	protein_coding	P63151	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22429
2.10351847790396e-56	-0.66313400892695	0.333	0.555	4.80759148124951e-52	SPR	Malignant cells	GSE175716	ENSG00000116096	6697	sepiapterin reductase	SDR38C1	protein_coding	P35270	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22430
2.94736069520869e-56	-0.645528666747298	0.113	0.366	6.73619286889946e-52	RCN1	Malignant cells	GSE175716	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22431
2.96572834092118e-56	-0.604745471339624	0.41	0.625	6.77817212317536e-52	KIF21A	Malignant cells	GSE175716	ENSG00000139116	55605	kinesin family member 21A	FEOM1|FLJ20052	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22432
3.39785657916744e-56	0.489094842031676	0.97	0.868	7.76580121168718e-52	WAC	Malignant cells	GSE175716	ENSG00000095787	51322	WW domain containing adaptor with coiled-coil	BM-016|FLJ31290|MGC10753|PRO1741|Wwp4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22433
3.46612608520133e-56	-0.675564874960497	0.24	0.484	7.92183116772764e-52	RAP2B	Malignant cells	GSE175716	ENSG00000181467	5912	RAP2B, member of RAS oncogene family	NA	protein_coding	P61225	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22434
5.11843314103667e-56	-0.603954756697898	0.591	0.733	1.16981789438393e-51	CD151	Malignant cells	GSE175716	ENSG00000177697	977	CD151 molecule (Raph blood group)	PETA-3|RAPH|SFA-1|TSPAN24	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22435
6.38231576436452e-56	-0.407932282738533	0.029	0.26	1.45867826794551e-51	SH2D4A	Malignant cells	GSE175716	ENSG00000104611	63898	SH2 domain containing 4A	FLJ20967|PPP1R38|SH2A	protein_coding	Q9H788	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22436
7.34267081605426e-56	0.659678410895051	0.528	0.331	1.6781674150092e-51	SRSF6	Malignant cells	GSE175716	ENSG00000124193	6431	serine and arginine rich splicing factor 6	B52|SFRS6|SRP55	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22437
7.88079551171578e-56	-0.517810447073788	0.149	0.415	1.80115581420264e-51	TMEM64	Malignant cells	GSE175716	ENSG00000180694	169200	transmembrane protein 64	DKFZp762C1112	protein_coding	Q6YI46	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22438
8.38318326317372e-56	-0.519741392148078	0.34	0.579	1.91597653479835e-51	IQGAP2	Malignant cells	GSE175716	ENSG00000145703	10788	IQ motif containing GTPase activating protein 2	NA	protein_coding	Q13576	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22439
8.47905080969289e-56	0.461280889031992	0.816	0.574	1.93788706255531e-51	LSM4	Malignant cells	GSE175716	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22440
9.49080738386991e-56	-0.423101664536919	0.109	0.373	2.16912402758347e-51	GNPNAT1	Malignant cells	GSE175716	ENSG00000100522	64841	glucosamine-phosphate N-acetyltransferase 1	FLJ10607|Gpnat1	protein_coding	Q96EK6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22441
9.66965970666893e-56	-0.510885143121545	0.129	0.393	2.21000072595918e-51	SMAP2	Malignant cells	GSE175716	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22442
1.00768889689832e-55	-0.49757844343822	0.059	0.301	2.3030729738611e-51	IL1RAP	Malignant cells	GSE175716	ENSG00000196083	3556	interleukin 1 receptor accessory protein	C3orf13|IL-1RAcP|IL1R3	protein_coding	Q9NPH3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22443
1.06478788896711e-55	-0.435765658838867	0.028	0.258	2.43357272023433e-51	B3GNT2	Malignant cells	GSE175716	ENSG00000170340	10678	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	B3GN-T1|B3GN-T2|B3GNT-2|B3GNT1|BETA3GNT	protein_coding	Q9NY97	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22444
1.19963453790806e-55	0.681618745715564	0.577	0.403	2.74176473638888e-51	C1QBP	Malignant cells	GSE175716	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22445
1.22575300186228e-55	-0.547910299601029	0.126	0.385	2.80145848575625e-51	DRAP1	Malignant cells	GSE175716	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22446
1.36112682714059e-55	-1.16229970524244	0.317	0.515	3.11085536342982e-51	PLK2	Malignant cells	GSE175716	ENSG00000145632	10769	polo like kinase 2	SNK	protein_coding	Q9NYY3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22447
1.41071022210545e-55	0.540701034764239	0.91	0.78	3.22417821262201e-51	STAU1	Malignant cells	GSE175716	ENSG00000124214	6780	staufen double-stranded RNA binding protein 1	PPP1R150|STAU	protein_coding	O95793	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22448
1.48153938622984e-55	-0.398068040715078	0.144	0.418	3.38605826722829e-51	TMEM9B	Malignant cells	GSE175716	ENSG00000175348	56674	TMEM9 domain family member B	C11orf15	protein_coding	Q9NQ34	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22449
1.74043714473148e-55	-0.518502447560363	0.283	0.535	3.97776909428379e-51	LPP	Malignant cells	GSE175716	ENSG00000145012	4026	LIM domain containing preferred translocation partner in lipoma	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22450
1.77488623025256e-55	-0.539854490899476	0.154	0.416	4.05650247924223e-51	YIPF4	Malignant cells	GSE175716	ENSG00000119820	84272	Yip1 domain family member 4	FinGER4|MGC11061	protein_coding	Q9BSR8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22451
1.97659731017881e-55	-0.80151137752471	0.432	0.63	4.51751315241366e-51	PFKFB3	Malignant cells	GSE175716	ENSG00000170525	5209	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	NA	protein_coding	Q16875	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22452
2.12575866565842e-55	0.391856726985524	0.288	0.11	4.85842143036231e-51	REEP6	Malignant cells	GSE175716	ENSG00000115255	92840	receptor accessory protein 6	C19orf32|DP1L1|FLJ25383|Yip2f	protein_coding	Q96HR9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22453
2.13757421745293e-55	-0.412525028356773	0.074	0.324	4.88542587398867e-51	CREB3	Malignant cells	GSE175716	ENSG00000107175	10488	cAMP responsive element binding protein 3	Luman|LZIP|sLZIP	protein_coding	O43889	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22454
2.61418654363214e-55	-0.504992737321316	0.197	0.465	5.97472334547124e-51	AFMID	Malignant cells	GSE175716	ENSG00000183077	125061	arylformamidase	DKFZp686F03259|KF	protein_coding	Q63HM1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22455
3.39729174826949e-55	-0.501075454633404	0.7	0.824	7.76451029066993e-51	TMEM14A	Malignant cells	GSE175716	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22456
3.39766954262791e-55	-0.415022627221889	0.629	0.797	7.76537373967609e-51	TFG	Malignant cells	GSE175716	ENSG00000114354	10342	trafficking from ER to golgi regulator	FLJ36137|SPG57|TF6	protein_coding	Q92734	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22457
3.45292166579421e-55	0.313531463334269	0.261	0.092	7.89165246717267e-51	AC090114.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22458
3.90904460125256e-55	-0.428921669853052	0.856	0.935	8.93412143616274e-51	TMED2	Malignant cells	GSE175716	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22459
4.12616672584859e-55	0.436474936400755	0.293	0.114	9.43035405192695e-51	GLDC	Malignant cells	GSE175716	ENSG00000178445	2731	glycine decarboxylase	GCSP|NKH	protein_coding	P23378	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22460
4.62496507891371e-55	-0.486705946268311	0.554	0.743	1.05703576878573e-50	ZNF24	Malignant cells	GSE175716	ENSG00000172466	7572	zinc finger protein 24	KOX17|Zfp191|ZNF191|ZSCAN3	protein_coding	P17028	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22461
5.59450454249316e-55	-0.433326281176471	0.09	0.341	1.27862401318681e-50	BLZF1	Malignant cells	GSE175716	ENSG00000117475	8548	basic leucine zipper nuclear factor 1	JEM-1	protein_coding	Q9H2G9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22462
6.52883869041459e-55	-0.475509373789003	0.08	0.327	1.49216608269425e-50	PANX1	Malignant cells	GSE175716	ENSG00000110218	24145	pannexin 1	MRS1|PX1|UNQ2529	protein_coding	Q96RD7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22463
6.86896968812921e-55	-0.543175067270127	0.746	0.864	1.56990302222193e-50	SRRM2	Malignant cells	GSE175716	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22464
8.35475252762033e-55	-0.48658239227036	0.198	0.466	1.90947869018763e-50	SYNJ2	Malignant cells	GSE175716	ENSG00000078269	8871	synaptojanin 2	INPP5H	protein_coding	O15056	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22465
9.98212689099519e-55	-0.453548363469275	0.12	0.38	2.28141510093695e-50	ZBTB41	Malignant cells	GSE175716	ENSG00000177888	360023	zinc finger and BTB domain containing 41	DKFZp686C06120|FLJ36199|FRBZ1|ZNF924	protein_coding	Q5SVQ8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22466
1.01941259948889e-54	-0.42552923121066	0.117	0.377	2.32986749613186e-50	CISD2	Malignant cells	GSE175716	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22467
1.08532448925964e-54	-0.539993827382413	0.088	0.338	2.4805091202029e-50	NR4A2	Malignant cells	GSE175716	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22468
1.1132886454553e-54	-0.53354451340727	0.606	0.749	2.54442119918808e-50	ANAPC16	Malignant cells	GSE175716	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22469
1.14583628416887e-54	-0.471316692959671	0.031	0.261	2.61880882746794e-50	CASC19	Malignant cells	GSE175716	ENSG00000254166	103164619	prostate cancer associated transcript 2	CARLo-6|LINC01245	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22470
1.19415281829763e-54	-0.632162299090183	0.396	0.596	2.72923626621923e-50	VEZT	Malignant cells	GSE175716	ENSG00000028203	55591	vezatin, adherens junctions transmembrane protein	DKFZP761C241	protein_coding	Q9HBM0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22471
1.22138492334836e-54	0.424940708107902	1	0.998	2.79147524231268e-50	RPS21	Malignant cells	GSE175716	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22472
1.22903575683252e-54	0.639127634483533	0.953	0.789	2.80896122224073e-50	HSPA1B	Malignant cells	GSE175716	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22473
1.46674727238128e-54	-0.476541586187172	0.122	0.385	3.3522508910274e-50	SNX1	Malignant cells	GSE175716	ENSG00000028528	6642	sorting nexin 1	HsT17379|MGC8664|SNX1A|Vps5	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22474
1.49505385600743e-54	0.524823043643084	0.342	0.153	3.41694558790497e-50	DSN1	Malignant cells	GSE175716	ENSG00000149636	79980	DSN1 component of MIS12 kinetochore complex	C20orf172|dJ469A13.2|hKNL-3|KNL3|MIS13	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22475
1.62332990379723e-54	-0.39639541302898	0.067	0.311	3.71012049512857e-50	INTS10	Malignant cells	GSE175716	ENSG00000104613	55174	integrator complex subunit 10	C8orf35|FLJ10569|INT10	protein_coding	Q9NVR2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22476
1.74618900135497e-54	-1.12187227975777	0.894	0.951	3.99091496259679e-50	PERP	Malignant cells	GSE175716	ENSG00000112378	64065	p53 apoptosis effector related to PMP22	dJ496H19.1|KCP1|KRTCAP1|PIGPC1|THW	protein_coding	Q96FX8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22477
1.86344287292436e-54	-0.471675866424263	0.046	0.28	4.25889868606862e-50	ANKRD50	Malignant cells	GSE175716	ENSG00000151458	57182	ankyrin repeat domain containing 50	KIAA1223	protein_coding	Q9ULJ7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22478
1.91205357369425e-54	0.673402626513243	0.578	0.395	4.36999844267821e-50	COQ8A	Malignant cells	GSE175716	ENSG00000163050	56997	coenzyme Q8A	ADCK3|CABC1|COQ8|SCAR9	protein_coding	Q8NI60	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22479
1.99481065759473e-54	-0.57296090030626	0.362	0.588	4.55913975793274e-50	AFTPH	Malignant cells	GSE175716	ENSG00000119844	54812	aftiphilin	FLJ20080|FLJ23793|MGC33965|Nbla10388	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22480
2.15283343736321e-54	-0.556241029025875	0.802	0.908	4.92030082109362e-50	CCDC47	Malignant cells	GSE175716	ENSG00000108588	57003	coiled-coil domain containing 47	GK001	protein_coding	Q96A33	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22481
2.44775036346119e-54	-0.749148232464718	0.168	0.412	5.59433345569056e-50	PRRG4	Malignant cells	GSE175716	ENSG00000135378	79056	proline rich and Gla domain 4	TMG4	protein_coding	Q9BZD6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22482
3.68606850266054e-54	-0.539210408150736	0.744	0.85	8.42450956283067e-50	JPT1	Malignant cells	GSE175716	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22483
3.94715469772444e-54	-1.12033599362106	0.46	0.589	9.02122206164922e-50	MED10	Malignant cells	GSE175716	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22484
3.98898333818782e-54	0.485560915820759	0.868	0.622	9.11682141942826e-50	ECHS1	Malignant cells	GSE175716	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22485
4.14105186344083e-54	-0.556709076863644	0.505	0.677	9.46437403389401e-50	EMC4	Malignant cells	GSE175716	ENSG00000128463	51234	ER membrane protein complex subunit 4	FLJ90746|MGC24415|PIG17|TMEM85	protein_coding	Q5J8M3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22486
4.64501476104782e-54	-0.500103353477178	0.606	0.75	1.06161812363748e-49	GTF2A2	Malignant cells	GSE175716	ENSG00000140307	2958	general transcription factor IIA subunit 2	HsT18745|TFIIA	protein_coding	P52657	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22487
5.23732741306485e-54	-0.469710372862146	0.15	0.416	1.19699118025597e-49	CCDC25	Malignant cells	GSE175716	ENSG00000147419	55246	coiled-coil domain containing 25	FLJ10853	protein_coding	Q86WR0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22488
5.61208948509726e-54	-0.448863533631788	0.101	0.353	1.28264305181898e-49	CCDC12	Malignant cells	GSE175716	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22489
6.086579628804e-54	-0.539379483209837	0.566	0.734	1.39108777416315e-49	ROCK1	Malignant cells	GSE175716	ENSG00000067900	6093	Rho associated coiled-coil containing protein kinase 1	p160ROCK	protein_coding	Q13464	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22490
7.16174550632142e-54	-0.512599891351327	0.151	0.413	1.63681693546976e-49	LAMTOR3	Malignant cells	GSE175716	ENSG00000109270	8649	late endosomal/lysosomal adaptor, MAPK and MTOR activator 3	MAP2K1IP1|MAPBP|MAPKSP1|MP1|Ragulator3	protein_coding	Q9UHA4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22491
7.78376824047832e-54	-0.372859930223934	0.035	0.264	1.77898023136132e-49	ATP8B1	Malignant cells	GSE175716	ENSG00000081923	5205	ATPase phospholipid transporting 8B1	ATPIC|BRIC|FIC1|PFIC|PFIC1	protein_coding	O43520	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22492
9.34464970571143e-54	0.499824809249922	0.375	0.18	2.13571969024035e-49	HSPA14	Malignant cells	GSE175716	ENSG00000187522	51182	heat shock protein family A (Hsp70) member 14	HSP70-4|HSP70L1	protein_coding	Q0VDF9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22493
1.0084472910251e-53	-0.514957100721639	0.66	0.805	2.30480628363786e-49	AIG1	Malignant cells	GSE175716	ENSG00000146416	51390	androgen induced 1	AIG-1|dJ95L4.1|FLJ10485	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22494
1.35731841675463e-53	0.671065594816702	0.618	0.425	3.10215124149271e-49	MCM7	Malignant cells	GSE175716	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22495
1.43531825096447e-53	-0.419072569519512	0.132	0.392	3.2804198625793e-49	NFE2L1	Malignant cells	GSE175716	ENSG00000082641	4779	NFE2 like bZIP transcription factor 1	FLJ00380|LCR-F1|NRF-1|NRF1|TCF11	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22496
1.44480768689261e-53	0.546071708860028	0.855	0.688	3.30210796839305e-49	H2AFY	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22497
1.44600964297119e-53	-1.00083869858379	0.307	0.499	3.30485503901066e-49	ISG20	Malignant cells	GSE175716	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22498
1.6470591629294e-53	0.695724229404212	0.926	0.766	3.76435371687513e-49	DNAJB1	Malignant cells	GSE175716	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22499
1.9188349063485e-53	0.394454047848482	0.886	0.7	4.3854971784595e-49	BNIP3	Malignant cells	GSE175716	ENSG00000176171	664	BCL2 interacting protein 3	HABON|Nip3	protein_coding	Q12983	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22500
1.9506872415212e-53	0.414044648301269	0.314	0.131	4.45829569049671e-49	CPSF3	Malignant cells	GSE175716	ENSG00000119203	51692	cleavage and polyadenylation specific factor 3	CPSF-73|CPSF73|YSH1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22501
2.18797086850917e-53	-0.411744894011416	0.126	0.385	5.00060741997772e-49	IER3IP1	Malignant cells	GSE175716	ENSG00000134049	51124	immediate early response 3 interacting protein 1	NA	protein_coding	Q9Y5U9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22502
2.73821618291027e-53	-0.466012679403962	0.051	0.282	6.25819308604142e-49	IFI35	Malignant cells	GSE175716	ENSG00000068079	3430	interferon induced protein 35	IFP35	protein_coding	P80217	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22503
2.75965513950631e-53	-0.451462876698125	0.236	0.498	6.30719182134166e-49	NSD3	Malignant cells	GSE175716	ENSG00000147548	54904	nuclear receptor binding SET domain protein 3	FLJ20353|KMT3F|WHISTLE|WHSC1L1	protein_coding	Q9BZ95	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22504
2.87202319902154e-53	0.555289290519533	0.409	0.203	6.56400902136374e-49	AMIGO2	Malignant cells	GSE175716	ENSG00000139211	347902	adhesion molecule with Ig like domain 2	ALI1|DEGA	protein_coding	Q86SJ2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22505
2.89530544579016e-53	-1.27874107455972	0.867	0.888	6.6172205963534e-49	BTG1	Malignant cells	GSE175716	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22506
3.67537095980524e-53	-0.371620194728782	0.034	0.259	8.40006032863488e-49	RTKN	Malignant cells	GSE175716	ENSG00000114993	6242	rhotekin	B5	protein_coding	Q9BST9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22507
3.93064031389092e-53	-0.407661523919629	0.043	0.274	8.9834784373977e-49	GLIS3	Malignant cells	GSE175716	ENSG00000107249	169792	GLIS family zinc finger 3	MGC33662|ZNF515	protein_coding	Q8NEA6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22508
4.07645656886523e-53	-0.810947580493281	0.961	0.97	9.31674148814148e-49	HSPA8	Malignant cells	GSE175716	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22509
7.7790977132228e-53	0.62197212844381	0.415	0.217	1.77791278235707e-48	FOXA2	Malignant cells	GSE175716	ENSG00000125798	3170	forkhead box A2	HNF3B	protein_coding	Q9Y261	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22510
8.06747028331876e-53	-0.422952038009256	0.076	0.317	1.8438203332525e-48	ADPRHL2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22511
8.22377459004452e-53	-0.511272388300315	0.073	0.312	1.87954368255467e-48	PFN1P1	Malignant cells	GSE175716	ENSG00000233328	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22512
1.0045206429965e-52	-0.430399780642868	0.104	0.355	2.2958319295685e-48	PTPN14	Malignant cells	GSE175716	ENSG00000152104	5784	protein tyrosine phosphatase non-receptor type 14	PEZ|PTPD2	protein_coding	Q15678	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22513
1.83791084080276e-52	-0.501847654479845	0.185	0.443	4.20054522665471e-48	AP1M2	Malignant cells	GSE175716	ENSG00000129354	10053	adaptor related protein complex 1 subunit mu 2	AP1-mu2|HSMU1B|mu2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22514
1.89697524105911e-52	-0.496931359600845	0.154	0.411	4.33553691344059e-48	HIPK3	Malignant cells	GSE175716	ENSG00000110422	10114	homeodomain interacting protein kinase 3	DYRK6|FIST3|PKY|YAK1	protein_coding	Q9H422	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22515
1.94031458504905e-52	-0.617903468160986	0.105	0.348	4.43458898412959e-48	FKBP4	Malignant cells	GSE175716	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22516
2.13702515333088e-52	-0.489800178308845	0.158	0.415	4.88417098793772e-48	TMEM263	Malignant cells	GSE175716	ENSG00000151135	90488	transmembrane protein 263	C12orf23|MGC17943	protein_coding	Q8WUH6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22517
2.18166785211469e-52	-0.487657101321172	0.137	0.391	4.98620187600812e-48	ATRX	Malignant cells	GSE175716	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22518
2.47065821353669e-52	-0.440315374714168	0.091	0.335	5.6466893470381e-48	ERCC1	Malignant cells	GSE175716	ENSG00000012061	2067	ERCC excision repair 1, endonuclease non-catalytic subunit	RAD10	protein_coding	P07992	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22519
2.55505168643604e-52	-0.402879835756656	0.079	0.32	5.83957062934957e-48	PKP2	Malignant cells	GSE175716	ENSG00000057294	5318	plakophilin 2	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22520
2.62965178227932e-52	-0.411545716047604	0.12	0.376	6.01006914839938e-48	PCGF5	Malignant cells	GSE175716	ENSG00000180628	84333	polycomb group ring finger 5	MGC16202|RNF159	protein_coding	Q86SE9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22521
2.73595599158238e-52	-0.447742650406999	0.127	0.38	6.25302741876153e-48	HCCS	Malignant cells	GSE175716	ENSG00000004961	3052	holocytochrome c synthase	CCHL|MLS	protein_coding	P53701	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22522
2.86363422469959e-52	-0.59210762765817	0.311	0.528	6.54483602055091e-48	CTSS	Malignant cells	GSE175716	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22523
2.96692224081849e-52	-0.454461026452562	0.214	0.479	6.78090078139067e-48	SPTY2D1	Malignant cells	GSE175716	ENSG00000179119	144108	SPT2 chromatin protein domain containing 1	DKFZp686I068|FLJ39441|Spt2	protein_coding	Q68D10	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22524
4.13138546129062e-52	-0.521392081013656	0.076	0.313	9.44228147177972e-48	ARL13B	Malignant cells	GSE175716	ENSG00000169379	200894	ADP ribosylation factor like GTPase 13B	ARL2L1|DKFZp761H079|JBTS8	protein_coding	Q3SXY8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22525
4.20527018764693e-52	0.647624132180258	0.572	0.391	9.61114501386706e-48	LAPTM4B	Malignant cells	GSE175716	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22526
4.27741266046554e-52	-0.466122367168315	0.043	0.268	9.77602663549399e-48	HOOK3	Malignant cells	GSE175716	ENSG00000168172	84376	hook microtubule tethering protein 3	HK3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22527
4.65802732849023e-52	-0.671526652821187	0.45	0.646	1.06459214592644e-47	DUSP5	Malignant cells	GSE175716	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22528
4.8626352402725e-52	-0.459635494554277	0.435	0.646	1.11135528416428e-47	RELA	Malignant cells	GSE175716	ENSG00000173039	5970	RELA proto-oncogene, NF-kB subunit	NFKB3|p65	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22529
4.86336137159166e-52	-0.847107372675667	0.4	0.568	1.11152124147727e-47	C19orf33	Malignant cells	GSE175716	ENSG00000167644	64073	chromosome 19 open reading frame 33	H2RSP|IMUP|IMUP-1|IMUP-2	protein_coding	Q9GZP8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22530
5.1380280473593e-52	-0.496569695871774	0.153	0.409	1.17429631022397e-47	MED13L	Malignant cells	GSE175716	ENSG00000123066	23389	mediator complex subunit 13L	KIAA1025|THRAP2|TRAP240L	protein_coding	Q71F56	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22531
5.26482741226752e-52	0.413029179892861	0.32	0.137	1.20327630507374e-47	EPB41L1	Malignant cells	GSE175716	ENSG00000088367	2036	erythrocyte membrane protein band 4.1 like 1	4.1N|KIAA0338	protein_coding	Q9H4G0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22532
5.62534451161832e-52	-0.490777254465256	0.382	0.606	1.28567248813037e-47	BIRC2	Malignant cells	GSE175716	ENSG00000110330	329	baculoviral IAP repeat containing 2	API1|c-IAP1|cIAP1|hiap-2|MIHB|RNF48	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22533
5.9078821733217e-52	-0.496158375679955	0.147	0.401	1.35024647071267e-47	EDEM3	Malignant cells	GSE175716	ENSG00000116406	80267	ER degradation enhancing alpha-mannosidase like protein 3	C1orf22	protein_coding	Q9BZQ6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22534
6.29765736951365e-52	-0.5787918563727	0.032	0.25	1.43932959180234e-47	PLCXD1	Malignant cells	GSE175716	ENSG00000182378	55344	phosphatidylinositol specific phospholipase C X domain containing 1	FLJ11323	protein_coding	Q9NUJ7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22535
6.41130071261171e-52	-0.594440311546207	0.911	0.929	1.46530277786741e-47	AC005912.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22536
6.50065456477872e-52	-0.429318297977692	0.066	0.301	1.48572460078018e-47	PRKAB2	Malignant cells	GSE175716	ENSG00000131791	5565	protein kinase AMP-activated non-catalytic subunit beta 2	NA	protein_coding	O43741	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22537
6.91057727209451e-52	-0.681443439331815	0.271	0.487	1.5794124355372e-47	CARD6	Malignant cells	GSE175716	ENSG00000132357	84674	caspase recruitment domain family member 6	CINCIN1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22538
6.91151084470563e-52	-0.421837561633377	0.204	0.469	1.57962580355747e-47	HNRNPH2	Malignant cells	GSE175716	ENSG00000126945	3188	heterogeneous nuclear ribonucleoprotein H2	FTP3|hnRNPH'|HNRPH'|HNRPH2	protein_coding	P55795	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22539
7.02275131852297e-52	-0.430023952684903	0.126	0.386	1.60504981384843e-47	ETV3	Malignant cells	GSE175716	ENSG00000117036	2117	ETS variant transcription factor 3	PE-1	protein_coding	P41162	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22540
7.30430868329331e-52	-0.560957991659056	0.108	0.354	1.66939974956669e-47	TIFA	Malignant cells	GSE175716	ENSG00000145365	92610	TRAF interacting protein with forkhead associated domain	MGC20791|T2BP|T6BP|TIFAA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22541
8.7086629171672e-52	-0.408880844768311	0.045	0.271	1.99036490971856e-47	AGPAT5	Malignant cells	GSE175716	ENSG00000284980	55326	1-acylglycerol-3-phosphate O-acyltransferase 5	FLJ11210|LPAAT-e|LPAAT-epsilon|LPLAT5	protein_coding	Q9NUQ2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22542
1.03023859176014e-51	-0.45107420047266	0.203	0.465	2.3546103014678e-47	GCH1	Malignant cells	GSE175716	ENSG00000131979	2643	GTP cyclohydrolase 1	DYT14|DYT5|DYT5a|GCH|GTPCH1	protein_coding	P30793	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22543
1.20853707277322e-51	0.685892496317085	0.568	0.397	2.76211147982318e-47	GGCT	Malignant cells	GSE175716	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22544
1.36681124672607e-51	-0.475696613476322	0.113	0.36	3.12384710439243e-47	GSKIP	Malignant cells	GSE175716	ENSG00000100744	51527	GSK3B interacting protein	C14orf129	protein_coding	Q9P0R6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22545
1.45931024970733e-51	0.608006164323543	0.456	0.248	3.3352535757061e-47	PFKP	Malignant cells	GSE175716	ENSG00000067057	5214	phosphofructokinase, platelet	PFK-C|PFKF	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22546
1.5811170590835e-51	-0.498321515641984	0.23	0.482	3.61364303853534e-47	FEM1B	Malignant cells	GSE175716	ENSG00000169018	10116	fem-1 homolog B	NA	protein_coding	Q9UK73	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22547
1.99537549693407e-51	-0.454670979584941	0.038	0.26	4.56043069824282e-47	CREB3L1	Malignant cells	GSE175716	ENSG00000157613	90993	cAMP responsive element binding protein 3 like 1	OASIS	protein_coding	Q96BA8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22548
1.9996809326521e-51	-0.422241839211859	0.118	0.369	4.57027077157638e-47	CCSER2	Malignant cells	GSE175716	ENSG00000107771	54462	coiled-coil serine rich protein 2	FAM190B|KIAA1128	protein_coding	Q9H7U1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22549
2.09355622987106e-51	-0.443120340267633	0.175	0.438	4.78482276337031e-47	KRAS	Malignant cells	GSE175716	ENSG00000133703	3845	KRAS proto-oncogene, GTPase	K-Ras4B|KRAS1|KRAS2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22550
2.11314737221919e-51	-0.461635854624705	0.681	0.818	4.82959831920696e-47	DPY30	Malignant cells	GSE175716	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22551
2.18126502919223e-51	-0.511035694211413	0.09	0.332	4.98528122421884e-47	VCPIP1	Malignant cells	GSE175716	ENSG00000175073	80124	valosin containing protein interacting protein 1	DUBA3|FLJ23132|KIAA1850|VCIP135	protein_coding	Q96JH7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22552
2.22909770670474e-51	-0.435750249016263	0.086	0.329	5.09460280867369e-47	FRS2	Malignant cells	GSE175716	ENSG00000166225	10818	fibroblast growth factor receptor substrate 2	FRS2A|FRS2alpha|SNT-1|SNT1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22553
2.34399294944611e-51	-0.436129565234086	0.056	0.283	5.35719588595908e-47	HDHD3	Malignant cells	GSE175716	ENSG00000119431	81932	haloacid dehalogenase like hydrolase domain containing 3	C9orf158|MGC12904	protein_coding	Q9BSH5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22554
2.75867253680147e-51	-0.404368822620352	0.122	0.375	6.30494608285976e-47	CDC42EP1	Malignant cells	GSE175716	ENSG00000128283	11135	CDC42 effector protein 1	Borg5|CEP1|MSE55	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22555
2.8446187632173e-51	-0.642458426032428	0.52	0.685	6.50137618333314e-47	RBBP8	Malignant cells	GSE175716	ENSG00000101773	5932	RB binding protein 8, endonuclease	COM1|CtIP|RIM|SCKL2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22556
3.79227504974647e-51	-0.604260118133316	0.495	0.666	8.66724462619556e-47	NFIC	Malignant cells	GSE175716	ENSG00000141905	4782	nuclear factor I C	CTF|CTF5|NF-I|NFI	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22557
3.99395438440643e-51	-0.475943297946379	0.098	0.341	9.12818274556089e-47	C11orf24	Malignant cells	GSE175716	ENSG00000171067	53838	chromosome 11 open reading frame 24	DM4E3	protein_coding	Q96F05	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22558
4.76176471283998e-51	-0.386992673402446	0.071	0.307	1.08830132511958e-46	MBD1	Malignant cells	GSE175716	ENSG00000141644	4152	methyl-CpG binding domain protein 1	CXXC3|PCM1	protein_coding	Q9UIS9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22559
4.98832173370844e-51	0.533548341552786	0.887	0.717	1.14008093223906e-46	MRPL13	Malignant cells	GSE175716	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22560
6.10774639772361e-51	-0.409477088295767	0.106	0.356	1.39592543919973e-46	OSBP	Malignant cells	GSE175716	ENSG00000110048	5007	oxysterol binding protein	OSBP1	protein_coding	P22059	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22561
6.31335077418248e-51	-0.477039368950127	0.088	0.323	1.44291631943941e-46	IRF3	Malignant cells	GSE175716	ENSG00000126456	3661	interferon regulatory factor 3	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22562
6.6241980990863e-51	0.418593981302083	0.373	0.172	1.51396047554617e-46	CSAG1	Malignant cells	GSE175716	ENSG00000198930	158511	chondrosarcoma associated gene 1	CSAGE|CT24.1	protein_coding	Q6PB30	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22563
7.47182696471033e-51	-0.488685287917272	0.493	0.675	1.70768605278455e-46	TSPAN13	Malignant cells	GSE175716	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22564
9.05626084659621e-51	0.293991772179917	1	1	2.06980841648956e-46	MT-CYB	Malignant cells	GSE175716	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22565
1.01858730219441e-50	0.341606533349751	0.253	0.092	2.32798127916533e-46	DUSP22	Malignant cells	GSE175716	ENSG00000112679	56940	dual specificity phosphatase 22	JKAP|JSP1|MKPX|VHX	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22566
1.0200658968315e-50	-0.460296594050995	0.141	0.389	2.33136060720838e-46	POP5	Malignant cells	GSE175716	ENSG00000167272	51367	POP5 homolog, ribonuclease P/MRP subunit	NA	protein_coding	Q969H6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22567
1.09639092097764e-50	0.58167299217942	0.515	0.336	2.50580144989441e-46	RPL37AP1	Malignant cells	GSE175716	ENSG00000226243	NA	NA	dJ1013A22.4	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22568
1.16945130410542e-50	0.546867553635451	0.445	0.253	2.67278095553295e-46	MLLT10	Malignant cells	GSE175716	ENSG00000078403	8028	MLLT10 histone lysine methyltransferase DOT1L cofactor	AF10	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22569
1.1901524143395e-50	0.40986889910684	0.98	0.721	2.72009334297293e-46	COX5B	Malignant cells	GSE175716	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22570
1.2590218770252e-50	-0.628375453914247	0.454	0.635	2.87749449994109e-46	PROCR	Malignant cells	GSE175716	ENSG00000101000	10544	protein C receptor	CCD41|CD201|EPCR	protein_coding	Q9UNN8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22571
1.35742596494128e-50	-0.529330627991487	0.122	0.363	3.10239704287331e-46	SRA1	Malignant cells	GSE175716	ENSG00000213523	10011	steroid receptor RNA activator 1	SRA|STRAA1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22572
1.41933764546379e-50	-0.438283646750766	0.056	0.281	3.24389618870749e-46	POLR3A	Malignant cells	GSE175716	ENSG00000148606	11128	RNA polymerase III subunit A	C160|hRPC155|RPC1|RPC155	protein_coding	O14802	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22573
1.45851285089169e-50	-0.426993721080364	0.07	0.302	3.33343112071295e-46	VPS13C	Malignant cells	GSE175716	ENSG00000129003	54832	vacuolar protein sorting 13 homolog C	BLTP5C|FLJ10381|FLJ20136|KIAA1421	protein_coding	Q709C8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22574
1.47857552108282e-50	-0.526486815693833	0.128	0.368	3.37928435343478e-46	SEC61A1	Malignant cells	GSE175716	ENSG00000058262	29927	SEC61 translocon subunit alpha 1	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22575
1.54525415837337e-50	0.486473968880892	0.398	0.204	3.53167837896233e-46	SUGT1	Malignant cells	GSE175716	ENSG00000165416	10910	SGT1 homolog, MIS12 kinetochore complex assembly cochaperone	SGT1	protein_coding	Q9Y2Z0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22576
1.60284485305849e-50	-0.496147009025663	0.109	0.35	3.66330191166519e-46	TMEM9	Malignant cells	GSE175716	ENSG00000116857	252839	transmembrane protein 9	TMEM9A	protein_coding	Q9P0T7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22577
1.74616280889089e-50	-0.431955806815236	0.112	0.36	3.99085509972013e-46	RNF168	Malignant cells	GSE175716	ENSG00000163961	165918	ring finger protein 168	FLJ35794	protein_coding	Q8IYW5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22578
1.75302928070374e-50	-0.438477139071445	0.063	0.292	4.0065484210484e-46	LEMD3	Malignant cells	GSE175716	ENSG00000174106	23592	LEM domain containing 3	MAN1	protein_coding	Q9Y2U8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22579
2.07342791217404e-50	0.639783628698047	0.515	0.336	4.73881949327378e-46	SUN1	Malignant cells	GSE175716	ENSG00000164828	23353	Sad1 and UNC84 domain containing 1	FLJ12407|KIAA0810|UNC84A	protein_coding	O94901	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22580
2.56846821007929e-50	-0.44897625034611	0.057	0.284	5.87023409413621e-46	CCDC186	Malignant cells	GSE175716	ENSG00000165813	55088	coiled-coil domain containing 186	C10orf118|CCCP-1|FLJ10188|FLJ35301|golgin104	protein_coding	Q7Z3E2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22581
2.75407563953376e-50	-0.538568196839509	0.033	0.251	6.2944398741544e-46	S100A14	Malignant cells	GSE175716	ENSG00000189334	57402	S100 calcium binding protein A14	BCMP84|S100A15	protein_coding	Q9HCY8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22582
2.83565025381763e-50	-0.407047303384383	0.099	0.339	6.4808786551002e-46	RNF141	Malignant cells	GSE175716	ENSG00000110315	50862	ring finger protein 141	ZFP26|ZNF230	protein_coding	Q8WVD5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22583
3.13295677290111e-50	0.514567712430237	0.875	0.7	7.16037270446548e-46	SF3B5	Malignant cells	GSE175716	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22584
3.19220960950539e-50	-0.433714271345599	0.217	0.472	7.29579506252457e-46	CDK7	Malignant cells	GSE175716	ENSG00000277273	1022	cyclin dependent kinase 7	CAK|CAK1|CDKN7|MO15|STK1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22585
3.41399954751427e-50	-1.40574772880254	0.627	0.646	7.80269596584387e-46	FAUP1	Malignant cells	GSE175716	ENSG00000235297	NA	NA	FAU1P	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22586
3.79248536686211e-50	-0.51200015523657	0.045	0.263	8.66772530596336e-46	WWC2	Malignant cells	GSE175716	ENSG00000151718	80014	WW and C2 domain containing 2	BOMB|FLJ22029	protein_coding	Q6AWC2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22587
3.84840206357472e-50	0.51088609849477	0.791	0.615	8.79552291630002e-46	NAA20	Malignant cells	GSE175716	ENSG00000173418	51126	N-alpha-acetyltransferase 20, NatB catalytic subunit	dJ1002M8.1|NAT3|NAT5	protein_coding	P61599	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22588
4.94548462897934e-50	-0.495310249202196	0.094	0.329	1.13029051195323e-45	MEX3C	Malignant cells	GSE175716	ENSG00000176624	51320	mex-3 RNA binding family member C	FLJ38871|RKHD2|RNF194	protein_coding	Q5U5Q3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22589
6.72368433755031e-50	0.501157655817743	0.392	0.202	1.53669805534712e-45	FAM45A	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22590
7.0378629911577e-50	-0.430476735876309	0.116	0.361	1.60850358662909e-45	C9orf3	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22591
7.54151471483574e-50	-0.358133399473912	0.039	0.257	1.72361318807571e-45	HTRA1	Malignant cells	GSE175716	ENSG00000166033	5654	HtrA serine peptidase 1	ARMD7|HtrA|IGFBP5-protease|PRSS11	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22592
8.54662997725556e-50	-0.403423649896856	0.132	0.382	1.95333228130176e-45	DDX6	Malignant cells	GSE175716	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22593
9.52532551231164e-50	0.588625139509976	0.452	0.264	2.17701314583883e-45	FARSB	Malignant cells	GSE175716	ENSG00000116120	10056	phenylalanyl-tRNA synthetase subunit beta	FARSLB|FRSB|PheHB	protein_coding	Q9NSD9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22594
9.81250572271489e-50	-0.460582414515046	0.115	0.357	2.24264818292649e-45	STXBP3	Malignant cells	GSE175716	ENSG00000116266	6814	syntaxin binding protein 3	UNC-18C	protein_coding	O00186	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22595
1.02394368590077e-49	-0.521324517075422	0.28	0.51	2.34022329412621e-45	ADAM10	Malignant cells	GSE175716	ENSG00000137845	102	ADAM metallopeptidase domain 10	CD156C|HsT18717|kuz|MADM	protein_coding	O14672	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22596
1.09643676190869e-49	-1.44324569838545	0.269	0.472	2.50590621934232e-45	CRP	Malignant cells	GSE175716	ENSG00000132693	1401	C-reactive protein	PTX1	protein_coding	P02741	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22597
1.15723487053408e-49	0.490929176874131	0.696	0.486	2.64486029660564e-45	TRIM28	Malignant cells	GSE175716	ENSG00000130726	10155	tripartite motif containing 28	KAP-1|KAP1|PPP1R157|RNF96|TF1B|TIF1-beta|TIF1B|TIF1beta	protein_coding	Q13263	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22598
1.15816274280833e-49	-0.391646361892664	0.045	0.264	2.64698094868845e-45	MAK16	Malignant cells	GSE175716	ENSG00000198042	84549	MAK16 homolog	MAK16L|RBM13	protein_coding	Q9BXY0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22599
1.64155708418816e-49	-0.606839959863362	0.569	0.707	3.75177871591203e-45	HNRNPCP2	Malignant cells	GSE175716	ENSG00000204253	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22600
1.77377495378145e-49	-0.783370935177189	0.068	0.287	4.0539626568675e-45	FGF2	Malignant cells	GSE175716	ENSG00000138685	2247	fibroblast growth factor 2	FGFB	protein_coding	P09038	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22601
1.79115280860597e-49	-0.410479258978978	0.07	0.298	4.09367974406894e-45	MINDY2	Malignant cells	GSE175716	ENSG00000128923	54629	MINDY lysine 48 deubiquitinase 2	FAM63B|KIAA1164	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22602
1.83142894109678e-49	-0.532027486818682	0.475	0.656	4.1857308448767e-45	CPD	Malignant cells	GSE175716	ENSG00000108582	1362	carboxypeptidase D	GP180	protein_coding	O75976	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22603
1.90567079792691e-49	-0.49312596847953	0.292	0.523	4.35541060866196e-45	EPHA2	Malignant cells	GSE175716	ENSG00000142627	1969	EPH receptor A2	ECK	protein_coding	P29317	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22604
2.44357813868325e-49	-0.388282972479902	0.096	0.334	5.58479783596056e-45	POLR2C	Malignant cells	GSE175716	ENSG00000102978	5432	RNA polymerase II subunit C	RPB3	protein_coding	P19387	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22605
2.61569128357802e-49	-0.697031713213327	0.63	0.761	5.97816242861757e-45	MAFF	Malignant cells	GSE175716	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22606
2.79205908301974e-49	-0.456154301060393	0.053	0.271	6.38125103424162e-45	NOSIP	Malignant cells	GSE175716	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22607
3.55558312000004e-49	-0.430780509611764	0.867	0.925	8.12628522076009e-45	ARF4	Malignant cells	GSE175716	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22608
3.77273565095684e-49	-0.556955290639255	0.162	0.404	8.62258733026185e-45	SERINC2	Malignant cells	GSE175716	ENSG00000168528	347735	serine incorporator 2	FKSG84|PRO0899|TDE2|TDE2L	protein_coding	Q96SA4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22609
4.52244292000441e-49	-0.371395446664538	0.043	0.26	1.03360432936701e-44	SIPA1L2	Malignant cells	GSE175716	ENSG00000116991	57568	signal induced proliferation associated 1 like 2	KIAA1389|SPAR2	protein_coding	Q9P2F8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22610
4.75097362596834e-49	0.612135680156306	0.523	0.345	1.08583502221506e-44	TCEA3	Malignant cells	GSE175716	ENSG00000282941	6920	transcription elongation factor A3	TFIIS.H	protein_coding	O75764	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22611
4.82975357737157e-49	0.435202159514852	0.996	0.952	1.10384018010827e-44	ATP5B	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22612
4.97886402551242e-49	0.323742376887598	0.257	0.097	1.13791937303086e-44	TOM1	Malignant cells	GSE175716	ENSG00000100284	10043	target of myb1 membrane trafficking protein	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22613
5.5484547684467e-49	-0.353637300288794	0.044	0.262	1.26809933732849e-44	BTBD3	Malignant cells	GSE175716	ENSG00000132640	22903	BTB domain containing 3	dJ742J24.1|KIAA0952	protein_coding	Q9Y2F9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22614
5.63776423757847e-49	-0.379953236749121	0.111	0.358	1.28851101649856e-44	PLOD1	Malignant cells	GSE175716	ENSG00000083444	5351	procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	LH1|LLH|PLOD	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22615
5.64685298099239e-49	-0.587136033028267	0.091	0.315	1.29058824880581e-44	YWHAZP3	Malignant cells	GSE175716	ENSG00000229932	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22616
5.68208906551164e-49	-0.365280997877419	0.038	0.25	1.29864145592268e-44	XPO7	Malignant cells	GSE175716	ENSG00000130227	23039	exportin 7	EXP7|KIAA0745|RANBP16	protein_coding	Q9UIA9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22617
6.25698856957414e-49	-0.431543432349608	0.826	0.892	1.43003473757617e-44	NONO	Malignant cells	GSE175716	ENSG00000147140	4841	non-POU domain containing octamer binding	NMT55|NRB54|P54|P54NRB|PPP1R114	protein_coding	Q15233	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22618
6.76374445598639e-49	0.463542481949387	0.861	0.672	1.54585379541569e-44	SAR1A	Malignant cells	GSE175716	ENSG00000079332	56681	secretion associated Ras related GTPase 1A	SAR1|Sara|SARA1	protein_coding	Q9NR31	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22619
7.0079124834855e-49	-0.461947451306913	0.626	0.774	1.60165839810061e-44	GABARAPL2	Malignant cells	GSE175716	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22620
7.03662434352221e-49	-0.403212667878216	0.089	0.322	1.608220493712e-44	TMEM170A	Malignant cells	GSE175716	ENSG00000166822	124491	transmembrane protein 170A	FLJ37611|TMEM170	protein_coding	Q8WVE7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22621
7.08645075176813e-49	-0.768490607083718	0.441	0.584	1.61960831931661e-44	P4HB	Malignant cells	GSE175716	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22622
7.11202831902635e-49	-0.374559113046965	0.104	0.346	1.62545407231347e-44	RIC8A	Malignant cells	GSE175716	ENSG00000177963	60626	RIC8 guanine nucleotide exchange factor A	synembryn|synembryn-A	protein_coding	Q9NPQ8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22623
7.42170935825662e-49	-0.44887517527402	0.561	0.725	1.69623167382955e-44	PAFAH1B2	Malignant cells	GSE175716	ENSG00000168092	5049	platelet activating factor acetylhydrolase 1b catalytic subunit 2	NA	protein_coding	P68402	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22624
7.66462296714847e-49	0.583314139292124	0.403	0.22	1.75174957914178e-44	FBXW2	Malignant cells	GSE175716	ENSG00000119402	26190	F-box and WD repeat domain containing 2	FBW2|Fwd2|Md6	protein_coding	Q9UKT8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22625
7.8343371641702e-49	-0.482674029057204	0.141	0.388	1.7905377588711e-44	FOSL1	Malignant cells	GSE175716	ENSG00000175592	8061	FOS like 1, AP-1 transcription factor subunit	fra-1	protein_coding	P15407	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22626
8.42132334311699e-49	-0.355355752340028	0.056	0.28	1.92469345006939e-44	TERF1	Malignant cells	GSE175716	ENSG00000147601	7013	telomeric repeat binding factor 1	PIN2|TRBF1|TRF|TRF1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22627
8.60703920767268e-49	-1.13382869119054	0.485	0.58	1.96713881091359e-44	C12orf57	Malignant cells	GSE175716	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22628
9.48957347297158e-49	-0.432884557930755	0.411	0.625	2.16884201724766e-44	MPZL1	Malignant cells	GSE175716	ENSG00000197965	9019	myelin protein zero like 1	FLJ21047|PZR	protein_coding	O95297	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22629
1.53443315663895e-48	-0.544985500290899	0.594	0.743	3.50694697949832e-44	LEPROT	Malignant cells	GSE175716	ENSG00000213625	54741	leptin receptor overlapping transcript	FLJ90360|OB-RGRP|OBRGRP|VPS55	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22630
1.57134934286668e-48	-0.414946853959902	0.132	0.376	3.5913189231218e-44	RHPN2	Malignant cells	GSE175716	ENSG00000131941	85415	rhophilin Rho GTPase binding protein 2	NA	protein_coding	Q8IUC4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22631
1.64686788052832e-48	-0.579989075591017	0.139	0.38	3.76391654094748e-44	RSF1	Malignant cells	GSE175716	ENSG00000048649	51773	remodeling and spacing factor 1	HBXAP|p325|RSF-1|XAP8	protein_coding	Q96T23	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22632
2.21680011226692e-48	-0.39378834574672	0.863	0.934	5.06649665658605e-44	MORF4L1	Malignant cells	GSE175716	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22633
2.24754418443645e-48	-0.449566362144137	0.633	0.781	5.13676223352952e-44	SUMO1	Malignant cells	GSE175716	ENSG00000116030	7341	small ubiquitin like modifier 1	GMP1|OFC10|PIC1|SMT3C|SMT3H3|SUMO-1|UBL1	protein_coding	P63165	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22634
2.53858948670651e-48	-0.575263706372414	0.915	0.932	5.80194627186774e-44	SNRPD2	Malignant cells	GSE175716	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22635
2.89394249338592e-48	0.487035988203199	0.83	0.677	6.61410556863352e-44	RPL41	Malignant cells	GSE175716	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22636
2.90475519813529e-48	-0.390545402611215	0.1	0.338	6.63881800533821e-44	MEF2D	Malignant cells	GSE175716	ENSG00000116604	4209	myocyte enhancer factor 2D	NA	protein_coding	Q14814	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22637
3.33475884503402e-48	-0.362709559554632	0.051	0.269	7.62159134032525e-44	MARVELD2	Malignant cells	GSE175716	ENSG00000274671	153562	MARVEL domain containing 2	DFNB49|FLJ30532|MRVLDC2|TRIC	protein_coding	Q8N4S9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22638
3.60161259317618e-48	-0.765116779894118	0.441	0.612	8.23148558170417e-44	RNF19A	Malignant cells	GSE175716	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22639
3.77507222917368e-48	-0.457476108945583	0.116	0.357	8.62792757977644e-44	MAN2A1	Malignant cells	GSE175716	ENSG00000112893	4124	mannosidase alpha class 2A member 1	GOLIM7|MANA2	protein_coding	Q16706	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22640
3.87143371645356e-48	-0.39444099792382	0.857	0.931	8.84816175895462e-44	MRFAP1	Malignant cells	GSE175716	ENSG00000179010	93621	Morf4 family associated protein 1	PAM14|PGR1	protein_coding	Q9Y605	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22641
4.44347511761175e-48	0.433827200959215	0.999	0.931	1.01555623813017e-43	CHCHD2	Malignant cells	GSE175716	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22642
4.92543065156076e-48	-0.317843828429053	0.915	0.965	1.12570717541421e-43	VAPA	Malignant cells	GSE175716	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22643
4.9912157665476e-48	-0.401208395104027	0.184	0.435	1.14074236344445e-43	TWF1	Malignant cells	GSE175716	ENSG00000151239	5756	twinfilin actin binding protein 1	A6|PTK9	protein_coding	Q12792	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22644
5.62633682473326e-48	-0.608478208706715	0.551	0.687	1.28589928129279e-43	MGST2	Malignant cells	GSE175716	ENSG00000085871	4258	microsomal glutathione S-transferase 2	MGST-II	protein_coding	Q99735	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22645
7.51389647541125e-48	-0.418296848405211	0.66	0.799	1.71730103945524e-43	PCNP	Malignant cells	GSE175716	ENSG00000081154	57092	PEST proteolytic signal containing nuclear protein	NA	protein_coding	Q8WW12	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22646
7.55222251077784e-48	0.548806798023185	0.46	0.267	1.72606045483828e-43	PXMP2	Malignant cells	GSE175716	ENSG00000176894	5827	peroxisomal membrane protein 2	MPV17L3|PMP22	protein_coding	Q9NR77	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22647
7.57830395258808e-48	0.492976165306044	0.921	0.756	1.73202136836401e-43	PRPF40A	Malignant cells	GSE175716	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22648
7.63775248900509e-48	0.491845164465893	0.921	0.779	1.74560833136211e-43	MRPS18B	Malignant cells	GSE175716	ENSG00000233813	28973	mitochondrial ribosomal protein S18B	C6orf14|HSPC183|MRPS18-2|PTD017	protein_coding	Q9Y676	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22649
8.00795428220714e-48	-0.535483520227729	0.074	0.294	1.83021795119844e-43	CLCN3	Malignant cells	GSE175716	ENSG00000109572	1182	chloride voltage-gated channel 3	ClC-3|CLC3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22650
8.14216584666978e-48	-0.548098869730182	0.626	0.762	1.86089200425638e-43	TFAM	Malignant cells	GSE175716	ENSG00000108064	7019	transcription factor A, mitochondrial	TCF6|TCF6L2	protein_coding	Q00059	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22651
8.32810392424778e-48	-0.452825660954665	0.222	0.471	1.90338815188683e-43	MIER1	Malignant cells	GSE175716	ENSG00000198160	57708	MIER1 transcriptional regulator	hMI-ER1|KIAA1610|MI-ER1	protein_coding	Q8N108	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22652
9.00581561685579e-48	-0.406653740112762	0.166	0.417	2.05827915923239e-43	SKA2	Malignant cells	GSE175716	ENSG00000182628	348235	spindle and kinetochore associated complex subunit 2	FAM33A|FLJ12758	protein_coding	Q8WVK7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22653
9.02874229002103e-48	-0.429582461464205	0.114	0.352	2.06351905038431e-43	GMCL1	Malignant cells	GSE175716	ENSG00000087338	64395	germ cell-less 1, spermatogenesis associated	BTBD13|FLJ13057|GCL1|SPATA29	protein_coding	Q96IK5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22654
9.70910129534053e-48	-0.391466249967684	0.084	0.313	2.21901510105008e-43	M6PR	Malignant cells	GSE175716	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22655
1.11132474044937e-47	-1.38543281307282	0.853	0.878	2.53993269429703e-43	CLDN1	Malignant cells	GSE175716	ENSG00000163347	9076	claudin 1	ILVASC|SEMP1	protein_coding	O95832	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22656
1.1518561160475e-47	0.547491613538417	0.553	0.382	2.63256715322657e-43	NACA2	Malignant cells	GSE175716	ENSG00000253506	342538	nascent polypeptide associated complex subunit alpha 2	MGC71999|NACAL	protein_coding	Q9H009	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22657
1.21839527878868e-47	-0.435602877628998	0.165	0.414	2.78464240967153e-43	ZNF106	Malignant cells	GSE175716	ENSG00000103994	64397	zinc finger protein 106	SH3BP3|ZFP106|ZNF474	protein_coding	Q9H2Y7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22658
1.25194886526481e-47	0.552346468772892	0.837	0.71	2.86132913156272e-43	MTCH1	Malignant cells	GSE175716	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22659
1.36346457013247e-47	-0.384444533278362	0.082	0.309	3.11619827503776e-43	PIK3C2A	Malignant cells	GSE175716	ENSG00000011405	5286	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha	PI3K-C2alpha	protein_coding	O00443	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22660
1.63397614983069e-47	-0.473720519635644	0.949	0.966	3.73445249043804e-43	CYSTM1	Malignant cells	GSE175716	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22661
1.6435603165444e-47	-0.343555076200568	0.046	0.259	3.75635710346223e-43	MED21	Malignant cells	GSE175716	ENSG00000152944	9412	mediator complex subunit 21	SRB7|SURB7	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22662
2.10785257987042e-47	-0.400785167531855	0.044	0.256	4.81749707129385e-43	FLII	Malignant cells	GSE175716	ENSG00000284571	2314	FLII actin remodeling protein	FLI|Fli1|FLIL|MGC39265	protein_coding	Q13045	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22663
2.12115770077834e-47	-0.440903259103016	0.723	0.835	4.8479059251289e-43	RPL4P4	Malignant cells	GSE175716	ENSG00000229638	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22664
2.14616790810797e-47	-0.392471880029796	0.117	0.354	4.90506675398077e-43	EIF2AK4	Malignant cells	GSE175716	ENSG00000128829	440275	eukaryotic translation initiation factor 2 alpha kinase 4	GCN2|KIAA1338	protein_coding	Q9P2K8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22665
2.18755278231109e-47	-1.25360524803886	0.334	0.499	4.999651883972e-43	DEFB1	Malignant cells	GSE175716	ENSG00000164825	1672	defensin beta 1	BD1|DEFB-1|DEFB101|HBD-1|HBD1|MGC51822	protein_coding	P60022	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22666
2.4385016020953e-47	-0.56811832592993	0.14	0.374	5.57319541158882e-43	LPIN1	Malignant cells	GSE175716	ENSG00000134324	23175	lipin 1	KIAA0188	protein_coding	Q14693	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22667
2.66464897940338e-47	0.477751767552837	0.638	0.436	6.09005524242642e-43	ITPA	Malignant cells	GSE175716	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22668
2.86318799914163e-47	-0.536950408705161	0.343	0.552	6.5438161720382e-43	CTNND1	Malignant cells	GSE175716	ENSG00000198561	1500	catenin delta 1	CTNND|KIAA0384|p120|p120cas|p120ctn	protein_coding	O60716	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22669
3.1119721581378e-47	-0.401490338716988	0.079	0.303	7.11241236742394e-43	MBD6	Malignant cells	GSE175716	ENSG00000166987	114785	methyl-CpG binding domain protein 6	KIAA1887	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22670
3.17321588686488e-47	-0.370730492926692	0.072	0.296	7.25238490942968e-43	C1GALT1C1	Malignant cells	GSE175716	ENSG00000288368	29071	C1GALT1 specific chaperone 1	C1GALT2|COSMC	protein_coding	Q96EU7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22671
3.21837581564124e-47	-0.467217146711708	0.126	0.365	7.35559792664806e-43	AFDN	Malignant cells	GSE175716	ENSG00000130396	4301	afadin, adherens junction formation factor	AF-6|AF6|MLLT4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22672
3.47075371806949e-47	-0.461958239700436	0.08	0.305	7.93240762264782e-43	BAMBI	Malignant cells	GSE175716	ENSG00000095739	25805	BMP and activin membrane bound inhibitor	NMA	protein_coding	Q13145	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22673
3.53094787209778e-47	-0.450206874347702	0.275	0.507	8.06998136167947e-43	TMED7	Malignant cells	GSE175716	ENSG00000134970	51014	transmembrane p24 trafficking protein 7	CGI-109|FLJ90481|p24g3|p24gamma3	protein_coding	Q9Y3B3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22674
3.69014122611394e-47	-0.614090429013812	0.21	0.445	8.43381777228341e-43	C6orf141	Malignant cells	GSE175716	ENSG00000197261	135398	chromosome 6 open reading frame 141	MGC46457	protein_coding	Q5SZD1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22675
3.7235588362597e-47	-0.386137216274482	0.07	0.293	8.51019372027154e-43	PATJ	Malignant cells	GSE175716	ENSG00000132849	10207	PATJ crumbs cell polarity complex component	Cipp|INADL	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22676
3.75815533521398e-47	-0.437970330554007	0.173	0.42	8.58926401863156e-43	TMEM167B	Malignant cells	GSE175716	ENSG00000215717	56900	transmembrane protein 167B	AD-020|C1orf119|FLJ90710	protein_coding	Q9NRX6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22677
4.99427176137184e-47	-0.499036101609715	0.057	0.272	1.14144081106153e-42	BAHCC1	Malignant cells	GSE175716	ENSG00000266074	57597	BAH domain and coiled-coil containing 1	BAHD2|KIAA1447	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22678
6.24945304123425e-47	-0.369605638822301	0.065	0.284	1.42831249257409e-42	CD58	Malignant cells	GSE175716	ENSG00000116815	965	CD58 molecule	LFA3	protein_coding	P19256	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22679
6.45415654734304e-47	0.490534246433985	0.955	0.888	1.47509747889525e-42	YWHAG	Malignant cells	GSE175716	ENSG00000170027	7532	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma	14-3-3GAMMA|PPP1R170	protein_coding	P61981	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22680
6.6765546437548e-47	-0.488314233185371	0.399	0.597	1.52592656383016e-42	NCSTN	Malignant cells	GSE175716	ENSG00000162736	23385	nicastrin	APH2|KIAA0253	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22681
7.1821104327193e-47	-0.515798193225771	0.385	0.584	1.641471339398e-42	SERTAD1	Malignant cells	GSE175716	ENSG00000197019	29950	SERTA domain containing 1	SEI1|TRIP-Br1	protein_coding	Q9UHV2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22682
7.26443199457303e-47	-0.395495733835529	0.102	0.334	1.66028593235967e-42	GEMIN7	Malignant cells	GSE175716	ENSG00000142252	79760	gem nuclear organelle associated protein 7	FLJ13956	protein_coding	Q9H840	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22683
8.59369736433559e-47	0.592212611564535	0.553	0.395	1.9640895326189e-42	MIR1244-2	Malignant cells	GSE175716	ENSG00000283498	100422885	microRNA 1244-2	hsa-mir-1244-2	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22684
1.06355813189694e-46	0.457881993044358	0.992	0.908	2.43076211045046e-42	TKT	Malignant cells	GSE175716	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22685
1.11107015009019e-46	-0.383976070751253	0.084	0.313	2.53935082803114e-42	IDS	Malignant cells	GSE175716	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22686
1.12471277728126e-46	-0.334779396279462	0.05	0.262	2.57053105247631e-42	TOR1B	Malignant cells	GSE175716	ENSG00000136816	27348	torsin family 1 member B	DQ1|MGC4386	protein_coding	O14657	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22687
1.16761085770755e-46	-0.521260642232058	0.292	0.513	2.66857461529061e-42	CMTM6	Malignant cells	GSE175716	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22688
1.33846714281878e-46	-0.379757694588353	0.08	0.305	3.05906665491232e-42	TBC1D23	Malignant cells	GSE175716	ENSG00000036054	55773	TBC1 domain family member 23	FLJ11046	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22689
1.35405947687661e-46	0.523092551105262	0.343	0.161	3.09470293440148e-42	KBTBD7	Malignant cells	GSE175716	ENSG00000120696	84078	kelch repeat and BTB domain containing 7	DKFZP434E2318	protein_coding	Q8WVZ9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22690
1.36174658740908e-46	0.352370631587873	0.852	0.564	3.11227182552344e-42	TSPO	Malignant cells	GSE175716	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22691
1.4153559658276e-46	-0.601867241699311	0.78	0.837	3.23479605989898e-42	FAM96A	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22692
1.49153413285264e-46	-0.429131608323467	0.577	0.733	3.40890126063471e-42	AP2M1	Malignant cells	GSE175716	ENSG00000161203	1173	adaptor related protein complex 2 subunit mu 1	AP50|CLAPM1|mu2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22693
1.57806165771372e-46	-0.36791817302982	0.101	0.335	3.6066599187047e-42	ALKBH5	Malignant cells	GSE175716	ENSG00000091542	54890	alkB homolog 5, RNA demethylase	FLJ20308|OFOXD1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22694
1.62141417705193e-46	-0.373063940003197	0.066	0.286	3.70574210165218e-42	HECTD3	Malignant cells	GSE175716	ENSG00000126107	79654	HECT domain E3 ubiquitin protein ligase 3	FLJ21156	protein_coding	Q5T447	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22695
1.68862572084512e-46	-0.537146196975858	0.14	0.371	3.85935408499151e-42	GNAI2	Malignant cells	GSE175716	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22696
1.85403246986676e-46	-0.385802649806692	0.103	0.332	4.23739120988049e-42	PRPS1	Malignant cells	GSE175716	ENSG00000147224	5631	phosphoribosyl pyrophosphate synthetase 1	CMTX5|DFN2|DFNX1|PPRibP|PRS-I	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22697
2.24835954976651e-46	-0.355650501192899	0.071	0.292	5.13862575099136e-42	NAA30	Malignant cells	GSE175716	ENSG00000139977	122830	N-alpha-acetyltransferase 30, NatC catalytic subunit	C14orf35|FLJ35355|MAK3|Mak3p|NAT12	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22698
2.29303604852007e-46	-0.482684136154456	0.719	0.804	5.24073388889262e-42	RER1	Malignant cells	GSE175716	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22699
2.297016210915e-46	-0.450053384970691	0.762	0.861	5.24983055004624e-42	CHMP2A	Malignant cells	GSE175716	ENSG00000130724	27243	charged multivesicular body protein 2A	BC-2|CHMP2|VPS2|VPS2A	protein_coding	O43633	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22700
2.32243359721741e-46	-0.402849674674538	0.29	0.524	5.30792198644039e-42	FBXO21	Malignant cells	GSE175716	ENSG00000135108	23014	F-box protein 21	FBX21|KIAA0875	protein_coding	O94952	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22701
2.40436903281723e-46	-0.365460797385668	0.115	0.349	5.49518542450377e-42	MRPL19	Malignant cells	GSE175716	ENSG00000115364	9801	mitochondrial ribosomal protein L19	KIAA0104|MRP-L15|RLX1|RPML15	protein_coding	P49406	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22702
2.90555991418206e-46	-0.346447843922561	0.054	0.268	6.6406571838631e-42	MRPL49	Malignant cells	GSE175716	ENSG00000149792	740	mitochondrial ribosomal protein L49	C11orf4|L49mt|NOF|NOF1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22703
2.99780905148432e-46	-0.545505303374363	0.446	0.625	6.85149258716742e-42	MFSD1	Malignant cells	GSE175716	ENSG00000118855	64747	major facilitator superfamily domain containing 1	FLJ14153|Minerva|UG0581B09	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22704
3.15467216868786e-46	-0.635517708743559	0.555	0.699	7.2100032415361e-42	VEZF1	Malignant cells	GSE175716	ENSG00000136451	7716	vascular endothelial zinc finger 1	DB1|ZNF161	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22705
3.22827280669097e-46	-0.431481112072678	0.331	0.549	7.37821749969221e-42	FNTA	Malignant cells	GSE175716	ENSG00000168522	2339	farnesyltransferase, CAAX box, alpha	FPTA|PGGT1A|PTAR2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22706
3.48392320211131e-46	-0.450778083728184	0.605	0.746	7.96250647842541e-42	SEC11C	Malignant cells	GSE175716	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22707
3.73722387325515e-46	-0.493244938625991	0.971	0.969	8.54142516232464e-42	PDIA3	Malignant cells	GSE175716	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22708
3.80029625716393e-46	0.430136035086142	0.708	0.456	8.68557709574816e-42	NFIL3	Malignant cells	GSE175716	ENSG00000165030	4783	nuclear factor, interleukin 3 regulated	E4BP4|IL3BP1|NF-IL3A|NFIL3A	protein_coding	Q16649	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22709
4.04365280021386e-46	-0.826248626084327	0.533	0.677	9.24176847488878e-42	DNAJB9	Malignant cells	GSE175716	ENSG00000128590	4189	DnaJ heat shock protein family (Hsp40) member B9	MDG1	protein_coding	Q9UBS3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22710
4.29147534431532e-46	0.396965549915102	0.995	0.898	9.80816689943266e-42	KLF6	Malignant cells	GSE175716	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22711
4.32703138248183e-46	-0.488321762217284	0.462	0.648	9.88943022466223e-42	SWAP70	Malignant cells	GSE175716	ENSG00000133789	23075	switching B cell complex subunit SWAP70	KIAA0640|SWAP-70	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22712
4.56192744802967e-46	-0.388150700082185	0.14	0.378	1.04262851824718e-41	LLPH	Malignant cells	GSE175716	ENSG00000139233	84298	LLP homolog, long-term synaptic facilitation factor	C12orf31|hLLP|MGC14817	protein_coding	Q9BRT6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22713
5.04503802001635e-46	-0.539555638619386	0.101	0.327	1.15304343947474e-41	BBX	Malignant cells	GSE175716	ENSG00000114439	56987	BBX high mobility group box domain containing	HBP2|HSPC339|MDS001	protein_coding	Q8WY36	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22714
5.33982174706902e-46	-0.438497754646775	0.113	0.34	1.22041626029262e-41	PLS1	Malignant cells	GSE175716	ENSG00000120756	5357	plastin 1	NA	protein_coding	Q14651	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22715
5.51856848084064e-46	-0.412824359957328	0.162	0.409	1.26126882629613e-41	SEL1L	Malignant cells	GSE175716	ENSG00000071537	6400	SEL1L adaptor subunit of ERAD E3 ubiquitin ligase	Hrd3|IBD2|SEL1L1	protein_coding	Q9UBV2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22716
5.6129375347964e-46	-0.335180584952283	0.061	0.277	1.28283687357772e-41	ARAF	Malignant cells	GSE175716	ENSG00000078061	369	A-Raf proto-oncogene, serine/threonine kinase	ARAF1	protein_coding	P10398	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22717
6.05974806315189e-46	0.593274987012893	0.46	0.285	1.38495541983337e-41	PUM3	Malignant cells	GSE175716	ENSG00000080608	9933	pumilio RNA binding family member 3	HA-8|hPUF-A|KIAA0020|PEN|Puf-A|PUF6|XTP5	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22718
6.65910504536898e-46	-0.42926171079508	0.144	0.389	1.52193845811908e-41	SPHK1	Malignant cells	GSE175716	ENSG00000176170	8877	sphingosine kinase 1	SPHK	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22719
6.85191513315199e-46	-0.33133613004386	0.047	0.257	1.56600520368189e-41	HFE	Malignant cells	GSE175716	ENSG00000010704	3077	homeostatic iron regulator	HFE1|HLA-H	protein_coding	Q30201	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22720
8.48153063159041e-46	-0.523444440110864	0.254	0.477	1.93845382584999e-41	BTBD1	Malignant cells	GSE175716	ENSG00000064726	53339	BTB domain containing 1	NA	protein_coding	Q9H0C5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22721
1.17502985538447e-45	-0.409630652721125	0.604	0.757	2.68553073448121e-41	POLDIP2	Malignant cells	GSE175716	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22722
1.22593198879185e-45	-0.46413402346153	0.059	0.269	2.80186756038377e-41	IRF6	Malignant cells	GSE175716	ENSG00000117595	3664	interferon regulatory factor 6	LPS|OFC6|VWS|VWS1	protein_coding	O14896	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22723
1.30825173587537e-45	0.461846896116403	0.958	0.799	2.99000934234315e-41	RBM8A	Malignant cells	GSE175716	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22724
1.3820140465881e-45	-0.480755781760958	0.445	0.634	3.1585931034771e-41	DNAJC22	Malignant cells	GSE175716	ENSG00000178401	79962	DnaJ heat shock protein family (Hsp40) member C22	FLJ13236|wus	protein_coding	Q8N4W6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22725
1.68333294885691e-45	-0.40356766797795	0.165	0.411	3.84725745461247e-41	CUL5	Malignant cells	GSE175716	ENSG00000166266	8065	cullin 5	VACM-1	protein_coding	Q93034	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22726
1.9491665446131e-45	0.410093708255649	0.989	0.88	4.45482013771325e-41	RBM3	Malignant cells	GSE175716	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22727
2.48171019462798e-45	0.363609739267858	0.279	0.118	5.67194864982226e-41	AC112191.2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22728
2.62112140137919e-45	-0.473068562333804	0.493	0.678	5.99057296285214e-41	SMAD3	Malignant cells	GSE175716	ENSG00000166949	4088	SMAD family member 3	HsT17436|JV15-2|MADH3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22729
2.65385544678469e-45	-0.883439820810584	0.4	0.552	6.0653866236264e-41	SIRT1	Malignant cells	GSE175716	ENSG00000096717	23411	sirtuin 1	SIR2L1	protein_coding	Q96EB6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22730
2.9083022262151e-45	-0.414065708026119	0.125	0.357	6.64692473801462e-41	LSG1	Malignant cells	GSE175716	ENSG00000041802	55341	large 60S subunit nuclear export GTPase 1	FLJ11301	protein_coding	Q9H089	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22731
2.96724600455089e-45	-0.662102195090126	0.531	0.66	6.78164074340106e-41	AC008038.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22732
2.968338216002e-45	-0.425410049825696	0.118	0.347	6.78413699267256e-41	PIR	Malignant cells	GSE175716	ENSG00000087842	8544	pirin	NA	protein_coding	O00625	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22733
2.97995522219313e-45	-0.890439035681098	0.66	0.713	6.8106876603224e-41	MANF	Malignant cells	GSE175716	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22734
3.02037499185688e-45	0.431511379053088	0.766	0.514	6.9030670438889e-41	LINC01287	Malignant cells	GSE175716	ENSG00000234722	103724390	long intergenic non-protein coding RNA 1287	TCONS_l2_00027522	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22735
3.76106661628709e-45	0.376498344015211	0.965	0.749	8.59591775152414e-41	SNRPB	Malignant cells	GSE175716	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22736
4.17419980463552e-45	-0.34982224674174	0.08	0.301	9.54013365349447e-41	ERLIN2	Malignant cells	GSE175716	ENSG00000147475	11160	ER lipid raft associated 2	C8orf2|Erlin-2|NET32|SPFH2|SPG18	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22737
4.73629306877675e-45	-0.383897224868774	0.166	0.41	1.08247978086893e-40	COPG1	Malignant cells	GSE175716	ENSG00000181789	22820	COPI coat complex subunit gamma 1	COPG	protein_coding	Q9Y678	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22738
4.88974653419014e-45	-0.676737355075918	0.346	0.534	1.11755157038916e-40	PLSCR1	Malignant cells	GSE175716	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22739
4.94974605976398e-45	-0.351193015566261	0.095	0.321	1.13126446195906e-40	MRFAP1L1	Malignant cells	GSE175716	ENSG00000178988	114932	Morf4 family associated protein 1 like 1	MGC9651	protein_coding	Q96HT8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22740
5.18664147920615e-45	0.45808267137335	0.956	0.881	1.18540691007257e-40	PPA1	Malignant cells	GSE175716	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22741
5.20393357271486e-45	-0.457179729854261	0.249	0.484	1.18935901804398e-40	SMIM19	Malignant cells	GSE175716	ENSG00000176209	114926	small integral membrane protein 19	C8orf40	protein_coding	Q96E16	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22742
5.2555115043556e-45	0.412776592944592	0.305	0.139	1.20114715432047e-40	GALNT11	Malignant cells	GSE175716	ENSG00000178234	63917	polypeptide N-acetylgalactosaminyltransferase 11	GalNAc-T11	protein_coding	Q8NCW6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22743
5.36317474964832e-45	-0.425007772619094	0.111	0.338	1.22575358903212e-40	HERC4	Malignant cells	GSE175716	ENSG00000148634	26091	HECT and RLD domain containing E3 ubiquitin protein ligase 4	DKFZP564G092|KIAA1593	protein_coding	Q5GLZ8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22744
5.81717882594791e-45	-0.437549703198562	0.148	0.381	1.32951622067039e-40	PSMB8	Malignant cells	GSE175716	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22745
6.01211716217467e-45	-0.347710596774196	0.053	0.261	1.37406937741502e-40	FAM126A	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22746
6.18845014080075e-45	-0.376053293521849	0.097	0.319	1.41437027968001e-40	SERINC5	Malignant cells	GSE175716	ENSG00000164300	256987	serine incorporator 5	C5orf12|TPO1	protein_coding	Q86VE9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22747
6.30285090621901e-45	-0.479273266643054	0.601	0.746	1.44051657461636e-40	NIPBL	Malignant cells	GSE175716	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22748
6.8275864214277e-45	-0.530976679010274	0.487	0.656	1.5604448766173e-40	SLC7A2	Malignant cells	GSE175716	ENSG00000003989	6542	solute carrier family 7 member 2	ATRC2|CAT-2|HCAT2	protein_coding	P52569	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22749
6.99962947143742e-45	-0.801395935538839	0.104	0.323	1.59976531569702e-40	TMEM45A	Malignant cells	GSE175716	ENSG00000181458	55076	transmembrane protein 45A	DERP7|FLJ10134	protein_coding	Q9NWC5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22750
8.3342993268776e-45	-0.385510216573144	0.148	0.388	1.90480411115788e-40	THUMPD3	Malignant cells	GSE175716	ENSG00000134077	25917	THUMP domain containing 3	DKFZP434F091	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22751
8.66883545906674e-45	-0.536371128278392	0.146	0.371	1.9812623441697e-40	NR1D2	Malignant cells	GSE175716	ENSG00000174738	9975	nuclear receptor subfamily 1 group D member 2	BD73|EAR-1r|Hs.37288|HZF2|REVERBB|REVERBbeta|RVR	protein_coding	Q14995	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22752
1.12122494350262e-44	-0.379734499108795	0.1	0.324	2.56255960837524e-40	KIAA1551	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22753
1.27270428483217e-44	0.480448660059911	0.813	0.638	2.90876564298391e-40	FAM213A	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22754
1.76303671027575e-44	-0.462522527790133	0.585	0.724	4.02942040133522e-40	EIF4G1	Malignant cells	GSE175716	ENSG00000114867	1981	eukaryotic translation initiation factor 4 gamma 1	EIF4F|EIF4G|p220|PARK18	protein_coding	Q04637	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22755
2.08900211582574e-44	0.431950423606378	1	0.884	4.77441433571972e-40	ALDOA	Malignant cells	GSE175716	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22756
2.15738089680413e-44	-0.380181892162118	0.789	0.879	4.93069403964585e-40	COPA	Malignant cells	GSE175716	ENSG00000122218	1314	COPI coat complex subunit alpha	HEP-COP	protein_coding	P53621	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22757
2.31135920393636e-44	-0.350699335772106	0.13	0.368	5.28261146059654e-40	XPR1	Malignant cells	GSE175716	ENSG00000143324	9213	xenotropic and polytropic retrovirus receptor 1	SLC53A1|SYG1|X3	protein_coding	Q9UBH6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22758
2.39258226374418e-44	-0.835735939034683	0.946	0.972	5.46824676378731e-40	DDX21	Malignant cells	GSE175716	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22759
2.5380785527711e-44	-0.381034639019071	0.224	0.47	5.80077853235836e-40	EIF3M	Malignant cells	GSE175716	ENSG00000149100	10480	eukaryotic translation initiation factor 3 subunit M	FLJ29030|GA17|hfl-B5|PCID1|TANGO7	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22760
2.76771993124817e-44	-0.405439196997136	0.295	0.525	6.3256239028677e-40	SCAMP2	Malignant cells	GSE175716	ENSG00000140497	10066	secretory carrier membrane protein 2	NA	protein_coding	O15127	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22761
2.84570592115668e-44	-0.583814187107373	0.192	0.403	6.50386088280359e-40	MRPL54	Malignant cells	GSE175716	ENSG00000183617	116541	mitochondrial ribosomal protein L54	NA	protein_coding	Q6P161	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22762
3.05658846614258e-44	0.642002473971914	0.731	0.54	6.98583293936886e-40	HLA-B	Malignant cells	GSE175716	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22763
3.26893747388654e-44	-0.410124619481547	0.146	0.379	7.47115659656768e-40	EXOC5	Malignant cells	GSE175716	ENSG00000070367	10640	exocyst complex component 5	SEC10|SEC10L1|SEC10P	protein_coding	O00471	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22764
3.27867397437521e-44	-0.802045125945696	0.623	0.695	7.49340936843455e-40	MRPL24	Malignant cells	GSE175716	ENSG00000143314	79590	mitochondrial ribosomal protein L24	MRP-L18	protein_coding	Q96A35	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22765
3.6157754523477e-44	-0.395323442704262	0.103	0.324	8.26385479634067e-40	C5orf15	Malignant cells	GSE175716	ENSG00000113583	56951	chromosome 5 open reading frame 15	HTGN29|KCT2	protein_coding	Q8NC54	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22766
3.67571524984837e-44	0.359042485278189	0.891	0.723	8.40084720352845e-40	TNFAIP3	Malignant cells	GSE175716	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22767
3.78822688868401e-44	0.408068982873224	0.332	0.159	8.65799255408729e-40	NT5DC1	Malignant cells	GSE175716	ENSG00000178425	221294	5'-nucleotidase domain containing 1	dJ486I3.1|MGC24302|NT5C2L1	protein_coding	Q5TFE4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22768
3.96995230561811e-44	-0.413726979761546	0.775	0.871	9.07332599449019e-40	RAB10	Malignant cells	GSE175716	ENSG00000084733	10890	RAB10, member RAS oncogene family	NA	protein_coding	P61026	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22769
4.2641428360073e-44	-0.452946521919122	0.054	0.26	9.74569845169469e-40	SLC6A8	Malignant cells	GSE175716	ENSG00000130821	6535	solute carrier family 6 member 8	CRT|CRT-1|CRT1|CRTR|CT1	protein_coding	P48029	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22770
4.4286178237553e-44	-0.51595998198889	0.687	0.795	1.01216060361927e-39	RDH11	Malignant cells	GSE175716	ENSG00000072042	51109	retinol dehydrogenase 11	ARSDR1|MDT1|SDR7C1	protein_coding	Q8TC12	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22771
5.5711660445623e-44	-0.450368446364247	0.366	0.579	1.27328999948471e-39	SUCO	Malignant cells	GSE175716	ENSG00000094975	51430	SUN domain containing ossification factor	C1orf9|CH1|OPT|SLP1	protein_coding	Q9UBS9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22772
6.38426987719119e-44	-0.439032483960443	0.126	0.354	1.45912488043205e-39	ALG2	Malignant cells	GSE175716	ENSG00000119523	85365	ALG2 alpha-1,3/1,6-mannosyltransferase	CDG1I|CDGIi|FLJ14511|hALPG2|NET38	protein_coding	Q9H553	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22773
7.03243763509026e-44	-0.414163344650961	0.101	0.319	1.60726362149988e-39	SNHG25	Malignant cells	GSE175716	ENSG00000266402	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22774
7.37643243653567e-44	-0.44448291738725	0.614	0.749	1.68588363337023e-39	EMC3	Malignant cells	GSE175716	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22775
9.37939360395302e-44	-0.386676825103552	0.178	0.421	2.14366040818346e-39	RCOR1	Malignant cells	GSE175716	ENSG00000089902	23186	REST corepressor 1	COREST|KIAA0071|RCOR	protein_coding	Q9UKL0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22776
1.23496304350923e-43	-0.41968707066431	0.125	0.35	2.82250803594035e-39	SNX18	Malignant cells	GSE175716	ENSG00000178996	112574	sorting nexin 18	SH3PX2|SH3PXD3B|SNAG1	protein_coding	Q96RF0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22777
1.26789948594429e-43	-0.424636421211506	0.416	0.612	2.89778427512568e-39	DEGS1	Malignant cells	GSE175716	ENSG00000143753	8560	delta 4-desaturase, sphingolipid 1	DEGS-1|Des-1|DES1|FADS7|MLD	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22778
1.28502019218352e-43	-0.334188939343211	1	1	2.93691364923544e-39	RPS13	Malignant cells	GSE175716	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22779
1.46713769411756e-43	-0.486628791825508	0.124	0.346	3.35314319990568e-39	NFKB1	Malignant cells	GSE175716	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22780
1.52030950919809e-43	0.492905343134418	0.953	0.851	3.47466738327223e-39	EIF2S2	Malignant cells	GSE175716	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22781
1.72904250698651e-43	0.409171622246425	0.951	0.756	3.95172664971768e-39	SNRPE	Malignant cells	GSE175716	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22782
1.75697456297844e-43	-0.465352813076513	0.117	0.337	4.01556536368722e-39	SUMF1	Malignant cells	GSE175716	ENSG00000144455	285362	sulfatase modifying factor 1	FGE|UNQ3037	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22783
1.81349549420537e-43	0.499757793493695	0.811	0.639	4.14474395200638e-39	ACO1	Malignant cells	GSE175716	ENSG00000122729	48	aconitase 1	IREB1|IREBP|IRP1	protein_coding	P21399	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22784
1.96476796677611e-43	-0.347192080595235	0.135	0.367	4.49047718806679e-39	DCUN1D5	Malignant cells	GSE175716	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22785
2.05986900362651e-43	-0.371745759082355	0.053	0.258	4.70783060778839e-39	ITM2C	Malignant cells	GSE175716	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22786
2.23627646551435e-43	0.480734675057476	0.336	0.166	5.11100986193304e-39	ELP1	Malignant cells	GSE175716	ENSG00000070061	8518	elongator acetyltransferase complex subunit 1	DYS|IKAP|IKBKAP|IKI3|TOT1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22787
2.52110614055915e-43	-0.365532335296933	0.051	0.252	5.76198808424794e-39	APOO	Malignant cells	GSE175716	ENSG00000184831	79135	apolipoprotein O	FAM121B|MGC4825|Mic23|MIC26|MICOS26|My025	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22788
2.75263297714868e-43	-0.470345113428599	0.18	0.406	6.2911426692733e-39	HMOX2	Malignant cells	GSE175716	ENSG00000277424	3163	heme oxygenase 2	HO-2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22789
2.86214090234542e-43	-0.445182495811291	0.93	0.954	6.54142303231045e-39	SEC61G	Malignant cells	GSE175716	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22790
3.28787909122778e-43	-0.981212247806224	0.507	0.594	7.51444766300109e-39	RHOC	Malignant cells	GSE175716	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22791
3.76102262661976e-43	0.312956805193738	0.27	0.112	8.59581721313947e-39	RPS3AP5	Malignant cells	GSE175716	ENSG00000178429	NA	NA	bA486O22.3	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22792
4.17105832803536e-43	-0.378254558776361	0.086	0.304	9.53295380872482e-39	KIAA1217	Malignant cells	GSE175716	ENSG00000120549	56243	KIAA1217	DKFZP761L0424|ETL4|SKT	protein_coding	Q5T5P2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22793
5.03757151652064e-43	-0.477839282345646	0.089	0.297	1.15133697010079e-38	SLC22A18	Malignant cells	GSE175716	ENSG00000276130	5002	solute carrier family 22 member 18	BWR1A|BWSCR1A|IMPT1|ITM|ORCTL2|SLC22A1L|TSSC5	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22794
5.31578751736478e-43	0.45875532170178	0.842	0.677	1.21492323709372e-38	SEC63	Malignant cells	GSE175716	ENSG00000025796	11231	SEC63 homolog, protein translocation regulator	DNAJC23|ERdj2|PRO2507|SEC63L	protein_coding	Q9UGP8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22795
5.97624887275394e-43	0.4955190759203	0.363	0.193	1.36587167986791e-38	PECR	Malignant cells	GSE175716	ENSG00000115425	55825	peroxisomal trans-2-enoyl-CoA reductase	HSA250303|SDR29C1|TERP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22796
6.30456563890487e-43	-0.438835363863336	0.173	0.406	1.44090847677171e-38	SETD5	Malignant cells	GSE175716	ENSG00000168137	55209	SET domain containing 5	FLJ10707|SETD5A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22797
6.45452242785426e-43	-0.353627393651242	0.092	0.309	1.47518110088609e-38	APPBP2	Malignant cells	GSE175716	ENSG00000062725	10513	amyloid beta precursor protein binding protein 2	Hs.84084|KIAA0228|PAT1	protein_coding	Q92624	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22798
6.47685027739852e-43	-0.486388674006718	0.144	0.369	1.48028413089943e-38	PAPD5	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22799
6.77905984557311e-43	-0.323774773404029	0.054	0.257	1.54935412770574e-38	NDUFAF1	Malignant cells	GSE175716	ENSG00000137806	51103	NADH:ubiquinone oxidoreductase complex assembly factor 1	CGI-65|CIA30	protein_coding	Q9Y375	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22800
6.90602084631427e-43	-0.387059936201793	0.749	0.838	1.57837106442513e-38	CNIH1	Malignant cells	GSE175716	ENSG00000100528	10175	cornichon family AMPA receptor auxiliary protein 1	CNIH|CNIL|TGAM77	protein_coding	O95406	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22801
7.12398646845048e-43	-0.419051818537328	0.152	0.386	1.62818710736436e-38	TEAD1	Malignant cells	GSE175716	ENSG00000187079	7003	TEA domain transcription factor 1	AA|TCF13|TEF-1	protein_coding	P28347	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22802
7.41012329774415e-43	-0.324923276263242	0.068	0.276	1.69358367969943e-38	TVP23B	Malignant cells	GSE175716	ENSG00000171928	51030	trans-golgi network vesicle protein 23 homolog B	CGI-148|FAM18B|FAM18B1|YDR084C	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22803
8.51217525231213e-43	0.522254702388632	0.606	0.436	1.94545765391594e-38	HAT1	Malignant cells	GSE175716	ENSG00000128708	8520	histone acetyltransferase 1	KAT1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22804
1.1050173846681e-42	-0.310079294087261	0.05	0.251	2.52551723265894e-38	CRADD	Malignant cells	GSE175716	ENSG00000169372	8738	CASP2 and RIPK1 domain containing adaptor with death domain	RAIDD	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22805
1.13530836194337e-42	-0.376243113295984	0.132	0.362	2.59474726122158e-38	CTDSP2	Malignant cells	GSE175716	ENSG00000175215	10106	CTD small phosphatase 2	OS4|PSR2|SCP2	protein_coding	O14595	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22806
1.24186106537678e-42	-0.458840509060479	0.101	0.315	2.83827346491863e-38	PLA2G4A	Malignant cells	GSE175716	ENSG00000116711	5321	phospholipase A2 group IVA	cPLA2-alpha|PLA2G4	protein_coding	P47712	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22807
1.29466815564438e-42	-0.345856239446157	0.091	0.307	2.95896406972524e-38	MED29	Malignant cells	GSE175716	ENSG00000063322	55588	mediator complex subunit 29	DKFZp434H247|IXL|MED2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22808
1.40311939397154e-42	0.451767161937209	0.855	0.7	3.20682937492195e-38	ARPC1A	Malignant cells	GSE175716	ENSG00000241685	10552	actin related protein 2/3 complex subunit 1A	Arc40|SOP2Hs|SOP2L	protein_coding	Q92747	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22809
1.5851510129419e-42	-0.363598639791855	0.065	0.269	3.62286264007871e-38	C1RL	Malignant cells	GSE175716	ENSG00000288124	51279	complement C1r subcomponent like	C1r-LP|C1RL1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22810
1.6457774681968e-42	-0.391369522260179	0.148	0.374	3.7614244035638e-38	TTC39C	Malignant cells	GSE175716	ENSG00000168234	125488	tetratricopeptide repeat domain 39C	C18orf17|FLJ33761|HsT2697	protein_coding	Q8N584	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22811
1.78153850874844e-42	0.569418869345797	0.446	0.278	4.07170626174457e-38	CSE1L	Malignant cells	GSE175716	ENSG00000124207	1434	chromosome segregation 1 like	CAS|CSE1|XPO2	protein_coding	P55060	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22812
1.93826987685148e-42	-0.31846642502817	0.101	0.321	4.42991580354406e-38	EIF2B2	Malignant cells	GSE175716	ENSG00000119718	8892	eukaryotic translation initiation factor 2B subunit beta	EIF-2Bbeta|EIF2B|EIF2Bbeta	protein_coding	P49770	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22813
2.15830029820517e-42	0.693496653213101	0.82	0.634	4.93279533154791e-38	GLRX	Malignant cells	GSE175716	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22814
2.4778100807319e-42	-0.424810295875082	0.148	0.374	5.66303493951275e-38	MAPK1	Malignant cells	GSE175716	ENSG00000100030	5594	mitogen-activated protein kinase 1	ERK|ERK2|MAPK2|p41mapk|PRKM1|PRKM2	protein_coding	P28482	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22815
3.37905313951369e-42	0.29198196559869	0.952	0.623	7.72282595035855e-38	ATP6V0B	Malignant cells	GSE175716	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22816
3.5070161388466e-42	-0.341003842863933	0.072	0.278	8.01528538533391e-38	PDE12	Malignant cells	GSE175716	ENSG00000174840	201626	phosphodiesterase 12	2'-PDE|3635|DKFZp667B1218	protein_coding	Q6L8Q7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22817
3.94917590182042e-42	-0.482168112337253	0.182	0.417	9.02584152361057e-38	EXT1	Malignant cells	GSE175716	ENSG00000182197	2131	exostosin glycosyltransferase 1	LGCR|LGS|ttv	protein_coding	Q16394	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22818
4.05918534319436e-42	-0.386407666455704	0.18	0.411	9.27726810187071e-38	TRIM8	Malignant cells	GSE175716	ENSG00000171206	81603	tripartite motif containing 8	GERP|RNF27	protein_coding	Q9BZR9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22819
4.458272320572e-42	-0.480828268551789	0.181	0.408	1.01893813886673e-37	ANKRD17	Malignant cells	GSE175716	ENSG00000132466	26057	ankyrin repeat domain 17	FLJ22206|GTAR|KIAA0697|MASK2|NY-BR-16	protein_coding	O75179	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22820
4.65496634207269e-42	-0.368996281794404	0.11	0.326	1.06389255748071e-37	CHURC1	Malignant cells	GSE175716	ENSG00000258289	91612	churchill domain containing 1	C14orf52|FLJ33064|My015	protein_coding	Q8WUH1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22821
4.65635618506288e-42	-0.405500949244762	0.127	0.349	1.06421020609612e-37	ARRB2	Malignant cells	GSE175716	ENSG00000141480	409	arrestin beta 2	ARR2|BARR2|DKFZp686L0365	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22822
4.67901918887106e-42	-0.535418410584585	0.973	0.992	1.06938983561648e-37	NAP1L1	Malignant cells	GSE175716	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22823
5.49224794616938e-42	-1.29250383627358	0.513	0.621	1.25525326809701e-37	ARID5B	Malignant cells	GSE175716	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22824
5.65576159940546e-42	-0.523808280016721	0.08	0.283	1.29262431354412e-37	DUSP10	Malignant cells	GSE175716	ENSG00000143507	11221	dual specificity phosphatase 10	MKP-5|MKP5	protein_coding	Q9Y6W6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22825
6.44610634713683e-42	-0.458629532231828	0.591	0.746	1.47325760563812e-37	TMEM2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22826
6.77935300160857e-42	-0.315153985157323	0.055	0.253	1.54942112851764e-37	PIP4K2C	Malignant cells	GSE175716	ENSG00000166908	79837	phosphatidylinositol-5-phosphate 4-kinase type 2 gamma	FLJ22055|PIP5K2C	protein_coding	Q8TBX8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22827
6.93761337115707e-42	-0.349474023225337	0.112	0.329	1.58559153597795e-37	GOLT1B	Malignant cells	GSE175716	ENSG00000111711	51026	golgi transport 1B	CGI-141|GOT1|YMR292W	protein_coding	Q9Y3E0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22828
6.93910511041679e-42	-0.425985813520174	0.157	0.381	1.58593247298576e-37	ZNF330	Malignant cells	GSE175716	ENSG00000109445	27309	zinc finger protein 330	HSA6591|NOA36	protein_coding	Q9Y3S2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22829
7.12406039695342e-42	-0.448242674094001	0.229	0.447	1.6282040037237e-37	MRPS7	Malignant cells	GSE175716	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22830
8.25370192413758e-42	-0.479450469679613	0.099	0.304	1.88638357476164e-37	SRC	Malignant cells	GSE175716	ENSG00000197122	6714	SRC proto-oncogene, non-receptor tyrosine kinase	ASV|c-src|SRC1	protein_coding	P12931	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22831
8.50144264103521e-42	-0.371260651255657	0.075	0.279	1.9430047156086e-37	IFT43	Malignant cells	GSE175716	ENSG00000119650	112752	intraflagellar transport 43	C14orf179|FLJ32173|MGC16028	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22832
1.00331569929305e-41	-0.308890229801669	0.057	0.258	2.29307803073426e-37	ORMDL2	Malignant cells	GSE175716	ENSG00000123353	29095	ORMDL sphingolipid biosynthesis regulator 2	adoplin-2|HSPC160|MST095|MSTP095	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22833
1.16938402106132e-41	0.463190763212732	0.457	0.27	2.67262718013565e-37	AL365357.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22834
1.17387356053467e-41	-0.940699070820028	0.537	0.64	2.68288802260199e-37	JMJD1C	Malignant cells	GSE175716	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22835
1.22788280257539e-41	-0.427272655449336	0.611	0.749	2.80632614528605e-37	ZFR	Malignant cells	GSE175716	ENSG00000056097	51663	zinc finger RNA binding protein	SPG71|ZFR1	protein_coding	Q96KR1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22836
1.24184577707775e-41	0.359075831668576	0.283	0.125	2.8382385235112e-37	ANKMY2	Malignant cells	GSE175716	ENSG00000106524	57037	ankyrin repeat and MYND domain containing 2	DKFZP564O043|ZMYND20	protein_coding	Q8IV38	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22837
1.39222369922376e-41	-0.351034186855486	0.13	0.356	3.18192726457591e-37	KDM2A	Malignant cells	GSE175716	ENSG00000173120	22992	lysine demethylase 2A	CXXC8|DKFZP434M1735|FBL11|FBL7|FBXL11|FLJ00115|JHDM1A|KIAA1004|LILINA	protein_coding	Q9Y2K7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22838
1.73389704381705e-41	-0.339313551386021	0.147	0.38	3.96282169364387e-37	GOT2	Malignant cells	GSE175716	ENSG00000125166	2806	glutamic-oxaloacetic transaminase 2	KAT4|KATIV|KYAT4|mitAAT	protein_coding	P00505	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22839
1.76305838149408e-41	-0.405738604498655	0.174	0.405	4.02946993090472e-37	ERBIN	Malignant cells	GSE175716	ENSG00000112851	55914	erbb2 interacting protein	ERBB2IP|LAP2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22840
1.8115930942364e-41	0.377084767132582	0.986	0.977	4.1403960168773e-37	SET	Malignant cells	GSE175716	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22841
1.84648558693842e-41	0.432189804409772	0.985	0.972	4.22014280894777e-37	HNRNPA1	Malignant cells	GSE175716	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22842
2.11736644326451e-41	-0.354786991866784	0.099	0.316	4.83924100608103e-37	EIF1AD	Malignant cells	GSE175716	ENSG00000175376	84285	eukaryotic translation initiation factor 1A domain containing	haponin|MGC11102	protein_coding	Q8N9N8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22843
2.13813403629788e-41	-0.413177768559349	0.142	0.363	4.8867053399588e-37	FECH	Malignant cells	GSE175716	ENSG00000066926	2235	ferrochelatase	NA	protein_coding	P22830	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22844
2.60559397067214e-41	-0.395922032168635	0.069	0.269	5.95508501997118e-37	ESCO1	Malignant cells	GSE175716	ENSG00000141446	114799	establishment of sister chromatid cohesion N-acetyltransferase 1	EFO1|ESO1|KIAA1911	protein_coding	Q5FWF5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22845
2.80793495498018e-41	-0.39556330960879	0.101	0.313	6.41753533960721e-37	ARL3	Malignant cells	GSE175716	ENSG00000138175	403	ADP ribosylation factor like GTPase 3	ARFL3	protein_coding	P36405	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22846
2.91067186813104e-41	-0.401403097427977	0.139	0.361	6.6523405546135e-37	ITPRIPL2	Malignant cells	GSE175716	ENSG00000205730	162073	ITPRIP like 2	FLJ22994|LOC162073|MGC126798|MGC126800	protein_coding	Q3MIP1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22847
3.15731123778564e-41	0.397907435571688	0.749	0.516	7.21603483395907e-37	IRAK1	Malignant cells	GSE175716	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22848
3.16381235862544e-41	-0.319418175080232	0.064	0.265	7.23089314563844e-37	WHAMM	Malignant cells	GSE175716	ENSG00000156232	123720	WASP homolog associated with actin, golgi membranes and microtubules	KIAA1971|WHAMM1|WHDC1	protein_coding	Q8TF30	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22849
3.20138750380193e-41	0.434996382196916	0.852	0.67	7.31677113993932e-37	DAP3	Malignant cells	GSE175716	ENSG00000132676	7818	death associated protein 3	bMRP-10|DAP-3|DKFZp686G12159|MGC126058|MGC126059|MRP-S29|MRPS29	protein_coding	P51398	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22850
3.84510354982201e-41	-0.362749666024085	0.151	0.386	8.78798416311821e-37	SPSB1	Malignant cells	GSE175716	ENSG00000171621	80176	splA/ryanodine receptor domain and SOCS box containing 1	SSB-1	protein_coding	Q96BD6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22851
3.91398512072397e-41	0.399035502645312	0.31	0.149	8.94541299341464e-37	EPHB4	Malignant cells	GSE175716	ENSG00000196411	2050	EPH receptor B4	HTK|Tyro11	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22852
4.07612558957527e-41	-0.40973497313458	0.539	0.694	9.31598503497429e-37	PSMD6	Malignant cells	GSE175716	ENSG00000163636	9861	proteasome 26S subunit, non-ATPase 6	KIAA0107|p44S10|Rpn7|S10	protein_coding	Q15008	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22853
4.25839701214596e-41	-0.384656697813521	0.743	0.828	9.73256637125958e-37	CHP1	Malignant cells	GSE175716	ENSG00000187446	11261	calcineurin like EF-hand protein 1	CHP|p22|p24|Sid470p|SLC9A1BP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22854
4.37215774723037e-41	0.436476531913325	0.341	0.174	9.99256653129502e-37	KPNA3	Malignant cells	GSE175716	ENSG00000102753	3839	karyopherin subunit alpha 3	hSRP1|IPOA4|SRP1gamma|SRP4	protein_coding	O00505	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22855
4.7623498114131e-41	0.444303807975057	0.637	0.438	1.08843504939846e-36	IFRD1	Malignant cells	GSE175716	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22856
5.10094556535998e-41	-0.411791191836019	0.337	0.548	1.16582110896302e-36	DYNLL2	Malignant cells	GSE175716	ENSG00000264364	140735	dynein light chain LC8-type 2	Dlc2|DNCL1B|MGC17810|RSPH22	protein_coding	Q96FJ2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22857
5.27328762966494e-41	-0.652766197330217	0.376	0.546	1.20520988775992e-36	PLEKHF2	Malignant cells	GSE175716	ENSG00000175895	79666	pleckstrin homology and FYVE domain containing 2	FLJ13187|PHAFIN2|ZFYVE18	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22858
5.55324640307364e-41	0.418445030638361	0.981	0.907	1.26919446542248e-36	YWHAB	Malignant cells	GSE175716	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22859
5.55536393559958e-41	-0.523902393508191	0.694	0.776	1.26967842748128e-36	FUNDC2	Malignant cells	GSE175716	ENSG00000165775	65991	FUN14 domain containing 2	DC44|HCBP6	protein_coding	Q9BWH2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22860
6.18838612329013e-41	-0.472935401644443	0.18	0.398	1.41435564847796e-36	RHOQ	Malignant cells	GSE175716	ENSG00000119729	23433	ras homolog family member Q	ARHQ|RASL7A|TC10	protein_coding	P17081	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22861
6.69585929207853e-41	-0.365207892653512	0.144	0.369	1.53033864120455e-36	RICTOR	Malignant cells	GSE175716	ENSG00000164327	253260	RPTOR independent companion of MTOR complex 2	AVO3|KIAA1999|MGC39830|PIA	protein_coding	Q6R327	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22862
7.29576259441426e-41	-0.409221805120613	0.157	0.383	1.66744654095338e-36	CTR9	Malignant cells	GSE175716	ENSG00000198730	9646	CTR9 homolog, Paf1/RNA polymerase II complex component	KIAA0155|p150TSP|SH2BP1|TSBP	protein_coding	Q6PD62	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22863
7.50988503651353e-41	-0.511804823289792	0.613	0.744	1.71638422509517e-36	RDH10	Malignant cells	GSE175716	ENSG00000121039	157506	retinol dehydrogenase 10	SDR16C4	protein_coding	Q8IZV5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22864
8.5784759056923e-41	0.364229095401256	0.272	0.119	1.96061066824597e-36	ABCA5	Malignant cells	GSE175716	ENSG00000154265	23461	ATP binding cassette subfamily A member 5	EST90625	protein_coding	Q8WWZ7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22865
9.87888592255299e-41	-0.368247726999411	0.073	0.275	2.25781937759949e-36	RASAL2	Malignant cells	GSE175716	ENSG00000075391	9462	RAS protein activator like 2	nGAP	protein_coding	Q9UJF2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22866
1.03033041041193e-40	0.400401756973829	0.362	0.182	2.35482015299648e-36	ABRACL	Malignant cells	GSE175716	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22867
1.04521737774075e-40	-0.422766073345517	0.558	0.705	2.38884431682649e-36	TIMM10	Malignant cells	GSE175716	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22868
1.05102767676807e-40	-0.482022089013204	0.091	0.294	2.40212375525343e-36	ANXA3	Malignant cells	GSE175716	ENSG00000138772	306	annexin A3	ANX3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22869
1.05700454991772e-40	0.412195381677632	0.328	0.167	2.41578389883695e-36	NUP205	Malignant cells	GSE175716	ENSG00000155561	23165	nucleoporin 205	C7orf14|KIAA0225	protein_coding	Q92621	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22870
1.07932136095826e-40	-0.51451057344137	0.113	0.316	2.46678897047011e-36	BAK1	Malignant cells	GSE175716	ENSG00000030110	578	BCL2 antagonist/killer 1	BAK|BCL2L7|CDN1	protein_coding	Q16611	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22871
1.20673234406606e-40	-0.35318013521591	0.129	0.352	2.75798677236297e-36	ZNF271P	Malignant cells	GSE175716	ENSG00000257267	10778	zinc finger protein 271, pseudogene	HZF7|ZNF271|ZNFEB	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22872
1.24479072874328e-40	-0.352990040775244	0.118	0.338	2.84496921054277e-36	HUWE1	Malignant cells	GSE175716	ENSG00000086758	10075	HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1	Ib772|KIAA0312|UREB1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22873
1.30013091383574e-40	-0.346452524751016	0.063	0.259	2.97144920357159e-36	AC004057.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22874
1.3333856519982e-40	-0.338029650387495	0.074	0.274	3.04745290764189e-36	ORMDL3	Malignant cells	GSE175716	ENSG00000172057	94103	ORMDL sphingolipid biosynthesis regulator 3	NA	protein_coding	Q8N138	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22875
1.34801628628861e-40	-0.539626972927807	0.625	0.727	3.08089122231262e-36	C2	Malignant cells	GSE175716	ENSG00000231543	717	complement C2	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22876
1.34938549934425e-40	-0.363971145191247	0.082	0.288	3.08402055875129e-36	RNF24	Malignant cells	GSE175716	ENSG00000101236	11237	ring finger protein 24	G1L	protein_coding	Q9Y225	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22877
1.49077558173238e-40	-0.370057337138055	0.147	0.369	3.40716759204936e-36	TCEAL4	Malignant cells	GSE175716	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22878
1.50748137363742e-40	-0.421717618001487	0.088	0.297	3.44534867944833e-36	CPEB4	Malignant cells	GSE175716	ENSG00000113742	80315	cytoplasmic polyadenylation element binding protein 4	KIAA1673	protein_coding	Q17RY0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22879
1.83983487525296e-40	-1.30450846063407	0.267	0.434	4.20494260739063e-36	TFPI2	Malignant cells	GSE175716	ENSG00000105825	7980	tissue factor pathway inhibitor 2	PP5|REF1|TFPI-2	protein_coding	P48307	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22880
2.00195856898716e-40	-0.322671053126407	0.078	0.281	4.57547630942015e-36	PSMD10	Malignant cells	GSE175716	ENSG00000101843	5716	proteasome 26S subunit, non-ATPase 10	p28	protein_coding	O75832	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22881
2.14582970988293e-40	-0.367876895973299	0.189	0.423	4.90429380193743e-36	RAB22A	Malignant cells	GSE175716	ENSG00000124209	57403	RAB22A, member RAS oncogene family	NA	protein_coding	Q9UL26	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22882
2.21709132595337e-40	0.352409635149706	0.99	0.834	5.06716222546643e-36	OAZ1	Malignant cells	GSE175716	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22883
2.24964193379563e-40	-0.384803591880361	0.09	0.297	5.1415566396899e-36	ATXN7	Malignant cells	GSE175716	ENSG00000163635	6314	ataxin 7	ADCAII|OPCA3|SCA7|SGF73	protein_coding	O15265	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22884
2.28048628037969e-40	-0.370372903302569	0.151	0.373	5.21205139380778e-36	RTL8C	Malignant cells	GSE175716	ENSG00000134590	8933	retrotransposon Gag like 8C	CXX1|FAM127A|Mar8|MAR8C|Mart8|SIRH5	protein_coding	A6ZKI3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22885
2.46665343720023e-40	-0.398326411913023	0.6	0.742	5.63753643072113e-36	CRK	Malignant cells	GSE175716	ENSG00000167193	1398	CRK proto-oncogene, adaptor protein	NA	protein_coding	P46108	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22886
2.76916853361e-40	0.511793664700398	0.899	0.789	6.32893468356564e-36	IARS2	Malignant cells	GSE175716	ENSG00000067704	55699	isoleucyl-tRNA synthetase 2, mitochondrial	FLJ10326	protein_coding	Q9NSE4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22887
2.93663255476991e-40	-0.532281657252392	0.117	0.324	6.71167370392664e-36	CSPP1	Malignant cells	GSE175716	ENSG00000104218	79848	centrosome and spindle pole associated protein 1	CSPP|CSPP-L|FLJ22490|JBTS21	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22888
3.35090634908798e-40	-0.346711008593926	0.178	0.412	7.65849646084058e-36	RTL8A	Malignant cells	GSE175716	ENSG00000203950	26071	retrotransposon Gag like 8A	CXX1b|DKFZP564B147|FAM127B|MAR8A|SIRH6	protein_coding	Q9BWD3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22889
3.3523764366353e-40	0.52006285771793	0.628	0.458	7.66185634592997e-36	ADSS	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22890
3.57934005287867e-40	-0.377836843602659	0.141	0.364	8.18058169085421e-36	NUP58	Malignant cells	GSE175716	ENSG00000139496	9818	nucleoporin 58	KIAA0410|NUP45|NUPL1	protein_coding	Q9BVL2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22891
3.77032502193644e-40	-0.357157247122102	0.133	0.351	8.61707783763574e-36	CCDC90B	Malignant cells	GSE175716	ENSG00000137500	60492	coiled-coil domain containing 90B	MDS011|MDS025	protein_coding	Q9GZT6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22892
3.89097199746367e-40	-0.353049249495461	0.089	0.293	8.89281650020322e-36	MLXIP	Malignant cells	GSE175716	ENSG00000281178	22877	MLX interacting protein	bHLHe36|KIAA0867|MIR|MONDOA	protein_coding	Q9HAP2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22893
3.94248014612568e-40	0.579807516212993	0.847	0.725	9.01053837397023e-36	LBR	Malignant cells	GSE175716	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22894
4.10252832744686e-40	-0.434880698756943	0.264	0.476	9.3763284923798e-36	MRPL43	Malignant cells	GSE175716	ENSG00000055950	84545	mitochondrial ribosomal protein L43	bMRP36a	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22895
4.45943376794485e-40	-0.362628478699837	0.084	0.287	1.0192035876638e-35	GPR157	Malignant cells	GSE175716	ENSG00000180758	80045	G protein-coupled receptor 157	FLJ12132	protein_coding	Q5UAW9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22896
4.67524074813367e-40	0.613871746580532	0.45	0.283	1.06852627298595e-35	FAM83A	Malignant cells	GSE175716	ENSG00000147689	84985	family with sequence similarity 83 member A	BJ-TSA-9|MGC14128	protein_coding	Q86UY5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22897
4.85358370475313e-40	-0.450406514380521	0.069	0.262	1.10928655572133e-35	PMP22	Malignant cells	GSE175716	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22898
5.00904407558195e-40	-0.339240516175669	0.12	0.34	1.14481702347426e-35	SETX	Malignant cells	GSE175716	ENSG00000107290	23064	senataxin	ALS4|AOA2|KIAA0625|SCAR1|Sen1|STEX	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22899
5.71510531414021e-40	0.384394468076991	0.797	0.602	1.30618731954675e-35	DARS	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22900
6.71884102259961e-40	0.441430440195937	0.74	0.534	1.53559111571514e-35	CTNNAL1	Malignant cells	GSE175716	ENSG00000119326	8727	catenin alpha like 1	alpha-CATU|CLLP	protein_coding	Q9UBT7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22901
7.41956501561837e-40	-0.386259177796639	0.188	0.414	1.69574158431958e-35	TPRKB	Malignant cells	GSE175716	ENSG00000144034	51002	TP53RK binding protein	CGI-121|CGI121	protein_coding	Q9Y3C4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22902
7.57915614452391e-40	-0.350278683007649	0.066	0.262	1.73221613683094e-35	DCAF5	Malignant cells	GSE175716	ENSG00000139990	8816	DDB1 and CUL4 associated factor 5	BCRG2|BCRP2|D14S1461E|KIAA1824|WDR22	protein_coding	Q96JK2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22903
7.67487680146283e-40	0.380306305459578	0.968	0.84	1.75409309297433e-35	CCT3	Malignant cells	GSE175716	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22904
8.41370527331038e-40	-0.379757694588353	0.091	0.293	1.92295234021509e-35	FBXW11	Malignant cells	GSE175716	ENSG00000072803	23291	F-box and WD repeat domain containing 11	BTRC2|BTRCP2|Fbw11|Fbw1b|FBXW1B|Hos|KIAA0696	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22905
9.25633461203993e-40	-0.354201738545223	0.134	0.352	2.11553527558173e-35	ANXA2P2	Malignant cells	GSE175716	ENSG00000231991	NA	NA	ANX2L2|ANX2P2|LPC2B	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22906
9.8705416930378e-40	-0.300111344245878	0.073	0.273	2.25591230394379e-35	SLC35A2	Malignant cells	GSE175716	ENSG00000102100	7355	solute carrier family 35 member A2	UGALT|UGAT|UGT|UGT1|UGT2|UGTL	protein_coding	P78381	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22907
1.01184625143888e-39	-0.396276721598004	0.175	0.396	2.31257460766355e-35	NADK2	Malignant cells	GSE175716	ENSG00000152620	133686	NAD kinase 2, mitochondrial	C5orf33|FLJ30596|MNADK|NADKD1	protein_coding	Q4G0N4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22908
1.02097454715242e-39	0.33151570593037	0.306	0.143	2.33343732751687e-35	ST8SIA6-AS1	Malignant cells	GSE175716	ENSG00000204832	100128098	ST8SIA6 antisense RNA 1	APAL	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22909
1.13002493229404e-39	0.353299268619767	0.347	0.174	2.58267198275803e-35	AL122020.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22910
1.15721067662632e-39	-0.310925341190143	0.1	0.309	2.64480500142946e-35	SNX12	Malignant cells	GSE175716	ENSG00000147164	29934	sorting nexin 12	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22911
1.25692886473472e-39	-0.362838432010739	0.143	0.363	2.87271092035121e-35	PTRHD1	Malignant cells	GSE175716	ENSG00000184924	391356	peptidyl-tRNA hydrolase domain containing 1	C2orf79|LOC391356	protein_coding	Q6GMV3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22912
1.25710425986336e-39	-0.367690040531069	0.106	0.317	2.87311178591771e-35	SERPINB9	Malignant cells	GSE175716	ENSG00000170542	5272	serpin family B member 9	CAP3|PI9	protein_coding	P50453	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22913
1.43565986201489e-39	-0.372418523043047	0.182	0.404	3.28120061463504e-35	NDUFV2P1	Malignant cells	GSE175716	ENSG00000267809	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22914
1.53531855730565e-39	-0.387245233808579	0.891	0.921	3.50897056272206e-35	RPN2	Malignant cells	GSE175716	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22915
1.70426315876062e-39	-0.631574152151399	0.955	0.922	3.89509344934741e-35	PGK1	Malignant cells	GSE175716	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22916
1.72709326751854e-39	-0.379214836392588	0.126	0.343	3.94727166291363e-35	TLCD1	Malignant cells	GSE175716	ENSG00000160606	116238	TLC domain containing 1	NA	protein_coding	Q96CP7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22917
1.90565533014552e-39	-0.397737393510669	0.999	0.999	4.35537525704759e-35	RPL15	Malignant cells	GSE175716	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22918
2.18946690275536e-39	-0.321426200625599	0.075	0.274	5.00402660624736e-35	KDELR3	Malignant cells	GSE175716	ENSG00000100196	11015	KDEL endoplasmic reticulum protein retention receptor 3	NA	protein_coding	O43731	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22919
2.20501812902214e-39	0.513841879509988	0.379	0.217	5.03956893388011e-35	TMEM120A	Malignant cells	GSE175716	ENSG00000189077	83862	transmembrane protein 120A	NET29|TACAN|TMPIT	protein_coding	Q9BXJ8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22920
2.28302212697734e-39	-0.429720654208241	0.173	0.395	5.21784707120672e-35	ATXN7L3B	Malignant cells	GSE175716	ENSG00000253719	552889	ataxin 7 like 3B	lnc-SCA7	protein_coding	Q96GX2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22921
2.31933564714899e-39	-0.393698784766032	0.133	0.345	5.30084162155901e-35	BTD	Malignant cells	GSE175716	ENSG00000169814	686	biotinidase	NA	protein_coding	P43251	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22922
2.38416560296865e-39	0.388995689077943	0.658	0.451	5.44901048558486e-35	HEBP2	Malignant cells	GSE175716	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22923
2.55502343690442e-39	-0.384559470194661	0.732	0.823	5.83950606504505e-35	MRPL27	Malignant cells	GSE175716	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22924
3.15578803910971e-39	-0.498065279968092	0.678	0.799	7.21255356338524e-35	DUSP6	Malignant cells	GSE175716	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22925
3.27449276638205e-39	0.38055216929203	0.815	0.617	7.48385321756617e-35	H3F3AP4	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22926
3.3187618717194e-39	-0.340793229083096	0.099	0.305	7.58503025781468e-35	TRIM26	Malignant cells	GSE175716	ENSG00000231002	7726	tripartite motif containing 26	RNF95|ZNF173	protein_coding	Q12899	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22927
3.42424058751217e-39	-0.360657976238993	0.174	0.399	7.82610186275906e-35	SPCS2P4	Malignant cells	GSE175716	ENSG00000228589	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22928
3.58100580468028e-39	-0.578721846822317	0.182	0.382	8.18438876659677e-35	EIF1P3	Malignant cells	GSE175716	ENSG00000231684	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22929
3.76939778042731e-39	-0.33444224668848	0.087	0.287	8.61495862716661e-35	LEO1	Malignant cells	GSE175716	ENSG00000166477	123169	LEO1 homolog, Paf1/RNA polymerase II complex component	NA	protein_coding	Q8WVC0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22930
3.92020530274768e-39	-0.35904159783336	0.117	0.326	8.95962921942982e-35	BTBD7	Malignant cells	GSE175716	ENSG00000277222	55727	BTB domain containing 7	FLJ10648|FUP1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22931
3.98028525525589e-39	-0.361641030400723	0.098	0.303	9.09694195088733e-35	RASSF1	Malignant cells	GSE175716	ENSG00000068028	11186	Ras association domain family member 1	123F2|NORE2A|RDA32|REH3P21	protein_coding	Q9NS23	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22932
4.01875282961452e-39	-0.337784183035935	0.088	0.287	9.18485959208399e-35	PIAS1	Malignant cells	GSE175716	ENSG00000033800	8554	protein inhibitor of activated STAT 1	DDXBP1|GBP|GU/RH-II|ZMIZ3	protein_coding	O75925	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22933
4.06813246070704e-39	-0.325514297266134	0.109	0.32	9.29771673894593e-35	SLC30A7	Malignant cells	GSE175716	ENSG00000162695	148867	solute carrier family 30 member 7	ZNT7|ZnTL2	protein_coding	Q8NEW0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22934
4.83284884329225e-39	-0.420796436983409	0.152	0.368	1.10454760313444e-34	SETD2	Malignant cells	GSE175716	ENSG00000181555	29072	SET domain containing 2, histone lysine methyltransferase	FLJ23184|HIF-1|HYPB|KIAA1732|KMT3A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22935
5.92741079584808e-39	-0.317253702736295	0.084	0.285	1.35470973739108e-34	LINC00667	Malignant cells	GSE175716	ENSG00000263753	339290	long intergenic non-protein coding RNA 667	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22936
6.17825164832454e-39	-0.405577471248875	0.093	0.293	1.41203941422457e-34	MAP3K1	Malignant cells	GSE175716	ENSG00000095015	4214	mitogen-activated protein kinase kinase kinase 1	MAPKKK1|MEKK|MEKK1	protein_coding	Q13233	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22937
6.2264642039986e-39	-0.409366689448478	0.124	0.332	1.42305839382388e-34	AP1AR	Malignant cells	GSE175716	ENSG00000138660	55435	adaptor related protein complex 1 associated regulatory protein	2C18|C4orf16|gamma-BAR|PRO0971	protein_coding	Q63HQ0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22938
6.53372526357424e-39	-0.404240314916775	0.197	0.421	1.49328290898989e-34	TJP2	Malignant cells	GSE175716	ENSG00000119139	9414	tight junction protein 2	DFNA51|X104|ZO-2|ZO2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22939
6.67792131920472e-39	-0.421647904631482	0.163	0.385	1.52623891750424e-34	BDP1	Malignant cells	GSE175716	ENSG00000274803	55814	B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB	HSA238520|KIAA1241|KIAA1689|TAF3B1|TFC5|TFIIIB150|TFIIIB90|TFNR	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22940
6.70549941647874e-39	0.552381358163559	0.439	0.266	1.53254189163622e-34	MAP3K8	Malignant cells	GSE175716	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22941
7.25466033594699e-39	-0.356095923238172	0.102	0.306	1.65805261978068e-34	COX17P1	Malignant cells	GSE175716	ENSG00000205105	NA	NA	COX17P	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22942
7.33397803022229e-39	-0.356801201157675	0.144	0.359	1.67618067880731e-34	PHAX	Malignant cells	GSE175716	ENSG00000164902	51808	phosphorylated adaptor for RNA export	FLJ13193|RNUXA	protein_coding	Q9H814	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22943
7.41359528685797e-39	-0.522438280604396	0.977	0.973	1.69437720281139e-34	SRP14	Malignant cells	GSE175716	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22944
7.46998333369817e-39	-0.331915920893776	0.064	0.253	1.70726469091672e-34	POMGNT1	Malignant cells	GSE175716	ENSG00000085998	55624	protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)	FLJ20277|LGMD2O|MEB|MGAT1.2	protein_coding	Q8WZA1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22945
8.09847580951322e-39	-0.394232654742897	0.823	0.887	1.85090664626425e-34	SCP2	Malignant cells	GSE175716	ENSG00000116171	6342	sterol carrier protein 2	NA	protein_coding	P22307	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22946
8.34156942862219e-39	-0.354983150772524	0.177	0.406	1.9064656929116e-34	CES1	Malignant cells	GSE175716	ENSG00000262243	1066	carboxylesterase 1	CEH|CES1A1|CES1A2|CES2|HMSE|HMSE1|SES1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22947
8.4776123877857e-39	-0.517391112633776	0.523	0.667	1.93755831122842e-34	FGD5-AS1	Malignant cells	GSE175716	ENSG00000225733	100505641	FGD5 antisense RNA 1	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22948
9.31175748992279e-39	-0.373422997439101	0.246	0.472	2.12820217432185e-34	YIPF5	Malignant cells	GSE175716	ENSG00000145817	81555	Yip1 domain family member 5	FinGER5|SMAP-5	protein_coding	Q969M3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22949
9.43546032370321e-39	-0.342689817699668	0.101	0.305	2.15647445698237e-34	RC3H1	Malignant cells	GSE175716	ENSG00000135870	149041	ring finger and CCCH-type domains 1	KIAA2025|RNF198|roquin|RP5-1198E17.5	protein_coding	Q5TC82	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22950
1.00294021420398e-38	-0.798458997842414	0.378	0.508	2.2922198595632e-34	SELENOW	Malignant cells	GSE175716	ENSG00000178980	6415	selenoprotein W	SELW|SEPW1	protein_coding	P63302	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22951
1.01146692073362e-38	-0.597505663072626	0.401	0.548	2.31170764733669e-34	ELOVL1	Malignant cells	GSE175716	ENSG00000066322	64834	ELOVL fatty acid elongase 1	Ssc1	protein_coding	Q9BW60	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22952
1.09406610785843e-38	-0.424990622805791	0.885	0.928	2.50048808951045e-34	PRRC2C	Malignant cells	GSE175716	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22953
1.10701135710885e-38	-0.49050196203995	0.143	0.348	2.53007445667228e-34	RASSF3	Malignant cells	GSE175716	ENSG00000153179	283349	Ras association domain family member 3	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22954
1.157854057137e-38	-0.424484626626075	0.788	0.861	2.64627544758662e-34	LSM3	Malignant cells	GSE175716	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22955
1.1951159115859e-38	0.332753432417887	0.257	0.111	2.73143741592957e-34	TTLL12	Malignant cells	GSE175716	ENSG00000100304	23170	tubulin tyrosine ligase like 12	KIAA0153	protein_coding	Q14166	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22956
1.20937003195767e-38	-0.361688866385796	0.148	0.364	2.76401520803925e-34	RAB5B	Malignant cells	GSE175716	ENSG00000111540	5869	RAB5B, member RAS oncogene family	NA	protein_coding	P61020	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22957
1.21341882586873e-38	-0.570708452490548	0.181	0.383	2.77326872652299e-34	CFAP97	Malignant cells	GSE175716	ENSG00000164323	57587	cilia and flagella associated protein 97	DKFZp434F1728|hmw|KIAA1430	protein_coding	Q9P2B7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22958
1.24132820531855e-38	-0.676306472391629	0.998	0.982	2.83705561325554e-34	COX6A1	Malignant cells	GSE175716	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22959
1.45542201234289e-38	-0.663899012703372	0.4	0.544	3.32636700920967e-34	EHD1	Malignant cells	GSE175716	ENSG00000110047	10938	EH domain containing 1	FLJ42622|FLJ44618|H-PAST|HPAST1|PAST1	protein_coding	Q9H4M9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22960
1.61967979304984e-38	0.400158956783049	0.333	0.171	3.7017781670154e-34	SMIM4	Malignant cells	GSE175716	ENSG00000168273	440957	small integral membrane protein 4	C3orf78	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22961
1.64547090187141e-38	0.452575203154847	0.861	0.722	3.7607237462271e-34	PDCD5	Malignant cells	GSE175716	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22962
1.64730961206403e-38	-0.334641065899894	0.144	0.367	3.76492611837234e-34	SAMD4B	Malignant cells	GSE175716	ENSG00000179134	55095	sterile alpha motif domain containing 4B	FLJ10211|hSmaug2|MGC99832|SMGB	protein_coding	Q5PRF9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22963
1.65554222381818e-38	-0.401606663424175	0.567	0.714	3.78374175253646e-34	AKIRIN1	Malignant cells	GSE175716	ENSG00000174574	79647	akirin 1	C1orf108|FLJ12666	protein_coding	Q9H9L7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22964
1.83899802719827e-38	-0.34612111729528	0.116	0.327	4.20302999116165e-34	LCOR	Malignant cells	GSE175716	ENSG00000196233	84458	ligand dependent nuclear receptor corepressor	C10orf12|DKFZP564P1916|FLJ13022|FLJ38026|KIAA1795|MLR2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22965
1.88988874466066e-38	-0.317995295225325	0.181	0.412	4.31934072592194e-34	SMIM20	Malignant cells	GSE175716	ENSG00000250317	389203	small integral membrane protein 20	C4orf52|MITRAC7|PNX	protein_coding	Q8N5G0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22966
1.93531304611247e-38	-0.35174010006039	0.698	0.805	4.42315796689004e-34	NDUFC1	Malignant cells	GSE175716	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22967
2.12738109498533e-38	-0.349971890958169	0.166	0.392	4.86212949258898e-34	RNF213	Malignant cells	GSE175716	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22968
2.38205919843462e-38	-0.373270315961826	0.084	0.278	5.44419629802233e-34	ADRM1	Malignant cells	GSE175716	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22969
2.82670991972747e-38	-0.574705764116309	0.552	0.675	6.46044552153712e-34	SAV1	Malignant cells	GSE175716	ENSG00000151748	60485	salvador family WW domain containing protein 1	salvador|WW45|WWP4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22970
3.29471685130902e-38	-0.315593715162879	0.098	0.299	7.53007536366678e-34	DPAGT1	Malignant cells	GSE175716	ENSG00000172269	1798	dolichyl-phosphate N-acetylglucosaminephosphotransferase 1	ALG7|CDG-Ij|D11S366|DGPT|DPAGT|DPAGT2|GPT	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22971
3.47427117228699e-38	-0.405017565725863	0.69	0.796	7.94044676426192e-34	PSMD12	Malignant cells	GSE175716	ENSG00000197170	5718	proteasome 26S subunit, non-ATPase 12	p55|Rpn5	protein_coding	O00232	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22972
3.7714594310223e-38	-0.357533621158785	0.168	0.385	8.61967052960146e-34	TRIM44	Malignant cells	GSE175716	ENSG00000166326	54765	tripartite motif containing 44	DIPB|MC7	protein_coding	Q96DX7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22973
3.82849460759308e-38	-0.420994799380059	0.181	0.397	8.75002442565399e-34	PDIA6	Malignant cells	GSE175716	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22974
5.21089732263723e-38	-0.468726413620397	0.164	0.369	1.19095058308874e-33	TMEM208	Malignant cells	GSE175716	ENSG00000168701	29100	transmembrane protein 208	hSND2|HSPC171	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22975
5.71655125422461e-38	0.553797166132728	0.477	0.32	1.30651778915304e-33	DAZAP1	Malignant cells	GSE175716	ENSG00000071626	26528	DAZ associated protein 1	MGC19907	protein_coding	Q96EP5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22976
5.80806261519533e-38	0.526822551097293	0.318	0.164	1.32743271070289e-33	RCAN1	Malignant cells	GSE175716	ENSG00000159200	1827	regulator of calcineurin 1	DSCR1	protein_coding	P53805	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22977
5.90127756268811e-38	0.422728226375109	0.956	0.901	1.34873698695237e-33	SSBP1	Malignant cells	GSE175716	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22978
6.46112549227409e-38	-0.325058564574315	0.183	0.412	1.47669023125924e-33	SYS1	Malignant cells	GSE175716	ENSG00000204070	90196	SYS1 golgi trafficking protein	C20orf169|dJ453C12.4	protein_coding	Q8N2H4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22979
6.6109756921138e-38	-0.417978709621683	0.762	0.847	1.51093849443261e-33	NCOA4	Malignant cells	GSE175716	ENSG00000266412	8031	nuclear receptor coactivator 4	ARA70|DKFZp762E1112|ELE1|PTC3|RFG	protein_coding	Q13772	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22980
6.85980970891078e-38	-0.350758708491175	0.094	0.292	1.56780950897156e-33	TUSC2	Malignant cells	GSE175716	ENSG00000114383	11334	tumor suppressor 2, mitochondrial calcium regulator	C3orf11|FUS1|PAP|PDAP2	protein_coding	O75896	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22981
6.91579288789465e-38	-0.378601695614111	0.175	0.395	1.58060446452832e-33	CDR2	Malignant cells	GSE175716	ENSG00000140743	1039	cerebellar degeneration related protein 2	CDR62|Yo	protein_coding	Q01850	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22982
7.1651755755095e-38	-0.32363349168882	0.116	0.324	1.6376008777827e-33	SDAD1	Malignant cells	GSE175716	ENSG00000198301	55153	SDA1 domain containing 1	FLJ10498	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22983
7.36324920295169e-38	-0.579428888664559	0.325	0.497	1.68287060533461e-33	CCDC6	Malignant cells	GSE175716	ENSG00000108091	8030	coiled-coil domain containing 6	D10S170|H4|PTC|TPC|TST1	protein_coding	Q16204	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22984
8.65425578093518e-38	-0.353581733094248	0.105	0.309	1.97793015873274e-33	REST	Malignant cells	GSE175716	ENSG00000084093	5978	RE1 silencing transcription factor	DFNA27|NRSF|XBR	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22985
9.00613066205597e-38	-0.326891523298095	0.087	0.283	2.05835116281289e-33	ARHGAP35	Malignant cells	GSE175716	ENSG00000160007	2909	Rho GTPase activating protein 35	GRF-1|GRLF1|KIAA1722|P190A|p190ARhoGAP|p190RhoGAP	protein_coding	Q9NRY4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22986
1.08055686794946e-37	0.374226088408235	0.999	0.995	2.46961272169849e-33	NDUFB9	Malignant cells	GSE175716	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22987
1.13485616905224e-37	-0.438405765071545	0.504	0.658	2.5937137743689e-33	TRMT10C	Malignant cells	GSE175716	ENSG00000174173	54931	tRNA methyltransferase 10C, mitochondrial RNase P subunit	FLJ20432|MRPP1|RG9MTD1	protein_coding	Q7L0Y3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22988
1.17280277137735e-37	-0.379665740408901	0.097	0.294	2.68044073398293e-33	C11orf1	Malignant cells	GSE175716	ENSG00000137720	64776	chromosome 11 open reading frame 1	FLJ23499	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22989
1.19331376894664e-37	-1.01574330390137	0.585	0.672	2.72731861892754e-33	FRMD4B	Malignant cells	GSE175716	ENSG00000114541	23150	FERM domain containing 4B	GRSP1|KIAA1013	protein_coding	Q9Y2L6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22990
1.21707641979476e-37	-0.466434121803906	0.126	0.325	2.78162815744091e-33	ACVR1	Malignant cells	GSE175716	ENSG00000115170	90	activin A receptor type 1	ACVR1A|ACVRLK2|ALK2|SKR1	protein_coding	Q04771	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22991
1.22485065539012e-37	0.449229064567668	0.922	0.817	2.79939617289412e-33	XRCC5	Malignant cells	GSE175716	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22992
1.26836182182415e-37	0.475848968318178	0.862	0.748	2.89884094377909e-33	MARCH6	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22993
1.28324382998001e-37	0.516005985746531	0.565	0.391	2.93285377341932e-33	MRPS34	Malignant cells	GSE175716	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22994
1.34715112158249e-37	-0.308367718406139	0.705	0.837	3.07891388837677e-33	SUPT4H1	Malignant cells	GSE175716	ENSG00000213246	6827	SPT4 homolog, DSIF elongation factor subunit	Spt4|SPT4H|Supt4a|SUPT4H	protein_coding	P63272	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22995
1.4651497859215e-37	0.395629228012131	0.913	0.731	3.3485998357236e-33	FUS	Malignant cells	GSE175716	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22996
1.50375992647907e-37	-0.404477532492366	0.423	0.603	3.43684331196792e-33	ARF3	Malignant cells	GSE175716	ENSG00000134287	377	ADP ribosylation factor 3	NA	protein_coding	P61204	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22997
1.56580077407165e-37	-0.380359391580962	0.191	0.413	3.57863766914075e-33	KMT2A	Malignant cells	GSE175716	ENSG00000118058	4297	lysine methyltransferase 2A	ALL-1|ALL1|CXXC7|HRX|HTRX|HTRX1|MLL|MLL1|MLL1A|TRX1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22998
1.65581813344788e-37	-0.478935888453523	0.315	0.51	3.78437234399513e-33	A1CF	Malignant cells	GSE175716	ENSG00000148584	29974	APOBEC1 complementation factor	ACF|ACF64|ACF65|APOBEC1CF|ASP	protein_coding	Q9NQ94	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	22999
1.91028886370088e-37	-0.356858881120783	0.12	0.324	4.36596519798836e-33	NGLY1	Malignant cells	GSE175716	ENSG00000151092	55768	N-glycanase 1	FLJ11005|PNG-1|PNG1	protein_coding	Q96IV0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23000
2.01131364820136e-37	-0.324739173638977	0.086	0.283	4.59685734296422e-33	GPATCH2L	Malignant cells	GSE175716	ENSG00000089916	55668	G-patch domain containing 2 like	C14orf118|FLJ10033|FLJ20689	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23001
2.08552694805066e-37	-0.400842796643565	0.175	0.385	4.76647183976979e-33	THUMPD1	Malignant cells	GSE175716	ENSG00000066654	55623	THUMP domain containing 1	FLJ20274|Tan1	protein_coding	Q9NXG2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23002
2.84574845161662e-37	-0.504338632389563	0.918	0.943	6.50395808616978e-33	AKR1B10	Malignant cells	GSE175716	ENSG00000198074	57016	aldo-keto reductase family 1 member B10	AKR1B11|AKR1B12|ALDRLn|ARL-1|ARL1|HIS|HSI	protein_coding	O60218	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23003
3.19935047836835e-37	-0.356446603237581	0.168	0.386	7.31211551831087e-33	C1D	Malignant cells	GSE175716	ENSG00000197223	10438	C1D nuclear receptor corepressor	LRP1|Rrp47|SUN-CoR|SUNCOR	protein_coding	Q13901	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23004
3.84834371424991e-37	-0.49884138104777	0.778	0.814	8.79538955891818e-33	DYNLRB1	Malignant cells	GSE175716	ENSG00000125971	83658	dynein light chain roadblock-type 1	DNCL2A|DNLC2A|ROBLD1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23005
5.36459572121588e-37	0.475928524550545	0.335	0.181	1.22607835208389e-32	RPA2	Malignant cells	GSE175716	ENSG00000117748	6118	replication protein A2	NA	protein_coding	P15927	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23006
5.57159376376183e-37	0.327014500802159	0.266	0.12	1.27338775470777e-32	NIPSNAP3A	Malignant cells	GSE175716	ENSG00000136783	25934	nipsnap homolog 3A	DKFZp564D177|FLJ13953|HSPC299|MGC14553|NIPSNAP4|TassC	protein_coding	Q9UFN0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23007
6.63546128277741e-37	0.461924688180479	0.924	0.83	1.51653467617878e-32	SLIRP	Malignant cells	GSE175716	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23008
6.71979625321187e-37	-0.758567886611307	0.522	0.63	1.53580943367157e-32	GLS	Malignant cells	GSE175716	ENSG00000115419	2744	glutaminase	GAC|GAM|GLS1|KGA|KIAA0838	protein_coding	O94925	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23009
7.23329054086016e-37	-0.356118918791758	0.067	0.252	1.65316855311359e-32	ETV6	Malignant cells	GSE175716	ENSG00000139083	2120	ETS variant transcription factor 6	TEL	protein_coding	P41212	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23010
8.02972203776675e-37	-0.429282928774118	0.628	0.756	1.83519297173159e-32	RDX	Malignant cells	GSE175716	ENSG00000137710	5962	radixin	DFNB24	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23011
8.03010571401078e-37	-0.364725305246139	0.732	0.832	1.83528066093716e-32	ZFAND6	Malignant cells	GSE175716	ENSG00000086666	54469	zinc finger AN1-type containing 6	AWP1|ZA20D3|ZFAND5B	protein_coding	Q6FIF0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23012
9.22159704077495e-37	0.38384704288821	0.296	0.144	2.10759600366911e-32	GRAMD1A	Malignant cells	GSE175716	ENSG00000089351	57655	GRAM domain containing 1A	FLJ90346|KIAA1533	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23013
9.85038710941393e-37	0.291458165192161	0.254	0.11	2.25130597385655e-32	SERBP1P5	Malignant cells	GSE175716	ENSG00000249565	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23014
1.03743855019329e-36	-0.442762599678512	0.839	0.888	2.37106580646676e-32	CREG1	Malignant cells	GSE175716	ENSG00000143162	8804	cellular repressor of E1A stimulated genes 1	CREG	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23015
1.07977598770488e-36	-0.393265094226177	0.145	0.351	2.46782801989951e-32	RPS6KB1	Malignant cells	GSE175716	ENSG00000108443	6198	ribosomal protein S6 kinase B1	p70(S6K)-alpha|PS6K|S6K|S6K1|STK14A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23016
1.27511814845131e-36	0.345623108887966	0.843	0.67	2.91428252828547e-32	SRSF7	Malignant cells	GSE175716	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23017
1.34306964329967e-36	-0.311146492249141	0.081	0.272	3.06958566976139e-32	FUCA1	Malignant cells	GSE175716	ENSG00000179163	2517	alpha-L-fucosidase 1	NA	protein_coding	P04066	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23018
1.48273190988271e-36	-0.344459580249596	0.13	0.336	3.38878378003694e-32	AGMAT	Malignant cells	GSE175716	ENSG00000116771	79814	agmatinase	FLJ23384	protein_coding	Q9BSE5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23019
1.49843760970467e-36	-0.404833127520431	0.167	0.376	3.42467915698002e-32	COL4A3BP	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23020
1.51803606014275e-36	-0.323391887632503	0.091	0.283	3.46947141545626e-32	JKAMP	Malignant cells	GSE175716	ENSG00000050130	51528	JNK1/MAPK8 associated membrane protein	C14orf100|CDA06|HSPC213|HSPC327|JAMP	protein_coding	Q9P055	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23021
1.52556959191675e-36	-0.485991545057195	0.534	0.651	3.48668930232572e-32	CHCHD1	Malignant cells	GSE175716	ENSG00000172586	118487	coiled-coil-helix-coiled-coil-helix domain containing 1	C10orf34|FLJ25854	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23022
1.58461857769876e-36	-0.316725001651817	0.108	0.307	3.62164575933051e-32	RAB3IP	Malignant cells	GSE175716	ENSG00000127328	117177	RAB3A interacting protein	FLJ22548|RABIN3|RABIN8	protein_coding	Q96QF0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23023
1.63926192891388e-36	-0.332505599791071	0.103	0.301	3.74653313853267e-32	GPATCH8	Malignant cells	GSE175716	ENSG00000186566	23131	G-patch domain containing 8	GPATC8|KIAA0553	protein_coding	Q9UKJ3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23024
1.63987574255114e-36	-0.379048916866801	0.311	0.515	3.74793600960063e-32	CPNE3	Malignant cells	GSE175716	ENSG00000085719	8895	copine 3	NA	protein_coding	O75131	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23025
1.9936981081948e-36	-0.379467815521568	0.238	0.458	4.55659702627922e-32	RAB6A	Malignant cells	GSE175716	ENSG00000175582	5870	RAB6A, member RAS oncogene family	RAB6	protein_coding	P20340	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23026
2.14844571344483e-36	-0.693217644714947	0.615	0.688	4.91027267807815e-32	WBP11	Malignant cells	GSE175716	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23027
2.17784925859471e-36	-0.3514251426276	0.104	0.299	4.97747448051822e-32	TCF12	Malignant cells	GSE175716	ENSG00000140262	6938	transcription factor 12	bHLHb20|HEB|HsT17266|HTF4|p64	protein_coding	Q99081	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23028
2.20578261829938e-36	-0.300487489553205	0.065	0.25	5.04131617412323e-32	NKAPD1	Malignant cells	GSE175716	ENSG00000150776	55216	NKAP domain containing 1	C11orf57|FLJ10726	protein_coding	Q6ZUT1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23029
2.26814347444628e-36	-0.33975085883868	0.129	0.333	5.18384191084697e-32	MED6	Malignant cells	GSE175716	ENSG00000133997	10001	mediator complex subunit 6	NY-REN-28	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23030
2.28019462757013e-36	-1.6079808919597	0.281	0.433	5.21138482131154e-32	OLFM4	Malignant cells	GSE175716	ENSG00000102837	10562	olfactomedin 4	GC1|GW112|OlfD	protein_coding	Q6UX06	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23031
2.31559984275969e-36	-0.526201025526005	0.678	0.758	5.29230344062727e-32	TPM4	Malignant cells	GSE175716	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23032
2.36647052068244e-36	0.346337763976034	0.293	0.14	5.40856837501972e-32	WBP4	Malignant cells	GSE175716	ENSG00000120688	11193	WW domain binding protein 4	FBP21|MGC117310	protein_coding	O75554	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23033
2.45091998853374e-36	-0.857115917099059	0.418	0.521	5.60157763379387e-32	SELENOM	Malignant cells	GSE175716	ENSG00000198832	140606	selenoprotein M	SELM|SEPM	protein_coding	Q8WWX9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23034
3.28593477941865e-36	-0.364182986228009	0.077	0.26	7.51000393836133e-32	ELOF1	Malignant cells	GSE175716	ENSG00000130165	84337	elongation factor 1	ELF1|MGC4549	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23035
3.46536281393338e-36	-0.500314500418433	0.151	0.352	7.92008671124473e-32	LRIF1	Malignant cells	GSE175716	ENSG00000121931	55791	ligand dependent nuclear receptor interacting factor 1	C1orf103|FLJ11269|RIF1	protein_coding	Q5T3J3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23036
3.60444844509701e-36	-0.532709655214205	0.148	0.342	8.23796692126921e-32	TMEM159	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23037
3.63735430783474e-36	-0.350596119540905	0.21	0.424	8.31317327055631e-32	PPCS	Malignant cells	GSE175716	ENSG00000127125	79717	phosphopantothenoylcysteine synthetase	FLJ11838	protein_coding	Q9HAB8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23038
4.00721765535783e-36	-0.340763363568373	0.215	0.434	9.15849595132032e-32	CALCOCO2	Malignant cells	GSE175716	ENSG00000136436	10241	calcium binding and coiled-coil domain 2	MGC17318|NDP52	protein_coding	Q13137	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23039
4.69190512825152e-36	-0.407844179898214	0.742	0.831	1.07233491706189e-31	TOP1	Malignant cells	GSE175716	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23040
4.75458040359061e-36	0.423657405901276	0.95	0.899	1.08665935124063e-31	CSDE1	Malignant cells	GSE175716	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23041
5.88580290708678e-36	0.324293578582517	0.297	0.146	1.34520025441468e-31	PSMA2	Malignant cells	GSE175716	ENSG00000106588	5683	proteasome 20S subunit alpha 2	HC3|MU|PMSA2	protein_coding	P25787	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23042
5.93952208347498e-36	-0.350501109824459	0.582	0.728	1.35747777217821e-31	ERG28	Malignant cells	GSE175716	ENSG00000133935	11161	ergosterol biosynthesis 28 homolog	C14orf1|NET51	protein_coding	Q9UKR5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23043
6.3085013214607e-36	-0.576179543784537	0.941	0.915	1.44180797701984e-31	C14orf2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23044
7.20200654155378e-36	-0.376550227984176	0.503	0.66	1.64601859507212e-31	SRPRB	Malignant cells	GSE175716	ENSG00000144867	58477	SRP receptor subunit beta	APMCF1|SR-beta	protein_coding	Q9Y5M8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23045
8.54692396950086e-36	-0.297762987227891	0.087	0.278	1.95339947322942e-31	SOCS4	Malignant cells	GSE175716	ENSG00000180008	122809	suppressor of cytokine signaling 4	SOCS7	protein_coding	Q8WXH5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23046
8.8148099277272e-36	0.513072520269737	0.612	0.458	2.01462480898205e-31	BRD4	Malignant cells	GSE175716	ENSG00000141867	23476	bromodomain containing 4	CAP|HUNK1|HUNKI|MCAP	protein_coding	O60885	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23047
9.41518680128218e-36	-0.407004533010085	0.717	0.815	2.15184094343304e-31	SEC62	Malignant cells	GSE175716	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23048
1.08463901356229e-35	-0.383769669317488	0.084	0.268	2.47894246549661e-31	MYO5C	Malignant cells	GSE175716	ENSG00000128833	55930	myosin VC	MGC74969	protein_coding	Q9NQX4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23049
1.14514203224265e-35	-0.489843983016585	0.528	0.645	2.61722211469058e-31	GOT1	Malignant cells	GSE175716	ENSG00000120053	2805	glutamic-oxaloacetic transaminase 1	AST|AST1|SGOT	protein_coding	P17174	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23050
1.1576267732075e-35	-0.429785580552953	0.504	0.657	2.64575599016573e-31	DIAPH1	Malignant cells	GSE175716	ENSG00000131504	1729	diaphanous related formin 1	DFNA1|hDIA1|LFHL1|mDia1	protein_coding	O60610	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23051
1.18726842545845e-35	-0.323304259592255	0.137	0.339	2.71350198638529e-31	ZCCHC9	Malignant cells	GSE175716	ENSG00000131732	84240	zinc finger CCHC-type containing 9	DKFZp761J139|PPP1R41	protein_coding	Q8N567	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23052
1.24245443843043e-35	-0.680569786937744	0.541	0.613	2.83962961903275e-31	MRPL36	Malignant cells	GSE175716	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23053
1.2963210575117e-35	-0.349304943726641	0.098	0.289	2.96274177694299e-31	ARFIP1	Malignant cells	GSE175716	ENSG00000164144	27236	ADP ribosylation factor interacting protein 1	HSU52521	protein_coding	P53367	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23054
1.31822126212993e-35	-0.437026411309417	0.354	0.544	3.01279469459795e-31	SMARCA5	Malignant cells	GSE175716	ENSG00000153147	8467	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5	hISWI|hSNF2H|ISWI	protein_coding	O60264	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23055
1.37449595362691e-35	0.502661160613053	0.379	0.211	3.1414105020143e-31	ADM	Malignant cells	GSE175716	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23056
1.48282771922966e-35	-0.320935571462261	0.162	0.374	3.38900275229938e-31	IREB2	Malignant cells	GSE175716	ENSG00000136381	3658	iron responsive element binding protein 2	IRP2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23057
1.6567139555189e-35	-0.440266521887133	0.395	0.571	3.78641974533846e-31	GSR	Malignant cells	GSE175716	ENSG00000104687	2936	glutathione-disulfide reductase	NA	protein_coding	P00390	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23058
1.71726283109477e-35	-0.479801744937739	0.491	0.638	3.92480420046711e-31	PPP1R12A	Malignant cells	GSE175716	ENSG00000058272	4659	protein phosphatase 1 regulatory subunit 12A	M130|MBS|MYPT1	protein_coding	O14974	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23059
2.02763062075401e-35	-0.907254949852976	0.302	0.457	4.63414978373328e-31	PTGS2	Malignant cells	GSE175716	ENSG00000073756	5743	prostaglandin-endoperoxide synthase 2	COX2	protein_coding	P35354	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23060
2.12706589108691e-35	-0.28392392365882	0.082	0.269	4.86140909407914e-31	FAM114A1	Malignant cells	GSE175716	ENSG00000197712	92689	family with sequence similarity 114 member A1	Noxp20	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23061
2.3337745782232e-35	-0.497944940886376	0.511	0.628	5.33384179852913e-31	GAPDH	Malignant cells	GSE175716	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23062
2.35638112004369e-35	-0.421210063145352	0.164	0.361	5.38550904985985e-31	OTUB1	Malignant cells	GSE175716	ENSG00000167770	55611	OTU deubiquitinase, ubiquitin aldehyde binding 1	FLJ20113|FLJ40710	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23063
2.49784967397505e-35	-0.285003490434436	0.166	0.383	5.70883542986998e-31	FKBP11	Malignant cells	GSE175716	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23064
2.61540055640784e-35	-0.400023693697195	0.296	0.494	5.97749797167012e-31	RRS1	Malignant cells	GSE175716	ENSG00000179041	23212	ribosome biogenesis regulator 1 homolog	KIAA0112	protein_coding	Q15050	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23065
2.65175176456836e-35	-0.328126134948411	0.088	0.278	6.06057865792099e-31	CHMP1B	Malignant cells	GSE175716	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23066
2.80062887202382e-35	-0.795074274664949	0.379	0.503	6.40083728701045e-31	PSME2P2	Malignant cells	GSE175716	ENSG00000225131	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23067
3.08346906408803e-35	0.458123220342716	0.968	0.908	7.04726854597318e-31	TUFM	Malignant cells	GSE175716	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23068
3.09190387504348e-35	0.477081036628768	0.859	0.722	7.06654630641188e-31	H2AFV	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23069
3.11940803316607e-35	0.444231858275672	0.74	0.588	7.12940705980105e-31	SUMO3	Malignant cells	GSE175716	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23070
3.31856917033413e-35	-0.291431460327761	0.077	0.265	7.58458983879865e-31	NDRG2	Malignant cells	GSE175716	ENSG00000165795	57447	NDRG family member 2	KIAA1248|SYLD	protein_coding	Q9UN36	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23071
3.4570573764257e-35	-0.315715484186811	0.152	0.359	7.90110463382094e-31	INIP	Malignant cells	GSE175716	ENSG00000148153	58493	INTS3 and NABP interacting protein	C9orf80|HSPC043|hSSBIP1|MISE|SOSS-C	protein_coding	Q9NRY2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23072
3.5669644822639e-35	-0.558318191657162	0.486	0.618	8.15229732421414e-31	MED13	Malignant cells	GSE175716	ENSG00000108510	9969	mediator complex subunit 13	KIAA0593|THRAP1|TRAP240	protein_coding	Q9UHV7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23073
3.82031568913711e-35	0.36360944795641	0.324	0.168	8.73133150752287e-31	SMARCD2	Malignant cells	GSE175716	ENSG00000108604	6603	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2	BAF60B|CRACD2|PRO2451|Rsc6p	protein_coding	Q92925	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23074
3.84290061183151e-35	-0.604062551202023	0.116	0.299	8.78294934834092e-31	CREBRF	Malignant cells	GSE175716	ENSG00000164463	153222	CREB3 regulatory factor	C5orf41|LRF	protein_coding	Q8IUR6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23075
4.13219706893868e-35	-0.510420678335658	0.462	0.6	9.44413640105934e-31	SELENOK	Malignant cells	GSE175716	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23076
4.2487276071406e-35	-0.406660281857948	0.167	0.368	9.71046694611983e-31	MRPL40	Malignant cells	GSE175716	ENSG00000185608	64976	mitochondrial ribosomal protein L40	MRP-L22|NLVCF	protein_coding	Q9NQ50	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23077
4.42335983768123e-35	-0.413228532824767	0.189	0.392	1.01095889090204e-30	SZRD1	Malignant cells	GSE175716	ENSG00000055070	26099	SUZ RNA binding domain containing 1	C1orf144|DKFZp566C0424	protein_coding	Q7Z422	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23078
4.67565904786366e-35	-0.327166906808367	0.187	0.404	1.06862187538924e-30	SRP68	Malignant cells	GSE175716	ENSG00000167881	6730	signal recognition particle 68	NA	protein_coding	Q9UHB9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23079
4.87183685903086e-35	0.360397259007338	0.782	0.596	1.1134583141315e-30	RAP1B	Malignant cells	GSE175716	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23080
4.93027866361203e-35	-0.372839018834697	0.132	0.331	1.12681518856853e-30	MACF1	Malignant cells	GSE175716	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23081
5.2233741541395e-35	-0.379664813374752	0.365	0.552	1.19380216292858e-30	PPP1R18	Malignant cells	GSE175716	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23082
5.7252043676297e-35	-0.342827020734241	0.091	0.278	1.30849545822177e-30	ATP2C1	Malignant cells	GSE175716	ENSG00000017260	27032	ATPase secretory pathway Ca2+ transporting 1	ATP2C1A|BCPM|KIAA1347|PMR1|SPCA1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23083
5.79720983262493e-35	-0.420412598834843	0.098	0.28	1.32495230724643e-30	CCDC124	Malignant cells	GSE175716	ENSG00000007080	115098	coiled-coil domain containing 124	Lso2|oxs1	protein_coding	Q96CT7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23084
5.8637888108269e-35	-0.457499528698191	0.372	0.551	1.34016893271449e-30	ARHGAP12	Malignant cells	GSE175716	ENSG00000165322	94134	Rho GTPase activating protein 12	FLJ10971|FLJ20737|FLJ21785	protein_coding	Q8IWW6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23085
5.89723580623638e-35	-0.374843977045995	0.177	0.386	1.34781324351532e-30	RNF13	Malignant cells	GSE175716	ENSG00000082996	11342	ring finger protein 13	RZF	protein_coding	O43567	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23086
7.02091198081915e-35	0.385544363533306	0.838	0.695	1.60462943321622e-30	HNRNPM	Malignant cells	GSE175716	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23087
7.09874343627725e-35	0.421186198638872	0.899	0.756	1.62241781236117e-30	AK2	Malignant cells	GSE175716	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23088
7.61197559731239e-35	0.628093491018228	0.9	0.808	1.73971702276575e-30	ELF3	Malignant cells	GSE175716	ENSG00000163435	1999	E74 like ETS transcription factor 3	EPR-1|ERT|ESE-1|ESX	protein_coding	P78545	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23089
7.76680528431573e-35	-0.517067769238278	0.299	0.471	1.77510334773036e-30	MRPL17	Malignant cells	GSE175716	ENSG00000158042	63875	mitochondrial ribosomal protein L17	MRP-L26|RPML26	protein_coding	Q9NRX2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23090
8.31543498171381e-35	-0.393288815481084	0.611	0.743	1.90049266507069e-30	ZFP91	Malignant cells	GSE175716	ENSG00000186660	80829	ZFP91 zinc finger protein, atypical E3 ubiquitin ligase	PZF|ZNF757	protein_coding	Q96JP5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23091
8.41772767901831e-35	-1.52852159575346	0.638	0.609	1.92387166103963e-30	AC007969.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23092
8.60988062032362e-35	-0.428856417236236	0.38	0.561	1.96778821577496e-30	NRP1	Malignant cells	GSE175716	ENSG00000099250	8829	neuropilin 1	CD304|NRP|VEGF165R	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23093
9.69946619004425e-35	-0.338374984035342	0.096	0.284	2.21681299773461e-30	ATXN7L3	Malignant cells	GSE175716	ENSG00000087152	56970	ataxin 7 like 3	DKFZp761G2113	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23094
1.01229808662653e-34	-0.311176134326349	0.106	0.3	2.31360727698494e-30	CYTH2	Malignant cells	GSE175716	ENSG00000105443	9266	cytohesin 2	ARNO|CTS18.1|cytohesin-2|PSCD2|PSCD2L|Sec7p-L|Sec7p-like	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23095
1.10803225824259e-34	-0.418473710757139	0.772	0.847	2.53240772621345e-30	MARCKSL1	Malignant cells	GSE175716	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23096
1.12434660646451e-34	-0.353103403366683	0.076	0.255	2.56969416907464e-30	CSNK1G3	Malignant cells	GSE175716	ENSG00000151292	1456	casein kinase 1 gamma 3	NA	protein_coding	Q9Y6M4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23097
1.13331548822102e-34	0.501999902894208	0.484	0.337	2.59019254832915e-30	ATIC	Malignant cells	GSE175716	ENSG00000138363	471	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	AICARFT|IMPCHASE|PURH	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23098
1.24567083810451e-34	-0.454059938208956	0.117	0.305	2.84698070048786e-30	TUBA4A	Malignant cells	GSE175716	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23099
1.32286307774887e-34	0.444177911078204	0.645	0.485	3.02340356419505e-30	GUSB	Malignant cells	GSE175716	ENSG00000169919	2990	glucuronidase beta	NA	protein_coding	P08236	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23100
1.34028997601e-34	-0.425791199371253	0.398	0.564	3.06323274017085e-30	XIAP	Malignant cells	GSE175716	ENSG00000101966	331	X-linked inhibitor of apoptosis	API3|BIRC4|hILP|ILP-1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23101
1.34567139328883e-34	-0.331499922638708	0.108	0.3	3.07553196936162e-30	DICER1	Malignant cells	GSE175716	ENSG00000100697	23405	dicer 1, ribonuclease III	Dicer|HERNA|K12H4.8-LIKE|KIAA0928|MNG1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23102
1.38613585608133e-34	-0.38128779906212	0.091	0.272	3.16801349907389e-30	CLPP	Malignant cells	GSE175716	ENSG00000125656	8192	caseinolytic mitochondrial matrix peptidase proteolytic subunit	NA	protein_coding	Q16740	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23103
1.42763887438921e-34	-0.317691527472432	0.115	0.309	3.26286864741655e-30	SOCS6	Malignant cells	GSE175716	ENSG00000170677	9306	suppressor of cytokine signaling 6	CIS4|Cish4|HSPC060|SOCS4|SSI4|STAI4|STATI4	protein_coding	O14544	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23104
1.45112234580279e-34	-0.332834223522135	0.67	0.786	3.31654012133229e-30	ADIPOR1	Malignant cells	GSE175716	ENSG00000159346	51094	adiponectin receptor 1	ACDCR1|PAQR1	protein_coding	Q96A54	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23105
1.66864317886521e-34	-0.35135839496791	0.098	0.289	3.81368398529643e-30	FAM133A	Malignant cells	GSE175716	ENSG00000179083	286499	family with sequence similarity 133 member A	CT115|FLJ37659|RP1-32F7.2	protein_coding	Q8N9E0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23106
1.69727378133915e-34	-0.370117183643615	0.074	0.252	3.87911922725064e-30	IL17RB	Malignant cells	GSE175716	ENSG00000056736	55540	interleukin 17 receptor B	CRL4|EVI27|IL17BR|IL17RH1	protein_coding	Q9NRM6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23107
1.77215940660727e-34	-0.388919770209657	0.367	0.554	4.05027032380091e-30	DPH3	Malignant cells	GSE175716	ENSG00000154813	285381	diphthamide biosynthesis 3	DELGIP|DELGIP1|DESR1|DPH3A|KTI11|MGC20197|ZCSL2	protein_coding	Q96FX2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23108
1.81914242292157e-34	-0.306207298705275	0.088	0.275	4.15765000758726e-30	BTBD10	Malignant cells	GSE175716	ENSG00000148925	84280	BTB domain containing 10	GMRP-1|GMRP1|MGC13007	protein_coding	Q9BSF8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23109
1.85632570299683e-34	-0.557079346500083	0.163	0.355	4.24263239419926e-30	ZNF292	Malignant cells	GSE175716	ENSG00000188994	23036	zinc finger protein 292	bA393I2.3|KIAA0530|ZFP292|Zn-15|Zn-16	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23110
1.9356302662411e-34	0.370998791763022	0.743	0.572	4.42388297349403e-30	CCT8	Malignant cells	GSE175716	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23111
2.00967084698432e-34	-0.332557172249086	0.122	0.315	4.59310272078266e-30	TMEM220	Malignant cells	GSE175716	ENSG00000187824	388335	transmembrane protein 220	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23112
2.19916921620494e-34	-0.326757455047119	0.139	0.337	5.02620124363639e-30	PIGP	Malignant cells	GSE175716	ENSG00000185808	51227	phosphatidylinositol glycan anchor biosynthesis class P	DCRC|DSCR5|DSRC	protein_coding	P57054	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23113
2.77019794447166e-34	-0.314334600486515	0.106	0.294	6.33128740208998e-30	YAF2	Malignant cells	GSE175716	ENSG00000015153	10138	YY1 associated factor 2	NA	protein_coding	Q8IY57	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23114
2.89325225038152e-34	0.48576149121959	0.43	0.272	6.61252801824696e-30	METTL26	Malignant cells	GSE175716	ENSG00000130731	84326	methyltransferase like 26	C16orf13|MGC13114	protein_coding	Q96S19	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23115
3.4804988884672e-34	-0.287841728077103	0.094	0.281	7.95468020959178e-30	KDM5C	Malignant cells	GSE175716	ENSG00000126012	8242	lysine demethylase 5C	DXS1272E|JARID1C|MRX13|SMCX|XE169	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23116
3.67161653872897e-34	-0.299830227793	0.092	0.275	8.39147959926505e-30	YOD1	Malignant cells	GSE175716	ENSG00000180667	55432	YOD1 deubiquitinase	DKFZp451J1719|DUBA8|OTUD2	protein_coding	Q5VVQ6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23117
4.14539329589736e-34	-0.335501385837322	0.127	0.324	9.47429637777342e-30	FAM222B	Malignant cells	GSE175716	ENSG00000173065	55731	family with sequence similarity 222 member B	C17orf63|FLJ10700	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23118
4.56410891815787e-34	-0.287300868579218	0.102	0.295	1.04312709324498e-29	RPP14	Malignant cells	GSE175716	ENSG00000163684	11102	ribonuclease P/MRP subunit p14	P14	protein_coding	O95059	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23119
4.74558000361108e-34	-0.296204370210939	0.13	0.329	1.08460230982531e-29	TMEM41B	Malignant cells	GSE175716	ENSG00000166471	440026	transmembrane protein 41B	KIAA0033	protein_coding	Q5BJD5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23120
4.84588460363421e-34	-0.340624992625638	0.162	0.365	1.1075269261606e-29	FGGY	Malignant cells	GSE175716	ENSG00000172456	55277	FGGY carbohydrate kinase domain containing	FLJ10986	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23121
4.96240136231405e-34	-0.487122222039386	0.17	0.361	1.13415683135688e-29	CENPB	Malignant cells	GSE175716	ENSG00000125817	1059	centromere protein B	NA	protein_coding	P07199	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23122
5.01661326314636e-34	-0.323912365657611	0.142	0.341	1.1465469612921e-29	QRICH1	Malignant cells	GSE175716	ENSG00000198218	54870	glutamine rich 1	AB-DIP|FLJ20259|VERBRAS	protein_coding	Q2TAL8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23123
5.05858845598054e-34	-0.333035128924978	0.37	0.568	1.15614039161435e-29	DCTN6	Malignant cells	GSE175716	ENSG00000104671	10671	dynactin subunit 6	WS-3	protein_coding	O00399	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23124
5.29830940528007e-34	-0.317287641075457	0.175	0.391	1.21092861457676e-29	HMGCR	Malignant cells	GSE175716	ENSG00000113161	3156	3-hydroxy-3-methylglutaryl-CoA reductase	NA	protein_coding	P04035	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23125
5.47327776886239e-34	-0.351588475869664	0.085	0.262	1.2509176340735e-29	SH3BGRL3	Malignant cells	GSE175716	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23126
5.85189225541239e-34	0.431054156208712	0.355	0.2	1.3374499749745e-29	MAPK3	Malignant cells	GSE175716	ENSG00000102882	5595	mitogen-activated protein kinase 3	ERK1|p44erk1|p44mapk|PRKM3	protein_coding	P27361	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23127
6.44606868558461e-34	-0.304341319675939	0.247	0.464	1.47324899809036e-29	MRPL16	Malignant cells	GSE175716	ENSG00000166902	54948	mitochondrial ribosomal protein L16	FLJ20484|PNAS-111	protein_coding	Q9NX20	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23128
6.55779026587732e-34	-0.292596375369868	0.1	0.289	1.49878296526626e-29	PVR	Malignant cells	GSE175716	ENSG00000073008	5817	PVR cell adhesion molecule	CD155|HVED|Necl-5|NECL5|PVS|Tage4	protein_coding	P15151	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23129
7.19271352825857e-34	-0.38501949181428	0.133	0.324	1.6438946768835e-29	DDX10	Malignant cells	GSE175716	ENSG00000178105	1662	DEAD-box helicase 10	Dbp4|HRH-J8	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23130
7.41730197256965e-34	-0.502041707719581	0.482	0.617	1.69522436583079e-29	NRBF2	Malignant cells	GSE175716	ENSG00000148572	29982	nuclear receptor binding factor 2	COPR1|COPR2|DKFZp564C1664|FLJ30395	protein_coding	Q96F24	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23131
7.42725628638402e-34	-0.335101608606847	0.123	0.316	1.69749942425307e-29	CCDC127	Malignant cells	GSE175716	ENSG00000164366	133957	coiled-coil domain containing 127	FLJ25701	protein_coding	Q96BQ5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23132
7.4737655995593e-34	-0.333477399909868	0.149	0.354	1.70812912777928e-29	AEN	Malignant cells	GSE175716	ENSG00000181026	64782	apoptosis enhancing nuclease	FLJ12484|FLJ12562|ISG20L1	protein_coding	Q8WTP8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23133
8.05143966552254e-34	-0.348742442234807	0.078	0.254	1.84015653555518e-29	TMX3	Malignant cells	GSE175716	ENSG00000166479	54495	thioredoxin related transmembrane protein 3	FLJ20793|KIAA1830|PDIA13|TXNDC10	protein_coding	Q96JJ7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23134
8.075518133605e-34	-0.452261415205557	0.136	0.321	1.84565966943542e-29	PAXX	Malignant cells	GSE175716	ENSG00000148362	286257	PAXX non-homologous end joining factor	C9orf142|XLS	protein_coding	Q9BUH6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23135
8.59512911191014e-34	-0.492696570069872	0.961	0.947	1.96441675852706e-29	JTB	Malignant cells	GSE175716	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23136
8.59715057255048e-34	-0.347019513359651	0.245	0.464	1.96487876335641e-29	RNF19B	Malignant cells	GSE175716	ENSG00000116514	127544	ring finger protein 19B	FLJ90005|IBRDC3|NKLAM	protein_coding	Q6ZMZ0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23137
8.67794556112319e-34	-0.467110625819259	0.461	0.606	1.98334445799471e-29	PDCD10	Malignant cells	GSE175716	ENSG00000114209	11235	programmed cell death 10	CCM3|TFAR15	protein_coding	Q9BUL8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23138
9.16921632162208e-34	0.490278289985683	0.805	0.69	2.09562439030673e-29	PSMF1	Malignant cells	GSE175716	ENSG00000125818	9491	proteasome inhibitor subunit 1	PI31	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23139
9.64597674675074e-34	-0.305371045303128	0.084	0.266	2.20458798546988e-29	TMCC1	Malignant cells	GSE175716	ENSG00000172765	23023	transmembrane and coiled-coil domain family 1	KIAA0779	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23140
1.03572610054462e-33	0.329038225570146	1	0.875	2.36715200279474e-29	RBP4	Malignant cells	GSE175716	ENSG00000138207	5950	retinol binding protein 4	NA	protein_coding	P02753	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23141
1.04766489613995e-33	0.423554924849041	0.771	0.606	2.39443812012785e-29	OCIAD2	Malignant cells	GSE175716	ENSG00000145247	132299	OCIA domain containing 2	MGC45416	protein_coding	Q56VL3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23142
1.1065717222244e-33	-0.396535694530497	0.559	0.695	2.52906967114388e-29	MAN1A2	Malignant cells	GSE175716	ENSG00000198162	10905	mannosidase alpha class 1A member 2	MAN1B	protein_coding	O60476	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23143
1.20078797054995e-33	0.412913924133784	0.333	0.184	2.74440090669191e-29	MRPS9	Malignant cells	GSE175716	ENSG00000135972	64965	mitochondrial ribosomal protein S9	MRP-S9|RPMS9|S9mt	protein_coding	P82933	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23144
1.22158316295136e-33	0.388870654044948	0.96	0.915	2.79192831892533e-29	SFPQ	Malignant cells	GSE175716	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23145
1.22643592714567e-33	0.379865410903456	0.879	0.764	2.80301931149143e-29	MRPL18	Malignant cells	GSE175716	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23146
1.29664308835488e-33	-0.39859193597648	0.425	0.586	2.96347777843508e-29	HTATSF1	Malignant cells	GSE175716	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23147
1.42263168499964e-33	-0.295378076535528	0.172	0.387	3.25142471606668e-29	PHLDA2	Malignant cells	GSE175716	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23148
1.57751974782056e-33	0.386883158980243	0.848	0.668	3.60542138364388e-29	NET1	Malignant cells	GSE175716	ENSG00000173848	10276	neuroepithelial cell transforming 1	ARHGEF8|NET1A	protein_coding	Q7Z628	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23149
1.67006799697951e-33	0.288262395560769	0.978	0.91	3.81694040709666e-29	HSPA1A	Malignant cells	GSE175716	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23150
1.69743649088322e-33	-0.295747431956373	0.094	0.281	3.87949109991361e-29	ZDHHC5	Malignant cells	GSE175716	ENSG00000156599	25921	zinc finger DHHC-type palmitoyltransferase 5	DHHC5|KIAA1748|ZNF375	protein_coding	Q9C0B5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23151
1.70247142234407e-33	-0.420808720675262	0.853	0.879	3.89099843576738e-29	ERH	Malignant cells	GSE175716	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23152
1.72219728003097e-33	-0.356021520568743	0.164	0.365	3.93608188351079e-29	ERLEC1	Malignant cells	GSE175716	ENSG00000068912	27248	endoplasmic reticulum lectin 1	C2orf30|CL25084|ERLECTIN|XTP3-B|XTP3TPB	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23153
1.72393182106057e-33	-0.357623673099045	0.143	0.336	3.94004617703393e-29	SCOC	Malignant cells	GSE175716	ENSG00000153130	60592	short coiled-coil protein	HRIHFB2072|SCOCO|UNC-69	protein_coding	Q9UIL1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23154
1.87197968818056e-33	-0.306233645865422	0.101	0.287	4.27840957733667e-29	IL1R1	Malignant cells	GSE175716	ENSG00000115594	3554	interleukin 1 receptor type 1	CD121A|D2S1473|IL1R|IL1RA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23155
1.89742151528175e-33	-0.273601452290959	0.079	0.26	4.33655687317644e-29	SLC39A9	Malignant cells	GSE175716	ENSG00000029364	55334	solute carrier family 39 member 9	FLJ11274	protein_coding	Q9NUM3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23156
2.02665319779183e-33	-0.713837961145528	0.498	0.583	4.63191588355324e-29	NDUFAF3	Malignant cells	GSE175716	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23157
2.12129463475959e-33	0.298069134960955	0.292	0.145	4.84821888774305e-29	AC009362.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23158
2.5308687784271e-33	-0.375603689682927	0.827	0.867	5.78430059309515e-29	COA6	Malignant cells	GSE175716	ENSG00000168275	388753	cytochrome c oxidase assembly factor 6	C1orf31	protein_coding	Q5JTJ3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23159
2.7579237263915e-33	0.328161229599671	0.739	0.539	6.30323467666778e-29	PYGL	Malignant cells	GSE175716	ENSG00000100504	5836	glycogen phosphorylase L	GSD6	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23160
3.0428217049416e-33	-0.376486586469988	0.258	0.461	6.95436900664404e-29	CAB39	Malignant cells	GSE175716	ENSG00000135932	51719	calcium binding protein 39	CGI-66|MO25	protein_coding	Q9Y376	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23161
3.10999058456692e-33	-0.339857560108757	0.153	0.358	7.10788348102769e-29	TAOK3	Malignant cells	GSE175716	ENSG00000135090	51347	TAO kinase 3	DPK|JIK|MAP3K18	protein_coding	Q9H2K8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23162
3.26964657962986e-33	-0.298270544615192	0.077	0.255	7.47277725774405e-29	GTF2F1	Malignant cells	GSE175716	ENSG00000125651	2962	general transcription factor IIF subunit 1	BTF4|RAP74|TF2F1|TFIIF	protein_coding	P35269	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23163
3.43616891560676e-33	-0.455638423476024	0.747	0.814	7.85336405661926e-29	SERP1	Malignant cells	GSE175716	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23164
3.63055794170587e-33	-0.413343289847975	0.516	0.663	8.29764017576876e-29	PDZD8	Malignant cells	GSE175716	ENSG00000165650	118987	PDZ domain containing 8	bA129M16.2|FLJ34427|PDZK8	protein_coding	Q8NEN9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23165
3.63615213279432e-33	0.333143679436165	0.324	0.167	8.31042569950143e-29	AKT3	Malignant cells	GSE175716	ENSG00000275199	10000	AKT serine/threonine kinase 3	PKBG|PRKBG|RAC-gamma	protein_coding	Q9Y243	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23166
3.70304480043678e-33	-0.320557644197112	0.174	0.378	8.46330889139825e-29	MAD2L1BP	Malignant cells	GSE175716	ENSG00000124688	9587	MAD2L1 binding protein	CMT2|dJ261G23.1|KIAA0110	protein_coding	Q15013	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23167
3.83029711163325e-33	-0.316130821365638	0.118	0.31	8.7541440486378e-29	CHIC2	Malignant cells	GSE175716	ENSG00000109220	26511	cysteine rich hydrophobic domain 2	BTL	protein_coding	Q9UKJ5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23168
3.95905502200837e-33	-0.32234691591292	0.08	0.257	9.04842025280012e-29	ZNF689	Malignant cells	GSE175716	ENSG00000156853	115509	zinc finger protein 689	FLJ90415|TIPUH1	protein_coding	Q96CS4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23169
4.63412849534374e-33	-0.31523905193626	0.127	0.318	1.05913006761081e-28	DHX29	Malignant cells	GSE175716	ENSG00000067248	54505	DExH-box helicase 29	DDX29	protein_coding	Q7Z478	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23170
6.825396754904e-33	-0.750888825210321	0.522	0.628	1.55994442833331e-28	MT2A	Malignant cells	GSE175716	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23171
6.89783314439815e-33	0.465501601372196	0.864	0.751	1.5764997651522e-28	HADHB	Malignant cells	GSE175716	ENSG00000138029	3032	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta	MTPB	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23172
7.1315267641431e-33	-0.337651544051135	0.135	0.324	1.6299104419449e-28	SCYL2	Malignant cells	GSE175716	ENSG00000136021	55681	SCY1 like pseudokinase 2	CVAK104|KIAA1360	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23173
7.61029261217303e-33	0.293812531374375	0.26	0.121	1.73933237651215e-28	BOP1	Malignant cells	GSE175716	ENSG00000285301	23246	BOP1 ribosomal biogenesis factor	KIAA0124	protein_coding	Q14137	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23174
7.75325951099507e-33	0.436935235290396	0.414	0.26	1.77200746123792e-28	NELFCD	Malignant cells	GSE175716	ENSG00000101158	51497	negative elongation factor complex member C/D	HSPC130|NELF-C|NELF-D|TH1|TH1L	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23175
8.33442481901461e-33	-0.505818760230745	0.257	0.44	1.90483279238579e-28	PPP3CA	Malignant cells	GSE175716	ENSG00000138814	5530	protein phosphatase 3 catalytic subunit alpha	CALN|CALNA|CNA1|PPP2B	protein_coding	Q08209	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23176
9.07576681738444e-33	-0.289278087539635	0.135	0.327	2.07426650611321e-28	GLTP	Malignant cells	GSE175716	ENSG00000139433	51228	glycolipid transfer protein	NA	protein_coding	Q9NZD2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23177
9.68096360209124e-33	-0.412522452192133	0.437	0.581	2.21258423125795e-28	MIEN1	Malignant cells	GSE175716	ENSG00000141741	84299	migration and invasion enhancer 1	C17orf37|C35|MGC14832|ORB3|Rdx12|XTP4	protein_coding	Q9BRT3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23178
1.02701798752459e-32	-0.262625428770489	0.133	0.331	2.34724961048744e-28	CPSF7	Malignant cells	GSE175716	ENSG00000149532	79869	cleavage and polyadenylation specific factor 7	CFIM59|FLJ12529	protein_coding	Q8N684	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23179
1.24325308843823e-32	0.493547478471883	0.428	0.284	2.84145493362557e-28	COA1	Malignant cells	GSE175716	ENSG00000106603	55744	cytochrome c oxidase assembly factor 1	C7orf44|FLJ10803|MITRAC15	protein_coding	Q9GZY4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23180
1.30786822624044e-32	-0.288527877765803	0.075	0.25	2.98913283107253e-28	BAZ2A	Malignant cells	GSE175716	ENSG00000076108	11176	bromodomain adjacent to zinc finger domain 2A	KIAA0314|TIP5|WALp3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23181
1.35656085293601e-32	-0.434225851107045	0.505	0.643	3.10041982938524e-28	RAB5A	Malignant cells	GSE175716	ENSG00000144566	5868	RAB5A, member RAS oncogene family	RAB5	protein_coding	P20339	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23182
1.59916602768172e-32	-0.415438236087292	0.445	0.592	3.65489395626658e-28	PHC2	Malignant cells	GSE175716	ENSG00000134686	1912	polyhomeotic homolog 2	EDR2|HPH2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23183
2.26065761806924e-32	0.444572360253795	0.484	0.324	5.16673298609725e-28	AC064799.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23184
2.45282643367323e-32	0.395617950393197	0.301	0.157	5.60593481416017e-28	MED24	Malignant cells	GSE175716	ENSG00000008838	9862	mediator complex subunit 24	CRSP100|CRSP4|DRIP100|KIAA0130|MED5|THRAP4|TRAP100	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23185
2.52111550017428e-32	-0.353910613517275	0.117	0.302	5.76200947564832e-28	MIR22HG	Malignant cells	GSE175716	ENSG00000282800	84981	MIR22 host gene	C17orf91|DKFZp686O06159|MGC14376	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23186
2.57658816127841e-32	0.434523871426429	0.653	0.499	5.88879224260181e-28	RPF2	Malignant cells	GSE175716	ENSG00000197498	84154	ribosome production factor 2 homolog	bA397G5.4|BXDC1|FLJ21087	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23187
2.80930297421203e-32	-0.318401005811464	0.123	0.312	6.42066194756159e-28	MPP5	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23188
2.95829888435375e-32	-0.335104457246627	0.382	0.561	6.7611921001905e-28	OAZ2	Malignant cells	GSE175716	ENSG00000180304	4947	ornithine decarboxylase antizyme 2	NA	protein_coding	O95190	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23189
3.06307944122248e-32	-0.2844072461341	0.114	0.303	7.00066806291398e-28	LPIN2	Malignant cells	GSE175716	ENSG00000101577	9663	lipin 2	KIAA0249	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23190
3.12293348812724e-32	-0.252890641111183	0.167	0.373	7.1374644871148e-28	MAX	Malignant cells	GSE175716	ENSG00000125952	4149	MYC associated factor X	bHLHd4|bHLHd5|bHLHd6|bHLHd7|bHLHd8	protein_coding	P61244	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23191
3.2084543088153e-32	-0.545890062105123	0.59	0.665	7.33292232279738e-28	HM13	Malignant cells	GSE175716	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23192
3.2103668323307e-32	0.541092083640489	0.446	0.302	7.33729339529181e-28	GNPDA1	Malignant cells	GSE175716	ENSG00000113552	10007	glucosamine-6-phosphate deaminase 1	GNPDA|GNPI|GPI|HLN|KIAA0060	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23193
4.11788427567213e-32	-0.295180763907313	0.142	0.336	9.41142451204866e-28	ISCA2	Malignant cells	GSE175716	ENSG00000165898	122961	iron-sulfur cluster assembly 2	HBLD1|ISA2	protein_coding	Q86U28	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23194
4.18462172715583e-32	-0.324890036452494	0.139	0.327	9.56395295741464e-28	RING1	Malignant cells	GSE175716	ENSG00000228520	6015	ring finger protein 1	RNF1	protein_coding	Q06587	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23195
4.36678652131918e-32	-0.316358762669653	0.169	0.371	9.98029059447498e-28	SAP30BP	Malignant cells	GSE175716	ENSG00000161526	29115	SAP30 binding protein	HCNGP|HTRG|HTRP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23196
4.43873740794613e-32	-0.357656306709438	0.098	0.276	1.01447343458609e-27	MKNK2	Malignant cells	GSE175716	ENSG00000099875	2872	MAPK interacting serine/threonine kinase 2	GPRK7|MNK2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23197
4.55865181488345e-32	-0.445029363038917	0.333	0.497	1.04187987229161e-27	BORCS7	Malignant cells	GSE175716	ENSG00000166275	119032	BLOC-1 related complex subunit 7	C10orf32|FLJ40752	protein_coding	Q96B45	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23198
4.61677518894674e-32	-0.347319207722513	0.181	0.379	1.05516396943378e-27	PPP4R1	Malignant cells	GSE175716	ENSG00000154845	9989	protein phosphatase 4 regulatory subunit 1	PP4R1	protein_coding	Q8TF05	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23199
4.671004856746e-32	-1.25705559875129	0.676	0.642	1.0675581600093e-27	EBP	Malignant cells	GSE175716	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23200
5.041624060367e-32	0.460903788280356	0.584	0.455	1.15226317899688e-27	DYNLT1	Malignant cells	GSE175716	ENSG00000146425	6993	dynein light chain Tctex-type 1	TCTEL1|Tctex-1|TCTEX1	protein_coding	P63172	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23201
5.15174312657324e-32	-0.449981480721449	0.427	0.583	1.17743089157831e-27	IKBIP	Malignant cells	GSE175716	ENSG00000166130	121457	IKBKB interacting protein	FLJ31051|IKIP	protein_coding	Q70UQ0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23202
5.2899615672796e-32	-0.371778009941343	0.518	0.664	1.20902071620175e-27	ARIH1	Malignant cells	GSE175716	ENSG00000166233	25820	ariadne RBR E3 ubiquitin protein ligase 1	ARI|HARI|HHARI|UBCH7BP	protein_coding	Q9Y4X5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23203
5.46247914041655e-32	-0.431157223909117	0.472	0.622	1.2484496075422e-27	MORF4L1P1	Malignant cells	GSE175716	ENSG00000218283	NA	NA	MORF4LP1|MRG1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23204
5.46389177645937e-32	-0.341199873935927	0.19	0.39	1.24877246550979e-27	GNAQ	Malignant cells	GSE175716	ENSG00000156052	2776	G protein subunit alpha q	G-ALPHA-q|GAQ	protein_coding	P50148	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23205
5.75658405213858e-32	-0.580171647685523	0.685	0.718	1.31566728511627e-27	TRMT112	Malignant cells	GSE175716	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23206
6.23638960019583e-32	-0.336707291692928	0.187	0.386	1.42532684312476e-27	TOB2	Malignant cells	GSE175716	ENSG00000183864	10766	transducer of ERBB2, 2	APRO5|bK223H9|TOB4|TOBL|TROB2	protein_coding	Q14106	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23207
6.27375949919571e-32	-0.305013739924956	0.145	0.335	1.43386773354118e-27	DYNC1LI1	Malignant cells	GSE175716	ENSG00000144635	51143	dynein cytoplasmic 1 light intermediate chain 1	DNCLI1	protein_coding	Q9Y6G9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23208
7.40419562114309e-32	-0.296003075932589	0.151	0.347	1.69222890921225e-27	NGDN	Malignant cells	GSE175716	ENSG00000129460	25983	neuroguidin	C14orf120|CANu1|DKFZP564O092|LCP5|lpd-2|NGD	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23209
8.32773248985483e-32	-0.438513035107995	0.13	0.305	1.90330326055632e-27	NME3	Malignant cells	GSE175716	ENSG00000103024	4832	NME/NM23 nucleoside diphosphate kinase 3	DR-nm23|NDPKC|NM23-H3	protein_coding	Q13232	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23210
8.99640465342124e-32	0.426949744030986	0.784	0.629	2.05612828353942e-27	DKC1	Malignant cells	GSE175716	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23211
9.42156113893662e-32	-0.316682767351466	0.12	0.301	2.15329779830396e-27	GMEB1	Malignant cells	GSE175716	ENSG00000162419	10691	glucocorticoid modulatory element binding protein 1	P96PIF|PIF96	protein_coding	Q9Y692	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23212
1.12179002399011e-31	-0.292603699575619	0.135	0.324	2.56385109982939e-27	DERL2	Malignant cells	GSE175716	ENSG00000072849	51009	derlin 2	CGI-101|derlin-2|F-LAN-1|F-LANa|FLANa	protein_coding	Q9GZP9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23213
1.2136523342359e-31	0.322844722008742	0.283	0.139	2.77380240989615e-27	MDFIC	Malignant cells	GSE175716	ENSG00000135272	29969	MyoD family inhibitor domain containing	HIC|MDFIC1	protein_coding	Q9P1T7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23214
1.24192541673261e-31	-0.394928957688698	0.673	0.771	2.83842053994239e-27	EIF3J	Malignant cells	GSE175716	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23215
1.30022687272778e-31	-0.365261412028841	0.385	0.556	2.97166851761935e-27	RIT1	Malignant cells	GSE175716	ENSG00000143622	6016	Ras like without CAAX 1	MGC125864|MGC125865|RIBB|RIT|ROC1	protein_coding	Q92963	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23216
1.36894855381944e-31	-0.295112789796466	0.902	0.96	3.12873191975432e-27	HNRNPF	Malignant cells	GSE175716	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23217
1.43236978814969e-31	-0.285625479197752	0.108	0.291	3.27368115081612e-27	GLG1	Malignant cells	GSE175716	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23218
1.43982161245238e-31	-0.548794221421639	0.365	0.524	3.2907122952599e-27	LAMB3	Malignant cells	GSE175716	ENSG00000196878	3914	laminin subunit beta 3	BM600-125kDa|kalinin-140kDa|LAMNB1|nicein-125kDa	protein_coding	Q13751	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23219
1.58498870803791e-31	-0.323031184363212	0.139	0.327	3.62249169222064e-27	PNMA1	Malignant cells	GSE175716	ENSG00000176903	9240	PNMA family member 1	MA1	protein_coding	Q8ND90	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23220
1.66960592295068e-31	0.278936284305578	0.944	0.728	3.81588433690378e-27	PGD	Malignant cells	GSE175716	ENSG00000142657	5226	phosphogluconate dehydrogenase	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23221
1.68320149454009e-31	-0.455277350064516	0.367	0.523	3.84695701577138e-27	SNF8	Malignant cells	GSE175716	ENSG00000159210	11267	SNF8 subunit of ESCRT-II	Dot3|EAP30|VPS22	protein_coding	Q96H20	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23222
1.69722558297569e-31	0.40298037098559	0.745	0.603	3.87900906989094e-27	PPP6C	Malignant cells	GSE175716	ENSG00000119414	5537	protein phosphatase 6 catalytic subunit	PP6	protein_coding	O00743	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23223
1.81924150216833e-31	-0.298000351704788	0.12	0.302	4.15787645320572e-27	SS18	Malignant cells	GSE175716	ENSG00000141380	6760	SS18 subunit of BAF chromatin remodeling complex	SMARCL1|SSXT|SYT	protein_coding	Q15532	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23224
1.89414873483268e-31	-0.492258930749289	0.167	0.341	4.32907693346009e-27	PQBP1	Malignant cells	GSE175716	ENSG00000102103	10084	polyglutamine binding protein 1	MRX2|MRX55|MRXS3|MRXS8|RENS1|SHS	protein_coding	O60828	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23225
1.93624002751671e-31	0.394250599235602	0.675	0.522	4.42527658288945e-27	PRELID3B	Malignant cells	GSE175716	ENSG00000101166	51012	PRELI domain containing 3B	C20orf45|dJ543J19.5|SLMO2	protein_coding	Q9Y3B1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23226
1.95421878866281e-31	-0.504022214342022	0.136	0.31	4.46636704148885e-27	C3orf58	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23227
2.13036351598496e-31	-0.309226005190097	0.517	0.67	4.86894581578362e-27	CGGBP1	Malignant cells	GSE175716	ENSG00000163320	8545	CGG triplet repeat binding protein 1	CGGBP|p20-CGGBP	protein_coding	Q9UFW8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23228
2.44037397592493e-31	-0.366965730824987	0.824	0.895	5.57747472197642e-27	CTSC	Malignant cells	GSE175716	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23229
2.73460300485494e-31	-0.371326139254941	0.115	0.296	6.24993516759596e-27	CLCF1	Malignant cells	GSE175716	ENSG00000175505	23529	cardiotrophin like cytokine factor 1	BSF-3|BSF3|CISS2|CLC|NNT-1|NNT1|NR6	protein_coding	Q9UBD9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23230
2.76946882116443e-31	-0.366833684527981	0.183	0.371	6.3296209907713e-27	LGMN	Malignant cells	GSE175716	ENSG00000100600	5641	legumain	LGMN1|PRSC1	protein_coding	Q99538	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23231
2.88531208114679e-31	-0.302585691282446	0.257	0.461	6.59438076146099e-27	CAMTA1	Malignant cells	GSE175716	ENSG00000171735	23261	calmodulin binding transcription activator 1	KIAA0833	protein_coding	Q9Y6Y1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23232
3.03393881540166e-31	0.37005407306852	0.793	0.619	6.93406716260049e-27	SLC3A2	Malignant cells	GSE175716	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23233
3.07962527450904e-31	-0.288795023105593	0.081	0.252	7.03848356489041e-27	ATF5	Malignant cells	GSE175716	ENSG00000169136	22809	activating transcription factor 5	NA	protein_coding	Q9Y2D1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23234
3.09613622054998e-31	-0.373269099731848	0.297	0.487	7.07621933206698e-27	MSI2	Malignant cells	GSE175716	ENSG00000153944	124540	musashi RNA binding protein 2	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23235
3.14447995465316e-31	0.401126920495597	0.817	0.663	7.18670893635979e-27	PPP1R15A	Malignant cells	GSE175716	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23236
3.28161090097877e-31	-0.252992587550888	0.1	0.28	7.50012171418698e-27	LYSMD3	Malignant cells	GSE175716	ENSG00000176018	116068	LysM domain containing 3	FLJ13542	protein_coding	Q7Z3D4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23237
3.64432126775084e-31	0.354913540989944	0.32	0.176	8.32909625744455e-27	SLC2A4RG	Malignant cells	GSE175716	ENSG00000125520	56731	SLC2A4 regulator	GEF|HDBP1|Si-1-2|Si-1-2-19	protein_coding	Q9NR83	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23238
3.67967845787715e-31	-0.280354241147903	0.113	0.297	8.40990511547822e-27	CANT1	Malignant cells	GSE175716	ENSG00000171302	124583	calcium activated nucleotidase 1	SCAN-1|SHAPY	protein_coding	Q8WVQ1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23239
3.70658986500091e-31	-0.278017718431834	0.1	0.278	8.47141113645958e-27	RRAS	Malignant cells	GSE175716	ENSG00000126458	6237	RAS related	R-Ras	protein_coding	P10301	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23240
4.05248749595539e-31	0.521393430430614	0.545	0.423	9.26196017200604e-27	RTFDC1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23241
4.1362137353502e-31	-0.337269531080001	0.11	0.285	9.45331649214289e-27	CLPTM1	Malignant cells	GSE175716	ENSG00000104853	1209	CLPTM1 regulator of GABA type A receptor forward trafficking	NA	protein_coding	O96005	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23242
4.53048142789437e-31	-0.319887254397977	0.108	0.288	1.03544153034526e-26	RNF103	Malignant cells	GSE175716	ENSG00000239305	7844	ring finger protein 103	hkf-1|KF1|ZFP103	protein_coding	O00237	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23243
4.53432537337771e-31	-0.427236639929379	0.403	0.551	1.03632006408548e-26	ZNF622	Malignant cells	GSE175716	ENSG00000173545	90441	zinc finger protein 622	MGC17552|MGC2485|ZPR9	protein_coding	Q969S3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23244
4.5419584469455e-31	-0.294836918423266	0.89	0.938	1.03806460304939e-26	SELENOF	Malignant cells	GSE175716	ENSG00000183291	9403	selenoprotein F	SEP15	protein_coding	O60613	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23245
4.75712421697874e-31	-0.314441284879195	0.096	0.27	1.08724073979049e-26	DAG1	Malignant cells	GSE175716	ENSG00000173402	1605	dystroglycan 1	156DAG|A3a|AGRNR|DAG	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23246
5.34014443563717e-31	0.521191913118447	0.483	0.351	1.22049001076487e-26	TFDP1	Malignant cells	GSE175716	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23247
6.15077235689649e-31	-0.302164058391128	0.187	0.389	1.40575902216869e-26	SP1	Malignant cells	GSE175716	ENSG00000185591	6667	Sp1 transcription factor	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23248
6.17306989607112e-31	-0.289936510194653	0.6	0.729	1.41085512474705e-26	TIMM23	Malignant cells	GSE175716	ENSG00000265354	100287932	translocase of inner mitochondrial membrane 23	TIM23	protein_coding	O14925	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23249
6.2968367317661e-31	-0.261338553203739	0.095	0.272	1.43914203504514e-26	ZNHIT3	Malignant cells	GSE175716	ENSG00000278574	9326	zinc finger HIT-type containing 3	Hit1|TRIP3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23250
7.4048516892381e-31	-0.288285353663324	0.132	0.32	1.69237885357537e-26	PCK2	Malignant cells	GSE175716	ENSG00000285241	5106	phosphoenolpyruvate carboxykinase 2, mitochondrial	PEPCK|PEPCK2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23251
7.67697637061691e-31	-1.88557326767169	0.137	0.294	1.7545729495045e-26	CCL2	Malignant cells	GSE175716	ENSG00000108691	6347	C-C motif chemokine ligand 2	GDCF-2|HC11|MCAF|MCP-1|MCP1|MGC9434|SCYA2|SMC-CF	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23252
7.89333082469673e-31	0.513699036030013	0.884	0.768	1.80402075998444e-26	ZNF281	Malignant cells	GSE175716	ENSG00000162702	23528	zinc finger protein 281	ZBP-99	protein_coding	Q9Y2X9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23253
8.1193698788707e-31	-0.289134380077273	0.144	0.335	1.8556819858159e-26	APPL1	Malignant cells	GSE175716	ENSG00000157500	26060	adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1	APPL	protein_coding	Q9UKG1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23254
8.60640058662324e-31	-0.279903933569434	0.154	0.346	1.96699285407274e-26	AL136126.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23255
9.0681317109434e-31	-0.386084779253912	0.447	0.598	2.07252150253611e-26	YIPF6	Malignant cells	GSE175716	ENSG00000181704	286451	Yip1 domain family member 6	FinGER6|MGC21416	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23256
9.39743701772953e-31	0.556407325847346	0.33	0.195	2.14778423040208e-26	EMP3	Malignant cells	GSE175716	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23257
1.05529137562497e-30	-0.311267692748019	0.178	0.373	2.41186843899086e-26	CDIPT	Malignant cells	GSE175716	ENSG00000103502	10423	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	PIS|PIS1	protein_coding	O14735	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23258
1.06285178913004e-30	0.399040160126548	0.663	0.512	2.42914776405672e-26	NDUFA10	Malignant cells	GSE175716	ENSG00000130414	4705	NADH:ubiquinone oxidoreductase subunit A10	CI-42k	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23259
1.09065005061123e-30	-0.309073349258818	0.233	0.436	2.49268069067197e-26	FAF2	Malignant cells	GSE175716	ENSG00000113194	23197	Fas associated factor family member 2	ETEA|KIAA0887|UBXD8|UBXN3B	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23260
1.16020090520161e-30	-0.390342433943575	0.709	0.799	2.65163916883828e-26	GALNT1	Malignant cells	GSE175716	ENSG00000141429	2589	polypeptide N-acetylgalactosaminyltransferase 1	GalNAc-T1	protein_coding	Q10472	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23261
1.23462492309883e-30	-0.315858231079993	0.218	0.42	2.82173526174237e-26	FAM168B	Malignant cells	GSE175716	ENSG00000152102	130074	family with sequence similarity 168 member B	KIAA0280L|MANI	protein_coding	A1KXE4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23262
1.25632054643396e-30	-0.35578188156578	0.406	0.574	2.87132060887482e-26	FOXJ3	Malignant cells	GSE175716	ENSG00000198815	22887	forkhead box J3	KIAA1041	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23263
1.26524450362177e-30	0.353085604203393	0.771	0.59	2.89171631302756e-26	NME4	Malignant cells	GSE175716	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23264
1.37783702376317e-30	-0.329673814382612	0.094	0.264	3.14904651781074e-26	BSDC1	Malignant cells	GSE175716	ENSG00000160058	55108	BSD domain containing 1	FLJ10276|RP4-811H24.7	protein_coding	Q9NW68	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23265
1.41580222241486e-30	-0.338786706719727	0.571	0.703	3.23581597932916e-26	DNAJC3	Malignant cells	GSE175716	ENSG00000102580	5611	DnaJ heat shock protein family (Hsp40) member C3	ERdj6|HP58|P58|p58(IPK)|P58IPK|PRKRI	protein_coding	Q13217	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23266
1.47459655411996e-30	-0.305374588520236	0.2	0.396	3.37019042444116e-26	COX11	Malignant cells	GSE175716	ENSG00000166260	1353	cytochrome c oxidase copper chaperone COX11	COX11P	protein_coding	Q9Y6N1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23267
1.47768952779247e-30	-0.320721448503805	0.197	0.395	3.3772594157697e-26	LRRFIP2	Malignant cells	GSE175716	ENSG00000093167	9209	LRR binding FLII interacting protein 2	HUFI-2	protein_coding	Q9Y608	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23268
1.47852667945055e-30	-0.329363974744891	0.718	0.819	3.37917272588423e-26	REEP5	Malignant cells	GSE175716	ENSG00000129625	7905	receptor accessory protein 5	C5orf18|D5S346|DP1|POB16|TB2|Yip2e	protein_coding	Q00765	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23269
1.58353871914742e-30	-0.612530525374415	0.152	0.324	3.61917774261143e-26	ZBTB10	Malignant cells	GSE175716	ENSG00000205189	65986	zinc finger and BTB domain containing 10	FLJ12752|RINZF	protein_coding	Q96DT7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23270
1.77603828447972e-30	0.370358128164679	0.46	0.278	4.05913549917839e-26	LURAP1L	Malignant cells	GSE175716	ENSG00000153714	286343	leucine rich adaptor protein 1 like	bA3L8.2|C9orf150|FLJ38505|LRAP35b|MGC46502	protein_coding	Q8IV03	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23271
2.0137376514576e-30	-0.937892202208741	0.548	0.581	4.60239740240634e-26	SDF2L1	Malignant cells	GSE175716	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23272
2.11897039682892e-30	0.38183654526849	0.879	0.743	4.84290684195249e-26	MMADHC	Malignant cells	GSE175716	ENSG00000168288	27249	metabolism of cobalamin associated D	C2orf25|cblD|CL25022	protein_coding	Q9H3L0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23273
2.18167118464389e-30	-0.277810754381205	0.175	0.378	4.98620949250362e-26	AKT2	Malignant cells	GSE175716	ENSG00000105221	208	AKT serine/threonine kinase 2	PKBbeta	protein_coding	P31751	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23274
2.72305436341424e-30	0.307328074984948	0.288	0.151	6.22354074758324e-26	TPT1P9	Malignant cells	GSE175716	ENSG00000234782	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23275
2.92518568146288e-30	-0.345273230796201	0.498	0.641	6.68551187498341e-26	TSTD1	Malignant cells	GSE175716	ENSG00000215845	100131187	thiosulfate sulfurtransferase like domain containing 1	KAT	protein_coding	Q8NFU3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23276
2.93813709037434e-30	-0.36616507973856	0.354	0.527	6.71511232005055e-26	SNAPIN	Malignant cells	GSE175716	ENSG00000143553	23557	SNAP associated protein	BLOC1S7|BORCS3|SNAPAP	protein_coding	O95295	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23277
2.96458771687628e-30	-0.400892843773869	0.598	0.709	6.77556522692074e-26	PDCD6IP	Malignant cells	GSE175716	ENSG00000170248	10015	programmed cell death 6 interacting protein	AIP1|Alix|Hp95	protein_coding	Q8WUM4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23278
3.26824732019475e-30	-0.308012621803155	0.675	0.78	7.46957925030511e-26	GRB2	Malignant cells	GSE175716	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23279
3.51406471974072e-30	-0.325777747824974	0.151	0.338	8.03139491696743e-26	CBX1	Malignant cells	GSE175716	ENSG00000108468	10951	chromobox 1	CBX|HP1-BETA|HP1Hs-beta|M31|MOD1	protein_coding	P83916	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23280
4.06354820242677e-30	-0.636401243490202	0.629	0.67	9.28723941664639e-26	MRPS16	Malignant cells	GSE175716	ENSG00000182180	51021	mitochondrial ribosomal protein S16	CGI-132	protein_coding	Q9Y3D3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23281
4.0932545601359e-30	0.455478233929541	0.383	0.242	9.3551332971906e-26	MAPK14	Malignant cells	GSE175716	ENSG00000112062	1432	mitogen-activated protein kinase 14	CSBP1|CSBP2|CSPB1|Mxi2|p38|PRKM14|PRKM15	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23282
4.29781895440718e-30	-0.292690925446217	0.137	0.319	9.82266522029761e-26	SLC15A4	Malignant cells	GSE175716	ENSG00000139370	121260	solute carrier family 15 member 4	PHT1|PTR4	protein_coding	Q8N697	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23283
4.33071614350447e-30	-0.737390221665257	0.353	0.496	9.89785174597946e-26	ETS1	Malignant cells	GSE175716	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23284
4.50509857647448e-30	-0.294250283728694	0.175	0.369	1.02964027965324e-25	PATL1	Malignant cells	GSE175716	ENSG00000166889	219988	PAT1 homolog 1, processing body mRNA decay factor	FLJ36874|Pat1b	protein_coding	Q86TB9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23285
4.62065162519321e-30	-0.252569752326849	0.129	0.316	1.05604992893791e-25	DCUN1D1	Malignant cells	GSE175716	ENSG00000043093	54165	defective in cullin neddylation 1 domain containing 1	DCUN1L1|RP42|SCCRO|SCRO|Tes3	protein_coding	Q96GG9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23286
4.63505444244996e-30	-0.376307668421857	0.109	0.281	1.05934169282194e-25	RAPGEF2	Malignant cells	GSE175716	ENSG00000109756	9693	Rap guanine nucleotide exchange factor 2	DKFZP586O1422|KIAA0313|PDZ-GEF1|PDZGEF1|RA-GEF	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23287
4.98422545726418e-30	-0.673682961723537	0.723	0.759	1.13914472825773e-25	MBNL1	Malignant cells	GSE175716	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23288
5.08475356222408e-30	-0.274883614688569	0.122	0.301	1.16212042664631e-25	RBM7	Malignant cells	GSE175716	ENSG00000076053	10179	RNA binding motif protein 7	NA	protein_coding	Q9Y580	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23289
5.2804502725244e-30	-0.297230180121918	0.103	0.277	1.20684690978545e-25	APEH	Malignant cells	GSE175716	ENSG00000164062	327	acylaminoacyl-peptide hydrolase	D3F15S2|D3S48E|DNF15S2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23290
5.30370701315929e-30	-0.295743676599587	0.132	0.313	1.21216223785756e-25	ADGRL2	Malignant cells	GSE175716	ENSG00000117114	23266	adhesion G protein-coupled receptor L2	CIRL2|KIAA0786|LEC1|LPHH1|LPHN2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23291
5.48416878288934e-30	-0.537658445932447	0.728	0.763	1.25340677532936e-25	COA4	Malignant cells	GSE175716	ENSG00000181924	51287	cytochrome c oxidase assembly factor 4 homolog	CHCHD8|CMC3|E2IG2	protein_coding	Q9NYJ1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23292
5.50038746683802e-30	0.27281558470084	1	0.999	1.25711355554583e-25	NACA	Malignant cells	GSE175716	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23293
5.75312459032452e-30	-0.399577972580222	0.435	0.594	1.31487662511867e-25	AFF4	Malignant cells	GSE175716	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23294
5.92161824544343e-30	-0.327028784620916	0.156	0.34	1.3533858499961e-25	PROS1	Malignant cells	GSE175716	ENSG00000184500	5627	protein S	PROS	protein_coding	P07225	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23295
6.60728047581615e-30	0.470356736129037	0.415	0.27	1.51009395274778e-25	SLC25A13	Malignant cells	GSE175716	ENSG00000004864	10165	solute carrier family 25 member 13	ARALAR2|CITRIN|CTLN2	protein_coding	Q9UJS0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23296
6.60991195022524e-30	-0.431487910872108	0.638	0.738	1.51069537622398e-25	AHNAK	Malignant cells	GSE175716	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23297
6.83112614840127e-30	0.321047348856216	0.305	0.163	1.56125388121711e-25	MED4	Malignant cells	GSE175716	ENSG00000136146	29079	mediator complex subunit 4	DRIP36|HSPC126|TRAP36|VDRIP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23298
7.2522395898742e-30	-0.346612014183424	0.474	0.624	1.65749935826575e-25	WDR82	Malignant cells	GSE175716	ENSG00000164091	80335	WD repeat domain 82	MST107|MSTP107|PRO2730|PRO34047|SWD2|TMEM113|WDR82A	protein_coding	Q6UXN9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23299
7.29300104856528e-30	-0.256002607634048	0.113	0.29	1.6668153896496e-25	PPP6R3	Malignant cells	GSE175716	ENSG00000110075	55291	protein phosphatase 6 regulatory subunit 3	C11orf23|DKFZp781E17107|DKFZp781E2374|DKFZp781O2362|FLJ11058|FLJ43065|KIAA1558|MGC125711|MGC125712|PP6R3|SAP190|SAPL|SAPLa|SAPS3	protein_coding	Q5H9R7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23300
7.80615136763521e-30	-0.323302720948136	0.3	0.489	1.78409589507303e-25	AK6	Malignant cells	GSE175716	ENSG00000279247	102157402	adenylate kinase 6	CINAP	protein_coding	Q9Y3D8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23301
8.26776458060309e-30	0.371063020265286	0.662	0.498	1.88959759489684e-25	AGFG1	Malignant cells	GSE175716	ENSG00000173744	3267	ArfGAP with FG repeats 1	HRB|RAB|RIP	protein_coding	P52594	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23302
8.27370588613776e-30	-0.388220781693329	0.162	0.336	1.89095548027678e-25	AC079140.2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23303
8.98368592024571e-30	0.286744136018017	0.864	0.673	2.05322141707216e-25	CCNL1	Malignant cells	GSE175716	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23304
9.14892582525588e-30	-0.322393569098003	0.529	0.672	2.09098699736223e-25	DR1	Malignant cells	GSE175716	ENSG00000117505	1810	down-regulator of transcription 1	NC2-BETA|NC2B|NCB2	protein_coding	Q01658	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23305
9.91913559699151e-30	-0.335335992412021	0.383	0.548	2.26701844069241e-25	YIPF3	Malignant cells	GSE175716	ENSG00000137207	25844	Yip1 domain family member 3	C6orf109|dJ337H4.3|DKFZp566C243|FinGER3|KLIP1	protein_coding	Q9GZM5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23306
1.01988364985393e-29	0.52628240716918	0.782	0.612	2.33094408174115e-25	PCNA	Malignant cells	GSE175716	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23307
1.07675516037704e-29	-0.34821594143473	0.165	0.354	2.46092391904173e-25	EP300	Malignant cells	GSE175716	ENSG00000100393	2033	E1A binding protein p300	KAT3B|p300	protein_coding	Q09472	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23308
1.15596048521397e-29	-0.283375801309675	0.094	0.263	2.64194768895652e-25	ACOT9	Malignant cells	GSE175716	ENSG00000123130	23597	acyl-CoA thioesterase 9	ACATE2|CGI-16|MT-ACT48	protein_coding	Q9Y305	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23309
1.30664066816331e-29	-0.577857871635146	0.584	0.67	2.98632724708726e-25	STX3	Malignant cells	GSE175716	ENSG00000166900	6809	syntaxin 3	STX3A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23310
1.35198141100807e-29	-0.286317691626595	0.189	0.386	3.08995351485895e-25	BLOC1S2	Malignant cells	GSE175716	ENSG00000196072	282991	biogenesis of lysosomal organelles complex 1 subunit 2	BLOS2|BORCS2|FLJ30135|MGC10120	protein_coding	Q6QNY1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23311
1.39850530048212e-29	0.423182990285199	0.876	0.762	3.19628386425189e-25	TFRC	Malignant cells	GSE175716	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23312
1.41550870194491e-29	-0.411736017493447	0.546	0.673	3.2351451382951e-25	PPP2R5E	Malignant cells	GSE175716	ENSG00000154001	5529	protein phosphatase 2 regulatory subunit B'epsilon	B56E|B56epsilon	protein_coding	Q16537	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23313
1.42623474975041e-29	0.467112968936986	0.382	0.244	3.25965952055455e-25	DARS2	Malignant cells	GSE175716	ENSG00000117593	55157	aspartyl-tRNA synthetase 2, mitochondrial	FLJ10514|mtAspRS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23314
1.50007902397993e-29	-0.347500479355233	0.77	0.84	3.42843060930612e-25	NSA2	Malignant cells	GSE175716	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23315
1.63140974590329e-29	-0.280076756230432	0.169	0.36	3.72858697426197e-25	GTF2B	Malignant cells	GSE175716	ENSG00000137947	2959	general transcription factor IIB	TFIIB	protein_coding	Q00403	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23316
1.73785533131238e-29	-0.275255285269224	0.124	0.303	3.97186835971444e-25	LONP2	Malignant cells	GSE175716	ENSG00000102910	83752	lon peptidase 2, peroxisomal	LONP|LONPL|MGC4840	protein_coding	Q86WA8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23317
1.82904504509211e-29	-0.648581531506582	0.12	0.281	4.18028245055801e-25	PMEPA1	Malignant cells	GSE175716	ENSG00000124225	56937	prostate transmembrane protein, androgen induced 1	STAG1|TMEPAI	protein_coding	Q969W9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23318
1.86044545041226e-29	0.529694423597658	0.415	0.285	4.25204807691722e-25	ISOC1	Malignant cells	GSE175716	ENSG00000066583	51015	isochorismatase domain containing 1	CGI-111	protein_coding	Q96CN7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23319
1.96574767292527e-29	-0.645478429260016	0.301	0.456	4.49271630647071e-25	GEM	Malignant cells	GSE175716	ENSG00000164949	2669	GTP binding protein overexpressed in skeletal muscle	KIR	protein_coding	P55040	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23320
2.04474088574112e-29	-0.341493512742253	0.477	0.617	4.67325529436134e-25	CMC1	Malignant cells	GSE175716	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23321
2.15764501070856e-29	-0.31433677583928	0.106	0.28	4.93129767197441e-25	CMIP	Malignant cells	GSE175716	ENSG00000153815	80790	c-Maf inducing protein	NA	protein_coding	Q8IY22	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23322
2.70642883026758e-29	0.363282087899367	0.343	0.199	6.18554309157656e-25	MTCO3P12	Malignant cells	GSE175716	ENSG00000198744	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23323
2.79488303957709e-29	-0.302627790162511	0.121	0.298	6.38770518695344e-25	CBLL1	Malignant cells	GSE175716	ENSG00000105879	79872	Cbl proto-oncogene like 1	FLJ23109|HAKAI|RNF188	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23324
3.08070587731026e-29	-0.863026954072877	0.498	0.549	7.0409532825926e-25	ETFB	Malignant cells	GSE175716	ENSG00000105379	2109	electron transfer flavoprotein subunit beta	NA	protein_coding	P38117	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23325
3.34256476213568e-29	-0.384659932708806	0.405	0.564	7.63943176386109e-25	IRAK2	Malignant cells	GSE175716	ENSG00000134070	3656	interleukin 1 receptor associated kinase 2	NA	protein_coding	O43187	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23326
3.64278474194646e-29	-0.794663362059451	0.809	0.773	8.32558452771864e-25	AC012354.2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23327
3.65585521173048e-29	-0.422282413271475	0.46	0.599	8.35545708641001e-25	BLOC1S6	Malignant cells	GSE175716	ENSG00000104164	26258	biogenesis of lysosomal organelles complex 1 subunit 6	HPS9|PA|PLDN	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23328
3.86433467766091e-29	-0.355704419965071	0.511	0.646	8.83193690579401e-25	MLEC	Malignant cells	GSE175716	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23329
3.95216333015892e-29	-0.303486987382996	0.164	0.351	9.03266929107821e-25	SMC1A	Malignant cells	GSE175716	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23330
3.96837636744159e-29	-0.372461514267216	0.515	0.643	9.06972418778775e-25	SLC39A6	Malignant cells	GSE175716	ENSG00000141424	25800	solute carrier family 39 member 6	LIV-1	protein_coding	Q13433	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23331
4.24664865715793e-29	-0.320197201817283	0.128	0.303	9.70571550593445e-25	ZNF639	Malignant cells	GSE175716	ENSG00000121864	51193	zinc finger protein 639	ANC-2H01|ZASC1	protein_coding	Q9UID6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23332
4.24855061624917e-29	-0.455559828187101	1	0.997	9.71006243343747e-25	RPS11	Malignant cells	GSE175716	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23333
4.30154718391545e-29	0.333846613005371	0.897	0.755	9.83118608883875e-25	PPIF	Malignant cells	GSE175716	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23334
4.38573445281999e-29	-0.289605762397916	0.132	0.309	1.00235960919201e-24	LASP1	Malignant cells	GSE175716	ENSG00000002834	3927	LIM and SH3 protein 1	Lasp-1|MLN50	protein_coding	Q14847	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23335
4.76659409700956e-29	0.511315697672545	0.439	0.3	1.08940508087153e-24	RBM24	Malignant cells	GSE175716	ENSG00000112183	221662	RNA binding motif protein 24	dJ259A10.1|FLJ30829|RNPC6	protein_coding	Q9BX46	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23336
5.59332635724896e-29	-0.286630019830533	0.098	0.267	1.27835473894925e-24	TMEM57	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23337
5.79694419402179e-29	-0.285289335258202	0.203	0.4	1.32489159554368e-24	SREK1IP1	Malignant cells	GSE175716	ENSG00000153006	285672	SREK1 interacting protein 1	FLJ36754|P18SRP|SFRS12IP1	protein_coding	Q8N9Q2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23338
6.27757380753465e-29	-0.257941610099512	0.086	0.251	1.43473949371204e-24	C16orf52	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23339
6.44014696775475e-29	-1.29516091150378	0.999	0.997	1.47189558948035e-24	YWHAZ	Malignant cells	GSE175716	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23340
6.81805137439213e-29	-0.417301281692138	0.444	0.581	1.55826564161732e-24	YES1	Malignant cells	GSE175716	ENSG00000176105	7525	YES proto-oncogene 1, Src family tyrosine kinase	c-yes|HsT441|Yes	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23341
6.82860297569087e-29	-0.561103255565391	0.634	0.707	1.56067721009415e-24	RYBP	Malignant cells	GSE175716	ENSG00000281766	23429	RING1 and YY1 binding protein	AAP1|DEDAF|YEAF1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23342
6.8944146304442e-29	-0.371091876772158	0.39	0.544	1.57571846378802e-24	TNFRSF1A	Malignant cells	GSE175716	ENSG00000067182	7132	TNF receptor superfamily member 1A	CD120a|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR60	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23343
7.13092683096775e-29	-0.29282886776409	0.884	0.946	1.62977332721768e-24	VDAC2	Malignant cells	GSE175716	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23344
7.1521287657098e-29	-0.262729782280774	0.132	0.313	1.63461902940298e-24	DVL3	Malignant cells	GSE175716	ENSG00000161202	1857	dishevelled segment polarity protein 3	KIAA0208	protein_coding	Q92997	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23345
8.09291042916557e-29	-0.272217713434797	0.189	0.383	1.84963467858579e-24	ATF1	Malignant cells	GSE175716	ENSG00000123268	466	activating transcription factor 1	TREB36	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23346
9.28424094413776e-29	0.367356546232108	0.946	0.863	2.12191326778268e-24	RAD23B	Malignant cells	GSE175716	ENSG00000119318	5887	RAD23 homolog B, nucleotide excision repair protein	HHR23B|HR23B|P58	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23347
9.95296728715548e-29	0.271768618280006	0.273	0.135	2.27475067347938e-24	ZNF704	Malignant cells	GSE175716	ENSG00000164684	619279	zinc finger protein 704	FLJ16218|Gig1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23348
1.00739038543303e-28	-0.363261046278494	0.485	0.626	2.30239072590718e-24	GOSR1	Malignant cells	GSE175716	ENSG00000108587	9527	golgi SNAP receptor complex member 1	GOLIM2|GOS-28|GOS28|GS28|P28	protein_coding	O95249	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23349
1.05822280794179e-28	-0.283102009778156	0.1	0.269	2.41856822755095e-24	STAT5B	Malignant cells	GSE175716	ENSG00000173757	6777	signal transducer and activator of transcription 5B	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23350
1.09201183456661e-28	-0.273075592966424	0.214	0.41	2.49579304790199e-24	DNAJB11	Malignant cells	GSE175716	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23351
1.22727710640324e-28	-0.330572720426316	0.548	0.677	2.80494182668461e-24	HMCES	Malignant cells	GSE175716	ENSG00000183624	56941	5-hydroxymethylcytosine binding, ES cell specific	C3orf37|DC12|SRAPD1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23352
1.30293109715961e-28	0.402702593095271	0.846	0.731	2.97784902255829e-24	HNRNPA0	Malignant cells	GSE175716	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23353
1.42912550435367e-28	-0.338858050731633	0.781	0.828	3.26626634020031e-24	HACD3	Malignant cells	GSE175716	ENSG00000074696	51495	3-hydroxyacyl-CoA dehydratase 3	B-ind1|HSPC121|PTPLAD1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23354
1.62211389388506e-28	0.303914199053024	0.283	0.146	3.7073413044743e-24	SLC7A7	Malignant cells	GSE175716	ENSG00000155465	9056	solute carrier family 7 member 7	LPI|y+LAT-1	protein_coding	Q9UM01	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23355
1.83989419511079e-28	-0.349879662951407	0.37	0.533	4.20507818292572e-24	SMC5	Malignant cells	GSE175716	ENSG00000198887	23137	structural maintenance of chromosomes 5	KIAA0594|SMC5L1	protein_coding	Q8IY18	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23356
1.93497364271828e-28	-0.423695872324759	0.52	0.646	4.42238226043264e-24	RAB32	Malignant cells	GSE175716	ENSG00000118508	10981	RAB32, member RAS oncogene family	NA	protein_coding	Q13637	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23357
2.21333137698287e-28	-0.252968159367737	0.136	0.317	5.05856886209434e-24	WSB2	Malignant cells	GSE175716	ENSG00000176871	55884	WD repeat and SOCS box containing 2	MGC10210|SBA2	protein_coding	Q9NYS7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23358
2.22119769759028e-28	0.3133987480914	0.3	0.16	5.07654733784259e-24	RHOT2	Malignant cells	GSE175716	ENSG00000140983	89941	ras homolog family member T2	ARHT2|C16orf39|MIRO-2|MIRO2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23359
2.35808192911899e-28	-0.267756257184847	0.914	0.945	5.38939624900146e-24	ATP5H	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23360
2.41409239493869e-28	-0.399478382537857	0.145	0.314	5.51740816863239e-24	NFKB2	Malignant cells	GSE175716	ENSG00000077150	4791	nuclear factor kappa B subunit 2	LYT-10|NF-kB2|p105|p49/p100|p52	protein_coding	Q00653	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23361
2.58550854688027e-28	-0.409477088295767	0.115	0.28	5.90917978389486e-24	HSPA4L	Malignant cells	GSE175716	ENSG00000164070	22824	heat shock protein family A (Hsp70) member 4 like	APG-1|HSPH3|Osp94	protein_coding	O95757	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23362
2.6251414347015e-28	-0.29688160839636	0.566	0.699	5.99976074901029e-24	RNF7	Malignant cells	GSE175716	ENSG00000114125	9616	ring finger protein 7	CKBBP1|RBX2|ROC2|SAG	protein_coding	Q9UBF6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23363
2.8092548636115e-28	-0.304094999880072	0.161	0.339	6.42055199078409e-24	WASHC4	Malignant cells	GSE175716	ENSG00000136051	23325	WASH complex subunit 4	KIAA1033|SWIP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23364
2.97716951208061e-28	-0.351194080555141	0.181	0.364	6.80432091986025e-24	SEC14L1	Malignant cells	GSE175716	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23365
3.0793390468048e-28	-0.309010667567922	0.166	0.344	7.03782939147237e-24	MRPL48	Malignant cells	GSE175716	ENSG00000175581	51642	mitochondrial ribosomal protein L48	CGI-118	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23366
3.52647002087603e-28	-0.306920473098939	0.154	0.333	8.05974723271218e-24	MPHOSPH8	Malignant cells	GSE175716	ENSG00000196199	54737	M-phase phosphoprotein 8	HSMPP8|mpp8	protein_coding	Q99549	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23367
3.67192871802685e-28	-0.341136398781776	0.104	0.265	8.39219308505036e-24	HMG20B	Malignant cells	GSE175716	ENSG00000064961	10362	high mobility group 20B	BRAF25|BRAF35|HMGX2|HMGXB2|SMARCE1r|SOXL	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23368
4.00049157402032e-28	-0.334535568171563	0.52	0.646	9.14312349242345e-24	CASP4	Malignant cells	GSE175716	ENSG00000196954	837	caspase 4	ICE(rel)II|ICH-2|TX	protein_coding	P49662	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23369
4.00481054372535e-28	-0.307817079207377	0.177	0.362	9.15299449768428e-24	PSMA6P1	Malignant cells	GSE175716	ENSG00000215414	NA	NA	PSMA6-LIKE|PSMA6P|PSMA6Y	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23370
4.01185992783585e-28	-0.360072128525082	0.196	0.381	9.16910586506883e-24	SGMS1	Malignant cells	GSE175716	ENSG00000198964	259230	sphingomyelin synthase 1	MGC17342|MOB|SMS1|TMEM23	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23371
4.05490716636602e-28	-0.436994116350634	0.809	0.833	9.26749032872954e-24	GHITM	Malignant cells	GSE175716	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23372
4.06856459286913e-28	-0.630255767583827	0.693	0.699	9.2987043770024e-24	VKORC1	Malignant cells	GSE175716	ENSG00000167397	79001	vitamin K epoxide reductase complex subunit 1	VKCFD2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23373
4.20076263021531e-28	0.328743770937887	0.933	0.83	9.6008429913571e-24	NAMPT	Malignant cells	GSE175716	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23374
4.31252356351279e-28	-0.332678153791146	0.146	0.32	9.85627260440848e-24	ZBTB11	Malignant cells	GSE175716	ENSG00000066422	27107	zinc finger and BTB domain containing 11	ZNF-U69274|ZNF913	protein_coding	O95625	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23375
4.58027620284238e-28	0.401063260769959	0.687	0.55	1.04682212615963e-23	TMEM219	Malignant cells	GSE175716	ENSG00000149932	124446	transmembrane protein 219	IGFBP-3R	protein_coding	Q86XT9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23376
5.17237375540084e-28	-0.272273773967435	0.122	0.295	1.18214602179686e-23	RAB20	Malignant cells	GSE175716	ENSG00000139832	55647	RAB20, member RAS oncogene family	FLJ20429	protein_coding	Q9NX57	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23377
5.45951891246465e-28	0.378532049987338	0.929	0.845	1.2477730474438e-23	KHDRBS1	Malignant cells	GSE175716	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23378
5.74359159850775e-28	-0.294787435870328	0.678	0.792	1.31269785983895e-23	VAMP8	Malignant cells	GSE175716	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23379
5.78463570833908e-28	-0.666143666277704	0.608	0.668	1.3220784911409e-23	TAF7	Malignant cells	GSE175716	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23380
5.89664677175626e-28	-0.710648659344369	0.559	0.632	1.34767861968489e-23	LACTB2	Malignant cells	GSE175716	ENSG00000147592	51110	lactamase beta 2	CGI-83	protein_coding	Q53H82	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23381
6.07540337967049e-28	-0.311166973698795	0.233	0.42	1.38853344242369e-23	DIEXF	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23382
6.08749969129322e-28	-0.315410136672357	0.122	0.289	1.39129805444507e-23	TMEM65	Malignant cells	GSE175716	ENSG00000164983	157378	transmembrane protein 65	NA	protein_coding	Q6PI78	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23383
6.76779177679737e-28	-0.260435570736451	0.162	0.349	1.54677881058704e-23	MID1IP1	Malignant cells	GSE175716	ENSG00000165175	58526	MID1 interacting protein 1	FLJ10386|G12-like|MIG12|STRAIT11499|THRSPL	protein_coding	Q9NPA3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23384
7.14782963010442e-28	-0.328816040042577	0.525	0.654	1.63363646196037e-23	SEPT9	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23385
7.20082414641856e-28	-0.332617028227376	0.147	0.322	1.64574835866396e-23	SLC41A2	Malignant cells	GSE175716	ENSG00000136052	84102	solute carrier family 41 member 2	DKFZP434K0427	protein_coding	Q96JW4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23386
7.63049476469038e-28	-0.939991971792277	0.565	0.573	1.74394957846999e-23	AP2S1	Malignant cells	GSE175716	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23387
8.19317774448265e-28	-0.335260508952403	0.696	0.778	1.87255077350151e-23	CTNNA1	Malignant cells	GSE175716	ENSG00000044115	1495	catenin alpha 1	CAP102	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23388
8.29611091584256e-28	-0.317966352702502	0.092	0.251	1.89607614981582e-23	MVP	Malignant cells	GSE175716	ENSG00000013364	9961	major vault protein	LRP|VAULT1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23389
8.9660204273715e-28	-0.293206750294772	0.097	0.261	2.04918396867576e-23	KIF2A	Malignant cells	GSE175716	ENSG00000068796	3796	kinesin family member 2A	HK2|KIF2	protein_coding	O00139	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23390
9.20182407165563e-28	0.485018618252413	0.454	0.329	2.10307689157689e-23	IDH3B	Malignant cells	GSE175716	ENSG00000101365	3420	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta	RP46	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23391
9.20910214669528e-28	-0.298046604531392	0.16	0.336	2.10474029562721e-23	HMGXB4	Malignant cells	GSE175716	ENSG00000100281	10042	HMG-box containing 4	HMG2L1|P53N|THC211630	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23392
1.07117085381312e-27	0.256192357706286	0.863	0.67	2.44816098638989e-23	NPM1P27	Malignant cells	GSE175716	ENSG00000249353	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23393
1.11966969420978e-27	-0.271735509740096	0.124	0.297	2.55900508611644e-23	GOLGA3	Malignant cells	GSE175716	ENSG00000090615	2802	golgin A3	GCP170|golgin-160|MEA-2	protein_coding	Q08378	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23394
1.19163853223033e-27	-0.329968058755883	0.472	0.61	2.72348986541242e-23	MOB1A	Malignant cells	GSE175716	ENSG00000114978	55233	MOB kinase activator 1A	C2orf6|FLJ10788|FLJ11595|Mats1|MOB1|Mob4B|MOBK1B|MOBKL1B	protein_coding	Q9H8S9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23395
1.20788655712014e-27	-0.340604517242039	0.208	0.387	2.76062472629808e-23	SNRNP27	Malignant cells	GSE175716	ENSG00000124380	11017	small nuclear ribonucleoprotein U4/U6.U5 subunit 27	RY1|U4/U6.U5-27K	protein_coding	Q8WVK2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23396
1.2232856928245e-27	0.474517116294748	0.473	0.347	2.7958194509504e-23	IMMT	Malignant cells	GSE175716	ENSG00000132305	10989	inner membrane mitochondrial protein	HMP|Mic60|MICOS60|MINOS2|P87|P89	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23397
1.25059379286418e-27	0.38926103808609	0.838	0.696	2.85823211359108e-23	PSMC2	Malignant cells	GSE175716	ENSG00000161057	5701	proteasome 26S subunit, ATPase 2	MSS1|Nbla10058|RPT1|S7	protein_coding	P35998	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23398
1.27619974782945e-27	-0.286440634787164	0.218	0.407	2.91675452366421e-23	PELO	Malignant cells	GSE175716	ENSG00000152684	53918	pelota mRNA surveillance and ribosome rescue factor	NA	protein_coding	Q9BRX2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23399
1.3545054426259e-27	-0.270407336218331	0.101	0.266	3.09572218912149e-23	LIN7C	Malignant cells	GSE175716	ENSG00000148943	55327	lin-7 homolog C, crumbs cell polarity complex component	FLJ11215|LIN-7-C|LIN-7C|MALS-3|VELI3	protein_coding	Q9NUP9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23400
1.36376275146998e-27	-0.30423110920284	0.704	0.781	3.11687976848464e-23	STRAP	Malignant cells	GSE175716	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23401
1.54845914506035e-27	-0.330111737827963	0.496	0.632	3.53900337603542e-23	CISD1	Malignant cells	GSE175716	ENSG00000122873	55847	CDGSH iron sulfur domain 1	C10orf70|MDS029|mitoNEET|ZCD1	protein_coding	Q9NZ45	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23402
1.65632922558059e-27	-0.408859742103303	0.656	0.761	3.78554044506445e-23	DDX3X	Malignant cells	GSE175716	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23403
1.72629345526556e-27	-0.313844788561003	0.129	0.296	3.94544369200945e-23	EIF3G	Malignant cells	GSE175716	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23404
1.80045880338271e-27	-0.642972933679123	0.435	0.517	4.11494859513119e-23	YIF1A	Malignant cells	GSE175716	ENSG00000174851	10897	Yip1 interacting factor homolog A, membrane trafficking protein	54TM|FinGER7|YIF1|YIF1P	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23405
2.10334847744705e-27	-0.337932149822434	0.922	0.968	4.80720294520523e-23	MCL1	Malignant cells	GSE175716	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23406
2.17524995864911e-27	-0.447752389824475	0.556	0.664	4.97153378049253e-23	PRPF38B	Malignant cells	GSE175716	ENSG00000134186	55119	pre-mRNA processing factor 38B	FLJ10330|NET1	protein_coding	Q5VTL8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23407
2.2500348282489e-27	-0.313544299791503	1	1	5.14245459996286e-23	RPL37	Malignant cells	GSE175716	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23408
2.46344644337849e-27	0.362896715252142	0.804	0.655	5.63020684634154e-23	ISCU	Malignant cells	GSE175716	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23409
2.50226394997465e-27	-0.458369616004198	0.616	0.707	5.71892425766707e-23	PDLIM5	Malignant cells	GSE175716	ENSG00000163110	10611	PDZ and LIM domain 5	Enh|LIM	protein_coding	Q96HC4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23410
2.86643983870131e-27	-0.284812341857024	0.095	0.253	6.55124825135185e-23	E2F6	Malignant cells	GSE175716	ENSG00000169016	1876	E2F transcription factor 6	E2F-6	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23411
2.923613651945e-27	-0.393752748870843	0.336	0.498	6.6819190015203e-23	TBC1D15	Malignant cells	GSE175716	ENSG00000121749	64786	TBC1 domain family member 15	DKFZp761D0223|FLJ12085	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23412
3.1117848436478e-27	-0.256970567937369	0.101	0.265	7.11198426015705e-23	STX5	Malignant cells	GSE175716	ENSG00000162236	6811	syntaxin 5	SED5|STX5A	protein_coding	Q13190	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23413
3.29402632681379e-27	0.303453129995636	0.275	0.144	7.52849716993292e-23	PGP	Malignant cells	GSE175716	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23414
3.43356867368186e-27	-0.254930788838692	0.106	0.271	7.84742120369989e-23	DPP8	Malignant cells	GSE175716	ENSG00000074603	54878	dipeptidyl peptidase 8	DP8|DPRP1|FLJ14920|FLJ20283|MGC26191|MSTP141	protein_coding	Q6V1X1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23415
3.59009358740504e-27	0.38758660389173	0.389	0.236	8.20515889401421e-23	LINC00665	Malignant cells	GSE175716	ENSG00000232677	100506930	long intergenic non-protein coding RNA 665	CIP2A-BP	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23416
3.81035031526505e-27	-0.276310041428531	0.96	0.977	8.70855564553826e-23	ANXA5	Malignant cells	GSE175716	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23417
4.5256990043446e-27	-0.384419198987927	0.434	0.575	1.03434850744296e-22	NSRP1	Malignant cells	GSE175716	ENSG00000126653	84081	nuclear speckle splicing regulatory protein 1	CCDC55|DKFZP434K1421|NSrp70	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23418
4.62738013039862e-27	-0.542538017195693	0.151	0.315	1.0575877288026e-22	F3	Malignant cells	GSE175716	ENSG00000117525	2152	coagulation factor III, tissue factor	CD142|TF	protein_coding	P13726	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23419
4.74674145220203e-27	-0.291041195400068	0.163	0.343	1.08486775890077e-22	TTC17	Malignant cells	GSE175716	ENSG00000052841	55761	tetratricopeptide repeat domain 17	FLJ10890	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23420
4.7864598450899e-27	-0.651374863105325	0.931	0.895	1.0939453975953e-22	PKM	Malignant cells	GSE175716	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23421
4.85755124150101e-27	-0.27390680950391	0.163	0.344	1.11019333624506e-22	CTDSP1	Malignant cells	GSE175716	ENSG00000144579	58190	CTD small phosphatase 1	NLIIF|SCP1	protein_coding	Q9GZU7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23422
5.08163916212996e-27	-0.415936182226998	0.563	0.654	1.1614086305048e-22	CYB5R3	Malignant cells	GSE175716	ENSG00000100243	1727	cytochrome b5 reductase 3	DIA1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23423
5.9130237826999e-27	-0.261356847450396	0.213	0.408	1.35142158553606e-22	TRIM16L	Malignant cells	GSE175716	ENSG00000108448	NA	NA	TRIM70	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23424
6.17362876962686e-27	-0.498148882353734	0.338	0.492	1.41098285529822e-22	DEDD2	Malignant cells	GSE175716	ENSG00000160570	162989	death effector domain containing 2	FLAME-3	protein_coding	Q8WXF8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23425
6.30051438265127e-27	-0.275774469356017	0.195	0.381	1.43998256215495e-22	PPIC	Malignant cells	GSE175716	ENSG00000168938	5480	peptidylprolyl isomerase C	CYPC	protein_coding	P45877	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23426
6.86456535823783e-27	-0.271102495788307	0.121	0.289	1.56889641262526e-22	FAM210A	Malignant cells	GSE175716	ENSG00000177150	125228	family with sequence similarity 210 member A	C18orf19|HsT2329|MGC24180	protein_coding	Q96ND0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23427
7.03311375207265e-27	-0.340968234557781	0.169	0.34	1.6074181480362e-22	ITPK1	Malignant cells	GSE175716	ENSG00000274958	3705	inositol-tetrakisphosphate 1-kinase	NA	protein_coding	Q13572	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23428
7.14751509879498e-27	-0.329352710628856	0.609	0.724	1.63356457582959e-22	LGR4	Malignant cells	GSE175716	ENSG00000205213	55366	leucine rich repeat containing G protein-coupled receptor 4	GPR48	protein_coding	Q9BXB1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23429
7.43991339732709e-27	-0.301365410964329	0.095	0.25	1.70039220695911e-22	ZBTB1	Malignant cells	GSE175716	ENSG00000126804	22890	zinc finger and BTB domain containing 1	KIAA0997|ZNF909	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23430
7.62876863290465e-27	0.381851420943639	0.603	0.469	1.74355507105036e-22	CRLS1	Malignant cells	GSE175716	ENSG00000088766	54675	cardiolipin synthase 1	C20orf155|CLS1|dJ967N21.6|GCD10	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23431
7.77124798996413e-27	0.414619124995552	0.928	0.834	1.7761187281063e-22	PPP1R15B	Malignant cells	GSE175716	ENSG00000158615	84919	protein phosphatase 1 regulatory subunit 15B	FLJ14744	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23432
7.98561763909594e-27	-0.372514653351702	0.196	0.373	1.82511291141538e-22	SECISBP2L	Malignant cells	GSE175716	ENSG00000138593	9728	SECIS binding protein 2 like	KIAA0256	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23433
8.9006812236939e-27	-0.480796263478862	0.771	0.783	2.03425069367524e-22	APRT	Malignant cells	GSE175716	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23434
9.0523300853414e-27	0.49350685370832	0.5	0.384	2.06891004100478e-22	RNF115	Malignant cells	GSE175716	ENSG00000265491	27246	ring finger protein 115	CL469780|ZNF364	protein_coding	Q9Y4L5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23435
1.10510615698762e-26	-0.276260195526247	0.239	0.433	2.5257201217952e-22	MKRN1	Malignant cells	GSE175716	ENSG00000133606	23608	makorin ring finger protein 1	RNF61	protein_coding	Q9UHC7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23436
1.13240600642865e-26	-0.305048733036604	0.426	0.576	2.58811392769269e-22	ARFIP2	Malignant cells	GSE175716	ENSG00000132254	23647	ADP ribosylation factor interacting protein 2	POR1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23437
1.14869791717039e-26	-0.364432226971695	0.197	0.374	2.62534908969292e-22	RNF149	Malignant cells	GSE175716	ENSG00000163162	284996	ring finger protein 149	FLJ90504	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23438
1.24284682619189e-26	0.302294018937844	0.29	0.158	2.84052642126156e-22	COMMD7	Malignant cells	GSE175716	ENSG00000149600	149951	COMM domain containing 7	C20orf92|dJ1085F17.3	protein_coding	Q86VX2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23439
1.39942488765136e-26	-0.369553362929476	0.221	0.403	3.19838558072718e-22	PLEKHA1	Malignant cells	GSE175716	ENSG00000107679	59338	pleckstrin homology domain containing A1	TAPP1	protein_coding	Q9HB21	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23440
1.50718882238071e-26	-0.257229288425979	0.183	0.368	3.44468005355112e-22	PRRC1	Malignant cells	GSE175716	ENSG00000164244	133619	proline rich coiled-coil 1	FLJ32875	protein_coding	Q96M27	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23441
1.60538236977693e-26	0.337436978575796	0.899	0.789	3.66910140612517e-22	TXNP4	Malignant cells	GSE175716	ENSG00000262519	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23442
1.67074571003445e-26	0.406666682210447	0.348	0.213	3.81848932028373e-22	PACSIN2	Malignant cells	GSE175716	ENSG00000100266	11252	protein kinase C and casein kinase substrate in neurons 2	SDPII	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23443
1.67918708137501e-26	-0.314956905828676	0.482	0.621	3.83778207448258e-22	TMEM70	Malignant cells	GSE175716	ENSG00000175606	54968	transmembrane protein 70	FLJ20533	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23444
1.75942995779913e-26	-0.278210272464427	0.19	0.368	4.02117716854992e-22	FBXO28	Malignant cells	GSE175716	ENSG00000143756	23219	F-box protein 28	CENP-30|Fbx28|FLJ10766|KIAA0483	protein_coding	Q9NVF7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23445
1.97523499521171e-26	-0.301338932240161	0.113	0.271	4.51439958155635e-22	SOS2	Malignant cells	GSE175716	ENSG00000100485	6655	SOS Ras/Rho guanine nucleotide exchange factor 2	NA	protein_coding	Q07890	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23446
2.13800314068277e-26	-0.279883771007867	0.204	0.387	4.88640617803047e-22	REXO2	Malignant cells	GSE175716	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23447
2.18498889270868e-26	-0.26603103362997	0.124	0.292	4.99379211428568e-22	VIRMA	Malignant cells	GSE175716	ENSG00000164944	25962	vir like m6A methyltransferase associated	DKFZP434I116|fSAP121|KIAA1429	protein_coding	Q69YN4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23448
2.32281610469066e-26	-0.292703398602719	0.196	0.377	5.30879620727051e-22	AP002784.2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23449
2.56989449830924e-26	-0.372938372087891	0.144	0.303	5.87349387588576e-22	MAP2K2	Malignant cells	GSE175716	ENSG00000126934	5605	mitogen-activated protein kinase kinase 2	MEK2|PRKMK2	protein_coding	P36507	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23450
2.60879883560962e-26	-0.277164923121478	0.184	0.358	5.96240973878579e-22	COPS5	Malignant cells	GSE175716	ENSG00000121022	10987	COP9 signalosome subunit 5	CSN5|JAB1|MOV-34|SGN5	protein_coding	Q92905	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23451
3.09665722842378e-26	-0.362283873755411	0.373	0.527	7.07741009556256e-22	YTHDF3	Malignant cells	GSE175716	ENSG00000185728	253943	YTH N6-methyladenosine RNA binding protein 3	FLJ31657	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23452
3.1336195289011e-26	-0.794608010802228	0.792	0.731	7.16188743330347e-22	RPL13P12	Malignant cells	GSE175716	ENSG00000215030	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23453
3.14882030188561e-26	-0.297507354563418	0.149	0.321	7.19662879995956e-22	RRAS2	Malignant cells	GSE175716	ENSG00000133818	22800	RAS related 2	TC21	protein_coding	P62070	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23454
3.16760378555524e-26	-0.282149747975274	0.117	0.28	7.23955845188649e-22	ZEB1	Malignant cells	GSE175716	ENSG00000148516	6935	zinc finger E-box binding homeobox 1	AREB6|BZP|FECD6|NIL-2-A|PPCD3|TCF8|ZEB|Zfhep|Zfhx1a	protein_coding	P37275	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23455
3.69691821106535e-26	-0.323755567891233	0.099	0.251	8.44930657138985e-22	INF2	Malignant cells	GSE175716	ENSG00000203485	64423	inverted formin 2	C14orf151|C14orf173|MGC13251	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23456
3.93613139908511e-26	0.416827681171189	0.875	0.77	8.99602831260902e-22	C6orf48	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23457
5.19664707271977e-26	-0.305581109264652	0.74	0.811	1.1876936884701e-21	ACADVL	Malignant cells	GSE175716	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23458
5.23667365318e-26	0.359345176722154	0.989	0.972	1.19684176343429e-21	RPS23	Malignant cells	GSE175716	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23459
5.25765963739293e-26	-0.326114380754249	0.4	0.56	1.20163811012615e-21	RAB21	Malignant cells	GSE175716	ENSG00000080371	23011	RAB21, member RAS oncogene family	KIAA0118	protein_coding	Q9UL25	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23460
5.48846743315793e-26	-0.545537659567683	0.576	0.67	1.25438923184824e-21	MSANTD3	Malignant cells	GSE175716	ENSG00000066697	91283	Myb/SANT DNA binding domain containing 3	C9orf30|MGC17337	protein_coding	Q96H12	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23461
5.55965220042889e-26	-0.83259143313058	0.541	0.562	1.27065851040802e-21	DPM3	Malignant cells	GSE175716	ENSG00000179085	54344	dolichyl-phosphate mannosyltransferase subunit 3, regulatory	MGC125904|MGC125905|MGC34275	protein_coding	Q9P2X0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23462
5.66378659433608e-26	-0.317220653815823	0.38	0.541	1.29445842613551e-21	MED1	Malignant cells	GSE175716	ENSG00000125686	5469	mediator complex subunit 1	CRSP1|CRSP200|DRIP230|PBP|PPARBP|PPARGBP|RB18A|TRAP220|TRIP2	protein_coding	Q15648	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23463
5.86060543124656e-26	0.330313094814906	0.771	0.641	1.3394413713114e-21	TMED4	Malignant cells	GSE175716	ENSG00000158604	222068	transmembrane p24 trafficking protein 4	HNLF|p24a3|p24alpha3	protein_coding	Q7Z7H5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23464
6.03007327091089e-26	-0.488822748194025	0.496	0.614	1.37817324606668e-21	DST	Malignant cells	GSE175716	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23465
6.38807186642348e-26	-0.439183700633664	0.383	0.527	1.45999382507109e-21	ITGA6	Malignant cells	GSE175716	ENSG00000091409	3655	integrin subunit alpha 6	CD49f	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23466
6.55575351719195e-26	-0.469669336141302	0.323	0.457	1.49831746635422e-21	NAA38	Malignant cells	GSE175716	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23467
6.79088713656999e-26	-0.472531770038868	0.747	0.765	1.55205725506307e-21	CHTOP	Malignant cells	GSE175716	ENSG00000160679	26097	chromatin target of PRMT1	C1orf77|DKFZP547E1010|FOP|SRAG	protein_coding	Q9Y3Y2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23468
6.88293747650498e-26	-0.433329059569448	0.662	0.738	1.57309536025521e-21	RBM47	Malignant cells	GSE175716	ENSG00000163694	54502	RNA binding motif protein 47	FLJ20273|NET18	protein_coding	A0AV96	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23469
7.22336171680156e-26	-0.312491539096281	0.245	0.427	1.650899320375e-21	CDK2AP2	Malignant cells	GSE175716	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23470
7.37565969569639e-26	-0.30180376137713	0.123	0.284	1.68570702345141e-21	KLF13	Malignant cells	GSE175716	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23471
7.48780203957058e-26	-0.316325933582919	0.467	0.604	1.71133715614386e-21	DCAF7	Malignant cells	GSE175716	ENSG00000136485	10238	DDB1 and CUL4 associated factor 7	HAN11|SWAN-1|WDR68	protein_coding	P61962	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23472
8.10258191512471e-26	-0.292120415764936	0.2	0.388	1.85184509670175e-21	NCOR1	Malignant cells	GSE175716	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23473
8.61774027739093e-26	-0.413070659885998	0.144	0.301	1.9695845403977e-21	REL	Malignant cells	GSE175716	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23474
9.09131661483098e-26	-0.469182265488578	0.574	0.665	2.07782041231962e-21	HSD17B11	Malignant cells	GSE175716	ENSG00000198189	51170	hydroxysteroid 17-beta dehydrogenase 11	17-BETA-HSD11|17-BETA-HSDXI|DHRS8|PAN1B|RetSDR2|SDR16C2	protein_coding	Q8NBQ5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23475
9.35052011018522e-26	-0.317862855024754	0.203	0.377	2.13706137118283e-21	CREM	Malignant cells	GSE175716	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23476
9.46432976335742e-26	-0.393572553767466	0.15	0.313	2.16307256741534e-21	KLHL24	Malignant cells	GSE175716	ENSG00000114796	54800	kelch like family member 24	DRE1|FLJ20059	protein_coding	Q6TFL4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23477
1.0890831812675e-25	-0.283347651257817	0.18	0.354	2.48909961078687e-21	RNMT	Malignant cells	GSE175716	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23478
1.15874999185914e-25	-0.560617136732145	0.569	0.646	2.64832310639406e-21	CD2AP	Malignant cells	GSE175716	ENSG00000198087	23607	CD2 associated protein	CMS	protein_coding	Q9Y5K6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23479
1.16789638359418e-25	-0.251687859452424	0.144	0.315	2.66922718470449e-21	SMIM10L1	Malignant cells	GSE175716	ENSG00000262986	100129361	small integral membrane protein 10 like 1	NA	protein_coding	P0DMW3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23480
1.26905872914921e-25	-0.252995860448812	0.128	0.293	2.90043372547051e-21	FTSJ3	Malignant cells	GSE175716	ENSG00000108592	117246	FtsJ RNA 2'-O-methyltransferase 3	SPB1	protein_coding	Q8IY81	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23481
1.29812389417735e-25	-0.395133550176999	0.491	0.616	2.96686216014233e-21	TMX1	Malignant cells	GSE175716	ENSG00000139921	81542	thioredoxin related transmembrane protein 1	PDIA11|TMX|TXNDC|TXNDC1	protein_coding	Q9H3N1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23482
1.45427372493671e-25	-0.467085041408166	0.603	0.684	3.32374259834285e-21	TANK	Malignant cells	GSE175716	ENSG00000136560	10010	TRAF family member associated NFKB activator	I-TRAF|TRAF2	protein_coding	Q92844	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23483
1.45806072017585e-25	0.374618495685603	0.682	0.549	3.33239777596191e-21	THRAP3	Malignant cells	GSE175716	ENSG00000054118	9967	thyroid hormone receptor associated protein 3	BCLAF2|TRAP150	protein_coding	Q9Y2W1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23484
1.49991401702601e-25	-0.378966758477348	0.157	0.315	3.42805348591296e-21	ABCC6	Malignant cells	GSE175716	ENSG00000275331	368	ATP binding cassette subfamily C member 6	ARA|EST349056|MLP1|MRP6|PXE|URG7	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23485
1.61676319856509e-25	-0.343616903546614	0.356	0.514	3.6951122903205e-21	FBXO45	Malignant cells	GSE175716	ENSG00000174013	200933	F-box protein 45	Fbx45	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23486
1.74199105415864e-25	-0.530323843756256	0.855	0.885	3.98132055427958e-21	TRA2B	Malignant cells	GSE175716	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23487
1.86617168218114e-25	-0.311882489042454	0.251	0.428	4.26513537962499e-21	HSD17B2	Malignant cells	GSE175716	ENSG00000086696	3294	hydroxysteroid 17-beta dehydrogenase 2	HSD17|SDR9C2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23488
1.89565178699634e-25	-0.330790914613504	0.875	0.913	4.33251215918013e-21	RAB7A	Malignant cells	GSE175716	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23489
2.0057875977965e-25	-0.283097053605726	0.68	0.768	4.58422755476389e-21	RAB5C	Malignant cells	GSE175716	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23490
2.04300164180803e-25	-0.435725573733374	0.662	0.729	4.66928025235226e-21	FXR1	Malignant cells	GSE175716	ENSG00000114416	8087	FMR1 autosomal homolog 1	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23491
2.07272399314279e-25	-0.400933228606766	0.616	0.686	4.73721068632784e-21	EIF3F	Malignant cells	GSE175716	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23492
2.10297595457141e-25	0.355985198557046	0.632	0.473	4.80635154417297e-21	GBP2	Malignant cells	GSE175716	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23493
2.11739384816604e-25	-0.324752441439018	0.224	0.402	4.8393036399835e-21	G6PC3	Malignant cells	GSE175716	ENSG00000141349	92579	glucose-6-phosphatase catalytic subunit 3	UGRP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23494
2.17429797025492e-25	-0.294831450052013	0.181	0.351	4.96935801101763e-21	PSMA3-AS1	Malignant cells	GSE175716	ENSG00000257621	379025	PSMA3 antisense RNA 1	FLJ31306	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23495
2.18937657278478e-25	-0.266843090082175	0.282	0.464	5.00382015709962e-21	BAIAP2L1	Malignant cells	GSE175716	ENSG00000006453	55971	BAR/IMD domain containing adaptor protein 2 like 1	IRTKS	protein_coding	Q9UHR4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23496
2.3866506371902e-25	0.459434716600556	0.48	0.353	5.4546900312982e-21	TRA2A	Malignant cells	GSE175716	ENSG00000164548	29896	transformer 2 alpha homolog	AWMS1|htra-2-alpha	protein_coding	Q13595	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23497
2.41145044129341e-25	-0.269270228111212	0.337	0.513	5.5113699835761e-21	SDF2	Malignant cells	GSE175716	ENSG00000132581	6388	stromal cell derived factor 2	NA	protein_coding	Q99470	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23498
2.71047726266076e-25	-0.28725528804571	0.168	0.335	6.19479578381116e-21	C1orf122	Malignant cells	GSE175716	ENSG00000197982	127687	chromosome 1 open reading frame 122	FLJ45459	protein_coding	Q6ZSJ8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23499
2.75190349258185e-25	-0.345449220369467	0.495	0.63	6.28947543229581e-21	FGFR1OP2	Malignant cells	GSE175716	ENSG00000111790	26127	FGFR1 oncogene partner 2	DKFZp564O1863	protein_coding	Q9NVK5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23500
2.88614808692921e-25	-0.330639989088678	0.606	0.698	6.59629145267672e-21	SLC39A7	Malignant cells	GSE175716	ENSG00000229802	7922	solute carrier family 39 member 7	D6S2244E|H2-KE4|HKE4|KE4|RING5|ZIP7	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23501
2.93055299583154e-25	-0.259042012448616	0.151	0.319	6.69777887197299e-21	SMIM13	Malignant cells	GSE175716	ENSG00000224531	221710	small integral membrane protein 13	C6orf228	protein_coding	P0DJ93	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23502
2.95485126598382e-25	0.437658637808001	0.463	0.339	6.75331256840601e-21	SEPHS1	Malignant cells	GSE175716	ENSG00000086475	22929	selenophosphate synthetase 1	SPS|SPS1	protein_coding	P49903	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23503
3.01730027139212e-25	0.318173585631818	0.691	0.529	6.8960397702667e-21	MAP3K20	Malignant cells	GSE175716	ENSG00000091436	51776	mitogen-activated protein kinase kinase kinase 20	MLK7|MLTK|MLTKalpha|MLTKbeta|MRK|ZAK	protein_coding	Q9NYL2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23504
3.13860207091724e-25	0.283866890245904	0.258	0.135	7.17327503308135e-21	AC073869.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23505
3.38154485132193e-25	-0.277350606215095	0.103	0.259	7.72852075769628e-21	BCL2L12	Malignant cells	GSE175716	ENSG00000126453	83596	BCL2 like 12	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23506
3.46513076754313e-25	-0.806498808349338	0.582	0.616	7.91955636921982e-21	RPL22L1	Malignant cells	GSE175716	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23507
3.66842919421135e-25	-0.300436685602089	0.133	0.296	8.38419492337003e-21	AJUBA	Malignant cells	GSE175716	ENSG00000129474	84962	ajuba LIM protein	JUB|MGC15563	protein_coding	Q96IF1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23508
3.91620709602314e-25	0.307167282289602	0.998	0.988	8.9504913179609e-21	HNRNPA2B1	Malignant cells	GSE175716	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23509
4.12924650775314e-25	0.439435845163848	0.54	0.406	9.4373928934698e-21	MPC1	Malignant cells	GSE175716	ENSG00000060762	51660	mitochondrial pyruvate carrier 1	BRP44L|CGI-129|dJ68L15.3|SLC54A1	protein_coding	Q9Y5U8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23510
4.15916092904714e-25	-0.350092967730846	0.501	0.632	9.50576230333723e-21	ETNK1	Malignant cells	GSE175716	ENSG00000139163	55500	ethanolamine kinase 1	EKI|EKI1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23511
4.66331160287603e-25	-0.842640340461294	0.891	0.929	1.06579986683732e-20	VMP1	Malignant cells	GSE175716	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23512
4.76764808555113e-25	0.340377980766567	0.986	0.975	1.08964596995271e-20	RPS7P1	Malignant cells	GSE175716	ENSG00000263266	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23513
4.8488775995349e-25	0.348427967365843	0.978	0.951	1.1082109753737e-20	NDUFAB1	Malignant cells	GSE175716	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23514
5.27289472676985e-25	0.412855093066039	0.929	0.872	1.20512008980325e-20	GLO1	Malignant cells	GSE175716	ENSG00000124767	2739	glyoxalase I	GLOD1	protein_coding	Q04760	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23515
5.28995853506706e-25	0.254075818422928	0.743	0.531	1.20902002318958e-20	NDUFA2	Malignant cells	GSE175716	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23516
5.44713717033313e-25	-0.393990361384276	0.588	0.682	1.24494320027964e-20	GNG12	Malignant cells	GSE175716	ENSG00000172380	55970	G protein subunit gamma 12	NA	protein_coding	Q9UBI6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23517
6.50675899553662e-25	0.368069418689229	0.309	0.182	1.48711976842989e-20	ZC3H13	Malignant cells	GSE175716	ENSG00000123200	23091	zinc finger CCCH-type containing 13	DKFZp434D1812|KIAA0853|Xio	protein_coding	Q5T200	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23518
6.50711298154205e-25	-0.353310123256847	0.115	0.265	1.48720067193144e-20	ZMYM5	Malignant cells	GSE175716	ENSG00000132950	9205	zinc finger MYM-type containing 5	MYM|ZNF198L1|ZNF237	protein_coding	Q9UJ78	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23519
6.57609244857603e-25	-0.277077207490827	0.102	0.254	1.50296592912205e-20	SIAH2	Malignant cells	GSE175716	ENSG00000181788	6478	siah E3 ubiquitin protein ligase 2	NA	protein_coding	O43255	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23520
7.0585878895909e-25	0.324142110341421	0.799	0.658	1.613240262166e-20	ELOVL5	Malignant cells	GSE175716	ENSG00000012660	60481	ELOVL fatty acid elongase 5	dJ483K16.1|HELO1|SCA38	protein_coding	Q9NYP7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23521
7.07935826594339e-25	-0.265965875240708	0.128	0.29	1.61798733168136e-20	TMEM39A	Malignant cells	GSE175716	ENSG00000176142	55254	transmembrane protein 39A	FLJ10902|SUSR2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23522
7.41680416813859e-25	-0.272657434083167	0.123	0.28	1.69511059262808e-20	AC027309.2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23523
8.55401500832462e-25	0.341326986837385	0.874	0.776	1.95502013015259e-20	RNPS1	Malignant cells	GSE175716	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23524
8.60913558638955e-25	-0.263939954946505	0.21	0.392	1.96761793826933e-20	CAPN1	Malignant cells	GSE175716	ENSG00000014216	823	calpain 1	CANP|CANPL1|muCANP|muCL	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23525
8.72899108943861e-25	-0.315832077423326	0.136	0.291	1.99501091349119e-20	ATF7IP	Malignant cells	GSE175716	ENSG00000171681	55729	activating transcription factor 7 interacting protein	ATF7IP1|FLJ10688|p621	protein_coding	Q6VMQ6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23526
9.40573552351157e-25	-0.255190906818953	0.157	0.325	2.14968085389857e-20	EFCAB14	Malignant cells	GSE175716	ENSG00000159658	9813	EF-hand calcium binding domain 14	KIAA0494	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23527
9.99408916591384e-25	-0.279147246178404	0.313	0.492	2.28414907886961e-20	INAVA	Malignant cells	GSE175716	ENSG00000163362	55765	innate immunity activator	C1orf106|FLJ10901	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23528
1.03961824180354e-24	-0.303649105179614	0.576	0.693	2.37604749164199e-20	POLR2H	Malignant cells	GSE175716	ENSG00000163882	5437	RNA polymerase II, I and III subunit H	RPB8	protein_coding	P52434	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23529
1.0668387587176e-24	-0.338543685712619	0.373	0.517	2.43825998304908e-20	ALG3	Malignant cells	GSE175716	ENSG00000214160	10195	ALG3 alpha-1,3- mannosyltransferase	CDGS4|D16Ertd36e|Not56|NOT56L	protein_coding	Q92685	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23530
1.1557000138354e-24	-0.250541324544356	0.818	0.893	2.64135238162081e-20	APLP2	Malignant cells	GSE175716	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23531
1.16237654353188e-24	-0.748100870102692	0.878	0.835	2.65661159024212e-20	PARK7	Malignant cells	GSE175716	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23532
1.16843248641926e-24	-0.301604182376307	0.146	0.309	2.67045244771123e-20	BZW1P2	Malignant cells	GSE175716	ENSG00000198406	NA	NA	BZW1L1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23533
1.18409185274101e-24	-0.359076897416323	0.998	0.99	2.70624192943957e-20	LDHA	Malignant cells	GSE175716	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23534
1.28926175386135e-24	0.334622221570844	0.985	0.952	2.94660773845011e-20	EIF3H	Malignant cells	GSE175716	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23535
1.33199239846579e-24	-0.279539768874905	0.207	0.382	3.04426862669357e-20	RASEF	Malignant cells	GSE175716	ENSG00000165105	158158	RAS and EF-hand domain containing	FLJ31614|RAB45|TSG	protein_coding	Q8IZ41	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23536
1.34809368009162e-24	-0.25400611945747	0.111	0.264	3.0810681058494e-20	SH3GL1	Malignant cells	GSE175716	ENSG00000141985	6455	SH3 domain containing GRB2 like 1, endophilin A2	CNSA1|EEN|MGC111371|SH3D2B|SH3P8	protein_coding	Q99961	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23537
1.36301753175942e-24	0.267250697755283	0.836	0.666	3.11517656883614e-20	QPRT	Malignant cells	GSE175716	ENSG00000103485	23475	quinolinate phosphoribosyltransferase	QPRTase	protein_coding	Q15274	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23538
1.6766797071836e-24	-0.497758152739987	0.577	0.659	3.83205147076811e-20	AK4	Malignant cells	GSE175716	ENSG00000162433	205	adenylate kinase 4	AK3|AK3L1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23539
1.77181095298386e-24	-0.293282183260515	0.123	0.278	4.0494739330446e-20	SDHAF2	Malignant cells	GSE175716	ENSG00000167985	54949	succinate dehydrogenase complex assembly factor 2	C11orf79|FLJ20487|PGL2|SDH5	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23540
1.99588446539886e-24	-0.367101208471705	0.134	0.283	4.56159394566909e-20	EXOSC4	Malignant cells	GSE175716	ENSG00000178896	54512	exosome component 4	FLJ20591|hRrp41p|p12A|RRP41|RRP41A|Rrp41p|SKI6|Ski6p	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23541
2.06660559348763e-24	-0.323031035339486	0.106	0.254	4.72322708391599e-20	FBLIM1	Malignant cells	GSE175716	ENSG00000162458	54751	filamin binding LIM protein 1	CAL|FBLP-1|migfilin	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23542
2.09746722720355e-24	-0.385737725900942	0.443	0.577	4.79376134777372e-20	OSBPL8	Malignant cells	GSE175716	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23543
2.18764825025879e-24	-0.305839768579691	0.148	0.308	4.99987007596647e-20	CEBPZ	Malignant cells	GSE175716	ENSG00000115816	10153	CCAAT enhancer binding protein zeta	CBF2|CTF2	protein_coding	Q03701	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23544
2.33147928086029e-24	0.351534364887887	0.785	0.656	5.32859589640619e-20	HSDL2	Malignant cells	GSE175716	ENSG00000119471	84263	hydroxysteroid dehydrogenase like 2	C9orf99|SDR13C1	protein_coding	Q6YN16	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23545
2.51803994722407e-24	-0.321690103135706	0.159	0.316	5.75498029938062e-20	OARD1	Malignant cells	GSE175716	ENSG00000124596	221443	O-acyl-ADP-ribose deacylase 1	C6orf130|dJ34B21.3|MGC19570|TARG1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23546
2.56757221174831e-24	-0.437378560504426	0.326	0.464	5.86818628995076e-20	C1orf21	Malignant cells	GSE175716	ENSG00000116667	81563	chromosome 1 open reading frame 21	PIG13	protein_coding	Q9H246	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23547
2.61857292486156e-24	0.379266949020122	0.625	0.499	5.98474841977108e-20	SFT2D1	Malignant cells	GSE175716	ENSG00000198818	113402	SFT2 domain containing 1	C6orf83|MGC19825|pRGR1	protein_coding	Q8WV19	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23548
2.64150092253048e-24	-0.266471295884124	0.598	0.737	6.03715035844342e-20	AADAC	Malignant cells	GSE175716	ENSG00000114771	13	arylacetamide deacetylase	CES5A1|DAC	protein_coding	P22760	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23549
2.81760736714031e-24	0.386654722811708	0.77	0.632	6.43964163759919e-20	STARD7	Malignant cells	GSE175716	ENSG00000084090	56910	StAR related lipid transfer domain containing 7	GTT1	protein_coding	Q9NQZ5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23550
2.85297047150511e-24	-0.696518299381273	0.431	0.539	6.52046401262494e-20	SMC4	Malignant cells	GSE175716	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23551
3.31001690498776e-24	0.409884568700558	0.408	0.276	7.56504363634953e-20	POP7	Malignant cells	GSE175716	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23552
3.32893376409616e-24	0.402175864331053	0.354	0.229	7.60827811784178e-20	ZSCAN16-AS1	Malignant cells	GSE175716	ENSG00000269293	100129195	ZSCAN16 antisense RNA 1	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23553
3.41075264671881e-24	-0.544089512455428	0.408	0.499	7.79527517407584e-20	RPL21P16	Malignant cells	GSE175716	ENSG00000220842	NA	NA	Em:AC073587.1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23554
3.6303594955856e-24	-0.36552661806925	0.675	0.751	8.29718662716088e-20	JPT2	Malignant cells	GSE175716	ENSG00000206053	90861	Jupiter microtubule associated homolog 2	C16orf34|FLJ13092|HN1L|KIAA1426|L11	protein_coding	Q9H910	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23555
3.69916893280088e-24	-0.318056901607327	0.168	0.327	8.4544505959164e-20	RPS19BP1	Malignant cells	GSE175716	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23556
4.33619182818004e-24	-0.289201407884303	0.586	0.694	9.91036642330549e-20	ARL1	Malignant cells	GSE175716	ENSG00000120805	400	ADP ribosylation factor like GTPase 1	ARFL1	protein_coding	P40616	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23557
4.44334297049839e-24	-0.28342988974749	0.197	0.366	1.01552603590741e-19	GON7	Malignant cells	GSE175716	ENSG00000275619	84520	GON7 subunit of KEOPS complex	C14orf142	protein_coding	Q9BXV9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23558
4.53722921645003e-24	-0.361477434803228	0.528	0.627	1.03698373741965e-19	PSMC4	Malignant cells	GSE175716	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23559
5.0399366205857e-24	-0.333676984147947	0.157	0.313	1.15187751463486e-19	DDAH2	Malignant cells	GSE175716	ENSG00000226634	23564	dimethylarginine dimethylaminohydrolase 2	G6A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23560
5.81427569521005e-24	-0.263067001680712	0.167	0.332	1.32885271014026e-19	POLR1C	Malignant cells	GSE175716	ENSG00000171453	9533	RNA polymerase I and III subunit C	AC40|RPA39|RPA40|RPA5|RPAC1|RPC40	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23561
5.90519748698125e-24	-0.288914486816049	0.158	0.318	1.34963288564956e-19	NF1	Malignant cells	GSE175716	ENSG00000196712	4763	neurofibromin 1	NA	protein_coding	P21359	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23562
6.05198756143325e-24	0.408577536960565	0.847	0.746	1.38318175716557e-19	CHMP4B	Malignant cells	GSE175716	ENSG00000101421	128866	charged multivesicular body protein 4B	C20orf178|dJ553F4.4|Shax1|SNF7-2|VPS32B	protein_coding	Q9H444	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23563
7.41032944580295e-24	-0.376942123970224	0.548	0.657	1.69363079483826e-19	TAOK1	Malignant cells	GSE175716	ENSG00000160551	57551	TAO kinase 1	FLJ14314|hKFC-B|hTAOK1|KIAA1361|MAP3K16|MARKK|PSK2|TAO1	protein_coding	Q7L7X3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23564
7.87565259567262e-24	-0.418261704952355	0.119	0.262	1.79998040074098e-19	ADGRG6	Malignant cells	GSE175716	ENSG00000112414	57211	adhesion G protein-coupled receptor G6	FLJ14937|GPR126	protein_coding	Q86SQ4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23565
8.16985910619668e-24	-0.277526039922659	0.205	0.374	1.86722129872125e-19	MRPL10	Malignant cells	GSE175716	ENSG00000159111	124995	mitochondrial ribosomal protein L10	L10MT|MGC17973|MRP-L10|MRP-L8|MRPL8|RPML8	protein_coding	Q7Z7H8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23566
8.36651848603165e-24	-0.45804206908072	0.288	0.424	1.91216779998253e-19	C19orf70	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23567
8.47370948110919e-24	-0.266400598972586	0.114	0.266	1.93666630190751e-19	OTUD4	Malignant cells	GSE175716	ENSG00000164164	54726	OTU deubiquitinase 4	DUBA6|HSHIN1|KIAA1046	protein_coding	Q01804	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23568
8.88401460699413e-24	-0.269203633990036	0.106	0.256	2.03044153842851e-19	ATP11B	Malignant cells	GSE175716	ENSG00000058063	23200	ATPase phospholipid transporting 11B (putative)	ATPIF|ATPIR|KIAA0956	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23569
1.00432529012556e-23	-0.29522474850123	0.279	0.45	2.29538545058197e-19	SAT2	Malignant cells	GSE175716	ENSG00000141504	112483	spermidine/spermine N1-acetyltransferase family member 2	SSAT2	protein_coding	Q96F10	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23570
1.12751328931975e-23	-0.354804257292696	0.193	0.351	2.57693162274028e-19	SUPV3L1	Malignant cells	GSE175716	ENSG00000156502	6832	Suv3 like RNA helicase	SUV3	protein_coding	Q8IYB8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23571
1.14464837053302e-23	0.3832635011646	0.451	0.323	2.61609385085321e-19	BLVRA	Malignant cells	GSE175716	ENSG00000106605	644	biliverdin reductase A	BLVR	protein_coding	P53004	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23572
1.15997251947464e-23	0.330774615995817	0.948	0.868	2.6511171932593e-19	SRSF11	Malignant cells	GSE175716	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23573
1.16331488010318e-23	-0.268368966147878	0.176	0.342	2.65875615847581e-19	PGM3	Malignant cells	GSE175716	ENSG00000013375	5238	phosphoglucomutase 3	AGM1|DKFZP434B187|PAGM	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23574
1.27527197750132e-23	-0.273491723561897	0.164	0.329	2.91463410457927e-19	GPATCH2	Malignant cells	GSE175716	ENSG00000092978	55105	G-patch domain containing 2	CT110|FLJ10252|GPATC2|Pfa1|PPP1R30	protein_coding	Q9NW75	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23575
1.28338744552273e-23	-0.260378988913092	0.135	0.292	2.9331820067422e-19	LGALS8	Malignant cells	GSE175716	ENSG00000116977	3964	galectin 8	PCTA-1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23576
1.34219050911379e-23	-0.525588174064975	0.839	0.831	3.06757640857956e-19	SDHC	Malignant cells	GSE175716	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23577
1.4306117300732e-23	-0.292737417014448	0.499	0.626	3.26966310908231e-19	PSMC6	Malignant cells	GSE175716	ENSG00000100519	5706	proteasome 26S subunit, ATPase 6	p42|RPT5	protein_coding	P62333	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23578
1.47665276654687e-23	-0.353478600071405	0.373	0.52	3.37488989794287e-19	NLN	Malignant cells	GSE175716	ENSG00000123213	57486	neurolysin	AGTBP|KIAA1226	protein_coding	Q9BYT8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23579
1.63216815252311e-23	-0.349384228123514	0.199	0.364	3.73032031259156e-19	HKDC1	Malignant cells	GSE175716	ENSG00000156510	80201	hexokinase domain containing 1	FLJ22761|FLJ37767	protein_coding	Q2TB90	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23580
1.67190034875249e-23	-0.398432322135974	0.399	0.52	3.8211282470738e-19	BID	Malignant cells	GSE175716	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23581
1.7793986680426e-23	-1.43660246752366	0.743	0.705	4.06681565581137e-19	GATM	Malignant cells	GSE175716	ENSG00000171766	2628	glycine amidinotransferase	AGAT	protein_coding	P50440	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23582
2.10643962188023e-23	-0.407556442801754	0.628	0.71	4.81426775580726e-19	SPAG9	Malignant cells	GSE175716	ENSG00000008294	9043	sperm associated antigen 9	CT89|FLJ13450|FLJ14006|FLJ26141|FLJ34602|HLC4|HSS|JIP-4|JIP4|JLP|KIAA0516|MGC117291|MGC14967|MGC74461|PHET|PIG6|SYD1	protein_coding	O60271	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23583
2.34579754168982e-23	-0.3592518328152	0.773	0.804	5.36132028153209e-19	PSMB6	Malignant cells	GSE175716	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23584
2.38889984789016e-23	-0.250212711020334	0.212	0.388	5.45983060235297e-19	MAFG	Malignant cells	GSE175716	ENSG00000197063	4097	MAF bZIP transcription factor G	MGC13090|MGC20149	protein_coding	O15525	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23585
2.49872856464667e-23	-0.358085879087606	0.847	0.878	5.71084413449997e-19	ACTR2	Malignant cells	GSE175716	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23586
2.5801509490135e-23	-0.325421007484305	0.228	0.389	5.89693499397036e-19	HSD17B10	Malignant cells	GSE175716	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23587
2.64361407669291e-23	0.350074268393071	0.691	0.549	6.04197997228166e-19	QKI	Malignant cells	GSE175716	ENSG00000112531	9444	QKI, KH domain containing RNA binding	QK3	protein_coding	Q96PU8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23588
2.94543862038236e-23	0.320504303252713	0.3	0.178	6.73179996688389e-19	SNRPGP2	Malignant cells	GSE175716	ENSG00000264350	NA	NA	HsT2742	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23589
3.06419020512461e-23	-0.276311757941444	0.178	0.345	7.00320671381228e-19	WAPL	Malignant cells	GSE175716	ENSG00000062650	23063	WAPL cohesin release factor	FOE|KIAA0261|WAPAL	protein_coding	Q7Z5K2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23590
3.09807259327994e-23	-0.438764971111898	0.148	0.294	7.08064491194131e-19	ARID4A	Malignant cells	GSE175716	ENSG00000032219	5926	AT-rich interaction domain 4A	RBBP1|RBP-1|RBP1	protein_coding	P29374	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23591
3.17530113591615e-23	0.40260755851094	0.315	0.193	7.25715074613635e-19	GADD45B	Malignant cells	GSE175716	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23592
3.61297498141367e-23	0.308516345670096	0.291	0.165	8.25745432002095e-19	PDK1	Malignant cells	GSE175716	ENSG00000152256	5163	pyruvate dehydrogenase kinase 1	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23593
3.79466593570694e-23	0.341223695062441	0.771	0.63	8.67270899605821e-19	PNKD	Malignant cells	GSE175716	ENSG00000127838	25953	PNKD metallo-beta-lactamase domain containing	BRP17|DKFZp564N1362|DYT8|FKSG19|FPD1|KIAA1184|KIPP1184|MGC31943|MR-1|MR-1S|PDC|PKND1|TAHCCP2	protein_coding	Q8N490	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23594
3.83947769528382e-23	-0.257711321697976	0.213	0.382	8.77512627257117e-19	TIMM9	Malignant cells	GSE175716	ENSG00000100575	26520	translocase of inner mitochondrial membrane 9	TIM9A	protein_coding	Q9Y5J7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23595
3.98711575509167e-23	-0.326862495586304	0.43	0.558	9.11255305826202e-19	TSPAN6	Malignant cells	GSE175716	ENSG00000000003	7105	tetraspanin 6	T245|TM4SF6|TSPAN-6	protein_coding	O43657	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23596
4.27311198555541e-23	-0.250285235426247	0.133	0.29	9.76619744298689e-19	PRKCI	Malignant cells	GSE175716	ENSG00000163558	5584	protein kinase C iota	DXS1179E|PKCI	protein_coding	P41743	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23597
4.58070171427673e-23	0.321791143369502	0.938	0.839	1.04691937679795e-18	TMEM14C	Malignant cells	GSE175716	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23598
4.84365697434941e-23	0.318660051919532	0.693	0.559	1.10701780148756e-18	HNRNPL	Malignant cells	GSE175716	ENSG00000282947	3191	heterogeneous nuclear ribonucleoprotein L	HNRPL	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23599
4.97930605338535e-23	0.377603512219394	0.351	0.224	1.13802039850122e-18	DDC	Malignant cells	GSE175716	ENSG00000132437	1644	dopa decarboxylase	AADC	protein_coding	P20711	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23600
5.5434744714463e-23	-0.347649521269208	0.151	0.301	1.26696109044905e-18	NRIP1	Malignant cells	GSE175716	ENSG00000180530	8204	nuclear receptor interacting protein 1	RIP140	protein_coding	P48552	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23601
5.93403106437489e-23	-0.251433271978593	0.183	0.344	1.35622279976288e-18	MTIF3	Malignant cells	GSE175716	ENSG00000122033	219402	mitochondrial translational initiation factor 3	IF-3mt|IF3(mt)	protein_coding	Q9H2K0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23602
6.0397493030214e-23	-0.311306880824529	0.612	0.703	1.38038470320554e-18	SF3B2	Malignant cells	GSE175716	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23603
6.59704800130269e-23	0.330359944954151	0.723	0.571	1.50775532069773e-18	ZBTB43	Malignant cells	GSE175716	ENSG00000169155	23099	zinc finger and BTB domain containing 43	FLJ22470|KIAA0414|ZBTB22B|ZNF-X|ZNF297B	protein_coding	O43298	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23604
6.73263382258769e-23	-0.344306906095582	0.585	0.676	1.53874346015242e-18	VPS26A	Malignant cells	GSE175716	ENSG00000122958	9559	VPS26 retromer complex component A	Hbeta58|PEP8A|VPS26	protein_coding	O75436	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23605
7.14420939672711e-23	-0.657125803875515	0.475	0.555	1.63280905762198e-18	RIPK2	Malignant cells	GSE175716	ENSG00000104312	8767	receptor interacting serine/threonine kinase 2	CARD3|CARDIAK|RICK|RIP2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23606
7.69253841207212e-23	-0.262974243658761	0.166	0.324	1.75812965407908e-18	SPPL3	Malignant cells	GSE175716	ENSG00000157837	121665	signal peptide peptidase like 3	DKFZP586C1324|IMP2|MGC126674|MGC126676|MGC90402|PSL4	protein_coding	Q8TCT6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23607
7.94061630712257e-23	0.345405659660622	0.34	0.218	1.81482785699286e-18	VAMP2	Malignant cells	GSE175716	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23608
8.21426596953674e-23	-0.688960382736941	0.552	0.592	1.87737048733762e-18	TUBB4B	Malignant cells	GSE175716	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23609
8.89787305155009e-23	-0.489939616095097	0.384	0.512	2.03360888593177e-18	JAG1	Malignant cells	GSE175716	ENSG00000101384	182	jagged canonical Notch ligand 1	AGS|AHD|AWS|CD339|HJ1|JAGL1	protein_coding	P78504	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23610
9.2437574639626e-23	0.322459130336035	0.326	0.199	2.11266076838865e-18	PRPF6	Malignant cells	GSE175716	ENSG00000101161	24148	pre-mRNA processing factor 6	ANT-1|bB152O15.1|C20orf14|hPrp6|Prp6|RP60|SNRNP102|TOM|U5-102K	protein_coding	O94906	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23611
9.39056561163146e-23	-0.258778633560073	0.153	0.311	2.14621377053837e-18	EIF2AK2	Malignant cells	GSE175716	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23612
9.79447796320842e-23	-0.308354024976508	0.209	0.369	2.23852793849128e-18	RNH1	Malignant cells	GSE175716	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23613
1.1660855975689e-22	-0.286758858131629	0.173	0.333	2.66508863324371e-18	PNO1	Malignant cells	GSE175716	ENSG00000115946	56902	partner of NOB1 homolog	KHRBP1|RRP20	protein_coding	Q9NRX1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23614
1.21201497684444e-22	0.349553313557385	0.415	0.282	2.77006022957797e-18	RNF130	Malignant cells	GSE175716	ENSG00000113269	55819	ring finger protein 130	G1RZFP|GOLIATH|GP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23615
1.35141200625114e-22	-0.383071116920699	0.375	0.501	3.08865214028698e-18	FLVCR1	Malignant cells	GSE175716	ENSG00000162769	28982	FLVCR heme transporter 1	AXPC1|FLVCR|MFSD7B|PCA|SLC49A1	protein_coding	Q9Y5Y0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23616
1.35460250613909e-22	0.326774469060373	0.31	0.186	3.09594402778088e-18	YBX3	Malignant cells	GSE175716	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23617
1.49794576912832e-22	-0.307449244045511	0.163	0.323	3.42355505534278e-18	P4HA1	Malignant cells	GSE175716	ENSG00000122884	5033	prolyl 4-hydroxylase subunit alpha 1	C-P4Halpha(I)|P4HA	protein_coding	P13674	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23618
1.57843056936144e-22	-0.36362429933602	0.557	0.654	3.60750306627557e-18	TMEM30A	Malignant cells	GSE175716	ENSG00000112697	55754	transmembrane protein 30A	C6orf67|CDC50A|FLJ10856	protein_coding	Q9NV96	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23619
1.59964766206914e-22	-0.271795432900998	0.181	0.348	3.65599473165903e-18	PCF11	Malignant cells	GSE175716	ENSG00000165494	51585	PCF11 cleavage and polyadenylation factor subunit	KIAA0824	protein_coding	O94913	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23620
1.66877445029811e-22	-0.255005774937146	0.221	0.391	3.81398400615634e-18	OTUD6B-AS1	Malignant cells	GSE175716	ENSG00000253738	NA	NA	GS1-251I9.4	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23621
1.69688652137595e-22	-0.293027872541382	0.115	0.26	3.87823414460474e-18	BPGM	Malignant cells	GSE175716	ENSG00000172331	669	bisphosphoglycerate mutase	NA	protein_coding	P07738	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23622
1.72470794103534e-22	0.273192605436685	0.955	0.841	3.94181999923628e-18	TMEM14B	Malignant cells	GSE175716	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23623
1.74643842612953e-22	0.302841033504164	0.714	0.576	3.99148502291903e-18	NDUFS1	Malignant cells	GSE175716	ENSG00000283447	4719	NADH:ubiquinone oxidoreductase core subunit S1	CI-75k	protein_coding	P28331	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23624
1.85350595791603e-22	-0.275682367211918	0.19	0.353	4.2361878668171e-18	ANO6	Malignant cells	GSE175716	ENSG00000177119	196527	anoctamin 6	DKFZp313M0720|TMEM16F	protein_coding	Q4KMQ2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23625
1.93031543110766e-22	-0.29800276549969	0.293	0.447	4.41173591779655e-18	MCTS1	Malignant cells	GSE175716	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23626
1.93130126297729e-22	-0.390308871191199	0.566	0.666	4.4139890365346e-18	TNFRSF21	Malignant cells	GSE175716	ENSG00000146072	27242	TNF receptor superfamily member 21	CD358|DR6	protein_coding	O75509	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23627
2.17958323875916e-22	-0.25232324847961	0.13	0.28	4.98143749218406e-18	CRIPT	Malignant cells	GSE175716	ENSG00000119878	9419	CXXC repeat containing interactor of PDZ3 domain	HSPC139	protein_coding	Q9P021	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23628
2.31967788409744e-22	-0.266530226067144	0.818	0.862	5.3016238041047e-18	NAA50	Malignant cells	GSE175716	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23629
2.3272552022186e-22	-0.255504479370281	0.105	0.251	5.31894176467061e-18	FXR2	Malignant cells	GSE175716	ENSG00000129245	9513	FMR1 autosomal homolog 2	FMR1L2	protein_coding	P51116	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23630
2.38599197361777e-22	-0.317310092153367	0.142	0.288	5.45318465570341e-18	CAMK2D	Malignant cells	GSE175716	ENSG00000145349	817	calcium/calmodulin dependent protein kinase II delta	CAMKD	protein_coding	Q13557	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23631
2.44884165268068e-22	-0.298247864455991	0.559	0.668	5.59682759720169e-18	CWC15	Malignant cells	GSE175716	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23632
2.60468377822822e-22	-0.289825885925216	0.561	0.674	5.9530047751406e-18	ACBD3	Malignant cells	GSE175716	ENSG00000182827	64746	acyl-CoA binding domain containing 3	GCP60|GOCAP1|GOLPH1|PAP7	protein_coding	Q9H3P7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23633
2.61755598474483e-22	-0.330430530219385	0.379	0.519	5.9824242031343e-18	MCCC2	Malignant cells	GSE175716	ENSG00000281742	64087	methylcrotonyl-CoA carboxylase subunit 2	MCCB|MCCCbeta	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23634
2.69811326085906e-22	0.376138912533358	0.383	0.26	6.16653785769339e-18	TCF25	Malignant cells	GSE175716	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23635
3.13589292580596e-22	-0.421069137221729	0.461	0.573	7.16708328192953e-18	YPEL5	Malignant cells	GSE175716	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23636
3.30746887281018e-22	-0.29550705004765	0.52	0.635	7.55922010880766e-18	SLC35B1	Malignant cells	GSE175716	ENSG00000121073	10237	solute carrier family 35 member B1	AXER|UGTREL1	protein_coding	P78383	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23637
3.75129664045457e-22	0.38525220849525	0.48	0.357	8.57358847175891e-18	XPO1	Malignant cells	GSE175716	ENSG00000082898	7514	exportin 1	CRM-1|CRM1|emb	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23638
4.22946833919572e-22	-0.298633272747698	0.111	0.25	9.66644988923183e-18	SLC6A6	Malignant cells	GSE175716	ENSG00000131389	6533	solute carrier family 6 member 6	TAUT	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23639
4.29583834117789e-22	-0.452321455354539	0.208	0.347	9.81813852876206e-18	PLEC	Malignant cells	GSE175716	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23640
4.30857885561659e-22	-0.309876012554573	0.497	0.618	9.84725697451172e-18	PTRH2	Malignant cells	GSE175716	ENSG00000141378	51651	peptidyl-tRNA hydrolase 2	BIT1|CFAP37|CGI-147|PTH2	protein_coding	Q9Y3E5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23641
4.35387359299858e-22	0.396597005655345	0.912	0.831	9.95077809679826e-18	CALD1	Malignant cells	GSE175716	ENSG00000122786	800	caldesmon 1	CDM|H-CAD|h-CD|L-CAD	protein_coding	Q05682	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23642
4.44827571143963e-22	0.300925539017417	0.283	0.166	1.01665341384953e-17	GLE1	Malignant cells	GSE175716	ENSG00000119392	2733	GLE1 RNA export mediator	GLE1L|hGLE1|LCCS1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23643
4.49745767611583e-22	0.413603328063529	0.435	0.322	1.02789395187627e-17	ESYT2	Malignant cells	GSE175716	ENSG00000117868	57488	extended synaptotagmin 2	CHR2SYT|FAM62B|KIAA1228	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23644
4.61430212596375e-22	-0.442125174152639	0.483	0.591	1.05459875088901e-17	HSP90AA2P	Malignant cells	GSE175716	ENSG00000224411	NA	NA	HSP90AA2|HSP90ALPHA|HSPCA|HSPCAL3	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23645
4.8439261235707e-22	-0.691922652291314	1	0.993	1.10707931554208e-17	RPL13	Malignant cells	GSE175716	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23646
4.89734578406646e-22	0.283637816978881	0.28	0.164	1.11928837894839e-17	AC025458.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23647
5.09239821938084e-22	-0.254043480652025	0.897	0.599	1.16386761303949e-17	ANXA1	Malignant cells	GSE175716	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23648
5.2374041624817e-22	0.371786611833115	0.307	0.188	1.19700872133519e-17	ZNF217	Malignant cells	GSE175716	ENSG00000171940	7764	zinc finger protein 217	ZABC1	protein_coding	O75362	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23649
5.61076936239714e-22	-0.260766729934711	0.154	0.308	1.28234133777587e-17	SIRPA	Malignant cells	GSE175716	ENSG00000198053	140885	signal regulatory protein alpha	BIT|CD172a|MFR|MYD-1|P84|PTPNS1|SHPS-1|SHPS1|SIRP|SIRP-ALPHA-1|SIRPalpha|SIRPalpha2	protein_coding	P78324	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23650
6.30856530641788e-22	0.425858675213837	0.367	0.244	1.44182260078181e-17	EZH2	Malignant cells	GSE175716	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23651
7.31094408372479e-22	0.324729342477621	0.291	0.175	1.6709162703353e-17	SEC22B	Malignant cells	GSE175716	ENSG00000265808	9554	SEC22 homolog B, vesicle trafficking protein	ERS-24|SEC22L1	protein_coding	O75396	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23652
7.3405077582683e-22	-0.279888398461604	0.184	0.343	1.67767304815222e-17	ANKRD11	Malignant cells	GSE175716	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23653
7.45399873949332e-22	-0.312677829957826	0.529	0.643	1.7036114119112e-17	CLDN7	Malignant cells	GSE175716	ENSG00000288292	1366	claudin 7	CEPTRL2|CPETRL2|Hs.84359	protein_coding	O95471	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23654
7.69148015181465e-22	-0.264820221181322	0.242	0.408	1.75788778869724e-17	MRPL11	Malignant cells	GSE175716	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23655
8.22294752509158e-22	0.324322781766492	0.72	0.589	1.87935465685968e-17	NDUFAF4	Malignant cells	GSE175716	ENSG00000123545	29078	NADH:ubiquinone oxidoreductase complex assembly factor 4	bA22L21.1|C6orf66|HRPAP20|HSPC125|My013	protein_coding	Q9P032	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23656
9.39723671852881e-22	-0.271343153768535	0.136	0.279	2.14773845201976e-17	TRMT112P6	Malignant cells	GSE175716	ENSG00000268412	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23657
1.00353239240095e-21	0.362827428338506	0.402	0.283	2.29357328283237e-17	MAGEA6	Malignant cells	GSE175716	ENSG00000197172	4105	MAGE family member A6	CT1.6|MAGE-3b|MAGE3B|MAGE6	protein_coding	P43360	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23658
1.06001391078225e-21	-0.271529551210192	0.173	0.326	2.42266179309283e-17	EPN1	Malignant cells	GSE175716	ENSG00000063245	29924	epsin 1	NA	protein_coding	Q9Y6I3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23659
1.15170519511013e-21	0.307016221944877	0.355	0.227	2.6322222234242e-17	YBX1P1	Malignant cells	GSE175716	ENSG00000224861	NA	NA	NSEP1P|PSDBPB1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23660
1.23082607004499e-21	-0.663965682174702	0.924	0.896	2.81305298308782e-17	CLIC1	Malignant cells	GSE175716	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23661
1.24729426962982e-21	0.404557862457293	0.368	0.25	2.85069105323895e-17	GJB2	Malignant cells	GSE175716	ENSG00000165474	2706	gap junction protein beta 2	CX26|DFNA3|DFNB1|NSRD1	protein_coding	P29033	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23662
1.25641590488596e-21	-0.27822864536206	0.205	0.362	2.87153855061687e-17	NABP2	Malignant cells	GSE175716	ENSG00000139579	79035	nucleic acid binding protein 2	hSSB1|MGC2731|OBFC2B|SOSS-B1|SSB1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23663
1.3410643074247e-21	-1.77954387134806	0.707	0.727	3.06500247461916e-17	EGR1	Malignant cells	GSE175716	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23664
1.43480260095215e-21	0.329242658287316	0.764	0.616	3.27924134447614e-17	GLRX2	Malignant cells	GSE175716	ENSG00000023572	51022	glutaredoxin 2	bA101E13.1|GRX2	protein_coding	Q9NS18	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23665
1.70196915517131e-21	-0.258172519227881	0.201	0.366	3.88985050414403e-17	ALDH6A1	Malignant cells	GSE175716	ENSG00000119711	4329	aldehyde dehydrogenase 6 family member A1	MMSDH	protein_coding	Q02252	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23666
2.02184716312595e-21	-0.300476164660721	0.431	0.566	4.62093169132436e-17	PCYOX1	Malignant cells	GSE175716	ENSG00000116005	51449	prenylcysteine oxidase 1	KIAA0908|PCL1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23667
2.22105183778793e-21	-0.324750655888636	0.692	0.746	5.0762139752643e-17	COPS9	Malignant cells	GSE175716	ENSG00000172428	150678	COP9 signalosome subunit 9	CSNAP|MYEOV2	protein_coding	Q8WXC6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23668
2.53944362086963e-21	-0.277951885106876	0.48	0.61	5.80389839549753e-17	C16orf72	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23669
2.63339393429289e-21	0.351091767267465	0.456	0.327	6.0186218368264e-17	RAC1P2	Malignant cells	GSE175716	ENSG00000249936	NA	NA	Psi2Rac1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23670
2.87831934272737e-21	-0.261339798306565	0.136	0.28	6.57839885780341e-17	MLLT3	Malignant cells	GSE175716	ENSG00000171843	4300	MLLT3 super elongation complex subunit	AF-9|AF9|YEATS3	protein_coding	P42568	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23671
3.39927689410894e-21	-0.25265243285923	0.163	0.316	7.76904734148598e-17	TLK2	Malignant cells	GSE175716	ENSG00000146872	11011	tousled like kinase 2	MGC44450|PKU-ALPHA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23672
3.67660970289156e-21	-0.270070986829732	0.503	0.629	8.40289147595866e-17	HCFC1R1	Malignant cells	GSE175716	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23673
3.85150975631949e-21	0.33557795920859	0.312	0.196	8.8026255480682e-17	ALDH7A1	Malignant cells	GSE175716	ENSG00000164904	501	aldehyde dehydrogenase 7 family member A1	ATQ1|EPD|PDE	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23674
3.8735566350667e-21	-0.260866934184391	0.394	0.543	8.85301368944495e-17	CDC27	Malignant cells	GSE175716	ENSG00000004897	996	cell division cycle 27	ANAPC3|APC3|D0S1430E|D17S978E|NUC2	protein_coding	P30260	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23675
3.8973209849856e-21	-0.279359484144985	0.204	0.36	8.9073271111846e-17	KMT5B	Malignant cells	GSE175716	ENSG00000110066	51111	lysine methyltransferase 5B	CGI-85|SUV420H1	protein_coding	Q4FZB7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23676
3.99533893481817e-21	0.295128332353928	0.965	0.873	9.13134713552693e-17	NDUFB2	Malignant cells	GSE175716	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23677
4.19491450654035e-21	0.366702596415584	0.357	0.235	9.58747710469796e-17	RBM26	Malignant cells	GSE175716	ENSG00000139746	64062	RNA binding motif protein 26	ARRS2|C13orf10|FLJ20957|PPP1R132|PRO1777|SE70-2|ZC3H17	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23678
4.22871451385221e-21	-0.288043526020396	0.257	0.421	9.66472702140924e-17	FAHD1	Malignant cells	GSE175716	ENSG00000180185	81889	fumarylacetoacetate hydrolase domain containing 1	C16orf36|DKFZP566J2046	protein_coding	Q6P587	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23679
4.24657144666834e-21	-0.680030472624909	0.769	0.778	9.70553904136048e-17	HERPUD1	Malignant cells	GSE175716	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23680
4.46860185814866e-21	0.43949972556391	0.371	0.26	1.02129895467988e-16	QDPR	Malignant cells	GSE175716	ENSG00000151552	5860	quinoid dihydropteridine reductase	DHPR|PKU2|SDR33C1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23681
4.48347420340442e-21	0.381790849594201	0.355	0.234	1.02469802918808e-16	ZBTB18	Malignant cells	GSE175716	ENSG00000179456	10472	zinc finger and BTB domain containing 18	C2H2-171|RP58|TAZ-1|ZNF238	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23682
4.49496165438405e-21	-0.313587423801812	0.143	0.286	1.02732348610948e-16	FOXA1	Malignant cells	GSE175716	ENSG00000129514	3169	forkhead box A1	HNF3A	protein_coding	P55317	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23683
4.83096506267663e-21	-0.335524303136731	0.728	0.767	1.10411706507474e-16	YTHDF2	Malignant cells	GSE175716	ENSG00000198492	51441	YTH N6-methyladenosine RNA binding protein 2	CAHL|HGRG8|NY-REN-2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23684
5.1205532988616e-21	-0.352615851988823	0.153	0.293	1.17030245645482e-16	DCBLD2	Malignant cells	GSE175716	ENSG00000057019	131566	discoidin, CUB and LCCL domain containing 2	CLCP1|ESDN	protein_coding	Q96PD2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23685
5.2750798071562e-21	-0.71947764788384	0.989	0.965	1.20561948992555e-16	MGST3	Malignant cells	GSE175716	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23686
5.34304860380964e-21	-0.280616157995278	0.657	0.75	1.22115375840069e-16	MRPL3	Malignant cells	GSE175716	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23687
5.392538615835e-21	-0.285939427903269	0.452	0.587	1.23246470064909e-16	DUSP3	Malignant cells	GSE175716	ENSG00000108861	1845	dual specificity phosphatase 3	VHR	protein_coding	P51452	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23688
5.39536905316602e-21	-0.295445423271399	0.159	0.305	1.23311159710109e-16	WDR36	Malignant cells	GSE175716	ENSG00000134987	134430	WD repeat domain 36	GLC1G|TA-WDRP|UTP21	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23689
5.66156121062169e-21	-0.348879100079739	0.636	0.712	1.29394981468759e-16	WASL	Malignant cells	GSE175716	ENSG00000106299	8976	WASP like actin nucleation promoting factor	N-WASP|NWASP|WASPB	protein_coding	O00401	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23690
5.74782203331344e-21	-0.351552868594041	0.454	0.571	1.31366472571379e-16	LIMA1	Malignant cells	GSE175716	ENSG00000050405	51474	LIM domain and actin binding 1	EPLIN	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23691
6.24681041006717e-21	-0.310647665072231	0.864	0.889	1.42770851922085e-16	PSMB5	Malignant cells	GSE175716	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23692
6.33072260121272e-21	-0.387841138024829	0.351	0.485	1.44688665050717e-16	LACTB	Malignant cells	GSE175716	ENSG00000103642	114294	lactamase beta	FLJ14902|MRPL56	protein_coding	P83111	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23693
7.89936900480114e-21	0.392832943375614	0.498	0.382	1.8054007860473e-16	QARS	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23694
7.95016922132478e-21	-0.43489723187512	0.544	0.625	1.81701117553378e-16	SSFA2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23695
8.33044013459354e-21	0.269270861596446	0.628	0.45	1.90392209276135e-16	NDUFV1	Malignant cells	GSE175716	ENSG00000167792	4723	NADH:ubiquinone oxidoreductase core subunit V1	CI-51K	protein_coding	P49821	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23696
8.44458190630884e-21	0.266014078692799	0.74	0.569	1.93000919468689e-16	SIGMAR1	Malignant cells	GSE175716	ENSG00000147955	10280	sigma non-opioid intracellular receptor 1	OPRS1|SR-BP1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23697
9.83155066821075e-21	-0.459937615223498	0.603	0.671	2.24700090521957e-16	CCDC50	Malignant cells	GSE175716	ENSG00000152492	152137	coiled-coil domain containing 50	C3orf6|DFNA44|Ymer	protein_coding	Q8IVM0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23698
1.00179789840863e-20	-0.278952862090182	0.674	0.745	2.28960909681292e-16	EIF2S1	Malignant cells	GSE175716	ENSG00000134001	1965	eukaryotic translation initiation factor 2 subunit alpha	EIF-2alpha|EIF2|EIF2A	protein_coding	P05198	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23699
1.01718094967033e-20	-0.260992144579582	0.133	0.277	2.32476706047153e-16	SYBU	Malignant cells	GSE175716	ENSG00000147642	55638	syntabulin	FLJ20366|GOLSYN|KIAA1472|OCSYN|SNPHL	protein_coding	Q9NX95	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23700
1.03626662124583e-20	-0.381249656985587	0.522	0.623	2.36838736285736e-16	COPB2	Malignant cells	GSE175716	ENSG00000184432	9276	COPI coat complex subunit beta 2	beta'-COP|betaprime-COP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23701
1.04226610753541e-20	0.328302337542273	0.346	0.225	2.38209918877218e-16	BAG2	Malignant cells	GSE175716	ENSG00000112208	9532	BAG cochaperone 2	NA	protein_coding	O95816	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23702
1.1213676081718e-20	0.417590557058962	0.341	0.229	2.56288566847664e-16	MCM3	Malignant cells	GSE175716	ENSG00000112118	4172	minichromosome maintenance complex component 3	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23703
1.15745486986711e-20	-0.773612008544758	0.858	0.837	2.64536310508128e-16	PDCD6	Malignant cells	GSE175716	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23704
1.16625199826669e-20	-0.278301212473653	0.442	0.576	2.66546894203853e-16	SRP19	Malignant cells	GSE175716	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23705
1.27589999916728e-20	0.335806134943901	0.401	0.273	2.91606944809683e-16	ASXL1	Malignant cells	GSE175716	ENSG00000171456	171023	ASXL transcriptional regulator 1	KIAA0978	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23706
1.37475212122971e-20	-0.268650460492398	0.153	0.298	3.14199597307051e-16	RAB40B	Malignant cells	GSE175716	ENSG00000141542	10966	RAB40B, member RAS oncogene family	RAR|SEC4L	protein_coding	Q12829	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23707
1.46809608593194e-20	-0.705467810313132	0.693	0.701	3.35533360439746e-16	HMOX1	Malignant cells	GSE175716	ENSG00000100292	3162	heme oxygenase 1	bK286B10|HO-1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23708
1.47972937450616e-20	-0.322485919064868	0.544	0.648	3.38192148543382e-16	COPS2	Malignant cells	GSE175716	ENSG00000166200	9318	COP9 signalosome subunit 2	ALIEN|CSN2|TRIP15	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23709
1.54865694414445e-20	-0.258396086325859	0.504	0.623	3.53945544584215e-16	POLE4	Malignant cells	GSE175716	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23710
1.67644824382471e-20	-0.276522915013973	0.178	0.331	3.83152246126137e-16	SRSF8	Malignant cells	GSE175716	ENSG00000263465	10929	serine and arginine rich splicing factor 8	SFRS2B|SRP46	protein_coding	Q9BRL6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23711
1.74807556804736e-20	0.388741235337448	0.441	0.325	3.99522671077223e-16	RRAGD	Malignant cells	GSE175716	ENSG00000025039	58528	Ras related GTP binding D	bA11D8.2.1|DKFZP761H171	protein_coding	Q9NQL2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23712
1.75112895039112e-20	-0.365177566008082	0.609	0.695	4.0022052161189e-16	SLTM	Malignant cells	GSE175716	ENSG00000137776	79811	SAFB like transcription modulator	FLJ13213|Met	protein_coding	Q9NWH9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23713
1.86386318762849e-20	-0.375210583586178	0.196	0.333	4.25985931532492e-16	ALKBH7	Malignant cells	GSE175716	ENSG00000125652	84266	alkB homolog 7	MGC10974|SPATA11	protein_coding	Q9BT30	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23714
1.88422024119709e-20	0.295250679900984	0.836	0.724	4.30638536125595e-16	RPS28	Malignant cells	GSE175716	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23715
1.88949433993384e-20	-0.281157581191255	0.335	0.493	4.31843931391879e-16	G3BP2	Malignant cells	GSE175716	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23716
2.26947546277867e-20	0.311346604930333	0.323	0.202	5.18688617018065e-16	F2	Malignant cells	GSE175716	ENSG00000180210	2147	coagulation factor II, thrombin	NA	protein_coding	P00734	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23717
2.35617218463643e-20	0.37037577477161	0.505	0.389	5.38503152798657e-16	PNISR	Malignant cells	GSE175716	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23718
2.36578013011859e-20	-0.304781805366457	0.188	0.336	5.40699048738604e-16	ZNF638	Malignant cells	GSE175716	ENSG00000075292	27332	zinc finger protein 638	MGC26130|NP220|ZFML|Zfp638	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23719
2.68168869000392e-20	-0.324382218947758	0.71	0.766	6.12899950100396e-16	CAPZA2	Malignant cells	GSE175716	ENSG00000198898	830	capping actin protein of muscle Z-line subunit alpha 2	CAPPA2|CAPZ	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23720
2.79573948062874e-20	-0.281019780364422	0.203	0.358	6.389662582977e-16	GTF3C4	Malignant cells	GSE175716	ENSG00000125484	9329	general transcription factor IIIC subunit 4	KAT12|TFIIIC90	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23721
2.84829435715239e-20	-0.285428968307547	0.318	0.468	6.50977675327178e-16	PPP2R1A	Malignant cells	GSE175716	ENSG00000105568	5518	protein phosphatase 2 scaffold subunit Aalpha	PP2A-Aalpha|PP2AA|PR65A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23722
2.97911709403977e-20	0.313871294907385	0.717	0.567	6.80877211842791e-16	OPTN	Malignant cells	GSE175716	ENSG00000123240	10133	optineurin	FIP-2|FIP2|GLC1E|HIP7|HYPL|NRP|TFIIIA-INTP	protein_coding	Q96CV9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23723
3.11825376846844e-20	-0.287031332242522	0.138	0.274	7.12676898783461e-16	CD320	Malignant cells	GSE175716	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23724
3.19139373322091e-20	0.368957593291423	0.577	0.476	7.29393037727638e-16	FOPNL	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23725
3.48768189831332e-20	-0.318128496892636	0.554	0.641	7.97109697859509e-16	RBBP7	Malignant cells	GSE175716	ENSG00000102054	5931	RB binding protein 7, chromatin remodeling factor	RbAp46	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23726
3.65369282771317e-20	-0.292607209474028	0.446	0.572	8.35051495773844e-16	POGK	Malignant cells	GSE175716	ENSG00000143157	57645	pogo transposable element derived with KRAB domain	BASS2|KIAA15131|KRBOX2|LST003	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23727
3.73882420956945e-20	-0.259700214667271	0.218	0.377	8.54508273097098e-16	CEP57	Malignant cells	GSE175716	ENSG00000166037	9702	centrosomal protein 57	KIAA0092|Translokin|TSP57	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23728
4.06774047177195e-20	-0.379674706952586	0.135	0.267	9.29682084823478e-16	HBP1	Malignant cells	GSE175716	ENSG00000283847	26959	HMG-box transcription factor 1	NA	protein_coding	O60381	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23729
4.07708056252378e-20	-0.271836683241707	0.752	0.81	9.3181676256481e-16	PTBP1	Malignant cells	GSE175716	ENSG00000011304	5725	polypyrimidine tract binding protein 1	HNRNP-I|HNRPI|pPTB|PTB|PTB-1|PTB2|PTB3|PTB4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23730
4.56530510065148e-20	0.417430455668611	0.418	0.303	1.0434004807539e-15	IFNGR2	Malignant cells	GSE175716	ENSG00000262795	3460	interferon gamma receptor 2	AF-1|IFNGT1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23731
4.77044050222123e-20	-0.291624201465417	0.473	0.599	1.09028417678266e-15	YTHDC1	Malignant cells	GSE175716	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23732
5.03714237527982e-20	-0.28032402802551	0.133	0.267	1.1512388898702e-15	TSTA3	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23733
5.26796771361547e-20	-0.321947974867191	0.215	0.365	1.20399402094681e-15	FNBP1L	Malignant cells	GSE175716	ENSG00000137942	54874	formin binding protein 1 like	C1orf39|FLJ20275|TOCA1	protein_coding	Q5T0N5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23734
5.71513561248309e-20	-0.281682346509686	0.142	0.285	1.30619424423301e-15	HIVEP2	Malignant cells	GSE175716	ENSG00000010818	3097	HIVEP zinc finger 2	HIV-EP2|MBP-2|MIBP1|Schnurri-2|ZAS2|ZNF40B	protein_coding	P31629	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23735
5.73341347374939e-20	0.290888967957497	0.955	0.923	1.31037164942542e-15	SERPINB1	Malignant cells	GSE175716	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23736
5.78805138499226e-20	0.335567884240692	0.332	0.219	1.32285914403998e-15	PLOD3	Malignant cells	GSE175716	ENSG00000106397	8985	procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	LH3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23737
6.34617008205176e-20	-0.259150910908392	0.312	0.471	1.45041717225293e-15	MSL1	Malignant cells	GSE175716	ENSG00000188895	339287	MSL complex subunit 1	DKFZp686P24239|hMSL1|MSL-1	protein_coding	Q68DK7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23738
6.97080817269364e-20	-0.264921994572412	0.379	0.522	1.59317820786913e-15	NUP62	Malignant cells	GSE175716	ENSG00000213024	23636	nucleoporin 62	DKFZp547L134|FLJ20822|FLJ43869|IBSN|MGC841|p62|SNDI	protein_coding	P37198	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23739
7.22507043546437e-20	-0.475902053157063	0.687	0.724	1.65128984802538e-15	GPBP1	Malignant cells	GSE175716	ENSG00000062194	65056	GC-rich promoter binding protein 1	DKFZp761C169	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23740
7.43865812000959e-20	-0.255881715909788	0.122	0.255	1.70010531332819e-15	ASNA1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23741
7.70198857809988e-20	-0.275628681311257	0.228	0.381	1.76028948952473e-15	CWC25	Malignant cells	GSE175716	ENSG00000276761	54883	CWC25 spliceosome associated protein homolog	CCDC49|FLJ20291	protein_coding	Q9NXE8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23742
7.71356153383321e-20	0.439414074667292	0.413	0.31	1.76293448855758e-15	ABCD3	Malignant cells	GSE175716	ENSG00000117528	5825	ATP binding cassette subfamily D member 3	PMP70|PXMP1|ZWS2	protein_coding	P28288	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23743
8.00699755463424e-20	-0.263827336023823	0.151	0.293	1.82999929111166e-15	CEP95	Malignant cells	GSE175716	ENSG00000258890	90799	centrosomal protein 95	CCDC45|DKFZp667E1824	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23744
8.59869736207439e-20	-0.282472391225237	0.133	0.265	1.9652322821021e-15	KANSL1	Malignant cells	GSE175716	ENSG00000275867	284058	KAT8 regulatory NSL complex subunit 1	CENP-36|DKFZP727C091|KIAA1267|MSL1v1|NSL1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23745
1.16675954003002e-19	0.367156932692036	0.403	0.29	2.66662892873861e-15	PEPD	Malignant cells	GSE175716	ENSG00000124299	5184	peptidase D	NA	protein_coding	P12955	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23746
1.19002896358541e-19	0.257949581922027	0.993	0.978	2.71981119627445e-15	NCL	Malignant cells	GSE175716	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23747
1.21318312185626e-19	0.322378463406129	0.777	0.667	2.77273002500248e-15	DERL1	Malignant cells	GSE175716	ENSG00000136986	79139	derlin 1	DER-1|DER1|derlin-1|FLJ13784|MGC3067|PRO2577	protein_coding	Q9BUN8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23748
1.23290739183502e-19	0.407288895649287	0.475	0.376	2.81780984403893e-15	SRPK1	Malignant cells	GSE175716	ENSG00000096063	6732	SRSF protein kinase 1	SFRSK1	protein_coding	Q96SB4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23749
1.31290244612699e-19	-0.354348521843547	0.167	0.306	3.00063854062323e-15	STK39	Malignant cells	GSE175716	ENSG00000198648	27347	serine/threonine kinase 39	DCHT|SPAK	protein_coding	Q9UEW8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23750
1.33931320099977e-19	-0.371033604528498	0.293	0.433	3.06100032088497e-15	MET	Malignant cells	GSE175716	ENSG00000105976	4233	MET proto-oncogene, receptor tyrosine kinase	DFNB97|HGFR|RCCP2	protein_coding	P08581	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23751
1.51376638338148e-19	-0.698655092656746	0.958	0.91	3.45971306921838e-15	SLC25A6	Malignant cells	GSE175716	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23752
1.55875513917792e-19	-0.461045569614816	0.253	0.386	3.56253487059114e-15	ERN1	Malignant cells	GSE175716	ENSG00000178607	2081	endoplasmic reticulum to nucleus signaling 1	IRE1|IRE1P	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23753
2.16569037894323e-19	-0.254710408141599	0.85	0.899	4.94968536107474e-15	SF3B6	Malignant cells	GSE175716	ENSG00000115128	51639	splicing factor 3b subunit 6	CGI-110|Ht006|P14|SAP14a|SF3B14a	protein_coding	Q9Y3B4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23754
2.19558024108811e-19	-0.501200957586831	0.76	0.794	5.01799864100686e-15	PTBP3	Malignant cells	GSE175716	ENSG00000119314	9991	polypyrimidine tract binding protein 3	DKFZp781I1117|ROD1	protein_coding	O95758	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23755
2.23004159584886e-19	0.312129299632405	0.284	0.177	5.09676006731258e-15	MOB4	Malignant cells	GSE175716	ENSG00000115540	25843	MOB family member 4, phocein	2C4D|CGI-95|DKFZP564M112|MOB3|MOBKL3|PHOCN|PREI3	protein_coding	Q9Y3A3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23756
2.24822058995815e-19	0.298308880432352	0.286	0.175	5.13830815834935e-15	C12orf45	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23757
2.33605050187085e-19	0.395830028205342	0.555	0.457	5.33904342202583e-15	LUC7L2	Malignant cells	GSE175716	ENSG00000146963	51631	LUC7 like 2, pre-mRNA splicing factor	CGI-59|CGI-74|FLJ10657|hLuc7B2|H_NH0792N18.3|LUC7B2	protein_coding	Q9Y383	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23758
2.6508272049902e-19	0.312905580898495	0.306	0.193	6.0584655770051e-15	DUS1L	Malignant cells	GSE175716	ENSG00000169718	64118	dihydrouridine synthase 1 like	DUS1|PP3111	protein_coding	Q6P1R4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23759
2.68300161077567e-19	-0.282779645271936	0.259	0.412	6.13200018142779e-15	CDK12	Malignant cells	GSE175716	ENSG00000167258	51755	cyclin dependent kinase 12	CRK7|CRKR|CRKRS|KIAA0904	protein_coding	Q9NYV4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23760
2.73196591429578e-19	0.287157448771765	0.375	0.247	6.24390809712299e-15	POLR2I	Malignant cells	GSE175716	ENSG00000105258	5438	RNA polymerase II subunit I	hRPB14.5|RPB9	protein_coding	P36954	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23761
3.48425648287928e-19	-0.396741298694007	0.374	0.474	7.96326819162059e-15	BLOC1S1	Malignant cells	GSE175716	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23762
3.49916126882475e-19	-0.263823505853218	0.453	0.575	7.99733307989896e-15	PTS	Malignant cells	GSE175716	ENSG00000150787	5805	6-pyruvoyltetrahydropterin synthase	PTPS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23763
3.80651854869442e-19	-0.313134720150151	0.447	0.551	8.69979814304109e-15	MRPL20	Malignant cells	GSE175716	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23764
4.02270540255761e-19	0.369069700501856	0.395	0.286	9.19389319754541e-15	MSRB2	Malignant cells	GSE175716	ENSG00000148450	22921	methionine sulfoxide reductase B2	CBS-1|CBS1|CGI-131|MSRB|PILB	protein_coding	Q9Y3D2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23765
4.50303065750594e-19	-0.340254673149193	0.415	0.523	1.02916765677298e-14	GGH	Malignant cells	GSE175716	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23766
4.63770065118313e-19	0.491935260660883	0.418	0.325	1.05994648382791e-14	PANK3	Malignant cells	GSE175716	ENSG00000120137	79646	pantothenate kinase 3	FLJ12899	protein_coding	Q9H999	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23767
4.71009932042268e-19	-1.07031904621091	0.999	0.965	1.0764931996826e-14	RPS19	Malignant cells	GSE175716	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23768
4.96950033999852e-19	-0.483191486411289	0.664	0.671	1.13577930270666e-14	C19orf53	Malignant cells	GSE175716	ENSG00000104979	28974	chromosome 19 open reading frame 53	HSPC023|LYDG10	protein_coding	Q9UNZ5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23769
5.23817983786733e-19	0.354845304756626	0.324	0.214	1.19718600194458e-14	TAF2	Malignant cells	GSE175716	ENSG00000064313	6873	TATA-box binding protein associated factor 2	CIF150|TAF2B|TAFII150	protein_coding	Q6P1X5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23770
5.2586605295638e-19	-0.273555174986497	0.171	0.312	1.20186686403181e-14	SINHCAF	Malignant cells	GSE175716	ENSG00000276371	58516	SIN3-HDAC complex associated factor	C12orf14|FAM60A|TERA	protein_coding	Q9NP50	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23771
5.27277433485142e-19	-0.36719290643486	0.537	0.621	1.20509257423029e-14	CLINT1	Malignant cells	GSE175716	ENSG00000113282	9685	clathrin interactor 1	CLINT|ENTH|EPNR|KIAA0171	protein_coding	Q14677	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23772
5.65760551731959e-19	0.386357732285802	0.435	0.339	1.29304574098339e-14	MPLKIP	Malignant cells	GSE175716	ENSG00000168303	136647	M-phase specific PLK1 interacting protein	C7orf11|ORF20|TTDN1	protein_coding	Q8TAP9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23773
6.68230293008704e-19	0.379603550450522	0.519	0.431	1.52724033467139e-14	DLD	Malignant cells	GSE175716	ENSG00000091140	1738	dihydrolipoamide dehydrogenase	DLDH|E3|GCSL|LAD|OGDC-E3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23774
7.14371102705866e-19	-0.276083325960446	0.266	0.416	1.63269515523426e-14	DHX36	Malignant cells	GSE175716	ENSG00000281763	170506	DEAH-box helicase 36	DDX36|KIAA1488|MLEL1|RHAU	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23775
8.42524737899999e-19	-0.326754178410206	0.916	0.9	1.92559028847045e-14	NME1	Malignant cells	GSE175716	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23776
8.84250321672619e-19	-0.318632904561274	0.594	0.673	2.02095411018277e-14	SEC31A	Malignant cells	GSE175716	ENSG00000138674	22872	SEC31 homolog A, COPII coat complex component	ABP125|ABP130|KIAA0905|SEC31L1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23777
9.17709994743475e-19	-0.374529277197644	0.535	0.604	2.09742619298621e-14	CTSH	Malignant cells	GSE175716	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23778
9.29521810063856e-19	-0.262168062287436	0.246	0.395	2.12442209690094e-14	SRP54	Malignant cells	GSE175716	ENSG00000100883	6729	signal recognition particle 54	NA	protein_coding	P61011	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23779
1.01253500373905e-18	-0.263857176706276	0.147	0.288	2.31414875104561e-14	SNHG12	Malignant cells	GSE175716	ENSG00000197989	85028	small nucleolar RNA host gene 12	ASLNC04080|C1orf79|LINC00100|PNAS-123	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23780
1.05057302757853e-18	-0.25115922108446	0.136	0.268	2.40108465453073e-14	RSRC1	Malignant cells	GSE175716	ENSG00000174891	51319	arginine and serine rich coiled-coil 1	BM-011|MGC12197|SFRS21|SRrp53	protein_coding	Q96IZ7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23781
1.10649643344967e-18	-0.425307344452477	0.281	0.415	2.52889759864921e-14	NAMPTP1	Malignant cells	GSE175716	ENSG00000229644	NA	NA	bA92J19.4|NAMPTL|PBEF2	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23782
1.11200723795418e-18	-0.358867589134671	0.603	0.678	2.54149254234428e-14	IBTK	Malignant cells	GSE175716	ENSG00000283068	25998	inhibitor of Bruton tyrosine kinase	BTBD26|BTKI|DKFZP564B116	protein_coding	Q9P2D0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23783
1.115796017324e-18	0.3181389544998	0.868	0.756	2.55015179759401e-14	EPRS	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23784
1.1776773309388e-18	-0.295654215260629	0.194	0.336	2.69158153986063e-14	ZCCHC6	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23785
1.2140412599519e-18	-0.289861274565604	0.709	0.748	2.77469129962006e-14	MRPL57	Malignant cells	GSE175716	ENSG00000173141	78988	mitochondrial ribosomal protein L57	MRP63	protein_coding	Q9BQC6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23786
1.30643138611948e-18	0.349105570386668	0.597	0.492	2.98584893297607e-14	RXRA	Malignant cells	GSE175716	ENSG00000186350	6256	retinoid X receptor alpha	NR2B1|RXR-alpha|RXRalpha	protein_coding	P19793	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23787
1.40586353847623e-18	0.318239722470847	0.36	0.241	3.21310111718743e-14	RNF217	Malignant cells	GSE175716	ENSG00000146373	154214	ring finger protein 217	C6orf172|dJ84N20.1|IBRDC1|MGC26996	protein_coding	Q8TC41	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23788
1.68755656848715e-18	-0.281002213901127	0.19	0.331	3.85691053727738e-14	EHF	Malignant cells	GSE175716	ENSG00000135373	26298	ETS homologous factor	ESE3|ESEJ	protein_coding	Q9NZC4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23789
1.79766276518857e-18	-0.296753538588815	0.985	0.985	4.10855824983849e-14	AC099560.2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23790
1.80859354076633e-18	0.256839260524817	0.811	0.696	4.13354053742145e-14	SRRM1	Malignant cells	GSE175716	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23791
1.94496299952569e-18	-0.296257627589342	0.58	0.664	4.44521293541596e-14	PAK2	Malignant cells	GSE175716	ENSG00000180370	5062	p21 (RAC1) activated kinase 2	PAK65|PAKgamma	protein_coding	Q13177	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23792
3.25187777245736e-18	-0.25374354982115	0.135	0.263	7.4321666489513e-14	STAMBP	Malignant cells	GSE175716	ENSG00000124356	10617	STAM binding protein	AMSH	protein_coding	O95630	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23793
3.30081111757e-18	-0.293643703462959	0.442	0.562	7.54400380920622e-14	RPS6KA3	Malignant cells	GSE175716	ENSG00000177189	6197	ribosomal protein S6 kinase A3	CLS|HU-3|MRX19|RSK2	protein_coding	P51812	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23794
3.53329974186995e-18	-0.265649912432515	0.256	0.402	8.07535656004378e-14	SENP6	Malignant cells	GSE175716	ENSG00000112701	26054	SUMO specific peptidase 6	KIAA0797|SUSP1	protein_coding	Q9GZR1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23795
3.63803152196477e-18	0.450865140036408	0.422	0.326	8.31472104345048e-14	NUS1	Malignant cells	GSE175716	ENSG00000153989	116150	NUS1 dehydrodolichyl diphosphate synthase subunit	C6orf68|MGC7199|NgBR|TANGO14	protein_coding	Q96E22	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23796
3.72086446956747e-18	-0.331296072916609	0.15	0.272	8.50403574519645e-14	GADD45GIP1	Malignant cells	GSE175716	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23797
3.93214277427552e-18	-0.807730360655495	0.664	0.683	8.98691231060671e-14	GADD45A	Malignant cells	GSE175716	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23798
4.26098183218798e-18	0.276290376408818	0.266	0.165	9.73847397746563e-14	PPIAP31	Malignant cells	GSE175716	ENSG00000217094	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23799
4.67075920169531e-18	-0.349489026774744	0.422	0.54	1.06750201554746e-13	TM7SF3	Malignant cells	GSE175716	ENSG00000064115	51768	transmembrane 7 superfamily member 3	NA	protein_coding	Q9NS93	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23800
4.78985561707235e-18	0.291493529643337	0.884	0.792	1.09472150128189e-13	YME1L1	Malignant cells	GSE175716	ENSG00000136758	10730	YME1 like 1 ATPase	YME1L	protein_coding	Q96TA2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23801
5.31884691454068e-18	0.322390771265355	0.648	0.545	1.21562246231827e-13	ACADM	Malignant cells	GSE175716	ENSG00000117054	34	acyl-CoA dehydrogenase medium chain	ACAD1|MCAD|MCADH	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23802
5.36821145533456e-18	-0.287480342502595	0.598	0.684	1.22690472811671e-13	LSM5	Malignant cells	GSE175716	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23803
5.61026473753253e-18	-0.26573076726554	0.854	0.882	1.28222600576306e-13	SSR1	Malignant cells	GSE175716	ENSG00000124783	6745	signal sequence receptor subunit 1	TRAPA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23804
5.92443010914165e-18	-0.286966084584652	0.501	0.602	1.35402850144432e-13	CSNK1E	Malignant cells	GSE175716	ENSG00000213923	1454	casein kinase 1 epsilon	CKIE|CKIepsilon|HCKIE	protein_coding	P49674	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23805
6.06588314555671e-18	-0.254806632495785	0.645	0.717	1.38635759291699e-13	MCFD2	Malignant cells	GSE175716	ENSG00000180398	90411	multiple coagulation factor deficiency 2, ER cargo receptor complex subunit	F5F8D|LMAN1IP|SDNSF	protein_coding	Q8NI22	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23806
6.17755021952125e-18	0.250941603061172	0.277	0.169	1.41187910267158e-13	PDXK	Malignant cells	GSE175716	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23807
6.30907441703455e-18	0.334108840779656	0.834	0.746	1.44193895801325e-13	MRPS33	Malignant cells	GSE175716	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23808
6.81122135060615e-18	-0.485773454154531	0.51	0.549	1.55670463968104e-13	PRKCSH	Malignant cells	GSE175716	ENSG00000130175	5589	protein kinase C substrate 80K-H	G19P1|GIIB|PCLD|PLD1|VASAP-60	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23809
7.86675117686495e-18	-0.395774431158229	0.976	0.984	1.79794598147248e-13	RTN4	Malignant cells	GSE175716	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23810
7.97355793736832e-18	0.31198297729227	0.351	0.24	1.82235666658553e-13	SLC19A2	Malignant cells	GSE175716	ENSG00000117479	10560	solute carrier family 19 member 2	ThT1|THTR1|TRMA	protein_coding	O60779	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23811
8.09577049306848e-18	-0.250563200914526	0.436	0.566	1.8502883461908e-13	YAP1	Malignant cells	GSE175716	ENSG00000137693	10413	Yes1 associated transcriptional regulator	YAP-1|YAP65	protein_coding	P46937	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23812
8.09867528512736e-18	0.399349422862474	0.401	0.301	1.85095223641586e-13	GLRX5	Malignant cells	GSE175716	ENSG00000182512	51218	glutaredoxin 5	C14orf87|GRX5|PR01238	protein_coding	Q86SX6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23813
8.12654226426337e-18	0.296188554190116	0.634	0.524	1.85732123449739e-13	MRPS5	Malignant cells	GSE175716	ENSG00000144029	64969	mitochondrial ribosomal protein S5	MRP-S5|S5mt	protein_coding	P82675	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23814
8.41944199396386e-18	-0.457125254046729	0.921	0.932	1.92426346772044e-13	RAB1A	Malignant cells	GSE175716	ENSG00000138069	5861	RAB1A, member RAS oncogene family	RAB1|YPT1	protein_coding	P62820	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23815
8.84230822552884e-18	-0.312701157658576	0.379	0.505	2.02090954494462e-13	COQ10B	Malignant cells	GSE175716	ENSG00000115520	80219	coenzyme Q10B	FLJ13448	protein_coding	Q9H8M1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23816
8.85525768767213e-18	-0.253879764920695	0.149	0.278	2.02386914451746e-13	NRBP1	Malignant cells	GSE175716	ENSG00000115216	29959	nuclear receptor binding protein 1	BCON3|MADM|MUDPNP|NRBP	protein_coding	Q9UHY1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23817
9.13073566779863e-18	0.259943442125957	0.254	0.151	2.08682963687538e-13	MDN1	Malignant cells	GSE175716	ENSG00000288121	23195	midasin AAA ATPase 1	KIAA0301|Rea1	protein_coding	Q9NU22	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23818
9.46346600397244e-18	0.338845515214433	0.541	0.436	2.1628751552079e-13	GATAD1	Malignant cells	GSE175716	ENSG00000157259	57798	GATA zinc finger domain containing 1	FLJ22489|ODAG|RG083M05.2	protein_coding	Q8WUU5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23819
9.89958456233993e-18	0.360710292376012	0.418	0.318	2.26255005172279e-13	MRPS6	Malignant cells	GSE175716	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23820
9.90094062770612e-18	-1.40028232599078	0.592	0.571	2.26285998046223e-13	THBS1	Malignant cells	GSE175716	ENSG00000137801	7057	thrombospondin 1	THBS|THBS-1|TSP|TSP-1|TSP1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23821
1.35637572395136e-17	-0.345841239185797	0.619	0.678	3.09999671709084e-13	PSMD2	Malignant cells	GSE175716	ENSG00000175166	5708	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	MGC14274|P97|Rpn1|S2|TRAP2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23822
1.61434108044602e-17	0.291509009767101	0.289	0.187	3.68957653935939e-13	ARV1	Malignant cells	GSE175716	ENSG00000173409	64801	ARV1 homolog, fatty acid homeostasis modulator	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23823
1.86219815552959e-17	-0.270289579296194	0.84	0.86	4.25605388446288e-13	PON2	Malignant cells	GSE175716	ENSG00000105854	5445	paraoxonase 2	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23824
1.97936391631633e-17	0.361602667381381	0.507	0.412	4.52383623074097e-13	METTL5	Malignant cells	GSE175716	ENSG00000138382	29081	methyltransferase 5, N6-adenosine	HSPC133	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23825
2.42501933199948e-17	0.290868376784887	0.36	0.244	5.54238168328481e-13	VEGFB	Malignant cells	GSE175716	ENSG00000173511	7423	vascular endothelial growth factor B	VEGFL|VRF	protein_coding	P49765	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23826
2.73706022640072e-17	-0.35804989974818	0.535	0.621	6.25555114743885e-13	MAP4K4	Malignant cells	GSE175716	ENSG00000071054	9448	mitogen-activated protein kinase kinase kinase kinase 4	FLH21957|HGK|NIK	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23827
2.74053092523711e-17	0.272094919297952	0.263	0.163	6.2634834296294e-13	ANXA6	Malignant cells	GSE175716	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23828
2.77797113731738e-17	0.304567574271741	0.899	0.823	6.34905303433888e-13	KDELR2	Malignant cells	GSE175716	ENSG00000136240	11014	KDEL endoplasmic reticulum protein retention receptor 2	ELP-1|ERD2.2	protein_coding	P33947	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23829
3.12249278416606e-17	-0.319847129284526	0.93	0.923	7.13645725821154e-13	RPL7P9	Malignant cells	GSE175716	ENSG00000137970	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23830
3.56831537602161e-17	-0.425765332894933	0.581	0.653	8.15538479189739e-13	PDK4	Malignant cells	GSE175716	ENSG00000004799	5166	pyruvate dehydrogenase kinase 4	NA	protein_coding	Q16654	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23831
3.60482499193665e-17	-0.337867922340591	0.36	0.463	8.23882751907121e-13	AC098934.3	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23832
3.7890873686458e-17	0.263436345473223	0.279	0.174	8.65995918103998e-13	MAVS	Malignant cells	GSE175716	ENSG00000088888	57506	mitochondrial antiviral signaling protein	Cardif|IPS-1|KIAA1271|VISA	protein_coding	Q7Z434	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23833
4.73477123029177e-17	0.325964256308364	0.326	0.226	1.08213196468318e-12	GART	Malignant cells	GSE175716	ENSG00000262473	2618	phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase	GARS-AIRS-GART|PGFT|PRGS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23834
4.77284232207963e-17	-0.285413680270455	0.539	0.63	1.0908331127113e-12	AKAP13	Malignant cells	GSE175716	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23835
5.30179383978449e-17	0.291900683994363	0.262	0.164	1.21172498208275e-12	COCH	Malignant cells	GSE175716	ENSG00000100473	1690	cochlin	COCH-5B2|DFNA31|DFNA9	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23836
5.3365272265317e-17	0.326751595099219	0.349	0.246	1.21966329762382e-12	CCNC	Malignant cells	GSE175716	ENSG00000112237	892	cyclin C	CycC	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23837
5.62940885495892e-17	0.256675436497482	0.992	0.993	1.28660139380086e-12	RAN	Malignant cells	GSE175716	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23838
6.02088327244686e-17	-0.277192800371738	0.175	0.3	1.37607287191773e-12	MPDU1	Malignant cells	GSE175716	ENSG00000129255	9526	mannose-P-dolichol utilization defect 1	CDGIf|Lec35|PQLC5|SL15|SLC66A5	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23839
6.16063360026145e-17	-1.75318959656888	0.767	0.707	1.40801280933975e-12	HSPH1	Malignant cells	GSE175716	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23840
6.34137278124546e-17	-0.261258661986941	0.994	0.989	1.44932074915365e-12	COX6B1	Malignant cells	GSE175716	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23841
6.43661117634374e-17	-0.531961167313246	0.476	0.522	1.47108748435336e-12	RPS2P55	Malignant cells	GSE175716	ENSG00000216866	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23842
7.02316111711506e-17	-0.278270780915659	0.595	0.659	1.60514347331665e-12	ADI1	Malignant cells	GSE175716	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23843
7.59684864272125e-17	-0.253704623666631	0.58	0.668	1.73625975729394e-12	LRRC59	Malignant cells	GSE175716	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23844
9.44225779612006e-17	0.263502341145825	0.934	0.878	2.15802801930324e-12	ILF2	Malignant cells	GSE175716	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23845
9.86599909292972e-17	-0.364719689422877	0.9	0.902	2.25487409268909e-12	POLR1D	Malignant cells	GSE175716	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23846
1.32018621475625e-16	-0.265863952113829	0.62	0.698	3.0172855938254e-12	DHRS7	Malignant cells	GSE175716	ENSG00000100612	51635	dehydrogenase/reductase 7	retDSR4|SDR34C1	protein_coding	Q9Y394	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23847
1.32106903331564e-16	-0.284471401271073	0.641	0.714	3.01930327564288e-12	NARS	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23848
1.35796285316657e-16	-0.281387345448491	0.187	0.315	3.1036241009122e-12	RLF	Malignant cells	GSE175716	ENSG00000117000	6018	RLF zinc finger	Zn-15L|ZNF292L	protein_coding	Q13129	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23849
1.3596173430174e-16	-0.280141898049776	0.197	0.325	3.10740543746627e-12	ZBTB44	Malignant cells	GSE175716	ENSG00000196323	29068	zinc finger and BTB domain containing 44	BTBD15|HSPC063|ZNF851	protein_coding	Q8NCP5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23850
1.37148899097848e-16	-0.415524043364446	0.912	0.876	3.13453808888132e-12	NDUFB4	Malignant cells	GSE175716	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23851
1.4018447874323e-16	0.334960931254125	0.31	0.208	3.20391626167653e-12	RBMXL1	Malignant cells	GSE175716	ENSG00000213516	494115	RBMX like 1	KAT3	protein_coding	Q96E39	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23852
1.44932156780195e-16	-0.403157828606578	0.399	0.499	3.31242444321135e-12	LATS2	Malignant cells	GSE175716	ENSG00000150457	26524	large tumor suppressor kinase 2	NA	protein_coding	Q9NRM7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23853
1.60163962714183e-16	0.309222065268609	0.35	0.247	3.66054736783265e-12	LARS	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23854
1.61395252921454e-16	-0.262443098202063	0.241	0.378	3.68868850551983e-12	MIB1	Malignant cells	GSE175716	ENSG00000101752	57534	MIB E3 ubiquitin protein ligase 1	DIP-1|KIAA1323|MIB|ZZANK2|ZZZ6	protein_coding	Q86YT6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23855
1.66201140199402e-16	-0.305004163927486	0.162	0.287	3.79852705925734e-12	ZNF395	Malignant cells	GSE175716	ENSG00000186918	55893	zinc finger protein 395	DKFZp434K1210|HDBP2|PBF|PRF-1	protein_coding	Q9H8N7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23856
1.84797505251146e-16	0.25962539833763	0.294	0.191	4.22354698251494e-12	YY1AP1	Malignant cells	GSE175716	ENSG00000163374	55249	YY1 associated protein 1	HCCA2|YAP|YY1AP	protein_coding	Q9H869	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23857
2.02187452707029e-16	-0.48072823568516	0.624	0.667	4.62099423161914e-12	RB1CC1	Malignant cells	GSE175716	ENSG00000023287	9821	RB1 inducible coiled-coil 1	ATG17|Cc1|DRAGOU14|FIP200|KIAA0203|PPP1R131	protein_coding	Q8TDY2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23858
2.63673152921308e-16	-0.397102991860324	0.552	0.601	6.02624991001651e-12	SNRPA1	Malignant cells	GSE175716	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23859
2.72560459139384e-16	-0.251896547284022	0.482	0.589	6.22936929363063e-12	PNP	Malignant cells	GSE175716	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23860
2.81012416460991e-16	0.314561784175133	0.319	0.219	6.42253877821594e-12	VOPP1	Malignant cells	GSE175716	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23861
2.82882419484057e-16	-0.280594228915249	0.856	0.899	6.46527769730812e-12	CDV3	Malignant cells	GSE175716	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23862
3.0784958860509e-16	0.270791902325489	0.92	0.886	7.03590234756932e-12	ZFAS1	Malignant cells	GSE175716	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23863
3.18952066186303e-16	0.343965935149718	0.96	0.938	7.28964947268796e-12	CYB5A	Malignant cells	GSE175716	ENSG00000166347	1528	cytochrome b5 type A	CYB5	protein_coding	P00167	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23864
3.4962328085675e-16	0.31833585285438	0.661	0.542	7.99064008398102e-12	PLA2G16	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23865
3.50530290906542e-16	-0.321953073288611	0.491	0.587	8.01136979866902e-12	KLHL21	Malignant cells	GSE175716	ENSG00000162413	9903	kelch like family member 21	KIAA0469	protein_coding	Q9UJP4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23866
4.33313045293773e-16	0.36397709694968	0.397	0.306	9.90336965018919e-12	RPL26L1	Malignant cells	GSE175716	ENSG00000037241	51121	ribosomal protein L26 like 1	RPL26P1	protein_coding	Q9UNX3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23867
4.61270302604368e-16	-0.334642299406063	0.367	0.482	1.05423327660228e-11	GCC2	Malignant cells	GSE175716	ENSG00000135968	9648	GRIP and coiled-coil domain containing 2	GCC185|KIAA0336	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23868
5.26388445178084e-16	-0.254461669691818	0.709	0.758	1.20306079145451e-11	RTRAF	Malignant cells	GSE175716	ENSG00000087302	51637	RNA transcription, translation and transport factor	C14orf166|CGI-99|CLE|CLE7|hCLE1|LCRP369|RLLM1	protein_coding	Q9Y224	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23869
5.6083222609878e-16	-0.290182914130502	0.392	0.508	1.28178205274876e-11	PPM1A	Malignant cells	GSE175716	ENSG00000100614	5494	protein phosphatase, Mg2+/Mn2+ dependent 1A	MGC9201|PP2CA|PP2Calpha	protein_coding	P35813	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23870
5.81970020825678e-16	-0.309961439958537	0.535	0.608	1.33009248259709e-11	LAMTOR1	Malignant cells	GSE175716	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23871
6.93481503509354e-16	-0.991492952585817	0.541	0.548	1.58495197627063e-11	RPL10P16	Malignant cells	GSE175716	ENSG00000178464	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23872
6.99665099286178e-16	0.29228895458727	0.851	0.764	1.59908458441856e-11	AK3	Malignant cells	GSE175716	ENSG00000147853	50808	adenylate kinase 3	AK3L1|AK6|AKL3L1	protein_coding	Q9UIJ7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23873
7.39766507004285e-16	-0.423817104831559	0.185	0.297	1.69073635175829e-11	PAX8-AS1	Malignant cells	GSE175716	ENSG00000189223	654433	PAX8 antisense RNA 1	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23874
7.59725881082506e-16	0.324344493455369	0.738	0.632	1.73635350121407e-11	NOLC1	Malignant cells	GSE175716	ENSG00000166197	9221	nucleolar and coiled-body phosphoprotein 1	KIAA0035|NOPP130|NOPP140|P130|Srp40	protein_coding	Q14978	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23875
8.33003234727548e-16	-0.850766825966428	0.704	0.617	1.90382889296981e-11	NDUFC2	Malignant cells	GSE175716	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23876
8.45072482284171e-16	0.265530378641629	0.256	0.161	1.93141315826047e-11	AKAP8	Malignant cells	GSE175716	ENSG00000105127	10270	A-kinase anchoring protein 8	AKAP95|DKFZp586B1222	protein_coding	O43823	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23877
9.1988303077976e-16	-0.251323027851082	0.205	0.331	2.10239266684714e-11	AGPS	Malignant cells	GSE175716	ENSG00000018510	8540	alkylglycerone phosphate synthase	ADAP-S|ADAS|ADHAPS|ADPS|ALDHPSY	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23878
9.48780841306522e-16	-0.335708013248358	0.451	0.536	2.16843861280606e-11	PSMC3	Malignant cells	GSE175716	ENSG00000165916	5702	proteasome 26S subunit, ATPase 3	RPT5|TBP-1|TBP1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23879
1.05680113067812e-15	0.275177832538273	0.334	0.227	2.41531898416485e-11	NUP88	Malignant cells	GSE175716	ENSG00000108559	4927	nucleoporin 88	MGC8530	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23880
1.11361318431296e-15	-0.753045063722052	0.823	0.713	2.54516293274726e-11	NDUFB11	Malignant cells	GSE175716	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23881
1.19397474976734e-15	-0.64232872338589	0.728	0.673	2.72882929059324e-11	RPL10P9	Malignant cells	GSE175716	ENSG00000233913	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23882
1.28348704345218e-15	0.346413020061757	0.36	0.265	2.93340963780997e-11	CPNE1	Malignant cells	GSE175716	ENSG00000214078	8904	copine 1	CPN1	protein_coding	Q99829	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23883
1.55954585150262e-15	0.302399955999167	0.456	0.341	3.56434204360924e-11	VPS28	Malignant cells	GSE175716	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23884
1.75005553849602e-15	0.303299557934653	0.818	0.749	3.99975193323266e-11	NDUFA5	Malignant cells	GSE175716	ENSG00000128609	4698	NADH:ubiquinone oxidoreductase subunit A5	B13|CI-13kB|CI-13KD-B|NUFM|UQOR13	protein_coding	Q16718	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23885
1.87324388597604e-15	0.31100348588496	0.855	0.779	4.28129890139825e-11	SNRPF	Malignant cells	GSE175716	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23886
1.895427248088e-15	0.280764257707844	0.994	0.988	4.33199897550512e-11	ATP5G2	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23887
2.04018784175912e-15	-0.543987817868715	0.573	0.601	4.66284931234047e-11	APOB	Malignant cells	GSE175716	ENSG00000084674	338	apolipoprotein B	NA	protein_coding	P04114	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23888
2.13470634438055e-15	-0.275380995451977	0.498	0.597	4.87887135008175e-11	SLK	Malignant cells	GSE175716	ENSG00000065613	9748	STE20 like kinase	KIAA0204|se20-9|STK2	protein_coding	Q9H2G2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23889
2.21114156626431e-15	-0.33055297420128	0.407	0.513	5.05356404969709e-11	ZNF644	Malignant cells	GSE175716	ENSG00000122482	84146	zinc finger protein 644	BM-005|KIAA1221|MGC60165|MGC70410	protein_coding	Q9H582	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23890
2.37957643712163e-15	0.253360146683287	0.562	0.438	5.43852194704149e-11	BAG6	Malignant cells	GSE175716	ENSG00000229524	7917	BAG cochaperone 6	BAT3|D6S52E|G3|Scythe	protein_coding	P46379	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23891
2.5296077412217e-15	-0.266384837067637	0.347	0.473	5.7814184925622e-11	SPIN1	Malignant cells	GSE175716	ENSG00000106723	10927	spindlin 1	SPIN|TDRD24	protein_coding	Q9Y657	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23892
2.53740225057886e-15	0.350172145025809	0.384	0.294	5.79923284369799e-11	LTV1	Malignant cells	GSE175716	ENSG00000135521	84946	LTV1 ribosome biogenesis factor	C6orf93|dJ468K18.4|FLJ14909	protein_coding	Q96GA3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23893
2.90792081846e-15	-0.302820742319433	0.259	0.376	6.64605303059033e-11	CDC37	Malignant cells	GSE175716	ENSG00000105401	11140	cell division cycle 37, HSP90 cochaperone	P50CDC37	protein_coding	Q16543	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23894
3.46949381631201e-15	0.257368899867422	0.289	0.191	7.92952811718109e-11	SDF4	Malignant cells	GSE175716	ENSG00000078808	51150	stromal cell derived factor 4	Cab45	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23895
3.93166508608831e-15	0.304354219747774	0.337	0.235	8.98582055425484e-11	MAP3K5	Malignant cells	GSE175716	ENSG00000197442	4217	mitogen-activated protein kinase kinase kinase 5	ASK1|MAPKKK5|MEKK5	protein_coding	Q99683	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23896
4.85131741923848e-15	0.28935425845763	0.405	0.301	1.10876859616696e-10	HMGB1P5	Malignant cells	GSE175716	ENSG00000132967	NA	NA	HMG1L5|HMGB1L15|HMGB1L5|HMGB1P2	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23897
5.66870616690849e-15	-0.294289602612588	0.204	0.32	1.29558279444693e-10	GNB2	Malignant cells	GSE175716	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23898
5.7985870200528e-15	0.296390596004546	0.332	0.233	1.32526706343307e-10	TBRG4	Malignant cells	GSE175716	ENSG00000136270	9238	transforming growth factor beta regulator 4	Cpr2|FASTKD4|H_TD2522F11.8|KIAA0948	protein_coding	Q969Z0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23899
6.21016111912667e-15	-0.447320527739945	0.501	0.538	1.4193323237764e-10	CISD3	Malignant cells	GSE175716	ENSG00000274768	284106	CDGSH iron sulfur domain 3	Miner2|MiNT	protein_coding	P0C7P0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23900
6.26780718727857e-15	0.261154135035643	0.584	0.485	1.43250733265252e-10	SRSF1	Malignant cells	GSE175716	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23901
6.47727520756948e-15	0.251375651193264	0.253	0.159	1.48038124869001e-10	TOMM34	Malignant cells	GSE175716	ENSG00000025772	10953	translocase of outer mitochondrial membrane 34	HTOM34P|TOM34	protein_coding	Q15785	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23902
6.52971905912826e-15	-0.712570130088181	0.7	0.638	1.49236729096376e-10	BLVRB	Malignant cells	GSE175716	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23903
6.54778035443899e-15	-0.343238141074497	0.813	0.859	1.49649520000703e-10	PNRC2	Malignant cells	GSE175716	ENSG00000189266	55629	proline rich nuclear receptor coactivator 2	NA	protein_coding	Q9NPJ4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23904
6.81273629714919e-15	0.306570814230601	0.389	0.292	1.55705088071345e-10	MTPAP	Malignant cells	GSE175716	ENSG00000107951	55149	mitochondrial poly(A) polymerase	FLJ10486|PAPD1|SPAX4|TENT6	protein_coding	Q9NVV4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23905
7.71246845622929e-15	-0.266649447261724	0.395	0.511	1.7626846656712e-10	C6orf62	Malignant cells	GSE175716	ENSG00000112308	81688	chromosome 6 open reading frame 62	DKFZP564G182|FLJ12619|XTP12	protein_coding	Q9GZU0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23906
7.76089007335321e-15	-0.266458678668296	0.169	0.285	1.77375142626488e-10	EPC2	Malignant cells	GSE175716	ENSG00000135999	26122	enhancer of polycomb homolog 2	DKFZP566F2124	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23907
8.58382559919142e-15	0.31285357384298	0.485	0.387	1.9618333406952e-10	AL450405.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23908
9.00048800388506e-15	-0.261683037343262	0.523	0.618	2.05706153328793e-10	THOC2	Malignant cells	GSE175716	ENSG00000125676	57187	THO complex subunit 2	CXorf3|dJ506G2.1|MRX12|MRX35|THO2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23909
9.16233215708742e-15	0.295319214440928	0.307	0.211	2.09405101450233e-10	NFIA	Malignant cells	GSE175716	ENSG00000162599	4774	nuclear factor I A	KIAA1439|NFI-L	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23910
1.08604927195395e-14	0.252122003182863	0.715	0.602	2.48216561105075e-10	GORASP2	Malignant cells	GSE175716	ENSG00000115806	26003	golgi reassembly stacking protein 2	GOLPH6|GRASP55|GRS2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23911
1.15554275103166e-14	0.305602392684979	0.271	0.18	2.64099295748285e-10	MTTP	Malignant cells	GSE175716	ENSG00000138823	4547	microsomal triglyceride transfer protein	ABL|MTP	protein_coding	P55157	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23912
1.17323713418191e-14	0.374269197876843	0.361	0.267	2.68143347017275e-10	MCM6	Malignant cells	GSE175716	ENSG00000076003	4175	minichromosome maintenance complex component 6	Mis5	protein_coding	Q14566	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23913
1.54169792703302e-14	0.404876952999937	0.411	0.323	3.52355061223396e-10	FASN	Malignant cells	GSE175716	ENSG00000169710	2194	fatty acid synthase	FAS|SDR27X1	protein_coding	P49327	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23914
1.72347493877061e-14	0.254856871738607	0.269	0.175	3.93900197256022e-10	RPIA	Malignant cells	GSE175716	ENSG00000153574	22934	ribose 5-phosphate isomerase A	NA	protein_coding	P49247	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23915
1.81762641317096e-14	-0.267831259548843	0.584	0.645	4.15418516730224e-10	AUP1	Malignant cells	GSE175716	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23916
2.05681084582883e-14	0.328195299826262	0.446	0.344	4.70084118814179e-10	TRAPPC2L	Malignant cells	GSE175716	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23917
2.8822988299545e-14	-0.294253172860201	0.662	0.697	6.58749397586101e-10	BRIX1	Malignant cells	GSE175716	ENSG00000113460	55299	biogenesis of ribosomes BRX1	BRIX|BXDC2|FLJ11100	protein_coding	Q8TDN6	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23918
3.44911828059265e-14	0.310637606169498	0.862	0.783	7.88295983029449e-10	MKKS	Malignant cells	GSE175716	ENSG00000125863	8195	MKKS centrosomal shuttling protein	BBS6|HMCS|KMS|MKS	protein_coding	Q9NPJ1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23919
4.17329319275573e-14	0.273439100795007	0.977	0.948	9.53806159204323e-10	GAS5	Malignant cells	GSE175716	ENSG00000234741	60674	growth arrest specific 5	NCRNA00030|SNHG2	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23920
4.25373315612218e-14	-1.35476999269421	0.757	0.597	9.72190712831724e-10	TMEM176A	Malignant cells	GSE175716	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23921
4.25828583311201e-14	-0.284838240381152	0.688	0.743	9.73231227157751e-10	PNPLA8	Malignant cells	GSE175716	ENSG00000135241	50640	patatin like phospholipase domain containing 8	IPLA2-2|IPLA2G|iPLA2gamma	protein_coding	Q9NP80	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23922
4.46911976144388e-14	0.302892007518565	0.356	0.265	1.021417321478e-09	SLC25A33	Malignant cells	GSE175716	ENSG00000171612	84275	solute carrier family 25 member 33	BMSC-MCP|MGC4399|PNC1	protein_coding	Q9BSK2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23923
4.60021669639434e-14	-0.438917473290181	0.396	0.47	1.05137952596093e-09	RNF145	Malignant cells	GSE175716	ENSG00000145860	153830	ring finger protein 145	FLJ31951	protein_coding	Q96MT1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23924
4.92387121798416e-14	-0.350159856401713	0.611	0.64	1.12535076687028e-09	SEC13	Malignant cells	GSE175716	ENSG00000157020	6396	SEC13 homolog, nuclear pore and COPII coat complex component	D3S1231E|npp-20|SEC13L1|SEC13R	protein_coding	P55735	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23925
5.87291439117399e-14	0.303233495573789	0.757	0.668	1.34225458410282e-09	PSMD14	Malignant cells	GSE175716	ENSG00000115233	10213	proteasome 26S subunit, non-ATPase 14	pad1|POH1|Rpn11	protein_coding	O00487	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23926
5.87336412501135e-14	0.270768276637429	0.252	0.164	1.34235737077134e-09	NDUFAF8	Malignant cells	GSE175716	ENSG00000224877	284184	NADH:ubiquinone oxidoreductase complex assembly factor 8	C17orf89	protein_coding	A1L188	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23927
5.98273072770366e-14	0.258782068719925	0.363	0.263	1.36735310781667e-09	BOD1	Malignant cells	GSE175716	ENSG00000145919	91272	biorientation of chromosomes in cell division 1	FAM44B	protein_coding	Q96IK1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23928
6.07823480540586e-14	0.281139802653238	0.348	0.25	1.38918056477551e-09	PSPC1	Malignant cells	GSE175716	ENSG00000121390	55269	paraspeckle component 1	FLJ10955|PSP1	protein_coding	Q8WXF1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23929
6.22426948196488e-14	0.303301789940873	0.358	0.266	1.42255679010307e-09	COMMD3	Malignant cells	GSE175716	ENSG00000148444	23412	COMM domain containing 3	BUP|C10orf8	protein_coding	Q9UBI1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23930
7.09060598521873e-14	-0.407383523826291	0.473	0.523	1.62055799792174e-09	COMMD4	Malignant cells	GSE175716	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23931
8.00677828763291e-14	-0.273335278739352	0.612	0.68	1.8299491776385e-09	PAFAH1B1	Malignant cells	GSE175716	ENSG00000007168	5048	platelet activating factor acetylhydrolase 1b regulatory subunit 1	LIS1|MDCR|MDS|NudF|PAFAH	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23932
8.82943736524649e-14	-0.501952647151818	0.568	0.562	2.01796790982708e-09	RPL13AP25	Malignant cells	GSE175716	ENSG00000136149	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23933
9.0517994231744e-14	0.281611762639932	0.342	0.25	2.06878875816651e-09	ZNF787	Malignant cells	GSE175716	ENSG00000142409	126208	zinc finger protein 787	NA	protein_coding	Q6DD87	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23934
9.18783799466126e-14	-1.27236308031332	0.992	0.927	2.09988037367983e-09	RPL13AP5	Malignant cells	GSE175716	ENSG00000236552	728658	ribosomal protein L13a pseudogene 5	bA196N24.2	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23935
1.04807194894679e-13	-0.269464536537576	0.718	0.744	2.39536843931789e-09	SLC25A39	Malignant cells	GSE175716	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23936
1.05247440093176e-13	0.366023770298256	0.353	0.263	2.40543024332953e-09	ATAD2	Malignant cells	GSE175716	ENSG00000156802	29028	ATPase family AAA domain containing 2	ANCCA|CT137|DKFZp667N1320|MGC29843|MGC5254|PRO2000	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23937
1.14778463912558e-13	0.30756240512021	0.349	0.26	2.62326179272152e-09	CCNH	Malignant cells	GSE175716	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23938
1.16265804240415e-13	-0.269974914967101	0.284	0.405	2.65725495591467e-09	NMD3	Malignant cells	GSE175716	ENSG00000169251	51068	NMD3 ribosome export adaptor	CGI-07	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23939
1.1635724160801e-13	0.355829058950091	0.859	0.797	2.65934475695107e-09	RIDA	Malignant cells	GSE175716	ENSG00000132541	10247	reactive intermediate imine deaminase A homolog	HRSP12|P14.5|PSP|UK114	protein_coding	P52758	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23940
1.22130823822292e-13	-0.394451450706959	0.986	0.966	2.79129997845848e-09	COX7A2	Malignant cells	GSE175716	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23941
1.42993733786346e-13	-0.251977631109487	0.651	0.692	3.26812178568693e-09	COX17	Malignant cells	GSE175716	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23942
1.48172474150424e-13	-0.310796366926985	0.253	0.36	3.38648189670795e-09	LAGE3	Malignant cells	GSE175716	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23943
1.73260248306828e-13	-0.431674281779346	0.701	0.734	3.95986297505256e-09	STOM	Malignant cells	GSE175716	ENSG00000148175	2040	stomatin	BND7|EPB7|EPB72	protein_coding	P27105	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23944
2.01563485131893e-13	0.274994636376446	0.771	0.667	4.60673345268943e-09	CAPZA1	Malignant cells	GSE175716	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23945
2.16913100954954e-13	0.292929692482843	0.599	0.503	4.95754892232548e-09	RNPEP	Malignant cells	GSE175716	ENSG00000176393	6051	arginyl aminopeptidase	APB	protein_coding	Q9H4A4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23946
2.34847800890164e-13	0.352533433781146	0.457	0.38	5.3674464893447e-09	NIPSNAP2	Malignant cells	GSE175716	ENSG00000146729	2631	nipsnap homolog 2	GBAS	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23947
2.4176357528012e-13	-0.382383464235536	0.533	0.585	5.52550651302714e-09	EBLN3P	Malignant cells	GSE175716	ENSG00000281649	100506710	endogenous Bornavirus like nucleoprotein 3, pseudogene	EBLN3|LOC100506710	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23948
3.42532647873512e-13	0.256015996157372	0.944	0.918	7.82858366714912e-09	ASPH	Malignant cells	GSE175716	ENSG00000198363	444	aspartate beta-hydroxylase	BAH|CASQ2BP1|HAAH|JCTN	protein_coding	Q12797	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23949
3.58542150029834e-13	-0.282667282412935	0.217	0.337	8.19448083893186e-09	RSRP1	Malignant cells	GSE175716	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23950
3.94546448527206e-13	-0.325443895588235	0.247	0.348	9.01735908108929e-09	NAA10	Malignant cells	GSE175716	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23951
4.08360876067675e-13	-0.25922347653292	0.212	0.332	9.3330878225267e-09	SLC25A4	Malignant cells	GSE175716	ENSG00000151729	291	solute carrier family 25 member 4	AAC1|ANT1|PEO2|PEO3|T1	protein_coding	P12235	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23952
4.18727025712079e-13	-0.263887408825067	0.992	0.99	9.57000617264956e-09	AC116533.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23953
4.33297315808301e-13	-0.514742469810425	0.43	0.502	9.90301015279872e-09	SLC25A37	Malignant cells	GSE175716	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23954
4.43119123773152e-13	-0.369533975608316	0.403	0.482	1.01274875738354e-08	CWC22	Malignant cells	GSE175716	ENSG00000163510	57703	CWC22 spliceosome associated protein homolog	EIF4GL|fSAPb|KIAA1604|NCM	protein_coding	Q9HCG8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23955
4.54259455879374e-13	-0.663040311923412	0.597	0.555	1.03820998641231e-08	COPE	Malignant cells	GSE175716	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23956
5.73414354041083e-13	-0.316079812950231	0.836	0.827	1.3105385061609e-08	PSMA4	Malignant cells	GSE175716	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23957
6.44849973908263e-13	0.270010581042806	0.355	0.262	1.47380461536734e-08	HINT3	Malignant cells	GSE175716	ENSG00000111911	135114	histidine triad nucleotide binding protein 3	FLJ33126|HINT4	protein_coding	Q9NQE9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23958
7.10770512845091e-13	0.301749298030926	0.307	0.219	1.62446600710746e-08	ZYG11B	Malignant cells	GSE175716	ENSG00000162378	79699	zyg-11 family member B, cell cycle regulator	FLJ13456|ZYG11	protein_coding	Q9C0D3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23959
7.50669305336965e-13	0.268699896296199	0.807	0.679	1.71565469734763e-08	HIGD1A	Malignant cells	GSE175716	ENSG00000181061	25994	HIG1 hypoxia inducible domain family member 1A	DKFZP564K247|HIG1|RCF1A	protein_coding	Q9Y241	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23960
7.77559290991367e-13	0.32424623363172	0.4	0.317	1.77711175956077e-08	TAF12	Malignant cells	GSE175716	ENSG00000120656	6883	TATA-box binding protein associated factor 12	TAF2J|TAFII20	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23961
7.78005620360579e-13	0.28009211802775	0.897	0.807	1.7781318453341e-08	NDUFB1	Malignant cells	GSE175716	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23962
9.59687843463789e-13	-0.375968068064466	0.73	0.723	2.19336656623649e-08	COX14	Malignant cells	GSE175716	ENSG00000178449	84987	cytochrome c oxidase assembly factor COX14	C12orf62|MGC14288	protein_coding	Q96I36	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23963
1.08688134952807e-12	0.264702428442132	0.909	0.842	2.48406732434641e-08	SYNCRIP	Malignant cells	GSE175716	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23964
1.18662243568887e-12	0.329534838591147	0.43	0.352	2.71202557676691e-08	MAGEA3	Malignant cells	GSE175716	ENSG00000221867	4102	MAGE family member A3	CT1.3|HIP8|HYPD|MAGE3|MGC14613	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23965
1.2429422111516e-12	0.299227181404512	0.348	0.258	2.84074442358698e-08	SMYD2	Malignant cells	GSE175716	ENSG00000143499	56950	SET and MYND domain containing 2	HSKM-B|KMT3C|ZMYND14	protein_coding	Q9NRG4	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23966
1.2577158687339e-12	-0.372949567153475	0.606	0.622	2.87450961799133e-08	DAP	Malignant cells	GSE175716	ENSG00000112977	1611	death associated protein	DAP1	protein_coding	P51397	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23967
1.46080783450068e-12	-0.264050081423264	0.243	0.351	3.33867630575131e-08	EIF4EBP1	Malignant cells	GSE175716	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23968
1.57274292939135e-12	0.358520411166429	0.416	0.34	3.59450396512393e-08	GID8	Malignant cells	GSE175716	ENSG00000101193	54994	GID complex subunit 8 homolog	bA305P22.1|C20orf11|FLJ20602|TWA1	protein_coding	Q9NWU2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23969
1.70776035845454e-12	-0.272598506089826	0.643	0.687	3.90308629924784e-08	VPS29	Malignant cells	GSE175716	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23970
1.80062806142258e-12	-0.303681216683853	0.236	0.332	4.1153354343813e-08	FBXW5	Malignant cells	GSE175716	ENSG00000159069	54461	F-box and WD repeat domain containing 5	DKFZP434B205|Fbw5|MGC20962	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23971
1.86421731400127e-12	0.30964982190556	0.823	0.753	4.26066867114991e-08	PPP2CA	Malignant cells	GSE175716	ENSG00000113575	5515	protein phosphatase 2 catalytic subunit alpha	PP2AC|PP2Calpha	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23972
2.69268794912246e-12	0.272624465008524	0.324	0.235	6.15413830771939e-08	GMPS	Malignant cells	GSE175716	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23973
2.76728555326862e-12	-0.376815169101667	0.867	0.832	6.32463113199544e-08	SRP9	Malignant cells	GSE175716	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23974
2.84634470404973e-12	-0.343492624448369	0.773	0.752	6.50532082110565e-08	PSMD8	Malignant cells	GSE175716	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23975
2.88710941627114e-12	0.302122034362421	0.414	0.335	6.5984885708877e-08	HSP90AB3P	Malignant cells	GSE175716	ENSG00000183199	NA	NA	HSPCP1	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23976
2.95302496501654e-12	0.346321799962511	0.405	0.337	6.74913855754529e-08	SDCCAG3	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23977
3.24476224210114e-12	0.26676742135857	0.301	0.215	7.41590410432215e-08	BRCC3	Malignant cells	GSE175716	ENSG00000185515	79184	BRCA1/BRCA2-containing complex subunit 3	BRCC36|C6.1A|CXorf53	protein_coding	P46736	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23978
3.63021224847264e-12	-0.413089192320961	0.481	0.539	8.29685009388423e-08	SKIL	Malignant cells	GSE175716	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23979
3.72273415714047e-12	-0.598507132441231	0.8	0.715	8.50830891614455e-08	NAXE	Malignant cells	GSE175716	ENSG00000163382	128240	NAD(P)HX epimerase	AIBP|APOA1BP|MGC119143|MGC119144|MGC119145|YJEFN1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23980
4.64300728810798e-12	-0.509309775666404	0.961	0.958	1.06115931569708e-07	DDX5	Malignant cells	GSE175716	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23981
5.64852248621424e-12	0.439513599619168	0.424	0.361	1.29096981422426e-07	PNPLA2	Malignant cells	GSE175716	ENSG00000177666	57104	patatin like phospholipase domain containing 2	ATGL|desnutrin|FP17548|iPLA2zeta|TTS-2.2	protein_coding	Q96AD5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23982
6.12260282305349e-12	-0.882778043470176	0.735	0.607	1.39932087520887e-07	CIB1	Malignant cells	GSE175716	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23983
6.65171263220714e-12	0.260313404152634	0.325	0.241	1.52024892209094e-07	PSPHP1	Malignant cells	GSE175716	ENSG00000226278	NA	NA	CO9|PSPHL	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23984
6.94625458024289e-12	0.275127696512998	0.975	0.967	1.58756648431451e-07	PTP4A2	Malignant cells	GSE175716	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23985
9.97494431059913e-12	0.258311213118689	0.349	0.265	2.27977352218743e-07	IGF2R	Malignant cells	GSE175716	ENSG00000197081	3482	insulin like growth factor 2 receptor	CD222|CI-M6PR|CI-MPR|CIMPR|M6P-R|MPR1|MPR300|MPRI	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23986
1.09178557965583e-11	-0.348523005112353	0.793	0.794	2.49527594230339e-07	YWHAH	Malignant cells	GSE175716	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23987
1.23649119575102e-11	0.367147621216445	0.43	0.365	2.82600062788895e-07	DMAC1	Malignant cells	GSE175716	ENSG00000137038	90871	distal membrane arm assembly component 1	C9orf123|MGC4730|TMEM261	protein_coding	Q96GE9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23988
1.46407471067728e-11	0.311481436509152	0.407	0.33	3.34614275125293e-07	NEK6	Malignant cells	GSE175716	ENSG00000119408	10783	NIMA related kinase 6	SID6-1512	protein_coding	Q9HC98	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23989
1.53177661456444e-11	0.261716005097892	0.826	0.704	3.50087545258702e-07	PARP1	Malignant cells	GSE175716	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23990
1.57832682163715e-11	-0.264568003997404	0.469	0.554	3.60726595085171e-07	FOSL2	Malignant cells	GSE175716	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23991
1.87832948329924e-11	-0.403099897430309	0.682	0.701	4.29292203408041e-07	AC131235.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23992
2.05352422933521e-11	-0.344249935145358	0.41	0.484	4.69332962614563e-07	CDH1	Malignant cells	GSE175716	ENSG00000039068	999	cadherin 1	CD324|UVO|uvomorulin	protein_coding	P12830	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23993
2.06415903483235e-11	-1.20964175247273	0.534	0.523	4.71763547410934e-07	EREG	Malignant cells	GSE175716	ENSG00000124882	2069	epiregulin	ER	protein_coding	O14944	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23994
2.5276307589663e-11	-0.288283628362387	0.236	0.326	5.77690009961748e-07	MRPL12	Malignant cells	GSE175716	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23995
2.83411516438074e-11	-0.25904555710075	0.49	0.564	6.47737020819217e-07	PPP4R3A	Malignant cells	GSE175716	ENSG00000100796	55671	protein phosphatase 4 regulatory subunit 3A	FLFL1|FLJ20707|KIAA2010|MSTP033|PP4R3|SMEK1|smk-1|smk1	protein_coding	Q6IN85	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23996
3.02220309913729e-11	0.297043375107995	0.39	0.314	6.90724518307827e-07	AL355032.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23997
3.20660484617786e-11	-0.584781812080421	0.952	0.992	7.3286953759395e-07	GC	Malignant cells	GSE175716	ENSG00000145321	2638	GC vitamin D binding protein	DBP|hDBP|VDBP	protein_coding	P02774	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23998
3.22630057110507e-11	0.275119480813114	0.59	0.516	7.37370995526063e-07	EIF4EBP2	Malignant cells	GSE175716	ENSG00000148730	1979	eukaryotic translation initiation factor 4E binding protein 2	NA	protein_coding	Q13542	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	23999
3.46465476543563e-11	0.300568004256612	0.384	0.309	7.91846846640313e-07	MGEA5	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24000
3.51130584919679e-11	-0.453869796710877	0.966	0.924	8.02508951833926e-07	SLC25A5	Malignant cells	GSE175716	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24001
3.97153419283291e-11	0.25070395472617	0.3	0.218	9.07694139771962e-07	HAGH	Malignant cells	GSE175716	ENSG00000063854	3029	hydroxyacylglutathione hydrolase	GLO2|GLXII|HAGH1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24002
4.31134910096653e-11	-0.276746598531649	0.549	0.605	9.85358837025901e-07	ZHX1	Malignant cells	GSE175716	ENSG00000165156	11244	zinc fingers and homeoboxes 1	NA	protein_coding	Q9UKY1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24003
4.36294159592218e-11	-1.13032839972419	0.811	0.619	9.97150301748014e-07	POLR2L	Malignant cells	GSE175716	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24004
4.8187057286067e-11	-0.294080449003212	0.608	0.65	1.10131519427306e-06	LARP4	Malignant cells	GSE175716	ENSG00000161813	113251	La ribonucleoprotein 4	PP13296	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24005
5.07431361757499e-11	-0.424452676175684	0.73	0.731	1.15973437729676e-06	RSRC2	Malignant cells	GSE175716	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24006
5.85054650133993e-11	-0.318249501556769	0.562	0.621	1.33714240288124e-06	SRF	Malignant cells	GSE175716	ENSG00000112658	6722	serum response factor	MCM1	protein_coding	P11831	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24007
6.64807292554647e-11	0.279492262047867	0.297	0.219	1.51941706713365e-06	ZYX	Malignant cells	GSE175716	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24008
6.9923804848536e-11	-0.491375567183487	0.523	0.55	1.59810855981329e-06	SERTAD2	Malignant cells	GSE175716	ENSG00000179833	9792	SERTA domain containing 2	KIAA0127|Sei-2|TRIP-Br2	protein_coding	Q14140	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24009
7.08091100077485e-11	0.311402010265808	0.351	0.272	1.61834220922709e-06	LAMB1	Malignant cells	GSE175716	ENSG00000091136	3912	laminin subunit beta 1	CLM	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24010
9.99238069838779e-11	-0.27628246199811	0.496	0.563	2.28375860861653e-06	CHD2	Malignant cells	GSE175716	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24011
1.38840384258144e-10	-0.40215569091964	0.404	0.471	3.17319698221987e-06	CBX4	Malignant cells	GSE175716	ENSG00000141582	8535	chromobox 4	hPC2|NBP16|PC2	protein_coding	O00257	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24012
1.53386705499881e-10	0.272690075168263	0.639	0.563	3.50565315419977e-06	CAMLG	Malignant cells	GSE175716	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24013
1.54725691896321e-10	-0.305177087554562	0.277	0.362	3.53625568829042e-06	ISOC2	Malignant cells	GSE175716	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24014
1.60362801834268e-10	0.261124653248517	0.292	0.217	3.66509183592221e-06	WDR5	Malignant cells	GSE175716	ENSG00000196363	11091	WD repeat domain 5	CFAP89|SWD3	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24015
1.67049593918289e-10	-0.453174049608353	0.73	0.686	3.81791846900249e-06	RPS2P5	Malignant cells	GSE175716	ENSG00000240342	NA	NA	bcm384	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24016
1.76982544287891e-10	-0.27466201956627	0.741	0.765	4.04493604969976e-06	SHMT2	Malignant cells	GSE175716	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24017
1.84294801106017e-10	0.369077212935883	0.445	0.4	4.21205767927801e-06	LAMC1	Malignant cells	GSE175716	ENSG00000135862	3915	laminin subunit gamma 1	LAMB2	protein_coding	P11047	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24018
2.01990793032809e-10	-0.275428887975252	0.718	0.499	4.61649957476485e-06	SOX4	Malignant cells	GSE175716	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24019
2.37316491676752e-10	-0.841449374442252	0.507	0.519	5.42386841727218e-06	DNAJB4	Malignant cells	GSE175716	ENSG00000162616	11080	DnaJ heat shock protein family (Hsp40) member B4	HLJ1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24020
2.40441210629281e-10	-0.419904657661604	0.573	0.609	5.49528386893221e-06	AKAP9	Malignant cells	GSE175716	ENSG00000127914	10142	A-kinase anchoring protein 9	AKAP350|AKAP450|CG-NAP|HYPERION|KIAA0803|LQT11|MU-RMS-40.16A|PPP1R45|PRKA9|YOTIAO	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24021
2.53706478160324e-10	-0.513577132210424	0.648	0.612	5.79846155835421e-06	PSME2	Malignant cells	GSE175716	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24022
2.87506177176435e-10	-0.272603681100939	0.495	0.546	6.57095367936743e-06	TRAPPC4	Malignant cells	GSE175716	ENSG00000280495	51399	trafficking protein particle complex subunit 4	PTD009|SBDN|TRS23	protein_coding	Q9Y296	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24023
2.97361488488013e-10	-0.406864625345224	0.609	0.626	6.79619681939354e-06	FNDC3B	Malignant cells	GSE175716	ENSG00000075420	64778	fibronectin type III domain containing 3B	DKFZp762K137|FAD104|FLJ23399|PRO4979|YVTM2421	protein_coding	Q53EP0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24024
3.15257196825793e-10	-0.293071599500479	0.901	0.88	7.20520323345349e-06	Z74021.1	Malignant cells	GSE175716	NA	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24025
3.18443850750435e-10	0.256496599415499	0.678	0.597	7.27803420890119e-06	BUB3	Malignant cells	GSE175716	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24026
3.31354472935893e-10	0.429624760538249	0.26	0.186	7.57310647894984e-06	PTTG1	Malignant cells	GSE175716	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24027
3.78071200399012e-10	0.269149472550414	0.933	0.904	8.64081728511941e-06	ENAH	Malignant cells	GSE175716	ENSG00000154380	55740	ENAH actin regulator	FLJ10773|MENA|NDPP1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24028
7.51037953041691e-10	-0.351798457261572	0.522	0.552	1.71649724167679e-05	RRBP1	Malignant cells	GSE175716	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24029
9.38597037494129e-10	0.268675786157506	0.347	0.279	2.14516352919283e-05	RAD23A	Malignant cells	GSE175716	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24030
1.05822089673128e-09	0.303118445014746	0.413	0.347	2.41856385947934e-05	AKIRIN2	Malignant cells	GSE175716	ENSG00000135334	55122	akirin 2	C6orf166|dJ486L4.2|FLJ10342	protein_coding	Q53H80	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24031
1.13665590647695e-09	0.285422576099692	0.882	0.814	2.59782707425307e-05	SRP72	Malignant cells	GSE175716	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24032
1.23301664421977e-09	-0.276962059424198	0.343	0.431	2.81805954036428e-05	ARL6IP6	Malignant cells	GSE175716	ENSG00000177917	151188	ADP ribosylation factor like GTPase 6 interacting protein 6	MGC33864	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24033
1.33459679758872e-09	-0.256613859784042	0.511	0.574	3.05022098088901e-05	CREBBP	Malignant cells	GSE175716	ENSG00000005339	1387	CREB binding protein	CBP|KAT3A|RSTS|RTS	protein_coding	Q92793	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24034
1.50882678144157e-09	-0.294496390111317	0.65	0.657	3.44842360898471e-05	PMVK	Malignant cells	GSE175716	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24035
1.92579237010316e-09	-0.332467498191482	0.746	0.756	4.40139846187077e-05	TXNP6	Malignant cells	GSE175716	ENSG00000234036	NA	NA	NA	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24036
1.95340970890104e-09	0.258874922725694	0.33	0.26	4.46451788969333e-05	MTX2	Malignant cells	GSE175716	ENSG00000128654	10651	metaxin 2	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24037
2.02342689289534e-09	0.431427165467727	0.73	0.68	4.62454216371229e-05	KYNU	Malignant cells	GSE175716	ENSG00000115919	8942	kynureninase	NA	protein_coding	Q16719	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24038
2.42008761439231e-09	-1.26006552334737	0.996	0.935	5.53111024269361e-05	SERF2	Malignant cells	GSE175716	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24039
2.61654519823679e-09	-0.397152741792014	0.476	0.523	5.98011405057019e-05	DUSP14	Malignant cells	GSE175716	ENSG00000275932	11072	dual specificity phosphatase 14	MKP-L|MKP6	protein_coding	O95147	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24040
2.69815239435929e-09	-0.388010710128021	0.765	0.74	6.16662729730817e-05	SERINC1	Malignant cells	GSE175716	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24041
4.29178324049308e-09	-0.275288728204724	0.711	0.723	9.80887059614694e-05	SOWAHC	Malignant cells	GSE175716	ENSG00000198142	65124	sosondowah ankyrin repeat domain family member C	ANKRD57|C2orf26|FLJ21870	protein_coding	Q53LP3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24042
4.90860723407112e-09	0.288872806824366	0.366	0.305	0.000112186218334695	RHBDD2	Malignant cells	GSE175716	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24043
5.04579486883747e-09	0.302980491346878	0.416	0.364	0.00011532164172728	CHCHD3	Malignant cells	GSE175716	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24044
5.15299970690038e-09	-0.266044575548306	0.627	0.652	0.000117771808301208	BPTF	Malignant cells	GSE175716	ENSG00000171634	2186	bromodomain PHD finger transcription factor	FAC1|FALZ|NURF301	protein_coding	Q12830	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24045
5.2976043730446e-09	-0.436605569382666	0.918	0.668	0.000121076747945934	MYC	Malignant cells	GSE175716	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24046
5.76919785202984e-09	-0.34551394684543	0.621	0.609	0.000131855016908142	NUDC	Malignant cells	GSE175716	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24047
6.26628397874641e-09	0.321674194394882	0.447	0.403	0.000143215920334249	TNPO3	Malignant cells	GSE175716	ENSG00000064419	23534	transportin 3	IPO12|LGMD1F|MTR10A|TRN-SR|TRN-SR2	protein_coding	Q9Y5L0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24048
6.36980628890328e-09	-1.12810835014724	0.771	0.592	0.000145581922732884	TMEM176B	Malignant cells	GSE175716	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24049
7.02036010985999e-09	-0.375707022424185	0.853	0.781	0.00016045033031085	PSMB3	Malignant cells	GSE175716	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24050
7.13301512708687e-09	-0.358274288544697	0.437	0.49	0.000163025060729571	CEBPD	Malignant cells	GSE175716	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24051
7.15609219085022e-09	0.327958200757475	0.433	0.383	0.000163552487021882	NDUFV3	Malignant cells	GSE175716	ENSG00000160194	4731	NADH:ubiquinone oxidoreductase subunit V3	CI-10k	protein_coding	P56181	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24052
7.99531062830851e-09	0.270825530302996	0.275	0.208	0.000182732824409991	CCDC34	Malignant cells	GSE175716	ENSG00000109881	91057	coiled-coil domain containing 34	L15|NY-REN-41|RAMA3	protein_coding	Q96HJ3	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24053
1.15300080839629e-08	-0.729634344918624	0.692	0.579	0.000263518334758971	AURKAIP1	Malignant cells	GSE175716	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24054
1.33731277101731e-08	0.258307785293746	0.881	0.821	0.000305642833816006	EZR	Malignant cells	GSE175716	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24055
1.3527685805455e-08	-0.312036437790051	0.456	0.494	0.000309175259083674	GSTA4	Malignant cells	GSE175716	ENSG00000170899	2941	glutathione S-transferase alpha 4	NA	protein_coding	O15217	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24056
1.37274826211826e-08	-0.368376943050213	0.504	0.536	0.000313741615307128	NBR1	Malignant cells	GSE175716	ENSG00000188554	4077	NBR1 autophagy cargo receptor	1A1-3B|CA125|KIAA0049|M17S2	protein_coding	Q14596	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24057
1.60001111968509e-08	-0.268779408185396	0.423	0.484	0.000365682541404028	SMIM30	Malignant cells	GSE175716	ENSG00000214194	401397	small integral membrane protein 30	LINC00998	protein_coding	A4D0T7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24058
2.63091792464125e-08	-0.348216758101237	0.926	0.866	0.000601296291676758	MRPS21	Malignant cells	GSE175716	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24059
2.69719788485166e-08	0.340683606808954	0.406	0.351	0.000616444576582847	RRM1	Malignant cells	GSE175716	ENSG00000167325	6240	ribonucleotide reductase catalytic subunit M1	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24060
3.02027353920183e-08	-0.332201187824415	0.403	0.445	0.000690283517384579	TNIP1	Malignant cells	GSE175716	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24061
3.81917825117696e-08	0.399154234960291	0.356	0.301	0.000872873189306495	NABP1	Malignant cells	GSE175716	ENSG00000173559	64859	nucleic acid binding protein 1	DKFZp667M1322|FLJ13624|FLJ22833|hSSB2|MGC111163|NABP1-OT1|OBFC2A|SOSS-B2|SSB2	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24062
4.29542712398851e-08	0.264438709676068	0.413	0.355	0.000981719869187574	GGPS1	Malignant cells	GSE175716	ENSG00000152904	9453	geranylgeranyl diphosphate synthase 1	GGPPS1	protein_coding	O95749	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24063
4.48112969959087e-08	-0.327602538538376	0.965	0.751	0.00102416219284149	CAV1	Malignant cells	GSE175716	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24064
4.81613204637399e-08	-0.307617753883274	0.66	0.672	0.00110072697919877	JAK1	Malignant cells	GSE175716	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24065
4.9692993931366e-08	-0.871399244880152	0.882	0.741	0.00113573337630137	ZFP36	Malignant cells	GSE175716	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24066
5.80199479252352e-08	0.295292072920726	0.296	0.238	0.00132604590983125	RABEPK	Malignant cells	GSE175716	ENSG00000136933	10244	Rab9 effector protein with kelch motifs	bA65N13.1|RAB9P40	protein_coding	Q7Z6M1	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24067
5.89707655576456e-08	-0.285144216677691	0.597	0.617	0.00134777684681999	GOLT1A	Malignant cells	GSE175716	ENSG00000174567	127845	golgi transport 1A	CGI-141|FLJ42654|GOT1|MGC62027|YMR292W	protein_coding	Q6ZVE7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24068
6.54548084065384e-08	-0.290043639528649	0.267	0.335	0.00149596964613144	PPP1R16A	Malignant cells	GSE175716	ENSG00000160972	84988	protein phosphatase 1 regulatory subunit 16A	MGC14333|MYPT3	protein_coding	Q96I34	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24069
6.76137516545186e-08	-0.357337379137839	0.341	0.414	0.00154531229406402	PLPP3	Malignant cells	GSE175716	ENSG00000162407	8613	phospholipid phosphatase 3	LPP3|PAP-2b|PPAP2B	protein_coding	O14495	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24070
6.78875077317229e-08	0.255148028852902	0.387	0.333	0.00155156898920853	BTF3L4	Malignant cells	GSE175716	ENSG00000134717	91408	basic transcription factor 3 like 4	MGC23908	protein_coding	Q96K17	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24071
7.42194573850681e-08	-0.286950763070623	0.834	0.805	0.00169628569853573	SF3B1	Malignant cells	GSE175716	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24072
7.50124874031437e-08	0.278645626573985	0.418	0.367	0.00171441039959885	C8orf33	Malignant cells	GSE175716	ENSG00000182307	65265	chromosome 8 open reading frame 33	FLJ20989	protein_coding	Q9H7E9	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24073
7.54520509635403e-08	0.275528576209353	0.455	0.406	0.00172445662477171	CHRAC1	Malignant cells	GSE175716	ENSG00000104472	54108	chromatin accessibility complex subunit 1	CHRAC15|YCL1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24074
9.78494492150981e-08	-0.983684009823872	0.984	0.86	0.00223634916181107	FAU	Malignant cells	GSE175716	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24075
1.07006260458553e-07	-0.267071979626757	0.579	0.603	0.00244562808278022	FLOT1	Malignant cells	GSE175716	ENSG00000223654	10211	flotillin 1	NA	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24076
1.0704085416981e-07	-0.554680666705531	0.905	0.775	0.00244641872205102	ROMO1	Malignant cells	GSE175716	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24077
1.92450372495565e-07	0.251690181874319	0.255	0.193	0.00439845326338614	TYMS	Malignant cells	GSE175716	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24078
1.93639882094151e-07	-0.423602489851935	0.732	0.725	0.00442563950526182	CKS2	Malignant cells	GSE175716	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24079
1.97068906846755e-07	-0.328086825195725	0.456	0.502	0.00450400986598258	TSC22D2	Malignant cells	GSE175716	ENSG00000196428	9819	TSC22 domain family member 2	KIAA0669|TILZ4a|TILZ4b|TILZ4c	protein_coding	O75157	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24080
2.77485153875042e-07	-0.576473033549026	0.599	0.588	0.0063419231918141	WEE1	Malignant cells	GSE175716	ENSG00000166483	7465	WEE1 G2 checkpoint kinase	WEE1A	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24081
3.39020175780736e-07	0.316886328284786	0.416	0.375	0.00774830611746872	FLOT2	Malignant cells	GSE175716	ENSG00000132589	2319	flotillin 2	ECS-1|ECS1|ESA|ESA1|M17S1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24082
3.85375590228943e-07	-0.369492023361982	0.782	0.705	0.00880775911468249	HIGD2A	Malignant cells	GSE175716	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24083
3.97219672495912e-07	0.261350729247499	0.479	0.444	0.00907845561489407	PGRMC2	Malignant cells	GSE175716	ENSG00000164040	10424	progesterone receptor membrane component 2	DG6|PMBP	protein_coding	O15173	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24084
4.03620234244471e-07	0.25097856688422	0.326	0.266	0.00922474045365739	ABLIM1	Malignant cells	GSE175716	ENSG00000099204	3983	actin binding LIM protein 1	ABLIM|LIMAB1|limatin	protein_coding	O14639	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24085
5.78790321710639e-07	-0.988604928646727	0.871	0.654	0.0132282528026967	EDF1	Malignant cells	GSE175716	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24086
5.87507429366418e-07	0.27001622558494	0.386	0.338	0.0134274822981695	NUDCD2	Malignant cells	GSE175716	ENSG00000170584	134492	NudC domain containing 2	DKFZp686E10109|NudCL2	protein_coding	Q8WVJ2	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24087
6.18063009019147e-07	-0.583532813622562	0.947	0.774	0.0141258300711326	RHOB	Malignant cells	GSE175716	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24088
7.20376464777177e-07	-0.926985605953869	0.827	0.608	0.0164642041024824	SSR4	Malignant cells	GSE175716	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24089
7.58686941934441e-07	-0.515718440624293	0.66	0.638	0.0173397900579116	ITGAV	Malignant cells	GSE175716	ENSG00000138448	3685	integrin subunit alpha V	CD51|MSK8|VNRA|VTNR	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24090
7.84383400825466e-07	-0.392073332669728	0.877	0.852	0.017927082625866	GSTA1	Malignant cells	GSE175716	ENSG00000243955	2938	glutathione S-transferase alpha 1	NA	protein_coding	P08263	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24091
8.69113389817864e-07	0.264799137972477	0.397	0.357	0.0198635865242873	PMPCB	Malignant cells	GSE175716	ENSG00000105819	9512	peptidase, mitochondrial processing subunit beta	beta-MPP|MAS1|MPPB|MPPP52	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24092
9.41829384620948e-07	-0.997543860934227	0.85	0.851	0.0215255105855118	CXCL8	Malignant cells	GSE175716	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24093
9.57810916103868e-07	-0.262017256563935	0.638	0.651	0.0218907684875539	PAWR	Malignant cells	GSE175716	ENSG00000177425	5074	pro-apoptotic WT1 regulator	par-4|PAR4	protein_coding	Q96IZ0	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24094
9.8775816293047e-07	-1.2353616495358	0.88	0.605	0.0225752128137759	RPL18AP3	Malignant cells	GSE175716	ENSG00000213442	NA	NA	bcm182	NA	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24095
1.14248507639823e-06	0.288316038140817	0.377	0.328	0.0261114964210815	LARP4B	Malignant cells	GSE175716	ENSG00000107929	23185	La ribonucleoprotein 4B	KIAA0217|LARP5	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24096
1.59482712534679e-06	0.253312074378953	0.489	0.442	0.036449773949801	DDX46	Malignant cells	GSE175716	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24097
1.64600963943447e-06	-0.280583871081658	0.54	0.561	0.0376195503092748	TBL1XR1	Malignant cells	GSE175716	ENSG00000177565	79718	TBL1X/Y related 1	C21|DC42|FLJ12894|IRA1|TBLR1	protein_coding	Q9BZK7	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24098
2.06072068551089e-06	-0.352428761461025	0.402	0.435	0.0470977712673514	TNFAIP6	Malignant cells	GSE175716	ENSG00000123610	7130	TNF alpha induced protein 6	TSG-6|TSG6	protein_coding	P98066	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24099
2.10463261372453e-06	0.267938622157145	0.395	0.349	0.0481013783866742	PRKDC	Malignant cells	GSE175716	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE175716	GSE175716	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	NA	sorafenib	Homo sapiens	PDX	Tumor tissue	resistant 1, sensitive 2	3	6823	Public on Aug 24, 2021	34421602	This dataset has 3 PDX.	PRJNA733283	BD Rhapsody system	NovelBio Bio-Pharm Technology Co., Ltd.	Liver_cancer	Targeted_therapy	24100
0	-0.898322020508143	0	0.52	0	AB019441.29	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24101
0	-1.96177720981511	0.007	0.838	0	ABCF1	Malignant cells	GSE186960	ENSG00000225989	23	ATP binding cassette subfamily F member 1	ABC50|EST123147	protein_coding	Q8NE71	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24102
0	-0.579440216310113	0	0.377	0	ABT1	Malignant cells	GSE186960	ENSG00000146109	29777	activator of basal transcription 1	Esf2	protein_coding	Q9ULW3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24103
0	-1.39892065224939	0.056	0.696	0	AC004453.8	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24104
0	-0.523022664402529	0	0.34	0	AC011998.4	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24105
0	-0.624171825119521	0.004	0.39	0	AC012354.8	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24106
0	-1.37706058809598	0.072	0.689	0	AC016739.2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24107
0	-0.423281493373752	0	0.287	0	AC018463.5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24108
0	-2.05276266087355	0	0.788	0	AC073325.2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24109
0	-1.04317895464079	0.001	0.577	0	AC092610.12	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24110
0	-0.536274427366567	0.001	0.348	0	AC098828.3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24111
0	-4.80454711520186	0	0.997	0	ACTG1	Malignant cells	GSE186960	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24112
0	-0.678330244273663	0	0.413	0	AMZ2	Malignant cells	GSE186960	ENSG00000196704	51321	archaelysin family metallopeptidase 2	NA	protein_coding	Q86W34	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24113
0	-0.806713389267751	0.012	0.474	0	ANXA2P2	Malignant cells	GSE186960	ENSG00000231991	NA	NA	ANX2L2|ANX2P2|LPC2B	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24114
0	-0.401539714219686	0	0.262	0	APH1A	Malignant cells	GSE186960	ENSG00000117362	51107	aph-1 homolog A, gamma-secretase subunit	APH-1A|CGI-78	protein_coding	Q96BI3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24115
0	-0.714048656774654	0	0.446	0	ARCN1	Malignant cells	GSE186960	ENSG00000095139	372	archain 1	COPD	protein_coding	P48444	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24116
0	-0.758179523074563	0	0.456	0	ATP5C1P1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24117
0	-3.49836061016826	0	0.973	0	ATP5L	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24118
0	-0.979181528492446	0	0.54	0	ATP6AP1	Malignant cells	GSE186960	ENSG00000071553	537	ATPase H+ transporting accessory protein 1	16A|Ac45|ATP6IP1|ATP6S1|CF2|ORF|VATPS1|XAP-3|XAP3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24119
0	-1.27688593549355	0.057	0.643	0	ATRX	Malignant cells	GSE186960	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24120
0	-0.669260735027816	0	0.421	0	BAG6	Malignant cells	GSE186960	ENSG00000229524	7917	BAG cochaperone 6	BAT3|D6S52E|G3|Scythe	protein_coding	P46379	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24121
0	-2.08053330415491	0.001	0.837	0	BAZ1B	Malignant cells	GSE186960	ENSG00000009954	9031	bromodomain adjacent to zinc finger domain 1B	WBSCR10|WBSCR9|WSTF	protein_coding	Q9UIG0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24122
0	-1.78574077351496	0.001	0.781	0	BCAP31	Malignant cells	GSE186960	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24123
0	-0.403103611436122	0	0.271	0	BCL7B	Malignant cells	GSE186960	ENSG00000106635	9275	BAF chromatin remodeling complex subunit BCL7B	SMARCJ2	protein_coding	Q9BQE9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24124
0	-0.62035113454687	0	0.393	0	BDP1	Malignant cells	GSE186960	ENSG00000274803	55814	B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB	HSA238520|KIAA1241|KIAA1689|TAF3B1|TFC5|TFIIIB150|TFIIIB90|TFNR	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24125
0	-0.404665815206405	0	0.266	0	BOLA1	Malignant cells	GSE186960	ENSG00000178096	51027	bolA family member 1	CGI-143	protein_coding	Q9Y3E2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24126
0	-0.440137389258733	0	0.288	0	BRCC3	Malignant cells	GSE186960	ENSG00000185515	79184	BRCA1/BRCA2-containing complex subunit 3	BRCC36|C6.1A|CXorf53	protein_coding	P46736	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24127
0	-0.951933056080942	0.001	0.524	0	BRD2	Malignant cells	GSE186960	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24128
0	-0.409342302415878	0	0.269	0	C11orf1	Malignant cells	GSE186960	ENSG00000137720	64776	chromosome 11 open reading frame 1	FLJ23499	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24129
0	-1.38105325798445	0	0.669	0	C12orf57	Malignant cells	GSE186960	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24130
0	-0.504862343941745	0.001	0.321	0	C2orf15	Malignant cells	GSE186960	ENSG00000273045	150590	chromosome 2 open reading frame 15	MGC29762	protein_coding	Q8WU43	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24131
0	-0.4798990588376	0.001	0.304	0	C6orf203	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24132
0	-1.53804714725725	0	0.741	0	C6orf48	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24133
0	-0.408707436536361	0.004	0.291	0	CACYBPP2	Malignant cells	GSE186960	ENSG00000177855	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24134
0	-0.641436820562188	0.002	0.413	0	CBX3P9	Malignant cells	GSE186960	ENSG00000217241	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24135
0	-0.968658542080438	0	0.533	0	CCDC84	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24136
0	-0.574672723310701	0.003	0.372	0	CCT6P2	Malignant cells	GSE186960	ENSG00000250526	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24137
0	-1.16193874526352	0.003	0.574	0	CDC20P1	Malignant cells	GSE186960	ENSG00000231007	NA	NA	CDC20P|OTTHUMG00000020142	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24138
0	-0.976032683937448	0	0.49	0	CDCA3	Malignant cells	GSE186960	ENSG00000111665	83461	cell division cycle associated 3	GRCC8|TOME-1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24139
0	-0.921423235298039	0	0.517	0	CEBPZ-AS1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24140
0	-0.677038085619535	0	0.408	0	CENPU	Malignant cells	GSE186960	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24141
0	-1.05076861074147	0	0.559	0	CETN2	Malignant cells	GSE186960	ENSG00000147400	1069	centrin 2	CALT|CEN2	protein_coding	P41208	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24142
0	-0.593206494816065	0	0.36	0	CHD1L	Malignant cells	GSE186960	ENSG00000131778	9557	chromodomain helicase DNA binding protein 1 like	ALC1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24143
0	-1.6397164594138	0	0.754	0	CLIC1	Malignant cells	GSE186960	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24144
0	-0.797626145659482	0.008	0.45	0	CNP	Malignant cells	GSE186960	ENSG00000173786	1267	2',3'-cyclic nucleotide 3' phosphodiesterase	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24145
0	-2.41778754900862	0.002	0.875	0	COX7B	Malignant cells	GSE186960	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24146
0	-0.829266170015913	0.008	0.484	0	COX7CP1	Malignant cells	GSE186960	ENSG00000235957	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24147
0	-0.514366468188544	0	0.295	0	CRIP2	Malignant cells	GSE186960	ENSG00000182809	1397	cysteine rich protein 2	CRP2|ESP1	protein_coding	P52943	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24148
0	-1.36749923969662	0	0.686	0	CSNK2B	Malignant cells	GSE186960	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24149
0	-2.07990497922235	0	0.828	0	CTB-152G17.5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24150
0	-1.95593095187942	0	0.824	0	CUTA	Malignant cells	GSE186960	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24151
0	-1.99138946358527	0.002	0.824	0	CWC15	Malignant cells	GSE186960	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24152
0	-1.22377033444824	0.018	0.638	0	DAXX	Malignant cells	GSE186960	ENSG00000231617	1616	death domain associated protein	DAP6	protein_coding	Q9UER7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24153
0	-0.587715736367615	0	0.358	0	DDAH2	Malignant cells	GSE186960	ENSG00000226634	23564	dimethylarginine dimethylaminohydrolase 2	G6A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24154
0	-1.82752087731969	0.011	0.802	0	DDX5	Malignant cells	GSE186960	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24155
0	-0.6653562805719	0	0.426	0	DHX16	Malignant cells	GSE186960	ENSG00000227222	8449	DEAH-box helicase 16	DBP2|DDX16|Prp2|PRPF2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24156
0	-2.22878051785185	0.001	0.874	0	DKC1	Malignant cells	GSE186960	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24157
0	-0.630006776300079	0.001	0.403	0	DLAT	Malignant cells	GSE186960	ENSG00000150768	1737	dihydrolipoamide S-acetyltransferase	DLTA|E2|PDC-E2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24158
0	-1.14350382370538	0	0.583	0	EBP	Malignant cells	GSE186960	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24159
0	-0.416307241409538	0.001	0.282	0	EIF2D	Malignant cells	GSE186960	ENSG00000143486	1939	eukaryotic translation initiation factor 2D	LGTN	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24160
0	-0.415428020500597	0.003	0.285	0	EIF2S2P3	Malignant cells	GSE186960	ENSG00000236493	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24161
0	-0.515282279014667	0	0.338	0	EIF4H	Malignant cells	GSE186960	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24162
0	-1.12561700027764	0	0.59	0	EMD	Malignant cells	GSE186960	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24163
0	-1.11042309499113	0.026	0.586	0	EMG1	Malignant cells	GSE186960	ENSG00000126749	10436	EMG1 N1-specific pseudouridine methyltransferase	C2F|Grcc2f|NEP1	protein_coding	Q92979	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24164
0	-0.899941797882219	0.008	0.395	0	EMP1	Malignant cells	GSE186960	ENSG00000134531	2012	epithelial membrane protein 1	CL-20|TMP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24165
0	-0.691188573962569	0	0.42	0	ENO2	Malignant cells	GSE186960	ENSG00000111674	2026	enolase 2	NSE	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24166
0	-0.747313156339621	0.001	0.287	0	EPHB6	Malignant cells	GSE186960	ENSG00000275482	2051	EPH receptor B6	HEP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24167
0	-0.775711676658459	0	0.474	0	EXOSC4	Malignant cells	GSE186960	ENSG00000178896	54512	exosome component 4	FLJ20591|hRrp41p|p12A|RRP41|RRP41A|Rrp41p|SKI6|Ski6p	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24168
0	1.86312961033478	0.988	0.58	0	FABP5	Malignant cells	GSE186960	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24169
0	-1.18045065826314	0	0.599	0	FAM101B	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24170
0	-0.575284586818802	0	0.36	0	FAM199X	Malignant cells	GSE186960	ENSG00000123575	139231	family with sequence similarity 199, X-linked	CXorf39	protein_coding	Q6PEV8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24171
0	-0.902750865247595	0	0.516	0	FAM211A-AS1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24172
0	-0.525896559856639	0	0.34	0	FAM229B	Malignant cells	GSE186960	ENSG00000203778	619208	family with sequence similarity 229 member B	C6orf225|DKFZp586F0922|LOC619208	protein_coding	Q4G0N7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24173
0	-1.31197271295052	0	0.645	0	FAM50A	Malignant cells	GSE186960	ENSG00000071859	9130	family with sequence similarity 50 member A	9F|DXS9928E|HXC-26|XAP5	protein_coding	Q14320	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24174
0	-0.860666281565375	0.033	0.513	0	FAUP1	Malignant cells	GSE186960	ENSG00000235297	NA	NA	FAU1P	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24175
0	-1.14767086772937	1	1	0	FBL	Malignant cells	GSE186960	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24176
0	-0.431704346368041	0.001	0.288	0	FKBP10	Malignant cells	GSE186960	ENSG00000141756	60681	FKBP prolyl isomerase 10	FKBP6|FKBP65|FLJ20683|FLJ22041|FLJ23833|hFKBP65	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24177
0	-0.590463727752526	0	0.361	0	FLNA	Malignant cells	GSE186960	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24178
0	-1.22445784050223	0	0.61	0	FLOT1	Malignant cells	GSE186960	ENSG00000223654	10211	flotillin 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24179
0	-0.63639610112219	0	0.41	0	FMR1	Malignant cells	GSE186960	ENSG00000102081	2332	fragile X messenger ribonucleoprotein 1	FMRP|FRAXA|MGC87458|POF|POF1	protein_coding	Q06787	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24180
0	-0.410367268804978	0	0.279	0	FRG1	Malignant cells	GSE186960	ENSG00000275145	2483	FSHD region gene 1	FRG1A|FSG1	protein_coding	Q14331	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24181
0	4.02056742194092	1	0.593	0	FTH1	Malignant cells	GSE186960	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24182
0	1.38048908726094	1	1	0	FTL	Malignant cells	GSE186960	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24183
0	-0.589090386343833	0	0.371	0	FUNDC2	Malignant cells	GSE186960	ENSG00000165775	65991	FUN14 domain containing 2	DC44|HCBP6	protein_coding	Q9BWH2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24184
0	1.0241864876509	1	1	0	GAPDH	Malignant cells	GSE186960	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24185
0	-0.681669290622372	0	0.408	0	GDI1	Malignant cells	GSE186960	ENSG00000203879	2664	GDP dissociation inhibitor 1	FLJ41411|GDIL|MRX41|MRX48|OPHN2|RABGDIA|XAP-4	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24186
0	-1.0133299685229	0.035	0.569	0	GGNBP2	Malignant cells	GSE186960	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24187
0	-0.737792116698632	0	0.446	0	GLA	Malignant cells	GSE186960	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24188
0	-0.593072344258298	0.003	0.384	0	GNAI2	Malignant cells	GSE186960	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24189
0	-0.521583566985556	0	0.347	0	GNL1	Malignant cells	GSE186960	ENSG00000229470	2794	G protein nucleolar 1 (putative)	HSR1	protein_coding	P36915	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24190
0	-0.719079856436461	0	0.457	0	GPAA1	Malignant cells	GSE186960	ENSG00000197858	8733	glycosylphosphatidylinositol anchor attachment 1	GAA1|hGAA1	protein_coding	O43292	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24191
0	-0.443181050811457	0	0.299	0	GPANK1	Malignant cells	GSE186960	ENSG00000223932	7918	G-patch domain and ankyrin repeats 1	ANKRD59|BAT4|D6S54E|G5|GPATCH10	protein_coding	O95872	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24192
0	-0.403103611436122	0	0.278	0	GPKOW	Malignant cells	GSE186960	ENSG00000068394	27238	G-patch domain and KOW motifs	GPATC5|GPATCH5|Mos2|Spp2|T54	protein_coding	Q92917	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24193
0	-0.611995960174219	0	0.384	0	GRINA	Malignant cells	GSE186960	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24194
0	-0.527331363595875	0	0.338	0	GSPT2	Malignant cells	GSE186960	ENSG00000189369	23708	G1 to S phase transition 2	eRF3b|FLJ10441	protein_coding	Q8IYD1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24195
0	-0.424822011449535	0	0.282	0	HCFC1	Malignant cells	GSE186960	ENSG00000172534	3054	host cell factor C1	CFF|HCF-1|HCF1|HFC1|MGC70925|MRX3|PPP1R89|VCAF	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24196
0	-1.26299283187546	0.001	0.62	0	HLA-A	Malignant cells	GSE186960	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24197
0	-0.935030150785165	0.001	0.467	0	HLA-B	Malignant cells	GSE186960	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24198
0	-0.490519611200416	0.002	0.322	0	HLA-C	Malignant cells	GSE186960	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24199
0	-1.07850899752793	0.007	0.586	0	HMGB1P21	Malignant cells	GSE186960	ENSG00000248909	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24200
0	-0.505658020976836	0	0.345	0	HMGB1P4	Malignant cells	GSE186960	ENSG00000214821	NA	NA	HMG1L4|HMG1L4P|HMGB1L4	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24201
0	-1.60170451801599	0.001	0.731	0	HMGB3	Malignant cells	GSE186960	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24202
0	-0.495974894352576	0.002	0.327	0	HMGN1P38	Malignant cells	GSE186960	ENSG00000253954	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24203
0	-0.385806787955089	0	0.258	0	HNRNPH2	Malignant cells	GSE186960	ENSG00000126945	3188	heterogeneous nuclear ribonucleoprotein H2	FTP3|hnRNPH'|HNRPH'|HNRPH2	protein_coding	P55795	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24204
0	-1.51212302882334	0.001	0.713	0	HSD17B10	Malignant cells	GSE186960	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24205
0	-0.506847809736669	0	0.334	0	HSP90AA4P	Malignant cells	GSE186960	ENSG00000281610	NA	NA	HSPCAL2	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24206
0	-0.64539337938838	0.003	0.408	0	HSP90AB2P	Malignant cells	GSE186960	ENSG00000205940	NA	NA	HSP90BB	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24207
0	-0.938482926325996	0.052	0.573	0	HSP90AB3P	Malignant cells	GSE186960	ENSG00000183199	NA	NA	HSPCP1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24208
0	-1.67703808561954	0	0.756	0	HSP90AB6P	Malignant cells	GSE186960	ENSG00000235137	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24209
0	-0.472473952170338	0.001	0.312	0	HSP90B3P	Malignant cells	GSE186960	ENSG00000203914	NA	NA	GRP94c|TRA1P2|TRAP2	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24210
0	-0.797280608910858	0	0.437	0	HSPA1A	Malignant cells	GSE186960	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24211
0	-0.521766904578484	0.011	0.334	0	HYOU1	Malignant cells	GSE186960	ENSG00000280682	10525	hypoxia up-regulated 1	Grp170|HSP12A|ORP150	protein_coding	Q9Y4L1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24212
0	-0.555731789397402	0	0.367	0	IDH3G	Malignant cells	GSE186960	ENSG00000067829	3421	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma	NA	protein_coding	P51553	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24213
0	-1.51436646818854	0	0.642	0	IER3	Malignant cells	GSE186960	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24214
0	-0.490135035880207	0.004	0.315	0	IFI30	Malignant cells	GSE186960	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24215
0	-0.59136403177743	0.013	0.39	0	IFNGR2	Malignant cells	GSE186960	ENSG00000262795	3460	interferon gamma receptor 2	AF-1|IFNGT1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24216
0	-0.790126734545369	0	0.436	0	IRAK1	Malignant cells	GSE186960	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24217
0	-0.568734035508465	0.006	0.375	0	KB-1208A12.3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24218
0	-0.471943744505095	0.001	0.299	0	KIFC1	Malignant cells	GSE186960	ENSG00000233450	3833	kinesin family member C1	HSET|KNSL2	protein_coding	Q9BW19	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24219
0	-0.437087292898783	0	0.264	0	KIFC3	Malignant cells	GSE186960	ENSG00000140859	3801	kinesin family member C3	NA	protein_coding	Q9BVG8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24220
0	-1.58977722046339	0	0.695	0	KMT2A	Malignant cells	GSE186960	ENSG00000118058	4297	lysine methyltransferase 2A	ALL-1|ALL1|CXXC7|HRX|HTRX|HTRX1|MLL|MLL1|MLL1A|TRX1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24221
0	-1.17862561685481	0	0.582	0	KPNA2	Malignant cells	GSE186960	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24222
0	-2.05740244300961	0.001	0.822	0	LAGE3	Malignant cells	GSE186960	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24223
0	-0.52446032774112	0	0.347	0	LENG1	Malignant cells	GSE186960	ENSG00000276628	79165	leukocyte receptor cluster member 1	NA	protein_coding	Q96BZ8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24224
0	-0.627058236542853	0	0.393	0	LEPREL4	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24225
0	-0.513691948108572	0.001	0.334	0	LINC00987	Malignant cells	GSE186960	ENSG00000237248	100499405	long intergenic non-protein coding RNA 987	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24226
0	-0.430172009483794	0.001	0.278	0	LIX1L	Malignant cells	GSE186960	ENSG00000271601	128077	limb and CNS expressed 1 like	MGC46719	protein_coding	Q8IVB5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24227
0	-1.26712845034075	0.016	0.65	0	LSM14A	Malignant cells	GSE186960	ENSG00000262860	26065	LSM14A mRNA processing body assembly factor	C19orf13|DKFZP434D1335|FAM61A|RAP55|RAP55A	protein_coding	Q8ND56	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24228
0	-1.21380404409291	0	0.61	0	LSM2	Malignant cells	GSE186960	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24229
0	-0.393694697385402	0	0.258	0	MAGED1	Malignant cells	GSE186960	ENSG00000179222	9500	MAGE family member D1	DLXIN-1|NRAGE	protein_coding	Q9Y5V3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24230
0	2.57142872491485	1	1	0	MALAT1	Malignant cells	GSE186960	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24231
0	-1.41942298601655	0	0.643	0	MANF	Malignant cells	GSE186960	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24232
0	-0.747673628212596	0	0.457	0	MBOAT7	Malignant cells	GSE186960	ENSG00000275118	79143	membrane bound O-acyltransferase domain containing 7	BB1|hMBOA-7|LENG4|LPIAT1|LPLAT|LPLAT11	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24233
0	-1.81448111904759	0	0.805	0	MDH2	Malignant cells	GSE186960	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24234
0	-0.59183576308265	0	0.393	0	MECP2	Malignant cells	GSE186960	ENSG00000169057	4204	methyl-CpG binding protein 2	MRX16|MRX79|RTT	protein_coding	P51608	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24235
0	-0.398406824734723	0	0.272	0	MMGT1	Malignant cells	GSE186960	ENSG00000169446	93380	membrane magnesium transporter 1	EMC5|TMEM32	protein_coding	Q8N4V1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24236
0	-0.727842456291027	0	0.437	0	MPP1	Malignant cells	GSE186960	ENSG00000130830	4354	MAGUK p55 scaffold protein 1	DXS552E|PEMP	protein_coding	Q00013	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24237
0	-0.483654111353234	0	0.338	0	MRPL45	Malignant cells	GSE186960	ENSG00000277936	84311	mitochondrial ribosomal protein L45	Mba1|MGC11321	protein_coding	Q9BRJ2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24238
0	-0.845238406592387	0	0.503	0	MRPS18B	Malignant cells	GSE186960	ENSG00000233813	28973	mitochondrial ribosomal protein S18B	C6orf14|HSPC183|MRPS18-2|PTD017	protein_coding	Q9Y676	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24239
0	-2.28015220344048	0.385	0.91	0	MT-ATP8	Malignant cells	GSE186960	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24240
0	1.62779182022531	1	1	0	MT-CO2	Malignant cells	GSE186960	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24241
0	-2.22613716533755	0.741	0.997	0	MT-ND6	Malignant cells	GSE186960	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24242
0	2.39123933830776	1	0.946	0	MT-RNR1	Malignant cells	GSE186960	ENSG00000211459	NA	NA	12S|MOTS-c|MTRNR1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24243
0	-0.701282760695284	0.002	0.421	0	MT-TQ	Malignant cells	GSE186960	ENSG00000210107	NA	NA	MTTQ|trnQ	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24244
0	-1.98911412431674	0.009	0.819	0	MT-TS1	Malignant cells	GSE186960	ENSG00000210151	113219467	microRNA 12136	MTTS1|TRNS1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24245
0	-0.929331627143809	0.001	0.509	0	NAA10	Malignant cells	GSE186960	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24246
0	-0.700115642757933	0.004	0.454	0	NAP1L1P1	Malignant cells	GSE186960	ENSG00000254759	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24247
0	-0.443181050811457	0	0.284	0	NCOA4	Malignant cells	GSE186960	ENSG00000266412	8031	nuclear receptor coactivator 4	ARA70|DKFZp762E1112|ELE1|PTC3|RFG	protein_coding	Q13772	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24248
0	-1.55009625472797	0	0.742	0	NDUFA3	Malignant cells	GSE186960	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24249
0	-2.26673285402485	0	0.87	0	NDUFA6	Malignant cells	GSE186960	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24250
0	-1.33017208898227	0	0.681	0	NDUFB11	Malignant cells	GSE186960	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24251
0	1.94180107217249	1	0.956	0	NEAT1	Malignant cells	GSE186960	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24252
0	-1.11383296501267	0.007	0.6	0	NELFE	Malignant cells	GSE186960	ENSG00000206268	7936	negative elongation factor complex member E	D6S45|NELF-E|RD|RDBP|RDP	protein_coding	P18615	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24253
0	-0.486607428742582	0	0.309	0	NEU1	Malignant cells	GSE186960	ENSG00000184494	4758	neuraminidase 1	NEU	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24254
0	-1.37069989556488	0	0.672	0	NIFK	Malignant cells	GSE186960	ENSG00000155438	84365	nucleolar protein interacting with the FHA domain of MKI67	hNIFK|MKI67IP|Nopp34	protein_coding	Q9BYG3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24255
0	-1.22749998732693	0.135	0.678	0	NME1-NME2	Malignant cells	GSE186960	ENSG00000011052	654364	NME1-NME2 readthrough	NM23-LV|NMELV	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24256
0	-1.65824933716509	0.819	0.996	0	NOP58	Malignant cells	GSE186960	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24257
0	-0.802030226504076	0	0.463	0	NPM1P28	Malignant cells	GSE186960	ENSG00000240804	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24258
0	-0.555731789397402	0	0.368	0	NSDHL	Malignant cells	GSE186960	ENSG00000147383	50814	NAD(P) dependent steroid dehydrogenase-like	H105e3|SDR31E1|XAP104	protein_coding	Q15738	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24259
0	-0.615803640961095	0.001	0.391	0	NSUN5	Malignant cells	GSE186960	ENSG00000130305	55695	NOP2/Sun RNA methyltransferase 5	FLJ10267|NOL1R|NSUN5A|p120(NOL1)|WBSCR20|WBSCR20A|Ynl022cL	protein_coding	Q96P11	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24260
0	-1.15784817950009	0.005	0.62	0	NT5C3B	Malignant cells	GSE186960	ENSG00000141698	115024	5'-nucleotidase, cytosolic IIIB	cN-IIIB|MGC20781|NT5C3L	protein_coding	Q969T7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24261
0	-0.932290445314727	0.017	0.533	0	PA2G4P4	Malignant cells	GSE186960	ENSG00000230457	NA	NA	PA2G4L1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24262
0	-1.80142535386727	1	1	0	PABPC1	Malignant cells	GSE186960	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24263
0	-0.72204609819757	0.001	0.417	0	PABPC1P4	Malignant cells	GSE186960	ENSG00000255642	NA	NA	PABPCP5|PABPL2	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24264
0	-0.574187355573332	0.008	0.377	0	PABPC3	Malignant cells	GSE186960	ENSG00000151846	5042	poly(A) binding protein cytoplasmic 3	PABP3|PABPL3|tPABP	protein_coding	Q9H361	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24265
0	-1.80534939168967	0.897	0.997	0	PAF1	Malignant cells	GSE186960	ENSG00000006712	54623	PAF1 homolog, Paf1/RNA polymerase II complex component	F23149_1|FLJ11123|PD2	protein_coding	Q8N7H5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24266
0	-0.976032683937448	0	0.562	0	PBDC1	Malignant cells	GSE186960	ENSG00000102390	51260	polysaccharide biosynthesis domain containing 1	CXorf26|MGC874	protein_coding	Q9BVG4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24267
0	-0.59183576308265	0	0.388	0	PDIA3P1	Malignant cells	GSE186960	ENSG00000180867	NA	NA	GRP58P|PDIA3P	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24268
0	-0.534484055693363	0	0.342	0	PEX11B	Malignant cells	GSE186960	ENSG00000131779	8799	peroxisomal biogenesis factor 11 beta	PEX11beta	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24269
0	-0.741505619497696	0	0.46	0	PFDN6	Malignant cells	GSE186960	ENSG00000235692	10471	prefoldin subunit 6	H2-KE2|HKE2|KE-2|PFD6	protein_coding	O15212	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24270
0	-2.07586757334696	0.001	0.825	0	PGK1	Malignant cells	GSE186960	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24271
0	-1.67380261657814	0	0.751	0	PHB2	Malignant cells	GSE186960	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24272
0	-0.417102918444628	0	0.274	0	PIAS3	Malignant cells	GSE186960	ENSG00000131788	10401	protein inhibitor of activated STAT 3	FLJ14651|ZMIZ5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24273
0	-0.515812779127608	0	0.33	0	PLP2	Malignant cells	GSE186960	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24274
0	-0.87484486867771	0	0.479	0	PLS3	Malignant cells	GSE186960	ENSG00000102024	5358	plastin 3	T-plastin	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24275
0	-0.882694541212431	0.01	0.493	0	POLR3GL	Malignant cells	GSE186960	ENSG00000121851	84265	RNA polymerase III subunit GL	flj32422|MGC3200	protein_coding	Q9BT43	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24276
0	-1.08781261893362	0.046	0.612	0	PPIAP22	Malignant cells	GSE186960	ENSG00000198618	NA	NA	PPIA3L|PPIAL3	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24277
0	-0.502743484549458	0	0.335	0	PPP1R10	Malignant cells	GSE186960	ENSG00000230995	5514	protein phosphatase 1 regulatory subunit 10	CAT53|FB19|p99|PNUTS	protein_coding	Q96QC0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24278
0	-0.558541322984226	0	0.365	0	PPP1R11	Malignant cells	GSE186960	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24279
0	-0.95646340991864	0	0.546	0	PQBP1	Malignant cells	GSE186960	ENSG00000102103	10084	polyglutamine binding protein 1	MRX2|MRX55|MRXS3|MRXS8|RENS1|SHS	protein_coding	O60828	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24280
0	1.81949593075259	0.994	0.51	0	PRELID1	Malignant cells	GSE186960	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24281
0	-0.46280985756039	0	0.311	0	PRKRIP1	Malignant cells	GSE186960	ENSG00000128563	79706	PRKR interacting protein 1	C114|FLJ13902|KRBOX3	protein_coding	Q9H875	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24282
0	-0.512918705858429	0	0.327	0	PRPF3	Malignant cells	GSE186960	ENSG00000117360	9129	pre-mRNA processing factor 3	hPrp3|Prp3|RP18|SNRNP90	protein_coding	O43395	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24283
0	-1.31280495701218	0	0.655	0	PRPF31	Malignant cells	GSE186960	ENSG00000274651	26121	pre-mRNA processing factor 31	hPrp31|NY-BR-99|PRP31|RP11|SNRNP61	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24284
0	-1.45259780622823	0.096	0.736	0	PSMA6	Malignant cells	GSE186960	ENSG00000100902	5687	proteasome 20S subunit alpha 6	IOTA|MGC22756|MGC2333|MGC23846|p27K|PROS27	protein_coding	P60900	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24285
0	1.62081204634901	0.999	0.777	0	PTMS	Malignant cells	GSE186960	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24286
0	-1.34245041876071	0	0.662	0	PTPLA	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24287
0	-1.35543313891157	0	0.672	0	PUF60	Malignant cells	GSE186960	ENSG00000274081	22827	poly(U) binding splicing factor 60	FIR|RoBPI|SIAHBP1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24288
0	-0.667934850327482	0.001	0.43	0	RABAC1	Malignant cells	GSE186960	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24289
0	-0.474757710864838	0	0.302	0	RAD17	Malignant cells	GSE186960	ENSG00000276618	5884	RAD17 checkpoint clamp loader component	CCYC|RAD17Sp|Rad24	protein_coding	O75943	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24290
0	-0.571116952603574	0	0.377	0	RBM10	Malignant cells	GSE186960	ENSG00000182872	8241	RNA binding motif protein 10	DXS8237E|GPATC9|GPATCH9|KIAA0122|S1-1|ZRANB5	protein_coding	P98175	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24291
0	-1.99696981769003	0.005	0.854	0	RBM3	Malignant cells	GSE186960	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24292
0	-2.24884768879079	0.01	0.868	0	RBM8A	Malignant cells	GSE186960	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24293
0	-0.662643463354582	0.005	0.427	0	REXO4	Malignant cells	GSE186960	ENSG00000280706	57109	REX4 homolog, 3'-5' exonuclease	hPMC2|XPMC2H	protein_coding	Q9GZR2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24294
0	-0.507113084177223	0	0.327	0	RNF34	Malignant cells	GSE186960	ENSG00000170633	80196	ring finger protein 34	FLJ21786|RIF|RIFF	protein_coding	Q969K3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24295
0	-0.575284586818802	0	0.37	0	RNF5	Malignant cells	GSE186960	ENSG00000223767	6048	ring finger protein 5	G16|NG2|RING5|RMA1	protein_coding	Q99942	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24296
0	-0.829748816131324	0.015	0.451	0	RP11-1033A18.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24297
0	-0.63639610112219	0	0.42	0	RP11-120J4.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24298
0	-0.401539714219686	0	0.266	0	RP11-129B9.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24299
0	-1.66728008694286	0.005	0.755	0	RP11-159C21.4	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24300
0	-0.956505021600476	0.053	0.543	0	RP11-166B2.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24301
0	-3.59878443266188	0.029	0.979	0	RP11-169K16.8	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24302
0	-0.640379615040687	0	0.408	0	RP11-248E9.7	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24303
0	-0.741505619497696	0	0.398	0	RP11-297H3.3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24304
0	-1.33673353311053	0	0.662	0	RP11-315I14.5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24305
0	-1.36215440238782	0	0.675	0	RP11-318C24.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24306
0	-1.66615649126005	0.022	0.741	0	RP11-333E13.2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24307
0	-1.15830154538088	0.022	0.612	0	RP11-367G18.2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24308
0	-0.948768149253245	0.023	0.539	0	RP11-36C20.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24309
0	-0.46280985756039	0	0.305	0	RP11-443I9.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24310
0	-1.96252959316509	0.054	0.818	0	RP11-475C16.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24311
0	-0.438613147129743	0	0.295	0	RP11-490M8.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24312
0	-1.11133748705901	0	0.579	0	RP11-545M17.2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24313
0	-2.08861760913591	0.012	0.837	0	RP11-715J22.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24314
0	-1.53952388576242	0.042	0.739	0	RP11-742N3.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24315
0	-0.796348649026994	0.001	0.48	0	RP11-750B16.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24316
0	-0.412451560173001	0	0.287	0	RP11-824M15.3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24317
0	-0.899831119657268	0.015	0.53	0	RP11-832N8.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24318
0	-1.23546275771262	0.001	0.639	0	RP3-406A7.3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24319
0	-0.434030734465444	0	0.285	0	RP3-432I18.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24320
0	-0.410294269005292	0.002	0.275	0	RPF2P1	Malignant cells	GSE186960	ENSG00000225357	NA	NA	bA353C18.4|BXDC1P|C20orf53|RPF2P	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24321
0	-3.20175137360509	0.006	0.933	0	RPL10	Malignant cells	GSE186960	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24322
0	-1.27316400417872	0.005	0.652	0	RPL10P3	Malignant cells	GSE186960	ENSG00000230734	NA	NA	bA567J2.2	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24323
0	1.18156876644052	1	1	0	RPL12	Malignant cells	GSE186960	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24324
0	-0.81669659935464	0.01	0.458	0	RPL13AP5	Malignant cells	GSE186960	ENSG00000236552	728658	ribosomal protein L13a pseudogene 5	bA196N24.2	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24325
0	-1.42713366240951	0.066	0.736	0	RPL13P12	Malignant cells	GSE186960	ENSG00000215030	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24326
0	-2.2856095882661	0.052	0.87	0	RPL14P1	Malignant cells	GSE186960	ENSG00000139239	NA	NA	bcm1298|RPL14L	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24327
0	2.36507740592678	1	0.781	0	RPL18A	Malignant cells	GSE186960	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24328
0	-1.3403469449417	0.05	0.705	0	RPL24P4	Malignant cells	GSE186960	ENSG00000181524	NA	NA	dJ125M3.1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24329
0	2.11804184199892	1	0.996	0	RPL28	Malignant cells	GSE186960	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24330
0	2.72459797189651	1	0.761	0	RPL29	Malignant cells	GSE186960	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24331
0	1.51995568797065	1	0.999	0	RPL30	Malignant cells	GSE186960	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24332
0	-1.57137354594523	0.981	1	0	RPL31	Malignant cells	GSE186960	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24333
0	1.18618055069645	1	0.997	0	RPL36	Malignant cells	GSE186960	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24334
0	-2.12751030112796	0	0.842	0	RPL36A	Malignant cells	GSE186960	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24335
0	-1.18644575579164	0.076	0.655	0	RPL3P4	Malignant cells	GSE186960	ENSG00000232573	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24336
0	-0.590521402564177	0.007	0.383	0	RPL4P4	Malignant cells	GSE186960	ENSG00000229638	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24337
0	-3.46318472960119	0	0.966	0	RPL7A	Malignant cells	GSE186960	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24338
0	-0.489554712792918	0	0.317	0	RPL7P9	Malignant cells	GSE186960	ENSG00000137970	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24339
0	1.31770277850147	1	0.989	0	RPL9	Malignant cells	GSE186960	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24340
0	-4.29552309260992	0.018	0.993	0	RPLP0P6	Malignant cells	GSE186960	ENSG00000213553	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24341
0	-0.468796152626121	0	0.324	0	RPP21	Malignant cells	GSE186960	ENSG00000239927	79897	ribonuclease P/MRP subunit p21	C6orf135|Em:AB014085.3|FLJ22638	protein_coding	Q9H633	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24342
0	-1.52111898235743	1	1	0	RPS16	Malignant cells	GSE186960	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24343
0	-4.24127637386263	0	0.991	0	RPS18	Malignant cells	GSE186960	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24344
0	-4.70061624569281	0.004	0.993	0	RPS19	Malignant cells	GSE186960	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24345
0	-0.899849460671906	0.006	0.53	0	RPS19P1	Malignant cells	GSE186960	ENSG00000214612	NA	NA	bA189K21.7	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24346
0	1.02261688268363	1	1	0	RPS2	Malignant cells	GSE186960	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24347
0	-4.09884654287582	0	0.984	0	RPS25	Malignant cells	GSE186960	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24348
0	-0.51039246409403	0.003	0.324	0	RPS2P5	Malignant cells	GSE186960	ENSG00000240342	NA	NA	bcm384	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24349
0	-0.461033148084461	0.006	0.321	0	RPS2P7	Malignant cells	GSE186960	ENSG00000235508	NA	NA	dJ688G8.1|RPS2L1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24350
0	1.9002556933441	1	0.857	0	RPS3A	Malignant cells	GSE186960	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24351
0	-0.780041457717044	0.004	0.487	0	RPS7P1	Malignant cells	GSE186960	ENSG00000263266	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24352
0	-3.13022865992623	0.001	0.958	0	RPS9	Malignant cells	GSE186960	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24353
0	-0.812524997735176	0.037	0.489	0	SC22CB-1E7.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24354
0	-1.3036237600153	0	0.656	0	SCAMP3	Malignant cells	GSE186960	ENSG00000263290	10067	secretory carrier membrane protein 3	C1orf3	protein_coding	O14828	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24355
0	-0.482104383556372	0.003	0.312	0	SEC22B	Malignant cells	GSE186960	ENSG00000265808	9554	SEC22 homolog B, vesicle trafficking protein	ERS-24|SEC22L1	protein_coding	O75396	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24356
0	-0.846647923191718	0.015	0.489	0	SEC31B	Malignant cells	GSE186960	ENSG00000075826	25956	SEC31 homolog B, COPII coat complex component	DKFZP434M183|SEC31B-1|SEC31L2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24357
0	-0.49054352539356	0.004	0.34	0	SEPT7P7	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24358
0	-0.849832980669637	0	0.496	0	SF3B4	Malignant cells	GSE186960	ENSG00000143368	10262	splicing factor 3b subunit 4	Hsh49|SAP49|SF3b49	protein_coding	Q15427	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24359
0	-0.594575925427562	0	0.365	0	SLC25A1	Malignant cells	GSE186960	ENSG00000100075	6576	solute carrier family 25 member 1	CTP|SLC20A3	protein_coding	P53007	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24360
0	-0.608199209291537	0	0.394	0	SLC39A7	Malignant cells	GSE186960	ENSG00000229802	7922	solute carrier family 39 member 7	D6S2244E|H2-KE4|HKE4|KE4|RING5|ZIP7	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24361
0	-0.491026100009586	0	0.328	0	SLC52A2	Malignant cells	GSE186960	ENSG00000285112	79581	solute carrier family 52 member 2	D15Ertd747e|FLJ11856|GPCR41|GPR172A|hRFT3|PAR1|RFVT2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24362
0	-1.19724932149872	0.001	0.597	0	SMC1A	Malignant cells	GSE186960	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24363
0	-0.785337700966424	0	0.46	0	SMDT1	Malignant cells	GSE186960	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24364
0	-1.04206198318465	0.003	0.546	0	SNRPGP2	Malignant cells	GSE186960	ENSG00000264350	NA	NA	HsT2742	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24365
0	1.79387592053902	1	0.812	0	SQSTM1	Malignant cells	GSE186960	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24366
0	-0.418074682480974	0.001	0.285	0	SRRM1P3	Malignant cells	GSE186960	ENSG00000237307	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24367
0	-2.06254859653869	0.001	0.821	0	SSR4	Malignant cells	GSE186960	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24368
0	-0.62177865160513	0.005	0.384	0	STAM	Malignant cells	GSE186960	ENSG00000136738	8027	signal transducing adaptor molecule	STAM1	protein_coding	Q92783	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24369
0	-0.365094079304795	0	0.254	0	STYXL1	Malignant cells	GSE186960	ENSG00000127952	51657	serine/threonine/tyrosine interacting like 1	DUSP24|MK-STYX	protein_coding	Q9Y6J8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24370
0	-0.468796152626121	0	0.314	0	SURF1	Malignant cells	GSE186960	ENSG00000280627	6834	SURF1 cytochrome c oxidase assembly factor	SHY1	protein_coding	Q15526	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24371
0	-0.796750108797916	0	0.483	0	SURF4	Malignant cells	GSE186960	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24372
0	-0.526175019164174	0.005	0.354	0	SURF6	Malignant cells	GSE186960	ENSG00000281309	6838	surfeit 6	FLJ30322|RRP14	protein_coding	O75683	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24373
0	-0.76443007795302	0.001	0.454	0	TAF15	Malignant cells	GSE186960	ENSG00000276833	8148	TATA-box binding protein associated factor 15	hTAFII68|Npl3|RBP56|TAF2N	protein_coding	Q92804	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24374
0	-1.49683315779874	0.001	0.736	0	TAF9	Malignant cells	GSE186960	ENSG00000276463	6880	TATA-box binding protein associated factor 9	AD-004|CGI-137|MGC1603|MGC3647|MGC5067|TAF2G|TAFII31|TAFII32|TAFIID32	protein_coding	Q16594	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24375
0	-0.89709337342797	0.002	0.5	0	TIMM17B	Malignant cells	GSE186960	ENSG00000126768	10245	translocase of inner mitochondrial membrane 17B	DXS9822|JM3	protein_coding	O60830	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24376
0	-0.81735937401695	0	0.48	0	TIMM8A	Malignant cells	GSE186960	ENSG00000126953	1678	translocase of inner mitochondrial membrane 8A	DDP|DFN1|MTS	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24377
0	-1.15375888817765	0	0.595	0	TKT	Malignant cells	GSE186960	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24378
0	-0.994823478332587	0	0.534	0	TMEM97	Malignant cells	GSE186960	ENSG00000109084	27346	transmembrane protein 97	σ2R|MAC30	protein_coding	Q5BJF2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24379
0	-0.65460018780295	0.002	0.408	0	TMSB10P1	Malignant cells	GSE186960	ENSG00000228499	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24380
0	-3.02052232387335	0	0.948	0	TPI1	Malignant cells	GSE186960	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24381
0	-0.443181050811457	0	0.292	0	TPT1P9	Malignant cells	GSE186960	ENSG00000234782	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24382
0	-0.96654470281452	0	0.54	0	TRAPPC4	Malignant cells	GSE186960	ENSG00000280495	51399	trafficking protein particle complex subunit 4	PTD009|SBDN|TRS23	protein_coding	Q9Y296	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24383
0	-0.726593910093768	0	0.431	0	TRIM27	Malignant cells	GSE186960	ENSG00000234495	5987	tripartite motif containing 27	RFP|RNF76	protein_coding	P14373	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24384
0	-1.06368094170824	0	0.573	0	TSEN34	Malignant cells	GSE186960	ENSG00000274078	79042	tRNA splicing endonuclease subunit 34	LENG5|SEN34|SEN34L	protein_coding	Q9BSV6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24385
0	3.03042941150203	1	0.589	0	TUBA1B	Malignant cells	GSE186960	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24386
0	1.77287953958472	0.998	0.797	0	TUBA1C	Malignant cells	GSE186960	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24387
0	-2.92414890215997	0	0.944	0	TUBB	Malignant cells	GSE186960	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24388
0	-0.898634829920893	0.001	0.516	0	TUSC2	Malignant cells	GSE186960	ENSG00000114383	11334	tumor suppressor 2, mitochondrial calcium regulator	C3orf11|FUS1|PAP|PDAP2	protein_coding	O75896	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24389
0	-0.562745391158456	0	0.37	0	UBA1	Malignant cells	GSE186960	ENSG00000130985	7317	ubiquitin like modifier activating enzyme 1	A1S9T|CFAP124|GXP1|POC20|UBE1|UBE1X	protein_coding	P22314	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24390
0	-0.408512053102236	0.002	0.288	0	UBA52P5	Malignant cells	GSE186960	ENSG00000243498	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24391
0	-3.32493618038128	0.001	0.958	0	UBBP1	Malignant cells	GSE186960	ENSG00000230037	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24392
0	-1.60072232779794	0	0.739	0	UBBP2	Malignant cells	GSE186960	ENSG00000228247	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24393
0	-0.47624425920954	0	0.308	0	UBBP5	Malignant cells	GSE186960	ENSG00000228074	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24394
0	-0.81735937401695	0	0.509	0	UBE2G2	Malignant cells	GSE186960	ENSG00000184787	7327	ubiquitin conjugating enzyme E2 G2	UBC7	protein_coding	P60604	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24395
0	2.6515975487422	0.997	0.579	0	UBE2S	Malignant cells	GSE186960	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24396
0	-0.557028701132549	0.002	0.36	0	UBL4A	Malignant cells	GSE186960	ENSG00000102178	8266	ubiquitin like 4A	DXS254E|GDX|GET5|MDY2|TMA24|UBL4	protein_coding	P11441	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24397
0	-0.889430896067829	0.004	0.509	0	USMG5P1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24398
0	-0.684773734399141	0	0.428	0	VARS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24399
0	-1.56471147213818	0.007	0.732	0	VBP1	Malignant cells	GSE186960	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24400
0	-1.07071158136827	0.012	0.593	0	VPS28	Malignant cells	GSE186960	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24401
0	-1.92960876358765	0.001	0.818	0	WBSCR22	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24402
0	-0.42019551350001	0	0.274	0	WDR13	Malignant cells	GSE186960	ENSG00000101940	64743	WD repeat domain 13	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24403
0	-1.09649977247357	0.007	0.597	0	YTHDC1	Malignant cells	GSE186960	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24404
0	-0.649631928278883	0	0.4	0	ZNRD1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24405
0	1.72432148525896	0.96	0.408	0	C17orf76-AS1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24406
0	1.53524833712169	0.951	0.374	0	UQCR11.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24407
0	1.92700951929113	0.992	0.448	0	RPL10.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24408
0	4.16225843928966	1	0.566	0	RNA18S5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24409
0	3.25013233239347	0.999	0.533	0	RNA28S5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24410
5.5685381446228e-308	-0.375488336801493	0.001	0.256	1.24039187171473e-303	TAPBP	Malignant cells	GSE186960	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24411
8.23166527980949e-308	2.29843909207658	0.95	0.464	1.83360344107756e-303	BCYRN1	Malignant cells	GSE186960	ENSG00000236824	618	brain cytoplasmic RNA 1	BC200|BC200a|LINC00004|NCRNA00004	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24412
4.61028740644309e-307	-0.373095736205536	0	0.251	1.0269415197852e-302	RPS8P3	Malignant cells	GSE186960	ENSG00000215457	NA	NA	HsT2707	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24413
4.62114464889856e-307	-0.376284013836583	0	0.251	1.02935997054215e-302	HDAC8	Malignant cells	GSE186960	ENSG00000147099	55869	histone deacetylase 8	HDACL1|KDAC8|MRXS6|RPD3|WTS	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24414
6.13671824849479e-304	1.55598917726417	0.978	0.549	1.36695398985221e-299	PPP1R14B	Malignant cells	GSE186960	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24415
3.77233856976545e-302	-0.387641244148084	0.001	0.255	8.40288416415254e-298	CDK7	Malignant cells	GSE186960	ENSG00000277273	1022	cyclin dependent kinase 7	CAK|CAK1|CDKN7|MO15|STK1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24416
4.57866057231522e-301	-1.82745109108422	0.37	0.877	1.01989664248322e-296	PTRF	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24417
3.70980173436756e-300	-0.388953791482518	0.001	0.255	8.26358336330375e-296	EIF4A1P7	Malignant cells	GSE186960	ENSG00000235472	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24418
1.80490631256758e-299	-0.428470188743787	0.004	0.277	4.02042881124428e-295	JUP	Malignant cells	GSE186960	ENSG00000173801	3728	junction plakoglobin	CTNNG|DP3|DPIII|PDGB|PG|PKGB	protein_coding	P14923	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24419
6.81202538695093e-298	-1.61478751885062	0.727	0.99	1.51737865494332e-293	PTTG1IP	Malignant cells	GSE186960	ENSG00000183255	754	PTTG1 interacting protein	C21orf1|C21orf3|PBF|PTTG1IP1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24420
2.64826184916042e-297	-1.53982029659647	0.814	0.993	5.89900326900484e-293	LUC7L3	Malignant cells	GSE186960	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24421
1.92861147396369e-296	1.05251544341332	1	0.997	4.29598205825412e-292	PFN1	Malignant cells	GSE186960	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24422
1.24878711649676e-295	1.5639415834094	0.935	0.374	2.78167330199654e-291	CKS1B	Malignant cells	GSE186960	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24423
4.28581083652644e-295	-2.522629685622	0.298	0.831	9.54664363836265e-291	AGR2	Malignant cells	GSE186960	ENSG00000106541	10551	anterior gradient 2, protein disulphide isomerase family member	AG2|HAG-2|PDIA17|XAG-2	protein_coding	O95994	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24424
3.31501370225889e-294	1.06253155945957	1	0.99	7.38419302178169e-290	RPL39	Malignant cells	GSE186960	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24425
8.57532843810961e-294	-0.378665504781893	0.003	0.264	1.91015440958892e-289	RPS18P12	Malignant cells	GSE186960	ENSG00000230897	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24426
6.32335963399369e-293	-0.971852286087991	1	1	1.40852835847209e-288	HNRNPA2B1	Malignant cells	GSE186960	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24427
1.46243116476283e-291	-0.444000768419958	0.007	0.291	3.25756541950919e-287	RPL34P18	Malignant cells	GSE186960	ENSG00000240509	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24428
5.80675315003315e-291	0.951049625301644	1	1	1.29345426416988e-286	NPM1	Malignant cells	GSE186960	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24429
6.55013780548231e-291	-0.518004003843708	0.019	0.361	1.45904319617118e-286	RPL24P8	Malignant cells	GSE186960	ENSG00000236801	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24430
1.12364953565412e-289	-1.42106140155548	0.934	1	2.50292934066955e-285	SNRPD2	Malignant cells	GSE186960	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24431
9.27474359745084e-289	1.48468874540699	0.972	0.523	2.06594913633217e-284	PPIB	Malignant cells	GSE186960	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24432
8.09166037449432e-285	0.926439862593968	1	1	1.80241734841861e-280	PTMA	Malignant cells	GSE186960	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24433
4.09460680733636e-283	-0.373372469132661	0.003	0.258	9.12073666334175e-279	RP11-571F15.3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24434
7.08154483370818e-282	1.39138639091411	0.994	0.83	1.5774141117085e-277	UBC	Malignant cells	GSE186960	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24435
2.69428162589942e-281	-0.365926392951215	0.003	0.254	6.00151232169097e-277	SERBP1P1	Malignant cells	GSE186960	ENSG00000213740	NA	NA	SERBP1P	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24436
6.30320686731459e-281	-1.8647904235074	0.851	0.993	1.40403932969432e-276	MT-ND4L	Malignant cells	GSE186960	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24437
6.68943390375238e-280	-0.389414745873585	0.006	0.278	1.49007140206084e-275	CTB-47B8.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24438
8.39622581589263e-280	1.10279345404669	1	0.981	1.87025930049008e-275	RPL23A	Malignant cells	GSE186960	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24439
3.73824189697994e-278	-0.932822028882801	0.999	1	8.32693382552281e-274	PSMA7	Malignant cells	GSE186960	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24440
5.44819147207112e-278	-0.547690985586451	0.022	0.362	1.21358465040384e-273	RPL30P4	Malignant cells	GSE186960	ENSG00000237676	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24441
1.11969261048368e-276	-0.883664256487831	0.062	0.497	2.4941152898524e-272	MTND2P28	Malignant cells	GSE186960	ENSG00000225630	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24442
1.97298882535626e-276	1.10273758190905	1	1	4.39483260848107e-272	MT-ND3	Malignant cells	GSE186960	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24443
7.66093433311108e-276	-1.24780665151835	0.204	0.738	1.70647312270049e-271	RP11-51O6.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24444
7.78546894360295e-275	1.34506182380112	0.986	0.712	1.73421320718756e-270	PHB	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24445
4.22190243974308e-269	1.14779439308949	0.999	0.943	9.40428768452771e-265	EIF5A	Malignant cells	GSE186960	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24446
4.87521210202417e-269	-0.399247230024948	0.009	0.288	1.08595349572588e-264	RP11-112J1.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24447
6.07447150424595e-266	1.22794872521761	1	1	1.35308852757078e-261	MT-ATP6	Malignant cells	GSE186960	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24448
6.92469078010755e-266	-0.35687113685826	0.005	0.255	1.54247487126896e-261	RP11-40C6.2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24449
2.06143454473112e-264	-0.627769830517086	0.034	0.4	4.59184544838856e-260	MORF4L1P1	Malignant cells	GSE186960	ENSG00000218283	NA	NA	MORF4LP1|MRG1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24450
4.84189620301846e-264	1.36911151879317	0.914	0.357	1.07853237922236e-259	STUB1	Malignant cells	GSE186960	ENSG00000103266	10273	STIP1 homology and U-box containing protein 1	CHIP|HSPABP2|NY-CO-7|SDCCAG7|UBOX1	protein_coding	Q9UNE7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24451
1.2838517183315e-263	1.45129393056378	0.959	0.524	2.85977970258342e-259	METRN	Malignant cells	GSE186960	ENSG00000103260	79006	meteorin, glial cell differentiation regulator	C16orf23|MGC2601	protein_coding	Q9UJH8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24452
3.61254699181729e-263	-1.51561574963233	0.645	0.957	8.04694842427302e-259	RPF2	Malignant cells	GSE186960	ENSG00000197498	84154	ribosome production factor 2 homolog	bA397G5.4|BXDC1|FLJ21087	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24453
8.60410351596401e-261	-1.11413538449279	0.165	0.682	1.91656405818098e-256	TIMM21	Malignant cells	GSE186960	ENSG00000075336	29090	translocase of inner mitochondrial membrane 21	C18orf55|HSPC154|TIM21	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24454
1.19564373559098e-260	-1.05950884976457	0.998	1	2.66329642102891e-256	RTN4	Malignant cells	GSE186960	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24455
1.36450260116111e-260	-0.810835311740368	0.077	0.523	3.03942954408637e-256	POLDIP2	Malignant cells	GSE186960	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24456
2.0759190902323e-260	-0.629617192316789	0.038	0.411	4.62410977349246e-256	CIRH1A	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24457
6.65236324392918e-260	-0.838995191771938	0.096	0.567	1.48181391258522e-255	RP11-466H18.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24458
1.95199501434055e-259	-0.443810380208057	0.017	0.325	4.34806889444357e-255	RPS15AP1	Malignant cells	GSE186960	ENSG00000214535	NA	NA	dJ872K7.6	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24459
1.81855269351925e-258	0.977301754748437	1	1	4.05082612481413e-254	MT-CO3	Malignant cells	GSE186960	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24460
9.2233780810686e-258	-1.33948283769757	0.829	0.996	2.05450746755803e-253	SSRP1	Malignant cells	GSE186960	ENSG00000149136	6749	structure specific recognition protein 1	FACT80	protein_coding	Q08945	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24461
9.74853294203985e-258	1.33858792285457	0.978	0.602	2.17148571283938e-253	POLR2A	Malignant cells	GSE186960	ENSG00000284832	5430	RNA polymerase II subunit A	POLR2|POLRA|RPB1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24462
1.33035099211628e-256	1.42099125035956	0.925	0.408	2.96335683493902e-252	JUND	Malignant cells	GSE186960	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24463
3.5674557249271e-256	-1.20749958419512	0.029	0.367	7.94650762727512e-252	KRT19	Malignant cells	GSE186960	ENSG00000171345	3880	keratin 19	CK19|K19|K1CS|MGC15366	protein_coding	P08727	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24464
2.78432010901342e-255	-0.876773164602382	1	1	6.2020730428274e-251	LDHB	Malignant cells	GSE186960	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24465
4.67388073470593e-253	-0.785154199280401	1	1	1.04110693365575e-248	RPL27A	Malignant cells	GSE186960	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24466
4.16484254112987e-252	0.801374096395365	1	1	9.27718676036678e-248	RPS4X	Malignant cells	GSE186960	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24467
1.38869938180766e-251	1.29349286742474	0.966	0.609	3.09332787297655e-247	DDT	Malignant cells	GSE186960	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24468
6.3095233261925e-249	-0.95156297652427	0.105	0.57	1.40544632090938e-244	EIF5AL1	Malignant cells	GSE186960	ENSG00000253626	143244	eukaryotic translation initiation factor 5A like 1	bA342M3.3|EIF5AP1	protein_coding	Q6IS14	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24469
9.33781797241205e-249	1.31191912334972	0.951	0.513	2.07999895335478e-244	TRIM28	Malignant cells	GSE186960	ENSG00000130726	10155	tripartite motif containing 28	KAP-1|KAP1|PPP1R157|RNF96|TF1B|TIF1-beta|TIF1B|TIF1beta	protein_coding	Q13263	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24470
1.63660147312422e-248	-0.924810836039629	0.999	1	3.6455297813842e-244	EIF3K	Malignant cells	GSE186960	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24471
3.44276109030967e-247	-1.19490376113753	0.966	1	7.66875032866478e-243	ARPC2	Malignant cells	GSE186960	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24472
2.47901320032263e-246	-1.0885750323812	0.981	1	5.52200190371865e-242	TPM3	Malignant cells	GSE186960	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24473
5.06305161902783e-246	1.27041226502001	0.879	0.307	1.12779474813845e-241	PSMA1	Malignant cells	GSE186960	ENSG00000129084	5682	proteasome 20S subunit alpha 1	HC2|MGC14542|MGC14575|MGC14751|MGC1667|MGC21459|MGC22853|MGC23915|NU|PROS30	protein_coding	P25786	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24474
2.49685573103647e-245	1.32009478281135	0.956	0.569	5.56174614088374e-241	SRM	Malignant cells	GSE186960	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24475
5.57596830720197e-245	-0.45606325509102	0.019	0.321	1.24204694042924e-240	RP11-393N4.2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24476
1.19980241818053e-243	-0.928837873253626	0.999	1	2.67255988649714e-239	SPINT2	Malignant cells	GSE186960	ENSG00000167642	10653	serine peptidase inhibitor, Kunitz type 2	HAI-2|HAI2|Kop	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24477
2.69830313513254e-243	-0.50028164942252	0.028	0.358	6.01047023350774e-239	NACA3P	Malignant cells	GSE186960	ENSG00000121089	NA	NA	NACA3	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24478
3.73053672445373e-243	-1.15009944522446	0.989	1	8.30977055372069e-239	SLC25A5	Malignant cells	GSE186960	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24479
4.11704405789688e-241	1.27038991231858	0.895	0.358	9.17071563896531e-237	EMC6	Malignant cells	GSE186960	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24480
2.06924896115715e-239	-1.34560745920168	0.955	1	4.60925206097755e-235	EBNA1BP2	Malignant cells	GSE186960	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24481
1.00967052729414e-238	-1.83286463709888	0.671	0.967	2.2490410995477e-234	TM4SF1	Malignant cells	GSE186960	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24482
1.52694513586177e-238	-1.15239105947012	0.955	1	3.40127029013209e-234	NOP56	Malignant cells	GSE186960	ENSG00000101361	10528	NOP56 ribonucleoprotein	NOL5A|SCA36	protein_coding	O00567	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24483
2.26094460478639e-238	-0.354257627023575	0.008	0.252	5.03625410716169e-234	RP11-314A20.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24484
7.43743935340087e-238	-1.4030210831089	0.839	0.993	1.65668961597004e-233	PDIA3	Malignant cells	GSE186960	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24485
2.84571683646674e-237	0.951002572222714	1	1	6.33883425322967e-233	MT-CYB	Malignant cells	GSE186960	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24486
1.8240045101385e-236	-0.403025017025016	0.013	0.282	4.0629700463335e-232	CTD-2192J16.15	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24487
2.36902288790019e-236	-0.94965522598946	0.998	1	5.27699848279767e-232	CCT6A	Malignant cells	GSE186960	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24488
1.85796260906322e-234	1.92877814506089	0.929	0.563	4.13861171168833e-230	GDF15	Malignant cells	GSE186960	ENSG00000130513	9518	growth differentiation factor 15	MIC-1|MIC1|NAG-1|PDF|PLAB|PTGFB	protein_coding	Q99988	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24489
1.33153923071931e-233	-1.31336987897608	0.658	0.958	2.96600363642727e-229	DLL3	Malignant cells	GSE186960	ENSG00000090932	10683	delta like canonical Notch ligand 3	SCDO1	protein_coding	Q9NYJ7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24490
1.18759669590483e-231	-1.13480508574508	0.205	0.702	2.64537164012801e-227	EIF4A1	Malignant cells	GSE186960	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24491
2.25699166894441e-230	-0.434807414337336	0.013	0.277	5.02744894257368e-226	PPIP5K2	Malignant cells	GSE186960	ENSG00000145725	23262	diphosphoinositol pentakisphosphate kinase 2	CFAP160|DFNB100|HISPPD1|KIAA0433|VIP2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24492
2.26123677996247e-230	0.978946488025304	1	0.956	5.0369049273664e-226	SUB1	Malignant cells	GSE186960	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24493
6.53315513691921e-230	-1.0948664471761	0.949	1	1.45526030674875e-225	PSMB4	Malignant cells	GSE186960	ENSG00000159377	5692	proteasome 20S subunit beta 4	HN3|PROS26	protein_coding	P28070	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24494
2.13573275751824e-229	-0.460742278290423	0.025	0.332	4.75734471737188e-225	RP11-488C13.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24495
2.82655363063757e-229	0.8751006999176	1	0.991	6.29614821224519e-225	RPSA	Malignant cells	GSE186960	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24496
3.26344348543253e-228	-1.22095155972503	0.816	0.991	7.26932036380097e-224	NDUFB6	Malignant cells	GSE186960	ENSG00000165264	4712	NADH:ubiquinone oxidoreductase subunit B6	B17|CI	protein_coding	O95139	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24497
4.28525461431967e-228	1.21313735454838	0.854	0.287	9.54540465339708e-224	NDUFB8.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24498
4.69807508307216e-228	-1.24259832418635	0.957	0.999	1.04649622475432e-223	HSP90B1	Malignant cells	GSE186960	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24499
1.7246720956969e-227	1.02545583648485	0.996	0.91	3.84170709316484e-223	CCT5	Malignant cells	GSE186960	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24500
2.73545135403962e-227	1.03570386024634	0.993	0.86	6.09321789112326e-223	TMA7	Malignant cells	GSE186960	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24501
6.70452079737864e-226	-1.00700418588715	0.99	1	1.49343200761609e-221	TIMM50	Malignant cells	GSE186960	ENSG00000105197	92609	translocase of inner mitochondrial membrane 50	TIM50|TIM50L	protein_coding	Q3ZCQ8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24502
1.39938353691072e-225	-0.509333274782576	0.021	0.312	3.11712682846864e-221	TM4SF18	Malignant cells	GSE186960	ENSG00000163762	116441	transmembrane 4 L six family member 18	L6D	protein_coding	Q96CE8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24503
8.91009984629547e-223	-1.29965926339016	0.555	0.907	1.98472474076232e-218	GRB2	Malignant cells	GSE186960	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24504
1.01085618276301e-222	-1.01473754392587	0.961	0.997	2.2516821471046e-218	SUPT5H	Malignant cells	GSE186960	ENSG00000196235	6829	SPT5 homolog, DSIF elongation factor subunit	FLJ34157|SPT5|SPT5H	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24505
9.70955007933994e-222	-0.583925707845322	0.042	0.387	2.16280228017297e-217	SNRPN	Malignant cells	GSE186960	ENSG00000128739	6638	small nuclear ribonucleoprotein polypeptide N	HCERN3|PWCR|RT-LI|SM-D|SMN|SNRNP-N|SNURF-SNRPN	protein_coding	P63162	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24506
1.60363162312023e-221	-0.470021169897787	0.024	0.322	3.57208944050032e-217	HMGB1P5	Malignant cells	GSE186960	ENSG00000132967	NA	NA	HMG1L5|HMGB1L15|HMGB1L5|HMGB1P2	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24507
1.75095642822178e-221	-1.06533525665842	0.979	1	3.90025544386402e-217	MYL12B	Malignant cells	GSE186960	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24508
1.03249037640906e-220	-1.34463989301301	0.499	0.888	2.29987231345119e-216	ANP32E	Malignant cells	GSE186960	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24509
3.26673971972862e-220	0.604939107923929	1	1	7.2766627256955e-216	RPL8	Malignant cells	GSE186960	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24510
1.09936161027732e-219	-0.351157892299286	0.012	0.262	2.44882798689273e-215	TAZ	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24511
1.70160079682576e-219	1.15956386073685	0.935	0.529	3.79031577492939e-215	USP22	Malignant cells	GSE186960	ENSG00000124422	23326	ubiquitin specific peptidase 22	KIAA1063|USP3L	protein_coding	Q9UPT9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24512
5.30184498171773e-219	-0.395067013429727	0.011	0.255	1.18098596967762e-214	PROCR	Malignant cells	GSE186960	ENSG00000101000	10544	protein C receptor	CCD41|CD201|EPCR	protein_coding	Q9UNN8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24513
1.90477126669425e-217	-0.786929229841034	0.999	1	4.24287799656145e-213	RPL27	Malignant cells	GSE186960	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24514
3.7188358752662e-217	1.12304585690322	0.965	0.672	8.28370691215547e-213	RPS26	Malignant cells	GSE186960	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24515
2.53906535463837e-216	0.825264590274294	1	0.996	5.65576807745696e-212	UBB	Malignant cells	GSE186960	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24516
3.05655477445099e-216	1.19764366483676	0.839	0.281	6.80847576008959e-212	MAZ	Malignant cells	GSE186960	ENSG00000103495	4150	MYC associated zinc finger protein	Pur-1|ZF87|Zif87|ZNF801	protein_coding	P56270	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24517
4.3406806120894e-216	-0.589490057708677	1	1	9.66886606342913e-212	RPLP2	Malignant cells	GSE186960	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24518
1.79295720508839e-215	-0.419636979695983	0.013	0.264	3.99381217433438e-211	SYNM	Malignant cells	GSE186960	ENSG00000182253	23336	synemin	DMN|KIAA0353|SYN	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24519
5.08517957391217e-215	0.809550611856339	1	1	1.13272375008893e-210	MT-CO1	Malignant cells	GSE186960	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24520
5.31205913224482e-215	1.16188898663871	0.829	0.254	1.18326117170753e-210	PSMA2.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24521
1.65779758589363e-214	0.754496744924946	1	1	3.69274412257807e-210	TPT1	Malignant cells	GSE186960	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24522
2.31627928671126e-214	-0.427798637812756	0.022	0.305	5.15951211114933e-210	RP11-889L3.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24523
7.31823432138109e-214	-0.897944213357837	0.995	0.999	1.63013669508764e-209	NUCKS1	Malignant cells	GSE186960	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24524
1.25034420224114e-213	-1.1080099133612	0.912	0.997	2.78514171049215e-209	EIF5B	Malignant cells	GSE186960	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24525
3.44399505695314e-213	-0.63154255157225	0.052	0.408	7.67149898936313e-209	GTF2I	Malignant cells	GSE186960	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24526
6.8400935708614e-212	-1.07721669245335	0.893	0.997	1.52363084290938e-207	SNRPC	Malignant cells	GSE186960	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24527
6.96236427515899e-212	-1.19834981854621	0.184	0.653	1.55086664229166e-207	ITGA2	Malignant cells	GSE186960	ENSG00000164171	3673	integrin subunit alpha 2	CD49B	protein_coding	P17301	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24528
1.89459611679345e-211	-0.674940787607141	1	1	4.2202128501574e-207	RPL35A	Malignant cells	GSE186960	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24529
9.31664305149265e-206	0.964475050154484	0.992	0.881	2.07528223971999e-201	SUMO2	Malignant cells	GSE186960	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24530
3.28090338978919e-205	-0.700800228244892	0.075	0.46	7.30821230075543e-201	RPS23P8	Malignant cells	GSE186960	ENSG00000230629	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24531
1.6030900108352e-204	-0.429300662977988	0.022	0.297	3.5708829991354e-200	HSP90B2P	Malignant cells	GSE186960	ENSG00000259706	NA	NA	GRP94b|GRP94P1|HSPCP2|TRA1P1|TRAP1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24532
7.14721181616455e-204	1.10733795035988	0.836	0.304	1.59204143205065e-199	MPG	Malignant cells	GSE186960	ENSG00000103152	4350	N-methylpurine DNA glycosylase	MDG	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24533
8.7378920870223e-203	1.03898916207058	0.985	0.815	1.94636546238422e-198	MTHFD2	Malignant cells	GSE186960	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24534
1.64833980796593e-202	-1.24776154239514	0.44	0.825	3.6716769222441e-198	MRPS21	Malignant cells	GSE186960	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24535
5.13205632242751e-201	1.17207853691968	0.876	0.427	1.14316554582073e-196	EMP3	Malignant cells	GSE186960	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24536
4.7343413072408e-199	1.12258222600968	0.938	0.609	1.05457452618789e-194	RAB32	Malignant cells	GSE186960	ENSG00000118508	10981	RAB32, member RAS oncogene family	NA	protein_coding	Q13637	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24537
3.38353630836295e-198	0.72634862573805	1	1	7.53682712687847e-194	EIF1	Malignant cells	GSE186960	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24538
1.08349521072749e-197	-1.07182422938901	0.122	0.539	2.41348558189549e-193	MT1A	Malignant cells	GSE186960	ENSG00000205362	4489	metallothionein 1A	MT1|MT1S	protein_coding	P04731	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24539
1.62895610345711e-197	-1.11942388147898	0.642	0.934	3.62849972045072e-193	SSBP1	Malignant cells	GSE186960	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24540
8.30381605876882e-197	0.976552576594822	0.987	0.801	1.84967502709075e-192	ST13	Malignant cells	GSE186960	ENSG00000100380	6767	ST13 Hsp70 interacting protein	FAM10A1|HIP|HSPABP1|P48|SNC6	protein_coding	P50502	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24541
8.96704508229268e-197	-1.20070688870755	0.385	0.795	1.99740929208069e-192	GTPBP4	Malignant cells	GSE186960	ENSG00000107937	23560	GTP binding protein 4	CRFG|FLJ10686|FLJ10690|NGB|NOG1	protein_coding	Q9BZE4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24542
4.61408286456332e-196	1.06781393013132	0.906	0.468	1.02778695808148e-191	BRI3	Malignant cells	GSE186960	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24543
3.44651328783161e-195	1.05104683054248	0.945	0.628	7.67710834864492e-191	EIF1AX	Malignant cells	GSE186960	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24544
5.67804641402128e-195	-0.904370480173115	0.969	1	1.26478483872324e-190	HNRNPM	Malignant cells	GSE186960	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24545
5.96692189066152e-195	0.554026637456407	1	1	1.32913185114485e-190	RPS12	Malignant cells	GSE186960	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24546
1.29863675682354e-193	1.01092044643437	0.981	0.812	2.89271337582443e-189	YBX3	Malignant cells	GSE186960	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24547
2.47702692602455e-193	0.687585016051691	1	1	5.51757747771968e-189	RPL10A	Malignant cells	GSE186960	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24548
8.27374994026256e-193	1.07915711107205	0.891	0.448	1.84297779919349e-188	UBE2M	Malignant cells	GSE186960	ENSG00000130725	9040	ubiquitin conjugating enzyme E2 M	hUbc12|UBC12	protein_coding	P61081	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24549
1.57236789974683e-192	-1.0868443732208	0.796	0.983	3.50244949668606e-188	ROMO1	Malignant cells	GSE186960	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24550
2.40301238084922e-192	-0.352314779714613	0.016	0.256	5.35271007834163e-188	NDUFV2P1	Malignant cells	GSE186960	ENSG00000267809	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24551
3.88500242522467e-192	1.12477966970261	0.994	0.957	8.65384290218794e-188	S100A11	Malignant cells	GSE186960	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24552
4.03277122798787e-190	-1.0794344465064	0.697	0.957	8.98299791034299e-186	HTATSF1	Malignant cells	GSE186960	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24553
6.09232858297214e-190	-1.458308422555	0.761	0.971	1.35706619185704e-185	CD59	Malignant cells	GSE186960	ENSG00000085063	966	CD59 molecule (CD59 blood group)	16.3A5|EJ16|EJ30|EL32|G344|MIC11|MIN1|MIN2|MIN3|MSK21|p18-20	protein_coding	P13987	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24554
1.74719229151973e-189	-0.715429932914193	0.084	0.461	3.89187082936019e-185	DNAJC7	Malignant cells	GSE186960	ENSG00000168259	7266	DnaJ heat shock protein family (Hsp40) member C7	TPR2|TTC2	protein_coding	Q99615	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24555
3.62719455187257e-189	-0.386152573673288	0.019	0.269	8.07957586429615e-185	NSRP1P1	Malignant cells	GSE186960	ENSG00000235613	NA	NA	CCDC55P1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24556
9.65408716680711e-189	-1.12618608804152	0.441	0.824	2.15044791640628e-184	BCCIP	Malignant cells	GSE186960	ENSG00000107949	56647	BRCA2 and CDKN1A interacting protein	BCCIPalpha|TOK-1	protein_coding	Q9P287	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24557
1.41595480962655e-188	0.81166739923558	0.999	0.984	3.15403933844314e-184	EEF2	Malignant cells	GSE186960	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24558
1.19825129972949e-187	0.591266227322226	1	1	2.66910477014745e-183	RPL13	Malignant cells	GSE186960	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24559
4.56983135894159e-187	-1.07596688137458	0.199	0.638	1.01792993520424e-182	SYCP2	Malignant cells	GSE186960	ENSG00000196074	10388	synaptonemal complex protein 2	SCP2	protein_coding	Q9BX26	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24560
7.29528872729566e-185	0.625873005906754	1	1	1.62502556400511e-180	RPS7	Malignant cells	GSE186960	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24561
1.51894580360648e-184	-0.639849114927745	0.064	0.408	3.38345177753344e-180	COX6A1P2	Malignant cells	GSE186960	ENSG00000226976	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24562
7.08197498447516e-184	0.746743130059031	0.999	0.999	1.57750992779184e-179	HMGB1	Malignant cells	GSE186960	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24563
5.55367568585059e-183	-1.27073987159403	0.234	0.656	1.23708125902322e-178	PDLIM1	Malignant cells	GSE186960	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24564
2.97701715037343e-182	-0.413237402810275	0.028	0.299	6.63130570245683e-178	RPL7AP6	Malignant cells	GSE186960	ENSG00000242071	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24565
3.0373386126129e-182	1.06459275669631	0.935	0.622	6.76567175959524e-178	PHGDH	Malignant cells	GSE186960	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24566
3.73947542650801e-182	-0.436935701531523	0.036	0.328	8.32968151254659e-178	YBX1P2	Malignant cells	GSE186960	ENSG00000231167	NA	NA	TCAG_1818537	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24567
3.01947945040516e-180	1.12478826557879	0.815	0.325	6.72589047577748e-176	DDIT4	Malignant cells	GSE186960	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24568
3.91309491669935e-179	-1.17457275394766	0.45	0.814	8.7164189269478e-175	DNTTIP2	Malignant cells	GSE186960	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24569
8.45810483132812e-179	-0.696282629719705	0.998	1	1.88404285117834e-174	RPL4	Malignant cells	GSE186960	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24570
1.9006452193593e-178	0.838461409929273	0.998	0.979	4.23368722612284e-174	SET	Malignant cells	GSE186960	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24571
1.52909533106837e-176	-1.02144726823925	0.938	1	3.40605984995479e-172	HSPA8	Malignant cells	GSE186960	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24572
1.59332027558278e-176	1.10519205711258	0.79	0.278	3.54912091386064e-172	SESN2	Malignant cells	GSE186960	ENSG00000285069	83667	sestrin 2	DKFZp761M0212|HI95|SES2|SEST2	protein_coding	P58004	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24573
2.41344176782498e-175	-1.33933465412909	0.737	0.95	5.37594153783015e-171	AKAP12	Malignant cells	GSE186960	ENSG00000131016	9590	A-kinase anchoring protein 12	AKAP250|SSeCKS	protein_coding	Q02952	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24574
2.80688565576459e-175	-0.404388714378819	0.019	0.254	6.25233779821563e-171	ITGBL1	Malignant cells	GSE186960	ENSG00000198542	9358	integrin subunit beta like 1	OSCP|TIED	protein_coding	O95965	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24575
3.02819542460819e-175	-0.878076993773802	0.956	0.997	6.74530530831475e-171	NDUFA1	Malignant cells	GSE186960	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24576
3.45934528152853e-175	0.645890836168449	1	1	7.70569161460481e-171	RPL14	Malignant cells	GSE186960	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24577
1.5396912201817e-174	0.966141424338067	0.953	0.688	3.42966219295473e-170	NXN	Malignant cells	GSE186960	ENSG00000281300	64359	nucleoredoxin	FLJ12614|NRX	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24578
2.49180445200444e-173	-1.0788823918842	0.701	0.944	5.55049441683988e-169	NOLC1	Malignant cells	GSE186960	ENSG00000166197	9221	nucleolar and coiled-body phosphoprotein 1	KIAA0035|NOPP130|NOPP140|P130|Srp40	protein_coding	Q14978	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24579
4.80507543496075e-173	1.0268304965642	0.85	0.42	1.07033055313751e-168	SNHG16	Malignant cells	GSE186960	ENSG00000163597	100507246	small nucleolar RNA host gene 16	Nbla10727|Nbla12061|ncRAN	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24580
2.21799249370893e-171	-0.551375411236418	0.058	0.383	4.94057827973664e-167	UBE4A	Malignant cells	GSE186960	ENSG00000110344	9354	ubiquitination factor E4A	E4|KIAA0126|UBOX2|UFD2	protein_coding	Q14139	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24581
3.06973274582479e-171	1.1583906509191	0.923	0.653	6.83782969132472e-167	BTG1	Malignant cells	GSE186960	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24582
7.67628546497521e-171	0.972255926723275	0.846	0.384	1.70989258732323e-166	MAP2K2	Malignant cells	GSE186960	ENSG00000126934	5605	mitogen-activated protein kinase kinase 2	MEK2|PRKMK2	protein_coding	P36507	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24583
1.2866058267753e-170	0.869524644831363	0.988	0.852	2.86591447914199e-166	MZT2B	Malignant cells	GSE186960	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24584
4.71393640342324e-170	-1.02452200123697	0.202	0.619	1.05002933386253e-165	F2RL1	Malignant cells	GSE186960	ENSG00000164251	2150	F2R like trypsin receptor 1	GPR11|PAR2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24585
5.83949124671275e-170	-0.616500301698499	1	1	1.30074667520527e-165	RPS5	Malignant cells	GSE186960	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24586
1.2854221278889e-168	-0.799278648038154	0.975	1	2.86327778987253e-164	PSMA4	Malignant cells	GSE186960	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24587
3.55691176848215e-168	0.815043133441608	0.996	0.938	7.92302096429399e-164	PRDX5	Malignant cells	GSE186960	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24588
4.99569854907266e-168	1.06027136403648	0.843	0.426	1.11279185180593e-163	FBXO2	Malignant cells	GSE186960	ENSG00000116661	26232	F-box protein 2	Fbg1|Fbs1|FBX2|Nfb42|OCP1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24589
5.7030921795641e-168	0.844401761865564	0.995	0.931	1.2703637829979e-163	PRKDC	Malignant cells	GSE186960	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24590
5.92587129012032e-168	0.777661011959187	0.998	0.968	1.3199878298743e-163	RPL7	Malignant cells	GSE186960	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24591
3.5093981773656e-167	-1.03667755431963	0.645	0.928	7.81718444008187e-163	AMD1	Malignant cells	GSE186960	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24592
4.9776376921566e-167	0.711885407914063	1	1	1.10876879592788e-162	MT-ND4	Malignant cells	GSE186960	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24593
3.00604366562352e-166	-1.11041629176787	0.353	0.738	6.69596226517638e-162	PFKP	Malignant cells	GSE186960	ENSG00000067057	5214	phosphofructokinase, platelet	PFK-C|PFKF	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24594
7.4912801854984e-166	0.987534471899134	0.82	0.361	1.66868266131977e-161	MIF	Malignant cells	GSE186960	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24595
2.26005895203934e-165	-0.950376990471403	0.819	0.98	5.03428131566764e-161	SRRM1	Malignant cells	GSE186960	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24596
2.60389340980425e-165	0.886454283033676	0.985	0.794	5.80017257033897e-161	BSG	Malignant cells	GSE186960	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24597
3.27075988954634e-164	0.527713861969347	1	1	7.28561765396448e-160	RPS15	Malignant cells	GSE186960	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24598
5.78420099964597e-164	-0.736173088485989	0.091	0.446	1.28843077267114e-159	MBP	Malignant cells	GSE186960	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24599
1.52567008913893e-163	-0.605291892891377	0.053	0.355	3.39843012355696e-159	SLC4A11	Malignant cells	GSE186960	ENSG00000088836	83959	solute carrier family 4 member 11	BTR1|CDPD1|CHED2|dJ794I6.2|FECD4|NaBC1	protein_coding	Q8NBS3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24600
1.52631706527431e-163	0.827806986200777	0.996	0.938	3.39987126289852e-159	TPM2	Malignant cells	GSE186960	ENSG00000198467	7169	tropomyosin 2	AMCD1|DA1|NEM4	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24601
1.0266700259039e-162	0.995089139062325	0.827	0.38	2.28690748270095e-158	ACAT2	Malignant cells	GSE186960	ENSG00000120437	39	acetyl-CoA acetyltransferase 2	NA	protein_coding	Q9BWD1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24602
1.09092362860657e-162	0.905050939136347	0.956	0.699	2.43003238272114e-158	CD81	Malignant cells	GSE186960	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24603
1.225627736246e-162	0.916288905703127	0.924	0.629	2.73008578248797e-158	PGAM1	Malignant cells	GSE186960	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24604
1.77534557470119e-162	-0.363561000265806	0.025	0.269	3.95458226764689e-158	RP11-632C17--A.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24605
1.30706451017394e-161	0.993692735793054	0.663	0.099	2.91148619641244e-157	SDHD	Malignant cells	GSE186960	ENSG00000204370	6392	succinate dehydrogenase complex subunit D	cybS|PGL|PGL1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24606
1.36542691277558e-161	-0.884648928257344	0.944	0.997	3.0414884482076e-157	HDAC2	Malignant cells	GSE186960	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24607
2.33879451994615e-161	-0.928709282406988	0.967	0.996	5.20966479318006e-157	MYL12A	Malignant cells	GSE186960	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24608
4.23669793669397e-161	-0.343460666835187	0.022	0.254	9.43724465398581e-157	RAC1P2	Malignant cells	GSE186960	ENSG00000249936	NA	NA	Psi2Rac1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24609
6.66200711030591e-161	0.99028831312119	0.659	0.096	1.48396208382064e-156	TMBIM4.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24610
2.98936818273277e-160	0.917190594507383	0.968	0.775	6.65881762703725e-156	SLC3A2	Malignant cells	GSE186960	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24611
1.27697895468624e-159	0.571639863441738	1	1	2.8444706215636e-155	ACTB	Malignant cells	GSE186960	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24612
1.6789613422983e-159	-0.372945854426543	0.029	0.281	3.73988638996946e-155	RP3-417G15.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24613
3.04101853349505e-159	-0.391134380411018	0.032	0.289	6.77386878336022e-155	GPR107	Malignant cells	GSE186960	ENSG00000148358	57720	G protein-coupled receptor 107	FLJ20998|KIAA1624|LUSTR1|RP11-88G17	protein_coding	Q5VW38	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24614
7.48412437650127e-159	-0.571235411926199	0.037	0.304	1.66708870486566e-154	IFITM3	Malignant cells	GSE186960	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24615
8.56492494423739e-158	-0.610548558385328	0.079	0.415	1.90783703132888e-153	UBE2V1	Malignant cells	GSE186960	ENSG00000244687	7335	ubiquitin conjugating enzyme E2 V1	CROC-1|CROC1|UBE2V|UEV-1|UEV1A	protein_coding	Q13404	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24616
1.02942970173259e-157	0.891529328814978	0.983	0.852	2.29305466060934e-153	TMEM14B	Malignant cells	GSE186960	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24617
1.49824850731902e-157	0.99069760995418	0.847	0.444	3.33734855005311e-153	FDPS	Malignant cells	GSE186960	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24618
2.09629884209458e-157	-0.910192988350135	0.946	0.999	4.66950567076567e-153	DDX21	Malignant cells	GSE186960	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24619
7.17819140585185e-157	0.94313911926446	0.879	0.547	1.5989421356535e-152	ISOC2	Malignant cells	GSE186960	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24620
2.323903413168e-156	0.690610203703581	1	1	5.17649485283172e-152	ALDOA	Malignant cells	GSE186960	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24621
3.91944449343073e-156	-0.37886909896177	0.032	0.288	8.73056260911696e-152	YBX1P10	Malignant cells	GSE186960	ENSG00000213866	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24622
4.44115786892017e-156	0.90560924145039	0.938	0.688	9.89267915301969e-152	TCEA1	Malignant cells	GSE186960	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24623
1.20672135341521e-155	-0.887781489211868	0.847	0.986	2.68797181473239e-151	ILF3	Malignant cells	GSE186960	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24624
6.81096802908389e-155	-0.544530646335205	1	1	1.51714312847844e-150	ENO1	Malignant cells	GSE186960	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24625
7.658466724586e-155	-0.80711081315624	0.961	0.999	1.70592346290153e-150	USMG5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24626
1.23165961243477e-154	-0.930181038833116	0.695	0.936	2.74352178669844e-150	TMEM123	Malignant cells	GSE186960	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24627
4.19067487657012e-154	-0.574316524020824	1	1	9.33472828755994e-150	RPS20	Malignant cells	GSE186960	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24628
4.60349436491566e-154	-0.999001638922399	0.737	0.943	1.02542836978496e-149	GBAS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24629
7.19324473007263e-154	0.99438245212546	0.638	0.086	1.60229526362368e-149	MKI67IP	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24630
1.6502257680072e-152	0.918983653968757	0.926	0.636	3.67587789823603e-148	CD151	Malignant cells	GSE186960	ENSG00000177697	977	CD151 molecule (Raph blood group)	PETA-3|RAPH|SFA-1|TSPAN24	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24631
2.49183510204669e-152	-0.6500814800422	0.997	1	5.55056268980899e-148	COX6B1	Malignant cells	GSE186960	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24632
8.36394239558739e-152	0.576323998063073	1	0.999	1.86306816861709e-147	PPIA	Malignant cells	GSE186960	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24633
4.84080237926036e-151	0.959468678770481	0.672	0.14	1.07828872998024e-146	CDK4	Malignant cells	GSE186960	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24634
5.83912484427383e-151	-0.37911138515482	0.038	0.301	1.300665059062e-146	EEF1A1P5	Malignant cells	GSE186960	ENSG00000196205	NA	NA	EEF1AL3	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24635
7.53479988900886e-151	-0.538295611479121	0.067	0.377	1.67837667527672e-146	EIF2S2P4	Malignant cells	GSE186960	ENSG00000128692	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24636
4.09421177796054e-150	1.05767860810597	0.991	0.91	9.11985673540711e-146	DST	Malignant cells	GSE186960	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24637
4.74056552473715e-150	0.966075938450545	0.661	0.128	1.0559609706352e-145	AES	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24638
1.21658434388497e-149	0.913785486210747	0.83	0.407	2.70994162600377e-145	LY6E	Malignant cells	GSE186960	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24639
2.10622809908045e-149	0.696046340602856	0.997	0.97	4.69162309070171e-145	EEF1B2	Malignant cells	GSE186960	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24640
1.61656911732311e-148	-0.51168999435135	0.043	0.312	3.60090770883722e-144	AFAP1L2	Malignant cells	GSE186960	ENSG00000169129	84632	actin filament associated protein 1 like 2	Em:AC005383.4|FLJ14564|KIAA1914|XB130	protein_coding	Q8N4X5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24641
1.73202346866494e-148	-0.920230470335891	0.163	0.543	3.85808227645116e-144	CRABP2	Malignant cells	GSE186960	ENSG00000143320	1382	cellular retinoic acid binding protein 2	CRABP-II	protein_coding	P29373	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24642
1.66646842413514e-147	-0.784429333050793	0.952	0.999	3.71205841476102e-143	TBCB	Malignant cells	GSE186960	ENSG00000105254	1155	tubulin folding cofactor B	CG22|CKAP1|CKAPI	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24643
6.88420401214839e-147	1.07944865992307	0.86	0.514	1.53345644370605e-142	SCD	Malignant cells	GSE186960	ENSG00000099194	6319	stearoyl-CoA desaturase	FADS5|SCD1|SCDOS	protein_coding	O00767	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24644
3.06987511418153e-146	-0.826487602806321	0.98	1	6.83814681683936e-142	B2M	Malignant cells	GSE186960	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24645
3.35801045963392e-146	-0.524003334319282	1	1	7.47996829883457e-142	RPL38	Malignant cells	GSE186960	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24646
3.64209432703489e-146	-0.530864894301055	1	1	8.11276511347021e-142	RPS6	Malignant cells	GSE186960	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24647
7.95328652670598e-146	-0.948882134615418	0.35	0.718	1.77159457382376e-141	RP11-425L10.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24648
8.78748904079659e-145	1.33130011913081	0.85	0.557	1.95741318383744e-140	GADD45A	Malignant cells	GSE186960	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24649
1.39092704654377e-144	-1.0889738413645	0.452	0.781	3.09828999617624e-140	GNL3	Malignant cells	GSE186960	ENSG00000163938	26354	G protein nucleolar 3	C77032|E2IG3|MGC800|NS	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24650
1.69429908881398e-144	0.961944142231421	0.743	0.281	3.77405122033315e-140	NPW	Malignant cells	GSE186960	ENSG00000183971	283869	neuropeptide W	PPL8	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24651
5.85499045030864e-144	-0.950986620686186	0.682	0.905	1.30419912280625e-139	THOC2	Malignant cells	GSE186960	ENSG00000125676	57187	THO complex subunit 2	CXorf3|dJ506G2.1|MRX12|MRX35|THO2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24652
4.49913705492235e-143	0.831040589661332	0.964	0.815	1.00218277898395e-138	ATP5D	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24653
1.67329167806864e-142	0.907723139880137	0.737	0.262	3.7272572128979e-138	PYCR1	Malignant cells	GSE186960	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24654
2.40620234093916e-142	-0.629562181515277	0.999	1	5.35981571444199e-138	RPL23	Malignant cells	GSE186960	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24655
8.83636928195394e-142	0.821835271357374	0.974	0.794	1.96830125755524e-137	SLC38A2	Malignant cells	GSE186960	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24656
1.50919143393105e-141	-0.444789361588425	0.03	0.265	3.36172391908141e-137	BCL2A1	Malignant cells	GSE186960	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24657
4.29788067952067e-141	-1.36030587791275	0.223	0.6	9.57352921363229e-137	S100A4	Malignant cells	GSE186960	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24658
1.20617940798909e-140	-0.865811433482355	0.232	0.615	2.68676463129571e-136	MRPS36	Malignant cells	GSE186960	ENSG00000278461	92259	mitochondrial ribosomal protein S36	DC47|MRP-S36	protein_coding	P82909	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24659
9.48314884670913e-140	0.6901998386774	1	1	2.11237140560446e-135	MT-ND1	Malignant cells	GSE186960	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24660
1.17330559457284e-139	-0.548728147000711	1	1	2.61353821191101e-135	ANXA2	Malignant cells	GSE186960	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24661
1.45623728345754e-139	0.863921993675592	0.899	0.607	3.24376854890168e-135	ZNF593	Malignant cells	GSE186960	ENSG00000142684	51042	zinc finger protein 593	ZT86	protein_coding	O00488	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24662
1.93008798005874e-139	0.415648839750911	1	1	4.29927097558084e-135	RPLP1	Malignant cells	GSE186960	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24663
4.27132677589477e-139	0.890901702751987	0.727	0.248	9.51438039330561e-135	GCSH	Malignant cells	GSE186960	ENSG00000140905	2653	glycine cleavage system protein H	NA	protein_coding	P23434	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24664
1.95752594254755e-138	0.863654649210525	0.841	0.483	4.36038903702466e-134	COPE	Malignant cells	GSE186960	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24665
3.10116431940274e-137	0.631405797711017	1	1	6.90784352146959e-133	RPL21	Malignant cells	GSE186960	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24666
3.24232484621687e-137	-0.619402697113899	0.065	0.354	7.22227859494808e-133	INHBB	Malignant cells	GSE186960	ENSG00000163083	3625	inhibin subunit beta B	NA	protein_coding	P09529	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24667
4.01150926446077e-137	-1.20678506368017	0.357	0.708	8.93563688658637e-133	ETS2	Malignant cells	GSE186960	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24668
1.40992559159338e-136	-0.842407148434966	0.896	0.991	3.14060925527424e-132	SRSF2	Malignant cells	GSE186960	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24669
1.80279220366127e-136	1.04094624057351	0.682	0.196	4.01571963365548e-132	MARCKS	Malignant cells	GSE186960	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24670
2.49594236222635e-136	-1.14328429757024	0.654	0.918	5.55971161185919e-132	PRSS23	Malignant cells	GSE186960	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24671
3.12560065957852e-136	0.78789683214364	0.937	0.711	6.96227546921116e-132	PPP1CA	Malignant cells	GSE186960	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24672
3.27474243524432e-136	0.82323386607568	0.931	0.702	7.29448877450671e-132	COX20	Malignant cells	GSE186960	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24673
8.34279141428703e-136	0.95921237831233	0.535	0.01	1.85835678753244e-131	MFSD12	Malignant cells	GSE186960	ENSG00000161091	126321	major facilitator superfamily domain containing 12	C19orf28|MGC20700|PP3501	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24674
5.33657318621291e-135	0.933104248169451	0.83	0.453	1.18872167722893e-130	DDIT3	Malignant cells	GSE186960	ENSG00000175197	1649	DNA damage inducible transcript 3	CHOP|CHOP10|GADD153	protein_coding	P35638	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24675
3.11206712741645e-134	-0.814707261253282	0.901	0.991	6.93212952632014e-130	COX6A1	Malignant cells	GSE186960	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24676
8.29873357636842e-134	-0.756505889413867	0.915	0.996	1.84854290413607e-129	RHOA	Malignant cells	GSE186960	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24677
4.26389375425088e-133	0.849116622539218	0.515	0	9.49782333759384e-129	AC007390.5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24678
7.26091132066322e-131	0.998569643160311	0.648	0.158	1.61736799667773e-126	ATF3	Malignant cells	GSE186960	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24679
9.09760494154321e-129	0.883494647686491	0.723	0.269	2.02649150072875e-124	SLC7A5	Malignant cells	GSE186960	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24680
1.82678301713765e-128	-0.942715459575008	0.435	0.749	4.06915917067412e-124	SMARCE1	Malignant cells	GSE186960	ENSG00000073584	6605	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1	BAF57	protein_coding	Q969G3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24681
3.50590682587651e-128	-0.729825811728511	0.939	0.991	7.80940745463993e-124	PEBP1	Malignant cells	GSE186960	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24682
5.73654845034268e-128	0.819440195684294	0.826	0.448	1.27781616731383e-123	ALYREF	Malignant cells	GSE186960	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24683
1.62907607709553e-127	-0.820370633787652	0.856	0.983	3.62876696173029e-123	DNMT1	Malignant cells	GSE186960	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24684
3.27920572624734e-127	0.839651544723088	0.874	0.55	7.30443075521594e-123	LMO4	Malignant cells	GSE186960	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24685
3.05972915966683e-126	-0.484151537924954	0.073	0.361	6.81554670315787e-122	RP11-169K16.7	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24686
9.42567089451398e-126	-0.342758094510191	0.04	0.278	2.09956819175299e-121	RPS2P46	Malignant cells	GSE186960	ENSG00000189343	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24687
1.4609398102585e-125	0.637638038890749	1	1	3.25424342735082e-121	TMSB4X	Malignant cells	GSE186960	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24688
1.79199176636172e-125	0.825205746232867	0.503	0.007	3.99166165957073e-121	ILK	Malignant cells	GSE186960	ENSG00000166333	3611	integrin linked kinase	NA	protein_coding	Q13418	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24689
2.11857901530975e-125	0.910393909277873	0.936	0.749	4.71913475660246e-121	BASP1	Malignant cells	GSE186960	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24690
2.45180488827065e-125	-0.853267981539585	0.673	0.894	5.46139538862287e-121	C1orf43	Malignant cells	GSE186960	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24691
2.77408289535706e-125	-0.77943947598402	0.933	0.996	6.17926964940785e-121	DNAJA1	Malignant cells	GSE186960	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24692
4.04074689337816e-125	-1.13505442237766	0.884	0.963	9.00076370499986e-121	MT1L	Malignant cells	GSE186960	ENSG00000260549	NA	NA	MT1|MT1R|MTF	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24693
4.7159991378665e-125	0.517245908093179	1	1	1.05048880795976e-120	RPL41	Malignant cells	GSE186960	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24694
8.89489017798932e-125	0.651199667075645	0.998	0.958	1.98133678714712e-120	YWHAZ	Malignant cells	GSE186960	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24695
1.14494852384756e-124	-0.648985281552696	0.994	1	2.55037283687043e-120	ATP5G1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24696
8.07895220950701e-124	0.592370801846885	1	1	1.79958660466769e-119	PERP	Malignant cells	GSE186960	ENSG00000112378	64065	p53 apoptosis effector related to PMP22	dJ496H19.1|KCP1|KRTCAP1|PIGPC1|THW	protein_coding	Q96FX8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24697
2.27276456600142e-123	-0.733441915216157	0.963	0.999	5.06258307076817e-119	RSL1D1	Malignant cells	GSE186960	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24698
4.3405247934042e-123	-1.18741411336832	0.635	0.861	9.66851897730786e-119	UACA	Malignant cells	GSE186960	ENSG00000137831	55075	uveal autoantigen with coiled-coil domains and ankyrin repeats	FLJ10128|KIAA1561	protein_coding	Q9BZF9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24699
5.75944001464909e-123	0.728894732077164	0.969	0.854	1.28291526326309e-118	EIF3E	Malignant cells	GSE186960	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24700
6.67802922917467e-123	0.864885865576761	0.519	0.023	1.48753101079866e-118	SLC7A11	Malignant cells	GSE186960	ENSG00000151012	23657	solute carrier family 7 member 11	xCT	protein_coding	Q9UPY5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24701
2.82267833283385e-122	-0.922343834767357	0.53	0.822	6.2875159863874e-118	TAF1D	Malignant cells	GSE186960	ENSG00000166012	79101	TATA-box binding protein associated factor, RNA polymerase I subunit D	JOSD3|MGC5306|TAF(I)41	protein_coding	Q9H5J8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24702
1.23079480759786e-121	0.540264331206031	1	0.999	2.74159543392422e-117	C1QBP	Malignant cells	GSE186960	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24703
1.60892262417856e-121	0.60345997905547	0.999	0.989	3.58387514535775e-117	SNRPB	Malignant cells	GSE186960	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24704
3.73586329413949e-121	-0.756042817074574	0.727	0.933	8.32163548769572e-117	RPF1	Malignant cells	GSE186960	ENSG00000117133	80135	ribosome production factor 1 homolog	BXDC5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24705
4.27416380939902e-121	-1.02656809851346	0.455	0.751	9.52069988543631e-117	ETFA	Malignant cells	GSE186960	ENSG00000140374	2108	electron transfer flavoprotein subunit alpha	EMA|GA2|MADD	protein_coding	P13804	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24706
5.0907602072821e-121	0.846899797181087	0.663	0.203	1.13396683617209e-116	BARX1	Malignant cells	GSE186960	ENSG00000131668	56033	BARX homeobox 1	NA	protein_coding	Q9HBU1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24707
5.23959241078217e-121	-0.821556346385253	0.663	0.895	1.16711920950173e-116	CISD1	Malignant cells	GSE186960	ENSG00000122873	55847	CDGSH iron sulfur domain 1	C10orf70|MDS029|mitoNEET|ZCD1	protein_coding	Q9NZ45	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24708
1.04471289448351e-120	0.775638102260254	0.882	0.58	2.32709797246202e-116	PSMC1	Malignant cells	GSE186960	ENSG00000100764	5700	proteasome 26S subunit, ATPase 1	p56|RPT2|S4	protein_coding	P62191	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24709
1.11088574739655e-120	0.822103770519095	0.928	0.731	2.47449800232581e-116	APP	Malignant cells	GSE186960	ENSG00000142192	351	amyloid beta precursor protein	AD1|alpha-sAPP	protein_coding	P05067	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24710
1.28525485239645e-120	0.403626463677279	1	1	2.86290518371309e-116	RPS14	Malignant cells	GSE186960	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24711
4.21565474289196e-120	0.836456322273948	0.707	0.265	9.39037093979183e-116	AC013394.2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24712
4.66064452416425e-120	-0.860309570738266	0.407	0.734	1.03815856775759e-115	MRPL24	Malignant cells	GSE186960	ENSG00000143314	79590	mitochondrial ribosomal protein L24	MRP-L18	protein_coding	Q96A35	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24713
4.95334080469105e-120	-0.664199596561964	0.983	1	1.10335666424493e-115	SLIRP	Malignant cells	GSE186960	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24714
1.12971539875679e-119	-0.524169319757123	1	1	2.51644105073075e-115	RPL34	Malignant cells	GSE186960	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24715
2.13988387527568e-119	-0.850420877220422	0.291	0.636	4.76659133217659e-115	RPL17	Malignant cells	GSE186960	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24716
7.82759166535985e-119	0.851589609477524	0.73	0.302	1.74359604345891e-114	STC2	Malignant cells	GSE186960	ENSG00000113739	8614	stanniocalcin 2	STC-2	protein_coding	O76061	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24717
2.29011691506624e-118	-0.926238092175915	0.389	0.729	5.10123542831006e-114	PRPF38B	Malignant cells	GSE186960	ENSG00000134186	55119	pre-mRNA processing factor 38B	FLJ10330|NET1	protein_coding	Q5VTL8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24718
3.3158082709725e-118	0.408338283411825	1	1	7.38596292359124e-114	RPL37	Malignant cells	GSE186960	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24719
6.47816909870529e-118	-0.801162095749247	0.743	0.933	1.4430121667366e-113	SUCLG1	Malignant cells	GSE186960	ENSG00000163541	8802	succinate-CoA ligase GDP/ADP-forming subunit alpha	NA	protein_coding	P53597	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24720
6.54591816861088e-118	-0.652395372227821	0.985	0.999	1.45810327205807e-113	STMN1	Malignant cells	GSE186960	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24721
3.51647639658847e-117	-0.751936304215286	0.785	0.967	7.83295117340082e-113	MRPS35	Malignant cells	GSE186960	ENSG00000061794	60488	mitochondrial ribosomal protein S35	MDS023|MRPS28	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24722
1.04355941100003e-116	0.839598653264745	0.622	0.15	2.32452858800257e-112	CEBPB	Malignant cells	GSE186960	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24723
1.57059451180647e-116	0.844515948875415	0.789	0.424	3.49849927504892e-112	XBP1	Malignant cells	GSE186960	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24724
1.57128131612185e-116	0.840461565437925	0.69	0.256	3.50002913166142e-112	HERPUD1	Malignant cells	GSE186960	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24725
9.95589008781337e-116	0.774774945448458	0.47	0	2.21767451706043e-111	ITFG3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24726
1.65099879519337e-115	-0.492494627405026	1	1	3.67759981629322e-111	RPS13	Malignant cells	GSE186960	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24727
4.76665412674963e-115	-0.724512291628108	0.908	0.989	1.06177220673348e-110	MATR3	Malignant cells	GSE186960	ENSG00000015479	9782	matrin 3	ALS21|MPD2|VCPDM|KIAA0723|MGC9105	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24728
9.68449649651907e-115	0.899776900397044	0.519	0.043	2.15722159459962e-110	AMIGO2	Malignant cells	GSE186960	ENSG00000139211	347902	adhesion molecule with Ig like domain 2	ALI1|DEGA	protein_coding	Q86SJ2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24729
3.46472169066244e-114	-0.577812584191926	0.996	0.999	7.71766756595059e-110	MYL6	Malignant cells	GSE186960	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24730
3.48370448973063e-114	-0.818660079601646	0.637	0.878	7.75995175087498e-110	CDC5L	Malignant cells	GSE186960	ENSG00000096401	988	cell division cycle 5 like	CDC5|CEF1|hCDC5|PCDC5RP	protein_coding	Q99459	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24731
5.80003587864677e-114	0.867028876858933	0.571	0.107	1.29195799196857e-109	PRDX2	Malignant cells	GSE186960	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24732
9.89912746772405e-114	0.749426047471134	0.876	0.605	2.20503064343553e-109	PGLS	Malignant cells	GSE186960	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24733
1.44539740710444e-113	-0.763944691152486	0.865	0.981	3.21962272432513e-109	LRRFIP1	Malignant cells	GSE186960	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24734
2.69470620359308e-113	0.817718576108165	0.649	0.205	6.00245806850357e-109	VAMP2	Malignant cells	GSE186960	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24735
1.91276838865893e-111	0.67326733764485	0.985	0.921	4.26069158573777e-107	NME4	Malignant cells	GSE186960	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24736
4.55973068490486e-111	0.881976826153138	0.525	0.056	1.01568001006256e-106	RP11-390P2.4	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24737
6.00355502089816e-111	0.789004904215573	0.547	0.079	1.33729188090506e-106	PITPNA-AS1	Malignant cells	GSE186960	ENSG00000236618	100306951	PITPNA antisense RNA 1	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24738
6.6579806715277e-111	-0.818906544288421	0.49	0.782	1.48306519458279e-106	TMEM126A	Malignant cells	GSE186960	ENSG00000171202	84233	transmembrane protein 126A	DKFZp586C1924|OPA7	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24739
9.39242339890285e-111	0.786106665185784	0.792	0.44	2.09216231210561e-106	FAT1	Malignant cells	GSE186960	ENSG00000083857	2195	FAT atypical cadherin 1	CDHF7|CDHR8|FAT	protein_coding	Q14517	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24740
3.19369038976615e-110	0.782272312727066	0.547	0.079	7.1139453432041e-106	FKBP8	Malignant cells	GSE186960	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24741
1.4008081647909e-109	-1.01848927831273	0.946	0.981	3.12030018707173e-105	KRT18	Malignant cells	GSE186960	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24742
2.91725756679639e-109	-0.88897332899041	0.386	0.689	6.49819123003897e-105	PTPN11	Malignant cells	GSE186960	ENSG00000179295	5781	protein tyrosine phosphatase non-receptor type 11	BPTP3|NS1|PTP2C|SH-PTP2|SHP-2|SHP2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24743
4.70992469211004e-109	0.767710661522823	0.726	0.327	1.04913572516751e-104	NUDT3	Malignant cells	GSE186960	ENSG00000272325	11165	nudix hydrolase 3	DIPP	protein_coding	O95989	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24744
6.33056550452014e-109	-0.654047673728931	0.163	0.49	1.41013346613186e-104	UTP3	Malignant cells	GSE186960	ENSG00000132467	57050	UTP3 small subunit processome component	CRLZ1|DKFZp761F222|FLJ23256|SAS10	protein_coding	Q9NQZ2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24745
1.05050226126743e-108	0.608186098492814	0.996	0.958	2.33999378697321e-104	KPNB1	Malignant cells	GSE186960	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24746
1.45746885059081e-108	-0.800364849645671	0.292	0.625	3.24651186469102e-104	NDUFV2	Malignant cells	GSE186960	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24747
1.46120880239063e-108	0.748632797080912	0.483	0.027	3.25484260732513e-104	ACO2	Malignant cells	GSE186960	ENSG00000100412	50	aconitase 2	ACONM	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24748
2.23823468348905e-108	-0.912916815324749	0.452	0.736	4.98566775747185e-104	BAIAP2L1	Malignant cells	GSE186960	ENSG00000006453	55971	BAR/IMD domain containing adaptor protein 2 like 1	IRTKS	protein_coding	Q9UHR4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24749
3.27061944515131e-108	0.671410022382481	0.963	0.844	7.28530481407454e-104	ATOX1	Malignant cells	GSE186960	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24750
5.38232799978786e-108	-0.83784963534405	0.857	0.977	1.19891356195274e-103	CAV1	Malignant cells	GSE186960	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24751
7.26080808792038e-108	-0.829749041437641	0.987	1	1.61734500158427e-103	S100A6	Malignant cells	GSE186960	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24752
1.50065250149879e-107	-0.78175258044135	0.576	0.835	3.34270344708855e-103	ACAT1	Malignant cells	GSE186960	ENSG00000075239	38	acetyl-CoA acetyltransferase 1	ACAT|THIL	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24753
3.38042848693082e-107	-0.881845822695663	0.458	0.745	7.52990445463841e-103	ACIN1	Malignant cells	GSE186960	ENSG00000100813	22985	apoptotic chromatin condensation inducer 1	ACINUS|fSAP152|KIAA0670	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24754
6.20948816452605e-107	0.746453859616828	0.932	0.794	1.38316348864818e-102	CARHSP1	Malignant cells	GSE186960	ENSG00000153048	23589	calcium regulated heat stable protein 1	CRHSP-24|CSDC1	protein_coding	Q9Y2V2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24755
1.70058162126078e-106	1.42240434229548	0.653	0.282	3.78804556135839e-102	HIST1H1B	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24756
1.91538260940233e-106	-0.691357041234467	0.911	0.989	4.26651476244368e-102	PSMD11	Malignant cells	GSE186960	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24757
4.09234554847521e-106	-0.64017400965739	0.953	0.996	9.11569970922853e-102	KHDRBS1	Malignant cells	GSE186960	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24758
8.92646624962248e-106	0.383193730800993	1	1	1.98837035710341e-101	RPS27A	Malignant cells	GSE186960	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24759
1.12733885459899e-105	-0.823236606256863	0.843	0.97	2.51114729861925e-101	PNN	Malignant cells	GSE186960	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24760
3.13191506214872e-105	-0.868450500834662	0.489	0.774	6.97634080093628e-101	EID2	Malignant cells	GSE186960	ENSG00000176396	163126	EP300 interacting inhibitor of differentiation 2	CRI2|EID-2|MGC20452	protein_coding	Q8N6I1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24761
3.26907851015784e-105	0.721427045155923	0.867	0.61	7.28187238137659e-101	BZW1	Malignant cells	GSE186960	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24762
4.79934334374079e-105	-0.401740951827555	0.052	0.284	1.06905372981826e-100	RPS14P3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24763
7.88850123169386e-105	-0.613380917469449	0.978	0.999	1.75716364935981e-100	LSM5	Malignant cells	GSE186960	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24764
1.50569773091413e-104	0.790028268016882	0.539	0.08	3.35394169561121e-100	BEX2	Malignant cells	GSE186960	ENSG00000133134	84707	brain expressed X-linked 2	DJ79P11.1	protein_coding	Q9BXY8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24765
6.86441192065364e-104	-0.789274032911138	0.231	0.559	1.5290477553256e-99	TSPAN5	Malignant cells	GSE186960	ENSG00000168785	10098	tetraspanin 5	NET-4|TM4SF9|Tspan-5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24766
1.3072469517756e-103	1.33841576439288	0.599	0.195	2.91189258508014e-99	HIST1H1D	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24767
1.89922189498865e-103	0.937052291461788	0.727	0.361	4.23051677108721e-99	PMEPA1	Malignant cells	GSE186960	ENSG00000124225	56937	prostate transmembrane protein, androgen induced 1	STAG1|TMEPAI	protein_coding	Q969W9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24768
2.15624077015873e-103	0.711529363016437	0.448	0.011	4.80302631552857e-99	TMED1	Malignant cells	GSE186960	ENSG00000099203	11018	transmembrane p24 trafficking protein 1	Il1rl1l|IL1RL1LG|MGC1270|p24g1|p24gamma1|ST2L	protein_coding	Q13445	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24769
2.936445259163e-103	-0.986381907651266	0.453	0.761	6.54093181478559e-99	SERPINE1	Malignant cells	GSE186960	ENSG00000106366	5054	serpin family E member 1	PAI|PAI1|PLANH1	protein_coding	P05121	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24770
3.28423525623412e-103	0.609085093861194	0.99	0.943	7.3156340332615e-99	CCT4	Malignant cells	GSE186960	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24771
4.23074693189975e-103	-0.503556007425413	0.088	0.358	9.42398879080669e-99	HUWE1	Malignant cells	GSE186960	ENSG00000086758	10075	HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1	Ib772|KIAA0312|UREB1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24772
5.00538763398677e-103	-0.746122037502056	0.636	0.877	1.11495009547055e-98	CALU	Malignant cells	GSE186960	ENSG00000128595	813	calumenin	NA	protein_coding	O43852	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24773
5.62479072664727e-103	-0.850516050798706	0.612	0.84	1.25292213436068e-98	GMNN	Malignant cells	GSE186960	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24774
8.44565999060775e-103	0.671783875169486	0.957	0.842	1.88127076290788e-98	EIF3I	Malignant cells	GSE186960	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24775
1.64787385101229e-102	0.766205533245862	0.636	0.218	3.67063900312989e-98	CHPT1	Malignant cells	GSE186960	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24776
2.41049204277473e-102	-0.422146482494407	0.049	0.271	5.36937102528071e-98	LAMB1	Malignant cells	GSE186960	ENSG00000091136	3912	laminin subunit beta 1	CLM	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24777
3.59368272454376e-102	-0.692544167037499	0.904	0.983	8.00492826892123e-98	METAP2	Malignant cells	GSE186960	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24778
1.97287608339682e-101	-0.661127596431501	0.791	0.958	4.39458147576642e-97	REXO2	Malignant cells	GSE186960	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24779
2.37421465772364e-101	0.821417719986929	0.799	0.473	5.28856315007941e-97	RASSF8	Malignant cells	GSE186960	ENSG00000123094	11228	Ras association domain family member 8	C12orf2|HoJ-1	protein_coding	Q8NHQ8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24780
2.39660299274192e-101	0.674691592826318	0.926	0.777	5.33843316633262e-97	NHP2	Malignant cells	GSE186960	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24781
2.74686874997161e-101	0.766177832212962	0.539	0.09	6.11865014056177e-97	LINC00662	Malignant cells	GSE186960	ENSG00000261824	148189	long intergenic non-protein coding RNA 662	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24782
3.03206227644838e-101	-0.839777034043567	0.429	0.713	6.75391872078877e-97	SEC13	Malignant cells	GSE186960	ENSG00000157020	6396	SEC13 homolog, nuclear pore and COPII coat complex component	D3S1231E|npp-20|SEC13L1|SEC13R	protein_coding	P55735	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24783
1.04266731709402e-100	-0.507027923240593	0.999	1	2.32254144882694e-96	COX7C	Malignant cells	GSE186960	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24784
1.93090889527395e-100	0.731450495970951	0.684	0.281	4.30109956422273e-96	GANAB	Malignant cells	GSE186960	ENSG00000089597	23193	glucosidase II alpha subunit	G2AN|GIIA|GluII|KIAA0088	protein_coding	Q14697	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24785
4.33646794005757e-100	-0.5901965334674	0.979	1	9.65948233647824e-96	NDUFB4	Malignant cells	GSE186960	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24786
7.12514091615506e-100	-0.564216260284169	0.984	1	1.58712513907354e-95	HNRNPU	Malignant cells	GSE186960	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24787
8.63708498502484e-100	0.640125153327761	0.969	0.872	1.92391068041428e-95	ERH	Malignant cells	GSE186960	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24788
1.80964039854087e-99	-1.22965772081281	0.378	0.66	4.03097398774979e-95	TIMP1	Malignant cells	GSE186960	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24789
1.83291522722939e-99	0.690460205869179	0.448	0.02	4.08281866865346e-95	C20orf24	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24790
3.68377365622582e-99	-0.642500432367623	0.958	0.997	8.20560581924301e-95	YWHAB	Malignant cells	GSE186960	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24791
4.41356407891222e-99	0.443625218482981	1	1	9.83121398577696e-95	CHCHD2	Malignant cells	GSE186960	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24792
5.4226435279825e-99	-0.649871737536372	0.869	0.98	1.2078938458581e-94	MRPL21	Malignant cells	GSE186960	ENSG00000197345	219927	mitochondrial ribosomal protein L21	NA	protein_coding	Q7Z2W9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24793
9.72475469516499e-99	0.591738683200687	0.983	0.927	2.166189108348e-94	SNX3	Malignant cells	GSE186960	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24794
1.04899782914381e-98	0.773081968945711	0.84	0.595	2.33664266441783e-94	MYH9	Malignant cells	GSE186960	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24795
2.29453587269283e-98	-0.813674724341823	0.542	0.795	5.11107865642328e-94	DNAJC2	Malignant cells	GSE186960	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24796
2.77374531466439e-98	-0.701436913150577	0.776	0.93	6.17851768841492e-94	PAPOLA	Malignant cells	GSE186960	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24797
5.87765481139377e-98	0.706818139742031	0.965	0.852	1.30924760923796e-93	CDV3	Malignant cells	GSE186960	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24798
6.79015693301027e-98	0.687329851809242	0.473	0.044	1.51250745682804e-93	HGS	Malignant cells	GSE186960	ENSG00000185359	9146	hepatocyte growth factor-regulated tyrosine kinase substrate	Hrs|Vps27|ZFYVE8	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24799
1.14294877492367e-97	0.713461515740288	0.782	0.438	2.54591839614247e-93	TNRC6B	Malignant cells	GSE186960	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24800
3.03247184014745e-97	0.666618713463257	0.416	0	6.75483102392844e-93	CSNK2B.2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24801
4.87180271836623e-97	-0.711550580281934	0.172	0.484	1.08519405551608e-92	RP11-304L19.5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24802
5.85535225012906e-97	0.632666594154374	0.974	0.871	1.30427971371625e-92	MRPL41	Malignant cells	GSE186960	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24803
9.73085308243031e-97	0.769672730499273	0.931	0.814	2.16754752411135e-92	TNFRSF12A	Malignant cells	GSE186960	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24804
9.9387102192958e-97	-0.698106074690907	0.785	0.947	2.21384770134814e-92	DYNLRB1	Malignant cells	GSE186960	ENSG00000125971	83658	dynein light chain roadblock-type 1	DNCL2A|DNLC2A|ROBLD1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24805
1.84970761114176e-96	0.70159652733555	0.476	0.05	4.12022370381828e-92	RHOQ	Malignant cells	GSE186960	ENSG00000119729	23433	ras homolog family member Q	ARHQ|RASL7A|TC10	protein_coding	P17081	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24806
2.00339848725381e-96	-0.715073269876957	0.799	0.946	4.46257013035786e-92	TTC1	Malignant cells	GSE186960	ENSG00000113312	7265	tetratricopeptide repeat domain 1	TPR1	protein_coding	Q99614	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24807
2.00959445773025e-96	-0.594460855432203	0.994	1	4.47637165459412e-92	SNHG5	Malignant cells	GSE186960	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24808
2.35993924756048e-96	0.682569331193326	0.427	0.011	5.25676467394097e-92	CCDC107	Malignant cells	GSE186960	ENSG00000159884	203260	coiled-coil domain containing 107	MGC31967	protein_coding	Q8WV48	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24809
3.71819181386239e-96	-0.590391156096073	0.13	0.421	8.28227226537848e-92	IL17RB	Malignant cells	GSE186960	ENSG00000056736	55540	interleukin 17 receptor B	CRL4|EVI27|IL17BR|IL17RH1	protein_coding	Q9NRM6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24810
5.42874709844831e-96	-0.725241834779162	0.758	0.927	1.20925341617936e-91	SLTM	Malignant cells	GSE186960	ENSG00000137776	79811	SAFB like transcription modulator	FLJ13213|Met	protein_coding	Q9NWH9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24811
6.62236302100024e-96	-0.681129662772098	0.738	0.931	1.4751313629278e-91	IMPDH2	Malignant cells	GSE186960	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24812
1.55570261429254e-95	0.853169966950851	0.632	0.228	3.46532757333664e-91	ID4	Malignant cells	GSE186960	ENSG00000172201	3400	inhibitor of DNA binding 4	bHLHb27	protein_coding	P47928	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24813
2.20002872813947e-95	-0.66842148204741	0.884	0.989	4.90056399193066e-91	COX17	Malignant cells	GSE186960	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24814
3.73761563310915e-95	0.7813231705232	0.99	0.973	8.32553882275062e-91	CENPF	Malignant cells	GSE186960	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24815
7.05925410641681e-95	-0.444599070882783	1	1	1.57244885220434e-90	RPLP0	Malignant cells	GSE186960	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24816
1.37561568478504e-94	0.713633713834462	0.549	0.117	3.06418393785868e-90	MRPL4	Malignant cells	GSE186960	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24817
1.64141768792349e-94	-0.827620846054796	0.378	0.668	3.65625789984958e-90	ITM2C	Malignant cells	GSE186960	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24818
3.37887193291809e-94	0.808067787786374	0.757	0.393	7.52643723057504e-90	COL11A1	Malignant cells	GSE186960	ENSG00000060718	1301	collagen type XI alpha 1 chain	CO11A1|COLL6|DFNA37|STL2	protein_coding	P12107	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24819
3.56375431510659e-94	0.722453773968026	0.581	0.159	7.93826273689993e-90	SAMD1	Malignant cells	GSE186960	ENSG00000288488	90378	sterile alpha motif domain containing 1	NA	protein_coding	Q6SPF0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24820
4.42218621450573e-94	0.705030551448157	0.627	0.208	9.85041979281151e-90	PABPN1	Malignant cells	GSE186960	ENSG00000100836	8106	poly(A) binding protein nuclear 1	OPMD|PAB2|PABP2	protein_coding	Q86U42	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24821
4.86832751242013e-94	-0.699588513039408	0.867	0.977	1.08441995339158e-89	ECH1	Malignant cells	GSE186960	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24822
6.854907470641e-94	0.692566754255988	0.769	0.424	1.52693063908528e-89	C1orf86	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24823
7.4233663980797e-94	0.711341481163065	0.507	0.082	1.65355486517225e-89	VEGFA	Malignant cells	GSE186960	ENSG00000112715	7422	vascular endothelial growth factor A	VEGF|VEGF-A|VPF	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24824
9.64999814634837e-94	-0.529234008594708	0.994	1	2.1495370870991e-89	COX8A	Malignant cells	GSE186960	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24825
1.12283915394368e-93	0.671473879600624	0.905	0.701	2.50112421540954e-89	PRPF8	Malignant cells	GSE186960	ENSG00000274442	10594	pre-mRNA processing factor 8	hPrp8|Prp8|PRPC8|RP13|SNRNP220	protein_coding	Q6P2Q9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24826
1.34920163046019e-93	-0.729845626150788	0.626	0.84	3.00534663185007e-89	UBE2A	Malignant cells	GSE186960	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24827
2.97183728758056e-93	-0.590953215319461	0.948	0.996	6.61976755808571e-89	TCEB1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24828
3.01426305868723e-93	-0.773527550159715	0.424	0.699	6.7142709632258e-89	C21orf59	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24829
4.26159259797067e-93	0.752961605922366	0.632	0.219	9.49269751197967e-89	SYT1	Malignant cells	GSE186960	ENSG00000067715	6857	synaptotagmin 1	P65|SVP65|SYT	protein_coding	P21579	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24830
1.972117797106e-92	0.648189297035943	0.43	0.024	4.3928923930536e-88	ANAPC15	Malignant cells	GSE186960	ENSG00000110200	25906	anaphase promoting complex subunit 15	APC15|C11orf51|DKFZP564M082|HSPC020	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24831
5.13907780354387e-92	0.737766455340552	0.772	0.443	1.1447295807394e-87	SREBF1	Malignant cells	GSE186960	ENSG00000072310	6720	sterol regulatory element binding transcription factor 1	bHLHd1|SREBP-1c|SREBP1|SREBP1a	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24832
5.24962379775945e-92	0.687942459232214	0.428	0.02	1.16935370095092e-87	SETD5-AS1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24833
6.35830531422635e-92	0.671748256344268	0.464	0.052	1.41631250874392e-87	AIDA	Malignant cells	GSE186960	ENSG00000186063	64853	axin interactor, dorsalization associated	C1orf80|FLJ12806	protein_coding	Q96BJ3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24834
1.27413275836245e-91	0.751964661471004	0.67	0.281	2.83813071925235e-87	PNRC1	Malignant cells	GSE186960	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24835
4.4509960498138e-91	0.364060630123336	1	1	9.91459370096025e-87	RPS15A	Malignant cells	GSE186960	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24836
9.39240288496035e-91	0.803985648658533	0.638	0.245	2.09215774262492e-86	UBALD2	Malignant cells	GSE186960	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24837
1.94848444678313e-90	0.622323826116083	0.394	0	4.34024910520941e-86	CHTF8	Malignant cells	GSE186960	ENSG00000168802	54921	chromosome transmission fidelity factor 8	CTF8|FLJ20400	protein_coding	P0CG13	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24838
2.29406846454023e-90	-0.416225909774596	1	1	5.11003750476336e-86	RPS21	Malignant cells	GSE186960	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24839
3.29957795444737e-90	-0.798364307108422	0.355	0.649	7.34980989353152e-86	UTP14A	Malignant cells	GSE186960	ENSG00000156697	10813	UTP14A small subunit processome component	NY-CO-16|SDCCAG16|Utp14	protein_coding	Q9BVJ6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24840
3.64188356928057e-90	-0.686047180805154	0.841	0.958	8.11229565057247e-86	RBM25	Malignant cells	GSE186960	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24841
1.14843062368846e-89	0.633784112708315	0.413	0.014	2.55812921426605e-85	CTC-524C5.2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24842
1.87297356205498e-89	-0.751663118257096	0.343	0.638	4.17204860947747e-85	DHX36	Malignant cells	GSE186960	ENSG00000281763	170506	DEAH-box helicase 36	DDX36|KIAA1488|MLEL1|RHAU	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24843
2.6400643011439e-89	-0.647433297402473	0.743	0.93	5.88074323079805e-85	EIF4A3	Malignant cells	GSE186960	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24844
2.89677702530478e-89	-0.521175503953753	0.993	1	6.4525708238664e-85	CYCS	Malignant cells	GSE186960	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24845
7.0204344043174e-89	-0.760479569355271	0.539	0.785	1.5638017635617e-84	SH3KBP1	Malignant cells	GSE186960	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24846
1.90845958765627e-88	-0.609946446410834	0.155	0.441	4.25109373150435e-84	TRAM2	Malignant cells	GSE186960	ENSG00000065308	9697	translocation associated membrane protein 2	KIAA0057	protein_coding	Q15035	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24847
1.92239682290877e-88	0.64646278515501	0.458	0.052	4.28213892302928e-84	DNASE2	Malignant cells	GSE186960	ENSG00000105612	1777	deoxyribonuclease 2, lysosomal	DNL|DNL2	protein_coding	O00115	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24848
3.93885282192529e-88	-0.514141130298779	0.995	1	8.77379466083858e-84	TOMM7	Malignant cells	GSE186960	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24849
5.59482277522873e-88	0.668841913591907	0.747	0.414	1.2462467731822e-83	PPIC	Malignant cells	GSE186960	ENSG00000168938	5480	peptidylprolyl isomerase C	CYPC	protein_coding	P45877	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24850
6.32639268209188e-88	0.702531720136212	0.948	0.878	1.40920396993597e-83	TUBB4B	Malignant cells	GSE186960	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24851
7.1029535937367e-88	-0.795096150708411	0.277	0.582	1.58218291300485e-83	SYTL2	Malignant cells	GSE186960	ENSG00000137501	54843	synaptotagmin like 2	CHR11SYT|exophilin-4|FLJ20163|FLJ21219|KIAA1597|MGC102768|PPP1R151|SGA72M|SLP2	protein_coding	Q9HCH5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24852
1.82040974136594e-87	0.888829741355498	0.447	0.047	4.05496269889264e-83	HIST1H1E	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24853
2.12318961875155e-87	0.661165136125135	0.501	0.093	4.72940487576908e-83	CORO1B	Malignant cells	GSE186960	ENSG00000172725	57175	coronin 1B	coronin-2	protein_coding	Q9BR76	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24854
4.36346492920654e-87	0.634160383088081	0.874	0.652	9.71961812980756e-83	RPL7L1	Malignant cells	GSE186960	ENSG00000146223	285855	ribosomal protein L7 like 1	dJ475N16.4	protein_coding	Q6DKI1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24855
6.22384893362473e-87	0.658668139195272	0.752	0.407	1.38636234996491e-82	BUD31	Malignant cells	GSE186960	ENSG00000106245	8896	BUD31 homolog	Cwc14|EDG-2|EDG2|fSAP17|G10|YCR063W	protein_coding	P41223	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24856
6.79179064648035e-87	0.676629900901837	0.528	0.116	1.5128713665035e-82	PAK4	Malignant cells	GSE186960	ENSG00000130669	10298	p21 (RAC1) activated kinase 4	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24857
7.43246408633307e-87	0.694411519358299	0.551	0.136	1.65558137523069e-82	MGST1	Malignant cells	GSE186960	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24858
8.15302424843568e-87	0.765563965462698	0.559	0.16	1.81608615133905e-82	TRIB3	Malignant cells	GSE186960	ENSG00000101255	57761	tribbles pseudokinase 3	C20orf97|dJ1103G7.3|TRB3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24859
1.89596012550179e-86	0.648607887785955	0.837	0.566	4.22325117955524e-82	MYO1C	Malignant cells	GSE186960	ENSG00000197879	4641	myosin IC	MyoIC|myr2|NMI	protein_coding	O00159	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24860
2.14610732421362e-86	-0.543927739614164	0.985	0.997	4.78045406468584e-82	H2AFV	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24861
2.52707704997419e-86	0.742109809944453	0.55	0.148	5.6290641288175e-82	ZFX	Malignant cells	GSE186960	ENSG00000005889	7543	zinc finger protein X-linked	ZNF926	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24862
2.68115137719943e-86	0.593019787154039	0.961	0.831	5.97226469271174e-82	PTP4A2	Malignant cells	GSE186960	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24863
3.1671771936148e-86	-0.638433419112705	0.802	0.95	7.05488719877696e-82	HDAC1	Malignant cells	GSE186960	ENSG00000116478	3065	histone deacetylase 1	GON-10|HD1|KDAC1|RPD3L1	protein_coding	Q13547	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24864
3.57765061344131e-86	0.631526009833973	0.438	0.044	7.96921674144052e-82	SRR	Malignant cells	GSE186960	ENSG00000167720	63826	serine racemase	ILV1|ISO1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24865
5.17018092680522e-86	0.779541602699924	0.422	0.029	1.15165780144586e-81	PCDH17	Malignant cells	GSE186960	ENSG00000118946	27253	protocadherin 17	PCDH68|PCH68	protein_coding	O14917	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24866
1.50401038420405e-85	0.609005299953453	0.928	0.779	3.35018313081452e-81	TRAPPC1	Malignant cells	GSE186960	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24867
1.77012666236088e-85	-0.664558102099799	0.904	0.979	3.94295714040886e-81	KIF5B	Malignant cells	GSE186960	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24868
2.65838115737983e-85	1.11693476619893	0.707	0.43	5.92154402806357e-81	HIST1H1C	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24869
2.79532392596302e-85	0.587530438624176	0.968	0.884	6.22658404508262e-81	TSPO	Malignant cells	GSE186960	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24870
4.11861631735861e-85	-0.662831285177462	0.717	0.903	9.17421784691631e-81	PPIG	Malignant cells	GSE186960	ENSG00000138398	9360	peptidylprolyl isomerase G	CARS-Cyp|SCAF10|SRCyp	protein_coding	Q13427	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24871
9.79058727213893e-85	-0.671616392990597	0.631	0.845	2.18085331486895e-80	PFDN4	Malignant cells	GSE186960	ENSG00000101132	5203	prefoldin subunit 4	C-1|C1|PFD4	protein_coding	Q9NQP4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24872
1.10397982538775e-84	-0.549968886079927	0.978	1	2.45911506105122e-80	SEPT7	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24873
1.35559329543261e-84	-0.815313312471529	0.593	0.809	3.01958406557614e-80	CCDC34	Malignant cells	GSE186960	ENSG00000109881	91057	coiled-coil domain containing 34	L15|NY-REN-41|RAMA3	protein_coding	Q96HJ3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24874
1.57620649891859e-84	-0.963228547031088	0.567	0.795	3.51099997634116e-80	H1F0	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24875
1.66590220024093e-84	0.734671303108312	0.6	0.216	3.71079715103668e-80	WEE1	Malignant cells	GSE186960	ENSG00000166483	7465	WEE1 G2 checkpoint kinase	WEE1A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24876
2.10509000475597e-84	-0.602068065080889	0.188	0.483	4.68908798559392e-80	NUAK1	Malignant cells	GSE186960	ENSG00000074590	9891	NUAK family kinase 1	ARK5|KIAA0537	protein_coding	O60285	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24877
2.48650359137466e-84	-0.656062233755162	0.638	0.854	5.53868674978706e-80	EMC4	Malignant cells	GSE186960	ENSG00000128463	51234	ER membrane protein complex subunit 4	FLJ90746|MGC24415|PIG17|TMEM85	protein_coding	Q5J8M3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24878
4.36476991393589e-84	0.6499068231079	0.943	0.821	9.72252498329219e-80	DYNC1H1	Malignant cells	GSE186960	ENSG00000197102	1778	dynein cytoplasmic 1 heavy chain 1	CMT2O|DHC1|DNCH1|Dnchc1|DNCL|DNECL|HL-3|p22	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24879
6.32373041711247e-84	0.645404134442823	0.803	0.519	1.4086109504118e-79	RABL6	Malignant cells	GSE186960	ENSG00000196642	55684	RAB, member RAS oncogene family like 6	bA216L13.9|C9orf86|FLJ10101|FLJ13045|Parf|pp8875|RBEL1	protein_coding	Q3YEC7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24880
7.85817550211886e-84	0.401514127230486	1	1	1.75040859309698e-79	RPL26	Malignant cells	GSE186960	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24881
9.73670191710924e-84	0.6982039444685	0.658	0.284	2.16885035203608e-79	NFIB	Malignant cells	GSE186960	ENSG00000147862	4781	nuclear factor I B	NFI-RED|NFIB2|NFIB3	protein_coding	O00712	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24882
1.08761721349423e-83	0.621911762760185	0.924	0.787	2.4226673430584e-79	XPO1	Malignant cells	GSE186960	ENSG00000082898	7514	exportin 1	CRM-1|CRM1|emb	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24883
1.16607464761961e-83	-0.604344144811215	0.934	0.989	2.59743127757268e-79	MRFAP1	Malignant cells	GSE186960	ENSG00000179010	93621	Morf4 family associated protein 1	PAM14|PGR1	protein_coding	Q9Y605	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24884
1.2009231168105e-83	0.657411829879743	0.493	0.102	2.67505624269539e-79	PRMT5	Malignant cells	GSE186960	ENSG00000100462	10419	protein arginine methyltransferase 5	HRMT1L5|SKB1|SKB1Hs	protein_coding	O14744	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24885
1.39224559531705e-83	0.662102489295354	0.705	0.351	3.10122706356873e-79	CBS	Malignant cells	GSE186960	ENSG00000160200	875	cystathionine beta-synthase	HIP4	protein_coding	P35520	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24886
1.82359319053207e-83	-0.44208048056012	0.088	0.328	4.06205383191019e-79	LARP4B	Malignant cells	GSE186960	ENSG00000107929	23185	La ribonucleoprotein 4B	KIAA0217|LARP5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24887
2.03012860458869e-83	-0.550295672913473	0.952	0.99	4.52211146672131e-79	SHFM1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24888
2.09263255087731e-83	0.626348403422638	0.971	0.881	4.6613390070792e-79	ANKRD11	Malignant cells	GSE186960	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24889
2.48647749621621e-83	-0.766242047328706	0.438	0.692	5.5386286228216e-79	GNL2	Malignant cells	GSE186960	ENSG00000134697	29889	G protein nucleolar 2	HUMAUANTIG|Ngp-1|Nog2|Nug2	protein_coding	Q13823	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24890
3.1059454326011e-83	0.685051747100445	0.68	0.324	6.91849345111894e-79	ARID1A	Malignant cells	GSE186960	ENSG00000117713	8289	AT-rich interaction domain 1A	B120|BAF250|BAF250a|C10rf4|C1orf4|P270|SMARCF1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24891
4.88863938466661e-83	0.417619031289519	1	1	1.08894442293449e-78	RPS28	Malignant cells	GSE186960	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24892
1.67023432796995e-82	0.598803935672711	0.421	0.039	3.72044696555305e-78	RPL18AP3	Malignant cells	GSE186960	ENSG00000213442	NA	NA	bcm182	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24893
2.76468655039721e-82	0.610963187696523	0.42	0.037	6.15833929100979e-78	RPL12P4	Malignant cells	GSE186960	ENSG00000185834	NA	NA	dJ800C24.1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24894
3.3227885033866e-82	-0.726479430586411	0.435	0.696	7.40151139129364e-78	SFSWAP	Malignant cells	GSE186960	ENSG00000061936	6433	splicing factor SWAP	SFRS8|SWAP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24895
3.45592895627504e-82	0.608203899367634	0.909	0.729	7.69808175010264e-78	CLTC	Malignant cells	GSE186960	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24896
3.82616965722887e-82	-0.412184134719944	1	1	8.52279291147731e-78	RPS11	Malignant cells	GSE186960	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24897
4.49554917752261e-82	0.686340459451926	0.629	0.258	1.00138357929316e-77	TP53	Malignant cells	GSE186960	ENSG00000141510	7157	tumor protein p53	LFS1|p53	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24898
5.74952906152701e-82	0.628784890553611	0.853	0.642	1.28070759845514e-77	ADRM1	Malignant cells	GSE186960	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24899
7.40162273718311e-82	-0.734044477248477	0.555	0.792	1.64871146470754e-77	NDUFAF4	Malignant cells	GSE186960	ENSG00000123545	29078	NADH:ubiquinone oxidoreductase complex assembly factor 4	bA22L21.1|C6orf66|HRPAP20|HSPC125|My013	protein_coding	Q9P032	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24900
9.20119697803583e-82	0.629619749030694	0.486	0.095	2.04956662685748e-77	C8orf82	Malignant cells	GSE186960	ENSG00000213563	414919	chromosome 8 open reading frame 82	MGC70857	protein_coding	Q6P1X6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24901
1.10811384642206e-81	0.588495488995621	0.366	0	2.46832359290514e-77	SRSF10	Malignant cells	GSE186960	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24902
2.02988008484008e-81	0.667349203802392	0.526	0.135	4.52155788898128e-77	SPTAN1	Malignant cells	GSE186960	ENSG00000197694	6709	spectrin alpha, non-erythrocytic 1	NA	protein_coding	Q13813	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24903
2.75874162398982e-81	-0.460213285239541	0.999	1	6.14509696743734e-77	GNG5	Malignant cells	GSE186960	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24904
2.91794553584611e-81	0.544736056536608	0.982	0.941	6.4997236810972e-77	PHPT1	Malignant cells	GSE186960	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24905
3.41780753893447e-81	-0.70753592243932	0.661	0.851	7.61316629297653e-77	NDUFAF3	Malignant cells	GSE186960	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24906
2.44439133554192e-80	0.598099867780407	0.442	0.057	5.44488169991963e-76	CTSZ	Malignant cells	GSE186960	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24907
2.83148061630656e-80	0.63651898138915	0.395	0.024	6.30712307282287e-76	HIST1H2BK	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24908
4.04539961906873e-80	-0.546577712681023	0.935	0.989	9.0111276514756e-76	C14orf2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24909
6.91382809780319e-80	0.587444815232662	0.398	0.027	1.54005520878566e-75	PKN1	Malignant cells	GSE186960	ENSG00000123143	5585	protein kinase N1	DBK|MGC46204|PAK1|PKN|PRK1|PRKCL1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24910
1.16845261460675e-79	0.618849364504743	0.397	0.026	2.60272819903654e-75	BCHE	Malignant cells	GSE186960	ENSG00000114200	590	butyrylcholinesterase	CHE1|CHE2|E1	protein_coding	P06276	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24911
1.49624616371405e-79	-0.658952592095485	0.585	0.819	3.33288832967305e-75	TRMT10C	Malignant cells	GSE186960	ENSG00000174173	54931	tRNA methyltransferase 10C, mitochondrial RNase P subunit	FLJ20432|MRPP1|RG9MTD1	protein_coding	Q7L0Y3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24912
1.82981151667776e-79	0.558185654838362	0.359	0	4.07590515339971e-75	AC108488.3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24913
2.02517457520285e-79	0.637980695461503	0.465	0.086	4.51107636626435e-75	PPP1R35	Malignant cells	GSE186960	ENSG00000160813	221908	protein phosphatase 1 regulatory subunit 35	C7orf47|MGC22793	protein_coding	Q8TAP8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24914
3.17851738915595e-79	-0.616341044243219	0.759	0.937	7.08014748434487e-75	ARL3	Malignant cells	GSE186960	ENSG00000138175	403	ADP ribosylation factor like GTPase 3	ARFL3	protein_coding	P36405	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24915
4.62817486891853e-79	0.649042839213982	0.514	0.132	1.0309259520516e-74	GAMT	Malignant cells	GSE186960	ENSG00000130005	2593	guanidinoacetate N-methyltransferase	PIG2|TP53I2	protein_coding	Q14353	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24916
6.01232116887569e-79	0.593199625046542	0.892	0.732	1.33924454036706e-74	ZNF706	Malignant cells	GSE186960	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24917
8.66862182607447e-79	-0.657448944764857	0.306	0.595	1.93093551175809e-74	RP11-234A1.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24918
9.91895871409058e-79	-0.640085932892967	0.693	0.888	2.20944805356368e-74	CSNK2A1	Malignant cells	GSE186960	ENSG00000101266	1457	casein kinase 2 alpha 1	Cka1|Cka2	protein_coding	P68400	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24919
1.091727858713e-78	0.661659438720684	0.53	0.136	2.4318238052832e-74	MEF2C	Malignant cells	GSE186960	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24920
1.50429017942446e-78	-0.659282194222947	0.644	0.841	3.35080637466798e-74	UTP11L	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24921
2.98320701399707e-78	0.634604307311744	0.488	0.105	6.64509362367848e-74	EEF1A2	Malignant cells	GSE186960	ENSG00000101210	1917	eukaryotic translation elongation factor 1 alpha 2	EEF1AL|HS1|STN|STNL	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24922
3.39895747406119e-78	0.572902981300266	0.929	0.802	7.57117777347131e-74	SUMO1	Malignant cells	GSE186960	ENSG00000116030	7341	small ubiquitin like modifier 1	GMP1|OFC10|PIC1|SMT3C|SMT3H3|SUMO-1|UBL1	protein_coding	P63165	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24923
3.55885407790302e-78	0.631747304409472	0.727	0.405	7.92734745852898e-74	AARS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24924
3.78879001619803e-78	0.655292776942408	0.544	0.153	8.43952976108111e-74	PMAIP1	Malignant cells	GSE186960	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24925
4.75287388300236e-78	0.641979664192332	0.654	0.288	1.05870265743878e-73	ATXN2L	Malignant cells	GSE186960	ENSG00000168488	11273	ataxin 2 like	A2D|A2lp	protein_coding	Q8WWM7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24926
7.38175595629877e-78	0.370291227471949	1	1	1.64428613926555e-73	RPL3	Malignant cells	GSE186960	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24927
8.04540033193214e-78	0.631212511878684	0.853	0.63	1.79211292393789e-73	PSAT1	Malignant cells	GSE186960	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24928
9.79885931365902e-78	-0.63227263524511	0.66	0.852	2.18269591211755e-73	MESDC2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24929
1.1951331958116e-77	0.391993026469897	1	1	2.66215919367033e-73	PRDX1	Malignant cells	GSE186960	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24930
1.28284712620754e-77	0.321263219989891	1	1	2.85754197362729e-73	RPS3	Malignant cells	GSE186960	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24931
1.33354692375898e-77	0.59256070200843	0.411	0.043	2.97047577267312e-73	NUMA1	Malignant cells	GSE186960	ENSG00000137497	4926	nuclear mitotic apparatus protein 1	NUMA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24932
2.4200012206745e-77	0.549329747668977	0.351	0	5.39055271905246e-73	IER3IP1.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24933
3.05523505910602e-77	0.573241870932	0.352	0	6.80553609415865e-73	MLF1IP	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24934
4.14223513652271e-77	0.616061433188852	0.701	0.364	9.22682876660433e-73	MTHFD1L	Malignant cells	GSE186960	ENSG00000120254	25902	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like	DKFZP586G1517|FLJ21145|FTHFSDC1	protein_coding	Q6UB35	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24935
4.25332436098381e-77	-0.687197368886718	0.593	0.814	9.47428001409144e-73	ARGLU1	Malignant cells	GSE186960	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24936
4.92211808883304e-77	-0.584677498478187	0.954	0.983	1.09640180428756e-72	DUT	Malignant cells	GSE186960	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24937
5.46948139908669e-77	-0.536867844760208	0.999	1	1.21832698164656e-72	MT-ND5	Malignant cells	GSE186960	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24938
8.43156377872181e-77	0.664825891666752	0.697	0.372	1.87813083171028e-72	MAT2A	Malignant cells	GSE186960	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24939
8.54439798432106e-77	0.555887833486425	0.937	0.769	1.90326465100752e-72	ATF4	Malignant cells	GSE186960	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24940
9.96819457379989e-77	0.617478097655826	0.779	0.509	2.22041534131393e-72	ARHGDIA	Malignant cells	GSE186960	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24941
1.75739597852757e-76	0.553469808546993	0.964	0.908	3.91459954217016e-72	PDIA6	Malignant cells	GSE186960	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24942
2.32005180623828e-76	-0.69029275098012	0.283	0.56	5.16791539839577e-72	MUS81	Malignant cells	GSE186960	ENSG00000172732	80198	MUS81 structure-specific endonuclease subunit	FLJ44872|SLX3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24943
4.45949158088818e-76	-0.658030343227957	0.591	0.801	9.93351749642841e-72	PWP1	Malignant cells	GSE186960	ENSG00000136045	11137	PWP1 homolog, endonuclein	IEF-SSP-9502	protein_coding	Q13610	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24944
5.21376895241063e-76	-0.42129528208784	0.105	0.348	1.16136703414947e-71	RNF115	Malignant cells	GSE186960	ENSG00000265491	27246	ring finger protein 115	CL469780|ZNF364	protein_coding	Q9Y4L5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24945
5.97218252838674e-76	0.604364797928254	0.904	0.738	1.33030365819815e-71	NFE2L2	Malignant cells	GSE186960	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24946
6.62985495798252e-76	0.579131333889984	0.444	0.073	1.47680019189061e-71	JOSD2	Malignant cells	GSE186960	ENSG00000161677	126119	Josephin domain containing 2	SBBI54	protein_coding	Q8TAC2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24947
7.83053065789822e-76	0.618122991309192	0.682	0.331	1.74425070404683e-71	KHSRP	Malignant cells	GSE186960	ENSG00000088247	8570	KH-type splicing regulatory protein	FBP2|FUBP2|KSRP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24948
9.6601739468003e-76	0.884174096451265	0.499	0.12	2.15180374664977e-71	COL1A1	Malignant cells	GSE186960	ENSG00000108821	1277	collagen type I alpha 1 chain	OI4	protein_coding	P02452	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24949
1.44122788908601e-75	0.625083093915011	0.51	0.132	3.2103351229391e-71	PITPNB	Malignant cells	GSE186960	ENSG00000180957	23760	phosphatidylinositol transfer protein beta	VIB1B	protein_coding	P48739	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24950
1.65625563161171e-75	0.644300517293619	0.858	0.702	3.68930941941509e-71	MAP1LC3B	Malignant cells	GSE186960	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24951
2.95001203397241e-75	0.597700319351328	0.441	0.07	6.57115180567355e-71	CHAC1	Malignant cells	GSE186960	ENSG00000128965	79094	ChaC glutathione specific gamma-glutamylcyclotransferase 1	MGC4504	protein_coding	Q9BUX1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24952
3.57850139306902e-75	0.591925548345377	0.478	0.1	7.97111185306124e-71	SLC2A4RG	Malignant cells	GSE186960	ENSG00000125520	56731	SLC2A4 regulator	GEF|HDBP1|Si-1-2|Si-1-2-19	protein_coding	Q9NR83	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24953
4.07595841009955e-75	0.573612229828958	0.945	0.828	9.07919735849674e-71	HMGN3	Malignant cells	GSE186960	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24954
4.4613903771585e-75	0.618981806023406	0.79	0.529	9.93774706512056e-71	SELM	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24955
5.19532138198659e-75	-0.551931134061389	0.872	0.967	1.15725783783751e-70	NDUFC1	Malignant cells	GSE186960	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24956
6.73365806632179e-75	-0.69996632245793	0.331	0.587	1.49992233427318e-70	RBM17	Malignant cells	GSE186960	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24957
8.58034142397493e-75	-0.511728115378179	0.951	0.991	1.91127105219042e-70	TMEM147	Malignant cells	GSE186960	ENSG00000105677	10430	transmembrane protein 147	MGC1936|NIFIE14	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24958
1.16153296479771e-74	0.604477652511055	0.5	0.128	2.58731467908691e-70	ZDHHC12	Malignant cells	GSE186960	ENSG00000160446	84885	zinc finger DHHC-type palmitoyltransferase 12	FLJ14524|ZNF400	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24959
1.17623949662245e-74	-0.569018383026466	0.941	0.989	2.6200734787265e-70	PRPF40A	Malignant cells	GSE186960	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24960
1.66340918866525e-74	0.599303570468335	0.48	0.105	3.70524396775184e-70	GIPC1	Malignant cells	GSE186960	ENSG00000123159	10755	GIPC PDZ domain containing family member 1	C19orf3|GIPC|GLUT1CBP|Hs.6454|NIP|RGS19IP1|SEMCAP|SYNECTIN|TIP-2	protein_coding	O14908	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24961
3.65661240220554e-74	-0.718946374704495	0.289	0.56	8.14510412591285e-70	LUZP1	Malignant cells	GSE186960	ENSG00000169641	7798	leucine zipper protein 1	LUZP	protein_coding	Q86V48	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24962
4.43167700422242e-74	-0.567664083174485	0.905	0.97	9.87156052690544e-70	PPM1G	Malignant cells	GSE186960	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24963
5.32577268981556e-74	0.604748042649372	0.519	0.142	1.18631586665642e-69	BAX	Malignant cells	GSE186960	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24964
5.64628085161969e-74	0.573566757653324	0.407	0.052	1.25770905969829e-69	DHCR7	Malignant cells	GSE186960	ENSG00000172893	1717	7-dehydrocholesterol reductase	SLOS	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24965
7.52106459835824e-74	0.653510882267744	0.914	0.785	1.6753171392843e-69	HMMR	Malignant cells	GSE186960	ENSG00000072571	3161	hyaluronan mediated motility receptor	CD168|RHAMM	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24966
1.99845798444467e-73	0.612262559528645	0.753	0.467	4.4515651603505e-69	PELP1	Malignant cells	GSE186960	ENSG00000141456	27043	proline, glutamate and leucine rich protein 1	MNAR	protein_coding	Q8IZL8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24967
2.09249974463398e-73	-0.661917768796831	0.675	0.855	4.66104318117219e-69	RTF1	Malignant cells	GSE186960	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24968
2.5792811964995e-73	-0.659354175607213	0.737	0.898	5.74534886520265e-69	SMARCA1	Malignant cells	GSE186960	ENSG00000102038	6594	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1	hSNF2L|ISWI|NURF140|SNF2L|SNF2L1|SNF2LB|SWI	protein_coding	P28370	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24969
2.79589851804245e-73	0.520952748639387	0.337	0	6.22786394893957e-69	TIMM10B	Malignant cells	GSE186960	ENSG00000132286	26515	translocase of inner mitochondrial membrane 10B	FXC1|TIM10B|Tim9b	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24970
3.27281898830884e-73	-0.816257043477632	0.312	0.577	7.29020429645794e-69	ZFP36	Malignant cells	GSE186960	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24971
5.96166055954829e-73	0.617911391191865	0.512	0.136	1.32795988963938e-68	CALD1	Malignant cells	GSE186960	ENSG00000122786	800	caldesmon 1	CDM|H-CAD|h-CD|L-CAD	protein_coding	Q05682	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24972
6.14715594444069e-73	-0.609826125095973	0.762	0.914	1.36927898662416e-68	C11orf31	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24973
6.69358584552745e-73	0.624184436658199	0.514	0.142	1.49099624709124e-68	TRPS1	Malignant cells	GSE186960	ENSG00000104447	7227	transcriptional repressor GATA binding 1	GC79|LGCR	protein_coding	Q9UHF7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24974
7.69129271895823e-73	-0.574287232874139	0.839	0.958	1.71323545314794e-68	SDHB	Malignant cells	GSE186960	ENSG00000117118	6390	succinate dehydrogenase complex iron sulfur subunit B	SDH|SDH1	protein_coding	P21912	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24975
1.67269455845395e-72	0.688568598685469	0.927	0.838	3.72592712895618e-68	ERRFI1	Malignant cells	GSE186960	ENSG00000116285	54206	ERBB receptor feedback inhibitor 1	GENE-33|MIG-6|RALT	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24976
1.68738800309595e-72	0.606897635901118	0.761	0.483	3.75865677689622e-68	CTDNEP1	Malignant cells	GSE186960	ENSG00000288307	23399	CTD nuclear envelope phosphatase 1	DULLARD|HSA011916|NET56	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24977
2.11058789952055e-72	0.566017825360582	0.902	0.752	4.70133454618203e-68	RPAIN	Malignant cells	GSE186960	ENSG00000129197	84268	RPA interacting protein	hRIP|MGC4189|RIP	protein_coding	Q86UA6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24978
3.8983500968943e-72	-0.714428082437942	0.366	0.617	8.68357484083206e-68	PON2	Malignant cells	GSE186960	ENSG00000105854	5445	paraoxonase 2	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24979
3.94988787423457e-72	0.620871425067802	0.655	0.321	8.79837523985751e-68	NOC2L	Malignant cells	GSE186960	ENSG00000188976	26155	NOC2 like nucleolar associated transcriptional repressor	DKFZP564C186|NET15|NET7|NIR|PPP1R112	protein_coding	Q9Y3T9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24980
5.10215706815516e-72	0.622754534636508	0.928	0.827	1.13650548693156e-67	TUBA1A	Malignant cells	GSE186960	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24981
5.55720919438731e-72	-0.469168595330773	0.999	1	1.23786834804977e-67	LGALS1	Malignant cells	GSE186960	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24982
6.73116858404749e-72	0.617608573328615	0.645	0.305	1.49936780209658e-67	MAF1	Malignant cells	GSE186960	ENSG00000179632	84232	MAF1 homolog, negative regulator of RNA polymerase III	DKFZp586G1123	protein_coding	Q9H063	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24983
8.44497540322294e-72	0.396172919282116	1	0.996	1.88111827106791e-67	PSMB1	Malignant cells	GSE186960	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24984
1.01820701074635e-71	-0.651633682828953	0.346	0.613	2.2680561164375e-67	SPG21	Malignant cells	GSE186960	ENSG00000090487	51324	SPG21 abhydrolase domain containing, maspardin	ABHD21|ACP33|BM-019|GL010|MAST	protein_coding	Q9NZD8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24985
1.04004195605436e-71	-0.605153167323296	0.78	0.936	2.31669345711109e-67	HDGF	Malignant cells	GSE186960	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24986
1.62786821880475e-71	-0.491994371590509	0.965	1	3.62607645738757e-67	ANAPC11	Malignant cells	GSE186960	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24987
1.72281031740796e-71	-0.619768731410568	0.78	0.923	3.83755998202622e-67	HOXB7	Malignant cells	GSE186960	ENSG00000260027	3217	homeobox B7	HOX2|HOX2C	protein_coding	P09629	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24988
1.84168952082302e-71	0.61407058240116	0.592	0.236	4.10236340763328e-67	RAB1B	Malignant cells	GSE186960	ENSG00000174903	81876	RAB1B, member RAS oncogene family	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24989
2.09187837860725e-71	-0.360612756832555	0.079	0.294	4.65965908834765e-67	CDK2AP1	Malignant cells	GSE186960	ENSG00000111328	8099	cyclin dependent kinase 2 associated protein 1	doc-1|DOC1|DORC1|p12DOC-1|ST19	protein_coding	O14519	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24990
2.51421465624178e-71	-0.580112820422271	0.799	0.943	5.60041314677856e-67	SDF4	Malignant cells	GSE186960	ENSG00000078808	51150	stromal cell derived factor 4	Cab45	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24991
2.65440987672714e-71	-0.489795913709818	0.153	0.414	5.91269800040971e-67	TSPAN15	Malignant cells	GSE186960	ENSG00000099282	23555	tetraspanin 15	NET-7|TM4SF15	protein_coding	O95858	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24992
2.99589806041559e-71	0.555326432114623	0.438	0.08	6.67336292957572e-67	LSM12	Malignant cells	GSE186960	ENSG00000161654	124801	LSM12 homolog	FLJ30656	protein_coding	Q3MHD2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24993
3.17174799734467e-71	-0.702121731452637	0.673	0.857	7.06506866408525e-67	SCP2	Malignant cells	GSE186960	ENSG00000116171	6342	sterol carrier protein 2	NA	protein_coding	P22307	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24994
3.25211780274092e-71	-0.483250922637402	0.965	0.999	7.24409240560539e-67	SRSF3	Malignant cells	GSE186960	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24995
3.58928116033272e-71	0.393158546873751	1	1	7.99512378464114e-67	HINT1	Malignant cells	GSE186960	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24996
4.21031721483084e-71	-0.853449689804338	0.296	0.552	9.3784815960357e-67	FOS	Malignant cells	GSE186960	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24997
5.55393629764297e-71	0.590290824288319	0.45	0.095	1.23713931029997e-66	SIAH1	Malignant cells	GSE186960	ENSG00000196470	6477	siah E3 ubiquitin protein ligase 1	hSIAH1	protein_coding	Q8IUQ4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24998
6.85891818158116e-71	0.57033766412056	0.809	0.559	1.5278240249472e-66	BRD4	Malignant cells	GSE186960	ENSG00000141867	23476	bromodomain containing 4	CAP|HUNK1|HUNKI|MCAP	protein_coding	O60885	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	24999
6.92657338813772e-71	0.584041432234798	0.83	0.622	1.54289422220768e-66	LRRC59	Malignant cells	GSE186960	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25000
7.99936283637664e-71	0.574275690425102	0.87	0.658	1.7818580718029e-66	PGP	Malignant cells	GSE186960	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25001
9.31597703273363e-71	-0.523866766775988	0.966	0.997	2.07513388404142e-66	ATP5G2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25002
1.03438149692536e-70	0.596745423703876	0.504	0.143	2.30408478440123e-66	MRPL2	Malignant cells	GSE186960	ENSG00000112651	51069	mitochondrial ribosomal protein L2	CGI-22|MRP-L14|RPML14	protein_coding	Q5T653	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25003
1.80580415690902e-70	-0.322769166138695	0.06	0.252	4.02242875951485e-66	YBX1P1	Malignant cells	GSE186960	ENSG00000224861	NA	NA	NSEP1P|PSDBPB1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25004
1.8078698199058e-70	-0.595114880545869	0.774	0.923	4.02703002384016e-66	RBMX	Malignant cells	GSE186960	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25005
1.87092765011649e-70	-0.611152735336308	0.204	0.471	4.16749134063447e-66	HOXB5	Malignant cells	GSE186960	ENSG00000120075	3215	homeobox B5	HOX2|HOX2A	protein_coding	P09067	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25006
1.91359845810345e-70	0.540266183987351	0.402	0.054	4.26254056542542e-66	SLC4A2	Malignant cells	GSE186960	ENSG00000164889	6522	solute carrier family 4 member 2	AE2|BND3L|EPB3L1|HKB3|NBND3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25007
2.01874709162379e-70	0.532775036115522	0.351	0.016	4.496759146592e-66	ZNF536	Malignant cells	GSE186960	ENSG00000198597	9745	zinc finger protein 536	KIAA0390	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25008
2.2315968551851e-70	-0.550180220844359	0.918	0.993	4.97088199492481e-66	HNRNPD	Malignant cells	GSE186960	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25009
2.68598908242971e-70	-0.539102640247779	0.96	0.993	5.98304068111217e-66	CANX	Malignant cells	GSE186960	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25010
2.69388150579276e-70	0.522707224259214	0.349	0.014	6.00062105415337e-66	RP11-792A8.4	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25011
2.79013231699991e-70	0.586712335484755	0.765	0.497	6.21501973611729e-66	HRAS	Malignant cells	GSE186960	ENSG00000276536	3265	HRas proto-oncogene, GTPase	HRAS1	protein_coding	P01112	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25012
3.79221776905574e-70	0.701889699799277	0.338	0.007	8.44716508057166e-66	FAM211A	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25013
4.24254397052706e-70	0.613469129469897	0.478	0.12	9.45026669434902e-66	CBX4	Malignant cells	GSE186960	ENSG00000141582	8535	chromobox 4	hPC2|NBP16|PC2	protein_coding	O00257	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25014
4.46187243415814e-70	0.67023386371048	0.776	0.526	9.93882084708725e-66	PLK1	Malignant cells	GSE186960	ENSG00000166851	5347	polo like kinase 1	PLK	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25015
5.63526060078457e-70	-0.499478067027355	0.177	0.444	1.25525429882476e-65	HOXB3	Malignant cells	GSE186960	ENSG00000120093	3213	homeobox B3	HOX2|HOX2G	protein_coding	P14651	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25016
6.73447840182976e-70	-0.664583139282423	0.355	0.617	1.50010506400758e-65	NOP16	Malignant cells	GSE186960	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25017
7.03299012609667e-70	-0.570144596897909	0.965	0.981	1.56659855058803e-65	PTTG1	Malignant cells	GSE186960	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25018
7.24234830718803e-70	0.529194851347712	0.373	0.033	1.61323308542613e-65	PKD1	Malignant cells	GSE186960	ENSG00000008710	5310	polycystin 1, transient receptor potential channel interacting	PBP|Pc-1|TRPP1	protein_coding	P98161	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25019
7.36471410848551e-70	-0.541699093835734	0.199	0.466	1.64049006766515e-65	TCHP	Malignant cells	GSE186960	ENSG00000139437	84260	trichoplein keratin filament binding	MGC10854|TpMs	protein_coding	Q9BT92	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25020
7.57774720556593e-70	0.500980295379168	0.343	0.011	1.68794319003981e-65	CCZ1	Malignant cells	GSE186960	ENSG00000122674	51622	CCZ1 homolog, vacuolar protein trafficking and biogenesis associated	C7orf28A|CCZ1A|CGI-43	protein_coding	P86791	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25021
7.63505360263404e-70	0.622539356245207	0.735	0.44	1.70070818998673e-65	RBCK1	Malignant cells	GSE186960	ENSG00000125826	10616	RANBP2-type and C3HC4-type zinc finger containing 1	C20orf18|HOIL1|RBCK2|RNF54|UBCE7IP3|XAP4|ZRANB4	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25022
8.15352859158882e-70	0.591025499473959	0.547	0.185	1.81619849377641e-65	SUMF2	Malignant cells	GSE186960	ENSG00000129103	25870	sulfatase modifying factor 2	DKFZp566I1024	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25023
9.35821164599646e-70	0.562432930029463	0.446	0.095	2.08454164414571e-65	MRPS18A	Malignant cells	GSE186960	ENSG00000096080	55168	mitochondrial ribosomal protein S18A	FLJ10548|MRPS18-3	protein_coding	Q9NVS2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25024
1.09426745668261e-69	-0.540621940264116	0.989	0.997	2.43748075976052e-65	ITGB1	Malignant cells	GSE186960	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25025
1.50208087390358e-69	-0.545297364329936	0.936	0.989	3.34588514662021e-65	DDX46	Malignant cells	GSE186960	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25026
1.84208690569161e-69	-0.572393088706067	0.954	0.996	4.10324858242807e-65	APLP2	Malignant cells	GSE186960	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25027
2.31028512846839e-69	0.561206130753803	0.423	0.076	5.14616012366333e-65	TMEM179B	Malignant cells	GSE186960	ENSG00000185475	374395	transmembrane protein 179B	NA	protein_coding	Q7Z7N9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25028
2.80446449169105e-69	0.573342209291992	0.436	0.085	6.24694465524181e-65	SAP30	Malignant cells	GSE186960	ENSG00000164105	8819	Sin3A associated protein 30	NA	protein_coding	O75446	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25029
3.00874409581449e-69	0.497842296436037	0.323	0	6.70197747342679e-65	RPL23AP79	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25030
4.08118539483386e-69	0.582426531545966	0.699	0.388	9.09084046699242e-65	TJP1	Malignant cells	GSE186960	ENSG00000277401	7082	tight junction protein 1	DKFZp686M05161|MGC133289|ZO-1	protein_coding	Q07157	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25031
4.51220832480743e-69	-0.645662375291415	0.7	0.867	1.00509440435085e-64	RALBP1	Malignant cells	GSE186960	ENSG00000017797	10928	ralA binding protein 1	RIP|RIP1|RLIP76	protein_coding	Q15311	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25032
5.81676595241855e-69	0.55938728355114	0.339	0.011	1.29568461590123e-64	LINC00910	Malignant cells	GSE186960	ENSG00000188825	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25033
6.02407803239815e-69	0.606723806749647	0.499	0.146	1.34186338171669e-64	TBX1	Malignant cells	GSE186960	ENSG00000184058	6899	T-box transcription factor 1	CATCH22|VCF	protein_coding	O43435	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25034
8.69088823119058e-69	0.561398926690254	0.475	0.117	1.9358953534977e-64	INTS1	Malignant cells	GSE186960	ENSG00000164880	26173	integrator complex subunit 1	DKFZp586J0619|INT1|KIAA1440|NET28	protein_coding	Q8N201	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25035
1.11433654560926e-68	0.513979279369069	0.331	0.007	2.48218465534462e-64	C1QL1	Malignant cells	GSE186960	ENSG00000131094	10882	complement C1q like 1	C1QRF|C1QTNF14|CRF|CTRP14	protein_coding	O75973	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25036
1.13033218936835e-68	0.571076739218331	0.456	0.1	2.51781495181801e-64	FOXO3	Malignant cells	GSE186960	ENSG00000118689	2309	forkhead box O3	AF6q21|FKHRL1|FOXO2|FOXO3A	protein_coding	O43524	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25037
1.26177239749033e-68	0.61352249458396	0.963	0.911	2.81059801540971e-64	TAGLN2	Malignant cells	GSE186960	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25038
1.61670024006762e-68	-0.436983559573772	0.117	0.352	3.60119978475062e-64	RNF113A	Malignant cells	GSE186960	ENSG00000125352	7737	ring finger protein 113A	Cwc24|RNF113|ZNF183	protein_coding	O15541	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25039
1.9735007949799e-68	0.659130350645343	0.921	0.818	4.39597302081774e-64	GSN	Malignant cells	GSE186960	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25040
2.72656070724103e-68	0.49765440882219	0.32	0	6.0734139753794e-64	MRPS17.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25041
3.55878043655237e-68	0.59837116720443	0.437	0.089	7.9271834224204e-64	OSGIN2	Malignant cells	GSE186960	ENSG00000164823	734	oxidative stress induced growth inhibitor family member 2	C8orf1|hT41	protein_coding	Q9Y236	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25042
4.22039418506966e-68	0.567078885348798	0.862	0.681	9.40092804724266e-64	PRMT1	Malignant cells	GSE186960	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25043
5.48955419587746e-68	0.55680543390179	0.45	0.1	1.2227981971317e-63	ZNF787	Malignant cells	GSE186960	ENSG00000142409	126208	zinc finger protein 787	NA	protein_coding	Q6DD87	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25044
6.89273851114791e-68	0.572577757161005	0.757	0.477	1.5353575033582e-63	MRPL34	Malignant cells	GSE186960	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25045
6.91997099595403e-68	-0.730896459470119	0.296	0.552	1.54142353934876e-63	TSPAN13	Malignant cells	GSE186960	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25046
8.23029305180131e-68	0.529960696683303	0.912	0.782	1.83329777728874e-63	SNX6	Malignant cells	GSE186960	ENSG00000129515	58533	sorting nexin 6	NA	protein_coding	Q9UNH7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25047
1.0604125513721e-67	-0.549583494800983	0.947	0.991	2.36206895818136e-63	GSPT1	Malignant cells	GSE186960	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25048
1.45938809487265e-67	-0.627147056256115	0.701	0.872	3.25078698132882e-63	SLBP	Malignant cells	GSE186960	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25049
1.46081060654772e-67	0.536161055550842	0.892	0.716	3.25395562608505e-63	DNAJC21	Malignant cells	GSE186960	ENSG00000168724	134218	DnaJ heat shock protein family (Hsp40) member C21	DNAJA5|GS3|JJJ1	protein_coding	Q5F1R6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25050
1.66086728676678e-67	0.569736031667038	0.844	0.64	3.69958188127301e-63	BTF3L4	Malignant cells	GSE186960	ENSG00000134717	91408	basic transcription factor 3 like 4	MGC23908	protein_coding	Q96K17	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25051
1.71470803600051e-67	0.62704055767295	0.533	0.178	3.81951215019115e-63	ZFP36L1	Malignant cells	GSE186960	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25052
1.72733979470622e-67	-0.673325463464274	0.359	0.609	3.84764939270811e-63	LARP7	Malignant cells	GSE186960	ENSG00000174720	51574	La ribonucleoprotein 7, transcriptional regulator	DKFZP564K112|HDCMA18P|PIP7S	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25053
1.74122712032557e-67	0.560742944472898	0.446	0.099	3.87858341052521e-63	FBXO11	Malignant cells	GSE186960	ENSG00000138081	80204	F-box protein 11	FBX11|UBR6	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25054
1.8439979252883e-67	0.558352831169305	0.918	0.811	4.10750537857969e-63	SBDS	Malignant cells	GSE186960	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25055
1.95479234305957e-67	0.523957948415474	0.98	0.943	4.35429994416519e-63	HNRNPAB	Malignant cells	GSE186960	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25056
2.00137340548227e-67	-0.621334511832489	0.538	0.755	4.45805926071175e-63	TARDBP	Malignant cells	GSE186960	ENSG00000120948	23435	TAR DNA binding protein	ALS10|TDP-43	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25057
3.17981109964615e-67	0.581052042310362	0.468	0.122	7.0830292244618e-63	SHC1	Malignant cells	GSE186960	ENSG00000160691	6464	SHC adaptor protein 1	p66|SHC|ShcA	protein_coding	P29353	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25058
3.38797927343655e-67	-0.651935802709412	0.421	0.659	7.54672383157991e-63	PSMD10	Malignant cells	GSE186960	ENSG00000101843	5716	proteasome 26S subunit, non-ATPase 10	p28	protein_coding	O75832	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25059
5.50731124244274e-67	0.535259663674789	0.397	0.06	1.22675357925412e-62	CDC26	Malignant cells	GSE186960	ENSG00000176386	246184	cell division cycle 26	ANAPC12|APC12|C9orf17	protein_coding	Q8NHZ8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25060
6.53709186611987e-67	0.58876312638508	0.481	0.132	1.4561372131782e-62	C9orf16	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25061
7.30751442538292e-67	0.56317138170307	0.806	0.579	1.62774883825404e-62	C1orf122	Malignant cells	GSE186960	ENSG00000197982	127687	chromosome 1 open reading frame 122	FLJ45459	protein_coding	Q6ZSJ8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25062
1.31651243435306e-66	0.57584076217967	0.49	0.139	2.93253144752143e-62	EVA1B	Malignant cells	GSE186960	ENSG00000142694	55194	eva-1 homolog B	C1orf78|FAM176B|FLJ10647	protein_coding	Q9NVM1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25063
1.4839496296492e-66	-0.740227115194101	0.449	0.665	3.30549780004359e-62	TUBB6	Malignant cells	GSE186960	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25064
1.48876236568365e-66	-0.510681450345875	0.194	0.454	3.31621816956034e-62	DDX55	Malignant cells	GSE186960	ENSG00000111364	57696	DEAD-box helicase 55	KIAA1595	protein_coding	Q8NHQ9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25065
1.87759910641101e-66	0.488039548395115	0.313	0	4.18235200953053e-62	TUBB.6	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25066
2.29251810399388e-66	0.528360434420785	0.39	0.054	5.10658407664636e-62	RNF169	Malignant cells	GSE186960	ENSG00000166439	254225	ring finger protein 169	KIAA1991	protein_coding	Q8NCN4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25067
2.42611401088151e-66	0.347628964817582	1	1	5.40416895923857e-62	RPL18	Malignant cells	GSE186960	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25068
2.80080963435072e-66	-0.55042475734412	0.243	0.514	6.23880346051622e-62	SART3	Malignant cells	GSE186960	ENSG00000075856	9733	spliceosome associated factor 3, U4/U6 recycling protein	KIAA0156|p110|RP11-13G14|TIP110	protein_coding	Q15020	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25069
2.81743379518449e-66	-0.538714584685328	0.855	0.958	6.27583377877345e-62	PARP1	Malignant cells	GSE186960	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25070
2.91956332003612e-66	-0.599491377311604	0.259	0.526	6.50332729538046e-62	RHOBTB3	Malignant cells	GSE186960	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25071
3.47697445398261e-66	-0.492063908454883	0.955	0.996	7.74496059624626e-62	STOML2	Malignant cells	GSE186960	ENSG00000165283	30968	stomatin like 2	HSPC108|SLP-2	protein_coding	Q9UJZ1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25072
3.75987763978778e-66	-0.829907825835099	0.558	0.761	8.37512744262728e-62	KCNMA1	Malignant cells	GSE186960	ENSG00000156113	3778	potassium calcium-activated channel subfamily M alpha 1	KCa1.1|mSLO1|SLO	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25073
3.94267153621915e-66	0.554130223809896	0.852	0.662	8.78230084692816e-62	MZT2A	Malignant cells	GSE186960	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25074
4.13744604851872e-66	0.651589634506382	0.805	0.626	9.21616107307545e-62	MT1X	Malignant cells	GSE186960	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25075
4.85985164706824e-66	0.550788231352263	0.425	0.083	1.08253195438445e-61	FOXM1	Malignant cells	GSE186960	ENSG00000111206	2305	forkhead box M1	FKHL16|HFH-11|HNF-3|INS-1|MPHOSPH2|MPP2|TGT3|trident	protein_coding	Q08050	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25076
5.41738257983148e-66	0.5308251438884	0.422	0.083	1.20672196965746e-61	LSM1	Malignant cells	GSE186960	ENSG00000175324	27257	LSM1 homolog, mRNA degradation associated	CASM|YJL124C	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25077
5.89116442513997e-66	-0.585130033296934	0.711	0.881	1.31225687569993e-61	CCDC137	Malignant cells	GSE186960	ENSG00000185298	339230	coiled-coil domain containing 137	MGC16597	protein_coding	Q6PK04	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25078
1.14683472768603e-65	0.548257640524538	0.443	0.099	2.55457435592063e-61	ZNF580	Malignant cells	GSE186960	ENSG00000213015	51157	zinc finger protein 580	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25079
1.4468282214884e-65	0.527158403132273	0.39	0.056	3.2228098633654e-61	PCK2	Malignant cells	GSE186960	ENSG00000285241	5106	phosphoenolpyruvate carboxykinase 2, mitochondrial	PEPCK|PEPCK2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25080
2.90649485673119e-65	0.616764593191619	0.836	0.645	6.47421729336872e-61	JMJD1C	Malignant cells	GSE186960	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25081
4.07742707852666e-65	0.360686163776008	1	1	9.08246881741814e-61	H3F3B	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25082
4.25594185168332e-65	0.524566984085383	0.405	0.07	9.48011047462459e-61	INO80E	Malignant cells	GSE186960	ENSG00000169592	283899	INO80 complex subunit E	CCDC95|FLJ90652	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25083
4.72296638155205e-65	0.590182142762795	0.531	0.178	1.05204076149072e-60	ASNS	Malignant cells	GSE186960	ENSG00000070669	440	asparagine synthetase (glutamine-hydrolyzing)	NA	protein_coding	P08243	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25084
5.14055105003905e-65	-0.599394993578121	0.939	0.994	1.1450577463962e-60	CCND1	Malignant cells	GSE186960	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25085
5.90975465723453e-65	0.515150152210295	0.403	0.069	1.31639784989899e-60	YRDC	Malignant cells	GSE186960	ENSG00000196449	79693	yrdC N6-threonylcarbamoyltransferase domain containing	FLJ23476|IRIP|SUA5	protein_coding	Q86U90	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25086
6.17433123955232e-65	0.570124047154635	0.524	0.176	1.37533228361028e-60	MGAT4B	Malignant cells	GSE186960	ENSG00000284501	11282	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GnT-Ivb	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25087
1.16446229897793e-64	0.524843407279179	0.4	0.067	2.59383977097334e-60	ADAM17	Malignant cells	GSE186960	ENSG00000151694	6868	ADAM metallopeptidase domain 17	CD156B|cSVP|TACE	protein_coding	P78536	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25088
1.39011360695107e-64	0.579437813395484	0.686	0.375	3.09647805948351e-60	VGLL4	Malignant cells	GSE186960	ENSG00000144560	9686	vestigial like family member 4	KIAA0121	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25089
1.52150233168962e-64	-0.520590914556979	0.197	0.454	3.38914644383863e-60	MAD2L1BP	Malignant cells	GSE186960	ENSG00000124688	9587	MAD2L1 binding protein	CMT2|dJ261G23.1|KIAA0110	protein_coding	Q15013	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25090
1.75334964519256e-64	0.477788777347217	0.306	0	3.90558633466644e-60	ENDOG	Malignant cells	GSE186960	ENSG00000167136	2021	endonuclease G	NA	protein_coding	Q14249	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25091
1.99936182534064e-64	0.464583676490616	0.305	0	4.45357846594627e-60	SLC25A10.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25092
2.26657736666344e-64	0.566635119264828	0.522	0.175	5.04880108424282e-60	CDKN2AIPNL	Malignant cells	GSE186960	ENSG00000237190	91368	CDKN2A interacting protein N-terminal like	C2AIL|MGC13017	protein_coding	Q96HQ2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25093
2.53793619087882e-64	0.566196738662543	0.78	0.533	5.65325286518257e-60	IRF2BP2	Malignant cells	GSE186960	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25094
2.57471976824714e-64	0.552512930559208	0.743	0.467	5.73518828377049e-60	SPAG7	Malignant cells	GSE186960	ENSG00000091640	9552	sperm associated antigen 7	ACRP|FSA-1|MGC20134	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25095
3.317527279366e-64	-0.358027155576708	1	1	7.38979201478776e-60	ATP5E	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25096
4.58187547560271e-64	0.57084915041879	0.943	0.845	1.0206127621905e-59	SMS	Malignant cells	GSE186960	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25097
4.76225271110086e-64	0.555400630950052	0.494	0.153	1.06079179139772e-59	DGCR6L	Malignant cells	GSE186960	ENSG00000128185	85359	DiGeorge syndrome critical region gene 6 like	FLJ10666	protein_coding	Q9BY27	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25098
5.46007705579186e-64	-0.628423508129972	0.377	0.625	1.21623216417764e-59	NEMF	Malignant cells	GSE186960	ENSG00000165525	9147	nuclear export mediator factor	FLJ10051|NY-CO-1|RQC2|SDCCAG1	protein_coding	O60524	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25099
6.87534546808878e-64	0.592180771635631	0.742	0.484	1.53148320301678e-59	IGF2BP3	Malignant cells	GSE186960	ENSG00000136231	10643	insulin like growth factor 2 mRNA binding protein 3	CT98|IMP-3|IMP3	protein_coding	O00425	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25100
8.33685349626956e-64	0.557948489277991	0.491	0.149	1.85703411629404e-59	RAC3	Malignant cells	GSE186960	ENSG00000169750	5881	Rac family small GTPase 3	NA	protein_coding	P60763	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25101
9.36054865331242e-64	0.271145806243107	1	1	2.08506221252534e-59	RPS8	Malignant cells	GSE186960	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25102
9.53286025837709e-64	-0.501059258915872	0.931	0.977	2.1234446225535e-59	TXNL4A	Malignant cells	GSE186960	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25103
9.82044314659389e-64	0.517961392142548	0.417	0.08	2.18750371090379e-59	HTT	Malignant cells	GSE186960	ENSG00000197386	3064	huntingtin	HD|IT15	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25104
1.47367782796055e-63	0.553242599904755	0.705	0.411	3.28261736178213e-59	TATDN1	Malignant cells	GSE186960	ENSG00000147687	83940	TatD DNase domain containing 1	CDA11	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25105
1.65511583098513e-63	-0.530118356138502	0.156	0.398	3.68677051351938e-59	SQRDL	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25106
1.78903212840625e-63	-0.561626341174022	0.706	0.87	3.98506906602493e-59	TMED4	Malignant cells	GSE186960	ENSG00000158604	222068	transmembrane p24 trafficking protein 4	HNLF|p24a3|p24alpha3	protein_coding	Q7Z7H5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25107
2.92581004951642e-63	-0.635012360400007	0.365	0.603	6.51724188529782e-59	ACBD6	Malignant cells	GSE186960	ENSG00000230124	84320	acyl-CoA binding domain containing 6	MGC2404	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25108
3.3391400247725e-63	0.491101657023024	0.952	0.883	7.43793440518074e-59	EIF3F	Malignant cells	GSE186960	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25109
4.55691671647171e-63	0.485363589015673	0.337	0.024	1.01505319859407e-58	NUDT22	Malignant cells	GSE186960	ENSG00000149761	84304	nudix hydrolase 22	MGC13045	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25110
5.64942362582275e-63	-0.355337376991226	0.095	0.308	1.25840911265202e-58	TMSB4XP4	Malignant cells	GSE186960	ENSG00000223551	NA	NA	TMSL4	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25111
7.22436407977423e-63	0.570153325889902	0.503	0.166	1.60922709876971e-58	AP1S1	Malignant cells	GSE186960	ENSG00000106367	1174	adaptor related protein complex 1 subunit sigma 1	AP19|CLAPS1|EKV3|SIGMA1A|WUGSC:H_DJ0747G18.2	protein_coding	P61966	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25112
8.53675262423101e-63	-0.401526391245038	0.996	1	1.90156164704746e-58	ATP5G3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25113
9.4891533177825e-63	-0.606544820613021	0.553	0.755	2.11370890153605e-58	AFG3L2	Malignant cells	GSE186960	ENSG00000141385	10939	AFG3 like matrix AAA peptidase subunit 2	SCA28|SPAX5	protein_coding	Q9Y4W6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25114
9.70396668344149e-63	-0.510177986886338	0.89	0.979	2.16155857873659e-58	NDUFB2	Malignant cells	GSE186960	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25115
1.08156938448769e-62	-0.623199986052196	0.214	0.463	2.40919580394633e-58	MTRNR2L1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25116
1.15663922589005e-62	-0.650738572533898	0.473	0.693	2.57641387567008e-58	GPATCH4	Malignant cells	GSE186960	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25117
1.22129596379731e-62	0.523750379461235	0.41	0.082	2.72043675935851e-58	CDC42EP1	Malignant cells	GSE186960	ENSG00000128283	11135	CDC42 effector protein 1	Borg5|CEP1|MSE55	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25118
1.30628474021635e-62	-0.583405715262463	0.376	0.632	2.90974925883193e-58	CCDC58	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25119
1.449778575008e-62	-0.571688037550852	0.621	0.811	3.22938177583033e-58	WBP11	Malignant cells	GSE186960	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25120
1.78028450649724e-62	-0.813615142416037	0.495	0.692	3.96558373822259e-58	ASPH	Malignant cells	GSE186960	ENSG00000198363	444	aspartate beta-hydroxylase	BAH|CASQ2BP1|HAAH|JCTN	protein_coding	Q12797	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25121
2.77655952607338e-62	0.529747029654039	0.418	0.087	6.18478634432845e-58	DYRK1B	Malignant cells	GSE186960	ENSG00000281320	9149	dual specificity tyrosine phosphorylation regulated kinase 1B	MIRK	protein_coding	Q9Y463	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25122
3.86663528409165e-62	-0.452267209657143	0.992	0.996	8.61293009531415e-58	CBX3	Malignant cells	GSE186960	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25123
4.87724453824906e-62	0.467152320424845	0.328	0.02	1.08640622089498e-57	GLI4	Malignant cells	GSE186960	ENSG00000250571	2738	GLI family zinc finger 4	HKR4|ZNF928	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25124
5.60869686770527e-62	-0.516063089015614	0.89	0.967	1.24933722728135e-57	ATP5A1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25125
8.25121690547123e-62	-0.555481305927844	0.888	0.964	1.83795856569372e-57	XRN2	Malignant cells	GSE186960	ENSG00000088930	22803	5'-3' exoribonuclease 2	NA	protein_coding	Q9H0D6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25126
8.70451955072188e-62	-0.518862634210238	0.845	0.964	1.9389317299233e-57	SF3B1	Malignant cells	GSE186960	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25127
1.88898262746563e-61	0.530745195290612	0.505	0.166	4.20770880267969e-57	PJA2	Malignant cells	GSE186960	ENSG00000198961	9867	praja ring finger ubiquitin ligase 2	KIAA0438|Neurodap1|PRAJA2|RNF131	protein_coding	O43164	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25128
1.99683947300742e-61	0.488057132925285	0.947	0.861	4.44795992612403e-57	CDC42	Malignant cells	GSE186960	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25129
2.99764796023971e-61	-0.5076388594377	0.833	0.964	6.67726083143395e-57	ARF1	Malignant cells	GSE186960	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25130
3.83516092611685e-61	-0.56414598713988	0.254	0.509	8.54282096292529e-57	ALKBH2	Malignant cells	GSE186960	ENSG00000189046	121642	alkB homolog 2, alpha-ketoglutarate dependent dioxygenase	ABH2|MGC90512	protein_coding	Q6NS38	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25131
4.44004795628943e-61	-0.531730371144925	0.815	0.933	9.8902068226347e-57	STIP1	Malignant cells	GSE186960	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25132
4.52198634350946e-61	0.545910306192643	0.758	0.504	1.00727245801673e-56	BCL7C	Malignant cells	GSE186960	ENSG00000099385	9274	BAF chromatin remodeling complex subunit BCL7C	SMARCJ3	protein_coding	Q8WUZ0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25133
1.00929577917253e-60	0.508376761813675	0.331	0.027	2.24820634810681e-56	MALL	Malignant cells	GSE186960	ENSG00000144063	7851	mal, T cell differentiation protein like	BENE	protein_coding	Q13021	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25134
1.3841474191192e-60	0.475175065892177	0.354	0.043	3.08318837608803e-56	RPS6KB2	Malignant cells	GSE186960	ENSG00000175634	6199	ribosomal protein S6 kinase B2	KLS|P70-BETA|p70S6Kb|S6KB|S6Kbeta|STK14B	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25135
1.39959350084722e-60	0.483947443707662	0.959	0.9	3.11759452313719e-56	BANF1	Malignant cells	GSE186960	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25136
1.87626794748512e-60	0.525234623445068	0.43	0.102	4.17938685302311e-56	TMEM54	Malignant cells	GSE186960	ENSG00000121900	113452	transmembrane protein 54	BCLP|CAC-1	protein_coding	Q969K7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25137
2.07458354585781e-60	-0.336068366750642	0.079	0.275	4.62113484839827e-56	METTL12	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25138
2.27509566128746e-60	-0.498554249256303	0.855	0.968	5.06777558551781e-56	CACYBP	Malignant cells	GSE186960	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25139
4.12001085120774e-60	0.526073049542033	0.753	0.49	9.17732417106525e-56	KCMF1	Malignant cells	GSE186960	ENSG00000176407	56888	potassium channel modulatory factor 1	DEBT91|DKFZP434L1021|PCMF|ZZZ1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25140
9.72970274301237e-60	-0.634762481043495	0.45	0.659	2.16729128600601e-55	SPA17	Malignant cells	GSE186960	ENSG00000064199	53340	sperm autoantigenic protein 17	CT22|SP17	protein_coding	Q15506	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25141
9.77584104538338e-60	0.556874643298486	0.376	0.063	2.17756859285915e-55	RND3	Malignant cells	GSE186960	ENSG00000115963	390	Rho family GTPase 3	ARHE|Rho8|RhoE	protein_coding	P61587	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25142
9.92830133860589e-60	0.564409970649698	0.567	0.242	2.21152912317446e-55	CHCHD5	Malignant cells	GSE186960	ENSG00000125611	84269	coiled-coil-helix-coiled-coil-helix domain containing 5	C2orf9|MGC11104|MIC14|MIX14	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25143
1.01092262354183e-59	0.542949103446089	0.753	0.504	2.25183014393942e-55	EIF4EBP1	Malignant cells	GSE186960	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25144
1.91515333713681e-59	0.444507211583596	0.996	0.984	4.26600405847225e-55	HN1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25145
2.05227944027591e-59	0.507003951785803	0.435	0.11	4.57145245321459e-55	PYURF	Malignant cells	GSE186960	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25146
2.05637673107498e-59	0.540338331409608	0.866	0.682	4.58057916846953e-55	FNDC3B	Malignant cells	GSE186960	ENSG00000075420	64778	fibronectin type III domain containing 3B	DKFZp762K137|FAD104|FLJ23399|PRO4979|YVTM2421	protein_coding	Q53EP0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25147
2.3814080944576e-59	0.523452944320832	0.417	0.096	5.30458653040431e-55	MSRB2	Malignant cells	GSE186960	ENSG00000148450	22921	methionine sulfoxide reductase B2	CBS-1|CBS1|CGI-131|MSRB|PILB	protein_coding	Q9Y3D2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25148
2.78429529778172e-59	-0.464174179510522	0.182	0.426	6.20201777580879e-55	CCDC109B	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25149
3.05330650093639e-59	0.527114705184128	0.439	0.115	6.8012402308358e-55	SETD8	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25150
5.20647878798391e-59	-0.559157812323481	0.862	0.964	1.15974315002342e-54	IQGAP1	Malignant cells	GSE186960	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25151
5.56044665330678e-59	-0.654421187326139	0.527	0.723	1.23858949202408e-54	TTC37	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25152
7.14852634874077e-59	0.550810498852505	0.548	0.221	1.59233424418201e-54	NCOA7	Malignant cells	GSE186960	ENSG00000111912	135112	nuclear receptor coactivator 7	dJ187J11.3|ERAP140|TLDC4	protein_coding	Q8NI08	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25153
8.61142303319633e-59	0.447709615129308	0.301	0.01	1.91819448064448e-54	CTXN1	Malignant cells	GSE186960	ENSG00000178531	404217	cortexin 1	FLJ25968	protein_coding	P60606	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25154
1.13981574037258e-58	0.434058983100449	0.291	0.004	2.53893956167993e-54	RFNG	Malignant cells	GSE186960	ENSG00000169733	5986	RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase	NA	protein_coding	Q9Y644	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25155
1.31758102996305e-58	0.500227128473638	0.387	0.073	2.93491174424269e-54	FAM53C	Malignant cells	GSE186960	ENSG00000120709	51307	family with sequence similarity 53 member C	C5orf6	protein_coding	Q9NYF3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25156
1.77260811183748e-58	-0.544434918026644	0.223	0.468	3.94848456911798e-54	RAD18	Malignant cells	GSE186960	ENSG00000070950	56852	RAD18 E3 ubiquitin protein ligase	RNF73	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25157
2.31568938589998e-58	0.471051583632573	0.928	0.851	5.15819810709221e-54	ATP5J2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25158
2.47249740917847e-58	0.499760415094946	0.44	0.115	5.50748797894503e-54	DSG2	Malignant cells	GSE186960	ENSG00000046604	1829	desmoglein 2	CDHF5	protein_coding	Q14126	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25159
2.67522233667075e-58	0.536556024475944	0.387	0.07	5.9590577549341e-54	MAP2	Malignant cells	GSE186960	ENSG00000078018	4133	microtubule associated protein 2	MAP2A|MAP2B|MAP2C	protein_coding	P11137	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25160
4.0799790348814e-58	0.498492746367361	0.412	0.095	9.08815330019832e-54	FAM89B	Malignant cells	GSE186960	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25161
4.62137646148185e-58	0.465250182307485	0.97	0.93	1.02941160679508e-53	SAP18	Malignant cells	GSE186960	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25162
5.42073621483492e-58	-0.54317691581305	0.633	0.811	1.20746899185448e-53	ATIC	Malignant cells	GSE186960	ENSG00000138363	471	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	AICARFT|IMPCHASE|PURH	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25163
6.00479874396484e-58	-0.496363231488006	0.821	0.947	1.33756892021817e-53	POLR2E	Malignant cells	GSE186960	ENSG00000099817	5434	RNA polymerase II, I and III subunit E	hRPB25|hsRPB5|RPABC1|RPB5|XAP4	protein_coding	P19388	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25164
6.19280745471428e-58	-0.500782809570117	0.908	0.979	1.37944786053761e-53	HNRNPDL	Malignant cells	GSE186960	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25165
7.26923774510664e-58	0.503813201700965	0.943	0.828	1.6192227077225e-53	NQO1	Malignant cells	GSE186960	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25166
7.68320292849193e-58	-0.54648429847206	0.302	0.547	1.71143345232158e-53	LUC7L	Malignant cells	GSE186960	ENSG00000007392	55692	LUC7 like	hLuc7B1|Luc7|LUC7B1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25167
8.78653511694332e-58	0.434438337574861	0.293	0.009	1.95720069729912e-53	HHLA3	Malignant cells	GSE186960	ENSG00000197568	11147	HERV-H LTR-associating 3	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25168
9.20701132499322e-58	-0.576977801611587	0.379	0.617	2.05086177264224e-53	RBMX2	Malignant cells	GSE186960	ENSG00000134597	51634	RNA binding motif protein X-linked 2	CGI-79|Snu17	protein_coding	Q9Y388	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25169
1.25207062621178e-57	-0.46306653312019	0.184	0.423	2.78898731988674e-53	ARV1	Malignant cells	GSE186960	ENSG00000173409	64801	ARV1 homolog, fatty acid homeostasis modulator	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25170
1.64753486970966e-57	0.489750132254316	0.406	0.09	3.66988392227826e-53	IDH1	Malignant cells	GSE186960	ENSG00000138413	3417	isocitrate dehydrogenase (NADP(+)) 1	NA	protein_coding	O75874	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25171
1.78804104954575e-57	0.487038503373014	0.9	0.768	3.98286143786316e-53	C7orf50	Malignant cells	GSE186960	ENSG00000146540	84310	chromosome 7 open reading frame 50	MGC11257|YCR016W	protein_coding	Q9BRJ6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25172
2.82719446549707e-57	0.485348632225729	0.879	0.738	6.29757567189472e-53	TAF10	Malignant cells	GSE186960	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25173
3.50558234119208e-57	0.497035186527605	0.976	0.915	7.80868466500535e-53	HMGB2	Malignant cells	GSE186960	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25174
3.84110087321196e-57	-0.638051550528369	0.485	0.685	8.55605219507964e-53	SLK	Malignant cells	GSE186960	ENSG00000065613	9748	STE20 like kinase	KIAA0204|se20-9|STK2	protein_coding	Q9H2G2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25175
4.10093306716643e-57	0.498893518269563	0.888	0.728	9.13482840711323e-53	MRPL40	Malignant cells	GSE186960	ENSG00000185608	64976	mitochondrial ribosomal protein L40	MRP-L22|NLVCF	protein_coding	Q9NQ50	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25176
4.17517798177271e-57	0.52271814522062	0.686	0.401	9.30020895439872e-53	LYRM2	Malignant cells	GSE186960	ENSG00000083099	57226	LYR motif containing 2	DJ122O8.2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25177
4.3373593536544e-57	0.567529315228055	0.48	0.163	9.66146796026518e-53	GPR126	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25178
4.78644003406771e-57	0.527250693846781	0.518	0.191	1.06617951758858e-52	COX19	Malignant cells	GSE186960	ENSG00000240230	90639	cytochrome c oxidase assembly factor COX19	MGC104475	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25179
6.28487833875987e-57	0.527091553278933	0.831	0.66	1.39995664995876e-52	QKI	Malignant cells	GSE186960	ENSG00000112531	9444	QKI, KH domain containing RNA binding	QK3	protein_coding	Q96PU8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25180
8.24637776676752e-57	-0.391952567107801	0.996	1	1.83688064754746e-52	POLR2L	Malignant cells	GSE186960	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25181
8.39366082351885e-57	0.458511565990643	0.346	0.049	1.86968794843882e-52	SRRD	Malignant cells	GSE186960	ENSG00000100104	402055	SRR1 domain containing	HC/HCC|SRR1L	protein_coding	Q9UH36	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25182
9.19225694995387e-57	0.553039640920962	0.645	0.348	2.04757523560222e-52	SERINC1	Malignant cells	GSE186960	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25183
9.50773142445661e-57	0.524978995334424	0.643	0.338	2.11784717479771e-52	ZNF292	Malignant cells	GSE186960	ENSG00000188994	23036	zinc finger protein 292	bA393I2.3|KIAA0530|ZFP292|Zn-15|Zn-16	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25184
1.30277886060983e-56	0.474958888206482	0.386	0.08	2.90193991200839e-52	VPS51	Malignant cells	GSE186960	ENSG00000149823	738	VPS51 subunit of GARP complex	ANG2|ANG3|C11orf2|C11orf3|FFR	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25185
1.58210972816111e-56	0.437347370212346	0.333	0.036	3.52414941947888e-52	MXRA7	Malignant cells	GSE186960	ENSG00000182534	439921	matrix remodeling associated 7	FLJ46603|PS1TP1|TMAP1	protein_coding	P84157	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25186
1.99945749288824e-56	0.548428611926474	0.652	0.37	4.45379156540856e-52	ISYNA1	Malignant cells	GSE186960	ENSG00000105655	51477	inositol-3-phosphate synthase 1	Ino1|INOS|IPS	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25187
2.40392749857481e-56	0.424795713562736	0.291	0.01	5.3547485030754e-52	GALNS	Malignant cells	GSE186960	ENSG00000141012	2588	galactosamine (N-acetyl)-6-sulfatase	GalN6S|GALNAC6S|GAS	protein_coding	P34059	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25188
2.76724677576467e-56	0.434974477494312	0.99	0.989	6.1640421930158e-52	HMGN2	Malignant cells	GSE186960	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25189
3.12609679817999e-56	-0.627739432649751	0.459	0.658	6.96338061794593e-52	C9orf78	Malignant cells	GSE186960	ENSG00000136819	51759	chromosome 9 open reading frame 78	CSU2|HCA59|HSPC220	protein_coding	Q9NZ63	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25190
4.03203170062764e-56	-0.522214696913914	0.794	0.928	8.98135061314806e-52	PSENEN	Malignant cells	GSE186960	ENSG00000205155	55851	presenilin enhancer, gamma-secretase subunit	PEN2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25191
4.14385611531824e-56	-0.31945498620392	0.073	0.254	9.23043949687137e-52	KAT2B	Malignant cells	GSE186960	ENSG00000114166	8850	lysine acetyltransferase 2B	GCN5|GCN5L|P/CAF|PCAF	protein_coding	Q92831	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25192
4.16835458589448e-56	-0.592131613350278	0.472	0.675	9.28500984007996e-52	ASUN	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25193
5.30447345409791e-56	0.483584436402902	0.344	0.047	1.18157146190031e-51	ZBTB10	Malignant cells	GSE186960	ENSG00000205189	65986	zinc finger and BTB domain containing 10	FLJ12752|RINZF	protein_coding	Q96DT7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25194
5.71892199638375e-56	0.462749523196468	0.339	0.046	1.27388987469448e-51	ZFPL1	Malignant cells	GSE186960	ENSG00000162300	7542	zinc finger protein like 1	D11S750|MCG4	protein_coding	O95159	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25195
6.76446770478828e-56	0.504148898087006	0.815	0.622	1.50678518124159e-51	PAIP2	Malignant cells	GSE186960	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25196
7.46601856717303e-56	-0.471723151914113	0.937	0.987	1.66305563583779e-51	SF3B2	Malignant cells	GSE186960	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25197
8.60474662767218e-56	0.51467241789947	0.59	0.272	1.91670731131398e-51	BRD7	Malignant cells	GSE186960	ENSG00000166164	29117	bromodomain containing 7	BP75|CELTIX1|SMARCI1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25198
8.7377461479932e-56	0.490183159391054	0.403	0.089	1.94633295446549e-51	KDM6B	Malignant cells	GSE186960	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25199
1.07024332128054e-55	-0.498163544496701	0.857	0.954	2.3839669981524e-51	HNRNPH3	Malignant cells	GSE186960	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25200
1.21594007415802e-55	0.495472049619175	0.468	0.149	2.708506515187e-51	SSBP4	Malignant cells	GSE186960	ENSG00000130511	170463	single stranded DNA binding protein 4	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25201
2.28876599639692e-55	0.476074170375744	0.419	0.106	5.09822625697415e-51	CTC-228N24.3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25202
2.42053878216552e-55	0.533580837685051	0.553	0.235	5.39175013727369e-51	N4BP2	Malignant cells	GSE186960	ENSG00000078177	55728	NEDD4 binding protein 2	B3BP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25203
2.61378244071269e-55	0.555173705688663	0.595	0.302	5.82220038668752e-51	TECR	Malignant cells	GSE186960	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25204
3.80705760773722e-55	-0.50373729049144	0.795	0.94	8.48022082123467e-51	IK	Malignant cells	GSE186960	ENSG00000113141	3550	IK cytokine	RED|RER	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25205
3.84711142796093e-55	-0.657747505562671	0.38	0.596	8.56944070578297e-51	ZMYND8	Malignant cells	GSE186960	ENSG00000101040	23613	zinc finger MYND-type containing 8	KIAA1125|PRKCBP1|RACK7	protein_coding	Q9ULU4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25206
7.26322209693638e-55	-0.594146943024081	0.322	0.554	1.61788272209258e-50	HOXB4	Malignant cells	GSE186960	ENSG00000182742	3214	homeobox B4	HOX2|HOX2F	protein_coding	P17483	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25207
7.73105730090343e-55	0.422446807777291	0.269	0	1.72209301377624e-50	PHF17	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25208
1.14918399005694e-54	0.481990976552447	0.936	0.855	2.55980733785183e-50	HNRNPA1	Malignant cells	GSE186960	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25209
1.61914061873998e-54	0.411663285714931	0.284	0.01	3.6066357282433e-50	TPGS1	Malignant cells	GSE186960	ENSG00000141933	91978	tubulin polyglutamylase complex subunit 1	C19orf20|GTRGEO22|PGs1	protein_coding	Q6ZTW0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25210
3.06789156726113e-54	-0.594375271667401	0.289	0.524	6.83372846607417e-50	TACC2	Malignant cells	GSE186960	ENSG00000138162	10579	transforming acidic coiled-coil containing protein 2	AZU-1|ECTACC	protein_coding	O95359	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25211
3.10353534459372e-54	-0.339628416651908	0.999	1	6.91312498008252e-50	NDUFA4	Malignant cells	GSE186960	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25212
3.13347156888152e-54	0.482012327512421	0.313	0.03	6.97980791968359e-50	PLEKHG1	Malignant cells	GSE186960	ENSG00000120278	57480	pleckstrin homology and RhoGEF domain containing G1	ARHGEF41|KIAA1209	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25213
3.1348642422155e-54	0.437248399706615	0.28	0.009	6.98291009953502e-50	IER5L	Malignant cells	GSE186960	ENSG00000188483	389792	immediate early response 5 like	bA247A12.2	protein_coding	Q5T953	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25214
3.90041024286035e-54	-0.487985083128269	0.229	0.467	8.68816381597142e-50	FBXO9	Malignant cells	GSE186960	ENSG00000112146	26268	F-box protein 9	FBX9|NY-REN-57	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25215
4.00447892490163e-54	0.562193473886663	0.797	0.6	8.91997680521839e-50	CD70	Malignant cells	GSE186960	ENSG00000125726	970	CD70 molecule	CD27L|CD27LG|TNFSF7	protein_coding	P32970	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25216
4.04120151802726e-54	-0.567339974783638	0.434	0.642	9.00177638140572e-50	PPP2R5C	Malignant cells	GSE186960	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25217
6.00990479602183e-54	-0.594853813083542	0.463	0.656	1.33870629331386e-49	COPS6	Malignant cells	GSE186960	ENSG00000168090	10980	COP9 signalosome subunit 6	CSN6|MOV34-34KD	protein_coding	Q7L5N1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25218
6.06647855138823e-54	0.605477168523906	0.579	0.284	1.35130809732173e-49	MDM2	Malignant cells	GSE186960	ENSG00000135679	4193	MDM2 proto-oncogene	HDM2|MGC5370	protein_coding	Q00987	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25219
7.67625359566734e-54	0.550018878344077	0.757	0.533	1.7098854884349e-49	AURKB	Malignant cells	GSE186960	ENSG00000178999	9212	aurora kinase B	Aik2|AIM-1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5	protein_coding	Q96GD4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25220
7.86143256825818e-54	-0.502793285530787	0.863	0.956	1.75113410457951e-49	SPCS1	Malignant cells	GSE186960	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25221
1.0965177953378e-53	0.438528317824309	0.324	0.042	2.44249338911494e-49	TRAF7	Malignant cells	GSE186960	ENSG00000131653	84231	TNF receptor associated factor 7	DKFZp586I021|MGC7807|RFWD1|RNF119	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25222
1.18067317703775e-53	-0.647873538452666	0.463	0.66	2.62994950185159e-49	GALNT1	Malignant cells	GSE186960	ENSG00000141429	2589	polypeptide N-acetylgalactosaminyltransferase 1	GalNAc-T1	protein_coding	Q10472	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25223
1.25578131494875e-53	-0.510561193784296	0.9	0.97	2.79725287904834e-49	RBM39	Malignant cells	GSE186960	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25224
1.75231742024979e-53	-0.489625390554568	0.627	0.817	3.90328705360641e-49	GTF2F1	Malignant cells	GSE186960	ENSG00000125651	2962	general transcription factor IIF subunit 1	BTF4|RAP74|TF2F1|TFIIF	protein_coding	P35269	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25225
1.80755594011275e-53	-0.471408872146675	0.155	0.372	4.02633085660114e-49	OTUB2	Malignant cells	GSE186960	ENSG00000277276	78990	OTU deubiquitinase, ubiquitin aldehyde binding 2	C14orf137|FLJ21916|MGC3102	protein_coding	Q96DC9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25226
2.19858010296065e-53	0.364395921239053	0.999	0.996	4.89733717934485e-49	DYNLL1	Malignant cells	GSE186960	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25227
2.21252105559691e-53	0.495718684607342	0.617	0.312	4.92839065134211e-49	PUM1	Malignant cells	GSE186960	ENSG00000134644	9698	pumilio RNA binding family member 1	KIAA0099|PUMH1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25228
2.47353487778994e-53	-0.622150956747623	0.46	0.656	5.50979894027709e-49	IFT27	Malignant cells	GSE186960	ENSG00000100360	11020	intraflagellar transport 27	BBS19|FAP156|RABL4|RAYL	protein_coding	Q9BW83	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25229
2.87826151664967e-53	0.54911433581084	0.656	0.372	6.41132752833713e-49	SKIL	Malignant cells	GSE186960	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25230
3.0666324429672e-53	0.43766025229317	0.952	0.901	6.83092376670944e-49	UBE2L3	Malignant cells	GSE186960	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25231
3.0954029219745e-53	0.385928262808278	0.995	0.984	6.89501000869819e-49	DBI	Malignant cells	GSE186960	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25232
3.31920062887408e-53	0.432150205298994	0.315	0.036	7.39351940081701e-49	CCZ1B	Malignant cells	GSE186960	ENSG00000146574	221960	CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated	C7orf28B|DKFZP586I1023|H_NH0577018.2|MGC19819	protein_coding	P86790	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25233
3.55843818864635e-53	0.46320505093524	0.367	0.076	7.92642106520975e-49	YBX2	Malignant cells	GSE186960	ENSG00000288504	51087	Y-box binding protein 2	Contrin|CSDA3|MSY2	protein_coding	Q9Y2T7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25234
4.23004649901548e-53	0.443889766622672	0.352	0.06	9.42242857655699e-49	TNRC18	Malignant cells	GSE186960	ENSG00000182095	84629	trinucleotide repeat containing 18	CAGL79|KIAA1856|TNRC18A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25235
4.57181622989207e-53	-0.365902005594736	0.998	1	1.01837206520846e-48	DSTN	Malignant cells	GSE186960	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25236
5.07621150130653e-53	0.391875286309376	0.99	0.979	1.13072611191603e-48	XRCC6	Malignant cells	GSE186960	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25237
6.42600745773469e-53	-0.49596117760027	0.939	0.987	1.4313931612104e-48	EZR	Malignant cells	GSE186960	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25238
6.44322137018738e-53	0.532143954753333	0.495	0.188	1.43522756020924e-48	TUBB2B	Malignant cells	GSE186960	ENSG00000137285	347733	tubulin beta 2B class IIb	bA506K6.1|DKFZp566F223|MGC8685	protein_coding	Q9BVA1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25239
8.35774463469371e-53	0.537534744680525	0.486	0.181	1.86168761737802e-48	ZNF217	Malignant cells	GSE186960	ENSG00000171940	7764	zinc finger protein 217	ZABC1	protein_coding	O75362	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25240
1.10341415695898e-52	-0.440307091800549	0.947	0.986	2.45785503462613e-48	RUVBL1	Malignant cells	GSE186960	ENSG00000284901	8607	RuvB like AAA ATPase 1	ECP54|INO80H|NMP238|Pontin52|RVB1|TIH1|TIP49|TIP49a	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25241
1.12727281482488e-52	-0.579745195354257	0.891	0.961	2.51100019502243e-48	PRC1	Malignant cells	GSE186960	ENSG00000198901	9055	protein regulator of cytokinesis 1	ASE1	protein_coding	O43663	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25242
1.15536662210449e-52	-0.564336670583347	0.353	0.582	2.57357915073775e-48	NSUN2	Malignant cells	GSE186960	ENSG00000037474	54888	NOP2/Sun RNA methyltransferase 2	FLJ20303|Misu|MRT5|SAKI|TRM4	protein_coding	Q08J23	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25243
1.18252437569387e-52	0.48181644153849	0.431	0.126	2.63407304685809e-48	C19orf40	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25244
1.39505526432105e-52	0.564662443843912	0.652	0.375	3.10748560127514e-48	FASN	Malignant cells	GSE186960	ENSG00000169710	2194	fatty acid synthase	FAS|SDR27X1	protein_coding	P49327	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25245
1.87082865900089e-52	0.426316451653873	0.321	0.04	4.16727083792449e-48	FAM115A	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25246
1.93325532948694e-52	-0.465961894618751	0.129	0.334	4.30632624643216e-48	ABLIM1	Malignant cells	GSE186960	ENSG00000099204	3983	actin binding LIM protein 1	ABLIM|LIMAB1|limatin	protein_coding	O14639	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25247
1.93548687885549e-52	0.379183162322056	0.995	0.99	4.31129702265061e-48	NDUFS6	Malignant cells	GSE186960	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25248
2.00011208372349e-52	0.451511312129129	0.348	0.062	4.45524966649408e-48	PKMYT1	Malignant cells	GSE186960	ENSG00000127564	9088	protein kinase, membrane associated tyrosine/threonine 1	MYT1|PPP1R126	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25249
2.13695244393415e-52	0.459540084686205	0.398	0.099	4.76006156886333e-48	CERS2	Malignant cells	GSE186960	ENSG00000143418	29956	ceramide synthase 2	FLJ10243|LASS2|SP260	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25250
2.18171449283751e-52	0.398091892185976	0.259	0	4.85976903279555e-48	SEC22B.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25251
2.24251950004708e-52	0.427706397397459	0.318	0.04	4.99521218635488e-48	ACAA1	Malignant cells	GSE186960	ENSG00000060971	30	acetyl-CoA acyltransferase 1	Lnc-Myd88	protein_coding	P09110	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25252
3.19659231517523e-52	0.444690701306686	0.34	0.056	7.12040938205281e-48	PLXNB2	Malignant cells	GSE186960	ENSG00000196576	23654	plexin B2	KIAA0315|MM1|PLEXB2	protein_coding	O15031	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25253
4.48868398181425e-52	0.456353904757444	0.359	0.07	9.99854356949123e-48	NUDT15	Malignant cells	GSE186960	ENSG00000136159	55270	nudix hydrolase 15	FLJ10956|MTH2	protein_coding	Q9NV35	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25254
5.53358176226108e-52	-0.468505527658457	0.777	0.921	1.23260533754366e-47	PPP4C	Malignant cells	GSE186960	ENSG00000149923	5531	protein phosphatase 4 catalytic subunit	PP4|PPX	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25255
5.9153242348654e-52	0.499768248088107	0.471	0.158	1.31763847331627e-47	IRF2BPL	Malignant cells	GSE186960	ENSG00000119669	64207	interferon regulatory factor 2 binding protein like	C14orf4|EAP1|KIAA1865	protein_coding	Q9H1B7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25256
6.72127577565875e-52	0.467688987422902	0.445	0.14	1.49716417902799e-47	ELOVL1	Malignant cells	GSE186960	ENSG00000066322	64834	ELOVL fatty acid elongase 1	Ssc1	protein_coding	Q9BW60	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25257
6.98702436446542e-52	-0.598051378089334	0.478	0.672	1.55635967718467e-47	USP10	Malignant cells	GSE186960	ENSG00000103194	9100	ubiquitin specific peptidase 10	KIAA0190|UBPO	protein_coding	Q14694	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25258
7.90154373211507e-52	-0.570221093126056	0.445	0.649	1.76006886632863e-47	C11orf48	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25259
8.26065190904987e-52	0.407852618255757	0.271	0.009	1.84006021274086e-47	OLFM2	Malignant cells	GSE186960	ENSG00000105088	93145	olfactomedin 2	NOE2|OlfC	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25260
1.06530097904212e-51	0.490825070432073	0.528	0.212	2.37295793081632e-47	ZSWIM7	Malignant cells	GSE186960	ENSG00000214941	125150	zinc finger SWIM-type containing 7	SWS1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25261
1.14732467659266e-51	-0.399562828875752	0.994	0.997	2.55566571711016e-47	ATP5J	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25262
1.25913635641461e-51	0.521170851874738	0.552	0.242	2.80472623391355e-47	LDLR	Malignant cells	GSE186960	ENSG00000130164	3949	low density lipoprotein receptor	LDLCQ2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25263
1.30913094756372e-51	-0.587273581423511	0.344	0.56	2.91608918569819e-47	ARL13B	Malignant cells	GSE186960	ENSG00000169379	200894	ADP ribosylation factor like GTPase 13B	ARL2L1|DKFZp761H079|JBTS8	protein_coding	Q3SXY8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25264
1.34720903232502e-51	-0.658363214325973	0.489	0.681	3.00090811950397e-47	VCL	Malignant cells	GSE186960	ENSG00000035403	7414	vinculin	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25265
1.3807259589207e-51	0.513100970093311	0.542	0.238	3.07556707349587e-47	VTI1B	Malignant cells	GSE186960	ENSG00000100568	10490	vesicle transport through interaction with t-SNAREs 1B	VTI2	protein_coding	Q9UEU0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25266
1.40702531114696e-51	0.441308686946929	0.347	0.063	3.13414888057986e-47	PPP5C	Malignant cells	GSE186960	ENSG00000011485	5536	protein phosphatase 5 catalytic subunit	PP5|PPP5	protein_coding	P53041	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25267
1.41741051453176e-51	0.369638050597692	0.997	0.99	3.1572819211195e-47	EEF1D	Malignant cells	GSE186960	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25268
1.61319001578798e-51	-0.589743150632583	0.561	0.739	3.59338076016773e-47	NSRP1	Malignant cells	GSE186960	ENSG00000126653	84081	nuclear speckle splicing regulatory protein 1	CCDC55|DKFZP434K1421|NSrp70	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25269
1.68970575195023e-51	0.391029860690756	0.997	0.991	3.76381956246914e-47	SEC61G	Malignant cells	GSE186960	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25270
1.83056296858888e-51	0.431488792812994	0.306	0.034	4.07757901253173e-47	AC005154.6	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25271
2.49844595003395e-51	-0.437115219361766	0.941	0.991	5.56528835370061e-47	TRMT112	Malignant cells	GSE186960	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25272
3.29277030694252e-51	-0.445477433810489	0.887	0.971	7.33464585871446e-47	NDUFB1	Malignant cells	GSE186960	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25273
3.51757488854156e-51	0.518545308120474	0.586	0.285	7.83539806422633e-47	SUPT6H	Malignant cells	GSE186960	ENSG00000109111	6830	SPT6 homolog, histone chaperone and transcription elongation factor	KIAA0162|SPT6H	protein_coding	Q7KZ85	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25274
3.58980391155238e-51	-0.581229657472818	0.492	0.683	7.99628821298292e-47	UCHL5	Malignant cells	GSE186960	ENSG00000116750	51377	ubiquitin C-terminal hydrolase L5	CGI-70|INO80R|UCH37	protein_coding	Q9Y5K5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25275
4.15491555758908e-51	0.435227553028608	0.293	0.026	9.25507440452967e-47	RP1-313I6.12	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25276
5.89942033404425e-51	0.394677877836376	0.268	0.009	1.31409587940836e-46	TMEM238	Malignant cells	GSE186960	ENSG00000233493	388564	transmembrane protein 238	NA	protein_coding	C9JI98	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25277
5.93748874222733e-51	0.524560122302294	0.594	0.308	1.32257561733114e-46	TRIO	Malignant cells	GSE186960	ENSG00000038382	7204	trio Rho guanine nucleotide exchange factor	ARHGEF23	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25278
5.95549591436957e-51	0.499710995116127	0.261	0.004	1.32658671492582e-46	HIST1H2AH	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25279
6.1973836527422e-51	-0.381127569042643	0.991	1	1.38046720864833e-46	UQCRQ	Malignant cells	GSE186960	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25280
6.45596987967812e-51	0.486106371294641	0.433	0.133	1.4380672906983e-46	ITGAV	Malignant cells	GSE186960	ENSG00000138448	3685	integrin subunit alpha V	CD51|MSK8|VNRA|VTNR	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25281
6.8347409607096e-51	-0.5382329045166	0.337	0.569	1.52243854899806e-46	SMNDC1	Malignant cells	GSE186960	ENSG00000119953	10285	survival motor neuron domain containing 1	SMNR|SPF30|TDRD16C	protein_coding	O75940	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25282
8.29004243409888e-51	-0.52499319689587	0.344	0.57	1.84660695219552e-46	APITD1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25283
8.59524728245678e-51	0.519032428207657	0.879	0.764	1.91459133216725e-46	H2AFX	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25284
1.00903326033323e-50	-0.403040030880576	0.134	0.341	2.24762158739227e-46	UBXN11	Malignant cells	GSE186960	ENSG00000158062	91544	UBX domain protein 11	SOC|SOCI|UBXD5	protein_coding	Q5T124	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25285
1.09438861629862e-50	-0.446223428681572	0.976	0.993	2.43775064280517e-46	LMNA	Malignant cells	GSE186960	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25286
1.11617050818503e-50	0.424030631336972	0.342	0.06	2.48626980698215e-46	ATP6V1E2	Malignant cells	GSE186960	ENSG00000250565	90423	ATPase H+ transporting V1 subunit E2	ATP6E1|ATP6EL2|ATP6V1EL2|MGC9341|VMA4	protein_coding	Q96A05	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25287
1.14189078289872e-50	0.544930117776128	0.448	0.148	2.54356171890689e-46	HES4	Malignant cells	GSE186960	ENSG00000188290	57801	hes family bHLH transcription factor 4	bHLHb42	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25288
1.16727917186922e-50	0.486190487675513	0.443	0.145	2.60011435533868e-46	BCL9L	Malignant cells	GSE186960	ENSG00000186174	283149	BCL9 like	B9L|Bcl9-2|DLNB11	protein_coding	Q86UU0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25289
1.25812022998286e-50	0.496571873286375	0.736	0.499	2.80246281228682e-46	BLVRB	Malignant cells	GSE186960	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25290
1.52090127367154e-50	0.393127051373463	0.265	0.009	3.38780758710336e-46	CLCN7	Malignant cells	GSE186960	ENSG00000103249	1186	chloride voltage-gated channel 7	CLC-7|CLC7|OPTA2|PPP1R63	protein_coding	P51798	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25291
1.82341343431546e-50	-0.472524172000751	0.875	0.963	4.06165342493769e-46	SON	Malignant cells	GSE186960	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25292
3.32296169322605e-50	-0.470646172461397	0.87	0.964	7.40189717166103e-46	HNRNPF	Malignant cells	GSE186960	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25293
3.50322251939339e-50	0.491856564284077	0.494	0.192	7.80342816194878e-46	TSPYL1	Malignant cells	GSE186960	ENSG00000189241	7259	TSPY like 1	TSPYL	protein_coding	Q9H0U9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25294
4.25472558614502e-50	-0.568134851271124	0.326	0.554	9.47740124313804e-46	C16orf45	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25295
4.91349202435871e-50	0.529489095370973	0.539	0.246	1.0944803484259e-45	HSD17B12	Malignant cells	GSE186960	ENSG00000149084	51144	hydroxysteroid 17-beta dehydrogenase 12	KAR|SDR12C1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25296
5.70368426027901e-50	0.476462271373996	0.402	0.112	1.27049566897715e-45	CDT1	Malignant cells	GSE186960	ENSG00000167513	81620	chromatin licensing and DNA replication factor 1	DUP|RIS2	protein_coding	Q9H211	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25297
6.13368635342319e-50	0.507825935913439	0.683	0.434	1.36627863522502e-45	WTAP	Malignant cells	GSE186960	ENSG00000146457	9589	WT1 associated protein	KIAA0105|MGC3925|Mum2	protein_coding	Q15007	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25298
6.3472073038465e-50	0.500819573056466	0.533	0.228	1.41384042693181e-45	CDC25B	Malignant cells	GSE186960	ENSG00000101224	994	cell division cycle 25B	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25299
6.41069767835907e-50	-0.447793759473292	0.93	0.981	1.42798290785448e-45	ATP5O	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25300
6.59520115777453e-50	0.430903954042382	0.97	0.928	1.46908105789428e-45	APRT	Malignant cells	GSE186960	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25301
6.93822341754925e-50	0.514228633357705	0.562	0.278	1.5454892662591e-45	SMARCB1	Malignant cells	GSE186960	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25302
8.01143882373742e-50	0.502743734290053	0.605	0.308	1.78454799798751e-45	RASSF8-AS1	Malignant cells	GSE186960	ENSG00000246695	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25303
8.45290395841729e-50	-0.318768133706983	0.085	0.264	1.88288435673745e-45	GSTO2	Malignant cells	GSE186960	ENSG00000065621	119391	glutathione S-transferase omega 2	NA	protein_coding	Q9H4Y5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25304
9.12415659473114e-50	0.424381714379974	0.337	0.06	2.03240588147636e-45	ABHD17A	Malignant cells	GSE186960	ENSG00000129968	81926	abhydrolase domain containing 17A, depalmitoylase	C19orf27|FAM108A1|MGC5244	protein_coding	Q96GS6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25305
9.32112062597008e-50	0.470737108322039	0.908	0.771	2.07627961943483e-45	TPM4	Malignant cells	GSE186960	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25306
1.18932828952619e-49	0.336147059367621	0.999	0.997	2.64922876491959e-45	PSMD8	Malignant cells	GSE186960	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25307
1.19458867739467e-49	0.422228138649949	0.331	0.056	2.66094627889662e-45	ZNF568	Malignant cells	GSE186960	ENSG00000198453	374900	zinc finger protein 568	DKFZp686B0797	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25308
1.61993282753081e-49	-0.409658145911071	0.972	0.994	3.60840037332489e-45	HNRNPR	Malignant cells	GSE186960	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25309
2.0657862007908e-49	0.387995550289845	0.258	0.007	4.60153876226151e-45	ZNF826P	Malignant cells	GSE186960	ENSG00000231205	NA	NA	FLJ44894|ZNF826	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25310
2.39754201813609e-49	-0.512265605331448	0.307	0.536	5.34052484539814e-45	FAM98A	Malignant cells	GSE186960	ENSG00000119812	25940	family with sequence similarity 98 member A	DKFZP564F0522	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25311
2.45863766201812e-49	0.501975937717591	0.883	0.782	5.47661539214537e-45	CCDC85B	Malignant cells	GSE186960	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25312
2.46575995484074e-49	0.450664371115449	0.425	0.132	5.49248029940775e-45	TBCD	Malignant cells	GSE186960	ENSG00000278759	6904	tubulin folding cofactor D	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25313
3.04327618161034e-49	0.387653040871998	0.989	0.95	6.77889769453702e-45	EPRS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25314
3.07547398598902e-49	-0.349117522419627	0.12	0.318	6.85061830379054e-45	AC007969.5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25315
3.08467068173459e-49	-0.533393085447378	0.438	0.64	6.87110394356379e-45	DPH3	Malignant cells	GSE186960	ENSG00000154813	285381	diphthamide biosynthesis 3	DELGIP|DELGIP1|DESR1|DPH3A|KTI11|MGC20197|ZCSL2	protein_coding	Q96FX2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25316
3.35086100332145e-49	0.42342216961648	0.332	0.059	7.46404288489852e-45	CIB2	Malignant cells	GSE186960	ENSG00000136425	10518	calcium and integrin binding family member 2	DFNB48|KIP2|USH1J	protein_coding	O75838	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25317
3.39269410984317e-49	0.472580641839169	0.396	0.106	7.55722612967567e-45	TFPI	Malignant cells	GSE186960	ENSG00000003436	7035	tissue factor pathway inhibitor	EPI|LACI|TFI|TFPI1	protein_coding	P10646	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25318
3.65472967024103e-49	-0.383377053745057	0.15	0.362	8.1409103404619e-45	PINX1	Malignant cells	GSE186960	ENSG00000254093	54984	PIN2 (TERF1) interacting telomerase inhibitor 1	FLJ20565|Gno1|LPTL|LPTS|MGC8850|Pxr1	protein_coding	Q96BK5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25319
4.01641332090609e-49	-0.487979302007608	0.264	0.497	8.94656067231831e-45	RRS1	Malignant cells	GSE186960	ENSG00000179041	23212	ribosome biogenesis regulator 1 homolog	KIAA0112	protein_coding	Q15050	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25320
4.27356097855412e-49	0.316095842673526	0.998	1	9.51935707972931e-45	H2AFZ	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25321
4.28486758816042e-49	-0.528636684587488	0.339	0.567	9.54454255262734e-45	TCEB3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25322
4.44192980876577e-49	-0.355948755411585	0.995	0.999	9.89439864902574e-45	CLTA	Malignant cells	GSE186960	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25323
4.81457469488751e-49	-0.487645824633216	0.762	0.9	1.07244651328619e-44	CSNK1A1	Malignant cells	GSE186960	ENSG00000113712	1452	casein kinase 1 alpha 1	CK1|CK1a|CK1alpha|CKIa|CKIalpha	protein_coding	P48729	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25324
4.83856398304081e-49	0.481223664482964	0.486	0.195	1.07779012722234e-44	USP9X	Malignant cells	GSE186960	ENSG00000124486	8239	ubiquitin specific peptidase 9 X-linked	DFFRX|FAF|MRX99	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25325
5.66915891578543e-49	0.501558863278105	0.677	0.42	1.2628051484912e-44	NQO2	Malignant cells	GSE186960	ENSG00000124588	4835	N-ribosyldihydronicotinamide:quinone reductase 2	DHQV|DIA6|NMOR2|QR2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25326
7.1131057322956e-49	0.396390191531014	0.983	0.944	1.58444430186884e-44	SEC61B	Malignant cells	GSE186960	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25327
9.04438685578596e-49	0.45874021877888	0.459	0.162	2.01463717212632e-44	ASL	Malignant cells	GSE186960	ENSG00000126522	435	argininosuccinate lyase	ASAL	protein_coding	P04424	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25328
1.04358716337038e-48	0.44745207076291	0.44	0.14	2.32459040640752e-44	ATXN1	Malignant cells	GSE186960	ENSG00000124788	6310	ataxin 1	ATX1|D6S504E|SCA1	protein_coding	P54253	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25329
1.17411933496589e-48	-0.461118477275587	0.243	0.471	2.61535081863651e-44	PPA2	Malignant cells	GSE186960	ENSG00000138777	27068	inorganic pyrophosphatase 2	FLJ20459	protein_coding	Q9H2U2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25330
1.20231358833497e-48	-0.519594739147043	0.616	0.785	2.67815351801615e-44	MCTS1	Malignant cells	GSE186960	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25331
1.45493922667523e-48	0.501535231716161	0.739	0.513	3.24087712741906e-44	N4BP2L2	Malignant cells	GSE186960	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25332
2.28598360409294e-48	-0.511429097268624	0.799	0.931	5.09202847811702e-44	CTNNAL1	Malignant cells	GSE186960	ENSG00000119326	8727	catenin alpha like 1	alpha-CATU|CLLP	protein_coding	Q9UBT7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25333
2.50106302977439e-48	0.415850902695935	0.98	0.941	5.57111789882246e-44	ANP32B	Malignant cells	GSE186960	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25334
2.50319689827878e-48	0.40462760023657	0.318	0.05	5.57587109091598e-44	FOXRED2	Malignant cells	GSE186960	ENSG00000100350	80020	FAD dependent oxidoreductase domain containing 2	ERFAD|FLJ23322	protein_coding	Q8IWF2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25335
2.55302357135386e-48	0.392123274810535	0.275	0.021	5.68686000519073e-44	AP2A1	Malignant cells	GSE186960	ENSG00000196961	160	adaptor related protein complex 2 subunit alpha 1	ADTAA|CLAPA1	protein_coding	O95782	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25336
2.70596016139268e-48	-0.510202611598181	0.315	0.539	6.02752625950219e-44	PUS1	Malignant cells	GSE186960	ENSG00000177192	80324	pseudouridine synthase 1	MLASA1	protein_coding	Q9Y606	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25337
2.85177235980447e-48	-0.554522305489615	0.337	0.559	6.35232293146445e-44	FAM216A	Malignant cells	GSE186960	ENSG00000204856	29902	family with sequence similarity 216 member A	C12orf24|HSU79274	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25338
3.42668650339852e-48	-0.521572074823919	0.661	0.83	7.63294418632021e-44	NPC2	Malignant cells	GSE186960	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25339
3.43658261492476e-48	-0.436565516539002	0.232	0.464	7.6549877747449e-44	IMP3	Malignant cells	GSE186960	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25340
3.57179766440111e-48	0.462788781290637	0.886	0.785	7.95617929745347e-44	TMEM14C	Malignant cells	GSE186960	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25341
4.01067311536779e-48	-0.398586407203826	0.121	0.317	8.93377436448175e-44	STAMBPL1	Malignant cells	GSE186960	ENSG00000138134	57559	STAM binding protein like 1	ALMalpha|AMSH-FP|AMSH-LP|bA399O19.2|FLJ31524|KIAA1373	protein_coding	Q96FJ0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25342
4.47651607638868e-48	0.768873155795214	0.663	0.431	9.97143956015578e-44	C15orf48	Malignant cells	GSE186960	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25343
5.19258448580092e-48	0.496672382345712	0.791	0.599	1.15664819421215e-43	OSBPL9	Malignant cells	GSE186960	ENSG00000117859	114883	oxysterol binding protein like 9	NA	protein_coding	Q96SU4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25344
5.71862278767544e-48	0.465176111721472	0.806	0.63	1.27382322595471e-43	PTP4A1	Malignant cells	GSE186960	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25345
6.97187513599393e-48	-0.421704562470824	0.185	0.404	1.55298518654265e-43	SCNM1	Malignant cells	GSE186960	ENSG00000163156	79005	sodium channel modifier 1	MGC3180	protein_coding	Q9BWG6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25346
9.43702775484497e-48	0.430786722155348	0.889	0.769	2.10209793239172e-43	ATP5F1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25347
1.01552339649915e-47	0.509803491488306	0.498	0.203	2.26207836570185e-43	PPP1R15A	Malignant cells	GSE186960	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25348
1.31256221801133e-47	0.47946668874847	0.78	0.579	2.92373234062023e-43	PYGB	Malignant cells	GSE186960	ENSG00000100994	5834	glycogen phosphorylase B	NA	protein_coding	P11216	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25349
1.31420762739537e-47	0.404115307732278	0.331	0.06	2.92739749002318e-43	BTBD2	Malignant cells	GSE186960	ENSG00000133243	55643	BTB domain containing 2	NA	protein_coding	Q9BX70	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25350
1.31631585143366e-47	-0.470215481295987	0.769	0.924	2.93209355906848e-43	GOLGA4	Malignant cells	GSE186960	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25351
1.97867250274544e-47	0.548273795003836	0.909	0.842	4.40749299986547e-43	ARHGAP29	Malignant cells	GSE186960	ENSG00000137962	9411	Rho GTPase activating protein 29	PARG1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25352
1.98799307857622e-47	0.43405240165765	0.398	0.113	4.42825458252853e-43	PITX1	Malignant cells	GSE186960	ENSG00000069011	5307	paired like homeodomain 1	BFT|POTX|PTX1	protein_coding	P78337	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25353
3.04387101567178e-47	0.436032396599429	0.42	0.133	6.78022268740888e-43	MYBL2	Malignant cells	GSE186960	ENSG00000101057	4605	MYB proto-oncogene like 2	B-MYB|BMYB	protein_coding	P10244	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25354
3.48169690701743e-47	0.391435285400583	0.312	0.049	7.75547986038133e-43	SREBF2	Malignant cells	GSE186960	ENSG00000198911	6721	sterol regulatory element binding transcription factor 2	bHLHd2|SREBP2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25355
3.60983737375237e-47	0.459442201587735	0.462	0.166	8.04091275003341e-43	SP3	Malignant cells	GSE186960	ENSG00000172845	6670	Sp3 transcription factor	SPR-2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25356
4.12558122270334e-47	0.491415717842433	0.524	0.238	9.18973217357168e-43	ARF6	Malignant cells	GSE186960	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25357
5.34017752979198e-47	0.405820534291094	0.317	0.054	1.18952454476116e-42	RNF135	Malignant cells	GSE186960	ENSG00000181481	84282	ring finger protein 135	MGC13061	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25358
5.6062014270197e-47	0.437902362613022	0.446	0.158	1.24878136786864e-42	AKT1	Malignant cells	GSE186960	ENSG00000142208	207	AKT serine/threonine kinase 1	AKT|PKB|PRKBA|RAC|RAC-alpha	protein_coding	P31749	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25359
5.62706286596171e-47	0.574490517492913	0.575	0.297	1.25342825339297e-42	FHL1	Malignant cells	GSE186960	ENSG00000022267	2273	four and a half LIM domains 1	bA535K18.1|FHL1B|FLH1A|KYO-T|MGC111107|SLIM1|XMPMA	protein_coding	Q13642	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25360
5.75687905045976e-47	0.475501679411844	0.749	0.537	1.28234480848991e-42	GLRX5	Malignant cells	GSE186960	ENSG00000182512	51218	glutaredoxin 5	C14orf87|GRX5|PR01238	protein_coding	Q86SX6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25361
7.71127028032946e-47	0.422372317684201	0.361	0.086	1.71768545494339e-42	DHFR	Malignant cells	GSE186960	ENSG00000228716	1719	dihydrofolate reductase	NA	protein_coding	P00374	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25362
8.24882707656465e-47	-0.516305990498175	0.366	0.577	1.83742623130478e-42	GOLGA2	Malignant cells	GSE186960	ENSG00000167110	2801	golgin A2	GM130|golgin-95	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25363
1.09065589715587e-46	-0.391482045788619	0.96	0.991	2.42943601091469e-42	ATP5H	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25364
1.38567975455746e-46	0.450515641505822	0.252	0.01	3.08660165327675e-42	HIST1H3B	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25365
1.39786160725513e-46	-0.33244254331799	0.998	1	3.11373673016079e-42	COX6C	Malignant cells	GSE186960	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25366
1.54713025981567e-46	-0.440921981713054	0.911	0.977	3.4462326537394e-42	FKBP2	Malignant cells	GSE186960	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25367
1.88173957454027e-46	-0.330274168890128	0.995	1	4.19157490228844e-42	ATP5B	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25368
2.02407779107209e-46	0.445975412454987	0.452	0.166	4.50863327961308e-42	DUS1L	Malignant cells	GSE186960	ENSG00000169718	64118	dihydrouridine synthase 1 like	DUS1|PP3111	protein_coding	Q6P1R4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25369
2.48829096155011e-46	-0.464218437630483	0.741	0.885	5.54266811685287e-42	PAICS	Malignant cells	GSE186960	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25370
2.77087058868939e-46	0.403496914997842	0.964	0.908	6.17211423630562e-42	RPS19BP1	Malignant cells	GSE186960	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25371
2.89181639504981e-46	0.471499530078076	0.521	0.232	6.44152101997345e-42	ME1	Malignant cells	GSE186960	ENSG00000065833	4199	malic enzyme 1	NA	protein_coding	P48163	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25372
3.06223572114242e-46	0.456905089103641	0.397	0.12	6.82113006884474e-42	OSBPL10	Malignant cells	GSE186960	ENSG00000144645	114884	oxysterol binding protein like 10	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25373
3.50160103632639e-46	0.436179469673518	0.91	0.809	7.79981630841703e-42	TOMM20	Malignant cells	GSE186960	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25374
3.51627091049584e-46	0.372624410346073	0.264	0.019	7.83249345312948e-42	CTC-444N24.11	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25375
3.53584732349686e-46	0.445269318088397	0.427	0.146	7.87609991308926e-42	GAS2L1	Malignant cells	GSE186960	ENSG00000185340	10634	growth arrest specific 2 like 1	GAR22	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25376
3.61963221287816e-46	0.534419176420816	0.379	0.106	8.06273075418611e-42	CDKN1A	Malignant cells	GSE186960	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25377
4.08985954282153e-46	-0.557725357374019	0.35	0.557	9.11016213163496e-42	TTLL7	Malignant cells	GSE186960	ENSG00000137941	79739	tubulin tyrosine ligase like 7	FLJ23033	protein_coding	Q6ZT98	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25378
4.4728423865934e-46	-0.402541308545261	0.903	0.974	9.96325641613679e-42	EIF3H	Malignant cells	GSE186960	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25379
6.68473372816817e-46	0.411414133001445	0.978	0.938	1.48902443794946e-41	HNRNPA3	Malignant cells	GSE186960	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25380
6.82563477890193e-46	0.417617523554462	0.924	0.85	1.52041014700041e-41	RER1	Malignant cells	GSE186960	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25381
8.70960325018226e-46	0.43657712171705	0.417	0.13	1.9400641239781e-41	GPSM2	Malignant cells	GSE186960	ENSG00000121957	29899	G protein signaling modulator 2	DFNB82|LGN|Pins	protein_coding	P81274	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25382
1.02167804930588e-45	-0.457561530505605	0.828	0.941	2.27578785482884e-41	VPS29	Malignant cells	GSE186960	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25383
1.10590363864963e-45	-0.473025739423799	0.6	0.775	2.46340035509205e-41	CDC123	Malignant cells	GSE186960	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25384
1.83004754184924e-45	-0.520819146682725	0.698	0.845	4.07643089946918e-41	CCAR1	Malignant cells	GSE186960	ENSG00000060339	55749	cell division cycle and apoptosis regulator 1	CARP-1|CARP1|FLJ10590	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25385
2.06197040928424e-45	-0.438388608467923	0.807	0.928	4.59303908668066e-41	COA4	Malignant cells	GSE186960	ENSG00000181924	51287	cytochrome c oxidase assembly factor 4 homolog	CHCHD8|CMC3|E2IG2	protein_coding	Q9NYJ1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25386
2.75453551477519e-45	-0.467513019385689	0.282	0.5	6.13572785916174e-41	THYN1	Malignant cells	GSE186960	ENSG00000151500	29087	thymocyte nuclear protein 1	THY28	protein_coding	Q9P016	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25387
3.13652148105354e-45	-0.530513866586619	0.288	0.501	6.98660159904677e-41	SPIRE1	Malignant cells	GSE186960	ENSG00000134278	56907	spire type actin nucleation factor 1	KIAA1135|spir-1	protein_coding	Q08AE8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25388
3.55715599124509e-45	0.369684146903738	0.279	0.032	7.92356497049844e-41	PEX10	Malignant cells	GSE186960	ENSG00000157911	5192	peroxisomal biogenesis factor 10	RNF69	protein_coding	O60683	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25389
3.61031076265492e-45	0.429424804449228	0.391	0.117	8.04196722381383e-41	GTPBP6	Malignant cells	GSE186960	ENSG00000178605	8225	GTP binding protein 6 (putative)	FLJ20977|PGPL	protein_coding	O43824	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25390
3.78218645541238e-45	0.44444036233816	0.445	0.165	8.42482032943107e-41	PPP2R1A	Malignant cells	GSE186960	ENSG00000105568	5518	protein phosphatase 2 scaffold subunit Aalpha	PP2A-Aalpha|PP2AA|PR65A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25391
4.07804647502548e-45	0.46232358917621	0.545	0.258	9.08384852311926e-41	TMEM134	Malignant cells	GSE186960	ENSG00000172663	80194	transmembrane protein 134	FLJ21749	protein_coding	Q9H6X4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25392
4.7198006979435e-45	-0.601366789288367	0.461	0.643	1.05133560546691e-40	UBASH3B	Malignant cells	GSE186960	ENSG00000154127	84959	ubiquitin associated and SH3 domain containing B	KIAA1959|STS-1|TULA-2|TULA2	protein_coding	Q8TF42	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25393
5.14874493812195e-45	0.428834496235175	0.398	0.123	1.14688293496666e-40	TST	Malignant cells	GSE186960	ENSG00000128311	7263	thiosulfate sulfurtransferase	RDS	protein_coding	Q16762	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25394
6.2014530506496e-45	0.446970802468206	0.534	0.242	1.3813736670322e-40	TCF7L2	Malignant cells	GSE186960	ENSG00000148737	6934	transcription factor 7 like 2	TCF-4|TCF4	protein_coding	Q9NQB0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25395
6.35269618590735e-45	0.560721203959395	0.674	0.428	1.41506307541086e-40	SOD2	Malignant cells	GSE186960	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25396
9.59758806817779e-45	0.382162321246863	0.291	0.04	2.1378627421866e-40	CD3EAP	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25397
1.01234878294314e-44	0.377521336211296	0.303	0.049	2.25500691400585e-40	CTD-2314B22.3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25398
1.16147394930098e-44	0.432296384867531	0.413	0.138	2.58718322206794e-40	NHSL1	Malignant cells	GSE186960	ENSG00000135540	57224	NHS like 1	bA43P8.1|C6orf63|KIAA1357	protein_coding	Q5SYE7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25399
1.23684959804797e-44	0.439551454258621	0.853	0.715	2.75508247965185e-40	HNRNPA0	Malignant cells	GSE186960	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25400
1.38745745463009e-44	0.468543281340387	0.846	0.713	3.09056148018852e-40	DDX3X	Malignant cells	GSE186960	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25401
1.68565365011559e-44	-0.529760256521118	0.58	0.761	3.75479350563249e-40	ANKRD12	Malignant cells	GSE186960	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25402
1.71345961996703e-44	0.477134404698202	0.55	0.265	3.81673130347657e-40	ETV5	Malignant cells	GSE186960	ENSG00000244405	2119	ETS variant transcription factor 5	ERM	protein_coding	P41161	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25403
2.07680943879682e-44	0.418229471227858	0.357	0.092	4.62609302491991e-40	TRIM59	Malignant cells	GSE186960	ENSG00000213186	286827	tripartite motif containing 59	Mrf1|RNF104|TRIM57|TSBF1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25404
2.24895534413167e-44	0.419530452733056	0.673	0.404	5.00954802905329e-40	NPLOC4	Malignant cells	GSE186960	ENSG00000182446	55666	NPL4 homolog, ubiquitin recognition factor	FLJ20657|KIAA1499|NPL4	protein_coding	Q8TAT6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25405
2.3624840009591e-44	-0.444888718068118	0.7	0.845	5.26243311213639e-40	RBBP7	Malignant cells	GSE186960	ENSG00000102054	5931	RB binding protein 7, chromatin remodeling factor	RbAp46	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25406
2.67690773493447e-44	0.444458714634175	0.483	0.198	5.96281197956653e-40	SLC7A1	Malignant cells	GSE186960	ENSG00000139514	6541	solute carrier family 7 member 1	ATRC1|CAT-1|ERR|HCAT1|REC1L	protein_coding	P30825	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25407
2.89063492215148e-44	-0.444893526023219	0.823	0.938	6.43888928909241e-40	FKBP3	Malignant cells	GSE186960	ENSG00000100442	2287	FKBP prolyl isomerase 3	FKBP-25|FKBP25	protein_coding	Q00688	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25408
3.23246600783136e-44	-0.463663942179847	0.914	0.984	7.20031803244435e-40	FUS	Malignant cells	GSE186960	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25409
3.34064063320171e-44	-0.466672468742512	0.273	0.494	7.4412770104568e-40	SDAD1	Malignant cells	GSE186960	ENSG00000198301	55153	SDA1 domain containing 1	FLJ10498	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25410
3.52213386512909e-44	-0.419100709224423	0.201	0.414	7.84555318457505e-40	RSBN1L	Malignant cells	GSE186960	ENSG00000187257	222194	round spermatid basic protein 1 like	FLJ42526|FLJ45813|MGC71764	protein_coding	Q6PCB5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25411
3.93774522187978e-44	-0.380562830052165	0.976	0.997	8.7713274817372e-40	CNBP	Malignant cells	GSE186960	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25412
3.94796261722082e-44	-0.542894425814481	0.958	0.977	8.79408672985937e-40	MT1E	Malignant cells	GSE186960	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25413
4.14535103910945e-44	0.462815985320765	0.544	0.262	9.23376943961631e-40	TSR3	Malignant cells	GSE186960	ENSG00000007520	115939	TSR3 ribosome maturation factor	C16orf42|MGC24381	protein_coding	Q9UJK0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25414
4.17299783447482e-44	-0.55907475958895	0.364	0.559	9.29535267629266e-40	ITSN1	Malignant cells	GSE186960	ENSG00000205726	6453	intersectin 1	ITSN|MGC134948|MGC134949|SH3D1A|SH3P17	protein_coding	Q15811	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25415
4.8128759695902e-44	0.390752392788551	0.338	0.077	1.07206812222622e-39	SMIM13	Malignant cells	GSE186960	ENSG00000224531	221710	small integral membrane protein 13	C6orf228	protein_coding	P0DJ93	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25416
4.88136112358417e-44	-0.395582448199013	0.18	0.39	1.08732319027837e-39	CMTM3	Malignant cells	GSE186960	ENSG00000140931	123920	CKLF like MARVEL transmembrane domain containing 3	BNAS2|CKLFSF3|FLJ31762	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25417
4.95037026893876e-44	0.361163658045323	0.25	0.016	1.10269497740611e-39	NNT-AS1	Malignant cells	GSE186960	ENSG00000248092	NA	NA	RP11-159F24.1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25418
5.2954599639207e-44	-0.478350752438699	0.247	0.46	1.17956370696334e-39	CPT1A	Malignant cells	GSE186960	ENSG00000110090	1374	carnitine palmitoyltransferase 1A	CPT1|CPT1-L|L-CPT1	protein_coding	P50416	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25419
5.64312748737566e-44	0.418447140975633	0.909	0.818	1.25700664781293e-39	AP2S1	Malignant cells	GSE186960	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25420
6.25724997158015e-44	0.39793136011147	0.311	0.057	1.39380243116948e-39	ZNF680	Malignant cells	GSE186960	ENSG00000173041	340252	zinc finger protein 680	FLJ90430	protein_coding	Q8NEM1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25421
6.26768002951305e-44	-0.434070811374781	0.777	0.907	1.39612572657403e-39	CTTN	Malignant cells	GSE186960	ENSG00000288401	2017	cortactin	EMS1	protein_coding	Q14247	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25422
7.21774096508835e-44	0.461037640055455	0.505	0.226	1.60775179997343e-39	MAP3K2	Malignant cells	GSE186960	ENSG00000169967	10746	mitogen-activated protein kinase kinase kinase 2	MEKK2|MEKK2B	protein_coding	Q9Y2U5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25423
9.95307294444313e-44	0.425207981740292	0.425	0.15	2.21704699837471e-39	FBLN1	Malignant cells	GSE186960	ENSG00000077942	2192	fibulin 1	FBLN	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25424
1.07140519191079e-43	0.385624493020722	0.302	0.053	2.3865550649813e-39	AK4	Malignant cells	GSE186960	ENSG00000162433	205	adenylate kinase 4	AK3|AK3L1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25425
1.31699354460463e-43	0.412892347144228	0.427	0.149	2.93360312060681e-39	ARID1B	Malignant cells	GSE186960	ENSG00000049618	57492	AT-rich interaction domain 1B	6A3-5|BAF250b|DAN15|ELD/OSA1|KIAA1235|p250R|SMARCF2	protein_coding	Q8NFD5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25426
1.40232644878312e-43	0.464767109860424	0.543	0.272	3.12368216466441e-39	NT5DC1	Malignant cells	GSE186960	ENSG00000178425	221294	5'-nucleotidase domain containing 1	dJ486I3.1|MGC24302|NT5C2L1	protein_coding	Q5TFE4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25427
1.45735591919352e-43	0.484636579736153	0.419	0.145	3.24626031000357e-39	CREB5	Malignant cells	GSE186960	ENSG00000146592	9586	cAMP responsive element binding protein 5	CRE-BPA|H_GS165L15.1	protein_coding	Q02930	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25428
1.52066435902068e-43	0.40253740653828	0.397	0.123	3.38727985971857e-39	FXR2	Malignant cells	GSE186960	ENSG00000129245	9513	FMR1 autosomal homolog 2	FMR1L2	protein_coding	P51116	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25429
1.57644863843392e-43	-0.464181219756943	0.704	0.84	3.51153934211155e-39	CLPTM1L	Malignant cells	GSE186960	ENSG00000274811	81037	CLPTM1 like	CRR9|FLJ14400	protein_coding	Q96KA5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25430
1.6252428494338e-43	0.372315821978987	0.303	0.053	3.62022844711379e-39	ERF	Malignant cells	GSE186960	ENSG00000105722	2077	ETS2 repressor factor	PE-2|PE2	protein_coding	P50548	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25431
1.86205928193969e-43	0.420980908320182	0.404	0.132	4.14773705052066e-39	BIRC6	Malignant cells	GSE186960	ENSG00000115760	57448	baculoviral IAP repeat containing 6	BRUCE	protein_coding	Q9NR09	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25432
1.97905065422115e-43	0.439730328549989	0.87	0.738	4.40833533227762e-39	SARS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25433
2.0302718391763e-43	0.402136540406156	0.924	0.858	4.5224305217652e-39	MRPS15	Malignant cells	GSE186960	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25434
2.20606410244406e-43	-0.580507279550502	0.339	0.552	4.91400778819413e-39	FOSL1	Malignant cells	GSE186960	ENSG00000175592	8061	FOS like 1, AP-1 transcription factor subunit	fra-1	protein_coding	P15407	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25435
2.23537510055491e-43	0.315697510950631	1	0.999	4.97929803648605e-39	EEF1A1	Malignant cells	GSE186960	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25436
2.25658467383739e-43	0.410672480266276	0.869	0.712	5.02654236097278e-39	SAMD4B	Malignant cells	GSE186960	ENSG00000179134	55095	sterile alpha motif domain containing 4B	FLJ10211|hSmaug2|MGC99832|SMGB	protein_coding	Q5PRF9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25437
2.26630447454786e-43	-0.495838812236226	0.351	0.557	5.04819321705536e-39	MRPL1	Malignant cells	GSE186960	ENSG00000169288	65008	mitochondrial ribosomal protein L1	BM022	protein_coding	Q9BYD6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25438
2.4027668774232e-43	-0.441810098519527	0.209	0.42	5.35216321946018e-39	JMJD6	Malignant cells	GSE186960	ENSG00000070495	23210	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	KIAA0585|PTDSR|PTDSR1	protein_coding	Q6NYC1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25439
2.44353890916271e-43	-0.320678688388158	0.997	1	5.44298292015994e-39	TMBIM6	Malignant cells	GSE186960	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25440
3.11996308175478e-43	-0.53163105373652	0.412	0.609	6.94971776460877e-39	MAP7D3	Malignant cells	GSE186960	ENSG00000129680	79649	MAP7 domain containing 3	FLJ12649	protein_coding	Q8IWC1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25441
3.17512227689003e-43	0.417475355675602	0.445	0.166	7.07258487177254e-39	ZNF451	Malignant cells	GSE186960	ENSG00000112200	26036	zinc finger protein 451	COASTER|dJ417I1.1|KIAA0576|KIAA1702|ZATT	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25442
3.66842236332623e-43	0.462076184413933	0.903	0.792	8.17141081430918e-39	SPTBN1	Malignant cells	GSE186960	ENSG00000115306	6711	spectrin beta, non-erythrocytic 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25443
3.83838668884447e-43	-0.93208059320297	0.746	0.865	8.55000634940106e-39	CYR61	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25444
3.8733535872133e-43	0.492462258714176	0.488	0.211	8.62789511551762e-39	CYBA	Malignant cells	GSE186960	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25445
3.92034135640977e-43	-0.448750090381023	0.638	0.812	8.73256037140275e-39	SNW1	Malignant cells	GSE186960	ENSG00000100603	22938	SNW domain containing 1	Bx42|FUN20|NCoA-62|Prp45|PRPF45|SKIIP|SKIP|SKIP1	protein_coding	Q13573	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25446
3.93026289678775e-43	0.418230561913409	0.882	0.761	8.75466060259471e-39	SSU72	Malignant cells	GSE186960	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25447
4.06316573191948e-43	0.382266046453609	0.299	0.053	9.05070166785064e-39	ANKRD54	Malignant cells	GSE186960	ENSG00000100124	129138	ankyrin repeat domain 54	LIAR	protein_coding	Q6NXT1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25448
4.48469041033928e-43	0.567445645760135	0.305	0.057	9.98964788903074e-39	IFI6	Malignant cells	GSE186960	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25449
5.62017395482115e-43	0.433536465423572	0.527	0.242	1.25189374843641e-38	TMEM259	Malignant cells	GSE186960	ENSG00000182087	91304	transmembrane protein 259	ASBABP1|C19orf6|MBRL|MGC4022	protein_coding	Q4ZIN3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25450
6.12747146506796e-43	0.345937025852554	0.25	0.019	1.36489426884389e-38	KAT5	Malignant cells	GSE186960	ENSG00000172977	10524	lysine acetyltransferase 5	cPLA2|ESA1|HTATIP|HTATIP1|PLIP|TIP60|ZC2HC5	protein_coding	Q92993	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25451
7.42197028797332e-43	-0.526680680426616	0.395	0.586	1.65324388164606e-38	PPIE	Malignant cells	GSE186960	ENSG00000084072	10450	peptidylprolyl isomerase E	CyP-33|MGC111222|MGC3736	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25452
7.70447378160141e-43	0.493563255033217	0.495	0.221	1.71617153485171e-38	CENPA	Malignant cells	GSE186960	ENSG00000115163	1058	centromere protein A	CenH3|CENP-A	protein_coding	P49450	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25453
8.34883750293561e-43	-0.502114297383184	0.7	0.827	1.85970355377891e-38	MAP4	Malignant cells	GSE186960	ENSG00000047849	4134	microtubule associated protein 4	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25454
8.42493159512562e-43	-0.537893581577836	0.285	0.49	1.87665351281423e-38	ZCCHC9	Malignant cells	GSE186960	ENSG00000131732	84240	zinc finger CCHC-type containing 9	DKFZp761J139|PPP1R41	protein_coding	Q8N567	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25455
1.02002296657495e-42	-0.407096436783684	0.976	0.996	2.27210115804569e-38	NDUFB9	Malignant cells	GSE186960	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25456
1.06138370420769e-42	-0.653568216634722	0.58	0.736	2.36423220112263e-38	ATP1B1	Malignant cells	GSE186960	ENSG00000143153	481	ATPase Na+/K+ transporting subunit beta 1	ATP1B	protein_coding	P05026	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25457
1.34438989662043e-42	-0.358564661618412	0.096	0.265	2.99462849472202e-38	EPHB2	Malignant cells	GSE186960	ENSG00000133216	2048	EPH receptor B2	DRT|EPHT3|ERK|Hek5|Tyro5	protein_coding	P29323	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25458
1.44219283220671e-42	-0.371626370152038	0.155	0.352	3.21248453374045e-38	F2R	Malignant cells	GSE186960	ENSG00000181104	2149	coagulation factor II thrombin receptor	CF2R|PAR-1|PAR1|TR	protein_coding	P25116	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25459
1.53136516153619e-42	0.416632158701649	0.398	0.132	3.41111589732187e-38	RP11-139H15.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25460
1.75744295028651e-42	0.466433882562835	0.476	0.203	3.9147041717632e-38	BRCA2	Malignant cells	GSE186960	ENSG00000139618	675	BRCA2 DNA repair associated	BRCC2|FACD|FAD|FAD1|FANCD|FANCD1|XRCC11	protein_coding	P51587	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25461
1.81655983209904e-42	-0.425532042291073	0.861	0.954	4.04638702600061e-38	PAK2	Malignant cells	GSE186960	ENSG00000180370	5062	p21 (RAC1) activated kinase 2	PAK65|PAKgamma	protein_coding	Q13177	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25462
2.08988950271985e-42	0.456109740631673	0.545	0.262	4.65522886730846e-38	FRYL	Malignant cells	GSE186960	ENSG00000075539	285527	FRY like transcription coactivator	AF4p12|DKFZp686E205|KIAA0826|MOR2	protein_coding	O94915	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25463
2.10295618614224e-42	0.423088571282173	0.782	0.577	4.68433490463183e-38	BOD1L1	Malignant cells	GSE186960	ENSG00000038219	259282	biorientation of chromosomes in cell division 1 like 1	BOD1L|FAM44A|FLJ33215|KIAA1327	protein_coding	Q8NFC6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25464
2.34648228100644e-42	0.446576037974123	0.67	0.421	5.22678928094185e-38	AIMP2	Malignant cells	GSE186960	ENSG00000106305	7965	aminoacyl tRNA synthetase complex interacting multifunctional protein 2	JTV-1|JTV1|p38|PRO0992	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25465
2.46442829256873e-42	-0.310043171727131	0.097	0.266	5.48951402169684e-38	TGIF2	Malignant cells	GSE186960	ENSG00000118707	60436	TGFB induced factor homeobox 2	NA	protein_coding	Q9GZN2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25466
4.0132442888599e-42	-0.531956889021204	0.452	0.633	8.93950165343543e-38	TMEM126B	Malignant cells	GSE186960	ENSG00000171204	55863	transmembrane protein 126B	HT007	protein_coding	Q8IUX1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25467
4.1876044010327e-42	0.427336126903322	0.501	0.222	9.32788880330034e-38	EP300	Malignant cells	GSE186960	ENSG00000100393	2033	E1A binding protein p300	KAT3B|p300	protein_coding	Q09472	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25468
4.5934482391935e-42	0.421573776140792	0.385	0.12	1.02319059528035e-37	NDE1	Malignant cells	GSE186960	ENSG00000275911	54820	nudE neurodevelopment protein 1	FLJ20101|NDE|nudE	protein_coding	Q9NXR1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25469
5.74095527730532e-42	0.405587253880602	0.429	0.158	1.27879778801976e-37	PHF10	Malignant cells	GSE186960	ENSG00000130024	55274	PHD finger protein 10	BAF45a|FLJ10975|SMARCG4|XAP135	protein_coding	Q8WUB8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25470
5.86992616097446e-42	0.428401302207318	0.485	0.209	1.30752605235706e-37	ERI3	Malignant cells	GSE186960	ENSG00000117419	79033	ERI1 exoribonuclease family member 3	FLJ22943|PINT1|PRNPIP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25471
8.57458956720329e-42	0.399340150646239	0.407	0.14	1.90998982609453e-37	RAB21	Malignant cells	GSE186960	ENSG00000080371	23011	RAB21, member RAS oncogene family	KIAA0118	protein_coding	Q9UL25	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25472
9.68992420299652e-42	-0.336970839172073	0.988	1	2.15843061621747e-37	UBL5	Malignant cells	GSE186960	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25473
9.77322054486056e-42	-0.379589224798216	0.997	1	2.17698487636769e-37	EIF4G2	Malignant cells	GSE186960	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25474
9.8712103457613e-42	-0.455802143207487	0.782	0.894	2.19881210451833e-37	MLEC	Malignant cells	GSE186960	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25475
1.0171598821014e-41	-0.612015923791742	0.451	0.619	2.26572363738086e-37	CTPS1	Malignant cells	GSE186960	ENSG00000171793	1503	CTP synthase 1	CTPS|GATD5A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25476
1.02789852761955e-41	-0.517946215137876	0.372	0.567	2.28964397027254e-37	CEP70	Malignant cells	GSE186960	ENSG00000114107	80321	centrosomal protein 70	BITE|FLJ13036	protein_coding	Q8NHQ1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25477
1.06276114728445e-41	-0.306922776498254	0.107	0.282	2.36730045557612e-37	PUS3	Malignant cells	GSE186960	ENSG00000110060	83480	pseudouridine synthase 3	DEG1|FKSG32	protein_coding	Q9BZE2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25478
1.16498077731792e-41	-0.452023884898009	0.816	0.917	2.59499468147567e-37	LMAN1	Malignant cells	GSE186960	ENSG00000074695	3998	lectin, mannose binding 1	ERGIC-53|ERGIC53|F5F8D|FMFD1|gp58|MCFD1|MR60	protein_coding	P49257	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25479
1.55353073617615e-41	0.448365392390156	0.62	0.367	3.46048971483237e-37	TGIF1	Malignant cells	GSE186960	ENSG00000177426	7050	TGFB induced factor homeobox 1	HPE4|TGIF	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25480
1.67787176523874e-41	-0.512187431972902	0.374	0.569	3.7374593570693e-37	ALAS1	Malignant cells	GSE186960	ENSG00000023330	211	5'-aminolevulinate synthase 1	ALAS|ALAS-H|ALAS3	protein_coding	P13196	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25481
1.93768474557318e-41	0.451781360537823	0.594	0.33	4.31619277076425e-37	BCAS2	Malignant cells	GSE186960	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25482
2.05028960260178e-41	0.404151094519485	0.463	0.185	4.56702008979546e-37	CDC34	Malignant cells	GSE186960	ENSG00000099804	997	cell division cycle 34, ubiqiutin conjugating enzyme	E2-CDC34|UBC3|UBE2R1	protein_coding	P49427	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25483
2.20211393898317e-41	-0.380992931018536	0.176	0.375	4.90520879908501e-37	RGS19	Malignant cells	GSE186960	ENSG00000171700	10287	regulator of G protein signaling 19	GAIP|RGSGAIP	protein_coding	P49795	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25484
2.23089552394658e-41	-0.348586436943198	0.996	0.999	4.969319779591e-37	CALM1	Malignant cells	GSE186960	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25485
2.24857312442062e-41	0.401493646873874	0.403	0.135	5.00869663464694e-37	AAK1	Malignant cells	GSE186960	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25486
2.51164919586229e-41	-0.472566469106776	0.805	0.92	5.59469858378325e-37	SMARCA5	Malignant cells	GSE186960	ENSG00000153147	8467	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5	hISWI|hSNF2H|ISWI	protein_coding	O60264	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25487
2.6804529507792e-41	-0.432256115886705	0.8	0.923	5.97070894786066e-37	H2AFY	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25488
2.83612060604398e-41	-0.412349293881342	0.192	0.394	6.31745864996296e-37	RP11-566K19.6	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25489
3.00315183198211e-41	-0.511354867377898	0.525	0.699	6.68952070574014e-37	PAK1IP1	Malignant cells	GSE186960	ENSG00000285226	55003	PAK1 interacting protein 1	bA421M1.5|FLJ20624|hPIP1|MAK11|PIP1|WDR84	protein_coding	Q9NWT1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25490
3.13127560394837e-41	-0.523222339645482	0.379	0.58	6.97491640779499e-37	CCNL1	Malignant cells	GSE186960	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25491
3.36695749530687e-41	-0.438921432040228	0.74	0.872	7.49989782079605e-37	CEBPZ	Malignant cells	GSE186960	ENSG00000115816	10153	CCAAT enhancer binding protein zeta	CBF2|CTF2	protein_coding	Q03701	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25492
4.17281273838462e-41	0.428507812177927	0.85	0.712	9.29494037475174e-37	WBP5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25493
4.73096527605325e-41	-0.518678573201178	0.488	0.663	1.05382251524086e-36	PXN	Malignant cells	GSE186960	ENSG00000089159	5829	paxillin	NA	protein_coding	P49023	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25494
4.77968430777805e-41	0.435466894043579	0.455	0.186	1.06467467955756e-36	MID1	Malignant cells	GSE186960	ENSG00000101871	4281	midline 1	FXY|OS|RNF59|TRIM18	protein_coding	O15344	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25495
5.29879450096502e-41	-0.499852966767486	0.904	0.977	1.18030647508996e-36	VMP1	Malignant cells	GSE186960	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25496
6.72285304998705e-41	0.368283129355958	0.29	0.052	1.49751551688462e-36	TCEAL8	Malignant cells	GSE186960	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25497
6.91254129148775e-41	0.449620515039255	0.682	0.458	1.5397685726789e-36	EPN1	Malignant cells	GSE186960	ENSG00000063245	29924	epsin 1	NA	protein_coding	Q9Y6I3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25498
7.73269975485552e-41	0.418266424882246	0.48	0.206	1.72245887039407e-36	NAT14	Malignant cells	GSE186960	ENSG00000090971	57106	N-acetyltransferase 14 (putative)	KLP1	protein_coding	Q8WUY8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25499
7.73933127314175e-41	-0.508208759943163	0.538	0.699	1.72393604109232e-36	TOMM5	Malignant cells	GSE186960	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25500
1.08692960575122e-40	0.380870558056179	0.37	0.113	2.42113569681085e-36	DPP3	Malignant cells	GSE186960	ENSG00000254986	10072	dipeptidyl peptidase 3	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25501
1.24470919444557e-40	-0.515877174899268	0.518	0.682	2.7725897306275e-36	CCDC50	Malignant cells	GSE186960	ENSG00000152492	152137	coiled-coil domain containing 50	C3orf6|DFNA44|Ymer	protein_coding	Q8IVM0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25502
1.43885060089036e-40	0.360541277454799	0.283	0.047	3.20503971348328e-36	RHOD	Malignant cells	GSE186960	ENSG00000173156	29984	ras homolog family member D	ARHD|Rho|RhoHP1	protein_coding	O00212	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25503
1.50258937019654e-40	-0.31147218089508	0.137	0.325	3.3470178221128e-36	TWSG1	Malignant cells	GSE186960	ENSG00000128791	57045	twisted gastrulation BMP signaling modulator 1	TSG	protein_coding	Q9GZX9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25504
1.73444522087994e-40	0.345833715660698	0.25	0.026	3.86347672951006e-36	TRAF4	Malignant cells	GSE186960	ENSG00000076604	9618	TNF receptor associated factor 4	CART1|MLN62|RNF83	protein_coding	Q9BUZ4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25505
1.82925305084987e-40	0.446996988830737	0.603	0.347	4.07466117076808e-36	MSN	Malignant cells	GSE186960	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25506
1.99181194373905e-40	0.436784347844324	0.581	0.321	4.43676110467873e-36	MED8	Malignant cells	GSE186960	ENSG00000159479	112950	mediator complex subunit 8	ARC32|MGC17544|MGC19641	protein_coding	Q96G25	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25507
2.16549554401134e-40	0.426867793606139	0.537	0.261	4.82364132428526e-36	GINM1	Malignant cells	GSE186960	ENSG00000055211	116254	glycosylated integral membrane protein 1	C6orf72|dJ12G14.2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25508
2.27035685743997e-40	0.433473117085945	0.608	0.348	5.05721989994753e-36	RP11-622K12.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25509
2.27759494344846e-40	0.438229137048392	0.72	0.509	5.07334273653145e-36	MRPL19	Malignant cells	GSE186960	ENSG00000115364	9801	mitochondrial ribosomal protein L19	KIAA0104|MRP-L15|RLX1|RPML15	protein_coding	P49406	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25510
2.62168480620154e-40	0.413407930431805	0.416	0.155	5.83980290581393e-36	GTF2A1	Malignant cells	GSE186960	ENSG00000165417	2957	general transcription factor IIA subunit 1	TFIIA	protein_coding	P52655	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25511
2.88877897127507e-40	0.261480383324863	1	1	6.43475515851522e-36	NACA	Malignant cells	GSE186960	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25512
2.90224706053716e-40	0.359759857819315	0.283	0.049	6.46475532734653e-36	PTK7	Malignant cells	GSE186960	ENSG00000112655	5754	protein tyrosine kinase 7 (inactive)	CCK4	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25513
2.93301762062253e-40	-0.449110099014721	0.745	0.881	6.53329674993668e-36	ZRANB2	Malignant cells	GSE186960	ENSG00000132485	9406	zinc finger RANBP2-type containing 2	ZIS|ZIS1|ZIS2|ZNF265	protein_coding	O95218	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25514
2.95142208739446e-40	0.417291665666232	0.475	0.205	6.57429269967116e-36	ASNA1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25515
3.0060534010644e-40	0.468398703185799	0.588	0.338	6.69598395087096e-36	PSPH	Malignant cells	GSE186960	ENSG00000146733	5723	phosphoserine phosphatase	PSP	protein_coding	P78330	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25516
3.04653209376362e-40	0.397102829171917	0.398	0.138	6.78615023885846e-36	VEGFB	Malignant cells	GSE186960	ENSG00000173511	7423	vascular endothelial growth factor B	VEGFL|VRF	protein_coding	P49765	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25517
3.19110715373328e-40	-0.453106495425159	0.816	0.944	7.10819118494089e-36	EML4	Malignant cells	GSE186960	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25518
3.75158718787595e-40	-0.489512776130244	0.36	0.56	8.35666046099369e-36	NAA15	Malignant cells	GSE186960	ENSG00000164134	80155	N-alpha-acetyltransferase 15, NatA auxiliary subunit	FLJ13340|NARG1|NATH|TBDN100	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25519
5.75753497571021e-40	0.432687647939525	0.909	0.828	1.28249091583945e-35	TXNRD1	Malignant cells	GSE186960	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25520
6.80518598066372e-40	-0.456722599087171	0.323	0.532	1.51585517719284e-35	PTPMT1	Malignant cells	GSE186960	ENSG00000285206	114971	protein tyrosine phosphatase mitochondrial 1	DUSP23|MOSP|PLIP	protein_coding	Q8WUK0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25521
7.13701592860909e-40	0.409838446543709	0.435	0.172	1.58977029809768e-35	RRAS	Malignant cells	GSE186960	ENSG00000126458	6237	RAS related	R-Ras	protein_coding	P10301	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25522
8.17015990200215e-40	-0.521182233190666	0.464	0.63	1.81990311817098e-35	RBBP8	Malignant cells	GSE186960	ENSG00000101773	5932	RB binding protein 8, endonuclease	COM1|CtIP|RIM|SCKL2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25523
8.17828628227304e-40	0.395900310212978	0.412	0.148	1.82171326937632e-35	PIP4K2A	Malignant cells	GSE186960	ENSG00000150867	5305	phosphatidylinositol-5-phosphate 4-kinase type 2 alpha	PIP5K2A|PIP5KIIA|PIP5KIIalpha	protein_coding	P48426	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25524
8.42992557470622e-40	0.338617723522613	0.266	0.039	1.87776592176581e-35	RAI1	Malignant cells	GSE186960	ENSG00000108557	10743	retinoic acid induced 1	DKFZP434A139|KIAA1820|MGC12824|SMCR|SMS	protein_coding	Q7Z5J4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25525
9.22205883036971e-40	0.450434927720903	0.689	0.484	2.05421360446485e-35	TOMM40	Malignant cells	GSE186960	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25526
1.06614575262399e-39	0.40943440421556	0.4	0.145	2.37483966396993e-35	NT5DC2	Malignant cells	GSE186960	ENSG00000168268	64943	5'-nucleotidase domain containing 2	FLJ12442	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25527
1.15796504880134e-39	0.443789764322961	0.527	0.262	2.57936714620499e-35	NCOR2	Malignant cells	GSE186960	ENSG00000196498	9612	nuclear receptor corepressor 2	CTG26|SMRT|SMRTE|TNRC14|TRAC-1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25528
1.22412012760844e-39	0.436535251486049	0.668	0.43	2.7267275842478e-35	RANGAP1	Malignant cells	GSE186960	ENSG00000100401	5905	Ran GTPase activating protein 1	Fug1|KIAA1835|SD	protein_coding	P46060	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25529
1.25260268749244e-39	0.422787217920246	0.722	0.493	2.79017248638941e-35	SAT2	Malignant cells	GSE186960	ENSG00000141504	112483	spermidine/spermine N1-acetyltransferase family member 2	SSAT2	protein_coding	Q96F10	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25530
1.36451785445632e-39	0.434189199981791	0.683	0.468	3.03946352080145e-35	RCN1	Malignant cells	GSE186960	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25531
1.50524304071259e-39	0.412995414945455	0.415	0.153	3.3529288731873e-35	OGFRL1	Malignant cells	GSE186960	ENSG00000119900	79627	opioid growth factor receptor like 1	dJ331H24.1	protein_coding	Q5TC84	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25532
1.5214399547637e-39	0.353552464366173	0.322	0.077	3.38900749923615e-35	GSK3A	Malignant cells	GSE186960	ENSG00000105723	2931	glycogen synthase kinase 3 alpha	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25533
1.73865157214429e-39	0.433982208383035	0.724	0.517	3.8728463769514e-35	VKORC1L1	Malignant cells	GSE186960	ENSG00000196715	154807	vitamin K epoxide reductase complex subunit 1 like 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25534
2.18818360879575e-39	0.468658547677349	0.819	0.675	4.87417898859253e-35	H1FX	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25535
2.46247229191187e-39	-0.455591822478069	0.29	0.49	5.48515703023369e-35	GYG1	Malignant cells	GSE186960	ENSG00000163754	2992	glycogenin 1	GYG	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25536
2.78557110397412e-39	0.364429209696148	0.973	0.951	6.20485963410236e-35	TCP1	Malignant cells	GSE186960	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25537
3.08649807518857e-39	-0.504971060584634	0.375	0.562	6.87517446248253e-35	SEPT11	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25538
3.42784938225553e-39	-0.426138936691099	0.23	0.433	7.63553449897419e-35	KDSR	Malignant cells	GSE186960	ENSG00000119537	2531	3-ketodihydrosphingosine reductase	DHSR|FVT1|SDR35C1	protein_coding	Q06136	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25539
4.07928762346262e-39	0.342152810987029	0.271	0.043	9.08661318126299e-35	RP11-545E17.3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25540
4.40557633465838e-39	-0.427339458636759	0.853	0.946	9.81342128545154e-35	PFN2	Malignant cells	GSE186960	ENSG00000070087	5217	profilin 2	NA	protein_coding	P35080	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25541
4.6607434606629e-39	-0.436915303191434	0.813	0.92	1.03818060586266e-34	VAPA	Malignant cells	GSE186960	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25542
4.98953622300911e-39	0.431889422117528	0.528	0.265	1.11141919367528e-34	FIS1	Malignant cells	GSE186960	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25543
6.71192105492844e-39	0.389408060920747	0.341	0.097	1.49508041498531e-34	CSRP2	Malignant cells	GSE186960	ENSG00000175183	1466	cysteine and glycine rich protein 2	CRP2|LMO5|SmLIM	protein_coding	Q16527	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25544
6.78698106013746e-39	0.361460130677921	0.325	0.085	1.51180003114562e-34	HSBP1L1	Malignant cells	GSE186960	ENSG00000226742	440498	heat shock factor binding protein 1 like 1	FLJ10967|MGC189743	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25545
6.78966871252836e-39	0.349865656134966	0.265	0.04	1.51239870571569e-34	TNFRSF10B	Malignant cells	GSE186960	ENSG00000120889	8795	TNF receptor superfamily member 10b	CD262|DR5|KILLER|TRAIL-R2|TRAILR2|TRICK2A|TRICKB	protein_coding	O14763	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25546
7.20937946112e-39	0.453143385280468	0.93	0.89	1.60588927496448e-34	TOP2A	Malignant cells	GSE186960	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25547
7.67727558883057e-39	0.371705925855203	0.331	0.09	1.71011313741201e-34	GSTZ1	Malignant cells	GSE186960	ENSG00000100577	2954	glutathione S-transferase zeta 1	GSTZ1-1|MAAI|MAI	protein_coding	O43708	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25548
7.78664939198015e-39	0.418293873167158	0.668	0.443	1.73447615206358e-34	BLOC1S1	Malignant cells	GSE186960	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25549
8.19325412049827e-39	0.414167050936582	0.506	0.236	1.82504735534099e-34	SMARCD1	Malignant cells	GSE186960	ENSG00000066117	6602	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1	BAF60A|CRACD1|Rsc6p	protein_coding	Q96GM5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25550
9.29645362121406e-39	-0.439763651813212	0.609	0.761	2.07078504412543e-34	NDUFA13	Malignant cells	GSE186960	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25551
9.57316658198664e-39	-0.504425758784489	0.273	0.467	2.13242285613753e-34	PLEKHG2	Malignant cells	GSE186960	ENSG00000090924	64857	pleckstrin homology and RhoGEF domain containing G2	ARHGEF42|CLG|FLJ00018	protein_coding	Q9H7P9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25552
9.6085416856115e-39	-0.550421747757424	0.498	0.652	2.14030266046996e-34	UPF3B	Malignant cells	GSE186960	ENSG00000125351	65109	UPF3B regulator of nonsense mediated mRNA decay	HUPF3B|MRX62|MRX82|RENT3B|UPF3BP1|UPF3BP2|UPF3BP3|UPF3X	protein_coding	Q9BZI7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25553
1.10400568091928e-38	-0.44794533787049	0.67	0.801	2.45917265424771e-34	UBE2N	Malignant cells	GSE186960	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25554
1.13980838671355e-38	0.434712990330024	0.719	0.507	2.53892318140444e-34	ACSL3	Malignant cells	GSE186960	ENSG00000123983	2181	acyl-CoA synthetase long chain family member 3	ACS3|FACL3|PRO2194	protein_coding	O95573	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25555
1.14795710428799e-38	0.424108083371151	0.512	0.251	2.5570744498015e-34	THUMPD1	Malignant cells	GSE186960	ENSG00000066654	55623	THUMP domain containing 1	FLJ20274|Tan1	protein_coding	Q9NXG2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25556
1.21168015410268e-38	-0.424970747248604	0.27	0.474	2.69901754326371e-34	TMEM43	Malignant cells	GSE186960	ENSG00000170876	79188	transmembrane protein 43	ARVD5|DKFZp586G1919|LUMA|MGC3222	protein_coding	Q9BTV4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25557
1.21996495049025e-38	-0.441491919506656	0.587	0.744	2.71747192721704e-34	HM13	Malignant cells	GSE186960	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25558
1.37126311079589e-38	0.334619351304851	0.254	0.034	3.05448857929785e-34	CTD-2270L9.4	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25559
1.37264621058329e-38	0.422175259334173	0.627	0.388	3.05756943407429e-34	CCDC124	Malignant cells	GSE186960	ENSG00000007080	115098	coiled-coil domain containing 124	Lso2|oxs1	protein_coding	Q96CT7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25560
1.41394741521403e-38	0.41116862233382	0.466	0.209	3.14956786738925e-34	TMEM181	Malignant cells	GSE186960	ENSG00000146433	57583	transmembrane protein 181	GPR178|KIAA1423	protein_coding	Q9P2C4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25561
1.65377121867229e-38	0.410346222129632	0.479	0.218	3.68377538959252e-34	MLST8	Malignant cells	GSE186960	ENSG00000167965	64223	MTOR associated protein, LST8 homolog	GbetaL|GBL|Lst8|Pop3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25562
1.67826837293816e-38	0.387223086330376	0.382	0.13	3.73834280071976e-34	NUS1	Malignant cells	GSE186960	ENSG00000153989	116150	NUS1 dehydrodolichyl diphosphate synthase subunit	C6orf68|MGC7199|NgBR|TANGO14	protein_coding	Q96E22	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25563
1.78356998775372e-38	-0.490930801635483	0.403	0.586	3.97290214772142e-34	BZW2	Malignant cells	GSE186960	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25564
1.85735702263657e-38	0.25278935405562	1	1	4.13726276792296e-34	CFL1	Malignant cells	GSE186960	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25565
1.94070323263997e-38	-0.483312689865751	0.515	0.685	4.32291645070554e-34	DDX27	Malignant cells	GSE186960	ENSG00000124228	55661	DEAD-box helicase 27	dJ686N3.1|DRS1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25566
2.1142182047588e-38	-0.535907774555126	0.312	0.5	4.70942105110023e-34	FEN1	Malignant cells	GSE186960	ENSG00000168496	2237	flap structure-specific endonuclease 1	FEN-1|MF1|RAD2	protein_coding	P39748	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25567
2.18291743888977e-38	0.322411640564441	0.262	0.039	4.86244859512697e-34	NACC1	Malignant cells	GSE186960	ENSG00000160877	112939	nucleus accumbens associated 1	BEND8|BTBD14B|BTBD30|NAC-1|NAC1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25568
2.57477578681303e-38	0.418323965581796	0.341	0.1	5.73531306512603e-34	SLC2A8	Malignant cells	GSE186960	ENSG00000136856	29988	solute carrier family 2 member 8	GLUT8|GLUTX1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25569
2.59592690809768e-38	-0.469836949479673	0.54	0.713	5.78242718778758e-34	LEO1	Malignant cells	GSE186960	ENSG00000166477	123169	LEO1 homolog, Paf1/RNA polymerase II complex component	NA	protein_coding	Q8WVC0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25570
3.00018320070362e-38	0.37465045476737	0.352	0.107	6.68290807956732e-34	SMG6	Malignant cells	GSE186960	ENSG00000070366	23293	SMG6 nonsense mediated mRNA decay factor	C17orf31|EST1A|KIAA0732|SMG-6	protein_coding	Q86US8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25571
3.42768262640471e-38	0.37133462356493	0.332	0.095	7.6351630503165e-34	MAN2B2	Malignant cells	GSE186960	ENSG00000013288	23324	mannosidase alpha class 2B member 2	EpMAN|KIAA0935	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25572
3.68344644876024e-38	-0.436026122181498	0.705	0.838	8.20487696461343e-34	FUBP1	Malignant cells	GSE186960	ENSG00000162613	8880	far upstream element binding protein 1	FBP|FUBP	protein_coding	Q96AE4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25573
4.41938617024062e-38	0.350352316340547	0.337	0.093	9.84418269421098e-34	GRK6	Malignant cells	GSE186960	ENSG00000198055	2870	G protein-coupled receptor kinase 6	GPRK6	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25574
4.51518720940772e-38	-0.316173357754116	0.126	0.301	1.00575795089557e-33	PMS2	Malignant cells	GSE186960	ENSG00000122512	5395	PMS1 homolog 2, mismatch repair system component	HNPCC4|H_DJ0042M02.9|MLH4|PMS-2|PMSL2	protein_coding	P54278	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25575
4.81379308476828e-38	-0.483600121724254	0.485	0.653	1.07227240963213e-33	C11orf73	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25576
5.06645217568097e-38	0.325087805046306	0.994	0.987	1.12855222213294e-33	PTGES3	Malignant cells	GSE186960	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25577
5.11476230709031e-38	0.393247906291167	0.465	0.205	1.13931330390437e-33	CDK16	Malignant cells	GSE186960	ENSG00000102225	5127	cyclin dependent kinase 16	FLJ16665|PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	protein_coding	Q00536	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25578
5.13775578969419e-38	-0.403286920455143	0.874	0.954	1.14443510215438e-33	ARPC5	Malignant cells	GSE186960	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25579
5.38730514500891e-38	0.39998486336484	0.459	0.196	1.20002222105073e-33	CSNK2A2	Malignant cells	GSE186960	ENSG00000070770	1459	casein kinase 2 alpha 2	CK2alpha'|CSNK2A1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25580
7.23138824578154e-38	-0.442087755783785	0.314	0.511	1.61079173174784e-33	PCYT1A	Malignant cells	GSE186960	ENSG00000161217	5130	phosphate cytidylyltransferase 1A, choline	CCTalpha|CT|CTPCT|PCYT1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25581
1.12054224319049e-37	0.405578479469417	0.626	0.378	2.49600784670681e-33	TRAP1	Malignant cells	GSE186960	ENSG00000126602	10131	TNF receptor associated protein 1	HSP75|HSP90L	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25582
1.26378111883357e-37	-0.472854396494874	0.321	0.513	2.81507244220178e-33	FTSJ3	Malignant cells	GSE186960	ENSG00000108592	117246	FtsJ RNA 2'-O-methyltransferase 3	SPB1	protein_coding	Q8IY81	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25583
1.36433105032422e-37	-0.569891432072269	0.448	0.603	3.03904741459721e-33	MCM2	Malignant cells	GSE186960	ENSG00000073111	4171	minichromosome maintenance complex component 2	BM28|CCNL1|cdc19|CDCL1|D3S3194|DFNA70|KIAA0030	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25584
1.50692997710575e-37	0.363169076635169	0.315	0.082	3.35668652400306e-33	MKL1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25585
1.79536977393475e-37	0.332666327138833	0.255	0.039	3.99918617143966e-33	E2F5	Malignant cells	GSE186960	ENSG00000133740	1875	E2F transcription factor 5	NA	protein_coding	Q15329	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25586
2.16889408466769e-37	-0.385683542282962	0.193	0.383	4.83121157359727e-33	HSD17B11	Malignant cells	GSE186960	ENSG00000198189	51170	hydroxysteroid 17-beta dehydrogenase 11	17-BETA-HSD11|17-BETA-HSDXI|DHRS8|PAN1B|RetSDR2|SDR16C2	protein_coding	Q8NBQ5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25587
2.19058307272021e-37	-0.365483712665174	0.171	0.36	4.87952379448426e-33	CDK2	Malignant cells	GSE186960	ENSG00000123374	1017	cyclin dependent kinase 2	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25588
2.2769822680593e-37	-0.489559908373008	0.458	0.623	5.0719780021021e-33	AIFM1	Malignant cells	GSE186960	ENSG00000156709	9131	apoptosis inducing factor mitochondria associated 1	AIF|AUNX1|CMTX4|DFNX5|NAMSD|PDCD8	protein_coding	O95831	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25589
2.33931493095971e-37	-0.488775960488145	0.451	0.615	5.21082400871275e-33	COX16	Malignant cells	GSE186960	ENSG00000133983	51241	cytochrome c oxidase assembly factor COX16	C14orf112|HSPC203	protein_coding	Q9P0S2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25590
2.34693917126154e-37	0.41501412829341	0.379	0.135	5.22780700398507e-33	KIF18A	Malignant cells	GSE186960	ENSG00000121621	81930	kinesin family member 18A	DKFZP434G2226|PPP1R99	protein_coding	Q8NI77	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25591
2.37030381226008e-37	0.325250123317418	0.252	0.036	5.27985174180934e-33	RCCD1	Malignant cells	GSE186960	ENSG00000166965	91433	RCC1 domain containing 1	MGC14386	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25592
2.83310733645294e-37	0.384544860655864	0.39	0.146	6.31074659194893e-33	ARFIP2	Malignant cells	GSE186960	ENSG00000132254	23647	ADP ribosylation factor interacting protein 2	POR1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25593
3.15389688799865e-37	-0.466860040704989	0.413	0.592	7.02530531801699e-33	ARPC1A	Malignant cells	GSE186960	ENSG00000241685	10552	actin related protein 2/3 complex subunit 1A	Arc40|SOP2Hs|SOP2L	protein_coding	Q92747	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25594
3.22639446094418e-37	0.360738820300478	0.267	0.047	7.18679366175317e-33	RHOB	Malignant cells	GSE186960	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25595
3.26400227643012e-37	0.399301711771847	0.405	0.153	7.27056507074809e-33	MMS22L	Malignant cells	GSE186960	ENSG00000146263	253714	MMS22 like, DNA repair protein	C6orf167|dJ39B17.2	protein_coding	Q6ZRQ5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25596
3.54243388741524e-37	-0.473698059938623	0.328	0.514	7.89077148421745e-33	RRP1B	Malignant cells	GSE186960	ENSG00000160208	23076	ribosomal RNA processing 1B	KIAA0179|Nnp1|PPP1R136|RRP1	protein_coding	Q14684	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25597
3.64180189584453e-37	0.372873736512162	0.415	0.156	8.11211372299368e-33	TBPL1	Malignant cells	GSE186960	ENSG00000028839	9519	TATA-box binding protein like 1	STUD|TLF|TLP|TRF2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25598
3.78864388287397e-37	0.419595020550349	0.673	0.457	8.43920424910177e-33	NRBP1	Malignant cells	GSE186960	ENSG00000115216	29959	nuclear receptor binding protein 1	BCON3|MADM|MUDPNP|NRBP	protein_coding	Q9UHY1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25599
5.44094239565263e-37	0.411075602530934	0.599	0.358	1.21196991863162e-32	RCC2	Malignant cells	GSE186960	ENSG00000281540	55920	regulator of chromosome condensation 2	TD-60	protein_coding	Q9P258	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25600
5.78698281463922e-37	-0.507250338634413	0.372	0.547	1.28905042196089e-32	CUL5	Malignant cells	GSE186960	ENSG00000166266	8065	cullin 5	VACM-1	protein_coding	Q93034	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25601
5.9460480420758e-37	0.335420007707489	0.298	0.069	1.32448220137238e-32	TAF6	Malignant cells	GSE186960	ENSG00000106290	6878	TATA-box binding protein associated factor 6	MGC:8964|TAF2E|TAFII70|TAFII80|TAFII85	protein_coding	P49848	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25602
6.11187264911337e-37	0.384533122422885	0.402	0.153	1.36141963259e-32	WDR62	Malignant cells	GSE186960	ENSG00000075702	284403	WD repeat domain 62	C19orf14|DKFZP434J046|FLJ33298|MCPH2	protein_coding	O43379	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25603
7.00700101808655e-37	0.388786753033142	0.419	0.17	1.56080947677878e-32	RP11-423H2.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25604
7.66663061779251e-37	-0.491860046540332	0.457	0.626	1.70774197011328e-32	ACAP2	Malignant cells	GSE186960	ENSG00000114331	23527	ArfGAP with coiled-coil, ankyrin repeat and PH domains 2	CENTB2|CNT-B2|KIAA0041	protein_coding	Q15057	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25605
8.15543498158321e-37	-0.476818538747262	0.346	0.533	1.81662314214766e-32	TMSB4XP8	Malignant cells	GSE186960	ENSG00000187653	NA	NA	TMSL3	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25606
8.93812608360599e-37	0.411331551645994	0.918	0.857	1.99096758512323e-32	MTATP6P1	Malignant cells	GSE186960	ENSG00000248527	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25607
9.23575192742297e-37	-0.475148637435113	0.384	0.572	2.05726374183347e-32	RHOG	Malignant cells	GSE186960	ENSG00000177105	391	ras homolog family member G	ARHG|MGC125835|MGC125836	protein_coding	P84095	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25608
9.46457336498628e-37	-0.392877697050834	0.831	0.923	2.10823371705069e-32	DDX1	Malignant cells	GSE186960	ENSG00000079785	1653	DEAD-box helicase 1	DBP-RB	protein_coding	Q92499	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25609
9.98292046425801e-37	0.384703446532329	0.483	0.221	2.22369553341347e-32	FLNB	Malignant cells	GSE186960	ENSG00000136068	2317	filamin B	ABP-278|FH1|FLN1L|LRS1|TABP|TAP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25610
1.05441438156028e-36	0.3731573026554	0.342	0.107	2.34870803492553e-32	FAM103A1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25611
1.24661088543265e-36	-0.496698368254872	0.408	0.582	2.77682574730123e-32	SELK	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25612
1.29981872236013e-36	0.612329865772364	0.727	0.537	2.8953462040572e-32	IGFBP4	Malignant cells	GSE186960	ENSG00000141753	3487	insulin like growth factor binding protein 4	BP-4|HT29-IGFBP|IBP4|IGFBP-4	protein_coding	P22692	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25613
1.49735072929468e-36	-0.434501828669407	0.686	0.808	3.33534874950389e-32	MRPS5	Malignant cells	GSE186960	ENSG00000144029	64969	mitochondrial ribosomal protein S5	MRP-S5|S5mt	protein_coding	P82675	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25614
1.5094306175168e-36	-0.424120423872308	0.256	0.453	3.36225670051867e-32	CAMSAP2	Malignant cells	GSE186960	ENSG00000118200	23271	calmodulin regulated spectrin associated protein family member 2	CAMSAP1L1|KIAA1078	protein_coding	Q08AD1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25615
1.67392229867822e-36	-0.465540530343823	0.512	0.668	3.72866192030574e-32	AIMP1	Malignant cells	GSE186960	ENSG00000164022	9255	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	EMAP-2|EMAPII|p43|SCYE1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25616
1.70341012107731e-36	0.336507369327165	0.309	0.077	3.79434604469971e-32	FLCN	Malignant cells	GSE186960	ENSG00000154803	201163	folliculin	BHD|DENND8B|MGC17998|MGC23445	protein_coding	Q8NFG4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25617
1.7126248663983e-36	-0.490657729196224	0.324	0.509	3.81487188990222e-32	C9orf89	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25618
1.73812662467368e-36	0.442514352693973	0.64	0.403	3.87167705646063e-32	SPECC1	Malignant cells	GSE186960	ENSG00000128487	92521	sperm antigen with calponin homology and coiled-coil domains 1	CYTSB|FLJ36955|HCMOGT-1|NSP	protein_coding	Q5M775	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25619
1.7534658492073e-36	0.433159032382041	0.647	0.421	3.90584517910926e-32	PIM3	Malignant cells	GSE186960	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25620
1.77932162021191e-36	-0.388412715734913	0.851	0.944	3.96343890902203e-32	IMMT	Malignant cells	GSE186960	ENSG00000132305	10989	inner membrane mitochondrial protein	HMP|Mic60|MICOS60|MINOS2|P87|P89	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25621
1.82445816564388e-36	0.404634935863995	0.891	0.815	4.06398056397175e-32	YWHAH	Malignant cells	GSE186960	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25622
1.89967970423435e-36	-0.401764152232585	0.749	0.875	4.23153654118201e-32	RNF181	Malignant cells	GSE186960	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25623
2.120952182203e-36	0.40071373062527	0.738	0.534	4.72442098585717e-32	NENF	Malignant cells	GSE186960	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25624
2.2142155867586e-36	0.409414788194525	0.506	0.256	4.93216521950478e-32	NDUFS7	Malignant cells	GSE186960	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25625
2.26245016933685e-36	0.347531306437514	0.997	0.994	5.03960775219783e-32	LDHA	Malignant cells	GSE186960	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25626
2.27593278800026e-36	0.363748630180859	0.36	0.12	5.06964028527058e-32	C12orf44	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25627
2.57185402371859e-36	-0.46139440528814	0.586	0.736	5.72880483783315e-32	MARS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25628
2.64625723158592e-36	-0.375561407165317	0.821	0.928	5.89453798335763e-32	NDUFA11	Malignant cells	GSE186960	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25629
2.72609608430474e-36	-0.437447240483816	0.916	0.968	6.07237902778881e-32	RAD21	Malignant cells	GSE186960	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25630
2.96551881612241e-36	0.343335341323457	0.962	0.926	6.60569316291267e-32	SRSF9	Malignant cells	GSE186960	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25631
2.98548864090329e-36	0.394928688954497	0.392	0.149	6.65017594761209e-32	FGFRL1	Malignant cells	GSE186960	ENSG00000127418	53834	fibroblast growth factor receptor like 1	NA	protein_coding	Q8N441	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25632
3.09237767975067e-36	-0.473343920111365	0.923	0.954	6.88827128164463e-32	SMC4	Malignant cells	GSE186960	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25633
3.54484952100794e-36	-0.44761416363272	0.619	0.759	7.89615230804518e-32	NCBP2	Malignant cells	GSE186960	ENSG00000114503	22916	nuclear cap binding protein subunit 2	Cbc2|CBP20|NIP1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25634
3.62263222313235e-36	-0.493367551068985	0.645	0.784	8.06941327702731e-32	GNG11	Malignant cells	GSE186960	ENSG00000127920	2791	G protein subunit gamma 11	GNGT11	protein_coding	P61952	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25635
3.97773253982209e-36	0.407129976566244	0.41	0.16	8.86039923245371e-32	KIAA1551	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25636
4.30279454934207e-36	-0.502678507999615	0.417	0.582	9.58447485865946e-32	HOXC9	Malignant cells	GSE186960	ENSG00000180806	3225	homeobox C9	HOX3|HOX3B	protein_coding	P31274	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25637
4.40827393274267e-36	0.417082359492113	0.438	0.191	9.81943018518429e-32	RHOH	Malignant cells	GSE186960	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25638
4.62236306072374e-36	0.345514015788489	0.267	0.049	1.02963137177621e-31	MXD4	Malignant cells	GSE186960	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25639
4.68494329020228e-36	-0.39066422378034	0.923	0.974	1.04357111789256e-31	SYNCRIP	Malignant cells	GSE186960	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25640
4.82179669108253e-36	0.350487787721535	0.283	0.062	1.07405521293863e-31	TSC22D1	Malignant cells	GSE186960	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25641
5.24741673150039e-36	-0.533492175520817	0.34	0.516	1.16886207694171e-31	SPAG5	Malignant cells	GSE186960	ENSG00000076382	10615	sperm associated antigen 5	DEEPEST|hMAP126|MAP126	protein_coding	Q96R06	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25642
5.80932981497377e-36	0.330814573642382	0.313	0.082	1.29402821628541e-31	RNF220	Malignant cells	GSE186960	ENSG00000187147	55182	ring finger protein 220	C1orf164|FLJ10597	protein_coding	Q5VTB9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25643
6.33479017155467e-36	-0.470133063451891	0.33	0.52	1.4110745107138e-31	CHMP4B	Malignant cells	GSE186960	ENSG00000101421	128866	charged multivesicular body protein 4B	C20orf178|dJ553F4.4|Shax1|SNF7-2|VPS32B	protein_coding	Q9H444	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25644
6.72839844816694e-36	0.345632365087296	0.313	0.085	1.49875075432919e-31	MACROD1	Malignant cells	GSE186960	ENSG00000133315	28992	mono-ADP ribosylhydrolase 1	LRP16	protein_coding	Q9BQ69	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25645
7.02530871832847e-36	0.373546478441297	0.366	0.13	1.56488751700767e-31	ZMYM2	Malignant cells	GSE186960	ENSG00000121741	7750	zinc finger MYM-type containing 2	FIM|MYM|RAMP|ZNF198	protein_coding	Q9UBW7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25646
7.59914908591755e-36	0.386060690818536	0.466	0.216	1.69271045888813e-31	TERF1	Malignant cells	GSE186960	ENSG00000147601	7013	telomeric repeat binding factor 1	PIN2|TRBF1|TRF|TRF1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25647
7.71429849176484e-36	0.355086253348265	0.353	0.116	1.71835998904062e-31	ZFAND1	Malignant cells	GSE186960	ENSG00000104231	79752	zinc finger AN1-type containing 1	FLJ14007	protein_coding	Q8TCF1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25648
8.00913515828519e-36	-0.531052046205408	0.642	0.784	1.78403485650803e-31	SPDL1	Malignant cells	GSE186960	ENSG00000040275	54908	spindle apparatus coiled-coil protein 1	CCDC99|FLJ20364|hSpindly	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25649
9.27236083897305e-36	-0.397061943034522	0.224	0.418	2.06541837688125e-31	EXOSC9	Malignant cells	GSE186960	ENSG00000123737	5393	exosome component 9	p5|p6|PM/Scl-75|PMSCL1|RRP45|Rrp45p	protein_coding	Q06265	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25650
9.61696799319085e-36	-0.421133654246096	0.697	0.821	2.14217962048326e-31	PTPLAD1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25651
1.1422530691578e-35	-0.399403604515229	0.935	0.966	2.54436871154901e-31	PRRC2C	Malignant cells	GSE186960	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25652
1.17215633466138e-35	0.377065077376726	0.392	0.149	2.61097823545822e-31	ASCC1	Malignant cells	GSE186960	ENSG00000138303	51008	activating signal cointegrator 1 complex subunit 1	ASC1p50|CGI-18|Em:AC022392.3|p50	protein_coding	Q8N9N2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25653
1.21559737555587e-35	0.483094932680267	0.722	0.529	2.70774315405071e-31	ASPM	Malignant cells	GSE186960	ENSG00000066279	259266	assembly factor for spindle microtubules	ASP|Calmbp1|FLJ10517|FLJ10549|MCPH5	protein_coding	Q8IZT6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25654
1.32167438100024e-35	0.36969244300918	0.413	0.163	2.94402968367803e-31	PVT1	Malignant cells	GSE186960	ENSG00000249859	NA	NA	LINC00079|MIR1204HG|NCRNA00079|onco-lncRNA-100|TP53LC09	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25655
1.3298761043549e-35	-0.407644970953851	0.199	0.387	2.96229902245054e-31	PARD3	Malignant cells	GSE186960	ENSG00000148498	56288	par-3 family cell polarity regulator	ASIP|Baz|Bazooka|PAR3|PARD3A|PPP1R118	protein_coding	Q8TEW0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25656
1.41447583865421e-35	0.41274251568209	0.581	0.341	3.15074493060225e-31	OAT	Malignant cells	GSE186960	ENSG00000065154	4942	ornithine aminotransferase	HOGA	protein_coding	P04181	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25657
1.99923871653507e-35	0.326637528498168	0.258	0.046	4.45330424108187e-31	HOXB-AS1	Malignant cells	GSE186960	ENSG00000230148	100874362	HOXB cluster antisense RNA 1	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25658
2.32210721866673e-35	-0.474871315881292	0.408	0.582	5.17249382958014e-31	CTR9	Malignant cells	GSE186960	ENSG00000198730	9646	CTR9 homolog, Paf1/RNA polymerase II complex component	KIAA0155|p150TSP|SH2BP1|TSBP	protein_coding	Q6PD62	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25659
2.4522965323572e-35	0.390705981329355	0.469	0.216	5.46249052582566e-31	COPA	Malignant cells	GSE186960	ENSG00000122218	1314	COPI coat complex subunit alpha	HEP-COP	protein_coding	P53621	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25660
2.50072001859637e-35	0.336424815196991	0.34	0.106	5.57035384142341e-31	NOTCH2	Malignant cells	GSE186960	ENSG00000134250	4853	notch receptor 2	NA	protein_coding	Q04721	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25661
2.79828463964254e-35	0.348780014464278	0.32	0.092	6.23317903480375e-31	PPP3R1	Malignant cells	GSE186960	ENSG00000221823	5534	protein phosphatase 3 regulatory subunit B, alpha	CALNB1|CNB|CNB1	protein_coding	P63098	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25662
3.60656451678213e-35	0.295961619705664	0.997	0.991	8.0336224611322e-31	HNRNPC	Malignant cells	GSE186960	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25663
3.76555824481406e-35	0.431048174370539	0.702	0.511	8.38778099032332e-31	EIF2AK2	Malignant cells	GSE186960	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25664
3.86729246270533e-35	-0.305535103456999	1	1	8.61439396067613e-31	PSMC4	Malignant cells	GSE186960	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25665
4.23796539314231e-35	0.387117932672524	0.856	0.738	9.4400679132245e-31	ECI1	Malignant cells	GSE186960	ENSG00000167969	1632	enoyl-CoA delta isomerase 1	DCI	protein_coding	P42126	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25666
4.73479617093479e-35	0.374489587815357	0.422	0.178	1.05467584707573e-30	BCL2L13	Malignant cells	GSE186960	ENSG00000099968	23786	BCL2 like 13	BCL-RAMBO|MIL1	protein_coding	Q9BXK5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25667
6.11928888632792e-35	-0.525009141720959	0.204	0.384	1.36307159942954e-30	CDCP1	Malignant cells	GSE186960	ENSG00000163814	64866	CUB domain containing protein 1	CD318|SIMA135	protein_coding	Q9H5V8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25668
6.3488746826222e-35	-0.438315511697715	0.589	0.742	1.41421183555409e-30	BAG2	Malignant cells	GSE186960	ENSG00000112208	9532	BAG cochaperone 2	NA	protein_coding	O95816	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25669
6.64549411940001e-35	0.380639206318394	0.399	0.16	1.48028381509635e-30	SYNGR1	Malignant cells	GSE186960	ENSG00000100321	9145	synaptogyrin 1	NA	protein_coding	O43759	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25670
8.20708886184118e-35	0.39838927018199	0.79	0.632	1.82812904397512e-30	RHEB	Malignant cells	GSE186960	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25671
8.28563117334271e-35	-0.461496286739514	0.498	0.66	1.84562434386209e-30	ATP5C1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25672
9.35873690355938e-35	0.393494973384667	0.85	0.749	2.08465864526785e-30	KRR1	Malignant cells	GSE186960	ENSG00000111615	11103	KRR1 small subunit processome component homolog	HRB2|RIP-1	protein_coding	Q13601	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25673
1.04524127514776e-34	0.293191497276842	0.997	0.983	2.32827494039163e-30	DEK	Malignant cells	GSE186960	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25674
1.04697213809515e-34	0.412652491647613	0.581	0.341	2.33213043760695e-30	TFAP2A	Malignant cells	GSE186960	ENSG00000137203	7020	transcription factor AP-2 alpha	AP-2|AP-2alpha|AP2TF|TFAP2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25675
1.09529551919673e-34	-0.356651669774246	0.959	0.994	2.43977076901071e-30	VDAC1	Malignant cells	GSE186960	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25676
1.21828801894377e-34	-0.386422964078324	0.22	0.408	2.71373656219726e-30	AKAP8	Malignant cells	GSE186960	ENSG00000105127	10270	A-kinase anchoring protein 8	AKAP95|DKFZp586B1222	protein_coding	O43823	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25677
1.23948729673396e-34	0.415970611228481	0.619	0.393	2.76095795347489e-30	DCTN1	Malignant cells	GSE186960	ENSG00000204843	1639	dynactin subunit 1	NA	protein_coding	Q14203	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25678
1.27043661896268e-34	-0.470555849293088	0.761	0.883	2.82989756873937e-30	KIAA0101	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25679
1.30109850575404e-34	0.375951756917217	0.91	0.848	2.89819692156713e-30	OLA1	Malignant cells	GSE186960	ENSG00000138430	29789	Obg like ATPase 1	GTPBP9|PTD004	protein_coding	Q9NTK5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25680
1.3560891360443e-34	0.31622771800125	0.258	0.049	3.02068855053869e-30	DVL3	Malignant cells	GSE186960	ENSG00000161202	1857	dishevelled segment polarity protein 3	KIAA0208	protein_coding	Q92997	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25681
1.37609296301083e-34	0.316773252713945	0.256	0.047	3.06524707510663e-30	ZMAT5	Malignant cells	GSE186960	ENSG00000100319	55954	zinc finger matrin-type 5	SNRNP20|ZC3H19	protein_coding	Q9UDW3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25682
1.60861689365578e-34	-0.263852509515229	0.998	1	3.58319413061826e-30	HSPD1	Malignant cells	GSE186960	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25683
1.62592667947531e-34	0.413021264627156	0.55	0.315	3.62175167853126e-30	PAIP1	Malignant cells	GSE186960	ENSG00000172239	10605	poly(A) binding protein interacting protein 1	NA	protein_coding	Q9H074	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25684
1.72427117463132e-34	-0.487776746073166	0.466	0.629	3.84081404149127e-30	TCERG1	Malignant cells	GSE186960	ENSG00000113649	10915	transcription elongation regulator 1	CA150|TAF2S|Urn1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25685
2.09081637578652e-34	0.35239212399503	0.392	0.152	4.65729347706448e-30	MTOR	Malignant cells	GSE186960	ENSG00000198793	2475	mechanistic target of rapamycin kinase	FLJ44809|FRAP|FRAP1|FRAP2|RAFT1|RAPT1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25686
2.09478129619398e-34	-0.478327615101478	0.484	0.635	4.6661253372721e-30	TIAL1	Malignant cells	GSE186960	ENSG00000151923	7073	TIA1 cytotoxic granule associated RNA binding protein like 1	TIAR	protein_coding	Q01085	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25687
2.26214699377505e-34	-0.422753299360865	0.594	0.742	5.03893242863391e-30	SRP72	Malignant cells	GSE186960	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25688
2.26808328536288e-34	0.292690112117839	0.996	0.997	5.05215551814581e-30	AURKAIP1	Malignant cells	GSE186960	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25689
2.55852522497905e-34	-0.502770100535262	0.526	0.682	5.69911493864083e-30	CAPN2	Malignant cells	GSE186960	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25690
2.80667091034574e-34	-0.397783644064662	0.292	0.486	6.25185945279514e-30	CDC16	Malignant cells	GSE186960	ENSG00000130177	8881	cell division cycle 16	ANAPC6|APC6|CUT9	protein_coding	Q13042	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25691
3.73738970012656e-34	0.395949499636245	0.542	0.294	8.32503555703192e-30	NUP98	Malignant cells	GSE186960	ENSG00000110713	4928	nucleoporin 98 and 96 precursor	NUP196|NUP96|Nup98-96|Nup98-Nup96	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25692
3.77108625561158e-34	0.324526975341533	0.262	0.054	8.40009463437479e-30	ZNF766	Malignant cells	GSE186960	ENSG00000196214	90321	zinc finger protein 766	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25693
3.85709784188017e-34	-0.291030005802849	0.994	1	8.59168544278809e-30	NOP10	Malignant cells	GSE186960	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25694
4.36858664066573e-34	-0.38656372573344	0.764	0.891	9.73102674208292e-30	DDX17	Malignant cells	GSE186960	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25695
5.44501032313551e-34	0.358464508444368	0.946	0.893	1.21287604947843e-29	PSMD7	Malignant cells	GSE186960	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25696
6.00498603265296e-34	-0.488415735947098	0.436	0.602	1.33761063877345e-29	SRRT	Malignant cells	GSE186960	ENSG00000087087	51593	serrate, RNA effector molecule	ARS2|Asr2|serrate	protein_coding	Q9BXP5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25697
6.16165875773765e-34	-0.389617808994829	0.791	0.917	1.37250948828606e-29	SEP15	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25698
6.658486841702e-34	0.402146616148334	0.607	0.371	1.48317794398912e-29	KPNA4	Malignant cells	GSE186960	ENSG00000186432	3840	karyopherin subunit alpha 4	IPOA3|MGC12217|MGC26703|QIP1|SRP3	protein_coding	O00629	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25699
7.26576002597058e-34	-0.503752977494059	0.418	0.574	1.61844804578495e-29	YES1	Malignant cells	GSE186960	ENSG00000176105	7525	YES proto-oncogene 1, Src family tyrosine kinase	c-yes|HsT441|Yes	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25700
7.5825424450173e-34	0.32170780605285	0.278	0.064	1.6890113296276e-29	FURIN	Malignant cells	GSE186960	ENSG00000140564	5045	furin, paired basic amino acid cleaving enzyme	FUR|PACE|PCSK3|SPC1	protein_coding	P09958	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25701
8.71865576849247e-34	-0.394257466976502	0.889	0.967	1.9420805724317e-29	PSMD14	Malignant cells	GSE186960	ENSG00000115233	10213	proteasome 26S subunit, non-ATPase 14	pad1|POH1|Rpn11	protein_coding	O00487	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25702
1.19077216439749e-33	0.320439371449399	0.27	0.062	2.65244499619542e-29	ZNF598	Malignant cells	GSE186960	ENSG00000167962	90850	zinc finger protein 598, E3 ubiquitin ligase	FLJ00086|HEL2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25703
1.19942666474637e-33	-0.270744723076482	0.099	0.251	2.67172289572255e-29	DDAH1	Malignant cells	GSE186960	ENSG00000153904	23576	dimethylarginine dimethylaminohydrolase 1	DDAH	protein_coding	O94760	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25704
1.29009176253768e-33	0.32466180035363	0.279	0.069	2.87367940105269e-29	WDR6	Malignant cells	GSE186960	ENSG00000178252	11180	WD repeat domain 6	Trm734	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25705
1.38183923312002e-33	-0.43276909503978	0.328	0.511	3.07804689177484e-29	RBFA	Malignant cells	GSE186960	ENSG00000101546	79863	ribosome binding factor A	C18orf22|FLJ21172|HsT169	protein_coding	Q8N0V3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25706
1.4318220661601e-33	-0.421413914708351	0.386	0.569	3.18938365237162e-29	ANAPC5	Malignant cells	GSE186960	ENSG00000089053	51433	anaphase promoting complex subunit 5	APC5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25707
1.49907982174169e-33	0.333452833231208	0.303	0.085	3.33920030292962e-29	MYL5	Malignant cells	GSE186960	ENSG00000215375	4636	myosin light chain 5	NA	protein_coding	Q02045	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25708
1.95006248342018e-33	-0.484182641583495	0.379	0.547	4.34376418181845e-29	CDK5RAP3	Malignant cells	GSE186960	ENSG00000108465	80279	CDK5 regulatory subunit associated protein 3	C53|FLJ13660|HSF-27|IC53|LZAP|MST016|OK/SW-cl.114	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25709
1.99049863441175e-33	0.39774277320965	0.473	0.226	4.43383570815216e-29	GAS2L3	Malignant cells	GSE186960	ENSG00000139354	283431	growth arrest specific 2 like 3	NA	protein_coding	Q86XJ1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25710
2.09697956338275e-33	-0.29205264741599	0.125	0.288	4.67102197743507e-29	CDK11A	Malignant cells	GSE186960	ENSG00000008128	728642	cyclin dependent kinase 11A	CDC2L2|CDC2L3|CDK11-p110|CDK11-p46|CDK11-p58|p58GTA|PITSLRE	protein_coding	Q9UQ88	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25711
2.48827798058928e-33	0.411270557176726	0.797	0.666	5.54263920176261e-29	DEPDC1	Malignant cells	GSE186960	ENSG00000024526	55635	DEP domain containing 1	DEP.8|DEPDC1A|FLJ20354|SDP35	protein_coding	Q5TB30	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25712
2.53920051262448e-33	0.369066302841898	0.409	0.173	5.65606914187104e-29	DEF8	Malignant cells	GSE186960	ENSG00000140995	54849	differentially expressed in FDCP 8 homolog	FLJ20186	protein_coding	Q6ZN54	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25713
2.77089978521785e-33	-0.36912404612791	0.706	0.842	6.17217927157275e-29	ZBTB8OS	Malignant cells	GSE186960	ENSG00000176261	339487	zinc finger and BTB domain containing 8 opposite strand	ARCH	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25714
3.11755428240408e-33	0.316408511928235	0.259	0.054	6.94435216405508e-29	STK16	Malignant cells	GSE186960	ENSG00000115661	8576	serine/threonine kinase 16	MPSK|PKL12	protein_coding	O75716	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25715
3.20995194571244e-33	0.400740653820454	0.833	0.729	7.15016795907446e-29	CALCOCO2	Malignant cells	GSE186960	ENSG00000136436	10241	calcium binding and coiled-coil domain 2	MGC17318|NDP52	protein_coding	Q13137	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25716
3.89697772192847e-33	0.356880051885912	0.392	0.159	8.68051787559567e-29	PNPLA2	Malignant cells	GSE186960	ENSG00000177666	57104	patatin like phospholipase domain containing 2	ATGL|desnutrin|FP17548|iPLA2zeta|TTS-2.2	protein_coding	Q96AD5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25717
3.91583317754762e-33	0.319132659852764	0.295	0.079	8.72251840298732e-29	SSH2	Malignant cells	GSE186960	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25718
3.93675949558849e-33	0.383376362776282	0.819	0.699	8.76913177642336e-29	NIPA2	Malignant cells	GSE186960	ENSG00000140157	81614	NIPA magnesium transporter 2	SLC57A2	protein_coding	Q8N8Q9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25719
4.25375355715431e-33	-0.452693757799896	0.611	0.756	9.47523604856122e-29	SRSF4	Malignant cells	GSE186960	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25720
4.47061035446686e-33	0.340377211761927	0.298	0.085	9.95828456457492e-29	PDGFC	Malignant cells	GSE186960	ENSG00000145431	56034	platelet derived growth factor C	fallotein|SCDGF	protein_coding	Q9NRA1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25721
4.69331363415114e-33	0.340537709947152	0.881	0.765	1.04543561200717e-28	CTSD	Malignant cells	GSE186960	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25722
4.71669236121065e-33	0.328749700944955	0.307	0.09	1.05064322345967e-28	B4GALT7	Malignant cells	GSE186960	ENSG00000027847	11285	beta-1,4-galactosyltransferase 7	beta4Gal-T7|XGALT-1	protein_coding	Q9UBV7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25723
5.44681711918763e-33	0.390232474309234	0.453	0.212	1.21327851329905e-28	ANKRD28	Malignant cells	GSE186960	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25724
5.85021435033433e-33	0.383881768512742	0.799	0.66	1.30313524653697e-28	POLR2K	Malignant cells	GSE186960	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25725
6.03874563461284e-33	0.369265871776027	0.531	0.284	1.34513059011001e-28	TNPO1	Malignant cells	GSE186960	ENSG00000083312	3842	transportin 1	IPO2|KPNB2|MIP|MIP1|TRN	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25726
6.19346629396197e-33	-0.380229373506716	0.765	0.891	1.37959461698003e-28	MRPL13	Malignant cells	GSE186960	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25727
6.37744055494136e-33	-0.269439863712045	0.102	0.252	1.42057488361319e-28	BBS2	Malignant cells	GSE186960	ENSG00000125124	583	Bardet-Biedl syndrome 2	BBS	protein_coding	Q9BXC9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25728
6.67055219381796e-33	0.332371647855324	0.364	0.133	1.48586550117295e-28	MRPL10	Malignant cells	GSE186960	ENSG00000159111	124995	mitochondrial ribosomal protein L10	L10MT|MGC17973|MRP-L10|MRP-L8|MRPL8|RPML8	protein_coding	Q7Z7H8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25729
6.75829015791019e-33	-0.417009692800459	0.567	0.725	1.5054091326745e-28	GOLIM4	Malignant cells	GSE186960	ENSG00000173905	27333	golgi integral membrane protein 4	GIMPC|GOLPH4|GPP130|P138	protein_coding	O00461	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25730
6.76634391464693e-33	0.385509030606187	0.668	0.454	1.5072031069876e-28	CCNC	Malignant cells	GSE186960	ENSG00000112237	892	cyclin C	CycC	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25731
6.94385546269427e-33	0.326689396492154	0.357	0.126	1.54674380431515e-28	DENND5A	Malignant cells	GSE186960	ENSG00000184014	23258	DENN domain containing 5A	FLJ22354|FLJ33829|FLJ43455|KIAA1091|RAB6IP1	protein_coding	Q6IQ26	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25732
7.32923982130738e-33	0.318330709377627	0.298	0.082	1.63258817019622e-28	FBXW4	Malignant cells	GSE186960	ENSG00000107829	6468	F-box and WD repeat domain containing 4	dactylin|Fbw4|SHFM3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25733
7.47041635038339e-33	-0.421649697524236	0.591	0.735	1.6640352420479e-28	FGFR1OP2	Malignant cells	GSE186960	ENSG00000111790	26127	FGFR1 oncogene partner 2	DKFZp564O1863	protein_coding	Q9NVK5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25734
7.60928742420045e-33	-0.423984439232305	0.853	0.946	1.69496877374065e-28	ZFAS1	Malignant cells	GSE186960	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25735
8.51728439709495e-33	0.30086815715483	0.996	0.991	1.8972250994529e-28	PKM	Malignant cells	GSE186960	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25736
8.55393009758716e-33	0.393838014083734	0.633	0.426	1.90538792923754e-28	RBBP4	Malignant cells	GSE186960	ENSG00000162521	5928	RB binding protein 4, chromatin remodeling factor	lin-53|NURF55|RbAp48	protein_coding	Q09028	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25737
1.24787077025592e-32	0.375211393774421	0.508	0.262	2.77963214074505e-28	MAPK1	Malignant cells	GSE186960	ENSG00000100030	5594	mitogen-activated protein kinase 1	ERK|ERK2|MAPK2|p41mapk|PRKM1|PRKM2	protein_coding	P28482	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25738
1.26915060110585e-32	0.334615792965117	0.336	0.113	2.82703296396328e-28	PPM1B	Malignant cells	GSE186960	ENSG00000138032	5495	protein phosphatase, Mg2+/Mn2+ dependent 1B	PP2CB|PP2CBETA|PPC2BETAX	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25739
1.28838334993606e-32	-0.472115506736304	0.493	0.64	2.86987391198257e-28	ROCK2	Malignant cells	GSE186960	ENSG00000134318	9475	Rho associated coiled-coil containing protein kinase 2	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25740
1.44213965354441e-32	-0.418693201094365	0.33	0.51	3.21236607827018e-28	STRBP	Malignant cells	GSE186960	ENSG00000165209	55342	spermatid perinuclear RNA binding protein	FLJ11307|ILF3L|SPNR	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25741
1.47608757534529e-32	-0.459644692614041	0.562	0.692	3.28798507408163e-28	EIF4A2	Malignant cells	GSE186960	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25742
1.57627178131609e-32	0.331617049335281	0.358	0.13	3.51114539288158e-28	CYHR1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25743
1.67683071282674e-32	0.286048651696719	0.259	0.054	3.73514041282156e-28	WIZ	Malignant cells	GSE186960	ENSG00000011451	58525	WIZ zinc finger	ZNF803	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25744
1.69266985269433e-32	0.376751479701184	0.803	0.682	3.77042209687661e-28	COMT	Malignant cells	GSE186960	ENSG00000093010	1312	catechol-O-methyltransferase	NA	protein_coding	P21964	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25745
1.95094144311254e-32	0.404932599930524	0.347	0.123	4.34572206453318e-28	ABL2	Malignant cells	GSE186960	ENSG00000143322	27	ABL proto-oncogene 2, non-receptor tyrosine kinase	ABLL|ARG	protein_coding	P42684	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25746
1.9554880641683e-32	0.303003127850647	0.274	0.066	4.35584966293488e-28	ATP6V0D1	Malignant cells	GSE186960	ENSG00000159720	9114	ATPase H+ transporting V0 subunit d1	ATP6D|ATP6DV|P39|VATX|Vma6|VPATPD	protein_coding	P61421	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25747
2.01573418867321e-32	-0.429520264280854	0.411	0.585	4.49004790526958e-28	NDUFS4	Malignant cells	GSE186960	ENSG00000164258	4724	NADH:ubiquinone oxidoreductase subunit S4	AQDQ|CI-18	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25748
2.06864227147012e-32	-0.408344724175957	0.778	0.891	4.6079006596997e-28	DDX24	Malignant cells	GSE186960	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25749
2.13207784854184e-32	0.309905146463029	0.263	0.06	4.74920340762695e-28	DANCR	Malignant cells	GSE186960	ENSG00000226950	57291	differentiation antagonizing non-protein coding RNA	AGU2|ANCR|KIAA0114|lncRNA-ANCR|SNHG13	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25750
2.13772478110466e-32	0.363469635343419	0.363	0.136	4.76178194991064e-28	CYB5D2	Malignant cells	GSE186960	ENSG00000167740	124936	cytochrome b5 domain containing 2	MGC32124	protein_coding	Q8WUJ1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25751
2.16590731504577e-32	0.359980141827971	0.39	0.158	4.82455854426445e-28	SHPRH	Malignant cells	GSE186960	ENSG00000146414	257218	SNF2 histone linker PHD RING helicase	bA545I5.2|FLJ90837|KIAA2023	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25752
2.31771652790042e-32	0.289264649482393	0.262	0.056	5.16271356589819e-28	INPPL1	Malignant cells	GSE186960	ENSG00000165458	3636	inositol polyphosphate phosphatase like 1	SHIP2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25753
2.32958819274953e-32	-0.396680848921487	0.888	0.946	5.18915769934959e-28	SMC3	Malignant cells	GSE186960	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25754
2.60664585636134e-32	-0.301510048782135	0.131	0.292	5.80630364504489e-28	ANKMY2	Malignant cells	GSE186960	ENSG00000106524	57037	ankyrin repeat and MYND domain containing 2	DKFZP564O043|ZMYND20	protein_coding	Q8IV38	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25755
2.92483317639958e-32	0.36258376092854	0.48	0.234	6.51506590043006e-28	DHX33	Malignant cells	GSE186960	ENSG00000005100	56919	DEAH-box helicase 33	DDX33|DKFZp762F2011|FLJ21972	protein_coding	Q9H6R0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25756
3.12728443070178e-32	0.413531265607134	0.672	0.477	6.96602606938821e-28	CDK1	Malignant cells	GSE186960	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25757
3.48483459226255e-32	0.319890723390702	0.965	0.956	7.76246905426483e-28	YWHAQ	Malignant cells	GSE186960	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25758
3.6491855690882e-32	0.34604419455621	0.4	0.168	8.12856085514397e-28	ABCC1	Malignant cells	GSE186960	ENSG00000278183	4363	ATP binding cassette subfamily C member 1	GS-X|MRP|MRP1	protein_coding	P33527	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25759
3.67746209835652e-32	0.408748758504738	0.59	0.371	8.19154682408915e-28	CTNND1	Malignant cells	GSE186960	ENSG00000198561	1500	catenin delta 1	CTNND|KIAA0384|p120|p120cas|p120ctn	protein_coding	O60716	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25760
4.60910510076583e-32	-0.344485442699499	0.937	0.971	1.02667816119559e-27	SNRPE	Malignant cells	GSE186960	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25761
5.02317768880851e-32	0.3196475376801	0.298	0.085	1.1189128301821e-27	ATP8B3	Malignant cells	GSE186960	ENSG00000130270	148229	ATPase phospholipid transporting 8B3	ATPIK	protein_coding	O60423	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25762
5.03564520185741e-32	-0.654401677149484	0.192	0.352	1.12168996871374e-27	SFRP1	Malignant cells	GSE186960	ENSG00000104332	6422	secreted frizzled related protein 1	FRP|FRP-1|SARP2	protein_coding	Q8N474	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25763
5.64936931367615e-32	0.311845386089795	0.257	0.057	1.25839701462136e-27	SLC35E2B	Malignant cells	GSE186960	ENSG00000189339	728661	solute carrier family 35 member E2B	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25764
7.27474105770128e-32	0.319982614268506	0.315	0.099	1.62044857060296e-27	C22orf39	Malignant cells	GSE186960	ENSG00000242259	128977	chromosome 22 open reading frame 39	MGC74441	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25765
7.29779283755094e-32	0.290738841817271	0.277	0.069	1.62558335456447e-27	MAPK3	Malignant cells	GSE186960	ENSG00000102882	5595	mitogen-activated protein kinase 3	ERK1|p44erk1|p44mapk|PRKM3	protein_coding	P27361	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25766
7.69774331985782e-32	-0.441149350846075	0.352	0.521	1.71467232449833e-27	MED19	Malignant cells	GSE186960	ENSG00000156603	219541	mediator complex subunit 19	LCMR1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25767
9.0745864540356e-32	0.372344307983063	0.729	0.547	2.02136413263643e-27	CIRBP	Malignant cells	GSE186960	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25768
9.44381645649425e-32	0.293877665653089	0.403	0.156	2.10361011568409e-27	ARHGAP18	Malignant cells	GSE186960	ENSG00000146376	93663	Rho GTPase activating protein 18	bA307O14.2|MacGAP	protein_coding	Q8N392	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25769
9.52508273896963e-32	-0.445756190427289	0.511	0.663	2.12171218010549e-27	USP16	Malignant cells	GSE186960	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25770
1.02670303195422e-31	-0.477096911712838	0.553	0.689	2.28698100367802e-27	NUCB2	Malignant cells	GSE186960	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25771
1.143888130823e-31	0.331040401032718	0.366	0.142	2.54801081140822e-27	CLPTM1	Malignant cells	GSE186960	ENSG00000104853	1209	CLPTM1 regulator of GABA type A receptor forward trafficking	NA	protein_coding	O96005	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25772
1.22166151862626e-31	0.32077664673811	0.278	0.074	2.72125103273999e-27	C10orf35	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25773
1.2279157677476e-31	-0.378926261600484	0.833	0.941	2.73518237265777e-27	MRPL33	Malignant cells	GSE186960	ENSG00000243147	9553	mitochondrial ribosomal protein L33	C2orf1|RPL33L	protein_coding	O75394	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25774
1.23356876326599e-31	0.293693429883253	0.267	0.063	2.747774420175e-27	SEPN1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25775
1.24074988549022e-31	0.358860748575915	0.442	0.208	2.76377036992946e-27	SF3B3	Malignant cells	GSE186960	ENSG00000189091	23450	splicing factor 3b subunit 3	KIAA0017|RSE1|SAP130|SF3b130	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25776
1.26313280227244e-31	0.332547791493844	0.367	0.139	2.81362831706185e-27	LITAF	Malignant cells	GSE186960	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25777
1.2932379399731e-31	-0.395239213201404	0.307	0.491	2.88068751129009e-27	MRFAP1L1	Malignant cells	GSE186960	ENSG00000178988	114932	Morf4 family associated protein 1 like 1	MGC9651	protein_coding	Q96HT8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25778
1.3233962818672e-31	0.394733363269346	0.542	0.312	2.94786521785919e-27	XPOT	Malignant cells	GSE186960	ENSG00000184575	11260	exportin for tRNA	XPO3	protein_coding	O43592	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25779
1.40960962422604e-31	0.359974721076567	0.361	0.139	3.13990543796351e-27	TRIM25	Malignant cells	GSE186960	ENSG00000121060	7706	tripartite motif containing 25	EFP|RNF147|ZNF147	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25780
1.47224756349923e-31	-0.333626352480895	0.18	0.354	3.27943144769454e-27	CWC25	Malignant cells	GSE186960	ENSG00000276761	54883	CWC25 spliceosome associated protein homolog	CCDC49|FLJ20291	protein_coding	Q9NXE8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25781
1.52380823776102e-31	0.368630659564306	0.779	0.628	3.39428284961267e-27	SMAP1	Malignant cells	GSE186960	ENSG00000112305	60682	small ArfGAP 1	FLJ13159|SMAP-1	protein_coding	Q8IYB5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25782
1.53706365844008e-31	-0.346389400358844	0.889	0.967	3.42380929917528e-27	PSMB3	Malignant cells	GSE186960	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25783
1.6348056451802e-31	0.311372540110744	0.278	0.073	3.6415295746389e-27	BPHL	Malignant cells	GSE186960	ENSG00000137274	670	biphenyl hydrolase like	Bph-rp|MCNAA|VACVase	protein_coding	Q86WA6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25784
1.64483635355516e-31	0.320223272323281	0.301	0.09	3.66387297754412e-27	CDK11B	Malignant cells	GSE186960	ENSG00000248333	984	cyclin dependent kinase 11B	CDC2L1|CDK11-p110|CDK11-p46|CDK11-p58	protein_coding	P21127	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25785
1.75969837357665e-31	0.405386735735314	0.735	0.569	3.919728127142e-27	NCAPG	Malignant cells	GSE186960	ENSG00000109805	64151	non-SMC condensin I complex subunit G	CAP-G|FLJ12450|hCAP-G|YCG1	protein_coding	Q9BPX3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25786
2.07223104247791e-31	0.335515592027842	0.891	0.801	4.61589464711954e-27	RSL24D1	Malignant cells	GSE186960	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25787
2.10732562745222e-31	-0.411984006967387	0.624	0.755	4.69406783514982e-27	ENSA	Malignant cells	GSE186960	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25788
2.31482411536033e-31	0.355645476420139	0.444	0.211	5.15627071696513e-27	PITPNA	Malignant cells	GSE186960	ENSG00000174238	5306	phosphatidylinositol transfer protein alpha	PITPN|VIB1A	protein_coding	Q00169	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25789
2.5771543863595e-31	-0.301570711625434	0.987	0.996	5.7406113956158e-27	NUDC	Malignant cells	GSE186960	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25790
3.01223901375285e-31	0.320154304676407	0.307	0.095	6.70976240313446e-27	RP11-558F24.4	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25791
3.52606018380324e-31	0.297738277903689	0.258	0.06	7.85429905942173e-27	AC027612.6	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25792
3.76777689776138e-31	-0.494161032888015	0.392	0.556	8.39272303976348e-27	CD9	Malignant cells	GSE186960	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25793
3.89365254782575e-31	-0.409176572520463	0.355	0.532	8.67311105028186e-27	SEC14L1	Malignant cells	GSE186960	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25794
3.93087219729931e-31	0.345600301602948	0.404	0.176	8.75601781948421e-27	MARCH5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25795
6.34166658275305e-31	0.3647823338039	0.476	0.241	1.41260623130824e-26	AIG1	Malignant cells	GSE186960	ENSG00000146416	51390	androgen induced 1	AIG-1|dJ95L4.1|FLJ10485	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25796
6.48422045973741e-31	-0.432674943412844	0.334	0.501	1.44436010740651e-26	HAUS1	Malignant cells	GSE186960	ENSG00000152240	115106	HAUS augmin like complex subunit 1	CCDC5|FLJ40084|HEI-C|HsT1461	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25797
6.6689932747766e-31	0.389936465304964	0.695	0.516	1.48551825195649e-26	HCFC1R1	Malignant cells	GSE186960	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25798
6.73990590740854e-31	0.32685014540965	0.337	0.122	1.50131404087525e-26	ISCA1	Malignant cells	GSE186960	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25799
7.20163443843614e-31	0.347837838544014	0.9	0.802	1.60416407116165e-26	SH3BGRL3	Malignant cells	GSE186960	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25800
7.61223807919708e-31	-0.717342829519094	0.584	0.703	1.69562603214115e-26	KRT8	Malignant cells	GSE186960	ENSG00000170421	3856	keratin 8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	protein_coding	P05787	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25801
7.94310492011131e-31	0.326942752345746	0.348	0.128	1.76932662095479e-26	JPX	Malignant cells	GSE186960	ENSG00000225470	554203	JPX transcript, XIST activator	DCBALD06|ENOX|LINC00183|NCRNA00183	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25802
8.57070835903267e-31	0.362976929151018	0.573	0.345	1.90912528697453e-26	MLLT4	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25803
8.65594896911154e-31	0.367982713476133	0.638	0.427	1.9281126328696e-26	USP34	Malignant cells	GSE186960	ENSG00000115464	9736	ubiquitin specific peptidase 34	KIAA0570|KIAA0729	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25804
1.0291017455775e-30	0.357671207654558	0.26	0.062	2.29232413827389e-26	HMOX1	Malignant cells	GSE186960	ENSG00000100292	3162	heme oxygenase 1	bK286B10|HO-1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25805
1.03803596435676e-30	-0.418037371820465	0.291	0.467	2.31222511060469e-26	TIA1	Malignant cells	GSE186960	ENSG00000116001	7072	TIA1 cytotoxic granule associated RNA binding protein	TIA-1	protein_coding	P31483	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25806
1.04803762243118e-30	-0.390168478225949	0.265	0.441	2.33450380396546e-26	AP3B1	Malignant cells	GSE186960	ENSG00000132842	8546	adaptor related protein complex 3 subunit beta 1	ADTB3A|HPS2	protein_coding	O00203	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25807
1.08223333668992e-30	0.360914013913581	0.483	0.252	2.41067475747679e-26	RAB3GAP2	Malignant cells	GSE186960	ENSG00000118873	25782	RAB3 GTPase activating non-catalytic protein subunit 2	DKFZP434D245|KIAA0839|RAB3-GAP150|SPG69	protein_coding	Q9H2M9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25808
1.29774952212988e-30	-0.446861332160087	0.306	0.487	2.8907370605443e-26	CDK6	Malignant cells	GSE186960	ENSG00000105810	1021	cyclin dependent kinase 6	PLSTIRE	protein_coding	Q00534	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25809
1.30003130691062e-30	-0.438311314952051	0.301	0.473	2.89581973614341e-26	TIMELESS	Malignant cells	GSE186960	ENSG00000111602	8914	timeless circadian regulator	hTIM|TIM|TIM1	protein_coding	Q9UNS1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25810
1.31270383193037e-30	-0.420014035946061	0.332	0.501	2.92404778562489e-26	C14orf119	Malignant cells	GSE186960	ENSG00000179933	55017	chromosome 14 open reading frame 119	FLJ20671	protein_coding	Q9NWQ9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25811
1.37469970340422e-30	0.307670255439111	0.339	0.122	3.06214358933291e-26	UBE3C	Malignant cells	GSE186960	ENSG00000009335	9690	ubiquitin protein ligase E3C	KIAA0010|KIAA10	protein_coding	Q15386	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25812
1.4131053010328e-30	0.306980226050917	0.279	0.077	3.14769205805056e-26	NADK2	Malignant cells	GSE186960	ENSG00000152620	133686	NAD kinase 2, mitochondrial	C5orf33|FLJ30596|MNADK|NADKD1	protein_coding	Q4G0N4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25813
1.42846223878343e-30	0.273310402693807	0.999	0.991	3.1818996368901e-26	GNAS	Malignant cells	GSE186960	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25814
1.4757354357072e-30	-0.361765290125067	0.871	0.948	3.28720068303779e-26	PDAP1	Malignant cells	GSE186960	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25815
1.96646897868896e-30	-0.303852585084438	0.139	0.297	4.38030965002966e-26	NFS1	Malignant cells	GSE186960	ENSG00000244005	9054	NFS1 cysteine desulfurase	IscS|NifS	protein_coding	Q9Y697	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25816
2.10849927152117e-30	0.338119668267456	0.438	0.205	4.6966821273134e-26	RNF187	Malignant cells	GSE186960	ENSG00000285426	149603	ring finger protein 187	RACO-1|RACO1	protein_coding	Q5TA31	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25817
2.30568164713436e-30	0.324446823390576	0.334	0.119	5.13590586899179e-26	SEZ6L2	Malignant cells	GSE186960	ENSG00000174938	26470	seizure related 6 homolog like 2	FLJ90517|PSK-1	protein_coding	Q6UXD5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25818
2.41915698631994e-30	-0.450915335268596	0.529	0.665	5.38867218702767e-26	CHORDC1	Malignant cells	GSE186960	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25819
2.7766972681544e-30	-0.39193784356873	0.606	0.741	6.18509316481393e-26	POLE3	Malignant cells	GSE186960	ENSG00000148229	54107	DNA polymerase epsilon 3, accessory subunit	CHARAC17|CHRAC17|CHRAC2|p17|Ybl1	protein_coding	Q9NRF9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25820
2.85880407572543e-30	0.314382496076331	0.315	0.105	6.3679860786784e-26	KDM4A	Malignant cells	GSE186960	ENSG00000066135	9682	lysine demethylase 4A	JHDM3A|JMJD2|JMJD2A|KIAA0677|TDRD14A	protein_coding	O75164	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25821
3.1901613050273e-30	-0.480336904059597	0.428	0.566	7.1060843069483e-26	EBAG9	Malignant cells	GSE186960	ENSG00000147654	9166	estrogen receptor binding site associated antigen 9	EB9|RCAS1	protein_coding	O00559	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25822
3.44274449078055e-30	0.307429670641289	0.273	0.074	7.66871335321368e-26	LINC00963	Malignant cells	GSE186960	ENSG00000204054	NA	NA	MetaLnc9	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25823
4.20413693467629e-30	-0.327039169837786	0.962	0.987	9.36471502199145e-26	SSB	Malignant cells	GSE186960	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25824
4.56938799833901e-30	0.28280098020996	0.25	0.056	1.01783117663001e-25	HABP4	Malignant cells	GSE186960	ENSG00000130956	22927	hyaluronan binding protein 4	IHABP4|SERBP1L	protein_coding	Q5JVS0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25825
4.92243782417038e-30	0.377089025529939	0.74	0.582	1.09647302533395e-25	IARS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25826
5.3722810005886e-30	-0.376707225760627	0.758	0.871	1.19667559288111e-25	DDX18	Malignant cells	GSE186960	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25827
7.57456536411315e-30	-0.426148909796014	0.782	0.895	1.6872344348562e-25	PCNA	Malignant cells	GSE186960	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25828
7.58672513354922e-30	0.379983044731471	0.503	0.271	1.68994302349809e-25	PRR11	Malignant cells	GSE186960	ENSG00000068489	55771	proline rich 11	FLJ11029	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25829
7.99992438170815e-30	-0.458394217046163	0.463	0.6	1.78198315602549e-25	TWISTNB	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25830
9.38109526117588e-30	0.323348233019263	0.334	0.123	2.08963896942693e-25	TCEA2	Malignant cells	GSE186960	ENSG00000171703	6919	transcription elongation factor A2	TFIIS	protein_coding	Q15560	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25831
1.09475714810192e-29	0.371712326780897	0.771	0.636	2.43857154739704e-25	ADH5	Malignant cells	GSE186960	ENSG00000197894	128	alcohol dehydrogenase 5 (class III), chi polypeptide	ADH-3|ADHX|FDH|GSNOR	protein_coding	P11766	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25832
1.09751347309573e-29	-0.485117199018813	0.41	0.562	2.44471126132074e-25	RAB31	Malignant cells	GSE186960	ENSG00000168461	11031	RAB31, member RAS oncogene family	Rab22B	protein_coding	Q13636	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25833
1.17889605634237e-29	0.372474458387096	0.673	0.476	2.62599096550263e-25	EAPP	Malignant cells	GSE186960	ENSG00000129518	55837	E2F associated phosphoprotein	BM036|C14orf11|FLJ20578	protein_coding	Q56P03	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25834
1.22017424191356e-29	0.325446134056554	0.34	0.128	2.71793812386245e-25	CBR4	Malignant cells	GSE186960	ENSG00000145439	84869	carbonyl reductase 4	FLJ14431|SDR45C1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25835
1.30452802960638e-29	0.305395594614601	0.296	0.092	2.90583618594821e-25	PCMTD1	Malignant cells	GSE186960	ENSG00000168300	115294	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1	FLJ10883	protein_coding	Q96MG8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25836
1.40802319006776e-29	0.371171836058178	0.485	0.258	3.13637165587594e-25	LINC00657	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25837
1.41624340018504e-29	-0.428276803421957	0.33	0.499	3.15468217391218e-25	SMIM4	Malignant cells	GSE186960	ENSG00000168273	440957	small integral membrane protein 4	C3orf78	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25838
1.45963313681689e-29	-0.455993111190651	0.543	0.676	3.25133281225962e-25	TOP1	Malignant cells	GSE186960	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25839
1.74544361203557e-29	0.342884598554527	0.426	0.199	3.88797564580923e-25	ZDHHC4	Malignant cells	GSE186960	ENSG00000136247	55146	zinc finger DHHC-type palmitoyltransferase 4	FLJ10479|ZNF374	protein_coding	Q9NPG8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25840
1.75214326416915e-29	-0.422428275367601	0.36	0.524	3.90289912093679e-25	RP11-864N7.2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25841
1.79560293306764e-29	0.333164183431144	0.36	0.145	3.99970553340817e-25	MDM4	Malignant cells	GSE186960	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25842
1.87683940851465e-29	-0.397117640441462	0.316	0.49	4.18065978246638e-25	ERLIN1	Malignant cells	GSE186960	ENSG00000107566	10613	ER lipid raft associated 1	C10orf69|Erlin-1|KE04|SPFH1|SPG62	protein_coding	O75477	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25843
1.91269271978568e-29	-0.446168981309559	0.388	0.549	4.26052303332261e-25	GDI2	Malignant cells	GSE186960	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25844
1.94002970357959e-29	0.368858358940933	0.75	0.602	4.32141616472353e-25	LRPPRC	Malignant cells	GSE186960	ENSG00000138095	10128	leucine rich pentatricopeptide repeat containing	GP130|LRP130|LSFC	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25845
2.0047077005891e-29	0.266285725279887	0.99	0.966	4.46548640306221e-25	TARS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25846
2.02586447459964e-29	0.3377830720438	0.432	0.209	4.51261311717069e-25	YIPF4	Malignant cells	GSE186960	ENSG00000119820	84272	Yip1 domain family member 4	FinGER4|MGC11061	protein_coding	Q9BSR8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25847
2.08002392651669e-29	-0.454349359601579	0.404	0.56	4.63325329631593e-25	C1orf52	Malignant cells	GSE186960	ENSG00000162642	148423	chromosome 1 open reading frame 52	FLJ44982|gm117	protein_coding	Q8N6N3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25848
2.32860435054789e-29	0.363633554333538	0.745	0.583	5.18696619084543e-25	ARF3	Malignant cells	GSE186960	ENSG00000134287	377	ADP ribosylation factor 3	NA	protein_coding	P61204	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25849
2.37462359603599e-29	0.36609150523681	0.696	0.526	5.28947406017016e-25	EIF2S3	Malignant cells	GSE186960	ENSG00000130741	1968	eukaryotic translation initiation factor 2 subunit gamma	EIF2|EIF2G|EIF2gamma	protein_coding	P41091	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25850
2.49083550964167e-29	0.285460749466552	0.283	0.082	5.54833609772682e-25	ZNRF1	Malignant cells	GSE186960	ENSG00000186187	84937	zinc and ring finger 1	DKFZp434E229|FLJ14846|nin283	protein_coding	Q8ND25	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25851
2.71159974872996e-29	0.301871239458851	0.303	0.099	6.04008844029598e-25	WDR74	Malignant cells	GSE186960	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25852
2.86915404581552e-29	0.286556296325934	0.254	0.063	6.39104063705408e-25	CYB561A3	Malignant cells	GSE186960	ENSG00000162144	220002	cytochrome b561 family member A3	CYBASC3	protein_coding	Q8NBI2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25853
2.99656107240185e-29	-0.397067133120401	0.853	0.92	6.67483978877513e-25	CCDC88A	Malignant cells	GSE186960	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25854
3.53354129579624e-29	0.362717598214923	0.573	0.352	7.87096323638612e-25	AKR7A2	Malignant cells	GSE186960	ENSG00000053371	8574	aldo-keto reductase family 7 member A2	AFAR	protein_coding	O43488	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25855
3.62415131078896e-29	0.294256388266463	0.335	0.122	8.07279704478242e-25	STK40	Malignant cells	GSE186960	ENSG00000196182	83931	serine/threonine kinase 40	MGC4796|SgK495	protein_coding	Q8N2I9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25856
3.64217301289581e-29	0.337086443222032	0.495	0.265	8.11294038622541e-25	TRABD	Malignant cells	GSE186960	ENSG00000170638	80305	TraB domain containing	PP2447	protein_coding	Q9H4I3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25857
3.64898798868081e-29	-0.467176588086847	0.48	0.62	8.12812074478651e-25	PTRH2	Malignant cells	GSE186960	ENSG00000141378	51651	peptidyl-tRNA hydrolase 2	BIT1|CFAP37|CGI-147|PTH2	protein_coding	Q9Y3E5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25858
3.70668991813729e-29	-0.414882749927471	0.486	0.63	8.25665179265081e-25	FRA10AC1	Malignant cells	GSE186960	ENSG00000148690	118924	FRA10A associated CGG repeat 1	C10orf4	protein_coding	Q70Z53	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25859
4.30288697093797e-29	0.318614940985911	0.35	0.138	9.58468072776433e-25	AGFG1	Malignant cells	GSE186960	ENSG00000173744	3267	ArfGAP with FG repeats 1	HRB|RAB|RIP	protein_coding	P52594	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25860
4.35867053934529e-29	-0.414406597231347	0.401	0.563	9.70893862639163e-25	PDHB	Malignant cells	GSE186960	ENSG00000168291	5162	pyruvate dehydrogenase E1 subunit beta	E1beta|PDHE1B	protein_coding	P11177	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25861
4.96186638328421e-29	0.284750890328671	0.266	0.072	1.10525573687656e-24	GPT2	Malignant cells	GSE186960	ENSG00000166123	84706	glutamic--pyruvic transaminase 2	ALT2	protein_coding	Q8TD30	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25862
5.21866984252991e-29	0.296406243428366	0.3	0.097	1.16245870742354e-24	AKT1S1	Malignant cells	GSE186960	ENSG00000204673	84335	AKT1 substrate 1	Lobe|MGC2865|PRAS40	protein_coding	Q96B36	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25863
5.32183928496809e-29	0.327688877115069	0.841	0.706	1.18543970072664e-24	CBX5	Malignant cells	GSE186960	ENSG00000094916	23468	chromobox 5	HP1|HP1-ALPHA|HP1Hs-alpha	protein_coding	P45973	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25864
5.40390862945612e-29	0.36750557201137	0.56	0.344	1.20372064721135e-24	ARL1	Malignant cells	GSE186960	ENSG00000120805	400	ADP ribosylation factor like GTPase 1	ARFL1	protein_coding	P40616	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25865
6.26850447576634e-29	0.288107521307378	0.982	0.964	1.39630937197695e-24	SNRPD3	Malignant cells	GSE186960	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25866
6.44824224004557e-29	0.376221736291919	0.882	0.789	1.43634595897015e-24	GOLGB1	Malignant cells	GSE186960	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25867
6.8174979475919e-29	-0.298592123102337	0.179	0.347	1.5185976678261e-24	CARM1	Malignant cells	GSE186960	ENSG00000142453	10498	coactivator associated arginine methyltransferase 1	PRMT4	protein_coding	Q86X55	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25868
6.85062769545242e-29	-0.339302326946351	0.942	0.979	1.52597731916203e-24	TAX1BP1	Malignant cells	GSE186960	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25869
6.86001067193012e-29	0.292590071625726	0.314	0.107	1.52806737717244e-24	PPP2R4	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25870
7.05170961136126e-29	-0.405900474223073	0.898	0.94	1.57076831593072e-24	TYMS	Malignant cells	GSE186960	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25871
7.26777655869392e-29	0.398564768677483	0.497	0.262	1.61889722844907e-24	ID2	Malignant cells	GSE186960	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25872
7.99963106667993e-29	-0.383737618141957	0.337	0.513	1.78191782010295e-24	GEMIN6	Malignant cells	GSE186960	ENSG00000152147	79833	gem nuclear organelle associated protein 6	FLJ23459	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25873
8.21371228948545e-29	0.330486609038879	0.323	0.12	1.82960441248288e-24	CDC42SE1	Malignant cells	GSE186960	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25874
8.37917853170494e-29	0.337745584677583	0.438	0.216	1.86646201793728e-24	MFN1	Malignant cells	GSE186960	ENSG00000171109	55669	mitofusin 1	FLJ20693	protein_coding	Q8IWA4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25875
8.52457678531113e-29	-0.355999720148881	0.798	0.895	1.89884947892805e-24	EWSR1	Malignant cells	GSE186960	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25876
8.64007009968596e-29	0.323747090286129	0.966	0.921	1.92457561470505e-24	P4HB	Malignant cells	GSE186960	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25877
9.22873727393315e-29	-0.387447007035312	0.868	0.936	2.05570122776861e-24	SRSF11	Malignant cells	GSE186960	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25878
9.4812705455853e-29	-0.321968483844726	0.155	0.311	2.11195301402913e-24	WBP1L	Malignant cells	GSE186960	ENSG00000166272	54838	WW domain binding protein 1 like	C10orf26|FLJ20154|OPAL1	protein_coding	Q9NX94	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25879
1.12428564149387e-28	0.311000644910856	0.353	0.142	2.50434626642759e-24	GPS2	Malignant cells	GSE186960	ENSG00000288325	2874	G protein pathway suppressor 2	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25880
1.18125919295211e-28	-0.314409825658818	0.191	0.36	2.63125485230082e-24	SLC20A1	Malignant cells	GSE186960	ENSG00000144136	6574	solute carrier family 20 member 1	Glvr-1|GLVR1|PiT-1|PiT1	protein_coding	Q8WUM9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25881
1.19047986248522e-28	0.299238479489367	0.894	0.792	2.65179389368582e-24	GNB1	Malignant cells	GSE186960	ENSG00000078369	2782	G protein subunit beta 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25882
1.20957110331601e-28	0.328858491355334	0.517	0.281	2.69431963263642e-24	UBLCP1	Malignant cells	GSE186960	ENSG00000164332	134510	ubiquitin like domain containing CTD phosphatase 1	CPUB1|MGC10067	protein_coding	Q8WVY7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25883
1.34573594813176e-28	-0.393622558695411	0.709	0.84	2.99762682446349e-24	RRP15	Malignant cells	GSE186960	ENSG00000067533	51018	ribosomal RNA processing 15 homolog	CGI-115|KIAA0507	protein_coding	Q9Y3B9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25884
1.43343941635383e-28	0.299089359335976	0.291	0.093	3.19298629992815e-24	UHRF1BP1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25885
1.43483478865078e-28	0.284421245950673	0.252	0.064	3.19609449171962e-24	DPH5	Malignant cells	GSE186960	ENSG00000117543	51611	diphthamide biosynthesis 5	CGI-30	protein_coding	Q9H2P9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25886
1.93337469194605e-28	0.270723456532981	0.27	0.074	4.30659212630983e-24	TRIOBP	Malignant cells	GSE186960	ENSG00000100106	11078	TRIO and F-actin binding protein	DFNB28|HRIHFB2122|KIAA1662|TAP68|Tara	protein_coding	Q9H2D6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25887
2.01862030408728e-28	-0.373493739345921	0.606	0.745	4.49647672735441e-24	VIMP	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25888
2.06506120665876e-28	0.304447132376522	0.322	0.117	4.59992383783238e-24	MNT	Malignant cells	GSE186960	ENSG00000070444	4335	MAX network transcriptional repressor	bHLHd3|lncRNA-HAL|MAD6|MXD6|ROX	protein_coding	Q99583	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25889
2.14312346803397e-28	0.372530181971259	0.617	0.428	4.77380752504566e-24	SLC25A33	Malignant cells	GSE186960	ENSG00000171612	84275	solute carrier family 25 member 33	BMSC-MCP|MGC4399|PNC1	protein_coding	Q9BSK2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25890
2.14647144987907e-28	0.376154259877041	0.718	0.557	4.78126515460563e-24	RPA1	Malignant cells	GSE186960	ENSG00000132383	6117	replication protein A1	HSSB|REPA1|RF-A|RP-A|RPA70	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25891
2.2219060213587e-28	-0.426982534895021	0.549	0.673	4.94929566257651e-24	HSPB1	Malignant cells	GSE186960	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25892
2.25388884704858e-28	0.35445670995519	0.608	0.394	5.02053740680071e-24	DNAH14	Malignant cells	GSE186960	ENSG00000185842	127602	dynein axonemal heavy chain 14	C1orf67|DKFZp781B1548|Dnahc14|HL-18|HL18|MGC27277	protein_coding	Q0VDD8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25893
2.34361044130177e-28	0.323096452514066	0.353	0.14	5.22039225799969e-24	AGPAT9	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25894
2.53228165652627e-28	-0.362959663266894	0.277	0.45	5.64065738991227e-24	NAPG	Malignant cells	GSE186960	ENSG00000134265	8774	NSF attachment protein gamma	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25895
2.65977479571192e-28	0.354641316274591	0.747	0.585	5.92464835744831e-24	COPRS	Malignant cells	GSE186960	ENSG00000172301	55352	coordinator of PRMT5 and differentiation stimulator	C17orf79|COPR5|HSA272196|TTP1	protein_coding	Q9NQ92	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25896
2.72151728047524e-28	0.318971983917841	0.386	0.17	6.06217974225861e-24	KBTBD2	Malignant cells	GSE186960	ENSG00000170852	25948	kelch repeat and BTB domain containing 2	BKLHD1|DKFZP566C134	protein_coding	Q8IY47	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25897
2.77640844438977e-28	0.348192230686415	0.881	0.814	6.18444980987822e-24	CHCHD10	Malignant cells	GSE186960	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25898
2.77690280959764e-28	0.342050387171726	0.9	0.834	6.18555100837873e-24	NUDT1	Malignant cells	GSE186960	ENSG00000106268	4521	nudix hydrolase 1	MTH1	protein_coding	P36639	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25899
2.8264736949821e-28	-0.359276152215076	0.745	0.872	6.29597015557263e-24	MRPL32	Malignant cells	GSE186960	ENSG00000106591	64983	mitochondrial ribosomal protein L32	bMRP-59b|HSPC283|L32mt|MRP-L32	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25900
2.85398805347087e-28	0.284555063614234	0.261	0.07	6.35725838910636e-24	PDLIM7	Malignant cells	GSE186960	ENSG00000196923	9260	PDZ and LIM domain 7	ENIGMA	protein_coding	Q9NR12	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25901
2.95323336885999e-28	-0.39235555998973	0.659	0.777	6.57832732913563e-24	DHX9	Malignant cells	GSE186960	ENSG00000135829	1660	DExH-box helicase 9	DDX9|LKP|RHA	protein_coding	Q08211	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25902
2.95636374699973e-28	0.356591602738415	0.497	0.277	6.58530024644189e-24	TFDP2	Malignant cells	GSE186960	ENSG00000114126	7029	transcription factor Dp-2	Dp-2	protein_coding	Q14188	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25903
3.17236612309785e-28	0.356777849038019	0.65	0.438	7.06644553920047e-24	COL18A1	Malignant cells	GSE186960	ENSG00000182871	80781	collagen type XVIII alpha 1 chain	KNO|KNO1|KS	protein_coding	P39060	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25904
3.21822249768318e-28	0.314008331106642	0.453	0.228	7.16859061358929e-24	PURA	Malignant cells	GSE186960	ENSG00000185129	5813	purine rich element binding protein A	PUR-ALPHA|PUR1|PURALPHA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25905
3.22926908319506e-28	0.440793523552571	0.386	0.172	7.19319688281699e-24	APOE	Malignant cells	GSE186960	ENSG00000130203	348	apolipoprotein E	AD2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25906
3.35931536141632e-28	-0.263450363507429	1	1	7.48287496755485e-24	TMSB10	Malignant cells	GSE186960	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25907
3.4596034917442e-28	0.33130961343394	0.486	0.255	7.70626677786021e-24	PRKCSH	Malignant cells	GSE186960	ENSG00000130175	5589	protein kinase C substrate 80K-H	G19P1|GIIB|PCLD|PLD1|VASAP-60	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25908
3.56139785743573e-28	0.325473433439509	0.311	0.109	7.93301372743808e-24	MYPN	Malignant cells	GSE186960	ENSG00000138347	84665	myopalladin	MYOP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25909
3.71900305961955e-28	0.32202998949176	0.437	0.216	8.28407931530255e-24	WDR82	Malignant cells	GSE186960	ENSG00000164091	80335	WD repeat domain 82	MST107|MSTP107|PRO2730|PRO34047|SWD2|TMEM113|WDR82A	protein_coding	Q6UXN9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25910
4.00691356851307e-28	0.305854664374347	0.354	0.143	8.92539997386285e-24	GABPB1-AS1	Malignant cells	GSE186960	ENSG00000244879	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25911
4.10135684272526e-28	0.322357896401948	0.374	0.162	9.13577236717051e-24	AGPAT2	Malignant cells	GSE186960	ENSG00000169692	10555	1-acylglycerol-3-phosphate O-acyltransferase 2	BSCL|LPAAT-beta|LPLAT2	protein_coding	O15120	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25912
4.65180343253852e-28	0.28128326100453	0.303	0.102	1.03618921459796e-23	PNPLA6	Malignant cells	GSE186960	ENSG00000032444	10908	patatin like phospholipase domain containing 6	iPLA2delta|NTE|SPG39|sws	protein_coding	Q8IY17	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25913
4.70145089331528e-28	-0.351833261361826	0.774	0.887	1.04724818648598e-23	POLR2H	Malignant cells	GSE186960	ENSG00000163882	5437	RNA polymerase II, I and III subunit H	RPB8	protein_coding	P52434	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25914
4.97966519855387e-28	-0.266392911731054	0.989	0.994	1.10922042297787e-23	PSMD2	Malignant cells	GSE186960	ENSG00000175166	5708	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	MGC14274|P97|Rpn1|S2|TRAP2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25915
5.02417922645234e-28	0.364709464006043	0.956	0.914	1.11913592269226e-23	ARL6IP1	Malignant cells	GSE186960	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25916
5.12870765208529e-28	0.358048341526608	0.691	0.514	1.142419629502e-23	ETFB	Malignant cells	GSE186960	ENSG00000105379	2109	electron transfer flavoprotein subunit beta	NA	protein_coding	P38117	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25917
6.48360991791517e-28	-0.4017407932978	0.472	0.623	1.4442241092156e-23	LINC00116	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25918
6.83581854803126e-28	-0.327512540254354	0.946	0.987	1.52267858157396e-23	STRA13	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25919
7.04624092304772e-28	-0.41388496647191	0.313	0.479	1.56955016560888e-23	CAPRIN2	Malignant cells	GSE186960	ENSG00000110888	65981	caprin family member 2	C1QDC1|caprin-2|EEG1|FLJ11391|FLJ22569|RNG140	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25920
7.18907460782061e-28	0.286446494228161	0.278	0.086	1.60136636889204e-23	TMEM222	Malignant cells	GSE186960	ENSG00000186501	84065	transmembrane protein 222	C1orf160|DKFZP564D0478	protein_coding	Q9H0R3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25921
7.48729555941324e-28	0.284479436820797	0.279	0.085	1.6677950858593e-23	CFLAR	Malignant cells	GSE186960	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25922
7.75162192056289e-28	0.291936396676647	0.328	0.123	1.72667378280538e-23	DHTKD1	Malignant cells	GSE186960	ENSG00000181192	55526	dehydrogenase E1 and transketolase domain containing 1	CMT2Q|DKFZP762M115|KIAA1630|MGC3090	protein_coding	Q96HY7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25923
7.99387718922704e-28	-0.370737547636971	0.217	0.383	1.78063614390032e-23	CXXC5	Malignant cells	GSE186960	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25924
8.04846184854279e-28	-0.368196901525321	0.283	0.457	1.79279487676291e-23	NPTN	Malignant cells	GSE186960	ENSG00000156642	27020	neuroplastin	GP55|GP65|np55|np65|SDFR1|SDR1	protein_coding	Q9Y639	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25925
8.32267785928321e-28	0.327562109294122	0.39	0.169	1.85387649315533e-23	TMEM156	Malignant cells	GSE186960	ENSG00000121895	80008	transmembrane protein 156	FLJ23235	protein_coding	Q8N614	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25926
8.39000881126595e-28	0.304526581990936	0.379	0.165	1.86887446270949e-23	ZDHHC24	Malignant cells	GSE186960	ENSG00000174165	254359	zinc finger DHHC-type containing 24	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25927
8.46984899830955e-28	0.350140948188711	0.467	0.241	1.88665886437345e-23	GCNT2	Malignant cells	GSE186960	ENSG00000285222	2651	glucosaminyl (N-acetyl) transferase 2 (I blood group)	bA360O19.2|bA421M1.1|CCAT|GCNT5|IGNT|II|NACGT1|NAGCT1|ULG3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25928
9.39853967720151e-28	0.302680408550964	0.294	0.099	2.09352471309664e-23	UHRF1	Malignant cells	GSE186960	ENSG00000276043	29128	ubiquitin like with PHD and ring finger domains 1	FLJ21925|ICBP90|Np95|RNF106|TDRD22	protein_coding	Q96T88	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25929
9.92569365076764e-28	0.382840739183997	0.682	0.504	2.21094826070849e-23	KIF11	Malignant cells	GSE186960	ENSG00000138160	3832	kinesin family member 11	Eg5|HKSP|KNSL1|TRIP5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25930
1.02802237115347e-27	0.313644555707805	0.374	0.162	2.28991983174435e-23	TRIM33	Malignant cells	GSE186960	ENSG00000197323	51592	tripartite motif containing 33	FLJ11429|KIAA1113|PTC7|RFG7|TF1G|TIF1G|TIF1GAMMA|TIFGAMMA	protein_coding	Q9UPN9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25931
1.13548964844739e-27	0.253881943024787	0.994	0.984	2.52930319191655e-23	HMGN1	Malignant cells	GSE186960	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25932
1.14509056774424e-27	0.293819132534473	0.305	0.107	2.55068923965029e-23	SF3A2	Malignant cells	GSE186960	ENSG00000104897	8175	splicing factor 3a subunit 2	Prp11|PRPF11|SAP62|SF3a66	protein_coding	Q15428	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25933
1.15542056238289e-27	-0.407287914996808	0.607	0.721	2.57369930270789e-23	DNAJB11	Malignant cells	GSE186960	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25934
1.19273242188316e-27	0.323033291227704	0.939	0.887	2.65681146974474e-23	ARL2	Malignant cells	GSE186960	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25935
1.22363518520799e-27	-0.370127813966709	0.863	0.944	2.7256473750508e-23	CYB5B	Malignant cells	GSE186960	ENSG00000103018	80777	cytochrome b5 type B	CYB5-M	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25936
1.24265869790004e-27	0.278124979809789	0.285	0.09	2.76802224957235e-23	UBE2W	Malignant cells	GSE186960	ENSG00000104343	55284	ubiquitin conjugating enzyme E2 W	FLJ11011|UBC-16	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25937
1.32028498215767e-27	0.345545712402244	0.764	0.613	2.94093479775622e-23	ERP29	Malignant cells	GSE186960	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25938
1.35502364025971e-27	-0.390855647571648	0.28	0.446	3.0183151586785e-23	NAA25	Malignant cells	GSE186960	ENSG00000111300	80018	N-alpha-acetyltransferase 25, NatB auxiliary subunit	C12orf30|FLJ13089	protein_coding	Q14CX7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25939
1.38236612305469e-27	0.310815797119712	0.897	0.827	3.07922053910433e-23	ELP5	Malignant cells	GSE186960	ENSG00000288485	23587	elongator acetyltransferase complex subunit 5	C17orf81|DERP6	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25940
1.46775216826248e-27	-0.33732241543951	0.194	0.355	3.26941795480467e-23	PMS1	Malignant cells	GSE186960	ENSG00000064933	5378	PMS1 homolog 1, mismatch repair system component	MLH2|PMSL1	protein_coding	P54277	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25941
1.48643553792284e-27	-0.270313201807695	0.121	0.265	3.31103516072314e-23	PPWD1	Malignant cells	GSE186960	ENSG00000113593	23398	peptidylprolyl isomerase domain and WD repeat containing 1	KIAA0073	protein_coding	Q96BP3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25942
1.48679118542243e-27	-0.403466237469964	0.494	0.635	3.31182736552846e-23	TIMM17A	Malignant cells	GSE186960	ENSG00000134375	10440	translocase of inner mitochondrial membrane 17A	TIM17|TIM17A	protein_coding	Q99595	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25943
1.5362497428217e-27	0.317953149238107	0.34	0.13	3.42199630213534e-23	PARP14	Malignant cells	GSE186960	ENSG00000173193	54625	poly(ADP-ribose) polymerase family member 14	ARTD8|BAL2|KIAA1268|pART8	protein_coding	Q460N5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25944
1.5949049412116e-27	-0.297122557367992	0.99	1	3.55265075654883e-23	SNRPG	Malignant cells	GSE186960	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25945
2.09178157228164e-27	0.314336459882922	0.395	0.182	4.65944345225734e-23	HSPA13	Malignant cells	GSE186960	ENSG00000155304	6782	heat shock protein family A (Hsp70) member 13	STCH	protein_coding	P48723	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25946
2.30353135128828e-27	-0.468146514225924	0.379	0.523	5.13111608499465e-23	CDCA5	Malignant cells	GSE186960	ENSG00000146670	113130	cell division cycle associated 5	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25947
2.31094333063886e-27	-0.350627643507162	0.827	0.903	5.14762626899806e-23	EIF6	Malignant cells	GSE186960	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25948
2.3391226856548e-27	0.265439714894164	0.25	0.066	5.21039578229607e-23	RNF139	Malignant cells	GSE186960	ENSG00000170881	11236	ring finger protein 139	HRCA1|RCA1|TRC8	protein_coding	Q8WU17	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25949
2.35812810432917e-27	0.301982638486153	0.291	0.096	5.25273035239324e-23	CDC25C	Malignant cells	GSE186960	ENSG00000158402	995	cell division cycle 25C	CDC25|PPP1R60	protein_coding	P30307	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25950
2.60640527677351e-27	0.27869449870943	0.28	0.087	5.805767754013e-23	ZNF569	Malignant cells	GSE186960	ENSG00000196437	148266	zinc finger protein 569	FLJ32053|ZAP1|Zfp74	protein_coding	Q5MCW4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25951
2.629243824352e-27	-0.439386410516814	0.473	0.607	5.85664061874409e-23	ZNHIT6	Malignant cells	GSE186960	ENSG00000117174	54680	zinc finger HIT-type containing 6	BCD1|C1orf181|FLJ20729|NY-BR-75	protein_coding	Q9NWK9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25952
2.62980800332859e-27	0.291267789646687	0.291	0.096	5.85789732741444e-23	CACHD1	Malignant cells	GSE186960	ENSG00000158966	57685	cache domain containing 1	KIAA1573|VWCD1	protein_coding	Q5VU97	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25953
2.77062906682562e-27	0.329219025520364	0.441	0.221	6.17157624635406e-23	TMEM107	Malignant cells	GSE186960	ENSG00000179029	84314	transmembrane protein 107	JBTS29|MGC10744|MKS13	protein_coding	Q6UX40	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25954
2.94682436026499e-27	-0.438252613307536	0.495	0.626	6.56405126249027e-23	MIEN1	Malignant cells	GSE186960	ENSG00000141741	84299	migration and invasion enhancer 1	C17orf37|C35|MGC14832|ORB3|Rdx12|XTP4	protein_coding	Q9BRT3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25955
3.1181824591074e-27	0.333087477931414	0.269	0.079	6.94575142766174e-23	PLEKHH2	Malignant cells	GSE186960	ENSG00000152527	130271	pleckstrin homology, MyTH4 and FERM domain containing H2	KIAA2028|PLEKHH1L	protein_coding	Q8IVE3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25956
3.13252453133643e-27	-0.439305196639382	0.469	0.602	6.9776983935519e-23	PDCD6IP	Malignant cells	GSE186960	ENSG00000170248	10015	programmed cell death 6 interacting protein	AIP1|Alix|Hp95	protein_coding	Q8WUM4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25957
3.24888319032281e-27	0.290677844948011	0.3	0.105	7.23688730644407e-23	PLD3	Malignant cells	GSE186960	ENSG00000105223	23646	phospholipase D family member 3	HU-K4	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25958
3.31625525544443e-27	0.291590548835245	0.319	0.117	7.38695858150246e-23	FCGRT	Malignant cells	GSE186960	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25959
3.62895871458482e-27	0.317495187815565	0.414	0.199	8.08350553673768e-23	MID1IP1	Malignant cells	GSE186960	ENSG00000165175	58526	MID1 interacting protein 1	FLJ10386|G12-like|MIG12|STRAIT11499|THRSPL	protein_coding	Q9NPA3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25960
4.4195850450927e-27	-0.300700393368924	0.146	0.297	9.84462568794398e-23	ANKRD18B	Malignant cells	GSE186960	ENSG00000230453	441459	ankyrin repeat domain 18B	bA255A11.3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25961
4.47520434925889e-27	-0.321310129574875	0.975	0.991	9.96851768797417e-23	EIF3A	Malignant cells	GSE186960	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25962
4.68261618046642e-27	0.299580618211302	0.38	0.166	1.0430527541989e-22	NFATC2IP	Malignant cells	GSE186960	ENSG00000176953	84901	nuclear factor of activated T cells 2 interacting protein	ESC2|FLJ14639|NIP45|RAD60	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25963
5.3554932659625e-27	0.363376227441537	0.61	0.413	1.19293612499315e-22	TUBGCP5	Malignant cells	GSE186960	ENSG00000280807	114791	tubulin gamma complex associated protein 5	GCP5|KIAA1899	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25964
5.61250075859405e-27	-0.369861948452185	0.603	0.739	1.25018454397683e-22	ISCU	Malignant cells	GSE186960	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25965
5.72729570237095e-27	-0.334529786770122	0.927	0.974	1.27575511770313e-22	TMED9	Malignant cells	GSE186960	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25966
6.58570755012353e-27	0.346471589737898	0.7	0.529	1.46696635679002e-22	ZNF644	Malignant cells	GSE186960	ENSG00000122482	84146	zinc finger protein 644	BM-005|KIAA1221|MGC60165|MGC70410	protein_coding	Q9H582	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25967
6.75469074009659e-27	-0.296682107039159	0.177	0.337	1.50460736235652e-22	RP11-641D5.1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25968
7.23592364633167e-27	0.342469065690416	0.548	0.325	1.61180199222038e-22	CHD3	Malignant cells	GSE186960	ENSG00000170004	1107	chromodomain helicase DNA binding protein 3	Mi-2a|Mi2-ALPHA|ZFH	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25969
8.06437161231471e-27	-0.379682574283056	0.74	0.858	1.7963387766431e-22	MCM3	Malignant cells	GSE186960	ENSG00000112118	4172	minichromosome maintenance complex component 3	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25970
8.34156584023808e-27	-0.485271146624632	0.447	0.586	1.85808379091303e-22	ITGB5	Malignant cells	GSE186960	ENSG00000082781	3693	integrin subunit beta 5	NA	protein_coding	P18084	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25971
8.62439930199451e-27	0.324949853273464	0.446	0.231	1.92108494451928e-22	HIF1A	Malignant cells	GSE186960	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25972
8.84475888710917e-27	-0.331633825460708	0.185	0.344	1.97017004210357e-22	MOSPD1	Malignant cells	GSE186960	ENSG00000101928	56180	motile sperm domain containing 1	dJ473B4	protein_coding	Q9UJG1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25973
9.13760262851579e-27	-0.410669864865395	0.517	0.669	2.03540098550189e-22	ITGA6	Malignant cells	GSE186960	ENSG00000091409	3655	integrin subunit alpha 6	CD49f	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25974
9.19482019165683e-27	-0.315785275696392	0.162	0.314	2.04814619769156e-22	RALB	Malignant cells	GSE186960	ENSG00000144118	5899	RAS like proto-oncogene B	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25975
9.22171187399086e-27	-0.38776916598356	0.339	0.499	2.05413631993146e-22	SEH1L	Malignant cells	GSE186960	ENSG00000085415	81929	SEH1 like nucleoporin	SEC13L|Seh1|SEH1A|SEH1B	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25976
9.34175326403186e-27	0.315520921286615	0.487	0.262	2.0808755395631e-22	GOT2	Malignant cells	GSE186960	ENSG00000125166	2806	glutamic-oxaloacetic transaminase 2	KAT4|KATIV|KYAT4|mitAAT	protein_coding	P00505	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25977
1.0800255856217e-26	0.289028545485905	0.332	0.133	2.40575699197233e-22	HERPUD2	Malignant cells	GSE186960	ENSG00000122557	64224	HERPUD family member 2	FLJ22313	protein_coding	Q9BSE4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25978
1.17178983242575e-26	0.33168836953929	0.469	0.251	2.61016185172835e-22	CDYL	Malignant cells	GSE186960	ENSG00000153046	9425	chromodomain Y like	CDYL1|DKFZP586C1622	protein_coding	Q9Y232	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25979
1.24402459755079e-26	-0.381020820064162	0.818	0.907	2.77106479104439e-22	CD44	Malignant cells	GSE186960	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25980
1.33528640163169e-26	0.326343057450116	0.441	0.235	2.97435045963459e-22	HDGFRP2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25981
1.49656921508915e-26	0.289647747864705	0.336	0.132	3.33360792661109e-22	NBL1	Malignant cells	GSE186960	ENSG00000158747	4681	NBL1, DAN family BMP antagonist	D1S1733E|DAN|DAND1|NB|NO3	protein_coding	P41271	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25982
1.62075212095475e-26	-0.380117331766795	0.341	0.501	3.6102253494267e-22	MPHOSPH6	Malignant cells	GSE186960	ENSG00000135698	10200	M-phase phosphoprotein 6	MPP6	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25983
1.63681244711708e-26	0.333442334557845	0.555	0.335	3.6459997259533e-22	FAM200B	Malignant cells	GSE186960	ENSG00000237765	285550	family with sequence similarity 200 member B	C4orf53	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25984
1.74867897337221e-26	-0.368145682643782	0.702	0.824	3.89518241318659e-22	CMSS1	Malignant cells	GSE186960	ENSG00000184220	84319	cms1 ribosomal small subunit homolog	C3orf26|MGC4308	protein_coding	Q9BQ75	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25985
1.81497001942085e-26	0.303642707689081	0.43	0.212	4.04284571825994e-22	MED13	Malignant cells	GSE186960	ENSG00000108510	9969	mediator complex subunit 13	KIAA0593|THRAP1|TRAP240	protein_coding	Q9UHV7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25986
1.8841929507153e-26	0.327746997682327	0.45	0.236	4.19703979771833e-22	PFKL	Malignant cells	GSE186960	ENSG00000141959	5211	phosphofructokinase, liver type	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25987
1.90578599855108e-26	-0.402379099161325	0.328	0.484	4.24513831177252e-22	MTF2	Malignant cells	GSE186960	ENSG00000143033	22823	metal response element binding transcription factor 2	M96|PCL2|TDRD19A	protein_coding	Q9Y483	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25988
1.9993387710562e-26	0.289155255410686	0.353	0.149	4.45352711252768e-22	UBE4B	Malignant cells	GSE186960	ENSG00000130939	10277	ubiquitination factor E4B	E4|KIAA0684|UBOX3|UFD2	protein_coding	O95155	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25989
2.04221466424175e-26	-0.315455360394463	0.828	0.926	4.54903316459849e-22	ACP1	Malignant cells	GSE186960	ENSG00000143727	52	acid phosphatase 1	HAAP|LMW-PTP|LMWPTP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25990
2.10629627040181e-26	0.281893421395748	0.299	0.107	4.69177494232003e-22	CPT2	Malignant cells	GSE186960	ENSG00000157184	1376	carnitine palmitoyltransferase 2	CPT1|CPTASE	protein_coding	P23786	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25991
2.20941856191661e-26	-0.317630028140684	0.942	0.976	4.92147984666925e-22	ZCRB1	Malignant cells	GSE186960	ENSG00000139168	85437	zinc finger CCHC-type and RNA binding motif containing 1	MADP-1|MADP1|RBM36|SNRNP31|ZCCHC19	protein_coding	Q8TBF4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25992
2.37346612065045e-26	0.285860091060183	0.293	0.103	5.28689578374888e-22	IFNGR1	Malignant cells	GSE186960	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25993
2.40519920139233e-26	-0.348194663205634	0.722	0.835	5.35758122110142e-22	APOA1BP	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25994
2.44829884385782e-26	-0.375135529419354	0.323	0.483	5.4535856746933e-22	FAM96A	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25995
2.46196293423475e-26	-0.322571664309965	0.241	0.405	5.4840224360079e-22	DDX6	Malignant cells	GSE186960	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25996
2.59351087685109e-26	0.369801055105974	0.532	0.318	5.7770454781858e-22	RERE	Malignant cells	GSE186960	ENSG00000142599	473	arginine-glutamic acid dipeptide repeats	ARG|ARP|ATN1L|ATN2|DNB1|KIAA0458	protein_coding	Q9P2R6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25997
2.87810750123089e-26	-0.325686996820493	0.851	0.941	6.4109844589918e-22	UBXN4	Malignant cells	GSE186960	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25998
3.06878749709198e-26	0.27212364593734	0.264	0.08	6.83572414977238e-22	FBXO42	Malignant cells	GSE186960	ENSG00000037637	54455	F-box protein 42	Fbx42|KIAA1332	protein_coding	Q6P3S6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	25999
3.28916761095563e-26	0.297553741214102	0.42	0.208	7.32662085340366e-22	KDM2A	Malignant cells	GSE186960	ENSG00000173120	22992	lysine demethylase 2A	CXXC8|DKFZP434M1735|FBL11|FBL7|FBXL11|FLJ00115|JHDM1A|KIAA1004|LILINA	protein_coding	Q9Y2K7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26000
3.98812529654942e-26	0.323367407932111	0.9	0.842	8.88354909806384e-22	EIF3M	Malignant cells	GSE186960	ENSG00000149100	10480	eukaryotic translation initiation factor 3 subunit M	FLJ29030|GA17|hfl-B5|PCID1|TANGO7	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26001
4.12797213620927e-26	0.283692476462602	0.274	0.089	9.19505793340614e-22	TIMP2	Malignant cells	GSE186960	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26002
4.29395341093922e-26	0.28755749076175	0.325	0.128	9.56478122286712e-22	TBC1D20	Malignant cells	GSE186960	ENSG00000125875	128637	TBC1 domain family member 20	C20orf140|dJ852M4.2	protein_coding	Q96BZ9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26003
4.34776141557732e-26	0.36770267659756	0.737	0.582	9.68463855319849e-22	FGFR1	Malignant cells	GSE186960	ENSG00000077782	2260	fibroblast growth factor receptor 1	BFGFR|CD331|CEK|FLG|FLT2|H2|H3|H4|H5|KAL2|N-SAM	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26004
4.41875121995032e-26	0.308591050966304	0.476	0.252	9.84276834243933e-22	CHD9	Malignant cells	GSE186960	ENSG00000177200	80205	chromodomain helicase DNA binding protein 9	BC022889|FLJ12178|KIAA0308	protein_coding	Q3L8U1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26005
4.51102786814143e-26	0.292542238946387	0.322	0.128	1.0048314576285e-21	PRIM2	Malignant cells	GSE186960	ENSG00000146143	5558	DNA primase subunit 2	PRIM2A	protein_coding	P49643	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26006
4.57531703693762e-26	0.355471508684988	0.689	0.509	1.01915186997785e-21	MAP1B	Malignant cells	GSE186960	ENSG00000131711	4131	microtubule associated protein 1B	MAP5|PPP1R102	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26007
4.81818261641937e-26	0.343290213529933	0.712	0.542	1.07325017780741e-21	CRNDE	Malignant cells	GSE186960	ENSG00000245694	101927480	uncharacterized LOC101927480	CRNDEP|LINC00180|LOC643911	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26008
5.11011938317018e-26	-0.569642510745146	0.326	0.466	1.13827909260116e-21	LIMA1	Malignant cells	GSE186960	ENSG00000050405	51474	LIM domain and actin binding 1	EPLIN	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26009
5.18773619106614e-26	-0.391097492079757	0.504	0.642	1.15556823655998e-21	MCM7	Malignant cells	GSE186960	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26010
5.9955560724117e-26	-0.356473019248313	0.248	0.41	1.33551011512971e-21	ISG20L2	Malignant cells	GSE186960	ENSG00000143319	81875	interferon stimulated exonuclease gene 20 like 2	FLJ12671	protein_coding	Q9H9L3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26011
6.073707997946e-26	0.268953735017518	0.258	0.077	1.35291845654247e-21	SMIM1	Malignant cells	GSE186960	ENSG00000235169	388588	small integral membrane protein 1 (Vel blood group)	Vel	protein_coding	B2RUZ4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26012
6.11928971227961e-26	0.284697333893951	0.941	0.901	1.36307178341028e-21	NDUFB7	Malignant cells	GSE186960	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26013
6.35082590572585e-26	0.323068030010014	0.431	0.213	1.41464647050043e-21	MCAM	Malignant cells	GSE186960	ENSG00000076706	4162	melanoma cell adhesion molecule	CD146|HEMCAM|MelCAM|METCAM|MUC18	protein_coding	P43121	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26014
6.91246691101809e-26	-0.395064685094349	0.191	0.341	1.53975200442928e-21	PLAC8	Malignant cells	GSE186960	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26015
7.02856446690547e-26	0.266050121097849	0.25	0.072	1.56561273500319e-21	REEP4	Malignant cells	GSE186960	ENSG00000168476	80346	receptor accessory protein 4	C8orf20|FLJ22246|FLJ22277|PP432|Yip2c	protein_coding	Q9H6H4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26016
7.32118624100407e-26	-0.321609207070497	0.196	0.355	1.63079423518366e-21	FAM178A	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26017
7.36162794933615e-26	-0.285331342060759	0.999	0.999	1.63980262571463e-21	TCEB2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26018
7.71059918924315e-26	-0.349181281442696	0.223	0.383	1.71753596940391e-21	CWF19L2	Malignant cells	GSE186960	ENSG00000152404	143884	CWF19 like cell cycle control factor 2	FLJ32343	protein_coding	Q2TBE0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26019
7.75398325958845e-26	-0.2649125606737	0.996	0.999	1.72719977107333e-21	S100A10	Malignant cells	GSE186960	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26020
8.44182179676175e-26	0.274443065376627	0.296	0.103	1.88041580522868e-21	FDXR	Malignant cells	GSE186960	ENSG00000161513	2232	ferredoxin reductase	ADR|ADXR	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26021
8.46993071487442e-26	0.327648245384925	0.329	0.139	1.88667706673828e-21	LINC00511	Malignant cells	GSE186960	ENSG00000227036	400619	long intergenic non-protein coding RNA 511	onco-lncRNA-12	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26022
9.29041765833316e-26	0.28624929803898	0.267	0.086	2.06944053339371e-21	RP11-111M22.3	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26023
9.48561772874467e-26	-0.387477692156825	0.357	0.511	2.11292134907788e-21	SREK1	Malignant cells	GSE186960	ENSG00000153914	140890	splicing regulatory glutamic acid and lysine rich protein 1	DKFZp564B176|SFRS12|SRrp508|SRrp86	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26024
1.01159449470524e-25	0.303567356705887	0.387	0.182	2.25332673695592e-21	NUP155	Malignant cells	GSE186960	ENSG00000113569	9631	nucleoporin 155	KIAA0791|N155	protein_coding	O75694	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26025
1.02395167749772e-25	0.28777587567752	0.395	0.185	2.28085236162616e-21	CENPB	Malignant cells	GSE186960	ENSG00000125817	1059	centromere protein B	NA	protein_coding	P07199	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26026
1.0531841610572e-25	-0.340450579247704	0.89	0.953	2.34596771875491e-21	ANP32A	Malignant cells	GSE186960	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26027
1.07461787000446e-25	0.288292655277034	0.362	0.158	2.39371130543493e-21	BAD	Malignant cells	GSE186960	ENSG00000002330	572	BCL2 associated agonist of cell death	BBC2|BCL2L8	protein_coding	Q92934	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26028
1.07479918249435e-25	0.307683465178119	0.466	0.248	2.39411517900617e-21	OARD1	Malignant cells	GSE186960	ENSG00000124596	221443	O-acyl-ADP-ribose deacylase 1	C6orf130|dJ34B21.3|MGC19570|TARG1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26029
1.08107089380972e-25	0.275009746023277	0.281	0.096	2.40808541596116e-21	PTPRS	Malignant cells	GSE186960	ENSG00000105426	5802	protein tyrosine phosphatase receptor type S	NA	protein_coding	Q13332	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26030
1.13535480390525e-25	0.265580097145724	0.272	0.087	2.52900282569894e-21	FAM210B	Malignant cells	GSE186960	ENSG00000124098	116151	family with sequence similarity 210 member B	C20orf108|dJ1167H4.1|DKFZP434A1114	protein_coding	Q96KR6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26031
1.14432820964044e-25	0.261896019295434	0.255	0.074	2.54899108697408e-21	FAM86A	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26032
1.19808524148809e-25	-0.352822553494374	0.599	0.734	2.66873487541472e-21	NDUFA8	Malignant cells	GSE186960	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26033
1.22163300525816e-25	0.274956234588361	0.354	0.152	2.72118751921254e-21	FAM118A	Malignant cells	GSE186960	ENSG00000100376	55007	family with sequence similarity 118 member A	bK268H5.C22.4|C22orf8|FLJ20635	protein_coding	Q9NWS6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26034
1.27865500332835e-25	0.279697828864368	0.311	0.117	2.84820401991389e-21	SH3GL1	Malignant cells	GSE186960	ENSG00000141985	6455	SH3 domain containing GRB2 like 1, endophilin A2	CNSA1|EEN|MGC111371|SH3D2B|SH3P8	protein_coding	Q99961	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26035
1.34963463283175e-25	0.307890602768961	0.395	0.188	3.00631114463272e-21	UBR5	Malignant cells	GSE186960	ENSG00000104517	51366	ubiquitin protein ligase E3 component n-recognin 5	DD5|EDD|EDD1|HYD|KIAA0896	protein_coding	O95071	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26036
1.36227741818738e-25	-0.341418368470539	0.233	0.393	3.03447294901239e-21	HAUS8	Malignant cells	GSE186960	ENSG00000131351	93323	HAUS augmin like complex subunit 8	HICE1|MGC20533|NY-SAR-48	protein_coding	Q9BT25	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26037
1.37920453466179e-25	0.32519704811158	0.683	0.501	3.07217810095914e-21	CHD2	Malignant cells	GSE186960	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26038
1.38995599608624e-25	0.326154430928892	0.488	0.274	3.0961269812821e-21	NCKAP1	Malignant cells	GSE186960	ENSG00000061676	10787	NCK associated protein 1	HEM2|Nap1|NAP125	protein_coding	Q9Y2A7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26039
1.40755683052806e-25	0.310851269129987	0.414	0.206	3.13533284000126e-21	PGM3	Malignant cells	GSE186960	ENSG00000013375	5238	phosphoglucomutase 3	AGM1|DKFZP434B187|PAGM	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26040
1.47609458560398e-25	-0.379801474539356	0.369	0.524	3.28800068943286e-21	EXOSC3	Malignant cells	GSE186960	ENSG00000107371	51010	exosome component 3	CGI-102|hRrp-40|hRrp40p|p10|RRP40|Rrp40p	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26041
1.51095093745934e-25	-0.315706271315938	0.76	0.887	3.36564321319068e-21	DNPH1	Malignant cells	GSE186960	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26042
1.54757661631982e-25	-0.404176497547335	0.703	0.814	3.44722691285241e-21	JAK1	Malignant cells	GSE186960	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26043
1.61884601847261e-25	0.33321896047818	0.446	0.235	3.60597950614775e-21	SLC1A5	Malignant cells	GSE186960	ENSG00000105281	6510	solute carrier family 1 member 5	AAAT|ASCT2|M7V1|RDRC	protein_coding	Q15758	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26044
1.65917800728185e-25	0.267317328196406	0.258	0.077	3.69581901122032e-21	CENPL	Malignant cells	GSE186960	ENSG00000120334	91687	centromere protein L	C1orf155|dJ383J4.3|FLJ31044	protein_coding	Q8N0S6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26045
1.77874298502605e-25	-0.438301064615571	0.395	0.539	3.96214999914553e-21	STAU1	Malignant cells	GSE186960	ENSG00000124214	6780	staufen double-stranded RNA binding protein 1	PPP1R150|STAU	protein_coding	O95793	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26046
1.79271774228414e-25	0.287959325860352	0.308	0.119	3.99327877093791e-21	POFUT1	Malignant cells	GSE186960	ENSG00000101346	23509	protein O-fucosyltransferase 1	FUT12|KIAA0180|O-Fuc-T|O-FUT	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26047
1.97895638454894e-25	0.259729850928418	0.318	0.122	4.40812534658277e-21	UPF1	Malignant cells	GSE186960	ENSG00000005007	5976	UPF1 RNA helicase and ATPase	HUPF1|KIAA0221|NORF1|pNORF1|RENT1|smg-2	protein_coding	Q92900	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26048
2.067711753132e-25	0.327865030885583	0.473	0.262	4.60582793010152e-21	RAD1	Malignant cells	GSE186960	ENSG00000113456	5810	RAD1 checkpoint DNA exonuclease	HRAD1|REC1	protein_coding	O60671	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26049
2.16452487059868e-25	0.344156630556901	0.537	0.33	4.82147914925855e-21	TMEM208	Malignant cells	GSE186960	ENSG00000168701	29100	transmembrane protein 208	hSND2|HSPC171	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26050
2.20714163772031e-25	0.315454048380629	0.36	0.158	4.91640799802199e-21	P4HA1	Malignant cells	GSE186960	ENSG00000122884	5033	prolyl 4-hydroxylase subunit alpha 1	C-P4Halpha(I)|P4HA	protein_coding	P13674	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26051
2.48022611789136e-25	-0.348651178616557	0.285	0.448	5.52470367760301e-21	ATF6	Malignant cells	GSE186960	ENSG00000118217	22926	activating transcription factor 6	ATF6A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26052
2.4971833413306e-25	-0.329491557721938	0.857	0.947	5.56247589281392e-21	BUB3	Malignant cells	GSE186960	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26053
2.49973170984845e-25	-0.37032431106707	0.684	0.782	5.56815238368742e-21	ZC3H13	Malignant cells	GSE186960	ENSG00000123200	23091	zinc finger CCCH-type containing 13	DKFZp434D1812|KIAA0853|Xio	protein_coding	Q5T200	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26054
2.63146933657604e-25	0.327550712260941	0.583	0.385	5.86159794722314e-21	AGTRAP	Malignant cells	GSE186960	ENSG00000177674	57085	angiotensin II receptor associated protein	ATRAP	protein_coding	Q6RW13	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26055
2.72904312776684e-25	0.456321016566043	0.574	0.398	6.07894356710064e-21	NFKBIA	Malignant cells	GSE186960	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26056
2.75520534170491e-25	-0.380524119874401	0.371	0.516	6.13721989864769e-21	NOSIP	Malignant cells	GSE186960	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26057
2.81063839585726e-25	0.335341600577176	0.613	0.418	6.26069702677204e-21	GNAI3	Malignant cells	GSE186960	ENSG00000065135	2773	G protein subunit alpha i3	87U6	protein_coding	P08754	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26058
2.816560306806e-25	-0.25962414476322	0.141	0.287	6.27388808341035e-21	HACL1	Malignant cells	GSE186960	ENSG00000131373	26061	2-hydroxyacyl-CoA lyase 1	2-HPCL|HPCL|PHYH2	protein_coding	Q9UJ83	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26059
2.8239617037655e-25	-0.342808100919362	0.229	0.388	6.29037469513765e-21	IL6ST	Malignant cells	GSE186960	ENSG00000134352	3572	interleukin 6 cytokine family signal transducer	CD130|GP130|IL-6RB|sGP130	protein_coding	P40189	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26060
2.90349299154193e-25	-0.358918065218447	0.261	0.418	6.46753063865964e-21	PPP4R1	Malignant cells	GSE186960	ENSG00000154845	9989	protein phosphatase 4 regulatory subunit 1	PP4R1	protein_coding	Q8TF05	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26061
3.00238511181916e-25	-0.339153964121271	0.672	0.785	6.68781283657718e-21	DAP3	Malignant cells	GSE186960	ENSG00000132676	7818	death associated protein 3	bMRP-10|DAP-3|DKFZp686G12159|MGC126058|MGC126059|MRP-S29|MRPS29	protein_coding	P51398	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26062
3.52568430963196e-25	0.27466570930371	0.268	0.087	7.85346179970519e-21	TRAPPC6A	Malignant cells	GSE186960	ENSG00000007255	79090	trafficking protein particle complex subunit 6A	HSPC289|MGC2650|TRS33	protein_coding	O75865	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26063
3.72917061069212e-25	0.335561783616499	0.765	0.64	8.30672753531671e-21	TSR1	Malignant cells	GSE186960	ENSG00000167721	55720	TSR1 ribosome maturation factor	FLJ10534	protein_coding	Q2NL82	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26064
3.7510907710159e-25	-0.424688641220242	0.823	0.898	8.35555469243792e-21	LYAR	Malignant cells	GSE186960	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26065
3.83132927033491e-25	0.307284751209061	0.353	0.159	8.53428594967101e-21	ATL2	Malignant cells	GSE186960	ENSG00000119787	64225	atlastin GTPase 2	ARL6IP2|atlastin2	protein_coding	Q8NHH9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26066
4.27184809692575e-25	0.321891551885903	0.574	0.37	9.5155416359021e-21	COMMD2	Malignant cells	GSE186960	ENSG00000114744	51122	COMM domain containing 2	HSPC042	protein_coding	Q86X83	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26067
4.30110305316195e-25	0.29183852037949	0.344	0.149	9.58070705091825e-21	KAT7	Malignant cells	GSE186960	ENSG00000136504	11143	lysine acetyltransferase 7	HBO1|HBOA|MYST2|ZC2HC7	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26068
5.15396788407859e-25	-0.354749744082719	0.686	0.777	1.14804634617851e-20	UBE2D3	Malignant cells	GSE186960	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26069
6.49471827548046e-25	-0.272884283184575	0.99	0.999	1.44669849586327e-20	NME1	Malignant cells	GSE186960	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26070
7.18281480347677e-25	-0.258025264671819	0.178	0.335	1.59997199747445e-20	TARBP2	Malignant cells	GSE186960	ENSG00000139546	6895	TARBP2 subunit of RISC loading complex	Trbp	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26071
7.23407385942016e-25	0.288045084591835	0.352	0.156	1.61138995218584e-20	HNRNPUL2	Malignant cells	GSE186960	ENSG00000214753	221092	heterogeneous nuclear ribonucleoprotein U like 2	DKFZp762N1910|HNRPUL2	protein_coding	Q1KMD3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26072
7.61768430524175e-25	-0.35050455050286	0.838	0.926	1.6968391789926e-20	ENAH	Malignant cells	GSE186960	ENSG00000154380	55740	ENAH actin regulator	FLJ10773|MENA|NDPP1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26073
7.65581260720349e-25	0.301693598838165	0.896	0.808	1.70533225825458e-20	COTL1	Malignant cells	GSE186960	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26074
7.69266693334183e-25	-0.367710860903582	0.629	0.742	1.71354155940189e-20	VMA21	Malignant cells	GSE186960	ENSG00000160131	203547	vacuolar ATPase assembly factor VMA21	MEAX|XMEA	protein_coding	Q3ZAQ7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26075
8.17495001802978e-25	-0.388116889660782	0.545	0.675	1.82097011651613e-20	SRSF1	Malignant cells	GSE186960	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26076
8.23808776467369e-25	0.286742734064528	0.411	0.203	1.83503404958106e-20	CLSTN1	Malignant cells	GSE186960	ENSG00000171603	22883	calsyntenin 1	CDHR12|CSTN1|KIAA0911	protein_coding	O94985	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26077
8.85731111892165e-25	0.344657381448133	0.728	0.582	1.9729660517398e-20	ACOT13	Malignant cells	GSE186960	ENSG00000112304	55856	acyl-CoA thioesterase 13	HT012|THEM2	protein_coding	Q9NPJ3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26078
9.57531549956804e-25	-0.412857108224163	0.676	0.772	2.13290152752878e-20	CBR1	Malignant cells	GSE186960	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26079
1.08280090951216e-24	0.326724881919163	0.788	0.662	2.41193902593833e-20	MBNL2	Malignant cells	GSE186960	ENSG00000139793	10150	muscleblind like splicing regulator 2	MBLL|MBLL39	protein_coding	Q5VZF2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26080
1.19145775967828e-24	0.305416163154207	0.472	0.256	2.65397215968336e-20	KCTD20	Malignant cells	GSE186960	ENSG00000112078	222658	potassium channel tetramerization domain containing 20	C6orf69|dJ108K11.3|MGC14254	protein_coding	Q7Z5Y7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26081
1.31214151713889e-24	0.296197772029752	0.364	0.166	2.92279522942689e-20	TYMP	Malignant cells	GSE186960	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26082
1.47906644880186e-24	0.341687552851196	0.631	0.448	3.29462051470615e-20	CENPV	Malignant cells	GSE186960	ENSG00000166582	201161	centromere protein V	CENP-V|p30|PRR6	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26083
1.7389727503786e-24	0.263198835136058	0.297	0.11	3.87356180146834e-20	PLEKHM2	Malignant cells	GSE186960	ENSG00000116786	23207	pleckstrin homology and RUN domain containing M2	KIAA0842	protein_coding	Q8IWE5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26084
1.75402691216103e-24	-0.416845977313757	0.505	0.635	3.90709494683869e-20	COA6	Malignant cells	GSE186960	ENSG00000168275	388753	cytochrome c oxidase assembly factor 6	C1orf31	protein_coding	Q5JTJ3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26085
1.77813605723798e-24	0.285718320201323	0.378	0.176	3.96079806749761e-20	ITPRIPL2	Malignant cells	GSE186960	ENSG00000205730	162073	ITPRIP like 2	FLJ22994|LOC162073|MGC126798|MGC126800	protein_coding	Q3MIP1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26086
1.78663091663592e-24	0.292559048982573	0.957	0.944	3.97972036680652e-20	RNH1	Malignant cells	GSE186960	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26087
1.81691929976572e-24	0.2791457824686	0.323	0.132	4.04718774022815e-20	LATS1	Malignant cells	GSE186960	ENSG00000131023	9113	large tumor suppressor kinase 1	WARTS	protein_coding	O95835	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26088
1.82373986932543e-24	0.307440013432538	0.397	0.198	4.0623805589224e-20	RNF26	Malignant cells	GSE186960	ENSG00000173456	79102	ring finger protein 26	MGC2642	protein_coding	Q9BY78	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26089
1.9653578964036e-24	0.288821467214905	0.367	0.17	4.37783471423901e-20	JOSD1	Malignant cells	GSE186960	ENSG00000100221	9929	Josephin domain containing 1	KIAA0063	protein_coding	Q15040	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26090
2.10911117945969e-24	0.319539208975891	0.569	0.36	4.69804515224646e-20	OSTM1	Malignant cells	GSE186960	ENSG00000081087	28962	osteoclastogenesis associated transmembrane protein 1	GL|HSPC019	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26091
2.19958413206766e-24	0.282828634797291	0.308	0.123	4.89957365418071e-20	SNX24	Malignant cells	GSE186960	ENSG00000064652	28966	sorting nexin 24	SBBI31	protein_coding	Q9Y343	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26092
2.20534460498715e-24	0.280062973749563	0.36	0.165	4.91240510760887e-20	PIK3C2A	Malignant cells	GSE186960	ENSG00000011405	5286	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha	PI3K-C2alpha	protein_coding	O00443	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26093
2.21508108830807e-24	-0.330700912322399	0.664	0.781	4.93409312420622e-20	ARPC5L	Malignant cells	GSE186960	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26094
2.26883425814851e-24	0.283257285532102	0.378	0.179	5.0538283100258e-20	RLIM	Malignant cells	GSE186960	ENSG00000131263	51132	ring finger protein, LIM domain interacting	MGC15161|NY-REN-43|RNF12	protein_coding	Q9NVW2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26095
2.44984675229668e-24	-0.406995586123495	0.395	0.54	5.45703364074084e-20	NOL8	Malignant cells	GSE186960	ENSG00000198000	55035	nucleolar protein 8	C9orf34|FLJ20736|Nop132	protein_coding	Q76FK4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26096
2.47488818803361e-24	0.282294683607174	0.476	0.256	5.51281343884486e-20	MAP9	Malignant cells	GSE186960	ENSG00000164114	79884	microtubule associated protein 9	ASAP|FLJ21159	protein_coding	Q49MG5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26097
2.50008637162689e-24	0.32184485112802	0.661	0.481	5.5689423927989e-20	C20orf27	Malignant cells	GSE186960	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26098
2.50983305407797e-24	0.306456222025931	0.426	0.223	5.59065312795868e-20	MLF1	Malignant cells	GSE186960	ENSG00000178053	4291	myeloid leukemia factor 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26099
2.59303706153445e-24	-0.288906454119516	0.165	0.312	5.77599005456798e-20	KLHL42	Malignant cells	GSE186960	ENSG00000087448	57542	kelch like family member 42	Ctb9|KIAA1340|KLHDC5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26100
2.62213354627439e-24	-0.353563076992671	0.661	0.766	5.8408024743262e-20	NDUFA10	Malignant cells	GSE186960	ENSG00000130414	4705	NADH:ubiquinone oxidoreductase subunit A10	CI-42k	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26101
2.66553474528829e-24	0.316725414738813	0.504	0.295	5.93747864512968e-20	LRP11	Malignant cells	GSE186960	ENSG00000120256	84918	LDL receptor related protein 11	bA350J20.3|MANSC3	protein_coding	Q86VZ4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26102
2.685518890129e-24	0.273287614304984	0.347	0.149	5.98199332776236e-20	B3GAT3	Malignant cells	GSE186960	ENSG00000149541	26229	beta-1,3-glucuronyltransferase 3	GlcAT-I	protein_coding	O94766	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26103
2.71453834377373e-24	0.302241027450687	0.895	0.844	6.04663416075598e-20	U2AF1	Malignant cells	GSE186960	ENSG00000160201	7307	U2 small nuclear RNA auxiliary factor 1	RN|RNU2AF1|U2AF35|U2AFBP	protein_coding	Q01081	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26104
2.73668425027773e-24	-0.411194615909336	0.522	0.64	6.09596416749364e-20	RFC4	Malignant cells	GSE186960	ENSG00000163918	5984	replication factor C subunit 4	A1|RFC37	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26105
2.86067934744303e-24	-0.314680047789637	0.701	0.822	6.37216324642935e-20	DNAJC15	Malignant cells	GSE186960	ENSG00000120675	29103	DnaJ heat shock protein family (Hsp40) member C15	DNAJD1|MCJ	protein_coding	Q9Y5T4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26106
3.0817244905193e-24	0.290950188304478	0.427	0.221	6.86454130263174e-20	THOP1	Malignant cells	GSE186960	ENSG00000172009	7064	thimet oligopeptidase 1	NA	protein_coding	P52888	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26107
3.39943369707887e-24	0.268908074540065	0.296	0.113	7.57223856024319e-20	ERAL1	Malignant cells	GSE186960	ENSG00000132591	26284	Era like 12S mitochondrial rRNA chaperone 1	HERA-B	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26108
3.5173397396686e-24	0.315688776598075	0.54	0.331	7.83487427011181e-20	PES1	Malignant cells	GSE186960	ENSG00000100029	23481	pescadillo ribosomal biogenesis factor 1	NOP7|PES	protein_coding	O00541	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26109
3.55181206812704e-24	0.322052728173627	0.385	0.193	7.91166138175298e-20	ARHGAP32	Malignant cells	GSE186960	ENSG00000134909	9743	Rho GTPase activating protein 32	GC-GAP|GRIT|KIAA0712|MGC1892|RICS	protein_coding	A7KAX9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26110
3.57762874291564e-24	-0.371163290538088	0.569	0.693	7.96916802484458e-20	RAB11A	Malignant cells	GSE186960	ENSG00000103769	8766	RAB11A, member RAS oncogene family	YL8	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26111
3.92914280641863e-24	0.256162041268402	0.28	0.099	8.7521656012975e-20	PIEZO1	Malignant cells	GSE186960	ENSG00000103335	9780	piezo type mechanosensitive ion channel component 1	FAM38A|KIAA0233	protein_coding	Q92508	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26112
3.97896087967471e-24	-0.328979039844335	0.771	0.858	8.86313535947542e-20	GRHPR	Malignant cells	GSE186960	ENSG00000137106	9380	glyoxylate and hydroxypyruvate reductase	GLXR|PH2	protein_coding	Q9UBQ7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26113
4.46998954504784e-24	0.298489245248764	0.428	0.222	9.95690171159406e-20	APOPT1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26114
4.62647468402307e-24	-0.402433774999061	0.447	0.577	1.03054723586614e-19	PDCL3	Malignant cells	GSE186960	ENSG00000115539	79031	phosducin like 3	VIAF1	protein_coding	Q9H2J4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26115
4.71334252363817e-24	0.338472532052568	0.532	0.334	1.0498970471404e-19	MPV17	Malignant cells	GSE186960	ENSG00000115204	4358	mitochondrial inner membrane protein MPV17	SYM1	protein_coding	P39210	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26116
4.99478331807135e-24	-0.431320536408198	0.364	0.506	1.11258798410039e-19	MCM6	Malignant cells	GSE186960	ENSG00000076003	4175	minichromosome maintenance complex component 6	Mis5	protein_coding	Q14566	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26117
5.76936823644179e-24	-0.403388507966426	0.311	0.463	1.28512677466741e-19	PRIM1	Malignant cells	GSE186960	ENSG00000198056	5557	DNA primase subunit 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26118
6.27335844699188e-24	0.368344712603967	0.633	0.448	1.39739059406744e-19	SOX4	Malignant cells	GSE186960	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26119
7.23388809666601e-24	0.278149544198296	0.349	0.155	1.61134857353235e-19	TRIM6	Malignant cells	GSE186960	ENSG00000121236	117854	tripartite motif containing 6	RNF89	protein_coding	Q9C030	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26120
7.83813587311562e-24	-0.342310276538685	0.887	0.933	1.7459447657365e-19	RAD50	Malignant cells	GSE186960	ENSG00000113522	10111	RAD50 double strand break repair protein	hRad50|RAD50-2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26121
8.24708840250315e-24	-0.418630411655403	0.457	0.583	1.83703894165758e-19	TRMT6	Malignant cells	GSE186960	ENSG00000089195	51605	tRNA methyltransferase 6 non-catalytic subunit	CGI-09|GCD10|Gcd10p|MGC5029	protein_coding	Q9UJA5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26122
8.26325263663287e-24	0.329984025321652	0.529	0.331	1.84063952480997e-19	HMGXB4	Malignant cells	GSE186960	ENSG00000100281	10042	HMG-box containing 4	HMG2L1|P53N|THC211630	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26123
8.39120525587357e-24	-0.444287340040246	0.546	0.668	1.86914097074584e-19	CD109	Malignant cells	GSE186960	ENSG00000156535	135228	CD109 molecule	CPAMD7|DKFZp762L1111|FLJ38569	protein_coding	Q6YHK3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26124
8.70188665413703e-24	0.257778559351805	0.295	0.113	1.93834525220902e-19	TRAPPC10	Malignant cells	GSE186960	ENSG00000160218	7109	trafficking protein particle complex subunit 10	EHOC-1|TMEM1|TRS130	protein_coding	P48553	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26125
8.88691318854068e-24	0.256574481629704	0.323	0.132	1.97955991274744e-19	GRPEL2	Malignant cells	GSE186960	ENSG00000164284	134266	GrpE like 2, mitochondrial	DKFZp451C205|FLJ23713|Mt-GrpE#2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26126
9.86792440063551e-24	-0.307949606199835	0.884	0.957	2.19808016024156e-19	NAP1L4	Malignant cells	GSE186960	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26127
9.99282234372256e-24	-0.378955206579916	0.352	0.509	2.2259011770642e-19	CTSC	Malignant cells	GSE186960	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26128
1.01481867082466e-23	0.297320434958971	0.961	0.95	2.26050858926192e-19	CKS2	Malignant cells	GSE186960	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26129
1.01554933792082e-23	0.282529987949781	0.351	0.159	2.26213615021863e-19	RNF19A	Malignant cells	GSE186960	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26130
1.05127662559716e-23	0.282915560029177	0.357	0.165	2.34171868351766e-19	XPO5	Malignant cells	GSE186960	ENSG00000124571	57510	exportin 5	KIAA1291	protein_coding	Q9HAV4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26131
1.14000000296685e-23	0.322771911208171	0.754	0.609	2.53935000660865e-19	SNRPA1	Malignant cells	GSE186960	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26132
1.16673809425337e-23	-0.315105373980393	0.835	0.928	2.59890910494938e-19	C19orf70	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26133
1.20123252702145e-23	-0.311979292797631	0.907	0.973	2.67574545394028e-19	TNNT1	Malignant cells	GSE186960	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26134
1.20177768253027e-23	0.263785356362498	0.328	0.139	2.67695978783618e-19	GATAD1	Malignant cells	GSE186960	ENSG00000157259	57798	GATA zinc finger domain containing 1	FLJ22489|ODAG|RG083M05.2	protein_coding	Q8WUU5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26135
1.59118759379052e-23	0.28364686589415	0.355	0.162	3.54437036516838e-19	ZBTB44	Malignant cells	GSE186960	ENSG00000196323	29068	zinc finger and BTB domain containing 44	BTBD15|HSPC063|ZNF851	protein_coding	Q8NCP5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26136
1.59396045361338e-23	0.318689187461442	0.504	0.302	3.5505469104238e-19	SDCBP	Malignant cells	GSE186960	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26137
1.63534133435415e-23	-0.311859267253182	0.194	0.344	3.64272282227388e-19	FAM217B	Malignant cells	GSE186960	ENSG00000196227	63939	family with sequence similarity 217 member B	C20orf177|dJ551D2.5	protein_coding	Q9NTX9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26138
1.67720633348674e-23	0.292015402530318	0.471	0.265	3.73597710784172e-19	NFYC	Malignant cells	GSE186960	ENSG00000066136	4802	nuclear transcription factor Y subunit gamma	CBF-C|NF-YC	protein_coding	Q13952	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26139
1.77143857327033e-23	-0.254756421694569	0.136	0.274	3.94587942195966e-19	KIN	Malignant cells	GSE186960	ENSG00000151657	22944	Kin17 DNA and RNA binding protein	KIN17|Rts2	protein_coding	O60870	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26140
1.80802928534692e-23	-0.329805989193237	0.206	0.357	4.02738523311026e-19	NRIP3	Malignant cells	GSE186960	ENSG00000175352	56675	nuclear receptor interacting protein 3	C11orf14	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26141
1.83866619357222e-23	0.30251312177104	0.413	0.213	4.09562894618213e-19	HYLS1	Malignant cells	GSE186960	ENSG00000198331	219844	HYLS1 centriolar and ciliogenesis associated	FLJ32915	protein_coding	Q96M11	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26142
1.86415842060761e-23	0.258123012970347	0.3	0.116	4.15241288190346e-19	DIP2B	Malignant cells	GSE186960	ENSG00000066084	57609	disco interacting protein 2 homolog B	FLJ34278|KIAA1463	protein_coding	Q9P265	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26143
1.89263901743375e-23	0.286782173826986	0.334	0.142	4.21585341133368e-19	ULK1	Malignant cells	GSE186960	ENSG00000177169	8408	unc-51 like autophagy activating kinase 1	ATG1|ATG1A	protein_coding	O75385	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26144
1.90966548616633e-23	0.258128369828063	0.282	0.103	4.25377987043549e-19	OSBP	Malignant cells	GSE186960	ENSG00000110048	5007	oxysterol binding protein	OSBP1	protein_coding	P22059	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26145
1.93712912866636e-23	0.291930751987548	0.46	0.255	4.31495513410431e-19	DEGS1	Malignant cells	GSE186960	ENSG00000143753	8560	delta 4-desaturase, sphingolipid 1	DEGS-1|Des-1|DES1|FADS7|MLD	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26146
2.14605984686816e-23	0.31055308294309	0.852	0.779	4.78034830889884e-19	ATP6V1E1	Malignant cells	GSE186960	ENSG00000131100	529	ATPase H+ transporting V1 subunit E1	ATP6E|ATP6E2|ATP6V1E|P31|Vma4	protein_coding	P36543	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26147
2.22907082401633e-23	-0.304553515447956	0.675	0.791	4.96525526049638e-19	ITPA	Malignant cells	GSE186960	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26148
2.24258465677265e-23	-0.369792003157085	0.463	0.6	4.99535732296109e-19	SRPR	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26149
2.3847813587943e-23	0.259750665178297	0.258	0.087	5.3121004767143e-19	LURAP1L	Malignant cells	GSE186960	ENSG00000153714	286343	leucine rich adaptor protein 1 like	bA3L8.2|C9orf150|FLJ38505|LRAP35b|MGC46502	protein_coding	Q8IV03	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26150
2.3966628318154e-23	0.2796133138237	0.436	0.228	5.3385664578688e-19	MYCBP2	Malignant cells	GSE186960	ENSG00000005810	23077	MYC binding protein 2	FLJ10106|KIAA0916|PAM|PHR1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26151
2.56406940971809e-23	0.304988535725225	0.405	0.208	5.71146461014705e-19	CKAP2L	Malignant cells	GSE186960	ENSG00000169607	150468	cytoskeleton associated protein 2 like	FLJ40629|radmis	protein_coding	Q8IYA6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26152
2.56981988560705e-23	-0.355683346186394	0.858	0.927	5.7242737951897e-19	RAB7A	Malignant cells	GSE186960	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26153
2.95439221708852e-23	-0.306390132908757	0.693	0.822	6.58090866356468e-19	SCRN1	Malignant cells	GSE186960	ENSG00000136193	9805	secernin 1	KIAA0193	protein_coding	Q12765	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26154
3.59603374286798e-23	-0.349743744853907	0.679	0.785	8.01016516223842e-19	TCOF1	Malignant cells	GSE186960	ENSG00000070814	6949	treacle ribosome biogenesis factor 1	TCS|treacle	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26155
3.68644630222345e-23	-0.394200398894783	0.486	0.61	8.21155913820273e-19	MBD4	Malignant cells	GSE186960	ENSG00000129071	8930	methyl-CpG binding domain 4, DNA glycosylase	MED1	protein_coding	O95243	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26156
3.71447698784226e-23	0.295476949550365	0.42	0.221	8.27399749041864e-19	FXYD5	Malignant cells	GSE186960	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26157
3.84198123828757e-23	-0.325509971632837	0.295	0.45	8.55801320828555e-19	PDCD2L	Malignant cells	GSE186960	ENSG00000126249	84306	programmed cell death 2 like	MGC13096	protein_coding	Q9BRP1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26158
3.8602435295379e-23	0.273347398503482	0.343	0.156	8.59869246204567e-19	TSNAX	Malignant cells	GSE186960	ENSG00000116918	7257	translin associated factor X	C3PO|TRAX	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26159
4.00531985436159e-23	-0.409156411562173	0.269	0.41	8.92184997559044e-19	WDHD1	Malignant cells	GSE186960	ENSG00000198554	11169	WD repeat and HMG-box DNA binding protein 1	AND-1|CHTF4|CTF4	protein_coding	O75717	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26160
4.60117268331819e-23	0.270169518234589	0.315	0.132	1.02491121520913e-18	FKBP9	Malignant cells	GSE186960	ENSG00000122642	11328	FKBP prolyl isomerase 9	FKBP60|FKBP63	protein_coding	O95302	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26161
4.73930513931651e-23	0.28423479764995	0.339	0.153	1.05568021978275e-18	HMGCL	Malignant cells	GSE186960	ENSG00000117305	3155	3-hydroxy-3-methylglutaryl-CoA lyase	HL	protein_coding	P35914	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26162
5.2278849068552e-23	-0.321697372232784	0.233	0.384	1.164511363002e-18	ZNF195	Malignant cells	GSE186960	ENSG00000005801	7748	zinc finger protein 195	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26163
5.52202573116818e-23	0.259316772912509	0.289	0.112	1.23003123161771e-18	CENPO	Malignant cells	GSE186960	ENSG00000138092	79172	centromere protein O	CENP-O|MGC11266	protein_coding	Q9BU64	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26164
5.56228441306338e-23	0.293420007504064	0.408	0.213	1.23899885300987e-18	HSD17B4	Malignant cells	GSE186960	ENSG00000133835	3295	hydroxysteroid 17-beta dehydrogenase 4	DBP|MFE-2|SDR8C1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26165
5.94964662719679e-23	0.279151162958768	0.373	0.181	1.32528378620809e-18	EPS15	Malignant cells	GSE186960	ENSG00000085832	2060	epidermal growth factor receptor pathway substrate 15	AF-1P|MLLT5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26166
6.0012357979358e-23	0.273245060669438	0.928	0.881	1.3367752739902e-18	IARS2	Malignant cells	GSE186960	ENSG00000067704	55699	isoleucyl-tRNA synthetase 2, mitochondrial	FLJ10326	protein_coding	Q9NSE4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26167
6.07855279003491e-23	0.289061207909008	0.394	0.201	1.35399763398028e-18	GPATCH2	Malignant cells	GSE186960	ENSG00000092978	55105	G-patch domain containing 2	CT110|FLJ10252|GPATC2|Pfa1|PPP1R30	protein_coding	Q9NW75	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26168
6.18904696127431e-23	-0.35877053362419	0.348	0.49	1.37861021062385e-18	RBM22	Malignant cells	GSE186960	ENSG00000086589	55696	RNA binding motif protein 22	Cwc2|FLJ10290|fSAP47|ZC3H16	protein_coding	Q9NW64	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26169
6.52504831224606e-23	0.273632681528726	0.291	0.117	1.45345451155281e-18	STRN	Malignant cells	GSE186960	ENSG00000115808	6801	striatin	PPP2R6A|STRN1	protein_coding	O43815	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26170
6.61312222012923e-23	0.27507514619287	0.432	0.231	1.47307297453379e-18	ZNF770	Malignant cells	GSE186960	ENSG00000198146	54989	zinc finger protein 770	FLJ20582|PRO1914	protein_coding	Q6IQ21	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26171
6.63152095010036e-23	-0.383568988821819	0.416	0.552	1.47717129163486e-18	CENPN	Malignant cells	GSE186960	ENSG00000166451	55839	centromere protein N	BM039|C16orf60|FLJ13607|FLJ22660	protein_coding	Q96H22	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26172
6.92511404311664e-23	0.270160668077756	0.306	0.128	1.54256915310423e-18	ANKFY1	Malignant cells	GSE186960	ENSG00000185722	51479	ankyrin repeat and FYVE domain containing 1	ANKHZN|BTBD23|KIAA1255|RANK-5|ZFYVE14	protein_coding	Q9P2R3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26173
7.28104344462439e-23	0.287253456391157	0.969	0.936	1.62185242729008e-18	ACTN4	Malignant cells	GSE186960	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26174
7.71384967016144e-23	0.258608960272022	0.257	0.089	1.71826001402846e-18	ULK2	Malignant cells	GSE186960	ENSG00000083290	9706	unc-51 like autophagy activating kinase 2	ATG1B|KIAA0623|Unc51.2	protein_coding	Q8IYT8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26175
7.73325976700048e-23	-0.259627664459038	0.146	0.284	1.72258361309936e-18	USP4	Malignant cells	GSE186960	ENSG00000114316	7375	ubiquitin specific peptidase 4	UNP|Unph	protein_coding	Q13107	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26176
8.0824423760285e-23	0.251658979710269	0.323	0.136	1.80036403926035e-18	MAP3K10	Malignant cells	GSE186960	ENSG00000130758	4294	mitogen-activated protein kinase kinase kinase 10	MEKK10|MLK2|MST	protein_coding	Q02779	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26177
8.17839717191829e-23	0.277016871389587	0.851	0.755	1.8217379700448e-18	CEBPG	Malignant cells	GSE186960	ENSG00000153879	1054	CCAAT enhancer binding protein gamma	GPE1BP|IG/EBP-1	protein_coding	P53567	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26178
8.44559069477567e-23	0.326267339820349	0.565	0.372	1.88125532726128e-18	SDHC	Malignant cells	GSE186960	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26179
8.81388939382006e-23	0.298122304302018	0.473	0.269	1.96329386247342e-18	GRN	Malignant cells	GSE186960	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26180
9.29405745126531e-23	0.297755946868473	0.489	0.282	2.07025129726935e-18	RDH11	Malignant cells	GSE186960	ENSG00000072042	51109	retinol dehydrogenase 11	ARSDR1|MDT1|SDR7C1	protein_coding	Q8TC12	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26181
9.8385104258032e-23	0.27220136994262	0.412	0.213	2.19152819734766e-18	RYK	Malignant cells	GSE186960	ENSG00000163785	6259	receptor like tyrosine kinase	D3S3195|JTK5|JTK5A|RYK1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26182
9.92567548222035e-23	0.287757635528976	0.715	0.552	2.21094421366458e-18	RAD23B	Malignant cells	GSE186960	ENSG00000119318	5887	RAD23 homolog B, nucleotide excision repair protein	HHR23B|HR23B|P58	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26183
1.02744958032452e-22	0.310452733853874	0.647	0.481	2.28864394017287e-18	FLII	Malignant cells	GSE186960	ENSG00000284571	2314	FLII actin remodeling protein	FLI|Fli1|FLIL|MGC39265	protein_coding	Q13045	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26184
1.04902438323901e-22	-0.287707832180702	0.198	0.345	2.33670181366489e-18	GLT8D1	Malignant cells	GSE186960	ENSG00000016864	55830	glycosyltransferase 8 domain containing 1	AD-017|FLJ14611	protein_coding	Q68CQ7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26185
1.05214170231994e-22	0.268301133935218	0.312	0.132	2.34364564191766e-18	LYRM5	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26186
1.05363814386217e-22	-0.400110275266547	0.475	0.593	2.34697896545299e-18	PRPS1	Malignant cells	GSE186960	ENSG00000147224	5631	phosphoribosyl pyrophosphate synthetase 1	CMTX5|DFN2|DFNX1|PPRibP|PRS-I	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26187
1.06596333696269e-22	0.267524714663147	0.295	0.12	2.37443333308439e-18	NT5C2	Malignant cells	GSE186960	ENSG00000076685	22978	5'-nucleotidase, cytosolic II	cN-II|GMP|NT5B|PNT5|SPG45|SPG65	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26188
1.08133953872108e-22	-0.282611442309564	0.184	0.33	2.4086838225012e-18	FAM126A	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26189
1.10546557707065e-22	0.256210032401339	0.319	0.135	2.46242457292488e-18	FAM45A	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26190
1.20666530353964e-22	0.303428295060313	0.489	0.289	2.68784696363456e-18	SCO1	Malignant cells	GSE186960	ENSG00000133028	6341	synthesis of cytochrome C oxidase 1	SCOD1	protein_coding	O75880	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26191
1.24519782181518e-22	0.306147152905034	0.524	0.319	2.77367814809331e-18	SNX2	Malignant cells	GSE186960	ENSG00000205302	6643	sorting nexin 2	NA	protein_coding	O60749	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26192
1.25670335439011e-22	0.262969801334611	0.302	0.123	2.79930672190398e-18	ZNF260	Malignant cells	GSE186960	ENSG00000254004	339324	zinc finger protein 260	ozrf1|Zfp260	protein_coding	Q3ZCT1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26193
1.43348648867186e-22	0.314394061313922	0.487	0.288	3.19309115351657e-18	ARL4A	Malignant cells	GSE186960	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26194
1.56806539756397e-22	-0.394679549586969	0.396	0.526	3.49286567307374e-18	SMARCC2	Malignant cells	GSE186960	ENSG00000139613	6601	SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2	BAF170|CRACC2|Rsc8	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26195
1.59454112793591e-22	0.30101454274406	0.49	0.292	3.55184036247723e-18	PEMT	Malignant cells	GSE186960	ENSG00000133027	10400	phosphatidylethanolamine N-methyltransferase	PEMPT|PEMT2	protein_coding	Q9UBM1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26196
1.67364343557851e-22	0.250141880291832	0.28	0.106	3.72804075275113e-18	PKP3	Malignant cells	GSE186960	ENSG00000184363	11187	plakophilin 3	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26197
1.72042847869137e-22	0.258648681939784	0.337	0.15	3.83225443628504e-18	TNKS2	Malignant cells	GSE186960	ENSG00000107854	80351	tankyrase 2	ARTD6|PARP-5b|PARP-5c|PARP5B|PARP5C|pART6|TANK2|TNKL	protein_coding	Q9H2K2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26198
1.7681603453242e-22	0.415914156594263	0.71	0.58	3.93857716920965e-18	ANXA1	Malignant cells	GSE186960	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26199
1.78277007628725e-22	0.28447964277517	0.45	0.245	3.97112034492984e-18	MTO1	Malignant cells	GSE186960	ENSG00000135297	25821	mitochondrial tRNA translation optimization 1	NA	protein_coding	Q9Y2Z2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26200
1.97097421327913e-22	0.276417067644233	0.414	0.219	4.39034506007926e-18	CHCHD3	Malignant cells	GSE186960	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26201
1.99736044450283e-22	0.273050429306379	0.321	0.14	4.44912039013006e-18	ZBED5	Malignant cells	GSE186960	ENSG00000236287	58486	zinc finger BED-type containing 5	Buster1	protein_coding	Q49AG3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26202
2.03901610900357e-22	-0.280163139167927	0.983	0.991	4.54190838280546e-18	U2SURP	Malignant cells	GSE186960	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26203
2.05323789175284e-22	-0.422385558420993	0.346	0.483	4.57358740387945e-18	SVIP	Malignant cells	GSE186960	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26204
2.06294256321006e-22	-0.296762158377173	0.905	0.961	4.59520455955042e-18	FXR1	Malignant cells	GSE186960	ENSG00000114416	8087	FMR1 autosomal homolog 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26205
2.07806186400349e-22	0.299770647673984	0.473	0.278	4.62888280206776e-18	AP2A2	Malignant cells	GSE186960	ENSG00000280759	161	adaptor related protein complex 2 subunit alpha 2	ADTAB|CLAPA2|DKFZP564D1864|HIP9|HYPJ|KIAA0899	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26206
2.32417943117073e-22	0.303480668562559	0.439	0.248	5.1771096829328e-18	MGMT	Malignant cells	GSE186960	ENSG00000170430	4255	O-6-methylguanine-DNA methyltransferase	NA	protein_coding	P16455	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26207
2.36617291404291e-22	-0.250582297679037	0.984	1	5.27065016603057e-18	GADD45GIP1	Malignant cells	GSE186960	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26208
2.68661554358218e-22	0.258699535976438	0.977	0.958	5.98443612332929e-18	NOL7	Malignant cells	GSE186960	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26209
2.77742441027779e-22	-0.355009217800871	0.74	0.828	6.18671287389377e-18	GRPEL1	Malignant cells	GSE186960	ENSG00000109519	80273	GrpE like 1, mitochondrial	FLJ25609|GrpE|hMGE	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26210
2.79045470104409e-22	0.294348103520918	0.704	0.542	6.21573784657572e-18	CRCP	Malignant cells	GSE186960	ENSG00000241258	27297	CGRP receptor component	C17|CGRP-RCP|POLR3I|RCP|RCP9	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26211
2.83623099604687e-22	0.254899369644038	0.335	0.149	6.3177045436944e-18	MED30	Malignant cells	GSE186960	ENSG00000164758	90390	mediator complex subunit 30	THRAP6|TRAP25	protein_coding	Q96HR3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26212
3.11258372188364e-22	0.274057794770311	0.409	0.215	6.9332802404958e-18	GTF2H3	Malignant cells	GSE186960	ENSG00000111358	2967	general transcription factor IIH subunit 3	BTF2|P34|TFIIH	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26213
3.24736343484203e-22	-0.33501027226269	0.584	0.713	7.23350205111062e-18	MPHOSPH10	Malignant cells	GSE186960	ENSG00000124383	10199	M-phase phosphoprotein 10	CT90|MPP10|MPP10P|PPP1R106	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26214
3.32474103690324e-22	0.27489144811273	0.326	0.146	7.40586065970196e-18	CMBL	Malignant cells	GSE186960	ENSG00000164237	134147	carboxymethylenebutenolidase homolog	FLJ23617	protein_coding	Q96DG6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26215
3.4124009840929e-22	0.32452395208807	0.64	0.468	7.60112319206692e-18	DDX43	Malignant cells	GSE186960	ENSG00000080007	55510	DEAD-box helicase 43	CT13|DKFZp434H2114|HAGE	protein_coding	Q9NXZ2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26216
3.61068894130336e-22	0.314787986957125	0.804	0.718	8.04280961675324e-18	NDUFB5	Malignant cells	GSE186960	ENSG00000136521	4711	NADH:ubiquinone oxidoreductase subunit B5	CI-SGDH|MGC12314|SGDH	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26217
4.11831679994048e-22	0.250299643427291	0.276	0.106	9.17355067186741e-18	ATXN3	Malignant cells	GSE186960	ENSG00000066427	4287	ataxin 3	ATX3|JOS|MJD|SCA3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26218
4.12273579573045e-22	-0.285853771281047	0.789	0.907	9.18339398498957e-18	HIGD2A	Malignant cells	GSE186960	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26219
4.12775171878911e-22	0.270114119372298	0.334	0.152	9.19456695360275e-18	BEND6	Malignant cells	GSE186960	ENSG00000151917	221336	BEN domain containing 6	bA203B9.1|C6orf65|FLJ30162	protein_coding	Q5SZJ8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26220
4.26223140005632e-22	-0.345386320165713	0.958	0.968	9.49412044362546e-18	CD63	Malignant cells	GSE186960	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26221
4.40364416116322e-22	-0.308962886272177	0.241	0.39	9.80911736899108e-18	C12orf43	Malignant cells	GSE186960	ENSG00000157895	64897	chromosome 12 open reading frame 43	Custos|FLJ12448	protein_coding	Q96C57	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26222
4.4661924180325e-22	-0.314989705030798	0.195	0.335	9.9484436111674e-18	ATP11A	Malignant cells	GSE186960	ENSG00000068650	23250	ATPase phospholipid transporting 11A	ATPIH|ATPIS|KIAA1021	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26223
4.55284832231227e-22	0.254366209211156	0.265	0.097	1.01414696379506e-17	SNHG14	Malignant cells	GSE186960	ENSG00000224078	NA	NA	NCRNA00214|UBE3A-AS|UBE3A-AS1|UBE3A-ATS	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26224
4.66510448642837e-22	-0.325675860102151	0.645	0.765	1.03915202435192e-17	UXT	Malignant cells	GSE186960	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26225
4.8739105144474e-22	-0.330847871806428	0.581	0.708	1.08566356709316e-17	TMCO1	Malignant cells	GSE186960	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26226
4.88998193539038e-22	0.34646359204963	0.575	0.403	1.08924347610821e-17	HTATIP2	Malignant cells	GSE186960	ENSG00000109854	10553	HIV-1 Tat interactive protein 2	CC3|FLJ26963|SDR44U1|TIP30	protein_coding	Q9BUP3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26227
4.98369018732357e-22	0.271133664377902	0.357	0.172	1.11011698922632e-17	PRKACB	Malignant cells	GSE186960	ENSG00000142875	5567	protein kinase cAMP-activated catalytic subunit beta	PKACb	protein_coding	P22694	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26228
5.09717339229379e-22	0.276760648270027	0.428	0.229	1.13539537313344e-17	TAB2	Malignant cells	GSE186960	ENSG00000055208	23118	TGF-beta activated kinase 1 (MAP3K7) binding protein 2	KIAA0733|MAP3K7IP2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26229
6.08303500943247e-22	0.309857356939024	0.502	0.309	1.35499604835108e-17	CISD2	Malignant cells	GSE186960	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26230
6.11959265925697e-22	-0.319564694165422	0.764	0.857	1.36313926484949e-17	CAST	Malignant cells	GSE186960	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26231
6.28585613183009e-22	-0.348779659350124	0.373	0.516	1.40017445336515e-17	TIMM23	Malignant cells	GSE186960	ENSG00000265354	100287932	translocase of inner mitochondrial membrane 23	TIM23	protein_coding	O14925	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26232
6.4082853990239e-22	0.262000299600655	0.321	0.143	1.42744557263257e-17	DPP9	Malignant cells	GSE186960	ENSG00000142002	91039	dipeptidyl peptidase 9	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26233
6.41789501027936e-22	-0.309933322389027	0.898	0.956	1.42958611353973e-17	UBE2K	Malignant cells	GSE186960	ENSG00000078140	3093	ubiquitin conjugating enzyme E2 K	HIP2|HYPG|UBC1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26234
6.75187127436475e-22	0.280173057912141	0.433	0.234	1.50397932636475e-17	SERPINH1	Malignant cells	GSE186960	ENSG00000149257	871	serpin family H member 1	CBP1|CBP2|HSP47|SERPINH2	protein_coding	P50454	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26235
6.9379307935057e-22	0.270911275380032	0.934	0.9	1.54542408425339e-17	UBE2I	Malignant cells	GSE186960	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26236
7.3450396351162e-22	0.257861259197054	0.319	0.14	1.63610757872213e-17	JMJD8	Malignant cells	GSE186960	ENSG00000161999	339123	jumonji domain containing 8	C16orf20	protein_coding	Q96S16	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26237
7.69322584185069e-22	0.259180065230969	0.392	0.198	1.71366605627224e-17	SLC39A1	Malignant cells	GSE186960	ENSG00000143570	27173	solute carrier family 39 member 1	ZIP1|ZIRTL	protein_coding	Q9NY26	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26238
7.89067464377596e-22	-0.338329642235514	0.258	0.403	1.7576477769011e-17	LARP1B	Malignant cells	GSE186960	ENSG00000138709	55132	La ribonucleoprotein 1B	DKFZp434K245|DKFZp686E0316|FLJ10378|LARP2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26239
8.25858238297058e-22	0.261420961355683	0.388	0.193	1.8395992258067e-17	STXBP3	Malignant cells	GSE186960	ENSG00000116266	6814	syntaxin binding protein 3	UNC-18C	protein_coding	O00186	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26240
8.86163647848293e-22	0.302230909143073	0.548	0.36	1.97392952558207e-17	TXNDC9	Malignant cells	GSE186960	ENSG00000115514	10190	thioredoxin domain containing 9	APACD	protein_coding	O14530	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26241
9.1110387303159e-22	-0.301291116008431	0.209	0.354	2.02948387717787e-17	EED	Malignant cells	GSE186960	ENSG00000074266	8726	embryonic ectoderm development	HEED|WAIT-1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26242
9.13267850456618e-22	0.269402630046878	0.371	0.185	2.03430413689212e-17	TP53I13	Malignant cells	GSE186960	ENSG00000167543	90313	tumor protein p53 inducible protein 13	DSCP1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26243
9.51946782915356e-22	-0.372527350690853	0.636	0.728	2.12046145894395e-17	LTV1	Malignant cells	GSE186960	ENSG00000135521	84946	LTV1 ribosome biogenesis factor	C6orf93|dJ468K18.4|FLJ14909	protein_coding	Q96GA3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26244
1.06106279244688e-21	-0.384007818764327	0.445	0.569	2.36351737017542e-17	USP8	Malignant cells	GSE186960	ENSG00000138592	9101	ubiquitin specific peptidase 8	HumORF8|KIAA0055|SPG59|UBPY	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26245
1.11069315608582e-21	-0.352171588362411	0.572	0.686	2.47406900518116e-17	CTSB	Malignant cells	GSE186960	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26246
1.13473252252122e-21	0.270453942319042	0.431	0.236	2.52761669391601e-17	FGD5-AS1	Malignant cells	GSE186960	ENSG00000225733	100505641	FGD5 antisense RNA 1	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26247
1.13579392354239e-21	0.273064544608818	0.393	0.203	2.52998096469066e-17	NPRL3	Malignant cells	GSE186960	ENSG00000103148	8131	NPR3 like, GATOR1 complex subunit	C16orf35|CGTHBA|HS-40|MARE|NPR3|RMD11	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26248
1.13649068428206e-21	-0.383213973881965	0.401	0.534	2.53153299923829e-17	SAFB2	Malignant cells	GSE186960	ENSG00000130254	9667	scaffold attachment factor B2	KIAA0138	protein_coding	Q14151	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26249
1.18842983547077e-21	0.274319480729225	0.304	0.13	2.64722745851115e-17	MVD	Malignant cells	GSE186960	ENSG00000167508	4597	mevalonate diphosphate decarboxylase	MPD	protein_coding	P53602	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26250
1.25622630987736e-21	0.324074236838685	0.654	0.487	2.79824410525181e-17	SQLE	Malignant cells	GSE186960	ENSG00000104549	6713	squalene epoxidase	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26251
1.40142802740538e-21	0.265492443003772	0.408	0.213	3.12168093104548e-17	HRSP12	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26252
1.41302017934359e-21	-0.351304504555769	0.791	0.875	3.14750244948785e-17	ACTN1	Malignant cells	GSE186960	ENSG00000072110	87	actinin alpha 1	NA	protein_coding	P12814	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26253
1.45583392051473e-21	0.29752861159652	0.892	0.832	3.24287005794655e-17	CCNB1	Malignant cells	GSE186960	ENSG00000134057	891	cyclin B1	CCNB	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26254
1.47395019128359e-21	-0.35424458790358	0.382	0.521	3.2832240510842e-17	TOX4	Malignant cells	GSE186960	ENSG00000092203	9878	TOX high mobility group box family member 4	C14orf92|KIAA0737|LCP1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26255
1.59269990990339e-21	-0.280584463353772	0.186	0.33	3.54773904930981e-17	WLS	Malignant cells	GSE186960	ENSG00000116729	79971	Wnt ligand secretion mediator	C1orf139|EVI|FLJ23091|GPR177|mig-14|MRP	protein_coding	Q5T9L3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26256
1.60573943225866e-21	0.290141163824512	0.705	0.557	3.57678458535616e-17	LAPTM4B	Malignant cells	GSE186960	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26257
1.69847044962267e-21	0.279822683656467	0.415	0.226	3.78334292653451e-17	YIPF5	Malignant cells	GSE186960	ENSG00000145817	81555	Yip1 domain family member 5	FinGER5|SMAP-5	protein_coding	Q969M3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26258
1.85366849987357e-21	0.30505491726232	0.666	0.506	4.12904658346837e-17	TMEM230	Malignant cells	GSE186960	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26259
1.86297646171473e-21	0.288299615691819	0.884	0.815	4.14978006846955e-17	PPA1	Malignant cells	GSE186960	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26260
1.96384690387235e-21	0.257242341155374	0.254	0.09	4.37446897837567e-17	TM7SF2	Malignant cells	GSE186960	ENSG00000149809	7108	transmembrane 7 superfamily member 2	ANG1|DHCR14A|NET47	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26261
2.07010703768022e-21	0.284137474504081	0.645	0.46	4.61116342643269e-17	CSNK1E	Malignant cells	GSE186960	ENSG00000213923	1454	casein kinase 1 epsilon	CKIE|CKIepsilon|HCKIE	protein_coding	P49674	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26262
2.16500627756188e-21	0.297586407274475	0.478	0.282	4.82255148326909e-17	QSER1	Malignant cells	GSE186960	ENSG00000060749	79832	glutamine and serine rich 1	FLJ21924	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26263
2.17809651926167e-21	0.303324356024685	0.674	0.511	4.85170999665536e-17	FIBP	Malignant cells	GSE186960	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26264
2.20304282992743e-21	0.250465460071881	0.299	0.126	4.90727790366334e-17	SBF2-AS1	Malignant cells	GSE186960	ENSG00000246273	283104	SBF2 antisense RNA 1	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26265
2.20861336905461e-21	0.283656285453765	0.831	0.738	4.91968627956914e-17	NONO	Malignant cells	GSE186960	ENSG00000147140	4841	non-POU domain containing octamer binding	NMT55|NRB54|P54|P54NRB|PPP1R114	protein_coding	Q15233	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26266
2.30621995740159e-21	0.272558485648339	0.928	0.891	5.13710495511205e-17	CCT8	Malignant cells	GSE186960	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26267
2.43068091406109e-21	-0.327855998098103	0.544	0.665	5.41434173607107e-17	CSNK1D	Malignant cells	GSE186960	ENSG00000141551	1453	casein kinase 1 delta	CKID|CKIdelta|HCKID	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26268
2.43302988136837e-21	-0.255099136611701	0.988	0.997	5.41957406074804e-17	BTF3	Malignant cells	GSE186960	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26269
2.68009969766588e-21	0.255049769809238	0.29	0.119	5.96992207655074e-17	KLF10	Malignant cells	GSE186960	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26270
2.68144395465955e-21	-0.372029646528575	0.452	0.572	5.97291640900416e-17	RSRC1	Malignant cells	GSE186960	ENSG00000174891	51319	arginine and serine rich coiled-coil 1	BM-011|MGC12197|SFRS21|SRrp53	protein_coding	Q96IZ7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26271
2.70279610411482e-21	0.296585756294788	0.427	0.234	6.02047832191577e-17	WARS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26272
2.72393899492251e-21	0.27602608635477	0.357	0.176	6.0675741111899e-17	PTPRK	Malignant cells	GSE186960	ENSG00000273993	5796	protein tyrosine phosphatase receptor type K	R-PTP-kappa	protein_coding	Q15262	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26273
2.95433474330768e-21	0.256020074589521	0.372	0.185	6.58078064071785e-17	NUP188	Malignant cells	GSE186960	ENSG00000095319	23511	nucleoporin 188	KIAA0169	protein_coding	Q5SRE5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26274
2.99666710393445e-21	0.321197250727679	0.464	0.274	6.67507597401398e-17	COMMD3	Malignant cells	GSE186960	ENSG00000148444	23412	COMM domain containing 3	BUP|C10orf8	protein_coding	Q9UBI1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26275
3.37622456455463e-21	0.260800540706628	0.326	0.148	7.52054021754545e-17	MYO1E	Malignant cells	GSE186960	ENSG00000157483	4643	myosin IE	HuncM-IC|MGC104638|MYO1C	protein_coding	Q12965	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26276
4.15460755042852e-21	-0.276283343804674	0.187	0.328	9.25438831857954e-17	AEBP2	Malignant cells	GSE186960	ENSG00000139154	121536	AE binding protein 2	MGC17922	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26277
4.50107329446786e-21	-0.306322694627124	0.79	0.871	1.00261407634272e-16	CHCHD1	Malignant cells	GSE186960	ENSG00000172586	118487	coiled-coil-helix-coiled-coil-helix domain containing 1	C10orf34|FLJ25854	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26278
4.66275129431721e-21	0.34263465067357	0.753	0.665	1.03862785080916e-16	UBE2C	Malignant cells	GSE186960	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26279
4.9989654018404e-21	-0.340601074149921	0.295	0.44	1.11351954325995e-16	PGRMC2	Malignant cells	GSE186960	ENSG00000164040	10424	progesterone receptor membrane component 2	DG6|PMBP	protein_coding	O15173	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26280
5.25045044411434e-21	-0.292247139169476	0.791	0.888	1.16953783642647e-16	UQCRC1	Malignant cells	GSE186960	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26281
5.67824466318213e-21	0.277675608218774	0.705	0.553	1.26482899872382e-16	EMC7	Malignant cells	GSE186960	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26282
6.22985244174201e-21	0.253441178633604	0.357	0.175	1.38769963139803e-16	CAD	Malignant cells	GSE186960	ENSG00000084774	790	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	GATD4	protein_coding	P27708	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26283
6.69470448836547e-21	0.262203208424532	0.402	0.212	1.49124542478341e-16	C15orf40	Malignant cells	GSE186960	ENSG00000169609	123207	chromosome 15 open reading frame 40	MGC29937	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26284
7.00687259991508e-21	0.255670959875095	0.348	0.166	1.56078087163108e-16	LRRC41	Malignant cells	GSE186960	ENSG00000132128	10489	leucine rich repeat containing 41	MUF1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26285
7.20621907967802e-21	-0.271732663036394	0.209	0.352	1.60518529999828e-16	PREB	Malignant cells	GSE186960	ENSG00000138073	10113	prolactin regulatory element binding	SEC12	protein_coding	Q9HCU5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26286
7.26889624758532e-21	-0.290466679652379	0.869	0.943	1.61914663914963e-16	LSM3	Malignant cells	GSE186960	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26287
7.26932954447521e-21	-0.358477004416045	0.366	0.503	1.61924315603185e-16	ING2	Malignant cells	GSE186960	ENSG00000168556	3622	inhibitor of growth family member 2	ING1L|p33ING2	protein_coding	Q9H160	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26288
7.34739509973139e-21	0.296025123852351	0.764	0.656	1.63663225846517e-16	YARS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26289
7.64863797172411e-21	0.254354338519278	0.324	0.148	1.70373410820155e-16	MAPK9	Malignant cells	GSE186960	ENSG00000050748	5601	mitogen-activated protein kinase 9	JNK2|p54a|PRKM9|SAPK	protein_coding	P45984	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26290
7.7391793143668e-21	0.272708677184676	0.373	0.193	1.7239021922752e-16	BSDC1	Malignant cells	GSE186960	ENSG00000160058	55108	BSD domain containing 1	FLJ10276|RP4-811H24.7	protein_coding	Q9NW68	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26291
7.79267313288009e-21	0.320144104398256	0.523	0.337	1.73581794034904e-16	LMNB1	Malignant cells	GSE186960	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26292
7.9119831071803e-21	-0.364675320428049	0.557	0.666	1.76239423712441e-16	CYB5A	Malignant cells	GSE186960	ENSG00000166347	1528	cytochrome b5 type A	CYB5	protein_coding	P00167	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26293
9.72815486650753e-21	0.273087009909063	0.866	0.785	2.16694649651455e-16	LARP1	Malignant cells	GSE186960	ENSG00000155506	23367	La ribonucleoprotein 1, translational regulator	KIAA0731|Lar1|LARP|Lhp1|MGC19556	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26294
9.80956470136365e-21	0.281558787022576	0.412	0.229	2.18508053722875e-16	CNOT1	Malignant cells	GSE186960	ENSG00000125107	23019	CCR4-NOT transcription complex subunit 1	AD-005|CDC39|KIAA1007|NOT1|NOT1H	protein_coding	A5YKK6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26295
1.05001238586307e-20	-0.291164058549626	0.245	0.393	2.33890258951e-16	PTPLB	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26296
1.13397371934111e-20	0.283383557256783	0.433	0.245	2.52592645983233e-16	PTPRA	Malignant cells	GSE186960	ENSG00000132670	5786	protein tyrosine phosphatase receptor type A	HLPR|HPTPA|LRP|PTPA|PTPRL2|RPTPA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26297
1.17657349006684e-20	-0.328717066182144	0.273	0.415	2.62081744912388e-16	DVL1	Malignant cells	GSE186960	ENSG00000107404	1855	dishevelled segment polarity protein 1	NA	protein_coding	O14640	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26298
1.44967247541647e-20	0.303305024667544	0.863	0.827	3.22914543899018e-16	NUSAP1	Malignant cells	GSE186960	ENSG00000137804	51203	nucleolar and spindle associated protein 1	ANKT|BM037|FLJ13421|LNP|PRO0310p1|Q0310|SAPL	protein_coding	Q9BXS6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26299
1.45711081479299e-20	-0.345955180491822	0.598	0.701	3.24571433995139e-16	SMARCC1	Malignant cells	GSE186960	ENSG00000173473	6599	SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1	BAF155|CRACC1|Rsc8|SRG3	protein_coding	Q92922	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26300
1.51699029478996e-20	0.269148286914043	0.38	0.198	3.37909588164464e-16	NUP153	Malignant cells	GSE186960	ENSG00000124789	9972	nucleoporin 153	HNUP153	protein_coding	P49790	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26301
1.55516190357737e-20	0.291122642395033	0.739	0.616	3.46412314021858e-16	ATP1A1	Malignant cells	GSE186960	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26302
1.61825901599661e-20	-0.292320156589007	0.851	0.92	3.60467195813244e-16	RDX	Malignant cells	GSE186960	ENSG00000137710	5962	radixin	DFNB24	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26303
1.6269610082145e-20	-0.297160829019579	0.918	0.966	3.6240556457978e-16	RAD23A	Malignant cells	GSE186960	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26304
1.69559211022923e-20	0.289615900488302	0.44	0.261	3.77693142553561e-16	RWDD4	Malignant cells	GSE186960	ENSG00000182552	201965	RWD domain containing 4	FAM28A|MGC10198|RWDD4A	protein_coding	Q6NW29	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26305
1.82488087575107e-20	0.257717650714245	0.388	0.205	4.0649221507355e-16	ZFAND3	Malignant cells	GSE186960	ENSG00000156639	60685	zinc finger AN1-type containing 3	FLJ13222|TEX27	protein_coding	Q9H8U3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26306
1.93967882090196e-20	0.251684439910853	0.309	0.14	4.32063457355911e-16	ZNF12	Malignant cells	GSE186960	ENSG00000164631	7559	zinc finger protein 12	GIOT-3|KOX3|ZNF325	protein_coding	P17014	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26307
2.06254619348689e-20	0.289132553011137	0.6	0.42	4.59432164599205e-16	CBX6	Malignant cells	GSE186960	ENSG00000183741	23466	chromobox 6	NA	protein_coding	O95503	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26308
2.08599832782818e-20	-0.368526366743427	0.48	0.595	4.64656127523726e-16	CPSF2	Malignant cells	GSE186960	ENSG00000165934	53981	cleavage and polyadenylation specific factor 2	CPSF100|KIAA1367	protein_coding	Q9P2I0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26309
2.16985991612381e-20	-0.29491700366464	0.763	0.851	4.8333629631658e-16	JTB	Malignant cells	GSE186960	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26310
2.21708456524694e-20	-0.355321327815119	0.396	0.532	4.93855586908757e-16	C12orf45	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26311
2.27132659638822e-20	0.253340570104198	0.513	0.305	5.05937999345475e-16	WAC	Malignant cells	GSE186960	ENSG00000095787	51322	WW domain containing adaptor with coiled-coil	BM-016|FLJ31290|MGC10753|PRO1741|Wwp4	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26312
2.39569316561798e-20	0.285594795203549	0.444	0.255	5.33640652641405e-16	LRP10	Malignant cells	GSE186960	ENSG00000197324	26020	LDL receptor related protein 10	DKFZP564C1940|LRP9|MGC8675|MST087|MSTP087	protein_coding	Q7Z4F1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26313
2.48527809424989e-20	0.271966890623189	0.452	0.265	5.53595695494163e-16	C9orf142	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26314
2.82209615593294e-20	-0.328948719209224	0.595	0.699	6.28621918734062e-16	GPN3	Malignant cells	GSE186960	ENSG00000111231	51184	GPN-loop GTPase 3	ATPBD1C|MGC14560	protein_coding	Q9UHW5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26315
2.82956712704832e-20	0.265609597453282	0.277	0.117	6.30286077550014e-16	NEDD4	Malignant cells	GSE186960	ENSG00000069869	4734	NEDD4 E3 ubiquitin protein ligase	KIAA0093|MGC176705|NEDD4-1|RPF1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26316
2.85161470554624e-20	-0.323454808477949	0.3	0.446	6.35197175660425e-16	ACAA2	Malignant cells	GSE186960	ENSG00000167315	10449	acetyl-CoA acyltransferase 2	DSAEC	protein_coding	P42765	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26317
3.20430447769843e-20	0.275239795420875	0.465	0.275	7.13758822407326e-16	SLC39A14	Malignant cells	GSE186960	ENSG00000104635	23516	solute carrier family 39 member 14	KIAA0062|NET34|ZIP14	protein_coding	Q15043	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26318
3.24843885536655e-20	0.256618741194858	0.358	0.181	7.23589755032899e-16	NAPRT1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26319
3.41082026665281e-20	0.281143010632464	0.443	0.254	7.59760214396913e-16	MARCH7	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26320
3.69697003602732e-20	0.251475223291305	0.311	0.142	8.23500075525087e-16	EXOC7	Malignant cells	GSE186960	ENSG00000182473	23265	exocyst complex component 7	BLOM4|EXO70|Exo70p|KIAA1067|YJL085W	protein_coding	Q9UPT5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26321
3.83718120351651e-20	0.279879350253762	0.846	0.758	8.54732113083303e-16	SNX9	Malignant cells	GSE186960	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26322
4.64275404079078e-20	0.257833936954701	0.348	0.175	1.03417346258615e-15	TYW1	Malignant cells	GSE186960	ENSG00000198874	55253	tRNA-yW synthesizing protein 1 homolog	FLJ10900|MGC23001|MGC60291|RSAFD1|TYW1A|YPL207W	protein_coding	Q9NV66	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26323
4.64417792373325e-20	0.276987699462906	0.846	0.785	1.03449063251158e-15	HDDC2	Malignant cells	GSE186960	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26324
4.90803291884899e-20	0.256183338236423	0.34	0.166	1.09326433267361e-15	B4GALT1	Malignant cells	GSE186960	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26325
5.45999007285849e-20	0.272234294788174	0.558	0.365	1.21621278872923e-15	CTBP1	Malignant cells	GSE186960	ENSG00000159692	1487	C-terminal binding protein 1	BARS	protein_coding	Q13363	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26326
5.50235890249561e-20	-0.274971543427166	0.813	0.898	1.2256504455309e-15	RPN1	Malignant cells	GSE186960	ENSG00000163902	6184	ribophorin I	OST1	protein_coding	P04843	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26327
5.51727453681522e-20	-0.43817665373827	0.467	0.559	1.22897290307559e-15	KIAA1524	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26328
5.98928619413195e-20	-0.287047179211489	0.209	0.347	1.33411349974289e-15	CENPJ	Malignant cells	GSE186960	ENSG00000151849	55835	centromere protein J	BM032|CPAP|LAP|LIP1|MCPH6|Sas-4|SASS4|SCKL4	protein_coding	Q9HC77	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26329
6.12364370671237e-20	0.271405800650261	0.479	0.295	1.36404163567018e-15	UCHL3	Malignant cells	GSE186960	ENSG00000118939	7347	ubiquitin C-terminal hydrolase L3	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26330
6.40551781133707e-20	0.2948195648639	0.661	0.503	1.42682909247533e-15	VTA1	Malignant cells	GSE186960	ENSG00000009844	51534	vesicle trafficking 1	C6orf55|HSPC228|My012	protein_coding	Q9NP79	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26331
6.93624468657665e-20	-0.346622679618985	0.358	0.49	1.54504850393495e-15	MAPKAP1	Malignant cells	GSE186960	ENSG00000119487	79109	MAPK associated protein 1	MGC2745|MIP1|SIN1	protein_coding	Q9BPZ7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26332
6.94725278910211e-20	0.258151171569859	0.373	0.195	1.5475005587725e-15	RHNO1	Malignant cells	GSE186960	ENSG00000171792	83695	RAD9-HUS1-RAD1 interacting nuclear orphan 1	C12orf32|HKMT1188|MGC13204|RHINO	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26333
8.49745408509389e-20	-0.413753196316184	0.271	0.407	1.89280789745466e-15	NT5E	Malignant cells	GSE186960	ENSG00000135318	4907	5'-nucleotidase ecto	CALJA|CD73|eN|eNT|NT5	protein_coding	P21589	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26334
8.772761832578e-20	-0.371720547461923	0.497	0.607	1.95413269820675e-15	NDUFV3	Malignant cells	GSE186960	ENSG00000160194	4731	NADH:ubiquinone oxidoreductase subunit V3	CI-10k	protein_coding	P56181	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26335
8.91099605182216e-20	-0.381533923294169	0.429	0.543	1.98492437054339e-15	CDCA7L	Malignant cells	GSE186960	ENSG00000164649	55536	cell division cycle associated 7 like	JPO2|R1|RAM2	protein_coding	Q96GN5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26336
9.1097188585664e-20	-0.34812720134185	0.277	0.411	2.02918987574567e-15	DECR2	Malignant cells	GSE186960	ENSG00000274296	26063	2,4-dienoyl-CoA reductase 2	PDCR|SDR17C1	protein_coding	Q9NUI1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26337
9.21792725761075e-20	0.257603320989235	0.446	0.256	2.05329329663279e-15	MRPL9	Malignant cells	GSE186960	ENSG00000143436	65005	mitochondrial ribosomal protein L9	NA	protein_coding	Q9BYD2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26338
9.24365715204464e-20	0.269421108896681	0.432	0.246	2.05902463061794e-15	ERO1L	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26339
9.44356592761308e-20	0.274174802022921	0.876	0.814	2.10355431037581e-15	NUDCD2	Malignant cells	GSE186960	ENSG00000170584	134492	NudC domain containing 2	DKFZp686E10109|NudCL2	protein_coding	Q8WVJ2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26340
9.48210335210691e-20	-0.325740524499682	0.596	0.708	2.11213852168182e-15	UBE3A	Malignant cells	GSE186960	ENSG00000114062	7337	ubiquitin protein ligase E3A	ANCR|AS|E6-AP|EPVE6AP|FLJ26981|HPVE6A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26341
9.48645269878047e-20	0.273403568897814	0.875	0.804	2.11310733865335e-15	EI24	Malignant cells	GSE186960	ENSG00000149547	9538	EI24 autophagy associated transmembrane protein	EPG4|PIG8|TP53I8	protein_coding	O14681	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26342
9.66858617734164e-20	-0.344254675592549	0.303	0.44	2.15367757100285e-15	FNBP1	Malignant cells	GSE186960	ENSG00000187239	23048	formin binding protein 1	FBP17|KIAA0554	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26343
1.01450044393608e-19	0.282771625173508	0.474	0.291	2.25979973886763e-15	RNF130	Malignant cells	GSE186960	ENSG00000113269	55819	ring finger protein 130	G1RZFP|GOLIATH|GP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26344
1.03664587974267e-19	0.26061521152134	0.46	0.266	2.30912869712679e-15	ADD1	Malignant cells	GSE186960	ENSG00000087274	118	adducin 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26345
1.05571833796259e-19	-0.293814403269337	0.231	0.37	2.35161259781167e-15	IFT81	Malignant cells	GSE186960	ENSG00000122970	28981	intraflagellar transport 81	CDV-1R|CDV1|MGC4027	protein_coding	Q8WYA0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26346
1.07917325404459e-19	0.294743213000216	0.646	0.484	2.40385842338432e-15	ACOT7	Malignant cells	GSE186960	ENSG00000097021	11332	acyl-CoA thioesterase 7	ACH1|ACT|BACH|CTE-II|hBACH|LACH1|MGC1126	protein_coding	O00154	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26347
1.10759660781021e-19	0.264472990571135	0.405	0.228	2.46717144389724e-15	POP4	Malignant cells	GSE186960	ENSG00000105171	10775	POP4 homolog, ribonuclease P/MRP subunit	RPP29	protein_coding	O95707	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26348
1.1092628711776e-19	0.267664954770278	0.274	0.113	2.47088304554812e-15	PDGFB	Malignant cells	GSE186960	ENSG00000100311	5155	platelet derived growth factor subunit B	SIS|SSV	protein_coding	P01127	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26349
1.12223678625977e-19	-0.304345070761507	0.23	0.368	2.49978244139364e-15	PLEKHA1	Malignant cells	GSE186960	ENSG00000107679	59338	pleckstrin homology domain containing A1	TAPP1	protein_coding	Q9HB21	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26350
1.12721638254578e-19	-0.270919149746627	0.174	0.305	2.51087449212072e-15	SAAL1	Malignant cells	GSE186960	ENSG00000166788	113174	serum amyloid A like 1	FLJ41463	protein_coding	Q96ER3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26351
1.17568903486923e-19	0.251803797928252	0.401	0.216	2.61884732517122e-15	EPN2	Malignant cells	GSE186960	ENSG00000072134	22905	epsin 2	EHB21|KIAA1065	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26352
1.2272974883912e-19	0.29853853939738	0.482	0.301	2.7338051553914e-15	CTHRC1	Malignant cells	GSE186960	ENSG00000164932	115908	collagen triple helix repeat containing 1	NA	protein_coding	Q96CG8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26353
1.28364788143036e-19	-0.351957344039799	0.476	0.593	2.85932565588614e-15	PSMG2	Malignant cells	GSE186960	ENSG00000128789	56984	proteasome assembly chaperone 2	CLAST3|HCCA3|HsT1707|MDS003|MGC15092|PAC2|TNFSF5IP1	protein_coding	Q969U7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26354
1.35736640602932e-19	0.288794593998314	0.691	0.544	3.02353366943031e-15	GNB2	Malignant cells	GSE186960	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26355
1.41380417336421e-19	-0.310253234667712	0.339	0.48	3.14924879616877e-15	MRPS14	Malignant cells	GSE186960	ENSG00000120333	63931	mitochondrial ribosomal protein S14	HSMRPS14	protein_coding	O60783	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26356
1.63960139592462e-19	-0.289629774157127	0.739	0.842	3.6522121094221e-15	PDCD10	Malignant cells	GSE186960	ENSG00000114209	11235	programmed cell death 10	CCM3|TFAR15	protein_coding	Q9BUL8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26357
1.84493931575131e-19	-0.380176852402817	0.397	0.519	4.10960232583604e-15	C12orf75	Malignant cells	GSE186960	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26358
2.00809133981987e-19	-0.269438948097426	0.873	0.943	4.47302345944875e-15	NDUFA2	Malignant cells	GSE186960	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26359
2.10816591511921e-19	0.282447346243928	0.457	0.279	4.69593957592805e-15	GSTT1	Malignant cells	GSE186960	ENSG00000277656	2952	glutathione S-transferase theta 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26360
2.14677439294284e-19	0.26707505085543	0.85	0.797	4.78193996028019e-15	RHOC	Malignant cells	GSE186960	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26361
2.30938083128857e-19	0.27306290599894	0.898	0.842	5.14414580169529e-15	MRPL18	Malignant cells	GSE186960	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26362
2.31215584809874e-19	-0.251734176644119	0.156	0.282	5.15032715163994e-15	SCRN2	Malignant cells	GSE186960	ENSG00000141295	90507	secernin 2	NA	protein_coding	Q96FV2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26363
2.43420126915957e-19	-0.345350691743139	0.293	0.423	5.42218332705295e-15	ANKRD32	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26364
2.45186896091931e-19	-0.289902715502981	0.259	0.4	5.46153811044776e-15	KIAA1586	Malignant cells	GSE186960	ENSG00000168116	57691	KIAA1586	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26365
2.52251674167367e-19	-0.365571335626616	0.503	0.602	5.61890604207809e-15	MCFD2	Malignant cells	GSE186960	ENSG00000180398	90411	multiple coagulation factor deficiency 2, ER cargo receptor complex subunit	F5F8D|LMAN1IP|SDNSF	protein_coding	Q8NI22	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26366
2.525219246302e-19	0.256284958022607	0.348	0.179	5.6249258711377e-15	STIM2	Malignant cells	GSE186960	ENSG00000109689	57620	stromal interaction molecule 2	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26367
2.5420582448494e-19	-0.336054878289866	0.814	0.885	5.66243474040203e-15	RSF1	Malignant cells	GSE186960	ENSG00000048649	51773	remodeling and spacing factor 1	HBXAP|p325|RSF-1|XAP8	protein_coding	Q96T23	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26368
2.60584428709164e-19	-0.283529462781247	0.749	0.838	5.80451814949662e-15	RARS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26369
2.70400088856607e-19	0.277473862263027	0.717	0.57	6.02316197928092e-15	SNRNP200	Malignant cells	GSE186960	ENSG00000144028	23020	small nuclear ribonucleoprotein U5 subunit 200	ASCC3L1|BRR2|HELIC2|KIAA0788|RP33|U5-200KD	protein_coding	O75643	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26370
3.19939103099105e-19	0.276959643878141	0.439	0.255	7.12664352153256e-15	NEK2	Malignant cells	GSE186960	ENSG00000117650	4751	NIMA related kinase 2	NEK2A|NLK1|PPP1R111|RP67	protein_coding	P51955	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26371
3.23388297996526e-19	-0.281988832113449	0.873	0.943	7.20347433787261e-15	LRPAP1	Malignant cells	GSE186960	ENSG00000163956	4043	LDL receptor related protein associated protein 1	A2MRAP|HBP44|RAP	protein_coding	P30533	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26372
3.3621282549005e-19	-0.316101138714835	0.646	0.754	7.48914068779087e-15	NDUFS3	Malignant cells	GSE186960	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26373
3.54751858815871e-19	0.258552745064448	0.498	0.304	7.90209765512353e-15	REV3L	Malignant cells	GSE186960	ENSG00000009413	5980	REV3 like, DNA directed polymerase zeta catalytic subunit	POLZ|REV3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26374
4.13088353139527e-19	-0.287404093688021	0.219	0.354	9.20154306618296e-15	POLR1C	Malignant cells	GSE186960	ENSG00000171453	9533	RNA polymerase I and III subunit C	AC40|RPA39|RPA40|RPA5|RPAC1|RPC40	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26375
4.13421670711645e-19	-0.32175949471066	0.229	0.364	9.20896771510189e-15	TCEAL1	Malignant cells	GSE186960	ENSG00000172465	9338	transcription elongation factor A like 1	p21|pp21|SIIR|WEX9	protein_coding	Q15170	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26376
4.24433997382679e-19	-0.30544015145791	0.696	0.809	9.45426729169917e-15	TK1	Malignant cells	GSE186960	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26377
4.37362183979298e-19	0.253027014518957	0.346	0.179	9.74224264813887e-15	RDH14	Malignant cells	GSE186960	ENSG00000240857	57665	retinol dehydrogenase 14	PAN2|SDR7C4	protein_coding	Q9HBH5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26378
4.91390143711184e-19	0.274466133338336	0.506	0.319	1.09457154511666e-14	USP11	Malignant cells	GSE186960	ENSG00000102226	8237	ubiquitin specific peptidase 11	UHX1	protein_coding	P51784	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26379
4.96496137483273e-19	0.279072472387945	0.887	0.824	1.10594514624399e-14	GUK1	Malignant cells	GSE186960	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26380
5.07816484315904e-19	0.251169522491258	0.392	0.218	1.13116121881368e-14	IMPAD1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26381
5.74170259619998e-19	-0.337962974022742	0.435	0.556	1.27896425330355e-14	ATP6V1D	Malignant cells	GSE186960	ENSG00000100554	51382	ATPase H+ transporting V1 subunit D	ATP6M|VATD|VMA8	protein_coding	Q9Y5K8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26382
6.54141544837809e-19	-0.275290482449583	0.175	0.301	1.45710029112622e-14	ZNF830	Malignant cells	GSE186960	ENSG00000198783	91603	zinc finger protein 830	CCDC16|MGC20398|OMCG1	protein_coding	Q96NB3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26383
7.19107329861562e-19	0.259973014742034	0.433	0.248	1.60181157726663e-14	PLOD1	Malignant cells	GSE186960	ENSG00000083444	5351	procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	LH1|LLH|PLOD	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26384
7.91919861311216e-19	0.291861748028637	0.535	0.36	1.76400149107073e-14	MED13L	Malignant cells	GSE186960	ENSG00000123066	23389	mediator complex subunit 13L	KIAA1025|THRAP2|TRAP240L	protein_coding	Q71F56	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26385
8.08361594508778e-19	0.261745407459195	0.446	0.264	1.8006254517683e-14	RNF167	Malignant cells	GSE186960	ENSG00000108523	26001	ring finger protein 167	DKFZP566H073	protein_coding	Q9H6Y7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26386
8.9626851441551e-19	-0.293974320693531	0.802	0.903	1.99643811586055e-14	WDR43	Malignant cells	GSE186960	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26387
9.1868851374398e-19	0.26251875453518	0.827	0.742	2.04637866436471e-14	ATP6V0B	Malignant cells	GSE186960	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26388
9.30710114000429e-19	-0.27519872510199	0.233	0.368	2.07315677893596e-14	MOCS2	Malignant cells	GSE186960	ENSG00000164172	4338	molybdenum cofactor synthesis 2	MOCO1|MOCS2A|MOCS2B	protein_coding	O96033	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26389
9.54061248016257e-19	-0.281288806776479	0.85	0.914	2.12517142995621e-14	MED29	Malignant cells	GSE186960	ENSG00000063322	55588	mediator complex subunit 29	DKFZp434H247|IXL|MED2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26390
9.7860127253685e-19	0.272679529307644	0.525	0.342	2.17983433457583e-14	OXA1L	Malignant cells	GSE186960	ENSG00000155463	5018	OXA1L mitochondrial inner membrane protein	MGC133129|OXA1|OXA1L1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26391
9.79930337439722e-19	-0.268160160077841	0.275	0.417	2.18279482664698e-14	GOLT1B	Malignant cells	GSE186960	ENSG00000111711	51026	golgi transport 1B	CGI-141|GOT1|YMR292W	protein_coding	Q9Y3E0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26392
1.11897791603958e-18	0.303190484153738	0.523	0.357	2.49252330797817e-14	TRIM44	Malignant cells	GSE186960	ENSG00000166326	54765	tripartite motif containing 44	DIPB|MC7	protein_coding	Q96DX7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26393
1.19463231958953e-18	0.282302870291186	0.638	0.473	2.66104349188569e-14	BBX	Malignant cells	GSE186960	ENSG00000114439	56987	BBX high mobility group box domain containing	HBP2|HSPC339|MDS001	protein_coding	Q8WY36	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26394
1.26623370560487e-18	-0.321198277748953	0.32	0.454	2.82053557923484e-14	PMPCB	Malignant cells	GSE186960	ENSG00000105819	9512	peptidase, mitochondrial processing subunit beta	beta-MPP|MAS1|MPPB|MPPP52	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26395
1.81165870890659e-18	-0.350541366716588	0.438	0.546	4.03546977408943e-14	RIC8A	Malignant cells	GSE186960	ENSG00000177963	60626	RIC8 guanine nucleotide exchange factor A	synembryn|synembryn-A	protein_coding	Q9NPQ8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26396
1.84179949502466e-18	0.27967249286681	0.798	0.713	4.10260837516743e-14	FKBP4	Malignant cells	GSE186960	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26397
1.92707035473571e-18	0.272829047523714	0.579	0.417	4.29254921517379e-14	TTC19	Malignant cells	GSE186960	ENSG00000011295	54902	tetratricopeptide repeat domain 19	FLJ20343|MGC19520	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26398
2.12650899522065e-18	-0.267713271934569	0.932	0.973	4.736798786854e-14	MORF4L1	Malignant cells	GSE186960	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26399
2.31075272346733e-18	-0.39075975817663	0.471	0.573	5.14720169152348e-14	RABEP1	Malignant cells	GSE186960	ENSG00000029725	9135	rabaptin, RAB GTPase binding effector protein 1	neurocrescin|RAB5EP|rabaptin-5|RABPT5	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26400
2.53113967254008e-18	0.268256622610817	0.521	0.341	5.63811362058302e-14	DESI1	Malignant cells	GSE186960	ENSG00000100418	27351	desumoylating isopeptidase 1	D15Wsu75e|DESI-1|FAM152B|POST|PPPDE2	protein_coding	Q6ICB0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26401
2.5480805113203e-18	-0.358986268451837	0.437	0.546	5.67584933896598e-14	C21orf33	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26402
2.64878267140961e-18	0.255956150080169	0.353	0.188	5.90016340056491e-14	ACTR10	Malignant cells	GSE186960	ENSG00000131966	55860	actin related protein 10	ACTR11|Arp10|Arp11|HARP11	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26403
2.8571370410085e-18	-0.285934753967387	0.914	0.96	6.36427275884643e-14	GLO1	Malignant cells	GSE186960	ENSG00000124767	2739	glyoxalase I	GLOD1	protein_coding	Q04760	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26404
2.92120519296264e-18	-0.256234364616819	0.201	0.334	6.50698456732429e-14	DGKD	Malignant cells	GSE186960	ENSG00000280873	8527	diacylglycerol kinase delta	DGKdelta|KIAA0145	protein_coding	Q16760	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26405
2.9475860301488e-18	0.253186575655614	0.392	0.221	6.56574788215646e-14	ZMYM4	Malignant cells	GSE186960	ENSG00000146463	9202	zinc finger MYM-type containing 4	KIAA0425|MYM|ZNF198L3|ZNF262	protein_coding	Q5VZL5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26406
3.15853230177818e-18	-0.357966881108598	0.538	0.632	7.0356307022109e-14	C4orf27	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26407
3.68903110744545e-18	-0.329969845634284	0.624	0.716	8.21731679183474e-14	SSSCA1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26408
3.70149314773158e-18	0.270791640936538	0.844	0.792	8.24507598657209e-14	CAPRIN1	Malignant cells	GSE186960	ENSG00000135387	4076	cell cycle associated protein 1	caprin-1|GPIAP1|M11S1|RNG105	protein_coding	Q14444	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26409
3.70429143761989e-18	-0.322243337883348	0.36	0.484	8.25130917729832e-14	USP39	Malignant cells	GSE186960	ENSG00000168883	10713	ubiquitin specific peptidase 39	CGI-21|SAD1|SNRNP65	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26410
3.91458243091841e-18	-0.360862031987229	0.413	0.527	8.71973236487076e-14	GUSB	Malignant cells	GSE186960	ENSG00000169919	2990	glucuronidase beta	NA	protein_coding	P08236	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26411
4.05221148837461e-18	-0.356697992772584	0.378	0.501	9.02630109035445e-14	HOXB2	Malignant cells	GSE186960	ENSG00000173917	3212	homeobox B2	HOX2|HOX2H	protein_coding	P14652	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26412
4.34836736846777e-18	-0.329949995429192	0.261	0.39	9.68598831326197e-14	CBFB	Malignant cells	GSE186960	ENSG00000067955	865	core-binding factor subunit beta	PEBP2B	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26413
4.62745910978821e-18	-0.287177496609275	0.719	0.827	1.03076651670532e-13	ROCK1	Malignant cells	GSE186960	ENSG00000067900	6093	Rho associated coiled-coil containing protein kinase 1	p160ROCK	protein_coding	Q13464	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26414
4.63895275107582e-18	-0.312894280464699	0.36	0.491	1.03332672530214e-13	ADK	Malignant cells	GSE186960	ENSG00000156110	132	adenosine kinase	AK	protein_coding	P55263	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26415
4.96776116242179e-18	0.297705957526382	0.729	0.612	1.10656879892945e-13	GTSE1	Malignant cells	GSE186960	ENSG00000075218	51512	G2 and S-phase expressed 1	B99|GTSE-1|Lnc_bc060912	protein_coding	Q9NYZ3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26416
5.40127773677218e-18	0.303122221335528	0.793	0.708	1.203134615866e-13	SEPHS2	Malignant cells	GSE186960	ENSG00000179918	22928	selenophosphate synthetase 2	SPS2|SPS2b	protein_coding	Q99611	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26417
5.57093093256836e-18	-0.291549423547858	0.232	0.362	1.2409248652296e-13	ANKRD26	Malignant cells	GSE186960	ENSG00000107890	22852	ankyrin repeat domain containing 26	KIAA1074|THC2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26418
5.67406618561756e-18	-0.352601903084211	0.511	0.612	1.26389824284631e-13	KIAA1430	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26419
5.71419986842866e-18	-0.289000193184924	0.263	0.395	1.27283802069248e-13	METAP1	Malignant cells	GSE186960	ENSG00000164024	23173	methionyl aminopeptidase 1	KIAA0094|MAP1A|MetAP1A	protein_coding	P53582	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26420
5.9150977404305e-18	-0.250623403541984	0.179	0.307	1.31758802168089e-13	PDE6D	Malignant cells	GSE186960	ENSG00000156973	5147	phosphodiesterase 6D	JBTS22	protein_coding	O43924	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26421
6.39875919010323e-18	-0.271870612935747	0.149	0.268	1.4253236095955e-13	FAM111B	Malignant cells	GSE186960	ENSG00000189057	374393	FAM111 trypsin like peptidase B	CANP	protein_coding	Q6SJ93	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26422
6.40420337709169e-18	-0.25565256602384	0.82	0.905	1.42653630224717e-13	MTCH1	Malignant cells	GSE186960	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26423
6.46618427350865e-18	0.252107429717237	0.458	0.281	1.44034254692405e-13	WHSC1L1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26424
6.7067187214462e-18	0.29909400287779	0.604	0.451	1.49392159520214e-13	CAND1	Malignant cells	GSE186960	ENSG00000111530	55832	cullin associated and neddylation dissociated 1	DKFZp434M1414|KIAA0829|TIP120|TIP120A	protein_coding	Q86VP6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26425
6.98075376126584e-18	-0.34590444295632	0.357	0.474	1.55496290032197e-13	ITSN2	Malignant cells	GSE186960	ENSG00000198399	50618	intersectin 2	KIAA1256|PRO2015|SH3D1B|SH3P18|SWA|SWAP	protein_coding	Q9NZM3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26426
7.09412171753795e-18	0.259373114982378	0.453	0.274	1.58021561258158e-13	MAP4K4	Malignant cells	GSE186960	ENSG00000071054	9448	mitogen-activated protein kinase kinase kinase kinase 4	FLH21957|HGK|NIK	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26427
7.52695949182966e-18	-0.318734035018726	0.247	0.372	1.67663022680506e-13	ITPR2	Malignant cells	GSE186960	ENSG00000123104	3709	inositol 1,4,5-trisphosphate receptor type 2	CFAP48|IP3R2	protein_coding	Q14571	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26428
7.69529139599229e-18	-0.271422138607314	0.902	0.98	1.71412615845728e-13	FKBP1A	Malignant cells	GSE186960	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26429
7.85801013636968e-18	-0.328471333009133	0.383	0.51	1.75037175787635e-13	SUDS3	Malignant cells	GSE186960	ENSG00000111707	64426	SDS3 homolog, SIN3A corepressor complex component	FLJ00052|SAP45|SDS3	protein_coding	Q9H7L9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26430
8.83870130073138e-18	-0.358638049144414	0.462	0.562	1.96882071473792e-13	TOPBP1	Malignant cells	GSE186960	ENSG00000163781	11073	DNA topoisomerase II binding protein 1	Dpb11|KIAA0259|TOP2BP1	protein_coding	Q92547	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26431
9.1362371179324e-18	-0.286419147168405	0.686	0.782	2.03509681801944e-13	PEPD	Malignant cells	GSE186960	ENSG00000124299	5184	peptidase D	NA	protein_coding	P12955	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26432
9.88476721025899e-18	0.251900006910689	0.411	0.239	2.20183189608519e-13	TNFRSF1A	Malignant cells	GSE186960	ENSG00000067182	7132	TNF receptor superfamily member 1A	CD120a|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR60	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26433
1.15487280532939e-17	0.250455879220409	0.491	0.309	2.57247917387121e-13	RNF126	Malignant cells	GSE186960	ENSG00000070423	55658	ring finger protein 126	FLJ20552	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26434
1.16045231052987e-17	0.259326515552768	0.472	0.298	2.58490752170528e-13	LYRM4	Malignant cells	GSE186960	ENSG00000214113	57128	LYR motif containing 4	C6orf149|CGI-203|ISD11	protein_coding	Q9HD34	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26435
1.21518204362547e-17	0.31431520984703	0.593	0.454	2.70681800217574e-13	LINC00152	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26436
1.38611191647432e-17	-0.322393688730622	0.376	0.503	3.08756429394656e-13	TDG	Malignant cells	GSE186960	ENSG00000139372	6996	thymine DNA glycosylase	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26437
1.49512341374231e-17	0.319203535976269	0.844	0.807	3.33038740411099e-13	GPI	Malignant cells	GSE186960	ENSG00000282019	2821	glucose-6-phosphate isomerase	AMF|NLK	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26438
1.50937848636837e-17	-0.305618301085769	0.283	0.413	3.36214057838556e-13	MINA	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26439
1.77130540551753e-17	-0.308984436818232	0.331	0.461	3.94558279079029e-13	RAE1	Malignant cells	GSE186960	ENSG00000101146	8480	ribonucleic acid export 1	Gle2|Mnrp41	protein_coding	P78406	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26440
1.82432569072285e-17	-0.311543742106164	0.339	0.464	4.06368547608514e-13	SLC39A6	Malignant cells	GSE186960	ENSG00000141424	25800	solute carrier family 39 member 6	LIV-1	protein_coding	Q13433	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26441
1.83161839662193e-17	0.258682914655164	0.529	0.354	4.07992997847535e-13	MRPL54	Malignant cells	GSE186960	ENSG00000183617	116541	mitochondrial ribosomal protein L54	NA	protein_coding	Q6P161	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26442
1.93483209193824e-17	0.251396681491961	0.891	0.857	4.30983848479242e-13	MLF2	Malignant cells	GSE186960	ENSG00000089693	8079	myeloid leukemia factor 2	NTN4	protein_coding	Q15773	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26443
2.04885673071277e-17	0.25932189449982	0.834	0.751	4.5638283676627e-13	TTC3	Malignant cells	GSE186960	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26444
2.45483865900549e-17	0.266685947338302	0.45	0.284	5.46815311293472e-13	SWI5	Malignant cells	GSE186960	ENSG00000175854	375757	SWI5 homologous recombination repair protein	bA395P17.9|C9orf119|SAE3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26445
2.83408635996527e-17	-0.312014379073661	0.336	0.467	6.31292736682265e-13	R3HDM1	Malignant cells	GSE186960	ENSG00000048991	23518	R3H domain containing 1	KIAA0029|R3HDM	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26446
2.92050243106933e-17	-0.323705818375588	0.762	0.852	6.50541916520693e-13	CLSPN	Malignant cells	GSE186960	ENSG00000092853	63967	claspin	NA	protein_coding	Q9HAW4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26447
3.06952001723097e-17	-0.290658065344237	0.282	0.411	6.83735583838199e-13	UNG	Malignant cells	GSE186960	ENSG00000076248	7374	uracil DNA glycosylase	DGU|HIGM4|UDG|UNG1|UNG2	protein_coding	P13051	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26448
3.11018976427505e-17	-0.261552996199159	0.197	0.321	6.92794769992268e-13	SH2D4A	Malignant cells	GSE186960	ENSG00000104611	63898	SH2 domain containing 4A	FLJ20967|PPP1R38|SH2A	protein_coding	Q9H788	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26449
3.1535744629659e-17	-0.273582261635073	0.227	0.355	7.02458711625654e-13	PPP2R5A	Malignant cells	GSE186960	ENSG00000066027	5525	protein phosphatase 2 regulatory subunit B'alpha	B56A|B56alpha|PR61A	protein_coding	Q15172	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26450
3.69736307799544e-17	-0.299396402421937	0.673	0.778	8.23587625623484e-13	SLC4A7	Malignant cells	GSE186960	ENSG00000033867	9497	solute carrier family 4 member 7	NBC3|SBC2|SLC4A6	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26451
4.08351654906152e-17	0.251299630041705	0.468	0.291	9.09603311303453e-13	NR2F2	Malignant cells	GSE186960	ENSG00000185551	7026	nuclear receptor subfamily 2 group F member 2	ARP1|COUP-TFII|COUPTF2|COUPTFB|NF-E3|SVP40|TFCOUP2	protein_coding	P24468	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26452
4.16515075403935e-17	0.251368163173466	0.865	0.791	9.27787330462265e-13	PDCD2	Malignant cells	GSE186960	ENSG00000071994	5134	programmed cell death 2	RP8|ZMYND7	protein_coding	Q16342	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26453
4.83161043278981e-17	-0.275766512209436	0.281	0.414	1.07624122390393e-12	NUB1	Malignant cells	GSE186960	ENSG00000013374	51667	negative regulator of ubiquitin like proteins 1	BS4|NUB1L|NYREN18	protein_coding	Q9Y5A7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26454
4.94014780950696e-17	-0.288131313590702	0.247	0.375	1.10041792456767e-12	R3HDM2	Malignant cells	GSE186960	ENSG00000179912	22864	R3H domain containing 2	KIAA1002	protein_coding	Q9Y2K5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26455
5.07822871915609e-17	-0.270846093388611	0.236	0.367	1.13117544719202e-12	GPATCH1	Malignant cells	GSE186960	ENSG00000076650	55094	G-patch domain containing 1	ECGP|FLJ10206|FLJ38686|GPATC1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26456
6.30035072107169e-17	-0.326982349367786	0.322	0.437	1.40340312311872e-12	DHX29	Malignant cells	GSE186960	ENSG00000067248	54505	DExH-box helicase 29	DDX29	protein_coding	Q7Z478	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26457
6.52331197243432e-17	-0.26590824591483	0.233	0.361	1.45306774185974e-12	MRPL48	Malignant cells	GSE186960	ENSG00000175581	51642	mitochondrial ribosomal protein L48	CGI-118	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26458
7.00281224032937e-17	0.274245876217744	0.527	0.365	1.55987642653337e-12	IAH1	Malignant cells	GSE186960	ENSG00000134330	285148	isoamyl acetate hydrolyzing esterase 1 (putative)	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26459
7.11099498677164e-17	-0.394529496993107	0.371	0.48	1.58397413330338e-12	NCAPH	Malignant cells	GSE186960	ENSG00000121152	23397	non-SMC condensin I complex subunit H	BRRN1|CAP-H|hCAP-H	protein_coding	Q15003	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26460
7.46357020112504e-17	0.254540697111656	0.449	0.279	1.6625102623006e-12	RIOK3	Malignant cells	GSE186960	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26461
9.30982515949519e-17	-0.316976929156948	0.269	0.388	2.07376355427755e-12	NOM1	Malignant cells	GSE186960	ENSG00000146909	64434	nucleolar protein with MIF4G domain 1	C7orf3|PPP1R113|SGD1	protein_coding	Q5C9Z4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26462
9.38923249000082e-17	-0.283412850991487	0.229	0.354	2.09145153714768e-12	RBMXL1	Malignant cells	GSE186960	ENSG00000213516	494115	RBMX like 1	KAT3	protein_coding	Q96E39	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26463
1.00944277273034e-16	0.257741888442723	0.519	0.352	2.24853377625684e-12	FAM207A	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26464
1.05249127990809e-16	-0.308298477128094	0.374	0.493	2.34442432599526e-12	TAF1B	Malignant cells	GSE186960	ENSG00000115750	9014	TATA-box binding protein associated factor, RNA polymerase I subunit B	RAF1B|RAFI63|SL1|TAFI63	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26465
1.10779314971179e-16	-0.261232104695563	0.216	0.342	2.46760924098302e-12	BICD1	Malignant cells	GSE186960	ENSG00000151746	636	BICD cargo adaptor 1	NA	protein_coding	Q96G01	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26466
1.15092822320081e-16	-0.362161861193502	0.5	0.592	2.5636926171798e-12	SWAP70	Malignant cells	GSE186960	ENSG00000133789	23075	switching B cell complex subunit SWAP70	KIAA0640|SWAP-70	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26467
1.19218702242336e-16	-0.266151143996843	0.149	0.265	2.65559659244803e-12	HEG1	Malignant cells	GSE186960	ENSG00000173706	57493	heart development protein with EGF like domains 1	HEG|KIAA1237	protein_coding	Q9ULI3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26468
1.21223667085211e-16	-0.261837222473509	0.743	0.834	2.70025718432307e-12	DARS	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26469
1.46182919609773e-16	0.271179982572622	0.715	0.597	3.25622453430769e-12	TRAPPC2L	Malignant cells	GSE186960	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26470
1.55050094330457e-16	-0.320702372316926	0.432	0.54	3.45374085121094e-12	DECR1	Malignant cells	GSE186960	ENSG00000104325	1666	2,4-dienoyl-CoA reductase 1	DECR|SDR18C1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26471
1.57687984557696e-16	-0.319749054101169	0.182	0.299	3.51249985602267e-12	ADM	Malignant cells	GSE186960	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26472
1.65272242955913e-16	-0.300030861144494	0.252	0.38	3.68143921184296e-12	ZADH2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26473
1.6716123904018e-16	-0.353063464533188	0.439	0.55	3.72351659962001e-12	NOC3L	Malignant cells	GSE186960	ENSG00000173145	64318	NOC3 like DNA replication regulator	AD24|C10orf117|FAD24|FLJ12820	protein_coding	Q8WTT2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26474
1.88100589992937e-16	0.273682416390015	0.634	0.481	4.18994064209268e-12	MDK	Malignant cells	GSE186960	ENSG00000110492	4192	midkine	FLJ27379|MK|NEGF2	protein_coding	P21741	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26475
2.63074877165548e-16	-0.25248657409175	0.685	0.781	5.85999288886259e-12	DDX39A	Malignant cells	GSE186960	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26476
2.66356306844105e-16	0.252593042280196	0.785	0.691	5.93308673495244e-12	MPC2	Malignant cells	GSE186960	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26477
3.07902527042133e-16	0.264247282175522	0.783	0.701	6.85852878986352e-12	C19orf60	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26478
3.0871099563767e-16	0.250162847106119	0.419	0.259	6.87653742782909e-12	GTF3C1	Malignant cells	GSE186960	ENSG00000077235	2975	general transcription factor IIIC subunit 1	TFIIIC220	protein_coding	Q12789	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26479
3.13113348942367e-16	-0.344668079070326	0.389	0.496	6.97459984769122e-12	PAK1	Malignant cells	GSE186960	ENSG00000149269	5058	p21 (RAC1) activated kinase 1	NA	protein_coding	Q13153	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26480
4.02839416113966e-16	-0.301947958043166	0.71	0.798	8.97324799393859e-12	ESF1	Malignant cells	GSE186960	ENSG00000089048	51575	ESF1 nucleolar pre-rRNA processing protein homolog	bA526K24.1|C20orf6	protein_coding	Q9H501	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26481
4.27154792581276e-16	-0.307240232984108	0.355	0.473	9.51487300474792e-12	TMEM9B	Malignant cells	GSE186960	ENSG00000175348	56674	TMEM9 domain family member B	C11orf15	protein_coding	Q9NQ34	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26482
5.03828242028352e-16	0.262400815004493	0.521	0.358	1.12227740911815e-11	TMEM59	Malignant cells	GSE186960	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26483
5.18286100337185e-16	-0.319828544261997	0.388	0.499	1.15448228850108e-11	PHF5A	Malignant cells	GSE186960	ENSG00000100410	84844	PHD finger protein 5A	bK223H9.2|INI|MGC1346|Rds3|SAP14b|SF3b14b|SF3B7	protein_coding	Q7RTV0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26484
5.46969995465206e-16	-0.310692942964919	0.385	0.499	1.21837566489875e-11	DDX50	Malignant cells	GSE186960	ENSG00000107625	79009	DExD-box helicase 50	GU2|GUB|MGC3199|RH-II/GuB	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26485
5.6171414411559e-16	-0.292938023501358	0.288	0.405	1.25121825601748e-11	RUFY1	Malignant cells	GSE186960	ENSG00000284260	80230	RUN and FYVE domain containing 1	FLJ22251|RABIP4|ZFYVE12	protein_coding	Q96T51	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26486
6.14341328717437e-16	-0.307747688856311	0.527	0.617	1.36844530971809e-11	METTL9	Malignant cells	GSE186960	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26487
6.24478794741366e-16	0.250442590105218	0.493	0.328	1.39102651528639e-11	IMP4	Malignant cells	GSE186960	ENSG00000136718	92856	IMP U3 small nucleolar ribonucleoprotein 4	BXDC4|MGC19606	protein_coding	Q96G21	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26488
6.25611470391006e-16	0.252323256729279	0.462	0.299	1.39354955029597e-11	PDXK	Malignant cells	GSE186960	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26489
6.73704011074458e-16	-0.351185353998157	0.421	0.524	1.50067568466835e-11	KIAA0020	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26490
7.55449108389353e-16	-0.289705512909947	0.366	0.489	1.68276288893728e-11	FAM32A	Malignant cells	GSE186960	ENSG00000105058	26017	family with sequence similarity 32 member A	DKFZP586O0120|OTAG-12	protein_coding	Q9Y421	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26491
7.92288380784146e-16	-0.29345669869691	0.245	0.365	1.76482236819669e-11	TBC1D8	Malignant cells	GSE186960	ENSG00000204634	11138	TBC1 domain family member 8	AD3|GRAMD8|HBLP1|VRP	protein_coding	O95759	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26492
8.39293148365302e-16	-0.265714699610027	0.845	0.921	1.86952548798371e-11	PRR13	Malignant cells	GSE186960	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26493
8.44595427488448e-16	0.254195159146641	0.824	0.746	1.88133631473052e-11	ODC1	Malignant cells	GSE186960	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26494
8.74870612238369e-16	0.273017792579076	0.548	0.397	1.94877428876097e-11	NCAPD2	Malignant cells	GSE186960	ENSG00000010292	9918	non-SMC condensin I complex subunit D2	CAP-D2|CNAP1|hCAP-D2|KIAA0159	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26495
9.34638748685575e-16	-0.337743530562328	0.56	0.656	2.08190781269712e-11	FBXO27	Malignant cells	GSE186960	ENSG00000161243	126433	F-box protein 27	Fbg5|Fbx27	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26496
9.88693721299397e-16	-0.319266982956349	0.525	0.63	2.20231526419441e-11	ZNF326	Malignant cells	GSE186960	ENSG00000162664	284695	zinc finger protein 326	FLJ20403|ZAN75|Zfp326|ZIRD	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26497
1.01000822860983e-15	0.255239027100789	0.521	0.361	2.2497933292284e-11	SAC3D1	Malignant cells	GSE186960	ENSG00000168061	29901	SAC3 domain containing 1	HSU79266|SHD1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26498
1.14904353522418e-15	-0.256546470115669	0.264	0.39	2.55949447471187e-11	NOP2	Malignant cells	GSE186960	ENSG00000111641	4839	NOP2 nucleolar protein	NOL1|NOP120|NSUN1|p120	protein_coding	P46087	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26499
1.21677329485156e-15	-0.321663043533498	0.275	0.397	2.71036251428185e-11	PHACTR2	Malignant cells	GSE186960	ENSG00000112419	9749	phosphatase and actin regulator 2	C6orf56|KIAA0680	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26500
1.33296868818307e-15	-0.25507283083499	0.85	0.91	2.96918775292779e-11	GSTO1	Malignant cells	GSE186960	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26501
1.61200395029645e-15	-0.310984441793982	0.372	0.484	3.59073879928535e-11	LSG1	Malignant cells	GSE186960	ENSG00000041802	55341	large 60S subunit nuclear export GTPase 1	FLJ11301	protein_coding	Q9H089	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26502
1.65248454539419e-15	-0.31680673810093	0.394	0.503	3.68090932486555e-11	CMAS	Malignant cells	GSE186960	ENSG00000111726	55907	cytidine monophosphate N-acetylneuraminic acid synthetase	NA	protein_coding	Q8NFW8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26503
1.65742568818693e-15	-0.316761978138192	0.354	0.468	3.69191572043639e-11	SLC29A1	Malignant cells	GSE186960	ENSG00000112759	2030	solute carrier family 29 member 1 (Augustine blood group)	ENT1	protein_coding	Q99808	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26504
1.6774475496761e-15	-0.261487806332761	0.803	0.881	3.73651441690351e-11	SSR3	Malignant cells	GSE186960	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26505
1.76852770559566e-15	-0.285954133917751	0.365	0.486	3.93939546421433e-11	HMCES	Malignant cells	GSE186960	ENSG00000183624	56941	5-hydroxymethylcytosine binding, ES cell specific	C3orf37|DC12|SRAPD1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26506
1.78366805146782e-15	-0.313593728805439	0.344	0.458	3.97312058464457e-11	RIOK1	Malignant cells	GSE186960	ENSG00000124784	83732	RIO kinase 1	AD034|bA288G3.1|FLJ30006|RRP10	protein_coding	Q9BRS2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26507
1.8072932122744e-15	-0.288034939371621	0.666	0.744	4.02574563034122e-11	THOC7	Malignant cells	GSE186960	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26508
1.86910658682012e-15	-0.287276510647221	0.526	0.632	4.16343492214181e-11	POLR2G	Malignant cells	GSE186960	ENSG00000168002	5436	RNA polymerase II subunit G	hRPB19|hsRPB7|RPB7	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26509
2.20310492538282e-15	-0.269342180546372	0.279	0.403	4.90741622129024e-11	RFK	Malignant cells	GSE186960	ENSG00000135002	55312	riboflavin kinase	FLJ11149|RIFK	protein_coding	Q969G6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26510
2.65197012363449e-15	0.257584947992608	0.252	0.119	5.90726345039583e-11	GAL	Malignant cells	GSE186960	ENSG00000069482	51083	galanin and GMAP prepropeptide	GAL-GMAP|GALN|GLNN|GMAP	protein_coding	P22466	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26511
2.67992040320461e-15	0.253032806547226	0.867	0.834	5.96952269813828e-11	C4orf48	Malignant cells	GSE186960	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26512
3.71357545287243e-15	-0.255497457510941	0.229	0.348	8.27198932127333e-11	MSL1	Malignant cells	GSE186960	ENSG00000188895	339287	MSL complex subunit 1	DKFZp686P24239|hMSL1|MSL-1	protein_coding	Q68DK7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26513
3.82096780496879e-15	0.250848131360234	0.901	0.854	8.51120578556798e-11	SPAG9	Malignant cells	GSE186960	ENSG00000008294	9043	sperm associated antigen 9	CT89|FLJ13450|FLJ14006|FLJ26141|FLJ34602|HLC4|HSS|JIP-4|JIP4|JLP|KIAA0516|MGC117291|MGC14967|MGC74461|PHET|PIG6|SYD1	protein_coding	O60271	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26514
4.45446722377639e-15	0.259290367295017	0.654	0.523	9.92232574096191e-11	PNPT1	Malignant cells	GSE186960	ENSG00000138035	87178	polyribonucleotide nucleotidyltransferase 1	DFNB70|old-35|OLD35|PNPase	protein_coding	Q8TCS8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26515
4.57375863175827e-15	-0.260889171272369	0.726	0.822	1.01880473522416e-10	GLRX3	Malignant cells	GSE186960	ENSG00000108010	10539	glutaredoxin 3	bA500G10.4|GLRX4|GRX3|GRX4|PICOT|TXNL2	protein_coding	O76003	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26516
4.86979012554064e-15	-0.345844905066376	0.502	0.58	1.08474575046418e-10	TAOK3	Malignant cells	GSE186960	ENSG00000135090	51347	TAO kinase 3	DPK|JIK|MAP3K18	protein_coding	Q9H2K8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26517
7.17857067749181e-15	-0.318927648198396	0.381	0.484	1.5990266184113e-10	MSRB3	Malignant cells	GSE186960	ENSG00000174099	253827	methionine sulfoxide reductase B3	DFNB74|DKFZp686C1178|FLJ36866	protein_coding	Q8IXL7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26518
7.5617355110234e-15	-0.269165589332596	0.269	0.388	1.68437658508046e-10	C16orf62	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26519
8.09441358293333e-15	-0.301558596361109	0.356	0.463	1.8030306255984e-10	EIF2B3	Malignant cells	GSE186960	ENSG00000070785	8891	eukaryotic translation initiation factor 2B subunit gamma	EIF-2B|EIF2Bgamma	protein_coding	Q9NR50	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26520
8.16437421374532e-15	-0.307088001750991	0.357	0.47	1.81861435611177e-10	MRPL49	Malignant cells	GSE186960	ENSG00000149792	740	mitochondrial ribosomal protein L49	C11orf4|L49mt|NOF|NOF1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26521
9.24143793673445e-15	-0.267621844087552	0.795	0.87	2.0585303004076e-10	USP1	Malignant cells	GSE186960	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26522
9.45813635144074e-15	-0.317404326293719	0.383	0.491	2.10679987228343e-10	DNAJB1	Malignant cells	GSE186960	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26523
9.67598985657869e-15	-0.331672152354066	0.433	0.521	2.1553267405529e-10	DDX56	Malignant cells	GSE186960	ENSG00000136271	54606	DEAD-box helicase 56	NOH61	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26524
9.68716414645952e-15	-0.301352677205205	0.436	0.534	2.15781581362386e-10	VPS26A	Malignant cells	GSE186960	ENSG00000122958	9559	VPS26 retromer complex component A	Hbeta58|PEP8A|VPS26	protein_coding	O75436	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26525
9.9272791619918e-15	-0.256995514906672	0.695	0.787	2.21130143333367e-10	APEX1	Malignant cells	GSE186960	ENSG00000100823	328	apurinic/apyrimidinic endodeoxyribonuclease 1	APE|APE-1|APEN|APEX|APX|HAP1|REF-1|REF1	protein_coding	P27695	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26526
1.09858236986102e-14	0.254863504228204	0.777	0.696	2.44709222886543e-10	SRA1	Malignant cells	GSE186960	ENSG00000213523	10011	steroid receptor RNA activator 1	SRA|STRAA1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26527
1.1211870686678e-14	0.283160788332544	0.595	0.466	2.49744419545753e-10	MSH6	Malignant cells	GSE186960	ENSG00000116062	2956	mutS homolog 6	GTBP|MSH-6	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26528
1.13705405682866e-14	-0.27255708806962	0.279	0.397	2.53278791158585e-10	PCCB	Malignant cells	GSE186960	ENSG00000114054	5096	propionyl-CoA carboxylase subunit beta	NA	protein_coding	P05166	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26529
1.28441958837188e-14	-0.297319434671468	0.359	0.467	2.86104463309836e-10	TRIP13	Malignant cells	GSE186960	ENSG00000071539	9319	thyroid hormone receptor interactor 13	16E1BP	protein_coding	Q15645	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26530
1.35946599442703e-14	-0.274487785802449	0.282	0.394	3.02821050258621e-10	DLD	Malignant cells	GSE186960	ENSG00000091140	1738	dihydrolipoamide dehydrogenase	DLDH|E3|GCSL|LAD|OGDC-E3	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26531
1.51007406096487e-14	-0.262829310299628	0.2	0.315	3.36368997079926e-10	C17orf70	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26532
1.57345863839746e-14	0.250337732325513	0.252	0.122	3.50487911703034e-10	SDC4	Malignant cells	GSE186960	ENSG00000124145	6385	syndecan 4	amphiglycan|ryudocan|SYND4	protein_coding	P31431	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26533
1.64016699830275e-14	-0.316460242217429	0.373	0.479	3.65347198871938e-10	IP6K2	Malignant cells	GSE186960	ENSG00000068745	51447	inositol hexakisphosphate kinase 2	IHPK2	protein_coding	Q9UHH9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26534
1.74403672097342e-14	-0.300423385399097	0.655	0.748	3.88484179596828e-10	PPP1R12A	Malignant cells	GSE186960	ENSG00000058272	4659	protein phosphatase 1 regulatory subunit 12A	M130|MBS|MYPT1	protein_coding	O14974	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26535
1.92493703556227e-14	-0.295424846215545	0.39	0.5	4.28779724671496e-10	FH	Malignant cells	GSE186960	ENSG00000091483	2271	fumarate hydratase	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26536
2.28157579766064e-14	-0.287111906145719	0.396	0.501	5.08221008928908e-10	RBM28	Malignant cells	GSE186960	ENSG00000106344	55131	RNA binding motif protein 28	FLJ10377	protein_coding	Q9NW13	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26537
2.34428721111822e-14	-0.272188242113886	0.265	0.381	5.22189976276583e-10	DHRS7	Malignant cells	GSE186960	ENSG00000100612	51635	dehydrogenase/reductase 7	retDSR4|SDR34C1	protein_coding	Q9Y394	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26538
2.58107898156231e-14	-0.284239999269424	0.365	0.473	5.74935343143004e-10	MRPL16	Malignant cells	GSE186960	ENSG00000166902	54948	mitochondrial ribosomal protein L16	FLJ20484|PNAS-111	protein_coding	Q9NX20	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26539
2.68916299438223e-14	-0.304437597993084	0.419	0.517	5.99011056998642e-10	MED4	Malignant cells	GSE186960	ENSG00000136146	29079	mediator complex subunit 4	DRIP36|HSPC126|TRAP36|VDRIP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26540
2.79324236715668e-14	0.280341904850095	0.649	0.537	6.2219473728415e-10	ARHGAP11A	Malignant cells	GSE186960	ENSG00000275568	9824	Rho GTPase activating protein 11A	KIAA0013	protein_coding	Q6P4F7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26541
2.86750091135342e-14	-0.267283627764568	0.636	0.719	6.38735828003973e-10	LLPH	Malignant cells	GSE186960	ENSG00000139233	84298	LLP homolog, long-term synaptic facilitation factor	C12orf31|hLLP|MGC14817	protein_coding	Q9BRT6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26542
3.38499957478786e-14	-0.324255676136234	0.417	0.516	7.54008655283995e-10	BPTF	Malignant cells	GSE186960	ENSG00000171634	2186	bromodomain PHD finger transcription factor	FAC1|FALZ|NURF301	protein_coding	Q12830	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26543
3.44450074377837e-14	-0.274561523529871	0.333	0.444	7.67262540676631e-10	CISD3	Malignant cells	GSE186960	ENSG00000274768	284106	CDGSH iron sulfur domain 3	Miner2|MiNT	protein_coding	P0C7P0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26544
3.46509800360375e-14	-0.317879888907798	0.42	0.523	7.71850580302736e-10	TOPORS	Malignant cells	GSE186960	ENSG00000197579	10210	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	LUN|RP31|TP53BPL	protein_coding	Q9NS56	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26545
3.66757939867469e-14	-0.295325934911121	0.947	0.983	8.16953311054788e-10	HSPA5	Malignant cells	GSE186960	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26546
4.19286628354589e-14	-0.250651124526371	0.879	0.933	9.33960964659848e-10	SUPT16H	Malignant cells	GSE186960	ENSG00000092201	11198	SPT16 homolog, facilitates chromatin remodeling subunit	CDC68|FACT|FACTP140|FLJ10857|FLJ14010|SPT16/CDC68	protein_coding	Q9Y5B9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26547
4.89064053770174e-14	-0.251085695437868	0.852	0.91	1.08939017977306e-09	EIF3D	Malignant cells	GSE186960	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26548
5.71375407650877e-14	-0.269526185201003	0.326	0.443	1.27273872054233e-09	ACTR1A	Malignant cells	GSE186960	ENSG00000138107	10121	actin related protein 1A	ARP1|Arp1A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26549
5.83427857562043e-14	-0.300019702999181	0.428	0.532	1.29958555271945e-09	NELFCD	Malignant cells	GSE186960	ENSG00000101158	51497	negative elongation factor complex member C/D	HSPC130|NELF-C|NELF-D|TH1|TH1L	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26550
6.98240000719796e-14	-0.273117258434949	0.451	0.55	1.55532960160335e-09	CCDC12	Malignant cells	GSE186960	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26551
7.00831070201541e-14	-0.282279987450728	0.34	0.45	1.56110120887393e-09	AKR1B1	Malignant cells	GSE186960	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26552
7.22314515203954e-14	-0.324008349919298	0.434	0.526	1.60895558261681e-09	EZH2	Malignant cells	GSE186960	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26553
8.22668223061617e-14	-0.317465395068543	0.422	0.521	1.83249346686975e-09	ZC3H14	Malignant cells	GSE186960	ENSG00000100722	79882	zinc finger CCCH-type containing 14	FLJ11806|NY-REN-37|UKp68	protein_coding	Q6PJT7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26554
1.00525078520463e-13	-0.334235497520051	0.626	0.689	2.2391961240433e-09	HELLS	Malignant cells	GSE186960	ENSG00000119969	3070	helicase, lymphoid specific	LSH|Nbla10143|PASG|SMARCA6	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26555
1.14280830840511e-13	-0.320197429132854	0.406	0.503	2.54560550697239e-09	FYTTD1	Malignant cells	GSE186960	ENSG00000122068	84248	forty-two-three domain containing 1	DKFZp761B1514|UIF	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26556
1.78750468430946e-13	-0.262628494033891	0.333	0.446	3.98166668429932e-09	ZCCHC7	Malignant cells	GSE186960	ENSG00000147905	84186	zinc finger CCHC-type containing 7	AIR1|FLJ22611	protein_coding	Q8N3Z6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26557
1.79626409312619e-13	-0.25275364545332	0.316	0.43	4.00117826743859e-09	QTRTD1	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26558
2.23069763166337e-13	-0.28031890745593	0.619	0.695	4.96887897453015e-09	PDIA4	Malignant cells	GSE186960	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26559
2.48894175691754e-13	-0.271412028511041	0.343	0.454	5.54411776353383e-09	SHOC2	Malignant cells	GSE186960	ENSG00000108061	8036	SHOC2 leucine rich repeat scaffold protein	KIAA0862|SOC-2|SOC2|SUR-8|SUR8	protein_coding	Q9UQ13	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26560
2.63627807063405e-13	-0.280947683523482	0.332	0.437	5.87230940233736e-09	FOXA2	Malignant cells	GSE186960	ENSG00000125798	3170	forkhead box A2	HNF3B	protein_coding	Q9Y261	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26561
3.22347894485297e-13	-0.28268434067197	0.348	0.448	7.18029934965998e-09	SEPT6	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26562
3.38554849076906e-13	-0.282604481814758	0.415	0.516	7.54130926318809e-09	HSPBP1	Malignant cells	GSE186960	ENSG00000133265	23640	HSPA (Hsp70) binding protein 1	FES1	protein_coding	Q9NZL4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26563
3.81184036868426e-13	-0.262032347817918	0.385	0.49	8.49087442124418e-09	PRPF19	Malignant cells	GSE186960	ENSG00000110107	27339	pre-mRNA processing factor 19	hPSO4|NMP200|PRP19|PSO4|SNEV|UBOX4	protein_coding	Q9UMS4	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26564
3.98961691184814e-13	-0.260854645844384	0.29	0.403	8.88687167114174e-09	ZWILCH	Malignant cells	GSE186960	ENSG00000174442	55055	zwilch kinetochore protein	FLJ10036|KNTC1AP	protein_coding	Q9H900	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26565
4.21795295749674e-13	-0.324159752398033	0.481	0.554	9.39549021282399e-09	ZCCHC17	Malignant cells	GSE186960	ENSG00000121766	51538	zinc finger CCHC-type containing 17	HSPC251|pNO40|PS1D	protein_coding	Q9NP64	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26566
4.35448400364279e-13	-0.283834862876046	0.437	0.527	9.69961311811431e-09	NSMCE1	Malignant cells	GSE186960	ENSG00000169189	197370	NSE1 homolog, SMC5-SMC6 complex component	NSE1	protein_coding	Q8WV22	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26567
4.78618990817535e-13	-0.274337238704721	0.366	0.47	1.06612380204606e-08	TSR2	Malignant cells	GSE186960	ENSG00000158526	90121	TSR2 ribosome maturation factor	DT1P1A10|RP1-112K5.2|WGG1	protein_coding	Q969E8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26568
4.86988953841422e-13	-0.250713479091659	0.274	0.388	1.08476789468177e-08	SSFA2	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26569
5.51181498815041e-13	-0.28227728639858	0.452	0.547	1.2277567886105e-08	BRMS1	Malignant cells	GSE186960	ENSG00000174744	25855	BRMS1 transcriptional repressor and anoikis regulator	DKFZP564A063	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26570
5.59947469061253e-13	-0.263779879766609	0.706	0.774	1.24728298733394e-08	USP7	Malignant cells	GSE186960	ENSG00000187555	7874	ubiquitin specific peptidase 7	HAUSP	protein_coding	Q93009	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26571
6.37881223990392e-13	-0.282564383297901	0.361	0.458	1.4208804264386e-08	BCL2L12	Malignant cells	GSE186960	ENSG00000126453	83596	BCL2 like 12	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26572
7.18511045956411e-13	-0.285163812222148	0.364	0.463	1.60048335486791e-08	CCM2	Malignant cells	GSE186960	ENSG00000136280	83605	CCM2 scaffold protein	C7orf22|MGC4607|OSM	protein_coding	Q9BSQ5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26573
7.60793858366138e-13	-0.25377337903579	0.56	0.649	1.69466831951057e-08	SUGT1	Malignant cells	GSE186960	ENSG00000165416	10910	SGT1 homolog, MIS12 kinetochore complex assembly cochaperone	SGT1	protein_coding	Q9Y2Z0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26574
8.67329110583742e-13	-0.279772776588125	0.461	0.56	1.93197559382529e-08	TMEM30A	Malignant cells	GSE186960	ENSG00000112697	55754	transmembrane protein 30A	C6orf67|CDC50A|FLJ10856	protein_coding	Q9NV96	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26575
9.46928712148829e-13	-0.270434834640058	0.466	0.557	2.10928370631152e-08	SAR1A	Malignant cells	GSE186960	ENSG00000079332	56681	secretion associated Ras related GTPase 1A	SAR1|Sara|SARA1	protein_coding	Q9NR31	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26576
9.85142155572548e-13	-0.269591166824073	0.381	0.483	2.19440415153785e-08	TMEM70	Malignant cells	GSE186960	ENSG00000175606	54968	transmembrane protein 70	FLJ20533	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26577
9.90723898064145e-13	-0.352099426000404	0.25	0.354	2.20683748293788e-08	GPRC5A	Malignant cells	GSE186960	ENSG00000013588	9052	G protein-coupled receptor class C group 5 member A	PEIG-1|RAI3|RAIG1|TIG1	protein_coding	Q8NFJ5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26578
1.02479866446736e-12	-0.287927988237551	0.412	0.511	2.28273902510104e-08	CLMN	Malignant cells	GSE186960	ENSG00000165959	79789	calmin	FLJ12383|KIAA0500|KIAA1188	protein_coding	Q96JQ2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26579
1.03273173796679e-12	-0.301830453087712	0.339	0.436	2.30040994632102e-08	CEP89	Malignant cells	GSE186960	ENSG00000121289	84902	centrosomal protein 89	CCDC123|FLJ14640	protein_coding	Q96ST8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26580
1.07735038597041e-12	-0.275320047828427	0.386	0.483	2.39979798474909e-08	HOXC10	Malignant cells	GSE186960	ENSG00000180818	3226	homeobox C10	HOX3I	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26581
1.29614006994868e-12	-0.296953635397535	0.457	0.532	2.88715200581069e-08	MAGOHB	Malignant cells	GSE186960	ENSG00000111196	55110	mago homolog B, exon junction complex subunit	FLJ10292|MGN2	protein_coding	Q96A72	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26582
1.63780306707936e-12	-0.330536466606615	0.372	0.46	3.64820633191926e-08	DAP	Malignant cells	GSE186960	ENSG00000112977	1611	death associated protein	DAP1	protein_coding	P51397	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26583
2.31552826404266e-12	-0.250073091510107	0.301	0.405	5.15783920815504e-08	RNF11	Malignant cells	GSE186960	ENSG00000123091	26994	ring finger protein 11	CGI-123|MGC51169|Sid1669p	protein_coding	Q9Y3C5	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26584
2.42885532499835e-12	-0.264538669740683	0.314	0.415	5.41027523643383e-08	RRP1	Malignant cells	GSE186960	ENSG00000160214	8568	ribosomal RNA processing 1	D21S2056E|NNP-1|Nop52|RRP1A	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26585
2.63626285843219e-12	-0.262791339930045	0.866	0.917	5.87227551715771e-08	HSPH1	Malignant cells	GSE186960	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26586
2.98912788060231e-12	-0.312318313811007	0.491	0.563	6.65828235404165e-08	RP11-357H14.17	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26587
3.00660144855591e-12	-0.294768899094152	0.45	0.537	6.69720472665829e-08	MYH10	Malignant cells	GSE186960	ENSG00000133026	4628	myosin heavy chain 10	NMMHCB	protein_coding	P35580	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26588
3.94274795464398e-12	-0.2977481318637	0.348	0.444	8.78247106896947e-08	MYBL1	Malignant cells	GSE186960	ENSG00000185697	4603	MYB proto-oncogene like 1	A-myb|AMYB	protein_coding	P10243	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26589
4.03676575557698e-12	-0.28529696480572	0.335	0.431	8.99189572054772e-08	POLD3	Malignant cells	GSE186960	ENSG00000077514	10714	DNA polymerase delta 3, accessory subunit	KIAA0039|P66|P68|PPP1R128	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26590
4.17359390961338e-12	-0.283099306116543	0.525	0.6	9.2966804336638e-08	TMEM167A	Malignant cells	GSE186960	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26591
4.45998007780133e-12	-0.266623243381929	0.357	0.456	9.93460562330247e-08	SNX4	Malignant cells	GSE186960	ENSG00000114520	8723	sorting nexin 4	ATG24B	protein_coding	O95219	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26592
4.48293423147551e-12	-0.303311408648109	0.59	0.668	9.9857360006117e-08	BAZ1A	Malignant cells	GSE186960	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26593
5.03620482924163e-12	-0.254344032407042	0.608	0.689	1.12181462571357e-07	TXNL1	Malignant cells	GSE186960	ENSG00000091164	9352	thioredoxin like 1	TRP32|Txl|TXNL	protein_coding	O43396	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26594
5.16062065997855e-12	-0.258978218800094	0.32	0.424	1.14952825201022e-07	FAM98B	Malignant cells	GSE186960	ENSG00000171262	283742	family with sequence similarity 98 member B	FLJ38426	protein_coding	Q52LJ0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26595
5.7555699397496e-12	-0.255702644853844	0.369	0.468	1.28205320407922e-07	KIF2A	Malignant cells	GSE186960	ENSG00000068796	3796	kinesin family member 2A	HK2|KIF2	protein_coding	O00139	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26596
6.32953315595261e-12	-0.28669435306133	0.302	0.401	1.40990351048844e-07	CDC6	Malignant cells	GSE186960	ENSG00000094804	990	cell division cycle 6	CDC18L	protein_coding	Q99741	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26597
7.15955695747152e-12	-0.265667745172749	0.549	0.64	1.59479131227678e-07	MYO10	Malignant cells	GSE186960	ENSG00000145555	4651	myosin X	KIAA0799|MyoX	protein_coding	Q9HD67	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26598
7.58295016278725e-12	-0.261037180465419	0.485	0.572	1.68910214876086e-07	C4orf3	Malignant cells	GSE186960	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26599
8.83793205336147e-12	-0.269940991138561	0.357	0.454	1.96864936488627e-07	POLR1E	Malignant cells	GSE186960	ENSG00000137054	64425	RNA polymerase I subunit E	FLJ13390|FLJ13970|PAF53|PRAF1|RPA49	protein_coding	Q9GZS1	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26600
9.70747864234185e-12	-0.25789679949231	0.588	0.672	2.16234086758165e-07	CCDC47	Malignant cells	GSE186960	ENSG00000108588	57003	coiled-coil domain containing 47	GK001	protein_coding	Q96A33	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26601
9.80509020673781e-12	-0.260665063304402	0.308	0.407	2.18408384355085e-07	UBE2Q1	Malignant cells	GSE186960	ENSG00000160714	55585	ubiquitin conjugating enzyme E2 Q1	NICE-5|PRO3094|UBE2Q	protein_coding	Q7Z7E8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26602
9.89172435740395e-12	-0.268222689366596	0.412	0.504	2.20338160061173e-07	RPA2	Malignant cells	GSE186960	ENSG00000117748	6118	replication protein A2	NA	protein_coding	P15927	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26603
9.97986556854193e-12	-0.311263812345905	0.441	0.519	2.22301505539271e-07	LAMP2	Malignant cells	GSE186960	ENSG00000005893	3920	lysosomal associated membrane protein 2	CD107b	protein_coding	P13473	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26604
1.00687813603082e-11	-0.264242274116053	0.461	0.549	2.24282104800864e-07	MRPS33	Malignant cells	GSE186960	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26605
1.10981994473807e-11	-0.3394917571553	0.705	0.779	2.47212392690404e-07	KLF6	Malignant cells	GSE186960	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26606
1.16770528925445e-11	-0.253154287425988	0.645	0.721	2.60106353181429e-07	LMNB2	Malignant cells	GSE186960	ENSG00000176619	84823	lamin B2	LMN2	protein_coding	Q03252	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26607
1.37701673107444e-11	-0.277020093598361	0.328	0.424	3.0673047684683e-07	MCM10	Malignant cells	GSE186960	ENSG00000065328	55388	minichromosome maintenance 10 replication initiation factor	CNA43|DNA43|PRO2249	protein_coding	Q7L590	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26608
1.57260045839996e-11	-0.252505509458245	0.3	0.401	3.50296752108592e-07	CCNL2	Malignant cells	GSE186960	ENSG00000221978	81669	cyclin L2	ania-6b|CCNM|CCNS|HLA-ISO|PCEE|SB138	protein_coding	Q96S94	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26609
1.58106604831839e-11	-0.298517348319756	0.509	0.577	3.52182462262921e-07	HEXB	Malignant cells	GSE186960	ENSG00000049860	3074	hexosaminidase subunit beta	NA	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26610
1.83030188792415e-11	-0.284857551359216	0.412	0.501	4.07699745535103e-07	RGS20	Malignant cells	GSE186960	ENSG00000147509	8601	regulator of G protein signaling 20	RGSZ1|ZGAP1	protein_coding	O76081	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26611
1.89432903173596e-11	-0.270951415571026	0.378	0.468	4.21961791819185e-07	NOL11	Malignant cells	GSE186960	ENSG00000130935	25926	nucleolar protein 11	DKFZP586L0724	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26612
2.08226673651956e-11	-0.321985225003135	0.452	0.534	4.63824915559731e-07	C19orf33	Malignant cells	GSE186960	ENSG00000167644	64073	chromosome 19 open reading frame 33	H2RSP|IMUP|IMUP-1|IMUP-2	protein_coding	Q9GZP8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26613
2.08833065708253e-11	-0.257541289074414	0.333	0.436	4.65175653865134e-07	UTP23	Malignant cells	GSE186960	ENSG00000147679	84294	UTP23 small subunit processome component	C8orf53|MGC14595	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26614
2.51649370848523e-11	-0.263279564469246	0.368	0.458	5.60548973565086e-07	NXT1	Malignant cells	GSE186960	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26615
2.66105753852948e-11	-0.258258098742044	0.649	0.723	5.92750566707441e-07	CYSTM1	Malignant cells	GSE186960	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26616
3.4928449226147e-11	-0.310006980584605	0.477	0.543	7.78031206512424e-07	EIF4G3	Malignant cells	GSE186960	ENSG00000075151	8672	eukaryotic translation initiation factor 4 gamma 3	eIF4GII	protein_coding	O43432	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26617
4.03823077062001e-11	-0.296881772685304	0.496	0.559	8.99515904155607e-07	BMS1	Malignant cells	GSE186960	ENSG00000165733	9790	BMS1 ribosome biogenesis factor	BMS1L|KIAA0187	protein_coding	Q14692	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26618
4.68682049915964e-11	-0.301774367648939	0.367	0.45	1.04398926618781e-06	COLGALT1	Malignant cells	GSE186960	ENSG00000130309	79709	collagen beta(1-O)galactosyltransferase 1	FLJ22329|GLT25D1	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26619
4.8619092932551e-11	-0.263157927298385	0.298	0.394	1.08299029507257e-06	HOXB6	Malignant cells	GSE186960	ENSG00000108511	3216	homeobox B6	HOX2|HOX2B	protein_coding	P17509	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26620
7.19781339961093e-11	0.282739875598435	0.919	0.913	1.60331293476334e-06	ID3	Malignant cells	GSE186960	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26621
8.08575189129306e-11	-0.42509189937705	0.255	0.344	1.80110123378553e-06	CTGF	Malignant cells	GSE186960	NA	NA	NA	NA	NA	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26622
1.17381704173718e-10	-0.253367781287552	0.352	0.441	2.61467746046956e-06	CRLS1	Malignant cells	GSE186960	ENSG00000088766	54675	cardiolipin synthase 1	C20orf155|CLS1|dJ967N21.6|GCD10	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26623
2.01165024650889e-10	-0.257082002065978	0.4	0.486	4.48095092409854e-06	CEP63	Malignant cells	GSE186960	ENSG00000182923	80254	centrosomal protein 63	FLJ13386	protein_coding	Q96MT8	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26624
2.31986747983387e-10	-0.288738418625983	0.4	0.479	5.16750481132994e-06	RAI14	Malignant cells	GSE186960	ENSG00000039560	26064	retinoic acid induced 14	DKFZp564G013|KIAA1334|NORPEG|RAI13	protein_coding	Q9P0K7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26625
8.50620920585424e-10	-0.269190727022825	0.5	0.564	1.89475810060403e-05	PGRMC1	Malignant cells	GSE186960	ENSG00000101856	10857	progesterone receptor membrane component 1	HPR6.6	protein_coding	O00264	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26626
1.07377281066158e-09	-0.258392914591214	0.509	0.58	2.39182893574868e-05	SYAP1	Malignant cells	GSE186960	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26627
1.92239998114323e-09	-0.268445139324455	0.458	0.521	4.28214595799655e-05	CAV2	Malignant cells	GSE186960	ENSG00000105971	858	caveolin 2	CAV	protein_coding	P51636	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26628
1.98312799365744e-09	-0.303365581453496	0.496	0.547	4.41741760587195e-05	BUB1B	Malignant cells	GSE186960	ENSG00000156970	701	BUB1 mitotic checkpoint serine/threonine kinase B	Bub1A|BUBR1|MAD3L|SSK1	protein_coding	O60566	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26629
2.67066139149513e-09	-0.255128623744811	0.465	0.532	5.94889824955541e-05	TYW3	Malignant cells	GSE186960	ENSG00000162623	127253	tRNA-yW synthesizing protein 3 homolog	C1orf171|FLJ40918	protein_coding	Q6IPR3	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26630
3.00563334592108e-09	-0.265790003192845	0.422	0.494	6.6950482780392e-05	PPP2R2A	Malignant cells	GSE186960	ENSG00000221914	5520	protein phosphatase 2 regulatory subunit Balpha	B55A|B55alpha|PR52A|PR55A|PR55alpha	protein_coding	P63151	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26631
3.01370126200222e-09	-0.252873205060669	0.484	0.546	6.71301956110995e-05	CAMLG	Malignant cells	GSE186960	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26632
1.70600270583609e-08	-0.259400705395074	0.41	0.476	0.000380012102724989	PHF20	Malignant cells	GSE186960	ENSG00000025293	51230	PHD finger protein 20	C20orf104|dJ1121G12.1|TDRD20A	protein_coding	Q9BVI0	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26633
2.04049397299836e-08	-0.273884333891443	0.622	0.669	0.000454520032485384	KIF20B	Malignant cells	GSE186960	ENSG00000138182	9585	kinesin family member 20B	CT90|KRMP1|MPHOSPH1|MPP1	protein_coding	Q96Q89	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26634
2.05034413397082e-08	-0.256717237133513	0.385	0.453	0.000456714155841999	EXOSC1	Malignant cells	GSE186960	ENSG00000171311	51013	exosome component 1	CGI-108|CSL4|Csl4p|hCsl4p|p13|SKI4|Ski4p	protein_coding	Q9Y3B2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26635
2.38935471310185e-08	-0.315316787404843	0.561	0.62	0.000532228762343437	PEG10	Malignant cells	GSE186960	ENSG00000242265	23089	paternally expressed 10	HB-1|KIAA1051|Mar2|Mart2|MEF3L|RGAG3|RTL2|SIRH1	protein_coding	Q86TG7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26636
3.79268923691442e-08	0.301035260007036	0.645	0.574	0.000844821527522686	ISG15	Malignant cells	GSE186960	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26637
3.84595428373191e-08	-0.258644861403986	0.458	0.519	0.000856686316701282	EMC3	Malignant cells	GSE186960	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26638
7.40937451732681e-07	-0.257504547053651	0.43	0.477	0.0165043817373455	TNRC6A	Malignant cells	GSE186960	ENSG00000288130	27327	trinucleotide repeat containing adaptor 6A	CAGH26|GW182|KIAA1460|TNRC6	protein_coding	Q8NDV7	GSE186960	GSE186960	Pancreatic cancer	Pancreatic ductal adenocarcinoma (PDAC)	Chemotherapy	NA	gemcitabine	Homo sapiens	Panc1 cell line	Cell line	resistant 1, sensitive 1	2	6136	Public on Mar 21, 2022	35476525	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA776896	DropSeq and 10x genomics	Casava1.7 and CellRanger 6.0.0	Pancreatic_cancer	Chemotherapy	26639
0	-0.358869721869919	0.999	0.999	0	RPL11	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26640
0	0.31891436354358	0.998	0.997	0	SH3BGRL3	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26641
0	-0.458454418484596	0.122	0.332	0	MAL	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000172005	4118	mal, T cell differentiation protein	MVP17|VIP17	protein_coding	P21145	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26642
0	0.726512534330066	0.579	0.348	0	DUSP2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26643
0	-0.457287822672836	0.997	0.998	0	RPL32	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26644
0	-0.402937198198892	0.998	0.998	0	RPL14	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26645
0	-0.525314055257034	0.073	0.259	0	CISH	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000114737	1154	cytokine inducible SH2 containing protein	CIS|CIS-1|G18|SOCS	protein_coding	Q9NSE2	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26646
0	-0.364325341525088	0.995	0.995	0	RPL35A	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26647
0	-0.641192985605736	0.919	0.952	0	RPL9	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26648
0	-0.452453104882371	0.997	0.996	0	RPL34	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26649
0	-0.592056281143378	0.181	0.409	0	IL7R	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26650
0	-0.444547603986254	0.998	0.998	0	RPS23	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26651
0	0.42607038021076	0.878	0.709	0	PSMB9	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26652
0	0.503597581651009	1	1	0	ACTB	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26653
0	0.409514725146073	0.986	0.965	0	PPIA	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26654
0	-0.480007456978383	0.998	0.999	0	RPL30	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26655
0	-0.491724914736005	0.954	0.983	0	IFITM1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26656
0	-0.338118324552602	0.998	0.999	0	FAU	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26657
0	0.343443442936087	0.999	0.993	0	CFL1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26658
0	-0.466589110079378	0.995	0.994	0	RPS25	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26659
0	0.378755853537519	0.994	0.966	0	MYL6	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26660
0	0.459465022069112	0.984	0.905	0	CORO1A	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26661
0	0.596604113541318	0.881	0.729	0	COTL1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26662
0	0.4238760513496	0.999	0.997	0	PFN1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26663
0	0.550457462525231	0.995	0.978	0	ACTG1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26664
0	-0.327291838546255	0.999	0.999	0	RPS15	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26665
0	-0.384135901572447	0.995	0.994	0	RPL36	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26666
0	-0.35018561382687	0.998	0.998	0	RPL18A	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26667
0	-0.662465790849732	1	1	0	RPS19	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26668
0	-0.410635900611205	1	1	0	RPL28	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26669
0	0.343751566457686	0.958	0.868	0	RAC2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26670
0	-0.478120264120314	0.996	0.993	0	RPL39	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26671
0	-0.555155352611549	0.648	0.878	0	RPS4Y1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26672
0	0.353053252809121	0.999	1	0	MT-CO1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26673
1.70654831939585e-306	-0.382661305583731	0.912	0.943	4.22899739029486e-302	RPL26	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26674
4.81724697242217e-300	-0.461761716655027	0.873	0.921	1.19376197223594e-295	FXYD5	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26675
1.16203547298944e-294	0.318343276964761	0.98	0.89	2.87964010561514e-290	CYBA	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26676
1.0791056616469e-291	0.371153596106439	0.549	0.329	2.67413174012717e-287	SIT1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000137078	27240	signaling threshold regulating transmembrane adaptor 1	SIT	protein_coding	Q9Y3P8	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26677
6.76497693760863e-290	0.463439434273907	0.997	0.985	1.67642893490879e-285	GAPDH	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26678
9.01147335035115e-289	0.440757933317203	0.858	0.586	2.23313321095052e-284	GZMA	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26679
1.0816121767654e-288	0.367979697574225	0.743	0.536	2.68034313524233e-284	ARPC5	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26680
2.59463721854193e-288	0.468405442217055	0.521	0.312	6.42977049126875e-284	CD27	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26681
1.00156967878586e-286	0.330525342859352	0.88	0.72	2.48198982099924e-282	PPP1CA	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26682
1.05508810456383e-281	-0.459990432334737	0.998	0.997	2.61461383191962e-277	RPS27	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26683
5.15390845539396e-277	-0.39479337578521	0.997	0.995	1.27719005433118e-272	RPS28	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26684
2.23109962959574e-276	0.454256244284258	0.838	0.732	5.52888799210121e-272	CNN2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26685
1.64007365977533e-275	-0.439791110656205	0.316	0.511	4.06426653628924e-271	PTGER2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000125384	5732	prostaglandin E receptor 2	EP2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26686
2.29540479202087e-270	-0.312418361650512	0.997	0.998	5.68824261510692e-266	RPL12	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26687
1.15560541338504e-268	0.344429412899453	0.919	0.806	2.86370577490946e-264	CD3D	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26688
5.91351845744127e-261	-0.448398769617591	0.992	0.992	1.46542900893852e-256	RPS3A	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26689
1.36732980246096e-260	0.387724320629869	0.978	0.942	3.3883799834785e-256	CD74	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26690
8.41144866071666e-260	0.345649016825282	0.915	0.819	2.0844410926122e-255	LIMD2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26691
6.01192848526895e-259	0.360122012826006	0.815	0.646	1.4898159979345e-254	CD3G	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26692
2.97980608428559e-257	0.478969961682994	0.841	0.652	7.38425745746811e-253	MT2A	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26693
1.48762698751151e-256	0.327937857493877	0.837	0.679	3.68648843775228e-252	LCK	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000182866	3932	LCK proto-oncogene, Src family tyrosine kinase	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26694
8.47211091936938e-256	-0.447223439070133	0.998	0.999	2.09947380692893e-251	RPS12	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26695
1.16063264723194e-253	0.720929580257489	0.429	0.241	2.87616376310548e-249	GZMK	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26696
6.0838927935925e-250	-0.328156700058283	1	1	1.50764947318016e-245	RPL41	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26697
2.47027644575283e-249	0.394601296129349	0.616	0.422	6.12159206022009e-245	JPT1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26698
9.31748549865082e-249	-0.354190862866616	0.997	0.998	2.30896608142066e-244	RPS13	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26699
2.65823324248538e-243	0.298506704019755	0.954	0.843	6.58736779820302e-239	CLIC1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26700
4.11788666525829e-241	-0.295511694652206	0.999	0.999	1.02045349451766e-236	RPL19	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26701
9.43556520593705e-240	-0.360830561616452	0.983	0.987	2.33822741368326e-235	RPL21	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26702
3.82379259766551e-238	0.295842543427584	0.893	0.767	9.4757404362749e-234	CAPZB	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26703
9.31102266548004e-238	0.298374749378338	0.939	0.779	2.30736452673261e-233	ITGB2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26704
2.23768809191362e-235	-0.361247590015247	0.794	0.868	5.54521486057113e-231	TOMM7	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26705
1.06489084554247e-234	-0.433994613154247	0.665	0.775	2.63890600433879e-230	CIRBP	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26706
8.04611858627249e-234	0.297778517697158	0.603	0.415	1.99390864686419e-229	TRMT112	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26707
7.2891246770028e-232	-0.399390083269942	1	1	1.80631798620806e-227	EEF1A1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26708
1.23519290850041e-230	-0.343761197748743	0.109	0.261	3.06093154655486e-226	GPR183	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26709
6.75218042497701e-230	0.295132071525608	0.786	0.562	1.67325783111355e-225	SLC9A3R1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26710
1.42170436520695e-229	0.330180361662704	0.73	0.557	3.52312558741934e-225	C12orf75	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26711
3.87507143317292e-229	0.299643627876916	0.69	0.488	9.60281451854581e-225	CSK	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26712
3.6662099201942e-227	0.31463166725916	0.564	0.375	9.08523480323326e-223	PARP1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26713
8.7216564586633e-225	-0.251682240704874	0.997	0.998	2.16131368702135e-220	RPS24	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26714
1.06493699440219e-224	0.322631826282927	0.63	0.431	2.63902036582806e-220	APOBEC3G	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26715
5.75546578756381e-223	-0.380824953464319	0.998	0.998	1.42626197681619e-218	RPL8	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26716
1.74813251910869e-221	-0.402217758879782	0.458	0.607	4.33204719560323e-217	RPL22	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26717
3.39769649100764e-221	0.349205613717204	0.661	0.514	8.41983167436603e-217	SEPTIN6	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000125354	23157	septin 6	KIAA0128|MGC16619|MGC20339|SEP2|SEPT2|SEPT6	protein_coding	Q14141	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26718
1.90238336432083e-218	-0.294227239505607	0.998	0.999	4.71429621512344e-214	TPT1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26719
1.72363286879047e-216	-0.260444133537431	0.985	0.991	4.27133461214966e-212	EEF1D	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26720
2.30217680514173e-216	0.281532122715426	0.797	0.612	5.70502434082172e-212	ANXA6	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26721
2.53698101351675e-215	0.349003694236719	0.845	0.723	6.28689264959587e-211	PLAAT4	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000133321	5920	phospholipase A and acyltransferase 4	HRASLS4|PLAAT-4|RARRES3|RIG1|TIG3	protein_coding	Q9UL19	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26722
2.84526757251353e-213	0.286365964173441	0.717	0.521	7.05085757144578e-209	PPP1R18	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26723
3.83463058832824e-211	-0.360323066315674	0.983	0.996	9.5025980609362e-207	MALAT1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26724
2.16663657953425e-210	0.255961173534147	1	1	5.36914210774382e-206	TMSB4X	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26725
4.10267644608065e-209	0.358426412049014	0.834	0.679	1.01668425010325e-204	S100A11	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26726
9.56204791016272e-208	-0.401382067648712	0.994	0.995	2.36957109261742e-203	EIF1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26727
3.99055052989984e-207	-0.571454189017756	0.57	0.686	9.8889832681448e-203	KLF6	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26728
1.24757705588245e-205	0.286081791640624	0.811	0.645	3.09162070218231e-201	CAP1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26729
3.99975488633398e-202	0.294684089406759	0.798	0.67	9.91179258382425e-198	PSMA7	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26730
9.01942904667752e-202	-0.423227633522894	0.988	0.985	2.23510471205716e-197	MT-ND4L	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26731
2.66065118343604e-201	0.328539413517674	0.837	0.675	6.59335969767284e-197	UCP2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26732
6.81800649448607e-200	0.357670168003604	0.827	0.744	1.68957018939859e-195	RPS2P5	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000240342	NA	NA	bcm384	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26733
3.94965594805366e-199	-0.351418823339174	0.995	0.996	9.78764240487178e-195	RPS16	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26734
5.82178778715701e-199	0.288711995434587	0.571	0.382	1.44269723153538e-194	DYNLL1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26735
1.38677825205274e-194	0.319471715161352	0.855	0.697	3.43657518641189e-190	FLNA	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26736
3.5480983480255e-194	-0.291817175886932	0.172	0.324	8.79254251624199e-190	FLT3LG	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000090554	2323	fms related receptor tyrosine kinase 3 ligand	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26737
5.52428827361346e-194	0.2762696429305	0.732	0.57	1.36897387708415e-189	SEPTIN1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000180096	1731	septin 1	DIFF6|PNUTL3|SEPT1	protein_coding	Q8WYJ6	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26738
7.45644228677543e-194	-0.303976301179099	1	0.999	1.84778096308582e-189	RPL10	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26739
1.34090872185147e-192	0.290193399141228	0.685	0.515	3.32290590362013e-188	IDH2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26740
8.75364816655281e-192	0.311009238545181	0.546	0.375	2.16924155215345e-187	TRAC	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26741
3.47990124547544e-190	0.279882467942247	0.872	0.76	8.62354327641268e-186	PSME2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26742
1.24299473067363e-187	0.393754932980652	0.653	0.514	3.08026524208233e-183	H2AZ2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000105968	94239	H2A.Z variant histone 2	H2AFV|H2AV|MGC10170|MGC10831|MGC1947	protein_coding	Q71UI9	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26743
1.37197923069365e-187	-0.265492379428056	0.142	0.288	3.39990173158193e-183	PVT1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000249859	NA	NA	LINC00079|MIR1204HG|NCRNA00079|onco-lncRNA-100|TP53LC09	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26744
4.9674342317467e-187	-0.281406195406939	0.998	0.999	1.23097987696915e-182	RPS27A	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26745
5.75843172327988e-187	0.259428752479582	0.933	0.846	1.42699696534599e-182	LSP1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26746
2.30631797664651e-186	-0.311260285357733	0.989	0.992	5.71528657792772e-182	RPL5	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26747
2.70583671919576e-186	-0.342730380877976	0.961	0.975	6.70533397383901e-182	FTL	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26748
4.95407057765122e-185	0.349346499390672	0.572	0.399	1.22766822984775e-180	TRBC1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26749
1.6523069018299e-184	0.341361064698157	0.319	0.171	4.09458173342468e-180	CXCR3	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000186810	2833	C-X-C motif chemokine receptor 3	CD183|CKR-L2|CMKAR3|GPR9|IP10-R|MigR	protein_coding	P49682	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26750
5.44221125691937e-184	0.315908949417395	0.771	0.625	1.34863437157719e-179	ANXA2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26751
3.04457348038518e-182	-0.319023605540788	0.852	0.895	7.54475754174251e-178	RPL7	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26752
7.8063506444122e-177	0.262751848488993	0.954	0.846	1.93449175319179e-172	PTPRC	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26753
4.90608897344508e-176	0.369110819787729	0.867	0.683	1.21577790850942e-171	NKG7	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26754
5.96102994556995e-175	-0.257250615951828	0.994	0.996	1.47720283081169e-170	RPL15	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26755
2.35584488949103e-174	0.407522643966491	0.489	0.325	5.83801922064771e-170	HLA-DRB5	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26756
1.63969830028936e-172	0.255067958336177	0.797	0.615	4.06333635794705e-168	GNAI2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26757
3.68714448233501e-172	-0.282280953558363	0.912	0.944	9.13711274167439e-168	PFDN5	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26758
2.38819164048467e-171	-0.44378797199808	0.439	0.579	5.91817770428506e-167	IFI6	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26759
9.88587863647228e-170	0.316636320078217	0.691	0.5	2.4498195849042e-165	HLA-DRB1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26760
3.22554820906855e-169	-0.329719903581152	0.955	0.956	7.99323101689277e-165	RPL36AL	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26761
2.31919933534366e-166	-0.353613501222379	0.274	0.417	5.74720787291512e-162	SBDS	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26762
9.18245216770433e-163	0.276258484041373	0.673	0.528	2.27550347167881e-158	SELPLG	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26763
4.66714417483086e-162	0.255845818240581	0.802	0.654	1.15656499796484e-157	MSN	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26764
1.17444113445256e-161	0.25592731235175	0.43	0.276	2.91038257528689e-157	KCNAB2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000069424	8514	potassium voltage-gated channel subfamily A regulatory beta subunit 2	AKR6A5|HKvbeta2.1|HKvbeta2.2|KCNA2B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26765
1.50346671297546e-160	0.28234883617323	0.939	0.897	3.72574086142449e-156	HNRNPA2B1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26766
2.48074736105998e-160	0.331655853273922	0.491	0.344	6.14754003544273e-156	HMGA1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26767
2.79335571436592e-160	-0.351947986937166	0.502	0.628	6.92221479577018e-156	RPL17	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26768
1.19493972292653e-159	0.354593829777915	0.784	0.703	2.96118012738425e-155	SLC25A5	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26769
3.03888327415406e-156	0.467174123944541	0.408	0.255	7.53065664168117e-152	STMN1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26770
3.33257323620386e-156	0.290768662238318	0.439	0.286	8.25844973663678e-152	ALYREF	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26771
1.1197337112722e-155	0.283098621854372	0.752	0.638	2.77481210990363e-151	CALM3	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26772
1.85478647636622e-154	0.336120908700708	0.446	0.293	4.59634636708313e-150	MT1E	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26773
3.13678629489452e-154	0.273509911895388	0.915	0.833	7.77327011737812e-150	HCST	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26774
1.51311534806786e-153	0.294031336170437	0.821	0.725	3.74965114404697e-149	ENO1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26775
1.62685730371506e-151	-0.259697161918613	0.997	0.998	4.03151508433628e-147	RPS14	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26776
4.4106872549701e-150	0.266512921117296	0.741	0.616	1.09301240865414e-145	GNAS	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26777
1.70060319081818e-147	0.316802944921334	0.536	0.382	4.21426476716652e-143	HLA-DRA	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26778
2.72693521505373e-147	0.458884796546382	0.644	0.515	6.75761815642465e-143	HMGB2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26779
1.61818487024254e-144	-0.264792010343773	1	1	4.01002392694805e-140	RPL13	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26780
3.61436399378614e-144	0.255750470443229	0.646	0.474	8.95675541300144e-140	CD81	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26781
2.77414843013614e-143	0.302969381480984	0.657	0.516	6.87461722472037e-139	JUND	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26782
7.36923573536013e-143	-0.373191686839435	0.37	0.498	1.82617030757959e-138	PIM1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26783
9.7206162825095e-143	-0.281596800174058	0.894	0.92	2.40886592096868e-138	PABPC1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26784
3.57604362405821e-138	0.366441214549203	0.474	0.341	8.86179370477866e-134	HSPD1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26785
3.52862332416428e-134	-0.290975059627249	0.345	0.485	8.74428145961151e-130	PLP2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26786
9.47784941817719e-132	0.268031124609949	0.59	0.455	2.34870586431849e-127	S1PR4	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000125910	8698	sphingosine-1-phosphate receptor 4	EDG6	protein_coding	O95977	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26787
3.65994038824854e-131	-0.297707482665198	0.419	0.544	9.0696982761187e-127	ARHGAP15	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000075884	55843	Rho GTPase activating protein 15	BM046	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26788
3.79704161732092e-130	0.638897233104237	0.491	0.357	9.40944883188297e-126	H4C3	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000197061	8364	H4 clustered histone 3	dJ221C16.1|H4/g|H4FG|HIST1H4C	protein_coding	P62805	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26789
7.20236864647606e-130	-0.49341828996518	0.84	0.849	1.78481897428323e-125	SARAF	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26790
1.42058697737647e-128	-0.342115146325733	0.317	0.439	3.52035658863662e-124	GATA3	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000107485	2625	GATA binding protein 3	HDR	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26791
4.93500935308438e-128	-0.52857693892396	0.984	0.981	1.22294466778784e-123	FTH1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26792
1.06216014818248e-126	0.29879696959437	0.942	0.914	2.632139063211e-122	HSP90AA1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26793
4.11570044333157e-126	0.4369485387702	0.263	0.146	1.019911726862e-121	TYMS	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26794
4.76261416177448e-125	-0.327548363048935	0.52	0.617	1.18022341542933e-120	SNHG6	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000245910	NA	NA	HBII-276HG|NCRNA00058|U87HG	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26795
5.79413986943427e-125	-0.321106220581145	0.534	0.635	1.43584580104451e-120	GAS5	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000234741	60674	growth arrest specific 5	NCRNA00030|SNHG2	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26796
3.55560639502271e-124	0.257502881067691	0.907	0.854	8.81114820750577e-120	HSPA8	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26797
4.16476348203536e-121	-0.256327628853717	0.245	0.366	1.03207003848318e-116	RHBDD2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26798
6.58792712392629e-120	0.277138988320257	0.814	0.659	1.63255422058017e-115	CST7	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26799
1.13214841484942e-118	0.537704079683054	0.583	0.476	2.80557698683835e-114	TUBB	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26800
8.71498000275667e-115	0.291611303245101	0.734	0.644	2.15965919448313e-110	TPI1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26801
1.18186339313466e-113	-0.286697362407898	0.489	0.618	2.92877567452701e-109	NFKBIA	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26802
1.58656415048744e-111	-0.262873109324929	0.323	0.444	3.93166462132292e-107	MGAT4A	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000071073	11320	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GnT-4a|GnT-Iva	protein_coding	Q9UM21	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26803
3.91036832481318e-111	0.350187792346406	0.643	0.494	9.69028374571954e-107	GZMH	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26804
3.02625454392695e-109	0.253789464750205	0.597	0.478	7.49936138530537e-105	DEK	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26805
5.22951870517572e-108	0.278861758280948	0.33	0.212	1.2959270303296e-103	UBE2S	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26806
6.5212842806625e-108	0.503754284135109	0.606	0.486	1.61603945759098e-103	GZMB	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26807
6.87039552345209e-106	-0.61229102870601	0.317	0.431	1.70255271466666e-101	GNLY	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26808
3.12088313095885e-104	-0.479225995202773	0.592	0.664	7.73386048682912e-100	LTB	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26809
1.70711245148491e-102	-0.290081775201399	0.966	0.943	4.23039536602477e-98	MT-ND3	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26810
3.10662627297506e-101	0.27111819830846	0.501	0.376	7.69853056705949e-97	PLEK	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26811
4.55353158888747e-99	-0.263175136697586	0.998	0.999	1.1284106630422e-94	MT-CYB	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26812
1.70241507219231e-98	0.338113990105715	0.467	0.359	4.21875479039975e-94	DUT	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26813
2.75867763447181e-95	0.270607061990127	0.626	0.531	6.83627904598459e-91	TXN	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26814
1.29832886721963e-93	-0.251169876416888	0.434	0.544	3.21738876585696e-89	ANKRD12	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26815
1.70510647548563e-90	0.296223183419159	0.811	0.77	4.22542435690094e-86	CALR	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26816
3.19105394006382e-90	-0.266424595744175	0.425	0.52	7.90775076887214e-86	G3BP2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26817
1.68859549193199e-88	-0.259648183622845	0.553	0.633	4.18450848855667e-84	SERP1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26818
2.86750048621586e-87	0.31131669471265	0.298	0.194	7.10595295489153e-83	MKI67	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26819
5.64704743515539e-84	0.270425114015562	0.363	0.261	1.39939482490586e-79	PTTG1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26820
1.10118827968551e-81	-0.293833080064827	0.539	0.615	2.72885467588865e-77	STK17B	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26821
3.83381148279795e-81	0.260370018880165	0.26	0.167	9.50056823552159e-77	MCM7	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26822
1.11643396000878e-80	0.368767309561096	0.777	0.739	2.76663499629775e-76	HMGN2	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26823
1.2265419633566e-78	0.258027394397874	0.49	0.383	3.03949363939399e-74	H1-3	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000124575	3007	H1.3 linker histone, cluster member	H1.3|H1d|H1F3|H1s-2|HIST1H1D	protein_coding	P16402	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26824
8.12659273991465e-74	0.296171181492716	0.598	0.539	2.01385094687825e-69	GZMM	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000197540	3004	granzyme M	LMET1|MET1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26825
2.18201819688735e-72	-0.302834721941201	0.972	0.957	5.40725929370655e-68	RPS26	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26826
3.41647834693214e-68	0.378683684409883	0.655	0.595	8.46637499153252e-64	H2AZ1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000164032	3015	H2A.Z variant histone 1	H2A.Z|H2AFZ|H2AZ	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26827
2.33931236400159e-67	-0.348195136910286	0.579	0.648	5.79704996923235e-63	CD69	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26828
1.07686489516727e-60	0.634056922814944	0.568	0.516	2.66857889671402e-56	TUBA1B	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26829
3.6641194063858e-60	0.296081753490105	0.356	0.273	9.08005430096465e-56	TUBB4B	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26830
5.14607291519763e-56	0.257877883229997	0.732	0.705	1.27524832911513e-51	RAN	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26831
1.79406663340824e-50	-0.318543278480051	0.493	0.551	4.44587652424897e-46	TNFAIP3	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26832
7.30813352223663e-50	-0.288730368068341	0.515	0.562	1.81102856814546e-45	LEPROTL1	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26833
9.4778679270224e-46	0.283418120149266	0.629	0.625	2.34871045099542e-41	CD8A	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26834
1.80055939024694e-34	-0.348591432837209	0.475	0.524	4.46196622497093e-30	FOS	CD8+ T cells	GSE197268_Axi-cel_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26835
0	-0.38559266638724	0.534	0.7	0	SMAP2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26836
0	0.310935972622829	0.999	0.999	0	RPS8	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26837
0	0.86270997915436	0.582	0.409	0	JUN	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26838
0	-0.347150472649745	0.158	0.339	0	IFI44L	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26839
0	-0.575063235246371	0.241	0.506	0	GBP1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26840
0	-0.39071050991891	0.369	0.566	0	GBP2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26841
0	-0.466919692399051	0.175	0.384	0	GBP5	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26842
0	-0.564261506949125	0.9	0.959	0	TXNIP	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26843
0	0.399540186973747	0.996	0.963	0	RPS27	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26844
0	0.536556086396929	0.506	0.272	0	RGS2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26845
0	0.287431985811747	0.264	0.102	0	NR4A2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26846
0	-0.637789949167592	0.432	0.703	0	STAT1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26847
0	0.342075830805967	0.988	0.917	0	RPL37A	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26848
0	-0.431745145127248	0.295	0.511	0	PARP14	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000173193	54625	poly(ADP-ribose) polymerase family member 14	ARTD8|BAL2|KIAA1268|pART8	protein_coding	Q460N5	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26849
0	-0.523363692443341	0.461	0.668	0	TNFSF10	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000121858	8743	TNF superfamily member 10	Apo-2L|CD253|TL2|TRAIL	protein_coding	P50591	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26850
0	0.318726396241702	0.998	0.993	0	RPL35A	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26851
0	-0.400199334064285	0.527	0.679	0	LAP3	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26852
0	0.270753106758669	0.999	0.998	0	RPL34	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26853
0	0.334894261481756	0.999	0.991	0	RPL37	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26854
0	-0.462378970620673	0.66	0.799	0	IRF1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26855
0	0.616511122530067	0.892	0.819	0	DUSP1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26856
0	0.314101174676052	0.998	0.997	0	RPS18	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26857
0	-0.508947013283811	0.395	0.792	0	TMEM176B	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26858
0	-0.562684367754689	0.716	0.865	0	LY6E	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26859
0	0.326159549918061	0.993	0.987	0	RPS6	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26860
0	-0.351848456305078	0.312	0.493	0	TRIM22	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000132274	10346	tripartite motif containing 22	GPSTAF50|RNF94|STAF50	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26861
0	-0.575214247082119	0.034	0.321	0	MTRNR2L8	Mono/Macro	GSE197268_Axi-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26862
0	-0.66471356207742	0.807	0.904	0	AHNAK	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26863
0	0.319551921153187	0.998	0.995	0	RPS3	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26864
0	0.272674135865687	1	1	0	RPL41	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26865
0	-0.621148988459137	0.976	0.993	0	LYZ	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26866
0	-0.316490939626116	0.131	0.302	0	OAS3	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000111331	4940	2'-5'-oligoadenylate synthetase 3	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26867
0	0.832408768473287	0.944	0.894	0	FOS	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26868
0	0.290468711376263	0.999	0.994	0	RPS15A	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26869
0	0.257656430135546	1	1	0	RPL13	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26870
0	-0.554337577626698	0.613	0.815	0	RNF213	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26871
0	-0.435154248049661	0.38	0.558	0	SMCHD1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26872
0	0.531744711428456	0.362	0.133	0	RETN	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26873
0	0.358215516749254	0.999	0.993	0	RPS28	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26874
0	0.511421529226227	0.824	0.715	0	JUND	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26875
0	0.451372859668498	1	0.998	0	RPS19	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26876
0	0.94929891793846	0.591	0.278	0	FOSB	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26877
0	0.348586232295144	0.38	0.187	0	NAPSB	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000131401	256236	napsin B aspartic peptidase, pseudogene	NAP1L|NAP2|NAPB|NAPSBP	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26878
0	0.361558637479038	1	1	0	RPS9	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26879
0	-0.335251133780316	0.171	0.355	0	TNNT1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26880
0	0.462246321317606	0.924	0.801	0	PPDPF	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26881
0	0.363700661902628	0.993	0.982	0	RPS4X	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26882
0	0.347662922234076	1	0.993	0	RPL39	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26883
0	0.430698205892546	0.99	0.916	0	MT-ND3	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26884
2.23053737336208e-305	-0.335192436861455	0.265	0.44	5.52749466492858e-301	JAK2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000096968	3717	Janus kinase 2	JTK10	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26885
1.04967958923768e-303	-0.494488311215377	0.452	0.622	2.60121099008989e-299	ISG15	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26886
5.24971194885559e-302	-0.479038994209764	0.564	0.724	1.3009311180459e-297	IFI6	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26887
1.40943040364499e-297	0.418888634413746	0.536	0.36	3.49270948327264e-293	AC020916.1	Mono/Macro	GSE197268_Axi-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26888
7.45912208827541e-292	-0.265896100414294	0.983	0.991	1.84844504469553e-287	ITGB2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26889
4.80725880352773e-290	-0.451201698673465	0.877	0.949	1.19128680410221e-285	IFITM3	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26890
2.59740937355433e-286	-0.394853332576446	0.445	0.598	6.43664016860497e-282	KLF10	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26891
1.6080135917769e-280	-0.315105480119592	0.295	0.471	3.98481848178233e-276	EPSTI1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26892
1.15509178256865e-271	0.251284593542198	0.331	0.166	2.86243294638338e-267	NQO2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000124588	4835	N-ribosyldihydronicotinamide:quinone reductase 2	DHQV|DIA6|NMOR2|QR2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26893
7.01025881147756e-270	0.279047709323443	0.999	0.999	1.73721223607225e-265	RPL10	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26894
2.9663153600928e-265	-0.288299003083207	0.229	0.393	7.35082609384597e-261	APOL6	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000221963	80830	apolipoprotein L6	APOL-VI|APOLVI	protein_coding	Q9BWW8	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26895
8.04784550400995e-263	-0.280778901189094	0.133	0.279	1.99433659434871e-258	IFIT3	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000119917	3437	interferon induced protein with tetratricopeptide repeats 3	CIG-49|GARG-49|IFI60|IFIT4|IRG2|ISG60|RIG-G	protein_coding	O14879	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26896
6.44957824369024e-260	-0.284386465192641	0.175	0.329	1.59826998456888e-255	GBP4	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26897
1.62604827163118e-258	0.28733329796279	0.972	0.946	4.02951022192922e-254	RPL21	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26898
3.87776080465964e-253	-0.28862631015625	0.768	0.858	9.60947905002706e-249	ANXA5	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26899
5.81981798853811e-252	-0.345579661137593	0.507	0.648	1.44220909573963e-247	UBE2L6	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26900
2.64299239984028e-250	-0.327375421659581	0.78	0.862	6.5495994660442e-246	PSME2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26901
5.17928740620768e-244	-0.272928828602737	0.161	0.311	1.28347921213233e-239	SERPING1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000149131	710	serpin family G member 1	C1-INH|C1IN|C1INH|C1NH|HAE1|HAE2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26902
1.62041299777297e-239	0.379046134249582	0.545	0.388	4.0155454497812e-235	ATP2B1-AS1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000271614	NA	NA	LINC00936	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26903
5.59252192812474e-239	-0.365957954412448	0.377	0.535	1.38588285900859e-234	MT-ND6	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26904
8.29511105397132e-236	-0.26600916884643	0.178	0.326	2.05561147028463e-231	AL133415.1	Mono/Macro	GSE197268_Axi-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26905
5.95351085736892e-234	-0.280712969950376	0.297	0.455	1.47533952556459e-229	STAT2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000170581	6773	signal transducer and activator of transcription 2	STAT113	protein_coding	P52630	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26906
1.35212566738067e-231	0.275224631476429	0.888	0.821	3.35070261633604e-227	RPL26	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26907
5.43763135510156e-224	0.260989788712676	0.829	0.722	1.34749942610772e-219	UQCRB	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26908
2.63026872074408e-222	0.285592406488838	0.95	0.928	6.5180689168759e-218	RPL10A	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26909
3.17614737690577e-221	-0.344073274308108	0.255	0.404	7.8708108147102e-217	F13A1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000124491	2162	coagulation factor XIII A chain	F13A	protein_coding	P00488	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26910
2.13521586635109e-218	0.311823544156511	0.468	0.307	5.29127843840463e-214	SMIM25	Mono/Macro	GSE197268_Axi-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26911
1.77997886256246e-217	0.265504320320368	0.423	0.267	4.41096561931603e-213	SNHG5	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26912
4.50409800013845e-215	-0.312562158657444	0.276	0.431	1.11616052541431e-210	MX1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26913
4.93297377765325e-214	-0.392853307543843	0.35	0.496	1.22244023184025e-209	H1-4	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000168298	3008	H1.4 linker histone, cluster member	H1.4|H1e|H1F4|H1s-4|HIST1H1E	protein_coding	P10412	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26914
3.82006649552147e-204	-0.263253823463087	0.285	0.431	9.46650678255176e-200	TAP1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26915
8.13565435500129e-201	-0.284708147730294	0.677	0.766	2.01609650571287e-196	PSMB10	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000205220	5699	proteasome 20S subunit beta 10	beta2i|LMP10|MECL1|MGC1665	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26916
3.01376358774738e-200	-0.257323446429159	0.853	0.91	7.46840754679678e-196	HNRNPA2B1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26917
2.04981150267332e-199	-0.295798579710836	0.769	0.844	5.07963788477475e-195	PNRC1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26918
1.93888749994826e-198	0.255408259648707	0.683	0.522	4.80475711362179e-194	SLC11A1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000018280	6556	solute carrier family 11 member 1	LSH|NRAMP|NRAMP1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26919
4.49468595684762e-195	-0.299296549160993	0.368	0.514	1.11382812696641e-190	PIM1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26920
1.48757359197621e-194	0.392556270078576	0.644	0.529	3.68635611827625e-190	ID2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26921
1.23437709135575e-190	-0.263183517214173	0.358	0.499	3.05890987008868e-186	IFI35	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000068079	3430	interferon induced protein 35	IFP35	protein_coding	P80217	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26922
1.951969363918e-190	-0.257603851725596	0.87	0.92	4.8371752807252e-186	FYB1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26923
2.13219634805289e-190	0.292409964575623	0.661	0.526	5.28379577010987e-186	LILRA5	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000278355	353514	leukocyte immunoglobulin like receptor A5	CD85|CD85f|ILT11|LILRB7|LIR9	protein_coding	A6NI73	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26924
1.2967255920071e-187	-0.308024376621355	0.449	0.58	3.21341568955279e-183	CD300E	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000186407	342510	CD300e molecule	CD300LE|CLM2|IREM2	protein_coding	Q496F6	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26925
4.78189733423536e-184	-0.254571051318961	0.444	0.58	1.18500197839686e-179	ADAR	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26926
6.31458111802447e-182	-0.299640904139889	0.35	0.488	1.56481634685764e-177	ASGR2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000161944	433	asialoglycoprotein receptor 2	CLEC4H2	protein_coding	P07307	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26927
2.82147380274533e-181	-0.25886437923969	0.373	0.509	6.99189423058321e-177	BACH1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000156273	571	BTB domain and CNC homolog 1	BACH-1|BTBD24	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26928
2.41761462072293e-178	-0.279478555584766	0.348	0.489	5.9910907916135e-174	CLU	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000120885	1191	clusterin	APOJ|CLI|CLU1|CLU2|KUB1|SGP-2|SP-40|TRPM-2	protein_coding	P10909	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26929
1.08584809054508e-175	-0.264428785770237	0.71	0.805	2.69084015317977e-171	SRRM2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26930
1.0342533708793e-172	-0.259662728470034	0.533	0.657	2.56298327837599e-168	SCO2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000284194	9997	synthesis of cytochrome C oxidase 2	MYP6|SCO1L	protein_coding	O43819	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26931
3.10588368221899e-172	-0.316819754423651	0.925	0.953	7.69669035290689e-168	IFITM2	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26932
2.26671855092934e-169	-0.331698084086053	0.734	0.797	5.617155241058e-165	CFD	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26933
6.30472544497666e-166	-0.311423351364703	0.732	0.799	1.56237401251967e-161	PLAC8	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26934
1.49263410327835e-164	-0.263456682080629	0.482	0.61	3.69889657133408e-160	WARS1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000140105	7453	tryptophanyl-tRNA synthetase 1	IFI53|IFP53|WARS	protein_coding	P23381	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26935
2.6039498160813e-159	-0.276977264549099	0.583	0.689	6.45284803923107e-155	MYH9	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26936
3.98415754052636e-159	0.331119119756669	0.988	0.991	9.87314080117838e-155	S100A9	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26937
1.58090647760601e-154	-0.372328924529982	0.301	0.423	3.91764434215544e-150	APOBEC3A	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000262156	200315	apolipoprotein B mRNA editing enzyme catalytic subunit 3A	ARP3|PHRBN	protein_coding	P31941	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26938
4.47333484403274e-149	-0.37342771170538	0.255	0.375	1.10853710769975e-144	NKG7	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26939
4.85420138279128e-148	-0.250189947991168	0.431	0.55	1.20291964466951e-143	TPM4	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26940
3.84068651140157e-143	0.273977033955936	0.697	0.597	9.51760524390422e-139	TSC22D3	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26941
1.82033767654021e-140	-0.312203134733765	0.263	0.38	4.51097879623431e-136	AL138963.4	Mono/Macro	GSE197268_Axi-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26942
2.12506936850991e-138	-0.42384423214773	0.318	0.435	5.2661344021044e-134	IFITM1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26943
6.09502156817505e-136	0.279534686655657	0.513	0.395	1.51040729480946e-131	SLC2A3	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26944
3.47691099487142e-125	-0.301167708694813	0.999	0.998	8.61613313639087e-121	MALAT1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26945
1.64382315001664e-118	-0.287191385309939	0.839	0.891	4.07355814805623e-114	NFKBIA	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26946
6.2867705027862e-106	-0.291069147372965	0.538	0.623	1.55792459829545e-101	ZFP36L1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26947
5.68674670044576e-97	0.258269539867855	0.838	0.783	1.40923269983746e-92	TIMP1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26948
3.98665967429771e-94	0.301179813625291	0.786	0.736	9.87934133887716e-90	MT-ATP8	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26949
1.41362931042983e-74	-0.251758034777963	0.864	0.893	3.50311479417615e-70	VCAN	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26950
2.58128477362301e-61	0.258401912165528	0.328	0.248	6.39668179751518e-57	HLA-DQA1	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26951
4.33718777398453e-32	0.382739442470648	0.3	0.251	1.07479850227111e-27	FCGR3A	Mono/Macro	GSE197268_Axi-cel_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26952
3.03395388495654e-92	-0.595914512962215	0.5	0.871	7.51844112231079e-88	RPS4Y1	NK cells	GSE197268_Axi-cel_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26953
3.91734690270357e-66	-0.494684815837243	0.089	0.357	9.70757735958971e-62	MTRNR2L8	NK cells	GSE197268_Axi-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26954
2.41679214803699e-48	0.579560671837972	0.982	0.975	5.98905262205047e-44	GZMB	NK cells	GSE197268_Axi-cel_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26955
7.46486464250408e-44	0.48397622299809	0.955	0.9	1.84986810705894e-39	RPS26	NK cells	GSE197268_Axi-cel_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26956
1.14594746200504e-27	0.435527879135433	0.4	0.233	2.83977240559469e-23	LAIR2	NK cells	GSE197268_Axi-cel_post	ENSG00000274084	3904	leukocyte associated immunoglobulin like receptor 2	CD306|LAIR-2	protein_coding	Q6ISS4	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26957
1.7505568616256e-23	0.484133599327635	0.71	0.579	4.33805495879439e-19	CLIC3	NK cells	GSE197268_Axi-cel_post	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26958
3.00066588760873e-22	0.336256989268263	0.813	0.709	7.43595013608319e-18	FCER1G	NK cells	GSE197268_Axi-cel_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26959
1.03729596312544e-18	0.261197701953886	0.709	0.53	2.57052312622116e-14	KLRC1	NK cells	GSE197268_Axi-cel_post	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26960
9.24253700458559e-18	0.291241082049946	0.63	0.482	2.29039309510635e-13	CMC1	NK cells	GSE197268_Axi-cel_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26961
1.27419430375529e-17	-0.309841581054106	1	1	3.15758090413597e-13	RPS19	NK cells	GSE197268_Axi-cel_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26962
5.83596373198605e-15	-0.293105228003283	0.997	0.999	1.44621017242346e-10	MALAT1	NK cells	GSE197268_Axi-cel_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26963
7.62940152250006e-15	0.305092022927032	0.954	0.927	1.89064199129074e-10	HSP90AA1	NK cells	GSE197268_Axi-cel_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26964
1.58576792734689e-14	0.345024310743235	0.278	0.171	3.92969150075833e-10	CAPG	NK cells	GSE197268_Axi-cel_post	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26965
1.72163975027938e-14	-0.384883087606296	0.55	0.636	4.26639546516733e-10	IFI6	NK cells	GSE197268_Axi-cel_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26966
6.16243515661454e-14	-0.294732509547355	0.253	0.362	1.52711305616065e-09	ITM2A	NK cells	GSE197268_Axi-cel_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26967
2.26353460004577e-10	0.288461015559348	0.657	0.602	5.60926509237342e-06	TCF25	NK cells	GSE197268_Axi-cel_post	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26968
1.09255877365114e-09	0.269852051546711	0.725	0.641	2.7074698969849e-05	HSPA5	NK cells	GSE197268_Axi-cel_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26969
3.13529979584806e-09	0.406638150371949	0.566	0.471	7.76958642409108e-05	H4C3	NK cells	GSE197268_Axi-cel_post	ENSG00000197061	8364	H4 clustered histone 3	dJ221C16.1|H4/g|H4FG|HIST1H4C	protein_coding	P62805	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26970
2.15815976996496e-08	-0.261983693208102	0.583	0.642	0.000534813572595018	ISG15	NK cells	GSE197268_Axi-cel_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26971
2.61532480452147e-07	0.327322845465222	0.443	0.36	0.00648103639808465	FOS	NK cells	GSE197268_Axi-cel_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26972
0	-1.09010810521958	0.305	0.902	0	RPS4Y1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26973
2.46963236445525e-151	0.540103238320527	0.309	0.037	6.11999596235657e-147	LAIR2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000274084	3904	leukocyte associated immunoglobulin like receptor 2	CD306|LAIR-2	protein_coding	Q6ISS4	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26974
9.33116482823957e-149	-0.559656811043199	0.988	0.997	2.31235595608605e-144	MT-ND4L	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26975
7.23387923881279e-137	0.446266164630061	1	0.999	1.7926276141702e-132	RPS4X	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26976
1.59174897066255e-103	-0.501836279848086	0.974	0.983	3.94451312419885e-99	MT-ND3	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26977
1.16525242490724e-92	-0.467556382512661	0.931	0.969	2.88761203416262e-88	RPL9	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26978
2.82365221587885e-91	0.426130712704831	0.935	0.812	6.99729255616938e-87	RPS2P5	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000240342	NA	NA	bcm384	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26979
2.75972106805201e-90	-0.384798246522651	0.998	0.997	6.83886477873968e-86	RPS27	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26980
9.29132640287776e-88	0.396286376979311	0.47	0.206	2.30248359589714e-83	HLA-H	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26981
2.02318422534604e-85	-0.275298708681318	0.067	0.257	5.01365282883002e-81	DDX3Y	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26982
1.61808662848906e-82	0.446886011600012	0.754	0.58	4.00978047405875e-78	SEPTIN6	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000125354	23157	septin 6	KIAA0128|MGC16619|MGC20339|SEP2|SEPT2|SEPT6	protein_coding	Q14141	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26983
9.95956556262625e-79	-0.371106819685882	0.991	0.996	2.46807994207441e-74	RPS3A	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26984
5.78827418749831e-77	0.639726327479616	0.981	0.978	1.43439222640396e-72	ACTG1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26985
5.79641080097469e-75	0.575254679135511	0.46	0.237	1.43640856058954e-70	MT1E	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26986
2.56321593875847e-74	-0.345532184963978	0.997	0.997	6.35190541783736e-70	RPL39	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26987
1.41360569872681e-73	-0.442762157841352	0.904	0.941	3.5030562820149e-69	MT-ATP8	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26988
2.10758718894555e-68	0.408797524939766	0.962	0.921	5.22281181292597e-64	CORO1A	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26989
9.07240220253752e-68	0.500532543204935	0.983	0.98	2.24823198981082e-63	GAPDH	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26990
8.96523394282568e-65	0.369792271021388	0.934	0.867	2.22167462337163e-60	LIMD2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26991
3.43570432976136e-64	0.412161178059939	0.867	0.703	8.51401889958162e-60	JUND	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26992
9.6625064322862e-62	0.435784266840511	0.866	0.772	2.39446571898484e-57	CNN2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26993
5.93696322186666e-61	0.413727681835176	0.763	0.597	1.47123885601078e-56	S1PR4	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000125910	8698	sphingosine-1-phosphate receptor 4	EDG6	protein_coding	O95977	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26994
6.72073842460125e-61	0.347591782006809	0.945	0.901	1.66546618900044e-56	RAC2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26995
5.30718584907092e-60	0.341685852437646	1	0.999	1.31517372525827e-55	TMSB4X	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26996
4.50787135174337e-59	0.414030563088784	0.992	0.998	1.11709559967552e-54	PFN1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26997
4.8642142278675e-57	0.480835973297387	0.999	1	1.20540092780784e-52	ACTB	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26998
6.02911980596989e-54	-0.413005133630904	0.836	0.945	1.4940761791174e-49	TXNIP	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	26999
9.13251482697195e-53	0.585407646677299	0.764	0.611	2.26312849927192e-48	MT2A	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27000
1.21199952113478e-51	-0.264854166306375	0.997	0.997	3.0034560133241e-47	RPS25	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27001
5.71157561194435e-51	0.352257552950199	0.991	0.988	1.41538555239593e-46	CFL1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27002
1.9685580536659e-49	0.361936001505462	0.994	0.98	4.87828371278947e-45	IL32	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27003
2.24076300071685e-49	-0.262317853823538	0.996	0.998	5.55283479207643e-45	RPL36	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27004
3.61350092179498e-49	0.268072513992637	0.978	0.956	8.95461663430014e-45	TLE5	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000104964	166	TLE family member 5, transcriptional modulator	AES|GRG5	protein_coding	Q08117	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27005
8.41951346203544e-49	-0.273355052946836	0.997	0.998	2.086439631027e-44	RPL34	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27006
1.4174817591715e-47	-0.280265543717157	0.997	0.998	3.51266154740291e-43	RPS23	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27007
3.97049778774673e-47	0.319882942842918	0.69	0.532	9.83929056781517e-43	PPP1R18	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27008
6.17530367688766e-46	0.298232601946468	0.808	0.688	1.53030200416953e-41	PPP1CA	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27009
2.84381213025123e-45	0.319577007367779	0.973	0.962	7.04725083997556e-41	MYL6	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27010
3.25121315566371e-45	-0.389898947437066	0.926	0.959	8.05683132105025e-41	MT-ND2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27011
4.20439852933294e-45	0.393197454637694	0.831	0.758	1.041891999554e-40	COTL1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27012
1.19968805862898e-44	0.265617337253219	0.872	0.72	2.97294697808846e-40	GNAI2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27013
1.58985084398145e-44	0.274436262967464	0.649	0.476	3.93980937647042e-40	MZT2A	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27014
4.86845597575365e-44	-0.29403378936241	0.989	0.99	1.20645207535151e-39	MT-ND5	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27015
7.05662612118428e-44	0.297658550661151	0.913	0.85	1.74870251909068e-39	LSP1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27016
1.20687491430617e-43	0.326169638382172	0.701	0.556	2.99075672514211e-39	SLC9A3R1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27017
2.04611113531931e-43	-0.269838001696653	0.999	0.998	5.07046800443479e-39	RPL30	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27018
2.53244646165511e-43	-0.453039438002373	0.654	0.785	6.27565557662754e-39	IL7R	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27019
1.96692085820016e-42	0.380747870848097	0.843	0.756	4.87422657870581e-38	UCP2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27020
2.74116032022948e-42	-0.339903848435754	0.991	0.998	6.79286938956066e-38	MALAT1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27021
5.58349925636443e-42	0.37746668055488	0.759	0.657	1.38364695071967e-37	SLC25A5	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27022
6.67544501524744e-42	-0.276112891749303	0.856	0.906	1.65424202922847e-37	TOMM7	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27023
1.016807669402e-41	0.293129994523197	0.981	0.99	2.5197510855451e-37	CD52	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27024
3.07616466567174e-41	-0.291610176336387	0.977	0.984	7.62304365800114e-37	RPL21	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27025
6.34744902678124e-41	0.295483101552626	0.661	0.508	1.57296134332666e-36	RCSD1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27026
8.15743102534548e-41	0.277936935808994	0.693	0.54	2.02149298239086e-36	CSK	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27027
1.67547105466817e-40	0.348482399524756	0.681	0.531	4.15198482057318e-36	H2AZ2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000105968	94239	H2A.Z variant histone 2	H2AFV|H2AV|MGC10170|MGC10831|MGC1947	protein_coding	Q71UI9	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27028
1.87901701748064e-40	0.27849250321183	0.591	0.434	4.65639207101877e-36	ABRACL	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27029
2.33500641791434e-39	0.28977023707538	0.848	0.707	5.78637940423353e-35	TGFB1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27030
4.39937757539748e-39	0.295710867227679	0.314	0.168	1.09020975695925e-34	LIMS2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000072163	55679	LIM zinc finger domain containing 2	PINCH-2|PINCH2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27031
1.95897867323864e-38	0.314306543277119	0.971	0.957	4.85454505015267e-34	PPIA	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27032
9.39995647606473e-37	-0.394827744165831	1	0.999	2.3294032143336e-32	RPS19	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27033
1.93560145878554e-36	0.271673131196075	0.983	0.993	4.79661397501645e-32	SH3BGRL3	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27034
6.00443239462616e-36	0.268729061454606	0.461	0.308	1.48795839171231e-31	MXD4	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27035
1.13463095832268e-35	0.303388661820521	0.699	0.563	2.81172897781944e-31	ARPC5	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27036
1.20586042917406e-34	-0.2549268781887	0.551	0.682	2.98824272953625e-30	GABARAP	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27037
5.62920636768552e-33	-0.261266487742378	0.397	0.568	1.39497362997615e-28	MAL	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000172005	4118	mal, T cell differentiation protein	MVP17|VIP17	protein_coding	P21145	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27038
1.05260320518744e-32	0.262562867805374	0.588	0.444	2.60845600277499e-28	TRAC	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27039
1.48687934269659e-32	0.317993168377874	0.435	0.286	3.68463569913641e-28	CXCR3	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000186810	2833	C-X-C motif chemokine receptor 3	CD183|CKR-L2|CMKAR3|GPR9|IP10-R|MigR	protein_coding	P49682	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27040
2.02104948289237e-32	-0.25678891693726	0.992	0.991	5.00836272355559e-28	MT-ND1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27041
3.9831801921043e-32	0.251522493024558	0.936	0.896	9.87071883405366e-28	ARPC2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27042
1.07519166213473e-31	0.310639322259121	0.676	0.546	2.66443245793609e-27	ITGA4	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27043
6.26481400040765e-31	0.265458774610915	0.982	0.973	1.55248355744102e-26	S100A6	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27044
1.10151106252426e-30	0.273452094166089	0.783	0.694	2.72965456404138e-26	GYPC	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27045
1.42538780080408e-30	0.252181622332112	0.767	0.644	3.5322535091726e-26	CAP1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27046
5.33835216994322e-30	-0.287898947867206	0.263	0.39	1.32289705123363e-25	PCBP2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27047
1.21321234174672e-29	-0.290865104083808	0.926	0.945	3.00646150408255e-25	FTL	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27048
1.9858817799788e-29	0.264504688429606	0.336	0.209	4.92121363896548e-25	MYADM	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27049
2.17582115774434e-29	-0.312598955090155	0.948	0.966	5.39190241100624e-25	IFITM1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27050
2.22898148200529e-29	0.291298485474256	0.368	0.231	5.52363901055732e-25	LGALS3	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27051
1.11346273176878e-28	0.254697549431495	0.764	0.659	2.75927199559622e-24	CALM3	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27052
1.12571065167493e-27	-0.254357823831302	0.882	0.907	2.78962356591564e-23	RPL7	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27053
3.21871066574781e-27	0.297915185234354	0.94	0.916	7.97628690078964e-23	CD74	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27054
1.05527911003016e-26	-0.313496337215092	0.445	0.566	2.61508716256573e-22	CXCR4	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27055
4.3969070653696e-26	-0.290987768921305	0.482	0.585	1.08959753986924e-21	RPL17	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27056
8.37340434442186e-26	0.287874585633434	0.621	0.5	2.07501333059118e-21	ITM2A	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27057
9.94818453106346e-26	0.472434207091387	0.743	0.682	2.46525960864284e-21	LGALS1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27058
2.33345210630904e-25	0.338440594444984	0.456	0.308	5.78252766464444e-21	GZMA	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27059
1.05951261956662e-24	0.259827930644214	0.571	0.427	2.62557822254805e-20	FOS	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27060
1.24289910234289e-24	-0.250000610396736	0.453	0.579	3.08002826551592e-20	TRIM22	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000132274	10346	tripartite motif containing 22	GPSTAF50|RNF94|STAF50	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27061
4.19504607945382e-24	-0.313622263188319	0.788	0.829	1.03957436894945e-19	ZFP36L2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27062
9.908793023191e-24	-0.265546053423237	0.359	0.461	2.45549799907696e-19	PTPRCAP	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27063
4.74557665532214e-20	0.262237065542798	0.823	0.774	1.17600135095538e-15	S100A11	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27064
5.36209094821798e-20	0.254942299038089	0.516	0.4	1.3287797578779e-15	TRBC1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27065
2.311151110156e-19	0.313177866272824	0.271	0.172	5.72726356607758e-15	STMN1	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27066
3.3843684135214e-19	-0.26647962691559	0.666	0.734	8.38680336554737e-15	MT-ND6	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27067
8.13959509111553e-18	-0.303358424554973	0.685	0.743	2.01707305952934e-13	KLF6	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27068
1.81399153719308e-16	0.263589424318448	0.567	0.477	4.49525242831818e-12	IER2	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27069
6.62627289556162e-16	0.436812406491478	0.54	0.458	1.64205668624913e-11	JUN	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27070
1.22947355690672e-14	0.337179526939394	0.512	0.437	3.04675842137055e-10	TCF7	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27071
2.94098616279015e-14	0.318457335683026	0.73	0.685	7.28805781001026e-10	NOSIP	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27072
7.13700403705858e-14	0.294746941661153	0.527	0.441	1.76862097042349e-09	TUBB	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27073
3.4972015072391e-13	0.526358640725197	0.274	0.194	8.66641505508921e-09	CCL5	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27074
9.22111591519293e-10	-0.278813475909313	0.447	0.495	2.28508473494396e-05	IFI6	CD4+ T cells	GSE197268_Axi-cel_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27075
5.59513582654178e-27	-1.72180075737048	0.046	0.939	1.38653060917532e-22	RPS4Y1	Progenitors	GSE197268_Axi-cel_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27076
9.02546488022304e-17	0.714503342174424	1	1	2.23660045196807e-12	RPS4X	Progenitors	GSE197268_Axi-cel_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27077
1.03559888897364e-15	0.82530067453773	1	0.988	2.56631760676558e-11	HLA-A	Progenitors	GSE197268_Axi-cel_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27078
2.4084574952011e-14	0.756728848987636	0.529	0	5.96839851885785e-10	XIST	Progenitors	GSE197268_Axi-cel_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27079
8.25314468901537e-12	1.06283843911235	1	0.89	2.0452117853849e-07	JUND	Progenitors	GSE197268_Axi-cel_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27080
1.5151118620436e-09	0.442784983398934	1	0.988	3.75459870533025e-05	EIF1	Progenitors	GSE197268_Axi-cel_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27081
1.64467262942666e-09	-0.626146802652679	1	1	4.0756632429822e-05	MT-CO1	Progenitors	GSE197268_Axi-cel_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27082
1.76275018543933e-09	-0.711166316497859	1	1	4.3682712345372e-05	GAPDH	Progenitors	GSE197268_Axi-cel_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27083
2.41107958756847e-09	-0.702115873419379	1	0.988	5.97489632595342e-05	MT-CO3	Progenitors	GSE197268_Axi-cel_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27084
3.73843249230596e-09	0.611962247036705	1	0.829	9.26420955918341e-05	UBC	Progenitors	GSE197268_Axi-cel_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27085
4.10493466294474e-09	0.59723150611318	1	0.976	0.000101724385882434	HLA-C	Progenitors	GSE197268_Axi-cel_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27086
7.5071964058256e-09	1.06567448296035	0.828	0.463	0.000186035834132764	IRF1	Progenitors	GSE197268_Axi-cel_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27087
7.59872256174703e-09	-0.651916743695125	0.805	0.951	0.000188303943802653	SLC25A3	Progenitors	GSE197268_Axi-cel_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27088
9.80614051595141e-09	0.909590434002731	0.77	0.378	0.000243005968125792	CD52	Progenitors	GSE197268_Axi-cel_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27089
1.14717882051928e-08	-0.838409490682217	0.494	0.756	0.000284282383512883	RBM3	Progenitors	GSE197268_Axi-cel_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27090
1.5104010763711e-08	-0.565000991805572	0.46	0.866	0.000374292490735522	NME2	Progenitors	GSE197268_Axi-cel_post	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27091
3.03672180739128e-08	-2.73263827020614	0.034	0.378	0.000752530031089633	MPO	Progenitors	GSE197268_Axi-cel_post	ENSG00000005381	4353	myeloperoxidase	NA	protein_coding	P05164	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27092
4.19208078081161e-08	0.615846398461036	0.977	0.744	0.00103883953829293	HLA-E	Progenitors	GSE197268_Axi-cel_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27093
6.14651787077093e-08	0.596021745083915	1	0.988	0.00152316859355574	H3-3B	Progenitors	GSE197268_Axi-cel_post	ENSG00000132475	3021	H3.3 histone B	H3.3B|H3F3B	protein_coding	P84243	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27094
6.16607387670156e-08	-0.654848571133527	0.977	1	0.00152801476738541	ACTG1	Progenitors	GSE197268_Axi-cel_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27095
1.4858184185834e-07	0.393913056233862	1	1	0.00368200662309151	RPS27	Progenitors	GSE197268_Axi-cel_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27096
2.21559890866611e-07	-0.552685227640912	0.655	0.902	0.00549047565556548	RAN	Progenitors	GSE197268_Axi-cel_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27097
2.88631689023397e-07	-0.417012982321851	0.023	0.317	0.0071525818856888	TXLNGY	Progenitors	GSE197268_Axi-cel_post	ENSG00000131002	NA	NA	CYorf15A|CYorf15B|TXLNG2P	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27098
2.93257165185405e-07	0.947585831215628	0.92	0.756	0.00726720581045953	H1-10	Progenitors	GSE197268_Axi-cel_post	ENSG00000184897	8971	H1.10 linker histone	H1FX|H1X|MGC15959|MGC8350	protein_coding	Q92522	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27099
4.29346667533045e-07	0.407206991341852	0.368	0.049	0.0106396397681364	ACCS	Progenitors	GSE197268_Axi-cel_post	ENSG00000110455	84680	1-aminocyclopropane-1-carboxylate synthase homolog (inactive)	ACS|PHACS	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27100
4.5008089499945e-07	-0.431499398613133	0.931	0.951	0.0111534546589814	RPL23A	Progenitors	GSE197268_Axi-cel_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27101
6.9615108887388e-07	0.408434828341022	1	1	0.0172513201333836	TPT1	Progenitors	GSE197268_Axi-cel_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27102
8.75761250456921e-07	-0.339315478619724	1	1	0.021702239547573	RPS14	Progenitors	GSE197268_Axi-cel_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27103
9.11402391903872e-07	0.734036263127534	0.828	0.561	0.0225854626737699	HLA-DRB5	Progenitors	GSE197268_Axi-cel_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27104
1.25736372440251e-06	-0.460430922577569	0.126	0.463	0.0311587304544185	MYC	Progenitors	GSE197268_Axi-cel_post	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27105
1.75597063856565e-06	0.499571009490512	0.506	0.159	0.0435147083942954	H2AC6	Progenitors	GSE197268_Axi-cel_post	ENSG00000180573	8334	H2A clustered histone 6	H2AFL|HIST1H2AC	protein_coding	Q93077	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27106
1.99484811107794e-06	-0.466640677053205	0.609	0.854	0.0494343310406223	PHB2	Progenitors	GSE197268_Axi-cel_post	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27107
1.78457883721483e-07	-0.694995208149106	0.092	0.467	0.00442236481650208	IFI44L	pDCs	GSE197268_Axi-cel_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27108
1.98991997906568e-06	0.473376865270643	1	1	0.0493122070012265	RPL37A	pDCs	GSE197268_Axi-cel_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27109
7.8561997576422e-24	-0.769649361550346	0.334	0.753	1.94684486194131e-19	PLP2	cDCs	GSE197268_Axi-cel_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27110
4.06969624523857e-21	1.14280283796698	0.885	0.753	1.00851142653257e-16	DUSP1	cDCs	GSE197268_Axi-cel_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27111
9.02102827947824e-20	-0.858853711382028	0.211	0.627	2.2355010179375e-15	HLA-DQA2	cDCs	GSE197268_Axi-cel_post	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27112
1.39447263627334e-18	0.509689484155037	1	0.994	3.45564263994895e-14	MT-ND1	cDCs	GSE197268_Axi-cel_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27113
1.81871614970611e-18	0.895545700886854	0.956	0.918	4.50696049058672e-14	FOS	cDCs	GSE197268_Axi-cel_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27114
2.13562782477096e-18	-0.698449988406199	0.597	0.854	5.29229931256491e-14	GNAS	cDCs	GSE197268_Axi-cel_post	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27115
1.03290677331002e-17	-0.488486651594426	0.081	0.373	2.55964627493957e-13	IFI44L	cDCs	GSE197268_Axi-cel_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27116
1.33133922917071e-17	0.604338296934886	0.432	0.057	3.29919174380794e-13	AC253572.2	cDCs	GSE197268_Axi-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27117
5.33195140873963e-17	0.578690184734326	0.713	0.38	1.32131087859977e-12	SNHG5	cDCs	GSE197268_Axi-cel_post	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27118
1.75422922546345e-16	-0.405928419310047	1	1	4.34715544362098e-12	HLA-B	cDCs	GSE197268_Axi-cel_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27119
2.16787139550363e-16	-0.437528470652262	0.983	1	5.37220210519756e-12	HLA-C	cDCs	GSE197268_Axi-cel_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27120
3.1087638061209e-16	-0.930966637615757	0.447	0.715	7.7038275879482e-12	IFI6	cDCs	GSE197268_Axi-cel_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27121
1.7559872935619e-15	0.583355973073524	0.975	0.861	4.35151211217574e-11	MT-ATP8	cDCs	GSE197268_Axi-cel_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27122
5.59014011345738e-15	0.534146551770887	0.995	0.968	1.38529262151587e-10	MT-ND4L	cDCs	GSE197268_Axi-cel_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27123
5.5982764538003e-15	0.289399197885089	1	1	1.38730888801625e-10	RPL15	cDCs	GSE197268_Axi-cel_post	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27124
6.10108410722941e-15	0.578039144391661	0.835	0.5	1.51190965261252e-10	PCBP2	cDCs	GSE197268_Axi-cel_post	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27125
6.17724139500904e-15	0.426117153937482	0.386	0.051	1.53078219009719e-10	GSTM1	cDCs	GSE197268_Axi-cel_post	ENSG00000134184	2944	glutathione S-transferase mu 1	GST1|H-B|MU	protein_coding	P09488	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27126
5.17457614815368e-14	0.541157597234029	0.936	0.918	1.28231171527396e-09	H3-3A	cDCs	GSE197268_Axi-cel_post	ENSG00000163041	3020	H3.3 histone A	H3.3A|H3F3|H3F3A	protein_coding	P84243	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27127
7.9657505243466e-14	0.844204171484834	0.587	0.228	1.97399263743833e-09	JUN	cDCs	GSE197268_Axi-cel_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27128
1.42807113928887e-13	0.674042740205275	0.958	0.924	3.53890309027174e-09	JUNB	cDCs	GSE197268_Axi-cel_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27129
2.02632177147149e-13	0.523028795940053	0.929	0.804	5.02142798188349e-09	RBM3	cDCs	GSE197268_Axi-cel_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27130
2.40090656878588e-13	-0.521983657347207	0.58	0.804	5.9496865681083e-09	EFHD2	cDCs	GSE197268_Axi-cel_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27131
3.58515511092832e-13	-0.459844726059554	0.052	0.266	8.88437288039147e-09	MTRNR2L8	cDCs	GSE197268_Axi-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27132
7.61404552128149e-13	-0.650506454951392	0.344	0.658	1.88683662062876e-08	H1-10	cDCs	GSE197268_Axi-cel_post	ENSG00000184897	8971	H1.10 linker histone	H1FX|H1X|MGC15959|MGC8350	protein_coding	Q92522	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27133
7.8064838463319e-13	0.603325684909986	0.604	0.278	1.93452476195951e-08	FOSB	cDCs	GSE197268_Axi-cel_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27134
8.05596460346636e-13	-0.568511283014683	0.329	0.614	1.996348588385e-08	BRI3	cDCs	GSE197268_Axi-cel_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27135
8.31581765314266e-13	0.469639354082584	0.998	0.842	2.06074277262528e-08	MT-ND3	cDCs	GSE197268_Axi-cel_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27136
1.59603762642112e-12	-0.422437411155096	0.074	0.297	3.95514084203417e-08	AL133415.1	cDCs	GSE197268_Axi-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27137
1.60826306150004e-12	-0.872868614226037	0.975	0.987	3.98543669270324e-08	LYZ	cDCs	GSE197268_Axi-cel_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27138
2.18563395280047e-12	-0.416532474896147	0.189	0.468	5.41621949843484e-08	XAF1	cDCs	GSE197268_Axi-cel_post	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27139
5.80404519269082e-12	-0.706734977781489	0.998	1	1.43830043920071e-07	HLA-DRB5	cDCs	GSE197268_Axi-cel_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27140
1.43383820800409e-11	0.588343829825604	1	0.994	3.55319446325493e-07	MT-RNR1	cDCs	GSE197268_Axi-cel_post	ENSG00000211459	NA	NA	12S|MOTS-c|MTRNR1	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27141
1.48439205601019e-11	0.330286151231764	1	1	3.67847195399886e-07	EIF1	cDCs	GSE197268_Axi-cel_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27142
2.05846920868635e-11	0.540282768928987	0.713	0.43	5.10109254604565e-07	KLF4	cDCs	GSE197268_Axi-cel_post	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27143
3.03698291444332e-11	0.329434226074405	1	1	7.52594736028198e-07	MT-CO2	cDCs	GSE197268_Axi-cel_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27144
5.62984561019914e-11	-0.448627591651428	0.081	0.291	1.39513204066345e-06	AL138963.4	cDCs	GSE197268_Axi-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27145
6.01084017063954e-11	-0.423109839524709	0.585	0.842	1.48954630268618e-06	ARF6	cDCs	GSE197268_Axi-cel_post	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27146
7.95517942025988e-11	0.283767419833915	1	1	1.9713730121346e-06	PPIA	cDCs	GSE197268_Axi-cel_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27147
1.06088430941208e-10	0.312866466326887	1	0.994	2.62897740715409e-06	RPS3A	cDCs	GSE197268_Axi-cel_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27148
1.77782799552978e-10	-0.513491394346626	0.929	0.981	4.40563555572234e-06	IFITM2	cDCs	GSE197268_Axi-cel_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27149
3.14473395144466e-10	-0.303840940632248	0.113	0.335	7.79296520507501e-06	AC024293.1	cDCs	GSE197268_Axi-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27150
3.55325999525018e-10	0.36694467109529	0.99	0.987	8.80533359422946e-06	GABARAP	cDCs	GSE197268_Axi-cel_post	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27151
4.43686550156789e-10	0.360214917102449	0.504	0.203	1.09949963994354e-05	EEF1G	cDCs	GSE197268_Axi-cel_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27152
5.31995299982997e-10	0.264716560920272	1	1	1.31833755288787e-05	EEF1A1	cDCs	GSE197268_Axi-cel_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27153
5.45223524982024e-10	0.345389146715871	0.99	0.968	1.35111841725795e-05	TPI1	cDCs	GSE197268_Axi-cel_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27154
5.7490550840689e-10	0.34640421654808	1	1	1.42467334038311e-05	FTH1	cDCs	GSE197268_Axi-cel_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27155
6.44860049081464e-10	-0.499269474413857	0.101	0.31	1.59802768762878e-05	EGR1	cDCs	GSE197268_Axi-cel_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27156
1.16362279887186e-09	-0.557103379370699	0.779	0.848	2.88357365788437e-05	LY6E	cDCs	GSE197268_Axi-cel_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27157
1.1750861239577e-09	-0.604355308167279	0.369	0.595	2.91198092377957e-05	ISG15	cDCs	GSE197268_Axi-cel_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27158
2.23002465406994e-09	0.250205401879773	1	1	5.52622409525071e-05	MT-CO3	cDCs	GSE197268_Axi-cel_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27159
2.2738807835188e-09	0.439661343291522	0.577	0.266	5.63490396963793e-05	NR4A2	cDCs	GSE197268_Axi-cel_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27160
2.38701495297489e-09	0.643997971018108	0.713	0.487	5.91526175496707e-05	NEAT1	cDCs	GSE197268_Axi-cel_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27161
2.40702801844047e-09	0.287500678360391	1	0.994	5.96485613249734e-05	RPL21	cDCs	GSE197268_Axi-cel_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27162
3.34009970675797e-09	0.314698787872357	0.998	0.994	8.27710108331692e-05	RPL37A	cDCs	GSE197268_Axi-cel_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27163
3.99431224046032e-09	-0.427488280035284	0.366	0.614	9.89830516308472e-05	MZT2B	cDCs	GSE197268_Axi-cel_post	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27164
4.57150530888769e-09	0.301509757073152	0.998	0.994	0.000113286473059546	RPL9	cDCs	GSE197268_Axi-cel_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27165
7.59182148815944e-09	-0.783752988920367	0.86	0.905	0.000188132928298079	IFITM3	cDCs	GSE197268_Axi-cel_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27166
1.0509973637562e-08	-0.359751001594937	0.297	0.532	0.000260447656712423	IRF7	cDCs	GSE197268_Axi-cel_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27167
1.3424096529963e-08	-0.427242920979617	0.7	0.835	0.000332662536109012	CAPG	cDCs	GSE197268_Axi-cel_post	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27168
1.93904881529149e-08	0.361153906255439	0.978	0.924	0.000480515686917384	ZFP36	cDCs	GSE197268_Axi-cel_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27169
1.94220101605974e-08	-0.51075183449437	0.246	0.475	0.000481296833789765	MX1	cDCs	GSE197268_Axi-cel_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27170
2.05862568471304e-08	-0.392849226572048	0.346	0.589	0.000510148030928738	TAF10	cDCs	GSE197268_Axi-cel_post	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27171
2.76825202000234e-08	-0.462463113481983	0.698	0.778	0.000686000533076781	GNAI2	cDCs	GSE197268_Axi-cel_post	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27172
3.33481472693574e-08	0.434975355165285	0.717	0.525	0.000826400437481946	TSC22D3	cDCs	GSE197268_Axi-cel_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27173
4.17347051850033e-08	-0.316857791235084	0.867	0.93	0.00103422772918957	RPL23A	cDCs	GSE197268_Axi-cel_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27174
4.38034560517549e-08	0.375136490109923	0.865	0.772	0.00108549344441854	NME2	cDCs	GSE197268_Axi-cel_post	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27175
4.39874772608672e-08	-0.522490526231098	0.764	0.804	0.00109005367400155	RPS2P5	cDCs	GSE197268_Axi-cel_post	ENSG00000240342	NA	NA	bcm384	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27176
6.79793516357072e-08	-0.516338712019536	0.993	0.994	0.00168459631288446	MT-ATP6	cDCs	GSE197268_Axi-cel_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27177
7.39734549067124e-08	0.29037995593842	0.312	0.095	0.00183313618604324	CEACAM4	cDCs	GSE197268_Axi-cel_post	ENSG00000274131	1089	CEA cell adhesion molecule 4	CGM7	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27178
7.93491452244447e-08	-0.3162919867362	0.206	0.424	0.00196635116780696	PPP1R14B	cDCs	GSE197268_Axi-cel_post	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27179
8.67625861824469e-08	-0.513830071825624	0.258	0.475	0.00215006364818722	H1-4	cDCs	GSE197268_Axi-cel_post	ENSG00000168298	3008	H1.4 linker histone, cluster member	H1.4|H1e|H1F4|H1s-4|HIST1H1E	protein_coding	P10412	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27180
9.22793000602911e-08	-0.367701347575183	0.283	0.5	0.00228677333479407	LMO2	cDCs	GSE197268_Axi-cel_post	ENSG00000135363	4005	LIM domain only 2	RBTN2|RBTNL1|RHOM2|TTG2	protein_coding	P25791	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27181
1.24517330005766e-07	0.338660942704265	0.919	0.842	0.00308566395487289	FKBP1A	cDCs	GSE197268_Axi-cel_post	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27182
1.59048097266272e-07	-0.312936410223889	0.26	0.487	0.00394137089835549	UNC93B1	cDCs	GSE197268_Axi-cel_post	ENSG00000110057	81622	unc-93 homolog B1, TLR signaling regulator	UNC93	protein_coding	Q9H1C4	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27183
1.89633498538811e-07	-0.749877944844423	0.658	0.823	0.00469930772729027	IFITM1	cDCs	GSE197268_Axi-cel_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27184
2.1758532400255e-07	-0.337089859919548	0.248	0.456	0.00539198191410718	DDX17	cDCs	GSE197268_Axi-cel_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27185
2.42581372475195e-07	-0.275705151036037	0.143	0.329	0.00601140899130782	OAS3	cDCs	GSE197268_Axi-cel_post	ENSG00000111331	4940	2'-5'-oligoadenylate synthetase 3	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27186
3.22839620432423e-07	0.281919232764264	0.359	0.139	0.00800028863393589	KLF9	cDCs	GSE197268_Axi-cel_post	ENSG00000119138	687	KLF transcription factor 9	BTEB1	protein_coding	Q13886	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27187
4.45320063432427e-07	-0.389083099023584	0.241	0.443	0.011035476491919	PKIB	cDCs	GSE197268_Axi-cel_post	ENSG00000135549	5570	cAMP-dependent protein kinase inhibitor beta	PRKACN2	protein_coding	Q9C010	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27188
4.91818774401388e-07	0.271740056330207	0.541	0.272	0.0121877610484408	RGS2	cDCs	GSE197268_Axi-cel_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27189
5.53563157935223e-07	0.38960920622723	0.737	0.557	0.0137178486167928	PPP1R15A	cDCs	GSE197268_Axi-cel_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27190
5.82968178663878e-07	0.265811449815504	1	1	0.0144465344354696	GAPDH	cDCs	GSE197268_Axi-cel_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27191
5.95169834519834e-07	0.294951383076801	0.897	0.772	0.014748903669236	ARPC1B	cDCs	GSE197268_Axi-cel_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27192
6.35283089829578e-07	0.414077478072518	0.57	0.348	0.0157429502490668	SNHG15	cDCs	GSE197268_Axi-cel_post	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27193
9.19061747211198e-07	0.434871155602862	0.784	0.671	0.0227752691576407	KLF6	cDCs	GSE197268_Axi-cel_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27194
9.39768467607278e-07	-0.425907515151344	0.835	0.835	0.0232884023957759	CTSZ	cDCs	GSE197268_Axi-cel_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27195
1.24333682683362e-06	-0.295260247475035	0.253	0.456	0.030811129905764	EIF2AK2	cDCs	GSE197268_Axi-cel_post	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27196
1.31462452428087e-06	-0.350516699866098	0.184	0.367	0.0325777103362042	ABI3	cDCs	GSE197268_Axi-cel_post	ENSG00000108798	51225	ABI family member 3	NESH|SSH3BP3	protein_coding	Q9P2A4	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27197
1.53435171256953e-06	-0.251702839230055	0.13	0.297	0.0380227697891854	OAS1	cDCs	GSE197268_Axi-cel_post	ENSG00000089127	4938	2'-5'-oligoadenylate synthetase 1	IFI-4|OIAS|OIASI	protein_coding	P00973	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27198
1.66288260457595e-06	-0.323411287789184	0.405	0.608	0.0412078938239965	TGFB1	cDCs	GSE197268_Axi-cel_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27199
2.01136183324001e-06	-0.292203689041696	0.509	0.69	0.0498435575895207	PTP4A2	cDCs	GSE197268_Axi-cel_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27200
0	0.401898807958148	0.998	0.998	0	S100A6	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27201
0	0.268158411576795	0.998	0.999	0	S100A4	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27202
0	-0.448334289988231	0.996	0.999	0	CD74	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27203
0	-0.577858095501158	0.234	0.465	0	HLA-DQA1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27204
0	-0.599811060454517	0.436	0.723	0	HLA-DQB1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27205
0	-0.345627196059115	0.998	0.999	0	RPS18	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27206
0	0.390591374251249	0.978	0.952	0	SRGN	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27207
0	0.508377831642569	0.989	0.976	0	NEAT1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27208
0	-0.729130684947432	0.323	0.767	0	RPS4Y1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27209
0	1.04129702198746	0.911	0.9	0	S100A8	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27210
0	0.52548613114744	0.29	0.009	0	XIST	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27211
3.94975448493256e-282	0.419751573987514	0.755	0.587	9.78788658911138e-278	SLC11A1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000018280	6556	solute carrier family 11 member 1	LSH|NRAMP|NRAMP1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27212
1.72497762705137e-280	0.554876314279847	0.851	0.761	4.27466705759601e-276	VCAN	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27213
6.84474613738207e-278	-0.446892144142016	0.703	0.865	1.69619654030465e-273	HLA-DPB1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27214
8.96516257614634e-274	-0.270144360253346	0.993	0.998	2.22165693799482e-269	RPS2	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27215
1.57805415738631e-264	0.399363827118916	0.953	0.912	3.91057600741903e-260	RPS26	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27216
1.80025803830776e-264	0.309268158134732	0.999	0.995	4.46121944473045e-260	MT-ND3	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27217
2.39425979582889e-257	0.252866509219931	0.998	0.995	5.93321520004358e-253	ATP5F1E	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27218
5.90594520482749e-256	-0.408106024177637	0.907	0.969	1.4635522812083e-251	HLA-DRA	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27219
5.02406114154936e-240	0.473368972562334	0.829	0.736	1.24501259148735e-235	CD14	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27220
8.45721216740911e-232	-0.392742058690058	0.731	0.879	2.09578174720565e-227	HLA-DPA1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27221
9.82753007482478e-227	-0.311233490651906	0.97	0.985	2.43536022784233e-222	RPLP0	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27222
1.73842513065589e-225	0.806216133738902	0.697	0.577	4.30799131627837e-221	S100A12	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27223
6.70967389468094e-222	-0.333138512693414	0.539	0.689	1.66272428784088e-217	PSMB10	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000205220	5699	proteasome 20S subunit beta 10	beta2i|LMP10|MECL1|MGC1665	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27224
7.03047134258715e-221	0.381557197165468	0.991	0.962	1.74222110340652e-216	LYZ	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27225
4.44028843226742e-213	-0.273697492903545	0.974	0.99	1.10034787640019e-208	RPL3	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27226
2.17701281220721e-209	-0.299186570960643	0.919	0.959	5.39485544993069e-205	RPS5	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27227
2.80007268531644e-203	0.338001611024795	0.916	0.843	6.93886012148268e-199	MNDA	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27228
1.01571354891429e-196	0.445720998317268	0.558	0.404	2.51703974556451e-192	IFI6	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27229
2.38882158511107e-196	0.557426391132746	0.538	0.394	5.91973877006375e-192	LGALS2	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27230
6.54029041944782e-196	0.394845596748379	0.68	0.534	1.62074936884337e-191	CTSD	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27231
6.93673166572822e-195	-0.283299494389722	0.835	0.911	1.71899147408411e-190	RPS2P5	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000240342	NA	NA	bcm384	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27232
2.84820256899705e-188	-0.448163183506655	0.414	0.565	7.0581307862316e-184	TMEM176B	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27233
3.34930420045974e-188	-0.291154912639024	0.896	0.964	8.29991073915929e-184	HLA-DRB1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27234
8.82501414881129e-188	-0.278866193125999	0.96	0.984	2.18692675621692e-183	MT-ND5	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27235
3.58064418356053e-178	0.2758581776881	0.349	0.199	8.87319435128134e-174	CLEC4E	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000166523	26253	C-type lectin domain family 4 member E	CLECSF9|MINCLE	protein_coding	Q9ULY5	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27236
1.54918987321803e-174	0.359035266291455	0.395	0.241	3.8390474248216e-170	MX1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27237
5.42709177879757e-173	-0.30173867714397	0.56	0.701	1.34488761370383e-168	HSP90AB1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27238
2.63713406270112e-160	-0.26616276655907	0.797	0.879	6.53508192077964e-156	EEF1B2	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27239
1.01639162547429e-157	0.260735802909378	0.259	0.132	2.51872008708784e-153	IFI44L	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27240
7.14924532235087e-157	0.347002497125326	0.869	0.824	1.77165448333177e-152	CEBPD	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27241
1.93035179839223e-155	0.359349059558215	0.571	0.434	4.78360479159579e-151	RGS2	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27242
1.31143664077712e-153	0.27272200649047	0.979	0.966	3.24987113950978e-149	S100A10	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27243
4.82612746603501e-151	0.284594088719514	0.443	0.287	1.19596264735814e-146	APOBEC3A	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000262156	200315	apolipoprotein B mRNA editing enzyme catalytic subunit 3A	ARP3|PHRBN	protein_coding	P31941	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27244
9.71369234085669e-149	0.273941214338881	0.291	0.162	2.4071500989877e-144	SLC2A3	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27245
1.07878244778927e-148	-0.253695625644344	0.884	0.934	2.6733307838666e-144	EEF2	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27246
2.61312669121441e-147	0.288853086705322	0.669	0.533	6.47558925349844e-143	LILRA5	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000278355	353514	leukocyte immunoglobulin like receptor A5	CD85|CD85f|ILT11|LILRB7|LIR9	protein_coding	A6NI73	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27247
2.72512161648768e-147	0.275909218745541	0.61	0.47	6.75312387781813e-143	PTPRE	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27248
5.76048142010943e-147	-0.280821974542247	0.431	0.573	1.42750490071732e-142	ITGA4	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27249
4.27732739936704e-141	-0.306273192300973	0.154	0.282	1.05996450283715e-136	NKG7	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27250
1.75736601749454e-134	0.311231027556375	0.726	0.612	4.35492872795321e-130	STXBP2	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000076944	6813	syntaxin binding protein 2	Hunc18b|MUNC18-2|Unc18-2|UNC18B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27251
1.93253399482181e-132	0.545906504845894	0.971	0.974	4.78901249256792e-128	S100A9	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27252
1.09074589632478e-113	0.360948392916917	0.529	0.42	2.70297740568243e-109	PLBD1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000121316	79887	phospholipase B domain containing 1	FLJ22662	protein_coding	Q6P4A8	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27253
2.17253240193483e-111	0.28150896387256	0.643	0.542	5.3837525452347e-107	FPR1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000171051	2357	formyl peptide receptor 1	FMLP|FPR	protein_coding	P21462	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27254
1.45656038410272e-108	-0.255460303813331	0.553	0.647	3.60950228784494e-104	SNHG29	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000175061	125144	small nucleolar RNA host gene 29	C17orf45|C17orf76-AS1|FAM211A-AS1|LRRC75A-AS1|MGC40157|NCRNA00188	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27255
9.78630896533955e-82	0.30939925990157	0.8	0.732	2.42514522470079e-77	TIMP1	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27256
2.05077381799392e-72	0.314547488089913	0.468	0.378	5.08202259837073e-68	ISG15	Mono/Macro	GSE197268_Axi-cel_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27257
1.22317802108996e-79	1.06185634706291	1	0.992	3.03115745406302e-75	HLA-DRB5	cDCs	GSE197268_Axi-cel_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27258
4.17538686343775e-52	0.881412197983644	0.99	0.91	1.03470261862851e-47	RPS26	cDCs	GSE197268_Axi-cel_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27259
3.63216101380151e-46	-0.816716376649942	0.433	0.914	9.00085820830152e-42	RPS4Y1	cDCs	GSE197268_Axi-cel_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27260
3.92321296330987e-33	0.524701835766821	0.314	0.022	9.72211404437819e-29	XIST	cDCs	GSE197268_Axi-cel_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27261
9.62555742736181e-23	0.473270973639482	0.616	0.284	2.38530938607453e-18	HLA-H	cDCs	GSE197268_Axi-cel_pre	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27262
2.06972426914202e-20	0.553977624007485	1	1	5.12898371136085e-16	HLA-DPA1	cDCs	GSE197268_Axi-cel_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27263
3.65198836426817e-19	-0.571323824861634	0.448	0.678	9.04999236549296e-15	AL365357.1	cDCs	GSE197268_Axi-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27264
6.49393766741457e-19	0.304766212570285	1	1	1.60926269336201e-14	RPS27	cDCs	GSE197268_Axi-cel_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27265
4.12008028382428e-15	-0.448465653267173	0.263	0.49	1.02099709513449e-10	AL591846.2	cDCs	GSE197268_Axi-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27266
1.25901879936779e-12	0.325148315443348	1	1	3.11997448671332e-08	HLA-DRB1	cDCs	GSE197268_Axi-cel_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27267
3.13153330446519e-12	0.294316186143909	0.995	0.969	7.7602526817952e-08	HLA-DMA	cDCs	GSE197268_Axi-cel_pre	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27268
6.49009939671296e-11	-0.357393784654743	0.985	0.99	1.60831153149944e-06	MT-ND5	cDCs	GSE197268_Axi-cel_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27269
4.22873623731199e-10	-0.487829058181235	0.631	0.765	1.04792312696828e-05	FCN1	cDCs	GSE197268_Axi-cel_pre	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27270
3.74621639289072e-09	0.289454000763648	1	1	9.28349884322249e-05	HLA-DPB1	cDCs	GSE197268_Axi-cel_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27271
7.30266481882686e-09	0.499358951998273	0.814	0.729	0.000180967336875349	CD1C	cDCs	GSE197268_Axi-cel_pre	ENSG00000158481	911	CD1c molecule	CD1	protein_coding	P29017	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27272
1.38911656662754e-08	0.391360353392288	0.997	0.992	0.000344236976375971	HLA-DQA1	cDCs	GSE197268_Axi-cel_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27273
1.85840774190854e-08	0.288043158484391	0.933	0.922	0.000460532022522355	C1orf162	cDCs	GSE197268_Axi-cel_pre	ENSG00000143110	128346	chromosome 1 open reading frame 162	MGC24133	protein_coding	Q8NEQ5	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27274
1.89191855739008e-08	0.389705856841709	0.992	0.994	0.000468836337706835	HLA-DQB1	cDCs	GSE197268_Axi-cel_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27275
2.87399759314842e-08	0.37747538768579	0.858	0.72	0.00071220534355811	CLEC10A	cDCs	GSE197268_Axi-cel_pre	ENSG00000132514	10462	C-type lectin domain containing 10A	CD301|CLECSF13|CLECSF14|HML|HML2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27276
2.83799195237478e-07	-0.263402039898599	0.557	0.686	0.00703282785717995	PSMB10	cDCs	GSE197268_Axi-cel_pre	ENSG00000205220	5699	proteasome 20S subunit beta 10	beta2i|LMP10|MECL1|MGC1665	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27277
6.91905504607751e-07	0.35952371511487	0.851	0.788	0.0171461103096847	FCER1A	cDCs	GSE197268_Axi-cel_pre	ENSG00000179639	2205	Fc epsilon receptor Ia	FCE1A|FcepsilonRIalpha|FCERIA	protein_coding	P12319	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27278
1.35716547799971e-06	0.259133638322439	1	0.998	0.0336319177103108	MT-ND3	cDCs	GSE197268_Axi-cel_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27279
0	0.762461723431415	0.993	0.973	0	RPS26	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27280
0	-0.837916607766894	0.372	0.831	0	RPS4Y1	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27281
1.61586259389849e-232	-0.419729630574722	0.268	0.621	4.00426909393986e-228	LYZ	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27282
2.22582506189111e-220	-0.403697779796465	0.225	0.564	5.51581708587236e-216	CST3	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27283
1.21910627531198e-203	-0.3812266188843	0.306	0.638	3.02106726085061e-199	S100A8	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27284
1.76045505215188e-203	-0.391142226927319	0.351	0.678	4.36258366473758e-199	S100A9	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27285
2.14922011065136e-197	0.515251233094136	0.997	0.994	5.32598235620514e-193	MT-ND3	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27286
9.0021904785084e-166	-0.34741917385111	1	1	2.23083282247917e-161	RPS18	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27287
9.02074147081497e-161	0.506112907550782	0.659	0.376	2.23542994388266e-156	HLA-H	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27288
7.59834648846406e-144	-0.279744513871225	1	1	1.88294624330628e-139	RPL13	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27289
4.65173797216728e-131	0.460998517937952	0.798	0.557	1.15274718688277e-126	CD81	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27290
2.06987792262248e-123	-0.463979154135526	0.528	0.775	5.12936448005076e-119	COTL1	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27291
2.91825326650724e-122	0.356719483084238	1	1	7.23172341973158e-118	MT-CYB	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27292
8.45093639800952e-120	0.287723936142275	1	1	2.09422654879074e-115	RPS27	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27293
1.5081558111335e-117	-0.279120152251894	1	1	3.73736091556993e-113	RPLP1	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27294
5.47996143850004e-116	-0.359338362330505	0.159	0.381	1.3579892440747e-111	TYMP	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27295
4.00667556669205e-101	-0.259799789524566	0.145	0.354	9.92894272181957e-97	FCN1	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27296
8.4405781601042e-90	0.479119991844803	0.759	0.586	2.09165967385542e-85	GZMB	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27297
1.2084227020874e-87	-0.302542928990242	0.351	0.561	2.9945922980428e-83	CTSS	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27298
1.13266255752411e-81	0.362024559047704	0.721	0.522	2.8068510838005e-77	KLRD1	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27299
4.7154829697416e-81	0.284556837262636	0.973	0.938	1.16854383473167e-76	RPS29	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27300
3.4418646365371e-78	0.254970262695555	0.997	0.994	8.52928475580259e-74	RPL37A	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27301
4.63390578435755e-78	0.388578392396041	0.589	0.395	1.14832819242165e-73	HOPX	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27302
1.25050841232812e-70	0.257747924922107	0.413	0.233	3.0988848965903e-66	BTN3A2	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27303
2.86829559862948e-67	0.340642381069257	0.584	0.397	7.10792332296372e-63	ITGB1	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27304
5.62471696514198e-67	0.28753971193812	0.876	0.786	1.39386111113183e-62	TMA7	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27305
4.12564236808474e-66	-0.251812355497514	0.393	0.586	1.02237543523508e-61	GPX1	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27306
2.97597533304376e-65	0.254606646389764	1	1	7.37476447281575e-61	MT-ATP6	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27307
6.11368616459246e-65	0.434598251339916	0.826	0.848	1.51503256844766e-60	GNLY	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27308
6.00661797553737e-61	-0.416858350344164	0.251	0.397	1.48850000051791e-56	AL365357.1	CD8+ T cells	GSE197268_Axi-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27309
7.09072124151883e-61	0.321111582992547	0.461	0.289	1.75715163086078e-56	FCGR3A	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27310
1.75701760584001e-60	0.302574885482101	0.429	0.267	4.35406532903212e-56	KCNAB2	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000069424	8514	potassium voltage-gated channel subfamily A regulatory beta subunit 2	AKR6A5|HKvbeta2.1|HKvbeta2.2|KCNA2B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27311
8.56649253052789e-54	0.281004035601448	0.619	0.44	2.12286251399012e-49	CD247	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27312
1.45962909364747e-52	-0.271107111323212	0.771	0.872	3.61710685696779e-48	SLC25A6	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27313
1.61984529273595e-49	-0.269078484714893	0.891	0.941	4.01413861992897e-45	EEF2	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27314
2.58561003610176e-46	0.282645995055825	0.414	0.265	6.40740023046378e-42	H4C3	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000197061	8364	H4 clustered histone 3	dJ221C16.1|H4/g|H4FG|HIST1H4C	protein_coding	P62805	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27315
9.43957162072858e-43	0.281669227068323	0.955	0.943	2.33922024333275e-38	MT-ATP8	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27316
3.21067384260917e-36	-0.38034370638193	0.26	0.356	7.95637084936978e-32	STAT1	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27317
5.09347688371806e-35	-0.321711463720728	0.325	0.422	1.26221450655417e-30	H1-4	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000168298	3008	H1.4 linker histone, cluster member	H1.4|H1e|H1F4|H1s-4|HIST1H1E	protein_coding	P10412	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27318
2.27532214732156e-33	-0.301227989206297	0.28	0.377	5.63847581327756e-29	ITM2A	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27319
2.55328964006132e-28	0.66121502086679	0.593	0.645	6.32730705703595e-24	TYROBP	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27320
9.86775784693666e-19	-0.252059364319477	0.671	0.714	2.44532907204937e-14	FGFBP2	CD8+ T cells	GSE197268_Axi-cel_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27321
0	-2.93916127781493	0.056	0.432	0	HBB	NK cells	GSE197268_Axi-cel_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27322
0	1.19375540507052	0.955	0.82	0	RPS26	NK cells	GSE197268_Axi-cel_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27323
3.10963860667539e-277	-1.78431857450422	0.041	0.378	7.70599543120229e-273	HBA1	NK cells	GSE197268_Axi-cel_pre	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27324
4.51219676044104e-272	-1.94933194816712	0.036	0.369	1.11816747920489e-267	HBA2	NK cells	GSE197268_Axi-cel_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27325
8.29113740313238e-253	0.673152082844822	0.593	0.262	2.05462675987024e-248	HLA-H	NK cells	GSE197268_Axi-cel_pre	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27326
6.14110478237913e-222	0.599655020840745	0.793	0.493	1.52182717612137e-217	CD81	NK cells	GSE197268_Axi-cel_pre	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27327
6.05787543062622e-215	0.502839467424229	0.999	0.993	1.50120211046348e-210	MT-CYB	NK cells	GSE197268_Axi-cel_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27328
6.96604573067392e-210	-1.15567822033224	0.029	0.296	1.7262557925183e-205	ALAS2	NK cells	GSE197268_Axi-cel_pre	ENSG00000158578	212	5'-aminolevulinate synthase 2	ALAS-E|ASB	protein_coding	P22557	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27329
8.1501978952741e-201	0.574579845651367	0.253	0.047	2.01970054042788e-196	MYOM2	NK cells	GSE197268_Axi-cel_pre	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27330
3.05476437743465e-195	0.43321934907228	1	0.999	7.5700116037208e-191	MT-CO1	NK cells	GSE197268_Axi-cel_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27331
1.36313951958468e-190	0.462787676198229	0.999	0.956	3.3779960434828e-186	MT-ND3	NK cells	GSE197268_Axi-cel_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27332
9.91382052654284e-190	-1.21029477299681	0.018	0.252	2.45674386468258e-185	HBD	NK cells	GSE197268_Axi-cel_pre	ENSG00000223609	3045	hemoglobin subunit delta	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27333
6.07105541000195e-184	0.45984734656244	0.999	0.991	1.50446824115258e-179	MT-ATP6	NK cells	GSE197268_Axi-cel_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27334
2.02422013017776e-169	-0.948293143556449	0.074	0.318	5.01621990459352e-165	SLC25A37	NK cells	GSE197268_Axi-cel_pre	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27335
1.42462258024116e-166	0.478508203671406	0.968	0.866	3.53035721609561e-162	CTSW	NK cells	GSE197268_Axi-cel_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27336
4.75353211528039e-152	-0.686771147083728	0.047	0.263	1.17797279348763e-147	SNCA	NK cells	GSE197268_Axi-cel_pre	ENSG00000145335	6622	synuclein alpha	NACP|PARK1|PARK4|PD1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27337
7.65258046168872e-152	0.363910997229931	0.997	0.996	1.89638596421108e-147	RPS27	NK cells	GSE197268_Axi-cel_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27338
3.34388940212296e-136	0.452372025948145	0.977	0.894	8.2864923274009e-132	GNLY	NK cells	GSE197268_Axi-cel_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27339
1.86036819621716e-128	0.366231451505766	0.998	0.973	4.61017842704574e-124	MT-ND4	NK cells	GSE197268_Axi-cel_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27340
3.36262732379322e-127	0.351929924700133	0.986	0.961	8.33292677109198e-123	RPL37A	NK cells	GSE197268_Axi-cel_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27341
2.0085814378339e-123	0.386979442183917	0.962	0.902	4.97746566109619e-119	HCST	NK cells	GSE197268_Axi-cel_pre	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27342
2.03245593643301e-117	-0.539449323308079	0.069	0.258	5.03662905607463e-113	YBX3	NK cells	GSE197268_Axi-cel_pre	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27343
1.69599986512829e-110	0.36427397157262	0.991	0.962	4.20285726577443e-106	TXNIP	NK cells	GSE197268_Axi-cel_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27344
6.23455182158509e-109	-0.815261675930506	0.231	0.417	1.544984286907e-104	SLC25A39	NK cells	GSE197268_Axi-cel_pre	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27345
1.37545183237289e-103	0.424309468228762	0.676	0.475	3.40850718580326e-99	PRMT2	NK cells	GSE197268_Axi-cel_pre	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27346
4.4714274040169e-100	0.267151369112189	0.998	0.999	1.10806442498943e-95	TMSB4X	NK cells	GSE197268_Axi-cel_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27347
4.45738718898964e-99	0.36452276140734	0.45	0.246	1.10458511930352e-94	KCNAB2	NK cells	GSE197268_Axi-cel_pre	ENSG00000069424	8514	potassium voltage-gated channel subfamily A regulatory beta subunit 2	AKR6A5|HKvbeta2.1|HKvbeta2.2|KCNA2B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27348
5.79396354974715e-98	0.425401854993292	0.775	0.58	1.43580210726284e-93	FCGR3A	NK cells	GSE197268_Axi-cel_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27349
3.79392420998711e-97	0.50762484378976	0.705	0.499	9.40172358476905e-93	CLIC3	NK cells	GSE197268_Axi-cel_pre	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27350
8.74555313497192e-97	0.309632083675182	0.995	0.993	2.16723552237739e-92	RPS4X	NK cells	GSE197268_Axi-cel_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27351
1.36825737127429e-96	0.334476350496615	0.926	0.86	3.39067859175481e-92	RPS29	NK cells	GSE197268_Axi-cel_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27352
2.26722260436355e-96	0.305925956307651	1	1	5.61840433587331e-92	MT-CO2	NK cells	GSE197268_Axi-cel_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27353
8.28483296934834e-94	0.280470828466193	0.999	0.997	2.05306445813421e-89	MT-CO3	NK cells	GSE197268_Axi-cel_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27354
7.82356290451468e-93	0.287342748835359	0.996	0.99	1.93875712336778e-88	RPS28	NK cells	GSE197268_Axi-cel_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27355
2.46287586331402e-92	0.27728768695747	0.996	0.992	6.10325267687847e-88	RPL37	NK cells	GSE197268_Axi-cel_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27356
3.0821596116429e-90	0.353533259384971	0.87	0.691	7.63789973361226e-86	KLRD1	NK cells	GSE197268_Axi-cel_pre	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27357
3.56250005445521e-90	0.349427236776921	0.945	0.81	8.82823138494546e-86	TYROBP	NK cells	GSE197268_Axi-cel_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27358
3.5266911181201e-88	0.357280141704319	0.597	0.388	8.73949325981341e-84	APOBEC3G	NK cells	GSE197268_Axi-cel_pre	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27359
8.01756301834146e-88	-0.452950754758674	0.406	0.609	1.9868322915752e-83	GPX1	NK cells	GSE197268_Axi-cel_pre	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27360
8.34816260570355e-86	0.282708417449682	0.988	0.973	2.0687581753194e-81	RPS21	NK cells	GSE197268_Axi-cel_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27361
1.12054011682028e-85	0.355941847897199	0.872	0.745	2.77681046349233e-81	GIMAP7	NK cells	GSE197268_Axi-cel_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27362
1.79697040497791e-85	0.342063957248564	0.683	0.442	4.45307236057576e-81	KLRB1	NK cells	GSE197268_Axi-cel_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27363
6.13793378576477e-83	0.409952424048204	0.488	0.287	1.52104137145037e-78	KLRC1	NK cells	GSE197268_Axi-cel_pre	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27364
3.474177657511e-82	-0.33151098039092	0.487	0.726	8.609359653078e-78	RPS4Y1	NK cells	GSE197268_Axi-cel_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27365
2.67582781651709e-80	0.37833871724253	0.569	0.373	6.63096891211101e-76	ITGB1	NK cells	GSE197268_Axi-cel_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27366
2.68553229110062e-78	0.264320969968193	0.994	0.973	6.65501757057645e-74	MT-ND4L	NK cells	GSE197268_Axi-cel_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27367
1.10809997372069e-76	0.261759454186575	0.997	0.973	2.74598254487724e-72	MT-ND1	NK cells	GSE197268_Axi-cel_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27368
9.53720305416953e-76	0.346218399369983	0.472	0.285	2.36341428885375e-71	TRDC	NK cells	GSE197268_Axi-cel_pre	ENSG00000211829	NA	NA	NA	TR_C_gene	B7Z8K6	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27369
4.7851692540658e-74	0.250823635721068	0.993	0.978	1.18581279285005e-69	CALM1	NK cells	GSE197268_Axi-cel_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27370
2.07994068213601e-73	0.25393174819956	0.331	0.17	5.15430100440125e-69	LAIR1	NK cells	GSE197268_Axi-cel_pre	ENSG00000276163	3903	leukocyte associated immunoglobulin like receptor 1	CD305|LAIR-1	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27371
2.78866851534262e-70	0.255315280224844	0.99	0.976	6.91059944787055e-66	CYBA	NK cells	GSE197268_Axi-cel_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27372
9.53911522382612e-70	0.283272763106024	1	1	2.36388814361635e-65	MT-RNR2	NK cells	GSE197268_Axi-cel_pre	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27373
4.76024796696667e-69	-0.297610157124474	0.314	0.502	1.17963704869401e-64	COTL1	NK cells	GSE197268_Axi-cel_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27374
2.15921664763327e-68	0.269134574684243	0.44	0.264	5.35075477450001e-64	BTN3A2	NK cells	GSE197268_Axi-cel_pre	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27375
2.02498211765466e-67	0.425065291272296	0.815	0.732	5.01810818576002e-63	IL32	NK cells	GSE197268_Axi-cel_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27376
4.77187943635563e-67	0.415847244570521	0.853	0.758	1.18251944312329e-62	CD7	NK cells	GSE197268_Axi-cel_pre	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27377
5.48975093980919e-67	0.297586163251281	0.867	0.697	1.36041518039412e-62	CD247	NK cells	GSE197268_Axi-cel_pre	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27378
2.59169686702516e-66	0.289616823397428	0.952	0.9	6.42248400617505e-62	SRGN	NK cells	GSE197268_Axi-cel_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27379
3.11386799875118e-64	0.25742334519968	0.958	0.9	7.71647628770531e-60	MT-ND2	NK cells	GSE197268_Axi-cel_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27380
8.10589040121562e-64	0.287357099234773	0.376	0.221	2.00872070032524e-59	DIP2A	NK cells	GSE197268_Axi-cel_pre	ENSG00000160305	23181	disco interacting protein 2 homolog A	C21orf106|Dip2|KIAA0184	protein_coding	Q14689	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27381
2.48928725866669e-62	0.27557709994868	0.532	0.352	6.16870275570193e-58	CD300A	NK cells	GSE197268_Axi-cel_pre	ENSG00000167851	11314	CD300a molecule	CMRF-35-H9|CMRF35H|IGSF12|IRC1|IRC2|Irp60	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27382
3.70440381529145e-61	0.308594281355522	0.81	0.649	9.17988309467375e-57	HOPX	NK cells	GSE197268_Axi-cel_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27383
3.90408463381621e-60	-0.452889888459865	0.509	0.599	9.67471213105996e-56	FKBP8	NK cells	GSE197268_Axi-cel_pre	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27384
4.35497629668072e-60	0.265391983700374	0.873	0.799	1.07920667608045e-55	RPL38	NK cells	GSE197268_Axi-cel_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27385
3.23035061247765e-58	0.257380670860836	0.849	0.74	8.00513185278087e-54	TMA7	NK cells	GSE197268_Axi-cel_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27386
5.49921137044091e-58	-0.431588610204896	0.878	0.912	1.36275956970896e-53	UBB	NK cells	GSE197268_Axi-cel_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27387
6.76006070651333e-58	0.278027453364793	0.944	0.877	1.67521064368107e-53	GZMA	NK cells	GSE197268_Axi-cel_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27388
7.30636191966894e-57	-0.450529168778423	0.173	0.303	1.81058954731316e-52	BNIP3L	NK cells	GSE197268_Axi-cel_pre	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27389
5.73463050566602e-56	0.27956987983857	0.635	0.453	1.4210987856091e-51	PLAC8	NK cells	GSE197268_Axi-cel_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27390
8.18999421086054e-55	0.383070256544148	0.506	0.361	2.02956246539335e-50	CMC1	NK cells	GSE197268_Axi-cel_pre	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27391
1.58290782953805e-53	-0.358243424146096	0.192	0.322	3.92260389237825e-49	ADIPOR1	NK cells	GSE197268_Axi-cel_pre	ENSG00000159346	51094	adiponectin receptor 1	ACDCR1|PAQR1	protein_coding	Q96A54	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27392
7.80379145331044e-51	0.306200592715653	0.691	0.538	1.93385756004486e-46	ID2	NK cells	GSE197268_Axi-cel_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27393
1.88729382185363e-50	0.260284283013503	0.701	0.538	4.67690281993548e-46	SPN	NK cells	GSE197268_Axi-cel_pre	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27394
2.72384258841474e-49	0.254466749318339	0.749	0.614	6.74995431835057e-45	CD63	NK cells	GSE197268_Axi-cel_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27395
7.30403472894592e-49	0.278430324309491	0.738	0.61	1.81001284618009e-44	EIF3G	NK cells	GSE197268_Axi-cel_pre	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27396
6.35716998821823e-48	0.272450206795	0.696	0.541	1.57537029478036e-43	TRBC1	NK cells	GSE197268_Axi-cel_pre	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27397
6.70815249161672e-46	0.255821862698597	0.632	0.472	1.66234726894754e-41	TCF25	NK cells	GSE197268_Axi-cel_pre	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27398
5.2797627767304e-45	0.25268560271142	0.718	0.582	1.30837801370156e-40	TRAF3IP3	NK cells	GSE197268_Axi-cel_pre	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27399
5.93145088362566e-45	0.322476733349915	0.925	0.792	1.46987284347127e-40	GZMB	NK cells	GSE197268_Axi-cel_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27400
2.00397419999063e-44	0.267134287539899	0.999	0.996	4.96604846499678e-40	MT-RNR1	NK cells	GSE197268_Axi-cel_pre	ENSG00000211459	NA	NA	12S|MOTS-c|MTRNR1	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27401
2.15315736404208e-44	-0.3600743935845	0.481	0.569	5.33573926383267e-40	GYPC	NK cells	GSE197268_Axi-cel_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27402
1.60935221826042e-43	-0.282100029792543	0.172	0.307	3.98813573207115e-39	CD3D	NK cells	GSE197268_Axi-cel_pre	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27403
3.2701934305163e-43	0.255718493287461	0.574	0.429	8.10386634016245e-39	C12orf75	NK cells	GSE197268_Axi-cel_pre	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27404
1.02734167317006e-42	0.254522858050896	0.678	0.542	2.54585540028273e-38	GIMAP4	NK cells	GSE197268_Axi-cel_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27405
1.16225013103465e-40	0.288451544495417	0.45	0.319	2.88017204971696e-36	DDIT4	NK cells	GSE197268_Axi-cel_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27406
2.81663135934338e-38	0.36530798914921	0.644	0.567	6.97989417158883e-34	CD3E	NK cells	GSE197268_Axi-cel_pre	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27407
5.98163641906592e-38	0.327267131177934	0.641	0.499	1.48230932100873e-33	CCL4	NK cells	GSE197268_Axi-cel_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27408
1.68691856709349e-36	-0.320632648409057	0.214	0.316	4.18035290111439e-32	BCL2L1	NK cells	GSE197268_Axi-cel_pre	ENSG00000171552	598	BCL2 like 1	Bcl-X|bcl-xL|bcl-xS|BCL2L|BCLX|PPP1R52	protein_coding	Q07817	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27409
1.97904153831865e-35	0.272438577156228	0.259	0.158	4.90426283610745e-31	XCL2	NK cells	GSE197268_Axi-cel_pre	ENSG00000143185	6846	X-C motif chemokine ligand 2	SCM-1b|SCYC2	protein_coding	Q9UBD3	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27410
2.62483290295564e-33	0.272012111771565	0.809	0.737	6.50459841681436e-29	GZMH	NK cells	GSE197268_Axi-cel_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27411
5.4478817518357e-29	-0.27518132961021	0.196	0.286	1.35003957692241e-24	MKRN1	NK cells	GSE197268_Axi-cel_pre	ENSG00000133606	23608	makorin ring finger protein 1	RNF61	protein_coding	Q9UHC7	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27412
1.27934499828137e-28	-0.326770983601361	0.175	0.261	3.17034484024105e-24	LGALS3	NK cells	GSE197268_Axi-cel_pre	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27413
7.82762219909036e-25	-0.2712203420605	0.284	0.363	1.93976305715658e-20	FBXO7	NK cells	GSE197268_Axi-cel_pre	ENSG00000100225	25793	F-box protein 7	Fbx|FBX7|PARK15	protein_coding	Q9Y3I1	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27414
5.96702410293189e-243	-1.48235061956362	0.167	0.883	1.47868824294755e-238	RPS4Y1	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27415
2.4140636227762e-161	0.953550952984998	0.987	0.943	5.98229106360171e-157	RPS26	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27416
1.58478506393e-149	0.494686189801992	0.32	0.005	3.92725586692492e-145	XIST	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27417
1.06233766501005e-80	-0.542299297267821	0.163	0.515	2.63257896766141e-76	S100A9	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27418
4.21561112785289e-80	-0.484422320341595	0.119	0.466	1.04467059359322e-75	LYZ	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27419
3.85920594818238e-76	-0.519824505194384	0.137	0.476	9.56349826019075e-72	S100A8	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27420
3.1341139764296e-67	0.547340819711848	1	0.998	7.7666478449902e-63	MT-ND3	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27421
2.85954128043729e-66	-0.395587689240301	0.104	0.415	7.08622924705164e-62	CST3	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27422
1.34412463181055e-65	0.415400933076376	1	0.999	3.33087525008971e-61	RPS4X	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27423
1.96151554490434e-59	-0.93369231795893	0.127	0.403	4.86083167182745e-55	RPL13P12	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000215030	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27424
2.90233442941734e-59	-0.328620255217366	0.138	0.442	7.19227494953911e-55	TYROBP	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27425
3.02442854195482e-53	0.310291490110405	1	1	7.49483636981824e-49	RPS27	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27426
4.78161449344283e-49	-0.305466046097259	0.041	0.264	1.18493188762007e-44	FCN1	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27427
9.19280117034318e-48	0.562163441944195	0.587	0.325	2.27806805802274e-43	CISH	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000114737	1154	cytokine inducible SH2 containing protein	CIS|CIS-1|G18|SOCS	protein_coding	Q9NSE2	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27428
7.51754757931879e-45	0.395725409680039	0.592	0.305	1.86292346563099e-40	HLA-H	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27429
2.88126302118595e-44	-0.469003423264968	0.382	0.683	7.14005789280091e-40	LGALS1	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27430
3.08795052613953e-44	-0.316751227535059	0.117	0.372	7.65225019882636e-40	HLA-DRA	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27431
5.95082928407781e-41	0.334073444088007	0.991	0.966	1.47467500488732e-36	RPS29	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27432
1.86622867427107e-37	0.402008513591427	0.659	0.407	4.62470127771113e-33	PRKCQ-AS1	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000237943	439949	PRKCQ antisense RNA 1	ENST00000414894.1	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27433
9.44018974231681e-36	0.275606822770217	1	0.998	2.33937342004353e-31	RPS21	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27434
2.38298655935413e-32	0.358554123568367	0.999	0.998	5.90527899273546e-28	MT-ND4L	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27435
5.44279405637274e-31	0.264344631760122	0.376	0.178	1.34877879510973e-26	BTN3A2	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27436
6.38299796832518e-29	0.38836151022374	0.652	0.444	1.58177072653066e-24	PIM1	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27437
1.94606521330878e-28	-0.275973609331587	0.125	0.309	4.82254420510048e-24	TYMP	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27438
3.08666884798524e-28	0.313329906212068	0.369	0.185	7.64907407219223e-24	CD69	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27439
2.4041866309607e-27	-0.318452087796138	0.246	0.454	5.95781489018371e-23	HLA-DPA1	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27440
3.51991616413105e-27	0.31537157528359	0.514	0.304	8.72270424633316e-23	CXCR4	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27441
5.44894037720649e-27	0.310775729657625	0.44	0.249	1.35030191487554e-22	BCL2	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000171791	596	BCL2 apoptosis regulator	Bcl-2|PPP1R50	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27442
5.08609055471314e-26	0.298233017205483	0.565	0.351	1.26038410036346e-21	CD81	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27443
1.17920699566125e-25	0.343783476641021	0.972	0.958	2.92219285594816e-21	MT-ATP8	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27444
1.24144174198488e-25	-0.268019548592542	0.286	0.497	3.07641678081274e-21	CTSS	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27445
4.02900851925888e-24	0.290183918625992	1	1	9.98428601157543e-20	MT-CO2	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27446
6.26937678590481e-24	0.381992987273404	0.449	0.282	1.55361426131507e-19	CCR7	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27447
7.27689113966837e-24	-0.349692367943644	0.646	0.781	1.80328639332122e-19	CD99	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27448
4.01981330954012e-22	0.299052217758911	0.975	0.975	9.96149936237137e-18	IFITM1	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27449
2.29188694671152e-21	0.36287767275208	0.955	0.94	5.67952504264583e-17	LTB	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27450
2.78400701720721e-21	-0.353159983029934	0.65	0.799	6.89904778934119e-17	COTL1	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27451
8.9630399748911e-20	0.252451290106441	1	0.999	2.22113093617776e-15	MT-CYB	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27452
3.11859763895166e-19	0.262146785778791	0.999	0.998	7.72819680908612e-15	MT-ND4	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27453
1.17014070338073e-18	-0.349761226225011	0.844	0.899	2.89972567704779e-14	CD74	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27454
2.74364931792596e-14	0.265964190720231	0.595	0.45	6.79903737475231e-10	MAL	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000172005	4118	mal, T cell differentiation protein	MVP17|VIP17	protein_coding	P21145	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27455
3.8637619096148e-14	0.255120558922857	0.679	0.532	9.57478838821644e-10	TCF7	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27456
6.7726281984948e-14	0.32925126330504	0.727	0.599	1.678324993869e-09	CD7	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27457
8.58517580794668e-14	-0.259725912898837	0.969	0.983	2.12749241696727e-09	GAPDH	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27458
5.35642892866141e-07	0.256798074254242	0.333	0.246	0.0132737665281158	KLRB1	CD4+ T cells	GSE197268_Axi-cel_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27459
2.24454995214103e-28	1.21837289790245	0.974	0.775	5.56221923640068e-24	HLA-DRB5	pDCs	GSE197268_Axi-cel_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27460
2.30857574107109e-20	0.692709093757564	0.325	0.004	5.72088154394826e-16	XIST	pDCs	GSE197268_Axi-cel_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27461
4.44992195110869e-12	0.735344197947343	0.982	0.952	1.10273515870424e-07	RPS26	pDCs	GSE197268_Axi-cel_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27462
1.38301177885027e-10	0.389030858360282	1	1	3.42724148916885e-06	RPS4X	pDCs	GSE197268_Axi-cel_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27463
1.91628491084823e-10	0.574570894874561	0.632	0.317	4.74874563757299e-06	HLA-H	pDCs	GSE197268_Axi-cel_pre	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27464
6.52523838655038e-08	0.405613820366166	0.991	0.92	0.00161701932457105	TYROBP	pDCs	GSE197268_Axi-cel_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27465
6.26193417998829e-07	0.268661044196007	1	0.992	0.015517699091429	RPL39	pDCs	GSE197268_Axi-cel_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE197268_Axi-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	axi-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 6); post (resistant 7, sensitive 9)	26	121362	Public on Jul 13, 2022	36097221	This dataset has 16 patients, 10 of whom have both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27466
0	-0.314696371329256	0.939	0.973	0	S100A10	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27467
0	0.360671188095274	0.999	0.999	0	RPS27	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27468
0	0.353128987819611	0.335	0.118	0	AL365357.1	CD8+ T cells	GSE197268_Tisa-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27469
0	0.400183653678666	0.474	0.306	0	STAT1	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27470
0	-0.4160904841533	0.244	0.392	0	GPX1	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27471
0	0.748910616868306	0.437	0.229	0	HLA-H	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27472
0	0.466055721891475	1	1	0	HLA-C	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27473
0	0.580223902230056	0.526	0.268	0	HLA-DQB1	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27474
0	-0.530182228682137	0.596	0.781	0	KLF6	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27475
0	0.48995811366708	0.946	0.945	0	IFITM1	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27476
0	0.388532732708459	0.515	0.39	0	IFITM3	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27477
0	-0.391305436496264	0.308	0.456	0	CD27	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27478
0	0.298381668804363	0.969	0.955	0	RPS29	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27479
0	-0.760972011035552	0.491	0.75	0	FOS	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27480
0	0.293527812103127	0.797	0.665	0	ABHD17A	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000129968	81926	abhydrolase domain containing 17A, depalmitoylase	C19orf27|FAM108A1|MGC5244	protein_coding	Q96GS6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27481
0	0.415650443152731	0.949	0.917	0	TGFB1	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27482
0	-0.387654315690206	0.385	0.555	0	PPP1R15A	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27483
0	0.318819045371163	0.735	0.585	0	RBM38	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27484
0	0.261290715214287	0.905	0.858	0	GNAS	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27485
1.64024477164619e-300	-0.351947187012454	0.557	0.644	4.08486557930767e-296	HLA-DRB5	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27486
8.87588303621022e-287	-0.278259838525003	0.974	0.981	2.21044991133779e-282	VIM	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27487
2.17639512678729e-275	-0.299667827345493	0.284	0.413	5.42009442375107e-271	SELL	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27488
1.47661228150974e-269	-0.262068587757875	0.425	0.545	3.67735522587186e-265	IL10RA	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27489
1.34745814655668e-262	0.335485832792588	0.312	0.192	3.35570976818475e-258	CMC1	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27490
3.72769934536344e-247	-0.253367922860783	0.797	0.875	9.28346244969311e-243	ANXA1	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27491
5.00127836901412e-235	0.310974275938128	0.987	0.991	1.24551836501928e-230	RPS26	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27492
5.00424868751204e-233	-0.282278065793274	0.588	0.716	1.246258093138e-228	LTB	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27493
1.065016740472e-227	0.325975487918406	0.655	0.556	2.65231769047147e-223	TUBA4A	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27494
5.54202255704173e-224	0.284426726142411	0.766	0.716	1.38018529760567e-219	EFHD2	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27495
1.02876704483344e-188	-0.271374742427972	0.368	0.469	2.5620414484532e-184	RGS1	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27496
3.94779135850233e-167	-0.255738363036752	0.842	0.901	9.83157959921421e-163	KLF2	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27497
2.59434284713049e-154	0.2523025752263	0.566	0.474	6.46095142649377e-150	GBP5	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27498
5.16915734735116e-126	-0.29048138484241	0.471	0.557	1.28732694578433e-121	GZMK	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27499
2.27193979326874e-118	0.266528160318651	0.809	0.795	5.65803886115648e-114	IRF1	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27500
1.80036495672338e-29	-0.279622310307439	0.47	0.493	4.4836288882239e-25	CCL4	CD8+ T cells	GSE197268_Tisa-cel_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27501
0	-0.564351729729803	0.122	0.308	0	CD8A	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27502
0	0.621941563964697	0.538	0.274	0	STAT1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27503
0	0.959072821649879	0.453	0.207	0	ITM2C	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27504
0	0.716115306964562	0.489	0.136	0	HLA-H	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27505
0	0.498443485197721	1	1	0	HLA-C	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27506
0	0.643109646033056	0.494	0.184	0	HLA-DQB1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27507
0	0.541543022702658	0.99	0.984	0	IFITM1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27508
0	0.576844764707621	0.652	0.469	0	IFITM3	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27509
0	0.415161475249453	0.927	0.896	0	TGFB1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27510
2.411850103436e-295	-0.337966616389862	0.984	0.994	6.00647149759702e-291	FTL	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27511
9.14124280247368e-283	0.340979432562607	0.561	0.35	2.27653510752805e-278	SMAP2	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27512
1.45283225566517e-275	-0.439475590159459	0.115	0.278	3.61813344950854e-271	CD8B	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000172116	926	CD8b molecule	CD8B1	protein_coding	P10966	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27513
3.10246714781515e-241	0.251796599222233	0.289	0.125	7.72638418491886e-237	FKBP5	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27514
1.60950701183073e-222	0.283467483755073	0.259	0.111	4.00831626226326e-218	EPSTI1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27515
2.71580407719045e-218	0.315767931183504	0.698	0.523	6.76343847383511e-214	RBM38	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27516
8.09931211496503e-216	-0.550304435652	0.666	0.8	2.01705268911089e-211	FOS	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27517
8.79597110911582e-205	-0.435974969647581	0.779	0.845	2.1905486450142e-200	KLF6	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27518
1.24131538230048e-202	0.27539587086315	0.25	0.108	3.09137182808112e-198	AL365357.1	CD4+ T cells	GSE197268_Tisa-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27519
1.73301938270046e-194	0.307292808525164	0.933	0.933	4.31591147067722e-190	RPS2P5	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000240342	NA	NA	bcm384	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27520
2.42032273297185e-194	0.280393375866614	0.491	0.316	6.02757173419309e-190	SLFN5	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27521
3.85492221893451e-194	0.339391787134144	0.3	0.155	9.60029829403451e-190	MX1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27522
3.64857359154164e-188	0.312653732943607	0.627	0.459	9.08640767237531e-184	TAP1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27523
2.8479300362922e-186	0.258709351213645	0.45	0.282	7.0924849623821e-182	BCL3	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000069399	602	BCL3 transcription coactivator	BCL4|D19S37	protein_coding	P20749	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27524
1.34122353300487e-185	0.256099110559189	0.875	0.84	3.34018308659532e-181	GNAS	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27525
3.80747730331624e-185	0.264579565020442	0.274	0.135	9.48214147617878e-181	GBP1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27526
6.19201780281801e-183	0.489237195563248	0.585	0.429	1.5420601136138e-178	ISG15	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27527
2.98565635151659e-179	-0.460836150005627	0.471	0.658	7.43547857781692e-175	CCL5	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27528
1.16243124106355e-176	0.302760163596183	0.349	0.202	2.89491876274467e-172	XAF1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27529
1.37083720705697e-175	0.378380303325949	0.451	0.29	3.41393298045468e-171	AL138963.4	CD4+ T cells	GSE197268_Tisa-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27530
5.58299757447377e-175	0.279277718288432	0.637	0.473	1.39038971594695e-170	UBE2L6	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27531
2.07728126229048e-162	-0.274891665152952	0.984	0.992	5.17326125560822e-158	MT-ND1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27532
2.57171870296446e-159	0.283899522677763	0.632	0.477	6.4046082578627e-155	GSPT1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27533
2.42507932337569e-153	0.313946325548859	0.949	0.951	6.03941754693481e-149	LY6E	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27534
5.08235595450609e-153	0.387130839769727	0.435	0.292	1.2657099269102e-148	IFI6	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27535
1.75256399793061e-150	-0.347139473983952	0.744	0.786	4.36458538044639e-146	CD69	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27536
2.62555311637883e-148	-0.325959893680604	0.891	0.923	6.53867748102984e-144	MT-ATP8	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27537
2.37490633907984e-147	0.267423259487675	0.599	0.451	5.91446674684444e-143	RHBDD2	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27538
9.6670933524747e-145	0.311743150226447	0.779	0.657	2.4074929285003e-140	ISG20	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27539
4.91726713121513e-143	-0.272663623600713	0.832	0.889	1.22459620635782e-138	HSP90AB1	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27540
2.05222305186953e-141	0.279683699987437	0.96	0.942	5.11085628837587e-137	TXNIP	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27541
2.31631000837153e-134	0.268905925461914	0.865	0.782	5.76853844484846e-130	IL7R	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27542
3.74041204644351e-134	0.2702838293487	0.66	0.525	9.31512216046293e-130	RNF213	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27543
2.12329445281259e-120	0.326942288993032	0.707	0.633	5.28785250528447e-116	H1-10	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000184897	8971	H1.10 linker histone	H1FX|H1X|MGC15959|MGC8350	protein_coding	Q92522	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27544
1.75219957904767e-106	-0.296582229722506	0.981	0.98	4.36367783166031e-102	MT-ND4L	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27545
4.60553183361384e-106	-0.271115538316732	0.999	0.999	1.14696164784319e-101	RPS3A	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27546
2.09598922018288e-99	0.284288069600948	0.451	0.336	5.21985155394345e-95	GBP5	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27547
8.76033283552824e-95	-0.281445888714791	0.735	0.788	2.18167328935995e-90	CXCR4	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27548
1.2358549086916e-84	-0.275800354332246	0.645	0.719	3.07777306460555e-80	CD7	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27549
1.26288486137557e-84	-0.296792494656818	0.767	0.838	3.14508845876972e-80	JUN	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27550
1.5386056497826e-81	-0.278861562411734	0.678	0.777	3.83174351021858e-77	GZMA	CD4+ T cells	GSE197268_Tisa-cel_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27551
0	-0.62435794153045	0.809	0.939	0	CD52	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27552
0	0.502981724018449	0.411	0.15	0	AL365357.1	Mono/Macro	GSE197268_Tisa-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27553
0	0.333610728470734	1	1	0	HLA-C	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27554
0	-0.353363944905176	0.369	0.619	0	TMEM176B	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27555
0	0.449860425905352	0.986	0.986	0	RPS26	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27556
1.81323159365731e-301	-0.761272321843004	0.26	0.453	4.51567196084417e-297	CXCL8	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27557
5.21873801275465e-299	-0.422510909283606	0.424	0.637	1.29967451469642e-294	RPS4Y1	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27558
4.81799064026353e-283	0.860209358947077	0.924	0.922	1.19987238905123e-278	IFITM3	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27559
8.65898922406752e-271	0.480144835747891	0.908	0.872	2.15643467636178e-266	LY6E	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27560
1.04181020234737e-252	0.453220650347396	0.439	0.258	2.5945241279259e-248	HLA-H	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27561
4.19656105393342e-241	0.577242116933708	0.591	0.42	1.04511156487158e-236	HLA-DQB1	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27562
5.4530557079521e-239	0.469922417448027	0.772	0.669	1.35802899350839e-234	VAMP5	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000168899	10791	vesicle associated membrane protein 5	NA	protein_coding	O95183	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27563
1.69312699384435e-217	-0.424082269520202	0.978	0.97	4.21656346546996e-213	FOS	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27564
7.01075145970337e-211	0.431625428457739	0.524	0.337	1.74595754352453e-206	LGALS2	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27565
2.81231458866065e-206	0.567100809981156	0.749	0.648	7.00378825160049e-202	IFI6	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27566
1.3807208716915e-188	0.278723542484011	0.981	0.949	3.4385472588605e-184	TYMP	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27567
7.53135751554724e-188	0.524801528187783	0.614	0.484	1.87560927567189e-183	ISG15	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27568
9.02783900978412e-186	0.265950438958689	0.321	0.168	2.24829302699664e-181	NPEPPS	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000141279	9520	aminopeptidase puromycin sensitive	MP100|PSA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27569
9.24868692452907e-185	-0.410758516164513	0.699	0.777	2.30329299168472e-180	IFNGR2	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000262795	3460	interferon gamma receptor 2	AF-1|IFNGT1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27570
1.59113586314306e-180	0.613124575869999	0.62	0.454	3.96256475357147e-176	IFITM1	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27571
5.06440109208024e-179	-0.309312571814202	0.473	0.637	1.26123844797166e-174	ETS2	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27572
4.99177513410861e-175	-0.334160315735204	0.564	0.698	1.24315167939841e-170	CD36	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000135218	948	CD36 molecule	FAT|GP3B|GP4|GPIV|SCARB3	protein_coding	P16671	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27573
5.84070924075382e-174	-0.305641647441474	0.505	0.645	1.45457022931733e-169	UBE2D1	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000072401	7321	ubiquitin conjugating enzyme E2 D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UbcH5A	protein_coding	P51668	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27574
8.79497563457694e-171	-0.275611760368554	0.249	0.396	2.19030073203504e-166	HLA-DRB6	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000229391	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27575
2.12414070371024e-164	0.302115878964894	0.317	0.177	5.28996000851999e-160	IFI44L	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27576
3.85418812414053e-153	-0.320035769169747	0.206	0.335	9.59847010435959e-149	NR4A2	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27577
2.65510985909209e-147	-0.274845674065058	0.47	0.607	6.61228559308294e-143	IRF2BP2	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27578
2.76074358159466e-141	-0.401825800797214	0.902	0.943	6.87535581560334e-137	NFKBIA	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27579
2.57627205769325e-137	0.347010903977891	0.422	0.292	6.41594793247927e-133	LAIR1	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000276163	3903	leukocyte associated immunoglobulin like receptor 1	CD305|LAIR-1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27580
1.51506909778971e-136	-0.400799075621216	0.696	0.791	3.77312808113549e-132	HLA-DRB5	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27581
2.10290600037072e-132	0.377120752769233	0.338	0.212	5.23707710332323e-128	EGR1	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27582
7.66496409090276e-132	0.29299419848976	0.437	0.296	1.90888265719842e-127	APOBEC3A	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000262156	200315	apolipoprotein B mRNA editing enzyme catalytic subunit 3A	ARP3|PHRBN	protein_coding	P31941	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27583
1.10764887763341e-127	-0.340397091027043	0.553	0.651	2.75848876485824e-123	PIM1	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27584
3.58519799589538e-121	-0.269999202341082	0.694	0.779	8.92857708897785e-117	PLEK	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27585
1.5490019349373e-120	-0.268013988319227	0.635	0.737	3.85763441876786e-116	PPP1R15A	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27586
4.50315696196413e-118	-0.253162141377305	0.519	0.63	1.12146620980755e-113	UBE2J1	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27587
6.40398377912737e-118	-0.264149210550461	0.353	0.477	1.59484812035388e-113	BHLHE40	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27588
1.69391646220929e-115	0.322586704464008	0.861	0.787	4.21852955748602e-111	MT2A	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27589
1.55484548840796e-114	-0.265522372206789	0.627	0.73	3.8721872043312e-110	HIF1A	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27590
2.83763451066879e-112	-0.368791621960613	0.39	0.505	7.06684498536955e-108	TNFAIP3	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27591
4.63475262540606e-111	-0.353697101180065	0.713	0.765	1.15423879383112e-106	TSC22D3	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27592
8.4530374636309e-108	-0.300299861867166	0.951	0.951	2.10514444994264e-103	DUSP1	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27593
1.00331789356911e-105	0.263691548450591	0.715	0.645	2.49866288214452e-101	RNF213	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27594
4.8746558277599e-104	0.280129305540609	0.874	0.844	1.21398428734533e-99	PSME2	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27595
2.29281436930809e-103	-0.343274801899108	0.677	0.732	5.71002490532488e-99	FOSB	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27596
5.51154165371193e-102	-0.258020314570932	0.538	0.641	1.37259433344042e-97	NINJ1	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27597
2.52172738460896e-98	0.251179171955263	0.464	0.353	6.28010987863016e-94	TNFSF10	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000121858	8743	TNF superfamily member 10	Apo-2L|CD253|TL2|TRAIL	protein_coding	P50591	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27598
9.24431417737207e-92	-0.252689284795482	0.397	0.512	2.30220400273274e-87	IER3	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27599
5.30745187757541e-90	-0.297976438100867	0.84	0.864	1.32176781559138e-85	VCAN	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27600
1.22260487845074e-84	-0.260343563809083	0.93	0.946	3.04477518929372e-80	ZFP36	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27601
1.5829102822509e-76	-0.259675354378026	0.395	0.49	3.94207976691764e-72	HSPA5	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27602
1.02481491098493e-72	0.8779046330799	0.267	0.193	2.55219905431688e-68	IL1R2	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000115590	7850	interleukin 1 receptor type 2	CD121b|IL1RB	protein_coding	P27930	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27603
3.49245880978212e-64	-0.250439402025897	0.961	0.964	8.69761941988139e-60	JUNB	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27604
5.11857392524902e-57	-0.295798996488588	0.207	0.285	1.27472965034402e-52	IL1B	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27605
7.28897409292775e-52	-0.267972320850643	0.559	0.631	1.81524610810273e-47	CALR	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27606
6.41630593334597e-36	0.313829188510223	0.424	0.36	1.59791682964048e-31	RETN	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27607
8.8391511004929e-28	0.38880553029961	0.389	0.356	2.20130219006675e-23	CD163	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000177575	9332	CD163 molecule	M130|MM130|SCARI1	protein_coding	Q86VB7	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27608
7.24061495366963e-16	0.282204042640012	0.82	0.82	1.80320274806189e-11	S100A12	Mono/Macro	GSE197268_Tisa-cel_post	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27609
0	-0.796225130636787	0.004	0.39	0	HLA-DQA2	NK cells	GSE197268_Tisa-cel_post	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27610
2.48242029972276e-197	1.16260505998067	0.55	0.17	6.18221951442956e-193	HLA-H	NK cells	GSE197268_Tisa-cel_post	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27611
4.63786453395055e-157	-0.637750152830805	0.209	0.523	1.15501378353504e-152	CX3CR1	NK cells	GSE197268_Tisa-cel_post	ENSG00000168329	1524	C-X3-C motif chemokine receptor 1	CCRL1|CMKBRL1|CMKDR1|GPR13|V28	protein_coding	P49238	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27612
4.23184985878531e-146	-0.614178808626675	0.904	0.966	1.05389988883189e-141	KLF2	NK cells	GSE197268_Tisa-cel_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27613
9.83237497592475e-136	0.509486284239042	0.36	0.056	2.4486546640043e-131	AL365357.1	NK cells	GSE197268_Tisa-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27614
1.03854172417329e-127	-0.690665334610013	0.714	0.897	2.58638430988117e-123	ID2	NK cells	GSE197268_Tisa-cel_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27615
1.09753599066633e-117	-0.594458850506062	0.517	0.756	2.73330363115543e-113	GADD45B	NK cells	GSE197268_Tisa-cel_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27616
1.24482938084288e-117	0.421983993454748	0.997	0.998	3.10012309005112e-113	RPS26	NK cells	GSE197268_Tisa-cel_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27617
1.74944287206365e-109	-0.734416451638665	0.473	0.699	4.35681252858731e-105	HLA-DRB5	NK cells	GSE197268_Tisa-cel_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27618
1.20512425424485e-108	0.358825816369455	0.999	0.995	3.00124144277138e-104	RPS9	NK cells	GSE197268_Tisa-cel_post	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27619
8.67490923151059e-105	-0.460677614451305	0.223	0.485	2.1603993950154e-100	TUBB4B	NK cells	GSE197268_Tisa-cel_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27620
2.46871013772739e-104	-0.712302508665785	0.695	0.86	6.14807572699629e-100	FOS	NK cells	GSE197268_Tisa-cel_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27621
1.34869537654824e-103	-0.507905069398654	0.334	0.602	3.35879096575575e-99	DYNLL1	NK cells	GSE197268_Tisa-cel_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27622
2.44596817519829e-100	-0.495243141916093	0.682	0.874	6.09143914351381e-96	SLC9A3R1	NK cells	GSE197268_Tisa-cel_post	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27623
5.46337842131631e-100	-0.520150270785985	0.145	0.376	1.36059976204462e-95	IFNG	NK cells	GSE197268_Tisa-cel_post	ENSG00000111537	3458	interferon gamma	NA	protein_coding	P01579	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27624
2.38595478589417e-98	0.253602857125499	1	1	5.94198179879084e-94	HLA-A	NK cells	GSE197268_Tisa-cel_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27625
6.75609715057091e-94	-0.46775770571713	0.498	0.806	1.68253843437818e-89	RPS4Y1	NK cells	GSE197268_Tisa-cel_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27626
1.99202945770529e-89	-0.488071130757069	0.595	0.795	4.96095016146926e-85	ADGRG1	NK cells	GSE197268_Tisa-cel_post	ENSG00000205336	9289	adhesion G protein-coupled receptor G1	GPR56|TM7LN4|TM7XN1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27627
5.36380714348251e-85	-0.439176355633815	0.406	0.635	1.33580253101288e-80	TBX21	NK cells	GSE197268_Tisa-cel_post	ENSG00000073861	30009	T-box transcription factor 21	T-bet|TBLYM	protein_coding	Q9UL17	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27628
8.47398191167205e-80	-0.438361872343904	0.306	0.546	2.11036045528281e-75	ASCL2	NK cells	GSE197268_Tisa-cel_post	ENSG00000183734	430	achaete-scute family bHLH transcription factor 2	ASH2|bHLHa45|HASH2	protein_coding	Q99929	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27629
3.42976915053264e-77	-0.421629050191131	0.508	0.727	8.54149709248649e-73	PLEK	NK cells	GSE197268_Tisa-cel_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27630
4.67162207262596e-72	-0.470096998578867	0.612	0.794	1.16342076096677e-67	KLF6	NK cells	GSE197268_Tisa-cel_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27631
9.30766642433869e-71	-0.372567839800799	0.566	0.756	2.31798124631731e-66	BIN1	NK cells	GSE197268_Tisa-cel_post	ENSG00000136717	274	bridging integrator 1	AMPH2|AMPHL|SH3P9	protein_coding	O00499	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27632
3.00623604278415e-70	-0.400013030868475	0.856	0.926	7.48673024094966e-66	HSPA8	NK cells	GSE197268_Tisa-cel_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27633
2.54339410495142e-68	-0.350424842845692	0.137	0.323	6.33406867897101e-64	RGS2	NK cells	GSE197268_Tisa-cel_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27634
8.13360258343975e-64	0.301958544247632	1	1	2.02559238737984e-59	MT-ATP6	NK cells	GSE197268_Tisa-cel_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27635
1.77708851546622e-62	-0.419124664120683	0.26	0.463	4.42566123891708e-58	ZFP36L1	NK cells	GSE197268_Tisa-cel_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27636
7.9275794389906e-61	-0.3705140729666	0.369	0.57	1.97428438348622e-56	TGFBR3	NK cells	GSE197268_Tisa-cel_post	ENSG00000069702	7049	transforming growth factor beta receptor 3	betaglycan|BGCAN	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27637
5.67792252743051e-60	-0.32043098258992	0.957	0.982	1.41402982623129e-55	PTPRC	NK cells	GSE197268_Tisa-cel_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27638
2.08336218197967e-58	-0.262180994723432	0.284	0.52	5.18840517800217e-54	RPL13P12	NK cells	GSE197268_Tisa-cel_post	ENSG00000215030	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27639
3.58458015344929e-58	0.331556941907889	0.994	0.98	8.92703841415011e-54	MT-ND1	NK cells	GSE197268_Tisa-cel_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27640
4.20767162794461e-58	0.333456403477761	1	1	1.04787854222333e-53	ACTB	NK cells	GSE197268_Tisa-cel_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27641
1.30957880219052e-56	-0.53088918251658	0.846	0.908	3.26137504897526e-52	CD247	NK cells	GSE197268_Tisa-cel_post	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27642
5.02193722311026e-56	-0.325624532242799	0.33	0.532	1.25066324604338e-51	IL10RA	NK cells	GSE197268_Tisa-cel_post	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27643
8.55012396628954e-56	-0.386613871075336	0.773	0.883	2.12932287256475e-51	IER2	NK cells	GSE197268_Tisa-cel_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27644
3.07305513340782e-55	-0.62134641953143	0.586	0.709	7.65313650423883e-51	KLRB1	NK cells	GSE197268_Tisa-cel_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27645
7.11092006088228e-55	-0.410154308944941	0.655	0.832	1.77090353196212e-50	CD3E	NK cells	GSE197268_Tisa-cel_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27646
7.32143733117929e-54	-0.391177574828581	0.305	0.488	1.82333075295689e-49	CITED2	NK cells	GSE197268_Tisa-cel_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27647
1.42922522707792e-53	-0.340099769285438	0.697	0.842	3.55934250551486e-49	RAP1B	NK cells	GSE197268_Tisa-cel_post	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27648
1.56413042596827e-53	-0.312288215635726	0.373	0.575	3.89531041283137e-49	S1PR4	NK cells	GSE197268_Tisa-cel_post	ENSG00000125910	8698	sphingosine-1-phosphate receptor 4	EDG6	protein_coding	O95977	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27649
2.65310646506677e-51	-0.334680061911707	0.43	0.623	6.6072963406023e-47	CDK2AP2	NK cells	GSE197268_Tisa-cel_post	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27650
1.08525009611917e-50	-0.333052974601831	0.224	0.396	2.70270683937518e-46	TIGIT	NK cells	GSE197268_Tisa-cel_post	ENSG00000181847	201633	T cell immunoreceptor with Ig and ITIM domains	DKFZp667A205|FLJ39873|VSIG9|VSTM3	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27651
2.14666062167225e-50	-0.306770992447101	0.993	0.997	5.34604361221257e-46	GZMB	NK cells	GSE197268_Tisa-cel_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27652
2.64498996238448e-48	-0.486299719614826	0.56	0.729	6.58708300232232e-44	JUN	NK cells	GSE197268_Tisa-cel_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27653
4.70859039292525e-48	-0.287350210191231	0.424	0.613	1.1726273514541e-43	APBB1IP	NK cells	GSE197268_Tisa-cel_post	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27654
1.44677353717963e-47	0.258523431710007	0.999	0.996	3.60304481699215e-43	RPS2	NK cells	GSE197268_Tisa-cel_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27655
2.04234822843083e-47	-0.302380371384065	0.342	0.523	5.08626402808414e-43	PYHIN1	NK cells	GSE197268_Tisa-cel_post	ENSG00000163564	149628	pyrin and HIN domain family member 1	IFIX|MGC23885	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27656
7.19829263898766e-47	-0.304835633923684	0.594	0.754	1.79266279881349e-42	TBC1D10C	NK cells	GSE197268_Tisa-cel_post	ENSG00000175463	374403	TBC1 domain family member 10C	Carabin|EPI64C|FLJ00332	protein_coding	Q8IV04	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27657
4.7903771063114e-45	0.43683039373648	0.741	0.636	1.19299551455579e-40	MAP3K8	NK cells	GSE197268_Tisa-cel_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27658
7.39895673531457e-45	-0.305651609695521	0.578	0.746	1.84263618536274e-40	SELPLG	NK cells	GSE197268_Tisa-cel_post	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27659
8.23297832608008e-45	0.421694878608751	0.387	0.22	2.05034092232698e-40	HLA-DQB1	NK cells	GSE197268_Tisa-cel_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27660
1.92489980921939e-44	-0.307066086949257	0.337	0.514	4.79377048487997e-40	SERTAD1	NK cells	GSE197268_Tisa-cel_post	ENSG00000197019	29950	SERTA domain containing 1	SEI1|TRIP-Br1	protein_coding	Q9UHV2	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27661
2.08827971973802e-44	-0.257591865901188	0.266	0.44	5.20065181403556e-40	MAT2B	NK cells	GSE197268_Tisa-cel_post	ENSG00000038274	27430	methionine adenosyltransferase 2B	MATIIbeta|SDR23E1	protein_coding	Q9NZL9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27662
3.34117650254345e-44	-0.299458317457365	0.424	0.597	8.32086596193421e-40	AKNA	NK cells	GSE197268_Tisa-cel_post	ENSG00000106948	80709	AT-hook transcription factor	KIAA1968	protein_coding	Q7Z591	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27663
3.8427946118402e-44	-0.277541924586316	0.356	0.535	9.57009570132682e-40	RCSD1	NK cells	GSE197268_Tisa-cel_post	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27664
3.84731703449459e-44	-0.311049274129892	0.365	0.534	9.58135834270534e-40	ABI3	NK cells	GSE197268_Tisa-cel_post	ENSG00000108798	51225	ABI family member 3	NESH|SSH3BP3	protein_coding	Q9P2A4	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27665
4.1490913917248e-44	0.338008624220117	0.936	0.912	1.03328972019514e-39	GSTP1	NK cells	GSE197268_Tisa-cel_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27666
1.25188979820318e-43	-0.286090154093821	0.568	0.736	3.11770635344519e-39	CSK	NK cells	GSE197268_Tisa-cel_post	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27667
2.57262301650635e-43	-0.250204386861496	0.223	0.387	6.40686036030742e-39	ARHGAP25	NK cells	GSE197268_Tisa-cel_post	ENSG00000163219	9938	Rho GTPase activating protein 25	KIAA0053	protein_coding	P42331	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27668
3.20416233483803e-42	-0.290131490434666	0.387	0.558	7.97964587868063e-38	CEP78	NK cells	GSE197268_Tisa-cel_post	ENSG00000148019	84131	centrosomal protein 78	C9orf81|FLJ12643	protein_coding	Q5JTW2	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27669
3.65858923016706e-42	-0.270440997302152	0.625	0.79	9.11135061880806e-38	ARL6IP5	NK cells	GSE197268_Tisa-cel_post	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27670
2.27989876497177e-41	-0.353141341755927	0.396	0.568	5.67785988428569e-37	DNAJB1	NK cells	GSE197268_Tisa-cel_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27671
3.43713931268958e-41	-0.280868048961987	0.464	0.629	8.55985174432212e-37	EIF4A2	NK cells	GSE197268_Tisa-cel_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27672
4.06644132722299e-41	-0.279691933810624	0.407	0.563	1.01270654813161e-36	RASSF1	NK cells	GSE197268_Tisa-cel_post	ENSG00000068028	11186	Ras association domain family member 1	123F2|NORE2A|RDA32|REH3P21	protein_coding	Q9NS23	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27673
5.24401628020887e-41	0.318925223486594	0.873	0.853	1.30596981442322e-36	PSME2	NK cells	GSE197268_Tisa-cel_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27674
4.93250915989662e-40	-0.296091394319908	0.485	0.652	1.22839208118065e-35	FGR	NK cells	GSE197268_Tisa-cel_post	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27675
6.78382377693938e-40	-0.372353331188267	0.679	0.789	1.68944347340898e-35	FCGR3A	NK cells	GSE197268_Tisa-cel_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27676
7.63819501793222e-40	-0.271530234832858	0.281	0.442	1.90221608726584e-35	IKZF3	NK cells	GSE197268_Tisa-cel_post	ENSG00000161405	22806	IKAROS family zinc finger 3	Aiolos|ZNFN1A3	protein_coding	Q9UKT9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27677
2.96906047075587e-39	-0.291744658829845	1	1	7.39414819637042e-35	MT-RNR1	NK cells	GSE197268_Tisa-cel_post	ENSG00000211459	NA	NA	12S|MOTS-c|MTRNR1	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27678
3.75015987824288e-39	-0.274368227137792	0.625	0.774	9.33939816077607e-35	YPEL3	NK cells	GSE197268_Tisa-cel_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27679
5.11299265224741e-39	0.343255272001064	0.991	0.989	1.2733396901157e-34	IFITM1	NK cells	GSE197268_Tisa-cel_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27680
5.6605498424607e-39	-0.267246034490483	0.827	0.907	1.40970333276641e-34	RPS2P5	NK cells	GSE197268_Tisa-cel_post	ENSG00000240342	NA	NA	bcm384	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27681
6.10673441210644e-39	-0.293503805095932	0.455	0.61	1.52082113799099e-34	SH2D2A	NK cells	GSE197268_Tisa-cel_post	ENSG00000027869	9047	SH2 domain containing 2A	F2771|TSAd	protein_coding	Q9NP31	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27682
1.07260214313495e-38	-0.292857733766292	0.402	0.568	2.67120837726327e-34	PPP1R15A	NK cells	GSE197268_Tisa-cel_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27683
1.36138252626449e-38	-0.303439064757448	0.398	0.551	3.39038704340908e-34	AOAH	NK cells	GSE197268_Tisa-cel_post	ENSG00000136250	313	acyloxyacyl hydrolase	NA	protein_coding	P28039	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27684
8.25395167284023e-38	0.383962573293066	0.786	0.716	2.05556412460413e-33	HLA-DPB1	NK cells	GSE197268_Tisa-cel_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27685
2.16014850626914e-37	-0.270377256234627	0.178	0.322	5.37963384001266e-33	AKR1C3	NK cells	GSE197268_Tisa-cel_post	ENSG00000196139	8644	aldo-keto reductase family 1 member C3	DDX|HAKRB|HSD17B5|KIAA0119|PGFS	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27686
3.81240902563756e-37	0.369506528898871	0.762	0.683	9.49442343744777e-33	PIK3R1	NK cells	GSE197268_Tisa-cel_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27687
5.61769064313629e-37	-0.282636459677535	0.443	0.606	1.39902967776666e-32	H4C3	NK cells	GSE197268_Tisa-cel_post	ENSG00000197061	8364	H4 clustered histone 3	dJ221C16.1|H4/g|H4FG|HIST1H4C	protein_coding	P62805	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27688
8.88252508500313e-37	-0.394906672349263	0.63	0.73	2.21210404716918e-32	TRBC1	NK cells	GSE197268_Tisa-cel_post	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27689
1.76488866662218e-36	0.278108199844605	0.93	0.899	4.39527873535588e-32	MT-ATP8	NK cells	GSE197268_Tisa-cel_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27690
2.50179972913746e-36	-0.352571641870786	0.325	0.486	6.23048204544393e-32	KLRC1	NK cells	GSE197268_Tisa-cel_post	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27691
4.39137887650025e-36	-0.722777479661152	0.653	0.779	1.09362899540362e-31	CCL4	NK cells	GSE197268_Tisa-cel_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27692
8.10797327513096e-36	0.418725565221236	0.825	0.775	2.01920966443861e-31	HLA-DRB1	NK cells	GSE197268_Tisa-cel_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27693
1.14622366813996e-35	-0.253375670161032	0.457	0.621	2.85455542313576e-31	CDC42SE1	NK cells	GSE197268_Tisa-cel_post	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27694
1.16763635555173e-35	-0.260610800885719	0.219	0.363	2.90788157986602e-31	AL138963.4	NK cells	GSE197268_Tisa-cel_post	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27695
2.04847304763916e-35	-0.264797970043938	0.988	0.994	5.10151727784058e-31	PRF1	NK cells	GSE197268_Tisa-cel_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27696
2.35693841581228e-35	-0.274509412656688	0.327	0.484	5.86971943073891e-31	FOSB	NK cells	GSE197268_Tisa-cel_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27697
8.24152848344715e-35	-0.287305796478636	0.494	0.655	2.05247025351768e-30	NR4A2	NK cells	GSE197268_Tisa-cel_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27698
1.54434892009707e-34	-0.261219446250568	0.447	0.599	3.84604655060974e-30	PPP1R12A	NK cells	GSE197268_Tisa-cel_post	ENSG00000058272	4659	protein phosphatase 1 regulatory subunit 12A	M130|MBS|MYPT1	protein_coding	O14974	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27699
1.28147502200069e-33	-0.260396861878863	0.51	0.654	3.19138539479051e-29	SASH3	NK cells	GSE197268_Tisa-cel_post	ENSG00000122122	54440	SAM and SH3 domain containing 3	753P9|CXorf9|HACS2|SH3D6C|SLY	protein_coding	O75995	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27700
2.60630960616286e-32	0.29873295081848	0.586	0.469	6.49075344318799e-28	PRMT2	NK cells	GSE197268_Tisa-cel_post	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27701
3.17645608200691e-32	-0.257106176862596	0.22	0.356	7.91064622663001e-28	MT1E	NK cells	GSE197268_Tisa-cel_post	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27702
8.76333840037982e-32	-0.348508540971533	0.201	0.333	2.18242179523059e-27	TNFRSF18	NK cells	GSE197268_Tisa-cel_post	ENSG00000186891	8784	TNF receptor superfamily member 18	AITR|CD357|GITR	protein_coding	Q9Y5U5	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27703
2.21775066166918e-31	-0.253935918686316	0.65	0.772	5.52308624782093e-27	ARHGAP9	NK cells	GSE197268_Tisa-cel_post	ENSG00000123329	64333	Rho GTPase activating protein 9	10C|MGC1295	protein_coding	Q9BRR9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27704
2.42799295338249e-31	-0.437111856478552	0.853	0.892	6.04667365110375e-27	JUNB	NK cells	GSE197268_Tisa-cel_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27705
1.0001718248384e-30	-0.255446628411288	0.327	0.472	2.49082791257755e-26	PTGER4	NK cells	GSE197268_Tisa-cel_post	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27706
2.96435737154895e-30	-0.371257957579344	0.733	0.827	7.38243559810552e-26	FGFBP2	NK cells	GSE197268_Tisa-cel_post	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27707
1.27489488065856e-29	0.564237194050194	0.683	0.595	3.17499821079207e-25	IFITM3	NK cells	GSE197268_Tisa-cel_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27708
3.66335374984756e-29	-0.256920454040705	1	1	9.12321617862037e-25	MT-RNR2	NK cells	GSE197268_Tisa-cel_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27709
7.02812897377926e-29	0.290935437002549	0.272	0.142	1.75028523962999e-24	KIR2DL3	NK cells	GSE197268_Tisa-cel_post	ENSG00000273947	3804	killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3	CD158B2|cl-6|nkat2|nkat2a|nkat2b|p58	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27710
8.8642176279914e-28	-0.272958765080726	0.751	0.851	2.20754475807498e-23	ANXA1	NK cells	GSE197268_Tisa-cel_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27711
5.92809346766393e-26	-0.255970927511188	0.307	0.423	1.47633239718703e-21	SH2D1B	NK cells	GSE197268_Tisa-cel_post	ENSG00000198574	117157	SH2 domain containing 1B	EAT2	protein_coding	O14796	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27712
5.36250920830882e-25	0.264867772780694	0.995	0.994	1.33547929323723e-20	FTH1	NK cells	GSE197268_Tisa-cel_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27713
6.61816234238272e-25	-0.31723367889396	0.342	0.472	1.64818714974699e-20	CCL3	NK cells	GSE197268_Tisa-cel_post	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27714
7.03414104484157e-24	0.268206080287621	0.759	0.698	1.75178248580734e-19	CNN2	NK cells	GSE197268_Tisa-cel_post	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27715
4.34313838557319e-23	0.430681279485272	0.349	0.23	1.08161518354315e-18	GZMK	NK cells	GSE197268_Tisa-cel_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27716
4.5706561518965e-23	0.268839766378479	0.873	0.834	1.1382762080683e-18	HOPX	NK cells	GSE197268_Tisa-cel_post	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27717
2.39499850153932e-22	0.284401785214442	0.856	0.817	5.96450426823353e-18	CALR	NK cells	GSE197268_Tisa-cel_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27718
3.77628574405001e-22	0.276203177030001	0.914	0.938	9.40446201698213e-18	CD7	NK cells	GSE197268_Tisa-cel_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27719
7.44466819571248e-22	0.364860157379952	0.413	0.298	1.85402016746024e-17	AREG	NK cells	GSE197268_Tisa-cel_post	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27720
4.39851811887796e-19	-0.294626465584134	0.604	0.705	1.09540695232537e-14	H1-4	NK cells	GSE197268_Tisa-cel_post	ENSG00000168298	3008	H1.4 linker histone, cluster member	H1.4|H1e|H1F4|H1s-4|HIST1H1E	protein_coding	P10412	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27721
4.73512358594407e-19	0.330824048831851	0.557	0.454	1.17923517784351e-14	COTL1	NK cells	GSE197268_Tisa-cel_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27722
9.76935751642435e-15	0.358774741468729	0.414	0.356	2.43296079589032e-10	LAIR1	NK cells	GSE197268_Tisa-cel_post	ENSG00000276163	3903	leukocyte associated immunoglobulin like receptor 1	CD305|LAIR-1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	post	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27723
0	0.976699423087145	0.449	0.017	0	AL365357.1	CD8+ T cells	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27724
0	0.973596389638071	0.604	0.154	0	HLA-H	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27725
0	0.808906769209177	0.991	0.977	0	IL32	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27726
0	0.491544647351168	0.999	0.999	0	TMSB4X	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27727
0	-0.750501811185966	0.504	0.898	0	RPS4Y1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27728
3.73329311510637e-297	0.691012804147506	0.543	0.186	9.2973931738609e-293	GIMAP7	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27729
3.1986261480455e-269	0.478805996247157	0.259	0.011	7.96585855909252e-265	AL591846.2	CD8+ T cells	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27730
1.82733126791757e-240	0.41940446369964	0.999	0.999	4.55078578962193e-236	TMSB10	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27731
2.20180631140284e-214	0.320773595364851	1	1	5.48337843791764e-210	B2M	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27732
6.22364439704819e-208	-0.53204046135464	0.584	0.851	1.54993640064088e-203	DUSP1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27733
2.61522780100159e-198	-0.533227950869761	0.499	0.785	6.51296331561435e-194	JUN	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27734
6.90134783622539e-195	0.513909869873427	0.384	0.122	1.71871166513357e-190	GIMAP4	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27735
2.9874744891015e-192	0.564050648941817	0.833	0.74	7.44000646765838e-188	PSMB9	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27736
3.39614914507054e-180	-0.55085036782269	0.382	0.651	8.45776983088366e-176	RPL13P12	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000215030	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27737
8.05859193183868e-161	0.532718038204256	0.461	0.206	2.00691173470511e-156	KLRG1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27738
4.32111561446549e-159	0.443851731667624	0.979	0.964	1.07613063262649e-154	CORO1A	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27739
8.59690636414371e-158	-0.50817230833761	0.772	0.924	2.14097356092635e-153	TSC22D3	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27740
5.93331913766525e-157	0.430700025131557	0.938	0.904	1.47763379804415e-152	RAC2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27741
3.1947051152237e-150	0.520436269170922	1	1	7.95609361895309e-146	ACTB	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27742
1.62126856651306e-147	0.508679878762214	0.38	0.152	4.03760723804413e-143	STAT1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27743
3.82494409716168e-146	0.447630135367788	0.352	0.129	9.52564077957144e-142	ITM2A	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27744
1.64986893146737e-140	-0.598644471897421	0.796	0.919	4.10883358692634e-136	ZFP36	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27745
6.94414741980321e-137	0.447147656305398	0.824	0.679	1.72937047342779e-132	PCED1B-AS1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000247774	100233209	PCED1B antisense RNA 1	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27746
1.3258958649878e-133	0.438861621124998	0.47	0.233	3.30201106216562e-129	TAP1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27747
1.91415547544569e-126	0.442219754913223	0.823	0.695	4.76701279604996e-122	PLAAT4	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000133321	5920	phospholipase A and acyltransferase 4	HRASLS4|PLAAT-4|RARRES3|RIG1|TIG3	protein_coding	Q9UL19	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27748
1.33463512359715e-122	0.446450891521473	0.393	0.179	3.32377531180635e-118	PLEK	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27749
7.03248758125786e-122	-0.414096133822618	0.278	0.495	1.75137070723646e-117	TYROBP	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27750
9.16410377460088e-118	-0.360257304250582	0.998	0.999	2.2822284040266e-113	EIF1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27751
2.05356145221335e-117	-0.446356231805999	0.672	0.834	5.11418944059212e-113	CXCR4	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27752
1.17211424854706e-116	0.426924853919907	0.558	0.324	2.91903332458161e-112	CD2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27753
2.04241239584875e-116	0.410328432776538	0.986	0.974	5.08642383062173e-112	CD52	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27754
1.05380258655052e-115	0.336318262325075	0.339	0.137	2.62438996154541e-111	CDK2AP2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27755
2.40928421027379e-114	0.392548111961268	0.51	0.279	6.00008139726585e-110	RIPOR2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27756
3.08272032753375e-112	0.342625997620324	0.34	0.141	7.67720670369004e-108	TRAC	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27757
5.40141365431747e-112	0.447120977839821	0.566	0.363	1.34516805647122e-107	CTSC	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27758
4.09128082793531e-110	0.377409529391919	0.887	0.789	1.01889257738901e-105	CD3D	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27759
1.30257436752887e-106	-0.443454904640559	0.946	0.979	3.24393120489389e-102	BTG1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27760
2.1155996642112e-106	0.353557525138483	0.942	0.921	5.26868940375156e-102	EMP3	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27761
4.80644875003598e-105	-0.464238329148905	0.621	0.796	1.19699799670896e-100	TNFAIP3	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27762
1.17397085204918e-102	0.398659967239769	0.259	0.095	2.92365700994328e-98	CD27	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27763
1.22841729028007e-101	-0.27478960396904	0.999	0.999	3.0592504197135e-97	RPS14	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27764
3.26041828500917e-101	0.368585592062653	0.703	0.514	8.11974569698683e-97	ANXA6	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27765
4.19021968390989e-100	0.358899505317509	0.51	0.288	1.04353231008092e-95	PRMT2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27766
1.04237841983019e-99	0.371157272354441	0.983	0.983	2.59593921674509e-95	IFITM1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27767
9.50396387626949e-99	-0.402127158972566	0.94	0.978	2.36686716374615e-94	ZFP36L2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27768
1.27493994451711e-98	0.296371017125236	0.329	0.142	3.17511043782541e-94	PSMA5	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27769
4.69018534052569e-98	0.328638861357236	0.356	0.165	1.16804375720452e-93	DYNLL1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27770
1.57798366680284e-93	0.552611523920048	0.811	0.853	3.9298105238058e-89	GZMA	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27771
4.10879391691095e-92	0.348992203427108	0.349	0.167	1.0232540370675e-87	GBP5	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27772
1.57641117567177e-90	-0.265305999213746	0.998	0.998	3.92589439189298e-86	FTH1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27773
2.44530679702337e-89	0.292864079124395	0.943	0.928	6.08979204730699e-85	PSME1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27774
4.57042778468263e-88	0.295391288177481	0.392	0.2	1.13821933549736e-83	ABRACL	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27775
7.00822494768883e-88	0.347354371200749	0.368	0.188	1.74532834097243e-83	PIM1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27776
1.20379412309842e-86	0.33485371326276	0.715	0.535	2.99792888416431e-82	LCK	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000182866	3932	LCK proto-oncogene, Src family tyrosine kinase	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27777
5.40789185226543e-86	0.266032790751604	0.298	0.131	1.34678138688818e-81	CLEC2D	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27778
1.7980934366202e-85	-0.315105320000046	0.634	0.828	4.47797189455896e-81	JUND	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27779
3.04652158286267e-85	0.328687603242307	0.449	0.254	7.5870573499612e-81	CSK	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27780
3.05401057079731e-85	0.294361221843462	0.394	0.203	7.60570792551361e-81	RNF167	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000108523	26001	ring finger protein 167	DKFZP566H073	protein_coding	Q9H6Y7	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27781
1.72024926076023e-83	0.304736287177925	0.999	0.998	4.28410875899727e-79	PFN1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27782
7.82573620567695e-82	0.298664173049521	0.331	0.161	1.94892134466179e-77	APOBEC3G	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27783
2.47258035214921e-81	0.486975786274069	0.956	0.971	6.1577141089924e-77	CD74	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27784
4.45299194643219e-81	0.266425597143859	0.312	0.145	1.10897311433947e-76	SASH3	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000122122	54440	SAM and SH3 domain containing 3	753P9|CXorf9|HACS2|SH3D6C|SLY	protein_coding	O75995	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27785
5.98767281546822e-81	0.280684670962084	0.339	0.166	1.49117003796421e-76	PTPN6	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27786
8.91158740910102e-81	0.258921991478011	0.331	0.158	2.21934172836252e-76	SLFN5	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27787
9.15303224707023e-81	0.278055407974799	0.489	0.283	2.27947115081037e-76	ATP6V0E1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27788
2.20089322524505e-80	0.356807528841469	0.695	0.54	5.48110448815028e-76	RNF213	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27789
4.26437877976639e-80	0.290082963369669	0.488	0.292	1.06200089131302e-75	SMDT1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27790
3.19298828216084e-78	0.368418041256832	0.607	0.435	7.95181801789336e-74	ITGA4	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27791
3.38370634715496e-78	-0.367638030479065	0.629	0.83	8.42678228695472e-74	NFKBIA	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27792
1.42247615659296e-76	0.3045765796998	0.905	0.89	3.5425346203791e-72	HSPA8	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27793
5.09487264148515e-76	0.262328569362264	0.386	0.203	1.26882708263546e-71	FAM107B	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27794
8.23476140866122e-76	0.291899024689988	0.454	0.264	2.05078498121299e-71	XBP1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27795
8.84783030664029e-76	0.282654900227893	0.439	0.25	2.2034636595657e-71	MBP	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27796
1.15383629351591e-75	0.350835187992807	0.259	0.116	2.87351390537202e-71	SELL	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27797
1.80178408290009e-75	0.35081767449606	0.393	0.22	4.48716308005438e-71	NOSIP	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27798
2.1021386751149e-74	0.296789295138472	0.541	0.358	5.23516615650616e-70	CD53	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27799
6.45827692588969e-74	0.32494230653442	0.966	0.942	1.60836928562357e-69	RPS29	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27800
6.78104029185125e-74	0.253582911529261	0.353	0.182	1.68875027428263e-69	M6PR	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27801
7.9247093416719e-74	0.260954861418567	0.998	0.998	1.97356961444997e-69	SH3BGRL3	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27802
2.06921621665601e-73	0.267466469464472	0.982	0.972	5.15317606596012e-69	MYL12A	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27803
5.53119078887937e-73	0.311504565323507	0.91	0.912	1.37748775406252e-68	CLIC1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27804
6.67997356635577e-73	0.327230702484302	0.656	0.525	1.66358061696524e-68	PSMB10	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000205220	5699	proteasome 20S subunit beta 10	beta2i|LMP10|MECL1|MGC1665	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27805
2.83515687136113e-71	0.309776111066639	0.441	0.276	7.06067467243775e-67	UBE2L6	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27806
3.66238810348178e-71	0.366298152979884	0.757	0.763	9.12081133291103e-67	S100A11	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27807
1.37296247491247e-70	0.297334741439226	0.889	0.883	3.41922574752201e-66	LIMD2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27808
1.41366827827044e-70	0.440019841899108	0.858	0.933	3.52059948020471e-66	NKG7	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27809
4.69384274468822e-70	0.361709310265014	0.476	0.306	1.16895459713715e-65	ITGB1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27810
8.38318523533073e-70	0.30074432219853	0.572	0.408	2.08774845100676e-65	SAMHD1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27811
2.36908082500905e-69	-0.905851907885424	0.32	0.461	5.89995888660255e-65	HBB	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27812
2.71696075275918e-69	-0.369205791098236	0.438	0.576	6.76631905867145e-65	DDIT4	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27813
3.10498392163367e-69	0.264618281667873	0.386	0.215	7.73265195843648e-65	SPN	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27814
1.62386319658889e-68	0.250011698913986	0.387	0.214	4.04406890478498e-64	ARHGAP30	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000186517	257106	Rho GTPase activating protein 30	FLJ00267	protein_coding	Q7Z6I6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27815
3.73292860793543e-68	0.382858902031755	0.779	0.774	9.2964854052024e-64	PSME2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27816
2.61801556789849e-67	0.297228968130708	0.85	0.85	6.5199059702944e-63	GSTK1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000197448	373156	glutathione S-transferase kappa 1	GST13	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27817
1.14336031017135e-66	0.281480962486226	0.485	0.309	2.84742451645073e-62	PPP1R18	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27818
1.80889105673971e-66	0.303759045064957	0.957	0.949	4.50486228770458e-62	S100A10	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27819
4.65047457901154e-66	0.256551678958518	0.999	0.994	1.15815418915703e-61	MT-ATP6	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27820
1.45019702367472e-65	0.263182671559191	0.347	0.189	3.61157066775953e-61	PRDX1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27821
1.82905792875784e-65	0.682571607601038	0.28	0.15	4.55508586577852e-61	GZMK	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27822
4.57701597442781e-65	-0.438858154463948	0.285	0.404	1.1398600582715e-60	RBM38	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27823
7.5203717392187e-65	-0.640385947944054	0.166	0.307	1.87287337793503e-60	HBA2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27824
1.63570906420657e-64	0.25913351132437	0.745	0.602	4.07356985350005e-60	ARL6IP5	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27825
6.0538845850981e-64	0.371007317935507	0.993	0.992	1.50765941707283e-59	ACTG1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27826
1.04324419303255e-63	0.288622833792311	0.703	0.542	2.59809533832827e-59	CD3G	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27827
3.98804785496942e-63	0.289622476992344	0.486	0.319	9.93183437801584e-59	ACTR3	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27828
6.92557809307002e-63	-0.608412132639948	0.165	0.302	1.72474596829816e-58	HBA1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27829
1.21582097386329e-62	0.330644141545023	0.741	0.681	3.02788055330914e-58	UCP2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27830
3.28372470622682e-62	0.26661050164907	0.485	0.318	8.17778800838728e-58	SELPLG	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27831
3.56648121961017e-62	0.283535510700337	0.63	0.468	8.88196482931716e-58	SLC9A3R1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27832
1.32525278082691e-58	0.252643808213949	0.381	0.223	3.30040952537133e-54	HNRNPF	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27833
3.88716726924886e-58	0.303973647613689	0.687	0.578	9.68060136733737e-54	PSMB8	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27834
2.84072926524833e-57	0.253985618891724	0.519	0.341	7.07455216217444e-53	TRAF3IP3	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27835
3.11672315565092e-57	0.339142514249766	0.627	0.489	7.76188734683304e-53	PRF1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27836
1.7088972176777e-56	-0.468935399354343	0.138	0.258	4.25583763090454e-52	ALAS2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000158578	212	5'-aminolevulinate synthase 2	ALAS-E|ASB	protein_coding	P22557	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27837
1.49249057198994e-55	0.291286746300325	0.611	0.463	3.71689852048373e-51	CD81	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27838
2.2414369969981e-55	0.25121357197047	0.955	0.95	5.58207469732407e-51	PTPRC	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27839
8.15541182608586e-55	0.279423510089373	0.294	0.16	2.03102376116842e-50	TPM4	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27840
3.10389488557934e-51	-0.431482440726342	0.17	0.288	7.72993982304679e-47	SLC25A37	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27841
7.07869352264669e-51	0.258767797074124	0.989	0.991	1.76287783487993e-46	S100A4	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27842
7.26970943000407e-47	0.505990717861409	0.816	0.89	1.81044843644821e-42	LGALS1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27843
2.26581767200063e-45	0.265633968113759	0.666	0.519	5.64279233035036e-41	GZMM	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000197540	3004	granzyme M	LMET1|MET1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27844
8.28407896869651e-44	0.329386543041754	0.704	0.683	2.06306702636418e-39	HLA-DPB1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27845
1.84562138419821e-43	0.277388183565432	0.876	0.882	4.59633549520723e-39	TAGLN2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27846
4.57886089973224e-43	0.282721238418846	0.856	0.858	1.14031951846932e-38	FLNA	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27847
7.54492098331565e-42	-0.269359393359064	0.704	0.806	1.87898712168493e-37	RBM39	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27848
1.55761646072426e-41	0.267388383418998	0.255	0.146	3.87908803378769e-37	CMC1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27849
2.99360829711018e-41	0.355874524610315	0.374	0.245	7.4552821031232e-37	TUBB	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27850
3.54472615227503e-41	0.617134187954742	0.97	0.986	8.82778600962573e-37	RPS26	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27851
3.9129146479379e-39	0.330787815505593	0.584	0.463	9.74472263922456e-35	TRBC2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27852
2.18826658600041e-35	-0.31150644636127	0.901	0.957	5.44965910577543e-31	UBB	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27853
7.3803825162436e-35	0.332342821274576	0.447	0.341	1.83801046184531e-30	CD8B	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000172116	926	CD8b molecule	CD8B1	protein_coding	P10966	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27854
8.66188944436325e-35	-0.259560711759254	0.241	0.333	2.15715694722422e-30	CEBPB	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27855
7.69177018637873e-34	-0.36263068108467	0.209	0.293	1.91555844721576e-29	SPON2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27856
5.2327765500751e-31	-0.286884654862081	0.217	0.302	1.3031706720307e-26	YBX3	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27857
4.23316549725473e-28	0.255525088218092	0.975	0.975	1.05422753543632e-23	VIM	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27858
7.44045720281124e-28	0.252437755320489	0.799	0.817	1.85297146178811e-23	ANXA1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27859
2.1568982697357e-27	-0.290085807781368	0.361	0.427	5.37153945094978e-23	HERPUD1	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27860
1.65014913955628e-25	-0.255404299774753	0.375	0.449	4.10953141715095e-21	HLA-DRB5	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27861
7.8527661096124e-25	0.448704156122481	0.523	0.443	1.95565287193787e-20	TUBA1B	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27862
2.41558545805158e-24	-0.291774652057756	0.246	0.305	6.01577402473165e-20	CCNH	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27863
6.72092062131755e-24	0.345308978372147	0.701	0.725	1.67377807153292e-19	GZMH	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27864
2.56702865804395e-19	-0.252665215684256	0.412	0.445	6.39292816999265e-15	KLF3	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27865
9.66617979681306e-16	0.263971156482562	0.677	0.727	2.40726541659832e-11	MT2A	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27866
3.07973712039028e-15	-0.370006422303989	0.325	0.36	7.66977732461995e-11	SLC25A39	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27867
6.35694411050623e-14	0.253047524732433	0.455	0.387	1.58313336128047e-09	HMGB2	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27868
1.47490886025592e-13	0.266901951239136	0.325	0.246	3.67311302558135e-09	H4C3	CD8+ T cells	GSE197268_Tisa-cel_pre	ENSG00000197061	8364	H4 clustered histone 3	dJ221C16.1|H4/g|H4FG|HIST1H4C	protein_coding	P62805	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27869
0	-1.62127204721508	0.582	0.888	0	HLA-DRB5	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27870
0	-1.74285188905577	0.026	0.605	0	HLA-DQA2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27871
0	0.949570182123733	0.931	0.65	0	BRI3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27872
0	2.00907406550012	0.88	0.707	0	S100A8	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27873
6.44955418381559e-305	1.63333346789134	0.967	0.87	1.60619697393744e-300	S100A9	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27874
4.3220065231992e-304	1.07915314365943	0.816	0.424	1.07635250453753e-299	MNDA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27875
2.46321883303309e-297	-2.14936546284029	0.132	0.476	6.13440018178562e-293	HBB	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27876
4.31778665073824e-268	1.21088747694219	0.98	0.908	1.07530158749985e-263	LYZ	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27877
1.3283498718125e-267	0.667540095518572	0.998	0.991	3.30812252076185e-263	S100A6	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27878
1.93773093939084e-234	1.21851240166236	0.764	0.414	4.82572513145896e-230	VCAN	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27879
7.68423721454518e-231	1.03299842885305	0.41	0.014	1.91368243591033e-226	FOLR3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000110203	2352	folate receptor gamma	FR-G|FRgamma	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27880
2.05533218741028e-229	0.75250618039173	0.993	0.988	5.11859927952656e-225	MT-ND3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27881
3.32980974545259e-223	0.731482939363385	0.97	0.863	8.29255819007513e-219	TYMP	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27882
5.61397457718853e-223	1.06597438326248	0.735	0.384	1.39810422870303e-218	CD14	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27883
3.66988955453338e-222	0.546116114516198	0.998	0.987	9.13949294660993e-218	ATP5F1E	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27884
7.50421007527751e-217	-1.44826688836396	0.06	0.292	1.86884847714711e-212	HBA2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27885
4.9946137750182e-215	0.505454001565411	0.999	0.999	1.24385861453053e-210	RPL39	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27886
2.95910812973704e-209	-1.3329419188024	0.058	0.282	7.36936288629713e-205	HBA1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27887
7.32368759944366e-205	0.401664963920944	1	1	1.82389115976545e-200	TMSB10	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27888
1.22770222493466e-200	0.572997035485452	0.996	0.96	3.05746962097729e-196	S100A11	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27889
3.79268101857212e-190	0.475969543228573	1	0.998	9.445292808652e-186	RPS28	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27890
1.54511874473354e-185	1.14994112459696	0.667	0.318	3.8479637218844e-181	S100A12	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27891
1.88904841972257e-185	0.743584233213142	0.94	0.77	4.70448618447709e-181	FCN1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27892
2.58831590167942e-185	0.464219576703951	0.999	0.998	6.44594192154242e-181	RPL37	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27893
2.57392700024775e-178	0.699073155748987	0.609	0.245	6.410107801417e-174	FPR1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000171051	2357	formyl peptide receptor 1	FMLP|FPR	protein_coding	P21462	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27894
7.48239232551391e-168	0.801254561884082	0.532	0.185	1.86341498474599e-163	IFI6	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27895
4.09883228728708e-163	0.766453631397991	0.559	0.217	1.02077319282598e-158	DUSP6	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27896
9.95140579562535e-159	0.69630147815313	0.619	0.272	2.47829809934254e-154	CTSD	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27897
9.64619764604335e-158	-0.531366143747334	0.643	0.919	2.40228906177064e-153	CD52	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27898
1.8572176148416e-140	-0.497474060515125	0.217	0.478	4.62521474800153e-136	CXCR4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27899
8.49705981961022e-138	0.609227896743256	0.688	0.379	2.11610777747573e-133	CSTA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27900
2.8210083829703e-136	-0.602358592190973	0.442	0.688	7.02543927694925e-132	RPL13P12	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000215030	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27901
9.00582005091512e-133	0.566086917281696	0.617	0.307	2.2428094254799e-128	NOP10	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27902
1.3477246085649e-131	0.652791901907733	0.704	0.4	3.35637336517002e-127	MS4A6A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000110077	64231	membrane spanning 4-domains A6A	CD20L3|MS4A6	protein_coding	Q9H2W1	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27903
1.85193783401955e-131	0.483837066405882	0.984	0.932	4.61206598184228e-127	CTSS	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27904
8.98592007219706e-117	0.511796635857793	0.349	0.081	2.23785353477996e-112	HLA-H	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27905
2.82762255513471e-115	0.418974090063224	0.993	0.978	7.04191121130749e-111	RPL37A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27906
3.58212345589934e-114	-0.417139072240957	0.248	0.491	8.92092025457172e-110	ARL4C	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27907
6.95089045144113e-113	0.563117301012545	0.358	0.093	1.7310497580269e-108	MX1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27908
1.18166219370488e-112	0.5538134723434	0.627	0.338	2.94281152720264e-108	CSF3R	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000119535	1441	colony stimulating factor 3 receptor	CD114|GCSFR	protein_coding	Q99062	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27909
8.31113545687341e-111	0.618022857932495	0.509	0.235	2.06980517417975e-106	PLAC8	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27910
3.82084784422741e-109	0.346388280422157	0.997	0.976	9.51543947126395e-105	TYROBP	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27911
7.11115640088492e-109	0.340047723758137	0.999	0.998	1.77096239007638e-104	SERF2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27912
7.8254782194178e-109	0.462072795543929	0.427	0.151	1.94885709576381e-104	GIMAP4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27913
2.77148040281888e-108	-0.443376550231732	0.193	0.41	6.90209479518013e-104	DDIT4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27914
3.7497686302374e-106	0.409387801574219	0.948	0.894	9.33842379674323e-102	RPL38	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27915
6.42484271273945e-104	0.491584114868358	0.867	0.694	1.60004282918063e-99	TALDO1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27916
4.88935705133559e-101	0.43681039287188	0.99	0.969	1.21764548006461e-96	LGALS1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27917
6.4154867518263e-101	-0.571891707873535	0.455	0.689	1.59771282067482e-96	JUN	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27918
3.54765456872762e-100	-0.342823491115671	0.429	0.675	8.83507893795926e-96	IL32	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27919
6.02816379705452e-98	0.338401682548096	0.997	0.993	1.50125391201846e-93	S100A4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27920
3.83778712044245e-97	0.395150671254241	0.933	0.844	9.55762504474987e-93	RPS29	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27921
2.70052420088338e-96	0.287259910239301	1	0.999	6.72538546987997e-92	RPS9	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27922
8.76153377669402e-96	0.41000905090402	0.893	0.733	2.18197237174788e-91	LAMTOR4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27923
1.46981480605916e-94	0.436681896581275	0.454	0.195	3.66042679300974e-90	GCA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000115271	25801	grancalcin	GCL	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27924
3.83398338610124e-94	0.455955180041282	0.606	0.345	9.54815222474653e-90	MPEG1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000197629	219972	macrophage expressed 1	MPG1	protein_coding	Q2M385	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27925
6.15797594912989e-94	0.442505169077852	0.386	0.139	1.53358233037131e-89	XAF1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27926
4.94860957501297e-93	0.409791303683776	0.438	0.186	1.23240172856123e-88	LILRB3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000277816	11025	leukocyte immunoglobulin like receptor B3	CD85a|HL9|ILT5|LIR-3|LIR3|PIR-B|PIRB	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27927
4.88391856957017e-92	-0.443170458064978	0.989	0.995	1.21629108056576e-87	RPS5	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27928
9.06430479273971e-92	-0.405134916823917	0.175	0.363	2.2573744655839e-87	HLA-DRB6	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000229391	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27929
1.44059905907098e-91	0.4549427122808	0.997	0.993	3.58766789671038e-87	VIM	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27930
1.06801506684302e-90	0.468384302488765	0.74	0.523	2.65978472246587e-86	C1orf162	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000143110	128346	chromosome 1 open reading frame 162	MGC24133	protein_coding	Q8NEQ5	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27931
2.59192504903169e-90	-0.427653559435918	0.379	0.615	6.45493014210852e-86	NKG7	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27932
2.72150779370864e-90	0.542744283456548	0.275	0.06	6.777643009452e-86	RETN	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27933
6.53689142415408e-90	0.387789000700143	0.401	0.153	1.62794744027133e-85	NDUFB1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27934
2.79426704256885e-89	0.40320982480569	0.417	0.172	6.95884264281346e-85	HRH2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000113749	3274	histamine receptor H2	NA	protein_coding	P25021	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27935
5.47291110633884e-89	-0.47542936562774	0.298	0.529	1.36297378192262e-84	GNLY	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27936
1.01340451257267e-88	0.463614658447989	0.538	0.287	2.52378259811097e-84	SCO2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000284194	9997	synthesis of cytochrome C oxidase 2	MYP6|SCO1L	protein_coding	O43819	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27937
4.53054256675963e-88	0.425479269326142	0.824	0.688	1.12828632082582e-83	ANXA5	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27938
5.89648111607093e-88	0.52698069618166	0.688	0.453	1.4684596571463e-83	TUBA1A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27939
1.2844449800702e-86	0.467583536817375	0.745	0.543	3.19878177836683e-82	RNF213	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27940
3.09615692957833e-86	0.42263680744093	0.547	0.289	7.71066921742186e-82	NUP214	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000126883	8021	nucleoporin 214	CAIN|CAN|D9S46E|N214	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27941
4.85579428062745e-86	-0.286609215990218	0.282	0.509	1.20928700764746e-81	CD3E	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27942
8.58404822882798e-86	-0.354028333523667	1	1	2.13777137090732e-81	RPS19	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27943
1.24405620072068e-85	0.417190312408445	0.635	0.374	3.09819756227479e-81	C4orf48	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27944
1.90071989787132e-85	-0.422158181122258	0.891	0.962	4.73355283365873e-81	MT-ND4L	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27945
1.39576999371658e-84	0.399049492177761	0.992	0.979	3.47602559235176e-80	MT-ND2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27946
1.46540881145381e-84	0.405114289207861	0.437	0.193	3.64945410404457e-80	CD300E	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000186407	342510	CD300e molecule	CD300LE|CLM2|IREM2	protein_coding	Q496F6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27947
4.70573428588116e-84	0.317657691051899	0.995	0.991	1.17191606655584e-79	RPS21	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27948
1.79779105189757e-83	-0.273635787923642	1	0.999	4.4772188356457e-79	RPL10	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27949
3.83234144945705e-83	0.445545892914795	0.602	0.359	9.54406314572783e-79	PGD	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000142657	5226	phosphogluconate dehydrogenase	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27950
2.2507486591593e-82	-0.471335565773525	0.711	0.861	5.60526446077032e-78	TSC22D3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27951
8.34926870640318e-82	0.395726630300872	0.529	0.281	2.07930187864265e-77	TIMP2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27952
3.95333314921241e-81	0.377036189575559	0.939	0.864	9.84538087479859e-77	ELOB	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27953
2.31429599892444e-80	-0.385524257149865	0.967	0.989	5.76352275572144e-76	EEF2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27954
3.15548984169725e-80	0.415652328662612	0.538	0.293	7.85843190176283e-76	PTPRE	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27955
4.64041513486069e-80	0.412142464794262	0.584	0.339	1.15564898518571e-75	LRP1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000123384	4035	LDL receptor related protein 1	A2MR|APOER|APR|CD91|IGFBP-3R|IGFBP3R1|LRP|LRP1A	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27956
4.95263076795695e-80	0.429355326114265	0.438	0.202	1.233403166452e-75	CDC42EP3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27957
6.19124175136801e-80	0.376737471021107	0.466	0.219	1.54186684576069e-75	ATP5ME	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27958
1.2958007353338e-79	0.443583183468632	0.638	0.399	3.2270621512753e-75	SLC11A1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000018280	6556	solute carrier family 11 member 1	LSH|NRAMP|NRAMP1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27959
3.95165112680053e-79	0.389014858503692	0.402	0.173	9.84119196618404e-75	PLSCR1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27960
2.61229000918141e-78	0.388605473637259	0.808	0.643	6.50564703886539e-74	UQCR11	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27961
2.85935214062539e-77	0.267841990157939	0.999	0.995	7.12093057101348e-73	OAZ1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27962
3.04832962741857e-77	0.415532167110076	0.605	0.378	7.59156010412321e-73	TNFSF13B	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000102524	10673	TNF superfamily member 13b	BAFF|BLYS|CD257|TALL-1|TALL1|THANK|TNFSF20	protein_coding	Q9Y275	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27963
7.2815317801627e-77	0.529914136465491	0.859	0.828	1.81339267453172e-72	LY6E	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27964
9.18096189875836e-76	0.347385957980214	0.33	0.115	2.28642675126678e-71	CD93	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000125810	22918	CD93 molecule	C1qR(P)|C1QR1|C1qRP|CDw93|dJ737E23.1|ECSM3|MXRA4	protein_coding	Q9NPY3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27965
3.84825934006868e-75	0.275656562791353	0.998	0.993	9.58370506050705e-71	RPL36	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27966
6.50627048759926e-75	-0.291447526678911	0.21	0.403	1.62032160223172e-70	CST7	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27967
7.60196729236498e-75	0.352810765615074	0.424	0.194	1.89319393449057e-70	LGALS9	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000168961	3965	galectin 9	LGALS9A	protein_coding	O00182	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27968
1.94651010934575e-74	0.324113439807228	0.358	0.138	4.84758877631466e-70	PRKACA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000288516	5566	protein kinase cAMP-activated catalytic subunit alpha	PKACa	protein_coding	P17612	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27969
2.96240959472301e-74	0.374090790441694	0.561	0.323	7.37758485469818e-70	SMDT1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27970
7.63701818300198e-74	0.383316931612473	0.378	0.157	1.90192300829481e-69	ITGAM	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000169896	3684	integrin subunit alpha M	CD11B|CR3A|MAC-1	protein_coding	P11215	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27971
2.65674114328577e-73	0.373737189811898	0.661	0.42	6.61634814323888e-69	AGTRAP	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000177674	57085	angiotensin II receptor associated protein	ATRAP	protein_coding	Q6RW13	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27972
6.65413709856463e-73	-0.400161848126843	0.291	0.483	1.65714630302653e-68	GYPC	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27973
1.38089497084868e-72	0.419107257023214	0.71	0.5	3.43898083540155e-68	APLP2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27974
5.42023538561383e-72	0.388923350664878	0.688	0.459	1.34985542043327e-67	BLVRB	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27975
6.59983503228888e-72	-0.373612714247939	0.344	0.55	1.64362291644122e-67	LTB	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27976
2.63912142397534e-71	0.363552892273713	0.492	0.255	6.57246799426818e-67	GLIPR2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000122694	152007	GLI pathogenesis related 2	C9orf19|GAPR-1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27977
6.62605311242465e-71	0.385195380819505	0.967	0.917	1.65015226711823e-66	GPX1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27978
7.10105924031879e-71	0.329355085955063	0.28	0.087	1.76844779320899e-66	NAIP	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000276068	4671	NLR family apoptosis inhibitory protein	BIRC1|NLRB1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27979
8.7943785615186e-71	0.356792290796171	0.852	0.703	2.19015203696059e-66	RAC1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27980
1.23861914527631e-70	0.386769865453366	0.749	0.546	3.08465711939613e-66	MYO1F	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27981
3.29646045530579e-70	0.260101775678472	0.999	0.997	8.20950511789354e-66	RPS27	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27982
1.30349625732406e-69	0.409775008068716	0.428	0.207	3.24622707923985e-65	PLBD1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000121316	79887	phospholipase B domain containing 1	FLJ22662	protein_coding	Q6P4A8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27983
9.61348021103176e-69	-0.319079186581856	0.345	0.543	2.39414111175535e-64	EVL	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27984
1.4049617573037e-68	0.346089323659473	0.871	0.733	3.49891676038914e-64	H3-3A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000163041	3020	H3.3 histone A	H3.3A|H3F3|H3F3A	protein_coding	P84243	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27985
2.51548241528845e-68	0.36768899177321	0.668	0.462	6.26455740703435e-64	ATP5MPL	Mono/Macro	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27986
2.77415340581085e-68	0.380333799100232	0.63	0.414	6.90875164183135e-64	POLR2L	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27987
7.67463785858463e-68	0.398773370686092	0.979	0.932	1.91129181230192e-63	NEAT1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27988
3.5510929490673e-67	0.34568757617518	0.516	0.287	8.84364188035719e-63	ODF3B	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000177989	440836	outer dense fiber of sperm tails 3B	FAP123	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27989
2.75417715509013e-66	0.344571833866589	0.998	0.998	6.85900278703647e-62	GAPDH	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27990
3.39326146761824e-66	0.54723730062535	0.47	0.267	8.45057835895647e-62	ISG15	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27991
5.17928976325136e-66	0.346015216918	0.427	0.212	1.28985032264012e-61	KCTD12	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000178695	115207	potassium channel tetramerization domain containing 12	C13orf2|KIAA1778|PFET1	protein_coding	Q96CX2	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27992
5.72846049623537e-66	0.352029720512031	0.776	0.589	1.42661580198246e-61	RNF130	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000113269	55819	ring finger protein 130	G1RZFP|GOLIATH|GP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27993
1.0275769448456e-65	0.346080111753356	0.41	0.196	2.55907762344348e-61	ASGR1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000141505	432	asialoglycoprotein receptor 1	CLEC4H1	protein_coding	P07306	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27994
1.3283512340902e-65	0.332651077518476	0.451	0.235	3.30812591337824e-61	RXRA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000186350	6256	retinoid X receptor alpha	NR2B1|RXR-alpha|RXRalpha	protein_coding	P19793	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27995
2.36091197772002e-65	0.401290903620279	0.67	0.474	5.87961518931394e-61	FGL2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000127951	10875	fibrinogen like 2	pT49|T49	protein_coding	Q14314	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27996
2.98817599256765e-65	-0.306910517554207	0.386	0.599	7.44175349189047e-61	CCL5	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27997
4.24580400211039e-65	0.305948721121958	0.274	0.088	1.05737502868557e-60	PTAFR	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000169403	5724	platelet activating factor receptor	NA	protein_coding	P25105	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27998
3.00143410777261e-64	0.304972463752159	0.279	0.093	7.4747715019969e-60	GIMAP7	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	27999
4.02655142849124e-64	0.358960227608436	0.595	0.375	1.00277236775146e-59	JAML	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000160593	120425	junction adhesion molecule like	AMICA|AMICA1|Gm638	protein_coding	Q86YT9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28000
6.69365321795229e-64	0.376847524200792	0.824	0.675	1.66698739739884e-59	GRN	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28001
7.66919644111543e-64	-0.404185108958424	0.75	0.867	1.90993668169539e-59	MT-ATP8	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28002
9.16482638070836e-64	0.379481676652689	0.76	0.579	2.28240836185161e-59	CYBB	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28003
1.03962201420864e-63	0.323773018979644	0.465	0.242	2.58907466418519e-59	ETV6	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000139083	2120	ETS variant transcription factor 6	TEL	protein_coding	P41212	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28004
1.21355152745016e-63	-0.354444876235273	0.607	0.798	3.02222872396187e-59	RPS4Y1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28005
1.44789868425231e-63	0.298100459672776	0.359	0.156	3.60584688326195e-59	SMCO4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000166002	56935	single-pass membrane protein with coiled-coil domains 4	C11orf75|FN5	protein_coding	Q9NRQ5	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28006
2.24548355711988e-63	-0.520868315181479	0.784	0.895	5.59215225065136e-59	UBB	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28007
8.16293112213146e-63	0.346426297089981	0.502	0.288	2.03289636665562e-58	RPL36A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28008
1.7243986485665e-62	0.367653095170415	0.985	0.973	4.29444239439001e-58	S100A10	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28009
2.01612685920194e-62	0.327326200570032	0.405	0.199	5.02096233015652e-58	IFI16	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28010
2.23471404056062e-62	0.333164888006245	0.28	0.099	5.56533184661217e-58	ANPEP	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000166825	290	alanyl aminopeptidase, membrane	AP-N|CD13|gp150|hAPN|LAP1|p150|PEPN	protein_coding	P15144	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28011
3.26062769475848e-62	0.305244940711726	0.982	0.965	8.12026721102651e-58	SRGN	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28012
6.40767389562578e-62	0.328860568206135	0.301	0.117	1.59576710696664e-57	MX2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000183486	4600	MX dynamin like GTPase 2	MXB	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28013
2.08967095513036e-61	0.326122263580935	0.38	0.18	5.20411654665666e-57	BLOC1S1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28014
2.24190819355135e-61	-0.571171375286127	0.228	0.375	5.58324816522027e-57	SLC25A39	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28015
4.30015940965003e-61	0.328838895348551	0.453	0.244	1.07091169937924e-56	ROMO1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28016
5.60511595059339e-61	0.338656592266457	0.505	0.299	1.39589807633578e-56	NAGK	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000124357	55577	N-acetylglucosamine kinase	GNK	protein_coding	Q9UJ70	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28017
6.24716299145463e-61	0.360812692256516	0.301	0.119	1.55579347139186e-56	LAIR1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000276163	3903	leukocyte associated immunoglobulin like receptor 1	CD305|LAIR-1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28018
6.8248590349148e-61	0.323095107322544	0.529	0.302	1.69966289405518e-56	GNB1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000078369	2782	G protein subunit beta 1	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28019
9.93901664518629e-61	-0.487110460681777	0.999	1	2.47521270531719e-56	CD74	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28020
1.40236965763459e-60	0.437643434444487	0.521	0.308	3.49246139537318e-56	MAFB	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000204103	9935	MAF bZIP transcription factor B	KRML	protein_coding	Q9Y5Q3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28021
2.48691897211819e-60	0.326830959964226	0.861	0.753	6.19342300816314e-56	FYB1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28022
3.96399282249768e-60	0.286286182873323	0.308	0.119	9.87192772514822e-56	AGFG1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000173744	3267	ArfGAP with FG repeats 1	HRB|RAB|RIP	protein_coding	P52594	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28023
4.35975614303139e-59	0.300860910304025	0.36	0.166	1.08575366986054e-54	TMEM167A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28024
7.6048034946059e-59	0.359006113820881	0.436	0.23	1.89390026229665e-54	CD36	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000135218	948	CD36 molecule	FAT|GP3B|GP4|GPIV|SCARB3	protein_coding	P16671	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28025
1.45272453786688e-58	0.325145921366862	0.529	0.317	3.61786518910369e-54	HSBP1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28026
1.67181543954766e-58	0.329345214934759	0.5	0.291	4.1634891706495e-54	IL17RA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000177663	23765	interleukin 17 receptor A	CD217|CDw217|hIL-17R|IL-17RA|IL17R	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28027
4.42842419507507e-58	0.439915599880729	0.416	0.216	1.1028547615415e-53	AC020916.1	Mono/Macro	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28028
4.78035500930738e-58	0.308273804841514	0.972	0.924	1.19049961151791e-53	TSPO	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28029
1.96053365736212e-57	0.327288085345049	0.673	0.473	4.88251302029462e-53	IQGAP1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28030
2.11746562459055e-57	0.336527889995991	0.477	0.276	5.27333639148031e-53	EVI2B	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28031
3.67791181682347e-57	0.27964228273819	0.965	0.936	9.15947158861717e-53	CLIC1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28032
6.22790573447241e-57	0.314839058168525	0.393	0.195	1.55099764411301e-52	MEGF9	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000106780	1955	multiple EGF like domains 9	EGFL5	protein_coding	Q9H1U4	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28033
6.6939596376785e-57	0.306647100701802	0.512	0.301	1.66706370816745e-52	ARPC1B	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28034
7.12313376863199e-57	0.312319531578138	0.378	0.186	1.77394523374011e-52	NCF4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000275990	4689	neutrophil cytosolic factor 4	p40phox|SH3PXD4	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28035
7.49655671093471e-57	0.325503145446393	0.535	0.331	1.86694248329118e-52	CASP1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000137752	834	caspase 1	ICE|IL1BC	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28036
1.61043532169347e-56	0.293645932973246	0.316	0.134	4.01062812514542e-52	FAM200B	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000237765	285550	family with sequence similarity 200 member B	C4orf53	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28037
3.60118130440906e-56	0.33514957720404	0.579	0.378	8.96838192050033e-52	CLEC7A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000172243	64581	C-type lectin domain containing 7A	CD369|CLECSF12|DECTIN-1|hDectin-1|SCARE2	protein_coding	Q9BXN2	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28038
3.60478596482447e-56	0.30915718342679	0.485	0.276	8.97735896679885e-52	ADAR	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28039
4.2301196264075e-56	0.331074777600755	0.308	0.129	1.05346899176052e-51	SOCS3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28040
5.45493417203818e-56	0.267791003021826	0.296	0.117	1.35849680620439e-51	TLR2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000137462	7097	toll like receptor 2	CD282|TIL4	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28041
7.96157189922699e-56	0.442876359976876	0.637	0.44	1.98274986578349e-51	LILRB2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000274513	10288	leukocyte immunoglobulin like receptor B2	CD85d|ILT4|LIR-2|LIR2|MIR-10|MIR10	protein_coding	Q8N423	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28042
1.13934262313248e-55	0.28527080335292	0.373	0.18	2.83741886864914e-51	PET100	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28043
2.36501901212292e-55	0.328916196500632	0.57	0.362	5.88984334779091e-51	GLRX	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28044
3.1168544050546e-55	0.255652144442049	0.272	0.1	7.76221421034799e-51	BRD7	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000166164	29117	bromodomain containing 7	BP75|CELTIX1|SMARCI1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28045
3.17764873209765e-55	-0.337495819697286	0.913	0.969	7.913616402416e-51	RPS2P5	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000240342	NA	NA	bcm384	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28046
3.27417765001336e-55	0.303082729048199	0.397	0.205	8.15401201959327e-51	FCGR2A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000143226	2212	Fc gamma receptor IIa	CD32|CD32A|CDw32|Fc-gamma-RIIa|FCG2|FcgammaRIIa|FCGR2|FCGR2A1|IGFR2	protein_coding	P12318	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28047
5.00417688507989e-55	0.294449791086643	0.404	0.204	1.2462402114603e-50	CTSA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000064601	5476	cathepsin A	GSL|PPGB	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28048
5.5148523156698e-55	-0.251278160759303	0.999	0.999	1.37341882069441e-50	HLA-A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28049
6.94550055802013e-55	-0.310871351240544	0.987	0.995	1.72970745896933e-50	RPL5	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28050
3.05380227816595e-54	0.314892652222272	0.555	0.348	7.60518919354448e-50	USP15	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28051
1.40796777340809e-53	-0.35685325511582	0.888	0.961	3.5064029428955e-49	FOS	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28052
1.44662985402734e-53	0.308605947215562	0.499	0.296	3.60268698846969e-49	HK3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000160883	3101	hexokinase 3	NA	protein_coding	P52790	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28053
2.14608620531207e-53	0.276428662228033	0.373	0.185	5.34461308570918e-49	MARCHF1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000145416	55016	membrane associated ring-CH-type finger 1	FLJ20668|MARCH-I|MARCH1|RNF171	protein_coding	Q8TCQ1	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28054
3.28018524296695e-53	0.297718062893398	0.365	0.18	8.1689733290849e-49	ARHGAP26	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000145819	23092	Rho GTPase activating protein 26	GRAF|KIAA0621|OPHN1L|OPHN1L1	protein_coding	Q9UNA1	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28055
8.0097139971233e-53	0.347296341344997	0.971	0.89	1.99473917384359e-48	AIF1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28056
1.27587083790305e-52	0.293652324487279	0.429	0.238	3.17742873471375e-48	PAK1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000149269	5058	p21 (RAC1) activated kinase 1	NA	protein_coding	Q13153	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28057
1.4006305827962e-52	0.321780394295059	0.559	0.356	3.48813040339565e-48	HEBP2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28058
2.29381518646209e-52	0.321955578538098	0.68	0.489	5.7125173403652e-48	HCK	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000101336	3055	HCK proto-oncogene, Src family tyrosine kinase	JTK9	protein_coding	P08631	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28059
5.03340524449704e-52	0.340856200795295	0.719	0.561	1.25351924208954e-47	CD63	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28060
5.14918261446744e-52	0.431913744083023	0.425	0.245	1.28235243830697e-47	LILRB1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000276452	10859	leukocyte immunoglobulin like receptor B1	CD85|CD85j|ILT2|LIR-1|LIR1|MIR-7|PIR-B|PIRB	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28061
5.48475959509682e-52	0.313378027287043	0.617	0.419	1.36592452956291e-47	CTSH	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28062
6.83075180362418e-52	0.289161313055455	0.347	0.167	1.70113042917457e-47	STAT2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000170581	6773	signal transducer and activator of transcription 2	STAT113	protein_coding	P52630	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28063
8.26784619935512e-52	0.316012937693627	0.976	0.948	2.0590244174874e-47	EMP3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28064
1.70475551910562e-51	-0.272548629953199	0.998	0.999	4.24552314478064e-47	RPS6	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28065
2.03503344007709e-51	0.330199288332789	0.611	0.418	5.06804727916798e-47	CARD16	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28066
5.35572654055276e-51	0.341474937574488	0.789	0.619	1.33379013765926e-46	CEBPB	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28067
6.4442062751888e-51	-0.551317009242229	0.852	0.935	1.60486513077302e-46	HLA-DPA1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28068
1.02258694270901e-50	-0.286469699025987	0.991	0.994	2.54665052212252e-46	RPL10A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28069
1.04940209469686e-50	0.270076874451605	0.928	0.841	2.61343097663305e-46	PYCARD	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28070
1.59508413433124e-50	0.310447543079123	0.754	0.582	3.97239752813852e-46	FCGRT	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28071
2.00509750074533e-50	0.323273795511759	0.709	0.528	4.99349481585617e-46	NCF2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000116701	4688	neutrophil cytosolic factor 2	NOXA2|p67phox	protein_coding	P19878	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28072
3.99269127975058e-50	0.297681321838177	0.322	0.151	9.94339836309084e-46	EPSTI1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28073
4.72749281297435e-50	0.36173145008492	0.885	0.762	1.17733481014313e-45	SERPINA1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28074
5.78945287017483e-50	0.252654396235659	0.299	0.127	1.44180534278834e-45	MAP4K4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000071054	9448	mitogen-activated protein kinase kinase kinase kinase 4	FLH21957|HGK|NIK	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28075
8.72001062379639e-50	-0.315643075783571	0.995	0.997	2.17163144575025e-45	RPL3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28076
1.47843388327923e-49	0.298575929424952	0.395	0.212	3.68189174291861e-45	IRF7	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28077
2.41847701290216e-49	0.272775587514967	0.441	0.25	6.02297515293153e-45	SEM1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28078
2.62256255741876e-49	0.258571570799963	0.287	0.122	6.53122979299569e-45	CKLF	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28079
3.29561231104176e-49	0.292008778040066	0.604	0.407	8.20739289941839e-45	RAB31	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000168461	11031	RAB31, member RAS oncogene family	Rab22B	protein_coding	Q13636	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28080
4.06904901137469e-49	0.345547743412503	0.481	0.293	1.01335596579275e-44	TNFSF10	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000121858	8743	TNF superfamily member 10	Apo-2L|CD253|TL2|TRAIL	protein_coding	P50591	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28081
5.45103036856653e-49	0.338226956042647	0.535	0.342	1.35752460298781e-44	CAPG	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28082
6.83402263370593e-49	0.318795844732643	0.475	0.285	1.70194499669813e-44	BCL2A1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28083
7.17253177032253e-49	-0.390508004625578	0.3	0.432	1.78624731208112e-44	MBD2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000134046	8932	methyl-CpG binding domain protein 2	NA	protein_coding	Q9UBB5	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28084
1.18220818315705e-48	0.263962347280422	0.397	0.211	2.94417125933433e-44	UBE2D1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000072401	7321	ubiquitin conjugating enzyme E2 D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UbcH5A	protein_coding	P51668	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28085
1.37547879806413e-48	0.273901291652388	0.32	0.151	3.42549239869892e-44	MSRB1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000198736	51734	methionine sulfoxide reductase B1	SELENOR|SELENOX|SelR|SelX|SepR|SEPX1	protein_coding	Q9NZV6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28086
2.91901393625692e-48	0.34808522427186	0.648	0.478	7.26951230685424e-44	POU2F2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000028277	5452	POU class 2 homeobox 2	OCT2|OTF2	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28087
3.19614213945637e-48	0.280453651895413	0.389	0.209	7.95967238410214e-44	BACH1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000156273	571	BTB domain and CNC homolog 1	BACH-1|BTBD24	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28088
6.97930034773119e-48	0.294426985133649	0.31	0.144	1.73812495859898e-43	NCF1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28089
1.3366877470398e-47	0.257513666141494	0.341	0.172	3.32888716522792e-43	SULF2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000196562	55959	sulfatase 2	HSULF-2|KIAA1247|SULF-2	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28090
1.37101546093326e-47	0.261296561212295	0.361	0.185	3.41437690390818e-43	CCNY	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000108100	219771	cyclin Y	C10orf9|CBCP1|CFP1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28091
1.9484911598992e-47	0.259088642230714	0.341	0.169	4.85252238461298e-43	ARPC4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28092
2.29544390138067e-47	-0.289317244827796	0.974	0.988	5.71657349199843e-43	PPIA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28093
2.95975233660249e-47	0.281854885785122	0.755	0.619	7.37096721907485e-43	UBL5	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28094
4.3587381334215e-47	0.253752478932508	0.34	0.165	1.08550014474729e-42	PSTPIP1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000140368	9051	proline-serine-threonine phosphatase interacting protein 1	CD2BP1|CD2BP1L|CD2BP1S|H-PIP|PAPAS|PSTPIP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28095
1.24373456195726e-46	0.270303221940037	0.462	0.274	3.09739655309837e-42	UBXN11	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000158062	91544	UBX domain protein 11	SOC|SOCI|UBXD5	protein_coding	Q5T124	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28096
1.9298968640014e-46	0.295315666610386	0.638	0.443	4.80621515010908e-42	GRK2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000173020	156	G protein-coupled receptor kinase 2	ADRBK1|BARK1	protein_coding	P25098	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28097
1.99092560962128e-46	-0.294316226311327	0.947	0.971	4.95820113820083e-42	LSP1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28098
2.07601253520934e-46	0.29386841453167	0.999	1	5.17010161768533e-42	MT-ND1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28099
2.14766789710476e-46	0.28463444027225	0.535	0.341	5.34855213094969e-42	ATP5MD	Mono/Macro	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28100
2.73415498576982e-46	0.288875035042469	0.32	0.157	6.80913957656115e-42	SULT1A1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000196502	6817	sulfotransferase family 1A member 1	P-PST|STP|STP1	protein_coding	P50225	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28101
2.82576376425343e-46	-0.278379906768407	0.354	0.511	7.03728207849675e-42	LITAF	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28102
4.6469833468676e-46	-0.480497578445912	0.191	0.338	1.15728473270391e-41	CDKN1C	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000273707	1028	cyclin dependent kinase inhibitor 1C	BWCR|BWS|KIP2|P57	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28103
5.55822329302572e-46	0.364218522073972	0.549	0.358	1.38421992889512e-41	NRGN	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000154146	4900	neurogranin	RC3	protein_coding	Q92686	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28104
1.11065777245714e-45	0.255466944968633	0.937	0.889	2.76598211652727e-41	GMFG	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28105
1.11494095578824e-45	0.31971352998258	0.418	0.24	2.77664895629504e-41	NAMPT	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28106
1.46702705811988e-45	0.278208100426871	0.409	0.232	3.65348418554175e-41	DMXL2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000104093	23312	Dmx like 2	DFNA71|KIAA0856|RC3	protein_coding	Q8TDJ6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28107
1.79376246481854e-45	0.282264667525753	0.685	0.531	4.46718604238408e-41	NDUFA1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28108
2.00132548676916e-45	0.267561487378521	0.323	0.158	4.98410099224992e-41	PARP14	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000173193	54625	poly(ADP-ribose) polymerase family member 14	ARTD8|BAL2|KIAA1268|pART8	protein_coding	Q460N5	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28109
2.16382191993761e-45	0.284006108555566	0.441	0.262	5.38878210941263e-41	SP110	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000135899	3431	SP110 nuclear body protein	IFI41|IFI75	protein_coding	Q9HB58	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28110
3.07851685800629e-45	0.308191141586556	0.511	0.332	7.66673838317886e-41	RIPOR2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28111
3.40881620166769e-45	0.260809947150287	0.489	0.3	8.48931586863322e-41	RAB32	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000118508	10981	RAB32, member RAS oncogene family	NA	protein_coding	Q13637	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28112
3.47983736378898e-45	0.30169820484997	0.566	0.384	8.66618697078009e-41	GLIPR1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28113
1.41060390594093e-44	0.278270659072632	0.659	0.469	3.5129679673553e-40	TCF25	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28114
2.06455768898929e-44	0.385650502121639	0.628	0.459	5.14157446865893e-40	ZFP36L1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28115
3.01129920274852e-44	0.261646388764606	0.434	0.255	7.49933953452492e-40	SAT2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000141504	112483	spermidine/spermine N1-acetyltransferase family member 2	SSAT2	protein_coding	Q96F10	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28116
3.15955523459788e-44	0.255784913755313	0.518	0.324	7.86855635624257e-40	RNF181	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28117
3.84626830573086e-44	0.263562136990001	0.581	0.39	9.57874658859213e-40	ATP5PD	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28118
4.78927960904624e-44	0.253714700523351	0.362	0.192	1.19272219383688e-39	RBMS1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000153250	5937	RNA binding motif single stranded interacting protein 1	C2orf12|DKFZp564H0764|HCC-4|MSSP-1|MSSP-2|MSSP-3|SCR2|YC1	protein_coding	P29558	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28119
4.80668285367866e-44	0.272692560006189	0.479	0.294	1.19705629788013e-39	ABRACL	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28120
6.35548368087111e-44	0.269888396822669	0.863	0.785	1.58276965588414e-39	TMA7	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28121
1.20702085810605e-43	0.254860364444348	0.36	0.189	3.00596474502729e-39	CD55	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28122
2.0902501383771e-43	0.27691326157928	0.521	0.338	5.20555894461433e-39	SDCBP	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28123
3.12451918947682e-43	-0.327706782558754	0.994	0.994	7.78130258947308e-39	RPLP0	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28124
3.60008887038412e-43	0.325821405685447	0.564	0.382	8.96566132280461e-39	CPVL	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28125
6.31719362072651e-43	0.277289343371391	0.472	0.295	1.57323389930573e-38	VMP1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28126
6.56713970779759e-43	0.260494752117039	0.408	0.234	1.63548047282991e-38	NDUFA3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28127
6.6432026113266e-43	0.276644064782828	0.695	0.498	1.65442317832478e-38	TNFAIP2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28128
7.58095612281395e-43	0.252171685352166	0.338	0.174	1.88796131282558e-38	GAS7	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000007237	8522	growth arrest specific 7	KIAA0394|MGC1348	protein_coding	O60861	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28129
9.98039965629401e-43	-0.315767733257728	0.934	0.954	2.48551873040346e-38	EEF1B2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28130
1.6472408587458e-42	0.273985816763662	0.709	0.56	4.10228863462054e-38	UQCR10	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28131
4.09328609599147e-42	0.261374461174215	0.808	0.667	1.01939196934572e-37	VAMP8	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28132
5.64375057354641e-42	0.322235519815306	0.668	0.51	1.405519642836e-37	SERPINB1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28133
8.17572394686484e-42	0.288067074692693	0.456	0.281	2.03608229172722e-37	LAP3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28134
9.66781753163837e-42	0.258205814335441	0.495	0.313	2.40767327807922e-37	BLVRA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000106605	644	biliverdin reductase A	BLVR	protein_coding	P53004	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28135
9.80039263707922e-42	0.265796676861256	0.49	0.307	2.44068978233821e-37	OGFRL1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000119900	79627	opioid growth factor receptor like 1	dJ331H24.1	protein_coding	Q5TC84	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28136
1.44549768693347e-41	0.284490425066561	0.459	0.282	3.59986743953912e-37	METTL9	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28137
2.23703884024463e-41	0.274837431334381	0.739	0.574	5.57112152774523e-37	FGR	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28138
2.2719708269379e-41	0.358621348790884	0.668	0.511	5.65811614740614e-37	LYN	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28139
2.50625180750614e-41	0.282931374536751	0.475	0.309	6.24156950141328e-37	SECTM1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000141574	6398	secreted and transmembrane 1	K12	protein_coding	Q8WVN6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28140
2.50836367009446e-41	0.294004243273246	0.301	0.145	6.24682888400324e-37	SLC2A3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28141
2.7276765765031e-41	0.251666867238347	0.867	0.804	6.79300574612332e-37	ATP5MG	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28142
4.26953128058597e-41	0.258137094610132	0.7	0.556	1.06328407011713e-36	ATP5MF	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28143
4.31651766216051e-41	0.266287442760956	0.475	0.296	1.07498555858445e-36	TPM4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28144
7.21336752564401e-41	0.260497555562053	0.812	0.714	1.79641704858639e-36	OST4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28145
7.68443863755563e-41	-0.286576208728392	0.664	0.773	1.91373259829685e-36	CIRBP	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28146
9.38618287307998e-41	0.250694878850818	0.255	0.113	2.33753498271184e-36	PIM1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28147
1.01631463706002e-40	0.285757956102831	0.629	0.457	2.53102997213428e-36	BST2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28148
2.01248365342153e-40	0.257053765259098	0.522	0.343	5.01188929048097e-36	RTN4	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28149
3.40919044529888e-40	0.252730773651118	0.918	0.858	8.49024788497233e-36	EFHD2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28150
3.60745770568773e-40	0.263473686248888	0.64	0.467	8.98401267024471e-36	GRINA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28151
9.35396114467504e-40	-0.281029959930695	0.935	0.965	2.32951048346987e-35	RPSA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28152
1.05679484386647e-39	-0.296173870575679	0.745	0.854	2.63184187916506e-35	SARAF	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28153
1.34494885851802e-39	0.259059281266036	0.414	0.246	3.34946063725327e-35	RAB11FIP1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28154
1.53405482352763e-39	0.260338488178549	0.642	0.486	3.82041013251322e-35	TMEM258	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28155
1.93957372894923e-39	-0.327713322131949	0.733	0.821	4.83031441457516e-35	JUND	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28156
2.14908931122432e-39	-0.298340693342639	0.639	0.739	5.35209202067304e-35	NOP53	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28157
2.88734457255321e-39	0.257798114823162	0.423	0.259	7.19064292348652e-35	CCDC88A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28158
3.03139452478147e-39	0.270726068313796	0.513	0.341	7.54938492451577e-35	DOK2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000147443	9046	docking protein 2	Dok-2|p56dok-2	protein_coding	O60496	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28159
7.67904962947826e-39	0.251440894981168	0.57	0.396	1.91239051972527e-34	THEMIS2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000130775	9473	thymocyte selection associated family member 2	C1orf38|ICB-1	protein_coding	Q5TEJ8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28160
8.46686514310002e-39	0.264472011128088	0.918	0.836	2.10858809523763e-34	TKT	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28161
1.33535053263518e-38	0.284781366003237	0.6	0.43	3.32555696647465e-34	PLP2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28162
1.84508670005918e-38	0.341790751563121	0.757	0.628	4.59500391782738e-34	MCL1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28163
2.37700328664435e-38	0.261004761681737	0.72	0.58	5.91968898505908e-34	PSMB3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28164
6.16155769790796e-38	0.277933166047993	0.782	0.645	1.534474329087e-33	CTSZ	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28165
6.36231322573904e-38	0.533534447684055	0.9	0.854	1.58447048573805e-33	IFITM3	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28166
7.72810614016295e-38	0.25576207835191	0.444	0.272	1.92460755314618e-33	STAT1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28167
1.36339260897666e-37	0.25586404389329	0.615	0.438	3.39539295339549e-33	VPS28	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28168
1.8700327150308e-37	0.270765293576016	0.647	0.475	4.6571294735127e-33	PLEKHO1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000023902	51177	pleckstrin homology domain containing O1	CKIP-1|OC120	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28169
5.08044061553588e-37	-0.289011811377194	0.886	0.936	1.26523293089306e-32	DUSP1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28170
8.60935222469089e-37	0.255581800494654	0.492	0.326	2.14407307803702e-32	DYNLL1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28171
9.08552683435339e-36	0.29648939697943	0.539	0.376	2.26265960282737e-31	NFKBIZ	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28172
1.16846392939789e-35	-0.342303519300031	0.26	0.377	2.9099425697725e-31	RNF144B	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000137393	255488	ring finger protein 144B	bA528A10.3|IBRDC2|P53RFP	protein_coding	Q7Z419	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28173
2.06159725743268e-35	0.270834695257543	0.651	0.487	5.13420180991035e-31	PLEK	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28174
2.33377749558411e-35	0.279307016522076	0.618	0.448	5.81203947500266e-31	LTA4H	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28175
2.66867556728198e-34	0.304621355444188	0.606	0.44	6.64606963275905e-30	ADGRE5	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28176
4.03993101588357e-34	0.266205347964305	0.481	0.323	1.00610442019565e-29	MYADM	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28177
6.22883417723898e-34	-0.25067847919881	0.553	0.696	1.55122886349959e-29	TLE5	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000104964	166	TLE family member 5, transcriptional modulator	AES|GRG5	protein_coding	Q08117	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28178
6.5009924705367e-34	0.253749090468394	0.482	0.324	1.61900716486246e-29	KLF10	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28179
3.96054231696085e-33	0.256773214509005	0.529	0.368	9.86333458615931e-29	GLUL	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28180
8.94369585088588e-32	-0.474697602875367	0.807	0.89	2.22733801470462e-27	HLA-DPB1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28181
5.01313876558982e-31	0.265781500887006	0.298	0.17	1.24847207818249e-26	CX3CR1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000168329	1524	C-X3-C motif chemokine receptor 1	CCRL1|CMKBRL1|CMKDR1|GPR13|V28	protein_coding	P49238	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28182
1.50658064870905e-30	-0.253496022986837	0.722	0.821	3.75198844754503e-26	NPM1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28183
3.38322128873538e-30	0.31364463090179	0.506	0.367	8.42557429746659e-26	MARCKS	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28184
8.41022155591973e-30	0.313397426803833	0.324	0.2	2.09448157628625e-25	TMEM176A	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28185
5.74627156208272e-27	0.275684790248239	0.755	0.701	1.43105146982108e-22	ANXA1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28186
4.69194389243802e-26	-0.25834193246663	0.685	0.782	1.16848170697276e-21	HSP90AB1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28187
1.17648911697308e-25	0.263751233574478	0.622	0.471	2.92992849690976e-21	ATP2B1-AS1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000271614	NA	NA	LINC00936	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28188
1.47516720881314e-25	0.258726995660915	0.487	0.349	3.67375641682824e-21	BTG2	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28189
4.96271047053347e-25	-0.27204748297688	0.673	0.727	1.23591341558166e-20	FKBP8	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28190
1.04845904058e-23	-0.353792237707052	0.854	0.9	2.61108239466044e-19	BTG1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28191
5.10670293271831e-21	-0.409509406980963	0.951	0.965	1.27177329836417e-16	HLA-DRA	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28192
2.20019389323498e-20	-0.271912895883905	0.338	0.416	5.4793628717124e-16	MT-ND6	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28193
1.03441862608185e-14	0.28658776692591	0.55	0.442	2.57611614639423e-10	MS4A7	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28194
7.20919441101599e-12	0.261291536563845	0.251	0.181	1.79537777611942e-07	EGR1	Mono/Macro	GSE197268_Tisa-cel_pre	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28195
0	-0.713049236345835	0.126	0.853	0	S100A9	NK cells	GSE197268_Tisa-cel_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28196
0	-0.680014418126605	0.095	0.789	0	S100A8	NK cells	GSE197268_Tisa-cel_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28197
9.73387739431709e-264	-1.12726846254378	0.249	0.902	2.42412482628073e-259	RPS4Y1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28198
1.47692422849767e-257	-0.58973939802738	0.058	0.596	3.6781320986506e-253	LYZ	NK cells	GSE197268_Tisa-cel_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28199
5.48789862365351e-216	1.33036551445897	0.684	0.102	1.36670627323467e-211	HLA-H	NK cells	GSE197268_Tisa-cel_pre	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28200
1.05076660147392e-169	-1.0332135954535	0.047	0.425	2.61682914431064e-165	HBB	NK cells	GSE197268_Tisa-cel_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28201
4.91678333663921e-134	0.834195888057717	0.397	0.004	1.22447572215663e-129	AL365357.1	NK cells	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28202
1.46325242704295e-123	0.915394081207742	0.369	0.003	3.64408384430777e-119	MYOM2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28203
2.29075745675702e-123	1.50627410571572	0.385	0.012	5.70490237030769e-119	S100B	NK cells	GSE197268_Tisa-cel_pre	ENSG00000160307	6285	S100 calcium binding protein B	S100beta	protein_coding	P04271	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28204
1.20893395970514e-120	0.63188791718346	1	1	3.01072913324968e-116	MT-ATP6	NK cells	GSE197268_Tisa-cel_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28205
8.52222289835553e-102	0.721941677714859	0.818	0.494	2.12237439060646e-97	CD81	NK cells	GSE197268_Tisa-cel_pre	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28206
6.52241365203343e-90	0.583845925105033	0.996	1	1.62434189590241e-85	GNLY	NK cells	GSE197268_Tisa-cel_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28207
1.20050875719112e-82	-0.279344545219607	0.566	0.965	2.98974700890875e-78	COTL1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28208
4.71127192511662e-82	0.910130661042565	0.32	0.036	1.17329516023104e-77	XCL2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000143185	6846	X-C motif chemokine ligand 2	SCM-1b|SCYC2	protein_coding	Q9UBD3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28209
7.44707000359929e-82	0.47265359863908	1	1	1.85461831369637e-77	RPS27	NK cells	GSE197268_Tisa-cel_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28210
6.65523427358097e-77	-0.692776458667693	0.154	0.428	1.6574195434926e-72	RPL13P12	NK cells	GSE197268_Tisa-cel_pre	ENSG00000215030	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28211
4.1996241753875e-75	0.652146664952759	0.517	0.172	1.0458744046385e-70	CD2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28212
2.1085681743338e-74	0.63870895791913	0.986	1	5.2511781813609e-70	RPS26	NK cells	GSE197268_Tisa-cel_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28213
2.0130830580673e-73	0.745613044512287	0.35	0.063	5.01338204781081e-69	SELL	NK cells	GSE197268_Tisa-cel_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28214
3.35207700213569e-72	0.556946250987489	0.332	0.051	8.34801256611871e-68	KLRG1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28215
7.78076955978941e-68	0.41720804087245	1	1	1.93772285116996e-63	MT-CO1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28216
6.11206231733488e-66	0.666894709519598	0.979	0.976	1.52214799950908e-61	GZMB	NK cells	GSE197268_Tisa-cel_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28217
1.1151059265147e-65	0.577321810767307	0.624	0.347	2.77705979939221e-61	KLRF1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000150045	51348	killer cell lectin like receptor F1	CLEC5C|NKp80	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28218
4.93094881085859e-64	0.409876873970868	1	1	1.22800349185622e-59	MT-CYB	NK cells	GSE197268_Tisa-cel_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28219
2.12782380827921e-63	-0.482813328144473	0.592	0.974	5.29913241213855e-59	JUND	NK cells	GSE197268_Tisa-cel_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28220
1.19648431554223e-61	0.572377246723343	0.585	0.254	2.97972453942637e-57	GIMAP7	NK cells	GSE197268_Tisa-cel_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28221
3.632219789754e-61	0.488393557051567	0.426	0.127	9.04568016440336e-57	GIMAP4	NK cells	GSE197268_Tisa-cel_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28222
4.13027331005426e-60	-0.301170528246298	0.305	0.66	1.02860326513591e-55	GPX1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28223
1.28038199966336e-58	0.508420865367997	0.993	0.997	3.18866333196163e-54	MT-ND3	NK cells	GSE197268_Tisa-cel_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28224
1.89577731947454e-57	-0.412241483023385	0.429	0.821	4.72124383641939e-53	H1-10	NK cells	GSE197268_Tisa-cel_pre	ENSG00000184897	8971	H1.10 linker histone	H1FX|H1X|MGC15959|MGC8350	protein_coding	Q92522	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28225
4.46665634881836e-57	0.391546154426767	1	1	1.11237609710972e-52	RPS4X	NK cells	GSE197268_Tisa-cel_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28226
9.36497009595892e-55	0.618609153347968	0.954	0.995	2.33225215269761e-50	CD52	NK cells	GSE197268_Tisa-cel_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28227
1.32888068896512e-54	0.523888707658355	0.644	0.321	3.30944446779874e-50	PLEK	NK cells	GSE197268_Tisa-cel_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28228
8.81820702221053e-53	0.479970992632807	0.979	0.99	2.19608627681131e-48	GZMA	NK cells	GSE197268_Tisa-cel_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28229
9.54128291917746e-53	0.496736909445969	0.422	0.144	2.37616109819195e-48	LAIR1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000276163	3903	leukocyte associated immunoglobulin like receptor 1	CD305|LAIR-1	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28230
4.72036073955407e-51	0.456174099549753	0.871	0.586	1.17555863857855e-46	KLRD1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28231
5.16919948938253e-51	0.468620614970102	0.511	0.214	1.28733744083582e-46	APOBEC3G	NK cells	GSE197268_Tisa-cel_pre	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28232
1.89745364237837e-50	-0.482681944168789	0.671	0.982	4.72541855097909e-46	TSC22D3	NK cells	GSE197268_Tisa-cel_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28233
3.05756746549805e-50	-0.416137118348355	1	1	7.61456601607635e-46	EIF1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28234
3.81622546603487e-48	0.374565459273412	0.397	0.13	9.50392790061324e-44	CD300A	NK cells	GSE197268_Tisa-cel_pre	ENSG00000167851	11314	CD300a molecule	CMRF-35-H9|CMRF35H|IGSF12|IRC1|IRC2|Irp60	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28235
4.28192636517004e-46	-0.328934858399309	0.543	0.926	1.06637094198195e-41	SAT1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28236
3.13507564702876e-45	-0.37058354002321	0.508	0.882	7.80759239136043e-41	TNFAIP3	NK cells	GSE197268_Tisa-cel_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28237
2.10406313461376e-44	0.50729694134466	0.503	0.234	5.2399588304421e-40	CX3CR1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000168329	1524	C-X3-C motif chemokine receptor 1	CCRL1|CMKBRL1|CMKDR1|GPR13|V28	protein_coding	P49238	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28238
5.84599112031286e-44	-0.515727743764893	0.649	0.812	1.45588562860271e-39	SPON2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28239
7.54137566660348e-44	0.398433785929573	0.945	0.991	1.87810419601093e-39	RPS29	NK cells	GSE197268_Tisa-cel_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28240
1.01940866595601e-43	0.254505622646158	1	1	2.53873534169685e-39	RPL41	NK cells	GSE197268_Tisa-cel_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28241
1.0682993983629e-43	0.365669256389443	0.999	1	2.66049282168297e-39	MT-ND4	NK cells	GSE197268_Tisa-cel_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28242
1.07409639975435e-43	-0.431212540417805	1	1	2.67492967394824e-39	FTH1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28243
6.94678429015742e-43	0.42493454985429	0.609	0.316	1.7300271596208e-38	XBP1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28244
7.81811545775496e-43	-0.340848809874598	0.476	0.8	1.9470234735993e-38	ZYX	NK cells	GSE197268_Tisa-cel_pre	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28245
6.20698272826071e-42	-0.309248498424174	0.309	0.583	1.54578697864605e-37	CTSS	NK cells	GSE197268_Tisa-cel_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28246
3.3097201536468e-41	0.344478551189917	0.479	0.201	8.24252707064198e-37	MAP2K2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000126934	5605	mitogen-activated protein kinase kinase 2	MEK2|PRKMK2	protein_coding	P36507	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28247
1.58736996467774e-40	0.294304350803483	1	1	3.95318616003345e-36	MT-CO3	NK cells	GSE197268_Tisa-cel_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28248
2.05552112621846e-40	0.37597530244265	0.559	0.266	5.11906981273444e-36	RIPOR2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28249
3.02957895642654e-39	-0.519443883969095	0.605	0.775	7.54486343308465e-35	DDIT4	NK cells	GSE197268_Tisa-cel_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28250
1.46122705193919e-38	0.286160240571838	1	1	3.63903985014936e-34	RPL37	NK cells	GSE197268_Tisa-cel_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28251
2.91059951325014e-38	0.424999336380858	0.75	0.583	7.24855702779815e-34	MTATP6P1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000248527	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28252
2.98901961511272e-38	0.360836637458838	0.599	0.307	7.44385444947673e-34	PRMT2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28253
2.09581389376112e-37	-0.251144291094293	0.508	0.887	5.21941492102268e-33	CNN2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28254
2.83984641108942e-37	0.331205082597281	0.424	0.174	7.0723535021771e-33	FAM107B	NK cells	GSE197268_Tisa-cel_pre	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28255
9.11573046429135e-37	-0.420116798705099	0.909	1	2.27018151482712e-32	TGFB1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28256
1.30849166313884e-36	0.333577404929334	0.497	0.228	3.25866763788095e-32	CDK2AP2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28257
4.42247826590029e-36	0.449878309810846	0.541	0.308	1.10137398733981e-31	ITGB1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28258
1.23225684632439e-35	0.309741921752679	0.413	0.171	3.06881245008627e-31	GBP5	NK cells	GSE197268_Tisa-cel_pre	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28259
1.86500105104711e-35	0.27452255758262	0.371	0.139	4.64459861752772e-31	RNPEPL1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000142327	57140	arginyl aminopeptidase like 1	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28260
5.76916115483303e-34	0.324368024287977	0.966	0.961	1.43675189399962e-29	TYROBP	NK cells	GSE197268_Tisa-cel_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28261
7.09350416163729e-34	0.274020071611396	0.258	0.087	1.76656627641415e-29	NCAM1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000149294	4684	neural cell adhesion molecule 1	CD56|NCAM	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28262
1.36533371711008e-33	0.535885694135719	0.67	0.445	3.40022708909094e-29	IL2RB	NK cells	GSE197268_Tisa-cel_pre	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28263
2.53859911198561e-33	0.295245327950554	0.508	0.241	6.32212722848897e-29	PIP4K2A	NK cells	GSE197268_Tisa-cel_pre	ENSG00000150867	5305	phosphatidylinositol-5-phosphate 4-kinase type 2 alpha	PIP5K2A|PIP5KIIA|PIP5KIIalpha	protein_coding	P48426	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28264
2.93614780910073e-33	-0.29546339118309	0.998	1	7.31218250378446e-29	FTL	NK cells	GSE197268_Tisa-cel_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28265
3.45554821921208e-33	0.289263450206469	0.378	0.154	8.60569728512577e-29	GRK2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000173020	156	G protein-coupled receptor kinase 2	ADRBK1|BARK1	protein_coding	P25098	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28266
1.64016220796056e-32	0.330322622167394	1	1	4.08465996270497e-28	RPS18	NK cells	GSE197268_Tisa-cel_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28267
2.28164018642514e-32	0.270927641023957	0.397	0.165	5.68219672027318e-28	SAMD3	NK cells	GSE197268_Tisa-cel_pre	ENSG00000164483	154075	sterile alpha motif domain containing 3	bA73O6.2|FLJ34032	protein_coding	Q8N6K7	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28268
2.36963278219684e-32	0.321477618844965	0.99	0.999	5.901333480783e-28	MT-ND2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28269
3.32636745811758e-32	0.280232957762133	0.998	1	8.28398551769603e-28	RPL37A	NK cells	GSE197268_Tisa-cel_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28270
3.75036037535343e-32	0.336759574365976	0.506	0.252	9.33989747878019e-28	AC004687.1	NK cells	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28271
6.07333690048856e-32	0.401272028608896	0.41	0.221	1.51250382169767e-27	TRDC	NK cells	GSE197268_Tisa-cel_pre	ENSG00000211829	NA	NA	NA	TR_C_gene	B7Z8K6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28272
7.20347326847613e-31	0.406239263369778	0.493	0.265	1.7939529827813e-26	PRSS23	NK cells	GSE197268_Tisa-cel_pre	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28273
2.03495739022708e-30	0.264961684207631	1	1	5.06785788462153e-26	MT-ND1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28274
2.40637544879127e-29	0.256696474532823	0.358	0.149	5.99283741766978e-25	NUCB2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28275
2.46873036760025e-29	0.260874699700163	0.325	0.149	6.14812610747165e-25	NCR1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000277334	9437	natural cytotoxicity triggering receptor 1	CD335|LY94|NK-p46|NKP46	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28276
1.07332163001496e-28	0.481899043553209	0.72	0.593	2.67300018738926e-24	FCER1G	NK cells	GSE197268_Tisa-cel_pre	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28277
1.08194002254203e-28	-0.265148211607063	0.517	0.81	2.69446343213868e-24	CXCR4	NK cells	GSE197268_Tisa-cel_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28278
1.62805449689435e-28	0.307695119697361	0.479	0.244	4.05450691906568e-24	BHLHE40	NK cells	GSE197268_Tisa-cel_pre	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28279
1.90366928048099e-28	0.28038311690861	0.332	0.139	4.74089797610985e-24	C1orf162	NK cells	GSE197268_Tisa-cel_pre	ENSG00000143110	128346	chromosome 1 open reading frame 162	MGC24133	protein_coding	Q8NEQ5	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28280
5.17083035768653e-28	0.25011800764075	0.407	0.185	1.28774359227825e-23	SLFN5	NK cells	GSE197268_Tisa-cel_pre	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28281
6.19933556498074e-27	0.275360045814718	0.596	0.331	1.5438825291028e-22	MBP	NK cells	GSE197268_Tisa-cel_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28282
6.42009347799296e-27	-0.302758339114446	0.646	0.933	1.59886007975937e-22	SLC25A5	NK cells	GSE197268_Tisa-cel_pre	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28283
1.14849907195545e-26	0.353588032344648	0.35	0.164	2.86022208879786e-22	SPOCK2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28284
1.54203825955664e-26	-0.34043506496573	0.941	0.994	3.84029208159985e-22	PNRC1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28285
2.77368819620691e-26	-0.281151276221298	0.586	0.881	6.90759308383369e-22	PSAP	NK cells	GSE197268_Tisa-cel_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28286
4.44496297775879e-26	0.272545158725959	0.416	0.203	1.10697357998105e-21	DYNLL1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28287
1.10412858691816e-25	0.268104951367953	0.577	0.325	2.74972183286099e-21	TPST2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000128294	8459	tyrosylprotein sulfotransferase 2	TANGO13B	protein_coding	O60704	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28288
2.78984441258845e-25	0.322157798504857	0.408	0.224	6.94782852511027e-21	RPL36A	NK cells	GSE197268_Tisa-cel_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28289
4.8634484921108e-25	-0.262430719776175	0.509	0.767	1.21119321247527e-20	NDUFB9	NK cells	GSE197268_Tisa-cel_pre	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28290
1.25850196265044e-24	0.270965807672766	0.555	0.316	3.13417328778464e-20	TRAF3IP3	NK cells	GSE197268_Tisa-cel_pre	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28291
2.75542600066623e-24	0.344292298032073	0.811	0.68	6.86211291205918e-20	HOPX	NK cells	GSE197268_Tisa-cel_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28292
3.89244425659452e-24	0.499635093207528	0.537	0.327	9.69374317662299e-20	CCL4	NK cells	GSE197268_Tisa-cel_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28293
5.17654033929648e-24	0.256774167574581	0.527	0.295	1.2891656060984e-19	SEPTIN6	NK cells	GSE197268_Tisa-cel_pre	ENSG00000125354	23157	septin 6	KIAA0128|MGC16619|MGC20339|SEP2|SEPT2|SEPT6	protein_coding	Q14141	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28294
6.42215897528069e-24	0.318511598653508	0.998	1	1.5993744712039e-19	IFITM1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28295
8.30610241510959e-24	0.288767608139605	0.77	0.64	2.06855174545889e-19	ANXA6	NK cells	GSE197268_Tisa-cel_pre	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28296
1.4560289872966e-23	0.263690274693533	0.885	0.982	3.62609458996345e-19	RPL38	NK cells	GSE197268_Tisa-cel_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28297
2.29983860490613e-23	0.324158928435531	0.682	0.482	5.72751806165822e-19	TRBC2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28298
3.617467761416e-23	-0.266108091181733	0.215	0.386	9.00894171303042e-19	HLA-DRB5	NK cells	GSE197268_Tisa-cel_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28299
4.3562985422224e-23	-0.378704897951731	0.716	0.821	1.08489258895507e-18	FGFBP2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28300
7.7238785331323e-23	0.265244190019672	0.465	0.265	1.92355470989127e-18	TAP1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28301
9.96249736348185e-23	0.263135998749775	0.994	0.992	2.48106034340152e-18	CTSW	NK cells	GSE197268_Tisa-cel_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28302
2.08027529401754e-22	0.295515088847845	0.976	0.915	5.18071759222129e-18	PRF1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28303
2.63027396768371e-22	0.286501703916027	0.615	0.382	6.55043428911951e-18	ADGRE5	NK cells	GSE197268_Tisa-cel_pre	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28304
3.15998040334743e-22	-0.25464693445494	1	1	7.86961519649643e-18	ACTB	NK cells	GSE197268_Tisa-cel_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28305
5.63770181387394e-22	0.389850730078383	0.619	0.427	1.40401325972717e-17	CMC1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28306
1.60636605423141e-21	-0.386278447397053	0.967	1	4.00049402145791e-17	BTG1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28307
6.27026168218519e-21	-0.273493803832778	0.965	0.999	1.5615459693314e-16	EEF2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28308
5.11599770897098e-20	0.28518414313954	1	1	1.27408806944213e-15	RPS2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28309
1.05151449210619e-19	0.33017701877432	0.405	0.263	2.61869169114126e-15	LGALS3	NK cells	GSE197268_Tisa-cel_pre	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28310
1.52647598520533e-19	-0.268819496537885	0.58	0.775	3.80153579355535e-15	ARHGDIA	NK cells	GSE197268_Tisa-cel_pre	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28311
1.78644213541791e-19	-0.364072669034209	0.303	0.43	4.44895549404476e-15	CEBPB	NK cells	GSE197268_Tisa-cel_pre	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28312
6.80178042219783e-19	0.260312026334031	0.573	0.4	1.69391539634415e-14	VPS28	NK cells	GSE197268_Tisa-cel_pre	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28313
1.07959774905601e-18	0.256513946881892	0.436	0.289	2.68863023424909e-14	PTGDR	NK cells	GSE197268_Tisa-cel_pre	ENSG00000168229	5729	prostaglandin D2 receptor	DP|DP1|PTGDR1	protein_coding	Q13258	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28314
1.39964260818141e-18	-0.272579923157393	0.917	0.992	3.48566995141499e-14	CD99	NK cells	GSE197268_Tisa-cel_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28315
1.19085420345982e-17	0.255755850494031	0.775	0.761	2.96570330829633e-13	PCED1B-AS1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000247774	100233209	PCED1B antisense RNA 1	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28316
2.15324985713556e-17	-0.259024848680862	0.638	0.855	5.36245344421039e-13	NOP53	NK cells	GSE197268_Tisa-cel_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28317
8.26664558500545e-17	-0.273081934248701	0.892	0.992	2.05872541648976e-12	LAPTM5	NK cells	GSE197268_Tisa-cel_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28318
9.63046193982444e-17	-0.269564168669991	0.859	0.987	2.39837024149388e-12	GNAI2	NK cells	GSE197268_Tisa-cel_pre	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28319
2.86620221232254e-16	-0.254200424586337	0.571	0.785	7.13798998956804e-12	LDHA	NK cells	GSE197268_Tisa-cel_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28320
1.71990069949881e-15	-0.2505487826595	0.602	0.763	4.28324070203183e-11	ATP6V1G1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28321
4.09865912187112e-15	-0.303230290962745	0.573	0.661	1.02073006771078e-10	KLRB1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28322
6.94521895708034e-15	-0.290516749588835	0.765	0.957	1.72963732907129e-10	RBM39	NK cells	GSE197268_Tisa-cel_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28323
2.50099375609149e-13	0.267813488653301	0.447	0.299	6.22847485017023e-09	KLRC1	NK cells	GSE197268_Tisa-cel_pre	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28324
6.08748209688555e-12	-0.271325834773959	0.47	0.571	1.51602654140838e-07	SFPQ	NK cells	GSE197268_Tisa-cel_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28325
2.61275089351194e-10	-0.252427988948983	0.477	0.553	6.50679482520214e-06	HNRNPL	NK cells	GSE197268_Tisa-cel_pre	ENSG00000282947	3191	heterogeneous nuclear ribonucleoprotein L	HNRPL	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28326
6.35006053946539e-09	0.358946393081984	0.695	0.841	0.000158141907674846	IFITM3	NK cells	GSE197268_Tisa-cel_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28327
8.44530237433717e-09	-0.251438304673209	0.456	0.505	0.000210321810330493	HNRNPA0	NK cells	GSE197268_Tisa-cel_pre	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28328
0	-0.465464540381213	0.07	0.503	0	S100A9	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28329
0	1.67058550507599	0.745	0.012	0	AL365357.1	CD4+ T cells	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28330
0	-0.536104392600529	0.136	0.718	0	GNLY	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28331
0	-1.73591611723102	0.147	0.87	0	RPL13P12	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000215030	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28332
0	-1.78456684902512	0.166	0.96	0	RPS4Y1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28333
0	-0.426737414393628	0.059	0.438	0	S100A8	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28334
9.74876782207329e-281	-0.404528761480991	0.052	0.394	2.42783313840913e-276	TYROBP	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28335
4.2512927420287e-276	-0.37343333766879	0.045	0.368	1.05874194447483e-271	LYZ	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28336
6.50734499775909e-258	0.918314366077541	0.993	0.993	1.62058919824192e-253	RPS26	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28337
8.26154377221787e-247	0.955277851441617	0.535	0.013	2.05745486103314e-242	AL591846.2	CD4+ T cells	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28338
9.68878907840083e-240	0.969014145854658	0.623	0.091	2.41289603208494e-235	HLA-H	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000231904	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28339
2.96798474683365e-236	-0.372226400207482	0.043	0.333	7.39146921351452e-232	GZMB	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28340
9.47066822892318e-228	-0.321861574088419	0.031	0.288	2.35857521573103e-223	CST3	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28341
1.38144351657325e-206	-0.397234835831708	0.159	0.576	3.44034693367403e-202	HLA-DRA	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28342
2.53270306427459e-197	-0.313477001617504	0.296	0.798	6.30744371126944e-193	NKG7	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28343
3.56034489287833e-191	0.639120199922806	1	1	8.86668292122419e-187	MT-ATP6	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28344
1.31493933345486e-162	0.482744180493668	1	1	3.27472491603599e-158	RPS4X	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28345
1.51284090088892e-159	-0.346225528025106	0.331	0.818	3.76757897957375e-155	CCL5	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28346
2.36250863872453e-159	0.623989096355729	0.385	0.003	5.88359151387958e-155	RPS14P8	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000239528	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28347
2.0819830596903e-137	-0.283876744861991	0.239	0.647	5.18497061185273e-133	GZMA	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28348
3.5220241542446e-132	-0.265511242846352	0.25	0.651	8.77124895373075e-128	HLA-DRB1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28349
2.37658730095617e-114	-0.310944104030666	1	1	5.91865301430124e-110	RPS14	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28350
6.53101087250229e-109	-0.485452366290987	0.103	0.325	1.62648294768797e-104	HBB	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28351
8.25435928211997e-107	0.468045543895266	0.461	0.116	2.05566563561916e-102	AC243919.1	CD4+ T cells	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28352
5.645370838251e-93	0.347126141428879	1	1	1.40592315355803e-88	RPL6	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28353
1.08746482047195e-88	0.384211139840067	1	1	2.70822238890334e-84	MT-CO1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28354
2.50208548515669e-85	0.520179702847479	0.491	0.183	6.23119369223421e-81	SOCS3	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28355
8.53794319494575e-85	0.431374930450301	0.699	0.323	2.12628937326929e-80	SMDT1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28356
5.25339279178007e-84	0.482336889919106	0.998	0.987	1.30830494086491e-79	IL32	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28357
1.12254136419203e-82	0.301825338771483	1	1	2.79557701338384e-78	RPS18	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28358
7.1284691061152e-79	-0.361468166635785	0.295	0.564	1.77527394618693e-74	EFHD2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28359
9.65568692633521e-76	0.31032525197424	1	0.999	2.40465227213452e-71	TMSB4X	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28360
2.8600628999012e-75	0.447959057796229	0.741	0.477	7.12270064591396e-71	UBALD2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28361
1.61833738167713e-73	0.498080097755487	0.574	0.269	4.03030741532871e-69	GIMAP7	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28362
1.32959239872989e-71	-0.622194597502637	0.659	0.83	3.31121690979691e-67	JUND	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28363
6.07709088661464e-71	0.392013562749115	0.542	0.234	1.51343871440251e-66	EIF2S3	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000130741	1968	eukaryotic translation initiation factor 2 subunit gamma	EIF2|EIF2G|EIF2gamma	protein_coding	P41091	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28364
4.56047387066644e-69	0.422528955056008	0.971	0.956	1.13574041275077e-64	RPL23A	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28365
6.49565980855881e-68	0.353849534161078	0.351	0.097	1.61767911872349e-63	CAPG	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28366
2.64299486538442e-67	-0.355539001219643	0.994	0.999	6.58211441275335e-63	FTL	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28367
8.20258638293712e-67	0.394493654957405	0.631	0.302	2.04277211280666e-62	RIPOR2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28368
8.83645095546933e-67	0.510505314107367	0.988	0.935	2.20062974595008e-62	LTB	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28369
1.20374031891143e-66	0.346366291331361	0.411	0.145	2.99779489021703e-62	OXNAD1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000154814	92106	oxidoreductase NAD binding domain containing 1	MGC15763	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28370
2.11044286263497e-66	0.290844874517727	1	1	5.25584690510612e-62	RPS2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28371
1.40278591184427e-65	0.316285099539872	0.364	0.107	3.49349803485697e-61	SRM	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28372
1.61578982340914e-64	0.310084489402199	0.37	0.113	4.02396297621812e-60	GRK6	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000198055	2870	G protein-coupled receptor kinase 6	GPRK6	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28373
7.05094323804661e-64	0.290637172829632	0.445	0.159	1.75596690400313e-59	MAP2K2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000126934	5605	mitogen-activated protein kinase kinase 2	MEK2|PRKMK2	protein_coding	P36507	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28374
1.07401918686772e-62	-0.306813148724871	0.325	0.595	2.67473738297536e-58	CST7	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28375
1.08649510816045e-62	-0.390086456805148	0.973	0.99	2.7058074173628e-58	RPS2P5	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000240342	NA	NA	bcm384	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28376
2.48818162981276e-61	-0.25165754537945	0.848	0.985	6.19656753088569e-57	CD74	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28377
4.13006002036034e-61	0.298080516495762	1	1	1.02855014747054e-56	MT-CYB	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28378
4.57543396703846e-61	0.350708793386732	0.558	0.257	1.13946607515126e-56	FAM107B	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28379
8.92109878379197e-61	0.299512650953025	0.274	0.06	2.22171044111555e-56	NPEPPS	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000141279	9520	aminopeptidase puromycin sensitive	MP100|PSA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28380
3.88762790665154e-60	0.301197996230101	1	1	9.68174853872498e-56	RPS6	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28381
3.43016406738791e-59	-0.269445329069626	1	1	8.54248059342286e-55	HLA-B	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28382
7.18998537788273e-58	0.289297288567785	0.348	0.11	1.79059395850791e-53	NCK2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000071051	8440	NCK adaptor protein 2	NCKbeta	protein_coding	O43639	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28383
1.77493194609414e-57	0.312898915467465	0.44	0.18	4.42029051855285e-53	MDFIC	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000135272	29969	MyoD family inhibitor domain containing	HIC|MDFIC1	protein_coding	Q9P1T7	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28384
1.15382471884066e-56	0.434557158968215	0.713	0.411	2.87348507980077e-52	RPL36A	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28385
1.24459755798058e-56	0.397638300434373	0.392	0.154	3.09954575839484e-52	MYC	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28386
3.28042052323697e-55	-0.386002091729298	0.474	0.683	8.16955927106934e-51	GSTP1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28387
9.0866120922595e-54	0.310102799531816	0.527	0.25	2.26292987545631e-49	TRADD	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000102871	8717	TNFRSF1A associated via death domain	Hs.89862	protein_coding	Q15628	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28388
1.69648087177066e-53	0.279899831986371	0.311	0.093	4.22491596305766e-49	PPP1R14B	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28389
2.44945018408737e-53	0.357143083282337	0.294	0.088	6.10011073845119e-49	CISH	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000114737	1154	cytokine inducible SH2 containing protein	CIS|CIS-1|G18|SOCS	protein_coding	Q9NSE2	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28390
2.90943500984847e-53	0.340937853019288	0.582	0.297	7.24565694852662e-49	RPL22	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28391
1.05890771445057e-52	0.295912011695168	0.53	0.248	2.63710377206771e-48	ABRACL	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28392
3.35329557544653e-52	0.325562096598663	0.564	0.285	8.35104730109204e-48	PRMT2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28393
1.09730248958843e-51	-0.393356673899518	0.702	0.906	2.73272212007102e-47	DUSP1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28394
1.47913261442396e-51	0.367673616044261	0.959	0.956	3.68363186296143e-47	RPL26	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28395
2.64906679691732e-51	0.29213167664758	0.482	0.214	6.59723595104289e-47	ITGB7	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000139626	3695	integrin subunit beta 7	NA	protein_coding	P26010	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28396
1.40444762622655e-50	0.273075545869919	0.291	0.087	3.4976363683546e-46	PHACTR2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000112419	9749	phosphatase and actin regulator 2	C6orf56|KIAA0680	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28397
1.9903151959594e-50	0.256871025830551	0.262	0.068	4.95668096401729e-46	BTN3A2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28398
1.05925047405904e-49	0.338310292249681	0.393	0.162	2.63795738059663e-45	GIMAP4	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28399
2.09973602746203e-49	0.396466133985732	0.646	0.386	5.22918260279144e-45	PIM1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28400
1.62972534475275e-47	-0.299674760610086	0.109	0.256	4.05866799857226e-43	HLA-DRB5	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28401
2.24400098983001e-47	-0.327503912414457	0.611	0.843	5.58846006507266e-43	JUN	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28402
2.26923039595384e-47	-0.389673212052501	0.747	0.887	5.65129137808343e-43	TGFB1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28403
3.36419469363032e-47	0.305553026906343	0.622	0.346	8.37819046501694e-43	SNHG5	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28404
3.9756937987193e-47	0.283627526083554	0.404	0.176	9.90106783633055e-43	AL450405.1	CD4+ T cells	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28405
5.39082070670058e-47	0.26263984397205	0.451	0.206	1.34252998879671e-42	TMEM238	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000233493	388564	transmembrane protein 238	NA	protein_coding	C9JI98	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28406
1.0038729822414e-46	0.255427422942664	0.999	0.999	2.50004527497398e-42	RPL21	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28407
2.31956826225895e-46	0.31140009082812	0.36	0.148	5.77665280032968e-42	GPR183	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28408
4.74753509736227e-46	0.279516147162367	0.351	0.142	1.1823261406471e-41	RPS10	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28409
2.33978862563005e-45	0.262549571699396	0.435	0.2	5.82700959326907e-41	TNFAIP8	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000145779	25816	TNF alpha induced protein 8	GG2-1|MDC-3.13|SCC-S2	protein_coding	O95379	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28410
4.15309372214573e-45	0.292677084265126	0.348	0.142	1.03428646056317e-40	SOCS1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000185338	8651	suppressor of cytokine signaling 1	Cish1|JAB|SOCS-1|SSI-1|TIP3	protein_coding	O15524	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28411
4.18895980947164e-45	0.316626762071051	0.431	0.198	1.04321855095082e-40	ITM2A	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28412
5.19442125481148e-45	0.255203684805959	0.361	0.143	1.29361866929825e-40	PIP4K2A	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000150867	5305	phosphatidylinositol-5-phosphate 4-kinase type 2 alpha	PIP5K2A|PIP5KIIA|PIP5KIIalpha	protein_coding	P48426	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28413
6.13327454156343e-45	0.255202260653807	0.319	0.113	1.52743069183096e-40	DYNLL1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28414
1.12956475067427e-43	-0.317204935624908	0.686	0.889	2.81306805507921e-39	ITGB2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28415
1.71944119609385e-43	-0.369343206776472	0.999	0.999	4.28209635475213e-39	FTH1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28416
4.17554096879555e-43	0.33939436163886	0.454	0.229	1.03987672286884e-38	AQP3	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28417
7.08615329515191e-43	0.304564265133058	0.94	0.904	1.76473561662463e-38	GSTK1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000197448	373156	glutathione S-transferase kappa 1	GST13	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28418
7.35090135018932e-43	-0.373225378910385	0.946	0.996	1.83066847225115e-38	ZFP36L2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28419
1.18844325554703e-42	-0.370147936936587	0.474	0.666	2.95969908361433e-38	CTSW	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28420
1.34284448326519e-42	0.300520517245379	0.52	0.284	3.34421990112362e-38	BCL2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000171791	596	BCL2 apoptosis regulator	Bcl-2|PPP1R50	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28421
5.55991118079865e-42	0.264574348798682	0.587	0.312	1.3846402804661e-37	VPS28	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28422
1.14016842034052e-41	0.260655332209905	0.552	0.294	2.83947543401604e-37	ADD3	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000148700	120	adducin 3	ADDL	protein_coding	Q9UEY8	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28423
2.23483709979529e-41	0.266156904524351	0.384	0.17	5.56563831333019e-37	SLFN5	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28424
5.97120928676756e-41	-0.269495239965865	0.258	0.435	1.48706996077659e-36	CTSS	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28425
2.31748828382969e-40	0.299079542010841	0.564	0.31	5.77147282204946e-36	CD2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28426
3.76075033885673e-39	0.261285387142436	0.434	0.21	9.36577264388881e-35	ERN1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000178607	2081	endoplasmic reticulum to nucleus signaling 1	IRE1|IRE1P	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28427
6.14561789478164e-39	-0.274516505547342	1	1	1.53050468051642e-34	EIF1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28428
9.46225554398512e-38	0.266346077392928	0.674	0.404	2.35648012067405e-33	EIF4A2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28429
5.01717298460083e-37	0.270261100567089	0.426	0.215	1.24947676008499e-32	NFKBIZ	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28430
5.2902541484993e-37	0.270425994629897	0.466	0.247	1.31748489314226e-32	AC024293.1	CD4+ T cells	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28431
5.94288936681947e-37	-0.27195878429547	0.542	0.743	1.48001716791272e-32	SAT1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28432
1.17735599868957e-36	0.332886362722427	0.986	0.991	2.9320873791365e-32	RPS29	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28433
1.22865851413232e-36	0.307219915967816	0.627	0.393	3.05985116359514e-32	MAL	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000172005	4118	mal, T cell differentiation protein	MVP17|VIP17	protein_coding	P21145	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28434
1.59151104250644e-36	0.275831452096583	0.996	0.998	3.96349910025803e-32	EEF1B2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28435
3.95511111709167e-36	0.302428131640385	0.904	0.811	9.8498087260051e-32	PCED1B-AS1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000247774	100233209	PCED1B antisense RNA 1	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28436
1.02132461438001e-35	0.268055411986976	0.529	0.301	2.54350681965199e-31	PIM2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28437
1.03472768047502e-35	0.267977444368117	0.998	0.999	2.57688581545499e-31	MT-ND4	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28438
1.22270345755453e-35	0.259914738992128	0.651	0.401	3.04502069069379e-31	ARHGAP15	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000075884	55843	Rho GTPase activating protein 15	BM046	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28439
5.25003223497254e-35	0.255910811088469	0.55	0.322	1.30746802779756e-30	RHOH	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28440
3.16562152469562e-32	0.309936964848695	0.6	0.362	7.88366384510198e-28	ITGB1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28441
3.30496055338641e-32	-0.265212929369975	0.378	0.558	8.23067376215351e-28	DUSP2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28442
1.12980682909155e-31	0.283377168795825	0.396	0.208	2.81367092716959e-27	TRBC1	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28443
1.42623620960586e-31	0.271899976964745	0.638	0.424	3.55189865640243e-27	TCF7	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28444
1.82274987807827e-31	0.251009201221238	0.942	0.938	4.53937629636612e-27	RPL7	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28445
3.13053004036965e-31	0.25034568009437	0.523	0.301	7.79627201253657e-27	SLC2A3	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28446
2.84249431709091e-30	0.28196944122692	0.317	0.156	7.07894784728321e-26	TNFRSF4	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000186827	7293	TNF receptor superfamily member 4	ACT35|CD134|OX40|TXGP1L	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28447
8.80995892166882e-29	0.274653235617239	0.482	0.285	2.1940321698524e-24	SELL	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28448
1.90920307236424e-28	0.304797260711252	0.737	0.525	4.7546793314159e-24	NOSIP	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28449
5.11804597257457e-28	-0.289416746038915	0.971	0.99	1.27459816900997e-23	KLF2	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28450
8.261581076265e-28	0.31236014286895	0.307	0.153	2.05746415123304e-23	LGALS3	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28451
2.27447536587829e-27	-0.278211054329244	0.543	0.678	5.66435345118329e-23	LITAF	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28452
2.5888308683118e-26	0.316476496293838	0.883	0.77	6.44722439444371e-22	IL7R	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28453
2.93259260372433e-26	0.374822136979492	0.78	0.649	7.30332862031508e-22	CD69	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28454
1.9801765433591e-22	-0.283335531054069	0.985	0.994	4.93143166358149e-18	SARAF	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28455
1.50572245946194e-19	-0.329774412985248	0.822	0.941	3.74985121304403e-15	SRGN	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28456
1.60167219959749e-17	-0.253582309112959	0.641	0.7	3.9888044458776e-13	GYPC	CD4+ T cells	GSE197268_Tisa-cel_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28457
3.14769632446552e-14	0.358280534488479	0.404	0.277	7.83902292644894e-10	AL138963.4	CD4+ T cells	GSE197268_Tisa-cel_pre	NA	NA	NA	NA	NA	NA	GSE197268_Tisa-cel	GSE197268	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	pre	tisa-cel (CAR-T)	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 2); post (resistant 8, sensitive 5)	19	157733	Public on Jul 13, 2022	36097221	This dataset has 13 patients, 6 of whom has both pre- and post-treatment samples.	phs002922.v1.p1	10x genomics	CellRanger 6.0.1	Acute_lymphoblastic_leukemia	Immunotherapy	28458
0	0.823593998737954	0.761	0.415	0	ENO1	CD4+ T cells	GSE199333_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28459
0	-0.590761395692506	0.715	0.877	0	SRRM1	CD4+ T cells	GSE199333_post	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28460
0	0.649759249775579	0.979	0.937	0	SH3BGRL3	CD4+ T cells	GSE199333_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28461
0	0.941862142340825	0.973	0.837	0	CD52	CD4+ T cells	GSE199333_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28462
0	0.698858149319158	0.675	0.343	0	LCK	CD4+ T cells	GSE199333_post	ENSG00000182866	3932	LCK proto-oncogene, Src family tyrosine kinase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28463
0	-0.712911034840048	0.587	0.837	0	SFPQ	CD4+ T cells	GSE199333_post	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28464
0	0.577398257399189	0.537	0.239	0	CD53	CD4+ T cells	GSE199333_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28465
0	0.862749710854458	0.819	0.568	0	S100A10	CD4+ T cells	GSE199333_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28466
0	0.860532830919188	0.441	0.132	0	S100A11	CD4+ T cells	GSE199333_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28467
0	0.767849515948558	0.95	0.855	0	S100A6	CD4+ T cells	GSE199333_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28468
0	-0.795213922498399	0.312	0.633	0	PFDN2	CD4+ T cells	GSE199333_post	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28469
0	0.792181459110722	0.533	0.219	0	SELL	CD4+ T cells	GSE199333_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28470
0	-0.771802694401827	0.763	0.93	0	PRRC2C	CD4+ T cells	GSE199333_post	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28471
0	0.69871762854686	0.537	0.158	0	ARPC5	CD4+ T cells	GSE199333_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28472
0	0.765040984116456	0.932	0.77	0	PTPRC	CD4+ T cells	GSE199333_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28473
0	0.787457282001467	0.669	0.277	0	TRAF3IP3	CD4+ T cells	GSE199333_post	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28474
0	-0.981234466862446	0.293	0.716	0	ODC1	CD4+ T cells	GSE199333_post	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28475
0	0.964273055868007	1	0.999	0	TMSB10	CD4+ T cells	GSE199333_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28476
0	0.55979979261475	0.574	0.273	0	VAMP8	CD4+ T cells	GSE199333_post	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28477
0	-0.82150459685208	0.204	0.635	0	ARID5A	CD4+ T cells	GSE199333_post	ENSG00000196843	10865	AT-rich interaction domain 5A	MRF-1|RP11-363D14	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28478
0	-0.679203364124518	0.301	0.634	0	CIR1	CD4+ T cells	GSE199333_post	ENSG00000138433	9541	corepressor interacting with RBPJ, CIR1	CIR	protein_coding	Q86X95	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28479
0	0.578096207945922	0.338	0.101	0	STAT1	CD4+ T cells	GSE199333_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28480
0	0.350128110187463	0.253	0.038	0	NDUFAF3	CD4+ T cells	GSE199333_post	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28481
0	-0.95528498379941	0.534	0.821	0	HMGB2	CD4+ T cells	GSE199333_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28482
0	0.99444443259929	0.849	0.718	0	IL7R	CD4+ T cells	GSE199333_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28483
0	0.735160712132472	0.463	0.086	0	ANXA6	CD4+ T cells	GSE199333_post	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28484
0	0.628254202859119	0.627	0.295	0	ATP6V0E1	CD4+ T cells	GSE199333_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28485
0	1.03462248932822	0.688	0.236	0	RIPOR2	CD4+ T cells	GSE199333_post	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28486
0	0.434749831687936	0.351	0.104	0	BTN3A2	CD4+ T cells	GSE199333_post	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28487
0	0.38165507414126	0.278	0.059	0	PPP1R18	CD4+ T cells	GSE199333_post	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28488
0	-0.459510290356058	0.998	0.999	0	HLA-C	CD4+ T cells	GSE199333_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28489
0	-0.474134724901298	1	1	0	HLA-B	CD4+ T cells	GSE199333_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28490
0	0.759294024345383	0.6	0.308	0	CLIC1	CD4+ T cells	GSE199333_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28491
0	0.626123130839851	0.548	0.243	0	PSMB9	CD4+ T cells	GSE199333_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28492
0	0.408269181100845	1	1	0	RPS18	CD4+ T cells	GSE199333_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28493
0	-0.646655073892585	0.884	0.964	0	PNRC1	CD4+ T cells	GSE199333_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28494
0	1.04475283524623	0.999	0.986	0	ACTB	CD4+ T cells	GSE199333_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28495
0	-0.679773463342316	0.4	0.701	0	STK17A	CD4+ T cells	GSE199333_post	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28496
0	0.538185967025522	0.948	0.835	0	PPIA	CD4+ T cells	GSE199333_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28497
0	-0.624053787401747	0.552	0.793	0	FAM133B	CD4+ T cells	GSE199333_post	ENSG00000234545	257415	family with sequence similarity 133 member B	MGC40405	protein_coding	Q5BKY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28498
0	1.04289005081962	0.727	0.277	0	ARPC1B	CD4+ T cells	GSE199333_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28499
0	0.430958309534733	0.365	0.108	0	TSC22D4	CD4+ T cells	GSE199333_post	ENSG00000166925	81628	TSC22 domain family member 4	THG-1|TILZ2	protein_coding	Q9Y3Q8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28500
0	0.618913348233924	0.446	0.107	0	GIMAP4	CD4+ T cells	GSE199333_post	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28501
0	0.987194076939661	1	1	0	TMSB4X	CD4+ T cells	GSE199333_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28502
0	0.63138773275014	0.598	0.285	0	IL2RG	CD4+ T cells	GSE199333_post	ENSG00000147168	3561	interleukin 2 receptor subunit gamma	CD132|CIDX|IMD4|SCIDX1	protein_coding	P31785	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28503
0	-0.618036307813331	0.984	0.997	0	SARAF	CD4+ T cells	GSE199333_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28504
0	-0.547084019307649	0.987	0.997	0	PABPC1	CD4+ T cells	GSE199333_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28505
0	0.490163909470334	0.405	0.138	0	LINC00861	CD4+ T cells	GSE199333_post	ENSG00000245164	100130231	long intergenic non-protein coding RNA 861	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28506
0	-0.822097503059556	0.476	0.766	0	HSPA5	CD4+ T cells	GSE199333_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28507
0	0.543969028320085	0.439	0.116	0	TALDO1	CD4+ T cells	GSE199333_post	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28508
0	1.37628117224327	0.994	0.871	0	HBB	CD4+ T cells	GSE199333_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28509
0	1.66323157607507	0.587	0.012	0	HBG2	CD4+ T cells	GSE199333_post	ENSG00000196565	3048	hemoglobin subunit gamma 2	HBG-T1	protein_coding	P69892	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28510
0	-1.26530888148663	0.997	1	0	FTH1	CD4+ T cells	GSE199333_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28511
0	-0.561771176835918	0.9	0.967	0	SF1	CD4+ T cells	GSE199333_post	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28512
0	-0.388636435077871	1	1	0	MALAT1	CD4+ T cells	GSE199333_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28513
0	0.764204733434202	0.977	0.892	0	CFL1	CD4+ T cells	GSE199333_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28514
0	0.6324412936429	0.545	0.2	0	PPP1CA	CD4+ T cells	GSE199333_post	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28515
0	1.0764411124278	0.618	0.123	0	UCP2	CD4+ T cells	GSE199333_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28516
0	0.866590979721732	0.911	0.673	0	CD3D	CD4+ T cells	GSE199333_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28517
0	0.787284051582013	0.827	0.547	0	CD3G	CD4+ T cells	GSE199333_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28518
0	0.71198149374175	0.882	0.705	0	HSPA8	CD4+ T cells	GSE199333_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28519
0	0.681792163415455	0.761	0.501	0	ETS1	CD4+ T cells	GSE199333_post	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28520
0	0.729575854436218	0.984	0.913	0	VIM	CD4+ T cells	GSE199333_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28521
0	-0.664185826366939	0.533	0.797	0	HNRNPH3	CD4+ T cells	GSE199333_post	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28522
0	0.639527382361856	0.532	0.228	0	CD27	CD4+ T cells	GSE199333_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28523
0	0.625493624076901	0.548	0.229	0	TPI1	CD4+ T cells	GSE199333_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28524
0	0.541066041051509	0.403	0.095	0	M6PR	CD4+ T cells	GSE199333_post	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28525
0	-0.911071760412023	1	0.999	0	RPS26	CD4+ T cells	GSE199333_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28526
0	0.666790670778564	0.955	0.822	0	MYL6	CD4+ T cells	GSE199333_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28527
0	-0.822394060268407	0.988	0.999	0	BTG1	CD4+ T cells	GSE199333_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28528
0	0.596751093568789	0.904	0.741	0	ARPC3	CD4+ T cells	GSE199333_post	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28529
0	-0.69701888076766	0.386	0.682	0	RSRC2	CD4+ T cells	GSE199333_post	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28530
0	1.16188028382355	0.893	0.603	0	TRAC	CD4+ T cells	GSE199333_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28531
0	0.646180178102842	0.562	0.207	0	DAD1	CD4+ T cells	GSE199333_post	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28532
0	0.709928466188168	0.627	0.325	0	PSME2	CD4+ T cells	GSE199333_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28533
0	-0.672820235152197	0.233	0.554	0	FAM177A1	CD4+ T cells	GSE199333_post	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28534
0	-1.12842709910029	0.468	0.815	0	NFKBIA	CD4+ T cells	GSE199333_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28535
0	0.507015169767667	0.292	0.041	0	PTGER2	CD4+ T cells	GSE199333_post	ENSG00000125384	5732	prostaglandin E receptor 2	EP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28536
0	-0.87726866053889	0.645	0.89	0	DDX24	CD4+ T cells	GSE199333_post	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28537
0	0.983781028390255	0.872	0.56	0	EVL	CD4+ T cells	GSE199333_post	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28538
0	0.488787393545543	1	1	0	B2M	CD4+ T cells	GSE199333_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28539
0	-0.329785770016299	1	1	0	RPLP1	CD4+ T cells	GSE199333_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28540
0	-1.0197476131418	0.196	0.685	0	WHAMM	CD4+ T cells	GSE199333_post	ENSG00000156232	123720	WASP homolog associated with actin, golgi membranes and microtubules	KIAA1971|WHAMM1|WHDC1	protein_coding	Q8TF30	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28541
0	1.78093368618577	0.985	0.792	0	HBA2	CD4+ T cells	GSE199333_post	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28542
0	1.48822183794258	0.958	0.675	0	HBA1	CD4+ T cells	GSE199333_post	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28543
0	1.89805192765552	0.951	0.586	0	IL32	CD4+ T cells	GSE199333_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28544
0	0.761517983231925	0.926	0.754	0	CORO1A	CD4+ T cells	GSE199333_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28545
0	-0.717789410842224	0.836	0.953	0	FUS	CD4+ T cells	GSE199333_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28546
0	0.80737011702649	0.908	0.708	0	CYBA	CD4+ T cells	GSE199333_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28547
0	0.855341095691197	0.973	0.867	0	PFN1	CD4+ T cells	GSE199333_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28548
0	-0.771431253679579	0.736	0.9	0	EIF5A	CD4+ T cells	GSE199333_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28549
0	-0.915284701296672	0.797	0.926	0	VAMP2	CD4+ T cells	GSE199333_post	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28550
0	-1.06576101380704	1	1	0	EIF1	CD4+ T cells	GSE199333_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28551
0	-0.579310409621572	0.998	1	0	H3F3B	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28552
0	0.804583928023482	0.988	0.935	0	ACTG1	CD4+ T cells	GSE199333_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28553
0	1.4739571109188	0.947	0.618	0	MYL12A	CD4+ T cells	GSE199333_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28554
0	-0.709745372174207	0.442	0.757	0	RNMT	CD4+ T cells	GSE199333_post	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28555
0	-0.823409810285833	0.346	0.672	0	RNF125	CD4+ T cells	GSE199333_post	ENSG00000101695	54941	ring finger protein 125	FLJ20456	protein_coding	Q96EQ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28556
0	0.689053470380403	0.555	0.248	0	BCL2	CD4+ T cells	GSE199333_post	ENSG00000171791	596	BCL2 apoptosis regulator	Bcl-2|PPP1R50	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28557
0	-0.768557160020743	0.81	0.949	0	RBM39	CD4+ T cells	GSE199333_post	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28558
0	0.640300906957876	0.592	0.275	0	SAMHD1	CD4+ T cells	GSE199333_post	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28559
0	-0.774742715092145	0.433	0.768	0	RBM38	CD4+ T cells	GSE199333_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28560
0	0.522051676168793	0.995	0.97	0	ATP5F1E	CD4+ T cells	GSE199333_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28561
0	-0.751108413079019	0.914	0.99	0	CIRBP	CD4+ T cells	GSE199333_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28562
0	0.948952848104131	0.91	0.608	0	OAZ1	CD4+ T cells	GSE199333_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28563
0	0.581558536746662	0.971	0.856	0	KLF2	CD4+ T cells	GSE199333_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28564
0	-0.656567605229176	0.077	0.451	0	RELB	CD4+ T cells	GSE199333_post	ENSG00000104856	5971	RELB proto-oncogene, NF-kB subunit	REL-B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28565
0	0.423765720615676	0.346	0.091	0	PRMT1	CD4+ T cells	GSE199333_post	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28566
0	-0.691406235276783	0.625	0.853	0	PIK3IP1	CD4+ T cells	GSE199333_post	ENSG00000100100	113791	phosphoinositide-3-kinase interacting protein 1	HGFL|MGC17330|TrIP	protein_coding	Q96FE7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28567
0	1.19054766104703	0.793	0.304	0	RAC2	CD4+ T cells	GSE199333_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28568
0	-0.613576055859159	0.446	0.723	0	SMDT1	CD4+ T cells	GSE199333_post	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28569
0	0.598306055449822	0.502	0.193	0	CSTB	CD4+ T cells	GSE199333_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28570
0	0.430710948210254	1	1	0	MT-ATP6	CD4+ T cells	GSE199333_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28571
0	0.48914840581554	1	1	0	MT-ND4	CD4+ T cells	GSE199333_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28572
0	0.663490750425987	0.997	0.992	0	MT-ND5	CD4+ T cells	GSE199333_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28573
2.3721228006603e-304	0.818075686694252	0.972	0.917	5.03625391808189e-300	LTB	CD4+ T cells	GSE199333_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28574
1.5278587533077e-303	0.404749223620048	0.348	0.106	3.24379691914758e-299	GIMAP1	CD4+ T cells	GSE199333_post	ENSG00000213203	170575	GTPase, IMAP family member 1	HIMAP1|IAN2|IMAP1|IMAP38	protein_coding	Q8WWP7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28575
1.59568104450511e-303	0.399491587776339	0.264	0.057	3.3877904255888e-299	SPN	CD4+ T cells	GSE199333_post	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28576
3.24579752862166e-301	0.638887679340152	0.712	0.455	6.89115273301664e-297	DDX17	CD4+ T cells	GSE199333_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28577
6.67510613729817e-300	-0.566187668896116	0.347	0.64	1.41719178400978e-295	PSMD7	CD4+ T cells	GSE199333_post	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28578
2.35417007099327e-299	-0.615783958949589	0.473	0.725	4.99813847772581e-295	EPC1	CD4+ T cells	GSE199333_post	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28579
3.38189895069334e-299	-0.58036250694962	0.739	0.88	7.18010966221702e-295	SNHG8	CD4+ T cells	GSE199333_post	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28580
1.19420215842372e-298	-0.60681558851004	0.609	0.812	2.53541060254939e-294	DDX6	CD4+ T cells	GSE199333_post	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28581
3.04202054543353e-298	-0.514752020001728	0.811	0.921	6.45851382000993e-294	RBM3	CD4+ T cells	GSE199333_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28582
8.80409439297446e-298	0.508842477943383	0.488	0.216	1.86919728057241e-293	ABRACL	CD4+ T cells	GSE199333_post	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28583
4.71339229364267e-297	-0.672209624652955	0.979	0.996	1.00070031786328e-292	UBC	CD4+ T cells	GSE199333_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28584
3.68282667660306e-296	0.530927620012704	0.594	0.316	7.81900931709596e-292	NEDD8	CD4+ T cells	GSE199333_post	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28585
2.30000703421011e-295	-0.571767294391955	0.614	0.806	4.88314493433149e-291	MORF4L1	CD4+ T cells	GSE199333_post	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28586
2.4068680983354e-293	0.673691578741288	0.725	0.49	5.11002165957588e-289	NOSIP	CD4+ T cells	GSE199333_post	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28587
4.74653059571915e-293	0.539934288935866	0.61	0.334	1.00773591077713e-288	PRDX2	CD4+ T cells	GSE199333_post	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28588
7.61245543859102e-293	-0.796943267806278	0.564	0.761	1.61620041416726e-288	PIK3R1	CD4+ T cells	GSE199333_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28589
8.65728657813204e-293	0.377294215427044	0.296	0.078	1.83802851340321e-288	GSTO1	CD4+ T cells	GSE199333_post	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28590
8.43368363297332e-292	-0.591063304567706	0.272	0.568	1.79055537211657e-287	CENPC	CD4+ T cells	GSE199333_post	ENSG00000145241	1060	centromere protein C	CENP-C|CENPC1|hcp-4|MIF2	protein_coding	Q03188	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28591
1.35500794840206e-289	0.444518051401794	0.986	0.952	2.87681737525242e-285	SERF2	CD4+ T cells	GSE199333_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28592
3.51933850402185e-289	0.388743159175221	0.323	0.095	7.4719075778888e-285	OSTF1	CD4+ T cells	GSE199333_post	ENSG00000134996	26578	osteoclast stimulating factor 1	bA235O14.1|OSF|SH3P2	protein_coding	Q92882	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28593
8.23382921183538e-288	-0.633668722856509	0.301	0.593	1.74812427996477e-283	REL	CD4+ T cells	GSE199333_post	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28594
5.9843414765904e-287	-0.566724907155276	0.316	0.605	1.27053553889491e-282	HSPA9	CD4+ T cells	GSE199333_post	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28595
5.32499775139039e-286	-0.523240354621615	0.131	0.418	1.13055027259769e-281	NFKB2	CD4+ T cells	GSE199333_post	ENSG00000077150	4791	nuclear factor kappa B subunit 2	LYT-10|NF-kB2|p105|p49/p100|p52	protein_coding	Q00653	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28596
4.74240054487509e-285	0.365004576294603	0.278	0.07	1.00685905968243e-280	SELPLG	CD4+ T cells	GSE199333_post	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28597
2.48095750898148e-284	0.448895119432837	0.358	0.119	5.26732088731858e-280	ANXA5	CD4+ T cells	GSE199333_post	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28598
2.70307827836226e-284	0.486860413709081	0.97	0.917	5.73890549279092e-280	LDHB	CD4+ T cells	GSE199333_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28599
4.80332582467164e-282	-0.54859903836129	0.57	0.796	1.01979410583604e-277	SF3B1	CD4+ T cells	GSE199333_post	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28600
8.32773529076261e-279	0.512456805008953	0.562	0.29	1.76806147958181e-274	XRCC5	CD4+ T cells	GSE199333_post	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28601
1.40549638180259e-277	-0.499651079046353	0.129	0.413	2.98400936820508e-273	RHBDD2	CD4+ T cells	GSE199333_post	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28602
1.39918026591633e-275	0.497746392762948	0.839	0.625	2.97059962256696e-271	COX6B1	CD4+ T cells	GSE199333_post	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28603
3.64098292108069e-275	-0.573013481651012	0.312	0.592	7.73017083974642e-271	SDCBP	CD4+ T cells	GSE199333_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28604
8.62630215178199e-271	0.422535871905914	1	1	1.83145020984483e-266	MT-ND3	CD4+ T cells	GSE199333_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28605
3.47626674975576e-270	0.534927417760362	0.536	0.275	7.38046193640645e-266	CAP1	CD4+ T cells	GSE199333_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28606
5.27803395921768e-270	0.544044464396612	0.672	0.425	1.12057938988151e-265	ANAPC16	CD4+ T cells	GSE199333_post	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28607
4.92000956905827e-268	-0.646564986853183	0.203	0.48	1.04456723160676e-263	PIM3	CD4+ T cells	GSE199333_post	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28608
7.63054142681282e-268	0.610416151170011	0.809	0.616	1.62004025032663e-263	FYB1	CD4+ T cells	GSE199333_post	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28609
5.97145506213619e-266	0.429667943340163	0.41	0.163	1.26779962424213e-261	BCAP31	CD4+ T cells	GSE199333_post	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28610
2.63792600270526e-263	0.546682671565125	0.708	0.47	5.60058069634355e-259	CAPZB	CD4+ T cells	GSE199333_post	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28611
3.89088371902222e-263	-0.54427395064619	0.278	0.557	8.26073522385606e-259	SNHG9	CD4+ T cells	GSE199333_post	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28612
7.37378508215825e-261	-0.356546591707372	0.999	1	1.56552831079302e-256	RPLP0	CD4+ T cells	GSE199333_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28613
1.81779073879837e-260	0.540275015775628	0.667	0.418	3.85935151754282e-256	TSPO	CD4+ T cells	GSE199333_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28614
2.17932840617317e-260	0.488870265497959	0.549	0.292	4.62693213914625e-256	BIN1	CD4+ T cells	GSE199333_post	ENSG00000136717	274	bridging integrator 1	AMPH2|AMPHL|SH3P9	protein_coding	O00499	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28615
4.50647236782879e-260	-0.545663166901118	0.468	0.716	9.56769148413732e-256	SRSF10	CD4+ T cells	GSE199333_post	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28616
1.18258739034524e-258	-0.549327225985677	0.578	0.785	2.51075128844198e-254	KMT2E	CD4+ T cells	GSE199333_post	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28617
3.5177449575758e-257	0.468832828258199	0.947	0.866	7.46852431942918e-253	HNRNPA2B1	CD4+ T cells	GSE199333_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28618
1.97025648287491e-256	0.507855732333173	0.587	0.331	4.18305153879172e-252	CCND3	CD4+ T cells	GSE199333_post	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28619
9.83848711238892e-256	0.378648561341464	0.314	0.099	2.08880919883129e-251	CARD16	CD4+ T cells	GSE199333_post	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28620
2.86416519165337e-252	-0.506239383138757	0.15	0.42	6.08090911839927e-248	HIF1A	CD4+ T cells	GSE199333_post	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28621
2.18455059200096e-250	0.814786278653845	0.431	0.204	4.63801936187725e-246	ITGB1	CD4+ T cells	GSE199333_post	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28622
2.6397477828054e-250	-0.515190451605793	0.212	0.49	5.60444851767413e-246	CNOT1	CD4+ T cells	GSE199333_post	ENSG00000125107	23019	CCR4-NOT transcription complex subunit 1	AD-005|CDC39|KIAA1007|NOT1|NOT1H	protein_coding	A5YKK6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28623
1.88329005656698e-249	0.501921055288811	0.566	0.313	3.99841311909735e-245	TBCA	CD4+ T cells	GSE199333_post	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28624
6.6904580760775e-248	-0.458161976108523	0.807	0.907	1.42045115413201e-243	UBE2D3	CD4+ T cells	GSE199333_post	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28625
2.6150290749329e-247	-0.478680256369657	0.208	0.481	5.55196822899005e-243	OSER1	CD4+ T cells	GSE199333_post	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28626
3.13310040728925e-246	0.517073630899509	0.567	0.32	6.65188547471581e-242	BIN2	CD4+ T cells	GSE199333_post	ENSG00000110934	51411	bridging integrator 2	BRAP-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28627
3.3468953811374e-246	-0.496237874891081	0.141	0.407	7.10579358369282e-242	DBF4	CD4+ T cells	GSE199333_post	ENSG00000006634	10926	DBF4 zinc finger	ASK|chif|DBF4A|ZDBF1	protein_coding	Q9UBU7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28628
1.35821802873342e-245	-0.473171284075505	0.756	0.893	2.88363269680393e-241	SON	CD4+ T cells	GSE199333_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28629
2.41965101658944e-245	0.460809191208203	0.492	0.241	5.13716107332104e-241	SELENOH	CD4+ T cells	GSE199333_post	ENSG00000211450	280636	selenoprotein H	C11orf31|SELH	protein_coding	Q8IZQ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28630
3.22904055002587e-245	0.512297689612223	0.513	0.267	6.85557599175993e-241	PKM	CD4+ T cells	GSE199333_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28631
3.41823334357915e-244	0.583765801873279	0.686	0.462	7.25725121175289e-240	IFITM2	CD4+ T cells	GSE199333_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28632
2.24820567418891e-242	-0.560402327849465	0.348	0.603	4.77316546687047e-238	DDX3Y	CD4+ T cells	GSE199333_post	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28633
2.37312138969152e-241	0.434072866717951	0.412	0.176	5.03837402245407e-237	MGST3	CD4+ T cells	GSE199333_post	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28634
3.12321075078678e-241	0.454801096559221	0.351	0.135	6.63088874499541e-237	TRADD	CD4+ T cells	GSE199333_post	ENSG00000102871	8717	TNFRSF1A associated via death domain	Hs.89862	protein_coding	Q15628	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28635
1.10395680077286e-240	-0.525092576262957	0.261	0.525	2.34381068372085e-236	ISCA1	CD4+ T cells	GSE199333_post	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28636
1.46495625795288e-240	-0.470370888097593	0.102	0.354	3.11024863125976e-236	SNX9	CD4+ T cells	GSE199333_post	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28637
1.47543156964749e-240	-0.522303188027193	0.493	0.72	3.1324887655186e-236	UBE2B	CD4+ T cells	GSE199333_post	ENSG00000119048	7320	ubiquitin conjugating enzyme E2 B	HHR6B|RAD6B|UBC2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28638
3.05265584870895e-239	-0.541181631889575	0.799	0.911	6.48109363239397e-235	ANKRD12	CD4+ T cells	GSE199333_post	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28639
9.23149791560063e-239	0.423811290801437	0.4	0.167	1.95993932246117e-234	BST2	CD4+ T cells	GSE199333_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28640
2.1386996265904e-237	-0.564053581946545	0.409	0.65	4.54067317721408e-233	IRF2BP2	CD4+ T cells	GSE199333_post	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28641
6.97890439391864e-236	-0.542176791293503	0.505	0.727	1.48169119187287e-231	BCLAF1	CD4+ T cells	GSE199333_post	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28642
1.47746379456799e-235	0.464263518198905	0.626	0.374	3.13680338224729e-231	ATP5IF1	CD4+ T cells	GSE199333_post	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28643
4.35491471381994e-235	0.442469238139191	0.542	0.287	9.24591942891112e-231	ATP5MF	CD4+ T cells	GSE199333_post	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28644
5.32970272879348e-235	-0.485954866807153	0.315	0.584	1.13154918635014e-230	KRR1	CD4+ T cells	GSE199333_post	ENSG00000111615	11103	KRR1 small subunit processome component homolog	HRB2|RIP-1	protein_coding	Q13601	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28645
6.58863572795189e-235	0.352575926560747	0.314	0.107	1.39883325140147e-230	GSDMD	CD4+ T cells	GSE199333_post	ENSG00000278718	79792	gasdermin D	DF5L|FLJ12150|GSDMDC1	protein_coding	P57764	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28646
1.43931404624167e-234	0.481641191651664	0.632	0.388	3.05580765157568e-230	ATP5MD	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28647
6.24927946343165e-234	-0.567292426748352	0.417	0.661	1.32678452288117e-229	YPEL5	CD4+ T cells	GSE199333_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28648
1.20298513994544e-233	-0.51631528076843	0.151	0.405	2.55405775061817e-229	NINJ1	CD4+ T cells	GSE199333_post	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28649
1.60996066410305e-233	-0.533942184542589	0.435	0.676	3.41810748595719e-229	SBDS	CD4+ T cells	GSE199333_post	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28650
2.88934380568869e-232	-0.487516616468817	0.717	0.859	6.13436583385766e-228	SRRM2	CD4+ T cells	GSE199333_post	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28651
5.40270183373028e-232	0.495152261441058	0.525	0.281	1.14704762631928e-227	ACTR3	CD4+ T cells	GSE199333_post	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28652
7.22151040584756e-231	-0.541534941982171	0.377	0.63	1.5331988742655e-226	RICTOR	CD4+ T cells	GSE199333_post	ENSG00000164327	253260	RPTOR independent companion of MTOR complex 2	AVO3|KIAA1999|MGC39830|PIA	protein_coding	Q6R327	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28653
1.15192661002899e-229	-0.464891239644199	0.145	0.401	2.44565538575255e-225	JMY	CD4+ T cells	GSE199333_post	ENSG00000152409	133746	junction mediating and regulatory protein, p53 cofactor	FLJ37870|WHAMM2	protein_coding	Q8N9B5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28654
8.2584339394111e-228	0.55501311971281	0.816	0.629	1.75334810967637e-223	EMP3	CD4+ T cells	GSE199333_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28655
1.85560019116117e-227	0.535993162986262	0.689	0.444	3.93962476585427e-223	TAGLN2	CD4+ T cells	GSE199333_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28656
2.86486369537707e-227	0.496835314534025	0.669	0.433	6.08239211165507e-223	ISG20	CD4+ T cells	GSE199333_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28657
4.12018379632101e-227	0.580625125553178	0.342	0.133	8.74756221796913e-223	ANXA2	CD4+ T cells	GSE199333_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28658
8.51034754574073e-227	0.397349455040197	0.404	0.174	1.80683188743621e-222	GDI2	CD4+ T cells	GSE199333_post	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28659
4.01987811361616e-226	0.312477188202621	0.301	0.1	8.53460322301847e-222	PHB	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28660
4.83616107713462e-226	0.537815121786419	0.83	0.667	1.02676535828645e-221	HCST	CD4+ T cells	GSE199333_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28661
6.19335282145674e-226	-0.487955538766276	0.296	0.554	1.31491073752348e-221	MAPK1IP1L	CD4+ T cells	GSE199333_post	ENSG00000168175	93487	mitogen-activated protein kinase 1 interacting protein 1 like	C14orf32	protein_coding	Q8NDC0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28662
2.23695675107778e-225	0.487642440995602	0.655	0.412	4.74928287821324e-221	ANXA1	CD4+ T cells	GSE199333_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28663
7.94294987202999e-224	-0.501991662950034	0.232	0.493	1.68636768733069e-219	IDI1	CD4+ T cells	GSE199333_post	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28664
2.61931900969231e-223	-0.580583352951292	0.559	0.752	5.56107618947775e-219	PDCD4	CD4+ T cells	GSE199333_post	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28665
2.64706514074463e-222	-0.494353377218107	0.167	0.418	5.61998400031493e-218	ZEB1	CD4+ T cells	GSE199333_post	ENSG00000148516	6935	zinc finger E-box binding homeobox 1	AREB6|BZP|FECD6|NIL-2-A|PPCD3|TCF8|ZEB|Zfhep|Zfhx1a	protein_coding	P37275	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28666
3.9889819967117e-222	-0.471317165453966	0.238	0.499	8.46900767721861e-218	KDM2A	CD4+ T cells	GSE199333_post	ENSG00000173120	22992	lysine demethylase 2A	CXXC8|DKFZP434M1735|FBL11|FBL7|FBXL11|FLJ00115|JHDM1A|KIAA1004|LILINA	protein_coding	Q9Y2K7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28667
1.8713865137153e-221	0.461762193823408	0.717	0.493	3.97314070726896e-217	UBL5	CD4+ T cells	GSE199333_post	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28668
3.96066302459297e-221	-0.52693434786274	0.532	0.742	8.40888366751334e-217	ARID4B	CD4+ T cells	GSE199333_post	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28669
1.53034423874779e-219	0.429413213054241	0.538	0.296	3.24907385328544e-215	BRK1	CD4+ T cells	GSE199333_post	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28670
1.88730842168099e-218	-0.5549246295044	0.526	0.724	4.00694451007092e-214	SELENOK	CD4+ T cells	GSE199333_post	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28671
4.29470870308124e-218	0.490561282314653	0.725	0.522	9.11809604751179e-214	ACAP1	CD4+ T cells	GSE199333_post	ENSG00000288169	9744	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	CENTB1|KIAA0050	protein_coding	Q15027	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28672
4.19195845815291e-216	-0.508219404580812	0.335	0.586	8.89994700250445e-212	CHD1	CD4+ T cells	GSE199333_post	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28673
2.7952025648176e-214	0.852113668152302	0.602	0.379	5.93449456536424e-210	TRBC1	CD4+ T cells	GSE199333_post	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28674
3.60644299880511e-214	0.351918176383909	0.366	0.151	7.65683913076312e-210	TMEM230	CD4+ T cells	GSE199333_post	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28675
3.6471292980069e-214	0.371232672489643	0.353	0.141	7.74322021259845e-210	GLG1	CD4+ T cells	GSE199333_post	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28676
8.10215940687074e-214	0.341393490305431	0.333	0.127	1.72016946367273e-209	NSMCE1	CD4+ T cells	GSE199333_post	ENSG00000169189	197370	NSE1 homolog, SMC5-SMC6 complex component	NSE1	protein_coding	Q8WV22	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28677
2.0160643452654e-213	0.378082693615186	0.376	0.16	4.28030621143297e-209	GRK6	CD4+ T cells	GSE199333_post	ENSG00000198055	2870	G protein-coupled receptor kinase 6	GPRK6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28678
1.65594080491956e-212	-0.447543082906882	0.186	0.434	3.51572792292471e-208	NR1H2	CD4+ T cells	GSE199333_post	ENSG00000131408	7376	nuclear receptor subfamily 1 group H member 2	LXR-b|LXRb|NER|NER-I|RIP15|UNR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28679
2.31513995736706e-212	-0.481017021323554	0.698	0.844	4.91527364348601e-208	HMGN2	CD4+ T cells	GSE199333_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28680
2.93098749793209e-212	-0.295995619889126	0.999	1	6.22277955685961e-208	RPS20	CD4+ T cells	GSE199333_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28681
2.98920244720669e-212	-0.504959200978091	0.323	0.571	6.34637571566452e-208	USP16	CD4+ T cells	GSE199333_post	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28682
6.92677570098078e-212	-0.781471332187371	0.436	0.65	1.47062374907523e-207	TNFAIP3	CD4+ T cells	GSE199333_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28683
2.61287080524394e-211	0.412625480275387	0.489	0.252	5.54738600661341e-207	TRAPPC1	CD4+ T cells	GSE199333_post	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28684
1.653366817548e-210	0.444110800096802	0.569	0.331	3.51026309033617e-206	TNFAIP8	CD4+ T cells	GSE199333_post	ENSG00000145779	25816	TNF alpha induced protein 8	GG2-1|MDC-3.13|SCC-S2	protein_coding	O95379	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28685
1.7372010592524e-210	-0.51243475815701	0.402	0.63	3.68825156889878e-206	DNAJB6	CD4+ T cells	GSE199333_post	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28686
2.71742017892469e-210	0.28283026542188	0.254	0.076	5.76935478187502e-206	HAGH	CD4+ T cells	GSE199333_post	ENSG00000063854	3029	hydroxyacylglutathione hydrolase	GLO2|GLXII|HAGH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28687
4.07855488930081e-209	0.40440024800377	0.491	0.254	8.65917988547456e-205	PRELID1	CD4+ T cells	GSE199333_post	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28688
4.37702850419337e-208	1.18235953339591	0.869	0.819	9.29286921725294e-204	S100A4	CD4+ T cells	GSE199333_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28689
7.53346167136339e-208	-0.442531367213208	0.272	0.524	1.59942924744716e-203	SNRPA1	CD4+ T cells	GSE199333_post	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28690
1.1345902087938e-207	0.299806319064907	0.264	0.084	2.40884847229012e-203	TWF2	CD4+ T cells	GSE199333_post	ENSG00000247596	11344	twinfilin actin binding protein 2	A6r|A6RP|PTK9L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28691
1.30756028040443e-207	0.315011501114535	0.273	0.09	2.77608123132664e-203	UBE2L6	CD4+ T cells	GSE199333_post	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28692
2.6587282707155e-207	-0.437883577716897	0.222	0.474	5.64474599155608e-203	SLC25A36	CD4+ T cells	GSE199333_post	ENSG00000114120	55186	solute carrier family 25 member 36	FLJ10618|PNC2	protein_coding	Q96CQ1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28693
1.23601994851904e-204	0.30936645932225	0.27	0.089	2.62419395270078e-200	PCED1B	CD4+ T cells	GSE199333_post	ENSG00000179715	91523	PC-esterase domain containing 1B	FAM113B|MGC16044	protein_coding	Q96HM7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28694
1.36936773399098e-204	0.433720391123296	0.486	0.256	2.90730463603625e-200	PRDX1	CD4+ T cells	GSE199333_post	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28695
1.05167894114514e-203	0.415240559401569	0.909	0.802	2.23281955994526e-199	OST4	CD4+ T cells	GSE199333_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28696
5.6472199130317e-202	0.299846741188097	0.264	0.086	1.19896125973576e-197	CCDC107	CD4+ T cells	GSE199333_post	ENSG00000159884	203260	coiled-coil domain containing 107	MGC31967	protein_coding	Q8WV48	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28697
4.76549203747118e-201	-0.502523310387936	0.297	0.538	1.01176161447551e-196	RB1CC1	CD4+ T cells	GSE199333_post	ENSG00000023287	9821	RB1 inducible coiled-coil 1	ATG17|Cc1|DRAGOU14|FIP200|KIAA0203|PPP1R131	protein_coding	Q8TDY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28698
9.57661826629422e-200	0.332202386427158	0.342	0.138	2.03321182411693e-195	ECH1	CD4+ T cells	GSE199333_post	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28699
2.02884425921904e-199	-0.498455014171517	0.374	0.605	4.30743924674794e-195	SFXN1	CD4+ T cells	GSE199333_post	ENSG00000164466	94081	sideroflexin 1	FLJ12876|SLC56A1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28700
4.07904821666184e-199	0.682472722552664	0.885	0.764	8.66022726879476e-195	NEAT1	CD4+ T cells	GSE199333_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28701
9.1866236170278e-198	-0.474549141396886	0.56	0.745	1.95041206013117e-193	C9orf78	CD4+ T cells	GSE199333_post	ENSG00000136819	51759	chromosome 9 open reading frame 78	CSU2|HCA59|HSPC220	protein_coding	Q9NZ63	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28702
1.55193452752777e-197	-0.477512057869716	0.566	0.753	3.29491219539421e-193	STAT3	CD4+ T cells	GSE199333_post	ENSG00000168610	6774	signal transducer and activator of transcription 3	APRF	protein_coding	P40763	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28703
7.94449602084417e-197	0.436539032410817	0.569	0.341	1.68669595018543e-192	ATP5PD	CD4+ T cells	GSE199333_post	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28704
1.11649187245043e-196	-0.427657079533538	0.189	0.43	2.37042389439951e-192	HAUS3	CD4+ T cells	GSE199333_post	ENSG00000214367	79441	HAUS augmin like complex subunit 3	C4orf15|dgt3|IT1|MGC4701	protein_coding	Q68CZ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28705
2.93948984619344e-196	-0.453530040504477	0.257	0.5	6.2408308924533e-192	ZNF644	CD4+ T cells	GSE199333_post	ENSG00000122482	84146	zinc finger protein 644	BM-005|KIAA1221|MGC60165|MGC70410	protein_coding	Q9H582	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28706
6.77508376678249e-196	0.332923957520312	0.292	0.106	1.43841803452559e-191	GLRX	CD4+ T cells	GSE199333_post	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28707
5.05099365504051e-195	-0.443776406146715	0.672	0.834	1.07237646290165e-190	CCNL1	CD4+ T cells	GSE199333_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28708
6.10730657664342e-194	0.381012117451458	0.454	0.229	1.29664225928716e-189	GNG5	CD4+ T cells	GSE199333_post	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28709
2.76696430936533e-191	-0.466972375557706	0.309	0.548	5.87454192521354e-187	YTHDC1	CD4+ T cells	GSE199333_post	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28710
3.27292589013973e-191	0.437482128704471	0.872	0.726	6.94874895735566e-187	PSME1	CD4+ T cells	GSE199333_post	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28711
3.92879099582781e-191	0.404097388921296	0.382	0.176	8.34121616324203e-187	CCND2	CD4+ T cells	GSE199333_post	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28712
4.05844871319853e-191	0.405586950840553	0.849	0.701	8.61649246299181e-187	EDF1	CD4+ T cells	GSE199333_post	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28713
4.83720600987241e-191	-0.538534636745483	0.424	0.638	1.02698720795601e-186	EML4	CD4+ T cells	GSE199333_post	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28714
7.21158188260632e-190	0.291684526838976	0.26	0.087	1.53109094949615e-185	TMEM14C	CD4+ T cells	GSE199333_post	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28715
1.58368742851921e-189	-0.395375419263143	0.143	0.372	3.36232677948913e-185	GPCPD1	CD4+ T cells	GSE199333_post	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28716
8.92651483288883e-188	0.466603081652975	0.539	0.318	1.89518836417063e-183	MYH9	CD4+ T cells	GSE199333_post	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28717
2.04363039208168e-187	0.524619784960782	0.764	0.598	4.33883168542862e-183	GYPC	CD4+ T cells	GSE199333_post	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28718
2.76597210217336e-187	-0.412669334919011	0.282	0.522	5.87243537012427e-183	SELENOT	CD4+ T cells	GSE199333_post	ENSG00000198843	51714	selenoprotein T	SELT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28719
5.52742809211573e-186	0.388014362397927	0.254	0.086	1.17352825823709e-181	CDK6	CD4+ T cells	GSE199333_post	ENSG00000105810	1021	cyclin dependent kinase 6	PLSTIRE	protein_coding	Q00534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28720
1.01402816751627e-185	0.409406956583709	0.847	0.694	2.1528832024538e-181	APRT	CD4+ T cells	GSE199333_post	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28721
4.87530655467689e-185	0.40145292647763	0.483	0.267	1.03507633462345e-180	PSMC5	CD4+ T cells	GSE199333_post	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28722
3.29891704822514e-184	-0.432889064663431	0.378	0.608	7.00393078508679e-180	EPB41L4A-AS1	CD4+ T cells	GSE199333_post	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28723
5.5888142802829e-183	0.372458642979983	0.42	0.207	1.18656115984686e-178	ARPC4	CD4+ T cells	GSE199333_post	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28724
4.71234788142736e-182	-0.337598674380814	0.991	0.997	1.00047857870584e-177	DDX5	CD4+ T cells	GSE199333_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28725
1.02138525033742e-181	-0.40646081486503	0.216	0.45	2.16850302499137e-177	SLU7	CD4+ T cells	GSE199333_post	ENSG00000164609	10569	SLU7 homolog, splicing factor	9G8	protein_coding	O95391	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28726
8.70333551367777e-181	0.378350717727092	0.382	0.18	1.84780516290893e-176	CD63	CD4+ T cells	GSE199333_post	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28727
1.40569608591029e-180	-0.424778821075917	0.213	0.445	2.98443335999613e-176	ZNF326	CD4+ T cells	GSE199333_post	ENSG00000162664	284695	zinc finger protein 326	FLJ20403|ZAN75|Zfp326|ZIRD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28728
1.89669053564479e-180	-0.413591587699654	0.121	0.338	4.02686367622745e-176	GRASP	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28729
2.47203215661625e-179	-0.44077361383231	0.343	0.572	5.24837147171197e-175	EIF1B	CD4+ T cells	GSE199333_post	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28730
2.67686396409248e-178	-0.314092147451164	0.987	0.997	5.68324988216475e-174	HNRNPA1	CD4+ T cells	GSE199333_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28731
1.3434489114914e-177	0.316987599485959	0.302	0.12	2.85227638398738e-173	CPNE1	CD4+ T cells	GSE199333_post	ENSG00000214078	8904	copine 1	CPN1	protein_coding	Q99829	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28732
6.96110474894871e-176	0.413592360609126	0.501	0.288	1.4779121492493e-171	NDUFB1	CD4+ T cells	GSE199333_post	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28733
1.76167256157668e-175	-0.474215150480859	0.394	0.616	3.74020701548345e-171	PHF3	CD4+ T cells	GSE199333_post	ENSG00000118482	23469	PHD finger protein 3	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28734
6.61936919189358e-175	-0.381540409269433	0.175	0.398	1.40535827313093e-170	TBC1D15	CD4+ T cells	GSE199333_post	ENSG00000121749	64786	TBC1 domain family member 15	DKFZp761D0223|FLJ12085	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28735
1.65988997384098e-174	0.256771955001621	1	1	3.52411240346178e-170	MT-CO2	CD4+ T cells	GSE199333_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28736
2.97261673060657e-174	0.317038568159654	0.332	0.142	6.31116258075081e-170	NAA38	CD4+ T cells	GSE199333_post	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28737
3.74521176725374e-174	0.370492656246483	0.325	0.139	7.95145910305642e-170	DYNLL1	CD4+ T cells	GSE199333_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28738
8.58751680313924e-174	-0.378588082216452	0.12	0.33	1.82321569247449e-169	COG3	CD4+ T cells	GSE199333_post	ENSG00000136152	83548	component of oligomeric golgi complex 3	SEC34	protein_coding	Q96JB2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28739
2.25460279864585e-173	0.27501211500385	0.268	0.098	4.78674720180501e-169	LCP2	CD4+ T cells	GSE199333_post	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28740
2.55609130313218e-173	0.287213219526029	0.282	0.107	5.42683744567994e-169	RASAL3	CD4+ T cells	GSE199333_post	ENSG00000105122	64926	RAS protein activator like 3	FLJ21438	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28741
2.60800488762304e-173	-0.343078058311963	0.125	0.338	5.53705517691247e-169	ZFAND2A	CD4+ T cells	GSE199333_post	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28742
3.3879698150194e-173	1.02339212584574	0.405	0.215	7.19299871426769e-169	LGALS1	CD4+ T cells	GSE199333_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28743
3.95803688731505e-173	-0.419760794583668	0.237	0.465	8.40330811545857e-169	RIOK3	CD4+ T cells	GSE199333_post	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28744
1.99598553943669e-172	-0.293156727969225	1	1	4.23767689877803e-168	PTMA	CD4+ T cells	GSE199333_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28745
3.10629833607176e-172	-0.471843117998216	0.303	0.525	6.59498199731395e-168	BIRC3	CD4+ T cells	GSE199333_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28746
7.42992780333647e-172	0.333874780495333	0.33	0.143	1.57744797192637e-167	CSK	CD4+ T cells	GSE199333_post	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28747
1.65837750942519e-171	-0.400599269067218	0.222	0.45	3.52090129026062e-167	DHX9	CD4+ T cells	GSE199333_post	ENSG00000135829	1660	DExH-box helicase 9	DDX9|LKP|RHA	protein_coding	Q08211	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28748
2.23943949769271e-171	-0.445775575534184	0.609	0.768	4.75455399755139e-167	RBM25	CD4+ T cells	GSE199333_post	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28749
5.30864712608843e-171	0.404351004314562	0.552	0.338	1.12707887133983e-166	LAT	CD4+ T cells	GSE199333_post	ENSG00000213658	27040	linker for activation of T cells	LAT1	protein_coding	O43561	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28750
3.52362896384888e-170	0.393839328386065	0.41	0.209	7.48101665314756e-166	TLN1	CD4+ T cells	GSE199333_post	ENSG00000137076	7094	talin 1	ILWEQ|TLN	protein_coding	Q9Y490	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28751
3.57901591803331e-170	0.266582959176576	0.251	0.088	7.59860869557652e-166	CARD8	CD4+ T cells	GSE199333_post	ENSG00000105483	22900	caspase recruitment domain family member 8	CARDINAL|Dakar|KIAA0955|NDPP|TUCAN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28752
8.83178915441776e-170	0.409629312038359	0.576	0.365	1.87507715537443e-165	POLR2L	CD4+ T cells	GSE199333_post	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28753
7.67358314276702e-169	-0.358364975751526	0.132	0.343	1.62917843704087e-164	TWISTNB	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28754
9.74014793321574e-169	0.362881461954811	0.448	0.239	2.06793080770103e-164	FKBP1A	CD4+ T cells	GSE199333_post	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28755
1.20932528655519e-168	-0.344797684643538	0.141	0.356	2.56751851588533e-164	DCP1A	CD4+ T cells	GSE199333_post	ENSG00000272886	55802	decapping mRNA 1A	HSA275986|SMAD4IP1|SMIF	protein_coding	Q9NPI6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28756
1.78157260706113e-168	-0.401484003915873	0.226	0.448	3.78245680205148e-164	SERINC1	CD4+ T cells	GSE199333_post	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28757
7.78213120612079e-168	0.436913584796656	0.665	0.464	1.65222427637151e-163	LSP1	CD4+ T cells	GSE199333_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28758
1.01891887180884e-167	0.343319749811481	0.346	0.158	2.16326665673735e-163	GNB2	CD4+ T cells	GSE199333_post	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28759
1.4721645851154e-167	-0.375913343041512	0.218	0.442	3.1255526306585e-163	RNF114	CD4+ T cells	GSE199333_post	ENSG00000124226	55905	ring finger protein 114	PSORS12|ZNF313	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28760
1.66288075228871e-167	-0.439538587026943	0.28	0.501	3.53046212518416e-163	CEBPZ	CD4+ T cells	GSE199333_post	ENSG00000115816	10153	CCAAT enhancer binding protein zeta	CBF2|CTF2	protein_coding	Q03701	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28761
2.2878598695246e-167	0.344130013860837	0.36	0.168	4.85735528898768e-163	ARHGAP30	CD4+ T cells	GSE199333_post	ENSG00000186517	257106	Rho GTPase activating protein 30	FLJ00267	protein_coding	Q7Z6I6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28762
2.47878421784565e-167	-0.412560253567013	0.278	0.502	5.26270677290811e-163	USP3	CD4+ T cells	GSE199333_post	ENSG00000140455	9960	ubiquitin specific peptidase 3	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28763
1.94226328782954e-166	0.324825374088466	0.979	0.934	4.12361918639091e-162	ARHGDIB	CD4+ T cells	GSE199333_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28764
2.4887061758025e-166	-0.44304380557802	0.389	0.609	5.28377208184629e-162	ZNF292	CD4+ T cells	GSE199333_post	ENSG00000188994	23036	zinc finger protein 292	bA393I2.3|KIAA0530|ZFP292|Zn-15|Zn-16	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28765
2.76921544962656e-166	0.284962468953415	0.293	0.118	5.87932132110215e-162	NDUFB5	CD4+ T cells	GSE199333_post	ENSG00000136521	4711	NADH:ubiquinone oxidoreductase subunit B5	CI-SGDH|MGC12314|SGDH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28766
3.71568986201931e-166	-0.401256677151487	0.17	0.386	7.8887811460532e-162	IRS2	CD4+ T cells	GSE199333_post	ENSG00000185950	8660	insulin receptor substrate 2	NA	protein_coding	Q9Y4H2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28767
1.95383486403575e-165	0.295799971435438	0.29	0.116	4.14818679983429e-161	DBNL	CD4+ T cells	GSE199333_post	ENSG00000136279	28988	drebrin like	ABP1|HIP-55|SH3P7	protein_coding	Q9UJU6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28768
9.31439233658058e-165	0.368245586977949	0.51	0.298	1.97753863697942e-160	NDUFB10	CD4+ T cells	GSE199333_post	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28769
1.98030360477618e-164	-0.383808058331957	0.154	0.363	4.20438258330031e-160	HMGXB4	CD4+ T cells	GSE199333_post	ENSG00000100281	10042	HMG-box containing 4	HMG2L1|P53N|THC211630	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28770
2.89461767024058e-164	-0.389321357881558	0.253	0.473	6.14556277568778e-160	PHF1	CD4+ T cells	GSE199333_post	ENSG00000225553	5252	PHD finger protein 1	MTF2L2|PCL1|TDRD19C	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28771
1.69894991884381e-163	-0.501399808968156	0.44	0.632	3.60704057269729e-159	DDX21	CD4+ T cells	GSE199333_post	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28772
2.38076167385608e-163	-0.473728385648362	0.25	0.471	5.05459510976384e-159	ZNF331	CD4+ T cells	GSE199333_post	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28773
2.68232321010637e-163	-0.379674551550593	0.904	0.953	5.69484040737683e-159	PNISR	CD4+ T cells	GSE199333_post	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28774
8.30847336364291e-163	0.388974317024842	0.487	0.283	1.76397197983503e-158	SUN2	CD4+ T cells	GSE199333_post	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28775
3.63225895904363e-162	-0.374893309833558	0.148	0.358	7.71164899594552e-158	ETF1	CD4+ T cells	GSE199333_post	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28776
3.8347876075268e-162	-0.361076184762658	0.158	0.369	8.14163756954015e-158	TOMM5	CD4+ T cells	GSE199333_post	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28777
5.95099735328229e-162	0.336802827342527	0.317	0.139	1.26345624807536e-157	CKLF	CD4+ T cells	GSE199333_post	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28778
1.73136881893007e-161	-0.404457404996065	0.322	0.534	3.67586913947043e-157	STRAP	CD4+ T cells	GSE199333_post	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28779
5.00321418187571e-161	0.273470476027247	0.261	0.098	1.06223240295403e-156	MRPL51	CD4+ T cells	GSE199333_post	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28780
2.05182807698979e-160	0.321305407309265	0.346	0.16	4.35623619025703e-156	LMAN2	CD4+ T cells	GSE199333_post	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28781
2.29108933569751e-160	0.385030573212913	0.352	0.165	4.86421176861938e-156	ISG15	CD4+ T cells	GSE199333_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28782
2.71042225633344e-160	-0.396262339163394	0.092	0.284	5.75449749242153e-156	PELI1	CD4+ T cells	GSE199333_post	ENSG00000197329	57162	pellino E3 ubiquitin protein ligase 1	NA	protein_coding	Q96FA3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28783
3.44357370646409e-160	-0.350008298857221	0.166	0.375	7.3110513361939e-156	DERL2	CD4+ T cells	GSE199333_post	ENSG00000072849	51009	derlin 2	CGI-101|derlin-2|F-LAN-1|F-LANa|FLANa	protein_coding	Q9GZP9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28784
3.98200304904366e-160	-0.375564099135089	0.197	0.41	8.45419067342459e-156	BCL7B	CD4+ T cells	GSE199333_post	ENSG00000106635	9275	BAF chromatin remodeling complex subunit BCL7B	SMARCJ2	protein_coding	Q9BQE9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28785
2.77123730349563e-159	0.438401219478941	0.627	0.428	5.88361391905156e-155	LCP1	CD4+ T cells	GSE199333_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28786
3.4744930712158e-159	-0.350717573079182	0.155	0.364	7.37669623949826e-155	SAP30BP	CD4+ T cells	GSE199333_post	ENSG00000161526	29115	SAP30 binding protein	HCNGP|HTRG|HTRP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28787
4.12454056505819e-159	0.402384571289852	0.684	0.496	8.75681207367505e-155	GNAI2	CD4+ T cells	GSE199333_post	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28788
5.7195991170176e-159	0.304449828257496	0.373	0.179	1.21432808853401e-154	CLNS1A	CD4+ T cells	GSE199333_post	ENSG00000074201	1207	chloride nucleotide-sensitive channel 1A	CLCI|ICln	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28789
1.46780874433847e-158	0.31357561306668	0.335	0.152	3.11630474510501e-154	TUBB	CD4+ T cells	GSE199333_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28790
4.07951447212876e-158	0.378931598806884	0.487	0.285	8.66121717577657e-154	NDUFA3	CD4+ T cells	GSE199333_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28791
5.33164249240006e-158	0.279185607409923	0.272	0.107	1.13196101756146e-153	FERMT3	CD4+ T cells	GSE199333_post	ENSG00000149781	83706	FERM domain containing kindlin 3	KIND3|MGC10966|MIG2B|UNC112C|URP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28792
2.46108776524145e-157	-0.350525023406706	0.117	0.316	5.22513543438413e-153	BICDL1	CD4+ T cells	GSE199333_post	ENSG00000135127	92558	BICD family like cargo adaptor 1	BICDR-1|CCDC64|FLJ26450	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28793
8.62266638811096e-157	0.400187742092649	0.461	0.259	1.83067830085984e-152	PIM1	CD4+ T cells	GSE199333_post	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28794
1.27710524993057e-156	-0.542967151091245	0.178	0.384	2.7114221561276e-152	GABARAPL1	CD4+ T cells	GSE199333_post	ENSG00000139112	23710	GABA type A receptor associated protein like 1	APG8L|ATG8B|ATG8L|gec1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28795
2.51098309345756e-156	0.46085219304957	0.623	0.432	5.33106820571974e-152	CD2	CD4+ T cells	GSE199333_post	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28796
1.74247471878987e-155	-0.385587522705357	0.265	0.477	3.69944807546278e-151	WBP11	CD4+ T cells	GSE199333_post	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28797
2.06970136329296e-155	0.382256140596988	0.805	0.659	4.39418296440728e-151	EIF3G	CD4+ T cells	GSE199333_post	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28798
6.64871813272905e-154	-0.393417122075513	0.658	0.795	1.4115893467597e-149	CSDE1	CD4+ T cells	GSE199333_post	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28799
5.81694634868069e-153	0.278555960012611	0.295	0.125	1.2349958792884e-148	UBE2M	CD4+ T cells	GSE199333_post	ENSG00000130725	9040	ubiquitin conjugating enzyme E2 M	hUbc12|UBC12	protein_coding	P61081	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28800
9.04824033345788e-153	-0.4705085587821	0.18	0.384	1.92103190519644e-148	TSPYL2	CD4+ T cells	GSE199333_post	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28801
2.60848866816184e-152	0.340532022187154	0.311	0.139	5.53808229137441e-148	SH3BP5	CD4+ T cells	GSE199333_post	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28802
5.79177640917066e-152	0.269101804942273	0.261	0.102	1.22965204943102e-147	CDC25B	CD4+ T cells	GSE199333_post	ENSG00000101224	994	cell division cycle 25B	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28803
7.66660369917803e-152	-0.473656517684089	0.428	0.624	1.62769663137249e-147	KLF3	CD4+ T cells	GSE199333_post	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28804
8.74387452499925e-152	0.372801516598626	0.254	0.1	1.85641200040259e-147	LIMS1	CD4+ T cells	GSE199333_post	ENSG00000169756	3987	LIM zinc finger domain containing 1	PINCH|PINCH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28805
1.21373180535535e-151	-0.344714752344746	0.147	0.348	2.57687399594995e-147	TAF11	CD4+ T cells	GSE199333_post	ENSG00000064995	6882	TATA-box binding protein associated factor 11	TAF2I|TAFII28	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28806
3.19605884614921e-151	0.328750888171146	0.36	0.175	6.78555253625939e-147	S1PR4	CD4+ T cells	GSE199333_post	ENSG00000125910	8698	sphingosine-1-phosphate receptor 4	EDG6	protein_coding	O95977	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28807
8.44324854664323e-151	0.404589193035636	0.982	0.938	1.79258609893783e-146	TXNIP	CD4+ T cells	GSE199333_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28808
1.68132245809331e-150	0.344685663556051	0.421	0.23	3.56961571077791e-146	AP2M1	CD4+ T cells	GSE199333_post	ENSG00000161203	1173	adaptor related protein complex 2 subunit mu 1	AP50|CLAPM1|mu2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28809
2.33595308763933e-150	-0.413470136448514	0.428	0.626	4.95946200036706e-146	U2SURP	CD4+ T cells	GSE199333_post	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28810
3.198484656633e-150	-0.397016158695825	0.365	0.574	6.79070277449752e-146	CCDC59	CD4+ T cells	GSE199333_post	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28811
4.78682345155619e-150	0.273189310093074	0.262	0.104	1.0162904869999e-145	RNASEH2C	CD4+ T cells	GSE199333_post	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28812
6.77752872786559e-150	0.283910625176838	0.278	0.114	1.43893712421314e-145	PARP1	CD4+ T cells	GSE199333_post	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28813
8.41625721008935e-150	0.287084991623431	0.304	0.133	1.78685556827407e-145	BANF1	CD4+ T cells	GSE199333_post	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28814
8.73432160664953e-149	0.29487555668886	0.342	0.162	1.85438382030776e-144	WAS	CD4+ T cells	GSE199333_post	ENSG00000015285	7454	WASP actin nucleation promoting factor	IMD2|THC|WASP|WASPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28815
1.42788555837395e-148	-0.404534760277396	0.406	0.604	3.03154382898374e-144	GGNBP2	CD4+ T cells	GSE199333_post	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28816
1.56439821835885e-148	0.365654773892141	0.572	0.369	3.32137385739768e-144	TMEM258	CD4+ T cells	GSE199333_post	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28817
2.00640710483857e-148	0.342769487065838	0.397	0.207	4.25980292428276e-144	YWHAQ	CD4+ T cells	GSE199333_post	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28818
2.85600095425073e-148	0.277856151474157	1	1	6.06357562596973e-144	MT-CO1	CD4+ T cells	GSE199333_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28819
2.80298057531088e-147	-0.400963281685622	0.353	0.556	5.95100805944254e-143	FNBP4	CD4+ T cells	GSE199333_post	ENSG00000285182	23360	formin binding protein 4	KIAA1014	protein_coding	Q8N3X1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28820
2.83611687462058e-147	-0.380556855839444	0.269	0.476	6.02135973650696e-143	SNW1	CD4+ T cells	GSE199333_post	ENSG00000100603	22938	SNW domain containing 1	Bx42|FUN20|NCoA-62|Prp45|PRPF45|SKIIP|SKIP|SKIP1	protein_coding	Q13573	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28821
3.38557929339098e-147	-0.414311211178529	0.411	0.602	7.18792339779838e-143	WTAP	CD4+ T cells	GSE199333_post	ENSG00000146457	9589	WT1 associated protein	KIAA0105|MGC3925|Mum2	protein_coding	Q15007	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28822
1.29533218688936e-146	0.268471813177155	0.262	0.105	2.7501197659848e-142	ICAM2	CD4+ T cells	GSE199333_post	ENSG00000108622	3384	intercellular adhesion molecule 2	CD102	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28823
4.02344030412005e-146	0.34139313294392	0.498	0.298	8.54216610967728e-142	COX5A	CD4+ T cells	GSE199333_post	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28824
5.72322637160832e-146	-0.444239752880072	0.965	0.991	1.21509819095616e-141	JUND	CD4+ T cells	GSE199333_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28825
7.85896094856799e-146	0.37203922209562	0.692	0.505	1.66853599899047e-141	RHOA	CD4+ T cells	GSE199333_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28826
9.30374753690045e-146	-0.307571237369656	0.094	0.276	1.97527863955934e-141	HIVEP1	CD4+ T cells	GSE199333_post	ENSG00000095951	3096	HIVEP zinc finger 1	CIRIP|CRYBP1|MBP-1|PRDII-BF1|Schnurri-1|ZAS1|ZNF40|ZNF40A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28827
7.54200074826091e-145	-0.354081263514495	0.187	0.39	1.60124217886327e-140	DNAJC2	CD4+ T cells	GSE199333_post	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28828
1.52844745432449e-143	0.292739200457742	0.329	0.154	3.24504679027632e-139	PIP4K2A	CD4+ T cells	GSE199333_post	ENSG00000150867	5305	phosphatidylinositol-5-phosphate 4-kinase type 2 alpha	PIP5K2A|PIP5KIIA|PIP5KIIalpha	protein_coding	P48426	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28829
1.73970102109705e-143	-0.434618510257385	0.454	0.632	3.69355923789115e-139	TAX1BP1	CD4+ T cells	GSE199333_post	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28830
1.74799252553233e-143	0.305614407587517	0.339	0.164	3.71116293095769e-139	APBB1IP	CD4+ T cells	GSE199333_post	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28831
1.93959860969547e-143	-0.410764398486949	0.413	0.604	4.11796180824445e-139	ZC3H15	CD4+ T cells	GSE199333_post	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28832
8.81265369332772e-143	-0.655477861362261	0.785	0.85	1.87101450563041e-138	SRGN	CD4+ T cells	GSE199333_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28833
1.13890881448842e-142	0.25738454472198	0.277	0.116	2.41801730404036e-138	IMPDH2	CD4+ T cells	GSE199333_post	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28834
1.17973852928259e-142	0.365654577627667	0.579	0.385	2.50470287151986e-138	NDUFA11	CD4+ T cells	GSE199333_post	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28835
2.21070445809121e-142	-0.42793811286441	0.416	0.608	4.69354663497345e-138	CDKN2D	CD4+ T cells	GSE199333_post	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28836
3.0741691023419e-141	-0.40763891354296	0.498	0.672	6.52676842118209e-137	EIF5	CD4+ T cells	GSE199333_post	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28837
4.36029654128554e-141	-0.262905520301932	1	1	9.25734558680333e-137	HLA-A	CD4+ T cells	GSE199333_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28838
4.43836279137144e-141	0.370268808020109	0.557	0.365	9.4230880423607e-137	RABAC1	CD4+ T cells	GSE199333_post	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28839
7.16996525772642e-141	0.385931802128726	0.5	0.301	1.5222553238679e-136	ATRX	CD4+ T cells	GSE199333_post	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28840
1.0515880482646e-140	-0.371985586494156	0.779	0.865	2.23262658527057e-136	PPDPF	CD4+ T cells	GSE199333_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28841
1.2411369279901e-140	-0.38603791157457	0.43	0.618	2.63505781181578e-136	RBM8A	CD4+ T cells	GSE199333_post	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28842
3.56682812085921e-139	0.417455134467756	0.689	0.534	7.5727327833962e-135	ARL6IP5	CD4+ T cells	GSE199333_post	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28843
3.80605545830847e-139	-0.388052743615524	0.312	0.51	8.08063634353471e-135	SLC3A2	CD4+ T cells	GSE199333_post	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28844
6.08600909482385e-139	0.329838958601919	0.377	0.2	1.29212059092205e-134	SYTL1	CD4+ T cells	GSE199333_post	ENSG00000142765	84958	synaptotagmin like 1	exophilin-7|FLJ14996|JFC1|SLP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28845
7.90731148654447e-139	0.332685823926688	0.478	0.283	1.67880130170826e-134	SH3BGRL	CD4+ T cells	GSE199333_post	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28846
8.10725793320069e-139	-0.398351970192792	0.316	0.514	1.72125193179784e-134	NOP58	CD4+ T cells	GSE199333_post	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28847
1.05715628397174e-138	0.295367921329622	0.986	0.96	2.24444850650039e-134	COX7C	CD4+ T cells	GSE199333_post	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28848
1.29105403220114e-138	-0.406979842968265	0.5	0.673	2.74103681576624e-134	SRSF11	CD4+ T cells	GSE199333_post	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28849
3.06955429131215e-138	-0.377004829756223	0.222	0.42	6.51697071588482e-134	JOSD1	CD4+ T cells	GSE199333_post	ENSG00000100221	9929	Josephin domain containing 1	KIAA0063	protein_coding	Q15040	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28850
4.19733699210791e-138	-0.384825351365758	0.588	0.735	8.9113661679443e-134	ARF1	CD4+ T cells	GSE199333_post	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28851
2.4889417059532e-137	-0.391104265076273	0.371	0.559	5.28427213590924e-133	MRPL54	CD4+ T cells	GSE199333_post	ENSG00000183617	116541	mitochondrial ribosomal protein L54	NA	protein_coding	Q6P161	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28852
4.69701883177741e-137	-0.33109572795452	0.097	0.274	9.97224068174661e-133	KIF20B	CD4+ T cells	GSE199333_post	ENSG00000138182	9585	kinesin family member 20B	CT90|KRMP1|MPHOSPH1|MPP1	protein_coding	Q96Q89	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28853
1.31493584228666e-136	-0.270939944809041	0.994	0.995	2.79174028675881e-132	COX4I1	CD4+ T cells	GSE199333_post	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28854
1.4614801130993e-136	-0.328527364036744	0.169	0.363	3.10286842812112e-132	MED23	CD4+ T cells	GSE199333_post	ENSG00000112282	9439	mediator complex subunit 23	CRSP130|CRSP3|DRIP130|MRT18|Sur2	protein_coding	Q9ULK4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28855
1.69139687218132e-136	0.351829871036396	0.541	0.343	3.59100469932817e-132	PA2G4	CD4+ T cells	GSE199333_post	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28856
3.05604049308776e-136	0.320743499541658	0.343	0.172	6.48827957087462e-132	ITGB7	CD4+ T cells	GSE199333_post	ENSG00000139626	3695	integrin subunit beta 7	NA	protein_coding	P26010	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28857
2.74740185958119e-135	-0.325684588988395	0.158	0.349	5.83300888807683e-131	CUL3	CD4+ T cells	GSE199333_post	ENSG00000036257	8452	cullin 3	NA	protein_coding	Q13618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28858
2.01043483280532e-134	0.326084195641856	0.459	0.273	4.26835419352897e-130	CCT3	CD4+ T cells	GSE199333_post	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28859
3.72718382405589e-134	-0.441779058902109	0.555	0.711	7.91318397685305e-130	ANKRD11	CD4+ T cells	GSE199333_post	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28860
1.74192830139731e-133	-0.331698510855579	0.226	0.422	3.69828797669662e-129	COMMD2	CD4+ T cells	GSE199333_post	ENSG00000114744	51122	COMM domain containing 2	HSPC042	protein_coding	Q86X83	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28861
1.97883865868674e-133	0.344224546069275	0.895	0.815	4.20127235625783e-129	MYL12B	CD4+ T cells	GSE199333_post	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28862
3.54267661744956e-133	0.356895073155697	0.509	0.323	7.52145672650716e-129	ABHD17A	CD4+ T cells	GSE199333_post	ENSG00000129968	81926	abhydrolase domain containing 17A, depalmitoylase	C19orf27|FAM108A1|MGC5244	protein_coding	Q96GS6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28863
4.72937108631482e-133	0.299431721833875	0.343	0.173	1.0040927753355e-128	TRAT1	CD4+ T cells	GSE199333_post	ENSG00000163519	50852	T cell receptor associated transmembrane adaptor 1	HSPC062|TCRIM|TRIM	protein_coding	Q6PIZ9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28864
6.61665101887915e-133	0.346468415638802	0.784	0.62	1.40478117781823e-128	ATP5F1D	CD4+ T cells	GSE199333_post	ENSG00000099624	513	ATP synthase F1 subunit delta	ATP5D	protein_coding	P30049	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28865
8.04995931984017e-133	0.385248790581507	0.421	0.239	1.70908686319527e-128	NUCB2	CD4+ T cells	GSE199333_post	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28866
2.53528408373917e-132	0.349189949830775	0.651	0.462	5.38266163818663e-128	NDUFA13	CD4+ T cells	GSE199333_post	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28867
3.18291033217001e-132	0.390005193417034	0.371	0.198	6.75763692623015e-128	AQP3	CD4+ T cells	GSE199333_post	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28868
4.45217010341525e-132	-0.427449419865098	0.336	0.52	9.45240234656092e-128	DNAJA1	CD4+ T cells	GSE199333_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28869
1.63806981844705e-131	0.38115553146414	0.641	0.457	3.47778603154493e-127	CLEC2D	CD4+ T cells	GSE199333_post	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28870
2.37758985966469e-131	-0.288707329450003	0.135	0.317	5.04786103105411e-127	MRPL22	CD4+ T cells	GSE199333_post	ENSG00000082515	29093	mitochondrial ribosomal protein L22	HSPC158|MRP-L25|RPML25	protein_coding	Q9NWU5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28871
3.25939378710269e-131	-0.397141190832241	0.222	0.416	6.92001894939773e-127	BIRC2	CD4+ T cells	GSE199333_post	ENSG00000110330	329	baculoviral IAP repeat containing 2	API1|c-IAP1|cIAP1|hiap-2|MIHB|RNF48	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28872
3.57526427604147e-131	-0.352943528413483	0.343	0.537	7.59064358446364e-127	EXOSC6	CD4+ T cells	GSE199333_post	ENSG00000223496	118460	exosome component 6	EAP4|hMtr3p|MTR3|Mtr3p|p11	protein_coding	Q5RKV6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28873
1.06561695234599e-130	0.34302864909548	0.549	0.365	2.26241135152578e-126	C4orf3	CD4+ T cells	GSE199333_post	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28874
2.39850120777193e-130	0.275351263786707	0.328	0.161	5.09225791422059e-126	PTPN4	CD4+ T cells	GSE199333_post	ENSG00000088179	5775	protein tyrosine phosphatase non-receptor type 4	PTPMEG	protein_coding	P29074	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28875
4.2531104724954e-130	0.351738684085832	0.512	0.328	9.02977884415499e-126	HCLS1	CD4+ T cells	GSE199333_post	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28876
6.17348671799527e-130	-0.360255054972552	0.391	0.58	1.31069296509758e-125	NOL7	CD4+ T cells	GSE199333_post	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28877
8.59828070160698e-130	-0.354796862614555	0.234	0.428	1.82550097575818e-125	BRAF	CD4+ T cells	GSE199333_post	ENSG00000157764	673	B-Raf proto-oncogene, serine/threonine kinase	BRAF-1|BRAF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28878
1.36408738760221e-129	-0.433524629782925	0.542	0.684	2.89609393261825e-125	MGAT4A	CD4+ T cells	GSE199333_post	ENSG00000071073	11320	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GnT-4a|GnT-Iva	protein_coding	Q9UM21	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28879
1.390746615683e-129	-0.301118975274553	0.124	0.301	2.95269413975657e-125	PIK3CA	CD4+ T cells	GSE199333_post	ENSG00000121879	5290	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	PI3K	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28880
2.86219810335636e-129	-0.364747034069586	0.228	0.421	6.07673279323589e-125	MAP3K2	CD4+ T cells	GSE199333_post	ENSG00000169967	10746	mitogen-activated protein kinase kinase kinase 2	MEKK2|MEKK2B	protein_coding	Q9Y2U5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28881
3.00079498458524e-129	-0.448313334164798	0.415	0.59	6.37098783177293e-125	PRPF4B	CD4+ T cells	GSE199333_post	ENSG00000112739	8899	pre-mRNA processing factor 4B	KIAA0536|PR4H|Prp4	protein_coding	Q13523	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28882
3.47956112667658e-129	0.321413260359323	0.429	0.247	7.38745622804705e-125	RBL2	CD4+ T cells	GSE199333_post	ENSG00000103479	5934	RB transcriptional corepressor like 2	p130|Rb2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28883
5.42834716263345e-129	-0.39747411120925	0.385	0.572	1.15249238609871e-124	CNOT6L	CD4+ T cells	GSE199333_post	ENSG00000138767	246175	CCR4-NOT transcription complex subunit 6 like	Ccr4b|DKFZp434K098	protein_coding	Q96LI5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28884
6.24660331650689e-129	-0.361084664071061	0.491	0.666	1.32621635012758e-124	HNRNPA0	CD4+ T cells	GSE199333_post	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28885
8.39716350798966e-129	0.271878659326306	0.3	0.141	1.78280178438129e-124	CCT5	CD4+ T cells	GSE199333_post	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28886
1.25601525989066e-128	0.43332614006234	0.565	0.398	2.66664599827387e-124	ITGB2	CD4+ T cells	GSE199333_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28887
1.97563363036539e-128	-0.396752881726952	0.33	0.519	4.19446776062877e-124	SREK1	CD4+ T cells	GSE199333_post	ENSG00000153914	140890	splicing regulatory glutamic acid and lysine rich protein 1	DKFZp564B176|SFRS12|SRrp508|SRrp86	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28888
6.84428533600116e-128	0.302155116490508	0.406	0.226	1.45311021968641e-123	GABARAPL2	CD4+ T cells	GSE199333_post	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28889
1.52569630512792e-127	-0.376120429527772	0.312	0.505	3.23920582541709e-123	RBBP6	CD4+ T cells	GSE199333_post	ENSG00000122257	5930	RB binding protein 6, ubiquitin ligase	P2P-R|PACT|SNAMA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28890
2.15485268478473e-127	-0.382833042352604	0.397	0.586	4.57496773506647e-123	OGA	CD4+ T cells	GSE199333_post	ENSG00000198408	10724	O-GlcNAcase	MEA5|MGEA5|NCOAT	protein_coding	O60502	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28891
3.2800250030581e-127	-0.286689558119196	0.156	0.34	6.96382108399265e-123	RAMMET	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28892
8.79797704536444e-127	-0.33197246392245	0.18	0.366	1.86789850650132e-122	SGTB	CD4+ T cells	GSE199333_post	ENSG00000197860	54557	small glutamine rich tetratricopeptide repeat co-chaperone beta	FLJ39002|Sgt2	protein_coding	Q96EQ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28893
1.60436659121967e-126	-0.308326753431028	0.158	0.34	3.40623070981848e-122	GOSR1	CD4+ T cells	GSE199333_post	ENSG00000108587	9527	golgi SNAP receptor complex member 1	GOLIM2|GOS-28|GOS28|GS28|P28	protein_coding	O95249	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28894
2.36231622722419e-126	0.324559103513433	0.46	0.278	5.01543358201968e-122	MINOS1	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28895
2.50802686067229e-126	-0.302286704846129	0.202	0.391	5.32479182789334e-122	EMC6	CD4+ T cells	GSE199333_post	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28896
5.8468243442743e-126	0.366091488561376	0.645	0.482	1.24133927653288e-121	PCBP1	CD4+ T cells	GSE199333_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28897
8.05279347272975e-126	0.282700792273889	0.369	0.196	1.70968858219525e-121	POLR3GL	CD4+ T cells	GSE199333_post	ENSG00000121851	84265	RNA polymerase III subunit GL	flj32422|MGC3200	protein_coding	Q9BT43	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28898
1.10446390845837e-125	0.25376009224711	0.304	0.144	2.34488732404797e-121	MRPL52	CD4+ T cells	GSE199333_post	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28899
4.36755283086697e-125	-0.303292109808474	0.164	0.349	9.27275141521366e-121	PER1	CD4+ T cells	GSE199333_post	ENSG00000179094	5187	period circadian regulator 1	PER|RIGUI	protein_coding	O15534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28900
4.45435625208808e-125	-0.304371371803574	0.216	0.407	9.45704375880821e-121	PITHD1	CD4+ T cells	GSE199333_post	ENSG00000057757	57095	PITH domain containing 1	C1orf128|HT014|TXNL1CL	protein_coding	Q9GZP4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28901
8.42343525929139e-125	0.320564029387452	0.398	0.225	1.78837953990015e-120	SPCS2	CD4+ T cells	GSE199333_post	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28902
1.93705216194633e-124	0.289645531440317	0.424	0.242	4.11255544502826e-120	NDUFS6	CD4+ T cells	GSE199333_post	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28903
2.15997488715801e-124	0.310242066919031	0.437	0.256	4.58584268292518e-120	TMBIM4	CD4+ T cells	GSE199333_post	ENSG00000155957	51643	transmembrane BAX inhibitor motif containing 4	CGI-119|GAAP|LFG4|S1R|ZPRO	protein_coding	Q9HC24	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28904
2.30724136605175e-124	0.280413022301587	0.335	0.171	4.89850414426446e-120	UGP2	CD4+ T cells	GSE199333_post	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28905
3.55106615971691e-124	0.393228396377969	0.646	0.473	7.53926856369498e-120	TNRC6B	CD4+ T cells	GSE199333_post	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28906
1.09503233597404e-123	0.367619933838036	0.488	0.309	2.32486315250648e-119	EPB41	CD4+ T cells	GSE199333_post	ENSG00000159023	2035	erythrocyte membrane protein band 4.1	4.1R|EL1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28907
1.57676690986752e-123	-0.297662048827218	0.165	0.346	3.34763382633973e-119	NOL11	CD4+ T cells	GSE199333_post	ENSG00000130935	25926	nucleolar protein 11	DKFZP586L0724	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28908
5.77910272372346e-123	0.309826707016272	0.265	0.12	1.22696129927373e-118	CTSC	CD4+ T cells	GSE199333_post	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28909
8.59113237212598e-123	0.35977895760247	0.605	0.424	1.82398331392607e-118	MSN	CD4+ T cells	GSE199333_post	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28910
1.11269114997205e-122	-0.42421785052493	0.684	0.806	2.36235458050567e-118	FOXP1	CD4+ T cells	GSE199333_post	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28911
1.48151486452944e-122	-0.453196497146129	0.398	0.58	3.14540420888246e-118	CLEC2B	CD4+ T cells	GSE199333_post	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28912
1.53838628735437e-122	-0.304836275991443	0.135	0.309	3.26614792668207e-118	ING3	CD4+ T cells	GSE199333_post	ENSG00000071243	54556	inhibitor of growth family member 3	Eaf4|FLJ20089|MEAF4|p47ING3	protein_coding	Q9NXR8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28913
2.4293729023356e-122	0.335099332838331	0.797	0.661	5.15780160894871e-118	EIF4A2	CD4+ T cells	GSE199333_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28914
3.96504826872713e-122	0.263976983313099	0.33	0.167	8.41819397933457e-118	NDUFB3	CD4+ T cells	GSE199333_post	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28915
5.06107397777166e-122	0.295293058186897	0.319	0.159	1.0745166162207e-117	IFI16	CD4+ T cells	GSE199333_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28916
1.07185325546107e-121	0.316364832338723	0.894	0.768	2.2756516466694e-117	GMFG	CD4+ T cells	GSE199333_post	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28917
9.52341887277521e-121	-0.397202282513743	0.334	0.524	2.0219170608789e-116	GOLGA4	CD4+ T cells	GSE199333_post	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28918
1.28535964517863e-120	0.307486545746527	0.921	0.856	2.72894706267875e-116	CD3E	CD4+ T cells	GSE199333_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28919
1.33178332407757e-120	-0.286397520857221	0.105	0.269	2.8275091753491e-116	USP12	CD4+ T cells	GSE199333_post	ENSG00000152484	219333	ubiquitin specific peptidase 12	USP12L1	protein_coding	O75317	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28920
1.65288458253392e-120	-0.261918260474031	0.091	0.253	3.50923925717777e-116	RYBP	CD4+ T cells	GSE199333_post	ENSG00000281766	23429	RING1 and YY1 binding protein	AAP1|DEDAF|YEAF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28921
3.05090004506345e-120	-0.297872877949978	0.137	0.309	6.4773658856742e-116	PNPLA8	CD4+ T cells	GSE199333_post	ENSG00000135241	50640	patatin like phospholipase domain containing 8	IPLA2-2|IPLA2G|iPLA2gamma	protein_coding	Q9NP80	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28922
7.19819647219132e-120	0.322742373898973	0.435	0.263	1.52824909301094e-115	SKAP1	CD4+ T cells	GSE199333_post	ENSG00000141293	8631	src kinase associated phosphoprotein 1	SCAP1|SKAP55	protein_coding	Q86WV1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28923
7.71193554033186e-120	-0.297570075712309	0.153	0.328	1.63732103456786e-115	ASB8	CD4+ T cells	GSE199333_post	ENSG00000177981	140461	ankyrin repeat and SOCS box containing 8	FLJ21255|MGC5540	protein_coding	Q9H765	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28924
7.71611283828554e-120	0.370974065606477	0.378	0.217	1.6382079166964e-115	MYO1G	CD4+ T cells	GSE199333_post	ENSG00000136286	64005	myosin IG	HA-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28925
7.95747378011333e-120	0.307188094320561	0.309	0.153	1.68945125825586e-115	ALOX5AP	CD4+ T cells	GSE199333_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28926
1.84090672848243e-119	-0.365407847203597	0.356	0.541	3.90842907524104e-115	PRPF40A	CD4+ T cells	GSE199333_post	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28927
2.7320507135694e-119	0.266194439549649	0.323	0.163	5.80041686997918e-115	NDUFS7	CD4+ T cells	GSE199333_post	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28928
3.08977741894062e-119	-0.326840557759245	0.212	0.396	6.55990643815282e-115	SREK1IP1	CD4+ T cells	GSE199333_post	ENSG00000153006	285672	SREK1 interacting protein 1	FLJ36754|P18SRP|SFRS12IP1	protein_coding	Q8N9Q2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28929
4.38083148583382e-119	-0.322468912519543	0.174	0.35	9.30094332757377e-115	POLR3E	CD4+ T cells	GSE199333_post	ENSG00000284282	55718	RNA polymerase III subunit E	C37|FLJ10509|RPC5|SIN	protein_coding	Q9NVU0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28930
7.47725100966464e-119	-0.333159733220052	0.323	0.513	1.5874951618619e-114	EIF4H	CD4+ T cells	GSE199333_post	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28931
2.00184692490794e-118	-0.419199210523026	0.529	0.669	4.25012120627204e-114	ELF1	CD4+ T cells	GSE199333_post	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28932
2.51558374686171e-118	0.377457657019466	0.496	0.319	5.3408358529621e-114	PAG1	CD4+ T cells	GSE199333_post	ENSG00000076641	55824	phosphoprotein membrane anchor with glycosphingolipid microdomains 1	CBP|PAG	protein_coding	Q9NWQ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28933
1.04372062618746e-117	-0.264749502264699	0.108	0.271	2.21592326145859e-113	NUP54	CD4+ T cells	GSE199333_post	ENSG00000138750	53371	nucleoporin 54	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28934
1.26307060599371e-117	-0.369546590727848	0.547	0.69	2.68162520358524e-113	KRT10	CD4+ T cells	GSE199333_post	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28935
1.90176031986044e-117	0.418608464353414	0.553	0.398	4.0376273350957e-113	PLP2	CD4+ T cells	GSE199333_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28936
4.81701746102703e-117	0.341899624278948	0.654	0.485	1.02270097715065e-112	PARK7	CD4+ T cells	GSE199333_post	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28937
5.98580016049845e-117	-0.37719351325873	0.279	0.459	1.27084523207543e-112	HIST1H4C	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28938
1.7881003392755e-116	-0.329222152303567	0.242	0.422	3.79631583031581e-112	PTPN1	CD4+ T cells	GSE199333_post	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28939
4.24449191105715e-116	-0.371217155791111	0.486	0.647	9.01148077636543e-112	PPIG	CD4+ T cells	GSE199333_post	ENSG00000138398	9360	peptidylprolyl isomerase G	CARS-Cyp|SCAF10|SRCyp	protein_coding	Q13427	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28940
5.23804453346846e-116	-0.319152265764531	0.479	0.651	1.11208923490069e-111	MED10	CD4+ T cells	GSE199333_post	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28941
8.83459202317777e-116	-0.39271830959512	0.52	0.665	1.87567223244087e-111	EIF4G2	CD4+ T cells	GSE199333_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28942
8.8441761785622e-116	-0.299718681425396	0.222	0.403	1.87770704447054e-111	MED6	CD4+ T cells	GSE199333_post	ENSG00000133997	10001	mediator complex subunit 6	NY-REN-28	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28943
9.70673827457953e-116	0.313775891262707	0.491	0.314	2.06083760307598e-111	NDUFB7	CD4+ T cells	GSE199333_post	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28944
1.4213214152611e-115	-0.283707908686144	0.14	0.309	3.01760749674085e-111	TOR1AIP1	CD4+ T cells	GSE199333_post	ENSG00000143337	26092	torsin 1A interacting protein 1	FLJ13142|LAP1|LAP1B|LAP1C	protein_coding	Q5JTV8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28945
1.4670563653491e-115	-0.348874952351576	0.292	0.478	3.11470736927267e-111	CLDND1	CD4+ T cells	GSE199333_post	ENSG00000080822	56650	claudin domain containing 1	C3orf4|Z38	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28946
1.47182939471486e-115	0.258847253799423	0.275	0.129	3.12484098791912e-111	GTF2I	CD4+ T cells	GSE199333_post	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28947
1.52418329646203e-115	-0.344831430281518	0.318	0.497	3.23599355671854e-111	CCDC12	CD4+ T cells	GSE199333_post	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28948
2.57255360225116e-115	0.305963533113155	0.374	0.208	5.46178855293943e-111	MT-ND6	CD4+ T cells	GSE199333_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28949
2.81835829628903e-115	-0.347515917304074	0.232	0.411	5.98365649885124e-111	PTP4A1	CD4+ T cells	GSE199333_post	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28950
2.82567498301349e-115	-0.285366187774091	0.134	0.3	5.99919055643594e-111	CTDSPL2	CD4+ T cells	GSE199333_post	ENSG00000137770	51496	CTD small phosphatase like 2	FLJ10523|HSPC129	protein_coding	Q05D32	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28951
3.94899584420463e-115	-0.349442000929351	0.326	0.508	8.38411307683085e-111	MIER1	CD4+ T cells	GSE199333_post	ENSG00000198160	57708	MIER1 transcriptional regulator	hMI-ER1|KIAA1610|MI-ER1	protein_coding	Q8N108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28952
7.98410282186203e-115	-0.346707815220676	0.32	0.499	1.69510487010953e-110	SEPT2	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28953
9.80939307983583e-115	-0.29789166925377	0.162	0.335	2.08263224477995e-110	TMEM87A	CD4+ T cells	GSE199333_post	ENSG00000103978	25963	transmembrane protein 87A	DKFZP564G2022	protein_coding	Q8NBN3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28954
1.13181417016003e-114	0.277768020078651	0.361	0.198	2.40295466466675e-110	MRPS34	CD4+ T cells	GSE199333_post	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28955
1.3712206245421e-114	-0.295945741541429	0.15	0.318	2.91123850796532e-110	FAM118A	CD4+ T cells	GSE199333_post	ENSG00000100376	55007	family with sequence similarity 118 member A	bK268H5.C22.4|C22orf8|FLJ20635	protein_coding	Q9NWS6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28956
2.92206640814311e-114	-0.330647602535203	0.191	0.366	6.20383919112863e-110	USP36	CD4+ T cells	GSE199333_post	ENSG00000055483	57602	ubiquitin specific peptidase 36	FLJ12851|KIAA1453	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28957
3.5604196708383e-114	-0.346932375818793	0.263	0.441	7.5591270031568e-110	PPP4R3A	CD4+ T cells	GSE199333_post	ENSG00000100796	55671	protein phosphatase 4 regulatory subunit 3A	FLFL1|FLJ20707|KIAA2010|MSTP033|PP4R3|SMEK1|smk-1|smk1	protein_coding	Q6IN85	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28958
3.97807627631336e-114	0.286491616575378	0.393	0.226	8.44585374224089e-110	ATP1A1	CD4+ T cells	GSE199333_post	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28959
5.07603645407081e-114	-0.338239136130325	0.369	0.545	1.07769329956377e-109	CAMLG	CD4+ T cells	GSE199333_post	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28960
1.32165485421497e-113	-0.270118196691602	0.1	0.256	2.8060054209838e-109	DHRS3	CD4+ T cells	GSE199333_post	ENSG00000162496	9249	dehydrogenase/reductase 3	RDH17|retSDR1|Rsdr1|SDR1|SDR16C1	protein_coding	O75911	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28961
2.36980442262775e-113	-0.264227279895966	0.128	0.294	5.03133176968097e-109	FBXO21	CD4+ T cells	GSE199333_post	ENSG00000135108	23014	F-box protein 21	FBX21|KIAA0875	protein_coding	O94952	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28962
3.01218483682738e-113	-0.265328180687013	0.107	0.267	6.39516962706822e-109	RPS6KB1	CD4+ T cells	GSE199333_post	ENSG00000108443	6198	ribosomal protein S6 kinase B1	p70(S6K)-alpha|PS6K|S6K|S6K1|STK14A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28963
3.68408935576e-113	-0.317889844242959	0.185	0.359	7.82169011121405e-109	MXI1	CD4+ T cells	GSE199333_post	ENSG00000119950	4601	MAX interactor 1, dimerization protein	bHLHc11|MAD2|MXD2|MXI	protein_coding	P50539	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28964
4.67750814841015e-113	-0.366419011132093	0.548	0.693	9.93081754988959e-109	SEC62	CD4+ T cells	GSE199333_post	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28965
9.70141087418524e-113	-0.273095600376526	0.111	0.272	2.05970654269827e-108	FAM76B	CD4+ T cells	GSE199333_post	ENSG00000077458	143684	family with sequence similarity 76 member B	MGC33371	protein_coding	Q5HYJ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28966
9.82622556941207e-113	0.444350119444818	0.497	0.329	2.08620595064188e-108	AHNAK	CD4+ T cells	GSE199333_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28967
1.32051294907503e-112	-0.257711850021076	0.106	0.265	2.8035810421812e-108	TLK2	CD4+ T cells	GSE199333_post	ENSG00000146872	11011	tousled like kinase 2	MGC44450|PKU-ALPHA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28968
5.2914848521139e-111	0.307731289610429	0.423	0.254	1.1234351489523e-106	SP110	CD4+ T cells	GSE199333_post	ENSG00000135899	3431	SP110 nuclear body protein	IFI41|IFI75	protein_coding	Q9HB58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28969
6.19495138645186e-111	-0.321093129222569	0.228	0.403	1.31525012885759e-106	RAB14	CD4+ T cells	GSE199333_post	ENSG00000119396	51552	RAB14, member RAS oncogene family	FBP|RAB-14	protein_coding	P61106	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28970
1.00766100195914e-110	0.290103730921393	0.429	0.26	2.13936507325946e-106	PRDX5	CD4+ T cells	GSE199333_post	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28971
9.57288774201612e-110	-0.455817736583833	0.197	0.37	2.03241979650744e-105	NR4A2	CD4+ T cells	GSE199333_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28972
1.9217320343139e-109	0.335646761062756	0.761	0.637	4.08002928205184e-105	GPSM3	CD4+ T cells	GSE199333_post	ENSG00000233490	63940	G protein signaling modulator 3	AGS4|C6orf9|G18|G18.1a|G18.1b|G18.2|NG1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28973
8.35550178295263e-109	-0.318256294207217	0.264	0.44	1.77395658353867e-104	PJA2	CD4+ T cells	GSE199333_post	ENSG00000198961	9867	praja ring finger ubiquitin ligase 2	KIAA0438|Neurodap1|PRAJA2|RNF131	protein_coding	O43164	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28974
1.40943964774047e-108	-0.395007589346536	0.299	0.476	2.9923813161178e-104	GADD45B	CD4+ T cells	GSE199333_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28975
2.4208335167135e-108	-0.266432287018216	0.132	0.295	5.13967163933442e-104	NR1D2	CD4+ T cells	GSE199333_post	ENSG00000174738	9975	nuclear receptor subfamily 1 group D member 2	BD73|EAR-1r|Hs.37288|HZF2|REVERBB|REVERBbeta|RVR	protein_coding	Q14995	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28976
3.0752339303269e-108	-0.282472830243373	0.166	0.334	6.52902915747704e-104	HBS1L	CD4+ T cells	GSE199333_post	ENSG00000112339	10767	HBS1 like translational GTPase	DKFZp434g247|EF-1a|eRF3c|ERFS|HBS1|HSPC276|KIAA1038	protein_coding	Q9Y450	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28977
3.1658870481606e-108	0.316620034419248	0.496	0.323	6.72149479194976e-104	ANKRD44	CD4+ T cells	GSE199333_post	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28978
4.7769773838342e-108	-0.322503328755236	0.331	0.511	1.01420006836184e-103	CHD2	CD4+ T cells	GSE199333_post	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28979
6.23930147965968e-108	-0.318280989741214	0.308	0.484	1.32466609714655e-103	CWC15	CD4+ T cells	GSE199333_post	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28980
1.64502631109532e-107	-0.286412754683193	0.196	0.367	3.49255536108647e-103	GTF2B	CD4+ T cells	GSE199333_post	ENSG00000137947	2959	general transcription factor IIB	TFIIB	protein_coding	Q00403	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28981
2.19471057738544e-107	-0.306411149582883	0.226	0.401	4.65959002684704e-103	CDC40	CD4+ T cells	GSE199333_post	ENSG00000168438	51362	cell division cycle 40	EHB3|FLJ10564|PRP17|PRPF17	protein_coding	O60508	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28982
2.66322557306941e-107	0.288006128779074	0.389	0.227	5.65429421418367e-103	PGLS	CD4+ T cells	GSE199333_post	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28983
5.70331990273628e-107	-0.303405952647824	0.198	0.366	1.21087184854994e-102	FBXO33	CD4+ T cells	GSE199333_post	ENSG00000165355	254170	F-box protein 33	Fbx33	protein_coding	Q7Z6M2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28984
1.12870914365406e-106	0.292724316560562	0.399	0.239	2.39636238289193e-102	RAP1A	CD4+ T cells	GSE199333_post	ENSG00000116473	5906	RAP1A, member of RAS oncogene family	KREV-1|SMGP21	protein_coding	P62834	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28985
1.13686429799337e-105	-0.253950907528729	0.114	0.269	2.41367659106971e-101	AP1G1	CD4+ T cells	GSE199333_post	ENSG00000166747	164	adaptor related protein complex 1 subunit gamma 1	ADTG|CLAPG1	protein_coding	O43747	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28986
1.17887664356994e-105	-0.407772761302613	0.264	0.435	2.50287300196335e-101	PDE4D	CD4+ T cells	GSE199333_post	ENSG00000113448	5144	phosphodiesterase 4D	DPDE3	protein_coding	Q08499	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28987
1.41822053481165e-105	0.307326846582274	0.424	0.26	3.01102401745861e-101	TRABD2A	CD4+ T cells	GSE199333_post	ENSG00000186854	129293	TraB domain containing 2A	C2orf89|TIKI1	protein_coding	Q86V40	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28988
2.17095463529768e-105	0.271775189403884	0.358	0.201	4.6091537862005e-101	BSG	CD4+ T cells	GSE199333_post	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28989
3.42587240865647e-105	-0.298312981632985	0.221	0.394	7.27346971081854e-101	ZNF800	CD4+ T cells	GSE199333_post	ENSG00000048405	168850	zinc finger protein 800	NA	protein_coding	Q2TB10	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28990
9.80765774804213e-105	-0.317716479087755	0.141	0.3	2.08226381648682e-100	CBX4	CD4+ T cells	GSE199333_post	ENSG00000141582	8535	chromobox 4	hPC2|NBP16|PC2	protein_coding	O00257	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28991
9.99105839512798e-105	-0.311881336632067	0.31	0.486	2.12120160786962e-100	SRP19	CD4+ T cells	GSE199333_post	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28992
1.39458717763776e-104	-0.322609760917601	0.401	0.577	2.96084803684273e-100	CD6	CD4+ T cells	GSE199333_post	ENSG00000013725	923	CD6 molecule	Tp120	protein_coding	P30203	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28993
2.61763306656973e-103	0.357946103021078	0.553	0.393	5.55749676363418e-99	RPS27L	CD4+ T cells	GSE199333_post	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28994
2.80283588160471e-103	-0.301361773250019	0.229	0.4	5.95070086023497e-99	SAR1A	CD4+ T cells	GSE199333_post	ENSG00000079332	56681	secretion associated Ras related GTPase 1A	SAR1|Sara|SARA1	protein_coding	Q9NR31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28995
3.4428134343126e-103	-0.326397636592964	0.307	0.482	7.30943720238908e-99	YME1L1	CD4+ T cells	GSE199333_post	ENSG00000136758	10730	YME1 like 1 ATPase	YME1L	protein_coding	Q96TA2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28996
3.526578162956e-103	-0.333832293960169	0.432	0.596	7.48727809777188e-99	TERF2IP	CD4+ T cells	GSE199333_post	ENSG00000166848	54386	TERF2 interacting protein	RAP1	protein_coding	Q9NYB0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28997
4.20238486556057e-103	0.309575194463807	0.567	0.4	8.92208330807165e-99	PRR13	CD4+ T cells	GSE199333_post	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28998
7.71216112905897e-103	-0.26942231973121	0.125	0.279	1.63736892931051e-98	CWC25	CD4+ T cells	GSE199333_post	ENSG00000276761	54883	CWC25 spliceosome associated protein homolog	CCDC49|FLJ20291	protein_coding	Q9NXE8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	28999
1.13698097370634e-102	-0.281161068830257	0.135	0.293	2.41392430527593e-98	YIPF5	CD4+ T cells	GSE199333_post	ENSG00000145817	81555	Yip1 domain family member 5	FinGER5|SMAP-5	protein_coding	Q969M3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29000
1.80350953663215e-102	-0.29809886134874	0.199	0.363	3.82903109722371e-98	ARRDC2	CD4+ T cells	GSE199333_post	ENSG00000105643	27106	arrestin domain containing 2	CLONE24945|PP2703	protein_coding	Q8TBH0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29001
1.96174730303252e-102	-0.324361893192148	0.316	0.485	4.16498569906835e-98	REST	CD4+ T cells	GSE199333_post	ENSG00000084093	5978	RE1 silencing transcription factor	DFNA27|NRSF|XBR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29002
3.5443386020935e-102	0.274091757135912	0.292	0.151	7.52498528610471e-98	JPT1	CD4+ T cells	GSE199333_post	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29003
1.56313274963528e-101	-0.274405564940163	0.131	0.286	3.31868714075067e-97	PSME4	CD4+ T cells	GSE199333_post	ENSG00000068878	23198	proteasome activator subunit 4	KIAA0077|PA200	protein_coding	Q14997	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29004
4.62746832856644e-101	-0.329567505573597	0.556	0.687	9.82457800837941e-97	PRDX6	CD4+ T cells	GSE199333_post	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29005
7.10491529525348e-101	-0.449226391502282	0.77	0.858	1.50844456633527e-96	H1FX	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29006
1.26509290246842e-100	-0.291792919361321	0.192	0.356	2.6859187412307e-96	ESCO1	CD4+ T cells	GSE199333_post	ENSG00000141446	114799	establishment of sister chromatid cohesion N-acetyltransferase 1	EFO1|ESO1|KIAA1911	protein_coding	Q5FWF5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29007
2.02108266499332e-100	-0.277789899007557	0.167	0.328	4.29096060604731e-96	ZFR	CD4+ T cells	GSE199333_post	ENSG00000056097	51663	zinc finger RNA binding protein	SPG71|ZFR1	protein_coding	Q96KR1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29008
2.54934443125555e-100	0.279569593599463	0.521	0.348	5.41251316199865e-96	DBI	CD4+ T cells	GSE199333_post	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29009
4.08173548679961e-100	-0.280478136049118	0.216	0.385	8.66593261202425e-96	EMC3	CD4+ T cells	GSE199333_post	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29010
5.72614666967922e-100	-0.277955499460527	0.165	0.325	1.2157181994396e-95	MORC3	CD4+ T cells	GSE199333_post	ENSG00000159256	23515	MORC family CW-type zinc finger 3	KIAA0136|NXP2|ZCW5|ZCWCC3	protein_coding	Q14149	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29011
7.79620922445951e-100	-0.339822102742255	0.563	0.695	1.655213180445e-95	SYF2	CD4+ T cells	GSE199333_post	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29012
1.22303329580998e-99	-0.396542318659007	0.309	0.473	2.59662199033418e-95	NR3C1	CD4+ T cells	GSE199333_post	ENSG00000113580	2908	nuclear receptor subfamily 3 group C member 1	GR|GRL	protein_coding	P04150	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29013
1.54454797276695e-99	-0.298623611655959	0.333	0.501	3.2792298009815e-95	SNRPC	CD4+ T cells	GSE199333_post	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29014
3.97676181178887e-99	-0.324232116111876	0.366	0.529	8.44306300260896e-95	EAPP	CD4+ T cells	GSE199333_post	ENSG00000129518	55837	E2F associated phosphoprotein	BM036|C14orf11|FLJ20578	protein_coding	Q56P03	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29015
4.0834561922629e-99	-0.318600957218167	0.217	0.381	8.66958584179337e-95	P2RY8	CD4+ T cells	GSE199333_post	ENSG00000182162	286530	P2Y receptor family member 8	P2Y8	protein_coding	Q86VZ1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29016
4.45239052300994e-99	-0.55528034894201	0.114	0.258	9.45287031940241e-95	PMAIP1	CD4+ T cells	GSE199333_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29017
1.00026084819393e-98	-0.366231816188828	0.347	0.518	2.12365380680054e-94	IDS	CD4+ T cells	GSE199333_post	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29018
1.42268041649963e-98	-0.284215669359297	0.251	0.418	3.02049279227037e-94	IMP3	CD4+ T cells	GSE199333_post	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29019
1.51000094419181e-98	0.309190673201651	0.568	0.403	3.20588300461363e-94	CNN2	CD4+ T cells	GSE199333_post	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29020
4.28778635638823e-98	-0.311533857370213	0.324	0.492	9.10339921324784e-94	AIMP1	CD4+ T cells	GSE199333_post	ENSG00000164022	9255	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	EMAP-2|EMAPII|p43|SCYE1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29021
6.85586010379144e-98	-0.326023468729628	0.394	0.555	1.45556765863596e-93	HEBP2	CD4+ T cells	GSE199333_post	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29022
1.05584422466976e-97	-0.339691464448243	0.708	0.793	2.24166287339636e-93	CDC42SE2	CD4+ T cells	GSE199333_post	ENSG00000158985	56990	CDC42 small effector 2	FLJ21967|SPEC2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29023
3.77077341544475e-97	-0.253860712647929	0.157	0.313	8.00572903833074e-93	RAB5A	CD4+ T cells	GSE199333_post	ENSG00000144566	5868	RAB5A, member RAS oncogene family	RAB5	protein_coding	P20339	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29024
8.09838593090781e-97	-0.251944873729644	0.127	0.276	1.71936831699104e-92	ASNSD1	CD4+ T cells	GSE199333_post	ENSG00000138381	54529	asparagine synthetase domain containing 1	FLJ20752|NBLA00058|NS3TP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29025
1.14321656251476e-96	0.254779715458023	0.911	0.835	2.42716308387509e-92	UBB	CD4+ T cells	GSE199333_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29026
1.84349636933549e-96	-0.293586050726201	0.247	0.412	3.91392714173619e-92	RBM23	CD4+ T cells	GSE199333_post	ENSG00000100461	55147	RNA binding motif protein 23	CAPERbeta|FLJ10482|RNPC4	protein_coding	Q86U06	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29027
1.96740820521947e-96	-0.27612923627396	0.969	0.982	4.17700436050145e-92	YBX1	CD4+ T cells	GSE199333_post	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29028
4.8637940789238e-96	0.315732860776626	0.568	0.418	1.03263212089631e-91	NDUFA12	CD4+ T cells	GSE199333_post	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29029
5.21430575236292e-96	-0.342417072695597	0.338	0.496	1.10704925428417e-91	DHX36	CD4+ T cells	GSE199333_post	ENSG00000281763	170506	DEAH-box helicase 36	DDX36|KIAA1488|MLEL1|RHAU	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29030
6.35527403252298e-96	-0.383905646255151	0.494	0.64	1.34928822984495e-91	BTG2	CD4+ T cells	GSE199333_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29031
9.510932685804e-96	-0.297444196957922	0.334	0.502	2.01926611852305e-91	SNRPD1	CD4+ T cells	GSE199333_post	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29032
1.36151516452278e-95	-0.265601077843621	0.168	0.326	2.8906328457983e-91	INO80D	CD4+ T cells	GSE199333_post	ENSG00000283510	54891	INO80 complex subunit D	FLJ20309	protein_coding	Q53TQ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29033
2.34332268183597e-95	-0.257687125517428	0.194	0.354	4.97510838580594e-91	CDC123	CD4+ T cells	GSE199333_post	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29034
1.48526863731821e-94	-0.302988109391884	0.332	0.497	3.1533738438903e-90	MECP2	CD4+ T cells	GSE199333_post	ENSG00000169057	4204	methyl-CpG binding protein 2	MRX16|MRX79|RTT	protein_coding	P51608	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29035
2.96328500651232e-94	-0.269479338671241	0.167	0.32	6.2913503973263e-90	ZC3H7A	CD4+ T cells	GSE199333_post	ENSG00000122299	29066	zinc finger CCCH-type containing 7A	FLJ20318|HSPC055|ZC3H7|ZC3HDC7	protein_coding	Q8IWR0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29036
7.83440864548381e-94	-0.297781048219774	0.303	0.465	1.66332329952267e-89	DNTTIP2	CD4+ T cells	GSE199333_post	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29037
1.23963252373252e-93	0.304135986911883	0.503	0.349	2.6318638111365e-89	CCT8	CD4+ T cells	GSE199333_post	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29038
1.31054559879563e-93	0.266259617632442	0.37	0.223	2.78241936080301e-89	SRI	CD4+ T cells	GSE199333_post	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29039
3.05204415583057e-93	0.354884869406156	0.615	0.469	6.47979494724388e-89	RNF213	CD4+ T cells	GSE199333_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29040
3.91845290117205e-93	-0.28866662710336	0.321	0.481	8.31926735447838e-89	NCBP2-AS2	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29041
8.560726386915e-93	-0.303438875909421	0.325	0.486	1.81752781920592e-88	RAB2A	CD4+ T cells	GSE199333_post	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29042
9.19917546147999e-93	-0.305635248287064	0.515	0.663	1.95307694222682e-88	GPBP1	CD4+ T cells	GSE199333_post	ENSG00000062194	65056	GC-rich promoter binding protein 1	DKFZp761C169	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29043
9.89348502536126e-93	0.326160593674539	0.618	0.466	2.10048580573445e-88	LUC7L3	CD4+ T cells	GSE199333_post	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29044
1.4563210742741e-92	-0.473034513075616	0.499	0.66	3.09191527279135e-88	JUN	CD4+ T cells	GSE199333_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29045
1.73352533962549e-92	0.274052345752247	0.398	0.248	3.68044764855888e-88	CSNK2B	CD4+ T cells	GSE199333_post	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29046
9.02616679854945e-92	-0.279158851821332	0.265	0.429	1.91634547300003e-87	PCGF5	CD4+ T cells	GSE199333_post	ENSG00000180628	84333	polycomb group ring finger 5	MGC16202|RNF159	protein_coding	Q86SE9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29047
9.13251721791895e-92	0.338188032105855	0.385	0.24	1.93892473053637e-87	MACF1	CD4+ T cells	GSE199333_post	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29048
1.41617211060082e-91	-0.3162283360438	0.593	0.714	3.00667500801661e-87	CIB1	CD4+ T cells	GSE199333_post	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29049
1.56614229416378e-91	0.287031683359845	0.525	0.37	3.32507670473911e-87	COX7A2L	CD4+ T cells	GSE199333_post	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29050
2.25213256375042e-91	-0.264200180911142	0.158	0.311	4.78150264609852e-87	DIS3	CD4+ T cells	GSE199333_post	ENSG00000083520	22894	DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease	dis3p|EXOSC11|KIAA1008|RRP44	protein_coding	Q9Y2L1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29051
2.97091437323065e-91	-0.26936763588118	0.187	0.341	6.307548305806e-87	PCIF1	CD4+ T cells	GSE199333_post	ENSG00000100982	63935	phosphorylated CTD interacting factor 1	bA465L10.1|C20orf67|CAPAM|PPP1R121	protein_coding	Q9H4Z3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29052
4.07448757716246e-91	-0.318632082091585	0.32	0.478	8.65054457507361e-87	PRDM2	CD4+ T cells	GSE199333_post	ENSG00000116731	7799	PR/SET domain 2	HUMHOXY1|KMT8|KMT8A|MTB-ZF|RIZ|RIZ1|RIZ2	protein_coding	Q13029	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29053
1.44573725218734e-90	-0.320654528607556	0.291	0.453	3.06944476011894e-86	JMJD1C	CD4+ T cells	GSE199333_post	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29054
1.4900264938151e-90	-0.280896138545824	0.245	0.406	3.16347524901885e-86	ZNF430	CD4+ T cells	GSE199333_post	ENSG00000278780	80264	zinc finger protein 430	FLJ13659	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29055
1.9668570586117e-90	-0.271825531469077	0.255	0.415	4.17583422113851e-86	BNIP2	CD4+ T cells	GSE199333_post	ENSG00000140299	663	BCL2 interacting protein 2	BNIP-2|Nip2	protein_coding	Q12982	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29056
2.08688847733328e-90	-0.320859408009656	0.629	0.748	4.43067292622628e-86	NKTR	CD4+ T cells	GSE199333_post	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29057
5.46850970775804e-90	-0.293551762610147	0.253	0.414	1.16101929605411e-85	KLHL24	CD4+ T cells	GSE199333_post	ENSG00000114796	54800	kelch like family member 24	DRE1|FLJ20059	protein_coding	Q6TFL4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29058
1.20477376298792e-89	-0.306494356127069	0.24	0.396	2.55785517619966e-85	NFKB1	CD4+ T cells	GSE199333_post	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29059
1.24788845349581e-89	-0.265918595242616	0.188	0.342	2.64939197561696e-85	ZNF451	CD4+ T cells	GSE199333_post	ENSG00000112200	26036	zinc finger protein 451	COASTER|dJ417I1.1|KIAA0576|KIAA1702|ZATT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29060
7.47471116738916e-89	-0.274438191585156	0.825	0.882	1.58695592794839e-84	ATP6V1G1	CD4+ T cells	GSE199333_post	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29061
9.52950802561326e-89	-0.280759322219765	0.238	0.395	2.02320984891795e-84	RAB21	CD4+ T cells	GSE199333_post	ENSG00000080371	23011	RAB21, member RAS oncogene family	KIAA0118	protein_coding	Q9UL25	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29062
1.03182713371463e-88	0.298768563901551	0.507	0.352	2.19067218758954e-84	TXN	CD4+ T cells	GSE199333_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29063
2.59892818132773e-88	0.275215725299315	0.487	0.332	5.5177844217769e-84	VPS28	CD4+ T cells	GSE199333_post	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29064
3.06375768761127e-88	0.269085882735251	0.577	0.416	6.50466394656748e-84	ATP5PF	CD4+ T cells	GSE199333_post	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29065
6.41742788229281e-88	0.358389858838878	0.418	0.279	1.36248411368959e-83	TIMP1	CD4+ T cells	GSE199333_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29066
7.68493546061138e-88	0.272371366094364	0.35	0.211	1.6315886476424e-83	DOCK8	CD4+ T cells	GSE199333_post	ENSG00000107099	81704	dedicator of cytokinesis 8	FLJ00026|FLJ00152|FLJ00346|ZIR8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29067
1.40835909261692e-87	-0.325280225735374	0.759	0.842	2.99008718953499e-83	SRSF7	CD4+ T cells	GSE199333_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29068
1.40846892099238e-87	-0.292513027152808	0.182	0.332	2.99032036615893e-83	SLBP	CD4+ T cells	GSE199333_post	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29069
5.17663512953988e-87	-0.273183945871111	0.189	0.339	1.09905140435261e-82	BRD1	CD4+ T cells	GSE199333_post	ENSG00000100425	23774	bromodomain containing 1	BRL|BRPF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29070
7.46488990453349e-87	-0.295534931325533	0.466	0.61	1.58487077563151e-82	VAPA	CD4+ T cells	GSE199333_post	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29071
9.82388564612582e-87	-0.348698044861505	0.195	0.341	2.08570916152897e-82	SYAP1	CD4+ T cells	GSE199333_post	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29072
1.15491028479208e-86	0.265008732653282	0.296	0.166	2.45199002564206e-82	MDFIC	CD4+ T cells	GSE199333_post	ENSG00000135272	29969	MyoD family inhibitor domain containing	HIC|MDFIC1	protein_coding	Q9P1T7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29073
1.54004300890696e-86	-0.289848959926454	0.245	0.401	3.26966531221036e-82	SMC3	CD4+ T cells	GSE199333_post	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29074
1.60344272495583e-86	-0.316039327231555	0.651	0.75	3.40426924935372e-82	TRA2B	CD4+ T cells	GSE199333_post	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29075
2.48142840497448e-86	0.288719659388463	0.425	0.28	5.26832064660132e-82	OXNAD1	CD4+ T cells	GSE199333_post	ENSG00000154814	92106	oxidoreductase NAD binding domain containing 1	MGC15763	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29076
5.47802460845185e-86	-0.273726247444418	0.163	0.307	1.16303940462041e-81	MAPKAPK2	CD4+ T cells	GSE199333_post	ENSG00000162889	9261	MAPK activated protein kinase 2	MK2	protein_coding	P49137	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29077
5.84905462054278e-86	-0.255464157715297	0.192	0.344	1.24181278648744e-81	STAU1	CD4+ T cells	GSE199333_post	ENSG00000124214	6780	staufen double-stranded RNA binding protein 1	PPP1R150|STAU	protein_coding	O95793	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29078
6.25700134253018e-86	0.270053175404714	0.656	0.505	1.32842395503258e-81	SLC25A5	CD4+ T cells	GSE199333_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29079
6.38550491837318e-86	-0.293044476456869	0.232	0.382	1.35570654921981e-81	LAPTM4A	CD4+ T cells	GSE199333_post	ENSG00000068697	9741	lysosomal protein transmembrane 4 alpha	HUMORF13|KIAA0108|LAPTM4|MBNT|Mtrp	protein_coding	Q15012	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29080
1.1025454720216e-85	-0.326209452036526	0.526	0.662	2.34081429164907e-81	SMCHD1	CD4+ T cells	GSE199333_post	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29081
8.55680422336294e-85	0.265870461248762	0.485	0.333	1.81669510466219e-80	TRMT112	CD4+ T cells	GSE199333_post	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29082
1.00319395056985e-84	0.261096175483306	0.481	0.33	2.12988107645484e-80	PSMB3	CD4+ T cells	GSE199333_post	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29083
1.03887614492476e-84	0.359513285006083	0.489	0.344	2.20563794328976e-80	FLNA	CD4+ T cells	GSE199333_post	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29084
3.8946731928271e-84	0.346667254395197	0.612	0.481	8.26878065569123e-80	MAL	CD4+ T cells	GSE199333_post	ENSG00000172005	4118	mal, T cell differentiation protein	MVP17|VIP17	protein_coding	P21145	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29085
1.06387494441935e-83	0.265972177943622	0.354	0.216	2.25871289449672e-79	CAPNS1	CD4+ T cells	GSE199333_post	ENSG00000126247	826	calpain small subunit 1	30K|CANP|CANPS|CAPN4|CDPS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29086
1.06443718649642e-83	-0.259583886138407	0.214	0.365	2.25990659065054e-79	SSH2	CD4+ T cells	GSE199333_post	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29087
1.23430034394823e-83	0.277160069827557	0.667	0.524	2.6205430602365e-79	PSMA7	CD4+ T cells	GSE199333_post	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29088
5.22125790818072e-83	-0.260222481413725	0.205	0.355	1.10852526648585e-78	IREB2	CD4+ T cells	GSE199333_post	ENSG00000136381	3658	iron responsive element binding protein 2	IRP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29089
1.08301120077183e-82	-0.261568309161521	0.138	0.273	2.29934108035868e-78	C12orf65	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29090
1.62708788861451e-82	0.281850838511212	0.393	0.252	3.45447029631747e-78	SLFN5	CD4+ T cells	GSE199333_post	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29091
5.16691700203123e-82	0.275428121038778	0.708	0.569	1.09698814870125e-77	GPX4	CD4+ T cells	GSE199333_post	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29092
2.90718966598219e-81	-0.272868676324679	0.282	0.431	6.1722543798468e-77	RNF145	CD4+ T cells	GSE199333_post	ENSG00000145860	153830	ring finger protein 145	FLJ31951	protein_coding	Q96MT1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29093
3.23931521690345e-81	-0.256210723586056	0.235	0.386	6.87739013700771e-77	HNRNPL	CD4+ T cells	GSE199333_post	ENSG00000282947	3191	heterogeneous nuclear ribonucleoprotein L	HNRPL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29094
3.5607087929022e-81	-0.297460459987248	0.356	0.505	7.55974083821067e-77	TUT4	CD4+ T cells	GSE199333_post	ENSG00000134744	23318	terminal uridylyl transferase 4	KIAA0191|PAPD3|TENT3A|ZCCHC11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29095
3.61183964837305e-81	-0.25098415787833	0.212	0.362	7.66829675746083e-77	MPHOSPH10	CD4+ T cells	GSE199333_post	ENSG00000124383	10199	M-phase phosphoprotein 10	CT90|MPP10|MPP10P|PPP1R106	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29096
3.9759618542757e-81	0.277511649408459	0.534	0.392	8.44136461281275e-77	CCDC85B	CD4+ T cells	GSE199333_post	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29097
4.79449225285134e-80	-0.260878335304514	0.247	0.397	1.01791865020287e-75	NECAP1	CD4+ T cells	GSE199333_post	ENSG00000089818	25977	NECAP endocytosis associated 1	DKFZP566B183	protein_coding	Q8NC96	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29098
6.21199903659437e-80	0.276749357251071	0.565	0.42	1.31886951545935e-75	DDT	CD4+ T cells	GSE199333_post	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29099
1.22929785035695e-79	-0.280330847943249	0.267	0.416	2.60992226609283e-75	SECISBP2	CD4+ T cells	GSE199333_post	ENSG00000187742	79048	SECIS binding protein 2	SBP2	protein_coding	Q96T21	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29100
1.26130724322047e-78	-0.286479415904155	0.407	0.557	2.67788140808137e-74	ADAR	CD4+ T cells	GSE199333_post	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29101
2.00350132429936e-78	-0.253633940638332	0.211	0.355	4.25363366161998e-74	ASXL1	CD4+ T cells	GSE199333_post	ENSG00000171456	171023	ASXL transcriptional regulator 1	KIAA0978	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29102
4.16005967201886e-78	-0.250298399394987	0.182	0.323	8.83222268966324e-74	RANBP2	CD4+ T cells	GSE199333_post	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29103
5.38275231784162e-78	-0.259394671153142	0.237	0.384	1.14281214460095e-73	N4BP1	CD4+ T cells	GSE199333_post	ENSG00000102921	9683	NEDD4 binding protein 1	NA	protein_coding	O75113	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29104
6.5261865956019e-78	0.289363014215597	0.551	0.408	1.38557467611224e-73	TUBA1B	CD4+ T cells	GSE199333_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29105
7.06793187647317e-78	-0.254026441816553	0.234	0.379	1.50059261669402e-73	BEX4	CD4+ T cells	GSE199333_post	ENSG00000102409	56271	brain expressed X-linked 4	BEXL1|FLJ10097	protein_coding	Q9NWD9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29106
7.5678621678932e-78	-0.280527330201752	0.646	0.747	1.60673281686541e-73	RSL24D1	CD4+ T cells	GSE199333_post	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29107
1.05100648827352e-77	-0.268742305637806	0.717	0.799	2.23139187525351e-73	TOMM20	CD4+ T cells	GSE199333_post	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29108
2.96813613028266e-77	-0.264079666544299	0.222	0.362	6.30164981820311e-73	BEX2	CD4+ T cells	GSE199333_post	ENSG00000133134	84707	brain expressed X-linked 2	DJ79P11.1	protein_coding	Q9BXY8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29109
3.98195834461144e-77	-0.282839586125184	0.346	0.494	8.45409576144454e-73	CLK1	CD4+ T cells	GSE199333_post	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29110
6.4798595228243e-77	0.301447290891116	0.492	0.353	1.37573897529083e-72	LEF1	CD4+ T cells	GSE199333_post	ENSG00000138795	51176	lymphoid enhancer binding factor 1	TCF10|TCF1ALPHA|TCF7L3	protein_coding	Q9UJU2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29111
1.10328097176712e-76	0.256512097792198	0.367	0.233	2.34237583115878e-72	SH3KBP1	CD4+ T cells	GSE199333_post	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29112
1.27847513533539e-76	-0.265034489599943	0.257	0.403	2.71433055983057e-72	ANKRD49	CD4+ T cells	GSE199333_post	ENSG00000168876	54851	ankyrin repeat domain 49	FGIF|FLJ20189|GBIF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29113
1.32632073551487e-76	0.255576215989251	0.382	0.245	2.81591155357162e-72	PRKCB	CD4+ T cells	GSE199333_post	ENSG00000166501	5579	protein kinase C beta	PKCB|PKCbeta|PRKCB1|PRKCB2	protein_coding	P05771	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29114
4.35854811188368e-76	-0.253816103653904	0.217	0.36	9.25363349634024e-72	ZBTB1	CD4+ T cells	GSE199333_post	ENSG00000126804	22890	zinc finger and BTB domain containing 1	KIAA0997|ZNF909	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29115
1.01458012365003e-75	0.267416055332266	0.501	0.362	2.15405506052137e-71	TSTD1	CD4+ T cells	GSE199333_post	ENSG00000215845	100131187	thiosulfate sulfurtransferase like domain containing 1	KAT	protein_coding	Q8NFU3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29116
2.49950351844735e-75	-0.339574333124466	0.71	0.794	5.30669592001557e-71	HNRNPH1	CD4+ T cells	GSE199333_post	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29117
1.26103370901452e-74	0.254977580834673	0.808	0.696	2.67730066760874e-70	UQCR11	CD4+ T cells	GSE199333_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29118
1.99801868599354e-74	-0.266028348252174	0.321	0.47	4.24199347223288e-70	RBM17	CD4+ T cells	GSE199333_post	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29119
4.5433728229402e-74	-0.285285001772121	0.288	0.43	9.64603484038434e-70	TMF1	CD4+ T cells	GSE199333_post	ENSG00000144747	7110	TATA element modulatory factor 1	ARA160|TMF	protein_coding	P82094	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29120
1.12085558659218e-73	0.263207027885938	0.494	0.357	2.37968849589386e-69	FIS1	CD4+ T cells	GSE199333_post	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29121
1.85588357315989e-73	-0.26560760906201	0.289	0.433	3.94022641417577e-69	STAG2	CD4+ T cells	GSE199333_post	ENSG00000101972	10735	stromal antigen 2	SA-2|SA2|SCC3B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29122
2.1609672268566e-73	-0.278655901327679	0.504	0.628	4.58794951933926e-69	SCAND1	CD4+ T cells	GSE199333_post	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29123
1.0022503908999e-72	-0.298612722724747	0.458	0.581	2.12787780491957e-68	POMP	CD4+ T cells	GSE199333_post	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29124
1.03214505311918e-72	-0.276523294963526	0.321	0.46	2.19134716227734e-68	ILF3	CD4+ T cells	GSE199333_post	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29125
2.90676487087359e-71	-0.25616309288404	0.476	0.617	6.17135249735173e-67	USP15	CD4+ T cells	GSE199333_post	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29126
9.62676856699469e-71	-0.261078438367258	0.397	0.532	2.04385923445864e-66	SIVA1	CD4+ T cells	GSE199333_post	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29127
2.51531904996798e-70	0.330086076270126	0.623	0.5	5.34027387498702e-66	ATM	CD4+ T cells	GSE199333_post	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29128
9.37342506934633e-69	-0.266634395327202	0.319	0.458	1.99007187647292e-64	AMD1	CD4+ T cells	GSE199333_post	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29129
1.21224501972866e-68	-0.253845334058733	0.843	0.895	2.57371740138592e-64	SUB1	CD4+ T cells	GSE199333_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29130
1.50450811795589e-68	-0.284761580461797	0.579	0.679	3.19422118523215e-64	PAIP2	CD4+ T cells	GSE199333_post	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29131
6.37230789345294e-68	0.252996640187633	0.593	0.466	1.35290468885899e-63	NDUFB8	CD4+ T cells	GSE199333_post	ENSG00000166136	4714	NADH:ubiquinone oxidoreductase subunit B8	ASHI|CI-ASHI	protein_coding	O95169	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29132
6.74462247886336e-68	-0.274309956318409	0.269	0.404	1.43195079848748e-63	CORO7	CD4+ T cells	GSE199333_post	ENSG00000282725	79585	coronin 7	FLJ22021|POD1	protein_coding	P57737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29133
8.0541783361109e-68	-0.254839467566202	0.609	0.721	1.7099826025397e-63	HNRNPM	CD4+ T cells	GSE199333_post	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29134
1.19268268880053e-67	0.27079956639304	0.449	0.323	2.5321846165924e-63	ARHGAP15	CD4+ T cells	GSE199333_post	ENSG00000075884	55843	Rho GTPase activating protein 15	BM046	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29135
1.77765708209155e-67	0.278491420968251	0.645	0.529	3.77414375098857e-63	RCAN3	CD4+ T cells	GSE199333_post	ENSG00000117602	11123	RCAN family member 3	DSCR1L2	protein_coding	Q9UKA8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29136
3.12717491030339e-67	-0.387162127345573	0.932	0.943	6.63930505206512e-63	ZFP36L2	CD4+ T cells	GSE199333_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29137
4.03930291993689e-67	-0.253048964865456	0.29	0.426	8.575844029318e-63	GPATCH8	CD4+ T cells	GSE199333_post	ENSG00000186566	23131	G-patch domain containing 8	GPATC8|KIAA0553	protein_coding	Q9UKJ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29138
9.89707438710457e-67	-0.323772671849311	0.44	0.563	2.10124786312617e-62	PPP1CB	CD4+ T cells	GSE199333_post	ENSG00000213639	5500	protein phosphatase 1 catalytic subunit beta	MP|PP-1B|PP1B|PP1beta|PP1c|PPP1beta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29139
1.02887472102966e-66	-0.281275493245293	0.581	0.684	2.18440392021808e-62	TAPBP	CD4+ T cells	GSE199333_post	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29140
1.28991567077252e-66	-0.277596426267313	0.537	0.661	2.73861996061714e-62	RWDD1	CD4+ T cells	GSE199333_post	ENSG00000111832	51389	RWD domain containing 1	PTD013	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29141
5.35357643276455e-66	-0.250103489071709	0.207	0.338	1.13661781244024e-61	SETD2	CD4+ T cells	GSE199333_post	ENSG00000181555	29072	SET domain containing 2, histone lysine methyltransferase	FLJ23184|HIF-1|HYPB|KIAA1732|KMT3A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29142
7.4222179343844e-66	-0.275473444583441	0.574	0.673	1.57581108964915e-61	SNU13	CD4+ T cells	GSE199333_post	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29143
9.26702741717855e-66	-0.262287921664498	0.577	0.679	1.96748259094118e-61	SNRPB	CD4+ T cells	GSE199333_post	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29144
2.17744886717896e-65	-0.271422695893395	0.267	0.398	4.62294168990766e-61	ITPKB	CD4+ T cells	GSE199333_post	ENSG00000143772	3707	inositol-trisphosphate 3-kinase B	IP3-3KB|IP3KB	protein_coding	P27987	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29145
4.02840162273849e-64	-0.327535597066074	0.245	0.373	8.55269948523609e-60	RNF19A	CD4+ T cells	GSE199333_post	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29146
8.64230600055352e-64	0.257924531282748	0.686	0.571	1.83484798697752e-59	ATP5ME	CD4+ T cells	GSE199333_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29147
9.34868233755516e-63	0.260837051566382	0.744	0.65	1.98481874708634e-58	HNRNPA3	CD4+ T cells	GSE199333_post	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29148
1.56466252704359e-62	-0.328442566625508	0.277	0.396	3.32193501116624e-58	CTSW	CD4+ T cells	GSE199333_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29149
6.99043387658933e-62	0.258574158334094	0.581	0.457	1.48413901633868e-57	ADD3	CD4+ T cells	GSE199333_post	ENSG00000148700	120	adducin 3	ADDL	protein_coding	Q9UEY8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29150
1.37647936946473e-61	0.267099452959301	0.628	0.517	2.92240334931057e-57	RARRES3	CD4+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29151
1.49691309368917e-60	-0.259760934502174	0.286	0.416	3.17809618921149e-56	BAZ1A	CD4+ T cells	GSE199333_post	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29152
2.45733470697752e-60	-0.254912255972244	0.365	0.494	5.21716731638396e-56	RTF1	CD4+ T cells	GSE199333_post	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29153
1.01881726938884e-59	-0.268986908571018	0.368	0.495	2.16305094463945e-55	PCM1	CD4+ T cells	GSE199333_post	ENSG00000078674	5108	pericentriolar material 1	PTC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29154
2.31383908862444e-58	-0.280564128687467	0.25	0.372	4.91251176905855e-54	GOLGB1	CD4+ T cells	GSE199333_post	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29155
8.82428641015878e-58	-0.308049802823652	0.552	0.644	1.87348424774081e-53	TCF25	CD4+ T cells	GSE199333_post	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29156
1.86018698783531e-55	-0.253948657030935	0.541	0.648	3.94936299387314e-51	SCAF11	CD4+ T cells	GSE199333_post	ENSG00000139218	9169	SR-related CTD associated factor 11	CASP11|SFRS2IP|SIP1|SRRP129|SRSF2IP	protein_coding	Q99590	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29157
1.26285780049796e-54	-0.255249915802598	0.446	0.556	2.68117339623722e-50	BZW1	CD4+ T cells	GSE199333_post	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29158
1.56964677597856e-54	0.265074336489841	0.429	0.309	3.33251707008009e-50	CRIP1	CD4+ T cells	GSE199333_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29159
1.89966155944205e-51	0.267436306027362	0.767	0.682	4.03317145685141e-47	TRBC2	CD4+ T cells	GSE199333_post	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29160
1.66566424145696e-50	-0.251819210955998	0.41	0.523	3.53637175103728e-46	MBP	CD4+ T cells	GSE199333_post	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29161
6.2989117755257e-49	-0.264979047596856	0.304	0.409	1.33732195906186e-44	GSPT1	CD4+ T cells	GSE199333_post	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29162
9.23922827714373e-47	-0.286621011573182	0.241	0.346	1.96158055552039e-42	CREM	CD4+ T cells	GSE199333_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29163
1.53186097534344e-45	-0.312109904588975	0.338	0.439	3.25229403675167e-41	RUNX3	CD4+ T cells	GSE199333_post	ENSG00000020633	864	RUNX family transcription factor 3	AML2|CBFA3|PEBP2A3	protein_coding	Q13761	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29164
4.82792510528679e-45	-0.530170052223279	0.366	0.453	1.02501677910344e-40	MT2A	CD4+ T cells	GSE199333_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29165
2.17131079771162e-36	-0.281671641529625	0.774	0.824	4.60990995462155e-32	CXCR4	CD4+ T cells	GSE199333_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29166
2.46756169820075e-36	0.289114994570675	0.628	0.56	5.23888024145001e-32	COTL1	CD4+ T cells	GSE199333_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29167
6.32026690973889e-35	-0.302241756835425	0.283	0.376	1.34185586760666e-30	FOS	CD4+ T cells	GSE199333_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29168
5.33948774324095e-31	-0.265774293098636	0.855	0.888	1.13362664276749e-26	JUNB	CD4+ T cells	GSE199333_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29169
3.02184039875848e-30	-0.404880549732988	0.456	0.516	6.41566935060412e-26	EZR	CD4+ T cells	GSE199333_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29170
1.87684025450224e-27	-0.313646283800997	0.406	0.478	3.98471954433371e-23	ZFP36	CD4+ T cells	GSE199333_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29171
0	0.932579070475955	0.51	0.11	0	S100A11	CD8+ T cells	GSE199333_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29172
0	1.0504977853298	0.969	0.904	0	S100A4	CD8+ T cells	GSE199333_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29173
0	0.635473075520252	1	1	0	RPL9	CD8+ T cells	GSE199333_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29174
0	-1.13409253736218	0.591	0.875	0	HMGB2	CD8+ T cells	GSE199333_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29175
0	-1.08619674748936	0.752	0.907	0	PIK3R1	CD8+ T cells	GSE199333_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29176
0	0.511817374446442	1	1	0	RPS23	CD8+ T cells	GSE199333_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29177
0	-0.596933374081816	1	1	0	HLA-B	CD8+ T cells	GSE199333_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29178
0	1.71328633354952	0.801	0.384	0	LTB	CD8+ T cells	GSE199333_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29179
0	0.859819002071435	1	1	0	RPS18	CD8+ T cells	GSE199333_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29180
0	0.649342676452278	1	0.998	0	RPL27A	CD8+ T cells	GSE199333_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29181
0	-0.701372960444619	1	1	0	MALAT1	CD8+ T cells	GSE199333_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29182
0	1.3203637683044	0.979	0.797	0	VIM	CD8+ T cells	GSE199333_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29183
0	-0.709016022955633	1	0.999	0	RPS26	CD8+ T cells	GSE199333_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29184
0	0.653514531240188	1	1	0	TPT1	CD8+ T cells	GSE199333_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29185
0	-0.89943886964924	0.874	0.97	0	FUS	CD8+ T cells	GSE199333_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29186
0	0.584941595667401	1	1	0	RPL13	CD8+ T cells	GSE199333_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29187
0	-0.857070143660927	0.724	0.897	0	VAMP2	CD8+ T cells	GSE199333_post	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29188
0	0.577815700086453	1	1	0	RPL23A	CD8+ T cells	GSE199333_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29189
0	-0.898277118819366	0.919	0.989	0	RBM39	CD8+ T cells	GSE199333_post	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29190
0	0.613606170181098	1	1	0	RPS16	CD8+ T cells	GSE199333_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29191
0	0.591818910106854	1	1	0	RPL13A	CD8+ T cells	GSE199333_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29192
0	0.52616162458952	1	1	0	RPS9	CD8+ T cells	GSE199333_post	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29193
0	0.884096546937751	1	1	0	MT-ND1	CD8+ T cells	GSE199333_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29194
0	0.607315424221044	1	1	0	MT-ND3	CD8+ T cells	GSE199333_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29195
0	0.557993701308773	1	1	0	MT-ND4	CD8+ T cells	GSE199333_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29196
0	0.780094697853966	1	0.994	0	MT-ND5	CD8+ T cells	GSE199333_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29197
5.33866417457451e-305	0.530846418556791	1	0.999	1.13345179090391e-300	RPS10	CD8+ T cells	GSE199333_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29198
7.76189926581501e-305	0.517217698686898	1	1	1.64792883312518e-300	RPS2	CD8+ T cells	GSE199333_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29199
1.21722350773026e-291	-0.98678729610829	0.562	0.835	2.58428722926212e-287	CTSW	CD8+ T cells	GSE199333_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29200
4.94208479700405e-288	0.455999796971944	1	1	1.04925402325193e-283	RPL26	CD8+ T cells	GSE199333_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29201
6.44377229656048e-282	0.632367812726612	1	1	1.36807729628276e-277	MT-ND2	CD8+ T cells	GSE199333_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29202
2.84480951372833e-271	0.511262561193976	1	1	6.03981507859662e-267	RPS12	CD8+ T cells	GSE199333_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29203
5.05342168985955e-264	-0.758587269303136	0.68	0.86	1.07289195897408e-259	DDX6	CD8+ T cells	GSE199333_post	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29204
7.49228567578936e-260	0.449663265640029	1	1	1.59068717182684e-255	RPS14	CD8+ T cells	GSE199333_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29205
9.20668535841741e-260	0.380979477050862	1	1	1.9546713684456e-255	MT-ATP6	CD8+ T cells	GSE199333_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29206
7.00619067509236e-255	0.686599662558997	0.521	0.212	1.48748434222886e-250	PLP2	CD8+ T cells	GSE199333_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29207
1.05249497348889e-250	0.445679001234017	1	1	2.23455207821425e-246	RPL32	CD8+ T cells	GSE199333_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29208
1.77139235270201e-247	-0.582513700833847	0.988	0.998	3.76084310402163e-243	DDX5	CD8+ T cells	GSE199333_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29209
1.47063062004134e-243	0.416431191831231	1	1	3.12229586940978e-239	RPL7A	CD8+ T cells	GSE199333_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29210
2.91083253294232e-239	-0.68835085077445	0.832	0.934	6.17998855068984e-235	PRRC2C	CD8+ T cells	GSE199333_post	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29211
2.85289894160035e-236	-0.898093955146882	0.454	0.724	6.05698974291171e-232	PRPF4B	CD8+ T cells	GSE199333_post	ENSG00000112739	8899	pre-mRNA processing factor 4B	KIAA0536|PR4H|Prp4	protein_coding	Q13523	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29212
9.16474537416216e-235	0.433141976321798	1	1	1.94576709038837e-230	RPL14	CD8+ T cells	GSE199333_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29213
7.1733475036819e-233	-0.508446777785684	0.999	1	1.5229734085067e-228	H3F3B	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29214
6.00617391066211e-232	0.432670984738628	1	1	1.27517078297267e-227	RPL15	CD8+ T cells	GSE199333_post	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29215
4.09895601053334e-231	0.457537118509824	1	1	8.70249350596334e-227	RPL8	CD8+ T cells	GSE199333_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29216
2.81702929368424e-230	0.700381078483121	0.8	0.567	5.98083489342101e-226	EMP3	CD8+ T cells	GSE199333_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29217
4.25607013477468e-229	0.39466735515547	1	1	9.03606250314012e-225	RPS3	CD8+ T cells	GSE199333_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29218
1.09458582603964e-228	0.710598233316266	0.815	0.535	2.32391516726477e-224	S100A10	CD8+ T cells	GSE199333_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29219
4.23105652292255e-226	0.40502490566786	1	1	8.98295610381686e-222	RPL11	CD8+ T cells	GSE199333_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29220
1.00486338869981e-224	0.47300080659655	1	0.999	2.13342546054857e-220	RPL27	CD8+ T cells	GSE199333_post	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29221
1.5703399317418e-224	0.405507734639538	1	1	3.33398870908102e-220	MT-CYB	CD8+ T cells	GSE199333_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29222
3.73508168271089e-224	0.466786633692794	1	1	7.92995192056348e-220	RPS6	CD8+ T cells	GSE199333_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29223
1.50459548647656e-223	-0.863719944485536	0.44	0.706	3.19440667733839e-219	CEMIP2	CD8+ T cells	GSE199333_post	ENSG00000135048	23670	cell migration inducing hyaluronidase 2	TMEM2	protein_coding	Q9UHN6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29224
4.00664592887885e-223	0.489723824258461	0.297	0.075	8.50650997160269e-219	AQP3	CD8+ T cells	GSE199333_post	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29225
2.08183720914992e-217	-0.756044043036596	0.126	0.452	4.41994857874619e-213	ZBP1	CD8+ T cells	GSE199333_post	ENSG00000124256	81030	Z-DNA binding protein 1	C20orf183|DAI|dJ718J7.3|DLM-1|DLM1	protein_coding	Q9H171	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29226
4.30956067763296e-217	-0.849806094063272	0.253	0.581	9.14962827468253e-213	ZEB2	CD8+ T cells	GSE199333_post	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29227
9.64695207256174e-215	0.482461504554086	0.999	0.998	2.04814439452558e-210	RPS11	CD8+ T cells	GSE199333_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29228
4.3836153343823e-213	0.46252813490904	1	0.999	9.30685371642707e-209	RPS5	CD8+ T cells	GSE199333_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29229
4.83149004616379e-212	-1.06310263595418	0.032	0.334	1.02577365170103e-207	TYROBP	CD8+ T cells	GSE199333_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29230
5.7637995177957e-211	-0.469871354554646	1	1	1.22371227562321e-206	HLA-C	CD8+ T cells	GSE199333_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29231
2.12247519135436e-210	-0.667893095285491	0.61	0.816	4.50622707876444e-206	BCLAF1	CD8+ T cells	GSE199333_post	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29232
4.34256433149705e-209	0.353105374032601	1	1	9.21969833220139e-205	RPL41	CD8+ T cells	GSE199333_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29233
1.31797885004576e-207	0.425975813171005	1	1	2.79820089653216e-203	RPL5	CD8+ T cells	GSE199333_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29234
1.50723633684479e-206	-0.658100757882631	0.74	0.877	3.20001346675516e-202	DDX24	CD8+ T cells	GSE199333_post	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29235
1.79667078941451e-206	0.426370259003753	1	1	3.81451175300595e-202	RPS4X	CD8+ T cells	GSE199333_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29236
5.18080661646668e-206	-0.653667187710071	0.601	0.8	1.09993705274204e-201	EPC1	CD8+ T cells	GSE199333_post	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29237
3.71313262417469e-201	-0.631462426955091	0.717	0.883	7.88335187438529e-197	SFPQ	CD8+ T cells	GSE199333_post	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29238
6.33421887082951e-201	0.378998411723661	1	1	1.34481800846581e-196	RPL19	CD8+ T cells	GSE199333_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29239
2.66956623792245e-200	0.420996496743477	1	1	5.66775607973316e-196	RPL18A	CD8+ T cells	GSE199333_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29240
4.30595285173427e-200	0.379418454858142	1	1	9.14196849951703e-196	RPL30	CD8+ T cells	GSE199333_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29241
2.41108685730422e-199	0.819339774017739	0.791	0.593	5.11897850674259e-195	ANXA1	CD8+ T cells	GSE199333_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29242
4.99915995223855e-198	0.375871457195433	1	1	1.06137164945977e-193	UBA52	CD8+ T cells	GSE199333_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29243
1.4459722461003e-195	0.621580102516904	0.84	0.643	3.06994367569555e-191	CD48	CD8+ T cells	GSE199333_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29244
2.71381974798774e-195	-0.680780470443071	0.558	0.763	5.76171070695278e-191	TAX1BP1	CD8+ T cells	GSE199333_post	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29245
4.22220471578329e-194	-0.565032788794462	0.817	0.929	8.9641628320795e-190	SRRM1	CD8+ T cells	GSE199333_post	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29246
4.41225722146602e-194	0.369426439626316	1	1	9.36766330689451e-190	RPL34	CD8+ T cells	GSE199333_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29247
4.95846170697591e-194	0.398527811802447	1	1	1.05273100500805e-189	RPL3	CD8+ T cells	GSE199333_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29248
1.36807784034293e-193	0.385687364876556	1	1	2.90456606283207e-189	RPS25	CD8+ T cells	GSE199333_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29249
1.37666959583456e-192	0.423862622619515	1	1	2.92280721891636e-188	RPL10A	CD8+ T cells	GSE199333_post	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29250
4.58948565075315e-191	0.385507222162603	1	1	9.74393698511401e-187	RPL24	CD8+ T cells	GSE199333_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29251
1.27249328794516e-190	0.460314932322529	0.382	0.139	2.70163049963638e-186	TNFAIP8	CD8+ T cells	GSE199333_post	ENSG00000145779	25816	TNF alpha induced protein 8	GG2-1|MDC-3.13|SCC-S2	protein_coding	O95379	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29252
2.85422562767136e-190	0.376393724549702	1	1	6.05980643010907e-186	RPL35	CD8+ T cells	GSE199333_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29253
2.08518656555086e-187	0.391842498400087	1	1	4.42705959732104e-183	RPL36	CD8+ T cells	GSE199333_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29254
5.05808289822115e-186	0.465395221047296	0.984	0.959	1.07388158012133e-181	TOMM7	CD8+ T cells	GSE199333_post	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29255
7.51104297516843e-186	0.453617512125986	1	0.998	1.59466953405801e-181	RPL7	CD8+ T cells	GSE199333_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29256
1.4791178704064e-184	0.341215547543893	1	1	3.14031515065983e-180	RPS27A	CD8+ T cells	GSE199333_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29257
2.26019463672273e-182	0.389925738177054	1	1	4.79861923322602e-178	RPS3A	CD8+ T cells	GSE199333_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29258
8.70391086897927e-182	0.631689855155404	0.383	0.143	1.84792731659299e-177	RGCC	CD8+ T cells	GSE199333_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29259
2.85575366304652e-181	0.390652265435525	1	1	6.06305060201407e-177	RPL12	CD8+ T cells	GSE199333_post	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29260
9.44821036012702e-178	0.326617268830354	1	1	2.00594954155857e-173	RPS24	CD8+ T cells	GSE199333_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29261
2.21957945132581e-177	0.496912771268365	0.472	0.205	4.71238913310983e-173	ANXA2	CD8+ T cells	GSE199333_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29262
2.31162786688186e-177	-0.595893234729883	0.799	0.915	4.90781712417688e-173	PNRC1	CD8+ T cells	GSE199333_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29263
2.33810470967896e-177	0.39043322504333	1	1	4.96403010911939e-173	RPL18	CD8+ T cells	GSE199333_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29264
5.59323164867477e-176	0.379425670582297	1	1	1.18749901133014e-171	RPL29	CD8+ T cells	GSE199333_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29265
1.68619802891881e-174	-0.561852020959441	0.633	0.819	3.57996703519753e-170	SF3B1	CD8+ T cells	GSE199333_post	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29266
1.02482205013801e-173	-0.458674782722174	1	1	2.17579969464802e-169	MT-CO1	CD8+ T cells	GSE199333_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29267
2.16189099091651e-172	0.411891314140004	1	1	4.58991076281483e-168	RPL10	CD8+ T cells	GSE199333_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29268
5.65186495023116e-172	-0.891597017735079	0.636	0.879	1.19994744758358e-167	NKG7	CD8+ T cells	GSE199333_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29269
3.17989193201605e-171	-0.709229507723739	0.473	0.674	6.75122856086327e-167	PFDN2	CD8+ T cells	GSE199333_post	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29270
1.07793450155824e-169	0.349048706541715	1	1	2.2885627402583e-165	RPL35A	CD8+ T cells	GSE199333_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29271
1.46706184004641e-169	-0.584958384064295	0.077	0.349	3.11471899260253e-165	ENC1	CD8+ T cells	GSE199333_post	ENSG00000171617	8507	ectodermal-neural cortex 1	ENC-1|KLHL37|NRPB|PIG10|TP53I10	protein_coding	O14682	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29272
7.38938265898984e-169	-0.685473569993838	0.49	0.703	1.56883983233013e-164	DDX3Y	CD8+ T cells	GSE199333_post	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29273
1.34462243494975e-167	-0.677828065610958	0.2	0.479	2.8547678916418e-163	CBX4	CD8+ T cells	GSE199333_post	ENSG00000141582	8535	chromobox 4	hPC2|NBP16|PC2	protein_coding	O00257	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29274
1.31670211133903e-162	0.828297195142032	0.663	0.416	2.79549025258389e-158	TRAC	CD8+ T cells	GSE199333_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29275
5.12301509410001e-162	-0.611178783647259	0.707	0.873	1.08766733462837e-157	NCL	CD8+ T cells	GSE199333_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29276
1.02639183419723e-161	-0.526075117305552	0.78	0.897	2.17913250318413e-157	SON	CD8+ T cells	GSE199333_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29277
2.17092161045789e-161	0.377828736627112	1	1	4.60908367116314e-157	EEF1A1	CD8+ T cells	GSE199333_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29278
8.45217855972515e-161	0.376050964220273	0.368	0.139	1.79448203001525e-156	RCAN3	CD8+ T cells	GSE199333_post	ENSG00000117602	11123	RCAN family member 3	DSCR1L2	protein_coding	Q9UKA8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29279
9.89091228560387e-160	0.412043176921179	0.27	0.083	2.09993958735656e-155	LGALS3	CD8+ T cells	GSE199333_post	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29280
1.3105064188639e-158	-0.561578331239502	0.638	0.814	2.78233617788996e-154	DNAJB6	CD8+ T cells	GSE199333_post	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29281
1.89693138255598e-158	0.3851588488388	1	0.999	4.02737501830461e-154	RACK1	CD8+ T cells	GSE199333_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29282
2.96770363305884e-158	-0.626091481831788	0.206	0.473	6.30073158334722e-154	RAB8B	CD8+ T cells	GSE199333_post	ENSG00000166128	51762	RAB8B, member RAS oncogene family	NA	protein_coding	Q92930	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29283
2.53200159599393e-157	0.667710815458122	0.353	0.135	5.37569258845472e-153	LMNA	CD8+ T cells	GSE199333_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29284
4.65787120359376e-156	-0.664276833542829	0.789	0.911	9.8891263523499e-152	HSPA5	CD8+ T cells	GSE199333_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29285
5.52334150368462e-156	-0.626432316895088	0.564	0.755	1.17266063464728e-151	REL	CD8+ T cells	GSE199333_post	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29286
1.72050135976072e-155	0.546239406255985	0.704	0.479	3.65279643690799e-151	TAGLN2	CD8+ T cells	GSE199333_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29287
5.75197738108411e-154	-0.383867234716181	1	1	1.22120231777797e-149	HLA-A	CD8+ T cells	GSE199333_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29288
7.44232255818622e-152	0.290673875527906	1	1	1.58007950232852e-147	MT-CO3	CD8+ T cells	GSE199333_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29289
1.49544071465589e-150	0.368039820962132	0.294	0.1	3.17497018128591e-146	TIMP1	CD8+ T cells	GSE199333_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29290
2.89978723040965e-150	-0.472455792043344	0.998	1	6.15653826888273e-146	UBC	CD8+ T cells	GSE199333_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29291
1.04599560114792e-149	0.378935373507908	0.996	0.986	2.22075326079714e-145	RPL36AL	CD8+ T cells	GSE199333_post	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29292
1.29970767114541e-149	-0.558183925261995	0.738	0.866	2.75940935660882e-145	CCNL1	CD8+ T cells	GSE199333_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29293
2.05773157787371e-149	0.332660987033183	1	0.999	4.36876991298367e-145	RPS21	CD8+ T cells	GSE199333_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29294
9.51798513836202e-149	-0.481192894708551	0.848	0.936	2.02076342472564e-144	SRRM2	CD8+ T cells	GSE199333_post	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29295
1.27738326835061e-147	-0.593531289646827	0.579	0.767	2.71201241703518e-143	SRSF10	CD8+ T cells	GSE199333_post	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29296
1.48812100751884e-146	-0.476895587494528	0.896	0.958	3.15942971106325e-142	PNISR	CD8+ T cells	GSE199333_post	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29297
1.98639961846848e-145	-0.577824987576166	0.539	0.729	4.21732502997043e-141	ELF1	CD8+ T cells	GSE199333_post	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29298
1.0973252783084e-143	-1.05956362296791	0.273	0.554	2.32973129837656e-139	GNLY	CD8+ T cells	GSE199333_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29299
2.2849667062588e-143	-0.57484818856073	0.665	0.844	4.85121281405805e-139	HMGN2	CD8+ T cells	GSE199333_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29300
1.05298080910363e-141	0.467701545018786	0.887	0.756	2.23558355580792e-137	MYL12B	CD8+ T cells	GSE199333_post	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29301
2.6573481993872e-141	-0.444427769902319	0.944	0.98	5.64181596211896e-137	SRSF5	CD8+ T cells	GSE199333_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29302
4.19249867553037e-141	0.322519344206935	1	1	8.90109393801852e-137	RPL39	CD8+ T cells	GSE199333_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29303
5.37495170485181e-141	-0.617453657329852	0.644	0.796	1.14115599645709e-136	NKTR	CD8+ T cells	GSE199333_post	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29304
3.43748116532155e-139	-0.902818314593902	0.13	0.391	7.29811626209419e-135	FGFBP2	CD8+ T cells	GSE199333_post	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29305
1.20293847684449e-138	0.758334896998595	0.491	0.256	2.55395868018855e-134	IL7R	CD8+ T cells	GSE199333_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29306
1.37044257681805e-138	0.499104040344022	1	1	2.9095866348424e-134	TMSB4X	CD8+ T cells	GSE199333_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29307
6.18022333174244e-136	0.544625753025204	0.532	0.301	1.31212321556224e-131	CD2	CD8+ T cells	GSE199333_post	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29308
4.3457347876974e-134	-0.60426244693748	0.736	0.862	9.22642952776034e-130	HNRNPH1	CD8+ T cells	GSE199333_post	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29309
7.10601850483285e-133	-0.687084453661493	0.72	0.892	1.50867878876106e-128	CCL5	CD8+ T cells	GSE199333_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29310
1.54974903170522e-132	-0.516583502530918	0.759	0.88	3.29027216921335e-128	EIF5A	CD8+ T cells	GSE199333_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29311
1.2098018209572e-131	0.315010999377258	1	1	2.56853024607422e-127	RPL21	CD8+ T cells	GSE199333_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29312
3.16128690581219e-127	0.350499323464117	1	1	6.71172822972986e-123	RPSA	CD8+ T cells	GSE199333_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29313
8.09213326564553e-127	-0.517237859779182	0.612	0.775	1.7180408136292e-122	RSRC2	CD8+ T cells	GSE199333_post	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29314
8.84682202833932e-126	-0.551013683196274	0.341	0.566	1.87826878483672e-121	RIOK3	CD8+ T cells	GSE199333_post	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29315
1.02716688886534e-125	-0.609064119075777	0.582	0.732	2.18077802175e-121	EML4	CD8+ T cells	GSE199333_post	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29316
2.23173667146125e-125	0.281705175478084	1	1	4.73820012717938e-121	RPS15	CD8+ T cells	GSE199333_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29317
5.84969515413526e-124	-0.52806453839878	0.695	0.814	1.24194877817446e-119	RBM25	CD8+ T cells	GSE199333_post	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29318
1.0642627083359e-123	0.279425271581512	1	1	2.25953615606795e-119	RPS15A	CD8+ T cells	GSE199333_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29319
1.38183623522309e-123	0.391773078910425	0.998	0.998	2.93377651100215e-119	EEF1B2	CD8+ T cells	GSE199333_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29320
1.82995155693159e-123	0.360712633503836	0.336	0.14	3.88517015052145e-119	PIM1	CD8+ T cells	GSE199333_post	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29321
4.02352655495522e-123	0.285734593206033	1	1	8.54234922882543e-119	RPL37A	CD8+ T cells	GSE199333_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29322
8.53362375715457e-123	0.319410489653001	1	0.999	1.81177365988149e-118	RPS13	CD8+ T cells	GSE199333_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29323
1.38475605916555e-121	-0.524781481079765	0.578	0.742	2.93997558921438e-117	BZW1	CD8+ T cells	GSE199333_post	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29324
1.59101181450881e-121	-0.921094247881951	0.448	0.623	3.37787718338366e-117	MT2A	CD8+ T cells	GSE199333_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29325
1.40924360086282e-120	0.32270337798008	1	1	2.99196508899185e-116	RPS19	CD8+ T cells	GSE199333_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29326
7.0010342669769e-119	-0.564787301470149	0.325	0.54	1.48638958522187e-114	SYAP1	CD8+ T cells	GSE199333_post	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29327
1.11605451784353e-118	-0.446569180093765	0.705	0.839	2.36949534683359e-114	MORF4L1	CD8+ T cells	GSE199333_post	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29328
3.10494168397613e-118	-0.586757906541752	0.507	0.679	6.59210168924972e-114	OGA	CD8+ T cells	GSE199333_post	ENSG00000198408	10724	O-GlcNAcase	MEA5|MGEA5|NCOAT	protein_coding	O60502	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29329
4.02653578028275e-117	-0.468816541430731	0.832	0.917	8.5487381151183e-113	SF1	CD8+ T cells	GSE199333_post	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29330
1.72900292647172e-116	0.355724854228775	0.957	0.907	3.67084611319212e-112	COX7C	CD8+ T cells	GSE199333_post	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29331
1.77414288328111e-116	-0.756030309464798	0.327	0.54	3.76668275549413e-112	TSPYL2	CD8+ T cells	GSE199333_post	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29332
2.1935406941432e-116	0.426997739906734	0.652	0.413	4.65710624773542e-112	AHNAK	CD8+ T cells	GSE199333_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29333
1.02776412655409e-115	0.318245639932286	1	0.999	2.18204601708699e-111	RPL22	CD8+ T cells	GSE199333_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29334
3.12736124343601e-114	0.444173963395697	0.921	0.821	6.639700655939e-110	CXCR4	CD8+ T cells	GSE199333_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29335
1.65814872929779e-113	-0.495376693203506	0.206	0.437	3.52041556717214e-109	IFITM1	CD8+ T cells	GSE199333_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29336
4.37614208710129e-112	0.430423489293818	0.385	0.189	9.29098726512476e-108	CSTB	CD8+ T cells	GSE199333_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29337
3.67587318168851e-111	0.79057105677055	0.924	0.827	7.80424635204287e-107	HBA2	CD8+ T cells	GSE199333_post	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29338
4.40156131271154e-110	-0.634300831000964	0.715	0.887	9.34495482301788e-106	CD74	CD8+ T cells	GSE199333_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29339
7.48309404337754e-110	0.255574485632744	0.264	0.1	1.58873569634949e-105	FLT3LG	CD8+ T cells	GSE199333_post	ENSG00000090554	2323	fms related receptor tyrosine kinase 3 ligand	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29340
5.12977828693608e-109	-0.463655256961415	0.674	0.804	1.0891032280994e-104	RBM38	CD8+ T cells	GSE199333_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29341
1.41552485336989e-108	0.45221561493569	0.407	0.207	3.0053008161896e-104	NOSIP	CD8+ T cells	GSE199333_post	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29342
2.63891431067153e-108	-0.356604836776418	1	1	5.60267897298672e-104	PTMA	CD8+ T cells	GSE199333_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29343
2.79031724661377e-108	0.424014630576953	0.834	0.745	5.9241225462857e-104	EIF3E	CD8+ T cells	GSE199333_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29344
4.80615106802139e-108	-0.453753038050202	0.103	0.311	1.02039393325162e-103	LMNB1	CD8+ T cells	GSE199333_post	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29345
4.61696615678719e-107	-0.48689754219766	0.11	0.322	9.80228084747488e-103	HIST1H1E	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29346
1.86929060581768e-106	-0.469309202926574	0.66	0.787	3.96869088521151e-102	ARGLU1	CD8+ T cells	GSE199333_post	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29347
2.68422878749388e-106	-0.490462545759395	0.567	0.734	5.69888613872826e-102	ODC1	CD8+ T cells	GSE199333_post	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29348
3.39979046769445e-106	0.296924208320151	0.302	0.127	7.2180951419621e-102	PLK3	CD8+ T cells	GSE199333_post	ENSG00000173846	1263	polo like kinase 3	CNK|FNK|PRK	protein_coding	Q9H4B4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29349
3.63557506070688e-106	0.380464311045903	0.841	0.722	7.71868941138679e-102	LDHB	CD8+ T cells	GSE199333_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29350
6.18800337573969e-106	0.438526767500222	0.911	0.771	1.31377499670329e-101	CD52	CD8+ T cells	GSE199333_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29351
1.67666324532234e-105	-0.521211583611302	0.465	0.644	3.55972373614385e-101	USP16	CD8+ T cells	GSE199333_post	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29352
3.92940204254287e-104	-0.468635513073367	0.629	0.776	8.34251347652277e-100	TRA2B	CD8+ T cells	GSE199333_post	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29353
1.44345459011664e-103	-0.366235803462004	0.98	0.993	3.06459844027665e-99	HMGB1	CD8+ T cells	GSE199333_post	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29354
1.69602449517339e-103	0.257900599882482	1	1	3.60082960570263e-99	RPLP2	CD8+ T cells	GSE199333_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29355
1.87947623126201e-103	-0.46404633704009	0.605	0.738	3.99031598659238e-99	C9orf78	CD8+ T cells	GSE199333_post	ENSG00000136819	51759	chromosome 9 open reading frame 78	CSU2|HCA59|HSPC220	protein_coding	Q9NZ63	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29356
1.56430499088229e-102	-0.489612299270904	0.532	0.696	3.3211759261422e-98	DDX3X	CD8+ T cells	GSE199333_post	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29357
3.94937718620134e-102	-0.518677953236649	0.614	0.759	8.38492270402405e-98	RNF125	CD8+ T cells	GSE199333_post	ENSG00000101695	54941	ring finger protein 125	FLJ20456	protein_coding	Q96EQ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29358
4.27553377738129e-101	-0.502768296615481	0.31	0.517	9.07738576275822e-97	PSME4	CD8+ T cells	GSE199333_post	ENSG00000068878	23198	proteasome activator subunit 4	KIAA0077|PA200	protein_coding	Q14997	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29359
5.57048969893374e-101	-0.494968212320748	0.351	0.551	1.18267066798062e-96	CD164	CD8+ T cells	GSE199333_post	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29360
1.27522654774674e-99	0.470821481081982	0.981	0.897	2.7074334835211e-95	HBB	CD8+ T cells	GSE199333_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29361
3.52258032867429e-99	-0.546413061424473	0.435	0.615	7.47879029580839e-95	ZNF292	CD8+ T cells	GSE199333_post	ENSG00000188994	23036	zinc finger protein 292	bA393I2.3|KIAA0530|ZFP292|Zn-15|Zn-16	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29362
2.86068952437985e-98	0.459888054745146	0.86	0.753	6.07352992921086e-94	CD44	CD8+ T cells	GSE199333_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29363
2.71497337108803e-97	0.301284549215124	0.33	0.152	5.76415996415701e-93	TNFRSF25	CD8+ T cells	GSE199333_post	ENSG00000215788	8718	TNF receptor superfamily member 25	APO-3|DDR3|DR3|LARD|TNFRSF12|TR3|TRAMP|WSL-1|WSL-LR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29364
4.59809340658365e-96	-0.463195866384665	0.611	0.751	9.76221211151775e-92	PDIA3	CD8+ T cells	GSE199333_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29365
7.50046389459084e-96	-0.449709366160388	0.738	0.846	1.59242348946058e-91	HNRNPU	CD8+ T cells	GSE199333_post	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29366
1.07385347016285e-95	-0.477287262510491	0.308	0.508	2.27989830250274e-91	SYTL3	CD8+ T cells	GSE199333_post	ENSG00000164674	94120	synaptotagmin like 3	exophilin-6|SLP3	protein_coding	Q4VX76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29367
2.45637981046041e-95	0.270524338252558	1	1	5.2151399755885e-91	RPS28	CD8+ T cells	GSE199333_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29368
2.65767456312548e-95	0.317292471995565	1	0.999	5.64250886497171e-91	RPS20	CD8+ T cells	GSE199333_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29369
6.23551208868107e-94	0.341452867159413	0.991	0.984	1.32386157154788e-89	SH3BGRL3	CD8+ T cells	GSE199333_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29370
8.06494453841505e-94	-0.531955230074391	0.207	0.416	1.7122683749509e-89	MAP3K8	CD8+ T cells	GSE199333_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29371
1.62025625787119e-93	0.270486069780709	1	0.999	3.43996606108631e-89	NACA	CD8+ T cells	GSE199333_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29372
2.80952592726578e-93	-0.528257773910274	0.39	0.573	5.96490449617798e-89	MDM4	CD8+ T cells	GSE199333_post	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29373
6.03573552231895e-92	-0.61343402839777	0.678	0.823	1.28144700874354e-87	H1FX	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29374
7.73425179816362e-92	-0.469289645319446	0.295	0.492	1.64205899926812e-87	DBF4	CD8+ T cells	GSE199333_post	ENSG00000006634	10926	DBF4 zinc finger	ASK|chif|DBF4A|ZDBF1	protein_coding	Q9UBU7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29375
3.78965820992871e-91	0.420883411698314	0.943	0.907	8.04582334549965e-87	S100A6	CD8+ T cells	GSE199333_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29376
4.90276558865425e-91	-0.499942734356398	0.322	0.509	1.04090616212718e-86	ZNF644	CD8+ T cells	GSE199333_post	ENSG00000122482	84146	zinc finger protein 644	BM-005|KIAA1221|MGC60165|MGC70410	protein_coding	Q9H582	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29377
1.39284932044964e-90	0.318104620752771	0.276	0.12	2.95715839224663e-86	SAMHD1	CD8+ T cells	GSE199333_post	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29378
5.0133601165028e-90	0.61849494779184	0.831	0.713	1.06438648633471e-85	HBA1	CD8+ T cells	GSE199333_post	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29379
1.38084412814037e-89	-0.449115362863459	0.268	0.465	2.93167016845483e-85	SH2D1A	CD8+ T cells	GSE199333_post	ENSG00000183918	4068	SH2 domain containing 1A	DSHP|EBVS|IMD5|LYP|MTCP1|SAP|XLP|XLPD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29380
1.71863557734257e-89	-0.448048692354663	0.492	0.655	3.64883519425601e-85	ZNF207	CD8+ T cells	GSE199333_post	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29381
1.12541978080661e-88	0.300350180953291	0.994	0.982	2.38937873663051e-84	RPL36A	CD8+ T cells	GSE199333_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29382
1.2338966076694e-88	-0.454832134624452	0.492	0.65	2.61968588774291e-84	DNAJA1	CD8+ T cells	GSE199333_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29383
1.28346396713024e-88	-0.455527551751856	0.593	0.719	2.72492234861422e-84	RNMT	CD8+ T cells	GSE199333_post	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29384
1.69099006157377e-88	0.347614118715654	0.452	0.263	3.59014099972726e-84	BIN1	CD8+ T cells	GSE199333_post	ENSG00000136717	274	bridging integrator 1	AMPH2|AMPHL|SH3P9	protein_coding	O00499	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29385
1.76763999240571e-88	-0.456288440731838	0.219	0.439	3.75287646787656e-84	HLA-DRA	CD8+ T cells	GSE199333_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29386
3.98927642912837e-88	-0.410537722648715	0.542	0.692	8.46963278668245e-84	CCDC12	CD8+ T cells	GSE199333_post	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29387
7.73740769021004e-88	-0.419350289571809	0.795	0.879	1.64272902670849e-83	PPDPF	CD8+ T cells	GSE199333_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29388
2.2025274536758e-87	0.418320363623057	0.309	0.148	4.67618603689909e-83	UCP2	CD8+ T cells	GSE199333_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29389
2.2705586638529e-86	-0.494702215771526	0.392	0.563	4.82062309922609e-82	YTHDC1	CD8+ T cells	GSE199333_post	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29390
3.50806082561818e-86	0.310227425511578	0.989	0.974	7.44796393886995e-82	RPL23	CD8+ T cells	GSE199333_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29391
3.76587359264631e-86	-0.42638986999555	0.528	0.726	7.99532622454738e-82	CST7	CD8+ T cells	GSE199333_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29392
5.68862312859046e-86	-0.446131343919559	0.273	0.462	1.20775157643104e-81	USP36	CD8+ T cells	GSE199333_post	ENSG00000055483	57602	ubiquitin specific peptidase 36	FLJ12851|KIAA1453	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29393
1.8739655298461e-85	-0.439325835870657	0.201	0.392	3.97861621641626e-81	HIF1A	CD8+ T cells	GSE199333_post	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29394
2.53968848052987e-85	-0.438982087630181	0.361	0.541	5.39201261301297e-81	SAR1A	CD8+ T cells	GSE199333_post	ENSG00000079332	56681	secretion associated Ras related GTPase 1A	SAR1|Sara|SARA1	protein_coding	Q9NR31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29395
3.09451914320424e-85	0.594661747619936	0.771	0.65	6.56997359293691e-81	JUN	CD8+ T cells	GSE199333_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29396
5.68021395766913e-85	-0.355636379293009	0.093	0.268	1.20596622535273e-80	LRMP	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29397
6.57504194419843e-85	-0.412310081198182	0.266	0.457	1.39594715517277e-80	TRAPPC10	CD8+ T cells	GSE199333_post	ENSG00000160218	7109	trafficking protein particle complex subunit 10	EHOC-1|TMEM1|TRS130	protein_coding	P48553	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29398
9.6441795014622e-85	-0.465899184856178	0.618	0.745	2.04755574995544e-80	SRSF11	CD8+ T cells	GSE199333_post	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29399
9.14112535230064e-84	0.378769430794686	0.398	0.218	1.94075232354695e-79	KDM6B	CD8+ T cells	GSE199333_post	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29400
1.73102405635332e-83	0.312103552549959	0.335	0.169	3.67513717404373e-79	S1PR4	CD8+ T cells	GSE199333_post	ENSG00000125910	8698	sphingosine-1-phosphate receptor 4	EDG6	protein_coding	O95977	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29401
2.29180416766578e-83	-0.278312230242208	1	1	4.86572942837122e-79	EIF1	CD8+ T cells	GSE199333_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29402
3.74615469248014e-83	-0.395348922518878	0.684	0.803	7.95346102760458e-79	EIF4G2	CD8+ T cells	GSE199333_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29403
8.76860241047343e-83	-0.4537690402472	0.358	0.531	1.86166197776761e-78	CNOT1	CD8+ T cells	GSE199333_post	ENSG00000125107	23019	CCR4-NOT transcription complex subunit 1	AD-005|CDC39|KIAA1007|NOT1|NOT1H	protein_coding	A5YKK6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29404
2.90363891179896e-82	-0.457321533759183	0.234	0.417	6.16471577364037e-78	PTPRE	CD8+ T cells	GSE199333_post	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29405
7.99382389233592e-82	-0.474735475321621	0.25	0.434	1.69716875058184e-77	APOL6	CD8+ T cells	GSE199333_post	ENSG00000221963	80830	apolipoprotein L6	APOL-VI|APOLVI	protein_coding	Q9BWW8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29406
1.02491542515375e-81	0.28466084966706	0.974	0.947	2.17599793914393e-77	UQCRB	CD8+ T cells	GSE199333_post	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29407
1.33431307149477e-81	-0.408073192455221	0.671	0.793	2.83288008209055e-77	FAM133B	CD8+ T cells	GSE199333_post	ENSG00000234545	257415	family with sequence similarity 133 member B	MGC40405	protein_coding	Q5BKY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29408
1.47517113629123e-81	-0.387122623073351	0.173	0.356	3.1319358394599e-77	PDZD8	CD8+ T cells	GSE199333_post	ENSG00000165650	118987	PDZ domain containing 8	bA129M16.2|FLJ34427|PDZK8	protein_coding	Q8NEN9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29409
3.06510580775358e-81	0.345609900822122	0.854	0.764	6.50752614044162e-77	OST4	CD8+ T cells	GSE199333_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29410
1.23762577573075e-80	-0.449492790128227	0.254	0.438	2.62760328445396e-76	SIRT2	CD8+ T cells	GSE199333_post	ENSG00000283100	22933	sirtuin 2	SIR2L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29411
4.38453400151234e-80	0.43431615498801	0.761	0.568	9.30880413861086e-76	CD3D	CD8+ T cells	GSE199333_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29412
1.70125078876974e-79	-0.443821187432825	0.623	0.732	3.61192554963703e-75	ARID4B	CD8+ T cells	GSE199333_post	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29413
3.06167549637274e-79	0.288466689012602	0.979	0.96	6.50024324634896e-75	RPS4Y1	CD8+ T cells	GSE199333_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29414
9.12435729257799e-79	0.328814534532554	0.396	0.224	1.93719229678723e-74	TBCA	CD8+ T cells	GSE199333_post	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29415
2.69756520712971e-78	0.275052799125348	1	0.998	5.72720069125708e-74	RPL4	CD8+ T cells	GSE199333_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29416
4.04174237993173e-78	0.354571173484998	0.44	0.266	8.58102324683306e-74	ATP6V0E1	CD8+ T cells	GSE199333_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29417
9.56086150094553e-78	-0.429618474008387	0.347	0.517	2.02986650526574e-73	SNHG9	CD8+ T cells	GSE199333_post	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29418
1.31622962523919e-77	0.319387025020145	0.42	0.246	2.79448711734533e-73	COX7A2L	CD8+ T cells	GSE199333_post	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29419
4.35332819982649e-77	-0.480980511371043	0.338	0.508	9.24255110105161e-73	CASP8	CD8+ T cells	GSE199333_post	ENSG00000064012	841	caspase 8	Casp-8|FLICE|MACH|MCH5	protein_coding	Q14790	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29420
6.04319260355583e-77	-0.447983243881307	0.49	0.628	1.28303022166094e-72	STAT3	CD8+ T cells	GSE199333_post	ENSG00000168610	6774	signal transducer and activator of transcription 3	APRF	protein_coding	P40763	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29421
1.10031188230707e-76	0.277718628998784	0.348	0.183	2.33607215732615e-72	ARHGAP15	CD8+ T cells	GSE199333_post	ENSG00000075884	55843	Rho GTPase activating protein 15	BM046	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29422
1.40400353215617e-76	-0.312245468458483	0.975	0.991	2.98083989912077e-72	HLA-E	CD8+ T cells	GSE199333_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29423
3.18757188298044e-76	0.267408863474351	0.293	0.14	6.76753386475577e-72	GPR183	CD8+ T cells	GSE199333_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29424
3.20494609670813e-76	0.365342633017507	0.532	0.347	6.80442105792103e-72	CLEC2D	CD8+ T cells	GSE199333_post	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29425
4.62353244443224e-74	0.67173586059284	0.764	0.721	9.8162217327741e-70	MYL12A	CD8+ T cells	GSE199333_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29426
1.18112239705948e-73	-0.473438670703168	0.387	0.548	2.50764096119698e-69	SREK1	CD8+ T cells	GSE199333_post	ENSG00000153914	140890	splicing regulatory glutamic acid and lysine rich protein 1	DKFZp564B176|SFRS12|SRrp508|SRrp86	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29427
1.97431051010032e-73	-0.62607948200824	0.154	0.327	4.19165864399399e-69	GZMB	CD8+ T cells	GSE199333_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29428
3.60889633649526e-73	-0.376605524407561	0.777	0.87	7.6620478120131e-69	TPM3	CD8+ T cells	GSE199333_post	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29429
4.49620743124686e-73	-0.345871093156527	0.774	0.853	9.54589799728022e-69	HNRNPK	CD8+ T cells	GSE199333_post	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29430
5.88252420026871e-73	-0.38370282766955	0.477	0.623	1.24891871295905e-68	HSPA9	CD8+ T cells	GSE199333_post	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29431
6.37480796468146e-73	-0.427296102836764	0.427	0.574	1.35343547898152e-68	ISCA1	CD8+ T cells	GSE199333_post	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29432
1.532584895437e-72	-0.373393492817433	0.609	0.739	3.25383099150231e-68	TAPBP	CD8+ T cells	GSE199333_post	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29433
1.63513224981797e-72	0.343484947857243	0.844	0.788	3.47154927958852e-68	ZFAS1	CD8+ T cells	GSE199333_post	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29434
2.12365379120241e-72	-0.45826838106167	0.38	0.536	4.50872936410183e-68	CNOT2	CD8+ T cells	GSE199333_post	ENSG00000111596	4848	CCR4-NOT transcription complex subunit 2	CDC36|NOT2|NOT2H	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29435
5.84317687425046e-72	-0.396217409560345	0.27	0.444	1.24056488217212e-67	SLC25A36	CD8+ T cells	GSE199333_post	ENSG00000114120	55186	solute carrier family 25 member 36	FLJ10618|PNC2	protein_coding	Q96CQ1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29436
6.01304789132133e-72	-0.423887974761732	0.302	0.467	1.27663019780643e-67	KDM2A	CD8+ T cells	GSE199333_post	ENSG00000173120	22992	lysine demethylase 2A	CXXC8|DKFZP434M1735|FBL11|FBL7|FBXL11|FLJ00115|JHDM1A|KIAA1004|LILINA	protein_coding	Q9Y2K7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29437
1.17945183677987e-71	-0.382609502443031	0.515	0.66	2.50409419466734e-67	ZC3H15	CD8+ T cells	GSE199333_post	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29438
3.87390448486928e-71	-0.527008838643012	0.404	0.556	8.22468661182596e-67	PDE4D	CD8+ T cells	GSE199333_post	ENSG00000113448	5144	phosphodiesterase 4D	DPDE3	protein_coding	Q08499	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29439
7.37234818679791e-71	-0.454140295742011	0.686	0.811	1.56522324353906e-66	CALR	CD8+ T cells	GSE199333_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29440
1.54956994833929e-70	-0.390032621687098	0.328	0.493	3.28989195731914e-66	CDC40	CD8+ T cells	GSE199333_post	ENSG00000168438	51362	cell division cycle 40	EHB3|FLJ10564|PRP17|PRPF17	protein_coding	O60508	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29441
2.05224848559159e-70	-0.439998787079988	0.314	0.479	4.3571287597595e-66	BRD1	CD8+ T cells	GSE199333_post	ENSG00000100425	23774	bromodomain containing 1	BRL|BRPF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29442
2.11509129338946e-70	-0.361683650365749	0.152	0.319	4.49055032499517e-66	MEX3C	CD8+ T cells	GSE199333_post	ENSG00000176624	51320	mex-3 RNA binding family member C	FLJ38871|RKHD2|RNF194	protein_coding	Q5U5Q3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29443
3.68243281751718e-70	-0.408988463924742	0.339	0.499	7.81817311487073e-66	PPP4R3A	CD8+ T cells	GSE199333_post	ENSG00000100796	55671	protein phosphatase 4 regulatory subunit 3A	FLFL1|FLJ20707|KIAA2010|MSTP033|PP4R3|SMEK1|smk-1|smk1	protein_coding	Q6IN85	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29444
9.52105502768249e-70	-0.427845949044652	0.379	0.538	2.02141519292727e-65	CENPC	CD8+ T cells	GSE199333_post	ENSG00000145241	1060	centromere protein C	CENP-C|CENPC1|hcp-4|MIF2	protein_coding	Q03188	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29445
1.99239033433641e-69	-0.420884425367139	0.345	0.505	4.23004391882964e-65	ZBTB1	CD8+ T cells	GSE199333_post	ENSG00000126804	22890	zinc finger and BTB domain containing 1	KIAA0997|ZNF909	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29446
2.1214721491465e-69	-0.362439394782253	0.598	0.71	4.50409751985293e-65	SF3B2	CD8+ T cells	GSE199333_post	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29447
3.01143357284336e-69	-0.495151711126419	0.285	0.45	6.39357461850374e-65	SRRT	CD8+ T cells	GSE199333_post	ENSG00000087087	51593	serrate, RNA effector molecule	ARS2|Asr2|serrate	protein_coding	Q9BXP5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29448
5.34906287305164e-69	0.260688736484927	0.305	0.157	1.13565953857759e-64	FAM129A	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29449
5.85261788940354e-69	0.282430284313269	0.429	0.256	1.24256930409927e-64	PBXIP1	CD8+ T cells	GSE199333_post	ENSG00000163346	57326	PBX homeobox interacting protein 1	HPIP	protein_coding	Q96AQ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29450
9.39660977254263e-69	-0.399301276573867	0.262	0.464	1.99499422080853e-64	GZMH	CD8+ T cells	GSE199333_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29451
3.34907880243518e-68	-0.365826168716729	0.163	0.325	7.11042920545012e-64	CCNT1	CD8+ T cells	GSE199333_post	ENSG00000129315	904	cyclin T1	CCNT|CYCT1|HIVE1	protein_coding	O60563	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29452
4.63062054245922e-68	-0.361448449061793	0.146	0.311	9.83127047369518e-64	XPO1	CD8+ T cells	GSE199333_post	ENSG00000082898	7514	exportin 1	CRM-1|CRM1|emb	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29453
5.65263873685959e-68	-0.384632358547942	0.285	0.454	1.20011173022266e-63	PTPN2	CD8+ T cells	GSE199333_post	ENSG00000175354	5771	protein tyrosine phosphatase non-receptor type 2	PTPT|TC-PTP|TCELLPTP|TCPTP	protein_coding	P17706	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29454
1.07308784337236e-67	-0.385987320631832	0.647	0.741	2.27827280026387e-63	JAK1	CD8+ T cells	GSE199333_post	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29455
1.18577243687015e-67	-0.476119813660311	0.476	0.614	2.51751346071902e-63	ATG2A	CD8+ T cells	GSE199333_post	ENSG00000110046	23130	autophagy related 2A	BLTP4A|KIAA0404	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29456
2.23509016159348e-67	-0.442482263497828	0.643	0.743	4.74531992207911e-63	ANKRD11	CD8+ T cells	GSE199333_post	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29457
6.95318978946099e-67	-0.421170747456357	0.324	0.477	1.47623172420046e-62	BRD2	CD8+ T cells	GSE199333_post	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29458
3.45790334780167e-66	-0.379253587213475	0.629	0.729	7.34147459771773e-62	STK17A	CD8+ T cells	GSE199333_post	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29459
3.63230825519001e-66	0.331827953071424	0.347	0.199	7.7117536565939e-62	APOBEC3G	CD8+ T cells	GSE199333_post	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29460
6.60754856228441e-66	-0.38184005452609	0.283	0.446	1.4028486352586e-61	ZNF800	CD8+ T cells	GSE199333_post	ENSG00000048405	168850	zinc finger protein 800	NA	protein_coding	Q2TB10	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29461
7.88963033368478e-66	-0.39675202016992	0.49	0.622	1.67504741614462e-61	CIR1	CD8+ T cells	GSE199333_post	ENSG00000138433	9541	corepressor interacting with RBPJ, CIR1	CIR	protein_coding	Q86X95	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29462
7.96500806431459e-66	-0.392967673575374	0.225	0.388	1.69105086213463e-61	NUFIP2	CD8+ T cells	GSE199333_post	ENSG00000108256	57532	nuclear FMR1 interacting protein 2	182-FIP|82-FIP|FIP-82|KIAA1321|MGC117262|NUFP2|PIG1	protein_coding	Q7Z417	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29463
1.01808647626818e-65	0.531040805147875	0.491	0.352	2.16149939776498e-61	RAC2	CD8+ T cells	GSE199333_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29464
1.49402850352514e-65	-0.301398477994552	0.454	0.651	3.17197191583422e-61	GSTP1	CD8+ T cells	GSE199333_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29465
4.98170159245801e-65	0.353217789599222	0.342	0.199	1.05766506509476e-60	CCND3	CD8+ T cells	GSE199333_post	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29466
7.74487474500226e-65	-0.334395960082658	0.629	0.753	1.64431435711143e-60	DAZAP2	CD8+ T cells	GSE199333_post	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29467
7.95676744777079e-65	-0.336992554819007	0.594	0.735	1.68930129683622e-60	PRDX6	CD8+ T cells	GSE199333_post	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29468
1.86092864921183e-64	-0.333820499424902	0.125	0.278	3.95093761514163e-60	FAM91A1	CD8+ T cells	GSE199333_post	ENSG00000176853	157769	family with sequence similarity 91 member A1	FLJ23790	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29469
2.33649280027496e-64	-0.420941574043188	0.303	0.465	4.96060786426377e-60	SYNE1	CD8+ T cells	GSE199333_post	ENSG00000131018	23345	spectrin repeat containing nuclear envelope protein 1	8B|ARCA1|C6orf98|CPG2|dJ45H2.2|enaptin|KIAA0796|MYNE1|Nesp1|Nesprin-1|SCAR8|SYNE-1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29470
2.70926724060987e-64	-0.293447640895218	0.997	0.996	5.75204527853881e-60	CALM1	CD8+ T cells	GSE199333_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29471
7.40602547455061e-64	-0.378891353674468	0.613	0.719	1.57237326850184e-59	RSRP1	CD8+ T cells	GSE199333_post	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29472
1.34017896270945e-63	-0.336706167070283	0.205	0.367	2.84533395572843e-59	TAF11	CD8+ T cells	GSE199333_post	ENSG00000064995	6882	TATA-box binding protein associated factor 11	TAF2I|TAFII28	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29473
1.52412983153086e-63	0.26752581067979	0.42	0.253	3.23588004532316e-59	TMEM123	CD8+ T cells	GSE199333_post	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29474
1.96300323378449e-63	0.379545449701194	0.399	0.251	4.16765216564785e-59	YIPF5	CD8+ T cells	GSE199333_post	ENSG00000145817	81555	Yip1 domain family member 5	FinGER5|SMAP-5	protein_coding	Q969M3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29475
2.95432182591989e-63	0.438537410123302	0.637	0.522	6.27232066861053e-59	CLIC1	CD8+ T cells	GSE199333_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29476
7.62381923697005e-63	0.283166277174989	0.255	0.128	1.61861306220111e-58	BCL2	CD8+ T cells	GSE199333_post	ENSG00000171791	596	BCL2 apoptosis regulator	Bcl-2|PPP1R50	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29477
8.28706972801883e-63	-0.367958921564304	0.182	0.337	1.75942777395568e-58	SPAG9	CD8+ T cells	GSE199333_post	ENSG00000008294	9043	sperm associated antigen 9	CT89|FLJ13450|FLJ14006|FLJ26141|FLJ34602|HLC4|HSS|JIP-4|JIP4|JLP|KIAA0516|MGC117291|MGC14967|MGC74461|PHET|PIG6|SYD1	protein_coding	O60271	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29478
1.10872385438361e-62	-0.354177905881773	0.231	0.392	2.35393161524185e-58	EP300	CD8+ T cells	GSE199333_post	ENSG00000100393	2033	E1A binding protein p300	KAT3B|p300	protein_coding	Q09472	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29479
1.19821875725572e-62	0.274322044171761	0.892	0.841	2.54393824352962e-58	RPL17	CD8+ T cells	GSE199333_post	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29480
1.28567988850061e-62	0.300837146546366	0.311	0.171	2.72962697127565e-58	DAD1	CD8+ T cells	GSE199333_post	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29481
1.81039606932171e-62	-0.324210751564278	0.179	0.339	3.84365189477691e-58	RASA2	CD8+ T cells	GSE199333_post	ENSG00000155903	5922	RAS p21 protein activator 2	GAP1M	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29482
2.99376301067801e-62	-0.359383592838922	0.316	0.475	6.35605824797048e-58	ETF1	CD8+ T cells	GSE199333_post	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29483
3.42893093498521e-62	-0.324351512167185	0.183	0.341	7.27996326806711e-58	PNPLA8	CD8+ T cells	GSE199333_post	ENSG00000135241	50640	patatin like phospholipase domain containing 8	IPLA2-2|IPLA2G|iPLA2gamma	protein_coding	Q9NP80	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29484
8.69614251303517e-62	-0.361802736342953	0.274	0.431	1.8462780169425e-57	EMD	CD8+ T cells	GSE199333_post	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29485
1.23404572132537e-61	0.25924392637177	0.379	0.221	2.62000247094589e-57	ATP5PD	CD8+ T cells	GSE199333_post	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29486
3.62375158498116e-61	-0.323741840240669	0.169	0.324	7.6935869900735e-57	CTDSPL2	CD8+ T cells	GSE199333_post	ENSG00000137770	51496	CTD small phosphatase like 2	FLJ10523|HSPC129	protein_coding	Q05D32	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29487
1.43285389319867e-60	0.369643828594526	0.799	0.716	3.04209210065009e-56	HSPA8	CD8+ T cells	GSE199333_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29488
2.99002078794381e-60	-0.366765140324398	0.285	0.442	6.3481131348835e-56	ESCO1	CD8+ T cells	GSE199333_post	ENSG00000141446	114799	establishment of sister chromatid cohesion N-acetyltransferase 1	EFO1|ESO1|KIAA1911	protein_coding	Q5FWF5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29489
5.16739698033998e-60	0.284304862954001	0.865	0.783	1.09709005289598e-55	LAPTM5	CD8+ T cells	GSE199333_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29490
5.39625738268966e-60	-0.367460455551459	0.5	0.631	1.14567940491884e-55	PRPF40A	CD8+ T cells	GSE199333_post	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29491
9.91994645805553e-60	-0.330980674950621	0.183	0.335	2.10610383250977e-55	CDK17	CD8+ T cells	GSE199333_post	ENSG00000059758	5128	cyclin dependent kinase 17	PCTAIRE2|PCTK2	protein_coding	Q00537	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29492
1.35490576265332e-59	-0.361703126198609	0.224	0.381	2.87660042468927e-55	KAT6B	CD8+ T cells	GSE199333_post	ENSG00000281813	23522	lysine acetyltransferase 6B	Morf|MOZ2|MYST4|qkf|querkopf|ZC2HC6B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29493
4.90254107461174e-59	-0.365869365034948	0.536	0.646	1.04085849555082e-54	TERF2IP	CD8+ T cells	GSE199333_post	ENSG00000166848	54386	TERF2 interacting protein	RAP1	protein_coding	Q9NYB0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29494
1.0545407913506e-58	0.430407004777718	0.251	0.132	2.23889555411645e-54	TRGC2	CD8+ T cells	GSE199333_post	ENSG00000227191	NA	NA	TCRGC2|TRGC2(2X)|TRGC2(3X)	TR_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29495
1.34528760735043e-58	0.879664851819945	0.672	0.587	2.85618011916569e-54	IL32	CD8+ T cells	GSE199333_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29496
2.05705185691453e-58	-0.37922022629101	0.255	0.406	4.36732679741523e-54	ZNF326	CD8+ T cells	GSE199333_post	ENSG00000162664	284695	zinc finger protein 326	FLJ20403|ZAN75|Zfp326|ZIRD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29497
2.36640324738397e-58	-0.338521644530132	0.218	0.371	5.0241107345209e-54	DYRK1A	CD8+ T cells	GSE199333_post	ENSG00000157540	1859	dual specificity tyrosine phosphorylation regulated kinase 1A	DYRK|DYRK1|MNBH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29498
2.40867595660592e-58	-0.309659109178805	0.784	0.854	5.11385992347002e-54	LIMD2	CD8+ T cells	GSE199333_post	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29499
6.52553199972933e-58	-0.299398783661619	0.139	0.296	1.38543569886253e-53	KLRD1	CD8+ T cells	GSE199333_post	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29500
7.6862697758617e-58	-0.371328534201447	0.307	0.454	1.6318719361132e-53	NECAP1	CD8+ T cells	GSE199333_post	ENSG00000089818	25977	NECAP endocytosis associated 1	DKFZP566B183	protein_coding	Q8NC96	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29501
7.83203001274131e-58	-0.363388840548763	0.252	0.402	1.66281829200511e-53	ELF2	CD8+ T cells	GSE199333_post	ENSG00000109381	1998	E74 like ETS transcription factor 2	EU32|NERF|NERF-1A|NERF-1B|NERF-2	protein_coding	Q15723	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29502
8.27448975140659e-58	-0.301446297864631	0.145	0.291	1.75675691912113e-53	ATP8A1	CD8+ T cells	GSE199333_post	ENSG00000124406	10396	ATPase phospholipid transporting 8A1	ATPIA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29503
1.0636574357425e-57	-0.310590693920656	0.165	0.314	2.25825110182489e-53	FAM76B	CD8+ T cells	GSE199333_post	ENSG00000077458	143684	family with sequence similarity 76 member B	MGC33371	protein_coding	Q5HYJ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29504
1.77924444924851e-57	-0.432326161923931	0.377	0.512	3.77751389019951e-53	TLE4	CD8+ T cells	GSE199333_post	ENSG00000106829	7091	TLE family member 4, transcriptional corepressor	E(spl)|ESG|GRG4	protein_coding	Q04727	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29505
8.53596441154783e-57	-0.364291103531632	0.695	0.78	1.81227060421572e-52	RUNX3	CD8+ T cells	GSE199333_post	ENSG00000020633	864	RUNX family transcription factor 3	AML2|CBFA3|PEBP2A3	protein_coding	Q13761	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29506
8.97500089355969e-57	-0.335796344153855	0.252	0.403	1.90548243971166e-52	MED23	CD8+ T cells	GSE199333_post	ENSG00000112282	9439	mediator complex subunit 23	CRSP130|CRSP3|DRIP130|MRT18|Sur2	protein_coding	Q9ULK4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29507
1.05967615360277e-56	-0.287625913750541	0.715	0.816	2.24979844171403e-52	HNRNPH3	CD8+ T cells	GSE199333_post	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29508
3.1931039106788e-56	-0.347203408543505	0.452	0.582	6.77927891276216e-52	KRR1	CD8+ T cells	GSE199333_post	ENSG00000111615	11103	KRR1 small subunit processome component homolog	HRB2|RIP-1	protein_coding	Q13601	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29509
3.55707262474077e-56	-0.336017326988195	0.273	0.425	7.55202088958713e-52	TMEM87A	CD8+ T cells	GSE199333_post	ENSG00000103978	25963	transmembrane protein 87A	DKFZP564G2022	protein_coding	Q8NBN3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29510
5.36293117956146e-56	0.264294066038428	0.886	0.839	1.13860391873269e-51	COMMD6	CD8+ T cells	GSE199333_post	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29511
7.53458765657411e-56	-0.340959575830978	0.272	0.422	1.59966830536725e-51	COG3	CD8+ T cells	GSE199333_post	ENSG00000136152	83548	component of oligomeric golgi complex 3	SEC34	protein_coding	Q96JB2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29512
2.28996745023805e-55	-0.368882647627687	0.236	0.383	4.8618298936004e-51	SMG1	CD8+ T cells	GSE199333_post	ENSG00000157106	23049	SMG1 nonsense mediated mRNA decay associated PI3K related kinase	ATX|KIAA0421|LIP	protein_coding	Q96Q15	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29513
2.4029080037341e-55	-0.297720104492866	0.726	0.812	5.10161398272786e-51	PCBP2	CD8+ T cells	GSE199333_post	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29514
2.55621619840983e-55	0.252209395082013	0.885	0.827	5.42710261084391e-51	EIF3K	CD8+ T cells	GSE199333_post	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29515
2.69257139302586e-55	-0.363205900288384	0.241	0.391	5.71659832453321e-51	OTULIN	CD8+ T cells	GSE199333_post	ENSG00000154124	90268	OTU deubiquitinase with linear linkage specificity	FAM105B|FLJ34884	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29516
4.31186130351278e-55	-0.352159724140016	0.205	0.35	9.15451273348798e-51	BLOC1S6	CD8+ T cells	GSE199333_post	ENSG00000104164	26258	biogenesis of lysosomal organelles complex 1 subunit 6	HPS9|PA|PLDN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29517
4.51848091913521e-55	-0.313474621070813	0.391	0.566	9.59318683941597e-51	HLA-DPB1	CD8+ T cells	GSE199333_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29518
4.57690654592316e-55	-0.337913035107135	0.206	0.353	9.71723028764945e-51	SPPL2A	CD8+ T cells	GSE199333_post	ENSG00000138600	84888	signal peptide peptidase like 2A	IMP3|PSL2	protein_coding	Q8TCT8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29519
4.60591306644187e-55	-0.3468554975811	0.353	0.503	9.77881403136273e-51	WHAMM	CD8+ T cells	GSE199333_post	ENSG00000156232	123720	WASP homolog associated with actin, golgi membranes and microtubules	KIAA1971|WHAMM1|WHDC1	protein_coding	Q8TF30	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29520
6.44246531072771e-55	-0.301859120032785	0.152	0.295	1.3677998101206e-50	RLF	CD8+ T cells	GSE199333_post	ENSG00000117000	6018	RLF zinc finger	Zn-15L|ZNF292L	protein_coding	Q13129	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29521
1.07922050837937e-54	-0.367675679337531	0.459	0.585	2.29129306134023e-50	RTF1	CD8+ T cells	GSE199333_post	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29522
1.6491571355564e-54	-0.342869132167128	0.224	0.369	3.5013255144998e-50	BNIP3L	CD8+ T cells	GSE199333_post	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29523
2.92352761642621e-54	-0.506473498372642	0.26	0.411	6.20694148243448e-50	PMAIP1	CD8+ T cells	GSE199333_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29524
4.93580769751807e-54	-0.357134627090003	0.242	0.392	1.04792133226006e-49	HIST1H1C	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29525
5.39471743024289e-54	-0.33110022647594	0.238	0.385	1.14535245761487e-49	CDK12	CD8+ T cells	GSE199333_post	ENSG00000167258	51755	cyclin dependent kinase 12	CRK7|CRKR|CRKRS|KIAA0904	protein_coding	Q9NYV4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29526
5.84913122627777e-54	-0.300491563209498	0.157	0.297	1.24182905065103e-49	SUPV3L1	CD8+ T cells	GSE199333_post	ENSG00000156502	6832	Suv3 like RNA helicase	SUV3	protein_coding	Q8IYB8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29527
6.50552966091811e-54	-0.360182306525876	0.339	0.484	1.38118900230952e-49	DNAJC2	CD8+ T cells	GSE199333_post	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29528
7.06593131465999e-54	-0.347969301983825	0.326	0.471	1.50016787741546e-49	MIER1	CD8+ T cells	GSE199333_post	ENSG00000198160	57708	MIER1 transcriptional regulator	hMI-ER1|KIAA1610|MI-ER1	protein_coding	Q8N108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29529
7.60744458318805e-54	-0.288935445272111	0.87	0.934	1.61513655945665e-49	RBM3	CD8+ T cells	GSE199333_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29530
1.30258053304266e-53	-0.401598084759596	0.39	0.523	2.76550872970287e-49	CHD2	CD8+ T cells	GSE199333_post	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29531
1.5039886536609e-53	-0.3380901326847	0.264	0.408	3.19311831058745e-49	RAB14	CD8+ T cells	GSE199333_post	ENSG00000119396	51552	RAB14, member RAS oncogene family	FBP|RAB-14	protein_coding	P61106	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29532
1.7989425256148e-53	-0.357712175365509	0.458	0.585	3.81933487613278e-49	ADAR	CD8+ T cells	GSE199333_post	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29533
4.78161563041321e-53	0.260684205080207	0.271	0.149	1.01518481449303e-48	ANXA6	CD8+ T cells	GSE199333_post	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29534
7.83795531224941e-53	-0.345175338284011	0.59	0.711	1.66407629234367e-48	PNN	CD8+ T cells	GSE199333_post	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29535
1.81496775654646e-52	-0.315403037435038	0.174	0.317	3.8533580439238e-48	TFDP2	CD8+ T cells	GSE199333_post	ENSG00000114126	7029	transcription factor Dp-2	Dp-2	protein_coding	Q14188	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29536
1.98826856392456e-52	-0.278886364790426	0.129	0.264	4.22129298806824e-48	CCDC93	CD8+ T cells	GSE199333_post	ENSG00000125633	54520	coiled-coil domain containing 93	FLJ10996	protein_coding	Q567U6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29537
2.57182937322938e-52	-0.345616636007448	0.496	0.603	5.4602509423033e-48	RNPS1	CD8+ T cells	GSE199333_post	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29538
3.12539035096175e-52	-0.335719662437348	0.4	0.567	6.6355162541269e-48	HLA-DPA1	CD8+ T cells	GSE199333_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29539
4.13017809392456e-52	-0.34479949285924	0.443	0.574	8.76878111121124e-48	WIPF1	CD8+ T cells	GSE199333_post	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29540
7.16827495230246e-52	-0.307425506275421	0.225	0.372	1.52189645512334e-47	RELB	CD8+ T cells	GSE199333_post	ENSG00000104856	5971	RELB proto-oncogene, NF-kB subunit	REL-B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29541
1.61343580594913e-51	-0.351623667598069	0.479	0.595	3.4254855596106e-47	GGNBP2	CD8+ T cells	GSE199333_post	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29542
2.70021685294459e-51	-0.384091187810355	0.462	0.587	5.73283040048666e-47	RB1CC1	CD8+ T cells	GSE199333_post	ENSG00000023287	9821	RB1 inducible coiled-coil 1	ATG17|Cc1|DRAGOU14|FIP200|KIAA0203|PPP1R131	protein_coding	Q8TDY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29543
9.8605808887656e-51	-0.382058953478964	0.467	0.586	2.09349992849382e-46	PSMA3-AS1	CD8+ T cells	GSE199333_post	ENSG00000257621	379025	PSMA3 antisense RNA 1	FLJ31306	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29544
1.13548669411905e-50	-0.362126979543592	0.383	0.518	2.41075180028416e-46	ZRANB2	CD8+ T cells	GSE199333_post	ENSG00000132485	9406	zinc finger RANBP2-type containing 2	ZIS|ZIS1|ZIS2|ZNF265	protein_coding	O95218	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29545
1.50233246827193e-50	-0.359593067613303	0.472	0.586	3.18960206338813e-46	USP15	CD8+ T cells	GSE199333_post	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29546
7.8688653650196e-50	0.253969786369144	0.715	0.586	1.67063880564731e-45	NDUFS5	CD8+ T cells	GSE199333_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29547
9.09061709730365e-50	-0.280181797867516	0.153	0.289	1.93002891592854e-45	SUCO	CD8+ T cells	GSE199333_post	ENSG00000094975	51430	SUN domain containing ossification factor	C1orf9|CH1|OPT|SLP1	protein_coding	Q9UBS9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29548
9.92344957915037e-50	-0.330479338433339	0.25	0.394	2.10684758014941e-45	UTRN	CD8+ T cells	GSE199333_post	ENSG00000152818	7402	utrophin	DMDL|DRP|DRP1	protein_coding	P46939	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29549
1.07375833517328e-49	-0.28173510269143	0.875	0.911	2.27969632140639e-45	GUK1	CD8+ T cells	GSE199333_post	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29550
1.1273286935691e-49	-0.353909950984773	0.378	0.51	2.39343154931656e-45	TMF1	CD8+ T cells	GSE199333_post	ENSG00000144747	7110	TATA element modulatory factor 1	ARA160|TMF	protein_coding	P82094	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29551
1.18912600557555e-49	-0.264900154717118	0.15	0.287	2.52463342243744e-45	CCNT2	CD8+ T cells	GSE199333_post	ENSG00000082258	905	cyclin T2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29552
1.41689086634627e-49	-0.303337596149975	0.204	0.343	3.00820099833976e-45	FUBP1	CD8+ T cells	GSE199333_post	ENSG00000162613	8880	far upstream element binding protein 1	FBP|FUBP	protein_coding	Q96AE4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29553
1.46592607497033e-49	-0.360069855495349	0.314	0.451	3.11230764976951e-45	SETD2	CD8+ T cells	GSE199333_post	ENSG00000181555	29072	SET domain containing 2, histone lysine methyltransferase	FLJ23184|HIF-1|HYPB|KIAA1732|KMT3A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29554
2.04393047955714e-49	-0.286427187199044	0.833	0.882	4.33946880114776e-45	YWHAZ	CD8+ T cells	GSE199333_post	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29555
2.17535911573463e-49	-0.324341278385514	0.278	0.42	4.61850493861619e-45	RBM33	CD8+ T cells	GSE199333_post	ENSG00000184863	155435	RNA binding motif protein 33	DKFZp434D1319|DKFZp686F102|MGC20460|PRR8	protein_coding	Q96EV2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29556
2.27556652508726e-49	-0.341597391420392	0.398	0.542	4.83125528941277e-45	IFITM2	CD8+ T cells	GSE199333_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29557
2.8731395617802e-49	-0.289798606237174	0.742	0.831	6.09996260361554e-45	HMGN1	CD8+ T cells	GSE199333_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29558
4.59206720736116e-49	-0.321032350412355	0.263	0.403	9.74941788794848e-45	ING3	CD8+ T cells	GSE199333_post	ENSG00000071243	54556	inhibitor of growth family member 3	Eaf4|FLJ20089|MEAF4|p47ING3	protein_coding	Q9NXR8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29559
4.72674191893799e-49	-0.354287940438636	0.305	0.44	1.00353457680972e-44	SEPT2	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29560
7.82525224386031e-49	-0.334149158330859	0.333	0.468	1.66137930389398e-44	HNRNPL	CD8+ T cells	GSE199333_post	ENSG00000282947	3191	heterogeneous nuclear ribonucleoprotein L	HNRPL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29561
1.89329290255321e-48	0.28575898750465	0.482	0.34	4.01965016141071e-44	TMEM258	CD8+ T cells	GSE199333_post	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29562
2.62996934549549e-48	-0.281772429829902	0.218	0.36	5.58368791742147e-44	FBXO33	CD8+ T cells	GSE199333_post	ENSG00000165355	254170	F-box protein 33	Fbx33	protein_coding	Q7Z6M2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29563
2.80890531000349e-48	-0.31792773955956	0.201	0.337	5.96358686366841e-44	NFKB2	CD8+ T cells	GSE199333_post	ENSG00000077150	4791	nuclear factor kappa B subunit 2	LYT-10|NF-kB2|p105|p49/p100|p52	protein_coding	Q00653	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29564
2.90523663286047e-48	-0.26819774287231	0.144	0.274	6.16810789522606e-44	WDR45B	CD8+ T cells	GSE199333_post	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29565
3.97883672211861e-48	-0.352837743677623	0.398	0.518	8.44746824473001e-44	RBBP6	CD8+ T cells	GSE199333_post	ENSG00000122257	5930	RB binding protein 6, ubiquitin ligase	P2P-R|PACT|SNAMA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29566
4.68006263566991e-48	-0.30529395389006	0.247	0.386	9.93624098179079e-44	CUL3	CD8+ T cells	GSE199333_post	ENSG00000036257	8452	cullin 3	NA	protein_coding	Q13618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29567
6.03426423391464e-48	-0.308238360328743	0.205	0.342	1.28113463950242e-43	AFF4	CD8+ T cells	GSE199333_post	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29568
6.12480452430638e-48	-0.363082817038159	0.655	0.734	1.30035724855549e-43	GZMM	CD8+ T cells	GSE199333_post	ENSG00000197540	3004	granzyme M	LMET1|MET1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29569
6.94897979849428e-48	-0.345320090814786	0.326	0.457	1.47533790101832e-43	GLS	CD8+ T cells	GSE199333_post	ENSG00000115419	2744	glutaminase	GAC|GAM|GLS1|KGA|KIAA0838	protein_coding	O94925	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29570
9.30834874283909e-48	-0.293675343947856	0.249	0.387	1.97625552159217e-43	RBM22	CD8+ T cells	GSE199333_post	ENSG00000086589	55696	RNA binding motif protein 22	Cwc2|FLJ10290|fSAP47|ZC3H16	protein_coding	Q9NW64	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29571
9.41574858882562e-48	-0.44460684557991	0.498	0.596	1.99905758289357e-43	SMCHD1	CD8+ T cells	GSE199333_post	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29572
1.06284486950461e-47	-0.309898629781034	0.342	0.476	2.25652594244525e-43	GRB2	CD8+ T cells	GSE199333_post	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29573
1.08594120776406e-47	-0.326959969393985	0.225	0.36	2.30556177820388e-43	SMARCA2	CD8+ T cells	GSE199333_post	ENSG00000080503	6595	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2	BAF190|BRM|hBRM|hSNF2a|SNF2|SNF2L2|SNF2LA|Sth1p|SWI2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29574
1.98793087388129e-47	-0.292711562728381	0.201	0.338	4.22057603833736e-43	AP1G1	CD8+ T cells	GSE199333_post	ENSG00000166747	164	adaptor related protein complex 1 subunit gamma 1	ADTG|CLAPG1	protein_coding	O43747	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29575
2.04307753160255e-47	-0.343490345328362	0.374	0.499	4.33765790734538e-43	EWSR1	CD8+ T cells	GSE199333_post	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29576
2.52306985588417e-47	-0.410372284445188	0.426	0.546	5.35672961102769e-43	RNF19A	CD8+ T cells	GSE199333_post	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29577
4.28436191633624e-47	-0.35359012578514	0.282	0.415	9.09612878457346e-43	MTCH1	CD8+ T cells	GSE199333_post	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29578
5.20230257809734e-47	-0.300184790595516	0.173	0.305	1.10450086035585e-42	CWF19L2	CD8+ T cells	GSE199333_post	ENSG00000152404	143884	CWF19 like cell cycle control factor 2	FLJ32343	protein_coding	Q2TBE0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29579
5.63405989802731e-47	-0.293116616490145	0.512	0.632	1.19616725695018e-42	VAPA	CD8+ T cells	GSE199333_post	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29580
8.93136206020412e-47	-0.328926110247481	0.377	0.502	1.89621747900194e-42	RAD21	CD8+ T cells	GSE199333_post	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29581
1.31631262609701e-46	-0.295367111087319	0.159	0.288	2.79466333646657e-42	THOC1	CD8+ T cells	GSE199333_post	ENSG00000079134	9984	THO complex subunit 1	HPR1|P84	protein_coding	Q96FV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29582
1.36032753354155e-46	-0.347676165499389	0.303	0.437	2.88811138646206e-42	RANBP2	CD8+ T cells	GSE199333_post	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29583
1.5078250932447e-46	-0.294065406915943	0.937	0.964	3.20126345546783e-42	ARPC2	CD8+ T cells	GSE199333_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29584
1.66217253243249e-46	-0.349039228974588	0.699	0.774	3.52895850360742e-42	TCF25	CD8+ T cells	GSE199333_post	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29585
2.1429241615072e-46	0.301120641858056	0.406	0.275	4.54964228729594e-42	ANAPC16	CD8+ T cells	GSE199333_post	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29586
2.19377619195558e-46	-0.334145460464507	0.294	0.424	4.65760623314088e-42	DDX39B	CD8+ T cells	GSE199333_post	ENSG00000225859	7919	DExD-box helicase 39B	BAT1|D6S81E|UAP56	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29587
2.21503915701873e-46	0.282828681156427	0.264	0.154	4.70274963426647e-42	CKLF	CD8+ T cells	GSE199333_post	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29588
2.24207825643861e-46	-0.349219165436562	0.405	0.522	4.76015634624482e-42	YME1L1	CD8+ T cells	GSE199333_post	ENSG00000136758	10730	YME1 like 1 ATPase	YME1L	protein_coding	Q96TA2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29589
2.29174546957288e-46	-0.293286383348745	0.267	0.402	4.86560480645019e-42	TOMM5	CD8+ T cells	GSE199333_post	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29590
3.1467250245675e-46	-0.331959341850225	0.32	0.451	6.68081189965926e-42	CDK11A	CD8+ T cells	GSE199333_post	ENSG00000008128	728642	cyclin dependent kinase 11A	CDC2L2|CDC2L3|CDK11-p110|CDK11-p46|CDK11-p58|p58GTA|PITSLRE	protein_coding	Q9UQ88	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29591
5.93756839421678e-46	-0.390732057230616	0.632	0.745	1.26060514577617e-41	SAT1	CD8+ T cells	GSE199333_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29592
6.62157838946075e-46	-0.279999273442386	0.238	0.376	1.40582730786641e-41	CCNK	CD8+ T cells	GSE199333_post	ENSG00000090061	8812	cyclin K	CPR4	protein_coding	O75909	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29593
1.13210010154582e-45	-0.334760443352884	0.458	0.564	2.40356172559192e-41	RAB2A	CD8+ T cells	GSE199333_post	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29594
1.22458784184943e-45	-0.349106828398673	0.575	0.653	2.59992244703052e-41	ARPC5L	CD8+ T cells	GSE199333_post	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29595
1.54661560371557e-45	-0.323246647947317	0.471	0.583	3.28361958824853e-41	U2SURP	CD8+ T cells	GSE199333_post	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29596
1.87115620505779e-45	-0.321549150045073	0.295	0.424	3.97265173895818e-41	RFC1	CD8+ T cells	GSE199333_post	ENSG00000035928	5981	replication factor C subunit 1	A1|MHCBFB|PO-GA|RFC140	protein_coding	P35251	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29597
1.93627235175639e-45	-0.354236242774431	0.366	0.486	4.11089983001398e-41	PRDM2	CD8+ T cells	GSE199333_post	ENSG00000116731	7799	PR/SET domain 2	HUMHOXY1|KMT8|KMT8A|MTB-ZF|RIZ|RIZ1|RIZ2	protein_coding	Q13029	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29598
2.58723466534188e-45	-0.363225180909302	0.629	0.704	5.49295791798734e-41	CLEC2B	CD8+ T cells	GSE199333_post	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29599
3.07014993704917e-45	-0.379569725203433	0.442	0.56	6.5182353313491e-41	GOLGA4	CD8+ T cells	GSE199333_post	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29600
3.26515325377784e-45	0.274250395845188	0.545	0.403	6.93224687309573e-41	ATP5MD	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29601
4.6824147372175e-45	-0.328648173673797	0.52	0.644	9.94123472858646e-41	HSP90B1	CD8+ T cells	GSE199333_post	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29602
4.9026413226581e-45	-0.26393401301814	0.175	0.306	1.04087977921354e-40	TMEM41B	CD8+ T cells	GSE199333_post	ENSG00000166471	440026	transmembrane protein 41B	KIAA0033	protein_coding	Q5BJD5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29603
5.24805482868784e-45	-0.345119932199952	0.37	0.493	1.11421452067872e-40	KANSL1	CD8+ T cells	GSE199333_post	ENSG00000275867	284058	KAT8 regulatory NSL complex subunit 1	CENP-36|DKFZP727C091|KIAA1267|MSL1v1|NSL1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29604
6.12753039868498e-45	-0.317146068231587	0.393	0.515	1.30093597894481e-40	FBXO7	CD8+ T cells	GSE199333_post	ENSG00000100225	25793	F-box protein 7	Fbx|FBX7|PARK15	protein_coding	Q9Y3I1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29605
6.19093656810911e-45	-0.327826914621574	0.24	0.369	1.31439774277524e-40	ACIN1	CD8+ T cells	GSE199333_post	ENSG00000100813	22985	apoptotic chromatin condensation inducer 1	ACINUS|fSAP152|KIAA0670	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29606
1.89369331552713e-44	0.285335527000608	0.692	0.593	4.02050027819566e-40	APRT	CD8+ T cells	GSE199333_post	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29607
1.92325402851846e-44	-0.329481223840685	0.506	0.612	4.08326062794753e-40	SLC38A1	CD8+ T cells	GSE199333_post	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29608
2.08020308420894e-44	-0.308981552029619	0.71	0.81	4.41647916808399e-40	SET	CD8+ T cells	GSE199333_post	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29609
2.24158896736706e-44	-0.335846426369642	0.258	0.387	4.75911753661701e-40	SFXN1	CD8+ T cells	GSE199333_post	ENSG00000164466	94081	sideroflexin 1	FLJ12876|SLC56A1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29610
3.14561064367169e-44	-0.374843042074163	0.401	0.51	6.67844595757936e-40	PHF3	CD8+ T cells	GSE199333_post	ENSG00000118482	23469	PHD finger protein 3	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29611
3.18191545327308e-44	-0.33623846402691	0.368	0.487	6.75552469884408e-40	ILF3	CD8+ T cells	GSE199333_post	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29612
4.093661192139e-44	-0.297910217733661	0.235	0.363	8.69125207703031e-40	ABI1	CD8+ T cells	GSE199333_post	ENSG00000136754	10006	abl interactor 1	ABI-1|E3B1|SSH3BP1	protein_coding	Q8IZP0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29613
5.07785263310445e-44	-0.335180559820948	0.321	0.443	1.07807889253441e-39	EIF1AX	CD8+ T cells	GSE199333_post	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29614
7.098146597733e-44	-0.315754133960355	0.693	0.753	1.50700750416469e-39	KMT2E	CD8+ T cells	GSE199333_post	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29615
7.16562639813638e-44	-0.309599905703077	0.248	0.376	1.52133414058833e-39	TSEN54	CD8+ T cells	GSE199333_post	ENSG00000182173	283989	tRNA splicing endonuclease subunit 54	SEN54|SEN54L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29616
7.24620972646379e-44	-0.297329837746627	0.282	0.41	1.53844278702553e-39	ALYREF	CD8+ T cells	GSE199333_post	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29617
7.94964920663194e-44	-0.341807131781313	0.298	0.421	1.68779002306003e-39	RBM5	CD8+ T cells	GSE199333_post	ENSG00000003756	10181	RNA binding motif protein 5	H37|LUCA-15|LUCA15	protein_coding	P52756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29618
8.58916274574004e-44	0.336554209592882	0.327	0.214	1.82356514254807e-39	RIPOR2	CD8+ T cells	GSE199333_post	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29619
1.13231714708052e-43	-0.310789992222806	0.559	0.657	2.40402253496665e-39	H2AFV	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29620
1.83941127276213e-43	-0.473962077600887	0.515	0.616	3.90525407320127e-39	NR4A2	CD8+ T cells	GSE199333_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29621
1.9503212627975e-43	-0.335725007833895	0.407	0.522	4.14072707304537e-39	SDCBP	CD8+ T cells	GSE199333_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29622
2.26477216005677e-43	-0.256938919521763	0.181	0.308	4.80833777301652e-39	ACBD3	CD8+ T cells	GSE199333_post	ENSG00000182827	64746	acyl-CoA binding domain containing 3	GCP60|GOCAP1|GOLPH1|PAP7	protein_coding	Q9H3P7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29623
3.01009685085228e-43	-0.33057356994439	0.321	0.447	6.39073662404447e-39	HELZ	CD8+ T cells	GSE199333_post	ENSG00000198265	9931	helicase with zinc finger	DHRC|HUMORF5|KIAA0054	protein_coding	P42694	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29624
3.33587320885146e-43	-0.268045487561686	0.776	0.848	7.08239240971254e-39	HNRNPC	CD8+ T cells	GSE199333_post	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29625
5.13234351766638e-43	-0.307974583314576	0.253	0.377	1.08964785223575e-38	ZC3H18	CD8+ T cells	GSE199333_post	ENSG00000158545	124245	zinc finger CCCH-type containing 18	NHN1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29626
5.13549152064167e-43	-0.306103898954843	0.242	0.371	1.09031620474743e-38	POLR2A	CD8+ T cells	GSE199333_post	ENSG00000284832	5430	RNA polymerase II subunit A	POLR2|POLRA|RPB1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29627
6.76607423738901e-43	-0.28877426796027	0.671	0.746	1.43650522134006e-38	POMP	CD8+ T cells	GSE199333_post	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29628
6.79292341882385e-43	-0.292851848729154	0.604	0.699	1.44220557105049e-38	SYF2	CD8+ T cells	GSE199333_post	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29629
7.2680784965091e-43	0.333941330169533	0.584	0.447	1.54308574559385e-38	CD3G	CD8+ T cells	GSE199333_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29630
9.08390962458767e-43	-0.284965950649885	0.242	0.372	1.92860485239621e-38	JMY	CD8+ T cells	GSE199333_post	ENSG00000152409	133746	junction mediating and regulatory protein, p53 cofactor	FLJ37870|WHAMM2	protein_coding	Q8N9B5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29631
1.10620256145015e-42	-0.319643038079434	0.297	0.423	2.34857865821482e-38	PTP4A1	CD8+ T cells	GSE199333_post	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29632
6.1225881241053e-42	0.28508189438871	0.289	0.174	1.2998866846288e-37	CD27	CD8+ T cells	GSE199333_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29633
8.4001694981999e-42	-0.349988787640394	0.327	0.443	1.78343998616282e-37	NIPBL	CD8+ T cells	GSE199333_post	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29634
8.68104345032149e-42	-0.330441451316965	0.393	0.51	1.84307233493776e-37	AMD1	CD8+ T cells	GSE199333_post	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29635
9.54515885422639e-42	-0.332129775279403	0.311	0.433	2.0265326763408e-37	C16orf72	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29636
1.04917651480981e-41	-0.296237753628267	0.276	0.403	2.22750665859271e-37	SAFB2	CD8+ T cells	GSE199333_post	ENSG00000130254	9667	scaffold attachment factor B2	KIAA0138	protein_coding	Q14151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29637
1.17945868434561e-41	-0.296440546409822	0.506	0.605	2.50410873273416e-37	MRPL54	CD8+ T cells	GSE199333_post	ENSG00000183617	116541	mitochondrial ribosomal protein L54	NA	protein_coding	Q6P161	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29638
1.3943162787788e-41	0.400036027379731	0.842	0.808	2.96027289147526e-37	KLF2	CD8+ T cells	GSE199333_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29639
2.32601783770261e-41	-0.286119945696516	0.29	0.414	4.93836847122641e-37	OTUB1	CD8+ T cells	GSE199333_post	ENSG00000167770	55611	OTU deubiquitinase, ubiquitin aldehyde binding 1	FLJ20113|FLJ40710	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29640
2.88468056073789e-41	0.279493039495805	0.508	0.376	6.12446529850261e-37	SAMSN1	CD8+ T cells	GSE199333_post	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29641
2.90738035972756e-41	-0.256454092973354	0.146	0.264	6.17265924173758e-37	TLK2	CD8+ T cells	GSE199333_post	ENSG00000146872	11011	tousled like kinase 2	MGC44450|PKU-ALPHA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29642
3.62648994506303e-41	-0.336270544136899	0.397	0.506	7.69940080236331e-37	TRA2A	CD8+ T cells	GSE199333_post	ENSG00000164548	29896	transformer 2 alpha homolog	AWMS1|htra-2-alpha	protein_coding	Q13595	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29643
4.73243151800785e-41	-0.275095205534038	0.164	0.285	1.00474253558825e-36	JARID2	CD8+ T cells	GSE199333_post	ENSG00000008083	3720	jumonji and AT-rich interaction domain containing 2	JMJ	protein_coding	Q92833	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29644
4.86767618346401e-41	-0.255666957378822	0.244	0.388	1.03345633051124e-36	YBX3	CD8+ T cells	GSE199333_post	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29645
6.84678376064169e-41	-0.288334315688895	0.972	0.991	1.45364066022184e-36	SRGN	CD8+ T cells	GSE199333_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29646
1.10907998819424e-40	-0.312816324852297	0.539	0.63	2.35468772293519e-36	CDV3	CD8+ T cells	GSE199333_post	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29647
1.25969406763106e-40	-0.357205201866191	0.735	0.762	2.67445647498749e-36	LITAF	CD8+ T cells	GSE199333_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29648
1.82193123940288e-40	-0.278341372649395	0.181	0.304	3.86814221437625e-36	FAM160B1	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29649
2.21111760784664e-40	-0.301298249554803	0.241	0.364	4.6944237932192e-36	CWC25	CD8+ T cells	GSE199333_post	ENSG00000276761	54883	CWC25 spliceosome associated protein homolog	CCDC49|FLJ20291	protein_coding	Q9NXE8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29650
2.73370037470378e-40	-0.271986033726836	0.203	0.326	5.80391926553359e-36	FBXO3	CD8+ T cells	GSE199333_post	ENSG00000110429	26273	F-box protein 3	FBA|FBX3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29651
3.36757440132432e-40	-0.27243373027987	0.342	0.467	7.14969721145166e-36	SAP30BP	CD8+ T cells	GSE199333_post	ENSG00000161526	29115	SAP30 binding protein	HCNGP|HTRG|HTRP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29652
3.49922395963835e-40	-0.25711421441322	0.174	0.296	7.42920238870818e-36	LYST	CD8+ T cells	GSE199333_post	ENSG00000143669	1130	lysosomal trafficking regulator	CHS|CHS1|Mauve	protein_coding	Q99698	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29653
3.52445649556457e-40	-0.356238557501609	0.468	0.564	7.48277358573314e-36	DDX21	CD8+ T cells	GSE199333_post	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29654
1.10564036064574e-39	-0.267831501233201	0.648	0.741	2.34738504968698e-35	RBM8A	CD8+ T cells	GSE199333_post	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29655
1.21083550721098e-39	-0.289891169560409	0.318	0.442	2.57072486535962e-35	DNAJC3	CD8+ T cells	GSE199333_post	ENSG00000102580	5611	DnaJ heat shock protein family (Hsp40) member C3	ERdj6|HP58|P58|p58(IPK)|P58IPK|PRKRI	protein_coding	Q13217	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29656
1.34089960061641e-39	-0.286360821295641	0.271	0.394	2.84686394206871e-35	ZNF655	CD8+ T cells	GSE199333_post	ENSG00000197343	79027	zinc finger protein 655	VIK|VIK-1	protein_coding	Q8N720	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29657
1.81457239175565e-39	-0.281596775813521	0.211	0.331	3.85251864493641e-35	GPCPD1	CD8+ T cells	GSE199333_post	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29658
2.0098141067647e-39	-0.292733759865412	0.362	0.476	4.26703633007214e-35	ZNF394	CD8+ T cells	GSE199333_post	ENSG00000160908	84124	zinc finger protein 394	FLJ12298|ZKSCAN14|ZSCAN46	protein_coding	Q53GI3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29659
2.02426787087281e-39	-0.283843448938948	0.225	0.347	4.29772311665007e-35	ARAP2	CD8+ T cells	GSE199333_post	ENSG00000047365	116984	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	CENTD1|PARX	protein_coding	Q8WZ64	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29660
2.1864525507141e-39	0.254210750338778	0.42	0.296	4.64205741042111e-35	C4orf3	CD8+ T cells	GSE199333_post	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29661
2.87084405923465e-39	-0.368483203687608	0.474	0.568	6.09508902216109e-35	RICTOR	CD8+ T cells	GSE199333_post	ENSG00000164327	253260	RPTOR independent companion of MTOR complex 2	AVO3|KIAA1999|MGC39830|PIA	protein_coding	Q6R327	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29662
2.87291040366269e-39	-0.330756315089943	0.409	0.515	6.09947607801625e-35	FKBP11	CD8+ T cells	GSE199333_post	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29663
3.26633373256708e-39	-0.323447816646352	0.268	0.386	6.93475314761317e-35	CTNNB1	CD8+ T cells	GSE199333_post	ENSG00000168036	1499	catenin beta 1	armadillo|beta-catenin|CTNNB	protein_coding	P35222	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29664
3.76922191235624e-39	-0.252872890172175	0.255	0.381	8.00243504212354e-35	ZFAND2A	CD8+ T cells	GSE199333_post	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29665
4.02013672587102e-39	-0.250089532837536	0.146	0.262	8.53515228269677e-35	PAXBP1	CD8+ T cells	GSE199333_post	ENSG00000263141	94104	PAX3 and PAX7 binding protein 1	C21orf66|fSAP105|GCFC|GCFC1	protein_coding	Q9Y5B6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29666
5.34579263027762e-39	-0.287612604316752	0.195	0.312	1.13496523333424e-34	INO80D	CD8+ T cells	GSE199333_post	ENSG00000283510	54891	INO80 complex subunit D	FLJ20309	protein_coding	Q53TQ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29667
7.00412140519966e-39	-0.250163976501019	0.184	0.303	1.48704501553794e-34	PPP2R2D	CD8+ T cells	GSE199333_post	ENSG00000175470	55844	protein phosphatase 2 regulatory subunit Bdelta	B55D|B55delta|MDS026	protein_coding	Q66LE6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29668
7.47480971059035e-39	-0.315344915444652	0.391	0.501	1.58697684965544e-34	FNBP4	CD8+ T cells	GSE199333_post	ENSG00000285182	23360	formin binding protein 4	KIAA1014	protein_coding	Q8N3X1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29669
7.72191115231033e-39	-0.359895715690924	0.279	0.395	1.63943895674701e-34	GNPTAB	CD8+ T cells	GSE199333_post	ENSG00000111670	79158	N-acetylglucosamine-1-phosphate transferase subunits alpha and beta	GNPTA|KIAA1208|MGC4170	protein_coding	Q3T906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29670
8.37282549018879e-39	-0.296121596076871	0.243	0.363	1.77763457982198e-34	PJA2	CD8+ T cells	GSE199333_post	ENSG00000198961	9867	praja ring finger ubiquitin ligase 2	KIAA0438|Neurodap1|PRAJA2|RNF131	protein_coding	O43164	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29671
8.76939260745858e-39	-0.406560438488464	0.236	0.358	1.86182974448953e-34	HIST1H4C	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29672
1.22090223294858e-38	-0.304060086819071	0.256	0.377	2.59209753077312e-34	ARHGAP9	CD8+ T cells	GSE199333_post	ENSG00000123329	64333	Rho GTPase activating protein 9	10C|MGC1295	protein_coding	Q9BRR9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29673
4.47823731774123e-38	-0.288571397867203	0.242	0.361	9.50774564929642e-34	LCOR	CD8+ T cells	GSE199333_post	ENSG00000196233	84458	ligand dependent nuclear receptor corepressor	C10orf12|DKFZP564P1916|FLJ13022|FLJ38026|KIAA1795|MLR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29674
5.69538503334873e-38	-0.363806552776678	0.597	0.676	1.20918719643027e-33	SYNE2	CD8+ T cells	GSE199333_post	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29675
7.29206893749846e-38	-0.257558558889225	0.21	0.33	1.5481791561203e-33	UBN1	CD8+ T cells	GSE199333_post	ENSG00000118900	29855	ubinuclein 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29676
7.6849798065056e-38	-0.283812563858557	0.238	0.357	1.6315980627192e-33	VPS37B	CD8+ T cells	GSE199333_post	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29677
8.70290173097481e-38	-0.297068234724306	0.289	0.413	1.84771306650326e-33	PLAC8	CD8+ T cells	GSE199333_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29678
1.09654092995959e-37	-0.280233029632516	0.237	0.361	2.3280660483972e-33	KIF20B	CD8+ T cells	GSE199333_post	ENSG00000138182	9585	kinesin family member 20B	CT90|KRMP1|MPHOSPH1|MPP1	protein_coding	Q96Q89	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29679
1.31937536920252e-37	-0.366656857328424	0.451	0.544	2.80116584635387e-33	BOD1L1	CD8+ T cells	GSE199333_post	ENSG00000038219	259282	biorientation of chromosomes in cell division 1 like 1	BOD1L|FAM44A|FLJ33215|KIAA1327	protein_coding	Q8NFC6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29680
1.59664658528589e-37	-0.259869272561448	0.152	0.265	3.38984036522047e-33	LRRC58	CD8+ T cells	GSE199333_post	ENSG00000163428	116064	leucine rich repeat containing 58	NA	protein_coding	Q96CX6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29681
1.7042815591835e-37	-0.2527086458122	0.184	0.3	3.61836017830249e-33	LMBR1L	CD8+ T cells	GSE199333_post	ENSG00000139636	55716	limb development membrane protein 1 like	FLJ10494|KIAA1174	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29682
2.19830754097189e-37	-0.314381635967826	0.326	0.439	4.66722674023743e-33	NFKB1	CD8+ T cells	GSE199333_post	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29683
2.27646713300394e-37	-0.252576454049995	0.153	0.266	4.83316737008066e-33	C5orf24	CD8+ T cells	GSE199333_post	ENSG00000181904	134553	chromosome 5 open reading frame 24	FLJ37562	protein_coding	Q7Z6I8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29684
3.01892316496002e-37	-0.263538155242578	0.196	0.313	6.40947577152662e-33	DIS3	CD8+ T cells	GSE199333_post	ENSG00000083520	22894	DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease	dis3p|EXOSC11|KIAA1008|RRP44	protein_coding	Q9Y2L1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29685
3.57937855180568e-37	-0.296679930643196	0.261	0.379	7.59937860333865e-33	TENT4B	CD8+ T cells	GSE199333_post	ENSG00000121274	64282	terminal nucleotidyltransferase 4B	PAPD5|TRF4-2|TUT3	protein_coding	Q8NDF8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29686
4.30613247983575e-37	-0.274540577347958	0.218	0.336	9.14234986793928e-33	ZNF451	CD8+ T cells	GSE199333_post	ENSG00000112200	26036	zinc finger protein 451	COASTER|dJ417I1.1|KIAA0576|KIAA1702|ZATT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29687
4.70383083093952e-37	0.370647013197721	0.426	0.305	9.98670323716769e-33	TRBC1	CD8+ T cells	GSE199333_post	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29688
4.92812979483024e-37	-0.312556457039568	0.42	0.524	1.04629123674041e-32	TENT5C	CD8+ T cells	GSE199333_post	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29689
8.40607408405956e-37	-0.276843651716432	0.226	0.343	1.78469358878668e-32	ZFC3H1	CD8+ T cells	GSE199333_post	ENSG00000133858	196441	zinc finger C3H1-type containing	CCDC131|CSRC2|KIAA0546|MGC23401|PSRC2	protein_coding	O60293	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29690
9.25827240220563e-37	-0.287040195795158	0.444	0.546	1.96562381371228e-32	PET100	CD8+ T cells	GSE199333_post	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29691
1.11337484985778e-36	-0.286727429551252	0.314	0.429	2.36380614373306e-32	ANAPC5	CD8+ T cells	GSE199333_post	ENSG00000089053	51433	anaphase promoting complex subunit 5	APC5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29692
1.74941578089733e-36	-0.29805868250186	0.31	0.421	3.71418464442313e-32	GPATCH8	CD8+ T cells	GSE199333_post	ENSG00000186566	23131	G-patch domain containing 8	GPATC8|KIAA0553	protein_coding	Q9UKJ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29693
1.86350287912742e-36	0.286832516239545	0.771	0.678	3.95640296267542e-32	TSC22D3	CD8+ T cells	GSE199333_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29694
1.92052168189069e-36	-0.265559018530544	0.218	0.336	4.07745958282213e-32	MIA3	CD8+ T cells	GSE199333_post	ENSG00000154305	375056	MIA SH3 domain ER export factor 3	FLJ39207|KIAA0268|TANGO|TANGO1|UNQ6077	protein_coding	Q5JRA6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29695
2.09946948768623e-36	-0.353873497450836	0.315	0.427	4.45738366930664e-32	HSPD1	CD8+ T cells	GSE199333_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29696
2.26786791885206e-36	-0.29864086233849	0.571	0.648	4.8149103785148e-32	FYN	CD8+ T cells	GSE199333_post	ENSG00000010810	2534	FYN proto-oncogene, Src family tyrosine kinase	MGC45350|SLK|SYN	protein_coding	P06241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29697
3.30095061577921e-36	-0.390774946970126	0.497	0.589	7.00824825236084e-32	ID2	CD8+ T cells	GSE199333_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29698
4.01856861141854e-36	-0.323670579312902	0.353	0.459	8.5318230189027e-32	RAB5IF	CD8+ T cells	GSE199333_post	ENSG00000101084	55969	RAB5 interacting factor	C20orf24|PNAS-11|RCAF1|RIP5	protein_coding	Q9BUV8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29699
6.1457232501458e-36	-0.273482435757346	0.249	0.365	1.30479850323845e-31	DDX27	CD8+ T cells	GSE199333_post	ENSG00000124228	55661	DEAD-box helicase 27	dJ686N3.1|DRS1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29700
6.82677915962139e-36	-0.282999719291292	0.247	0.36	1.44939348337922e-31	CDC5L	CD8+ T cells	GSE199333_post	ENSG00000096401	988	cell division cycle 5 like	CDC5|CEF1|hCDC5|PCDC5RP	protein_coding	Q99459	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29701
8.35050700215878e-36	-0.278842089893546	0.27	0.387	1.77289614162833e-31	TIPARP	CD8+ T cells	GSE199333_post	ENSG00000163659	25976	TCDD inducible poly(ADP-ribose) polymerase	ARTD14|DDF1|DKFZP434J214|DKFZp686N0351|PARP-1|PARP-7|PARP7|pART14|RM1	protein_coding	Q7Z3E1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29702
9.17516049906433e-36	-0.282589238960291	0.276	0.388	1.94797832555635e-31	VPS4B	CD8+ T cells	GSE199333_post	ENSG00000119541	9525	vacuolar protein sorting 4 homolog B	SKD1|SKD1B|VPS4-2	protein_coding	O75351	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29703
1.09824601082496e-35	-0.263585469414611	0.33	0.441	2.33168610558246e-31	MED6	CD8+ T cells	GSE199333_post	ENSG00000133997	10001	mediator complex subunit 6	NY-REN-28	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29704
1.19121107088439e-35	-0.27145914585176	0.224	0.339	2.52906022459465e-31	CHD8	CD8+ T cells	GSE199333_post	ENSG00000100888	57680	chromodomain helicase DNA binding protein 8	DUPLIN|HELSNF1|KIAA1564	protein_coding	Q9HCK8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29705
1.51579739341191e-35	-0.269954381551105	0.549	0.647	3.21818944595284e-31	HNRNPD	CD8+ T cells	GSE199333_post	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29706
3.64982023653498e-35	-0.262572575428362	0.325	0.438	7.74893334418741e-31	BCL7B	CD8+ T cells	GSE199333_post	ENSG00000106635	9275	BAF chromatin remodeling complex subunit BCL7B	SMARCJ2	protein_coding	Q9BQE9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29707
5.53936826555213e-35	-0.26968228455661	0.222	0.334	1.17606327645937e-30	IST1	CD8+ T cells	GSE199333_post	ENSG00000182149	9798	IST1 factor associated with ESCRT-III	CHMP8|KIAA0174	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29708
5.78835460912528e-35	-0.297934574723865	0.423	0.526	1.22892556706339e-30	EIF4A1	CD8+ T cells	GSE199333_post	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29709
6.90662904914107e-35	-0.252856162232319	0.213	0.327	1.46634641342314e-30	ASXL1	CD8+ T cells	GSE199333_post	ENSG00000171456	171023	ASXL transcriptional regulator 1	KIAA0978	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29710
7.39440565405755e-35	-0.26336053613623	0.583	0.661	1.56990626441296e-30	SCAND1	CD8+ T cells	GSE199333_post	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29711
1.64912684422745e-34	-0.256799561387415	0.2	0.314	3.5012612029793e-30	PRDM1	CD8+ T cells	GSE199333_post	ENSG00000057657	639	PR/SET domain 1	BLIMP1|PRDI-BF1	protein_coding	O75626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29712
1.85196625908709e-34	-0.304017566444736	0.291	0.404	3.9319095646678e-30	BDP1	CD8+ T cells	GSE199333_post	ENSG00000274803	55814	B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB	HSA238520|KIAA1241|KIAA1689|TAF3B1|TFC5|TFIIIB150|TFIIIB90|TFNR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29713
2.18917314445779e-34	-0.266790747332932	0.342	0.457	4.64783350299833e-30	N4BP1	CD8+ T cells	GSE199333_post	ENSG00000102921	9683	NEDD4 binding protein 1	NA	protein_coding	O75113	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29714
2.80335991413691e-34	-0.285206274774058	0.577	0.662	5.95181343370407e-30	SCAF11	CD8+ T cells	GSE199333_post	ENSG00000139218	9169	SR-related CTD associated factor 11	CASP11|SFRS2IP|SIP1|SRRP129|SRSF2IP	protein_coding	Q99590	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29715
4.49241257399264e-34	-0.342303204221364	0.466	0.552	9.53784113584378e-30	DYNC1H1	CD8+ T cells	GSE199333_post	ENSG00000197102	1778	dynein cytoplasmic 1 heavy chain 1	CMT2O|DHC1|DNCH1|Dnchc1|DNCL|DNECL|HL-3|p22	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29716
6.17529950199385e-34	-0.251701840400176	0.287	0.408	1.31107783726831e-29	METRNL	CD8+ T cells	GSE199333_post	ENSG00000275031	284207	meteorin like, glial cell differentiation regulator	NA	protein_coding	Q641Q3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29717
6.31444481401151e-34	-0.252720340169172	0.214	0.326	1.34061977846278e-29	ANKRD49	CD8+ T cells	GSE199333_post	ENSG00000168876	54851	ankyrin repeat domain 49	FGIF|FLJ20189|GBIF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29718
7.30766861298523e-34	0.305626202360026	0.47	0.369	1.55149112322289e-29	ARPC1B	CD8+ T cells	GSE199333_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29719
8.87714860171064e-34	-0.272540227729429	0.409	0.509	1.88470741962919e-29	DNTTIP2	CD8+ T cells	GSE199333_post	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29720
1.04615290001213e-33	-0.250362130482338	0.21	0.322	2.22108722201575e-29	DNM1L	CD8+ T cells	GSE199333_post	ENSG00000087470	10059	dynamin 1 like	DRP1|DVLP|DYMPLE|HDYNIV|VPS1	protein_coding	O00429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29721
1.87974657248308e-33	-0.303544513843623	0.474	0.562	3.99088994803883e-29	CAPZA1	CD8+ T cells	GSE199333_post	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29722
1.90599736185605e-33	-0.258675756302029	0.308	0.418	4.04662299895657e-29	SERINC1	CD8+ T cells	GSE199333_post	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29723
4.77745660299943e-33	-0.275260417371455	0.683	0.748	1.01430181138281e-28	IER2	CD8+ T cells	GSE199333_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29724
9.33782282613958e-33	-0.26571222316536	0.366	0.474	1.98251316421769e-28	DHX9	CD8+ T cells	GSE199333_post	ENSG00000135829	1660	DExH-box helicase 9	DDX9|LKP|RHA	protein_coding	Q08211	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29725
1.420460061003e-32	-0.34148167380126	0.384	0.481	3.01577875551547e-28	PCM1	CD8+ T cells	GSE199333_post	ENSG00000078674	5108	pericentriolar material 1	PTC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29726
1.49290556252456e-32	-0.301743175114342	0.351	0.451	3.16958779979589e-28	LENG8	CD8+ T cells	GSE199333_post	ENSG00000276458	114823	leukocyte receptor cluster member 8	KIAA1932|MGC40108|pp13842	protein_coding	Q96PV6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29727
1.96901723763094e-32	-0.275690099309552	0.413	0.511	4.18042049721424e-28	MAPK1IP1L	CD8+ T cells	GSE199333_post	ENSG00000168175	93487	mitogen-activated protein kinase 1 interacting protein 1 like	C14orf32	protein_coding	Q8NDC0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29728
3.36991037937463e-32	-0.275819065381153	0.393	0.489	7.15465672645027e-28	RBM17	CD8+ T cells	GSE199333_post	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29729
1.26749061790784e-31	-0.299489654334488	0.38	0.473	2.69100933088013e-27	SLTM	CD8+ T cells	GSE199333_post	ENSG00000137776	79811	SAFB like transcription modulator	FLJ13213|Met	protein_coding	Q9NWH9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29730
1.93019949969669e-31	-0.28171839024934	0.408	0.504	4.09800655780604e-27	YY1	CD8+ T cells	GSE199333_post	ENSG00000100811	7528	YY1 transcription factor	DELTA|INO80S|NF-E1|UCRBP|YIN-YANG-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29731
2.0022141161212e-31	-0.256394948995597	0.187	0.291	4.25090078993692e-27	NAMPT	CD8+ T cells	GSE199333_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29732
2.29698054433924e-31	-0.268792780054625	0.382	0.485	4.87671939368664e-27	JOSD1	CD8+ T cells	GSE199333_post	ENSG00000100221	9929	Josephin domain containing 1	KIAA0063	protein_coding	Q15040	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29733
2.32841718417453e-31	-0.260253627410268	0.615	0.693	4.94346252372095e-27	IRF1	CD8+ T cells	GSE199333_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29734
3.66853668380769e-31	-0.264942842733502	0.348	0.456	7.7886702333921e-27	H2AFY	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29735
3.71206406398995e-31	-0.259654505557527	0.196	0.299	7.88108321425705e-27	DDX52	CD8+ T cells	GSE199333_post	ENSG00000277594	11056	DExD-box helicase 52	ROK1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29736
6.38715650858203e-31	0.320987799065882	0.587	0.495	1.35605719833705e-26	EVL	CD8+ T cells	GSE199333_post	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29737
7.21809536216766e-31	-0.290848962783461	0.482	0.564	1.53247382634182e-26	CLK1	CD8+ T cells	GSE199333_post	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29738
1.49933401708118e-30	-0.260778644300813	0.314	0.418	3.18323605166506e-26	METAP2	CD8+ T cells	GSE199333_post	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29739
2.91234783188114e-30	-0.26480461745263	0.388	0.49	6.18320568186685e-26	PRKCH	CD8+ T cells	GSE199333_post	ENSG00000027075	5583	protein kinase C eta	PKC-L|PKCL|PRKCL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29740
3.22222587722443e-30	-0.340626532392715	0.468	0.553	6.84110775993519e-26	EFHD2	CD8+ T cells	GSE199333_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29741
4.04163840469169e-30	-0.320648803669438	0.518	0.595	8.58080249700092e-26	CHD1	CD8+ T cells	GSE199333_post	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29742
5.13783797786917e-30	0.815573534490511	0.483	0.435	1.0908143810814e-25	GZMK	CD8+ T cells	GSE199333_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29743
1.12290506380276e-29	-0.253711523711216	0.318	0.421	2.38403974095964e-25	ZFAND6	CD8+ T cells	GSE199333_post	ENSG00000086666	54469	zinc finger AN1-type containing 6	AWP1|ZA20D3|ZFAND5B	protein_coding	Q6FIF0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29744
1.49591642962593e-29	-0.302999236461276	0.251	0.35	3.1759801717388e-25	GPRIN3	CD8+ T cells	GSE199333_post	ENSG00000185477	285513	GPRIN family member 3	FLJ42625|GRIN3	protein_coding	Q6ZVF9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29745
1.58772598269778e-29	-0.26740370051446	0.293	0.392	3.37090103386565e-25	SREK1IP1	CD8+ T cells	GSE199333_post	ENSG00000153006	285672	SREK1 interacting protein 1	FLJ36754|P18SRP|SFRS12IP1	protein_coding	Q8N9Q2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29746
2.36564056060793e-29	-0.255472328900665	0.317	0.417	5.0224914742267e-25	SH3GLB1	CD8+ T cells	GSE199333_post	ENSG00000097033	51100	SH3 domain containing GRB2 like, endophilin B1	Bif-1|CGI-61|KIAA0491|PPP1R70	protein_coding	Q9Y371	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29747
6.24076579222846e-29	-0.261576640173571	0.494	0.574	1.32497698534802e-24	SPCS3	CD8+ T cells	GSE199333_post	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29748
1.25061299635474e-28	0.28480138645999	0.343	0.247	2.65517645256074e-24	NINJ1	CD8+ T cells	GSE199333_post	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29749
1.34828612411827e-28	-0.282993999392223	0.281	0.383	2.8625462701155e-24	AC004687.1	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29750
1.51850988749251e-28	-0.258260772102042	0.263	0.36	3.22394834213535e-24	SYNCRIP	CD8+ T cells	GSE199333_post	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29751
1.72380967201732e-28	-0.27140969621929	0.315	0.416	3.65982031465998e-24	BRAF	CD8+ T cells	GSE199333_post	ENSG00000157764	673	B-Raf proto-oncogene, serine/threonine kinase	BRAF-1|BRAF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29752
3.25181321467361e-28	-0.270111059740956	0.365	0.456	6.90392463607355e-24	NOP58	CD8+ T cells	GSE199333_post	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29753
4.91947156856295e-28	-0.260422395995323	0.335	0.432	1.0444530087216e-23	TGOLN2	CD8+ T cells	GSE199333_post	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29754
1.18319169491596e-27	-0.320133537926732	0.38	0.468	2.51203428747608e-23	CALM3	CD8+ T cells	GSE199333_post	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29755
1.44488909745942e-27	-0.25161989719834	0.451	0.535	3.06764404281609e-23	SLC3A2	CD8+ T cells	GSE199333_post	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29756
2.85409037643008e-27	-0.251405532575903	0.509	0.595	6.05951927819871e-23	MXD4	CD8+ T cells	GSE199333_post	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29757
3.41559415539034e-27	-0.270571961150225	0.409	0.525	7.25164795130923e-23	CD8A	CD8+ T cells	GSE199333_post	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29758
6.53342327759521e-27	0.301498165726043	0.66	0.583	1.38711109606624e-22	KLF6	CD8+ T cells	GSE199333_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29759
1.01091950821298e-26	-0.285040331974096	0.387	0.47	2.14628320788698e-22	MECP2	CD8+ T cells	GSE199333_post	ENSG00000169057	4204	methyl-CpG binding protein 2	MRX16|MRX79|RTT	protein_coding	P51608	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29760
1.33770550018577e-26	-0.258506566063114	0.944	0.966	2.84008254744441e-22	ARHGDIB	CD8+ T cells	GSE199333_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29761
1.99375709584982e-26	-0.26334136158607	0.356	0.445	4.23294569019876e-22	TMEM259	CD8+ T cells	GSE199333_post	ENSG00000182087	91304	transmembrane protein 259	ASBABP1|C19orf6|MBRL|MGC4022	protein_coding	Q4ZIN3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29762
2.61302144642687e-26	-0.276069360204181	0.331	0.422	5.54770583290889e-22	TUT4	CD8+ T cells	GSE199333_post	ENSG00000134744	23318	terminal uridylyl transferase 4	KIAA0191|PAPD3|TENT3A|ZCCHC11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29763
1.08447770676147e-25	0.294431009396762	0.404	0.315	2.30245461922527e-21	LCK	CD8+ T cells	GSE199333_post	ENSG00000182866	3932	LCK proto-oncogene, Src family tyrosine kinase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29764
2.12576298614121e-25	-0.257770550447256	0.409	0.501	4.51320739587641e-21	ARID1B	CD8+ T cells	GSE199333_post	ENSG00000049618	57492	AT-rich interaction domain 1B	6A3-5|BAF250b|DAN15|ELD/OSA1|KIAA1235|p250R|SMARCF2	protein_coding	Q8NFD5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29765
4.32682762852295e-25	-0.270029524379873	0.517	0.58	9.18628773811708e-21	MAP1LC3B	CD8+ T cells	GSE199333_post	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29766
5.33921777684647e-25	-0.263696730367319	0.344	0.433	1.13356932620227e-20	ZBTB7A	CD8+ T cells	GSE199333_post	ENSG00000178951	51341	zinc finger and BTB domain containing 7A	DKFZp547O146|FBI-1|LRF|pokemon|ZBTB7|ZNF857A	protein_coding	O95365	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29767
7.2123270948057e-25	-0.29955023244144	0.515	0.587	1.5312491654982e-20	EIF3A	CD8+ T cells	GSE199333_post	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29768
2.85829304584259e-24	-0.251952878322124	0.241	0.33	6.0684419656284e-20	PRKX	CD8+ T cells	GSE199333_post	ENSG00000183943	5613	protein kinase cAMP-dependent X-linked catalytic subunit	PKX1	protein_coding	P51817	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29769
2.94722567194048e-24	0.42943573986807	0.521	0.465	6.25725482409684e-20	LGALS1	CD8+ T cells	GSE199333_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29770
6.57244950209064e-24	-0.253948855529423	0.316	0.401	1.39539675378886e-19	DNAJB14	CD8+ T cells	GSE199333_post	ENSG00000164031	79982	DnaJ heat shock protein family (Hsp40) member B14	FLJ14281	protein_coding	Q8TBM8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29771
1.06998455103342e-23	-0.252652028843829	0.207	0.295	2.27168420029905e-19	SERTAD1	CD8+ T cells	GSE199333_post	ENSG00000197019	29950	SERTA domain containing 1	SEI1|TRIP-Br1	protein_coding	Q9UHV2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29772
1.3212986309871e-23	-0.257323505681331	0.876	0.958	2.80524912344872e-19	PFN1	CD8+ T cells	GSE199333_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29773
5.56237350520029e-23	-0.255394575143772	0.402	0.479	1.18094751888907e-18	DHX36	CD8+ T cells	GSE199333_post	ENSG00000281763	170506	DEAH-box helicase 36	DDX36|KIAA1488|MLEL1|RHAU	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29774
7.29299567250451e-23	-0.252256921915683	0.356	0.439	1.54837591122943e-18	SNRNP200	CD8+ T cells	GSE199333_post	ENSG00000144028	23020	small nuclear ribonucleoprotein U5 subunit 200	ASCC3L1|BRR2|HELIC2|KIAA0788|RP33|U5-200KD	protein_coding	O75643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29775
7.31699377100389e-23	-0.257992073762193	0.356	0.435	1.55347094752184e-18	CREBRF	CD8+ T cells	GSE199333_post	ENSG00000164463	153222	CREB3 regulatory factor	C5orf41|LRF	protein_coding	Q8IUR6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29776
1.13210151286351e-22	-0.270867533865543	0.428	0.503	2.40356472196051e-18	TPR	CD8+ T cells	GSE199333_post	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29777
1.16377825018276e-22	-0.256282974478523	0.472	0.545	2.47081760296302e-18	CDKN2D	CD8+ T cells	GSE199333_post	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29778
1.7784052844168e-21	-0.283464961853591	0.495	0.55	3.77573225934531e-17	HSPE1	CD8+ T cells	GSE199333_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29779
4.08953709841507e-21	-0.263153384464565	0.486	0.545	8.68249621364504e-17	CYTH1	CD8+ T cells	GSE199333_post	ENSG00000108669	9267	cytohesin 1	B2-1|cytohesin-1|D17S811E|PSCD1	protein_coding	Q15438	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29780
5.00713222782568e-21	-0.251377477284539	0.261	0.345	1.06306424328967e-16	PHIP	CD8+ T cells	GSE199333_post	ENSG00000146247	55023	pleckstrin homology domain interacting protein	BRWD2|DCAF14|FLJ20705|ndrp|WDR11	protein_coding	Q8WWQ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29781
9.40437836593649e-21	-0.254743391843752	0.37	0.443	1.99664357087198e-16	SURF4	CD8+ T cells	GSE199333_post	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29782
1.43785282360057e-16	-0.26596908689842	0.424	0.48	3.05270532978638e-12	AKAP9	CD8+ T cells	GSE199333_post	ENSG00000127914	10142	A-kinase anchoring protein 9	AKAP350|AKAP450|CG-NAP|HYPERION|KIAA0803|LQT11|MU-RMS-40.16A|PPP1R45|PRKA9|YOTIAO	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29783
3.13095584584338e-15	-0.25441604872209	0.572	0.636	6.64733235631007e-11	H2AFZ	CD8+ T cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29784
1.48999802646736e-13	-0.270754561385851	0.357	0.411	3.16341480999286e-09	GOLGB1	CD8+ T cells	GSE199333_post	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29785
2.78061081982078e-13	0.316047668959638	0.436	0.372	5.90351483156149e-09	DUSP1	CD8+ T cells	GSE199333_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29786
1.02240510019588e-07	0.389085205451947	0.818	0.831	0.00217066826822588	JUNB	CD8+ T cells	GSE199333_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29787
2.65558815712575e-07	0.272845754887426	1	1	0.00563807921639367	FTH1	CD8+ T cells	GSE199333_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29788
0	0.707006365756217	0.83	0.503	0	PARK7	Malignant cells	GSE199333_post	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29789
0	1.32771484781008	0.98	0.811	0	ENO1	Malignant cells	GSE199333_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29790
0	-0.765447501437756	0.089	0.372	0	TNFRSF1B	Malignant cells	GSE199333_post	ENSG00000028137	7133	TNF receptor superfamily member 1B	CD120b|p75|TNF-R-II|TNF-R75|TNFBR|TNFR2|TNFR80	protein_coding	P20333	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29791
0	-0.759650468920187	0.858	0.954	0	CDC42	Malignant cells	GSE199333_post	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29792
0	1.53581529596732	0.751	0.173	0	STMN1	Malignant cells	GSE199333_post	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29793
0	0.756855633875014	0.787	0.383	0	ATP5IF1	Malignant cells	GSE199333_post	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29794
0	-1.01430967008379	0.733	0.92	0	PTP4A2	Malignant cells	GSE199333_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29795
0	1.38688143424534	0.805	0.287	0	ARMH1	Malignant cells	GSE199333_post	ENSG00000198520	339541	armadillo like helical domain containing 1	C1orf228|MGC33556|NCRNA00082|p40	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29796
0	1.19078982460457	0.757	0.286	0	PRDX1	Malignant cells	GSE199333_post	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29797
0	-1.58953515074807	0.577	0.885	0	MCL1	Malignant cells	GSE199333_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29798
0	-1.5334288666082	0.197	0.58	0	S100A10	Malignant cells	GSE199333_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29799
0	-0.677584529168588	0.113	0.601	0	S100A9	Malignant cells	GSE199333_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29800
0	-0.577108661335332	0.031	0.26	0	S100A12	Malignant cells	GSE199333_post	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29801
0	-1.03177510999214	0.113	0.503	0	S100A8	Malignant cells	GSE199333_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29802
0	-0.680090285366427	0.173	0.499	0	RIT1	Malignant cells	GSE199333_post	ENSG00000143622	6016	Ras like without CAAX 1	MGC125864|MGC125865|RIBB|RIT|ROC1	protein_coding	Q92963	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29803
0	-1.33667643207183	0.129	0.535	0	LMNA	Malignant cells	GSE199333_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29804
0	0.723389876747381	0.602	0.218	0	CCT3	Malignant cells	GSE199333_post	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29805
0	-0.59612694484316	0.158	0.447	0	MEF2D	Malignant cells	GSE199333_post	ENSG00000116604	4209	myocyte enhancer factor 2D	NA	protein_coding	Q14814	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29806
0	0.758842445733638	0.528	0.107	0	IFI16	Malignant cells	GSE199333_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29807
0	0.759377939176388	0.57	0.14	0	TSTD1	Malignant cells	GSE199333_post	ENSG00000215845	100131187	thiosulfate sulfurtransferase like domain containing 1	KAT	protein_coding	Q8NFU3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29808
0	0.981046080801715	0.559	0.131	0	SELL	Malignant cells	GSE199333_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29809
0	0.898858698996588	0.471	0.024	0	CD34	Malignant cells	GSE199333_post	ENSG00000174059	947	CD34 molecule	NA	protein_coding	P28906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29810
0	-1.87056818413053	0.006	0.291	0	G0S2	Malignant cells	GSE199333_post	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29811
0	0.634933604524211	0.503	0.113	0	SDCCAG8	Malignant cells	GSE199333_post	ENSG00000276111	10806	SHH signaling and ciliogenesis regulator SDCCAG8	BBS16|CCCAP|NPHP10|NY-CO-8|SLSN7	protein_coding	Q86SQ7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29812
0	-1.47441949854752	0.244	0.581	0	FOSL2	Malignant cells	GSE199333_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29813
0	1.03148019485511	0.885	0.508	0	ZFP36L2	Malignant cells	GSE199333_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29814
0	1.09241638961734	0.852	0.475	0	CALM2	Malignant cells	GSE199333_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29815
0	-1.05860783878544	0.32	0.712	0	REL	Malignant cells	GSE199333_post	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29816
0	0.719789308034013	0.611	0.181	0	MDH1	Malignant cells	GSE199333_post	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29817
0	-0.616215731860575	0.066	0.353	0	PELI1	Malignant cells	GSE199333_post	ENSG00000197329	57162	pellino E3 ubiquitin protein ligase 1	NA	protein_coding	Q96FA3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29818
0	0.81475406982592	0.644	0.193	0	CCT7	Malignant cells	GSE199333_post	ENSG00000135624	10574	chaperonin containing TCP1 subunit 7	Ccth|Nip7-1	protein_coding	Q99832	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29819
0	0.606247576682627	0.997	0.994	0	TMSB10	Malignant cells	GSE199333_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29820
0	0.727689212079985	0.572	0.174	0	MAT2A	Malignant cells	GSE199333_post	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29821
0	1.12031622574351	0.947	0.656	0	VAMP8	Malignant cells	GSE199333_post	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29822
0	-0.599780451699151	0.033	0.284	0	BCL2L11	Malignant cells	GSE199333_post	ENSG00000153094	10018	BCL2 like 11	BIM|BimEL|BimL|BimS|BOD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29823
0	-0.964013745188599	0.285	0.603	0	MAP3K2	Malignant cells	GSE199333_post	ENSG00000169967	10746	mitogen-activated protein kinase kinase kinase 2	MEKK2|MEKK2B	protein_coding	Q9Y2U5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29824
0	0.742448090032111	0.91	0.679	0	MZT2B	Malignant cells	GSE199333_post	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29825
0	1.14993569208979	0.807	0.428	0	HSPD1	Malignant cells	GSE199333_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29826
0	0.945025166120891	0.712	0.324	0	HSPE1	Malignant cells	GSE199333_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29827
0	-0.886130894539258	0.495	0.79	0	BZW1	Malignant cells	GSE199333_post	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29828
0	0.711323850507116	0.996	0.984	0	EEF1B2	Malignant cells	GSE199333_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29829
0	-0.590157167779791	0.058	0.291	0	SLC11A1	Malignant cells	GSE199333_post	ENSG00000018280	6556	solute carrier family 11 member 1	LSH|NRAMP|NRAMP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29830
0	-0.767350883958545	0.187	0.492	0	AGFG1	Malignant cells	GSE199333_post	ENSG00000173744	3267	ArfGAP with FG repeats 1	HRB|RAB|RIP	protein_coding	P52594	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29831
0	-1.56032322912021	0.017	0.377	0	ARL4C	Malignant cells	GSE199333_post	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29832
0	-1.62231528505297	0.021	0.377	0	NEU4	Malignant cells	GSE199333_post	ENSG00000277926	129807	neuraminidase 4	NA	protein_coding	Q8WWR8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29833
0	-0.485130424546376	0.05	0.272	0	IQSEC1	Malignant cells	GSE199333_post	ENSG00000144711	9922	IQ motif and Sec7 domain ArfGEF 1	ARF-GEP100|BRAG2|GEP100|KIAA0763	protein_coding	Q6DN90	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29834
0	-0.580377039100681	0.029	0.265	0	SH3BP5	Malignant cells	GSE199333_post	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29835
0	-0.652258482828939	0.11	0.439	0	EAF1	Malignant cells	GSE199333_post	ENSG00000144597	85403	ELL associated factor 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29836
0	0.594541378055705	0.999	0.999	0	RPL15	Malignant cells	GSE199333_post	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29837
0	-0.411368753438286	0.055	0.271	0	NR1D2	Malignant cells	GSE199333_post	ENSG00000174738	9975	nuclear receptor subfamily 1 group D member 2	BD73|EAR-1r|Hs.37288|HZF2|REVERBB|REVERBbeta|RVR	protein_coding	Q14995	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29838
0	0.744121320129904	0.997	0.985	0	RPSA	Malignant cells	GSE199333_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29839
0	-1.72533595622997	0.466	0.85	0	CTNNB1	Malignant cells	GSE199333_post	ENSG00000168036	1499	catenin beta 1	armadillo|beta-catenin|CTNNB	protein_coding	P35222	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29840
0	0.844246778950321	0.735	0.299	0	IMPDH2	Malignant cells	GSE199333_post	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29841
0	0.773149642611069	0.998	0.998	0	RPL29	Malignant cells	GSE199333_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29842
0	-0.728612916911204	0.189	0.503	0	RYBP	Malignant cells	GSE199333_post	ENSG00000281766	23429	RING1 and YY1 binding protein	AAP1|DEDAF|YEAF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29843
0	0.691561215541904	0.432	0.041	0	CD96	Malignant cells	GSE199333_post	ENSG00000153283	10225	CD96 molecule	TACTILE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29844
0	-0.740711744037762	0.061	0.385	0	SKIL	Malignant cells	GSE199333_post	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29845
0	-0.88249649911456	0.189	0.533	0	ATP13A3	Malignant cells	GSE199333_post	ENSG00000133657	79572	ATPase 13A3	AFURS1	protein_coding	Q9H7F0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29846
0	0.781031754699403	0.545	0.127	0	CD38	Malignant cells	GSE199333_post	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29847
0	-0.941226279165837	0.341	0.681	0	RBPJ	Malignant cells	GSE199333_post	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29848
0	1.14479970861012	0.817	0.368	0	IGFBP7	Malignant cells	GSE199333_post	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29849
0	-0.721508155315559	0.067	0.332	0	RASGEF1B	Malignant cells	GSE199333_post	ENSG00000138670	153020	RasGEF domain family member 1B	FLJ31695|GPIG4	protein_coding	Q0VAM2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29850
0	-0.747587652149893	0.214	0.528	0	NFKB1	Malignant cells	GSE199333_post	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29851
0	-0.617968308049341	0.847	0.95	0	UBE2D3	Malignant cells	GSE199333_post	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29852
0	-0.791647157030855	0.089	0.406	0	ACSL1	Malignant cells	GSE199333_post	ENSG00000151726	2180	acyl-CoA synthetase long chain family member 1	ACS1|FACL1|FACL2|LACS|LACS1|LACS2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29853
0	-0.965526565844361	0.008	0.346	0	BASP1	Malignant cells	GSE199333_post	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29854
0	0.581896132370027	0.997	0.969	0	BTF3	Malignant cells	GSE199333_post	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29855
0	-0.946271091904371	0.046	0.359	0	VCAN	Malignant cells	GSE199333_post	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29856
0	-0.777605165133973	0.271	0.622	0	CHD1	Malignant cells	GSE199333_post	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29857
0	0.965266752276996	0.991	0.891	0	HINT1	Malignant cells	GSE199333_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29858
0	-0.885633859325493	0.288	0.691	0	ETF1	Malignant cells	GSE199333_post	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29859
0	0.895030743951978	0.678	0.194	0	TMEM173	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29860
0	-0.582461842149998	0.016	0.28	0	HBEGF	Malignant cells	GSE199333_post	ENSG00000113070	1839	heparin binding EGF like growth factor	DTR|DTS|HEGFL	protein_coding	Q99075	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29861
0	0.587165044218552	0.999	0.999	0	RPS14	Malignant cells	GSE199333_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29862
0	0.873113026966801	0.988	0.917	0	NPM1	Malignant cells	GSE199333_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29863
0	0.874355576012298	0.732	0.265	0	ATP6V0E1	Malignant cells	GSE199333_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29864
0	-0.7108542971458	0.143	0.43	0	CPEB4	Malignant cells	GSE199333_post	ENSG00000113742	80315	cytoplasmic polyadenylation element binding protein 4	KIAA1673	protein_coding	Q17RY0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29865
0	0.75024422498486	0.998	0.996	0	RACK1	Malignant cells	GSE199333_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29866
0	0.80051331471454	0.738	0.333	0	SERPINB6	Malignant cells	GSE199333_post	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29867
0	1.36691614870003	0.871	0.388	0	SOX4	Malignant cells	GSE199333_post	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29868
0	1.31873898260642	0.825	0.421	0	TUBB	Malignant cells	GSE199333_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29869
0	-1.0979470937895	0.023	0.384	0	IER3	Malignant cells	GSE199333_post	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29870
0	-0.89610341298327	0.899	0.97	0	HLA-C	Malignant cells	GSE199333_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29871
0	-1.48838576165156	0.95	0.996	0	HLA-B	Malignant cells	GSE199333_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29872
0	0.670033438826233	0.647	0.237	0	LSM2	Malignant cells	GSE199333_post	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29873
0	0.996916068358716	0.395	0.006	0	HLA-DRB5	Malignant cells	GSE199333_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29874
0	1.41637412442712	0.89	0.392	0	HLA-DRB1	Malignant cells	GSE199333_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29875
0	0.622231628245629	0.71	0.211	0	HLA-DQB1	Malignant cells	GSE199333_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29876
0	0.84120003665002	0.999	0.998	0	RPS18	Malignant cells	GSE199333_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29877
0	0.79419784820561	0.997	0.992	0	RPL10A	Malignant cells	GSE199333_post	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29878
0	-0.470502852412776	0.058	0.281	0	TREM1	Malignant cells	GSE199333_post	ENSG00000124731	54210	triggering receptor expressed on myeloid cells 1	CD354|TREM-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29879
0	-1.00802324304639	0.026	0.316	0	VEGFA	Malignant cells	GSE199333_post	ENSG00000112715	7422	vascular endothelial growth factor A	VEGF|VEGF-A|VPF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29880
0	0.702580948758101	0.984	0.912	0	HSP90AB1	Malignant cells	GSE199333_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29881
0	-0.718650959539868	0.169	0.462	0	FOXO3	Malignant cells	GSE199333_post	ENSG00000118689	2309	forkhead box O3	AF6q21|FKHRL1|FOXO2|FOXO3A	protein_coding	O43524	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29882
0	-0.91590172128171	0.047	0.35	0	SGK1	Malignant cells	GSE199333_post	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29883
0	-0.84948616431516	0.181	0.474	0	IFNGR1	Malignant cells	GSE199333_post	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29884
0	0.738272976120587	0.719	0.32	0	ABRACL	Malignant cells	GSE199333_post	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29885
0	-0.491616505998656	0.092	0.346	0	HECA	Malignant cells	GSE199333_post	ENSG00000112406	51696	hdc homolog, cell cycle regulator	dJ225E12.1|HDC|HDCL|hHDC	protein_coding	Q9UBI9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29886
0	-0.680596192466123	0.105	0.439	0	STX11	Malignant cells	GSE199333_post	ENSG00000135604	8676	syntaxin 11	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29887
0	-0.743193316859009	0.031	0.393	0	SNX9	Malignant cells	GSE199333_post	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29888
0	0.700438970471534	0.983	0.905	0	HNRNPA2B1	Malignant cells	GSE199333_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29889
0	-1.00814425061793	0.187	0.467	0	HOTAIRM1	Malignant cells	GSE199333_post	ENSG00000233429	NA	NA	HOXA-AS1|HOXA1-AS1|NCRNA00179	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29890
0	-0.974480208888668	0.057	0.388	0	HOXA5	Malignant cells	GSE199333_post	ENSG00000106004	3202	homeobox A5	HOX1|HOX1C	protein_coding	P20719	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29891
0	0.720650260198038	0.984	0.907	0	PPIA	Malignant cells	GSE199333_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29892
0	0.722500793518544	0.573	0.142	0	LAT2	Malignant cells	GSE199333_post	ENSG00000086730	7462	linker for activation of T cells family member 2	HSPC046|LAB|NTAL|WBSCR15|WBSCR5|WSCR5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29893
0	0.679095376865409	0.614	0.22	0	SRI	Malignant cells	GSE199333_post	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29894
0	-0.992037861096635	0.395	0.742	0	FAM133B	Malignant cells	GSE199333_post	ENSG00000234545	257415	family with sequence similarity 133 member B	MGC40405	protein_coding	Q5BKY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29895
0	1.1491236076079	0.751	0.321	0	CDK6	Malignant cells	GSE199333_post	ENSG00000105810	1021	cyclin dependent kinase 6	PLSTIRE	protein_coding	Q00534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29896
0	-2.42943183257545	0.265	0.796	0	NAMPT	Malignant cells	GSE199333_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29897
0	-0.785762273065534	0.055	0.368	0	AC016831.5	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29898
0	0.659649034142714	0.439	0.052	0	AL034397.3	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29899
0	0.613296507643865	0.998	0.997	0	RPS4X	Malignant cells	GSE199333_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29900
0	-0.988937442339272	0.335	0.722	0	RB1CC1	Malignant cells	GSE199333_post	ENSG00000023287	9821	RB1 inducible coiled-coil 1	ATG17|Cc1|DRAGOU14|FIP200|KIAA0203|PPP1R131	protein_coding	Q8TDY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29901
0	-1.03410154135259	0.37	0.655	0	LYN	Malignant cells	GSE199333_post	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29902
0	0.907889846232783	0.642	0.216	0	FABP5	Malignant cells	GSE199333_post	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29903
0	-0.508980702539078	0.033	0.255	0	MTSS1	Malignant cells	GSE199333_post	ENSG00000170873	9788	MTSS I-BAR domain containing 1	KIAA0429|MIM|MIMA|MIMB	protein_coding	O43312	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29904
0	0.734706756150601	0.57	0.125	0	GSDMD	Malignant cells	GSE199333_post	ENSG00000278718	79792	gasdermin D	DF5L|FLJ12150|GSDMDC1	protein_coding	P57764	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29905
0	0.517077510649571	0.999	1	0	RPL8	Malignant cells	GSE199333_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29906
0	-0.805006908547845	0.095	0.474	0	B4GALT1	Malignant cells	GSE199333_post	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29907
0	-1.43204637953069	0.013	0.304	0	CTSL	Malignant cells	GSE199333_post	ENSG00000135047	1514	cathepsin L	CTSL1|FLJ31037	protein_coding	P07711	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29908
0	-1.32075844045582	0.09	0.517	0	NINJ1	Malignant cells	GSE199333_post	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29909
0	0.776121650851544	0.939	0.748	0	ANP32B	Malignant cells	GSE199333_post	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29910
0	-0.792315605680217	0.062	0.363	0	ABCA1	Malignant cells	GSE199333_post	ENSG00000165029	19	ATP binding cassette subfamily A member 1	ABC1|HDLDT1|TGD	protein_coding	O95477	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29911
0	-0.976730422908439	0.044	0.37	0	KLF4	Malignant cells	GSE199333_post	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29912
0	0.53502093861026	0.998	0.997	0	RPL35	Malignant cells	GSE199333_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29913
0	-1.34824481569409	0.136	0.635	0	ZBTB43	Malignant cells	GSE199333_post	ENSG00000169155	23099	zinc finger and BTB domain containing 43	FLJ22470|KIAA0414|ZBTB22B|ZNF-X|ZNF297B	protein_coding	O43298	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29914
0	0.590579851129011	0.999	0.999	0	RPL7A	Malignant cells	GSE199333_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29915
0	-1.124054151133	0.089	0.4	0	FCN1	Malignant cells	GSE199333_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29916
0	0.933449490527631	0.619	0.146	0	EGFL7	Malignant cells	GSE199333_post	ENSG00000172889	51162	EGF like domain multiple 7	ZNEU1	protein_coding	Q9UHF1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29917
0	1.07525376521606	0.964	0.687	0	TALDO1	Malignant cells	GSE199333_post	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29918
0	-1.84447761507297	0.173	0.605	0	HBB	Malignant cells	GSE199333_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29919
0	1.11666230706509	0.871	0.483	0	NUCB2	Malignant cells	GSE199333_post	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29920
0	1.61526481449526	0.869	0.481	0	CAT	Malignant cells	GSE199333_post	ENSG00000121691	847	catalase	NA	protein_coding	P04040	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29921
0	1.46539704491114	0.489	0.056	0	C1QTNF4	Malignant cells	GSE199333_post	ENSG00000284838	114900	C1q and TNF related 4	CTRP4|ZACRP4	protein_coding	Q9BXJ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29922
0	0.640549635233777	0.745	0.384	0	SELENOH	Malignant cells	GSE199333_post	ENSG00000211450	280636	selenoprotein H	C11orf31|SELH	protein_coding	Q8IZQ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29923
0	-3.24677163508446	0.95	0.999	0	FTH1	Malignant cells	GSE199333_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29924
0	0.802016364509126	0.781	0.401	0	PPP1R14B	Malignant cells	GSE199333_post	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29925
0	0.69756310226092	0.716	0.326	0	TRMT112	Malignant cells	GSE199333_post	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29926
0	0.652591531340092	0.738	0.386	0	PRDX5	Malignant cells	GSE199333_post	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29927
0	0.651850836495201	0.514	0.104	0	ARL2	Malignant cells	GSE199333_post	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29928
0	-1.19368904048495	1	0.999	0	MALAT1	Malignant cells	GSE199333_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29929
0	0.83365594064789	0.798	0.372	0	LAMTOR1	Malignant cells	GSE199333_post	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29930
0	0.671750424383808	0.999	0.999	0	RPS3	Malignant cells	GSE199333_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29931
0	0.725491725691896	0.644	0.221	0	CLNS1A	Malignant cells	GSE199333_post	ENSG00000074201	1207	chloride nucleotide-sensitive channel 1A	CLCI|ICln	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29932
0	0.81820591437292	0.769	0.398	0	CTSC	Malignant cells	GSE199333_post	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29933
0	-0.743474364208672	0.089	0.379	0	IL10RA	Malignant cells	GSE199333_post	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29934
0	1.07323450881849	0.892	0.596	0	HSPA8	Malignant cells	GSE199333_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29935
0	-0.731508302836346	0.057	0.371	0	PFKFB3	Malignant cells	GSE199333_post	ENSG00000170525	5209	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	NA	protein_coding	Q16875	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29936
0	-1.10699396267765	0.357	0.802	0	EPC1	Malignant cells	GSE199333_post	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29937
0	-0.621018576495702	0.187	0.497	0	CSGALNACT2	Malignant cells	GSE199333_post	ENSG00000169826	55454	chondroitin sulfate N-acetylgalactosaminyltransferase 2	GALNACT-2|GALNACT2|MGC40204|PRO0082	protein_coding	Q8N6G5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29938
0	-0.847644656243115	0.144	0.517	0	UBE2D1	Malignant cells	GSE199333_post	ENSG00000072401	7321	ubiquitin conjugating enzyme E2 D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UbcH5A	protein_coding	P51668	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29939
0	0.82057635556318	0.585	0.175	0	PDLIM1	Malignant cells	GSE199333_post	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29940
0	-0.540520313830895	0.059	0.306	0	NFKB2	Malignant cells	GSE199333_post	ENSG00000077150	4791	nuclear factor kappa B subunit 2	LYT-10|NF-kB2|p105|p49/p100|p52	protein_coding	Q00653	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29941
0	-1.01781288073509	0.18	0.608	0	PTPRE	Malignant cells	GSE199333_post	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29942
0	0.837364445763614	0.649	0.199	0	MRPL51	Malignant cells	GSE199333_post	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29943
0	0.785446981640523	0.998	0.993	0	GAPDH	Malignant cells	GSE199333_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29944
0	0.779916502918566	0.923	0.726	0	TPI1	Malignant cells	GSE199333_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29945
0	1.02605951108657	0.567	0.123	0	CD69	Malignant cells	GSE199333_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29946
0	-1.41628287578683	0.048	0.435	0	CLEC7A	Malignant cells	GSE199333_post	ENSG00000172243	64581	C-type lectin domain containing 7A	CD369|CLECSF12|DECTIN-1|hDectin-1|SCARE2	protein_coding	Q9BXN2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29947
0	-1.57396385536677	0.109	0.532	0	GABARAPL1	Malignant cells	GSE199333_post	ENSG00000139112	23710	GABA type A receptor associated protein like 1	APG8L|ATG8B|ATG8L|gec1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29948
0	1.06876859365892	0.984	0.798	0	ARHGDIB	Malignant cells	GSE199333_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29949
0	1.34861228499117	0.892	0.47	0	MGST1	Malignant cells	GSE199333_post	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29950
0	1.41786668023536	0.96	0.653	0	LDHB	Malignant cells	GSE199333_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29951
0	0.869439894054146	0.622	0.145	0	TM7SF3	Malignant cells	GSE199333_post	ENSG00000064115	51768	transmembrane 7 superfamily member 3	NA	protein_coding	Q9NS93	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29952
0	1.34486175700216	0.903	0.592	0	TUBA1B	Malignant cells	GSE199333_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29953
0	-0.97006854727403	0.656	0.895	0	DAZAP2	Malignant cells	GSE199333_post	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29954
0	-0.512353009369568	0.035	0.258	0	GRASP	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29955
0	-0.463076312520736	0.055	0.283	0	ZNF385A	Malignant cells	GSE199333_post	ENSG00000161642	25946	zinc finger protein 385A	DKFZp586G1122|Hzf|ZFP385|ZNF385	protein_coding	Q96PM9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29956
0	0.979724627817876	0.762	0.335	0	AC084033.3	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29957
0	-1.05381415716089	0.029	0.302	0	AC020656.1	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29958
0	-1.38379210616105	0.083	0.409	0	PHLDA1	Malignant cells	GSE199333_post	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29959
0	-2.04324078720752	0.284	0.792	0	ATP2B1	Malignant cells	GSE199333_post	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29960
0	0.500960435202622	0.997	0.993	0	RPLP0	Malignant cells	GSE199333_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29961
0	1.40364157767775	0.807	0.249	0	DYNLL1	Malignant cells	GSE199333_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29962
0	0.903818243917902	0.867	0.661	0	RAN	Malignant cells	GSE199333_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29963
0	-0.66344872335808	0.085	0.397	0	ULK1	Malignant cells	GSE199333_post	ENSG00000177169	8408	unc-51 like autophagy activating kinase 1	ATG1|ATG1A	protein_coding	O75385	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29964
0	0.732553164915964	0.738	0.361	0	MRPL57	Malignant cells	GSE199333_post	ENSG00000173141	78988	mitochondrial ribosomal protein L57	MRP63	protein_coding	Q9BQC6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29965
0	-0.720469063295821	0.151	0.512	0	USP12	Malignant cells	GSE199333_post	ENSG00000152484	219333	ubiquitin specific peptidase 12	USP12L1	protein_coding	O75317	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29966
0	0.725680066937806	0.842	0.575	0	GTF3A	Malignant cells	GSE199333_post	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29967
0	-0.697605146085275	0.111	0.388	0	ALOX5AP	Malignant cells	GSE199333_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29968
0	-1.6497158593918	0.237	0.64	0	RGCC	Malignant cells	GSE199333_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29969
0	-0.732724520802783	0.114	0.491	0	COG3	Malignant cells	GSE199333_post	ENSG00000136152	83548	component of oligomeric golgi complex 3	SEC34	protein_coding	Q96JB2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29970
0	0.663787242603102	0.647	0.262	0	ESD	Malignant cells	GSE199333_post	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29971
0	0.664255791875728	0.722	0.344	0	EBPL	Malignant cells	GSE199333_post	ENSG00000123179	84650	EBP like	EBRP	protein_coding	Q9BY08	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29972
0	-0.725615128520088	0.223	0.569	0	DNAJC3	Malignant cells	GSE199333_post	ENSG00000102580	5611	DnaJ heat shock protein family (Hsp40) member C3	ERdj6|HP58|P58|p58(IPK)|P58IPK|PRKRI	protein_coding	Q13217	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29973
0	-0.916106518185358	0.056	0.339	0	GPR183	Malignant cells	GSE199333_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29974
0	0.884462573404515	0.632	0.218	0	TNFSF13B	Malignant cells	GSE199333_post	ENSG00000102524	10673	TNF superfamily member 13b	BAFF|BLYS|CD257|TALL-1|TALL1|THANK|TNFSF20	protein_coding	Q9Y275	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29975
0	0.888001195661786	0.834	0.465	0	APEX1	Malignant cells	GSE199333_post	ENSG00000100823	328	apurinic/apyrimidinic endodeoxyribonuclease 1	APE|APE-1|APEN|APEX|APX|HAP1|REF-1|REF1	protein_coding	P27695	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29976
0	-1.19129595679455	0.533	0.82	0	NFKBIA	Malignant cells	GSE199333_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29977
0	0.680032200642169	0.528	0.13	0	FKBP3	Malignant cells	GSE199333_post	ENSG00000100442	2287	FKBP prolyl isomerase 3	FKBP-25|FKBP25	protein_coding	Q00688	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29978
0	-1.34524183010441	0.086	0.435	0	LGALS3	Malignant cells	GSE199333_post	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29979
0	-2.17731411624339	0.348	0.825	0	HIF1A	Malignant cells	GSE199333_post	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29980
0	0.65614529788704	0.569	0.158	0	SPTLC2	Malignant cells	GSE199333_post	ENSG00000100596	9517	serine palmitoyltransferase long chain base subunit 2	hLCB2a|KIAA0526|LCB2|LCB2A	protein_coding	O15270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29981
0	-0.861696266598418	0.081	0.408	0	SERPINA1	Malignant cells	GSE199333_post	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29982
0	-0.690670484295867	0.226	0.534	0	PPP2R5C	Malignant cells	GSE199333_post	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29983
0	1.03696557507012	0.99	0.899	0	HSP90AA1	Malignant cells	GSE199333_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29984
0	-0.657384948351083	0.081	0.355	0	TNFAIP2	Malignant cells	GSE199333_post	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29985
0	-0.808052857229718	0.67	0.867	0	EIF5	Malignant cells	GSE199333_post	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29986
0	1.05803245792254	0.722	0.278	0	DUT	Malignant cells	GSE199333_post	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29987
0	-0.560451410413582	0.156	0.463	0	MAPK6	Malignant cells	GSE199333_post	ENSG00000069956	5597	mitogen-activated protein kinase 6	ERK3|HsT17250|p97MAPK|PRKM6	protein_coding	Q16659	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29988
0	1.05131321030811	0.815	0.442	0	RPS27L	Malignant cells	GSE199333_post	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29989
0	-0.687988786827026	0.163	0.507	0	USP3	Malignant cells	GSE199333_post	ENSG00000140455	9960	ubiquitin specific peptidase 3	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29990
0	0.569901251076022	0.997	0.974	0	RPL4	Malignant cells	GSE199333_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29991
0	0.755129121952134	0.74	0.337	0	ANP32A	Malignant cells	GSE199333_post	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29992
0	0.684850724024125	0.617	0.218	0	MPG	Malignant cells	GSE199333_post	ENSG00000103152	4350	N-methylpurine DNA glycosylase	MDG	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29993
0	-1.25249380631025	0.148	0.522	0	HBA2	Malignant cells	GSE199333_post	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29994
0	0.741398121648214	0.999	1	0	RPS2	Malignant cells	GSE199333_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29995
0	-1.47394070516518	0.211	0.583	0	SNHG9	Malignant cells	GSE199333_post	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29996
0	-0.96930526263417	0.264	0.69	0	C16orf72	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29997
0	0.839494255701207	0.722	0.308	0	SPN	Malignant cells	GSE199333_post	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29998
0	0.868381068755061	0.828	0.445	0	PYCARD	Malignant cells	GSE199333_post	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	29999
0	-1.47587701714899	0.153	0.431	0	ITGAX	Malignant cells	GSE199333_post	ENSG00000140678	3687	integrin subunit alpha X	CD11C	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30000
0	-0.675190759627464	0.279	0.594	0	CYLD	Malignant cells	GSE199333_post	ENSG00000083799	1540	CYLD lysine 63 deubiquitinase	CYLD1|KIAA0849|USPL2	protein_coding	Q9NQC7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30001
0	-0.808582381357212	0.254	0.574	0	HERPUD1	Malignant cells	GSE199333_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30002
0	-0.506869423672342	0.134	0.423	0	AP1G1	Malignant cells	GSE199333_post	ENSG00000166747	164	adaptor related protein complex 1 subunit gamma 1	ADTG|CLAPG1	protein_coding	O43747	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30003
0	0.491300123249476	0.999	1	0	RPL13	Malignant cells	GSE199333_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30004
0	-0.710947969300265	0.039	0.306	0	SLC43A2	Malignant cells	GSE199333_post	ENSG00000278550	124935	solute carrier family 43 member 2	MGC34680	protein_coding	Q8N370	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30005
0	-0.861594730608213	0.033	0.415	0	MIR22HG	Malignant cells	GSE199333_post	ENSG00000282800	84981	MIR22 host gene	C17orf91|DKFZp686O06159|MGC14376	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30006
0	-0.971853020371149	0.016	0.341	0	CXCL16	Malignant cells	GSE199333_post	ENSG00000161921	58191	C-X-C motif chemokine ligand 16	CXCLG16|SR-PSOX|SRPSOX	protein_coding	Q9H2A7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30007
0	0.77089509493167	0.794	0.468	0	C1QBP	Malignant cells	GSE199333_post	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30008
0	-1.08454057649097	0.168	0.473	0	KDM6B	Malignant cells	GSE199333_post	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30009
0	0.508420516071273	0.998	0.996	0	RPL23A	Malignant cells	GSE199333_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30010
0	-0.722649844850106	0.181	0.528	0	CPD	Malignant cells	GSE199333_post	ENSG00000108582	1362	carboxypeptidase D	GP180	protein_coding	O75976	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30011
0	0.590225265038659	0.999	0.999	0	RPL19	Malignant cells	GSE199333_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30012
0	-1.30795288563444	1	1	0	EIF1	Malignant cells	GSE199333_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30013
0	0.731928931559645	0.6	0.185	0	PHB	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30014
0	-0.857022988058565	0.211	0.597	0	SPAG9	Malignant cells	GSE199333_post	ENSG00000008294	9043	sperm associated antigen 9	CT89|FLJ13450|FLJ14006|FLJ26141|FLJ34602|HLC4|HSS|JIP-4|JIP4|JLP|KIAA0516|MGC117291|MGC14967|MGC74461|PHET|PIG6|SYD1	protein_coding	O60271	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30015
0	-0.635333453069097	0.054	0.291	0	AC015912.3	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30016
0	2.49306140439751	0.533	0.136	0	MPO	Malignant cells	GSE199333_post	ENSG00000005381	4353	myeloperoxidase	NA	protein_coding	P05164	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30017
0	-0.690842026227413	0.972	0.989	0	DDX5	Malignant cells	GSE199333_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30018
0	-0.995585376159823	0.188	0.533	0	GNA13	Malignant cells	GSE199333_post	ENSG00000120063	10672	G protein subunit alpha 13	G13|MGC46138	protein_coding	Q14344	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30019
0	-0.648138397444676	0.029	0.265	0	CD300E	Malignant cells	GSE199333_post	ENSG00000186407	342510	CD300e molecule	CD300LE|CLM2|IREM2	protein_coding	Q496F6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30020
0	-0.783563143727007	0.055	0.388	0	SOCS3	Malignant cells	GSE199333_post	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30021
0	-0.730872547743389	0.143	0.434	0	CYTH1	Malignant cells	GSE199333_post	ENSG00000108669	9267	cytohesin 1	B2-1|cytohesin-1|D17S811E|PSCD1	protein_coding	Q15438	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30022
0	1.1452049293203	0.998	0.956	0	ACTG1	Malignant cells	GSE199333_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30023
0	-0.516200517795111	0.149	0.457	0	WDR45B	Malignant cells	GSE199333_post	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30024
0	-0.736348853472118	0.049	0.421	0	METRNL	Malignant cells	GSE199333_post	ENSG00000275031	284207	meteorin like, glial cell differentiation regulator	NA	protein_coding	Q641Q3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30025
0	0.958014527562978	0.848	0.47	0	MYL12A	Malignant cells	GSE199333_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30026
0	-0.773862327585354	0.71	0.889	0	VAPA	Malignant cells	GSE199333_post	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30027
0	-1.04467704748687	0.293	0.737	0	RIOK3	Malignant cells	GSE199333_post	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30028
0	-1.23450624128633	0.209	0.632	0	GPCPD1	Malignant cells	GSE199333_post	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30029
0	-1.74344202066702	0.438	0.835	0	CST3	Malignant cells	GSE199333_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30030
0	-0.698489532505128	0.178	0.529	0	CHMP4B	Malignant cells	GSE199333_post	ENSG00000101421	128866	charged multivesicular body protein 4B	C20orf178|dJ553F4.4|Shax1|SNF7-2|VPS32B	protein_coding	Q9H444	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30031
0	-0.598013341507793	0.018	0.312	0	TP53INP2	Malignant cells	GSE199333_post	ENSG00000078804	58476	tumor protein p53 inducible nuclear protein 2	C20orf110|dJ1181N3.1|DKFZp434B2411|DKFZp434O0827|DOR|FLJ21759|FLJ23500|PINH	protein_coding	Q8IXH6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30032
0	-0.959485419307082	0.852	0.961	0	RBM39	Malignant cells	GSE199333_post	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30033
0	-1.79740460024483	0.023	0.415	0	MAFB	Malignant cells	GSE199333_post	ENSG00000204103	9935	MAF bZIP transcription factor B	KRML	protein_coding	Q9Y5Q3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30034
0	0.776618245491993	0.706	0.339	0	CTSA	Malignant cells	GSE199333_post	ENSG00000064601	5476	cathepsin A	GSL|PPGB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30035
0	-1.64454551803562	0.4	0.64	0	CEBPB	Malignant cells	GSE199333_post	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30036
0	1.69928229512484	0.894	0.364	0	PRSS57	Malignant cells	GSE199333_post	ENSG00000185198	400668	serine protease 57	PRSSL1|UNQ782	protein_coding	Q6UWY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30037
0	-2.38282857690588	0.536	0.826	0	CFD	Malignant cells	GSE199333_post	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30038
0	-1.17243807436342	0.301	0.711	0	MIDN	Malignant cells	GSE199333_post	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30039
0	0.701344022253544	0.479	0.068	0	S1PR4	Malignant cells	GSE199333_post	ENSG00000125910	8698	sphingosine-1-phosphate receptor 4	EDG6	protein_coding	O95977	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30040
0	-0.563093441366384	0.067	0.342	0	RFX2	Malignant cells	GSE199333_post	ENSG00000087903	5990	regulatory factor X2	FLJ14226	protein_coding	P48378	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30041
0	-0.572837181531526	0.06	0.28	0	ICAM1	Malignant cells	GSE199333_post	ENSG00000090339	3383	intercellular adhesion molecule 1	BB2|CD54	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30042
0	1.07669299865944	0.937	0.748	0	CALR	Malignant cells	GSE199333_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30043
0	1.0770311353791	0.741	0.166	0	LYL1	Malignant cells	GSE199333_post	ENSG00000104903	4066	LYL1 basic helix-loop-helix family member	bHLHa18	protein_coding	P12980	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30044
0	0.953427439799388	0.614	0.081	0	HSH2D	Malignant cells	GSE199333_post	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30045
0	0.65350921057281	0.999	0.999	0	RPL18A	Malignant cells	GSE199333_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30046
0	-0.546739811951383	0.024	0.256	0	IFI30	Malignant cells	GSE199333_post	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30047
0	-0.824875601264857	0.968	0.996	0	JUND	Malignant cells	GSE199333_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30048
0	1.2292496953524	0.633	0.169	0	CEBPA	Malignant cells	GSE199333_post	ENSG00000245848	1050	CCAAT enhancer binding protein alpha	C/EBP-alpha|CEBP	protein_coding	P49715	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30049
0	0.898771953273481	0.928	0.736	0	HCST	Malignant cells	GSE199333_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30050
0	1.00223067356158	0.96	0.674	0	GMFG	Malignant cells	GSE199333_post	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30051
0	-1.63532315639129	0.372	0.743	0	ZFP36	Malignant cells	GSE199333_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30052
0	0.566537454820477	0.999	0.999	0	RPS19	Malignant cells	GSE199333_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30053
0	-1.01952605750666	0.118	0.424	0	PLAUR	Malignant cells	GSE199333_post	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30054
0	-0.480265099199067	0.098	0.356	0	BCL3	Malignant cells	GSE199333_post	ENSG00000069399	602	BCL3 transcription coactivator	BCL4|D19S37	protein_coding	P20749	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30055
0	-0.571204397507025	0.066	0.389	0	RELB	Malignant cells	GSE199333_post	ENSG00000104856	5971	RELB proto-oncogene, NF-kB subunit	REL-B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30056
0	-0.558892399524938	0.025	0.268	0	C5AR1	Malignant cells	GSE199333_post	ENSG00000197405	728	complement C5a receptor 1	C5A|C5AR|C5R1|CD88	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30057
0	0.748649422426409	0.591	0.166	0	CD33	Malignant cells	GSE199333_post	ENSG00000105383	945	CD33 molecule	FLJ00391|p67|SIGLEC-3|SIGLEC3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30058
0	0.725987273727636	0.62	0.228	0	ETFB	Malignant cells	GSE199333_post	ENSG00000105379	2109	electron transfer flavoprotein subunit beta	NA	protein_coding	P38117	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30059
0	1.07618788223348	0.997	0.983	0	RPS5	Malignant cells	GSE199333_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30060
0	0.714787340706963	0.73	0.324	0	COMT	Malignant cells	GSE199333_post	ENSG00000093010	1312	catechol-O-methyltransferase	NA	protein_coding	P21964	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30061
0	0.689580317136137	0.697	0.32	0	SNRPD3	Malignant cells	GSE199333_post	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30062
0	0.685869339117309	0.806	0.489	0	UQCR10	Malignant cells	GSE199333_post	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30063
0	-0.542133883300917	0.11	0.375	0	TOM1	Malignant cells	GSE199333_post	ENSG00000100284	10043	target of myb1 membrane trafficking protein	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30064
0	-1.939245775085	0.032	0.428	0	HMOX1	Malignant cells	GSE199333_post	ENSG00000100292	3162	heme oxygenase 1	bK286B10|HO-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30065
0	1.04612908388392	0.874	0.428	0	RAC2	Malignant cells	GSE199333_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30066
0	0.778371238275428	0.998	0.996	0	RPL3	Malignant cells	GSE199333_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30067
0	-0.709536899074117	0.234	0.607	0	EP300	Malignant cells	GSE199333_post	ENSG00000100393	2033	E1A binding protein p300	KAT3B|p300	protein_coding	Q09472	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30068
0	-1.01212128614858	0.209	0.596	0	PIM3	Malignant cells	GSE199333_post	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30069
0	-1.12468953744799	0.258	0.637	0	NRIP1	Malignant cells	GSE199333_post	ENSG00000180530	8204	nuclear receptor interacting protein 1	RIP140	protein_coding	P48552	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30070
0	-0.754364206041656	0.153	0.506	0	BACH1	Malignant cells	GSE199333_post	ENSG00000156273	571	BTB domain and CNC homolog 1	BACH-1|BTBD24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30071
0	0.718536850906772	0.783	0.426	0	SOD1	Malignant cells	GSE199333_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30072
0	0.585414544312005	1	0.999	0	MT-ND4	Malignant cells	GSE199333_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30073
1.41395204768902e-307	-0.594200507934566	0.204	0.507	3.00196159244855e-303	NFAT5	Malignant cells	GSE199333_post	ENSG00000102908	10725	nuclear factor of activated T cells 5	KIAA0827|NF-AT5|NFATL1|NFATZ|OREBP|TONEBP	protein_coding	O94916	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30074
6.46488225936017e-307	-0.436306852616158	0.079	0.316	1.37255915248476e-302	EML4	Malignant cells	GSE199333_post	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30075
1.30543830545881e-306	0.668150490790266	0.809	0.486	2.7715760663196e-302	CORO1A	Malignant cells	GSE199333_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30076
6.37899708168136e-305	0.583394544967471	0.483	0.098	1.35432487041177e-300	MGMT	Malignant cells	GSE199333_post	ENSG00000170430	4255	O-6-methylguanine-DNA methyltransferase	NA	protein_coding	P16455	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30077
1.62058009988981e-304	0.617046715779994	0.867	0.565	3.44065361007605e-300	ATP5PF	Malignant cells	GSE199333_post	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30078
5.73311443644846e-304	0.640861772065955	0.704	0.324	1.21719752600237e-299	PSME2	Malignant cells	GSE199333_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30079
1.33820728193868e-303	-0.469874575215588	0.085	0.324	2.84114788028401e-299	GAB2	Malignant cells	GSE199333_post	ENSG00000033327	9846	GRB2 associated binding protein 2	KIAA0571	protein_coding	Q9UQC2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30080
1.66363199451838e-303	0.651988504796648	0.864	0.624	3.53205708756197e-299	ATP5F1B	Malignant cells	GSE199333_post	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30081
8.35380020112999e-303	-1.60496807058225	0.723	0.861	1.77359532070191e-298	BTG1	Malignant cells	GSE199333_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30082
1.50766769380408e-301	0.643098028559053	0.642	0.263	3.20092928071545e-297	SCCPDH	Malignant cells	GSE199333_post	ENSG00000143653	51097	saccharopine dehydrogenase (putative)	CGI-49|NET11	protein_coding	Q8NBX0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30083
1.81873281608648e-301	-0.802533911198187	0.368	0.654	3.8613516418332e-297	TRA2A	Malignant cells	GSE199333_post	ENSG00000164548	29896	transformer 2 alpha homolog	AWMS1|htra-2-alpha	protein_coding	Q13595	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30084
2.94507415595707e-301	0.665989456189181	0.575	0.192	6.25268694051246e-297	MRPS34	Malignant cells	GSE199333_post	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30085
3.76510406977384e-301	0.684451444748343	0.667	0.286	7.99369245053685e-297	ARPC5	Malignant cells	GSE199333_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30086
6.11946038573458e-301	0.652689580558348	0.598	0.212	1.29922263449531e-296	PRMT1	Malignant cells	GSE199333_post	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30087
6.72476456331149e-301	0.548762890956336	0.949	0.725	1.42773476443666e-296	CD74	Malignant cells	GSE199333_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30088
1.67326593029208e-300	-0.837230187188614	0.224	0.505	3.55251089660311e-296	MYO9B	Malignant cells	GSE199333_post	ENSG00000099331	4650	myosin IXB	CELIAC4	protein_coding	Q13459	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30089
5.54372260667896e-300	0.616393837060142	0.776	0.437	1.17698774662401e-295	NEDD8	Malignant cells	GSE199333_post	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30090
1.00210940124616e-298	0.669199480823354	0.532	0.15	2.12757846978573e-294	MYB	Malignant cells	GSE199333_post	ENSG00000118513	4602	MYB proto-oncogene, transcription factor	c-myb	protein_coding	P10242	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30091
1.01227046113767e-298	-0.476953327084378	0.136	0.411	2.14915141604138e-294	ING3	Malignant cells	GSE199333_post	ENSG00000071243	54556	inhibitor of growth family member 3	Eaf4|FLJ20089|MEAF4|p47ING3	protein_coding	Q9NXR8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30092
1.6078660761252e-298	0.646497657635059	0.635	0.258	3.41366046622142e-294	BANF1	Malignant cells	GSE199333_post	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30093
1.15640420706459e-294	0.609623221054094	0.555	0.173	2.45516177201884e-290	AKR1A1	Malignant cells	GSE199333_post	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30094
2.72949463935989e-294	-0.768914818292294	0.112	0.357	5.79499006882498e-290	SLC7A5	Malignant cells	GSE199333_post	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30095
2.41553317979684e-293	-0.629520750481809	0.123	0.386	5.12841849402667e-289	ANXA5	Malignant cells	GSE199333_post	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30096
4.76131073268404e-293	0.589740767921368	0.589	0.207	1.01087388165615e-288	TMEM14C	Malignant cells	GSE199333_post	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30097
5.08740554399747e-293	0.632038084198065	0.566	0.189	1.0801070710461e-288	VDAC3	Malignant cells	GSE199333_post	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30098
6.04826821536129e-293	0.601718932903125	0.468	0.094	1.28410782480336e-288	NUDT5	Malignant cells	GSE199333_post	ENSG00000165609	11164	nudix hydrolase 5	hYSAH1|YSA1H	protein_coding	Q9UKK9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30099
1.61234061733677e-292	0.601640654930972	0.523	0.141	3.42316036466769e-288	SKAP2	Malignant cells	GSE199333_post	ENSG00000005020	8935	src kinase associated phosphoprotein 2	RA70|SAPS|SCAP2|SKAP-HOM|SKAP55R	protein_coding	O75563	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30100
3.27166160591462e-291	0.660398451834212	0.625	0.252	6.94606475551733e-287	NUDT1	Malignant cells	GSE199333_post	ENSG00000106268	4521	nudix hydrolase 1	MTH1	protein_coding	P36639	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30101
7.63145597903697e-291	-0.731643745539572	0.775	0.91	1.62023441890934e-286	EIF4G2	Malignant cells	GSE199333_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30102
8.74656493911059e-290	0.636262819786494	0.857	0.596	1.85698320222257e-285	ATP5MC3	Malignant cells	GSE199333_post	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30103
9.57235004229224e-290	-0.579036157902695	0.184	0.467	2.03230563747907e-285	CWC25	Malignant cells	GSE199333_post	ENSG00000276761	54883	CWC25 spliceosome associated protein homolog	CCDC49|FLJ20291	protein_coding	Q9NXE8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30104
2.52717545496492e-289	0.676493205795368	0.673	0.317	5.36544620843602e-285	GADD45GIP1	Malignant cells	GSE199333_post	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30105
5.37764271018736e-289	0.71601179673388	0.874	0.664	1.14172732379988e-284	LDHA	Malignant cells	GSE199333_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30106
5.44155875343684e-288	0.459329126972772	0.999	0.999	1.15529733894218e-283	RPS6	Malignant cells	GSE199333_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30107
1.02781110681086e-286	0.719042383130859	0.568	0.204	2.18214576087014e-282	NOP56	Malignant cells	GSE199333_post	ENSG00000101361	10528	NOP56 ribonucleoprotein	NOL5A|SCA36	protein_coding	O00567	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30108
1.09835465522144e-286	-0.656126330122046	0.193	0.474	2.33191676850064e-282	MECP2	Malignant cells	GSE199333_post	ENSG00000169057	4204	methyl-CpG binding protein 2	MRX16|MRX79|RTT	protein_coding	P51608	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30109
3.61001713401035e-286	0.605459905850271	0.567	0.193	7.66442737721738e-282	NMI	Malignant cells	GSE199333_post	ENSG00000123609	9111	N-myc and STAT interactor	NA	protein_coding	Q13287	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30110
4.4285890749377e-286	-0.499647484305557	0.097	0.337	9.40233746500024e-282	TENT4B	Malignant cells	GSE199333_post	ENSG00000121274	64282	terminal nucleotidyltransferase 4B	PAPD5|TRF4-2|TUT3	protein_coding	Q8NDF8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30111
5.20248925362529e-286	0.492613675342409	0.999	1	1.10454049343719e-281	RPS3A	Malignant cells	GSE199333_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30112
8.96019203705749e-286	0.971019056804099	0.692	0.357	1.90233837138768e-281	GABPB1-AS1	Malignant cells	GSE199333_post	ENSG00000244879	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30113
1.0994888482783e-285	0.664798343460077	0.652	0.281	2.33432477377966e-281	CD53	Malignant cells	GSE199333_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30114
3.71846798535333e-285	0.648040805776779	0.576	0.203	7.89467937970366e-281	CKLF	Malignant cells	GSE199333_post	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30115
1.16191010478187e-284	-0.663943821479396	0.216	0.5	2.46685134346238e-280	PRNP	Malignant cells	GSE199333_post	ENSG00000171867	5621	prion protein	AltPrP|CD230|CJD|GSS|PRIP|PRP	protein_coding	P04156	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30116
2.87215566357877e-284	-0.759101990320518	0.53	0.767	6.09787368934409e-280	TCF25	Malignant cells	GSE199333_post	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30117
3.02002179973256e-284	-1.1876137963017	0.359	0.609	6.4118082830122e-280	JARID2	Malignant cells	GSE199333_post	ENSG00000008083	3720	jumonji and AT-rich interaction domain containing 2	JMJ	protein_coding	Q92833	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30118
1.39534259810812e-283	0.587691919868411	0.473	0.098	2.96245187004335e-279	IL2RG	Malignant cells	GSE199333_post	ENSG00000147168	3561	interleukin 2 receptor subunit gamma	CD132|CIDX|IMD4|SCIDX1	protein_coding	P31785	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30119
9.67566473803367e-283	0.580187361781248	0.407	0.048	2.05424038053193e-278	ICAM2	Malignant cells	GSE199333_post	ENSG00000108622	3384	intercellular adhesion molecule 2	CD102	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30120
2.68369856858066e-282	0.665765132836868	0.569	0.197	5.69776043095359e-278	MBOAT7	Malignant cells	GSE199333_post	ENSG00000275118	79143	membrane bound O-acyltransferase domain containing 7	BB1|hMBOA-7|LENG4|LPIAT1|LPLAT|LPLAT11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30121
6.99937123188859e-282	0.481950817704375	0.998	0.996	1.48603650624227e-277	RPL14	Malignant cells	GSE199333_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30122
3.44188591268264e-281	0.863952459744004	0.436	0.066	7.3074679812165e-277	FAM30A	Malignant cells	GSE199333_post	ENSG00000277059	9834	family with sequence similarity 30 member A	C14orf110|HSPC053|KIAA0125	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30123
4.65403526536505e-281	0.554214439540229	0.884	0.669	9.88098227189655e-277	EDF1	Malignant cells	GSE199333_post	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30124
5.92075609628768e-281	0.613114393079895	0.808	0.522	1.25703572680284e-276	ATP5F1C	Malignant cells	GSE199333_post	ENSG00000165629	509	ATP synthase F1 subunit gamma	ATP5C|ATP5C1|ATP5CL1	protein_coding	P36542	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30125
1.42556981398858e-280	0.609514834888965	0.617	0.253	3.02662727207916e-276	LMAN2	Malignant cells	GSE199333_post	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30126
1.64103285887773e-280	0.615404820851484	0.562	0.194	3.4840768626833e-276	DARS	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30127
1.16924183113897e-279	0.643884711443246	0.702	0.344	2.48241733169114e-275	ARL6IP5	Malignant cells	GSE199333_post	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30128
1.19284552031959e-279	1.03972555257905	0.854	0.607	2.53253032419052e-275	H2AFZ	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30129
1.51275839921983e-279	-0.784269744573865	0.778	0.889	3.21173735738363e-275	SRRM1	Malignant cells	GSE199333_post	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30130
6.42094846970212e-279	-0.717704354848553	0.429	0.722	1.36323156960246e-274	YPEL5	Malignant cells	GSE199333_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30131
1.08468824051715e-278	-0.594534071801907	0.804	0.935	2.30290160344197e-274	RBM3	Malignant cells	GSE199333_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30132
4.33427862830926e-278	-0.844253943580763	0.732	0.89	9.20210695576338e-274	HLA-E	Malignant cells	GSE199333_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30133
7.24147358469166e-278	0.776591489665373	0.601	0.243	1.53743725676589e-273	NME1	Malignant cells	GSE199333_post	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30134
1.92888997432197e-277	0.575117633908953	0.523	0.153	4.09522630448298e-273	NCF4	Malignant cells	GSE199333_post	ENSG00000275990	4689	neutrophil cytosolic factor 4	p40phox|SH3PXD4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30135
6.12443300162451e-277	0.594167160889014	0.495	0.129	1.3002783705749e-272	UGP2	Malignant cells	GSE199333_post	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30136
8.33074083324662e-277	-0.8210409059383	0.489	0.719	1.76869958630659e-272	IQGAP1	Malignant cells	GSE199333_post	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30137
1.11515616301826e-276	-0.564497490138422	0.213	0.499	2.36758804970406e-272	BCL7B	Malignant cells	GSE199333_post	ENSG00000106635	9275	BAF chromatin remodeling complex subunit BCL7B	SMARCJ2	protein_coding	Q9BQE9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30138
7.18817152711158e-276	0.606281866771923	0.862	0.569	1.52612069692106e-271	PEBP1	Malignant cells	GSE199333_post	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30139
2.34669051548047e-275	-0.65624728827392	0.393	0.664	4.98225863341659e-271	WTAP	Malignant cells	GSE199333_post	ENSG00000146457	9589	WT1 associated protein	KIAA0105|MGC3925|Mum2	protein_coding	Q15007	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30140
4.79415504336258e-275	0.633712726859257	0.457	0.096	1.01784705725631e-270	SLC39A3	Malignant cells	GSE199333_post	ENSG00000141873	29985	solute carrier family 39 member 3	ZIP3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30141
5.024498564979e-275	0.605167860591126	0.442	0.084	1.06675129033069e-270	ZNRF1	Malignant cells	GSE199333_post	ENSG00000186187	84937	zinc and ring finger 1	DKFZp434E229|FLJ14846|nin283	protein_coding	Q8ND25	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30142
5.7181089953916e-275	0.651597902581214	0.732	0.415	1.21401172081159e-270	PSMA4	Malignant cells	GSE199333_post	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30143
6.97058171792058e-275	-0.541080493552991	0.12	0.368	1.47992420453172e-270	PLK3	Malignant cells	GSE199333_post	ENSG00000173846	1263	polo like kinase 3	CNK|FNK|PRK	protein_coding	Q9H4B4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30144
9.14002303169165e-275	0.587958709124392	0.611	0.244	1.94051828985845e-270	TRAPPC1	Malignant cells	GSE199333_post	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30145
1.14803041731098e-274	0.62868299878581	0.509	0.143	2.43738337899294e-270	RAB37	Malignant cells	GSE199333_post	ENSG00000172794	326624	RAB37, member RAS oncogene family	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30146
1.18217489134327e-273	-1.31027020570574	0.849	0.904	2.50987551181089e-269	LAPTM5	Malignant cells	GSE199333_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30147
2.23049657408608e-272	-0.555535535887069	0.173	0.447	4.73556727644215e-268	RELT	Malignant cells	GSE199333_post	ENSG00000054967	84957	RELT TNF receptor	FLJ14993|TNFRSF19L	protein_coding	Q969Z4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30148
4.41382207393192e-271	0.648125213835855	0.67	0.322	9.37098564516487e-267	HNRNPF	Malignant cells	GSE199333_post	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30149
1.24864552608639e-270	-0.396932482219447	0.069	0.28	2.65099931643401e-266	TMEM170B	Malignant cells	GSE199333_post	ENSG00000205269	100113407	transmembrane protein 170B	NA	protein_coding	Q5T4T1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30150
1.29832387814476e-270	-0.931311372679697	0.49	0.715	2.75647142568915e-266	SQSTM1	Malignant cells	GSE199333_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30151
5.45513416439818e-270	0.680022818443624	0.614	0.256	1.15817953444338e-265	LSM4	Malignant cells	GSE199333_post	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30152
9.00991494989664e-270	0.665848227202489	0.717	0.376	1.91289504301256e-265	NAA38	Malignant cells	GSE199333_post	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30153
1.22515613837782e-269	0.636284396511865	0.869	0.669	2.60112899738995e-265	PTGES3	Malignant cells	GSE199333_post	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30154
1.59059776527253e-269	0.64405219653865	0.736	0.408	3.3769981154501e-265	SRSF7	Malignant cells	GSE199333_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30155
1.61991608776928e-269	-1.53580777216928	0.55	0.723	3.43924384594297e-265	PSAP	Malignant cells	GSE199333_post	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30156
1.77481574136885e-269	0.930635145619738	0.392	0.047	3.76811130050021e-265	HGF	Malignant cells	GSE199333_post	ENSG00000019991	3082	hepatocyte growth factor	DFNB39|F-TCF|HGFB|HPTA|SF	protein_coding	P14210	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30157
6.1356618187217e-269	0.547082269421785	0.407	0.058	1.3026623607328e-264	GAPT	Malignant cells	GSE199333_post	ENSG00000175857	202309	GRB2 binding adaptor protein, transmembrane	C5orf29|FLJ33641	protein_coding	Q8N292	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30158
3.46653505537804e-268	-0.81992236547182	0.201	0.458	7.35980057607313e-264	TLE3	Malignant cells	GSE199333_post	ENSG00000140332	7090	TLE family member 3, transcriptional corepressor	ESG|ESG3|GRG3|HsT18976|KIAA1547	protein_coding	Q04726	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30159
1.17965276395514e-267	-0.407759630813038	0.076	0.301	2.50452078315316e-263	CYBB	Malignant cells	GSE199333_post	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30160
1.48433116277572e-267	0.595279711951423	0.957	0.843	3.15138349168913e-263	EIF3E	Malignant cells	GSE199333_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30161
3.42280510430384e-267	-1.69592668622843	0.542	0.713	7.26695751694748e-263	COTL1	Malignant cells	GSE199333_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30162
1.17698660881133e-265	0.744288958284324	0.692	0.37	2.49886026916733e-261	SEPT6	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30163
2.64934880400912e-265	-0.954932074700496	0.301	0.573	5.62483244579176e-261	AC103591.3	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30164
7.31064731404994e-265	0.558037718439384	0.502	0.145	1.55212353124594e-260	UBE2L6	Malignant cells	GSE199333_post	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30165
1.29838227692846e-264	-0.619773168445844	0.295	0.581	2.75659541214681e-260	USP16	Malignant cells	GSE199333_post	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30166
2.00412530245324e-264	-0.558753482091906	0.058	0.252	4.25495842963848e-260	EMP1	Malignant cells	GSE199333_post	ENSG00000134531	2012	epithelial membrane protein 1	CL-20|TMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30167
2.23322254636452e-264	0.60760040399814	0.463	0.109	4.74135478818652e-260	CDK4	Malignant cells	GSE199333_post	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30168
3.58030526526001e-264	0.853454366921592	0.514	0.152	7.60134610867353e-260	CCL5	Malignant cells	GSE199333_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30169
4.21466268706215e-264	-0.436740655783956	0.131	0.387	8.94815035090166e-260	PCIF1	Malignant cells	GSE199333_post	ENSG00000100982	63935	phosphorylated CTD interacting factor 1	bA465L10.1|C20orf67|CAPAM|PPP1R121	protein_coding	Q9H4Z3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30170
3.22907150943989e-263	-1.39665660793558	0.67	0.829	6.85564172169184e-259	LYZ	Malignant cells	GSE199333_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30171
1.2600494863565e-262	-0.775459818266516	0.127	0.365	2.67521106448349e-258	ZFYVE16	Malignant cells	GSE199333_post	ENSG00000039319	9765	zinc finger FYVE-type containing 16	KIAA0305|PPP1R69	protein_coding	Q7Z3T8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30172
1.64698208098184e-262	-0.448474390178737	0.118	0.363	3.49670765613254e-258	UBAP1	Malignant cells	GSE199333_post	ENSG00000165006	51271	ubiquitin associated protein 1	UBAP	protein_coding	Q9NZ09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30173
1.83991749678154e-261	0.569860948503252	0.726	0.394	3.9063288374169e-257	CUTA	Malignant cells	GSE199333_post	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30174
2.17009795671703e-261	0.538370613925362	0.369	0.033	4.60733497190593e-257	SELPLG	Malignant cells	GSE199333_post	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30175
2.57927332649721e-261	0.592506894307475	0.476	0.124	5.47605519948622e-257	FDPS	Malignant cells	GSE199333_post	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30176
5.72249260062323e-261	-0.699360578467919	0.433	0.69	1.21494240403832e-256	PPP1CB	Malignant cells	GSE199333_post	ENSG00000213639	5500	protein phosphatase 1 catalytic subunit beta	MP|PP-1B|PP1B|PP1beta|PP1c|PPP1beta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30177
5.34694697309356e-260	-0.368297998896325	0.06	0.256	1.13521031185749e-255	SNN	Malignant cells	GSE199333_post	ENSG00000184602	8303	stannin	NA	protein_coding	O75324	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30178
1.16205487729898e-259	0.603432405549497	0.975	0.898	2.46715870999347e-255	GSTP1	Malignant cells	GSE199333_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30179
1.17356681517521e-259	0.474845801016927	0.999	0.998	2.49159970529849e-255	RPS23	Malignant cells	GSE199333_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30180
1.39946652250367e-259	0.602835456554295	0.641	0.29	2.97120737392753e-255	EIF2S2	Malignant cells	GSE199333_post	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30181
2.17062038062338e-259	0.525527126788683	0.975	0.855	4.6084441301015e-255	CLIC1	Malignant cells	GSE199333_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30182
3.10687530894136e-259	0.604382018786801	0.441	0.085	6.59620696841341e-255	ITM2A	Malignant cells	GSE199333_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30183
8.167203631166e-259	0.531506233096462	0.381	0.044	1.73397900293285e-254	FARSA	Malignant cells	GSE199333_post	ENSG00000179115	2193	phenylalanyl-tRNA synthetase subunit alpha	CML33|FARSL|FARSLA	protein_coding	Q9Y285	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30184
9.53427160224281e-259	0.561835287197326	0.58	0.226	2.02422120387217e-254	ECHS1	Malignant cells	GSE199333_post	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30185
1.91422891310476e-258	-1.29769487814314	0.132	0.409	4.06409940541272e-254	HBA1	Malignant cells	GSE199333_post	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30186
3.53874911577939e-257	-0.676530388136827	0.427	0.687	7.51311824771123e-253	CMTM6	Malignant cells	GSE199333_post	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30187
3.89899440435889e-257	0.719964409618682	0.565	0.208	8.27795501989437e-253	CAPG	Malignant cells	GSE199333_post	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30188
4.81911918769064e-257	-0.529288625039259	0.205	0.482	1.0231471947386e-252	WDR26	Malignant cells	GSE199333_post	ENSG00000162923	80232	WD repeat domain 26	FLJ21016|GID7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30189
2.46116630959725e-256	0.587064320747674	0.46	0.101	5.22530219190591e-252	SMIM24	Malignant cells	GSE199333_post	ENSG00000095932	284422	small integral membrane protein 24	C19orf77|HSPC323	protein_coding	O75264	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30190
3.12423763982586e-255	0.577526058354398	0.663	0.325	6.63306893311428e-251	C4orf3	Malignant cells	GSE199333_post	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30191
4.73010693942318e-255	-1.1848054840188	0.122	0.353	1.00424900430894e-250	ZFP36L1	Malignant cells	GSE199333_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30192
9.25649849719197e-255	0.569711550162899	0.522	0.166	1.96524719593883e-250	IL18	Malignant cells	GSE199333_post	ENSG00000150782	3606	interleukin 18	IGIF|IL-18|IL-1g|IL1F4	protein_coding	Q14116	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30193
1.33675393406339e-254	-0.629624552015499	0.152	0.407	2.83806227740999e-250	IRS2	Malignant cells	GSE199333_post	ENSG00000185950	8660	insulin receptor substrate 2	NA	protein_coding	Q9Y4H2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30194
2.06431145027036e-254	0.508811987356963	0.99	0.938	4.38273964006899e-250	OAZ1	Malignant cells	GSE199333_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30195
2.18128318868493e-254	0.591289128085254	0.672	0.336	4.63108233789698e-250	CCT8	Malignant cells	GSE199333_post	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30196
2.41599046785528e-254	0.585235647151511	0.859	0.574	5.12938936230354e-250	LSM7	Malignant cells	GSE199333_post	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30197
3.77002151390748e-254	0.60555461489904	0.427	0.085	8.00413267617698e-250	DCTPP1	Malignant cells	GSE199333_post	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30198
6.96981180051617e-254	0.53289224721655	0.474	0.127	1.47976074336759e-249	MRPL18	Malignant cells	GSE199333_post	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30199
1.30441233353982e-253	-0.569019628901618	0.154	0.405	2.7693978253384e-249	STK24	Malignant cells	GSE199333_post	ENSG00000102572	8428	serine/threonine kinase 24	MST-3|MST3|MST3B|STE20|STK3	protein_coding	Q9Y6E0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30200
3.29008989969625e-253	-0.744082848251207	0.484	0.774	6.98518986604512e-249	JUNB	Malignant cells	GSE199333_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30201
6.41471688227031e-253	0.614805975845191	0.562	0.22	1.36190854127481e-248	MLEC	Malignant cells	GSE199333_post	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30202
1.17350416349264e-252	0.522820410541772	0.378	0.046	2.49146668951122e-248	NFE2	Malignant cells	GSE199333_post	ENSG00000123405	4778	nuclear factor, erythroid 2	NF-E2	protein_coding	Q16621	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30203
2.06875958303327e-252	-0.664936917375925	0.524	0.737	4.39218347073794e-248	UBE2J1	Malignant cells	GSE199333_post	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30204
2.80994992377122e-252	0.592591024060706	0.477	0.13	5.96580468315867e-248	MRPL12	Malignant cells	GSE199333_post	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30205
2.90873304011524e-252	-1.03841518528695	0.225	0.465	6.17553111746866e-248	UPP1	Malignant cells	GSE199333_post	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30206
3.81499163147223e-252	0.622796759908976	0.845	0.593	8.09960873277869e-248	DDX17	Malignant cells	GSE199333_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30207
1.41971106092144e-251	0.689383546660926	0.652	0.302	3.01418855344231e-247	NASP	Malignant cells	GSE199333_post	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30208
1.50760279117725e-250	0.581874593273096	0.416	0.076	3.20079148594842e-246	EVL	Malignant cells	GSE199333_post	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30209
4.49819271945361e-250	0.581433941449648	0.711	0.365	9.55011296267196e-246	HMGN3	Malignant cells	GSE199333_post	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30210
5.58991233837973e-250	-0.388863714208323	0.106	0.338	1.1867942885614e-245	RLF	Malignant cells	GSE199333_post	ENSG00000117000	6018	RLF zinc finger	Zn-15L|ZNF292L	protein_coding	Q13129	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30211
7.09215001454022e-250	0.585675058640051	0.565	0.213	1.50573436958703e-245	ATRX	Malignant cells	GSE199333_post	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30212
8.8907445848474e-250	0.628139998257166	0.727	0.434	1.88759398280895e-245	TUFM	Malignant cells	GSE199333_post	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30213
1.64687311496089e-249	0.520552270101704	0.446	0.102	3.49647631037347e-245	MSRB2	Malignant cells	GSE199333_post	ENSG00000148450	22921	methionine sulfoxide reductase B2	CBS-1|CBS1|CGI-131|MSRB|PILB	protein_coding	Q9Y3D2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30214
2.24730956840463e-249	0.576660894108379	0.571	0.234	4.77126294467986e-245	STOML2	Malignant cells	GSE199333_post	ENSG00000165283	30968	stomatin like 2	HSPC108|SLP-2	protein_coding	Q9UJZ1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30215
4.26207035752029e-249	0.673823568895106	0.794	0.525	9.04880157605132e-245	RAB32	Malignant cells	GSE199333_post	ENSG00000118508	10981	RAB32, member RAS oncogene family	NA	protein_coding	Q13637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30216
5.09554358813185e-248	0.610445335114434	0.365	0.037	1.08183485919627e-243	CYTL1	Malignant cells	GSE199333_post	ENSG00000170891	54360	cytokine like 1	C17|C4orf4	protein_coding	Q9NRR1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30217
9.5158333670653e-248	0.585490261492697	0.708	0.395	2.02030658216163e-243	BCAP31	Malignant cells	GSE199333_post	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30218
1.2201254946276e-247	-0.638756114486636	0.179	0.439	2.59044843764386e-243	BHLHE40	Malignant cells	GSE199333_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30219
2.39047955475726e-247	0.475390125081192	0.997	0.958	5.07522714270514e-243	SERF2	Malignant cells	GSE199333_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30220
1.23580589487153e-246	0.653081344788536	0.605	0.259	2.62373949540174e-242	AC004687.1	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30221
1.32672026061607e-246	0.853313109688741	0.398	0.055	2.81675978531397e-242	IGLL1	Malignant cells	GSE199333_post	ENSG00000128322	3543	immunoglobulin lambda like polypeptide 1	14.1|CD179B|IGL5|IGLL|IGVPB	protein_coding	P15814	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30222
1.79403619826987e-246	0.694140657887843	0.548	0.209	3.80891825254675e-242	SRM	Malignant cells	GSE199333_post	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30223
4.03212307157902e-246	0.54039005433795	0.51	0.16	8.56060049326942e-242	EAF2	Malignant cells	GSE199333_post	ENSG00000145088	55840	ELL associated factor 2	BM040|TRAITS|U19	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30224
3.82423222710476e-245	0.515651688415268	0.474	0.133	8.11922744136611e-241	CUEDC2	Malignant cells	GSE199333_post	ENSG00000107874	79004	CUE domain containing 2	C10orf66|MGC2491	protein_coding	Q9H467	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30225
6.48080292708463e-245	0.57422970049581	0.788	0.492	1.37593926944934e-240	TBCA	Malignant cells	GSE199333_post	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30226
9.0369631041417e-245	1.04068708711616	0.879	0.596	1.91863763664032e-240	LGALS1	Malignant cells	GSE199333_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30227
1.80579384985019e-244	0.566580938728092	0.802	0.498	3.83388092261694e-240	ATP5MF	Malignant cells	GSE199333_post	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30228
3.14353164535535e-244	0.561884846800007	0.58	0.233	6.67403203625395e-240	MZT2A	Malignant cells	GSE199333_post	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30229
1.42760568631515e-243	0.48640996101354	0.391	0.062	3.03094963261569e-239	PMVK	Malignant cells	GSE199333_post	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30230
2.02719687856121e-243	-0.551321712286064	0.113	0.339	4.3039416928733e-239	RARA	Malignant cells	GSE199333_post	ENSG00000131759	5914	retinoic acid receptor alpha	NR1B1|RAR|RAR-alpha|RARalpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30231
2.2246316773685e-243	-0.688110919708176	0.558	0.766	4.72311551422106e-239	DNAJB6	Malignant cells	GSE199333_post	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30232
2.23215920380029e-243	-0.677957951853125	0.677	0.836	4.7390972055884e-239	BCLAF1	Malignant cells	GSE199333_post	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30233
1.24866626356313e-242	-0.562213661193585	0.137	0.383	2.65104334417088e-238	RAB31	Malignant cells	GSE199333_post	ENSG00000168461	11031	RAB31, member RAS oncogene family	Rab22B	protein_coding	Q13636	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30234
2.91940687734206e-242	0.987613118713572	0.44	0.101	6.19819274128493e-238	PCLAF	Malignant cells	GSE199333_post	ENSG00000166803	9768	PCNA clamp associated factor	KIAA0101|NS5ATP9|OEATC-1|p15(PAF)|PAF15	protein_coding	Q15004	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30235
1.22731161681342e-241	0.629395528168226	0.463	0.123	2.60570529365656e-237	PARP1	Malignant cells	GSE199333_post	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30236
5.56106002732028e-241	-0.340010842249216	0.085	0.299	1.18066865440037e-236	UHRF1BP1L	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30237
8.53541608409042e-240	0.521432101020426	0.347	0.03	1.81215418881324e-235	AKR1C3	Malignant cells	GSE199333_post	ENSG00000196139	8644	aldo-keto reductase family 1 member C3	DDX|HAKRB|HSD17B5|KIAA0119|PGFS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30238
2.26169244112644e-239	0.541430001067921	0.432	0.101	4.80179922175554e-235	PSMB5	Malignant cells	GSE199333_post	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30239
2.4244703639948e-239	-0.74844348725099	0.772	0.902	5.14739302979735e-235	CCNL1	Malignant cells	GSE199333_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30240
7.81099744555478e-239	0.538664210074104	0.443	0.109	1.65835286766574e-234	EVA1B	Malignant cells	GSE199333_post	ENSG00000142694	55194	eva-1 homolog B	C1orf78|FAM176B|FLJ10647	protein_coding	Q9NVM1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30241
1.77515042635983e-238	0.723150384915755	0.666	0.347	3.76882187020456e-234	RANBP1	Malignant cells	GSE199333_post	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30242
3.99057416868622e-238	0.55287946220724	0.598	0.266	8.47238801753772e-234	PSMC5	Malignant cells	GSE199333_post	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30243
2.75862451199583e-237	0.543202186447144	0.566	0.23	5.85683570141836e-233	PSMA5	Malignant cells	GSE199333_post	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30244
3.9917079869134e-237	0.583230722190958	0.677	0.352	8.47479522701584e-233	XRCC5	Malignant cells	GSE199333_post	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30245
8.3348324324037e-237	0.731405616356981	0.713	0.415	1.76956827372363e-232	VMP1	Malignant cells	GSE199333_post	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30246
1.32812767770576e-236	0.486623560376284	0.362	0.044	2.8197478725371e-232	CASP6	Malignant cells	GSE199333_post	ENSG00000138794	839	caspase 6	MCH2	protein_coding	P55212	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30247
2.13219315950571e-236	-0.542845325513322	0.232	0.497	4.52685929694658e-232	CSNK1D	Malignant cells	GSE199333_post	ENSG00000141551	1453	casein kinase 1 delta	CKID|CKIdelta|HCKID	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30248
3.20711234897949e-236	-0.385009561145311	0.082	0.288	6.80902022811835e-232	CBX6	Malignant cells	GSE199333_post	ENSG00000183741	23466	chromobox 6	NA	protein_coding	O95503	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30249
3.62991226231063e-236	0.619073451837622	0.32	0.014	7.7066667241117e-232	RHEX	Malignant cells	GSE199333_post	ENSG00000263961	440712	regulator of hemoglobinization and erythroid cell expansion	C1orf186|FLJ16052	protein_coding	Q6ZWK4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30250
4.29329985055203e-236	0.387099186484958	0.999	1	9.11510491270701e-232	RPS15	Malignant cells	GSE199333_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30251
4.6037038726653e-236	-0.632761005981628	0.579	0.774	9.77412369205569e-232	CDV3	Malignant cells	GSE199333_post	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30252
1.12462553137195e-235	0.547565464320557	0.85	0.607	2.3876924656558e-231	APRT	Malignant cells	GSE199333_post	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30253
2.15547626128301e-235	-0.494685534882861	0.172	0.425	4.57629165032996e-231	RNF145	Malignant cells	GSE199333_post	ENSG00000145860	153830	ring finger protein 145	FLJ31951	protein_coding	Q96MT1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30254
2.70287240230445e-235	0.633349750290013	0.702	0.379	5.73846839733259e-231	NUCKS1	Malignant cells	GSE199333_post	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30255
3.91061458415108e-235	-0.452971835594772	0.066	0.258	8.30262582361117e-231	LRRC25	Malignant cells	GSE199333_post	ENSG00000175489	126364	leucine rich repeat containing 25	FLJ38116|MAPA	protein_coding	Q8N386	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30256
9.97303280661639e-235	-0.325386377485969	0.069	0.263	2.11737459517273e-230	PER2	Malignant cells	GSE199333_post	ENSG00000132326	8864	period circadian regulator 2	KIAA0347	protein_coding	O15055	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30257
1.68758206817315e-234	0.517792393416847	0.422	0.094	3.58290548893842e-230	COA4	Malignant cells	GSE199333_post	ENSG00000181924	51287	cytochrome c oxidase assembly factor 4 homolog	CHCHD8|CMC3|E2IG2	protein_coding	Q9NYJ1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30258
2.53265494762429e-234	-0.51935556784177	0.214	0.477	5.37707971930112e-230	CHP1	Malignant cells	GSE199333_post	ENSG00000187446	11261	calcineurin like EF-hand protein 1	CHP|p22|p24|Sid470p|SLC9A1BP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30259
4.01173779506775e-234	-0.346415940654759	0.09	0.303	8.51732051270834e-230	TP53BP2	Malignant cells	GSE199333_post	ENSG00000143514	7159	tumor protein p53 binding protein 2	53BP2|ASPP2|PPP1R13A	protein_coding	Q13625	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30260
4.17432773087781e-234	0.777851684564473	0.671	0.381	8.86251520542668e-230	NKG7	Malignant cells	GSE199333_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30261
2.41092151246989e-233	0.6509936019333	0.734	0.455	5.11862746312483e-229	SNRPD1	Malignant cells	GSE199333_post	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30262
4.123120848606e-233	0.570007292230235	0.744	0.445	8.75379787367541e-229	SSBP1	Malignant cells	GSE199333_post	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30263
5.13183357123469e-233	0.560941983141074	0.631	0.306	1.08953958550884e-228	NDUFA12	Malignant cells	GSE199333_post	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30264
2.01329935162282e-232	-0.725002055782301	0.148	0.376	4.27443585343042e-228	EHD1	Malignant cells	GSE199333_post	ENSG00000110047	10938	EH domain containing 1	FLJ42622|FLJ44618|H-PAST|HPAST1|PAST1	protein_coding	Q9H4M9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30265
2.20843489042188e-232	0.507016050064531	0.461	0.131	4.68872811585469e-228	SNX17	Malignant cells	GSE199333_post	ENSG00000115234	9784	sorting nexin 17	KIAA0064	protein_coding	Q15036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30266
4.71035320436019e-232	0.631824770779876	0.46	0.127	1.00005508881771e-227	CKS2	Malignant cells	GSE199333_post	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30267
1.14956542969338e-231	0.532681989094031	0.617	0.282	2.44064236378202e-227	PSMB8	Malignant cells	GSE199333_post	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30268
1.23988606745304e-231	0.514045612900804	0.43	0.103	2.63240210980956e-227	TIMM10	Malignant cells	GSE199333_post	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30269
1.30534836771809e-231	0.621166236001371	0.478	0.135	2.77138511950227e-227	HLA-DQA1	Malignant cells	GSE199333_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30270
2.0903343009779e-231	0.497834940191578	0.906	0.738	4.43798875440618e-227	MYL12B	Malignant cells	GSE199333_post	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30271
3.71558645203377e-231	0.602751740699266	0.711	0.402	7.8885615963129e-227	BST2	Malignant cells	GSE199333_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30272
7.48353848241953e-231	0.466542381243596	0.338	0.03	1.58883005520249e-226	IDH1	Malignant cells	GSE199333_post	ENSG00000138413	3417	isocitrate dehydrogenase (NADP(+)) 1	NA	protein_coding	O75874	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30273
3.68671642121829e-230	0.552673380794051	0.768	0.492	7.82726763388856e-226	EID1	Malignant cells	GSE199333_post	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30274
3.79072558198652e-230	0.551380164463358	0.68	0.37	8.04808948311558e-226	MRPS21	Malignant cells	GSE199333_post	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30275
6.96752484351336e-229	0.550598570499803	0.797	0.541	1.47927519952632e-224	ATP5F1A	Malignant cells	GSE199333_post	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30276
9.01540009762995e-229	0.506235998834254	0.427	0.102	1.91405959472781e-224	TSPAN4	Malignant cells	GSE199333_post	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30277
3.13047511776696e-228	0.476320163296383	0.967	0.865	6.64631172253103e-224	UQCRH	Malignant cells	GSE199333_post	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30278
3.96719069359115e-228	-1.56663563812755	0.52	0.695	8.42274256156337e-224	TIMP1	Malignant cells	GSE199333_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30279
7.51052298980756e-228	0.629621998443667	0.523	0.199	1.59455913596604e-223	CLEC12A	Malignant cells	GSE199333_post	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30280
7.84730828196634e-228	-0.645382898207961	0.246	0.504	1.66606202134427e-223	FAM107B	Malignant cells	GSE199333_post	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30281
8.27458567372153e-228	0.537474987537308	0.488	0.157	1.75677728438782e-223	NDUFB3	Malignant cells	GSE199333_post	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30282
1.01854527407954e-227	0.447233431931029	0.337	0.032	2.16247347139826e-223	DPPA4	Malignant cells	GSE199333_post	ENSG00000121570	55211	developmental pluripotency associated 4	FLJ10713	protein_coding	Q7L190	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30283
1.57757626602182e-227	-0.631607701810953	0.985	0.993	3.34935217039093e-223	UBC	Malignant cells	GSE199333_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30284
2.56972395612832e-227	-1.75990077464305	0.798	0.864	5.45578093125604e-223	SAT1	Malignant cells	GSE199333_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30285
3.3256497802905e-227	0.519940330726715	0.422	0.101	7.06068704853477e-223	DCAF7	Malignant cells	GSE199333_post	ENSG00000136485	10238	DDB1 and CUL4 associated factor 7	HAN11|SWAN-1|WDR68	protein_coding	P61962	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30286
3.49990107227371e-227	0.578082516992019	0.618	0.292	7.43063996654432e-223	RNASEH2B	Malignant cells	GSE199333_post	ENSG00000136104	79621	ribonuclease H2 subunit B	AGS2|DLEU8|FLJ11712	protein_coding	Q5TBB1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30287
3.65143208991341e-227	0.590073186528488	0.658	0.337	7.75235547009517e-223	NHP2	Malignant cells	GSE199333_post	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30288
4.48500270894607e-227	0.84726762146685	0.478	0.157	9.52210925136339e-223	RHOB	Malignant cells	GSE199333_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30289
1.72210017955288e-226	-0.470065882358677	0.174	0.424	3.65619089120872e-222	PPTC7	Malignant cells	GSE199333_post	ENSG00000196850	160760	protein phosphatase targeting COQ7	TA-PP2C	protein_coding	Q8NI37	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30290
1.79443559338392e-226	0.520599542898725	0.509	0.18	3.8097662083134e-222	MGST2	Malignant cells	GSE199333_post	ENSG00000085871	4258	microsomal glutathione S-transferase 2	MGST-II	protein_coding	Q99735	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30291
2.63181022880482e-226	-0.558292929610786	0.255	0.517	5.5875962967755e-222	ARL8A	Malignant cells	GSE199333_post	ENSG00000143862	127829	ADP ribosylation factor like GTPase 8A	ARL10B|FLJ45195|Gie2	protein_coding	Q96BM9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30292
4.09637681478903e-226	0.419028276056849	0.999	0.999	8.69701761547859e-222	RPS15A	Malignant cells	GSE199333_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30293
3.13543029097488e-225	0.623679124881319	0.556	0.234	6.65683205076878e-221	EIF4EBP1	Malignant cells	GSE199333_post	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30294
3.41608848339225e-225	0.554152515622676	0.74	0.442	7.25269745909008e-221	NDUFB2	Malignant cells	GSE199333_post	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30295
3.51006950944355e-225	-0.614851378969628	0.857	0.938	7.4522285754996e-221	SFPQ	Malignant cells	GSE199333_post	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30296
9.26071674035063e-225	0.52633641812488	0.403	0.084	1.96614277114384e-220	RIPOR2	Malignant cells	GSE199333_post	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30297
9.27738214456504e-225	-0.414828903056996	0.157	0.403	1.9696810031126e-220	YTHDF3	Malignant cells	GSE199333_post	ENSG00000185728	253943	YTH N6-methyladenosine RNA binding protein 3	FLJ31657	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30298
9.96439601701984e-225	-0.45890684256736	0.17	0.419	2.11554091837348e-220	RC3H1	Malignant cells	GSE199333_post	ENSG00000135870	149041	ring finger and CCCH-type domains 1	KIAA2025|RNF198|roquin|RP5-1198E17.5	protein_coding	Q5TC82	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30299
1.98628754180726e-224	-0.431198338074614	0.158	0.403	4.217087080011e-220	RNF11	Malignant cells	GSE199333_post	ENSG00000123091	26994	ring finger protein 11	CGI-123|MGC51169|Sid1669p	protein_coding	Q9Y3C5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30300
2.5394044358032e-224	0.527149149897096	0.308	0.014	5.39140955765378e-220	C9orf139	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30301
2.70366575947871e-224	-0.435756547066435	0.118	0.344	5.74015277394926e-220	TOB1	Malignant cells	GSE199333_post	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30302
3.19089615076578e-224	0.501469718839984	0.352	0.045	6.77459161769082e-220	CHST12	Malignant cells	GSE199333_post	ENSG00000136213	55501	carbohydrate sulfotransferase 12	C4S-2|C4ST2	protein_coding	Q9NRB3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30303
3.81289255884017e-224	0.618204785835197	0.58	0.253	8.09515219167356e-220	SYNGR1	Malignant cells	GSE199333_post	ENSG00000100321	9145	synaptogyrin 1	NA	protein_coding	O43759	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30304
7.63601650796762e-224	0.580194303630218	0.69	0.382	1.6212026648066e-219	HSD17B11	Malignant cells	GSE199333_post	ENSG00000198189	51170	hydroxysteroid 17-beta dehydrogenase 11	17-BETA-HSD11|17-BETA-HSDXI|DHRS8|PAN1B|RetSDR2|SDR16C2	protein_coding	Q8NBQ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30305
7.88760194085413e-224	-0.37216048963898	0.068	0.254	1.67461676806274e-219	RNF19B	Malignant cells	GSE199333_post	ENSG00000116514	127544	ring finger protein 19B	FLJ90005|IBRDC3|NKLAM	protein_coding	Q6ZMZ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30306
1.12129850091114e-223	-0.805073118497035	0.44	0.706	2.38062884728444e-219	MAP3K8	Malignant cells	GSE199333_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30307
2.06414076447616e-223	-0.606546125402631	0.124	0.34	4.38237725705933e-219	SMAD3	Malignant cells	GSE199333_post	ENSG00000166949	4088	SMAD family member 3	HsT17436|JV15-2|MADH3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30308
7.66464763711681e-223	0.561976088324441	0.698	0.387	1.62728133983627e-218	TIMM13	Malignant cells	GSE199333_post	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30309
1.6244832736913e-222	-0.725321998986923	0.305	0.554	3.448940438374e-218	ZBTB7A	Malignant cells	GSE199333_post	ENSG00000178951	51341	zinc finger and BTB domain containing 7A	DKFZp547O146|FBI-1|LRF|pokemon|ZBTB7|ZNF857A	protein_coding	O95365	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30310
3.20559996305247e-222	0.457169735418041	0.361	0.054	6.80580928155671e-218	COA3	Malignant cells	GSE199333_post	ENSG00000183978	28958	cytochrome c oxidase assembly factor 3	CCDC56|COX25|hCOA3|HSPC009|MITRAC12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30311
1.2979683712637e-221	0.498731036593836	0.511	0.186	2.75571664902995e-217	PDCD6	Malignant cells	GSE199333_post	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30312
1.61886058415766e-221	-0.45873183372229	0.147	0.383	3.43700290622512e-217	AHCTF1	Malignant cells	GSE199333_post	ENSG00000153207	25909	AT-hook containing transcription factor 1	ELYS	protein_coding	Q8WYP5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30313
3.02017509085208e-221	0.505100177669041	0.938	0.792	6.41213373538806e-217	HMGN1	Malignant cells	GSE199333_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30314
5.17774369675797e-221	0.478378915712751	0.999	0.999	1.09928676425869e-216	RPLP1	Malignant cells	GSE199333_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30315
2.45186944088061e-220	0.489105641644574	0.452	0.132	5.20556400993362e-216	MPLKIP	Malignant cells	GSE199333_post	ENSG00000168303	136647	M-phase specific PLK1 interacting protein	C7orf11|ORF20|TTDN1	protein_coding	Q8TAP9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30316
2.49795752978398e-220	-0.756963952677612	0.345	0.583	5.30341363148436e-216	FMNL1	Malignant cells	GSE199333_post	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30317
3.63445428434552e-220	-0.516533330715803	0.197	0.445	7.71630989109398e-216	LACTB	Malignant cells	GSE199333_post	ENSG00000103642	114294	lactamase beta	FLJ14902|MRPL56	protein_coding	P83111	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30318
5.13220620119581e-220	0.536706496635948	0.748	0.472	1.08961869857588e-215	PPP1CA	Malignant cells	GSE199333_post	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30319
6.12814805641925e-220	-0.522903575966446	0.253	0.523	1.30106711385837e-215	TYMP	Malignant cells	GSE199333_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30320
6.27180207733882e-220	0.508510069150681	0.5	0.173	1.33156629903981e-215	AK2	Malignant cells	GSE199333_post	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30321
3.74815526211412e-219	0.707919061493542	0.815	0.577	7.95770843699449e-215	DBI	Malignant cells	GSE199333_post	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30322
5.88257911379998e-219	0.566891874756696	0.342	0.041	1.24893037165087e-214	NPR3	Malignant cells	GSE199333_post	ENSG00000113389	4883	natriuretic peptide receptor 3	ANPRC|C5orf23|FLJ14054|GUCY2B|NPRC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30323
8.76301651465261e-219	-0.530201981931064	0.237	0.493	1.8604760362259e-214	ADAM17	Malignant cells	GSE199333_post	ENSG00000151694	6868	ADAM metallopeptidase domain 17	CD156B|cSVP|TACE	protein_coding	P78536	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30324
8.95464589583653e-219	-0.38746691745859	0.122	0.347	1.90116087014505e-214	SPTY2D1	Malignant cells	GSE199333_post	ENSG00000179119	144108	SPT2 chromatin protein domain containing 1	DKFZp686I068|FLJ39441|Spt2	protein_coding	Q68D10	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30325
1.02287509268675e-218	0.560078869121379	0.468	0.149	2.17166610928325e-214	PAICS	Malignant cells	GSE199333_post	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30326
3.91687302663567e-218	0.458794595366573	0.381	0.071	8.31591312285019e-214	NDUFA8	Malignant cells	GSE199333_post	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30327
8.01876783811523e-218	0.474434194383898	0.47	0.146	1.70246459971024e-213	SDHC	Malignant cells	GSE199333_post	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30328
8.87802661708258e-218	0.45694970802077	0.399	0.087	1.8848938310728e-213	HIKESHI	Malignant cells	GSE199333_post	ENSG00000149196	51501	heat shock protein nuclear import factor hikeshi	C11orf73|HSPC138|HSPC179|OPI10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30329
3.14354514405922e-217	0.566464365816272	0.419	0.101	6.67406069535212e-213	TSC22D1	Malignant cells	GSE199333_post	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30330
1.21653413984505e-216	0.595177571203071	0.613	0.285	2.58282363230502e-212	ATP5MC1	Malignant cells	GSE199333_post	ENSG00000159199	516	ATP synthase membrane subunit c locus 1	ATP5G|ATP5G1	protein_coding	P05496	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30331
2.3315374879034e-216	0.522499913330206	0.746	0.456	4.95008724056772e-212	SEM1	Malignant cells	GSE199333_post	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30332
2.97545974245035e-216	0.493594483666242	0.419	0.105	6.31719857919634e-212	MTIF3	Malignant cells	GSE199333_post	ENSG00000122033	219402	mitochondrial translational initiation factor 3	IF-3mt|IF3(mt)	protein_coding	Q9H2K0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30333
4.36698279730396e-216	-0.560296404054637	0.246	0.499	9.27154117695604e-212	AAK1	Malignant cells	GSE199333_post	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30334
7.06516159109727e-216	0.524522125395907	0.375	0.07	1.50000445740586e-211	FKBP4	Malignant cells	GSE199333_post	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30335
1.06421235730309e-215	-0.682851205897787	0.277	0.534	2.2594292557902e-211	RAB11FIP1	Malignant cells	GSE199333_post	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30336
3.87807064886999e-215	-0.484095144589623	0.152	0.388	8.23353179461587e-211	CSRNP1	Malignant cells	GSE199333_post	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30337
6.99308752271361e-215	-0.733157784387941	0.344	0.594	1.48470241194733e-210	STK17B	Malignant cells	GSE199333_post	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30338
1.01931136484058e-214	0.444347680445995	0.32	0.03	2.16409995869304e-210	HENMT1	Malignant cells	GSE199333_post	ENSG00000162639	113802	HEN methyltransferase 1	C1orf59|FLJ30525|HEN1	protein_coding	Q5T8I9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30339
1.07690287762736e-214	-0.445178328565534	0.174	0.421	2.28637249949065e-210	TET2	Malignant cells	GSE199333_post	ENSG00000168769	54790	tet methylcytosine dioxygenase 2	FLJ20032|KIAA1546	protein_coding	Q6N021	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30340
1.07767326544736e-214	-0.763126613358846	0.192	0.424	2.28800810987129e-210	AHR	Malignant cells	GSE199333_post	ENSG00000106546	196	aryl hydrocarbon receptor	bHLHe76	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30341
1.62555789227166e-214	0.669750687762431	0.326	0.032	3.45122196108197e-210	HOPX	Malignant cells	GSE199333_post	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30342
2.47883150820612e-214	0.495505129765189	0.401	0.09	5.26280717507242e-210	SYTL1	Malignant cells	GSE199333_post	ENSG00000142765	84958	synaptotagmin like 1	exophilin-7|FLJ14996|JFC1|SLP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30343
7.95551352266627e-214	-0.663098662870252	0.549	0.743	1.68903507599728e-209	RSRC2	Malignant cells	GSE199333_post	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30344
2.06742583082797e-213	0.536881923703435	0.463	0.147	4.38935178143086e-209	ZNF22	Malignant cells	GSE199333_post	ENSG00000165512	7570	zinc finger protein 22	HKR-T1|KOX15|Zfp422|ZNF422	protein_coding	P17026	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30345
6.238566921559e-213	0.877083868129976	0.401	0.086	1.32451014311619e-208	TYMS	Malignant cells	GSE199333_post	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30346
6.31944022498792e-213	-0.419997566778323	0.187	0.438	1.34168035416719e-208	CCNK	Malignant cells	GSE199333_post	ENSG00000090061	8812	cyclin K	CPR4	protein_coding	O75909	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30347
1.13240066331822e-212	0.519281015399914	0.443	0.13	2.40419984829092e-208	UQCC2	Malignant cells	GSE199333_post	ENSG00000137288	84300	ubiquinol-cytochrome c reductase complex assembly factor 2	bA6B20.2|C6orf125|Cbp6|M19|MGC14833|MNF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30348
1.75261249457371e-212	-2.03470890051819	0.989	0.97	3.72097158722945e-208	NEAT1	Malignant cells	GSE199333_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30349
2.99813335562381e-212	0.691023869731357	0.524	0.214	6.36533692732492e-208	CTSW	Malignant cells	GSE199333_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30350
3.54106825143665e-212	0.521313780353318	0.563	0.232	7.51804200462514e-208	IDH2	Malignant cells	GSE199333_post	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30351
4.55531399729664e-212	-0.451065559614833	0.11	0.32	9.67138714766049e-208	GNA12	Malignant cells	GSE199333_post	ENSG00000146535	2768	G protein subunit alpha 12	gep	protein_coding	Q03113	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30352
2.04725625250873e-211	0.513128247250786	0.666	0.348	4.34652974970128e-207	DAD1	Malignant cells	GSE199333_post	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30353
3.3680792415965e-211	-0.376672946888345	0.115	0.332	7.15076903783353e-207	ZFAND2A	Malignant cells	GSE199333_post	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30354
1.03998381521261e-209	0.553722638922441	0.636	0.333	2.20798963807789e-205	LSM5	Malignant cells	GSE199333_post	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30355
3.22905807058914e-209	-0.637274390894067	0.214	0.472	6.8556131896678e-205	S100A11	Malignant cells	GSE199333_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30356
5.82593197425549e-209	0.517769775799275	0.537	0.22	1.23690361745418e-204	HDAC2	Malignant cells	GSE199333_post	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30357
6.80826053159274e-209	-0.62302809642097	0.531	0.734	1.44546179346245e-204	SREK1	Malignant cells	GSE199333_post	ENSG00000153914	140890	splicing regulatory glutamic acid and lysine rich protein 1	DKFZp564B176|SFRS12|SRrp508|SRrp86	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30358
7.15539604186628e-209	-0.566654397729045	0.439	0.672	1.51916213364863e-204	SPCS3	Malignant cells	GSE199333_post	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30359
9.26124312595177e-209	-0.3897090797394	0.109	0.32	1.96625452807082e-204	RAB8B	Malignant cells	GSE199333_post	ENSG00000166128	51762	RAB8B, member RAS oncogene family	NA	protein_coding	Q92930	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30360
1.51251872305046e-208	0.473819933470034	0.464	0.147	3.21122850090844e-204	PSMB9	Malignant cells	GSE199333_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30361
1.57425392106936e-208	0.48217837821097	0.41	0.104	3.34229849982237e-204	FAH	Malignant cells	GSE199333_post	ENSG00000103876	2184	fumarylacetoacetate hydrolase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30362
2.22131226885225e-208	0.260766478748619	0.843	0.503	4.71606807800021e-204	HLA-DPA1	Malignant cells	GSE199333_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30363
7.42787395305738e-208	-0.579399632209804	0.612	0.789	1.57701191897361e-203	SYF2	Malignant cells	GSE199333_post	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30364
2.95147581148689e-207	0.513984037313415	0.571	0.251	6.26627829536782e-203	NME4	Malignant cells	GSE199333_post	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30365
4.11927295520682e-207	0.536596722744261	0.378	0.073	8.7456284111996e-203	BEX3	Malignant cells	GSE199333_post	ENSG00000166681	27018	brain expressed X-linked 3	Bex|DXS6984E|HGR74|NADE|NGFRAP1	protein_coding	Q00994	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30366
1.41140006046825e-206	0.462926407313072	0.402	0.098	2.99654346838015e-202	ORAI3	Malignant cells	GSE199333_post	ENSG00000175938	93129	ORAI calcium release-activated calcium modulator 3	MGC13024|TMEM142C	protein_coding	Q9BRQ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30367
1.77293728613883e-206	0.531644297903927	0.581	0.272	3.76412315220135e-202	GTF3C6	Malignant cells	GSE199333_post	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30368
2.17065913961652e-206	-0.611617177913525	0.373	0.618	4.60852641931984e-202	MED13L	Malignant cells	GSE199333_post	ENSG00000123066	23389	mediator complex subunit 13L	KIAA1025|THRAP2|TRAP240L	protein_coding	Q71F56	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30369
2.78121583922876e-206	-0.894509727330056	0.143	0.367	5.90479934826658e-202	TNFAIP3	Malignant cells	GSE199333_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30370
3.136818314614e-206	-0.458629514931802	0.16	0.393	6.65977896375699e-202	PNPLA8	Malignant cells	GSE199333_post	ENSG00000135241	50640	patatin like phospholipase domain containing 8	IPLA2-2|IPLA2G|iPLA2gamma	protein_coding	Q9NP80	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30371
9.59451001164806e-206	0.680191098425587	0.434	0.13	2.037010420573e-201	FLT3	Malignant cells	GSE199333_post	ENSG00000122025	2322	fms related receptor tyrosine kinase 3	CD135|FLK2|STK1	protein_coding	P36888	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30372
1.15730548169814e-205	0.505156705008424	0.57	0.256	2.45707526819333e-201	NDUFV1	Malignant cells	GSE199333_post	ENSG00000167792	4723	NADH:ubiquinone oxidoreductase core subunit V1	CI-51K	protein_coding	P49821	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30373
1.95361256535303e-205	-0.694149626735787	0.232	0.465	4.14771483750103e-201	RAP2B	Malignant cells	GSE199333_post	ENSG00000181467	5912	RAP2B, member of RAS oncogene family	NA	protein_coding	P61225	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30374
2.47726219444901e-205	0.441202749288633	0.339	0.049	5.25947536503469e-201	FSCN1	Malignant cells	GSE199333_post	ENSG00000075618	6624	fascin actin-bundling protein 1	FLJ38511|p55|SNL	protein_coding	Q16658	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30375
3.26715267211977e-205	0.539665505058404	0.911	0.761	6.93649183817748e-201	PSMA7	Malignant cells	GSE199333_post	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30376
4.87941558364689e-205	0.497710343902624	0.677	0.383	1.03594872256407e-200	VPS28	Malignant cells	GSE199333_post	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30377
5.1950429239446e-205	-0.534093730685909	0.761	0.882	1.10295956318268e-200	SRRM2	Malignant cells	GSE199333_post	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30378
7.11342917195956e-205	-0.372091614464471	0.129	0.351	1.51025214749873e-200	ITCH	Malignant cells	GSE199333_post	ENSG00000078747	83737	itchy E3 ubiquitin protein ligase	AIP4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30379
1.29359018362424e-204	-0.489158303570456	0.253	0.508	2.74642131885263e-200	AFF4	Malignant cells	GSE199333_post	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30380
1.52085566766342e-204	-1.19295714195973	0.702	0.801	3.2289286680162e-200	ZEB2	Malignant cells	GSE199333_post	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30381
1.76417112330975e-204	0.441832097908993	0.303	0.024	3.74551171189894e-200	FAM69B	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30382
2.19552890236201e-204	0.555580995793439	0.409	0.106	4.66132741260478e-200	RPA3	Malignant cells	GSE199333_post	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30383
2.31356892530945e-204	-0.357124214946516	0.112	0.326	4.91193818532449e-200	TCF7L2	Malignant cells	GSE199333_post	ENSG00000148737	6934	transcription factor 7 like 2	TCF-4|TCF4	protein_coding	Q9NQB0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30384
3.23822986555124e-204	0.843938923175221	0.482	0.19	6.87508582755184e-200	ITM2C	Malignant cells	GSE199333_post	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30385
4.28176618747716e-204	-0.572080160037394	0.465	0.686	9.09061779263275e-200	GGNBP2	Malignant cells	GSE199333_post	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30386
4.73614922024545e-204	-0.396540239152721	0.151	0.382	1.00553184095031e-199	DCP1A	Malignant cells	GSE199333_post	ENSG00000272886	55802	decapping mRNA 1A	HSA275986|SMAD4IP1|SMIF	protein_coding	Q9NPI6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30387
4.90991237425476e-204	0.362682123204607	0.928	0.636	1.04242349617803e-199	HLA-DRA	Malignant cells	GSE199333_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30388
7.52510833792441e-204	-0.731574176925702	0.833	0.899	1.59765575122473e-199	PNRC1	Malignant cells	GSE199333_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30389
1.06994042536408e-203	-0.541167360839053	0.228	0.481	2.27159051709048e-199	CAST	Malignant cells	GSE199333_post	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30390
1.18007231706433e-203	-0.498539704652408	0.788	0.896	2.50541153635929e-199	CSDE1	Malignant cells	GSE199333_post	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30391
1.8449232631111e-203	0.540269250961311	0.672	0.366	3.91695657991117e-199	MFSD10	Malignant cells	GSE199333_post	ENSG00000109736	10227	major facilitator superfamily domain containing 10	IT10C3|TETRAN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30392
5.98818539226285e-203	0.476308628976083	0.624	0.284	1.27135164063132e-198	HLA-DMA	Malignant cells	GSE199333_post	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30393
9.0079565410526e-203	0.423854622444924	0.98	0.909	1.91247925323088e-198	COX7C	Malignant cells	GSE199333_post	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30394
1.05653515573671e-202	0.452469210020586	0.385	0.087	2.2431297891446e-198	ATIC	Malignant cells	GSE199333_post	ENSG00000138363	471	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	AICARFT|IMPCHASE|PURH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30395
1.40329886117982e-202	0.536710294983898	0.612	0.315	2.97934381217087e-198	NDUFV2	Malignant cells	GSE199333_post	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30396
8.72923302660586e-202	0.577107376065813	0.413	0.117	1.85330346387869e-197	SEPT11	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30397
9.28535935054726e-202	0.419894840267163	0.999	0.995	1.97137464371469e-197	NACA	Malignant cells	GSE199333_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30398
4.96490729447022e-201	0.491533459150804	0.726	0.444	1.05409946768897e-196	PHB2	Malignant cells	GSE199333_post	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30399
5.05469168172941e-201	0.741186420463959	0.815	0.593	1.07316159094797e-196	HMGB2	Malignant cells	GSE199333_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30400
6.76848879838832e-201	-0.398113932327888	0.141	0.365	1.43701785678582e-196	PLEKHM2	Malignant cells	GSE199333_post	ENSG00000116786	23207	pleckstrin homology and RUN domain containing M2	KIAA0842	protein_coding	Q8IWE5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30401
8.95504380683065e-201	-0.485985096786414	0.273	0.527	1.90124535062822e-196	PPP1R2	Malignant cells	GSE199333_post	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30402
1.44528418686273e-200	0.476074290267717	0.402	0.102	3.06848285712827e-196	MRPS6	Malignant cells	GSE199333_post	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30403
1.92820841074359e-200	-0.665078894479992	0.146	0.364	4.09377927684973e-196	IFITM3	Malignant cells	GSE199333_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30404
5.93928681375066e-200	-0.600051942204236	0.662	0.817	1.2609699834274e-195	ATF4	Malignant cells	GSE199333_post	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30405
9.68665702149901e-200	0.45276018887052	0.439	0.136	2.05657415223446e-195	ITPA	Malignant cells	GSE199333_post	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30406
1.02489257512746e-199	-0.868502567592776	0.181	0.393	2.17594942625311e-195	SAMSN1	Malignant cells	GSE199333_post	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30407
1.37262543828206e-199	0.559969891616278	0.721	0.449	2.91422106801665e-195	SNRPE	Malignant cells	GSE199333_post	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30408
1.44791925192738e-198	-0.529603889174484	0.997	0.997	3.07407736376701e-194	PABPC1	Malignant cells	GSE199333_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30409
1.52879263384824e-198	0.665122322800787	0.785	0.566	3.24577964092321e-194	XBP1	Malignant cells	GSE199333_post	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30410
2.13644189111484e-198	-0.490925022498254	0.301	0.553	4.53587977902591e-194	HNRNPL	Malignant cells	GSE199333_post	ENSG00000282947	3191	heterogeneous nuclear ribonucleoprotein L	HNRPL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30411
4.73269713691948e-198	0.480073197973604	0.385	0.092	1.00479892913937e-193	AHSA1	Malignant cells	GSE199333_post	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30412
7.31477406005631e-198	0.479724076493999	0.468	0.165	1.55299968069055e-193	PNKD	Malignant cells	GSE199333_post	ENSG00000127838	25953	PNKD metallo-beta-lactamase domain containing	BRP17|DKFZp564N1362|DYT8|FKSG19|FPD1|KIAA1184|KIPP1184|MGC31943|MR-1|MR-1S|PDC|PKND1|TAHCCP2	protein_coding	Q8N490	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30413
1.41286385868708e-197	0.450432339468982	0.475	0.163	2.99965125837853e-193	NDUFAF3	Malignant cells	GSE199333_post	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30414
1.82082251691197e-197	0.432912944259527	0.334	0.05	3.8657882856558e-193	RUVBL1	Malignant cells	GSE199333_post	ENSG00000284901	8607	RuvB like AAA ATPase 1	ECP54|INO80H|NMP238|Pontin52|RVB1|TIH1|TIP49|TIP49a	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30415
2.57099734464776e-197	0.490239953092127	0.474	0.166	5.45848446242165e-193	PRDX3	Malignant cells	GSE199333_post	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30416
3.13204765041366e-197	-0.943068984365443	0.294	0.52	6.64965036659323e-193	CD68	Malignant cells	GSE199333_post	ENSG00000129226	968	CD68 molecule	DKFZp686M18236|GP110|LAMP4|SCARD1	protein_coding	P34810	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30417
3.37695895944671e-197	0.44388482471748	0.376	0.084	7.16962156680132e-193	SLC25A1	Malignant cells	GSE199333_post	ENSG00000100075	6576	solute carrier family 25 member 1	CTP|SLC20A3	protein_coding	P53007	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30418
6.15177533769283e-197	0.40121201603657	0.319	0.04	1.30608342194556e-192	B3GNTL1	Malignant cells	GSE199333_post	ENSG00000277033	146712	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1	B3GNT8	protein_coding	Q67FW5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30419
6.39768885199054e-197	0.440626939437973	0.404	0.105	1.35829332016611e-192	CPNE1	Malignant cells	GSE199333_post	ENSG00000214078	8904	copine 1	CPN1	protein_coding	Q99829	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30420
9.97759907867163e-197	0.470703754302875	0.96	0.848	2.11834406039277e-192	SERPINB1	Malignant cells	GSE199333_post	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30421
1.0650360680326e-196	0.444688642996642	0.422	0.122	2.26117807604001e-192	MYL6B	Malignant cells	GSE199333_post	ENSG00000196465	140465	myosin light chain 6B	MLC1SA	protein_coding	P14649	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30422
1.126186704982e-196	0.510975492873928	0.627	0.323	2.39100699334729e-192	MGST3	Malignant cells	GSE199333_post	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30423
2.22918445791474e-196	-0.428383091538952	0.163	0.392	4.73278152259879e-192	CREBBP	Malignant cells	GSE199333_post	ENSG00000005339	1387	CREB binding protein	CBP|KAT3A|RSTS|RTS	protein_coding	Q92793	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30424
2.2387038310366e-196	-0.307879513311279	0.078	0.263	4.75299210367381e-192	BCL6	Malignant cells	GSE199333_post	ENSG00000113916	604	BCL6 transcription repressor	BCL5|BCL6A|LAZ3|ZBTB27|ZNF51	protein_coding	P41182	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30425
3.31807727830671e-196	-0.655511574087887	0.416	0.634	7.04460986957297e-192	TOP1	Malignant cells	GSE199333_post	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30426
3.49909394087394e-196	0.456103137370068	0.449	0.147	7.42892634586947e-192	MRPS33	Malignant cells	GSE199333_post	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30427
6.05177633445079e-196	0.518836057820868	0.547	0.244	1.28485263356725e-191	MRPL20	Malignant cells	GSE199333_post	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30428
1.08208542598723e-195	-0.540977541552591	0.309	0.554	2.29737556791349e-191	RNMT	Malignant cells	GSE199333_post	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30429
2.0129939565174e-195	0.34688086689732	0.998	0.997	4.27378746908209e-191	RPL36	Malignant cells	GSE199333_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30430
2.20035134071998e-195	0.459277599378547	0.462	0.158	4.67156593148259e-191	AGPAT2	Malignant cells	GSE199333_post	ENSG00000169692	10555	1-acylglycerol-3-phosphate O-acyltransferase 2	BSCL|LPAAT-beta|LPLAT2	protein_coding	O15120	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30431
9.74257234026607e-195	0.500700810348114	0.74	0.47	2.06844553356189e-190	EIF3D	Malignant cells	GSE199333_post	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30432
1.17894394706435e-194	0.455037221619748	0.464	0.161	2.50301589401233e-190	VKORC1	Malignant cells	GSE199333_post	ENSG00000167397	79001	vitamin K epoxide reductase complex subunit 1	VKCFD2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30433
1.80339092173322e-194	0.442568814295818	0.322	0.045	3.82877926593179e-190	S100Z	Malignant cells	GSE199333_post	ENSG00000171643	170591	S100 calcium binding protein Z	Gm625|S100-zeta	protein_coding	Q8WXG8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30434
3.92607526719623e-194	-0.327089477586091	0.093	0.286	8.33545039978432e-190	ARFGEF2	Malignant cells	GSE199333_post	ENSG00000124198	10564	ADP ribosylation factor guanine nucleotide exchange factor 2	BIG2	protein_coding	Q9Y6D5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30435
8.13014382013054e-194	-0.336172438897131	0.086	0.274	1.72611083445192e-189	FEM1C	Malignant cells	GSE199333_post	ENSG00000145780	56929	fem-1 homolog C	EUROIMAGE686608|EUROIMAGE783647|FEM1A|KIAA1785	protein_coding	Q96JP0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30436
8.41643161004276e-194	0.550567000324809	0.657	0.371	1.78689259512818e-189	NDUFS6	Malignant cells	GSE199333_post	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30437
1.19496321663588e-193	-0.649856837013772	0.384	0.623	2.53702640523964e-189	ANKRD12	Malignant cells	GSE199333_post	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30438
1.69470356906694e-193	-0.448950401694101	0.105	0.307	3.59802514748602e-189	NR4A2	Malignant cells	GSE199333_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30439
1.89481618672113e-193	-0.500495053247418	0.896	0.957	4.02288424602762e-189	SRSF5	Malignant cells	GSE199333_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30440
8.27623261728683e-193	0.490174151019887	0.463	0.162	1.75712694697617e-188	IQGAP2	Malignant cells	GSE199333_post	ENSG00000145703	10788	IQ motif containing GTPase activating protein 2	NA	protein_coding	Q13576	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30441
1.17901232920456e-192	0.525475108076177	0.339	0.059	2.50316107613419e-188	AC002454.1	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30442
2.46488968213895e-192	0.359989262570755	1	1	5.23320728414921e-188	TPT1	Malignant cells	GSE199333_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30443
6.30460440704678e-192	0.421673825558595	0.375	0.087	1.3385305616601e-187	TEX264	Malignant cells	GSE199333_post	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30444
8.91588927907546e-192	0.425925174360919	0.339	0.061	1.89293245284051e-187	NTPCR	Malignant cells	GSE199333_post	ENSG00000135778	84284	nucleoside-triphosphatase, cancer-related	C1orf57|HCR-NTPase|MGC13186|THEP1	protein_coding	Q9BSD7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30445
1.28684140664799e-191	-0.566782755431837	0.327	0.562	2.73209299045435e-187	CIR1	Malignant cells	GSE199333_post	ENSG00000138433	9541	corepressor interacting with RBPJ, CIR1	CIR	protein_coding	Q86X95	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30446
1.41859923166987e-191	-0.6203066001978	0.421	0.645	3.01182802875829e-187	JMJD1C	Malignant cells	GSE199333_post	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30447
1.50300497046194e-191	0.470679453952661	0.426	0.131	3.19102985278776e-187	MRPL3	Malignant cells	GSE199333_post	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30448
1.98181798962077e-191	0.552608629962385	0.325	0.047	4.20759777376386e-187	MCM3	Malignant cells	GSE199333_post	ENSG00000112118	4172	minichromosome maintenance complex component 3	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30449
2.60928308977273e-191	-0.574131237344811	0.367	0.596	5.53976892789648e-187	TRAM1	Malignant cells	GSE199333_post	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30450
2.64021410059852e-191	0.560019896937978	0.948	0.848	5.60543855698072e-187	CD99	Malignant cells	GSE199333_post	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30451
5.54168918431664e-191	-0.36366909783845	0.121	0.329	1.17655603072227e-186	ADNP2	Malignant cells	GSE199333_post	ENSG00000101544	22850	ADNP homeobox 2	KIAA0863|ZNF508	protein_coding	Q6IQ32	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30452
6.84676037209729e-191	-0.528017331875186	0.751	0.88	1.45363569459998e-186	RAC1	Malignant cells	GSE199333_post	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30453
7.12236875107852e-191	-0.356727775576607	0.082	0.263	1.51215010954148e-186	PLEKHO2	Malignant cells	GSE199333_post	ENSG00000241839	80301	pleckstrin homology domain containing O2	DKFZp761K2312|PLEKHQ1|PP1628|pp9099	protein_coding	Q8TD55	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30454
1.74051770324782e-190	-0.523208668513957	0.355	0.592	3.69529313576546e-186	QKI	Malignant cells	GSE199333_post	ENSG00000112531	9444	QKI, KH domain containing RNA binding	QK3	protein_coding	Q96PU8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30455
1.82055843134031e-190	0.313830541951251	1	0.999	3.86522760557862e-186	MT-ATP6	Malignant cells	GSE199333_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30456
3.93004547933479e-190	0.476485778078502	0.49	0.19	8.3438795571757e-186	VPS35	Malignant cells	GSE199333_post	ENSG00000069329	55737	VPS35 retromer complex component	FLJ10752|MEM3|PARK17	protein_coding	Q96QK1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30457
7.15877605437621e-190	0.393787628309529	0.999	0.999	1.51987974410461e-185	RPL10	Malignant cells	GSE199333_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30458
8.16258552955151e-190	0.443756851216694	0.418	0.126	1.73299853377908e-185	PHF14	Malignant cells	GSE199333_post	ENSG00000106443	9678	PHD finger protein 14	KIAA0783	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30459
1.87889108271489e-189	0.469237530786046	0.408	0.115	3.98907365771199e-185	ACAP1	Malignant cells	GSE199333_post	ENSG00000288169	9744	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	CENTB1|KIAA0050	protein_coding	Q15027	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30460
2.5738853013184e-189	0.530901323918769	0.576	0.283	5.4646158832291e-185	CACYBP	Malignant cells	GSE199333_post	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30461
2.63547469008324e-189	0.486643088923734	0.674	0.387	5.59537631451573e-185	NDUFB7	Malignant cells	GSE199333_post	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30462
3.4920977769018e-189	0.502083529473255	0.557	0.251	7.41407279014021e-185	BZW2	Malignant cells	GSE199333_post	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30463
5.88819544216197e-189	0.47758905102662	0.698	0.409	1.25012277432541e-184	OSTC	Malignant cells	GSE199333_post	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30464
7.47171507271609e-189	0.399402556222128	0.322	0.049	1.58631982708835e-184	TIMMDC1	Malignant cells	GSE199333_post	ENSG00000113845	51300	translocase of inner mitochondrial membrane domain containing 1	C3orf1|FLJ22597	protein_coding	Q9NPL8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30465
9.05145082320486e-189	0.475297134566857	0.558	0.256	1.92171352427462e-184	TMED9	Malignant cells	GSE199333_post	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30466
9.16290715665581e-189	0.421976977657178	0.394	0.105	1.9453768184296e-184	MRPL40	Malignant cells	GSE199333_post	ENSG00000185608	64976	mitochondrial ribosomal protein L40	MRP-L22|NLVCF	protein_coding	Q9NQ50	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30467
1.18063125470264e-188	0.442337982976651	0.423	0.131	2.50659821685918e-184	NSMCE1	Malignant cells	GSE199333_post	ENSG00000169189	197370	NSE1 homolog, SMC5-SMC6 complex component	NSE1	protein_coding	Q8WV22	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30468
1.32521109099174e-188	0.454584598382793	0.527	0.227	2.81355566728455e-184	TXN2	Malignant cells	GSE199333_post	ENSG00000100348	25828	thioredoxin 2	MT-TRX	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30469
2.27362572124774e-188	-1.34738374273549	0.348	0.547	4.82713476878108e-184	ATP2B1-AS1	Malignant cells	GSE199333_post	ENSG00000271614	NA	NA	LINC00936	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30470
4.07766571764537e-188	0.482777319831906	0.504	0.207	8.65729208513288e-184	TIMM8B	Malignant cells	GSE199333_post	ENSG00000150779	26521	translocase of inner mitochondrial membrane 8 homolog B	DDP2|FLJ21744|MGC102866|MGC117373|TIM8B	protein_coding	Q9Y5J9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30471
4.93714681763047e-188	0.487589051911045	0.551	0.258	1.04820564085112e-183	LAMTOR2	Malignant cells	GSE199333_post	ENSG00000116586	28956	late endosomal/lysosomal adaptor, MAPK and MTOR activator 2	ENDAP|MAPBPIP|MAPKSP1AP|p14|Ragulator2|ROBLD3	protein_coding	Q9Y2Q5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30472
6.88840137679086e-188	-0.759176021570497	0.166	0.381	1.46247649630647e-183	CD83	Malignant cells	GSE199333_post	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30473
6.28816904642289e-187	0.461746308777182	0.676	0.372	1.33504117024604e-182	MAZ	Malignant cells	GSE199333_post	ENSG00000103495	4150	MYC associated zinc finger protein	Pur-1|ZF87|Zif87|ZNF801	protein_coding	P56270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30474
6.29145490582352e-187	0.455052728747323	0.426	0.138	1.33573879105539e-182	MRPS12	Malignant cells	GSE199333_post	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30475
7.15284788264698e-187	0.511770893022761	0.677	0.4	1.51862113396478e-182	RPN2	Malignant cells	GSE199333_post	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30476
4.42258075227343e-186	0.426456891058868	0.404	0.114	9.38958119515172e-182	AKR7A2	Malignant cells	GSE199333_post	ENSG00000053371	8574	aldo-keto reductase family 7 member A2	AFAR	protein_coding	O43488	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30477
6.02730574666569e-186	-0.451026324583871	0.181	0.408	1.27965728307459e-181	PTPN1	Malignant cells	GSE199333_post	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30478
2.6187958582193e-185	0.403141089484253	0.327	0.056	5.55996548658539e-181	CYBC1	Malignant cells	GSE199333_post	ENSG00000178927	79415	cytochrome b-245 chaperone 1	C17orf62|Eros|FLJ90469|MGC4368	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30479
7.94352686402998e-185	0.458460486637074	0.487	0.19	1.6864901885022e-180	PFKL	Malignant cells	GSE199333_post	ENSG00000141959	5211	phosphofructokinase, liver type	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30480
2.5378576437966e-184	0.478154670272094	0.494	0.194	5.38812556354456e-180	LARS	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30481
2.74644458762297e-184	-0.478808223988253	0.262	0.501	5.83097650398232e-180	ZFAND6	Malignant cells	GSE199333_post	ENSG00000086666	54469	zinc finger AN1-type containing 6	AWP1|ZA20D3|ZFAND5B	protein_coding	Q6FIF0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30482
2.9313937961514e-184	0.476964459414786	0.567	0.274	6.22364216860904e-180	NDUFS8	Malignant cells	GSE199333_post	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30483
7.53430494167878e-184	0.648623170097379	0.715	0.449	1.59960828216782e-179	TUBA1A	Malignant cells	GSE199333_post	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30484
8.08259505646554e-184	-0.504862432046897	0.356	0.593	1.7160157564382e-179	YTHDC1	Malignant cells	GSE199333_post	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30485
9.6264990180223e-184	0.511393757974629	0.292	0.029	2.04380200651631e-179	TPSAB1	Malignant cells	GSE199333_post	ENSG00000172236	7177	tryptase alpha/beta 1	TPS1|TPS2|TPSB1	protein_coding	Q15661	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30486
9.71466364791605e-184	-0.625251927414724	0.432	0.638	2.06252023908906e-179	ARF6	Malignant cells	GSE199333_post	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30487
2.20202338428633e-183	0.469728004603959	0.559	0.263	4.6751158471783e-179	MAPKAPK3	Malignant cells	GSE199333_post	ENSG00000114738	7867	MAPK activated protein kinase 3	3pK|MAPKAP3|MK-3|MK3	protein_coding	Q16644	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30488
2.54580078103276e-183	-0.547735584206477	0.335	0.563	5.40498963821066e-179	MIER1	Malignant cells	GSE199333_post	ENSG00000198160	57708	MIER1 transcriptional regulator	hMI-ER1|KIAA1610|MI-ER1	protein_coding	Q8N108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30489
3.39656742365063e-183	-0.603432353999545	0.561	0.74	7.21125229715264e-179	ELF1	Malignant cells	GSE199333_post	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30490
7.17425808118628e-183	-0.568532092051996	0.384	0.611	1.52316673321666e-178	EFHD2	Malignant cells	GSE199333_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30491
1.49407400689989e-182	0.492541468564251	0.376	0.098	3.17206852404916e-178	FKBP5	Malignant cells	GSE199333_post	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30492
4.02041830776989e-182	0.428795198749134	0.381	0.1	8.53575010922625e-178	IMPA2	Malignant cells	GSE199333_post	ENSG00000141401	3613	inositol monophosphatase 2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30493
4.18867018095684e-182	-0.498942673327629	0.121	0.317	8.89296566118946e-178	TLNRD1	Malignant cells	GSE199333_post	ENSG00000140406	59274	talin rod domain containing 1	MESDC1|MGC99595	protein_coding	Q9H1K6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30494
6.7748983428795e-182	-0.633705345623615	0.277	0.499	1.43837866717675e-177	CNOT1	Malignant cells	GSE199333_post	ENSG00000125107	23019	CCR4-NOT transcription complex subunit 1	AD-005|CDC39|KIAA1007|NOT1|NOT1H	protein_coding	A5YKK6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30495
1.17843332853827e-181	0.442723515742661	0.483	0.187	2.50193179981961e-177	ADH5	Malignant cells	GSE199333_post	ENSG00000197894	128	alcohol dehydrogenase 5 (class III), chi polypeptide	ADH-3|ADHX|FDH|GSNOR	protein_coding	P11766	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30496
3.84546141922699e-181	0.478159888937635	0.7	0.434	8.16429913916083e-177	CLTA	Malignant cells	GSE199333_post	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30497
4.2935962181352e-181	0.433949172028035	0.475	0.183	9.11573413072285e-177	TWF2	Malignant cells	GSE199333_post	ENSG00000247596	11344	twinfilin actin binding protein 2	A6r|A6RP|PTK9L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30498
4.63514508014169e-181	0.602750772005971	0.589	0.311	9.84087651964881e-177	KPNB1	Malignant cells	GSE199333_post	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30499
5.59439449497462e-181	-1.04524952971696	1	0.999	1.18774589522806e-176	FTL	Malignant cells	GSE199333_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30500
5.70269632961007e-181	0.464998206340437	0.451	0.164	1.21073945773951e-176	NAPRT	Malignant cells	GSE199333_post	ENSG00000278488	93100	nicotinate phosphoribosyltransferase	NAPRT1|PP3856	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30501
6.10629708272575e-181	0.46521438518056	0.556	0.266	1.2964279336335e-176	STUB1	Malignant cells	GSE199333_post	ENSG00000103266	10273	STIP1 homology and U-box containing protein 1	CHIP|HSPABP2|NY-CO-7|SDCCAG7|UBOX1	protein_coding	Q9UNE7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30502
1.09800866743695e-180	0.432642403007307	0.35	0.077	2.33118220183539e-176	NUP210	Malignant cells	GSE199333_post	ENSG00000132182	23225	nucleoporin 210	FLJ22389|GP210|KIAA0906|POM210	protein_coding	Q8TEM1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30503
1.15972907372733e-180	-0.460729662318255	0.142	0.348	2.46222079643049e-176	SLC6A6	Malignant cells	GSE199333_post	ENSG00000131389	6533	solute carrier family 6 member 6	TAUT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30504
1.21233041647697e-180	0.412158027977515	0.4	0.118	2.57389870722225e-176	RFXANK	Malignant cells	GSE199333_post	ENSG00000064490	8625	regulatory factor X associated ankyrin containing protein	ANKRA1|BLS|F14150_1|MGC138628|RFX-B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30505
9.6142540725779e-180	0.384049434316288	0.999	1	2.04120228214901e-175	EEF1A1	Malignant cells	GSE199333_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30506
1.38347711454419e-179	-0.33515960620865	0.111	0.307	2.93726026188876e-175	MTMR6	Malignant cells	GSE199333_post	ENSG00000139505	9107	myotubularin related protein 6	NA	protein_coding	Q9Y217	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30507
2.31459621309288e-179	-0.472268414042143	0.168	0.386	4.9141192200175e-175	MAP4K4	Malignant cells	GSE199333_post	ENSG00000071054	9448	mitogen-activated protein kinase kinase kinase kinase 4	FLH21957|HGK|NIK	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30508
2.59742738795584e-179	-0.546205670341014	0.158	0.363	5.51459808736904e-175	PRKAG2	Malignant cells	GSE199333_post	ENSG00000106617	51422	protein kinase AMP-activated non-catalytic subunit gamma 2	AAKG|AAKG2|CMH6|H91620p|WPWS	protein_coding	Q9UGJ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30509
4.75006682731439e-179	0.397805798165856	0.368	0.091	1.00848668810712e-174	TPGS2	Malignant cells	GSE199333_post	ENSG00000134779	25941	tubulin polyglutamylase complex subunit 2	C18orf10|DKFZP586M1523|HsT3006|PGs2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30510
5.74525564962792e-179	-0.725391958629134	0.625	0.788	1.2197752269725e-174	TYROBP	Malignant cells	GSE199333_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30511
6.53991887613525e-179	-0.491442454614272	0.109	0.299	1.38849017659228e-174	SNX18	Malignant cells	GSE199333_post	ENSG00000178996	112574	sorting nexin 18	SH3PX2|SH3PXD3B|SNAG1	protein_coding	Q96RF0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30512
1.29049625129101e-178	0.58825905345577	0.57	0.296	2.73985259111595e-174	CCT5	Malignant cells	GSE199333_post	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30513
2.30280383120862e-178	0.435881338756347	0.399	0.117	4.88908281403902e-174	RGS19	Malignant cells	GSE199333_post	ENSG00000171700	10287	regulator of G protein signaling 19	GAIP|RGSGAIP	protein_coding	P49795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30514
2.56703868804806e-178	-0.503775252692287	0.45	0.667	5.45007983859483e-174	WAC	Malignant cells	GSE199333_post	ENSG00000095787	51322	WW domain containing adaptor with coiled-coil	BM-016|FLJ31290|MGC10753|PRO1741|Wwp4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30515
3.29540352269201e-178	0.485360884154769	0.449	0.161	6.9964712190274e-174	UCP2	Malignant cells	GSE199333_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30516
3.72714250596176e-178	-0.860154381051358	0.657	0.786	7.91309625440741e-174	EMP3	Malignant cells	GSE199333_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30517
6.38712622045763e-178	0.424452043859187	0.383	0.104	1.35605076786536e-173	RUVBL2	Malignant cells	GSE199333_post	ENSG00000183207	10856	RuvB like AAA ATPase 2	ECP51|INO80J|Reptin52|RVB2|TIH2|TIP48|TIP49b	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30518
7.56531394938768e-178	-0.539389099485049	0.329	0.553	1.6061918045945e-173	MAPKAPK2	Malignant cells	GSE199333_post	ENSG00000162889	9261	MAPK activated protein kinase 2	MK2	protein_coding	P49137	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30519
7.71643142899494e-178	0.533361472766354	0.323	0.058	1.63827555668992e-173	HSPA1A	Malignant cells	GSE199333_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30520
8.95292285517642e-178	-0.475333900893312	0.312	0.548	1.90079505138251e-173	RAB1A	Malignant cells	GSE199333_post	ENSG00000138069	5861	RAB1A, member RAS oncogene family	RAB1|YPT1	protein_coding	P62820	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30521
1.27315740483376e-177	0.451101991094808	0.429	0.141	2.70304048620256e-173	GSN	Malignant cells	GSE199333_post	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30522
3.68494714164158e-177	0.399203813217499	0.36	0.086	7.82351127641925e-173	SLC25A11	Malignant cells	GSE199333_post	ENSG00000108528	8402	solute carrier family 25 member 11	OGC|SLC20A4	protein_coding	Q02978	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30523
4.13966345122391e-177	-0.291073187253762	0.077	0.253	8.78891947329348e-173	RXRA	Malignant cells	GSE199333_post	ENSG00000186350	6256	retinoid X receptor alpha	NR2B1|RXR-alpha|RXRalpha	protein_coding	P19793	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30524
5.2297485906325e-177	0.393923879026831	0.358	0.084	1.11032792327719e-172	TSNAX	Malignant cells	GSE199333_post	ENSG00000116918	7257	translin associated factor X	C3PO|TRAX	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30525
7.38540450153568e-177	0.400492680930632	0.333	0.065	1.56799522972104e-172	CD79B	Malignant cells	GSE199333_post	ENSG00000007312	974	CD79b molecule	B29|Ig-beta|IGB|Igbeta	protein_coding	P40259	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30526
1.07116492809491e-176	0.450970149347212	0.376	0.101	2.2741902588383e-172	GAMT	Malignant cells	GSE199333_post	ENSG00000130005	2593	guanidinoacetate N-methyltransferase	PIG2|TP53I2	protein_coding	Q14353	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30527
1.11671761306565e-176	0.489417097249731	0.356	0.087	2.37090316429967e-172	SSBP2	Malignant cells	GSE199333_post	ENSG00000145687	23635	single stranded DNA binding protein 2	HSPC116	protein_coding	P81877	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30528
1.96792031859297e-176	0.422605521381511	0.399	0.12	4.17809162840473e-172	MFNG	Malignant cells	GSE199333_post	ENSG00000100060	4242	MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase	NA	protein_coding	O00587	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30529
4.85285631741425e-176	0.538535081823407	0.566	0.27	1.03030992475022e-171	HSPB1	Malignant cells	GSE199333_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30530
6.9138228827418e-176	0.381940150810071	0.292	0.037	1.46787373623491e-171	CBR1	Malignant cells	GSE199333_post	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30531
1.05125714204495e-175	0.385449445917681	0.334	0.067	2.23192403827564e-171	ACADM	Malignant cells	GSE199333_post	ENSG00000117054	34	acyl-CoA dehydrogenase medium chain	ACAD1|MCAD|MCADH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30532
2.08213541314408e-175	-0.341556001035644	0.099	0.284	4.42058169564619e-171	ZNF267	Malignant cells	GSE199333_post	ENSG00000185947	10308	zinc finger protein 267	HZF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30533
3.70108782003934e-175	-0.58669920919089	0.466	0.676	7.85777955072552e-171	MAP1LC3B	Malignant cells	GSE199333_post	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30534
3.74342860988381e-175	-0.354472345147472	0.147	0.359	7.94767328164431e-171	ZDHHC20	Malignant cells	GSE199333_post	ENSG00000180776	253832	zinc finger DHHC-type palmitoyltransferase 20	DHHC20|FLJ25952	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30535
9.04766564878857e-175	0.365026211094631	0.998	0.999	1.9209098938943e-170	RPS9	Malignant cells	GSE199333_post	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30536
1.4582469804244e-174	0.497547399881474	0.594	0.311	3.09600416413905e-170	RNH1	Malignant cells	GSE199333_post	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30537
1.47732434976366e-174	0.683602148232634	0.371	0.101	3.13650732698323e-170	MYC	Malignant cells	GSE199333_post	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30538
1.84528448528262e-174	0.614795816608545	0.563	0.288	3.91772349070353e-170	GLIPR1	Malignant cells	GSE199333_post	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30539
2.37392595312927e-174	0.452662909429839	0.605	0.323	5.04008219108876e-170	NDUFB5	Malignant cells	GSE199333_post	ENSG00000136521	4711	NADH:ubiquinone oxidoreductase subunit B5	CI-SGDH|MGC12314|SGDH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30540
3.23581676021752e-174	0.423616626572107	0.377	0.103	6.86996256361783e-170	DMAC1	Malignant cells	GSE199333_post	ENSG00000137038	90871	distal membrane arm assembly component 1	C9orf123|MGC4730|TMEM261	protein_coding	Q96GE9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30541
1.46415628949436e-173	-0.618342543181347	0.317	0.535	3.10855021822548e-169	TACC1	Malignant cells	GSE199333_post	ENSG00000147526	6867	transforming acidic coiled-coil containing protein 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30542
2.68617609778098e-173	0.457775243293778	0.788	0.541	5.70302047319881e-169	GDI2	Malignant cells	GSE199333_post	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30543
5.12632203817801e-173	0.484602267553462	0.569	0.266	1.08836943192557e-168	SORL1	Malignant cells	GSE199333_post	ENSG00000137642	6653	sortilin related receptor 1	C11orf32|gp250|LR11|LRP9|SorLA|SorLA-1	protein_coding	Q92673	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30544
1.32288835621096e-172	0.503428602618411	0.474	0.193	2.80862426907149e-168	COMMD3	Malignant cells	GSE199333_post	ENSG00000148444	23412	COMM domain containing 3	BUP|C10orf8	protein_coding	Q9UBI1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30545
1.62216742878965e-172	0.469305644371271	0.268	0.022	3.4440236680633e-168	ANGPT1	Malignant cells	GSE199333_post	ENSG00000154188	284	angiopoietin 1	AGPT-1|Ang1|KIAA0003	protein_coding	Q15389	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30546
1.76790965234832e-172	-0.447158177961925	0.212	0.438	3.75344898290072e-168	FAM91A1	Malignant cells	GSE199333_post	ENSG00000176853	157769	family with sequence similarity 91 member A1	FLJ23790	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30547
2.10002765347147e-172	0.425284439857435	0.396	0.122	4.45856871108528e-168	CHCHD1	Malignant cells	GSE199333_post	ENSG00000172586	118487	coiled-coil-helix-coiled-coil-helix domain containing 1	C10orf34|FLJ25854	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30548
2.90916112532427e-172	-0.50916020288373	0.251	0.477	6.17643998517595e-168	SERINC1	Malignant cells	GSE199333_post	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30549
3.50848700287653e-172	0.385305539273835	0.328	0.065	7.44886875580716e-168	YDJC	Malignant cells	GSE199333_post	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30550
6.01801494973564e-172	-0.583584533374845	0.107	0.286	1.27768475397837e-167	DSE	Malignant cells	GSE199333_post	ENSG00000111817	29940	dermatan sulfate epimerase	DS-Epi1|DSEPI|SART2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30551
1.65403464709815e-171	0.415367896677397	0.519	0.22	3.51168095925409e-167	XPO1	Malignant cells	GSE199333_post	ENSG00000082898	7514	exportin 1	CRM-1|CRM1|emb	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30552
8.33854874319748e-171	0.377460891233353	0.256	0.017	1.77035728366826e-166	LINC01268	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30553
1.13298859903825e-170	-0.505327594668256	0.28	0.507	2.4054480946181e-166	SERTAD2	Malignant cells	GSE199333_post	ENSG00000179833	9792	SERTA domain containing 2	KIAA0127|Sei-2|TRIP-Br2	protein_coding	Q14140	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30554
1.98141538890239e-170	0.417436317883111	0.908	0.727	4.20674301217867e-166	COX5B	Malignant cells	GSE199333_post	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30555
2.54517108536113e-170	0.508426642452087	0.689	0.426	5.40365273133021e-166	LUC7L3	Malignant cells	GSE199333_post	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30556
2.94572559382865e-170	0.481217817029077	0.685	0.4	6.25407000825761e-166	GYPC	Malignant cells	GSE199333_post	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30557
6.14476321891359e-170	0.396070489550863	0.341	0.077	1.30459467900754e-165	RPA2	Malignant cells	GSE199333_post	ENSG00000117748	6118	replication protein A2	NA	protein_coding	P15927	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30558
1.55364328023802e-169	0.382911293967916	0.35	0.083	3.29854004827333e-165	TACC3	Malignant cells	GSE199333_post	ENSG00000013810	10460	transforming acidic coiled-coil containing protein 3	ERIC-1|ERIC1|maskin|Tacc4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30559
2.72214375866657e-169	-0.385656300924207	0.181	0.399	5.779383414025e-165	ACBD3	Malignant cells	GSE199333_post	ENSG00000182827	64746	acyl-CoA binding domain containing 3	GCP60|GOCAP1|GOLPH1|PAP7	protein_coding	Q9H3P7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30560
5.58324305081525e-169	0.462035565333542	0.629	0.343	1.18537833211858e-164	GTF2A2	Malignant cells	GSE199333_post	ENSG00000140307	2958	general transcription factor IIA subunit 2	HsT18745|TFIIA	protein_coding	P52657	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30561
6.01666792752589e-169	0.584678666149799	0.501	0.233	1.27739876769302e-164	KMT2A	Malignant cells	GSE199333_post	ENSG00000118058	4297	lysine methyltransferase 2A	ALL-1|ALL1|CXXC7|HRX|HTRX|HTRX1|MLL|MLL1|MLL1A|TRX1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30562
9.26787428319303e-169	0.44222675618959	0.58	0.296	1.96766238906471e-164	RASGRP2	Malignant cells	GSE199333_post	ENSG00000068831	10235	RAS guanyl releasing protein 2	CALDAG-GEFI	protein_coding	Q7LDG7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30563
1.05554576028027e-168	0.397002144177553	0.395	0.121	2.24102920365105e-164	CMTM7	Malignant cells	GSE199333_post	ENSG00000153551	112616	CKLF like MARVEL transmembrane domain containing 7	CKLFSF7|FLJ30992	protein_coding	Q96FZ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30564
1.23222223168474e-168	-0.301086157956004	0.103	0.289	2.61613102008987e-164	RPRD1B	Malignant cells	GSE199333_post	ENSG00000101413	58490	regulation of nuclear pre-mRNA domain containing 1B	C20orf77|CREPT|dJ1057B20.2|DKFZp434P0735|FLJ44520|K-H|Kub5-Hera|NET60	protein_coding	Q9NQG5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30565
1.82046803034748e-168	-0.473402553910675	0.268	0.495	3.86503567523074e-164	LCOR	Malignant cells	GSE199333_post	ENSG00000196233	84458	ligand dependent nuclear receptor corepressor	C10orf12|DKFZP564P1916|FLJ13022|FLJ38026|KIAA1795|MLR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30566
2.40021435580908e-168	0.450592977126242	0.432	0.156	5.09589509881827e-164	EPRS	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30567
2.48969109927157e-168	0.431030205752595	0.32	0.063	5.28586317286348e-164	CDCA7	Malignant cells	GSE199333_post	ENSG00000144354	83879	cell division cycle associated 7	FLJ14736|JPO1	protein_coding	Q9BWT1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30568
3.03410254975943e-168	0.389856543591524	0.361	0.094	6.44170312339424e-164	NIPSNAP3A	Malignant cells	GSE199333_post	ENSG00000136783	25934	nipsnap homolog 3A	DKFZp564D177|FLJ13953|HSPC299|MGC14553|NIPSNAP4|TassC	protein_coding	Q9UFN0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30569
3.05291868292094e-168	0.432791284175132	0.499	0.216	6.48165165570945e-164	CNPY2	Malignant cells	GSE199333_post	ENSG00000257727	10330	canopy FGF signaling regulator 2	HP10390|TMEM4|ZSIG9	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30570
4.47371633254687e-168	0.393927164028405	0.369	0.102	9.49814714563025e-164	DHRS4L2	Malignant cells	GSE199333_post	ENSG00000187630	317749	dehydrogenase/reductase 4 like 2	SDR25C3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30571
6.82306319188692e-168	0.446702318250125	0.851	0.623	1.44860454626951e-163	ARPC1B	Malignant cells	GSE199333_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30572
1.18367795394295e-167	0.52336349717172	0.468	0.188	2.51306666401628e-163	MIR181A1HG	Malignant cells	GSE199333_post	ENSG00000229989	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30573
1.28697541256668e-167	-0.4911882239495	0.361	0.593	2.73237749842031e-163	USP15	Malignant cells	GSE199333_post	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30574
2.23256748314807e-167	0.383370589470276	0.784	0.45	4.73996402347166e-163	PLAC8	Malignant cells	GSE199333_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30575
2.56786292543394e-167	0.414099855311331	0.488	0.205	5.45182977698879e-163	PSMD4	Malignant cells	GSE199333_post	ENSG00000159352	5710	proteasome 26S subunit ubiquitin receptor, non-ATPase 4	AF|AF-1|Rpn10|S5A	protein_coding	P55036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30576
4.57096637140338e-167	0.421890372682948	0.36	0.094	9.70461870312651e-163	PRKACB	Malignant cells	GSE199333_post	ENSG00000142875	5567	protein kinase cAMP-activated catalytic subunit beta	PKACb	protein_coding	P22694	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30577
4.64379683278229e-167	0.404416406302803	0.382	0.111	9.85924505568008e-163	NHLRC3	Malignant cells	GSE199333_post	ENSG00000188811	387921	NHL repeat containing 3	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30578
6.19407479674751e-167	-0.453012890762109	0.197	0.413	1.31506402009746e-162	PSME4	Malignant cells	GSE199333_post	ENSG00000068878	23198	proteasome activator subunit 4	KIAA0077|PA200	protein_coding	Q14997	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30579
7.9929187151206e-167	-0.37093451471646	0.085	0.255	1.69697657240726e-162	NLRP3	Malignant cells	GSE199333_post	ENSG00000162711	114548	NLR family pyrin domain containing 3	AGTAVPRL|AII|AVP|C1orf7|CIAS1|CLR1.1|DFNA34|FCAS|FCU|MWS|NALP3|PYPAF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30580
2.4998840571711e-166	0.476742250433713	0.636	0.355	5.30750384177997e-162	ANAPC11	Malignant cells	GSE199333_post	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30581
2.59722220309285e-166	-0.476656825295113	0.244	0.471	5.51416245938642e-162	CREBRF	Malignant cells	GSE199333_post	ENSG00000164463	153222	CREB3 regulatory factor	C5orf41|LRF	protein_coding	Q8IUR6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30582
2.78301440146229e-166	0.373210491821244	0.302	0.051	5.90861787574458e-162	SPATC1L	Malignant cells	GSE199333_post	ENSG00000274679	84221	spermatogenesis and centriole associated 1 like	C21orf56	protein_coding	Q9H0A9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30583
6.45666592186533e-166	0.387612096795751	0.382	0.11	1.37081474187123e-161	NREP	Malignant cells	GSE199333_post	ENSG00000134986	9315	neuronal regeneration related protein	C5orf13|D4S114|P311|PRO1873|PTZ17|SEZ17	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30584
8.08836119027684e-166	0.440554419854447	0.495	0.216	1.71723996430768e-161	POLR2I	Malignant cells	GSE199333_post	ENSG00000105258	5438	RNA polymerase II subunit I	hRPB14.5|RPB9	protein_coding	P36954	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30585
1.21553749210867e-165	0.463108529954301	0.549	0.267	2.58070764949591e-161	FERMT3	Malignant cells	GSE199333_post	ENSG00000149781	83706	FERM domain containing kindlin 3	KIND3|MGC10966|MIG2B|UNC112C|URP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30586
1.63442721721115e-165	0.425829141889329	0.974	0.904	3.470052424861e-161	UBB	Malignant cells	GSE199333_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30587
1.76442896850818e-165	-0.390858243555753	0.169	0.383	3.74605914303971e-161	HMGXB4	Malignant cells	GSE199333_post	ENSG00000100281	10042	HMG-box containing 4	HMG2L1|P53N|THC211630	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30588
2.1108225966744e-165	-0.409726489691264	0.212	0.435	4.48148745499941e-161	DYRK1A	Malignant cells	GSE199333_post	ENSG00000157540	1859	dual specificity tyrosine phosphorylation regulated kinase 1A	DYRK|DYRK1|MNBH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30589
2.27002995846489e-165	0.436721878798425	0.595	0.296	4.81950060481681e-161	MSRB3	Malignant cells	GSE199333_post	ENSG00000174099	253827	methionine sulfoxide reductase B3	DFNB74|DKFZp686C1178|FLJ36866	protein_coding	Q8IXL7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30590
6.43129670082409e-165	0.381157445989408	0.337	0.077	1.36542860255196e-160	CPXM1	Malignant cells	GSE199333_post	ENSG00000088882	56265	carboxypeptidase X, M14 family member 1	CPX-1|CPX1|CPXM	protein_coding	Q96SM3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30591
7.4959505528882e-165	0.404211699616664	0.343	0.083	1.59146526188369e-160	ERLIN1	Malignant cells	GSE199333_post	ENSG00000107566	10613	ER lipid raft associated 1	C10orf69|Erlin-1|KE04|SPFH1|SPG62	protein_coding	O75477	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30592
9.66620292341025e-165	0.394469466010652	0.359	0.096	2.05223154266923e-160	TFEC	Malignant cells	GSE199333_post	ENSG00000105967	22797	transcription factor EC	bHLHe34|TCFEC|TFECL	protein_coding	O14948	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30593
1.09218047918634e-164	0.424236708688058	0.498	0.209	2.31880837536053e-160	INPP5D	Malignant cells	GSE199333_post	ENSG00000281614	3635	inositol polyphosphate-5-phosphatase D	hp51CN|SHIP|SHIP1	protein_coding	Q92835	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30594
1.130517339006e-164	0.384457837542963	0.316	0.063	2.40020136244365e-160	MRPL24	Malignant cells	GSE199333_post	ENSG00000143314	79590	mitochondrial ribosomal protein L24	MRP-L18	protein_coding	Q96A35	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30595
1.78569732913975e-164	0.459021599532685	0.317	0.062	3.79121399949661e-160	RGS18	Malignant cells	GSE199333_post	ENSG00000150681	64407	regulator of G protein signaling 18	RGS13	protein_coding	Q9NS28	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30596
2.55079766400069e-164	-0.554102008461701	0.521	0.713	5.41559852043987e-160	EIF1B	Malignant cells	GSE199333_post	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30597
7.23991964098515e-164	0.445739451207165	0.606	0.334	1.53710733897756e-159	FIS1	Malignant cells	GSE199333_post	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30598
8.14334940724707e-164	-0.442182801576373	0.86	0.934	1.72891451265263e-159	PCBP2	Malignant cells	GSE199333_post	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30599
8.45774529513117e-164	0.339785416415847	0.818	0.536	1.7956639036093e-159	JUN	Malignant cells	GSE199333_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30600
1.78004513090599e-163	0.405692914190559	0.481	0.199	3.77921381742651e-159	ECH1	Malignant cells	GSE199333_post	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30601
2.0169994495896e-163	0.644416884460474	0.373	0.106	4.28229153142368e-159	PCNA	Malignant cells	GSE199333_post	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30602
2.40422624510429e-163	0.379283394581208	0.35	0.088	5.10441274098092e-159	PIH1D1	Malignant cells	GSE199333_post	ENSG00000104872	55011	PIH1 domain containing 1	DNAAF14|FLJ20643|MOT48|NOP17|Pih1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30603
2.48479087474568e-163	0.33491317463645	0.999	0.999	5.27545950617256e-159	RPL32	Malignant cells	GSE199333_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30604
2.61842927214433e-163	0.44928240860372	0.406	0.137	5.55918718768963e-159	POLD2	Malignant cells	GSE199333_post	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30605
4.19528144854316e-163	-0.461363130182668	0.246	0.466	8.90700204340199e-159	RAB21	Malignant cells	GSE199333_post	ENSG00000080371	23011	RAB21, member RAS oncogene family	KIAA0118	protein_coding	Q9UL25	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30606
4.32905896053492e-163	-0.366678950863268	0.105	0.287	9.19102507911169e-159	RASSF5	Malignant cells	GSE199333_post	ENSG00000266094	83593	Ras association domain family member 5	Maxp1|NORE1|RAPL	protein_coding	Q8WWW0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30607
4.53238146272626e-163	0.39504332074135	0.373	0.109	9.62269908351412e-159	POLR3GL	Malignant cells	GSE199333_post	ENSG00000121851	84265	RNA polymerase III subunit GL	flj32422|MGC3200	protein_coding	Q9BT43	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30608
6.13573767223734e-163	-0.391745659452898	0.088	0.256	1.30267846519271e-158	VOPP1	Malignant cells	GSE199333_post	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30609
9.76828087763628e-163	0.419645986111159	0.861	0.695	2.07390371313096e-158	ATP5PO	Malignant cells	GSE199333_post	ENSG00000241837	539	ATP synthase peripheral stalk subunit OSCP	ATP5O|ATPO|OSCP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30610
1.1948879318831e-162	0.442008229872907	0.428	0.151	2.53686656818101e-158	SPINT2	Malignant cells	GSE199333_post	ENSG00000167642	10653	serine peptidase inhibitor, Kunitz type 2	HAI-2|HAI2|Kop	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30611
2.96140825049319e-162	0.40626054576001	0.378	0.115	6.28736585662208e-158	MRPS26	Malignant cells	GSE199333_post	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30612
9.4201810360112e-162	-0.47413443802631	0.259	0.478	1.99999863575554e-157	AKIRIN1	Malignant cells	GSE199333_post	ENSG00000174574	79647	akirin 1	C1orf108|FLJ12666	protein_coding	Q9H9L7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30613
1.10447409136023e-161	0.428726759988413	0.885	0.723	2.34490894336691e-157	RPL22L1	Malignant cells	GSE199333_post	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30614
1.36422402303668e-161	0.373740163807869	0.362	0.1	2.89638402330917e-157	HAX1	Malignant cells	GSE199333_post	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30615
1.69499887900888e-161	-0.464093171107084	0.209	0.422	3.59865212002375e-157	GRINA	Malignant cells	GSE199333_post	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30616
3.45905460400541e-161	-0.46157671812712	0.242	0.468	7.34391882976388e-157	MXD1	Malignant cells	GSE199333_post	ENSG00000059728	4084	MAX dimerization protein 1	bHLHc58|MAD|MAD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30617
4.49321575908762e-161	0.473200021424911	0.55	0.271	9.53954637811892e-157	MACF1	Malignant cells	GSE199333_post	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30618
4.8068346352506e-161	0.354707789873558	0.253	0.021	1.02053906141006e-156	C14orf119	Malignant cells	GSE199333_post	ENSG00000179933	55017	chromosome 14 open reading frame 119	FLJ20671	protein_coding	Q9NWQ9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30619
1.44966616817129e-160	0.589094569289567	0.54	0.279	3.07778624164448e-156	SMC4	Malignant cells	GSE199333_post	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30620
1.58181885837332e-160	0.440295036349622	0.486	0.215	3.3583596182124e-156	MRPL11	Malignant cells	GSE199333_post	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30621
1.65909056401908e-160	0.385625690394578	0.383	0.119	3.52241517646892e-156	DNAJC19	Malignant cells	GSE199333_post	ENSG00000205981	131118	DnaJ heat shock protein family (Hsp40) member C19	Pam18|Tim14|TIMM14	protein_coding	Q96DA6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30622
1.91577725581606e-160	0.440612851465301	0.353	0.095	4.06738669182309e-156	FAM111A	Malignant cells	GSE199333_post	ENSG00000166801	63901	FAM111 trypsin like peptidase A	FLJ22794|KIAA1895	protein_coding	Q96PZ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30623
2.44239155692544e-160	-0.346810599491257	0.106	0.288	5.18544151450841e-156	CAPN2	Malignant cells	GSE199333_post	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30624
3.85573999392942e-160	0.371084263859793	0.286	0.044	8.18612158111156e-156	ACYP1	Malignant cells	GSE199333_post	ENSG00000119640	97	acylphosphatase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30625
4.8064293350159e-160	-0.527931707552024	0.718	0.835	1.02045301211723e-155	SON	Malignant cells	GSE199333_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30626
1.10223263532985e-159	0.47489739322396	0.6	0.339	2.34015010806881e-155	TMBIM4	Malignant cells	GSE199333_post	ENSG00000155957	51643	transmembrane BAX inhibitor motif containing 4	CGI-119|GAAP|LFG4|S1R|ZPRO	protein_coding	Q9HC24	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30627
1.61723860622681e-159	0.39994004416922	0.458	0.185	3.43355928488014e-155	SUCLG1	Malignant cells	GSE199333_post	ENSG00000163541	8802	succinate-CoA ligase GDP/ADP-forming subunit alpha	NA	protein_coding	P53597	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30628
1.66500500386074e-159	0.376175167325243	0.354	0.095	3.53497212369674e-155	CCDC90B	Malignant cells	GSE199333_post	ENSG00000137500	60492	coiled-coil domain containing 90B	MDS011|MDS025	protein_coding	Q9GZT6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30629
1.74084656099484e-159	0.476690269826194	0.506	0.24	3.69599133364814e-155	PRAM1	Malignant cells	GSE199333_post	ENSG00000133246	84106	PML-RARA regulated adaptor molecule 1	PML-RAR	protein_coding	Q96QH2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30630
1.77063477233125e-159	0.419171807923107	0.555	0.281	3.75923468513648e-155	UBE2M	Malignant cells	GSE199333_post	ENSG00000130725	9040	ubiquitin conjugating enzyme E2 M	hUbc12|UBC12	protein_coding	P61081	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30631
2.39133153564382e-159	0.484478623549166	0.508	0.237	5.0770359833254e-155	YWHAH	Malignant cells	GSE199333_post	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30632
2.67266257686722e-159	-0.361405468389893	0.148	0.348	5.67432991694679e-155	OSGIN2	Malignant cells	GSE199333_post	ENSG00000164823	734	oxidative stress induced growth inhibitor family member 2	C8orf1|hT41	protein_coding	Q9Y236	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30633
3.17395343464483e-159	-0.34100698472814	0.118	0.305	6.73862053709443e-155	MED23	Malignant cells	GSE199333_post	ENSG00000112282	9439	mediator complex subunit 23	CRSP130|CRSP3|DRIP130|MRT18|Sur2	protein_coding	Q9ULK4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30634
5.49678377761479e-159	0.519407483449756	0.349	0.096	1.1670221638254e-154	AIG1	Malignant cells	GSE199333_post	ENSG00000146416	51390	androgen induced 1	AIG-1|dJ95L4.1|FLJ10485	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30635
7.49699873030493e-159	0.39950885334562	0.48	0.2	1.59168780043104e-154	UBE2E3	Malignant cells	GSE199333_post	ENSG00000170035	10477	ubiquitin conjugating enzyme E2 E3	UbcH9	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30636
8.0089921371588e-159	0.379367708220999	0.306	0.059	1.70038912064018e-154	CRNDE	Malignant cells	GSE199333_post	ENSG00000245694	101927480	uncharacterized LOC101927480	CRNDEP|LINC00180|LOC643911	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30637
1.04868267433086e-158	0.494084980256445	0.552	0.285	2.22645818587184e-154	NUDC	Malignant cells	GSE199333_post	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30638
1.08351768996136e-158	0.500179994105754	0.337	0.081	2.30041640755696e-154	CKS1B	Malignant cells	GSE199333_post	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30639
1.18441990536186e-158	0.498715076331513	0.69	0.45	2.51464190107377e-154	SSB	Malignant cells	GSE199333_post	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30640
1.72116907011751e-158	0.341508169348947	0.29	0.047	3.65421405276649e-154	SMIM30	Malignant cells	GSE199333_post	ENSG00000214194	401397	small integral membrane protein 30	LINC00998	protein_coding	A4D0T7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30641
2.06331111758006e-158	0.417436174097303	0.836	0.646	4.38061583373422e-154	PRDX6	Malignant cells	GSE199333_post	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30642
3.37082730706717e-158	0.487053356112694	0.622	0.367	7.1566034556343e-154	VDAC1	Malignant cells	GSE199333_post	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30643
8.57567121918924e-158	0.663511120567009	0.538	0.263	1.82070075654607e-153	CITED2	Malignant cells	GSE199333_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30644
9.40691898442541e-158	0.401899631695778	0.402	0.137	1.99718296958336e-153	MRPS16	Malignant cells	GSE199333_post	ENSG00000182180	51021	mitochondrial ribosomal protein S16	CGI-132	protein_coding	Q9Y3D3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30645
1.61912375197293e-157	0.399202929007782	0.458	0.188	3.43756163781372e-153	PARVG	Malignant cells	GSE199333_post	ENSG00000138964	64098	parvin gamma	NA	protein_coding	Q9HBI0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30646
2.60975917507784e-157	0.412635016269941	0.429	0.16	5.54077970460776e-153	DOCK8	Malignant cells	GSE199333_post	ENSG00000107099	81704	dedicator of cytokinesis 8	FLJ00026|FLJ00152|FLJ00346|ZIR8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30647
3.09809124966048e-157	-0.544273138742908	0.98	0.983	6.57755753215417e-153	HLA-A	Malignant cells	GSE199333_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30648
4.97516420431445e-157	0.386262405795582	0.369	0.109	1.056277112218e-152	MESD	Malignant cells	GSE199333_post	ENSG00000117899	23184	mesoderm development LRP chaperone	BOCA|KIAA0081|MESDC2	protein_coding	Q14696	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30649
4.99821228282345e-157	-0.730190030116045	0.212	0.405	1.06117044976625e-152	PHACTR1	Malignant cells	GSE199333_post	ENSG00000112137	221692	phosphatase and actin regulator 1	dJ257A7.2|KIAA1733|RPEL1	protein_coding	Q9C0D0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30650
5.47697004872249e-157	-0.519520682250481	0.472	0.677	1.16281551104427e-152	KMT2E	Malignant cells	GSE199333_post	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30651
5.47927230668222e-157	0.411671477896309	0.478	0.205	1.1633043034317e-152	SNRPA	Malignant cells	GSE199333_post	ENSG00000077312	6626	small nuclear ribonucleoprotein polypeptide A	Mud1|U1-A|U1A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30652
5.83701677645973e-157	0.355299506798967	0.296	0.054	1.23925703181016e-152	APEH	Malignant cells	GSE199333_post	ENSG00000164062	327	acylaminoacyl-peptide hydrolase	D3F15S2|D3S48E|DNF15S2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30653
6.36433956467718e-157	-0.324626222625116	0.113	0.296	1.35121293297661e-152	CCDC186	Malignant cells	GSE199333_post	ENSG00000165813	55088	coiled-coil domain containing 186	C10orf118|CCCP-1|FLJ10188|FLJ35301|golgin104	protein_coding	Q7Z3E2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30654
8.05251983579534e-157	0.413827445687584	0.34	0.086	1.70963048633771e-152	SPARC	Malignant cells	GSE199333_post	ENSG00000113140	6678	secreted protein acidic and cysteine rich	BM-40|ON|ONT	protein_coding	P09486	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30655
1.14272358153558e-156	-0.422581739081983	0.148	0.346	2.42611643595818e-152	SEC14L1	Malignant cells	GSE199333_post	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30656
1.4251945468028e-156	0.410373755688592	0.472	0.197	3.02583054231703e-152	TECR	Malignant cells	GSE199333_post	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30657
1.90679749862658e-156	-0.420453925747226	0.237	0.456	4.04832176933409e-152	SHOC2	Malignant cells	GSE199333_post	ENSG00000108061	8036	SHOC2 leucine rich repeat scaffold protein	KIAA0862|SOC-2|SOC2|SUR-8|SUR8	protein_coding	Q9UQ13	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30658
4.40633694287501e-156	-0.427379031247392	0.263	0.484	9.35509396341794e-152	COPS2	Malignant cells	GSE199333_post	ENSG00000166200	9318	COP9 signalosome subunit 2	ALIEN|CSN2|TRIP15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30659
4.86171295734592e-156	0.384835012125177	0.405	0.138	1.03219027797411e-151	FES	Malignant cells	GSE199333_post	ENSG00000182511	2242	FES proto-oncogene, tyrosine kinase	FPS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30660
6.00104202137355e-156	0.462767860684978	0.578	0.295	1.27408123155782e-151	ICAM3	Malignant cells	GSE199333_post	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30661
6.65290308318431e-156	0.376908973196841	0.339	0.087	1.41247785359086e-151	CARD8	Malignant cells	GSE199333_post	ENSG00000105483	22900	caspase recruitment domain family member 8	CARDINAL|Dakar|KIAA0955|NDPP|TUCAN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30662
1.53545609100698e-155	0.386571285690936	0.419	0.153	3.25992682681692e-151	ATXN10	Malignant cells	GSE199333_post	ENSG00000130638	25814	ataxin 10	ATX10|E46L|FLJ37990|SCA10	protein_coding	Q9UBB4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30663
1.59437011941262e-155	0.417715880258559	0.59	0.314	3.38500720052494e-151	ACTN4	Malignant cells	GSE199333_post	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30664
2.16873615609776e-155	0.383490811233899	0.358	0.102	4.60444373301116e-151	PPA2	Malignant cells	GSE199333_post	ENSG00000138777	27068	inorganic pyrophosphatase 2	FLJ20459	protein_coding	Q9H2U2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30665
2.96823652902541e-155	0.387553511541328	0.42	0.155	6.30186297477385e-151	ETFA	Malignant cells	GSE199333_post	ENSG00000140374	2108	electron transfer flavoprotein subunit alpha	EMA|GA2|MADD	protein_coding	P13804	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30666
3.97028759658108e-155	0.383365984858161	0.386	0.126	8.4293175963013e-151	ZDHHC24	Malignant cells	GSE199333_post	ENSG00000174165	254359	zinc finger DHHC-type containing 24	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30667
5.70404430549993e-155	0.405287604650013	0.482	0.208	1.21102564650069e-150	NDUFS2	Malignant cells	GSE199333_post	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30668
7.15390825193606e-155	-0.371318368498662	0.14	0.334	1.51884626096855e-150	AKIRIN2	Malignant cells	GSE199333_post	ENSG00000135334	55122	akirin 2	C6orf166|dJ486L4.2|FLJ10342	protein_coding	Q53H80	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30669
7.46559263128137e-155	-0.425876972653753	0.113	0.288	1.58501997154735e-150	RAPGEF1	Malignant cells	GSE199333_post	ENSG00000107263	2889	Rap guanine nucleotide exchange factor 1	C3G|GRF2	protein_coding	Q13905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30670
8.91408499608597e-155	0.514286433763237	0.854	0.72	1.89254938551901e-150	SERBP1	Malignant cells	GSE199333_post	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30671
1.25932824118956e-154	-0.483657104410469	0.772	0.88	2.67367978886955e-150	YWHAZ	Malignant cells	GSE199333_post	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30672
2.28759345652312e-154	0.35798995237399	0.322	0.075	4.85678966754424e-150	NMRAL1	Malignant cells	GSE199333_post	ENSG00000274684	57407	NmrA like redox sensor 1	FLJ25918|HSCARG|SDR48A1	protein_coding	Q9HBL8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30673
4.20581445891899e-154	0.364473424757518	0.342	0.09	8.9293646777309e-150	SIPA1	Malignant cells	GSE199333_post	ENSG00000213445	6494	signal-induced proliferation-associated 1	SPA1	protein_coding	Q96FS4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30674
4.44142616457278e-154	0.422035504899062	0.456	0.192	9.42959189000448e-150	FDFT1	Malignant cells	GSE199333_post	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30675
5.34010464712389e-154	0.356254314693396	0.294	0.054	1.13375761763087e-149	ATP2B4	Malignant cells	GSE199333_post	ENSG00000058668	493	ATPase plasma membrane Ca2+ transporting 4	ATP2B2|MXRA1|PMCA4	protein_coding	P23634	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30676
6.65888720713652e-154	0.383017686397438	0.41	0.147	1.41374834294715e-149	MCTS1	Malignant cells	GSE199333_post	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30677
6.66650491161541e-154	0.462234019134513	0.592	0.314	1.41536565778507e-149	CD82	Malignant cells	GSE199333_post	ENSG00000085117	3732	CD82 molecule	IA4|KAI1|R2|ST6|TSPAN27	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30678
8.34389599098615e-154	-0.527457846525865	0.316	0.528	1.77149255784627e-149	RICTOR	Malignant cells	GSE199333_post	ENSG00000164327	253260	RPTOR independent companion of MTOR complex 2	AVO3|KIAA1999|MGC39830|PIA	protein_coding	Q6R327	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30679
1.20759372691692e-153	0.408389532653911	0.449	0.181	2.56384224161732e-149	MRPL4	Malignant cells	GSE199333_post	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30680
1.69274640745324e-153	-0.48066918166181	0.298	0.516	3.59386989766398e-149	KMT2C	Malignant cells	GSE199333_post	ENSG00000055609	58508	lysine methyltransferase 2C	HALR|KIAA1506|MLL3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30681
1.99617821470948e-153	0.385545707687437	0.381	0.123	4.2380859676497e-149	MRPL13	Malignant cells	GSE199333_post	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30682
2.55115580683172e-153	0.395233999189701	0.319	0.074	5.41635889348442e-149	PFKP	Malignant cells	GSE199333_post	ENSG00000067057	5214	phosphofructokinase, platelet	PFK-C|PFKF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30683
2.5677556920363e-153	0.378597219982138	0.381	0.123	5.45160210976228e-149	NUDCD2	Malignant cells	GSE199333_post	ENSG00000170584	134492	NudC domain containing 2	DKFZp686E10109|NudCL2	protein_coding	Q8WVJ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30684
3.29529828744366e-153	-0.5134393228056	0.19	0.397	6.99624779407163e-149	DMXL2	Malignant cells	GSE199333_post	ENSG00000104093	23312	Dmx like 2	DFNA71|KIAA0856|RC3	protein_coding	Q8TDJ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30685
3.51536615744551e-153	0.422065872108132	0.771	0.535	7.46347388887256e-149	DDT	Malignant cells	GSE199333_post	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30686
4.30274690072818e-153	-0.596719220548611	0.654	0.771	9.13516194493601e-149	BRI3	Malignant cells	GSE199333_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30687
6.30851103274656e-153	-0.365294492494377	0.178	0.383	1.33935997736242e-148	FBXO11	Malignant cells	GSE199333_post	ENSG00000138081	80204	F-box protein 11	FBX11|UBR6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30688
6.75515323503519e-153	0.476847868964421	0.643	0.384	1.43418658333032e-148	CCT2	Malignant cells	GSE199333_post	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30689
7.00755358909358e-153	0.392187609621045	0.357	0.102	1.48777370250046e-148	TRAF3IP3	Malignant cells	GSE199333_post	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30690
8.04284898939285e-153	-0.504079435887196	0.417	0.623	1.707577268938e-148	UBALD2	Malignant cells	GSE199333_post	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30691
1.29851116770252e-152	0.376303301865175	0.364	0.109	2.75686906014921e-148	MRPL15	Malignant cells	GSE199333_post	ENSG00000137547	29088	mitochondrial ribosomal protein L15	HSPC145|L15mt|MRP-L15|MRP-L7|RPML7	protein_coding	Q9P015	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30692
1.63837472561498e-152	-0.39904580769656	0.224	0.438	3.47843337995316e-148	USP7	Malignant cells	GSE199333_post	ENSG00000187555	7874	ubiquitin specific peptidase 7	HAUSP	protein_coding	Q93009	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30693
2.70805794508647e-152	0.410052708678465	0.353	0.101	5.74947782321308e-148	ZKSCAN1	Malignant cells	GSE199333_post	ENSG00000106261	7586	zinc finger with KRAB and SCAN domains 1	KOX18|PHZ-37|ZNF139|ZNF36|ZSCAN33	protein_coding	P17029	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30694
3.33752098695791e-152	0.398464324398059	0.456	0.189	7.08589080741033e-148	PPP6R1	Malignant cells	GSE199333_post	ENSG00000105063	22870	protein phosphatase 6 regulatory subunit 1	KIAA1115|SAP190|SAPS1	protein_coding	Q9UPN7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30695
3.98353401190797e-152	0.356517646428034	0.29	0.053	8.4574410606818e-148	MAGOHB	Malignant cells	GSE199333_post	ENSG00000111196	55110	mago homolog B, exon junction complex subunit	FLJ10292|MGN2	protein_coding	Q96A72	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30696
4.4130575720963e-152	0.358511488637422	0.315	0.072	9.36936253131765e-148	FMC1	Malignant cells	GSE199333_post	ENSG00000164898	154791	formation of mitochondrial complex V assembly factor 1 homolog	C7orf55|HSPC268	protein_coding	Q96HJ9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30697
4.81311790137695e-152	0.431669191185899	0.722	0.464	1.02187306164134e-147	LIMD2	Malignant cells	GSE199333_post	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30698
5.18117862949326e-152	0.389697729114542	0.37	0.115	1.10001603482771e-147	C19orf48	Malignant cells	GSE199333_post	ENSG00000167747	84798	multidrug resistance-related protein	BC006151|MGC13170	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30699
5.80352732187145e-152	0.363419456544815	0.34	0.091	1.23214688570653e-147	OXLD1	Malignant cells	GSE199333_post	ENSG00000204237	339229	oxidoreductase like domain containing 1	C17orf90|MGC104712	protein_coding	Q5BKU9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30700
7.80004438114824e-152	0.383330518626101	0.443	0.172	1.65602742256158e-147	EIF1AY	Malignant cells	GSE199333_post	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30701
9.36453095555633e-152	0.424713226014415	0.68	0.427	1.98818356717417e-147	NDUFB10	Malignant cells	GSE199333_post	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30702
1.07135345868755e-151	0.470844568963276	0.251	0.026	2.27459052813953e-147	HIST1H2BG	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30703
1.19970751090986e-151	0.379553531556302	0.405	0.146	2.54709901641273e-147	COPZ1	Malignant cells	GSE199333_post	ENSG00000111481	22818	COPI coat complex subunit zeta 1	CGI-120|COPZ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30704
1.41390678375034e-151	0.421034383282048	0.514	0.251	3.00186549258035e-147	COMMD7	Malignant cells	GSE199333_post	ENSG00000149600	149951	COMM domain containing 7	C20orf92|dJ1085F17.3	protein_coding	Q86VX2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30705
1.5802919176864e-151	0.427838917540452	0.739	0.508	3.35511777044e-147	COX7A2L	Malignant cells	GSE199333_post	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30706
2.7237024051449e-151	0.360811782918661	0.305	0.064	5.78269257636315e-147	EMG1	Malignant cells	GSE199333_post	ENSG00000126749	10436	EMG1 N1-specific pseudouridine methyltransferase	C2F|Grcc2f|NEP1	protein_coding	Q92979	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30707
3.17257754439377e-151	0.484966799383792	0.641	0.389	6.73569938450241e-147	PHPT1	Malignant cells	GSE199333_post	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30708
4.01951255341293e-151	0.390738617568345	0.447	0.18	8.53382710215099e-147	TMED3	Malignant cells	GSE199333_post	ENSG00000166557	23423	transmembrane p24 trafficking protein 3	C15orf22|p24B|p24g4|p24gamma4	protein_coding	Q9Y3Q3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30709
5.6308453772837e-151	-0.458909079349056	0.099	0.265	1.1954847820511e-146	FAM49A	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30710
7.05323396901561e-151	0.386892250379704	0.921	0.796	1.4974721039617e-146	SUMO2	Malignant cells	GSE199333_post	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30711
9.50108981302725e-151	0.375910975424723	0.389	0.131	2.01717637820382e-146	ARHGAP15	Malignant cells	GSE199333_post	ENSG00000075884	55843	Rho GTPase activating protein 15	BM046	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30712
1.28538794447915e-150	0.334682910807954	0.253	0.028	2.72900714492368e-146	TSPAN13	Malignant cells	GSE199333_post	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30713
1.33183377961886e-150	0.534654776244065	0.549	0.289	2.8276162975088e-146	FYB1	Malignant cells	GSE199333_post	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30714
1.47989881872213e-150	-0.41193921659395	0.282	0.504	3.14197318202896e-146	GABARAP	Malignant cells	GSE199333_post	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30715
3.10243692051467e-150	0.385117263207388	0.462	0.196	6.5867838259447e-146	PDCD2	Malignant cells	GSE199333_post	ENSG00000071994	5134	programmed cell death 2	RP8|ZMYND7	protein_coding	Q16342	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30716
3.10833883740476e-150	0.394810129814119	0.979	0.945	6.59931418569406e-146	CHCHD2	Malignant cells	GSE199333_post	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30717
3.40201193727339e-150	0.398531919751064	0.444	0.182	7.22281154402513e-146	C19orf24	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30718
4.28304292127062e-150	0.391827386216651	0.403	0.146	9.09332842614965e-146	CAPN1	Malignant cells	GSE199333_post	ENSG00000014216	823	calpain 1	CANP|CANPL1|muCANP|muCL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30719
5.27925230355335e-150	-0.432322886844634	0.207	0.412	1.12083805656741e-145	BIRC2	Malignant cells	GSE199333_post	ENSG00000110330	329	baculoviral IAP repeat containing 2	API1|c-IAP1|cIAP1|hiap-2|MIHB|RNF48	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30720
7.2821741379038e-150	0.4079169578482	0.5	0.238	1.54607839121836e-145	COPS6	Malignant cells	GSE199333_post	ENSG00000168090	10980	COP9 signalosome subunit 6	CSN6|MOV34-34KD	protein_coding	Q7L5N1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30721
1.38846128569828e-149	0.422818115516571	0.559	0.297	2.94784215566603e-145	C19orf70	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30722
3.62728635058681e-149	-0.529696728221852	0.701	0.874	7.70109165093086e-145	HSPA5	Malignant cells	GSE199333_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30723
4.2272762906296e-149	0.363078978366038	0.328	0.084	8.97493029263571e-145	PM20D2	Malignant cells	GSE199333_post	ENSG00000146281	135293	peptidase M20 domain containing 2	ACY1L2|bA63L7.3	protein_coding	Q8IYS1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30724
8.32505907655075e-149	0.487341762378462	0.573	0.321	1.76749329254249e-144	BAX	Malignant cells	GSE199333_post	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30725
1.220440200542e-148	0.40762269435501	0.557	0.287	2.59111658977072e-144	RALBP1	Malignant cells	GSE199333_post	ENSG00000017797	10928	ralA binding protein 1	RIP|RIP1|RLIP76	protein_coding	Q15311	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30726
2.97552251769166e-148	-0.409750054575338	0.213	0.421	6.31733185731117e-144	SBDS	Malignant cells	GSE199333_post	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30727
7.39203195318748e-148	0.413271761381859	0.59	0.329	1.56940230398123e-143	PSMB7	Malignant cells	GSE199333_post	ENSG00000136930	5695	proteasome 20S subunit beta 7	Z	protein_coding	Q99436	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30728
8.30894840691181e-148	0.363774551749121	0.345	0.098	1.76407283627145e-143	CDCA7L	Malignant cells	GSE199333_post	ENSG00000164649	55536	cell division cycle associated 7 like	JPO2|R1|RAM2	protein_coding	Q96GN5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30729
1.04214655916935e-147	0.390796517424661	0.359	0.11	2.21258135977244e-143	ORAI1	Malignant cells	GSE199333_post	ENSG00000276045	84876	ORAI calcium release-activated calcium modulator 1	CRACM1|FLJ14466|TMEM142A	protein_coding	Q96D31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30730
2.35874270482793e-147	0.588179585974695	0.436	0.166	5.00784663662017e-143	NPW	Malignant cells	GSE199333_post	ENSG00000183971	283869	neuropeptide W	PPL8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30731
2.92290482768556e-147	-0.387035391271254	0.214	0.425	6.20561923965922e-143	UBXN7	Malignant cells	GSE199333_post	ENSG00000163960	26043	UBX domain protein 7	KIAA0794|UBXD7	protein_coding	O94888	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30732
2.96810847664503e-147	-0.857279551626004	0.496	0.656	6.30159110676507e-143	RFLNB	Malignant cells	GSE199333_post	ENSG00000283979	359845	refilin B	Cfm1|FAM101B|MGC45871|RefilinB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30733
3.25417750860553e-147	-0.373231987049126	0.158	0.353	6.9089442685204e-143	WDFY1	Malignant cells	GSE199333_post	ENSG00000085449	57590	WD repeat and FYVE domain containing 1	FENS-1|KIAA1435|WDF1|ZFYVE17	protein_coding	Q8IWB7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30734
3.56348955441575e-147	-0.938403672685829	0.496	0.629	7.56564467298008e-143	CTSS	Malignant cells	GSE199333_post	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30735
4.69243974166639e-147	0.321482620755872	0.998	0.997	9.96251881553191e-143	RPS16	Malignant cells	GSE199333_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30736
8.44877691774055e-147	0.337311665349318	0.287	0.055	1.7937598274055e-142	ST3GAL4	Malignant cells	GSE199333_post	ENSG00000110080	6484	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	CGS23|FLJ11867|NANTA3|SAT3|SIAT4|SIAT4C|STZ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30737
2.10478028146625e-146	0.728805168753875	0.887	0.821	4.468659015581e-142	TAGLN2	Malignant cells	GSE199333_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30738
2.95347608440672e-146	0.404230532267721	0.633	0.371	6.2705250748039e-142	AP2M1	Malignant cells	GSE199333_post	ENSG00000161203	1173	adaptor related protein complex 2 subunit mu 1	AP50|CLAPM1|mu2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30739
3.65428745963704e-146	-0.417159100568281	0.257	0.472	7.7584177055554e-142	PPP4R3A	Malignant cells	GSE199333_post	ENSG00000100796	55671	protein phosphatase 4 regulatory subunit 3A	FLFL1|FLJ20707|KIAA2010|MSTP033|PP4R3|SMEK1|smk-1|smk1	protein_coding	Q6IN85	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30740
5.0283977675184e-146	-0.350404759270784	0.187	0.391	1.06757913002183e-141	DCTN4	Malignant cells	GSE199333_post	ENSG00000132912	51164	dynactin subunit 4	Dyn4|p62	protein_coding	Q9UJW0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30741
9.1490984332784e-146	0.365286251534789	0.303	0.068	1.94244508836934e-141	SPOP	Malignant cells	GSE199333_post	ENSG00000121067	8405	speckle type BTB/POZ protein	BTBD32|TEF2	protein_coding	O43791	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30742
1.89158281742729e-145	0.261438138286871	1	1	4.01601947967987e-141	PTMA	Malignant cells	GSE199333_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30743
3.05935768047283e-145	0.345572781646817	0.308	0.073	6.49532229141188e-141	ECHDC1	Malignant cells	GSE199333_post	ENSG00000093144	55862	ethylmalonyl-CoA decarboxylase 1	dJ351K20.2	protein_coding	Q9NTX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30744
4.4078053803808e-145	0.394566981485051	0.408	0.154	9.35821160308647e-141	HSPB11	Malignant cells	GSE199333_post	ENSG00000081870	51668	heat shock protein family B (small) member 11	C1orf41|FAP232|HSPCO34|IFT25|PP25	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30745
5.47907165059334e-145	0.370752927232994	0.402	0.146	1.16326170213747e-140	LAGE3	Malignant cells	GSE199333_post	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30746
5.65278210568586e-145	0.384004852361624	0.357	0.111	1.20014216885817e-140	UBTF	Malignant cells	GSE199333_post	ENSG00000108312	7343	upstream binding transcription factor	NOR-90|UBF|UBF1|UBF2	protein_coding	P17480	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30747
6.18145900532005e-145	-0.812652266158779	0.849	0.886	1.3123855614195e-140	S100A6	Malignant cells	GSE199333_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30748
6.41602225967318e-145	0.305474378540445	1	0.999	1.36218568595121e-140	MT-CO1	Malignant cells	GSE199333_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30749
6.83383317713999e-145	0.352914018652899	0.25	0.031	1.45089112183859e-140	GUCY1A1	Malignant cells	GSE199333_post	ENSG00000164116	2982	guanylate cyclase 1 soluble subunit alpha 1	GC-SA3|GUC1A3|GUCY1A3	protein_coding	Q02108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30750
8.04477082486068e-145	0.408768088789895	0.555	0.292	1.70798529382617e-140	LGALS9	Malignant cells	GSE199333_post	ENSG00000168961	3965	galectin 9	LGALS9A	protein_coding	O00182	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30751
9.02058815111123e-145	0.378297310445189	0.467	0.207	1.91516107036242e-140	POLR2G	Malignant cells	GSE199333_post	ENSG00000168002	5436	RNA polymerase II subunit G	hRPB19|hsRPB7|RPB7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30752
1.68769532917123e-144	0.365177059474458	0.363	0.114	3.58314595336343e-140	UBE2V2	Malignant cells	GSE199333_post	ENSG00000169139	7336	ubiquitin conjugating enzyme E2 V2	DDVit-1|DDVIT1|EDAF-1|EDPF-1|EDPF1|MMS2|UEV-2|UEV2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30753
1.78181703583224e-144	-0.373039405274003	0.127	0.306	3.78297574877543e-140	SH2B3	Malignant cells	GSE199333_post	ENSG00000111252	10019	SH2B adaptor protein 3	IDDM20|LNK	protein_coding	Q9UQQ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30754
2.18554083698794e-144	0.373935117836045	0.402	0.148	4.64012175100909e-140	MRPL37	Malignant cells	GSE199333_post	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30755
2.19217123408903e-144	0.325477452161244	0.256	0.035	4.65419874709442e-140	ING4	Malignant cells	GSE199333_post	ENSG00000111653	51147	inhibitor of growth family member 4	my036|p29ING4	protein_coding	Q9UNL4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30756
2.26643645325412e-144	-0.647768092272059	0.305	0.502	4.81187123390382e-140	CTSB	Malignant cells	GSE199333_post	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30757
3.09447024165873e-144	0.376747223384238	0.446	0.183	6.56986977006565e-140	DGKZ	Malignant cells	GSE199333_post	ENSG00000149091	8525	diacylglycerol kinase zeta	DAGK5|DAGK6|DGK-ZETA|hDGKzeta	protein_coding	Q13574	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30758
4.74967094496242e-144	0.40872746708478	0.448	0.193	1.00840263832497e-139	RAB34	Malignant cells	GSE199333_post	ENSG00000109113	83871	RAB34, member RAS oncogene family	NARR|RAB39|RAH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30759
5.33940020597534e-144	-0.317265651932824	0.133	0.318	1.13360805773062e-139	VAMP3	Malignant cells	GSE199333_post	ENSG00000049245	9341	vesicle associated membrane protein 3	CEB	protein_coding	Q15836	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30760
9.51980423903584e-144	-0.295835783432854	0.115	0.291	2.0211496379897e-139	ZRANB1	Malignant cells	GSE199333_post	ENSG00000019995	54764	zinc finger RANBP2-type containing 1	TRABID	protein_coding	Q9UGI0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30761
1.07607407403492e-143	0.434852654008324	0.551	0.291	2.28461286658354e-139	GTF2I	Malignant cells	GSE199333_post	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30762
1.19984577223535e-143	-0.350508294273251	0.162	0.358	2.54739255903286e-139	HBP1	Malignant cells	GSE199333_post	ENSG00000283847	26959	HMG-box transcription factor 1	NA	protein_coding	O60381	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30763
1.27749786235999e-143	-0.501544441434264	0.13	0.308	2.7122557115765e-139	CDC42EP3	Malignant cells	GSE199333_post	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30764
1.38497409673376e-143	0.405443372956649	0.791	0.574	2.94043850477544e-139	PRR13	Malignant cells	GSE199333_post	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30765
3.28337504472751e-143	0.344539106480448	0.314	0.077	6.97093355746098e-139	HADH	Malignant cells	GSE199333_post	ENSG00000138796	3033	hydroxyacyl-CoA dehydrogenase	HADH1|HADHSC|SCHAD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30766
5.73605871684265e-143	-0.42222757536271	0.193	0.398	1.21782262617286e-138	MDM2	Malignant cells	GSE199333_post	ENSG00000135679	4193	MDM2 proto-oncogene	HDM2|MGC5370	protein_coding	Q00987	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30767
6.90545002523572e-143	0.401554239378456	0.292	0.061	1.4660960948578e-138	SMC2	Malignant cells	GSE199333_post	ENSG00000136824	10592	structural maintenance of chromosomes 2	CAP-E|hCAP-E|SMC2L1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30768
8.95600441275583e-143	0.329506263170134	0.278	0.051	1.90144929687219e-138	PYCR2	Malignant cells	GSE199333_post	ENSG00000143811	29920	pyrroline-5-carboxylate reductase 2	P5CR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30769
1.00172856463224e-142	0.351141946942761	0.317	0.081	2.12676991557072e-138	ISOC2	Malignant cells	GSE199333_post	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30770
1.41289829583643e-142	0.34602289710184	0.342	0.1	2.99972437189032e-138	THYN1	Malignant cells	GSE199333_post	ENSG00000151500	29087	thymocyte nuclear protein 1	THY28	protein_coding	Q9P016	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30771
3.77206246927474e-142	0.348301770619759	0.326	0.088	8.0084658285172e-138	MRPS18B	Malignant cells	GSE199333_post	ENSG00000233813	28973	mitochondrial ribosomal protein S18B	C6orf14|HSPC183|MRPS18-2|PTD017	protein_coding	Q9Y676	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30772
5.14758481571099e-142	-0.383926770147878	0.195	0.396	1.0928837322236e-137	ARIH1	Malignant cells	GSE199333_post	ENSG00000166233	25820	ariadne RBR E3 ubiquitin protein ligase 1	ARI|HARI|HHARI|UBCH7BP	protein_coding	Q9Y4X5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30773
5.60382224709483e-142	-0.393314362405728	0.101	0.266	1.1897475012807e-137	PLEC	Malignant cells	GSE199333_post	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30774
1.4232202746092e-141	0.38339734093641	0.446	0.191	3.02163896502278e-137	MRPL16	Malignant cells	GSE199333_post	ENSG00000166902	54948	mitochondrial ribosomal protein L16	FLJ20484|PNAS-111	protein_coding	Q9NX20	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30775
4.94777670600463e-141	0.350372113244019	0.31	0.077	1.05046247245184e-136	ACAT1	Malignant cells	GSE199333_post	ENSG00000075239	38	acetyl-CoA acetyltransferase 1	ACAT|THIL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30776
5.80156027399674e-141	0.337474332594478	0.317	0.081	1.23172926177225e-136	GPX7	Malignant cells	GSE199333_post	ENSG00000116157	2882	glutathione peroxidase 7	FLJ14777|GPX6|NPGPx	protein_coding	Q96SL4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30777
1.23887996820805e-140	0.338570132899794	0.306	0.074	2.63026606050251e-136	WASHC3	Malignant cells	GSE199333_post	ENSG00000120860	51019	WASH complex subunit 3	CCDC53|CGI-116	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30778
1.34014104577599e-140	-0.377680211769737	0.186	0.393	2.845253454287e-136	FCGRT	Malignant cells	GSE199333_post	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30779
2.13518163610711e-140	-0.383646275507281	0.238	0.447	4.53320413161902e-136	SAR1A	Malignant cells	GSE199333_post	ENSG00000079332	56681	secretion associated Ras related GTPase 1A	SAR1|Sara|SARA1	protein_coding	Q9NR31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30780
2.59546821955374e-140	0.378997529931281	0.408	0.159	5.51043857693454e-136	AHCY	Malignant cells	GSE199333_post	ENSG00000101444	191	adenosylhomocysteinase	AdoHcyase|SAHH	protein_coding	P23526	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30781
2.93330106236852e-140	0.395706851882538	0.575	0.318	6.22769148551462e-136	M6PR	Malignant cells	GSE199333_post	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30782
3.72682202696939e-140	-0.442152108963698	0.217	0.416	7.9124158454587e-136	RIPK2	Malignant cells	GSE199333_post	ENSG00000104312	8767	receptor interacting serine/threonine kinase 2	CARD3|CARDIAK|RICK|RIP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30783
5.00964522869238e-140	0.356486422624109	0.999	0.999	1.06359777850368e-135	RPS12	Malignant cells	GSE199333_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30784
6.86315346983275e-140	-0.493234945870312	0.84	0.911	1.45711611318019e-135	HNRNPDL	Malignant cells	GSE199333_post	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30785
7.44550198242753e-140	-0.392172533709412	0.201	0.402	1.58075452588919e-135	HGS	Malignant cells	GSE199333_post	ENSG00000185359	9146	hepatocyte growth factor-regulated tyrosine kinase substrate	Hrs|Vps27|ZFYVE8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30786
8.18485270444756e-140	0.405085814850188	0.585	0.33	1.73772607768126e-135	PSMB2	Malignant cells	GSE199333_post	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30787
1.5825101920872e-139	-0.60277575542521	0.363	0.545	3.35982738882033e-135	PRPF4B	Malignant cells	GSE199333_post	ENSG00000112739	8899	pre-mRNA processing factor 4B	KIAA0536|PR4H|Prp4	protein_coding	Q13523	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30788
1.89861515785885e-139	-0.306168122955906	0.126	0.306	4.03094984165012e-135	WHAMM	Malignant cells	GSE199333_post	ENSG00000156232	123720	WASP homolog associated with actin, golgi membranes and microtubules	KIAA1971|WHAMM1|WHDC1	protein_coding	Q8TF30	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30789
2.07303607091535e-139	-0.292404568427964	0.112	0.284	4.40126288216038e-135	COQ10B	Malignant cells	GSE199333_post	ENSG00000115520	80219	coenzyme Q10B	FLJ13448	protein_coding	Q9H8M1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30790
3.06616256248938e-139	0.337166715164155	1	0.999	6.50976973642119e-135	MT-CYB	Malignant cells	GSE199333_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30791
3.82538539164076e-139	0.390617591942072	0.322	0.087	8.1216757249925e-135	METTL7A	Malignant cells	GSE199333_post	ENSG00000185432	25840	methyltransferase like 7A	DKFZP586A0522	protein_coding	Q9H8H3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30792
4.5625654859438e-139	0.357842569294462	0.369	0.125	9.68678278320728e-135	GTF2H5	Malignant cells	GSE199333_post	ENSG00000272047	404672	general transcription factor IIH subunit 5	bA120J8.2|C6orf175|FLJ30544|TFB5|TFIIH|TTD|TTD-A|TTDA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30793
5.51617026196273e-139	0.348498883253316	0.313	0.081	1.17113810831731e-134	VGLL4	Malignant cells	GSE199333_post	ENSG00000144560	9686	vestigial like family member 4	KIAA0121	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30794
6.84638621122908e-139	-0.392950168222194	0.174	0.367	1.45355625650605e-134	STK17A	Malignant cells	GSE199333_post	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30795
7.42208873003223e-139	0.369800968315842	0.323	0.091	1.57578365827314e-134	NPM3	Malignant cells	GSE199333_post	ENSG00000107833	10360	nucleophosmin/nucleoplasmin 3	NA	protein_coding	O75607	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30796
9.2090210501834e-139	0.354158740332473	0.372	0.126	1.95516725916444e-134	PDHA1	Malignant cells	GSE199333_post	ENSG00000131828	5160	pyruvate dehydrogenase E1 subunit alpha 1	E1alpha|PDHA	protein_coding	P08559	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30797
2.29770649719011e-138	0.38688530573912	0.882	0.745	4.87826066418432e-134	GPX4	Malignant cells	GSE199333_post	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30798
3.95902378402786e-138	-0.415352438392604	0.287	0.494	8.40540339586954e-134	PPP4R2	Malignant cells	GSE199333_post	ENSG00000163605	151987	protein phosphatase 4 regulatory subunit 2	NA	protein_coding	Q9NY27	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30799
4.03386849050525e-138	0.419043163262628	0.743	0.529	8.5643061921917e-134	ENY2	Malignant cells	GSE199333_post	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30800
4.62447222880522e-138	0.400242302252008	0.301	0.072	9.81821698897637e-134	DTYMK	Malignant cells	GSE199333_post	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30801
4.89899518491312e-138	0.395847533432241	0.751	0.525	1.0401056677089e-133	PGLS	Malignant cells	GSE199333_post	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30802
5.05952495708368e-138	0.324429848558205	0.276	0.054	1.07418774363844e-133	TRIM27	Malignant cells	GSE199333_post	ENSG00000234495	5987	tripartite motif containing 27	RFP|RNF76	protein_coding	P14373	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30803
5.32536478569706e-138	0.319903469484366	0.272	0.051	1.13062819765134e-133	ARRB1	Malignant cells	GSE199333_post	ENSG00000137486	408	arrestin beta 1	ARR1	protein_coding	P49407	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30804
7.41513961935711e-138	0.350970218244959	0.387	0.139	1.57430829258571e-133	BTK	Malignant cells	GSE199333_post	ENSG00000010671	695	Bruton tyrosine kinase	AGMX1|ATK|IMD1|PSCTK1|XLA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30805
2.0861931218874e-137	-0.662608631791054	0.506	0.675	4.42919661707915e-133	ZFAND5	Malignant cells	GSE199333_post	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30806
2.33780806469025e-137	0.380800438451348	0.46	0.207	4.96340030214386e-133	PIN1	Malignant cells	GSE199333_post	ENSG00000127445	5300	peptidylprolyl cis/trans isomerase, NIMA-interacting 1	dod	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30807
2.85349144490994e-137	0.420757453944466	0.559	0.317	6.05824768668829e-133	SSU72	Malignant cells	GSE199333_post	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30808
3.27288371038613e-137	0.389348856241342	0.617	0.366	6.94865940552079e-133	SNRPC	Malignant cells	GSE199333_post	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30809
3.74879274765817e-137	-0.430074232084814	0.335	0.539	7.95906188255305e-133	MAPK1IP1L	Malignant cells	GSE199333_post	ENSG00000168175	93487	mitogen-activated protein kinase 1 interacting protein 1 like	C14orf32	protein_coding	Q8NDC0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30810
4.07358112169637e-137	0.381463809015421	0.422	0.174	8.64862007947356e-133	APBB1IP	Malignant cells	GSE199333_post	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30811
4.85366994030515e-137	0.393336692274321	0.61	0.357	1.03048266502619e-132	RBX1	Malignant cells	GSE199333_post	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30812
7.04420381394974e-137	0.378321223376443	0.397	0.15	1.49555491173967e-132	NDUFB6	Malignant cells	GSE199333_post	ENSG00000165264	4712	NADH:ubiquinone oxidoreductase subunit B6	B17|CI	protein_coding	O95139	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30813
9.51926250061547e-137	0.345780641111451	0.337	0.101	2.02103462150567e-132	PIGP	Malignant cells	GSE199333_post	ENSG00000185808	51227	phosphatidylinositol glycan anchor biosynthesis class P	DCRC|DSCR5|DSRC	protein_coding	P57054	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30814
9.56711201546271e-137	0.351687285816329	0.271	0.053	2.03119355200289e-132	MRPL17	Malignant cells	GSE199333_post	ENSG00000158042	63875	mitochondrial ribosomal protein L17	MRP-L26|RPML26	protein_coding	Q9NRX2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30815
1.240312582381e-136	0.380265780713376	0.421	0.168	2.63330764365309e-132	ATP8B4	Malignant cells	GSE199333_post	ENSG00000104043	79895	ATPase phospholipid transporting 8B4 (putative)	ATPIM|KIAA1939	protein_coding	Q8TF62	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30816
1.37455945412003e-136	0.379453793713025	0.431	0.182	2.91832717704224e-132	SNX5	Malignant cells	GSE199333_post	ENSG00000089006	27131	sorting nexin 5	NA	protein_coding	Q9Y5X3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30817
1.70366816239397e-136	0.327278078113433	0.314	0.083	3.61705787557863e-132	JAGN1	Malignant cells	GSE199333_post	ENSG00000171135	84522	jagunal homolog 1	FLJ14602|GL009	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30818
1.87723188796278e-136	0.33986619112327	0.269	0.051	3.98555102133379e-132	BTN3A2	Malignant cells	GSE199333_post	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30819
2.87072477337763e-136	-0.387290458742797	0.235	0.442	6.09483576635804e-132	RBM33	Malignant cells	GSE199333_post	ENSG00000184863	155435	RNA binding motif protein 33	DKFZp434D1319|DKFZp686F102|MGC20460|PRR8	protein_coding	Q96EV2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30820
3.06934775182286e-136	-0.273611207049312	0.101	0.266	6.51653221189512e-132	MAP3K20	Malignant cells	GSE199333_post	ENSG00000091436	51776	mitogen-activated protein kinase kinase kinase 20	MLK7|MLTK|MLTKalpha|MLTKbeta|MRK|ZAK	protein_coding	Q9NYL2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30821
4.97817955370257e-136	0.259446256100119	0.483	0.21	1.05691730104659e-131	PMAIP1	Malignant cells	GSE199333_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30822
5.66255194149442e-136	0.440223395227873	0.83	0.665	1.20221640269868e-131	HMGA1	Malignant cells	GSE199333_post	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30823
1.15579519761988e-135	0.389598684237386	0.284	0.062	2.45386878406678e-131	ZMAT3	Malignant cells	GSE199333_post	ENSG00000172667	64393	zinc finger matrin-type 3	FLJ12296|MGC10613|PAG608|WIG-1|WIG1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30824
2.1164343715467e-135	0.308613242950286	0.259	0.044	4.4934018142308e-131	ECI2	Malignant cells	GSE199333_post	ENSG00000198721	10455	enoyl-CoA delta isomerase 2	ACBD2|DRS1|HCA88|PECI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30825
3.83799386004748e-135	-0.329467647701038	0.151	0.336	8.14844476426681e-131	PCGF5	Malignant cells	GSE199333_post	ENSG00000180628	84333	polycomb group ring finger 5	MGC16202|RNF159	protein_coding	Q86SE9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30826
7.19565652402533e-135	0.335748020772823	0.311	0.082	1.52770983661582e-130	C11orf1	Malignant cells	GSE199333_post	ENSG00000137720	64776	chromosome 11 open reading frame 1	FLJ23499	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30827
7.99662214392653e-135	0.32700671576025	0.291	0.067	1.69776284737704e-130	COPB2	Malignant cells	GSE199333_post	ENSG00000184432	9276	COPI coat complex subunit beta 2	beta'-COP|betaprime-COP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30828
8.83308532864708e-135	0.38148339015275	0.285	0.06	1.87535234612506e-130	PHGDH	Malignant cells	GSE199333_post	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30829
1.14548049833641e-134	0.32296746038091	0.316	0.085	2.43196964601804e-130	DPY30	Malignant cells	GSE199333_post	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30830
1.94995986329807e-134	0.327479502173638	0.287	0.065	4.13995978576813e-130	EXOSC5	Malignant cells	GSE199333_post	ENSG00000077348	56915	exosome component 5	hRrp46p|MGC12901|p12B|RRP41B|RRP46|Rrp46p	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30831
2.11402277324521e-134	0.336672007885231	0.34	0.107	4.4882817498769e-130	FAM96A	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30832
2.94270959844894e-134	0.391966022720462	0.267	0.05	6.24766674846694e-130	AL031777.3	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30833
4.98836818722138e-134	0.345611692022272	0.294	0.069	1.05908044982897e-129	ILK	Malignant cells	GSE199333_post	ENSG00000166333	3611	integrin linked kinase	NA	protein_coding	Q13418	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30834
9.38393874769956e-134	0.331435015612847	0.981	0.917	1.99230403552409e-129	GNAS	Malignant cells	GSE199333_post	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30835
7.06629240134596e-133	0.364172561429696	0.428	0.181	1.50024453972976e-128	MPST	Malignant cells	GSE199333_post	ENSG00000128309	4357	mercaptopyruvate sulfurtransferase	MST|TST2|TUM1	protein_coding	P25325	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30836
9.28977133269322e-133	-0.555894785283078	0.459	0.632	1.9723113516441e-128	SDCBP	Malignant cells	GSE199333_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30837
9.41512610257207e-133	0.366554466126487	0.477	0.226	1.99892542283708e-128	SSNA1	Malignant cells	GSE199333_post	ENSG00000176101	8636	SS nuclear autoantigen 1	N14|NA14	protein_coding	O43805	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30838
2.04416351834175e-132	-0.445237858160351	0.252	0.449	4.33996356579136e-128	SSFA2	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30839
2.17475897481335e-132	0.328469736141592	0.326	0.096	4.61723077942622e-128	METTL23	Malignant cells	GSE199333_post	ENSG00000181038	124512	methyltransferase like 23	C17orf95|LOC124512	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30840
2.19162033496935e-132	0.341627946841702	0.317	0.091	4.65302913317343e-128	YIF1A	Malignant cells	GSE199333_post	ENSG00000174851	10897	Yip1 interacting factor homolog A, membrane trafficking protein	54TM|FinGER7|YIF1|YIF1P	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30841
2.61315507053061e-132	0.3712742979725	0.404	0.165	5.54798953024354e-128	CEP57	Malignant cells	GSE199333_post	ENSG00000166037	9702	centrosomal protein 57	KIAA0092|Translokin|TSP57	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30842
3.4369730990759e-132	0.361820347717304	0.365	0.13	7.29703758664805e-128	ECI1	Malignant cells	GSE199333_post	ENSG00000167969	1632	enoyl-CoA delta isomerase 1	DCI	protein_coding	P42126	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30843
6.74947700247544e-132	-0.479067047945505	0.775	0.855	1.43298146239556e-127	SEC61B	Malignant cells	GSE199333_post	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30844
7.66496522631894e-132	0.414558767642358	0.474	0.226	1.62734876719977e-127	ACTN1	Malignant cells	GSE199333_post	ENSG00000072110	87	actinin alpha 1	NA	protein_coding	P12814	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30845
7.994651401244e-132	0.326773360039522	0.321	0.093	1.69734443899811e-127	PIN4	Malignant cells	GSE199333_post	ENSG00000102309	5303	peptidylprolyl cis/trans isomerase, NIMA-interacting 4	EPVH|PAR14|PAR17	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30846
1.44945576216203e-131	0.392029606966306	0.565	0.317	3.0773395286462e-127	SRP9	Malignant cells	GSE199333_post	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30847
1.54632342020518e-131	-0.416070549513564	0.229	0.424	3.28299925343761e-127	TANK	Malignant cells	GSE199333_post	ENSG00000136560	10010	TRAF family member associated NFKB activator	I-TRAF|TRAF2	protein_coding	Q92844	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30848
1.67455679131942e-131	0.371702421402259	0.375	0.139	3.55525152365025e-127	PLEKHJ1	Malignant cells	GSE199333_post	ENSG00000104886	55111	pleckstrin homology domain containing J1	FLJ10297	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30849
3.88486430948918e-131	0.301775507429097	0.999	0.997	8.24795541547648e-127	RPL26	Malignant cells	GSE199333_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30850
4.2142538435289e-131	0.395367867340369	0.584	0.343	8.9472823351962e-127	TXNL4A	Malignant cells	GSE199333_post	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30851
5.45653114044321e-131	0.322493528710957	0.259	0.048	1.1584761264275e-126	TRIM14	Malignant cells	GSE199333_post	ENSG00000106785	9830	tripartite motif containing 14	KIAA0129	protein_coding	Q14142	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30852
5.5069338389359e-131	-0.472208444942149	0.385	0.574	1.16917712334448e-126	CLK1	Malignant cells	GSE199333_post	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30853
7.93196820379853e-131	0.378853861290473	0.981	0.934	1.68403616934847e-126	MYL6	Malignant cells	GSE199333_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30854
2.10455190350945e-130	-0.430120327797656	0.594	0.75	4.46817414634092e-126	PAIP2	Malignant cells	GSE199333_post	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30855
2.76351358029676e-130	0.396031386826279	0.404	0.165	5.86721568232805e-126	SSRP1	Malignant cells	GSE199333_post	ENSG00000149136	6749	structure specific recognition protein 1	FACT80	protein_coding	Q08945	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30856
3.011918473086e-130	0.3351794084511	0.346	0.113	6.39460411020889e-126	TMC8	Malignant cells	GSE199333_post	ENSG00000167895	147138	transmembrane channel like 8	EVER2|EVIN2	protein_coding	Q8IU68	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30857
3.12689915682572e-130	-0.608675100937197	0.292	0.485	6.63871959985668e-126	KLF10	Malignant cells	GSE199333_post	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30858
4.27110409697384e-130	0.356953014242452	0.401	0.16	9.06798110828516e-126	NIT2	Malignant cells	GSE199333_post	ENSG00000114021	56954	nitrilase family member 2	NA	protein_coding	Q9NQR4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30859
5.09497758415101e-130	0.347050216258033	0.383	0.145	1.0817146908911e-125	CHMP5	Malignant cells	GSE199333_post	ENSG00000086065	51510	charged multivesicular body protein 5	C9orf83|CGI-34|HSPC177|SNF7DC2|Vps60	protein_coding	Q9NZZ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30860
7.07589836590254e-130	0.388687945400819	0.583	0.34	1.50228398206477e-125	RALY	Malignant cells	GSE199333_post	ENSG00000125970	22913	RALY heterogeneous nuclear ribonucleoprotein	HNRPCL2|P542	protein_coding	Q9UKM9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30861
7.1637410775267e-130	0.381224619657332	0.589	0.338	1.52093386816969e-125	PYURF	Malignant cells	GSE199333_post	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30862
9.86244795060041e-130	0.373116319841354	0.435	0.19	2.09389632439197e-125	ELMO1	Malignant cells	GSE199333_post	ENSG00000155849	9844	engulfment and cell motility 1	CED-12|CED12|ELMO-1|KIAA0281	protein_coding	Q92556	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30863
1.11186814019074e-129	-0.463686072370169	0.186	0.374	2.36060724843896e-125	TRIB1	Malignant cells	GSE199333_post	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30864
1.64343653495179e-129	0.364752151779165	0.877	0.731	3.48918010735614e-125	ATP5F1D	Malignant cells	GSE199333_post	ENSG00000099624	513	ATP synthase F1 subunit delta	ATP5D	protein_coding	P30049	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30865
2.06395562798596e-129	-0.599282236973912	0.339	0.514	4.38198419377699e-125	HIPK1	Malignant cells	GSE199333_post	ENSG00000163349	204851	homeodomain interacting protein kinase 1	KIAA0630|MGC26642|MGC33446|MGC33548|Myak|Nbak2	protein_coding	Q86Z02	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30866
2.3667886194207e-129	0.326910731954011	0.327	0.098	5.02492891789209e-125	TCEAL8	Malignant cells	GSE199333_post	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30867
2.66792726194077e-129	0.344494803494658	0.322	0.096	5.66427636982646e-125	MRTO4	Malignant cells	GSE199333_post	ENSG00000053372	51154	MRT4 homolog, ribosome maturation factor	C1orf33|dJ657E11.4|MRT4	protein_coding	Q9UKD2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30868
3.28915078440982e-129	0.340564791949528	0.388	0.15	6.98319603038049e-125	ARRDC1	Malignant cells	GSE199333_post	ENSG00000197070	92714	arrestin domain containing 1	MGC40555	protein_coding	Q8N5I2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30869
4.26554858783275e-129	0.335385121430469	0.349	0.117	9.05618620682771e-125	MRPL1	Malignant cells	GSE199333_post	ENSG00000169288	65008	mitochondrial ribosomal protein L1	BM022	protein_coding	Q9BYD6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30870
4.61795144315279e-129	0.368246543456371	0.456	0.216	9.8043727089577e-125	FIBP	Malignant cells	GSE199333_post	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30871
4.62673175599232e-129	-0.561546628992214	0.801	0.868	9.82301419114729e-125	HNRNPH1	Malignant cells	GSE199333_post	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30872
6.21420552936644e-129	0.324762909721793	0.323	0.096	1.31933797593979e-124	GMPR2	Malignant cells	GSE199333_post	ENSG00000284752	51292	guanosine monophosphate reductase 2	NA	protein_coding	Q9P2T1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30873
6.50171032923035e-129	-0.608920801765485	0.344	0.52	1.3803781199989e-124	MAP2K3	Malignant cells	GSE199333_post	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30874
8.0211640888598e-129	0.35488289764685	0.406	0.167	1.70297334770583e-124	COPS5	Malignant cells	GSE199333_post	ENSG00000121022	10987	COP9 signalosome subunit 5	CSN5|JAB1|MOV-34|SGN5	protein_coding	Q92905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30875
8.26338579220722e-129	-0.372547742308874	0.173	0.36	1.75439943754351e-124	PER1	Malignant cells	GSE199333_post	ENSG00000179094	5187	period circadian regulator 1	PER|RIGUI	protein_coding	O15534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30876
9.29598373766892e-129	0.323964345411507	0.323	0.096	1.97363030734449e-124	PFDN6	Malignant cells	GSE199333_post	ENSG00000235692	10471	prefoldin subunit 6	H2-KE2|HKE2|KE-2|PFD6	protein_coding	O15212	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30877
9.81501874108709e-129	0.354700536174946	0.252	0.045	2.0838266289202e-124	RGL4	Malignant cells	GSE199333_post	ENSG00000159496	266747	ral guanine nucleotide dissociation stimulator like 4	Rgr	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30878
1.22559180295288e-128	0.323854560737914	0.301	0.08	2.60205395684925e-124	PIEZO1	Malignant cells	GSE199333_post	ENSG00000103335	9780	piezo type mechanosensitive ion channel component 1	FAM38A|KIAA0233	protein_coding	Q92508	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30879
1.62278112340124e-128	-0.534862491750434	0.311	0.499	3.44532660309317e-124	CD55	Malignant cells	GSE199333_post	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30880
2.52444971212201e-128	0.374169279797363	0.556	0.309	5.35965918380624e-124	REX1BD	Malignant cells	GSE199333_post	ENSG00000006015	55049	required for excision 1-B domain containing	C19orf60|FLJ20850|FLJ30108|FLJ34606|FLJ37391	protein_coding	Q96EN9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30881
2.6796102187983e-128	0.428961538060813	0.517	0.285	5.68908045553067e-124	ADRM1	Malignant cells	GSE199333_post	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30882
3.04795712229516e-128	0.356224497665731	0.633	0.354	6.47111776634485e-124	LSP1	Malignant cells	GSE199333_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30883
4.3457996475092e-128	-0.373077336827851	0.168	0.351	9.22656723162678e-124	PPP1R15B	Malignant cells	GSE199333_post	ENSG00000158615	84919	protein phosphatase 1 regulatory subunit 15B	FLJ14744	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30884
5.68310698857374e-128	0.349362012807517	0.308	0.087	1.20658044474409e-123	CMSS1	Malignant cells	GSE199333_post	ENSG00000184220	84319	cms1 ribosomal small subunit homolog	C3orf26|MGC4308	protein_coding	Q9BQ75	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30885
8.36426548069675e-128	0.35307367227544	0.363	0.132	1.77581720420673e-123	DECR1	Malignant cells	GSE199333_post	ENSG00000104325	1666	2,4-dienoyl-CoA reductase 1	DECR|SDR18C1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30886
9.33676107347235e-128	0.694701497788557	0.997	0.996	1.98228774350892e-123	MT-ND5	Malignant cells	GSE199333_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30887
1.5034836769388e-127	0.405896170041873	0.665	0.429	3.19204619450877e-123	CAPNS1	Malignant cells	GSE199333_post	ENSG00000126247	826	calpain small subunit 1	30K|CANP|CANPS|CAPN4|CDPS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30888
1.5156900829561e-127	0.303773602393102	0.277	0.063	3.2179616151241e-123	RNF5	Malignant cells	GSE199333_post	ENSG00000223767	6048	ring finger protein 5	G16|NG2|RING5|RMA1	protein_coding	Q99942	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30889
1.74325912602819e-127	0.378894826089863	0.424	0.184	3.70111345047045e-123	MPHOSPH8	Malignant cells	GSE199333_post	ENSG00000196199	54737	M-phase phosphoprotein 8	HSMPP8|mpp8	protein_coding	Q99549	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30890
1.86462529338598e-127	0.330262483375957	0.3	0.081	3.95878596038778e-123	ANXA4	Malignant cells	GSE199333_post	ENSG00000196975	307	annexin A4	ANX4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30891
2.05259507575437e-127	0.421331905708201	0.744	0.504	4.3578646053341e-123	PA2G4	Malignant cells	GSE199333_post	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30892
2.20334667898128e-127	0.365939657732062	0.487	0.239	4.67792533414516e-123	MRPL52	Malignant cells	GSE199333_post	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30893
2.54561746536246e-127	0.375690635198735	0.461	0.217	5.40460044071104e-123	CCNG1	Malignant cells	GSE199333_post	ENSG00000113328	900	cyclin G1	CCNG	protein_coding	P51959	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30894
2.69868640276226e-127	0.503881850810215	0.297	0.08	5.72958110170456e-123	CD7	Malignant cells	GSE199333_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30895
3.04247530821945e-127	0.386393300606182	0.557	0.313	6.45947932688072e-123	RABAC1	Malignant cells	GSE199333_post	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30896
4.19965386848149e-127	0.303421077641115	0.31	0.085	8.91628512817305e-123	UROD	Malignant cells	GSE199333_post	ENSG00000126088	7389	uroporphyrinogen decarboxylase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30897
4.54959059420388e-127	0.380082662756532	0.474	0.233	9.65923579055426e-123	TOP2B	Malignant cells	GSE199333_post	ENSG00000077097	7155	DNA topoisomerase II beta	top2beta|TOPIIB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30898
5.13801917638242e-127	0.318041424008217	0.323	0.098	1.09085285133775e-122	DHPS	Malignant cells	GSE199333_post	ENSG00000095059	1725	deoxyhypusine synthase	MIG13	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30899
5.60315006027666e-127	0.340138540466842	0.331	0.105	1.18960478929734e-122	EIF2S1	Malignant cells	GSE199333_post	ENSG00000134001	1965	eukaryotic translation initiation factor 2 subunit alpha	EIF-2alpha|EIF2|EIF2A	protein_coding	P05198	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30900
5.90450780733361e-127	0.375579973136896	0.355	0.125	1.253586052575e-122	CBX5	Malignant cells	GSE199333_post	ENSG00000094916	23468	chromobox 5	HP1|HP1-ALPHA|HP1Hs-alpha	protein_coding	P45973	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30901
6.95744855370242e-127	0.441145943590676	0.398	0.165	1.47713590243656e-122	MANF	Malignant cells	GSE199333_post	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30902
1.26686193239964e-126	0.423439494765617	0.45	0.215	2.68967456867767e-122	SUPT16H	Malignant cells	GSE199333_post	ENSG00000092201	11198	SPT16 homolog, facilitates chromatin remodeling subunit	CDC68|FACT|FACTP140|FLJ10857|FLJ14010|SPT16/CDC68	protein_coding	Q9Y5B9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30903
2.13730956644861e-126	0.305347909817253	0.266	0.056	4.53772194052704e-122	CYB5B	Malignant cells	GSE199333_post	ENSG00000103018	80777	cytochrome b5 type B	CYB5-M	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30904
2.20173111418953e-126	-0.435560984013793	0.373	0.566	4.67449532853579e-122	PJA2	Malignant cells	GSE199333_post	ENSG00000198961	9867	praja ring finger ubiquitin ligase 2	KIAA0438|Neurodap1|PRAJA2|RNF131	protein_coding	O43164	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30905
2.44383717750731e-126	0.324393652388908	0.282	0.068	5.18851071156577e-122	GART	Malignant cells	GSE199333_post	ENSG00000262473	2618	phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase	GARS-AIRS-GART|PGFT|PRGS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30906
2.73604472769717e-126	0.397441564653852	0.599	0.369	5.80889656137387e-122	TCP1	Malignant cells	GSE199333_post	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30907
3.07096508993927e-126	0.316246900325517	0.305	0.084	6.51996598245007e-122	CMC1	Malignant cells	GSE199333_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30908
4.51914992954618e-126	0.387547566655277	0.587	0.35	9.59460721541949e-122	PSMB6	Malignant cells	GSE199333_post	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30909
4.99491382945134e-126	0.378552750365147	0.651	0.415	1.06047015513082e-121	RTN3	Malignant cells	GSE199333_post	ENSG00000133318	10313	reticulon 3	ASYIP|HAP|NSPL2|NSPLII|RTN3-A1	protein_coding	O95197	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30910
5.66336598868402e-126	0.343600196330899	0.363	0.135	1.2023892330575e-121	CLPP	Malignant cells	GSE199333_post	ENSG00000125656	8192	caseinolytic mitochondrial matrix peptidase proteolytic subunit	NA	protein_coding	Q16740	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30911
8.48901734288404e-126	0.344882177300922	0.362	0.127	1.80230327206771e-121	SP110	Malignant cells	GSE199333_post	ENSG00000135899	3431	SP110 nuclear body protein	IFI41|IFI75	protein_coding	Q9HB58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30912
1.06707949123412e-125	0.343197003796644	0.438	0.189	2.26551646783917e-121	PTPN7	Malignant cells	GSE199333_post	ENSG00000143851	5778	protein tyrosine phosphatase non-receptor type 7	HEPTP|LC-PTP	protein_coding	P35236	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30913
1.17221875489123e-125	0.360573161431722	0.378	0.145	2.48873763850956e-121	AHCYL1	Malignant cells	GSE199333_post	ENSG00000168710	10768	adenosylhomocysteinase like 1	IRBIT|PPP1R78|XPVKONA	protein_coding	O43865	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30914
1.90402110183537e-125	0.297497599493612	0.258	0.052	4.04242720130668e-121	ARFRP1	Malignant cells	GSE199333_post	ENSG00000101246	10139	ADP ribosylation factor related protein 1	ARL18|ARP|Arp1	protein_coding	Q13795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30915
2.23202281329592e-125	0.344228623225617	0.382	0.147	4.73880763490856e-121	MAPK14	Malignant cells	GSE199333_post	ENSG00000112062	1432	mitogen-activated protein kinase 14	CSBP1|CSBP2|CSPB1|Mxi2|p38|PRKM14|PRKM15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30916
2.23906761183412e-125	0.351269995198656	0.265	0.056	4.75376444668502e-121	MAD2L1	Malignant cells	GSE199333_post	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30917
3.076884806903e-125	0.396405523954677	0.708	0.478	6.53253413353575e-121	C8orf59	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30918
5.62991576627446e-125	0.307367426587524	0.283	0.069	1.19528741633773e-120	AK6	Malignant cells	GSE199333_post	ENSG00000279247	102157402	adenylate kinase 6	CINAP	protein_coding	Q9Y3D8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30919
1.18849940558001e-124	-0.294040152848209	0.143	0.317	2.52330308798692e-120	FBXL3	Malignant cells	GSE199333_post	ENSG00000005812	26224	F-box and leucine rich repeat protein 3	FBL3|FBL3A|FBXL3A	protein_coding	Q9UKT7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30920
1.50939422532642e-124	0.293930647451791	0.25	0.046	3.20459487979052e-120	HDDC3	Malignant cells	GSE199333_post	ENSG00000184508	374659	HD domain containing 3	MESH1|MGC45386	protein_coding	Q8N4P3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30921
3.46807092316605e-124	0.398851529075161	0.839	0.694	7.36306137697385e-120	PGK1	Malignant cells	GSE199333_post	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30922
4.93262679628202e-124	-0.370528667833468	0.276	0.472	1.04724599511864e-119	WBP11	Malignant cells	GSE199333_post	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30923
1.57179529756716e-123	0.396575189316158	0.433	0.199	3.33707859626483e-119	RCSD1	Malignant cells	GSE199333_post	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30924
2.3028509560868e-123	0.325012714136033	0.343	0.116	4.88918286486788e-119	RPS6KA1	Malignant cells	GSE199333_post	ENSG00000281877	6195	ribosomal protein S6 kinase A1	HU-1|MAPKAPK1|p90Rsk|RSK1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30925
2.74269293493263e-123	0.382599513838191	0.453	0.215	5.82301137015546e-119	NIFK	Malignant cells	GSE199333_post	ENSG00000155438	84365	nucleolar protein interacting with the FHA domain of MKI67	hNIFK|MKI67IP|Nopp34	protein_coding	Q9BYG3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30926
3.0111430542949e-123	0.430211314133508	0.544	0.309	6.39295781857351e-119	MYCBP2	Malignant cells	GSE199333_post	ENSG00000005810	23077	MYC binding protein 2	FLJ10106|KIAA0916|PAM|PHR1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30927
5.06928091762792e-123	0.361320602187453	0.528	0.291	1.07625903162158e-118	SELENOF	Malignant cells	GSE199333_post	ENSG00000183291	9403	selenoprotein F	SEP15	protein_coding	O60613	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30928
6.48966450120214e-123	0.362083599483479	0.494	0.244	1.37782067025023e-118	PDCD5	Malignant cells	GSE199333_post	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30929
9.5005234785308e-123	0.396092024373692	0.761	0.556	2.01705613972687e-118	SNRPF	Malignant cells	GSE199333_post	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30930
9.88963927483769e-123	-0.319273934694173	0.194	0.383	2.09966931444079e-118	PPM1A	Malignant cells	GSE199333_post	ENSG00000100614	5494	protein phosphatase, Mg2+/Mn2+ dependent 1A	MGC9201|PP2CA|PP2Calpha	protein_coding	P35813	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30931
1.01427466908237e-122	0.333984951487705	0.313	0.094	2.15340654992878e-118	ATXN2	Malignant cells	GSE199333_post	ENSG00000204842	6311	ataxin 2	ATX2|SCA2|TNRC13	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30932
1.01677759338556e-122	-0.30185379577616	0.101	0.254	2.15872050851688e-118	ARHGAP26	Malignant cells	GSE199333_post	ENSG00000145819	23092	Rho GTPase activating protein 26	GRAF|KIAA0621|OPHN1L|OPHN1L1	protein_coding	Q9UNA1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30933
1.08518011862833e-122	0.290858863916163	0.258	0.053	2.30394590985981e-118	SLC35C2	Malignant cells	GSE199333_post	ENSG00000080189	51006	solute carrier family 35 member C2	bA394O2.1|C20orf5|CGI-15|OVCOV1	protein_coding	Q9NQQ7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30934
1.49729912211692e-122	0.303658582125493	0.299	0.084	3.17891576616644e-118	MRPS11	Malignant cells	GSE199333_post	ENSG00000181991	64963	mitochondrial ribosomal protein S11	FLJ22512|FLJ23406|HCC-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30935
1.67102067719728e-122	0.436729511286207	0.357	0.127	3.54774399975755e-118	MCM7	Malignant cells	GSE199333_post	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30936
1.77064196668478e-122	0.35816771852776	0.384	0.154	3.75924995946847e-118	CNTRL	Malignant cells	GSE199333_post	ENSG00000119397	11064	centriolin	CEP1|CEP110	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30937
2.35378480590933e-122	-0.383904015060016	0.248	0.438	4.99732052142609e-118	TMED5	Malignant cells	GSE199333_post	ENSG00000117500	50999	transmembrane p24 trafficking protein 5	CGI-100|p24g2|p24gamma2	protein_coding	Q9Y3A6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30938
3.28480175923473e-122	0.316657135851137	0.267	0.061	6.97396261503126e-118	MTHFD1	Malignant cells	GSE199333_post	ENSG00000100714	4522	methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1	MTHFC|MTHFD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30939
3.79763852645133e-122	0.406339439803218	0.54	0.3	8.06276635550882e-118	PPM1G	Malignant cells	GSE199333_post	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30940
5.62545443686415e-122	0.328665030244383	0.31	0.092	1.19434023149063e-117	ABTB1	Malignant cells	GSE199333_post	ENSG00000114626	80325	ankyrin repeat and BTB domain containing 1	BPOZ|Btb3|BTBD21|EF1ABP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30941
8.26412656871896e-122	0.313980889980404	0.312	0.095	1.75455671180472e-117	MRPL14	Malignant cells	GSE199333_post	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30942
9.07390869293122e-122	0.351057582138653	0.537	0.292	1.92648155459623e-117	EIF6	Malignant cells	GSE199333_post	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30943
9.24038760057504e-122	0.413498705357852	0.648	0.42	1.96182669147809e-117	ERH	Malignant cells	GSE199333_post	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30944
1.25230954875758e-121	0.347450144489596	0.803	0.599	2.65877840296723e-117	EIF3G	Malignant cells	GSE199333_post	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30945
1.52912394591455e-121	0.465290106569833	0.561	0.342	3.24648304957118e-117	LMO2	Malignant cells	GSE199333_post	ENSG00000135363	4005	LIM domain only 2	RBTN2|RBTNL1|RHOM2|TTG2	protein_coding	P25791	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30946
1.74654526370884e-121	0.33453568493273	0.294	0.081	3.70809024938023e-117	BRI3BP	Malignant cells	GSE199333_post	ENSG00000184992	140707	BRI3 binding protein	BNAS1|HCCR-2|HCCRBP-3|KG19	protein_coding	Q8WY22	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30947
1.84335394777731e-121	0.349416523438784	0.376	0.15	3.913624766526e-117	GANAB	Malignant cells	GSE199333_post	ENSG00000089597	23193	glucosidase II alpha subunit	G2AN|GIIA|GluII|KIAA0088	protein_coding	Q14697	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30948
2.05284218469189e-121	0.36594697391167	0.538	0.298	4.35838924231936e-117	CYC1	Malignant cells	GSE199333_post	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30949
2.29037990577977e-121	0.309124901497282	0.293	0.08	4.86270557796102e-117	RMDN1	Malignant cells	GSE199333_post	ENSG00000176623	51115	regulator of microtubule dynamics 1	CGI-90|FAM82B|FLJ20665|RMD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30950
2.31930755164655e-121	-0.452342403425817	0.689	0.792	4.9241218629008e-117	ZNF207	Malignant cells	GSE199333_post	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30951
5.01677606974524e-121	0.330064164503268	0.361	0.135	1.06511172736761e-116	MRPS23	Malignant cells	GSE199333_post	ENSG00000181610	51649	mitochondrial ribosomal protein S23	CGI-138|HSPC329|MRP-S23	protein_coding	Q9Y3D9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30952
5.07100335685316e-121	0.416453621321937	0.587	0.36	1.0766247226935e-116	CCT6A	Malignant cells	GSE199333_post	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30953
5.17325874371654e-121	0.34747225536813	0.464	0.222	1.09833456387846e-116	BIN2	Malignant cells	GSE199333_post	ENSG00000110934	51411	bridging integrator 2	BRAP-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30954
5.69609701507073e-121	0.316624192836752	0.339	0.116	1.20933835726967e-116	MRPS25	Malignant cells	GSE199333_post	ENSG00000131368	64432	mitochondrial ribosomal protein S25	DKFZp313H0817|FLJ00023|MRP-S25|RPMS25	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30955
5.80675966521029e-121	0.323184541944447	0.308	0.092	1.2328331445208e-116	MRPL36	Malignant cells	GSE199333_post	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30956
6.02400235826325e-121	0.36976271030225	0.297	0.083	1.27895594068287e-116	HSPH1	Malignant cells	GSE199333_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30957
7.20500236868422e-121	0.355592305711733	0.625	0.382	1.52969405289535e-116	ANAPC16	Malignant cells	GSE199333_post	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30958
7.76201212051502e-121	0.339046772849476	0.442	0.208	1.64795279330654e-116	GRHPR	Malignant cells	GSE199333_post	ENSG00000137106	9380	glyoxylate and hydroxypyruvate reductase	GLXR|PH2	protein_coding	Q9UBQ7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30959
7.79231495547929e-121	0.32371548197205	0.336	0.114	1.65438638819781e-116	LYRM1	Malignant cells	GSE199333_post	ENSG00000102897	57149	LYR motif containing 1	A211C6.1	protein_coding	O43325	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30960
9.00207784866614e-121	0.329007589812742	0.385	0.156	1.91123114805031e-116	MRPL28	Malignant cells	GSE199333_post	ENSG00000086504	10573	mitochondrial ribosomal protein L28	MAAT1|p15	protein_coding	Q13084	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30961
1.29039896793445e-120	0.36548341229482	0.512	0.274	2.73964604882163e-116	DHRS7	Malignant cells	GSE199333_post	ENSG00000100612	51635	dehydrogenase/reductase 7	retDSR4|SDR34C1	protein_coding	Q9Y394	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30962
1.31980879723523e-120	0.31212123212395	0.287	0.076	2.80208605741011e-116	TBC1D10C	Malignant cells	GSE199333_post	ENSG00000175463	374403	TBC1 domain family member 10C	Carabin|EPI64C|FLJ00332	protein_coding	Q8IV04	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30963
1.72202041932652e-120	0.378024382454296	0.646	0.412	3.65602155227214e-116	LSM3	Malignant cells	GSE199333_post	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30964
1.93851956912204e-120	0.272485465459844	0.999	0.999	4.11567089720299e-116	RPL18	Malignant cells	GSE199333_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30965
1.95269359976987e-120	0.308039046850508	0.268	0.062	4.14576378167141e-116	IKBIP	Malignant cells	GSE199333_post	ENSG00000166130	121457	IKBKB interacting protein	FLJ31051|IKIP	protein_coding	Q70UQ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30966
2.10168240575928e-120	0.358726158973166	0.524	0.284	4.46208191566753e-116	DYNLRB1	Malignant cells	GSE199333_post	ENSG00000125971	83658	dynein light chain roadblock-type 1	DNCL2A|DNLC2A|ROBLD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30967
3.38687886632673e-120	0.353419489247342	0.336	0.117	7.19068252109829e-116	RAB10	Malignant cells	GSE199333_post	ENSG00000084733	10890	RAB10, member RAS oncogene family	NA	protein_coding	P61026	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30968
4.04539221674265e-120	-0.283798463342571	0.122	0.285	8.58877221536632e-116	TSC22D2	Malignant cells	GSE199333_post	ENSG00000196428	9819	TSC22 domain family member 2	KIAA0669|TILZ4a|TILZ4b|TILZ4c	protein_coding	O75157	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30969
4.13019099375357e-120	0.342110458387772	0.39	0.162	8.76880849883821e-116	ETHE1	Malignant cells	GSE199333_post	ENSG00000105755	23474	ETHE1 persulfide dioxygenase	HSCO|YF13H12	protein_coding	O95571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30970
5.08959360147443e-120	-0.422004265636269	0.421	0.605	1.08057161752904e-115	UBE2B	Malignant cells	GSE199333_post	ENSG00000119048	7320	ubiquitin conjugating enzyme E2 B	HHR6B|RAD6B|UBC2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30971
5.14494180956341e-120	0.292868041781192	0.267	0.063	1.09232259558841e-115	DEAF1	Malignant cells	GSE199333_post	ENSG00000282712	10522	DEAF1 transcription factor	NUDR|SPN|ZMYND5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30972
6.63038946422973e-120	-0.36399161419471	0.228	0.415	1.40769798715061e-115	RNF138	Malignant cells	GSE199333_post	ENSG00000134758	51444	ring finger protein 138	NARF|STRIN	protein_coding	Q8WVD3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30973
7.09223751438554e-120	0.353516211088847	0.415	0.183	1.50575294667919e-115	ADI1	Malignant cells	GSE199333_post	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30974
8.20920293066919e-120	0.36131298169818	0.547	0.311	1.74289587421038e-115	ATRAID	Malignant cells	GSE199333_post	ENSG00000138085	51374	all-trans retinoic acid induced differentiation factor	APR3|C2orf28|HSPC013|p18	protein_coding	Q6UW56	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30975
9.77779950229624e-120	-0.39777658311405	0.214	0.399	2.07592461233251e-115	BRAF	Malignant cells	GSE199333_post	ENSG00000157764	673	B-Raf proto-oncogene, serine/threonine kinase	BRAF-1|BRAF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30976
1.11100747043185e-119	0.330671573633477	0.576	0.32	2.35877996047385e-115	RNASEH2C	Malignant cells	GSE199333_post	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30977
1.28455274072208e-119	0.339465760227042	0.276	0.07	2.72723392382704e-115	ISYNA1	Malignant cells	GSE199333_post	ENSG00000105655	51477	inositol-3-phosphate synthase 1	Ino1|INOS|IPS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30978
1.56325547625532e-119	0.309506038106708	0.283	0.073	3.31894770163767e-115	CCM2	Malignant cells	GSE199333_post	ENSG00000136280	83605	CCM2 scaffold protein	C7orf22|MGC4607|OSM	protein_coding	Q9BSQ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30979
3.23468898110286e-119	0.297611613302301	0.288	0.078	6.86756817577948e-115	BCKDK	Malignant cells	GSE199333_post	ENSG00000103507	10295	branched chain keto acid dehydrogenase kinase	NA	protein_coding	O14874	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30980
3.8448035602169e-119	0.356976447883066	0.268	0.064	8.16290243869649e-115	FAM117A	Malignant cells	GSE199333_post	ENSG00000121104	81558	family with sequence similarity 117 member A	NA	protein_coding	Q9C073	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30981
5.71145359430365e-119	0.337328329849557	0.376	0.149	1.21259871260661e-114	DYNC1I2	Malignant cells	GSE199333_post	ENSG00000077380	1781	dynein cytoplasmic 1 intermediate chain 2	DIC74|DNCI2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30982
8.24501937296254e-119	-0.325876992709908	0.123	0.283	1.75050006307368e-114	CCDC69	Malignant cells	GSE199333_post	ENSG00000198624	26112	coiled-coil domain containing 69	DKFZP434C171|FLJ13705	protein_coding	A6NI79	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30983
1.13731868089965e-118	-0.588993375209626	0.384	0.578	2.41464129141806e-114	MYADM	Malignant cells	GSE199333_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30984
2.19592701274887e-118	-0.27074625530628	0.126	0.289	4.66217264076713e-114	PTBP2	Malignant cells	GSE199333_post	ENSG00000117569	58155	polypyrimidine tract binding protein 2	brPTB|nPTB|PTB|PTBLP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30985
2.86961058709786e-118	-0.328215478380633	0.102	0.252	6.09247023746746e-114	TRIM11	Malignant cells	GSE199333_post	ENSG00000154370	81559	tripartite motif containing 11	BIA1|RNF92	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30986
3.1974556258766e-118	0.38234862527759	0.595	0.364	6.7885180392986e-114	CCDC85B	Malignant cells	GSE199333_post	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30987
4.4283837956429e-118	-0.330785075993695	0.21	0.398	9.40190163652944e-114	TMEM167B	Malignant cells	GSE199333_post	ENSG00000215717	56900	transmembrane protein 167B	AD-020|C1orf119|FLJ90710	protein_coding	Q9NRX6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30988
6.9776223548063e-118	0.344722922000407	0.457	0.225	1.48141900214893e-113	SUGT1	Malignant cells	GSE199333_post	ENSG00000165416	10910	SGT1 homolog, MIS12 kinetochore complex assembly cochaperone	SGT1	protein_coding	Q9Y2Z0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30989
7.79835085804997e-118	0.283998046568616	0.268	0.064	1.65566787067259e-113	PPIE	Malignant cells	GSE199333_post	ENSG00000084072	10450	peptidylprolyl isomerase E	CyP-33|MGC111222|MGC3736	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30990
8.43068612355415e-118	0.322416947612593	0.37	0.143	1.78991897089178e-113	STOM	Malignant cells	GSE199333_post	ENSG00000148175	2040	stomatin	BND7|EPB7|EPB72	protein_coding	P27105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30991
9.57805129708557e-118	-0.414509005227097	0.347	0.534	2.03351607088424e-113	PUM1	Malignant cells	GSE199333_post	ENSG00000134644	9698	pumilio RNA binding family member 1	KIAA0099|PUMH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30992
1.52931535573988e-117	0.325574456547955	0.4	0.171	3.24688943177133e-113	METTL5	Malignant cells	GSE199333_post	ENSG00000138382	29081	methyltransferase 5, N6-adenosine	HSPC133	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30993
2.41106517091091e-117	0.300136117237628	0.28	0.074	5.11893246436096e-113	ZDHHC12	Malignant cells	GSE199333_post	ENSG00000160446	84885	zinc finger DHHC-type palmitoyltransferase 12	FLJ14524|ZNF400	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30994
2.62402249369182e-117	0.316220071226855	0.343	0.124	5.5710621563571e-113	WDR61	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30995
7.36404230203765e-117	0.357667902956704	0.427	0.198	1.56345982114561e-112	BUB3	Malignant cells	GSE199333_post	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30996
7.51384777315288e-117	0.339585043276429	0.407	0.179	1.59526502071809e-112	SRSF1	Malignant cells	GSE199333_post	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30997
7.98787518061415e-117	0.419802586163427	0.578	0.353	1.69590577959619e-112	CYCS	Malignant cells	GSE199333_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30998
1.49582567114114e-116	0.351343696280041	0.383	0.158	3.17578748239975e-112	PRMT2	Malignant cells	GSE199333_post	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	30999
1.62882164210345e-116	0.284725752542069	0.252	0.055	3.45815122834984e-112	DGLUCY	Malignant cells	GSE199333_post	ENSG00000133943	80017	D-glutamate cyclase	C14orf159|FLJ39975	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31000
1.65113148404296e-116	-0.4289216949854	0.992	0.992	3.50551725377162e-112	RPL23	Malignant cells	GSE199333_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31001
3.53125802373571e-116	0.305303419206324	0.305	0.095	7.49721391019328e-112	TSR3	Malignant cells	GSE199333_post	ENSG00000007520	115939	TSR3 ribosome maturation factor	C16orf42|MGC24381	protein_coding	Q9UJK0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31002
3.69153347434893e-116	0.38674960044094	0.352	0.134	7.8374947193902e-112	CCND3	Malignant cells	GSE199333_post	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31003
4.60169821831032e-116	0.297195096143909	0.279	0.075	9.76986548729464e-112	WDR18	Malignant cells	GSE199333_post	ENSG00000065268	57418	WD repeat domain 18	Ipi3	protein_coding	Q9BV38	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31004
5.37991491611259e-116	0.337387438686178	0.34	0.122	1.14220973583986e-111	EBNA1BP2	Malignant cells	GSE199333_post	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31005
5.59647496465451e-116	0.28547309498281	0.252	0.055	1.1881875997458e-111	ERG28	Malignant cells	GSE199333_post	ENSG00000133935	11161	ergosterol biosynthesis 28 homolog	C14orf1|NET51	protein_coding	Q9UKR5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31006
6.89561402004682e-116	0.304464604595992	0.327	0.112	1.46400781259614e-111	MRPL34	Malignant cells	GSE199333_post	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31007
7.26738849427702e-116	-0.309228761099043	0.183	0.365	1.54293925121995e-111	RAB5A	Malignant cells	GSE199333_post	ENSG00000144566	5868	RAB5A, member RAS oncogene family	RAB5	protein_coding	P20339	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31008
8.94378371130705e-116	0.291944893938665	0.256	0.058	1.8988547197476e-111	GPN3	Malignant cells	GSE199333_post	ENSG00000111231	51184	GPN-loop GTPase 3	ATPBD1C|MGC14560	protein_coding	Q9UHW5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31009
1.00516179383185e-115	-0.470229673210801	0.385	0.558	2.1340590044844e-111	ITGB1	Malignant cells	GSE199333_post	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31010
1.04560769596486e-115	0.395363441798168	0.603	0.379	2.21992969930299e-111	METTL26	Malignant cells	GSE199333_post	ENSG00000130731	84326	methyltransferase like 26	C16orf13|MGC13114	protein_coding	Q96S19	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31011
1.21830213218253e-115	0.346784020226111	0.388	0.163	2.58657725683672e-111	CALHM6	Malignant cells	GSE199333_post	ENSG00000188820	441168	calcium homeostasis modulator family member 6	C6orf187|dJ93H18.5|FAM26F|INAM|OTTHUMP00000017061|OTTHUMP00000017062|RP1-93H18.5	protein_coding	Q5R3K3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31012
1.27788954621843e-115	-0.411376424070393	1	0.997	2.71308729557636e-111	MT-ND2	Malignant cells	GSE199333_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31013
1.38845063935777e-115	0.357431402428094	0.287	0.08	2.94781955242048e-111	CDT1	Malignant cells	GSE199333_post	ENSG00000167513	81620	chromatin licensing and DNA replication factor 1	DUP|RIS2	protein_coding	Q9H211	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31014
1.51432925363848e-115	-0.561334273368906	0.522	0.657	3.21507243839987e-111	TLE4	Malignant cells	GSE199333_post	ENSG00000106829	7091	TLE family member 4, transcriptional corepressor	E(spl)|ESG|GRG4	protein_coding	Q04727	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31015
2.75508007997872e-115	0.357388807582095	0.766	0.571	5.84931051780282e-111	SNX3	Malignant cells	GSE199333_post	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31016
6.92789165469078e-115	0.321492896061307	0.395	0.169	1.4708606772074e-110	ACAA1	Malignant cells	GSE199333_post	ENSG00000060971	30	acetyl-CoA acyltransferase 1	Lnc-Myd88	protein_coding	P09110	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31017
8.26368221123969e-115	0.303391121158047	0.93	0.799	1.7544623702683e-110	NDUFA4	Malignant cells	GSE199333_post	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31018
1.44882153875731e-114	0.378547033264783	0.797	0.614	3.07599300893565e-110	NDUFS5	Malignant cells	GSE199333_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31019
1.6832122467351e-114	0.322813554815908	0.401	0.174	3.57362792104329e-110	DGUOK	Malignant cells	GSE199333_post	ENSG00000114956	1716	deoxyguanosine kinase	dGK	protein_coding	Q16854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31020
1.80742448482699e-114	-0.368364298013451	0.142	0.304	3.83734292373617e-110	FURIN	Malignant cells	GSE199333_post	ENSG00000140564	5045	furin, paired basic amino acid cleaving enzyme	FUR|PACE|PCSK3|SPC1	protein_coding	P09958	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31021
2.68498341936396e-114	-0.265945438668155	0.103	0.252	5.70048829765162e-110	ENTPD4	Malignant cells	GSE199333_post	ENSG00000197217	9583	ectonucleoside triphosphate diphosphohydrolase 4	KIAA0392|LALP70|LAP70|LYSAL1|NTPDase-4|UDPase	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31022
3.07022551375155e-114	0.285567372836927	0.296	0.087	6.51839578824591e-110	TADA3	Malignant cells	GSE199333_post	ENSG00000171148	10474	transcriptional adaptor 3	ADA3|FLJ20221|FLJ21329|hADA3|NGG1|TADA3L	protein_coding	O75528	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31023
3.22609113764859e-114	0.295846987297182	0.291	0.086	6.84931409434172e-110	ISCA2	Malignant cells	GSE199333_post	ENSG00000165898	122961	iron-sulfur cluster assembly 2	HBLD1|ISA2	protein_coding	Q86U28	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31024
5.66216739737104e-114	0.299823982642048	0.295	0.088	1.20213476013585e-109	B3GAT3	Malignant cells	GSE199333_post	ENSG00000149541	26229	beta-1,3-glucuronyltransferase 3	GlcAT-I	protein_coding	O94766	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31025
7.09644704497414e-114	-0.426591874613974	0.46	0.627	1.50664667211846e-109	LENG8	Malignant cells	GSE199333_post	ENSG00000276458	114823	leukocyte receptor cluster member 8	KIAA1932|MGC40108|pp13842	protein_coding	Q96PV6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31026
1.00005475091734e-113	0.287202231632234	0.259	0.062	2.1232162416726e-109	DCPS	Malignant cells	GSE199333_post	ENSG00000110063	28960	decapping enzyme, scavenger	HINT-5|HINT5|HSL1|HSPC015	protein_coding	Q96C86	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31027
1.24083640281683e-113	0.30457686831376	0.314	0.104	2.63441976682041e-109	IRF3	Malignant cells	GSE199333_post	ENSG00000126456	3661	interferon regulatory factor 3	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31028
1.3319704020404e-113	0.307137023388794	0.295	0.088	2.82790636057197e-109	FAM89B	Malignant cells	GSE199333_post	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31029
2.02552255225396e-113	0.330357584496305	0.469	0.236	4.30038693069039e-109	COX14	Malignant cells	GSE199333_post	ENSG00000178449	84987	cytochrome c oxidase assembly factor COX14	C12orf62|MGC14288	protein_coding	Q96I36	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31030
2.47768354994166e-113	0.287712557561746	0.294	0.088	5.26036994488113e-109	COMMD1	Malignant cells	GSE199333_post	ENSG00000173163	150684	copper metabolism domain containing 1	C2orf5|MGC27155|MURR1	protein_coding	Q8N668	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31031
4.79299784666065e-113	0.31832743846143	0.929	0.8	1.01760137282452e-108	COX6B1	Malignant cells	GSE199333_post	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31032
5.0508591428481e-113	0.297151317655183	0.287	0.084	1.07234790461808e-108	DCUN1D5	Malignant cells	GSE199333_post	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31033
5.2455820306164e-113	0.358284204790107	0.576	0.346	1.11368952092017e-108	AURKAIP1	Malignant cells	GSE199333_post	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31034
5.50651146370351e-113	0.351256705083945	0.516	0.285	1.16908744885889e-108	RBBP4	Malignant cells	GSE199333_post	ENSG00000162521	5928	RB binding protein 4, chromatin remodeling factor	lin-53|NURF55|RbAp48	protein_coding	Q09028	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31035
5.56387020913327e-113	0.301719909009326	0.296	0.091	1.18126528410109e-108	ALG3	Malignant cells	GSE199333_post	ENSG00000214160	10195	ALG3 alpha-1,3- mannosyltransferase	CDGS4|D16Ertd36e|Not56|NOT56L	protein_coding	Q92685	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31036
6.47041261338255e-113	0.3259442638816	0.363	0.145	1.37373330194725e-108	IMMT	Malignant cells	GSE199333_post	ENSG00000132305	10989	inner membrane mitochondrial protein	HMP|Mic60|MICOS60|MINOS2|P87|P89	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31037
6.56359929528814e-113	-0.487893612105514	0.64	0.749	1.39351776638263e-108	SRSF10	Malignant cells	GSE199333_post	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31038
9.50983710624242e-113	-0.272532999528666	0.115	0.269	2.01903351602633e-108	TXNDC11	Malignant cells	GSE199333_post	ENSG00000153066	51061	thioredoxin domain containing 11	EFP1	protein_coding	Q6PKC3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31039
1.39380229148106e-112	-0.431794758529238	0.382	0.559	2.95918164504343e-108	NUFIP2	Malignant cells	GSE199333_post	ENSG00000108256	57532	nuclear FMR1 interacting protein 2	182-FIP|82-FIP|FIP-82|KIAA1321|MGC117262|NUFP2|PIG1	protein_coding	Q7Z417	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31040
1.4290853266145e-112	0.289892264159561	0.272	0.073	3.03409105693524e-108	KLHDC3	Malignant cells	GSE199333_post	ENSG00000124702	116138	kelch domain containing 3	dJ20C7.3|hPeas|PEAS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31041
1.9028924587482e-112	-0.558078404491965	0.232	0.4	4.0400309791683e-108	IFNGR2	Malignant cells	GSE199333_post	ENSG00000262795	3460	interferon gamma receptor 2	AF-1|IFNGT1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31042
1.90311424732072e-112	0.306159925248188	0.284	0.081	4.04050185848662e-108	RSBN1L	Malignant cells	GSE199333_post	ENSG00000187257	222194	round spermatid basic protein 1 like	FLJ42526|FLJ45813|MGC71764	protein_coding	Q6PCB5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31043
1.91636285695258e-112	0.365730280917299	0.371	0.15	4.06862998159602e-108	YPEL3	Malignant cells	GSE199333_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31044
2.26465665903652e-112	0.341816967682691	0.479	0.251	4.80809255280044e-108	TMEM160	Malignant cells	GSE199333_post	ENSG00000130748	54958	transmembrane protein 160	FLJ20512	protein_coding	Q9NX00	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31045
2.91815175531889e-112	-0.45177883609651	0.394	0.572	6.19552799171753e-108	DDX6	Malignant cells	GSE199333_post	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31046
4.57887080076167e-112	0.348184789443635	0.709	0.503	9.72140059709709e-108	BSG	Malignant cells	GSE199333_post	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31047
6.13696633492008e-112	-0.427122682704942	0.377	0.551	1.30293932256688e-107	CCDC59	Malignant cells	GSE199333_post	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31048
6.24773090472604e-112	-0.373677599607157	0.25	0.435	1.32645574838239e-107	ZNF644	Malignant cells	GSE199333_post	ENSG00000122482	84146	zinc finger protein 644	BM-005|KIAA1221|MGC60165|MGC70410	protein_coding	Q9H582	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31049
1.37529129155213e-111	0.320352259776045	0.362	0.144	2.91988094109432e-107	ZBTB44	Malignant cells	GSE199333_post	ENSG00000196323	29068	zinc finger and BTB domain containing 44	BTBD15|HSPC063|ZNF851	protein_coding	Q8NCP5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31050
1.76822610509872e-111	0.354588582912837	0.459	0.233	3.75412084373509e-107	NDUFAF8	Malignant cells	GSE199333_post	ENSG00000224877	284184	NADH:ubiquinone oxidoreductase complex assembly factor 8	C17orf89	protein_coding	A1L188	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31051
1.89247420284527e-111	0.288265363812867	0.265	0.068	4.0179119800608e-107	GALK1	Malignant cells	GSE199333_post	ENSG00000108479	2584	galactokinase 1	GALK	protein_coding	P51570	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31052
1.99952939821174e-111	-0.310788506838888	0.182	0.358	4.24520086534335e-107	FBRS	Malignant cells	GSE199333_post	ENSG00000156860	64319	fibrosin	FBS|FBS1|FLJ11618	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31053
2.88341616716736e-111	0.329234424228158	0.312	0.105	6.12178086451301e-107	NOL8	Malignant cells	GSE199333_post	ENSG00000198000	55035	nucleolar protein 8	C9orf34|FLJ20736|Nop132	protein_coding	Q76FK4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31054
3.90122942916324e-111	0.334783506562644	0.783	0.573	8.28270020105648e-107	TMEM258	Malignant cells	GSE199333_post	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31055
4.14604546698364e-111	0.363337807796311	0.601	0.352	8.80246913095297e-107	JPT1	Malignant cells	GSE199333_post	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31056
4.60891379699091e-111	0.291624743261868	0.259	0.064	9.7851848823914e-107	ESYT1	Malignant cells	GSE199333_post	ENSG00000139641	23344	extended synaptotagmin 1	FAM62A|KIAA0747|MBC2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31057
6.80640655062223e-111	0.356327299086311	0.513	0.282	1.44506817476261e-106	TRIM28	Malignant cells	GSE199333_post	ENSG00000130726	10155	tripartite motif containing 28	KAP-1|KAP1|PPP1R157|RNF96|TF1B|TIF1-beta|TIF1B|TIF1beta	protein_coding	Q13263	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31058
9.22451693654805e-111	-0.56514373212249	0.296	0.474	1.95845719079852e-106	SOD2	Malignant cells	GSE199333_post	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31059
1.21052139397846e-110	0.290534334101102	0.27	0.073	2.57005797155567e-106	LTB4R	Malignant cells	GSE199333_post	ENSG00000285456	1241	leukotriene B4 receptor	BLTR|CMKRL1|GPR16|LTB4R1|P2RY7|P2Y7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31060
1.21238643641382e-110	-0.60969098960681	0.332	0.497	2.57401764315019e-106	ETS2	Malignant cells	GSE199333_post	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31061
1.2265587647202e-110	0.495951257351751	0.917	0.862	2.60410691337745e-106	HMGN2	Malignant cells	GSE199333_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31062
1.5672736942585e-110	0.373162068214752	0.532	0.303	3.32747878028023e-106	ETV6	Malignant cells	GSE199333_post	ENSG00000139083	2120	ETS variant transcription factor 6	TEL	protein_coding	P41212	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31063
2.64213558678082e-110	0.29511770109006	0.295	0.092	5.60951806429437e-106	CDC26	Malignant cells	GSE199333_post	ENSG00000176386	246184	cell division cycle 26	ANAPC12|APC12|C9orf17	protein_coding	Q8NHZ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31064
4.3081293078456e-110	0.36924876394058	0.724	0.525	9.14658933348699e-106	PSMB3	Malignant cells	GSE199333_post	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31065
4.37499441998751e-110	0.433460429583718	0.482	0.264	9.28855065307548e-106	PRKDC	Malignant cells	GSE199333_post	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31066
1.24548405206208e-109	0.293980587999974	0.293	0.091	2.64428719093301e-105	SFXN4	Malignant cells	GSE199333_post	ENSG00000183605	119559	sideroflexin 4	SLC56A4	protein_coding	Q6P4A7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31067
1.27613508280586e-109	0.273853066320463	0.258	0.065	2.70936239430512e-105	CUTC	Malignant cells	GSE199333_post	ENSG00000119929	51076	cutC copper transporter	CGI-32	protein_coding	Q9NTM9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31068
1.33099662398254e-109	0.292622833200294	0.56	0.312	2.82583893237734e-105	TPM4	Malignant cells	GSE199333_post	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31069
1.35851116281703e-109	0.374507898770039	0.515	0.293	2.88425504977683e-105	RAD23A	Malignant cells	GSE199333_post	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31070
1.43864092478811e-109	0.305410463997538	0.344	0.131	3.05437854741764e-105	ARHGEF6	Malignant cells	GSE199333_post	ENSG00000129675	9459	Rac/Cdc42 guanine nucleotide exchange factor 6	alpha-PIX|alphaPIX|Cool-2|Cool2|KIAA0006|MRX46	protein_coding	Q15052	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31071
1.84545495885385e-109	-0.376351817418741	0.34	0.524	3.9180854231426e-105	PPP2CA	Malignant cells	GSE199333_post	ENSG00000113575	5515	protein phosphatase 2 catalytic subunit alpha	PP2AC|PP2Calpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31072
2.24962336524318e-109	0.35835478914067	0.8	0.632	4.7761753667478e-105	SRSF9	Malignant cells	GSE199333_post	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31073
2.28025846832091e-109	0.302263349205315	0.328	0.12	4.84121675409212e-105	TTC1	Malignant cells	GSE199333_post	ENSG00000113312	7265	tetratricopeptide repeat domain 1	TPR1	protein_coding	Q99614	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31074
3.37956054354191e-109	0.287934075815647	0.269	0.073	7.17514498999383e-105	UBA7	Malignant cells	GSE199333_post	ENSG00000182179	7318	ubiquitin like modifier activating enzyme 7	D8|UBA1B|UBE1L|UBE2	protein_coding	P41226	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31075
3.87743910670912e-109	-0.281223167060942	0.128	0.285	8.23219096745412e-105	SIK3	Malignant cells	GSE199333_post	ENSG00000160584	23387	SIK family kinase 3	FLJ12240|KIAA0999|L19|QSK	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31076
3.87980831987759e-109	0.361688449202127	0.572	0.35	8.23722104393211e-105	ZNF706	Malignant cells	GSE199333_post	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31077
4.2038358923975e-109	0.338368229058401	0.564	0.337	8.92516398314913e-105	NDUFS7	Malignant cells	GSE199333_post	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31078
4.75350384813048e-109	0.378677485186842	0.491	0.269	1.00921640199658e-104	CD47	Malignant cells	GSE199333_post	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31079
8.58091168154069e-109	-0.869469909992076	0.315	0.48	1.8218133591079e-104	CXCR4	Malignant cells	GSE199333_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31080
8.90639700364069e-109	0.310631362535696	0.37	0.154	1.89091714784296e-104	RBCK1	Malignant cells	GSE199333_post	ENSG00000125826	10616	RANBP2-type and C3HC4-type zinc finger containing 1	C20orf18|HOIL1|RBCK2|RNF54|UBCE7IP3|XAP4|ZRANB4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31081
1.03031733014915e-108	0.337338585442524	0.502	0.273	2.18746672363965e-104	ZCRB1	Malignant cells	GSE199333_post	ENSG00000139168	85437	zinc finger CCHC-type and RNA binding motif containing 1	MADP-1|MADP1|RBM36|SNRNP31|ZCCHC19	protein_coding	Q8TBF4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31082
1.10821191037368e-108	-0.354263466338951	0.193	0.366	2.35284470691436e-104	SLCO3A1	Malignant cells	GSE199333_post	ENSG00000176463	28232	solute carrier organic anion transporter family member 3A1	OATP-D|OATP3A1|SLC21A11	protein_coding	Q9UIG8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31083
1.23166437569541e-108	0.327169611585711	0.659	0.424	2.61494663603892e-104	NOP10	Malignant cells	GSE199333_post	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31084
1.71209934619768e-108	0.349048315026517	0.719	0.504	3.6349581219123e-104	SNU13	Malignant cells	GSE199333_post	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31085
1.98409690417577e-108	0.32223219694294	0.423	0.2	4.21243613725559e-104	MRPS15	Malignant cells	GSE199333_post	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31086
2.10410779296491e-108	-0.375001847186601	0.246	0.425	4.4672312552438e-104	RANBP2	Malignant cells	GSE199333_post	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31087
5.29887217728808e-108	0.302886034188836	0.288	0.089	1.12500355196003e-103	IARS	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31088
6.11372533024829e-108	0.291769570180113	0.331	0.122	1.29800502486501e-103	PRPF31	Malignant cells	GSE199333_post	ENSG00000274651	26121	pre-mRNA processing factor 31	hPrp31|NY-BR-99|PRP31|RP11|SNRNP61	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31089
8.59985558687147e-108	0.323008183719656	0.517	0.286	1.82583533964868e-103	C1orf43	Malignant cells	GSE199333_post	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31090
1.13634502150091e-107	0.308463260041186	0.32	0.115	2.41257411514858e-103	PDCD7	Malignant cells	GSE199333_post	ENSG00000090470	10081	programmed cell death 7	59K|ES18|HES18	protein_coding	Q8N8D1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31091
1.41907832587602e-107	0.313355419837532	0.538	0.307	3.01284519366739e-103	CDC37	Malignant cells	GSE199333_post	ENSG00000105401	11140	cell division cycle 37, HSP90 cochaperone	P50CDC37	protein_coding	Q16543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31092
1.4517383465623e-107	0.303326941256785	0.264	0.072	3.08218568358643e-103	GPATCH4	Malignant cells	GSE199333_post	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31093
1.53389245373014e-107	0.288125456357873	0.27	0.075	3.25660706851446e-103	G6PD	Malignant cells	GSE199333_post	ENSG00000160211	2539	glucose-6-phosphate dehydrogenase	G6PD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31094
1.53609542273874e-107	-0.435518772687826	0.818	0.872	3.26128419201662e-103	RPL17	Malignant cells	GSE199333_post	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31095
1.55469257970785e-107	-0.351070931075427	0.127	0.279	3.30076781597773e-103	CYTIP	Malignant cells	GSE199333_post	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31096
1.68991666432137e-107	-0.325921112632894	0.136	0.294	3.5878620700207e-103	FGR	Malignant cells	GSE199333_post	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31097
1.78519202778221e-107	0.281320559897298	0.261	0.069	3.7901411941844e-103	KATNBL1	Malignant cells	GSE199333_post	ENSG00000134152	79768	katanin regulatory subunit B1 like 1	C15orf29|FLJ22557	protein_coding	Q9H079	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31098
2.12493510108273e-107	0.363887548623997	0.371	0.159	4.51144971310875e-103	CENPX	Malignant cells	GSE199333_post	ENSG00000169689	201254	centromere protein X	CENP-X|FAAP10|MGC14480|MHF2|STRA13	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31099
2.54386358411796e-107	0.302241049141796	0.335	0.128	5.40087677544084e-103	FNTA	Malignant cells	GSE199333_post	ENSG00000168522	2339	farnesyltransferase, CAAX box, alpha	FPTA|PGGT1A|PTAR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31100
2.84312650241624e-107	0.341290149594733	0.452	0.227	6.03624187727991e-103	PSIP1	Malignant cells	GSE199333_post	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31101
3.2589551096078e-107	0.455744752548884	0.422	0.205	6.91908759320832e-103	CITED4	Malignant cells	GSE199333_post	ENSG00000179862	163732	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4	NA	protein_coding	Q96RK1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31102
3.32034450113289e-107	0.314233083451467	0.361	0.147	7.04942341035524e-103	GATAD1	Malignant cells	GSE199333_post	ENSG00000157259	57798	GATA zinc finger domain containing 1	FLJ22489|ODAG|RG083M05.2	protein_coding	Q8WUU5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31103
3.66483529057045e-107	0.290530889641308	0.298	0.097	7.78081180541011e-103	PDHB	Malignant cells	GSE199333_post	ENSG00000168291	5162	pyruvate dehydrogenase E1 subunit beta	E1beta|PDHE1B	protein_coding	P11177	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31104
3.71463213870641e-107	0.334220265367031	0.439	0.222	7.88653549368758e-103	RER1	Malignant cells	GSE199333_post	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31105
4.32619539923972e-107	-0.383323990350936	0.204	0.374	9.18494545212586e-103	SYAP1	Malignant cells	GSE199333_post	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31106
5.94858213237926e-107	0.303869217626008	0.357	0.146	1.26294347252544e-102	BABAM1	Malignant cells	GSE199333_post	ENSG00000105393	29086	BRISC and BRCA1 A complex member 1	C19orf62|FLJ20571|HSPC142|MERIT40|NBA1	protein_coding	Q9NWV8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31107
7.37971453451424e-107	-0.283381458252633	0.153	0.318	1.56678719282272e-102	TNKS2	Malignant cells	GSE199333_post	ENSG00000107854	80351	tankyrase 2	ARTD6|PARP-5b|PARP-5c|PARP5B|PARP5C|pART6|TANK2|TNKL	protein_coding	Q9H2K2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31108
8.56153921198445e-107	-0.433311932508199	0.412	0.576	1.81770039009642e-102	PSMA3-AS1	Malignant cells	GSE199333_post	ENSG00000257621	379025	PSMA3 antisense RNA 1	FLJ31306	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31109
9.49335037891289e-107	0.291281219139737	0.324	0.118	2.015533218947e-102	OSGEP	Malignant cells	GSE199333_post	ENSG00000092094	55644	O-sialoglycoprotein endopeptidase	GCPL1|KAE1|OSGEP1|PRSMG1|TCS3	protein_coding	Q9NPF4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31110
1.3726663367356e-106	-0.31596853291216	0.209	0.386	2.91430789952335e-102	GTF2B	Malignant cells	GSE199333_post	ENSG00000137947	2959	general transcription factor IIB	TFIIB	protein_coding	Q00403	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31111
1.40242963787278e-106	-0.298229382087111	0.106	0.25	2.9774983641677e-102	PIK3CG	Malignant cells	GSE199333_post	ENSG00000105851	5294	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	NA	protein_coding	P48736	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31112
1.47433473615536e-106	0.39604968055849	0.484	0.25	3.13016007833145e-102	MSI2	Malignant cells	GSE199333_post	ENSG00000153944	124540	musashi RNA binding protein 2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31113
1.87232629940789e-106	0.308847201734666	0.384	0.17	3.97513596627289e-102	PPP1R7	Malignant cells	GSE199333_post	ENSG00000115685	5510	protein phosphatase 1 regulatory subunit 7	sds22	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31114
2.3596018989499e-106	0.316757334948584	0.379	0.167	5.00967079166053e-102	HSD17B10	Malignant cells	GSE199333_post	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31115
2.80065664524234e-106	0.34374452548152	0.488	0.257	5.946074123514e-102	ANP32E	Malignant cells	GSE199333_post	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31116
2.82050753264639e-106	0.276524958198994	0.274	0.08	5.98821954256154e-102	FAM234A	Malignant cells	GSE199333_post	ENSG00000167930	83986	family with sequence similarity 234 member A	C16orf9|DKFZP761D0211|FLJ32603|ITFG3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31117
4.02438339864662e-106	0.292558500309866	0.29	0.092	8.54416839366664e-102	GALNT7	Malignant cells	GSE199333_post	ENSG00000109586	51809	polypeptide N-acetylgalactosaminyltransferase 7	GALNAC-T7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31118
4.88685394456272e-106	0.335327518871492	0.34	0.134	1.03752796097011e-101	TOMM40	Malignant cells	GSE199333_post	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31119
5.54286372403298e-106	0.336004817697223	0.458	0.236	1.17680539724944e-101	NAA10	Malignant cells	GSE199333_post	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31120
5.6907056809568e-106	0.315896804693871	0.877	0.718	1.20819372312394e-101	PSME1	Malignant cells	GSE199333_post	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31121
6.76887292969538e-106	-0.511806217594712	0.426	0.59	1.43709941170363e-101	PIK3R1	Malignant cells	GSE199333_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31122
8.78046949781947e-106	0.30560530772589	0.289	0.092	1.86418147908205e-101	BCAT1	Malignant cells	GSE199333_post	ENSG00000060982	586	branched chain amino acid transaminase 1	BCATc|BCT1	protein_coding	P54687	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31123
8.93322500544479e-106	0.289080790021763	0.271	0.077	1.89661300090598e-101	MAVS	Malignant cells	GSE199333_post	ENSG00000088888	57506	mitochondrial antiviral signaling protein	Cardif|IPS-1|KIAA1271|VISA	protein_coding	Q7Z434	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31124
1.04867584152299e-105	-0.431853025583917	0.16	0.316	2.22644367913745e-101	CCDC71L	Malignant cells	GSE199333_post	ENSG00000253276	168455	coiled-coil domain containing 71 like	C7orf74|FLJ36031	protein_coding	Q8N9Z2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31125
1.19627672530815e-105	0.33393267153414	0.702	0.489	2.53981511550173e-101	MDH2	Malignant cells	GSE199333_post	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31126
1.20009775139513e-105	0.318444836858631	0.354	0.145	2.54792753598699e-101	MTCH2	Malignant cells	GSE199333_post	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31127
1.21713517034454e-105	0.297916878992231	0.273	0.08	2.58409968015848e-101	IFRD2	Malignant cells	GSE199333_post	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31128
1.22469551236211e-105	0.32162956510451	0.431	0.212	2.600151042296e-101	PDAP1	Malignant cells	GSE199333_post	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31129
1.27267453636127e-105	0.317356521558363	0.412	0.195	2.70201530814862e-101	CHMP4A	Malignant cells	GSE199333_post	ENSG00000285302	29082	charged multivesicular body protein 4A	C14orf123|HSPC134|VPS32A	protein_coding	Q9BY43	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31130
1.47416953975637e-105	0.321212030665025	0.457	0.235	3.12980934985676e-101	TBCB	Malignant cells	GSE199333_post	ENSG00000105254	1155	tubulin folding cofactor B	CG22|CKAP1|CKAPI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31131
2.19881553947537e-105	-0.31934191565721	0.232	0.414	4.66830527186015e-101	CUL3	Malignant cells	GSE199333_post	ENSG00000036257	8452	cullin 3	NA	protein_coding	Q13618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31132
2.24286354832577e-105	0.291262528999488	0.336	0.129	4.76182359945045e-101	ZNRD1	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31133
2.35067009027802e-105	0.336423662192097	0.574	0.351	4.99070766866925e-101	CHMP2A	Malignant cells	GSE199333_post	ENSG00000130724	27243	charged multivesicular body protein 2A	BC-2|CHMP2|VPS2|VPS2A	protein_coding	O43633	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31134
2.98823299156722e-105	0.305898800384159	0.322	0.116	6.34431746439636e-101	VAT1	Malignant cells	GSE199333_post	ENSG00000108828	10493	vesicle amine transport 1	FLJ20230|VATI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31135
4.02235737713549e-105	-0.370039846788528	0.152	0.308	8.53986694739636e-101	RALGDS	Malignant cells	GSE199333_post	ENSG00000160271	5900	ral guanine nucleotide dissociation stimulator	RalGEF|RGDS|RGF	protein_coding	Q12967	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31136
5.04282804046783e-105	0.275923632858864	0.261	0.071	1.07064282127173e-100	PCID2	Malignant cells	GSE199333_post	ENSG00000126226	55795	PCI domain containing 2	FLJ11305	protein_coding	Q5JVF3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31137
5.19220732257112e-105	0.335046466581652	0.591	0.367	1.10235753665507e-100	ZNHIT1	Malignant cells	GSE199333_post	ENSG00000106400	10467	zinc finger HIT-type containing 1	CG1I|H_DJ0747G18.14|ZNFN4A1	protein_coding	O43257	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31138
5.59605470093648e-105	0.525487299716079	0.541	0.324	1.18809837355582e-100	HIST1H4C	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31139
5.67146458546129e-105	0.323007602092915	0.6	0.37	1.20410864613929e-100	THOC7	Malignant cells	GSE199333_post	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31140
8.06683611301942e-105	0.327095917263962	0.372	0.162	1.71266997515515e-100	TNRC18	Malignant cells	GSE199333_post	ENSG00000182095	84629	trinucleotide repeat containing 18	CAGL79|KIAA1856|TNRC18A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31141
1.00179205557054e-104	0.293300968659437	0.295	0.097	2.12690471318181e-100	TMEM109	Malignant cells	GSE199333_post	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31142
1.92208099827078e-104	0.277774159232102	0.269	0.076	4.08077016742869e-100	REXO2	Malignant cells	GSE199333_post	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31143
2.21015321315234e-104	0.27453139273917	0.274	0.08	4.69237628684374e-100	PAFAH1B3	Malignant cells	GSE199333_post	ENSG00000079462	5050	platelet activating factor acetylhydrolase 1b catalytic subunit 3	NA	protein_coding	Q15102	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31144
2.55464398153956e-104	0.267643302525333	0.25	0.064	5.42376463720664e-100	EBAG9	Malignant cells	GSE199333_post	ENSG00000147654	9166	estrogen receptor binding site associated antigen 9	EB9|RCAS1	protein_coding	O00559	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31145
3.21640292652097e-104	0.33879322885823	0.42	0.204	6.82874505329666e-100	GSPT1	Malignant cells	GSE199333_post	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31146
3.83221187248966e-104	0.335655363651591	0.261	0.073	8.13616902648279e-100	RRM1	Malignant cells	GSE199333_post	ENSG00000167325	6240	ribonucleotide reductase catalytic subunit M1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31147
4.95485458867881e-104	0.263872530466588	0.251	0.065	1.0519651777224e-99	NUDT22	Malignant cells	GSE199333_post	ENSG00000149761	84304	nudix hydrolase 22	MGC13045	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31148
6.28396171120073e-104	0.278184322285744	0.287	0.092	1.33414791090503e-99	TMEM126B	Malignant cells	GSE199333_post	ENSG00000171204	55863	transmembrane protein 126B	HT007	protein_coding	Q8IUX1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31149
6.3972610783772e-104	0.317564523946694	0.517	0.288	1.35820249955026e-99	DDOST	Malignant cells	GSE199333_post	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31150
8.22362065286925e-104	0.270863433564431	0.272	0.08	1.74595690081067e-99	CYHR1	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31151
8.39976690496645e-104	0.289608552872107	0.322	0.118	1.78335451159343e-99	NUBP2	Malignant cells	GSE199333_post	ENSG00000095906	10101	NUBP iron-sulfur cluster assembly factor 2, cytosolic	CFD1|CIAO6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31152
1.72658862139091e-103	-0.357908665573672	0.291	0.466	3.66572030207505e-99	UBQLN1	Malignant cells	GSE199333_post	ENSG00000135018	29979	ubiquilin 1	DA41|DSK2|PLIC-1|XDRP1	protein_coding	Q9UMX0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31153
1.82780279499848e-103	-0.337705769660571	0.153	0.316	3.88060811406128e-99	SCPEP1	Malignant cells	GSE199333_post	ENSG00000121064	59342	serine carboxypeptidase 1	RISC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31154
2.27834265592134e-103	0.269176271086045	0.254	0.067	4.8371492927866e-99	IVD	Malignant cells	GSE199333_post	ENSG00000128928	3712	isovaleryl-CoA dehydrogenase	ACAD2|IVDH	protein_coding	P26440	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31155
2.56946054147891e-103	-0.320862780534061	0.209	0.383	5.45522167561387e-99	SAP30BP	Malignant cells	GSE199333_post	ENSG00000161526	29115	SAP30 binding protein	HCNGP|HTRG|HTRP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31156
2.62111629370563e-103	0.263362822366748	0.25	0.063	5.56489200316642e-99	ENOSF1	Malignant cells	GSE199333_post	ENSG00000132199	55556	enolase superfamily member 1	FUCD|HSRTSBETA|rTS|TYMSAS	protein_coding	Q7L5Y1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31157
2.70286087541136e-103	0.279638176182202	0.27	0.08	5.73844392458586e-99	HAUS1	Malignant cells	GSE199333_post	ENSG00000152240	115106	HAUS augmin like complex subunit 1	CCDC5|FLJ40084|HEI-C|HsT1461	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31158
2.96920109418372e-103	0.336536332520716	0.529	0.309	6.30391084306146e-99	UQCRC1	Malignant cells	GSE199333_post	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31159
3.45837639249226e-103	0.303404187798762	0.29	0.094	7.34247891890032e-99	RARRES3	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31160
3.60059919112259e-103	0.303536186108937	0.909	0.773	7.64443214267236e-99	COX6C	Malignant cells	GSE199333_post	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31161
4.39409965243337e-103	-0.318489778151916	0.211	0.384	9.32911297208129e-99	SP3	Malignant cells	GSE199333_post	ENSG00000172845	6670	Sp3 transcription factor	SPR-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31162
4.56358442706197e-103	0.287753330781504	0.303	0.105	9.68894609709527e-99	PLXND1	Malignant cells	GSE199333_post	ENSG00000004399	23129	plexin D1	KIAA0620	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31163
7.96838947642961e-103	-0.342159972896874	0.159	0.319	1.69176876974077e-98	ZNF791	Malignant cells	GSE199333_post	ENSG00000173875	163049	zinc finger protein 791	FLJ90396	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31164
9.37005960466978e-103	0.274155827474653	0.252	0.066	1.98935735466744e-98	SMIM37	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31165
1.23275292513298e-102	0.283862538359949	0.27	0.078	2.61725773534982e-98	LMNB1	Malignant cells	GSE199333_post	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31166
1.60041362102226e-102	0.342682416502092	0.532	0.308	3.39783815879236e-98	BPTF	Malignant cells	GSE199333_post	ENSG00000171634	2186	bromodomain PHD finger transcription factor	FAC1|FALZ|NURF301	protein_coding	Q12830	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31167
1.68410593414792e-102	0.373543405029463	0.784	0.618	3.57552530878945e-98	H2AFV	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31168
2.7065099212513e-102	0.279553193515805	0.298	0.102	5.74619121380863e-98	COMMD4	Malignant cells	GSE199333_post	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31169
2.95610074495507e-102	0.310073229904386	0.368	0.159	6.27609749161411e-98	CHID1	Malignant cells	GSE199333_post	ENSG00000177830	66005	chitinase domain containing 1	FLJ42707|MGC3234|SI-CLP	protein_coding	Q9BWS9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31170
3.09905972832851e-102	0.275646438867945	0.305	0.107	6.57961370921425e-98	DDRGK1	Malignant cells	GSE199333_post	ENSG00000198171	65992	DDRGK domain containing 1	C20orf116|dJ1187M17.3|UFBP1	protein_coding	Q96HY6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31171
3.31702524726022e-102	0.38566863765724	0.409	0.198	7.04237630245817e-98	BCL11A	Malignant cells	GSE199333_post	ENSG00000119866	53335	BAF chromatin remodeling complex subunit BCL11A	BCL11A-L|BCL11A-S|BCL11A-XL|CTIP1|EVI9|HBFQTL5|SMARCM1|ZNF856	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31172
3.44925632653341e-102	0.359303984364257	0.393	0.179	7.32311610686309e-98	TNRC6B	Malignant cells	GSE199333_post	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31173
3.53628735063149e-102	0.330538774352793	0.448	0.231	7.50789167412571e-98	ATG3	Malignant cells	GSE199333_post	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31174
4.28990381422647e-102	0.275263138833592	0.271	0.08	9.10789478798422e-98	SRSF8	Malignant cells	GSE199333_post	ENSG00000263465	10929	serine and arginine rich splicing factor 8	SFRS2B|SRP46	protein_coding	Q9BRL6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31175
4.29669757007267e-102	0.269101617921616	0.278	0.086	9.1223186110213e-98	ARMC10	Malignant cells	GSE199333_post	ENSG00000282813	83787	armadillo repeat containing 10	MGC3195|SVH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31176
5.51119298920265e-102	0.321330719233252	0.528	0.308	1.17008138353761e-97	TMEM230	Malignant cells	GSE199333_post	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31177
9.66358987698372e-102	0.272914104138971	0.28	0.088	2.05167676678241e-97	MEA1	Malignant cells	GSE199333_post	ENSG00000124733	4201	male-enhanced antigen 1	MEA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31178
1.0478684754347e-101	0.315939472009165	0.506	0.284	2.22472956019542e-97	FAM96B	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31179
1.20401865473431e-101	-0.408143066614756	0.592	0.725	2.55625200586641e-97	CSNK1A1	Malignant cells	GSE199333_post	ENSG00000113712	1452	casein kinase 1 alpha 1	CK1|CK1a|CK1alpha|CKIa|CKIalpha	protein_coding	P48729	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31180
1.22873323188281e-101	0.318646710970243	0.494	0.275	2.60872352461039e-97	OLA1	Malignant cells	GSE199333_post	ENSG00000138430	29789	Obg like ATPase 1	GTPBP9|PTD004	protein_coding	Q9NTK5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31181
1.2577967686982e-101	0.288776778558277	0.269	0.08	2.67042831962315e-97	FHL3	Malignant cells	GSE199333_post	ENSG00000183386	2275	four and a half LIM domains 3	SLIM2	protein_coding	Q13643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31182
1.31427410621991e-101	-0.32963712195966	0.234	0.412	2.7903353549155e-97	KDM2A	Malignant cells	GSE199333_post	ENSG00000173120	22992	lysine demethylase 2A	CXXC8|DKFZP434M1735|FBL11|FBL7|FBXL11|FLJ00115|JHDM1A|KIAA1004|LILINA	protein_coding	Q9Y2K7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31183
1.41582356771815e-101	0.259795476540072	0.984	0.954	3.0059350166224e-97	PFN1	Malignant cells	GSE199333_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31184
1.44289122287168e-101	0.297560471878922	0.351	0.145	3.06340235527887e-97	SEPHS2	Malignant cells	GSE199333_post	ENSG00000179918	22928	selenophosphate synthetase 2	SPS2|SPS2b	protein_coding	Q99611	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31185
2.00448392811489e-101	0.435156466994855	0.737	0.568	4.25571982778073e-97	PKM	Malignant cells	GSE199333_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31186
2.13070091072866e-101	0.356100992607683	0.461	0.249	4.52369110356801e-97	G3BP1	Malignant cells	GSE199333_post	ENSG00000145907	10146	G3BP stress granule assembly factor 1	G3BP|HDH-VIII	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31187
2.33418973226783e-101	0.344469524094823	0.625	0.41	4.95571822057783e-97	HNRNPR	Malignant cells	GSE199333_post	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31188
2.98041369475128e-101	0.317840363940961	0.476	0.26	6.32771631532643e-97	HADHB	Malignant cells	GSE199333_post	ENSG00000138029	3032	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta	MTPB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31189
3.54564976196285e-101	0.293875582588826	0.336	0.134	7.52776900962332e-97	POP5	Malignant cells	GSE199333_post	ENSG00000167272	51367	POP5 homolog, ribonuclease P/MRP subunit	NA	protein_coding	Q969H6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31190
4.02338678973648e-101	0.347080617035328	0.913	0.84	8.54205249328953e-97	SLC25A3	Malignant cells	GSE199333_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31191
4.79058477942221e-101	0.420465344123758	0.408	0.191	1.01708905451913e-96	CTSG	Malignant cells	GSE199333_post	ENSG00000100448	1511	cathepsin G	CG	protein_coding	P08311	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31192
4.83401277551854e-101	0.333562282998113	0.614	0.4	1.02630925237034e-96	ENSA	Malignant cells	GSE199333_post	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31193
4.94923701533696e-101	-0.282874091633902	0.119	0.266	1.05077251072619e-96	TLR2	Malignant cells	GSE199333_post	ENSG00000137462	7097	toll like receptor 2	CD282|TIL4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31194
6.82254014178745e-101	-0.368694029101516	0.272	0.449	1.44849349750289e-96	CDC42SE2	Malignant cells	GSE199333_post	ENSG00000158985	56990	CDC42 small effector 2	FLJ21967|SPEC2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31195
7.53223562754222e-101	0.310647210514694	0.377	0.169	1.59916894608349e-96	SPART	Malignant cells	GSE199333_post	ENSG00000133104	23111	spartin	KIAA0610|SPG20|TAHCCP1	protein_coding	Q8N0X7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31196
7.59774421949793e-101	0.336689266531238	0.415	0.205	1.61307707524161e-96	HPRT1	Malignant cells	GSE199333_post	ENSG00000165704	3251	hypoxanthine phosphoribosyltransferase 1	HGPRT|HPRT	protein_coding	P00492	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31197
9.60295544304122e-101	0.27883041298554	0.311	0.112	2.03880347011208e-96	OARD1	Malignant cells	GSE199333_post	ENSG00000124596	221443	O-acyl-ADP-ribose deacylase 1	C6orf130|dJ34B21.3|MGC19570|TARG1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31198
1.72107302314667e-100	0.285348842341566	0.251	0.068	3.6540101354427e-96	CHCHD7	Malignant cells	GSE199333_post	ENSG00000170791	79145	coiled-coil-helix-coiled-coil-helix domain containing 7	COX23|MGC2217	protein_coding	Q9BUK0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31199
2.54084264030877e-100	0.317857374925398	0.45	0.236	5.39446300963955e-96	ABHD14B	Malignant cells	GSE199333_post	ENSG00000114779	84836	abhydrolase domain containing 14B	CIB|MGC15429	protein_coding	Q96IU4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31200
2.76990905344956e-100	0.276127295804196	0.313	0.116	5.88079391137877e-96	URM1	Malignant cells	GSE199333_post	ENSG00000167118	81605	ubiquitin related modifier 1	C9orf74|MGC2668	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31201
3.36366926250118e-100	0.264214278535365	0.254	0.07	7.14140621121626e-96	MRPS31	Malignant cells	GSE199333_post	ENSG00000102738	10240	mitochondrial ribosomal protein S31	IMOGN38	protein_coding	Q92665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31202
3.87972405754281e-100	0.337091568324715	0.411	0.198	8.23704214656914e-96	ITGA4	Malignant cells	GSE199333_post	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31203
4.74698425036472e-100	-0.547132815480191	0.367	0.523	1.00783222619493e-95	DYNC1H1	Malignant cells	GSE199333_post	ENSG00000197102	1778	dynein cytoplasmic 1 heavy chain 1	CMT2O|DHC1|DNCH1|Dnchc1|DNCL|DNECL|HL-3|p22	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31204
6.7476545304404e-100	0.306510776224961	0.382	0.172	1.4325945333578e-95	SLC2A4RG	Malignant cells	GSE199333_post	ENSG00000125520	56731	SLC2A4 regulator	GEF|HDBP1|Si-1-2|Si-1-2-19	protein_coding	Q9NR83	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31205
7.20114843952911e-100	0.332218939527918	0.599	0.378	1.52887582519642e-95	FBL	Malignant cells	GSE199333_post	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31206
1.02519312538492e-99	0.346698943121016	0.37	0.163	2.17658752450472e-95	DNMT1	Malignant cells	GSE199333_post	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31207
1.17687393169682e-99	0.333979140776664	0.665	0.463	2.49862104438551e-95	EIF3I	Malignant cells	GSE199333_post	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31208
1.28862854544146e-99	-0.466567278840667	0.153	0.302	2.73588726482677e-95	INSIG1	Malignant cells	GSE199333_post	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31209
1.33970323820533e-99	0.349625123171509	0.572	0.362	2.84432394503374e-95	VPS29	Malignant cells	GSE199333_post	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31210
1.40979997529777e-99	0.311951771912306	0.451	0.234	2.9931463275547e-95	FKBP2	Malignant cells	GSE199333_post	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31211
1.54315415269818e-99	0.305417475435577	0.381	0.174	3.27627058159351e-95	IMP3	Malignant cells	GSE199333_post	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31212
1.60245394845271e-99	0.285418048102526	0.304	0.109	3.40216997795995e-95	SLC38A10	Malignant cells	GSE199333_post	ENSG00000157637	124565	solute carrier family 38 member 10	MGC15523|PP1744	protein_coding	Q9HBR0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31213
2.61539160186956e-99	0.281988886031502	0.318	0.118	5.55273790992926e-95	CREBZF	Malignant cells	GSE199333_post	ENSG00000137504	58487	CREB/ATF bZIP transcription factor	ZF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31214
3.08341493045164e-99	0.312315421304943	0.394	0.186	6.54639823884187e-95	NME3	Malignant cells	GSE199333_post	ENSG00000103024	4832	NME/NM23 nucleoside diphosphate kinase 3	DR-nm23|NDPKC|NM23-H3	protein_coding	Q13232	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31215
3.33061854392793e-99	-0.34167418311616	0.162	0.317	7.07123623061338e-95	C15orf39	Malignant cells	GSE199333_post	ENSG00000167173	56905	chromosome 15 open reading frame 39	DKFZP434H132|FLJ46337	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31216
3.97599662626942e-99	-0.331677448609713	0.241	0.416	8.44143843723261e-95	COL4A3BP	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31217
4.42742302730395e-99	-0.355883061865938	0.221	0.391	9.39986182926902e-95	KLHL24	Malignant cells	GSE199333_post	ENSG00000114796	54800	kelch like family member 24	DRE1|FLJ20059	protein_coding	Q6TFL4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31218
4.49981464927237e-99	0.265976688324521	0.266	0.08	9.55355648187016e-95	ERI3	Malignant cells	GSE199333_post	ENSG00000117419	79033	ERI1 exoribonuclease family member 3	FLJ22943|PINT1|PRNPIP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31219
5.05449882301932e-99	0.277080864331629	0.289	0.098	1.07312064511523e-94	TARBP1	Malignant cells	GSE199333_post	ENSG00000059588	6894	TAR (HIV-1) RNA binding protein 1	TRM3|TRMT3|TRP-185	protein_coding	Q13395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31220
5.31140416649629e-99	0.319501781321337	0.427	0.212	1.12766421858883e-94	CSK	Malignant cells	GSE199333_post	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31221
5.66254610636146e-99	-0.255123888044473	0.126	0.274	1.2022151638416e-94	KDM3A	Malignant cells	GSE199333_post	ENSG00000115548	55818	lysine demethylase 3A	JHMD2A|JMJD1|JMJD1A|KIAA0742|TSGA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31222
6.19710675998282e-99	0.324379600938051	0.485	0.273	1.31570773621195e-94	NDUFS3	Malignant cells	GSE199333_post	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31223
6.34918407468708e-99	-0.365165020613321	0.317	0.493	1.34799527089681e-94	TM9SF3	Malignant cells	GSE199333_post	ENSG00000077147	56889	transmembrane 9 superfamily member 3	SMBP	protein_coding	Q9HD45	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31224
9.28093260041527e-99	0.285824336390919	0.327	0.128	1.97043480039417e-94	CARS2	Malignant cells	GSE199333_post	ENSG00000134905	79587	cysteinyl-tRNA synthetase 2, mitochondrial	FLJ12118	protein_coding	Q9HA77	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31225
1.00873643914406e-98	0.3026302083517	0.327	0.13	2.14164833394675e-94	UROS	Malignant cells	GSE199333_post	ENSG00000188690	7390	uroporphyrinogen III synthase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31226
1.04530656979271e-98	0.30257473774564	0.423	0.208	2.21929037832689e-94	CYTOR	Malignant cells	GSE199333_post	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31227
1.51213988878983e-98	0.311356592783577	0.385	0.176	3.2104241978897e-94	BBX	Malignant cells	GSE199333_post	ENSG00000114439	56987	BBX high mobility group box domain containing	HBP2|HSPC339|MDS001	protein_coding	Q8WY36	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31228
2.22813971942119e-98	0.320694141853312	0.673	0.457	4.73056343830313e-94	ATP5PD	Malignant cells	GSE199333_post	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31229
2.36727568542845e-98	0.294050429130402	0.9	0.78	5.02596300773313e-94	OST4	Malignant cells	GSE199333_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31230
2.50395055539412e-98	0.283169008646423	0.259	0.074	5.31613742415727e-94	MATK	Malignant cells	GSE199333_post	ENSG00000007264	4145	megakaryocyte-associated tyrosine kinase	CHK|CTK|DKFZp434N1212|HHYLTK|HYL|HYLTK|Lsk|MGC1708|MGC2101	protein_coding	P42679	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31231
2.91919858189136e-98	-0.425524076044515	0.53	0.697	6.19775050921355e-94	PPP1R15A	Malignant cells	GSE199333_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31232
3.0870608484973e-98	0.295069284969725	0.353	0.151	6.55413888744462e-94	POLR2H	Malignant cells	GSE199333_post	ENSG00000163882	5437	RNA polymerase II, I and III subunit H	RPB8	protein_coding	P52434	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31233
4.49059056906365e-98	0.325594167686348	0.605	0.398	9.53397283717903e-94	OCIAD1	Malignant cells	GSE199333_post	ENSG00000109180	54940	OCIA domain containing 1	Asrij|FLJ20455|OCIA|TPA018	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31234
5.85901930023485e-98	0.312328413343822	0.403	0.196	1.24392838763286e-93	NT5C	Malignant cells	GSE199333_post	ENSG00000125458	30833	5', 3'-nucleotidase, cytosolic	cdN|DNT-1|DNT1|PN-I|UMPH2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31235
5.86050290822447e-98	0.287514949278363	0.347	0.145	1.24424337244514e-93	COMMD8	Malignant cells	GSE199333_post	ENSG00000169019	54951	COMM domain containing 8	FLJ20502	protein_coding	Q9NX08	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31236
7.53063226647161e-98	0.338099253809212	0.311	0.116	1.59882853649459e-93	CENPW	Malignant cells	GSE199333_post	ENSG00000203760	387103	centromere protein W	C6orf173|CUG2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31237
7.61970080606604e-98	0.315826177243505	0.401	0.192	1.61773867813588e-93	GLRX	Malignant cells	GSE199333_post	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31238
1.09919872497663e-97	0.33770155978367	0.601	0.385	2.33370881299788e-93	TTC3	Malignant cells	GSE199333_post	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31239
1.13310520427442e-97	-0.387276079625958	0.516	0.67	2.40569565919502e-93	TAX1BP1	Malignant cells	GSE199333_post	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31240
1.53498153939423e-97	0.315195590052162	0.738	0.54	3.25891930628789e-93	BRK1	Malignant cells	GSE199333_post	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31241
2.02312238363547e-97	-0.545304979162875	0.547	0.663	4.29529113269647e-93	DDX21	Malignant cells	GSE199333_post	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31242
2.12945990334668e-97	0.265155593561138	0.255	0.073	4.52105632079534e-93	AKR1B1	Malignant cells	GSE199333_post	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31243
2.54201751063854e-97	0.288841088329853	0.345	0.144	5.39695737683667e-93	AIP	Malignant cells	GSE199333_post	ENSG00000110711	9049	aryl hydrocarbon receptor interacting protein	ARA9|FKBP16|FKBP37|XAP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31244
2.57839623170416e-97	-0.267677149614209	0.117	0.259	5.4741930395311e-93	BRD1	Malignant cells	GSE199333_post	ENSG00000100425	23774	bromodomain containing 1	BRL|BRPF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31245
3.14358026352989e-97	0.301695233541598	0.28	0.095	6.67413525750031e-93	COLGALT1	Malignant cells	GSE199333_post	ENSG00000130309	79709	collagen beta(1-O)galactosyltransferase 1	FLJ22329|GLT25D1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31246
3.21312777521278e-97	0.311926257210632	0.6	0.385	6.82179157955426e-93	UQCRC2	Malignant cells	GSE199333_post	ENSG00000140740	7385	ubiquinol-cytochrome c reductase core protein 2	QCR2|UQCR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31247
3.5506802234922e-97	0.304937415671161	0.276	0.09	7.53844918249628e-93	PBXIP1	Malignant cells	GSE199333_post	ENSG00000163346	57326	PBX homeobox interacting protein 1	HPIP	protein_coding	Q96AQ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31248
3.78944445347857e-97	0.305181298612186	0.409	0.2	8.04536951918035e-93	MRPS18C	Malignant cells	GSE199333_post	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31249
4.31048078235121e-97	0.356520271187979	0.321	0.126	9.15158174900986e-93	LTC4S	Malignant cells	GSE199333_post	ENSG00000283887	4056	leukotriene C4 synthase	MGC33147	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31250
4.59968435361704e-97	-0.584136854013788	0.4	0.532	9.76558985116434e-93	DSTN	Malignant cells	GSE199333_post	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31251
5.56424798741252e-97	-0.453376433260598	0.274	0.441	1.18134549020755e-92	KLF3	Malignant cells	GSE199333_post	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31252
6.90070837500804e-97	0.301825098931636	0.838	0.671	1.46508939509796e-92	SNRPD2	Malignant cells	GSE199333_post	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31253
9.82229007406047e-97	0.350959808466347	0.637	0.431	2.08537040562378e-92	PGAM1	Malignant cells	GSE199333_post	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31254
1.24674154549589e-96	0.283187965482655	0.983	0.962	2.64695697524233e-92	CFL1	Malignant cells	GSE199333_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31255
1.27922187703189e-96	0.289110663906221	0.365	0.159	2.71591596712641e-92	NCBP2	Malignant cells	GSE199333_post	ENSG00000114503	22916	nuclear cap binding protein subunit 2	Cbc2|CBP20|NIP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31256
1.28102134949618e-96	0.290484113759628	0.365	0.161	2.71973642711533e-92	PCMT1	Malignant cells	GSE199333_post	ENSG00000120265	5110	protein-L-isoaspartate (D-aspartate) O-methyltransferase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31257
1.58547822270493e-96	0.294828254732158	0.341	0.141	3.36612881462483e-92	EXOSC8	Malignant cells	GSE199333_post	ENSG00000120699	11340	exosome component 8	bA421P11.3|CIP3|EAP2|OIP2|p9|RRP43|Rrp43p	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31258
1.61194411009606e-96	0.257683148918338	0.26	0.079	3.42231854014496e-92	EDEM2	Malignant cells	GSE199333_post	ENSG00000088298	55741	ER degradation enhancing alpha-mannosidase like protein 2	bA4204.1|C20orf31|C20orf49|FLJ10783	protein_coding	Q9BV94	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31259
1.78373976646324e-96	-0.27714007763078	0.134	0.281	3.78705789817811e-92	SLC25A33	Malignant cells	GSE199333_post	ENSG00000171612	84275	solute carrier family 25 member 33	BMSC-MCP|MGC4399|PNC1	protein_coding	Q9BSK2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31260
2.14698136676006e-96	0.296936261263508	0.419	0.211	4.55825613976828e-92	SDHD	Malignant cells	GSE199333_post	ENSG00000204370	6392	succinate dehydrogenase complex subunit D	cybS|PGL|PGL1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31261
2.20780224467561e-96	0.273700506579525	0.299	0.107	4.68738494567078e-92	SHISA5	Malignant cells	GSE199333_post	ENSG00000164054	51246	shisa family member 5	hShisa5|SCOTIN	protein_coding	Q8N114	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31262
2.90503126626838e-96	0.276626081855578	0.332	0.136	6.16767188141439e-92	TRAPPC3	Malignant cells	GSE199333_post	ENSG00000054116	27095	trafficking protein particle complex subunit 3	BET3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31263
3.38552533171605e-96	0.314231927305396	0.396	0.194	7.18780883176635e-92	LSM6	Malignant cells	GSE199333_post	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31264
3.84435917475984e-96	0.365323838379057	0.429	0.226	8.16195896393261e-92	DKC1	Malignant cells	GSE199333_post	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31265
5.32279380913547e-96	-0.377990148069855	0.667	0.79	1.13008235361755e-91	DDX3X	Malignant cells	GSE199333_post	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31266
7.78011016394549e-96	0.31915608181202	0.556	0.344	1.65179518890727e-91	CTDNEP1	Malignant cells	GSE199333_post	ENSG00000288307	23399	CTD nuclear envelope phosphatase 1	DULLARD|HSA011916|NET56	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31267
1.1709274781417e-95	-0.344623087543717	0.252	0.421	2.48599612884264e-91	PSMD12	Malignant cells	GSE199333_post	ENSG00000197170	5718	proteasome 26S subunit, non-ATPase 12	p55|Rpn5	protein_coding	O00232	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31268
1.20054761922181e-95	0.317364530980085	0.825	0.669	2.54888265036982e-91	UBL5	Malignant cells	GSE199333_post	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31269
1.26534553304762e-95	0.303894408559669	0.48	0.265	2.68645510121341e-91	ATP6AP1	Malignant cells	GSE199333_post	ENSG00000071553	537	ATPase H+ transporting accessory protein 1	16A|Ac45|ATP6IP1|ATP6S1|CF2|ORF|VATPS1|XAP-3|XAP3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31270
1.3907271530136e-95	0.258315062695379	0.267	0.084	2.95265281856318e-91	CWC27	Malignant cells	GSE199333_post	ENSG00000153015	10283	CWC27 spliceosome associated cyclophilin	NY-CO-10|SDCCAG-10|SDCCAG10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31271
1.66326337094995e-95	-0.362206554143817	0.217	0.382	3.53127446286384e-91	KLF13	Malignant cells	GSE199333_post	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31272
1.95765497880831e-95	-0.381202782941605	0.748	0.822	4.15629728550792e-91	MORF4L1	Malignant cells	GSE199333_post	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31273
2.43588925850487e-95	0.292629683832265	0.35	0.153	5.1716364847317e-91	YWHAG	Malignant cells	GSE199333_post	ENSG00000170027	7532	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma	14-3-3GAMMA|PPP1R170	protein_coding	P61981	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31274
2.47843137988669e-95	0.278287781367819	0.294	0.106	5.26195766263744e-91	TSPAN32	Malignant cells	GSE199333_post	ENSG00000064201	10077	tetraspanin 32	PHEMX|TSSC6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31275
2.5775133509805e-95	0.281930486008412	0.409	0.195	5.4723185954667e-91	CCND2	Malignant cells	GSE199333_post	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31276
3.2170334837159e-95	0.302742004978259	0.475	0.264	6.83008378927723e-91	PSMD13	Malignant cells	GSE199333_post	ENSG00000185627	5719	proteasome 26S subunit, non-ATPase 13	p40.5|Rpn9	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31277
3.31311848229351e-95	0.269090544423233	0.304	0.113	7.03408184975735e-91	FAM192A	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31278
3.43595418664218e-95	0.261375304327312	0.275	0.091	7.29487433366001e-91	DEF6	Malignant cells	GSE199333_post	ENSG00000023892	50619	DEF6 guanine nucleotide exchange factor	IBP|SLAT|SWAP70L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31279
5.65096346179907e-95	0.268321704122899	0.271	0.088	1.19975605257456e-90	UCHL5	Malignant cells	GSE199333_post	ENSG00000116750	51377	ubiquitin C-terminal hydrolase L5	CGI-70|INO80R|UCH37	protein_coding	Q9Y5K5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31280
5.7946052666654e-95	-0.34251921391224	0.205	0.366	1.23025264416573e-90	RNF19A	Malignant cells	GSE199333_post	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31281
7.22835449350797e-95	0.3478671424632	0.573	0.369	1.53465194251668e-90	NDUFAB1	Malignant cells	GSE199333_post	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31282
7.78913109711048e-95	0.264801144483143	0.27	0.086	1.65371042322753e-90	MBD3	Malignant cells	GSE199333_post	ENSG00000071655	53615	methyl-CpG binding domain protein 3	NA	protein_coding	O95983	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31283
8.53410453989551e-95	-0.637460221780588	0.653	0.719	1.81187573486522e-90	NPC2	Malignant cells	GSE199333_post	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31284
9.27868780275955e-95	0.341969941512337	0.639	0.433	1.96995820740388e-90	N4BP2L2	Malignant cells	GSE199333_post	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31285
9.89214485040766e-95	0.301518983549374	0.35	0.152	2.10020127319005e-90	TBXAS1	Malignant cells	GSE199333_post	ENSG00000059377	6916	thromboxane A synthase 1	CYP5|CYP5A1|THAS|TS|TXAS|TXS	protein_coding	P24557	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31286
1.18631312378573e-94	0.264739882734906	0.261	0.081	2.51866139310949e-90	ZCCHC17	Malignant cells	GSE199333_post	ENSG00000121766	51538	zinc finger CCHC-type containing 17	HSPC251|pNO40|PS1D	protein_coding	Q9NP64	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31287
1.34264800711953e-94	0.272751752855011	0.291	0.104	2.85057598391548e-90	HINT2	Malignant cells	GSE199333_post	ENSG00000137133	84681	histidine triad nucleotide binding protein 2	NA	protein_coding	Q9BX68	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31288
1.99141349637627e-94	0.309213024171044	0.301	0.113	4.22796999415646e-90	SNRNP25	Malignant cells	GSE199333_post	ENSG00000161981	79622	small nuclear ribonucleoprotein U11/U12 subunit 25	C16orf33|U11/U12-25K	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31289
2.55729041454652e-94	0.268790053824151	0.288	0.102	5.42938327912371e-90	FXN	Malignant cells	GSE199333_post	ENSG00000165060	2395	frataxin	CyaY|FA|FARR|FRDA|X25	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31290
3.56917167970569e-94	0.310008011623883	0.716	0.524	7.57770839318315e-90	PSMA1	Malignant cells	GSE199333_post	ENSG00000129084	5682	proteasome 20S subunit alpha 1	HC2|MGC14542|MGC14575|MGC14751|MGC1667|MGC21459|MGC22853|MGC23915|NU|PROS30	protein_coding	P25786	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31291
6.30684993460921e-94	0.273048675357716	0.376	0.171	1.33900730961688e-89	CASP2	Malignant cells	GSE199333_post	ENSG00000106144	835	caspase 2	ICH1|MGC2181|NEDD2|PPP1R57	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31292
1.11646486669077e-93	0.285421607548532	0.343	0.147	2.37036655847117e-89	MRPS7	Malignant cells	GSE199333_post	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31293
1.1579493174259e-93	0.277745007084674	0.432	0.221	2.45844219582694e-89	APP	Malignant cells	GSE199333_post	ENSG00000142192	351	amyloid beta precursor protein	AD1|alpha-sAPP	protein_coding	P05067	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31294
1.16465990690421e-93	0.327427707517609	0.86	0.732	2.47268944834833e-89	COX5A	Malignant cells	GSE199333_post	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31295
1.28832540411546e-93	0.293879580943434	0.4	0.193	2.73524366547753e-89	TAF15	Malignant cells	GSE199333_post	ENSG00000276833	8148	TATA-box binding protein associated factor 15	hTAFII68|Npl3|RBP56|TAF2N	protein_coding	Q92804	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31296
1.77379959267574e-93	0.284795710397541	0.566	0.338	3.76595391520986e-89	GNA15	Malignant cells	GSE199333_post	ENSG00000060558	2769	G protein subunit alpha 15	GNA16	protein_coding	P30679	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31297
2.06921975911038e-93	0.324999788058779	0.334	0.138	4.39316047056724e-89	TMPO	Malignant cells	GSE199333_post	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31298
3.86972414896157e-93	-0.409901492476089	0.258	0.419	8.21581134066031e-89	MAFG	Malignant cells	GSE199333_post	ENSG00000197063	4097	MAF bZIP transcription factor G	MGC13090|MGC20149	protein_coding	O15525	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31299
5.25659292493621e-93	0.34222236453977	0.456	0.253	1.11602724389321e-88	TXNDC17	Malignant cells	GSE199333_post	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31300
5.97775426456594e-93	0.3096453737907	0.683	0.481	1.26913700790999e-88	NDUFB4	Malignant cells	GSE199333_post	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31301
7.26290889091125e-93	0.288210527080773	0.32	0.126	1.54198818662937e-88	SLC38A1	Malignant cells	GSE199333_post	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31302
1.27081532201089e-92	-0.395798952266034	0.38	0.544	2.69806801016131e-88	RBM5	Malignant cells	GSE199333_post	ENSG00000003756	10181	RNA binding motif protein 5	H37|LUCA-15|LUCA15	protein_coding	P52756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31303
1.43999982141002e-92	0.304599461306146	0.396	0.186	3.05726362083561e-88	CD84	Malignant cells	GSE199333_post	ENSG00000066294	8832	CD84 molecule	hCD84|mCD84|SLAMF5	protein_coding	Q9UIB8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31304
1.72213796953579e-92	-0.321653428031617	0.961	0.955	3.65627112312143e-88	SRGN	Malignant cells	GSE199333_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31305
1.80361794485922e-92	0.272054279606761	0.324	0.132	3.8292612587306e-88	VBP1	Malignant cells	GSE199333_post	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31306
1.82412475999812e-92	0.352064667750107	0.589	0.371	3.872799277952e-88	HNRNPAB	Malignant cells	GSE199333_post	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31307
2.45316423590574e-92	0.261289097161739	0.316	0.124	5.20831298925147e-88	NOSIP	Malignant cells	GSE199333_post	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31308
3.37742247292368e-92	0.292377655964055	0.428	0.221	7.17060565226427e-88	ZNF428	Malignant cells	GSE199333_post	ENSG00000131116	126299	zinc finger protein 428	C19orf37|MGC51082|Zfp428	protein_coding	Q96B54	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31309
3.85211731298858e-92	-0.357549082609753	0.252	0.413	8.17843026720606e-88	DCP2	Malignant cells	GSE199333_post	ENSG00000172795	167227	decapping mRNA 2	NUDT20	protein_coding	Q8IU60	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31310
4.32107500100676e-92	0.271652155581188	0.295	0.11	9.17407433463744e-88	C1orf123	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31311
4.67329987676062e-92	0.393867254268073	0.52	0.319	9.92188296835046e-88	TUBA1C	Malignant cells	GSE199333_post	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31312
5.1586472171287e-92	0.297873139126923	0.335	0.143	1.09523239066859e-87	PHKB	Malignant cells	GSE199333_post	ENSG00000102893	5257	phosphorylase kinase regulatory subunit beta	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31313
5.65307453564708e-92	0.293433177696391	0.36	0.165	1.20020425466323e-87	ESYT2	Malignant cells	GSE199333_post	ENSG00000117868	57488	extended synaptotagmin 2	CHR2SYT|FAM62B|KIAA1228	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31314
8.89581738798515e-92	0.287934559070587	0.293	0.107	1.88867098964313e-87	SPNS3	Malignant cells	GSE199333_post	ENSG00000182557	201305	sphingolipid transporter 3 (putative)	MGC29671|SLC63A3	protein_coding	Q6ZMD2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31315
9.82803705945463e-92	-0.26308998171557	0.132	0.276	2.08659054809281e-87	ZFAND3	Malignant cells	GSE199333_post	ENSG00000156639	60685	zinc finger AN1-type containing 3	FLJ13222|TEX27	protein_coding	Q9H8U3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31316
1.11654321999896e-91	0.261500191890127	0.289	0.105	2.3705329103798e-87	GLOD4	Malignant cells	GSE199333_post	ENSG00000167699	51031	glyoxalase domain containing 4	C17orf25|CGI-150|HC71	protein_coding	Q9HC38	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31317
1.6340917507443e-91	0.326386736211361	0.566	0.35	3.46934019600523e-87	PTPN6	Malignant cells	GSE199333_post	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31318
1.67331866639854e-91	0.273576684252941	0.287	0.104	3.55262286063075e-87	UQCC3	Malignant cells	GSE199333_post	ENSG00000204922	790955	ubiquinol-cytochrome c reductase complex assembly factor 3	C11orf83|UNQ655	protein_coding	Q6UW78	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31319
1.76641363538134e-91	0.275629569971062	0.25	0.074	3.75027278927813e-87	GGH	Malignant cells	GSE199333_post	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31320
2.77608124709954e-91	-0.288044916244706	0.182	0.339	5.89389809571703e-87	COX19	Malignant cells	GSE199333_post	ENSG00000240230	90639	cytochrome c oxidase assembly factor COX19	MGC104475	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31321
4.60554676633953e-91	0.270380676524739	0.355	0.159	9.77803633961545e-87	ASNA1	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31322
8.29400936385387e-91	-0.399944758857953	0.168	0.318	1.76090112803981e-86	CDKN2D	Malignant cells	GSE199333_post	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31323
1.13620962293213e-90	0.260624816631799	0.29	0.106	2.41228665044721e-86	ADSS	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31324
1.33397333862819e-90	0.257838979928089	0.267	0.089	2.83215879524151e-86	SF3B3	Malignant cells	GSE199333_post	ENSG00000189091	23450	splicing factor 3b subunit 3	KIAA0017|RSE1|SAP130|SF3b130	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31325
1.80909868164785e-90	0.420352967463984	0.471	0.259	3.84089741100654e-86	CLU	Malignant cells	GSE199333_post	ENSG00000120885	1191	clusterin	APOJ|CLI|CLU1|CLU2|KUB1|SGP-2|SP-40|TRPM-2	protein_coding	P10909	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31326
3.01353753758562e-90	0.633100261732605	0.455	0.28	6.39804154604803e-86	CD52	Malignant cells	GSE199333_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31327
3.10333997176724e-90	0.259843305961487	0.265	0.088	6.58870109405902e-86	C1orf35	Malignant cells	GSE199333_post	ENSG00000143793	79169	chromosome 1 open reading frame 35	MGC4174|MMTAG2	protein_coding	Q9BU76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31328
3.10873168535169e-90	0.269158264938482	0.319	0.131	6.60014824117018e-86	TPGS1	Malignant cells	GSE199333_post	ENSG00000141933	91978	tubulin polyglutamylase complex subunit 1	C19orf20|GTRGEO22|PGs1	protein_coding	Q6ZTW0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31329
3.68234683675348e-90	0.317796167447595	0.803	0.642	7.81799056911131e-86	NDUFA13	Malignant cells	GSE199333_post	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31330
5.26629637297406e-90	0.325665009877421	0.532	0.324	1.11808738294612e-85	CHD4	Malignant cells	GSE199333_post	ENSG00000111642	1108	chromodomain helicase DNA binding protein 4	Mi-2b|Mi2-BETA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31331
5.54880136984866e-90	-0.275883042342242	0.181	0.338	1.17806601883257e-85	GATAD2A	Malignant cells	GSE199333_post	ENSG00000167491	54815	GATA zinc finger domain containing 2A	p66alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31332
1.30144001420654e-89	0.317792183001126	0.756	0.574	2.76308729416191e-85	FKBP1A	Malignant cells	GSE199333_post	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31333
2.02483809080559e-89	-0.271393838700942	0.191	0.35	4.29893375058935e-85	PPP6C	Malignant cells	GSE199333_post	ENSG00000119414	5537	protein phosphatase 6 catalytic subunit	PP6	protein_coding	O00743	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31334
3.90808458744838e-89	-0.342930219340523	0.253	0.416	8.29725438761165e-85	NR3C1	Malignant cells	GSE199333_post	ENSG00000113580	2908	nuclear receptor subfamily 3 group C member 1	GR|GRL	protein_coding	P04150	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31335
3.92669594645079e-89	-0.366997929675107	0.864	0.91	8.33676816390968e-85	CIRBP	Malignant cells	GSE199333_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31336
4.23059663628655e-89	0.30723923855063	0.831	0.673	8.98197971849998e-85	NDUFB11	Malignant cells	GSE199333_post	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31337
4.51909541751656e-89	0.286825929690953	0.464	0.259	9.59449148092942e-85	MAP2K2	Malignant cells	GSE199333_post	ENSG00000126934	5605	mitogen-activated protein kinase kinase 2	MEK2|PRKMK2	protein_coding	P36507	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31338
7.56302519099213e-89	0.288350821775802	0.418	0.215	1.60570587829954e-84	TMEM205	Malignant cells	GSE199333_post	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31339
7.7580132869345e-89	0.291212650615628	0.775	0.602	1.64710380094906e-84	WDR83OS	Malignant cells	GSE199333_post	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31340
8.73033122869904e-89	-0.269865005553521	0.175	0.33	1.85353662316509e-84	RNF139	Malignant cells	GSE199333_post	ENSG00000170881	11236	ring finger protein 139	HRCA1|RCA1|TRC8	protein_coding	Q8WU17	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31341
1.72572652599202e-88	-0.292322878375104	0.194	0.352	3.66388998733367e-84	MED13	Malignant cells	GSE199333_post	ENSG00000108510	9969	mediator complex subunit 13	KIAA0593|THRAP1|TRAP240	protein_coding	Q9UHV7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31342
2.27579071895714e-88	-0.264736272376468	0.121	0.258	4.8317312754179e-84	MGAT4A	Malignant cells	GSE199333_post	ENSG00000071073	11320	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GnT-4a|GnT-Iva	protein_coding	Q9UM21	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31343
2.40250580348218e-88	0.260502159342074	0.284	0.105	5.10076007137301e-84	PPP1R35	Malignant cells	GSE199333_post	ENSG00000160813	221908	protein phosphatase 1 regulatory subunit 35	C7orf47|MGC22793	protein_coding	Q8TAP8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31344
2.44450189198922e-88	0.269670909012841	0.325	0.137	5.18992196688232e-84	DUSP23	Malignant cells	GSE199333_post	ENSG00000158716	54935	dual specificity phosphatase 23	DUSP25|FLJ20442	protein_coding	Q9BVJ7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31345
2.66508044215113e-88	0.29188446608032	0.477	0.274	5.65823228673106e-84	KCNAB2	Malignant cells	GSE199333_post	ENSG00000069424	8514	potassium voltage-gated channel subfamily A regulatory beta subunit 2	AKR6A5|HKvbeta2.1|HKvbeta2.2|KCNA2B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31346
3.14255216155293e-88	0.286115516326246	0.317	0.131	6.67195249419303e-84	MTHFD2	Malignant cells	GSE199333_post	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31347
3.16740794352042e-88	0.314668827612754	0.354	0.157	6.72472380488821e-84	PECAM1	Malignant cells	GSE199333_post	ENSG00000261371	5175	platelet and endothelial cell adhesion molecule 1	CD31	protein_coding	P16284	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31348
3.17553244004579e-88	0.325144113350096	0.401	0.197	6.74197292346122e-84	GADD45A	Malignant cells	GSE199333_post	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31349
3.25146323061651e-88	0.286129290210872	0.39	0.191	6.90318158492191e-84	RNF220	Malignant cells	GSE199333_post	ENSG00000187147	55182	ring finger protein 220	C1orf164|FLJ10597	protein_coding	Q5VTB9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31350
3.68883533039625e-88	0.307723823544308	0.364	0.172	7.83176628996429e-84	CCPG1	Malignant cells	GSE199333_post	ENSG00000260916	9236	cell cycle progression 1	CPR8|KIAA1254	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31351
4.06076367885078e-88	0.333216283996178	0.334	0.15	8.62140736656809e-84	RAB27A	Malignant cells	GSE199333_post	ENSG00000069974	5873	RAB27A, member RAS oncogene family	GS2|HsT18676|RAB27|RAM	protein_coding	P51159	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31352
6.0766497104754e-88	-0.325986900716462	0.277	0.443	1.29013350003103e-83	MT-ATP8	Malignant cells	GSE199333_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31353
6.77239956485728e-88	0.290354352303377	0.324	0.14	1.43784815161485e-83	MRPL27	Malignant cells	GSE199333_post	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31354
9.02366043088339e-88	0.262443733076404	0.301	0.117	1.91581334608085e-83	CFAP298	Malignant cells	GSE199333_post	ENSG00000159079	56683	cilia and flagella associated protein 298	C21orf48|C21orf59|CILD26|DNAAF16|FBB18|FLJ20467|Kur	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31355
1.08404802370654e-87	0.287487797584849	0.251	0.081	2.30154235913135e-83	GBP4	Malignant cells	GSE199333_post	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31356
1.59727790092102e-87	0.260885363395465	0.284	0.106	3.39118071144542e-83	ELOVL1	Malignant cells	GSE199333_post	ENSG00000066322	64834	ELOVL fatty acid elongase 1	Ssc1	protein_coding	Q9BW60	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31357
1.9883759041595e-87	0.253304560011574	0.255	0.084	4.22152088212103e-83	TP53	Malignant cells	GSE199333_post	ENSG00000141510	7157	tumor protein p53	LFS1|p53	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31358
3.00705059731956e-87	-0.302526719925375	0.21	0.368	6.38426912316915e-83	ADIPOR1	Malignant cells	GSE199333_post	ENSG00000159346	51094	adiponectin receptor 1	ACDCR1|PAQR1	protein_coding	Q96A54	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31359
3.16055812891158e-87	0.262057428468647	0.308	0.126	6.71018096349218e-83	GPS1	Malignant cells	GSE199333_post	ENSG00000169727	2873	G protein pathway suppressor 1	COPS1|CSN1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31360
3.25988818948595e-87	0.254701713498288	0.28	0.102	6.92106861509762e-83	PAPSS1	Malignant cells	GSE199333_post	ENSG00000138801	9061	3'-phosphoadenosine 5'-phosphosulfate synthase 1	ATPSK1|PAPSS	protein_coding	O43252	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31361
4.95615596035405e-87	0.266360581864447	0.298	0.116	1.05224147194277e-82	DCAF13	Malignant cells	GSE199333_post	ENSG00000164934	25879	DDB1 and CUL4 associated factor 13	DKFZP564O0463|Gm83|HSPC064|Sof1|WDSOF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31362
6.24599614385829e-87	0.279752328847279	0.414	0.215	1.32608744130255e-82	NAP1L4	Malignant cells	GSE199333_post	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31363
1.00604404537886e-86	-0.385425280069033	0.46	0.598	2.13593211274385e-82	BNIP2	Malignant cells	GSE199333_post	ENSG00000140299	663	BCL2 interacting protein 2	BNIP-2|Nip2	protein_coding	Q12982	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31364
1.47031890089656e-86	0.307392287443621	0.395	0.202	3.12163405849349e-82	GGCT	Malignant cells	GSE199333_post	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31365
1.54422933907625e-86	0.260276741395505	0.292	0.113	3.27855330979279e-82	WRNIP1	Malignant cells	GSE199333_post	ENSG00000124535	56897	WRN helicase interacting protein 1	bA420G6.2|CFAP93|FAP93|FLJ22526|WHIP	protein_coding	Q96S55	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31366
1.61853438582786e-86	-0.267355059194228	0.15	0.294	3.43631035455112e-82	WIPF2	Malignant cells	GSE199333_post	ENSG00000171475	147179	WAS/WASL interacting protein family member 2	WICH|WIRE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31367
2.29512769633733e-86	0.262486386388957	0.348	0.157	4.8727856120938e-82	SMARCD2	Malignant cells	GSE199333_post	ENSG00000108604	6603	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2	BAF60B|CRACD2|PRO2451|Rsc6p	protein_coding	Q92925	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31368
2.29712800659785e-86	0.394474714448818	0.38	0.19	4.87703247080789e-82	PTGER4	Malignant cells	GSE199333_post	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31369
3.09718105234754e-86	-0.370347725956122	0.385	0.533	6.57562509223905e-82	FAM204A	Malignant cells	GSE199333_post	ENSG00000165669	63877	family with sequence similarity 204 member A	bA319I23.1|C10orf84|FLJ13188	protein_coding	Q9H8W3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31370
5.15025177455377e-86	0.263477414546069	0.312	0.128	1.09344995425551e-81	ADA	Malignant cells	GSE199333_post	ENSG00000196839	100	adenosine deaminase	ADA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31371
8.82508444959942e-86	-0.655562065655767	0.215	0.353	1.87365367949445e-81	BCL2A1	Malignant cells	GSE199333_post	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31372
9.06199632909253e-86	0.277439968327595	0.358	0.167	1.92395244062963e-81	TSC22D4	Malignant cells	GSE199333_post	ENSG00000166925	81628	TSC22 domain family member 4	THG-1|TILZ2	protein_coding	Q9Y3Q8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31373
1.06589131139627e-85	-0.410215775483329	0.991	0.988	2.26299384322542e-81	RPL36A	Malignant cells	GSE199333_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31374
1.22666355071602e-85	0.30292728821678	0.711	0.527	2.60432938452518e-81	GSTK1	Malignant cells	GSE199333_post	ENSG00000197448	373156	glutathione S-transferase kappa 1	GST13	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31375
1.29364648597236e-85	0.258068616846114	0.3	0.12	2.74654085436792e-81	GLA	Malignant cells	GSE199333_post	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31376
1.77965397822971e-85	0.282446423749763	0.407	0.209	3.7783833611795e-81	RASSF1	Malignant cells	GSE199333_post	ENSG00000068028	11186	Ras association domain family member 1	123F2|NORE2A|RDA32|REH3P21	protein_coding	Q9NS23	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31377
1.83922996645519e-85	0.258162966758565	0.301	0.12	3.90486914178101e-81	TMA16	Malignant cells	GSE199333_post	ENSG00000198498	55319	translation machinery associated 16 homolog	C4orf43|FLJ11184	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31378
2.23508116985257e-85	0.260663984620129	0.305	0.124	4.74530083171399e-81	SNRNP40	Malignant cells	GSE199333_post	ENSG00000060688	9410	small nuclear ribonucleoprotein U5 subunit 40	HPRP8BP|PRP8BP|PRPF8BP|SPF38|WDR57	protein_coding	Q96DI7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31379
2.80998081501825e-85	-0.344045780085303	0.725	0.808	5.96587026836525e-81	TOMM20	Malignant cells	GSE199333_post	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31380
3.38925944193211e-85	0.283910274965877	0.655	0.449	7.19573672116607e-81	CSTB	Malignant cells	GSE199333_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31381
3.86010018589238e-85	0.280256987797057	0.344	0.156	8.19537870466811e-81	SQOR	Malignant cells	GSE199333_post	ENSG00000137767	58472	sulfide quinone oxidoreductase	CGI-44|SQR|SQRDL	protein_coding	Q9Y6N5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31382
4.03030157455674e-85	0.320097946946639	0.81	0.657	8.55673327294141e-81	MSN	Malignant cells	GSE199333_post	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31383
4.50697605174142e-85	0.263575509482031	0.403	0.207	9.5687608554522e-81	HEBP1	Malignant cells	GSE199333_post	ENSG00000013583	50865	heme binding protein 1	HBP|HEBP	protein_coding	Q9NRV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31384
5.18863281014339e-85	-0.288335584108681	0.216	0.375	1.10159863192154e-80	ZNF800	Malignant cells	GSE199333_post	ENSG00000048405	168850	zinc finger protein 800	NA	protein_coding	Q2TB10	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31385
5.37002812330939e-85	-0.593167253590499	0.453	0.555	1.14011067085982e-80	UBE2R2	Malignant cells	GSE199333_post	ENSG00000107341	54926	ubiquitin conjugating enzyme E2 R2	CDC34B|FLJ20419|MGC10481|UBC3B	protein_coding	Q712K3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31386
8.3636091317989e-85	0.289293552005432	0.413	0.218	1.77567785477223e-80	GABARAPL2	Malignant cells	GSE199333_post	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31387
8.98197908665224e-85	0.28106888012166	0.364	0.175	1.90696397988714e-80	PPIH	Malignant cells	GSE199333_post	ENSG00000171960	10465	peptidylprolyl isomerase H	CYP-20|CYPH|MGC5016|SnuCyp-20|USA-CYP	protein_coding	O43447	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31388
1.11948802149338e-84	0.256771991901021	0.276	0.102	2.3767850184326e-80	PHF19	Malignant cells	GSE199333_post	ENSG00000119403	26147	PHD finger protein 19	DKFZP727G051|MTF2L1|PCL3|TDRD19B	protein_coding	Q5T6S3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31389
1.22668683201301e-84	-0.349806714211899	0.271	0.426	2.60437881304682e-80	TOR1AIP2	Malignant cells	GSE199333_post	ENSG00000169905	163590	torsin 1A interacting protein 2	IFRG15|LULL1|NET9	protein_coding	Q8NFQ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31390
1.34450322127062e-84	0.286970417113008	0.291	0.112	2.85451478907965e-80	ISG15	Malignant cells	GSE199333_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31391
1.39374772979784e-84	0.29906128377202	0.534	0.334	2.95906580513379e-80	SPCS2	Malignant cells	GSE199333_post	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31392
1.70052599972685e-84	0.254207082500389	0.311	0.125	3.61038675002008e-80	DNAJC9	Malignant cells	GSE199333_post	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31393
2.02306224795465e-84	0.258794643743566	0.347	0.16	4.29516345863251e-80	MRPL43	Malignant cells	GSE199333_post	ENSG00000055950	84545	mitochondrial ribosomal protein L43	bMRP36a	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31394
2.06536370738722e-84	0.290533809125416	0.601	0.401	4.38497368715381e-80	DRAP1	Malignant cells	GSE199333_post	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31395
2.35556213285749e-84	0.299180487926303	0.385	0.195	5.00109396426974e-80	GNL3	Malignant cells	GSE199333_post	ENSG00000163938	26354	G protein nucleolar 3	C77032|E2IG3|MGC800|NS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31396
3.94849313642959e-84	0.280285842055068	0.329	0.147	8.38304577795367e-80	EEF1E1	Malignant cells	GSE199333_post	ENSG00000124802	9521	eukaryotic translation elongation factor 1 epsilon 1	AIMP3|P18	protein_coding	O43324	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31397
5.14333270696448e-84	0.271418381338311	0.329	0.147	1.09198096701563e-79	SHMT2	Malignant cells	GSE199333_post	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31398
5.28603174469537e-84	-0.322927967673377	0.133	0.27	1.12227739971627e-79	HIST2H2AC	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31399
6.01607978676639e-84	0.252288629675519	0.286	0.111	1.27727389952837e-79	RBFA	Malignant cells	GSE199333_post	ENSG00000101546	79863	ribosome binding factor A	C18orf22|FLJ21172|HsT169	protein_coding	Q8N0V3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31400
6.96101157477333e-84	0.271579165103583	0.747	0.541	1.47789236744013e-79	UFC1	Malignant cells	GSE199333_post	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31401
9.24250846708352e-84	-0.264982494925141	0.182	0.333	1.9622769726465e-79	ATP11B	Malignant cells	GSE199333_post	ENSG00000058063	23200	ATPase phospholipid transporting 11B (putative)	ATPIF|ATPIR|KIAA0956	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31402
1.34677150744323e-83	0.251585108618784	0.271	0.099	2.85933058745273e-79	AP1M1	Malignant cells	GSE199333_post	ENSG00000072958	8907	adaptor related protein complex 1 subunit mu 1	AP47|CLAPM2|mu1A	protein_coding	Q9BXS5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31403
1.38727144755852e-83	0.2869915107648	0.406	0.214	2.94531601031149e-79	SF3A3	Malignant cells	GSE199333_post	ENSG00000183431	10946	splicing factor 3a subunit 3	PRP9|PRPF9|SAP61|SF3a60	protein_coding	Q12874	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31404
1.6278817337871e-83	0.262821689313137	0.328	0.146	3.45615570900339e-79	CHCHD3	Malignant cells	GSE199333_post	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31405
1.76645011418699e-83	0.253176245665259	0.312	0.132	3.7503502374304e-79	NOC2L	Malignant cells	GSE199333_post	ENSG00000188976	26155	NOC2 like nucleolar associated transcriptional repressor	DKFZP564C186|NET15|NET7|NIR|PPP1R112	protein_coding	Q9Y3T9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31406
1.79006292878772e-83	0.320102296021448	0.655	0.478	3.80048260410922e-79	XRCC6	Malignant cells	GSE199333_post	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31407
2.79861965296849e-83	0.283326230991768	0.38	0.189	5.9417493852174e-79	RABL6	Malignant cells	GSE199333_post	ENSG00000196642	55684	RAB, member RAS oncogene family like 6	bA216L13.9|C9orf86|FLJ10101|FLJ13045|Parf|pp8875|RBEL1	protein_coding	Q3YEC7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31408
2.85352499778581e-83	-0.337594962158104	0.402	0.557	6.05831892279905e-79	RBBP6	Malignant cells	GSE199333_post	ENSG00000122257	5930	RB binding protein 6, ubiquitin ligase	P2P-R|PACT|SNAMA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31409
3.51638333277622e-83	0.28420889103747	0.893	0.778	7.4656334538172e-79	COX7A2	Malignant cells	GSE199333_post	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31410
5.13522119320314e-83	-0.316399286595163	0.15	0.287	1.09025881152896e-78	GGA2	Malignant cells	GSE199333_post	ENSG00000103365	23062	golgi associated, gamma adaptin ear containing, ARF binding protein 2	KIAA1080|VEAR	protein_coding	Q9UJY4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31411
7.06567586361623e-83	0.303330719518389	0.298	0.125	1.50011364260436e-78	NFIX	Malignant cells	GSE199333_post	ENSG00000008441	4784	nuclear factor I X	NF1A	protein_coding	Q14938	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31412
8.03833860614886e-83	0.28487596315691	0.327	0.148	1.70661966947146e-78	STIP1	Malignant cells	GSE199333_post	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31413
9.59143479275554e-83	0.295798740037521	0.737	0.57	2.03635752084993e-78	COPE	Malignant cells	GSE199333_post	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31414
1.18143238744103e-82	-0.261106973529217	0.143	0.283	2.50829910177605e-78	SPPL2A	Malignant cells	GSE199333_post	ENSG00000138600	84888	signal peptide peptidase like 2A	IMP3|PSL2	protein_coding	Q8TCT8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31415
1.49972382106578e-82	0.256005328985348	0.319	0.138	3.18406364450475e-78	HDAC1	Malignant cells	GSE199333_post	ENSG00000116478	3065	histone deacetylase 1	GON-10|HD1|KDAC1|RPD3L1	protein_coding	Q13547	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31416
2.17202246274963e-82	0.267447709238692	0.362	0.174	4.61142089066373e-78	DCXR	Malignant cells	GSE199333_post	ENSG00000169738	51181	dicarbonyl and L-xylulose reductase	DCR|HCR2|KIDCR|P34H|SDR20C1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31417
2.40399981602477e-82	0.289614117136811	0.653	0.459	5.10393200940219e-78	CSNK2B	Malignant cells	GSE199333_post	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31418
2.47123971206526e-82	0.314057621019774	0.643	0.456	5.24668903268576e-78	ILF2	Malignant cells	GSE199333_post	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31419
2.77417804966981e-82	-0.376353743429132	0.415	0.556	5.88985741725398e-78	SH3GLB1	Malignant cells	GSE199333_post	ENSG00000097033	51100	SH3 domain containing GRB2 like, endophilin B1	Bif-1|CGI-61|KIAA0491|PPP1R70	protein_coding	Q9Y371	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31420
3.62243253026528e-82	0.272188999478869	0.36	0.175	7.69078650500622e-78	VPS36	Malignant cells	GSE199333_post	ENSG00000136100	51028	vacuolar protein sorting 36 homolog	C13orf9|CGI-145|Eap45	protein_coding	Q86VN1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31421
4.19220991100256e-82	0.281635075875203	0.521	0.313	8.90048086204953e-78	EIF5B	Malignant cells	GSE199333_post	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31422
6.2607616420644e-82	-0.373187563215546	0.407	0.556	1.32922230422669e-77	FAM49B	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31423
6.27990649349493e-82	0.27456978770369	0.413	0.221	1.33328694763391e-77	PCBD1	Malignant cells	GSE199333_post	ENSG00000166228	5092	pterin-4 alpha-carbinolamine dehydratase 1	DCOH|PCBD|PCD	protein_coding	P61457	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31424
6.62221702323627e-82	-0.290892785389707	0.202	0.352	1.40596289620329e-77	DYNC1LI2	Malignant cells	GSE199333_post	ENSG00000135720	1783	dynein cytoplasmic 1 light intermediate chain 2	DNCLI2	protein_coding	O43237	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31425
6.84140976730061e-82	0.320348763315052	0.817	0.663	1.45249970769559e-77	LCP1	Malignant cells	GSE199333_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31426
6.91754722919193e-82	0.293541739212473	0.398	0.211	1.46866445222974e-77	DNAJC4	Malignant cells	GSE199333_post	ENSG00000110011	3338	DnaJ heat shock protein family (Hsp40) member C4	HSPF2|MCG18	protein_coding	Q9NNZ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31427
8.3735054237069e-82	0.29089412413475	0.732	0.551	1.77777893650721e-77	C11orf58	Malignant cells	GSE199333_post	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31428
9.64195874004038e-82	0.260091985031222	0.307	0.13	2.04708426009797e-77	UBA1	Malignant cells	GSE199333_post	ENSG00000130985	7317	ubiquitin like modifier activating enzyme 1	A1S9T|CFAP124|GXP1|POC20|UBE1|UBE1X	protein_coding	P22314	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31429
9.93522554229154e-82	0.309077748847249	0.532	0.337	2.10934773488392e-77	SLIRP	Malignant cells	GSE199333_post	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31430
1.37925394809568e-81	0.309295298978768	0.814	0.652	2.92829405720195e-77	RTN4	Malignant cells	GSE199333_post	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31431
1.73181492706118e-81	-0.292590735958608	0.228	0.384	3.6768162716436e-77	PPP2R2A	Malignant cells	GSE199333_post	ENSG00000221914	5520	protein phosphatase 2 regulatory subunit Balpha	B55A|B55alpha|PR52A|PR55A|PR55alpha	protein_coding	P63151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31432
2.16710487624192e-81	-0.319371342411655	0.286	0.446	4.60098036274921e-77	IST1	Malignant cells	GSE199333_post	ENSG00000182149	9798	IST1 factor associated with ESCRT-III	CHMP8|KIAA0174	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31433
1.06456087693253e-80	-0.523403759159099	0.862	0.874	2.26016919781545e-76	RPS17	Malignant cells	GSE199333_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31434
1.24722264690209e-80	0.25361868746027	0.264	0.095	2.64797840163783e-76	ATM	Malignant cells	GSE199333_post	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31435
1.35026685806705e-80	0.266489111698184	0.297	0.125	2.86675156636215e-76	CCS	Malignant cells	GSE199333_post	ENSG00000173992	9973	copper chaperone for superoxide dismutase	NA	protein_coding	O14618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31436
1.37219260019542e-80	0.291160016304824	0.455	0.265	2.9133021094749e-76	TMEM147	Malignant cells	GSE199333_post	ENSG00000105677	10430	transmembrane protein 147	MGC1936|NIFIE14	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31437
1.43506168167661e-80	0.391171146715998	0.281	0.111	3.04677945636762e-76	PTTG1	Malignant cells	GSE199333_post	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31438
1.54477137126972e-80	0.256340642876782	0.318	0.14	3.27970409834275e-76	FLI1	Malignant cells	GSE199333_post	ENSG00000151702	2313	Fli-1 proto-oncogene, ETS transcription factor	EWSR2|FLI-1|SIC-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31439
1.6949894615164e-80	0.305310263522502	0.613	0.428	3.59863212574547e-76	CNPY3	Malignant cells	GSE199333_post	ENSG00000137161	10695	canopy FGF signaling regulator 3	CAG4A|TNRC5	protein_coding	Q9BT09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31440
1.95279274832401e-80	0.297087616678379	0.741	0.578	4.1459742839667e-76	TMEM59	Malignant cells	GSE199333_post	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31441
3.66714689300095e-80	-0.307944340894117	0.989	0.987	7.78571956853031e-76	ATP5F1E	Malignant cells	GSE199333_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31442
3.76847385879691e-80	0.256997354855899	0.261	0.096	8.00084684961173e-76	HACD3	Malignant cells	GSE199333_post	ENSG00000074696	51495	3-hydroxyacyl-CoA dehydratase 3	B-ind1|HSPC121|PTPLAD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31443
4.03604655933621e-80	0.255355581223575	0.378	0.19	8.56893045012671e-76	PPCS	Malignant cells	GSE199333_post	ENSG00000127125	79717	phosphopantothenoylcysteine synthetase	FLJ11838	protein_coding	Q9HAB8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31444
4.32473600360496e-80	-0.834685951503557	0.779	0.784	9.18184700925369e-76	IRF2BP2	Malignant cells	GSE199333_post	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31445
5.21918757823573e-80	-0.279270087709892	0.215	0.367	1.10808571473523e-75	ZFP91	Malignant cells	GSE199333_post	ENSG00000186660	80829	ZFP91 zinc finger protein, atypical E3 ubiquitin ligase	PZF|ZNF757	protein_coding	Q96JP5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31446
5.36780203330806e-80	0.253266279564991	0.327	0.147	1.13963804969163e-75	MTX1	Malignant cells	GSE199333_post	ENSG00000173171	4580	metaxin 1	MTX|MTXN	protein_coding	Q13505	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31447
5.76202307429135e-80	0.253735903587883	0.285	0.114	1.2233351189028e-75	TRIM22	Malignant cells	GSE199333_post	ENSG00000132274	10346	tripartite motif containing 22	GPSTAF50|RNF94|STAF50	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31448
6.76635464813392e-80	0.264800248079336	0.439	0.244	1.43656475534531e-75	TMCO1	Malignant cells	GSE199333_post	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31449
7.4956741449775e-80	-0.412561400618623	0.525	0.629	1.59140657772017e-75	FXR1	Malignant cells	GSE199333_post	ENSG00000114416	8087	FMR1 autosomal homolog 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31450
7.98650595484352e-80	0.27295109066881	0.27	0.102	1.69561507927283e-75	FTX	Malignant cells	GSE199333_post	ENSG00000230590	100302692	FTX transcript, XIST regulator	FLJ33139|LINC00182|MIR374AHG|NCRNA00182	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31451
8.1941269412931e-80	0.290725817116593	0.31	0.135	1.73969509090594e-75	SMC1A	Malignant cells	GSE199333_post	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31452
8.26163305633481e-80	0.256614554229216	0.338	0.156	1.75402731419044e-75	GMPS	Malignant cells	GSE199333_post	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31453
1.04237168506315e-79	0.29479891392621	0.631	0.446	2.21305932455758e-75	PSMD8	Malignant cells	GSE199333_post	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31454
1.08326891514923e-79	-0.302208069299761	0.189	0.335	2.29988823375334e-75	NUDT4	Malignant cells	GSE199333_post	ENSG00000173598	11163	nudix hydrolase 4	DIPP2|DIPP2alpha|DIPP2beta|HDCMB47P|KIAA0487	protein_coding	Q9NZJ9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31455
1.10897394184801e-79	0.274326111900265	0.423	0.233	2.35446257593751e-75	NBDY	Malignant cells	GSE199333_post	ENSG00000204272	550643	negative regulator of P-body association	LINC01420|NoBody	protein_coding	A0A0U1RRE5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31456
1.1351638593541e-79	0.282924366026429	0.57	0.378	2.4100663897947e-75	GHITM	Malignant cells	GSE199333_post	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31457
1.16178756949471e-79	-0.374758524638994	0.362	0.512	2.46659118879421e-75	DDX3Y	Malignant cells	GSE199333_post	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31458
2.96447263647741e-79	-0.302665829939632	0.213	0.364	6.29387185450519e-75	ATP2A2	Malignant cells	GSE199333_post	ENSG00000174437	488	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2	ATP2B|DAR|SERCA2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31459
5.03258490448545e-79	0.286396307089564	0.589	0.398	1.06846810107131e-74	NDUFB8	Malignant cells	GSE199333_post	ENSG00000166136	4714	NADH:ubiquinone oxidoreductase subunit B8	ASHI|CI-ASHI	protein_coding	O95169	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31460
5.76419870621649e-79	0.257488017119448	0.321	0.142	1.22379702731682e-74	NABP1	Malignant cells	GSE199333_post	ENSG00000173559	64859	nucleic acid binding protein 1	DKFZp667M1322|FLJ13624|FLJ22833|hSSB2|MGC111163|NABP1-OT1|OBFC2A|SOSS-B2|SSB2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31461
1.31121314904151e-78	0.258283497694839	0.294	0.123	2.78383663673002e-74	ZNF638	Malignant cells	GSE199333_post	ENSG00000075292	27332	zinc finger protein 638	MGC26130|NP220|ZFML|Zfp638	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31462
1.5431765354343e-78	-0.724762629585526	0.751	0.848	3.27631810238057e-74	FOS	Malignant cells	GSE199333_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31463
3.58385660044904e-78	0.287656061750973	0.81	0.669	7.60888594841337e-74	EIF3M	Malignant cells	GSE199333_post	ENSG00000149100	10480	eukaryotic translation initiation factor 3 subunit M	FLJ29030|GA17|hfl-B5|PCID1|TANGO7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31464
4.24142341091069e-78	0.2832069424941	0.563	0.372	9.00496604370449e-74	SYPL1	Malignant cells	GSE199333_post	ENSG00000008282	6856	synaptophysin like 1	SYPL	protein_coding	Q16563	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31465
1.10202264514885e-77	-0.274104048943328	0.132	0.26	2.33970427791552e-73	DENND6A	Malignant cells	GSE199333_post	ENSG00000174839	201627	DENN domain containing 6A	AFI1A|FAM116A|FLJ34969	protein_coding	Q8IWF6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31466
1.21678049456155e-77	0.260029602220741	0.41	0.221	2.58334666800363e-73	TRAPPC2L	Malignant cells	GSE199333_post	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31467
1.42631775664929e-77	0.265769913762585	0.417	0.23	3.02821522914211e-73	SCAMP2	Malignant cells	GSE199333_post	ENSG00000140497	10066	secretory carrier membrane protein 2	NA	protein_coding	O15127	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31468
2.00116699032751e-77	0.263317829923045	0.388	0.204	4.24867763716433e-73	SMARCA4	Malignant cells	GSE199333_post	ENSG00000127616	6597	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	BAF190|BRG1|FLJ39786|hSNF2b|SNF2|SNF2-BETA|SNF2L4|SNF2LB|SWI2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31469
2.96871250533286e-77	0.290099140015746	0.547	0.349	6.3028735200722e-73	ATOX1	Malignant cells	GSE199333_post	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31470
3.09726586819832e-77	-0.335482625440341	0.427	0.573	6.57580516477185e-73	RAB2A	Malignant cells	GSE199333_post	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31471
7.11322684010916e-77	0.254164531387044	0.388	0.204	1.51020919042357e-72	BCL7C	Malignant cells	GSE199333_post	ENSG00000099385	9274	BAF chromatin remodeling complex subunit BCL7C	SMARCJ3	protein_coding	Q8WUZ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31472
8.07085910696127e-77	-0.391985559444111	0.561	0.675	1.71352409699895e-72	MDM4	Malignant cells	GSE199333_post	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31473
1.21920443132484e-76	0.272576222412585	0.502	0.31	2.58849292814576e-72	CASP4	Malignant cells	GSE199333_post	ENSG00000196954	837	caspase 4	ICE(rel)II|ICH-2|TX	protein_coding	P49662	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31474
1.8448661812715e-76	0.264923562718205	0.416	0.229	3.91683538945751e-72	HACD4	Malignant cells	GSE199333_post	ENSG00000188921	401494	3-hydroxyacyl-CoA dehydratase 4	Em:AL662879.1|OTTHUMG00000021016|PTPLAD2	protein_coding	Q5VWC8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31475
1.89196357460801e-76	0.272006859641915	0.351	0.175	4.01682786525027e-72	PSMG1	Malignant cells	GSE199333_post	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31476
2.19515396889438e-76	-0.316918324369512	0.643	0.751	4.66053139135965e-72	SF3B1	Malignant cells	GSE199333_post	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31477
2.66727714497656e-76	0.256284751013366	0.348	0.171	5.66289610649974e-72	TMEM179B	Malignant cells	GSE199333_post	ENSG00000185475	374395	transmembrane protein 179B	NA	protein_coding	Q7Z7N9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31478
3.01194002770416e-76	0.279024724686546	0.305	0.132	6.39464987281869e-72	MCM5	Malignant cells	GSE199333_post	ENSG00000100297	4174	minichromosome maintenance complex component 5	CDC46	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31479
4.54818366553551e-76	-0.300480025037866	0.127	0.256	9.65624874029844e-72	TSPOAP1	Malignant cells	GSE199333_post	ENSG00000005379	9256	TSPO associated protein 1	BZRAP1|KIAA0612|PRAX-1|RIM-BP1|RIMBP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31480
5.15745961181877e-76	-0.254417557312253	0.193	0.34	1.09498025018524e-71	ISCA1	Malignant cells	GSE199333_post	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31481
5.48249695312417e-76	0.283310852310441	0.571	0.376	1.16398892811779e-71	SNHG7	Malignant cells	GSE199333_post	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31482
5.66771260693239e-76	-0.29113451049227	0.216	0.363	1.20331206357782e-71	CACUL1	Malignant cells	GSE199333_post	ENSG00000151893	143384	CDK2 associated cullin domain 1	C10orf46|CAC1|FLJ40409|MGC33215	protein_coding	Q86Y37	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31483
7.71328121596905e-76	-0.584631514101441	0.35	0.482	1.63760673496239e-71	PLIN2	Malignant cells	GSE199333_post	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31484
7.77586210700162e-76	0.250567781157655	0.342	0.167	1.65089328393751e-71	NOB1	Malignant cells	GSE199333_post	ENSG00000141101	28987	NIN1 (RPN12) binding protein 1 homolog	ART-4|MST158|NOB1P|PSMD8BP1	protein_coding	Q9ULX3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31485
8.32465149105096e-76	0.262949304900562	0.598	0.387	1.76740675806503e-71	HDGF	Malignant cells	GSE199333_post	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31486
9.30770374102997e-76	0.27855331035525	0.616	0.426	1.97611858125807e-71	HADHA	Malignant cells	GSE199333_post	ENSG00000084754	3030	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha	GBP|LCEH|LCHAD|MTPA	protein_coding	P40939	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31487
9.56764668349098e-76	0.252638382036499	0.354	0.174	2.03130706737197e-71	RCN1	Malignant cells	GSE199333_post	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31488
1.19559211994932e-75	0.250270271114649	0.316	0.142	2.53836162986439e-71	LNPEP	Malignant cells	GSE199333_post	ENSG00000113441	4012	leucyl and cystinyl aminopeptidase	CAP|IRAP|P-LAP|PLAP	protein_coding	Q9UIQ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31489
1.43664213794063e-75	0.315190872573861	0.611	0.429	3.05013492306176e-71	MINOS1	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31490
1.47285316678382e-75	-0.289152128358413	0.149	0.28	3.12701455839873e-71	ARID5A	Malignant cells	GSE199333_post	ENSG00000196843	10865	AT-rich interaction domain 5A	MRF-1|RP11-363D14	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31491
1.85081022453351e-75	0.264454239464728	0.355	0.177	3.9294551877071e-71	CD151	Malignant cells	GSE199333_post	ENSG00000177697	977	CD151 molecule (Raph blood group)	PETA-3|RAPH|SFA-1|TSPAN24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31492
2.53001236520671e-75	0.298103138127182	0.629	0.448	5.37146925257037e-71	STMP1	Malignant cells	GSE199333_post	ENSG00000243317	647087	short transmembrane mitochondrial protein 1	C7orf73|Mm47|PL-5283	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31493
2.82611435445073e-75	0.27490666819671	0.491	0.304	6.00012338593434e-71	PLIN3	Malignant cells	GSE199333_post	ENSG00000105355	10226	perilipin 3	M6PRBP1|PP17|TIP47	protein_coding	O60664	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31494
7.3524789381266e-75	0.276290627794573	0.481	0.298	1.56100480335366e-70	AUP1	Malignant cells	GSE199333_post	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31495
1.02128229685757e-74	0.265362998995795	0.799	0.649	2.16828444445831e-70	ERP29	Malignant cells	GSE199333_post	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31496
1.17662167746472e-74	0.261977368974284	0.334	0.157	2.49808548342535e-70	CARD16	Malignant cells	GSE199333_post	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31497
2.08234735395089e-74	0.251766576716545	0.337	0.164	4.42103166717313e-70	DCTN2	Malignant cells	GSE199333_post	ENSG00000175203	10540	dynactin subunit 2	DCTN-50|RBP50	protein_coding	Q13561	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31498
2.69942730904249e-74	0.269047755329273	0.784	0.631	5.73115411982812e-70	PNN	Malignant cells	GSE199333_post	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31499
3.7721134867836e-74	0.276208471712294	0.794	0.644	8.00857414379027e-70	ST13	Malignant cells	GSE199333_post	ENSG00000100380	6767	ST13 Hsp70 interacting protein	FAM10A1|HIP|HSPABP1|P48|SNC6	protein_coding	P50502	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31500
4.06556857849406e-74	-0.65902845189243	0.383	0.501	8.63160864900074e-70	ARL4A	Malignant cells	GSE199333_post	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31501
4.54911374827403e-74	0.260812324005578	0.287	0.124	9.65822339896059e-70	NOLC1	Malignant cells	GSE199333_post	ENSG00000166197	9221	nucleolar and coiled-body phosphoprotein 1	KIAA0035|NOPP130|NOPP140|P130|Srp40	protein_coding	Q14978	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31502
6.75515838769993e-74	-0.400927631840584	0.278	0.416	1.43418767729257e-69	IRAK1	Malignant cells	GSE199333_post	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31503
8.18522603388817e-74	-0.329775360691831	0.265	0.412	1.7378053392548e-69	PRDM2	Malignant cells	GSE199333_post	ENSG00000116731	7799	PR/SET domain 2	HUMHOXY1|KMT8|KMT8A|MTB-ZF|RIZ|RIZ1|RIZ2	protein_coding	Q13029	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31504
1.40978313802893e-73	0.269148087856359	0.367	0.189	2.99311058034923e-69	ORAI2	Malignant cells	GSE199333_post	ENSG00000160991	80228	ORAI calcium release-activated calcium modulator 2	C7orf19|CBCIP2|FLJ12474|FLJ14733|H_NH0514P08.8|TMEM142B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31505
1.46290031851828e-73	0.25853822313423	0.348	0.171	3.10588366624616e-69	CASP1	Malignant cells	GSE199333_post	ENSG00000137752	834	caspase 1	ICE|IL1BC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31506
1.96769912199378e-73	0.251877569378593	0.457	0.27	4.17762200590499e-69	NDUFS4	Malignant cells	GSE199333_post	ENSG00000164258	4724	NADH:ubiquinone oxidoreductase subunit S4	AQDQ|CI-18	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31507
2.44484480517351e-73	-0.297929329087993	0.307	0.459	5.19065000586388e-69	MKRN1	Malignant cells	GSE199333_post	ENSG00000133606	23608	makorin ring finger protein 1	RNF61	protein_coding	Q9UHC7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31508
2.60614157916807e-73	0.335794482589131	0.693	0.53	5.53309918673173e-69	ARID1B	Malignant cells	GSE199333_post	ENSG00000049618	57492	AT-rich interaction domain 1B	6A3-5|BAF250b|DAN15|ELD/OSA1|KIAA1235|p250R|SMARCF2	protein_coding	Q8NFD5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31509
3.66156309404749e-73	-0.264817963282241	0.141	0.269	7.77386460497223e-69	TMEM189	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31510
7.0940430666539e-73	0.342783104592774	0.468	0.295	1.50613628348129e-68	AGTRAP	Malignant cells	GSE199333_post	ENSG00000177674	57085	angiotensin II receptor associated protein	ATRAP	protein_coding	Q6RW13	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31511
7.95337870785685e-73	-0.340819330160469	0.311	0.458	1.68858183346509e-68	OSBPL8	Malignant cells	GSE199333_post	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31512
9.60083053717824e-73	-0.403784521334569	0.272	0.412	2.03835233134831e-68	CHMP1B	Malignant cells	GSE199333_post	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31513
1.57316449627829e-72	0.265718072685674	0.473	0.282	3.33998554204844e-68	NOP58	Malignant cells	GSE199333_post	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31514
2.06728886814405e-72	-0.375868798366392	0.463	0.581	4.38906099595663e-68	RTF1	Malignant cells	GSE199333_post	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31515
2.33233176510286e-72	-0.373148818404957	0.705	0.79	4.95177357048989e-68	PDIA3	Malignant cells	GSE199333_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31516
3.25486659943703e-72	0.265766252075097	0.59	0.397	6.91040727726476e-68	MYDGF	Malignant cells	GSE199333_post	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31517
6.91376375059297e-72	-0.340780498275062	0.927	0.95	1.46786118188839e-67	TPM3	Malignant cells	GSE199333_post	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31518
7.4370400341977e-72	0.250928089259099	0.364	0.189	1.57895796966051e-67	C20orf27	Malignant cells	GSE199333_post	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31519
2.40867781010667e-71	-0.25551203536396	0.176	0.314	5.11386385863746e-67	RLIM	Malignant cells	GSE199333_post	ENSG00000131263	51132	ring finger protein, LIM domain interacting	MGC15161|NY-REN-43|RNF12	protein_coding	Q9NVW2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31520
2.73807215013948e-71	0.502028256758004	0.352	0.197	5.81320098196113e-67	MNDA	Malignant cells	GSE199333_post	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31521
3.34877041817839e-71	-0.320819944486789	0.18	0.313	7.10977447483455e-67	NCOR2	Malignant cells	GSE199333_post	ENSG00000196498	9612	nuclear receptor corepressor 2	CTG26|SMRT|SMRTE|TNRC14|TRAC-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31522
3.48129876472467e-71	-0.401607900137396	0.23	0.362	7.39114540738695e-67	SH3BP2	Malignant cells	GSE199333_post	ENSG00000087266	6452	SH3 domain binding protein 2	CRBM|RES4-23	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31523
5.1549538332251e-71	-0.392712325869215	0.447	0.564	1.09444824833202e-66	SLC25A36	Malignant cells	GSE199333_post	ENSG00000114120	55186	solute carrier family 25 member 36	FLJ10618|PNC2	protein_coding	Q96CQ1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31524
1.12196200000904e-70	0.295324633876439	0.537	0.36	2.38203752221919e-66	THRAP3	Malignant cells	GSE199333_post	ENSG00000054118	9967	thyroid hormone receptor associated protein 3	BCLAF2|TRAP150	protein_coding	Q9Y2W1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31525
1.1982918357172e-70	0.255407538552545	0.336	0.166	2.54409339641119e-66	CARHSP1	Malignant cells	GSE199333_post	ENSG00000153048	23589	calcium regulated heat stable protein 1	CRHSP-24|CSDC1	protein_coding	Q9Y2V2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31526
1.35478915777244e-70	-0.307692445398952	0.25	0.394	2.87635286086667e-66	SETD2	Malignant cells	GSE199333_post	ENSG00000181555	29072	SET domain containing 2, histone lysine methyltransferase	FLJ23184|HIF-1|HYPB|KIAA1732|KMT3A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31527
6.79037380463794e-70	0.259762094656441	0.401	0.223	1.44166426246268e-65	PYGL	Malignant cells	GSE199333_post	ENSG00000100504	5836	glycogen phosphorylase L	GSD6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31528
1.0303009152929e-69	0.254031619359854	0.471	0.291	2.18743187325835e-65	SCP2	Malignant cells	GSE199333_post	ENSG00000116171	6342	sterol carrier protein 2	NA	protein_coding	P22307	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31529
1.81414202043481e-69	-0.306807094634267	0.478	0.612	3.85160492358514e-65	MOB1A	Malignant cells	GSE199333_post	ENSG00000114978	55233	MOB kinase activator 1A	C2orf6|FLJ10788|FLJ11595|Mats1|MOB1|Mob4B|MOBK1B|MOBKL1B	protein_coding	Q9H8S9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31530
3.33070735396191e-69	0.259611556268221	0.401	0.226	7.07142478319652e-65	SSBP4	Malignant cells	GSE199333_post	ENSG00000130511	170463	single stranded DNA binding protein 4	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31531
4.03412545698445e-69	0.286018478532363	0.546	0.361	8.56485175772368e-65	TPR	Malignant cells	GSE199333_post	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31532
1.14226835035522e-68	0.25374604898697	0.339	0.171	2.42514993463917e-64	FAM129A	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31533
1.63365506238788e-68	0.265695100174604	0.487	0.307	3.4684130629557e-64	ANAPC5	Malignant cells	GSE199333_post	ENSG00000089053	51433	anaphase promoting complex subunit 5	APC5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31534
2.4490249460926e-68	-0.260500106575461	0.201	0.339	5.1995248630492e-64	VEZF1	Malignant cells	GSE199333_post	ENSG00000136451	7716	vascular endothelial zinc finger 1	DB1|ZNF161	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31535
3.33765343190436e-68	0.255399810071522	0.987	0.964	7.08617200127615e-64	EEF2	Malignant cells	GSE199333_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31536
4.39207420452089e-68	0.262278370916946	0.479	0.296	9.32481274361831e-64	HCLS1	Malignant cells	GSE199333_post	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31537
4.78960028639874e-68	0.255670838449195	0.812	0.669	1.01688003680532e-63	EIF4A2	Malignant cells	GSE199333_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31538
6.61733537893953e-68	-0.350790420363385	0.286	0.419	1.40492647430265e-63	SNHG25	Malignant cells	GSE199333_post	ENSG00000266402	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31539
7.74895036327155e-68	0.272714993154844	0.43	0.262	1.64517965162618e-63	LARP1	Malignant cells	GSE199333_post	ENSG00000155506	23367	La ribonucleoprotein 1, translational regulator	KIAA0731|Lar1|LARP|Lhp1|MGC19556	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31540
8.43976810124456e-68	-0.272642773094652	0.22	0.361	1.79184716557523e-63	KAT6A	Malignant cells	GSE199333_post	ENSG00000083168	7994	lysine acetyltransferase 6A	MOZ|MYST3|RUNXBP2|ZC2HC6A|ZNF220	protein_coding	Q92794	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31541
1.55995880519316e-67	0.270271389363034	0.71	0.558	3.31194853930559e-63	ATP5PB	Malignant cells	GSE199333_post	ENSG00000116459	515	ATP synthase peripheral stalk-membrane subunit b	ATP5F1	protein_coding	P24539	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31542
4.00732859432818e-67	-0.362999552354387	0.391	0.523	8.50795933861815e-63	SMCHD1	Malignant cells	GSE199333_post	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31543
4.22483073948577e-67	0.256531127628039	0.768	0.62	8.96973814300223e-63	UXT	Malignant cells	GSE199333_post	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31544
9.87878539375279e-67	-0.925756074057242	0.476	0.537	2.09736492694765e-62	LITAF	Malignant cells	GSE199333_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31545
1.15810759952655e-66	0.257266245561284	0.425	0.25	2.45877824455481e-62	DBNL	Malignant cells	GSE199333_post	ENSG00000136279	28988	drebrin like	ABP1|HIP-55|SH3P7	protein_coding	Q9UJU6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31546
1.20166367073547e-66	-0.457900495019618	0.471	0.613	2.55125213933848e-62	CEBPD	Malignant cells	GSE199333_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31547
1.31373698588777e-66	0.269498488597462	0.456	0.281	2.78919499473833e-62	BAZ1A	Malignant cells	GSE199333_post	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31548
1.61962969110313e-66	-0.357590910422521	0.191	0.316	3.43863579718106e-62	IVNS1ABP	Malignant cells	GSE199333_post	ENSG00000116679	10625	influenza virus NS1A binding protein	ARA3|HSPC068|KIAA0850|KLHL39|ND1|NS-1|NS1-BP	protein_coding	Q9Y6Y0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31549
6.29685907520276e-66	-0.327295554321286	0.778	0.837	1.3368861502563e-61	ATP6V0B	Malignant cells	GSE199333_post	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31550
9.79944660960414e-66	-0.778065545948859	0.225	0.343	2.08052050968505e-61	H1F0	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31551
1.40442373272638e-65	-0.583381592033686	0.341	0.464	2.98173202695138e-61	TFRC	Malignant cells	GSE199333_post	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31552
1.42540074285426e-65	0.295676376598211	0.408	0.239	3.02626831715389e-61	UBE2S	Malignant cells	GSE199333_post	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31553
1.5154742339106e-65	0.253624414777828	0.346	0.183	3.21750334601559e-61	ABCE1	Malignant cells	GSE199333_post	ENSG00000164163	6059	ATP binding cassette subfamily E member 1	OABP|RLI|RLI1|RNASEL1|RNASELI|RNS4I	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31554
5.85271067933028e-65	0.264220379922039	0.463	0.291	1.24258900432861e-60	PTTG1IP	Malignant cells	GSE199333_post	ENSG00000183255	754	PTTG1 interacting protein	C21orf1|C21orf3|PBF|PTTG1IP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31555
6.13555397899662e-65	-0.327554066326356	0.145	0.261	1.30263946528077e-60	ACSL4	Malignant cells	GSE199333_post	ENSG00000068366	2182	acyl-CoA synthetase long chain family member 4	ACS4|FACL4|LACS4|MRX63|MRX68	protein_coding	O60488	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31556
8.82580625307985e-65	-0.832626035433888	0.493	0.566	1.87380692559138e-60	CLEC2B	Malignant cells	GSE199333_post	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31557
1.35673440813225e-64	-0.281824894947551	0.21	0.341	2.88048282190558e-60	PPP3R1	Malignant cells	GSE199333_post	ENSG00000221823	5534	protein phosphatase 3 regulatory subunit B, alpha	CALNB1|CNB|CNB1	protein_coding	P63098	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31558
1.4804985312939e-64	-0.382233613951901	0.305	0.461	3.14324643179008e-60	GADD45B	Malignant cells	GSE199333_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31559
1.880822524385e-64	0.258627305922026	0.761	0.636	3.99317430152179e-60	SNRPB	Malignant cells	GSE199333_post	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31560
2.0260275959027e-64	0.257710098321106	0.356	0.191	4.30145918886102e-60	PRDX4	Malignant cells	GSE199333_post	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31561
4.88016175349848e-64	0.251700283906854	0.626	0.45	1.03610714188526e-59	NDUFB1	Malignant cells	GSE199333_post	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31562
5.54852231553121e-64	0.297007082189434	0.416	0.253	1.17800677281043e-59	CALCOCO2	Malignant cells	GSE199333_post	ENSG00000136436	10241	calcium binding and coiled-coil domain 2	MGC17318|NDP52	protein_coding	Q13137	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31563
5.85243186696603e-64	0.281547788363778	0.793	0.687	1.24252980967556e-59	HNRNPD	Malignant cells	GSE199333_post	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31564
7.77139770336723e-64	0.411640940887292	0.985	0.974	1.6499454464019e-59	HMGB1	Malignant cells	GSE199333_post	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31565
1.43283442595177e-63	-0.722067676322753	0.705	0.729	3.04205076973819e-59	ASAH1	Malignant cells	GSE199333_post	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31566
3.62974623970346e-63	-0.282994090897088	0.184	0.311	7.70631424151442e-59	MKNK2	Malignant cells	GSE199333_post	ENSG00000099875	2872	MAPK interacting serine/threonine kinase 2	GPRK7|MNK2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31567
4.8300152805197e-63	0.250842341265427	0.344	0.184	1.02546054420714e-58	BAZ1B	Malignant cells	GSE199333_post	ENSG00000009954	9031	bromodomain adjacent to zinc finger domain 1B	WBSCR10|WBSCR9|WSTF	protein_coding	Q9UIG0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31568
5.76249474251913e-63	-0.320339515125949	0.311	0.445	1.22343525878424e-58	SELENOS	Malignant cells	GSE199333_post	ENSG00000131871	55829	selenoprotein S	AD-015|MGC2553|SBBI8|SELS|SEPS1|VIMP	protein_coding	Q9BQE4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31569
2.93242788820226e-62	-0.305940136065333	0.18	0.302	6.22583764944222e-58	GAS7	Malignant cells	GSE199333_post	ENSG00000007237	8522	growth arrest specific 7	KIAA0394|MGC1348	protein_coding	O60861	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31570
4.81752373505949e-62	0.286206538134694	0.681	0.524	1.02280846419048e-57	AP2S1	Malignant cells	GSE199333_post	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31571
5.91131685919197e-62	-0.260767519929496	0.2	0.33	1.25503168237505e-57	PKN2	Malignant cells	GSE199333_post	ENSG00000065243	5586	protein kinase N2	Pak-2|PRK2|PRKCL2|STK7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31572
6.77080755888217e-62	-0.345564812618437	0.388	0.511	1.43751015282627e-57	ZNF326	Malignant cells	GSE199333_post	ENSG00000162664	284695	zinc finger protein 326	FLJ20403|ZAN75|Zfp326|ZIRD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31573
8.87502155355637e-62	-0.319525049761193	0.348	0.478	1.88425582603555e-57	ARL8B	Malignant cells	GSE199333_post	ENSG00000134108	55207	ADP ribosylation factor like GTPase 8B	ARL10C|FLJ10702|Gie1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31574
1.51875088677954e-61	0.317090405489343	0.73	0.599	3.22446000772163e-57	DEK	Malignant cells	GSE199333_post	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31575
2.63952519608392e-61	-0.318217276983968	0.459	0.572	5.60397594380577e-57	RAB5C	Malignant cells	GSE199333_post	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31576
7.7102613830191e-61	-0.258367266935879	0.232	0.363	1.63696559422879e-56	CHMP2B	Malignant cells	GSE199333_post	ENSG00000083937	25978	charged multivesicular body protein 2B	CHMP2.5|DKFZP564O123|VPS2B	protein_coding	Q9UQN3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31577
1.01272466744254e-60	0.252743858799712	0.408	0.244	2.15011574144727e-56	PXK	Malignant cells	GSE199333_post	ENSG00000168297	54899	PX domain containing serine/threonine kinase like	FLJ20335|Slob	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31578
3.05305752634422e-60	0.269514441908782	0.418	0.26	6.48194643418142e-56	PSMC3	Malignant cells	GSE199333_post	ENSG00000165916	5702	proteasome 26S subunit, ATPase 3	RPT5|TBP-1|TBP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31579
4.07435247992936e-60	0.294819518460514	0.409	0.245	8.65025775013803e-56	MAN1A1	Malignant cells	GSE199333_post	ENSG00000111885	4121	mannosidase alpha class 1A member 1	NA	protein_coding	P33908	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31580
4.62902844625344e-60	-0.257211386630109	0.22	0.35	9.82789029424069e-56	SMNDC1	Malignant cells	GSE199333_post	ENSG00000119953	10285	survival motor neuron domain containing 1	SMNR|SPF30|TDRD16C	protein_coding	O75940	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31581
4.97831852821785e-60	0.306661578888604	0.647	0.503	1.05694680672593e-55	CAP1	Malignant cells	GSE199333_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31582
5.86134026492669e-60	0.276763479320043	0.539	0.378	1.24442115164659e-55	HP1BP3	Malignant cells	GSE199333_post	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31583
7.31101579289664e-60	0.255283691480419	0.358	0.204	1.55220176298989e-55	TRAPPC6A	Malignant cells	GSE199333_post	ENSG00000007255	79090	trafficking protein particle complex subunit 6A	HSPC289|MGC2650|TRS33	protein_coding	O75865	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31584
8.87174386609773e-60	-1.45248508430621	0.334	0.442	1.88355994021121e-55	CXCL8	Malignant cells	GSE199333_post	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31585
1.21084834139149e-59	0.266456679591495	0.542	0.38	2.57075211360828e-55	MRPL33	Malignant cells	GSE199333_post	ENSG00000243147	9553	mitochondrial ribosomal protein L33	C2orf1|RPL33L	protein_coding	O75394	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31586
1.61924307804108e-59	-0.326463474949734	0.181	0.299	3.43781497898902e-55	PLEKHA2	Malignant cells	GSE199333_post	ENSG00000169499	59339	pleckstrin homology domain containing A2	TAPP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31587
2.37057789755218e-59	-0.304407878141648	0.468	0.582	5.03297393429303e-55	KIF5B	Malignant cells	GSE199333_post	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31588
3.26195353136314e-59	-0.277679937276618	0.276	0.406	6.92545354243709e-55	AZIN1	Malignant cells	GSE199333_post	ENSG00000155096	51582	antizyme inhibitor 1	OAZI|OAZIN|ODC1L	protein_coding	O14977	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31589
7.08832309668274e-59	0.263833193259154	0.682	0.526	1.50492187665671e-54	RBMX	Malignant cells	GSE199333_post	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31590
7.51882476706983e-59	-0.270961756014733	0.32	0.457	1.5963216862966e-54	PSMD11	Malignant cells	GSE199333_post	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31591
7.78157127570147e-59	-0.350850504502819	0.999	0.998	1.65210539754418e-54	H3F3B	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31592
1.19554472917303e-58	0.285307622056265	0.542	0.386	2.53826101450725e-54	ATP1B3	Malignant cells	GSE199333_post	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31593
5.57960965819875e-58	-0.287440919063786	0.462	0.581	1.18460692653218e-53	ARL6IP1	Malignant cells	GSE199333_post	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31594
5.90011288972054e-58	0.404794204602544	0.436	0.277	1.25265296761657e-53	RNASE2	Malignant cells	GSE199333_post	ENSG00000169385	6036	ribonuclease A family member 2	EDN|RAF3|RNS2	protein_coding	P10153	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31595
6.07307824592619e-58	-0.332108205960047	0.448	0.556	1.28937524239259e-53	PET100	Malignant cells	GSE199333_post	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31596
2.21182439313172e-57	0.298303574016665	0.82	0.738	4.69592436905796e-53	SNHG8	Malignant cells	GSE199333_post	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31597
2.52317951935336e-57	-0.420347197528085	0.311	0.422	5.35696243753912e-53	BID	Malignant cells	GSE199333_post	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31598
3.20608507523473e-57	-0.274103001989124	0.814	0.853	6.80683922323086e-53	ARF1	Malignant cells	GSE199333_post	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31599
5.80249228990412e-56	-0.311970641904622	0.401	0.528	1.23192713806954e-51	OGA	Malignant cells	GSE199333_post	ENSG00000198408	10724	O-GlcNAcase	MEA5|MGEA5|NCOAT	protein_coding	O60502	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31600
6.77529986924396e-56	0.287625599355912	0.874	0.77	1.43846391523919e-51	TSPO	Malignant cells	GSE199333_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31601
1.53520208458279e-55	-0.282285539178925	0.572	0.665	3.25938754577772e-51	PAPOLA	Malignant cells	GSE199333_post	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31602
4.88132543955579e-55	0.277954506774461	0.306	0.159	1.03635420407209e-50	ZBTB20	Malignant cells	GSE199333_post	ENSG00000181722	26137	zinc finger and BTB domain containing 20	DKFZp566F123|DPZF|ODA-8S|ZNF288	protein_coding	Q9HC78	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31603
8.85750212388075e-55	0.256219525693623	0.748	0.607	1.88053627592112e-50	POLR2L	Malignant cells	GSE199333_post	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31604
9.93899072212566e-55	-0.287703405390661	0.286	0.41	2.1101471202145e-50	KRT10	Malignant cells	GSE199333_post	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31605
1.05246422587418e-54	-0.306959197801093	0.252	0.382	2.23448679795347e-50	NFIL3	Malignant cells	GSE199333_post	ENSG00000165030	4783	nuclear factor, interleukin 3 regulated	E4BP4|IL3BP1|NF-IL3A|NFIL3A	protein_coding	Q16649	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31606
1.51209388934998e-54	-0.306758186619673	0.172	0.284	3.21032653647893e-50	AGO2	Malignant cells	GSE199333_post	ENSG00000123908	27161	argonaute RISC catalytic component 2	CASC7|EIF2C2|hAGO2|LINC00980|Q10	protein_coding	Q9UKV8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31607
2.6923908640584e-54	-0.542925332204292	0.246	0.358	5.71621504348239e-50	SLC2A3	Malignant cells	GSE199333_post	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31608
3.24567696171699e-54	-0.257973634165575	0.215	0.335	6.89089675742134e-50	EPN1	Malignant cells	GSE199333_post	ENSG00000063245	29924	epsin 1	NA	protein_coding	Q9Y6I3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31609
3.92325198937987e-54	-0.342278783656706	0.663	0.717	8.3294562986524e-50	ZC3H15	Malignant cells	GSE199333_post	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31610
4.45396104187953e-54	-0.384930300785264	0.898	0.905	9.45620468801443e-50	MT-ND4L	Malignant cells	GSE199333_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31611
4.55509446591865e-54	-0.333469137883414	0.646	0.722	9.67092106059188e-50	RBM8A	Malignant cells	GSE199333_post	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31612
4.72972958289545e-54	-0.25289557547349	0.198	0.317	1.00416888774453e-49	ARFGAP3	Malignant cells	GSE199333_post	ENSG00000242247	26286	ADP ribosylation factor GTPase activating protein 3	ARFGAP1	protein_coding	Q9NP61	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31613
5.37830215923284e-54	-0.322476097341517	0.743	0.803	1.14186733142673e-49	PRRC2C	Malignant cells	GSE199333_post	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31614
2.04912805440134e-53	-0.256553648837902	0.193	0.311	4.35050377229949e-49	THEMIS2	Malignant cells	GSE199333_post	ENSG00000130775	9473	thymocyte selection associated family member 2	C1orf38|ICB-1	protein_coding	Q5TEJ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31615
2.05793698047259e-53	-0.314514935417165	0.356	0.491	4.36920600324137e-49	IER5	Malignant cells	GSE199333_post	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31616
2.5362442020016e-53	-0.437963617030314	0.411	0.501	5.38470006526961e-49	ARRB2	Malignant cells	GSE199333_post	ENSG00000141480	409	arrestin beta 2	ARR2|BARR2|DKFZp686L0365	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31617
3.43086075958029e-53	-0.281470391426052	0.274	0.397	7.28406047866491e-49	ITSN2	Malignant cells	GSE199333_post	ENSG00000198399	50618	intersectin 2	KIAA1256|PRO2015|SH3D1B|SH3P18|SWA|SWAP	protein_coding	Q9NZM3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31618
1.55875914748827e-52	-0.295170035792099	0.361	0.48	3.30940154603234e-48	PLEKHB2	Malignant cells	GSE199333_post	ENSG00000115762	55041	pleckstrin homology domain containing B2	EVT2|FLJ20783	protein_coding	Q96CS7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31619
3.45499971121424e-52	-0.26574754761951	0.235	0.357	7.33530988687895e-48	USP8	Malignant cells	GSE199333_post	ENSG00000138592	9101	ubiquitin specific peptidase 8	HumORF8|KIAA0055|SPG59|UBPY	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31620
3.79965122185597e-52	-0.304610912031751	0.59	0.673	8.06703950912242e-48	SEC62	Malignant cells	GSE199333_post	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31621
6.07974510411197e-52	-0.350043216667885	0.748	0.832	1.29079068305401e-47	CALM1	Malignant cells	GSE199333_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31622
6.5261855806936e-52	-1.12303233617366	0.914	0.895	1.38557446063706e-47	H1FX	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31623
6.95537659434527e-52	-0.275614856421593	1	0.999	1.47669600474544e-47	B2M	Malignant cells	GSE199333_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31624
7.64602017588487e-52	-0.258303499509896	0.274	0.395	1.62332654354212e-47	C1D	Malignant cells	GSE199333_post	ENSG00000197223	10438	C1D nuclear receptor corepressor	LRP1|Rrp47|SUN-CoR|SUNCOR	protein_coding	Q13901	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31625
8.94366604799178e-52	-0.263055303345304	0.201	0.317	1.89882973864913e-47	ARID2	Malignant cells	GSE199333_post	ENSG00000189079	196528	AT-rich interaction domain 2	BAF200|DKFZp686G052|FLJ30619|KIAA1557|SMARCF3	protein_coding	Q68CP9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31626
9.16995082839574e-52	-0.275314280517639	0.366	0.489	1.9468722603767e-47	CNOT2	Malignant cells	GSE199333_post	ENSG00000111596	4848	CCR4-NOT transcription complex subunit 2	CDC36|NOT2|NOT2H	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31627
1.52962661235196e-51	-0.314273815359557	0.394	0.509	3.24755026068445e-47	FNIP1	Malignant cells	GSE199333_post	ENSG00000217128	96459	folliculin interacting protein 1	KIAA1961	protein_coding	Q8TF40	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31628
2.75910941597733e-51	-0.315466311040806	1	0.998	5.85786520106147e-47	MT-ND1	Malignant cells	GSE199333_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31629
3.90069730678923e-51	-0.287285132940822	0.385	0.5	8.2815704520442e-47	UFM1	Malignant cells	GSE199333_post	ENSG00000120686	51569	ubiquitin fold modifier 1	bA131P10.1|C13orf20	protein_coding	P61960	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31630
4.32858456930307e-51	-0.847372943506387	0.486	0.535	9.19001789908734e-47	SLC25A37	Malignant cells	GSE199333_post	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31631
1.02090797279765e-50	-0.301133506016783	0.567	0.653	2.16748971704669e-46	EWSR1	Malignant cells	GSE199333_post	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31632
1.58468604757131e-50	-0.526967518345231	0.33	0.426	3.36444694759866e-46	MGAT1	Malignant cells	GSE199333_post	ENSG00000131446	4245	alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GLCNAC-TI|GLYT1|GNT-1|GnTI|MGAT	protein_coding	P26572	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31633
1.72429190390293e-50	0.299991649248647	0.625	0.494	3.66084414117631e-46	SNRPG	Malignant cells	GSE199333_post	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31634
3.58451896445682e-50	-0.277165714824373	0.327	0.446	7.61029221343828e-46	TMF1	Malignant cells	GSE199333_post	ENSG00000144747	7110	TATA element modulatory factor 1	ARA160|TMF	protein_coding	P82094	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31635
6.36353464188788e-50	-0.266409133747919	0.228	0.346	1.35104203981922e-45	CLIP1	Malignant cells	GSE199333_post	ENSG00000130779	6249	CAP-Gly domain containing linker protein 1	CLIP|CLIP-170|CLIP170|CYLN1|RSN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31636
6.64248587244668e-50	0.262036547586979	0.997	0.992	1.41026617557915e-45	RPS20	Malignant cells	GSE199333_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31637
7.45245184073362e-50	-0.274219654851772	0.23	0.345	1.58223005030615e-45	TOMM5	Malignant cells	GSE199333_post	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31638
1.44437688286868e-49	-0.28547797642454	0.29	0.413	3.06655656001849e-45	GOLGA4	Malignant cells	GSE199333_post	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31639
2.03329067176855e-49	-0.578563311136625	0.755	0.752	4.31687942523181e-45	MBNL1	Malignant cells	GSE199333_post	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31640
2.50504486351583e-49	-0.264601206288624	0.326	0.449	5.31846074973046e-45	ABI1	Malignant cells	GSE199333_post	ENSG00000136754	10006	abl interactor 1	ABI-1|E3B1|SSH3BP1	protein_coding	Q8IZP0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31641
2.8809104496789e-49	0.252925698138573	0.691	0.55	6.11646097571328e-45	PPA1	Malignant cells	GSE199333_post	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31642
3.91927925830793e-49	-0.259600860936536	0.258	0.377	8.32102179331356e-45	CDK12	Malignant cells	GSE199333_post	ENSG00000167258	51755	cyclin dependent kinase 12	CRK7|CRKR|CRKRS|KIAA0904	protein_coding	Q9NYV4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31643
4.03801632809551e-49	-0.45758754094587	0.337	0.433	8.57311246617958e-45	CXXC5	Malignant cells	GSE199333_post	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31644
2.32372082323313e-47	-0.259549650668062	0.225	0.334	4.93349167980625e-43	C16orf87	Malignant cells	GSE199333_post	ENSG00000155330	388272	chromosome 16 open reading frame 87	NA	protein_coding	Q6PH81	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31645
2.46150761329359e-47	-0.270054908339442	0.616	0.698	5.22602681378361e-43	RNPS1	Malignant cells	GSE199333_post	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31646
2.84964987491541e-47	-0.268182306477178	0.999	0.996	6.05009164943291e-43	ACTB	Malignant cells	GSE199333_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31647
2.91751284141632e-47	-0.385266413458422	0.647	0.689	6.19417151361098e-43	PLEK	Malignant cells	GSE199333_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31648
6.0281070085336e-47	-0.280953521380028	0.366	0.479	1.27982739898177e-42	NIPBL	Malignant cells	GSE199333_post	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31649
1.01021718036734e-46	-0.317391037750348	0.474	0.569	2.14479209563791e-42	DDX24	Malignant cells	GSE199333_post	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31650
1.177377244512e-46	-0.281905024641991	0.318	0.43	2.49968962782343e-42	ATP6V0D1	Malignant cells	GSE199333_post	ENSG00000159720	9114	ATPase H+ transporting V0 subunit d1	ATP6D|ATP6DV|P39|VATX|Vma6|VPATPD	protein_coding	P61421	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31651
4.19148985055311e-46	-0.270042929392106	0.318	0.431	8.89895210170931e-42	PAFAH1B2	Malignant cells	GSE199333_post	ENSG00000168092	5049	platelet activating factor acetylhydrolase 1b catalytic subunit 2	NA	protein_coding	P68402	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31652
6.33115779570494e-46	0.302227049062944	0.512	0.36	1.34416811160612e-41	LIMS1	Malignant cells	GSE199333_post	ENSG00000169756	3987	LIM zinc finger domain containing 1	PINCH|PINCH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31653
5.77373218273338e-45	-0.290905494578364	0.303	0.409	1.22582107971612e-40	SELENOK	Malignant cells	GSE199333_post	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31654
2.06599947423882e-44	-0.266540727272086	0.168	0.27	4.38632348375645e-40	TIPARP	Malignant cells	GSE199333_post	ENSG00000163659	25976	TCDD inducible poly(ADP-ribose) polymerase	ARTD14|DDF1|DKFZP434J214|DKFZp686N0351|PARP-1|PARP-7|PARP7|pART14|RM1	protein_coding	Q7Z3E1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31655
3.46480039321651e-44	0.308586494502983	0.548	0.413	7.35611771483797e-40	TENT5A	Malignant cells	GSE199333_post	ENSG00000112773	55603	terminal nucleotidyltransferase 5A	C6orf37|FAM46A|FLJ20037	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31656
5.32285380865159e-44	-0.36885165915223	0.479	0.552	1.13009509211482e-39	ELOC	Malignant cells	GSE199333_post	ENSG00000154582	6921	elongin C	SIII|TCEB1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31657
1.41266494346231e-43	-0.34777187590591	0.319	0.415	2.99922894146483e-39	ARHGEF2	Malignant cells	GSE199333_post	ENSG00000116584	9181	Rho/Rac guanine nucleotide exchange factor 2	GEF-H1|GEFH1|KIAA0651|Lfc|LFP40|P40	protein_coding	Q92974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31658
1.64667169699744e-43	-0.404669300721051	0.857	0.884	3.49604867989527e-39	FUS	Malignant cells	GSE199333_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31659
7.59313414841994e-43	-0.300814447638793	0.462	0.555	1.61209831105104e-38	ARID4B	Malignant cells	GSE199333_post	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31660
8.40324908410187e-43	-0.259740337446953	0.821	0.841	1.78409381304567e-38	ATP5MPL	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31661
1.02900558730106e-42	-0.367271466166453	0.331	0.453	2.18468176239889e-38	ID2	Malignant cells	GSE199333_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31662
1.09114457839393e-42	-0.279493272332752	0.316	0.421	2.31660905438815e-38	ELF2	Malignant cells	GSE199333_post	ENSG00000109381	1998	E74 like ETS transcription factor 2	EU32|NERF|NERF-1A|NERF-1B|NERF-2	protein_coding	Q15723	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31663
1.25978445528522e-42	-0.342909638691372	0.653	0.699	2.67464837701606e-38	ITGB2	Malignant cells	GSE199333_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31664
2.58488505731834e-42	-0.282221086514575	0.394	0.49	5.48796946519257e-38	RAB14	Malignant cells	GSE199333_post	ENSG00000119396	51552	RAB14, member RAS oncogene family	FBP|RAB-14	protein_coding	P61106	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31665
3.31611164649219e-42	-0.273162627842405	0.313	0.417	7.04043663666756e-38	MTCH1	Malignant cells	GSE199333_post	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31666
4.66407566457394e-41	-0.567619504792868	0.998	0.995	9.90229904345692e-37	RPS26	Malignant cells	GSE199333_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31667
9.53369144201937e-40	-0.330292295552155	0.371	0.463	2.02409803005513e-35	ZNF292	Malignant cells	GSE199333_post	ENSG00000188994	23036	zinc finger protein 292	bA393I2.3|KIAA0530|ZFP292|Zn-15|Zn-16	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31668
9.56958101047442e-40	-0.295123229517112	0.362	0.472	2.03171774433382e-35	GRN	Malignant cells	GSE199333_post	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31669
1.95036164157693e-39	-0.26679448057506	0.327	0.43	4.14081280123197e-35	FOXN3	Malignant cells	GSE199333_post	ENSG00000053254	1112	forkhead box N3	C14orf116|CHES1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31670
2.04459129746724e-39	0.310046925614831	0.792	0.672	4.34087178365269e-35	DUSP1	Malignant cells	GSE199333_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31671
6.22733524064442e-38	-0.318890627136103	0.504	0.576	1.32212554494122e-33	CELF1	Malignant cells	GSE199333_post	ENSG00000149187	10658	CUGBP Elav-like family member 1	BRUNOL2|CUG-BP|CUGBP|CUGBP1|EDEN-BP|hNab50|NAB50|NAPOR	protein_coding	Q92879	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31672
1.47289397618081e-37	-0.332878822241197	0.63	0.67	3.12710120082949e-33	ATP6V1F	Malignant cells	GSE199333_post	ENSG00000128524	9296	ATPase H+ transporting V1 subunit F	ATP6S14|VATF|Vma7	protein_coding	Q16864	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31673
3.80041780360106e-37	-0.305275954362533	0.821	0.842	8.06866703882542e-33	LRRFIP1	Malignant cells	GSE199333_post	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31674
3.82555422337299e-37	-0.254200979904948	0.395	0.482	8.1220341716432e-33	AP3S1	Malignant cells	GSE199333_post	ENSG00000177879	1176	adaptor related protein complex 3 subunit sigma 1	CLAPS3	protein_coding	Q92572	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31675
2.54294890248915e-36	-1.2563054034234	0.359	0.415	5.39893481487471e-32	LRRC75A	Malignant cells	GSE199333_post	ENSG00000181350	388341	leucine rich repeat containing 75A	C17orf76|FAM211A|FLJ35696	protein_coding	Q8NAA5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31676
7.23195116260726e-36	0.284086308572577	0.325	0.217	1.53541555133315e-31	TUBB6	Malignant cells	GSE199333_post	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31677
7.2740596257375e-36	-0.295975515407946	0.404	0.489	1.54435559914033e-31	BOD1L1	Malignant cells	GSE199333_post	ENSG00000038219	259282	biorientation of chromosomes in cell division 1 like 1	BOD1L|FAM44A|FLJ33215|KIAA1327	protein_coding	Q8NFC6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31678
9.94092022775105e-36	-0.283969736229727	0.212	0.302	2.11055677355383e-31	RHOQ	Malignant cells	GSE199333_post	ENSG00000119729	23433	ras homolog family member Q	ARHQ|RASL7A|TC10	protein_coding	P17081	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31679
2.1544832176687e-35	-0.255026529702458	0.361	0.454	4.57418331943242e-31	PTPN2	Malignant cells	GSE199333_post	ENSG00000175354	5771	protein tyrosine phosphatase non-receptor type 2	PTPT|TC-PTP|TCELLPTP|TCPTP	protein_coding	P17706	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31680
8.00275044299488e-35	-0.283514451783715	0.725	0.77	1.69906394655224e-30	RBM25	Malignant cells	GSE199333_post	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31681
6.2385766553765e-34	-0.270705553297982	0.263	0.355	1.32451220970298e-29	TFDP1	Malignant cells	GSE199333_post	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31682
7.16003905983093e-33	-0.273622118162945	0.478	0.551	1.5201478927927e-28	CLINT1	Malignant cells	GSE199333_post	ENSG00000113282	9685	clathrin interactor 1	CLINT|ENTH|EPNR|KIAA0171	protein_coding	Q14677	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31683
3.19401229675644e-32	0.265689987516791	0.479	0.361	6.7812075072436e-28	HIST1H1C	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31684
1.64197784236518e-31	-0.256003725333498	0.472	0.547	3.48608315712551e-27	CAPZA2	Malignant cells	GSE199333_post	ENSG00000198898	830	capping actin protein of muscle Z-line subunit alpha 2	CAPPA2|CAPZ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31685
2.38917607365535e-31	-0.263133199181788	0.996	0.992	5.07245972197767e-27	RPS10	Malignant cells	GSE199333_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31686
5.31070262947252e-31	0.526425703594082	0.53	0.432	1.12751527526331e-26	KLF2	Malignant cells	GSE199333_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31687
7.69808846052062e-31	-0.466480840526213	0.79	0.787	1.63438116105313e-26	YBX3	Malignant cells	GSE199333_post	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31688
2.25853758576636e-30	-1.01588337941353	0.405	0.452	4.79510114834055e-26	MT2A	Malignant cells	GSE199333_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31689
2.3845221473063e-30	-0.359659634931278	0.265	0.349	5.062578970946e-26	AC007952.4	Malignant cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31690
6.5951901556712e-30	-0.291877916493485	0.228	0.306	1.40022482195055e-25	ZMIZ1	Malignant cells	GSE199333_post	ENSG00000108175	57178	zinc finger MIZ-type containing 1	FLJ13541|hZIMP10|KIAA1224|MIZ|RAI17|RP11-519K18.1|Zimp10	protein_coding	Q9ULJ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31691
2.05840811606945e-29	-0.995693810258209	0.34	0.389	4.37020627122705e-25	MARCKS	Malignant cells	GSE199333_post	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31692
5.39803717996898e-29	-1.75063931564163	0.274	0.329	1.14605727367921e-24	PRTN3	Malignant cells	GSE199333_post	ENSG00000277804	5657	proteinase 3	ACPA|AGP7|C-ANCA|MBT|P29|PR-3	protein_coding	P24158	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31693
1.49972875110961e-27	-0.285065694744915	0.375	0.454	3.1840741114808e-23	ODC1	Malignant cells	GSE199333_post	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31694
8.62220159734828e-27	-0.266410180184351	0.382	0.454	1.83057962113301e-22	IDS	Malignant cells	GSE199333_post	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31695
1.9074118384891e-26	-0.27316096045881	0.328	0.404	4.0496260742962e-22	SNHG15	Malignant cells	GSE199333_post	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31696
2.80881944558936e-26	-0.444985457061805	0.192	0.256	5.96340456493078e-22	CD93	Malignant cells	GSE199333_post	ENSG00000125810	22918	CD93 molecule	C1qR(P)|C1QR1|C1qRP|CDw93|dJ737E23.1|ECSM3|MXRA4	protein_coding	Q9NPY3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31697
9.13868283059729e-26	-0.329086705619137	0.272	0.337	1.94023375176411e-21	LCP2	Malignant cells	GSE199333_post	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31698
1.50786733362722e-25	-0.261650314429505	0.783	0.82	3.20135313602395e-21	SARAF	Malignant cells	GSE199333_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31699
1.95437186209952e-25	-0.317632261486914	0.503	0.552	4.14932690042348e-21	ADGRE5	Malignant cells	GSE199333_post	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31700
3.91077635106947e-25	-0.42246708952362	0.209	0.269	8.30296927095558e-21	SLA	Malignant cells	GSE199333_post	ENSG00000155926	6503	Src like adaptor	hSLAP|SLA1|SLAP|SLAP-1	protein_coding	Q13239	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31701
5.60271597935869e-25	-0.270060112082228	0.826	0.826	1.18951262957764e-20	PCBP1	Malignant cells	GSE199333_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31702
8.80761282315208e-25	-0.406417298018866	0.338	0.402	1.86994427848342e-20	MARCKSL1	Malignant cells	GSE199333_post	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31703
1.62718815930902e-24	-0.264459537879838	0.374	0.436	3.45468318102898e-20	TRABD	Malignant cells	GSE199333_post	ENSG00000170638	80305	TraB domain containing	PP2447	protein_coding	Q9H4I3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31704
1.79818342856979e-24	-0.311109813227948	0.523	0.56	3.81772323719652e-20	SPI1	Malignant cells	GSE199333_post	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31705
4.34946078061725e-24	-0.348333352532961	0.787	0.798	9.23434018332849e-20	TRA2B	Malignant cells	GSE199333_post	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31706
1.02396639468492e-23	-0.315441099552079	0.224	0.291	2.17398305255555e-19	ATG4B	Malignant cells	GSE199333_post	ENSG00000168397	23192	autophagy related 4B cysteine peptidase	APG4B|AUTL1|DKFZp586D1822|KIAA0943	protein_coding	Q9Y4P1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31707
8.14687533373132e-21	-0.370718510988581	0.875	0.843	1.7296631021045e-16	CD44	Malignant cells	GSE199333_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31708
1.74989308992983e-20	-0.333915733646	0.309	0.368	3.71519801923001e-16	NXT1	Malignant cells	GSE199333_post	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31709
2.0573678627736e-20	-0.286382187890425	0.34	0.409	4.36799770945463e-16	EZR	Malignant cells	GSE199333_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31710
2.13142453131732e-20	-0.469599355015955	0.663	0.664	4.5252274224398e-16	FOSB	Malignant cells	GSE199333_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31711
1.08963687843822e-19	-0.405956027658757	0.504	0.521	2.31340805661219e-15	IFITM2	Malignant cells	GSE199333_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31712
1.51722199513951e-18	-0.325155856683703	0.579	0.606	3.22121401788069e-14	SLC38A2	Malignant cells	GSE199333_post	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31713
8.35825503710835e-16	-0.363426985711412	0.855	0.859	1.77454112692847e-11	VIM	Malignant cells	GSE199333_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31714
1.1040281083326e-15	-0.360270001885044	0.457	0.493	2.34396207680094e-11	NFKBIZ	Malignant cells	GSE199333_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31715
2.70306215134665e-13	-0.256344681882383	0.885	0.858	5.73887125352407e-09	CD63	Malignant cells	GSE199333_post	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31716
2.5355220062839e-12	-0.263528923121056	0.537	0.559	5.38316677154135e-08	ANKRD11	Malignant cells	GSE199333_post	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31717
1.0621998409853e-11	0.643880765328575	0.535	0.478	2.2551564823959e-07	AZU1	Malignant cells	GSE199333_post	ENSG00000278624	566	azurocidin 1	AZAMP|AZU|CAP37|HBP|HUMAZUR|NAZC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31718
4.47273667673354e-11	-0.295960358765402	0.936	0.893	9.49606723837297e-07	S100A4	Malignant cells	GSE199333_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31719
1.0798474059889e-07	-0.327029906714699	0.908	0.777	0.00229262402765503	CTSD	Malignant cells	GSE199333_post	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31720
0	0.892296938002549	0.999	0.983	0	SH3BGRL3	NK cells	GSE199333_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31721
0	1.79886033256305	0.97	0.609	0	CD52	NK cells	GSE199333_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31722
0	1.21365770867081	0.621	0.141	0	S100A11	NK cells	GSE199333_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31723
0	1.65954792099131	0.997	0.918	0	S100A4	NK cells	GSE199333_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31724
0	0.97975460291129	0.96	0.787	0	PTPRC	NK cells	GSE199333_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31725
0	-0.852198177587882	1	1	0	PTMA	NK cells	GSE199333_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31726
0	-1.3310636994183	0.575	0.918	0	PIK3R1	NK cells	GSE199333_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31727
0	-0.597949919118046	1	1	0	HLA-B	NK cells	GSE199333_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31728
0	1.17240233197578	0.906	0.569	0	CLIC1	NK cells	GSE199333_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31729
0	0.919034004672062	1	1	0	TMSB4X	NK cells	GSE199333_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31730
0	1.13565286280676	0.925	0.573	0	ANXA1	NK cells	GSE199333_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31731
0	-1.45714671739923	0.654	0.947	0	HSPA5	NK cells	GSE199333_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31732
0	1.52300681571663	0.997	0.798	0	HBB	NK cells	GSE199333_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31733
0	1.66960519552916	0.559	0.021	0	HBG2	NK cells	GSE199333_post	ENSG00000196565	3048	hemoglobin subunit gamma 2	HBG-T1	protein_coding	P69892	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31734
0	1.22222839518274	0.694	0.21	0	UCP2	NK cells	GSE199333_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31735
0	1.56677513840105	0.701	0.195	0	CD3D	NK cells	GSE199333_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31736
0	1.41660841947776	0.634	0.147	0	CD3G	NK cells	GSE199333_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31737
0	-1.05269151128893	0.437	0.858	0	EPC1	NK cells	GSE199333_post	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31738
0	1.88758375092326	0.986	0.72	0	HBA2	NK cells	GSE199333_post	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31739
0	1.56425481222139	0.944	0.625	0	HBA1	NK cells	GSE199333_post	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31740
0	2.17000031619168	0.932	0.485	0	IL32	NK cells	GSE199333_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31741
0	-1.24455559297712	1	1	0	EIF1	NK cells	GSE199333_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31742
0	-0.987817955449528	1	1	0	H3F3B	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31743
0	1.17950515272622	0.965	0.785	0	MYL12A	NK cells	GSE199333_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31744
0	1.00572672355424	0.938	0.66	0	MYL12B	NK cells	GSE199333_post	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31745
0	-1.06074005323053	0.915	0.992	0	RBM39	NK cells	GSE199333_post	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31746
0	-1.15519198644657	0.459	0.892	0	RBM38	NK cells	GSE199333_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31747
0	1.1887834024093	0.91	0.59	0	EMP3	NK cells	GSE199333_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31748
0	0.589365933197794	1	1	0	MT-ATP6	NK cells	GSE199333_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31749
0	1.0626413471406	1	0.991	0	MT-ND5	NK cells	GSE199333_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31750
5.32550310986817e-288	-1.20417236263997	0.999	1	1.13065756525611e-283	FTH1	NK cells	GSE199333_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31751
2.35438438005828e-284	-1.14108335739323	0.28	0.719	4.99859347730174e-280	PDE4D	NK cells	GSE199333_post	ENSG00000113448	5144	phosphodiesterase 4D	DPDE3	protein_coding	Q08499	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31752
1.47199830353278e-283	-0.926217104800787	0.846	0.968	3.12519959823044e-279	FUS	NK cells	GSE199333_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31753
7.91198809127359e-283	0.908406858036455	0.94	0.705	1.6797941916583e-278	OAZ1	NK cells	GSE199333_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31754
1.67292844125666e-276	1.0122506289458	0.945	0.666	3.55179437363201e-272	VIM	NK cells	GSE199333_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31755
5.29305158849675e-274	-0.870537542061026	0.723	0.93	1.12376778275375e-269	SRRM1	NK cells	GSE199333_post	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31756
6.40564289449095e-274	0.981838976455283	0.84	0.508	1.35998204292937e-269	RAC2	NK cells	GSE199333_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31757
1.11469434605347e-273	0.637157054309872	1	1	2.36660756610613e-269	MT-ND4	NK cells	GSE199333_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31758
8.4456638066091e-263	-0.969399549961135	0.428	0.808	1.79309888278118e-258	RSRC2	NK cells	GSE199333_post	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31759
3.00422582890503e-262	-0.759313323638957	0.897	0.98	6.37827185734827e-258	CIRBP	NK cells	GSE199333_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31760
9.37791300353542e-257	1.01435182251186	0.857	0.587	1.9910247097806e-252	S100A10	NK cells	GSE199333_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31761
6.48715343027855e-256	-0.98641219008814	0.217	0.65	1.37728754478244e-251	ODC1	NK cells	GSE199333_post	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31762
8.11408583341176e-256	0.962840918857611	0.669	0.255	1.72270156329165e-251	LCK	NK cells	GSE199333_post	ENSG00000182866	3932	LCK proto-oncogene, Src family tyrosine kinase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31763
1.43312834560973e-255	-0.860639349381396	0.782	0.942	3.04267479056402e-251	PNRC1	NK cells	GSE199333_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31764
7.2033149729634e-254	0.691300395481719	1	1	1.52933580190986e-249	MT-ND3	NK cells	GSE199333_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31765
1.26021408347693e-249	-0.912842413479626	0.533	0.857	2.67556052062987e-245	DNAJB6	NK cells	GSE199333_post	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31766
6.30768952032497e-248	0.955680646535782	0.639	0.225	1.33918556206019e-243	APOBEC3G	NK cells	GSE199333_post	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31767
4.22235456705587e-246	-0.746378052299149	0.921	0.979	8.96448098131632e-242	SRSF5	NK cells	GSE199333_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31768
7.99206476843349e-245	1.04740788317043	0.522	0.12	1.69679527098611e-240	KLRG1	NK cells	GSE199333_post	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31769
9.16627194150913e-243	-0.921579038520717	0.481	0.829	1.9460911959018e-238	TAX1BP1	NK cells	GSE199333_post	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31770
8.03742860940737e-236	-0.881002512508044	0.496	0.839	1.70642646806328e-231	BCLAF1	NK cells	GSE199333_post	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31771
1.22456181324024e-235	0.898535114252229	0.904	0.686	2.59986718569035e-231	CORO1A	NK cells	GSE199333_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31772
1.86590179781987e-233	1.17922280712467	0.854	0.624	3.96149610695136e-229	PRF1	NK cells	GSE199333_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31773
5.75800560857347e-232	1.40925626918476	0.488	0.11	1.22248217075623e-227	TRGC1	NK cells	GSE199333_post	ENSG00000211689	445347	TCR gamma alternate reading frame protein	CD3G|TCRG|TCRGC1|TCRGC2|TCRGV|C1	TR_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31774
4.40190678932907e-231	0.946424515409273	0.736	0.366	9.34568830442455e-227	ARPC1B	NK cells	GSE199333_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31775
1.15568851857755e-229	-1.18403000876441	0.154	0.546	2.45364229379199e-225	TSPYL2	NK cells	GSE199333_post	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31776
7.00529484924916e-229	1.0190064666405	0.453	0.074	1.48729414944409e-224	TRGC2	NK cells	GSE199333_post	ENSG00000227191	NA	NA	TCRGC2|TRGC2(2X)|TRGC2(3X)	TR_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31777
1.17801227936551e-226	-0.922954449455319	0.326	0.719	2.50103787032092e-222	PFDN2	NK cells	GSE199333_post	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31778
3.66717809891837e-223	-0.84848440529752	0.235	0.64	7.78578582181358e-219	RAB8B	NK cells	GSE199333_post	ENSG00000166128	51762	RAB8B, member RAS oncogene family	NA	protein_coding	Q92930	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31779
1.96896707233459e-222	-0.649594155228238	0.998	1	4.18031399127358e-218	UBC	NK cells	GSE199333_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31780
2.08224194113816e-220	0.910421887495909	0.96	0.837	4.42080786523044e-216	GZMA	NK cells	GSE199333_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31781
4.6314103898024e-220	-0.775695668597298	0.75	0.929	9.83294739858948e-216	PRRC2C	NK cells	GSE199333_post	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31782
4.05324493219434e-218	0.877848020810813	0.685	0.31	8.60544431554179e-214	PSMB9	NK cells	GSE199333_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31783
6.00005021331507e-216	-0.489258566032015	1	1	1.27387066078892e-211	HLA-A	NK cells	GSE199333_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31784
5.16208258078688e-213	-1.21504542358274	0.273	0.653	1.09596175272686e-208	NR4A2	NK cells	GSE199333_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31785
2.7262088131815e-211	-0.760381801390936	0.179	0.574	5.78801393126565e-207	MEX3C	NK cells	GSE199333_post	ENSG00000176624	51320	mex-3 RNA binding family member C	FLJ38871|RKHD2|RNF194	protein_coding	Q5U5Q3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31786
4.8061765976459e-210	-0.883523350333244	0.327	0.707	1.0203993534462e-205	DDX3Y	NK cells	GSE199333_post	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31787
4.02576245456874e-209	-0.787271358573913	0.604	0.865	8.5470962672949e-205	SFPQ	NK cells	GSE199333_post	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31788
1.401546867903e-208	-0.838366059314441	0.555	0.842	2.97562415524487e-204	BZW1	NK cells	GSE199333_post	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31789
3.50906332739669e-208	0.884231242017931	0.619	0.244	7.45009235039592e-204	ANXA6	NK cells	GSE199333_post	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31790
3.67912540932154e-207	-0.740378662335572	0.712	0.907	7.81115115653056e-203	EIF5A	NK cells	GSE199333_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31791
4.38955314490063e-207	-0.478296269883247	1	1	9.31946028193853e-203	HLA-C	NK cells	GSE199333_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31792
6.48735455719747e-203	0.758010579704793	0.989	0.918	1.37733024603859e-198	S100A6	NK cells	GSE199333_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31793
2.63182000040858e-202	0.830901203508766	0.569	0.202	5.58761704286745e-198	ARPC5	NK cells	GSE199333_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31794
9.64867276176031e-202	-0.723175592762472	0.166	0.552	2.04850971404933e-197	COG3	NK cells	GSE199333_post	ENSG00000136152	83548	component of oligomeric golgi complex 3	SEC34	protein_coding	Q96JB2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31795
7.11784595886639e-200	0.825301222833172	0.819	0.568	1.51118987552692e-195	EVL	NK cells	GSE199333_post	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31796
7.30108789874787e-200	0.390300078136823	1	1	1.55009397178316e-195	B2M	NK cells	GSE199333_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31797
1.79028596400297e-199	0.854836871768526	0.613	0.26	3.8009561301747e-195	RIPOR2	NK cells	GSE199333_post	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31798
3.41331526540069e-195	0.783504282467691	0.799	0.491	7.2468096399722e-191	ENO1	NK cells	GSE199333_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31799
4.11697457771649e-194	-0.864105305782769	0.389	0.745	8.74074872594988e-190	RNF125	NK cells	GSE199333_post	ENSG00000101695	54941	ring finger protein 125	FLJ20456	protein_coding	Q96EQ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31800
6.25482508340155e-194	-0.847335405925904	0.454	0.777	1.32796191345698e-189	PRPF4B	NK cells	GSE199333_post	ENSG00000112739	8899	pre-mRNA processing factor 4B	KIAA0536|PR4H|Prp4	protein_coding	Q13523	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31801
8.07404778868596e-192	-0.709354387809553	0.157	0.53	1.71420108601592e-187	ETF1	NK cells	GSE199333_post	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31802
2.02697630515625e-191	0.507156159526257	1	1	4.30347339347724e-187	TMSB10	NK cells	GSE199333_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31803
2.74160579952294e-186	1.18890493644106	0.578	0.243	5.82070327296715e-182	KLRC1	NK cells	GSE199333_post	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31804
9.71933135835961e-183	-0.794282931462713	0.294	0.665	2.06351124069333e-178	CNOT2	NK cells	GSE199333_post	ENSG00000111596	4848	CCR4-NOT transcription complex subunit 2	CDC36|NOT2|NOT2H	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31805
4.61468098422455e-181	-0.694994256687031	0.174	0.535	9.79742919760715e-177	DBF4	NK cells	GSE199333_post	ENSG00000006634	10926	DBF4 zinc finger	ASK|chif|DBF4A|ZDBF1	protein_coding	Q9UBU7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31806
1.43722692769307e-180	-0.782541942575963	0.237	0.598	3.05137649018516e-176	CBX4	NK cells	GSE199333_post	ENSG00000141582	8535	chromobox 4	hPC2|NBP16|PC2	protein_coding	O00257	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31807
6.53894791869477e-179	-0.765510328511036	0.271	0.636	1.38828403261809e-174	ISCA1	NK cells	GSE199333_post	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31808
2.28056609267532e-178	-0.59390626800682	0.964	0.991	4.84186987135896e-174	YBX1	NK cells	GSE199333_post	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31809
1.68559970767298e-177	-0.783357452786502	0.35	0.702	3.57869673936051e-173	DNAJA1	NK cells	GSE199333_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31810
1.05880136030254e-176	-0.799391947465561	0.455	0.777	2.24794116805833e-172	REL	NK cells	GSE199333_post	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31811
1.07697295398236e-176	-0.512173394587246	0.995	1	2.28652127859995e-172	DDX5	NK cells	GSE199333_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31812
1.32280618869791e-176	0.802406916326951	0.561	0.219	2.80844981922453e-172	ANXA2	NK cells	GSE199333_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31813
5.65090518464632e-176	-0.871691468496621	0.59	0.81	1.19974367975226e-171	HMGB2	NK cells	GSE199333_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31814
2.55475714878477e-175	0.765261707635497	0.629	0.307	5.42400490258495e-171	ATP6V0E1	NK cells	GSE199333_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31815
1.6410125627004e-173	-0.742783006336669	0.446	0.76	3.48403377186922e-169	SRSF10	NK cells	GSE199333_post	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31816
2.13439976880723e-173	0.787894676957303	0.683	0.389	4.53154414915464e-169	CD53	NK cells	GSE199333_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31817
2.30608528770374e-172	-0.735879960525501	0.03	0.307	4.89604967432381e-168	GRASP	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31818
1.51654022719905e-170	0.370223091650054	1	1	3.21976655636631e-166	MT-CO2	NK cells	GSE199333_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31819
4.35332669590485e-170	-0.682871636713283	0.104	0.426	9.2425479080756e-166	ENC1	NK cells	GSE199333_post	ENSG00000171617	8507	ectodermal-neural cortex 1	ENC-1|KLHL37|NRPB|PIG10|TP53I10	protein_coding	O14682	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31820
3.36849660494389e-169	-0.836645545177074	0.426	0.756	7.15165514195638e-165	TNFAIP3	NK cells	GSE199333_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31821
3.66816937261471e-169	-0.694097740511469	0.303	0.663	7.78789039499829e-165	HSPA9	NK cells	GSE199333_post	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31822
5.13263891874925e-169	-0.743742048673587	0.416	0.74	1.08971056883965e-164	STK17A	NK cells	GSE199333_post	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31823
2.85332128272666e-168	-0.634200385390993	0.784	0.921	6.05788641535697e-164	RBM3	NK cells	GSE199333_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31824
4.36511603533571e-168	-0.724088609112489	0.265	0.616	9.26757785462124e-164	SNHG9	NK cells	GSE199333_post	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31825
1.99406789058089e-167	-0.622017051768699	0.751	0.922	4.23360553849228e-163	SRRM2	NK cells	GSE199333_post	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31826
2.70339680893608e-166	-0.693422745990187	0.251	0.608	5.73958176505219e-162	CNOT1	NK cells	GSE199333_post	ENSG00000125107	23019	CCR4-NOT transcription complex subunit 1	AD-005|CDC39|KIAA1007|NOT1|NOT1H	protein_coding	A5YKK6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31827
4.02164106548937e-166	-0.57250911394596	0.08	0.389	8.53834614614048e-162	RELB	NK cells	GSE199333_post	ENSG00000104856	5971	RELB proto-oncogene, NF-kB subunit	REL-B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31828
1.6330889848907e-164	-0.699638263883912	0.406	0.74	3.46721122382144e-160	RNMT	NK cells	GSE199333_post	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31829
5.39929859042672e-164	-0.716888618917728	0.315	0.666	1.1463250837335e-159	RIOK3	NK cells	GSE199333_post	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31830
4.09179841478493e-163	-0.552639031834217	1	1	8.68729721442988e-159	RPS26	NK cells	GSE199333_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31831
5.87469501422744e-163	-0.750665577277348	0.389	0.725	1.24725649847063e-158	YPEL5	NK cells	GSE199333_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31832
1.91180133082784e-162	0.702961260415398	0.449	0.129	4.05894540548059e-158	SAMHD1	NK cells	GSE199333_post	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31833
6.28534508313062e-162	0.715360752977957	0.527	0.202	1.33444161459946e-157	CSTB	NK cells	GSE199333_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31834
1.81981264534462e-161	-0.68814834573182	0.221	0.566	3.86364422733117e-157	WHAMM	NK cells	GSE199333_post	ENSG00000156232	123720	WASP homolog associated with actin, golgi membranes and microtubules	KIAA1971|WHAMM1|WHDC1	protein_coding	Q8TF30	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31835
2.06399435855089e-161	-0.6444498780574	0.208	0.554	4.3820664226394e-157	OSER1	NK cells	GSE199333_post	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31836
4.15874058594915e-161	0.607801233451514	0.962	0.817	8.82942213802865e-157	ARPC3	NK cells	GSE199333_post	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31837
8.31729971768993e-161	-0.534806980588907	0.978	0.992	1.76584590306275e-156	HNRNPA1	NK cells	GSE199333_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31838
1.20205602313239e-160	-0.713722279584753	0.436	0.753	2.55208514271237e-156	ELF1	NK cells	GSE199333_post	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31839
5.90714053412945e-159	-0.684453836194265	0.637	0.867	1.25414500680102e-154	DDX6	NK cells	GSE199333_post	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31840
1.55388572425764e-158	-0.691882180344462	0.959	0.989	3.2990547811714e-154	BTG1	NK cells	GSE199333_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31841
7.38015603368311e-158	0.621869495179788	0.404	0.098	1.56688092751126e-153	GIMAP4	NK cells	GSE199333_post	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31842
6.15193642993101e-157	-0.651507522043208	0.126	0.443	1.30611762343865e-152	NFKB1	NK cells	GSE199333_post	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31843
7.66720344808113e-157	1.41284071302825	0.597	0.34	1.62782396406211e-152	TRDC	NK cells	GSE199333_post	ENSG00000211829	NA	NA	NA	TR_C_gene	B7Z8K6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31844
2.35872625123339e-156	-0.661090521726184	0.098	0.401	5.0078117039936e-152	LMNB1	NK cells	GSE199333_post	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31845
3.11643055003673e-155	1.97467476628828	0.361	0.076	6.61649370078297e-151	S100B	NK cells	GSE199333_post	ENSG00000160307	6285	S100 calcium binding protein B	S100beta	protein_coding	P04271	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31846
7.34663292629801e-154	-0.878181800453504	0.4	0.719	1.55976363658233e-149	MAP3K8	NK cells	GSE199333_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31847
1.10451606947065e-153	-0.714355736279436	0.043	0.308	2.34499806709314e-149	IRF8	NK cells	GSE199333_post	ENSG00000140968	3394	interferon regulatory factor 8	ICSBP|ICSBP1|IRF-8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31848
1.19195251359878e-151	-0.655417663602764	0.671	0.88	2.53063438162157e-147	CCNL1	NK cells	GSE199333_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31849
4.66098620825494e-150	1.02770277660199	0.453	0.143	9.89573981874607e-146	TRAC	NK cells	GSE199333_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31850
1.54004529829468e-149	-0.675540001121296	0.395	0.711	3.26967017280944e-145	RAB2A	NK cells	GSE199333_post	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31851
2.00105913678306e-149	-0.618737782824121	0.124	0.436	4.24844865330411e-145	HIF1A	NK cells	GSE199333_post	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31852
2.10324472358762e-149	-0.666944056220699	0.168	0.488	4.46539887264888e-145	PTP4A1	NK cells	GSE199333_post	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31853
5.81196775805135e-149	-0.695594077957808	0.359	0.685	1.23393887471188e-144	CIR1	NK cells	GSE199333_post	ENSG00000138433	9541	corepressor interacting with RBPJ, CIR1	CIR	protein_coding	Q86X95	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31854
6.13462321962183e-149	-0.719495129177439	0.295	0.626	1.30244185575791e-144	ZBP1	NK cells	GSE199333_post	ENSG00000124256	81030	Z-DNA binding protein 1	C20orf183|DAI|dJ718J7.3|DLM-1|DLM1	protein_coding	Q9H171	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31855
7.74189120231334e-147	-0.660752779293123	0.294	0.631	1.64368092116314e-142	USP16	NK cells	GSE199333_post	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31856
1.40981554345943e-146	0.70873177436277	0.568	0.263	2.99317938031872e-142	TRAF3IP3	NK cells	GSE199333_post	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31857
1.50305370934883e-146	0.740036543143122	0.697	0.432	3.19113333031851e-142	DDX17	NK cells	GSE199333_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31858
2.81979831635053e-146	0.607894346021935	0.43	0.129	5.98671380544381e-142	TALDO1	NK cells	GSE199333_post	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31859
1.78927437755452e-145	-0.606187887108433	0.621	0.834	3.798808430986e-141	MORF4L1	NK cells	GSE199333_post	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31860
1.79852166923619e-145	-0.711533728609483	0.273	0.595	3.81844135595535e-141	EML4	NK cells	GSE199333_post	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31861
2.02639778129244e-145	-0.419856952483172	1	1	4.30224512946199e-141	RPL37	NK cells	GSE199333_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31862
2.0909459639642e-145	0.551049654646575	0.332	0.059	4.43928737609239e-141	TNFAIP8	NK cells	GSE199333_post	ENSG00000145779	25816	TNF alpha induced protein 8	GG2-1|MDC-3.13|SCC-S2	protein_coding	O95379	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31863
5.25653543929508e-145	0.682279083322089	0.523	0.218	1.11601503911674e-140	DAD1	NK cells	GSE199333_post	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31864
7.14217247815627e-145	-1.61195829905608	0.091	0.37	1.51635463883736e-140	CCL3	NK cells	GSE199333_post	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31865
2.19450607175485e-143	-0.645233855755795	0.755	0.901	4.65915584094273e-139	VAMP2	NK cells	GSE199333_post	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31866
3.05177506192297e-143	-0.667379673355989	0.377	0.696	6.47922363396865e-139	ZC3H15	NK cells	GSE199333_post	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31867
3.12306972037551e-143	-0.672581064102983	0.253	0.576	6.63058932332925e-139	SYAP1	NK cells	GSE199333_post	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31868
3.27219565068351e-141	0.576571296270168	0.355	0.078	6.94719858596616e-137	SELPLG	NK cells	GSE199333_post	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31869
1.2049034974049e-140	-0.527674666906451	0.121	0.421	2.55813061534033e-136	PER1	NK cells	GSE199333_post	ENSG00000179094	5187	period circadian regulator 1	PER|RIGUI	protein_coding	O15534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31870
1.98260553237751e-140	0.793527783372289	0.657	0.398	4.2092698057907e-136	PRMT2	NK cells	GSE199333_post	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31871
4.11470027941242e-140	-0.650277016703322	0.335	0.663	8.73592016322052e-136	SAR1A	NK cells	GSE199333_post	ENSG00000079332	56681	secretion associated Ras related GTPase 1A	SAR1|Sara|SARA1	protein_coding	Q9NR31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31872
5.94307976322856e-140	0.697174042574025	0.615	0.327	1.26177526453106e-135	CCND3	NK cells	GSE199333_post	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31873
2.80842479220719e-139	1.03935548172459	0.818	0.612	5.96256667633508e-135	LGALS1	NK cells	GSE199333_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31874
4.47770519284804e-139	0.654622800574015	0.509	0.21	9.50661589493567e-135	OSTF1	NK cells	GSE199333_post	ENSG00000134996	26578	osteoclast stimulating factor 1	bA235O14.1|OSF|SH3P2	protein_coding	Q92882	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31875
1.40877685286696e-137	0.774396891898145	0.534	0.244	2.99097413632185e-133	CD2	NK cells	GSE199333_post	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31876
1.08406517488457e-135	-0.583223945885491	0.19	0.502	2.30157877279742e-131	DNAJC2	NK cells	GSE199333_post	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31877
1.99935159433708e-135	-0.651817127416172	0.143	0.436	4.24482336993704e-131	DDIT3	NK cells	GSE199333_post	ENSG00000175197	1649	DNA damage inducible transcript 3	CHOP|CHOP10|GADD153	protein_coding	P35638	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31878
4.10230545169268e-135	-0.748897077711583	0.984	0.989	8.70960470448873e-131	JUND	NK cells	GSE199333_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31879
1.40340396732712e-134	-0.629423175025697	0.36	0.679	2.97956696303221e-130	PRPF40A	NK cells	GSE199333_post	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31880
1.21065343193851e-133	0.667961468479471	0.475	0.185	2.57033830134865e-129	PRDX2	NK cells	GSE199333_post	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31881
1.38979655494422e-133	0.717198565556321	0.515	0.222	2.95067706580208e-129	SPN	NK cells	GSE199333_post	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31882
3.83061060296013e-133	-0.665824660292426	0.276	0.582	8.13276937114466e-129	SIRT2	NK cells	GSE199333_post	ENSG00000283100	22933	sirtuin 2	SIR2L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31883
5.4037460984548e-133	-0.962886965301508	0.502	0.744	1.14726933416294e-128	NFKBIA	NK cells	GSE199333_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31884
5.04562889771108e-132	-0.595427903542539	0.212	0.524	1.07123747127304e-127	DNAJC3	NK cells	GSE199333_post	ENSG00000102580	5611	DnaJ heat shock protein family (Hsp40) member C3	ERdj6|HP58|P58|p58(IPK)|P58IPK|PRKRI	protein_coding	Q13217	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31885
1.1923841821455e-131	-0.630359796744919	0.594	0.827	2.53155085711311e-127	DDX24	NK cells	GSE199333_post	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31886
1.86438616647007e-131	-0.646672152017307	0.115	0.408	3.95827827003261e-127	IGFBP7	NK cells	GSE199333_post	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31887
2.70158341080046e-131	0.693664182287075	0.485	0.196	5.73573173947046e-127	CLEC2D	NK cells	GSE199333_post	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31888
5.61180813816919e-131	0.896284253322807	0.33	0.076	1.1914429858147e-126	MYOM2	NK cells	GSE199333_post	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31889
2.95491165418439e-130	-0.59504749598293	0.125	0.404	6.27357293299887e-126	CSRNP1	NK cells	GSE199333_post	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31890
5.39025395262158e-130	-0.634611621095325	0.539	0.792	1.14440481668109e-125	FAM133B	NK cells	GSE199333_post	ENSG00000234545	257415	family with sequence similarity 133 member B	MGC40405	protein_coding	Q5BKY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31891
7.68943369082933e-130	0.676147604610983	0.743	0.482	1.63254366689998e-125	TAGLN2	NK cells	GSE199333_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31892
3.55901528156086e-129	-0.593098883918998	0.258	0.564	7.55614534428187e-125	TRAPPC10	NK cells	GSE199333_post	ENSG00000160218	7109	trafficking protein particle complex subunit 10	EHOC-1|TMEM1|TRS130	protein_coding	P48553	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31893
5.57502251805873e-129	0.670216983541098	0.521	0.238	1.18363303080905e-124	TPST2	NK cells	GSE199333_post	ENSG00000128294	8459	tyrosylprotein sulfotransferase 2	TANGO13B	protein_coding	O60704	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31894
2.17657634402169e-127	-0.624131451736528	0.389	0.691	4.62108923599245e-123	GGNBP2	NK cells	GSE199333_post	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31895
2.22993053852539e-127	0.500427586528075	0.993	0.965	4.73436552634326e-123	MYL6	NK cells	GSE199333_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31896
7.23601710683481e-127	-0.565045805706948	0.263	0.578	1.5362787919521e-122	NECAP1	NK cells	GSE199333_post	ENSG00000089818	25977	NECAP endocytosis associated 1	DKFZP566B183	protein_coding	Q8NC96	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31897
7.13893205225614e-126	-0.59775307660997	0.558	0.798	1.5156666640145e-121	RBM8A	NK cells	GSE199333_post	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31898
2.02216964199016e-125	0.510598259807239	0.991	0.967	4.2932683669093e-121	CYBA	NK cells	GSE199333_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31899
2.1278735455314e-125	-0.612321860529817	0.214	0.514	4.51768832451772e-121	TENT4B	NK cells	GSE199333_post	ENSG00000121274	64282	terminal nucleotidyltransferase 4B	PAPD5|TRF4-2|TUT3	protein_coding	Q8NDF8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31900
2.84393064036797e-125	-0.57904038029079	0.411	0.718	6.03794914256523e-121	BUD31	NK cells	GSE199333_post	ENSG00000106245	8896	BUD31 homolog	Cwc14|EDG-2|EDG2|fSAP17|G10|YCR063W	protein_coding	P41223	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31901
3.6221613660699e-125	0.734237287268824	0.803	0.644	7.690210796303e-121	KLRD1	NK cells	GSE199333_post	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31902
7.61003408871435e-125	0.602308391309479	0.979	0.905	1.61568633737494e-120	TXNIP	NK cells	GSE199333_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31903
1.35437281009208e-124	-0.627217638373104	0.33	0.627	2.87546891310649e-120	IDI1	NK cells	GSE199333_post	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31904
5.30134691430386e-124	-0.625370771644565	0.274	0.58	1.12552896337585e-119	SDCBP	NK cells	GSE199333_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31905
8.1437149290955e-124	-0.612018269605141	0.241	0.542	1.72899211659627e-119	FAM177A1	NK cells	GSE199333_post	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31906
3.10749869526135e-123	-0.555879796022431	0.152	0.432	6.59753047990938e-119	TIPARP	NK cells	GSE199333_post	ENSG00000163659	25976	TCDD inducible poly(ADP-ribose) polymerase	ARTD14|DDF1|DKFZP434J214|DKFZp686N0351|PARP-1|PARP-7|PARP7|pART14|RM1	protein_coding	Q7Z3E1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31907
4.26488584024883e-123	-0.572424628346002	0.224	0.53	9.05477912743228e-119	PSME4	NK cells	GSE199333_post	ENSG00000068878	23198	proteasome activator subunit 4	KIAA0077|PA200	protein_coding	Q14997	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31908
1.24972925843899e-122	-0.555028776756976	0.21	0.512	2.65330018859183e-118	SLC25A36	NK cells	GSE199333_post	ENSG00000114120	55186	solute carrier family 25 member 36	FLJ10618|PNC2	protein_coding	Q96CQ1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31909
2.97156824511036e-122	-0.583216254983975	0.273	0.583	6.3089365411938e-118	YTHDC1	NK cells	GSE199333_post	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31910
1.02910453046784e-121	-0.552318771707198	0.215	0.513	2.18489182863627e-117	JOSD1	NK cells	GSE199333_post	ENSG00000100221	9929	Josephin domain containing 1	KIAA0063	protein_coding	Q15040	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31911
3.37916285839327e-121	-0.468406410355102	0.088	0.342	7.17430066465475e-117	B3GNT7	NK cells	GSE199333_post	ENSG00000156966	93010	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	beta3GnT7	protein_coding	Q8NFL0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31912
7.15549127595468e-121	-0.619909897747928	0.607	0.811	1.51918235279794e-116	TRA2B	NK cells	GSE199333_post	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31913
1.08625260940329e-120	-0.615410907636166	0.267	0.565	2.30622291502412e-116	TENT5C	NK cells	GSE199333_post	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31914
1.51167945795515e-120	-0.484306058535273	0.938	0.989	3.20944665718457e-116	CTSW	NK cells	GSE199333_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31915
2.41682453450829e-120	0.859214811651453	0.603	0.35	5.13116016921456e-116	TRBC1	NK cells	GSE199333_post	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31916
1.28687720979032e-119	-0.551708013963521	0.489	0.771	2.73216900410582e-115	CCDC12	NK cells	GSE199333_post	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31917
4.78681721609567e-119	-0.415853405350433	0.06	0.294	1.01628916314927e-114	SLC25A33	NK cells	GSE199333_post	ENSG00000171612	84275	solute carrier family 25 member 33	BMSC-MCP|MGC4399|PNC1	protein_coding	Q9BSK2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31918
5.49799502111734e-119	-0.513043427026361	0.754	0.905	1.16727932293342e-114	SON	NK cells	GSE199333_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31919
1.5969291995705e-118	-0.551198693562085	0.257	0.561	3.39044038360812e-114	EPB41L4A-AS1	NK cells	GSE199333_post	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31920
1.98023319706565e-118	1.35922661006652	0.413	0.153	4.20423310069008e-114	LTB	NK cells	GSE199333_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31921
6.11264355639219e-118	0.545486762410957	0.87	0.697	1.29777535345763e-113	OST4	NK cells	GSE199333_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31922
8.94324463810553e-118	-0.655824963247482	0.316	0.606	1.89874026911619e-113	BHLHE40	NK cells	GSE199333_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31923
3.20809401752236e-117	0.375557629846867	0.273	0.046	6.81110440860172e-113	CX3CR1	NK cells	GSE199333_post	ENSG00000168329	1524	C-X3-C motif chemokine receptor 1	CCRL1|CMKBRL1|CMKDR1|GPR13|V28	protein_coding	P49238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31924
6.22138182207992e-117	0.599266763869188	0.491	0.218	1.32086157464579e-112	TBCA	NK cells	GSE199333_post	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31925
8.67808564898672e-117	-0.558286256533099	0.306	0.612	1.84244436413637e-112	KRR1	NK cells	GSE199333_post	ENSG00000111615	11103	KRR1 small subunit processome component homolog	HRB2|RIP-1	protein_coding	Q13601	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31926
2.28295276904427e-116	0.458290692879858	0.997	0.979	4.8469370239579e-112	ATP5F1E	NK cells	GSE199333_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31927
2.92591700197987e-116	-0.531291334755521	0.189	0.473	6.21201438690346e-112	ING3	NK cells	GSE199333_post	ENSG00000071243	54556	inhibitor of growth family member 3	Eaf4|FLJ20089|MEAF4|p47ING3	protein_coding	Q9NXR8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31928
5.33141734770417e-116	-0.403560393609386	0.06	0.289	1.13191321709107e-111	TLE1	NK cells	GSE199333_post	ENSG00000196781	7088	TLE family member 1, transcriptional corepressor	ESG|ESG1|GRG1|TLE-1	protein_coding	Q04724	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31929
1.19049148754006e-115	-0.599688711013581	0.415	0.704	2.52753247719631e-111	CDV3	NK cells	GSE199333_post	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31930
3.01419612108032e-115	0.601043475783041	0.627	0.379	6.39943978466563e-111	NEDD8	NK cells	GSE199333_post	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31931
1.57210753885323e-114	-0.5341478284344	0.279	0.576	3.3377415157393e-110	CDC40	NK cells	GSE199333_post	ENSG00000168438	51362	cell division cycle 40	EHB3|FLJ10564|PRP17|PRPF17	protein_coding	O60508	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31932
1.57712602922878e-114	-0.588349856079063	0.308	0.594	3.34839627265562e-110	DNTTIP2	NK cells	GSE199333_post	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31933
1.87451346562349e-114	-0.722179191414827	0.493	0.738	3.97977953886523e-110	CEMIP2	NK cells	GSE199333_post	ENSG00000135048	23670	cell migration inducing hyaluronidase 2	TMEM2	protein_coding	Q9UHN6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31934
1.96557433460622e-114	-0.459368689410112	0.117	0.38	4.17311086980246e-110	CDK17	NK cells	GSE199333_post	ENSG00000059758	5128	cyclin dependent kinase 17	PCTAIRE2|PCTK2	protein_coding	Q00537	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31935
4.0423523533276e-114	-0.565054435106618	0.481	0.755	8.58231828134983e-110	HNRNPH3	NK cells	GSE199333_post	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31936
4.44711600182745e-114	-0.500662655488471	0.174	0.453	9.44167198347987e-110	TOMM5	NK cells	GSE199333_post	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31937
6.36607244890812e-114	-0.468749587271525	0.113	0.369	1.35158084162768e-109	JMY	NK cells	GSE199333_post	ENSG00000152409	133746	junction mediating and regulatory protein, p53 cofactor	FLJ37870|WHAMM2	protein_coding	Q8N9B5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31938
6.75272670081972e-114	-0.462664705745963	0.125	0.389	1.43367140585103e-109	PNPLA8	NK cells	GSE199333_post	ENSG00000135241	50640	patatin like phospholipase domain containing 8	IPLA2-2|IPLA2G|iPLA2gamma	protein_coding	Q9NP80	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31939
6.82981103653166e-114	-0.467246528289665	0.128	0.39	1.45003718116604e-109	OTULINL	NK cells	GSE199333_post	ENSG00000145569	54491	OTU deubiquitinase with linear linkage specificity like	FAM105A|FLJ11127|NET20	protein_coding	Q9NUU6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31940
2.36732224570269e-113	0.633158465992815	0.707	0.488	5.02606185985139e-109	PSME2	NK cells	GSE199333_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31941
3.43291362947832e-113	-0.562250610465326	0.447	0.73	7.28841892674542e-109	OGA	NK cells	GSE199333_post	ENSG00000198408	10724	O-GlcNAcase	MEA5|MGEA5|NCOAT	protein_coding	O60502	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31942
4.33504690978447e-113	0.646175047164943	0.706	0.472	9.2037380941634e-109	AHNAK	NK cells	GSE199333_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31943
5.24698680715424e-113	0.590968559574984	0.697	0.462	1.11398776902692e-108	TSPO	NK cells	GSE199333_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31944
5.29495602877785e-113	0.613397907783843	0.425	0.169	1.12417211446982e-108	CKLF	NK cells	GSE199333_post	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31945
2.21873637919742e-112	-0.601398958840202	0.513	0.772	4.71059920667405e-108	ARID4B	NK cells	GSE199333_post	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31946
3.29745342695216e-112	-0.581266026797648	0.517	0.755	7.00082337076213e-108	EIF4G2	NK cells	GSE199333_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31947
4.52937290979974e-112	-0.517819423619247	0.188	0.464	9.61631162479583e-108	NFKBIB	NK cells	GSE199333_post	ENSG00000282905	4793	NFKB inhibitor beta	IKBB|TRIP9	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31948
1.99654777921877e-111	-0.601696247759964	0.331	0.614	4.23887059005938e-107	SLC3A2	NK cells	GSE199333_post	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31949
4.19535199942694e-111	-0.456437956058842	0.132	0.394	8.90715182998333e-107	WDR45B	NK cells	GSE199333_post	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31950
6.04804990970937e-111	-0.610034239447487	0.159	0.421	1.2840614763304e-106	SERTAD1	NK cells	GSE199333_post	ENSG00000197019	29950	SERTA domain containing 1	SEI1|TRIP-Br1	protein_coding	Q9UHV2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31951
7.39307703692166e-111	-0.561707603845236	0.216	0.497	1.56962418570884e-106	PTPRE	NK cells	GSE199333_post	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31952
7.81378349331261e-111	-0.513398791953322	0.199	0.48	1.6589443734652e-106	ESCO1	NK cells	GSE199333_post	ENSG00000141446	114799	establishment of sister chromatid cohesion N-acetyltransferase 1	EFO1|ESO1|KIAA1911	protein_coding	Q5FWF5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31953
9.392886334915e-111	-0.592439804868869	0.7	0.855	1.9942036977658e-106	HNRNPH1	NK cells	GSE199333_post	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31954
1.00888863742389e-110	0.605453397076027	0.795	0.558	2.14197146611466e-106	CD3E	NK cells	GSE199333_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31955
2.31242231376966e-110	0.607837715157866	0.517	0.255	4.90950381436436e-106	LAT	NK cells	GSE199333_post	ENSG00000213658	27040	linker for activation of T cells	LAT1	protein_coding	O43561	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31956
1.07275685872239e-109	-0.420915762079422	0.986	0.995	2.2775700867535e-105	HMGB1	NK cells	GSE199333_post	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31957
1.38282238288562e-109	0.534862107102716	0.389	0.135	2.93587020110446e-105	ANXA5	NK cells	GSE199333_post	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31958
1.40508836699137e-109	0.492067292343275	0.987	0.951	2.98314311195938e-105	HCST	NK cells	GSE199333_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31959
1.82094327376258e-109	-0.572792999586696	0.315	0.6	3.86604466452534e-105	LAPTM4A	NK cells	GSE199333_post	ENSG00000068697	9741	lysosomal protein transmembrane 4 alpha	HUMORF13|KIAA0108|LAPTM4|MBNT|Mtrp	protein_coding	Q15012	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31960
7.39833266172359e-109	-0.51886467802417	0.156	0.424	1.57074000741054e-104	OTULIN	NK cells	GSE199333_post	ENSG00000154124	90268	OTU deubiquitinase with linear linkage specificity	FAM105B|FLJ34884	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31961
1.77944404298726e-108	-0.54733383639013	0.327	0.619	3.77793764766624e-104	STRAP	NK cells	GSE199333_post	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31962
2.04326686581532e-108	-0.506077625295792	0.239	0.525	4.3380598828125e-104	SAP30BP	NK cells	GSE199333_post	ENSG00000161526	29115	SAP30 binding protein	HCNGP|HTRG|HTRP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31963
2.07441637400075e-108	-0.634521403480407	0.47	0.724	4.40419340364099e-104	CD164	NK cells	GSE199333_post	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31964
3.38521459629004e-108	-0.603872874371579	0.599	0.809	7.18714910938338e-104	ARPC5L	NK cells	GSE199333_post	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31965
4.02915011999252e-108	-0.58937938757257	0.314	0.598	8.55428861975611e-104	CHD1	NK cells	GSE199333_post	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31966
4.29252806226037e-108	0.381035426914516	1	1	9.113466328985e-104	MT-CYB	NK cells	GSE199333_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31967
2.22528880316183e-107	-0.479344616965144	0.195	0.47	4.72451065799287e-103	PHF1	NK cells	GSE199333_post	ENSG00000225553	5252	PHD finger protein 1	MTF2L2|PCL1|TDRD19C	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31968
3.9337586872893e-107	0.490777250800746	0.325	0.089	8.35176306898391e-103	MRPS6	NK cells	GSE199333_post	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31969
7.33633345089104e-107	-0.531802221747893	0.292	0.578	1.55757695495868e-102	HNRNPL	NK cells	GSE199333_post	ENSG00000282947	3191	heterogeneous nuclear ribonucleoprotein L	HNRPL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31970
7.98949037625572e-107	-0.518309831783323	0.983	0.991	1.69624870178285e-102	SRGN	NK cells	GSE199333_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31971
4.39381014406286e-106	0.50963771200965	0.316	0.085	9.32849831685986e-102	PYCARD	NK cells	GSE199333_post	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31972
5.67487355998898e-106	0.504644088971081	0.416	0.161	1.20483240552126e-101	CCDC107	NK cells	GSE199333_post	ENSG00000159884	203260	coiled-coil domain containing 107	MGC31967	protein_coding	Q8WV48	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31973
1.19739813928621e-105	0.456970228930354	0.323	0.089	2.54219598951856e-101	TC2N	NK cells	GSE199333_post	ENSG00000276776	123036	tandem C2 domains, nuclear	C14orf47|C2CD1|FLJ36557|MTAC2D1|Tac2-N	protein_coding	Q8N9U0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31974
1.50513010992457e-105	-0.526206136221685	0.268	0.551	3.19554173638085e-101	PPP4R3A	NK cells	GSE199333_post	ENSG00000100796	55671	protein phosphatase 4 regulatory subunit 3A	FLFL1|FLJ20707|KIAA2010|MSTP033|PP4R3|SMEK1|smk-1|smk1	protein_coding	Q6IN85	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31975
1.79968531625519e-105	-0.542238675612645	0.39	0.685	3.82091189494139e-101	IFITM1	NK cells	GSE199333_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31976
2.81095930629961e-105	-0.558545740303681	0.311	0.59	5.9679477032047e-101	ZBTB1	NK cells	GSE199333_post	ENSG00000126804	22890	zinc finger and BTB domain containing 1	KIAA0997|ZNF909	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31977
1.47947446646727e-104	-0.476659672556112	0.15	0.412	3.14107223975667e-100	PDZD8	NK cells	GSE199333_post	ENSG00000165650	118987	PDZ domain containing 8	bA129M16.2|FLJ34427|PDZK8	protein_coding	Q8NEN9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31978
1.75765121489406e-104	0.571667293108824	0.53	0.281	3.73166929434157e-100	BIN1	NK cells	GSE199333_post	ENSG00000136717	274	bridging integrator 1	AMPH2|AMPHL|SH3P9	protein_coding	O00499	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31979
4.19104520637211e-104	-0.374592858271741	0.073	0.298	8.89800807764862e-100	OSGIN2	NK cells	GSE199333_post	ENSG00000164823	734	oxidative stress induced growth inhibitor family member 2	C8orf1|hT41	protein_coding	Q9Y236	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31980
4.96302911601056e-104	-0.523155727540813	0.584	0.812	1.0537007116202e-99	SF3B1	NK cells	GSE199333_post	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31981
2.04025964707537e-103	-0.397290965660849	0.064	0.28	4.33167525670572e-99	THEMIS2	NK cells	GSE199333_post	ENSG00000130775	9473	thymocyte selection associated family member 2	C1orf38|ICB-1	protein_coding	Q5TEJ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31982
5.4515673416135e-103	-0.452112100152223	0.902	0.959	1.15742226229796e-98	PNISR	NK cells	GSE199333_post	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31983
1.25581576993494e-102	-0.582659229619045	0.388	0.657	2.66622246114888e-98	SLC38A1	NK cells	GSE199333_post	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31984
2.02863226209094e-102	-0.479647860830263	0.21	0.485	4.30698915564528e-98	ZFAND2A	NK cells	GSE199333_post	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31985
2.5872438201337e-102	-0.572778082097482	0.28	0.551	5.49297735452586e-98	AMD1	NK cells	GSE199333_post	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31986
3.32223565221471e-102	0.569150900850021	0.705	0.508	7.05343851321704e-98	ARL6IP5	NK cells	GSE199333_post	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31987
8.57283088704706e-102	-0.51045675270286	0.127	0.37	1.82009772562896e-97	YES1	NK cells	GSE199333_post	ENSG00000176105	7525	YES proto-oncogene 1, Src family tyrosine kinase	c-yes|HsT441|Yes	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31988
1.69923578166897e-101	0.569736407801156	0.751	0.561	3.60764748806139e-97	RARRES3	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31989
2.30183318835889e-101	-0.321459129701241	1	1	4.88702204220476e-97	RPL10	NK cells	GSE199333_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31990
3.9839590079352e-101	-0.47923737177615	0.261	0.544	8.45834336974722e-97	DERL1	NK cells	GSE199333_post	ENSG00000136986	79139	derlin 1	DER-1|DER1|derlin-1|FLJ13784|MGC3067|PRO2577	protein_coding	Q9BUN8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31991
6.06579578697532e-101	0.497818432928571	0.859	0.692	1.28782910353273e-96	GMFG	NK cells	GSE199333_post	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31992
1.26934478790174e-100	-0.414887966830577	0.097	0.329	2.69494591919417e-96	RNF138	NK cells	GSE199333_post	ENSG00000134758	51444	ring finger protein 138	NARF|STRIN	protein_coding	Q8WVD3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31993
1.08221107028694e-99	0.5438950376047	0.387	0.147	2.2976423233262e-95	PRDX1	NK cells	GSE199333_post	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31994
1.09779922877796e-99	0.529934176765944	0.452	0.202	2.33073754261848e-95	BTN3A2	NK cells	GSE199333_post	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31995
1.69311143016193e-99	0.526746388515496	0.45	0.194	3.5946448773768e-95	MYBL1	NK cells	GSE199333_post	ENSG00000185697	4603	MYB proto-oncogene like 1	A-myb|AMYB	protein_coding	P10243	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31996
4.06433635660297e-99	-0.500698064058542	0.209	0.475	8.62899251870376e-95	BRD1	NK cells	GSE199333_post	ENSG00000100425	23774	bromodomain containing 1	BRL|BRPF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31997
4.5825377127841e-99	-0.469696102608058	0.209	0.477	9.72918581801192e-95	ALYREF	NK cells	GSE199333_post	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31998
1.69545177415639e-98	0.549450360272084	0.476	0.225	3.59961366171143e-94	PPP1R18	NK cells	GSE199333_post	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	31999
1.82571099072634e-98	-0.49149892209165	0.265	0.544	3.87616700441109e-94	METRNL	NK cells	GSE199333_post	ENSG00000275031	284207	meteorin like, glial cell differentiation regulator	NA	protein_coding	Q641Q3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32000
2.13325418073247e-98	0.384821410754065	0.998	0.986	4.5291119511131e-94	SERF2	NK cells	GSE199333_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32001
8.99465376921605e-98	-0.39927246360562	0.087	0.312	1.90965494174226e-93	USP12	NK cells	GSE199333_post	ENSG00000152484	219333	ubiquitin specific peptidase 12	USP12L1	protein_coding	O75317	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32002
1.00861972064028e-97	0.449071276476503	0.975	0.906	2.14140052889137e-93	HNRNPA2B1	NK cells	GSE199333_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32003
1.46712231675108e-97	0.558004911770157	0.789	0.617	3.11484739069422e-93	MSN	NK cells	GSE199333_post	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32004
2.07707892541318e-97	-0.543562849411827	0.29	0.56	4.40984626654473e-93	DDX21	NK cells	GSE199333_post	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32005
2.59093722381635e-97	-0.810143637566823	0.172	0.417	5.5008188198845e-93	PMAIP1	NK cells	GSE199333_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32006
6.23139993438853e-97	-0.611851397238881	0.39	0.648	1.32298852007003e-92	RAB5IF	NK cells	GSE199333_post	ENSG00000101084	55969	RAB5 interacting factor	C20orf24|PNAS-11|RCAF1|RIP5	protein_coding	Q9BUV8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32007
3.48567363522793e-96	-0.47776949123188	0.187	0.448	7.40043369495241e-92	CDC5L	NK cells	GSE199333_post	ENSG00000096401	988	cell division cycle 5 like	CDC5|CEF1|hCDC5|PCDC5RP	protein_coding	Q99459	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32008
5.46768448924886e-96	-0.475787048281675	0.164	0.417	1.16084409391243e-91	ARID5A	NK cells	GSE199333_post	ENSG00000196843	10865	AT-rich interaction domain 5A	MRF-1|RP11-363D14	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32009
9.00312038895605e-96	-0.40088775367278	0.116	0.352	1.91145248977926e-91	ACBD3	NK cells	GSE199333_post	ENSG00000182827	64746	acyl-CoA binding domain containing 3	GCP60|GOCAP1|GOLPH1|PAP7	protein_coding	Q9H3P7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32010
9.79509899261163e-96	-0.472279892166916	0.204	0.468	2.07959746712137e-91	PLEKHA2	NK cells	GSE199333_post	ENSG00000169499	59339	pleckstrin homology domain containing A2	TAPP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32011
1.2182874537896e-95	-0.513436648580274	0.251	0.516	2.58654609314069e-91	ZNF644	NK cells	GSE199333_post	ENSG00000122482	84146	zinc finger protein 644	BM-005|KIAA1221|MGC60165|MGC70410	protein_coding	Q9H582	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32012
1.85312357955807e-95	0.649588519363738	0.782	0.629	3.93436667175974e-91	HOPX	NK cells	GSE199333_post	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32013
2.29612104010822e-95	-0.532058929156678	0.335	0.607	4.87489458025377e-91	SBDS	NK cells	GSE199333_post	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32014
3.17548736474751e-95	0.529543152541089	0.385	0.156	6.74187722409544e-91	MGST3	NK cells	GSE199333_post	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32015
3.47534561387999e-95	-0.539159259722544	0.562	0.78	7.37850627282861e-91	KMT2E	NK cells	GSE199333_post	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32016
5.94516895731926e-95	-0.475595047710551	0.235	0.503	1.26221882132845e-90	WBP11	NK cells	GSE199333_post	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32017
8.91977377791507e-95	-0.493166861468476	0.251	0.518	1.89375717078915e-90	ZNF800	NK cells	GSE199333_post	ENSG00000048405	168850	zinc finger protein 800	NA	protein_coding	Q2TB10	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32018
2.59715911514533e-94	-0.424550223592658	0.106	0.333	5.51402851736506e-90	NFKB2	NK cells	GSE199333_post	ENSG00000077150	4791	nuclear factor kappa B subunit 2	LYT-10|NF-kB2|p105|p49/p100|p52	protein_coding	Q00653	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32019
3.2023568713799e-94	0.693646116402314	0.8	0.624	6.79892387362667e-90	GZMH	NK cells	GSE199333_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32020
4.61246338969205e-94	-0.464721363547246	0.199	0.454	9.79272102265518e-90	NR1H2	NK cells	GSE199333_post	ENSG00000131408	7376	nuclear receptor subfamily 1 group H member 2	LXR-b|LXRb|NER|NER-I|RIP15|UNR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32021
1.98573094897158e-93	0.587815585609702	0.568	0.335	4.21590537776156e-89	MBP	NK cells	GSE199333_post	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32022
2.67580695537073e-93	-0.586356353958667	0.563	0.769	5.6810057469476e-89	SRSF2	NK cells	GSE199333_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32023
3.47715629706362e-93	0.534850566463281	0.439	0.205	7.38235053429577e-89	TMBIM4	NK cells	GSE199333_post	ENSG00000155957	51643	transmembrane BAX inhibitor motif containing 4	CGI-119|GAAP|LFG4|S1R|ZPRO	protein_coding	Q9HC24	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32024
5.97419050354763e-93	-0.437140020386594	0.139	0.378	1.2683803858082e-88	CWC25	NK cells	GSE199333_post	ENSG00000276761	54883	CWC25 spliceosome associated protein homolog	CCDC49|FLJ20291	protein_coding	Q9NXE8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32025
6.2281858689381e-93	-0.570934595790632	0.288	0.574	1.32230614183425e-88	CMC1	NK cells	GSE199333_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32026
1.81778932889949e-92	-0.370870867784584	0.072	0.279	3.8593485241865e-88	RIOK1	NK cells	GSE199333_post	ENSG00000124784	83732	RIO kinase 1	AD034|bA288G3.1|FLJ30006|RRP10	protein_coding	Q9BRS2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32027
1.88274018428658e-92	0.525382346917104	0.416	0.184	3.99724568525884e-88	CSK	NK cells	GSE199333_post	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32028
2.41203827615532e-92	-0.437945290554206	0.157	0.401	5.12099846410535e-88	SUPV3L1	NK cells	GSE199333_post	ENSG00000156502	6832	Suv3 like RNA helicase	SUV3	protein_coding	Q8IYB8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32029
3.55934206693101e-92	-0.529825397196881	0.663	0.848	7.55683914230123e-88	RUNX3	NK cells	GSE199333_post	ENSG00000020633	864	RUNX family transcription factor 3	AML2|CBFA3|PEBP2A3	protein_coding	Q13761	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32030
6.73671257363333e-92	-0.5522529100691	0.674	0.837	1.43027144650809e-87	TCF25	NK cells	GSE199333_post	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32031
6.90395704963186e-92	-0.390807775523189	0.104	0.328	1.46577912120734e-87	SUCO	NK cells	GSE199333_post	ENSG00000094975	51430	SUN domain containing ossification factor	C1orf9|CH1|OPT|SLP1	protein_coding	Q9UBS9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32032
7.70793183715146e-92	-0.50321473690962	0.322	0.59	1.63647100834563e-87	PTPN2	NK cells	GSE199333_post	ENSG00000175354	5771	protein tyrosine phosphatase non-receptor type 2	PTPT|TC-PTP|TCELLPTP|TCPTP	protein_coding	P17706	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32033
2.53361156673726e-91	-0.509291911903256	0.716	0.865	5.37911071733988e-87	PDIA3	NK cells	GSE199333_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32034
3.43854759946747e-91	-0.448932972371605	0.202	0.454	7.3003804084294e-87	BCL7B	NK cells	GSE199333_post	ENSG00000106635	9275	BAF chromatin remodeling complex subunit BCL7B	SMARCJ2	protein_coding	Q9BQE9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32035
4.89322751294378e-91	-0.467270369612226	0.232	0.494	1.03888113327309e-86	DHX9	NK cells	GSE199333_post	ENSG00000135829	1660	DExH-box helicase 9	DDX9|LKP|RHA	protein_coding	Q08211	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32036
4.8973917852171e-91	-0.452651058064405	0.168	0.416	1.03976524991944e-86	RANBP2	NK cells	GSE199333_post	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32037
6.53813889361093e-91	-0.420576967118248	0.142	0.38	1.38811226850254e-86	PGRMC2	NK cells	GSE199333_post	ENSG00000164040	10424	progesterone receptor membrane component 2	DG6|PMBP	protein_coding	O15173	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32038
1.23908626554781e-90	0.581373600046748	0.384	0.161	2.63070405038456e-86	NOSIP	NK cells	GSE199333_post	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32039
2.9767476340481e-90	-0.357776744537827	0.079	0.287	6.31993290184751e-86	CCDC93	NK cells	GSE199333_post	ENSG00000125633	54520	coiled-coil domain containing 93	FLJ10996	protein_coding	Q567U6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32040
9.20057936425477e-90	0.7492859777382	0.566	0.349	1.95337500482493e-85	HLA-DRB1	NK cells	GSE199333_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32041
1.3015509865155e-89	-0.446662264572563	0.7	0.858	2.76332289947105e-85	ARF1	NK cells	GSE199333_post	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32042
1.3074467379486e-89	0.486858049621321	0.767	0.59	2.77584016933867e-85	UBL5	NK cells	GSE199333_post	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32043
2.67960854448192e-89	-0.470142425331231	0.164	0.401	5.68907690078955e-85	USP36	NK cells	GSE199333_post	ENSG00000055483	57602	ubiquitin specific peptidase 36	FLJ12851|KIAA1453	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32044
2.86376897289446e-89	-0.488454001885988	0.261	0.521	6.08006790635224e-85	CENPC	NK cells	GSE199333_post	ENSG00000145241	1060	centromere protein C	CENP-C|CENPC1|hcp-4|MIF2	protein_coding	Q03188	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32045
3.083155817479e-89	-0.478270922859906	0.786	0.914	6.54584811608966e-85	TGFB1	NK cells	GSE199333_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32046
5.14647619697717e-89	-0.50291662055658	0.52	0.751	1.09264836138022e-84	RWDD1	NK cells	GSE199333_post	ENSG00000111832	51389	RWD domain containing 1	PTD013	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32047
6.96159098370385e-89	-0.480720187790931	0.29	0.558	1.47801538175016e-84	RBBP6	NK cells	GSE199333_post	ENSG00000122257	5930	RB binding protein 6, ubiquitin ligase	P2P-R|PACT|SNAMA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32048
1.05962027198279e-88	0.593440161847296	0.475	0.246	2.24967979944665e-84	DYNLL1	NK cells	GSE199333_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32049
1.27109070458493e-88	-0.447369638743237	0.218	0.472	2.69865267490426e-84	NRBP1	NK cells	GSE199333_post	ENSG00000115216	29959	nuclear receptor binding protein 1	BCON3|MADM|MUDPNP|NRBP	protein_coding	Q9UHY1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32050
1.28215475060005e-88	-0.424098582445814	0.938	0.964	2.72214275099896e-84	PABPC1	NK cells	GSE199333_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32051
1.35318783526405e-88	-0.569837102807063	0.697	0.86	2.8729530930491e-84	IER2	NK cells	GSE199333_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32052
1.45047374782515e-88	-0.445180510057046	0.218	0.472	3.07950081400757e-84	RBM22	NK cells	GSE199333_post	ENSG00000086589	55696	RNA binding motif protein 22	Cwc2|FLJ10290|fSAP47|ZC3H16	protein_coding	Q9NW64	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32053
2.52866283047931e-88	0.532205166843316	0.653	0.439	5.36860405539063e-84	VAMP8	NK cells	GSE199333_post	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32054
1.78793860932416e-87	0.51064098555026	0.437	0.205	3.79597246145612e-83	ATP5PD	NK cells	GSE199333_post	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32055
2.53227228621925e-87	-0.354846829283465	0.072	0.271	5.37626729087208e-83	ATG14	NK cells	GSE199333_post	ENSG00000126775	22863	autophagy related 14	ATG14L|KIAA0831	protein_coding	Q6ZNE5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32056
2.85908102303595e-87	0.45647216709641	1	1	6.07011492000763e-83	MT-ND1	NK cells	GSE199333_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32057
3.13349416297742e-87	-0.464679064664578	0.529	0.874	6.65272145741736e-83	TYROBP	NK cells	GSE199333_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32058
1.03196670363304e-86	-0.418153411526408	0.138	0.373	2.19096850848331e-82	LYN	NK cells	GSE199333_post	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32059
1.07320901906161e-86	-0.479399584105185	0.253	0.508	2.27853006836971e-82	CEBPZ	NK cells	GSE199333_post	ENSG00000115816	10153	CCAAT enhancer binding protein zeta	CBF2|CTF2	protein_coding	Q03701	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32060
1.34801952291346e-86	-0.369181203923487	0.991	0.995	2.86198024909756e-82	RPS20	NK cells	GSE199333_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32061
2.53806861109327e-86	-0.408529983953188	0.189	0.438	5.38857346821213e-82	MRPL22	NK cells	GSE199333_post	ENSG00000082515	29093	mitochondrial ribosomal protein L22	HSPC158|MRP-L25|RPML25	protein_coding	Q9NWU5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32062
3.82378156927791e-86	-0.495226913944806	0.306	0.568	8.11827064973393e-82	RB1CC1	NK cells	GSE199333_post	ENSG00000023287	9821	RB1 inducible coiled-coil 1	ATG17|Cc1|DRAGOU14|FIP200|KIAA0203|PPP1R131	protein_coding	Q8TDY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32063
5.05543690134031e-86	0.500221750515753	0.652	0.443	1.07331980852356e-81	ATP5MD	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32064
5.92453471681366e-86	-0.391252642723876	0.099	0.31	1.25783796572671e-81	LRMP	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32065
8.10349384184492e-86	-0.425477194681759	0.203	0.449	1.72045277756209e-81	MED23	NK cells	GSE199333_post	ENSG00000112282	9439	mediator complex subunit 23	CRSP130|CRSP3|DRIP130|MRT18|Sur2	protein_coding	Q9ULK4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32066
1.27545909328941e-85	0.381010912671238	0.259	0.067	2.70792720096275e-81	HAGH	NK cells	GSE199333_post	ENSG00000063854	3029	hydroxyacylglutathione hydrolase	GLO2|GLXII|HAGH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32067
1.4861252259047e-85	0.603704961514103	0.528	0.31	3.15519246711827e-81	TNRC6B	NK cells	GSE199333_post	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32068
4.21051706061094e-85	0.576726376445035	0.587	0.372	8.93934877138309e-81	ATM	NK cells	GSE199333_post	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32069
5.12637609052233e-85	0.51778316294578	0.422	0.187	1.0883809077788e-80	LINC01871	NK cells	GSE199333_post	ENSG00000235576	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32070
2.143917961852e-84	0.43110534800861	0.324	0.114	4.55175222480797e-80	PHB	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32071
4.83522689315644e-84	-0.412361325288102	0.914	0.956	1.02656702168604e-79	SUB1	NK cells	GSE199333_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32072
5.98118239108797e-84	-0.457521941397859	0.276	0.533	1.26986483345189e-79	MAPK1IP1L	NK cells	GSE199333_post	ENSG00000168175	93487	mitogen-activated protein kinase 1 interacting protein 1 like	C14orf32	protein_coding	Q8NDC0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32073
2.1567404491011e-83	-0.427638407402147	0.175	0.41	4.57897564748655e-79	CLINT1	NK cells	GSE199333_post	ENSG00000113282	9685	clathrin interactor 1	CLINT|ENTH|EPNR|KIAA0171	protein_coding	Q14677	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32074
2.79149934794196e-83	-0.489175987889439	0.36	0.617	5.92663226561558e-79	CLK1	NK cells	GSE199333_post	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32075
3.79217747100707e-83	-0.366170654813089	0.124	0.343	8.05117198869511e-79	NR1D2	NK cells	GSE199333_post	ENSG00000174738	9975	nuclear receptor subfamily 1 group D member 2	BD73|EAR-1r|Hs.37288|HZF2|REVERBB|REVERBbeta|RVR	protein_coding	Q14995	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32076
3.81323808567018e-83	-0.419115191428433	0.184	0.426	8.09588577968636e-79	UBE2J1	NK cells	GSE199333_post	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32077
4.63833847644962e-83	0.496096659667277	0.713	0.532	9.8476564193502e-79	TMBIM6	NK cells	GSE199333_post	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32078
1.03804608267898e-81	-0.459908334603083	0.329	0.585	2.20387563813573e-77	CCDC59	NK cells	GSE199333_post	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32079
2.22460375972428e-81	0.551350422884536	0.617	0.424	4.72305624227062e-77	CTSC	NK cells	GSE199333_post	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32080
2.25990854491704e-81	-0.392334133141974	0.13	0.348	4.79801183171337e-77	WDR43	NK cells	GSE199333_post	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32081
4.3878434978794e-81	0.568156181478708	0.603	0.399	9.31583053034775e-77	RPS27L	NK cells	GSE199333_post	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32082
5.68404232402948e-81	-0.346688512518894	0.099	0.303	1.2067790258147e-76	RLF	NK cells	GSE199333_post	ENSG00000117000	6018	RLF zinc finger	Zn-15L|ZNF292L	protein_coding	Q13129	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32083
1.00685107288999e-80	-0.460841895216576	0.391	0.64	2.13764551285275e-76	MRPL54	NK cells	GSE199333_post	ENSG00000183617	116541	mitochondrial ribosomal protein L54	NA	protein_coding	Q6P161	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32084
1.17956533251268e-80	-0.843257126178006	0.478	0.686	2.50433515745768e-76	ZFP36	NK cells	GSE199333_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32085
1.18131965237666e-80	0.471122130780027	0.522	0.286	2.50805975396089e-76	SAMD3	NK cells	GSE199333_post	ENSG00000164483	154075	sterile alpha motif domain containing 3	bA73O6.2|FLJ34032	protein_coding	Q8N6K7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32086
1.3662379900663e-80	-0.410946415578893	0.208	0.453	2.90065987670976e-76	PPP2CA	NK cells	GSE199333_post	ENSG00000113575	5515	protein phosphatase 2 catalytic subunit alpha	PP2AC|PP2Calpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32087
1.78654808939622e-80	0.624352887499672	0.567	0.377	3.79302024859711e-76	ITGB1	NK cells	GSE199333_post	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32088
1.87105029503804e-80	-0.406367646241979	0.21	0.453	3.97242688139525e-76	TMEM87A	NK cells	GSE199333_post	ENSG00000103978	25963	transmembrane protein 87A	DKFZP564G2022	protein_coding	Q8NBN3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32089
4.77282914661227e-80	0.489734335725581	0.688	0.498	1.01331935611725e-75	PARK7	NK cells	GSE199333_post	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32090
5.91632396233856e-80	-0.466004584911735	0.294	0.543	1.2560947404441e-75	YME1L1	NK cells	GSE199333_post	ENSG00000136758	10730	YME1 like 1 ATPase	YME1L	protein_coding	Q96TA2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32091
6.11889704542779e-80	-0.389606914724551	0.147	0.368	1.29910303171477e-75	CTDSPL2	NK cells	GSE199333_post	ENSG00000137770	51496	CTD small phosphatase like 2	FLJ10523|HSPC129	protein_coding	Q05D32	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32092
8.42227096192519e-80	0.476680649373387	0.398	0.181	1.78813234792634e-75	ABRACL	NK cells	GSE199333_post	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32093
8.90946783130142e-80	-0.453118019669975	0.387	0.645	1.8915691152636e-75	SRP19	NK cells	GSE199333_post	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32094
9.63835887634761e-80	0.424444731984109	0.301	0.103	2.04631997303736e-75	GSTO1	NK cells	GSE199333_post	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32095
1.26526038870923e-79	-0.354028275293421	0.125	0.342	2.68627433126857e-75	AP1G1	NK cells	GSE199333_post	ENSG00000166747	164	adaptor related protein complex 1 subunit gamma 1	ADTG|CLAPG1	protein_coding	O43747	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32096
1.41296157199615e-79	-0.365259676254502	0.125	0.342	2.99985871350502e-75	FAM76B	NK cells	GSE199333_post	ENSG00000077458	143684	family with sequence similarity 76 member B	MGC33371	protein_coding	Q5HYJ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32097
1.63926514494827e-79	0.506957100727431	0.687	0.505	3.48032382923967e-75	BIN2	NK cells	GSE199333_post	ENSG00000110934	51411	bridging integrator 2	BRAP-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32098
2.3418561171117e-79	-0.395067241828253	0.142	0.359	4.97199472223986e-75	CRCP	NK cells	GSE199333_post	ENSG00000241258	27297	CGRP receptor component	C17|CGRP-RCP|POLR3I|RCP|RCP9	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32099
3.17494142301894e-79	0.425580918638205	0.318	0.116	6.74071813521152e-75	NDUFB3	NK cells	GSE199333_post	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32100
3.8379385102473e-79	-0.386028731924638	0.159	0.386	8.14832725110604e-75	RAD23B	NK cells	GSE199333_post	ENSG00000119318	5887	RAD23 homolog B, nucleotide excision repair protein	HHR23B|HR23B|P58	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32101
1.26994530195203e-78	0.505614026469267	0.534	0.325	2.69622087057436e-74	ANAPC16	NK cells	GSE199333_post	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32102
1.30069874151985e-78	0.409783236947668	0.281	0.09	2.7615134981208e-74	ATP2B4	NK cells	GSE199333_post	ENSG00000058668	493	ATPase plasma membrane Ca2+ transporting 4	ATP2B2|MXRA1|PMCA4	protein_coding	P23634	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32103
1.35864768091357e-78	-0.470670757184259	0.518	0.733	2.8845448913476e-74	SRSF11	NK cells	GSE199333_post	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32104
2.42224365906842e-78	-0.405085695054609	0.121	0.334	5.14266551256815e-74	TENT5A	NK cells	GSE199333_post	ENSG00000112773	55603	terminal nucleotidyltransferase 5A	C6orf37|FAM46A|FLJ20037	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32105
1.01757546658661e-77	-0.403821369438928	0.743	0.869	2.16041447311002e-73	UBE2D3	NK cells	GSE199333_post	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32106
1.30755750193355e-77	-0.501998809434961	0.48	0.695	2.77607533235512e-73	DDX3X	NK cells	GSE199333_post	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32107
1.53068170791092e-77	-0.341872263251056	0.075	0.264	3.24979033406568e-73	SLC7A5	NK cells	GSE199333_post	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32108
1.60700819241748e-77	-0.488103383356109	0.369	0.615	3.41183909332155e-73	ZNF292	NK cells	GSE199333_post	ENSG00000188994	23036	zinc finger protein 292	bA393I2.3|KIAA0530|ZFP292|Zn-15|Zn-16	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32109
2.1279739377702e-77	-0.390182780449226	0.135	0.348	4.5179014672799e-73	GNA13	NK cells	GSE199333_post	ENSG00000120063	10672	G protein subunit alpha 13	G13|MGC46138	protein_coding	Q14344	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32110
2.42925559348254e-77	0.492715122807347	0.511	0.294	5.15755255052277e-73	SKAP1	NK cells	GSE199333_post	ENSG00000141293	8631	src kinase associated phosphoprotein 1	SCAP1|SKAP55	protein_coding	Q86WV1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32111
2.50866787737956e-77	-0.41339230835062	0.23	0.466	5.32615277046455e-73	DERL2	NK cells	GSE199333_post	ENSG00000072849	51009	derlin 2	CGI-101|derlin-2|F-LAN-1|F-LANa|FLANa	protein_coding	Q9GZP9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32112
3.19404296740585e-77	0.451420566081193	0.356	0.146	6.78127262409936e-73	RGS10	NK cells	GSE199333_post	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32113
7.02926456972475e-77	-0.479334055353401	0.275	0.515	1.49238316079826e-72	MAP2K3	NK cells	GSE199333_post	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32114
9.81232963254695e-77	-0.350168299026049	0.093	0.29	2.08325570428604e-72	SKIL	NK cells	GSE199333_post	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32115
1.28721865731943e-76	0.542333653866178	0.513	0.309	2.73289393135488e-72	BST2	NK cells	GSE199333_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32116
2.03448695000639e-76	-0.476201907868039	0.425	0.655	4.31941924355856e-72	SPCS3	NK cells	GSE199333_post	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32117
2.51021376609561e-76	0.476310729567429	0.705	0.524	5.32943484679758e-72	PPP1CA	NK cells	GSE199333_post	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32118
2.83866285681681e-76	0.467474848473416	0.399	0.191	6.02676511130777e-72	PSMA5	NK cells	GSE199333_post	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32119
5.93612988085529e-76	-0.479489102853878	0.353	0.599	1.26029973500439e-71	BRD2	NK cells	GSE199333_post	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32120
1.11051244166794e-75	0.500493240456198	0.492	0.284	2.3577289649052e-71	XRCC5	NK cells	GSE199333_post	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32121
1.18681012393375e-75	-0.495996068880429	0.082	0.268	2.51971657412374e-71	AREG	NK cells	GSE199333_post	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32122
1.29479557632093e-75	-0.292670551217952	1	1	2.74898048808696e-71	RPLP1	NK cells	GSE199333_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32123
1.87543179125197e-75	-0.448809620346267	0.163	0.376	3.98172923600705e-71	SLC15A4	NK cells	GSE199333_post	ENSG00000139370	121260	solute carrier family 15 member 4	PHT1|PTR4	protein_coding	Q8N697	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32124
1.91752294514912e-75	-0.393510812218095	0.221	0.457	4.07109296484609e-71	RNF114	NK cells	GSE199333_post	ENSG00000124226	55905	ring finger protein 114	PSORS12|ZNF313	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32125
2.30614325056467e-75	-0.827224497705308	0.177	0.381	4.89617273527386e-71	FOS	NK cells	GSE199333_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32126
2.84946792342833e-75	-0.361273413832524	0.106	0.305	6.04970534823068e-71	KIF20B	NK cells	GSE199333_post	ENSG00000138182	9585	kinesin family member 20B	CT90|KRMP1|MPHOSPH1|MPP1	protein_coding	Q96Q89	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32127
2.87947851299379e-75	0.485778645199552	0.383	0.177	6.11342083093712e-71	CDK2AP2	NK cells	GSE199333_post	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32128
3.54702104437226e-75	0.497033349468648	0.667	0.5	7.53068037930674e-71	CAPZB	NK cells	GSE199333_post	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32129
5.20198458229445e-75	-0.354062236691772	0.147	0.363	1.10443334666693e-70	TIMM17A	NK cells	GSE199333_post	ENSG00000134375	10440	translocase of inner mitochondrial membrane 17A	TIM17|TIM17A	protein_coding	Q99595	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32130
6.40059325057139e-75	-0.351076099084304	0.135	0.349	1.35890995302881e-70	FAM91A1	NK cells	GSE199333_post	ENSG00000176853	157769	family with sequence similarity 91 member A1	FLJ23790	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32131
9.69374483851941e-75	-0.415879816324214	0.206	0.432	2.05807896666606e-70	SPTY2D1	NK cells	GSE199333_post	ENSG00000179119	144108	SPT2 chromatin protein domain containing 1	DKFZp686I068|FLJ39441|Spt2	protein_coding	Q68D10	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32132
1.9710021417286e-74	-0.403863273395526	0.241	0.474	4.18463464710399e-70	MED6	NK cells	GSE199333_post	ENSG00000133997	10001	mediator complex subunit 6	NY-REN-28	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32133
2.53949048020663e-74	-0.350100607304354	0.123	0.33	5.3915922385267e-70	GPCPD1	NK cells	GSE199333_post	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32134
2.80231423474111e-74	0.483940753987989	0.678	0.498	5.94959335177884e-70	MYO1F	NK cells	GSE199333_post	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32135
2.97533915874884e-74	0.450944776399281	0.367	0.166	6.31694256793965e-70	ECH1	NK cells	GSE199333_post	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32136
3.19918221883919e-74	-0.430529398501403	0.398	0.643	6.79218376881749e-70	PSMD7	NK cells	GSE199333_post	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32137
5.4179619585465e-74	0.410131076947548	0.259	0.079	1.15028750341901e-69	TRG-AS1	NK cells	GSE199333_post	ENSG00000281103	100506776	T cell receptor gamma locus antisense RNA 1	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32138
6.56985111094402e-74	-0.426792236265112	0.275	0.514	1.39484508936452e-69	KDM2A	NK cells	GSE199333_post	ENSG00000173120	22992	lysine demethylase 2A	CXXC8|DKFZP434M1735|FBL11|FBL7|FBXL11|FLJ00115|JHDM1A|KIAA1004|LILINA	protein_coding	Q9Y2K7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32139
7.17397584075296e-74	-0.38511505549075	0.149	0.36	1.52310681075026e-69	MEF2D	NK cells	GSE199333_post	ENSG00000116604	4209	myocyte enhancer factor 2D	NA	protein_coding	Q14814	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32140
8.73425587662554e-74	-0.363444711159853	0.131	0.338	1.85436986516637e-69	JMJD6	NK cells	GSE199333_post	ENSG00000070495	23210	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	KIAA0585|PTDSR|PTDSR1	protein_coding	Q6NYC1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32141
1.79693338035237e-73	0.449091378159841	0.397	0.19	3.81506925982611e-69	RASAL3	NK cells	GSE199333_post	ENSG00000105122	64926	RAS protein activator like 3	FLJ21438	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32142
2.49473584551669e-73	-0.36096908410991	0.154	0.368	5.29657367361649e-69	RAB5A	NK cells	GSE199333_post	ENSG00000144566	5868	RAB5A, member RAS oncogene family	RAB5	protein_coding	P20339	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32143
2.64589598222905e-73	-0.501726329927995	0.358	0.59	5.6175017598705e-69	TLE4	NK cells	GSE199333_post	ENSG00000106829	7091	TLE family member 4, transcriptional corepressor	E(spl)|ESG|GRG4	protein_coding	Q04727	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32144
4.28137211030846e-73	-0.437604079681212	0.281	0.518	9.08978112739589e-69	TMF1	NK cells	GSE199333_post	ENSG00000144747	7110	TATA element modulatory factor 1	ARA160|TMF	protein_coding	P82094	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32145
4.36802302179183e-73	-0.415794982549982	0.675	0.824	9.27374967756624e-69	HMGN2	NK cells	GSE199333_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32146
5.80367620041661e-73	-0.457008441867291	0.787	0.894	1.23217849411045e-68	SRSF7	NK cells	GSE199333_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32147
7.28396171509078e-73	-0.368827593473842	0.128	0.332	1.54645791173092e-68	TWISTNB	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32148
7.60126701490521e-73	-0.382777710636976	0.198	0.424	1.61382499993452e-68	PCIF1	NK cells	GSE199333_post	ENSG00000100982	63935	phosphorylated CTD interacting factor 1	bA465L10.1|C20orf67|CAPAM|PPP1R121	protein_coding	Q9H4Z3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32149
9.29183154886453e-73	0.387164781566491	0.282	0.097	1.97274875613943e-68	RPS6KA1	NK cells	GSE199333_post	ENSG00000281877	6195	ribosomal protein S6 kinase A1	HU-1|MAPKAPK1|p90Rsk|RSK1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32150
1.11988304249541e-72	0.431337550347352	0.756	0.582	2.377623687522e-68	ATP5F1D	NK cells	GSE199333_post	ENSG00000099624	513	ATP synthase F1 subunit delta	ATP5D	protein_coding	P30049	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32151
1.17159905690059e-72	0.523274183185815	0.581	0.397	2.48742195770564e-68	MYH9	NK cells	GSE199333_post	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32152
1.17646599621295e-72	-0.4793660538257	0.344	0.579	2.49775495655972e-68	SQSTM1	NK cells	GSE199333_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32153
1.30375171834102e-72	-0.431311167809936	0.29	0.527	2.76799527320981e-68	KIF5B	NK cells	GSE199333_post	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32154
1.42620953176146e-72	0.488502663733883	0.5	0.297	3.02798545688275e-68	SLC9A3R1	NK cells	GSE199333_post	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32155
1.67377887648452e-72	-0.35949676249772	0.128	0.329	3.55359993266428e-68	UAP1	NK cells	GSE199333_post	ENSG00000117143	6675	UDP-N-acetylglucosamine pyrophosphorylase 1	AgX|AGX1|SPAG2	protein_coding	Q16222	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32156
1.85853902944931e-72	0.3437615536283	0.252	0.074	3.94586421342382e-68	ANXA4	NK cells	GSE199333_post	ENSG00000196975	307	annexin A4	ANX4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32157
2.7644825434637e-72	-0.342271400662783	0.147	0.357	5.86927288802777e-68	GORASP2	NK cells	GSE199333_post	ENSG00000115806	26003	golgi reassembly stacking protein 2	GOLPH6|GRASP55|GRS2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32158
2.96774560788965e-72	-0.555637828231594	0.503	0.735	6.30082070011051e-68	KLRB1	NK cells	GSE199333_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32159
3.08427907058426e-72	-0.392216582032191	0.219	0.445	6.54823289475744e-68	PCGF5	NK cells	GSE199333_post	ENSG00000180628	84333	polycomb group ring finger 5	MGC16202|RNF159	protein_coding	Q86SE9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32160
3.85796519449279e-72	0.413881141074385	0.948	0.898	8.19084590442765e-68	PPIA	NK cells	GSE199333_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32161
4.80066592849203e-72	-0.362638422683807	0.153	0.367	1.01922938327814e-67	RNF220	NK cells	GSE199333_post	ENSG00000187147	55182	ring finger protein 220	C1orf164|FLJ10597	protein_coding	Q5VTB9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32162
4.89730822773186e-72	-0.407630874250826	0.192	0.418	1.03974750982975e-67	ZNF326	NK cells	GSE199333_post	ENSG00000162664	284695	zinc finger protein 326	FLJ20403|ZAN75|Zfp326|ZIRD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32163
5.39745754972104e-72	0.425059560478771	0.358	0.161	1.14593421238127e-67	FAM89B	NK cells	GSE199333_post	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32164
1.53638955620341e-71	-0.479031279628194	0.274	0.498	3.26190866677546e-67	CTNNB1	NK cells	GSE199333_post	ENSG00000168036	1499	catenin beta 1	armadillo|beta-catenin|CTNNB	protein_coding	P35222	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32165
1.61426140131285e-71	0.502982397771479	0.556	0.364	3.4272383811273e-67	MYO1G	NK cells	GSE199333_post	ENSG00000136286	64005	myosin IG	HA-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32166
1.88975523304385e-71	-0.436019421526561	0.292	0.524	4.0121393352754e-67	ELF2	NK cells	GSE199333_post	ENSG00000109381	1998	E74 like ETS transcription factor 2	EU32|NERF|NERF-1A|NERF-1B|NERF-2	protein_coding	Q15723	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32167
2.57606104798543e-71	-0.371271826567749	0.193	0.414	5.46923521097787e-67	CCNK	NK cells	GSE199333_post	ENSG00000090061	8812	cyclin K	CPR4	protein_coding	O75909	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32168
2.58065322152871e-71	0.435689166540852	0.411	0.207	5.47898485462761e-67	GABARAPL2	NK cells	GSE199333_post	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32169
4.20543763102719e-71	0.534463981868431	0.553	0.355	8.92856463443382e-67	PLEK	NK cells	GSE199333_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32170
4.57936707831084e-71	-0.410097292955935	0.305	0.545	9.72245424396175e-67	HELZ	NK cells	GSE199333_post	ENSG00000198265	9931	helicase with zinc finger	DHRC|HUMORF5|KIAA0054	protein_coding	P42694	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32171
5.12527940485686e-71	-0.416353268781436	0.867	0.926	1.08814807044516e-66	SARAF	NK cells	GSE199333_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32172
1.37426152069022e-70	0.396899454436289	0.834	0.685	2.9176946345774e-66	COX6B1	NK cells	GSE199333_post	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32173
1.60722738881902e-70	-0.417156855722881	0.213	0.434	3.41230446920166e-66	SETD2	NK cells	GSE199333_post	ENSG00000181555	29072	SET domain containing 2, histone lysine methyltransferase	FLJ23184|HIF-1|HYPB|KIAA1732|KMT3A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32174
2.75030553115157e-70	-0.46283425400298	0.809	0.893	5.8391736731879e-66	NCL	NK cells	GSE199333_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32175
2.95485581180412e-70	-0.421225553430414	0.243	0.468	6.27345437404132e-66	SLU7	NK cells	GSE199333_post	ENSG00000164609	10569	SLU7 homolog, splicing factor	9G8	protein_coding	O95391	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32176
3.05201403431991e-70	0.470621798129984	0.526	0.328	6.47973099626461e-66	C4orf3	NK cells	GSE199333_post	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32177
3.4239729811327e-70	-0.417081234859302	0.279	0.517	7.26943703624284e-66	RBM17	NK cells	GSE199333_post	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32178
5.45276287917147e-70	-0.422167117095718	0.308	0.537	1.15767608687689e-65	TSEN54	NK cells	GSE199333_post	ENSG00000182173	283989	tRNA splicing endonuclease subunit 54	SEN54|SEN54L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32179
6.52934781861511e-70	-0.406597948128136	0.375	0.617	1.38624583537017e-65	FBXO7	NK cells	GSE199333_post	ENSG00000100225	25793	F-box protein 7	Fbx|FBX7|PARK15	protein_coding	Q9Y3I1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32180
9.40417421870015e-70	0.388111429384198	0.311	0.122	1.99660022837223e-65	S1PR4	NK cells	GSE199333_post	ENSG00000125910	8698	sphingosine-1-phosphate receptor 4	EDG6	protein_coding	O95977	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32181
1.08477844094281e-69	-0.453103952823907	0.188	0.403	2.30309310796568e-65	HIST1H4C	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32182
1.41602828777498e-69	0.449998872210667	0.369	0.175	3.00636965777505e-65	APBB1IP	NK cells	GSE199333_post	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32183
1.42225565269649e-69	-0.449245183118613	0.205	0.421	3.01959097623993e-65	HIST1H1E	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32184
1.88167702782264e-69	-0.475416021038931	0.293	0.507	3.99498849777026e-65	IRF2BP2	NK cells	GSE199333_post	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32185
1.99691666924866e-69	0.340374117669502	0.996	0.989	4.23965378048183e-65	CFL1	NK cells	GSE199333_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32186
2.25637869004601e-69	-0.405908386963467	0.22	0.444	4.79051759683669e-65	BIRC2	NK cells	GSE199333_post	ENSG00000110330	329	baculoviral IAP repeat containing 2	API1|c-IAP1|cIAP1|hiap-2|MIHB|RNF48	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32187
2.26880304111255e-69	-0.478796548758968	0.17	0.375	4.81689573658606e-65	ZNF331	NK cells	GSE199333_post	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32188
2.61713066975127e-69	0.449627456781039	0.398	0.199	5.55643012494891e-65	MINOS1	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32189
3.05248832445855e-69	-0.367194204186564	0.199	0.421	6.48073796165794e-65	GTF2B	NK cells	GSE199333_post	ENSG00000137947	2959	general transcription factor IIB	TFIIB	protein_coding	Q00403	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32190
3.07906701547106e-69	0.484067254298412	0.622	0.45	6.5371671805466e-65	CAP1	NK cells	GSE199333_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32191
4.80564852911679e-69	-0.35449158993501	0.201	0.421	1.02028723921679e-64	RAMMET	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32192
5.87543754464761e-69	0.441208507444782	0.686	0.509	1.24741414510413e-64	ATP5IF1	NK cells	GSE199333_post	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32193
6.27930377729446e-69	0.45034543934758	0.569	0.368	1.33315898495739e-64	ATP5PF	NK cells	GSE199333_post	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32194
1.43617576607538e-68	-0.3691348988214	0.209	0.43	3.04914476895464e-64	RPF1	NK cells	GSE199333_post	ENSG00000117133	80135	ribosome production factor 1 homolog	BXDC5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32195
2.05924732271744e-68	0.423133737605656	0.773	0.58	4.3719879908614e-64	LDHB	NK cells	GSE199333_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32196
3.2944553652253e-68	-0.387500350046791	0.206	0.424	6.99445818590983e-64	EP300	NK cells	GSE199333_post	ENSG00000100393	2033	E1A binding protein p300	KAT3B|p300	protein_coding	Q09472	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32197
3.54504745736965e-68	0.428422564810061	0.396	0.193	7.5264902567415e-64	GLRX	NK cells	GSE199333_post	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32198
5.71615230297487e-68	-0.37650829084948	0.202	0.422	1.2135962954446e-63	AFF4	NK cells	GSE199333_post	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32199
6.25898550222759e-68	-0.44246144160182	0.154	0.354	1.32884521197794e-63	PIM3	NK cells	GSE199333_post	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32200
7.81672874087153e-68	-0.400683743187756	0.35	0.588	1.65956967897444e-63	SNRPD1	NK cells	GSE199333_post	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32201
7.88883389348379e-68	-0.415403537023935	0.256	0.483	1.67487832392554e-63	FXR1	NK cells	GSE199333_post	ENSG00000114416	8087	FMR1 autosomal homolog 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32202
8.96623108021406e-68	-0.381089049585609	0.2	0.418	1.90362052064025e-63	BLOC1S6	NK cells	GSE199333_post	ENSG00000104164	26258	biogenesis of lysosomal organelles complex 1 subunit 6	HPS9|PA|PLDN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32203
1.59047857399289e-67	-0.449774854024348	0.579	0.751	3.37674506044431e-63	SYF2	NK cells	GSE199333_post	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32204
1.90284980591196e-67	-0.353761785988882	0.156	0.36	4.03994042293167e-63	FBXO33	NK cells	GSE199333_post	ENSG00000165355	254170	F-box protein 33	Fbx33	protein_coding	Q7Z6M2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32205
2.66523835056471e-67	-0.442494950409583	0.26	0.479	5.65856754208393e-63	SURF4	NK cells	GSE199333_post	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32206
4.58394937430364e-67	-0.500046694407891	0.83	0.913	9.73218291658406e-63	LITAF	NK cells	GSE199333_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32207
4.68149459338161e-67	-0.349458024365884	0.17	0.381	9.9392811712085e-63	TAF11	NK cells	GSE199333_post	ENSG00000064995	6882	TATA-box binding protein associated factor 11	TAF2I|TAFII28	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32208
5.98308236102598e-67	-0.323564719565458	0.132	0.329	1.27026821606943e-62	DCP1A	NK cells	GSE199333_post	ENSG00000272886	55802	decapping mRNA 1A	HSA275986|SMAD4IP1|SMIF	protein_coding	Q9NPI6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32209
7.20155853192326e-67	-0.399534788217033	0.777	0.906	1.52896289191263e-62	CD7	NK cells	GSE199333_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32210
1.08175486012552e-66	-0.346876493311177	0.174	0.384	2.29667374353249e-62	CUL3	NK cells	GSE199333_post	ENSG00000036257	8452	cullin 3	NA	protein_coding	Q13618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32211
1.22315491366762e-66	-0.397617609931485	0.252	0.474	2.59688019720773e-62	SNRPA1	NK cells	GSE199333_post	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32212
2.19064654017202e-66	-0.397939228704227	0.219	0.437	4.65096166943923e-62	BNIP3L	NK cells	GSE199333_post	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32213
2.2411799959667e-66	-0.431373351081043	0.239	0.458	4.7582492494369e-62	SNHG7	NK cells	GSE199333_post	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32214
2.54606813051603e-66	-0.430705856232359	0.422	0.654	5.40555724789858e-62	EIF4A1	NK cells	GSE199333_post	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32215
3.57037419609936e-66	-0.421666376441235	0.267	0.49	7.58026145573856e-62	GABARAPL1	NK cells	GSE199333_post	ENSG00000139112	23710	GABA type A receptor associated protein like 1	APG8L|ATG8B|ATG8L|gec1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32216
4.19478250722856e-66	-0.333401177785367	0.127	0.319	8.90594274109696e-62	PTS	NK cells	GSE199333_post	ENSG00000150787	5805	6-pyruvoyltetrahydropterin synthase	PTPS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32217
6.82434463362615e-66	0.461491718739429	0.36	0.173	1.44887660916517e-61	APOBEC3C	NK cells	GSE199333_post	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32218
1.08954875405062e-65	-0.405920660856429	0.625	0.803	2.31322095972487e-61	DAZAP2	NK cells	GSE199333_post	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32219
1.10040442227533e-65	0.376744439829325	0.324	0.138	2.33626862893274e-61	HMOX2	NK cells	GSE199333_post	ENSG00000277424	3163	heme oxygenase 2	HO-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32220
1.10603846779914e-65	-0.461530441503512	0.673	0.836	2.34823027098436e-61	CLEC2B	NK cells	GSE199333_post	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32221
1.41956021669215e-65	-0.419194796252642	0.246	0.466	3.01386829605909e-61	EIF3B	NK cells	GSE199333_post	ENSG00000106263	8662	eukaryotic translation initiation factor 3 subunit B	EIF3S9|PRT1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32222
2.40294162583782e-65	0.441579175825618	0.47	0.267	5.10168536581627e-61	CARD16	NK cells	GSE199333_post	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32223
2.54600819743369e-65	-0.370309286962547	0.242	0.462	5.40543000397147e-61	CDK11A	NK cells	GSE199333_post	ENSG00000008128	728642	cyclin dependent kinase 11A	CDC2L2|CDC2L3|CDK11-p110|CDK11-p46|CDK11-p58|p58GTA|PITSLRE	protein_coding	Q9UQ88	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32224
2.7179607216149e-65	-0.442321615176826	0.423	0.646	5.7705024080606e-61	PDCD4	NK cells	GSE199333_post	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32225
2.99831268984235e-65	0.423240075818328	0.776	0.643	6.3657176718043e-61	RHOA	NK cells	GSE199333_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32226
3.50617277321072e-65	-0.412265986232928	0.363	0.594	7.44395541480368e-61	CASP8	NK cells	GSE199333_post	ENSG00000064012	841	caspase 8	Casp-8|FLICE|MACH|MCH5	protein_coding	Q14790	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32227
5.64367175923118e-65	-0.404807182781735	0.257	0.476	1.19820795120237e-60	RAB14	NK cells	GSE199333_post	ENSG00000119396	51552	RAB14, member RAS oncogene family	FBP|RAB-14	protein_coding	P61106	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32228
5.7214277904224e-65	-0.468660823891556	0.355	0.572	1.21471633418458e-60	APOL6	NK cells	GSE199333_post	ENSG00000221963	80830	apolipoprotein L6	APOL-VI|APOLVI	protein_coding	Q9BWW8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32229
5.89465820184586e-65	-0.319200222485081	0.126	0.315	1.25149488283389e-60	NUP54	NK cells	GSE199333_post	ENSG00000138750	53371	nucleoporin 54	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32230
6.34266875136531e-65	-0.424589170451934	0.17	0.37	1.34661200260237e-60	RGS2	NK cells	GSE199333_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32231
9.81726214972483e-65	-0.431485226036454	0.619	0.785	2.08430292700808e-60	RBM25	NK cells	GSE199333_post	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32232
1.06817570996718e-64	-0.369734671915094	0.198	0.412	2.26784384983132e-60	KAT6B	NK cells	GSE199333_post	ENSG00000281813	23522	lysine acetyltransferase 6B	Morf|MOZ2|MYST4|qkf|querkopf|ZC2HC6B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32233
1.161519161235e-64	0.463445158046625	0.568	0.392	2.46602133121803e-60	SSBP4	NK cells	GSE199333_post	ENSG00000130511	170463	single stranded DNA binding protein 4	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32234
1.34775355434898e-64	-0.325562240954612	0.145	0.345	2.86141557123832e-60	DIS3	NK cells	GSE199333_post	ENSG00000083520	22894	DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease	dis3p|EXOSC11|KIAA1008|RRP44	protein_coding	Q9Y2L1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32235
1.38837922682783e-64	-0.307526408770024	0.097	0.273	2.94766793647817e-60	NAMPT	NK cells	GSE199333_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32236
2.19813761339285e-64	-0.409158606763194	0.261	0.476	4.66686596699436e-60	SPPL2A	NK cells	GSE199333_post	ENSG00000138600	84888	signal peptide peptidase like 2A	IMP3|PSL2	protein_coding	Q8TCT8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32237
2.63014624907995e-64	-0.389042668179435	0.229	0.442	5.58406350142164e-60	EMD	NK cells	GSE199333_post	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32238
2.6492627159295e-64	0.394313637900231	0.316	0.136	5.62464967218993e-60	CASP1	NK cells	GSE199333_post	ENSG00000137752	834	caspase 1	ICE|IL1BC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32239
2.91205214771254e-64	-0.420227282640795	0.282	0.5	6.1825779148085e-60	VPS37B	NK cells	GSE199333_post	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32240
3.82362979890311e-64	-0.287228510837397	0.112	0.295	8.1179484260512e-60	ELOA	NK cells	GSE199333_post	ENSG00000011007	6924	elongin A	SIII|TCEB3|TCEB3A	protein_coding	Q14241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32241
4.46458109519962e-64	-0.285885601304748	0.092	0.264	9.47875212321831e-60	HSPA14.1	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32242
4.56788045738732e-64	-0.443203274634664	0.319	0.536	9.69806699907901e-60	FOSL2	NK cells	GSE199333_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32243
6.55907618128884e-64	-0.434680005141754	0.332	0.534	1.39255746404943e-59	S1PR5	NK cells	GSE199333_post	ENSG00000180739	53637	sphingosine-1-phosphate receptor 5	Edg-8|EDG8	protein_coding	Q9H228	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32244
8.54001388340556e-64	-0.349636123961667	0.172	0.375	1.81313034758583e-59	STAU1	NK cells	GSE199333_post	ENSG00000124214	6780	staufen double-stranded RNA binding protein 1	PPP1R150|STAU	protein_coding	O95793	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32245
9.92123956149388e-64	-0.356651128909337	0.165	0.363	2.10637837130077e-59	PRKAR2A	NK cells	GSE199333_post	ENSG00000114302	5576	protein kinase cAMP-dependent type II regulatory subunit alpha	PRKAR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32246
1.09547246433643e-63	-0.294508035409089	0.091	0.264	2.32579758903268e-59	TEN1	NK cells	GSE199333_post	ENSG00000257949	100134934	TEN1 subunit of CST complex	C17orf106|FLJ39785	protein_coding	Q86WV5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32247
1.39682425412011e-63	-0.337908646136956	0.171	0.376	2.96559757392241e-59	HMGXB4	NK cells	GSE199333_post	ENSG00000100281	10042	HMG-box containing 4	HMG2L1|P53N|THC211630	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32248
1.47875977497769e-63	0.428059716993372	0.36	0.174	3.13955487825514e-59	PGLS	NK cells	GSE199333_post	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32249
1.86722269607575e-63	-0.366955596724543	0.188	0.393	3.96430050603843e-59	TMEM170A	NK cells	GSE199333_post	ENSG00000166822	124491	transmembrane protein 170A	FLJ37611|TMEM170	protein_coding	Q8WVE7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32250
2.09168560778208e-63	0.433788395280463	0.722	0.563	4.44085771388214e-59	APRT	NK cells	GSE199333_post	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32251
2.22223050215698e-63	0.425408384409654	0.647	0.466	4.71801757912947e-59	SOD1	NK cells	GSE199333_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32252
3.04786453045914e-63	-0.395450791333409	0.463	0.679	6.47092118461779e-59	VAPA	NK cells	GSE199333_post	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32253
3.60222987915956e-63	-0.5155164638868	0.271	0.473	7.64789425644365e-59	CREM	NK cells	GSE199333_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32254
4.71710729692789e-63	-0.390482030501264	0.59	0.784	1.00148905021076e-58	SF3B2	NK cells	GSE199333_post	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32255
6.0188414333198e-63	-0.451610805720458	0.572	0.746	1.27786022470813e-58	MAP1LC3B	NK cells	GSE199333_post	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32256
7.29174004577356e-63	0.362529167302147	0.272	0.101	1.54810932911818e-58	COPZ1	NK cells	GSE199333_post	ENSG00000111481	22818	COPI coat complex subunit zeta 1	CGI-120|COPZ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32257
9.23360252081555e-63	0.335233187329141	0.267	0.097	1.96038615119435e-58	CYBC1	NK cells	GSE199333_post	ENSG00000178927	79415	cytochrome b-245 chaperone 1	C17orf62|Eros|FLJ90469|MGC4368	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32258
1.13413363792787e-62	-0.4149713783749	0.316	0.533	2.40787912668466e-58	RSL1D1	NK cells	GSE199333_post	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32259
1.43951607759399e-62	-0.383700301721197	0.248	0.465	3.0562365843398e-58	UFM1	NK cells	GSE199333_post	ENSG00000120686	51569	ubiquitin fold modifier 1	bA131P10.1|C13orf20	protein_coding	P61960	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32260
3.57017358607498e-62	-0.381991081960197	0.299	0.523	7.57983554059579e-58	EXOSC6	NK cells	GSE199333_post	ENSG00000223496	118460	exosome component 6	EAP4|hMtr3p|MTR3|Mtr3p|p11	protein_coding	Q5RKV6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32261
6.46963028295517e-62	0.383939614384626	0.288	0.116	1.37356720537421e-57	MRPL51	NK cells	GSE199333_post	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32262
7.1035421258888e-62	0.399455193239607	0.342	0.161	1.50815302874745e-57	RNF167	NK cells	GSE199333_post	ENSG00000108523	26001	ring finger protein 167	DKFZP566H073	protein_coding	Q9H6Y7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32263
7.83903934700029e-62	-0.270975524806326	0.103	0.279	1.66430644376163e-57	RAE1	NK cells	GSE199333_post	ENSG00000101146	8480	ribonucleic acid export 1	Gle2|Mnrp41	protein_coding	P78406	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32264
1.02204580516681e-61	0.383970858494071	0.332	0.152	2.16990544894966e-57	PDCD6	NK cells	GSE199333_post	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32265
1.6508010914865e-61	-0.397396167867982	0.289	0.509	3.50481579733499e-57	FNBP4	NK cells	GSE199333_post	ENSG00000285182	23360	formin binding protein 4	KIAA1014	protein_coding	Q8N3X1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32266
1.87052330911402e-61	-0.369852171177716	0.17	0.366	3.97130803757997e-57	ZFAND5	NK cells	GSE199333_post	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32267
1.97585059090748e-61	-0.39204298272394	0.275	0.492	4.19492838955566e-57	CHD2	NK cells	GSE199333_post	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32268
2.55935600289834e-61	-0.296029329482678	0.141	0.331	5.43376872975346e-57	KANSL2	NK cells	GSE199333_post	ENSG00000139620	54934	KAT8 regulatory NSL complex subunit 2	C12orf41|FLJ20436|NSL2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32269
2.67012808215128e-61	0.412956379773145	0.719	0.563	5.66894893121539e-57	IL2RG	NK cells	GSE199333_post	ENSG00000147168	3561	interleukin 2 receptor subunit gamma	CD132|CIDX|IMD4|SCIDX1	protein_coding	P31785	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32270
2.74853187622901e-61	-0.306436277660808	0.113	0.29	5.83540802642182e-57	WDFY1	NK cells	GSE199333_post	ENSG00000085449	57590	WD repeat and FYVE domain containing 1	FENS-1|KIAA1435|WDF1|ZFYVE17	protein_coding	Q8IWB7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32271
3.74509946523844e-61	-0.337376450927949	0.194	0.4	7.95122067464774e-57	DYRK1A	NK cells	GSE199333_post	ENSG00000157540	1859	dual specificity tyrosine phosphorylation regulated kinase 1A	DYRK|DYRK1|MNBH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32272
3.82899942944798e-61	-0.324699708716073	0.158	0.35	8.129348688661e-57	CSNK1G3	NK cells	GSE199333_post	ENSG00000151292	1456	casein kinase 1 gamma 3	NA	protein_coding	Q9Y6M4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32273
8.46192807319167e-61	-0.308143684547753	0.092	0.258	1.79655194921932e-56	GALNT2	NK cells	GSE199333_post	ENSG00000143641	2590	polypeptide N-acetylgalactosaminyltransferase 2	GalNAc-T2	protein_coding	Q10471	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32274
9.27696281685586e-61	-0.341477717555273	0.172	0.369	1.96959197564667e-56	RAB1A	NK cells	GSE199333_post	ENSG00000138069	5861	RAB1A, member RAS oncogene family	RAB1|YPT1	protein_coding	P62820	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32275
9.8470677344276e-61	0.431858800084988	0.418	0.236	2.09063095069632e-56	COX7A2L	NK cells	GSE199333_post	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32276
1.08682919385814e-60	0.44341889932037	0.455	0.267	2.30744706148021e-56	ANKRD44	NK cells	GSE199333_post	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32277
1.34584148720403e-60	-0.396164484871746	0.261	0.473	2.85735606148288e-56	EIF1AX	NK cells	GSE199333_post	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32278
1.83856528058652e-60	-0.407755528487089	0.363	0.578	3.90345794721323e-56	SYTL3	NK cells	GSE199333_post	ENSG00000164674	94120	synaptotagmin like 3	exophilin-6|SLP3	protein_coding	Q4VX76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32279
2.54870410527642e-60	-0.410244644896437	0.451	0.663	5.41115368591237e-56	MDM4	NK cells	GSE199333_post	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32280
2.81613100300611e-60	-0.358234983113241	0.25	0.467	5.97892773248227e-56	RBM33	NK cells	GSE199333_post	ENSG00000184863	155435	RNA binding motif protein 33	DKFZp434D1319|DKFZp686F102|MGC20460|PRR8	protein_coding	Q96EV2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32281
3.08251399221364e-60	-0.394332035655848	0.592	0.775	6.54448545686877e-56	ARF6	NK cells	GSE199333_post	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32282
3.11040080627422e-60	-0.257624140184787	0.096	0.267	6.60369195180079e-56	PDRG1	NK cells	GSE199333_post	ENSG00000088356	81572	p53 and DNA damage regulated 1	C20orf126|dJ310O13.3	protein_coding	Q9NUG6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32283
3.7589240387843e-60	-0.402447258232449	0.494	0.676	7.98057162674294e-56	TOMM20	NK cells	GSE199333_post	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32284
4.58191455708018e-60	0.293874701986593	0.263	0.094	9.72786279613693e-56	LINC00861	NK cells	GSE199333_post	ENSG00000245164	100130231	long intergenic non-protein coding RNA 861	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32285
4.80113766453802e-60	-0.409647791582945	0.559	0.739	1.01932953755807e-55	C9orf78	NK cells	GSE199333_post	ENSG00000136819	51759	chromosome 9 open reading frame 78	CSU2|HCA59|HSPC220	protein_coding	Q9NZ63	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32286
9.57538035117728e-60	0.429385663806547	0.686	0.529	2.03294900235845e-55	TPI1	NK cells	GSE199333_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32287
1.07749304079766e-59	-0.407608011587885	0.528	0.722	2.28762547491752e-55	MED10	NK cells	GSE199333_post	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32288
2.02160871781287e-59	-0.403682085176668	0.425	0.634	4.2920774687885e-55	WTAP	NK cells	GSE199333_post	ENSG00000146457	9589	WT1 associated protein	KIAA0105|MGC3925|Mum2	protein_coding	Q15007	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32289
2.15471895567467e-59	-0.309913475676917	0.122	0.299	4.5746838147929e-55	MADD	NK cells	GSE199333_post	ENSG00000110514	8567	MAP kinase activating death domain	DENN|KIAA0358|RAB3GEP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32290
2.1915911286268e-59	-0.406664610916325	0.363	0.584	4.65296712518755e-55	SREK1	NK cells	GSE199333_post	ENSG00000153914	140890	splicing regulatory glutamic acid and lysine rich protein 1	DKFZp564B176|SFRS12|SRrp508|SRrp86	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32291
3.17309097553606e-59	0.343337007369393	0.28	0.112	6.73678945016062e-55	CDC25B	NK cells	GSE199333_post	ENSG00000101224	994	cell division cycle 25B	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32292
4.12445002757623e-59	-0.33315645864188	0.215	0.426	8.7566198535471e-55	SERINC1	NK cells	GSE199333_post	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32293
4.67284899109578e-59	-0.419264612301183	0.304	0.513	9.92092569299545e-55	B4GALT1	NK cells	GSE199333_post	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32294
7.65112087371255e-59	-0.358438498277378	0.266	0.48	1.62440947269791e-54	PPP1CC	NK cells	GSE199333_post	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32295
8.68054457359627e-59	0.395509469739621	1	1	1.84296641842022e-54	ACTB	NK cells	GSE199333_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32296
9.26997303088191e-59	0.358731761881491	0.306	0.133	1.96810797418654e-54	SNX17	NK cells	GSE199333_post	ENSG00000115234	9784	sorting nexin 17	KIAA0064	protein_coding	Q15036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32297
1.31015454427379e-58	0.544803098307947	0.534	0.357	2.78158911294768e-54	CRIP1	NK cells	GSE199333_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32298
1.43516993990734e-58	-0.343213026420094	0.176	0.367	3.04700929941728e-54	PPP2R2D	NK cells	GSE199333_post	ENSG00000175470	55844	protein phosphatase 2 regulatory subunit Bdelta	B55D|B55delta|MDS026	protein_coding	Q66LE6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32299
1.60027648949149e-58	-0.403730733658097	0.303	0.509	3.39754701483939e-54	ARHGAP9	NK cells	GSE199333_post	ENSG00000123329	64333	Rho GTPase activating protein 9	10C|MGC1295	protein_coding	Q9BRR9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32300
1.9609921855863e-58	-0.318217567659576	0.222	0.431	4.16338250921828e-54	COQ10B	NK cells	GSE199333_post	ENSG00000115520	80219	coenzyme Q10B	FLJ13448	protein_coding	Q9H8M1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32301
2.37694214321356e-58	-0.29519779372128	0.124	0.302	5.0464858642567e-54	NOL11	NK cells	GSE199333_post	ENSG00000130935	25926	nucleolar protein 11	DKFZP586L0724	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32302
2.66954180390816e-58	-0.374452293073928	0.641	0.792	5.66770420387741e-54	PCBP2	NK cells	GSE199333_post	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32303
2.91645952033672e-58	-0.289515164802073	0.129	0.31	6.19193520762689e-54	COIL	NK cells	GSE199333_post	ENSG00000121058	8161	coilin	CLN80|p80-coilin	protein_coding	P38432	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32304
3.00509386399957e-58	-0.306085362391974	0.14	0.321	6.38011478265749e-54	HAUS3	NK cells	GSE199333_post	ENSG00000214367	79441	HAUS augmin like complex subunit 3	C4orf15|dgt3|IT1|MGC4701	protein_coding	Q68CZ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32305
4.73634743246547e-58	0.396399112622804	0.392	0.208	1.00557392338674e-53	TAP1	NK cells	GSE199333_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32306
5.00686977241542e-58	0.341458276063332	0.943	0.871	1.06300852138152e-53	COX7C	NK cells	GSE199333_post	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32307
5.75872267417919e-58	-0.275030473294502	0.112	0.284	1.22263441095498e-53	HAUS2	NK cells	GSE199333_post	ENSG00000137814	55142	HAUS augmin like complex subunit 2	C15orf25|CEP27|FLJ10460|HsT17025	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32308
6.01080209839118e-58	0.435182014848998	0.475	0.301	1.27615339350943e-53	PGAM1	NK cells	GSE199333_post	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32309
6.76073578927701e-58	-0.423083702097115	0.49	0.68	1.4353718154214e-53	EIF5	NK cells	GSE199333_post	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32310
7.21855597175037e-58	-0.294316679790285	0.116	0.289	1.53257161836232e-53	JADE1	NK cells	GSE199333_post	ENSG00000077684	79960	jade family PHD finger 1	JADE-1|PHF17	protein_coding	Q6IE81	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32311
1.52730861945983e-57	-0.338224395729342	0.136	0.314	3.24262892997517e-53	IFNGR1	NK cells	GSE199333_post	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32312
1.58883315918541e-57	-0.302764796072772	0.186	0.384	3.37325168026655e-53	TSN	NK cells	GSE199333_post	ENSG00000211460	7247	translin	BCLF-1|REHF-1|TRSLN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32313
2.97723838906984e-57	0.426652605545122	0.537	0.365	6.32097482383418e-53	TMEM258	NK cells	GSE199333_post	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32314
3.80175050880277e-57	-0.29507776624009	0.106	0.273	8.07149650523916e-53	PAXBP1	NK cells	GSE199333_post	ENSG00000263141	94104	PAX3 and PAX7 binding protein 1	C21orf66|fSAP105|GCFC|GCFC1	protein_coding	Q9Y5B6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32315
4.03878885899838e-57	0.446309730651376	0.985	0.947	8.57475262653947e-53	NEAT1	NK cells	GSE199333_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32316
4.06394316819737e-57	-0.376377487130051	0.237	0.441	8.62815774039985e-53	NUFIP2	NK cells	GSE199333_post	ENSG00000108256	57532	nuclear FMR1 interacting protein 2	182-FIP|82-FIP|FIP-82|KIAA1321|MGC117262|NUFP2|PIG1	protein_coding	Q7Z417	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32317
4.37776604889359e-57	-0.349082574505639	0.204	0.403	9.29443509840597e-53	CDK12	NK cells	GSE199333_post	ENSG00000167258	51755	cyclin dependent kinase 12	CRK7|CRKR|CRKRS|KIAA0904	protein_coding	Q9NYV4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32318
5.8091761255937e-57	-0.306666155204429	0.156	0.342	1.2333461832248e-52	CCNT2	NK cells	GSE199333_post	ENSG00000082258	905	cyclin T2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32319
6.46239300496423e-57	0.355763171399234	0.274	0.112	1.37203065888396e-52	RGS19	NK cells	GSE199333_post	ENSG00000171700	10287	regulator of G protein signaling 19	GAIP|RGSGAIP	protein_coding	P49795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32320
9.55043305929556e-57	0.353339285999937	0.743	0.578	2.02765244281904e-52	TSC22D3	NK cells	GSE199333_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32321
1.19684325762126e-56	-0.33841743060723	0.239	0.446	2.54101792025569e-52	YTHDF2	NK cells	GSE199333_post	ENSG00000198492	51441	YTH N6-methyladenosine RNA binding protein 2	CAHL|HGRG8|NY-REN-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32322
1.29198444313048e-56	-0.394039757737622	0.614	0.779	2.74301217121031e-52	NKTR	NK cells	GSE199333_post	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32323
1.29608149297089e-56	-0.444077007769795	0.221	0.418	2.75171061772649e-52	HIST1H1C	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32324
2.76439594270672e-56	0.424070324756759	0.556	0.39	5.86908902596063e-52	CD47	NK cells	GSE199333_post	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32325
4.02194963175733e-56	-0.43559634712707	0.463	0.648	8.539001263184e-52	STAT3	NK cells	GSE199333_post	ENSG00000168610	6774	signal transducer and activator of transcription 3	APRF	protein_coding	P40763	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32326
4.42774664480278e-56	-0.282679365942256	0.165	0.357	9.40054890158078e-52	NGDN	NK cells	GSE199333_post	ENSG00000129460	25983	neuroguidin	C14orf120|CANu1|DKFZP564O092|LCP5|lpd-2|NGD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32327
6.45040299058214e-56	0.359358397550491	0.3	0.133	1.36948505893049e-51	GSDMD	NK cells	GSE199333_post	ENSG00000278718	79792	gasdermin D	DF5L|FLJ12150|GSDMDC1	protein_coding	P57764	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32328
6.9825059006939e-56	-0.303846769601444	0.147	0.329	1.48245582777632e-51	TFAM	NK cells	GSE199333_post	ENSG00000108064	7019	transcription factor A, mitochondrial	TCF6|TCF6L2	protein_coding	Q00059	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32329
7.2285544856169e-56	-0.36922287157017	0.361	0.58	1.53469440284132e-51	LAMP1	NK cells	GSE199333_post	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32330
8.28831249054705e-56	0.480193546714651	0.383	0.205	1.75969162486804e-51	ALOX5AP	NK cells	GSE199333_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32331
9.02117169587377e-56	-0.416977784030132	0.461	0.662	1.91528496275096e-51	MXD4	NK cells	GSE199333_post	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32332
9.18040039251608e-56	-0.357697591024566	0.184	0.37	1.94909080733509e-51	CCNT1	NK cells	GSE199333_post	ENSG00000129315	904	cyclin T1	CCNT|CYCT1|HIVE1	protein_coding	O60563	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32333
1.3479300946314e-55	-0.325025825315719	0.168	0.355	2.86179038391193e-51	DYNC1LI2	NK cells	GSE199333_post	ENSG00000135720	1783	dynein cytoplasmic 1 light intermediate chain 2	DNCLI2	protein_coding	O43237	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32334
1.60234048370518e-55	-0.350762365556531	0.279	0.485	3.40192908095447e-51	MAPKAPK2	NK cells	GSE199333_post	ENSG00000162889	9261	MAPK activated protein kinase 2	MK2	protein_coding	P49137	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32335
1.76642795887782e-55	-0.415404467813476	0.574	0.768	3.7503031994935e-51	ZEB2	NK cells	GSE199333_post	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32336
1.77566222093662e-55	-0.30517648619667	0.184	0.378	3.76990846127053e-51	IST1	NK cells	GSE199333_post	ENSG00000182149	9798	IST1 factor associated with ESCRT-III	CHMP8|KIAA0174	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32337
2.41914779242584e-55	0.396811211824394	0.296	0.134	5.1360926780993e-51	CD300A	NK cells	GSE199333_post	ENSG00000167851	11314	CD300a molecule	CMRF-35-H9|CMRF35H|IGSF12|IRC1|IRC2|Irp60	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32338
4.8692561217916e-55	0.408710886092909	0.778	0.663	1.03379176721757e-50	HSPA8	NK cells	GSE199333_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32339
5.18926741932517e-55	-0.363012272443042	0.282	0.492	1.10173336579693e-50	NIPBL	NK cells	GSE199333_post	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32340
6.40612028571554e-55	-0.302636734867373	0.178	0.366	1.36008339786027e-50	CDK11B	NK cells	GSE199333_post	ENSG00000248333	984	cyclin dependent kinase 11B	CDC2L1|CDK11-p110|CDK11-p46|CDK11-p58	protein_coding	P21127	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32341
6.83822534621948e-55	-0.299647750451504	0.138	0.318	1.45182362325586e-50	SERPINB6	NK cells	GSE199333_post	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32342
7.37479470040413e-55	0.42079679511424	0.612	0.458	1.5657426628428e-50	RABAC1	NK cells	GSE199333_post	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32343
8.55248932434794e-55	0.36532614437046	0.31	0.143	1.81577900845231e-50	PRMT1	NK cells	GSE199333_post	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32344
1.68306633121872e-54	-0.26116306658724	0.112	0.278	3.57331812781047e-50	TLK2	NK cells	GSE199333_post	ENSG00000146872	11011	tousled like kinase 2	MGC44450|PKU-ALPHA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32345
1.70827796838396e-54	-0.369062120470859	0.309	0.518	3.62684495467598e-50	WAC	NK cells	GSE199333_post	ENSG00000095787	51322	WW domain containing adaptor with coiled-coil	BM-016|FLJ31290|MGC10753|PRO1741|Wwp4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32346
1.89069471778629e-54	-0.363556751401408	0.266	0.468	4.01413395533208e-50	ILF3	NK cells	GSE199333_post	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32347
1.98332203863767e-54	-0.2947720315058	0.138	0.315	4.21079102023164e-50	CUL5	NK cells	GSE199333_post	ENSG00000166266	8065	cullin 5	VACM-1	protein_coding	Q93034	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32348
2.25778696705718e-54	-0.339156226236445	0.25	0.45	4.79350750975911e-50	MAPRE1	NK cells	GSE199333_post	ENSG00000101367	22919	microtubule associated protein RP/EB family member 1	EB1	protein_coding	Q15691	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32349
3.72687422161466e-54	-0.384150782657585	0.502	0.68	7.91252665991008e-50	PRDX6	NK cells	GSE199333_post	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32350
3.88139305892299e-54	-0.428897045276031	0.367	0.571	8.24058560339941e-50	GOLGA4	NK cells	GSE199333_post	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32351
4.0061917314339e-54	-0.344352186579166	0.387	0.602	8.50554566500731e-50	IL2RB	NK cells	GSE199333_post	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32352
4.46930512024587e-54	0.424283390989198	0.297	0.134	9.48878170079401e-50	TIMP1	NK cells	GSE199333_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32353
5.48321052203449e-54	-0.310940625639427	0.133	0.304	1.16414042593314e-49	RP9	NK cells	GSE199333_post	ENSG00000164610	6100	RP9 pre-mRNA splicing factor	PAP-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32354
6.22434487841484e-54	-0.348673379155374	0.307	0.52	1.32149066113626e-49	EIF4H	NK cells	GSE199333_post	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32355
9.88705413342905e-54	-0.371794211780864	0.368	0.579	2.09912046306832e-49	U2SURP	NK cells	GSE199333_post	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32356
9.89129392801127e-54	-0.267914624657883	0.096	0.252	2.10002061385607e-49	RBM18	NK cells	GSE199333_post	ENSG00000119446	92400	RNA binding motif protein 18	MGC2734	protein_coding	Q96H35	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32357
1.21970938485285e-53	-0.359092737024019	0.341	0.544	2.58956499498109e-49	ZNF394	NK cells	GSE199333_post	ENSG00000160908	84124	zinc finger protein 394	FLJ12298|ZKSCAN14|ZSCAN46	protein_coding	Q53GI3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32358
1.52565292268876e-53	-0.394526042761944	0.265	0.464	3.23911372016051e-49	IER5	NK cells	GSE199333_post	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32359
1.529857218946e-53	-0.341319388639026	0.189	0.373	3.24803986154425e-49	SEC14L1	NK cells	GSE199333_post	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32360
3.20075343631948e-53	0.33624412797625	0.286	0.125	6.79551962064989e-49	PTGER2	NK cells	GSE199333_post	ENSG00000125384	5732	prostaglandin E receptor 2	EP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32361
4.18870111948015e-53	0.38713625163035	0.682	0.531	8.89303134676831e-49	GYPC	NK cells	GSE199333_post	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32362
8.3321983926424e-53	0.338839815488732	1	0.999	1.76900904074191e-48	MT-ND2	NK cells	GSE199333_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32363
8.67101671530707e-53	-0.332534570076277	0.176	0.359	1.84094355882684e-48	JARID2	NK cells	GSE199333_post	ENSG00000008083	3720	jumonji and AT-rich interaction domain containing 2	JMJ	protein_coding	Q92833	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32364
1.40470488224115e-52	-0.330774476603788	0.268	0.474	2.98232893548618e-48	RFC1	NK cells	GSE199333_post	ENSG00000035928	5981	replication factor C subunit 1	A1|MHCBFB|PO-GA|RFC140	protein_coding	P35251	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32365
1.66782721671123e-52	-0.262183582359641	0.098	0.254	3.5409639637996e-48	CEBPG	NK cells	GSE199333_post	ENSG00000153879	1054	CCAAT enhancer binding protein gamma	GPE1BP|IG/EBP-1	protein_coding	P53567	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32366
1.70398295541607e-52	-0.37363464817608	0.328	0.526	3.61772621264386e-48	CWC15	NK cells	GSE199333_post	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32367
1.87536743510345e-52	-0.28015234398315	0.147	0.319	3.98159260146813e-48	DUSP11	NK cells	GSE199333_post	ENSG00000144048	8446	dual specificity phosphatase 11	PIR1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32368
2.24010781040506e-52	0.350162480262164	0.282	0.124	4.75597289227099e-48	GDI2	NK cells	GSE199333_post	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32369
3.01327817843567e-52	0.42793928445497	0.426	0.256	6.39749090063677e-48	IFI16	NK cells	GSE199333_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32370
4.27060127350152e-52	0.365359063563748	0.341	0.175	9.06691356377108e-48	TMEM230	NK cells	GSE199333_post	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32371
4.3741091735391e-52	-0.301386827470976	0.201	0.392	9.28667118634086e-48	RHEB	NK cells	GSE199333_post	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32372
4.875838038325e-52	0.425612537455831	0.439	0.271	1.03518917391678e-47	NDUFB1	NK cells	GSE199333_post	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32373
5.32885681317892e-52	-0.37944510638196	0.436	0.64	1.13136959000602e-47	RTF1	NK cells	GSE199333_post	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32374
6.08688602233475e-52	-0.403987749655016	0.243	0.431	1.29230677140189e-47	CLDND1	NK cells	GSE199333_post	ENSG00000080822	56650	claudin domain containing 1	C3orf4|Z38	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32375
8.83008014882026e-52	0.472944677761729	0.526	0.371	1.87471431639603e-47	ISG20	NK cells	GSE199333_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32376
9.61564675803275e-52	-0.314429774534899	0.2	0.385	2.04149796319793e-47	DDA1	NK cells	GSE199333_post	ENSG00000130311	79016	DET1 and DDB1 associated 1	C19orf58|MGC2594|PCIA1	protein_coding	Q9BW61	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32377
9.92015601924349e-52	-0.274351975313091	0.123	0.287	2.10614832444559e-47	ARNTL	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32378
1.06966095280341e-51	-0.29028428217402	0.16	0.339	2.27099716889691e-47	COPS3	NK cells	GSE199333_post	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32379
1.11527411055615e-51	-0.275191708815144	0.104	0.262	2.36783846412177e-47	USF3	NK cells	GSE199333_post	ENSG00000176542	205717	upstream transcription factor family member 3	KIAA2018	protein_coding	Q68DE3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32380
1.12582924592072e-51	0.405761057504355	0.526	0.365	2.39024807201428e-47	VPS28	NK cells	GSE199333_post	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32381
2.08637197497073e-51	-0.310794152491083	0.237	0.432	4.42957634006036e-47	CDC123	NK cells	GSE199333_post	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32382
2.21384816786494e-51	0.350354351872167	0.251	0.102	4.70022104519406e-47	GLIPR1	NK cells	GSE199333_post	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32383
2.80039022155583e-51	-0.345369611841273	0.249	0.444	5.94550847938519e-47	C16orf72	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32384
2.89494545008446e-51	0.381692960346661	0.837	0.752	6.14625868507431e-47	RAP1B	NK cells	GSE199333_post	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32385
4.7835282581773e-51	-0.286947395305208	0.147	0.318	1.01559088449362e-46	TOR1AIP1	NK cells	GSE199333_post	ENSG00000143337	26092	torsin 1A interacting protein 1	FLJ13142|LAP1|LAP1B|LAP1C	protein_coding	Q5JTV8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32386
5.50034250272835e-51	-0.315154030327411	0.273	0.473	1.16777771675426e-46	BUD23	NK cells	GSE199333_post	ENSG00000071462	114049	BUD23 rRNA methyltransferase and ribosome maturation factor	MERM1|MGC19709|MGC2022|MGC5140|PP3381|WBMT|WBSCR22	protein_coding	O43709	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32387
6.80248755077788e-51	-0.29875718596795	0.183	0.368	1.44423613190565e-46	SPAG9	NK cells	GSE199333_post	ENSG00000008294	9043	sperm associated antigen 9	CT89|FLJ13450|FLJ14006|FLJ26141|FLJ34602|HLC4|HSS|JIP-4|JIP4|JLP|KIAA0516|MGC117291|MGC14967|MGC74461|PHET|PIG6|SYD1	protein_coding	O60271	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32388
8.37284147038622e-51	0.414385025946084	0.554	0.4	1.7776379725777e-46	TBC1D10C	NK cells	GSE199333_post	ENSG00000175463	374403	TBC1 domain family member 10C	Carabin|EPI64C|FLJ00332	protein_coding	Q8IV04	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32389
9.14251830342587e-51	0.350252315550236	0.338	0.173	1.94104806100035e-46	ITGB1BP1	NK cells	GSE199333_post	ENSG00000119185	9270	integrin subunit beta 1 binding protein 1	ICAP-1A|ICAP-1alpha|ICAP-1B|ICAP1|ICAP1A|ICAP1B	protein_coding	O14713	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32390
9.25044561850419e-51	0.400996870009315	0.62	0.48	1.96396210926462e-46	ACAP1	NK cells	GSE199333_post	ENSG00000288169	9744	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	CENTB1|KIAA0050	protein_coding	Q15027	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32391
1.05300776655693e-50	-0.558320236397965	0.413	0.588	2.23564078917701e-46	SPON2	NK cells	GSE199333_post	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32392
1.10844778426438e-50	0.400973464530857	0.583	0.431	2.3533454907717e-46	PCBP1	NK cells	GSE199333_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32393
1.17458996548573e-50	-0.343272582089874	0.418	0.622	2.49377195572276e-46	RAB5C	NK cells	GSE199333_post	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32394
1.43438861903121e-50	-0.43841890518061	0.401	0.586	3.04535047706515e-46	HSPE1	NK cells	GSE199333_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32395
1.50158442443414e-50	-0.280021362068202	0.165	0.34	3.18801389151611e-46	COPS8	NK cells	GSE199333_post	ENSG00000198612	10920	COP9 signalosome subunit 8	COP9|CSN8|MGC1297|SGN8	protein_coding	Q99627	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32396
1.63383774555003e-50	-0.376195371887049	0.294	0.489	3.46880091757726e-46	ATF4	NK cells	GSE199333_post	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32397
1.69470573910982e-50	-0.387051375457881	0.38	0.57	3.59802975470407e-46	UPP1	NK cells	GSE199333_post	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32398
1.89912156409599e-50	-0.259958020071754	0.111	0.269	4.03202499273221e-46	WDR48	NK cells	GSE199333_post	ENSG00000114742	57599	WD repeat domain 48	Bun62|KIAA1449|P80|SPG60	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32399
2.1258231308029e-50	0.42118559794158	0.513	0.343	4.51333508900765e-46	SERPINB1	NK cells	GSE199333_post	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32400
2.1777612337894e-50	-0.351231838955873	0.274	0.464	4.62360487545827e-46	VPS4B	NK cells	GSE199333_post	ENSG00000119541	9525	vacuolar protein sorting 4 homolog B	SKD1|SKD1B|VPS4-2	protein_coding	O75351	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32401
2.31657844458181e-50	-0.284017395007284	0.176	0.356	4.91832769569163e-46	RNF139	NK cells	GSE199333_post	ENSG00000170881	11236	ring finger protein 139	HRCA1|RCA1|TRC8	protein_coding	Q8WU17	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32402
3.1261711682573e-50	-0.280337758883316	0.114	0.271	6.63717400732707e-46	ITPRIP	NK cells	GSE199333_post	ENSG00000148841	85450	inositol 1,4,5-trisphosphate receptor interacting protein	bA127L20.2|DANGER|KIAA1754	protein_coding	Q8IWB1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32403
3.28960517739376e-50	-0.359593415068149	0.469	0.665	6.9841607521247e-46	UBALD2	NK cells	GSE199333_post	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32404
3.42281094972117e-50	0.351933365362498	0.363	0.192	7.26696992735301e-46	SEPT1	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32405
4.02808741218339e-50	-0.25348571440908	0.12	0.28	8.55203238480656e-46	AC016831.7	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32406
4.87944563651778e-50	-0.332528182477864	0.764	0.849	1.03595510308909e-45	SF1	NK cells	GSE199333_post	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32407
5.20832044122448e-50	-0.302141486298755	0.287	0.49	1.10577851287637e-45	TMEM9B	NK cells	GSE199333_post	ENSG00000175348	56674	TMEM9 domain family member B	C11orf15	protein_coding	Q9NQ34	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32408
5.96842606852947e-50	0.374742963740737	0.585	0.43	1.26715653860949e-45	NDUFB8	NK cells	GSE199333_post	ENSG00000166136	4714	NADH:ubiquinone oxidoreductase subunit B8	ASHI|CI-ASHI	protein_coding	O95169	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32409
6.10837562404274e-50	-0.250549128201245	0.113	0.272	1.29686922874051e-45	ASNSD1	NK cells	GSE199333_post	ENSG00000138381	54529	asparagine synthetase domain containing 1	FLJ20752|NBLA00058|NS3TP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32410
6.71350626896318e-50	-0.452323005244112	0.569	0.731	1.42534451596357e-45	ANKRD11	NK cells	GSE199333_post	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32411
6.94686389450414e-50	0.405073088634402	0.539	0.386	1.47488867344217e-45	DHRS7	NK cells	GSE199333_post	ENSG00000100612	51635	dehydrogenase/reductase 7	retDSR4|SDR34C1	protein_coding	Q9Y394	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32412
9.99475400316043e-50	-0.359578151194839	0.334	0.533	2.12198622241099e-45	SH3GLB1	NK cells	GSE199333_post	ENSG00000097033	51100	SH3 domain containing GRB2 like, endophilin B1	Bif-1|CGI-61|KIAA0491|PPP1R70	protein_coding	Q9Y371	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32413
1.24191273791684e-49	-0.500954280663786	0.528	0.726	2.63670493387125e-45	DUSP2	NK cells	GSE199333_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32414
2.15596974235123e-49	-0.337298303585219	0.202	0.386	4.5773393599859e-45	ATP2B1	NK cells	GSE199333_post	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32415
2.2059192497909e-49	-0.27119781293966	0.126	0.287	4.68338715923105e-45	TBC1D15	NK cells	GSE199333_post	ENSG00000121749	64786	TBC1 domain family member 15	DKFZp761D0223|FLJ12085	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32416
2.86983110815515e-49	-0.343145335524079	0.274	0.471	6.0929384257242e-45	SNW1	NK cells	GSE199333_post	ENSG00000100603	22938	SNW domain containing 1	Bx42|FUN20|NCoA-62|Prp45|PRPF45|SKIIP|SKIP|SKIP1	protein_coding	Q13573	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32417
3.5327209580741e-49	-0.285649764517621	0.163	0.337	7.50031986608713e-45	DNM1L	NK cells	GSE199333_post	ENSG00000087470	10059	dynamin 1 like	DRP1|DVLP|DYMPLE|HDYNIV|VPS1	protein_coding	O00429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32418
4.11643357006904e-49	-0.35212728331381	0.477	0.666	8.73960011261358e-45	RNPS1	NK cells	GSE199333_post	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32419
4.45711597827808e-49	-0.326516310466255	0.22	0.407	9.46290293348218e-45	LCOR	NK cells	GSE199333_post	ENSG00000196233	84458	ligand dependent nuclear receptor corepressor	C10orf12|DKFZP564P1916|FLJ13022|FLJ38026|KIAA1795|MLR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32420
4.46747330945956e-49	-0.312394436134245	0.212	0.395	9.48489258331359e-45	MAP2K7	NK cells	GSE199333_post	ENSG00000076984	5609	mitogen-activated protein kinase kinase 7	Jnkk2|MKK7|PRKMK7	protein_coding	O14733	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32421
5.13195981761648e-49	-0.299083449438913	0.194	0.372	1.08956638887816e-44	SP3	NK cells	GSE199333_post	ENSG00000172845	6670	Sp3 transcription factor	SPR-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32422
6.08021684768264e-49	0.333982797193889	0.32	0.16	1.2908908389315e-44	CCM2	NK cells	GSE199333_post	ENSG00000136280	83605	CCM2 scaffold protein	C7orf22|MGC4607|OSM	protein_coding	Q9BSQ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32423
7.62178004964121e-49	0.307435601188106	0.265	0.116	1.61818012233933e-44	PCMT1	NK cells	GSE199333_post	ENSG00000120265	5110	protein-L-isoaspartate (D-aspartate) O-methyltransferase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32424
9.46686066087636e-49	-0.325524273147632	0.702	0.831	2.00990918691066e-44	SNRPB	NK cells	GSE199333_post	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32425
1.04915689156533e-48	-0.307459597370686	0.229	0.421	2.22746499648234e-44	ABI1	NK cells	GSE199333_post	ENSG00000136754	10006	abl interactor 1	ABI-1|E3B1|SSH3BP1	protein_coding	Q8IZP0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32426
1.19013600662963e-48	0.360235522798429	0.405	0.238	2.52677775567537e-44	SELENOF	NK cells	GSE199333_post	ENSG00000183291	9403	selenoprotein F	SEP15	protein_coding	O60613	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32427
1.58070219185249e-48	0.428538322379285	0.515	0.362	3.35598882352203e-44	ACTR3	NK cells	GSE199333_post	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32428
1.77305343511282e-48	0.441744092909571	0.457	0.295	3.76436974808802e-44	ADGRG1	NK cells	GSE199333_post	ENSG00000205336	9289	adhesion G protein-coupled receptor G1	GPR56|TM7LN4|TM7XN1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32429
3.02945035728091e-48	0.346158479809548	0.28	0.127	6.43182605354311e-44	RALBP1	NK cells	GSE199333_post	ENSG00000017797	10928	ralA binding protein 1	RIP|RIP1|RLIP76	protein_coding	Q15311	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32430
3.06689683530988e-48	-0.26303819042842	0.135	0.298	6.51132867104641e-44	C1orf174	NK cells	GSE199333_post	ENSG00000198912	339448	chromosome 1 open reading frame 174	RP13-531C17.2	protein_coding	Q8IYL3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32431
3.23502883155013e-48	-0.28145428982736	0.189	0.371	6.86828971226407e-44	PSMD11	NK cells	GSE199333_post	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32432
3.32735741113311e-48	0.414316168022541	0.667	0.539	7.0643125195767e-44	N4BP2L2	NK cells	GSE199333_post	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32433
3.49467762630801e-48	-0.25926014454979	0.147	0.315	7.41955006841454e-44	TMEM242	NK cells	GSE199333_post	ENSG00000215712	729515	transmembrane protein 242	BM033|C6orf35	protein_coding	Q9NWH2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32434
3.60044229697339e-48	-0.346446407374089	0.224	0.407	7.64409904070419e-44	BRAF	NK cells	GSE199333_post	ENSG00000157764	673	B-Raf proto-oncogene, serine/threonine kinase	BRAF-1|BRAF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32435
4.5943773579162e-48	-0.266919814357801	0.113	0.267	9.75432256859189e-44	MSL2	NK cells	GSE199333_post	ENSG00000174579	55167	MSL complex subunit 2	FLJ10546|KIAA1585|msl-2|MSL2L1|RNF184	protein_coding	Q9HCI7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32436
5.1903905069099e-48	-0.308331632483994	0.228	0.413	1.10197180852204e-43	USP3	NK cells	GSE199333_post	ENSG00000140455	9960	ubiquitin specific peptidase 3	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32437
5.21766660034224e-48	-0.316314278013225	0.186	0.359	1.10776279591866e-43	RNF168	NK cells	GSE199333_post	ENSG00000163961	165918	ring finger protein 168	FLJ35794	protein_coding	Q8IYW5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32438
6.16016381723434e-48	-0.282416982938211	0.187	0.363	1.30786438003702e-43	TMEM183A	NK cells	GSE199333_post	ENSG00000163444	92703	transmembrane protein 183A	C1orf37	protein_coding	Q8IXX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32439
6.46758682210666e-48	-0.293088875058243	0.218	0.402	1.37313335820147e-43	MPHOSPH10	NK cells	GSE199333_post	ENSG00000124383	10199	M-phase phosphoprotein 10	CT90|MPP10|MPP10P|PPP1R106	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32440
1.02319611439458e-47	0.308571722436725	0.27	0.121	2.17234767047114e-43	TSPAN14	NK cells	GSE199333_post	ENSG00000108219	81619	tetraspanin 14	DC-TM4F2|MGC11352|TM4SF14	protein_coding	Q8NG11	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32441
1.06452754857776e-47	-0.296855031066542	0.204	0.386	2.26009843838545e-43	HECTD1	NK cells	GSE199333_post	ENSG00000092148	25831	HECT domain E3 ubiquitin protein ligase 1	KIAA1131	protein_coding	Q9ULT8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32442
1.06610142743193e-47	-0.354655489605283	0.659	0.793	2.26343994058073e-43	ARGLU1	NK cells	GSE199333_post	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32443
1.34309810538247e-47	-0.351513759913517	0.651	0.787	2.85153158753751e-43	POMP	NK cells	GSE199333_post	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32444
1.42823534431237e-47	0.427248325813305	0.58	0.435	3.0322864595096e-43	FYB1	NK cells	GSE199333_post	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32445
1.55594046949929e-47	-0.358846485183026	0.368	0.563	3.30341721079394e-43	TRA2A	NK cells	GSE199333_post	ENSG00000164548	29896	transformer 2 alpha homolog	AWMS1|htra-2-alpha	protein_coding	Q13595	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32446
1.72858482119446e-47	-0.338117332900027	0.565	0.729	3.66995843387795e-43	RSL24D1	NK cells	GSE199333_post	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32447
1.76310226806802e-47	-0.361877663423932	0.515	0.69	3.74324242533521e-43	SCAND1	NK cells	GSE199333_post	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32448
2.17552720893745e-47	-0.363011355309236	0.494	0.675	4.6188618172951e-43	TERF2IP	NK cells	GSE199333_post	ENSG00000166848	54386	TERF2 interacting protein	RAP1	protein_coding	Q9NYB0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32449
3.05850547031391e-47	0.405789289053091	0.691	0.574	6.49351296402346e-43	C12orf75	NK cells	GSE199333_post	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32450
4.00954454076123e-47	-0.344931806011564	0.585	0.74	8.51266401449016e-43	SF3B5	NK cells	GSE199333_post	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32451
5.20721338270259e-47	0.381093038025607	0.544	0.386	1.10554347328159e-42	TRAPPC1	NK cells	GSE199333_post	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32452
5.51065260688368e-47	-0.269104859663439	0.158	0.325	1.16996665496747e-42	CWF19L2	NK cells	GSE199333_post	ENSG00000152404	143884	CWF19 like cell cycle control factor 2	FLJ32343	protein_coding	Q2TBE0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32453
6.6142743474543e-47	0.385767377736595	0.68	0.54	1.40427658670802e-42	CAST	NK cells	GSE199333_post	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32454
1.0679403826277e-46	-0.309733243648613	0.223	0.404	2.26734422635688e-42	RASA2	NK cells	GSE199333_post	ENSG00000155903	5922	RAS p21 protein activator 2	GAP1M	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32455
1.2736951219873e-46	-0.267180948239332	0.144	0.305	2.70418211349123e-42	CNOT8	NK cells	GSE199333_post	ENSG00000155508	9337	CCR4-NOT transcription complex subunit 8	CAF1|CALIF|hCAF1|POP2	protein_coding	Q9UFF9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32456
1.42829874312058e-46	-0.281101106370239	0.162	0.329	3.03242106151931e-42	ASB8	NK cells	GSE199333_post	ENSG00000177981	140461	ankyrin repeat and SOCS box containing 8	FLJ21255|MGC5540	protein_coding	Q9H765	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32457
1.63982638296124e-46	0.320426492314267	0.816	0.708	3.48151539366501e-42	EDF1	NK cells	GSE199333_post	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32458
1.9447813467955e-46	0.341561882506812	0.356	0.194	4.12896527738152e-42	GLG1	NK cells	GSE199333_post	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32459
2.07970547402047e-46	0.386472000006158	0.519	0.367	4.41542269189285e-42	NDUFA3	NK cells	GSE199333_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32460
2.18258648630471e-46	-0.263254989986734	0.995	0.996	4.63384936907354e-42	EEF1B2	NK cells	GSE199333_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32461
2.19810655982277e-46	-0.294656775723818	0.179	0.348	4.66680003715972e-42	SMNDC1	NK cells	GSE199333_post	ENSG00000119953	10285	survival motor neuron domain containing 1	SMNR|SPF30|TDRD16C	protein_coding	O75940	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32462
2.24110241862893e-46	-0.331646585813832	0.316	0.513	4.75808454499108e-42	MIER1	NK cells	GSE199333_post	ENSG00000198160	57708	MIER1 transcriptional regulator	hMI-ER1|KIAA1610|MI-ER1	protein_coding	Q8N108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32463
2.50892536061242e-46	0.374640299327565	0.802	0.713	5.32669943311623e-42	LCP1	NK cells	GSE199333_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32464
3.13517275962807e-46	-0.261024645083221	0.12	0.274	6.65628528596636e-42	TCERG1	NK cells	GSE199333_post	ENSG00000113649	10915	transcription elongation regulator 1	CA150|TAF2S|Urn1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32465
3.40180021411986e-46	-0.385852191783236	0.227	0.398	7.22236203459788e-42	HSPD1	NK cells	GSE199333_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32466
4.11420690830981e-46	-0.37357582714879	0.421	0.6	8.73487268703257e-42	FKBP11	NK cells	GSE199333_post	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32467
6.17009020327294e-46	-0.254701067342223	0.137	0.297	1.30997185105688e-41	UBQLN1	NK cells	GSE199333_post	ENSG00000135018	29979	ubiquilin 1	DA41|DSK2|PLIC-1|XDRP1	protein_coding	Q9UMX0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32468
1.01072732091402e-45	-0.326360368722506	0.29	0.48	2.14587517503256e-41	LSM14A	NK cells	GSE199333_post	ENSG00000262860	26065	LSM14A mRNA processing body assembly factor	C19orf13|DKFZP434D1335|FAM61A|RAP55|RAP55A	protein_coding	Q8ND56	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32469
1.18353419785587e-45	-0.258903869102304	0.16	0.324	2.5127614554678e-41	CHD6	NK cells	GSE199333_post	ENSG00000124177	84181	chromodomain helicase DNA binding protein 6	CHD5|dJ620E11.1|FLJ22369|KIAA1335|RIGB	protein_coding	Q8TD26	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32470
1.51964622674503e-45	-0.350232670027538	0.391	0.578	3.22636090400237e-41	HNRNPA0	NK cells	GSE199333_post	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32471
1.99027088653875e-45	0.306959785186106	0.292	0.141	4.22554411921042e-41	ATP1A1	NK cells	GSE199333_post	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32472
2.20131937337385e-45	0.378056381748192	0.483	0.317	4.67362116161002e-41	ITGB7	NK cells	GSE199333_post	ENSG00000139626	3695	integrin subunit beta 7	NA	protein_coding	P26010	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32473
2.33491774392634e-45	0.379689009079219	0.385	0.233	4.95726386213001e-41	NAA38	NK cells	GSE199333_post	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32474
2.38064442680875e-45	-0.284809360029844	0.163	0.329	5.05434618255766e-41	BEX4	NK cells	GSE199333_post	ENSG00000102409	56271	brain expressed X-linked 4	BEXL1|FLJ10097	protein_coding	Q9NWD9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32475
3.056855120575e-45	-0.258594536371936	0.161	0.324	6.49000910649278e-41	MOB4	NK cells	GSE199333_post	ENSG00000115540	25843	MOB family member 4, phocein	2C4D|CGI-95|DKFZP564M112|MOB3|MOBKL3|PHOCN|PREI3	protein_coding	Q9Y3A3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32476
4.14238106612081e-45	0.281391182067063	0.992	0.987	8.79468924148109e-41	PFN1	NK cells	GSE199333_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32477
4.32334219023161e-45	0.309992809590127	0.912	0.828	9.17888780408073e-41	PSME1	NK cells	GSE199333_post	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32478
4.52273957972765e-45	-0.354416195478818	0.185	0.353	9.60222840171978e-41	SRRT	NK cells	GSE199333_post	ENSG00000087087	51593	serrate, RNA effector molecule	ARS2|Asr2|serrate	protein_coding	Q9BXP5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32479
5.18749421198976e-45	-0.28852135779116	0.229	0.409	1.10135689614755e-40	BLOC1S2	NK cells	GSE199333_post	ENSG00000196072	282991	biogenesis of lysosomal organelles complex 1 subunit 2	BLOS2|BORCS2|FLJ30135|MGC10120	protein_coding	Q6QNY1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32480
6.86590565363266e-45	-0.322514487235943	0.378	0.574	1.45770042932275e-40	SNRPC	NK cells	GSE199333_post	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32481
7.71679044051835e-45	0.351205603303287	0.35	0.196	1.63835177842645e-40	UBE2L6	NK cells	GSE199333_post	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32482
8.03961681196556e-45	-0.296698008630016	0.134	0.284	1.70689104534841e-40	THOC1	NK cells	GSE199333_post	ENSG00000079134	9984	THO complex subunit 1	HPR1|P84	protein_coding	Q96FV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32483
8.35980515478535e-45	-0.339161079010811	0.71	0.834	1.77487023241248e-40	TAPBP	NK cells	GSE199333_post	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32484
8.80025300915194e-45	0.302315889302954	0.287	0.139	1.86838171637305e-40	MVP	NK cells	GSE199333_post	ENSG00000013364	9961	major vault protein	LRP|VAULT1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32485
8.89586931177485e-45	-0.360859471252571	0.308	0.491	1.88868201358292e-40	ANKRD13D	NK cells	GSE199333_post	ENSG00000172932	338692	ankyrin repeat domain 13D	NA	protein_coding	Q6ZTN6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32486
1.53047130237572e-44	-0.300742806518649	0.991	0.993	3.2493436220739e-40	UBB	NK cells	GSE199333_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32487
2.21023687333026e-44	0.263994082263061	0.263	0.117	4.69255390576748e-40	FGR	NK cells	GSE199333_post	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32488
2.36874208524842e-44	-0.263766889835962	0.17	0.334	5.02907632119092e-40	ZNF622	NK cells	GSE199333_post	ENSG00000173545	90441	zinc finger protein 622	MGC17552|MGC2485|ZPR9	protein_coding	Q969S3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32489
2.69752917135894e-44	-0.253922790786195	0.128	0.28	5.72712418371216e-40	TNPO1	NK cells	GSE199333_post	ENSG00000083312	3842	transportin 1	IPO2|KPNB2|MIP|MIP1|TRN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32490
2.87064171547096e-44	-0.313217160487992	0.295	0.484	6.0946594261164e-40	CAMLG	NK cells	GSE199333_post	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32491
3.00305718613687e-44	-0.335075745512606	0.349	0.538	6.37579071188719e-40	EWSR1	NK cells	GSE199333_post	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32492
3.02742741113339e-44	-0.319043908351611	0.315	0.502	6.42753113657731e-40	NCBP2-AS2	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32493
3.63557159183074e-44	0.318448802721558	0.289	0.143	7.71868204661585e-40	LAMTOR2	NK cells	GSE199333_post	ENSG00000116586	28956	late endosomal/lysosomal adaptor, MAPK and MTOR activator 2	ENDAP|MAPBPIP|MAPKSP1AP|p14|Ragulator2|ROBLD3	protein_coding	Q9Y2Q5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32494
3.70932419663092e-44	-0.305015155310481	0.731	0.84	7.8752662018671e-40	ATP6V1G1	NK cells	GSE199333_post	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32495
3.81774561843159e-44	0.333699519368759	0.595	0.433	8.10545572249211e-40	TXN	NK cells	GSE199333_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32496
4.44570138274279e-44	0.36622724960595	0.459	0.303	9.43866860570121e-40	PTPN4	NK cells	GSE199333_post	ENSG00000088179	5775	protein tyrosine phosphatase non-receptor type 4	PTPMEG	protein_coding	P29074	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32497
6.2178029943108e-44	-0.274710010221334	0.172	0.334	1.32010175372213e-39	PTPRJ	NK cells	GSE199333_post	ENSG00000149177	5795	protein tyrosine phosphatase receptor type J	CD148|DEP1|HPTPeta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32498
6.35613179102756e-44	-0.328417646591903	0.386	0.578	1.34947034055306e-39	VDAC2	NK cells	GSE199333_post	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32499
6.89118049563614e-44	0.338535120827057	0.33	0.176	1.46306653102851e-39	CPNE1	NK cells	GSE199333_post	ENSG00000214078	8904	copine 1	CPN1	protein_coding	Q99829	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32500
7.22750293019548e-44	-0.33646493846764	0.758	0.855	1.5344711471098e-39	PPDPF	NK cells	GSE199333_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32501
7.6237934778348e-44	-0.271281083688127	0.212	0.39	1.61860759327911e-39	FUBP1	NK cells	GSE199333_post	ENSG00000162613	8880	far upstream element binding protein 1	FBP|FUBP	protein_coding	Q96AE4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32502
8.27238235237475e-44	0.390100744299761	0.507	0.358	1.75630949723268e-39	PRKCB	NK cells	GSE199333_post	ENSG00000166501	5579	protein kinase C beta	PKCB|PKCbeta|PRKCB1|PRKCB2	protein_coding	P05771	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32503
9.20975078947845e-44	0.39392857315814	0.427	0.278	1.95532219011417e-39	PKM	NK cells	GSE199333_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32504
1.06671373733683e-43	-0.261787282618501	0.119	0.264	2.26473993573983e-39	LMBR1L	NK cells	GSE199333_post	ENSG00000139636	55716	limb development membrane protein 1 like	FLJ10494|KIAA1174	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32505
1.09144561703003e-43	0.357427950869486	0.588	0.443	2.31724818951645e-39	ATP5MF	NK cells	GSE199333_post	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32506
1.4887118182536e-43	-0.285533330092102	0.177	0.343	3.16068406133421e-39	TOPORS	NK cells	GSE199333_post	ENSG00000197579	10210	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	LUN|RP31|TP53BPL	protein_coding	Q9NS56	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32507
2.01924878388798e-43	-0.330512737012945	0.287	0.467	4.28706709307257e-39	NOL7	NK cells	GSE199333_post	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32508
2.26594887352353e-43	0.369172175479758	0.499	0.347	4.8108360533778e-39	SPCS2	NK cells	GSE199333_post	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32509
2.38485463263982e-43	-0.329468409151416	0.266	0.444	5.0632848705576e-39	ABCF1	NK cells	GSE199333_post	ENSG00000225989	23	ATP binding cassette subfamily F member 1	ABC50|EST123147	protein_coding	Q8NE71	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32510
3.26422717501306e-43	-0.259965749911873	0.161	0.321	6.93028071527023e-39	CTR9	NK cells	GSE199333_post	ENSG00000198730	9646	CTR9 homolog, Paf1/RNA polymerase II complex component	KIAA0155|p150TSP|SH2BP1|TSBP	protein_coding	Q6PD62	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32511
3.9445943254316e-43	-0.267309033598664	0.147	0.3	8.37476821232383e-39	ATP8A1	NK cells	GSE199333_post	ENSG00000124406	10396	ATPase phospholipid transporting 8A1	ATPIA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32512
4.05124507590885e-43	-0.352513533638512	0.721	0.829	8.60119842066208e-39	JAK1	NK cells	GSE199333_post	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32513
4.35277619128732e-43	-0.391131290620565	0.486	0.65	9.24137913172211e-39	GNG2	NK cells	GSE199333_post	ENSG00000186469	54331	G protein subunit gamma 2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32514
5.20715286273585e-43	-0.308203307561766	0.166	0.323	1.10553062428745e-38	LRRC58	NK cells	GSE199333_post	ENSG00000163428	116064	leucine rich repeat containing 58	NA	protein_coding	Q96CX6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32515
6.21927894247662e-43	0.330599282258249	0.993	0.969	1.32041511227721e-38	ACTG1	NK cells	GSE199333_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32516
6.82809284852523e-43	0.374852333298244	0.504	0.359	1.44967239267039e-38	SCP2	NK cells	GSE199333_post	ENSG00000116171	6342	sterol carrier protein 2	NA	protein_coding	P22307	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32517
7.67236610014259e-43	-0.298859174908483	0.208	0.375	1.62892004672127e-38	EIF2A	NK cells	GSE199333_post	ENSG00000144895	83939	eukaryotic translation initiation factor 2A	EIF-2A	protein_coding	Q9BY44	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32518
8.57267759281263e-43	0.370210182356715	0.424	0.272	1.82006517973005e-38	ARHGAP30	NK cells	GSE199333_post	ENSG00000186517	257106	Rho GTPase activating protein 30	FLJ00267	protein_coding	Q7Z6I6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32519
8.9897677815092e-43	-0.272170671431401	0.18	0.344	1.90861759769222e-38	BROX	NK cells	GSE199333_post	ENSG00000162819	148362	BRO1 domain and CAAX motif containing	C1orf58|FLJ32421	protein_coding	Q5VW32	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32520
1.43854056286201e-42	-0.328757592489685	0.256	0.435	3.05416546901234e-38	JMJD1C	NK cells	GSE199333_post	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32521
1.56481422576057e-42	-0.302441243949979	0.206	0.375	3.32225708271228e-38	ACIN1	NK cells	GSE199333_post	ENSG00000100813	22985	apoptotic chromatin condensation inducer 1	ACINUS|fSAP152|KIAA0670	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32522
1.74080727772755e-42	-0.297085182762463	0.862	0.914	3.69590793134336e-38	TPM3	NK cells	GSE199333_post	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32523
2.70911873194437e-42	0.370045862310853	0.45	0.307	5.75172997979109e-38	LMAN2	NK cells	GSE199333_post	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32524
2.78221815491835e-42	-0.252920443125881	0.173	0.337	5.90692736470715e-38	PPP6C	NK cells	GSE199333_post	ENSG00000119414	5537	protein phosphatase 6 catalytic subunit	PP6	protein_coding	O00743	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32525
3.74213157846759e-42	-0.290581117149957	0.19	0.353	7.94491955424455e-38	CHD8	NK cells	GSE199333_post	ENSG00000100888	57680	chromodomain helicase DNA binding protein 8	DUPLIN|HELSNF1|KIAA1564	protein_coding	Q9HCK8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32526
4.25792288415418e-42	-0.26796435044422	0.132	0.28	9.03999607534775e-38	MAFF	NK cells	GSE199333_post	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32527
4.96789484943112e-42	-0.319053195300727	0.316	0.499	1.05473375548272e-37	PRDM2	NK cells	GSE199333_post	ENSG00000116731	7799	PR/SET domain 2	HUMHOXY1|KMT8|KMT8A|MTB-ZF|RIZ|RIZ1|RIZ2	protein_coding	Q13029	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32528
6.58479953024975e-42	-0.374260833128948	0.528	0.687	1.39801878826732e-37	CDKN2D	NK cells	GSE199333_post	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32529
6.61154401588042e-42	-0.306475009446757	0.251	0.425	1.40369691001157e-37	SREK1IP1	NK cells	GSE199333_post	ENSG00000153006	285672	SREK1 interacting protein 1	FLJ36754|P18SRP|SFRS12IP1	protein_coding	Q8N9Q2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32530
7.28467767093168e-42	0.356024750073076	0.335	0.187	1.5466099163155e-37	SLFN5	NK cells	GSE199333_post	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32531
7.63774113777218e-42	-0.315729171325737	0.341	0.53	1.62156882096041e-37	SLTM	NK cells	GSE199333_post	ENSG00000137776	79811	SAFB like transcription modulator	FLJ13213|Met	protein_coding	Q9NWH9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32532
7.68106174828114e-42	-0.272064149930447	0.238	0.416	1.63076621977757e-37	PMF1	NK cells	GSE199333_post	ENSG00000160783	11243	polyamine modulated factor 1	NA	protein_coding	Q6P1K2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32533
7.79616657594676e-42	0.349155979352802	0.433	0.283	1.65520412573926e-37	BCAP31	NK cells	GSE199333_post	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32534
1.03164024641183e-41	0.358456541561973	0.595	0.469	2.19027540715696e-37	BRK1	NK cells	GSE199333_post	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32535
1.18040923234235e-41	0.488748486053652	0.584	0.459	2.50612684118604e-37	TRBC2	NK cells	GSE199333_post	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32536
2.16747853870203e-41	-0.286199350629628	0.167	0.321	4.60177368551827e-37	INO80D	NK cells	GSE199333_post	ENSG00000283510	54891	INO80 complex subunit D	FLJ20309	protein_coding	Q53TQ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32537
2.68363624926157e-41	-0.300046462235806	0.333	0.522	5.69762812080725e-37	SIVA1	NK cells	GSE199333_post	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32538
2.70582231305538e-41	0.356418935169955	0.524	0.378	5.74473135284789e-37	SH3BGRL	NK cells	GSE199333_post	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32539
5.36055621019814e-41	-0.366741228633036	0.382	0.565	1.13809968898717e-36	GADD45B	NK cells	GSE199333_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32540
6.53617180871301e-41	-0.309361744244094	0.333	0.52	1.38769463670786e-36	MIF	NK cells	GSE199333_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32541
7.73483313173654e-41	0.333044715900993	0.368	0.217	1.64218242219899e-36	FERMT3	NK cells	GSE199333_post	ENSG00000149781	83706	FERM domain containing kindlin 3	KIND3|MGC10966|MIG2B|UNC112C|URP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32542
8.32892761286667e-41	-0.263175177797017	0.153	0.305	1.76831462148772e-36	FAM53B	NK cells	GSE199333_post	ENSG00000189319	9679	family with sequence similarity 53 member B	bA12J10.2|KIAA0140|smp	protein_coding	Q14153	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32543
8.99548526278096e-41	-0.298692174361584	0.229	0.397	1.90983147614103e-36	NOP58	NK cells	GSE199333_post	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32544
9.90349095403293e-41	-0.348587109840907	0.365	0.535	2.10261016445073e-36	RTN4	NK cells	GSE199333_post	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32545
1.01297507087171e-40	-0.294469504487505	0.331	0.518	2.15064737296772e-36	PPP1R2	NK cells	GSE199333_post	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32546
1.62055842769027e-40	0.366556345850764	0.544	0.407	3.44060759782921e-36	CAPNS1	NK cells	GSE199333_post	ENSG00000126247	826	calpain small subunit 1	30K|CANP|CANPS|CAPN4|CDPS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32547
1.82269757306038e-40	-0.449161002248932	0.465	0.62	3.8697692173645e-36	ATG2A	NK cells	GSE199333_post	ENSG00000110046	23130	autophagy related 2A	BLTP4A|KIAA0404	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32548
2.23496357754862e-40	-0.355113082725683	0.547	0.699	4.74505117149348e-36	SELENOK	NK cells	GSE199333_post	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32549
2.45068632456325e-40	0.348904230404822	0.344	0.201	5.20305213568024e-36	M6PR	NK cells	GSE199333_post	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32550
3.33193165147045e-40	0.335299078102597	0.818	0.736	7.07402408923692e-36	FLNA	NK cells	GSE199333_post	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32551
3.86321453485898e-40	-0.266721459330771	0.203	0.366	8.2019907789591e-36	COPS2	NK cells	GSE199333_post	ENSG00000166200	9318	COP9 signalosome subunit 2	ALIEN|CSN2|TRIP15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32552
4.53865231869987e-40	-0.852921211707675	0.757	0.767	9.6360127378317e-36	H1FX	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32553
4.60137846541085e-40	-0.328775097215688	0.374	0.55	9.76918661991379e-36	EAPP	NK cells	GSE199333_post	ENSG00000129518	55837	E2F associated phosphoprotein	BM036|C14orf11|FLJ20578	protein_coding	Q56P03	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32554
4.65944578956985e-40	-0.271504908653202	0.206	0.369	9.89246935583575e-36	AKIRIN1	NK cells	GSE199333_post	ENSG00000174574	79647	akirin 1	C1orf108|FLJ12666	protein_coding	Q9H9L7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32555
5.21317241400541e-40	-0.334800953616861	0.456	0.63	1.10680863521749e-35	LEPROTL1	NK cells	GSE199333_post	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32556
6.66152400499291e-40	-0.271510121483308	0.222	0.39	1.41430816150005e-35	RIN3	NK cells	GSE199333_post	ENSG00000100599	79890	Ras and Rab interactor 3	FLJ22439	protein_coding	Q8TB24	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32557
1.00752755871768e-39	0.331014676807117	0.778	0.692	2.13908175991351e-35	LSP1	NK cells	GSE199333_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32558
1.18610289066422e-39	0.289176359362509	0.28	0.143	2.51821504716921e-35	DECR1	NK cells	GSE199333_post	ENSG00000104325	1666	2,4-dienoyl-CoA reductase 1	DECR|SDR18C1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32559
1.4039809605769e-39	-0.270211631552601	0.172	0.326	2.98079197740081e-35	LYST	NK cells	GSE199333_post	ENSG00000143669	1130	lysosomal trafficking regulator	CHS|CHS1|Mauve	protein_coding	Q99698	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32560
1.43288010724405e-39	-0.292673737682863	0.219	0.381	3.04214775568984e-35	SAFB2	NK cells	GSE199333_post	ENSG00000130254	9667	scaffold attachment factor B2	KIAA0138	protein_coding	Q14151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32561
1.95246149170404e-39	-0.298527701811472	0.284	0.459	4.14527099303684e-35	ELOC	NK cells	GSE199333_post	ENSG00000154582	6921	elongin C	SIII|TCEB1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32562
2.21821322361169e-39	0.469808008128154	0.902	0.898	4.70948849504999e-35	GZMB	NK cells	GSE199333_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32563
3.20193134625938e-39	-0.287221428451258	0.392	0.579	6.79802044124328e-35	USP15	NK cells	GSE199333_post	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32564
3.25804697208354e-39	-0.259664806438804	0.187	0.351	6.91715952643056e-35	YWHAE	NK cells	GSE199333_post	ENSG00000274474	7531	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon	FLJ45465	protein_coding	P62258	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32565
3.60469997754543e-39	-0.320158916285655	0.461	0.632	7.6531385223267e-35	UQCRFS1	NK cells	GSE199333_post	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32566
3.91268813780918e-39	-0.300831127863968	0.123	0.257	8.30702818538267e-35	NINJ1	NK cells	GSE199333_post	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32567
4.54979646990574e-39	-0.291154151053616	0.271	0.444	9.65967288525687e-35	RBM5	NK cells	GSE199333_post	ENSG00000003756	10181	RNA binding motif protein 5	H37|LUCA-15|LUCA15	protein_coding	P52756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32568
6.20768483670856e-39	0.365993771260354	0.549	0.416	1.31795356768159e-34	HCLS1	NK cells	GSE199333_post	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32569
8.28076827807632e-39	-0.270481184025383	0.146	0.29	1.75808991311838e-34	EIF4A3	NK cells	GSE199333_post	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32570
9.16236946289233e-39	-0.256059131901788	0.996	0.994	1.94526266066667e-34	HLA-E	NK cells	GSE199333_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32571
1.04190106562961e-38	-0.27047265587126	0.234	0.4	2.21206015243822e-34	MKRN1	NK cells	GSE199333_post	ENSG00000133606	23608	makorin ring finger protein 1	RNF61	protein_coding	Q9UHC7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32572
1.07279233179004e-38	-0.301223876066384	0.306	0.482	2.27764539962343e-34	EIF1B	NK cells	GSE199333_post	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32573
1.23486878148991e-38	-0.284980228743031	0.26	0.434	2.62174990998122e-34	NEMF	NK cells	GSE199333_post	ENSG00000165525	9147	nuclear export mediator factor	FLJ10051|NY-CO-1|RQC2|SDCCAG1	protein_coding	O60524	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32574
1.30969948173568e-38	-0.26052806858811	0.135	0.279	2.78062296967303e-34	CEBPD	NK cells	GSE199333_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32575
2.41645111383235e-38	-0.256745467414464	0.182	0.336	5.13036735977746e-34	BAG5	NK cells	GSE199333_post	ENSG00000166170	9529	BAG cochaperone 5	NA	protein_coding	Q9UL15	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32576
2.51425392537024e-38	-0.292006222813349	0.238	0.404	5.33801250895355e-34	CCND2	NK cells	GSE199333_post	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32577
2.56976605133304e-38	-0.308492936885172	0.258	0.426	5.45587030358517e-34	POLR2A	NK cells	GSE199333_post	ENSG00000284832	5430	RNA polymerase II subunit A	POLR2|POLRA|RPB1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32578
3.28247804591505e-38	-0.30219809648966	0.319	0.496	6.96902913928224e-34	CSNK1D	NK cells	GSE199333_post	ENSG00000141551	1453	casein kinase 1 delta	CKID|CKIdelta|HCKID	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32579
3.33086084014019e-38	-0.307944147916897	0.371	0.548	7.07175064970163e-34	RAD21	NK cells	GSE199333_post	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32580
4.72430908312298e-38	0.320157653971349	0.647	0.512	1.00301806143784e-33	CNBP	NK cells	GSE199333_post	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32581
5.34492630739604e-38	0.323120843398366	0.557	0.424	1.13478130432325e-33	NDUFA11	NK cells	GSE199333_post	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32582
6.13791831275366e-38	0.31289069589981	0.742	0.606	1.30314143698073e-33	EIF3E	NK cells	GSE199333_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32583
6.3444895572189e-38	-0.257552565759353	0.187	0.345	1.34699857789314e-33	HSH2D	NK cells	GSE199333_post	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32584
9.32985661249317e-38	0.296939482261766	0.301	0.164	1.98082185739843e-33	RER1	NK cells	GSE199333_post	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32585
1.52668038697361e-37	-0.289802078679611	0.347	0.526	3.24129512958366e-33	TMED2	NK cells	GSE199333_post	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32586
1.53660449425462e-37	-0.251727640213048	0.125	0.259	3.26236500175199e-33	ZCCHC2	NK cells	GSE199333_post	ENSG00000141664	54877	zinc finger CCHC-type containing 2	C18orf49|FLJ20222|FLJ20281|KIAA1744	protein_coding	Q9C0B9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32587
2.73584728345497e-37	-0.31341204027228	0.312	0.482	5.80847736750326e-33	PHF3	NK cells	GSE199333_post	ENSG00000118482	23469	PHD finger protein 3	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32588
7.87528574678565e-37	0.301258315753996	0.267	0.135	1.67200191690006e-32	TRIM56	NK cells	GSE199333_post	ENSG00000169871	81844	tripartite motif containing 56	RNF109	protein_coding	Q9BRZ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32589
8.54600639419323e-37	-0.278145223365958	0.276	0.44	1.81440261755116e-32	BCAS2	NK cells	GSE199333_post	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32590
9.22372864669928e-37	0.361179995444328	0.304	0.166	1.95828982898072e-32	PTMS	NK cells	GSE199333_post	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32591
1.00396062760188e-36	-0.297218484173236	0.293	0.466	2.13150880846155e-32	TFDP2	NK cells	GSE199333_post	ENSG00000114126	7029	transcription factor Dp-2	Dp-2	protein_coding	Q14188	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32592
1.13279087388658e-36	0.312617567909688	0.285	0.153	2.40502830434859e-32	RNASEH2C	NK cells	GSE199333_post	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32593
1.36014017576276e-36	-0.29742652094986	0.345	0.521	2.88771360716191e-32	TRAM1	NK cells	GSE199333_post	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32594
1.72853042856882e-36	-0.273392595247259	0.164	0.305	3.66984295289447e-32	AC016831.5	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32595
1.8457947252098e-36	0.315172758127499	0.341	0.202	3.91880678109294e-32	DDX18	NK cells	GSE199333_post	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32596
2.09939316251823e-36	0.33843468123771	0.412	0.272	4.45722162334245e-32	SYTL1	NK cells	GSE199333_post	ENSG00000142765	84958	synaptotagmin like 1	exophilin-7|FLJ14996|JFC1|SLP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32597
2.4142521490556e-36	-0.315615069008897	0.249	0.407	5.12569873765995e-32	HIPK1	NK cells	GSE199333_post	ENSG00000163349	204851	homeodomain interacting protein kinase 1	KIAA0630|MGC26642|MGC33446|MGC33548|Myak|Nbak2	protein_coding	Q86Z02	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32598
2.73049962091061e-36	0.286970665919346	0.287	0.154	5.79712374515532e-32	RAB27A	NK cells	GSE199333_post	ENSG00000069974	5873	RAB27A, member RAS oncogene family	GS2|HsT18676|RAB27|RAM	protein_coding	P51159	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32599
3.33865732326567e-36	-0.284190104142189	0.232	0.386	7.08830336302535e-32	FAM32A	NK cells	GSE199333_post	ENSG00000105058	26017	family with sequence similarity 32 member A	DKFZP586O0120|OTAG-12	protein_coding	Q9Y421	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32600
3.75546460479997e-36	0.355528881473013	0.453	0.314	7.97322690245082e-32	SEPT6	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32601
4.48605943414036e-36	-0.287624126973483	0.301	0.464	9.52435278462341e-32	ZFAND6	NK cells	GSE199333_post	ENSG00000086666	54469	zinc finger AN1-type containing 6	AWP1|ZA20D3|ZFAND5B	protein_coding	Q6FIF0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32602
4.53323898059068e-36	-0.288924603329497	0.468	0.646	9.62451967969207e-32	PAPOLA	NK cells	GSE199333_post	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32603
4.60703022485422e-36	-0.309105683677718	0.218	0.371	9.781185870388e-32	UBE2S	NK cells	GSE199333_post	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32604
5.91869975068194e-36	-0.254032142658576	0.263	0.434	1.25659914406728e-31	BRI3	NK cells	GSE199333_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32605
5.93914487671398e-36	0.367145190082482	0.449	0.309	1.26093984877515e-31	ATRX	NK cells	GSE199333_post	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32606
6.58514052778992e-36	-0.313225605395368	0.482	0.658	1.39809118545508e-31	IDS	NK cells	GSE199333_post	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32607
7.95591259072264e-36	0.323176967354788	0.598	0.472	1.68911980213632e-31	PRELID1	NK cells	GSE199333_post	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32608
8.98411097882442e-36	0.293009588742675	0.293	0.162	1.90741660191421e-31	DBNL	NK cells	GSE199333_post	ENSG00000136279	28988	drebrin like	ABP1|HIP-55|SH3P7	protein_coding	Q9UJU6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32609
9.75455346241484e-36	-0.27413528084074	0.804	0.871	2.07098924560529e-31	NOP53	NK cells	GSE199333_post	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32610
1.16374734545569e-35	-0.261484098652144	0.242	0.406	2.47075198913697e-31	CCT2	NK cells	GSE199333_post	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32611
1.20830491935616e-35	-0.282304515118142	0.229	0.388	2.56535217428507e-31	TOP1	NK cells	GSE199333_post	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32612
1.30428199195957e-35	-0.322230670092481	0.316	0.474	2.76912109712936e-31	SPTAN1	NK cells	GSE199333_post	ENSG00000197694	6709	spectrin alpha, non-erythrocytic 1	NA	protein_coding	Q13813	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32613
1.65292515978964e-35	-0.295012560972547	0.21	0.36	3.50932540674939e-31	SLC38A2	NK cells	GSE199333_post	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32614
1.69273952660452e-35	-0.323262758854514	0.46	0.623	3.59385528893406e-31	PSMA3-AS1	NK cells	GSE199333_post	ENSG00000257621	379025	PSMA3 antisense RNA 1	FLJ31306	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32615
1.8222687317712e-35	-0.254927633835908	0.993	0.995	3.86885874442344e-31	RPLP0	NK cells	GSE199333_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32616
1.84040282648343e-35	0.322014919480432	0.579	0.451	3.90735924090697e-31	PSMB3	NK cells	GSE199333_post	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32617
2.58332905686715e-35	-0.265928174765442	0.21	0.363	5.48466592063465e-31	PRKX	NK cells	GSE199333_post	ENSG00000183943	5613	protein kinase cAMP-dependent X-linked catalytic subunit	PKX1	protein_coding	P51817	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32618
3.53540043662786e-35	-0.292942236363431	0.316	0.483	7.50600866700461e-31	TACC1	NK cells	GSE199333_post	ENSG00000147526	6867	transforming acidic coiled-coil containing protein 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32619
4.72960226396378e-35	-0.338433370869793	0.424	0.583	1.00414185666215e-30	DYNC1H1	NK cells	GSE199333_post	ENSG00000197102	1778	dynein cytoplasmic 1 heavy chain 1	CMT2O|DHC1|DNCH1|Dnchc1|DNCL|DNECL|HL-3|p22	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32620
5.93739109211017e-35	0.292141080801281	0.275	0.148	1.26056750276591e-30	PARP1	NK cells	GSE199333_post	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32621
7.5630184399513e-35	-0.275571855646842	0.748	0.842	1.60570444498606e-30	SAP18	NK cells	GSE199333_post	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32622
8.69047228095427e-35	0.263179816521404	0.251	0.127	1.8450741699694e-30	SDHC	NK cells	GSE199333_post	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32623
8.86719402943812e-35	0.301671619034312	0.318	0.186	1.88259396439001e-30	DGUOK	NK cells	GSE199333_post	ENSG00000114956	1716	deoxyguanosine kinase	dGK	protein_coding	Q16854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32624
9.26590977629943e-35	0.30475545843689	0.341	0.208	1.96724530460613e-30	PSMD4	NK cells	GSE199333_post	ENSG00000159352	5710	proteasome 26S subunit ubiquitin receptor, non-ATPase 4	AF|AF-1|Rpn10|S5A	protein_coding	P55036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32625
9.73061724632237e-35	-0.252474670992607	0.26	0.419	2.0659073475667e-30	NDUFA9	NK cells	GSE199333_post	ENSG00000139180	4704	NADH:ubiquinone oxidoreductase subunit A9	CI-39k|COQ11|NDUFS2L|SDR22E1	protein_coding	Q16795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32626
1.568446495335e-34	0.305691224757912	0.374	0.236	3.32996875424574e-30	POLR3GL	NK cells	GSE199333_post	ENSG00000121851	84265	RNA polymerase III subunit GL	flj32422|MGC3200	protein_coding	Q9BT43	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32627
1.68269241896753e-34	-0.271851759102041	0.311	0.483	3.57252427470997e-30	SRP72	NK cells	GSE199333_post	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32628
1.95150164479425e-34	0.271826330351293	0.263	0.137	4.14323314206268e-30	FAM173A	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32629
2.43126792594974e-34	-0.303976281784097	0.726	0.824	5.16182493358389e-30	SRSF3	NK cells	GSE199333_post	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32630
2.66875725804166e-34	0.339484701961055	0.588	0.485	5.66603853454825e-30	NDUFA12	NK cells	GSE199333_post	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32631
2.87466573239104e-34	0.335089135636804	0.335	0.208	6.10320281643942e-30	WNK1	NK cells	GSE199333_post	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32632
3.07489172298783e-34	-0.280528189660157	0.212	0.362	6.52830261707545e-30	MAP3K2	NK cells	GSE199333_post	ENSG00000169967	10746	mitogen-activated protein kinase kinase kinase 2	MEKK2|MEKK2B	protein_coding	Q9Y2U5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32633
3.17536482611004e-34	0.304841891264266	0.315	0.184	6.74161706231422e-30	RBL2	NK cells	GSE199333_post	ENSG00000103479	5934	RB transcriptional corepressor like 2	p130|Rb2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32634
3.38869885271157e-34	0.312844326968818	0.447	0.31	7.19454653419194e-30	ATP5F1C	NK cells	GSE199333_post	ENSG00000165629	509	ATP synthase F1 subunit gamma	ATP5C|ATP5C1|ATP5CL1	protein_coding	P36542	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32635
3.92364646423e-34	-0.262986204462156	0.26	0.422	8.33029380820671e-30	MTCH1	NK cells	GSE199333_post	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32636
4.37850942523951e-34	0.320571076093397	0.606	0.492	9.296013360726e-30	PRR13	NK cells	GSE199333_post	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32637
4.62036614964691e-34	-0.257034468155256	0.206	0.356	9.80949937231536e-30	ARID4A	NK cells	GSE199333_post	ENSG00000032219	5926	AT-rich interaction domain 4A	RBBP1|RBP-1|RBP1	protein_coding	P29374	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32638
5.09043076152377e-34	-0.272633722752374	0.498	0.668	1.08074935497911e-29	SUMO1	NK cells	GSE199333_post	ENSG00000116030	7341	small ubiquitin like modifier 1	GMP1|OFC10|PIC1|SMT3C|SMT3H3|SUMO-1|UBL1	protein_coding	P63165	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32639
6.43148154007724e-34	-0.252440258178087	0.247	0.404	1.3654678457738e-29	SFSWAP	NK cells	GSE199333_post	ENSG00000061936	6433	splicing factor SWAP	SFRS8|SWAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32640
6.94728326156906e-34	0.265959550679793	0.276	0.148	1.47497770926373e-29	CISD3	NK cells	GSE199333_post	ENSG00000274768	284106	CDGSH iron sulfur domain 3	Miner2|MiNT	protein_coding	P0C7P0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32641
8.69266835429064e-34	0.333841305638396	0.574	0.46	1.84554041829945e-29	ARPC4	NK cells	GSE199333_post	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32642
1.14728410802926e-33	0.28196732191973	0.303	0.172	2.43579888975692e-29	TMOD3	NK cells	GSE199333_post	ENSG00000138594	29766	tropomodulin 3	UTMOD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32643
1.17073326008871e-33	0.293159810272296	0.295	0.163	2.48558378449435e-29	TUBB	NK cells	GSE199333_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32644
1.36372478474618e-33	-0.286235445153891	0.433	0.6	2.89532409049462e-29	CYLD	NK cells	GSE199333_post	ENSG00000083799	1540	CYLD lysine 63 deubiquitinase	CYLD1|KIAA0849|USPL2	protein_coding	Q9NQC7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32645
1.54865403655131e-33	0.334157718356767	0.51	0.384	3.28794738500209e-29	FIS1	NK cells	GSE199333_post	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32646
1.71702104188137e-33	-0.253959838028531	0.25	0.407	3.64540737401833e-29	ZC3H18	NK cells	GSE199333_post	ENSG00000158545	124245	zinc finger CCCH-type containing 18	NHN1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32647
3.60287621338381e-33	0.325669978668212	0.361	0.234	7.64926648863516e-29	C19orf70	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32648
3.80814122915532e-33	-0.271966024286689	0.266	0.424	8.08506464361967e-29	PJA2	NK cells	GSE199333_post	ENSG00000198961	9867	praja ring finger ubiquitin ligase 2	KIAA0438|Neurodap1|PRAJA2|RNF131	protein_coding	O43164	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32649
4.40930492371192e-33	0.254338953016231	0.256	0.134	9.36139528353278e-29	TEX264	NK cells	GSE199333_post	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32650
5.59314482063669e-33	0.342090855810042	0.536	0.422	1.18748057686938e-28	ACTN4	NK cells	GSE199333_post	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32651
6.16874436067617e-33	0.306958846765409	0.38	0.25	1.30968611521516e-28	WAS	NK cells	GSE199333_post	ENSG00000015285	7454	WASP actin nucleation promoting factor	IMD2|THC|WASP|WASPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32652
6.46156360811549e-33	-0.25429072334936	0.235	0.391	1.371854569639e-28	SYNCRIP	NK cells	GSE199333_post	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32653
7.28959175293632e-33	0.312754161223715	0.846	0.783	1.54765322506591e-28	PPP2R5C	NK cells	GSE199333_post	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32654
7.76336184415226e-33	-0.25053754318463	0.293	0.457	1.64823935313197e-28	GPATCH8	NK cells	GSE199333_post	ENSG00000186566	23131	G-patch domain containing 8	GPATC8|KIAA0553	protein_coding	Q9UKJ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32655
8.70756120867171e-33	-0.305581112083501	0.543	0.679	1.84870232021309e-28	SNU13	NK cells	GSE199333_post	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32656
8.85002964447461e-33	0.324967244524508	0.612	0.518	1.8789497938184e-28	GPSM3	NK cells	GSE199333_post	ENSG00000233490	63940	G protein signaling modulator 3	AGS4|C6orf9|G18|G18.1a|G18.1b|G18.2|NG1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32657
9.08479649716293e-33	-0.308761805327471	0.494	0.648	1.92879314431266e-28	H2AFV	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32658
1.03650294720377e-32	0.276595439725769	0.309	0.179	2.20059940720832e-28	SH3BP5	NK cells	GSE199333_post	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32659
1.12767476365423e-32	-0.320264117744467	0.221	0.365	2.39416629071429e-28	H2AFJ	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32660
1.42697258163127e-32	0.278345547778112	0.29	0.165	3.02960548806134e-28	C4orf48	NK cells	GSE199333_post	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32661
1.84529322438331e-32	0.297554526582769	0.297	0.172	3.91774204468821e-28	NBDY	NK cells	GSE199333_post	ENSG00000204272	550643	negative regulator of P-body association	LINC01420|NoBody	protein_coding	A0A0U1RRE5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32662
2.83275589393179e-32	-0.276249959347116	0.316	0.471	6.01422403840658e-28	RASSF5	NK cells	GSE199333_post	ENSG00000266094	83593	Ras association domain family member 5	Maxp1|NORE1|RAPL	protein_coding	Q8WWW0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32663
3.15318929406771e-32	-0.250613514021665	0.241	0.394	6.69453619023516e-28	UBN1	NK cells	GSE199333_post	ENSG00000118900	29855	ubinuclein 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32664
3.16416643575282e-32	-0.257402949092634	0.278	0.437	6.71784175974682e-28	EMC3	NK cells	GSE199333_post	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32665
3.52715550607346e-32	-0.308314932341157	0.406	0.562	7.48850385494457e-28	RICTOR	NK cells	GSE199333_post	ENSG00000164327	253260	RPTOR independent companion of MTOR complex 2	AVO3|KIAA1999|MGC39830|PIA	protein_coding	Q6R327	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32666
5.034341625327e-32	0.270344343299958	0.291	0.165	1.06884107047317e-27	PRR5	NK cells	GSE199333_post	ENSG00000186654	55615	proline rich 5	FLJ20185k|PP610|Protor-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32667
5.24409443329318e-32	0.304292425485974	0.329	0.202	1.11337368913248e-27	DOCK8	NK cells	GSE199333_post	ENSG00000107099	81704	dedicator of cytokinesis 8	FLJ00026|FLJ00152|FLJ00346|ZIR8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32668
6.37809447001005e-32	-0.286437813067846	0.284	0.439	1.35413323692783e-27	BDP1	NK cells	GSE199333_post	ENSG00000274803	55814	B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB	HSA238520|KIAA1241|KIAA1689|TAF3B1|TFC5|TFIIIB150|TFIIIB90|TFNR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32669
6.9051348991766e-32	0.30440506889065	0.325	0.197	1.46602919044418e-27	CD320	NK cells	GSE199333_post	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32670
7.49802203785662e-32	-0.315341309165079	0.632	0.755	1.59190505885734e-27	FMNL1	NK cells	GSE199333_post	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32671
8.84841781964801e-32	0.311289299775226	0.478	0.354	1.87860758728947e-27	AP2M1	NK cells	GSE199333_post	ENSG00000161203	1173	adaptor related protein complex 2 subunit mu 1	AP50|CLAPM1|mu2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32672
1.01121558548375e-31	-0.286408778957828	0.347	0.51	2.14691180954055e-27	SSB	NK cells	GSE199333_post	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32673
1.06556953149363e-31	0.307354603175647	0.445	0.32	2.26231067231413e-27	PSMC5	NK cells	GSE199333_post	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32674
1.715699036173e-31	-0.283438372325295	0.521	0.669	3.6426006236989e-27	SF3B6	NK cells	GSE199333_post	ENSG00000115128	51639	splicing factor 3b subunit 6	CGI-110|Ht006|P14|SAP14a|SF3B14a	protein_coding	Q9Y3B4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32675
1.94214089166071e-31	0.430215872663825	0.439	0.32	4.12335932708485e-27	TECR	NK cells	GSE199333_post	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32676
2.34262282934101e-31	-0.277105722735951	0.309	0.459	4.97362252897391e-27	ATG12	NK cells	GSE199333_post	ENSG00000145782	9140	autophagy related 12	APG12|APG12L	protein_coding	O94817	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32677
2.37091098222474e-31	0.288904275938574	0.327	0.2	5.03368110636134e-27	GRK6	NK cells	GSE199333_post	ENSG00000198055	2870	G protein-coupled receptor kinase 6	GPRK6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32678
2.48888411072229e-31	0.322533261031038	0.423	0.304	5.28414985547448e-27	SSU72	NK cells	GSE199333_post	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32679
3.11022638186941e-31	-0.266366124263947	0.248	0.398	6.60332163134693e-27	LARP7	NK cells	GSE199333_post	ENSG00000174720	51574	La ribonucleoprotein 7, transcriptional regulator	DKFZP564K112|HDCMA18P|PIP7S	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32680
4.68616194017726e-31	0.28804283918048	0.765	0.707	9.94919041519033e-27	CD81	NK cells	GSE199333_post	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32681
5.6328292337902e-31	-0.272094464840366	0.661	0.772	1.195905974626e-26	SEC61B	NK cells	GSE199333_post	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32682
1.17931208996693e-30	-0.269334504821408	0.233	0.375	2.50379749820879e-26	AC058791.1	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32683
1.34966873440422e-30	0.292559281603075	0.396	0.271	2.86548169001361e-26	ORAI1	NK cells	GSE199333_post	ENSG00000276045	84876	ORAI calcium release-activated calcium modulator 1	CRACM1|FLJ14466|TMEM142A	protein_coding	Q96D31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32684
1.42486323093914e-30	0.325881608501377	0.712	0.634	3.02512712560688e-26	CD48	NK cells	GSE199333_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32685
3.18140126828429e-30	0.305965329409323	0.333	0.211	6.75443303269438e-26	IDH2	NK cells	GSE199333_post	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32686
3.22548468746577e-30	-0.314483083410476	0.402	0.557	6.84802653995858e-26	BOD1L1	NK cells	GSE199333_post	ENSG00000038219	259282	biorientation of chromosomes in cell division 1 like 1	BOD1L|FAM44A|FLJ33215|KIAA1327	protein_coding	Q8NFC6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32687
4.37160310979372e-30	-0.30797455715981	0.754	0.82	9.28135056240306e-26	RPL17	NK cells	GSE199333_post	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32688
4.42900596947821e-30	0.301990804770327	0.942	0.932	9.40322257379919e-26	CST7	NK cells	GSE199333_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32689
5.15928392017567e-30	0.255868082613834	0.291	0.17	1.0953675690925e-25	MRPL34	NK cells	GSE199333_post	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32690
5.62757132069152e-30	0.299310836204418	0.473	0.349	1.19478966709602e-25	RBX1	NK cells	GSE199333_post	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32691
6.12627501689673e-30	0.309500929931668	0.395	0.273	1.30066944883734e-25	CCT3	NK cells	GSE199333_post	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32692
6.25535076302576e-30	-0.266476789536999	0.424	0.58	1.328073520498e-25	SELENOT	NK cells	GSE199333_post	ENSG00000198843	51714	selenoprotein T	SELT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32693
6.34315169549648e-30	0.354423851062492	0.497	0.384	1.34671453647086e-25	MACF1	NK cells	GSE199333_post	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32694
8.38409480994471e-30	-0.254246969090965	0.196	0.33	1.78002716909936e-25	NXT1	NK cells	GSE199333_post	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32695
8.44856583229988e-30	0.298945009956858	0.338	0.217	1.79371501185559e-25	FDPS	NK cells	GSE199333_post	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32696
9.27190179582057e-30	0.295162079962019	0.359	0.234	1.96851747027066e-25	SP110	NK cells	GSE199333_post	ENSG00000135899	3431	SP110 nuclear body protein	IFI41|IFI75	protein_coding	Q9HB58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32697
9.32568361389515e-30	-0.251881028660472	0.268	0.419	1.97993588806608e-25	FAM204A	NK cells	GSE199333_post	ENSG00000165669	63877	family with sequence similarity 204 member A	bA319I23.1|C10orf84|FLJ13188	protein_coding	Q9H8W3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32698
1.34308087327956e-29	0.265883408547259	0.829	0.757	2.85149500205984e-25	LAPTM5	NK cells	GSE199333_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32699
1.44431831938609e-29	0.2516033015881	0.259	0.144	3.0664322238886e-25	CYTH4	NK cells	GSE199333_post	ENSG00000100055	27128	cytohesin 4	CYT4|cytohesin-4|PSCD4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32700
2.85587712746279e-29	0.294969391075324	0.353	0.233	6.06331272931624e-25	IRF3	NK cells	GSE199333_post	ENSG00000126456	3661	interferon regulatory factor 3	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32701
3.16334479308249e-29	0.315502100637564	0.657	0.561	6.71609733019342e-25	CELF2	NK cells	GSE199333_post	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32702
3.48471507356974e-29	0.286439434178721	0.333	0.211	7.39839857269592e-25	IKZF3	NK cells	GSE199333_post	ENSG00000161405	22806	IKAROS family zinc finger 3	Aiolos|ZNFN1A3	protein_coding	Q9UKT9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32703
3.63207387658431e-29	-0.257797622188269	0.282	0.434	7.71125604737615e-25	SMG1	NK cells	GSE199333_post	ENSG00000157106	23049	SMG1 nonsense mediated mRNA decay associated PI3K related kinase	ATX|KIAA0421|LIP	protein_coding	Q96Q15	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32704
4.09997582091113e-29	-0.31470379723996	0.389	0.532	8.70465866537643e-25	BTG2	NK cells	GSE199333_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32705
4.80991339831475e-29	-0.270292703939563	0.479	0.632	1.0211927135962e-24	ADAR	NK cells	GSE199333_post	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32706
5.31858110418129e-29	0.306657138850247	0.513	0.408	1.12918795422873e-24	MAP2K2	NK cells	GSE199333_post	ENSG00000126934	5605	mitogen-activated protein kinase kinase 2	MEK2|PRKMK2	protein_coding	P36507	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32707
5.65257676657841e-29	0.304053211351976	0.403	0.286	1.20009857331226e-24	FKBP1A	NK cells	GSE199333_post	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32708
6.4354830431325e-29	0.296024626498107	0.276	0.163	1.36631740488746e-24	ZBTB44	NK cells	GSE199333_post	ENSG00000196323	29068	zinc finger and BTB domain containing 44	BTBD15|HSPC063|ZNF851	protein_coding	Q8NCP5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32709
1.42272146246936e-28	0.311847947695589	0.429	0.308	3.02057993696869e-24	DIAPH1	NK cells	GSE199333_post	ENSG00000131504	1729	diaphanous related formin 1	DFNA1|hDIA1|LFHL1|mDia1	protein_coding	O60610	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32710
1.86829241002932e-28	-0.250613603808223	0.849	0.886	3.96657161573325e-24	HNRNPDL	NK cells	GSE199333_post	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32711
3.69539346336362e-28	0.290791075974792	0.322	0.204	7.8456898620673e-24	EIF2S2	NK cells	GSE199333_post	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32712
8.42081510218104e-28	-0.277220805704857	0.431	0.581	1.78782325434406e-23	SNRPB2	NK cells	GSE199333_post	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32713
1.17267025627314e-27	-0.250175997551958	0.341	0.492	2.4896962210935e-23	LENG8	NK cells	GSE199333_post	ENSG00000276458	114823	leukocyte receptor cluster member 8	KIAA1932|MGC40108|pp13842	protein_coding	Q96PV6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32714
1.71621045084281e-27	0.259658741047111	0.32	0.202	3.64368640818437e-23	NDUFS7	NK cells	GSE199333_post	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32715
2.86410044414451e-27	0.278391970024589	0.377	0.26	6.08077165296321e-23	FBXW5	NK cells	GSE199333_post	ENSG00000159069	54461	F-box and WD repeat domain containing 5	DKFZP434B205|Fbw5|MGC20962	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32716
2.8777399521287e-27	0.260405233445316	0.295	0.182	6.10972969236445e-23	ATP5MC1	NK cells	GSE199333_post	ENSG00000159199	516	ATP synthase membrane subunit c locus 1	ATP5G|ATP5G1	protein_coding	P05496	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32717
3.85907766565024e-27	0.283490534253089	0.398	0.279	8.19320779194203e-23	CHMP2A	NK cells	GSE199333_post	ENSG00000130724	27243	charged multivesicular body protein 2A	BC-2|CHMP2|VPS2|VPS2A	protein_coding	O43633	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32718
4.12215794419618e-27	-0.268010359298444	0.382	0.529	8.7517535313229e-23	ENY2	NK cells	GSE199333_post	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32719
4.22431228403948e-27	0.280229450110103	0.664	0.585	8.96863741024421e-23	NDUFB7	NK cells	GSE199333_post	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32720
4.83389574129809e-27	0.29745817111377	0.424	0.306	1.026284404835e-22	ADD3	NK cells	GSE199333_post	ENSG00000148700	120	adducin 3	ADDL	protein_coding	Q9UEY8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32721
6.04231695441162e-27	-0.252106785457735	0.445	0.601	1.28284431259113e-22	GPBP1	NK cells	GSE199333_post	ENSG00000062194	65056	GC-rich promoter binding protein 1	DKFZp761C169	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32722
6.07019072404849e-27	0.283729589128285	0.379	0.264	1.28876219262274e-22	NDUFS8	NK cells	GSE199333_post	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32723
8.09943874619658e-27	0.284920780117881	0.44	0.322	1.719591840205e-22	DDT	NK cells	GSE199333_post	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32724
8.20109429999071e-27	-0.253333492741574	0.773	0.836	1.74117433083103e-22	HNRNPU	NK cells	GSE199333_post	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32725
1.02535706052447e-26	-0.776551703470429	0.65	0.695	2.17693557519951e-22	MT2A	NK cells	GSE199333_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32726
1.15717039739555e-26	0.284300644228414	0.441	0.327	2.4567884707105e-22	TSC22D4	NK cells	GSE199333_post	ENSG00000166925	81628	TSC22 domain family member 4	THG-1|TILZ2	protein_coding	Q9Y3Q8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32727
1.89622611747191e-26	-0.269594481986116	0.348	0.495	4.0258776700046e-22	SDF2L1	NK cells	GSE199333_post	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32728
4.83205914581784e-26	0.290845213724496	0.289	0.18	1.02589447724859e-21	DIP2A	NK cells	GSE199333_post	ENSG00000160305	23181	disco interacting protein 2 homolog A	C21orf106|Dip2|KIAA0184	protein_coding	Q14689	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32729
5.33940940426982e-26	0.276584777156046	0.395	0.28	1.13361001062053e-21	JPT1	NK cells	GSE199333_post	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32730
8.66372233900477e-26	-0.260238060299547	0.616	0.729	1.8393948897941e-21	SERBP1	NK cells	GSE199333_post	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32731
1.19157056060501e-25	0.276772917511214	0.546	0.45	2.5298234572205e-21	NDUFB10	NK cells	GSE199333_post	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32732
1.60180071194318e-25	0.266325841771772	0.318	0.208	3.40078309152657e-21	ZMAT2	NK cells	GSE199333_post	ENSG00000146007	153527	zinc finger matrin-type 2	FLJ31121|hSNU23|Snu23	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32733
2.67170204458584e-25	-0.356165550204345	0.279	0.406	5.6722906108602e-21	SLC2A3	NK cells	GSE199333_post	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32734
3.29341463760875e-25	0.282994773752023	0.358	0.249	6.99224861710713e-21	VASP	NK cells	GSE199333_post	ENSG00000125753	7408	vasodilator stimulated phosphoprotein	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32735
3.38338740444784e-25	0.255009693202606	0.803	0.739	7.18326979838321e-21	YWHAB	NK cells	GSE199333_post	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32736
3.82278022303577e-25	-0.260523441506614	0.616	0.742	8.11614469152725e-21	CDC42SE2	NK cells	GSE199333_post	ENSG00000158985	56990	CDC42 small effector 2	FLJ21967|SPEC2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32737
4.7844833346964e-25	0.254782428638634	0.652	0.549	1.01579365678939e-20	UQCR10	NK cells	GSE199333_post	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32738
5.50220545574509e-25	0.28846609126561	0.383	0.279	1.16817324030924e-20	SRI	NK cells	GSE199333_post	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32739
6.21283762223599e-25	0.255270121078387	0.311	0.202	1.31904755557692e-20	RAP1A	NK cells	GSE199333_post	ENSG00000116473	5906	RAP1A, member of RAS oncogene family	KREV-1|SMGP21	protein_coding	P62834	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32740
2.68597348917208e-24	0.269510186739604	0.423	0.318	5.70259031486124e-20	DYNLRB1	NK cells	GSE199333_post	ENSG00000125971	83658	dynein light chain roadblock-type 1	DNCL2A|DNLC2A|ROBLD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32741
2.94643958648904e-24	0.277097313841924	0.553	0.437	6.25558588607488e-20	GIMAP7	NK cells	GSE199333_post	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32742
3.84847574953976e-24	-0.258971393905363	0.401	0.545	8.17069886384786e-20	MCL1	NK cells	GSE199333_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32743
5.26349110782467e-24	0.288904275938575	0.554	0.465	1.11749179710225e-19	YWHAQ	NK cells	GSE199333_post	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32744
1.06624884291927e-23	0.254440585335915	0.332	0.226	2.26375291840191e-19	MDH1	NK cells	GSE199333_post	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32745
1.44469510364661e-23	0.252744942647741	0.286	0.183	3.06723217455212e-19	ARHGAP15	NK cells	GSE199333_post	ENSG00000075884	55843	Rho GTPase activating protein 15	BM046	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32746
1.49889409447502e-23	0.276888702049264	0.418	0.305	3.18230205197991e-19	CNN2	NK cells	GSE199333_post	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32747
1.63467457409289e-23	0.251191722985619	0.589	0.487	3.47057758825662e-19	C11orf58	NK cells	GSE199333_post	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32748
1.91752897820898e-23	-0.283724758388029	0.198	0.31	4.07110577363549e-19	IFRD1	NK cells	GSE199333_post	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32749
1.97658281910028e-23	-0.254494950798478	0.392	0.526	4.1964829832318e-19	CREBRF	NK cells	GSE199333_post	ENSG00000164463	153222	CREB3 regulatory factor	C5orf41|LRF	protein_coding	Q8IUR6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32750
2.44750852665924e-23	-0.278414863845715	0.414	0.543	5.19630535295023e-19	TUBA4A	NK cells	GSE199333_post	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32751
6.4350169948807e-23	0.278566758836942	0.35	0.251	1.36621845818312e-18	BANF1	NK cells	GSE199333_post	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32752
7.44594975443828e-23	-0.273589508626879	0.918	0.915	1.58084959236479e-18	HSP90AB1	NK cells	GSE199333_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32753
8.60444046305176e-23	0.255706778983344	0.36	0.254	1.82680875471052e-18	NUB1	NK cells	GSE199333_post	ENSG00000013374	51667	negative regulator of ubiquitin like proteins 1	BS4|NUB1L|NYREN18	protein_coding	Q9Y5A7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32754
8.70249613759658e-23	0.260576251707008	0.625	0.546	1.84762695497313e-18	COPE	NK cells	GSE199333_post	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32755
1.51108696283601e-22	0.268432933382781	0.369	0.266	3.20818873079714e-18	MRPS21	NK cells	GSE199333_post	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32756
3.42998990295348e-22	0.283947615881065	0.447	0.356	7.28221156296052e-18	EMB	NK cells	GSE199333_post	ENSG00000170571	133418	embigin	MGC71745	protein_coding	Q6PCB8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32757
3.56987374035219e-22	-0.254341340935708	0.355	0.486	7.57919893814174e-18	RNF19A	NK cells	GSE199333_post	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32758
4.92706582992891e-22	0.260948284794915	0.352	0.252	1.04606534635221e-17	PSMB2	NK cells	GSE199333_post	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32759
1.512888291853e-21	0.252902899283232	0.371	0.269	3.21201313243311e-17	CCT7	NK cells	GSE199333_post	ENSG00000135624	10574	chaperonin containing TCP1 subunit 7	Ccth|Nip7-1	protein_coding	Q99832	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32760
3.70961902077711e-21	-0.263048176348484	0.695	0.774	7.87589214301188e-17	HSP90B1	NK cells	GSE199333_post	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32761
6.39541434721688e-21	0.256484472901182	0.478	0.389	1.35781042005762e-16	RNPEPL1	NK cells	GSE199333_post	ENSG00000142327	57140	arginyl aminopeptidase like 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32762
6.67107774254468e-21	0.271791295612606	0.38	0.288	1.41633651551966e-16	ARRB2	NK cells	GSE199333_post	ENSG00000141480	409	arrestin beta 2	ARR2|BARR2|DKFZp686L0365	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32763
7.5781321540682e-21	0.254834065344225	0.441	0.345	1.60891323763022e-16	GNB2	NK cells	GSE199333_post	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32764
1.71823083564396e-20	0.250106420786033	0.555	0.47	3.64797588715569e-16	CCDC85B	NK cells	GSE199333_post	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32765
2.80123912491254e-20	0.251788682781285	0.359	0.261	5.94731078610182e-16	NFATC3	NK cells	GSE199333_post	ENSG00000072736	4775	nuclear factor of activated T cells 3	NFAT4|NFATX	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32766
2.9082879664309e-20	0.254462974590991	0.338	0.24	6.17458618152945e-16	GTF2I	NK cells	GSE199333_post	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32767
1.31899930263818e-19	0.255359225618826	0.414	0.321	2.80036741943112e-15	NOP10	NK cells	GSE199333_post	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32768
1.49709491334611e-19	0.282251417588474	0.778	0.712	3.17848221052512e-15	CD63	NK cells	GSE199333_post	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32769
3.58437920726468e-19	0.266208823346853	0.418	0.332	7.60999549494364e-15	ANP32A	NK cells	GSE199333_post	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32770
4.68410119726672e-19	0.875705566705283	0.262	0.184	9.94481525191697e-15	GZMK	NK cells	GSE199333_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32771
8.66322669377233e-19	0.256942133158751	0.444	0.355	1.8392896593548e-14	DDX46	NK cells	GSE199333_post	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32772
1.21076503344662e-18	0.330461588945296	0.525	0.446	2.57057524251052e-14	FCGR3A	NK cells	GSE199333_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32773
1.00603117514105e-17	-0.256899683130693	0.282	0.388	2.13590478794195e-13	GOLGB1	NK cells	GSE199333_post	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32774
1.09204004208146e-17	-0.266894432624789	0.365	0.476	2.31851021334316e-13	CEBPB	NK cells	GSE199333_post	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32775
2.35362171529961e-17	0.261458711747638	0.567	0.498	4.99697426375259e-13	POLR2J3.1	NK cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32776
1.80925505222814e-15	-0.255470695145578	0.807	0.837	3.84122940138557e-11	CALR	NK cells	GSE199333_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32777
2.19912232411462e-15	-0.276432018220033	0.297	0.404	4.66895660632775e-11	DUSP1	NK cells	GSE199333_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32778
1.55874906088757e-14	0.445130071908756	0.475	0.404	3.3093801311704e-10	CLIC3	NK cells	GSE199333_post	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32779
0	1.87558849325244	0.92	0.479	0	SH3BGRL3	Erythrocytes	GSE199333_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32780
0	-0.831553437241926	0.074	0.513	0	NFIA	Erythrocytes	GSE199333_post	ENSG00000162599	4774	nuclear factor I A	KIAA1439|NFI-L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32781
0	-0.40925875485894	0.001	0.284	0	CNN3	Erythrocytes	GSE199333_post	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32782
0	0.970938521375281	0.798	0.531	0	ADIPOR1	Erythrocytes	GSE199333_post	ENSG00000159346	51094	adiponectin receptor 1	ACDCR1|PAQR1	protein_coding	Q96A54	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32783
0	0.903565062394189	0.971	0.931	0	GUK1	Erythrocytes	GSE199333_post	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32784
0	-1.5658824390245	0.388	0.835	0	H1FX	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32785
0	-1.12461422585686	0.101	0.509	0	HIST1H1E	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32786
0	-1.03717293607117	0.116	0.436	0	HIST1H1D	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32787
0	-0.658273009319653	0.035	0.307	0	HIST1H2AJ	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32788
0	-0.432689051791669	0.049	0.319	0	SLC29A1	Erythrocytes	GSE199333_post	ENSG00000112759	2030	solute carrier family 29 member 1 (Augustine blood group)	ENT1	protein_coding	Q99808	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32789
0	1.46178629448066	0.612	0.241	0	ARL4A	Erythrocytes	GSE199333_post	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32790
0	-0.67555614111167	0.124	0.482	0	ACHE	Erythrocytes	GSE199333_post	ENSG00000087085	43	acetylcholinesterase (Cartwright blood group)	YT	protein_coding	P22303	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32791
0	0.833282290562719	0.572	0.165	0	WDR45	Erythrocytes	GSE199333_post	ENSG00000196998	11152	WD repeat domain 45	JM5|NBIA5|WDRX1|WIPI4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32792
0	-1.09287367119141	0.814	0.952	0	CA1	Erythrocytes	GSE199333_post	ENSG00000133742	759	carbonic anhydrase 1	Car1	protein_coding	P00915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32793
0	-0.473101387947597	0.039	0.332	0	GRINA	Erythrocytes	GSE199333_post	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32794
0	-0.439190226145032	0.023	0.277	0	GADD45G	Erythrocytes	GSE199333_post	ENSG00000130222	10912	growth arrest and DNA damage inducible gamma	CR6|DDIT2|GADD45gamma|GRP17	protein_coding	O95257	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32795
0	4.40796321887816	0.623	0.075	0	HBG2	Erythrocytes	GSE199333_post	ENSG00000196565	3048	hemoglobin subunit gamma 2	HBG-T1	protein_coding	P69892	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32796
0	-0.465035009179089	0.071	0.369	0	SLC43A1	Erythrocytes	GSE199333_post	ENSG00000149150	8501	solute carrier family 43 member 1	PB39|POV1|R00504	protein_coding	O75387	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32797
0	2.41914721990714	0.68	0.05	0	AC092490.1	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32798
0	0.969822733256258	0.963	0.957	0	YBX3	Erythrocytes	GSE199333_post	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32799
0	-0.592672560661065	0.177	0.557	0	CHPT1	Erythrocytes	GSE199333_post	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32800
0	-0.980434825190775	0.212	0.584	0	KLF13	Erythrocytes	GSE199333_post	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32801
0	0.750766763269951	0.991	0.925	0	SERF2	Erythrocytes	GSE199333_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32802
0	-1.23878537163625	0.654	0.887	0	HBM	Erythrocytes	GSE199333_post	ENSG00000206177	3042	hemoglobin subunit mu	HBAP2|HBK	protein_coding	Q6B0K9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32803
0	-1.04442459899352	0.631	0.928	0	H3F3B	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32804
0	1.08744955169252	0.577	0.187	0	LPIN2	Erythrocytes	GSE199333_post	ENSG00000101577	9663	lipin 2	KIAA0249	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32805
0	0.799011747407914	0.598	0.182	0	R3HDM4	Erythrocytes	GSE199333_post	ENSG00000198858	91300	R3H domain containing 4	C19orf22|MGC16353	protein_coding	Q96D70	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32806
0	1.54192920865266	0.978	0.892	0	OAZ1	Erythrocytes	GSE199333_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32807
0	1.2663105132681	0.687	0.318	0	LYL1	Erythrocytes	GSE199333_post	ENSG00000104903	4066	LYL1 basic helix-loop-helix family member	bHLHa18	protein_coding	P12980	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32808
0	0.831489250850831	0.95	0.886	0	FKBP8	Erythrocytes	GSE199333_post	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32809
0	1.08128746006471	0.999	0.996	0	FTL	Erythrocytes	GSE199333_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32810
0	-1.91215796689485	0.251	0.773	0	H1F0	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32811
0	-0.45907620206466	0.044	0.341	0	COL18A1	Erythrocytes	GSE199333_post	ENSG00000182871	80781	collagen type XVIII alpha 1 chain	KNO|KNO1|KS	protein_coding	P39060	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32812
0	-1.0092674355956	0.728	0.966	0	MT-ATP6	Erythrocytes	GSE199333_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32813
0	-1.4899978022599	0.802	0.98	0	MT-CO3	Erythrocytes	GSE199333_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32814
0	-1.00057023510667	0.625	0.961	0	MT-CYB	Erythrocytes	GSE199333_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32815
5.01130240711178e-308	-0.689242043803246	0.225	0.572	1.0639496140539e-303	GCLM	Erythrocytes	GSE199333_post	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32816
7.61982769468364e-306	-1.55921492767252	0.228	0.574	1.61776561785828e-301	HIST1H4C	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32817
5.10675944566236e-305	0.782509147605135	0.843	0.602	1.08421609790858e-300	STMP1	Erythrocytes	GSE199333_post	ENSG00000243317	647087	short transmembrane mitochondrial protein 1	C7orf73|Mm47|PL-5283	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32818
2.58171587751129e-304	-0.681532293410608	0.228	0.587	5.48124097954423e-300	HNRNPH3	Erythrocytes	GSE199333_post	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32819
2.2401732553618e-302	-1.14791946461965	0.361	0.73	4.75611183845864e-298	TUBA1B	Erythrocytes	GSE199333_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32820
1.09235414122191e-300	-0.722995407061731	0.294	0.658	2.31917707722824e-296	TRA2B	Erythrocytes	GSE199333_post	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32821
2.16390584233786e-299	-0.507013920181758	0.088	0.381	4.59418849386752e-295	ACKR1	Erythrocytes	GSE199333_post	ENSG00000213088	2532	atypical chemokine receptor 1 (Duffy blood group)	CCBP1|CD234|DARC|Dfy|FY|GPD	protein_coding	Q16570	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32822
2.73886066481086e-299	-0.733136886651418	0.208	0.568	5.81487507745994e-295	DNAJC9	Erythrocytes	GSE199333_post	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32823
6.16030435766554e-298	-0.966862185758254	0.35	0.709	1.30789421817597e-293	MGST3	Erythrocytes	GSE199333_post	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32824
1.26185310587262e-294	0.784899292495697	0.844	0.632	2.67904032907816e-290	FIS1	Erythrocytes	GSE199333_post	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32825
2.21854999881348e-292	-0.585144464378372	0.278	0.643	4.71020350248089e-288	ACP1	Erythrocytes	GSE199333_post	ENSG00000143727	52	acid phosphatase 1	HAAP|LMW-PTP|LMWPTP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32826
1.17567695191079e-289	0.958184027479596	0.861	0.714	2.49607973660179e-285	BNIP3L	Erythrocytes	GSE199333_post	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32827
1.98956708399197e-289	-0.449125727945751	0.052	0.305	4.22404987602335e-285	PARVB	Erythrocytes	GSE199333_post	ENSG00000188677	29780	parvin beta	CGI-56	protein_coding	Q9HBI1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32828
2.03153694643018e-289	0.83522144603751	0.815	0.599	4.31315609096591e-285	GABARAPL2	Erythrocytes	GSE199333_post	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32829
3.35583104852543e-289	0.875727735747557	0.595	0.233	7.12476489912434e-285	DCAF12	Erythrocytes	GSE199333_post	ENSG00000198876	25853	DDB1 and CUL4 associated factor 12	CT102|DKFZP434O125|KIAA1892|MGC1058|TCC52|WDR40A	protein_coding	Q5T6F0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32830
3.49623261599944e-289	0.954613375901034	0.619	0.268	7.4228514670284e-285	ARF4	Erythrocytes	GSE199333_post	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32831
5.19774781284362e-288	-0.816339504850171	0.837	0.97	1.10353383814483e-283	YBX1	Erythrocytes	GSE199333_post	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32832
2.16300819097536e-287	-0.593265202705622	0.18	0.51	4.59228269025979e-283	DNAJA4	Erythrocytes	GSE199333_post	ENSG00000140403	55466	DnaJ heat shock protein family (Hsp40) member A4	PRO1472	protein_coding	Q8WW22	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32833
1.3270780383514e-286	-0.746088044811304	0.311	0.674	2.81751938322386e-282	ZNF451	Erythrocytes	GSE199333_post	ENSG00000112200	26036	zinc finger protein 451	COASTER|dJ417I1.1|KIAA0576|KIAA1702|ZATT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32834
1.98709912807716e-284	-1.0076670737999	0.786	0.969	4.21881015882061e-280	MT-CO2	Erythrocytes	GSE199333_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32835
1.26133231332218e-283	0.998776330431405	0.78	0.561	2.67793463441433e-279	SELENBP1	Erythrocytes	GSE199333_post	ENSG00000143416	8991	selenium binding protein 1	hSBP|hSP56|LPSB	protein_coding	Q13228	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32836
1.78201234569339e-283	-0.925192473485532	0.394	0.766	3.78339041114165e-279	HMGB2	Erythrocytes	GSE199333_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32837
1.472519524894e-280	0.87689800485353	0.733	0.464	3.12630620330244e-276	RNF10	Erythrocytes	GSE199333_post	ENSG00000022840	9921	ring finger protein 10	KIAA0262|RIE2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32838
1.17711915917052e-277	1.11269442874063	0.799	0.616	2.49914168683492e-273	HBQ1	Erythrocytes	GSE199333_post	ENSG00000086506	3049	hemoglobin subunit theta 1	HBQ	protein_coding	P09105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32839
4.19325583777344e-273	-0.328828997617064	0.033	0.256	8.90270146917678e-269	EPN2	Erythrocytes	GSE199333_post	ENSG00000072134	22905	epsin 2	EHB21|KIAA1065	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32840
8.37883441897709e-270	-1.00021132573871	0.185	0.52	1.77891033549303e-265	MKI67	Erythrocytes	GSE199333_post	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32841
3.41819114108199e-267	0.808663783108755	0.811	0.596	7.25716161163117e-263	MAP1LC3B	Erythrocytes	GSE199333_post	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32842
1.75708990300428e-266	-0.593352792413661	0.112	0.403	3.73047757306839e-262	CENPU	Erythrocytes	GSE199333_post	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32843
1.8681237071433e-266	0.648840924190709	0.854	0.565	3.96621344263595e-262	UQCR11	Erythrocytes	GSE199333_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32844
2.31600123481122e-266	-0.678687109104129	0.066	0.319	4.91710222162771e-262	FBXO5	Erythrocytes	GSE199333_post	ENSG00000112029	26271	F-box protein 5	EMI1|FBX5|Fbxo31	protein_coding	Q9UKT4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32845
5.66736021402739e-266	-0.632474546987117	0.163	0.478	1.20323724704016e-261	MT2A	Erythrocytes	GSE199333_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32846
7.05496031237129e-262	1.3178873390152	0.657	0.331	1.49783862391955e-257	GPX4	Erythrocytes	GSE199333_post	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32847
1.62357355358604e-261	-1.06463174963941	0.674	0.932	3.44700901161852e-257	RPS26	Erythrocytes	GSE199333_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32848
6.08630973778297e-260	-0.838274697720661	0.374	0.753	1.2921844204287e-255	HLA-B	Erythrocytes	GSE199333_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32849
3.40761457625831e-259	1.03823331596428	0.673	0.397	7.23470650685402e-255	SIAH2	Erythrocytes	GSE199333_post	ENSG00000181788	6478	siah E3 ubiquitin protein ligase 2	NA	protein_coding	O43255	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32850
8.85356893782243e-257	-0.503199643112323	0.091	0.359	1.87970122118908e-252	C20orf27	Erythrocytes	GSE199333_post	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32851
2.51196186632364e-256	-0.564695349248751	0.115	0.396	5.33314623839171e-252	HSPB1	Erythrocytes	GSE199333_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32852
2.67650620324789e-254	-0.658980817930285	0.253	0.586	5.6824903201156e-250	BCLAF1	Erythrocytes	GSE199333_post	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32853
1.12424575275903e-253	-0.412495189567422	0.038	0.256	2.38688615768271e-249	CA3	Erythrocytes	GSE199333_post	ENSG00000164879	761	carbonic anhydrase 3	CAIII|Car3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32854
4.93205258371899e-253	-0.536890436975534	0.217	0.558	1.04712408404938e-248	ABCB10	Erythrocytes	GSE199333_post	ENSG00000135776	23456	ATP binding cassette subfamily B member 10	EST20237|M-ABC2|MTABC2	protein_coding	Q9NRK6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32855
3.71286778549886e-252	-0.519486048337132	0.084	0.345	7.88278959539264e-248	CDCA4	Erythrocytes	GSE199333_post	ENSG00000170779	55038	cell division cycle associated 4	FLJ20764|Hepp	protein_coding	Q9BXL8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32856
6.64763749227397e-252	0.816185396933311	0.325	0.017	1.41135991598469e-247	SELENOP	Erythrocytes	GSE199333_post	ENSG00000250722	6414	selenoprotein P	SELP|SeP|SEPP|SEPP1	protein_coding	P49908	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32857
1.74090885691406e-249	-0.480074727138257	0.137	0.431	3.69612359411425e-245	PPME1	Erythrocytes	GSE199333_post	ENSG00000214517	51400	protein phosphatase methylesterase 1	ABDH19|PME-1	protein_coding	Q9Y570	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32858
2.03192628037656e-248	-0.635964951788499	0.206	0.528	4.31398268586747e-244	PRPF4B	Erythrocytes	GSE199333_post	ENSG00000112739	8899	pre-mRNA processing factor 4B	KIAA0536|PR4H|Prp4	protein_coding	Q13523	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32859
2.04086633727826e-248	-0.691845636072316	0.571	0.892	4.33296332067548e-244	MT-ND5	Erythrocytes	GSE199333_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32860
6.81647496627894e-248	-0.750236175716343	0.306	0.643	1.44720580009068e-243	DEK	Erythrocytes	GSE199333_post	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32861
3.47848153858693e-247	-0.572656174764704	0.214	0.546	7.38516415457392e-243	LBR	Erythrocytes	GSE199333_post	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32862
5.69582942119751e-246	-0.933644268413482	0.303	0.648	1.20928154441444e-241	TUBB	Erythrocytes	GSE199333_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32863
1.22788355052656e-245	-0.808025301469876	0.535	0.825	2.60691956612295e-241	HEMGN	Erythrocytes	GSE199333_post	ENSG00000136929	55363	hemogen	CT155|EDAG|NDR	protein_coding	Q9BXL5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32864
4.3849146359431e-244	-0.675634364013199	0.427	0.727	9.30961226357079e-240	TXN	Erythrocytes	GSE199333_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32865
8.64456444499415e-244	-0.54469175758688	0.28	0.607	1.83532747731671e-239	E2F4	Erythrocytes	GSE199333_post	ENSG00000205250	1874	E2F transcription factor 4	E2F-4	protein_coding	Q16254	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32866
2.21192398413575e-243	-0.729461496621168	0.103	0.369	4.6961358107186e-239	HIST2H2AC	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32867
6.30052374269024e-243	0.982062185678782	0.822	0.691	1.33766419581056e-238	MAP2K3	Erythrocytes	GSE199333_post	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32868
4.37970481945252e-242	-0.609101631607501	0.336	0.678	9.29855130217965e-238	CPOX	Erythrocytes	GSE199333_post	ENSG00000080819	1371	coproporphyrinogen oxidase	CPO|CPX|HCP	protein_coding	P36551	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32869
2.00504306261712e-240	-0.575468826608116	0.673	0.956	4.2569069262424e-236	MT-ND4	Erythrocytes	GSE199333_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32870
2.50495626046966e-240	-0.433828921721137	0.08	0.33	5.31827263660314e-236	SUCO	Erythrocytes	GSE199333_post	ENSG00000094975	51430	SUN domain containing ossification factor	C1orf9|CH1|OPT|SLP1	protein_coding	Q9UBS9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32871
3.21033158166168e-240	-0.395389712564764	0.06	0.293	6.81585498102591e-236	MYH10	Erythrocytes	GSE199333_post	ENSG00000133026	4628	myosin heavy chain 10	NMMHCB	protein_coding	P35580	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32872
1.36812725680708e-239	-0.613560587204113	0.338	0.702	2.90467097892712e-235	CD36	Erythrocytes	GSE199333_post	ENSG00000135218	948	CD36 molecule	FAT|GP3B|GP4|GPIV|SCARB3	protein_coding	P16671	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32873
2.32751229380146e-239	-0.732150877597149	0.334	0.643	4.94154135096987e-235	SLC3A2	Erythrocytes	GSE199333_post	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32874
7.96048428066858e-239	-0.503596803503511	0.097	0.359	1.69009041762875e-234	BCAM	Erythrocytes	GSE199333_post	ENSG00000187244	4059	basal cell adhesion molecule (Lutheran blood group)	CD239|LU	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32875
1.19961182984718e-237	-0.552617678826034	0.165	0.476	2.54689587594855e-233	HEBP1	Erythrocytes	GSE199333_post	ENSG00000013583	50865	heme binding protein 1	HBP|HEBP	protein_coding	Q9NRV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32876
7.6334632905187e-236	0.875921811028811	0.962	0.954	1.62066059121003e-231	SLC25A39	Erythrocytes	GSE199333_post	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32877
1.05961935696446e-235	-0.701044155357025	0.256	0.571	2.24967785677124e-231	SRSF10	Erythrocytes	GSE199333_post	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32878
2.33556873596435e-235	-0.607780586268308	0.211	0.517	4.95864598332592e-231	GARS	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32879
1.49950642568788e-232	0.815454765055921	0.945	0.916	3.18360209237793e-228	GLRX5	Erythrocytes	GSE199333_post	ENSG00000182512	51218	glutaredoxin 5	C14orf87|GRX5|PR01238	protein_coding	Q86SX6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32880
3.66021725289579e-230	-0.572423671809512	0.149	0.436	7.77100724962305e-226	CKAP2	Erythrocytes	GSE199333_post	ENSG00000136108	26586	cytoskeleton associated protein 2	FLJ10749|LB1|se20-10|TMAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32881
1.52234329462982e-229	-0.896787771440127	0.321	0.621	3.23208704882858e-225	UBE2S	Erythrocytes	GSE199333_post	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32882
9.68104542754654e-229	-0.490959154810984	0.089	0.339	2.05538275472241e-224	CKAP2L	Erythrocytes	GSE199333_post	ENSG00000169607	150468	cytoskeleton associated protein 2 like	FLJ40629|radmis	protein_coding	Q8IYA6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32883
2.32502729377508e-226	1.17969216271811	0.712	0.505	4.93626544741386e-222	BPGM	Erythrocytes	GSE199333_post	ENSG00000172331	669	bisphosphoglycerate mutase	NA	protein_coding	P07738	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32884
5.84116269845623e-226	-0.543469282010911	0.178	0.48	1.24013725250924e-221	SMC3	Erythrocytes	GSE199333_post	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32885
2.96940802531385e-225	-0.62502225674779	0.208	0.501	6.30435017854384e-221	CARHSP1	Erythrocytes	GSE199333_post	ENSG00000153048	23589	calcium regulated heat stable protein 1	CRHSP-24|CSDC1	protein_coding	Q9Y2V2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32886
2.29754379576874e-223	-0.492233526496925	0.099	0.356	4.87791523279662e-219	ATAD5	Erythrocytes	GSE199333_post	ENSG00000176208	79915	ATPase family AAA domain containing 5	C17orf41|ELG1|FLJ12735|FRAG1	protein_coding	Q96QE3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32887
1.93615636012965e-222	-0.66535430965866	0.362	0.678	4.11065356819125e-218	RHCE	Erythrocytes	GSE199333_post	ENSG00000188672	6006	Rh blood group CcEe antigens	CD240CE|RH	protein_coding	P18577	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32888
8.53367860086734e-222	-0.657944795592147	0.209	0.508	1.81178530375015e-217	SMC4	Erythrocytes	GSE199333_post	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32889
4.2118747285553e-221	-0.412851090444497	0.114	0.378	8.94223123619575e-217	ELOVL1	Erythrocytes	GSE199333_post	ENSG00000066322	64834	ELOVL fatty acid elongase 1	Ssc1	protein_coding	Q9BW60	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32890
1.36721013790407e-220	-0.605966924628179	0.47	0.766	2.90272384378414e-216	SON	Erythrocytes	GSE199333_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32891
3.62011447827382e-220	0.937332581677297	0.901	0.851	7.68586504882315e-216	ALAS2	Erythrocytes	GSE199333_post	ENSG00000158578	212	5'-aminolevulinate synthase 2	ALAS-E|ASB	protein_coding	P22557	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32892
6.68528253932632e-220	-0.46894586032591	0.128	0.398	1.41935233592437e-215	ITGA4	Erythrocytes	GSE199333_post	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32893
1.00305137271973e-219	-0.850792033390185	0.228	0.547	2.12957836942126e-215	CENPF	Erythrocytes	GSE199333_post	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32894
8.14923188307742e-219	-0.521404857100867	0.612	0.92	1.73016342109617e-214	MT-ND2	Erythrocytes	GSE199333_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32895
2.15750832691527e-218	0.760674010650623	0.713	0.481	4.58060592887382e-214	BCL2L1	Erythrocytes	GSE199333_post	ENSG00000171552	598	BCL2 like 1	Bcl-X|bcl-xL|bcl-xS|BCL2L|BCLX|PPP1R52	protein_coding	Q07817	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32896
5.004875625907e-218	-0.607505943660358	0.254	0.568	1.06258514413632e-213	IDH2	Erythrocytes	GSE199333_post	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32897
1.07916243140857e-217	-0.343578593987016	0.069	0.295	2.29116975812353e-213	C5orf30	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32898
1.58469384102971e-217	-0.567767487188828	0.329	0.656	3.36446349389017e-213	RBM3	Erythrocytes	GSE199333_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32899
2.62274132233436e-217	-0.522005449376927	0.249	0.558	5.56834210144809e-213	SRP9	Erythrocytes	GSE199333_post	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32900
7.00532560147949e-216	-0.791508074622113	0.861	0.946	1.48730067845011e-211	PRDX2	Erythrocytes	GSE199333_post	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32901
3.861647616977e-214	-0.322188829788073	0.056	0.27	8.19866405560387e-210	ANKLE1	Erythrocytes	GSE199333_post	ENSG00000160117	126549	ankyrin repeat and LEM domain containing 1	ANKRD41|FLJ39369|LEMD6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32902
9.20207542079511e-214	-0.576428422143437	0.186	0.466	1.95369263258901e-209	TOPORS	Erythrocytes	GSE199333_post	ENSG00000197579	10210	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	LUN|RP31|TP53BPL	protein_coding	Q9NS56	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32903
3.92134914553736e-212	-0.480548291012795	0.172	0.45	8.32541637089037e-208	PQLC1	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32904
1.71738377126822e-210	1.13269101783412	0.463	0.154	3.64617748477955e-206	TMCC2	Erythrocytes	GSE199333_post	ENSG00000133069	9911	transmembrane and coiled-coil domain family 2	FLJ38497|HUCEP11	protein_coding	O75069	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32905
2.22922792449262e-210	-0.464434834891969	0.078	0.308	4.73287380649029e-206	CDT1	Erythrocytes	GSE199333_post	ENSG00000167513	81620	chromatin licensing and DNA replication factor 1	DUP|RIS2	protein_coding	Q9H211	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32906
2.69200990877935e-210	-0.584048063978135	0.074	0.3	5.71540623732944e-206	HIST1H1B	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32907
3.64963436616134e-210	-0.64630106176831	0.533	0.831	7.74853872279713e-206	HNRNPA2B1	Erythrocytes	GSE199333_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32908
7.23632652623834e-210	0.452787671972759	0.295	0.025	1.53634448478566e-205	RAP1GAP	Erythrocytes	GSE199333_post	ENSG00000076864	5909	RAP1 GTPase activating protein	KIAA0474|RAP1GA1|RAP1GAP1|RAP1GAPII	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32909
1.49656888303762e-209	-0.578367892269627	0.342	0.655	3.17736539557716e-205	SRRM2	Erythrocytes	GSE199333_post	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32910
1.19770040022388e-208	-0.626214600048895	0.148	0.427	2.54283771971533e-204	PCNA	Erythrocytes	GSE199333_post	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32911
2.12899892403904e-205	0.825354356772019	0.791	0.602	4.52007761562728e-201	UCP2	Erythrocytes	GSE199333_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32912
2.17319355705004e-205	0.76981234207097	0.699	0.464	4.61390724097293e-201	MKRN1	Erythrocytes	GSE199333_post	ENSG00000133606	23608	makorin ring finger protein 1	RNF61	protein_coding	Q9UHC7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32913
5.40035478970934e-205	-0.710511056619864	0.373	0.694	1.14654932540319e-200	RAN	Erythrocytes	GSE199333_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32914
1.20001361042829e-203	-0.354723726742307	0.077	0.302	2.54774889630029e-199	B3GNT2	Erythrocytes	GSE199333_post	ENSG00000170340	10678	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	B3GN-T1|B3GN-T2|B3GNT-2|B3GNT1|BETA3GNT	protein_coding	Q9NY97	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32915
5.13011028049848e-203	-0.330751963694638	0.057	0.269	1.08917371365263e-198	MAL	Erythrocytes	GSE199333_post	ENSG00000172005	4118	mal, T cell differentiation protein	MVP17|VIP17	protein_coding	P21145	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32916
2.068097845307e-201	-0.505229509336969	0.15	0.413	4.39077853537129e-197	ALYREF	Erythrocytes	GSE199333_post	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32917
3.80843289148594e-201	-0.840463556780996	0.62	0.846	8.0856838719138e-197	HMGB1	Erythrocytes	GSE199333_post	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32918
4.19846013269133e-201	-0.43427600683346	0.14	0.402	8.91375070771696e-197	NCEH1	Erythrocytes	GSE199333_post	ENSG00000144959	57552	neutral cholesterol ester hydrolase 1	AADACL1|KIAA1363|NCEH	protein_coding	Q6PIU2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32919
7.60989990403017e-201	0.706767910582285	0.544	0.25	1.61565784862464e-196	CREG1	Erythrocytes	GSE199333_post	ENSG00000143162	8804	cellular repressor of E1A stimulated genes 1	CREG	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32920
6.6170373969077e-200	-0.651582052726486	0.196	0.478	1.40486320973747e-195	HNRNPAB	Erythrocytes	GSE199333_post	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32921
7.94450841200441e-200	-0.52324964285788	0.21	0.514	1.68669858095266e-195	TMPO	Erythrocytes	GSE199333_post	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32922
1.17420191497394e-199	-0.502688733547394	0.288	0.592	2.49294808568117e-195	TMEM56	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32923
1.19432662231006e-199	-0.566194454168655	0.242	0.562	2.53567485182648e-195	PTTG1	Erythrocytes	GSE199333_post	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32924
1.30005233686772e-198	-0.587718063726425	0.399	0.676	2.76014111640385e-194	ODC1	Erythrocytes	GSE199333_post	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32925
2.27808956149826e-198	-0.633214110041798	0.27	0.567	4.83661194801696e-194	SNRPB	Erythrocytes	GSE199333_post	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32926
1.59452057049701e-197	-0.528856138901592	0.187	0.46	3.3853266232222e-193	SIVA1	Erythrocytes	GSE199333_post	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32927
4.25542617668063e-197	-0.707379731556432	0.607	0.845	9.03469531571065e-193	GYPA	Erythrocytes	GSE199333_post	ENSG00000170180	2993	glycophorin A (MNS blood group)	CD235a|GPA|MN|MNS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32928
3.91888091589919e-196	-0.342175062751995	0.065	0.274	8.32017607254556e-192	F8A1	Erythrocytes	GSE199333_post	ENSG00000288722	8263	coagulation factor VIII associated 1	DXS522E|F8A	protein_coding	P23610	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32929
3.3503706900964e-195	-0.623940196148734	0.236	0.515	7.11317201214367e-191	BTG2	Erythrocytes	GSE199333_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32930
3.48689186796208e-195	-0.452713756827254	0.135	0.393	7.40302012487029e-191	USP1	Erythrocytes	GSE199333_post	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32931
5.30892927339464e-195	0.491344312839665	0.291	0.031	1.12713877403442e-190	VCL	Erythrocytes	GSE199333_post	ENSG00000035403	7414	vinculin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32932
7.48896277078797e-195	-0.756300113254691	0.331	0.634	1.58998168586599e-190	H2AFZ	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32933
2.64574059871842e-194	-0.356631401946813	0.097	0.327	5.61717186513908e-190	MRPL23	Erythrocytes	GSE199333_post	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32934
4.66722598117625e-194	0.768468560751154	0.764	0.568	9.90898748063529e-190	TOP1	Erythrocytes	GSE199333_post	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32935
8.89462604267059e-194	-0.400939106857578	0.126	0.373	1.88841805511939e-189	ASXL1	Erythrocytes	GSE199333_post	ENSG00000171456	171023	ASXL transcriptional regulator 1	KIAA0978	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32936
1.30002968316916e-193	-0.797173647715925	0.207	0.478	2.76009302033645e-189	DUT	Erythrocytes	GSE199333_post	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32937
2.07357186367613e-192	-0.443694585099514	0.092	0.319	4.4024004237708e-188	SAMD1	Erythrocytes	GSE199333_post	ENSG00000288488	90378	sterile alpha motif domain containing 1	NA	protein_coding	Q6SPF0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32938
6.8529171686502e-192	-0.507858660247694	0.2	0.48	1.45494284407612e-187	SUZ12	Erythrocytes	GSE199333_post	ENSG00000178691	23512	SUZ12 polycomb repressive complex 2 subunit	CHET9|JJAZ1|KIAA0160	protein_coding	Q15022	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32939
6.06519186190576e-191	-0.455633271186081	0.111	0.356	1.28770088420121e-186	CDK1	Erythrocytes	GSE199333_post	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32940
7.57693487205263e-191	-0.633181626868538	0.252	0.525	1.60865904268549e-186	SRSF2	Erythrocytes	GSE199333_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32941
2.73891303515363e-190	-0.417291695574972	0.087	0.309	5.81498626493468e-186	BLVRA	Erythrocytes	GSE199333_post	ENSG00000106605	644	biliverdin reductase A	BLVR	protein_coding	P53004	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32942
3.97896594485105e-190	-0.534658311502699	0.16	0.428	8.44774259751327e-186	CCNB2	Erythrocytes	GSE199333_post	ENSG00000157456	9133	cyclin B2	HsT17299	protein_coding	O95067	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32943
6.18075177732e-190	-0.297442714468373	0.059	0.261	1.31223540984281e-185	SNX9	Erythrocytes	GSE199333_post	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32944
9.47664709462226e-189	-0.417276070616717	0.145	0.405	2.01198694465925e-184	HMGB3	Erythrocytes	GSE199333_post	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32945
1.37990297607483e-188	-0.458241914678361	0.126	0.374	2.92967200850447e-184	AQP1	Erythrocytes	GSE199333_post	ENSG00000240583	358	aquaporin 1 (Colton blood group)	CHIP28|CO	protein_coding	P29972	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32946
2.40443260770185e-188	-0.932327828956352	0.32	0.58	5.1048508694118e-184	HES6	Erythrocytes	GSE199333_post	ENSG00000144485	55502	hes family bHLH transcription factor 6	bHLHb41	protein_coding	Q96HZ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32947
1.05620118246776e-187	-0.628625624478599	0.46	0.727	2.2424207304973e-183	UBAC1	Erythrocytes	GSE199333_post	ENSG00000130560	10422	UBA domain containing 1	GBDR1|KPC2|UBADC1	protein_coding	Q9BSL1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32948
5.65997829933927e-187	-0.67672614416866	0.416	0.72	1.20166999273272e-182	HLA-C	Erythrocytes	GSE199333_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32949
2.90936573237492e-186	-0.585951937546265	0.804	0.949	6.1768743864052e-182	H3F3A	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32950
1.70000301247371e-184	-0.66769146066709	0.439	0.706	3.60927639578294e-180	PPP1R15A	Erythrocytes	GSE199333_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32951
1.70012263456177e-184	-0.434792699807089	0.123	0.361	3.60953036543809e-180	C3orf58	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32952
3.98566479556165e-184	-0.513505909519213	0.353	0.651	8.46196492745694e-180	LEPROT	Erythrocytes	GSE199333_post	ENSG00000213625	54741	leptin receptor overlapping transcript	FLJ90360|OB-RGRP|OBRGRP|VPS55	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32953
4.17366231312228e-184	-0.647825283982154	0.318	0.596	8.86110245698992e-180	FUS	Erythrocytes	GSE199333_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32954
6.91188228215375e-184	-0.38694130307519	0.161	0.423	1.46746172732406e-179	MFHAS1	Erythrocytes	GSE199333_post	ENSG00000147324	9258	multifunctional ROCO family signaling regulator 1	LRRC65|MASL1	protein_coding	Q9Y4C4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32955
2.55882370796664e-183	-0.461596620259515	0.179	0.446	5.43263861438398e-179	LCOR	Erythrocytes	GSE199333_post	ENSG00000196233	84458	ligand dependent nuclear receptor corepressor	C10orf12|DKFZP564P1916|FLJ13022|FLJ38026|KIAA1795|MLR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32956
4.29748292215075e-183	-0.422122817647207	0.169	0.429	9.12398599201825e-179	DHX9	Erythrocytes	GSE199333_post	ENSG00000135829	1660	DExH-box helicase 9	DDX9|LKP|RHA	protein_coding	Q08211	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32957
6.61342431758041e-183	0.494591337116075	0.257	0.018	1.4040961168655e-178	SHISA4	Erythrocytes	GSE199333_post	ENSG00000198892	149345	shisa family member 4	C1orf40|hShisa4|TMEM58	protein_coding	Q96DD7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32958
8.27735812969849e-183	-0.569573853126718	0.343	0.634	1.75736590451629e-178	HNRNPU	Erythrocytes	GSE199333_post	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32959
2.71671072425288e-182	-0.363187022421486	0.132	0.379	5.76784853866128e-178	PGRMC2	Erythrocytes	GSE199333_post	ENSG00000164040	10424	progesterone receptor membrane component 2	DG6|PMBP	protein_coding	O15173	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32960
3.19181972575139e-182	-0.455260866681977	0.408	0.731	6.77655245974278e-178	MZT2B	Erythrocytes	GSE199333_post	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32961
2.27769335237893e-181	-0.518908735663408	0.174	0.427	4.83577075643571e-177	NUP50	Erythrocytes	GSE199333_post	ENSG00000093000	10762	nucleoporin 50	NPAP60L	protein_coding	Q9UKX7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32962
5.75906941536226e-181	-0.66919532032668	0.256	0.529	1.22270802757556e-176	METAP2	Erythrocytes	GSE199333_post	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32963
4.18973428989279e-179	0.740908989913404	0.787	0.619	8.89522487087138e-175	YPEL3	Erythrocytes	GSE199333_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32964
7.81188475978606e-179	-0.391424439878342	0.105	0.338	1.65854125335018e-174	GMNN	Erythrocytes	GSE199333_post	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32965
3.33078935318492e-178	-0.640942256337752	0.332	0.597	7.0715988757469e-174	NME4	Erythrocytes	GSE199333_post	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32966
6.97112728231099e-178	1.03363570134733	0.356	0.09	1.48004003330745e-173	IFIT1B	Erythrocytes	GSE199333_post	ENSG00000204010	439996	interferon induced protein with tetratricopeptide repeats 1B	bA149I23.6|IFIT1L	protein_coding	Q5T764	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32967
4.65040219050523e-177	-0.531569908765421	0.14	0.379	9.87326889066165e-173	SLBP	Erythrocytes	GSE199333_post	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32968
5.7006134262978e-177	-0.678525658427829	0.945	0.983	1.21029723653729e-172	MT-CO1	Erythrocytes	GSE199333_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32969
9.1956613518472e-177	1.01475704851796	0.573	0.339	1.95233086161068e-172	SMIM5	Erythrocytes	GSE199333_post	ENSG00000204323	643008	small integral membrane protein 5	C17orf109	protein_coding	Q71RC9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32970
1.81361575484667e-176	-0.409451548464342	0.152	0.399	3.85048760911497e-172	KRR1	Erythrocytes	GSE199333_post	ENSG00000111615	11103	KRR1 small subunit processome component homolog	HRB2|RIP-1	protein_coding	Q13601	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32971
6.39667488931601e-176	0.770122704433931	0.749	0.561	1.35807804575068e-171	NCOA4	Erythrocytes	GSE199333_post	ENSG00000266412	8031	nuclear receptor coactivator 4	ARA70|DKFZp762E1112|ELE1|PTC3|RFG	protein_coding	Q13772	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32972
1.69875663237558e-175	-0.29224095784886	0.067	0.266	3.60663020619659e-171	SLC22A16	Erythrocytes	GSE199333_post	ENSG00000004809	85413	solute carrier family 22 member 16	CT2|FLIPT2|OAT6|OKB1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32973
6.78945674949391e-175	-0.433405039730163	0.215	0.483	1.44146956248505e-170	PIGQ	Erythrocytes	GSE199333_post	ENSG00000007541	9091	phosphatidylinositol glycan anchor biosynthesis class Q	GPI1|hGPI1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32974
8.09200650866124e-175	-0.385206254973639	0.685	0.936	1.71801390185387e-170	MT-ND1	Erythrocytes	GSE199333_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32975
4.88665256928245e-174	0.555413171414652	0.299	0.05	1.03748520698436e-169	RHD	Erythrocytes	GSE199333_post	ENSG00000187010	6007	Rh blood group D antigen	CD240D|DIIIc|RH|Rh30a|Rh4|RhII|RhPI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32976
1.29270826669278e-173	-0.399115820613632	0.124	0.363	2.74454892101544e-169	UBE2T	Erythrocytes	GSE199333_post	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32977
2.62372543133984e-173	-0.479395270388184	0.186	0.462	5.57043146327762e-169	BIRC5	Erythrocytes	GSE199333_post	ENSG00000089685	332	baculoviral IAP repeat containing 5	API4|EPR-1|survivin	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32978
2.86812654593651e-173	-0.509958694442128	0.276	0.558	6.0893194696778e-169	HNRNPM	Erythrocytes	GSE199333_post	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32979
4.86508027262863e-173	-0.9045450535241	0.56	0.825	1.03290519268179e-168	PTMA	Erythrocytes	GSE199333_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32980
5.63644775031398e-173	-0.440385713323148	0.166	0.43	1.19667422186916e-168	CDKN3	Erythrocytes	GSE199333_post	ENSG00000100526	1033	cyclin dependent kinase inhibitor 3	CDI1|KAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32981
1.58207158312804e-172	1.6014814083529	0.288	0.043	3.35889617813913e-168	GDF15	Erythrocytes	GSE199333_post	ENSG00000130513	9518	growth differentiation factor 15	MIC-1|MIC1|NAG-1|PDF|PLAB|PTGFB	protein_coding	Q99988	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32982
3.20694542754232e-172	-0.335850719013379	0.065	0.26	6.80866583721511e-168	PKMYT1	Erythrocytes	GSE199333_post	ENSG00000127564	9088	protein kinase, membrane associated tyrosine/threonine 1	MYT1|PPP1R126	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32983
6.27713524406648e-172	-0.577600749135022	0.194	0.472	1.33269858366775e-167	NUSAP1	Erythrocytes	GSE199333_post	ENSG00000137804	51203	nucleolar and spindle associated protein 1	ANKT|BM037|FLJ13421|LNP|PRO0310p1|Q0310|SAPL	protein_coding	Q9BXS6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32984
8.79074972905171e-172	-0.378888337326355	0.134	0.37	1.86636407497497e-167	ZNF800	Erythrocytes	GSE199333_post	ENSG00000048405	168850	zinc finger protein 800	NA	protein_coding	Q2TB10	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32985
2.17832616917214e-171	0.497717660845961	0.451	0.175	4.62480428976938e-167	RETREG2	Erythrocytes	GSE199333_post	ENSG00000144567	79137	reticulophagy regulator family member 2	C2orf17|FAM134A|MAG-2|MGC3035	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32986
3.36844849193902e-171	-0.47515800531333	0.125	0.36	7.15155299323574e-167	ATAD2	Erythrocytes	GSE199333_post	ENSG00000156802	29028	ATPase family AAA domain containing 2	ANCCA|CT137|DKFZp667N1320|MGC29843|MGC5254|PRO2000	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32987
7.81906628516428e-171	-0.419458938068869	0.227	0.486	1.66006596300323e-166	TCF3	Erythrocytes	GSE199333_post	ENSG00000071564	6929	transcription factor 3	bHLHb21|E2A|E47|ITF1|MGC129647|MGC129648|p75|VDIR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32988
1.03384264434253e-170	-0.468766557140108	0.098	0.316	2.19495131820362e-166	MCM4	Erythrocytes	GSE199333_post	ENSG00000104738	4173	minichromosome maintenance complex component 4	CDC21|CDC54|hCdc21|MGC33310|P1-Cdc21	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32989
2.31537066286068e-170	-0.53423884643234	0.55	0.855	4.91576345431951e-166	DDX5	Erythrocytes	GSE199333_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32990
1.32584591373865e-169	-0.48543037224071	0.251	0.523	2.81490345945852e-165	MTDH	Erythrocytes	GSE199333_post	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32991
3.4912697814287e-169	-0.571076189486833	0.292	0.557	7.41231487295127e-165	SRRM1	Erythrocytes	GSE199333_post	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32992
7.44903976657763e-169	-0.516738800520602	0.648	0.859	1.5815056328421e-164	UROD	Erythrocytes	GSE199333_post	ENSG00000126088	7389	uroporphyrinogen decarboxylase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32993
7.78075261335278e-169	-0.285115047572704	0.063	0.253	1.65193158734093e-164	TMEM86B	Erythrocytes	GSE199333_post	ENSG00000180089	255043	transmembrane protein 86B	MGC30208	protein_coding	Q8N661	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32994
9.64903075787299e-169	-0.454121207229766	0.099	0.31	2.04858572020401e-164	ASNS	Erythrocytes	GSE199333_post	ENSG00000070669	440	asparagine synthetase (glutamine-hydrolyzing)	NA	protein_coding	P08243	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32995
1.28206862751391e-168	0.95697860925333	0.745	0.573	2.72195990307479e-164	MYL4	Erythrocytes	GSE199333_post	ENSG00000198336	4635	myosin light chain 4	ALC1|AMLC|GT1|PRO1957	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32996
1.15541495483568e-167	-0.491266676939179	0.289	0.56	2.45306149061163e-163	RBM25	Erythrocytes	GSE199333_post	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32997
2.17523509976706e-167	-0.361440101827511	0.092	0.303	4.61824164031545e-163	RDX	Erythrocytes	GSE199333_post	ENSG00000137710	5962	radixin	DFNB24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32998
4.30062619244061e-167	0.556393305115412	0.607	0.351	9.13065946917066e-163	TMOD1	Erythrocytes	GSE199333_post	ENSG00000136842	7111	tropomodulin 1	D9S57E|ETMOD|TMOD	protein_coding	P28289	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	32999
5.73204425086071e-167	-0.607098875917382	0.129	0.364	1.21697031490024e-162	ASPM	Erythrocytes	GSE199333_post	ENSG00000066279	259266	assembly factor for spindle microtubules	ASP|Calmbp1|FLJ10517|FLJ10549|MCPH5	protein_coding	Q8IZT6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33000
1.08918184734716e-166	-0.330659108432975	0.107	0.326	2.31244198010275e-162	UGCG	Erythrocytes	GSE199333_post	ENSG00000148154	7357	UDP-glucose ceramide glucosyltransferase	GCS	protein_coding	Q16739	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33001
2.68663821778085e-166	-0.385747814370432	0.18	0.434	5.70400160017051e-162	AMD1	Erythrocytes	GSE199333_post	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33002
2.84109018165984e-166	-0.349485654246522	0.073	0.271	6.03191856468201e-162	ID2	Erythrocytes	GSE199333_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33003
3.1954328137913e-166	0.712308684705629	0.736	0.55	6.7842234069603e-162	RIOK3	Erythrocytes	GSE199333_post	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33004
1.1618655961829e-165	0.750688704488684	0.576	0.325	2.46675684725591e-161	PRDX5	Erythrocytes	GSE199333_post	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33005
2.44844089111712e-165	-0.349047454886817	0.112	0.334	5.19828485593076e-161	SLC2A4RG	Erythrocytes	GSE199333_post	ENSG00000125520	56731	SLC2A4 regulator	GEF|HDBP1|Si-1-2|Si-1-2-19	protein_coding	Q9NR83	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33006
5.48805346283458e-165	-0.34518567010581	0.103	0.317	1.16516863069441e-160	ATP1B2	Erythrocytes	GSE199333_post	ENSG00000129244	482	ATPase Na+/K+ transporting subunit beta 2	AMOG	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33007
5.84475103498921e-165	-0.435007438829738	0.168	0.427	1.24089909223856e-160	SMC2	Erythrocytes	GSE199333_post	ENSG00000136824	10592	structural maintenance of chromosomes 2	CAP-E|hCAP-E|SMC2L1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33008
8.57232197777578e-165	-0.389943514198539	0.208	0.471	1.81998967910158e-160	USP14	Erythrocytes	GSE199333_post	ENSG00000101557	9097	ubiquitin specific peptidase 14	TGT|Ubp6	protein_coding	P54578	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33009
2.49490868750275e-164	-0.412423353625252	0.178	0.425	5.29694063443709e-160	RBM17	Erythrocytes	GSE199333_post	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33010
6.32417219126405e-164	0.397313051347557	0.29	0.05	1.34268499792727e-159	TBCEL	Erythrocytes	GSE199333_post	ENSG00000154114	219899	tubulin folding cofactor E like	LRRC35|MGC10233	protein_coding	Q5QJ74	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33011
6.88932728211029e-164	-0.409126875218597	0.199	0.452	1.46267307526484e-159	HTRA2	Erythrocytes	GSE199333_post	ENSG00000115317	27429	HtrA serine peptidase 2	OMI|PARK13|PRSS25	protein_coding	O43464	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33012
8.16417698731057e-164	-0.42682541371349	0.268	0.528	1.73333641617591e-159	SLC38A5	Erythrocytes	GSE199333_post	ENSG00000017483	92745	solute carrier family 38 member 5	JM24|SN2	protein_coding	Q8WUX1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33013
8.732534503596e-164	-0.536335686762411	0.285	0.558	1.85400440045847e-159	HNRNPD	Erythrocytes	GSE199333_post	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33014
1.41735326457305e-162	-0.435965682926143	0.178	0.422	3.00918271601505e-158	KIF22	Erythrocytes	GSE199333_post	ENSG00000079616	3835	kinesin family member 22	Kid|KNSL4|OBP-1|OBP-2	protein_coding	Q14807	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33015
3.27657696360109e-162	-0.38955892647275	0.166	0.41	6.95650055142148e-158	EPC1	Erythrocytes	GSE199333_post	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33016
4.37660475869021e-162	-0.409394250750622	0.199	0.454	9.29196956317518e-158	ILF3	Erythrocytes	GSE199333_post	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33017
7.8490314502829e-162	-0.56778434592808	0.577	0.764	1.66642786720956e-157	TFDP1	Erythrocytes	GSE199333_post	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33018
1.91208846880195e-161	-0.438818671014265	0.14	0.383	4.05955502811342e-157	RRM2	Erythrocytes	GSE199333_post	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33019
6.30056127493889e-161	-0.474300256424586	0.315	0.587	1.33767216428228e-156	EIF4G2	Erythrocytes	GSE199333_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33020
4.80276672460079e-160	0.508315821984899	0.992	0.994	1.01967540329999e-155	HBA2	Erythrocytes	GSE199333_post	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33021
1.12574225140369e-159	-0.380594785750874	0.198	0.453	2.39006337395518e-155	PPP1CC	Erythrocytes	GSE199333_post	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33022
4.28722965472744e-159	-0.493568650163137	0.373	0.657	9.10221727995184e-155	SFPQ	Erythrocytes	GSE199333_post	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33023
1.39473406862277e-158	-0.534560183890749	0.236	0.484	2.96115990109299e-154	CYC1	Erythrocytes	GSE199333_post	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33024
3.02324469144938e-158	-0.382970883044542	0.129	0.354	6.41865080441618e-154	RFC1	Erythrocytes	GSE199333_post	ENSG00000035928	5981	replication factor C subunit 1	A1|MHCBFB|PO-GA|RFC140	protein_coding	P35251	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33025
8.22443288941643e-158	-0.518626654539804	0.361	0.633	1.746129346752e-153	HNRNPA3	Erythrocytes	GSE199333_post	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33026
8.71437482599048e-158	-0.428493817745696	0.112	0.33	1.85014891930604e-153	MCM5	Erythrocytes	GSE199333_post	ENSG00000100297	4174	minichromosome maintenance complex component 5	CDC46	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33027
1.55483581866836e-156	-0.323172966420859	0.113	0.326	3.30107192661479e-152	YRDC	Erythrocytes	GSE199333_post	ENSG00000196449	79693	yrdC N6-threonylcarbamoyltransferase domain containing	FLJ23476|IRIP|SUA5	protein_coding	Q86U90	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33028
1.77146362969729e-156	-0.383815397005484	0.095	0.302	3.76099443221031e-152	CLSPN	Erythrocytes	GSE199333_post	ENSG00000092853	63967	claspin	NA	protein_coding	Q9HAW4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33029
1.76522299984235e-155	-0.346228866013796	0.074	0.26	3.7477449509653e-151	CDCA8	Erythrocytes	GSE199333_post	ENSG00000134690	55143	cell division cycle associated 8	BOR|DasraB|FLJ12042|MESRGP	protein_coding	Q53HL2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33030
6.49934526458216e-155	-0.466483489053565	0.386	0.669	1.37987599312344e-150	SRSF5	Erythrocytes	GSE199333_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33031
1.30116329197995e-154	-0.335027610188841	0.108	0.317	2.76249978520264e-150	CDC5L	Erythrocytes	GSE199333_post	ENSG00000096401	988	cell division cycle 5 like	CDC5|CEF1|hCDC5|PCDC5RP	protein_coding	Q99459	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33032
7.0584763018097e-154	-0.539819517540293	0.17	0.402	1.49858510363722e-149	MCM7	Erythrocytes	GSE199333_post	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33033
1.11732440410333e-153	-0.425812838242545	0.173	0.413	2.37219144235177e-149	MIS18BP1	Erythrocytes	GSE199333_post	ENSG00000129534	55320	MIS18 binding protein 1	C14orf106|FLJ11186|KIAA1903|KNL2|M18BP1	protein_coding	Q6P0N0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33034
5.1614985870439e-153	-0.424617694635334	0.307	0.577	1.09583776501529e-148	SF3B1	Erythrocytes	GSE199333_post	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33035
1.25034670063547e-152	-0.329188241237183	0.136	0.371	2.65461108011916e-148	WDR34	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33036
9.37684065024338e-152	-0.358084666453226	0.088	0.281	1.99079703845317e-147	HLTF	Erythrocytes	GSE199333_post	ENSG00000071794	6596	helicase like transcription factor	HIP116A|HLTF1|RNF80|SMARCA3|SNF2L3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33037
1.35477461650944e-151	-0.382283169081959	0.241	0.507	2.8763219883112e-147	NUDT1	Erythrocytes	GSE199333_post	ENSG00000106268	4521	nudix hydrolase 1	MTH1	protein_coding	P36639	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33038
2.15428802677942e-151	-0.367926476201128	0.159	0.397	4.57376890965539e-147	SEC22C	Erythrocytes	GSE199333_post	ENSG00000093183	9117	SEC22 homolog C, vesicle trafficking protein	MGC13261|MGC5373|SEC22L3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33039
1.10795372984334e-150	-0.359986513681978	0.108	0.312	2.35229656383039e-146	EIF4A3	Erythrocytes	GSE199333_post	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33040
2.03608009518272e-150	-0.43678595937243	0.213	0.458	4.32280165008243e-146	PSIP1	Erythrocytes	GSE199333_post	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33041
4.03247331671452e-150	-0.436723770294279	0.146	0.374	8.5613440987166e-146	RIF1	Erythrocytes	GSE199333_post	ENSG00000080345	55183	replication timing regulatory factor 1	FLJ10599|FLJ12870	protein_coding	Q5UIP0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33042
5.82502691335826e-150	-0.311581743533523	0.076	0.261	1.23671146397509e-145	CCNT2	Erythrocytes	GSE199333_post	ENSG00000082258	905	cyclin T2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33043
6.46971941192018e-150	-0.407914246009135	0.173	0.422	1.37358612834477e-145	TPX2	Erythrocytes	GSE199333_post	ENSG00000088325	22974	TPX2 microtubule nucleation factor	C20orf1|C20orf2|DIL-2|FLS353|HCA519|p100	protein_coding	Q9ULW0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33044
7.67965727445715e-150	-0.463383859867671	0.288	0.557	1.63046803594e-145	H2AFV	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33045
8.05414341347784e-150	-0.470362311864569	0.292	0.055	1.70997518811548e-145	HBG1	Erythrocytes	GSE199333_post	ENSG00000213934	3047	hemoglobin subunit gamma 1	HBG-T2	protein_coding	P69891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33046
1.70926916939821e-149	-0.427674438851284	0.149	0.373	3.62894937354935e-145	ADD2	Erythrocytes	GSE199333_post	ENSG00000075340	119	adducin 2	ADDB	protein_coding	P35612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33047
1.90803639988936e-149	-0.554338974455667	0.194	0.434	4.05095208060511e-145	CKS2	Erythrocytes	GSE199333_post	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33048
9.00298129265636e-149	0.455485933470873	0.384	0.137	1.91142295824387e-144	UBAP1	Erythrocytes	GSE199333_post	ENSG00000165006	51271	ubiquitin associated protein 1	UBAP	protein_coding	Q9NZ09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33049
9.03406784995229e-149	-0.386812962231973	0.076	0.262	1.91802294522337e-144	HELLS	Erythrocytes	GSE199333_post	ENSG00000119969	3070	helicase, lymphoid specific	LSH|Nbla10143|PASG|SMARCA6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33050
1.03565256323748e-148	-0.313153567230735	0.083	0.272	2.1987939570095e-144	ENDOD1	Erythrocytes	GSE199333_post	ENSG00000149218	23052	endonuclease domain containing 1	KIAA0830	protein_coding	O94919	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33051
1.24259842077641e-148	-0.405792774883552	0.08	0.265	2.6381607071504e-144	MXD3	Erythrocytes	GSE199333_post	ENSG00000213347	83463	MAX dimerization protein 3	bHLHc13|MAD3	protein_coding	Q9BW11	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33052
1.92436971847534e-148	0.691304044964156	0.872	0.772	4.085629349295e-144	EIF1AY	Erythrocytes	GSE199333_post	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33053
8.42993025197883e-148	-0.396452363324299	0.159	0.39	1.78975849179763e-143	BTG3	Erythrocytes	GSE199333_post	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33054
2.03636182497325e-147	-0.425093768188387	0.212	0.461	4.32339979060071e-143	TUBG1	Erythrocytes	GSE199333_post	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33055
6.17311263556176e-147	-0.401523728367312	0.162	0.388	1.31061354365612e-142	PSMD12	Erythrocytes	GSE199333_post	ENSG00000197170	5718	proteasome 26S subunit, non-ATPase 12	p55|Rpn5	protein_coding	O00232	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33056
7.28959647038691e-147	-0.26130940281635	0.61	0.917	1.54765422662784e-142	MT-ND3	Erythrocytes	GSE199333_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33057
1.69314870709316e-146	-0.385926695041527	0.211	0.455	3.59472402002949e-142	FRG1	Erythrocytes	GSE199333_post	ENSG00000275145	2483	FSHD region gene 1	FRG1A|FSG1	protein_coding	Q14331	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33058
5.26638654691256e-146	-0.460134742128677	0.276	0.523	1.11810652777501e-141	CBX3	Erythrocytes	GSE199333_post	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33059
5.60416919664337e-146	0.767929331480006	0.359	0.122	1.18982116213935e-141	RSAD2	Erythrocytes	GSE199333_post	ENSG00000134321	91543	radical S-adenosyl methionine domain containing 2	cig5|vig1|Viperin	protein_coding	Q8WXG1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33060
8.57186463387102e-146	-0.480043084962655	0.198	0.436	1.81989258041716e-141	RPA3	Erythrocytes	GSE199333_post	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33061
4.16216541992232e-145	-0.359343419560161	0.141	0.37	8.83669340303708e-141	CENPW	Erythrocytes	GSE199333_post	ENSG00000203760	387103	centromere protein W	C6orf173|CUG2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33062
4.34501248934975e-144	-0.446462901908039	0.31	0.557	9.22489601613845e-140	SF3B6	Erythrocytes	GSE199333_post	ENSG00000115128	51639	splicing factor 3b subunit 6	CGI-110|Ht006|P14|SAP14a|SF3B14a	protein_coding	Q9Y3B4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33063
4.83560166738777e-144	0.486258700507289	0.422	0.177	1.0266465900031e-139	PNPLA2	Erythrocytes	GSE199333_post	ENSG00000177666	57104	patatin like phospholipase domain containing 2	ATGL|desnutrin|FP17548|iPLA2zeta|TTS-2.2	protein_coding	Q96AD5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33064
6.99149648846249e-144	-0.340718893433124	0.123	0.34	1.48436461946547e-139	MYBL2	Erythrocytes	GSE199333_post	ENSG00000101057	4605	MYB proto-oncogene like 2	B-MYB|BMYB	protein_coding	P10244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33065
1.39746368619761e-143	0.46372611474477	0.367	0.127	2.96695515216614e-139	B4GALT3	Erythrocytes	GSE199333_post	ENSG00000158850	8703	beta-1,4-galactosyltransferase 3	beta4Gal-T3	protein_coding	O60512	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33066
2.26651307029773e-143	-0.305535202357061	0.47	0.764	4.81203389954911e-139	TXNIP	Erythrocytes	GSE199333_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33067
2.41110331663218e-143	-0.462961041092949	0.339	0.606	5.11901345154179e-139	GSTP1	Erythrocytes	GSE199333_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33068
2.45554426412666e-143	-0.420472698850049	0.284	0.552	5.21336602716732e-139	ANP32E	Erythrocytes	GSE199333_post	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33069
4.25847919984379e-142	-0.40966198740812	0.128	0.338	9.04117718918835e-138	KNL1	Erythrocytes	GSE199333_post	ENSG00000137812	57082	kinetochore scaffold 1	AF15Q14|CASC5|CT29|D40|hKNL-1|hSpc105|KIAA1570|MCPH4|PPP1R55|Spc7	protein_coding	Q8NG31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33070
1.2988627854394e-141	-0.344416732573184	0.361	0.668	2.75761557976638e-137	HMGN2	Erythrocytes	GSE199333_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33071
1.41556051982117e-140	0.394233738103137	0.395	0.15	3.00537653963232e-136	PINK1	Erythrocytes	GSE199333_post	ENSG00000158828	65018	PTEN induced kinase 1	BRPK|PARK6	protein_coding	Q9BXM7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33072
1.92797077971826e-140	-0.359227036837587	0.097	0.29	4.09327476241983e-136	KIF23	Erythrocytes	GSE199333_post	ENSG00000137807	9493	kinesin family member 23	KNSL5|MKLP-1|MKLP1	protein_coding	Q02241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33073
3.23992418634886e-140	-0.263735824649227	0.078	0.258	6.87868304003726e-136	CARM1	Erythrocytes	GSE199333_post	ENSG00000142453	10498	coactivator associated arginine methyltransferase 1	PRMT4	protein_coding	Q86X55	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33074
4.27085778563358e-140	-0.361516340353732	0.104	0.298	9.06745816467865e-136	SERTAD2	Erythrocytes	GSE199333_post	ENSG00000179833	9792	SERTA domain containing 2	KIAA0127|Sei-2|TRIP-Br2	protein_coding	Q14140	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33075
1.18433762497045e-139	-0.459350126666951	0.198	0.453	2.51446721157476e-135	PCLAF	Erythrocytes	GSE199333_post	ENSG00000166803	9768	PCNA clamp associated factor	KIAA0101|NS5ATP9|OEATC-1|p15(PAF)|PAF15	protein_coding	Q15004	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33076
1.76176441117973e-139	-0.417318042339734	0.373	0.655	3.74040202137569e-135	SLC25A3	Erythrocytes	GSE199333_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33077
2.07705423808399e-139	-0.470732693265003	0.274	0.515	4.40979385287611e-135	DDT	Erythrocytes	GSE199333_post	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33078
2.3701208891103e-139	-0.35222815809776	0.115	0.313	5.03200365967007e-135	GAR1	Erythrocytes	GSE199333_post	ENSG00000109534	54433	GAR1 ribonucleoprotein	NOLA1	protein_coding	Q9NY12	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33079
4.55896450101025e-139	-0.381962528398213	0.237	0.484	9.67913753209487e-135	RFESD	Erythrocytes	GSE199333_post	ENSG00000175449	317671	Rieske Fe-S domain containing	NA	protein_coding	Q8TAC1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33080
1.32073201450068e-138	-0.445572903854715	0.192	0.42	2.8040461399864e-134	BOLA3	Erythrocytes	GSE199333_post	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33081
4.56878952988786e-138	-0.313367941823466	0.102	0.295	9.69999705090491e-134	FAM76B	Erythrocytes	GSE199333_post	ENSG00000077458	143684	family with sequence similarity 76 member B	MGC33371	protein_coding	Q5HYJ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33082
1.1048539786297e-137	-0.400335798300343	0.25	0.5	2.34571548202871e-133	PCM1	Erythrocytes	GSE199333_post	ENSG00000078674	5108	pericentriolar material 1	PTC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33083
1.36359221537868e-137	-0.424662240755439	0.258	0.497	2.89504263247047e-133	NDUFC1	Erythrocytes	GSE199333_post	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33084
5.29269783234697e-137	-0.314096056643935	0.091	0.276	1.12369267678559e-132	ILF3-DT	Erythrocytes	GSE199333_post	ENSG00000267100	147727	ILF3 divergent transcript	ILF3-AS1	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33085
2.2646361931105e-136	0.512356102241593	0.786	0.554	4.80804910159289e-132	NDUFA4	Erythrocytes	GSE199333_post	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33086
6.87441373790174e-136	-0.373024475619778	0.187	0.412	1.45950678069392e-131	BRD7	Erythrocytes	GSE199333_post	ENSG00000166164	29117	bromodomain containing 7	BP75|CELTIX1|SMARCI1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33087
2.71735451906428e-134	0.353375671894233	0.327	0.098	5.76921537942538e-130	AC130456.3	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33088
5.86123312501986e-134	-0.395639525681232	0.179	0.399	1.24439840477297e-129	PHF3	Erythrocytes	GSE199333_post	ENSG00000118482	23469	PHD finger protein 3	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33089
8.59317596023516e-134	-0.368823802085121	0.195	0.423	1.82441718811753e-129	PRKAR2B	Erythrocytes	GSE199333_post	ENSG00000284096	5577	protein kinase cAMP-dependent type II regulatory subunit beta	PRKAR2	protein_coding	P31323	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33090
1.67787873893416e-133	-0.313412769221775	0.125	0.328	3.56230435063111e-129	VRK1	Erythrocytes	GSE199333_post	ENSG00000100749	7443	VRK serine/threonine kinase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33091
2.4041982930186e-132	-0.298492497295482	0.094	0.278	5.10435339590779e-128	CDC40	Erythrocytes	GSE199333_post	ENSG00000168438	51362	cell division cycle 40	EHB3|FLJ10564|PRP17|PRPF17	protein_coding	O60508	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33092
2.83177322785856e-132	-0.329680346967848	0.167	0.385	6.01213774006651e-128	SCFD1	Erythrocytes	GSE199333_post	ENSG00000092108	23256	sec1 family domain containing 1	C14orf163|KIAA0917|RA410|SLY1|STXBP1L2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33093
6.38903161726999e-132	-0.377550542757449	0.184	0.404	1.35645530266259e-127	EIF1AX	Erythrocytes	GSE199333_post	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33094
7.11341789574825e-132	-0.280648690353564	0.09	0.271	1.51024975344631e-127	MIA3	Erythrocytes	GSE199333_post	ENSG00000154305	375056	MIA SH3 domain ER export factor 3	FLJ39207|KIAA0268|TANGO|TANGO1|UNQ6077	protein_coding	Q5JRA6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33095
1.57911455479392e-131	-0.385825172938901	0.157	0.368	3.35261811128297e-127	BUB3	Erythrocytes	GSE199333_post	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33096
1.77258347217688e-131	-0.353107940690017	0.144	0.351	3.76337196977872e-127	SNRNP200	Erythrocytes	GSE199333_post	ENSG00000144028	23020	small nuclear ribonucleoprotein U5 subunit 200	ASCC3L1|BRR2|HELIC2|KIAA0788|RP33|U5-200KD	protein_coding	O75643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33097
4.39951383462605e-131	-0.315184335673762	0.131	0.334	9.34060782229457e-127	QKI	Erythrocytes	GSE199333_post	ENSG00000112531	9444	QKI, KH domain containing RNA binding	QK3	protein_coding	Q96PU8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33098
1.55409974193508e-130	-0.310675708557409	0.12	0.319	3.29950916210236e-126	AQP3	Erythrocytes	GSE199333_post	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33099
1.6124185093086e-130	-0.315413437052472	0.094	0.28	3.42332573711309e-126	ORC6	Erythrocytes	GSE199333_post	ENSG00000091651	23594	origin recognition complex subunit 6	ORC6L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33100
1.75237573765076e-130	-0.35282555145996	0.135	0.335	3.72046892860633e-126	BAZ1B	Erythrocytes	GSE199333_post	ENSG00000009954	9031	bromodomain adjacent to zinc finger domain 1B	WBSCR10|WBSCR9|WSTF	protein_coding	Q9UIG0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33101
2.4126980520148e-130	-0.340965193530826	0.243	0.474	5.12239923423263e-126	GUCD1	Erythrocytes	GSE199333_post	ENSG00000138867	83606	guanylyl cyclase domain containing 1	C22orf13|LLN4|MGC1842	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33102
3.22409935807591e-130	-0.408422290752865	0.157	0.369	6.84508534713097e-126	KPNA2	Erythrocytes	GSE199333_post	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33103
6.87363942948347e-130	-0.314968536275083	0.107	0.296	1.45934238727363e-125	XPO1	Erythrocytes	GSE199333_post	ENSG00000082898	7514	exportin 1	CRM-1|CRM1|emb	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33104
9.3032749929459e-130	-0.383475791486989	0.214	0.443	1.97517831375234e-125	SF3B2	Erythrocytes	GSE199333_post	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33105
9.42388668801795e-130	-0.376609979519383	0.192	0.412	2.00078538273309e-125	EIF4H	Erythrocytes	GSE199333_post	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33106
1.08169043217668e-129	-0.299752433983129	0.101	0.29	2.2965369565543e-125	NCAPG	Erythrocytes	GSE199333_post	ENSG00000109805	64151	non-SMC condensin I complex subunit G	CAP-G|FLJ12450|hCAP-G|YCG1	protein_coding	Q9BPX3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33107
4.60858705975998e-129	-0.351627794006008	0.194	0.414	9.78449118657641e-125	SPTB	Erythrocytes	GSE199333_post	ENSG00000070182	6710	spectrin beta, erythrocytic	NA	protein_coding	P11277	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33108
5.62154652436048e-129	-0.500674846996633	0.258	0.486	1.19351054258697e-124	FAM117A	Erythrocytes	GSE199333_post	ENSG00000121104	81558	family with sequence similarity 117 member A	NA	protein_coding	Q9C073	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33109
1.38399832164123e-128	-0.384690592633787	0.237	0.465	2.9383668366765e-124	NDUFS8	Erythrocytes	GSE199333_post	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33110
2.30476567390363e-128	-0.367101731726725	0.166	0.375	4.89324800226479e-124	TARS	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33111
3.3300742608501e-128	-0.368254145095443	0.187	0.409	7.07008066321084e-124	OGA	Erythrocytes	GSE199333_post	ENSG00000198408	10724	O-GlcNAcase	MEA5|MGEA5|NCOAT	protein_coding	O60502	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33112
1.82181290199408e-127	-0.40820826438304	0.387	0.639	3.86789097222362e-123	PSMB1	Erythrocytes	GSE199333_post	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33113
2.41073080402748e-127	-0.467015508867925	0.096	0.279	5.11822257003075e-123	CDC20	Erythrocytes	GSE199333_post	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33114
2.72767855223577e-127	-0.258125118652211	0.086	0.261	5.79113433425176e-123	KAT7	Erythrocytes	GSE199333_post	ENSG00000136504	11143	lysine acetyltransferase 7	HBO1|HBOA|MYST2|ZC2HC7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33115
5.34680645249553e-127	-0.321384910676929	0.121	0.312	1.13518047792933e-122	ERFE	Erythrocytes	GSE199333_post	ENSG00000178752	151176	erythroferrone	C1QTNF15|CTRP15|FAM132B|FLJ37034	protein_coding	Q4G0M1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33116
2.21801291863819e-126	0.526308371041519	0.749	0.591	4.70906322756075e-122	TERF2IP	Erythrocytes	GSE199333_post	ENSG00000166848	54386	TERF2 interacting protein	RAP1	protein_coding	Q9NYB0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33117
2.98140535319297e-126	-0.349084808377602	0.226	0.455	6.32982170536399e-122	SEPT2	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33118
3.17037261323851e-126	-0.279009359370548	0.099	0.281	6.73101809516668e-122	CNOT1	Erythrocytes	GSE199333_post	ENSG00000125107	23019	CCR4-NOT transcription complex subunit 1	AD-005|CDC39|KIAA1007|NOT1|NOT1H	protein_coding	A5YKK6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33119
6.64641827688321e-126	-0.37854250843361	0.276	0.518	1.41110106436508e-121	ALAD	Erythrocytes	GSE199333_post	ENSG00000148218	210	aminolevulinate dehydratase	ALADH|PBGS	protein_coding	P13716	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33120
8.23586599224758e-126	-0.430218880088094	0.37	0.612	1.74855670881408e-121	GADD45A	Erythrocytes	GSE199333_post	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33121
1.92390524057909e-125	-0.308866354120202	0.083	0.256	4.08464321627346e-121	ESCO2	Erythrocytes	GSE199333_post	ENSG00000171320	157570	establishment of sister chromatid cohesion N-acetyltransferase 2	EFO2|RBS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33122
2.24368635905102e-125	-0.707957793323149	0.335	0.563	4.76357050890121e-121	NCL	Erythrocytes	GSE199333_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33123
2.28437699828752e-125	-0.323490224528377	0.187	0.412	4.84996080506423e-121	GGNBP2	Erythrocytes	GSE199333_post	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33124
2.38833718008233e-125	-0.548547957468174	0.458	0.665	5.07067866703279e-121	PTMS	Erythrocytes	GSE199333_post	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33125
4.45789812619184e-125	-0.357371474298459	0.179	0.393	9.4645635117179e-121	KMT5A	Erythrocytes	GSE199333_post	ENSG00000183955	387893	lysine methyltransferase 5A	PR-Set7|SET07|SET8|SETD8	protein_coding	Q9NQR1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33126
6.80863568082964e-125	-0.491481480479881	0.906	0.949	1.44554144139694e-120	BLVRB	Erythrocytes	GSE199333_post	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33127
7.36170395021236e-125	-0.331439256001165	0.183	0.398	1.56296336566959e-120	DHX29	Erythrocytes	GSE199333_post	ENSG00000067248	54505	DExH-box helicase 29	DDX29	protein_coding	Q7Z478	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33128
8.08992361384705e-125	-0.439670826402351	0.241	0.466	1.71757168245587e-120	CCNL1	Erythrocytes	GSE199333_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33129
1.59651870448276e-124	-0.373223639964554	0.197	0.418	3.38956886148736e-120	KMT2A	Erythrocytes	GSE199333_post	ENSG00000118058	4297	lysine methyltransferase 2A	ALL-1|ALL1|CXXC7|HRX|HTRX|HTRX1|MLL|MLL1|MLL1A|TRX1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33130
5.96303229963701e-124	0.374116604616116	0.399	0.169	1.26601138753593e-119	ABTB1	Erythrocytes	GSE199333_post	ENSG00000114626	80325	ankyrin repeat and BTB domain containing 1	BPOZ|Btb3|BTBD21|EF1ABP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33131
7.63086397171504e-124	-0.340009145728862	0.156	0.36	1.62010872983482e-119	KIAA1586	Erythrocytes	GSE199333_post	ENSG00000168116	57691	KIAA1586	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33132
1.03330498134787e-123	-0.402867612776131	0.258	0.491	2.19380980589965e-119	ARGLU1	Erythrocytes	GSE199333_post	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33133
2.08756971834832e-123	-0.411311245509298	0.212	0.425	4.43211926902532e-119	E2F2	Erythrocytes	GSE199333_post	ENSG00000282899	1870	E2F transcription factor 2	E2F-2	protein_coding	Q14209	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33134
3.6008963379901e-123	-0.407561553912274	0.609	0.818	7.64506301518678e-119	HNRNPK	Erythrocytes	GSE199333_post	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33135
5.84036031512737e-123	-0.49594265899571	0.22	0.442	1.23996689850469e-118	SNRPG	Erythrocytes	GSE199333_post	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33136
9.44698915528425e-123	-0.419100665752481	0.23	0.454	2.0056902675584e-118	HNRNPR	Erythrocytes	GSE199333_post	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33137
1.56463367331662e-122	-0.397806922560968	0.433	0.685	3.32187375181852e-118	LGALS3	Erythrocytes	GSE199333_post	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33138
2.39421080686106e-122	-0.417971816980495	0.22	0.438	5.08314896404672e-118	TCP1	Erythrocytes	GSE199333_post	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33139
3.8521510739474e-122	0.40118930525187	0.322	0.107	8.17850194509773e-118	ATP6V0E1	Erythrocytes	GSE199333_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33140
3.65515738379934e-121	0.414810545688436	0.466	0.238	7.76026464154437e-117	VTI1B	Erythrocytes	GSE199333_post	ENSG00000100568	10490	vesicle transport through interaction with t-SNAREs 1B	VTI2	protein_coding	Q9UEU0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33141
4.98731020271892e-121	0.721954080166071	0.705	0.566	1.05885582913925e-116	KLF1	Erythrocytes	GSE199333_post	ENSG00000105610	10661	KLF transcription factor 1	EKLF	protein_coding	Q13351	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33142
7.41040454201474e-121	-0.406577571759143	0.282	0.516	1.57330298831515e-116	KMT2E	Erythrocytes	GSE199333_post	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33143
5.24820691384153e-120	-0.280714027412032	0.104	0.288	1.1142468098777e-115	FEN1	Erythrocytes	GSE199333_post	ENSG00000168496	2237	flap structure-specific endonuclease 1	FEN-1|MF1|RAD2	protein_coding	P39748	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33144
5.64444792690042e-120	-0.306024074278975	0.137	0.334	1.19837273936023e-115	PKN2	Erythrocytes	GSE199333_post	ENSG00000065243	5586	protein kinase N2	Pak-2|PRK2|PRKCL2|STK7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33145
6.2205348494754e-120	-0.328044055169336	0.131	0.322	1.32068175389212e-115	DYNC1H1	Erythrocytes	GSE199333_post	ENSG00000197102	1778	dynein cytoplasmic 1 heavy chain 1	CMT2O|DHC1|DNCH1|Dnchc1|DNCL|DNECL|HL-3|p22	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33146
7.29391309662781e-120	-0.433231676476674	0.131	0.328	1.54857068954505e-115	CENPE	Erythrocytes	GSE199333_post	ENSG00000138778	1062	centromere protein E	KIF10|PPP1R61	protein_coding	Q02224	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33147
8.74750575666559e-120	-0.462069470376154	0.444	0.68	1.85718294719767e-115	SUMO2	Erythrocytes	GSE199333_post	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33148
9.09414082524525e-120	-0.321975172034308	0.454	0.691	1.93077703860782e-115	TCEA1	Erythrocytes	GSE199333_post	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33149
1.14251493134335e-119	-0.263684975439801	0.083	0.25	2.42567345073507e-115	NSD1	Erythrocytes	GSE199333_post	ENSG00000165671	64324	nuclear receptor binding SET domain protein 1	ARA267|FLJ22263|KMT3B|STO	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33150
3.16012744613135e-119	-0.301786984980793	0.125	0.314	6.70926658088147e-115	PPP4R3A	Erythrocytes	GSE199333_post	ENSG00000100796	55671	protein phosphatase 4 regulatory subunit 3A	FLFL1|FLJ20707|KIAA2010|MSTP033|PP4R3|SMEK1|smk-1|smk1	protein_coding	Q6IN85	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33151
3.33677031321896e-119	-0.3350318756005	0.139	0.344	7.08429705199518e-115	TOP2A	Erythrocytes	GSE199333_post	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33152
1.03643230645859e-118	0.436263323404234	0.588	0.372	2.20044942984222e-114	HPS1	Erythrocytes	GSE199333_post	ENSG00000107521	3257	HPS1 biogenesis of lysosomal organelles complex 3 subunit 1	BLOC3S1|HPS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33153
1.58567522749741e-118	-0.37474575520529	0.196	0.407	3.36654707549974e-114	PTBP1	Erythrocytes	GSE199333_post	ENSG00000011304	5725	polypyrimidine tract binding protein 1	HNRNP-I|HNRPI|pPTB|PTB|PTB-1|PTB2|PTB3|PTB4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33154
1.64272350636231e-118	-0.338639625290005	0.2	0.415	3.48766627635782e-114	EWSR1	Erythrocytes	GSE199333_post	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33155
2.60713956068234e-118	-0.627927034373792	0.142	0.332	5.53521800128468e-114	KCNH2	Erythrocytes	GSE199333_post	ENSG00000055118	3757	potassium voltage-gated channel subfamily H member 2	erg1|HERG|Kv11.1|LQT2	protein_coding	Q12809	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33156
3.618571390351e-118	-0.442055189382606	0.192	0.395	7.68258891885422e-114	HSPA9	Erythrocytes	GSE199333_post	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33157
5.4685033719499e-118	-0.288031551799767	0.121	0.307	1.16101795089868e-113	PDZD8	Erythrocytes	GSE199333_post	ENSG00000165650	118987	PDZ domain containing 8	bA129M16.2|FLJ34427|PDZK8	protein_coding	Q8NEN9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33158
7.51414777468487e-118	0.693820157001205	0.882	0.897	1.59532871404335e-113	SNCA	Erythrocytes	GSE199333_post	ENSG00000145335	6622	synuclein alpha	NACP|PARK1|PARK4|PD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33159
9.6631760498422e-118	-0.344165552676317	0.172	0.374	2.051588907142e-113	RBBP4	Erythrocytes	GSE199333_post	ENSG00000162521	5928	RB binding protein 4, chromatin remodeling factor	lin-53|NURF55|RbAp48	protein_coding	Q09028	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33160
1.31110413111374e-117	-0.353985592673851	0.16	0.36	2.78360518076758e-113	MRPL37	Erythrocytes	GSE199333_post	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33161
3.39110115339732e-117	-0.434563809978833	0.267	0.495	7.19964685877784e-113	JUNB	Erythrocytes	GSE199333_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33162
4.42276152273687e-117	-0.381121802899909	0.423	0.655	9.38996498892265e-113	PTP4A2	Erythrocytes	GSE199333_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33163
7.04131863022558e-117	-0.422471305920834	0.264	0.49	1.49494235838319e-112	GOLGA4	Erythrocytes	GSE199333_post	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33164
1.23606583291949e-116	0.445432722427768	0.566	0.351	2.62429136987138e-112	VPS28	Erythrocytes	GSE199333_post	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33165
2.3444336302955e-116	-0.353885539791059	0.208	0.424	4.97746704048037e-112	DDX46	Erythrocytes	GSE199333_post	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33166
3.62391341351012e-116	0.480782664039265	0.674	0.498	7.69393056822335e-112	MAF1	Erythrocytes	GSE199333_post	ENSG00000179632	84232	MAF1 homolog, negative regulator of RNA polymerase III	DKFZp586G1123	protein_coding	Q9H063	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33167
3.84358844983871e-116	0.439456629743191	0.506	0.282	8.16032263785257e-112	PIP4K2A	Erythrocytes	GSE199333_post	ENSG00000150867	5305	phosphatidylinositol-5-phosphate 4-kinase type 2 alpha	PIP5K2A|PIP5KIIA|PIP5KIIalpha	protein_coding	P48426	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33168
5.58124754482416e-116	-0.32396459012348	0.131	0.322	1.18495466624162e-111	EZH2	Erythrocytes	GSE199333_post	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33169
7.7985077554757e-116	-0.318042430916694	0.248	0.484	1.65570118156505e-111	MINPP1	Erythrocytes	GSE199333_post	ENSG00000107789	9562	multiple inositol-polyphosphate phosphatase 1	MIPP	protein_coding	Q9UNW1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33170
1.15223145101197e-115	-0.269178351254487	0.087	0.251	2.44630259364351e-111	SRRT	Erythrocytes	GSE199333_post	ENSG00000087087	51593	serrate, RNA effector molecule	ARS2|Asr2|serrate	protein_coding	Q9BXP5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33171
1.19468390841601e-115	-0.359797436596403	0.865	0.922	2.53643340595803e-111	FBXO7	Erythrocytes	GSE199333_post	ENSG00000100225	25793	F-box protein 7	Fbx|FBX7|PARK15	protein_coding	Q9Y3I1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33172
1.39217096689973e-115	-0.392629330746777	0.732	0.952	2.95571817982481e-111	RPS27A	Erythrocytes	GSE199333_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33173
2.88446587125605e-115	-0.342969578782961	0.211	0.43	6.12400949126371e-111	SRSF4	Erythrocytes	GSE199333_post	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33174
3.2006453149465e-115	0.620610390331736	0.978	0.982	6.79529006816291e-111	UBB	Erythrocytes	GSE199333_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33175
3.24845613989298e-115	-0.557440199371498	0.396	0.618	6.89679723060679e-111	SERBP1	Erythrocytes	GSE199333_post	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33176
3.86381178958838e-115	-0.293103738886988	0.129	0.319	8.20325881047508e-111	TACC3	Erythrocytes	GSE199333_post	ENSG00000013810	10460	transforming acidic coiled-coil containing protein 3	ERIC-1|ERIC1|maskin|Tacc4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33177
4.04160515911828e-115	-0.363275115089282	0.17	0.373	8.58073191332402e-111	EPRS	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33178
4.2484594865682e-115	-0.27708040476982	0.122	0.312	9.01990433593294e-111	CCNA2	Erythrocytes	GSE199333_post	ENSG00000145386	890	cyclin A2	CCN1|CCNA	protein_coding	P20248	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33179
1.15837490308261e-114	-0.369479002674944	0.153	0.352	2.45934575673468e-110	DHFR	Erythrocytes	GSE199333_post	ENSG00000228716	1719	dihydrofolate reductase	NA	protein_coding	P00374	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33180
1.74017344139248e-114	-0.423856125487572	0.422	0.658	3.69456223342038e-110	SUB1	Erythrocytes	GSE199333_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33181
2.45024749216937e-114	-0.302629187361618	0.161	0.359	5.2021204506248e-110	MIER1	Erythrocytes	GSE199333_post	ENSG00000198160	57708	MIER1 transcriptional regulator	hMI-ER1|KIAA1610|MI-ER1	protein_coding	Q8N108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33182
4.48654748829104e-114	-0.502741239332616	0.459	0.657	9.52538897239071e-110	COX5B	Erythrocytes	GSE199333_post	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33183
1.14567453175338e-113	-0.364914915558707	0.181	0.379	2.4323815983656e-109	TXNL4A	Erythrocytes	GSE199333_post	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33184
2.65588322720486e-113	-0.254188506387267	0.101	0.272	5.63870567967864e-109	SNX22	Erythrocytes	GSE199333_post	ENSG00000157734	79856	sorting nexin 22	FLJ13952	protein_coding	Q96L94	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33185
3.20896403241419e-113	-0.379943932614821	0.446	0.681	6.81295153721856e-109	CALM3	Erythrocytes	GSE199333_post	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33186
5.54675616457992e-113	-0.300008267712816	0.161	0.359	1.17763180130196e-108	MPDU1	Erythrocytes	GSE199333_post	ENSG00000129255	9526	mannose-P-dolichol utilization defect 1	CDGIf|Lec35|PQLC5|SL15|SLC66A5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33187
1.21770437414715e-112	0.364597328178908	0.384	0.165	2.58530815675181e-108	PCMTD1	Erythrocytes	GSE199333_post	ENSG00000168300	115294	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1	FLJ10883	protein_coding	Q96MG8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33188
1.28088251258273e-112	-0.399886072239815	0.246	0.461	2.7194416624644e-108	UQCRFS1	Erythrocytes	GSE199333_post	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33189
3.02892590615479e-112	0.553180617614261	0.581	0.397	6.43071259135724e-108	CDC34	Erythrocytes	GSE199333_post	ENSG00000099804	997	cell division cycle 34, ubiqiutin conjugating enzyme	E2-CDC34|UBC3|UBE2R1	protein_coding	P49427	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33190
3.904972521162e-112	-0.275305567769019	0.131	0.322	8.29064715967904e-108	NSD2	Erythrocytes	GSE199333_post	ENSG00000109685	7468	nuclear receptor binding SET domain protein 2	KMT3G|MMSET|WHSC1	protein_coding	O96028	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33191
4.48097749476421e-112	-0.277634632849843	0.136	0.332	9.51356331913389e-108	PRC1	Erythrocytes	GSE199333_post	ENSG00000198901	9055	protein regulator of cytokinesis 1	ASE1	protein_coding	O43663	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33192
6.83461218043122e-112	-0.276414503411801	0.124	0.31	1.45105651202735e-107	HMGXB4	Erythrocytes	GSE199333_post	ENSG00000100281	10042	HMG-box containing 4	HMG2L1|P53N|THC211630	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33193
1.02702822518999e-111	-0.342085373796095	0.253	0.47	2.18048362490087e-107	MMADHC	Erythrocytes	GSE199333_post	ENSG00000168288	27249	metabolism of cobalamin associated D	C2orf25|cblD|CL25022	protein_coding	Q9H3L0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33194
1.35521585107667e-111	-0.429912112896728	0.148	0.334	2.87725877342087e-107	SLC20A1	Erythrocytes	GSE199333_post	ENSG00000144136	6574	solute carrier family 20 member 1	Glvr-1|GLVR1|PiT-1|PiT1	protein_coding	Q8WUM9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33195
2.91329526710135e-111	0.554259337969352	0.473	0.267	6.18521718158287e-107	YPEL4	Erythrocytes	GSE199333_post	ENSG00000166793	219539	yippee like 4	FLJ30213	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33196
3.68705463315465e-111	-0.329007125282034	0.124	0.303	7.82798569165063e-107	DDX3Y	Erythrocytes	GSE199333_post	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33197
4.0156247946037e-111	-0.303727342848085	0.178	0.382	8.52557300142311e-107	RABL6	Erythrocytes	GSE199333_post	ENSG00000196642	55684	RAB, member RAS oncogene family like 6	bA216L13.9|C9orf86|FLJ10101|FLJ13045|Parf|pp8875|RBEL1	protein_coding	Q3YEC7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33198
4.79948489662227e-111	-0.261348440448145	0.099	0.271	1.01897863840187e-106	NDC80	Erythrocytes	GSE199333_post	ENSG00000080986	10403	NDC80 kinetochore complex component	HEC|HEC1|hsNDC80|KNTC2|TID3	protein_coding	O14777	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33199
6.81680238525674e-111	-0.409844703607693	0.333	0.552	1.44727531441386e-106	DDX6	Erythrocytes	GSE199333_post	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33200
1.06880982710283e-110	0.370983208764491	0.995	0.997	2.26919014392202e-106	HBA1	Erythrocytes	GSE199333_post	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33201
1.38087764127459e-110	-0.288937454506337	0.172	0.371	2.93174132019009e-106	MED10	Erythrocytes	GSE199333_post	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33202
2.00079019677038e-110	-0.327472563691716	0.234	0.454	4.2478776667632e-106	MT-ND4L	Erythrocytes	GSE199333_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33203
2.75340543532586e-110	-0.353961388110163	0.224	0.439	5.84575507974033e-106	U2SURP	Erythrocytes	GSE199333_post	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33204
2.81340416268034e-110	-0.271581628197204	0.103	0.273	5.97313837778664e-106	DBF4	Erythrocytes	GSE199333_post	ENSG00000006634	10926	DBF4 zinc finger	ASK|chif|DBF4A|ZDBF1	protein_coding	Q9UBU7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33205
4.53227586084558e-110	-0.259182941798235	0.118	0.297	9.62247488016126e-106	FBXO3	Erythrocytes	GSE199333_post	ENSG00000110429	26273	F-box protein 3	FBA|FBX3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33206
5.31686309245624e-110	0.536231986129042	0.44	0.226	1.12882320315938e-105	NATD1	Erythrocytes	GSE199333_post	ENSG00000274180	256302	N-acetyltransferase domain containing 1	C17orf103|Gtlf3b|MGC33894	protein_coding	Q8N6N6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33207
1.69058622314033e-109	-0.312315302674107	0.156	0.36	3.58928361034923e-105	DLGAP5	Erythrocytes	GSE199333_post	ENSG00000126787	9787	DLG associated protein 5	DLG1|DLG7|HURP|KIAA0008	protein_coding	Q15398	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33208
1.99475012427964e-109	-0.33823372475634	0.3	0.546	4.23505398885809e-105	NUCKS1	Erythrocytes	GSE199333_post	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33209
2.15463717688021e-109	-0.302226749060515	0.157	0.347	4.57451019023438e-105	MAPK1IP1L	Erythrocytes	GSE199333_post	ENSG00000168175	93487	mitogen-activated protein kinase 1 interacting protein 1 like	C14orf32	protein_coding	Q8NDC0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33210
3.26665569262838e-109	-0.285563010380498	0.121	0.297	6.93543670101932e-105	IRS2	Erythrocytes	GSE199333_post	ENSG00000185950	8660	insulin receptor substrate 2	NA	protein_coding	Q9Y4H2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33211
4.02069469777015e-109	-0.337781047854314	0.339	0.584	8.5363369128358e-105	HNRNPH1	Erythrocytes	GSE199333_post	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33212
5.18449375087324e-109	-0.297259378664825	0.174	0.369	1.1007198682479e-104	AUP1	Erythrocytes	GSE199333_post	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33213
1.80170046883873e-108	-0.275393728667534	0.1	0.268	3.82519026539151e-104	HJURP	Erythrocytes	GSE199333_post	ENSG00000123485	55355	Holliday junction recognition protein	DKFZp762E1312|FAKTS|hFLEG1|URLC9	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33214
2.77803139657311e-108	-0.410932004127279	0.687	0.913	5.89803845806437e-104	RPL24	Erythrocytes	GSE199333_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33215
5.99327894966985e-108	-0.356581747158706	0.212	0.425	1.27243305380441e-103	PHIP	Erythrocytes	GSE199333_post	ENSG00000146247	55023	pleckstrin homology domain interacting protein	BRWD2|DCAF14|FLJ20705|ndrp|WDR11	protein_coding	Q8WWQ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33216
1.84521481996678e-107	-0.312846471039056	0.129	0.305	3.91757558427147e-103	FRMD4A	Erythrocytes	GSE199333_post	ENSG00000151474	55691	FERM domain containing 4A	bA295P9.4|FLJ10210|FRMD4|KIAA1294	protein_coding	Q9P2Q2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33217
1.85440597424039e-107	0.560523323924709	0.677	0.524	3.93708932390978e-103	TSTA3	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33218
5.233897665793e-107	-0.407268860869749	0.338	0.574	1.11120881342451e-102	SRSF3	Erythrocytes	GSE199333_post	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33219
1.58678678989219e-106	0.433093572969033	0.562	0.353	3.3689070336201e-102	POLR1D	Erythrocytes	GSE199333_post	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33220
4.32907268340553e-106	-0.356512936671758	0.324	0.539	9.19105421413828e-102	IK	Erythrocytes	GSE199333_post	ENSG00000113141	3550	IK cytokine	RED|RER	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33221
9.09103667793638e-106	-0.421206201920434	0.853	0.958	1.93011799709267e-101	RPLP2	Erythrocytes	GSE199333_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33222
1.12619225230883e-105	-0.509067729066547	0.65	0.864	2.39101877087689e-101	RPL35	Erythrocytes	GSE199333_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33223
1.50609044192876e-105	-0.647050472872453	0.619	0.812	3.19758061725894e-101	HSP90AA1	Erythrocytes	GSE199333_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33224
2.20677330714027e-105	0.636968250597646	0.953	0.946	4.68520040838951e-101	BSG	Erythrocytes	GSE199333_post	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33225
2.75339709389877e-105	0.555223108394028	0.755	0.657	5.84573737005648e-101	ISCA1	Erythrocytes	GSE199333_post	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33226
3.0160317932381e-105	-0.320431704615767	0.285	0.511	6.40333710022381e-101	ZNF207	Erythrocytes	GSE199333_post	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33227
4.41602683510642e-105	-0.261719896222046	0.102	0.267	9.37566657361443e-101	SFXN1	Erythrocytes	GSE199333_post	ENSG00000164466	94081	sideroflexin 1	FLJ12876|SLC56A1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33228
7.55756442618913e-105	-0.331561877276542	0.232	0.449	1.60454650332421e-100	SOX6	Erythrocytes	GSE199333_post	ENSG00000110693	55553	SRY-box transcription factor 6	NA	protein_coding	P35712	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33229
1.21469328723611e-104	-0.369672490489716	0.288	0.509	2.57891531813098e-100	UROS	Erythrocytes	GSE199333_post	ENSG00000188690	7390	uroporphyrinogen III synthase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33230
1.91165153479483e-104	1.1643430907133	0.399	0.202	4.05862737352291e-100	IFI27	Erythrocytes	GSE199333_post	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33231
2.16898243412635e-104	-0.436374992877376	0.32	0.536	4.60496660589366e-100	PDZK1IP1	Erythrocytes	GSE199333_post	ENSG00000162366	10158	PDZK1 interacting protein 1	DD96|MAP17|SPAP	protein_coding	Q13113	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33232
3.24350096012018e-104	-0.473553449105007	0.798	0.878	6.88627688843115e-100	ANP32B	Erythrocytes	GSE199333_post	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33233
7.76083251412513e-104	0.813146761102261	0.655	0.536	1.64770235107391e-99	PITHD1	Erythrocytes	GSE199333_post	ENSG00000057757	57095	PITH domain containing 1	C1orf128|HT014|TXNL1CL	protein_coding	Q9GZP4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33234
2.039523743441e-103	-0.340419490866495	0.249	0.462	4.33011285969959e-99	TSPAN17	Erythrocytes	GSE199333_post	ENSG00000048140	26262	tetraspanin 17	FBX23|FBXO23|TM4SF17	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33235
5.20281272576037e-103	-0.327349597446496	0.251	0.462	1.10460916980618e-98	PSMD6	Erythrocytes	GSE199333_post	ENSG00000163636	9861	proteasome 26S subunit, non-ATPase 6	KIAA0107|p44S10|Rpn7|S10	protein_coding	Q15008	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33236
6.66633069255154e-103	-0.26324785306151	0.162	0.355	1.41532866933562e-98	BCAP29	Erythrocytes	GSE199333_post	ENSG00000283852	55973	B cell receptor associated protein 29	BAP29|DKFZp686M2086	protein_coding	Q9UHQ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33237
7.19832166017534e-103	-0.417497703711041	0.274	0.482	1.52827567167183e-98	PRRC2C	Erythrocytes	GSE199333_post	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33238
1.54379177287479e-102	-0.257220435407783	0.138	0.318	3.27762431299047e-98	ARMC8	Erythrocytes	GSE199333_post	ENSG00000114098	25852	armadillo repeat containing 8	DKFZP434A043|GID5|HSPC056|VID28	protein_coding	Q8IUR7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33239
1.81016262619041e-102	-0.276053342367936	0.132	0.309	3.84315627166487e-98	SLC30A1	Erythrocytes	GSE199333_post	ENSG00000170385	7779	solute carrier family 30 member 1	ZNT1|ZRC1	protein_coding	Q9Y6M5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33240
3.49481867524334e-102	-0.274554205212434	0.152	0.335	7.41984952940914e-98	BTF3L4	Erythrocytes	GSE199333_post	ENSG00000134717	91408	basic transcription factor 3 like 4	MGC23908	protein_coding	Q96K17	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33241
4.18161102471702e-102	-0.298860244870599	0.166	0.357	8.8779783665767e-98	BAZ1A	Erythrocytes	GSE199333_post	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33242
6.73499855058285e-102	-0.341569801836025	0.306	0.521	1.42990754227425e-97	SYF2	Erythrocytes	GSE199333_post	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33243
7.08997676938504e-102	-0.376841522754328	0.491	0.723	1.50527296790814e-97	RBM39	Erythrocytes	GSE199333_post	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33244
7.36596620776423e-102	-0.343400939464678	0.266	0.474	1.56386828557042e-97	ERMAP	Erythrocytes	GSE199333_post	ENSG00000164010	114625	erythroblast membrane associated protein (Scianna blood group)	BTN5|RD|SC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33245
7.75875183270103e-102	-0.266688362086277	0.162	0.348	1.64726060160076e-97	ARPC1A	Erythrocytes	GSE199333_post	ENSG00000241685	10552	actin related protein 2/3 complex subunit 1A	Arc40|SOP2Hs|SOP2L	protein_coding	Q92747	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33246
1.21041344229039e-101	-0.393039389690353	0.255	0.466	2.56982877932672e-97	SRSF7	Erythrocytes	GSE199333_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33247
2.9960161218557e-101	-0.270757165704986	0.138	0.323	6.36084182831183e-97	RRM1	Erythrocytes	GSE199333_post	ENSG00000167325	6240	ribonucleotide reductase catalytic subunit M1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33248
3.21996319710811e-101	-0.294839501007402	0.134	0.306	6.83630386378023e-97	NDUFS3	Erythrocytes	GSE199333_post	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33249
7.02096615924942e-101	-0.396462120349478	0.669	0.898	1.49062132527024e-96	RPS13	Erythrocytes	GSE199333_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33250
9.12159814339106e-101	-0.262204670380767	0.113	0.279	1.93660650182335e-96	UBN1	Erythrocytes	GSE199333_post	ENSG00000118900	29855	ubinuclein 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33251
9.66141588684255e-101	-0.409374780936304	0.671	0.793	2.05121520693554e-96	HDGF	Erythrocytes	GSE199333_post	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33252
9.67259832091614e-101	-0.373418374462338	0.897	0.971	2.05358934951371e-96	AHSP	Erythrocytes	GSE199333_post	ENSG00000169877	51327	alpha hemoglobin stabilizing protein	EDRF|ERAF	protein_coding	Q9NZD4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33253
1.79551432062559e-100	-0.441722625376904	0.161	0.345	3.81205645412018e-96	SNRPD1	Erythrocytes	GSE199333_post	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33254
1.85140637137408e-100	-0.481058038290293	0.244	0.436	3.9307208670643e-96	CAST	Erythrocytes	GSE199333_post	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33255
3.04199556019263e-100	-0.524451190306995	0.665	0.861	6.45846077384496e-96	RPLP0	Erythrocytes	GSE199333_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33256
6.52503106544038e-100	-0.354485553030584	0.226	0.421	1.38532934550365e-95	RNPS1	Erythrocytes	GSE199333_post	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33257
1.15731940334502e-99	-0.303179433556678	0.242	0.46	2.45710482524182e-95	PPIG	Erythrocytes	GSE199333_post	ENSG00000138398	9360	peptidylprolyl isomerase G	CARS-Cyp|SCAF10|SRCyp	protein_coding	Q13427	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33258
3.24175329935542e-99	-0.365196382857328	0.668	0.924	6.88256642986149e-95	RPS3	Erythrocytes	GSE199333_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33259
6.40420603180919e-99	-0.320150557020433	0.24	0.445	1.35967698261341e-94	VBP1	Erythrocytes	GSE199333_post	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33260
9.54636168719748e-99	-0.454319796506997	0.206	0.403	2.0267880498089e-94	RANBP1	Erythrocytes	GSE199333_post	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33261
9.66650927795088e-99	-0.326427281815345	0.283	0.494	2.05229658480175e-94	CLTC	Erythrocytes	GSE199333_post	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33262
3.95164217244736e-98	0.384279201450421	0.327	0.134	8.38973149632298e-94	C4orf3	Erythrocytes	GSE199333_post	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33263
4.17867150773581e-98	-0.312190098166359	0.31	0.53	8.87173747807389e-94	PSMD7	Erythrocytes	GSE199333_post	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33264
4.29432424149377e-98	-0.310045960674202	0.146	0.327	9.11727979711542e-94	DNMT1	Erythrocytes	GSE199333_post	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33265
4.75868546543678e-98	-0.256372822510327	0.119	0.287	1.01031651116688e-93	SNRPA1	Erythrocytes	GSE199333_post	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33266
6.29674023454166e-98	-0.275346942216811	0.159	0.348	1.33686091919554e-93	IER5	Erythrocytes	GSE199333_post	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33267
6.78661323632429e-98	-0.253110004004625	0.127	0.298	1.44086585620401e-93	MRPL22	Erythrocytes	GSE199333_post	ENSG00000082515	29093	mitochondrial ribosomal protein L22	HSPC158|MRP-L25|RPML25	protein_coding	Q9NWU5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33268
1.53564593044283e-97	-0.532558042944937	0.131	0.299	3.26032987492316e-93	DDIT4	Erythrocytes	GSE199333_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33269
3.00939356248024e-97	-0.325451216141695	0.176	0.36	6.3892434725018e-93	YTHDC1	Erythrocytes	GSE199333_post	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33270
4.82160317651191e-97	-0.281202043681289	0.132	0.3	1.02367457040524e-92	MRPL18	Erythrocytes	GSE199333_post	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33271
5.45289062999264e-97	0.313822642751399	0.36	0.155	1.15770320965374e-92	TCP11L2	Erythrocytes	GSE199333_post	ENSG00000166046	255394	t-complex 11 like 2	MGC40368	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33272
7.28824603131436e-97	-0.536646769570406	0.238	0.424	1.54736751490835e-92	SLIRP	Erythrocytes	GSE199333_post	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33273
1.2879710376042e-96	-0.326253106740435	0.304	0.521	2.73449130993747e-92	RSRC2	Erythrocytes	GSE199333_post	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33274
2.90713850392244e-96	-0.251569078139799	0.131	0.306	6.17214575767773e-92	MAD2L1	Erythrocytes	GSE199333_post	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33275
3.32278979321264e-96	-0.383321413981436	0.247	0.445	7.05461500996975e-92	PSMB3	Erythrocytes	GSE199333_post	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33276
9.64684949419547e-96	-0.394352302405626	0.234	0.43	2.04812261611264e-91	ERH	Erythrocytes	GSE199333_post	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33277
1.38132361610281e-95	-0.291620945466516	0.201	0.395	2.93268816934787e-91	SUMO3	Erythrocytes	GSE199333_post	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33278
1.87141885711904e-95	-0.292140836602883	0.165	0.344	3.97320937554943e-91	CTCF	Erythrocytes	GSE199333_post	ENSG00000102974	10664	CCCTC-binding factor	CFAP108|FAP108	protein_coding	P49711	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33279
2.21590790663322e-95	-0.500041826722147	0.135	0.299	4.704594076573e-91	PIK3R1	Erythrocytes	GSE199333_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33280
3.21032890817051e-95	-0.428693493409446	0.694	0.908	6.81584930493682e-91	RPS8	Erythrocytes	GSE199333_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33281
3.87233821648498e-95	-0.280014515504628	0.149	0.33	8.22136126741927e-91	KIF20B	Erythrocytes	GSE199333_post	ENSG00000138182	9585	kinesin family member 20B	CT90|KRMP1|MPHOSPH1|MPP1	protein_coding	Q96Q89	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33282
7.43436283265014e-95	-0.406938012749623	0.265	0.463	1.57838957299995e-90	SSB	Erythrocytes	GSE199333_post	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33283
8.0814106748589e-95	-0.375795735900331	0.817	0.959	1.71576430037929e-90	RPS15A	Erythrocytes	GSE199333_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33284
1.29726992018992e-94	-0.295175930960321	0.198	0.394	2.75423376755522e-90	SREK1	Erythrocytes	GSE199333_post	ENSG00000153914	140890	splicing regulatory glutamic acid and lysine rich protein 1	DKFZp564B176|SFRS12|SRrp508|SRrp86	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33285
4.97023826023322e-94	-0.406021354974803	0.456	0.63	1.05523128503012e-89	MAZ	Erythrocytes	GSE199333_post	ENSG00000103495	4150	MYC associated zinc finger protein	Pur-1|ZF87|Zif87|ZNF801	protein_coding	P56270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33286
6.19291072726877e-94	-0.270645594201773	0.199	0.39	1.31481687650643e-89	PSMD11	Erythrocytes	GSE199333_post	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33287
1.66105536870301e-93	-0.294341630742124	0.134	0.299	3.52658665329337e-89	SETD2	Erythrocytes	GSE199333_post	ENSG00000181555	29072	SET domain containing 2, histone lysine methyltransferase	FLJ23184|HIF-1|HYPB|KIAA1732|KMT3A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33288
2.38902292301101e-93	-0.271762483987697	0.128	0.294	5.07213456784467e-89	IARS	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33289
3.09648244598196e-93	-0.308871942975901	0.315	0.52	6.5741418810643e-89	AP2A1	Erythrocytes	GSE199333_post	ENSG00000196961	160	adaptor related protein complex 2 subunit alpha 1	ADTAA|CLAPA1	protein_coding	O95782	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33290
3.53396662726444e-93	-0.320804639284531	0.203	0.39	7.50296454634513e-89	PSMD1	Erythrocytes	GSE199333_post	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33291
6.62782688656434e-93	-0.300681503013988	0.164	0.338	1.40715392628647e-88	KIF5B	Erythrocytes	GSE199333_post	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33292
8.35964572099745e-93	-0.330356551471587	0.154	0.323	1.77483638302497e-88	UQCRC1	Erythrocytes	GSE199333_post	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33293
1.08654115525821e-92	0.338767090351367	0.297	0.114	2.3068355267287e-88	TAOK3	Erythrocytes	GSE199333_post	ENSG00000135090	51347	TAO kinase 3	DPK|JIK|MAP3K18	protein_coding	Q9H2K8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33294
1.08736150052111e-92	-0.279081223285478	0.195	0.38	2.30857720175638e-88	CWC15	Erythrocytes	GSE199333_post	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33295
1.24691258809274e-92	-0.464481245975604	0.565	0.814	2.6473201157797e-88	RPSA	Erythrocytes	GSE199333_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33296
1.84705711193133e-92	-0.409387015539637	0.451	0.65	3.92148695434141e-88	CALM2	Erythrocytes	GSE199333_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33297
5.39958443371949e-92	0.463122640831241	0.607	0.414	1.14638577112298e-87	UBE2H	Erythrocytes	GSE199333_post	ENSG00000186591	7328	ubiquitin conjugating enzyme E2 H	GID3|UBC8|UBCH	protein_coding	P62256	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33298
7.06598220589186e-92	-0.267913929649727	0.129	0.303	1.5001786821329e-87	CCNB1	Erythrocytes	GSE199333_post	ENSG00000134057	891	cyclin B1	CCNB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33299
7.9349673882781e-92	-0.325289596848781	0.221	0.415	1.68467292620532e-87	PRPF40A	Erythrocytes	GSE199333_post	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33300
1.03704514660237e-91	-0.331544962370325	0.563	0.818	2.20175055075149e-87	RPS21	Erythrocytes	GSE199333_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33301
1.30294758342234e-91	-0.420787460387945	0.56	0.8	2.76628801436396e-87	RPL4	Erythrocytes	GSE199333_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33302
1.75373957049104e-91	-0.307900070259548	0.244	0.443	3.72336448210953e-87	TLN1	Erythrocytes	GSE199333_post	ENSG00000137076	7094	talin 1	ILWEQ|TLN	protein_coding	Q9Y490	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33303
2.0820393511654e-91	-0.278796231057416	0.152	0.32	4.42037774645926e-87	WBP11	Erythrocytes	GSE199333_post	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33304
2.1035538288482e-91	-0.315562653489062	0.265	0.462	4.46605513402762e-87	HADHA	Erythrocytes	GSE199333_post	ENSG00000084754	3030	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha	GBP|LCEH|LCHAD|MTPA	protein_coding	P40939	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33305
2.77458033509958e-91	-0.252972966639021	0.146	0.316	5.89071150944991e-87	SLC25A38	Erythrocytes	GSE199333_post	ENSG00000144659	54977	solute carrier family 25 member 38	FLJ20551	protein_coding	Q96DW6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33306
4.92181543397388e-91	-0.277884925406206	0.172	0.35	1.044950634787e-86	GYPE	Erythrocytes	GSE199333_post	ENSG00000197465	2996	glycophorin E (MNS blood group)	GPE|MNS	protein_coding	P15421	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33307
9.25172197488423e-91	-0.424125930143981	0.246	0.428	1.96423309248767e-86	VAMP2	Erythrocytes	GSE199333_post	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33308
1.05587785362798e-90	-0.461897524980616	0.17	0.345	2.24173427103756e-86	NASP	Erythrocytes	GSE199333_post	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33309
1.17783983827482e-90	-0.362766531790202	0.6	0.771	2.50067176064128e-86	PPDPF	Erythrocytes	GSE199333_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33310
1.86101985792695e-90	-0.390561230557659	0.403	0.616	3.9511312603647e-86	HNRNPC	Erythrocytes	GSE199333_post	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33311
3.973483878405e-90	-0.378121646508482	0.606	0.771	8.43610362224165e-86	SLC2A1	Erythrocytes	GSE199333_post	ENSG00000117394	6513	solute carrier family 2 member 1	CSE|DYT18|DYT9|GLUT|GLUT-1|GLUT1|HTLVR	protein_coding	P11166	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33312
1.19147613532412e-89	-0.31738479725111	0.155	0.325	2.52962298290665e-85	RNASEH2B	Erythrocytes	GSE199333_post	ENSG00000136104	79621	ribonuclease H2 subunit B	AGS2|DLEU8|FLJ11712	protein_coding	Q5TBB1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33313
1.23783438814043e-89	-0.285566913898882	0.22	0.41	2.62804618946094e-85	ARF6	Erythrocytes	GSE199333_post	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33314
1.56954231723398e-89	0.316853421723075	0.361	0.171	3.33229529371947e-85	GABARAP	Erythrocytes	GSE199333_post	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33315
1.88314205723275e-89	-0.392780860062006	0.255	0.444	3.99809890171085e-85	CCT2	Erythrocytes	GSE199333_post	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33316
2.65821628120101e-89	-0.284691274732449	0.168	0.342	5.64365898661787e-85	CCDC59	Erythrocytes	GSE199333_post	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33317
3.6302630798555e-89	0.406458755195656	0.937	0.838	7.70741154484121e-85	GNAS	Erythrocytes	GSE199333_post	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33318
5.21268778775378e-89	0.351095693519475	0.414	0.222	1.106705744218e-84	ATP6V1D	Erythrocytes	GSE199333_post	ENSG00000100554	51382	ATPase H+ transporting V1 subunit D	ATP6M|VATD|VMA8	protein_coding	Q9Y5K8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33319
1.05942714271404e-88	-0.330355402040801	0.414	0.613	2.24926976669619e-84	RAD21	Erythrocytes	GSE199333_post	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33320
1.13437112432899e-88	-0.403106715399348	0.192	0.367	2.40838333406287e-84	TAF9	Erythrocytes	GSE199333_post	ENSG00000276463	6880	TATA-box binding protein associated factor 9	AD-004|CGI-137|MGC1603|MGC3647|MGC5067|TAF2G|TAFII31|TAFII32|TAFIID32	protein_coding	Q16594	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33321
1.66264880489625e-88	0.396508368754049	0.878	0.827	3.52996967767522e-84	TALDO1	Erythrocytes	GSE199333_post	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33322
1.69388830290512e-88	-0.341867623178503	0.345	0.548	3.59629425589787e-84	HSPA5	Erythrocytes	GSE199333_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33323
1.91084922379108e-88	-0.263632787721622	0.117	0.272	4.05692398703084e-84	EXOSC8	Erythrocytes	GSE199333_post	ENSG00000120699	11340	exosome component 8	bA421P11.3|CIP3|EAP2|OIP2|p9|RRP43|Rrp43p	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33324
4.46467146391554e-88	-0.480744505212412	0.526	0.692	9.47894398503909e-84	PA2G4	Erythrocytes	GSE199333_post	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33325
7.31690035735096e-88	-0.266175912766866	0.114	0.272	1.55345111486918e-83	HMMR	Erythrocytes	GSE199333_post	ENSG00000072571	3161	hyaluronan mediated motility receptor	CD168|RHAMM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33326
2.44917552020744e-87	0.438543922288137	0.817	0.707	5.19984454695243e-83	OST4	Erythrocytes	GSE199333_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33327
3.57509738750599e-87	-0.289500686815295	0.257	0.462	7.59028926341397e-83	H2AFY	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33328
3.79218838359894e-87	-0.389189186765678	0.703	0.905	8.0511951572189e-83	RPL29	Erythrocytes	GSE199333_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33329
1.7088884411111e-86	-0.410504376147673	0.253	0.438	3.62814104932298e-82	SRI	Erythrocytes	GSE199333_post	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33330
1.92517936229668e-86	-0.340289074640794	0.53	0.728	4.08734830409208e-82	USP15	Erythrocytes	GSE199333_post	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33331
4.78990232047685e-86	-0.34916690113132	0.227	0.408	1.01694416166044e-81	FAM133B	Erythrocytes	GSE199333_post	ENSG00000234545	257415	family with sequence similarity 133 member B	MGC40405	protein_coding	Q5BKY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33332
5.23006049468513e-86	0.354493271872367	0.543	0.355	1.1103941436266e-81	ZMAT2	Erythrocytes	GSE199333_post	ENSG00000146007	153527	zinc finger matrin-type 2	FLJ31121|hSNU23|Snu23	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33333
5.48111122142353e-86	-0.349256958774387	0.265	0.457	1.16369472342043e-81	AKAP9	Erythrocytes	GSE199333_post	ENSG00000127914	10142	A-kinase anchoring protein 9	AKAP350|AKAP450|CG-NAP|HYPERION|KIAA0803|LQT11|MU-RMS-40.16A|PPP1R45|PRKA9|YOTIAO	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33334
1.94982332163001e-85	-0.256981062453019	0.165	0.335	4.13966989415266e-81	SUGT1	Erythrocytes	GSE199333_post	ENSG00000165416	10910	SGT1 homolog, MIS12 kinetochore complex assembly cochaperone	SGT1	protein_coding	Q9Y2Z0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33335
2.24696821740712e-85	-0.269007860105532	0.152	0.317	4.77053822237706e-81	MRPL41	Erythrocytes	GSE199333_post	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33336
5.38024896327055e-85	0.621388734420532	0.627	0.482	1.14228065739197e-80	GMPR	Erythrocytes	GSE199333_post	ENSG00000137198	2766	guanosine monophosphate reductase	NA	protein_coding	P36959	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33337
1.1300896395285e-84	-0.331243168512025	0.413	0.603	2.39929331368296e-80	MORF4L1	Erythrocytes	GSE199333_post	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33338
1.14948557183091e-84	0.412548353451045	0.736	0.623	2.44047281755421e-80	STRADB	Erythrocytes	GSE199333_post	ENSG00000082146	55437	STE20 related adaptor beta	ALS2CR2|CALS-21|ILPIP|ILPIPA|PAPK	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33339
5.4328051041092e-84	-0.317634137813964	0.277	0.471	1.15343885165342e-79	SRSF11	Erythrocytes	GSE199333_post	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33340
8.00799416105637e-84	-0.255949246971753	0.165	0.336	1.70017724033388e-79	RBBP6	Erythrocytes	GSE199333_post	ENSG00000122257	5930	RB binding protein 6, ubiquitin ligase	P2P-R|PACT|SNAMA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33341
1.01885789003664e-83	-0.263540313464444	0.16	0.328	2.16313718633679e-79	RBBP7	Erythrocytes	GSE199333_post	ENSG00000102054	5931	RB binding protein 7, chromatin remodeling factor	RbAp46	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33342
1.11699786848515e-83	-0.254496254431917	0.204	0.385	2.37149817458082e-79	STAM	Erythrocytes	GSE199333_post	ENSG00000136738	8027	signal transducing adaptor molecule	STAM1	protein_coding	Q92783	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33343
1.59424541144815e-83	-0.325619111723979	0.265	0.456	3.38474243304558e-79	EP300	Erythrocytes	GSE199333_post	ENSG00000100393	2033	E1A binding protein p300	KAT3B|p300	protein_coding	Q09472	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33344
1.76013600052041e-83	-0.380625243877477	0.221	0.394	3.73694474270488e-79	SNRPD3	Erythrocytes	GSE199333_post	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33345
2.19095636229657e-83	-0.331709168903786	0.217	0.394	4.65161945279185e-79	PPM1G	Erythrocytes	GSE199333_post	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33346
2.24857195463302e-83	-0.441969268849234	0.53	0.693	4.77394311688136e-79	ATP5MF	Erythrocytes	GSE199333_post	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33347
2.48036613674829e-83	-0.362519173493188	0.778	0.949	5.2660653449303e-79	RPL32	Erythrocytes	GSE199333_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33348
2.80154170255077e-83	-0.346897814528496	0.156	0.319	5.94795318868554e-79	PRKDC	Erythrocytes	GSE199333_post	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33349
3.56683970014593e-83	-0.376018219287863	0.183	0.35	7.57275736737982e-79	NDUFAB1	Erythrocytes	GSE199333_post	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33350
5.39440056908283e-83	-0.278531914264303	0.211	0.386	1.14528518482198e-78	HIGD1A	Erythrocytes	GSE199333_post	ENSG00000181061	25994	HIG1 hypoxia inducible domain family member 1A	DKFZP564K247|HIG1|RCF1A	protein_coding	Q9Y241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33351
7.32157601470729e-83	-0.265754860144017	0.24	0.428	1.5544438036825e-78	ASAP1	Erythrocytes	GSE199333_post	ENSG00000153317	50807	ArfGAP with SH3 domain, ankyrin repeat and PH domain 1	CENTB4|DDEF1|KIAA1249|PAP|ZG14P	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33352
3.29900102592315e-82	0.416117203592461	0.766	0.692	7.00410907813745e-78	MPP1	Erythrocytes	GSE199333_post	ENSG00000130830	4354	MAGUK p55 scaffold protein 1	DXS552E|PEMP	protein_coding	Q00013	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33353
3.52219704809258e-82	-0.406345538011235	0.601	0.829	7.47797655280536e-78	RPL5	Erythrocytes	GSE199333_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33354
4.16320527314706e-82	-0.349550229442639	0.803	0.842	8.83890111541852e-78	SLC4A1	Erythrocytes	GSE199333_post	ENSG00000004939	6521	solute carrier family 4 member 1 (Diego blood group)	AE1|CD233|DI|EPB3|FR|RTA1A|SW|WD|WR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33355
8.29317041359415e-82	-0.285385226409976	0.286	0.476	1.76072301051017e-77	DCTN3	Erythrocytes	GSE199333_post	ENSG00000137100	11258	dynactin subunit 3	DCTN-22	protein_coding	O75935	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33356
1.09152720908526e-81	-0.291823311663688	0.173	0.34	2.31742141760891e-77	KMT2C	Erythrocytes	GSE199333_post	ENSG00000055609	58508	lysine methyltransferase 2C	HALR|KIAA1506|MLL3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33357
1.13891546701654e-81	-0.395174756912208	0.385	0.578	2.41803142802283e-77	SET	Erythrocytes	GSE199333_post	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33358
1.53429103077683e-81	-0.338458835783701	0.201	0.372	3.25745328744229e-77	EIF5B	Erythrocytes	GSE199333_post	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33359
2.415599305864e-81	0.476111358241515	0.664	0.49	5.12855888627986e-77	DYNLL1	Erythrocytes	GSE199333_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33360
2.74040813672683e-81	-0.264698058254984	0.127	0.279	5.81816051508473e-77	PSMA3	Erythrocytes	GSE199333_post	ENSG00000100567	5684	proteasome 20S subunit alpha 3	HC8	protein_coding	P25788	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33361
2.98457472219745e-81	-0.272490527466328	0.809	0.961	6.33655059269741e-77	RPL30	Erythrocytes	GSE199333_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33362
4.00285520583378e-81	0.575540107604256	0.426	0.26	8.4984618875057e-77	MIR4435-2HG	Erythrocytes	GSE199333_post	ENSG00000172965	541471	MIR4435-2 host gene	AGD2|AK001796|LINC00978|lncRNA-AWPPH|MIR4435-1HG|MORRBID	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33363
8.29857079081827e-81	-0.338690453637921	0.843	0.969	1.76186956459863e-76	RPL35A	Erythrocytes	GSE199333_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33364
8.82910423469187e-81	-0.252186338632501	0.183	0.356	1.87450712006743e-76	PSMG3	Erythrocytes	GSE199333_post	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33365
1.022752222749e-80	-0.374930062459808	0.273	0.452	2.17140524411841e-76	DDX24	Erythrocytes	GSE199333_post	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33366
1.17999266473584e-80	-0.275059736781609	0.133	0.287	2.50524242650065e-76	SSRP1	Erythrocytes	GSE199333_post	ENSG00000149136	6749	structure specific recognition protein 1	FACT80	protein_coding	Q08945	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33367
1.93348693899416e-80	-0.376440642788224	0.745	0.849	4.1049861201785e-76	HMBS	Erythrocytes	GSE199333_post	ENSG00000256269	3145	hydroxymethylbilane synthase	PBGD|PORC|UPS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33368
2.21935729050145e-80	-0.319175142127397	0.441	0.64	4.71191746346364e-76	POMP	Erythrocytes	GSE199333_post	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33369
2.39702041663193e-80	0.589656287153132	0.565	0.428	5.08911404655126e-76	TSPAN5	Erythrocytes	GSE199333_post	ENSG00000168785	10098	tetraspanin 5	NET-4|TM4SF9|Tspan-5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33370
2.91622447944822e-80	-0.27695176432136	0.648	0.88	6.19143619231652e-76	RPL10	Erythrocytes	GSE199333_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33371
7.07541576646862e-80	-0.397352153290502	0.713	0.838	1.50218152137895e-75	CA2	Erythrocytes	GSE199333_post	ENSG00000104267	760	carbonic anhydrase 2	CA-II|CAII|Car2	protein_coding	P00918	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33372
1.24051155436404e-79	-0.26435742717546	0.161	0.323	2.63373008107029e-75	RTF1	Erythrocytes	GSE199333_post	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33373
1.29471910978677e-79	-0.257856945682501	0.662	0.887	2.7488181419883e-75	RPL23A	Erythrocytes	GSE199333_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33374
1.33789276236032e-79	0.269481907793019	0.286	0.116	2.84048012376719e-75	CLIC2	Erythrocytes	GSE199333_post	ENSG00000155962	1193	chloride intracellular channel 2	CLCNL2|XAP121	protein_coding	O15247	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33375
2.05956496559508e-79	-0.27527549303596	0.238	0.418	4.37266237845491e-75	SPCS2	Erythrocytes	GSE199333_post	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33376
5.06364724011137e-79	-0.30192811346346	0.619	0.856	1.07506294554805e-74	RPS16	Erythrocytes	GSE199333_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33377
5.7399316670886e-79	-0.271538760069599	0.191	0.36	1.21864489223958e-74	TAF7	Erythrocytes	GSE199333_post	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33378
6.41665447683862e-79	-0.253223386321402	0.183	0.352	1.36231991197761e-74	HNRNPA0	Erythrocytes	GSE199333_post	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33379
1.05199277880653e-78	0.479927995259877	0.696	0.587	2.23348586868414e-74	DPM2	Erythrocytes	GSE199333_post	ENSG00000136908	8818	dolichyl-phosphate mannosyltransferase subunit 2, regulatory	MGC111193|MGC21559	protein_coding	O94777	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33380
1.95868151163928e-78	-0.256991745301011	0.198	0.372	4.15847671736135e-74	CTSZ	Erythrocytes	GSE199333_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33381
2.15082998941565e-78	-0.272871273946799	0.158	0.318	4.56642715052837e-74	RNMT	Erythrocytes	GSE199333_post	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33382
7.01214326003093e-78	-0.358149382911003	0.592	0.812	1.48874813553717e-73	RPL22	Erythrocytes	GSE199333_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33383
7.19035102907011e-78	-0.351198435453168	0.272	0.448	1.52658342698187e-73	TOMM20	Erythrocytes	GSE199333_post	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33384
1.87891864154443e-77	-0.302039493488072	0.259	0.437	3.98913216786298e-73	YWHAH	Erythrocytes	GSE199333_post	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33385
1.94887179506365e-77	-0.263599061434305	0.162	0.321	4.13764970809964e-73	MAGOH	Erythrocytes	GSE199333_post	ENSG00000162385	4116	mago homolog, exon junction complex subunit	MAGOH1|MAGOHA	protein_coding	P61326	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33386
2.0999691522663e-77	-0.278792128862728	0.208	0.384	4.45844450717658e-73	TPR	Erythrocytes	GSE199333_post	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33387
2.67419947831715e-77	-0.257984916311866	0.18	0.344	5.67759291241515e-73	C1GALT1	Erythrocytes	GSE199333_post	ENSG00000106392	56913	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	C1GALT|T-synthase	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33388
2.72920400008382e-77	0.390715515190537	0.627	0.477	5.79437301257797e-73	PSMF1	Erythrocytes	GSE199333_post	ENSG00000125818	9491	proteasome inhibitor subunit 1	PI31	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33389
4.71094579880078e-77	-0.272636764832581	0.157	0.317	1.00018090254339e-72	DDX39A	Erythrocytes	GSE199333_post	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33390
6.47861491221409e-77	-0.283932351918945	0.632	0.831	1.37547473201217e-72	CHCHD2	Erythrocytes	GSE199333_post	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33391
2.99839867696261e-76	0.402632706920762	0.557	0.38	6.36590023105932e-72	RALBP1	Erythrocytes	GSE199333_post	ENSG00000017797	10928	ralA binding protein 1	RIP|RIP1|RLIP76	protein_coding	Q15311	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33392
3.15301473630789e-76	-0.303965765001952	0.606	0.805	6.69416558665527e-72	EEF1D	Erythrocytes	GSE199333_post	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33393
3.81202171244896e-76	-0.426942646313957	0.401	0.575	8.09330329770039e-72	ARL6IP1	Erythrocytes	GSE199333_post	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33394
4.9141446876296e-76	0.348075479155297	0.567	0.393	1.04332205863064e-71	MARCH8	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33395
1.02670196084057e-75	-0.336954014653369	0.719	0.913	2.17979093306062e-71	RPS7	Erythrocytes	GSE199333_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33396
4.0922605289245e-75	-0.285548882983123	0.687	0.898	8.68827832895961e-71	RPL34	Erythrocytes	GSE199333_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33397
1.42878922160067e-74	0.582664646135742	0.677	0.588	3.03346239638038e-70	PNP	Erythrocytes	GSE199333_post	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33398
1.73806286523225e-74	-0.282679181430111	0.154	0.303	3.6900812691746e-70	POLR2F	Erythrocytes	GSE199333_post	ENSG00000100142	5435	RNA polymerase II, I and III subunit F	HRBP14.4|RPB6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33399
1.80785719028708e-74	-0.302854460385811	0.459	0.636	3.8382616006985e-70	SAP18	Erythrocytes	GSE199333_post	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33400
3.07809888643725e-74	-0.263950469432798	0.158	0.31	6.53511174579493e-70	MRPS18C	Erythrocytes	GSE199333_post	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33401
3.18641741831654e-74	-0.265724389535976	0.795	0.956	6.76508282082785e-70	EEF1A1	Erythrocytes	GSE199333_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33402
3.58981937485993e-74	-0.365868179995674	0.281	0.46	7.62154551476512e-70	EIF3A	Erythrocytes	GSE199333_post	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33403
3.81043668560356e-74	-0.302308982882748	0.226	0.394	8.08993812720491e-70	JPT1	Erythrocytes	GSE199333_post	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33404
5.78346735886625e-74	0.275477073610065	0.599	0.387	1.22788795496089e-69	REXO2	Erythrocytes	GSE199333_post	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33405
7.74766483367727e-74	-0.309683022889766	0.511	0.717	1.64490672083802e-69	PFN1	Erythrocytes	GSE199333_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33406
1.39555249848966e-73	-0.251578436127111	0.182	0.34	2.9628975095434e-69	HBS1L	Erythrocytes	GSE199333_post	ENSG00000112339	10767	HBS1 like translational GTPase	DKFZp434g247|EF-1a|eRF3c|ERFS|HBS1|HSPC276|KIAA1038	protein_coding	Q9Y450	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33407
1.44424600450178e-73	-0.351300061220419	0.31	0.493	3.06627869215773e-69	ATP5PO	Erythrocytes	GSE199333_post	ENSG00000241837	539	ATP synthase peripheral stalk subunit OSCP	ATP5O|ATPO|OSCP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33408
1.93819979187571e-73	-0.264357623855184	0.185	0.346	4.11499197813131e-69	HDAC2	Erythrocytes	GSE199333_post	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33409
2.45801813324261e-73	-0.269698265310672	0.258	0.431	5.21861829868738e-69	SNW1	Erythrocytes	GSE199333_post	ENSG00000100603	22938	SNW domain containing 1	Bx42|FUN20|NCoA-62|Prp45|PRPF45|SKIIP|SKIP|SKIP1	protein_coding	Q13573	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33410
2.60660788141651e-73	-0.255889267375328	0.163	0.318	5.5340891930354e-69	RBM33	Erythrocytes	GSE199333_post	ENSG00000184863	155435	RNA binding motif protein 33	DKFZp434D1319|DKFZp686F102|MGC20460|PRR8	protein_coding	Q96EV2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33411
1.4094577644939e-72	-0.394681213113999	0.578	0.721	2.992419779797e-68	COX7B	Erythrocytes	GSE199333_post	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33412
4.98607725509858e-72	-0.609646751018884	0.403	0.591	1.05859406202998e-67	PPIA	Erythrocytes	GSE199333_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33413
5.5183567191107e-72	-0.313157757564907	0.336	0.51	1.17160231503439e-67	SPECC1	Erythrocytes	GSE199333_post	ENSG00000128487	92521	sperm antigen with calponin homology and coiled-coil domains 1	CYTSB|FLJ36955|HCMOGT-1|NSP	protein_coding	Q5M775	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33414
2.17320101983469e-71	-0.252246328734502	0.351	0.543	4.61392308521104e-67	H2AFJ	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33415
3.40475398142868e-71	-0.311315210987768	0.317	0.493	7.22863317797123e-67	NDUFB9	Erythrocytes	GSE199333_post	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33416
6.3807346470529e-71	-0.276761077347422	0.199	0.36	1.3546937729158e-66	PDIA3	Erythrocytes	GSE199333_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33417
7.22823910105548e-71	-0.2501625725817	0.179	0.335	1.53462744354509e-66	MRPL57	Erythrocytes	GSE199333_post	ENSG00000173141	78988	mitochondrial ribosomal protein L57	MRP63	protein_coding	Q9BQC6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33418
1.33488889822421e-70	0.324878948772721	0.586	0.426	2.83410261981983e-66	STK11	Erythrocytes	GSE199333_post	ENSG00000118046	6794	serine/threonine kinase 11	LKB1|PJS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33419
2.58739503551791e-70	-0.474932500911209	0.584	0.706	5.49329839990807e-66	TUBB4B	Erythrocytes	GSE199333_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33420
4.06954645253855e-70	1.90771458515166	0.569	0.493	8.6400540733846e-66	NEAT1	Erythrocytes	GSE199333_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33421
6.82878352685891e-70	-0.336905615332382	0.373	0.559	1.44981903058742e-65	RB1CC1	Erythrocytes	GSE199333_post	ENSG00000023287	9821	RB1 inducible coiled-coil 1	ATG17|Cc1|DRAGOU14|FIP200|KIAA0203|PPP1R131	protein_coding	Q8TDY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33422
7.27423938554376e-70	-0.286138155823483	0.15	0.297	1.5443937639448e-65	SUPT16H	Erythrocytes	GSE199333_post	ENSG00000092201	11198	SPT16 homolog, facilitates chromatin remodeling subunit	CDC68|FACT|FACTP140|FLJ10857|FLJ14010|SPT16/CDC68	protein_coding	Q9Y5B9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33423
9.68343372255719e-70	-0.315896075188622	0.716	0.896	2.05588981363612e-65	RPL18	Erythrocytes	GSE199333_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33424
1.61887910846342e-69	-0.331489835616251	0.511	0.725	3.43704223517868e-65	EEF1B2	Erythrocytes	GSE199333_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33425
2.53406369740085e-69	-0.291098753453598	0.187	0.339	5.38007063595175e-65	PSMA5	Erythrocytes	GSE199333_post	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33426
4.21121034416729e-69	-0.363980366183743	0.173	0.321	8.94082068170157e-65	CACYBP	Erythrocytes	GSE199333_post	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33427
5.36078750381598e-69	0.325740599828245	0.56	0.386	1.13814879493517e-64	WDR83OS	Erythrocytes	GSE199333_post	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33428
7.98955564311202e-69	0.315205734937466	0.254	0.105	1.69626255858911e-64	FAM83A	Erythrocytes	GSE199333_post	ENSG00000147689	84985	family with sequence similarity 83 member A	BJ-TSA-9|MGC14128	protein_coding	Q86UY5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33429
1.02233961996582e-68	-0.278463983880116	0.147	0.291	2.17052924714943e-64	CENPX	Erythrocytes	GSE199333_post	ENSG00000169689	201254	centromere protein X	CENP-X|FAAP10|MGC14480|MHF2|STRA13	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33430
3.83057037774292e-68	-0.254358449399542	0.287	0.459	8.132683968986e-64	AKAP8L	Erythrocytes	GSE199333_post	ENSG00000011243	26993	A-kinase anchoring protein 8 like	HAP95|NAKAP95	protein_coding	Q9ULX6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33431
8.25462434194513e-68	0.550228037539255	0.415	0.262	1.75253929403837e-63	MYL12A	Erythrocytes	GSE199333_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33432
9.1019678255916e-68	-0.260274162281302	0.187	0.341	1.93243878905135e-63	SLTM	Erythrocytes	GSE199333_post	ENSG00000137776	79811	SAFB like transcription modulator	FLJ13213|Met	protein_coding	Q9NWH9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33433
9.48752485070338e-68	-0.268532768267397	0.291	0.471	2.01429640105284e-63	HP1BP3	Erythrocytes	GSE199333_post	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33434
1.22257288889538e-67	0.265197655806159	0.361	0.195	2.59564450041378e-63	NPL	Erythrocytes	GSE199333_post	ENSG00000135838	80896	N-acetylneuraminate pyruvate lyase	C1orf13|DHDPS1|NPL1	protein_coding	Q9BXD5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33435
1.61868235234645e-67	-0.323653467751976	0.466	0.633	3.43662450226675e-63	TENT5C	Erythrocytes	GSE199333_post	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33436
1.81632473591883e-67	-0.251548819102412	0.226	0.387	3.85623904682927e-63	ELOC	Erythrocytes	GSE199333_post	ENSG00000154582	6921	elongin C	SIII|TCEB1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33437
2.92175826444157e-67	0.321110937233057	0.895	0.831	6.2031849712359e-63	MYL6	Erythrocytes	GSE199333_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33438
6.12577078491731e-67	-0.32267198688637	0.248	0.403	1.30056239534579e-62	ATG3	Erythrocytes	GSE199333_post	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33439
1.06091393639151e-66	-0.280941905988251	0.689	0.892	2.25242637835282e-62	RPL19	Erythrocytes	GSE199333_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33440
1.7623008622655e-66	-0.25327451392424	0.303	0.479	3.74154096067589e-62	VAPA	Erythrocytes	GSE199333_post	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33441
1.77053030223943e-66	0.256157127046988	0.274	0.121	3.75901288468454e-62	OSER1	Erythrocytes	GSE199333_post	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33442
2.02242250239705e-66	-0.262538848211711	0.185	0.335	4.29380521483919e-62	SNRPB2	Erythrocytes	GSE199333_post	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33443
2.38043830706443e-66	-0.294467705688796	0.194	0.35	5.05390856972849e-62	CHD2	Erythrocytes	GSE199333_post	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33444
9.03477611125344e-66	-0.376785291196913	0.428	0.576	1.91817331618022e-61	POLR2L	Erythrocytes	GSE199333_post	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33445
1.37125993191137e-65	-0.272461393093775	0.172	0.321	2.91132196144103e-61	NUCB2	Erythrocytes	GSE199333_post	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33446
1.86055169776948e-65	-0.257283242036706	0.194	0.347	3.95013730953439e-61	NDUFB6	Erythrocytes	GSE199333_post	ENSG00000165264	4712	NADH:ubiquinone oxidoreductase subunit B6	B17|CI	protein_coding	O95139	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33447
2.09681250708698e-65	0.566657133545479	0.462	0.315	4.45174263379637e-61	ZFAND5	Erythrocytes	GSE199333_post	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33448
6.70827705685636e-65	-0.328212469564575	0.423	0.617	1.42423430194117e-60	CFL1	Erythrocytes	GSE199333_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33449
7.04399859778502e-64	-0.281316350040112	0.402	0.568	1.49551134229574e-59	NAP1L4	Erythrocytes	GSE199333_post	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33450
2.35554673202787e-63	0.330137057924559	0.351	0.198	5.00106126676837e-59	DYNLRB1	Erythrocytes	GSE199333_post	ENSG00000125971	83658	dynein light chain roadblock-type 1	DNCL2A|DNLC2A|ROBLD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33451
2.70352997527367e-63	-0.304613900421007	0.312	0.472	5.73986449050353e-59	RBM8A	Erythrocytes	GSE199333_post	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33452
2.92453400794933e-63	-0.317764764853298	0.661	0.865	6.20907815227723e-59	RPL6	Erythrocytes	GSE199333_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33453
4.68242608396536e-63	-0.32082602975508	0.266	0.421	9.94125881886687e-59	HNRNPF	Erythrocytes	GSE199333_post	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33454
5.97251659775633e-63	0.364775385132072	0.602	0.466	1.26802499886965e-58	ISCU	Erythrocytes	GSE199333_post	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33455
1.45601340848857e-62	-0.38338598736071	0.271	0.433	3.09126206756208e-58	ATP5F1A	Erythrocytes	GSE199333_post	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33456
1.75547639388257e-62	-0.363581008966001	0.197	0.342	3.72705193185208e-58	ILF2	Erythrocytes	GSE199333_post	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33457
4.01822843783934e-62	-0.279683852604868	0.213	0.358	8.53110079637671e-58	NDUFS7	Erythrocytes	GSE199333_post	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33458
4.47932703207173e-62	0.278110031712575	0.362	0.202	9.51005922179148e-58	SMOX	Erythrocytes	GSE199333_post	ENSG00000088826	54498	spermine oxidase	C20orf16|dJ779E11.1|FLJ20746|MGC1010|PAO|PAOh1|SMO	protein_coding	Q9NWM0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33459
4.6121058106081e-62	0.250308170479617	0.378	0.217	9.79196184650205e-58	FURIN	Erythrocytes	GSE199333_post	ENSG00000140564	5045	furin, paired basic amino acid cleaving enzyme	FUR|PACE|PCSK3|SPC1	protein_coding	P09958	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33460
6.55993479242085e-62	-0.326234319155073	0.44	0.627	1.39273975577887e-57	UQCRH	Erythrocytes	GSE199333_post	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33461
1.22675387256537e-61	0.319007004978183	0.33	0.177	2.60452114684354e-57	MAN1A1	Erythrocytes	GSE199333_post	ENSG00000111885	4121	mannosidase alpha class 1A member 1	NA	protein_coding	P33908	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33462
1.49958113784047e-61	-0.29790304741308	0.819	0.879	3.18376071374911e-57	RAD23A	Erythrocytes	GSE199333_post	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33463
1.65264623458741e-61	-0.32587272004816	0.52	0.664	3.50873322065253e-57	PSMA7	Erythrocytes	GSE199333_post	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33464
1.83752502093165e-61	-0.394116284657174	0.162	0.297	3.90124937193998e-57	SNRPE	Erythrocytes	GSE199333_post	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33465
2.83513174727712e-61	-0.250271480288038	0.281	0.442	6.01926821264405e-57	EHBP1L1	Erythrocytes	GSE199333_post	ENSG00000173442	254102	EH domain binding protein 1 like 1	DKFZp762C186|TANGERIN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33466
4.05549844036786e-61	0.60335643570957	0.946	0.923	8.610228738745e-57	HBD	Erythrocytes	GSE199333_post	ENSG00000223609	3045	hemoglobin subunit delta	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33467
1.27106604382489e-60	-0.339960766382916	0.678	0.833	2.69860031764461e-56	RPL38	Erythrocytes	GSE199333_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33468
2.68227428754094e-60	-0.33875283330238	0.233	0.376	5.69473653987817e-56	SNU13	Erythrocytes	GSE199333_post	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33469
5.61441828798422e-60	-0.259390349046281	0.293	0.463	1.19199714672193e-55	HNRNPDL	Erythrocytes	GSE199333_post	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33470
7.16125923108051e-60	-0.256498691226129	0.227	0.377	1.5204069473507e-55	ATP5PD	Erythrocytes	GSE199333_post	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33471
1.00514298838107e-59	-0.266126273807676	0.206	0.355	2.13401907863185e-55	EIF3M	Erythrocytes	GSE199333_post	ENSG00000149100	10480	eukaryotic translation initiation factor 3 subunit M	FLJ29030|GA17|hfl-B5|PCID1|TANGO7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33472
1.10640078287418e-59	-0.257331403920685	0.214	0.363	2.34899950212018e-55	VPS29	Erythrocytes	GSE199333_post	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33473
1.30139459858665e-59	-0.282571590032608	0.742	0.911	2.76299087225931e-55	RPL18A	Erythrocytes	GSE199333_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33474
2.11927597071151e-59	-0.261156772201904	0.774	0.935	4.49943481341761e-55	RPL28	Erythrocytes	GSE199333_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33475
2.26777809376308e-59	-0.396085544783052	0.192	0.33	4.81471967086839e-55	SNRPF	Erythrocytes	GSE199333_post	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33476
2.379521570182e-59	-0.33081044824965	0.224	0.374	5.0519622456534e-55	HSP90B1	Erythrocytes	GSE199333_post	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33477
3.48200117395086e-59	0.412003609081909	0.593	0.447	7.39263669241506e-55	TRIM58	Erythrocytes	GSE199333_post	ENSG00000162722	25893	tripartite motif containing 58	BIA2	protein_coding	Q8NG06	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33478
7.90609901523112e-59	-0.290496855785108	0.781	0.926	1.67854388192372e-54	RPS14	Erythrocytes	GSE199333_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33479
1.77238786334771e-58	-0.284763545374898	0.554	0.767	3.76295667267353e-54	RACK1	Erythrocytes	GSE199333_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33480
3.79366316677125e-58	-0.27900067881457	0.219	0.361	8.05432626937204e-54	PFDN2	Erythrocytes	GSE199333_post	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33481
4.24373095389819e-58	-0.278843670280727	0.262	0.408	9.00986518822126e-54	SRSF8	Erythrocytes	GSE199333_post	ENSG00000263465	10929	serine and arginine rich splicing factor 8	SFRS2B|SRP46	protein_coding	Q9BRL6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33482
9.65819218010554e-58	-0.292391398881932	0.741	0.9	2.05053078175821e-53	RPS29	Erythrocytes	GSE199333_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33483
1.3700790141321e-57	-0.265009718814302	0.143	0.27	2.90881475490387e-53	RSL1D1	Erythrocytes	GSE199333_post	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33484
1.75903745551333e-57	0.545628058495447	0.533	0.398	3.73461242180034e-53	RGCC	Erythrocytes	GSE199333_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33485
1.94956967764834e-57	-0.265210548174152	0.272	0.428	4.13913138261518e-53	VDAC3	Erythrocytes	GSE199333_post	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33486
2.92155883454842e-57	-0.359017791618035	0.678	0.858	6.20276156162975e-53	RPL37A	Erythrocytes	GSE199333_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33487
5.60925048293117e-57	0.401997541079165	0.774	0.667	1.19089997003112e-52	WNK1	Erythrocytes	GSE199333_post	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33488
5.83637484857342e-57	-0.257075283747124	0.274	0.424	1.23912074410062e-52	COPS3	Erythrocytes	GSE199333_post	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33489
1.04879511406233e-56	-0.261499598592441	0.291	0.443	2.22669690666573e-52	NDUFA6	Erythrocytes	GSE199333_post	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33490
1.07186599371851e-56	-0.308955437075906	0.627	0.774	2.27567869126378e-52	TMA7	Erythrocytes	GSE199333_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33491
1.3534810157862e-56	-0.253672828244585	0.164	0.297	2.87357554461568e-52	POLE3	Erythrocytes	GSE199333_post	ENSG00000148229	54107	DNA polymerase epsilon 3, accessory subunit	CHARAC17|CHRAC17|CHRAC2|p17|Ybl1	protein_coding	Q9NRF9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33492
1.4132208272911e-56	-0.254232553738859	0.886	0.956	3.00040913842173e-52	FAU	Erythrocytes	GSE199333_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33493
1.46931506871063e-56	0.414246015219435	0.287	0.15	3.11950282237954e-52	ARRDC2	Erythrocytes	GSE199333_post	ENSG00000105643	27106	arrestin domain containing 2	CLONE24945|PP2703	protein_coding	Q8TBH0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33494
1.6560962419618e-56	-0.255215290094608	0.328	0.49	3.51605793130909e-52	ATF4	Erythrocytes	GSE199333_post	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33495
1.68912591367697e-56	-0.290803251492879	0.227	0.371	3.58618322732758e-52	NDUFC2	Erythrocytes	GSE199333_post	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33496
3.98091477230283e-56	-0.367507708481057	0.489	0.663	8.45188015307613e-52	COX4I1	Erythrocytes	GSE199333_post	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33497
1.22066553698077e-55	0.354709029284971	0.724	0.627	2.59159500156387e-51	EMC3	Erythrocytes	GSE199333_post	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33498
1.96745769154167e-55	-0.518722290624477	0.464	0.642	4.17710942491212e-51	GAPDH	Erythrocytes	GSE199333_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33499
2.40320327874797e-55	-0.483944006127418	0.284	0.435	5.10224088110981e-51	ATP5MC3	Erythrocytes	GSE199333_post	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33500
2.60145193759203e-55	-0.265283963126627	0.196	0.336	5.52314260870163e-51	NKTR	Erythrocytes	GSE199333_post	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33501
1.43416177758373e-54	0.349111174289746	0.618	0.501	3.04486886998802e-50	FBXO9	Erythrocytes	GSE199333_post	ENSG00000112146	26268	F-box protein 9	FBX9|NY-REN-57	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33502
1.55436232685402e-54	0.366476354947737	0.533	0.408	3.30006665614378e-50	METTL9	Erythrocytes	GSE199333_post	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33503
1.79871280121214e-54	-0.313161337107281	0.218	0.359	3.81884714825348e-50	SSBP1	Erythrocytes	GSE199333_post	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33504
5.27212087936251e-54	-0.310653178190343	0.336	0.48	1.11932398389745e-49	TRMT112	Erythrocytes	GSE199333_post	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33505
6.2869912230339e-54	-0.252878331109565	0.145	0.268	1.33479110656233e-49	TRIM28	Erythrocytes	GSE199333_post	ENSG00000130726	10155	tripartite motif containing 28	KAP-1|KAP1|PPP1R157|RNF96|TF1B|TIF1-beta|TIF1B|TIF1beta	protein_coding	Q13263	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33506
8.18794092723009e-54	-0.318890567747113	0.746	0.889	1.73838173826022e-49	RPS2	Erythrocytes	GSE199333_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33507
9.65917215013556e-54	0.643012433058331	0.826	0.831	2.05073883919528e-49	RBM38	Erythrocytes	GSE199333_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33508
1.0878459282751e-53	0.32061652350349	0.424	0.284	2.30960569032086e-49	CNPPD1	Erythrocytes	GSE199333_post	ENSG00000115649	27013	cyclin Pas1/PHO80 domain containing 1	C2orf24|CGI-57	protein_coding	Q9BV87	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33509
1.36945728833616e-53	-0.49947159998795	0.627	0.727	2.90749476886651e-49	EIF5A	Erythrocytes	GSE199333_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33510
1.72721134042966e-53	0.301941418637985	0.526	0.375	3.66704239686622e-49	CCS	Erythrocytes	GSE199333_post	ENSG00000173992	9973	copper chaperone for superoxide dismutase	NA	protein_coding	O14618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33511
6.52456144513957e-53	-0.264110012060445	0.255	0.396	1.38522964041758e-48	NDUFB7	Erythrocytes	GSE199333_post	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33512
6.76690342409645e-53	-0.310371847827976	0.66	0.833	1.43668126596992e-48	RPS5	Erythrocytes	GSE199333_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33513
1.24715265217451e-52	-0.293243548270918	0.724	0.896	2.64782979583171e-48	RPL11	Erythrocytes	GSE199333_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33514
2.5778547552497e-52	0.923853419226386	0.426	0.295	5.47304343087064e-48	SAT1	Erythrocytes	GSE199333_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33515
1.11690885135396e-51	-0.43364836592459	0.684	0.791	2.3713091823096e-47	HLA-A	Erythrocytes	GSE199333_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33516
1.18631953341448e-51	0.275567865390705	0.326	0.188	2.51867500139229e-47	CYSTM1	Erythrocytes	GSE199333_post	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33517
2.22277223581585e-51	-0.292242524739507	0.282	0.421	4.71916773386063e-47	RSL24D1	Erythrocytes	GSE199333_post	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33518
2.46773596030206e-51	-0.252758469855851	0.149	0.266	5.23925021731731e-47	ECH1	Erythrocytes	GSE199333_post	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33519
2.55208195222482e-51	-0.298271955584087	0.278	0.417	5.41832519276852e-47	SF1	Erythrocytes	GSE199333_post	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33520
7.82313288202009e-51	-0.281016924446742	0.552	0.676	1.66092934218169e-46	SLC1A5	Erythrocytes	GSE199333_post	ENSG00000105281	6510	solute carrier family 1 member 5	AAAT|ASCT2|M7V1|RDRC	protein_coding	Q15758	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33521
2.31631438255825e-50	-0.272486234275689	0.159	0.28	4.91776706560943e-46	DDX21	Erythrocytes	GSE199333_post	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33522
1.55844769925054e-49	0.406663745310944	0.498	0.381	3.30874031027883e-45	CHST2	Erythrocytes	GSE199333_post	ENSG00000175040	9435	carbohydrate sulfotransferase 2	C6ST	protein_coding	Q9Y4C5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33523
1.86485027379088e-49	0.478689857707779	0.3	0.175	3.95926361628541e-45	EMP3	Erythrocytes	GSE199333_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33524
2.09799202061479e-49	-0.392376617185994	0.287	0.424	4.45424685896725e-45	UQCRQ	Erythrocytes	GSE199333_post	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33525
4.22761289857261e-49	-0.294340065609958	0.771	0.92	8.97564494495951e-45	RPS28	Erythrocytes	GSE199333_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33526
5.67275762947035e-49	-0.255717205974847	0.401	0.551	1.20438317231285e-44	COX8A	Erythrocytes	GSE199333_post	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33527
6.00595220361101e-49	0.252371297460076	0.409	0.268	1.27512371234865e-44	UBXN6	Erythrocytes	GSE199333_post	ENSG00000167671	80700	UBX domain protein 6	UBXD1|UBXDC2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33528
1.66775359260337e-48	-0.282408036960951	0.756	0.898	3.54080765245623e-44	RPS25	Erythrocytes	GSE199333_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33529
2.67485168835789e-48	-0.331067590223576	0.15	0.262	5.67897761955264e-44	MRPS34	Erythrocytes	GSE199333_post	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33530
4.30747787114798e-48	-0.259821907291784	0.137	0.251	9.14520626823429e-44	PRDX3	Erythrocytes	GSE199333_post	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33531
1.73417705541971e-47	0.256657512139159	0.9	0.836	3.68183130636158e-43	ELOB	Erythrocytes	GSE199333_post	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33532
1.84473468219315e-47	-0.291134485043513	0.859	0.94	3.91655620376428e-43	RPS15	Erythrocytes	GSE199333_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33533
4.17802889974777e-47	-0.328593851839037	0.687	0.864	8.87037315705449e-43	RPL14	Erythrocytes	GSE199333_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33534
6.96365181425898e-47	-0.286047399644802	0.169	0.286	1.47845291668532e-42	SNRPC	Erythrocytes	GSE199333_post	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33535
1.92961020017793e-46	-0.293538870570733	0.721	0.877	4.09675541599776e-42	RPL7A	Erythrocytes	GSE199333_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33536
8.58703593379343e-46	-0.326714031777639	0.634	0.741	1.82311359910368e-41	TMEM14B	Erythrocytes	GSE199333_post	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33537
1.51519982047714e-45	-0.461025396959001	0.525	0.66	3.21692073885502e-41	HIST1H1C	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33538
2.39869179443845e-45	-0.269461971812746	0.21	0.33	5.09266254877228e-41	MRPL20	Erythrocytes	GSE199333_post	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33539
1.49394999278543e-44	0.250102779644536	0.398	0.264	3.17180522968274e-40	SEC14L1	Erythrocytes	GSE199333_post	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33540
1.74473129256406e-44	0.274326097918001	0.436	0.299	3.70423900724275e-40	FAM89B	Erythrocytes	GSE199333_post	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33541
1.94933656729679e-44	-0.355081828318988	0.442	0.609	4.1386364660278e-40	HNRNPA1	Erythrocytes	GSE199333_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33542
2.11198347968076e-44	-0.335250234227869	0.364	0.504	4.48395212571022e-40	CALM1	Erythrocytes	GSE199333_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33543
2.80880486949689e-44	-0.437458388536257	0.176	0.29	5.96337361842885e-40	HSPE1	Erythrocytes	GSE199333_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33544
4.02400359141368e-44	0.316084416466439	0.558	0.438	8.54336202493037e-40	DCUN1D1	Erythrocytes	GSE199333_post	ENSG00000043093	54165	defective in cullin neddylation 1 domain containing 1	DCUN1L1|RP42|SCCRO|SCRO|Tes3	protein_coding	Q96GG9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33545
2.47857236918959e-43	-0.357389073936215	0.737	0.879	5.26225699702641e-39	UBC	Erythrocytes	GSE199333_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33546
3.82789021569809e-43	-0.257024936275145	0.577	0.754	8.12699371694862e-39	RPL27	Erythrocytes	GSE199333_post	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33547
9.68146180160744e-43	-0.263074657212487	0.438	0.579	2.05547115509928e-38	EIF3K	Erythrocytes	GSE199333_post	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33548
3.37042232618178e-42	-0.317834165792865	0.326	0.464	7.15574364071654e-38	SLC25A5	Erythrocytes	GSE199333_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33549
3.00899472566975e-41	0.408715654138259	0.635	0.564	6.38839670206945e-37	BAG1	Erythrocytes	GSE199333_post	ENSG00000107262	573	BAG cochaperone 1	NA	protein_coding	Q99933	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33550
9.93597323915287e-41	-0.282309653842645	0.487	0.607	2.10950647840455e-36	UQCR10	Erythrocytes	GSE199333_post	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33551
5.99816820038259e-39	0.305912065638215	0.691	0.6	1.27347109062323e-34	EPB41	Erythrocytes	GSE199333_post	ENSG00000159023	2035	erythrocyte membrane protein band 4.1	4.1R|EL1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33552
8.5126292672374e-39	-0.267513232432094	0.239	0.353	1.80731631972717e-34	EIF4B	Erythrocytes	GSE199333_post	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33553
9.51807273208109e-39	-0.361758845509531	0.148	0.254	2.02078202174814e-34	STMN1	Erythrocytes	GSE199333_post	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33554
5.61622101812619e-38	0.347039558593569	0.746	0.718	1.19237988435837e-33	CCNDBP1	Erythrocytes	GSE199333_post	ENSG00000166946	23582	cyclin D1 binding protein 1	DIP1|GCIP|HHM	protein_coding	O95273	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33555
1.12674565544622e-37	0.255415975832287	0.525	0.414	2.39219370107786e-33	NAPA	Erythrocytes	GSE199333_post	ENSG00000105402	8775	NSF attachment protein alpha	NA	protein_coding	P54920	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33556
1.18944148171046e-37	-0.270312339859871	0.842	0.915	2.52530320981947e-33	RPL8	Erythrocytes	GSE199333_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33557
6.37971679091782e-37	0.293132973622608	0.255	0.152	1.35447767187976e-32	ARRB2	Erythrocytes	GSE199333_post	ENSG00000141480	409	arrestin beta 2	ARR2|BARR2|DKFZp686L0365	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33558
7.39521767661509e-37	-0.324256522533484	0.292	0.41	1.57007866492215e-32	RPS17	Erythrocytes	GSE199333_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33559
7.84145577576e-37	-0.283656375831723	0.318	0.435	1.66481947575161e-32	SNRPD2	Erythrocytes	GSE199333_post	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33560
1.93316931709676e-32	-0.256885740049739	0.383	0.492	4.10431177712814e-28	NDUFB11	Erythrocytes	GSE199333_post	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33561
1.01629097366823e-31	-0.293969221789478	0.215	0.311	2.15768736619503e-27	PHB2	Erythrocytes	GSE199333_post	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33562
3.54216259537059e-31	0.418681684051373	0.348	0.251	7.52036540623131e-27	GSTO1	Erythrocytes	GSE199333_post	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33563
6.60969744697426e-31	-0.624691989672592	0.192	0.283	1.40330486496711e-26	HSPD1	Erythrocytes	GSE199333_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33564
8.23838632326203e-31	-0.253952055826829	0.201	0.299	1.74909180029176e-26	LSM7	Erythrocytes	GSE199333_post	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33565
2.17101200431928e-30	0.264184079878819	0.341	0.239	4.60927558637027e-26	SLC40A1	Erythrocytes	GSE199333_post	ENSG00000138449	30061	solute carrier family 40 member 1	FPN1|HFE4|IREG1|MTP1|SLC11A3	protein_coding	Q9NP59	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33566
2.19980462567444e-30	-0.265483631605236	0.235	0.331	4.67040520076939e-26	ATP5PB	Erythrocytes	GSE199333_post	ENSG00000116459	515	ATP synthase peripheral stalk-membrane subunit b	ATP5F1	protein_coding	P24539	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33567
2.68346828492139e-30	-0.256272938313879	0.476	0.599	5.6972715157166e-26	RPL31	Erythrocytes	GSE199333_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33568
3.42709437616554e-30	-0.263839390020162	0.185	0.277	7.27606407003705e-26	CCT5	Erythrocytes	GSE199333_post	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33569
1.79939637297486e-29	-0.322776587695783	0.214	0.311	3.82029843946292e-25	CCT6A	Erythrocytes	GSE199333_post	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33570
2.00407079807794e-28	-0.449013295619081	0.57	0.666	4.25484271139928e-24	HSP90AB1	Erythrocytes	GSE199333_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33571
6.65941410700533e-28	-0.406588839788707	0.456	0.564	1.4138602090583e-23	RPL23	Erythrocytes	GSE199333_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33572
1.36576340563617e-27	0.258754495572633	0.418	0.314	2.89965228650614e-23	ARHGEF12	Erythrocytes	GSE199333_post	ENSG00000196914	23365	Rho guanine nucleotide exchange factor 12	KIAA0382|LARG	protein_coding	Q9NZN5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33573
3.52860978390456e-27	0.465170307590254	0.957	0.948	7.49159143220778e-23	SLC25A37	Erythrocytes	GSE199333_post	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33574
5.14371489829836e-26	0.532084951321448	0.372	0.29	1.09206211005772e-21	XPO7	Erythrocytes	GSE199333_post	ENSG00000130227	23039	exportin 7	EXP7|KIAA0745|RANBP16	protein_coding	Q9UIA9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33575
5.30360398375165e-26	0.274380733475052	0.258	0.172	1.12600816179031e-21	SNRPN	Erythrocytes	GSE199333_post	ENSG00000128739	6638	small nuclear ribonucleoprotein polypeptide N	HCERN3|PWCR|RT-LI|SM-D|SMN|SNRNP-N|SNURF-SNRPN	protein_coding	P63162	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33576
5.79290139252394e-26	-0.639643996661152	0.382	0.483	1.22989089464676e-21	NPM1	Erythrocytes	GSE199333_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33577
8.59308880003177e-25	0.338255947823235	0.547	0.481	1.82439868313475e-20	NDFIP1	Erythrocytes	GSE199333_post	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33578
1.17819822927663e-22	-0.341807698838871	0.21	0.292	2.50143266057722e-18	RPL22L1	Erythrocytes	GSE199333_post	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33579
1.88716609038591e-22	0.302704135918706	0.594	0.53	4.00664232649833e-18	EIF5	Erythrocytes	GSE199333_post	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33580
2.53657570363137e-22	-0.32827560646852	0.283	0.364	5.38540387637976e-18	NOP10	Erythrocytes	GSE199333_post	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33581
3.17334132895471e-22	-0.311127976846989	0.177	0.25	6.73732097550375e-18	PEBP1	Erythrocytes	GSE199333_post	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33582
3.52050207914727e-22	-0.294610341212769	0.285	0.372	7.47437796423758e-18	HMGN1	Erythrocytes	GSE199333_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33583
2.89413423447599e-21	0.368090512813443	0.35	0.275	6.14453639321598e-17	RSRP1	Erythrocytes	GSE199333_post	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33584
4.19537080905312e-20	0.254972624219801	0.488	0.431	8.90719176470067e-16	PDCD10	Erythrocytes	GSE199333_post	ENSG00000114209	11235	programmed cell death 10	CCM3|TFAR15	protein_coding	Q9BUL8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33585
2.82597314950534e-19	-0.261932029302206	0.267	0.338	5.99982359371478e-15	NDUFS6	Erythrocytes	GSE199333_post	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33586
4.51846862510607e-19	-0.268816947995722	0.375	0.453	9.59316073796269e-15	ATP5MPL	Erythrocytes	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33587
5.24738558734949e-19	0.269283509553113	0.741	0.723	1.11407243405017e-14	TESC	Erythrocytes	GSE199333_post	ENSG00000088992	54997	tescalcin	CHP3|FLJ20607|TSC	protein_coding	Q96BS2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33588
1.5969337198481e-18	-0.364962820531346	0.572	0.621	3.39044998060951e-14	ATP5F1B	Erythrocytes	GSE199333_post	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33589
5.77339447739395e-18	0.26535192942843	0.285	0.212	1.22574938149551e-13	MIR22HG	Erythrocytes	GSE199333_post	ENSG00000282800	84981	MIR22 host gene	C17orf91|DKFZp686O06159|MGC14376	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33590
5.82051180713526e-17	-0.296788297042797	0.302	0.373	1.23575286177289e-12	NDUFS5	Erythrocytes	GSE199333_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33591
9.19605733970606e-17	-0.310002641939841	0.203	0.265	1.95241493379299e-12	COX5A	Erythrocytes	GSE199333_post	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33592
1.64742291844018e-16	-0.295146513817484	0.405	0.463	3.49764359814035e-12	ATP5ME	Erythrocytes	GSE199333_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33593
2.94906020504466e-15	-0.304803546202007	0.214	0.273	6.26114972133032e-11	C1QBP	Erythrocytes	GSE199333_post	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33594
7.54810655441118e-13	0.587531674306463	0.389	0.337	1.60253850256704e-08	S100A4	Erythrocytes	GSE199333_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33595
2.62173908750926e-12	0.269379921249443	0.359	0.452	5.56621425669091e-08	TMSB10	Erythrocytes	GSE199333_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33596
2.27063068671368e-11	0.300246534875389	0.535	0.524	4.82077601096181e-07	NFE2	Erythrocytes	GSE199333_post	ENSG00000123405	4778	nuclear factor, erythroid 2	NF-E2	protein_coding	Q16621	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33597
1.258822937428e-10	-0.406901393410469	0.289	0.34	2.67260697845338e-06	LDHB	Erythrocytes	GSE199333_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33598
1.32082243376929e-10	-0.296593953269099	0.239	0.287	2.80423810913559e-06	TPI1	Erythrocytes	GSE199333_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33599
9.65044518479003e-09	0.438107416166041	0.252	0.211	0.000204888601718277	VIM	Erythrocytes	GSE199333_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33600
1.28732913005601e-13	4.3894579425031	0.963	0.379	2.73312847602191e-09	HBB	B cells	GSE199333_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33601
1.56069144142599e-13	3.46323825806658	0.95	0.241	3.31350399929152e-09	HBA1	B cells	GSE199333_post	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33602
2.02011651422024e-13	3.98331584554581	0.95	0.345	4.28890937134098e-09	HBA2	B cells	GSE199333_post	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33603
5.40595883642633e-12	1.83861567026064	0.85	0.034	1.14773912056167e-07	HBG2	B cells	GSE199333_post	ENSG00000196565	3048	hemoglobin subunit gamma 2	HBG-T1	protein_coding	P69892	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33604
1.14277877442882e-11	2.30281113363699	1	0.793	2.42623361598983e-07	TMSB10	B cells	GSE199333_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33605
3.26927938929414e-11	2.16444367302107	0.988	0.69	6.9410070714104e-07	MT-CO1	B cells	GSE199333_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33606
3.63783597869526e-11	1.94853336233868	1	0.793	7.7234895663679e-07	MT-CO3	B cells	GSE199333_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33607
7.83361228939205e-11	2.69514796848177	0.988	0.655	1.66315422516083e-06	TMSB4X	B cells	GSE199333_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33608
1.30563904370562e-10	1.78440573651733	0.988	0.862	2.7720022536914e-06	MT-ATP6	B cells	GSE199333_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33609
1.82663322243619e-10	1.55925802904428	1	1	3.87812499455427e-06	RPS18	B cells	GSE199333_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33610
3.58617795121188e-10	1.4673401501562	0.9	0.31	7.61381440821794e-06	RAC2	B cells	GSE199333_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33611
3.73132814291723e-10	1.67283824839701	1	0.828	7.92198278022758e-06	MT-CO2	B cells	GSE199333_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33612
8.36938705716474e-10	1.54055429247515	0.85	0.138	1.77690456610665e-05	COTL1	B cells	GSE199333_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33613
9.24899468182176e-10	1.62421983864503	1	0.759	1.96365406089758e-05	MT-ND4	B cells	GSE199333_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33614
1.49315395589902e-09	2.69280251293479	0.875	0.241	3.17011516376922e-05	HLA-DRB1	B cells	GSE199333_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33615
1.66408207875806e-09	1.60531556267732	0.912	0.414	3.53301266141124e-05	S100A10	B cells	GSE199333_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33616
1.77978754442691e-09	1.58758320088029	0.9	0.276	3.77866693557277e-05	CORO1A	B cells	GSE199333_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33617
2.48820093276037e-09	1.32190843950768	1	0.724	5.28269940034355e-05	MT-ND1	B cells	GSE199333_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33618
2.60911790950884e-09	2.17208958555564	0.887	0.31	5.53941823367821e-05	CD52	B cells	GSE199333_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33619
2.68878154560746e-09	1.44034170066045	0.838	0.172	5.70855209947921e-05	EVI2B	B cells	GSE199333_post	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33620
5.75077248410461e-09	1.01410019704485	0.775	0.069	0.000122094650610025	CNN2	B cells	GSE199333_post	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33621
9.34206598438277e-09	1.53605290024021	0.887	0.276	0.000198341402914431	MYL12A	B cells	GSE199333_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33622
1.04062716396884e-08	1.30707202717534	1	0.793	0.000220935553182225	MT-CYB	B cells	GSE199333_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33623
1.08029201728648e-08	1.81682367037081	0.725	0.069	0.000229356798190092	PTPRC	B cells	GSE199333_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33624
1.66798303461321e-08	1.81491227323569	0.875	0.379	0.000354129478078731	S100A6	B cells	GSE199333_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33625
1.77139739214269e-08	1.15849010638003	0.787	0.103	0.000376085380325814	DDX17	B cells	GSE199333_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33626
2.03182226943101e-08	1.25594498104747	0.988	0.414	0.000431376186022899	PFN1	B cells	GSE199333_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33627
2.13775326143673e-08	1.28105368182865	1	1	0.000453866394935633	RPL13	B cells	GSE199333_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33628
2.19543290858134e-08	1.46893870438167	0.738	0.103	0.000466112360820903	RIPOR2	B cells	GSE199333_post	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33629
2.33676713652133e-08	1.17990909001493	0.975	0.828	0.000496119030754844	OAZ1	B cells	GSE199333_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33630
3.36896796295534e-08	1.04560799830334	0.8	0.172	0.000715265588215047	PCBP1	B cells	GSE199333_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33631
4.05176811198691e-08	1.21241172970226	0.95	0.517	0.00086023088785594	CFL1	B cells	GSE199333_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33632
4.4357964180664e-08	-0.601450623509725	0	0.345	0.000941763937519677	SDC1	B cells	GSE199333_post	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33633
5.79024785659946e-08	1.31586879869953	0.925	0.379	0.00122932752243463	TAGLN2	B cells	GSE199333_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33634
5.79484737008312e-08	0.956013078088098	1	1	0.00123030404514235	B2M	B cells	GSE199333_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33635
6.15607480980388e-08	1.51743722207286	0.787	0.172	0.00130699624286946	UCP2	B cells	GSE199333_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33636
6.44142905628524e-08	1.12421783299971	0.963	0.379	0.00136757980293992	SH3BGRL3	B cells	GSE199333_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33637
6.5224695740406e-08	1.79592002699532	0.838	0.207	0.00138478551526456	CRIP1	B cells	GSE199333_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33638
6.54403699861255e-08	1.2513234233071	0.963	0.483	0.00138936449517543	CLIC1	B cells	GSE199333_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33639
6.89364063424222e-08	1.15171219818428	0.675	0.069	0.00146358884305597	TRAF3IP3	B cells	GSE199333_post	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33640
6.95685991888365e-08	-0.678685948552803	0.013	0.379	0.00147701092937819	SPAG4	B cells	GSE199333_post	ENSG00000061656	6676	sperm associated antigen 4	CT127|SUN4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33641
8.09401289576587e-08	1.33958611134541	0.875	0.414	0.00171843987790005	LIMD2	B cells	GSE199333_post	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33642
9.23240966620853e-08	1.39282001642289	0.775	0.172	0.00196013289623273	ARPC1B	B cells	GSE199333_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33643
1.00474809363901e-07	1.40440889442974	0.812	0.276	0.00213318067760499	CALM2	B cells	GSE199333_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33644
1.10282677854098e-07	1.04513241068048	1	1	0.00234141153352035	RPL37A	B cells	GSE199333_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33645
1.10531575467455e-07	1.3734572302213	1	0.828	0.00234669587874953	MT-ND3	B cells	GSE199333_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33646
1.15557012981982e-07	1.04560799830334	0.75	0.103	0.00245339094262047	ARPC5	B cells	GSE199333_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33647
1.16260784203991e-07	1.21437249958316	1	0.828	0.00246833270943493	RPSA	B cells	GSE199333_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33648
1.27998483419358e-07	1.19755695583436	0.863	0.345	0.0027175358014764	ANXA2	B cells	GSE199333_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33649
1.35116514468921e-07	1.05099481301853	1	1	0.00286865871868966	RPS15A	B cells	GSE199333_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33650
1.35431833394183e-07	1.13679349442055	1	1	0.00287535325479189	RPL28	B cells	GSE199333_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33651
1.41049303738292e-07	1.17122684691513	0.975	0.621	0.00299461776766768	ARPC3	B cells	GSE199333_post	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33652
1.4358029648766e-07	1.0740179214242	0.9	0.345	0.0030483532747295	LSP1	B cells	GSE199333_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33653
1.50332944899534e-07	1.4365172266893	1	0.69	0.003191718753162	MT-ND5	B cells	GSE199333_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33654
1.51566120713778e-07	1.13242016423362	0.838	0.207	0.00321790030887422	CD53	B cells	GSE199333_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33655
1.57049753200402e-07	1.22567776233317	1	0.966	0.00333432331019773	RPL39	B cells	GSE199333_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33656
2.00652359563192e-07	1.3245487950465	0.7	0.138	0.00426005024588613	RALGPS2	B cells	GSE199333_post	ENSG00000116191	55103	Ral GEF with PH domain and SH3 binding motif 2	FLJ10244|FLJ25604|KIAA0351	protein_coding	Q86X27	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33657
2.07232517812837e-07	1.00202736474428	0.787	0.207	0.00439975358568435	STK4	B cells	GSE199333_post	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33658
2.75981233639018e-07	1.31874576806354	0.9	0.448	0.00585935757139	EMP3	B cells	GSE199333_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33659
2.92712795833472e-07	1.10735082598241	1	1	0.00621458536834044	RPS2	B cells	GSE199333_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33660
3.25552557593855e-07	1.12101540096137	1	1	0.00691180635027514	RPS15	B cells	GSE199333_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33661
3.33196848780448e-07	1.0073586191658	0.838	0.345	0.0070741022964577	CD48	B cells	GSE199333_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33662
3.51699652382966e-07	1.05961485629722	0.738	0.172	0.00746693531974275	SMCHD1	B cells	GSE199333_post	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33663
3.75362444352753e-07	1.21065261344604	0.887	0.31	0.0079693200560533	ARHGDIB	B cells	GSE199333_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33664
3.82863198487322e-07	1.07547461705118	1	1	0.00812856856708434	RPL18A	B cells	GSE199333_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33665
3.99929692202647e-07	1.28107504927747	1	1	0.00849090729515441	RPL32	B cells	GSE199333_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33666
4.01186073222567e-07	1.06777337968439	0.925	0.483	0.00851758152058833	ARPC2	B cells	GSE199333_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33667
4.04071443819252e-07	1.1042536102772	0.975	0.517	0.00857884082372654	PPIA	B cells	GSE199333_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33668
4.30262436513084e-07	1.194264382992	0.625	0.034	0.00913490178960928	AC004687.1	B cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33669
4.4677815795047e-07	0.807083977392342	1	1	0.00948554707144642	RPLP1	B cells	GSE199333_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33670
4.48589626349456e-07	1.21251375544686	0.988	1	0.0095240063570253	RPL36	B cells	GSE199333_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33671
4.84803648307018e-07	1.07250057269273	0.988	0.552	0.0102928662572063	H3F3A	B cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33672
4.87333548310447e-07	1.82673006114313	0.713	0.138	0.0103465785641791	HLA-DQA1	B cells	GSE199333_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33673
5.24827796027606e-07	0.908178551986143	1	0.931	0.0111426189374621	RPL35	B cells	GSE199333_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33674
6.23020705567482e-07	1.7604256857049	0.787	0.241	0.0132273525999032	CD37	B cells	GSE199333_post	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33675
6.92466667221122e-07	1.26540531029654	0.863	0.241	0.0147017598117716	AHNAK	B cells	GSE199333_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33676
7.27536861433579e-07	0.926512376798387	0.75	0.276	0.0154463351050963	C9orf16	B cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33677
7.93782509028087e-07	0.934419367691775	1	0.966	0.0168527964491753	RPL8	B cells	GSE199333_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33678
8.00348586959503e-07	0.79614174130971	0.988	0.966	0.0169922008497372	SERF2	B cells	GSE199333_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33679
8.18455005452627e-07	0.990585719464668	1	0.897	0.0173766182207647	PTMA	B cells	GSE199333_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33680
8.44829817207828e-07	1.2381989403317	0.912	0.379	0.0179365818491394	AES	B cells	GSE199333_post	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33681
9.28915071836334e-07	0.82978410329692	0.613	0.069	0.0197217958901572	HP1BP3	B cells	GSE199333_post	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33682
9.34287315974288e-07	0.988911864954021	0.75	0.207	0.0198358540054501	CAPZB	B cells	GSE199333_post	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33683
9.43088951295685e-07	0.888125458867139	1	1	0.0200227215249587	RPL18	B cells	GSE199333_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33684
9.53837571034076e-07	0.963591183088171	1	0.966	0.0202509254706245	RPS16	B cells	GSE199333_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33685
1.09101153519776e-06	1.92071675047553	0.688	0.138	0.0231632659037836	S100A4	B cells	GSE199333_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33686
1.13282287188418e-06	0.951441206825558	1	1	0.024050962392973	RPS9	B cells	GSE199333_post	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33687
1.1437443529883e-06	1.03223192197267	1	1	0.0242828363582945	RPL12	B cells	GSE199333_post	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33688
1.15245314746483e-06	1.28304558659378	1	1	0.0244677327738258	RPS27	B cells	GSE199333_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33689
1.17865928311352e-06	0.955137232581755	1	0.897	0.0250241152397832	UBA52	B cells	GSE199333_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33690
1.25486264703647e-06	-0.696607856550065	0	0.276	0.0266419888592314	HLA-DQA2	B cells	GSE199333_post	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33691
1.27686989920946e-06	0.969146893555024	1	1	0.0271092248301161	RPL19	B cells	GSE199333_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33692
1.31721846105361e-06	0.955956154690869	0.738	0.241	0.0279658651466292	SEL1L3	B cells	GSE199333_post	ENSG00000091490	23231	SEL1L family member 3	KIAA0746	protein_coding	Q68CR1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33693
1.39910977957467e-06	0.867762015920158	1	0.862	0.0297044997301498	RPL27A	B cells	GSE199333_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33694
1.53447297317518e-06	1.00755735117808	0.988	0.862	0.0325783956934821	ATP5F1E	B cells	GSE199333_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33695
1.54560440101193e-06	0.952039228912603	0.95	0.552	0.0328147270378843	BTF3	B cells	GSE199333_post	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33696
1.58495416570302e-06	0.828834649468056	0.562	0.034	0.0336501618920408	ABRACL	B cells	GSE199333_post	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33697
1.64349191074803e-06	1.06379053226842	0.562	0.034	0.0348929767570915	SP110	B cells	GSE199333_post	ENSG00000135899	3431	SP110 nuclear body protein	IFI41|IFI75	protein_coding	Q9HB58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33698
1.73011740022708e-06	0.675716686496434	0.988	0.724	0.0367321225242211	GAPDH	B cells	GSE199333_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33699
1.73684648589032e-06	0.824622398181141	0.662	0.103	0.0368749877419375	CAP1	B cells	GSE199333_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33700
1.76165019531131e-06	0.999123095940855	0.938	0.586	0.0374015952966544	HINT1	B cells	GSE199333_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33701
1.80174236589836e-06	0.84219210932344	1	1	0.0382527921703882	FAU	B cells	GSE199333_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33702
1.81105626319745e-06	1.08778742271269	0.988	0.69	0.0384505355239451	MT-ND2	B cells	GSE199333_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33703
1.85647373437811e-06	1.05592037273948	0.662	0.172	0.0394147938545817	CCDC50	B cells	GSE199333_post	ENSG00000152492	152137	coiled-coil domain containing 50	C3orf6|DFNA44|Ymer	protein_coding	Q8IVM0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33704
1.85735633445977e-06	0.944668217030775	1	1	0.0394335323369154	RPL37	B cells	GSE199333_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33705
1.93999030332928e-06	-0.905456810399825	0.013	0.31	0.0411879341299839	CST3	B cells	GSE199333_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33706
2.00606596341181e-06	1.03528552693548	0.875	0.379	0.0425907864691961	YWHAZ	B cells	GSE199333_post	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33707
2.06384913291258e-06	0.978805777730877	0.963	0.759	0.0438175809408669	MYL6	B cells	GSE199333_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33708
2.32998154630351e-06	0.899801170822199	0.662	0.138	0.0494678382095698	PARP1	B cells	GSE199333_post	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	post	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33709
0	-0.80599194544518	0.07	0.27	0	TNFRSF4	Malignant cells	GSE199333_pre	ENSG00000186827	7293	TNF receptor superfamily member 4	ACT35|CD134|OX40|TXGP1L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33710
0	0.319341359887997	0.337	0.11	0	TNFRSF14	Malignant cells	GSE199333_pre	ENSG00000273936	8764	TNF receptor superfamily member 14	ATAR|CD270|HVEA|HVEM|LIGHTR|TR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33711
0	-0.29248268093589	0.243	0.434	0	CAMTA1	Malignant cells	GSE199333_pre	ENSG00000171735	23261	calmodulin binding transcription activator 1	KIAA0833	protein_coding	Q9Y6Y1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33712
0	0.263847741754285	0.981	0.95	0	ENO1	Malignant cells	GSE199333_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33713
0	-0.648772131472542	0.32	0.628	0	EFHD2	Malignant cells	GSE199333_pre	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33714
0	-0.398482422982543	0.349	0.541	0	RCC2	Malignant cells	GSE199333_pre	ENSG00000281540	55920	regulator of chromosome condensation 2	TD-60	protein_coding	Q9P258	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33715
0	-0.430028598427108	0.886	0.919	0	CDC42	Malignant cells	GSE199333_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33716
0	0.413152111416126	1	1	0	RPL11	Malignant cells	GSE199333_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33717
0	-0.389141677336975	0.678	0.813	0	SRSF10	Malignant cells	GSE199333_pre	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33718
0	-0.461561303478204	0.407	0.679	0	TMEM50A	Malignant cells	GSE199333_pre	ENSG00000183726	23585	transmembrane protein 50A	SMP1	protein_coding	O95807	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33719
0	-0.372255874951252	0.421	0.638	0	SRSF4	Malignant cells	GSE199333_pre	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33720
0	-0.38229604000152	0.619	0.809	0	KHDRBS1	Malignant cells	GSE199333_pre	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33721
0	-0.391635504829099	0.93	0.965	0	SFPQ	Malignant cells	GSE199333_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33722
0	-0.315680224660556	0.223	0.424	0	MAP7D1	Malignant cells	GSE199333_pre	ENSG00000116871	55700	MAP7 domain containing 1	FLJ10350|FLJ39022|PARCC1|RPRC1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33723
0	-0.380030456540087	0.326	0.562	0	THRAP3	Malignant cells	GSE199333_pre	ENSG00000054118	9967	thyroid hormone receptor associated protein 3	BCLAF2|TRAP150	protein_coding	Q9Y2W1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33724
0	0.529338479757511	0.652	0.343	0	CSF3R	Malignant cells	GSE199333_pre	ENSG00000119535	1441	colony stimulating factor 3 receptor	CD114|GCSFR	protein_coding	Q99062	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33725
0	-0.49860707272865	0.419	0.721	0	CAP1	Malignant cells	GSE199333_pre	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33726
0	1.82054827591058	0.789	0.377	0	ARMH1	Malignant cells	GSE199333_pre	ENSG00000198520	339541	armadillo like helical domain containing 1	C1orf228|MGC33556|NCRNA00082|p40	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33727
0	-0.53318442120266	0.195	0.455	0	AC103591.3	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33728
0	-0.319254411176488	0.668	0.82	0	GNG5	Malignant cells	GSE199333_pre	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33729
0	-0.273121927882763	0.082	0.271	0	LMO4	Malignant cells	GSE199333_pre	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33730
0	-0.564685518200706	0.171	0.471	0	RAP1A	Malignant cells	GSE199333_pre	ENSG00000116473	5906	RAP1A, member of RAS oncogene family	KREV-1|SMGP21	protein_coding	P62834	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33731
0	-0.292951583336291	0.381	0.581	0	CAPZA1	Malignant cells	GSE199333_pre	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33732
0	-0.313305826133632	0.082	0.264	0	RHOC	Malignant cells	GSE199333_pre	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33733
0	-0.383996633826805	0.342	0.562	0	PLEKHO1	Malignant cells	GSE199333_pre	ENSG00000023902	51177	pleckstrin homology domain containing O1	CKIP-1|OC120	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33734
0	-1.20288356030592	0.068	0.418	0	S100A10	Malignant cells	GSE199333_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33735
0	-0.795516785656545	0.052	0.347	0	S100A11	Malignant cells	GSE199333_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33736
0	-1.21782241551899	0.586	0.763	0	S100A6	Malignant cells	GSE199333_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33737
0	-0.389021004548941	0.169	0.439	0	RAB13	Malignant cells	GSE199333_pre	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33738
0	0.364826907460873	1	1	0	RPS27	Malignant cells	GSE199333_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33739
0	-0.41767417299774	0.907	0.959	0	TPM3	Malignant cells	GSE199333_pre	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33740
0	-1.62652468017242	0.071	0.59	0	LMNA	Malignant cells	GSE199333_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33741
0	-0.369583111634162	0.384	0.566	0	CCT3	Malignant cells	GSE199333_pre	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33742
0	-0.322285438272634	0.222	0.408	0	MEF2D	Malignant cells	GSE199333_pre	ENSG00000116604	4209	myocyte enhancer factor 2D	NA	protein_coding	Q14814	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33743
0	0.415485764550104	0.427	0.189	0	CD84	Malignant cells	GSE199333_pre	ENSG00000066294	8832	CD84 molecule	hCD84|mCD84|SLAMF5	protein_coding	Q9UIB8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33744
0	-0.316616566501769	0.523	0.695	0	PFDN2	Malignant cells	GSE199333_pre	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33745
0	0.420651792679449	0.39	0.175	0	SELL	Malignant cells	GSE199333_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33746
0	-0.645940283820672	0.349	0.696	0	PTPRC	Malignant cells	GSE199333_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33747
0	0.710733702995274	0.523	0.211	0	MIR181A1HG	Malignant cells	GSE199333_pre	ENSG00000229989	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33748
0	-0.484284106491318	0.303	0.528	0	PTPN7	Malignant cells	GSE199333_pre	ENSG00000143851	5778	protein tyrosine phosphatase non-receptor type 7	HEPTP|LC-PTP	protein_coding	P35236	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33749
0	0.474054729862046	0.498	0.192	0	CD34	Malignant cells	GSE199333_pre	ENSG00000174059	947	CD34 molecule	NA	protein_coding	P28906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33750
0	-0.3602590996514	0.206	0.414	0	GALNT2	Malignant cells	GSE199333_pre	ENSG00000143641	2590	polypeptide N-acetylgalactosaminyltransferase 2	GalNAc-T2	protein_coding	Q10471	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33751
0	-0.73468091193053	0.792	0.931	0	HNRNPU	Malignant cells	GSE199333_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33752
0	-0.376314741376108	0.139	0.363	0	LPIN1	Malignant cells	GSE199333_pre	ENSG00000134324	23175	lipin 1	KIAA0188	protein_coding	Q14693	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33753
0	-0.41707871232168	0.25	0.452	0	ITSN2	Malignant cells	GSE199333_pre	ENSG00000198399	50618	intersectin 2	KIAA1256|PRO2015|SH3D1B|SH3P18|SWA|SWAP	protein_coding	Q9NZM3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33754
0	-0.327641650676507	0.367	0.557	0	PPM1G	Malignant cells	GSE199333_pre	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33755
0	-0.290998753392897	0.13	0.308	0	RHOQ	Malignant cells	GSE199333_pre	ENSG00000119729	23433	ras homolog family member Q	ARHQ|RASL7A|TC10	protein_coding	P17081	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33756
0	-0.410616631024322	0.6	0.795	0	CALM2	Malignant cells	GSE199333_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33757
0	-0.467551688485534	0.694	0.827	0	RTN4	Malignant cells	GSE199333_pre	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33758
0	-0.44477658635801	0.284	0.531	0	BCL11A	Malignant cells	GSE199333_pre	ENSG00000119866	53335	BAF chromatin remodeling complex subunit BCL11A	BCL11A-L|BCL11A-S|BCL11A-XL|CTIP1|EVI9|HBFQTL5|SMARCM1|ZNF856	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33759
0	-0.562082414443937	0.469	0.616	0	REL	Malignant cells	GSE199333_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33760
0	-0.480351658615114	0.589	0.822	0	ACTR2	Malignant cells	GSE199333_pre	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33761
0	-0.255280716248785	0.075	0.256	0	MEIS1	Malignant cells	GSE199333_pre	ENSG00000143995	4211	Meis homeobox 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33762
0	-0.607163229280149	0.368	0.638	0	PLEK	Malignant cells	GSE199333_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33763
0	-0.324562278455691	0.445	0.625	0	SNRPG	Malignant cells	GSE199333_pre	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33764
0	0.305327917852951	0.646	0.433	0	CAPG	Malignant cells	GSE199333_pre	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33765
0	0.603465153584723	0.997	0.984	0	RPL31	Malignant cells	GSE199333_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33766
0	-0.409710946924467	0.333	0.561	0	LIMS1	Malignant cells	GSE199333_pre	ENSG00000169756	3987	LIM zinc finger domain containing 1	PINCH|PINCH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33767
0	0.570557084081998	0.686	0.441	0	GYPC	Malignant cells	GSE199333_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33768
0	-0.847887147230825	0.316	0.697	0	ZEB2	Malignant cells	GSE199333_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33769
0	-0.471125049253722	0.573	0.798	0	PRPF40A	Malignant cells	GSE199333_pre	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33770
0	-0.344369528636806	0.181	0.361	0	TANK	Malignant cells	GSE199333_pre	ENSG00000136560	10010	TRAF family member associated NFKB activator	I-TRAF|TRAF2	protein_coding	Q92844	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33771
0	-0.331627034220483	0.515	0.696	0	SSB	Malignant cells	GSE199333_pre	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33772
0	-0.335668639367738	0.078	0.307	0	MAP3K20	Malignant cells	GSE199333_pre	ENSG00000091436	51776	mitogen-activated protein kinase kinase kinase 20	MLK7|MLTK|MLTKalpha|MLTKbeta|MRK|ZAK	protein_coding	Q9NYL2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33773
0	-0.465455950566088	0.728	0.912	0	HNRNPA3	Malignant cells	GSE199333_pre	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33774
0	-0.398282851092283	0.618	0.78	0	BZW1	Malignant cells	GSE199333_pre	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33775
0	-0.308856649744837	0.06	0.268	0	ABI2	Malignant cells	GSE199333_pre	ENSG00000138443	10152	abl interactor 2	ABI-2|ABI2B|AblBP3|AIP-1|argBPIA|SSH3BP2	protein_coding	Q9NYB9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33776
0	0.422363899351889	1	0.999	0	EEF1B2	Malignant cells	GSE199333_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33777
0	0.3107770441529	0.34	0.139	0	CRYGD	Malignant cells	GSE199333_pre	ENSG00000285434	1421	crystallin gamma D	CRYG4	protein_coding	P07320	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33778
0	-0.384821615636059	0.477	0.67	0	XRCC5	Malignant cells	GSE199333_pre	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33779
0	0.484757408532133	1	1	0	RPL37A	Malignant cells	GSE199333_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33780
0	-0.564383466103606	0.046	0.33	0	IGFBP2	Malignant cells	GSE199333_pre	ENSG00000115457	3485	insulin like growth factor binding protein 2	IBP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33781
0	-0.677355036538583	0.709	0.87	0	LRRFIP1	Malignant cells	GSE199333_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33782
0	-1.38645939075519	0.067	0.337	0	NEU4	Malignant cells	GSE199333_pre	ENSG00000277926	129807	neuraminidase 4	NA	protein_coding	Q8WWR8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33783
0	-0.437098375374843	0.18	0.362	0	BHLHE40	Malignant cells	GSE199333_pre	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33784
0	-0.371496217892043	0.172	0.422	0	ARL8B	Malignant cells	GSE199333_pre	ENSG00000134108	55207	ADP ribosylation factor like GTPase 8B	ARL10C|FLJ10702|Gie1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33785
0	-0.334329434689921	0.202	0.415	0	THUMPD3-AS1	Malignant cells	GSE199333_pre	ENSG00000206573	440944	THUMPD3 antisense RNA 1	SETD5-AS1	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33786
0	-0.3017691675196	0.148	0.339	0	SETD5	Malignant cells	GSE199333_pre	ENSG00000168137	55209	SET domain containing 5	FLJ10707|SETD5A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33787
0	0.273684912430877	1	1	0	RPL32	Malignant cells	GSE199333_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33788
0	-0.541003214859575	0.429	0.656	0	CMTM6	Malignant cells	GSE199333_pre	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33789
0	0.613722578763682	1	0.999	0	RPSA	Malignant cells	GSE199333_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33790
0	0.442721497272878	1	1	0	RPL14	Malignant cells	GSE199333_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33791
0	-0.337260755325582	0.37	0.578	0	CCDC12	Malignant cells	GSE199333_pre	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33792
0	-0.460555148803792	0.822	0.939	0	RHOA	Malignant cells	GSE199333_pre	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33793
0	0.436213418372967	0.607	0.375	0	RASSF1	Malignant cells	GSE199333_pre	ENSG00000068028	11186	Ras association domain family member 1	123F2|NORE2A|RDA32|REH3P21	protein_coding	Q9NS23	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33794
0	-0.749539293039048	0.411	0.738	0	ARL6IP5	Malignant cells	GSE199333_pre	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33795
0	0.566749820719087	1	1	0	RPL24	Malignant cells	GSE199333_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33796
0	-0.414619285410579	0.394	0.58	0	CD47	Malignant cells	GSE199333_pre	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33797
0	-0.264114898770237	0.139	0.322	0	NAA50	Malignant cells	GSE199333_pre	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33798
0	0.492528558744317	0.57	0.305	0	ZBTB20	Malignant cells	GSE199333_pre	ENSG00000181722	26137	zinc finger and BTB domain containing 20	DKFZp566F123|DPZF|ODA-8S|ZNF288	protein_coding	Q9HC78	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33799
0	-0.377833696388712	0.282	0.505	0	GOLGB1	Malignant cells	GSE199333_pre	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33800
0	-0.33723523582034	0.249	0.455	0	PARP14	Malignant cells	GSE199333_pre	ENSG00000173193	54625	poly(ADP-ribose) polymerase family member 14	ARTD8|BAL2|KIAA1268|pART8	protein_coding	Q460N5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33801
0	0.379048121833886	0.366	0.134	0	ABTB1	Malignant cells	GSE199333_pre	ENSG00000114626	80325	ankyrin repeat and BTB domain containing 1	BPOZ|Btb3|BTBD21|EF1ABP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33802
0	-0.525415455434226	0.149	0.364	0	GATA2	Malignant cells	GSE199333_pre	ENSG00000179348	2624	GATA binding protein 2	NFE1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33803
0	-0.372410432053978	0.517	0.709	0	RNF7	Malignant cells	GSE199333_pre	ENSG00000114125	9616	ring finger protein 7	CKBBP1|RBX2|ROC2|SAG	protein_coding	Q9UBF6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33804
0	-0.506724373675764	0.573	0.739	0	MBNL1	Malignant cells	GSE199333_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33805
0	-0.406401886549755	0.289	0.558	0	SSR3	Malignant cells	GSE199333_pre	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33806
0	-0.748210874063277	0.249	0.573	0	SMC4	Malignant cells	GSE199333_pre	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33807
0	-0.28001785554688	0.228	0.42	0	EIF4G1	Malignant cells	GSE199333_pre	ENSG00000114867	1981	eukaryotic translation initiation factor 4 gamma 1	EIF4F|EIF4G|p220|PARK18	protein_coding	Q04637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33808
0	-0.311387779638121	0.338	0.539	0	IGF2BP2	Malignant cells	GSE199333_pre	ENSG00000073792	10644	insulin like growth factor 2 mRNA binding protein 2	IMP-2|p62	protein_coding	Q9Y6M1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33809
0	-0.358618365233962	0.086	0.307	0	IL1RAP	Malignant cells	GSE199333_pre	ENSG00000196083	3556	interleukin 1 receptor accessory protein	C3orf13|IL-1RAcP|IL1R3	protein_coding	Q9NPH3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33810
0	-0.335603375470866	0.27	0.485	0	ACAP2	Malignant cells	GSE199333_pre	ENSG00000114331	23527	ArfGAP with coiled-coil, ankyrin repeat and PH domains 2	CENTB2|CNT-B2|KIAA0041	protein_coding	Q15057	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33811
0	-0.289965769613035	0.185	0.366	0	GAK	Malignant cells	GSE199333_pre	ENSG00000178950	2580	cyclin G associated kinase	DNAJC26	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33812
0	-0.61257525705528	0.084	0.47	0	C4orf48	Malignant cells	GSE199333_pre	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33813
0	-0.476415033496303	0.115	0.344	0	SH3BP2	Malignant cells	GSE199333_pre	ENSG00000087266	6452	SH3 domain binding protein 2	CRBM|RES4-23	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33814
0	0.48883077997279	0.583	0.26	0	CYTL1	Malignant cells	GSE199333_pre	ENSG00000170891	54360	cytokine like 1	C17|C4orf4	protein_coding	Q9NRR1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33815
0	-0.44931298631078	0.258	0.534	0	RBPJ	Malignant cells	GSE199333_pre	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33816
0	0.294426554524708	0.272	0.082	0	TMEM156	Malignant cells	GSE199333_pre	ENSG00000121895	80008	transmembrane protein 156	FLJ23235	protein_coding	Q8N614	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33817
0	0.578817198049572	1	1	0	RPL9	Malignant cells	GSE199333_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33818
0	-0.322829041215984	0.242	0.461	0	UBE2K	Malignant cells	GSE199333_pre	ENSG00000078140	3093	ubiquitin conjugating enzyme E2 K	HIP2|HYPG|UBC1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33819
0	-1.20039823959081	0.381	0.545	0	SPINK2	Malignant cells	GSE199333_pre	ENSG00000128040	6691	serine peptidase inhibitor Kazal type 2	HUSI-II	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33820
0	0.821106309782086	0.74	0.407	0	IGFBP7	Malignant cells	GSE199333_pre	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33821
0	-1.59171435266852	0.021	0.286	0	JCHAIN	Malignant cells	GSE199333_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33822
0	-1.34320026586224	0.159	0.34	0	CXCL8	Malignant cells	GSE199333_pre	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33823
0	1.10631660421344	0.27	0.084	0	AREG	Malignant cells	GSE199333_pre	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33824
0	-0.41549458221648	0.615	0.795	0	HNRNPD	Malignant cells	GSE199333_pre	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33825
0	-0.563130474721035	0.21	0.428	0	NFKB1	Malignant cells	GSE199333_pre	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33826
0	0.501892476887784	1	1	0	RPS3A	Malignant cells	GSE199333_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33827
0	-0.370327251035442	0.282	0.482	0	CCT5	Malignant cells	GSE199333_pre	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33828
0	-0.35174606169252	0.241	0.491	0	ZFR	Malignant cells	GSE199333_pre	ENSG00000056097	51663	zinc finger RNA binding protein	SPG71|ZFR1	protein_coding	Q96KR1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33829
0	-0.405225998920559	0.884	0.951	0	SUB1	Malignant cells	GSE199333_pre	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33830
0	0.293300146404344	0.371	0.173	0	NPR3	Malignant cells	GSE199333_pre	ENSG00000113389	4883	natriuretic peptide receptor 3	ANPRC|C5orf23|FLJ14054|GUCY2B|NPRC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33831
0	-0.383503144824345	0.35	0.545	0	RICTOR	Malignant cells	GSE199333_pre	ENSG00000164327	253260	RPTOR independent companion of MTOR complex 2	AVO3|KIAA1999|MGC39830|PIA	protein_coding	Q6R327	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33832
0	0.415265936086477	0.393	0.118	0	FYB1	Malignant cells	GSE199333_pre	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33833
0	0.370310224405717	1	1	0	RPL37	Malignant cells	GSE199333_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33834
0	-0.416487794783456	0.396	0.618	0	EMB	Malignant cells	GSE199333_pre	ENSG00000170571	133418	embigin	MGC71745	protein_coding	Q6PCB8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33835
0	0.337742705724153	1	0.998	0	BTF3	Malignant cells	GSE199333_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33836
0	0.357156903932402	0.858	0.745	0	NSA2	Malignant cells	GSE199333_pre	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33837
0	-0.297738872266628	0.195	0.385	0	COL4A3BP	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33838
0	0.315911760584464	1	1	0	RPS23	Malignant cells	GSE199333_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33839
0	-0.390117880797442	0.22	0.415	0	MEF2C	Malignant cells	GSE199333_pre	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33840
0	-0.460449280227075	0.136	0.396	0	CAST	Malignant cells	GSE199333_pre	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33841
0	-0.344352361266791	0.103	0.296	0	TNFAIP8	Malignant cells	GSE199333_pre	ENSG00000145779	25816	TNF alpha induced protein 8	GG2-1|MDC-3.13|SCC-S2	protein_coding	O95379	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33842
0	0.262588971799263	0.998	0.991	0	HINT1	Malignant cells	GSE199333_pre	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33843
0	-0.636643955093886	0.409	0.691	0	IRF1	Malignant cells	GSE199333_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33844
0	-0.296074433097673	0.149	0.358	0	HSPA4	Malignant cells	GSE199333_pre	ENSG00000170606	3308	heat shock protein family A (Hsp70) member 4	HS24/P52|HSPH2	protein_coding	P34932	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33845
0	-0.275197257337541	0.093	0.288	0	CTNNA1	Malignant cells	GSE199333_pre	ENSG00000044115	1495	catenin alpha 1	CAP102	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33846
0	-0.767662898455791	0.449	0.669	0	CXXC5	Malignant cells	GSE199333_pre	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33847
0	-0.364019352677823	0.357	0.595	0	IK	Malignant cells	GSE199333_pre	ENSG00000113141	3550	IK cytokine	RED|RER	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33848
0	-0.283321468378981	0.177	0.393	0	NDFIP1	Malignant cells	GSE199333_pre	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33849
0	-0.379459922810228	0.535	0.743	0	CSNK1A1	Malignant cells	GSE199333_pre	ENSG00000113712	1452	casein kinase 1 alpha 1	CK1|CK1a|CK1alpha|CKIa|CKIalpha	protein_coding	P48729	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33850
0	-0.689163719757848	0.361	0.654	0	SMIM3	Malignant cells	GSE199333_pre	ENSG00000256235	85027	small integral membrane protein 3	C5orf62|MSTP150|NID67	protein_coding	Q9BZL3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33851
0	-0.510155088150252	0.247	0.45	0	TNIP1	Malignant cells	GSE199333_pre	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33852
0	-0.503166916770299	0.533	0.758	0	PRELID1	Malignant cells	GSE199333_pre	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33853
0	-0.435852161625741	0.496	0.678	0	HNRNPAB	Malignant cells	GSE199333_pre	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33854
0	-0.517591795345285	0.434	0.632	0	SQSTM1	Malignant cells	GSE199333_pre	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33855
0	-0.421812788306171	0.103	0.335	0	FOXC1	Malignant cells	GSE199333_pre	ENSG00000054598	2296	forkhead box C1	ARA|FKHL7|FREAC3|IGDA|IHG1|IRID1	protein_coding	Q12948	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33856
0	-0.586689867077063	0.553	0.763	0	DEK	Malignant cells	GSE199333_pre	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33857
0	-1.01641143739023	0.328	0.517	0	HIST1H4C	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33858
0	-0.409980629904851	0.145	0.332	0	HIST1H1E	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33859
0	-0.887924814384175	0.99	0.998	0	HLA-A	Malignant cells	GSE199333_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33860
0	-0.390734919306731	0.74	0.91	0	HLA-E	Malignant cells	GSE199333_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33861
0	-0.440798091325889	0.343	0.578	0	PPP1R18	Malignant cells	GSE199333_pre	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33862
0	-0.713782059244204	0.63	0.754	0	TUBB	Malignant cells	GSE199333_pre	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33863
0	-0.796456577160713	0.044	0.295	0	IER3	Malignant cells	GSE199333_pre	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33864
0	-0.705464173828925	0.946	0.973	0	HLA-C	Malignant cells	GSE199333_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33865
0	-1.62273465689451	0.968	1	0	HLA-B	Malignant cells	GSE199333_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33866
0	-0.63064133794945	0.039	0.256	0	LTB	Malignant cells	GSE199333_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33867
0	-0.312417511668946	0.524	0.691	0	CSNK2B	Malignant cells	GSE199333_pre	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33868
0	-0.676941120110075	0.927	0.981	0	CLIC1	Malignant cells	GSE199333_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33869
0	0.454338897518154	0.812	0.665	0	C6orf48	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33870
0	0.332975066838677	0.97	0.773	0	HLA-DRA	Malignant cells	GSE199333_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33871
0	1.32785512696405	0.934	0.518	0	HLA-DRB1	Malignant cells	GSE199333_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33872
0	0.657776997031312	0.571	0.208	0	HLA-DQA1	Malignant cells	GSE199333_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33873
0	0.474673696373988	0.645	0.258	0	HLA-DQB1	Malignant cells	GSE199333_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33874
0	0.430907557507407	0.916	0.708	0	HLA-DPA1	Malignant cells	GSE199333_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33875
0	0.960034957323534	0.892	0.644	0	HLA-DPB1	Malignant cells	GSE199333_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33876
0	-0.411378699436301	0.682	0.82	0	TAPBP	Malignant cells	GSE199333_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33877
0	-0.30467079035867	0.279	0.489	0	NUDT3	Malignant cells	GSE199333_pre	ENSG00000272325	11165	nudix hydrolase 3	DIPP	protein_coding	O95989	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33878
0	0.520877388991627	1	1	0	RPS10	Malignant cells	GSE199333_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33879
0	0.456012612800643	1	1	0	RPL10A	Malignant cells	GSE199333_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33880
0	-0.290500041752196	0.183	0.385	0	SRPK1	Malignant cells	GSE199333_pre	ENSG00000096063	6732	SRSF protein kinase 1	SFRSK1	protein_coding	Q96SB4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33881
0	-0.310331469547713	0.302	0.495	0	MTCH1	Malignant cells	GSE199333_pre	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33882
0	-0.404812329190482	0.127	0.369	0	PIM1	Malignant cells	GSE199333_pre	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33883
0	-0.548778309897643	0.165	0.468	0	CCND3	Malignant cells	GSE199333_pre	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33884
0	0.315339501185449	0.262	0.067	0	DST	Malignant cells	GSE199333_pre	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33885
0	0.252510677353122	1	1	0	EEF1A1	Malignant cells	GSE199333_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33886
0	-0.309894132013937	0.162	0.373	0	TMEM30A	Malignant cells	GSE199333_pre	ENSG00000112697	55754	transmembrane protein 30A	C6orf67|CDC50A|FLJ10856	protein_coding	Q9NV96	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33887
0	0.456043753541179	0.526	0.329	0	TENT5A	Malignant cells	GSE199333_pre	ENSG00000112773	55603	terminal nucleotidyltransferase 5A	C6orf37|FAM46A|FLJ20037	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33888
0	-0.487697439310376	0.375	0.641	0	SYNCRIP	Malignant cells	GSE199333_pre	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33889
0	-0.451918881932091	0.519	0.7	0	UBE2J1	Malignant cells	GSE199333_pre	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33890
0	-0.340711076338409	0.282	0.502	0	SEC63	Malignant cells	GSE199333_pre	ENSG00000025796	11231	SEC63 homolog, protein translocation regulator	DNAJC23|ERdj2|PRO2507|SEC63L	protein_coding	Q9UGP8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33891
0	0.310146523429962	0.361	0.161	0	CALHM6	Malignant cells	GSE199333_pre	ENSG00000188820	441168	calcium homeostasis modulator family member 6	C6orf187|dJ93H18.5|FAM26F|INAM|OTTHUMP00000017061|OTTHUMP00000017062|RP1-93H18.5	protein_coding	Q5R3K3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33892
0	0.399571625262622	1	1	0	RPS12	Malignant cells	GSE199333_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33893
0	-0.494734748117523	0.533	0.737	0	HEBP2	Malignant cells	GSE199333_pre	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33894
0	-0.793635827966868	0.101	0.411	0	SYNJ2	Malignant cells	GSE199333_pre	ENSG00000078269	8871	synaptojanin 2	INPP5H	protein_coding	O15056	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33895
0	-0.781080173612296	0.189	0.527	0	EZR	Malignant cells	GSE199333_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33896
0	-0.303770887566025	0.309	0.514	0	QKI	Malignant cells	GSE199333_pre	ENSG00000112531	9444	QKI, KH domain containing RNA binding	QK3	protein_coding	Q96PU8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33897
0	-0.695976359289488	0.604	0.895	0	RAC1	Malignant cells	GSE199333_pre	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33898
0	-0.518283834540422	0.169	0.438	0	AHR	Malignant cells	GSE199333_pre	ENSG00000106546	196	aryl hydrocarbon receptor	bHLHe76	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33899
0	-0.569574937354349	0.098	0.297	0	MACC1	Malignant cells	GSE199333_pre	ENSG00000183742	346389	MET transcriptional regulator MACC1	7A5|SH3BP4L	protein_coding	Q6ZN28	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33900
0	0.433031350811962	0.958	0.904	0	TOMM7	Malignant cells	GSE199333_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33901
0	-0.314366936034197	0.942	0.98	0	HNRNPA2B1	Malignant cells	GSE199333_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33902
0	-0.271489831601829	0.126	0.303	0	SNX10	Malignant cells	GSE199333_pre	ENSG00000086300	29887	sorting nexin 10	NA	protein_coding	Q9Y5X0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33903
0	-0.649330749555161	0.221	0.488	0	HOTAIRM1	Malignant cells	GSE199333_pre	ENSG00000233429	NA	NA	HOXA-AS1|HOXA1-AS1|NCRNA00179	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33904
0	-0.563316031409961	0.086	0.413	0	HOXA5	Malignant cells	GSE199333_pre	ENSG00000106004	3202	homeobox A5	HOX1|HOX1C	protein_coding	P20719	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33905
0	-0.53081987311254	0.249	0.561	0	HOXA9	Malignant cells	GSE199333_pre	ENSG00000078399	3205	homeobox A9	HOX1|HOX1G	protein_coding	P31269	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33906
0	-0.316929046370357	0.126	0.315	0	CPVL	Malignant cells	GSE199333_pre	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33907
0	-0.319398455282802	0.18	0.365	0	GGCT	Malignant cells	GSE199333_pre	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33908
0	-0.525728455949739	0.082	0.365	0	TRGC2	Malignant cells	GSE199333_pre	ENSG00000227191	NA	NA	TCRGC2|TRGC2(2X)|TRGC2(3X)	TR_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33909
0	-0.406365723511624	0.148	0.395	0	RALA	Malignant cells	GSE199333_pre	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33910
0	-0.367003710526318	0.396	0.61	0	CCT6A	Malignant cells	GSE199333_pre	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33911
0	-0.395442335808905	0.263	0.454	0	HSPB1	Malignant cells	GSE199333_pre	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33912
0	-0.353193306622067	0.257	0.454	0	ZNF655	Malignant cells	GSE199333_pre	ENSG00000197343	79027	zinc finger protein 655	VIK|VIK-1	protein_coding	Q8N720	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33913
0	-0.399749429582523	0.286	0.521	0	KMT2C	Malignant cells	GSE199333_pre	ENSG00000055609	58508	lysine methyltransferase 2C	HALR|KIAA1506|MLL3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33914
0	-0.337319093187951	0.184	0.39	0	IL3RA	Malignant cells	GSE199333_pre	ENSG00000185291	3563	interleukin 3 receptor subunit alpha	CD123	protein_coding	P26951	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33915
0	-0.400703655252267	0.15	0.405	0	PRDX4	Malignant cells	GSE199333_pre	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33916
0	-0.694221296911172	0.349	0.682	0	TIMP1	Malignant cells	GSE199333_pre	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33917
0	-0.597568881477204	0.558	0.764	0	PLP2	Malignant cells	GSE199333_pre	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33918
0	-0.592221464288606	0.749	0.882	0	MSN	Malignant cells	GSE199333_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33919
0	0.295134218296683	0.285	0.103	0	AL034397.3	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33920
0	0.27812083965486	1	1	0	RPS4X	Malignant cells	GSE199333_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33921
0	0.846038282539991	0.752	0.344	0	ITM2A	Malignant cells	GSE199333_pre	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33922
0	0.61128227972522	0.999	0.986	0	RPL36A	Malignant cells	GSE199333_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33923
0	-0.422801536927887	0.871	0.943	0	SLC25A5	Malignant cells	GSE199333_pre	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33924
0	-0.298904433936802	0.233	0.435	0	UBE2A	Malignant cells	GSE199333_pre	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33925
0	-0.347215263687006	0.224	0.458	0	STAG2	Malignant cells	GSE199333_pre	ENSG00000101972	10735	stromal antigen 2	SA-2|SA2|SCC3B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33926
0	-0.439293186659783	0.412	0.591	0	FLNA	Malignant cells	GSE199333_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33927
0	0.363575339835704	1	1	0	RPL10	Malignant cells	GSE199333_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33928
0	-0.433640506470029	0.236	0.472	0	FDFT1	Malignant cells	GSE199333_pre	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33929
0	-0.387717362663207	0.208	0.408	0	CTSB	Malignant cells	GSE199333_pre	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33930
0	0.416520141182858	0.703	0.497	0	ASAH1	Malignant cells	GSE199333_pre	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33931
0	-0.381535359956207	0.161	0.372	0	CLU	Malignant cells	GSE199333_pre	ENSG00000120885	1191	clusterin	APOJ|CLI|CLU1|CLU2|KUB1|SGP-2|SP-40|TRPM-2	protein_coding	P10909	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33932
0	-0.775193308130365	0.327	0.543	0	RAB11FIP1	Malignant cells	GSE199333_pre	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33933
0	-0.437819741490204	0.384	0.582	0	TACC1	Malignant cells	GSE199333_pre	ENSG00000147526	6867	transforming acidic coiled-coil containing protein 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33934
0	-0.326556887879021	0.148	0.36	0	HOOK3	Malignant cells	GSE199333_pre	ENSG00000168172	84376	hook microtubule tethering protein 3	HK3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33935
0	-0.612515622258012	0.327	0.648	0	LYN	Malignant cells	GSE199333_pre	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33936
0	1.02776866253749	1	0.998	0	RPS20	Malignant cells	GSE199333_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33937
0	-0.345776951989965	0.449	0.654	0	RAB2A	Malignant cells	GSE199333_pre	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33938
0	-0.463473228188282	0.42	0.692	0	TRAM1	Malignant cells	GSE199333_pre	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33939
0	-0.384431873201574	0.518	0.684	0	C8orf59	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33940
0	-0.431737305158307	0.075	0.317	0	FAM92A	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33941
0	-0.582571836242414	0.745	0.906	0	MTDH	Malignant cells	GSE199333_pre	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33942
0	-0.699401944900025	0.118	0.466	0	LAPTM4B	Malignant cells	GSE199333_pre	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33943
0	-0.555217763910871	0.697	0.868	0	YWHAZ	Malignant cells	GSE199333_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33944
0	-0.304183255539486	0.367	0.581	0	ZNF706	Malignant cells	GSE199333_pre	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33945
0	-0.281351951975967	0.088	0.284	0	TMEM65	Malignant cells	GSE199333_pre	ENSG00000164983	157378	transmembrane protein 65	NA	protein_coding	Q6PI78	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33946
0	-0.453601425323085	0.141	0.369	0	AGO2	Malignant cells	GSE199333_pre	ENSG00000123908	27161	argonaute RISC catalytic component 2	CASC7|EIF2C2|hAGO2|LINC00980|Q10	protein_coding	Q9UKV8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33947
0	-0.476851581275537	0.042	0.278	0	PLEC	Malignant cells	GSE199333_pre	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33948
0	-0.434929600297134	0.509	0.725	0	DNAJA1	Malignant cells	GSE199333_pre	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33949
0	-0.301057679480463	0.124	0.301	0	B4GALT1	Malignant cells	GSE199333_pre	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33950
0	-0.339086865497822	0.286	0.501	0	UBE2R2	Malignant cells	GSE199333_pre	ENSG00000107341	54926	ubiquitin conjugating enzyme E2 R2	CDC34B|FLJ20419|MGC10481|UBC3B	protein_coding	Q712K3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33951
0	-0.350363782876004	0.401	0.645	0	VCP	Malignant cells	GSE199333_pre	ENSG00000165280	7415	valosin containing protein	CDC48|IBMPFD|p97|TERA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33952
0	-0.353168623518653	0.485	0.659	0	CLTA	Malignant cells	GSE199333_pre	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33953
0	0.265917526754283	0.318	0.144	0	NFIL3	Malignant cells	GSE199333_pre	ENSG00000165030	4783	nuclear factor, interleukin 3 regulated	E4BP4|IL3BP1|NF-IL3A|NFIL3A	protein_coding	Q16649	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33954
0	-0.897535627802222	0.099	0.418	0	NINJ1	Malignant cells	GSE199333_pre	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33955
0	-0.47867481849088	0.781	0.912	0	SEC61B	Malignant cells	GSE199333_pre	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33956
0	-0.777752976750589	0.249	0.69	0	PTBP3	Malignant cells	GSE199333_pre	ENSG00000119314	9991	polypyrimidine tract binding protein 3	DKFZp781I1117|ROD1	protein_coding	O95758	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33957
0	-0.613492954935113	0.33	0.642	0	ARPC5L	Malignant cells	GSE199333_pre	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33958
0	-0.483020251836403	0.199	0.491	0	PBX3	Malignant cells	GSE199333_pre	ENSG00000167081	5090	PBX homeobox 3	NA	protein_coding	P40426	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33959
0	-0.73770710738471	0.274	0.598	0	ZBTB43	Malignant cells	GSE199333_pre	ENSG00000169155	23099	zinc finger and BTB domain containing 43	FLJ22470|KIAA0414|ZBTB22B|ZNF-X|ZNF297B	protein_coding	O43298	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33960
0	-0.396266491457263	0.176	0.353	0	RALGDS	Malignant cells	GSE199333_pre	ENSG00000160271	5900	ral guanine nucleotide dissociation stimulator	RalGEF|RGDS|RGF	protein_coding	Q12967	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33961
0	0.25250153027363	1	1	0	RPL7A	Malignant cells	GSE199333_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33962
0	0.316620001832642	0.292	0.078	0	FAM69B	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33963
0	-0.76010598487559	0.328	0.572	0	TUBB4B	Malignant cells	GSE199333_pre	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33964
0	-0.377088219010605	0.325	0.523	0	MRPL41	Malignant cells	GSE199333_pre	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33965
0	-0.722815036434274	0.076	0.369	0	IFITM3	Malignant cells	GSE199333_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33966
0	0.404423420079434	0.927	0.835	0	TALDO1	Malignant cells	GSE199333_pre	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33967
0	0.596121448531303	1	1	0	RPLP2	Malignant cells	GSE199333_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33968
0	0.441900185169711	0.347	0.079	0	TSPAN4	Malignant cells	GSE199333_pre	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33969
0	0.374999980490132	0.84	0.677	0	CTSD	Malignant cells	GSE199333_pre	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33970
0	0.391499404189475	0.774	0.531	0	LSP1	Malignant cells	GSE199333_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33971
0	-0.399058535085799	0.203	0.457	0	MRPL23	Malignant cells	GSE199333_pre	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33972
0	-0.423357800018567	0.293	0.675	0	CD81	Malignant cells	GSE199333_pre	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33973
0	-0.563382855048794	0.11	0.309	0	KCNQ1OT1	Malignant cells	GSE199333_pre	ENSG00000269821	10984	KCNQ1 opposite strand/antisense transcript 1	KCNQ1-AS2|KvDMR1|KvLQT1-AS|LIT1|NCRNA00012	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33974
0	0.718500001989361	0.29	0.108	0	HBB	Malignant cells	GSE199333_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33975
0	0.752181833194287	1	0.998	0	RPL27A	Malignant cells	GSE199333_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33976
0	0.310999462675173	1	1	0	RPS13	Malignant cells	GSE199333_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33977
0	-0.25225467812951	0.352	0.59	0	LMO2	Malignant cells	GSE199333_pre	ENSG00000135363	4005	LIM domain only 2	RBTN2|RBTNL1|RHOM2|TTG2	protein_coding	P25791	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33978
0	-0.626226275198363	0.377	0.635	0	SPI1	Malignant cells	GSE199333_pre	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33979
0	-0.412772669465303	0.458	0.656	0	CELF1	Malignant cells	GSE199333_pre	ENSG00000149187	10658	CUGBP Elav-like family member 1	BRUNOL2|CUG-BP|CUGBP|CUGBP1|EDEN-BP|hNab50|NAB50|NAPOR	protein_coding	Q92879	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33980
0	1.91718396826164	0.764	0.067	0	C1QTNF4	Malignant cells	GSE199333_pre	ENSG00000284838	114900	C1q and TNF related 4	CTRP4|ZACRP4	protein_coding	Q9BXJ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33981
0	-0.350533277062836	0.067	0.284	0	FADS1	Malignant cells	GSE199333_pre	ENSG00000149485	3992	fatty acid desaturase 1	D5D|FADS6|FADSD5|LLCDL1|TU12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33982
0	-0.905053971217508	0.222	0.526	0	AHNAK	Malignant cells	GSE199333_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33983
0	-0.330327272738611	0.471	0.695	0	UBXN1	Malignant cells	GSE199333_pre	ENSG00000162191	51035	UBX domain protein 1	2B28|LOC51035|SAKS1|UBXD10	protein_coding	Q04323	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33984
0	0.279957292540806	0.409	0.224	0	RARRES3	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33985
0	0.319036824082357	1	1	0	FAU	Malignant cells	GSE199333_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33986
0	0.402351897925714	1	0.999	0	MALAT1	Malignant cells	GSE199333_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33987
0	-0.376244485326248	0.97	0.989	0	CFL1	Malignant cells	GSE199333_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33988
0	0.559316431005975	0.756	0.666	0	CTSW	Malignant cells	GSE199333_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33989
0	0.48178877707158	0.976	0.937	0	GSTP1	Malignant cells	GSE199333_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33990
0	-0.262949429647204	0.087	0.252	0	UNC93B1	Malignant cells	GSE199333_pre	ENSG00000110057	81622	unc-93 homolog B1, TLR signaling regulator	UNC93	protein_coding	Q9H1C4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33991
0	0.41770579597821	0.77	0.617	0	LAMTOR1	Malignant cells	GSE199333_pre	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33992
0	-0.359612288271986	0.146	0.356	0	RELT	Malignant cells	GSE199333_pre	ENSG00000054967	84957	RELT TNF receptor	FLJ14993|TNFRSF19L	protein_coding	Q969Z4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33993
0	-0.437391566613654	0.304	0.565	0	SPCS2	Malignant cells	GSE199333_pre	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33994
0	0.264743363483508	1	1	0	RPS3	Malignant cells	GSE199333_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33995
0	-0.359448769436396	0.392	0.569	0	CLNS1A	Malignant cells	GSE199333_pre	ENSG00000074201	1207	chloride nucleotide-sensitive channel 1A	CLCI|ICln	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33996
0	-0.346926576761363	0.375	0.582	0	RSF1	Malignant cells	GSE199333_pre	ENSG00000048649	51773	remodeling and spacing factor 1	HBXAP|p325|RSF-1|XAP8	protein_coding	Q96T23	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33997
0	0.38675937897021	0.493	0.259	0	C11orf1	Malignant cells	GSE199333_pre	ENSG00000137720	64776	chromosome 11 open reading frame 1	FLJ23499	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33998
0	0.313363668664723	0.314	0.112	0	ZBTB16	Malignant cells	GSE199333_pre	ENSG00000109906	7704	zinc finger and BTB domain containing 16	PLZF|ZNF145	protein_coding	Q05516	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	33999
0	-0.362027898359698	0.25	0.455	0	PCSK7	Malignant cells	GSE199333_pre	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34000
0	0.394516519356491	1	1	0	RPS25	Malignant cells	GSE199333_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34001
0	0.883586978172044	0.58	0.098	0	SORL1	Malignant cells	GSE199333_pre	ENSG00000137642	6653	sortilin related receptor 1	C11orf32|gp250|LR11|LRP9|SorLA|SorLA-1	protein_coding	Q92673	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34002
0	-0.771200681433618	0.624	0.812	0	HSPA8	Malignant cells	GSE199333_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34003
0	-0.318958172900054	0.322	0.519	0	GTPBP4	Malignant cells	GSE199333_pre	ENSG00000107937	23560	GTP binding protein 4	CRFG|FLJ10686|FLJ10690|NGB|NOG1	protein_coding	Q9BZE4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34004
0	-0.568236492632134	0.003	0.264	0	IL2RA	Malignant cells	GSE199333_pre	ENSG00000134460	3559	interleukin 2 receptor subunit alpha	CD25|IDDM10|IL2R	protein_coding	P01589	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34005
0	-0.599956706001476	0.394	0.702	0	RBM17	Malignant cells	GSE199333_pre	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34006
0	-0.309757993386514	0.254	0.476	0	CDC123	Malignant cells	GSE199333_pre	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34007
0	-0.637802770064184	0.098	0.457	0	FAM107B	Malignant cells	GSE199333_pre	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34008
0	-1.07672670976403	0.809	0.922	0	VIM	Malignant cells	GSE199333_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34009
0	-0.597475982952903	0.283	0.526	0	DNAJC1	Malignant cells	GSE199333_pre	ENSG00000136770	64215	DnaJ heat shock protein family (Hsp40) member C1	DNAJL1|ERdj1|MTJ1	protein_coding	Q96KC8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34010
0	-0.479245381622693	0.266	0.495	0	COMMD3	Malignant cells	GSE199333_pre	ENSG00000148444	23412	COMM domain containing 3	BUP|C10orf8	protein_coding	Q9UBI1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34011
0	-0.372186676624055	0.421	0.634	0	WAC	Malignant cells	GSE199333_pre	ENSG00000095787	51322	WW domain containing adaptor with coiled-coil	BM-016|FLJ31290|MGC10753|PRO1741|Wwp4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34012
0	1.12632484393175	0.726	0.419	0	MAP3K8	Malignant cells	GSE199333_pre	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34013
0	-0.89261094621522	0.628	0.927	0	SRGN	Malignant cells	GSE199333_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34014
0	-0.532621575844858	0.549	0.777	0	PPA1	Malignant cells	GSE199333_pre	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34015
0	-0.550531721578179	0.206	0.512	0	VSIR	Malignant cells	GSE199333_pre	ENSG00000107738	64115	V-set immunoregulatory receptor	B7-H5|B7H5|C10orf54|Dies1|GI24|PD-1H|SISP1|VISTA	protein_coding	Q9H7M9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34016
0	-0.545203126053169	0.105	0.32	0	DDIT4	Malignant cells	GSE199333_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34017
0	0.325859180621734	1	1	0	RPS24	Malignant cells	GSE199333_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34018
0	0.601104065742768	0.7	0.588	0	PDLIM1	Malignant cells	GSE199333_pre	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34019
0	-0.376708280098623	0.295	0.541	0	TM9SF3	Malignant cells	GSE199333_pre	ENSG00000077147	56889	transmembrane 9 superfamily member 3	SMBP	protein_coding	Q9HD45	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34020
0	-0.420453218470743	0.466	0.683	0	PGAM1	Malignant cells	GSE199333_pre	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34021
0	-0.290806062379371	0.115	0.309	0	SFXN3	Malignant cells	GSE199333_pre	ENSG00000107819	81855	sideroflexin 3	SFX3|SLC56A3	protein_coding	Q9BWM7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34022
0	-0.524805598082001	0.06	0.295	0	NFKB2	Malignant cells	GSE199333_pre	ENSG00000077150	4791	nuclear factor kappa B subunit 2	LYT-10|NF-kB2|p105|p49/p100|p52	protein_coding	Q00653	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34023
0	-0.538267091072034	0.342	0.577	0	TRIM8	Malignant cells	GSE199333_pre	ENSG00000171206	81603	tripartite motif containing 8	GERP|RNF27	protein_coding	Q9BZR9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34024
0	-0.328138810683151	0.215	0.416	0	SLK	Malignant cells	GSE199333_pre	ENSG00000065613	9748	STE20 like kinase	KIAA0204|se20-9|STK2	protein_coding	Q9H2G2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34025
0	-0.3418345539836	0.458	0.65	0	GSTO1	Malignant cells	GSE199333_pre	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34026
0	-0.271989934300128	0.182	0.367	0	SHOC2	Malignant cells	GSE199333_pre	ENSG00000108061	8036	SHOC2 leucine rich repeat scaffold protein	KIAA0862|SOC-2|SOC2|SUR-8|SUR8	protein_coding	Q9UQ13	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34027
0	-0.585917705921537	0.509	0.787	0	EIF3A	Malignant cells	GSE199333_pre	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34028
0	-0.280833603531493	0.118	0.3	0	FAM45A	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34029
0	-0.429290658499082	0.157	0.395	0	PRDX3	Malignant cells	GSE199333_pre	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34030
0	-0.330402175960833	0.248	0.47	0	KDM5A	Malignant cells	GSE199333_pre	ENSG00000073614	5927	lysine demethylase 5A	JARID1A|RBBP2	protein_coding	P29375	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34031
0	0.337607796971285	0.523	0.313	0	CCND2	Malignant cells	GSE199333_pre	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34032
0	-0.299092034605284	0.2	0.402	0	TNFRSF1A	Malignant cells	GSE199333_pre	ENSG00000067182	7132	TNF receptor superfamily member 1A	CD120a|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR60	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34033
0	-0.419541746539718	0.405	0.634	0	CHD4	Malignant cells	GSE199333_pre	ENSG00000111642	1108	chromodomain helicase DNA binding protein 4	Mi-2b|Mi2-BETA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34034
0	-0.467070395159333	0.39	0.62	0	PTPN6	Malignant cells	GSE199333_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34035
0	0.420744567408589	0.957	0.891	0	ARHGDIB	Malignant cells	GSE199333_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34036
0	0.630636352834941	0.682	0.411	0	MGST1	Malignant cells	GSE199333_pre	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34037
0	-0.625031986631908	0.235	0.521	0	KRAS	Malignant cells	GSE199333_pre	ENSG00000133703	3845	KRAS proto-oncogene, GTPase	K-Ras4B|KRAS1|KRAS2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34038
0	-0.399276746179911	0.576	0.779	0	SCAF11	Malignant cells	GSE199333_pre	ENSG00000139218	9169	SR-related CTD associated factor 11	CASP11|SFRS2IP|SIP1|SRRP129|SRSF2IP	protein_coding	Q99590	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34039
0	-0.432746268945875	0.114	0.371	0	ITGA5	Malignant cells	GSE199333_pre	ENSG00000161638	3678	integrin subunit alpha 5	CD49e|FNRA	protein_coding	P08648	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34040
0	0.323605296664264	1	0.997	0	RPS26	Malignant cells	GSE199333_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34041
0	-0.390546412697086	0.322	0.534	0	BAZ2A	Malignant cells	GSE199333_pre	ENSG00000076108	11176	bromodomain adjacent to zinc finger domain 2A	KIAA0314|TIP5|WALp3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34042
0	-0.41922007951942	0.658	0.842	0	PTGES3	Malignant cells	GSE199333_pre	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34043
0	0.364338717306056	1	1	0	NACA	Malignant cells	GSE199333_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34044
0	1.05074035447091	0.811	0.576	0	AC084033.3	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34045
0	-0.395148291955991	0.419	0.622	0	USP15	Malignant cells	GSE199333_pre	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34046
0	-0.861434486967213	0.408	0.733	0	RAP1B	Malignant cells	GSE199333_pre	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34047
0	-0.397467389273431	0.941	0.966	0	NAP1L1	Malignant cells	GSE199333_pre	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34048
0	-0.542211954553983	0.25	0.552	0	OSBPL8	Malignant cells	GSE199333_pre	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34049
0	-0.421087747366775	0.125	0.318	0	DUSP6	Malignant cells	GSE199333_pre	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34050
0	-0.526200718095671	0.263	0.501	0	ATP2B1	Malignant cells	GSE199333_pre	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34051
0	-0.361623141333014	0.346	0.582	0	UBE2N	Malignant cells	GSE199333_pre	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34052
0	-0.527831332560125	0.209	0.42	0	SOCS2	Malignant cells	GSE199333_pre	ENSG00000120833	8835	suppressor of cytokine signaling 2	CIS2|Cish2|SOCS-2|SSI-2|SSI2|STATI2	protein_coding	O14508	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34053
0	-0.352378854007131	0.934	0.975	0	SLC25A3	Malignant cells	GSE199333_pre	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34054
0	-0.254313718665184	0.105	0.275	0	UHRF1BP1L	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34055
0	-0.32261615790565	0.382	0.572	0	GNPTAB	Malignant cells	GSE199333_pre	ENSG00000111670	79158	N-acetylglucosamine-1-phosphate transferase subunits alpha and beta	GNPTA|KIAA1208|MGC4170	protein_coding	Q3T906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34056
0	-0.270890614049181	0.079	0.259	0	CORO1C	Malignant cells	GSE199333_pre	ENSG00000110880	23603	coronin 1C	coronin-3|HCRNN4	protein_coding	Q9ULV4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34057
0	-0.322138241323024	0.21	0.429	0	ATP2A2	Malignant cells	GSE199333_pre	ENSG00000174437	488	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2	ATP2B|DAR|SERCA2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34058
0	-0.419733439289801	0.107	0.368	0	SH2B3	Malignant cells	GSE199333_pre	ENSG00000111252	10019	SH2B adaptor protein 3	IDDM20|LNK	protein_coding	Q9UQQ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34059
0	-0.44054632451635	0.425	0.631	0	MED13L	Malignant cells	GSE199333_pre	ENSG00000123066	23389	mediator complex subunit 13L	KIAA1025|THRAP2|TRAP240L	protein_coding	Q71F56	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34060
0	-0.465010094777401	0.346	0.601	0	TAOK3	Malignant cells	GSE199333_pre	ENSG00000135090	51347	TAO kinase 3	DPK|JIK|MAP3K18	protein_coding	Q9H2K8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34061
0	-0.345016917460448	0.202	0.426	0	ORAI1	Malignant cells	GSE199333_pre	ENSG00000276045	84876	ORAI calcium release-activated calcium modulator 1	CRACM1|FLJ14466|TMEM142A	protein_coding	Q96D31	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34062
0	-0.330715326311106	0.239	0.458	0	SBNO1	Malignant cells	GSE199333_pre	ENSG00000139697	55206	strawberry notch homolog 1	FLJ10701|FLJ10833|MOP3|Sno	protein_coding	A3KN83	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34063
0	-0.415820512520863	0.476	0.696	0	RILPL2	Malignant cells	GSE199333_pre	ENSG00000150977	196383	Rab interacting lysosomal protein like 2	FLJ30380|FLJ32372|MGC7036	protein_coding	Q969X0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34064
0	-0.46757536922899	0.727	0.837	0	RAN	Malignant cells	GSE199333_pre	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34065
0	-0.319845006545596	0.206	0.407	0	ANKLE2	Malignant cells	GSE199333_pre	ENSG00000176915	23141	ankyrin repeat and LEM domain containing 2	KIAA0692|Lem4|LEMD7	protein_coding	Q86XL3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34066
0	0.251776614712598	1	1	0	RPL21	Malignant cells	GSE199333_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34067
0	0.435269434099621	0.867	0.794	0	GTF3A	Malignant cells	GSE199333_pre	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34068
0	-0.449741127899112	0.583	0.799	0	POMP	Malignant cells	GSE199333_pre	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34069
0	-0.51291806259736	0.135	0.323	0	RGCC	Malignant cells	GSE199333_pre	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34070
0	-0.313768251554407	0.258	0.481	0	DNAJC15	Malignant cells	GSE199333_pre	ENSG00000120675	29103	DnaJ heat shock protein family (Hsp40) member C15	DNAJD1|MCJ	protein_coding	Q9Y5T4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34071
0	-0.470420860195812	0.52	0.699	0	LCP1	Malignant cells	GSE199333_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34072
0	0.444168361448461	0.743	0.545	0	EBPL	Malignant cells	GSE199333_pre	ENSG00000123179	84650	EBP like	EBRP	protein_coding	Q9BY08	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34073
0	-0.280616387304041	0.206	0.411	0	TM9SF2	Malignant cells	GSE199333_pre	ENSG00000125304	9375	transmembrane 9 superfamily member 2	P76	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34074
0	-0.403397853319404	0.106	0.306	0	ARHGEF7	Malignant cells	GSE199333_pre	ENSG00000102606	8874	Rho guanine nucleotide exchange factor 7	BETA-PIX|COOL1|DKFZp686C12170|DKFZp761K1021|KIAA0142|Nbla10314|P50|P50BP|P85|P85COOL1|P85SPR|PAK3|PIXB	protein_coding	Q14155	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34075
0	-0.27899529705358	0.112	0.287	0	PNP	Malignant cells	GSE199333_pre	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34076
0	-0.389566761852486	0.888	0.956	0	HNRNPC	Malignant cells	GSE199333_pre	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34077
0	-0.302312093934575	0.264	0.456	0	SUPT16H	Malignant cells	GSE199333_pre	ENSG00000092201	11198	SPT16 homolog, facilitates chromatin remodeling subunit	CDC68|FACT|FACTP140|FLJ10857|FLJ14010|SPT16/CDC68	protein_coding	Q9Y5B9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34078
0	-0.567042358700999	0.077	0.292	0	CTSG	Malignant cells	GSE199333_pre	ENSG00000100448	1511	cathepsin G	CG	protein_coding	P08311	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34079
0	0.435671408877484	1	1	0	RPS29	Malignant cells	GSE199333_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34080
0	-0.280691883650508	0.941	0.983	0	RPL36AL	Malignant cells	GSE199333_pre	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34081
0	-0.327774067085191	0.717	0.845	0	RBM25	Malignant cells	GSE199333_pre	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34082
0	-0.301801684227053	0.439	0.63	0	TMED10	Malignant cells	GSE199333_pre	ENSG00000170348	10972	transmembrane p24 trafficking protein 10	p23|P24(DELTA)|p24d1|p24delta1|TMP21	protein_coding	P49755	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34083
0	-0.612654430326715	0.586	0.78	0	CALM1	Malignant cells	GSE199333_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34084
0	0.372689342238951	0.479	0.224	0	EVL	Malignant cells	GSE199333_pre	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34085
0	-0.353042745237759	0.524	0.721	0	YY1	Malignant cells	GSE199333_pre	ENSG00000100811	7528	YY1 transcription factor	DELTA|INO80S|NF-E1|UCRBP|YIN-YANG-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34086
0	-1.64352864695051	0.061	0.391	0	TNFAIP2	Malignant cells	GSE199333_pre	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34087
0	-0.569981732586684	0.121	0.327	0	CRIP1	Malignant cells	GSE199333_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34088
0	-0.811757628392818	0.196	0.497	0	IGHM	Malignant cells	GSE199333_pre	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34089
0	-0.355436044138147	0.68	0.835	0	PDIA3	Malignant cells	GSE199333_pre	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34090
0	-0.314713881095825	0.307	0.523	0	EIF3J	Malignant cells	GSE199333_pre	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34091
0	-0.400606541949698	1	1	0	B2M	Malignant cells	GSE199333_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34092
0	-0.360144446535757	0.183	0.412	0	USP8	Malignant cells	GSE199333_pre	ENSG00000138592	9101	ubiquitin specific peptidase 8	HumORF8|KIAA0055|SPG59|UBPY	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34093
0	-0.281385746848886	0.13	0.311	0	SPPL2A	Malignant cells	GSE199333_pre	ENSG00000138600	84888	signal peptide peptidase like 2A	IMP3|PSL2	protein_coding	Q8TCT8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34094
0	-0.72462577540916	0.263	0.539	0	ANXA2	Malignant cells	GSE199333_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34095
0	-0.602961335195762	0.116	0.304	0	PCLAF	Malignant cells	GSE199333_pre	ENSG00000166803	9768	PCNA clamp associated factor	KIAA0101|NS5ATP9|OEATC-1|p15(PAF)|PAF15	protein_coding	Q15004	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34096
0	-0.5493507460021	0.034	0.291	0	SMAD3	Malignant cells	GSE199333_pre	ENSG00000166949	4088	SMAD family member 3	HsT17436|JV15-2|MADH3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34097
0	-0.416881384360873	0.472	0.705	0	ANP32A	Malignant cells	GSE199333_pre	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34098
0	0.431456532536408	1	1	0	RPLP1	Malignant cells	GSE199333_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34099
0	-0.729182666418893	0.387	0.724	0	PKM	Malignant cells	GSE199333_pre	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34100
0	-0.357057094605071	0.063	0.279	0	ARID3B	Malignant cells	GSE199333_pre	ENSG00000179361	10620	AT-rich interaction domain 3B	BDP|DRIL2	protein_coding	Q8IVW6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34101
0	0.658374822747178	0.909	0.794	0	RPS17	Malignant cells	GSE199333_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34102
0	-0.398417238580008	0.164	0.397	0	ABHD2	Malignant cells	GSE199333_pre	ENSG00000140526	11057	abhydrolase domain containing 2, acylglycerol lipase	LABH2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34103
0	-0.448561923890996	0.314	0.502	0	IQGAP1	Malignant cells	GSE199333_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34104
0	0.265648625816152	1	1	0	RPS2	Malignant cells	GSE199333_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34105
0	0.422201461607799	0.389	0.203	0	NPW	Malignant cells	GSE199333_pre	ENSG00000183971	283869	neuropeptide W	PPL8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34106
0	0.318316735701758	1	1	0	RPS15A	Malignant cells	GSE199333_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34107
0	-0.348916600495243	0.333	0.562	0	NDUFAB1	Malignant cells	GSE199333_pre	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34108
0	-0.280780681421234	0.108	0.293	0	TNRC6A	Malignant cells	GSE199333_pre	ENSG00000288130	27327	trinucleotide repeat containing adaptor 6A	CAGH26|GW182|KIAA1460|TNRC6	protein_coding	Q8NDV7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34109
0	-0.511917206460558	0.553	0.759	0	SPN	Malignant cells	GSE199333_pre	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34110
0	-0.560038891646916	0.089	0.399	0	QPRT	Malignant cells	GSE199333_pre	ENSG00000103485	23475	quinolinate phosphoribosyltransferase	QPRTase	protein_coding	Q15274	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34111
0	-0.330982176892527	0.321	0.548	0	PPP4C	Malignant cells	GSE199333_pre	ENSG00000149923	5531	protein phosphatase 4 catalytic subunit	PP4|PPX	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34112
0	0.309912444197544	0.457	0.253	0	YPEL3	Malignant cells	GSE199333_pre	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34113
0	-0.365164639063148	0.213	0.452	0	ATP6V0D1	Malignant cells	GSE199333_pre	ENSG00000159720	9114	ATPase H+ transporting V0 subunit d1	ATP6D|ATP6DV|P39|VATX|Vma6|VPATPD	protein_coding	P61421	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34114
0	-0.689408622389182	0.457	0.712	0	RFLNB	Malignant cells	GSE199333_pre	ENSG00000283979	359845	refilin B	Cfm1|FAM101B|MGC45871|RefilinB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34115
0	-0.345063642192964	0.607	0.769	0	YWHAE	Malignant cells	GSE199333_pre	ENSG00000274474	7531	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon	FLJ45465	protein_coding	P62258	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34116
0	-0.453145933334525	0.044	0.255	0	SLC43A2	Malignant cells	GSE199333_pre	ENSG00000278550	124935	solute carrier family 43 member 2	MGC34680	protein_coding	Q8N370	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34117
0	-0.417435943822989	0.063	0.263	0	MIR22HG	Malignant cells	GSE199333_pre	ENSG00000282800	84981	MIR22 host gene	C17orf91|DKFZp686O06159|MGC14376	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34118
0	-0.547974755290439	0.941	0.976	0	PFN1	Malignant cells	GSE199333_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34119
0	-0.353243378212668	0.186	0.418	0	TXNDC17	Malignant cells	GSE199333_pre	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34120
0	-0.495995415150986	0.136	0.349	0	KDM6B	Malignant cells	GSE199333_pre	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34121
0	0.28813325006035	0.99	0.961	0	UBB	Malignant cells	GSE199333_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34122
0	-0.548410760432766	0.112	0.513	0	RAB34	Malignant cells	GSE199333_pre	ENSG00000109113	83871	RAB34, member RAS oncogene family	NARR|RAB39|RAH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34123
0	0.597451029046105	1	1	0	RPL23A	Malignant cells	GSE199333_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34124
0	0.409243194638427	0.434	0.221	0	CCL5	Malignant cells	GSE199333_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34125
0	-0.339533555835908	0.569	0.742	0	PSMB3	Malignant cells	GSE199333_pre	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34126
0	0.385091802503203	0.998	0.991	0	RPL23	Malignant cells	GSE199333_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34127
0	-0.288404441871981	0.16	0.356	0	LASP1	Malignant cells	GSE199333_pre	ENSG00000002834	3927	LIM and SH3 protein 1	Lasp-1|MLN50	protein_coding	Q14847	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34128
0	0.349181345729021	1	1	0	RPL19	Malignant cells	GSE199333_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34129
0	0.431145448590195	0.281	0.019	0	ZNF385C	Malignant cells	GSE199333_pre	ENSG00000187595	201181	zinc finger protein 385C	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34130
0	0.633291459882408	1	0.999	0	RPL27	Malignant cells	GSE199333_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34131
0	-0.449714635167102	0.227	0.482	0	GRN	Malignant cells	GSE199333_pre	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34132
0	-0.436628699040327	0.506	0.653	0	FMNL1	Malignant cells	GSE199333_pre	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34133
0	-0.310116876515692	0.229	0.431	0	NPEPPS	Malignant cells	GSE199333_pre	ENSG00000141279	9520	aminopeptidase puromycin sensitive	MP100|PSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34134
0	-0.342190423191552	0.449	0.648	0	KPNB1	Malignant cells	GSE199333_pre	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34135
0	-0.321547274043953	0.14	0.344	0	HOXB2	Malignant cells	GSE199333_pre	ENSG00000173917	3212	homeobox B2	HOX2|HOX2H	protein_coding	P14652	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34136
0	-0.530016935216218	0.114	0.429	0	HOXB3	Malignant cells	GSE199333_pre	ENSG00000120093	3213	homeobox B3	HOX2|HOX2G	protein_coding	P14651	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34137
0	-0.409933132323782	0.101	0.369	0	HOXB4	Malignant cells	GSE199333_pre	ENSG00000182742	3214	homeobox B4	HOX2|HOX2F	protein_coding	P17483	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34138
0	-0.331620062721253	0.263	0.459	0	SPAG9	Malignant cells	GSE199333_pre	ENSG00000008294	9043	sperm associated antigen 9	CT89|FLJ13450|FLJ14006|FLJ26141|FLJ34602|HLC4|HSS|JIP-4|JIP4|JLP|KIAA0516|MGC117291|MGC14967|MGC74461|PHET|PIG6|SYD1	protein_coding	O60271	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34139
0	1.0416623224617	0.638	0.194	0	MPO	Malignant cells	GSE199333_pre	ENSG00000005381	4353	myeloperoxidase	NA	protein_coding	P05164	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34140
0	0.463319285017192	0.638	0.468	0	AC004687.1	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34141
0	-0.324134852485915	0.243	0.469	0	CLTC	Malignant cells	GSE199333_pre	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34142
0	-0.309759503750522	0.183	0.403	0	CCDC47	Malignant cells	GSE199333_pre	ENSG00000108588	57003	coiled-coil domain containing 47	GK001	protein_coding	Q96A33	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34143
0	-0.264953990494317	0.182	0.372	0	DDX42	Malignant cells	GSE199333_pre	ENSG00000198231	11325	DEAD-box helicase 42	RHELP|RNAHP|SF3b125|SF3B8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34144
0	-0.340750680545658	0.247	0.46	0	PSMD12	Malignant cells	GSE199333_pre	ENSG00000197170	5718	proteasome 26S subunit, non-ATPase 12	p55|Rpn5	protein_coding	O00232	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34145
0	0.488190927661122	1	0.997	0	RPL38	Malignant cells	GSE199333_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34146
0	0.306966895063944	0.511	0.318	0	RAB37	Malignant cells	GSE199333_pre	ENSG00000172794	326624	RAB37, member RAS oncogene family	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34147
0	-0.424309827272947	0.294	0.493	0	SLC9A3R1	Malignant cells	GSE199333_pre	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34148
0	-0.427186517737054	0.814	0.948	0	SUMO2	Malignant cells	GSE199333_pre	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34149
0	-0.406417206036551	0.444	0.665	0	GRB2	Malignant cells	GSE199333_pre	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34150
0	-0.290442417471761	0.191	0.384	0	SYNGR2	Malignant cells	GSE199333_pre	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34151
0	-0.331014432240776	0.128	0.326	0	CYTH1	Malignant cells	GSE199333_pre	ENSG00000108669	9267	cytohesin 1	B2-1|cytohesin-1|D17S811E|PSCD1	protein_coding	Q15438	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34152
0	-0.70194790316055	0.129	0.492	0	LGALS3BP	Malignant cells	GSE199333_pre	ENSG00000108679	3959	galectin 3 binding protein	90K|BTBD17B|CyCAP|gp90|M2BP|MAC-2-BP|TANGO10B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34153
0	-0.510505572900248	0.237	0.515	0	BAHCC1	Malignant cells	GSE199333_pre	ENSG00000266074	57597	BAH domain and coiled-coil containing 1	BAHD2|KIAA1447	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34154
0	-0.637418874571816	0.997	0.999	0	ACTG1	Malignant cells	GSE199333_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34155
0	-0.306512724909401	0.139	0.346	0	HGS	Malignant cells	GSE199333_pre	ENSG00000185359	9146	hepatocyte growth factor-regulated tyrosine kinase substrate	Hrs|Vps27|ZFYVE8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34156
0	-0.528555128775224	0.542	0.699	0	P4HB	Malignant cells	GSE199333_pre	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34157
0	1.0541617494286	0.63	0.287	0	CD7	Malignant cells	GSE199333_pre	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34158
0	-0.348814638502828	0.138	0.329	0	METRNL	Malignant cells	GSE199333_pre	ENSG00000275031	284207	meteorin like, glial cell differentiation regulator	NA	protein_coding	Q641Q3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34159
0	-0.378040405545543	0.563	0.741	0	MYL12A	Malignant cells	GSE199333_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34160
0	-0.497957088674402	0.388	0.678	0	NDUFV2	Malignant cells	GSE199333_pre	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34161
0	-0.68154025533592	0.425	0.685	0	ANKRD12	Malignant cells	GSE199333_pre	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34162
0	-0.436409308068823	0.034	0.311	0	TUBB6	Malignant cells	GSE199333_pre	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34163
0	-0.393553527469432	0.364	0.545	0	RIOK3	Malignant cells	GSE199333_pre	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34164
0	0.341641502957872	0.384	0.193	0	RNF125	Malignant cells	GSE199333_pre	ENSG00000101695	54941	ring finger protein 125	FLJ20456	protein_coding	Q96EQ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34165
0	0.583520515891048	0.953	0.844	0	RPL17	Malignant cells	GSE199333_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34166
0	-0.443175672207062	0.281	0.565	0	CSNK2A1	Malignant cells	GSE199333_pre	ENSG00000101266	1457	casein kinase 2 alpha 1	Cka1|Cka2	protein_coding	P68400	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34167
0	-0.337941368059984	0.124	0.34	0	RASSF2	Malignant cells	GSE199333_pre	ENSG00000101265	9770	Ras association domain family member 2	CENP-34|KIAA0168	protein_coding	P50749	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34168
0	-0.660072463860033	0.289	0.62	0	DSTN	Malignant cells	GSE199333_pre	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34169
0	-0.616112584311361	0.184	0.549	0	RRBP1	Malignant cells	GSE199333_pre	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34170
0	-0.399372788544639	0.196	0.453	0	SNX5	Malignant cells	GSE199333_pre	ENSG00000089006	27131	sorting nexin 5	NA	protein_coding	Q9Y5X3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34171
0	-1.24843268976351	0.426	0.866	0	CST3	Malignant cells	GSE199333_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34172
0	0.351312157349181	0.311	0.091	0	CST7	Malignant cells	GSE199333_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34173
0	-0.371525300439853	0.349	0.584	0	HM13	Malignant cells	GSE199333_pre	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34174
0	-0.386167010621803	0.19	0.413	0	CHMP4B	Malignant cells	GSE199333_pre	ENSG00000101421	128866	charged multivesicular body protein 4B	C20orf178|dJ553F4.4|Shax1|SNF7-2|VPS32B	protein_coding	Q9H444	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34175
0	-0.860343722712244	0.021	0.251	0	SAMHD1	Malignant cells	GSE199333_pre	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34176
0	-0.506583950369173	0.576	0.823	0	YWHAB	Malignant cells	GSE199333_pre	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34177
0	0.570627713374558	0.623	0.377	0	CTSA	Malignant cells	GSE199333_pre	ENSG00000064601	5476	cathepsin A	GSL|PPGB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34178
0	-0.278704321517729	0.123	0.306	0	NCOA3	Malignant cells	GSE199333_pre	ENSG00000124151	8202	nuclear receptor coactivator 3	ACTR|AIB1|bHLHe42|CAGH16|KAT13B|p/CIP|RAC3|SRC-3|SRC3|TNRC16|TRAM-1	protein_coding	Q9Y6Q9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34179
0	-0.283732890065531	0.99	0.996	0	GNAS	Malignant cells	GSE199333_pre	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34180
0	-0.462960827251792	0.257	0.453	0	CTSZ	Malignant cells	GSE199333_pre	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34181
0	0.448123741862046	1	1	0	RPS21	Malignant cells	GSE199333_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34182
0	0.453624195486218	0.94	0.844	0	PRSS57	Malignant cells	GSE199333_pre	ENSG00000185198	400668	serine protease 57	PRSSL1|UNQ782	protein_coding	Q6UWY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34183
0	-1.08476990093849	0.101	0.336	0	AZU1	Malignant cells	GSE199333_pre	ENSG00000278624	566	azurocidin 1	AZAMP|AZU|CAP37|HBP|HUMAZUR|NAZC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34184
0	-1.51309130831395	0.204	0.516	0	CFD	Malignant cells	GSE199333_pre	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34185
0	-0.287962381477624	0.122	0.295	0	ARID3A	Malignant cells	GSE199333_pre	ENSG00000116017	1820	AT-rich interaction domain 3A	BRIGHT|DRIL1	protein_coding	Q99856	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34186
0	0.406008848227181	0.54	0.276	0	CNN2	Malignant cells	GSE199333_pre	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34187
0	0.654358036387581	0.722	0.372	0	SMIM24	Malignant cells	GSE199333_pre	ENSG00000095932	284422	small integral membrane protein 24	C19orf77|HSPC323	protein_coding	O75264	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34188
0	-0.60020706880675	0.266	0.575	0	ZBTB7A	Malignant cells	GSE199333_pre	ENSG00000178951	51341	zinc finger and BTB domain containing 7A	DKFZp547O146|FBI-1|LRF|pokemon|ZBTB7|ZNF857A	protein_coding	O95365	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34189
0	0.325107713546443	0.26	0.055	0	TMIGD2	Malignant cells	GSE199333_pre	ENSG00000167664	126259	transmembrane and immunoglobulin domain containing 2	CD28H|IGPR-1|MGC23244	protein_coding	Q96BF3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34190
0	0.361257864914718	1	1	0	RPL36	Malignant cells	GSE199333_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34191
0	0.414302070158103	0.826	0.569	0	ICAM3	Malignant cells	GSE199333_pre	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34192
0	-0.489936012649709	0.156	0.395	0	CDKN2D	Malignant cells	GSE199333_pre	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34193
0	0.319859398752972	0.608	0.4	0	LYL1	Malignant cells	GSE199333_pre	ENSG00000104903	4066	LYL1 basic helix-loop-helix family member	bHLHa18	protein_coding	P12980	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34194
0	-1.17470490366576	0.279	0.708	0	ADGRE5	Malignant cells	GSE199333_pre	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34195
0	-0.438936774238754	0.109	0.336	0	ADGRE2	Malignant cells	GSE199333_pre	ENSG00000127507	30817	adhesion G protein-coupled receptor E2	CD312|EMR2	protein_coding	Q9UHX3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34196
0	0.447355264634848	0.586	0.33	0	HSH2D	Malignant cells	GSE199333_pre	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34197
0	0.614213179664614	1	1	0	RPL18A	Malignant cells	GSE199333_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34198
0	0.413050622864567	0.997	0.996	0	JUND	Malignant cells	GSE199333_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34199
0	0.447279902112148	1	1	0	UBA52	Malignant cells	GSE199333_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34200
0	0.724361873307182	0.663	0.444	0	CEBPA	Malignant cells	GSE199333_pre	ENSG00000245848	1050	CCAAT enhancer binding protein alpha	C/EBP-alpha|CEBP	protein_coding	P49715	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34201
0	-0.388829786780502	0.079	0.281	0	NFKBID	Malignant cells	GSE199333_pre	ENSG00000167604	84807	NFKB inhibitor delta	IkappaBNS|IkBNS|TA-NFKBH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34202
0	0.884420017587394	0.839	0.704	0	HCST	Malignant cells	GSE199333_pre	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34203
0	0.312311998953626	0.917	0.789	0	GMFG	Malignant cells	GSE199333_pre	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34204
0	0.612379081343895	1	1	0	RPS16	Malignant cells	GSE199333_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34205
0	-0.367371168857704	0.084	0.255	0	PLAUR	Malignant cells	GSE199333_pre	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34206
0	-0.345841558584493	0.164	0.355	0	RELB	Malignant cells	GSE199333_pre	ENSG00000104856	5971	RELB proto-oncogene, NF-kB subunit	REL-B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34207
0	0.310487081041237	0.955	0.919	0	NOP53	Malignant cells	GSE199333_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34208
0	-1.61750584046162	0.433	0.808	0	EMP3	Malignant cells	GSE199333_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34209
0	0.323264928536379	1	1	0	RPL18	Malignant cells	GSE199333_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34210
0	-0.467190892291496	0.732	0.85	0	CD37	Malignant cells	GSE199333_pre	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34211
0	0.525415824087527	1	1	0	RPL13A	Malignant cells	GSE199333_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34212
0	0.607061885201967	1	1	0	RPS11	Malignant cells	GSE199333_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34213
0	-1.4122037315754	0.201	0.637	0	CLEC11A	Malignant cells	GSE199333_pre	ENSG00000105472	6320	C-type lectin domain containing 11A	CLECSF3|LSLCL|P47|SCGF	protein_coding	Q9Y240	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34214
0	-0.886387423699696	0.285	0.672	0	MYADM	Malignant cells	GSE199333_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34215
0	0.590158845820982	1	0.999	0	RPS5	Malignant cells	GSE199333_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34216
0	0.356775063105933	0.978	0.946	0	RPS4Y1	Malignant cells	GSE199333_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34217
0	-0.558811456453582	0.259	0.547	0	BID	Malignant cells	GSE199333_pre	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34218
0	-0.375135633679967	0.512	0.713	0	UBE2L3	Malignant cells	GSE199333_pre	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34219
0	0.32275595215764	0.577	0.254	0	IGLL1	Malignant cells	GSE199333_pre	ENSG00000128322	3543	immunoglobulin lambda like polypeptide 1	14.1|CD179B|IGL5|IGLL|IGVPB	protein_coding	P15814	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34220
0	-0.419137223452399	0.528	0.747	0	EWSR1	Malignant cells	GSE199333_pre	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34221
0	-0.390742675817082	0.094	0.286	0	CYTH4	Malignant cells	GSE199333_pre	ENSG00000100055	27128	cytohesin 4	CYT4|cytohesin-4|PSCD4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34222
0	-0.345288627686201	0.086	0.308	0	CBX6	Malignant cells	GSE199333_pre	ENSG00000183741	23466	chromobox 6	NA	protein_coding	O95503	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34223
0	0.276958704411157	1	1	0	RPL3	Malignant cells	GSE199333_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34224
0	0.641341468209294	0.639	0.341	0	SYNGR1	Malignant cells	GSE199333_pre	ENSG00000100321	9145	synaptogyrin 1	NA	protein_coding	O43759	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34225
0	-0.309761660950364	0.325	0.529	0	RBX1	Malignant cells	GSE199333_pre	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34226
0	-0.367260698025622	0.545	0.742	0	XRCC6	Malignant cells	GSE199333_pre	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34227
0	-0.361825673508348	0.74	0.848	0	TSPO	Malignant cells	GSE199333_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34228
0	-0.359470477724122	0.078	0.325	0	PARVB	Malignant cells	GSE199333_pre	ENSG00000188677	29780	parvin beta	CGI-56	protein_coding	Q9HBI1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34229
0	-0.261208070900938	0.116	0.29	0	PLXNB2	Malignant cells	GSE199333_pre	ENSG00000196576	23654	plexin B2	KIAA0315|MM1|PLEXB2	protein_coding	O15031	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34230
0	-0.370040557174532	0.472	0.66	0	CCT8	Malignant cells	GSE199333_pre	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34231
0	-0.392060852931056	0.124	0.307	0	IFNGR2	Malignant cells	GSE199333_pre	ENSG00000262795	3460	interferon gamma receptor 2	AF-1|IFNGT1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34232
0	-0.561842268192877	0.465	0.739	0	RUNX1	Malignant cells	GSE199333_pre	ENSG00000159216	861	RUNX family transcription factor 1	AML1|AMLCR1|CBFA2|PEBP2A2	protein_coding	Q01196	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34233
0	-0.347248280138711	0.205	0.411	0	DYRK1A	Malignant cells	GSE199333_pre	ENSG00000157540	1859	dual specificity tyrosine phosphorylation regulated kinase 1A	DYRK|DYRK1|MNBH	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34234
0	-0.559185633155247	0.279	0.579	0	ETS2	Malignant cells	GSE199333_pre	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34235
0	-0.513388689534523	1	1	0	MT-CO3	Malignant cells	GSE199333_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34236
0	-0.26013383971423	0.104	0.287	0	GTSF1	Malignant cells	GSE199333_pre	ENSG00000170627	121355	gametocyte specific factor 1	Cue110|FAM112B|FLJ32942	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34237
0	-0.293488581595235	0.155	0.358	0	HOXB-AS3	Malignant cells	GSE199333_pre	ENSG00000233101	404266	HOXB cluster antisense RNA 3	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34238
2.06811396520213e-307	-0.277480670154938	0.261	0.458	4.39081275952065e-303	THOC2	Malignant cells	GSE199333_pre	ENSG00000125676	57187	THO complex subunit 2	CXorf3|dJ506G2.1|MRX12|MRX35|THO2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34239
2.73065694590854e-307	-0.276324778933609	0.237	0.428	5.79745776185843e-303	RPN1	Malignant cells	GSE199333_pre	ENSG00000163902	6184	ribophorin I	OST1	protein_coding	P04843	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34240
3.42628287424172e-307	-0.35417196802875	0.329	0.516	7.27434117030259e-303	TMF1	Malignant cells	GSE199333_pre	ENSG00000144747	7110	TATA element modulatory factor 1	ARA160|TMF	protein_coding	P82094	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34241
6.46095615991572e-307	0.357220414526889	0.725	0.584	1.37172560231171e-302	HMGN3	Malignant cells	GSE199333_pre	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34242
1.3956648945776e-306	-0.261129390531449	0.171	0.354	2.96313613767769e-302	UBR5	Malignant cells	GSE199333_pre	ENSG00000104517	51366	ubiquitin protein ligase E3 component n-recognin 5	DD5|EDD|EDD1|HYD|KIAA0896	protein_coding	O95071	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34243
1.64754724170845e-306	-0.391996278774774	0.499	0.67	3.4979075488712e-302	ANKRD11	Malignant cells	GSE199333_pre	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34244
2.58998416973716e-306	-0.258280010300053	0.168	0.35	5.49879539076897e-302	PRKAR2A	Malignant cells	GSE199333_pre	ENSG00000114302	5576	protein kinase cAMP-dependent type II regulatory subunit alpha	PRKAR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34245
4.80737682436081e-305	-0.360013682475554	0.267	0.444	1.02065417358004e-300	NFAT5	Malignant cells	GSE199333_pre	ENSG00000102908	10725	nuclear factor of activated T cells 5	KIAA0827|NF-AT5|NFATL1|NFATZ|OREBP|TONEBP	protein_coding	O94916	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34246
1.05763019093726e-303	-0.297962814412314	0.295	0.485	2.24545465837889e-299	SUGP2	Malignant cells	GSE199333_pre	ENSG00000064607	10147	SURP and G-patch domain containing 2	KIAA0365|SFRS14	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34247
2.01137354993557e-303	-0.307602679258329	0.536	0.712	4.2703471838682e-299	WASF2	Malignant cells	GSE199333_pre	ENSG00000158195	10163	WASP family member 2	SCAR2|WAVE2	protein_coding	Q9Y6W5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34248
2.86910615025953e-303	-0.269119324809033	0.149	0.322	6.091399267616e-299	NUMB	Malignant cells	GSE199333_pre	ENSG00000133961	8650	NUMB endocytic adaptor protein	C14orf41	protein_coding	P49757	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34249
1.00486543636646e-301	-0.304490988198259	0.176	0.35	2.13342980794963e-297	AGO1	Malignant cells	GSE199333_pre	ENSG00000092847	26523	argonaute RISC component 1	EIF2C1|hAGO1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34250
1.80686567898365e-301	-0.262316835902745	0.21	0.397	3.83615652305019e-297	HPRT1	Malignant cells	GSE199333_pre	ENSG00000165704	3251	hypoxanthine phosphoribosyltransferase 1	HGPRT|HPRT	protein_coding	P00492	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34251
3.20100775932646e-301	-0.258360510940323	0.206	0.394	6.79605957382601e-297	CUL3	Malignant cells	GSE199333_pre	ENSG00000036257	8452	cullin 3	NA	protein_coding	Q13618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34252
6.14999091648802e-301	-0.37068439004978	0.729	0.84	1.30570457147957e-296	PPIB	Malignant cells	GSE199333_pre	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34253
9.05973197647127e-301	-0.268881618179163	0.19	0.373	1.92347169592462e-296	NUP214	Malignant cells	GSE199333_pre	ENSG00000126883	8021	nucleoporin 214	CAIN|CAN|D9S46E|N214	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34254
1.88218807868817e-300	-0.279595158599982	0.231	0.418	3.99607350986286e-296	USP7	Malignant cells	GSE199333_pre	ENSG00000187555	7874	ubiquitin specific peptidase 7	HAUSP	protein_coding	Q93009	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34255
2.33283255967162e-300	-0.341782053968488	0.292	0.495	4.95283680743882e-296	TCF4	Malignant cells	GSE199333_pre	ENSG00000196628	6925	transcription factor 4	bHLHb19|E2-2|ITF2|SEF2-1B	protein_coding	P15884	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34256
3.18875678765183e-300	-0.318246803540444	0.391	0.574	6.77004953586361e-296	RAB14	Malignant cells	GSE199333_pre	ENSG00000119396	51552	RAB14, member RAS oncogene family	FBP|RAB-14	protein_coding	P61106	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34257
3.35371592480962e-300	-0.312781008937607	0.409	0.595	7.1202742799633e-296	ACTR3	Malignant cells	GSE199333_pre	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34258
5.99441865017818e-300	-0.259260948399548	0.11	0.27	1.27267502361933e-295	DEDD2	Malignant cells	GSE199333_pre	ENSG00000160570	162989	death effector domain containing 2	FLAME-3	protein_coding	Q8WXF8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34259
8.47931852121563e-300	0.35986812875075	0.824	0.761	1.80024411523929e-295	NDUFA13	Malignant cells	GSE199333_pre	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34260
1.31175751830246e-299	-0.322858828058479	0.399	0.581	2.78499238710796e-295	MYH9	Malignant cells	GSE199333_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34261
2.17822505522744e-299	-0.259713037714985	0.1	0.257	4.62458961475338e-295	MAP3K1	Malignant cells	GSE199333_pre	ENSG00000095015	4214	mitogen-activated protein kinase kinase kinase 1	MAPKKK1|MEKK|MEKK1	protein_coding	Q13233	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34262
2.35548526454785e-299	-0.318140995975063	0.44	0.626	5.00093076516153e-295	NUFIP2	Malignant cells	GSE199333_pre	ENSG00000108256	57532	nuclear FMR1 interacting protein 2	182-FIP|82-FIP|FIP-82|KIAA1321|MGC117262|NUFP2|PIG1	protein_coding	Q7Z417	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34263
4.01375604937294e-299	-0.484933924933199	0.168	0.335	8.52160546842368e-295	ATP2B1-AS1	Malignant cells	GSE199333_pre	ENSG00000271614	NA	NA	LINC00936	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34264
6.29549957896505e-299	-0.27374762748866	0.141	0.311	1.33659751561007e-294	USP1	Malignant cells	GSE199333_pre	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34265
6.7054264156478e-298	-0.411456910644352	0.863	0.917	1.42362908230618e-293	NCL	Malignant cells	GSE199333_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34266
9.99325699849029e-298	-0.255629683237744	0.14	0.309	2.12166839334947e-293	PPP3R1	Malignant cells	GSE199333_pre	ENSG00000221823	5534	protein phosphatase 3 regulatory subunit B, alpha	CALNB1|CNB|CNB1	protein_coding	P63098	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34267
1.00588791426712e-297	-0.28896196387186	0.192	0.371	2.13560063078052e-293	AAK1	Malignant cells	GSE199333_pre	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34268
4.73295826069106e-297	-0.250544191544081	0.159	0.334	1.00485436832732e-292	STIP1	Malignant cells	GSE199333_pre	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34269
1.50843061072244e-296	-0.253991517067127	0.196	0.379	3.20254902962482e-292	PPP6C	Malignant cells	GSE199333_pre	ENSG00000119414	5537	protein phosphatase 6 catalytic subunit	PP6	protein_coding	O00743	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34270
2.1616684411091e-296	-0.306189576730004	0.255	0.439	4.58943826731874e-292	SMG1	Malignant cells	GSE199333_pre	ENSG00000157106	23049	SMG1 nonsense mediated mRNA decay associated PI3K related kinase	ATX|KIAA0421|LIP	protein_coding	Q96Q15	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34271
3.69627833071429e-296	-0.262710897623627	0.207	0.39	7.8475685239395e-292	SEC61A1	Malignant cells	GSE199333_pre	ENSG00000058262	29927	SEC61 translocon subunit alpha 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34272
9.96236929750887e-295	-0.285929149521323	0.276	0.469	2.11511062555411e-290	NCOA4	Malignant cells	GSE199333_pre	ENSG00000266412	8031	nuclear receptor coactivator 4	ARA70|DKFZp762E1112|ELE1|PTC3|RFG	protein_coding	Q13772	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34273
1.93556117575943e-294	-0.353433769294989	0.783	0.873	4.10938993225484e-290	COX5A	Malignant cells	GSE199333_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34274
2.32086818011333e-294	-0.277478371742041	0.573	0.742	4.92743523319861e-290	ATP5PB	Malignant cells	GSE199333_pre	ENSG00000116459	515	ATP synthase peripheral stalk-membrane subunit b	ATP5F1	protein_coding	P24539	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34275
8.24778551457296e-293	-0.251518589914204	0.432	0.639	1.75108734259899e-288	TSC22D3	Malignant cells	GSE199333_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34276
9.95793128826164e-293	-0.462402338211598	0.512	0.646	2.11416839181083e-288	KMT2E	Malignant cells	GSE199333_pre	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34277
4.00282942863044e-292	-0.28503840832971	0.221	0.403	8.4984071599253e-288	DYNC1LI2	Malignant cells	GSE199333_pre	ENSG00000135720	1783	dynein cytoplasmic 1 light intermediate chain 2	DNCLI2	protein_coding	O43237	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34278
4.54773303779742e-292	-0.390401327862629	0.761	0.842	9.6552920125477e-288	PSMA7	Malignant cells	GSE199333_pre	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34279
6.12316368341932e-291	-0.288182960932486	0.219	0.398	1.30000888162676e-286	PPTC7	Malignant cells	GSE199333_pre	ENSG00000196850	160760	protein phosphatase targeting COQ7	TA-PP2C	protein_coding	Q8NI37	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34280
8.06070035035991e-291	-0.28932466505099	0.516	0.693	1.71136729138491e-286	NONO	Malignant cells	GSE199333_pre	ENSG00000147140	4841	non-POU domain containing octamer binding	NMT55|NRB54|P54|P54NRB|PPP1R114	protein_coding	Q15233	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34281
4.65688739817782e-290	-0.296816498331035	0.312	0.499	9.88703763507133e-286	RAB5IF	Malignant cells	GSE199333_pre	ENSG00000101084	55969	RAB5 interacting factor	C20orf24|PNAS-11|RCAF1|RIP5	protein_coding	Q9BUV8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34282
1.25331825756613e-289	-0.257677444338156	0.962	0.986	2.66091999263866e-285	SRP14	Malignant cells	GSE199333_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34283
4.54976281052775e-289	-0.290568164041479	0.359	0.55	9.65960142303148e-285	EIF5B	Malignant cells	GSE199333_pre	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34284
2.00115454731281e-288	-0.304240510012069	0.153	0.328	4.24865121939982e-284	KRT18	Malignant cells	GSE199333_pre	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34285
3.02138374186536e-287	-0.28400571050259	0.232	0.413	6.41469982235435e-283	SPEN	Malignant cells	GSE199333_pre	ENSG00000065526	23013	spen family transcriptional repressor	KIAA0929|MINT|RBM15C|SHARP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34286
5.29035390521241e-287	-0.306737024511981	0.461	0.64	1.12319503761565e-282	RHOG	Malignant cells	GSE199333_pre	ENSG00000177105	391	ras homolog family member G	ARHG|MGC125835|MGC125836	protein_coding	P84095	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34287
6.88355871292675e-287	-0.297442078518106	0.286	0.47	1.46144835034148e-282	DNAJC3	Malignant cells	GSE199333_pre	ENSG00000102580	5611	DnaJ heat shock protein family (Hsp40) member C3	ERdj6|HP58|P58|p58(IPK)|P58IPK|PRKRI	protein_coding	Q13217	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34288
2.86478792803196e-286	-0.308565424150031	0.592	0.752	6.08223125000465e-282	MTPN	Malignant cells	GSE199333_pre	ENSG00000105887	136319	myotrophin	GCDP|MYOTROPHIN|V-1	protein_coding	P58546	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34289
3.69962985420739e-286	-0.345490860901377	0.427	0.591	7.8546841434677e-282	ELOC	Malignant cells	GSE199333_pre	ENSG00000154582	6921	elongin C	SIII|TCEB1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34290
4.81127294561473e-286	-0.29250633600037	0.22	0.397	1.02148135908346e-281	MBD2	Malignant cells	GSE199333_pre	ENSG00000134046	8932	methyl-CpG binding domain protein 2	NA	protein_coding	Q9UBB5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34291
8.70571300687928e-286	-0.28269601175028	0.24	0.421	1.84830992849054e-281	MCFD2	Malignant cells	GSE199333_pre	ENSG00000180398	90411	multiple coagulation factor deficiency 2, ER cargo receptor complex subunit	F5F8D|LMAN1IP|SDNSF	protein_coding	Q8NI22	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34292
1.17090999176577e-284	0.441046302437087	0.683	0.62	2.48595900351791e-280	ITM2C	Malignant cells	GSE199333_pre	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34293
1.49638300796514e-284	-0.288788224832238	0.659	0.801	3.17697076421078e-280	SEPT7	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34294
3.33209457261238e-284	-0.274833308793114	0.139	0.303	7.07436998711334e-280	MOB1B	Malignant cells	GSE199333_pre	ENSG00000173542	92597	MOB kinase activator 1B	MOB4A|MOBKL1A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34295
1.98354846714814e-283	-0.373387733673967	0.68	0.816	4.21127175060222e-279	HSP90B1	Malignant cells	GSE199333_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34296
4.81318371772998e-283	-0.360834200311425	0.224	0.396	1.02188703511125e-278	PHACTR4	Malignant cells	GSE199333_pre	ENSG00000204138	65979	phosphatase and actin regulator 4	FLJ13171|PPP1R124	protein_coding	Q8IZ21	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34297
5.16988530715686e-283	-0.265083653843947	0.186	0.367	1.09761834956247e-278	LAIR1	Malignant cells	GSE199333_pre	ENSG00000276163	3903	leukocyte associated immunoglobulin like receptor 1	CD305|LAIR-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34298
4.53266892574073e-282	-0.292756473665211	0.469	0.645	9.62330939624014e-278	VDAC1	Malignant cells	GSE199333_pre	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34299
5.04966860787385e-282	-0.310327137869985	0.223	0.398	1.0720951421377e-277	H2AFJ	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34300
1.11386283969868e-281	-0.30466385333704	0.735	0.849	2.36484219496427e-277	ZNF207	Malignant cells	GSE199333_pre	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34301
2.94543178982054e-281	-0.398867180276351	0.57	0.701	6.253446232968e-277	PA2G4	Malignant cells	GSE199333_pre	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34302
9.34867430823644e-281	-0.29151528297366	0.823	0.899	1.98481704238168e-276	ELOB	Malignant cells	GSE199333_pre	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34303
1.76131800909341e-279	-0.283750964901018	0.222	0.397	3.73945426510622e-275	STARD7	Malignant cells	GSE199333_pre	ENSG00000084090	56910	StAR related lipid transfer domain containing 7	GTT1	protein_coding	Q9NQZ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34304
7.09091819156556e-279	-0.617627806816057	0.928	0.945	1.50547284125128e-274	TXN	Malignant cells	GSE199333_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34305
1.23807165529171e-277	-0.262841938785125	0.148	0.312	2.62854993134982e-273	TCIRG1	Malignant cells	GSE199333_pre	ENSG00000110719	10312	T cell immune regulator 1, ATPase H+ transporting V0 subunit a3	a3|Atp6i|ATP6N1C|ATP6V0A3|OC-116|OC116|TIRC7	protein_coding	Q13488	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34306
2.68538223688607e-277	-0.464915518573942	0.193	0.367	5.70133502713282e-273	KLF2	Malignant cells	GSE199333_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34307
4.85518359920884e-277	-0.316983101501931	0.726	0.842	1.03080402994803e-272	ATP6V0B	Malignant cells	GSE199333_pre	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34308
2.33226519511092e-276	-0.2661184224637	0.311	0.495	4.95163223574e-272	PSMD2	Malignant cells	GSE199333_pre	ENSG00000175166	5708	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	MGC14274|P97|Rpn1|S2|TRAP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34309
3.61697238714597e-276	-0.294118168161076	0.288	0.468	7.67919407514962e-272	ERP44	Malignant cells	GSE199333_pre	ENSG00000023318	23071	endoplasmic reticulum protein 44	KIAA0573|PDIA10|TXNDC4	protein_coding	Q9BS26	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34310
3.65004121066229e-275	-0.261141758828455	0.307	0.497	7.74940249435711e-271	RAB7A	Malignant cells	GSE199333_pre	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34311
6.6986640870289e-275	-0.323089974007232	0.303	0.479	1.4221933723171e-270	CSNK1D	Malignant cells	GSE199333_pre	ENSG00000141551	1453	casein kinase 1 delta	CKID|CKIdelta|HCKID	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34312
9.36764808186553e-275	-0.316480036396845	0.256	0.427	1.98884536426087e-270	SURF4	Malignant cells	GSE199333_pre	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34313
2.78962949167131e-274	-0.263801326733165	0.218	0.395	5.92266237376737e-270	GRINA	Malignant cells	GSE199333_pre	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34314
9.06895661772671e-274	-0.547609676084577	0.106	0.251	1.92543017950956e-269	TYMS	Malignant cells	GSE199333_pre	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34315
2.37075985217428e-272	-0.260781022956477	0.153	0.315	5.03336024215122e-268	PLSCR1	Malignant cells	GSE199333_pre	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34316
5.20700095344134e-272	-0.28208558068177	0.242	0.42	1.10549837242513e-267	UBA6	Malignant cells	GSE199333_pre	ENSG00000033178	55236	ubiquitin like modifier activating enzyme 6	FLJ10808|UBE1L2	protein_coding	A0AVT1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34317
8.05353889112127e-272	-0.255840077976593	0.275	0.458	1.70984684197396e-267	MORF4L2	Malignant cells	GSE199333_pre	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34318
2.50538532971891e-271	-0.328692372849571	0.991	0.994	5.31918359352621e-267	HSP90AA1	Malignant cells	GSE199333_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34319
7.62528977378784e-271	-0.329952710540776	0.39	0.56	1.6189252718729e-266	SLBP	Malignant cells	GSE199333_pre	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34320
4.53635969830152e-270	-0.266238143821959	0.25	0.431	9.63114527546396e-266	UBE3A	Malignant cells	GSE199333_pre	ENSG00000114062	7337	ubiquitin protein ligase E3A	ANCR|AS|E6-AP|EPVE6AP|FLJ26981|HPVE6A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34321
9.20081425109925e-270	0.337804609640859	0.887	0.833	1.95342487365088e-265	CALR	Malignant cells	GSE199333_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34322
1.07404581922616e-269	-0.297592190927201	0.671	0.806	2.28030667879906e-265	SRSF11	Malignant cells	GSE199333_pre	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34323
1.2676273534457e-269	-0.277069881513742	0.4	0.583	2.69129963410057e-265	APPL1	Malignant cells	GSE199333_pre	ENSG00000157500	26060	adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1	APPL	protein_coding	Q9UKG1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34324
1.48481226806331e-268	-0.507416602674836	0.507	0.634	3.15240492632521e-264	HSPD1	Malignant cells	GSE199333_pre	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34325
1.3448857427516e-267	-0.330672865552496	0.354	0.523	2.85532692043591e-263	LCOR	Malignant cells	GSE199333_pre	ENSG00000196233	84458	ligand dependent nuclear receptor corepressor	C10orf12|DKFZP564P1916|FLJ13022|FLJ38026|KIAA1795|MLR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34326
1.96613975535191e-267	-0.332330180643322	0.37	0.538	4.17431131458763e-263	MIER1	Malignant cells	GSE199333_pre	ENSG00000198160	57708	MIER1 transcriptional regulator	hMI-ER1|KIAA1610|MI-ER1	protein_coding	Q8N108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34327
2.6453365363884e-267	-0.436642230985334	0.636	0.748	5.61631400040622e-263	XBP1	Malignant cells	GSE199333_pre	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34328
4.4639348439821e-267	-0.275650376588605	0.425	0.603	9.47738006725839e-263	EIF3B	Malignant cells	GSE199333_pre	ENSG00000106263	8662	eukaryotic translation initiation factor 3 subunit B	EIF3S9|PRT1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34329
1.04684954379091e-266	-0.326214073164608	0.486	0.648	2.22256626642248e-262	TAX1BP1	Malignant cells	GSE199333_pre	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34330
1.61621909543555e-266	-0.484838990629682	0.491	0.623	3.43139476151922e-262	CTNNB1	Malignant cells	GSE199333_pre	ENSG00000168036	1499	catenin beta 1	armadillo|beta-catenin|CTNNB	protein_coding	P35222	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34331
2.10486377124777e-266	-0.314901201061124	0.304	0.476	4.46883627273614e-262	SSH2	Malignant cells	GSE199333_pre	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34332
3.13371338551787e-266	-0.323115570358421	0.414	0.579	6.65318688879299e-262	LENG8	Malignant cells	GSE199333_pre	ENSG00000276458	114823	leukocyte receptor cluster member 8	KIAA1932|MGC40108|pp13842	protein_coding	Q96PV6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34333
3.23031648524419e-266	-0.325117731125689	0.309	0.477	6.85828492982193e-262	EPS15	Malignant cells	GSE199333_pre	ENSG00000085832	2060	epidermal growth factor receptor pathway substrate 15	AF-1P|MLLT5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34334
3.57752617223631e-266	-0.269003709355766	0.232	0.407	7.5954458162749e-262	ZNF106	Malignant cells	GSE199333_pre	ENSG00000103994	64397	zinc finger protein 106	SH3BP3|ZFP106|ZNF474	protein_coding	Q9H2Y7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34335
8.13086509370176e-266	-0.29730919193271	0.165	0.324	1.72626396804382e-261	SLC6A6	Malignant cells	GSE199333_pre	ENSG00000131389	6533	solute carrier family 6 member 6	TAUT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34336
1.7467552959831e-265	0.316385354145323	0.637	0.464	3.70853616890173e-261	SPNS3	Malignant cells	GSE199333_pre	ENSG00000182557	201305	sphingolipid transporter 3 (putative)	MGC29671|SLC63A3	protein_coding	Q6ZMD2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34337
1.56510406017234e-264	-0.282478399045484	0.677	0.808	3.3228724301519e-260	UBE2I	Malignant cells	GSE199333_pre	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34338
1.80863167275777e-264	-0.268936259095422	0.202	0.373	3.83990590443202e-260	RGS10	Malignant cells	GSE199333_pre	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34339
4.04926786367201e-264	0.268666984434389	0.86	0.779	8.59700060136204e-260	ATP6V1G1	Malignant cells	GSE199333_pre	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34340
1.45573762811227e-262	-0.264232921416837	0.144	0.3	3.09067655824516e-258	CCDC69	Malignant cells	GSE199333_pre	ENSG00000198624	26112	coiled-coil domain containing 69	DKFZP434C171|FLJ13705	protein_coding	A6NI79	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34341
1.72400099597728e-262	-0.368724797617361	0.6	0.727	3.66022651455937e-258	ENY2	Malignant cells	GSE199333_pre	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34342
6.40857493488016e-262	-0.279560935752039	0.331	0.509	1.36060454442441e-257	NIPBL	Malignant cells	GSE199333_pre	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34343
1.49047662125136e-261	-0.263565478778213	0.168	0.329	3.16443091457876e-257	NECAP2	Malignant cells	GSE199333_pre	ENSG00000157191	55707	NECAP endocytosis associated 2	FLJ10420	protein_coding	Q9NVZ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34344
1.69536178067639e-261	-0.301711334749697	0.43	0.596	3.59942259655404e-257	ACADVL	Malignant cells	GSE199333_pre	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34345
1.78591450859682e-261	-0.25228482851499	0.265	0.444	3.79167509320191e-257	CNIH1	Malignant cells	GSE199333_pre	ENSG00000100528	10175	cornichon family AMPA receptor auxiliary protein 1	CNIH|CNIL|TGAM77	protein_coding	O95406	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34346
2.78141648158589e-261	-0.265510388076847	0.856	0.934	5.90522533205499e-257	PCBP2	Malignant cells	GSE199333_pre	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34347
2.12718609577116e-260	0.25837275418129	0.34	0.176	4.51622879993174e-256	DDIT3	Malignant cells	GSE199333_pre	ENSG00000175197	1649	DNA damage inducible transcript 3	CHOP|CHOP10|GADD153	protein_coding	P35638	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34348
4.82608829023146e-260	-0.346656854068495	0.431	0.582	1.02462680489904e-255	ETF1	Malignant cells	GSE199333_pre	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34349
7.59514853877048e-260	0.278856982335272	0.552	0.375	1.61252598626636e-255	TSTD1	Malignant cells	GSE199333_pre	ENSG00000215845	100131187	thiosulfate sulfurtransferase like domain containing 1	KAT	protein_coding	Q8NFU3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34350
7.14325941214155e-259	-0.347263123307737	0.279	0.445	1.51658540579177e-254	NRIP1	Malignant cells	GSE199333_pre	ENSG00000180530	8204	nuclear receptor interacting protein 1	RIP140	protein_coding	P48552	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34351
2.07706119050552e-257	-0.318567631805796	0.544	0.693	4.40980861356228e-253	CCDC88A	Malignant cells	GSE199333_pre	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34352
2.81624794705468e-257	-0.252432313488891	0.209	0.378	5.97917601639179e-253	FBXO11	Malignant cells	GSE199333_pre	ENSG00000138081	80204	F-box protein 11	FBX11|UBR6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34353
1.86798024106919e-256	-0.307166990931795	0.301	0.472	3.96590884981401e-252	TRIM38	Malignant cells	GSE199333_pre	ENSG00000112343	10475	tripartite motif containing 38	RNF15|RORET	protein_coding	O00635	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34354
4.23040563556604e-256	-0.264864293547752	0.254	0.427	8.98157420487026e-252	PIAS1	Malignant cells	GSE199333_pre	ENSG00000033800	8554	protein inhibitor of activated STAT 1	DDXBP1|GBP|GU/RH-II|ZMIZ3	protein_coding	O75925	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34355
1.17402637189639e-255	-0.298689604936343	0.311	0.48	2.49257539017323e-251	DNAJB14	Malignant cells	GSE199333_pre	ENSG00000164031	79982	DnaJ heat shock protein family (Hsp40) member B14	FLJ14281	protein_coding	Q8TBM8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34356
1.42255928867653e-255	-0.29233981519216	0.302	0.47	3.02023562578914e-251	FAM91A1	Malignant cells	GSE199333_pre	ENSG00000176853	157769	family with sequence similarity 91 member A1	FLJ23790	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34357
1.99563425732945e-255	-0.375641274522199	0.341	0.502	4.23693109173615e-251	SERTAD2	Malignant cells	GSE199333_pre	ENSG00000179833	9792	SERTA domain containing 2	KIAA0127|Sei-2|TRIP-Br2	protein_coding	Q14140	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34358
8.32912679028179e-255	-0.277713212337741	0.828	0.902	1.76835690884473e-250	PSMB1	Malignant cells	GSE199333_pre	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34359
3.50025552885488e-254	-0.261172360388517	0.21	0.377	7.4313925133118e-250	RC3H1	Malignant cells	GSE199333_pre	ENSG00000135870	149041	ring finger and CCCH-type domains 1	KIAA2025|RNF198|roquin|RP5-1198E17.5	protein_coding	Q5TC82	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34360
8.65775837656437e-254	-0.29421650407961	0.436	0.605	1.83812868092838e-249	TPR	Malignant cells	GSE199333_pre	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34361
4.61121546775905e-252	-0.335911643205886	0.461	0.626	9.79007155959924e-248	PPP1CB	Malignant cells	GSE199333_pre	ENSG00000213639	5500	protein phosphatase 1 catalytic subunit beta	MP|PP-1B|PP1B|PP1beta|PP1c|PPP1beta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34362
8.10430196883387e-252	-0.349953212885733	0.445	0.591	1.72062435100312e-247	PSMB8	Malignant cells	GSE199333_pre	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34363
1.57679832133619e-251	-0.256150572230573	0.247	0.42	3.34770051602888e-247	SF3A3	Malignant cells	GSE199333_pre	ENSG00000183431	10946	splicing factor 3a subunit 3	PRP9|PRPF9|SAP61|SF3a60	protein_coding	Q12874	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34364
1.24894044291805e-250	-0.340274026801068	0.127	0.272	2.6516254543593e-246	CHML	Malignant cells	GSE199333_pre	ENSG00000203668	1122	CHM like Rab escort protein	REP-2	protein_coding	P26374	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34365
1.79371405121329e-250	0.28924030369176	0.685	0.54	3.80823430213094e-246	SERPINB6	Malignant cells	GSE199333_pre	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34366
2.25723495418472e-250	-0.329434281060799	0.132	0.279	4.79233553122958e-246	PTTG1	Malignant cells	GSE199333_pre	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34367
6.87047606677832e-250	-0.29629665380611	0.503	0.66	1.45867077373771e-245	CTSC	Malignant cells	GSE199333_pre	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34368
7.68372570130225e-250	0.251322934125384	0.524	0.34	1.63133180364348e-245	ACAP1	Malignant cells	GSE199333_pre	ENSG00000288169	9744	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	CENTB1|KIAA0050	protein_coding	Q15027	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34369
8.33807495416149e-250	-0.445452616650892	0.338	0.494	1.77025669351802e-245	PIM3	Malignant cells	GSE199333_pre	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34370
1.1919341425278e-249	-0.251095192531616	0.166	0.324	2.53059537800078e-245	MGAT1	Malignant cells	GSE199333_pre	ENSG00000131446	4245	alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GLCNAC-TI|GLYT1|GNT-1|GnTI|MGAT	protein_coding	P26572	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34371
8.89466032922055e-249	0.307397568891475	0.417	0.254	1.88842533449682e-244	CD96	Malignant cells	GSE199333_pre	ENSG00000153283	10225	CD96 molecule	TACTILE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34372
2.69134345993744e-248	-0.302219203464938	0.546	0.688	5.71399129979318e-244	ARHGDIA	Malignant cells	GSE199333_pre	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34373
5.58730389569138e-248	-0.256758674685378	0.354	0.528	1.18624049009424e-243	PPP1CC	Malignant cells	GSE199333_pre	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34374
7.6628840179285e-248	-0.278858062624952	0.674	0.803	1.6269069058464e-243	TMBIM6	Malignant cells	GSE199333_pre	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34375
1.70792005069177e-247	-0.267781944605965	0.254	0.423	3.62608505962371e-243	SELENOW	Malignant cells	GSE199333_pre	ENSG00000178980	6415	selenoprotein W	SELW|SEPW1	protein_coding	P63302	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34376
2.8892455068307e-247	-0.269380750809016	0.229	0.395	6.13415713555227e-243	ARID2	Malignant cells	GSE199333_pre	ENSG00000189079	196528	AT-rich interaction domain 2	BAF200|DKFZp686G052|FLJ30619|KIAA1557|SMARCF3	protein_coding	Q68CP9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34377
4.51340483579497e-247	-0.289670601871547	0.12	0.265	9.5824098068763e-243	CFP	Malignant cells	GSE199333_pre	ENSG00000126759	5199	complement factor properdin	PFC	protein_coding	P27918	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34378
1.18832738571933e-246	-0.268532780730083	0.223	0.386	2.5229378726207e-242	LRRFIP2	Malignant cells	GSE199333_pre	ENSG00000093167	9209	LRR binding FLII interacting protein 2	HUFI-2	protein_coding	Q9Y608	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34379
1.45447022151443e-246	-0.300877049026639	0.289	0.456	3.08798572729728e-242	YWHAH	Malignant cells	GSE199333_pre	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34380
2.59030445504262e-246	-0.286519352096636	0.318	0.487	5.49947538850099e-242	CHD1	Malignant cells	GSE199333_pre	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34381
3.76942910927516e-246	-0.280726270306482	0.487	0.654	8.00287494190209e-242	UBXN4	Malignant cells	GSE199333_pre	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34382
1.93450548005094e-245	-0.286989050769891	0.272	0.44	4.10714858469616e-241	PTPN1	Malignant cells	GSE199333_pre	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34383
2.49011766357524e-245	-0.310314478863313	0.775	0.866	5.28676881153659e-241	PRRC2C	Malignant cells	GSE199333_pre	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34384
4.00215779465389e-245	-0.280135781321887	0.352	0.523	8.49698121382967e-241	ATP1B3	Malignant cells	GSE199333_pre	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34385
1.08314488309083e-244	-0.277025062299599	0.805	0.888	2.29962490129015e-240	CSDE1	Malignant cells	GSE199333_pre	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34386
2.15011285117412e-243	-0.26925085352347	0.352	0.526	4.56490459432777e-239	PUM1	Malignant cells	GSE199333_pre	ENSG00000134644	9698	pumilio RNA binding family member 1	KIAA0099|PUMH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34387
2.155629721489e-243	-0.452026547543236	0.321	0.477	4.5766174616933e-239	DYNLL1	Malignant cells	GSE199333_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34388
2.46994096204704e-243	0.351035186565936	0.291	0.147	5.24393165652206e-239	HOPX	Malignant cells	GSE199333_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34389
4.46156201873201e-243	-0.280117944891025	0.353	0.522	9.47234232196992e-239	WDR1	Malignant cells	GSE199333_pre	ENSG00000071127	9948	WD repeat domain 1	AIP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34390
4.52474836165035e-243	-0.293033578792951	0.424	0.584	9.60649324661986e-239	GTF3C6	Malignant cells	GSE199333_pre	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34391
5.78149328624792e-243	-0.269251452301817	0.189	0.346	1.2274688396033e-238	ATP13A3	Malignant cells	GSE199333_pre	ENSG00000133657	79572	ATPase 13A3	AFURS1	protein_coding	Q9H7F0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34392
1.0577273044186e-242	-0.297324230613187	0.295	0.459	2.24566084001112e-238	ADD1	Malignant cells	GSE199333_pre	ENSG00000087274	118	adducin 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34393
2.02565565836828e-242	-0.325749746072429	0.307	0.466	4.3006695282817e-238	SNHG9	Malignant cells	GSE199333_pre	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34394
1.23712961488928e-241	-0.261582849175388	0.294	0.463	2.62654988537142e-237	CNOT1	Malignant cells	GSE199333_pre	ENSG00000125107	23019	CCR4-NOT transcription complex subunit 1	AD-005|CDC39|KIAA1007|NOT1|NOT1H	protein_coding	A5YKK6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34395
5.04911323352585e-241	0.29875737776801	0.646	0.483	1.07197723060987e-236	LEPROT	Malignant cells	GSE199333_pre	ENSG00000213625	54741	leptin receptor overlapping transcript	FLJ90360|OB-RGRP|OBRGRP|VPS55	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34396
5.11216018962221e-240	0.258606359883431	0.956	0.918	1.08536272985869e-235	HMGN1	Malignant cells	GSE199333_pre	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34397
5.59811849888441e-239	-0.294660988302435	0.323	0.492	1.18853653849815e-234	TBL1XR1	Malignant cells	GSE199333_pre	ENSG00000177565	79718	TBL1X/Y related 1	C21|DC42|FLJ12894|IRA1|TBLR1	protein_coding	Q9BZK7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34398
1.44171851314709e-238	-0.273149325170613	0.416	0.579	3.0609125752626e-234	FAM49B	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34399
1.72491105230078e-238	-0.28315896465567	0.416	0.582	3.66215865513978e-234	SEPT2	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34400
4.36038870565702e-238	-0.265331640993203	0.194	0.353	9.25754126098043e-234	INTS6	Malignant cells	GSE199333_pre	ENSG00000102786	26512	integrator complex subunit 6	DBI-1|DDX26|DDX26A|DICE1|HDB|INT6|Notchl2	protein_coding	Q9UL03	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34401
2.92489641532264e-237	-0.283668847638746	0.299	0.467	6.2098475793715e-233	BAZ1A	Malignant cells	GSE199333_pre	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34402
5.87824194309971e-236	-0.256853822565645	0.419	0.587	1.2480095469395e-231	SRP9	Malignant cells	GSE199333_pre	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34403
8.71913884214579e-236	-0.318615510279538	0.388	0.554	1.85116036757597e-231	ARL6IP1	Malignant cells	GSE199333_pre	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34404
1.01471361724446e-233	-0.374690525970495	0.31	0.465	2.1543384807717e-229	PRKDC	Malignant cells	GSE199333_pre	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34405
1.37507295851552e-233	-0.555661426455716	0.383	0.533	2.9194173982243e-229	JUN	Malignant cells	GSE199333_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34406
2.9649909935818e-233	-0.269178314187998	0.741	0.84	6.29497237847353e-229	HNRNPM	Malignant cells	GSE199333_pre	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34407
3.81502198274049e-232	-0.264844809865482	0.344	0.513	8.09967317155634e-228	KPNA4	Malignant cells	GSE199333_pre	ENSG00000186432	3840	karyopherin subunit alpha 4	IPOA3|MGC12217|MGC26703|QIP1|SRP3	protein_coding	O00629	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34408
4.65818716392204e-232	-0.350756779652626	0.544	0.671	9.88979716772287e-228	POLR2J3.1	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34409
1.46581518796429e-230	-0.291127563407481	0.116	0.257	3.11207222556699e-226	MDK	Malignant cells	GSE199333_pre	ENSG00000110492	4192	midkine	FLJ27379|MK|NEGF2	protein_coding	P21741	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34410
5.77426240553663e-230	-0.270314028230487	0.313	0.476	1.22593365131948e-225	DDX39B	Malignant cells	GSE199333_pre	ENSG00000225859	7919	DExD-box helicase 39B	BAT1|D6S81E|UAP56	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34411
6.89135469768689e-230	-0.254252209950906	0.352	0.518	1.4631035158659e-225	SSR1	Malignant cells	GSE199333_pre	ENSG00000124783	6745	signal sequence receptor subunit 1	TRAPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34412
2.37768933556822e-229	-0.252108854352439	0.292	0.458	5.04807222834489e-225	TCERG1	Malignant cells	GSE199333_pre	ENSG00000113649	10915	transcription elongation regulator 1	CA150|TAF2S|Urn1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34413
1.31099337922443e-228	-0.309735307897118	0.463	0.611	2.78337004343139e-224	PDIA6	Malignant cells	GSE199333_pre	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34414
2.67529154079294e-228	-0.26062965054257	0.276	0.443	5.67991147025749e-224	RANBP2	Malignant cells	GSE199333_pre	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34415
1.20217023386461e-227	-0.265901120409187	0.287	0.451	2.55232762351796e-223	DIAPH1	Malignant cells	GSE199333_pre	ENSG00000131504	1729	diaphanous related formin 1	DFNA1|hDIA1|LFHL1|mDia1	protein_coding	O60610	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34416
9.62478496150022e-227	-0.270623192189034	0.164	0.311	2.04343809517611e-222	GTF3C5	Malignant cells	GSE199333_pre	ENSG00000148308	9328	general transcription factor IIIC subunit 5	TFiiiC2-63|TFIIIC63|TFIIICepsilon	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34417
3.06408132849095e-226	-0.274902457863898	0.382	0.542	6.50535106851913e-222	SMC3	Malignant cells	GSE199333_pre	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34418
4.16769867126331e-226	-0.254217066285682	0.207	0.361	8.84844104895914e-222	SAMD4B	Malignant cells	GSE199333_pre	ENSG00000179134	55095	sterile alpha motif domain containing 4B	FLJ10211|hSmaug2|MGC99832|SMGB	protein_coding	Q5PRF9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34419
8.0514427939217e-226	-0.301204220110326	0.757	0.847	1.70940181957752e-221	SERBP1	Malignant cells	GSE199333_pre	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34420
1.68304910793522e-225	-0.266525908477868	0.598	0.745	3.57328156105727e-221	CDV3	Malignant cells	GSE199333_pre	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34421
3.9495195277382e-225	-1.0334546088327	0.57	0.622	8.38522490934097e-221	NFKBIA	Malignant cells	GSE199333_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34422
9.11122020700566e-223	-0.261260511537218	0.271	0.432	1.93440316214937e-218	SETD2	Malignant cells	GSE199333_pre	ENSG00000181555	29072	SET domain containing 2, histone lysine methyltransferase	FLJ23184|HIF-1|HYPB|KIAA1732|KMT3A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34423
1.12308583045248e-222	0.253816044565451	0.364	0.212	2.38442352663365e-218	ARRDC3	Malignant cells	GSE199333_pre	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34424
2.04905453426577e-222	-0.313904982048147	0.239	0.394	4.35034768169966e-218	FLT3	Malignant cells	GSE199333_pre	ENSG00000122025	2322	fms related receptor tyrosine kinase 3	CD135|FLK2|STK1	protein_coding	P36888	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34425
3.60509823859408e-222	-0.274146390016289	0.932	0.953	7.6539840703591e-218	SET	Malignant cells	GSE199333_pre	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34426
3.60943482367997e-222	-0.253515753328412	0.236	0.393	7.66319107415493e-218	TRIM33	Malignant cells	GSE199333_pre	ENSG00000197323	51592	tripartite motif containing 33	FLJ11429|KIAA1113|PTC7|RFG7|TF1G|TIF1G|TIF1GAMMA|TIFGAMMA	protein_coding	Q9UPN9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34427
3.61534299203363e-222	-0.255725347821802	0.611	0.744	7.6757347063866e-218	DPP7	Malignant cells	GSE199333_pre	ENSG00000176978	29952	dipeptidyl peptidase 7	DPP2|DPPII	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34428
1.56043614484287e-221	-0.255511022991862	0.534	0.68	3.3129619791159e-217	ILF3	Malignant cells	GSE199333_pre	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34429
3.94817373995773e-221	-0.251885674601756	0.358	0.521	8.38236766730425e-217	CAPRIN1	Malignant cells	GSE199333_pre	ENSG00000135387	4076	cell cycle associated protein 1	caprin-1|GPIAP1|M11S1|RNG105	protein_coding	Q14444	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34430
5.03696217089299e-221	-0.294756526341063	0.351	0.505	1.06939743850229e-216	SDCBP	Malignant cells	GSE199333_pre	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34431
5.62008641154232e-221	0.261507031741745	0.459	0.296	1.19320054603455e-216	LTC4S	Malignant cells	GSE199333_pre	ENSG00000283887	4056	leukotriene C4 synthase	MGC33147	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34432
1.18317291703175e-220	-0.256579845983294	0.442	0.602	2.5119944201501e-216	ZYX	Malignant cells	GSE199333_pre	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34433
1.55952650411766e-220	0.252284022361515	0.859	0.741	3.31103072089221e-216	CD44	Malignant cells	GSE199333_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34434
1.53834696561093e-219	-0.30127859414752	0.396	0.544	3.26606444268856e-215	CALM3	Malignant cells	GSE199333_pre	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34435
6.97327985238825e-219	-0.295126711006644	0.707	0.805	1.48049704546055e-214	COX8A	Malignant cells	GSE199333_pre	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34436
9.51699432012044e-219	-0.259693054947929	0.296	0.456	2.02055306410477e-214	RREB1	Malignant cells	GSE199333_pre	ENSG00000124782	6239	ras responsive element binding protein 1	HNT	protein_coding	Q92766	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34437
1.13603361215647e-218	0.336647627854783	0.596	0.459	2.41191296196941e-214	ANKRD13D	Malignant cells	GSE199333_pre	ENSG00000172932	338692	ankyrin repeat domain 13D	NA	protein_coding	Q6ZTN6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34438
5.11397024825053e-218	-0.311927771554678	0.161	0.3	1.08574702340607e-213	SAP30	Malignant cells	GSE199333_pre	ENSG00000164105	8819	Sin3A associated protein 30	NA	protein_coding	O75446	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34439
1.29574687119143e-216	-0.281590112132579	0.386	0.54	2.75100018222653e-212	RNASEH2B	Malignant cells	GSE199333_pre	ENSG00000136104	79621	ribonuclease H2 subunit B	AGS2|DLEU8|FLJ11712	protein_coding	Q5TBB1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34440
3.29774284208665e-216	0.571529893411226	0.668	0.535	7.00143782803416e-212	DUSP1	Malignant cells	GSE199333_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34441
3.92775147477401e-215	-0.254767205509454	0.264	0.424	8.33900915609269e-211	WNK1	Malignant cells	GSE199333_pre	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34442
1.63129805273153e-214	-0.269378821421908	0.219	0.372	3.46340889575432e-210	IER5	Malignant cells	GSE199333_pre	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34443
8.37396105906592e-214	-0.250688479279178	0.602	0.74	1.77787567245029e-209	SRP72	Malignant cells	GSE199333_pre	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34444
1.20837366126858e-213	-0.271958285653049	0.411	0.568	2.56549812023931e-209	GNAQ	Malignant cells	GSE199333_pre	ENSG00000156052	2776	G protein subunit alpha q	G-ALPHA-q|GAQ	protein_coding	P50148	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34445
3.69664183326039e-212	-0.257591709573023	0.516	0.669	7.84834027619513e-208	GDI2	Malignant cells	GSE199333_pre	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34446
9.95149891012743e-212	-0.332340461380761	0.282	0.439	2.11280273360915e-207	TSC22D1	Malignant cells	GSE199333_pre	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34447
5.80147684080838e-211	-0.261058939512692	0.518	0.664	1.23171154807203e-206	GNB1	Malignant cells	GSE199333_pre	ENSG00000078369	2782	G protein subunit beta 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34448
1.6561045951372e-209	-0.311284081354845	0.638	0.746	3.51607566593579e-205	SREK1	Malignant cells	GSE199333_pre	ENSG00000153914	140890	splicing regulatory glutamic acid and lysine rich protein 1	DKFZp564B176|SFRS12|SRrp508|SRrp86	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34449
5.70637382409689e-209	-0.259147587240405	0.25	0.401	1.21152022659401e-204	AK2	Malignant cells	GSE199333_pre	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34450
9.10464351788836e-208	-0.29302644973891	0.714	0.816	1.93300686528288e-203	VAPA	Malignant cells	GSE199333_pre	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34451
6.69359432422881e-206	0.345929407370586	0.53	0.413	1.42111701097702e-201	ADRM1	Malignant cells	GSE199333_pre	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34452
1.45189762129799e-205	0.266343371137787	0.686	0.562	3.08252383977777e-201	HSD17B11	Malignant cells	GSE199333_pre	ENSG00000198189	51170	hydroxysteroid 17-beta dehydrogenase 11	17-BETA-HSD11|17-BETA-HSDXI|DHRS8|PAN1B|RetSDR2|SDR16C2	protein_coding	Q8NBQ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34453
1.97361930023978e-205	-0.53438474575869	0.167	0.295	4.19019113633907e-201	HIST1H1D	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34454
2.95580754833743e-203	-0.25194540097471	0.238	0.385	6.2754750058752e-199	WDR26	Malignant cells	GSE199333_pre	ENSG00000162923	80232	WD repeat domain 26	FLJ21016|GID7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34455
3.44689158478767e-203	-0.254767544594983	0.25	0.399	7.31809552366271e-199	UBXN7	Malignant cells	GSE199333_pre	ENSG00000163960	26043	UBX domain protein 7	KIAA0794|UBXD7	protein_coding	O94888	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34456
3.85589844492576e-203	0.287767825376758	0.573	0.435	8.18645798842189e-199	LAT2	Malignant cells	GSE199333_pre	ENSG00000086730	7462	linker for activation of T cells family member 2	HSPC046|LAB|NTAL|WBSCR15|WBSCR5|WSCR5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34457
1.05143650021027e-201	-0.305293590303319	0.339	0.484	2.23230483359642e-197	MAPKAPK2	Malignant cells	GSE199333_pre	ENSG00000162889	9261	MAPK activated protein kinase 2	MK2	protein_coding	P49137	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34458
1.48805405714836e-200	-0.256980242007375	0.373	0.527	3.15928756873168e-196	USP16	Malignant cells	GSE199333_pre	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34459
2.4637654978674e-200	-0.39068667452418	0.345	0.508	5.23082052852227e-196	CD52	Malignant cells	GSE199333_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34460
2.63571369894123e-199	-0.289677545949992	0.351	0.496	5.59588375422213e-195	WDFY2	Malignant cells	GSE199333_pre	ENSG00000139668	115825	WD repeat and FYVE domain containing 2	ZFYVE22	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34461
4.99624011282228e-198	-0.307552121491677	0.77	0.846	1.0607517383533e-193	BCLAF1	Malignant cells	GSE199333_pre	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34462
3.45268314261866e-196	-0.290617053460546	0.198	0.34	7.33039158009367e-192	NAMPT	Malignant cells	GSE199333_pre	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34463
5.72594244336014e-196	-0.830010023770126	0.165	0.281	1.21567484014979e-191	SLC44A1	Malignant cells	GSE199333_pre	ENSG00000070214	23446	solute carrier family 44 member 1	CD92|CDW92|CHTL1|CTL1	protein_coding	Q8WWI5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34464
1.40682858659529e-195	-0.321375706921137	0.55	0.671	2.98683777220047e-191	PCM1	Malignant cells	GSE199333_pre	ENSG00000078674	5108	pericentriolar material 1	PTC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34465
3.42026045665079e-195	-0.273451053845713	0.45	0.585	7.26155497551529e-191	RAB5C	Malignant cells	GSE199333_pre	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34466
2.14306362781195e-194	-0.264629585428664	0.682	0.792	4.54993838820755e-190	PAIP2	Malignant cells	GSE199333_pre	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34467
2.38151825659625e-194	-0.253920715862791	0.548	0.689	5.05620141057949e-190	RTF1	Malignant cells	GSE199333_pre	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34468
2.65228627456095e-193	-0.264955899745807	0.648	0.761	5.63106898952036e-189	GUK1	Malignant cells	GSE199333_pre	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34469
1.26587113244766e-192	-0.260125483816512	0.234	0.373	2.68757100129962e-188	RNF11	Malignant cells	GSE199333_pre	ENSG00000123091	26994	ring finger protein 11	CGI-123|MGC51169|Sid1669p	protein_coding	Q9Y3C5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34470
3.85446953746157e-191	-0.260979126144303	0.243	0.385	8.18342427498466e-187	BUB3	Malignant cells	GSE199333_pre	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34471
5.37161791402066e-191	-0.342885030322003	0.534	0.645	1.14044819932573e-186	NDUFB9	Malignant cells	GSE199333_pre	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34472
2.07722446304071e-190	-0.255382852445887	0.192	0.331	4.41015525748173e-186	KPNA2	Malignant cells	GSE199333_pre	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34473
3.34342514472535e-189	-0.257056495073198	0.296	0.439	7.0984259247664e-185	HDAC2	Malignant cells	GSE199333_pre	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34474
9.7087774197408e-188	-0.285750971672393	0.572	0.694	2.06127053398517e-183	DYNC1H1	Malignant cells	GSE199333_pre	ENSG00000197102	1778	dynein cytoplasmic 1 heavy chain 1	CMT2O|DHC1|DNCH1|Dnchc1|DNCL|DNECL|HL-3|p22	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34475
4.70618612271198e-187	-0.637068150353615	0.836	0.902	9.99170375712981e-183	TUBA1B	Malignant cells	GSE199333_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34476
7.02805929151659e-187	-0.258006278572747	0.521	0.652	1.49212726818189e-182	TCP1	Malignant cells	GSE199333_pre	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34477
2.26781382575276e-185	-0.336909066073386	0.443	0.56	4.81479553345567e-181	CYLD	Malignant cells	GSE199333_pre	ENSG00000083799	1540	CYLD lysine 63 deubiquitinase	CYLD1|KIAA0849|USPL2	protein_coding	Q9NQC7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34478
2.59108765688366e-185	-0.254053505135225	0.396	0.546	5.50113820432969e-181	FOXP1	Malignant cells	GSE199333_pre	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34479
3.1685930138263e-185	0.284186445530594	0.699	0.554	6.72723982765461e-181	YPEL5	Malignant cells	GSE199333_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34480
6.43417671328037e-185	-0.351606821985439	0.775	0.853	1.36604005799655e-180	LDHA	Malignant cells	GSE199333_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34481
1.13038099666891e-183	-0.359811425077225	0.298	0.428	2.39991189402777e-179	UCP2	Malignant cells	GSE199333_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34482
4.8104998389167e-183	-0.305074869540618	0.431	0.567	1.0213172208004e-178	HSPE1	Malignant cells	GSE199333_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34483
6.70877401392017e-183	-0.323948924844519	0.325	0.457	1.42433981089539e-178	MAP2K3	Malignant cells	GSE199333_pre	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34484
8.86939864398056e-183	-0.279268862026478	0.596	0.7	1.88306202610351e-178	ATP5MF	Malignant cells	GSE199333_pre	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34485
1.46645441991398e-182	-0.253718258504236	0.338	0.488	3.11342937891937e-178	GCC2	Malignant cells	GSE199333_pre	ENSG00000135968	9648	GRIP and coiled-coil domain containing 2	GCC185|KIAA0336	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34486
3.84828809209991e-182	-0.272999040975498	0.435	0.579	8.17030044833732e-178	RAD21	Malignant cells	GSE199333_pre	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34487
1.49464734056012e-180	-0.266789872706719	0.18	0.311	3.17328576874318e-176	TMPO	Malignant cells	GSE199333_pre	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34488
2.01176643064862e-180	-0.3271933436337	0.471	0.61	4.27118130891008e-176	TAF9	Malignant cells	GSE199333_pre	ENSG00000276463	6880	TATA-box binding protein associated factor 9	AD-004|CGI-137|MGC1603|MGC3647|MGC5067|TAF2G|TAFII31|TAFII32|TAFIID32	protein_coding	Q16594	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34489
1.43238570581112e-179	-0.802659662656768	0.715	0.74	3.04109809200759e-175	SAT1	Malignant cells	GSE199333_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34490
2.66353090054623e-179	-0.269962854801883	0.398	0.532	5.6549424549497e-175	C16orf72	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34491
2.97708594318369e-179	-0.252962536888497	0.797	0.863	6.3206511659733e-175	ATP5MC3	Malignant cells	GSE199333_pre	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34492
3.9639413571197e-179	-0.261463221274716	0.491	0.63	8.41584389530084e-175	DDX21	Malignant cells	GSE199333_pre	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34493
2.75869609481899e-178	-0.26366396689037	0.475	0.611	5.8569876789102e-174	ZNF292	Malignant cells	GSE199333_pre	ENSG00000188994	23036	zinc finger protein 292	bA393I2.3|KIAA0530|ZFP292|Zn-15|Zn-16	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34494
6.65179748243462e-178	-0.27923483528677	0.994	0.997	1.41224312349569e-173	PABPC1	Malignant cells	GSE199333_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34495
2.44760507171788e-177	-0.319288754519499	0.133	0.257	5.19651032776423e-173	HIST2H2BE	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34496
7.45510531743142e-177	-0.253124203002924	0.411	0.549	1.58279340994386e-172	HNRNPF	Malignant cells	GSE199333_pre	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34497
2.22604649898125e-175	-0.286585092712695	0.347	0.481	4.7261193219871e-171	PRDM2	Malignant cells	GSE199333_pre	ENSG00000116731	7799	PR/SET domain 2	HUMHOXY1|KMT8|KMT8A|MTB-ZF|RIZ|RIZ1|RIZ2	protein_coding	Q13029	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34498
2.17282435428226e-173	-0.27055309519718	0.329	0.466	4.61312338657666e-169	MAP3K2	Malignant cells	GSE199333_pre	ENSG00000169967	10746	mitogen-activated protein kinase kinase kinase 2	MEKK2|MEKK2B	protein_coding	Q9Y2U5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34499
1.39426047555228e-172	-0.274638482198548	0.286	0.418	2.96015441564505e-168	RNF145	Malignant cells	GSE199333_pre	ENSG00000145860	153830	ring finger protein 145	FLJ31951	protein_coding	Q96MT1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34500
6.25502952555669e-172	-0.296763515697756	0.388	0.516	1.32800531857094e-167	MAFG	Malignant cells	GSE199333_pre	ENSG00000197063	4097	MAF bZIP transcription factor G	MGC13090|MGC20149	protein_coding	O15525	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34501
1.32250750270018e-171	-0.272153623602668	0.597	0.703	2.80781567898276e-167	BSG	Malignant cells	GSE199333_pre	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34502
2.34883679540387e-171	-0.256249427532314	0.332	0.493	4.98681540032196e-167	HIST1H1C	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34503
1.51269137116131e-169	-0.255246443440687	0.324	0.458	3.21159505011259e-165	CHST11	Malignant cells	GSE199333_pre	ENSG00000171310	50515	carbohydrate sulfotransferase 11	C4ST|C4St-1|C4ST1|HSA269537	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34504
2.19392865665146e-169	-0.258645056321315	0.171	0.293	4.65792993093671e-165	R3HCC1	Malignant cells	GSE199333_pre	ENSG00000104679	203069	R3H domain and coiled-coil containing 1	DKFZp564N123	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34505
1.36146837111832e-165	-0.461309270924415	0.778	0.805	2.89053349872131e-161	IRF2BP2	Malignant cells	GSE199333_pre	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34506
2.96703730316924e-164	-0.282049845783823	0.48	0.588	6.29931689835861e-160	MIF	Malignant cells	GSE199333_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34507
2.15352412473414e-163	-0.335574908451373	0.337	0.464	4.57214706922305e-159	HIF1A	Malignant cells	GSE199333_pre	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34508
2.99863066136626e-163	-0.835878018647915	0.851	0.837	6.3663927571467e-159	ANXA1	Malignant cells	GSE199333_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34509
2.32458482657939e-161	-0.257256152964611	0.18	0.3	4.93532604531071e-157	DNMT1	Malignant cells	GSE199333_pre	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34510
6.85137513051198e-161	-0.320983178470765	0.154	0.271	1.454615453959e-156	CKS2	Malignant cells	GSE199333_pre	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34511
9.95885874683214e-161	-0.254754312158655	0.406	0.533	2.11436530053993e-156	BRD4	Malignant cells	GSE199333_pre	ENSG00000141867	23476	bromodomain containing 4	CAP|HUNK1|HUNKI|MCAP	protein_coding	O60885	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34512
1.88249843102343e-157	-0.30453976608578	0.681	0.813	3.99673241890585e-153	YBX3	Malignant cells	GSE199333_pre	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34513
3.82576329913487e-156	-0.264528438246944	0.367	0.493	8.12247806039325e-152	PARP1	Malignant cells	GSE199333_pre	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34514
2.08610251523595e-154	-0.331321611370003	0.297	0.416	4.42900425009744e-150	ARL4A	Malignant cells	GSE199333_pre	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34515
4.90635153896649e-154	0.255436407616159	0.79	0.69	1.04166749523798e-149	DNAJB6	Malignant cells	GSE199333_pre	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34516
6.37207388131526e-154	0.292530978177097	0.564	0.458	1.35285500574204e-149	ODC1	Malignant cells	GSE199333_pre	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34517
1.61070220946292e-147	-0.593298411847718	0.757	0.769	3.41968186091072e-143	RPL22L1	Malignant cells	GSE199333_pre	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34518
2.19708200594276e-147	-0.27464415534522	0.532	0.636	4.66462480681707e-143	GGNBP2	Malignant cells	GSE199333_pre	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34519
1.55913353715426e-144	-0.254689380005669	0.896	0.918	3.31019641273221e-140	HMGA1	Malignant cells	GSE199333_pre	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34520
3.46139308532237e-144	-0.267711221257707	0.381	0.51	7.34888365944792e-140	AKAP13	Malignant cells	GSE199333_pre	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34521
1.59602513115373e-141	-0.254298584775095	0.59	0.691	3.38852095595249e-137	LUC7L3	Malignant cells	GSE199333_pre	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34522
8.67559745759875e-138	-0.668288958277012	0.903	0.91	1.84191609622279e-133	S100A4	Malignant cells	GSE199333_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34523
3.80623426105861e-136	-0.276395270413984	0.757	0.813	8.08101595965354e-132	PTP4A2	Malignant cells	GSE199333_pre	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34524
3.31265559550103e-131	-0.377634568070262	0.427	0.522	7.03309909480824e-127	NASP	Malignant cells	GSE199333_pre	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34525
1.06200042276637e-130	-0.26662293746179	0.498	0.587	2.25473309757529e-126	NDUFS6	Malignant cells	GSE199333_pre	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34526
3.85351848980396e-129	-0.694047658176293	0.999	0.999	8.18140510570279e-125	FTH1	Malignant cells	GSE199333_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34527
4.75438721004752e-128	-0.492277997920072	0.71	0.769	1.00940394856519e-123	KLF6	Malignant cells	GSE199333_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34528
7.61231043718852e-126	-0.330169828584816	0.419	0.513	1.6161696289195e-121	CKLF	Malignant cells	GSE199333_pre	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34529
6.64684499728952e-125	-0.250085652593067	0.338	0.447	1.41119166137454e-120	BRAF	Malignant cells	GSE199333_pre	ENSG00000157764	673	B-Raf proto-oncogene, serine/threonine kinase	BRAF-1|BRAF1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34530
1.60654171110711e-122	-0.290901864764851	0.151	0.25	3.4108487068515e-118	GRASP	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34531
4.29777281643652e-121	-0.744672586795525	0.979	0.938	9.12460146657637e-117	NEAT1	Malignant cells	GSE199333_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34532
4.52537730322339e-121	-0.264889263843114	0.224	0.333	9.60782855247359e-117	RBM38	Malignant cells	GSE199333_pre	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34533
8.20942893343213e-118	-0.530098325269494	0.422	0.521	1.74294385685698e-113	COTL1	Malignant cells	GSE199333_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34534
1.77740259516021e-117	-0.64637260457846	0.439	0.532	3.77360344978465e-113	CLEC2B	Malignant cells	GSE199333_pre	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34535
7.21892962748284e-116	-0.300081939643529	0.275	0.381	1.53265094921088e-111	PLD4	Malignant cells	GSE199333_pre	ENSG00000166428	122618	phospholipase D family member 4	C14orf175	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34536
2.94143142249778e-115	-0.263824911462411	0.765	0.793	6.24495305310503e-111	TKT	Malignant cells	GSE199333_pre	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34537
1.7251285002059e-102	-0.359669660307254	0.604	0.672	3.66262031878715e-98	PRDX1	Malignant cells	GSE199333_pre	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34538
7.71672929004302e-102	-0.302187581955548	0.543	0.622	1.63833879556903e-97	CYC1	Malignant cells	GSE199333_pre	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34539
8.86432835368211e-101	-0.30379491549425	0.517	0.585	1.88198555277025e-96	PHPT1	Malignant cells	GSE199333_pre	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34540
2.70020690077206e-96	-0.251558102942361	0.207	0.298	5.73280927102916e-92	MCM7	Malignant cells	GSE199333_pre	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34541
9.1825240700731e-91	-0.312388102552793	0.344	0.427	1.94954168531722e-86	KLF10	Malignant cells	GSE199333_pre	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34542
9.57431127515374e-85	-0.290226622259696	0.562	0.625	2.03272202682789e-80	NUCKS1	Malignant cells	GSE199333_pre	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34543
1.99586538363675e-75	0.464921519102986	0.459	0.391	4.23742179599918e-71	STK17B	Malignant cells	GSE199333_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34544
1.44003557622594e-74	-0.409070931816295	0.655	0.705	3.05733953188529e-70	CD164	Malignant cells	GSE199333_pre	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34545
1.79384734291117e-68	-0.311905477075395	0.677	0.677	3.80851729373471e-64	GNA15	Malignant cells	GSE199333_pre	ENSG00000060558	2769	G protein subunit alpha 15	GNA16	protein_coding	P30679	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34546
6.45887215590096e-60	-0.635294131368255	0.566	0.556	1.37128314741933e-55	STMN1	Malignant cells	GSE199333_pre	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34547
1.83678661338979e-56	0.288500997107572	0.999	0.999	3.89968165888785e-52	H3F3B	Malignant cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34548
4.95108054259297e-56	-0.856185545200068	0.597	0.625	1.05116390999791e-51	LGALS1	Malignant cells	GSE199333_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34549
7.16201713892258e-55	-0.377849725011465	0.895	0.851	1.52056785876465e-50	LAPTM5	Malignant cells	GSE199333_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34550
3.56440357966844e-46	-0.312245242625882	0.427	0.485	7.56758523999407e-42	PSAP	Malignant cells	GSE199333_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34551
8.53966249542037e-35	-0.289746850807467	0.548	0.561	1.8130557444027e-30	RPS27L	Malignant cells	GSE199333_pre	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34552
1.95376274077986e-29	-0.293011238183329	0.373	0.401	4.14803367494973e-25	EIF4EBP1	Malignant cells	GSE199333_pre	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34553
2.37127459115808e-27	-0.316254159738893	0.477	0.525	5.03445308448771e-23	CTSS	Malignant cells	GSE199333_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34554
1.40646380216188e-13	-0.258421459636999	0.512	0.511	2.98606329836989e-09	DUT	Malignant cells	GSE199333_pre	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34555
9.61415614441778e-10	-0.250329853697114	0.992	0.976	2.04118149102134e-05	ACTB	Malignant cells	GSE199333_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34556
3.5863028265656e-08	0.601843498828043	0.624	0.674	0.000761407953108142	FOS	Malignant cells	GSE199333_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34557
3.93143346797569e-174	-2.20623239767096	0.477	0.947	8.34682639585918e-170	HLA-B	Erythrocytes	GSE199333_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34558
5.88166502612444e-111	-1.29243020017976	0.597	0.911	1.24873630169648e-106	HLA-C	Erythrocytes	GSE199333_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34559
3.33911541738166e-108	1.27621102204512	0.875	0.451	7.08927594264301e-104	SELENBP1	Erythrocytes	GSE199333_pre	ENSG00000143416	8991	selenium binding protein 1	hSBP|hSP56|LPSB	protein_coding	Q13228	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34560
1.96523351639059e-101	-1.16929886864958	0.981	0.998	4.17238727864886e-97	B2M	Erythrocytes	GSE199333_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34561
3.97849988530216e-89	-1.1979753600038	0.631	0.926	8.44675310648503e-85	HLA-A	Erythrocytes	GSE199333_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34562
3.99476403967638e-79	0.968739024087368	0.894	0.589	8.48128353263693e-75	UCP2	Erythrocytes	GSE199333_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34563
3.78794689063003e-77	-0.715610595759159	0.16	0.546	8.04219004349661e-73	HSPB1	Erythrocytes	GSE199333_pre	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34564
1.72309539197566e-76	-1.143872141606	0.515	0.835	3.65830382670353e-72	TXNIP	Erythrocytes	GSE199333_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34565
6.43280019764232e-74	1.05263659469146	0.884	0.614	1.36574780996144e-69	MYL4	Erythrocytes	GSE199333_pre	ENSG00000198336	4635	myosin light chain 4	ALC1|AMLC|GT1|PRO1957	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34566
6.24008614598042e-73	1.10603838425507	0.915	0.76	1.3248326896531e-68	TFRC	Erythrocytes	GSE199333_pre	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34567
9.34789702562694e-56	1.02448743787963	0.966	0.894	1.98465201751086e-51	SLC25A37	Erythrocytes	GSE199333_pre	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34568
3.91423117330051e-54	0.712313983134131	0.539	0.125	8.31030420403431e-50	RHD	Erythrocytes	GSE199333_pre	ENSG00000187010	6007	Rh blood group D antigen	CD240D|DIIIc|RH|Rh30a|Rh4|RhII|RhPI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34569
1.41108035316362e-50	-0.957936128211464	0.341	0.635	2.99586469780169e-46	HIST1H1E	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34570
2.77776343869399e-50	0.649930172296512	0.954	0.878	5.89746955669122e-46	CAT	Erythrocytes	GSE199333_pre	ENSG00000121691	847	catalase	NA	protein_coding	P04040	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34571
8.46715138771563e-50	1.13520293744081	0.373	0.034	1.79766091112591e-45	IGKC	Erythrocytes	GSE199333_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34572
1.56837404973364e-46	-0.624913606592111	0.228	0.536	3.3298149449895e-42	NFIA	Erythrocytes	GSE199333_pre	ENSG00000162599	4774	nuclear factor I A	KIAA1439|NFI-L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34573
2.47667443778117e-46	0.735284518304051	0.935	0.795	5.2582274988532e-42	ALAS2	Erythrocytes	GSE199333_pre	ENSG00000158578	212	5'-aminolevulinate synthase 2	ALAS-E|ASB	protein_coding	P22557	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34574
9.40094650632824e-44	0.754524444869149	0.916	0.816	1.99591495275855e-39	RHAG	Erythrocytes	GSE199333_pre	ENSG00000112077	6005	Rh associated glycoprotein	CD241|RH50A|SLC42A1	protein_coding	Q02094	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34575
7.34036428138998e-41	-0.369726389401917	0.092	0.333	1.55843274058191e-36	GRINA	Erythrocytes	GSE199333_pre	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34576
4.19944202383104e-40	0.602915260332839	0.48	0.162	8.91583536079567e-36	YPEL4	Erythrocytes	GSE199333_pre	ENSG00000166793	219539	yippee like 4	FLJ30213	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34577
1.10692731961505e-38	0.593714795094526	0.571	0.264	2.35011739227471e-34	MIR4435-2HG	Erythrocytes	GSE199333_pre	ENSG00000172965	541471	MIR4435-2 host gene	AGD2|AK001796|LINC00978|lncRNA-AWPPH|MIR4435-1HG|MORRBID	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34578
1.76559313548802e-38	-0.294702328170811	0.066	0.278	3.74853078595462e-34	C17orf99	Erythrocytes	GSE199333_pre	ENSG00000187997	100141515	chromosome 17 open reading frame 99	GLPG464|UNQ464	protein_coding	Q6UX52	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34579
6.43567288568522e-38	-0.550937628513786	0.227	0.49	1.36635771035983e-33	ACHE	Erythrocytes	GSE199333_pre	ENSG00000087085	43	acetylcholinesterase (Cartwright blood group)	YT	protein_coding	P22303	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34580
1.62477386015459e-36	0.708152040514364	0.891	0.793	3.44955738249422e-32	SNCA	Erythrocytes	GSE199333_pre	ENSG00000145335	6622	synuclein alpha	NACP|PARK1|PARK4|PD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34581
1.3888127026201e-35	0.613267939322996	0.293	0.03	2.94858824893274e-31	AC092490.1	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34582
1.84046705626273e-35	0.605525030227484	0.865	0.703	3.90749560715139e-31	EIF1AY	Erythrocytes	GSE199333_pre	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34583
2.25552841284297e-35	-0.888668681854905	0.87	0.958	4.7887123733069e-31	H1FX	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34584
6.89294289981077e-35	0.480338062864731	0.302	0.04	1.46344070705883e-30	AKR1C1	Erythrocytes	GSE199333_pre	ENSG00000187134	1645	aldo-keto reductase family 1 member C1	DD1|DDH|DDH1|HAKRC|MBAB	protein_coding	Q04828	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34585
7.22126444149751e-35	0.539472231245203	0.79	0.567	1.53314665357434e-30	STMP1	Erythrocytes	GSE199333_pre	ENSG00000243317	647087	short transmembrane mitochondrial protein 1	C7orf73|Mm47|PL-5283	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34586
1.05409889273305e-34	-0.644751109846816	0.725	0.878	2.23795735916154e-30	TXN	Erythrocytes	GSE199333_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34587
3.53898177194804e-34	-0.594509554716321	0.106	0.327	7.51361220002288e-30	IRF1	Erythrocytes	GSE199333_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34588
3.94394496089279e-34	0.690417999674717	0.833	0.65	8.37338954647149e-30	SPTA1	Erythrocytes	GSE199333_pre	ENSG00000163554	6708	spectrin alpha, erythrocytic 1	EL2	protein_coding	P02549	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34589
6.2156359126774e-34	-0.409047526061004	0.141	0.38	1.31964166062054e-29	B3GNT2	Erythrocytes	GSE199333_pre	ENSG00000170340	10678	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	B3GN-T1|B3GN-T2|B3GNT-2|B3GNT1|BETA3GNT	protein_coding	Q9NY97	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34590
9.01151074499542e-34	0.548254200572891	0.855	0.679	1.91323384626998e-29	FECH	Erythrocytes	GSE199333_pre	ENSG00000066926	2235	ferrochelatase	NA	protein_coding	P22830	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34591
1.60755875206285e-33	-0.596092488379818	0.18	0.43	3.41300798650464e-29	PDZK1IP1	Erythrocytes	GSE199333_pre	ENSG00000162366	10158	PDZK1 interacting protein 1	DD96|MAP17|SPAP	protein_coding	Q13113	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34592
2.70273541664637e-33	0.586869797216391	0.497	0.211	5.7381775630819e-29	FRYL	Erythrocytes	GSE199333_pre	ENSG00000075539	285527	FRY like transcription coactivator	AF4p12|DKFZp686E205|KIAA0826|MOR2	protein_coding	O94915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34593
2.7717920101788e-33	0.385100647283948	0.313	0.051	5.88479161681062e-29	MICALL2	Erythrocytes	GSE199333_pre	ENSG00000164877	79778	MICAL like 2	FLJ23471|JRAB|MGC46023|MICAL-L2	protein_coding	Q8IY33	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34594
8.32762009371674e-33	-1.08060446643512	0.527	0.721	1.768037022097e-28	HIST1H1C	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34595
1.15943889471177e-32	-0.929306014199706	0.397	0.618	2.46160471736256e-28	HIST1H1D	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34596
1.60433280384995e-32	0.5874337038022	0.605	0.329	3.40615897585384e-28	DAAM1	Erythrocytes	GSE199333_pre	ENSG00000100592	23002	dishevelled associated activator of morphogenesis 1	KIAA0666	protein_coding	Q9Y4D1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34597
3.04824477638404e-32	0.448541342827711	0.304	0.051	6.47172848474095e-28	CRNDE	Erythrocytes	GSE199333_pre	ENSG00000245694	101927480	uncharacterized LOC101927480	CRNDEP|LINC00180|LOC643911	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34598
3.21685159464938e-32	-0.968517179395879	0.65	0.806	6.8296976206001e-28	H1F0	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34599
4.22198116105964e-32	0.511341337094818	0.976	0.949	8.96368820304573e-28	YBX3	Erythrocytes	GSE199333_pre	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34600
5.96597675523096e-32	0.523775345626485	0.733	0.494	1.26663652490309e-27	MBOAT2	Erythrocytes	GSE199333_pre	ENSG00000143797	129642	membrane bound O-acyltransferase domain containing 2	FLJ14415|FLJ90298|LPLAT13|OACT2	protein_coding	Q6ZWT7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34601
6.1926357031464e-32	0.516115907084195	0.304	0.051	1.31475848613501e-27	SELENOP	Erythrocytes	GSE199333_pre	ENSG00000250722	6414	selenoprotein P	SELP|SeP|SEPP|SEPP1	protein_coding	P49908	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34602
7.06156061203269e-31	0.56631400350204	0.602	0.338	1.49923993354066e-26	AMMECR1	Erythrocytes	GSE199333_pre	ENSG00000101935	9949	AMMECR nuclear protein 1	NA	protein_coding	Q9Y4X0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34603
4.47774429044902e-30	0.67450817419283	0.801	0.582	9.50669890305232e-26	SH3BGRL3	Erythrocytes	GSE199333_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34604
1.11289636038387e-29	0.511944069460064	0.71	0.479	2.362790262731e-25	EIF2S2	Erythrocytes	GSE199333_pre	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34605
2.44651588850991e-29	-0.300946323869153	0.079	0.264	5.19419788289539e-25	ARRDC3	Erythrocytes	GSE199333_pre	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34606
1.49886904815254e-28	-0.389367120844974	0.159	0.376	3.18224887613265e-24	TAPBP	Erythrocytes	GSE199333_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34607
1.52455446466138e-28	-0.552415176336314	0.544	0.702	3.23678158392257e-24	PSME1	Erythrocytes	GSE199333_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34608
2.38457501811529e-28	-0.361375427201114	0.112	0.31	5.06269122096058e-24	FAM118A	Erythrocytes	GSE199333_pre	ENSG00000100376	55007	family with sequence similarity 118 member A	bK268H5.C22.4|C22orf8|FLJ20635	protein_coding	Q9NWS6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34609
3.09851278998399e-28	-1.09902962248345	0.403	0.637	6.57845250441502e-24	TMSB10	Erythrocytes	GSE199333_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34610
3.13690201991506e-28	0.367326972999363	0.386	0.131	6.65995667848166e-24	NPL	Erythrocytes	GSE199333_pre	ENSG00000135838	80896	N-acetylneuraminate pyruvate lyase	C1orf13|DHDPS1|NPL1	protein_coding	Q9BXD5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34611
6.05437829204751e-28	-0.56525806966927	0.994	1	1.28540505518461e-23	MT-CO3	Erythrocytes	GSE199333_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34612
5.40366117864094e-27	-0.504803970389219	0.988	0.998	1.14725130483726e-22	MT-ATP6	Erythrocytes	GSE199333_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34613
1.238518689255e-26	0.574124441485163	0.642	0.403	2.6294990291573e-22	TRAK2	Erythrocytes	GSE199333_pre	ENSG00000115993	66008	trafficking kinesin protein 2	ALS2CR3|CALS-C|GRIF-1|KIAA0549|MILT2|OIP98	protein_coding	O60296	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34614
1.52697675302763e-26	0.54029843306797	0.879	0.779	3.24192434435296e-22	ANK1	Erythrocytes	GSE199333_pre	ENSG00000029534	286	ankyrin 1	ANK|SPH1	protein_coding	P16157	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34615
5.76196678026091e-26	-0.573545192591087	0.778	0.894	1.22332316711719e-21	PFN1	Erythrocytes	GSE199333_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34616
1.49677945995073e-25	-0.410628664381465	0.492	0.681	3.1778124714214e-21	SSR4	Erythrocytes	GSE199333_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34617
9.1687048040128e-25	0.337472622634344	0.283	0.065	1.94660771693996e-20	HOXB5	Erythrocytes	GSE199333_pre	ENSG00000120075	3215	homeobox B5	HOX2|HOX2A	protein_coding	P09067	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34618
1.92267855804539e-24	0.406460054638452	0.887	0.728	4.08203884658616e-20	NDUFA4	Erythrocytes	GSE199333_pre	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34619
2.0589803546943e-24	0.577295932821984	0.802	0.698	4.37142119105147e-20	MPC2	Erythrocytes	GSE199333_pre	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34620
4.51808564720689e-24	0.455258374721738	0.963	0.909	9.59234763758494e-20	GUK1	Erythrocytes	GSE199333_pre	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34621
1.29483609906464e-23	-0.638885899742757	0.175	0.365	2.74906652192415e-19	CD63	Erythrocytes	GSE199333_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34622
3.30599791761085e-23	-0.378185325503759	0.182	0.384	7.0189641788796e-19	SUCO	Erythrocytes	GSE199333_pre	ENSG00000094975	51430	SUN domain containing ossification factor	C1orf9|CH1|OPT|SLP1	protein_coding	Q9UBS9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34623
4.50350315777294e-23	0.411661952391903	0.425	0.194	9.56138755426773e-19	RABGAP1L	Erythrocytes	GSE199333_pre	ENSG00000152061	9910	RAB GTPase activating protein 1 like	FLJ38519|HHL|KIAA0471|TBC1D18	protein_coding	Q5R372	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34624
2.10315607377159e-22	-0.337200775365053	0.163	0.361	4.46521066022445e-18	CCDC88A	Erythrocytes	GSE199333_pre	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34625
1.61610364667424e-21	0.377077658409442	0.554	0.335	3.43114965225407e-17	KEL	Erythrocytes	GSE199333_pre	ENSG00000276615	3792	Kell metallo-endopeptidase (Kell blood group)	CD238|ECE3	protein_coding	P23276	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34626
1.77146750272732e-21	-0.269968078887695	0.141	0.325	3.76100265504036e-17	ENDOD1	Erythrocytes	GSE199333_pre	ENSG00000149218	23052	endonuclease domain containing 1	KIAA0830	protein_coding	O94919	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34627
2.09780103685939e-21	-0.405111625337693	0.182	0.378	4.45384138135618e-17	PLIN2	Erythrocytes	GSE199333_pre	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34628
2.27579581038565e-21	0.601077418811571	0.807	0.703	4.83174208502978e-17	HNRNPH1	Erythrocytes	GSE199333_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34629
2.5646021886062e-21	0.615408590177766	0.731	0.608	5.44490690662983e-17	KLF3	Erythrocytes	GSE199333_pre	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34630
2.8669380800732e-21	0.367633667167476	0.505	0.268	6.0867962378034e-17	RSRC1	Erythrocytes	GSE199333_pre	ENSG00000174891	51319	arginine and serine rich coiled-coil 1	BM-011|MGC12197|SFRS21|SRrp53	protein_coding	Q96IZ7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34631
3.34997076314136e-21	-0.947400718585237	0.274	0.466	7.11232292722543e-17	MT2A	Erythrocytes	GSE199333_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34632
8.55371011935051e-21	-0.403670424713224	0.293	0.489	1.81603819543931e-16	VAMP2	Erythrocytes	GSE199333_pre	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34633
1.11658224250095e-20	-0.572326758324217	0.681	0.846	2.37061575905377e-16	HSP90AB1	Erythrocytes	GSE199333_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34634
1.15035447581671e-20	-0.869321060845807	0.23	0.416	2.44231758760646e-16	CYBA	Erythrocytes	GSE199333_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34635
1.63469703746635e-20	0.364814771018688	0.946	0.907	3.4706252802448e-16	GLRX5	Erythrocytes	GSE199333_pre	ENSG00000182512	51218	glutaredoxin 5	C14orf87|GRX5|PR01238	protein_coding	Q86SX6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34636
2.34646769008638e-20	-0.380865907003541	0.508	0.702	4.98178555282238e-16	EIF4G2	Erythrocytes	GSE199333_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34637
2.40681811470485e-20	0.420268626139713	0.776	0.597	5.10991553932987e-16	TOP1	Erythrocytes	GSE199333_pre	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34638
3.32192549514023e-20	-0.498029970576843	0.679	0.787	7.05278001873223e-16	PPP1R15A	Erythrocytes	GSE199333_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34639
3.37353006923102e-20	-0.251818071508943	0.112	0.278	7.16234168998439e-16	TMEM86B	Erythrocytes	GSE199333_pre	ENSG00000180089	255043	transmembrane protein 86B	MGC30208	protein_coding	Q8N661	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34640
3.59410296387781e-20	-0.367087201953993	0.246	0.449	7.63064000260899e-16	ARL6IP5	Erythrocytes	GSE199333_pre	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34641
6.23994874866473e-20	-0.32078816065181	0.146	0.323	1.32480351882901e-15	SERTAD2	Erythrocytes	GSE199333_pre	ENSG00000179833	9792	SERTA domain containing 2	KIAA0127|Sei-2|TRIP-Br2	protein_coding	Q14140	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34642
6.72293221276907e-20	-0.261023585203964	0.12	0.287	1.427345738093e-15	NEDD4L	Erythrocytes	GSE199333_pre	ENSG00000049759	23327	NEDD4 like E3 ubiquitin protein ligase	KIAA0439|NEDD4-2|RSP5	protein_coding	Q96PU5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34643
1.85788129361373e-19	0.552246457568063	0.716	0.597	3.94446777447131e-15	ABHD5	Erythrocytes	GSE199333_pre	ENSG00000011198	51099	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	CGI-58|NCIE2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34644
4.06558018748164e-19	0.321882422903452	0.357	0.156	8.63163329604227e-15	RIPOR3	Erythrocytes	GSE199333_pre	ENSG00000042062	140876	RIPOR family member 3	C20orf175|C20orf176|dJ530I15.2|dJ530I15.3|FAM65C	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34645
4.76798059310934e-19	-0.325064924758679	0.139	0.306	1.01228995972304e-14	EPM2AIP1	Erythrocytes	GSE199333_pre	ENSG00000178567	9852	EPM2A interacting protein 1	FLJ11207|KIAA0766	protein_coding	Q7L775	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34646
5.72213862787257e-19	0.325218810903468	0.273	0.089	1.21486725208363e-14	CBWD1	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34647
1.06856864109048e-18	-0.366889970542872	0.183	0.363	2.2686780818992e-14	SPN	Erythrocytes	GSE199333_pre	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34648
1.36386361475594e-18	0.365477802429462	0.563	0.352	2.89561884048834e-14	SVIP	Erythrocytes	GSE199333_pre	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34649
1.69392981901825e-18	0.410512113756714	0.409	0.203	3.59638239875765e-14	DENND4A	Erythrocytes	GSE199333_pre	ENSG00000174485	10260	DENN domain containing 4A	IRLB|MYCPBP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34650
1.82378098160151e-18	0.341926088291442	0.34	0.143	3.87206940203817e-14	FANCI	Erythrocytes	GSE199333_pre	ENSG00000140525	55215	FA complementation group I	FLJ10719|KIAA1794	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34651
3.14346082202431e-18	0.385116078540265	0.829	0.694	6.67388167123982e-14	TFDP1	Erythrocytes	GSE199333_pre	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34652
3.50404341991711e-18	0.408011425592932	0.632	0.464	7.43943458482602e-14	COX7A2L	Erythrocytes	GSE199333_pre	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34653
3.96410552248786e-18	-0.324806947263833	0.977	0.994	8.41619243479397e-14	MT-CYB	Erythrocytes	GSE199333_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34654
4.79420850599898e-18	-0.617292022179856	0.212	0.382	1.01785840790864e-13	IFI27	Erythrocytes	GSE199333_pre	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34655
5.1576827520344e-18	0.42093304438588	0.566	0.373	1.09502762508442e-13	GSTO1	Erythrocytes	GSE199333_pre	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34656
5.17424074322121e-18	0.330547794706998	0.447	0.238	1.0985430521933e-13	ARF4	Erythrocytes	GSE199333_pre	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34657
6.18583283502851e-18	-0.472981656977341	0.146	0.306	1.3133141692049e-13	PRSS57	Erythrocytes	GSE199333_pre	ENSG00000185198	400668	serine protease 57	PRSSL1|UNQ782	protein_coding	Q6UWY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34658
9.47647072342076e-18	-0.335783477830013	0.21	0.392	2.01194949928946e-13	ZNF800	Erythrocytes	GSE199333_pre	ENSG00000048405	168850	zinc finger protein 800	NA	protein_coding	Q2TB10	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34659
1.21000890038749e-17	0.338548413154512	0.295	0.114	2.56896989641268e-13	ABCA7	Erythrocytes	GSE199333_pre	ENSG00000064687	10347	ATP binding cassette subfamily A member 7	ABCX	protein_coding	Q8IZY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34660
1.33496109664617e-17	-0.418720861592555	0.198	0.365	2.83425590428948e-13	C3orf58	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34661
1.79118422006347e-17	0.358206603412256	0.41	0.217	3.80286321761675e-13	LRRCC1	Erythrocytes	GSE199333_pre	ENSG00000133739	85444	leucine rich repeat and coiled-coil centrosomal protein 1	CLERC|KIAA1764|VFL1	protein_coding	Q9C099	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34662
2.91662798704309e-17	-0.455283169401933	0.96	0.977	6.19229287929119e-13	H3F3B	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34663
3.53790030809477e-17	0.337962031377625	0.927	0.861	7.51131614411601e-13	UROD	Erythrocytes	GSE199333_pre	ENSG00000126088	7389	uroporphyrinogen decarboxylase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34664
4.00594240059636e-17	-0.946338550106799	0.163	0.323	8.50501631070614e-13	HLA-DRA	Erythrocytes	GSE199333_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34665
4.32935240869682e-17	0.45824748867291	0.784	0.665	9.19164809890421e-13	ATP5IF1	Erythrocytes	GSE199333_pre	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34666
6.2608169855514e-17	0.347765339205848	0.513	0.317	1.32923405420242e-12	C9orf40	Erythrocytes	GSE199333_pre	ENSG00000135045	55071	chromosome 9 open reading frame 40	FLJ10110	protein_coding	Q8IXQ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34667
9.36102684797237e-17	-0.847026543008975	0.448	0.629	1.98743961009301e-12	ACTG1	Erythrocytes	GSE199333_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34668
1.29279255612316e-16	0.41180399915088	0.751	0.61	2.74472787590508e-12	NUDT4	Erythrocytes	GSE199333_pre	ENSG00000173598	11163	nudix hydrolase 4	DIPP2|DIPP2alpha|DIPP2beta|HDCMB47P|KIAA0487	protein_coding	Q9NZJ9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34669
1.62414036933819e-16	-0.283399132643105	0.107	0.251	3.44821241814191e-12	PLP2	Erythrocytes	GSE199333_pre	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34670
1.73836295025371e-16	0.432152025988107	0.891	0.717	3.69071837968366e-12	HEMGN	Erythrocytes	GSE199333_pre	ENSG00000136929	55363	hemogen	CT155|EDAG|NDR	protein_coding	Q9BXL5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34671
2.33460932225517e-16	0.675715127284883	0.983	0.971	4.95660905207994e-12	HBD	Erythrocytes	GSE199333_pre	ENSG00000223609	3045	hemoglobin subunit delta	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34672
2.84268151530579e-16	-0.375421634486406	0.267	0.432	6.03529712514573e-12	ACKR1	Erythrocytes	GSE199333_pre	ENSG00000213088	2532	atypical chemokine receptor 1 (Duffy blood group)	CCBP1|CD234|DARC|Dfy|FY|GPD	protein_coding	Q16570	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34673
3.08422563482348e-16	-0.312346534214117	0.259	0.437	6.54811944529372e-12	C20orf27	Erythrocytes	GSE199333_pre	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34674
3.25642510492685e-16	0.348279841066333	0.647	0.473	6.9137161402702e-12	NDFIP1	Erythrocytes	GSE199333_pre	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34675
6.21034968381124e-16	0.371547475105048	0.478	0.291	1.31851934136996e-11	CHST2	Erythrocytes	GSE199333_pre	ENSG00000175040	9435	carbohydrate sulfotransferase 2	C6ST	protein_coding	Q9Y4C5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34676
6.37152437444161e-16	-0.408882635859241	0.244	0.405	1.3527383399377e-11	PSME2	Erythrocytes	GSE199333_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34677
8.49456139908733e-16	-0.789328597361667	0.535	0.656	1.80348033064023e-11	HES6	Erythrocytes	GSE199333_pre	ENSG00000144485	55502	hes family bHLH transcription factor 6	bHLHb41	protein_coding	Q96HZ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34678
1.21624341259524e-15	0.447610262131035	0.824	0.711	2.58220638928095e-11	WNK1	Erythrocytes	GSE199333_pre	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34679
1.30381272107574e-15	-0.529848120553343	0.438	0.582	2.76812478811591e-11	GADD45A	Erythrocytes	GSE199333_pre	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34680
1.55596014614729e-15	0.340984603928398	0.511	0.323	3.30345898628531e-11	LPCAT3	Erythrocytes	GSE199333_pre	ENSG00000111684	10162	lysophosphatidylcholine acyltransferase 3	C3F|LPLAT12|MBOAT5|nessy|OACT5	protein_coding	Q6P1A2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34681
1.79043456863634e-15	0.34729854136474	0.485	0.306	3.80127163267182e-11	PICALM	Erythrocytes	GSE199333_pre	ENSG00000073921	8301	phosphatidylinositol binding clathrin assembly protein	CALM|CLTH	protein_coding	Q13492	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34682
1.82387092857094e-15	0.286489230552687	0.353	0.165	3.87226036844896e-11	NFE2L2	Erythrocytes	GSE199333_pre	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34683
1.95152273849381e-15	-0.375665115939553	0.931	0.956	4.1432779260962e-11	RPS26	Erythrocytes	GSE199333_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34684
2.58535133427704e-15	-0.39112454561899	0.431	0.605	5.48895941780358e-11	SF1	Erythrocytes	GSE199333_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34685
3.41287314121363e-15	-0.293095691062392	0.317	0.496	7.24587096611065e-11	CDV3	Erythrocytes	GSE199333_pre	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34686
3.48265549511718e-15	-0.297414069234802	0.231	0.395	7.39402588168328e-11	SLC29A1	Erythrocytes	GSE199333_pre	ENSG00000112759	2030	solute carrier family 29 member 1 (Augustine blood group)	ENT1	protein_coding	Q99808	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34687
4.4215239225743e-15	-0.333996172226444	0.298	0.466	9.3873374400175e-11	XPO1	Erythrocytes	GSE199333_pre	ENSG00000082898	7514	exportin 1	CRM-1|CRM1|emb	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34688
5.04262361195644e-15	-0.310655910897248	0.242	0.413	1.07059941905447e-10	HLA-E	Erythrocytes	GSE199333_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34689
8.07876246827745e-15	0.320011710096643	0.499	0.325	1.71520205963999e-10	NAA50	Erythrocytes	GSE199333_pre	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34690
8.51700631469452e-15	0.35642846693783	0.569	0.388	1.80824561067279e-10	DCUN1D1	Erythrocytes	GSE199333_pre	ENSG00000043093	54165	defective in cullin neddylation 1 domain containing 1	DCUN1L1|RP42|SCCRO|SCRO|Tes3	protein_coding	Q96GG9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34691
1.1105684244908e-14	-0.334116531627583	0.193	0.346	2.35784782203642e-10	SRSF8	Erythrocytes	GSE199333_pre	ENSG00000263465	10929	serine and arginine rich splicing factor 8	SFRS2B|SRP46	protein_coding	Q9BRL6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34692
1.11495326377739e-14	0.446248109280511	0.423	0.247	2.36715727432577e-10	SCPEP1	Erythrocytes	GSE199333_pre	ENSG00000121064	59342	serine carboxypeptidase 1	RISC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34693
1.34775025198379e-14	-0.84179556029182	0.24	0.401	2.86140855998678e-10	CD74	Erythrocytes	GSE199333_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34694
1.49180176077088e-14	-0.511018766425648	0.55	0.677	3.16724431829265e-10	PIM1	Erythrocytes	GSE199333_pre	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34695
1.89807743441993e-14	-0.386954773831318	0.243	0.399	4.02980820101695e-10	ARHGDIB	Erythrocytes	GSE199333_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34696
4.26142816588116e-14	-0.319861141816792	0.845	0.89	9.0474381389823e-10	FBXO7	Erythrocytes	GSE199333_pre	ENSG00000100225	25793	F-box protein 7	Fbx|FBX7|PARK15	protein_coding	Q9Y3I1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34697
4.7310503441546e-14	-0.287986221194968	0.492	0.671	1.00444929856746e-09	MBNL1	Erythrocytes	GSE199333_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34698
5.02497889305614e-14	0.361028886843996	0.542	0.373	1.06685326878475e-09	JAZF1	Erythrocytes	GSE199333_pre	ENSG00000153814	221895	JAZF zinc finger 1	DKFZp761K2222|TIP27|ZNF802	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34699
6.74792428132579e-14	0.373515284509576	0.87	0.837	1.43265180416828e-09	HMGN2	Erythrocytes	GSE199333_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34700
8.87287964199584e-14	0.318665122230192	0.606	0.439	1.88380107679214e-09	RPIA	Erythrocytes	GSE199333_pre	ENSG00000153574	22934	ribose 5-phosphate isomerase A	NA	protein_coding	P49247	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34701
1.00235685732119e-13	0.308677083833293	0.423	0.259	2.12810384377862e-09	SNRNP25	Erythrocytes	GSE199333_pre	ENSG00000161981	79622	small nuclear ribonucleoprotein U11/U12 subunit 25	C16orf33|U11/U12-25K	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34702
1.11562228490353e-13	0.274054440060283	0.359	0.186	2.36857767307869e-09	FAXDC2	Erythrocytes	GSE199333_pre	ENSG00000170271	10826	fatty acid hydroxylase domain containing 2	C5orf4|FLJ13758	protein_coding	Q96IV6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34703
1.16486527145728e-13	0.32842513891136	0.999	0.962	2.47312545783095e-09	HBA1	Erythrocytes	GSE199333_pre	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34704
1.46736577765901e-13	0.316730516181196	0.37	0.209	3.11536428254784e-09	TMEM106C	Erythrocytes	GSE199333_pre	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34705
1.97980760847128e-13	-0.718357383071746	0.77	0.85	4.20332953354537e-09	GAPDH	Erythrocytes	GSE199333_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34706
2.68915167702023e-13	0.253864792209901	0.494	0.316	5.70933792548166e-09	C1D	Erythrocytes	GSE199333_pre	ENSG00000197223	10438	C1D nuclear receptor corepressor	LRP1|Rrp47|SUN-CoR|SUNCOR	protein_coding	Q13901	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34707
2.70319385438421e-13	-0.366340866631335	0.379	0.54	5.73915087224311e-09	IRF2BP2	Erythrocytes	GSE199333_pre	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34708
2.74823858664556e-13	0.338180070630096	0.639	0.483	5.83478534330719e-09	RGS10	Erythrocytes	GSE199333_pre	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34709
2.8720169819641e-13	0.262982091927125	0.528	0.34	6.09757925440798e-09	NFIX	Erythrocytes	GSE199333_pre	ENSG00000008441	4784	nuclear factor I X	NF1A	protein_coding	Q14938	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34710
2.89562868974805e-13	-0.262692027003456	0.464	0.644	6.14770927120408e-09	ODC1	Erythrocytes	GSE199333_pre	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34711
4.6100299188553e-13	-0.357838406624355	0.451	0.605	9.78755452072168e-09	CCNL1	Erythrocytes	GSE199333_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34712
4.83514854242722e-13	0.285096202503317	0.895	0.833	1.02655038704272e-08	FKBP8	Erythrocytes	GSE199333_pre	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34713
4.98764034711103e-13	0.316953755161786	0.735	0.633	1.05892592209514e-08	CYTOR	Erythrocytes	GSE199333_pre	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34714
5.38497185145792e-13	0.322442519296053	0.446	0.281	1.14328337378303e-08	WRN	Erythrocytes	GSE199333_pre	ENSG00000165392	7486	WRN RecQ like helicase	RECQ3|RECQL2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34715
6.00115165413244e-13	-0.260904119720746	0.159	0.302	1.27410450768886e-08	KLF10	Erythrocytes	GSE199333_pre	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34716
7.52774201548588e-13	0.29333099203157	0.522	0.361	1.59821490730781e-08	UBE2E3	Erythrocytes	GSE199333_pre	ENSG00000170035	10477	ubiquitin conjugating enzyme E2 E3	UbcH9	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34717
9.73051245907315e-13	0.26647877420256	0.421	0.253	2.06588510018582e-08	TMEM256	Erythrocytes	GSE199333_pre	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34718
1.02469693902347e-12	-0.257976083688095	0.147	0.278	2.17553407124072e-08	BZW2	Erythrocytes	GSE199333_pre	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34719
1.03871803637795e-12	-0.345829952191374	0.224	0.359	2.20530226303403e-08	UBE2L6	Erythrocytes	GSE199333_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34720
1.05968876510989e-12	0.264483426230002	0.361	0.194	2.24982521720481e-08	CENPK	Erythrocytes	GSE199333_pre	ENSG00000123219	64105	centromere protein K	CENP-K|FKSG14|SOLT	protein_coding	Q9BS16	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34721
1.17959188739803e-12	0.291392192080088	0.44	0.27	2.50439153613476e-08	PPP1R12A	Erythrocytes	GSE199333_pre	ENSG00000058272	4659	protein phosphatase 1 regulatory subunit 12A	M130|MBS|MYPT1	protein_coding	O14974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34722
1.26755581215416e-12	0.352755226245546	0.432	0.264	2.69114774478449e-08	ARHGEF12	Erythrocytes	GSE199333_pre	ENSG00000196914	23365	Rho guanine nucleotide exchange factor 12	KIAA0382|LARG	protein_coding	Q9NZN5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34723
1.48168008499837e-12	0.326837656184255	0.669	0.532	3.14575498846003e-08	TFDP2	Erythrocytes	GSE199333_pre	ENSG00000114126	7029	transcription factor Dp-2	Dp-2	protein_coding	Q14188	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34724
1.49485950136481e-12	-0.267587617054376	0.24	0.388	3.17373620734763e-08	SLC43A1	Erythrocytes	GSE199333_pre	ENSG00000149150	8501	solute carrier family 43 member 1	PB39|POV1|R00504	protein_coding	O75387	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34725
1.86189270813949e-12	0.268324726881431	0.299	0.148	3.95298440865096e-08	PAN3	Erythrocytes	GSE199333_pre	ENSG00000152520	255967	poly(A) specific ribonuclease subunit PAN3	NA	protein_coding	Q58A45	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34726
1.96830101893846e-12	-0.343580080265813	0.719	0.776	4.17889989330825e-08	COX5B	Erythrocytes	GSE199333_pre	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34727
2.02259920138676e-12	-0.393006244392228	0.148	0.274	4.29418036446424e-08	AC084033.3	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34728
2.25788050164745e-12	0.377392296973705	0.732	0.652	4.79370609304771e-08	TOMM7	Erythrocytes	GSE199333_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34729
2.65638812501815e-12	-0.343880842302875	0.501	0.622	5.63977762822603e-08	TOMM20	Erythrocytes	GSE199333_pre	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34730
2.70552520649472e-12	0.309588027782597	0.366	0.207	5.74410056590894e-08	TIMM10	Erythrocytes	GSE199333_pre	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34731
2.83857973325307e-12	0.279030806070467	0.46	0.287	6.02658863166959e-08	TNS1	Erythrocytes	GSE199333_pre	ENSG00000079308	7145	tensin 1	DKFZp586K0617|MXRA6|PPP1R155|TNS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34732
2.96192792715965e-12	0.448395818799899	0.579	0.443	6.28846918215265e-08	TYMS	Erythrocytes	GSE199333_pre	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34733
3.03526774595926e-12	0.307098697287387	0.771	0.681	6.44417695144611e-08	FIS1	Erythrocytes	GSE199333_pre	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34734
3.53622508091834e-12	0.325198738764271	0.258	0.118	7.50775946929772e-08	LINC01133	Erythrocytes	GSE199333_pre	ENSG00000224259	NA	NA	lncRNA-PAGBC	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34735
3.69910945488349e-12	-0.257156633142716	0.143	0.268	7.85357928366313e-08	PRDX4	Erythrocytes	GSE199333_pre	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34736
4.22521454021682e-12	0.286779414682636	0.601	0.439	8.97055299033433e-08	CDC27	Erythrocytes	GSE199333_pre	ENSG00000004897	996	cell division cycle 27	ANAPC3|APC3|D0S1430E|D17S978E|NUC2	protein_coding	P30260	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34737
4.32654324659847e-12	-0.317763609183622	0.228	0.375	9.18568396685322e-08	ZBTB43	Erythrocytes	GSE199333_pre	ENSG00000169155	23099	zinc finger and BTB domain containing 43	FLJ22470|KIAA0414|ZBTB22B|ZNF-X|ZNF297B	protein_coding	O43298	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34738
4.33407260927193e-12	0.447194341963245	0.876	0.76	9.20166955674523e-08	SLC4A1	Erythrocytes	GSE199333_pre	ENSG00000004939	6521	solute carrier family 4 member 1 (Diego blood group)	AE1|CD233|DI|EPB3|FR|RTA1A|SW|WD|WR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34739
5.12165286536741e-12	-0.351975329391269	0.634	0.724	1.08737811984616e-07	RBM3	Erythrocytes	GSE199333_pre	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34740
5.23733984413078e-12	-0.380506540224205	0.342	0.481	1.11193962230741e-07	PNRC1	Erythrocytes	GSE199333_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34741
6.75576356205979e-12	-0.638652348921983	0.746	0.776	1.43431616186091e-07	HBM	Erythrocytes	GSE199333_pre	ENSG00000206177	3042	hemoglobin subunit mu	HBAP2|HBK	protein_coding	Q6B0K9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34742
7.5855024766745e-12	-0.310503357674388	0.217	0.35	1.61047803082276e-07	BLVRA	Erythrocytes	GSE199333_pre	ENSG00000106605	644	biliverdin reductase A	BLVR	protein_coding	P53004	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34743
7.70057225372883e-12	0.363553338866233	0.749	0.625	1.63490849518917e-07	BNIP3L	Erythrocytes	GSE199333_pre	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34744
8.73684123469996e-12	0.274874579180678	0.308	0.16	1.85491876253915e-07	XRN1	Erythrocytes	GSE199333_pre	ENSG00000114127	54464	5'-3' exoribonuclease 1	SEP1	protein_coding	Q8IZH2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34745
9.34057593887056e-12	0.417011351537176	0.587	0.432	1.98309767758161e-07	TSPO2	Erythrocytes	GSE199333_pre	ENSG00000112212	222642	translocator protein 2	BZRPL1|dJ34B21.2	protein_coding	Q5TGU0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34746
9.86732042942815e-12	0.419218277665432	0.669	0.536	2.09493080037189e-07	PCLAF	Erythrocytes	GSE199333_pre	ENSG00000166803	9768	PCNA clamp associated factor	KIAA0101|NS5ATP9|OEATC-1|p15(PAF)|PAF15	protein_coding	Q15004	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34747
1.04135902880425e-11	0.327241148117698	0.687	0.572	2.21090935405431e-07	PNP	Erythrocytes	GSE199333_pre	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34748
1.05176310551575e-11	-0.311367075029119	0.215	0.359	2.2329982493205e-07	CD44	Erythrocytes	GSE199333_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34749
1.10473779583314e-11	-0.263111496125705	0.397	0.549	2.34546881433333e-07	C9orf78	Erythrocytes	GSE199333_pre	ENSG00000136819	51759	chromosome 9 open reading frame 78	CSU2|HCA59|HSPC220	protein_coding	Q9NZ63	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34750
1.13743679230824e-11	0.399011376336375	0.455	0.308	2.41489205374961e-07	TK1	Erythrocytes	GSE199333_pre	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34751
1.17020790825245e-11	0.285594096991635	0.421	0.26	2.48446841001077e-07	USP9X	Erythrocytes	GSE199333_pre	ENSG00000124486	8239	ubiquitin specific peptidase 9 X-linked	DFFRX|FAF|MRX99	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34752
1.3193967092812e-11	0.272029576611193	0.492	0.331	2.80121115347492e-07	TMBIM1	Erythrocytes	GSE199333_pre	ENSG00000135926	64114	transmembrane BAX inhibitor motif containing 1	LFG3|PP1201|RECS1	protein_coding	Q969X1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34753
1.39956424650148e-11	0.276775023231747	0.859	0.779	2.97141485174729e-07	AP2S1	Erythrocytes	GSE199333_pre	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34754
1.40226121090141e-11	0.258109196854639	0.291	0.141	2.97714077686477e-07	STK17B	Erythrocytes	GSE199333_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34755
1.43511511911567e-11	0.32563535049966	0.767	0.648	3.04689290939448e-07	NUCKS1	Erythrocytes	GSE199333_pre	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34756
1.48066581526283e-11	-0.349893554651473	0.461	0.586	3.14360159238451e-07	GCLM	Erythrocytes	GSE199333_pre	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34757
2.21896615587083e-11	0.290158555767152	0.52	0.375	4.71108704552936e-07	PDCD10	Erythrocytes	GSE199333_pre	ENSG00000114209	11235	programmed cell death 10	CCM3|TFAR15	protein_coding	Q9BUL8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34758
2.40854440157985e-11	-0.292861174999997	0.27	0.413	5.11358061899417e-07	NCEH1	Erythrocytes	GSE199333_pre	ENSG00000144959	57552	neutral cholesterol ester hydrolase 1	AADACL1|KIAA1363|NCEH	protein_coding	Q6PIU2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34759
2.80466665406852e-11	-0.33091795209434	0.185	0.327	5.95458777325287e-07	NFKBIA	Erythrocytes	GSE199333_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34760
3.08019363479052e-11	0.453252845502099	0.973	0.924	6.53955910602375e-07	CA1	Erythrocytes	GSE199333_pre	ENSG00000133742	759	carbonic anhydrase 1	Car1	protein_coding	P00915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34761
3.50921316201208e-11	-0.298505890770166	0.309	0.456	7.45041046426784e-07	ITGA4	Erythrocytes	GSE199333_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34762
3.61360462849626e-11	-0.252472128080496	0.311	0.46	7.6720439867604e-07	CWC15	Erythrocytes	GSE199333_pre	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34763
3.78636143316455e-11	0.263792572878786	0.857	0.684	8.03882395875165e-07	GYPB	Erythrocytes	GSE199333_pre	ENSG00000250361	2994	glycophorin B (MNS blood group)	CD235b|GPB|MNS|SS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34764
4.01440606861332e-11	-0.287808825207485	0.357	0.494	8.52298552427294e-07	DAZAP2	Erythrocytes	GSE199333_pre	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34765
4.13645797061707e-11	0.294026686146413	0.557	0.413	8.7821139174171e-07	BMP2K	Erythrocytes	GSE199333_pre	ENSG00000138756	55589	BMP2 inducible kinase	BIKe|DKFZp434K0614	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34766
4.43120586089146e-11	-0.26539152973123	0.994	0.998	9.40789316325865e-07	MT-CO2	Erythrocytes	GSE199333_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34767
4.92854411644924e-11	0.296057297770069	0.359	0.217	1.04637920136334e-06	RAD51AP1	Erythrocytes	GSE199333_pre	ENSG00000111247	10635	RAD51 associated protein 1	PIR51	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34768
5.12213387122812e-11	0.263327637075988	0.575	0.437	1.08748024220044e-06	ATP1B3	Erythrocytes	GSE199333_pre	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34769
6.9681744439971e-11	0.335197516831268	0.37	0.228	1.47941311620502e-06	RICTOR	Erythrocytes	GSE199333_pre	ENSG00000164327	253260	RPTOR independent companion of MTOR complex 2	AVO3|KIAA1999|MGC39830|PIA	protein_coding	Q6R327	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34770
7.12776799776384e-11	-0.575127159990287	0.445	0.584	1.51329642360524e-06	GLUL	Erythrocytes	GSE199333_pre	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34771
8.90188679647874e-11	0.48013805953636	0.815	0.728	1.8899595857604e-06	NEAT1	Erythrocytes	GSE199333_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34772
9.91426274579818e-11	0.272975445003128	0.51	0.352	2.10489712356041e-06	GFI1B	Erythrocytes	GSE199333_pre	ENSG00000165702	8328	growth factor independent 1B transcriptional repressor	ZNF163B	protein_coding	Q5VTD9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34773
1.04852246287911e-10	0.304693056133479	0.371	0.234	2.22611804093863e-06	FAM13A	Erythrocytes	GSE199333_pre	ENSG00000138640	10144	family with sequence similarity 13 member A	ARHGAP48|FAM13A1|KIAA0914	protein_coding	O94988	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34774
1.1844766526034e-10	0.308166229715008	0.995	0.914	2.51476238114228e-06	HBA2	Erythrocytes	GSE199333_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34775
1.6927778297639e-10	0.361569432556994	0.607	0.489	3.59393661037173e-06	BSDC1	Erythrocytes	GSE199333_pre	ENSG00000160058	55108	BSD domain containing 1	FLJ10276|RP4-811H24.7	protein_coding	Q9NW68	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34776
1.99836945846057e-10	0.327663702302581	0.524	0.384	4.24273819725764e-06	TSPAN5	Erythrocytes	GSE199333_pre	ENSG00000168785	10098	tetraspanin 5	NET-4|TM4SF9|Tspan-5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34777
2.10878022390758e-10	-0.403337832090594	0.464	0.58	4.47715129337818e-06	LMNA	Erythrocytes	GSE199333_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34778
2.8731613219285e-10	-0.304484132685605	0.451	0.57	6.10000880258639e-06	TLN1	Erythrocytes	GSE199333_pre	ENSG00000137076	7094	talin 1	ILWEQ|TLN	protein_coding	Q9Y490	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34779
2.91046576274483e-10	0.425732850695483	0.532	0.399	6.17920986088356e-06	RRM2	Erythrocytes	GSE199333_pre	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34780
4.94390454892529e-10	0.281835907644509	0.446	0.312	1.04964037478233e-05	ZWINT	Erythrocytes	GSE199333_pre	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34781
5.44626245513086e-10	0.275215521360199	0.418	0.281	1.15629598184883e-05	YEATS4	Erythrocytes	GSE199333_pre	ENSG00000127337	8089	YEATS domain containing 4	GAS41|NuBI-1|YAF9	protein_coding	O95619	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34782
5.61750006261571e-10	0.406479157968868	0.68	0.576	1.19265143829394e-05	NUSAP1	Erythrocytes	GSE199333_pre	ENSG00000137804	51203	nucleolar and spindle associated protein 1	ANKT|BM037|FLJ13421|LNP|PRO0310p1|Q0310|SAPL	protein_coding	Q9BXS6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34783
5.78855705431087e-10	0.339098459196048	0.702	0.584	1.22896854820074e-05	KLF1	Erythrocytes	GSE199333_pre	ENSG00000105610	10661	KLF transcription factor 1	EKLF	protein_coding	Q13351	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34784
6.16807592090639e-10	-0.267226006529442	0.625	0.736	1.30954419876763e-05	PTP4A2	Erythrocytes	GSE199333_pre	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34785
6.58179468768899e-10	-0.265915116481656	0.267	0.39	1.39738083014325e-05	PPME1	Erythrocytes	GSE199333_pre	ENSG00000214517	51400	protein phosphatase methylesterase 1	ABDH19|PME-1	protein_coding	Q9Y570	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34786
7.53505736357724e-10	0.263621122888255	0.526	0.384	1.59976802886108e-05	PSMG3	Erythrocytes	GSE199333_pre	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34787
7.73306134563766e-10	0.449003218579048	0.486	0.361	1.64180625429233e-05	RSRP1	Erythrocytes	GSE199333_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34788
8.38194335787038e-10	0.348162525090839	0.529	0.388	1.77957039430946e-05	ATAD2	Erythrocytes	GSE199333_pre	ENSG00000156802	29028	ATPase family AAA domain containing 2	ANCCA|CT137|DKFZp667N1320|MGC29843|MGC5254|PRO2000	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34789
9.4440563505992e-10	-0.342091119903784	0.171	0.289	2.00506760379572e-05	LAPTM5	Erythrocytes	GSE199333_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34790
9.56093282091007e-10	0.482637156579382	0.295	0.163	2.02988164720742e-05	AKR1C3	Erythrocytes	GSE199333_pre	ENSG00000196139	8644	aldo-keto reductase family 1 member C3	DDX|HAKRB|HSD17B5|KIAA0119|PGFS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34791
1.01876644474208e-09	0.289154327527927	0.864	0.787	2.16294303883191e-05	EIF2AK1	Erythrocytes	GSE199333_pre	ENSG00000086232	27102	eukaryotic translation initiation factor 2 alpha kinase 1	HCR|hHRI|HRI|KIAA1369	protein_coding	Q9BQI3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34792
1.19056232607554e-09	0.272099519377526	0.47	0.346	2.52768287449097e-05	HAT1	Erythrocytes	GSE199333_pre	ENSG00000128708	8520	histone acetyltransferase 1	KAT1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34793
1.23998711004161e-09	0.258799996808551	0.302	0.165	2.63261663332934e-05	LPIN2	Erythrocytes	GSE199333_pre	ENSG00000101577	9663	lipin 2	KIAA0249	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34794
1.25619664791182e-09	0.269781210992222	0.295	0.169	2.66703110318157e-05	ADI1	Erythrocytes	GSE199333_pre	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34795
1.30488653028421e-09	0.288769965902929	0.936	0.911	2.77040459244641e-05	JUND	Erythrocytes	GSE199333_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34796
1.35546774155892e-09	0.283608408510746	0.921	0.875	2.87779356210374e-05	SRP14	Erythrocytes	GSE199333_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34797
1.47876958471913e-09	0.292136117760929	0.513	0.365	3.13957570531718e-05	DLGAP5	Erythrocytes	GSE199333_pre	ENSG00000126787	9787	DLG associated protein 5	DLG1|DLG7|HURP|KIAA0008	protein_coding	Q15398	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34798
1.57108610037009e-09	0.332336374181294	0.714	0.576	3.33557289969574e-05	TMEM14C	Erythrocytes	GSE199333_pre	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34799
1.90238654236415e-09	0.262032436175888	0.539	0.407	4.03895686809332e-05	ASAP1	Erythrocytes	GSE199333_pre	ENSG00000153317	50807	ArfGAP with SH3 domain, ankyrin repeat and PH domain 1	CENTB4|DDEF1|KIAA1249|PAP|ZG14P	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34800
2.20188504005416e-09	-0.294621342431097	0.885	0.939	4.67482212853899e-05	BTF3	Erythrocytes	GSE199333_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34801
2.45768022248552e-09	-0.287410619326663	0.308	0.439	5.217900880359e-05	BTG1	Erythrocytes	GSE199333_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34802
2.73852423399282e-09	-0.250177713127688	0.629	0.753	5.81416080119015e-05	PA2G4	Erythrocytes	GSE199333_pre	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34803
2.8705248850032e-09	0.40351895100984	0.591	0.479	6.09441138335029e-05	RB1CC1	Erythrocytes	GSE199333_pre	ENSG00000023287	9821	RB1 inducible coiled-coil 1	ATG17|Cc1|DRAGOU14|FIP200|KIAA0203|PPP1R131	protein_coding	Q8TDY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34804
3.30576248571483e-09	-0.269589568288954	0.237	0.357	7.01846433342116e-05	C12orf57	Erythrocytes	GSE199333_pre	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34805
3.39840369987619e-09	0.315627265257048	0.928	0.859	7.21515089520713e-05	RPL27A	Erythrocytes	GSE199333_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34806
3.5160270000126e-09	-0.282379886260718	0.257	0.376	7.46487692372676e-05	PDIA6	Erythrocytes	GSE199333_pre	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34807
4.16745352561467e-09	-0.353551845112447	0.195	0.298	8.8479205802325e-05	CST3	Erythrocytes	GSE199333_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34808
4.58219295068958e-09	-0.265562014830449	0.915	0.954	9.72845385360905e-05	MT-ND5	Erythrocytes	GSE199333_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34809
5.6493801298453e-09	-0.269036740379004	0.425	0.553	0.000119941989536746	H2AFJ	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34810
6.78437227391385e-09	0.318282864987206	0.365	0.234	0.000144039007747465	XPO7	Erythrocytes	GSE199333_pre	ENSG00000130227	23039	exportin 7	EXP7|KIAA0745|RANBP16	protein_coding	Q9UIA9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34811
1.07786238777287e-08	0.314122755239745	0.376	0.251	0.000228840963548057	BRCA2	Erythrocytes	GSE199333_pre	ENSG00000139618	675	BRCA2 DNA repair associated	BRCC2|FACD|FAD|FAD1|FANCD|FANCD1|XRCC11	protein_coding	P51587	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34812
1.35632693006059e-08	0.274802682765236	0.314	0.194	0.000287961770521163	MBNL2	Erythrocytes	GSE199333_pre	ENSG00000139793	10150	muscleblind like splicing regulator 2	MBLL|MBLL39	protein_coding	Q5VZF2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34813
1.68981730235925e-08	0.309341292263663	0.551	0.439	0.000358765111463891	N4BP2L2	Erythrocytes	GSE199333_pre	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34814
1.86574593728117e-08	0.296220905557468	0.818	0.755	0.000396116519944166	TMEM14B	Erythrocytes	GSE199333_pre	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34815
2.83774137804766e-08	0.291197604059549	0.504	0.38	0.000602480871973298	ANKRD12	Erythrocytes	GSE199333_pre	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34816
3.13470819734391e-08	0.267571690695403	0.737	0.646	0.000665529897378085	IDH2	Erythrocytes	GSE199333_pre	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34817
3.20676964910488e-08	0.304736721784494	0.46	0.338	0.000680829264201457	MLXIP	Erythrocytes	GSE199333_pre	ENSG00000281178	22877	MLX interacting protein	bHLHe36|KIAA0867|MIR|MONDOA	protein_coding	Q9HAP2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34818
3.22935108297867e-08	0.267449591651643	0.689	0.584	0.000685623528427202	HBQ1	Erythrocytes	GSE199333_pre	ENSG00000086506	3049	hemoglobin subunit theta 1	HBQ	protein_coding	P09105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34819
4.35043781891295e-08	-0.306982053458529	0.694	0.745	0.000923641453333408	SET	Erythrocytes	GSE199333_pre	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34820
4.95833306426876e-08	0.270879844397572	0.418	0.297	0.0010527036928749	DDI2	Erythrocytes	GSE199333_pre	ENSG00000197312	84301	DNA damage inducible 1 homolog 2	MGC14844	protein_coding	Q5TDH0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34821
5.42593801473925e-08	-0.465016102127852	0.351	0.449	0.00115198089990929	HIST1H1B	Erythrocytes	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34822
7.54427653407203e-08	0.275326553417889	0.771	0.7	0.00160172535094883	SRSF3	Erythrocytes	GSE199333_pre	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34823
8.57996911674089e-08	-0.313491304106436	0.717	0.762	0.00182161324317526	HNRNPU	Erythrocytes	GSE199333_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34824
8.78000553565614e-08	-0.268687673103918	0.364	0.466	0.00186408297527516	SH3BGRL	Erythrocytes	GSE199333_pre	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34825
9.22854587629134e-08	-0.262651076593204	0.409	0.504	0.00195931257499541	DNAJA4	Erythrocytes	GSE199333_pre	ENSG00000140403	55466	DnaJ heat shock protein family (Hsp40) member A4	PRO1472	protein_coding	Q8WW22	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34826
9.45727563281449e-08	-0.317056001040169	0.419	0.53	0.00200787418960284	HSP90B1	Erythrocytes	GSE199333_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34827
1.00937929497288e-07	-0.348932918690464	0.568	0.646	0.00214301318115692	HNRNPAB	Erythrocytes	GSE199333_pre	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34828
1.19666893445281e-07	-0.486496801903373	0.978	0.973	0.00254064781473677	RPS8	Erythrocytes	GSE199333_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34829
1.37028581198803e-07	-0.339020519823096	0.384	0.496	0.00290925380743179	COX5A	Erythrocytes	GSE199333_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34830
1.39927050720812e-07	-0.308091310403828	0.737	0.802	0.00297079121385356	MGST3	Erythrocytes	GSE199333_pre	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34831
1.9408085398387e-07	-0.268046671685757	0.733	0.814	0.00412053061093154	SFPQ	Erythrocytes	GSE199333_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34832
3.18053153838696e-07	-0.390527309923092	0.331	0.428	0.00675258650914935	ENO1	Erythrocytes	GSE199333_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34833
3.22204743152232e-07	-0.321820245879423	0.951	0.971	0.00684072890186504	RPS13	Erythrocytes	GSE199333_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34834
3.36016019789573e-07	-0.527165316735319	0.332	0.42	0.00713395611615241	TAGLN2	Erythrocytes	GSE199333_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34835
3.82330907011001e-07	-0.265973437162533	0.604	0.686	0.00811726748675056	BCLAF1	Erythrocytes	GSE199333_pre	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34836
4.01153287469906e-07	-0.262697740199795	0.32	0.422	0.00851688544627358	CITED2	Erythrocytes	GSE199333_pre	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34837
4.02153470011657e-07	-0.462305213054963	0.249	0.346	0.00853812032181749	KLF6	Erythrocytes	GSE199333_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34838
4.05489883410289e-07	-0.315540897510814	0.263	0.356	0.00860895571468384	VAMP8	Erythrocytes	GSE199333_pre	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34839
4.73412216671729e-07	0.271590961106274	0.377	0.27	0.0100510147721575	ORC6	Erythrocytes	GSE199333_pre	ENSG00000091651	23594	origin recognition complex subunit 6	ORC6L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34840
5.17992146213652e-07	-0.267288043550108	0.315	0.42	0.0109974912562621	YOD1	Erythrocytes	GSE199333_pre	ENSG00000180667	55432	YOD1 deubiquitinase	DKFZp451J1719|DUBA8|OTUD2	protein_coding	Q5VVQ6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34841
5.45249837299907e-07	0.287789194387108	0.588	0.487	0.0115761992957143	SOX6	Erythrocytes	GSE199333_pre	ENSG00000110693	55553	SRY-box transcription factor 6	NA	protein_coding	P35712	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34842
6.0057878362545e-07	-0.405009525655216	0.435	0.534	0.0127508881551519	LDHB	Erythrocytes	GSE199333_pre	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34843
6.44937390074567e-07	0.302763114542943	0.586	0.513	0.0136926657286731	PPIG	Erythrocytes	GSE199333_pre	ENSG00000138398	9360	peptidylprolyl isomerase G	CARS-Cyp|SCAF10|SRCyp	protein_coding	Q13427	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34844
7.24245759512853e-07	-0.287313676491531	0.306	0.413	0.0153764617202174	TKT	Erythrocytes	GSE199333_pre	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34845
7.27931011067118e-07	-0.275702652596088	0.379	0.47	0.015454703295966	PPIB	Erythrocytes	GSE199333_pre	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34846
7.77675030162094e-07	0.265000870974442	0.565	0.464	0.0165108185653714	VDAC3	Erythrocytes	GSE199333_pre	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34847
9.32069190511676e-07	-0.351856268678052	0.316	0.416	0.0197887609837534	SRGN	Erythrocytes	GSE199333_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34848
9.66361560077661e-07	-0.885153899131485	0.421	0.506	0.0205168222820088	TMSB4X	Erythrocytes	GSE199333_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34849
1.18400295196993e-06	-0.281842148749438	0.529	0.629	0.0251375666732737	UBALD2	Erythrocytes	GSE199333_pre	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34850
1.7438782758703e-06	-0.28992166854317	0.988	0.987	0.0370242796750024	RPS15A	Erythrocytes	GSE199333_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34851
2.1523959448629e-06	-0.345481115649463	0.974	0.977	0.0456975183053843	RPL29	Erythrocytes	GSE199333_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34852
4.52552452769306e-84	2.02652386107196	0.875	0.143	9.60814112474514e-80	CXCR4	NK cells	GSE199333_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34853
1.51367557978396e-79	1.59186215511733	0.969	0.808	3.21368462343933e-75	HBB	NK cells	GSE199333_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34854
3.88676039270953e-64	-1.52144508143643	0.757	0.97	8.2519809897616e-60	TXNIP	NK cells	GSE199333_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34855
3.08366186401462e-56	1.47348146989624	0.787	0.204	6.54692250348944e-52	ZFP36	NK cells	GSE199333_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34856
5.24407417266056e-56	1.15707787703202	0.889	0.664	1.11336938759756e-51	HBA2	NK cells	GSE199333_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34857
5.44480159060377e-49	1.55950230156388	0.619	0.064	1.15598582570109e-44	IGKC	NK cells	GSE199333_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34858
3.15805738465441e-44	1.18758099935446	0.963	0.581	6.70487163335979e-40	CD52	NK cells	GSE199333_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34859
4.56226846338293e-43	1.29501384780829	0.503	0.008	9.68615217460829e-39	MYOM2	NK cells	GSE199333_pre	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34860
8.23066279813907e-43	1.40449991446227	0.72	0.234	1.74745201867291e-38	DUSP2	NK cells	GSE199333_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34861
1.16954247784688e-39	1.11105514037644	0.673	0.177	2.48305563471671e-35	TNFAIP3	NK cells	GSE199333_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34862
6.07134845338152e-39	2.3549765811686	0.883	0.642	1.28900799013743e-34	CCL4	NK cells	GSE199333_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34863
1.0617847180841e-34	1.17885108869689	0.855	0.525	2.25427513496436e-30	JUNB	NK cells	GSE199333_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34864
2.44265304745914e-34	-1.04509731042116	0.498	0.789	5.18599668506051e-30	GIMAP7	NK cells	GSE199333_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34865
7.7935221974726e-34	1.26642785079317	0.601	0.136	1.65464269774541e-29	CD3G	NK cells	GSE199333_pre	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34866
8.89422103466952e-34	1.99868863999293	0.621	0.204	1.88833206787068e-29	S100B	NK cells	GSE199333_pre	ENSG00000160307	6285	S100 calcium binding protein B	S100beta	protein_coding	P04271	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34867
2.60402084989029e-33	0.935939053824794	0.997	0.974	5.52859666640207e-29	S100A4	NK cells	GSE199333_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34868
1.09719775542014e-32	-1.11998032624429	0.282	0.717	2.32946055453249e-28	FCER1G	NK cells	GSE199333_pre	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34869
2.26872627919302e-32	1.10280803279182	0.725	0.298	4.81673276335469e-28	CD3E	NK cells	GSE199333_pre	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34870
8.99141311429444e-32	1.26880739955753	0.66	0.2	1.90896691829585e-27	CD3D	NK cells	GSE199333_pre	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34871
6.24989084930502e-31	1.20347934791837	0.609	0.208	1.32691432621595e-26	HLA-DRB1	NK cells	GSE199333_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34872
6.69905017183642e-29	0.948972010171795	0.739	0.336	1.42227534198259e-24	NFKBIA	NK cells	GSE199333_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34873
3.80448655124944e-28	0.974289972440133	0.549	0.151	8.07730539695768e-24	NR4A2	NK cells	GSE199333_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34874
5.31511662531377e-28	-0.936968294331077	0.153	0.491	1.12845241072037e-23	IGFBP7	NK cells	GSE199333_pre	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34875
6.68770315388937e-28	0.678400888128276	0.769	0.54	1.41986625660225e-23	HBA1	NK cells	GSE199333_pre	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34876
1.43628039243476e-27	-0.414597369865949	1	1	3.04936690117823e-23	HLA-B	NK cells	GSE199333_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34877
3.07562475181382e-27	-0.496702671280546	1	1	6.52985891057592e-23	RPL10	NK cells	GSE199333_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34878
2.75660312412038e-26	1.02045980083643	0.816	0.517	5.85254409281999e-22	TSC22D3	NK cells	GSE199333_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34879
3.28764604713345e-26	0.896214050644597	0.907	0.611	6.98000132266902e-22	IL32	NK cells	GSE199333_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34880
1.18051482158327e-25	0.808042626621561	0.607	0.219	2.50635101770345e-21	DDIT4	NK cells	GSE199333_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34881
2.69815026438431e-24	0.799081709881895	0.839	0.547	5.72844282631433e-20	PPP2R5C	NK cells	GSE199333_pre	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34882
1.01937199547253e-23	0.757445502676355	0.692	0.302	2.16422868358774e-19	KLRG1	NK cells	GSE199333_pre	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34883
2.07805224812289e-22	0.694644299688901	0.43	0.087	4.41191272798971e-18	TENT5C	NK cells	GSE199333_pre	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34884
7.89297937081994e-20	0.811398719877762	0.616	0.287	1.67575845021878e-15	CD69	NK cells	GSE199333_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34885
1.5878061943085e-18	-0.610190705406211	0.34	0.653	3.37107133113637e-14	CMC1	NK cells	GSE199333_pre	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34886
2.65695331667026e-18	0.310783686394882	1	1	5.64097758662263e-14	B2M	NK cells	GSE199333_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34887
3.49471850300165e-18	0.463486909657102	0.997	0.996	7.41963685372279e-14	SRGN	NK cells	GSE199333_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34888
5.52052425566624e-18	1.0683298939257	0.567	0.302	1.1720625047205e-13	TRGC1	NK cells	GSE199333_pre	ENSG00000211689	445347	TCR gamma alternate reading frame protein	CD3G|TCRG|TCRGC1|TCRGC2|TCRGV|C1	TR_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34889
1.23651027028886e-17	0.716817797269437	0.52	0.196	2.62523495485028e-13	CEMIP2	NK cells	GSE199333_pre	ENSG00000135048	23670	cell migration inducing hyaluronidase 2	TMEM2	protein_coding	Q9UHN6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34890
1.81663808080137e-17	0.368629810721788	1	1	3.85690430934939e-13	TMSB4X	NK cells	GSE199333_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34891
6.0080414155222e-17	-0.724496911165569	0.13	0.351	1.27556727292952e-12	CEBPD	NK cells	GSE199333_pre	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34892
1.58512778155677e-16	1.55559861113056	0.365	0.102	3.36538479302317e-12	CCL4L2	NK cells	GSE199333_pre	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34893
1.59540285260217e-16	0.798903828597104	0.285	0.038	3.38719979635967e-12	AREG	NK cells	GSE199333_pre	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34894
1.94693952122223e-16	0.632374025395332	0.507	0.196	4.13354729750692e-12	SPOCK2	NK cells	GSE199333_pre	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34895
2.15725007489118e-16	0.569516912235246	0.984	0.906	4.58005763400147e-12	S100A6	NK cells	GSE199333_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34896
2.49617057257821e-16	0.5966972058994	0.518	0.215	5.29961974264079e-12	PRDX2	NK cells	GSE199333_pre	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34897
2.9314790861402e-16	-0.64767558402964	0.197	0.442	6.22382324778425e-12	CD38	NK cells	GSE199333_pre	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34898
5.62287192470142e-16	0.670809587661787	0.678	0.4	1.19379193833336e-11	PIK3R1	NK cells	GSE199333_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34899
1.06692555822759e-15	0.47914444652782	1	1	2.265189652673e-11	MT-ND2	NK cells	GSE199333_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34900
1.50343455001088e-15	-0.625361483067433	0.129	0.343	3.19194189312811e-11	CXXC5	NK cells	GSE199333_pre	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34901
2.70950685356028e-15	0.507773791190991	0.982	0.951	5.75255400079384e-11	BTG1	NK cells	GSE199333_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34902
3.60702354532537e-15	0.502420631137814	0.41	0.128	7.65807168908029e-11	SERTAD1	NK cells	GSE199333_pre	ENSG00000197019	29950	SERTA domain containing 1	SEI1|TRIP-Br1	protein_coding	Q9UHV2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34903
3.70168909689811e-15	0.499992141624752	1	0.894	7.85905612162438e-11	GNLY	NK cells	GSE199333_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34904
7.18297753705062e-15	0.478069204947767	0.279	0.045	1.52501796089122e-10	SERTAD3	NK cells	GSE199333_pre	ENSG00000167565	29946	SERTA domain containing 3	RBT1	protein_coding	Q9UJW9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34905
9.39725059965884e-15	0.297935998890861	1	1	1.99513027481357e-10	MT-ATP6	NK cells	GSE199333_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34906
1.44708599981717e-14	0.74058058385576	0.601	0.332	3.07230828621184e-10	KLRC1	NK cells	GSE199333_pre	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34907
1.9715325877452e-14	-1.17149752027223	0.505	0.638	4.18576083704184e-10	SPON2	NK cells	GSE199333_pre	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34908
2.16467138634922e-14	0.391830159621566	1	0.996	4.59581382035803e-10	H3F3B	NK cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34909
2.46248696782346e-14	0.545337329325083	0.497	0.215	5.22810608138599e-10	BTG2	NK cells	GSE199333_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34910
3.42085851928871e-14	0.376134915029003	0.288	0.06	7.26282472230187e-10	IGLC2	NK cells	GSE199333_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34911
2.21742138601748e-13	0.558479704147264	0.423	0.158	4.70780734465371e-09	ATG2A	NK cells	GSE199333_pre	ENSG00000110046	23130	autophagy related 2A	BLTP4A|KIAA0404	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34912
3.92474983257861e-13	0.448168433231004	0.29	0.064	8.33263636954765e-09	TOB1	NK cells	GSE199333_pre	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34913
4.59834809554308e-13	0.913912254236308	0.477	0.23	9.76275284164752e-09	TRGC2	NK cells	GSE199333_pre	ENSG00000227191	NA	NA	TCRGC2|TRGC2(2X)|TRGC2(3X)	TR_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34914
5.3938861838807e-13	-0.358789198297575	1	1	1.14517597569971e-08	RPLP1	NK cells	GSE199333_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34915
9.72865282394949e-13	-0.257233750692928	0.08	0.257	2.06549028105272e-08	EOMES	NK cells	GSE199333_pre	ENSG00000163508	8320	eomesodermin	TBR2	protein_coding	O95936	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34916
1.04536717672461e-12	0.510415760217091	0.575	0.313	2.21941905290402e-08	NDUFB8	NK cells	GSE199333_pre	ENSG00000166136	4714	NADH:ubiquinone oxidoreductase subunit B8	ASHI|CI-ASHI	protein_coding	O95169	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34917
1.09813472626601e-12	0.465207884910027	0.728	0.457	2.33144983733536e-08	LCK	NK cells	GSE199333_pre	ENSG00000182866	3932	LCK proto-oncogene, Src family tyrosine kinase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34918
1.53982317785307e-12	0.437671646642308	0.295	0.072	3.26919858889985e-08	CSRNP1	NK cells	GSE199333_pre	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34919
1.99777715372055e-12	0.501655108437565	0.749	0.513	4.24148067506411e-08	TSPO	NK cells	GSE199333_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34920
3.114826056826e-12	0.462453309620746	0.406	0.151	6.61308720124729e-08	CREM	NK cells	GSE199333_pre	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34921
3.22977693064954e-12	0.505728845420454	0.472	0.215	6.85713940146205e-08	BHLHE40	NK cells	GSE199333_pre	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34922
4.67181426971315e-12	0.357720538834979	1	1	9.91872887602799e-08	RPS10	NK cells	GSE199333_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34923
5.14317813941146e-12	0.480775950658991	0.34	0.113	1.09194815077845e-07	IFRD1	NK cells	GSE199333_pre	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34924
5.3050971380325e-12	0.627665599960155	0.588	0.332	1.12632517337568e-07	DUSP1	NK cells	GSE199333_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34925
5.45597994342573e-12	0.476739269344767	0.347	0.117	1.15835910178872e-07	ERAP2	NK cells	GSE199333_pre	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34926
7.60091730019588e-12	-0.52955776273661	0.664	0.815	1.61375075200459e-07	JAK1	NK cells	GSE199333_pre	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34927
7.87170451118041e-12	0.839017432427422	0.344	0.117	1.67124158476871e-07	PTGDS	NK cells	GSE199333_pre	ENSG00000107317	5730	prostaglandin D2 synthase	L-PGDS|PGDS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34928
8.21975418507355e-12	0.390638112798801	0.311	0.087	1.74513601103297e-07	ANXA5	NK cells	GSE199333_pre	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34929
8.7158947054879e-12	0.747398937390254	0.748	0.611	1.85047160492214e-07	TRDC	NK cells	GSE199333_pre	ENSG00000211829	NA	NA	NA	TR_C_gene	B7Z8K6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34930
1.38746131105232e-11	0.435559849398795	0.735	0.494	2.94571910949519e-07	ATP6V1G1	NK cells	GSE199333_pre	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34931
1.76334349341182e-11	0.462760429375155	0.834	0.626	3.74375457086263e-07	PLAC8	NK cells	GSE199333_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34932
4.47222534843134e-11	0.443547975398509	0.857	0.675	9.49498163725458e-07	SRSF7	NK cells	GSE199333_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34933
6.0298562480679e-11	0.415602017654714	0.435	0.174	1.2801987800273e-06	TRAC	NK cells	GSE199333_pre	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34934
6.19645145179753e-11	0.493339622323218	0.495	0.257	1.31556860773113e-06	GADD45B	NK cells	GSE199333_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34935
8.81419775006185e-11	0.460410265707936	0.436	0.2	1.87134232431563e-06	CD320	NK cells	GSE199333_pre	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34936
9.37250327444452e-11	-0.830434420174429	0.109	0.268	1.98987617019732e-06	COTL1	NK cells	GSE199333_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34937
9.43786234843054e-11	0.48008630231819	0.533	0.291	2.00375255519529e-06	YPEL5	NK cells	GSE199333_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34938
1.10465668584065e-10	-0.528198586331369	0.809	0.845	2.34529660970829e-06	KLF2	NK cells	GSE199333_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34939
1.49178707054557e-10	0.35711934975052	0.301	0.094	3.16721312947531e-06	LAIR1	NK cells	GSE199333_pre	ENSG00000276163	3903	leukocyte associated immunoglobulin like receptor 1	CD305|LAIR-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34940
1.71263200186695e-10	0.354714785379809	0.997	1	3.63608900316373e-06	SH3BGRL3	NK cells	GSE199333_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34941
2.14054875046024e-10	-0.424509330236812	0.795	0.864	4.54459905210214e-06	CD63	NK cells	GSE199333_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34942
2.20486162831889e-10	0.435098076529431	0.404	0.181	4.68114172308383e-06	FOSL2	NK cells	GSE199333_pre	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34943
3.1900323594962e-10	-0.421047142253055	0.15	0.325	6.77275770244638e-06	SERPINB6	NK cells	GSE199333_pre	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34944
6.88463982087579e-10	0.460679142552658	0.591	0.37	1.46167788037014e-05	STK17B	NK cells	GSE199333_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34945
7.41964724884111e-10	0.379777055428063	0.829	0.6	1.57526530740146e-05	GZMH	NK cells	GSE199333_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34946
7.68324578757384e-10	0.472955460439497	0.809	0.66	1.6312299131598e-05	IER2	NK cells	GSE199333_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34947
9.18210371046654e-10	-0.45124011431123	0.228	0.4	1.94945243876915e-05	GIMAP1	NK cells	GSE199333_pre	ENSG00000213203	170575	GTPase, IMAP family member 1	HIMAP1|IAN2|IMAP1|IMAP38	protein_coding	Q8WWP7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34948
1.01079922169268e-09	-0.405887366335738	0.109	0.264	2.14602782757573e-05	ITGAX	NK cells	GSE199333_pre	ENSG00000140678	3687	integrin subunit alpha X	CD11C	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34949
1.29028725188202e-09	0.347195083565716	0.99	0.996	2.73940886447072e-05	HSP90AA1	NK cells	GSE199333_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34950
1.50172726058802e-09	0.357979661544641	0.318	0.117	3.18831714695443e-05	DNAJB1	NK cells	GSE199333_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34951
1.53801000826968e-09	0.371548503369204	0.876	0.758	3.26534904855736e-05	LAPTM5	NK cells	GSE199333_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34952
2.09472816365854e-09	0.434916026517089	0.454	0.23	4.44731736426345e-05	RNF19A	NK cells	GSE199333_pre	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34953
2.14237109994068e-09	0.407149701865412	0.381	0.174	4.54846808228406e-05	ZBTB1	NK cells	GSE199333_pre	ENSG00000126804	22890	zinc finger and BTB domain containing 1	KIAA0997|ZNF909	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34954
3.25522396939934e-09	-0.335145962536042	0.397	0.649	6.91116600943174e-05	KLRF1	NK cells	GSE199333_pre	ENSG00000150045	51348	killer cell lectin like receptor F1	CLEC5C|NKp80	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34955
3.4814315978026e-09	-0.338707648877968	0.213	0.389	7.3914274252947e-05	TXK	NK cells	GSE199333_pre	ENSG00000074966	7294	TXK tyrosine kinase	BTKL|PSCTK5|PTK4|RLK|TKL	protein_coding	P42681	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34956
3.75725600288553e-09	0.387437710508304	0.933	0.826	7.97703021972628e-05	ARL4C	NK cells	GSE199333_pre	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34957
4.16042568511255e-09	0.444100838038304	0.48	0.268	8.83299977206245e-05	HERPUD1	NK cells	GSE199333_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34958
4.75516029993538e-09	0.421625805282485	0.365	0.162	0.000100956808327928	GTF3C1	NK cells	GSE199333_pre	ENSG00000077235	2975	general transcription factor IIIC subunit 1	TFIIIC220	protein_coding	Q12789	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34959
5.78795039206671e-09	0.434116749465682	0.415	0.208	0.000122883974773968	CEBPB	NK cells	GSE199333_pre	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34960
6.27554569673528e-09	0.338745361473803	0.875	0.736	0.000133236110687387	GZMM	NK cells	GSE199333_pre	ENSG00000197540	3004	granzyme M	LMET1|MET1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34961
6.75043178276767e-09	0.359912856995513	0.821	0.653	0.00014331841717994	LITAF	NK cells	GSE199333_pre	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34962
7.115439192046e-09	0.325227279020219	0.34	0.14	0.000151067889486329	PDE4D	NK cells	GSE199333_pre	ENSG00000113448	5144	phosphodiesterase 4D	DPDE3	protein_coding	Q08499	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34963
9.23180896564274e-09	0.422391363825728	0.269	0.094	0.000196000536149561	MYADM	NK cells	GSE199333_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34964
9.68997378602983e-09	0.44341919614474	0.373	0.181	0.000205727833451199	ITM2A	NK cells	GSE199333_pre	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34965
9.93274106765748e-09	-0.509486758914174	0.137	0.287	0.000210882025607436	TNFRSF18	NK cells	GSE199333_pre	ENSG00000186891	8784	TNF receptor superfamily member 18	AITR|CD357|GITR	protein_coding	Q9Y5U5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34966
9.98843124183695e-09	-0.41607511235469	0.15	0.309	0.00021206438369544	TRIM56	NK cells	GSE199333_pre	ENSG00000169871	81844	tripartite motif containing 56	RNF109	protein_coding	Q9BRZ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34967
1.01696301235618e-08	0.354597347611139	0.735	0.525	0.00021591141715334	SRSF2	NK cells	GSE199333_pre	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34968
1.37836525975567e-08	0.302560303824474	0.318	0.136	0.000292640728298726	PATL2	NK cells	GSE199333_pre	ENSG00000282077	197135	PAT1 homolog 2	Pat1a	protein_coding	C9JE40	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34969
2.54070697689264e-08	0.436537006362912	0.95	0.966	0.000539417498264076	VIM	NK cells	GSE199333_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34970
2.69430109368069e-08	0.39771722255286	0.836	0.717	0.000572027065199348	HOPX	NK cells	GSE199333_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34971
2.71279002839105e-08	0.318234411876966	1	1	0.000575952450927704	ACTB	NK cells	GSE199333_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34972
3.36801727365239e-08	-0.464164669559238	0.27	0.419	0.00071506374736914	TUBB	NK cells	GSE199333_pre	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34973
4.16017793557256e-08	-0.28140157164483	1	1	0.000883247377501411	RPL37	NK cells	GSE199333_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34974
4.25021697536953e-08	-0.261637983053313	1	1	0.000902363566040705	RPS14	NK cells	GSE199333_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34975
5.01372801896492e-08	0.34625786490784	0.744	0.547	0.00106446459570644	GYPC	NK cells	GSE199333_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34976
5.72205642753734e-08	0.387645449454037	0.767	0.642	0.00121484980013045	HNRNPH1	NK cells	GSE199333_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34977
6.1375353213666e-08	0.421983749718235	0.428	0.23	0.00130306012407934	SLC2A3	NK cells	GSE199333_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34978
6.2777550188504e-08	0.346517440801327	0.987	0.992	0.00133283016805213	JUND	NK cells	GSE199333_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34979
7.61739885108937e-08	0.370994611469689	0.666	0.472	0.00161724995007478	NSA2	NK cells	GSE199333_pre	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34980
8.34119767091382e-08	0.460039688887714	0.806	0.691	0.00177091967751171	FGFBP2	NK cells	GSE199333_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34981
1.93108564196094e-07	0.322138105629352	0.349	0.166	0.00409988792644726	IER5	NK cells	GSE199333_pre	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34982
1.9441020291617e-07	0.311424366390763	0.689	0.509	0.00412752301811321	SOD1	NK cells	GSE199333_pre	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34983
2.49270874935858e-07	-0.392581470647934	0.795	0.842	0.0052922699457632	HSPA8	NK cells	GSE199333_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34984
3.28889121839506e-07	0.296068822645189	0.321	0.147	0.00698264494577456	VPS37B	NK cells	GSE199333_pre	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34985
3.39743525300861e-07	0.370461993341529	0.461	0.275	0.00721309478566258	PPP1CB	NK cells	GSE199333_pre	ENSG00000213639	5500	protein phosphatase 1 catalytic subunit beta	MP|PP-1B|PP1B|PP1beta|PP1c|PPP1beta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34986
4.3079434155692e-07	0.302936236664162	0.98	0.913	0.00914619466559496	MYL12A	NK cells	GSE199333_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34987
4.44722603936189e-07	0.348737341867099	0.63	0.434	0.00944190560416923	DNAJB6	NK cells	GSE199333_pre	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34988
5.12285844431991e-07	-0.358097162383073	0.252	0.396	0.0108763407631356	GBP4	NK cells	GSE199333_pre	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34989
6.98206627310314e-07	0.285732903206898	0.35	0.17	0.0148236249044253	PTGER4	NK cells	GSE199333_pre	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34990
8.74205603209312e-07	0.256882193750282	0.326	0.155	0.0185602591617369	TC2N	NK cells	GSE199333_pre	ENSG00000276776	123036	tandem C2 domains, nuclear	C14orf47|C2CD1|FLJ36557|MTAC2D1|Tac2-N	protein_coding	Q8N9U0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34991
8.82164260103669e-07	-0.359803484333476	0.179	0.309	0.018729229406261	PILRB	NK cells	GSE199333_pre	ENSG00000121716	29990	paired immunoglobin like type 2 receptor beta	FDFACT1|FDFACT2	protein_coding	Q9UKJ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34992
8.87129212774189e-07	0.283356684662895	0.283	0.125	0.0188346403164088	BRD1	NK cells	GSE199333_pre	ENSG00000100425	23774	bromodomain containing 1	BRL|BRPF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34993
9.0521106379113e-07	0.521869060162674	0.503	0.347	0.0192185360953495	TECR	NK cells	GSE199333_pre	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34994
9.07727444796044e-07	-0.269510501364377	0.275	0.423	0.0192719613804648	PTGDR	NK cells	GSE199333_pre	ENSG00000168229	5729	prostaglandin D2 receptor	DP|DP1|PTGDR1	protein_coding	Q13258	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34995
9.11773685963394e-07	0.28245172014926	0.979	0.974	0.0193578671266888	PPIA	NK cells	GSE199333_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34996
9.40357186912565e-07	0.271440247516213	0.948	0.909	0.0199647234353407	MYL12B	NK cells	GSE199333_pre	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34997
1.09058786434392e-06	0.325348357115879	0.777	0.615	0.0231542709478858	CD53	NK cells	GSE199333_pre	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34998
1.17162235268918e-06	-0.432394888900235	0.44	0.551	0.024874714169944	XBP1	NK cells	GSE199333_pre	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	34999
1.22652615680884e-06	0.316518445877515	0.394	0.234	0.0260403768352085	TGFBR3	NK cells	GSE199333_pre	ENSG00000069702	7049	transforming growth factor beta receptor 3	betaglycan|BGCAN	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35000
1.27910285157549e-06	-0.278741707706525	0.99	1	0.0271566326417992	EEF1B2	NK cells	GSE199333_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35001
1.40747335249959e-06	-0.393254796490946	0.163	0.291	0.0298820667469188	LYST	NK cells	GSE199333_pre	ENSG00000143669	1130	lysosomal trafficking regulator	CHS|CHS1|Mauve	protein_coding	Q99698	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35002
1.4238413139645e-06	-0.314125909938832	0.191	0.328	0.0302295749367803	HSH2D	NK cells	GSE199333_pre	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35003
1.48128024043973e-06	-0.399457487811386	0.314	0.442	0.031449060784776	DENND2D	NK cells	GSE199333_pre	ENSG00000162777	79961	DENN domain containing 2D	FLJ22457|RP5-1180E21.2	protein_coding	Q9H6A0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35004
1.49359901337798e-06	0.325254851095269	0.433	0.253	0.0317106006530279	RNMT	NK cells	GSE199333_pre	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35005
1.56570636356022e-06	0.29175835880494	0.642	0.423	0.033241511804747	JUN	NK cells	GSE199333_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35006
1.5945997848564e-06	-0.388254852375457	0.22	0.362	0.0338549480322863	HIST1H4C	NK cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35007
1.81388940177945e-06	0.279341818309782	0.492	0.298	0.0385106858891794	DDX3Y	NK cells	GSE199333_pre	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35008
2.10326393623655e-06	0.311791980520599	0.436	0.253	0.0446543966302382	ITGB7	NK cells	GSE199333_pre	ENSG00000139626	3695	integrin subunit beta 7	NA	protein_coding	P26010	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35009
2.18171068328153e-06	-0.388939852814365	0.443	0.57	0.0463198995167502	CFLAR	NK cells	GSE199333_pre	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35010
1.51444710093489e-117	1.58395453615188	0.944	0.513	3.21532263999487e-113	CXCR4	CD8+ T cells	GSE199333_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35011
1.93508125380869e-71	-1.13062711284911	0.987	1	4.10837100996123e-67	GAPDH	CD8+ T cells	GSE199333_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35012
2.71091894081317e-71	1.21612940876678	0.89	0.746	5.75555200324045e-67	HBB	CD8+ T cells	GSE199333_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35013
2.46722720112237e-70	-0.654124625278959	1	1	5.23817007070291e-66	HLA-B	CD8+ T cells	GSE199333_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35014
1.06732456896067e-68	1.05013483563821	0.963	0.853	2.26603679236039e-64	ZFP36L2	CD8+ T cells	GSE199333_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35015
5.161078685004e-64	0.633235525392795	1	0.998	1.0957486156132e-59	RPS10	CD8+ T cells	GSE199333_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35016
4.23323418884164e-63	1.66049271872371	0.897	0.696	8.98757950632968e-59	JUNB	CD8+ T cells	GSE199333_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35017
8.14562122204276e-62	0.77068317928742	1	0.993	1.7293968416519e-57	RPL27A	CD8+ T cells	GSE199333_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35018
8.72726525937791e-56	1.40338747137482	0.734	0.367	1.85288568721852e-51	DUSP1	CD8+ T cells	GSE199333_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35019
3.22730685379404e-54	0.953659783645105	0.811	0.628	6.85189518129013e-50	HBA2	CD8+ T cells	GSE199333_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35020
4.90036237371351e-53	1.16575549064679	0.785	0.408	1.04039593556311e-48	ZFP36	CD8+ T cells	GSE199333_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35021
9.23431400825576e-53	-1.2025075245372	0.706	0.932	1.96053720709278e-48	NKG7	CD8+ T cells	GSE199333_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35022
1.53169426673825e-51	0.4864921398413	1	1	3.25194009771198e-47	RPS29	CD8+ T cells	GSE199333_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35023
2.31871455734898e-51	0.59558426665942	1	0.998	4.92286287670763e-47	RPL9	CD8+ T cells	GSE199333_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35024
4.2838340397877e-51	0.671074474683657	0.999	0.952	9.09500804987327e-47	BTG1	CD8+ T cells	GSE199333_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35025
1.34535865780769e-49	1.1679510097968	0.4	0.05	2.85633096639151e-45	IGKC	CD8+ T cells	GSE199333_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35026
4.84104791703993e-49	-1.04950615450621	0.081	0.392	1.02780288326675e-44	FGFBP2	CD8+ T cells	GSE199333_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35027
7.81433734845153e-47	0.466067146398908	1	1	1.65906196244974e-42	RPL30	CD8+ T cells	GSE199333_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35028
1.14217867000064e-46	0.798561151354388	0.689	0.286	2.42495953427835e-42	NR4A2	CD8+ T cells	GSE199333_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35029
2.00572004416758e-46	0.583327166658774	1	1	4.25834422577219e-42	MT-ND3	CD8+ T cells	GSE199333_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35030
1.2329386379804e-45	0.705545724869815	1	0.989	2.61765202229619e-41	JUND	CD8+ T cells	GSE199333_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35031
1.94187795240191e-45	-1.26916842218837	0.781	0.971	4.12280108074449e-41	CD74	CD8+ T cells	GSE199333_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35032
6.67289409217789e-44	1.56984837382409	0.748	0.497	1.41672214471029e-39	FOS	CD8+ T cells	GSE199333_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35033
6.16360234842042e-42	0.548993600047401	1	1	1.30859441459314e-37	RPL13A	CD8+ T cells	GSE199333_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35034
7.39734848491136e-42	0.45877355534813	1	1	1.57053105683153e-37	RPL21	CD8+ T cells	GSE199333_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35035
5.46339353789886e-41	0.455076953795508	1	1	1.15993308203131e-36	RPS3A	CD8+ T cells	GSE199333_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35036
7.42070016807914e-41	0.414211207826398	1	1	1.57548885268488e-36	RPS28	CD8+ T cells	GSE199333_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35037
7.80281558309455e-41	0.960438204808257	0.755	0.456	1.6566157764468e-36	CD69	CD8+ T cells	GSE199333_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35038
8.30389952929603e-41	0.963932056099101	0.88	0.664	1.76300090906484e-36	TSC22D3	CD8+ T cells	GSE199333_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35039
2.81517212088416e-40	-1.04833466029576	0.373	0.694	5.97689192984917e-36	HLA-DRA	CD8+ T cells	GSE199333_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35040
1.04816304789499e-39	-0.986355931421147	0.682	0.85	2.22535496698585e-35	TXNIP	CD8+ T cells	GSE199333_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35041
1.80463201615805e-39	0.450803215883695	1	1	3.83141423350516e-35	RPL36	CD8+ T cells	GSE199333_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35042
1.41198376376275e-38	-1.06257739664432	0.084	0.343	2.99778272884469e-34	GZMB	CD8+ T cells	GSE199333_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35043
2.41365035116253e-38	0.767861704103809	0.783	0.444	5.12442106055317e-34	TNFAIP3	CD8+ T cells	GSE199333_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35044
4.01057593469192e-38	0.441474069584265	1	1	8.51485376694442e-34	RPL34	CD8+ T cells	GSE199333_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35045
4.88093240893204e-37	0.668979459685453	0.827	0.515	1.03627075974036e-32	YPEL5	CD8+ T cells	GSE199333_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35046
9.22142468058167e-37	0.421723624532818	1	1	1.95780067393429e-32	RPL32	CD8+ T cells	GSE199333_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35047
8.46763300506623e-36	0.462098827111016	0.998	0.996	1.79776316330561e-31	RPL38	CD8+ T cells	GSE199333_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35048
3.65731214424259e-35	0.749027984224005	0.548	0.222	7.76483941344145e-31	ZNF331	CD8+ T cells	GSE199333_pre	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35049
6.69044293102119e-35	-0.590934696053076	1	1	1.42044793868511e-30	TMSB10	CD8+ T cells	GSE199333_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35050
8.18081486964492e-35	0.385369867535665	1	1	1.73686880497431e-30	RPS27	CD8+ T cells	GSE199333_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35051
9.56661682430211e-35	0.377205019761073	1	1	2.03108841796758e-30	RPL13	CD8+ T cells	GSE199333_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35052
1.08124890319025e-34	0.335529376892645	1	1	2.29559954636323e-30	RPL41	CD8+ T cells	GSE199333_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35053
1.20483071973845e-34	0.455531533304381	1	1	2.5579761010767e-30	RPS18	CD8+ T cells	GSE199333_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35054
3.24475347367566e-33	0.635352155740688	1	0.998	6.88893609996078e-29	MT-ND2	CD8+ T cells	GSE199333_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35055
5.47955441234763e-33	-0.738556371602486	0.192	0.469	1.16336419728553e-28	PRF1	CD8+ T cells	GSE199333_pre	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35056
6.71833281513216e-33	0.534378487404489	0.999	0.991	1.42636923998071e-28	RPS20	CD8+ T cells	GSE199333_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35057
1.93446706740525e-32	-1.15947450216178	0.22	0.481	4.10706703080809e-28	GZMH	CD8+ T cells	GSE199333_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35058
2.1202843330255e-32	0.618181025448648	0.756	0.479	4.50157566744644e-28	PDCD4	CD8+ T cells	GSE199333_pre	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35059
2.23774345653703e-32	-1.05623549170814	0.916	0.989	4.75095313257378e-28	PFN1	CD8+ T cells	GSE199333_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35060
5.17922508986408e-32	-0.73746522159985	0.434	0.712	1.09960127882904e-27	HLA-DPA1	CD8+ T cells	GSE199333_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35061
5.94370070322751e-32	1.3347846756249	0.453	0.165	1.26190709630223e-27	IL7R	CD8+ T cells	GSE199333_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35062
8.31161159299355e-32	0.35588801461933	1	1	1.76463825730846e-27	RPL39	CD8+ T cells	GSE199333_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35063
4.93966446029111e-31	0.517590280220454	0.982	0.911	1.0487401615644e-26	SARAF	CD8+ T cells	GSE199333_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35064
2.7956420758305e-30	-0.726296817202432	0.645	0.868	5.93542769119573e-26	ENO1	CD8+ T cells	GSE199333_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35065
1.03055963714778e-29	-0.546160943657072	0.866	0.961	2.18798116562845e-25	CD99	CD8+ T cells	GSE199333_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35066
4.98257250671911e-29	0.645044701645403	0.725	0.454	1.05784996890153e-24	NFKBIA	CD8+ T cells	GSE199333_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35067
8.45771208253526e-29	-0.654067013013928	0.951	0.998	1.79565685224306e-24	MYL6	CD8+ T cells	GSE199333_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35068
1.34815829746648e-28	-0.774847816577407	0.935	0.977	2.86227488135109e-24	NEAT1	CD8+ T cells	GSE199333_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35069
1.99211304952705e-28	0.472313419506523	1	1	4.22945521545087e-24	TPT1	CD8+ T cells	GSE199333_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35070
1.08111337562971e-27	-0.63352044645213	0.452	0.662	2.29531180779944e-23	COX5A	CD8+ T cells	GSE199333_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35071
1.45434345140695e-27	0.669489219238797	0.696	0.535	3.08771658168209e-23	HBA1	CD8+ T cells	GSE199333_pre	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35072
2.87303576461135e-27	-0.560698439687734	0.931	0.987	6.09974223184636e-23	ARPC2	CD8+ T cells	GSE199333_pre	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35073
3.46727299787785e-27	0.574543280443824	0.806	0.619	7.36136730179447e-23	CD48	CD8+ T cells	GSE199333_pre	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35074
4.09982473335276e-27	0.361503068345423	1	1	8.70433789138124e-23	MT-ND4	CD8+ T cells	GSE199333_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35075
4.3867538080706e-27	0.631922512889523	1	1	9.3135170099147e-23	MT-ND1	CD8+ T cells	GSE199333_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35076
5.36773446897958e-27	0.362309410289587	0.999	0.998	1.13962370510905e-22	RPS21	CD8+ T cells	GSE199333_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35077
1.84436345412824e-26	0.389146616023681	1	1	3.91576804945967e-22	RPS12	CD8+ T cells	GSE199333_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35078
2.04291898109586e-26	0.853745097064524	0.292	0.061	4.33732128876462e-22	AREG	CD8+ T cells	GSE199333_pre	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35079
4.26206345597162e-26	0.32654555120105	1	1	9.04878692337335e-22	RPL37	CD8+ T cells	GSE199333_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35080
4.42838529799336e-26	0.586278757662781	0.484	0.202	9.40190482616971e-22	BTG2	CD8+ T cells	GSE199333_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35081
4.83733508912938e-26	0.444498694295431	0.982	0.95	1.02701461277306e-21	TOMM7	CD8+ T cells	GSE199333_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35082
5.73772158468155e-26	0.489934968285046	0.998	1	1.21817566964374e-21	MT-ND5	CD8+ T cells	GSE199333_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35083
1.34680369594133e-25	-0.554468754900586	0.995	0.998	2.85939892685303e-21	SH3BGRL3	CD8+ T cells	GSE199333_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35084
1.38589948939836e-25	-0.774114781770112	0.085	0.279	2.94240320594166e-21	PTMS	CD8+ T cells	GSE199333_pre	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35085
3.40883385523895e-25	-0.577067905221497	0.926	0.95	7.2372951580578e-21	SUB1	CD8+ T cells	GSE199333_pre	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35086
3.92704664972509e-25	0.355190891098272	1	1	8.33751274203135e-21	RPS5	CD8+ T cells	GSE199333_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35087
8.70651387596425e-25	0.291329241798014	1	1	1.84847996100597e-20	RPS27A	CD8+ T cells	GSE199333_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35088
1.24913559164993e-24	-0.984763896131564	0.362	0.53	2.65203977463196e-20	GIMAP7	CD8+ T cells	GSE199333_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35089
1.41271978280951e-24	0.778110932539044	0.734	0.488	2.99934537088288e-20	DUSP2	CD8+ T cells	GSE199333_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35090
2.16740361744097e-24	0.438049125241644	0.992	0.984	4.60161462018892e-20	PABPC1	CD8+ T cells	GSE199333_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35091
5.28803165417656e-24	0.364605055577567	1	1	1.12270200049822e-19	EEF1A1	CD8+ T cells	GSE199333_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35092
6.18297131134934e-24	0.350501331808144	1	1	1.31270663911258e-19	RPL14	CD8+ T cells	GSE199333_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35093
7.89332443313387e-24	0.335947195104587	1	1	1.67583171039865e-19	RPL37A	CD8+ T cells	GSE199333_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35094
6.55133587252893e-23	0.904003881750861	0.638	0.404	1.39091411909662e-18	LTB	CD8+ T cells	GSE199333_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35095
1.83305890530089e-22	-0.944833801108701	0.212	0.404	3.89176736184431e-18	GIMAP4	CD8+ T cells	GSE199333_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35096
2.50823056001658e-22	0.449938106230094	0.989	0.987	5.3252243019712e-18	RPL23	CD8+ T cells	GSE199333_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35097
3.34225183706772e-22	0.300190986725411	1	1	7.09593487527848e-18	RPS23	CD8+ T cells	GSE199333_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35098
5.2378748162421e-22	-1.29323919009906	0.488	0.614	1.11205320223636e-17	COTL1	CD8+ T cells	GSE199333_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35099
5.33599215847012e-22	-0.534944035115662	0.726	0.869	1.13288449516479e-17	PSMA7	CD8+ T cells	GSE199333_pre	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35100
8.59974420576775e-22	-0.750400628366009	0.416	0.564	1.82581169232655e-17	PSMB8	CD8+ T cells	GSE199333_pre	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35101
9.16359172520132e-22	0.398946414826673	0.999	0.998	1.94552215917749e-17	RPL7	CD8+ T cells	GSE199333_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35102
1.10861887404756e-21	0.327603019294139	1	1	2.35370873149037e-17	RPS25	CD8+ T cells	GSE199333_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35103
1.79620879721618e-21	-0.680453344391028	0.425	0.601	3.81353089736966e-17	PPP1CA	CD8+ T cells	GSE199333_pre	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35104
2.91640696442877e-21	0.774122263254191	0.425	0.197	6.19182362617872e-17	RGCC	CD8+ T cells	GSE199333_pre	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35105
3.37789266173404e-21	-0.538790477550869	0.985	0.996	7.17160391012754e-17	HMGB1	CD8+ T cells	GSE199333_pre	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35106
3.56118193277133e-21	0.396431165454808	1	1	7.56074536146682e-17	RPS16	CD8+ T cells	GSE199333_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35107
4.49772736941757e-21	-0.392703212525268	0.099	0.286	9.54912497801045e-17	GBP4	CD8+ T cells	GSE199333_pre	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35108
4.87138626276142e-21	-0.862068018925114	0.109	0.288	1.03424401744688e-16	FABP5	CD8+ T cells	GSE199333_pre	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35109
4.94565643724265e-21	-0.588369488423408	0.419	0.646	1.05001231819099e-16	HLA-DPB1	CD8+ T cells	GSE199333_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35110
5.19521529151798e-21	-0.886656810932473	0.244	0.454	1.10299615854218e-16	TUBB	CD8+ T cells	GSE199333_pre	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35111
1.1750319725343e-20	0.466486440561873	0.51	0.249	2.49471038088756e-16	AC058791.1	CD8+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35112
1.20987858918824e-20	0.551164439805469	0.519	0.265	2.56869323270555e-16	DDIT4	CD8+ T cells	GSE199333_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35113
1.25361266985238e-20	0.792555359764926	0.429	0.199	2.66154505936359e-16	RGS1	CD8+ T cells	GSE199333_pre	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35114
1.58469746018502e-20	-0.576488691748227	0.157	0.36	3.36447117771882e-16	PLEK	CD8+ T cells	GSE199333_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35115
1.70250447454537e-20	-0.679655439687377	0.954	0.995	3.61458724990727e-16	CFL1	CD8+ T cells	GSE199333_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35116
1.83564893228192e-20	-0.949541997694231	0.606	0.776	3.89726624812774e-16	HMGB2	CD8+ T cells	GSE199333_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35117
2.31530886542373e-20	-0.371670806480761	1	1	4.91563225218113e-16	HLA-A	CD8+ T cells	GSE199333_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35118
2.37792962406691e-20	0.345490568459261	1	1	5.04858238485645e-16	RPS6	CD8+ T cells	GSE199333_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35119
3.06565983493779e-20	-0.502850080760562	0.84	0.914	6.50870239555642e-16	TPM3	CD8+ T cells	GSE199333_pre	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35120
3.62049905878105e-20	0.530441696009161	0.414	0.175	7.68668155169805e-16	KDM6B	CD8+ T cells	GSE199333_pre	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35121
4.92314616551906e-20	0.30058613808554	1	1	1.04523316240135e-15	RPL35	CD8+ T cells	GSE199333_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35122
5.47663696491223e-20	-0.492358123305173	0.575	0.732	1.16274479402052e-15	MSN	CD8+ T cells	GSE199333_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35123
6.70904634387058e-20	0.264971004126931	1	1	1.42439762926716e-15	RPS3	CD8+ T cells	GSE199333_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35124
9.39274963594585e-20	0.34576042941127	1	1	1.99417467520766e-15	RPL22	CD8+ T cells	GSE199333_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35125
1.27181984302598e-19	0.286526030538662	1	1	2.70020070872846e-15	RPL26	CD8+ T cells	GSE199333_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35126
1.75920360469169e-19	-0.735836292780597	0.124	0.302	3.73496517312094e-15	LAG3	CD8+ T cells	GSE199333_pre	ENSG00000089692	3902	lymphocyte activating 3	CD223	protein_coding	P18627	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35127
2.22551341353893e-19	0.394385709086597	0.993	0.991	4.7249875282845e-15	SRGN	CD8+ T cells	GSE199333_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35128
2.708547659082e-19	-0.416696698201989	0.656	0.882	5.75051753499698e-15	GSTP1	CD8+ T cells	GSE199333_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35129
2.77531579582021e-19	-0.5496146678072	0.531	0.682	5.89227296610589e-15	DBI	CD8+ T cells	GSE199333_pre	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35130
3.18610112375027e-19	-0.772587034734433	0.445	0.581	6.76441129583419e-15	PSME2	CD8+ T cells	GSE199333_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35131
3.48996273846916e-19	-0.467642451662588	0.955	0.984	7.40953989004388e-15	UBB	CD8+ T cells	GSE199333_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35132
4.49062748264276e-19	0.67421562390207	0.807	0.642	9.53405120839885e-15	JUN	CD8+ T cells	GSE199333_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35133
4.67593797242125e-19	0.465148452005453	0.732	0.496	9.92748390924755e-15	STK17B	CD8+ T cells	GSE199333_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35134
6.11850600516672e-19	-0.616779948733572	0.636	0.773	1.29902000995695e-14	CTSW	CD8+ T cells	GSE199333_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35135
7.65929585972381e-19	-0.616392309840693	0.261	0.447	1.62614510397796e-14	JPT1	CD8+ T cells	GSE199333_pre	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35136
8.29126017599403e-19	0.329021476875495	1	1	1.76031744796529e-14	RPL23A	CD8+ T cells	GSE199333_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35137
9.1423216026982e-19	-0.494740399529171	0.5	0.682	1.94100629946885e-14	CLEC2B	CD8+ T cells	GSE199333_pre	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35138
9.96649793782516e-19	-0.472965216654893	0.779	0.918	2.11598717717966e-14	PSME1	CD8+ T cells	GSE199333_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35139
1.00650766442198e-18	-1.10238523652362	0.592	0.771	2.13691642233432e-14	TUBA1B	CD8+ T cells	GSE199333_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35140
1.82693412928563e-18	0.375309492399897	0.933	0.864	3.87876384988633e-14	NOP53	CD8+ T cells	GSE199333_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35141
1.84758483948506e-18	0.314278459302341	1	1	3.92260737271074e-14	RPL3	CD8+ T cells	GSE199333_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35142
4.94631483427855e-18	0.3406233256829	1	0.996	1.05015210246568e-13	RPS11	CD8+ T cells	GSE199333_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35143
5.19489662314982e-18	-0.463567633464331	0.697	0.826	1.10292850206094e-13	SNRPB	CD8+ T cells	GSE199333_pre	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35144
5.34698154553084e-18	0.344008534328777	0.358	0.14	1.13521765193165e-13	PDE4B	CD8+ T cells	GSE199333_pre	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35145
1.1869968073818e-17	-0.623912206559159	0.346	0.508	2.5201129217523e-13	CRIP1	CD8+ T cells	GSE199333_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35146
1.82672521482863e-17	-0.441401375148881	0.101	0.261	3.87832030360266e-13	GBP1	CD8+ T cells	GSE199333_pre	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35147
1.88298560218747e-17	-0.497794192365697	0.74	0.83	3.99776673200421e-13	LIMD2	CD8+ T cells	GSE199333_pre	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35148
2.00437188367612e-17	0.407625607909469	0.502	0.267	4.25548194623276e-13	FOXP1	CD8+ T cells	GSE199333_pre	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35149
2.14932122580567e-17	0.437476629246077	0.288	0.102	4.56322389450801e-13	ZBTB20	CD8+ T cells	GSE199333_pre	ENSG00000181722	26137	zinc finger and BTB domain containing 20	DKFZp566F123|DPZF|ODA-8S|ZNF288	protein_coding	Q9HC78	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35150
2.51782346621396e-17	0.383466778497124	0.829	0.726	5.34559100111885e-13	RPL17	CD8+ T cells	GSE199333_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35151
6.55084465057991e-17	0.542311905461551	0.393	0.193	1.39080982776462e-12	MYADM	CD8+ T cells	GSE199333_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35152
7.98502714657544e-17	0.403573649549422	0.395	0.179	1.69530111348943e-12	AC044849.1	CD8+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35153
9.43475544525621e-17	-0.455093027780034	0.476	0.649	2.00309292858235e-12	ARPC5L	CD8+ T cells	GSE199333_pre	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35154
9.50803604165132e-17	-0.916315646445678	0.98	0.998	2.01865113200299e-12	ACTG1	CD8+ T cells	GSE199333_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35155
1.04051539003075e-16	0.271019773100925	1	1	2.20911822457429e-12	RPL24	CD8+ T cells	GSE199333_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35156
1.06498958426056e-16	0.466443426253661	0.892	0.812	2.2610793863436e-12	PNRC1	CD8+ T cells	GSE199333_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35157
1.12625882227482e-16	0.37095780677439	0.402	0.186	2.39116010557167e-12	TMEM123	CD8+ T cells	GSE199333_pre	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35158
1.57325829292089e-16	-0.550787837436409	0.765	0.864	3.34018468170035e-12	CLIC1	CD8+ T cells	GSE199333_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35159
1.66073939915239e-16	-0.73478201632631	0.127	0.288	3.52591581834043e-12	STMN1	CD8+ T cells	GSE199333_pre	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35160
2.04790581255072e-16	0.258367193228832	1	1	4.34790883062644e-12	RPS13	CD8+ T cells	GSE199333_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35161
2.53847365335688e-16	0.395392976968918	0.39	0.181	5.389433413442e-12	ALOX5AP	CD8+ T cells	GSE199333_pre	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35162
3.41347586158548e-16	-0.496811822043454	0.231	0.401	7.24715060173214e-12	CYTOR	CD8+ T cells	GSE199333_pre	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35163
4.3282455275317e-16	0.630626815442614	0.535	0.333	9.18929807950256e-12	FOSB	CD8+ T cells	GSE199333_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35164
4.53086241108427e-16	0.364561291348893	0.332	0.143	9.61947398497301e-12	RCAN3	CD8+ T cells	GSE199333_pre	ENSG00000117602	11123	RCAN family member 3	DSCR1L2	protein_coding	Q9UKA8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35165
4.64922852927335e-16	0.438138815606952	0.679	0.496	9.87077709050024e-12	LEPROTL1	CD8+ T cells	GSE199333_pre	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35166
5.23318561415982e-16	0.574529069532918	0.488	0.295	1.11105763774227e-11	CREM	CD8+ T cells	GSE199333_pre	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35167
9.17303450804115e-16	-0.409524437900532	0.735	0.839	1.94752695640222e-11	YWHAB	CD8+ T cells	GSE199333_pre	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35168
1.18633809751851e-15	0.281421680853926	0.265	0.088	2.51871441484155e-11	PLK3	CD8+ T cells	GSE199333_pre	ENSG00000173846	1263	polo like kinase 3	CNK|FNK|PRK	protein_coding	Q9H4B4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35169
1.39111999631245e-15	0.330338602536568	0.575	0.349	2.95348686417096e-11	DNAJB1	CD8+ T cells	GSE199333_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35170
1.62276127179193e-15	-0.465989356623765	0.864	0.952	3.44528445614146e-11	ARPC3	CD8+ T cells	GSE199333_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35171
1.62521995512465e-15	-0.507054110573877	1	1	3.45050448672514e-11	UBC	CD8+ T cells	GSE199333_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35172
1.63341592673828e-15	-0.435788954138472	0.286	0.454	3.46790535405804e-11	NOP10	CD8+ T cells	GSE199333_pre	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35173
1.70266381346812e-15	-0.467552519210029	0.174	0.333	3.61492554237416e-11	GBP2	CD8+ T cells	GSE199333_pre	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35174
1.72977112179905e-15	0.473724359094459	0.398	0.204	3.67247706869157e-11	PTGER4	CD8+ T cells	GSE199333_pre	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35175
2.07420101616119e-15	-0.337841277490749	0.169	0.342	4.40373617741182e-11	MIEN1	CD8+ T cells	GSE199333_pre	ENSG00000141741	84299	migration and invasion enhancer 1	C17orf37|C35|MGC14832|ORB3|Rdx12|XTP4	protein_coding	Q9BRT3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35176
2.20046913530409e-15	0.373828855005028	0.434	0.218	4.67181602116411e-11	PIK3IP1	CD8+ T cells	GSE199333_pre	ENSG00000100100	113791	phosphoinositide-3-kinase interacting protein 1	HGFL|MGC17330|TrIP	protein_coding	Q96FE7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35177
2.36078889585e-15	-0.401148887919552	0.799	0.887	5.01219090477913e-11	SLC25A3	CD8+ T cells	GSE199333_pre	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35178
3.11021475011563e-15	-0.935269327528996	0.467	0.583	6.6032969359705e-11	MT2A	CD8+ T cells	GSE199333_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35179
3.32730991759894e-15	0.326848415701141	0.282	0.107	7.06421168605431e-11	TSPYL1	CD8+ T cells	GSE199333_pre	ENSG00000189241	7259	TSPY like 1	TSPYL	protein_coding	Q9H0U9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35180
5.33041040645282e-15	0.366189854684569	0.475	0.259	1.131699433394e-10	TENT5C	CD8+ T cells	GSE199333_pre	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35181
6.5467812997987e-15	0.26156738107651	1	0.998	1.38994713776026e-10	RPL8	CD8+ T cells	GSE199333_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35182
6.86746786045767e-15	-0.857317205636245	0.839	0.882	1.45803210145377e-10	CORO1A	CD8+ T cells	GSE199333_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35183
8.05477097334624e-15	-0.549559088900019	0.409	0.574	1.71010842535114e-10	EFHD2	CD8+ T cells	GSE199333_pre	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35184
9.64949932572866e-15	0.392580984331991	0.289	0.116	2.04868520184545e-10	RGS2	CD8+ T cells	GSE199333_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35185
9.86249273925889e-15	0.515144104632397	0.414	0.22	2.09390583347206e-10	IFRD1	CD8+ T cells	GSE199333_pre	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35186
1.08789327532999e-14	-0.469519667772288	0.218	0.385	2.30970621285311e-10	TAP1	CD8+ T cells	GSE199333_pre	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35187
1.14275650470432e-14	-0.439399871718049	0.615	0.725	2.42618633513775e-10	ATP5F1B	CD8+ T cells	GSE199333_pre	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35188
1.17096988336176e-14	-0.497869854882608	0.695	0.803	2.48608615936535e-10	RAN	CD8+ T cells	GSE199333_pre	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35189
1.21007408196132e-14	0.267945728109967	1	1	2.56910828341208e-10	RPL5	CD8+ T cells	GSE199333_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35190
1.35987039753448e-14	-0.478605563872587	0.959	0.991	2.88714084100545e-10	ARHGDIB	CD8+ T cells	GSE199333_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35191
1.641581482923e-14	-0.573747850483817	0.599	0.691	3.48524164639382e-10	PARK7	CD8+ T cells	GSE199333_pre	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35192
1.70110105773216e-14	-0.466219959632521	0.441	0.572	3.61160765567114e-10	GNG5	CD8+ T cells	GSE199333_pre	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35193
1.72686179959241e-14	0.375354116357889	0.61	0.39	3.66630028671465e-10	RNF125	CD8+ T cells	GSE199333_pre	ENSG00000101695	54941	ring finger protein 125	FLJ20456	protein_coding	Q96EQ8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35194
2.23883670231961e-14	0.294882567886109	0.404	0.193	4.75327420269477e-10	CSRNP1	CD8+ T cells	GSE199333_pre	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35195
2.33271001799526e-14	-0.474500293220172	0.163	0.318	4.95257663920573e-10	CDK2AP2	CD8+ T cells	GSE199333_pre	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35196
2.85150650538094e-14	-0.470857891496505	0.142	0.286	6.05403346157427e-10	GIMAP1	CD8+ T cells	GSE199333_pre	ENSG00000213203	170575	GTPase, IMAP family member 1	HIMAP1|IAN2|IMAP1|IMAP38	protein_coding	Q8WWP7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35197
3.48226744010858e-14	-0.418727356237053	0.719	0.826	7.39320200209453e-10	TAGLN2	CD8+ T cells	GSE199333_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35198
3.50339053161522e-14	-0.46569662718931	0.534	0.662	7.43804843767227e-10	ITGB2	CD8+ T cells	GSE199333_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35199
3.60297123314997e-14	-0.944089218830257	0.478	0.63	7.6494682251007e-10	LGALS1	CD8+ T cells	GSE199333_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35200
3.77314259583934e-14	-0.522255589426964	0.481	0.653	8.01075904522651e-10	TPI1	CD8+ T cells	GSE199333_pre	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35201
5.18358858288991e-14	-0.454684180562812	0.299	0.449	1.10052769203336e-09	PSMA4	CD8+ T cells	GSE199333_pre	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35202
5.38244094703818e-14	-0.266397092692961	1	1	1.14274603746568e-09	MT-CO1	CD8+ T cells	GSE199333_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35203
9.37766788378231e-14	-0.402553678726997	0.202	0.356	1.99097266840582e-09	CLTA	CD8+ T cells	GSE199333_pre	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35204
9.75591524071843e-14	0.292736347545261	1	0.998	2.07127836475693e-09	RPL27	CD8+ T cells	GSE199333_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35205
1.51886318474729e-13	-0.305504467484707	0.391	0.587	3.22469842753698e-09	TALDO1	CD8+ T cells	GSE199333_pre	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35206
1.62564942015374e-13	-0.502507032292546	0.455	0.572	3.45141628392841e-09	FLNA	CD8+ T cells	GSE199333_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35207
1.71691770552109e-13	-0.392304753982747	0.127	0.27	3.64518798059183e-09	CCDC167	CD8+ T cells	GSE199333_pre	ENSG00000198937	154467	coiled-coil domain containing 167	C6orf129|dJ153P14.2	protein_coding	Q9P0B6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35208
2.25457252688728e-13	-0.471898030978216	0.161	0.306	4.78668293183438e-09	DENND2D	CD8+ T cells	GSE199333_pre	ENSG00000162777	79961	DENN domain containing 2D	FLJ22457|RP5-1180E21.2	protein_coding	Q9H6A0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35209
2.30589424931152e-13	-0.494356878652423	0.167	0.309	4.8956440807133e-09	TPM4	CD8+ T cells	GSE199333_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35210
2.3090739642769e-13	0.395252382817815	0.881	0.878	4.90239493355629e-09	EIF3E	CD8+ T cells	GSE199333_pre	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35211
3.04191147831196e-13	0.419446316793207	0.52	0.318	6.45828225960412e-09	GADD45B	CD8+ T cells	GSE199333_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35212
3.57127087296478e-13	-0.383884629386746	0.204	0.354	7.58216519039153e-09	CYC1	CD8+ T cells	GSE199333_pre	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35213
3.60882834264193e-13	0.281032555726639	0.985	0.973	7.66190345426309e-09	RPL31	CD8+ T cells	GSE199333_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35214
3.67458382570298e-13	0.289495685292295	0.986	0.957	7.80150892034999e-09	RPL36A	CD8+ T cells	GSE199333_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35215
3.86649151316986e-13	-0.361788657374835	0.155	0.302	8.20894813161093e-09	FDPS	CD8+ T cells	GSE199333_pre	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35216
3.92247460454044e-13	0.392342357675152	0.255	0.098	8.32780583289981e-09	AQP3	CD8+ T cells	GSE199333_pre	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35217
4.51807045584966e-13	-0.441273812145978	0.605	0.716	9.5923153848144e-09	ATP5MC3	CD8+ T cells	GSE199333_pre	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35218
4.83322296888593e-13	-0.386451221715371	0.597	0.751	1.02614156852417e-08	TXN	CD8+ T cells	GSE199333_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35219
5.30472758694848e-13	-0.893141679825937	0.312	0.433	1.12624671398503e-08	CD27	CD8+ T cells	GSE199333_pre	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35220
5.56335379082141e-13	-0.344303528120446	0.165	0.315	1.18115564332929e-08	TWF2	CD8+ T cells	GSE199333_pre	ENSG00000247596	11344	twinfilin actin binding protein 2	A6r|A6RP|PTK9L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35221
5.8502130794092e-13	0.364804243491581	0.589	0.394	1.24205873888937e-08	PPP1CB	CD8+ T cells	GSE199333_pre	ENSG00000213639	5500	protein phosphatase 1 catalytic subunit beta	MP|PP-1B|PP1B|PP1beta|PP1c|PPP1beta	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35222
6.18528779813126e-13	-0.393392630021682	0.533	0.635	1.31319845242125e-08	COPE	CD8+ T cells	GSE199333_pre	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35223
6.40826799279476e-13	-0.417740048020212	0.605	0.696	1.36053937755026e-08	LY6E	CD8+ T cells	GSE199333_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35224
6.76824255149993e-13	-0.401428311916465	0.617	0.717	1.43696557610895e-08	POMP	CD8+ T cells	GSE199333_pre	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35225
1.0218940795471e-12	-0.283021789387557	0.966	0.989	2.16958332028644e-08	SRP14	CD8+ T cells	GSE199333_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35226
1.33855030412082e-12	-0.3564788184833	0.131	0.267	2.84187615067892e-08	TXNDC17	CD8+ T cells	GSE199333_pre	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35227
1.45313099352283e-12	-0.528046040554045	0.721	0.834	3.08514241234832e-08	HMGN2	CD8+ T cells	GSE199333_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35228
1.54609790538129e-12	-0.368973310283416	0.861	0.928	3.28252046291502e-08	AES	CD8+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35229
1.6629763265098e-12	0.286936685195327	0.999	0.993	3.53066503881296e-08	EEF1B2	CD8+ T cells	GSE199333_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35230
2.04703853244383e-12	-0.42621194380261	0.738	0.882	4.34606750823149e-08	CALR	CD8+ T cells	GSE199333_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35231
2.0519001661481e-12	-0.320604572565446	0.171	0.327	4.35638924274903e-08	PYCARD	CD8+ T cells	GSE199333_pre	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35232
2.47054219775453e-12	-0.373567338401233	0.187	0.34	5.24520814005265e-08	PHPT1	CD8+ T cells	GSE199333_pre	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35233
2.9247965725101e-12	-0.312157744696076	0.76	0.871	6.20963560309619e-08	ELOB	CD8+ T cells	GSE199333_pre	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35234
2.98887455834412e-12	-0.341441716197189	0.778	0.846	6.3456795748204e-08	COX5B	CD8+ T cells	GSE199333_pre	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35235
3.0322272778108e-12	-0.36517998608126	0.146	0.284	6.4377217335201e-08	YARS	CD8+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35236
3.36241130012495e-12	-0.479048770004103	0.333	0.47	7.13873543129527e-08	APOBEC3G	CD8+ T cells	GSE199333_pre	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35237
3.61062588645084e-12	0.34584730358337	0.315	0.152	7.66571981952377e-08	C16orf54	CD8+ T cells	GSE199333_pre	ENSG00000185905	283897	chromosome 16 open reading frame 54	FLJ35681	protein_coding	Q6UWD8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35238
3.61814700938171e-12	-0.44837142471206	0.893	0.977	7.6816879156183e-08	PPIA	CD8+ T cells	GSE199333_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35239
4.42988290010522e-12	-0.542351577789326	0.314	0.444	9.40508438521338e-08	DYNLL1	CD8+ T cells	GSE199333_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35240
4.70867583278351e-12	-0.330102436763188	0.823	0.894	9.99698966058267e-08	PRRC2C	CD8+ T cells	GSE199333_pre	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35241
4.87984665366141e-12	-0.428264931728567	0.366	0.503	1.03604024303885e-07	CFLAR	CD8+ T cells	GSE199333_pre	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35242
5.05185206844676e-12	0.541074690540725	0.366	0.202	1.07255871265193e-07	TRGC2	CD8+ T cells	GSE199333_pre	ENSG00000227191	NA	NA	TCRGC2|TRGC2(2X)|TRGC2(3X)	TR_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35243
5.23055951278296e-12	0.309640240841266	0.382	0.2	1.11050009015895e-07	AC016831.5	CD8+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35244
6.81979562945061e-12	-0.444238432682163	0.297	0.431	1.44791081008866e-07	PPM1G	CD8+ T cells	GSE199333_pre	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35245
7.21075953710868e-12	0.261296675432017	1	1	1.53091635732354e-07	MT-CYB	CD8+ T cells	GSE199333_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35246
8.63859865120073e-12	-0.416607483883308	0.309	0.445	1.83406087963643e-07	NDUFS6	CD8+ T cells	GSE199333_pre	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35247
1.10415895801448e-11	-0.294733555935662	0.127	0.259	2.34423988376054e-07	MRPS12	CD8+ T cells	GSE199333_pre	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35248
1.15233759766128e-11	-0.347706784992242	0.512	0.628	2.44652795359467e-07	RAC1	CD8+ T cells	GSE199333_pre	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35249
1.16643205824614e-11	-0.482544850277728	0.263	0.394	2.47645190286239e-07	WDR1	CD8+ T cells	GSE199333_pre	ENSG00000071127	9948	WD repeat domain 1	AIP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35250
1.17719899101134e-11	-0.423713531636647	0.211	0.351	2.49931117781617e-07	ARHGAP30	CD8+ T cells	GSE199333_pre	ENSG00000186517	257106	Rho GTPase activating protein 30	FLJ00267	protein_coding	Q7Z6I6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35251
1.20166256991136e-11	-0.470284560352627	0.153	0.286	2.55124980217881e-07	LIMS1	CD8+ T cells	GSE199333_pre	ENSG00000169756	3987	LIM zinc finger domain containing 1	PINCH|PINCH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35252
1.49496905973069e-11	-0.446217438535541	0.338	0.469	3.17396881071422e-07	C12orf75	CD8+ T cells	GSE199333_pre	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35253
1.68408678346921e-11	0.344633917749436	0.656	0.483	3.57548464998348e-07	SELENOK	CD8+ T cells	GSE199333_pre	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35254
1.70971867435692e-11	-0.475532420077139	0.432	0.572	3.62990371752717e-07	DEK	CD8+ T cells	GSE199333_pre	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35255
1.78880215269926e-11	-0.481472073395682	0.42	0.549	3.7978058503958e-07	SYNE2	CD8+ T cells	GSE199333_pre	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35256
1.80057604040276e-11	0.349806887204971	0.456	0.281	3.82280299137911e-07	TNRC6B	CD8+ T cells	GSE199333_pre	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35257
1.85416747653908e-11	-0.253231322810865	1	1	3.93658296944012e-07	HLA-C	CD8+ T cells	GSE199333_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35258
2.25931647289177e-11	-0.408956976988104	0.434	0.555	4.79675480359651e-07	ATP5MF	CD8+ T cells	GSE199333_pre	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35259
2.68633930440804e-11	-0.308843580796281	0.976	1	5.70336697718871e-07	SERF2	CD8+ T cells	GSE199333_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35260
2.86977014134383e-11	-0.331433522342198	0.895	0.989	6.09280898708708e-07	CYBA	CD8+ T cells	GSE199333_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35261
3.10619065098333e-11	-0.3805399035986	0.274	0.406	6.59475337110271e-07	AP2S1	CD8+ T cells	GSE199333_pre	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35262
3.72422877707829e-11	0.278162506910516	1	1	7.90691011661492e-07	H3F3B	CD8+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35263
4.18499881455126e-11	-0.444806516784202	0.259	0.392	8.88517098317378e-07	SH2D1A	CD8+ T cells	GSE199333_pre	ENSG00000183918	4068	SH2 domain containing 1A	DSHP|EBVS|IMD5|LYP|MTCP1|SAP|XLP|XLPD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35264
6.1809338480078e-11	0.324944640818827	0.421	0.247	1.31227406527054e-06	SAMSN1	CD8+ T cells	GSE199333_pre	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35265
7.10504280170989e-11	-0.365678740781354	0.468	0.59	1.50847163723103e-06	EIF3A	CD8+ T cells	GSE199333_pre	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35266
7.94538139333942e-11	-0.37717942544125	0.722	0.832	1.68688392361989e-06	EIF5A	CD8+ T cells	GSE199333_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35267
8.93875239568716e-11	0.337621608994531	0.694	0.569	1.89778652112834e-06	MT-ND4L	CD8+ T cells	GSE199333_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35268
9.33234281512677e-11	0.321945408172257	0.92	0.88	1.98134970307957e-06	SRSF7	CD8+ T cells	GSE199333_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35269
9.37277515040739e-11	-0.35819899053374	0.219	0.365	1.98993389218299e-06	AC004687.1	CD8+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35270
9.97523509318047e-11	-0.37236466825708	0.335	0.463	2.11784216263315e-06	MDH2	CD8+ T cells	GSE199333_pre	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35271
1.06384656294043e-10	-0.304459523506398	0.141	0.265	2.25865263777883e-06	SIT1	CD8+ T cells	GSE199333_pre	ENSG00000137078	27240	signaling threshold regulating transmembrane adaptor 1	SIT	protein_coding	Q9Y3P8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35272
1.08165798992041e-10	-0.531847734369977	0.534	0.655	2.29646807840001e-06	ARPC1B	CD8+ T cells	GSE199333_pre	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35273
1.12667364941693e-10	-0.420120748681479	0.127	0.256	2.39204082507708e-06	HLA-DMA	CD8+ T cells	GSE199333_pre	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35274
1.15443225190373e-10	-0.34450500777176	0.148	0.272	2.4509751140168e-06	MT1X	CD8+ T cells	GSE199333_pre	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35275
1.44379753218452e-10	-0.352557289319777	0.245	0.379	3.06532654058096e-06	GTF3C6	CD8+ T cells	GSE199333_pre	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35276
1.51008426206705e-10	-0.300790208851195	0.879	0.962	3.20605989679455e-06	ATP5MC2	CD8+ T cells	GSE199333_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35277
1.58987134566357e-10	-0.324140366914174	0.759	0.848	3.37545585397832e-06	COX6B1	CD8+ T cells	GSE199333_pre	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35278
1.66015872652158e-10	-0.650235027539935	0.605	0.705	3.52468299227796e-06	H2AFZ	CD8+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35279
2.21296277499304e-10	-0.44827421604503	0.4	0.499	4.69834126758773e-06	PSMB3	CD8+ T cells	GSE199333_pre	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35280
2.31396033952525e-10	-0.399946779432974	0.237	0.37	4.91276919684606e-06	PPP1R18	CD8+ T cells	GSE199333_pre	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35281
2.40371943735781e-10	0.295786381989168	0.354	0.19	5.10333673745436e-06	IER5	CD8+ T cells	GSE199333_pre	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35282
2.47629367083161e-10	-0.324035477965719	0.24	0.377	5.2574190925426e-06	ISG15	CD8+ T cells	GSE199333_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35283
3.7774886643506e-10	0.4473040457654	0.266	0.134	8.01998618328276e-06	GADD45A	CD8+ T cells	GSE199333_pre	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35284
4.42908301661575e-10	-0.40306372413099	0.144	0.261	9.40338615257689e-06	TIGIT	CD8+ T cells	GSE199333_pre	ENSG00000181847	201633	T cell immunoreceptor with Ig and ITIM domains	DKFZp667A205|FLJ39873|VSIG9|VSTM3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35285
5.91078617621702e-10	-0.405469207901457	0.522	0.601	1.25491901307263e-05	CAPZB	CD8+ T cells	GSE199333_pre	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35286
7.0622335427431e-10	-0.413822924837612	0.325	0.444	1.49938280345979e-05	TBC1D10C	CD8+ T cells	GSE199333_pre	ENSG00000175463	374403	TBC1 domain family member 10C	Carabin|EPI64C|FLJ00332	protein_coding	Q8IV04	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35287
7.65521772556937e-10	-0.288307088628207	0.169	0.297	1.62527927531563e-05	NDUFV1	CD8+ T cells	GSE199333_pre	ENSG00000167792	4723	NADH:ubiquinone oxidoreductase core subunit V1	CI-51K	protein_coding	P49821	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35288
7.94588367360006e-10	-0.326504501586588	0.189	0.317	1.68699056274203e-05	MRPS34	CD8+ T cells	GSE199333_pre	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35289
8.07948594926256e-10	-0.374037231257867	0.223	0.347	1.71535566188793e-05	PSMB2	CD8+ T cells	GSE199333_pre	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35290
8.65158165905421e-10	-0.383858602493161	0.604	0.744	1.8368173020338e-05	CST7	CD8+ T cells	GSE199333_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35291
8.89359698930366e-10	-0.321706995230487	0.645	0.726	1.88819957679906e-05	COX7B	CD8+ T cells	GSE199333_pre	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35292
1.03440911334522e-09	-0.348488521690258	0.378	0.487	2.19615398854324e-05	MRPL41	CD8+ T cells	GSE199333_pre	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35293
1.05368615036652e-09	-0.498969105310882	0.311	0.415	2.23708106584316e-05	PGAM1	CD8+ T cells	GSE199333_pre	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35294
1.0850401599766e-09	-0.331452949528202	0.535	0.63	2.30364876364633e-05	SF3B2	CD8+ T cells	GSE199333_pre	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35295
1.09114394165348e-09	-0.601898197951078	0.563	0.673	2.31660770252451e-05	GZMA	CD8+ T cells	GSE199333_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35296
1.37018275269825e-09	-0.288642174370443	0.165	0.29	2.90903500225366e-05	APOBEC3C	CD8+ T cells	GSE199333_pre	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35297
1.38102527561834e-09	-0.324271578946671	0.639	0.757	2.9320547626653e-05	SF3B1	CD8+ T cells	GSE199333_pre	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35298
1.41600743472591e-09	-0.472704713797607	0.296	0.42	3.00632538466659e-05	UCP2	CD8+ T cells	GSE199333_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35299
1.48318865913108e-09	-0.363764622556224	0.251	0.381	3.14895784220121e-05	IFI16	CD8+ T cells	GSE199333_pre	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35300
1.54879822727689e-09	-0.35864838791048	0.428	0.53	3.28825351633156e-05	BRK1	CD8+ T cells	GSE199333_pre	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35301
1.63896847550312e-09	-0.298426002881024	0.976	0.995	3.47969397034067e-05	HSP90AA1	CD8+ T cells	GSE199333_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35302
1.64654648580609e-09	-0.311569928648628	0.753	0.853	3.49578284401491e-05	MZT2B	CD8+ T cells	GSE199333_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35303
1.72136720730803e-09	0.398037733291345	0.55	0.411	3.65463471783568e-05	RORA	CD8+ T cells	GSE199333_pre	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35304
1.81582935411808e-09	-0.347227324323935	0.274	0.408	3.8551873017281e-05	TRAF3IP3	CD8+ T cells	GSE199333_pre	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35305
1.90541196721051e-09	-0.353648770775356	0.597	0.703	4.04538014758464e-05	LCP1	CD8+ T cells	GSE199333_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35306
2.22051033862493e-09	-0.39856639095388	0.352	0.453	4.7143654999346e-05	NDUFA12	CD8+ T cells	GSE199333_pre	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35307
2.33300382725884e-09	-0.698867842119484	0.308	0.404	4.95320042565324e-05	PKM	CD8+ T cells	GSE199333_pre	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35308
2.37776862371193e-09	-0.327757496761719	0.55	0.639	5.0482405650028e-05	NDUFA1	CD8+ T cells	GSE199333_pre	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35309
2.43199577157379e-09	-0.288307088628207	0.179	0.301	5.16337022262831e-05	MMADHC	CD8+ T cells	GSE199333_pre	ENSG00000168288	27249	metabolism of cobalamin associated D	C2orf25|cblD|CL25022	protein_coding	Q9H3L0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35310
2.61265509053562e-09	-0.416400795635346	0.672	0.732	5.54692802271617e-05	COX8A	CD8+ T cells	GSE199333_pre	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35311
3.14665853832004e-09	-0.490852895996715	0.38	0.479	6.68067074270727e-05	ACTR3	CD8+ T cells	GSE199333_pre	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35312
3.35043681831069e-09	-0.298939926674357	0.8	0.902	7.11331240895543e-05	NCL	CD8+ T cells	GSE199333_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35313
3.54109409963545e-09	-0.31814674443142	0.205	0.331	7.51809688293603e-05	KPNB1	CD8+ T cells	GSE199333_pre	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35314
3.55165083479329e-09	0.276033915145646	0.469	0.299	7.54050988734964e-05	SLC2A3	CD8+ T cells	GSE199333_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35315
3.7889826386814e-09	0.337261507329437	0.925	0.943	8.04438904018449e-05	ITM2B	CD8+ T cells	GSE199333_pre	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35316
4.13862208575127e-09	-0.348242872951219	0.26	0.381	8.78670855025853e-05	VCP	CD8+ T cells	GSE199333_pre	ENSG00000165280	7415	valosin containing protein	CDC48|IBMPFD|p97|TERA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35317
4.34850991195849e-09	-0.346309951943198	0.161	0.277	9.23232139407907e-05	MAP2K3	CD8+ T cells	GSE199333_pre	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35318
4.37966073995366e-09	-0.278380547046019	0.855	0.921	9.29845771699562e-05	RBM3	CD8+ T cells	GSE199333_pre	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35319
4.63621945839963e-09	-0.342554871082227	0.347	0.478	9.84315753212825e-05	HMGA1	CD8+ T cells	GSE199333_pre	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35320
5.18929096426767e-09	-0.388865280515216	0.545	0.631	0.000110173836462367	HNRNPD	CD8+ T cells	GSE199333_pre	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35321
5.25486459119135e-09	-0.321032989804195	0.237	0.358	0.000111566030135584	DDX39B	CD8+ T cells	GSE199333_pre	ENSG00000225859	7919	DExD-box helicase 39B	BAT1|D6S81E|UAP56	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35322
5.65978300866965e-09	0.256507691220484	0.334	0.19	0.000120162853057065	ZBTB1	CD8+ T cells	GSE199333_pre	ENSG00000126804	22890	zinc finger and BTB domain containing 1	KIAA0997|ZNF909	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35323
6.05417468075769e-09	0.255945073617413	0.364	0.209	0.000128536182647167	SNHG7	CD8+ T cells	GSE199333_pre	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35324
6.61145935916358e-09	-0.281741867597215	0.421	0.549	0.000140367893654402	NDUFA11	CD8+ T cells	GSE199333_pre	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35325
7.29229442777709e-09	-0.389092259672945	0.78	0.873	0.000154822702996135	GMFG	CD8+ T cells	GSE199333_pre	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35326
8.25872402729037e-09	-0.337841277490749	0.243	0.369	0.000175340969823402	ANXA6	CD8+ T cells	GSE199333_pre	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35327
8.94227822135486e-09	0.292591739744582	0.534	0.372	0.000189853508917585	CNOT6L	CD8+ T cells	GSE199333_pre	ENSG00000138767	246175	CCR4-NOT transcription complex subunit 6 like	Ccr4b|DKFZp434K098	protein_coding	Q96LI5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35328
8.9794887907856e-09	-0.293599848510899	0.688	0.778	0.000190643526517169	PSMB1	CD8+ T cells	GSE199333_pre	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35329
9.396774247051e-09	-0.294504022319188	0.171	0.286	0.00019950291403914	SCAMP2	CD8+ T cells	GSE199333_pre	ENSG00000140497	10066	secretory carrier membrane protein 2	NA	protein_coding	O15127	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35330
9.44113467493147e-09	-0.321572888346	0.501	0.596	0.00020044473028347	NDUFB2	CD8+ T cells	GSE199333_pre	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35331
1.24654665738595e-08	-0.335547904625335	0.299	0.413	0.000264654320829611	NDUFA2	CD8+ T cells	GSE199333_pre	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35332
1.31713527354799e-08	-0.421884873443887	0.173	0.292	0.000279640989926974	HIST1H1D	CD8+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35333
1.3393619868959e-08	-0.355296153537846	0.257	0.379	0.000284359943437868	CSK	CD8+ T cells	GSE199333_pre	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35334
1.51131559679745e-08	0.280623834180341	0.372	0.224	0.000320867414356067	TTC3	CD8+ T cells	GSE199333_pre	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35335
1.53681074873195e-08	-0.346510143662137	0.259	0.386	0.000326280290063281	ITGA4	CD8+ T cells	GSE199333_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35336
1.62068981559685e-08	-0.318926529979464	0.443	0.56	0.000344088654749366	HIGD2A	CD8+ T cells	GSE199333_pre	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35337
1.65306908235105e-08	-0.417735062378067	0.407	0.504	0.000350963096873951	PFDN2	CD8+ T cells	GSE199333_pre	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35338
1.6578929998034e-08	0.263228033728957	0.68	0.567	0.00035198726278826	SNHG8	CD8+ T cells	GSE199333_pre	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35339
1.74442026085426e-08	0.250291982838351	0.441	0.281	0.000370357865581969	SDCBP	CD8+ T cells	GSE199333_pre	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35340
1.89062429819619e-08	-0.26795106568836	0.158	0.267	0.000401398444750033	PSMC4	CD8+ T cells	GSE199333_pre	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35341
1.97795129856367e-08	-0.30721122598992	0.23	0.352	0.000419938840198053	LBR	CD8+ T cells	GSE199333_pre	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35342
2.04497002458973e-08	0.638442653535443	0.255	0.143	0.000434167585920646	XCL2	CD8+ T cells	GSE199333_pre	ENSG00000143185	6846	X-C motif chemokine ligand 2	SCM-1b|SCYC2	protein_coding	Q9UBD3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35343
2.23111229933902e-08	-0.31178405623279	0.539	0.624	0.000473687452272668	NDUFC2	CD8+ T cells	GSE199333_pre	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35344
2.26974201785918e-08	0.296719269732954	0.786	0.671	0.000481888927811683	ARL4C	CD8+ T cells	GSE199333_pre	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35345
2.29990254034829e-08	-0.339338625877252	0.331	0.444	0.000488292308341346	TRAPPC1	CD8+ T cells	GSE199333_pre	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35346
2.3018274473737e-08	-0.519284822994738	0.703	0.767	0.00048870098535191	VAMP2	CD8+ T cells	GSE199333_pre	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35347
2.38782373280441e-08	-0.302342596269363	0.667	0.746	0.000506958856711703	SERBP1	CD8+ T cells	GSE199333_pre	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35348
2.635123860207e-08	0.704896369737265	0.424	0.301	0.000559463146760549	KLRB1	CD8+ T cells	GSE199333_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35349
2.86132113912213e-08	-0.27531470691002	0.691	0.784	0.000607487091047019	RHOA	CD8+ T cells	GSE199333_pre	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35350
2.93628687385186e-08	-0.342131185620115	0.408	0.506	0.000623403066187488	SNRPD1	CD8+ T cells	GSE199333_pre	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35351
2.97675401966552e-08	-0.379912553184425	0.34	0.436	0.000631994645915186	NDUFV2	CD8+ T cells	GSE199333_pre	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35352
2.98453495911171e-08	-0.251911098703573	0.157	0.27	0.000633646617169007	DEF6	CD8+ T cells	GSE199333_pre	ENSG00000023892	50619	DEF6 guanine nucleotide exchange factor	IBP|SLAT|SWAP70L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35353
2.98902087794994e-08	-0.299581944304397	0.532	0.605	0.000634599022597552	C19orf53	CD8+ T cells	GSE199333_pre	ENSG00000104979	28974	chromosome 19 open reading frame 53	HSPC023|LYDG10	protein_coding	Q9UNZ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35354
3.02071741340433e-08	0.323209838637793	0.312	0.179	0.000641328514039873	HOPX	CD8+ T cells	GSE199333_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35355
3.08335074855377e-08	-0.281692631749478	0.253	0.377	0.000654626197425451	YWHAE	CD8+ T cells	GSE199333_pre	ENSG00000274474	7531	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon	FLJ45465	protein_coding	P62258	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35356
3.52816222279439e-08	-0.332961415246394	0.27	0.379	0.000749064121521478	MYO1G	CD8+ T cells	GSE199333_pre	ENSG00000136286	64005	myosin IG	HA-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35357
3.78981353841329e-08	-0.328183929887617	0.265	0.37	0.000804615312340526	CASP8	CD8+ T cells	GSE199333_pre	ENSG00000064012	841	caspase 8	Casp-8|FLICE|MACH|MCH5	protein_coding	Q14790	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35358
3.81394652220533e-08	-0.382968589763641	0.387	0.488	0.000809738986129414	LAT	CD8+ T cells	GSE199333_pre	ENSG00000213658	27040	linker for activation of T cells	LAT1	protein_coding	O43561	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35359
3.84606045901826e-08	-0.360337593611805	0.389	0.467	0.000816557096054166	PSMB6	CD8+ T cells	GSE199333_pre	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35360
4.31544996742755e-08	0.276084706218928	0.343	0.209	0.000916213182584542	SVIP	CD8+ T cells	GSE199333_pre	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35361
4.37161708157521e-08	0.254368361029	0.264	0.143	0.000928138022589232	CHMP1B	CD8+ T cells	GSE199333_pre	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35362
4.3970135039324e-08	-0.461136289245822	0.679	0.726	0.000933529937019888	S100A10	CD8+ T cells	GSE199333_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35363
4.77027220178886e-08	-0.300584331883456	0.565	0.651	0.00101277649116179	UQCR10	CD8+ T cells	GSE199333_pre	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35364
4.95008247880812e-08	-0.255830933731923	0.808	0.884	0.00105095201107575	UQCRH	CD8+ T cells	GSE199333_pre	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35365
5.23683921674636e-08	-0.29473777552049	0.199	0.311	0.00111183333410742	UBE2L6	CD8+ T cells	GSE199333_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35366
5.39220804507385e-08	-0.250689328395667	0.153	0.261	0.00114481969004963	NDUFS2	CD8+ T cells	GSE199333_pre	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35367
5.43551546183783e-08	-0.315661042641971	0.268	0.386	0.00115401428770279	SLBP	CD8+ T cells	GSE199333_pre	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35368
5.58846600754489e-08	-0.296519555916373	0.442	0.544	0.00118648721806185	RNPS1	CD8+ T cells	GSE199333_pre	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35369
5.61583903316383e-08	-0.349056064986676	0.163	0.267	0.00119229878513101	GBP5	CD8+ T cells	GSE199333_pre	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35370
5.93456387987428e-08	-0.300321932158693	0.407	0.515	0.00125996725733611	UQCRQ	CD8+ T cells	GSE199333_pre	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35371
6.18548345153614e-08	-0.255060042866228	0.968	0.975	0.00131323999159564	CHCHD2	CD8+ T cells	GSE199333_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35372
6.20979347524069e-08	-0.398377748093878	0.191	0.301	0.00131840125272835	IDH2	CD8+ T cells	GSE199333_pre	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35373
6.22832605519473e-08	-0.277267757033473	0.224	0.338	0.00132233590477839	SUMO3	CD8+ T cells	GSE199333_pre	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35374
6.28734026375754e-08	-0.397444729730171	0.655	0.733	0.00133486521139836	SLC25A5	CD8+ T cells	GSE199333_pre	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35375
7.19929093848451e-08	-0.269580690926307	0.197	0.304	0.00152848145914965	ADH5	CD8+ T cells	GSE199333_pre	ENSG00000197894	128	alcohol dehydrogenase 5 (class III), chi polypeptide	ADH-3|ADHX|FDH|GSNOR	protein_coding	P11766	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35376
7.95377989077331e-08	-0.380559897448684	0.385	0.483	0.00168866700861008	TPR	CD8+ T cells	GSE199333_pre	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35377
8.06077670431477e-08	-0.28230181912435	0.671	0.748	0.00171138350209307	ATP5MPL	CD8+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35378
9.39351442242166e-08	-0.302702268670791	0.533	0.608	0.00199433704702434	RTRAF	CD8+ T cells	GSE199333_pre	ENSG00000087302	51637	RNA transcription, translation and transport factor	C14orf166|CGI-99|CLE|CLE7|hCLE1|LCRP369|RLLM1	protein_coding	Q9Y224	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35379
9.83502490104351e-08	-0.286606624063559	0.208	0.315	0.00208807413674055	DERL1	CD8+ T cells	GSE199333_pre	ENSG00000136986	79139	derlin 1	DER-1|DER1|derlin-1|FLJ13784|MGC3067|PRO2577	protein_coding	Q9BUN8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35380
1.01077820340376e-07	-0.379980951590157	0.318	0.401	0.00214598320364652	SEM1	CD8+ T cells	GSE199333_pre	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35381
1.06392141515006e-07	-0.307668239591389	0.196	0.301	0.00225881155650508	ARRB2	CD8+ T cells	GSE199333_pre	ENSG00000141480	409	arrestin beta 2	ARR2|BARR2|DKFZp686L0365	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35382
1.12591619157732e-07	-0.25559179438929	0.175	0.283	0.00239043266633781	EBP	CD8+ T cells	GSE199333_pre	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35383
1.15863829250516e-07	-0.275438036644428	0.157	0.259	0.0024599049588177	NUDT1	CD8+ T cells	GSE199333_pre	ENSG00000106268	4521	nudix hydrolase 1	MTH1	protein_coding	P36639	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35384
1.19226904340744e-07	-0.286075297168677	0.293	0.404	0.00253130640605834	ILF3	CD8+ T cells	GSE199333_pre	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35385
1.27054224298892e-07	-0.308654543397673	0.176	0.279	0.00269748823608978	HDGF	CD8+ T cells	GSE199333_pre	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35386
1.29520846840223e-07	-0.558426439161812	0.454	0.497	0.00274985709926478	PSMB9	CD8+ T cells	GSE199333_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35387
1.65537628708004e-07	-0.252005108011445	0.621	0.714	0.00351452939509963	GTF3A	CD8+ T cells	GSE199333_pre	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35388
1.66456876751317e-07	-0.274253117367094	0.42	0.517	0.0035340459503072	LAMTOR5	CD8+ T cells	GSE199333_pre	ENSG00000134248	10542	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	HBXIP|MGC71071|XIP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35389
1.66728083514151e-07	-0.252566297065005	0.18	0.286	0.00353980394108894	ABI1	CD8+ T cells	GSE199333_pre	ENSG00000136754	10006	abl interactor 1	ABI-1|E3B1|SSH3BP1	protein_coding	Q8IZP0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35390
1.69516704946531e-07	-0.377720876016526	0.231	0.329	0.0035990091627198	PSMA5	CD8+ T cells	GSE199333_pre	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35391
1.71624287534783e-07	-0.331005791184653	0.46	0.522	0.00364375524865098	PSMD8	CD8+ T cells	GSE199333_pre	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35392
1.94898960107517e-07	-0.318870252798017	0.332	0.442	0.0041378998220427	HCLS1	CD8+ T cells	GSE199333_pre	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35393
2.39975253317055e-07	0.26209225042395	0.287	0.168	0.00509491460317439	TAGAP	CD8+ T cells	GSE199333_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35394
2.44647476563753e-07	-0.261523369885567	0.19	0.299	0.00519411057492503	GSTO1	CD8+ T cells	GSE199333_pre	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35395
2.46457095601818e-07	-0.250972015775995	0.17	0.274	0.00523253059672219	GLRX	CD8+ T cells	GSE199333_pre	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35396
2.6277732318128e-07	-0.283237946833086	0.787	0.864	0.00557902534846175	HMGN1	CD8+ T cells	GSE199333_pre	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35397
2.72324932683523e-07	0.278029940231573	0.494	0.354	0.00578173064580387	GCC2	CD8+ T cells	GSE199333_pre	ENSG00000135968	9648	GRIP and coiled-coil domain containing 2	GCC185|KIAA0336	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35398
2.92125955718817e-07	-0.299181201208368	0.354	0.453	0.00620212616586621	ATP5PB	CD8+ T cells	GSE199333_pre	ENSG00000116459	515	ATP synthase peripheral stalk-membrane subunit b	ATP5F1	protein_coding	P24539	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35399
3.06991742107687e-07	-0.257710394688534	0.652	0.769	0.0065177416766883	RBM25	CD8+ T cells	GSE199333_pre	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35400
3.22290144545924e-07	-0.315596640132883	0.185	0.284	0.00684254205885451	RNASEH2B	CD8+ T cells	GSE199333_pre	ENSG00000136104	79621	ribonuclease H2 subunit B	AGS2|DLEU8|FLJ11712	protein_coding	Q5TBB1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35401
3.28255422704725e-07	-0.409592280840372	0.245	0.345	0.00696919087944402	RIPOR2	CD8+ T cells	GSE199333_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35402
3.60290020287038e-07	-0.295955466572122	0.433	0.538	0.00764931742071411	ZNF207	CD8+ T cells	GSE199333_pre	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35403
3.6148060981468e-07	0.370378165171435	0.608	0.492	0.00767459482697547	TUBA4A	CD8+ T cells	GSE199333_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35404
3.75166027295365e-07	-0.259838765489476	0.775	0.853	0.00796514992550789	PPIB	CD8+ T cells	GSE199333_pre	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35405
4.22513796565675e-07	-0.281450095640351	0.402	0.513	0.00897039041488585	ATP6V0B	CD8+ T cells	GSE199333_pre	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35406
4.22770508823504e-07	-0.343865065118519	0.271	0.37	0.00897584067283181	MYO1F	CD8+ T cells	GSE199333_pre	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35407
4.58267277405275e-07	-0.252891405071029	0.429	0.533	0.0097294725665914	FKBP8	CD8+ T cells	GSE199333_pre	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35408
4.66652461236285e-07	-0.257670928806766	0.163	0.261	0.00990749840450756	SNRPA	CD8+ T cells	GSE199333_pre	ENSG00000077312	6626	small nuclear ribonucleoprotein polypeptide A	Mud1|U1-A|U1A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35409
4.92261597090396e-07	-0.293631634194294	0.514	0.589	0.0104512059678262	DRAP1	CD8+ T cells	GSE199333_pre	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35410
5.1108101184549e-07	-0.29445483788332	0.442	0.522	0.0108507609624916	MRPL54	CD8+ T cells	GSE199333_pre	ENSG00000183617	116541	mitochondrial ribosomal protein L54	NA	protein_coding	Q6P161	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35411
5.13774885781175e-07	-0.268554506046509	0.226	0.331	0.0109079546000201	CARD16	CD8+ T cells	GSE199333_pre	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35412
5.79917758017558e-07	-0.279751542228333	0.312	0.419	0.0123122339204708	EWSR1	CD8+ T cells	GSE199333_pre	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35413
5.91146929002946e-07	-0.343487840631891	0.374	0.472	0.0125506404496615	PCSK7	CD8+ T cells	GSE199333_pre	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35414
6.18558334850602e-07	-0.311160026929189	0.323	0.428	0.0131326120072131	TLN1	CD8+ T cells	GSE199333_pre	ENSG00000137076	7094	talin 1	ILWEQ|TLN	protein_coding	Q9Y490	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35415
6.26723366426618e-07	-0.279791706449945	0.72	0.798	0.0133059637926035	COX6A1	CD8+ T cells	GSE199333_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35416
7.18756975953637e-07	-0.377183777665987	0.478	0.549	0.0152599293564717	AHNAK	CD8+ T cells	GSE199333_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35417
8.21419863550027e-07	-0.30094169467922	0.214	0.315	0.0174395651230306	BANF1	CD8+ T cells	GSE199333_pre	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35418
8.56946484194472e-07	-0.313915438245269	0.19	0.281	0.0181938308059328	NDUFB3	CD8+ T cells	GSE199333_pre	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35419
8.6109660858043e-07	-0.309435965512301	0.441	0.519	0.0182819420967711	PRPF40A	CD8+ T cells	GSE199333_pre	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35420
8.79127475288991e-07	-0.301825201659086	0.417	0.51	0.0186647554278606	PA2G4	CD8+ T cells	GSE199333_pre	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35421
8.98223888437806e-07	-0.384405956766844	0.638	0.676	0.0190701913754231	CD81	CD8+ T cells	GSE199333_pre	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35422
9.14663904360189e-07	-0.340408143586375	0.552	0.61	0.0194192293534712	H2AFV	CD8+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35423
9.37546295623689e-07	-0.297245041278384	0.454	0.555	0.0199050454023865	ZC3H15	CD8+ T cells	GSE199333_pre	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35424
9.77712019383292e-07	-0.304299073375768	0.368	0.462	0.0207578038835267	BUD31	CD8+ T cells	GSE199333_pre	ENSG00000106245	8896	BUD31 homolog	Cwc14|EDG-2|EDG2|fSAP17|G10|YCR063W	protein_coding	P41223	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35425
9.8389813092683e-07	-0.264754993805991	0.707	0.767	0.0208891412177075	ATP5F1D	CD8+ T cells	GSE199333_pre	ENSG00000099624	513	ATP synthase F1 subunit delta	ATP5D	protein_coding	P30049	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35426
1.00290007502772e-06	-0.372040850876551	0.423	0.49	0.0212925714929135	CAP1	CD8+ T cells	GSE199333_pre	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35427
1.00772618010911e-06	-0.261695017445525	0.71	0.775	0.0213950345298966	LRRFIP1	CD8+ T cells	GSE199333_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35428
1.01773135754788e-06	-0.304693001273737	0.446	0.533	0.0216074544520989	CCDC12	CD8+ T cells	GSE199333_pre	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35429
1.02540579085237e-06	-0.378971153450604	0.537	0.583	0.0217703903455868	RNF213	CD8+ T cells	GSE199333_pre	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35430
1.02593392387519e-06	-0.259772797129836	0.885	0.919	0.0217816031377942	COX6C	CD8+ T cells	GSE199333_pre	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35431
1.06724996160585e-06	-0.269053370207924	0.642	0.717	0.0226587839348538	PDIA3	CD8+ T cells	GSE199333_pre	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35432
1.0719742553733e-06	-0.303203191529525	0.398	0.474	0.0227590854158305	NDUFB10	CD8+ T cells	GSE199333_pre	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35433
1.10397909041452e-06	-0.281356536304964	0.271	0.365	0.0234385800685906	UBE2N	CD8+ T cells	GSE199333_pre	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35434
1.14757757725196e-06	-0.285512507373275	0.287	0.383	0.0243642195426364	CHMP2A	CD8+ T cells	GSE199333_pre	ENSG00000130724	27243	charged multivesicular body protein 2A	BC-2|CHMP2|VPS2|VPS2A	protein_coding	O43633	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35435
1.17837139739878e-06	-0.291168018573159	0.185	0.284	0.0250180031381735	PTPN6	CD8+ T cells	GSE199333_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35436
1.22918471872273e-06	-0.259041035283423	0.21	0.308	0.0260968207632023	LSM2	CD8+ T cells	GSE199333_pre	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35437
1.26997962676592e-06	-0.28779378675895	0.441	0.526	0.0269629374558673	C1QBP	CD8+ T cells	GSE199333_pre	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35438
1.32837515506377e-06	-0.262656766018847	0.234	0.335	0.0282027329171588	NDUFS7	CD8+ T cells	GSE199333_pre	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35439
1.38478064427064e-06	-0.262324640636515	0.252	0.347	0.0294002778585099	PPP4C	CD8+ T cells	GSE199333_pre	ENSG00000149923	5531	protein phosphatase 4 catalytic subunit	PP4|PPX	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35440
1.42852453425562e-06	-0.303242615966782	0.19	0.283	0.0303290043867812	GNPTAB	CD8+ T cells	GSE199333_pre	ENSG00000111670	79158	N-acetylglucosamine-1-phosphate transferase subunits alpha and beta	GNPTA|KIAA1208|MGC4170	protein_coding	Q3T906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35441
1.45744629530026e-06	0.27049777993327	1	1	0.0309430422955199	FTH1	CD8+ T cells	GSE199333_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35442
1.45777392462351e-06	-0.301772022783227	0.639	0.707	0.0309499981936817	GNAI2	CD8+ T cells	GSE199333_pre	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35443
1.51436323899509e-06	-0.304167188440421	0.52	0.585	0.0321514459271048	ABHD17A	CD8+ T cells	GSE199333_pre	ENSG00000129968	81926	abhydrolase domain containing 17A, depalmitoylase	C19orf27|FAM108A1|MGC5244	protein_coding	Q96GS6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35444
1.578634588772e-06	-0.277494098452301	0.624	0.696	0.0335159909542184	PNN	CD8+ T cells	GSE199333_pre	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35445
1.6438435722976e-06	-0.359354370112199	0.28	0.369	0.0349004428834504	SYAP1	CD8+ T cells	GSE199333_pre	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35446
1.64603256897081e-06	-0.306111283864519	0.349	0.46	0.0349469174718193	YBX3	CD8+ T cells	GSE199333_pre	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35447
1.66563829135592e-06	-0.306382519134018	0.559	0.617	0.0353631665637776	ATP5IF1	CD8+ T cells	GSE199333_pre	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35448
1.67445854865001e-06	-0.292053563947665	0.5	0.574	0.0355504294463884	ARHGDIA	CD8+ T cells	GSE199333_pre	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35449
1.74935001103416e-06	-0.254463276970559	0.166	0.261	0.0371404500842663	USP8	CD8+ T cells	GSE199333_pre	ENSG00000138592	9101	ubiquitin specific peptidase 8	HumORF8|KIAA0055|SPG59|UBPY	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35450
1.78127141211946e-06	-0.303503869847612	0.332	0.435	0.0378181733507083	CTSC	CD8+ T cells	GSE199333_pre	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35451
1.85219750486283e-06	0.474128426721213	0.827	0.803	0.0393240052257427	KLF6	CD8+ T cells	GSE199333_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35452
1.92333865223723e-06	-0.263644477748011	0.239	0.331	0.0408344029256486	ADRM1	CD8+ T cells	GSE199333_pre	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35453
1.92871219446655e-06	-0.315483027315325	0.751	0.81	0.0409484886007192	EMP3	CD8+ T cells	GSE199333_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35454
1.94693672771557e-06	-0.280845911946607	0.223	0.322	0.0413354136661294	SYNE1	CD8+ T cells	GSE199333_pre	ENSG00000131018	23345	spectrin repeat containing nuclear envelope protein 1	8B|ARCA1|C6orf98|CPG2|dJ45H2.2|enaptin|KIAA0796|MYNE1|Nesp1|Nesprin-1|SCAR8|SYNE-1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35455
1.97683963468956e-06	-0.292494120275128	0.235	0.329	0.041970282284094	SYNCRIP	CD8+ T cells	GSE199333_pre	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35456
2.16028620229687e-06	-0.258216146853094	0.215	0.313	0.0458650363609648	LBH	CD8+ T cells	GSE199333_pre	ENSG00000213626	81606	LBH regulator of WNT signaling pathway	NA	protein_coding	Q53QV2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35457
1.24388559606289e-20	-1.91802837879751	0.977	1	2.64089350900112e-16	HLA-B	B cells	GSE199333_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35458
1.96761543923209e-19	-2.89045194711021	0.885	0.984	4.17744433903365e-15	CD74	B cells	GSE199333_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35459
4.17661403782625e-19	-2.09288602777757	0.69	0.969	8.8673692637089e-15	HLA-A	B cells	GSE199333_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35460
5.24963974267841e-19	-2.32973288540074	0.092	0.797	1.11455101376805e-14	LIMD2	B cells	GSE199333_pre	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35461
1.74154210712937e-18	-1.93578779458145	0.057	0.75	3.69746804764636e-14	TXNIP	B cells	GSE199333_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35462
2.76990632501011e-18	-2.24859411169408	0.149	0.828	5.88078811862896e-14	ARHGDIB	B cells	GSE199333_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35463
2.90345069130137e-18	1.75499588176318	0.954	0.297	6.16431616270194e-14	PRDX4	B cells	GSE199333_pre	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35464
3.16454653353935e-18	-1.9451254801216	1	1	6.71864874535738e-14	RPL10	B cells	GSE199333_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35465
5.59602805119814e-18	-1.79645423594597	0.943	1	1.18809271554988e-13	FAU	B cells	GSE199333_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35466
5.64218832354315e-18	-2.74122032267145	0.046	0.734	1.19789300297145e-13	HLA-DPB1	B cells	GSE199333_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35467
6.7271273037697e-18	-2.81041237464628	0.747	0.984	1.42823639786335e-13	PTMA	B cells	GSE199333_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35468
1.65053286348766e-17	-1.87525898655941	0.391	0.922	3.50424632247065e-13	BTF3	B cells	GSE199333_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35469
1.93954092287533e-17	-3.27765888129833	0.069	0.75	4.1178393333566e-13	HLA-DRA	B cells	GSE199333_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35470
3.9168414988377e-17	-1.874396958269	0.333	0.891	8.31584618618232e-13	ARPC3	B cells	GSE199333_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35471
1.00240944879513e-16	-1.79846958179101	0.885	1	2.12821550073695e-12	RPS25	B cells	GSE199333_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35472
1.21262791774504e-16	-2.8232155769669	0.115	0.75	2.57453033216449e-12	HLA-DPA1	B cells	GSE199333_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35473
1.30781915277497e-16	-1.58299145595642	0.126	0.75	2.77663084325653e-12	TPM3	B cells	GSE199333_pre	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35474
1.83572247265388e-16	-2.10767327336722	0.31	0.859	3.89742238169145e-12	HNRNPA1	B cells	GSE199333_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35475
1.98757987923726e-16	1.75096036852802	0.989	0.391	4.21983084160863e-12	SEC11C	B cells	GSE199333_pre	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35476
2.51032281265145e-16	-2.92765452293438	0.747	0.938	5.32966636354029e-12	TMSB10	B cells	GSE199333_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35477
2.74861682277997e-16	-2.09768596470726	0.966	1	5.83558837644414e-12	RPL19	B cells	GSE199333_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35478
4.12226463363692e-16	-1.69594470092318	0.977	1	8.75198004367455e-12	RPL6	B cells	GSE199333_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35479
4.53028716294357e-16	-1.98083774291311	0.241	0.828	9.61825267564549e-12	PABPC1	B cells	GSE199333_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35480
4.683341389834e-16	-2.66606143645663	0.195	0.797	9.94320210475657e-12	CD37	B cells	GSE199333_pre	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35481
6.72088900541319e-16	-2.41676861298454	0.655	0.938	1.42691194473927e-11	ACTG1	B cells	GSE199333_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35482
7.88965947157913e-16	-1.70597790168252	0.057	0.672	1.67505360241097e-11	ARGLU1	B cells	GSE199333_pre	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35483
8.79925338066549e-16	-2.02213520871194	0.92	0.984	1.86816948524909e-11	RPL37	B cells	GSE199333_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35484
1.0259836517856e-15	-1.87635952444243	0.138	0.766	2.17826589110602e-11	CORO1A	B cells	GSE199333_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35485
1.02640918568435e-15	-1.69670008809451	0.264	0.875	2.17916934212645e-11	SH3BGRL3	B cells	GSE199333_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35486
1.73740395414403e-15	-1.48375673027694	1	1	3.68868233504319e-11	RPS14	B cells	GSE199333_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35487
2.0823113961935e-15	-1.86125612716043	0.184	0.766	4.42095532525841e-11	PNISR	B cells	GSE199333_pre	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35488
2.63070311184199e-15	-1.79236819917651	0.874	0.953	5.58524577675173e-11	NACA	B cells	GSE199333_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35489
2.75719968987165e-15	-1.90470486071841	0.977	1	5.85381066156649e-11	RPS12	B cells	GSE199333_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35490
2.76182160313385e-15	-1.99965438380516	0.966	0.984	5.86362344561348e-11	RPS24	B cells	GSE199333_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35491
2.79725058695106e-15	-1.24792751344359	0	0.562	5.9388427211558e-11	HLA-DQA2	B cells	GSE199333_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35492
3.15401939907648e-15	-2.07508097916194	0.966	0.984	6.69629858617928e-11	RPS23	B cells	GSE199333_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35493
3.24060994221393e-15	-1.91126107771761	0.575	0.906	6.88013896831439e-11	RPL4	B cells	GSE199333_pre	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35494
3.38451705874385e-15	1.57131719727644	0.966	0.297	7.18566816741906e-11	FKBP11	B cells	GSE199333_pre	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35495
3.49308821269615e-15	-1.92324363519808	0.989	1	7.41617558437519e-11	EEF1A1	B cells	GSE199333_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35496
4.78967772082018e-15	-1.63180031330142	0.356	0.875	1.01689647690733e-10	HNRNPA2B1	B cells	GSE199333_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35497
4.94256024040628e-15	-1.91537948449921	0.977	0.984	1.04935496464066e-10	RPL15	B cells	GSE199333_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35498
5.11025295929469e-15	-1.46485827227717	0.632	0.938	1.08495780578786e-10	HLA-E	B cells	GSE199333_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35499
5.17102807581468e-15	-1.46213706108204	0.184	0.781	1.09786097077621e-10	EIF3F	B cells	GSE199333_pre	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35500
5.79352398957295e-15	-1.60340816804197	0.218	0.797	1.23002307822623e-10	RPS4Y1	B cells	GSE199333_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35501
6.54874126923886e-15	-1.58468460511385	0.977	1	1.3903632588721e-10	RPS3	B cells	GSE199333_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35502
6.58442250188129e-15	1.74750989743812	0.989	0.844	1.39793874137442e-10	MZB1	B cells	GSE199333_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35503
7.24378002151503e-15	-1.97785350269081	0.943	1	1.53792693636786e-10	RPS13	B cells	GSE199333_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35504
7.46638537331046e-15	-1.72254009302977	0.345	0.891	1.58518827860754e-10	PFN1	B cells	GSE199333_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35505
8.97192847390069e-15	-1.2075654329178	0.046	0.625	1.90483013429385e-10	SCAF11	B cells	GSE199333_pre	ENSG00000139218	9169	SR-related CTD associated factor 11	CASP11|SFRS2IP|SIP1|SRRP129|SRSF2IP	protein_coding	Q99590	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35506
9.29565545421466e-15	-1.4898101008867	0.161	0.75	1.97356060948431e-10	RBM3	B cells	GSE199333_pre	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35507
1.17295194268029e-14	-1.51752382214294	0.793	0.984	2.49029426950452e-10	RPS21	B cells	GSE199333_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35508
1.1939894503199e-14	-1.64663247850677	0.092	0.703	2.53495900197418e-10	LAPTM5	B cells	GSE199333_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35509
1.20309986530717e-14	-1.83221789906249	0.126	0.719	2.55430132403365e-10	AES	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35510
1.24340199815922e-14	-2.25601206910073	0.149	0.75	2.63986678229185e-10	CD52	B cells	GSE199333_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35511
1.32113223928418e-14	-1.74743389839228	0.724	0.953	2.80489585722423e-10	FTH1	B cells	GSE199333_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35512
1.57318426585205e-14	1.20858662181142	0.931	0.406	3.34002751483048e-10	SPCS3	B cells	GSE199333_pre	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35513
1.61819604365942e-14	-1.60258259145814	0.954	1	3.43559202029331e-10	RPL34	B cells	GSE199333_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35514
1.66841950358778e-14	-1.45098081491415	0.529	0.953	3.54222144806723e-10	COX4I1	B cells	GSE199333_pre	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35515
1.68974455370409e-14	-1.64337058568838	0.126	0.703	3.58749666196915e-10	SF1	B cells	GSE199333_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35516
1.91712815278261e-14	-1.34127207795382	0.483	0.953	4.07025478117276e-10	SRP14	B cells	GSE199333_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35517
2.05325068636783e-14	-1.41235517601531	0.437	0.891	4.35925653222754e-10	CIRBP	B cells	GSE199333_pre	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35518
2.06183917811558e-14	-1.79209305947112	0.46	0.859	4.37749075905718e-10	CFL1	B cells	GSE199333_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35519
2.1486194598762e-14	-1.56299924786644	0.253	0.797	4.56173397526316e-10	CCNI	B cells	GSE199333_pre	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35520
2.1816651810935e-14	-1.64201484295056	0.966	1	4.63189334597962e-10	RPL18	B cells	GSE199333_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35521
2.50978144274199e-14	-1.68979564787036	0.989	1	5.32851698108551e-10	RPS27A	B cells	GSE199333_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35522
2.51977988224529e-14	-1.71993905187488	1	1	5.34974466799497e-10	RPL11	B cells	GSE199333_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35523
2.80486914653957e-14	-1.67352015304343	0.989	1	5.95501768501816e-10	RPL29	B cells	GSE199333_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35524
3.6033319211578e-14	-2.23700159529287	0.563	0.875	7.65023400181013e-10	H3F3A	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35525
4.4471568387299e-14	-2.83685770356182	0.333	0.797	9.44175868430745e-10	CD79B	B cells	GSE199333_pre	ENSG00000007312	974	CD79b molecule	B29|Ig-beta|IGB|Igbeta	protein_coding	P40259	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35526
4.5813745988019e-14	-1.8721227869782	0.874	0.969	9.72671641071632e-10	RACK1	B cells	GSE199333_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35527
4.80552858408435e-14	-1.26074016462798	0.31	0.875	1.02026177368695e-09	HSP90AA1	B cells	GSE199333_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35528
5.09903897606675e-14	-1.75160756711622	0.816	0.969	1.08257696500873e-09	MT-CO3	B cells	GSE199333_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35529
5.71170644543071e-14	-1.5508730551344	1	1	1.21265239542939e-09	RPS16	B cells	GSE199333_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35530
5.8420899940105e-14	0.890480237876464	0.782	0.156	1.24033412662837e-09	TXNDC15	B cells	GSE199333_pre	ENSG00000113621	79770	thioredoxin domain containing 15	2310047H23Rik|C5orf14|FLJ22625	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35531
6.13551139119707e-14	-1.55132431410619	0.736	0.953	1.30263042346505e-09	MT-ND3	B cells	GSE199333_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35532
6.37602131758288e-14	-1.69087100929231	0.989	1	1.35369308593602e-09	RPL28	B cells	GSE199333_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35533
6.74711807089728e-14	-1.49024921062709	0.023	0.562	1.4324806376322e-09	RCSD1	B cells	GSE199333_pre	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35534
6.7978399103086e-14	-1.67914171671021	0.977	1	1.44324939135762e-09	RPS7	B cells	GSE199333_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35535
7.28316054928632e-14	-1.54199086509954	0.977	0.984	1.54628781621898e-09	RPS15A	B cells	GSE199333_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35536
7.46297615363851e-14	-1.29835242992638	0.977	1	1.58446446717899e-09	RPL7A	B cells	GSE199333_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35537
7.52700337490792e-14	-1.76096713628017	0.793	0.984	1.5980580865267e-09	RPL22	B cells	GSE199333_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35538
8.39725680668167e-14	-1.98735920490956	0.655	0.953	1.78282159262658e-09	ACTB	B cells	GSE199333_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35539
8.60483836612747e-14	-1.46903272471739	0.333	0.844	1.82689323351252e-09	ARPC2	B cells	GSE199333_pre	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35540
8.63636785265446e-14	-1.2524215897993	0.08	0.641	1.83358725879707e-09	UBXN1	B cells	GSE199333_pre	ENSG00000162191	51035	UBX domain protein 1	2B28|LOC51035|SAKS1|UBXD10	protein_coding	Q04323	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35541
9.56327634440412e-14	-1.67267789252634	0.402	0.859	2.03037920068044e-09	HMGB1	B cells	GSE199333_pre	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35542
1.03481814137908e-13	-1.85425790908485	0.943	0.969	2.19702239596193e-09	RPL10A	B cells	GSE199333_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35543
1.0366870030599e-13	-1.63440684399873	0.954	0.984	2.20099017619647e-09	RPL30	B cells	GSE199333_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35544
1.08732086222808e-13	-1.69544174083559	0.966	0.984	2.30849092259643e-09	RPLP2	B cells	GSE199333_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35545
1.13234553699364e-13	-1.5180344124301	0.966	1	2.40408280959121e-09	RPL23A	B cells	GSE199333_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35546
1.15857415002466e-13	-1.61255103771425	0.943	0.984	2.45976877791736e-09	RPL35A	B cells	GSE199333_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35547
1.17854129100033e-13	-1.31561933194182	0.977	1	2.5021610149228e-09	RPS28	B cells	GSE199333_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35548
1.1829797447653e-13	-1.76416247543998	0.989	1	2.51158429611121e-09	RPL18A	B cells	GSE199333_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35549
1.1930090742096e-13	-1.19332960577726	0.115	0.719	2.5328775654544e-09	SFPQ	B cells	GSE199333_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35550
1.26891642000301e-13	-2.1252031979248	0.425	0.859	2.69403645130839e-09	TMSB4X	B cells	GSE199333_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35551
1.3346701577004e-13	-1.89547225423134	0.793	0.953	2.83363821181372e-09	MT-CO1	B cells	GSE199333_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35552
1.60755928779279e-13	-1.7474616868094	0.989	0.984	3.41300912391286e-09	RPS27	B cells	GSE199333_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35553
1.62272724999676e-13	-1.37718905036501	0.678	0.953	3.44521222446813e-09	MYL6	B cells	GSE199333_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35554
1.67433992791589e-13	-1.58554789129153	0.494	0.859	3.55479110095822e-09	ATP5MC2	B cells	GSE199333_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35555
1.89159562057352e-13	-1.71568216500437	0.977	0.984	4.01604666203964e-09	RPS8	B cells	GSE199333_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35556
1.90547194841783e-13	1.62085315473224	0.943	0.391	4.04550749368589e-09	XBP1	B cells	GSE199333_pre	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35557
1.94129027144403e-13	-1.57659311089949	0.954	1	4.12155337530283e-09	RPL9	B cells	GSE199333_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35558
2.03961501378976e-13	-1.89397919336497	0.517	0.875	4.33030663577704e-09	DDX5	B cells	GSE199333_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35559
2.22276489667793e-13	5.99162008477609	0.621	0.016	4.71915215213692e-09	IGHG4	B cells	GSE199333_pre	ENSG00000277016	NA	NA	NA	IG_C_gene	P01861	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35560
2.38648999314092e-13	-1.27199348900565	0.805	0.969	5.0667569044375e-09	ATP5F1E	B cells	GSE199333_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35561
2.45343976128997e-13	-1.40946879129764	0.046	0.609	5.20889795719473e-09	HLA-DQA1	B cells	GSE199333_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35562
2.45890939964814e-13	-1.43601933769194	0.989	1	5.22051054639296e-09	RPS4X	B cells	GSE199333_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35563
2.467402684297e-13	-1.73670478231521	1	1	5.23854263903095e-09	RPL26	B cells	GSE199333_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35564
2.62119230950718e-13	-1.88820314354183	0.805	0.953	5.56505339231469e-09	RPSA	B cells	GSE199333_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35565
2.66072170507247e-13	-1.7867962892831	0.736	0.984	5.64897825203937e-09	MALAT1	B cells	GSE199333_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35566
2.78546616496976e-13	-1.37718905036501	0.115	0.656	5.9138232148473e-09	SEPT6	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35567
3.50832231742108e-13	-1.52619899949808	0.092	0.641	7.4485191121167e-09	TAGLN2	B cells	GSE199333_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35568
3.50865450785329e-13	-1.5810154946993	0.989	1	7.44922438562331e-09	RPL39	B cells	GSE199333_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35569
3.52185028072654e-13	-1.36048133565676	0.103	0.672	7.47724033101052e-09	HMGN2	B cells	GSE199333_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35570
3.5494199144189e-13	-1.29596721947851	0.655	0.953	7.53577342030277e-09	SLC25A6	B cells	GSE199333_pre	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35571
3.75215659063229e-13	-1.26339407551802	0.046	0.578	7.96620365757142e-09	HLA-DMB	B cells	GSE199333_pre	ENSG00000242386	3109	major histocompatibility complex, class II, DM beta	D6S221E|RING7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35572
3.76591026505427e-13	-1.35788772589596	0.437	0.844	7.99540408373672e-09	PSME1	B cells	GSE199333_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35573
3.77396393356827e-13	-1.66442970167743	0.954	0.984	8.0125028273588e-09	RPL5	B cells	GSE199333_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35574
3.77620230318e-13	1.40410458131267	1	0.859	8.01725510988145e-09	SSR4	B cells	GSE199333_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35575
3.9896264701775e-13	-1.73279340752264	0.885	0.984	8.47037595883384e-09	RPS11	B cells	GSE199333_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35576
4.0079160454898e-13	2.93196118604301	0.77	0.141	8.5092065561794e-09	IGHG1	B cells	GSE199333_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35577
4.00933582883411e-13	-1.49408234484053	0.092	0.625	8.5122208981977e-09	PNN	B cells	GSE199333_pre	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35578
4.11414937672113e-13	-1.60944055627883	0.954	0.984	8.73475054171663e-09	RPL12	B cells	GSE199333_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35579
4.25163763406759e-13	-1.82283782038161	0.989	1	9.02665186088889e-09	RPS3A	B cells	GSE199333_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35580
4.40708716805509e-13	-1.43311806599265	0.897	1	9.35668676649777e-09	RPS29	B cells	GSE199333_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35581
5.39225424233721e-13	-1.33910768486419	0.77	0.938	1.14482949819061e-08	PFDN5	B cells	GSE199333_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35582
5.6217154576142e-13	-1.35777611258605	0.391	0.891	1.19354640880607e-08	YBX1	B cells	GSE199333_pre	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35583
6.20123715893492e-13	-1.08746284125034	0	0.484	1.31658466121347e-08	TCL1A	B cells	GSE199333_pre	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35584
6.96000166754433e-13	-1.69473986395972	0.989	1	1.47767795403634e-08	RPS2	B cells	GSE199333_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35585
7.55157294533761e-13	-1.73883372983457	0.287	0.766	1.60327445202463e-08	CD81	B cells	GSE199333_pre	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35586
8.90634258853611e-13	-1.78959402014732	0.885	0.953	1.8909055949721e-08	RPL13A	B cells	GSE199333_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35587
1.08225762866333e-12	-1.60504899283174	0.54	0.891	2.29774117141511e-08	EEF2	B cells	GSE199333_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35588
1.09431163977683e-12	-1.42740624431636	1	1	2.32333304241019e-08	RPL13	B cells	GSE199333_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35589
1.13117385261806e-12	-1.23739618114153	1	1	2.40159520649341e-08	RPL41	B cells	GSE199333_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35590
1.43107547329271e-12	-1.51956477745164	0.161	0.688	3.03831633734776e-08	DDX17	B cells	GSE199333_pre	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35591
1.47153524144881e-12	-1.41231187719506	0.23	0.734	3.12421647111997e-08	MYL12A	B cells	GSE199333_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35592
1.47273212638251e-12	-1.49503200699718	0.345	0.812	3.12675757752271e-08	RPL31	B cells	GSE199333_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35593
1.5075003809174e-12	-1.13287555617143	0.149	0.703	3.20057405872572e-08	ENO1	B cells	GSE199333_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35594
1.55530024983487e-12	-1.40883564152846	0.172	0.672	3.30205796042442e-08	SKP1	B cells	GSE199333_pre	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35595
1.64981715650717e-12	0.978092744051559	0.839	0.172	3.50272680498038e-08	SELENOM	B cells	GSE199333_pre	ENSG00000198832	140606	selenoprotein M	SELM|SEPM	protein_coding	Q8WWX9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35596
1.76090110667682e-12	-1.36746776597286	0.989	1	3.73856913958556e-08	RPL21	B cells	GSE199333_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35597
1.85949149704123e-12	-1.1378177565259	0.989	1	3.94788639736823e-08	RPLP1	B cells	GSE199333_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35598
1.87106870404863e-12	-1.55541822510714	0.172	0.719	3.97246596556564e-08	CALM2	B cells	GSE199333_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35599
2.07453303284603e-12	-1.59197909759091	1	1	4.40444108203541e-08	RPS6	B cells	GSE199333_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35600
2.10929810260355e-12	-1.45187662061874	0.356	0.828	4.4782508016376e-08	PPIA	B cells	GSE199333_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35601
2.6193499157383e-12	-2.26049418501222	0.264	0.734	5.56114180610397e-08	BTG1	B cells	GSE199333_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35602
3.00982076586309e-12	-1.23143939065502	0.161	0.703	6.39015046800392e-08	NAP1L1	B cells	GSE199333_pre	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35603
3.18938685033605e-12	-1.39403389536778	0.299	0.844	6.77138722194846e-08	HSP90AB1	B cells	GSE199333_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35604
3.24386009387275e-12	-1.02610104820373	0.977	1	6.88703936530124e-08	TPT1	B cells	GSE199333_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35605
3.25760103560936e-12	-1.4036939556469	0.966	0.984	6.91621275870223e-08	RPLP0	B cells	GSE199333_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35606
3.37484651304629e-12	-1.73545510275936	0.161	0.656	7.16513663184858e-08	PTPRC	B cells	GSE199333_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35607
3.50873050306036e-12	-1.17429548355141	0.149	0.656	7.44938573104746e-08	EIF3L	B cells	GSE199333_pre	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35608
3.81118297610133e-12	-1.15810471969659	0.241	0.766	8.09152257656073e-08	SON	B cells	GSE199333_pre	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35609
3.94775839983173e-12	-1.7755188349356	0.138	0.641	8.38148585868275e-08	UCP2	B cells	GSE199333_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35610
4.28428864390483e-12	-1.52085441107267	0.977	1	9.09597321987435e-08	RPS19	B cells	GSE199333_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35611
4.57111992133197e-12	-1.5644070083344	0.989	1	9.7049447049799e-08	RPL32	B cells	GSE199333_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35612
4.62130412239901e-12	-0.981969712403026	0.218	0.781	9.81149078226534e-08	LDHB	B cells	GSE199333_pre	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35613
4.72713569406869e-12	-0.722097567045799	0.023	0.5	1.00361817920772e-07	PPP1R14A	B cells	GSE199333_pre	ENSG00000167641	94274	protein phosphatase 1 regulatory inhibitor subunit 14A	CPI-17|PPP1INL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35614
4.83507405664673e-12	-1.29270086026812	0.034	0.516	1.02653457296667e-07	FOXP1	B cells	GSE199333_pre	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35615
5.01717759470572e-12	-1.160543765148	0.011	0.484	1.06519697513197e-07	AC004687.1	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35616
5.85247184505319e-12	-1.6350301472152	0.793	0.922	1.24253829742324e-07	UBA52	B cells	GSE199333_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35617
6.6135679170194e-12	-1.47172833667797	0.828	0.953	1.40412660446239e-07	MT-ATP6	B cells	GSE199333_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35618
6.80678231525754e-12	-1.22212521001039	0.816	0.953	1.44514795335233e-07	GNAS	B cells	GSE199333_pre	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35619
6.9595540109954e-12	-1.51489333772774	0.011	0.469	1.47758291207443e-07	ZEB2	B cells	GSE199333_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35620
7.10939016289067e-12	0.907155271729795	0.644	0.078	1.50939462548332e-07	SPAG4	B cells	GSE199333_pre	ENSG00000061656	6676	sperm associated antigen 4	CT127|SUN4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35621
7.48287964129286e-12	-1.2150186830543	0.92	0.984	1.58869017664289e-07	RPL14	B cells	GSE199333_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35622
7.54534390921945e-12	-0.902375114486025	0.011	0.469	1.60195196536638e-07	GAPT	B cells	GSE199333_pre	ENSG00000175857	202309	GRB2 binding adaptor protein, transmembrane	C5orf29|FLJ33641	protein_coding	Q8N292	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35623
7.92977074192322e-12	-1.35805459826222	0.149	0.641	1.68356962621772e-07	SNX3	B cells	GSE199333_pre	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35624
8.79243216526521e-12	-1.58099567716028	0.713	0.938	1.86672127300746e-07	RPL27	B cells	GSE199333_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35625
9.9908980735149e-12	-1.44294349584873	0.149	0.656	2.12116756998795e-07	FUS	B cells	GSE199333_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35626
1.0037755351808e-11	-1.40446934803409	0.299	0.781	2.13111583874236e-07	RBM39	B cells	GSE199333_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35627
1.00945639901829e-11	1.10770464034709	0.966	0.5	2.14317688075574e-07	FKBP2	B cells	GSE199333_pre	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35628
1.06008253306182e-11	-1.22026916048288	0.989	1	2.25066122594355e-07	RPL3	B cells	GSE199333_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35629
1.26987860366701e-11	-1.31366047890376	0.149	0.641	2.69607926344544e-07	EIF3H	B cells	GSE199333_pre	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35630
1.32032587553476e-11	-1.04912248247958	0.034	0.5	2.80318386634786e-07	CMTM7	B cells	GSE199333_pre	ENSG00000153551	112616	CKLF like MARVEL transmembrane domain containing 7	CKLFSF7|FLJ30992	protein_coding	Q96FZ5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35631
1.38704065307812e-11	-1.26880818410281	0.862	0.984	2.94482601055015e-07	MT-CO2	B cells	GSE199333_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35632
1.53249968866119e-11	-1.17785762142769	1	1	3.25365008899657e-07	RPS5	B cells	GSE199333_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35633
1.75821043117556e-11	-1.28515225004227	0.195	0.688	3.73285656642882e-07	SET	B cells	GSE199333_pre	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35634
1.82026096409324e-11	-1.16495874854896	0.057	0.547	3.86459605286635e-07	MTPN	B cells	GSE199333_pre	ENSG00000105887	136319	myotrophin	GCDP|MYOTROPHIN|V-1	protein_coding	P58546	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35635
1.84323706932427e-11	-1.20927114964628	0.161	0.656	3.91337662188236e-07	HNRNPC	B cells	GSE199333_pre	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35636
1.97034871568336e-11	-1.34983409145725	0.011	0.453	4.18324735826733e-07	PLD4	B cells	GSE199333_pre	ENSG00000166428	122618	phospholipase D family member 4	C14orf175	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35637
2.04554808961598e-11	-1.25569167667655	0.759	0.969	4.3429031490637e-07	MT-ND4	B cells	GSE199333_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35638
2.12384427278998e-11	-1.27538939886916	0.218	0.703	4.50913377556041e-07	SLC25A3	B cells	GSE199333_pre	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35639
2.15577975207812e-11	-1.30926506061676	0.184	0.688	4.57693599163706e-07	HNRNPU	B cells	GSE199333_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35640
2.30415114614817e-11	-1.3471845130433	0.172	0.656	4.89194329838717e-07	YWHAZ	B cells	GSE199333_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35641
2.67087813248305e-11	-1.27601385816558	0.943	0.984	5.67054136307477e-07	RPL24	B cells	GSE199333_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35642
2.74982346589102e-11	-1.47184653346468	0.977	1	5.83815020043322e-07	RPS9	B cells	GSE199333_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35643
2.8672496188327e-11	0.902281218949772	0.989	0.688	6.0874576657437e-07	TMBIM6	B cells	GSE199333_pre	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35644
3.1458504501846e-11	1.28922794945471	1	0.469	6.67895509078692e-07	HERPUD1	B cells	GSE199333_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35645
3.22817856093993e-11	-1.09502019242842	0.046	0.5	6.85374590273157e-07	STX7	B cells	GSE199333_pre	ENSG00000079950	8417	syntaxin 7	NA	protein_coding	O15400	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35646
3.28797957612768e-11	-1.37021317206209	0.977	1	6.98070943807668e-07	RPL37A	B cells	GSE199333_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35647
3.53562590983488e-11	-1.25127178691271	1	1	7.50648736917044e-07	RPL8	B cells	GSE199333_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35648
3.63464680916718e-11	-1.22382620654514	0.103	0.609	7.71671864054283e-07	ZFAS1	B cells	GSE199333_pre	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35649
3.76323121942776e-11	-1.28139963519407	0.264	0.719	7.98971620196707e-07	SLC25A5	B cells	GSE199333_pre	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35650
3.78034526627534e-11	0.903978978505503	0.805	0.203	8.02605103482917e-07	CD27	B cells	GSE199333_pre	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35651
3.79194081352094e-11	-1.38711510753671	0.989	1	8.05066954118632e-07	RPS18	B cells	GSE199333_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35652
3.89860166946358e-11	-1.16464233336162	0.218	0.703	8.27712120443812e-07	COMMD6	B cells	GSE199333_pre	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35653
3.90535869505837e-11	-1.51248442910181	0.425	0.812	8.29146704547843e-07	NPM1	B cells	GSE199333_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35654
4.01165139699465e-11	0.95177401905052	0.966	0.531	8.51713708095933e-07	TMEM59	B cells	GSE199333_pre	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35655
4.07286623309989e-11	-1.29472291778684	0.816	0.953	8.64710229949438e-07	MT-CYB	B cells	GSE199333_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35656
4.63361024642672e-11	-1.18660374258894	0.46	0.938	9.83761791418856e-07	HINT1	B cells	GSE199333_pre	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35657
5.33238615490826e-11	-1.96562171831554	0.621	0.891	1.13211890454857e-06	CD79A	B cells	GSE199333_pre	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35658
6.34012888504814e-11	-1.28869670826422	0.391	0.844	1.34607276358457e-06	RPL36A	B cells	GSE199333_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35659
6.50742119432719e-11	-1.26949198313964	0.276	0.75	1.38159059376761e-06	NOP53	B cells	GSE199333_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35660
6.62615646835494e-11	-1.24924650751275	0.989	1	1.40679927979644e-06	RPS15	B cells	GSE199333_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35661
7.30399242702372e-11	-1.1403807258283	0.195	0.672	1.55071063218141e-06	SERBP1	B cells	GSE199333_pre	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35662
7.64530319847559e-11	-1.23143939065502	0.103	0.562	1.62317432206835e-06	ACTR2	B cells	GSE199333_pre	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35663
7.85658212630221e-11	-1.37088855871992	0.517	0.891	1.66803095123522e-06	RPS20	B cells	GSE199333_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35664
8.01918333044613e-11	-1.07482704395738	0.586	0.984	1.70255281288702e-06	GAPDH	B cells	GSE199333_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35665
8.30418945435209e-11	-1.26397335480341	0.253	0.734	1.76306246305349e-06	NCL	B cells	GSE199333_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35666
9.1728882547953e-11	-1.33602829193222	0.161	0.625	1.94749590537559e-06	GNAI2	B cells	GSE199333_pre	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35667
9.17949438618289e-11	1.00229424120581	0.897	0.484	1.94889845313049e-06	CD63	B cells	GSE199333_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35668
9.54986041246362e-11	-1.01230914151887	0.034	0.484	2.02753086417015e-06	TRIM38	B cells	GSE199333_pre	ENSG00000112343	10475	tripartite motif containing 38	RNF15|RORET	protein_coding	O00635	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35669
9.57582646362718e-11	-1.4262647547021	0	0.406	2.03304371649269e-06	VPREB1	B cells	GSE199333_pre	ENSG00000169575	7441	V-set pre-B cell surrogate light chain 1	CD179A|VpreB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35670
1.08793277513616e-10	-1.16642586065131	0.287	0.75	2.30979007489159e-06	SRSF5	B cells	GSE199333_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35671
1.10340758147533e-10	-1.44294349584873	0.126	0.594	2.34264463623028e-06	GMFG	B cells	GSE199333_pre	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35672
1.33012923448654e-10	0.739920561301082	0.667	0.125	2.82399737773838e-06	SDC1	B cells	GSE199333_pre	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35673
1.49721009660782e-10	-0.990431291151222	0.034	0.469	3.17872675610807e-06	ARID4B	B cells	GSE199333_pre	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35674
1.51618755643651e-10	-1.62514682706948	0.115	0.578	3.21901780107035e-06	TCF4	B cells	GSE199333_pre	ENSG00000196628	6925	transcription factor 4	bHLHb19|E2-2|ITF2|SEF2-1B	protein_coding	P15884	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35675
1.60870234601226e-10	-1.23700159529287	0.218	0.641	3.41543595081862e-06	TRIR	B cells	GSE199333_pre	ENSG00000123144	79002	telomerase RNA component interacting RNase	C19orf43|fSAP18|MGC2803|TERCIR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35676
1.6567667024282e-10	-1.32684643092586	0.506	0.844	3.51748138592532e-06	RPL23	B cells	GSE199333_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35677
2.20496667718546e-10	-1.81527654417333	0.034	0.453	4.68136475233245e-06	SOX4	B cells	GSE199333_pre	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35678
2.61105099890241e-10	-1.22165363095944	0.644	0.969	5.54352237576971e-06	MT-ND2	B cells	GSE199333_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35679
3.35057029724839e-10	0.816248843690671	0.839	0.328	7.11359579808805e-06	KRTCAP2	B cells	GSE199333_pre	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35680
3.380587764145e-10	-0.910722457199545	0.069	0.5	7.17732588205624e-06	DDX46	B cells	GSE199333_pre	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35681
3.40494840256655e-10	-1.11197026135836	0.138	0.562	7.22904595348904e-06	GDI2	B cells	GSE199333_pre	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35682
3.46436491582826e-10	-1.04740217219568	0.08	0.531	7.35519315279499e-06	MDM4	B cells	GSE199333_pre	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35683
3.5040349625192e-10	-1.10868865128593	0.552	0.922	7.43941662892452e-06	UBB	B cells	GSE199333_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35684
3.96761361924929e-10	-1.12426106046502	0.218	0.656	8.42364047502816e-06	PPP1CA	B cells	GSE199333_pre	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35685
4.29691153717009e-10	1.27603635284411	0.828	0.531	9.12277288456581e-06	HBB	B cells	GSE199333_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35686
4.59422982700049e-10	0.848822628528382	0.724	0.156	9.75400934570474e-06	TNFRSF17	B cells	GSE199333_pre	ENSG00000048462	608	TNF receptor superfamily member 17	BCM|BCMA|CD269|TNFRSF13A	protein_coding	Q02223	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35687
4.62681360637054e-10	-1.08893542996744	0.149	0.609	9.8231879676853e-06	SRRM1	B cells	GSE199333_pre	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35688
4.63728002423861e-10	-1.60321832725732	0.782	0.922	9.84540921946099e-06	H3F3B	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35689
4.92246943700035e-10	-1.09761496838129	0.115	0.562	1.04508948616954e-05	EIF4G2	B cells	GSE199333_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35690
5.09331196463108e-10	-1.32807953881673	0.092	0.531	1.08136106321082e-05	PTPN6	B cells	GSE199333_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35691
5.18804029504474e-10	-1.09225640797994	0.069	0.5	1.10147283504095e-05	BPTF	B cells	GSE199333_pre	ENSG00000171634	2186	bromodomain PHD finger transcription factor	FAC1|FALZ|NURF301	protein_coding	Q12830	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35692
5.24967155452847e-10	-0.895455700546235	0.08	0.516	1.11455776774194e-05	DBNL	B cells	GSE199333_pre	ENSG00000136279	28988	drebrin like	ABP1|HIP-55|SH3P7	protein_coding	Q9UJU6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35693
5.37282512605366e-10	-1.02004387879691	0.667	0.953	1.14070450251245e-05	MT-ND1	B cells	GSE199333_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35694
5.40186184903255e-10	-1.09829532446128	0.264	0.719	1.1468692891681e-05	HMGN1	B cells	GSE199333_pre	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35695
5.8878828512643e-10	-1.08261188866002	0.402	0.797	1.25005640815192e-05	TOMM7	B cells	GSE199333_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35696
5.908808475164e-10	-0.98180958198043	0.149	0.609	1.25449912736207e-05	PCBP2	B cells	GSE199333_pre	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35697
6.22138725251438e-10	-0.857980995127572	0	0.375	1.32086272758133e-05	LGALS9	B cells	GSE199333_pre	ENSG00000168961	3965	galectin 9	LGALS9A	protein_coding	O00182	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35698
6.4098320145082e-10	-1.14254856251101	0.299	0.75	1.36087143500023e-05	EIF3E	B cells	GSE199333_pre	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35699
6.53364271402427e-10	-1.14450375388374	0.103	0.547	1.38715768461449e-05	VAMP8	B cells	GSE199333_pre	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35700
6.622751952711e-10	-1.15987133677839	0	0.375	1.40607646708007e-05	BCL7A	B cells	GSE199333_pre	ENSG00000282873	605	BAF chromatin remodeling complex subunit BCL7A	BCL7|SMARCJ1	protein_coding	Q4VC05	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35701
7.1245114668682e-10	-1.12101540096137	0.034	0.438	1.51260502953079e-05	RBM38	B cells	GSE199333_pre	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35702
7.33926750405769e-10	-1.12947697970956	0.977	0.969	1.55819988378649e-05	RPS26	B cells	GSE199333_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35703
7.51902412851705e-10	-1.13772927452264	0.253	0.688	1.59636401272546e-05	HNRNPK	B cells	GSE199333_pre	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35704
7.75826076830577e-10	-1.19832112712882	0.195	0.625	1.647156343719e-05	MYL12B	B cells	GSE199333_pre	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35705
8.41792961128281e-10	2.35551628669023	0.609	0.109	1.78721063577145e-05	IGHG3	B cells	GSE199333_pre	ENSG00000282184	NA	NA	NA	IG_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35706
8.5461860715697e-10	-1.05408992837354	0.046	0.453	1.81444076485496e-05	WASF2	B cells	GSE199333_pre	ENSG00000158195	10163	WASP family member 2	SCAR2|WAVE2	protein_coding	Q9Y6W5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35707
8.55114175571828e-10	-1.01196445270086	0.046	0.453	1.81549290615655e-05	APBB1IP	B cells	GSE199333_pre	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35708
8.74414974513436e-10	-1.07935276198856	0.069	0.5	1.85647043238948e-05	TUBA1A	B cells	GSE199333_pre	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35709
8.79485545189057e-10	-1.84097456982188	0.069	0.484	1.86723576099089e-05	YBX3	B cells	GSE199333_pre	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35710
8.96024327987876e-10	-1.04780555400759	0.092	0.516	1.90234925075106e-05	MBNL1	B cells	GSE199333_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35711
9.60043036432722e-10	-1.23762458787122	0.092	0.516	2.03826737065031e-05	RSRP1	B cells	GSE199333_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35712
1.0204251338525e-09	-1.20327308308045	0.115	0.531	2.16646460168225e-05	LUC7L3	B cells	GSE199333_pre	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35713
1.09314274243328e-09	-1.00543865644395	0.402	0.828	2.3208513564601e-05	CLIC1	B cells	GSE199333_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35714
1.17731134365157e-09	0.922705976467952	0.943	0.359	2.49954971370665e-05	DERL3	B cells	GSE199333_pre	ENSG00000274437	91319	derlin 3	C22orf14|derlin-3|FLJ43842|IZP6|MGC71803	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35715
1.18645056354245e-09	-1.04822598094948	0.069	0.484	2.51895319145697e-05	SNHG7	B cells	GSE199333_pre	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35716
1.21788002277085e-09	-0.71143233177463	0.011	0.391	2.58568107634479e-05	SPIB	B cells	GSE199333_pre	ENSG00000269404	6689	Spi-B transcription factor	SPI-B	protein_coding	Q01892	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35717
1.21901441815501e-09	-1.05592037273948	0.218	0.672	2.5880895111849e-05	CDC42	B cells	GSE199333_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35718
1.46865041479996e-09	-1.17990909001493	0.08	0.5	3.11809169566181e-05	LRRFIP1	B cells	GSE199333_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35719
1.51514205662426e-09	-0.811539650237376	0.977	1	3.21679810041897e-05	EIF1	B cells	GSE199333_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35720
1.53247655494966e-09	-1.24821510340584	0.092	0.516	3.25360097381363e-05	ACTR3	B cells	GSE199333_pre	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35721
1.61963518528811e-09	-0.98161234429595	0.069	0.484	3.4386474618852e-05	EVL	B cells	GSE199333_pre	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35722
1.69084460306233e-09	-0.99687910094926	0.057	0.469	3.58983217676163e-05	UBE2I	B cells	GSE199333_pre	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35723
1.69284960082393e-09	-0.90972457022157	0.011	0.391	3.59408898750928e-05	AFF3	B cells	GSE199333_pre	ENSG00000144218	3899	ALF transcription elongation factor 3	LAF4|MLLT2-like	protein_coding	P51826	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35724
1.87888407139922e-09	-1.2875498132029	0.724	0.906	3.98905877198769e-05	RPL7	B cells	GSE199333_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35725
1.97106229844447e-09	-0.939775086291219	0.034	0.422	4.18476236582745e-05	CDC40	B cells	GSE199333_pre	ENSG00000168438	51362	cell division cycle 40	EHB3|FLJ10564|PRP17|PRPF17	protein_coding	O60508	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35726
2.03410082981717e-09	-1.2173837954336	0.471	0.875	4.31859947178484e-05	RPL38	B cells	GSE199333_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35727
2.24079101963673e-09	-0.96055072876812	0.057	0.469	4.75742341379073e-05	IKZF1	B cells	GSE199333_pre	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35728
2.24359286565125e-09	-1.13015605481784	0.195	0.641	4.76337201306416e-05	YWHAB	B cells	GSE199333_pre	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35729
2.25580185243144e-09	-0.778810781693964	0.126	0.594	4.78929291289719e-05	CD99	B cells	GSE199333_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35730
2.32887475616957e-09	-1.1010239257739	0.172	0.609	4.94443399482361e-05	PSMB9	B cells	GSE199333_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35731
2.39855492062854e-09	-1.01844566732082	0.057	0.484	5.09237195198644e-05	BANK1	B cells	GSE199333_pre	ENSG00000153064	55024	B cell scaffold protein with ankyrin repeats 1	BANK|FLJ20706	protein_coding	Q8NDB2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35732
2.47106544114329e-09	-0.923833542422198	0.034	0.422	5.24631903809133e-05	RASGRP2	B cells	GSE199333_pre	ENSG00000068831	10235	RAS guanyl releasing protein 2	CALDAG-GEFI	protein_coding	Q7LDG7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35733
2.63499897517887e-09	-1.07802947599572	0.322	0.734	5.59436632420227e-05	COX6C	B cells	GSE199333_pre	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35734
2.6477571805612e-09	-1.05846346354585	0.161	0.609	5.62145327004949e-05	RBM25	B cells	GSE199333_pre	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35735
2.65474095027525e-09	-0.924070185585345	0.08	0.5	5.63628051152938e-05	SNHG8	B cells	GSE199333_pre	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35736
2.75437561243718e-09	-0.996197136842546	0.057	0.453	5.84781486276537e-05	SP100	B cells	GSE199333_pre	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35737
2.8819913264763e-09	-1.16965899332118	0.195	0.625	6.11875578524182e-05	HLA-DMA	B cells	GSE199333_pre	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35738
3.11594316321188e-09	-0.971322468203517	0.149	0.562	6.61545892981515e-05	PSMB8	B cells	GSE199333_pre	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35739
3.33317656006192e-09	-1.01062800513805	0.195	0.625	7.07666715466746e-05	LSM7	B cells	GSE199333_pre	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35740
3.65918481561335e-09	-0.953138228167912	0.103	0.516	7.76881528202869e-05	CBX3	B cells	GSE199333_pre	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35741
3.83178679165103e-09	-0.978152961372785	0.23	0.672	8.13526653735431e-05	HNRNPDL	B cells	GSE199333_pre	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35742
4.03495378744375e-09	-0.910069506276026	0.115	0.531	8.56661038612183e-05	JAK1	B cells	GSE199333_pre	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35743
4.18833831061601e-09	0.707081948155879	0.598	0.125	8.89226106726885e-05	GAS6	B cells	GSE199333_pre	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35744
4.49283853669488e-09	-1.10676141728112	0.023	0.391	9.5387454972569e-05	CYB561A3	B cells	GSE199333_pre	ENSG00000162144	220002	cytochrome b561 family member A3	CYBASC3	protein_coding	Q8NBI2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35745
4.51322637038879e-09	-0.869208250550826	0.092	0.5	9.58203090697245e-05	HLA-F	B cells	GSE199333_pre	ENSG00000234487	3134	major histocompatibility complex, class I, F	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35746
4.59405396508892e-09	-0.813055124246056	0.989	1	9.75363597328029e-05	HLA-C	B cells	GSE199333_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35747
4.66759730699837e-09	0.756365312374678	0.885	0.422	9.90977584248823e-05	LMAN2	B cells	GSE199333_pre	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35748
5.15551089249789e-09	-0.970455724385985	0.161	0.609	0.000109456651758623	ANP32B	B cells	GSE199333_pre	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35749
5.24837864040152e-09	-2.1959614953003	0.08	0.5	0.000111428326914365	LTB	B cells	GSE199333_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35750
5.85173060146066e-09	-1.00567604918642	0.149	0.578	0.000124238092399611	SEPT7	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35751
5.91986408635907e-09	2.25983921036941	1	0.672	0.000125684634417489	IGKC	B cells	GSE199333_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35752
6.06180917812792e-09	-0.998906124847332	0.322	0.719	0.000128698270660834	SUMO2	B cells	GSE199333_pre	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35753
6.11733712402848e-09	-0.783980413683795	0.023	0.391	0.000129877184480249	PAK2	B cells	GSE199333_pre	ENSG00000180370	5062	p21 (RAC1) activated kinase 2	PAK65|PAKgamma	protein_coding	Q13177	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35754
6.25817539780047e-09	0.844714696953888	0.954	0.656	0.000132867321870702	ITM2C	B cells	GSE199333_pre	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35755
6.32069410981499e-09	-0.945443836377911	0.08	0.484	0.000134194656645482	DAZAP2	B cells	GSE199333_pre	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35756
6.41896488530318e-09	-0.993140578409208	0.23	0.625	0.000136281043479872	PSMA7	B cells	GSE199333_pre	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35757
6.52954465767898e-09	-0.961971726385108	0.069	0.469	0.000138628762627182	SH3BGRL	B cells	GSE199333_pre	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35758
6.88529736104913e-09	1.21088086301723	0.552	0.094	0.000146181748272434	JSRP1	B cells	GSE199333_pre	ENSG00000167476	126306	junctional sarcoplasmic reticulum protein 1	FLJ32416|JP-45	protein_coding	Q96MG2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35759
7.08544556059186e-09	0.688653386934485	0.747	0.234	0.000150431094696926	DNAJB9	B cells	GSE199333_pre	ENSG00000128590	4189	DnaJ heat shock protein family (Hsp40) member B9	MDG1	protein_coding	Q9UBS3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35760
7.92097086702171e-09	-0.997532347526366	0.092	0.484	0.000168170132477738	MYCBP2	B cells	GSE199333_pre	ENSG00000005810	23077	MYC binding protein 2	FLJ10106|KIAA0916|PAM|PHR1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35761
8.30829482562663e-09	-1.44986290978852	0.103	0.5	0.000176393407442879	HLA-DQB1	B cells	GSE199333_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35762
8.44308281972179e-09	-0.627368066986156	0.011	0.359	0.000179255091345513	CD72	B cells	GSE199333_pre	ENSG00000137101	971	CD72 molecule	CD72b|LYB2	protein_coding	P21854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35763
8.99385567778261e-09	-1.00290199043999	0.092	0.484	0.000190948549895003	CAPZB	B cells	GSE199333_pre	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35764
9.02079606395611e-09	-1.44294349584873	0.149	0.547	0.000191520521233852	POU2F2	B cells	GSE199333_pre	ENSG00000028277	5452	POU class 2 homeobox 2	OCT2|OTF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35765
9.03096877305486e-09	-0.977600914721819	0.195	0.594	0.000191736498020728	LAMTOR5	B cells	GSE199333_pre	ENSG00000134248	10542	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	HBXIP|MGC71071|XIP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35766
1.02075795275055e-08	-0.903495654379941	0.253	0.656	0.00021671712094847	GTF3A	B cells	GSE199333_pre	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35767
1.04642342566755e-08	-0.9140150300419	0.126	0.531	0.000222166157503477	PARP1	B cells	GSE199333_pre	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35768
1.08804077362224e-08	-1.13148240001243	0.103	0.516	0.000231001936647739	IRF1	B cells	GSE199333_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35769
1.14737287136473e-08	-1.01141787378132	0.563	0.859	0.000243598734319447	COX7C	B cells	GSE199333_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35770
1.22169882584055e-08	-0.873087887517781	0.034	0.406	0.000259378877714207	S1PR4	B cells	GSE199333_pre	ENSG00000125910	8698	sphingosine-1-phosphate receptor 4	EDG6	protein_coding	O95977	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35771
1.23826958782125e-08	-0.922552996423656	0.345	0.766	0.00026289701619033	PNRC1	B cells	GSE199333_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35772
1.30392458796716e-08	-0.906890595608519	0.253	0.641	0.000276836229271307	NEDD8	B cells	GSE199333_pre	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35773
1.58298864421981e-08	-0.835260918627489	0.08	0.469	0.000336084319054309	POLR1D	B cells	GSE199333_pre	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35774
1.61434772891913e-08	-0.846665681899738	0.092	0.469	0.000342742166326821	ANP32A	B cells	GSE199333_pre	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35775
1.67901370726629e-08	-0.960195768874368	0.92	0.938	0.000356471400189707	OAZ1	B cells	GSE199333_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35776
1.82228793774641e-08	-0.950592145312447	0.954	1	0.00038688995206294	RPL36	B cells	GSE199333_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35777
1.90477869476378e-08	-0.777927743561537	0.011	0.344	0.000404403564685298	CDKN2D	B cells	GSE199333_pre	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35778
1.91122570290064e-08	-0.688520704605976	0.08	0.484	0.000405772328982834	VPREB3	B cells	GSE199333_pre	ENSG00000128218	29802	V-set pre-B cell surrogate light chain 3	8HS20	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35779
1.97265887006658e-08	-0.683951595352523	0.011	0.344	0.000418815204703836	FXR1	B cells	GSE199333_pre	ENSG00000114416	8087	FMR1 autosomal homolog 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35780
1.98632794950185e-08	-1.04628452588474	0.943	0.969	0.000421717286958737	EEF1B2	B cells	GSE199333_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35781
2.027747499462e-08	-1.17139759015942	0.126	0.516	0.000430511071610777	LY6E	B cells	GSE199333_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35782
2.09540829335658e-08	-0.869208250550826	0.046	0.422	0.000444876134762535	RIPOR2	B cells	GSE199333_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35783
2.16230892351573e-08	-1.0792528765701	0.057	0.422	0.000459079807551625	LYN	B cells	GSE199333_pre	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35784
2.17035996783683e-08	-1.08922234789031	0.954	0.984	0.000460789124771438	RPL35	B cells	GSE199333_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35785
2.32575243020865e-08	-1.08893542996744	0.161	0.562	0.000493780498457598	N4BP2L2	B cells	GSE199333_pre	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35786
2.49685374414578e-08	-0.898622979624918	0.149	0.547	0.00053010701841959	SNRPB	B cells	GSE199333_pre	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35787
2.66339621961624e-08	-1.09225640797994	0.046	0.406	0.000565465651386724	BCL11A	B cells	GSE199333_pre	ENSG00000119866	53335	BAF chromatin remodeling complex subunit BCL11A	BCL11A-L|BCL11A-S|BCL11A-XL|CTIP1|EVI9|HBFQTL5|SMARCM1|ZNF856	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35788
2.69484073295682e-08	-0.659754884921876	0.241	0.656	0.000572141636014063	TUBA1B	B cells	GSE199333_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35789
2.97747683706622e-08	-1.03576811434285	0.264	0.656	0.00063214810727753	SRRM2	B cells	GSE199333_pre	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35790
2.99472522899299e-08	-0.996395023824667	0.736	0.938	0.000635810113367501	ATP5MG	B cells	GSE199333_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35791
3.18294124288307e-08	-0.764871590736091	0.034	0.391	0.000675770255276505	SMIM14	B cells	GSE199333_pre	ENSG00000163683	201895	small integral membrane protein 14	C4orf34|FLJ13289	protein_coding	Q96QK8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35792
3.23296097652881e-08	-0.924283365495727	0.149	0.531	0.000686389944926832	EID1	B cells	GSE199333_pre	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35793
3.33416528877347e-08	0.764997769190179	0.908	0.359	0.000707876632459495	MYDGF	B cells	GSE199333_pre	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35794
3.44902753457455e-08	-1.06461777492641	0.908	0.938	0.000732263035865524	RPS10	B cells	GSE199333_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35795
3.55062199078489e-08	-0.735124247342039	0.115	0.5	0.00075383255486354	CSDE1	B cells	GSE199333_pre	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35796
3.80440500898452e-08	-0.913263430628762	0.08	0.453	0.000807713227457504	PKM	B cells	GSE199333_pre	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35797
3.9690666666044e-08	0.628315187321094	0.644	0.188	0.00084267254398678	CHID1	B cells	GSE199333_pre	ENSG00000177830	66005	chitinase domain containing 1	FLJ42707|MGC3234|SI-CLP	protein_coding	Q9BWS9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35798
4.02876855734801e-08	-1.02790599656988	0.46	0.797	0.000855347852410556	EIF3K	B cells	GSE199333_pre	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35799
4.10862732349436e-08	-0.946376111073286	0.046	0.391	0.000872302667051088	SLTM	B cells	GSE199333_pre	ENSG00000137776	79811	SAFB like transcription modulator	FLJ13213|Met	protein_coding	Q9NWH9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35800
4.12039737953373e-08	0.486173017994762	0.575	0.125	0.000874801567648805	SRPRB	B cells	GSE199333_pre	ENSG00000144867	58477	SRP receptor subunit beta	APMCF1|SR-beta	protein_coding	Q9Y5M8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35801
4.15278446896233e-08	-0.842550954557966	0.057	0.422	0.000881677670605391	NCOR1	B cells	GSE199333_pre	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35802
4.24483544569117e-08	-0.821455119102458	0.034	0.375	0.000901221013474693	RGS19	B cells	GSE199333_pre	ENSG00000171700	10287	regulator of G protein signaling 19	GAIP|RGSGAIP	protein_coding	P49795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35803
4.3556185111252e-08	-1.08448952493625	0.034	0.391	0.00092474136609699	MS4A1	B cells	GSE199333_pre	ENSG00000156738	931	membrane spanning 4-domains A1	B1|Bp35|CD20|FMC7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35804
4.40285838167877e-08	-0.6925573859202	0.034	0.375	0.000934770863014219	SNX6	B cells	GSE199333_pre	ENSG00000129515	58533	sorting nexin 6	NA	protein_coding	Q9UNH7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35805
4.49895662982955e-08	-0.823765279789659	0.103	0.484	0.000955173482079112	HCST	B cells	GSE199333_pre	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35806
4.69401265413198e-08	-1.16876853240973	0.149	0.516	0.00099658582659876	ARID1B	B cells	GSE199333_pre	ENSG00000049618	57492	AT-rich interaction domain 1B	6A3-5|BAF250b|DAN15|ELD/OSA1|KIAA1235|p250R|SMARCF2	protein_coding	Q8NFD5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35807
4.94762458429852e-08	-0.65444760104244	0.057	0.422	0.00105043017549242	CCT5	B cells	GSE199333_pre	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35808
5.16575490854417e-08	-0.926460733010339	0.172	0.562	0.00109674142463301	RSL24D1	B cells	GSE199333_pre	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35809
5.24331526400618e-08	-0.889345166036907	0.046	0.391	0.00111320826370115	SYK	B cells	GSE199333_pre	ENSG00000165025	6850	spleen associated tyrosine kinase	NA	protein_coding	P43405	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35810
5.61481999318218e-08	0.671568385274977	0.851	0.406	0.00119208243275251	SELENOK	B cells	GSE199333_pre	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35811
5.67455633622298e-08	-0.854257909084855	0.069	0.438	0.0012047650557435	TBC1D10C	B cells	GSE199333_pre	ENSG00000175463	374403	TBC1 domain family member 10C	Carabin|EPI64C|FLJ00332	protein_coding	Q8IV04	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35812
5.78540348042385e-08	-0.690036357813501	0.046	0.391	0.00122829901292879	CASP4	B cells	GSE199333_pre	ENSG00000196954	837	caspase 4	ICE(rel)II|ICH-2|TX	protein_coding	P49662	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35813
5.8576084826069e-08	-0.975493043690041	0.943	0.969	0.00124362885694227	EEF1D	B cells	GSE199333_pre	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35814
6.15178138126265e-08	-0.859705675597033	0.724	0.922	0.00130608470505587	CHCHD2	B cells	GSE199333_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35815
6.34501338218214e-08	-0.987264012072538	0.092	0.453	0.00134710979117109	TRABD	B cells	GSE199333_pre	ENSG00000170638	80305	TraB domain containing	PP2447	protein_coding	Q9H4I3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35816
6.39050144329432e-08	-0.567749951585009	0.092	0.484	0.00135676736142582	HLA-DRB1	B cells	GSE199333_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35817
6.66320352915945e-08	-0.687565864568642	0.057	0.406	0.00141466474127584	SEPT9	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35818
6.71370662337525e-08	-0.739560502206903	0.057	0.406	0.0014253870532088	PGLS	B cells	GSE199333_pre	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35819
6.74034701025697e-08	-0.955278196482487	0.287	0.672	0.00143104307374766	RAC2	B cells	GSE199333_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35820
7.70693932055391e-08	-0.69513051944553	0.023	0.344	0.0016362602871468	PFKL	B cells	GSE199333_pre	ENSG00000141959	5211	phosphofructokinase, liver type	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35821
7.70885463096941e-08	-0.752271553956457	0.057	0.406	0.00163666692670112	BTK	B cells	GSE199333_pre	ENSG00000010671	695	Bruton tyrosine kinase	AGMX1|ATK|IMD1|PSCTK1|XLA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35822
7.74184680892482e-08	-1.0150819562123	0.195	0.578	0.00164367149600283	PRRC2C	B cells	GSE199333_pre	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35823
7.92655897445296e-08	-0.820310577161517	0.103	0.469	0.00168288773586611	HNRNPF	B cells	GSE199333_pre	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35824
7.94839043448798e-08	-0.854138928833178	0.057	0.406	0.00168752277314614	OGA	B cells	GSE199333_pre	ENSG00000198408	10724	O-GlcNAcase	MEA5|MGEA5|NCOAT	protein_coding	O60502	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35825
8.02419093893445e-08	-0.708677051283478	0.023	0.344	0.00170361597824517	CCDC191	B cells	GSE199333_pre	ENSG00000163617	57577	coiled-coil domain containing 191	KIAA1407	protein_coding	Q8NCU4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35826
8.33472689540693e-08	-0.819091981733977	0.057	0.406	0.00176954586716384	TPR	B cells	GSE199333_pre	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35827
8.3667984816957e-08	0.782476618185288	0.402	0.016	0.00177635498564881	DPEP1	B cells	GSE199333_pre	ENSG00000015413	1800	dipeptidase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35828
8.51458431737704e-08	-0.758719363754495	0.057	0.406	0.00180773139642232	BRD4	B cells	GSE199333_pre	ENSG00000141867	23476	bromodomain containing 4	CAP|HUNK1|HUNKI|MCAP	protein_coding	O60885	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35829
9.04169584152241e-08	-1.08254125314673	0.046	0.391	0.00191964244411362	STMN1	B cells	GSE199333_pre	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35830
9.39382242798296e-08	0.800725585118135	0.862	0.406	0.00199440243968506	SDF2L1	B cells	GSE199333_pre	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35831
1.0200524084644e-07	-0.506368875990362	0.023	0.344	0.00216567326841076	MARCH1	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35832
1.06917244002497e-07	0.756127851253101	0.759	0.328	0.00226996000741701	ERLEC1	B cells	GSE199333_pre	ENSG00000068912	27248	endoplasmic reticulum lectin 1	C2orf30|CL25084|ERLECTIN|XTP3-B|XTP3TPB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35833
1.07159889009957e-07	0.665580960929441	0.356	0	0.0022751116035704	IGLV3-1	B cells	GSE199333_pre	ENSG00000211673	NA	NA	NA	IG_V_gene	P01715	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35834
1.13011796601411e-07	0.547406334117552	0.552	0.109	0.00239935345364455	LY96	B cells	GSE199333_pre	ENSG00000154589	23643	lymphocyte antigen 96	MD-2	protein_coding	Q9Y6Y9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35835
1.20775963797885e-07	-0.993495965784053	0.08	0.438	0.0025641944873929	PRKCB	B cells	GSE199333_pre	ENSG00000166501	5579	protein kinase C beta	PKCB|PKCbeta|PRKCB1|PRKCB2	protein_coding	P05771	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35836
1.22128064001784e-07	-0.802271562541284	0.092	0.453	0.00259290092682187	SNRPB2	B cells	GSE199333_pre	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35837
1.26538787856844e-07	-0.665335917185176	0.034	0.359	0.00268654500498865	PSMB8-AS1	B cells	GSE199333_pre	ENSG00000235540	100507463	PSMB8 antisense RNA 1 (head to head)	TAP1-AS1|TAPSAR1|XXbac-BPG246D15.8	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35838
1.28800231926654e-07	0.668648195277257	0.966	0.5	0.0027345577240348	SSR3	B cells	GSE199333_pre	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35839
1.39450574653664e-07	0.733645235874595	0.954	0.609	0.00296067515047193	SPCS1	B cells	GSE199333_pre	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35840
1.41672387118137e-07	-0.946111905406237	0.356	0.672	0.00300784645090517	ATP6V1G1	B cells	GSE199333_pre	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35841
1.43570257929362e-07	-0.83824477706631	0.046	0.375	0.00304814014609829	APEX1	B cells	GSE199333_pre	ENSG00000100823	328	apurinic/apyrimidinic endodeoxyribonuclease 1	APE|APE-1|APEN|APEX|APX|HAP1|REF-1|REF1	protein_coding	P27695	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35842
1.46179550320006e-07	-0.818155014634384	0.138	0.5	0.00310353803284405	BCLAF1	B cells	GSE199333_pre	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35843
1.54280527463347e-07	0.703213339660634	0.908	0.531	0.00327552987857431	TMEM258	B cells	GSE199333_pre	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35844
1.54803948165413e-07	-0.744324213332005	0.115	0.484	0.00328664262349989	TALDO1	B cells	GSE199333_pre	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35845
1.58682139924027e-07	1.7959748225786	0.46	0.047	0.00336898051272701	IGHG2	B cells	GSE199333_pre	ENSG00000274497	NA	NA	NA	IG_C_gene	P01859	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35846
1.61871260799104e-07	-0.643856189774725	0	0.281	0.00343668873802578	AC245060.5	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35847
1.63395783072418e-07	-0.78135971352466	0	0.281	0.0034690558704105	HCK	B cells	GSE199333_pre	ENSG00000101336	3055	HCK proto-oncogene, Src family tyrosine kinase	JTK9	protein_coding	P08631	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35848
1.68627109842723e-07	-0.886932368823701	0.195	0.562	0.00358012216907085	SAP18	B cells	GSE199333_pre	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35849
1.75207457945487e-07	-0.567122907069458	0.011	0.312	0.00371982953964063	LSM14A	B cells	GSE199333_pre	ENSG00000262860	26065	LSM14A mRNA processing body assembly factor	C19orf13|DKFZP434D1335|FAM61A|RAP55|RAP55A	protein_coding	Q8ND56	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35850
1.86546903693685e-07	-0.74856977840699	0.023	0.328	0.00396057731232063	SMARCC1	B cells	GSE199333_pre	ENSG00000173473	6599	SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1	BAF155|CRACC1|Rsc8|SRG3	protein_coding	Q92922	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35851
1.87836048575609e-07	-0.843030653661601	0.103	0.453	0.00398794714730875	SF3B2	B cells	GSE199333_pre	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35852
1.91977525233572e-07	-1.01355070359281	0.115	0.469	0.00407587483823397	SRSF11	B cells	GSE199333_pre	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35853
1.99581494060678e-07	0.76762349009093	0.483	0.094	0.00423731470040226	ELL2	B cells	GSE199333_pre	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35854
2.00391801774646e-07	-0.903577861567683	0.184	0.547	0.00425451834347751	SRSF7	B cells	GSE199333_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35855
2.0840824857694e-07	-0.779593096442856	0.414	0.812	0.00442471552553701	CALM1	B cells	GSE199333_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35856
2.08769397905261e-07	-0.857980995127572	0.494	0.766	0.00443238308692659	HSPA8	B cells	GSE199333_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35857
2.11622407964898e-07	-1.02313675242201	0.138	0.484	0.00449295534350275	SP110	B cells	GSE199333_pre	ENSG00000135899	3431	SP110 nuclear body protein	IFI41|IFI75	protein_coding	Q9HB58	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35858
2.17830040392006e-07	-0.880348808156027	0.103	0.438	0.00462474958756267	TRAPPC1	B cells	GSE199333_pre	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35859
2.38565613844757e-07	-0.732450113043713	0.023	0.328	0.00506498654753804	ADD1	B cells	GSE199333_pre	ENSG00000087274	118	adducin 1	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35860
2.41584236084899e-07	-0.861347846225971	0.161	0.516	0.0051290749163185	SRSF2	B cells	GSE199333_pre	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35861
2.71529055533514e-07	-0.665335917185176	0.034	0.344	0.00576483337803203	MAP2K3	B cells	GSE199333_pre	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35862
2.97245065661861e-07	-0.594946589293778	0.034	0.344	0.00631080998906697	PKN1	B cells	GSE199333_pre	ENSG00000123143	5585	protein kinase N1	DBK|MGC46204|PAK1|PKN|PRK1|PRKCL1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35863
3.1195423327709e-07	-0.598221721326639	0.011	0.297	0.00662310032670589	HHEX	B cells	GSE199333_pre	ENSG00000152804	3087	hematopoietically expressed homeobox	HEX|HOX11L-PEN|PRHX	protein_coding	Q03014	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35864
3.30547951248315e-07	-0.843597076964916	0.966	0.984	0.00701786355295297	SERF2	B cells	GSE199333_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35865
3.33430379374048e-07	-0.649394373316155	0.046	0.359	0.00707906038449041	ROCK1	B cells	GSE199333_pre	ENSG00000067900	6093	Rho associated coiled-coil containing protein kinase 1	p160ROCK	protein_coding	Q13464	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35866
3.68776123269759e-07	-1.03201039490262	0.253	0.594	0.00782948587314025	ATP5F1B	B cells	GSE199333_pre	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35867
3.76083701181475e-07	-0.357552004618084	0	0.266	0.0079846330597839	FAM129C	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35868
3.84331860803503e-07	-0.841492872339003	0.126	0.484	0.00815974973671916	ARPC1B	B cells	GSE199333_pre	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35869
3.90058144253112e-07	-0.961410584782977	0.218	0.562	0.00828132446063782	EZR	B cells	GSE199333_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35870
3.93118229155217e-07	-0.62935662007961	0	0.266	0.00834629312319441	FAM118A	B cells	GSE199333_pre	ENSG00000100376	55007	family with sequence similarity 118 member A	bK268H5.C22.4|C22orf8|FLJ20635	protein_coding	Q9NWS6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35871
4.22603192388242e-07	-0.963333995273801	0.103	0.438	0.00897228837759476	DDX24	B cells	GSE199333_pre	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35872
4.28822117213359e-07	-0.795245239779609	0.08	0.406	0.00910432237055683	GNB2	B cells	GSE199333_pre	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35873
4.35762009255015e-07	1.0575819024954	0.816	0.484	0.00925166321849323	HBA2	B cells	GSE199333_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35874
4.36730846824227e-07	-0.718577938462156	0.092	0.422	0.00927223260892516	GPBP1	B cells	GSE199333_pre	ENSG00000062194	65056	GC-rich promoter binding protein 1	DKFZp761C169	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35875
4.63667609838708e-07	-0.605882066974934	0.034	0.344	0.00984412702448561	SYPL1	B cells	GSE199333_pre	ENSG00000008282	6856	synaptophysin like 1	SYPL	protein_coding	Q16563	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35876
4.72138577395485e-07	-0.722097567045799	0.023	0.312	0.0100239741366836	ITGA4	B cells	GSE199333_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35877
4.75229108274402e-07	-0.557402220433643	0.069	0.422	0.0100895891977738	TUBB	B cells	GSE199333_pre	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35878
4.83318596028845e-07	0.590071561379235	0.839	0.375	0.0102613371122884	PSAP	B cells	GSE199333_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35879
4.92601055225075e-07	-0.985261659161391	0.161	0.5	0.0104584130034836	CXXC5	B cells	GSE199333_pre	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35880
5.03522842372814e-07	-0.787389027297518	0.023	0.312	0.0106902934664172	RALBP1	B cells	GSE199333_pre	ENSG00000017797	10928	ralA binding protein 1	RIP|RIP1|RLIP76	protein_coding	Q15311	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35881
5.07903171504978e-07	-0.758970989296406	0.08	0.422	0.0107832922342222	KMT2E	B cells	GSE199333_pre	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35882
5.08920611410313e-07	-0.830869149510331	0.046	0.359	0.0108048935008523	CAPG	B cells	GSE199333_pre	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35883
5.12062242548469e-07	-0.721244658335833	0.08	0.406	0.0108715934715465	TTC14	B cells	GSE199333_pre	ENSG00000163728	151613	tetratricopeptide repeat domain 14	FLJ00166|KIAA1980	protein_coding	Q96N46	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35884
5.1350242378154e-07	0.582367592680459	0.874	0.453	0.0109021699593059	KDELR2	B cells	GSE199333_pre	ENSG00000136240	11014	KDEL endoplasmic reticulum protein retention receptor 2	ELP-1|ERD2.2	protein_coding	P33947	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35885
5.18561462179009e-07	-0.708677051283478	0.023	0.312	0.0110095784035225	GRK2	B cells	GSE199333_pre	ENSG00000173020	156	G protein-coupled receptor kinase 2	ADRBK1|BARK1	protein_coding	P25098	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35886
5.2882431106269e-07	0.651574102935561	0.747	0.312	0.011227468948172	KDELR1	B cells	GSE199333_pre	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35887
5.83704523109421e-07	-0.682770510521197	0.069	0.391	0.0123926307301361	TRA2A	B cells	GSE199333_pre	ENSG00000164548	29896	transformer 2 alpha homolog	AWMS1|htra-2-alpha	protein_coding	Q13595	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35888
5.86398257736295e-07	-0.749921249270119	0.08	0.406	0.0124498214099993	DDX6	B cells	GSE199333_pre	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35889
5.95338397464221e-07	-0.979444507613239	0.241	0.562	0.0126396295165629	HNRNPA3	B cells	GSE199333_pre	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35890
6.05123357410237e-07	-0.779371160431206	0.126	0.469	0.0128473740011768	MPHOSPH8	B cells	GSE199333_pre	ENSG00000196199	54737	M-phase phosphoprotein 8	HSMPP8|mpp8	protein_coding	Q99549	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35891
6.11662578366775e-07	-0.865176496531776	0.115	0.453	0.012986208201305	SNRPD3	B cells	GSE199333_pre	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35892
6.30483750405104e-07	-0.971967824976027	0.494	0.75	0.0133858005048508	TMA7	B cells	GSE199333_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35893
6.4697914405511e-07	-0.843030653661601	0.092	0.422	0.013736014207434	ATP5F1C	B cells	GSE199333_pre	ENSG00000165629	509	ATP synthase F1 subunit gamma	ATP5C|ATP5C1|ATP5CL1	protein_coding	P36542	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35894
6.65584712405021e-07	-0.857980995127572	0.23	0.547	0.014131029029071	UBE2D2	B cells	GSE199333_pre	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35895
6.90297665768243e-07	-0.579362694075323	0.092	0.438	0.0146557097419256	HIST1H4C	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35896
6.99414214112461e-07	-0.651530117660146	0.034	0.328	0.0148492631798217	LBR	B cells	GSE199333_pre	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35897
7.06592632644718e-07	0.557056504151272	0.678	0.25	0.01500166818368	ICAM2	B cells	GSE199333_pre	ENSG00000108622	3384	intercellular adhesion molecule 2	CD102	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35898
7.12450102463782e-07	-0.968263050142483	0.138	0.484	0.0151260281254086	ATRX	B cells	GSE199333_pre	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35899
7.26486008605376e-07	-0.854574393684323	0.184	0.516	0.0154240244487007	BRK1	B cells	GSE199333_pre	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35900
7.31792626124699e-07	-0.651530117660146	0.034	0.328	0.0155366892452535	PLEKHA2	B cells	GSE199333_pre	ENSG00000169499	59339	pleckstrin homology domain containing A2	TAPP2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35901
7.49964233974586e-07	-0.887424773020054	0.103	0.422	0.0159224906515144	GTF2I	B cells	GSE199333_pre	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35902
7.53615155006194e-07	-1.0150819562123	0.218	0.547	0.0160000033559365	SRSF3	B cells	GSE199333_pre	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35903
7.58054623560491e-07	-0.745127655437676	0.092	0.438	0.0160942577128128	H2AFY	B cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35904
7.63478789883615e-07	-0.924812503605781	0.287	0.594	0.016209418188019	EIF3G	B cells	GSE199333_pre	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35905
7.94314920200657e-07	-0.683951595352523	0.115	0.453	0.0168641000707802	UBE2B	B cells	GSE199333_pre	ENSG00000119048	7320	ubiquitin conjugating enzyme E2 B	HHR6B|RAD6B|UBC2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35906
8.5000621090228e-07	-0.762880292916999	0.425	0.766	0.0180464818636663	SARAF	B cells	GSE199333_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35907
8.67085217606717e-07	-0.693266849932968	0.069	0.391	0.0184090862550082	SSB	B cells	GSE199333_pre	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35908
8.70814507803403e-07	-0.507634110447056	1	1	0.018488262815174	B2M	B cells	GSE199333_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35909
8.73450726205381e-07	-0.663069310213231	0.046	0.344	0.0185442323680664	VPS13C	B cells	GSE199333_pre	ENSG00000129003	54832	vacuolar protein sorting 13 homolog C	BLTP5C|FLJ10381|FLJ20136|KIAA1421	protein_coding	Q709C8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35910
9.24424054422747e-07	-0.698598371316925	0.115	0.453	0.0196264470994493	SMARCB1	B cells	GSE199333_pre	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35911
9.41192924493739e-07	-0.749921249270119	0.08	0.406	0.0199824669799266	ARL6IP5	B cells	GSE199333_pre	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35912
9.80778625638526e-07	-0.639340708652232	0.057	0.375	0.0208229110009315	HMGA1	B cells	GSE199333_pre	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35913
9.83891360618135e-07	-0.873993313116203	0.253	0.562	0.0208889974772836	UBXN4	B cells	GSE199333_pre	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35914
1.01693908626149e-06	-0.682770510521197	0.08	0.391	0.0215906337404178	TOMM22	B cells	GSE199333_pre	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35915
1.03146411240088e-06	-0.593360338401827	0.046	0.344	0.0218990145703831	EBLN3P	B cells	GSE199333_pre	ENSG00000281649	100506710	endogenous Bornavirus like nucleoprotein 3, pseudogene	EBLN3|LOC100506710	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35916
1.05462274520937e-06	-0.743452607101185	0.092	0.406	0.0223906955035401	DDAH2	B cells	GSE199333_pre	ENSG00000226634	23564	dimethylarginine dimethylaminohydrolase 2	G6A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35917
1.0625308811769e-06	-0.781745409300487	0.126	0.453	0.0225585931382667	CAP1	B cells	GSE199333_pre	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35918
1.10684520476364e-06	-0.590285211923915	0.034	0.328	0.0234994305423369	CMTM6	B cells	GSE199333_pre	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35919
1.16646928891159e-06	-0.611066254657055	0.023	0.297	0.0247653094728819	PNRC2	B cells	GSE199333_pre	ENSG00000189266	55629	proline rich nuclear receptor coactivator 2	NA	protein_coding	Q9NPJ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35920
1.17070330821705e-06	-0.827284197904656	0.08	0.391	0.0248552019367562	ZCCHC7	B cells	GSE199333_pre	ENSG00000147905	84186	zinc finger CCHC-type containing 7	AIR1|FLJ22611	protein_coding	Q8N3Z6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35921
1.20531371995255e-06	-0.809482477436382	0.23	0.594	0.0255900155883127	RAN	B cells	GSE199333_pre	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35922
1.21968970245657e-06	-0.56323772956644	0.034	0.328	0.0258952320728554	PHF14	B cells	GSE199333_pre	ENSG00000106443	9678	PHD finger protein 14	KIAA0783	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35923
1.22837338345333e-06	0.542842644931571	0.736	0.266	0.0260795953040976	CRELD2	B cells	GSE199333_pre	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35924
1.25244844915774e-06	-0.611066254657055	0.023	0.297	0.026590733024068	KIF2A	B cells	GSE199333_pre	ENSG00000068796	3796	kinesin family member 2A	HK2|KIF2	protein_coding	O00139	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35925
1.26962949990613e-06	-0.738399379374899	0.667	0.875	0.026955503912507	EDF1	B cells	GSE199333_pre	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35926
1.28916370735538e-06	-0.567122907069458	0.023	0.297	0.027370234670862	CSNK1G2	B cells	GSE199333_pre	ENSG00000133275	1455	casein kinase 1 gamma 2	CK1g2	protein_coding	P78368	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35927
1.29493713377425e-06	-0.77074815707276	0.103	0.422	0.0274928102871612	BOD1L1	B cells	GSE199333_pre	ENSG00000038219	259282	biorientation of chromosomes in cell division 1 like 1	BOD1L|FAM44A|FLJ33215|KIAA1327	protein_coding	Q8NFC6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35928
1.3263765820099e-06	-0.537065673213278	0.023	0.297	0.0281603012126522	CYFIP2	B cells	GSE199333_pre	ENSG00000055163	26999	cytoplasmic FMR1 interacting protein 2	PIR121	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35929
1.38287460409973e-06	-1.19890849769272	0.632	0.875	0.0293598107196414	JUND	B cells	GSE199333_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35930
1.42562058407204e-06	-0.922686684515387	0.195	0.516	0.0302673506204335	DBI	B cells	GSE199333_pre	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35931
1.49998149621575e-06	-0.777362534919288	0.563	0.75	0.0318461071461566	COX7A2	B cells	GSE199333_pre	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35932
1.53861656205905e-06	-0.825800589378422	0.126	0.453	0.0326663682290757	SF3B1	B cells	GSE199333_pre	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35933
1.54959856512464e-06	-0.776844232402167	0.08	0.391	0.0328995271361613	TAF7	B cells	GSE199333_pre	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35934
1.56164252270319e-06	-0.680442809575385	0.092	0.406	0.0331552323995115	CTDNEP1	B cells	GSE199333_pre	ENSG00000288307	23399	CTD nuclear envelope phosphatase 1	DULLARD|HSA011916|NET56	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35935
1.59997607958085e-06	-0.656538968948017	0.08	0.391	0.033969092145581	CHURC1	B cells	GSE199333_pre	ENSG00000258289	91612	churchill domain containing 1	C14orf52|FLJ33064|My015	protein_coding	Q8WUH1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35936
1.60362511713851e-06	-0.762763927774099	0.368	0.688	0.0340465648619677	COX5B	B cells	GSE199333_pre	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35937
1.67819763440857e-06	-0.937052566118771	0.414	0.688	0.0356298139761285	COX6B1	B cells	GSE199333_pre	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35938
1.70912346381734e-06	-0.656538968948017	0.057	0.359	0.0362864002603059	SNX2	B cells	GSE199333_pre	ENSG00000205302	6643	sorting nexin 2	NA	protein_coding	O60749	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35939
1.74614293582588e-06	-0.565800243634262	0.034	0.312	0.0370723606705193	LYPLA1	B cells	GSE199333_pre	ENSG00000120992	10434	lysophospholipase 1	APT-1|LPL1	protein_coding	O75608	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35940
1.78692499659771e-06	-0.813055124246056	0.138	0.469	0.0379382046027659	EIF3D	B cells	GSE199333_pre	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35941
1.82296027026619e-06	-0.780524855047576	0.207	0.531	0.0387032694980214	PHB2	B cells	GSE199333_pre	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35942
1.82707468453158e-06	-0.841492872339003	0.011	0.266	0.0387906226272901	CDC25B	B cells	GSE199333_pre	ENSG00000101224	994	cell division cycle 25B	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35943
1.82748182833992e-06	-0.551003241706181	0.034	0.312	0.0387992666974848	ARHGEF1	B cells	GSE199333_pre	ENSG00000076928	9138	Rho guanine nucleotide exchange factor 1	LBCL2|P115-RHOGEF|SUB1.5	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35944
1.84320664148746e-06	-0.679010854082253	0.034	0.312	0.0391331202054203	MACF1	B cells	GSE199333_pre	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35945
1.84416782984603e-06	-0.538100728889068	0.011	0.266	0.039153527195461	BNIP2	B cells	GSE199333_pre	ENSG00000140299	663	BCL2 interacting protein 2	BNIP-2|Nip2	protein_coding	Q12982	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35946
1.84814016533734e-06	-0.553367485542379	0.011	0.266	0.039237863850277	PSIP1	B cells	GSE199333_pre	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35947
1.85199894046175e-06	-0.670012404394649	0.011	0.266	0.0393197895049434	MLXIP	B cells	GSE199333_pre	ENSG00000281178	22877	MLX interacting protein	bHLHe36|KIAA0867|MIR|MONDOA	protein_coding	Q9HAP2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35948
1.86635364440983e-06	-0.882055130106429	0.161	0.469	0.039624554224465	HCLS1	B cells	GSE199333_pre	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35949
1.87176172169655e-06	-0.507073833268444	0.011	0.266	0.0397393731133395	CDC123	B cells	GSE199333_pre	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35950
1.92235399008717e-06	-0.703333180426958	0.034	0.312	0.0408134975635408	PDLIM1	B cells	GSE199333_pre	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35951
1.92879787930993e-06	-0.701476509447581	0.184	0.516	0.0409503077756291	PTGES3	B cells	GSE199333_pre	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35952
1.93279871134006e-06	-0.507073833268444	0.011	0.266	0.0410352494404609	DCK	B cells	GSE199333_pre	ENSG00000156136	1633	deoxycytidine kinase	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35953
1.99957119072203e-06	-0.870053827428147	0.276	0.578	0.0424528959502194	SNRPD2	B cells	GSE199333_pre	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35954
2.00233764692803e-06	0.474594343959299	0.46	0.094	0.0425116305819291	TXNDC5	B cells	GSE199333_pre	ENSG00000239264	81567	thioredoxin domain containing 5	EndoPDI|ERp46|FLJ21353|FLJ90810|Hcc-2|MGC3178|PDIA15	protein_coding	Q8NBS9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35955
2.00370947162766e-06	0.517743580126446	0.667	0.266	0.0425407557921268	PLPP5	B cells	GSE199333_pre	ENSG00000147535	84513	phospholipid phosphatase 5	DPPL1|HTPAP|PPAPDC1B	protein_coding	Q8NEB5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35956
2.04393420143126e-06	-0.850367811017697	0.092	0.391	0.0433947670305871	MSN	B cells	GSE199333_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35957
2.14214443970141e-06	0.777701263201452	0.816	0.406	0.0454798685993007	MANF	B cells	GSE199333_pre	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35958
2.22259858880695e-06	-0.780638906594407	0.046	0.328	0.0471879906389603	LBH	B cells	GSE199333_pre	ENSG00000213626	81606	LBH regulator of WNT signaling pathway	NA	protein_coding	Q53QV2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35959
2.25546069244578e-06	-0.857980995127572	0.08	0.391	0.0478856859613164	LCP1	B cells	GSE199333_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35960
2.30829398811631e-06	-0.834522022303583	0.069	0.359	0.0490073896616975	CDK13	B cells	GSE199333_pre	ENSG00000065883	8621	cyclin dependent kinase 13	CDC2L|CDC2L5|CHED|KIAA1791	protein_coding	Q14004	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35961
1.99917358246732e-88	1.46308401309663	0.956	0.587	4.24444543293636e-84	HBB	CD4+ T cells	GSE199333_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35962
2.12449033285183e-73	-0.760074959985619	1	1	4.51050542567772e-69	HLA-B	CD4+ T cells	GSE199333_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35963
2.62055418421263e-65	0.680695693572317	1	1	5.56369858850183e-61	RPS10	CD4+ T cells	GSE199333_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35964
8.48352267629781e-65	1.66438664439114	0.622	0.072	1.80113669940479e-60	IGKC	CD4+ T cells	GSE199333_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35965
6.58422698435715e-59	1.15755399331983	0.883	0.435	1.39789723104887e-54	CXCR4	CD4+ T cells	GSE199333_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35966
3.28911048772542e-56	1.0370906447033	0.844	0.482	6.98311047648984e-52	HBA2	CD4+ T cells	GSE199333_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35967
1.66269629883824e-50	1.20187234286965	0.954	0.832	3.53007051206347e-46	JUNB	CD4+ T cells	GSE199333_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35968
2.56540679995045e-45	0.966296286198465	0.734	0.375	5.4466151769748e-41	HBA1	CD4+ T cells	GSE199333_pre	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35969
5.61751144091277e-42	0.435330926704675	1	1	1.19265385402019e-37	RPS3A	CD4+ T cells	GSE199333_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35970
5.62105829592878e-40	0.416458262114469	1	1	1.19340688680864e-35	RPL21	CD4+ T cells	GSE199333_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35971
9.06835411662905e-40	-0.412250789246928	1	1	1.92530226250151e-35	RPLP1	CD4+ T cells	GSE199333_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35972
2.27678290728009e-38	-0.588973844805442	1	1	4.83383779044636e-34	HLA-A	CD4+ T cells	GSE199333_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35973
3.02545414486859e-38	1.55208948218844	0.408	0.033	6.42334169497051e-34	S100B	CD4+ T cells	GSE199333_pre	ENSG00000160307	6285	S100 calcium binding protein B	S100beta	protein_coding	P04271	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35974
2.49049096588972e-34	0.373680894178689	1	1	5.28756136968046e-30	RPS24	CD4+ T cells	GSE199333_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35975
5.13931934831679e-32	0.38687263610629	1	1	1.09112889084114e-27	RPL9	CD4+ T cells	GSE199333_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35976
1.01677993483488e-31	0.445609845955525	1	0.997	2.15872547964792e-27	RPL7	CD4+ T cells	GSE199333_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35977
5.79747003645303e-30	-0.651961749712382	0.075	0.328	1.23086086343934e-25	AC004687.1	CD4+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35978
8.47918470528955e-29	0.328127074026328	1	1	1.80021570478002e-24	RPL34	CD4+ T cells	GSE199333_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35979
1.33941654995027e-27	-0.685968798735876	0.607	0.857	2.84371527719942e-23	CD74	CD4+ T cells	GSE199333_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35980
1.90390486247424e-27	-0.740816813940729	0.958	0.994	4.04218041351906e-23	GAPDH	CD4+ T cells	GSE199333_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35981
4.57505836729286e-27	0.662716686707091	0.897	0.697	9.71330641959947e-23	TSC22D3	CD4+ T cells	GSE199333_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35982
1.18692162755686e-25	0.999614478644908	0.783	0.543	2.51995330746596e-21	FOS	CD4+ T cells	GSE199333_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35983
1.1963357209579e-25	0.312372812228707	1	1	2.53994036916572e-21	RPL32	CD4+ T cells	GSE199333_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35984
1.98039853347485e-25	0.286963572365211	1	1	4.20458412642045e-21	RPL26	CD4+ T cells	GSE199333_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35985
2.13580387480857e-25	-0.920031143709715	0.465	0.661	4.53452520660607e-21	GIMAP7	CD4+ T cells	GSE199333_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35986
9.05634335931366e-25	0.60441429422428	0.607	0.281	1.92275225861588e-20	GZMM	CD4+ T cells	GSE199333_pre	ENSG00000197540	3004	granzyme M	LMET1|MET1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35987
1.02391079789485e-24	-0.625184079063017	0.319	0.601	2.17386501501056e-20	SMDT1	CD4+ T cells	GSE199333_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35988
3.78434602380363e-24	-0.864696326248577	0.834	0.953	8.03454504313749e-20	NEAT1	CD4+ T cells	GSE199333_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35989
9.98843792086401e-24	0.432118440775679	1	1	2.12064525497864e-19	RPL27A	CD4+ T cells	GSE199333_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35990
4.72056168678855e-23	0.339408827814964	1	1	1.00222245172208e-18	RPS5	CD4+ T cells	GSE199333_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35991
9.68484629125483e-23	0.68351752949747	0.665	0.331	2.05618971609631e-18	TNFAIP3	CD4+ T cells	GSE199333_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35992
1.03064613411143e-22	0.305349923652875	1	1	2.18816480733199e-18	RPL37A	CD4+ T cells	GSE199333_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35993
2.32493494462966e-21	-0.407821035216268	0.999	1	4.93606938094323e-17	HLA-C	CD4+ T cells	GSE199333_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35994
1.85225997847988e-20	-0.809345958416535	0.255	0.493	3.93253316031064e-16	S100A11	CD4+ T cells	GSE199333_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35995
2.26953263733724e-20	0.278218682234655	1	1	4.8184447423307e-16	RPL14	CD4+ T cells	GSE199333_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35996
2.69465181631874e-20	0.386904236702175	0.276	0.041	5.72101527122632e-16	IGLC2	CD4+ T cells	GSE199333_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35997
5.4186302046998e-20	-0.327930748632885	1	1	1.15042937875981e-15	RPLP0	CD4+ T cells	GSE199333_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35998
1.77484029063014e-19	0.324087445417889	1	1	3.76816342103686e-15	RPL38	CD4+ T cells	GSE199333_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	35999
4.38667311480019e-19	-0.504066355675927	0.866	0.939	9.31334569003228e-15	FXYD5	CD4+ T cells	GSE199333_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36000
1.42022238795402e-18	0.464906748703449	0.88	0.697	3.01527415186518e-14	NSA2	CD4+ T cells	GSE199333_pre	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36001
1.46449393072193e-18	0.495525364844916	0.7	0.41	3.10926706431573e-14	YPEL5	CD4+ T cells	GSE199333_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36002
4.37139832259388e-18	-0.583229772340822	0.806	0.909	9.28091577869906e-14	TXNIP	CD4+ T cells	GSE199333_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36003
4.54721511937959e-18	0.269099151112917	1	1	9.6541924199548e-14	RPS9	CD4+ T cells	GSE199333_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36004
1.4095929499576e-17	0.702456182982521	0.385	0.135	2.99270679205497e-13	CD8B	CD4+ T cells	GSE199333_pre	ENSG00000172116	926	CD8b molecule	CD8B1	protein_coding	P10966	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36005
2.24714571640136e-17	0.271905176889637	1	1	4.77091507049173e-13	RPL22	CD4+ T cells	GSE199333_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36006
3.23836275643542e-16	0.251824601330187	1	1	6.87536796818804e-12	RPS13	CD4+ T cells	GSE199333_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36007
3.36409297623276e-16	0.390060069045289	0.961	0.928	7.14230579783977e-12	EIF3E	CD4+ T cells	GSE199333_pre	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36008
3.6283648454924e-16	-0.297420330976382	1	1	7.70338140346492e-12	MT-CO3	CD4+ T cells	GSE199333_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36009
6.39513978900343e-16	0.472571939627947	0.314	0.088	1.35775212860332e-11	CD8A	CD4+ T cells	GSE199333_pre	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36010
1.40017099225304e-15	0.506013239157896	0.929	0.854	2.97270303365242e-11	KLF2	CD4+ T cells	GSE199333_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36011
3.37645180009276e-15	0.462038566762955	0.824	0.708	7.16854481677694e-11	GYPC	CD4+ T cells	GSE199333_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36012
6.3517343062697e-15	0.299136598352281	1	1	1.34853671056412e-10	EEF1B2	CD4+ T cells	GSE199333_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36013
1.65347123552037e-14	-0.439168831298016	0.19	0.388	3.5104847801333e-10	HLA-DPB1	CD4+ T cells	GSE199333_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36014
1.90992407281151e-14	0.301033098535431	0.996	0.997	4.05495979898612e-10	NPM1	CD4+ T cells	GSE199333_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36015
4.66728366215359e-14	-0.47343931963909	0.545	0.702	9.9091099431183e-10	CIB1	CD4+ T cells	GSE199333_pre	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36016
4.88712471187577e-14	0.460504258131485	0.459	0.22	1.03758544757835e-09	DDIT4	CD4+ T cells	GSE199333_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36017
8.9808732930719e-14	-0.400811345762685	0.115	0.287	1.9067292088521e-09	TNFSF10	CD4+ T cells	GSE199333_pre	ENSG00000121858	8743	TNF superfamily member 10	Apo-2L|CD253|TL2|TRAIL	protein_coding	P50591	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36018
9.0730479222635e-14	0.42455874180078	0.608	0.375	1.92629880437576e-09	SLC2A3	CD4+ T cells	GSE199333_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36019
9.79995019153695e-14	-0.402455482718433	0.668	0.824	2.08062742516521e-09	CD99	CD4+ T cells	GSE199333_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36020
1.62976851111859e-13	0.578165686191361	0.811	0.667	3.46016152595588e-09	IL7R	CD4+ T cells	GSE199333_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36021
1.9228802833319e-13	-0.463560925443525	0.274	0.474	4.08246712954197e-09	CFLAR	CD4+ T cells	GSE199333_pre	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36022
2.14569307600245e-13	-0.637353094474972	0.257	0.446	4.5555209696608e-09	CORO1B	CD4+ T cells	GSE199333_pre	ENSG00000172725	57175	coronin 1B	coronin-2	protein_coding	Q9BR76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36023
2.43861486650498e-13	0.459314900459094	0.436	0.198	5.17742322307672e-09	ZNF331	CD4+ T cells	GSE199333_pre	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36024
4.7852187541186e-13	0.335659174892311	0.345	0.143	1.01594979368692e-08	LDLRAP1	CD4+ T cells	GSE199333_pre	ENSG00000157978	26119	low density lipoprotein receptor adaptor protein 1	ARH|ARH2|DKFZp586D0624|FHCB1|FHCB2|MGC34705	protein_coding	Q5SW96	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36025
9.23185161107884e-13	-0.506849286758295	0.218	0.408	1.96001441554815e-08	ARID5B	CD4+ T cells	GSE199333_pre	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36026
1.02141043046246e-12	-0.501410125040263	0.611	0.749	2.16855648491484e-08	TAGLN2	CD4+ T cells	GSE199333_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36027
1.64759093111554e-12	-0.411989106607233	0.172	0.344	3.49800030585141e-08	FAM118A	CD4+ T cells	GSE199333_pre	ENSG00000100376	55007	family with sequence similarity 118 member A	bK268H5.C22.4|C22orf8|FLJ20635	protein_coding	Q9NWS6	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36028
2.04357681973348e-12	-0.509826492686122	0.646	0.791	4.33871794597615e-08	KLF6	CD4+ T cells	GSE199333_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36029
2.64490161048512e-12	0.36641310845236	0.89	0.78	5.61539060922097e-08	CD48	CD4+ T cells	GSE199333_pre	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36030
2.83818893443848e-12	-0.695020150683637	0.921	0.904	6.02575892670634e-08	LTB	CD4+ T cells	GSE199333_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36031
3.21362350468245e-12	-0.393903956546795	0.177	0.358	6.82284406279132e-08	BIRC3	CD4+ T cells	GSE199333_pre	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36032
3.32351333734497e-12	-0.376567712228523	0.758	0.84	7.05615116651711e-08	MZT2B	CD4+ T cells	GSE199333_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36033
7.09099387422146e-12	-0.329129030956657	0.175	0.358	1.50548890943596e-07	OPTN	CD4+ T cells	GSE199333_pre	ENSG00000123240	10133	optineurin	FIP-2|FIP2|GLC1E|HIP7|HYPL|NRP|TFIIIA-INTP	protein_coding	Q96CV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36034
1.01486882586052e-11	0.301899202389413	1	0.997	2.15466800418446e-07	ACTB	CD4+ T cells	GSE199333_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36035
1.39775154810728e-11	0.356653858051425	0.683	0.46	2.96756631178657e-07	CD69	CD4+ T cells	GSE199333_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36036
2.469659646131e-11	-0.348101544727501	0.136	0.295	5.24333439470073e-07	GBP4	CD4+ T cells	GSE199333_pre	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36037
4.53746153403401e-11	-0.361063851521503	0.207	0.383	9.6334845829076e-07	HLA-DPA1	CD4+ T cells	GSE199333_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36038
5.52852882004576e-11	0.376699080954047	0.323	0.143	1.17376195378392e-06	LRRC75A	CD4+ T cells	GSE199333_pre	ENSG00000181350	388341	leucine rich repeat containing 75A	C17orf76|FAM211A|FLJ35696	protein_coding	Q8NAA5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36039
9.93342506432404e-11	0.339587049382301	0.548	0.336	2.10896547540664e-06	DNAJB1	CD4+ T cells	GSE199333_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36040
1.42013889380977e-10	0.327198790343438	0.823	0.697	3.01509688544753e-06	ATP6V1G1	CD4+ T cells	GSE199333_pre	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36041
1.4697642938128e-10	0.324067303927579	0.873	0.771	3.12045657219397e-06	RPL17	CD4+ T cells	GSE199333_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36042
3.18051611716668e-10	-0.359317558047927	0.223	0.388	6.75255376835658e-06	HEBP2	CD4+ T cells	GSE199333_pre	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36043
3.41486771616478e-10	0.408088616703604	0.489	0.287	7.25010564818945e-06	ZFP36	CD4+ T cells	GSE199333_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36044
5.94948647149432e-10	0.30761197388881	0.996	0.989	1.26313547276296e-05	RPL23	CD4+ T cells	GSE199333_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36045
7.57327271728394e-10	-0.467809834272975	0.288	0.449	1.60788153060655e-05	CRIP1	CD4+ T cells	GSE199333_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36046
8.48945252646969e-10	-0.461938453280715	0.366	0.532	1.80239566589478e-05	SYNE2	CD4+ T cells	GSE199333_pre	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36047
8.53067090932522e-10	-0.458288891544934	0.174	0.317	1.81114674075884e-05	ARID5A	CD4+ T cells	GSE199333_pre	ENSG00000196843	10865	AT-rich interaction domain 5A	MRF-1|RP11-363D14	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36048
9.01894842822094e-10	0.333875222223293	0.25	0.091	1.91481294079559e-05	GADD45A	CD4+ T cells	GSE199333_pre	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36049
9.41440803174328e-10	0.314429509489358	0.455	0.253	1.99877296921942e-05	CNOT6L	CD4+ T cells	GSE199333_pre	ENSG00000138767	246175	CCR4-NOT transcription complex subunit 6 like	Ccr4b|DKFZp434K098	protein_coding	Q96LI5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36050
1.10227841205692e-09	0.313013370079615	0.823	0.711	2.34024729663805e-05	SRSF3	CD4+ T cells	GSE199333_pre	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36051
1.37382224626685e-09	0.379926911107709	0.565	0.391	2.91676201104914e-05	NUCB2	CD4+ T cells	GSE199333_pre	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36052
1.41575480064317e-09	0.327027474191944	0.399	0.223	3.00578901724552e-05	TOB1	CD4+ T cells	GSE199333_pre	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36053
1.80262794469594e-09	-0.508326341733766	0.245	0.399	3.82715938938394e-05	AHNAK	CD4+ T cells	GSE199333_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36054
1.90194223122313e-09	0.357940379037959	0.627	0.419	4.03801355110983e-05	TNRC6B	CD4+ T cells	GSE199333_pre	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36055
2.03647052318602e-09	-0.43478235920197	0.63	0.73	4.32363056777624e-05	LRRFIP1	CD4+ T cells	GSE199333_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36056
2.10986055849561e-09	-0.400928012971839	0.473	0.62	4.47944495174202e-05	ARID4B	CD4+ T cells	GSE199333_pre	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36057
2.14244989083638e-09	-0.403667440762185	0.264	0.416	4.54863536323471e-05	PIM1	CD4+ T cells	GSE199333_pre	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36058
3.4058886899287e-09	-0.309467294708322	0.18	0.331	7.23104227758762e-05	UPP1	CD4+ T cells	GSE199333_pre	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36059
3.63867747050269e-09	-0.430792785083024	0.643	0.738	7.72527613762425e-05	GSTK1	CD4+ T cells	GSE199333_pre	ENSG00000197448	373156	glutathione S-transferase kappa 1	GST13	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36060
3.90547539609383e-09	-0.262235762977116	0.978	0.994	8.29171481344681e-05	EEF2	CD4+ T cells	GSE199333_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36061
6.26098591472003e-09	-0.322989366417066	0.729	0.826	0.000132926991955421	ENO1	CD4+ T cells	GSE199333_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36062
7.71659180619309e-09	0.332033891278422	0.805	0.669	0.000163830960637286	HNRNPH1	CD4+ T cells	GSE199333_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36063
1.28850424426236e-08	-0.426319044947791	0.989	0.994	0.000273562336099342	UBC	CD4+ T cells	GSE199333_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36064
1.2914804568149e-08	0.339781859317046	0.532	0.339	0.000274194215786372	SOCS3	CD4+ T cells	GSE199333_pre	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36065
1.63255533589478e-08	0.325623375364669	0.676	0.496	0.000346607823363822	ANAPC16	CD4+ T cells	GSE199333_pre	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36066
1.6967137079753e-08	-0.361552652149892	0.728	0.824	0.000360229287340236	ANKRD12	CD4+ T cells	GSE199333_pre	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36067
1.84924360616905e-08	-0.290992815964441	0.959	0.978	0.000392612910025751	YBX1	CD4+ T cells	GSE199333_pre	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36068
3.28733932926655e-08	0.398673050303362	0.596	0.43	0.000697935012996582	DUSP1	CD4+ T cells	GSE199333_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36069
3.55981451483664e-08	-0.335435620556179	0.797	0.84	0.000755784219644966	RBM3	CD4+ T cells	GSE199333_pre	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36070
4.15196459023839e-08	-0.305321299594506	0.214	0.355	0.000881503602153513	TAP1	CD4+ T cells	GSE199333_pre	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36071
4.40701273208599e-08	-0.316399101764553	0.136	0.262	0.000935652873149177	PIM3	CD4+ T cells	GSE199333_pre	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36072
4.4744595818687e-08	-0.476804044555087	0.854	0.939	0.000949972513826544	S100A4	CD4+ T cells	GSE199333_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36073
4.71654125967009e-08	0.310873120031028	0.791	0.68	0.00100136887484056	C12orf57	CD4+ T cells	GSE199333_pre	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36074
6.05021710275957e-08	-0.405945210731989	0.51	0.606	0.00128452159308688	RSRP1	CD4+ T cells	GSE199333_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36075
6.80726208255414e-08	-0.302102471620041	0.259	0.397	0.00144524981274707	TUBB	CD4+ T cells	GSE199333_pre	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36076
7.89320251273755e-08	0.283328017220054	0.916	0.832	0.00167580582547931	MYL12A	CD4+ T cells	GSE199333_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36077
8.24084705723475e-08	0.316292253506548	0.38	0.223	0.00174961423872151	AC044849.1	CD4+ T cells	GSE199333_pre	NA	NA	NA	NA	NA	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36078
8.84809424978631e-08	-0.302372660193144	0.523	0.667	0.00187853889017213	TUBA1B	CD4+ T cells	GSE199333_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36079
9.48792329736451e-08	0.255944166303703	0.98	0.97	0.00201438099526346	UQCRB	CD4+ T cells	GSE199333_pre	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36080
1.08774865192851e-07	0.326114528984941	0.878	0.799	0.00230939916290942	HCST	CD4+ T cells	GSE199333_pre	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36081
1.10059607231536e-07	-0.321042809750885	0.695	0.791	0.00233667552113275	GUK1	CD4+ T cells	GSE199333_pre	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36082
1.30954720945123e-07	-0.336122944961345	0.139	0.253	0.00278029968038591	RIF1	CD4+ T cells	GSE199333_pre	ENSG00000080345	55183	replication timing regulatory factor 1	FLJ10599|FLJ12870	protein_coding	Q5UIP0	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36083
1.31016589740083e-07	-0.314457429520706	0.141	0.264	0.0027816132167717	ANXA2	CD4+ T cells	GSE199333_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36084
1.41109394953561e-07	0.328829517744809	0.564	0.405	0.00299589356425905	LITAF	CD4+ T cells	GSE199333_pre	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36085
1.77811979972989e-07	-0.320441177237992	0.798	0.846	0.00377512614680653	PRRC2C	CD4+ T cells	GSE199333_pre	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36086
2.03703856298348e-07	-0.440214995056482	0.469	0.603	0.00432483657307022	HMGB2	CD4+ T cells	GSE199333_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36087
2.16672286556399e-07	0.256569686896896	0.33	0.179	0.00460016931587891	DYNLT1	CD4+ T cells	GSE199333_pre	ENSG00000146425	6993	dynein light chain Tctex-type 1	TCTEL1|Tctex-1|TCTEX1	protein_coding	P63172	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36088
2.18745814855167e-07	-0.356327762360362	0.814	0.871	0.00464419239519005	LIMD2	CD4+ T cells	GSE199333_pre	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36089
2.56249750821953e-07	0.363575326237341	0.743	0.642	0.00544043845970087	ARL4C	CD4+ T cells	GSE199333_pre	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36090
2.94228302324819e-07	-0.296825556228359	0.226	0.358	0.00624676108665823	TRAT1	CD4+ T cells	GSE199333_pre	ENSG00000163519	50852	T cell receptor associated transmembrane adaptor 1	HSPC062|TCRIM|TRIM	protein_coding	Q6PIZ9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36091
3.04902196661708e-07	-0.418979110533575	0.373	0.51	0.00647337853732471	EZR	CD4+ T cells	GSE199333_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36092
3.27959314178784e-07	0.332790010935122	0.374	0.229	0.00696290419932976	C1orf56	CD4+ T cells	GSE199333_pre	ENSG00000143443	54964	chromosome 1 open reading frame 56	FLJ20519|MENT	protein_coding	Q9BUN1	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36093
3.74197828605328e-07	-0.50221967538037	0.378	0.501	0.00794459409911972	MT2A	CD4+ T cells	GSE199333_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36094
4.12041419123586e-07	-0.393573001727103	0.233	0.358	0.00874805136941285	ITGA4	CD4+ T cells	GSE199333_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36095
4.12548670079151e-07	0.284763949624002	0.779	0.697	0.00875882081445045	LEPROTL1	CD4+ T cells	GSE199333_pre	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36096
4.21495409471074e-07	0.275497540185668	0.531	0.375	0.00894876903848038	CCT8	CD4+ T cells	GSE199333_pre	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36097
4.64311662335719e-07	-0.347732442752399	0.251	0.386	0.00985780090304965	ISG15	CD4+ T cells	GSE199333_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36098
4.90473022385074e-07	0.269096286934162	0.342	0.196	0.0104132327382575	C16orf54	CD4+ T cells	GSE199333_pre	ENSG00000185905	283897	chromosome 16 open reading frame 54	FLJ35681	protein_coding	Q6UWD8	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36099
5.41819829990286e-07	-0.265004087928807	0.228	0.361	0.0115033768105238	TUBA4A	CD4+ T cells	GSE199333_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36100
5.90112910230131e-07	0.259165567917164	0.313	0.171	0.0125286871970959	RFLNB	CD4+ T cells	GSE199333_pre	ENSG00000283979	359845	refilin B	Cfm1|FAM101B|MGC45871|RefilinB	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36101
8.21222949815525e-07	-0.371539295180065	0.163	0.284	0.0174353844475334	LIMS1	CD4+ T cells	GSE199333_pre	ENSG00000169756	3987	LIM zinc finger domain containing 1	PINCH|PINCH1	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36102
1.20968468923392e-06	-0.291700531347552	0.319	0.446	0.0256828156371253	PRPF40A	CD4+ T cells	GSE199333_pre	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36103
1.21300713216109e-06	0.269681227577964	0.307	0.174	0.0257533544229121	ERAP2	CD4+ T cells	GSE199333_pre	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36104
1.27238494219748e-06	-0.542812344301458	0.42	0.51	0.0270140047077947	GIMAP4	CD4+ T cells	GSE199333_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36105
1.35543481107223e-06	-0.339523034813137	0.286	0.413	0.0287772364738745	CLEC2B	CD4+ T cells	GSE199333_pre	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36106
1.47256495907429e-06	-0.462630997747832	0.537	0.62	0.0312640266461063	COTL1	CD4+ T cells	GSE199333_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36107
1.51118295290251e-06	-0.359184437705237	0.347	0.471	0.0320839252730731	IDS	CD4+ T cells	GSE199333_pre	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36108
1.66526272761521e-06	0.252427446854782	0.601	0.449	0.0353551929699986	KRT10	CD4+ T cells	GSE199333_pre	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36109
1.85819171006587e-06	-0.290131544684708	0.229	0.347	0.0394512681964086	JPT1	CD4+ T cells	GSE199333_pre	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36110
1.92825237747091e-06	-0.347767822084647	0.829	0.873	0.040938726226085	PSME1	CD4+ T cells	GSE199333_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36111
1.93321251007628e-06	0.271593085729751	0.702	0.559	0.0410440348014295	FOXP1	CD4+ T cells	GSE199333_pre	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE199333	GSE199333	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	pre	gilteritinib	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 3, sensitive 4); post (resistant 3, sensitive 4)	14	105004	Public on Jul 07, 2022	NA	This dataset has 7 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.1.0	Acute_myeloid_leukemia	Targeted_therapy	36112
1.21699183689682e-212	-2.97499907762826	0.002	0.893	2.05902848884572e-208	IGHM	Malignant cells	GSE111014_post	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36113
1.74104753898741e-153	1.32641369272888	1	0.888	2.94567833121281e-149	RPL41	Malignant cells	GSE111014_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36114
4.20878429992618e-151	0.770852973709374	1	1	7.12084215704511e-147	B2M	Malignant cells	GSE111014_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36115
4.98544426690301e-148	1.0693619978491	1	0.996	8.4348731551732e-144	TMSB4X	Malignant cells	GSE111014_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36116
2.72109767220731e-145	1.247363840882	1	0.756	4.60382515160755e-141	RPL39	Malignant cells	GSE111014_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36117
6.0356412780858e-119	0.664621780327182	0.362	0.043	1.02117014783934e-114	SELL	Malignant cells	GSE111014_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36118
1.07885509270363e-98	0.898254323923859	0.996	0.812	1.82531493134527e-94	EEF1A1	Malignant cells	GSE111014_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36119
2.43990751171739e-92	0.520496274100037	0.316	0.043	4.12807951907466e-88	PLAC8	Malignant cells	GSE111014_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36120
2.27405351918735e-88	0.637603086300726	0.368	0.064	3.84747114911308e-84	TYROBP	Malignant cells	GSE111014_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36121
3.21205872840306e-86	0.729414790884377	0.987	0.846	5.43448216258513e-82	SERF2	Malignant cells	GSE111014_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36122
3.18838397479689e-82	0.54947618622963	1	1	5.39442684695885e-78	CD74	Malignant cells	GSE111014_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36123
1.37061796041693e-77	0.72636223902852	0.952	0.866	2.31894852722941e-73	CYBA	Malignant cells	GSE111014_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36124
1.2795646524154e-75	-0.693280490678255	0.974	0.997	2.16489543542162e-71	RPL37A	Malignant cells	GSE111014_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36125
7.62388662905318e-73	-1.05745107285223	0.501	0.827	1.28988537876951e-68	RPS26	Malignant cells	GSE111014_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36126
2.74775464798911e-69	0.475396542310708	0.325	0.064	4.64892608893278e-65	HLA-DRB5	Malignant cells	GSE111014_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36127
5.50531833067358e-65	-0.460698557773067	1	1	9.31444808366664e-61	MALAT1	Malignant cells	GSE111014_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36128
4.88490502260709e-63	-0.61289361286027	1	1	8.26477080774893e-59	MT-CO1	Malignant cells	GSE111014_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36129
3.21060011805095e-55	0.584074663080864	0.383	0.115	5.43201433973041e-51	BIRC3	Malignant cells	GSE111014_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36130
5.77200093038155e-55	0.603401411043784	0.858	0.722	9.76564837411255e-51	MYL6	Malignant cells	GSE111014_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36131
3.93932532317683e-52	0.572985176640491	0.514	0.189	6.66494451428289e-48	H3F3A	Malignant cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36132
7.08774295547185e-48	0.581770698113084	1	0.937	1.19917523063628e-43	CD52	Malignant cells	GSE111014_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36133
1.08963545719351e-46	0.538240921766761	0.948	0.907	1.8435542300257e-42	PFDN5	Malignant cells	GSE111014_post	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36134
1.39314232130557e-45	-0.497802245881518	0.989	0.995	2.3570574934169e-41	RPL26	Malignant cells	GSE111014_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36135
2.84001674035359e-45	0.67578077074164	0.477	0.198	4.80502432300423e-41	IGHG1	Malignant cells	GSE111014_post	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36136
5.54858302109417e-45	0.414123339457729	1	0.999	9.38764761338922e-41	RPS15	Malignant cells	GSE111014_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36137
1.19696915299399e-44	0.403476289625505	1	1	2.02515210995054e-40	RPL10	Malignant cells	GSE111014_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36138
4.28047655746631e-44	-0.81244960935436	0.065	0.403	7.24213828757726e-40	RP11-386I14.4	Malignant cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36139
8.5899120597607e-44	-0.687062137375187	0.12	0.466	1.45332722139091e-39	VPREB3	Malignant cells	GSE111014_post	ENSG00000128218	29802	V-set pre-B cell surrogate light chain 3	8HS20	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36140
2.68750729353358e-42	-0.515506050353946	0	0.304	4.54699358992946e-38	RPS4Y1	Malignant cells	GSE111014_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36141
4.22894744596798e-41	-0.646434046403247	0.1	0.434	7.15495618383323e-37	GABPB1-AS1	Malignant cells	GSE111014_post	ENSG00000244879	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36142
8.66755660783386e-39	-0.51910469288057	0.002	0.288	1.46646390247941e-34	IGHD	Malignant cells	GSE111014_post	ENSG00000278801	NA	NA	FLJ00382|FLJ46727|MGC29633	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36143
1.59714217764228e-38	-0.510420511066704	0.074	0.387	2.70220485035298e-34	MZB1	Malignant cells	GSE111014_post	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36144
3.033296262797e-38	0.673847480019153	0.617	0.447	5.13203394702625e-34	ARHGDIB	Malignant cells	GSE111014_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36145
1.00821762219232e-37	-0.455347640855567	0.972	0.993	1.70580339498718e-33	RPS17	Malignant cells	GSE111014_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36146
1.39721194685682e-36	-0.50545175730144	0.048	0.346	2.36394289288706e-32	ADTRP	Malignant cells	GSE111014_post	ENSG00000111863	84830	androgen dependent TFPI regulating protein	AIG1L|C6orf105|dJ413H6.1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36147
1.11529257190382e-35	0.414421156854803	1	0.995	1.88696350240407e-31	RPS4X	Malignant cells	GSE111014_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36148
3.22032570959048e-34	0.46767670865597	0.969	0.901	5.44846906805614e-30	FTH1	Malignant cells	GSE111014_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36149
4.09413692380166e-34	0.33861493142699	1	0.999	6.92687026138003e-30	RPS14	Malignant cells	GSE111014_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36150
5.14566074368717e-33	-0.474292834263876	0.813	0.955	8.70594341224432e-29	RPS11	Malignant cells	GSE111014_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36151
3.30024822471915e-32	-0.48908598868066	0.115	0.401	5.58368997140233e-28	VAMP2	Malignant cells	GSE111014_post	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36152
4.26357922269818e-32	-0.654803096939251	0.076	0.352	7.21354968688305e-28	CH17-373J23.1	Malignant cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36153
2.76499220486039e-30	-0.720491518816874	0.155	0.435	4.67809031140329e-26	JUN	Malignant cells	GSE111014_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36154
3.58461413094761e-30	0.33372958308837	1	1	6.06480864815025e-26	RPS2	Malignant cells	GSE111014_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36155
1.75447194009021e-29	-0.499973256127953	0.126	0.4	2.96839107543862e-25	ORAI2	Malignant cells	GSE111014_post	ENSG00000160991	80228	ORAI calcium release-activated calcium modulator 2	C7orf19|CBCIP2|FLJ12474|FLJ14733|H_NH0514P08.8|TMEM142B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36156
4.44496158059175e-28	-0.485002540533463	0.608	0.865	7.52043049820318e-24	MT-ND1	Malignant cells	GSE111014_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36157
4.733452335485e-28	-0.478346455150074	0.089	0.342	8.00852800640708e-24	RCSD1	Malignant cells	GSE111014_post	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36158
5.34531097091342e-27	-0.429076137727086	0.048	0.282	9.04373163168842e-23	RRBP1	Malignant cells	GSE111014_post	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36159
1.71567929852597e-26	0.377543661160021	0.956	0.927	2.90275780517609e-22	RPLP0	Malignant cells	GSE111014_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36160
4.18417426523958e-26	0.463935348979228	0.793	0.745	7.07920443935885e-22	RPL36A	Malignant cells	GSE111014_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36161
8.36026688663985e-26	-0.380396938221497	0.033	0.254	1.4144735545506e-21	SYNE2	Malignant cells	GSE111014_post	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36162
7.99912147305374e-25	-0.445468919317513	0.298	0.587	1.35337136202596e-20	EEF2	Malignant cells	GSE111014_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36163
9.69407539343571e-25	0.501571266702825	0.556	0.377	1.64014061581539e-20	LIMD2	Malignant cells	GSE111014_post	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36164
7.11302214043674e-24	0.396139750192093	0.993	0.94	1.20345221594049e-19	ACTB	Malignant cells	GSE111014_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36165
8.4261116129309e-24	0.353391076666381	0.993	0.97	1.42561382379178e-19	FTL	Malignant cells	GSE111014_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36166
4.13312945969159e-23	0.420645199306112	0.427	0.235	6.99284173285221e-19	PSMB9	Malignant cells	GSE111014_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36167
4.55776032932819e-23	0.368020310666906	0.294	0.127	7.71127470119037e-19	BLOC1S1	Malignant cells	GSE111014_post	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36168
1.75042957304183e-22	0.405395981563639	0.325	0.142	2.96155179462947e-18	LGALS1	Malignant cells	GSE111014_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36169
2.70395270494004e-22	-0.365720782158715	0.072	0.283	4.57481758148805e-18	ARRDC3	Malignant cells	GSE111014_post	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36170
6.96130982366994e-22	-0.429142225545725	0.874	0.972	1.17778400906672e-17	MT-ND2	Malignant cells	GSE111014_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36171
8.81451687702305e-22	-0.373745811529651	0.146	0.378	1.49132811042353e-17	SNHG7	Malignant cells	GSE111014_post	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36172
3.7062415043096e-21	-0.352427168211691	0.083	0.295	6.27059000114142e-17	METTL8	Malignant cells	GSE111014_post	ENSG00000123600	79828	methyltransferase 8, methylcytidine	FLJ13984|TIP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36173
1.01770183663748e-20	0.432923643597556	0.388	0.213	1.72184973740696e-16	PRR13	Malignant cells	GSE111014_post	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36174
1.37835672061564e-20	-0.32154625697821	0.092	0.306	2.3320417356096e-16	WASF2	Malignant cells	GSE111014_post	ENSG00000158195	10163	WASP family member 2	SCAR2|WAVE2	protein_coding	Q9Y6W5	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36175
1.49229631632481e-20	0.304275142546723	0.993	0.969	2.52481613758994e-16	RPL18	Malignant cells	GSE111014_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36176
1.52309649535529e-20	-0.388427988427247	0.144	0.37	2.57692696049161e-16	FOXP1	Malignant cells	GSE111014_post	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36177
7.21664630112706e-20	-0.340741913957263	0.094	0.298	1.22098438768769e-15	DDX17	Malignant cells	GSE111014_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36178
1.23790568778781e-19	-0.386571951421679	0.314	0.558	2.09441263316819e-15	CD79B	Malignant cells	GSE111014_post	ENSG00000007312	974	CD79b molecule	B29|Ig-beta|IGB|Igbeta	protein_coding	P40259	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36179
2.58330814071673e-19	-0.32462843975775	0.061	0.253	4.37069904327863e-15	PCDH9	Malignant cells	GSE111014_post	ENSG00000184226	5101	protocadherin 9	NA	protein_coding	Q9HC56	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36180
3.42780398845211e-19	0.379339203593979	0.789	0.746	5.79950156806212e-15	CFL1	Malignant cells	GSE111014_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36181
3.74937223399479e-19	-0.398230141946427	0.224	0.442	6.34356288269578e-15	CD24	Malignant cells	GSE111014_post	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36182
3.7614947931229e-19	-0.331934745004325	0.107	0.31	6.36407304048463e-15	SF1	Malignant cells	GSE111014_post	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36183
5.58257801445346e-19	-0.302102412244753	0.065	0.255	9.44516374265381e-15	SMCHD1	Malignant cells	GSE111014_post	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36184
8.07914917599727e-19	-0.485091561411089	0.397	0.597	1.36691124908698e-14	CXCR4	Malignant cells	GSE111014_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36185
1.04196879021024e-18	-0.324635016190367	0.096	0.293	1.7629069961567e-14	UBE2D2	Malignant cells	GSE111014_post	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36186
1.13540714883182e-18	-0.39671924352343	0.359	0.609	1.92099535510855e-14	LAPTM5	Malignant cells	GSE111014_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36187
2.58506696636575e-18	0.351400140957765	0.832	0.787	4.37367480039421e-14	ATP5E	Malignant cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36188
4.07946302485917e-18	-0.312233577962901	0.174	0.406	6.90204349175923e-14	PNISR	Malignant cells	GSE111014_post	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36189
4.66985039318738e-18	-0.374538158093879	0.135	0.334	7.90091988023373e-14	LINC00926	Malignant cells	GSE111014_post	ENSG00000247982	283663	long intergenic non-protein coding RNA 926	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36190
7.38498105586508e-18	0.358679919645576	1	0.995	1.24946494484181e-13	IGKC	Malignant cells	GSE111014_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36191
1.14301438579714e-17	-0.316429345707282	0.076	0.256	1.93386603933018e-13	BTG2	Malignant cells	GSE111014_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36192
1.6158967392723e-17	-0.328214206905757	0.124	0.318	2.73393569317481e-13	ARGLU1	Malignant cells	GSE111014_post	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36193
2.80622734806574e-17	0.283104983998862	0.871	0.687	4.74785605019242e-13	S100A4	Malignant cells	GSE111014_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36194
3.9371746758433e-17	-0.342889405129958	0.296	0.544	6.66130583405927e-13	MT-ND5	Malignant cells	GSE111014_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36195
4.15507037346374e-17	-0.317442573214186	0.102	0.292	7.0299635648633e-13	ZFP36L2	Malignant cells	GSE111014_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36196
7.56406062295102e-17	-0.310922820300439	0.129	0.322	1.27976341679708e-12	CCNI	Malignant cells	GSE111014_post	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36197
4.26514971206275e-16	0.304244598164747	0.996	0.978	7.21620679783897e-12	HLA-A	Malignant cells	GSE111014_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36198
1.4099325321889e-15	0.376975536689149	0.451	0.306	2.3854648512104e-11	ATP6V0E1	Malignant cells	GSE111014_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36199
1.48511050206216e-15	-0.307213826062353	0.187	0.383	2.51265845843897e-11	RBM39	Malignant cells	GSE111014_post	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36200
4.02291716567543e-15	-0.327090228012893	0.281	0.489	6.80637355260626e-11	SRSF5	Malignant cells	GSE111014_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36201
4.62684758327485e-15	0.351479817688354	0.355	0.21	7.82816342614272e-11	CD63	Malignant cells	GSE111014_post	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36202
1.0664224838819e-14	-0.289053007749015	0.146	0.327	1.80428020047979e-10	PNRC1	Malignant cells	GSE111014_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36203
1.81863469033462e-14	0.344438455537143	0.723	0.653	3.07694803257715e-10	SH3BGRL3	Malignant cells	GSE111014_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36204
1.82439909471249e-14	-0.279576677368307	0.153	0.338	3.08670082834407e-10	N4BP2L2	Malignant cells	GSE111014_post	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36205
2.17403323022638e-14	-0.26185736576171	0.1	0.272	3.67824682222001e-10	LUC7L3	Malignant cells	GSE111014_post	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36206
3.28712369942307e-14	0.321399192176003	0.854	0.796	5.5614845870539e-10	S100A6	Malignant cells	GSE111014_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36207
4.81574213031807e-14	0.267278467073636	0.318	0.169	8.14775411028514e-10	HMGN2	Malignant cells	GSE111014_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36208
5.4164270862798e-14	-0.285155970074705	0.12	0.287	9.16405298727679e-10	PRKCB	Malignant cells	GSE111014_post	ENSG00000166501	5579	protein kinase C beta	PKCB|PKCbeta|PRKCB1|PRKCB2	protein_coding	P05771	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36209
5.69915380900542e-14	-0.325506650905757	0.129	0.293	9.64239832945627e-10	TSC22D3	Malignant cells	GSE111014_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36210
1.20247005716948e-13	-0.26978533368847	0.168	0.349	2.03445908972504e-09	HLA-DMB	Malignant cells	GSE111014_post	ENSG00000242386	3109	major histocompatibility complex, class II, DM beta	D6S221E|RING7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36211
1.41782311110002e-13	-0.26342832394832	0.139	0.312	2.39881492167013e-09	TCF4	Malignant cells	GSE111014_post	ENSG00000196628	6925	transcription factor 4	bHLHb19|E2-2|ITF2|SEF2-1B	protein_coding	P15884	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36212
1.89884787813376e-13	0.347234726882392	0.425	0.289	3.21266072501451e-09	COX6A1	Malignant cells	GSE111014_post	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36213
1.9299506494394e-13	-0.275973930611321	0.107	0.265	3.26528350378652e-09	STX7	Malignant cells	GSE111014_post	ENSG00000079950	8417	syntaxin 7	NA	protein_coding	O15400	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36214
3.18580559591997e-13	-0.251681527510422	1	0.999	5.390064487737e-09	HLA-B	Malignant cells	GSE111014_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36215
4.35635853174912e-13	-0.293095957485447	0.987	0.991	7.37052299986633e-09	MT-ND4	Malignant cells	GSE111014_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36216
6.00823067525462e-13	-0.277456459367885	0.144	0.311	1.01653254794633e-08	DBI	Malignant cells	GSE111014_post	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36217
9.35336329330262e-13	0.419545535709705	0.51	0.453	1.58249553559387e-08	GAPDH	Malignant cells	GSE111014_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36218
1.22801275838636e-12	0.287899267923641	0.778	0.775	2.07767478591388e-08	BTG1	Malignant cells	GSE111014_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36219
1.582059979588e-12	-0.254392305569865	0.115	0.27	2.67668727946493e-08	TNRC6B	Malignant cells	GSE111014_post	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36220
2.2512574252044e-12	0.352123165046872	0.338	0.211	3.80890243770332e-08	DYNLL1	Malignant cells	GSE111014_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36221
3.06882106180993e-12	-0.260935176735458	0.181	0.355	5.19213835447623e-08	VIM	Malignant cells	GSE111014_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36222
3.35405673784709e-12	-0.275758497056069	0.294	0.48	5.6747285947635e-08	GLTSCR2	Malignant cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36223
5.44911819734558e-12	0.362550018112848	0.488	0.363	9.21936307808898e-08	HSP90AB1	Malignant cells	GSE111014_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36224
6.7149253323424e-12	-0.260639334890932	1	0.996	1.13609821697901e-07	MT-CO3	Malignant cells	GSE111014_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36225
1.08365675502058e-11	-0.276283999530474	0.847	0.944	1.83343886381931e-07	TPT1	Malignant cells	GSE111014_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36226
1.44184444057573e-11	0.310824244646312	0.656	0.573	2.43945660901008e-07	RPL22	Malignant cells	GSE111014_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36227
9.26169630327345e-11	0.295365920741269	0.357	0.234	1.56698639755083e-06	BST2	Malignant cells	GSE111014_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36228
1.85805159686505e-10	0.306854879856149	0.399	0.275	3.14363749673597e-06	TRMT112	Malignant cells	GSE111014_post	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36229
3.09526174308018e-10	0.323555713677105	0.383	0.271	5.23687334311736e-06	EMP3	Malignant cells	GSE111014_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36230
7.08663274748855e-10	0.353184703937377	0.46	0.376	1.19898739454759e-05	ARPC3	Malignant cells	GSE111014_post	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36231
1.4484034444474e-09	-0.262685457382152	0.168	0.298	2.45055378766056e-05	MIF	Malignant cells	GSE111014_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36232
1.61226552156395e-09	0.263515691762826	0.355	0.24	2.72779203593405e-05	UQCRH	Malignant cells	GSE111014_post	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36233
1.97069925486265e-09	-0.272919918639805	0.484	0.635	3.33422606930212e-05	EEF1B2	Malignant cells	GSE111014_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36234
5.45363309703142e-09	0.321013738266704	0.49	0.416	9.22700183686747e-05	ATP5L	Malignant cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36235
3.33083694758021e-08	-0.277724576703605	0.183	0.309	0.000563544303161095	JUNB	Malignant cells	GSE111014_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36236
5.32757664337902e-07	0.272618780573497	0.49	0.432	0.00901372692293296	OST4	Malignant cells	GSE111014_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36237
1.80368539929126e-06	0.280366520348188	0.344	0.264	0.0305165532706088	CORO1A	Malignant cells	GSE111014_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36238
1.98363697698251e-06	0.283478559445506	0.484	0.418	0.033561154013567	HNRNPA1	Malignant cells	GSE111014_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36239
0	-0.99294524246605	0	0.649	0	RPS4Y1	CD8+ T cells	GSE111014_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36240
3.21593116560356e-118	-2.02179750739536	0.515	0.966	5.44103393908466e-114	RPS26	CD8+ T cells	GSE111014_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36241
1.26933801696074e-109	2.01258852647063	1	0.829	2.14759299089587e-105	RPL41	CD8+ T cells	GSE111014_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36242
2.50932183547479e-105	1.82030434921405	0.999	0.668	4.24552161343979e-101	RPL39	CD8+ T cells	GSE111014_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36243
7.96067867854445e-99	0.738492223259572	1	1	1.34686722562293e-94	B2M	CD8+ T cells	GSE111014_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36244
4.53480354941307e-90	0.781774696964159	1	1	7.67243412525198e-86	TMSB4X	CD8+ T cells	GSE111014_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36245
2.4810080066745e-85	-0.625766579098549	0.055	0.424	4.19761744649258e-81	TRGC1	CD8+ T cells	GSE111014_post	ENSG00000211689	445347	TCR gamma alternate reading frame protein	CD3G|TCRG|TCRGC1|TCRGC2|TCRGV|C1	TR_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36246
3.33443377493332e-80	1.32378440110456	0.986	0.62	5.64152850380969e-76	EEF1A1	CD8+ T cells	GSE111014_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36247
1.71442871039413e-78	-0.777347620529895	0.033	0.322	2.90064193511583e-74	GZMK	CD8+ T cells	GSE111014_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36248
1.44221509688375e-73	-0.793385872919538	1	1	2.44008372241762e-69	MALAT1	CD8+ T cells	GSE111014_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36249
2.96320391530784e-73	-0.421491876107488	0.025	0.278	5.01344470430933e-69	GABPB1-AS1	CD8+ T cells	GSE111014_post	ENSG00000244879	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36250
1.99589544185071e-70	1.61377515869418	0.976	0.473	3.37685549806721e-66	GNLY	CD8+ T cells	GSE111014_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36251
5.61299467813685e-69	-1.12749919436061	0.371	0.878	9.49662569593973e-65	MT-ND1	CD8+ T cells	GSE111014_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36252
4.75826563764968e-67	-0.29880246724152	0.023	0.259	8.0505096323395e-63	A2M-AS1	CD8+ T cells	GSE111014_post	ENSG00000245105	144571	A2M antisense RNA 1	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36253
2.19339001308403e-59	-1.11996747286341	0.595	0.961	3.71099656313686e-55	MT-ND2	CD8+ T cells	GSE111014_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36254
2.36245204947016e-59	-0.438465332656081	0.069	0.4	3.99703262249856e-55	HMHA1	CD8+ T cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36255
9.56797723300278e-55	0.885148862350154	0.996	0.971	1.61880606805174e-50	S100A4	CD8+ T cells	GSE111014_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36256
1.41011481484784e-53	-0.782668306619522	0.999	1	2.38577325524107e-49	MT-CO1	CD8+ T cells	GSE111014_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36257
1.8453293806939e-48	0.787668841524489	0.999	0.976	3.122112779196e-44	CD52	CD8+ T cells	GSE111014_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36258
1.64785041656482e-42	-0.764466575579424	0.237	0.639	2.78799811978601e-38	NEAT1	CD8+ T cells	GSE111014_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36259
5.8241271808349e-40	-0.314453766304682	0.057	0.302	9.85384077725456e-36	ZNF90	CD8+ T cells	GSE111014_post	ENSG00000213988	7643	zinc finger protein 90	HTF9	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36260
1.12543228071713e-39	-0.650781032162376	0.265	0.663	1.90411887574531e-35	EEF2	CD8+ T cells	GSE111014_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36261
1.16805230387197e-37	-0.376027597263057	0.074	0.337	1.97622769292098e-33	ATM	CD8+ T cells	GSE111014_post	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36262
2.35573808341983e-35	0.738627445986626	0.946	0.824	3.98567326333801e-31	S100A6	CD8+ T cells	GSE111014_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36263
3.26112665302891e-35	-0.384641885613461	0.093	0.371	5.51750018425962e-31	ARHGEF1	CD8+ T cells	GSE111014_post	ENSG00000076928	9138	Rho guanine nucleotide exchange factor 1	LBCL2|P115-RHOGEF|SUB1.5	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36264
6.07268878626874e-35	1.0559643580149	0.749	0.337	1.02743821574881e-30	LGALS1	CD8+ T cells	GSE111014_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36265
1.46576625312007e-34	-0.51789162010752	0.999	1	2.47992992365384e-30	HLA-B	CD8+ T cells	GSE111014_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36266
9.50275191161267e-34	0.793946099575997	0.573	0.117	1.60777059592575e-29	H3F3A	CD8+ T cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36267
3.16722625792009e-33	-0.468631878487283	0.174	0.507	5.358630105775e-29	ACAP1	CD8+ T cells	GSE111014_post	ENSG00000288169	9744	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	CENTB1|KIAA0050	protein_coding	Q15027	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36268
7.54265951805421e-33	-0.29463607474179	0.051	0.259	1.27614256385959e-28	GCC2	CD8+ T cells	GSE111014_post	ENSG00000135968	9648	GRIP and coiled-coil domain containing 2	GCC185|KIAA0336	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36269
4.95937127223271e-32	-0.387654378914821	0.072	0.307	8.39076025549052e-28	DUSP1	CD8+ T cells	GSE111014_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36270
9.24452462935369e-32	-0.330223907649932	0.079	0.322	1.56408112204035e-27	PRKCH	CD8+ T cells	GSE111014_post	ENSG00000027075	5583	protein kinase C eta	PKC-L|PKCL|PRKCL	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36271
2.76578325713703e-31	-0.365349240637018	0.091	0.346	4.67942869275013e-27	SEPT9	CD8+ T cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36272
2.83411873890003e-31	-0.752750812990367	0.136	0.415	4.79504549434496e-27	JUN	CD8+ T cells	GSE111014_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36273
3.45055207091123e-31	-0.607480149645082	0.94	0.995	5.83798904877471e-27	MT-ND4	CD8+ T cells	GSE111014_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36274
7.34876044176082e-31	-0.409484356846276	0.115	0.39	1.24333677914151e-26	SUN2	CD8+ T cells	GSE111014_post	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36275
5.58359346379816e-30	-0.357121637395385	0.084	0.327	9.44688178140011e-26	AKNA	CD8+ T cells	GSE111014_post	ENSG00000106948	80709	AT-hook transcription factor	KIAA1968	protein_coding	Q7Z591	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36276
7.38311583151455e-30	-0.33661745719025	0.075	0.307	1.24914936753395e-25	SNHG8	CD8+ T cells	GSE111014_post	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36277
1.78101480813172e-29	-0.356202155970319	0.115	0.39	3.01329895387806e-25	ARHGAP30	CD8+ T cells	GSE111014_post	ENSG00000186517	257106	Rho GTPase activating protein 30	FLJ00267	protein_coding	Q7Z6I6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36278
6.63929402573691e-29	0.584785811071193	0.942	0.888	1.12330215621443e-24	SERF2	CD8+ T cells	GSE111014_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36279
1.35370438862585e-28	-0.267290512228994	0.057	0.259	2.29033245511608e-24	IKZF3	CD8+ T cells	GSE111014_post	ENSG00000161405	22806	IKAROS family zinc finger 3	Aiolos|ZNFN1A3	protein_coding	Q9UKT9	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36280
1.41404701458808e-28	-0.303171227671303	0.066	0.278	2.39242614398157e-24	RUNX3	CD8+ T cells	GSE111014_post	ENSG00000020633	864	RUNX family transcription factor 3	AML2|CBFA3|PEBP2A3	protein_coding	Q13761	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36281
4.75316699173765e-28	-0.336244589488977	0.084	0.317	8.04188323332093e-24	ITGAL	CD8+ T cells	GSE111014_post	ENSG00000005844	3683	integrin subunit alpha L	CD11A|LFA-1|LFA1A	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36282
7.23910959319201e-28	-0.303863089933967	0.071	0.288	1.22478495207216e-23	IKZF1	CD8+ T cells	GSE111014_post	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36283
1.13270755144268e-27	-0.414919551867819	0.181	0.493	1.91642790628587e-23	PNISR	CD8+ T cells	GSE111014_post	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36284
1.5556054319376e-27	0.570963032584518	0.983	0.927	2.63192883029523e-23	SH3BGRL3	CD8+ T cells	GSE111014_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36285
1.70574435883491e-27	-0.348290478245174	0.106	0.361	2.88594888071278e-23	SF1	CD8+ T cells	GSE111014_post	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36286
1.97247798698563e-27	-0.426179344152904	0.164	0.459	3.33723550618099e-23	CCNI	CD8+ T cells	GSE111014_post	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36287
2.31927492579443e-27	-0.340536167642165	0.084	0.312	3.92398124695159e-23	FYN	CD8+ T cells	GSE111014_post	ENSG00000010810	2534	FYN proto-oncogene, Src family tyrosine kinase	MGC45350|SLK|SYN	protein_coding	P06241	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36288
2.51482803893805e-27	-0.377691917196962	0.127	0.395	4.25483755907928e-23	PRPF38B	CD8+ T cells	GSE111014_post	ENSG00000134186	55119	pre-mRNA processing factor 38B	FLJ10330|NET1	protein_coding	Q5VTL8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36289
2.74634943154847e-27	-0.487184626022852	0.986	1	4.64654860323685e-23	RPL28	CD8+ T cells	GSE111014_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36290
2.948036057642e-27	-0.379455561405663	0.132	0.405	4.9877822059245e-23	PCSK7	CD8+ T cells	GSE111014_post	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36291
6.80488129147574e-27	-0.424253436404187	0.175	0.468	1.15131786570478e-22	FYB	CD8+ T cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36292
8.95918325568165e-27	-0.327608262173992	0.082	0.307	1.51580421502878e-22	NKTR	CD8+ T cells	GSE111014_post	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36293
9.97912752941458e-27	-0.467170020401559	0.996	1	1.68836858670165e-22	RPS15A	CD8+ T cells	GSE111014_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36294
5.31809914241768e-26	-0.404854248179487	0.179	0.473	8.99769193905647e-22	PNRC1	CD8+ T cells	GSE111014_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36295
9.28556401132522e-26	-0.448769619065149	0.964	0.995	1.57102457507611e-21	RPL30	CD8+ T cells	GSE111014_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36296
9.50219313434871e-26	-0.471449837960625	0.201	0.498	1.60767605640046e-21	ZFP36L2	CD8+ T cells	GSE111014_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36297
1.04070579194684e-25	-0.258215801486222	0.068	0.273	1.76077012939487e-21	RCSD1	CD8+ T cells	GSE111014_post	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36298
1.66852039297911e-25	-0.290285651536018	0.078	0.293	2.82296965288135e-21	INPP5D	CD8+ T cells	GSE111014_post	ENSG00000281614	3635	inositol polyphosphate-5-phosphatase D	hp51CN|SHIP|SHIP1	protein_coding	Q92835	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36299
2.00313252545663e-25	-0.259265198821602	0.06	0.254	3.38909991982007e-21	STK10	CD8+ T cells	GSE111014_post	ENSG00000072786	6793	serine/threonine kinase 10	LOK|PRO2729	protein_coding	O94804	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36300
3.68090418294909e-25	-0.3061106186977	0.069	0.273	6.22772178713157e-21	SELL	CD8+ T cells	GSE111014_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36301
3.69190096941067e-25	0.893365389618963	0.648	0.293	6.24632725014591e-21	GZMB	CD8+ T cells	GSE111014_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36302
5.51467168104238e-25	-0.312490030025789	0.108	0.351	9.3302730171556e-21	TSC22D4	CD8+ T cells	GSE111014_post	ENSG00000166925	81628	TSC22 domain family member 4	THG-1|TILZ2	protein_coding	Q9Y3Q8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36303
5.9867436131823e-25	-0.345725882718646	0.104	0.341	1.01289715191431e-20	ANKRD12	CD8+ T cells	GSE111014_post	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36304
6.36338262175564e-25	-0.434496549887164	0.183	0.473	1.07662070577484e-20	COTL1	CD8+ T cells	GSE111014_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36305
1.14026640102052e-24	-0.347550903919596	0.126	0.38	1.92921672388662e-20	MYO1G	CD8+ T cells	GSE111014_post	ENSG00000136286	64005	myosin IG	HA-2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36306
2.74947616820034e-24	0.548001079940914	0.989	0.985	4.65183872897815e-20	PFN1	CD8+ T cells	GSE111014_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36307
2.95353933949668e-24	-0.408326117931422	0.231	0.546	4.99709320849444e-20	RBM39	CD8+ T cells	GSE111014_post	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36308
5.45974574682687e-24	-0.36983884108294	0.138	0.395	9.23734382905639e-20	CFLAR	CD8+ T cells	GSE111014_post	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36309
1.19524515779893e-23	-0.415680785454348	0.257	0.576	2.02223528248e-19	TRAF3IP3	CD8+ T cells	GSE111014_post	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36310
1.34721512939129e-23	-0.257078739899246	0.075	0.278	2.27935327741712e-19	PIP4K2A	CD8+ T cells	GSE111014_post	ENSG00000150867	5305	phosphatidylinositol-5-phosphate 4-kinase type 2 alpha	PIP5K2A|PIP5KIIA|PIP5KIIalpha	protein_coding	P48426	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36311
1.42551676480152e-23	-0.400793593249992	0.226	0.532	2.41183181436768e-19	FUS	CD8+ T cells	GSE111014_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36312
1.89176584875186e-23	-0.361299315304332	0.154	0.42	3.20067863950327e-19	AAK1	CD8+ T cells	GSE111014_post	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36313
7.88771712611701e-23	-0.54007371775301	0.115	0.341	1.33452286056774e-18	CMC1	CD8+ T cells	GSE111014_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36314
9.62943838430403e-23	-0.295579951205531	0.078	0.278	1.6292046802404e-18	PPP1R15A	CD8+ T cells	GSE111014_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36315
2.72354381091093e-22	-0.45336407219206	0.99	1	4.6079637736802e-18	RPS12	CD8+ T cells	GSE111014_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36316
5.05095589500555e-22	-0.36615942012401	0.234	0.537	8.5457122787599e-18	RBM3	CD8+ T cells	GSE111014_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36317
6.78968757904146e-22	0.387689884507576	1	1	1.14874724149802e-17	TMSB10	CD8+ T cells	GSE111014_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36318
6.87271516550224e-22	-0.274285172842303	0.08	0.278	1.16279467885132e-17	C8orf59	CD8+ T cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36319
1.27247739958162e-21	-0.268030371932838	0.073	0.263	2.15290451235213e-17	LUC7L3	CD8+ T cells	GSE111014_post	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36320
1.66797010188932e-21	0.527704814458405	0.952	0.859	2.82203861538653e-17	FTL	CD8+ T cells	GSE111014_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36321
1.79869850083614e-21	-0.269617265019033	0.071	0.259	3.04321799356467e-17	CSK	CD8+ T cells	GSE111014_post	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36322
3.07627771009034e-21	-0.294019457554454	0.115	0.341	5.20475425770184e-17	FNBP1	CD8+ T cells	GSE111014_post	ENSG00000187239	23048	formin binding protein 1	FBP17|KIAA0554	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36323
3.5331904335664e-21	-0.291304679545951	0.109	0.332	5.97780489455099e-17	PRRC2C	CD8+ T cells	GSE111014_post	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36324
5.69633003371016e-21	-0.553508944637717	0.978	0.99	9.63762078403422e-17	MT-CO3	CD8+ T cells	GSE111014_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36325
1.70674277088237e-20	-0.257182989695845	0.078	0.268	2.88763809405589e-16	SYNE1	CD8+ T cells	GSE111014_post	ENSG00000131018	23345	spectrin repeat containing nuclear envelope protein 1	8B|ARCA1|C6orf98|CPG2|dJ45H2.2|enaptin|KIAA0796|MYNE1|Nesp1|Nesprin-1|SCAR8|SYNE-1B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36326
2.38126394568317e-20	-0.293143578371788	0.12	0.346	4.02886046970136e-16	EIF4G2	CD8+ T cells	GSE111014_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36327
2.77470119060772e-20	-0.267533582614597	0.096	0.302	4.6945169443892e-16	ATF6B	CD8+ T cells	GSE111014_post	ENSG00000228628	1388	activating transcription factor 6 beta	CREBL1|G13	protein_coding	Q99941	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36328
3.59708006509991e-20	-0.362289485849234	0.24	0.527	6.08589976214254e-16	RNF213	CD8+ T cells	GSE111014_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36329
4.17030387370608e-20	0.531996284753143	0.891	0.81	7.05573712392331e-16	CYBA	CD8+ T cells	GSE111014_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36330
1.17320841473682e-19	-0.540247360032829	0.233	0.483	1.98495131689322e-15	KLF6	CD8+ T cells	GSE111014_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36331
1.85438071148986e-19	-0.417795360213953	0.512	0.815	3.13742672576969e-15	ITGB2	CD8+ T cells	GSE111014_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36332
2.12905380155504e-19	0.48935635923906	0.936	0.878	3.60214612685097e-15	H3F3B	CD8+ T cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36333
2.41561669310455e-19	-0.260154237809871	0.079	0.263	4.08698188306358e-15	SH2D1A	CD8+ T cells	GSE111014_post	ENSG00000183918	4068	SH2 domain containing 1A	DSHP|EBVS|IMD5|LYP|MTCP1|SAP|XLP|XLPD	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36334
3.10968619246836e-19	-0.293289402710653	0.103	0.307	5.26127806903721e-15	NUCKS1	CD8+ T cells	GSE111014_post	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36335
5.01573973516843e-19	-0.332491684959011	0.177	0.424	8.48613005793147e-15	STK17A	CD8+ T cells	GSE111014_post	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36336
5.9393728008077e-19	-0.270358045909759	0.093	0.288	1.00488248416866e-14	RBMX	CD8+ T cells	GSE111014_post	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36337
7.70768876484671e-19	-0.251936260285358	0.09	0.283	1.30406386212441e-14	ATRX	CD8+ T cells	GSE111014_post	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36338
8.75687755197326e-19	-0.391468004060253	0.319	0.615	1.48157611301836e-14	GLTSCR2	CD8+ T cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36339
1.1696952755081e-18	0.549912617720026	0.842	0.717	1.97900743663216e-14	UBB	CD8+ T cells	GSE111014_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36340
1.3183994468664e-18	-0.280867453306813	0.077	0.254	2.23060002415326e-14	ANKRD44	CD8+ T cells	GSE111014_post	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36341
1.86966996728888e-18	-0.276834802201212	0.085	0.268	3.16329461765606e-14	DDX17	CD8+ T cells	GSE111014_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36342
2.40370522688299e-18	-0.29453756126887	0.136	0.361	4.06682887336333e-14	IL10RA	CD8+ T cells	GSE111014_post	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36343
2.52428192028864e-18	-0.275388456040171	0.103	0.302	4.27083258093636e-14	SEPT6	CD8+ T cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36344
3.62908974572428e-18	-0.299657676880344	0.221	0.493	6.14005694079091e-14	ICAM3	CD8+ T cells	GSE111014_post	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36345
4.24840836519998e-18	-0.317580801886397	0.14	0.361	7.18788211308185e-14	AHNAK	CD8+ T cells	GSE111014_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36346
4.8893430543513e-18	-0.271570224981959	0.091	0.278	8.27227951365697e-14	CNN2	CD8+ T cells	GSE111014_post	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36347
6.48792790129796e-18	-0.34102926499095	0.215	0.473	1.0976925216206e-13	N4BP2L2	CD8+ T cells	GSE111014_post	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36348
7.5559619569718e-18	-0.416064681969094	0.358	0.639	1.27839320350006e-13	PABPC1	CD8+ T cells	GSE111014_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36349
1.06631610780112e-17	0.389884447521128	0.998	0.99	1.80410022278872e-13	RPS4X	CD8+ T cells	GSE111014_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36350
1.37891166657528e-17	-0.340868545886356	0.233	0.498	2.33298064867872e-13	BIN2	CD8+ T cells	GSE111014_post	ENSG00000110934	51411	bridging integrator 2	BRAP-1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36351
1.5621307555436e-17	-0.391989910512145	0.94	0.99	2.64296902530422e-13	RPL37A	CD8+ T cells	GSE111014_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36352
1.71309814320695e-17	-0.474179457592858	0.986	0.99	2.89839074849185e-13	MT-CO2	CD8+ T cells	GSE111014_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36353
2.87887169507952e-17	-0.261441542222699	0.109	0.307	4.87076302090505e-13	CYTH1	CD8+ T cells	GSE111014_post	ENSG00000108669	9267	cytohesin 1	B2-1|cytohesin-1|D17S811E|PSCD1	protein_coding	Q15438	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36354
4.30413965397634e-17	-0.302522648370229	0.159	0.385	7.28217388056258e-13	TAPBP	CD8+ T cells	GSE111014_post	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36355
7.41376295297086e-17	-0.265922082820245	0.092	0.273	1.25433455401314e-12	MGEA5	CD8+ T cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36356
8.68447350275087e-17	-0.277592321273952	0.126	0.332	1.46932607193042e-12	ZEB2	CD8+ T cells	GSE111014_post	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36357
8.80597835183562e-17	0.459564802270682	0.88	0.785	1.48988347734707e-12	FTH1	CD8+ T cells	GSE111014_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36358
1.07098406427119e-16	-0.302822985517203	0.142	0.356	1.81199793834043e-12	MBNL1	CD8+ T cells	GSE111014_post	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36359
1.25662737513679e-16	-0.259586533219636	0.101	0.288	2.12608785599394e-12	ARID4B	CD8+ T cells	GSE111014_post	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36360
2.05430556816922e-16	-0.360590304083384	0.276	0.537	3.47567959078551e-12	MYO1F	CD8+ T cells	GSE111014_post	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36361
2.42557072880793e-16	-0.361349249370545	0.299	0.556	4.10382311607013e-12	VAMP2	CD8+ T cells	GSE111014_post	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36362
2.50663841413515e-16	-0.279642629069837	0.149	0.366	4.24098153287526e-12	CDC42SE2	CD8+ T cells	GSE111014_post	ENSG00000158985	56990	CDC42 small effector 2	FLJ21967|SPEC2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36363
4.62907472189285e-16	-0.349630186762249	0.254	0.507	7.83193152197051e-12	PPP2R5C	CD8+ T cells	GSE111014_post	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36364
5.96259274271954e-16	-0.328847482208635	0.204	0.439	1.00881106614072e-11	LRRFIP1	CD8+ T cells	GSE111014_post	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36365
7.25324438900966e-16	-0.25554809129965	0.129	0.332	1.22717641817654e-11	ITGB1BP1	CD8+ T cells	GSE111014_post	ENSG00000119185	9270	integrin subunit beta 1 binding protein 1	ICAP-1A|ICAP-1alpha|ICAP-1B|ICAP1|ICAP1A|ICAP1B	protein_coding	O14713	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36366
9.2467070166789e-16	-0.352914221158841	0.933	0.99	1.5644503601519e-11	RPL37	CD8+ T cells	GSE111014_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36367
1.32929128625048e-15	-0.254581139883031	0.096	0.273	2.24902792720718e-11	RBM25	CD8+ T cells	GSE111014_post	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36368
1.39613992820027e-15	0.47737245639455	0.451	0.161	2.36212914452204e-11	ZNF683	CD8+ T cells	GSE111014_post	ENSG00000176083	257101	zinc finger protein 683	Hobit|MGC33414	protein_coding	Q8IZ20	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36369
1.60367412468594e-15	-0.306180407843164	0.184	0.41	2.71325625155615e-11	MT-ND4L	CD8+ T cells	GSE111014_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36370
1.81480730781417e-15	-0.28497185163955	0.139	0.341	3.07047248409079e-11	RSRP1	CD8+ T cells	GSE111014_post	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36371
1.8229667898529e-15	-0.347947751653785	0.313	0.58	3.08427751175212e-11	CDC42	CD8+ T cells	GSE111014_post	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36372
1.93382313352238e-15	-0.253209970171972	0.094	0.268	3.27183535960652e-11	HNRNPH1	CD8+ T cells	GSE111014_post	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36373
4.76508882937873e-15	0.336377172429481	0.999	1	8.06205379042587e-11	HLA-C	CD8+ T cells	GSE111014_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36374
5.81432101401939e-15	-0.295997905094455	0.148	0.351	9.83724972361941e-11	P4HB	CD8+ T cells	GSE111014_post	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36375
7.16918648964417e-15	-0.299047036851273	0.182	0.4	1.2129546621829e-10	SYNE2	CD8+ T cells	GSE111014_post	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36376
1.77747516326327e-14	-0.357538292067773	0.38	0.639	3.00731022872513e-10	KLRG1	CD8+ T cells	GSE111014_post	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36377
2.48566152023784e-14	-0.250086333995691	0.152	0.356	4.2054907260904e-10	CAPZA1	CD8+ T cells	GSE111014_post	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36378
2.69747542673606e-14	-0.355201279831046	0.914	0.995	4.56385867449474e-10	RPS7	CD8+ T cells	GSE111014_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36379
2.70719359665922e-14	-0.292864076140301	0.111	0.288	4.58030084618773e-10	TAOK3	CD8+ T cells	GSE111014_post	ENSG00000135090	51347	TAO kinase 3	DPK|JIK|MAP3K18	protein_coding	Q9H2K8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36380
2.85464106917966e-14	-0.353559999921594	0.357	0.605	4.82976722494507e-10	CD3G	CD8+ T cells	GSE111014_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36381
3.69059288471976e-14	-0.252991407743104	0.201	0.429	6.24411410165736e-10	EIF3G	CD8+ T cells	GSE111014_post	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36382
4.09620887958252e-14	0.487287523645404	0.435	0.176	6.93037580336566e-10	ITGB1	CD8+ T cells	GSE111014_post	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36383
5.94492374804473e-14	-0.259880870676719	0.14	0.332	1.00582164893169e-09	ZFAS1	CD8+ T cells	GSE111014_post	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36384
6.61709636195907e-14	0.29262386407432	1	1	1.11954653347985e-09	RPS14	CD8+ T cells	GSE111014_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36385
1.15604970901821e-13	-0.25072571542127	0.144	0.337	1.9559205026879e-09	NAP1L1	CD8+ T cells	GSE111014_post	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36386
1.21443776823991e-13	-0.359683402017516	0.314	0.546	2.0547072600851e-09	SRSF5	CD8+ T cells	GSE111014_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36387
1.58836705558585e-13	-0.261972698031898	0.16	0.361	2.68735822134571e-09	CCNL1	CD8+ T cells	GSE111014_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36388
1.63048229897498e-13	-0.271075061919233	0.188	0.4	2.75861300163577e-09	MSN	CD8+ T cells	GSE111014_post	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36389
2.22469773393177e-13	-0.432229942915218	0.268	0.473	3.76396609603915e-09	CD8B	CD8+ T cells	GSE111014_post	ENSG00000172116	926	CD8b molecule	CD8B1	protein_coding	P10966	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36390
4.21199746446565e-13	0.411027841633305	0.366	0.117	7.12627851012943e-09	HMGN2	CD8+ T cells	GSE111014_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36391
6.53235302314014e-13	-0.29138241557933	0.294	0.532	1.10520880798508e-08	LCP1	CD8+ T cells	GSE111014_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36392
8.56105248125115e-13	-0.291549954414176	0.34	0.585	1.44844446930288e-08	CIRBP	CD8+ T cells	GSE111014_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36393
9.5321941495262e-13	-0.310416868197013	0.354	0.595	1.61275192815834e-08	LCK	CD8+ T cells	GSE111014_post	ENSG00000182866	3932	LCK proto-oncogene, Src family tyrosine kinase	NA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36394
1.20356613432595e-12	0.4063351440857	0.874	0.888	2.03631354266607e-08	MYL6	CD8+ T cells	GSE111014_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36395
1.48188672875946e-12	0.362126251444346	0.984	0.932	2.50720415638813e-08	IL32	CD8+ T cells	GSE111014_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36396
2.25037083891743e-12	-0.359335187995398	0.863	0.966	3.8074024223644e-08	RPL38	CD8+ T cells	GSE111014_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36397
2.43514454264303e-12	-0.259455069587823	0.24	0.463	4.12002105169774e-08	EIF3E	CD8+ T cells	GSE111014_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36398
3.04373158982324e-12	-0.2842696393887	0.221	0.429	5.14968947682194e-08	ARPC4	CD8+ T cells	GSE111014_post	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36399
3.25484489056835e-12	-0.351626590474812	0.385	0.615	5.5068720703526e-08	EEF1B2	CD8+ T cells	GSE111014_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36400
6.20815077297413e-12	-0.288687093175312	0.251	0.468	1.05035702927949e-07	YWHAZ	CD8+ T cells	GSE111014_post	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36401
6.46164731096529e-12	-0.26556484604454	0.135	0.307	1.09324610854222e-07	ARL4C	CD8+ T cells	GSE111014_post	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36402
7.36094190357131e-12	-0.344697717770222	0.498	0.717	1.24539776066523e-07	TOMM7	CD8+ T cells	GSE111014_post	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36403
8.62471231291529e-12	-0.280089630259804	0.158	0.337	1.45921507622214e-07	ARGLU1	CD8+ T cells	GSE111014_post	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36404
9.4980245052802e-12	-0.31730783375924	0.299	0.517	1.60697076604836e-07	LYAR	CD8+ T cells	GSE111014_post	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36405
1.68714925672606e-11	-0.346532175582526	0.632	0.859	2.85448782745482e-07	DDX5	CD8+ T cells	GSE111014_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36406
2.6260820160158e-11	0.463895831582948	0.877	0.82	4.44306816289714e-07	GZMA	CD8+ T cells	GSE111014_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36407
4.10513578635801e-11	-0.27465104596183	0.176	0.356	6.94547923693912e-07	TCF25	CD8+ T cells	GSE111014_post	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36408
4.28552292927606e-11	-0.350441343237506	0.874	0.966	7.25067624404216e-07	RPL9	CD8+ T cells	GSE111014_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36409
4.46168042703453e-11	-0.278698661693045	0.419	0.654	7.54871711449972e-07	EVL	CD8+ T cells	GSE111014_post	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36410
4.76651639511158e-11	-0.256546858768075	0.239	0.444	8.06446908888929e-07	C9orf142	CD8+ T cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36411
5.36542301143986e-11	0.323809645642882	0.963	0.956	9.0777591930551e-07	PTMA	CD8+ T cells	GSE111014_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36412
5.42313407023122e-11	-0.276081542528636	0.275	0.483	9.17540053342421e-07	SARAF	CD8+ T cells	GSE111014_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36413
7.05881586652732e-11	-0.356966029643461	0.845	0.961	1.19428105645776e-06	TPT1	CD8+ T cells	GSE111014_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36414
1.50269422716728e-10	-0.368337727800485	0.828	0.961	2.54240836294433e-06	MT-ATP6	CD8+ T cells	GSE111014_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36415
2.85024182071393e-10	-0.342506921234799	0.312	0.498	4.82232413646591e-06	CD8A	CD8+ T cells	GSE111014_post	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36416
4.56082307274359e-10	0.448335844178087	0.604	0.424	7.71645655677488e-06	S100A11	CD8+ T cells	GSE111014_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36417
6.54836159885445e-10	-0.359749753995625	0.456	0.663	1.10791729891018e-05	MT-ND5	CD8+ T cells	GSE111014_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36418
6.74133530752605e-10	-0.376734830323515	0.72	0.878	1.14056652068033e-05	MT-ND3	CD8+ T cells	GSE111014_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36419
1.19370406219751e-09	-0.268050533553947	0.25	0.439	2.01962790283196e-05	CLEC2D	CD8+ T cells	GSE111014_post	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36420
1.99484394684707e-09	-0.251771801321213	0.203	0.376	3.37507647367057e-05	NCL	CD8+ T cells	GSE111014_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36421
2.78494602085345e-09	0.33148196889517	0.367	0.166	4.71185017268196e-05	EIF5A	CD8+ T cells	GSE111014_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36422
8.23526003930894e-09	-0.292639887979917	0.716	0.873	0.000139332364605068	RPL24	CD8+ T cells	GSE111014_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36423
4.27486663422613e-08	0.337613810462624	0.76	0.727	0.000723264685844719	OAZ1	CD8+ T cells	GSE111014_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36424
4.79317015120968e-08	-0.373366699911356	0.931	0.961	0.000810956457883167	MT-CYB	CD8+ T cells	GSE111014_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36425
7.84982474904669e-08	-0.263815079505802	0.931	0.98	0.00132811184929121	RPS16	CD8+ T cells	GSE111014_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36426
8.57785517900842e-08	-0.260304248866298	0.735	0.917	0.00145128731773644	RPL5	CD8+ T cells	GSE111014_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36427
1.45580487470003e-07	0.368333978169668	0.641	0.498	0.00246307626750498	RPL22	CD8+ T cells	GSE111014_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36428
1.6403844177268e-07	-0.257205702771932	0.941	0.98	0.00277536639635198	RPS17	CD8+ T cells	GSE111014_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36429
2.0540350922396e-07	-0.262298244379792	0.764	0.917	0.00347522197256017	RPL7A	CD8+ T cells	GSE111014_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36430
2.2497751181772e-07	-0.25917482911432	0.623	0.824	0.003806394522444	NACA	CD8+ T cells	GSE111014_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36431
2.35581782898679e-07	0.294937421355321	0.914	0.941	0.00398580818486274	CFL1	CD8+ T cells	GSE111014_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36432
4.82315324114634e-07	0.343661120738583	0.46	0.293	0.00816029296869549	DYNLL1	CD8+ T cells	GSE111014_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36433
6.18111790681076e-07	0.348924828875122	0.508	0.341	0.0104578333865331	TRGC2	CD8+ T cells	GSE111014_post	ENSG00000227191	NA	NA	TCRGC2|TRGC2(2X)|TRGC2(3X)	TR_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36434
9.12718838359582e-07	0.324691089709931	0.512	0.361	0.0154422900262058	ATP6V0E1	CD8+ T cells	GSE111014_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36435
1.61546535137613e-06	0.297687863212186	0.85	0.8	0.0273320582799328	MYL12A	CD8+ T cells	GSE111014_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36436
3.72991467974068e-91	-0.684498174272071	0	0.348	6.31064264665325e-87	RPS4Y1	CD4+ T cells	GSE111014_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36437
1.45138119742596e-57	-0.379739356699291	0.007	0.286	2.45559184792498e-53	IGHM	CD4+ T cells	GSE111014_post	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36438
1.04323713660609e-34	0.75371177519818	1	1	1.76505291142384e-30	B2M	CD4+ T cells	GSE111014_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36439
7.64145109449592e-30	-1.20305467239432	0.532	0.938	1.29285711067776e-25	RPS26	CD4+ T cells	GSE111014_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36440
5.52244581170062e-23	-0.790756112035392	0.968	1	9.34342606881627e-19	MT-CO3	CD4+ T cells	GSE111014_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36441
9.6340074949215e-23	0.767488142274043	0.997	0.946	1.62997772806577e-18	RPL39	CD4+ T cells	GSE111014_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36442
1.43993876197253e-22	0.710633203032909	1	0.973	2.43623239138132e-18	RPL41	CD4+ T cells	GSE111014_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36443
3.93339438205738e-20	-0.696245530612188	0.451	0.884	6.65490995500287e-16	MT-ND1	CD4+ T cells	GSE111014_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36444
4.68446911538078e-20	-1.21893506958878	0.378	0.723	7.92565329631274e-16	HLA-DRA	CD4+ T cells	GSE111014_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36445
2.92335155350064e-18	0.532082262132071	1	1	4.94601849336774e-14	RPS14	CD4+ T cells	GSE111014_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36446
3.35790056147526e-18	0.547967879379554	1	1	5.68123195995999e-14	RPL10	CD4+ T cells	GSE111014_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36447
2.74187860481018e-16	0.535104871807385	0.999	0.991	4.63898441147835e-12	RPL34	CD4+ T cells	GSE111014_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36448
3.91967161701971e-16	0.56907126210571	1	1	6.63169240883564e-12	RPS27	CD4+ T cells	GSE111014_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36449
7.36137719520371e-15	0.493186002410303	0.998	0.991	1.24547140765652e-10	RPS4X	CD4+ T cells	GSE111014_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36450
1.83754049330344e-14	-0.504501962360863	0.394	0.652	3.1089347606201e-10	IGKC	CD4+ T cells	GSE111014_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36451
3.27068252708728e-14	0.445646488669804	1	1	5.53366776757898e-10	RPL21	CD4+ T cells	GSE111014_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36452
3.57638281869559e-14	0.443682077397615	1	1	6.05088209095106e-10	RPL13	CD4+ T cells	GSE111014_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36453
7.08673579507233e-14	-0.66967627983677	0.316	0.67	1.19900482916829e-09	HLA-DPA1	CD4+ T cells	GSE111014_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36454
2.20853802069872e-13	0.594975360362285	0.919	0.893	3.73662547722016e-09	RPL36A	CD4+ T cells	GSE111014_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36455
7.10267076497519e-13	-1.06246196175836	0.766	0.911	1.20170086672615e-08	CD74	CD4+ T cells	GSE111014_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36456
7.92853443488938e-13	0.41493460193742	1	1	1.34142874103893e-08	RPS19	CD4+ T cells	GSE111014_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36457
8.81504101940918e-13	0.473835970128528	0.989	0.982	1.49141679007384e-08	RPS25	CD4+ T cells	GSE111014_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36458
2.45906290075365e-12	0.47456683353835	0.998	0.991	4.16048852178511e-08	RPS6	CD4+ T cells	GSE111014_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36459
4.59567860373789e-12	0.421534383705412	0.998	1	7.77542862966413e-08	RPL3	CD4+ T cells	GSE111014_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36460
8.84931055598656e-12	-0.534738625525955	0.992	1	1.49721485296737e-07	MT-CO1	CD4+ T cells	GSE111014_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36461
9.41988671674594e-12	0.503459323341819	0.981	0.964	1.59375063360624e-07	CD52	CD4+ T cells	GSE111014_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36462
1.60214995026386e-11	-1.01622230577336	0.346	0.571	2.71067750085142e-07	COTL1	CD4+ T cells	GSE111014_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36463
1.86979783779193e-11	-0.834292175021196	0.432	0.732	3.16351096176017e-07	HLA-DRB1	CD4+ T cells	GSE111014_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36464
8.77080567571707e-11	-0.433594331952344	0.402	0.714	1.48393261227457e-06	EEF2	CD4+ T cells	GSE111014_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36465
1.18338788397145e-10	0.46355584993448	0.996	0.938	2.0021739608913e-06	EEF1A1	CD4+ T cells	GSE111014_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36466
2.69711099556715e-10	0.425277930912778	0.996	0.991	4.56324209340006e-06	RPL7	CD4+ T cells	GSE111014_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36467
5.13508457035111e-10	0.374900748560393	0.999	1	8.68804958457705e-06	RPL23A	CD4+ T cells	GSE111014_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36468
1.36104328019033e-09	-0.407176053798957	0.983	0.991	2.30274912575403e-05	MT-CO2	CD4+ T cells	GSE111014_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36469
1.99002456957864e-09	0.41888876093773	0.4	0.089	3.3669225692701e-05	GADD45B	CD4+ T cells	GSE111014_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36470
2.89420817895665e-09	0.598586318639414	0.916	0.688	4.89671081797675e-05	IL32	CD4+ T cells	GSE111014_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36471
7.43725609741032e-09	0.348393837235312	0.996	0.991	0.000125830935912085	RPL36	CD4+ T cells	GSE111014_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36472
1.38391272999853e-08	0.343696806438662	0.995	1	0.000234144194788451	RPL31	CD4+ T cells	GSE111014_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36473
1.46191954597575e-08	0.305528187256026	1	1	0.000247342167983637	RPL13A	CD4+ T cells	GSE111014_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36474
2.06222694102362e-08	0.361794030323397	0.996	0.991	0.000348908176151786	RPL35A	CD4+ T cells	GSE111014_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36475
2.51656963636301e-08	0.316319027297182	0.999	1	0.000425778416776257	RPS27A	CD4+ T cells	GSE111014_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36476
2.94981352020267e-08	0.391399646374007	0.616	0.304	0.000499078949483089	PPDPF	CD4+ T cells	GSE111014_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36477
3.3132389255473e-08	0.324874892745947	1	1	0.000560566893813348	RPS29	CD4+ T cells	GSE111014_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36478
1.46884808064551e-07	0.474531239569912	0.604	0.357	0.00248514406764414	HCST	CD4+ T cells	GSE111014_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36479
1.92226786299374e-07	0.365570432832875	0.434	0.161	0.0032522849973991	ISG20	CD4+ T cells	GSE111014_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36480
3.01708016695505e-07	0.282118968796387	1	1	0.00510459793447125	RPL18A	CD4+ T cells	GSE111014_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36481
3.256330966914e-07	-0.515202466225015	0.375	0.643	0.0055093863629218	HLA-DPB1	CD4+ T cells	GSE111014_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36482
3.27315073706035e-07	-0.809790963590832	0.634	0.75	0.0055378437320324	ACTG1	CD4+ T cells	GSE111014_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36483
3.32865894764011e-07	0.337428371892777	0.765	0.464	0.0056317580735123	TRAC	CD4+ T cells	GSE111014_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36484
4.97871320850153e-07	-0.593634623046316	0.229	0.393	0.00842348487746374	RBM3	CD4+ T cells	GSE111014_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36485
7.20070459406399e-07	-0.720412926757819	0.996	1	0.0121828721026969	ACTB	CD4+ T cells	GSE111014_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36486
8.54658365107055e-07	0.276584493370677	1	1	0.0144599648792463	RPS2	CD4+ T cells	GSE111014_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36487
1.25143240958494e-06	0.331735444573683	0.944	0.911	0.0211729849377675	H3F3B	CD4+ T cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36488
1.75063809708534e-06	0.436732224409166	0.742	0.438	0.0296190459645868	LTB	CD4+ T cells	GSE111014_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36489
2.0434778579223e-06	0.403148249888594	0.846	0.723	0.0345736018781873	MYL12A	CD4+ T cells	GSE111014_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36490
2.12470305798128e-06	0.268576466166905	0.999	1	0.0359478510379853	RPLP2	CD4+ T cells	GSE111014_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36491
2.1772497331705e-06	0.417863026773732	0.68	0.411	0.0368368882355117	OST4	CD4+ T cells	GSE111014_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36492
2.25406708348078e-06	0.376813714640746	0.593	0.339	0.0381365609854114	MYL12B	CD4+ T cells	GSE111014_post	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36493
9.81794735381957e-121	1.54344133227967	0.687	0.051	1.66109851279273e-116	FCER1G	NK cells	GSE111014_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36494
5.08794029017421e-111	1.16089181219785	1	1	8.60828617694575e-107	B2M	NK cells	GSE111014_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36495
4.64895580056722e-97	0.956757423669739	1	0.999	7.86556831897968e-93	TMSB4X	NK cells	GSE111014_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36496
1.55961872753376e-95	-1.89574282978158	0.282	0.832	2.63871892511437e-91	AC090498.1	NK cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36497
8.20714174660576e-91	1.79893357528261	0.969	0.695	1.38856631210823e-86	GNLY	NK cells	GSE111014_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36498
2.50088725111947e-84	1.37262251118983	0.862	0.345	4.23125114016904e-80	GZMA	NK cells	GSE111014_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36499
1.86312491000075e-82	1.22468835917325	0.975	0.769	3.15222103523027e-78	NKG7	NK cells	GSE111014_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36500
5.55861110231639e-82	1.34885223616363	0.825	0.286	9.4046141240091e-78	CTSW	NK cells	GSE111014_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36501
3.26887219464568e-77	1.16634779771809	0.724	0.182	5.53060486612103e-73	SRGN	NK cells	GSE111014_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36502
3.4195625352886e-77	1.14881416793334	0.651	0.136	5.78555785345478e-73	KLRB1	NK cells	GSE111014_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36503
1.40327936645244e-76	0.947661659726248	0.538	0.058	2.37420836010088e-72	PLAC8	NK cells	GSE111014_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36504
7.39369070484726e-73	1.01585252573373	0.673	0.139	1.25093853035311e-68	CD7	NK cells	GSE111014_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36505
1.33168919427005e-70	1.01936277903967	0.997	0.993	2.25308494778549e-66	PFN1	NK cells	GSE111014_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36506
5.9100730608519e-70	-0.524234147290655	0.738	0.963	9.99925261165533e-66	IGKC	NK cells	GSE111014_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36507
7.07671969284167e-68	1.10465257255652	0.868	0.367	1.19731020483188e-63	CST7	NK cells	GSE111014_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36508
2.2345324075229e-67	1.07995183160381	0.696	0.163	3.78060538028799e-63	TYROBP	NK cells	GSE111014_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36509
2.67764891512763e-67	-0.917325686956698	0.986	1	4.53031419950444e-63	MT-CO3	NK cells	GSE111014_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36510
1.12397596262683e-66	0.71184554374275	0.465	0.052	1.90165493116834e-62	KLRF1	NK cells	GSE111014_post	ENSG00000150045	51348	killer cell lectin like receptor F1	CLEC5C|NKp80	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36511
2.86209222518608e-65	-0.713809240718675	1	1	4.84237383579233e-61	RPS27	NK cells	GSE111014_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36512
1.11057813131314e-64	1.41151830098023	0.823	0.358	1.8789871403687e-60	GZMB	NK cells	GSE111014_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36513
3.13667515737473e-64	0.782553824574949	1	0.999	5.3069406987623e-60	HLA-A	NK cells	GSE111014_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36514
5.18428779877047e-64	-1.14091529028105	0.53	0.928	8.77129652673975e-60	RPS26	NK cells	GSE111014_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36515
7.40690369589305e-61	1.09766754820758	0.78	0.293	1.25317403630815e-56	PRF1	NK cells	GSE111014_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36516
1.29451601489107e-59	-0.638297847708882	1	1	2.19019164559421e-55	MALAT1	NK cells	GSE111014_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36517
8.82980713300482e-57	0.764300137227271	0.482	0.072	1.49391506883309e-52	FCGR3A	NK cells	GSE111014_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36518
9.84407342360621e-57	-0.751516030667084	1	1	1.66551878253994e-52	RPS29	NK cells	GSE111014_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36519
2.76583388895596e-54	0.68523540950923	1	0.999	4.67951435672459e-50	HLA-C	NK cells	GSE111014_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36520
3.01399522764362e-53	-0.492034021328226	0.704	0.951	5.09937852565024e-49	HLA-DRA	NK cells	GSE111014_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36521
3.65574533244694e-53	1.02228819289674	1	0.999	6.18515552796697e-49	ACTB	NK cells	GSE111014_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36522
4.99299660520446e-53	-0.823764086648839	0.445	0.912	8.44765095634543e-49	MT-ND1	NK cells	GSE111014_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36523
7.36318149988389e-53	0.646046720393894	0.425	0.062	1.24577667796536e-48	TRDC	NK cells	GSE111014_post	ENSG00000211829	NA	NA	NA	TR_C_gene	B7Z8K6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36524
5.9978905549456e-52	0.935891021599184	0.707	0.249	1.01478310299125e-47	IFITM2	NK cells	GSE111014_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36525
6.99317598008275e-50	0.820054842579424	0.685	0.224	1.1831754440702e-45	CLIC1	NK cells	GSE111014_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36526
1.11114889915508e-48	0.715379977959257	0.504	0.11	1.87995282248048e-44	CD53	NK cells	GSE111014_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36527
2.60842429375865e-47	0.723145989391725	0.679	0.212	4.41319306261027e-43	PSMB9	NK cells	GSE111014_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36528
7.76660188383434e-46	0.906714653129876	0.831	0.472	1.31403137272593e-41	MYL12A	NK cells	GSE111014_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36529
1.70006252009232e-45	0.71368938627702	0.932	0.941	2.87633577774419e-41	CFL1	NK cells	GSE111014_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36530
1.44885306401701e-44	0.745199763929919	0.513	0.127	2.45131449901038e-40	HOPX	NK cells	GSE111014_post	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36531
3.59915063546655e-43	0.609855680128619	0.493	0.11	6.08940296014585e-39	CD247	NK cells	GSE111014_post	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36532
4.31193935725007e-42	0.645394536918708	0.366	0.057	7.29537019853139e-38	ALOX5AP	NK cells	GSE111014_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36533
1.30991611574146e-40	0.731263052830395	0.423	0.097	2.21624707622297e-36	SPON2	NK cells	GSE111014_post	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36534
5.52288072528432e-40	0.692187400974204	0.631	0.21	9.34416189910854e-36	KLRD1	NK cells	GSE111014_post	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36535
1.00676961428235e-39	0.602884875868916	0.411	0.091	1.70335351040431e-35	CLIC3	NK cells	GSE111014_post	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36536
1.12117409495752e-39	-0.673939913438643	0.87	0.998	1.89691445125863e-35	CD52	NK cells	GSE111014_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36537
1.85035066141869e-39	0.732174016446828	0.679	0.255	3.13060828405428e-35	ARPC2	NK cells	GSE111014_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36538
1.52262577782658e-38	0.681179263457122	0.572	0.182	2.5761305535048e-34	RAC2	NK cells	GSE111014_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36539
3.06018985770034e-38	-0.643627061975044	0.977	1	5.17753522024321e-34	RPS12	NK cells	GSE111014_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36540
1.22350316445131e-36	-0.582931155794511	0.997	1	2.07004500393518e-32	RPL23A	NK cells	GSE111014_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36541
5.6079286446354e-36	0.796762483765507	0.527	0.166	9.48805447385864e-32	FGFBP2	NK cells	GSE111014_post	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36542
3.61585519815417e-35	0.513501692173967	0.392	0.081	6.11766540975705e-31	EIF5A	NK cells	GSE111014_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36543
1.13216658364847e-34	0.519411401547625	0.437	0.106	1.91551264287484e-30	BST2	NK cells	GSE111014_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36544
1.33904104577529e-34	0.57850222468115	0.493	0.137	2.26552354534722e-30	CD63	NK cells	GSE111014_post	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36545
1.56184668235169e-34	-0.616147056243235	0.994	1	2.64248840187083e-30	MT-CO2	NK cells	GSE111014_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36546
1.79550837844957e-34	0.522563458721555	0.434	0.106	3.03782062549882e-30	TPI1	NK cells	GSE111014_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36547
2.28313175022599e-34	-0.57130201228167	1	1	3.86283060820735e-30	MT-CO1	NK cells	GSE111014_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36548
1.11148873934732e-33	-0.753018430171853	0.744	0.963	1.88052779810174e-29	MT-ND2	NK cells	GSE111014_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36549
1.92181807644111e-33	0.63800346159429	0.946	0.969	3.25152400353071e-29	CYBA	NK cells	GSE111014_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36550
2.76127393197373e-33	0.347915860306431	0.276	0.035	4.67179936550635e-29	DHRS7	NK cells	GSE111014_post	ENSG00000100612	51635	dehydrogenase/reductase 7	retDSR4|SDR34C1	protein_coding	Q9Y394	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36551
5.99340228049738e-33	-0.582665600102738	0.941	0.999	1.01402373183735e-28	RPL37A	NK cells	GSE111014_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36552
1.93562329161869e-32	0.591196036811056	0.518	0.157	3.27488104708965e-28	CCL4	NK cells	GSE111014_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36553
2.04879665446705e-32	-0.514227994698568	1	1	3.46635905969281e-28	RPL34	NK cells	GSE111014_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36554
2.38384496421218e-32	0.640768159587745	0.668	0.282	4.03322729495059e-28	CALM1	NK cells	GSE111014_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36555
7.19563820819708e-32	0.544275452115076	0.496	0.149	1.21743002844486e-27	S100A11	NK cells	GSE111014_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36556
8.14470404786817e-32	0.470472845459444	1	1	1.37800247785882e-27	HLA-B	NK cells	GSE111014_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36557
9.0035713224967e-32	0.602009082094137	0.575	0.206	1.52331423205322e-27	PSME2	NK cells	GSE111014_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36558
2.34555436347052e-31	0.487505222159302	0.394	0.095	3.96844342755578e-27	PRR13	NK cells	GSE111014_post	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36559
2.60680575325208e-31	0.494405585539998	0.417	0.107	4.4104546539272e-27	VAMP8	NK cells	GSE111014_post	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36560
6.87281367027176e-31	0.550064885048166	0.476	0.144	1.16281134487328e-26	ITM2B	NK cells	GSE111014_post	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36561
7.65607280915649e-31	0.492159327092681	0.439	0.12	1.29533095858119e-26	LITAF	NK cells	GSE111014_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36562
2.16772344830271e-30	-0.545225963865537	0.989	1	3.66757130218335e-26	RPS15A	NK cells	GSE111014_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36563
3.11368165005664e-30	-0.529715525786818	0.997	1	5.26803798373084e-26	RPL32	NK cells	GSE111014_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36564
5.42210263985059e-30	0.49834321361243	0.496	0.154	9.17365545636321e-26	IL2RG	NK cells	GSE111014_post	ENSG00000147168	3561	interleukin 2 receptor subunit gamma	CD132|CIDX|IMD4|SCIDX1	protein_coding	P31785	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36565
8.62929855851882e-30	0.378051211476172	0.31	0.057	1.4599910231158e-25	RAP1B	NK cells	GSE111014_post	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36566
1.83366720699626e-29	0.360530766266502	0.293	0.051	3.10238154751697e-25	BANF1	NK cells	GSE111014_post	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36567
3.22614671484339e-29	0.588061361852756	0.566	0.213	5.45831762684353e-25	RARRES3	NK cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36568
3.62796527081032e-29	-0.305918809852049	0.448	0.894	6.13815444168398e-25	HLA-DPA1	NK cells	GSE111014_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36569
8.94019164395059e-29	0.472890729399282	0.454	0.134	1.51259102424e-24	ATP6V0E1	NK cells	GSE111014_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36570
9.68508493821292e-29	-0.638447520796663	0.808	0.983	1.63861952069624e-24	MT-ND3	NK cells	GSE111014_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36571
1.7993252073885e-28	0.424777435587025	0.33	0.07	3.0442783183806e-24	ARPC5	NK cells	GSE111014_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36572
3.02859745989369e-28	0.609816786464971	0.577	0.229	5.12408404239413e-24	ID2	NK cells	GSE111014_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36573
3.20572699580244e-28	0.527407018984972	0.437	0.133	5.42376950419815e-24	GSTP1	NK cells	GSE111014_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36574
6.40247340365425e-28	0.360910078654778	0.296	0.055	1.08323447516426e-23	DOK2	NK cells	GSE111014_post	ENSG00000147443	9046	docking protein 2	Dok-2|p56dok-2	protein_coding	O60496	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36575
1.13363544803343e-27	0.359610335563295	0.273	0.047	1.91799781452776e-23	HSPA5	NK cells	GSE111014_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36576
1.35544677977182e-27	0.642544298834794	0.499	0.178	2.29328040669594e-23	CMC1	NK cells	GSE111014_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36577
1.99225277231695e-27	0.799014209907482	0.834	0.673	3.37069246548305e-23	CCL5	NK cells	GSE111014_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36578
2.06667448321502e-27	-0.472663158716681	0.997	1	3.4966065581515e-23	RPS18	NK cells	GSE111014_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36579
2.290164826893e-27	0.586492507406283	0.521	0.196	3.87472987062026e-23	LY6E	NK cells	GSE111014_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36580
3.05091689313464e-27	0.505441630776063	0.53	0.192	5.1618462914945e-23	MYL12B	NK cells	GSE111014_post	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36581
6.22110942711997e-27	0.470449944553948	0.454	0.143	1.05254950397443e-22	PPP1CA	NK cells	GSE111014_post	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36582
9.88580111589372e-27	0.455382756234406	0.445	0.138	1.67257869079806e-22	GIMAP7	NK cells	GSE111014_post	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36583
1.53720157990891e-26	0.465344177740943	0.414	0.123	2.60079135304789e-22	DBI	NK cells	GSE111014_post	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36584
1.56412490520185e-26	0.331881030043246	0.296	0.059	2.64634292711101e-22	CYCS	NK cells	GSE111014_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36585
4.56194769320513e-26	0.366278595312767	0.282	0.054	7.71835930213376e-22	TMEM59	NK cells	GSE111014_post	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36586
1.01198730828312e-25	0.548621748539405	0.851	0.795	1.71218132688421e-21	UBB	NK cells	GSE111014_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36587
3.31348908025398e-25	0.458980592154435	0.983	0.985	5.60609217488171e-21	SERF2	NK cells	GSE111014_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36588
3.93257674983217e-25	0.363201126567407	0.324	0.076	6.65352660304106e-21	GIMAP4	NK cells	GSE111014_post	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36589
5.13610348598515e-25	0.431553302593512	0.47	0.159	8.68977348793827e-21	CHCHD2	NK cells	GSE111014_post	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36590
5.20150264413246e-25	0.487069156082326	0.377	0.112	8.8004223236077e-21	DYNLL1	NK cells	GSE111014_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36591
9.00823617287598e-25	0.337046237789816	0.276	0.055	1.52410347808889e-20	UBE2L6	NK cells	GSE111014_post	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36592
9.31374290131549e-25	0.528753176487187	0.938	0.978	1.57579216147357e-20	SH3BGRL3	NK cells	GSE111014_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36593
1.57602926669729e-24	0.444548322275477	0.408	0.128	2.66648391632514e-20	ALDOA	NK cells	GSE111014_post	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36594
1.60519763400979e-24	0.423858591436554	0.38	0.111	2.71583387698116e-20	TMBIM6	NK cells	GSE111014_post	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36595
1.67160622686723e-24	-0.711409696774675	0.152	0.454	2.82819057523666e-20	JUN	NK cells	GSE111014_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36596
1.86142126360061e-24	0.389081454054459	0.346	0.092	3.14933863588587e-20	ARL6IP5	NK cells	GSE111014_post	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36597
2.18553947087874e-24	0.374059021169639	0.282	0.059	3.69771423077974e-20	RHOC	NK cells	GSE111014_post	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36598
5.99746989465601e-24	-0.46358623583531	0.975	0.999	1.01471193147685e-19	RPL35	NK cells	GSE111014_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36599
8.48650060647632e-24	0.410523176300569	0.321	0.083	1.43583103760973e-19	C12orf75	NK cells	GSE111014_post	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36600
1.96137506274575e-23	0.575842077918629	0.758	0.434	3.31845046865953e-19	HCST	NK cells	GSE111014_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36601
2.35109761997817e-23	0.438272512662799	0.383	0.12	3.97782206324107e-19	SUMO2	NK cells	GSE111014_post	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36602
3.24338439759652e-23	0.458793142525465	0.645	0.29	5.48748206229355e-19	ITGB2	NK cells	GSE111014_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36603
4.74488264635684e-23	0.406055946655225	0.4	0.126	8.02786694937114e-19	SKP1	NK cells	GSE111014_post	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36604
5.50829850130656e-23	0.377818664006793	0.301	0.075	9.31949023436057e-19	SPCS2	NK cells	GSE111014_post	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36605
6.13764620078452e-23	0.492631578929888	0.958	0.983	1.03842836071073e-18	H3F3B	NK cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36606
1.03460239758931e-22	-0.446739744055529	0.98	0.999	1.75044379648135e-18	RPL11	NK cells	GSE111014_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36607
1.26176492591773e-22	0.420869814831345	0.392	0.125	2.1347800781602e-18	UCP2	NK cells	GSE111014_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36608
2.36328896403815e-22	0.350324543708904	0.315	0.083	3.99844859825615e-18	EIF4A2	NK cells	GSE111014_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36609
2.75871707840619e-22	-0.271648216469433	0.423	0.838	4.66747342495543e-18	CD37	NK cells	GSE111014_post	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36610
2.9748380876419e-22	0.421092418010756	0.33	0.095	5.03312856048133e-18	XBP1	NK cells	GSE111014_post	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36611
3.08893172579685e-22	0.358090909366094	0.335	0.092	5.22616358687568e-18	CTSC	NK cells	GSE111014_post	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36612
4.19925510849571e-22	-0.444565594043226	0.98	0.998	7.10471971806389e-18	RPS23	NK cells	GSE111014_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36613
6.22126083869998e-22	0.442664137748452	0.482	0.182	1.05257512129965e-17	ARPC1B	NK cells	GSE111014_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36614
6.36220555926551e-22	0.402151752079187	0.338	0.099	1.07642155857213e-17	PDIA3	NK cells	GSE111014_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36615
6.37933739073389e-22	-0.54247856096082	0.882	0.995	1.07932009313827e-17	RPS20	NK cells	GSE111014_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36616
6.75686008240286e-22	-0.473198176767648	0.245	0.578	1.14319315734174e-17	EEF2	NK cells	GSE111014_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36617
3.43015139282739e-21	-0.369060574199247	1	1	5.80347314152465e-17	RPL13A	NK cells	GSE111014_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36618
5.77381791899849e-21	0.490343137287807	0.854	0.762	9.76872253715354e-17	HLA-E	NK cells	GSE111014_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36619
7.31283997641934e-21	0.325235926162614	0.363	0.112	1.23725939561039e-16	EIF3G	NK cells	GSE111014_post	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36620
7.36555743735853e-21	-0.475433529722288	0.952	0.995	1.24617866282669e-16	RPL37	NK cells	GSE111014_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36621
1.57826631687313e-20	0.344798792564184	0.315	0.09	2.67026878151764e-16	ENO1	NK cells	GSE111014_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36622
1.69225972180544e-20	-0.383279987285369	0.992	1	2.86313422332262e-16	RPLP2	NK cells	GSE111014_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36623
2.43802478527126e-20	0.502952469237898	0.634	0.326	4.12489413420045e-16	EMP3	NK cells	GSE111014_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36624
2.90402316908097e-20	0.283416439291171	0.279	0.069	4.9133167997681e-16	FAM49B	NK cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36625
5.04157618206801e-20	0.334578241044051	0.299	0.083	8.52984274244087e-16	C4orf3	NK cells	GSE111014_post	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36626
7.06079653660514e-20	-0.399615302177398	0.983	1	1.19461616602822e-15	RPL27A	NK cells	GSE111014_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36627
9.73276644465453e-20	0.538856114158918	0.758	0.694	1.6466867547711e-15	ARHGDIB	NK cells	GSE111014_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36628
9.80129638194022e-20	0.390199339551476	0.423	0.158	1.65828133486047e-15	ANXA1	NK cells	GSE111014_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36629
1.38492626392108e-19	-0.395877826697671	0.997	1	2.34315674592807e-15	RPL18A	NK cells	GSE111014_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36630
1.7106652461257e-19	0.336414733839143	0.33	0.101	2.89427452992008e-15	JAK1	NK cells	GSE111014_post	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36631
1.81940652393227e-19	0.334599932747301	0.259	0.065	3.07825389784101e-15	ANXA2	NK cells	GSE111014_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36632
1.98723409207722e-19	0.28217806306483	0.254	0.06	3.36220136038544e-15	ACTR3	NK cells	GSE111014_post	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36633
2.58326814388572e-19	-0.457034431564099	0.977	1	4.37063137264025e-15	RPL26	NK cells	GSE111014_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36634
2.87511026590458e-19	0.466101034151698	0.563	0.268	4.86439905888396e-15	PSME1	NK cells	GSE111014_post	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36635
3.69283737889337e-19	0.31060982839598	0.29	0.081	6.2479115613497e-15	PPP1R18	NK cells	GSE111014_post	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36636
4.65257270678225e-19	0.286821964773792	0.349	0.11	7.87168776260488e-15	PSMB1	NK cells	GSE111014_post	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36637
4.73260803313015e-19	-0.498507451268395	0.806	0.988	8.00709953125291e-15	RPL38	NK cells	GSE111014_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36638
5.31977413689759e-19	0.429122430829569	0.431	0.173	9.00052586221704e-15	CALM2	NK cells	GSE111014_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36639
8.92112617733357e-19	-0.452159803089939	0.944	0.993	1.50936533794307e-14	MT-CYB	NK cells	GSE111014_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36640
1.94288246783354e-18	0.269382457759742	0.259	0.068	3.28716284732757e-14	PSMA4	NK cells	GSE111014_post	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36641
1.95092824995438e-18	0.321470562043398	0.31	0.095	3.30077550609782e-14	CAP1	NK cells	GSE111014_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36642
2.29828169201076e-18	-0.434163768883346	0.98	1	3.888462794713e-14	EEF1A1	NK cells	GSE111014_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36643
2.84668434902005e-18	0.399954773127114	0.49	0.208	4.81630525010703e-14	HNRNPA2B1	NK cells	GSE111014_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36644
4.56049479737618e-18	0.332912669447755	0.358	0.123	7.71590114768076e-14	UBE2D3	NK cells	GSE111014_post	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36645
5.24042785194089e-18	0.276593720879685	0.276	0.078	8.86627988269879e-14	NOP10	NK cells	GSE111014_post	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36646
6.51828876375085e-18	0.313236673581834	0.332	0.109	1.10282927593901e-13	RHOA	NK cells	GSE111014_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36647
7.86398677808643e-18	-0.411981239380991	0.997	1	1.33050792298444e-13	RPS28	NK cells	GSE111014_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36648
8.0512914441253e-18	0.320690048193795	0.315	0.102	1.36219799943156e-13	ERH	NK cells	GSE111014_post	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36649
9.63531026658203e-18	0.468036956075441	0.659	0.343	1.63019814400301e-13	CORO1A	NK cells	GSE111014_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36650
1.26416027461685e-17	-0.417244269834496	0.992	1	2.13883276862424e-13	RPL31	NK cells	GSE111014_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36651
1.55224515985547e-17	0.309895802625071	0.315	0.102	2.62624358595947e-13	SRSF3	NK cells	GSE111014_post	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36652
3.54484610615009e-17	0.27329121867678	0.251	0.067	5.99752512699534e-13	CD47	NK cells	GSE111014_post	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36653
3.63699553677204e-17	-0.469082545250852	0.856	0.993	6.15343274866461e-13	RPS21	NK cells	GSE111014_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36654
3.83894522603741e-17	0.274177011458874	0.299	0.092	6.4951114279327e-13	MORF4L1	NK cells	GSE111014_post	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36655
6.44131678827885e-17	0.320364069544397	0.327	0.11	1.0898063874089e-12	PLEK	NK cells	GSE111014_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36656
6.52703855443395e-17	0.270770861218213	0.293	0.091	1.10430965302468e-12	BRK1	NK cells	GSE111014_post	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36657
7.7926241682792e-17	0.281381040664331	0.344	0.118	1.31843408303116e-12	TRMT112	NK cells	GSE111014_post	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36658
8.53744617715009e-17	0.307123464082018	0.282	0.086	1.44445051871202e-12	GADD45B	NK cells	GSE111014_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36659
8.76758913788938e-17	-0.285725263823787	0.639	0.938	1.4833884062395e-12	HLA-DRB1	NK cells	GSE111014_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36660
8.79788975609883e-17	-0.376775203714568	1	1	1.48851496783436e-12	RPL41	NK cells	GSE111014_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36661
9.51346241473839e-17	0.333450530603968	0.341	0.121	1.60958270594959e-12	HMGN2	NK cells	GSE111014_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36662
9.81706767031833e-17	-0.42730885684867	0.623	0.936	1.66094967914116e-12	RPL23	NK cells	GSE111014_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36663
2.14539307063376e-16	0.258136802390004	0.254	0.072	3.62979053620525e-12	SRSF9	NK cells	GSE111014_post	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36664
2.32158662809353e-16	0.266201210515062	0.254	0.073	3.92789241607145e-12	STK17A	NK cells	GSE111014_post	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36665
4.45995264983784e-16	0.317654441697099	0.332	0.118	7.54579388826065e-12	HNRNPK	NK cells	GSE111014_post	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36666
7.02756389199615e-16	0.317906916689445	0.307	0.107	1.18899353488683e-11	COPE	NK cells	GSE111014_post	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36667
1.35954312708905e-15	-0.434872251352296	0.763	0.974	2.30021101672196e-11	RPS11	NK cells	GSE111014_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36668
2.59490984735387e-15	0.318252060742022	0.454	0.197	4.390327970738e-11	POLR2L	NK cells	GSE111014_post	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36669
3.18015537044354e-15	0.375594842997617	0.49	0.238	5.38050487125343e-11	COX6B1	NK cells	GSE111014_post	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36670
3.92678699643136e-15	-0.331336261183031	0.515	0.885	6.64373091926222e-11	RPL4	NK cells	GSE111014_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36671
4.3965289365085e-15	0.41249402859873	0.989	0.989	7.43848730767873e-11	PTMA	NK cells	GSE111014_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36672
4.8571608621366e-15	0.36194247730625	0.479	0.221	8.21783046264891e-11	CD99	NK cells	GSE111014_post	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36673
5.64288771613816e-15	0.265116692063664	0.273	0.09	9.54720172693415e-11	JTB	NK cells	GSE111014_post	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36674
6.34879808043844e-15	0.257067058585366	0.287	0.096	1.07415314722938e-10	PRDX5	NK cells	GSE111014_post	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36675
8.84781523021959e-15	0.302189151742007	0.363	0.145	1.49696185880085e-10	PSMB8	NK cells	GSE111014_post	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36676
1.11551574444862e-14	0.312015467983257	0.386	0.16	1.88734108803262e-10	PSMA7	NK cells	GSE111014_post	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36677
1.12617592198928e-14	0.319769192907217	0.428	0.186	1.90537704241366e-10	NDUFB2	NK cells	GSE111014_post	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36678
1.1452480529543e-14	0.368026128866196	0.482	0.231	1.93764518079337e-10	PPDPF	NK cells	GSE111014_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36679
1.15522485537412e-14	0.277443237789044	0.313	0.115	1.95452493280747e-10	WDR83OS	NK cells	GSE111014_post	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36680
1.17039294195004e-14	0.297065126517285	0.268	0.089	1.98018781848528e-10	RAN	NK cells	GSE111014_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36681
1.30446246899767e-14	0.2554989891212	0.307	0.109	2.20702005129716e-10	ARF6	NK cells	GSE111014_post	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36682
1.52311928120652e-14	0.265883471269005	0.293	0.102	2.57696551187331e-10	ISG15	NK cells	GSE111014_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36683
3.05272817659927e-14	0.371876727103728	0.456	0.217	5.16491080198831e-10	UBL5	NK cells	GSE111014_post	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36684
3.82464021849121e-14	0.515471481777798	0.631	0.407	6.47090878566528e-10	ACTG1	NK cells	GSE111014_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36685
4.07450781445449e-14	0.284815828551896	0.341	0.133	6.89365977127556e-10	CAPZB	NK cells	GSE111014_post	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36686
4.34311611433404e-14	0.251071277080392	0.315	0.116	7.34811815384175e-10	RBX1	NK cells	GSE111014_post	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36687
5.02657531597159e-14	-0.377518804745871	0.98	1	8.50446277709233e-10	RPL36	NK cells	GSE111014_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36688
5.12077531187267e-14	0.430042627019993	0.527	0.329	8.66383975015738e-10	ARPC3	NK cells	GSE111014_post	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36689
6.31285495825652e-14	-0.33825242896205	0.983	0.999	1.06807193038742e-09	RPS8	NK cells	GSE111014_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36690
6.49312086946387e-14	0.297840065257841	0.375	0.158	1.09857111990459e-09	HSPA8	NK cells	GSE111014_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36691
6.57917123677265e-14	0.282678428378464	0.442	0.196	1.11312998154956e-09	FXYD5	NK cells	GSE111014_post	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36692
6.72100682327667e-14	-0.259078770733534	0.955	0.986	1.13712714443018e-09	CD74	NK cells	GSE111014_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36693
9.00680856185602e-14	0.355461441469156	0.521	0.26	1.52386194058042e-09	UQCR11	NK cells	GSE111014_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36694
1.19469964952175e-13	-0.342286111829047	0.977	1	2.02131233702585e-09	RPL28	NK cells	GSE111014_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36695
1.34517908329573e-13	0.284820861141719	0.363	0.15	2.27590849102804e-09	APRT	NK cells	GSE111014_post	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36696
1.38446959117113e-13	0.318213713732127	0.473	0.223	2.34238410130243e-09	LSP1	NK cells	GSE111014_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36697
1.55353309884765e-13	0.26353093093379	0.307	0.117	2.62842264994033e-09	TRAPPC1	NK cells	GSE111014_post	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36698
1.60086890836792e-13	0.29718283508349	0.439	0.199	2.70851010606768e-09	COX7A2	NK cells	GSE111014_post	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36699
1.64465914529706e-13	0.351201201178747	0.89	0.957	2.7825988079281e-09	MYL6	NK cells	GSE111014_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36700
1.82742419032484e-13	0.404783862184379	0.445	0.223	3.0918189876106e-09	LIMD2	NK cells	GSE111014_post	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36701
2.30930369737679e-13	0.295861308929381	0.414	0.186	3.9071109255918e-09	COX6A1	NK cells	GSE111014_post	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36702
2.6459233147744e-13	0.253668307118275	0.254	0.086	4.47663765626681e-09	PSMB3	NK cells	GSE111014_post	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36703
2.66355006446268e-13	-0.322495311041142	0.546	0.875	4.50646035406442e-09	NACA	NK cells	GSE111014_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36704
2.74292988986001e-13	0.259500468466573	0.338	0.134	4.64076308065415e-09	SSR2	NK cells	GSE111014_post	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36705
3.37341935817762e-13	0.302026662942124	0.377	0.166	5.70748821210071e-09	DRAP1	NK cells	GSE111014_post	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36706
6.57531329243396e-13	-0.309195052080406	0.969	0.999	1.1124772559469e-08	RPS9	NK cells	GSE111014_post	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36707
7.39669956293157e-13	0.306490577309718	0.408	0.191	1.25144759905239e-08	HSP90AA1	NK cells	GSE111014_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36708
7.93945171128269e-13	0.373241364793639	0.423	0.203	1.34327583503192e-08	TRBC1	NK cells	GSE111014_post	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36709
1.16108571286402e-12	0.293380079709429	0.33	0.138	1.96444091759463e-08	HSP90AB1	NK cells	GSE111014_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36710
1.27697818869336e-12	0.251044962293373	0.369	0.158	2.16051939745029e-08	GPSM3	NK cells	GSE111014_post	ENSG00000233490	63940	G protein signaling modulator 3	AGS4|C6orf9|G18|G18.1a|G18.1b|G18.2|NG1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36711
1.68414838990872e-12	0.294929757757709	0.352	0.152	2.84941066088656e-08	NDUFA4	NK cells	GSE111014_post	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36712
1.70257809758938e-12	0.291503450260395	0.406	0.184	2.88059188331147e-08	CIRBP	NK cells	GSE111014_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36713
1.78734866638217e-12	0.29316622566241	0.4	0.182	3.02401520865199e-08	GUK1	NK cells	GSE111014_post	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36714
1.87582096783008e-12	0.282749270918319	0.332	0.141	3.17370149547171e-08	TAGLN2	NK cells	GSE111014_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36715
1.9219476020217e-12	0.286623379795638	0.403	0.184	3.25174314786051e-08	PPIB	NK cells	GSE111014_post	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36716
6.43584313609118e-12	-0.583848866131084	0.265	0.416	1.08888030019527e-07	IFITM1	NK cells	GSE111014_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36717
6.46343415652948e-12	-0.347656152361774	0.899	0.998	1.09354842494322e-07	RPS7	NK cells	GSE111014_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36718
7.65145565986646e-12	-0.317911944080291	0.997	1	1.29454978309281e-07	RPL19	NK cells	GSE111014_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36719
1.03740384103922e-11	0.286183455732752	0.535	0.277	1.75518355865425e-07	OST4	NK cells	GSE111014_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36720
1.13141956961857e-11	-0.342673050445769	0.927	0.994	1.91424876983766e-07	RPS17	NK cells	GSE111014_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36721
2.36099329175784e-11	0.296312830352146	0.372	0.174	3.99456455032508e-07	GZMM	NK cells	GSE111014_post	ENSG00000197540	3004	granzyme M	LMET1|MET1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36722
3.41766711709246e-11	-0.323448897477584	0.955	0.999	5.78235099540873e-07	RPL30	NK cells	GSE111014_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36723
3.76871135571268e-11	-0.338129014272526	0.693	0.959	6.37628274273028e-07	RPL5	NK cells	GSE111014_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36724
5.27223141272452e-11	-0.278688722325657	1	1	8.92008832718861e-07	RPL21	NK cells	GSE111014_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36725
5.86214881807598e-11	-0.376087790881688	0.634	0.891	9.91816958530274e-07	RPL36A	NK cells	GSE111014_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36726
6.80069739816387e-11	0.324122728448848	0.496	0.271	1.15060999279535e-06	H3F3A	NK cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36727
8.6769830384432e-11	-0.390331245583537	0.859	0.975	1.4680587602742e-06	MT-ATP6	NK cells	GSE111014_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36728
1.12172535077625e-10	0.280816618245517	0.532	0.29	1.89784712097833e-06	HNRNPA1	NK cells	GSE111014_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36729
1.36713566993181e-10	-0.337341896364035	0.876	0.998	2.31305683995762e-06	RPL29	NK cells	GSE111014_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36730
1.51730996698923e-10	-0.550583622903111	0.169	0.327	2.56713673314908e-06	CRIP1	NK cells	GSE111014_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36731
1.55127471652068e-10	-0.313263851267028	0.98	0.998	2.62460169288134e-06	RPL35A	NK cells	GSE111014_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36732
2.85669891163463e-10	-0.314386225773786	0.746	0.974	4.83324888859464e-06	RPL7A	NK cells	GSE111014_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36733
3.54942519816093e-10	-0.276875586991587	0.992	1	6.00527249276847e-06	RPS27A	NK cells	GSE111014_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36734
4.40551843659525e-10	-0.30727500712768	0.983	0.998	7.4536966428755e-06	RPS25	NK cells	GSE111014_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36735
6.7209941825761e-10	-0.296403591484254	0.952	0.993	1.13712500575005e-05	RPS24	NK cells	GSE111014_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36736
7.55993648844974e-10	-0.275023849374215	0.961	0.998	1.27906565448081e-05	FAU	NK cells	GSE111014_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36737
1.05381435238645e-09	-0.480028030660735	0.183	0.321	1.78294850280264e-05	MT-ND4L	NK cells	GSE111014_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36738
1.23443330997157e-09	0.275639295229048	0.425	0.226	2.08853771714089e-05	TRBC2	NK cells	GSE111014_post	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36739
1.36442300384038e-09	-0.332368196906883	0.986	0.999	2.30846728019754e-05	RPL39	NK cells	GSE111014_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36740
1.41081240372651e-09	-0.479075718852126	0.31	0.435	2.38695350586488e-05	NBEAL1	NK cells	GSE111014_post	ENSG00000144426	65065	neurobeachin like 1	ALS2CR16|ALS2CR17|MGC164581	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36741
4.31738327839138e-09	-0.4394086619514	0.155	0.291	7.30458076871038e-05	AC092580.4	NK cells	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36742
2.08626170134624e-08	0.273299012383724	0.611	0.436	0.000352974617250771	SRP14	NK cells	GSE111014_post	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36743
4.27844614046217e-08	0.25248609329984	0.944	0.977	0.000723870302504794	FTH1	NK cells	GSE111014_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36744
4.58807603627057e-08	-0.260670204691339	0.935	0.996	0.000776256584576617	RPS16	NK cells	GSE111014_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36745
1.38590615636667e-07	-0.314008039904728	0.851	0.979	0.00234481462595677	TPT1	NK cells	GSE111014_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36746
4.33698263822879e-07	-0.258004956141198	0.707	0.937	0.0073377409256193	RPL24	NK cells	GSE111014_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36747
7.7218705415904e-07	-0.311897854640575	0.203	0.342	0.0130646327693168	CD3D	NK cells	GSE111014_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36748
7.8956930416074e-07	-0.379857780227641	0.22	0.332	0.0133587230570956	FLNA	NK cells	GSE111014_post	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36749
3.83345864342611e-102	-0.868755466721748	0	0.565	6.48582867881263e-98	RPS4Y1	Mono/Macro	GSE111014_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36750
3.32728280739517e-78	-2.36547327499379	0.012	0.696	5.62942978183189e-74	RP11-1143G9.4	Mono/Macro	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36751
1.46429576239829e-13	-1.36201450147877	0.498	1	2.47744200040167e-09	RPS26	Mono/Macro	GSE111014_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36752
5.16452364917815e-11	1.34394759577921	0.996	0.739	8.73785756204451e-07	RPL39	Mono/Macro	GSE111014_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36753
3.90399562728398e-10	-0.344334507935642	0.026	0.261	6.60517020180176e-06	GABPB1-AS1	Mono/Macro	GSE111014_post	ENSG00000244879	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36754
3.25186529035675e-09	-1.47253301822123	0.606	0.957	5.50183088475459e-05	MT-ND1	Mono/Macro	GSE111014_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36755
5.83545122446251e-09	-0.913476349202015	0.919	1	9.87299992666811e-05	RPS12	Mono/Macro	GSE111014_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36756
1.24098139191035e-08	1.19555319634867	0.946	0.565	0.000209961641697313	S100A11	Mono/Macro	GSE111014_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36757
3.49765331029553e-08	1.13116967169295	0.872	0.261	0.000591767963568901	H3F3A	Mono/Macro	GSE111014_post	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36758
3.92595259605686e-08	1.03721035230424	1	0.652	0.00066423191972686	RPL41	Mono/Macro	GSE111014_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36759
2.20020068249227e-07	-0.470342392847748	0.082	0.391	0.00372251953470867	FOSB	Mono/Macro	GSE111014_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36760
3.0160042373995e-07	1.2836967146774	0.843	0.391	0.00510277756925621	IFITM3	Mono/Macro	GSE111014_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36761
3.22033835289729e-07	-0.716420344435885	0.951	1	0.00544849045926693	RPS15A	Mono/Macro	GSE111014_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36762
5.02168857024329e-07	-1.18709476612444	0.763	1	0.00849619489199462	MT-ND2	Mono/Macro	GSE111014_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36763
5.05246644842066e-07	-0.64964298125352	0.831	1	0.00854826798408292	RPL38	Mono/Macro	GSE111014_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36764
9.84568692979291e-07	-0.712726289371662	0.843	1	0.0166579177165166	RPL30	Mono/Macro	GSE111014_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36765
1.18498350971115e-06	1.26940564198979	0.808	0.391	0.020048736000803	MT2A	Mono/Macro	GSE111014_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36766
1.41254923451645e-06	1.04480316445327	0.802	0.261	0.0238989204987839	NCF1	Mono/Macro	GSE111014_post	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36767
1.64076327249108e-06	0.788192484350267	0.996	0.957	0.0277600738072767	SH3BGRL3	Mono/Macro	GSE111014_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	post	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36768
0	0.730860569938609	0.791	0.476	0	RPL22	Malignant cells	GSE111014_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36769
0	0.773209942954233	0.803	0.481	0	SH3BGRL3	Malignant cells	GSE111014_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36770
0	0.685815561468087	0.995	0.945	0	CD52	Malignant cells	GSE111014_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36771
0	-1.31326387966368	0.442	0.855	0	JUN	Malignant cells	GSE111014_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36772
0	-0.564098754634052	0.054	0.37	0	RP11-386I14.4	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36773
0	-0.823961148488406	0.028	0.48	0	CH17-373J23.1	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36774
0	1.36114617232774	0.919	0.534	0	S100A6	Malignant cells	GSE111014_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36775
0	1.7158913105675	0.885	0.39	0	S100A4	Malignant cells	GSE111014_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36776
0	0.659425917557051	1	0.999	0	RPS27	Malignant cells	GSE111014_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36777
0	-0.39500679028781	0.029	0.293	0	FMOD	Malignant cells	GSE111014_pre	ENSG00000122176	2331	fibromodulin	SLRR2E	protein_coding	Q06828	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36778
0	1.34376295076707	0.786	0.07	0	H3F3A	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36779
0	-0.4574088253069	0.083	0.378	0	ZFP36L2	Malignant cells	GSE111014_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36780
0	-0.754559207840998	0.305	0.649	0	DBI	Malignant cells	GSE111014_pre	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36781
0	-0.920209089084657	0.091	0.601	0	CXCR4	Malignant cells	GSE111014_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36782
0	0.547668493751185	0.999	0.993	0	RPL15	Malignant cells	GSE111014_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36783
0	-0.346625164598933	0.015	0.255	0	ARRDC3	Malignant cells	GSE111014_pre	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36784
0	-0.517378393399549	0.067	0.407	0	MZB1	Malignant cells	GSE111014_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36785
0	0.532363623994739	1	0.998	0	RPS14	Malignant cells	GSE111014_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36786
0	-0.670643372549245	0.123	0.458	0	DUSP1	Malignant cells	GSE111014_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36787
0	-0.532836197039839	0.979	0.997	0	HLA-B	Malignant cells	GSE111014_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36788
0	0.439428711054293	1	0.998	0	RPS18	Malignant cells	GSE111014_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36789
0	0.600557257641501	0.877	0.687	0	RPS10	Malignant cells	GSE111014_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36790
0	2.47786168760402	1	0.582	0	EEF1A1	Malignant cells	GSE111014_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36791
0	0.682687928466573	0.466	0.021	0	AC090498.1	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36792
0	0.953737891327836	1	0.998	0	TMSB4X	Malignant cells	GSE111014_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36793
0	0.672596239214366	1	0.993	0	RPS4X	Malignant cells	GSE111014_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36794
0	1.17703506899259	0.877	0.407	0	RPL36A	Malignant cells	GSE111014_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36795
0	2.8482410979451	0.999	0.287	0	RPL39	Malignant cells	GSE111014_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36796
0	0.378052172219049	1	0.999	0	RPL10	Malignant cells	GSE111014_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36797
0	0.44540162748222	0.996	0.979	0	RPL7	Malignant cells	GSE111014_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36798
0	-0.947000963996224	0.123	0.62	0	MS4A1	Malignant cells	GSE111014_pre	ENSG00000156738	931	membrane spanning 4-domains A1	B1|Bp35|CD20|FMC7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36799
0	-0.801843874912191	1	1	0	MALAT1	Malignant cells	GSE111014_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36800
0	0.484063613615124	0.983	0.93	0	RPS25	Malignant cells	GSE111014_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36801
0	0.581990330319685	0.451	0.11	0	ITGB1	Malignant cells	GSE111014_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36802
0	1.07068974812937	0.826	0.441	0	CD27	Malignant cells	GSE111014_pre	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36803
0	0.842908033889366	0.807	0.518	0	GAPDH	Malignant cells	GSE111014_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36804
0	0.755251111196475	0.83	0.537	0	ARHGDIB	Malignant cells	GSE111014_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36805
0	0.751933862770215	0.966	0.825	0	PFDN5	Malignant cells	GSE111014_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36806
0	0.573567998878463	0.543	0.21	0	CD63	Malignant cells	GSE111014_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36807
0	3.31132082470612	1	0.659	0	RPL41	Malignant cells	GSE111014_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36808
0	0.795854331726432	0.923	0.727	0	MYL6	Malignant cells	GSE111014_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36809
0	0.688915408529405	0.942	0.781	0	BTG1	Malignant cells	GSE111014_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36810
0	0.508508511677074	0.994	0.97	0	RPL6	Malignant cells	GSE111014_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36811
0	0.79233366578889	0.97	0.858	0	RPLP0	Malignant cells	GSE111014_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36812
0	0.511120883899946	1	0.996	0	RPL21	Malignant cells	GSE111014_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36813
0	0.591348637675991	1	0.982	0	RPS29	Malignant cells	GSE111014_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36814
0	-0.793471927668911	0	0.266	0	IGHE	Malignant cells	GSE111014_pre	ENSG00000276192	NA	NA	NA	IG_C_gene	P01854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36815
0	1.1195811230417	0.756	0.16	0	IGHG1	Malignant cells	GSE111014_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36816
0	-1.01834713304909	0	0.604	0	IGHD	Malignant cells	GSE111014_pre	ENSG00000278801	NA	NA	FLJ00382|FLJ46727|MGC29633	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36817
0	-3.18569997245935	0	0.947	0	IGHM	Malignant cells	GSE111014_pre	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36818
0	0.751112297981805	0.986	0.913	0	SERF2	Malignant cells	GSE111014_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36819
0	-0.684234063806345	0.209	0.606	0	GABPB1-AS1	Malignant cells	GSE111014_pre	ENSG00000244879	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36820
0	-0.631102015026717	0.15	0.55	0	LINC00926	Malignant cells	GSE111014_pre	ENSG00000247982	283663	long intergenic non-protein coding RNA 926	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36821
0	0.645744748069938	1	0.998	0	RPLP1	Malignant cells	GSE111014_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36822
0	0.602149294552334	0.924	0.764	0	CYBA	Malignant cells	GSE111014_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36823
0	-0.538804307923665	0.122	0.507	0	VAMP2	Malignant cells	GSE111014_pre	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36824
0	-0.439713925213374	0.022	0.296	0	TMEM107	Malignant cells	GSE111014_pre	ENSG00000179029	84314	transmembrane protein 107	JBTS29|MGC10744|MKS13	protein_coding	Q6UX40	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36825
0	0.700462516468083	1	0.994	0	RPS15	Malignant cells	GSE111014_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36826
0	0.63029336658454	0.994	0.955	0	RPL36	Malignant cells	GSE111014_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36827
0	0.687286966507641	0.996	0.96	0	RPS28	Malignant cells	GSE111014_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36828
0	-0.660030123739153	0.1	0.468	0	IER2	Malignant cells	GSE111014_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36829
0	0.773865781815385	0.668	0.26	0	EMP3	Malignant cells	GSE111014_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36830
0	-0.671857846513855	0	0.375	0	RPS4Y1	Malignant cells	GSE111014_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36831
0	-3.01572512301985	0.16	0.583	0	IGLC3	Malignant cells	GSE111014_pre	ENSG00000211679	NA	NA	IGLC	IG_C_gene	P0DOY3	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36832
0	-2.04670871661498	0.002	0.33	0	IGLC6	Malignant cells	GSE111014_pre	ENSG00000222037	NA	NA	IGLC	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36833
0	-1.46257187653803	0.007	0.322	0	IGLC7	Malignant cells	GSE111014_pre	ENSG00000211685	NA	NA	NA	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36834
0	1.03180855803031	0.681	0.262	0	LGALS1	Malignant cells	GSE111014_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36835
0	-0.712816488048268	0.997	0.999	0	MT-CO1	Malignant cells	GSE111014_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36836
0	-0.559758698466928	0.973	0.997	0	MT-ND4	Malignant cells	GSE111014_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36837
4.66588632649079e-308	-0.559313370873199	0.258	0.58	7.89421307578978e-304	YBX3	Malignant cells	GSE111014_pre	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36838
3.05133715402033e-307	0.348085936186583	1	1	5.16255733088699e-303	CD74	Malignant cells	GSE111014_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36839
1.04772529855195e-296	0.557042697999841	0.648	0.355	1.77264643262004e-292	PRR13	Malignant cells	GSE111014_pre	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36840
1.83359798531799e-296	-0.585999659017866	0.889	0.967	3.10226443135951e-292	MT-ATP6	Malignant cells	GSE111014_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36841
2.54564127139829e-296	0.561361950162312	0.742	0.483	4.30697046707877e-292	ATP5L	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36842
7.60967911962699e-288	0.541760910494282	0.621	0.327	1.28748161024969e-283	COX6A1	Malignant cells	GSE111014_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36843
2.33067298924112e-287	-0.481901837545188	0.232	0.549	3.94326563049705e-283	RCSD1	Malignant cells	GSE111014_pre	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36844
7.37982662059954e-277	-0.423732887644296	0.089	0.36	1.24859286593924e-272	RP5-1171I10.5	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36845
1.64534074906233e-276	-0.489442952668947	0.196	0.502	2.78375201333855e-272	IL4R	Malignant cells	GSE111014_pre	ENSG00000077238	3566	interleukin 4 receptor	CD124	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36846
6.85980118503317e-274	0.499891861944005	0.557	0.242	1.16060976249576e-269	TYROBP	Malignant cells	GSE111014_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36847
8.42644440767025e-274	0.567320269707246	0.745	0.506	1.42567012933373e-269	SLC25A6	Malignant cells	GSE111014_pre	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36848
8.24629512491808e-272	-0.554755614541186	0.884	0.965	1.39519067218489e-267	MT-ND2	Malignant cells	GSE111014_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36849
3.18472827168643e-268	-0.594711546359342	0.681	0.856	5.38824176286627e-264	LAPTM5	Malignant cells	GSE111014_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36850
6.09703635736172e-262	0.426691407239288	0.986	0.961	1.03155758130203e-257	RPL18	Malignant cells	GSE111014_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36851
1.0661911855579e-254	-0.465155870327469	0.303	0.606	1.8038888668454e-250	FUS	Malignant cells	GSE111014_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36852
7.69363220375246e-248	-0.340850164237066	0.037	0.253	1.30168563255288e-243	GADD45B	Malignant cells	GSE111014_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36853
1.46261893056541e-243	-0.398404655851214	0.12	0.386	2.47460496862362e-239	SYNE2	Malignant cells	GSE111014_pre	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36854
9.40130406539656e-243	-0.396696095875412	0.149	0.425	1.59060663482444e-238	ANKRD12	Malignant cells	GSE111014_pre	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36855
2.16051484286923e-241	-0.418681654047164	0.955	0.981	3.65537506265045e-237	RPL26	Malignant cells	GSE111014_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36856
7.25863743351034e-240	0.422932365213157	0.393	0.123	1.22808886737561e-235	HMGN2	Malignant cells	GSE111014_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36857
1.511982642843e-228	-0.425270356020674	0.182	0.456	2.55812343342608e-224	ADTRP	Malignant cells	GSE111014_pre	ENSG00000111863	84830	androgen dependent TFPI regulating protein	AIG1L|C6orf105|dJ413H6.1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36858
3.68996673874712e-227	-0.392225847612269	0.113	0.364	6.24305472528625e-223	FCRL5	Malignant cells	GSE111014_pre	ENSG00000143297	83416	Fc receptor like 5	BXMAS1|CD307e|FCRH5|IRTA2	protein_coding	Q96RD9	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36859
3.97088887231524e-227	-0.340840933125499	0.064	0.288	6.71834688307016e-223	RRBP1	Malignant cells	GSE111014_pre	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36860
7.23419312681568e-223	-0.449709983191315	0.287	0.565	1.22395313512594e-218	SRSF7	Malignant cells	GSE111014_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36861
2.6664144692173e-221	0.574423735967764	0.571	0.318	4.51130664046875e-217	TAGLN2	Malignant cells	GSE111014_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36862
1.55338128977126e-217	-0.32114538630011	0.063	0.28	2.62816580416399e-213	PIM1	Malignant cells	GSE111014_pre	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36863
1.55389932622853e-212	0.496050488806104	0.369	0.124	2.62904227004606e-208	S100A10	Malignant cells	GSE111014_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36864
1.82893616329036e-211	-0.442478031415333	0.248	0.517	3.09437709467095e-207	TSC22D3	Malignant cells	GSE111014_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36865
9.12037126948876e-210	-0.589847131762285	0.318	0.57	1.5430756150848e-205	JUNB	Malignant cells	GSE111014_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36866
4.1626296983137e-209	-0.34790450949249	0.137	0.386	7.04275318657695e-205	MSI2	Malignant cells	GSE111014_pre	ENSG00000153944	124540	musashi RNA binding protein 2	NA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36867
4.17262660176079e-209	-0.36865752124528	0.173	0.433	7.05966694751908e-205	PNN	Malignant cells	GSE111014_pre	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36868
9.55245009379413e-209	-0.389194211119763	0.123	0.365	1.61617903136903e-204	PCDH9	Malignant cells	GSE111014_pre	ENSG00000184226	5101	protocadherin 9	NA	protein_coding	Q9HC56	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36869
3.22941067743899e-205	0.365498080861467	0.995	0.972	5.46383992515904e-201	RPL31	Malignant cells	GSE111014_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36870
7.82452885388947e-203	-0.377967000328021	0.251	0.521	1.32383203678956e-198	SH3BP5	Malignant cells	GSE111014_pre	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36871
1.35002450840503e-201	0.383024662851518	0.381	0.136	2.28410646577048e-197	PYCARD	Malignant cells	GSE111014_pre	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36872
1.01520820194682e-200	-0.449236598164183	0.333	0.594	1.71763075687383e-196	FCER2	Malignant cells	GSE111014_pre	ENSG00000104921	2208	Fc epsilon receptor II	CD23|CD23A|CLEC4J|FCE2|FcepsilonRII|FCErII	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36873
1.10995398187336e-199	-0.372829685279469	0.196	0.452	1.87793114193154e-195	LUC7L3	Malignant cells	GSE111014_pre	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36874
2.58397274110437e-199	-0.362195268810318	0.157	0.405	4.37182348067448e-195	CCDC191	Malignant cells	GSE111014_pre	ENSG00000163617	57577	coiled-coil domain containing 191	KIAA1407	protein_coding	Q8NCU4	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36875
1.06553506104643e-193	-0.335227331423137	0.132	0.369	1.80277876978445e-189	ADAM28	Malignant cells	GSE111014_pre	ENSG00000042980	10863	ADAM metallopeptidase domain 28	ADAM23|eMDCII|MDC-Lm|MDC-Ls	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36876
1.16569829841432e-191	-0.493635941812206	0.873	0.946	1.97224495108719e-187	H3F3B	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36877
1.35727728101806e-191	-0.405838231023481	0.251	0.507	2.29637743175445e-187	ORAI2	Malignant cells	GSE111014_pre	ENSG00000160991	80228	ORAI calcium release-activated calcium modulator 2	C7orf19|CBCIP2|FLJ12474|FLJ14733|H_NH0514P08.8|TMEM142B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36878
1.34348787797197e-190	0.276652925176672	1	0.999	2.27304714074077e-186	RPL34	Malignant cells	GSE111014_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36879
4.92082803562502e-190	-0.312822824470189	0.118	0.346	8.32554895347398e-186	NCOR1	Malignant cells	GSE111014_pre	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36880
1.61851644268599e-189	0.405353714209784	0.98	0.935	2.73836796938043e-185	FTL	Malignant cells	GSE111014_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36881
7.54676830576946e-187	-0.299753523911141	0.076	0.28	1.27683772965313e-182	TMEM154	Malignant cells	GSE111014_pre	ENSG00000170006	201799	transmembrane protein 154	FLJ32028	protein_coding	Q6P9G4	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36882
1.8913771251849e-184	-0.315685744248524	0.113	0.335	3.20002095810034e-180	PTPN2	Malignant cells	GSE111014_pre	ENSG00000175354	5771	protein tyrosine phosphatase non-receptor type 2	PTPT|TC-PTP|TCELLPTP|TCPTP	protein_coding	P17706	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36883
8.12672500972684e-184	-0.337046130792901	0.107	0.325	1.37496060439568e-179	HIST1H1C	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36884
7.49633015810369e-181	0.342398479520668	0.258	0.06	1.26830409944956e-176	TCTN1	Malignant cells	GSE111014_pre	ENSG00000204852	79600	tectonic family member 1	FLJ21127|JBTS13|TECT1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36885
1.07072797075745e-180	-0.381114655217056	0.393	0.648	1.81156465372453e-176	PNISR	Malignant cells	GSE111014_pre	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36886
2.53490086190816e-179	0.404359823950325	0.444	0.199	4.28879876826241e-175	SELL	Malignant cells	GSE111014_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36887
4.01336236887254e-179	0.431206229723925	0.74	0.558	6.79020779189545e-175	TMA7	Malignant cells	GSE111014_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36888
5.11195992013813e-178	-0.431620526095998	0.778	0.901	8.6489249888817e-174	MT-ND1	Malignant cells	GSE111014_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36889
1.49536964198405e-177	-0.335756417770544	0.227	0.477	2.53001589727281e-173	UBE2D2	Malignant cells	GSE111014_pre	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36890
7.18783598801498e-169	-0.363839920472314	0.807	0.934	1.21610997081225e-164	RPS11	Malignant cells	GSE111014_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36891
2.35553511523113e-168	-0.341347674829685	0.177	0.404	3.98532986145954e-164	GLO1	Malignant cells	GSE111014_pre	ENSG00000124767	2739	glyoxalase I	GLOD1	protein_coding	Q04760	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36892
8.70208314456042e-167	-0.39121435561706	0.261	0.5	1.47230544722818e-162	CCR7	Malignant cells	GSE111014_pre	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36893
1.75001186154838e-163	0.376524075764122	0.957	0.899	2.9608450685537e-159	FTH1	Malignant cells	GSE111014_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36894
1.37909056114197e-161	0.358157837951377	0.515	0.265	2.33328332039609e-157	HLA-DRB5	Malignant cells	GSE111014_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36895
1.19459509498272e-158	0.27548393603827	0.999	0.998	2.02113544120126e-154	RPL18A	Malignant cells	GSE111014_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36896
1.80592548230498e-157	-0.281041877403818	0.088	0.278	3.05544532351179e-153	TLE4	Malignant cells	GSE111014_pre	ENSG00000106829	7091	TLE family member 4, transcriptional corepressor	E(spl)|ESG|GRG4	protein_coding	Q04727	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36897
1.11718826698452e-155	-0.271647953887964	0.1	0.295	1.8901708289111e-151	LYN	Malignant cells	GSE111014_pre	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36898
3.10519479921296e-155	-0.398965121434152	0.599	0.798	5.25367908078841e-151	MT-ND5	Malignant cells	GSE111014_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36899
1.81161696687731e-154	0.357345085309387	0.445	0.224	3.06507474625972e-150	BLOC1S1	Malignant cells	GSE111014_pre	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36900
1.11889622766861e-152	-0.344824888209574	0.298	0.529	1.89306052759252e-148	CCNI	Malignant cells	GSE111014_pre	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36901
1.52328206871397e-151	-0.357768420864338	0.329	0.563	2.57724093205717e-147	FOXP1	Malignant cells	GSE111014_pre	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36902
8.89262368990305e-151	0.339112505836803	0.341	0.136	1.5045430020947e-146	AL928768.3	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36903
5.53482140049013e-150	-0.288660575548459	0.142	0.349	9.36436432748924e-146	CXXC5	Malignant cells	GSE111014_pre	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36904
1.92878200986808e-149	-0.306468408966989	0.12	0.317	3.2633062824958e-145	CALR	Malignant cells	GSE111014_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36905
1.97683691920234e-148	-0.376386032756501	0.619	0.802	3.34461038359844e-144	CD79B	Malignant cells	GSE111014_pre	ENSG00000007312	974	CD79b molecule	B29|Ig-beta|IGB|Igbeta	protein_coding	P40259	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36906
2.36168201838196e-148	0.40340505642794	0.743	0.596	3.99572980690043e-144	ATP5G2	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36907
5.81181319742687e-147	-0.336026226065331	0.353	0.584	9.83300674872652e-143	RBM39	Malignant cells	GSE111014_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36908
2.91423677415473e-146	0.451568933488809	0.618	0.442	4.93059719819239e-142	UQCRH	Malignant cells	GSE111014_pre	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36909
1.15094261576858e-144	0.308375302986683	0.325	0.125	1.94727981161886e-140	XIST	Malignant cells	GSE111014_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36910
1.97891878925096e-144	-0.317711545712806	0.223	0.443	3.34813269953369e-140	CLNK	Malignant cells	GSE111014_pre	ENSG00000109684	116449	cytokine dependent hematopoietic cell linker	MIST	protein_coding	Q7Z7G1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36911
2.44330636519228e-144	-0.414598936017364	0.688	0.846	4.13383003926881e-140	TCL1A	Malignant cells	GSE111014_pre	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36912
4.89952728253896e-143	0.289427224395447	0.295	0.104	8.28951020932767e-139	NBEAL1	Malignant cells	GSE111014_pre	ENSG00000144426	65065	neurobeachin like 1	ALS2CR16|ALS2CR17|MGC164581	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36913
1.23569248257913e-142	-0.316798494348732	0.243	0.465	2.09066811127563e-138	STX7	Malignant cells	GSE111014_pre	ENSG00000079950	8417	syntaxin 7	NA	protein_coding	O15400	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36914
1.0303944941244e-139	0.350695434961661	0.882	0.781	1.74332444460907e-135	ATP5E	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36915
3.06264809154535e-139	-0.328724009997471	0.255	0.472	5.18169430608558e-135	TRA2B	Malignant cells	GSE111014_pre	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36916
6.17524643790539e-139	0.30347752225733	0.988	0.963	1.04478994482921e-134	RPS13	Malignant cells	GSE111014_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36917
7.25820273982667e-139	-0.295382457789976	0.155	0.354	1.22801532155127e-134	BTG2	Malignant cells	GSE111014_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36918
6.33680582656807e-138	0.286042315503042	1	0.999	1.07212417779705e-133	RPS2	Malignant cells	GSE111014_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36919
8.6859572679463e-138	-0.26574057704025	0.112	0.296	1.46957711016383e-133	GABPB1	Malignant cells	GSE111014_pre	ENSG00000104064	2553	GA binding protein transcription factor subunit beta 1	E4TF1-47|GABPB|GABPB2	protein_coding	Q06547	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36920
1.54237405670469e-136	-0.310816108687611	0.255	0.472	2.60954266653866e-132	DDX17	Malignant cells	GSE111014_pre	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36921
8.59979542828075e-135	-0.257527090347349	0.11	0.293	1.45499938851082e-130	TNFRSF13C	Malignant cells	GSE111014_pre	ENSG00000159958	115650	TNF receptor superfamily member 13C	BAFFR|CD268	protein_coding	Q96RJ3	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36922
1.70427971366702e-134	-0.336884038111758	0.429	0.647	2.88347084755323e-130	FCMR	Malignant cells	GSE111014_pre	ENSG00000162894	9214	Fc mu receptor	FAIM3|FcmuR|TOSO	protein_coding	O60667	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36923
3.98796384461716e-132	-0.29684502496136	0.97	0.987	6.74723602870777e-128	RPL30	Malignant cells	GSE111014_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36924
4.12473628032099e-132	0.288997632818242	0.989	0.97	6.97864131267508e-128	RPL8	Malignant cells	GSE111014_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36925
8.65567498839901e-132	0.280917767709162	0.992	0.979	1.46445365128723e-127	RPL35	Malignant cells	GSE111014_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36926
3.61183608723775e-129	-0.251324222483417	0.125	0.309	6.11086547599754e-125	EBLN3	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36927
5.05548597815147e-127	-0.406634213102662	0.442	0.634	8.55337672643447e-123	TXNIP	Malignant cells	GSE111014_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36928
1.65818023523366e-126	0.373315897381066	0.777	0.668	2.80547513999183e-122	ARPC3	Malignant cells	GSE111014_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36929
2.01970784199207e-125	-0.251673351424152	0.134	0.318	3.41714369786639e-121	SNRNP70	Malignant cells	GSE111014_pre	ENSG00000104852	6625	small nuclear ribonucleoprotein U1 subunit 70	RNPU1Z|RPU1|Snp1|SNRP70|U1-70K	protein_coding	P08621	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36930
2.18935412720558e-124	-0.310384139005164	0.19	0.388	3.70416824781912e-120	VPREB3	Malignant cells	GSE111014_pre	ENSG00000128218	29802	V-set pre-B cell surrogate light chain 3	8HS20	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36931
6.0246443791947e-124	0.303948633802442	0.412	0.215	1.01930958251595e-119	NDUFA13	Malignant cells	GSE111014_pre	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36932
5.2038281587732e-122	0.387375162445883	0.557	0.377	8.80435686182837e-118	DYNLL1	Malignant cells	GSE111014_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36933
7.04039558572229e-122	-0.258005681457666	0.148	0.333	1.19116452914835e-117	SMAP2	Malignant cells	GSE111014_pre	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36934
2.59493507924213e-119	-0.278256304920478	0.243	0.443	4.39037066056977e-115	EIF4G2	Malignant cells	GSE111014_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36935
5.03611930911991e-119	-0.277387638815208	0.142	0.321	8.52061025909997e-115	HIST1H1E	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36936
1.22711978962384e-118	-0.265906008377276	0.19	0.382	2.07616397206457e-114	SMCHD1	Malignant cells	GSE111014_pre	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36937
1.45875277633796e-118	0.328931556602322	0.469	0.279	2.46806382228619e-114	RPL17	Malignant cells	GSE111014_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36938
8.22517539609426e-118	-0.298528095359646	0.325	0.532	1.39161742526519e-113	PNRC1	Malignant cells	GSE111014_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36939
1.79126400202697e-117	-0.419378920374651	0.505	0.699	3.03063956502944e-113	LTB	Malignant cells	GSE111014_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36940
6.87909551344966e-117	0.303452070611762	0.92	0.856	1.16387416992055e-112	OAZ1	Malignant cells	GSE111014_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36941
1.06173499472812e-116	-0.331094120390862	0.852	0.926	1.79634943758051e-112	DDX5	Malignant cells	GSE111014_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36942
4.85989598351964e-116	-0.314716959462177	0.267	0.465	8.22245801451688e-112	CCDC88A	Malignant cells	GSE111014_pre	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36943
9.18288799744715e-116	-0.289081312400762	0.308	0.513	1.55365282028808e-111	N4BP2L2	Malignant cells	GSE111014_pre	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36944
1.43720999230256e-115	0.33428029120026	0.828	0.725	2.4316155859767e-111	CFL1	Malignant cells	GSE111014_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36945
4.57647962966585e-115	-0.27771663481263	0.271	0.472	7.74294588543165e-111	SF1	Malignant cells	GSE111014_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36946
2.93612598607883e-113	-0.252018542475475	0.17	0.353	4.96763155584678e-109	TMEM243	Malignant cells	GSE111014_pre	ENSG00000135185	79161	transmembrane protein 243	C7orf23|MGC4175|MM-TRAG	protein_coding	Q9BU79	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36947
5.98625953458113e-112	0.37590975750684	0.536	0.361	1.01281525065578e-107	GSTP1	Malignant cells	GSE111014_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36948
7.11948912392011e-112	0.400753606531974	1	0.685	1.20454636487604e-107	IGKC	Malignant cells	GSE111014_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36949
2.81463667858832e-110	-0.303149949563836	0.543	0.726	4.76208379650357e-106	CIRBP	Malignant cells	GSE111014_pre	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36950
4.71959842307688e-106	-0.26528129689868	0.261	0.451	7.98508857200377e-102	GRB2	Malignant cells	GSE111014_pre	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36951
5.46988422244743e-106	-0.316627156662258	0.993	0.995	9.2544971159588e-102	MT-CO2	Malignant cells	GSE111014_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36952
3.31794111143808e-105	0.345378462383534	0.669	0.526	5.61362456644208e-101	RPL36AL	Malignant cells	GSE111014_pre	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36953
7.57948201691578e-105	0.296849468092504	0.933	0.879	1.28237256244198e-100	RPS21	Malignant cells	GSE111014_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36954
3.50834191367921e-103	0.300632186896325	0.479	0.299	5.93576368375386e-99	SMDT1	Malignant cells	GSE111014_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36955
6.11118492958207e-103	-0.264188888769397	0.167	0.337	1.03395137823599e-98	PPP1R15A	Malignant cells	GSE111014_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36956
1.07962920960721e-99	-0.253233825035978	0.331	0.524	1.82662465973444e-95	SMARCB1	Malignant cells	GSE111014_pre	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36957
3.53966973382887e-99	0.33051840915571	0.615	0.462	5.98876722266507e-95	CORO1A	Malignant cells	GSE111014_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36958
5.16963312356845e-99	-0.261709445428704	0.325	0.518	8.74650228176547e-95	ARGLU1	Malignant cells	GSE111014_pre	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36959
3.81268045621815e-94	0.32267617828308	0.429	0.265	6.45067406387549e-90	ANXA2	Malignant cells	GSE111014_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36960
9.00667182759527e-94	0.323294127138199	0.734	0.625	1.52383880651084e-89	PEBP1	Malignant cells	GSE111014_pre	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36961
3.04285240402954e-93	-0.300309453399444	0.843	0.9	5.14820198237757e-89	TPT1	Malignant cells	GSE111014_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36962
5.35448258472818e-93	-0.260155299363813	0.242	0.416	9.05924908510161e-89	EIF5A	Malignant cells	GSE111014_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36963
7.76327082636308e-93	-0.27360061677986	0.535	0.7	1.31346779111237e-88	HNRNPA2B1	Malignant cells	GSE111014_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36964
2.73828162005218e-91	-0.257043616036181	0.988	0.993	4.63289867296628e-87	RPS12	Malignant cells	GSE111014_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36965
7.03099403141906e-88	-0.268046916093474	0.537	0.699	1.18957388017579e-83	SRSF5	Malignant cells	GSE111014_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36966
4.28999183879658e-85	0.307542484979227	0.754	0.662	7.25823719205993e-81	LIMD2	Malignant cells	GSE111014_pre	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36967
1.70322330908243e-84	-0.260897139047619	0.442	0.617	2.88168351663656e-80	SEC62	Malignant cells	GSE111014_pre	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36968
2.68785665929057e-84	0.293808665057133	0.508	0.356	4.54758468185371e-80	TPI1	Malignant cells	GSE111014_pre	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36969
2.94518103266529e-83	0.304400236196672	0.556	0.402	4.9829517891664e-79	SAT1	Malignant cells	GSE111014_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36970
4.81972557424376e-83	0.306635641111268	0.506	0.349	8.15449369906301e-79	TUBA1B	Malignant cells	GSE111014_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36971
1.79042540827971e-81	-0.250017297187999	0.279	0.45	3.02922074826843e-77	CLEC2D	Malignant cells	GSE111014_pre	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36972
2.59171508406654e-81	0.305822971638397	0.746	0.647	4.38492275073218e-77	UCP2	Malignant cells	GSE111014_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36973
1.30367093954613e-79	0.292198985889867	0.611	0.487	2.20568086261809e-75	ATP6V0E1	Malignant cells	GSE111014_pre	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36974
1.79626320349037e-77	-0.257454164751934	0.227	0.379	3.03909771398535e-73	HIST1H4C	Malignant cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36975
6.52707214295662e-77	0.318184055614538	0.65	0.531	1.10431533586683e-72	HNRNPA1	Malignant cells	GSE111014_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36976
1.21839809921779e-76	-0.27893175467132	0.533	0.679	2.06140774406659e-72	NOSIP	Malignant cells	GSE111014_pre	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36977
2.3458201117932e-76	-0.288202967197627	0.714	0.828	3.96889304714291e-72	CD79A	Malignant cells	GSE111014_pre	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36978
4.26171550977814e-73	0.253049422894322	0.405	0.258	7.21039647099363e-69	APRT	Malignant cells	GSE111014_pre	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36979
2.43529134740349e-72	-0.25439765544679	0.636	0.766	4.12026943067196e-68	EEF1B2	Malignant cells	GSE111014_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36980
2.68363325492935e-68	0.267410053721056	0.571	0.448	4.54043910401497e-64	UQCR11	Malignant cells	GSE111014_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36981
8.88733169582684e-66	0.263534411431956	0.47	0.332	1.50364764961694e-61	LBH	Malignant cells	GSE111014_pre	ENSG00000213626	81606	LBH regulator of WNT signaling pathway	NA	protein_coding	Q53QV2	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36982
1.13106217452404e-64	0.262279599398087	0.587	0.464	1.91364409307723e-60	LSP1	Malignant cells	GSE111014_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36983
1.43943767131104e-64	0.270090685989293	0.611	0.497	2.43538459609114e-60	CALM2	Malignant cells	GSE111014_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36984
4.42718240081988e-63	0.26237161802145	0.573	0.453	7.49034990394715e-59	CLIC1	Malignant cells	GSE111014_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36985
2.285517814938e-62	0.25589170584482	0.598	0.484	3.8668675910936e-58	SNX3	Malignant cells	GSE111014_pre	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36986
3.90930724227772e-61	-0.433648597722485	0.589	0.621	6.61415692320967e-57	RPS26	Malignant cells	GSE111014_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36987
7.97267383825062e-61	0.250741588245459	0.267	0.147	1.34889668669362e-56	CRIP1	Malignant cells	GSE111014_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36988
2.18003643487821e-58	0.294170652994043	0.577	0.469	3.68840364417045e-54	ISG20	Malignant cells	GSE111014_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36989
4.95841576874696e-43	-0.288328561525018	0.965	0.961	8.38914363914298e-39	HLA-DRB1	Malignant cells	GSE111014_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36990
1.27722170230473e-138	2.51418481755121	1	0.485	2.16093139812937e-134	RPL39	CD8+ T cells	GSE111014_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36991
5.11030313831378e-133	2.63967060520969	1	0.691	8.64612187971309e-129	RPL41	CD8+ T cells	GSE111014_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36992
9.94433317018331e-125	1.97652676691836	0.996	0.577	1.68248172906331e-120	EEF1A1	CD8+ T cells	GSE111014_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36993
1.6157808611107e-88	-1.51118347138066	0.524	0.953	2.73373963891319e-84	RPS26	CD8+ T cells	GSE111014_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36994
1.27728594767524e-87	0.869456556354753	0.551	0.071	2.16104009487174e-83	H3F3A	CD8+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36995
4.7272473654607e-85	-0.782721644248924	1	1	7.99802981762296e-81	MALAT1	CD8+ T cells	GSE111014_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36996
4.22301816926074e-80	1.20183907106108	0.716	0.151	7.14492444057225e-76	IGKC	CD8+ T cells	GSE111014_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36997
2.56235653228206e-69	1.66605737037303	0.92	0.448	4.33525101696802e-65	GNLY	CD8+ T cells	GSE111014_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36998
6.90593969763261e-67	-1.11271895718116	0	0.68	1.16841593744246e-62	RPS4Y1	CD8+ T cells	GSE111014_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	36999
5.6713805555421e-63	0.441168844213203	0.302	0.018	9.59540876192168e-59	AC090498.1	CD8+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37000
1.12238474395122e-60	0.524191770610635	1	1	1.89896274829107e-56	B2M	CD8+ T cells	GSE111014_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37001
8.01819996691536e-55	-0.79270023558614	0.996	1	1.35659925240241e-50	MT-CO1	CD8+ T cells	GSE111014_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37002
1.0924474726618e-51	0.882196735892776	0.996	0.953	1.8483118789965e-47	S100A4	CD8+ T cells	GSE111014_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37003
1.29280515148555e-44	0.958299954287057	0.782	0.446	2.1872970357984e-40	RPL36A	CD8+ T cells	GSE111014_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37004
4.01553910015182e-44	0.460053878457511	1	1	6.79389060354686e-40	TMSB4X	CD8+ T cells	GSE111014_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37005
3.43619789038554e-40	0.705573706231301	0.987	0.935	5.81370321074329e-36	RPS28	CD8+ T cells	GSE111014_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37006
3.7832729626581e-39	0.486783818632071	1	0.999	6.40091952552124e-35	RPS27	CD8+ T cells	GSE111014_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37007
7.70934399789835e-39	-0.78448352623684	0.093	0.573	1.30434391100442e-34	ZFP36L2	CD8+ T cells	GSE111014_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37008
6.02298190928025e-35	-0.813797077217124	0.484	0.855	1.01902830923112e-30	MT-ND1	CD8+ T cells	GSE111014_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37009
1.83327352419365e-32	-0.479320461740092	1	1	3.10171547558323e-28	HLA-B	CD8+ T cells	GSE111014_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37010
1.87377074801035e-32	0.568020382591341	0.44	0.129	3.17023272855872e-28	ITGB1	CD8+ T cells	GSE111014_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37011
8.04540925627267e-32	0.599958489858915	0.476	0.151	1.36120279206877e-27	ZNF683	CD8+ T cells	GSE111014_pre	ENSG00000176083	257101	zinc finger protein 683	Hobit|MGC33414	protein_coding	Q8IZ20	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37012
9.83218998835391e-30	0.694447734066483	0.916	0.833	1.6635082241296e-25	S100A6	CD8+ T cells	GSE111014_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37013
1.68058008175578e-29	-0.730195203605416	0.053	0.464	2.8433734403226e-25	TRGC1	CD8+ T cells	GSE111014_pre	ENSG00000211689	445347	TCR gamma alternate reading frame protein	CD3G|TCRG|TCRGC1|TCRGC2|TCRGV|C1	TR_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37014
1.94359407230349e-29	0.446541572937159	0.387	0.106	3.28836681093027e-25	HMGN2	CD8+ T cells	GSE111014_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37015
2.31907768848652e-29	-0.501362611401604	1	0.997	3.92364754115035e-25	RPL28	CD8+ T cells	GSE111014_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37016
2.32286527720075e-29	0.438241635263916	1	0.998	3.93005576249594e-25	RPL21	CD8+ T cells	GSE111014_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37017
7.30018195242857e-29	0.939626775342563	0.738	0.438	1.23511778453139e-24	LGALS1	CD8+ T cells	GSE111014_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37018
2.76747397151172e-27	-0.943977853422454	0.351	0.716	4.68228921240068e-23	JUN	CD8+ T cells	GSE111014_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37019
4.00300407738182e-27	-0.722668576870151	0.68	0.922	6.77268259852231e-23	MT-ND2	CD8+ T cells	GSE111014_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37020
4.43478627454418e-27	-0.597733017426827	0.964	0.989	7.50321489790129e-23	MT-ND4	CD8+ T cells	GSE111014_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37021
1.37920932140743e-24	0.521359929036024	0.996	0.978	2.33348425088923e-20	CD52	CD8+ T cells	GSE111014_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37022
2.44828071396279e-24	-0.588922638650929	0.258	0.616	4.14224613995364e-20	FUS	CD8+ T cells	GSE111014_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37023
1.13361626125401e-23	0.460388535790634	0.987	0.973	1.91796535241566e-19	RPL7	CD8+ T cells	GSE111014_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37024
1.32162387534281e-23	0.448106571500918	1	0.996	2.23605543469249e-19	RPS29	CD8+ T cells	GSE111014_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37025
6.40467845713158e-23	-0.474695970006088	0.996	0.997	1.08360754816209e-18	RPS12	CD8+ T cells	GSE111014_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37026
2.80534389053734e-22	-0.597902889480821	0.364	0.695	4.74636132840012e-18	NEAT1	CD8+ T cells	GSE111014_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37027
2.21970966065034e-21	-0.473133697295579	0.067	0.394	3.75552677485431e-17	NKTR	CD8+ T cells	GSE111014_pre	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37028
2.67327706086176e-21	-0.606095785196586	0.333	0.652	4.52291745927201e-17	IER2	CD8+ T cells	GSE111014_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37029
5.43378757911763e-20	0.444899011170945	0.947	0.878	9.19342520510912e-16	SERF2	CD8+ T cells	GSE111014_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37030
8.65448763505124e-20	-0.411981348572551	0.96	0.991	1.46425276297432e-15	RPL30	CD8+ T cells	GSE111014_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37031
1.20064864321403e-19	-0.469945339897368	0.071	0.381	2.03137743945381e-15	RP5-1171I10.5	CD8+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37032
1.96539173098494e-18	-0.419659372647017	0.062	0.358	3.32524626965342e-14	AKNA	CD8+ T cells	GSE111014_pre	ENSG00000106948	80709	AT-hook transcription factor	KIAA1968	protein_coding	Q7Z591	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37033
6.94599384423401e-18	-0.50245092473793	0.2	0.509	1.17519269850595e-13	COTL1	CD8+ T cells	GSE111014_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37034
1.21194179773008e-17	-0.429243562124663	0.129	0.43	2.05048432757952e-13	SUN2	CD8+ T cells	GSE111014_pre	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37035
1.70458678575065e-17	-0.455136501924934	0.987	0.99	2.88399038281153e-13	MT-CO2	CD8+ T cells	GSE111014_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37036
2.16262474057404e-17	-0.45700628418987	0.333	0.632	3.65894479857721e-13	CDC42	CD8+ T cells	GSE111014_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37037
4.13780496161721e-17	0.443191815310997	0.991	0.977	7.00075221456016e-13	PFN1	CD8+ T cells	GSE111014_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37038
4.86288086796967e-17	-0.318279517417787	0.996	1	8.22750814051789e-13	RPS15A	CD8+ T cells	GSE111014_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37039
5.46803343788628e-17	0.581112099391056	0.764	0.643	9.25136577355979e-13	RPS10	CD8+ T cells	GSE111014_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37040
7.56496736289087e-17	0.382261637902888	1	0.994	1.27991682812751e-12	RPS4X	CD8+ T cells	GSE111014_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37041
1.93450806706462e-16	-0.442888651496815	0.369	0.654	3.27299419866664e-12	CD3G	CD8+ T cells	GSE111014_pre	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37042
3.79709843680936e-16	0.53449207741925	0.649	0.458	6.42431084523776e-12	RPL22	CD8+ T cells	GSE111014_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37043
1.64999798360597e-15	-0.401363296191393	0.324	0.607	2.79163158846294e-11	VAMP2	CD8+ T cells	GSE111014_pre	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37044
3.79651511536647e-15	-0.380025339092256	0.973	0.986	6.42332392368853e-11	CCL5	CD8+ T cells	GSE111014_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37045
3.86449162964172e-15	-0.409807816987746	0.129	0.394	6.53833338819083e-11	ZEB2	CD8+ T cells	GSE111014_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37046
4.11310750325583e-15	-0.387878240915804	0.107	0.38	6.95896658475854e-11	GADD45B	CD8+ T cells	GSE111014_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37047
8.64911159967678e-15	0.388357464528074	0.973	0.98	1.46334319154931e-10	RPL15	CD8+ T cells	GSE111014_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37048
2.44126365596943e-14	-0.402561489434549	0.858	0.968	4.13037397953468e-10	TPT1	CD8+ T cells	GSE111014_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37049
3.29523183187731e-14	-0.382903633286085	0.547	0.787	5.57520273635323e-10	ITGB2	CD8+ T cells	GSE111014_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37050
3.32318178475232e-14	-0.409252086937196	0.333	0.598	5.62249126162245e-10	SRSF7	CD8+ T cells	GSE111014_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37051
3.47186057608049e-14	-0.435095561622299	0.222	0.481	5.87404090867058e-10	IRF1	CD8+ T cells	GSE111014_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37052
6.10517376361177e-14	0.291988182740446	1	1	1.03293434906547e-09	RPL34	CD8+ T cells	GSE111014_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37053
6.41911057706375e-14	-0.506685321201554	0.133	0.39	1.08604931853342e-09	CMC1	CD8+ T cells	GSE111014_pre	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37054
6.82283436588834e-14	-0.456514829192179	0.538	0.792	1.15435534636465e-09	MT-ND5	CD8+ T cells	GSE111014_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37055
9.67717838468603e-14	-0.355957454327832	0.4	0.67	1.63728181090503e-09	GIMAP7	CD8+ T cells	GSE111014_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37056
1.45958093784409e-13	-0.291039255042872	0.991	0.997	2.46946498873842e-09	HLA-A	CD8+ T cells	GSE111014_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37057
1.82228690847974e-13	0.26048448679499	1	1	3.08312722045688e-09	RPS14	CD8+ T cells	GSE111014_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37058
2.3551852725135e-13	-0.365143302156495	0.12	0.368	3.98473796256558e-09	PRPF38B	CD8+ T cells	GSE111014_pre	ENSG00000134186	55119	pre-mRNA processing factor 38B	FLJ10330|NET1	protein_coding	Q5VTL8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37059
3.79002941373045e-13	0.430315804375354	0.756	0.647	6.41235076509055e-09	TMA7	CD8+ T cells	GSE111014_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37060
3.9302561655131e-13	-0.366528543575702	0.347	0.597	6.64960040643161e-09	GZMM	CD8+ T cells	GSE111014_pre	ENSG00000197540	3004	granzyme M	LMET1|MET1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37061
4.03928588856829e-13	-0.381072273574495	0.36	0.603	6.83406779486869e-09	MYO1F	CD8+ T cells	GSE111014_pre	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37062
5.23010785597542e-13	-0.364257724177127	0.32	0.577	8.8488194815248e-09	SARAF	CD8+ T cells	GSE111014_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37063
1.35251251843521e-12	-0.351241050123389	0.129	0.369	2.28831592994054e-08	MYO1G	CD8+ T cells	GSE111014_pre	ENSG00000136286	64005	myosin IG	HA-2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37064
2.29722318764597e-12	-0.369880880153264	0.244	0.485	3.88667191117822e-08	CCNI	CD8+ T cells	GSE111014_pre	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37065
2.89964704879317e-12	-0.435353750964324	0.48	0.694	4.90591284185317e-08	ID2	CD8+ T cells	GSE111014_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37066
2.91398787038085e-12	-0.34813073489842	0.169	0.411	4.93017607789736e-08	TAPBP	CD8+ T cells	GSE111014_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37067
3.05628891414562e-12	-0.358117036955656	0.151	0.384	5.17093521384297e-08	IFITM1	CD8+ T cells	GSE111014_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37068
1.3095793494035e-11	-0.326091099021006	0.12	0.348	2.21567730125579e-07	CFLAR	CD8+ T cells	GSE111014_pre	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37069
1.56436687966309e-11	-0.329474150211446	0.156	0.384	2.64675232370199e-07	DDX17	CD8+ T cells	GSE111014_pre	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37070
1.83291555251288e-11	-0.320569517331619	0.178	0.411	3.10110982329655e-07	ARHGAP30	CD8+ T cells	GSE111014_pre	ENSG00000186517	257106	Rho GTPase activating protein 30	FLJ00267	protein_coding	Q7Z6I6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37071
1.84016285763688e-11	-0.324857453335896	0.067	0.273	3.11337153883583e-07	ADGRG1	CD8+ T cells	GSE111014_pre	ENSG00000205336	9289	adhesion G protein-coupled receptor G1	GPR56|TM7LN4|TM7XN1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37072
1.910409068408e-11	-0.308583225031083	0.067	0.274	3.23222110283949e-07	GCC2	CD8+ T cells	GSE111014_pre	ENSG00000135968	9648	GRIP and coiled-coil domain containing 2	GCC185|KIAA0336	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37073
2.12167815826626e-11	-0.349043662710398	0.427	0.661	3.58966727597069e-07	EEF1B2	CD8+ T cells	GSE111014_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37074
2.28367063353877e-11	-0.317419219526517	0.173	0.407	3.86374234488425e-07	MBP	CD8+ T cells	GSE111014_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37075
2.37231174819108e-11	-0.276569603733374	0.053	0.257	4.0137142467645e-07	FMNL1	CD8+ T cells	GSE111014_pre	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37076
2.97299557775747e-11	-0.313997334189774	0.084	0.294	5.03001121800787e-07	GBP5	CD8+ T cells	GSE111014_pre	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37077
4.2719414178444e-11	-0.309808577308207	0.12	0.337	7.22769768485094e-07	ATRX	CD8+ T cells	GSE111014_pre	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37078
4.43734444441811e-11	-0.307619828551024	0.187	0.42	7.507543065511e-07	FAM65B	CD8+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37079
5.93207750314506e-11	-0.314973282166034	0.124	0.337	1.00364819275711e-06	FYN	CD8+ T cells	GSE111014_pre	ENSG00000010810	2534	FYN proto-oncogene, Src family tyrosine kinase	MGC45350|SLK|SYN	protein_coding	P06241	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37080
6.13039178084481e-11	-0.333920843458348	0.582	0.772	1.03720098540113e-06	CD3E	CD8+ T cells	GSE111014_pre	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37081
7.01749250041739e-11	-0.305552265933518	0.147	0.366	1.18728955614562e-06	BIN1	CD8+ T cells	GSE111014_pre	ENSG00000136717	274	bridging integrator 1	AMPH2|AMPHL|SH3P9	protein_coding	O00499	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37082
9.01352850850981e-11	0.324618682544644	0.96	0.956	1.52499888835477e-06	RPS25	CD8+ T cells	GSE111014_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37083
9.17942668533514e-11	-0.449588831436843	0.258	0.475	1.55306720089185e-06	SAT1	CD8+ T cells	GSE111014_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37084
1.12011015645098e-10	-0.297478143892602	0.076	0.275	1.89511437369942e-06	SYNE1	CD8+ T cells	GSE111014_pre	ENSG00000131018	23345	spectrin repeat containing nuclear envelope protein 1	8B|ARCA1|C6orf98|CPG2|dJ45H2.2|enaptin|KIAA0796|MYNE1|Nesp1|Nesprin-1|SCAR8|SYNE-1B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37085
1.17396945134473e-10	-0.281210714537468	0.102	0.314	1.98623891473015e-06	HMHA1	CD8+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37086
1.70633783294287e-10	-0.315400051889864	0.307	0.542	2.88695297955604e-06	PPP2R5C	CD8+ T cells	GSE111014_pre	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37087
2.29820900179838e-10	-0.306670489764896	0.16	0.373	3.88833981014268e-06	PRRC2C	CD8+ T cells	GSE111014_pre	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37088
2.40252560682468e-10	0.300593247261535	0.329	0.163	4.06483307418667e-06	EIF5A	CD8+ T cells	GSE111014_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37089
2.54237207979562e-10	-0.359513356958472	0.422	0.632	4.3014393218062e-06	KLRG1	CD8+ T cells	GSE111014_pre	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37090
3.08377364378398e-10	-0.292284475133107	0.489	0.726	5.21743662791812e-06	RARRES3	CD8+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37091
3.28991819147788e-10	-0.420015642805132	0.213	0.421	5.56621258816143e-06	CD8B	CD8+ T cells	GSE111014_pre	ENSG00000172116	926	CD8b molecule	CD8B1	protein_coding	P10966	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37092
3.83880331841132e-10	-0.321433967709099	0.342	0.563	6.49487133442011e-06	BIN2	CD8+ T cells	GSE111014_pre	ENSG00000110934	51411	bridging integrator 2	BRAP-1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37093
4.47029740193743e-10	-0.337362211356027	0.124	0.324	7.56329617433793e-06	HIST1H1E	CD8+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37094
4.9501392344066e-10	-0.308194183280828	0.213	0.43	8.37514057069253e-06	SYNE2	CD8+ T cells	GSE111014_pre	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37095
4.99448580015404e-10	0.323156534179711	0.871	0.834	8.45017052528062e-06	RPS21	CD8+ T cells	GSE111014_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37096
5.41308395355146e-10	-0.295834983076149	0.111	0.309	9.15839674101372e-06	ATM	CD8+ T cells	GSE111014_pre	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37097
5.43916734579053e-10	-0.327510923425301	0.293	0.503	9.202527232343e-06	PNISR	CD8+ T cells	GSE111014_pre	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37098
5.73416542168386e-10	0.369448673967187	0.973	0.956	9.70163447694692e-06	SH3BGRL3	CD8+ T cells	GSE111014_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37099
5.93822567114001e-10	-0.330122556186132	0.484	0.747	1.00468840130018e-05	BTG1	CD8+ T cells	GSE111014_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37100
6.17830529120829e-10	-0.317334437400856	0.222	0.444	1.04530747221953e-05	RNF213	CD8+ T cells	GSE111014_pre	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37101
1.01367719802412e-09	-0.307417917179476	0.289	0.5	1.71504045133702e-05	N4BP2L2	CD8+ T cells	GSE111014_pre	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37102
1.03255018658577e-09	-0.275841708767913	0.222	0.444	1.74697166068446e-05	ACAP1	CD8+ T cells	GSE111014_pre	ENSG00000288169	9744	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	CENTB1|KIAA0050	protein_coding	Q15027	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37103
1.10268581763871e-09	-0.312351029886601	0.244	0.457	1.86563413486293e-05	LRRFIP1	CD8+ T cells	GSE111014_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37104
1.17695772565819e-09	-0.297429876272167	0.884	0.98	1.99129477604109e-05	RPS17	CD8+ T cells	GSE111014_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37105
1.41002400763165e-09	-0.334807394349113	0.978	0.991	2.38561961851198e-05	MT-CO3	CD8+ T cells	GSE111014_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37106
1.80774311018878e-09	-0.289219323516005	0.52	0.724	3.0585205681284e-05	TOMM7	CD8+ T cells	GSE111014_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37107
1.81000450898504e-09	-0.279934940085676	0.284	0.499	3.06234662875179e-05	RBM39	CD8+ T cells	GSE111014_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37108
1.93175218384394e-09	-0.270947513182093	0.116	0.308	3.26833151984556e-05	SF1	CD8+ T cells	GSE111014_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37109
2.10080771658332e-09	0.317393882791591	0.991	0.966	3.55435657568731e-05	RPL35	CD8+ T cells	GSE111014_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37110
2.1130882974056e-09	-0.322012212492732	0.191	0.389	3.57513409038053e-05	RORA	CD8+ T cells	GSE111014_pre	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37111
2.34341167127635e-09	-0.257401095731085	0.138	0.342	3.96481820663245e-05	SRSF11	CD8+ T cells	GSE111014_pre	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37112
3.13729931675162e-09	-0.289133277230775	0.098	0.283	5.30799671401206e-05	PLAC8	CD8+ T cells	GSE111014_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37113
3.20531312886638e-09	-0.266337565198684	0.138	0.334	5.42306928272903e-05	SEPT9	CD8+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37114
6.20563295617177e-09	-0.259241077665017	0.084	0.261	0.00010499310398547	SLFN5	CD8+ T cells	GSE111014_pre	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37115
6.59464697326818e-09	-0.263999259025948	0.093	0.273	0.000111574832140724	AKAP9	CD8+ T cells	GSE111014_pre	ENSG00000127914	10142	A-kinase anchoring protein 9	AKAP350|AKAP450|CG-NAP|HYPERION|KIAA0803|LQT11|MU-RMS-40.16A|PPP1R45|PRKA9|YOTIAO	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37116
6.73206870031761e-09	-0.266950585758379	0.231	0.439	0.000113899870340674	ARPC4	CD8+ T cells	GSE111014_pre	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37117
7.10139320837048e-09	-0.266802618518832	0.524	0.728	0.00012014847169242	HNRNPA2B1	CD8+ T cells	GSE111014_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37118
7.73949643207771e-09	0.344643472047412	0.871	0.834	0.000130944540134323	CYBA	CD8+ T cells	GSE111014_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37119
8.96339264480563e-09	-0.3310315910749	0.236	0.429	0.000151651640157466	CALR	CD8+ T cells	GSE111014_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37120
9.93532256748042e-09	-0.258141144927241	0.107	0.286	0.000168095722519201	EIF4A1	CD8+ T cells	GSE111014_pre	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37121
1.00714118989815e-08	-0.25573099940814	0.102	0.281	0.000170398217918869	TGFB1	CD8+ T cells	GSE111014_pre	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37122
1.09697764837437e-08	-0.296226574977128	0.111	0.29	0.00018559764832846	CLIC3	CD8+ T cells	GSE111014_pre	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37123
1.16471641842468e-08	-0.2609708319069	0.08	0.251	0.000197058370833272	DDX3X	CD8+ T cells	GSE111014_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37124
1.36735078529769e-08	-0.267883620268927	0.249	0.451	0.000231342079364516	FYB	CD8+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37125
1.8193414014455e-08	-0.280385054100352	0.213	0.409	0.000307814371710563	CHST12	CD8+ T cells	GSE111014_pre	ENSG00000136213	55501	carbohydrate sulfotransferase 12	C4S-2|C4ST2	protein_coding	Q9NRB3	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37126
1.85497650202149e-08	-0.267899015393032	0.173	0.362	0.000313843474377016	EIF4G2	CD8+ T cells	GSE111014_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37127
1.8583931776814e-08	-0.266175333996509	0.138	0.321	0.000314421541731917	ARL4C	CD8+ T cells	GSE111014_pre	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37128
1.87705250274686e-08	-0.273025100168063	0.284	0.488	0.00031757851293974	SRSF3	CD8+ T cells	GSE111014_pre	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37129
2.11041649950903e-08	-0.341838513114009	0.956	0.963	0.000357061367551932	MT-CYB	CD8+ T cells	GSE111014_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37130
2.22145471275018e-08	-0.251789256629529	0.169	0.365	0.000375847922850203	CCNL1	CD8+ T cells	GSE111014_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37131
2.29323344946425e-08	-0.257494912583981	0.147	0.333	0.000387992167314856	PTP4A2	CD8+ T cells	GSE111014_pre	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37132
2.30113359873848e-08	-0.258685660895543	0.124	0.301	0.000389328793570563	AHNAK	CD8+ T cells	GSE111014_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37133
2.82593959883622e-08	-0.293300157233957	0.204	0.389	0.000478120720727099	PCSK7	CD8+ T cells	GSE111014_pre	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37134
2.90126971504104e-08	-0.253198572541707	0.116	0.288	0.000490865823087794	GNAS	CD8+ T cells	GSE111014_pre	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37135
3.46176657903552e-08	-0.272596555670366	0.364	0.563	0.000585696287507019	TRAF3IP3	CD8+ T cells	GSE111014_pre	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37136
3.64454744690587e-08	-0.259302025021834	0.231	0.421	0.000616620982542005	HMGB2	CD8+ T cells	GSE111014_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37137
3.91056453509464e-08	-0.259625043746607	0.991	0.986	0.000661628413692662	NKG7	CD8+ T cells	GSE111014_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37138
4.33474725947982e-08	-0.274650214438341	0.711	0.886	0.000733395888831391	RPL24	CD8+ T cells	GSE111014_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37139
4.36866538895179e-08	-0.252470812651002	0.093	0.26	0.000739134497156753	CEP78	CD8+ T cells	GSE111014_pre	ENSG00000148019	84131	centrosomal protein 78	C9orf81|FLJ12643	protein_coding	Q5JTW2	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37140
4.64971999382895e-08	-0.263585972986731	0.907	0.978	0.000786686125755921	RPS7	CD8+ T cells	GSE111014_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37141
7.01200464027148e-08	0.481525385853133	0.902	0.764	0.00118636106508753	CD74	CD8+ T cells	GSE111014_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37142
7.10771000210122e-08	-0.283857194834198	0.338	0.524	0.00120255345525551	MT2A	CD8+ T cells	GSE111014_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37143
8.60112066698141e-08	0.434184338073108	0.582	0.411	0.00145522360564658	HLA-DRA	CD8+ T cells	GSE111014_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37144
8.70211716723525e-08	-0.303034786724049	0.653	0.838	0.00147231120352453	TXNIP	CD8+ T cells	GSE111014_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37145
8.76161986729731e-08	-0.273187769829202	0.187	0.359	0.00148237846534803	IL10RA	CD8+ T cells	GSE111014_pre	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37146
1.42015351863894e-07	0.289022762837109	0.876	0.86	0.00240275773818521	MYL6	CD8+ T cells	GSE111014_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37147
1.59114704934042e-07	-0.266175333996509	0.249	0.429	0.00269206169277906	ARGLU1	CD8+ T cells	GSE111014_pre	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37148
1.7301286170403e-07	-0.265732014372553	0.876	0.957	0.00292720460717048	EIF1	CD8+ T cells	GSE111014_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37149
2.24172262003875e-07	0.355741912180921	0.813	0.73	0.00379277050084356	TRAC	CD8+ T cells	GSE111014_pre	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37150
2.36072773753581e-07	-0.26873679387373	0.369	0.537	0.00399411525913683	LYAR	CD8+ T cells	GSE111014_pre	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37151
3.53350574712108e-07	-0.261725249555893	0.338	0.526	0.00597833837355415	PLEK	CD8+ T cells	GSE111014_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37152
4.16730827749332e-07	-0.254827582358674	0.196	0.361	0.00705066887469095	TAP1	CD8+ T cells	GSE111014_pre	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37153
5.63435145566886e-07	-0.270088876615233	0.218	0.377	0.00953275922784615	FCRL6	CD8+ T cells	GSE111014_pre	ENSG00000181036	343413	Fc receptor like 6	FcRH6|FLJ16056|IFGP6	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37154
1.12474032029241e-06	0.282507436660808	0.796	0.731	0.0190294814790274	EMP3	CD8+ T cells	GSE111014_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37155
1.32743580468348e-06	-0.31790727245101	0.871	0.919	0.0224588863794398	MT-ATP6	CD8+ T cells	GSE111014_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37156
1.39078884781789e-06	0.253490115388734	0.964	0.965	0.0235307565162309	PTMA	CD8+ T cells	GSE111014_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37157
2.0273033323912e-06	-0.322682486774125	0.329	0.488	0.0342999450807267	JUNB	CD8+ T cells	GSE111014_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37158
6.57928035457805e-74	2.08849037290572	1	0.093	1.11314844319106e-69	H3F3A	Mono/Macro	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37159
2.75677321528963e-53	0.713741490840047	0.395	0.011	4.66418460294853e-49	XIST	Mono/Macro	GSE111014_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37160
2.05931090876906e-33	0.436901285481222	0.289	0.011	3.48414812654638e-29	AC090498.1	Mono/Macro	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37161
5.32532564454895e-30	2.48809756413816	1	0.458	9.00991845801238e-26	RPL41	Mono/Macro	GSE111014_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37162
3.06190403491034e-29	2.51767313233832	1	0.493	5.1804354366648e-25	RPL39	Mono/Macro	GSE111014_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37163
2.00708214931692e-28	2.33572760609078	1	0.427	3.3957822884293e-24	EEF1A1	Mono/Macro	GSE111014_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37164
3.47832301771364e-21	0.797934835507981	0.658	0.118	5.88497471366971e-17	HLA-DRB5	Mono/Macro	GSE111014_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37165
1.05052623510165e-17	1.00183232634378	0.474	0.075	1.77738533716848e-13	IGKC	Mono/Macro	GSE111014_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37166
1.30087409605795e-17	-2.53031347593393	0	0.808	2.20094888312045e-13	RP11-1143G9.4	Mono/Macro	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37167
1.4389219832006e-17	-1.34783088927199	0.763	0.981	2.4345121033771e-13	MT-ND1	Mono/Macro	GSE111014_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37168
1.53131696400585e-16	0.438525451841996	0.421	0.063	2.5908351714015e-12	TNNT1	Mono/Macro	GSE111014_pre	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37169
9.43338004035402e-16	0.548043750016354	0.5	0.094	1.5960335690275e-11	HMGN2	Mono/Macro	GSE111014_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37170
9.11078552191354e-15	1.04364802890523	0.895	0.426	1.54145380245255e-10	RPL36A	Mono/Macro	GSE111014_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37171
1.35767438650309e-13	-0.845082668761424	0.974	0.998	2.29704929452457e-09	RPS12	Mono/Macro	GSE111014_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37172
2.93972880930135e-13	-0.894601947541947	0.947	0.998	4.97372717245696e-09	HLA-B	Mono/Macro	GSE111014_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37173
2.99441775174786e-12	-0.954829062129108	0	0.625	5.0662553941822e-08	RPS4Y1	Mono/Macro	GSE111014_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37174
1.52199844513902e-11	0.42754505603055	0.368	0.07	2.57506916933071e-07	EGR1	Mono/Macro	GSE111014_pre	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37175
3.86903419190954e-11	-0.939730876644283	0.447	0.886	6.54601894929175e-07	RPS26	Mono/Macro	GSE111014_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37176
1.08166150137572e-10	-0.772577403163929	0.842	0.989	1.83006309417759e-06	RPL30	Mono/Macro	GSE111014_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37177
9.83883699548225e-10	0.443474958061104	0.447	0.117	1.66463283126564e-05	GABARAP	Mono/Macro	GSE111014_pre	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37178
1.14964238578743e-09	-0.805940278419495	0.947	0.983	1.94507995251375e-05	MT-ND2	Mono/Macro	GSE111014_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37179
3.41823032096745e-09	-0.630875184029108	0.947	0.986	5.78330388004483e-05	RPL12	Mono/Macro	GSE111014_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37180
3.5076717984034e-09	-0.736983033710735	0.711	0.962	5.93462991571871e-05	RPS20	Mono/Macro	GSE111014_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37181
3.78675694503014e-09	0.662315962983894	0.737	0.327	6.40681407529649e-05	HLA-DQB1	Mono/Macro	GSE111014_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37182
4.7133935344312e-09	0.318610684477386	0.342	0.074	7.97459052090414e-05	M6PR	Mono/Macro	GSE111014_pre	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37183
5.44740214198907e-09	0.716331608305754	0.737	0.362	9.21645968403131e-05	ZFP36	Mono/Macro	GSE111014_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37184
8.38950702673804e-09	0.568299362700782	1	0.987	0.000141942069385381	RPL21	Mono/Macro	GSE111014_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37185
1.49503084432002e-08	0.616165699227263	1	0.977	0.000252944268550504	SH3BGRL3	Mono/Macro	GSE111014_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37186
1.5534586479258e-08	-0.633059220508997	0.974	0.998	0.000262829668642566	RPLP2	Mono/Macro	GSE111014_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37187
2.32743828169338e-08	0.939179677507304	0.921	0.795	0.000393779282879702	FOS	Mono/Macro	GSE111014_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37188
2.68954341189887e-08	-0.565180294341225	1	1	0.00045504384985917	MALAT1	Mono/Macro	GSE111014_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37189
1.12831794471e-07	-0.547652755532765	0.974	0.999	0.00190900113065485	RPL28	Mono/Macro	GSE111014_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37190
1.9651650160937e-07	-0.587673257192423	0.842	0.965	0.00332486269072893	RPL27	Mono/Macro	GSE111014_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37191
2.55094677223474e-07	-0.964734700401309	0.421	0.734	0.00431594684394396	LGALS2	Mono/Macro	GSE111014_pre	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37192
4.08416274803877e-07	-0.495205179987397	1	1	0.0069099949534068	RPS2	Mono/Macro	GSE111014_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37193
4.43129257737566e-07	0.28397723146036	0.316	0.08	0.00749730391166188	PGAM1	Mono/Macro	GSE111014_pre	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37194
7.85554324741933e-07	-0.645054478365074	0.658	0.921	0.0132907936203088	NACA	Mono/Macro	GSE111014_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37195
8.03040109726603e-07	0.423704685464867	0.5	0.186	0.0135866356164644	ELF1	Mono/Macro	GSE111014_pre	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37196
9.97084954636046e-07	-0.459402452547137	1	0.997	0.0168696803474873	RPS9	Mono/Macro	GSE111014_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37197
1.10384699224797e-06	0.527689732439593	1	0.915	0.0186759872618434	RPS28	Mono/Macro	GSE111014_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37198
1.26285557820973e-06	0.304098960705069	0.316	0.085	0.0213662535277303	BZW1	Mono/Macro	GSE111014_pre	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37199
1.6503527925342e-06	-0.507430034015113	0.947	0.993	0.0279223188968861	RPL19	Mono/Macro	GSE111014_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37200
1.666505744088e-06	0.431566803237838	0.658	0.302	0.0281956106842249	TBCA	Mono/Macro	GSE111014_pre	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37201
2.16722829685339e-06	-0.59632439075055	0.105	0.513	0.0366673355544625	TMEM176B	Mono/Macro	GSE111014_pre	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37202
5.98407471512978e-51	-1.29123129766445	0	0.789	1.01244560105281e-46	RPS4Y1	CD4+ T cells	GSE111014_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37203
1.67875319811463e-50	2.95931949175625	1	0.64	2.84028253589015e-46	RPL41	CD4+ T cells	GSE111014_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37204
2.32936390173423e-50	2.66289656880843	1	0.474	3.94105078534415e-46	RPL39	CD4+ T cells	GSE111014_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37205
4.16881856411518e-49	2.48568609485732	1	0.623	7.05322412862648e-45	EEF1A1	CD4+ T cells	GSE111014_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37206
1.04981167351423e-31	1.45599546005945	0.762	0.053	1.77617637041872e-27	H3F3A	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37207
1.44243376566144e-27	3.48563698695441	0.729	0.07	2.44045368812259e-23	IGKC	CD4+ T cells	GSE111014_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37208
2.09857778190431e-24	-0.978596899270353	0.841	1	3.5505837492039e-20	TPT1	CD4+ T cells	GSE111014_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37209
4.4915384226422e-23	-0.710449829277594	0.056	0.526	7.59923385726834e-19	ZFP36L2	CD4+ T cells	GSE111014_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37210
1.50767630292936e-21	0.937299882444175	0.925	0.57	2.55083753692619e-17	RPL36A	CD4+ T cells	GSE111014_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37211
2.11059743808505e-20	1.8913984194556	0.907	0.5	3.5709198054961e-16	CD74	CD4+ T cells	GSE111014_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37212
4.04110132198714e-20	-0.959710935183671	0.981	1	6.83713932667004e-16	MT-CO1	CD4+ T cells	GSE111014_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37213
2.42301314073008e-18	-1.1133967641249	0.383	0.789	4.09949593280122e-14	JUN	CD4+ T cells	GSE111014_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37214
1.12618887778433e-17	-0.788414648095533	0.949	0.991	1.9053989623233e-13	MT-ND4	CD4+ T cells	GSE111014_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37215
1.20140967608302e-17	0.797137687945361	0.883	0.596	2.03266503096486e-13	RPL22	CD4+ T cells	GSE111014_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37216
1.24161033206494e-17	-0.598968234158746	0.991	1	2.10068052082067e-13	RPL28	CD4+ T cells	GSE111014_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37217
2.2270949410712e-17	-0.829813825936451	0.664	0.93	3.76802193079836e-13	RPS26	CD4+ T cells	GSE111014_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37218
8.04246843103643e-16	-0.728709167546514	0.206	0.64	1.36070523384705e-11	IER2	CD4+ T cells	GSE111014_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37219
2.37342125885855e-15	0.607261167829931	0.411	0	4.01559142786278e-11	AC090498.1	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37220
3.97871183303579e-15	-0.560151075171967	0.187	0.614	6.73158255031325e-11	FYB	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37221
5.54972095790276e-15	-0.61719794070865	0.178	0.588	9.38957288867568e-11	CD3G	CD4+ T cells	GSE111014_pre	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37222
1.22954796318108e-14	-0.817064352779254	0.78	0.947	2.08027219890606e-10	MT-ND2	CD4+ T cells	GSE111014_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37223
2.6793317588819e-14	0.712230727431473	0.935	0.754	4.53316140285228e-10	SERF2	CD4+ T cells	GSE111014_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37224
3.63361875816241e-14	-0.812147209553312	0.654	0.895	6.14771957693498e-10	MT-ND1	CD4+ T cells	GSE111014_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37225
5.90779063912875e-14	-0.607623006442784	0.107	0.465	9.99539098234194e-10	CNN2	CD4+ T cells	GSE111014_pre	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37226
8.43886193111153e-14	1.71783597197825	0.626	0.228	1.42777105012476e-09	HLA-DRA	CD4+ T cells	GSE111014_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37227
6.1077619604303e-13	-0.477419807594285	0.098	0.447	1.0333722460852e-08	TIMP1	CD4+ T cells	GSE111014_pre	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37228
9.14018940064241e-13	-0.622387900318988	0.949	1	1.54642864469469e-08	MT-CYB	CD4+ T cells	GSE111014_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37229
9.32940454411468e-13	1.12336592026635	0.467	0.079	1.57844195481876e-08	HLA-DQB1	CD4+ T cells	GSE111014_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37230
1.08406457302232e-12	0.848033151076071	0.458	0.079	1.83412885109646e-08	HLA-DMA	CD4+ T cells	GSE111014_pre	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37231
1.65307129645032e-12	0.8937423599239	0.43	0.053	2.7968313264643e-08	HLA-DQA1	CD4+ T cells	GSE111014_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37232
2.78066964428678e-12	-0.39217875799832	0.056	0.351	4.70461497116881e-08	CAPN2	CD4+ T cells	GSE111014_pre	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37233
2.80471470252559e-12	-0.667586250936494	1	1	4.74529680520304e-08	MALAT1	CD4+ T cells	GSE111014_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37234
3.01291193443295e-12	0.757804322075016	0.925	0.781	5.0975457018671e-08	FTL	CD4+ T cells	GSE111014_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37235
4.27515225070819e-12	-0.602860963327267	0.972	1	7.23313009297319e-08	RPL30	CD4+ T cells	GSE111014_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37236
5.04585706895499e-12	0.660030915634449	0.804	0.57	8.53708557496495e-08	TMA7	CD4+ T cells	GSE111014_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37237
7.90158007035788e-12	-0.485365541511861	0.098	0.412	1.33686833210385e-07	SYNE2	CD4+ T cells	GSE111014_pre	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37238
9.03746047631695e-12	0.616085018216937	0.327	0	1.52904793798806e-07	IGHG1	CD4+ T cells	GSE111014_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37239
9.20455901643877e-12	0.939419934318545	0.341	0.009	1.55731933999128e-07	IGLC2	CD4+ T cells	GSE111014_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37240
9.64893341757797e-12	-0.817524992108502	0.369	0.702	1.63250304492002e-07	VIM	CD4+ T cells	GSE111014_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37241
9.6873463763331e-12	-0.571130002173429	1	1	1.6390021334118e-07	RPS12	CD4+ T cells	GSE111014_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37242
1.63472894652928e-11	0.680321943043921	0.874	0.675	2.76579790463289e-07	RPS10	CD4+ T cells	GSE111014_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37243
1.82515550756026e-11	-0.650164124142989	0.967	0.991	3.08798060324121e-07	MT-CO2	CD4+ T cells	GSE111014_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37244
1.97028795317329e-11	-0.413251683999926	0.089	0.395	3.33353018797389e-07	IFITM1	CD4+ T cells	GSE111014_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37245
2.11054855069173e-11	-0.482134709685312	0.164	0.509	3.57083709291534e-07	BIN2	CD4+ T cells	GSE111014_pre	ENSG00000110934	51411	bridging integrator 2	BRAP-1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37246
3.5616401785819e-11	-0.861076548632476	0.14	0.456	6.02593901814271e-07	HMGB2	CD4+ T cells	GSE111014_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37247
1.07907010551063e-10	0.82937643096592	0.57	0.246	1.82567871151343e-06	PEBP1	CD4+ T cells	GSE111014_pre	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37248
1.48813660950754e-10	0.864012531660522	0.631	0.307	2.5177783296258e-06	HLA-DPA1	CD4+ T cells	GSE111014_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37249
2.91317555973801e-10	-0.339416327638142	0.051	0.307	4.92880172952074e-06	SELPLG	CD4+ T cells	GSE111014_pre	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37250
3.06511304001773e-10	-0.437396394920028	0.201	0.526	5.18586475240599e-06	LRRFIP1	CD4+ T cells	GSE111014_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37251
3.88411075943457e-10	-0.683870685061711	0.313	0.623	6.57152699388735e-06	NEAT1	CD4+ T cells	GSE111014_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37252
4.43979535937233e-10	-0.326845592778262	0.042	0.281	7.51168976852204e-06	IFRD1	CD4+ T cells	GSE111014_pre	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37253
4.64347685981279e-10	-0.507257754205341	0.953	0.982	7.85629849911727e-06	HLA-B	CD4+ T cells	GSE111014_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37254
4.70686285540075e-10	-0.530065348982675	0.07	0.333	7.96354126505252e-06	FOS	CD4+ T cells	GSE111014_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37255
5.92086719396321e-10	-0.370307706963291	0.061	0.316	1.00175152054664e-05	RP5-1171I10.5	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37256
8.00612835496077e-10	1.11864449649862	0.631	0.316	1.35455685637581e-05	HLA-DRB1	CD4+ T cells	GSE111014_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37257
8.01108954115458e-10	0.513487793936407	0.444	0.114	1.35539623946794e-05	HMGN2	CD4+ T cells	GSE111014_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37258
1.47871001786324e-09	-0.490264340924701	0.271	0.605	2.50182947922282e-05	GIMAP7	CD4+ T cells	GSE111014_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37259
1.64471954554472e-09	0.569001993111151	0.836	0.623	2.78270099910711e-05	OAZ1	CD4+ T cells	GSE111014_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37260
1.77723969809098e-09	-0.603231761544647	0.374	0.702	3.00691184520012e-05	S100A10	CD4+ T cells	GSE111014_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37261
2.87834148961462e-09	0.616620383626437	0.276	0.009	4.86986596627898e-05	LINC01480	CD4+ T cells	GSE111014_pre	ENSG00000280540	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37262
3.19309291466663e-09	-0.294070195901234	0.037	0.254	5.40239390232446e-05	PSMD5-AS1	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37263
3.47865315600746e-09	-0.307349417152465	0.042	0.263	5.88553327464902e-05	ILF3-AS1	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37264
3.62931807862307e-09	-0.387744808934965	0.07	0.316	6.14044325722238e-05	GADD45B	CD4+ T cells	GSE111014_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37265
4.41944547907877e-09	-0.329793046444373	0.079	0.333	7.47725980605336e-05	RORA	CD4+ T cells	GSE111014_pre	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37266
4.42604735865447e-09	-0.408025655507699	1	1	7.48842952610751e-05	RPS15A	CD4+ T cells	GSE111014_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37267
4.64702953418185e-09	-0.310847175441371	0.061	0.298	7.86230926888227e-05	VMP1	CD4+ T cells	GSE111014_pre	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37268
5.22834298398272e-09	-0.397324157698258	0.145	0.43	8.84583349460037e-05	ANKRD12	CD4+ T cells	GSE111014_pre	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37269
5.33636085303033e-09	-0.317300697583047	0.065	0.307	9.02858892724202e-05	GLIPR1	CD4+ T cells	GSE111014_pre	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37270
5.85408860815606e-09	-0.465388432643413	0.243	0.553	9.90453251613924e-05	FUS	CD4+ T cells	GSE111014_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37271
7.15703976263236e-09	-0.682916837066047	0.528	0.86	0.000121089955743977	IL32	CD4+ T cells	GSE111014_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37272
7.23749862260781e-09	0.544328712632881	0.523	0.211	0.000122451239195901	EIF5A	CD4+ T cells	GSE111014_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37273
7.61867910554163e-09	-0.713320680837471	0.364	0.64	0.000128900431786659	COTL1	CD4+ T cells	GSE111014_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37274
7.93322669760901e-09	-0.428706102026108	0.299	0.658	0.000134222262496847	CD3E	CD4+ T cells	GSE111014_pre	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37275
8.78730387038221e-09	-0.326680774563033	0.079	0.333	0.000148672394182997	HMHA1	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37276
1.36551655741401e-08	0.555974482084016	0.696	0.474	0.000231031746348877	CALM2	CD4+ T cells	GSE111014_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37277
1.49171828159814e-08	-0.29148185057444	0.056	0.281	0.000252383816063589	GATA3	CD4+ T cells	GSE111014_pre	ENSG00000107485	2625	GATA binding protein 3	HDR	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37278
1.59048504238229e-08	-0.903678172823566	0.505	0.737	0.00026909416432066	LTB	CD4+ T cells	GSE111014_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37279
1.75069029368899e-08	-0.401137842017303	0.308	0.649	0.00029619929078924	ITGB2	CD4+ T cells	GSE111014_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37280
1.81004899850492e-08	-0.413812280486827	0.131	0.395	0.000306242190057047	DUSP1	CD4+ T cells	GSE111014_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37281
2.04523218350581e-08	0.612384528555901	0.664	0.412	0.000346032833127347	COX6A1	CD4+ T cells	GSE111014_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37282
2.06814367175834e-08	0.602384947040974	0.318	0.053	0.000349909227824794	LRMP	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37283
2.06940475890399e-08	0.425032927698592	0.341	0.061	0.000350122591158965	HLA-DRB5	CD4+ T cells	GSE111014_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37284
2.20541552622781e-08	-0.480381251078276	0.173	0.447	0.000373134252882483	CALM3	CD4+ T cells	GSE111014_pre	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37285
2.43164996627733e-08	-0.549295462866673	0.257	0.561	0.000411410857794462	IL7R	CD4+ T cells	GSE111014_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37286
2.64989693725718e-08	-0.384643904912809	0.136	0.395	0.000448336062814542	PBXIP1	CD4+ T cells	GSE111014_pre	ENSG00000163346	57326	PBX homeobox interacting protein 1	HPIP	protein_coding	Q96AQ6	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37287
2.76176734786175e-08	-0.354676070663271	0.995	1	0.00046726341758473	RPS3	CD4+ T cells	GSE111014_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37288
3.21921569341263e-08	0.4492706969059	0.294	0.035	0.000544659103168483	CYB561A3	CD4+ T cells	GSE111014_pre	ENSG00000162144	220002	cytochrome b561 family member A3	CYBASC3	protein_coding	Q8NBI2	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37289
3.36329604592264e-08	-0.45383704892383	0.346	0.623	0.000569036058009651	SRSF7	CD4+ T cells	GSE111014_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37290
3.61558209237717e-08	0.496937752923932	0.916	0.763	0.000611720334209294	PFDN5	CD4+ T cells	GSE111014_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37291
3.72991643746474e-08	-0.508773986652722	0.341	0.64	0.00063106456205466	GSTK1	CD4+ T cells	GSE111014_pre	ENSG00000197448	373156	glutathione S-transferase kappa 1	GST13	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37292
5.02776372444714e-08	0.418317375544306	0.257	0.018	0.000850647344539212	CLECL1	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37293
5.86093922572308e-08	-0.344676087043079	0.112	0.36	0.000991612307600088	PSIP1	CD4+ T cells	GSE111014_pre	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37294
7.3419403505898e-08	0.418317375544306	0.252	0.018	0.00124218288791629	IGHA1	CD4+ T cells	GSE111014_pre	ENSG00000282633	NA	NA	AL928768.3	IG_C_gene	P01876	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37295
7.63906372394679e-08	-0.614483085545768	0.453	0.719	0.00129245319145456	TXNIP	CD4+ T cells	GSE111014_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37296
9.15716211022906e-08	0.381090758928359	1	1	0.00154930025742965	RPS27	CD4+ T cells	GSE111014_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37297
9.2883655441304e-08	-0.438073196100164	0.304	0.632	0.00157149856641142	CD2	CD4+ T cells	GSE111014_pre	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37298
9.71778907014794e-08	-0.353239640624527	0.121	0.368	0.00164415273277833	PCSK7	CD4+ T cells	GSE111014_pre	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37299
1.03350330728952e-07	-0.39711228416464	0.925	0.974	0.00174858424560314	RPL14	CD4+ T cells	GSE111014_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37300
1.0461206921931e-07	0.425032927698592	0.341	0.079	0.00176993159912151	SYNGR2	CD4+ T cells	GSE111014_pre	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37301
1.07054224412514e-07	-0.368994375019258	0.173	0.447	0.00181125042283533	CRIP1	CD4+ T cells	GSE111014_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37302
1.18145451966518e-07	-0.321098873596466	1	1	0.00199890290182152	RPL11	CD4+ T cells	GSE111014_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37303
1.19068455560962e-07	0.473101930096007	0.664	0.386	0.00201451919963592	UQCR11	CD4+ T cells	GSE111014_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37304
1.3263494499333e-07	-0.422048430586592	0.187	0.456	0.00224405063434215	ACAP1	CD4+ T cells	GSE111014_pre	ENSG00000288169	9744	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	CENTB1|KIAA0050	protein_coding	Q15027	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37305
1.37303119384176e-07	-0.356944924376343	1	1	0.00232303147686088	RPS27A	CD4+ T cells	GSE111014_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37306
1.48356004247463e-07	-0.317539957105564	0.098	0.333	0.00251003523586283	PLP2	CD4+ T cells	GSE111014_pre	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37307
1.50895954927723e-07	-0.379274298825658	0.864	0.982	0.00255300866142215	RPL24	CD4+ T cells	GSE111014_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37308
1.57023113347293e-07	-0.295232670145426	0.079	0.298	0.00265667405472284	TMEM173	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37309
1.58776297567972e-07	0.335244741176952	1	1	0.00268633617855252	RPS4X	CD4+ T cells	GSE111014_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37310
1.80486532081408e-07	-0.345391413910501	0.178	0.456	0.00305365163628534	FAM65B	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37311
1.81130719878367e-07	-0.331977944449876	0.164	0.439	0.00306455064962209	CD44	CD4+ T cells	GSE111014_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37312
1.90853459422832e-07	-0.420312365685892	0.939	0.965	0.0032290496799749	RPS20	CD4+ T cells	GSE111014_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37313
2.00437544165008e-07	-0.363298172987731	0.145	0.395	0.00339120280972777	H2AFV	CD4+ T cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37314
2.12548409576252e-07	0.646941750592269	0.374	0.114	0.0035961065416206	ATOX1	CD4+ T cells	GSE111014_pre	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37315
2.17803472717887e-07	0.464711544569513	0.547	0.263	0.00368501695491393	RPL17	CD4+ T cells	GSE111014_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37316
2.19308845501564e-07	0.511077155112808	0.252	0.026	0.00371048635704097	MIR155HG	CD4+ T cells	GSE111014_pre	ENSG00000234883	114614	MIR155 host gene	BIC|miPEP155|MIRHG2|NCRNA00172	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37317
2.34899302619739e-07	-0.418251345653325	0.696	0.877	0.00397426130102336	EEF2	CD4+ T cells	GSE111014_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37318
2.78560468537403e-07	-0.30978219833568	0.168	0.439	0.00471296456718433	MYO1F	CD4+ T cells	GSE111014_pre	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37319
2.89432754887627e-07	0.341263507287534	0.28	0.044	0.00489691277994376	XIST	CD4+ T cells	GSE111014_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37320
3.04861629568537e-07	-0.323614471515249	0.145	0.395	0.00515795391067007	NKTR	CD4+ T cells	GSE111014_pre	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37321
3.89871297670738e-07	0.355922842601887	1	0.974	0.00659623248529122	RPL15	CD4+ T cells	GSE111014_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37322
4.02402691937423e-07	0.362349749959443	0.995	0.982	0.00680825114488926	RPL7	CD4+ T cells	GSE111014_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37323
4.05867744747441e-07	0.497788225027988	0.519	0.272	0.00686687637338195	ERH	CD4+ T cells	GSE111014_pre	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37324
4.58004889536524e-07	0.441456460331311	0.262	0.035	0.00774898472606844	TCL1A	CD4+ T cells	GSE111014_pre	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37325
4.65488876603697e-07	-0.442751363043385	0.444	0.754	0.00787560630325795	CD3D	CD4+ T cells	GSE111014_pre	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37326
5.05102035474056e-07	0.364148856575968	0.995	0.982	0.00854582133818556	RPS28	CD4+ T cells	GSE111014_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37327
5.2997662480651e-07	-0.375025001698171	0.379	0.64	0.00896667451510133	CAPZB	CD4+ T cells	GSE111014_pre	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37328
5.48683058924341e-07	0.519104736294662	0.491	0.246	0.00928316867394092	NOP10	CD4+ T cells	GSE111014_pre	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37329
6.1471737512211e-07	-0.459058947183452	0.991	1	0.010400403269691	TMSB10	CD4+ T cells	GSE111014_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37330
6.66572490368827e-07	-0.323614471515249	0.107	0.325	0.0112777399645502	CD247	CD4+ T cells	GSE111014_pre	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37331
7.1176946600694e-07	-0.447500006481912	0.832	0.956	0.0120424275953714	MT-ATP6	CD4+ T cells	GSE111014_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37332
7.47144374376002e-07	-0.287545216807727	0.126	0.36	0.0126409356700676	TMEM123	CD4+ T cells	GSE111014_pre	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37333
8.36323255434048e-07	-0.393300217319603	0.322	0.57	0.0141497531586887	CCNI	CD4+ T cells	GSE111014_pre	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37334
8.44599163947587e-07	-0.385357821228145	0.206	0.447	0.0142897732548292	VAMP2	CD4+ T cells	GSE111014_pre	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37335
9.41331718027211e-07	0.401378480984881	0.28	0.053	0.0159263913373024	FCER2	CD4+ T cells	GSE111014_pre	ENSG00000104921	2208	Fc epsilon receptor II	CD23|CD23A|CLEC4J|FCE2|FcepsilonRII|FCErII	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37336
9.76859313555821e-07	-0.375584461814108	0.206	0.447	0.0165274827260509	ARPC4	CD4+ T cells	GSE111014_pre	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37337
1.2434651210605e-06	0.47076881989913	0.397	0.149	0.0210381863832226	PTPN6	CD4+ T cells	GSE111014_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37338
1.26299219555838e-06	-0.57826921173307	0.154	0.377	0.0213685649566523	MT2A	CD4+ T cells	GSE111014_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37339
1.26500195313218e-06	0.461445410852002	0.813	0.658	0.0214025680450433	UBB	CD4+ T cells	GSE111014_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37340
1.28298817893653e-06	0.601700718884497	0.654	0.439	0.0217068769994272	RAN	CD4+ T cells	GSE111014_pre	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37341
1.3416616338744e-06	-0.29916142779071	0.103	0.316	0.022699573183521	AKAP9	CD4+ T cells	GSE111014_pre	ENSG00000127914	10142	A-kinase anchoring protein 9	AKAP350|AKAP450|CG-NAP|HYPERION|KIAA0803|LQT11|MU-RMS-40.16A|PPP1R45|PRKA9|YOTIAO	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37342
1.37107954414045e-06	-0.347998630142208	0.131	0.368	0.0231972948073123	ID2	CD4+ T cells	GSE111014_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37343
1.45122588124403e-06	0.44668830652507	0.556	0.307	0.0245532906847677	PRR13	CD4+ T cells	GSE111014_pre	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37344
1.48170143627664e-06	0.426024952686068	0.435	0.184	0.0250689066003645	GPX1	CD4+ T cells	GSE111014_pre	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37345
1.84472184095021e-06	0.332431127267389	0.397	0.14	0.0312108488270366	CD63	CD4+ T cells	GSE111014_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37346
2.38585091065511e-06	-0.270464764996484	0.089	0.289	0.0403662115573737	MGST3	CD4+ T cells	GSE111014_pre	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37347
2.51469387280177e-06	-0.294585422903717	0.154	0.386	0.0425461056339332	TUBA1A	CD4+ T cells	GSE111014_pre	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37348
2.66856292622668e-06	0.501852745926895	0.71	0.509	0.0451494161488292	LIMD2	CD4+ T cells	GSE111014_pre	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37349
2.89014083974959e-06	-0.256500275656712	0.07	0.254	0.0488982928677233	SUN2	CD4+ T cells	GSE111014_pre	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37350
1.55195014845075e-26	2.1677673142735	1	0.446	2.62574445616383e-22	RPL39	NK cells	GSE111014_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37351
2.85618396561952e-26	2.42177349257877	1	0.62	4.83237765143167e-22	RPL41	NK cells	GSE111014_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37352
2.25374324575085e-25	1.9722629318641	1	0.587	3.81310819748587e-21	EEF1A1	NK cells	GSE111014_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37353
6.89863369886504e-19	1.29229983208667	0.685	0.066	1.16717983551098e-14	H3F3A	NK cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37354
3.01761540830789e-18	1.59732511266691	0.759	0.116	5.10550350931612e-14	IGKC	NK cells	GSE111014_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37355
1.33330597946832e-14	-1.06982144949757	0	0.661	2.25582038666246e-10	RPS4Y1	NK cells	GSE111014_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37356
1.00400042475943e-12	-0.836708980156064	1	1	1.69866831865048e-08	MALAT1	NK cells	GSE111014_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37357
6.02480910499768e-11	-0.800638666152977	1	1	1.01933745247456e-06	MT-CO1	NK cells	GSE111014_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37358
4.0602701853897e-10	-1.01593335490381	0.481	0.851	6.86957112666083e-06	RPS26	NK cells	GSE111014_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37359
5.72225970367994e-10	-0.762332314324633	0.981	1	9.68149119265608e-06	MT-ND4	NK cells	GSE111014_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37360
6.53974659360506e-10	0.587665104642879	1	0.992	1.10645972617204e-05	TMSB4X	NK cells	GSE111014_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37361
2.53334749345152e-09	-0.749312631695543	0.093	0.587	4.28617062417063e-05	RP5-1171I10.5	NK cells	GSE111014_pre	NA	NA	NA	NA	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37362
2.6140824110079e-09	-0.698520741138939	0.148	0.669	4.42276603118426e-05	ZFP36L2	NK cells	GSE111014_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37363
6.72742446585926e-09	-0.665293963374919	0.037	0.496	0.000113821294537873	AKNA	NK cells	GSE111014_pre	ENSG00000106948	80709	AT-hook transcription factor	KIAA1968	protein_coding	Q7Z591	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37364
7.09454507280845e-09	-0.849486524695437	0.296	0.769	0.000120032608086846	NEAT1	NK cells	GSE111014_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37365
9.20487122791195e-09	0.476693417607131	1	1	0.000155737216305042	B2M	NK cells	GSE111014_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37366
1.00282363242748e-08	0.56149547313194	1	0.975	0.000169667730370405	RPL7	NK cells	GSE111014_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37367
1.72454238258051e-08	-0.616537574727837	0.148	0.603	0.000291775325708796	TPST2	NK cells	GSE111014_pre	ENSG00000128294	8459	tyrosylprotein sulfotransferase 2	TANGO13B	protein_coding	O60704	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37368
1.75861980876806e-08	-0.931181497929214	0.556	0.893	0.000297540885445469	MT-ND1	NK cells	GSE111014_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37369
1.97339472588582e-08	-1.07085378946354	0.426	0.802	0.000333878653672622	JUN	NK cells	GSE111014_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37370
2.39316408752923e-08	-0.912598789996477	0.722	0.926	0.00040489943196907	MT-ND2	NK cells	GSE111014_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37371
1.7301114360313e-07	1.04428066872018	0.907	0.636	0.00292717553862136	CD74	NK cells	GSE111014_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37372
2.17838990701021e-07	-0.616002748015173	0.278	0.719	0.00368561788367057	FUS	NK cells	GSE111014_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37373
6.96368985766991e-07	0.846634909719415	0.556	0.207	0.0117818668701917	HLA-DRA	NK cells	GSE111014_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37374
7.12307091633166e-07	-0.607632105050602	1	0.983	0.0120515236833415	RPS12	NK cells	GSE111014_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37375
1.76603095330794e-06	-0.560711529276643	0.093	0.463	0.029879477699017	FLNA	NK cells	GSE111014_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37376
2.02069399944747e-06	-0.510928890922828	0.056	0.413	0.0341881217766518	CALM3	NK cells	GSE111014_pre	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE111014	GSE111014	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia (CLL)	Targeted therapy	pre	ibrutinib	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 1, sensitive 3); post (resistant 1, sensitive 3)	8	24790	Public on Feb 22, 2019	31996669	This dataset has 4 patients with both pre -and post-treatment samples.	PRJNA435591	10x genomics	CellRanger 2.0.0 	Chronic_lymphocytic_leukemia	Targeted_therapy	37377
0	-2.12813278330514	0.046	0.882	0	IL32	Malignant cells	GSE131984_JQ1	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37378
9.13307408268512e-305	1.0109871482413	1	1	1.47855336324589e-300	GPX4	Malignant cells	GSE131984_JQ1	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37379
2.80070121754316e-237	1.13308827767563	1	1	4.53405520108061e-233	FTH1	Malignant cells	GSE131984_JQ1	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37380
2.77060104269706e-227	1.0300923204078	1	1	4.48532602802226e-223	FTL	Malignant cells	GSE131984_JQ1	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37381
4.13458897027764e-227	0.437925276358706	1	1	6.69348608398247e-223	RPL13	Malignant cells	GSE131984_JQ1	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37382
8.65237365535241e-214	0.485692502871692	1	1	1.400732771065e-209	RPLP1	Malignant cells	GSE131984_JQ1	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37383
2.16732128572826e-210	0.580681914047607	1	1	3.50867642946547e-206	TMSB10	Malignant cells	GSE131984_JQ1	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37384
1.3724196393553e-199	1.46071999278764	0.842	0.322	2.22181015415229e-195	VSTM2L	Malignant cells	GSE131984_JQ1	ENSG00000132821	128434	V-set and transmembrane domain containing 2 like	C20orf102|dJ1118M15.2	protein_coding	Q96N03	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37385
1.42888343644261e-197	-0.955759831403857	0.959	0.998	2.31321939525694e-193	NDUFA1	Malignant cells	GSE131984_JQ1	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37386
7.21504077170817e-196	-0.916885161369599	0.99	1	1.16804295053184e-191	PLP2	Malignant cells	GSE131984_JQ1	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37387
1.78547844987811e-187	-1.14799710804823	0.913	0.989	2.89051106250767e-183	PRDX4	Malignant cells	GSE131984_JQ1	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37388
4.72137797453405e-187	-0.830806662466427	0.999	1	7.64343880297318e-183	RBM3	Malignant cells	GSE131984_JQ1	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37389
1.02545800745804e-183	-1.08479013635188	0.897	0.987	1.66011396827382e-179	SMS	Malignant cells	GSE131984_JQ1	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37390
2.07329054742405e-183	0.849992277777284	0.999	0.979	3.3564500672248e-179	C9orf16	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37391
2.4470459088736e-181	1.2802577105905	0.95	0.731	3.96152262187547e-177	HCFC1R1	Malignant cells	GSE131984_JQ1	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37392
1.64057659629948e-180	-0.905568290516893	0.921	0.99	2.65592945174923e-176	GTF3C6	Malignant cells	GSE131984_JQ1	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37393
5.15789588823653e-179	-1.26073963963894	0.735	0.975	8.35011765346612e-175	NNMT	Malignant cells	GSE131984_JQ1	ENSG00000166741	4837	nicotinamide N-methyltransferase	NA	protein_coding	P40261	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37394
5.38290819626286e-179	0.803048189931231	0.999	0.993	8.71439007892995e-175	PPDPF	Malignant cells	GSE131984_JQ1	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37395
1.81908102684542e-178	-2.06137612845196	0.528	0.908	2.94491027436005e-174	IL8	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37396
6.67251062185569e-178	0.410916893967931	1	1	1.08021274457222e-173	RPS2	Malignant cells	GSE131984_JQ1	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37397
6.44594619556186e-177	-0.959274840016201	0.948	1	1.04353422959951e-172	EMP3	Malignant cells	GSE131984_JQ1	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37398
2.05908910860741e-175	0.430840209072128	1	1	3.33345935792454e-171	RPL28	Malignant cells	GSE131984_JQ1	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37399
3.73641631220769e-168	-1.69549909761831	0.486	0.896	6.04888436783303e-164	CXCL2	Malignant cells	GSE131984_JQ1	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37400
1.96151580327281e-167	-0.9484243021032	0.984	0.998	3.17549793391835e-163	CLIC1	Malignant cells	GSE131984_JQ1	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37401
4.17655582669018e-164	-1.20867524660455	0.743	0.96	6.76142622782873e-160	NFKBIA	Malignant cells	GSE131984_JQ1	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37402
1.15358568495419e-163	0.426685952293496	1	1	1.86753986537233e-159	RPL12	Malignant cells	GSE131984_JQ1	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37403
3.48781674592454e-163	-0.874639423648021	0.911	0.993	5.64642652997723e-159	IFITM3	Malignant cells	GSE131984_JQ1	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37404
3.39831615205692e-162	-0.745547113638922	1	1	5.50153401856495e-158	TMSB4X	Malignant cells	GSE131984_JQ1	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37405
1.74254829261937e-160	-0.790138738267476	0.978	0.999	2.8210114309215e-156	SNRPB	Malignant cells	GSE131984_JQ1	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37406
2.05624483925825e-160	0.84339606758949	0.999	0.939	3.32885477027518e-156	MMP24-AS1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37407
1.05765385688735e-156	-0.557971258162766	1	1	1.71223582891493e-152	RPL39	Malignant cells	GSE131984_JQ1	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37408
7.25444997454292e-156	-1.00039746786417	0.136	0.607	1.17442290637875e-151	TNNT1	Malignant cells	GSE131984_JQ1	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37409
8.14121157204737e-155	-0.84337904674943	0.788	0.963	1.31798074139875e-150	CLPP	Malignant cells	GSE131984_JQ1	ENSG00000125656	8192	caseinolytic mitochondrial matrix peptidase proteolytic subunit	NA	protein_coding	Q16740	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37410
1.17415285613935e-153	-0.769985691107756	0.985	1	1.90083605880399e-149	ATP5G1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37411
8.34406805867136e-152	-1.0771580206365	0.318	0.77	1.35082117801831e-147	LY6K	Malignant cells	GSE131984_JQ1	ENSG00000160886	54742	lymphocyte antigen 6 family member K	CT97|FLJ35226|HSJ001348	protein_coding	Q17RY6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37412
3.2507892574932e-151	-0.73860203514109	0.957	0.999	5.26270272895573e-147	OCIAD2	Malignant cells	GSE131984_JQ1	ENSG00000145247	132299	OCIA domain containing 2	MGC45416	protein_coding	Q56VL3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37413
4.98249883645419e-149	-0.895614544460082	0.974	0.997	8.0661673663357e-145	NME1	Malignant cells	GSE131984_JQ1	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37414
1.43357161042877e-148	-0.785494377673088	0.996	1	2.32080908012313e-144	S100A11	Malignant cells	GSE131984_JQ1	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37415
4.41586974426213e-148	-0.821014290779905	0.975	0.997	7.14885152898597e-144	EIF1AX	Malignant cells	GSE131984_JQ1	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37416
1.22928928543765e-146	-1.0538527457988	0.837	0.963	1.99009642419502e-142	EBP	Malignant cells	GSE131984_JQ1	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37417
5.75022673794375e-144	-1.20631505060728	0.298	0.737	9.30904206605713e-140	S100A2	Malignant cells	GSE131984_JQ1	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37418
8.13114304582364e-144	-0.941871399729824	0.914	0.986	1.31635074768839e-139	MORF4L2	Malignant cells	GSE131984_JQ1	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37419
3.72976672081318e-142	-0.714549351835029	0.992	0.999	6.03811934432446e-138	COX7B	Malignant cells	GSE131984_JQ1	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37420
3.77733269678278e-142	-0.966209009873915	0.84	0.979	6.11512390282165e-138	EBNA1BP2	Malignant cells	GSE131984_JQ1	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37421
1.61169411702308e-141	-0.858745173973781	0.919	0.989	2.60917160604866e-137	PA2G4	Malignant cells	GSE131984_JQ1	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37422
9.90553781111375e-141	-0.735366303189067	1	1	1.60360751624121e-136	SLC25A5	Malignant cells	GSE131984_JQ1	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37423
1.76236202583178e-140	0.924802080262491	1	1	2.85308788361907e-136	MALAT1	Malignant cells	GSE131984_JQ1	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37424
1.14843723960564e-138	-0.66018996474356	0.994	0.999	1.85920504719757e-134	SEC61G	Malignant cells	GSE131984_JQ1	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37425
5.77629847551606e-138	1.33343245594097	0.872	0.566	9.35124960201295e-134	PEG10	Malignant cells	GSE131984_JQ1	ENSG00000242265	23089	paternally expressed 10	HB-1|KIAA1051|Mar2|Mart2|MEF3L|RGAG3|RTL2|SIRH1	protein_coding	Q86TG7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37426
1.14002871585506e-137	-0.724436427982641	0.991	0.999	1.84559248809775e-133	PPP1R14B	Malignant cells	GSE131984_JQ1	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37427
1.25628537949275e-137	-0.876596396414166	0.909	0.989	2.03380040086082e-133	PFDN2	Malignant cells	GSE131984_JQ1	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37428
3.54175357174586e-137	-0.84322034362766	0.891	0.99	5.73374485729938e-133	LRRC59	Malignant cells	GSE131984_JQ1	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37429
6.16568301360017e-137	-0.926098447940394	0.74	0.938	9.98162423071731e-133	HSD17B10	Malignant cells	GSE131984_JQ1	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37430
2.27533498985531e-136	-1.20947259494667	0.185	0.631	3.68353981507677e-132	SCG5	Malignant cells	GSE131984_JQ1	ENSG00000277614	6447	secretogranin V	7B2|SGNE1|SgV	protein_coding	P05408	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37431
5.82195094944937e-136	-1.07235338102087	0.203	0.667	9.42515639206358e-132	SPANXC	Malignant cells	GSE131984_JQ1	ENSG00000198573	64663	SPANX family member C	CT11.3|CTp11	protein_coding	Q9NY87	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37432
3.59809383967519e-135	-0.491988141991475	1	1	5.82495411705016e-131	RPL21	Malignant cells	GSE131984_JQ1	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37433
3.97740854610057e-135	0.339815508940947	1	1	6.43902669528222e-131	RPS5	Malignant cells	GSE131984_JQ1	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37434
1.23125532778596e-133	-0.874063744249207	0.477	0.844	1.99327925015269e-129	PSMB8	Malignant cells	GSE131984_JQ1	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37435
7.72623201847445e-132	0.911069155544455	0.998	0.99	1.25079970147083e-127	CCDC85B	Malignant cells	GSE131984_JQ1	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37436
2.08879684833103e-131	-1.10870261675004	0.825	0.952	3.3815532177631e-127	SOD2	Malignant cells	GSE131984_JQ1	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37437
3.23735941413517e-131	0.727053224187332	0.999	0.999	5.24096115554343e-127	MT-CYB	Malignant cells	GSE131984_JQ1	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37438
1.43273455275809e-130	-0.598485685518806	0.991	1	2.31945396746008e-126	MRPL23	Malignant cells	GSE131984_JQ1	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37439
4.71189892057265e-130	-0.62177740533445	0.994	1	7.62809316251507e-126	SNRPE	Malignant cells	GSE131984_JQ1	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37440
2.40291376240967e-129	-0.850244618100201	0.735	0.943	3.89007708996502e-125	PDLIM4	Malignant cells	GSE131984_JQ1	ENSG00000131435	8572	PDZ and LIM domain 4	RIL	protein_coding	P50479	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37441
7.23872241437363e-129	-0.708881710331681	0.889	0.988	1.17187677166295e-124	MRPS15	Malignant cells	GSE131984_JQ1	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37442
1.3610395332291e-128	0.657940374926263	1	0.999	2.20338690034458e-124	NPC2	Malignant cells	GSE131984_JQ1	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37443
2.6376431917483e-128	-1.03261707696467	0.948	0.997	4.27008056312132e-124	PGK1	Malignant cells	GSE131984_JQ1	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37444
2.98355343077601e-128	-0.716992114944554	0.906	0.992	4.83007464908328e-124	NDUFC1	Malignant cells	GSE131984_JQ1	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37445
2.24439571303799e-127	-0.774286894067101	0.961	0.996	3.63345221983721e-123	RANBP1	Malignant cells	GSE131984_JQ1	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37446
1.86625889545644e-125	-0.742377714424923	0.998	0.999	3.02128652585443e-121	POMP	Malignant cells	GSE131984_JQ1	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37447
1.46588898029875e-123	0.513731908382098	1	1	2.37312767020564e-119	TPT1	Malignant cells	GSE131984_JQ1	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37448
1.6461826681775e-123	-0.77790970530178	0.782	0.957	2.66500512151255e-119	DNPH1	Malignant cells	GSE131984_JQ1	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37449
2.28872569429141e-123	-0.679323997513679	0.999	1	3.70521802648837e-119	EIF5A	Malignant cells	GSE131984_JQ1	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37450
3.81166295101488e-123	-0.834114350960469	0.538	0.85	6.17070115139798e-119	FAM136A	Malignant cells	GSE131984_JQ1	ENSG00000035141	84908	family with sequence similarity 136 member A	FLJ14668	protein_coding	Q96C01	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37451
1.8949777485244e-122	-0.953342156277763	0.9	0.979	3.06777947708614e-118	TM4SF1	Malignant cells	GSE131984_JQ1	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37452
4.88321974537534e-122	-0.66811595668888	0.974	1	7.90544444578814e-118	SLIRP	Malignant cells	GSE131984_JQ1	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37453
1.0602168528123e-121	-0.918974115349737	0.705	0.93	1.71638506301784e-117	HMGB3	Malignant cells	GSE131984_JQ1	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37454
4.44304227830266e-121	-0.881026285787859	0.543	0.852	7.19284114434417e-117	PGRMC1	Malignant cells	GSE131984_JQ1	ENSG00000101856	10857	progesterone receptor membrane component 1	HPR6.6	protein_coding	O00264	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37455
3.11403556578505e-120	0.706448988078511	0.996	0.953	5.04131217744941e-116	CIRBP	Malignant cells	GSE131984_JQ1	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37456
7.58003682452303e-120	-0.64112307612336	0.969	0.999	1.22713216152203e-115	TIMM13	Malignant cells	GSE131984_JQ1	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37457
4.09955023850747e-119	-0.679222670529208	0.995	1	6.63676188111974e-115	HSPE1	Malignant cells	GSE131984_JQ1	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37458
5.03413210416817e-119	-0.660292603611498	0.986	0.999	8.14975646343785e-115	VDAC1	Malignant cells	GSE131984_JQ1	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37459
1.17343956150229e-117	-0.81677385012503	0.693	0.914	1.89968130611607e-113	MRPL3	Malignant cells	GSE131984_JQ1	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37460
4.3800733648479e-117	-0.681421428000019	0.996	1	7.09090077035226e-113	HMGB1	Malignant cells	GSE131984_JQ1	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37461
7.8068795667835e-117	-0.899694568770594	0.998	1	1.26385573306658e-112	AKR1B1	Malignant cells	GSE131984_JQ1	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37462
1.4354176060747e-116	0.85412508079004	0.861	0.554	2.32379756247434e-112	FAM89B	Malignant cells	GSE131984_JQ1	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37463
4.3383256306736e-116	-0.722303813111411	0.979	0.997	7.02331536349749e-112	CYCS	Malignant cells	GSE131984_JQ1	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37464
1.02618601275208e-115	-0.677422494580448	0.961	0.997	1.66129253604434e-111	SNRPD1	Malignant cells	GSE131984_JQ1	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37465
3.00966842250125e-115	-0.752166374404481	0.705	0.924	4.87235220918727e-111	UBE2M	Malignant cells	GSE131984_JQ1	ENSG00000130725	9040	ubiquitin conjugating enzyme E2 M	hUbc12|UBC12	protein_coding	P61081	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37466
1.96489131359159e-114	-1.16315301221069	0.458	0.812	3.18096254757343e-110	ISG15	Malignant cells	GSE131984_JQ1	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37467
2.27683448227154e-114	-0.697643968012911	0.955	0.992	3.68596734334939e-110	PSMB5	Malignant cells	GSE131984_JQ1	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37468
4.0991054590102e-114	-0.807434968351681	0.803	0.955	6.63604182759162e-110	SDF2L1	Malignant cells	GSE131984_JQ1	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37469
1.85170728350451e-113	-0.929213654559536	0.654	0.892	2.99772892126546e-109	MCTS1	Malignant cells	GSE131984_JQ1	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37470
7.303748638215e-113	-0.83693043041896	0.575	0.861	1.18240386704063e-108	IFRD2	Malignant cells	GSE131984_JQ1	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37471
4.14978990472567e-112	-0.822624221210129	0.985	0.997	6.71809487676039e-108	C5orf38	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37472
3.47894604056049e-110	0.331699589331737	1	1	5.63206574506338e-106	RPLP0	Malignant cells	GSE131984_JQ1	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37473
1.29223877845888e-107	-0.760281105031392	0.917	0.986	2.09200535844708e-103	PSMB3	Malignant cells	GSE131984_JQ1	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37474
1.75354395962587e-107	-0.582931051400876	0.999	0.999	2.83881231623832e-103	H2AFZ	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37475
3.25506561117962e-107	-0.644532457330039	0.905	0.976	5.26962571793869e-103	CUTA	Malignant cells	GSE131984_JQ1	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37476
9.62465310404178e-107	-0.797344281461365	0.273	0.662	1.55813509101332e-102	PIR	Malignant cells	GSE131984_JQ1	ENSG00000087842	8544	pirin	NA	protein_coding	O00625	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37477
1.32646787408441e-106	-0.782174678555906	0.577	0.836	2.14741884135525e-102	NKAP	Malignant cells	GSE131984_JQ1	ENSG00000101882	79576	NFKB activating protein	FLJ22626	protein_coding	Q8N5F7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37478
1.22284775242991e-104	-0.826352307042057	0.504	0.841	1.97966822640878e-100	CRADD	Malignant cells	GSE131984_JQ1	ENSG00000169372	8738	CASP2 and RIPK1 domain containing adaptor with death domain	RAIDD	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37479
2.75059209974295e-104	0.402305167493496	1	1	4.45293355027385e-100	EEF1D	Malignant cells	GSE131984_JQ1	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37480
3.48169423791667e-104	-0.817844094736336	0.296	0.687	5.6365148017633e-100	S100A3	Malignant cells	GSE131984_JQ1	ENSG00000188015	6274	S100 calcium binding protein A3	S100E	protein_coding	P33764	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37481
5.64557447938602e-104	-0.655615938035136	0.962	0.994	9.13962052467803e-100	PSMB7	Malignant cells	GSE131984_JQ1	ENSG00000136930	5695	proteasome 20S subunit beta 7	Z	protein_coding	Q99436	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37482
3.11928691889367e-103	-0.841519604462698	0.24	0.631	5.04981359299696e-99	GYPC	Malignant cells	GSE131984_JQ1	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37483
1.48366331602591e-102	-0.651958211150472	0.967	0.993	2.40190254231434e-98	PHB	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37484
3.58831166996317e-102	-0.539210070216713	0.99	0.999	5.80911776250338e-98	SNRPG	Malignant cells	GSE131984_JQ1	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37485
1.12454669300472e-101	-0.620202249629525	0.974	1	1.82052864130534e-97	CYC1	Malignant cells	GSE131984_JQ1	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37486
1.39336521703817e-101	-0.606862681740243	0.967	0.992	2.25571894986309e-97	C19orf10	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37487
5.18548390003514e-101	-0.711832653390277	0.999	1	8.39477988576689e-97	ENO1	Malignant cells	GSE131984_JQ1	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37488
5.74774169399828e-101	-0.566288520210355	0.987	0.997	9.30501902841382e-97	EIF2S2	Malignant cells	GSE131984_JQ1	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37489
8.6754127927275e-101	-0.652982771105937	0.969	0.993	1.40446257701465e-96	SRSF3	Malignant cells	GSE131984_JQ1	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37490
1.25473639415082e-100	-0.540387135270395	0.994	0.999	2.03129274849076e-96	RPL36A	Malignant cells	GSE131984_JQ1	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37491
1.52451959528589e-100	-0.76563533967163	0.602	0.862	2.46804477280833e-96	COA6	Malignant cells	GSE131984_JQ1	ENSG00000168275	388753	cytochrome c oxidase assembly factor 6	C1orf31	protein_coding	Q5JTJ3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37492
2.55658445798996e-100	-0.843628196167649	0.783	0.935	4.13885457903995e-96	PSME2	Malignant cells	GSE131984_JQ1	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37493
2.80006111947209e-100	-0.87604478780948	0.796	0.949	4.53301894631337e-96	CACYBP	Malignant cells	GSE131984_JQ1	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37494
6.36154070483223e-100	-0.462043123224207	1	1	1.02986982470529e-95	TXN	Malignant cells	GSE131984_JQ1	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37495
7.49305659430299e-100	-0.890124904372871	0.502	0.807	1.21305093205171e-95	PDHA1	Malignant cells	GSE131984_JQ1	ENSG00000131828	5160	pyruvate dehydrogenase E1 subunit alpha 1	E1alpha|PDHA	protein_coding	P08559	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37496
8.24264683719334e-100	-0.765987548544205	0.748	0.924	1.33440209647323e-95	MRPS18C	Malignant cells	GSE131984_JQ1	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37497
2.5072637251732e-99	-0.677792871445188	0.799	0.96	4.05900924468289e-95	SNRPC	Malignant cells	GSE131984_JQ1	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37498
3.81221937246851e-99	-0.771119298788079	0.862	0.975	6.17160194208928e-95	PSMB6	Malignant cells	GSE131984_JQ1	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37499
1.90738732461185e-98	0.972449030504882	0.79	0.451	3.08786933981413e-94	RAMP1	Malignant cells	GSE131984_JQ1	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37500
6.91235543871113e-98	0.55258905367624	1	0.999	1.11904122197295e-93	MT-CO3	Malignant cells	GSE131984_JQ1	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37501
1.25860805148567e-97	-0.581013561618911	0.936	0.992	2.03756057455015e-93	PRR13	Malignant cells	GSE131984_JQ1	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37502
2.43314154030262e-97	0.517274416830588	0.999	0.999	3.93901283959591e-93	MT-ND4	Malignant cells	GSE131984_JQ1	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37503
3.94251756504056e-97	-0.640438492870866	0.088	0.43	6.38254168604417e-93	SFTA1P	Malignant cells	GSE131984_JQ1	ENSG00000225383	207107	surfactant associated 1, lncRNA	SFTPF	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37504
5.17577110742485e-97	-0.727164497957417	0.539	0.831	8.37905584581009e-93	TIMM17B	Malignant cells	GSE131984_JQ1	ENSG00000126768	10245	translocase of inner mitochondrial membrane 17B	DXS9822|JM3	protein_coding	O60830	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37505
1.05964269101668e-96	-0.779994809094931	0.348	0.695	1.71545555248691e-92	PRPS1	Malignant cells	GSE131984_JQ1	ENSG00000147224	5631	phosphoribosyl pyrophosphate synthetase 1	CMTX5|DFN2|DFNX1|PPRibP|PRS-I	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37506
1.12096125158009e-96	-0.530974506885198	0.993	1	1.81472417018301e-92	SNRPF	Malignant cells	GSE131984_JQ1	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37507
2.82014276106196e-96	-0.797435290072088	0.574	0.845	4.56552911588321e-92	NOP16	Malignant cells	GSE131984_JQ1	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37508
4.0617830189647e-96	-0.907448793944795	0.583	0.846	6.57562052940196e-92	EXOSC8	Malignant cells	GSE131984_JQ1	ENSG00000120699	11340	exosome component 8	bA421P11.3|CIP3|EAP2|OIP2|p9|RRP43|Rrp43p	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37509
5.42671935929415e-96	-0.557079431638832	0.983	0.997	8.7853159707613e-92	LSM5	Malignant cells	GSE131984_JQ1	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37510
6.0232113765053e-96	0.831860873920105	0.953	0.844	9.75097689742443e-92	MXD4	Malignant cells	GSE131984_JQ1	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37511
1.31937652262086e-95	-0.541583047882178	0.996	1	2.13593865247091e-91	NAA10	Malignant cells	GSE131984_JQ1	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37512
3.11497137117263e-95	-0.837261436756161	0.481	0.777	5.04282715279138e-91	LYAR	Malignant cells	GSE131984_JQ1	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37513
4.09589312792715e-95	-0.494703324798407	0.052	0.366	6.63084138480127e-91	CDC42EP1	Malignant cells	GSE131984_JQ1	ENSG00000128283	11135	CDC42 effector protein 1	Borg5|CEP1|MSE55	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37514
6.74965561736768e-95	-0.705272109087165	0.321	0.705	1.09270174789565e-90	IFITM2	Malignant cells	GSE131984_JQ1	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37515
1.05940021339535e-94	-0.599164952136674	0.887	0.977	1.71506300546573e-90	METTL5	Malignant cells	GSE131984_JQ1	ENSG00000138382	29081	methyltransferase 5, N6-adenosine	HSPC133	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37516
1.53687771881589e-94	-0.558799638754465	0.983	0.996	2.48805133899105e-90	NDUFAB1	Malignant cells	GSE131984_JQ1	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37517
1.98883867902567e-94	-0.791282475389962	0.154	0.508	3.21973093747466e-90	SLC14A1	Malignant cells	GSE131984_JQ1	ENSG00000141469	6563	solute carrier family 14 member 1 (Kidd blood group)	HsT1341|JK|RACH1|RACH2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37518
5.04769173256462e-94	-0.68473405937429	0.779	0.938	8.17170814584887e-90	PSMG1	Malignant cells	GSE131984_JQ1	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37519
1.46764678517082e-93	-0.4674321644839	0.996	0.998	2.37597338051303e-89	AURKAIP1	Malignant cells	GSE131984_JQ1	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37520
1.66289370212074e-93	-0.705479008821243	0.624	0.863	2.69205861436327e-89	ATG3	Malignant cells	GSE131984_JQ1	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37521
2.70436502862556e-93	-0.712914589034005	0.588	0.859	4.37809654484191e-89	LRR1	Malignant cells	GSE131984_JQ1	ENSG00000165501	122769	leucine rich repeat protein 1	LRR-1|MGC20689|PPIL5	protein_coding	Q96L50	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37522
3.07857612842796e-93	-0.674947635966163	0.801	0.933	4.98390689431203e-89	PAICS	Malignant cells	GSE131984_JQ1	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37523
3.99697477950466e-93	-0.567031881642583	0.966	0.993	6.47070247054009e-89	LSM3	Malignant cells	GSE131984_JQ1	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37524
4.51273809460673e-93	0.314063024010146	1	1	7.30567170135884e-89	RPL13A	Malignant cells	GSE131984_JQ1	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37525
4.84398031405563e-93	-0.583112359276629	0.972	0.995	7.84191973042466e-89	SRM	Malignant cells	GSE131984_JQ1	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37526
5.27448741259668e-93	0.705882504610855	0.935	0.792	8.53886767225277e-89	TTC3	Malignant cells	GSE131984_JQ1	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37527
5.4419305286237e-93	-0.743525153284578	0.708	0.914	8.8099413327889e-89	VBP1	Malignant cells	GSE131984_JQ1	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37528
1.29852315451962e-92	0.258364379141606	1	1	2.10217913485182e-88	RPL8	Malignant cells	GSE131984_JQ1	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37529
1.588960410702e-92	-0.641225698457643	0.829	0.96	2.57236800888546e-88	CISD1	Malignant cells	GSE131984_JQ1	ENSG00000122873	55847	CDGSH iron sulfur domain 1	C10orf70|MDS029|mitoNEET|ZCD1	protein_coding	Q9NZ45	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37530
2.01201896981503e-92	-0.623573738583922	0.96	0.994	3.25725751023356e-88	DNAJC15	Malignant cells	GSE131984_JQ1	ENSG00000120675	29103	DnaJ heat shock protein family (Hsp40) member C15	DNAJD1|MCJ	protein_coding	Q9Y5T4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37531
2.26087797659849e-92	-0.58218497738115	0.091	0.423	3.66013535631529e-88	CASP1	Malignant cells	GSE131984_JQ1	ENSG00000137752	834	caspase 1	ICE|IL1BC	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37532
2.31173015259144e-92	-0.811126052252035	0.427	0.779	3.74245994403028e-88	PBK	Malignant cells	GSE131984_JQ1	ENSG00000168078	55872	PDZ binding kinase	CT84|FLJ14385|Nori-3|SPK|TOPK	protein_coding	Q96KB5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37533
3.22323621101495e-92	0.591552126670024	0.99	0.976	5.21809710201211e-88	POLE4	Malignant cells	GSE131984_JQ1	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37534
7.53609005654418e-92	-0.76710670630217	0.351	0.694	1.22001761925394e-87	HCCS	Malignant cells	GSE131984_JQ1	ENSG00000004961	3052	holocytochrome c synthase	CCHL|MLS	protein_coding	P53701	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37535
1.40354256773805e-91	0.273089948021476	1	1	2.27219506291113e-87	RPS20	Malignant cells	GSE131984_JQ1	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37536
2.23782764731333e-91	-0.729399201543924	0.376	0.72	3.62281917823554e-87	GAR1	Malignant cells	GSE131984_JQ1	ENSG00000109534	54433	GAR1 ribonucleoprotein	NOLA1	protein_coding	Q9NY12	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37537
2.55356397805788e-91	0.669009496473349	0.392	0.042	4.13396472407791e-87	NR2F1	Malignant cells	GSE131984_JQ1	ENSG00000175745	7025	nuclear receptor subfamily 2 group F member 1	COUP-TFI|COUPTF1|EAR-3|ERBAL3|SVP44|TCFCOUP1|TFCOUP1	protein_coding	P10589	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37538
3.89996443178038e-91	-0.791330097559733	0.702	0.883	6.31365241860925e-87	ILF2	Malignant cells	GSE131984_JQ1	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37539
7.57353730590601e-91	-0.7097967208165	0.553	0.83	1.22607995445312e-86	MRPL15	Malignant cells	GSE131984_JQ1	ENSG00000137547	29088	mitochondrial ribosomal protein L15	HSPC145|L15mt|MRP-L15|MRP-L7|RPML7	protein_coding	Q9P015	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37540
8.19471316527766e-91	-0.752324996628649	0.364	0.703	1.3266421143268e-86	PYCR1	Malignant cells	GSE131984_JQ1	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37541
2.07114477243556e-90	-0.958167050206651	0.114	0.457	3.35297627209593e-86	KRT75	Malignant cells	GSE131984_JQ1	ENSG00000170454	9119	keratin 75	K6HF	protein_coding	O95678	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37542
7.01644518717602e-90	-0.654180501471084	0.822	0.944	1.13589231135193e-85	NAA20	Malignant cells	GSE131984_JQ1	ENSG00000173418	51126	N-alpha-acetyltransferase 20, NatB catalytic subunit	dJ1002M8.1|NAT3|NAT5	protein_coding	P61599	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37543
7.11430900381e-90	-0.776783315475781	0.781	0.903	1.1517354846268e-85	TCEAL4	Malignant cells	GSE131984_JQ1	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37544
2.01905716460826e-89	-0.736467394671964	0.569	0.828	3.26865164378432e-85	TSPAN4	Malignant cells	GSE131984_JQ1	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37545
1.05615887686028e-88	1.11005481727737	0.824	0.551	1.70981560574912e-84	FN1	Malignant cells	GSE131984_JQ1	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37546
1.97805168885131e-88	-0.587072996545166	0.962	0.992	3.20226787908138e-84	PTGES3	Malignant cells	GSE131984_JQ1	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37547
4.28376128263397e-88	-0.854770023075867	0.756	0.914	6.93498114045613e-84	PSMA3	Malignant cells	GSE131984_JQ1	ENSG00000100567	5684	proteasome 20S subunit alpha 3	HC8	protein_coding	P25788	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37548
4.65750131911372e-88	-0.682783160061349	0.742	0.92	7.5400288855132e-84	DCUN1D5	Malignant cells	GSE131984_JQ1	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37549
1.04565008188296e-87	-0.703824956852311	0.748	0.922	1.69280291756033e-83	IRAK1	Malignant cells	GSE131984_JQ1	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37550
1.59034735792387e-87	-0.726199242064691	0.852	0.956	2.57461333774295e-83	ESD	Malignant cells	GSE131984_JQ1	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37551
6.44476753163919e-87	-0.599726809895357	0.999	1	1.04334341569707e-82	TUBB	Malignant cells	GSE131984_JQ1	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37552
1.58897827032161e-86	-0.685399460109805	0.76	0.913	2.57239692182366e-82	MRPL22	Malignant cells	GSE131984_JQ1	ENSG00000082515	29093	mitochondrial ribosomal protein L22	HSPC158|MRP-L25|RPML25	protein_coding	Q9NWU5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37553
5.60632154134061e-86	-0.821562843771645	0.933	0.985	9.07607394327631e-82	CCT5	Malignant cells	GSE131984_JQ1	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37554
9.26649228861751e-86	-0.541271778232213	0.941	0.993	1.50015243660429e-81	LSM7	Malignant cells	GSE131984_JQ1	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37555
2.4435896028153e-85	-0.704209632238945	0.987	0.997	3.95592720799769e-81	C1QBP	Malignant cells	GSE131984_JQ1	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37556
2.71026320383705e-85	-0.556384966261959	0.971	0.993	4.38764510069179e-81	NDUFB11	Malignant cells	GSE131984_JQ1	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37557
3.78200435604218e-85	-0.596730434498337	0.835	0.948	6.12268685199669e-81	HDGF	Malignant cells	GSE131984_JQ1	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37558
4.23633909075312e-85	-0.488846162375927	0.99	0.997	6.85820935402022e-81	ATP5I	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37559
6.22202171986159e-85	-0.524897668268104	1	1	1.00728309622839e-80	RAN	Malignant cells	GSE131984_JQ1	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37560
9.54798388863216e-85	-0.623815177878563	0.974	0.996	1.54572311173066e-80	HNRNPDL	Malignant cells	GSE131984_JQ1	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37561
1.10076417095913e-84	-0.631687707533855	0.656	0.87	1.78202711636573e-80	UFC1	Malignant cells	GSE131984_JQ1	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37562
2.19185328020354e-84	-0.592538600527901	0.936	0.992	3.54839127532152e-80	EIF3I	Malignant cells	GSE131984_JQ1	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37563
2.2012349314733e-84	-0.595393889577284	0.849	0.961	3.56357923056212e-80	MRPL52	Malignant cells	GSE131984_JQ1	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37564
2.79137831043075e-84	-0.642864767618777	0.903	0.978	4.51896234675634e-80	DDX21	Malignant cells	GSE131984_JQ1	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37565
3.11335090897862e-84	-0.719300700150134	0.544	0.812	5.04020378654548e-80	ANP32E	Malignant cells	GSE131984_JQ1	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37566
3.46569530224761e-84	-0.58020455158772	0.954	0.992	5.61061412480866e-80	ANP32B	Malignant cells	GSE131984_JQ1	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37567
3.53550181429686e-84	-0.729110619030428	0.208	0.544	5.72362388716519e-80	CASC8	Malignant cells	GSE131984_JQ1	ENSG00000246228	727677	cancer susceptibility 8	CARLo-1|LINC00860	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37568
6.85497344103077e-84	-0.63978582137891	0.971	0.992	1.10975165036847e-79	STRA13	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37569
8.37810710235632e-84	-0.679432352956009	0.903	0.974	1.35633175880047e-79	SRSF7	Malignant cells	GSE131984_JQ1	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37570
9.50510109068241e-84	-0.581083059249616	0.878	0.969	1.53878081557058e-79	NDUFAF2	Malignant cells	GSE131984_JQ1	ENSG00000164182	91942	NADH:ubiquinone oxidoreductase complex assembly factor 2	B17.2L|mimitin|MMTN|NDUFA12L	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37571
2.9304463713951e-83	-0.441522936034453	1	1	4.74409963065153e-79	SUB1	Malignant cells	GSE131984_JQ1	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37572
3.88237269451458e-83	-0.66990773390251	0.842	0.964	6.28517315514965e-79	PSMB2	Malignant cells	GSE131984_JQ1	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37573
3.99015088389665e-83	-0.559842973243971	0.955	0.992	6.45965526594029e-79	TCEB1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37574
4.36052912011042e-83	-0.584545906970086	0.971	0.993	7.05926059254676e-79	MRPL12	Malignant cells	GSE131984_JQ1	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37575
6.46392239798319e-83	0.557618363171129	0.993	0.959	1.0464443970095e-78	AHNAK	Malignant cells	GSE131984_JQ1	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37576
2.85773373932042e-82	-0.708991210097428	0.418	0.715	4.62638515058583e-78	UROD	Malignant cells	GSE131984_JQ1	ENSG00000126088	7389	uroporphyrinogen decarboxylase	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37577
3.11101399344393e-82	-0.724594224286358	0.691	0.883	5.03642055398638e-78	PSMC1	Malignant cells	GSE131984_JQ1	ENSG00000100764	5700	proteasome 26S subunit, ATPase 1	p56|RPT2|S4	protein_coding	P62191	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37578
3.4964176667543e-82	-0.413289367051725	0.999	1	5.66035056070853e-78	TSPO	Malignant cells	GSE131984_JQ1	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37579
5.19626808777607e-82	-0.608674137193611	0.836	0.961	8.41223840730068e-78	TOMM40	Malignant cells	GSE131984_JQ1	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37580
5.64830047513701e-82	-0.457876375263845	0.031	0.289	9.1440336391993e-78	IL7R	Malignant cells	GSE131984_JQ1	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37581
6.0269355664655e-82	-0.685078049210452	0.28	0.627	9.757005988551e-78	CARD16	Malignant cells	GSE131984_JQ1	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37582
6.61514512704212e-82	-0.527189505089539	0.973	0.993	1.07092584461685e-77	C14orf166	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37583
8.07843698617161e-82	-0.561130197466253	0.946	0.99	1.30781816369132e-77	CNBP	Malignant cells	GSE131984_JQ1	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37584
8.72716906473058e-82	-0.65439089561802	0.461	0.761	1.41284139988923e-77	FTSJ1	Malignant cells	GSE131984_JQ1	ENSG00000068438	24140	FtsJ RNA 2'-O-methyltransferase 1	CDLIV|JM23|MRX44|MRX9|SPB1|TRM7|TRMT7	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37585
9.98670017937949e-82	0.642173146793984	0.376	0.049	1.61674689203975e-77	IGFBP2	Malignant cells	GSE131984_JQ1	ENSG00000115457	3485	insulin like growth factor binding protein 2	IBP2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37586
1.21005756998408e-81	-0.613429424377302	0.254	0.599	1.95896220004722e-77	PRPS2	Malignant cells	GSE131984_JQ1	ENSG00000101911	5634	phosphoribosyl pyrophosphate synthetase 2	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37587
1.55522088662849e-81	-0.479385789142584	0.026	0.277	2.51774709336287e-77	TSPAN8	Malignant cells	GSE131984_JQ1	ENSG00000127324	7103	tetraspanin 8	CO-029|TM4SF3	protein_coding	P19075	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37588
1.57394999737053e-81	-0.49536614848795	0.999	1	2.54806765074314e-77	TAGLN2	Malignant cells	GSE131984_JQ1	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37589
2.53616052788715e-81	-0.643837085960179	0.808	0.924	4.10579027859651e-77	LINC00116	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37590
3.69635067421972e-81	-0.514210913402877	0.992	0.999	5.9840221064943e-77	NOP10	Malignant cells	GSE131984_JQ1	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37591
7.31423216279336e-81	-0.635603296477014	0.661	0.878	1.18410104483462e-76	PAFAH1B3	Malignant cells	GSE131984_JQ1	ENSG00000079462	5050	platelet activating factor acetylhydrolase 1b catalytic subunit 3	NA	protein_coding	Q15102	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37592
1.89301309361392e-80	-0.519118911703477	0.065	0.352	3.06459889725158e-76	TMEM98	Malignant cells	GSE131984_JQ1	ENSG00000006042	26022	transmembrane protein 98	DKFZP564K1964	protein_coding	Q9Y2Y6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37593
2.0764719553459e-80	-0.431736812878997	0.997	1	3.36160044850948e-76	TBCA	Malignant cells	GSE131984_JQ1	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37594
2.60982244800874e-80	-0.662677931036002	0.47	0.773	4.22504156108134e-76	PPIF	Malignant cells	GSE131984_JQ1	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37595
3.25660449220983e-80	-0.479564997300577	0.049	0.321	5.2721170124385e-76	RP11-527H14.3	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37596
2.15493953637815e-78	0.637486968923395	0.978	0.931	3.48863161544259e-74	DCXR	Malignant cells	GSE131984_JQ1	ENSG00000169738	51181	dicarbonyl and L-xylulose reductase	DCR|HCR2|KIDCR|P34H|SDR20C1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37597
3.14299640679169e-78	-0.572032870720358	0.842	0.941	5.08819688295506e-74	SRP72	Malignant cells	GSE131984_JQ1	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37598
3.94059284406443e-78	-0.572195394566374	0.959	0.993	6.3794257552559e-74	ERH	Malignant cells	GSE131984_JQ1	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37599
6.00491258563396e-78	-0.435321321765122	0.997	1	9.72135298488282e-74	PDCD5	Malignant cells	GSE131984_JQ1	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37600
6.35722284758167e-78	-0.807612402953115	0.472	0.751	1.029170806795e-73	BRIX1	Malignant cells	GSE131984_JQ1	ENSG00000113460	55299	biogenesis of ribosomes BRX1	BRIX|BXDC2|FLJ11100	protein_coding	Q8TDN6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37601
7.19761835046295e-78	-0.548859695673568	0.992	0.997	1.16522243475645e-73	MRPL36	Malignant cells	GSE131984_JQ1	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37602
7.37334728567032e-78	-0.634424591218651	0.87	0.957	1.19367119207717e-73	GLRX3	Malignant cells	GSE131984_JQ1	ENSG00000108010	10539	glutaredoxin 3	bA500G10.4|GLRX4|GRX3|GRX4|PICOT|TXNL2	protein_coding	O76003	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37603
8.18096916149502e-78	-0.462737358338948	0.991	1	1.32441709755443e-73	GADD45GIP1	Malignant cells	GSE131984_JQ1	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37604
9.87892001348052e-78	-0.672719248017244	0.506	0.782	1.59929836098236e-73	VAMP8	Malignant cells	GSE131984_JQ1	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37605
1.25473215240845e-77	0.591819868567008	0.41	0.08	2.03128588153404e-73	IFITM10	Malignant cells	GSE131984_JQ1	ENSG00000281618	402778	interferon induced transmembrane protein 10	DSPA3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37606
1.52953745654222e-77	0.493364537957397	0.999	0.998	2.4761681883962e-73	MT-ATP6	Malignant cells	GSE131984_JQ1	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37607
2.83732468781084e-77	-0.717000517773701	0.757	0.923	4.59334493709697e-73	PSMD7	Malignant cells	GSE131984_JQ1	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37608
4.00085601162937e-77	-0.642303071010663	0.921	0.992	6.47698579722678e-73	PTTG1	Malignant cells	GSE131984_JQ1	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37609
7.15461411534281e-77	-0.696736798442539	0.412	0.709	1.15826047913285e-72	MAGOHB	Malignant cells	GSE131984_JQ1	ENSG00000111196	55110	mago homolog B, exon junction complex subunit	FLJ10292|MGN2	protein_coding	Q96A72	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37610
9.58429161757185e-77	-0.486669695955208	0.987	0.998	1.55160096996871e-72	SF3B5	Malignant cells	GSE131984_JQ1	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37611
9.82194575714559e-77	-0.678002043639849	0.463	0.746	1.5900747986243e-72	TIMM8A	Malignant cells	GSE131984_JQ1	ENSG00000126953	1678	translocase of inner mitochondrial membrane 8A	DDP|DFN1|MTS	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37612
1.10555308919631e-76	-0.712875354742237	0.711	0.899	1.78977989609991e-72	SNRPA1	Malignant cells	GSE131984_JQ1	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37613
1.45606664515578e-76	-0.559084166133861	0.848	0.964	2.35722629184269e-72	MRPL4	Malignant cells	GSE131984_JQ1	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37614
2.80209306009607e-76	-0.584643397721145	0.929	0.988	4.53630845498953e-72	U2AF1	Malignant cells	GSE131984_JQ1	ENSG00000160201	7307	U2 small nuclear RNA auxiliary factor 1	RN|RNU2AF1|U2AF35|U2AFBP	protein_coding	Q01081	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37615
4.59892497706674e-76	-0.735371060342968	0.734	0.888	7.44519964537335e-72	NUDC	Malignant cells	GSE131984_JQ1	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37616
1.40148703300854e-75	0.599412004441556	0.626	0.287	2.26886735773752e-71	ITFG3	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37617
1.55989692784224e-75	-0.33588963754184	1	1	2.5253171364838e-71	RPL38	Malignant cells	GSE131984_JQ1	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37618
3.01821881599946e-75	-0.610401163712456	0.967	0.992	4.88619444122152e-71	SSBP1	Malignant cells	GSE131984_JQ1	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37619
6.86707303944134e-75	-0.688978170247061	0.507	0.774	1.11171045435516e-70	ALG5	Malignant cells	GSE131984_JQ1	ENSG00000120697	29880	ALG5 dolichyl-phosphate beta-glucosyltransferase	bA421P11.2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37620
1.52976598273701e-74	-0.559317326205589	0.765	0.91	2.47653814945294e-70	HAX1	Malignant cells	GSE131984_JQ1	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37621
1.62284672875197e-74	-0.60863395709179	0.787	0.919	2.62722656917657e-70	TIMM17A	Malignant cells	GSE131984_JQ1	ENSG00000134375	10440	translocase of inner mitochondrial membrane 17A	TIM17|TIM17A	protein_coding	Q99595	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37622
1.80326302006967e-74	-0.621224593844536	0.851	0.942	2.91930250319078e-70	EIF6	Malignant cells	GSE131984_JQ1	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37623
2.26730282460786e-74	-0.455255483061509	0.982	0.995	3.67053654275766e-70	GNG5	Malignant cells	GSE131984_JQ1	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37624
2.80991353034306e-74	-0.544389315555831	0.866	0.976	4.54896901427237e-70	MRPL18	Malignant cells	GSE131984_JQ1	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37625
3.22292693340172e-74	-0.523494646602644	0.125	0.43	5.21759641248405e-70	STEAP1	Malignant cells	GSE131984_JQ1	ENSG00000164647	26872	STEAP family member 1	PRSS24|STEAP	protein_coding	Q9UHE8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37626
3.60807479057514e-74	-0.556432730503745	0.06	0.327	5.84111227846209e-70	DIO2	Malignant cells	GSE131984_JQ1	ENSG00000211448	1734	iodothyronine deiodinase 2	SELENOY|SelY|TXDI2	protein_coding	Q92813	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37627
8.25463140404428e-74	0.302366071730447	1	1	1.33634227800073e-69	OAZ1	Malignant cells	GSE131984_JQ1	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37628
1.12032818414336e-73	-0.603662551809734	0.813	0.935	1.81369929730969e-69	CNIH4	Malignant cells	GSE131984_JQ1	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37629
1.29177180103593e-73	0.63974350603334	0.919	0.792	2.09124936869706e-69	RNASEH2C	Malignant cells	GSE131984_JQ1	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37630
1.82703036968847e-73	-0.651383365345216	0.693	0.887	2.95777946548866e-69	DCTPP1	Malignant cells	GSE131984_JQ1	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37631
3.91375593724328e-73	-0.580026351993515	0.494	0.778	6.33597948680315e-69	COMMD7	Malignant cells	GSE131984_JQ1	ENSG00000149600	149951	COMM domain containing 7	C20orf92|dJ1085F17.3	protein_coding	Q86VX2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37632
5.9575110847067e-73	-0.719427285146451	0.601	0.824	9.64461469503168e-69	MRPL13	Malignant cells	GSE131984_JQ1	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37633
7.38505920265323e-73	-0.578444528960868	0.707	0.901	1.19556723431753e-68	ZNF593	Malignant cells	GSE131984_JQ1	ENSG00000142684	51042	zinc finger protein 593	ZT86	protein_coding	O00488	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37634
8.46899222977123e-73	-0.623319328800678	0.901	0.97	1.37104515207766e-68	HNRNPD	Malignant cells	GSE131984_JQ1	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37635
1.17586401021432e-72	-0.602374180496992	0.824	0.95	1.90360624613596e-68	REXO2	Malignant cells	GSE131984_JQ1	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37636
1.74222075351931e-72	-0.633970078565439	0.892	0.969	2.82048117787241e-68	CCT4	Malignant cells	GSE131984_JQ1	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37637
1.77762690817895e-72	-0.637101388924075	0.63	0.848	2.87780020165091e-68	MRPL47	Malignant cells	GSE131984_JQ1	ENSG00000136522	57129	mitochondrial ribosomal protein L47	CGI-204|NCM1	protein_coding	Q9HD33	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37638
2.08141698632866e-72	-0.617544356523689	0.596	0.839	3.36960595916746e-68	ICT1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37639
2.53123518621813e-72	-0.669321354012959	0.498	0.765	4.09781664296853e-68	MRTO4	Malignant cells	GSE131984_JQ1	ENSG00000053372	51154	MRT4 homolog, ribosome maturation factor	C1orf33|dJ657E11.4|MRT4	protein_coding	Q9UKD2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37640
2.87064083567367e-72	0.845837156044034	0.969	0.906	4.6472804488721e-68	TGFBI	Malignant cells	GSE131984_JQ1	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37641
3.4364803678993e-72	-0.595269542459084	0.912	0.978	5.56331806759217e-68	PSMA1	Malignant cells	GSE131984_JQ1	ENSG00000129084	5682	proteasome 20S subunit alpha 1	HC2|MGC14542|MGC14575|MGC14751|MGC1667|MGC21459|MGC22853|MGC23915|NU|PROS30	protein_coding	P25786	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37642
4.83165540185285e-72	-0.609703878620508	0.08	0.352	7.82196693005958e-68	PRSS23	Malignant cells	GSE131984_JQ1	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37643
5.55264608257841e-72	-0.559361547571571	0.953	0.984	8.98917874308618e-68	PSMD8	Malignant cells	GSE131984_JQ1	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37644
9.1900936786871e-72	-0.509624202709702	0.916	0.979	1.48778426564265e-67	RAB34	Malignant cells	GSE131984_JQ1	ENSG00000109113	83871	RAB34, member RAS oncogene family	NARR|RAB39|RAH	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37645
1.26408031759112e-71	0.253145158124973	1	1	2.04641962614827e-67	RPS15A	Malignant cells	GSE131984_JQ1	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37646
1.47684568325323e-71	-0.70396468095674	0.241	0.557	2.39086547661866e-67	COL8A1	Malignant cells	GSE131984_JQ1	ENSG00000144810	1295	collagen type VIII alpha 1 chain	C3orf7|MGC9568	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37647
1.48137299499149e-71	-0.578225427634057	0.556	0.81	2.39819474159172e-67	CUEDC2	Malignant cells	GSE131984_JQ1	ENSG00000107874	79004	CUE domain containing 2	C10orf66|MGC2491	protein_coding	Q9H467	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37648
2.80781932771469e-71	-0.614151360326415	0.847	0.937	4.54557870963732e-67	SDHB	Malignant cells	GSE131984_JQ1	ENSG00000117118	6390	succinate dehydrogenase complex iron sulfur subunit B	SDH|SDH1	protein_coding	P21912	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37649
3.09076862934951e-71	-0.432725926132579	1	0.999	5.00364533405393e-67	NDUFS6	Malignant cells	GSE131984_JQ1	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37650
4.01131500847572e-71	-0.478061906631309	0.972	0.993	6.49391786722135e-67	UBE2D2	Malignant cells	GSE131984_JQ1	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37651
4.65394091380883e-71	-0.514484738195552	0.932	0.982	7.53426494536512e-67	MRPL33	Malignant cells	GSE131984_JQ1	ENSG00000243147	9553	mitochondrial ribosomal protein L33	C2orf1|RPL33L	protein_coding	O75394	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37652
4.72256587694788e-71	-0.697869935460337	0.103	0.385	7.64536189819092e-67	NUPR1	Malignant cells	GSE131984_JQ1	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37653
5.5939379529353e-71	-0.650360618968498	0.636	0.847	9.05602615200696e-67	DKC1	Malignant cells	GSE131984_JQ1	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37654
7.09873961227076e-71	-0.501921774067613	0.96	0.992	1.14921495583051e-66	SRSF2	Malignant cells	GSE131984_JQ1	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37655
9.60068252972724e-71	-0.722860414151335	0.643	0.847	1.55425449473754e-66	CDC123	Malignant cells	GSE131984_JQ1	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37656
1.13152000229074e-70	-0.613448872544932	0.642	0.848	1.83181773170848e-66	AP1S1	Malignant cells	GSE131984_JQ1	ENSG00000106367	1174	adaptor related protein complex 1 subunit sigma 1	AP19|CLAPS1|EKV3|SIGMA1A|WUGSC:H_DJ0747G18.2	protein_coding	P61966	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37657
1.1822832921179e-70	-0.539672391376462	0.861	0.954	1.91399842160967e-66	NPM3	Malignant cells	GSE131984_JQ1	ENSG00000107833	10360	nucleophosmin/nucleoplasmin 3	NA	protein_coding	O75607	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37658
1.58206440007911e-70	-0.533057755108032	0.87	0.964	2.56120405728808e-66	CDK4	Malignant cells	GSE131984_JQ1	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37659
2.15269024395759e-70	0.549107139044488	0.973	0.922	3.48499023594294e-66	PHPT1	Malignant cells	GSE131984_JQ1	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37660
2.1896622140233e-70	-0.402409740563227	0.999	1	3.54484415828232e-66	MZT2B	Malignant cells	GSE131984_JQ1	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37661
2.71692414566988e-70	-0.346258927744738	1	1	4.39842849942497e-66	RPS29	Malignant cells	GSE131984_JQ1	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37662
4.07865565716648e-70	-0.717484257071591	0.452	0.746	6.60293564338681e-66	UBE2T	Malignant cells	GSE131984_JQ1	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37663
4.10379144228098e-70	0.27283296796038	1	1	6.64362796590868e-66	UBA52	Malignant cells	GSE131984_JQ1	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37664
4.69679799703134e-70	-0.576462353198232	0.687	0.874	7.60364627739403e-66	IER3IP1.1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37665
5.76261422954325e-70	-0.451226779254144	0.987	0.997	9.32909617620757e-66	JTB	Malignant cells	GSE131984_JQ1	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37666
1.06763674150798e-69	-0.466505660876348	0.948	0.992	1.72839712082727e-65	MZT2A	Malignant cells	GSE131984_JQ1	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37667
1.12364952480707e-69	0.709873240414955	0.788	0.523	1.81907621571016e-65	AHNAK2	Malignant cells	GSE131984_JQ1	ENSG00000185567	113146	AHNAK nucleoprotein 2	C14orf78	protein_coding	Q8IVF2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37668
1.19575842588869e-69	-0.646845011763722	0.787	0.921	1.9358133156712e-65	RBBP7	Malignant cells	GSE131984_JQ1	ENSG00000102054	5931	RB binding protein 7, chromatin remodeling factor	RbAp46	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37669
2.04028866683579e-69	-0.633675237534608	0.956	0.982	3.30302332274046e-65	GNG11	Malignant cells	GSE131984_JQ1	ENSG00000127920	2791	G protein subunit gamma 11	GNGT11	protein_coding	P61952	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37670
2.59512790401918e-69	-0.431283796523551	0.997	1	4.20125256381666e-65	SERBP1	Malignant cells	GSE131984_JQ1	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37671
2.85431524790816e-69	-0.611993659427414	0.718	0.888	4.62085095483851e-65	MRPS7	Malignant cells	GSE131984_JQ1	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37672
3.12196570954568e-69	0.609630785913371	0.976	0.935	5.05415028718351e-65	LAGE3	Malignant cells	GSE131984_JQ1	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37673
5.56693859433852e-69	-0.607130906389667	0.893	0.962	9.01231689037464e-65	GSTO1	Malignant cells	GSE131984_JQ1	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37674
8.58306807602145e-69	-0.68196695637596	0.36	0.652	1.38951289082711e-64	PBDC1	Malignant cells	GSE131984_JQ1	ENSG00000102390	51260	polysaccharide biosynthesis domain containing 1	CXorf26|MGC874	protein_coding	Q9BVG4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37675
1.62941681291849e-68	-0.716144604781262	0.476	0.736	2.63786287843374e-64	NUCB2	Malignant cells	GSE131984_JQ1	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37676
2.03883549928109e-68	-0.585853249032173	0.19	0.508	3.30067078978615e-64	TNFAIP3	Malignant cells	GSE131984_JQ1	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37677
2.05542177809804e-68	-0.56156868757903	0.917	0.981	3.32752231656291e-64	ATP6V0B	Malignant cells	GSE131984_JQ1	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37678
3.25787056579665e-68	-0.439283211815189	0.987	0.995	5.27416665896819e-64	MRPL14	Malignant cells	GSE131984_JQ1	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37679
3.88434311733144e-68	-0.509931365251672	0.918	0.975	6.28836307264786e-64	RAB32	Malignant cells	GSE131984_JQ1	ENSG00000118508	10981	RAB32, member RAS oncogene family	NA	protein_coding	Q13637	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37680
4.3217056578545e-68	0.625414988183806	0.84	0.635	6.99640928950066e-64	TMPRSS15	Malignant cells	GSE131984_JQ1	ENSG00000154646	5651	transmembrane serine protease 15	ENTK|MGC133046|PRSS7	protein_coding	P98073	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37681
6.12793868480552e-68	-0.551438719622199	0.826	0.964	9.92051993683166e-64	DTYMK	Malignant cells	GSE131984_JQ1	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37682
6.58257555720659e-68	-0.630761209002519	0.511	0.751	1.06565315695617e-63	UBE2E1	Malignant cells	GSE131984_JQ1	ENSG00000170142	7324	ubiquitin conjugating enzyme E2 E1	UbcH6	protein_coding	P51965	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37683
6.63979966118895e-68	-0.511250675840349	0.941	0.992	1.07491716714988e-63	DUT	Malignant cells	GSE131984_JQ1	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37684
8.48574091190292e-68	0.823753633502409	0.509	0.188	1.37375659622796e-63	STAC2	Malignant cells	GSE131984_JQ1	ENSG00000141750	342667	SH3 and cysteine rich domain 2	24b2	protein_coding	Q6ZMT1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37685
9.48243849171899e-68	-0.553707594915137	0.83	0.931	1.53511196742439e-63	THOC7	Malignant cells	GSE131984_JQ1	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37686
1.03161635853116e-67	0.40264785625455	1	1	1.67008372282609e-63	GAPDH	Malignant cells	GSE131984_JQ1	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37687
1.09253419000397e-67	-0.50468010833804	0.934	0.979	1.76870360019743e-63	RPS19BP1	Malignant cells	GSE131984_JQ1	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37688
1.09813588200301e-67	-0.54632316948165	0.848	0.964	1.77777217937468e-63	EMC4	Malignant cells	GSE131984_JQ1	ENSG00000128463	51234	ER membrane protein complex subunit 4	FLJ90746|MGC24415|PIG17|TMEM85	protein_coding	Q5J8M3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37689
3.57186465176517e-67	-0.279415652182727	1	1	5.78249168474264e-63	BTF3	Malignant cells	GSE131984_JQ1	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37690
3.79194120909042e-67	-0.534211272838783	0.937	0.985	6.13877362339649e-63	VAPA	Malignant cells	GSE131984_JQ1	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37691
5.01594798510374e-67	-0.46428824099838	0.981	0.998	8.12031819308445e-63	MRPL20	Malignant cells	GSE131984_JQ1	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37692
5.45999195382433e-67	-0.488701101908684	0.955	0.992	8.83918097404622e-63	RHEB	Malignant cells	GSE131984_JQ1	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37693
1.6050840796935e-66	-0.555181152279296	0.248	0.555	2.5984706166158e-62	SFN	Malignant cells	GSE131984_JQ1	ENSG00000175793	2810	stratifin	YWHAS	protein_coding	P31947	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37694
2.25541684184742e-66	-0.584360368278824	0.983	0.998	3.6512943252668e-62	CALM2	Malignant cells	GSE131984_JQ1	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37695
2.38324765175445e-66	-0.446192364165797	1	0.999	3.85823962342528e-62	HNRNPA2B1	Malignant cells	GSE131984_JQ1	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37696
2.94234967669909e-66	-0.596371271521749	0.684	0.865	4.76336989160815e-62	TARS	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37697
3.0337414122109e-66	0.640407638587732	0.87	0.667	4.91132397222823e-62	ITGA3	Malignant cells	GSE131984_JQ1	ENSG00000005884	3675	integrin subunit alpha 3	CD49c|GAP-B3|MSK18|VCA-2|VLA3a	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37698
4.62898564559862e-66	-0.552854401829383	0.82	0.939	7.49386486165961e-62	SNRPD3	Malignant cells	GSE131984_JQ1	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37699
4.63282794824456e-66	-0.423866617339336	0.99	0.997	7.50008516541312e-62	UQCR10	Malignant cells	GSE131984_JQ1	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37700
5.24462924694115e-66	-0.593367344751817	0.873	0.956	8.49053028787302e-62	PSMA5	Malignant cells	GSE131984_JQ1	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37701
7.52704280793322e-66	-0.476681010496692	0.964	0.991	1.21855296017631e-61	NDUFB4	Malignant cells	GSE131984_JQ1	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37702
8.05994835831768e-66	-0.637349380383211	0.397	0.687	1.30482503972805e-61	MAGOH	Malignant cells	GSE131984_JQ1	ENSG00000162385	4116	mago homolog, exon junction complex subunit	MAGOH1|MAGOHA	protein_coding	P61326	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37703
1.74507545060958e-65	-0.597641600435845	0.126	0.404	2.82510264699184e-61	AC003092.1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37704
1.92206971709868e-65	-0.65471414911423	0.615	0.828	3.11163866501106e-61	SRGN	Malignant cells	GSE131984_JQ1	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37705
2.53005369509411e-65	-0.731226665195444	0.4	0.677	4.09590392698786e-61	WBP5	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37706
3.19147405974218e-65	-0.621261810164428	0.775	0.892	5.16667735531661e-61	SNRPB2	Malignant cells	GSE131984_JQ1	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37707
3.40172078486125e-65	0.641805408497286	0.969	0.931	5.50704577861188e-61	TXNRD1	Malignant cells	GSE131984_JQ1	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37708
8.72024498857559e-65	-0.493412622283967	0.2	0.5	1.4117204612005e-60	C9orf40	Malignant cells	GSE131984_JQ1	ENSG00000135045	55071	chromosome 9 open reading frame 40	FLJ10110	protein_coding	Q8IXQ3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37709
8.74556482384336e-65	-0.608116219948439	0.738	0.893	1.415819489332e-60	EEF1E1	Malignant cells	GSE131984_JQ1	ENSG00000124802	9521	eukaryotic translation elongation factor 1 epsilon 1	AIMP3|P18	protein_coding	O43324	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37710
1.49450790574228e-64	-0.67128567432165	0.753	0.877	2.41945884860618e-60	PSMD14	Malignant cells	GSE131984_JQ1	ENSG00000115233	10213	proteasome 26S subunit, non-ATPase 14	pad1|POH1|Rpn11	protein_coding	O00487	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37711
1.56185279579699e-64	0.642759744233402	0.912	0.762	2.52848349111575e-60	ANPEP	Malignant cells	GSE131984_JQ1	ENSG00000166825	290	alanyl aminopeptidase, membrane	AP-N|CD13|gp150|hAPN|LAP1|p150|PEPN	protein_coding	P15144	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37712
2.09478194069232e-64	-0.574231739564143	0.724	0.883	3.39124248378679e-60	SLC35B1	Malignant cells	GSE131984_JQ1	ENSG00000121073	10237	solute carrier family 35 member B1	AXER|UGTREL1	protein_coding	P78383	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37713
4.31872465006753e-64	-0.532799326954757	0.815	0.921	6.99158333599432e-60	LAPTM4B	Malignant cells	GSE131984_JQ1	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37714
5.1557029469893e-64	-0.457711841668891	0.969	0.998	8.34656750088098e-60	EIF4EBP1	Malignant cells	GSE131984_JQ1	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37715
6.71442114501903e-64	0.515005105744606	0.987	0.95	1.08699763916713e-59	COMMD6	Malignant cells	GSE131984_JQ1	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37716
7.31462785591263e-64	-0.604935259372201	0.382	0.667	1.1841651035937e-59	HMGN5	Malignant cells	GSE131984_JQ1	ENSG00000198157	79366	high mobility group nucleosome binding domain 5	NSBP1	protein_coding	P82970	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37717
7.57218281609938e-64	-0.542471169874784	0.948	0.988	1.22586067609833e-59	CCT6A	Malignant cells	GSE131984_JQ1	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37718
9.00434045998014e-64	-0.486825351139463	0.939	0.98	1.45771267706618e-59	CYB5A	Malignant cells	GSE131984_JQ1	ENSG00000166347	1528	cytochrome b5 type A	CYB5	protein_coding	P00167	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37719
1.06251186471579e-63	0.560568295316918	0.663	0.352	1.72010045778839e-59	RP11-545E17.3	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37720
1.59376695751872e-63	-0.383172254339361	0.999	1	2.58014932752705e-59	PRELID1	Malignant cells	GSE131984_JQ1	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37721
1.64985130050802e-63	-0.593701539487265	0.64	0.839	2.67094427039243e-59	WBSCR22	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37722
1.65877842084605e-63	-0.546711115632931	0.095	0.357	2.68539638550767e-59	BIRC3	Malignant cells	GSE131984_JQ1	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37723
2.03066290379529e-63	0.360732776809327	1	1	3.28744017495419e-59	ATP5E	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37724
2.10342391378793e-63	-0.566227018462195	0.596	0.811	3.40523297403127e-59	LSM6	Malignant cells	GSE131984_JQ1	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37725
2.23884139141524e-63	-0.472997202858139	0.918	0.978	3.62446032856214e-59	NDUFB8.1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37726
2.4437020046118e-63	-0.527795256943071	0.774	0.917	3.95610917526604e-59	MRPL17	Malignant cells	GSE131984_JQ1	ENSG00000158042	63875	mitochondrial ribosomal protein L17	MRP-L26|RPML26	protein_coding	Q9NRX2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37727
2.80788937892896e-63	-0.540437079054032	0.285	0.581	4.5456921155481e-59	GLA	Malignant cells	GSE131984_JQ1	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37728
4.65248464661173e-63	-0.537760229306361	0.748	0.921	7.53190739439972e-59	FAM96A	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37729
5.25662114701991e-63	-0.556052400680953	0.576	0.805	8.50994397491054e-59	SLC39A1	Malignant cells	GSE131984_JQ1	ENSG00000143570	27173	solute carrier family 39 member 1	ZIP1|ZIRTL	protein_coding	Q9NY26	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37730
7.28326962990312e-63	-0.598423558393576	0.39	0.67	1.17908852038502e-58	GALE	Malignant cells	GSE131984_JQ1	ENSG00000117308	2582	UDP-galactose-4-epimerase	SDR1E1	protein_coding	Q14376	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37731
7.77407773144005e-63	-0.622961090855954	0.657	0.838	1.25854544394283e-58	PSMD11	Malignant cells	GSE131984_JQ1	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37732
1.29194780667143e-62	-0.640854696361941	0.518	0.76	2.09153430422038e-58	PPP1R15A	Malignant cells	GSE131984_JQ1	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37733
1.36587036084281e-62	-0.411763394619797	0.072	0.32	2.21120752716843e-58	RP11-350J20.12	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37734
1.60017139446447e-62	-0.711034195598595	0.447	0.723	2.59051747049853e-58	BASP1	Malignant cells	GSE131984_JQ1	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37735
1.86966265113929e-62	-0.616350439162083	0.709	0.865	3.02679686592939e-58	MRPS23	Malignant cells	GSE131984_JQ1	ENSG00000181610	51649	mitochondrial ribosomal protein S23	CGI-138|HSPC329|MRP-S23	protein_coding	Q9Y3D9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37736
1.90610088598504e-62	-0.525612377249587	0.204	0.497	3.08578672432118e-58	C10orf90	Malignant cells	GSE131984_JQ1	ENSG00000154493	118611	chromosome 10 open reading frame 90	bA422P15.2|FATS|FLJ32938	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37737
2.01726395540465e-62	-0.589808562825634	0.564	0.794	3.26574861740458e-58	ISOC2	Malignant cells	GSE131984_JQ1	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37738
3.87880621749291e-62	-0.55671598815003	0.103	0.366	6.27939938549927e-58	SULT1B1	Malignant cells	GSE131984_JQ1	ENSG00000173597	27284	sulfotransferase family 1B member 1	ST1B2	protein_coding	O43704	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37739
4.02878271962359e-62	-0.642368862432714	0.871	0.966	6.52219634479864e-58	HSP90B1	Malignant cells	GSE131984_JQ1	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37740
4.96487786504979e-62	-0.484694809689547	0.947	0.982	8.0376407757291e-58	ATP5J2	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37741
7.48007599353358e-62	-0.534841773199101	0.875	0.974	1.21094950259315e-57	SELK	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37742
7.5426132006483e-62	-0.425598013645244	0.99	1	1.22107365105295e-57	NHP2L1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37743
7.91180733361882e-62	-0.552705653915642	0.812	0.935	1.28084248923955e-57	TXNL1	Malignant cells	GSE131984_JQ1	ENSG00000091164	9352	thioredoxin like 1	TRP32|Txl|TXNL	protein_coding	O43396	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37744
1.50565956025821e-61	-0.469292164801808	0.952	0.984	2.43751226210201e-57	MRPS34	Malignant cells	GSE131984_JQ1	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37745
1.75436048082232e-61	-0.597550666522943	0.923	0.969	2.84013418240326e-57	CCT2	Malignant cells	GSE131984_JQ1	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37746
2.44080279141184e-61	-0.570128356808889	0.627	0.843	3.95141563901663e-57	ABRACL	Malignant cells	GSE131984_JQ1	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37747
2.50520992484078e-61	-0.747616135628726	0.308	0.593	4.05568434732473e-57	HES4	Malignant cells	GSE131984_JQ1	ENSG00000188290	57801	hes family bHLH transcription factor 4	bHLHb42	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37748
3.59089028145158e-61	-0.561637997840759	0.886	0.964	5.81329227664197e-57	TMED9	Malignant cells	GSE131984_JQ1	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37749
3.64832418736483e-61	-0.496818168343376	0.826	0.949	5.90627202692493e-57	SSRP1	Malignant cells	GSE131984_JQ1	ENSG00000149136	6749	structure specific recognition protein 1	FACT80	protein_coding	Q08945	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37750
6.91765160491917e-61	-0.538761038569779	0.33	0.621	1.11989861832036e-56	PLSCR1	Malignant cells	GSE131984_JQ1	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37751
7.27894131010091e-61	-0.421083073688284	0.964	0.99	1.17838780869224e-56	STOML2	Malignant cells	GSE131984_JQ1	ENSG00000165283	30968	stomatin like 2	HSPC108|SLP-2	protein_coding	Q9UJZ1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37752
8.64344008655118e-61	-0.537933802433947	0.918	0.976	1.39928651561177e-56	TFDP1	Malignant cells	GSE131984_JQ1	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37753
1.18291255979516e-60	-0.507969678147153	0.899	0.971	1.91501714305239e-56	DAD1	Malignant cells	GSE131984_JQ1	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37754
1.63647252456486e-60	-0.572957399540815	0.648	0.835	2.64928537001805e-56	MRPL28	Malignant cells	GSE131984_JQ1	ENSG00000086504	10573	mitochondrial ribosomal protein L28	MAAT1|p15	protein_coding	Q13084	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37755
2.6115631559738e-60	-0.585080525467396	0.603	0.811	4.22785959320599e-56	SEC13	Malignant cells	GSE131984_JQ1	ENSG00000157020	6396	SEC13 homolog, nuclear pore and COPII coat complex component	D3S1231E|npp-20|SEC13L1|SEC13R	protein_coding	P55735	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37756
2.74596023131157e-60	0.690613694638089	0.996	0.976	4.44543501847029e-56	NQO1	Malignant cells	GSE131984_JQ1	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37757
2.87233941533491e-60	-0.544498846146825	0.677	0.861	4.65003027948568e-56	TIMM10	Malignant cells	GSE131984_JQ1	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37758
4.85654290127714e-60	-0.58376599686539	0.596	0.818	7.86225730287756e-56	NXT1	Malignant cells	GSE131984_JQ1	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37759
9.66041066900443e-60	0.585135060695829	0.739	0.495	1.56392388320513e-55	EHD2	Malignant cells	GSE131984_JQ1	ENSG00000024422	30846	EH domain containing 2	PAST2	protein_coding	Q9NZN4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37760
1.11190403042999e-59	-0.616700823177498	0.626	0.831	1.80006143486311e-55	TUBA4A	Malignant cells	GSE131984_JQ1	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37761
1.35658805219822e-59	-0.542714918600196	0.997	1	2.19618039770369e-55	HSP90AB1	Malignant cells	GSE131984_JQ1	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37762
1.46976318496824e-59	-0.538206210016025	0.595	0.806	2.37939962014509e-55	TMA16	Malignant cells	GSE131984_JQ1	ENSG00000198498	55319	translation machinery associated 16 homolog	C4orf43|FLJ11184	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37763
1.50515833599397e-59	0.466972233797904	0.376	0.095	2.43670083014064e-55	MRC2	Malignant cells	GSE131984_JQ1	ENSG00000011028	9902	mannose receptor C type 2	CD280|CLEC13E|ENDO180|KIAA0709	protein_coding	Q9UBG0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37764
1.62299726865624e-59	-0.472561513964933	0.969	0.992	2.62747027822759e-55	MDH2	Malignant cells	GSE131984_JQ1	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37765
2.06104797546151e-59	-0.562043016861129	0.3	0.589	3.33663056747464e-55	EXOSC9	Malignant cells	GSE131984_JQ1	ENSG00000123737	5393	exosome component 9	p5|p6|PM/Scl-75|PMSCL1|RRP45|Rrp45p	protein_coding	Q06265	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37766
2.0978289703904e-59	-0.584009755844706	0.85	0.932	3.39617532016502e-55	PCMT1	Malignant cells	GSE131984_JQ1	ENSG00000120265	5110	protein-L-isoaspartate (D-aspartate) O-methyltransferase	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37767
3.06394442285621e-59	-0.537745280533795	0.824	0.943	4.96021962616192e-55	VPS29	Malignant cells	GSE131984_JQ1	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37768
4.22417404945969e-59	-0.565965793946118	0.711	0.877	6.83851536867029e-55	CENPV	Malignant cells	GSE131984_JQ1	ENSG00000166582	201161	centromere protein V	CENP-V|p30|PRR6	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37769
6.52242263507765e-59	-0.564937989434502	0.256	0.537	1.05591500039272e-54	AC074389.9	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37770
7.46043914988497e-59	-0.366258325289174	0.999	0.998	1.20777049397488e-54	USMG5	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37771
7.47010624290618e-59	-0.599290040870207	0.392	0.664	1.20933549966408e-54	ACOT9	Malignant cells	GSE131984_JQ1	ENSG00000123130	23597	acyl-CoA thioesterase 9	ACATE2|CGI-16|MT-ACT48	protein_coding	Q9Y305	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37772
9.16203699621337e-59	-0.55750868776977	0.66	0.849	1.48324216931698e-54	AK2	Malignant cells	GSE131984_JQ1	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37773
1.00368560215753e-58	-0.61316610334419	0.424	0.688	1.62486662133282e-54	GRPEL1	Malignant cells	GSE131984_JQ1	ENSG00000109519	80273	GrpE like 1, mitochondrial	FLJ25609|GrpE|hMGE	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37774
1.24099039644952e-58	-0.365356755485284	1	1	2.00903935281213e-54	PTMA	Malignant cells	GSE131984_JQ1	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37775
1.46179212934499e-58	-0.536513803677825	1	1	2.3664952781966e-54	NPM1	Malignant cells	GSE131984_JQ1	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37776
1.4783285893919e-58	-0.527201690870827	0.256	0.547	2.39326615336654e-54	TRIM7	Malignant cells	GSE131984_JQ1	ENSG00000146054	81786	tripartite motif containing 7	GNIP|RNF90	protein_coding	Q9C029	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37777
1.74125155484974e-58	-0.609905386617062	0.468	0.734	2.81891214214624e-54	AHSA1	Malignant cells	GSE131984_JQ1	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37778
1.95997330990477e-58	-0.45138756733305	0.964	0.977	3.17300079140482e-54	UXT	Malignant cells	GSE131984_JQ1	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37779
1.96866040229208e-58	-0.57339594542613	0.368	0.644	3.18706432527065e-54	UPF3B	Malignant cells	GSE131984_JQ1	ENSG00000125351	65109	UPF3B regulator of nonsense mediated mRNA decay	HUPF3B|MRX62|MRX82|RENT3B|UPF3BP1|UPF3BP2|UPF3BP3|UPF3X	protein_coding	Q9BZI7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37780
2.00057278764984e-58	0.560037261970089	0.83	0.621	3.23872728592632e-54	DPYSL2	Malignant cells	GSE131984_JQ1	ENSG00000092964	1808	dihydropyrimidinase like 2	CRMP2|DHPRP2|DRP-2|DRP2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37781
2.07130715313516e-58	-0.416851219129512	0.98	0.994	3.35323915021051e-54	NDUFV2	Malignant cells	GSE131984_JQ1	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37782
2.1317950848242e-58	0.259757055221052	1	1	3.4511630628219e-54	RPL4	Malignant cells	GSE131984_JQ1	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37783
2.17863597340049e-58	0.571918786230432	0.9	0.727	3.52699377733805e-54	PLEC	Malignant cells	GSE131984_JQ1	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37784
2.75205443634883e-58	-0.686019846196257	0.32	0.601	4.45530092700513e-54	CES1	Malignant cells	GSE131984_JQ1	ENSG00000262243	1066	carboxylesterase 1	CEH|CES1A1|CES1A2|CES2|HMSE|HMSE1|SES1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37785
2.94148713148389e-58	0.582797110875055	0.844	0.628	4.76197351715928e-54	GCHFR	Malignant cells	GSE131984_JQ1	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37786
5.24681713060148e-58	-0.45910906375518	0.951	0.987	8.49407225273074e-54	TUFM	Malignant cells	GSE131984_JQ1	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37787
5.66996221089422e-58	-0.585548501281952	0.625	0.82	9.17910182321665e-54	NAE1	Malignant cells	GSE131984_JQ1	ENSG00000159593	8883	NEDD8 activating enzyme E1 subunit 1	APP-BP1|APPBP1|ula-1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37788
6.5602075729595e-58	-0.402426004706214	1	1	1.06203200398641e-53	ACTB	Malignant cells	GSE131984_JQ1	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37789
9.02524186574199e-58	-0.442088427435191	0.956	0.992	1.46109640564497e-53	PYURF	Malignant cells	GSE131984_JQ1	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37790
9.4211434788304e-58	-0.397660682016713	0.998	1	1.52518891778785e-53	NHP2	Malignant cells	GSE131984_JQ1	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37791
9.4778913686e-58	-0.515246906087797	0.794	0.909	1.53437583366265e-53	TMEM126A	Malignant cells	GSE131984_JQ1	ENSG00000171202	84233	transmembrane protein 126A	DKFZp586C1924|OPA7	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37792
9.65248641364961e-58	-0.786704368827433	0.336	0.613	1.56264102550573e-53	CDA	Malignant cells	GSE131984_JQ1	ENSG00000158825	978	cytidine deaminase	CDD	protein_coding	P32320	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37793
1.0965944761436e-57	-0.436528426447836	0.931	0.985	1.77527679742888e-53	TMEM167A	Malignant cells	GSE131984_JQ1	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37794
1.18764323815706e-57	-0.483495001972756	0.24	0.541	1.92267563825247e-53	RP1-276N6.2	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37795
1.20964036999171e-57	-0.456255883540338	0.975	0.992	1.95828679497958e-53	SERP1	Malignant cells	GSE131984_JQ1	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37796
1.3206618055823e-57	-0.564024323603887	0.463	0.71	2.13801939705718e-53	HOMER3	Malignant cells	GSE131984_JQ1	ENSG00000051128	9454	homer scaffold protein 3	HOMER-3	protein_coding	Q9NSC5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37797
1.33529907095103e-57	0.620153248616487	0.744	0.492	2.16171566596262e-53	ABCC3	Malignant cells	GSE131984_JQ1	ENSG00000108846	8714	ATP binding cassette subfamily C member 3	cMOAT2|EST90757|MLP2|MOAT-D|MRP3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37798
1.65496624958435e-57	-0.696208091224015	0.647	0.856	2.6792248614521e-53	KPNA2	Malignant cells	GSE131984_JQ1	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37799
2.08142007226177e-57	-0.586870550105681	0.442	0.699	3.36961095498457e-53	GLIPR1	Malignant cells	GSE131984_JQ1	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37800
2.683857225624e-57	-0.584048905079577	0.704	0.861	4.34489646256269e-53	UBE2A	Malignant cells	GSE131984_JQ1	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37801
2.79187177781003e-57	-0.854240884606067	0.528	0.772	4.51976122109666e-53	CCNB1	Malignant cells	GSE131984_JQ1	ENSG00000134057	891	cyclin B1	CCNB	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37802
3.12033825556731e-57	0.429011582981178	0.997	0.989	5.05151560193792e-53	PTMS	Malignant cells	GSE131984_JQ1	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37803
3.19562507634962e-57	-0.588408837356345	0.546	0.783	5.1733974361024e-53	PSMB9	Malignant cells	GSE131984_JQ1	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37804
3.85019777644126e-57	-0.418205190125037	0.984	0.994	6.23308518028075e-53	UQCRFS1	Malignant cells	GSE131984_JQ1	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37805
4.68999904857686e-57	-0.46579869954374	0.923	0.976	7.59263945974108e-53	GLRX5	Malignant cells	GSE131984_JQ1	ENSG00000182512	51218	glutaredoxin 5	C14orf87|GRX5|PR01238	protein_coding	Q86SX6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37806
5.9427580054913e-57	-0.603329877629684	0.499	0.747	9.62073093508987e-53	DNAJB11	Malignant cells	GSE131984_JQ1	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37807
7.75678367991213e-57	0.401064068318735	1	0.999	1.25574570994097e-52	MT-CO2	Malignant cells	GSE131984_JQ1	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37808
3.89803906584106e-56	0.501383711002581	0.905	0.746	6.3105354436901e-52	DGCR6L	Malignant cells	GSE131984_JQ1	ENSG00000128185	85359	DiGeorge syndrome critical region gene 6 like	FLJ10666	protein_coding	Q9BY27	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37809
4.7906954930206e-56	-0.552597015750983	0.408	0.665	7.75565693365106e-52	FKBP4	Malignant cells	GSE131984_JQ1	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37810
4.98180037052351e-56	-0.516923339807115	0.94	0.983	8.06503661984051e-52	PRSS3	Malignant cells	GSE131984_JQ1	ENSG00000010438	5646	serine protease 3	PRSS4|TRY3|TRY4	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37811
5.36207461505185e-56	-0.477069989368664	0.9	0.969	8.68066259430744e-52	ADRM1	Malignant cells	GSE131984_JQ1	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37812
7.83186119152607e-56	-0.512604888485054	0.688	0.856	1.26790000829616e-51	COMT	Malignant cells	GSE131984_JQ1	ENSG00000093010	1312	catechol-O-methyltransferase	NA	protein_coding	P21964	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37813
8.58767314902003e-56	-0.506078009036478	0.715	0.919	1.39025840609485e-51	CENPW	Malignant cells	GSE131984_JQ1	ENSG00000203760	387103	centromere protein W	C6orf173|CUG2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37814
9.9787880667894e-56	-0.538345240200009	0.981	0.998	1.61546600013254e-51	HSPD1	Malignant cells	GSE131984_JQ1	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37815
9.98626409557847e-56	-0.423679135824509	0.92	0.976	1.6166762944332e-51	MTCH2	Malignant cells	GSE131984_JQ1	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37816
1.14628412920509e-55	-0.403088344319024	0.981	0.998	1.85571937677013e-51	UBE2D3	Malignant cells	GSE131984_JQ1	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37817
1.28021325157935e-55	-0.585641025076333	0.535	0.758	2.0725372329818e-51	DDX39A	Malignant cells	GSE131984_JQ1	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37818
1.68973874562554e-55	-0.55033077784205	0.323	0.589	2.73551805529319e-51	FUNDC1	Malignant cells	GSE131984_JQ1	ENSG00000069509	139341	FUN14 domain containing 1	MGC51029	protein_coding	Q8IVP5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37819
1.89782595434216e-55	-0.482575978146868	0.207	0.489	3.07239043748453e-51	CKAP4	Malignant cells	GSE131984_JQ1	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37820
2.49453211751976e-55	-0.472168744378923	0.796	0.927	4.03839804505274e-51	AUP1	Malignant cells	GSE131984_JQ1	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37821
2.58818039581863e-55	-0.432122050423004	0.955	0.987	4.19000524279079e-51	ARF1	Malignant cells	GSE131984_JQ1	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37822
2.63301967547273e-55	-0.577134711476214	0.667	0.833	4.2625955526228e-51	SEC11C	Malignant cells	GSE131984_JQ1	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37823
3.28725367031527e-55	-0.497225784763546	0.799	0.929	5.3217349668734e-51	C3orf14	Malignant cells	GSE131984_JQ1	ENSG00000114405	57415	chromosome 3 open reading frame 14	HT021	protein_coding	Q9HBI5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37824
6.3239631631592e-55	-0.633997714758685	0.7	0.859	1.02378639648384e-50	NUDT4	Malignant cells	GSE131984_JQ1	ENSG00000173598	11163	nudix hydrolase 4	DIPP2|DIPP2alpha|DIPP2beta|HDCMB47P|KIAA0487	protein_coding	Q9NZJ9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37825
7.00485062538028e-55	-0.393732022753905	0.974	0.996	1.13401526774281e-50	TMEM147	Malignant cells	GSE131984_JQ1	ENSG00000105677	10430	transmembrane protein 147	MGC1936|NIFIE14	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37826
7.10100518950824e-55	-0.348915296337331	0.999	1	1.14958173012949e-50	SEC61B	Malignant cells	GSE131984_JQ1	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37827
7.73746767877996e-55	-0.539187910140158	0.4	0.667	1.25261864251769e-50	ECH1	Malignant cells	GSE131984_JQ1	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37828
9.63154795887882e-55	-0.510491155301325	0.475	0.734	1.55925129906289e-50	DPM3	Malignant cells	GSE131984_JQ1	ENSG00000179085	54344	dolichyl-phosphate mannosyltransferase subunit 3, regulatory	MGC125904|MGC125905|MGC34275	protein_coding	Q9P2X0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37829
1.15503394784237e-54	-0.427418463886115	0.106	0.352	1.86988445816202e-50	AP1M2	Malignant cells	GSE131984_JQ1	ENSG00000129354	10053	adaptor related protein complex 1 subunit mu 2	AP1-mu2|HSMU1B|mu2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37830
1.30481830064248e-54	-0.513390943619106	0.932	0.983	2.11237034691011e-50	STMN1	Malignant cells	GSE131984_JQ1	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37831
1.34110862969382e-54	-0.503277187597927	0.762	0.908	2.17112076061133e-50	RNF126	Malignant cells	GSE131984_JQ1	ENSG00000070423	55658	ring finger protein 126	FLJ20552	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37832
1.66217430817373e-54	-0.527883129615961	0.905	0.97	2.69089398750245e-50	SNHG8	Malignant cells	GSE131984_JQ1	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37833
1.73580099551981e-54	-0.627636702968502	0.462	0.7	2.81008823164702e-50	MAGEA3	Malignant cells	GSE131984_JQ1	ENSG00000221867	4102	MAGE family member A3	CT1.3|HIP8|HYPD|MAGE3|MGC14613	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37834
1.77587292529557e-54	-0.525233438633981	0.936	0.984	2.874960678761e-50	EIF5	Malignant cells	GSE131984_JQ1	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37835
2.15655635818098e-54	-0.491828291385065	0.816	0.921	3.49124908825919e-50	MRPS26	Malignant cells	GSE131984_JQ1	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37836
2.24482291750505e-54	-0.396560077682723	0.999	1	3.63414382114893e-50	CD63	Malignant cells	GSE131984_JQ1	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37837
2.36646453427877e-54	-0.416472792238447	0.971	0.994	3.8310694345439e-50	NDUFC2	Malignant cells	GSE131984_JQ1	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37838
2.48320865301921e-54	-0.575716852910083	0.761	0.896	4.02006648837279e-50	PRMT1	Malignant cells	GSE131984_JQ1	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37839
2.52294611384057e-54	-0.530283072504636	0.617	0.831	4.0843974636965e-50	TMEM205	Malignant cells	GSE131984_JQ1	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37840
3.06474918298165e-54	-0.462512012419821	0.868	0.956	4.961522452329e-50	COA4	Malignant cells	GSE131984_JQ1	ENSG00000181924	51287	cytochrome c oxidase assembly factor 4 homolog	CHCHD8|CMC3|E2IG2	protein_coding	Q9NYJ1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37841
3.47699638390167e-54	-0.486196416976441	0.764	0.894	5.62890944589842e-50	COA1	Malignant cells	GSE131984_JQ1	ENSG00000106603	55744	cytochrome c oxidase assembly factor 1	C7orf44|FLJ10803|MITRAC15	protein_coding	Q9GZY4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37842
3.93058096805402e-54	-0.462804258396125	0.852	0.946	6.36321752918266e-50	PPM1G	Malignant cells	GSE131984_JQ1	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37843
4.0979502923361e-54	-0.426066972951717	0.949	0.981	6.63417172826292e-50	C1orf43	Malignant cells	GSE131984_JQ1	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37844
4.22572752025531e-54	-0.451771969085177	0.125	0.373	6.84103028254133e-50	NRG1	Malignant cells	GSE131984_JQ1	ENSG00000157168	3084	neuregulin 1	GGF|HGL|HRG|NDF|NRG1-IT2	protein_coding	Q02297	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37845
4.55491442782009e-54	-0.461156506419553	0.81	0.919	7.37395096719795e-50	TRAPPC3	Malignant cells	GSE131984_JQ1	ENSG00000054116	27095	trafficking protein particle complex subunit 3	BET3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37846
5.14985326996435e-54	-0.6611362724136	0.603	0.777	8.33709745874528e-50	HDAC2	Malignant cells	GSE131984_JQ1	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37847
6.18599668531802e-54	-0.448883362957968	0.998	1	1.00145100338613e-49	MGST1	Malignant cells	GSE131984_JQ1	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37848
9.90212717414242e-54	-0.368632521276678	0.996	0.999	1.60305536822192e-49	MTDH	Malignant cells	GSE131984_JQ1	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37849
1.01679701721145e-53	-0.311387813555265	0.999	1	1.64609269116361e-49	RPL36AL	Malignant cells	GSE131984_JQ1	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37850
1.6804750298058e-53	-0.451906794633684	0.93	0.977	2.72052102575262e-49	GHITM	Malignant cells	GSE131984_JQ1	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37851
2.09984484906587e-53	-0.452050936137185	0.81	0.917	3.39943882615274e-49	LSM1	Malignant cells	GSE131984_JQ1	ENSG00000175324	27257	LSM1 homolog, mRNA degradation associated	CASM|YJL124C	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37852
2.10686289846128e-53	-0.523169230706922	0.624	0.811	3.41080034631897e-49	SREK1IP1	Malignant cells	GSE131984_JQ1	ENSG00000153006	285672	SREK1 interacting protein 1	FLJ36754|P18SRP|SFRS12IP1	protein_coding	Q8N9Q2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37853
2.57679563836079e-53	-0.415084732320156	0.171	0.434	4.17157445894228e-49	NME6	Malignant cells	GSE131984_JQ1	ENSG00000172113	10201	NME/NM23 nucleoside diphosphate kinase 6	IPIA-ALPHA|NM23-H6	protein_coding	O75414	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37854
2.75786984553787e-53	-0.488735220796195	0.229	0.5	4.46471549294126e-49	AIFM1	Malignant cells	GSE131984_JQ1	ENSG00000156709	9131	apoptosis inducing factor mitochondria associated 1	AIF|AUNX1|CMTX4|DFNX5|NAMSD|PDCD8	protein_coding	O95831	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37855
2.88186371108089e-53	-0.525289164900926	0.452	0.706	4.66544916186886e-49	TMEM70	Malignant cells	GSE131984_JQ1	ENSG00000175606	54968	transmembrane protein 70	FLJ20533	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37856
3.3810460457476e-53	-0.496806806979624	0.674	0.852	5.47357544346079e-49	DDX1	Malignant cells	GSE131984_JQ1	ENSG00000079785	1653	DEAD-box helicase 1	DBP-RB	protein_coding	Q92499	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37857
4.13880403232001e-53	-0.615046338862773	0.678	0.838	6.70030984792287e-49	SH3KBP1	Malignant cells	GSE131984_JQ1	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37858
4.23896333897943e-53	-0.352125468389842	0.996	1	6.8624577494738e-49	NDUFS5	Malignant cells	GSE131984_JQ1	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37859
4.42762165082116e-53	-0.523418407307032	0.534	0.767	7.16787669051438e-49	CCDC59	Malignant cells	GSE131984_JQ1	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37860
7.85964000986757e-53	-0.418583288327706	0.149	0.404	1.27239712119746e-48	PRR16	Malignant cells	GSE131984_JQ1	ENSG00000184838	51334	proline rich 16	DSC54	protein_coding	Q569H4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37861
7.90476829052516e-53	-0.506661328149423	0.246	0.519	1.27970293855312e-48	VRK1	Malignant cells	GSE131984_JQ1	ENSG00000100749	7443	VRK serine/threonine kinase 1	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37862
7.98347092825879e-53	-0.465164203131176	0.859	0.931	1.29244410857582e-48	H2AFY	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37863
8.58987013224054e-53	-0.484926275121452	0.424	0.691	1.39061407570842e-48	MTX1	Malignant cells	GSE131984_JQ1	ENSG00000173171	4580	metaxin 1	MTX|MTXN	protein_coding	Q13505	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37864
8.72799717565596e-53	-0.492745023853101	0.199	0.465	1.41297546276694e-48	MRPL39	Malignant cells	GSE131984_JQ1	ENSG00000154719	54148	mitochondrial ribosomal protein L39	C21orf92|FLJ20451|L39mt|MGC104174|MGC3400|MRP-L5|MSTP003|PRED22|PRED66|RPML5	protein_coding	Q9NYK5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37865
8.95516431933361e-53	-0.412874776487906	0.969	0.997	1.44975155165692e-48	UBE2L3	Malignant cells	GSE131984_JQ1	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37866
9.93937827340084e-53	-0.460371042375445	0.889	0.96	1.60908594868086e-48	CBR1	Malignant cells	GSE131984_JQ1	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37867
1.24012105158861e-52	-0.485280887241923	0.209	0.479	2.0076319704168e-48	POLR3G	Malignant cells	GSE131984_JQ1	ENSG00000113356	10622	RNA polymerase III subunit G	C31|RPC32|RPC7	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37868
1.4389397004783e-52	-0.52795813418084	0.591	0.805	2.32949948110433e-48	PQBP1	Malignant cells	GSE131984_JQ1	ENSG00000102103	10084	polyglutamine binding protein 1	MRX2|MRX55|MRXS3|MRXS8|RENS1|SHS	protein_coding	O60828	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37869
1.46048036828226e-52	0.655955378813391	1	0.997	2.36437166821215e-48	MT2A	Malignant cells	GSE131984_JQ1	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37870
1.92314445980774e-52	-0.502745071394464	0.352	0.622	3.11337856598274e-48	SNRNP40	Malignant cells	GSE131984_JQ1	ENSG00000060688	9410	small nuclear ribonucleoprotein U5 subunit 40	HPRP8BP|PRP8BP|PRPF8BP|SPF38|WDR57	protein_coding	Q96DI7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37871
2.03068885649133e-52	-0.51165510129859	0.982	0.998	3.28748218977381e-48	UBE2S	Malignant cells	GSE131984_JQ1	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37872
2.22398554176776e-52	-0.473130347103599	0.969	0.984	3.60041019356783e-48	MYL12A	Malignant cells	GSE131984_JQ1	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37873
2.59445326112569e-52	-0.269983881542287	1	1	4.20016038443638e-48	RPL37	Malignant cells	GSE131984_JQ1	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37874
2.74296660313458e-52	-0.456659733130938	0.845	0.932	4.44058863381458e-48	YIF1A	Malignant cells	GSE131984_JQ1	ENSG00000174851	10897	Yip1 interacting factor homolog A, membrane trafficking protein	54TM|FinGER7|YIF1|YIF1P	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37875
2.7981651860263e-52	-0.473681266635993	0.213	0.483	4.52994961965797e-48	BTG3	Malignant cells	GSE131984_JQ1	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37876
2.8338382951552e-52	-0.436857288001175	0.993	0.996	4.58770081602675e-48	GTF3A	Malignant cells	GSE131984_JQ1	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37877
3.1589122403754e-52	-0.51775483035447	0.433	0.674	5.11396302594374e-48	DNTTIP1	Malignant cells	GSE131984_JQ1	ENSG00000101457	116092	deoxynucleotidyltransferase terminal interacting protein 1	C20orf167|dJ447F3.4|Tdif1	protein_coding	Q9H147	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37878
3.26317442047199e-52	-0.420750640029456	0.97	0.994	5.28275306930211e-48	PGAM1	Malignant cells	GSE131984_JQ1	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37879
4.72613646320034e-52	-0.542875626664017	0.619	0.807	7.65114232027504e-48	MRPL19	Malignant cells	GSE131984_JQ1	ENSG00000115364	9801	mitochondrial ribosomal protein L19	KIAA0104|MRP-L15|RLX1|RPML15	protein_coding	P49406	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37880
4.7496571932886e-52	-0.702381573220696	0.886	0.95	7.68922003021492e-48	PSMA4	Malignant cells	GSE131984_JQ1	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37881
8.89803814723361e-52	-0.553548016488707	0.439	0.687	1.44050339565565e-47	PSME3	Malignant cells	GSE131984_JQ1	ENSG00000131467	10197	proteasome activator subunit 3	Ki|PA28-gamma|PA28G|REG-GAMMA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37882
9.13928388600245e-52	-0.461585182804273	0.296	0.567	1.47955866830494e-47	RAB27A	Malignant cells	GSE131984_JQ1	ENSG00000069974	5873	RAB27A, member RAS oncogene family	GS2|HsT18676|RAB27|RAM	protein_coding	P51159	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37883
9.16619727545815e-52	-0.521825348399038	0.443	0.697	1.48391567692392e-47	PLEK2	Malignant cells	GSE131984_JQ1	ENSG00000100558	26499	pleckstrin 2	NA	protein_coding	Q9NYT0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37884
9.74986225310035e-52	-0.499240504186946	0.453	0.697	1.57840520015442e-47	AGTRAP	Malignant cells	GSE131984_JQ1	ENSG00000177674	57085	angiotensin II receptor associated protein	ATRAP	protein_coding	Q6RW13	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37885
1.00755520529718e-51	-0.499305566782712	0.728	0.87	1.63113112185561e-47	NT5C	Malignant cells	GSE131984_JQ1	ENSG00000125458	30833	5', 3'-nucleotidase, cytosolic	cdN|DNT-1|DNT1|PN-I|UMPH2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37886
1.08874339837934e-51	-0.395000796426337	0.958	0.991	1.76256668763632e-47	LSM2	Malignant cells	GSE131984_JQ1	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37887
1.5903773381087e-51	-0.50866515887665	0.739	0.874	2.57466187266418e-47	CHCHD3	Malignant cells	GSE131984_JQ1	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37888
1.65560795988165e-51	-0.447081219109649	0.914	0.973	2.68026372625241e-47	COX17	Malignant cells	GSE131984_JQ1	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37889
1.71293902473247e-51	-0.529745582266185	0.466	0.707	2.77307698713939e-47	PCBD1	Malignant cells	GSE131984_JQ1	ENSG00000166228	5092	pterin-4 alpha-carbinolamine dehydratase 1	DCOH|PCBD|PCD	protein_coding	P61457	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37890
1.9617474820862e-51	-0.422638664859789	0.971	0.994	3.17587299874935e-47	SF3B14	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37891
2.6385869156833e-51	-0.492361227453332	0.955	0.992	4.27160835779969e-47	FABP5	Malignant cells	GSE131984_JQ1	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37892
3.06175097212268e-51	-0.586781517464112	0.668	0.83	4.95666864876941e-47	HSPA9	Malignant cells	GSE131984_JQ1	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37893
3.2148805934159e-51	-0.551396954206332	0.535	0.756	5.20457019268101e-47	TNIP1	Malignant cells	GSE131984_JQ1	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37894
3.59634400175187e-51	-0.48333025433744	0.626	0.83	5.82212130443611e-47	NTMT1	Malignant cells	GSE131984_JQ1	ENSG00000148335	28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1	AD-003|C9orf32|HOMT1A|METTL11A|NRMT|NRMT1	protein_coding	Q9BV86	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37895
4.65897773112543e-51	-0.510046037810305	0.709	0.867	7.54241904891896e-47	PLIN3	Malignant cells	GSE131984_JQ1	ENSG00000105355	10226	perilipin 3	M6PRBP1|PP17|TIP47	protein_coding	O60664	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37896
4.78801638795577e-51	-0.514009692828579	0.304	0.566	7.7513197304616e-47	UGDH	Malignant cells	GSE131984_JQ1	ENSG00000109814	7358	UDP-glucose 6-dehydrogenase	NA	protein_coding	O60701	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37897
5.10399927925809e-51	-0.425373614443234	0.181	0.437	8.26286443319093e-47	MTHFD1L	Malignant cells	GSE131984_JQ1	ENSG00000120254	25902	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like	DKFZP586G1517|FLJ21145|FTHFSDC1	protein_coding	Q6UB35	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37898
5.78136987724566e-51	-0.307283195217431	0.999	1	9.35945969427301e-47	TMA7	Malignant cells	GSE131984_JQ1	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37899
6.85740132234653e-51	-0.486185754790557	0.256	0.52	1.11014470007468e-46	APOO	Malignant cells	GSE131984_JQ1	ENSG00000184831	79135	apolipoprotein O	FAM121B|MGC4825|Mic23|MIC26|MICOS26|My025	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37900
7.45858267131636e-51	-0.428062523189495	0.896	0.964	1.20746994865941e-46	HDDC2	Malignant cells	GSE131984_JQ1	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37901
8.60741039073336e-51	-0.537881137504373	0.565	0.78	1.39345366815582e-46	PHF19	Malignant cells	GSE131984_JQ1	ENSG00000119403	26147	PHD finger protein 19	DKFZP727G051|MTF2L1|PCL3|TDRD19B	protein_coding	Q5T6S3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37902
9.62017551188282e-51	-0.502431290244862	0.699	0.857	1.55741021361871e-46	MRPL32	Malignant cells	GSE131984_JQ1	ENSG00000106591	64983	mitochondrial ribosomal protein L32	bMRP-59b|HSPC283|L32mt|MRP-L32	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37903
1.05475166763049e-50	0.462011932385276	0.593	0.314	1.70753747472701e-46	KANK2	Malignant cells	GSE131984_JQ1	ENSG00000197256	25959	KN motif and ankyrin repeat domains 2	ANKRD25|KIAA1518|MXRA3	protein_coding	Q63ZY3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37904
1.34167970856341e-50	-0.540064432640466	0.488	0.739	2.1720452801933e-46	TRIP13	Malignant cells	GSE131984_JQ1	ENSG00000071539	9319	thyroid hormone receptor interactor 13	16E1BP	protein_coding	Q15645	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37905
1.52651823604735e-50	-0.38056442196232	0.994	0.998	2.47128037233706e-46	PPA1	Malignant cells	GSE131984_JQ1	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37906
1.53447880990598e-50	-0.418484316074419	0.924	0.986	2.48416774535679e-46	EIF5B	Malignant cells	GSE131984_JQ1	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37907
1.94221828203522e-50	-0.321135448853915	0.998	1	3.14425717678682e-46	ATP5J	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37908
2.35088209002802e-50	-0.579672358811635	0.642	0.811	3.80584301554637e-46	FDPS	Malignant cells	GSE131984_JQ1	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37909
2.43065633236194e-50	-0.415585080446208	0.93	0.984	3.93498953646075e-46	UBE2I	Malignant cells	GSE131984_JQ1	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37910
2.44675948476302e-50	0.30326648651856	1	1	3.96105892988285e-46	LGALS1	Malignant cells	GSE131984_JQ1	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37911
2.81151914566903e-50	0.351303173557591	1	1	4.55156834492359e-46	ZFAS1	Malignant cells	GSE131984_JQ1	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37912
3.26465365656552e-50	-0.437107848636058	0.912	0.969	5.28514780461393e-46	ARPC5	Malignant cells	GSE131984_JQ1	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37913
3.27589849112234e-50	-0.543465453205034	0.587	0.764	5.30335206727795e-46	PPP2CA	Malignant cells	GSE131984_JQ1	ENSG00000113575	5515	protein phosphatase 2 catalytic subunit alpha	PP2AC|PP2Calpha	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37914
3.47089624331027e-50	-0.430184446633845	0.224	0.491	5.61903392829499e-46	ANKRD29	Malignant cells	GSE131984_JQ1	ENSG00000154065	147463	ankyrin repeat domain 29	FLJ25053	protein_coding	Q8N6D5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37915
3.6932799068904e-50	-0.521466953807634	0.64	0.805	5.97905084126488e-46	MRPL24	Malignant cells	GSE131984_JQ1	ENSG00000143314	79590	mitochondrial ribosomal protein L24	MRP-L18	protein_coding	Q96A35	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37916
4.73664983868015e-50	-0.476140096369252	0.875	0.941	7.6681624238393e-46	RSL1D1	Malignant cells	GSE131984_JQ1	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37917
5.83544296893366e-50	-0.469093921269452	0.925	0.968	9.4469986224067e-46	PDIA6	Malignant cells	GSE131984_JQ1	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37918
6.22419154960921e-50	-0.394272424925695	0.959	0.99	1.00763436996624e-45	PHB2	Malignant cells	GSE131984_JQ1	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37919
6.59428250640435e-50	-0.474691989036303	0.463	0.708	1.0675483949618e-45	KRTCAP2	Malignant cells	GSE131984_JQ1	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37920
8.45613092740659e-50	-0.550076450570609	0.558	0.76	1.36896303583785e-45	RAB9A	Malignant cells	GSE131984_JQ1	ENSG00000123595	9367	RAB9A, member RAS oncogene family	RAB9	protein_coding	P51151	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37921
9.22661743915757e-50	-0.407067553190504	0.997	1	1.49369709722522e-45	HMGA1	Malignant cells	GSE131984_JQ1	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37922
1.09654286047242e-49	-0.519588130158348	0.707	0.843	1.7751932368188e-45	COA3	Malignant cells	GSE131984_JQ1	ENSG00000183978	28958	cytochrome c oxidase assembly factor 3	CCDC56|COX25|hCOA3|HSPC009|MITRAC12	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37923
1.37917151802495e-49	-0.510420258895588	0.668	0.838	2.2327407705306e-45	GPATCH4	Malignant cells	GSE131984_JQ1	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37924
1.80510951534814e-49	-0.53975297577588	0.665	0.841	2.92229179439711e-45	SPCS3	Malignant cells	GSE131984_JQ1	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37925
2.44250696496173e-49	0.306142674715183	1	1	3.95417452557654e-45	EEF2	Malignant cells	GSE131984_JQ1	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37926
2.51976376414208e-49	-0.509559276979653	0.604	0.801	4.07924555776961e-45	RRP7A	Malignant cells	GSE131984_JQ1	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37927
2.59148987018114e-49	-0.546443665585706	0.927	0.977	4.19536295083625e-45	C12orf75	Malignant cells	GSE131984_JQ1	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37928
3.06466276444836e-49	-0.562357641873403	0.65	0.815	4.96138254936545e-45	HPRT1	Malignant cells	GSE131984_JQ1	ENSG00000165704	3251	hypoxanthine phosphoribosyltransferase 1	HGPRT|HPRT	protein_coding	P00492	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37929
3.43651461747613e-49	-0.442458235805554	0.776	0.902	5.5633735142321e-45	CHCHD1	Malignant cells	GSE131984_JQ1	ENSG00000172586	118487	coiled-coil-helix-coiled-coil-helix domain containing 1	C10orf34|FLJ25854	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37930
3.63169604124167e-49	-0.4469028801826	0.261	0.534	5.87935272116613e-45	EVA1A	Malignant cells	GSE131984_JQ1	ENSG00000115363	84141	eva-1 homolog A, regulator of programmed cell death	FAM176A|FLJ13391|TMEM166	protein_coding	Q9H8M9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37931
4.57372598396954e-49	-0.52755405674972	0.852	0.938	7.40440499544829e-45	SQSTM1	Malignant cells	GSE131984_JQ1	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37932
5.25281384240313e-49	-0.351360447555646	0.127	0.368	8.50378032946643e-45	IL15RA	Malignant cells	GSE131984_JQ1	ENSG00000134470	3601	interleukin 15 receptor subunit alpha	CD215|IL-15RA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37933
7.63535079758937e-49	-0.518493911811369	0.481	0.717	1.23608694062174e-44	ECHDC1	Malignant cells	GSE131984_JQ1	ENSG00000093144	55862	ethylmalonyl-CoA decarboxylase 1	dJ351K20.2	protein_coding	Q9NTX5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37934
8.12231415314348e-49	-0.415644478543948	0.99	0.998	1.3149214382524e-44	MYL12B	Malignant cells	GSE131984_JQ1	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37935
8.52123570278732e-49	-0.626372256431319	0.415	0.664	1.37950284792424e-44	MAD2L1	Malignant cells	GSE131984_JQ1	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37936
1.01000095381497e-48	-0.516094085850374	0.65	0.82	1.63509054413105e-44	UFM1	Malignant cells	GSE131984_JQ1	ENSG00000120686	51569	ubiquitin fold modifier 1	bA131P10.1|C13orf20	protein_coding	P61960	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37937
1.16802709815476e-48	0.526505157319413	0.817	0.615	1.89091906920275e-44	NME3	Malignant cells	GSE131984_JQ1	ENSG00000103024	4832	NME/NM23 nucleoside diphosphate kinase 3	DR-nm23|NDPKC|NM23-H3	protein_coding	Q13232	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37938
1.29453239246883e-48	-0.48810820622628	0.731	0.877	2.0957184901678e-44	FAM127B	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37939
1.29545365129884e-48	-0.45824672868177	0.279	0.542	2.0972099160877e-44	LDOC1	Malignant cells	GSE131984_JQ1	ENSG00000182195	23641	LDOC1 regulator of NFKB signaling	BCUR1|Mar7|Mart7|RTL7|SIRH7	protein_coding	O95751	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37940
1.32707579354302e-48	-0.440759757609955	0.909	0.968	2.14840300216679e-44	CLTB	Malignant cells	GSE131984_JQ1	ENSG00000175416	1212	clathrin light chain B	Lcb	protein_coding	P09497	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37941
1.5361486118628e-48	-0.418604711009091	0.961	0.989	2.48687098774469e-44	ATPIF1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37942
1.60551685660841e-48	-0.482697806359873	0.27	0.53	2.59917123916336e-44	TYMP	Malignant cells	GSE131984_JQ1	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37943
1.65581313984153e-48	-0.369952978597301	0.962	0.985	2.68059589208945e-44	C19orf70	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37944
1.74848030623301e-48	-0.383651137430686	0.958	0.984	2.83061476776063e-44	EI24	Malignant cells	GSE131984_JQ1	ENSG00000149547	9538	EI24 autophagy associated transmembrane protein	EPG4|PIG8|TP53I8	protein_coding	O14681	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37945
2.15803330515559e-48	-0.494320860208758	0.557	0.755	3.49364011771638e-44	SLC30A5	Malignant cells	GSE131984_JQ1	ENSG00000145740	64924	solute carrier family 30 member 5	FLJ12496|FLJ12756|MGC5499|ZnT-5|ZNT5|ZNTL1|ZTL1	protein_coding	Q8TAD4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37946
2.52001334809408e-48	-0.497094271977412	0.639	0.821	4.0796496092295e-44	TUBG1	Malignant cells	GSE131984_JQ1	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37947
3.18465225443837e-48	-0.443690157038197	0.839	0.926	5.15563353471028e-44	DTD1	Malignant cells	GSE131984_JQ1	ENSG00000125821	92675	D-aminoacyl-tRNA deacylase 1	bA379J5.3|bA555E18.1|C20orf88|DUEB|HARS2|MGC119131|MGC41905|pqn-68	protein_coding	Q8TEA8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37948
3.23752598460926e-48	-0.500407888088112	0.985	0.997	5.24123081648392e-44	ATP5B	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37949
3.36210458790079e-48	-0.566432857145475	0.528	0.726	5.4429111173526e-44	PSMC4	Malignant cells	GSE131984_JQ1	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37950
3.86319004975518e-48	-0.467628596513735	0.874	0.953	6.25411837154867e-44	RBM8A	Malignant cells	GSE131984_JQ1	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37951
3.89123698265413e-48	-0.471587934764815	0.962	0.988	6.29952355121878e-44	NCL	Malignant cells	GSE131984_JQ1	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37952
4.22649529797867e-48	-0.452060934507093	0.816	0.925	6.84227323789766e-44	MRPL37	Malignant cells	GSE131984_JQ1	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37953
4.23691589715438e-48	-0.332539957887562	0.103	0.33	6.85914314590323e-44	PACSIN3	Malignant cells	GSE131984_JQ1	ENSG00000165912	29763	protein kinase C and casein kinase substrate in neurons 3	SDPIII	protein_coding	Q9UKS6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37954
4.39013095884735e-48	-0.440300222583546	0.987	0.995	7.10718300927798e-44	CAV1	Malignant cells	GSE131984_JQ1	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37955
4.57140079900816e-48	-0.492494343669063	0.573	0.787	7.40064075351431e-44	SUCLA2	Malignant cells	GSE131984_JQ1	ENSG00000136143	8803	succinate-CoA ligase ADP-forming subunit beta	LINC00444	protein_coding	Q9P2R7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37956
4.73714843598156e-48	0.499233020634503	0.829	0.651	7.66896960301054e-44	LINC00657	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37957
4.85800433206642e-48	-0.373568589301676	0.989	0.993	7.86462321318232e-44	VDAC2	Malignant cells	GSE131984_JQ1	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37958
4.95709864299182e-48	-0.495496219379449	0.812	0.911	8.02504699313946e-44	XRCC5	Malignant cells	GSE131984_JQ1	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37959
6.42648053329252e-48	-0.42157525323359	0.959	0.987	1.04038293353473e-43	CHCHD10	Malignant cells	GSE131984_JQ1	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37960
7.36131719522344e-48	-0.428417953158718	0.886	0.958	1.19172364073472e-43	GGCT	Malignant cells	GSE131984_JQ1	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37961
7.44733785897232e-48	-0.511645307791737	0.535	0.759	1.20564952598903e-43	ACOT13	Malignant cells	GSE131984_JQ1	ENSG00000112304	55856	acyl-CoA thioesterase 13	HT012|THEM2	protein_coding	Q9NPJ3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37962
1.15992766816088e-47	-0.473130000323967	0.581	0.78	1.87780690198564e-43	MRPS18B	Malignant cells	GSE131984_JQ1	ENSG00000233813	28973	mitochondrial ribosomal protein S18B	C6orf14|HSPC183|MRPS18-2|PTD017	protein_coding	Q9Y676	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37963
1.23043497334389e-47	-0.486769854516711	0.365	0.615	1.99195117834643e-43	MAP7D3	Malignant cells	GSE131984_JQ1	ENSG00000129680	79649	MAP7 domain containing 3	FLJ12649	protein_coding	Q8IWC1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37964
1.45917666438611e-47	-0.559218574708015	0.477	0.7	2.36226110197467e-43	RUVBL1	Malignant cells	GSE131984_JQ1	ENSG00000284901	8607	RuvB like AAA ATPase 1	ECP54|INO80H|NMP238|Pontin52|RVB1|TIH1|TIP49|TIP49a	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37965
1.48069088713839e-47	-0.425725143466783	0.787	0.944	2.39709047718834e-43	CKS1B	Malignant cells	GSE131984_JQ1	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37966
1.5560478263362e-47	-0.360661654354075	0.975	0.992	2.51908582605568e-43	NDUFS8	Malignant cells	GSE131984_JQ1	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37967
1.64092053689031e-47	-0.44998357078215	0.254	0.517	2.65648625717172e-43	SCML1	Malignant cells	GSE131984_JQ1	ENSG00000047634	6322	Scm polycomb group protein like 1	NA	protein_coding	Q9UN30	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37968
1.69385581652023e-47	-0.517840712088321	0.751	0.866	2.74218318136461e-43	VDAC3	Malignant cells	GSE131984_JQ1	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37969
1.70190479418381e-47	-0.453200274847054	0.804	0.91	2.75521367130417e-43	UBE2N	Malignant cells	GSE131984_JQ1	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37970
1.80489261248065e-47	-0.341633612908047	0.999	0.999	2.92194065034493e-43	PARK7	Malignant cells	GSE131984_JQ1	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37971
2.57598722196138e-47	-0.393183903925651	0.146	0.384	4.17026571363329e-43	ACOX2	Malignant cells	GSE131984_JQ1	ENSG00000168306	8309	acyl-CoA oxidase 2	BRCACOX|BRCOX|THCCox	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37972
4.01430110985956e-47	-0.514830934532666	0.766	0.891	6.49875206675164e-43	HNRNPH3	Malignant cells	GSE131984_JQ1	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37973
4.40247054649694e-47	-0.504894376076995	0.87	0.951	7.1271595677239e-43	DUSP23	Malignant cells	GSE131984_JQ1	ENSG00000158716	54935	dual specificity phosphatase 23	DUSP25|FLJ20442	protein_coding	Q9BVJ7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37974
5.33001069599693e-47	-0.391076587251788	0.942	0.977	8.62875431574943e-43	TOMM22	Malignant cells	GSE131984_JQ1	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37975
5.84668189649454e-47	-0.513147007682549	0.498	0.726	9.465193322235e-43	EMG1	Malignant cells	GSE131984_JQ1	ENSG00000126749	10436	EMG1 N1-specific pseudouridine methyltransferase	C2F|Grcc2f|NEP1	protein_coding	Q92979	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37976
6.80555122177278e-47	-0.427258365705866	0.311	0.57	1.1017506872928e-42	PEMT	Malignant cells	GSE131984_JQ1	ENSG00000133027	10400	phosphatidylethanolamine N-methyltransferase	PEMPT|PEMT2	protein_coding	Q9UBM1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37977
7.19050755549189e-47	-0.441654344541438	0.788	0.907	1.16407126815858e-42	PRRC2C	Malignant cells	GSE131984_JQ1	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37978
1.01054502827438e-46	-0.5760909652128	0.765	0.883	1.63597134627339e-42	PDIA3	Malignant cells	GSE131984_JQ1	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37979
1.06350981509266e-46	-0.417974115379604	0.912	0.978	1.72171603965351e-42	COPRS	Malignant cells	GSE131984_JQ1	ENSG00000172301	55352	coordinator of PRMT5 and differentiation stimulator	C17orf79|COPR5|HSA272196|TTP1	protein_coding	Q9NQ92	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37980
1.09737223222136e-46	0.475435611648269	0.895	0.759	1.77653590674316e-42	SHC1	Malignant cells	GSE131984_JQ1	ENSG00000160691	6464	SHC adaptor protein 1	p66|SHC|ShcA	protein_coding	P29353	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37981
1.2719358319228e-46	-0.532484213012387	0.474	0.704	2.05913691829981e-42	MCM7	Malignant cells	GSE131984_JQ1	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37982
1.34660874269402e-46	-0.407941429745431	0.858	0.947	2.18002489354735e-42	MRPL11	Malignant cells	GSE131984_JQ1	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37983
2.74180822582523e-46	-0.468243032230385	0.825	0.938	4.43871333678847e-42	EIF3D	Malignant cells	GSE131984_JQ1	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37984
3.93744252884687e-46	-0.547747544653995	0.643	0.826	6.3743257099502e-42	HLA-B	Malignant cells	GSE131984_JQ1	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37985
4.25004317771959e-46	-0.431996714969078	0.803	0.92	6.88039490041025e-42	C20orf24	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37986
5.91918068233819e-46	-0.514759761337801	0.486	0.705	9.58256160663729e-42	MAGEA12	Malignant cells	GSE131984_JQ1	ENSG00000213401	4111	MAGE family member A12	CT1.12|MAGE12	protein_coding	P43365	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37987
7.11775018304153e-46	0.731674289377673	0.969	0.94	1.15229257713259e-41	MT1X	Malignant cells	GSE131984_JQ1	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37988
8.02881753225843e-46	-0.30439824764543	0.068	0.268	1.29978527029732e-41	ACSL5	Malignant cells	GSE131984_JQ1	ENSG00000197142	51703	acyl-CoA synthetase long chain family member 5	ACS2|ACS5|FACL5	protein_coding	Q9ULC5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37989
8.11488641794307e-46	0.782890754884566	0.999	0.992	1.3137189622008e-41	NEAT1	Malignant cells	GSE131984_JQ1	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37990
9.97683961944713e-46	-0.533120483725396	0.397	0.641	1.6151505659923e-41	GMNN	Malignant cells	GSE131984_JQ1	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37991
1.16168551093298e-45	-0.561414845881688	0.275	0.533	1.88065267364939e-41	TRIB3	Malignant cells	GSE131984_JQ1	ENSG00000101255	57761	tribbles pseudokinase 3	C20orf97|dJ1103G7.3|TRB3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37992
1.29525897539484e-45	-0.470829607458372	0.327	0.575	2.0968947552667e-41	AIFM2	Malignant cells	GSE131984_JQ1	ENSG00000042286	84883	apoptosis inducing factor mitochondria associated 2	AMID|FLJ14497|FSP1|PRG3	protein_coding	Q9BRQ8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37993
1.87945832319658e-45	-0.438180847148563	0.335	0.587	3.04265507942294e-41	TACO1	Malignant cells	GSE131984_JQ1	ENSG00000136463	51204	translational activator of cytochrome c oxidase I	CCDC44	protein_coding	Q9BSH4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37994
2.51000727440561e-45	-0.439081549711122	0.829	0.927	4.06345077653524e-41	PDCD2	Malignant cells	GSE131984_JQ1	ENSG00000071994	5134	programmed cell death 2	RP8|ZMYND7	protein_coding	Q16342	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37995
2.60137142885107e-45	-0.490530361200053	0.469	0.704	4.211360206167e-41	EMP2	Malignant cells	GSE131984_JQ1	ENSG00000213853	2013	epithelial membrane protein 2	XMP	protein_coding	P54851	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37996
2.78935955009057e-45	-0.47135792520601	0.669	0.845	4.51569417564163e-41	PDLIM2	Malignant cells	GSE131984_JQ1	ENSG00000120913	64236	PDZ and LIM domain 2	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37997
2.84351550372495e-45	-0.488831244484876	0.336	0.581	4.60336724898032e-41	EXOSC7	Malignant cells	GSE131984_JQ1	ENSG00000075914	23016	exosome component 7	EAP1|hRrp42p|KIAA0116|p8|RRP42|Rrp42p	protein_coding	Q15024	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37998
3.67172334815897e-45	-0.479202010765523	0.49	0.708	5.94415292833456e-41	MRPS35	Malignant cells	GSE131984_JQ1	ENSG00000061794	60488	mitochondrial ribosomal protein S35	MDS023|MRPS28	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	37999
4.42913095999558e-45	-0.515380079666027	0.481	0.683	7.17032011113685e-41	TCEAL8	Malignant cells	GSE131984_JQ1	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38000
4.78118685710726e-45	-0.469468420173315	0.701	0.85	7.74026340297095e-41	PSMD3	Malignant cells	GSE131984_JQ1	ENSG00000108344	5709	proteasome 26S subunit, non-ATPase 3	P58|Rpn3|S3|TSTA2	protein_coding	O43242	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38001
4.99414942011378e-45	-0.449241889526445	0.274	0.523	8.08502849622221e-41	MRPS31	Malignant cells	GSE131984_JQ1	ENSG00000102738	10240	mitochondrial ribosomal protein S31	IMOGN38	protein_coding	Q92665	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38002
5.17982531820901e-45	-0.445850577467939	0.242	0.486	8.38561920764857e-41	LAS1L	Malignant cells	GSE131984_JQ1	ENSG00000001497	81887	LAS1 like ribosome biogenesis factor	FLJ12525|Las1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38003
6.72507795163101e-45	-0.430862151901914	0.373	0.622	1.08872286958954e-40	TIMM23	Malignant cells	GSE131984_JQ1	ENSG00000265354	100287932	translocase of inner mitochondrial membrane 23	TIM23	protein_coding	O14925	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38004
8.57610245466967e-45	-0.482569055457651	0.397	0.636	1.38838522638647e-40	GPANK1	Malignant cells	GSE131984_JQ1	ENSG00000223932	7918	G-patch domain and ankyrin repeats 1	ANKRD59|BAT4|D6S54E|G5|GPATCH10	protein_coding	O95872	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38005
9.37228554106799e-45	0.576086065512675	0.98	0.959	1.5172793062435e-40	MYC	Malignant cells	GSE131984_JQ1	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38006
9.41320409326517e-45	-0.489804716968717	0.735	0.862	1.5239036106587e-40	MLLT11	Malignant cells	GSE131984_JQ1	ENSG00000213190	10962	MLLT11 transcription factor 7 cofactor	AF1Q	protein_coding	Q13015	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38007
9.64912148530112e-45	-0.461286378450535	0.694	0.831	1.5620962772554e-40	PDZD11	Malignant cells	GSE131984_JQ1	ENSG00000120509	51248	PDZ domain containing 11	PDZK11	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38008
1.02358111872303e-44	0.504828526162019	0.959	0.869	1.65707547310072e-40	CTSD	Malignant cells	GSE131984_JQ1	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38009
1.05663767179084e-44	-0.594909428510293	0.335	0.583	1.7105907268622e-40	CCNA2	Malignant cells	GSE131984_JQ1	ENSG00000145386	890	cyclin A2	CCN1|CCNA	protein_coding	P20248	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38010
1.06835555322001e-44	-0.352689856358044	0.991	0.997	1.72956080510788e-40	MIF	Malignant cells	GSE131984_JQ1	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38011
1.07363514314098e-44	-0.504447105752708	0.23	0.482	1.73810793323093e-40	SPC25	Malignant cells	GSE131984_JQ1	ENSG00000277909	57405	SPC25 component of NDC80 kinetochore complex	AD024|MGC22228|SPBC25	protein_coding	Q9HBM1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38012
1.10221196481144e-44	-0.465019371512676	0.217	0.465	1.78437094983324e-40	PCOLCE	Malignant cells	GSE131984_JQ1	ENSG00000106333	5118	procollagen C-endopeptidase enhancer	PCPE|PCPE1	protein_coding	Q15113	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38013
1.38587911638708e-44	-0.433536580793853	0.296	0.537	2.24359970151905e-40	PEF1	Malignant cells	GSE131984_JQ1	ENSG00000162517	553115	penta-EF-hand domain containing 1	PEF1A	protein_coding	Q9UBV8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38014
1.58926969505846e-44	-0.426473696684789	0.19	0.426	2.57286870933014e-40	APOBEC3B	Malignant cells	GSE131984_JQ1	ENSG00000179750	9582	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	FLJ21201|PHRBNL	protein_coding	Q9UH17	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38015
1.77087788506084e-44	-0.448505007199323	0.328	0.58	2.866874208125e-40	COMTD1	Malignant cells	GSE131984_JQ1	ENSG00000165644	118881	catechol-O-methyltransferase domain containing 1	FLJ23841	protein_coding	Q86VU5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38016
1.91115246714029e-44	0.468317808419087	0.978	0.93	3.09396472905342e-40	SLC38A2	Malignant cells	GSE131984_JQ1	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38017
2.55115620264579e-44	-0.466111272979728	0.378	0.626	4.13006677646327e-40	PELO	Malignant cells	GSE131984_JQ1	ENSG00000152684	53918	pelota mRNA surveillance and ribosome rescue factor	NA	protein_coding	Q9BRX2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38018
2.78256895743728e-44	-0.434913021370356	0.865	0.948	4.50470088519521e-40	CAPN2	Malignant cells	GSE131984_JQ1	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38019
3.03235696522777e-44	-0.620529167462619	0.583	0.75	4.90908269100724e-40	PSMD6	Malignant cells	GSE131984_JQ1	ENSG00000163636	9861	proteasome 26S subunit, non-ATPase 6	KIAA0107|p44S10|Rpn7|S10	protein_coding	Q15008	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38020
3.23109686994834e-44	-0.471225679879486	0.631	0.811	5.23082272275937e-40	JPX	Malignant cells	GSE131984_JQ1	ENSG00000225470	554203	JPX transcript, XIST activator	DCBALD06|ENOX|LINC00183|NCRNA00183	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38021
3.50392799442817e-44	0.568570073486771	0.884	0.797	5.67250903017976e-40	XIST	Malignant cells	GSE131984_JQ1	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38022
3.64175091876827e-44	-0.469107525439648	0.315	0.554	5.89563056239396e-40	SMAGP	Malignant cells	GSE131984_JQ1	ENSG00000170545	57228	small cell adhesion glycoprotein	hSMAGP|MGC149453|MGC149454	protein_coding	Q0VAQ4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38023
4.07942893862403e-44	-0.510440335540033	0.425	0.648	6.60418750873844e-40	MRPS30	Malignant cells	GSE131984_JQ1	ENSG00000112996	10884	mitochondrial ribosomal protein S30	PAP|PDCD9	protein_coding	Q9NP92	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38024
4.2752422574292e-44	0.657393180365526	0.773	0.549	6.92118969055214e-40	CTGF	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38025
4.43637294948975e-44	-0.471360021500174	0.418	0.655	7.18204416792896e-40	IFI16	Malignant cells	GSE131984_JQ1	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38026
5.00807817764143e-44	-0.444117148830951	0.78	0.894	8.10757776178371e-40	GSPT1	Malignant cells	GSE131984_JQ1	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38027
5.63681401407151e-44	-0.425635335492765	0.921	0.956	9.12543820738036e-40	OSTC	Malignant cells	GSE131984_JQ1	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38028
5.69128910012541e-44	-0.468629227248544	0.64	0.806	9.21362792419303e-40	RWDD4	Malignant cells	GSE131984_JQ1	ENSG00000182552	201965	RWD domain containing 4	FAM28A|MGC10198|RWDD4A	protein_coding	Q6NW29	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38029
6.91725404380703e-44	-0.402532320873319	0.905	0.962	1.11983425715192e-39	C11orf31	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38030
7.31798798643314e-44	-0.501467185972912	0.173	0.404	1.18470907512366e-39	CCAT1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38031
8.25389039380284e-44	0.390438670657928	0.983	0.946	1.33622231585274e-39	SMDT1	Malignant cells	GSE131984_JQ1	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38032
8.32802413421391e-44	0.451193775353818	0.943	0.89	1.34822382708789e-39	GNAS	Malignant cells	GSE131984_JQ1	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38033
8.9756388984804e-44	-0.436519420910987	0.541	0.749	1.45306618127499e-39	MVB12A	Malignant cells	GSE131984_JQ1	ENSG00000141971	93343	multivesicular body subunit 12A	FAM125A|FLJ32495	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38034
9.79513212670449e-44	-0.491962726929204	0.496	0.71	1.58573393999219e-39	HTATSF1	Malignant cells	GSE131984_JQ1	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38035
1.07740226509745e-43	-0.455870534804591	0.649	0.811	1.74420652696625e-39	BTF3L4	Malignant cells	GSE131984_JQ1	ENSG00000134717	91408	basic transcription factor 3 like 4	MGC23908	protein_coding	Q96K17	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38036
1.13733769517921e-43	-0.425507067041857	0.356	0.606	1.84123599472562e-39	HSPBP1	Malignant cells	GSE131984_JQ1	ENSG00000133265	23640	HSPA (Hsp70) binding protein 1	FES1	protein_coding	Q9NZL4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38037
1.14149835933547e-43	-0.475437362012309	0.635	0.81	1.84797169392819e-39	MTIF3	Malignant cells	GSE131984_JQ1	ENSG00000122033	219402	mitochondrial translational initiation factor 3	IF-3mt|IF3(mt)	protein_coding	Q9H2K0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38038
1.32447031467414e-43	-0.443477697062664	0.744	0.882	2.14418499242597e-39	ACTR3	Malignant cells	GSE131984_JQ1	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38039
1.41829340337809e-43	-0.446053255376059	0.911	0.949	2.29607519072878e-39	SSR3	Malignant cells	GSE131984_JQ1	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38040
1.45911928346395e-43	-0.350345074812652	0.121	0.34	2.36216820799979e-39	L3HYPDH	Malignant cells	GSE131984_JQ1	ENSG00000126790	112849	trans-L-3-hydroxyproline dehydratase	C14orf149|FLJ25436	protein_coding	Q96EM0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38041
2.04374046887881e-43	-0.367239173036995	0.988	0.993	3.30861144506791e-39	SSR2	Malignant cells	GSE131984_JQ1	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38042
2.16114665788974e-43	-0.408668225615922	0.824	0.927	3.4986803244577e-39	C8orf59	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38043
2.85132536787184e-43	-0.45139528916429	0.387	0.629	4.61601063804773e-39	TSR2	Malignant cells	GSE131984_JQ1	ENSG00000158526	90121	TSR2 ribosome maturation factor	DT1P1A10|RP1-112K5.2|WGG1	protein_coding	Q969E8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38044
3.17410728192432e-43	-0.466012557357172	0.583	0.754	5.13856227870728e-39	MRPS5	Malignant cells	GSE131984_JQ1	ENSG00000144029	64969	mitochondrial ribosomal protein S5	MRP-S5|S5mt	protein_coding	P82675	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38045
3.21816578608809e-43	-0.458987637917452	0.65	0.822	5.20988859109801e-39	EMC8	Malignant cells	GSE131984_JQ1	ENSG00000131148	10328	ER membrane protein complex subunit 8	C16orf2|C16orf4|COX4NB|FAM158B|NOC4	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38046
3.282379424403e-43	-0.326420673003499	0.09	0.295	5.31384405016602e-39	RP5-884M6.1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38047
3.49675860146975e-43	-0.508628582920666	0.412	0.649	5.66090249991937e-39	UTP11L	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38048
4.01085338224308e-43	-0.492351025924966	0.589	0.767	6.49317054051333e-39	COPS3	Malignant cells	GSE131984_JQ1	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38049
4.69033351108123e-43	-0.393869840844171	0.901	0.962	7.59318092108941e-39	RPL26L1	Malignant cells	GSE131984_JQ1	ENSG00000037241	51121	ribosomal protein L26 like 1	RPL26P1	protein_coding	Q9UNX3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38050
5.88535311019594e-43	-0.458990933648629	0.636	0.804	9.52779815009621e-39	NDUFA5	Malignant cells	GSE131984_JQ1	ENSG00000128609	4698	NADH:ubiquinone oxidoreductase subunit A5	B13|CI-13kB|CI-13KD-B|NUFM|UQOR13	protein_coding	Q16718	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38051
5.93904766250014e-43	-0.477918472606167	0.709	0.842	9.61472426082147e-39	HNRNPF	Malignant cells	GSE131984_JQ1	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38052
6.32685413954956e-43	-0.427857179037703	0.809	0.909	1.02425441665168e-38	PRPF40A	Malignant cells	GSE131984_JQ1	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38053
8.18228011450114e-43	0.476705579078377	0.821	0.644	1.32462932773659e-38	APLP2	Malignant cells	GSE131984_JQ1	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38054
9.08926896771904e-43	-0.474790309283616	0.528	0.742	1.47146175318404e-38	DNAJC2	Malignant cells	GSE131984_JQ1	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38055
9.09876787614428e-43	-0.48763847224113	0.564	0.759	1.472999531469e-38	PFKP	Malignant cells	GSE131984_JQ1	ENSG00000067057	5214	phosphofructokinase, platelet	PFK-C|PFKF	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38056
1.02633481378919e-42	-0.400428414005559	0.877	0.961	1.66153343004332e-38	ZC3H15	Malignant cells	GSE131984_JQ1	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38057
1.24607268557876e-42	-0.534751463691311	0.537	0.73	2.01726707068346e-38	PSMD12	Malignant cells	GSE131984_JQ1	ENSG00000197170	5718	proteasome 26S subunit, non-ATPase 12	p55|Rpn5	protein_coding	O00232	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38058
1.41018277117886e-42	0.53773672114988	0.51	0.263	2.28294488826146e-38	CRIP2	Malignant cells	GSE131984_JQ1	ENSG00000182809	1397	cysteine rich protein 2	CRP2|ESP1	protein_coding	P52943	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38059
1.45539747934942e-42	-0.30800860346316	0.067	0.254	2.35614297931877e-38	RP11-525A16.4	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38060
1.64963801351161e-42	-0.432331774575539	0.914	0.971	2.67059898007395e-38	PRDX2	Malignant cells	GSE131984_JQ1	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38061
1.91327335228644e-42	-0.421270721499928	0.328	0.578	3.09739823001651e-38	RFC2	Malignant cells	GSE131984_JQ1	ENSG00000049541	5982	replication factor C subunit 2	A1|RFC40	protein_coding	P35250	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38062
2.10072201252815e-42	-0.438071295525087	0.465	0.691	3.40085886608183e-38	PHF5A	Malignant cells	GSE131984_JQ1	ENSG00000100410	84844	PHD finger protein 5A	bK223H9.2|INI|MGC1346|Rds3|SAP14b|SF3b14b|SF3B7	protein_coding	Q7RTV0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38063
2.22120683894017e-42	-0.399293360571836	0.974	0.988	3.59591175156024e-38	ATP5C1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38064
2.46311772391303e-42	-0.443271544920015	0.555	0.744	3.9875412832428e-38	MRPL9	Malignant cells	GSE131984_JQ1	ENSG00000143436	65005	mitochondrial ribosomal protein L9	NA	protein_coding	Q9BYD2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38065
2.90017951032086e-42	-0.471338915852109	0.433	0.659	4.69510060925843e-38	EXOSC3	Malignant cells	GSE131984_JQ1	ENSG00000107371	51010	exosome component 3	CGI-102|hRrp-40|hRrp40p|p10|RRP40|Rrp40p	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38066
3.05127799308572e-42	-0.599324413427065	0.187	0.414	4.93971394300647e-38	PTX3	Malignant cells	GSE131984_JQ1	ENSG00000163661	5806	pentraxin 3	TNFAIP5|TSG-14	protein_coding	P26022	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38067
3.11261167823652e-42	-0.440702207582008	0.68	0.843	5.0390070458971e-38	CCDC34	Malignant cells	GSE131984_JQ1	ENSG00000109881	91057	coiled-coil domain containing 34	L15|NY-REN-41|RAMA3	protein_coding	Q96HJ3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38068
3.11704127238878e-42	0.326370496582966	1	1	5.0461781158702e-38	SH3BGRL3	Malignant cells	GSE131984_JQ1	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38069
3.22967125489293e-42	-0.484175663758641	0.734	0.851	5.22851479454616e-38	COPS8	Malignant cells	GSE131984_JQ1	ENSG00000198612	10920	COP9 signalosome subunit 8	COP9|CSN8|MGC1297|SGN8	protein_coding	Q99627	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38070
3.32516869002303e-42	-0.466223289910761	0.391	0.646	5.38311559227828e-38	RP3-460G2.2	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38071
3.3292031344598e-42	-0.562382097995841	0.096	0.296	5.38964695437698e-38	PMAIP1	Malignant cells	GSE131984_JQ1	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38072
3.42227054587004e-42	-0.373344633065684	0.926	0.978	5.540313786709e-38	RAD23A	Malignant cells	GSE131984_JQ1	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38073
3.74692753398538e-42	-0.530931560455946	0.36	0.598	6.06590098476894e-38	EIF4A3	Malignant cells	GSE131984_JQ1	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38074
3.83754964168028e-42	-0.292650367345137	0.082	0.281	6.21260911491621e-38	UGT2B7	Malignant cells	GSE131984_JQ1	ENSG00000171234	7364	UDP glucuronosyltransferase family 2 member B7	UGT2B9	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38075
3.98738452107325e-42	-0.440710243371014	0.775	0.892	6.45517680116548e-38	RAB2A	Malignant cells	GSE131984_JQ1	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38076
4.61741507503863e-42	-0.490288779083726	0.881	0.947	7.47513326498005e-38	CCT7	Malignant cells	GSE131984_JQ1	ENSG00000135624	10574	chaperonin containing TCP1 subunit 7	Ccth|Nip7-1	protein_coding	Q99832	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38077
5.0746079168456e-42	-0.396994838404265	0.282	0.525	8.21528275658134e-38	CHCHD4	Malignant cells	GSE131984_JQ1	ENSG00000163528	131474	coiled-coil-helix-coiled-coil-helix domain containing 4	FLJ31709|MIA40|TIMM40	protein_coding	Q8N4Q1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38078
5.58032676197032e-42	-0.48960482404612	0.528	0.715	9.03399099495376e-38	HAUS1	Malignant cells	GSE131984_JQ1	ENSG00000152240	115106	HAUS augmin like complex subunit 1	CCDC5|FLJ40084|HEI-C|HsT1461	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38079
6.79201524531568e-42	-0.445054487274262	0.898	0.958	1.09955934806416e-37	NOL7	Malignant cells	GSE131984_JQ1	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38080
7.83130456250199e-42	-0.536856082277507	0.864	0.941	1.26780989562345e-37	SSB	Malignant cells	GSE131984_JQ1	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38081
7.8806238389269e-42	-0.360865615761794	0.963	0.991	1.27579419328388e-37	CBX3	Malignant cells	GSE131984_JQ1	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38082
8.53697351596296e-42	-0.481378519509265	0.42	0.643	1.38205064249924e-37	FRG1	Malignant cells	GSE131984_JQ1	ENSG00000275145	2483	FSHD region gene 1	FRG1A|FSG1	protein_coding	Q14331	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38083
1.30588053932064e-41	0.36694058892282	1	0.999	2.11409000510618e-37	MT-CO1	Malignant cells	GSE131984_JQ1	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38084
1.56204168657327e-41	-0.519196425383184	0.753	0.887	2.52878928639346e-37	CTSC	Malignant cells	GSE131984_JQ1	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38085
1.57542845042811e-41	-0.444939148205631	0.33	0.564	2.55046111839807e-37	MAGEA6	Malignant cells	GSE131984_JQ1	ENSG00000197172	4105	MAGE family member A6	CT1.6|MAGE-3b|MAGE3B|MAGE6	protein_coding	P43360	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38086
1.76929050411293e-41	-0.500131236201064	0.668	0.828	2.86430439710843e-37	BUB3	Malignant cells	GSE131984_JQ1	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38087
1.85529986296912e-41	-0.401850814416142	0.893	0.958	3.00354494816071e-37	EMC6	Malignant cells	GSE131984_JQ1	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38088
2.03201683822839e-41	-0.546292203924503	0.424	0.648	3.28963205940794e-37	CTSL	Malignant cells	GSE131984_JQ1	ENSG00000135047	1514	cathepsin L	CTSL1|FLJ31037	protein_coding	P07711	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38089
3.0702925994541e-41	-0.441012299729883	0.802	0.943	4.97049668925624e-37	CDKN3	Malignant cells	GSE131984_JQ1	ENSG00000100526	1033	cyclin dependent kinase inhibitor 3	CDI1|KAP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38090
3.3315519441801e-41	-0.435237898613788	0.638	0.834	5.39344944243317e-37	IFI27	Malignant cells	GSE131984_JQ1	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38091
3.62276329309691e-41	-0.529451181459573	0.979	0.988	5.86489149519459e-37	UBB	Malignant cells	GSE131984_JQ1	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38092
3.91120722315573e-41	0.459844711700079	0.79	0.588	6.33185337356681e-37	EMP1	Malignant cells	GSE131984_JQ1	ENSG00000134531	2012	epithelial membrane protein 1	CL-20|TMP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38093
4.87933820205745e-41	-0.486853458581645	0.698	0.843	7.89916061531081e-37	PSMC3	Malignant cells	GSE131984_JQ1	ENSG00000165916	5702	proteasome 26S subunit, ATPase 3	RPT5|TBP-1|TBP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38094
5.87774187544439e-41	-0.392731926448068	0.921	0.951	9.51547632215693e-37	BCAP31	Malignant cells	GSE131984_JQ1	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38095
6.20237176881054e-41	-0.403568581291439	0.33	0.573	1.00410196565274e-36	SORBS3	Malignant cells	GSE131984_JQ1	ENSG00000120896	10174	sorbin and SH3 domain containing 3	SCAM-1|SH3D4|vinexin	protein_coding	O60504	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38096
6.24748945966348e-41	-0.484715016950174	0.394	0.634	1.01140606862492e-36	FEN1	Malignant cells	GSE131984_JQ1	ENSG00000168496	2237	flap structure-specific endonuclease 1	FEN-1|MF1|RAD2	protein_coding	P39748	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38097
7.16081349498773e-41	-0.445465930309783	0.79	0.893	1.15926409670356e-36	GLO1	Malignant cells	GSE131984_JQ1	ENSG00000124767	2739	glyoxalase I	GLOD1	protein_coding	Q04760	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38098
7.18301403866072e-41	-0.346425479067699	0.962	0.987	1.16285814271878e-36	SRP9	Malignant cells	GSE131984_JQ1	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38099
8.43491877140725e-41	-0.438001925198787	0.389	0.618	1.36552899990312e-36	SPG20	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38100
1.0127858343793e-40	-0.488957105954246	0.435	0.682	1.63959898727666e-36	CCNB2	Malignant cells	GSE131984_JQ1	ENSG00000157456	9133	cyclin B2	HsT17299	protein_coding	O95067	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38101
1.14775577404053e-40	-0.468472853852305	0.75	0.859	1.85810182259422e-36	RAB7A	Malignant cells	GSE131984_JQ1	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38102
1.2687093594395e-40	-0.370944663446386	0.934	0.98	2.0539135819966e-36	BOLA3	Malignant cells	GSE131984_JQ1	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38103
1.29357724169914e-40	-0.293476247002105	0.998	1	2.09417219658674e-36	ATP5G3	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38104
1.88189355978106e-40	-0.434198664257096	0.847	0.915	3.04659748392956e-36	LINC00152	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38105
2.15184131375071e-40	-0.425925794210612	0.876	0.928	3.48361590283102e-36	BID	Malignant cells	GSE131984_JQ1	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38106
2.34015164556861e-40	-0.49905060523976	0.5	0.7	3.78847149901102e-36	PDCD10	Malignant cells	GSE131984_JQ1	ENSG00000114209	11235	programmed cell death 10	CCM3|TFAR15	protein_coding	Q9BUL8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38107
2.85393590524565e-40	-0.403446987600195	0.314	0.555	4.62023683700218e-36	UCK2	Malignant cells	GSE131984_JQ1	ENSG00000143179	7371	uridine-cytidine kinase 2	UMPK	protein_coding	Q9BZX2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38108
2.96137581289264e-40	-0.381588765447043	0.14	0.354	4.79417130349189e-36	MEST	Malignant cells	GSE131984_JQ1	ENSG00000106484	4232	mesoderm specific transcript	PEG1	protein_coding	Q5EB52	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38109
4.16089069101767e-40	-0.36946605158465	0.928	0.975	6.7360659396885e-36	NUDCD2	Malignant cells	GSE131984_JQ1	ENSG00000170584	134492	NudC domain containing 2	DKFZp686E10109|NudCL2	protein_coding	Q8WVJ2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38110
4.53778765553457e-40	-0.434040685178516	0.728	0.846	7.34622443554492e-36	NDUFS3	Malignant cells	GSE131984_JQ1	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38111
4.69423075640245e-40	-0.416926867336384	0.373	0.602	7.59949017153993e-36	ENOPH1	Malignant cells	GSE131984_JQ1	ENSG00000145293	58478	enolase-phosphatase 1	E1|MASA|mtnC	protein_coding	Q9UHY7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38112
5.29811839109538e-40	-0.454042535781435	0.426	0.646	8.5771238633443e-36	GMPS	Malignant cells	GSE131984_JQ1	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38113
6.23476649874906e-40	-0.376654936466244	0.277	0.515	1.00934634848248e-35	ETV4	Malignant cells	GSE131984_JQ1	ENSG00000175832	2118	ETS variant transcription factor 4	E1A-F|E1AF|PEA3	protein_coding	P43268	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38114
6.31572993824077e-40	-0.422018612338744	0.224	0.455	1.0224535197018e-35	IRF1	Malignant cells	GSE131984_JQ1	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38115
6.55835076632329e-40	-0.465562077724626	0.848	0.936	1.06173140556008e-35	UPP1	Malignant cells	GSE131984_JQ1	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38116
6.72436971224518e-40	-0.389989308295288	0.222	0.451	1.08860821271537e-35	ALG14	Malignant cells	GSE131984_JQ1	ENSG00000172339	199857	ALG14 UDP-N-acetylglucosaminyltransferase subunit	MGC19780	protein_coding	Q96F25	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38117
8.2357673261266e-40	-0.476271211394339	0.662	0.823	1.33328837242664e-35	SBDS	Malignant cells	GSE131984_JQ1	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38118
8.69168883883938e-40	-0.425544021470637	0.325	0.561	1.40709750611971e-35	PLS3	Malignant cells	GSE131984_JQ1	ENSG00000102024	5358	plastin 3	T-plastin	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38119
8.69641914461611e-40	-0.411112561073434	0.707	0.849	1.4078632953219e-35	BCKDK	Malignant cells	GSE131984_JQ1	ENSG00000103507	10295	branched chain keto acid dehydrogenase kinase	NA	protein_coding	O14874	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38120
9.17786822775703e-40	-0.503119457274896	0.461	0.664	1.48580508739159e-35	NDUFAF4	Malignant cells	GSE131984_JQ1	ENSG00000123545	29078	NADH:ubiquinone oxidoreductase complex assembly factor 4	bA22L21.1|C6orf66|HRPAP20|HSPC125|My013	protein_coding	Q9P032	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38121
9.31736455356709e-40	-0.475196447781271	0.487	0.697	1.50838814757698e-35	CHMP2B	Malignant cells	GSE131984_JQ1	ENSG00000083937	25978	charged multivesicular body protein 2B	CHMP2.5|DKFZP564O123|VPS2B	protein_coding	Q9UQN3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38122
9.98069646176317e-40	0.501608701953909	0.403	0.172	1.61577495019484e-35	ASS1	Malignant cells	GSE131984_JQ1	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38123
1.00528346428925e-39	-0.454710336260552	0.458	0.672	1.62745340033786e-35	RBMX2	Malignant cells	GSE131984_JQ1	ENSG00000134597	51634	RNA binding motif protein X-linked 2	CGI-79|Snu17	protein_coding	Q9Y388	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38124
1.03894235660282e-39	-0.405209606550915	0.98	0.997	1.68194378110431e-35	PSMB1	Malignant cells	GSE131984_JQ1	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38125
1.12836835962479e-39	0.444134327403263	0.946	0.824	1.82671553739657e-35	G6PD	Malignant cells	GSE131984_JQ1	ENSG00000160211	2539	glucose-6-phosphate dehydrogenase	G6PD1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38126
1.60112605628595e-39	-0.429158074148552	0.742	0.874	2.59206297252133e-35	HLA-C	Malignant cells	GSE131984_JQ1	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38127
1.86631412975337e-39	-0.504190637409336	0.541	0.783	3.02137594465773e-35	CDC20	Malignant cells	GSE131984_JQ1	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38128
1.93119903288013e-39	-0.43773344220021	0.369	0.602	3.12641811432964e-35	GNL2	Malignant cells	GSE131984_JQ1	ENSG00000134697	29889	G protein nucleolar 2	HUMAUANTIG|Ngp-1|Nog2|Nug2	protein_coding	Q13823	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38129
2.01949473346211e-39	-0.495681200403385	0.491	0.688	3.26936002400181e-35	FH	Malignant cells	GSE131984_JQ1	ENSG00000091483	2271	fumarate hydratase	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38130
2.10439307578679e-39	-0.418449614215329	0.837	0.912	3.40680195039124e-35	MMADHC	Malignant cells	GSE131984_JQ1	ENSG00000168288	27249	metabolism of cobalamin associated D	C2orf25|cblD|CL25022	protein_coding	Q9H3L0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38131
2.19095376025426e-39	-0.421154166714234	0.272	0.5	3.54693504247562e-35	TXLNG	Malignant cells	GSE131984_JQ1	ENSG00000086712	55787	taxilin gamma	CXorf15|FIAT|FLJ11209|LSR5|MGC126621|MGC126625|TXLNGX	protein_coding	Q9NUQ3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38132
2.54183326758232e-39	-0.501177550501269	0.769	0.861	4.11497387688902e-35	SPCS2	Malignant cells	GSE131984_JQ1	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38133
2.56888994963813e-39	-0.427082949036283	0.794	0.906	4.15877593946916e-35	HNRNPM	Malignant cells	GSE131984_JQ1	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38134
4.10311881894867e-39	-0.384221379056046	0.264	0.501	6.642539055996e-35	CCDC58	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38135
4.41640714894221e-39	-0.356926496931822	0.985	0.997	7.14972153342254e-35	SPCS1	Malignant cells	GSE131984_JQ1	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38136
4.77784988387326e-39	-0.444484932409368	0.241	0.463	7.73486117700241e-35	TXNRD2	Malignant cells	GSE131984_JQ1	ENSG00000184470	10587	thioredoxin reductase 2	SELZ|TR|TR3|TRXR2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38137
4.9726390154682e-39	-0.27953468744144	0.073	0.256	8.05020530214146e-35	PODXL2	Malignant cells	GSE131984_JQ1	ENSG00000114631	50512	podocalyxin like 2	endoglycan|PODLX2	protein_coding	Q9NZ53	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38138
6.25584611671103e-39	-0.424385104658163	0.732	0.872	1.01275892783435e-34	DDX18	Malignant cells	GSE131984_JQ1	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38139
6.40273555683364e-39	-0.276680141265146	0.997	1	1.0365388592958e-34	NDUFB10	Malignant cells	GSE131984_JQ1	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38140
7.37690969918019e-39	-0.422185101255298	0.764	0.878	1.19424791120028e-34	MRPL42	Malignant cells	GSE131984_JQ1	ENSG00000198015	28977	mitochondrial ribosomal protein L42	HSPC204|MRP-L31|MRPL31|MRPS32|PTD007|RPML31	protein_coding	Q9Y6G3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38141
7.5550770727108e-39	-0.436481904067062	0.709	0.847	1.22309142730115e-34	WTAP	Malignant cells	GSE131984_JQ1	ENSG00000146457	9589	WT1 associated protein	KIAA0105|MGC3925|Mum2	protein_coding	Q15007	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38142
8.25307379147374e-39	-0.45117807573314	0.925	0.971	1.33609011610168e-34	ATF4	Malignant cells	GSE131984_JQ1	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38143
9.18421117655806e-39	-0.860838087285043	0.961	0.979	1.48683194737298e-34	HIST1H4C	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38144
1.22899504087916e-38	-0.383789153841896	0.886	0.959	1.98962007167927e-34	ATP1B3	Malignant cells	GSE131984_JQ1	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38145
1.3270901902356e-38	-0.435110749625844	0.461	0.681	2.14842630897242e-34	BAZ1A	Malignant cells	GSE131984_JQ1	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38146
1.35447041298229e-38	0.377198768072996	0.951	0.85	2.19275215157704e-34	TAF10	Malignant cells	GSE131984_JQ1	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38147
1.43852333171462e-38	-0.345959567269465	0.986	0.992	2.3288254217128e-34	HNRNPC	Malignant cells	GSE131984_JQ1	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38148
1.62322770876929e-38	-0.40167536481929	0.351	0.579	2.62784333772661e-34	WDR18	Malignant cells	GSE131984_JQ1	ENSG00000065268	57418	WD repeat domain 18	Ipi3	protein_coding	Q9BV38	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38149
1.79030638470277e-38	-0.412777842176079	0.433	0.649	2.89832700619532e-34	CHCHD6	Malignant cells	GSE131984_JQ1	ENSG00000159685	84303	coiled-coil-helix-coiled-coil-helix domain containing 6	CHCM1|MGC13016|Mic25|MICOS25|PPP1R23	protein_coding	Q9BRQ6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38150
2.0051239277439e-38	-0.53258936969825	0.5	0.698	3.24609512662459e-34	PSMC2	Malignant cells	GSE131984_JQ1	ENSG00000161057	5701	proteasome 26S subunit, ATPase 2	MSS1|Nbla10058|RPT1|S7	protein_coding	P35998	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38151
2.85503561305163e-38	-0.43124289050324	0.437	0.647	4.62201715396929e-34	MTX2	Malignant cells	GSE131984_JQ1	ENSG00000128654	10651	metaxin 2	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38152
2.93293609882705e-38	-0.431139675240627	0.541	0.744	4.74813025039111e-34	COMMD4	Malignant cells	GSE131984_JQ1	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38153
3.3767772017562e-38	-0.391316645842914	0.297	0.53	5.46666461192311e-34	RAI14	Malignant cells	GSE131984_JQ1	ENSG00000039560	26064	retinoic acid induced 14	DKFZp564G013|KIAA1334|NORPEG|RAI13	protein_coding	Q9P0K7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38154
3.78011931338957e-38	-0.422534536149772	0.662	0.824	6.11963515644638e-34	POLR3K	Malignant cells	GSE131984_JQ1	ENSG00000161980	51728	RNA polymerase III subunit K	C11|RPC11	protein_coding	Q9Y2Y1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38155
3.7853924560803e-38	-0.426256712287661	0.768	0.868	6.12817184714839e-34	SFT2D1	Malignant cells	GSE131984_JQ1	ENSG00000198818	113402	SFT2 domain containing 1	C6orf83|MGC19825|pRGR1	protein_coding	Q8WV19	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38156
4.07974553196087e-38	-0.427199743162897	0.381	0.61	6.60470004169146e-34	WDR45	Malignant cells	GSE131984_JQ1	ENSG00000196998	11152	WD repeat domain 45	JM5|NBIA5|WDRX1|WIPI4	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38157
4.12091210518857e-38	-0.333770606571924	0.974	0.995	6.67134460708978e-34	ZNF706	Malignant cells	GSE131984_JQ1	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38158
4.48871550055085e-38	-0.440132756760092	0.648	0.809	7.26678152384177e-34	DNAJC7	Malignant cells	GSE131984_JQ1	ENSG00000168259	7266	DnaJ heat shock protein family (Hsp40) member C7	TPR2|TTC2	protein_coding	Q99615	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38159
4.71272025594496e-38	-0.363515058902617	0.9	0.96	7.62942282234929e-34	POLD2	Malignant cells	GSE131984_JQ1	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38160
4.81121036726073e-38	-0.436356359700264	0.523	0.727	7.78886846355839e-34	PUF60	Malignant cells	GSE131984_JQ1	ENSG00000274081	22827	poly(U) binding splicing factor 60	FIR|RoBPI|SIAHBP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38161
4.94068521810033e-38	-0.294863807702232	0.098	0.29	7.99847529958262e-34	CSTF2	Malignant cells	GSE131984_JQ1	ENSG00000101811	1478	cleavage stimulation factor subunit 2	CstF-64	protein_coding	P33240	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38162
5.15768976069833e-38	-0.448845120834319	0.674	0.815	8.34978395359452e-34	GTF2F2	Malignant cells	GSE131984_JQ1	ENSG00000188342	2963	general transcription factor IIF subunit 2	BTF4|RAP30|TFIIF	protein_coding	P13984	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38163
5.33533940892427e-38	-0.468536618178592	0.502	0.706	8.6373809691075e-34	ACAA2	Malignant cells	GSE131984_JQ1	ENSG00000167315	10449	acetyl-CoA acyltransferase 2	DSAEC	protein_coding	P42765	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38164
8.83730135728444e-38	-0.340586627460876	0.957	0.989	1.43067071673078e-33	GTF2A2	Malignant cells	GSE131984_JQ1	ENSG00000140307	2958	general transcription factor IIA subunit 2	HsT18745|TFIIA	protein_coding	P52657	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38165
8.99350277334116e-38	-0.431251275813973	0.713	0.855	1.4559581639762e-33	SUCLG1	Malignant cells	GSE131984_JQ1	ENSG00000163541	8802	succinate-CoA ligase GDP/ADP-forming subunit alpha	NA	protein_coding	P53597	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38166
9.31565472749747e-38	-0.409105222025425	0.981	0.997	1.50811134383457e-33	KRT18	Malignant cells	GSE131984_JQ1	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38167
9.67282986996295e-38	-0.309072027930677	0.994	0.996	1.5659344276483e-33	NDUFB9	Malignant cells	GSE131984_JQ1	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38168
1.02610831471379e-37	-0.397141289401212	0.743	0.876	1.66116675069015e-33	POLR2K	Malignant cells	GSE131984_JQ1	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38169
1.16534086752703e-37	-0.370361178783046	0.909	0.954	1.88657033043952e-33	CSNK2B	Malignant cells	GSE131984_JQ1	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38170
1.18223873099136e-37	-0.437523330884791	0.281	0.502	1.91392628160192e-33	SRPX	Malignant cells	GSE131984_JQ1	ENSG00000101955	8406	sushi repeat containing protein X-linked	ETX1|SRPX1	protein_coding	P78539	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38171
1.20567340656156e-37	-0.34349265196677	0.974	0.989	1.95186467788251e-33	NDUFB1	Malignant cells	GSE131984_JQ1	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38172
1.25151465096845e-37	-0.461574803969264	0.312	0.534	2.02607706845282e-33	PAK1IP1	Malignant cells	GSE131984_JQ1	ENSG00000285226	55003	PAK1 interacting protein 1	bA421M1.5|FLJ20624|hPIP1|MAK11|PIP1|WDR84	protein_coding	Q9NWT1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38173
1.28398503128526e-37	-0.449459524726097	0.949	0.968	2.07864336714771e-33	CCT3	Malignant cells	GSE131984_JQ1	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38174
1.30261717731674e-37	-0.392514555001835	0.747	0.878	2.10880694835807e-33	SEP15	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38175
1.31838678029136e-37	0.471288012010998	0.724	0.533	2.13433635861369e-33	MPRIP	Malignant cells	GSE131984_JQ1	ENSG00000133030	23164	myosin phosphatase Rho interacting protein	M-RIP|p116Rip|RHOIP3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38176
1.3970755385163e-37	0.468160045637192	0.706	0.473	2.26172558930404e-33	CITED2	Malignant cells	GSE131984_JQ1	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38177
1.47081222038687e-37	-0.41149971047802	0.332	0.56	2.3810979035843e-33	WDR74	Malignant cells	GSE131984_JQ1	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38178
1.90181167100758e-37	-0.439930485422281	0.458	0.666	3.07884291419417e-33	PPIH	Malignant cells	GSE131984_JQ1	ENSG00000171960	10465	peptidylprolyl isomerase H	CYP-20|CYPH|MGC5016|SnuCyp-20|USA-CYP	protein_coding	O43447	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38179
1.95895847161097e-37	-0.440625494607127	0.382	0.601	3.17135786969101e-33	C21orf59	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38180
2.04462440073807e-37	-0.634336885272504	0.425	0.634	3.31004244235486e-33	SLC3A2	Malignant cells	GSE131984_JQ1	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38181
2.12748230006722e-37	-0.376168926650206	0.895	0.947	3.44418109557882e-33	POLDIP2	Malignant cells	GSE131984_JQ1	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38182
2.23946149410509e-37	-0.73226912000953	0.44	0.618	3.62546421280674e-33	PKIB	Malignant cells	GSE131984_JQ1	ENSG00000135549	5570	cAMP-dependent protein kinase inhibitor beta	PRKACN2	protein_coding	Q9C010	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38183
2.83231000445966e-37	-0.301261414484611	0.079	0.257	4.58522666621975e-33	MT1F	Malignant cells	GSE131984_JQ1	ENSG00000198417	4494	metallothionein 1F	MT1	protein_coding	P04733	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38184
3.58744811421682e-37	-0.395735678031949	0.35	0.581	5.80771975210561e-33	TOR3A	Malignant cells	GSE131984_JQ1	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38185
4.66211998656792e-37	-0.304627753228213	0.102	0.294	7.5475060462548e-33	NMI	Malignant cells	GSE131984_JQ1	ENSG00000123609	9111	N-myc and STAT interactor	NA	protein_coding	Q13287	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38186
5.08597680084734e-37	-0.371923105491983	0.878	0.937	8.23368784289176e-33	MRPL21	Malignant cells	GSE131984_JQ1	ENSG00000197345	219927	mitochondrial ribosomal protein L21	NA	protein_coding	Q7Z2W9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38187
5.81875331589859e-37	-0.42480223261487	0.578	0.779	9.41997974310822e-33	USP1	Malignant cells	GSE131984_JQ1	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38188
7.12127004361713e-37	-0.260134456104606	1	1	1.15286240736118e-32	DSTN	Malignant cells	GSE131984_JQ1	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38189
7.59072729876487e-37	-0.410703392509912	0.758	0.87	1.22886284239704e-32	SNRNP70	Malignant cells	GSE131984_JQ1	ENSG00000104852	6625	small nuclear ribonucleoprotein U1 subunit 70	RNPU1Z|RPU1|Snp1|SNRP70|U1-70K	protein_coding	P08621	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38190
7.61713182504746e-37	-0.383286237444547	0.32	0.548	1.23313747115693e-32	METTL21A	Malignant cells	GSE131984_JQ1	ENSG00000144401	151194	methyltransferase 21A, HSPA lysine	FAM119A|HCA557b|HSPA-KMT|LOC151194	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38191
7.7583389075599e-37	-0.507423221304269	0.61	0.765	1.25599748574487e-32	GARS	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38192
8.43603060583805e-37	-0.394887260970161	0.213	0.433	1.36570899477912e-32	FUOM	Malignant cells	GSE131984_JQ1	ENSG00000148803	282969	fucose mutarotase	C10orf125|FLJ26016|FucM|FucU	protein_coding	A2VDF0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38193
9.62272163922503e-37	-0.427723689455137	0.304	0.53	1.55782240617414e-32	PLAUR	Malignant cells	GSE131984_JQ1	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38194
9.80232948043858e-37	-0.279566713631253	0.103	0.295	1.5868991195882e-32	PRELID2	Malignant cells	GSE131984_JQ1	ENSG00000186314	153768	PRELI domain containing 2	FLJ38376|MGC21644	protein_coding	Q8N945	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38195
1.05651723964295e-36	-0.422807328361372	0.654	0.797	1.71039575925798e-32	DAZAP1	Malignant cells	GSE131984_JQ1	ENSG00000071626	26528	DAZ associated protein 1	MGC19907	protein_coding	Q96EP5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38196
1.24173886600821e-36	-0.60429599456284	0.516	0.704	2.01025105018069e-32	PCNA	Malignant cells	GSE131984_JQ1	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38197
1.45279157858695e-36	-0.372800530335949	0.874	0.946	2.35192428657441e-32	SRRM1	Malignant cells	GSE131984_JQ1	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38198
1.74233806845637e-36	-0.416856754436796	0.663	0.801	2.82067109902402e-32	ITPA	Malignant cells	GSE131984_JQ1	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38199
1.82200233390661e-36	-0.388178776054869	0.82	0.913	2.94963957836141e-32	MPLKIP	Malignant cells	GSE131984_JQ1	ENSG00000168303	136647	M-phase specific PLK1 interacting protein	C7orf11|ORF20|TTDN1	protein_coding	Q8TAP9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38200
1.93347192058196e-36	-0.464119810736596	0.308	0.53	3.13009769223014e-32	MAGED2	Malignant cells	GSE131984_JQ1	ENSG00000102316	10916	MAGE family member D2	11B6|BCG1|HCA10|JCL-1|MAGE-D2|MAGED|MGC8386	protein_coding	Q9UNF1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38201
2.07521673012646e-36	-0.651121752940526	0.725	0.841	3.35956836440173e-32	ANXA1	Malignant cells	GSE131984_JQ1	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38202
2.18732797741764e-36	0.445826496646045	0.815	0.648	3.54106526264142e-32	GPC1	Malignant cells	GSE131984_JQ1	ENSG00000063660	2817	glypican 1	glypican	protein_coding	P35052	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38203
2.27333852828803e-36	-0.355906931897322	0.934	0.975	3.68030774344548e-32	MRPS21	Malignant cells	GSE131984_JQ1	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38204
2.30021202482359e-36	0.445253621641026	0.624	0.402	3.72381324698691e-32	DDX17	Malignant cells	GSE131984_JQ1	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38205
2.39640776566355e-36	-0.386970933168509	0.222	0.441	3.87954453183273e-32	APEX2	Malignant cells	GSE131984_JQ1	ENSG00000169188	27301	apurinic/apyrimidinic endodeoxyribonuclease 2	APE2|APEXL2|XTH2|ZGRF2	protein_coding	Q9UBZ4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38206
2.42635489260266e-36	-0.382450911560945	0.915	0.964	3.92802593563444e-32	MRPS12	Malignant cells	GSE131984_JQ1	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38207
2.53491993004393e-36	-0.325650536002561	0.986	0.996	4.10378187474812e-32	PRDX6	Malignant cells	GSE131984_JQ1	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38208
2.96705533410429e-36	-0.40560833381209	0.325	0.542	4.80336588038143e-32	TMEM9	Malignant cells	GSE131984_JQ1	ENSG00000116857	252839	transmembrane protein 9	TMEM9A	protein_coding	Q9P0T7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38209
3.23390794688796e-36	-0.443059875292009	0.263	0.479	5.23537357521692e-32	NUP37	Malignant cells	GSE131984_JQ1	ENSG00000075188	79023	nucleoporin 37	FLJ22618|MGC5585	protein_coding	Q8NFH4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38210
3.49636503860477e-36	-0.433056949029438	0.525	0.708	5.66026536099726e-32	PIN4	Malignant cells	GSE131984_JQ1	ENSG00000102309	5303	peptidylprolyl cis/trans isomerase, NIMA-interacting 4	EPVH|PAR14|PAR17	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38211
3.54449327990014e-36	-0.344138803672497	0.961	0.986	5.73818017083033e-32	TMEM14C	Malignant cells	GSE131984_JQ1	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38212
3.65810805630156e-36	-0.339285905520838	0.989	0.995	5.92211113234659e-32	ARPC3	Malignant cells	GSE131984_JQ1	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38213
3.90684960963512e-36	-0.48458866197942	0.452	0.657	6.3247988330383e-32	RPF2	Malignant cells	GSE131984_JQ1	ENSG00000197498	84154	ribosome production factor 2 homolog	bA397G5.4|BXDC1|FLJ21087	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38214
4.09382050170963e-36	-0.46713017016886	0.555	0.728	6.62748601021772e-32	PSMD13	Malignant cells	GSE131984_JQ1	ENSG00000185627	5719	proteasome 26S subunit, non-ATPase 13	p40.5|Rpn9	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38215
4.30040724292265e-36	-0.348399997632672	0.884	0.959	6.96192928556748e-32	PGP	Malignant cells	GSE131984_JQ1	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38216
4.38343485910966e-36	-0.435154040510029	0.399	0.615	7.09634269341262e-32	C4orf27	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38217
4.79883534003074e-36	-0.401816065658664	0.479	0.688	7.76883453197576e-32	TIMM44	Malignant cells	GSE131984_JQ1	ENSG00000104980	10469	translocase of inner mitochondrial membrane 44	TIM44	protein_coding	O43615	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38218
5.59261603206399e-36	-0.407007367482036	0.396	0.614	9.05388609430839e-32	YRDC	Malignant cells	GSE131984_JQ1	ENSG00000196449	79693	yrdC N6-threonylcarbamoyltransferase domain containing	FLJ23476|IRIP|SUA5	protein_coding	Q86U90	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38219
5.98850675026637e-36	-0.421409291440645	0.417	0.636	9.69479357800623e-32	C1D	Malignant cells	GSE131984_JQ1	ENSG00000197223	10438	C1D nuclear receptor corepressor	LRP1|Rrp47|SUN-CoR|SUNCOR	protein_coding	Q13901	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38220
6.1275900678058e-36	-0.468418504472532	0.462	0.648	9.91995556077081e-32	NDUFA9	Malignant cells	GSE131984_JQ1	ENSG00000139180	4704	NADH:ubiquinone oxidoreductase subunit A9	CI-39k|COQ11|NDUFS2L|SDR22E1	protein_coding	Q16795	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38221
6.51509640090752e-36	0.454410333845913	0.973	0.936	1.05472895634292e-31	CCND1	Malignant cells	GSE131984_JQ1	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38222
7.26136354109371e-36	-0.404691655934476	0.342	0.556	1.17554214366766e-31	PPID	Malignant cells	GSE131984_JQ1	ENSG00000171497	5481	peptidylprolyl isomerase D	CYP-40|CypD	protein_coding	Q08752	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38223
7.78185798876575e-36	-0.447712262479376	0.429	0.633	1.25980498980129e-31	SQRDL	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38224
8.04874756772449e-36	-0.312913239859444	0.111	0.299	1.30301174373892e-31	XRCC4	Malignant cells	GSE131984_JQ1	ENSG00000152422	7518	X-ray repair cross complementing 4	NA	protein_coding	Q13426	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38225
8.54211756981779e-36	-0.261568657999352	1	1	1.3828834133778e-31	COX7C	Malignant cells	GSE131984_JQ1	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38226
9.39765163837796e-36	-0.810993491909794	0.658	0.785	1.52138582373701e-31	HSPA5	Malignant cells	GSE131984_JQ1	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38227
9.45533553342629e-36	-0.411427486319441	0.488	0.698	1.53072426950638e-31	TSTA3	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38228
1.31481695418901e-35	-0.255262601941307	1	1	2.12855716713659e-31	SUMO2	Malignant cells	GSE131984_JQ1	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38229
1.35158705703096e-35	0.439697266873283	0.916	0.794	2.18808428662743e-31	ID1	Malignant cells	GSE131984_JQ1	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38230
1.57256707580776e-35	-0.387319479953102	0.282	0.501	2.54582883902518e-31	CUTC	Malignant cells	GSE131984_JQ1	ENSG00000119929	51076	cutC copper transporter	CGI-32	protein_coding	Q9NTM9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38231
1.76483869569902e-35	0.413363342492601	0.615	0.388	2.85709736446715e-31	SPTAN1	Malignant cells	GSE131984_JQ1	ENSG00000197694	6709	spectrin alpha, non-erythrocytic 1	NA	protein_coding	Q13813	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38232
2.2208136240018e-35	-0.426495898237297	0.665	0.823	3.59527517589652e-31	CD47	Malignant cells	GSE131984_JQ1	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38233
2.23127870646878e-35	0.389057257098679	0.459	0.239	3.61221709790231e-31	ACYP2	Malignant cells	GSE131984_JQ1	ENSG00000170634	98	acylphosphatase 2	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38234
2.31175438615436e-35	-0.459251660785869	0.358	0.563	3.7424991757453e-31	IQSEC2	Malignant cells	GSE131984_JQ1	ENSG00000124313	23096	IQ motif and Sec7 domain ArfGEF 2	BRAG1|IQ-ArfGEF|KIAA0522|MRX1|MRX18|MRX78	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38235
2.60866863043343e-35	-0.409620268053088	0.449	0.67	4.22317364580868e-31	SMC2	Malignant cells	GSE131984_JQ1	ENSG00000136824	10592	structural maintenance of chromosomes 2	CAP-E|hCAP-E|SMC2L1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38236
2.63265825213991e-35	-0.391616058231699	0.749	0.855	4.26201044438931e-31	KARS	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38237
2.84033518887178e-35	-0.379811816331286	0.969	0.985	4.59821863726453e-31	CCT8	Malignant cells	GSE131984_JQ1	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38238
3.09149373471699e-35	-0.460466787237338	0.551	0.718	5.00481920713334e-31	PSMC6	Malignant cells	GSE131984_JQ1	ENSG00000100519	5706	proteasome 26S subunit, ATPase 6	p42|RPT5	protein_coding	P62333	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38239
3.57681421833432e-35	-0.37732038660287	0.844	0.926	5.79050453806144e-31	BANF1	Malignant cells	GSE131984_JQ1	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38240
3.61304559425908e-35	-0.418752784252601	0.703	0.867	5.84915951254602e-31	BST2	Malignant cells	GSE131984_JQ1	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38241
3.79511361652294e-35	-0.407527265305459	0.697	0.836	6.14390943378898e-31	AP1S2	Malignant cells	GSE131984_JQ1	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38242
4.54807558492091e-35	-0.426175752467403	0.749	0.854	7.36287956442847e-31	NUDT5	Malignant cells	GSE131984_JQ1	ENSG00000165609	11164	nudix hydrolase 5	hYSAH1|YSA1H	protein_coding	Q9UKK9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38243
4.59563716643383e-35	-0.403459088598714	0.741	0.85	7.43987700873973e-31	PPP4C	Malignant cells	GSE131984_JQ1	ENSG00000149923	5531	protein phosphatase 4 catalytic subunit	PP4|PPX	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38244
4.84778743592428e-35	-0.327683202707153	0.977	0.988	7.84808308001781e-31	FBL	Malignant cells	GSE131984_JQ1	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38245
5.27284299650185e-35	-0.454222097533053	0.404	0.61	8.53620552703685e-31	DCAF13	Malignant cells	GSE131984_JQ1	ENSG00000164934	25879	DDB1 and CUL4 associated factor 13	DKFZP564O0463|Gm83|HSPC064|Sof1|WDSOF1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38246
5.3594582814517e-35	-0.389137470125372	0.476	0.698	8.67642701184216e-31	PFDN6	Malignant cells	GSE131984_JQ1	ENSG00000235692	10471	prefoldin subunit 6	H2-KE2|HKE2|KE-2|PFD6	protein_coding	O15212	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38247
5.96533038648189e-35	0.399666663329913	0.54	0.314	9.65727336267553e-31	GLG1	Malignant cells	GSE131984_JQ1	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38248
6.31200125791829e-35	-0.385272157161438	0.27	0.486	1.02184988364439e-30	CCDC86	Malignant cells	GSE131984_JQ1	ENSG00000110104	79080	coiled-coil domain containing 86	cyclon|MGC2574	protein_coding	Q9H6F5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38249
6.61503049719913e-35	-0.347564109598147	0.235	0.451	1.07090728719157e-30	SFXN4	Malignant cells	GSE131984_JQ1	ENSG00000183605	119559	sideroflexin 4	SLC56A4	protein_coding	Q6P4A7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38250
7.48042613905789e-35	-0.317944858465118	0.979	0.995	1.21100618765208e-30	LAMTOR5	Malignant cells	GSE131984_JQ1	ENSG00000134248	10542	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	HBXIP|MGC71071|XIP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38251
9.63349780189615e-35	-0.371278742670879	0.993	0.996	1.55956695914897e-30	SSR4	Malignant cells	GSE131984_JQ1	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38252
1.16303101901614e-34	-0.374346487331269	0.365	0.585	1.88283091668522e-30	MED8	Malignant cells	GSE131984_JQ1	ENSG00000159479	112950	mediator complex subunit 8	ARC32|MGC17544|MGC19641	protein_coding	Q96G25	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38253
1.26453885700159e-34	-0.303403759920557	0.967	0.988	2.04716195559987e-30	TMEM258	Malignant cells	GSE131984_JQ1	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38254
1.4603752582499e-34	-0.373459432712636	0.212	0.421	2.36420150558076e-30	SORD	Malignant cells	GSE131984_JQ1	ENSG00000140263	6652	sorbitol dehydrogenase	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38255
1.46094396728745e-34	-0.370350026337706	0.347	0.569	2.36512218864165e-30	ACYP1	Malignant cells	GSE131984_JQ1	ENSG00000119640	97	acylphosphatase 1	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38256
1.48950280430678e-34	-0.403906878265181	0.597	0.784	2.41135608989225e-30	CMC2	Malignant cells	GSE131984_JQ1	ENSG00000103121	56942	C-X9-C motif containing 2	C16orf61|DC13|MGC45036	protein_coding	Q9NRP2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38257
1.52194780819463e-34	-0.423765563132524	0.486	0.676	2.46388130668628e-30	UGP2	Malignant cells	GSE131984_JQ1	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38258
1.59647814808068e-34	-0.423681408708078	0.439	0.646	2.58453847392781e-30	BCCIP	Malignant cells	GSE131984_JQ1	ENSG00000107949	56647	BRCA2 and CDKN1A interacting protein	BCCIPalpha|TOK-1	protein_coding	Q9P287	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38259
1.94607038152874e-34	-0.421832682744267	0.624	0.766	3.15049334065687e-30	MRPS2	Malignant cells	GSE131984_JQ1	ENSG00000122140	51116	mitochondrial ribosomal protein S2	CGI-91	protein_coding	Q9Y399	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38260
2.08760394376237e-34	-0.404442012780578	0.751	0.871	3.37962202455691e-30	CDC26	Malignant cells	GSE131984_JQ1	ENSG00000176386	246184	cell division cycle 26	ANAPC12|APC12|C9orf17	protein_coding	Q8NHZ8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38261
2.15537593019464e-34	-0.302777732027553	0.192	0.409	3.48933809339211e-30	CMTM7	Malignant cells	GSE131984_JQ1	ENSG00000153551	112616	CKLF like MARVEL transmembrane domain containing 7	CKLFSF7|FLJ30992	protein_coding	Q96FZ5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38262
2.16302324089565e-34	-0.422749252214731	0.373	0.581	3.50171832468597e-30	YIPF6	Malignant cells	GSE131984_JQ1	ENSG00000181704	286451	Yip1 domain family member 6	FinGER6|MGC21416	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38263
2.20525298656246e-34	-0.444920404802354	0.456	0.664	3.57008405994597e-30	MYBL2	Malignant cells	GSE131984_JQ1	ENSG00000101057	4605	MYB proto-oncogene like 2	B-MYB|BMYB	protein_coding	P10244	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38264
2.51751118769212e-34	-0.345418922027338	0.342	0.565	4.07559886175477e-30	ZNF330	Malignant cells	GSE131984_JQ1	ENSG00000109445	27309	zinc finger protein 330	HSA6591|NOA36	protein_coding	Q9Y3S2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38265
2.59950929394827e-34	-0.438334404025387	0.769	0.87	4.20834559597285e-30	ARL6IP5	Malignant cells	GSE131984_JQ1	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38266
2.68751442840721e-34	-0.455945188016408	0.515	0.711	4.35081710814843e-30	NREP	Malignant cells	GSE131984_JQ1	ENSG00000134986	9315	neuronal regeneration related protein	C5orf13|D4S114|P311|PRO1873|PTZ17|SEZ17	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38267
2.71311057722935e-34	-0.421448134205014	0.732	0.848	4.39225471347659e-30	WDR13	Malignant cells	GSE131984_JQ1	ENSG00000101940	64743	WD repeat domain 13	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38268
3.2166973076132e-34	-0.530441336362355	0.477	0.65	5.20751127129501e-30	KCNMA1	Malignant cells	GSE131984_JQ1	ENSG00000156113	3778	potassium calcium-activated channel subfamily M alpha 1	KCa1.1|mSLO1|SLO	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38269
3.30586398387394e-34	-0.411541669580798	0.709	0.84	5.35186320349352e-30	EMC7	Malignant cells	GSE131984_JQ1	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38270
3.32941857652724e-34	-0.505044059418506	0.998	0.999	5.38999573353995e-30	HSP90AA1	Malignant cells	GSE131984_JQ1	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38271
3.42487767584525e-34	-0.324340627732022	0.161	0.362	5.54453446942588e-30	CCDC51	Malignant cells	GSE131984_JQ1	ENSG00000164051	79714	coiled-coil domain containing 51	FLJ12436	protein_coding	Q96ER9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38272
3.45118524576703e-34	-0.377402080203344	0.766	0.887	5.58712379437224e-30	ARL5A	Malignant cells	GSE131984_JQ1	ENSG00000162980	26225	ADP ribosylation factor like GTPase 5A	ARL5	protein_coding	Q9Y689	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38273
3.79939488123462e-34	-0.366055012163615	0.86	0.931	6.15084037323073e-30	MPST	Malignant cells	GSE131984_JQ1	ENSG00000128309	4357	mercaptopyruvate sulfurtransferase	MST|TST2|TUM1	protein_coding	P25325	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38274
3.83364041273821e-34	-0.467860495782549	0.514	0.702	6.20628046418188e-30	TWISTNB	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38275
4.02144528982559e-34	-0.337927742900986	0.907	0.971	6.51031777969865e-30	NDUFA6	Malignant cells	GSE131984_JQ1	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38276
4.10642514732908e-34	-0.393059838479396	0.797	0.883	6.64789167101104e-30	LSM10	Malignant cells	GSE131984_JQ1	ENSG00000181817	84967	LSM10, U7 small nuclear RNA associated	MGC15749	protein_coding	Q969L4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38277
4.56287236544481e-34	-0.391259229954331	0.74	0.916	7.3868340724186e-30	BIRC5	Malignant cells	GSE131984_JQ1	ENSG00000089685	332	baculoviral IAP repeat containing 5	API4|EPR-1|survivin	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38278
4.72563372786415e-34	-0.421827973976839	0.952	0.972	7.65032844203927e-30	ATP5F1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38279
6.51979299272592e-34	-0.44198729416309	0.602	0.769	1.0554892875924e-29	NASP	Malignant cells	GSE131984_JQ1	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38280
7.5830755430193e-34	-0.414822237339081	0.139	0.335	1.22762409965939e-29	APOC1	Malignant cells	GSE131984_JQ1	ENSG00000130208	341	apolipoprotein C1	NA	protein_coding	P02654	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38281
7.61873007302524e-34	-0.382430583108257	0.838	0.921	1.23339621152206e-29	RCN1	Malignant cells	GSE131984_JQ1	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38282
7.72012852105218e-34	-0.366284913689118	0.852	0.929	1.24981160627314e-29	PSMD4	Malignant cells	GSE131984_JQ1	ENSG00000159352	5710	proteasome 26S subunit ubiquitin receptor, non-ATPase 4	AF|AF-1|Rpn10|S5A	protein_coding	P55036	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38283
8.85962640390197e-34	-0.276468371524091	0.086	0.257	1.43428491852769e-29	POLE2	Malignant cells	GSE131984_JQ1	ENSG00000100479	5427	DNA polymerase epsilon 2, accessory subunit	DPE2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38284
9.0780854657677e-34	-0.274185096664968	1	1	1.46965125605313e-29	PSMA7	Malignant cells	GSE131984_JQ1	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38285
9.73370391998094e-34	-0.433712562548787	0.652	0.781	1.57578932760571e-29	AIMP1	Malignant cells	GSE131984_JQ1	ENSG00000164022	9255	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	EMAP-2|EMAPII|p43|SCYE1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38286
9.79079691476249e-34	-0.408796773925618	0.443	0.644	1.5850321125309e-29	GEMIN6	Malignant cells	GSE131984_JQ1	ENSG00000152147	79833	gem nuclear organelle associated protein 6	FLJ23459	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38287
1.0120248935397e-33	0.358560898471705	0.299	0.103	1.63836710015142e-29	CXXC5	Malignant cells	GSE131984_JQ1	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38288
1.0401014991481e-33	-0.381336774029708	0.4	0.618	1.68382031697086e-29	DHRSX	Malignant cells	GSE131984_JQ1	ENSG00000169084	207063	dehydrogenase/reductase X-linked	DHRS5X|DHRS5Y|DHRSXY|DHRSY|SDR46C1|SDR7C6	protein_coding	Q8N5I4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38289
1.07146919769428e-33	-0.342668912264408	0.911	0.959	1.73460148414727e-29	MRPS16	Malignant cells	GSE131984_JQ1	ENSG00000182180	51021	mitochondrial ribosomal protein S16	CGI-132	protein_coding	Q9Y3D3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38290
1.113440515754e-33	-0.381650162268402	0.618	0.784	1.80254885095415e-29	UBE2J2	Malignant cells	GSE131984_JQ1	ENSG00000160087	118424	ubiquitin conjugating enzyme E2 J2	NCUBE2|Ubc6p	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38291
1.33208331663767e-33	-0.438253994380221	0.422	0.622	2.15650968130473e-29	TXNDC9	Malignant cells	GSE131984_JQ1	ENSG00000115514	10190	thioredoxin domain containing 9	APACD	protein_coding	O14530	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38292
1.34415051701323e-33	-0.4029893315992	0.14	0.334	2.17604527199272e-29	ADM	Malignant cells	GSE131984_JQ1	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38293
1.39831347798963e-33	-0.389345557896672	0.476	0.68	2.26372968951741e-29	MRPL35	Malignant cells	GSE131984_JQ1	ENSG00000132313	51318	mitochondrial ribosomal protein L35	NA	protein_coding	Q9NZE8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38294
1.63255918173272e-33	-0.3316241928447	0.102	0.279	2.6429500593071e-29	KYNU	Malignant cells	GSE131984_JQ1	ENSG00000115919	8942	kynureninase	NA	protein_coding	Q16719	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38295
1.63942821691858e-33	-0.408300426191745	0.555	0.727	2.6540703403695e-29	TMEM109	Malignant cells	GSE131984_JQ1	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38296
1.79631017890711e-33	-0.430882977724954	0.592	0.749	2.90804654863272e-29	PMP22	Malignant cells	GSE131984_JQ1	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38297
1.86010208280406e-33	-0.390322870346286	0.457	0.65	3.01131926185149e-29	SMIM11	Malignant cells	GSE131984_JQ1	ENSG00000205670	54065	small integral membrane protein 11	C21orf51|FAM165B|SMIM11A	protein_coding	P58511	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38298
1.89077750328587e-33	-0.311373870888854	0.955	1	3.0609797000695e-29	KRT7	Malignant cells	GSE131984_JQ1	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38299
1.89899533499134e-33	-0.319227140224802	0.914	0.971	3.07428354781747e-29	TMED3	Malignant cells	GSE131984_JQ1	ENSG00000166557	23423	transmembrane p24 trafficking protein 3	C15orf22|p24B|p24g4|p24gamma4	protein_coding	Q9Y3Q3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38300
2.02449671771346e-33	-0.303447371584178	0.164	0.366	3.27745773630632e-29	GPKOW	Malignant cells	GSE131984_JQ1	ENSG00000068394	27238	G-patch domain and KOW motifs	GPATC5|GPATCH5|Mos2|Spp2|T54	protein_coding	Q92917	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38301
2.08834898794825e-33	0.420530724994449	0.644	0.444	3.38082817658943e-29	MGEA5	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38302
2.15637274625198e-33	-0.344210455259899	0.191	0.396	3.49095183890734e-29	COQ3	Malignant cells	GSE131984_JQ1	ENSG00000132423	51805	coenzyme Q3, methyltransferase	bA9819.1	protein_coding	Q9NZJ6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38303
2.27733759628159e-33	0.324079179194672	0.328	0.123	3.68678183462027e-29	AR	Malignant cells	GSE131984_JQ1	ENSG00000169083	367	androgen receptor	AIS|DHTR|HUMARA|NR3C4|SBMA|SMAX1	protein_coding	P10275	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38304
2.3581931977419e-33	-0.412812788344466	0.392	0.602	3.81767896782435e-29	RBM42	Malignant cells	GSE131984_JQ1	ENSG00000126254	79171	RNA binding motif protein 42	MGC10433	protein_coding	Q9BTD8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38305
2.68396345793914e-33	0.397482466704173	0.84	0.727	4.34506844205767e-29	FAM173A	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38306
2.95863422167693e-33	-0.307737593638372	0.138	0.333	4.78973294147278e-29	PTPRF	Malignant cells	GSE131984_JQ1	ENSG00000142949	5792	protein tyrosine phosphatase receptor type F	LAR	protein_coding	P10586	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38307
3.02312132865529e-33	-0.340210249649843	0.205	0.412	4.89413111896005e-29	PPIL1	Malignant cells	GSE131984_JQ1	ENSG00000137168	51645	peptidylprolyl isomerase like 1	CYPL1	protein_coding	Q9Y3C6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38308
3.4852470650239e-33	-0.276534563758194	0.988	0.998	5.6422664735672e-29	NDUFB7	Malignant cells	GSE131984_JQ1	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38309
3.50226643990989e-33	-0.358169504086411	0.933	0.963	5.66981913957012e-29	SYAP1	Malignant cells	GSE131984_JQ1	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38310
3.63441248411397e-33	-0.377926280736089	0.261	0.487	5.8837503705321e-29	SGOL1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38311
3.64002702255736e-33	-0.394291170696844	0.529	0.71	5.8928397468181e-29	LLPH	Malignant cells	GSE131984_JQ1	ENSG00000139233	84298	LLP homolog, long-term synaptic facilitation factor	C12orf31|hLLP|MGC14817	protein_coding	Q9BRT6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38312
3.87241307663947e-33	-0.388799869407113	0.419	0.62	6.26904952977164e-29	ATAD3A	Malignant cells	GSE131984_JQ1	ENSG00000197785	55210	ATPase family AAA domain containing 3A	FLJ10709	protein_coding	Q9NVI7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38313
4.04762690377807e-33	-0.281595848818203	0.985	0.998	6.55270319452632e-29	MINOS1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38314
4.47737235940071e-33	-0.412121750926143	0.388	0.593	7.24841811263381e-29	AATF	Malignant cells	GSE131984_JQ1	ENSG00000276072	26574	apoptosis antagonizing transcription factor	BFR2|CHE-1|CHE1|DED	protein_coding	Q9NY61	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38315
4.59486383548265e-33	-0.427811559169842	0.576	0.738	7.43862506326286e-29	EIF4E	Malignant cells	GSE131984_JQ1	ENSG00000151247	1977	eukaryotic translation initiation factor 4E	EIF4E1|EIF4EL1|EIF4F	protein_coding	P06730	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38316
5.01235579168093e-33	-0.390812999462904	0.725	0.851	8.11450279115226e-29	NABP2	Malignant cells	GSE131984_JQ1	ENSG00000139579	79035	nucleic acid binding protein 2	hSSB1|MGC2731|OBFC2B|SOSS-B1|SSB1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38317
5.28432608396876e-33	-0.335270613138702	0.944	0.976	8.55479549733702e-29	RSL24D1	Malignant cells	GSE131984_JQ1	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38318
5.46378467079453e-33	-0.453730758440363	0.849	0.932	8.84532100354926e-29	MANF	Malignant cells	GSE131984_JQ1	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38319
6.73126591037866e-33	0.366760379404541	0.465	0.251	1.0897246382312e-28	SLC48A1	Malignant cells	GSE131984_JQ1	ENSG00000211584	55652	solute carrier family 48 member 1	FLJ20489|hHRG-1|HRG1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38320
6.95770438339094e-33	0.414216392892247	0.863	0.732	1.12638276262716e-28	SLC25A1	Malignant cells	GSE131984_JQ1	ENSG00000100075	6576	solute carrier family 25 member 1	CTP|SLC20A3	protein_coding	P53007	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38321
7.57342715303927e-33	-0.370650412625575	0.461	0.669	1.22606212180553e-28	ABCE1	Malignant cells	GSE131984_JQ1	ENSG00000164163	6059	ATP binding cassette subfamily E member 1	OABP|RLI|RLI1|RNASEL1|RNASELI|RNS4I	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38322
7.96393017249814e-33	-0.41854857683944	0.76	0.868	1.28928065562572e-28	MED10	Malignant cells	GSE131984_JQ1	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38323
9.15802464960615e-33	-0.416873793092252	0.392	0.599	1.48259261052474e-28	TAF7	Malignant cells	GSE131984_JQ1	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38324
9.48029610477439e-33	-0.36218190724584	0.344	0.556	1.53476513640193e-28	IL13RA1	Malignant cells	GSE131984_JQ1	ENSG00000131724	3597	interleukin 13 receptor subunit alpha 1	CD213a1|IL-13Ra|NR4	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38325
9.55881609313449e-33	-0.340011731358057	0.169	0.367	1.54747673731754e-28	DAB2	Malignant cells	GSE131984_JQ1	ENSG00000153071	1601	DAB adaptor protein 2	DOC-2	protein_coding	P98082	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38326
1.00463196846039e-32	-0.380244848218152	0.833	0.905	1.62639869374053e-28	GDI2	Malignant cells	GSE131984_JQ1	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38327
1.07025611506894e-32	0.352859951251254	0.478	0.258	1.7326376246851e-28	BEST1	Malignant cells	GSE131984_JQ1	ENSG00000167995	7439	bestrophin 1	BEST|BMD|RP50|VMD2	protein_coding	O76090	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38328
1.07548477798237e-32	-0.349160953120246	0.268	0.483	1.74110230707566e-28	MITD1	Malignant cells	GSE131984_JQ1	ENSG00000158411	129531	microtubule interacting and trafficking domain containing 1	LOC129531	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38329
1.07910283063144e-32	-0.411973281526711	0.327	0.532	1.74695957250924e-28	PRMT5	Malignant cells	GSE131984_JQ1	ENSG00000100462	10419	protein arginine methyltransferase 5	HRMT1L5|SKB1|SKB1Hs	protein_coding	O14744	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38330
1.11455401896114e-32	-0.381931092970798	0.414	0.644	1.80435150129619e-28	GINS2	Malignant cells	GSE131984_JQ1	ENSG00000131153	51659	GINS complex subunit 2	Pfs2|PSF2	protein_coding	Q9Y248	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38331
1.27096241107227e-32	-0.335498961452792	0.996	0.997	2.05756104728489e-28	S100A16	Malignant cells	GSE131984_JQ1	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38332
1.30055099058786e-32	-0.398881437585298	0.668	0.809	2.10546199866269e-28	GRSF1	Malignant cells	GSE131984_JQ1	ENSG00000132463	2926	G-rich RNA sequence binding factor 1	NA	protein_coding	Q12849	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38333
1.32204603513209e-32	-0.30120083744642	0.996	0.998	2.14026032627534e-28	HN1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38334
1.35349058266974e-32	-0.426163458360185	0.622	0.763	2.19116590428404e-28	IDH3G	Malignant cells	GSE131984_JQ1	ENSG00000067829	3421	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma	NA	protein_coding	P51553	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38335
1.4618705318944e-32	-0.394537188386696	0.535	0.718	2.36662220408384e-28	EXOSC4	Malignant cells	GSE131984_JQ1	ENSG00000178896	54512	exosome component 4	FLJ20591|hRrp41p|p12A|RRP41|RRP41A|Rrp41p|SKI6|Ski6p	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38336
1.59993462969064e-32	-0.333407220959336	0.967	0.987	2.59013417200617e-28	HNRNPA3	Malignant cells	GSE131984_JQ1	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38337
1.63413734522416e-32	-0.334683915062796	0.153	0.345	2.6455049481834e-28	FANCB	Malignant cells	GSE131984_JQ1	ENSG00000181544	2187	FA complementation group B	FAAP95|FAB|FLJ34064	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38338
1.77029417169226e-32	-0.383218633646253	0.498	0.687	2.86592923455261e-28	RP11-345J4.5	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38339
1.78210966022852e-32	-0.356613795561731	0.881	0.968	2.88505732894395e-28	HNRNPAB	Malignant cells	GSE131984_JQ1	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38340
1.79170780303101e-32	-0.406938784150838	0.518	0.713	2.9005957623269e-28	C14orf119	Malignant cells	GSE131984_JQ1	ENSG00000179933	55017	chromosome 14 open reading frame 119	FLJ20671	protein_coding	Q9NWQ9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38341
2.03181572025681e-32	-0.376282864518672	0.739	0.868	3.28930646952375e-28	SPTSSA	Malignant cells	GSE131984_JQ1	ENSG00000165389	171546	serine palmitoyltransferase small subunit A	C14orf147|ssSPTa	protein_coding	Q969W0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38342
2.42118979839395e-32	-0.455440168280171	0.649	0.785	3.91966416461997e-28	EIF2S1	Malignant cells	GSE131984_JQ1	ENSG00000134001	1965	eukaryotic translation initiation factor 2 subunit alpha	EIF-2alpha|EIF2|EIF2A	protein_coding	P05198	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38343
2.82227595295341e-32	-0.38652269879876	0.309	0.517	4.56898254023628e-28	DDX56	Malignant cells	GSE131984_JQ1	ENSG00000136271	54606	DEAD-box helicase 56	NOH61	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38344
2.86359736423202e-32	-0.360810685951244	0.702	0.837	4.63587777295522e-28	CMC1	Malignant cells	GSE131984_JQ1	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38345
3.45653065691049e-32	-0.40253415710479	0.413	0.623	5.5957774804724e-28	FARSA	Malignant cells	GSE131984_JQ1	ENSG00000179115	2193	phenylalanyl-tRNA synthetase subunit alpha	CML33|FARSL|FARSLA	protein_coding	Q9Y285	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38346
3.56251334036322e-32	-0.489518238699181	0.212	0.418	5.76735284671401e-28	PLAC8	Malignant cells	GSE131984_JQ1	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38347
4.32741294967095e-32	-0.298317703856214	0.954	0.982	7.00564882422229e-28	FAM96B	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38348
4.49285861559433e-32	-0.406463284695248	0.458	0.652	7.27348881278566e-28	CMAS	Malignant cells	GSE131984_JQ1	ENSG00000111726	55907	cytidine monophosphate N-acetylneuraminic acid synthetase	NA	protein_coding	Q8NFW8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38349
4.61652535817212e-32	-0.302218075850314	0.954	0.982	7.47369290234484e-28	PDAP1	Malignant cells	GSE131984_JQ1	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38350
4.63865351154991e-32	-0.37644026567634	0.764	0.896	7.50951616984815e-28	HSPB11	Malignant cells	GSE131984_JQ1	ENSG00000081870	51668	heat shock protein family B (small) member 11	C1orf41|FAP232|HSPCO34|IFT25|PP25	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38351
5.01252821125356e-32	-0.321744442846694	0.935	0.975	8.11478192119839e-28	PTP4A2	Malignant cells	GSE131984_JQ1	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38352
5.35089418038602e-32	-0.371827789242023	0.746	0.855	8.66256258862693e-28	C11orf73	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38353
5.64837760510579e-32	-0.25457784550936	0.999	1	9.14415850490577e-28	ARPC2	Malignant cells	GSE131984_JQ1	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38354
5.77113529794182e-32	-0.390267438099946	0.757	0.861	9.342890933838e-28	RNH1	Malignant cells	GSE131984_JQ1	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38355
6.51107124416718e-32	-0.35929251801368	0.724	0.853	1.05407732371822e-27	PFDN1	Malignant cells	GSE131984_JQ1	ENSG00000113068	5201	prefoldin subunit 1	PFD1	protein_coding	O60925	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38356
7.12670138050769e-32	-0.370599052789703	0.709	0.834	1.15374168649039e-27	IMP4	Malignant cells	GSE131984_JQ1	ENSG00000136718	92856	IMP U3 small nucleolar ribonucleoprotein 4	BXDC4|MGC19606	protein_coding	Q96G21	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38357
7.33899200757284e-32	0.347838971331189	0.307	0.117	1.18810941610597e-27	PIK3R3	Malignant cells	GSE131984_JQ1	ENSG00000117461	8503	phosphoinositide-3-kinase regulatory subunit 3	p55	protein_coding	Q92569	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38358
7.5624369204315e-32	-0.412110066849967	0.652	0.799	1.22428291304866e-27	NAA50	Malignant cells	GSE131984_JQ1	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38359
7.90217003143801e-32	-0.401138230252972	0.281	0.479	1.2792823063895e-27	RFC4	Malignant cells	GSE131984_JQ1	ENSG00000163918	5984	replication factor C subunit 4	A1|RFC37	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38360
7.97819503748904e-32	-0.338948687742297	0.228	0.434	1.2915899946191e-27	RNF113A	Malignant cells	GSE131984_JQ1	ENSG00000125352	7737	ring finger protein 113A	Cwc24|RNF113|ZNF183	protein_coding	O15541	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38361
8.3183340877924e-32	-0.375982836788339	0.424	0.636	1.34665510547271e-27	CDCP1	Malignant cells	GSE131984_JQ1	ENSG00000163814	64866	CUB domain containing protein 1	CD318|SIMA135	protein_coding	Q9H5V8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38362
8.89050259728675e-32	-0.390757475956022	0.606	0.766	1.43928346547475e-27	MRPS25	Malignant cells	GSE131984_JQ1	ENSG00000131368	64432	mitochondrial ribosomal protein S25	DKFZp313H0817|FLJ00023|MRP-S25|RPMS25	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38363
9.12037381188806e-32	-0.393600047462616	0.826	0.921	1.47649731640656e-27	XRCC6	Malignant cells	GSE131984_JQ1	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38364
1.04385914831779e-31	-0.361403366858745	0.243	0.452	1.68990357521168e-27	RAD51AP1	Malignant cells	GSE131984_JQ1	ENSG00000111247	10635	RAD51 associated protein 1	PIR51	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38365
1.08384299529322e-31	-0.316207510056245	0.989	0.994	1.7546334250802e-27	YWHAB	Malignant cells	GSE131984_JQ1	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38366
1.16674370652992e-31	-0.405070452757261	0.599	0.752	1.88884138650129e-27	TIMM50	Malignant cells	GSE131984_JQ1	ENSG00000105197	92609	translocase of inner mitochondrial membrane 50	TIM50|TIM50L	protein_coding	Q3ZCQ8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38367
1.17755731036729e-31	-0.440747737769987	0.56	0.714	1.90634752975361e-27	GPX8	Malignant cells	GSE131984_JQ1	ENSG00000164294	493869	glutathione peroxidase 8 (putative)	EPLA847|UNQ847	protein_coding	Q8TED1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38368
1.19252651834375e-31	-0.414793375624984	0.607	0.773	1.93058118054669e-27	BOD1	Malignant cells	GSE131984_JQ1	ENSG00000145919	91272	biorientation of chromosomes in cell division 1	FAM44B	protein_coding	Q96IK1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38369
1.2014780649239e-31	-0.394481303371034	0.568	0.726	1.94507283930531e-27	TMEM126B	Malignant cells	GSE131984_JQ1	ENSG00000171204	55863	transmembrane protein 126B	HT007	protein_coding	Q8IUX1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38370
1.23917002170046e-31	-0.362319181089522	0.989	0.993	2.00609234813087e-27	PPIB	Malignant cells	GSE131984_JQ1	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38371
1.26012974381237e-31	-0.392659967614277	0.387	0.601	2.04002404225785e-27	MND1	Malignant cells	GSE131984_JQ1	ENSG00000121211	84057	meiotic nuclear divisions 1	GAJ	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38372
1.37182217557028e-31	-0.37663334013571	0.847	0.921	2.22084292003073e-27	COPS6	Malignant cells	GSE131984_JQ1	ENSG00000168090	10980	COP9 signalosome subunit 6	CSN6|MOV34-34KD	protein_coding	Q7L5N1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38373
1.53885429335944e-31	0.396514845272633	0.77	0.603	2.4912512155196e-27	TGFB1	Malignant cells	GSE131984_JQ1	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38374
1.55347840822126e-31	-0.424562208115106	0.413	0.609	2.5149261950694e-27	RP11-1094M14.11	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38375
1.64066977903599e-31	-0.412341993776484	0.518	0.694	2.65608030528137e-27	DIMT1	Malignant cells	GSE131984_JQ1	ENSG00000086189	27292	DIM1 rRNA methyltransferase and ribosome maturation factor	DIMT1L|HSA9761	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38376
2.18220588748421e-31	-0.411018112491705	0.745	0.852	3.53277311124818e-27	MTHFD2	Malignant cells	GSE131984_JQ1	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38377
2.35108784343931e-31	0.425214224609151	0.552	0.35	3.8061761097439e-27	PILRB	Malignant cells	GSE131984_JQ1	ENSG00000121716	29990	paired immunoglobin like type 2 receptor beta	FDFACT1|FDFACT2	protein_coding	Q9UKJ0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38378
2.62294084506583e-31	-0.379463115512071	0.64	0.778	4.24627893407707e-27	SMIM12	Malignant cells	GSE131984_JQ1	ENSG00000163866	113444	small integral membrane protein 12	C1orf212|FLJ90372	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38379
2.64929042060038e-31	-0.369915658569638	0.457	0.653	4.28893626190996e-27	DNPEP	Malignant cells	GSE131984_JQ1	ENSG00000123992	23549	aspartyl aminopeptidase	ASPEP|DAP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38380
2.68071531510742e-31	-0.372904493371296	0.42	0.62	4.33981002362741e-27	ENDOG	Malignant cells	GSE131984_JQ1	ENSG00000167136	2021	endonuclease G	NA	protein_coding	Q14249	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38381
2.81946415293297e-31	-0.378719927474884	0.371	0.581	4.56443051718319e-27	RCC1	Malignant cells	GSE131984_JQ1	ENSG00000180198	1104	regulator of chromosome condensation 1	CHC1	protein_coding	P18754	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38382
2.89923697226358e-31	-0.49803471090315	0.687	0.82	4.69357473439751e-27	ARF4	Malignant cells	GSE131984_JQ1	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38383
3.34093447974894e-31	-0.302558434338885	0.978	0.991	5.40863882926556e-27	CLTA	Malignant cells	GSE131984_JQ1	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38384
3.52408946138818e-31	-0.46961605383437	0.306	0.515	5.70514842904132e-27	AKAP12	Malignant cells	GSE131984_JQ1	ENSG00000131016	9590	A-kinase anchoring protein 12	AKAP250|SSeCKS	protein_coding	Q02952	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38385
3.56851233757404e-31	-0.292085304084407	0.133	0.317	5.77706462329861e-27	RELB	Malignant cells	GSE131984_JQ1	ENSG00000104856	5971	RELB proto-oncogene, NF-kB subunit	REL-B	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38386
4.36788054969965e-31	0.378732185958606	0.951	0.924	7.07116182190876e-27	SNRNP25	Malignant cells	GSE131984_JQ1	ENSG00000161981	79622	small nuclear ribonucleoprotein U11/U12 subunit 25	C16orf33|U11/U12-25K	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38387
4.52872829478465e-31	0.410036338233967	0.898	0.819	7.33155823642687e-27	FKBP5	Malignant cells	GSE131984_JQ1	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38388
4.67462183487523e-31	-0.381335909033059	0.82	0.9	7.56774528847951e-27	LINC00998	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38389
5.83070302274207e-31	-0.355042439203159	0.743	0.868	9.43932512351714e-27	FDX1	Malignant cells	GSE131984_JQ1	ENSG00000137714	2230	ferredoxin 1	ADX|FDX	protein_coding	P10109	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38390
6.38323444863197e-31	-0.387611988518266	0.417	0.613	1.03338182488903e-26	UBE2L6	Malignant cells	GSE131984_JQ1	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38391
6.6507528729315e-31	-0.334380643794006	0.894	0.936	1.07669038259888e-26	MTCH1	Malignant cells	GSE131984_JQ1	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38392
7.34780936226476e-31	-0.344630898033606	0.884	0.941	1.18953685765704e-26	LMAN2	Malignant cells	GSE131984_JQ1	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38393
8.44627753218626e-31	0.43841160411532	0.596	0.393	1.36736786968563e-26	CDKN1A	Malignant cells	GSE131984_JQ1	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38394
8.9033763636328e-31	-0.388532550170935	0.992	1	1.44136759950851e-26	TUBA1B	Malignant cells	GSE131984_JQ1	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38395
9.05823341641964e-31	-0.391018614091754	0.456	0.641	1.46643740778418e-26	GYG1	Malignant cells	GSE131984_JQ1	ENSG00000163754	2992	glycogenin 1	GYG	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38396
1.00128565055433e-30	-0.359410152047857	0.822	0.894	1.62098133968241e-26	CTDNEP1	Malignant cells	GSE131984_JQ1	ENSG00000288307	23399	CTD nuclear envelope phosphatase 1	DULLARD|HSA011916|NET56	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38397
1.0370710689728e-30	-0.35162862923998	0.889	0.938	1.67891435356007e-26	MRPL27	Malignant cells	GSE131984_JQ1	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38398
1.037616735605e-30	-0.389676571644481	0.429	0.624	1.67979773327093e-26	BAG2	Malignant cells	GSE131984_JQ1	ENSG00000112208	9532	BAG cochaperone 2	NA	protein_coding	O95816	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38399
1.0522894880854e-30	-0.373682107654618	0.3	0.512	1.70355145226146e-26	RFC3	Malignant cells	GSE131984_JQ1	ENSG00000133119	5983	replication factor C subunit 3	MGC5276|RFC38	protein_coding	P40938	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38400
1.11258632203502e-30	-0.373865533755354	0.482	0.676	1.80116599674249e-26	DCTN6	Malignant cells	GSE131984_JQ1	ENSG00000104671	10671	dynactin subunit 6	WS-3	protein_coding	O00399	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38401
1.19594054947583e-30	-0.352151379093798	0.733	0.86	1.93610815554642e-26	HIGD1A	Malignant cells	GSE131984_JQ1	ENSG00000181061	25994	HIG1 hypoxia inducible domain family member 1A	DKFZP564K247|HIG1|RCF1A	protein_coding	Q9Y241	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38402
1.3549210554786e-30	-0.328007004087619	0.259	0.466	2.1934816967143e-26	ME2	Malignant cells	GSE131984_JQ1	ENSG00000082212	4200	malic enzyme 2	NA	protein_coding	P23368	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38403
1.36010873077728e-30	0.388318081775703	0.832	0.696	2.20188002425534e-26	BNIP3L	Malignant cells	GSE131984_JQ1	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38404
1.68227997809119e-30	-0.370140170419871	0.225	0.422	2.72344305653182e-26	TPD52L1	Malignant cells	GSE131984_JQ1	ENSG00000111907	7164	TPD52 like 1	D53|hD53|TPD53	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38405
1.80282561362904e-30	-0.384588820128463	0.397	0.591	2.91859438590405e-26	PCID2	Malignant cells	GSE131984_JQ1	ENSG00000126226	55795	PCI domain containing 2	FLJ11305	protein_coding	Q5JVF3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38406
1.89484552442518e-30	-0.366006483963746	0.463	0.661	3.06756541949192e-26	CECR5	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38407
1.89843506188506e-30	0.380915036912725	0.548	0.345	3.07337652168572e-26	ESYT1	Malignant cells	GSE131984_JQ1	ENSG00000139641	23344	extended synaptotagmin 1	FAM62A|KIAA0747|MBC2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38408
1.95159295406793e-30	0.397193950430647	0.759	0.572	3.15943383334057e-26	PYGB	Malignant cells	GSE131984_JQ1	ENSG00000100994	5834	glycogen phosphorylase B	NA	protein_coding	P11216	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38409
1.98753285606111e-30	-0.386777486227747	0.474	0.66	3.21761694067732e-26	NARS	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38410
2.11754509263812e-30	-0.413550032317776	0.493	0.674	3.42809375047186e-26	XBP1	Malignant cells	GSE131984_JQ1	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38411
2.23500655114644e-30	0.290561130551851	1	0.999	3.61825210565098e-26	MT-ND1	Malignant cells	GSE131984_JQ1	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38412
2.28824735368498e-30	-0.401154582055858	0.665	0.795	3.70444364088062e-26	TMCO1	Malignant cells	GSE131984_JQ1	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38413
2.30231167269555e-30	-0.335931805390419	0.963	0.977	3.72721236692682e-26	CDC42	Malignant cells	GSE131984_JQ1	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38414
2.60472265687327e-30	-0.361198772624305	0.875	0.94	4.21678550921213e-26	COX16	Malignant cells	GSE131984_JQ1	ENSG00000133983	51241	cytochrome c oxidase assembly factor COX16	C14orf112|HSPC203	protein_coding	Q9P0S2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38415
3.05781502126999e-30	-0.42093711204625	0.489	0.671	4.95029673793399e-26	ACAT2	Malignant cells	GSE131984_JQ1	ENSG00000120437	39	acetyl-CoA acetyltransferase 2	NA	protein_coding	Q9BWD1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38416
3.14029251948817e-30	-0.295366306396146	0.997	1	5.08381955979939e-26	KRT10	Malignant cells	GSE131984_JQ1	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38417
3.19181457467271e-30	-0.432041996230519	0.592	0.753	5.16722861493765e-26	SLBP	Malignant cells	GSE131984_JQ1	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38418
3.50794470007392e-30	-0.295253677198217	0.178	0.372	5.67901167494967e-26	MAPK3	Malignant cells	GSE131984_JQ1	ENSG00000102882	5595	mitogen-activated protein kinase 3	ERK1|p44erk1|p44mapk|PRKM3	protein_coding	P27361	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38419
3.7018434358383e-30	-0.37802079789243	0.599	0.757	5.99291433827862e-26	WBP11	Malignant cells	GSE131984_JQ1	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38420
3.71812657661886e-30	-0.323268522358445	0.235	0.436	6.01927511488827e-26	RRP9	Malignant cells	GSE131984_JQ1	ENSG00000114767	9136	ribosomal RNA processing 9, U3 small nucleolar RNA binding protein	RNU3IP2|U3-55K	protein_coding	O43818	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38421
3.77979058202965e-30	0.362934535430002	0.404	0.199	6.1191029732478e-26	PCDH7	Malignant cells	GSE131984_JQ1	ENSG00000169851	5099	protocadherin 7	BH-Pcdh|PPP1R120	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38422
4.03509737392396e-30	-0.324136780244309	0.895	0.959	6.5324191386455e-26	MRPL34	Malignant cells	GSE131984_JQ1	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38423
4.46041731330172e-30	-0.378141673472175	0.355	0.555	7.22096958850415e-26	MRPL1	Malignant cells	GSE131984_JQ1	ENSG00000169288	65008	mitochondrial ribosomal protein L1	BM022	protein_coding	Q9BYD6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38424
4.58037616801319e-30	-0.317039961174633	0.944	0.982	7.41517097839656e-26	RAB13	Malignant cells	GSE131984_JQ1	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38425
4.59832061776385e-30	-0.356778297665753	0.387	0.582	7.4442212480979e-26	ZNRD1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38426
4.62409673152916e-30	-0.306165173819618	0.186	0.378	7.48595019867256e-26	LACTB2	Malignant cells	GSE131984_JQ1	ENSG00000147592	51110	lactamase beta 2	CGI-83	protein_coding	Q53H82	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38427
5.23594249546296e-30	-0.429493467626963	0.517	0.687	8.47646730590499e-26	NOP58	Malignant cells	GSE131984_JQ1	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38428
5.67294656584321e-30	-0.329390587499921	0.912	0.955	9.18393319544357e-26	NAA38	Malignant cells	GSE131984_JQ1	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38429
6.60745203380113e-30	-0.298487029812851	0.143	0.325	1.06968040975207e-25	FAM101B	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38430
6.62068131617666e-30	-0.361338432884922	0.358	0.562	1.07182209827584e-25	EGFLAM	Malignant cells	GSE131984_JQ1	ENSG00000164318	133584	EGF like, fibronectin type III and laminin G domains	AGRINL|AGRNL|FLJ39155|PIKA	protein_coding	Q63HQ2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38431
6.79355326267114e-30	-0.324362288610169	0.889	0.953	1.09980833769383e-25	UQCC2	Malignant cells	GSE131984_JQ1	ENSG00000137288	84300	ubiquinol-cytochrome c reductase complex assembly factor 2	bA6B20.2|C6orf125|Cbp6|M19|MGC14833|MNF1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38432
7.49618322999989e-30	-0.26636640372226	0.997	1	1.21355710310468e-25	SHFM1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38433
8.07695008463234e-30	-0.321085563069383	0.196	0.387	1.30757744920113e-25	MGST2	Malignant cells	GSE131984_JQ1	ENSG00000085871	4258	microsomal glutathione S-transferase 2	MGST-II	protein_coding	Q99735	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38434
8.16918309817229e-30	-0.362043236121974	0.489	0.672	1.32250905176311e-25	NTPCR	Malignant cells	GSE131984_JQ1	ENSG00000135778	84284	nucleoside-triphosphatase, cancer-related	C1orf57|HCR-NTPase|MGC13186|THEP1	protein_coding	Q9BSD7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38435
8.3229553834918e-30	-0.414727025021466	0.734	0.838	1.34740324703349e-25	BLVRB	Malignant cells	GSE131984_JQ1	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38436
8.38477348116711e-30	-0.471159052841619	0.345	0.562	1.35741097886614e-25	PLK1	Malignant cells	GSE131984_JQ1	ENSG00000166851	5347	polo like kinase 1	PLK	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38437
8.7330181502326e-30	-0.368484445433237	0.598	0.757	1.41378830834116e-25	TMUB1	Malignant cells	GSE131984_JQ1	ENSG00000164897	83590	transmembrane and ubiquitin like domain containing 1	C7orf21|HOPS|SB144	protein_coding	Q9BVT8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38438
8.80923736706653e-30	-0.300304778384204	0.969	0.983	1.4261274373544e-25	HNRNPK	Malignant cells	GSE131984_JQ1	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38439
9.05975893897364e-30	-0.374638052154773	0.506	0.683	1.46668437463044e-25	ZNF259	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38440
9.08064185223278e-30	-0.286255018355707	0.988	0.996	1.47006510945797e-25	PDCD6	Malignant cells	GSE131984_JQ1	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38441
9.10608868466904e-30	0.358281425724565	0.45	0.247	1.47418469716107e-25	RXRA	Malignant cells	GSE131984_JQ1	ENSG00000186350	6256	retinoid X receptor alpha	NR2B1|RXR-alpha|RXRalpha	protein_coding	P19793	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38442
9.30924189555998e-30	-0.362045415047688	0.344	0.538	1.5070731704722e-25	ALYREF	Malignant cells	GSE131984_JQ1	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38443
9.94106210996953e-30	-0.413035737822736	0.498	0.669	1.60935854498297e-25	MRPS22	Malignant cells	GSE131984_JQ1	ENSG00000175110	56945	mitochondrial ribosomal protein S22	C3orf5|GIBT|GK002|MRP-S22	protein_coding	P82650	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38444
1.06481800841019e-29	-0.376579388850649	0.485	0.669	1.72383387381526e-25	CREM	Malignant cells	GSE131984_JQ1	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38445
1.18361081941076e-29	-0.39233299369896	0.666	0.795	1.91614755554408e-25	FAM58A	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38446
1.28407513775484e-29	-0.360468390466908	0.275	0.476	2.07878924051132e-25	RP11-660L16.2	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38447
1.38696475951374e-29	-0.376380377726727	0.738	0.843	2.2453572491768e-25	RPL7L1	Malignant cells	GSE131984_JQ1	ENSG00000146223	285855	ribosomal protein L7 like 1	dJ475N16.4	protein_coding	Q6DKI1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38448
1.3893344111635e-29	-0.318096565252842	0.864	0.929	2.24919347823259e-25	MRPL43	Malignant cells	GSE131984_JQ1	ENSG00000055950	84545	mitochondrial ribosomal protein L43	bMRP36a	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38449
1.44939529417412e-29	-0.346063741962385	0.307	0.508	2.34642604173849e-25	DNTTIP2	Malignant cells	GSE131984_JQ1	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38450
1.5463918112775e-29	-0.352591337554058	0.86	0.926	2.50345370327715e-25	PDLIM1	Malignant cells	GSE131984_JQ1	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38451
1.5904138742536e-29	-0.370600980794717	0.383	0.579	2.57472102102916e-25	UTP18	Malignant cells	GSE131984_JQ1	ENSG00000011260	51096	UTP18 small subunit processome component	CGI-48|WDR50	protein_coding	Q9Y5J1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38452
1.60278557239311e-29	-0.435148645012822	0.578	0.786	2.59474956314721e-25	MKI67	Malignant cells	GSE131984_JQ1	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38453
1.62793242490743e-29	-0.595173020036122	0.44	0.657	2.63545980268264e-25	UBE2C	Malignant cells	GSE131984_JQ1	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38454
1.74338497858477e-29	-0.314992204665705	0.206	0.4	2.82236594183088e-25	GMPPA	Malignant cells	GSE131984_JQ1	ENSG00000144591	29926	GDP-mannose pyrophosphorylase A	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38455
1.77935740412343e-29	-0.359328733456646	0.768	0.866	2.88060170153541e-25	PAIP1	Malignant cells	GSE131984_JQ1	ENSG00000172239	10605	poly(A) binding protein interacting protein 1	NA	protein_coding	Q9H074	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38456
1.80661825318554e-29	-0.296725010687585	0.994	0.999	2.92473429008207e-25	POLR1D	Malignant cells	GSE131984_JQ1	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38457
1.97847685086966e-29	-0.34051211405145	0.325	0.529	3.20295617387289e-25	MSL3	Malignant cells	GSE131984_JQ1	ENSG00000005302	10943	MSL complex subunit 3	MSL3L1	protein_coding	Q8N5Y2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38458
2.33819419285601e-29	-0.433237568971588	0.486	0.663	3.78530257881459e-25	CDCA4	Malignant cells	GSE131984_JQ1	ENSG00000170779	55038	cell division cycle associated 4	FLJ20764|Hepp	protein_coding	Q9BXL8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38459
2.41082112597614e-29	-0.343564256742333	0.869	0.939	3.90287832084277e-25	EMD	Malignant cells	GSE131984_JQ1	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38460
2.44145121686626e-29	-0.321630351804744	0.265	0.467	3.95246537498479e-25	HDAC8	Malignant cells	GSE131984_JQ1	ENSG00000147099	55869	histone deacetylase 8	HDACL1|KDAC8|MRXS6|RPD3|WTS	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38461
2.72077139984733e-29	-0.354374988174312	0.705	0.833	4.40465681921285e-25	ETF1	Malignant cells	GSE131984_JQ1	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38462
2.75484481399454e-29	-0.36660586386443	0.644	0.778	4.45981826937576e-25	SRPK1	Malignant cells	GSE131984_JQ1	ENSG00000096063	6732	SRSF protein kinase 1	SFRSK1	protein_coding	Q96SB4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38463
2.7878807683225e-29	-0.365579684735071	0.28	0.477	4.51330017583729e-25	CHORDC1	Malignant cells	GSE131984_JQ1	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38464
3.00647351867488e-29	-0.413804001519237	0.751	0.853	4.86717997938277e-25	DNAJA1	Malignant cells	GSE131984_JQ1	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38465
3.14524991074792e-29	-0.385850518049563	0.496	0.675	5.09184508050981e-25	GTPBP4	Malignant cells	GSE131984_JQ1	ENSG00000107937	23560	GTP binding protein 4	CRFG|FLJ10686|FLJ10690|NGB|NOG1	protein_coding	Q9BZE4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38466
3.51650725820787e-29	-0.333082102593505	0.286	0.489	5.69287360031272e-25	HSPA14	Malignant cells	GSE131984_JQ1	ENSG00000187522	51182	heat shock protein family A (Hsp70) member 14	HSP70-4|HSP70L1	protein_coding	Q0VDF9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38467
3.65008780087654e-29	-0.369867936155663	0.89	0.943	5.90912714083904e-25	NT5C3B	Malignant cells	GSE131984_JQ1	ENSG00000141698	115024	5'-nucleotidase, cytosolic IIIB	cN-IIIB|MGC20781|NT5C3L	protein_coding	Q969T7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38468
3.66623423916291e-29	-0.293925829385692	0.112	0.278	5.93526660978083e-25	CPNE7	Malignant cells	GSE131984_JQ1	ENSG00000178773	27132	copine 7	NA	protein_coding	Q9UBL6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38469
3.74846603134286e-29	0.458268258905574	0.668	0.467	6.06839165814096e-25	MARCKSL1	Malignant cells	GSE131984_JQ1	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38470
3.89836562773518e-29	-0.408064042513928	0.573	0.732	6.31106411474048e-25	GNL3	Malignant cells	GSE131984_JQ1	ENSG00000163938	26354	G protein nucleolar 3	C77032|E2IG3|MGC800|NS	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38471
4.210544776794e-29	-0.336420702644276	0.819	0.892	6.81645093915181e-25	KDELR1	Malignant cells	GSE131984_JQ1	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38472
4.89214356790768e-29	-0.272882064715124	0.096	0.259	7.91989122208574e-25	SOCS3	Malignant cells	GSE131984_JQ1	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38473
5.03573217838833e-29	-0.363291936698999	0.394	0.586	8.15234682359287e-25	OXCT1	Malignant cells	GSE131984_JQ1	ENSG00000083720	5019	3-oxoacid CoA-transferase 1	OXCT|SCOT	protein_coding	P55809	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38474
5.07065521553474e-29	-0.361452095693182	0.375	0.558	8.20888372842919e-25	NEK6	Malignant cells	GSE131984_JQ1	ENSG00000119408	10783	NIMA related kinase 6	SID6-1512	protein_coding	Q9HC98	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38475
5.20877658140506e-29	-0.322779968714749	0.799	0.91	8.43248840763666e-25	MRPL40	Malignant cells	GSE131984_JQ1	ENSG00000185608	64976	mitochondrial ribosomal protein L40	MRP-L22|NLVCF	protein_coding	Q9NQ50	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38476
5.29550129750779e-29	-0.375009985883712	0.709	0.826	8.57288705053535e-25	SMIM15	Malignant cells	GSE131984_JQ1	ENSG00000188725	643155	small integral membrane protein 15	C5orf43|DKFZP686E2158	protein_coding	Q7Z3B0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38477
5.44965414272534e-29	0.348729341557031	0.541	0.333	8.82244509165805e-25	C1orf53	Malignant cells	GSE131984_JQ1	ENSG00000203724	388722	chromosome 1 open reading frame 53	NA	protein_coding	Q5VUE5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38478
5.66303968592676e-29	0.387710285382384	0.314	0.133	9.16789494754684e-25	HTRA1	Malignant cells	GSE131984_JQ1	ENSG00000166033	5654	HtrA serine peptidase 1	ARMD7|HtrA|IGFBP5-protease|PRSS11	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38479
5.97379568324035e-29	-0.337895651281669	0.284	0.482	9.6709778315978e-25	MIS18A	Malignant cells	GSE131984_JQ1	ENSG00000159055	54069	MIS18 kinetochore protein A	B28|C21orf45|C21orf46|FASP1|hMis18alpha	protein_coding	Q9NYP9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38480
6.21903277716754e-29	-0.36161662413556	0.764	0.877	1.00679921629565e-24	CMSS1	Malignant cells	GSE131984_JQ1	ENSG00000184220	84319	cms1 ribosomal small subunit homolog	C3orf26|MGC4308	protein_coding	Q9BQ75	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38481
6.49784388868665e-29	-0.305156437209588	0.237	0.434	1.05193594713948e-24	ABHD5	Malignant cells	GSE131984_JQ1	ENSG00000011198	51099	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	CGI-58|NCIE2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38482
7.01413656958034e-29	-0.335712443154499	0.341	0.545	1.13551856924936e-24	TBRG4	Malignant cells	GSE131984_JQ1	ENSG00000136270	9238	transforming growth factor beta regulator 4	Cpr2|FASTKD4|H_TD2522F11.8|KIAA0948	protein_coding	Q969Z0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38483
7.15489396788823e-29	0.340617903731732	0.348	0.155	1.15830578446143e-24	FSTL1	Malignant cells	GSE131984_JQ1	ENSG00000163430	11167	follistatin like 1	FRP|FSL1|OCC-1|OCC1|tsc36	protein_coding	Q12841	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38484
7.46067805984429e-29	-0.350070106030713	0.747	0.873	1.20780917110819e-24	NELFE	Malignant cells	GSE131984_JQ1	ENSG00000206268	7936	negative elongation factor complex member E	D6S45|NELF-E|RD|RDBP|RDP	protein_coding	P18615	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38485
9.0149072036095e-29	-0.357226900391609	0.735	0.836	1.45942332719234e-24	SDHC	Malignant cells	GSE131984_JQ1	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38486
9.41762891683628e-29	-0.391665001519727	0.249	0.441	1.52461994534663e-24	PSAT1	Malignant cells	GSE131984_JQ1	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38487
9.43005034844743e-29	-0.347856562665902	0.802	0.902	1.52663085091015e-24	MALSU1	Malignant cells	GSE131984_JQ1	ENSG00000156928	115416	mitochondrial assembly of ribosomal large subunit 1	C7orf30|mtRsfA	protein_coding	Q96EH3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38488
1.19163202567593e-28	-0.35413755161236	0.702	0.827	1.92913308636676e-24	NDUFV1	Malignant cells	GSE131984_JQ1	ENSG00000167792	4723	NADH:ubiquinone oxidoreductase core subunit V1	CI-51K	protein_coding	P49821	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38489
1.23321548517262e-28	-0.380197268572357	0.559	0.723	1.99645254894595e-24	PON2	Malignant cells	GSE131984_JQ1	ENSG00000105854	5445	paraoxonase 2	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38490
1.35163440802712e-28	-0.375615168496543	0.555	0.716	2.1881609431551e-24	TOMM5	Malignant cells	GSE131984_JQ1	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38491
1.37524000361822e-28	-0.32938137127692	0.244	0.437	2.22637604185754e-24	KIFC3	Malignant cells	GSE131984_JQ1	ENSG00000140859	3801	kinesin family member C3	NA	protein_coding	Q9BVG8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38492
1.60504199876374e-28	-0.364230732919462	0.396	0.594	2.59840249179862e-24	SLC25A33	Malignant cells	GSE131984_JQ1	ENSG00000171612	84275	solute carrier family 25 member 33	BMSC-MCP|MGC4399|PNC1	protein_coding	Q9BSK2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38493
1.92974124230409e-28	-0.376003846221598	0.488	0.664	3.12405809716609e-24	DYNLT3	Malignant cells	GSE131984_JQ1	ENSG00000165169	6990	dynein light chain Tctex-type 3	TCTE1L|TCTEX1L	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38494
1.93933740728752e-28	-0.341921319657707	0.27	0.46	3.13959332865777e-24	PYCR2	Malignant cells	GSE131984_JQ1	ENSG00000143811	29920	pyrroline-5-carboxylate reductase 2	P5CR2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38495
1.98298520021018e-28	0.336065083424382	0.544	0.337	3.21025474062026e-24	MBTPS1	Malignant cells	GSE131984_JQ1	ENSG00000140943	8720	membrane bound transcription factor peptidase, site 1	KIAA0091|PCSK8|S1P|SKI-1	protein_coding	Q14703	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38496
1.99423833118436e-28	-0.377891007881124	0.35	0.536	3.22847243435435e-24	RPA2	Malignant cells	GSE131984_JQ1	ENSG00000117748	6118	replication protein A2	NA	protein_coding	P15927	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38497
2.11038161575684e-28	-0.360278825274622	0.807	0.9	3.41649679774875e-24	UQCRC1	Malignant cells	GSE131984_JQ1	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38498
2.23193108380149e-28	-0.351981996148085	0.462	0.654	3.61327323156624e-24	RFK	Malignant cells	GSE131984_JQ1	ENSG00000135002	55312	riboflavin kinase	FLJ11149|RIFK	protein_coding	Q969G6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38499
2.26331459536572e-28	-0.334542756830803	0.244	0.437	3.66407999843757e-24	PRKAG2	Malignant cells	GSE131984_JQ1	ENSG00000106617	51422	protein kinase AMP-activated non-catalytic subunit gamma 2	AAKG|AAKG2|CMH6|H91620p|WPWS	protein_coding	Q9UGJ0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38500
2.26821924317521e-28	-0.331340107513876	0.85	0.919	3.67202013277634e-24	POP7	Malignant cells	GSE131984_JQ1	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38501
2.63092276585611e-28	-0.347693124521182	0.699	0.834	4.25920086564446e-24	AGPAT2	Malignant cells	GSE131984_JQ1	ENSG00000169692	10555	1-acylglycerol-3-phosphate O-acyltransferase 2	BSCL|LPAAT-beta|LPLAT2	protein_coding	O15120	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38502
2.6456693676374e-28	-0.340861177487551	0.278	0.472	4.28307413926819e-24	UNC50	Malignant cells	GSE131984_JQ1	ENSG00000115446	25972	unc-50 inner nuclear membrane RNA binding protein	GMH1|UNCL|URP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38503
3.09046641609787e-28	-0.327091142888639	0.157	0.335	5.00315608102085e-24	C1GALT1C1	Malignant cells	GSE131984_JQ1	ENSG00000288368	29071	C1GALT1 specific chaperone 1	C1GALT2|COSMC	protein_coding	Q96EU7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38504
3.54070332103494e-28	-0.347974280766545	0.601	0.757	5.73204460642347e-24	MED28	Malignant cells	GSE131984_JQ1	ENSG00000118579	80306	mediator complex subunit 28	DKFZP434N185|EG1|magicin	protein_coding	Q9H204	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38505
3.58184195134959e-28	-0.383167296953801	0.597	0.742	5.79864393503984e-24	COX11	Malignant cells	GSE131984_JQ1	ENSG00000166260	1353	cytochrome c oxidase copper chaperone COX11	COX11P	protein_coding	Q9Y6N1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38506
3.68840470646609e-28	-0.366504013570501	0.543	0.71	5.97115837929796e-24	ALG3	Malignant cells	GSE131984_JQ1	ENSG00000214160	10195	ALG3 alpha-1,3- mannosyltransferase	CDGS4|D16Ertd36e|Not56|NOT56L	protein_coding	Q92685	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38507
3.82169493372578e-28	-0.337079235509012	0.808	0.895	6.18694192820866e-24	NDUFA8	Malignant cells	GSE131984_JQ1	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38508
3.83704485410875e-28	-0.377934207964812	0.573	0.732	6.21179191431666e-24	SMC3	Malignant cells	GSE131984_JQ1	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38509
3.95448455261847e-28	-0.364700159143772	0.199	0.386	6.40191504223404e-24	HES7	Malignant cells	GSE131984_JQ1	ENSG00000179111	84667	hes family bHLH transcription factor 7	bHLHb37	protein_coding	Q9BYE0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38510
4.53859165178855e-28	-0.342950347533628	0.762	0.868	7.34752602508049e-24	RNF181	Malignant cells	GSE131984_JQ1	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38511
4.58692150569758e-28	0.321561624947917	0.43	0.227	7.4257672255738e-24	RAPH1	Malignant cells	GSE131984_JQ1	ENSG00000173166	65059	Ras association (RalGDS/AF-6) and pleckstrin homology domains 1	ALS2CR18|ALS2CR9|KIAA1681	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38512
4.985603937814e-28	-0.294558999311033	0.197	0.385	8.07119421492709e-24	MSRA	Malignant cells	GSE131984_JQ1	ENSG00000175806	4482	methionine sulfoxide reductase A	NA	protein_coding	Q9UJ68	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38513
5.69705568179116e-28	0.426280606438333	0.727	0.53	9.2229634432517e-24	PLAT	Malignant cells	GSE131984_JQ1	ENSG00000104368	5327	plasminogen activator, tissue type	NA	protein_coding	P00750	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38514
6.56633071691555e-28	-0.295562416837571	0.174	0.356	1.06302327976146e-23	NSDHL	Malignant cells	GSE131984_JQ1	ENSG00000147383	50814	NAD(P) dependent steroid dehydrogenase-like	H105e3|SDR31E1|XAP104	protein_coding	Q15738	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38515
6.57393420808966e-28	0.295023219021005	0.336	0.147	1.06425420894763e-23	CD33	Malignant cells	GSE131984_JQ1	ENSG00000105383	945	CD33 molecule	FLJ00391|p67|SIGLEC-3|SIGLEC3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38516
7.04955091525442e-28	-0.317577332724197	0.946	0.965	1.14125179767054e-23	ARHGDIA	Malignant cells	GSE131984_JQ1	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38517
8.02969233927116e-28	-0.389789085267412	0.509	0.668	1.29992689280461e-23	MRPL16	Malignant cells	GSE131984_JQ1	ENSG00000166902	54948	mitochondrial ribosomal protein L16	FLJ20484|PNAS-111	protein_coding	Q9NX20	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38518
8.268973101937e-28	-0.330849955354728	0.893	0.939	1.33866405547258e-23	CALD1	Malignant cells	GSE131984_JQ1	ENSG00000122786	800	caldesmon 1	CDM|H-CAD|h-CD|L-CAD	protein_coding	Q05682	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38519
8.64909576711177e-28	-0.33271198662978	0.824	0.92	1.40020211373772e-23	WDR1	Malignant cells	GSE131984_JQ1	ENSG00000071127	9948	WD repeat domain 1	AIP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38520
9.26197031130518e-28	-0.263577811166796	0.158	0.336	1.4994203736972e-23	DRAM1	Malignant cells	GSE131984_JQ1	ENSG00000136048	55332	DNA damage regulated autophagy modulator 1	DRAM|FLJ11259	protein_coding	Q8N682	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38521
9.64936798234254e-28	-0.34357502797763	0.723	0.84	1.56213618266143e-23	TRIP6	Malignant cells	GSE131984_JQ1	ENSG00000087077	7205	thyroid hormone receptor interactor 6	MGC10556|MGC10558|MGC29959|MGC3837|MGC4423|OIP1|ZRP-1	protein_coding	Q15654	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38522
9.70125914257157e-28	-0.365738684628115	0.339	0.527	1.57053684259091e-23	LTV1	Malignant cells	GSE131984_JQ1	ENSG00000135521	84946	LTV1 ribosome biogenesis factor	C6orf93|dJ468K18.4|FLJ14909	protein_coding	Q96GA3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38523
9.76794325271297e-28	-0.316683963961966	0.913	0.961	1.5813323331817e-23	RER1	Malignant cells	GSE131984_JQ1	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38524
1.00441898079946e-27	-0.367128480197797	0.506	0.673	1.62605388801625e-23	ERGIC2	Malignant cells	GSE131984_JQ1	ENSG00000087502	51290	ERGIC and golgi 2	Erv41|PTX1	protein_coding	Q96RQ1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38525
1.01742959176578e-27	0.272660198690131	0.994	0.989	1.64711676610962e-23	STUB1	Malignant cells	GSE131984_JQ1	ENSG00000103266	10273	STIP1 homology and U-box containing protein 1	CHIP|HSPABP2|NY-CO-7|SDCCAG7|UBOX1	protein_coding	Q9UNE7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38526
1.13727952225758e-27	-0.348800291222024	0.402	0.597	1.84114181858279e-23	EIF2B1	Malignant cells	GSE131984_JQ1	ENSG00000111361	1967	eukaryotic translation initiation factor 2B subunit alpha	EIF-2B|EIF-2Balpha|EIF2B|EIF2BA|EIF2Balpha	protein_coding	Q14232	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38527
1.18908844013102e-27	-0.358944540748634	0.36	0.544	1.9250152757281e-23	DYRK4	Malignant cells	GSE131984_JQ1	ENSG00000010219	8798	dual specificity tyrosine phosphorylation regulated kinase 4	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38528
1.28337409362105e-27	-0.295343839827038	0.209	0.399	2.07765432016312e-23	C2orf47	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38529
1.31933751538992e-27	0.395855211579585	0.532	0.341	2.13587550366474e-23	DUSP4	Malignant cells	GSE131984_JQ1	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38530
1.3560693804704e-27	-0.420061945820612	0.504	0.662	2.19534072004353e-23	SARS	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38531
1.56026853209143e-27	-0.290175538268897	0.967	0.977	2.52591872660282e-23	NSA2	Malignant cells	GSE131984_JQ1	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38532
1.60606480225058e-27	-0.366023690813466	0.944	0.987	2.60005830836347e-23	TUBA1C	Malignant cells	GSE131984_JQ1	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38533
1.68223621285473e-27	-0.373241812893962	0.482	0.656	2.72337220499053e-23	POLR2C	Malignant cells	GSE131984_JQ1	ENSG00000102978	5432	RNA polymerase II subunit C	RPB3	protein_coding	P19387	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38534
1.78059574360956e-27	-0.400028212109267	0.473	0.641	2.88260644932952e-23	HSPH1	Malignant cells	GSE131984_JQ1	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38535
1.88275230523897e-27	-0.371600661049782	0.601	0.754	3.04798770695137e-23	COPS5	Malignant cells	GSE131984_JQ1	ENSG00000121022	10987	COP9 signalosome subunit 5	CSN5|JAB1|MOV-34|SGN5	protein_coding	Q92905	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38536
1.98350627434945e-27	-0.387163050988034	0.429	0.599	3.21109830754433e-23	BET1	Malignant cells	GSE131984_JQ1	ENSG00000105829	10282	Bet1 golgi vesicular membrane trafficking protein	hbet1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38537
2.0016240633834e-27	-0.305647485052441	0.213	0.399	3.24042919621139e-23	FAIM	Malignant cells	GSE131984_JQ1	ENSG00000158234	55179	Fas apoptotic inhibitory molecule	FAIM1|FLJ10582	protein_coding	Q9NVQ4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38538
2.09041843948174e-27	-0.312716698517063	0.923	0.977	3.38417841167699e-23	DDX46	Malignant cells	GSE131984_JQ1	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38539
2.18442228899788e-27	-0.283741442048898	0.208	0.398	3.53636124365867e-23	SLC35A2	Malignant cells	GSE131984_JQ1	ENSG00000102100	7355	solute carrier family 35 member A2	UGALT|UGAT|UGT|UGT1|UGT2|UGTL	protein_coding	P78381	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38540
2.44527081286796e-27	-0.340591743079739	0.578	0.755	3.95864891895193e-23	TYW3	Malignant cells	GSE131984_JQ1	ENSG00000162623	127253	tRNA-yW synthesizing protein 3 homolog	C1orf171|FLJ40918	protein_coding	Q6IPR3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38541
3.04652426256617e-27	-0.349887201451459	0.361	0.553	4.93201812866837e-23	RRP1	Malignant cells	GSE131984_JQ1	ENSG00000160214	8568	ribosomal RNA processing 1	D21S2056E|NNP-1|Nop52|RRP1A	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38542
3.07004597428071e-27	0.266318421027456	0.319	0.136	4.97009742776304e-23	GLCE	Malignant cells	GSE131984_JQ1	ENSG00000138604	26035	glucuronic acid epimerase	HSEPI|KIAA0836	protein_coding	O94923	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38543
3.34407075211001e-27	-0.32941245479876	0.285	0.478	5.4137161405909e-23	WDR77	Malignant cells	GSE131984_JQ1	ENSG00000116455	79084	WD repeat domain 77	MEP50|p44	protein_coding	Q9BQA1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38544
3.533464124603e-27	-0.348224574620302	0.519	0.698	5.7203250713198e-23	UBL4A	Malignant cells	GSE131984_JQ1	ENSG00000102178	8266	ubiquitin like 4A	DXS254E|GDX|GET5|MDY2|TMA24|UBL4	protein_coding	P11441	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38545
3.55420296805232e-27	-0.304377133232626	0.179	0.358	5.7538991849799e-23	RPGR	Malignant cells	GSE131984_JQ1	ENSG00000156313	6103	retinitis pigmentosa GTPase regulator	COD1|CORDX1|CRD|RP15|RP3	protein_coding	Q92834	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38546
3.67681014782791e-27	-0.300958574495401	0.213	0.398	5.95238794831861e-23	TEAD4	Malignant cells	GSE131984_JQ1	ENSG00000197905	7004	TEA domain transcription factor 4	EFTR-2|RTEF-1|TCF13L1|TEF-3|TEFR-1	protein_coding	Q15561	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38547
3.68124450200211e-27	-0.780661828776537	0.193	0.361	5.95956672429122e-23	TFPI2	Malignant cells	GSE131984_JQ1	ENSG00000105825	7980	tissue factor pathway inhibitor 2	PP5|REF1|TFPI-2	protein_coding	P48307	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38548
3.91779321989081e-27	0.376928784866502	0.691	0.53	6.34251544368124e-23	PTPN14	Malignant cells	GSE131984_JQ1	ENSG00000152104	5784	protein tyrosine phosphatase non-receptor type 14	PEZ|PTPD2	protein_coding	Q15678	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38549
4.01442317795496e-27	-0.353574168620783	0.678	0.81	6.49894968279128e-23	CDV3	Malignant cells	GSE131984_JQ1	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38550
4.15251969693e-27	0.374652917671708	0.518	0.322	6.72251413735998e-23	EPHA2	Malignant cells	GSE131984_JQ1	ENSG00000142627	1969	EPH receptor A2	ECK	protein_coding	P29317	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38551
4.21520866626073e-27	-0.3567928905304	0.47	0.649	6.82400130980949e-23	NSMCE1	Malignant cells	GSE131984_JQ1	ENSG00000169189	197370	NSE1 homolog, SMC5-SMC6 complex component	NSE1	protein_coding	Q8WV22	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38552
4.28261356379924e-27	-0.303073294302878	0.928	0.988	6.93312309843458e-23	DEK	Malignant cells	GSE131984_JQ1	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38553
4.37804709131922e-27	-0.296294254313735	0.954	0.969	7.08762043613668e-23	GCSH	Malignant cells	GSE131984_JQ1	ENSG00000140905	2653	glycine cleavage system protein H	NA	protein_coding	P23434	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38554
4.4280521317941e-27	-0.325172163064407	0.334	0.524	7.16857359616147e-23	MRPL2	Malignant cells	GSE131984_JQ1	ENSG00000112651	51069	mitochondrial ribosomal protein L2	CGI-22|MRP-L14|RPML14	protein_coding	Q5T653	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38555
4.6599619302192e-27	-0.354138552814015	0.331	0.516	7.54401236883186e-23	PDCL3	Malignant cells	GSE131984_JQ1	ENSG00000115539	79031	phosducin like 3	VIAF1	protein_coding	Q9H2J4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38556
4.94763749929514e-27	-0.353272275141833	0.413	0.605	8.0097303476089e-23	TCOF1	Malignant cells	GSE131984_JQ1	ENSG00000070814	6949	treacle ribosome biogenesis factor 1	TCS|treacle	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38557
5.043707898463e-27	-0.413366356191812	0.58	0.704	8.16525871682176e-23	ADH5	Malignant cells	GSE131984_JQ1	ENSG00000197894	128	alcohol dehydrogenase 5 (class III), chi polypeptide	ADH-3|ADHX|FDH|GSNOR	protein_coding	P11766	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38558
5.30712342439547e-27	-0.381210159392591	0.597	0.742	8.59170211175383e-23	CRELD2	Malignant cells	GSE131984_JQ1	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38559
5.68808232377307e-27	-0.394585791617389	0.482	0.645	9.20843647395623e-23	SNW1	Malignant cells	GSE131984_JQ1	ENSG00000100603	22938	SNW domain containing 1	Bx42|FUN20|NCoA-62|Prp45|PRPF45|SKIIP|SKIP|SKIP1	protein_coding	Q13573	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38560
6.23267221172855e-27	-0.269912529023916	0.139	0.308	1.00900730435674e-22	FERMT1	Malignant cells	GSE131984_JQ1	ENSG00000101311	55612	FERM domain containing kindlin 1	C20orf42|FLJ20116|KIND1|UNC112A|URP1	protein_coding	Q9BQL6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38561
6.29282616420331e-27	-0.284432319811291	0.95	0.98	1.01874562772287e-22	DGUOK	Malignant cells	GSE131984_JQ1	ENSG00000114956	1716	deoxyguanosine kinase	dGK	protein_coding	Q16854	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38562
6.46748746747067e-27	-0.309187936419884	0.967	0.99	1.04702154610883e-22	KRT8	Malignant cells	GSE131984_JQ1	ENSG00000170421	3856	keratin 8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	protein_coding	P05787	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38563
6.53680190640122e-27	-0.46322994806758	0.36	0.536	1.05824286062729e-22	SNAPC1	Malignant cells	GSE131984_JQ1	ENSG00000023608	6617	small nuclear RNA activating complex polypeptide 1	PTFgamma|SNAP43	protein_coding	Q16533	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38564
6.68557756699329e-27	-0.274257768790299	0.136	0.303	1.08232815232054e-22	CATSPER1	Malignant cells	GSE131984_JQ1	ENSG00000175294	117144	cation channel sperm associated 1	CATSPER	protein_coding	Q8NEC5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38565
6.97118370066851e-27	-0.30206466407415	0.286	0.479	1.12856492930122e-22	RABEPK	Malignant cells	GSE131984_JQ1	ENSG00000136933	10244	Rab9 effector protein with kelch motifs	bA65N13.1|RAB9P40	protein_coding	Q7Z6M1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38566
7.44984792433268e-27	-0.348708323741798	0.365	0.543	1.20605588047022e-22	LACTB	Malignant cells	GSE131984_JQ1	ENSG00000103642	114294	lactamase beta	FLJ14902|MRPL56	protein_coding	P83111	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38567
7.778477732811e-27	-0.3451697786827	0.351	0.544	1.25925776016477e-22	CCDC28B	Malignant cells	GSE131984_JQ1	ENSG00000160050	79140	coiled-coil domain containing 28B	MGC1203|RP4-622L5.5	protein_coding	Q9BUN5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38568
7.97180551769616e-27	-0.311616991143932	0.887	0.93	1.29055559525983e-22	HNRNPR	Malignant cells	GSE131984_JQ1	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38569
8.97686226884704e-27	-0.382813670011448	0.46	0.637	1.45326423270365e-22	RNASEH2A	Malignant cells	GSE131984_JQ1	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38570
9.45509853443119e-27	-0.294349675742084	0.226	0.414	1.53068590173907e-22	SPR	Malignant cells	GSE131984_JQ1	ENSG00000116096	6697	sepiapterin reductase	SDR38C1	protein_coding	P35270	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38571
1.00649229885017e-26	-0.337572431082478	0.69	0.828	1.62941038260853e-22	SPATS2L	Malignant cells	GSE131984_JQ1	ENSG00000196141	26010	spermatogenesis associated serine rich 2 like	DNAPTP6|SGNP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38572
1.04374201071846e-26	-0.343445970375228	0.376	0.559	1.68971394115212e-22	WLS	Malignant cells	GSE131984_JQ1	ENSG00000116729	79971	Wnt ligand secretion mediator	C1orf139|EVI|FLJ23091|GPR177|mig-14|MRP	protein_coding	Q5T9L3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38573
1.07398361476796e-26	-0.351768142263045	0.609	0.761	1.73867207394785e-22	NSFL1C	Malignant cells	GSE131984_JQ1	ENSG00000088833	55968	NSFL1 cofactor	dJ776F14.1|p47|UBX1|UBXD10|UBXN2C	protein_coding	Q9UNZ2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38574
1.09799096259728e-26	-0.333925917825839	0.331	0.522	1.77753756934874e-22	RPIA	Malignant cells	GSE131984_JQ1	ENSG00000153574	22934	ribose 5-phosphate isomerase A	NA	protein_coding	P49247	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38575
1.17604373526191e-26	-0.328868301265244	0.213	0.391	1.90389720301551e-22	ATAD3B	Malignant cells	GSE131984_JQ1	ENSG00000160072	83858	ATPase family AAA domain containing 3B	KIAA1273|TOB3	protein_coding	Q5T9A4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38576
1.19109310158955e-26	-0.318855761486232	0.134	0.297	1.92826062216333e-22	ARHGDIB	Malignant cells	GSE131984_JQ1	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38577
1.19651377707947e-26	0.380451745420048	0.896	0.829	1.93703615371396e-22	ENAH	Malignant cells	GSE131984_JQ1	ENSG00000154380	55740	ENAH actin regulator	FLJ10773|MENA|NDPP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38578
1.29049110030261e-26	-0.303769793492987	0.252	0.439	2.08917604227989e-22	NGDN	Malignant cells	GSE131984_JQ1	ENSG00000129460	25983	neuroguidin	C14orf120|CANu1|DKFZP564O092|LCP5|lpd-2|NGD	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38579
1.31763973575663e-26	0.320153165597986	0.315	0.137	2.13312696821641e-22	SOX9	Malignant cells	GSE131984_JQ1	ENSG00000125398	6662	SRY-box transcription factor 9	CMD1|CMPD1|SRA1	protein_coding	P48436	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38580
1.56487270358699e-26	-0.346664536099371	0.873	0.914	2.53337241983697e-22	REEP5	Malignant cells	GSE131984_JQ1	ENSG00000129625	7905	receptor accessory protein 5	C5orf18|D5S346|DP1|POB16|TB2|Yip2e	protein_coding	Q00765	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38581
1.78412105891524e-26	-0.350071007432017	0.964	0.986	2.88831358227789e-22	ANXA5	Malignant cells	GSE131984_JQ1	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38582
1.88287145341037e-26	-0.316908408906476	0.804	0.882	3.04818059592605e-22	UBE2V2	Malignant cells	GSE131984_JQ1	ENSG00000169139	7336	ubiquitin conjugating enzyme E2 V2	DDVit-1|DDVIT1|EDAF-1|EDPF-1|EDPF1|MMS2|UEV-2|UEV2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38583
1.97790689803837e-26	0.338593467188927	0.427	0.237	3.20203347723432e-22	TP53I3	Malignant cells	GSE131984_JQ1	ENSG00000115129	9540	tumor protein p53 inducible protein 3	PIG3	protein_coding	Q53FA7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38584
1.99266823957146e-26	-0.262990979193201	1	1	3.22593061304223e-22	ACTG1	Malignant cells	GSE131984_JQ1	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38585
2.03187334131915e-26	-0.305011919916997	0.81	0.901	3.28939975226157e-22	DPY30	Malignant cells	GSE131984_JQ1	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38586
2.16093925376095e-26	-0.324279543143708	0.873	0.933	3.49834455791361e-22	PRDX3	Malignant cells	GSE131984_JQ1	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38587
2.35917214174867e-26	-0.286546678988563	0.243	0.437	3.81926378027692e-22	UBA5	Malignant cells	GSE131984_JQ1	ENSG00000081307	79876	ubiquitin like modifier activating enzyme 5	FLJ23251|UBE1DC1	protein_coding	Q9GZZ9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38588
2.46924251960983e-26	-0.360031420993555	0.804	0.873	3.99745671499636e-22	PSMG3	Malignant cells	GSE131984_JQ1	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38589
2.55244261135058e-26	-0.324079724019276	0.98	0.986	4.13214934351546e-22	TCP1	Malignant cells	GSE131984_JQ1	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38590
2.60091387702055e-26	-0.310384022168737	0.799	0.897	4.21061947550857e-22	BAX	Malignant cells	GSE131984_JQ1	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38591
2.7103908124064e-26	-0.332316197508534	0.284	0.476	4.38785168620473e-22	KDELR3	Malignant cells	GSE131984_JQ1	ENSG00000100196	11015	KDEL endoplasmic reticulum protein retention receptor 3	NA	protein_coding	O43731	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38592
2.76974364618079e-26	0.470507686142708	0.641	0.471	4.48393798880208e-22	DUSP6	Malignant cells	GSE131984_JQ1	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38593
2.85404655243723e-26	-0.264051797221454	0.137	0.303	4.62041596374063e-22	FAM216A	Malignant cells	GSE131984_JQ1	ENSG00000204856	29902	family with sequence similarity 216 member A	C12orf24|HSU79274	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38594
2.85595373409037e-26	-0.366711104587826	0.48	0.647	4.6235035001189e-22	YARS	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38595
2.95882707107132e-26	-0.346129059099837	0.449	0.645	4.79004514535735e-22	TRAPPC4	Malignant cells	GSE131984_JQ1	ENSG00000280495	51399	trafficking protein particle complex subunit 4	PTD009|SBDN|TRS23	protein_coding	Q9Y296	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38596
2.96157248731101e-26	0.295081829534768	0.353	0.171	4.7944896997078e-22	NXN	Malignant cells	GSE131984_JQ1	ENSG00000281300	64359	nucleoredoxin	FLJ12614|NRX	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38597
4.06039795651107e-26	-0.319795183196988	0.247	0.426	6.57337825179578e-22	MOK	Malignant cells	GSE131984_JQ1	ENSG00000080823	5891	MOK protein kinase	RAGE|RAGE1|STK30	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38598
4.19358332725008e-26	-0.329023525308916	0.828	0.895	6.78899204848516e-22	DNAJB6	Malignant cells	GSE131984_JQ1	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38599
4.20414796709989e-26	-0.307773880550212	0.312	0.497	6.80609514393801e-22	NDUFAF6	Malignant cells	GSE131984_JQ1	ENSG00000156170	137682	NADH:ubiquinone oxidoreductase complex assembly factor 6	C8orf38|MGC40214	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38600
4.37629830047926e-26	-0.299193632803028	0.286	0.477	7.08478931864588e-22	WARS	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38601
4.40323653527705e-26	0.253539884839475	0.999	0.999	7.12839962696002e-22	MT-ND2	Malignant cells	GSE131984_JQ1	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38602
4.62731476504934e-26	-0.334595715856989	0.801	0.891	7.49115987313837e-22	FAM3C	Malignant cells	GSE131984_JQ1	ENSG00000196937	10447	FAM3 metabolism regulating signaling molecule C	GS3876|ILEI	protein_coding	Q92520	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38603
5.06022328289836e-26	0.345046657477133	0.505	0.321	8.19199547268416e-22	UBE2D4	Malignant cells	GSE131984_JQ1	ENSG00000078967	51619	ubiquitin conjugating enzyme E2 D4 (putative)	HBUCE1	protein_coding	Q9Y2X8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38604
5.09288220889593e-26	-0.33480205976794	0.319	0.511	8.24486700798163e-22	TSFM	Malignant cells	GSE131984_JQ1	ENSG00000123297	10102	Ts translation elongation factor, mitochondrial	EF-TS|EF-Tsmt	protein_coding	P43897	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38605
5.28935899173977e-26	-0.297398875450289	0.174	0.348	8.56294327172752e-22	LAMB3	Malignant cells	GSE131984_JQ1	ENSG00000196878	3914	laminin subunit beta 3	BM600-125kDa|kalinin-140kDa|LAMNB1|nicein-125kDa	protein_coding	Q13751	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38606
6.24591338577822e-26	0.321867019248845	0.362	0.181	1.01115091802364e-21	LAMA5	Malignant cells	GSE131984_JQ1	ENSG00000130702	3911	laminin subunit alpha 5	NA	protein_coding	O15230	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38607
6.29216617425638e-26	-0.335705007440253	0.803	0.883	1.01863878195036e-21	VMA21	Malignant cells	GSE131984_JQ1	ENSG00000160131	203547	vacuolar ATPase assembly factor VMA21	MEAX|XMEA	protein_coding	Q3ZAQ7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38608
6.37239103417908e-26	-0.351699206790595	0.611	0.769	1.03162638452325e-21	MIR4435-1HG	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38609
7.64261961186908e-26	-0.340243140035947	0.356	0.543	1.23726368896549e-21	HAT1	Malignant cells	GSE131984_JQ1	ENSG00000128708	8520	histone acetyltransferase 1	KAT1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38610
8.15407631995204e-26	-0.328428842670123	0.842	0.926	1.32006341543704e-21	ARPC5L	Malignant cells	GSE131984_JQ1	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38611
8.37928860059184e-26	-0.439092272436876	0.391	0.558	1.35652303154981e-21	NME4	Malignant cells	GSE131984_JQ1	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38612
9.12656950539729e-26	0.307564442065717	1	1	1.47750033722877e-21	S100A10	Malignant cells	GSE131984_JQ1	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38613
9.72510278149192e-26	-0.266777516832902	1	1	1.57439688929573e-21	LDHA	Malignant cells	GSE131984_JQ1	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38614
1.00857820791516e-25	-0.281074316373554	0.937	0.979	1.63278726079386e-21	NDUFA12	Malignant cells	GSE131984_JQ1	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38615
1.05168314120872e-25	-0.328505019240731	0.893	0.957	1.70256983730279e-21	PSMC5	Malignant cells	GSE131984_JQ1	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38616
1.15901205612225e-25	0.317801779828151	0.502	0.309	1.87632461765632e-21	EIF4EBP2	Malignant cells	GSE131984_JQ1	ENSG00000148730	1979	eukaryotic translation initiation factor 4E binding protein 2	NA	protein_coding	Q13542	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38617
1.23213237539835e-25	-0.344463023537104	0.412	0.592	1.99469910253239e-21	UAP1	Malignant cells	GSE131984_JQ1	ENSG00000117143	6675	UDP-N-acetylglucosamine pyrophosphorylase 1	AgX|AGX1|SPAG2	protein_coding	Q16222	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38618
1.44782613022308e-25	-0.332938258655292	0.566	0.728	2.34388572221814e-21	SSBP4	Malignant cells	GSE131984_JQ1	ENSG00000130511	170463	single stranded DNA binding protein 4	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38619
1.50776055952881e-25	-0.395613985726725	0.62	0.75	2.44091356982118e-21	HEXB	Malignant cells	GSE131984_JQ1	ENSG00000049860	3074	hexosaminidase subunit beta	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38620
1.61521968045842e-25	0.357311905012002	0.588	0.402	2.61487914069413e-21	PCSK7	Malignant cells	GSE131984_JQ1	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38621
1.69374915215827e-25	-0.334494006603861	0.432	0.619	2.74201050242903e-21	LARS	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38622
1.84550113050931e-25	-0.347347341399209	0.604	0.752	2.98768178018152e-21	TEX264	Malignant cells	GSE131984_JQ1	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38623
1.8748045561503e-25	-0.300049541566082	0.359	0.555	3.03512109595173e-21	ABT1	Malignant cells	GSE131984_JQ1	ENSG00000146109	29777	activator of basal transcription 1	Esf2	protein_coding	Q9ULW3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38624
1.89723733224764e-25	-0.342304537602889	0.5	0.671	3.0714375171757e-21	ERO1L	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38625
2.16109032206262e-25	-0.268178249781616	0.111	0.266	3.49858912238718e-21	HHIP	Malignant cells	GSE131984_JQ1	ENSG00000164161	64399	hedgehog interacting protein	FLJ20992|HIP	protein_coding	Q96QV1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38626
2.20404758845414e-25	-0.337827053508883	0.319	0.51	3.56813264094841e-21	PSMC3IP	Malignant cells	GSE131984_JQ1	ENSG00000131470	29893	PSMC3 interacting protein	GT198|Hop2|HUMGT198A|TBPIP	protein_coding	Q9P2W1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38627
2.22239455579577e-25	-0.364992944363372	0.391	0.565	3.59783454637777e-21	RPP30	Malignant cells	GSE131984_JQ1	ENSG00000148688	10556	ribonuclease P/MRP subunit p30	TSG15	protein_coding	P78346	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38628
2.23009937059943e-25	0.318694115739188	0.921	0.842	3.61030787106342e-21	HDLBP	Malignant cells	GSE131984_JQ1	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38629
2.25279769706094e-25	-0.370635117525273	0.452	0.614	3.64705419177195e-21	THYN1	Malignant cells	GSE131984_JQ1	ENSG00000151500	29087	thymocyte nuclear protein 1	THY28	protein_coding	Q9P016	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38630
2.38458347299775e-25	-0.351959390931843	0.215	0.388	3.86040218443606e-21	LINC01133	Malignant cells	GSE131984_JQ1	ENSG00000224259	NA	NA	lncRNA-PAGBC	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38631
2.46128597037565e-25	-0.340686048143472	0.371	0.553	3.98457585744114e-21	MCMBP	Malignant cells	GSE131984_JQ1	ENSG00000197771	79892	minichromosome maintenance complex binding protein	C10orf119|FLJ13081|MCM-BP	protein_coding	Q9BTE3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38632
2.51531676501473e-25	0.340491178234815	0.546	0.367	4.07204631088234e-21	PNPLA2	Malignant cells	GSE131984_JQ1	ENSG00000177666	57104	patatin like phospholipase domain containing 2	ATGL|desnutrin|FP17548|iPLA2zeta|TTS-2.2	protein_coding	Q96AD5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38633
2.58165697294915e-25	-0.307348671733252	0.346	0.533	4.17944447350738e-21	RPP38	Malignant cells	GSE131984_JQ1	ENSG00000152464	10557	ribonuclease P/MRP subunit p38	NA	protein_coding	P78345	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38634
2.60958659710181e-25	-0.318654600700047	0.962	0.979	4.22465974204812e-21	C17orf89	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38635
2.69429461868432e-25	0.281476553055728	0.332	0.156	4.36179355818804e-21	KLF5	Malignant cells	GSE131984_JQ1	ENSG00000102554	688	KLF transcription factor 5	BTEB2|CKLF|IKLF	protein_coding	Q13887	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38636
3.19533888523953e-25	-0.341051739446222	0.344	0.529	5.17293412131427e-21	DCPS	Malignant cells	GSE131984_JQ1	ENSG00000110063	28960	decapping enzyme, scavenger	HINT-5|HINT5|HSL1|HSPC015	protein_coding	Q96C86	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38637
3.29462289176631e-25	-0.307609125282324	0.742	0.848	5.33366499948048e-21	UBE2K	Malignant cells	GSE131984_JQ1	ENSG00000078140	3093	ubiquitin conjugating enzyme E2 K	HIP2|HYPG|UBC1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38638
3.54227407906519e-25	-0.332719659533201	0.73	0.841	5.73458750659864e-21	ADSL	Malignant cells	GSE131984_JQ1	ENSG00000239900	158	adenylosuccinate lyase	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38639
4.06343654115723e-25	-0.292767269353638	0.949	0.983	6.57829741647943e-21	EIF3M	Malignant cells	GSE131984_JQ1	ENSG00000149100	10480	eukaryotic translation initiation factor 3 subunit M	FLJ29030|GA17|hfl-B5|PCID1|TANGO7	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38640
4.51906518463118e-25	-0.377976280697523	0.333	0.509	7.31591462739941e-21	SAP30	Malignant cells	GSE131984_JQ1	ENSG00000164105	8819	Sin3A associated protein 30	NA	protein_coding	O75446	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38641
4.67309241713441e-25	-0.250496691637982	0.105	0.256	7.56526931409889e-21	SMCO4	Malignant cells	GSE131984_JQ1	ENSG00000166002	56935	single-pass membrane protein with coiled-coil domains 4	C11orf75|FN5	protein_coding	Q9NRQ5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38642
5.0335222250423e-25	-0.329764120508361	0.787	0.873	8.14876913012098e-21	SYNCRIP	Malignant cells	GSE131984_JQ1	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38643
5.2059145327352e-25	-0.263158083174549	0.125	0.281	8.42785503704502e-21	CDC45	Malignant cells	GSE131984_JQ1	ENSG00000093009	8318	cell division cycle 45	CDC45L|CDC45L2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38644
5.42348895121812e-25	-0.339036360065992	0.405	0.586	8.78008626312701e-21	KIF9	Malignant cells	GSE131984_JQ1	ENSG00000088727	64147	kinesin family member 9	MGC104186	protein_coding	Q9HAQ2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38645
5.44501019477555e-25	-0.346264536016884	0.413	0.587	8.81492700432214e-21	TMX2	Malignant cells	GSE131984_JQ1	ENSG00000213593	51075	thioredoxin related transmembrane protein 2	PDIA12|TXNDC14	protein_coding	Q9Y320	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38646
5.79220643648146e-25	-0.276312579043858	0.217	0.397	9.37700300001983e-21	MSRB3	Malignant cells	GSE131984_JQ1	ENSG00000174099	253827	methionine sulfoxide reductase B3	DFNB74|DKFZp686C1178|FLJ36866	protein_coding	Q8IXL7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38647
6.72959912602389e-25	-0.310689236665903	0.627	0.779	1.08945480251201e-20	CRLS1	Malignant cells	GSE131984_JQ1	ENSG00000088766	54675	cardiolipin synthase 1	C20orf155|CLS1|dJ967N21.6|GCD10	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38648
6.82469242094456e-25	-0.316218838483541	0.394	0.577	1.10484945602672e-20	TMEM237	Malignant cells	GSE131984_JQ1	ENSG00000155755	65062	transmembrane protein 237	ALS2CR4|JBTS14	protein_coding	Q96Q45	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38649
6.82893450474726e-25	-0.295595932109431	0.256	0.44	1.10553620697353e-20	CLMP	Malignant cells	GSE131984_JQ1	ENSG00000166250	79827	CXADR like membrane protein	ACAM|ASAM|FLJ22415	protein_coding	Q9H6B4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38650
6.83533531152997e-25	-0.286650727031895	0.188	0.361	1.10657243358359e-20	PLEKHO1	Malignant cells	GSE131984_JQ1	ENSG00000023902	51177	pleckstrin homology domain containing O1	CKIP-1|OC120	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38651
7.19051465018885e-25	-0.307035149325133	0.261	0.442	1.16407241671907e-20	PPARG	Malignant cells	GSE131984_JQ1	ENSG00000132170	5468	peroxisome proliferator activated receptor gamma	NR1C3|PPARG1|PPARG2|PPARgamma	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38652
7.39366486488395e-25	0.293062778226621	0.994	0.987	1.19696040497606e-20	COX6A1	Malignant cells	GSE131984_JQ1	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38653
7.44104799506182e-25	-0.334136059523394	0.592	0.741	1.20463125992056e-20	MANBAL	Malignant cells	GSE131984_JQ1	ENSG00000101363	63905	mannosidase beta like	dJ1141E15.2	protein_coding	Q9NQG1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38654
7.69571280590113e-25	-0.317765006393708	0.341	0.518	1.24585894614733e-20	CIAPIN1	Malignant cells	GSE131984_JQ1	ENSG00000005194	57019	cytokine induced apoptosis inhibitor 1	CIAE2	protein_coding	Q6FI81	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38655
7.79589799251524e-25	-0.352356147391763	0.502	0.665	1.26207792600829e-20	DRG1	Malignant cells	GSE131984_JQ1	ENSG00000185721	4733	developmentally regulated GTP binding protein 1	NEDD3	protein_coding	Q9Y295	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38656
8.13102009389491e-25	-0.316012212010579	0.916	0.953	1.31633084300065e-20	C11orf58	Malignant cells	GSE131984_JQ1	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38657
9.73557896108489e-25	-0.321263692833616	0.396	0.572	1.57609287801003e-20	MRPS18A	Malignant cells	GSE131984_JQ1	ENSG00000096080	55168	mitochondrial ribosomal protein S18A	FLJ10548|MRPS18-3	protein_coding	Q9NVS2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38658
1.02911291176954e-24	-0.326633827245272	0.383	0.558	1.66603089286371e-20	TOR1A	Malignant cells	GSE131984_JQ1	ENSG00000136827	1861	torsin family 1 member A	DQ2|DYT1	protein_coding	O14656	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38659
1.0433348871313e-24	-0.363829939620159	0.693	0.799	1.68905484877686e-20	RUVBL2	Malignant cells	GSE131984_JQ1	ENSG00000183207	10856	RuvB like AAA ATPase 2	ECP51|INO80J|Reptin52|RVB2|TIH2|TIP48|TIP49b	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38660
1.09861181811755e-24	-0.358006759813912	0.175	0.342	1.7785426723505e-20	ATF3	Malignant cells	GSE131984_JQ1	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38661
1.148502799508e-24	-0.337777924617164	0.704	0.828	1.8593111821235e-20	EIF3J	Malignant cells	GSE131984_JQ1	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38662
1.16064849468699e-24	-0.337304645124744	0.563	0.72	1.87897384804876e-20	NIPA2	Malignant cells	GSE131984_JQ1	ENSG00000140157	81614	NIPA magnesium transporter 2	SLC57A2	protein_coding	Q8N8Q9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38663
1.19960504812798e-24	0.346152594703303	0.942	0.879	1.94204061241438e-20	ZFP36L1	Malignant cells	GSE131984_JQ1	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38664
1.31481079952391e-24	0.356832975739813	0.999	0.997	2.12854720334925e-20	IRX2	Malignant cells	GSE131984_JQ1	ENSG00000170561	153572	iroquois homeobox 2	NA	protein_coding	Q9BZI1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38665
1.38386213072291e-24	-0.341906752180059	0.698	0.813	2.24033440342731e-20	TMEM165	Malignant cells	GSE131984_JQ1	ENSG00000134851	55858	transmembrane protein 165	GDT1|SLC64A1|TMPT27|TPARL	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38666
1.50311478020627e-24	0.337091848628343	0.675	0.506	2.43339251767592e-20	C5orf55	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38667
1.52608832580099e-24	-0.288386525346915	0.129	0.284	2.47058439063922e-20	ADAMTS9	Malignant cells	GSE131984_JQ1	ENSG00000163638	56999	ADAM metallopeptidase with thrombospondin type 1 motif 9	KIAA1312	protein_coding	Q9P2N4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38668
1.73068792456209e-24	-0.454026708600312	0.332	0.519	2.80181068107356e-20	AURKA	Malignant cells	GSE131984_JQ1	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38669
1.76421334929412e-24	-0.345141141077621	0.417	0.589	2.85608499117225e-20	WDR43	Malignant cells	GSE131984_JQ1	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38670
1.80103200497578e-24	-0.334840032297781	0.87	0.929	2.91569071285528e-20	SEPT7	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38671
1.80451433843248e-24	-0.316399688781327	0.504	0.673	2.92132826248833e-20	PKIG	Malignant cells	GSE131984_JQ1	ENSG00000168734	11142	cAMP-dependent protein kinase inhibitor gamma	NA	protein_coding	Q9Y2B9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38672
1.8111845725773e-24	-0.349128723847715	0.516	0.668	2.9321267045454e-20	IDH3B	Malignant cells	GSE131984_JQ1	ENSG00000101365	3420	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta	RP46	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38673
1.8658606019931e-24	-0.370615205924405	0.712	0.872	3.02064172856664e-20	HMGB2	Malignant cells	GSE131984_JQ1	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38674
2.36177383597816e-24	-0.356285316334633	0.465	0.633	3.82347566306505e-20	MRPS28	Malignant cells	GSE131984_JQ1	ENSG00000147586	28957	mitochondrial ribosomal protein S28	HSPC007|MRP-S28|MRPS35	protein_coding	Q9Y2Q9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38675
2.59233382441062e-24	-0.331371307836817	0.656	0.783	4.19672922833835e-20	DESI1	Malignant cells	GSE131984_JQ1	ENSG00000100418	27351	desumoylating isopeptidase 1	D15Wsu75e|DESI-1|FAM152B|POST|PPPDE2	protein_coding	Q6ICB0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38676
2.97727865098103e-24	-0.370550247762144	0.625	0.749	4.81991640807319e-20	YDJC	Malignant cells	GSE131984_JQ1	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38677
3.32912903327072e-24	-0.295412853853663	0.293	0.474	5.38952699196196e-20	FIP1L1	Malignant cells	GSE131984_JQ1	ENSG00000145216	81608	factor interacting with PAPOLA and CPSF1	DKFZp586K0717|FIP1|hFip1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38678
3.34123922405041e-24	-0.352267955801137	0.56	0.704	5.40913217981521e-20	FRA10AC1	Malignant cells	GSE131984_JQ1	ENSG00000148690	118924	FRA10A associated CGG repeat 1	C10orf4	protein_coding	Q70Z53	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38679
3.69792194214486e-24	-0.266508973467828	0.174	0.339	5.98656583213832e-20	ICAM3	Malignant cells	GSE131984_JQ1	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38680
3.92179330980873e-24	-0.33045132587402	0.419	0.596	6.34899118924935e-20	FARSB	Malignant cells	GSE131984_JQ1	ENSG00000116120	10056	phenylalanyl-tRNA synthetase subunit beta	FARSLB|FRSB|PheHB	protein_coding	Q9NSD9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38681
4.08321761922696e-24	-0.269804676069739	0.192	0.363	6.61032100376653e-20	SCRN2	Malignant cells	GSE131984_JQ1	ENSG00000141295	90507	secernin 2	NA	protein_coding	Q96FV2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38682
4.177454334064e-24	-0.302853960429207	0.312	0.493	6.76288082141621e-20	TSR1	Malignant cells	GSE131984_JQ1	ENSG00000167721	55720	TSR1 ribosome maturation factor	FLJ10534	protein_coding	Q2NL82	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38683
4.84217498545295e-24	0.343517904706244	0.45	0.27	7.83899708394978e-20	SEMA3C	Malignant cells	GSE131984_JQ1	ENSG00000075223	10512	semaphorin 3C	SEMAE|SemE	protein_coding	Q99985	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38684
4.87428953332607e-24	-0.320586676532047	0.787	0.865	7.89098732550157e-20	PDXK	Malignant cells	GSE131984_JQ1	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38685
5.26145542553245e-24	0.275528913897266	0.978	0.949	8.51777018839448e-20	GLTSCR2	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38686
5.35987960782484e-24	-0.26930746938492	0.229	0.409	8.67710909710763e-20	AGAP2-AS1	Malignant cells	GSE131984_JQ1	ENSG00000255737	100130776	AGAP2 antisense RNA 1	LOC100130776|PUNISHER	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38687
5.43384313874908e-24	-0.269733257884136	0.207	0.377	8.79684865732088e-20	RCHY1	Malignant cells	GSE131984_JQ1	ENSG00000163743	25898	ring finger and CHY zinc finger domain containing 1	ARNIP|CHIMP|DKFZp586C1620|PIRH2|PRO1996|RNF199|ZCHY|ZNF363	protein_coding	Q96PM5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38688
5.55385155260351e-24	-0.345156111685661	0.496	0.671	8.99113027850983e-20	NETO2	Malignant cells	GSE131984_JQ1	ENSG00000171208	81831	neuropilin and tolloid like 2	FLJ10430|NEOT2	protein_coding	Q8NC67	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38689
5.74906036189547e-24	-0.302895608588183	0.281	0.459	9.30715381987258e-20	NUP54	Malignant cells	GSE131984_JQ1	ENSG00000138750	53371	nucleoporin 54	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38690
6.19892637792849e-24	-0.367614655084782	0.649	0.756	1.00354419132284e-19	SSSCA1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38691
6.62327977747491e-24	-0.272268547695151	0.167	0.331	1.07224276317541e-19	HDHD1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38692
6.79434474482027e-24	-0.326418734204433	0.739	0.849	1.09993647073895e-19	SRP19	Malignant cells	GSE131984_JQ1	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38693
7.09177374611351e-24	-0.28115581647802	0.953	0.981	1.14808725175832e-19	ATP6V0E1	Malignant cells	GSE131984_JQ1	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38694
7.16504927418328e-24	-0.253064075986313	0.974	0.988	1.15994982699753e-19	SIVA1	Malignant cells	GSE131984_JQ1	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38695
7.40515200491365e-24	-0.323490585339358	0.793	0.889	1.19882005807547e-19	PTS	Malignant cells	GSE131984_JQ1	ENSG00000150787	5805	6-pyruvoyltetrahydropterin synthase	PTPS	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38696
7.4723050892374e-24	-0.352700872545838	0.642	0.763	1.20969147089664e-19	DDOST	Malignant cells	GSE131984_JQ1	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38697
7.96455761598083e-24	-0.330827404086087	0.401	0.57	1.28938223245114e-19	UCHL5	Malignant cells	GSE131984_JQ1	ENSG00000116750	51377	ubiquitin C-terminal hydrolase L5	CGI-70|INO80R|UCH37	protein_coding	Q9Y5K5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38698
8.19424801300011e-24	-0.365488843103037	0.523	0.674	1.32656681082459e-19	HM13	Malignant cells	GSE131984_JQ1	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38699
8.20554579153844e-24	-0.312692769290875	0.353	0.533	1.32839580819216e-19	C8orf88	Malignant cells	GSE131984_JQ1	ENSG00000253250	100127983	chromosome 8 open reading frame 88	NA	protein_coding	P0DMB2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38700
8.24207667208193e-24	-0.348747964501029	0.249	0.428	1.33430979244334e-19	DEPDC1	Malignant cells	GSE131984_JQ1	ENSG00000024526	55635	DEP domain containing 1	DEP.8|DEPDC1A|FLJ20354|SDP35	protein_coding	Q5TB30	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38701
8.41177524647248e-24	-0.315444362376515	0.323	0.515	1.36178229465143e-19	DBF4	Malignant cells	GSE131984_JQ1	ENSG00000006634	10926	DBF4 zinc finger	ASK|chif|DBF4A|ZDBF1	protein_coding	Q9UBU7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38702
9.28237698167973e-24	0.334037753864107	0.46	0.284	1.50272400956413e-19	DLG5	Malignant cells	GSE131984_JQ1	ENSG00000274429	9231	discs large MAGUK scaffold protein 5	KIAA0583|P-dlg	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38703
9.64832434032541e-24	-0.317172467776068	0.712	0.817	1.56196722745528e-19	RAB5C	Malignant cells	GSE131984_JQ1	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38704
9.88838259881469e-24	-0.323568024014839	0.767	0.861	1.60083025892211e-19	BZW2	Malignant cells	GSE131984_JQ1	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38705
1.06948596618724e-23	-0.297000698569874	0.263	0.443	1.73139083066053e-19	ASPHD1	Malignant cells	GSE131984_JQ1	ENSG00000174939	253982	aspartate beta-hydroxylase domain containing 1	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38706
1.15558832144608e-23	-0.312711579018142	0.49	0.662	1.87078193358907e-19	ING2	Malignant cells	GSE131984_JQ1	ENSG00000168556	3622	inhibitor of growth family member 2	ING1L|p33ING2	protein_coding	Q9H160	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38707
1.26092614084583e-23	-0.325055142910823	0.715	0.825	2.04131332941531e-19	JAGN1	Malignant cells	GSE131984_JQ1	ENSG00000171135	84522	jagunal homolog 1	FLJ14602|GL009	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38708
1.50996192829019e-23	-0.286183658007234	0.986	0.998	2.44447736570899e-19	RTN4	Malignant cells	GSE131984_JQ1	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38709
1.53942490604279e-23	-0.290807383335872	0.898	0.942	2.49217498039267e-19	MRPS36	Malignant cells	GSE131984_JQ1	ENSG00000278461	92259	mitochondrial ribosomal protein S36	DC47|MRP-S36	protein_coding	P82909	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38710
1.59477819147941e-23	-0.344288718934799	0.327	0.498	2.58178641418601e-19	CMTM8	Malignant cells	GSE131984_JQ1	ENSG00000170293	152189	CKLF like MARVEL transmembrane domain containing 8	CKLFSF8	protein_coding	Q8IZV2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38711
1.62637547693442e-23	-0.309401023550939	0.392	0.571	2.63293925960914e-19	PREB	Malignant cells	GSE131984_JQ1	ENSG00000138073	10113	prolactin regulatory element binding	SEC12	protein_coding	Q9HCU5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38712
1.62714907894359e-23	-0.318680286920137	0.623	0.774	2.63419164390178e-19	SHISA5	Malignant cells	GSE131984_JQ1	ENSG00000164054	51246	shisa family member 5	hShisa5|SCOTIN	protein_coding	Q8N114	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38713
1.7701155185403e-23	-0.327116808810622	0.704	0.806	2.86564001296488e-19	LIMS1	Malignant cells	GSE131984_JQ1	ENSG00000169756	3987	LIM zinc finger domain containing 1	PINCH|PINCH1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38714
1.87135362383737e-23	-0.295098769164017	0.576	0.759	3.02953438163032e-19	TROAP	Malignant cells	GSE131984_JQ1	ENSG00000135451	10024	trophinin associated protein	TASTIN	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38715
1.92496977907835e-23	-0.370707898539658	0.584	0.709	3.11633357534993e-19	ANP32A	Malignant cells	GSE131984_JQ1	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38716
2.0967073006888e-23	0.254889184761642	0.327	0.155	3.39435944908509e-19	SDC2	Malignant cells	GSE131984_JQ1	ENSG00000169439	6383	syndecan 2	CD362|fibroglycan|HSPG|HSPG1|SYND2	protein_coding	P34741	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38717
2.42103936073686e-23	-0.328281815994114	0.556	0.703	3.9194206210969e-19	CCDC12	Malignant cells	GSE131984_JQ1	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38718
2.75628368357015e-23	-0.325135203951149	0.678	0.801	4.46214765533171e-19	ELAVL1	Malignant cells	GSE131984_JQ1	ENSG00000066044	1994	ELAV like RNA binding protein 1	Hua|HUR|MelG	protein_coding	Q15717	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38719
2.82277908490061e-23	-0.3551620673914	0.56	0.71	4.5697970605456e-19	POLR2G	Malignant cells	GSE131984_JQ1	ENSG00000168002	5436	RNA polymerase II subunit G	hRPB19|hsRPB7|RPB7	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38720
3.08535133716338e-23	-0.27273106683996	0.195	0.362	4.9948752797338e-19	RP11-879F14.2	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38721
3.17621212244164e-23	0.311783897062343	0.399	0.222	5.14196980502078e-19	AMOTL2	Malignant cells	GSE131984_JQ1	ENSG00000114019	51421	angiomotin like 2	LCCP	protein_coding	Q9Y2J4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38722
3.25992202694554e-23	0.32504295097696	0.628	0.464	5.27748776942213e-19	RP11-792A8.4	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38723
3.46948515464609e-23	-0.314673065625105	0.522	0.681	5.61674951685656e-19	AKR1A1	Malignant cells	GSE131984_JQ1	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38724
3.5431106342242e-23	-0.350021350040802	0.511	0.667	5.73594180574555e-19	STK17A	Malignant cells	GSE131984_JQ1	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38725
3.92228098204961e-23	-0.299333989414614	0.489	0.672	6.34978068184011e-19	SLC52A2	Malignant cells	GSE131984_JQ1	ENSG00000285112	79581	solute carrier family 52 member 2	D15Ertd747e|FLJ11856|GPCR41|GPR172A|hRFT3|PAR1|RFVT2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38726
4.19286460055861e-23	-0.336818395161699	0.417	0.597	6.78782850184433e-19	CENPK	Malignant cells	GSE131984_JQ1	ENSG00000123219	64105	centromere protein K	CENP-K|FKSG14|SOLT	protein_coding	Q9BS16	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38727
4.24985037045145e-23	-0.296474939049707	0.964	0.978	6.88008276472385e-19	CD99	Malignant cells	GSE131984_JQ1	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38728
4.33499931982708e-23	-0.320979459973981	0.812	0.893	7.01793039886807e-19	ETFA	Malignant cells	GSE131984_JQ1	ENSG00000140374	2108	electron transfer flavoprotein subunit alpha	EMA|GA2|MADD	protein_coding	P13804	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38729
4.47681869818729e-23	-0.301269408694321	0.484	0.655	7.2475217904954e-19	ITGB3BP	Malignant cells	GSE131984_JQ1	ENSG00000142856	23421	integrin subunit beta 3 binding protein	CENPR|HSU37139|NRIF3|TAP20	protein_coding	Q13352	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38730
5.01041264899988e-23	-0.387576700946292	0.363	0.517	8.11135703746591e-19	CCNH	Malignant cells	GSE131984_JQ1	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38731
5.2665851745269e-23	-0.334395152563512	0.381	0.551	8.52607473904159e-19	ZNF622	Malignant cells	GSE131984_JQ1	ENSG00000173545	90441	zinc finger protein 622	MGC17552|MGC2485|ZPR9	protein_coding	Q969S3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38732
5.60799569170655e-23	-0.323767870078319	0.807	0.863	9.07878422530373e-19	ECI2	Malignant cells	GSE131984_JQ1	ENSG00000198721	10455	enoyl-CoA delta isomerase 2	ACBD2|DRS1|HCA88|PECI	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38733
5.845992816083e-23	-0.274950323730056	0.849	0.924	9.46407776995676e-19	MRPS6	Malignant cells	GSE131984_JQ1	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38734
5.90157148047469e-23	-0.317253950378868	0.589	0.736	9.55405406974048e-19	SDHD	Malignant cells	GSE131984_JQ1	ENSG00000204370	6392	succinate dehydrogenase complex subunit D	cybS|PGL|PGL1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38735
6.09480978369589e-23	-0.325634527819214	0.396	0.56	9.86688755882528e-19	HRSP12	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38736
6.43790159638139e-23	-0.319576556430678	0.438	0.608	1.04223188943818e-18	RDH11	Malignant cells	GSE131984_JQ1	ENSG00000072042	51109	retinol dehydrogenase 11	ARSDR1|MDT1|SDR7C1	protein_coding	Q8TC12	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38737
6.64679081990122e-23	-0.349322356670781	0.445	0.604	1.07604896583381e-18	TMEM11	Malignant cells	GSE131984_JQ1	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38738
7.55331275246365e-23	-0.251991861210655	0.955	0.98	1.22280580149634e-18	NDUFB3	Malignant cells	GSE131984_JQ1	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38739
8.41075413012376e-23	-0.31653704353048	0.337	0.516	1.36161698612574e-18	GPSM2	Malignant cells	GSE131984_JQ1	ENSG00000121957	29899	G protein signaling modulator 2	DFNB82|LGN|Pins	protein_coding	P81274	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38740
9.33285987630419e-23	-0.258853711322587	0.247	0.426	1.51089668537489e-18	RFC5	Malignant cells	GSE131984_JQ1	ENSG00000111445	5985	replication factor C subunit 5	RFC36	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38741
1.05124461849407e-22	-0.299427392372386	0.358	0.535	1.70185991288006e-18	ASB1	Malignant cells	GSE131984_JQ1	ENSG00000065802	51665	ankyrin repeat and SOCS box containing 1	ASB-1	protein_coding	Q9Y576	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38742
1.08947816030201e-22	-0.333028766880282	0.369	0.535	1.76375619371293e-18	HSPA4	Malignant cells	GSE131984_JQ1	ENSG00000170606	3308	heat shock protein family A (Hsp70) member 4	HS24/P52|HSPH2	protein_coding	P34932	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38743
1.19455414914111e-22	-0.335209561149037	0.459	0.633	1.93386371204454e-18	ZWINT	Malignant cells	GSE131984_JQ1	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38744
1.21826337470471e-22	-0.263532335429085	0.247	0.421	1.97224657730946e-18	PDHX	Malignant cells	GSE131984_JQ1	ENSG00000110435	8050	pyruvate dehydrogenase complex component X	DLDBP|E3BP|OPDX|PDX1|proX	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38745
1.27579007536518e-22	0.25292715457314	0.331	0.161	2.0653765530087e-18	ZCCHC24	Malignant cells	GSE131984_JQ1	ENSG00000165424	219654	zinc finger CCHC-type containing 24	C10orf56|FLJ90798|Z3CXXC8	protein_coding	Q8N2G6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38746
1.28374154838448e-22	-0.336828709445969	0.383	0.544	2.07824919267963e-18	GOSR2	Malignant cells	GSE131984_JQ1	ENSG00000108433	9570	golgi SNAP receptor complex member 2	Bos1|GS27	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38747
1.29870612904149e-22	-0.300793677584123	0.872	0.926	2.10247535230527e-18	BZW1	Malignant cells	GSE131984_JQ1	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38748
1.3843877637497e-22	0.305856124527064	0.881	0.789	2.24118535073439e-18	UROS	Malignant cells	GSE131984_JQ1	ENSG00000188690	7390	uroporphyrinogen III synthase	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38749
1.48259721793663e-22	-0.351249815409035	0.899	0.961	2.40017663611761e-18	CKS2	Malignant cells	GSE131984_JQ1	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38750
1.50814723884877e-22	-0.290313755654444	0.764	0.858	2.44153956497228e-18	EFHD2	Malignant cells	GSE131984_JQ1	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38751
1.78466563872461e-22	0.313385933365089	0.502	0.325	2.88919520253128e-18	PCYOX1	Malignant cells	GSE131984_JQ1	ENSG00000116005	51449	prenylcysteine oxidase 1	KIAA0908|PCL1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38752
1.93754476291971e-22	-0.292391854592415	0.25	0.42	3.13669121669072e-18	C14orf80	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38753
1.95126962698683e-22	0.311133180214927	0.604	0.445	3.15891039912898e-18	FAM210B	Malignant cells	GSE131984_JQ1	ENSG00000124098	116151	family with sequence similarity 210 member B	C20orf108|dJ1167H4.1|DKFZP434A1114	protein_coding	Q96KR6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38754
1.9654430369233e-22	-0.318476473832665	0.358	0.524	3.18185573247513e-18	PRPSAP1	Malignant cells	GSE131984_JQ1	ENSG00000161542	5635	phosphoribosyl pyrophosphate synthetase associated protein 1	PAP39	protein_coding	Q14558	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38755
1.97233427255348e-22	-0.349000958754368	0.447	0.609	3.19301195383683e-18	ARL1	Malignant cells	GSE131984_JQ1	ENSG00000120805	400	ADP ribosylation factor like GTPase 1	ARFL1	protein_coding	P40616	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38756
2.02306214432347e-22	0.265532342737923	0.289	0.13	3.27513530544527e-18	OSBPL5	Malignant cells	GSE131984_JQ1	ENSG00000021762	114879	oxysterol binding protein like 5	KIAA1534|OBPH1|ORP5	protein_coding	Q9H0X9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38757
2.02794245412032e-22	-0.387473753649237	0.56	0.696	3.28303603897539e-18	AIMP2	Malignant cells	GSE131984_JQ1	ENSG00000106305	7965	aminoacyl tRNA synthetase complex interacting multifunctional protein 2	JTV-1|JTV1|p38|PRO0992	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38758
2.14979202031129e-22	-0.306141974330325	0.312	0.485	3.48029830168195e-18	C14orf142	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38759
2.1644399755212e-22	-0.267344810667629	0.877	0.935	3.50401187637127e-18	DNAJC19	Malignant cells	GSE131984_JQ1	ENSG00000205981	131118	DnaJ heat shock protein family (Hsp40) member C19	Pam18|Tim14|TIMM14	protein_coding	Q96DA6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38760
2.23509388551587e-22	-0.340701888344539	0.465	0.619	3.61839349126164e-18	C1orf35	Malignant cells	GSE131984_JQ1	ENSG00000143793	79169	chromosome 1 open reading frame 35	MGC4174|MMTAG2	protein_coding	Q9BU76	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38761
2.35559122536936e-22	-0.313054660271029	0.528	0.69	3.81346663475046e-18	MRPL50	Malignant cells	GSE131984_JQ1	ENSG00000136897	54534	mitochondrial ribosomal protein L50	FLJ20493|MRP-L50	protein_coding	Q8N5N7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38762
2.51823050693206e-22	-0.255352333399552	0.972	0.989	4.07676336767231e-18	TMED2	Malignant cells	GSE131984_JQ1	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38763
2.77633346249286e-22	-0.269355756101485	0.299	0.475	4.49460624242969e-18	ALKBH3	Malignant cells	GSE131984_JQ1	ENSG00000166199	221120	alkB homolog 3, alpha-ketoglutarate dependent dioxygenase	DEPC-1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38764
2.81145178612501e-22	-0.316951297988515	0.697	0.819	4.55145929655778e-18	SMARCB1	Malignant cells	GSE131984_JQ1	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38765
2.99311100464896e-22	-0.316638594851602	0.574	0.713	4.84554740542621e-18	VPS4A	Malignant cells	GSE131984_JQ1	ENSG00000132612	27183	vacuolar protein sorting 4 homolog A	FLJ22197|SKD1|SKD1A|SKD2|VPS4|VPS4-1	protein_coding	Q9UN37	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38766
3.12443582781225e-22	-0.269275186744905	0.181	0.339	5.05814916164525e-18	RNASEH1-AS1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38767
3.26286538087156e-22	-0.321569866817941	0.384	0.55	5.28225276509297e-18	ATIC	Malignant cells	GSE131984_JQ1	ENSG00000138363	471	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	AICARFT|IMPCHASE|PURH	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38768
3.26436519569916e-22	-0.269232249392494	0.242	0.406	5.28468081531737e-18	CIRH1A	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38769
3.31526450750122e-22	-0.278421036903341	0.872	0.931	5.36708171119372e-18	LINC00493	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38770
3.37894433785589e-22	-0.294526851011447	0.431	0.61	5.4701729885549e-18	PEX2	Malignant cells	GSE131984_JQ1	ENSG00000164751	5828	peroxisomal biogenesis factor 2	PAF-1|PMP35|PXMP3|RNF72|ZWS3	protein_coding	P28328	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38771
3.41880574215367e-22	-0.325179658411085	0.357	0.53	5.53470461597257e-18	DYNC1LI1	Malignant cells	GSE131984_JQ1	ENSG00000144635	51143	dynein cytoplasmic 1 light intermediate chain 1	DNCLI1	protein_coding	Q9Y6G9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38772
3.51847108721731e-22	-0.314312105067815	0.992	0.994	5.6960528430961e-18	IER3	Malignant cells	GSE131984_JQ1	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38773
3.77458227577677e-22	-0.313090704038385	0.417	0.59	6.11067124625501e-18	ACTL6A	Malignant cells	GSE131984_JQ1	ENSG00000136518	86	actin like 6A	Actl6|Arp4|BAF53A|INO80K|SMARCN1	protein_coding	O96019	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38774
3.8541689852492e-22	-0.352298961830451	0.725	0.818	6.23951417021993e-18	RAB11A	Malignant cells	GSE131984_JQ1	ENSG00000103769	8766	RAB11A, member RAS oncogene family	YL8	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38775
3.90355792328996e-22	-0.32498680278335	0.5	0.67	6.31946992201412e-18	TFAM	Malignant cells	GSE131984_JQ1	ENSG00000108064	7019	transcription factor A, mitochondrial	TCF6|TCF6L2	protein_coding	Q00059	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38776
4.17984321486041e-22	-0.277875942034892	1	1	6.76674818053752e-18	LDHB	Malignant cells	GSE131984_JQ1	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38777
4.20250260557571e-22	-0.311784445286368	0.728	0.824	6.80343146816652e-18	PSMG2	Malignant cells	GSE131984_JQ1	ENSG00000128789	56984	proteasome assembly chaperone 2	CLAST3|HCCA3|HsT1707|MDS003|MGC15092|PAC2|TNFSF5IP1	protein_coding	Q969U7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38778
4.28201673338933e-22	-0.310161351344635	0.792	0.887	6.93215688968398e-18	CHPT1	Malignant cells	GSE131984_JQ1	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38779
4.33055162449536e-22	-0.257890647583558	0.203	0.374	7.01073002489553e-18	UBBP4	Malignant cells	GSE131984_JQ1	ENSG00000263563	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38780
4.38852553514847e-22	0.330049692486318	0.667	0.5	7.10458398885185e-18	LASP1	Malignant cells	GSE131984_JQ1	ENSG00000002834	3927	LIM and SH3 protein 1	Lasp-1|MLN50	protein_coding	Q14847	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38781
4.48296032272731e-22	-0.28482230377469	0.301	0.471	7.25746446646324e-18	THOC3	Malignant cells	GSE131984_JQ1	ENSG00000051596	84321	THO complex subunit 3	MGC5469|TEX1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38782
4.5135207383017e-22	-0.294734348348153	0.502	0.676	7.30693872323662e-18	STARD3NL	Malignant cells	GSE131984_JQ1	ENSG00000010270	83930	STARD3 N-terminal like	MENTHO|MGC3251	protein_coding	O95772	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38783
4.64642533018052e-22	-0.269322635858409	0.341	0.518	7.52209796702925e-18	MYO1B	Malignant cells	GSE131984_JQ1	ENSG00000128641	4430	myosin IB	myr1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38784
4.6774339180817e-22	-0.365596713854067	0.483	0.63	7.57229776998246e-18	BCAS2	Malignant cells	GSE131984_JQ1	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38785
4.73640067162557e-22	-0.333757484305412	0.49	0.653	7.66775904729463e-18	EEA1	Malignant cells	GSE131984_JQ1	ENSG00000102189	8411	early endosome antigen 1	ZFYVE2	protein_coding	Q15075	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38786
5.0084927654669e-22	-0.275196195661852	0.21	0.373	8.10824893801437e-18	MOSPD1	Malignant cells	GSE131984_JQ1	ENSG00000101928	56180	motile sperm domain containing 1	dJ473B4	protein_coding	Q9UJG1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38787
5.12302142802257e-22	-0.276540295095296	0.309	0.483	8.29365938982574e-18	SF3B4	Malignant cells	GSE131984_JQ1	ENSG00000143368	10262	splicing factor 3b subunit 4	Hsh49|SAP49|SF3b49	protein_coding	Q15427	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38788
5.18751309286656e-22	-0.295028155743654	0.245	0.408	8.39806494604167e-18	PNP	Malignant cells	GSE131984_JQ1	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38789
5.2115180764769e-22	-0.290232639486421	0.571	0.732	8.43692661400845e-18	BRMS1	Malignant cells	GSE131984_JQ1	ENSG00000174744	25855	BRMS1 transcriptional repressor and anoikis regulator	DKFZP564A063	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38790
5.35208834416644e-22	-0.34434058109325	0.588	0.726	8.66449582037106e-18	MESDC2	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38791
5.74816568704531e-22	-0.35770051221357	0.596	0.717	9.30570543075765e-18	EIF1B	Malignant cells	GSE131984_JQ1	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38792
6.04725798371979e-22	0.350193324594938	0.623	0.465	9.78990594984396e-18	PIK3R1	Malignant cells	GSE131984_JQ1	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38793
6.97746707881373e-22	-0.311937977582669	0.833	0.894	1.12958214538915e-17	SF3B2	Malignant cells	GSE131984_JQ1	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38794
7.42901087585055e-22	-0.322219754186017	0.827	0.9	1.20268257069145e-17	CAV2	Malignant cells	GSE131984_JQ1	ENSG00000105971	858	caveolin 2	CAV	protein_coding	P51636	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38795
8.15557232607394e-22	-0.305369681178776	0.557	0.701	1.32030560386811e-17	SEC22C	Malignant cells	GSE131984_JQ1	ENSG00000093183	9117	SEC22 homolog C, vesicle trafficking protein	MGC13261|MGC5373|SEC22L3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38796
9.53895376494342e-22	0.274186167739754	0.369	0.2	1.54426122500669e-17	AGRN	Malignant cells	GSE131984_JQ1	ENSG00000188157	375790	agrin	AGRIN	protein_coding	O00468	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38797
9.61537494674526e-22	-0.281669612230056	0.272	0.438	1.55663305012859e-17	WDR12	Malignant cells	GSE131984_JQ1	ENSG00000138442	55759	WD repeat domain 12	FLJ10881|YTM1	protein_coding	Q9GZL7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38798
9.68908923464292e-22	-0.35113713301414	0.482	0.63	1.56856665619634e-17	FDFT1	Malignant cells	GSE131984_JQ1	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38799
1.02139061180866e-21	-0.279885849020769	0.206	0.365	1.65352926145704e-17	SCO1	Malignant cells	GSE131984_JQ1	ENSG00000133028	6341	synthesis of cytochrome C oxidase 1	SCOD1	protein_coding	O75880	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38800
1.02743745927521e-21	-0.271012079150883	0.314	0.487	1.66331850282064e-17	SNX12	Malignant cells	GSE131984_JQ1	ENSG00000147164	29934	sorting nexin 12	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38801
1.13783443579143e-21	-0.348163342372622	0.553	0.685	1.84204016810274e-17	RARS	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38802
1.14305887449874e-21	-0.265046451658056	0.209	0.372	1.850498011926e-17	PDCD2L	Malignant cells	GSE131984_JQ1	ENSG00000126249	84306	programmed cell death 2 like	MGC13096	protein_coding	Q9BRP1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38803
1.15208013445297e-21	-0.375495755677573	0.478	0.63	1.86510252966592e-17	FHL2	Malignant cells	GSE131984_JQ1	ENSG00000115641	2274	four and a half LIM domains 2	DRAL|SLIM3	protein_coding	Q14192	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38804
1.15214035157025e-21	-0.284480905257454	0.838	0.897	1.86520001515707e-17	PCNP	Malignant cells	GSE131984_JQ1	ENSG00000081154	57092	PEST proteolytic signal containing nuclear protein	NA	protein_coding	Q8WW12	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38805
1.2591370830457e-21	-0.295892301624599	0.391	0.557	2.03841702374269e-17	REXO4	Malignant cells	GSE131984_JQ1	ENSG00000280706	57109	REX4 homolog, 3'-5' exonuclease	hPMC2|XPMC2H	protein_coding	Q9GZR2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38806
1.36233077991161e-21	-0.306711085565203	0.515	0.678	2.20547729959891e-17	SP100	Malignant cells	GSE131984_JQ1	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38807
1.51886757912092e-21	-0.350375754203947	0.655	0.769	2.45889472383885e-17	ANXA7	Malignant cells	GSE131984_JQ1	ENSG00000138279	310	annexin A7	ANX7	protein_coding	P20073	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38808
1.56201044930636e-21	-0.305137446842259	0.273	0.446	2.52873871638207e-17	KIF22	Malignant cells	GSE131984_JQ1	ENSG00000079616	3835	kinesin family member 22	Kid|KNSL4|OBP-1|OBP-2	protein_coding	Q14807	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38809
1.6033288518058e-21	-0.356305063131306	0.694	0.794	2.59562907818841e-17	RALA	Malignant cells	GSE131984_JQ1	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38810
1.70510722637031e-21	-0.315771887832738	0.265	0.434	2.76039808877089e-17	NFKBIZ	Malignant cells	GSE131984_JQ1	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38811
1.84430406474604e-21	-0.362816113792018	0.374	0.528	2.98574385041737e-17	TRMT6	Malignant cells	GSE131984_JQ1	ENSG00000089195	51605	tRNA methyltransferase 6 non-catalytic subunit	CGI-09|GCD10|Gcd10p|MGC5029	protein_coding	Q9UJA5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38812
2.04276009212619e-21	-0.320010374797003	0.619	0.758	3.30702431314308e-17	NOB1	Malignant cells	GSE131984_JQ1	ENSG00000141101	28987	NIN1 (RPN12) binding protein 1 homolog	ART-4|MST158|NOB1P|PSMD8BP1	protein_coding	Q9ULX3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38813
2.17462825708028e-21	-0.275723507294099	0.3	0.474	3.52050568538726e-17	CENPU	Malignant cells	GSE131984_JQ1	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38814
2.2593748392528e-21	-0.299663543884081	0.433	0.592	3.65770192726636e-17	PPT1	Malignant cells	GSE131984_JQ1	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38815
2.44674204692314e-21	0.365994296203545	0.873	0.814	3.96103069976387e-17	PSAP	Malignant cells	GSE131984_JQ1	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38816
2.45861364233005e-21	0.365909112256491	0.884	0.814	3.98024962556812e-17	CDC25B	Malignant cells	GSE131984_JQ1	ENSG00000101224	994	cell division cycle 25B	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38817
2.53395737391552e-21	-0.353351624621337	0.594	0.703	4.10222359263183e-17	PSMD1	Malignant cells	GSE131984_JQ1	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38818
2.56807868040877e-21	-0.267002906334795	0.979	0.995	4.15746257571375e-17	HLA-A	Malignant cells	GSE131984_JQ1	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38819
2.57777576239673e-21	-0.320290497888323	0.436	0.598	4.17316118174407e-17	SKP2	Malignant cells	GSE131984_JQ1	ENSG00000145604	6502	S-phase kinase associated protein 2	FBL1|FBXL1|p45	protein_coding	Q13309	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38820
2.58536007303463e-21	-0.302974407450995	0.812	0.882	4.18543942223576e-17	IFI27L2	Malignant cells	GSE131984_JQ1	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38821
2.59285146459155e-21	0.322099193165672	0.955	0.904	4.19756723602726e-17	MYH9	Malignant cells	GSE131984_JQ1	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38822
2.66859169895117e-21	-0.308700666635482	0.567	0.698	4.32018310143205e-17	SS18L2	Malignant cells	GSE131984_JQ1	ENSG00000008324	51188	SS18 like 2	KIAA-iso	protein_coding	Q9UHA2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38823
3.00955846845992e-21	-0.290492764582485	0.404	0.573	4.87217420458977e-17	TCERG1	Malignant cells	GSE131984_JQ1	ENSG00000113649	10915	transcription elongation regulator 1	CA150|TAF2S|Urn1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38824
3.03352387876515e-21	-0.34910373674128	0.525	0.662	4.9109718073329e-17	TRMT10C	Malignant cells	GSE131984_JQ1	ENSG00000174173	54931	tRNA methyltransferase 10C, mitochondrial RNase P subunit	FLJ20432|MRPP1|RG9MTD1	protein_coding	Q7L0Y3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38825
3.27329486912262e-21	-0.274716888130445	0.277	0.448	5.29913706362261e-17	BYSL	Malignant cells	GSE131984_JQ1	ENSG00000112578	705	bystin like	Enp1	protein_coding	Q13895	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38826
3.33710135650989e-21	-0.327188918659171	0.793	0.869	5.40243338605387e-17	VIMP	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38827
3.89314699656743e-21	-0.312428547044698	0.277	0.439	6.30261567274302e-17	NDUFS2	Malignant cells	GSE131984_JQ1	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38828
3.97292957757843e-21	-0.276008523972103	0.209	0.369	6.43177569314171e-17	NFKB1	Malignant cells	GSE131984_JQ1	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38829
4.19706538995916e-21	-0.313175723158103	0.61	0.734	6.79462915980489e-17	PWP1	Malignant cells	GSE131984_JQ1	ENSG00000136045	11137	PWP1 homolog, endonuclein	IEF-SSP-9502	protein_coding	Q13610	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38830
4.37217394510277e-21	-0.297416691413146	0.843	0.896	7.07811239972688e-17	PARP1	Malignant cells	GSE131984_JQ1	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38831
4.45083717973893e-21	-0.300778066220872	0.335	0.5	7.20546031027935e-17	RRP15	Malignant cells	GSE131984_JQ1	ENSG00000067533	51018	ribosomal RNA processing 15 homolog	CGI-115|KIAA0507	protein_coding	Q9Y3B9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38832
4.90383806318033e-21	-0.287159503476444	0.379	0.544	7.93882344048264e-17	SLC39A6	Malignant cells	GSE131984_JQ1	ENSG00000141424	25800	solute carrier family 39 member 6	LIV-1	protein_coding	Q13433	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38833
5.15642859486227e-21	-0.432004686783013	0.642	0.752	8.34774225222253e-17	MDH1	Malignant cells	GSE131984_JQ1	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38834
5.18956825062465e-21	-0.286953329265224	0.836	0.905	8.40139204093624e-17	ITGAE	Malignant cells	GSE131984_JQ1	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38835
5.42205853857166e-21	-0.275935779989187	0.118	0.256	8.77777056809365e-17	PTN	Malignant cells	GSE131984_JQ1	ENSG00000105894	5764	pleiotrophin	HBGF8|HBNF|NEGF1	protein_coding	P21246	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38836
5.57593253619393e-21	-0.319851391510199	0.3	0.462	9.02687718284436e-17	ZFAND2A	Malignant cells	GSE131984_JQ1	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38837
5.59359661915208e-21	0.338700983919563	0.321	0.164	9.0554735667453e-17	LINC00632	Malignant cells	GSE131984_JQ1	ENSG00000203930	286411	long intergenic non-protein coding RNA 632	ARST|ASINC	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38838
6.76785967801386e-21	-0.296606071214087	0.279	0.441	1.09564880327366e-16	ARV1	Malignant cells	GSE131984_JQ1	ENSG00000173409	64801	ARV1 homolog, fatty acid homeostasis modulator	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38839
7.25440641755874e-21	-0.330396826453278	0.569	0.694	1.17441585493858e-16	RAD51C	Malignant cells	GSE131984_JQ1	ENSG00000108384	5889	RAD51 paralog C	FANCO|RAD51L2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38840
7.50457876049191e-21	-0.336356160537633	0.348	0.507	1.21491625553604e-16	USP53	Malignant cells	GSE131984_JQ1	ENSG00000145390	54532	ubiquitin specific peptidase 53	KIAA1350	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38841
7.69040658633431e-21	-0.290577355948432	0.806	0.895	1.24499992226166e-16	SELT	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38842
8.20384135949023e-21	-0.309655694701866	0.714	0.829	1.32811987768787e-16	DNAJC8	Malignant cells	GSE131984_JQ1	ENSG00000285317	22826	DnaJ heat shock protein family (Hsp40) member C8	SPF31	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38843
8.82389261407054e-21	0.314467749674817	0.417	0.249	1.42849997529188e-16	FAM43A	Malignant cells	GSE131984_JQ1	ENSG00000185112	131583	family with sequence similarity 43 member A	FLJ90022	protein_coding	Q8N2R8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38844
9.00688624073749e-21	-0.337483497056777	0.503	0.641	1.45812481351299e-16	STIP1	Malignant cells	GSE131984_JQ1	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38845
9.06500208766483e-21	-0.268983494441359	0.3	0.466	1.46753318797206e-16	MRPL44	Malignant cells	GSE131984_JQ1	ENSG00000135900	65080	mitochondrial ribosomal protein L44	FLJ12701|FLJ13990	protein_coding	Q9H9J2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38846
9.0749291763429e-21	-0.250970300812889	0.932	0.967	1.46914028435815e-16	POLR2I	Malignant cells	GSE131984_JQ1	ENSG00000105258	5438	RNA polymerase II subunit I	hRPB14.5|RPB9	protein_coding	P36954	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38847
9.2701724843042e-21	-0.328395919161163	0.483	0.633	1.50074822348401e-16	VPS25	Malignant cells	GSE131984_JQ1	ENSG00000131475	84313	vacuolar protein sorting 25 homolog	DERP9|EAP20|MGC10540	protein_coding	Q9BRG1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38848
9.65173974189507e-21	-0.282718422305194	0.26	0.421	1.56252014681539e-16	CTPS1	Malignant cells	GSE131984_JQ1	ENSG00000171793	1503	CTP synthase 1	CTPS|GATD5A	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38849
1.0077201360578e-20	-0.308571405716572	0.608	0.731	1.63139812826397e-16	PMVK	Malignant cells	GSE131984_JQ1	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38850
1.07218144069581e-20	-0.302491304247057	0.305	0.468	1.73575453434245e-16	GNPDA1	Malignant cells	GSE131984_JQ1	ENSG00000113552	10007	glucosamine-6-phosphate deaminase 1	GNPDA|GNPI|GPI|HLN|KIAA0060	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38851
1.07224882328165e-20	-0.311710453065301	0.456	0.612	1.73586362001066e-16	DERL1	Malignant cells	GSE131984_JQ1	ENSG00000136986	79139	derlin 1	DER-1|DER1|derlin-1|FLJ13784|MGC3067|PRO2577	protein_coding	Q9BUN8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38852
1.10307820972414e-20	-0.322648084936195	0.711	0.844	1.78577331372241e-16	SMC4	Malignant cells	GSE131984_JQ1	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38853
1.13555184758638e-20	-0.366410261543795	0.419	0.585	1.83834488605759e-16	COL1A1	Malignant cells	GSE131984_JQ1	ENSG00000108821	1277	collagen type I alpha 1 chain	OI4	protein_coding	P02452	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38854
1.19505447334483e-20	-0.27406185783022	0.963	0.977	1.93467368689795e-16	PHLDA2	Malignant cells	GSE131984_JQ1	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38855
1.32605938560052e-20	-0.301779450337337	0.5	0.654	2.14675753934869e-16	POP4	Malignant cells	GSE131984_JQ1	ENSG00000105171	10775	POP4 homolog, ribonuclease P/MRP subunit	RPP29	protein_coding	O95707	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38856
1.49430451887804e-20	-0.445765840392552	0.551	0.663	2.41912958561166e-16	MAGEC2	Malignant cells	GSE131984_JQ1	ENSG00000046774	51438	MAGE family member C2	CT10|HCA587|MAGE-C2|MAGEE1	protein_coding	Q9UBF1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38857
1.53215645064401e-20	-0.325278128103745	0.511	0.654	2.48040807794759e-16	TRAP1	Malignant cells	GSE131984_JQ1	ENSG00000126602	10131	TNF receptor associated protein 1	HSP75|HSP90L	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38858
1.5381187642408e-20	0.322836016831181	0.635	0.488	2.49006046742942e-16	DAG1	Malignant cells	GSE131984_JQ1	ENSG00000173402	1605	dystroglycan 1	156DAG|A3a|AGRNR|DAG	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38859
1.5625058139609e-20	-0.314229492162301	0.465	0.608	2.5295406622213e-16	EXOSC1	Malignant cells	GSE131984_JQ1	ENSG00000171311	51013	exosome component 1	CGI-108|CSL4|Csl4p|hCsl4p|p13|SKI4|Ski4p	protein_coding	Q9Y3B2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38860
1.64586167477845e-20	-0.329604180529936	0.338	0.501	2.66448546529883e-16	PNO1	Malignant cells	GSE131984_JQ1	ENSG00000115946	56902	partner of NOB1 homolog	KHRBP1|RRP20	protein_coding	Q9NRX1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38861
1.65582514989966e-20	-0.278759286065561	0.339	0.51	2.68061533517255e-16	PALLD	Malignant cells	GSE131984_JQ1	ENSG00000129116	23022	palladin, cytoskeletal associated protein	CGI-151|KIAA0992|SIH002	protein_coding	Q8WX93	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38862
1.75212387950844e-20	-0.27474724149071	0.817	0.896	2.83651334853621e-16	RBM17	Malignant cells	GSE131984_JQ1	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38863
1.76738513666611e-20	-0.286380412586668	0.245	0.401	2.86121979774877e-16	LYPLAL1	Malignant cells	GSE131984_JQ1	ENSG00000143353	127018	lysophospholipase like 1	Q96AV0	protein_coding	Q5VWZ2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38864
1.84107410911255e-20	-0.289722465946345	0.616	0.746	2.98051487524231e-16	UBA2	Malignant cells	GSE131984_JQ1	ENSG00000126261	10054	ubiquitin like modifier activating enzyme 2	FLJ13058|HRIHFB2115|SAE2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38865
1.86348661871484e-20	-0.300841351562681	0.619	0.735	3.01679848703745e-16	HTATIP2	Malignant cells	GSE131984_JQ1	ENSG00000109854	10553	HIV-1 Tat interactive protein 2	CC3|FLJ26963|SDR44U1|TIP30	protein_coding	Q9BUP3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38866
2.0063282999138e-20	0.341912671918667	0.635	0.491	3.24804488473046e-16	EVA1B	Malignant cells	GSE131984_JQ1	ENSG00000142694	55194	eva-1 homolog B	C1orf78|FAM176B|FLJ10647	protein_coding	Q9NVM1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38867
2.01249789804851e-20	-0.304439465737255	0.712	0.823	3.25803284715073e-16	PLEKHJ1	Malignant cells	GSE131984_JQ1	ENSG00000104886	55111	pleckstrin homology domain containing J1	FLJ10297	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38868
2.05585797762954e-20	-0.269442259606328	0.256	0.418	3.32822847998446e-16	C16orf80	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38869
2.22694676200258e-20	-0.32543421481745	0.616	0.759	3.60520411300598e-16	SMC1A	Malignant cells	GSE131984_JQ1	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38870
2.2365577515171e-20	-0.265225092732665	0.353	0.521	3.62076334393103e-16	FADD	Malignant cells	GSE131984_JQ1	ENSG00000168040	8772	Fas associated via death domain	GIG3|MORT1	protein_coding	Q13158	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38871
2.33472723100674e-20	-0.251218692708934	0.206	0.363	3.7796899142768e-16	PKMYT1	Malignant cells	GSE131984_JQ1	ENSG00000127564	9088	protein kinase, membrane associated tyrosine/threonine 1	MYT1|PPP1R126	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38872
2.39925378364999e-20	-0.281770570191367	0.329	0.5	3.88415195035098e-16	SPRYD7	Malignant cells	GSE131984_JQ1	ENSG00000123178	57213	SPRY domain containing 7	C13orf1|CLLD6	protein_coding	Q5W111	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38873
2.53810414973635e-20	-0.293433157693193	0.392	0.566	4.10893680800818e-16	GNA15	Malignant cells	GSE131984_JQ1	ENSG00000060558	2769	G protein subunit alpha 15	GNA16	protein_coding	P30679	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38874
2.55822955577061e-20	-0.261535169372399	0.311	0.477	4.14151782783704e-16	CHMP6	Malignant cells	GSE131984_JQ1	ENSG00000176108	79643	charged multivesicular body protein 6	FLJ11749|VPS20	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38875
2.63204065051163e-20	-0.277843802660136	0.857	0.916	4.26101060911328e-16	CAPZB	Malignant cells	GSE131984_JQ1	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38876
2.68129508679343e-20	-0.264688537843459	0.221	0.38	4.34074861600988e-16	MCM5	Malignant cells	GSE131984_JQ1	ENSG00000100297	4174	minichromosome maintenance complex component 5	CDC46	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38877
2.77060010956951e-20	-0.262355989116211	0.877	0.931	4.48532451738208e-16	GTF2H5	Malignant cells	GSE131984_JQ1	ENSG00000272047	404672	general transcription factor IIH subunit 5	bA120J8.2|C6orf175|FLJ30544|TFB5|TFIIH|TTD|TTD-A|TTDA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38878
2.78150564280544e-20	-0.282921033017438	0.846	0.914	4.50297948513773e-16	LRRFIP1	Malignant cells	GSE131984_JQ1	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38879
2.81928866647165e-20	-0.306015178233915	0.453	0.617	4.56414642215096e-16	ATP6V1E1	Malignant cells	GSE131984_JQ1	ENSG00000131100	529	ATPase H+ transporting V1 subunit E1	ATP6E|ATP6E2|ATP6V1E|P31|Vma4	protein_coding	P36543	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38880
2.90365631928932e-20	0.291885784052849	0.394	0.232	4.70072921529749e-16	PLXNB2	Malignant cells	GSE131984_JQ1	ENSG00000196576	23654	plexin B2	KIAA0315|MM1|PLEXB2	protein_coding	O15031	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38881
2.94257713059943e-20	-0.289475639535119	0.719	0.811	4.76373811672742e-16	AMZ2	Malignant cells	GSE131984_JQ1	ENSG00000196704	51321	archaelysin family metallopeptidase 2	NA	protein_coding	Q86W34	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38882
3.196269872755e-20	-0.27736595249795	0.27	0.43	5.17444129700307e-16	ERAL1	Malignant cells	GSE131984_JQ1	ENSG00000132591	26284	Era like 12S mitochondrial rRNA chaperone 1	HERA-B	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38883
3.20460240204438e-20	-0.261803558940002	0.834	0.894	5.18793082866966e-16	CWC15	Malignant cells	GSE131984_JQ1	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38884
3.2969791571665e-20	-0.304649935568397	0.565	0.695	5.33747955753684e-16	SCP2	Malignant cells	GSE131984_JQ1	ENSG00000116171	6342	sterol carrier protein 2	NA	protein_coding	P22307	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38885
3.36515000302805e-20	-0.284486098388981	0.511	0.674	5.44784133990211e-16	BCAT1	Malignant cells	GSE131984_JQ1	ENSG00000060982	586	branched chain amino acid transaminase 1	BCATc|BCT1	protein_coding	P54687	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38886
3.40125920741547e-20	-0.297703595071422	0.288	0.451	5.50629853088491e-16	CDC6	Malignant cells	GSE131984_JQ1	ENSG00000094804	990	cell division cycle 6	CDC18L	protein_coding	Q99741	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38887
3.41099324071819e-20	-0.284948517778573	0.796	0.849	5.52205695739868e-16	DCTN2	Malignant cells	GSE131984_JQ1	ENSG00000175203	10540	dynactin subunit 2	DCTN-50|RBP50	protein_coding	Q13561	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38888
3.781288696415e-20	0.288691572143724	0.38	0.221	6.12152827062624e-16	SDC3	Malignant cells	GSE131984_JQ1	ENSG00000162512	9672	syndecan 3	N-syndecan|SYND3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38889
4.10229607010472e-20	-0.264714109543514	0.317	0.482	6.64120710789253e-16	ASUN	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38890
4.13203323204314e-20	-0.267490341876581	0.897	0.954	6.68934859935464e-16	YWHAH	Malignant cells	GSE131984_JQ1	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38891
4.23112356999305e-20	-0.294330114268191	0.707	0.848	6.84976594746176e-16	TYMS	Malignant cells	GSE131984_JQ1	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38892
4.28812938378168e-20	-0.280809662110398	0.512	0.678	6.94205265940416e-16	QDPR	Malignant cells	GSE131984_JQ1	ENSG00000151552	5860	quinoid dihydropteridine reductase	DHPR|PKU2|SDR33C1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38893
4.97728032375242e-20	-0.28484662493994	0.454	0.628	8.05771911612279e-16	TTC1	Malignant cells	GSE131984_JQ1	ENSG00000113312	7265	tetratricopeptide repeat domain 1	TPR1	protein_coding	Q99614	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38894
5.14490739973361e-20	-0.279098354916027	0.27	0.433	8.32909058942874e-16	RP11-554I8.2	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38895
5.22993598890881e-20	-0.302532456917893	0.534	0.682	8.46674337244447e-16	THOC2	Malignant cells	GSE131984_JQ1	ENSG00000125676	57187	THO complex subunit 2	CXorf3|dJ506G2.1|MRX12|MRX35|THO2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38896
5.45492321822092e-20	-0.310265233342732	0.794	0.866	8.83097519797785e-16	APEX1	Malignant cells	GSE131984_JQ1	ENSG00000100823	328	apurinic/apyrimidinic endodeoxyribonuclease 1	APE|APE-1|APEN|APEX|APX|HAP1|REF-1|REF1	protein_coding	P27695	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38897
6.03558904937604e-20	-0.261876868583077	0.261	0.422	9.77101511203488e-16	NME7	Malignant cells	GSE131984_JQ1	ENSG00000143156	29922	NME/NM23 family member 7	CFAP67|FLJ37194|NM23-H7	protein_coding	Q9Y5B8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38898
6.12984319257582e-20	-0.317403202237411	0.328	0.495	9.923603144461e-16	CD55	Malignant cells	GSE131984_JQ1	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38899
6.22044271696547e-20	0.264527538213567	0.936	0.897	1.00702747144954e-15	NBEAL1	Malignant cells	GSE131984_JQ1	ENSG00000144426	65065	neurobeachin like 1	ALS2CR16|ALS2CR17|MGC164581	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38900
6.35030508085525e-20	-0.320287896009378	0.565	0.694	1.02805088953966e-15	C12orf45	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38901
6.49854949552642e-20	-0.287889305244466	0.406	0.572	1.05205017783077e-15	FAM103A1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38902
7.04148813442149e-20	-0.298892288105209	0.481	0.626	1.1399465140815e-15	GORASP2	Malignant cells	GSE131984_JQ1	ENSG00000115806	26003	golgi reassembly stacking protein 2	GOLPH6|GRASP55|GRS2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38903
7.18327537096238e-20	-0.304646408303099	0.509	0.674	1.1629004498051e-15	TMPO	Malignant cells	GSE131984_JQ1	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38904
7.21394730291405e-20	-0.300423096425014	0.553	0.696	1.16786592886876e-15	RAB18	Malignant cells	GSE131984_JQ1	ENSG00000099246	22931	RAB18, member RAS oncogene family	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38905
7.65408949891678e-20	-0.284582673337981	0.326	0.482	1.23912054897964e-15	PSMD10	Malignant cells	GSE131984_JQ1	ENSG00000101843	5716	proteasome 26S subunit, non-ATPase 10	p28	protein_coding	O75832	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38906
8.12150515804553e-20	-0.26079593104392	0.238	0.398	1.31479047003599e-15	TRIM47	Malignant cells	GSE131984_JQ1	ENSG00000132481	91107	tripartite motif containing 47	GOA|RNF100	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38907
8.79538457016178e-20	-0.273687871688174	0.685	0.806	1.42388480806349e-15	APH1A	Malignant cells	GSE131984_JQ1	ENSG00000117362	51107	aph-1 homolog A, gamma-secretase subunit	APH-1A|CGI-78	protein_coding	Q96BI3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38908
8.85917275100855e-20	-0.359682169285207	0.59	0.713	1.43421147666077e-15	GCLM	Malignant cells	GSE131984_JQ1	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38909
9.30089063802174e-20	-0.332500757094116	0.445	0.581	1.50572118538934e-15	RPF1	Malignant cells	GSE131984_JQ1	ENSG00000117133	80135	ribosome production factor 1 homolog	BXDC5	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38910
9.47410003446495e-20	0.320827079872889	0.596	0.436	1.53376205457953e-15	TIMP2	Malignant cells	GSE131984_JQ1	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38911
1.01630523749321e-19	-0.27906312702288	0.888	0.94	1.64529654897775e-15	RBMX	Malignant cells	GSE131984_JQ1	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38912
1.07386689784333e-19	0.261457704222886	0.951	0.929	1.73848312091857e-15	FIBP	Malignant cells	GSE131984_JQ1	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38913
1.20483588476086e-19	0.302365798039942	0.422	0.261	1.95050881383936e-15	ARRDC3	Malignant cells	GSE131984_JQ1	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38914
1.24947106811512e-19	-0.272734750468708	0.861	0.91	2.02276871217156e-15	ARL2	Malignant cells	GSE131984_JQ1	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38915
1.27671469749676e-19	-0.292746530453141	0.56	0.699	2.0668734237775e-15	CCDC53	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38916
1.28142970991965e-19	0.260745793304144	0.308	0.148	2.07450655738892e-15	AC073236.3	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38917
1.29869248399987e-19	-0.348321424852743	0.794	0.848	2.10245326234739e-15	LAPTM4A	Malignant cells	GSE131984_JQ1	ENSG00000068697	9741	lysosomal protein transmembrane 4 alpha	HUMORF13|KIAA0108|LAPTM4|MBNT|Mtrp	protein_coding	Q15012	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38918
1.35897608334321e-19	-0.273122870596228	0.311	0.472	2.20004638132432e-15	WDR46	Malignant cells	GSE131984_JQ1	ENSG00000226916	9277	WD repeat domain 46	BING4|C6orf11|UTP7	protein_coding	O15213	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38919
1.40149235451e-19	0.312586001304773	0.736	0.605	2.26887597271625e-15	CLIC4	Malignant cells	GSE131984_JQ1	ENSG00000169504	25932	chloride intracellular channel 4	CLIC4L|DKFZP566G223|H1|huH1|P64H1	protein_coding	Q9Y696	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38920
1.41346759449411e-19	-0.268582829337985	0.859	0.919	2.28826268872652e-15	UFD1L	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38921
1.42918280424127e-19	-0.267430583957621	0.326	0.486	2.31370404178618e-15	CXorf40B	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38922
1.43010018119806e-19	-0.275885484865731	0.28	0.44	2.31518918334153e-15	EIF2B3	Malignant cells	GSE131984_JQ1	ENSG00000070785	8891	eukaryotic translation initiation factor 2B subunit gamma	EIF-2B|EIF2Bgamma	protein_coding	Q9NR50	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38923
1.44108214238387e-19	-0.273730233661531	0.262	0.417	2.33296788030525e-15	CXorf38	Malignant cells	GSE131984_JQ1	ENSG00000185753	159013	chromosome X open reading frame 38	MGC39350	protein_coding	Q8TB03	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38924
1.4686273693413e-19	-0.320707063654502	0.564	0.686	2.37756084822663e-15	PPP1R7	Malignant cells	GSE131984_JQ1	ENSG00000115685	5510	protein phosphatase 1 regulatory subunit 7	sds22	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38925
1.48131916043243e-19	-0.276634567785325	0.654	0.78	2.39810758882406e-15	PSMF1	Malignant cells	GSE131984_JQ1	ENSG00000125818	9491	proteasome inhibitor subunit 1	PI31	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38926
1.5253297810252e-19	-0.365289491127357	0.312	0.479	2.4693563825017e-15	AURKB	Malignant cells	GSE131984_JQ1	ENSG00000178999	9212	aurora kinase B	Aik2|AIM-1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5	protein_coding	Q96GD4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38927
1.5253635994061e-19	0.262211873298653	0.99	0.961	2.46941113107853e-15	C7orf50	Malignant cells	GSE131984_JQ1	ENSG00000146540	84310	chromosome 7 open reading frame 50	MGC11257|YCR016W	protein_coding	Q9BRJ6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38928
1.53465949332309e-19	-0.274639405262399	0.373	0.54	2.48446025374075e-15	SIGIRR	Malignant cells	GSE131984_JQ1	ENSG00000185187	59307	single Ig and TIR domain containing	IL-1R8|TIR8	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38929
1.63670523040733e-19	0.41524263434142	0.352	0.201	2.64966209750642e-15	NR4A1	Malignant cells	GSE131984_JQ1	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38930
1.65215024236938e-19	-0.292533729569649	0.74	0.817	2.67466602737178e-15	STX10	Malignant cells	GSE131984_JQ1	ENSG00000104915	8677	syntaxin 10	hsyn10|SYN10	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38931
1.6643860192348e-19	-0.297075517115969	0.702	0.799	2.69447452653922e-15	EIF2A	Malignant cells	GSE131984_JQ1	ENSG00000144895	83939	eukaryotic translation initiation factor 2A	EIF-2A	protein_coding	Q9BY44	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38932
1.66773740337773e-19	-0.314151267009732	0.469	0.628	2.69990008232821e-15	RRM1	Malignant cells	GSE131984_JQ1	ENSG00000167325	6240	ribonucleotide reductase catalytic subunit M1	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38933
1.73349313395941e-19	0.274607792621014	0.382	0.224	2.80635203456688e-15	METTL7A	Malignant cells	GSE131984_JQ1	ENSG00000185432	25840	methyltransferase like 7A	DKFZP586A0522	protein_coding	Q9H8H3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38934
1.79307420894749e-19	-0.290468952617987	0.386	0.542	2.90280783686509e-15	SLC27A5	Malignant cells	GSE131984_JQ1	ENSG00000083807	10998	solute carrier family 27 member 5	ACSB|ACSVL6|FACVL3|FATP5|FLJ22987|VLACSR|VLCS-H2|VLCSH2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38935
1.97334935414897e-19	-0.291080652877687	0.382	0.537	3.19465526943177e-15	DUSP12	Malignant cells	GSE131984_JQ1	ENSG00000081721	11266	dual specificity phosphatase 12	DUSP1|YVH1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38936
2.0513627939944e-19	-0.31475138145396	0.416	0.568	3.32095122719754e-15	OSER1	Malignant cells	GSE131984_JQ1	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38937
2.06112995454651e-19	-0.281264026798341	0.821	0.877	3.33676328341535e-15	SEC62	Malignant cells	GSE131984_JQ1	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38938
2.15654344635484e-19	-0.318288587499693	0.77	0.842	3.49122818530386e-15	RAB1A	Malignant cells	GSE131984_JQ1	ENSG00000138069	5861	RAB1A, member RAS oncogene family	RAB1|YPT1	protein_coding	P62820	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38939
2.38718821054064e-19	-0.313085484815281	0.347	0.5	3.86461899404424e-15	PPAN	Malignant cells	GSE131984_JQ1	ENSG00000130810	56342	peter pan homolog	BXDC3|SSF|SSF1|SSF2	protein_coding	Q9NQ55	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38940
2.84893718815236e-19	-0.273093381618214	0.426	0.583	4.61214441389985e-15	AKIP1	Malignant cells	GSE131984_JQ1	ENSG00000166452	56672	A-kinase interacting protein 1	BCA3|C11orf17	protein_coding	Q9NQ31	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38941
2.9893913131848e-19	-0.269328405639247	0.237	0.391	4.83952559691487e-15	TGFB1I1	Malignant cells	GSE131984_JQ1	ENSG00000140682	7041	transforming growth factor beta 1 induced transcript 1	ARA55|Hic-5|TSC-5	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38942
3.10993384451702e-19	-0.291352382531649	0.332	0.487	5.0346719008886e-15	ARMCX6	Malignant cells	GSE131984_JQ1	ENSG00000198960	54470	armadillo repeat containing X-linked 6	FLJ20811|GASP10	protein_coding	Q7L4S7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38943
3.21607103574952e-19	-0.285166129096365	0.378	0.535	5.20649739977491e-15	MCM3	Malignant cells	GSE131984_JQ1	ENSG00000112118	4172	minichromosome maintenance complex component 3	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38944
3.28027036323398e-19	0.280201315075395	0.868	0.774	5.31042969103949e-15	PTRF	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38945
3.3727901203605e-19	0.604823050714925	0.911	0.877	5.46020992585162e-15	MT1E	Malignant cells	GSE131984_JQ1	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38946
3.75914163460741e-19	-0.292454822802733	0.558	0.697	6.08567439226594e-15	SFXN1	Malignant cells	GSE131984_JQ1	ENSG00000164466	94081	sideroflexin 1	FLJ12876|SLC56A1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38947
3.96067003730419e-19	-0.280591384368195	0.856	0.91	6.41192872339175e-15	EIF2S3	Malignant cells	GSE131984_JQ1	ENSG00000130741	1968	eukaryotic translation initiation factor 2 subunit gamma	EIF2|EIF2G|EIF2gamma	protein_coding	P41091	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38948
3.96081485286493e-19	-0.282112049013711	0.357	0.518	6.41216316530304e-15	MAFF	Malignant cells	GSE131984_JQ1	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38949
3.97544587038947e-19	-0.300002993036455	0.597	0.738	6.43584931957351e-15	ZNHIT3	Malignant cells	GSE131984_JQ1	ENSG00000278574	9326	zinc finger HIT-type containing 3	Hit1|TRIP3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38950
3.98305890161895e-19	-0.253958542452303	0.337	0.504	6.44817405583092e-15	UBE2D1	Malignant cells	GSE131984_JQ1	ENSG00000072401	7321	ubiquitin conjugating enzyme E2 D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UbcH5A	protein_coding	P51668	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38951
4.10989936836111e-19	-0.255691188191848	0.919	0.956	6.6535160874398e-15	FKBP2	Malignant cells	GSE131984_JQ1	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38952
4.15879913298297e-19	-0.259466675112727	0.856	0.915	6.73267991638614e-15	EIF4E2	Malignant cells	GSE131984_JQ1	ENSG00000135930	9470	eukaryotic translation initiation factor 4E family member 2	4EHP|EIF4EL3|IF4e	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38953
4.30545953072952e-19	-0.260329457429517	0.222	0.372	6.97010843429802e-15	FAM122B	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38954
5.15398970250772e-19	-0.253679311399534	0.328	0.509	8.34379392938975e-15	CEP55	Malignant cells	GSE131984_JQ1	ENSG00000138180	55165	centrosomal protein 55	C10orf3|CT111|FLJ10540	protein_coding	Q53EZ4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38955
5.60750927736993e-19	-0.261733050297974	0.242	0.392	9.07799676913417e-15	NUDT11	Malignant cells	GSE131984_JQ1	ENSG00000196368	55190	nudix hydrolase 11	DIPP3b|FLJ10628|hDIPP3beta	protein_coding	Q96G61	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38956
5.61584401678059e-19	0.300798565335115	0.723	0.605	9.09148987876609e-15	VAT1	Malignant cells	GSE131984_JQ1	ENSG00000108828	10493	vesicle amine transport 1	FLJ20230|VATI	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38957
5.63989967148951e-19	0.311546160884457	0.561	0.409	9.13043357817437e-15	JUND	Malignant cells	GSE131984_JQ1	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38958
5.64812530671615e-19	-0.250707046295939	0.252	0.41	9.14375005904278e-15	TFPT	Malignant cells	GSE131984_JQ1	ENSG00000276504	29844	TCF3 fusion partner	amida|FB1|INO80F	protein_coding	P0C1Z6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38959
5.88532698355252e-19	0.293726680428438	0.455	0.294	9.52775585367317e-15	HEXIM1	Malignant cells	GSE131984_JQ1	ENSG00000186834	10614	HEXIM P-TEFb complex subunit 1	CLP-1|EDG1|HIS1|MAQ1	protein_coding	O94992	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38960
6.01538010279987e-19	-0.272382849011612	0.482	0.639	9.73829884842271e-15	ERI3	Malignant cells	GSE131984_JQ1	ENSG00000117419	79033	ERI1 exoribonuclease family member 3	FLJ22943|PINT1|PRNPIP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38961
6.02242620452656e-19	-0.271407914152897	0.475	0.64	9.74970578250805e-15	LITAF	Malignant cells	GSE131984_JQ1	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38962
6.07379568844909e-19	-0.291365760314993	0.703	0.814	9.83286784003023e-15	NCOR1	Malignant cells	GSE131984_JQ1	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38963
6.84433795470042e-19	-0.258747070854572	0.267	0.426	1.10802987148645e-14	ALKBH2	Malignant cells	GSE131984_JQ1	ENSG00000189046	121642	alkB homolog 2, alpha-ketoglutarate dependent dioxygenase	ABH2|MGC90512	protein_coding	Q6NS38	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38964
6.97064691053369e-19	-0.293414223978526	0.457	0.599	1.1284780283463e-14	TRABD	Malignant cells	GSE131984_JQ1	ENSG00000170638	80305	TraB domain containing	PP2447	protein_coding	Q9H4I3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38965
7.10407887361996e-19	-0.275292617950607	0.265	0.42	1.15007932885034e-14	NT5DC2	Malignant cells	GSE131984_JQ1	ENSG00000168268	64943	5'-nucleotidase domain containing 2	FLJ12442	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38966
7.2495822411574e-19	-0.255327321412843	0.842	0.91	1.17363486902097e-14	CCDC124	Malignant cells	GSE131984_JQ1	ENSG00000007080	115098	coiled-coil domain containing 124	Lso2|oxs1	protein_coding	Q96CT7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38967
7.24967427893067e-19	-0.271231383710231	0.314	0.482	1.17364976901609e-14	CHAF1A	Malignant cells	GSE131984_JQ1	ENSG00000167670	10036	chromatin assembly factor 1 subunit A	CAF-1|CAF1|CAF1B|CAF1P150|MGC71229|P150	protein_coding	Q13111	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38968
7.55700239910575e-19	-0.294634606152711	0.592	0.735	1.22340311839123e-14	CUL4A	Malignant cells	GSE131984_JQ1	ENSG00000139842	8451	cullin 4A	NA	protein_coding	Q13619	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38969
7.71421588077056e-19	0.290286160201805	0.507	0.352	1.24885440893795e-14	STX16	Malignant cells	GSE131984_JQ1	ENSG00000124222	8675	syntaxin 16	hsyn16|SYN-16|SYN16	protein_coding	O14662	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38970
7.72717918790104e-19	-0.278724275568904	0.575	0.707	1.2509530387293e-14	SNRPA	Malignant cells	GSE131984_JQ1	ENSG00000077312	6626	small nuclear ribonucleoprotein polypeptide A	Mud1|U1-A|U1A	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38971
8.67990985224198e-19	-0.2870607416285	0.79	0.865	1.40519060597945e-14	IGBP1	Malignant cells	GSE131984_JQ1	ENSG00000089289	3476	immunoglobulin binding protein 1	alpha4|IBP1	protein_coding	P78318	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38972
8.84410523772871e-19	0.263000676769221	0.504	0.334	1.4317721969359e-14	TP53TG1	Malignant cells	GSE131984_JQ1	ENSG00000182165	NA	NA	H_RG012D21.9|LINC00096|TP53AP1|TP53LC12	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38973
9.50335834580049e-19	-0.25890161093971	0.918	0.965	1.53849868260164e-14	MKKS	Malignant cells	GSE131984_JQ1	ENSG00000125863	8195	MKKS centrosomal shuttling protein	BBS6|HMCS|KMS|MKS	protein_coding	Q9NPJ1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38974
9.81403416261162e-19	0.346462818345158	0.774	0.68	1.58879399058519e-14	TFRC	Malignant cells	GSE131984_JQ1	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38975
1.07780644919616e-18	-0.304136625527447	0.727	0.82	1.74486086060367e-14	UBXN4	Malignant cells	GSE131984_JQ1	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38976
1.11236264644884e-18	-0.273270918542709	0.551	0.684	1.80080388833603e-14	GTF2E2	Malignant cells	GSE131984_JQ1	ENSG00000197265	2961	general transcription factor IIE subunit 2	FE|TF2E2|TFIIE-B	protein_coding	P29084	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38977
1.23527815085284e-18	-0.283132237003148	0.57	0.705	1.99979179841567e-14	TIPRL	Malignant cells	GSE131984_JQ1	ENSG00000143155	261726	TOR signaling pathway regulator	dJ69E11.3|MGC3794|TIP41|TIPRL1	protein_coding	O75663	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38978
1.274313424296e-18	-0.283316489284046	0.344	0.526	2.0629860025928e-14	CDCA3	Malignant cells	GSE131984_JQ1	ENSG00000111665	83461	cell division cycle associated 3	GRCC8|TOME-1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38979
1.32574514553156e-18	-0.310499710073501	0.698	0.791	2.14624881610105e-14	BAG1	Malignant cells	GSE131984_JQ1	ENSG00000107262	573	BAG cochaperone 1	NA	protein_coding	Q99933	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38980
1.36649468660525e-18	-0.279915848317826	0.501	0.649	2.21221824814524e-14	TSSC4	Malignant cells	GSE131984_JQ1	ENSG00000184281	10078	tumor suppressing subtransferable candidate 4	NA	protein_coding	Q9Y5U2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38981
1.4150965570704e-18	-0.28005228366315	0.371	0.523	2.29089981624128e-14	RTCA	Malignant cells	GSE131984_JQ1	ENSG00000137996	8634	RNA 3'-terminal phosphate cyclase	RPC|RTC1|RTCD1	protein_coding	O00442	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38982
1.54029387235431e-18	-0.271144529308418	0.852	0.912	2.49358174995439e-14	NDUFB6	Malignant cells	GSE131984_JQ1	ENSG00000165264	4712	NADH:ubiquinone oxidoreductase subunit B6	B17|CI	protein_coding	O95139	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38983
1.60821637393157e-18	-0.332151087265949	0.47	0.603	2.60354148775781e-14	ABL2	Malignant cells	GSE131984_JQ1	ENSG00000143322	27	ABL proto-oncogene 2, non-receptor tyrosine kinase	ABLL|ARG	protein_coding	P42684	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38984
1.62803645841033e-18	-0.324719513627164	0.208	0.35	2.63562822252048e-14	IFI44	Malignant cells	GSE131984_JQ1	ENSG00000137965	10561	interferon induced protein 44	MTAP44|p44|TLDC5	protein_coding	Q8TCB0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38985
1.63894371023474e-18	-0.286394429385519	0.455	0.609	2.65328597249902e-14	PET117	Malignant cells	GSE131984_JQ1	ENSG00000232838	100303755	PET117 cytochrome c oxidase chaperone	CSRP2BP	protein_coding	Q6UWS5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38986
1.64267636052723e-18	-0.305008395694655	0.43	0.582	2.65932876005754e-14	RP6-109B7.3	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38987
1.68318139107075e-18	-0.26204221225557	0.365	0.517	2.72490235400444e-14	PPIL3	Malignant cells	GSE131984_JQ1	ENSG00000240344	53938	peptidylprolyl isomerase like 3	CyPJ	protein_coding	Q9H2H8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38988
1.69572870021777e-18	-0.255118512151846	0.833	0.893	2.74521519278255e-14	SURF4	Malignant cells	GSE131984_JQ1	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38989
1.70442950541511e-18	0.371908578097508	0.93	0.882	2.75930092631651e-14	SCD	Malignant cells	GSE131984_JQ1	ENSG00000099194	6319	stearoyl-CoA desaturase	FADS5|SCD1|SCDOS	protein_coding	O00767	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38990
1.76160673643041e-18	0.334231762461026	0.879	0.766	2.8518651456072e-14	AXL	Malignant cells	GSE131984_JQ1	ENSG00000167601	558	AXL receptor tyrosine kinase	ARK|JTK11|Tyro7|UFO	protein_coding	P30530	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38991
1.76230965338681e-18	-0.257945517338572	0.348	0.51	2.85300309786791e-14	PPIE	Malignant cells	GSE131984_JQ1	ENSG00000084072	10450	peptidylprolyl isomerase E	CyP-33|MGC111222|MGC3736	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38992
1.76532748078696e-18	-0.286067937067929	0.378	0.536	2.85788865864601e-14	GPN3	Malignant cells	GSE131984_JQ1	ENSG00000111231	51184	GPN-loop GTPase 3	ATPBD1C|MGC14560	protein_coding	Q9UHW5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38993
1.86643700998362e-18	-0.339011064740918	0.741	0.833	3.02157487546247e-14	SNORA76	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38994
1.92018808475839e-18	-0.3143103400586	0.481	0.624	3.10859249041536e-14	ZNF385D	Malignant cells	GSE131984_JQ1	ENSG00000151789	79750	zinc finger protein 385D	FLJ22419|ZNF659	protein_coding	Q9H6B1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38995
1.97650405603648e-18	-0.327447917143076	0.215	0.355	3.19976241631745e-14	DDX10	Malignant cells	GSE131984_JQ1	ENSG00000178105	1662	DEAD-box helicase 10	Dbp4|HRH-J8	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38996
2.16598534025685e-18	-0.346613195552369	0.403	0.571	3.50651366734181e-14	CENPA	Malignant cells	GSE131984_JQ1	ENSG00000115163	1058	centromere protein A	CenH3|CENP-A	protein_coding	P49450	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38997
2.22243595206502e-18	-0.258011581162136	0.367	0.528	3.59790156279806e-14	SLC50A1	Malignant cells	GSE131984_JQ1	ENSG00000169241	55974	solute carrier family 50 member 1	HsSWEET1|RAG1AP1|RP11-540D14.5|RZPDo834D038D|SCP|slv|SWEET1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38998
2.22377693808541e-18	-0.250492908536938	0.41	0.575	3.60007248506647e-14	HTRA2	Malignant cells	GSE131984_JQ1	ENSG00000115317	27429	HtrA serine peptidase 2	OMI|PARK13|PRSS25	protein_coding	O43464	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	38999
2.41849041528171e-18	-0.28879804184953	0.371	0.521	3.91529413329957e-14	NSUN5	Malignant cells	GSE131984_JQ1	ENSG00000130305	55695	NOP2/Sun RNA methyltransferase 5	FLJ10267|NOL1R|NSUN5A|p120(NOL1)|WBSCR20|WBSCR20A|Ynl022cL	protein_coding	Q96P11	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39000
2.49628313349295e-18	-0.295195192842849	0.658	0.777	4.04123276481173e-14	DDX24	Malignant cells	GSE131984_JQ1	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39001
2.52757347838505e-18	-0.282112759765171	0.576	0.716	4.09188870415755e-14	TRIAP1	Malignant cells	GSE131984_JQ1	ENSG00000170855	51499	TP53 regulated inhibitor of apoptosis 1	HSPC132|MDM35|P53CSV|WF-1	protein_coding	O43715	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39002
2.54377966176712e-18	-0.296450018986406	0.434	0.578	4.11812489443479e-14	DERL2	Malignant cells	GSE131984_JQ1	ENSG00000072849	51009	derlin 2	CGI-101|derlin-2|F-LAN-1|F-LANa|FLANa	protein_coding	Q9GZP9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39003
2.73390163067201e-18	-0.317978532888396	1	0.999	4.42591334989491e-14	EIF4A1	Malignant cells	GSE131984_JQ1	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39004
2.80167620236283e-18	0.277150452175446	0.316	0.17	4.53563360400518e-14	KCNQ1OT1	Malignant cells	GSE131984_JQ1	ENSG00000269821	10984	KCNQ1 opposite strand/antisense transcript 1	KCNQ1-AS2|KvDMR1|KvLQT1-AS|LIT1|NCRNA00012	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39005
2.98557841540594e-18	-0.296917706428326	0.536	0.672	4.83335289670068e-14	RABEP1	Malignant cells	GSE131984_JQ1	ENSG00000029725	9135	rabaptin, RAB GTPase binding effector protein 1	neurocrescin|RAB5EP|rabaptin-5|RABPT5	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39006
3.1493900873514e-18	-0.322095182019194	0.381	0.544	5.09854761241317e-14	KNSTRN	Malignant cells	GSE131984_JQ1	ENSG00000128944	90417	kinetochore localized astrin (SPAG5) binding protein	C15orf23|FLJ14502|kinastrin|SKAP|TRAF4AF1	protein_coding	Q9Y448	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39007
3.39680857034908e-18	0.3420659218602	0.876	0.777	5.49909339453813e-14	DDIT4	Malignant cells	GSE131984_JQ1	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39008
3.51600538084125e-18	-0.280393709951341	0.245	0.402	5.6920611110439e-14	FAM64A	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39009
3.60180072640493e-18	0.298093623189564	0.605	0.461	5.83095519597694e-14	MAN1A2	Malignant cells	GSE131984_JQ1	ENSG00000198162	10905	mannosidase alpha class 1A member 2	MAN1B	protein_coding	O60476	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39010
3.8490039084906e-18	-0.330858821506745	0.318	0.467	6.23115242745543e-14	FKBP11	Malignant cells	GSE131984_JQ1	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39011
3.99889436189485e-18	-0.314633991021299	0.642	0.763	6.47381008247158e-14	LCP1	Malignant cells	GSE131984_JQ1	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39012
4.31337099985246e-18	-0.282480972378802	0.473	0.631	6.98291631166114e-14	OPTN	Malignant cells	GSE131984_JQ1	ENSG00000123240	10133	optineurin	FIP-2|FIP2|GLC1E|HIP7|HYPL|NRP|TFIIIA-INTP	protein_coding	Q96CV9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39013
4.39091144107359e-18	-0.272301178810757	0.278	0.43	7.10844653195404e-14	NAMPT	Malignant cells	GSE131984_JQ1	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39014
4.41644184906541e-18	-0.277245569883102	0.479	0.626	7.14977770945199e-14	COMMD1	Malignant cells	GSE131984_JQ1	ENSG00000173163	150684	copper metabolism domain containing 1	C2orf5|MGC27155|MURR1	protein_coding	Q8N668	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39015
4.41999681231955e-18	-0.46493332583952	0.32	0.48	7.15553283946412e-14	CDK1	Malignant cells	GSE131984_JQ1	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39016
4.42214698832211e-18	-0.256624402978543	0.843	0.892	7.15901375939466e-14	MAP2K2	Malignant cells	GSE131984_JQ1	ENSG00000126934	5605	mitogen-activated protein kinase kinase 2	MEK2|PRKMK2	protein_coding	P36507	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39017
4.62664494772341e-18	-0.276965853165087	0.57	0.694	7.49007550586944e-14	DCTD	Malignant cells	GSE131984_JQ1	ENSG00000129187	1635	dCMP deaminase	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39018
5.07636733205386e-18	-0.316326942640748	0.522	0.658	8.21813107386199e-14	INO80C	Malignant cells	GSE131984_JQ1	ENSG00000153391	125476	INO80 complex subunit C	C18orf37|FLJ38183|hIes6|IES6	protein_coding	Q6PI98	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39019
5.36197853465163e-18	-0.308095200918018	0.65	0.756	8.68050704974752e-14	TFG	Malignant cells	GSE131984_JQ1	ENSG00000114354	10342	trafficking from ER to golgi regulator	FLJ36137|SPG57|TF6	protein_coding	Q92734	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39020
5.52111854022001e-18	-0.250082932948937	0.303	0.464	8.93813880476217e-14	CCDC137	Malignant cells	GSE131984_JQ1	ENSG00000185298	339230	coiled-coil domain containing 137	MGC16597	protein_coding	Q6PK04	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39021
5.84151409197609e-18	-0.263756263148084	0.723	0.832	9.45682716350009e-14	NANS	Malignant cells	GSE131984_JQ1	ENSG00000095380	54187	N-acetylneuraminate synthase	SAS	protein_coding	Q9NR45	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39022
5.99124898386114e-18	-0.280332863944456	0.497	0.643	9.6992329799728e-14	APITD1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39023
6.02766711746588e-18	-0.290190919185141	0.845	0.919	9.75819029646552e-14	PSME1	Malignant cells	GSE131984_JQ1	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39024
7.10733594290709e-18	-0.266640306028704	0.385	0.544	1.15060661579723e-13	EXOSC5	Malignant cells	GSE131984_JQ1	ENSG00000077348	56915	exosome component 5	hRrp46p|MGC12901|p12B|RRP41B|RRP46|Rrp46p	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39025
7.17278223012809e-18	0.258606310031159	0.59	0.428	1.16120171523544e-13	CASC4	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39026
7.31625523762325e-18	-0.276861211706045	0.341	0.488	1.18442856041883e-13	FHL3	Malignant cells	GSE131984_JQ1	ENSG00000183386	2275	four and a half LIM domains 3	SLIM2	protein_coding	Q13643	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39027
8.35901372546974e-18	-0.267674080334901	0.357	0.511	1.3532407320163e-13	PAWR	Malignant cells	GSE131984_JQ1	ENSG00000177425	5074	pro-apoptotic WT1 regulator	par-4|PAR4	protein_coding	Q96IZ0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39028
8.36521406636594e-18	-0.254697675050254	0.412	0.574	1.35424450520398e-13	CFLAR	Malignant cells	GSE131984_JQ1	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39029
8.43183723852956e-18	-0.272806262283855	0.685	0.787	1.36503013054555e-13	PPIG	Malignant cells	GSE131984_JQ1	ENSG00000138398	9360	peptidylprolyl isomerase G	CARS-Cyp|SCAF10|SRCyp	protein_coding	Q13427	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39030
8.50873732408861e-18	0.285765713434223	0.777	0.665	1.37747948539671e-13	TCF25	Malignant cells	GSE131984_JQ1	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39031
8.91459068675365e-18	-0.266850211052951	0.465	0.618	1.44318308627855e-13	C14orf1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39032
9.53769586832987e-18	0.279308467753967	0.519	0.367	1.54405758412392e-13	SRD5A1	Malignant cells	GSE131984_JQ1	ENSG00000145545	6715	steroid 5 alpha-reductase 1	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39033
1.05931496983777e-17	-0.276529571967012	0.394	0.543	1.71492500467036e-13	SRPRB	Malignant cells	GSE131984_JQ1	ENSG00000144867	58477	SRP receptor subunit beta	APMCF1|SR-beta	protein_coding	Q9Y5M8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39034
1.09045179019948e-17	-0.271793869251846	0.723	0.824	1.76533240315394e-13	U2SURP	Malignant cells	GSE131984_JQ1	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39035
1.17284890055154e-17	-0.326676503404262	0.735	0.813	1.89872508510288e-13	LMAN1	Malignant cells	GSE131984_JQ1	ENSG00000074695	3998	lectin, mannose binding 1	ERGIC-53|ERGIC53|F5F8D|FMFD1|gp58|MCFD1|MR60	protein_coding	P49257	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39036
1.17790847917373e-17	-0.317436589805787	0.512	0.645	1.90691603693436e-13	SNHG15	Malignant cells	GSE131984_JQ1	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39037
1.17906912968134e-17	-0.272324748704502	0.472	0.616	1.90879501404112e-13	TMX1	Malignant cells	GSE131984_JQ1	ENSG00000139921	81542	thioredoxin related transmembrane protein 1	PDIA11|TMX|TXNDC|TXNDC1	protein_coding	Q9H3N1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39038
1.23091926521966e-17	-0.26046024076885	0.31	0.459	1.99273519846412e-13	C1orf131	Malignant cells	GSE131984_JQ1	ENSG00000143633	128061	chromosome 1 open reading frame 131	DKFZp547B1713	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39039
1.24192121806693e-17	-0.268770496050196	0.327	0.486	2.01054625992855e-13	SNCA	Malignant cells	GSE131984_JQ1	ENSG00000145335	6622	synuclein alpha	NACP|PARK1|PARK4|PD1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39040
1.24675439644548e-17	-0.271994997257349	0.589	0.713	2.01837069240559e-13	MFSD10	Malignant cells	GSE131984_JQ1	ENSG00000109736	10227	major facilitator superfamily domain containing 10	IT10C3|TETRAN	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39041
1.49137296605692e-17	-0.275394407925938	0.585	0.698	2.41438369474956e-13	IARS2	Malignant cells	GSE131984_JQ1	ENSG00000067704	55699	isoleucyl-tRNA synthetase 2, mitochondrial	FLJ10326	protein_coding	Q9NSE4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39042
1.5285452221277e-17	-0.260675475336836	0.782	0.861	2.47456186010254e-13	TMEM14A	Malignant cells	GSE131984_JQ1	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39043
1.59387268616974e-17	-0.268079448384749	0.371	0.517	2.5803204916402e-13	LAP3	Malignant cells	GSE131984_JQ1	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39044
1.6125061826036e-17	-0.282780544037422	0.61	0.727	2.61048625901696e-13	CWC27	Malignant cells	GSE131984_JQ1	ENSG00000153015	10283	CWC27 spliceosome associated cyclophilin	NY-CO-10|SDCCAG-10|SDCCAG10	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39045
1.7236586198413e-17	-0.291293189378619	0.413	0.549	2.79043093966109e-13	MRPS9	Malignant cells	GSE131984_JQ1	ENSG00000135972	64965	mitochondrial ribosomal protein S9	MRP-S9|RPMS9|S9mt	protein_coding	P82933	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39046
1.81775810333295e-17	-0.297937400280732	0.411	0.554	2.94276859348572e-13	FTSJ2	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39047
1.82648233619806e-17	-0.265705133080914	0.36	0.514	2.95689225407104e-13	PUSL1	Malignant cells	GSE131984_JQ1	ENSG00000169972	126789	pseudouridine synthase like 1	FLJ90811	protein_coding	Q8N0Z8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39048
1.8410486598849e-17	-0.269713023590194	0.518	0.656	2.98047367548767e-13	KDSR	Malignant cells	GSE131984_JQ1	ENSG00000119537	2531	3-ketodihydrosphingosine reductase	DHSR|FVT1|SDR35C1	protein_coding	Q06136	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39049
1.941698007252e-17	-0.262761448028508	0.24	0.385	3.14341490394027e-13	GOT1	Malignant cells	GSE131984_JQ1	ENSG00000120053	2805	glutamic-oxaloacetic transaminase 1	AST|AST1|SGOT	protein_coding	P17174	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39050
1.9589555500632e-17	0.363015012934697	0.824	0.737	3.17135313999731e-13	SPARC	Malignant cells	GSE131984_JQ1	ENSG00000113140	6678	secreted protein acidic and cysteine rich	BM-40|ON|ONT	protein_coding	P09486	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39051
1.98597408750618e-17	-0.308877708908022	0.479	0.609	3.21509345026375e-13	RTCB	Malignant cells	GSE131984_JQ1	ENSG00000100220	51493	RNA 2',3'-cyclic phosphate and 5'-OH ligase	C22orf28|FAAP|HSPC117	protein_coding	Q9Y3I0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39052
2.11048271161951e-17	-0.254238133280604	0.279	0.429	3.41666046184082e-13	CYB561	Malignant cells	GSE131984_JQ1	ENSG00000008283	1534	cytochrome b561	CYB561A1|FRRS2	protein_coding	P49447	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39053
2.16141224944893e-17	-0.279317821838799	0.463	0.628	3.49911029063288e-13	PRC1	Malignant cells	GSE131984_JQ1	ENSG00000198901	9055	protein regulator of cytokinesis 1	ASE1	protein_coding	O43663	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39054
2.18548687099593e-17	-0.263822933436618	0.412	0.561	3.53808469545531e-13	ORAI1	Malignant cells	GSE131984_JQ1	ENSG00000276045	84876	ORAI calcium release-activated calcium modulator 1	CRACM1|FLJ14466|TMEM142A	protein_coding	Q96D31	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39055
2.20841732229386e-17	-0.299742740345021	0.226	0.371	3.57520680306153e-13	NUF2	Malignant cells	GSE131984_JQ1	ENSG00000143228	83540	NUF2 component of NDC80 kinetochore complex	CDCA1|CT106|NUF2R	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39056
2.43276497730009e-17	-0.263662329535701	0.468	0.617	3.93840322175112e-13	AAMP	Malignant cells	GSE131984_JQ1	ENSG00000127837	14	angio associated migratory cell protein	NA	protein_coding	Q13685	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39057
2.43934803444429e-17	-0.26245274788837	0.582	0.707	3.94906053296187e-13	RFC1	Malignant cells	GSE131984_JQ1	ENSG00000035928	5981	replication factor C subunit 1	A1|MHCBFB|PO-GA|RFC140	protein_coding	P35251	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39058
2.46925661177418e-17	-0.549383969354592	0.277	0.433	3.99747952880122e-13	CXCL3	Malignant cells	GSE131984_JQ1	ENSG00000163734	2921	C-X-C motif chemokine ligand 3	CINC-2b|GRO3|GROg|MIP-2b|SCYB3	protein_coding	P19876	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39059
2.49234411508156e-17	-0.269143830042425	0.408	0.556	4.03485588790553e-13	STAG2	Malignant cells	GSE131984_JQ1	ENSG00000101972	10735	stromal antigen 2	SA-2|SA2|SCC3B	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39060
2.67038184685526e-17	-0.277461368290222	0.603	0.726	4.32308117187398e-13	PPP1R11	Malignant cells	GSE131984_JQ1	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39061
2.81465021286686e-17	-0.299210851040896	0.651	0.744	4.55663722961016e-13	NDFIP1	Malignant cells	GSE131984_JQ1	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39062
2.82101061133682e-17	-0.261649557932082	0.999	0.999	4.56693407869318e-13	HSPA8	Malignant cells	GSE131984_JQ1	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39063
2.8496856327661e-17	-0.280259218483044	0.491	0.631	4.61335607088504e-13	NSMCE4A	Malignant cells	GSE131984_JQ1	ENSG00000107672	54780	NSE4 homolog A, SMC5-SMC6 complex component	bA500G22.3|C10orf86|FLJ20003|NSE4A	protein_coding	Q9NXX6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39064
2.93848724831448e-17	-0.255130472629189	0.86	0.899	4.75711700629631e-13	CISD2	Malignant cells	GSE131984_JQ1	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39065
2.95081152884544e-17	-0.283475234145014	0.628	0.746	4.77706878404787e-13	FUCA2	Malignant cells	GSE131984_JQ1	ENSG00000001036	2519	alpha-L-fucosidase 2	dJ20N2.5|MGC1314	protein_coding	Q9BTY2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39066
3.03149291486223e-17	0.278199566362268	0.877	0.808	4.90768387987046e-13	AKR7A2	Malignant cells	GSE131984_JQ1	ENSG00000053371	8574	aldo-keto reductase family 7 member A2	AFAR	protein_coding	O43488	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39067
3.23675344106469e-17	-0.253792935343733	0.347	0.5	5.23998014573962e-13	INTS12	Malignant cells	GSE131984_JQ1	ENSG00000138785	57117	integrator complex subunit 12	INT12|PHF22|SBBI22	protein_coding	Q96CB8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39068
3.27532747867307e-17	-0.270916295356195	0.451	0.588	5.30242765522384e-13	DAXX	Malignant cells	GSE131984_JQ1	ENSG00000231617	1616	death domain associated protein	DAP6	protein_coding	Q9UER7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39069
3.78782135248859e-17	-0.295243433718191	0.57	0.692	6.13210398754378e-13	PITX1	Malignant cells	GSE131984_JQ1	ENSG00000069011	5307	paired like homeodomain 1	BFT|POTX|PTX1	protein_coding	P78337	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39070
4.06820095407773e-17	-0.255488647164484	0.694	0.794	6.58601052455644e-13	FAM204A	Malignant cells	GSE131984_JQ1	ENSG00000165669	63877	family with sequence similarity 204 member A	bA319I23.1|C10orf84|FLJ13188	protein_coding	Q9H8W3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39071
4.10730081313271e-17	-0.267930219413619	0.496	0.644	6.64930928638054e-13	CEBPZ	Malignant cells	GSE131984_JQ1	ENSG00000115816	10153	CCAAT enhancer binding protein zeta	CBF2|CTF2	protein_coding	Q03701	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39072
4.18880523111128e-17	-0.256442365197931	0.339	0.495	6.78125678864605e-13	NOL10	Malignant cells	GSE131984_JQ1	ENSG00000115761	79954	nucleolar protein 10	FLJ14075|PQBP5	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39073
4.26465030095312e-17	-0.262762671482855	0.693	0.786	6.90404237221301e-13	FKBP8	Malignant cells	GSE131984_JQ1	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39074
4.27020982322154e-17	-0.290240599391802	0.343	0.484	6.91304268281335e-13	ACTR10	Malignant cells	GSE131984_JQ1	ENSG00000131966	55860	actin related protein 10	ACTR11|Arp10|Arp11|HARP11	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39075
4.30607750898623e-17	-0.260207942930229	0.311	0.459	6.97110887929781e-13	TXNDC15	Malignant cells	GSE131984_JQ1	ENSG00000113621	79770	thioredoxin domain containing 15	2310047H23Rik|C5orf14|FLJ22625	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39076
4.38686424562704e-17	0.265365946367264	0.396	0.244	7.10189452724561e-13	HES6	Malignant cells	GSE131984_JQ1	ENSG00000144485	55502	hes family bHLH transcription factor 6	bHLHb41	protein_coding	Q96HZ4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39077
4.39298680465675e-17	-0.263598755091714	0.702	0.805	7.11180633805882e-13	PARL	Malignant cells	GSE131984_JQ1	ENSG00000175193	55486	presenilin associated rhomboid like	PRO2207|PSARL|PSARL1|RHBDS1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39078
4.61520717308282e-17	0.310106417781823	0.832	0.73	7.47155889250378e-13	COL6A3	Malignant cells	GSE131984_JQ1	ENSG00000163359	1293	collagen type VI alpha 3 chain	NA	protein_coding	P12111	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39079
5.03602768965692e-17	0.281187082360815	0.465	0.319	8.15282522678558e-13	IRF2BPL	Malignant cells	GSE131984_JQ1	ENSG00000119669	64207	interferon regulatory factor 2 binding protein like	C14orf4|EAP1|KIAA1865	protein_coding	Q9H1B7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39080
5.07040481981941e-17	-0.267207302538744	0.443	0.586	8.20847836280564e-13	SCAMP3	Malignant cells	GSE131984_JQ1	ENSG00000263290	10067	secretory carrier membrane protein 3	C1orf3	protein_coding	O14828	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39081
5.45048756843443e-17	-0.272894432932875	0.59	0.72	8.8237943245385e-13	POLE3	Malignant cells	GSE131984_JQ1	ENSG00000148229	54107	DNA polymerase epsilon 3, accessory subunit	CHARAC17|CHRAC17|CHRAC2|p17|Ybl1	protein_coding	Q9NRF9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39082
5.76244081702206e-17	0.29772045206864	0.572	0.421	9.32881543867702e-13	PTGR1	Malignant cells	GSE131984_JQ1	ENSG00000106853	22949	prostaglandin reductase 1	LTB4DH|ZADH3	protein_coding	Q14914	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39083
5.80828034119126e-17	0.257702691396243	0.836	0.742	9.40302504435453e-13	BRD2	Malignant cells	GSE131984_JQ1	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39084
5.84388722290996e-17	-0.272883664353484	0.403	0.551	9.46066902516894e-13	TMEM156	Malignant cells	GSE131984_JQ1	ENSG00000121895	80008	transmembrane protein 156	FLJ23235	protein_coding	Q8N614	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39085
6.2882581031605e-17	0.281022972585086	0.753	0.643	1.01800610432065e-12	SPTBN1	Malignant cells	GSE131984_JQ1	ENSG00000115306	6711	spectrin beta, non-erythrocytic 1	NA	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39086
6.323417051656e-17	-0.260833793242707	0.341	0.486	1.02369798649259e-12	TSEN15	Malignant cells	GSE131984_JQ1	ENSG00000198860	116461	tRNA splicing endonuclease subunit 15	C1orf19	protein_coding	Q8WW01	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39087
6.36673462576707e-17	-0.283146776708976	0.337	0.488	1.03071066856543e-12	NXT2	Malignant cells	GSE131984_JQ1	ENSG00000101888	55916	nuclear transport factor 2 like export factor 2	P15-2	protein_coding	Q9NPJ8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39088
6.62885222604518e-17	-0.250372778812567	0.357	0.507	1.07314488687445e-12	FXN	Malignant cells	GSE131984_JQ1	ENSG00000165060	2395	frataxin	CyaY|FA|FARR|FRDA|X25	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39089
7.93086960948369e-17	-0.260876471702716	0.44	0.59	1.28392848107931e-12	NMT1	Malignant cells	GSE131984_JQ1	ENSG00000136448	4836	N-myristoyltransferase 1	NMT	protein_coding	P30419	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39090
8.14638546596126e-17	0.298743922205659	0.482	0.336	1.31881834308447e-12	COL5A1	Malignant cells	GSE131984_JQ1	ENSG00000130635	1289	collagen type V alpha 1 chain	NA	protein_coding	P20908	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39091
9.39745525983056e-17	-0.264891119799319	0.962	0.977	1.52135403201397e-12	TPM1	Malignant cells	GSE131984_JQ1	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39092
9.44593153413772e-17	-0.255053616615572	0.576	0.707	1.52920185606156e-12	SRSF4	Malignant cells	GSE131984_JQ1	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39093
1.02318964659362e-16	-0.281088007455379	0.694	0.788	1.65644171887041e-12	C4orf32	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39094
1.05580062196764e-16	0.401757771088697	0.268	0.137	1.70923562690341e-12	AQP3	Malignant cells	GSE131984_JQ1	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39095
1.06461825693869e-16	-0.256578262310337	0.804	0.878	1.72351049615804e-12	SRA1	Malignant cells	GSE131984_JQ1	ENSG00000213523	10011	steroid receptor RNA activator 1	SRA|STRAA1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39096
1.07230412456458e-16	-0.291751745184399	0.462	0.603	1.7359531472576e-12	ATP6AP2	Malignant cells	GSE131984_JQ1	ENSG00000182220	10159	ATPase H+ transporting accessory protein 2	APT6M8-9|ATP6IP2|ATP6M8-9|M8-9|PRR|RENR	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39097
1.13356953223859e-16	-0.30303234897218	0.587	0.703	1.83513571574105e-12	DPM1	Malignant cells	GSE131984_JQ1	ENSG00000000419	8813	dolichyl-phosphate mannosyltransferase subunit 1, catalytic	CDGIE|MPDS	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39098
1.19439721520842e-16	0.271688711513805	0.9	0.827	1.93360965170092e-12	PERP	Malignant cells	GSE131984_JQ1	ENSG00000112378	64065	p53 apoptosis effector related to PMP22	dJ496H19.1|KCP1|KRTCAP1|PIGPC1|THW	protein_coding	Q96FX8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39099
1.31762504269946e-16	-0.268440870188603	0.732	0.803	2.13310318162615e-12	RAD23B	Malignant cells	GSE131984_JQ1	ENSG00000119318	5887	RAD23 homolog B, nucleotide excision repair protein	HHR23B|HR23B|P58	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39100
1.34596092333449e-16	-0.256616403028223	0.682	0.8	2.17897613878621e-12	TSEN34	Malignant cells	GSE131984_JQ1	ENSG00000274078	79042	tRNA splicing endonuclease subunit 34	LENG5|SEN34|SEN34L	protein_coding	Q9BSV6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39101
1.39778699897172e-16	-0.254825531123426	0.523	0.663	2.26287737263532e-12	SCOC	Malignant cells	GSE131984_JQ1	ENSG00000153130	60592	short coiled-coil protein	HRIHFB2072|SCOCO|UNC-69	protein_coding	Q9UIL1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39102
1.45950047404931e-16	-0.262665713002529	0.457	0.598	2.36278531743843e-12	RPP25L	Malignant cells	GSE131984_JQ1	ENSG00000164967	138716	ribonuclease P/MRP subunit p25 like	bA296L22.5|C9orf23|MGC29635	protein_coding	Q8N5L8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39103
1.49292813985506e-16	-0.276235037978376	0.627	0.727	2.41690136561136e-12	EMC3	Malignant cells	GSE131984_JQ1	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39104
1.64483436571296e-16	-0.278174429986169	0.518	0.657	2.66282235465271e-12	GNPNAT1	Malignant cells	GSE131984_JQ1	ENSG00000100522	64841	glucosamine-phosphate N-acetyltransferase 1	FLJ10607|Gpnat1	protein_coding	Q96EK6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39105
1.75666337075017e-16	-0.27203041175704	0.615	0.74	2.84386233090745e-12	TIAL1	Malignant cells	GSE131984_JQ1	ENSG00000151923	7073	TIA1 cytotoxic granule associated RNA binding protein like 1	TIAR	protein_coding	Q01085	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39106
1.8084529781149e-16	-0.252868954332912	0.305	0.449	2.92770452627021e-12	MED30	Malignant cells	GSE131984_JQ1	ENSG00000164758	90390	mediator complex subunit 30	THRAP6|TRAP25	protein_coding	Q96HR3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39107
2.00942476432199e-16	-0.253276431471946	0.308	0.451	3.25305775096087e-12	MTHFD1	Malignant cells	GSE131984_JQ1	ENSG00000100714	4522	methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1	MTHFC|MTHFD	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39108
2.02539525687693e-16	-0.276215819130621	0.286	0.432	3.27891238135806e-12	IFRD1	Malignant cells	GSE131984_JQ1	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39109
2.03105533636764e-16	-0.277744690668905	0.404	0.545	3.28807548404557e-12	SLC39A7	Malignant cells	GSE131984_JQ1	ENSG00000229802	7922	solute carrier family 39 member 7	D6S2244E|H2-KE4|HKE4|KE4|RING5|ZIP7	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39110
2.12788494880231e-16	-0.251577202091732	0.334	0.483	3.44483294361605e-12	SUCLG2	Malignant cells	GSE131984_JQ1	ENSG00000172340	8801	succinate-CoA ligase GDP-forming subunit beta	NA	protein_coding	Q96I99	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39111
2.17288053783305e-16	-0.261060773799141	0.513	0.655	3.51767630269792e-12	IARS	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39112
2.33644738985459e-16	-0.26300531576882	0.356	0.492	3.78247467943559e-12	COPS4	Malignant cells	GSE131984_JQ1	ENSG00000138663	51138	COP9 signalosome subunit 4	CSN4|SGN4	protein_coding	Q9BT78	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39113
2.46918138707462e-16	0.263561443940285	0.737	0.611	3.99735774753509e-12	MBNL1	Malignant cells	GSE131984_JQ1	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39114
2.76293319674307e-16	0.269336997652472	0.74	0.622	4.47291255220735e-12	TMEM134	Malignant cells	GSE131984_JQ1	ENSG00000172663	80194	transmembrane protein 134	FLJ21749	protein_coding	Q9H6X4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39115
2.78807734982687e-16	-0.255198866556887	0.155	0.279	4.51361842163472e-12	HIST1H1E	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39116
2.89777184201979e-16	-0.271749579846147	0.309	0.447	4.69120283504584e-12	ACSL4	Malignant cells	GSE131984_JQ1	ENSG00000068366	2182	acyl-CoA synthetase long chain family member 4	ACS4|FACL4|LACS4|MRX63|MRX68	protein_coding	O60488	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39117
2.90823415682539e-16	-0.274226925167365	0.142	0.267	4.70814027648463e-12	HIST1H1D	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39118
3.17488337822592e-16	-0.255240876363235	0.415	0.562	5.13981870100994e-12	CEP57	Malignant cells	GSE131984_JQ1	ENSG00000166037	9702	centrosomal protein 57	KIAA0092|Translokin|TSP57	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39119
3.32458471060918e-16	-0.258057790611133	0.907	0.932	5.3821701880052e-12	NONO	Malignant cells	GSE131984_JQ1	ENSG00000147140	4841	non-POU domain containing octamer binding	NMT55|NRB54|P54|P54NRB|PPP1R114	protein_coding	Q15233	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39120
3.39042971864161e-16	-0.25008223026933	0.649	0.763	5.4887666715089e-12	PRPF31	Malignant cells	GSE131984_JQ1	ENSG00000274651	26121	pre-mRNA processing factor 31	hPrp31|NY-BR-99|PRP31|RP11|SNRNP61	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39121
3.48915763129785e-16	-0.263898502579516	0.452	0.592	5.6485972893081e-12	CTBP2	Malignant cells	GSE131984_JQ1	ENSG00000175029	1488	C-terminal binding protein 2	ribeye	protein_coding	P56545	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39122
3.74617398110704e-16	-0.299368224549558	0.528	0.66	6.06468105801419e-12	CSTF3	Malignant cells	GSE131984_JQ1	ENSG00000176102	1479	cleavage stimulation factor subunit 3	CstF-77	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39123
3.96694314689697e-16	-0.259466926772746	0.497	0.637	6.42208426051151e-12	FAM49B	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39124
4.13974961457239e-16	-0.260272242934937	0.416	0.559	6.70184065103124e-12	PET100	Malignant cells	GSE131984_JQ1	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39125
4.18936871350163e-16	-0.252872681180953	0.835	0.88	6.78216901028778e-12	ECHS1	Malignant cells	GSE131984_JQ1	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39126
4.36247133316147e-16	-0.268935678083547	0.741	0.807	7.0624048412551e-12	THRAP3	Malignant cells	GSE131984_JQ1	ENSG00000054118	9967	thyroid hormone receptor associated protein 3	BCLAF2|TRAP150	protein_coding	Q9Y2W1	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39127
4.37693782238197e-16	-0.268971876528106	0.477	0.614	7.08582464065418e-12	SAT2	Malignant cells	GSE131984_JQ1	ENSG00000141504	112483	spermidine/spermine N1-acetyltransferase family member 2	SSAT2	protein_coding	Q96F10	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39128
4.4991897354098e-16	-0.257840500899013	0.497	0.634	7.28373826265492e-12	FAM192A	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39129
4.66092644369658e-16	-0.269112666181379	0.692	0.779	7.54557381970039e-12	SERPINB6	Malignant cells	GSE131984_JQ1	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39130
4.78794451660999e-16	0.266901545584745	0.691	0.573	7.75120337793991e-12	WNK1	Malignant cells	GSE131984_JQ1	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39131
4.96546358309979e-16	-0.27293568992248	0.591	0.708	8.03858899468025e-12	DARS	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39132
5.16959393095326e-16	0.282673686384751	0.73	0.621	8.36905561482023e-12	C6orf62	Malignant cells	GSE131984_JQ1	ENSG00000112308	81688	chromosome 6 open reading frame 62	DKFZP564G182|FLJ12619|XTP12	protein_coding	Q9GZU0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39133
5.20081396332958e-16	-0.403291938744595	0.306	0.438	8.41959772523425e-12	JUN	Malignant cells	GSE131984_JQ1	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39134
5.43066801111262e-16	-0.254765842726255	0.319	0.458	8.79170844319023e-12	ANAPC10	Malignant cells	GSE131984_JQ1	ENSG00000164162	10393	anaphase promoting complex subunit 10	APC10|DKFZP564L0562|DOC1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39135
5.54995162814556e-16	-0.254860594065687	0.825	0.877	8.98481669080484e-12	SLMO2	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39136
5.80509964973107e-16	0.299097415035213	0.71	0.578	9.39787582294963e-12	ITGA5	Malignant cells	GSE131984_JQ1	ENSG00000161638	3678	integrin subunit alpha 5	CD49e|FNRA	protein_coding	P08648	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39137
5.85459281767207e-16	0.256642915273909	0.688	0.549	9.47800031252932e-12	LTA4H	Malignant cells	GSE131984_JQ1	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39138
7.21237249402586e-16	-0.282048561395012	0.616	0.732	1.16761098305785e-11	GGH	Malignant cells	GSE131984_JQ1	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39139
8.10640061803375e-16	-0.256701157837622	0.541	0.666	1.31234519605348e-11	PTDSS1	Malignant cells	GSE131984_JQ1	ENSG00000156471	9791	phosphatidylserine synthase 1	KIAA0024|PSS1|PSSA	protein_coding	P48651	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39140
8.90195687587641e-16	-0.260515679245372	0.537	0.666	1.44113779863563e-11	IK	Malignant cells	GSE131984_JQ1	ENSG00000113141	3550	IK cytokine	RED|RER	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39141
8.96003990532301e-16	0.250317327261597	0.598	0.46	1.45054086027274e-11	SLC44A1	Malignant cells	GSE131984_JQ1	ENSG00000070214	23446	solute carrier family 44 member 1	CD92|CDW92|CHTL1|CTL1	protein_coding	Q8WWI5	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39142
1.07431516882591e-15	-0.278770846210397	0.53	0.647	1.73920882681226e-11	DNAJA2	Malignant cells	GSE131984_JQ1	ENSG00000069345	10294	DnaJ heat shock protein family (Hsp40) member A2	CPR3|DNAJ|DNJ3|HIRIP4	protein_coding	O60884	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39143
1.11239886598596e-15	0.270463663106756	0.649	0.518	1.80086252414467e-11	PXN	Malignant cells	GSE131984_JQ1	ENSG00000089159	5829	paxillin	NA	protein_coding	P49023	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39144
1.16294287478925e-15	0.307017369809978	0.585	0.455	1.88268821999631e-11	SREBF1	Malignant cells	GSE131984_JQ1	ENSG00000072310	6720	sterol regulatory element binding transcription factor 1	bHLHd1|SREBP-1c|SREBP1|SREBP1a	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39145
1.18197133282062e-15	-0.261325221308434	0.327	0.47	1.9134933907033e-11	SNHG10	Malignant cells	GSE131984_JQ1	ENSG00000247092	283596	small nucleolar RNA host gene 10	C14orf62|FLJ40557|LINC00063|NCRNA00063|TP53LC16	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39146
1.25208026486888e-15	-0.259144503267403	0.777	0.834	2.02699274079622e-11	NCBP2-AS2	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39147
1.2940198536672e-15	-0.270222858649315	0.559	0.682	2.09488874110184e-11	RAD50	Malignant cells	GSE131984_JQ1	ENSG00000113522	10111	RAD50 double strand break repair protein	hRad50|RAD50-2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39148
1.33031913608399e-15	0.276300608422805	0.556	0.418	2.15365364940638e-11	ITGB5	Malignant cells	GSE131984_JQ1	ENSG00000082781	3693	integrin subunit beta 5	NA	protein_coding	P18084	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39149
1.33661954194749e-15	-0.28274598779827	0.421	0.549	2.16385337645879e-11	PES1	Malignant cells	GSE131984_JQ1	ENSG00000100029	23481	pescadillo ribosomal biogenesis factor 1	NOP7|PES	protein_coding	O00541	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39150
1.35004433485051e-15	-0.258299810569753	0.459	0.602	2.1855867736895e-11	TXNDC12	Malignant cells	GSE131984_JQ1	ENSG00000117862	51060	thioredoxin domain containing 12	AGR1|ERP18|ERP19|hAG-1|PDIA16|TLP19	protein_coding	O95881	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39151
1.51934155882867e-15	-0.265108530845056	0.707	0.8	2.45966204958774e-11	ASNA1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39152
1.8615467840312e-15	-0.264148101410509	0.652	0.76	3.01365808866812e-11	CCDC109B	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39153
1.91095184609277e-15	-0.268024884442583	0.59	0.703	3.09363994363958e-11	MRPS10	Malignant cells	GSE131984_JQ1	ENSG00000048544	55173	mitochondrial ribosomal protein S10	FLJ10567	protein_coding	P82664	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39154
2.03330931588166e-15	-0.299489108963796	0.153	0.274	3.29172445148082e-11	FHL1	Malignant cells	GSE131984_JQ1	ENSG00000022267	2273	four and a half LIM domains 1	bA535K18.1|FHL1B|FLH1A|KYO-T|MGC111107|SLIM1|XMPMA	protein_coding	Q13642	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39155
2.06042076956426e-15	-0.264290330913644	0.757	0.837	3.33561518384757e-11	TMED10	Malignant cells	GSE131984_JQ1	ENSG00000170348	10972	transmembrane p24 trafficking protein 10	p23|P24(DELTA)|p24d1|p24delta1|TMP21	protein_coding	P49755	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39156
2.2256481135734e-15	0.286230154351386	0.924	0.882	3.60310173106398e-11	ADI1	Malignant cells	GSE131984_JQ1	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39157
2.35894113534765e-15	-0.259563190235736	0.827	0.89	3.81888980401432e-11	SRSF11	Malignant cells	GSE131984_JQ1	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39158
2.41928845738643e-15	0.267203897057278	0.562	0.422	3.9165860836629e-11	TSPYL1	Malignant cells	GSE131984_JQ1	ENSG00000189241	7259	TSPY like 1	TSPYL	protein_coding	Q9H0U9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39159
2.5923680391634e-15	-0.260745227036317	0.525	0.645	4.19678461860163e-11	ATG5	Malignant cells	GSE131984_JQ1	ENSG00000057663	9474	autophagy related 5	APG5|APG5L|ASP|hAPG5	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39160
2.73263899699454e-15	-0.259990738993429	0.505	0.637	4.42386927223446e-11	KDM1A	Malignant cells	GSE131984_JQ1	ENSG00000004487	23028	lysine demethylase 1A	AOF2|BHC110|KDM1|KIAA0601|LSD1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39161
2.93941253195741e-15	0.258476005020705	0.502	0.364	4.75861494798586e-11	MEF2A	Malignant cells	GSE131984_JQ1	ENSG00000068305	4205	myocyte enhancer factor 2A	RSRFC4|RSRFC9	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39162
3.7965661878525e-15	-0.255780424906582	0.764	0.827	6.14626100151441e-11	RAP1B	Malignant cells	GSE131984_JQ1	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39163
3.84145221468515e-15	-0.298675970063031	0.596	0.717	6.21892699035379e-11	PDIA4	Malignant cells	GSE131984_JQ1	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39164
3.84599620367209e-15	0.324899494990053	0.844	0.717	6.22628325412474e-11	TUBA1A	Malignant cells	GSE131984_JQ1	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39165
4.1426955902909e-15	-0.265263799651775	0.685	0.769	6.70660989112195e-11	MRPS11	Malignant cells	GSE131984_JQ1	ENSG00000181991	64963	mitochondrial ribosomal protein S11	FLJ22512|FLJ23406|HCC-2	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39166
4.4011592805127e-15	-0.258107065086341	0.51	0.642	7.12503675922201e-11	DFFA	Malignant cells	GSE131984_JQ1	ENSG00000160049	1676	DNA fragmentation factor subunit alpha	DFF-45|DFF1|DFF45|ICAD	protein_coding	O00273	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39167
4.44607189861212e-15	-0.25794722692684	0.622	0.723	7.19774579666316e-11	CDC34	Malignant cells	GSE131984_JQ1	ENSG00000099804	997	cell division cycle 34, ubiqiutin conjugating enzyme	E2-CDC34|UBC3|UBE2R1	protein_coding	P49427	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39168
4.89692476756662e-15	0.267567904799416	0.379	0.246	7.9276315062136e-11	CPEB4	Malignant cells	GSE131984_JQ1	ENSG00000113742	80315	cytoplasmic polyadenylation element binding protein 4	KIAA1673	protein_coding	Q17RY0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39169
5.03032147980844e-15	-0.262800080924826	0.488	0.619	8.14358744366188e-11	SAR1B	Malignant cells	GSE131984_JQ1	ENSG00000152700	51128	secretion associated Ras related GTPase 1B	SARA2	protein_coding	Q9Y6B6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39170
5.2829627929329e-15	-0.26203844806174	0.429	0.552	8.55258846547907e-11	GNL1	Malignant cells	GSE131984_JQ1	ENSG00000229470	2794	G protein nucleolar 1 (putative)	HSR1	protein_coding	P36915	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39171
5.54782265569472e-15	0.266425402232569	0.495	0.355	8.98137009730419e-11	MFGE8	Malignant cells	GSE131984_JQ1	ENSG00000140545	4240	milk fat globule EGF and factor V/VIII domain containing	BA46|EDIL1|hP47|HsT19888|MFG-E8|OAcGD3S|SED1|SPAG10	protein_coding	Q08431	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39172
5.5885783428972e-15	0.43782909544358	0.37	0.239	9.04734947931628e-11	SEPP1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39173
5.81883387687104e-15	-0.252192533109272	0.585	0.692	9.42011016326652e-11	DAP3	Malignant cells	GSE131984_JQ1	ENSG00000132676	7818	death associated protein 3	bMRP-10|DAP-3|DKFZp686G12159|MGC126058|MGC126059|MRP-S29|MRPS29	protein_coding	P51398	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39174
5.95209783575299e-15	-0.252443034535809	0.667	0.775	9.63585118630051e-11	GOLGA4	Malignant cells	GSE131984_JQ1	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39175
6.19609879525431e-15	-0.262376340120751	0.533	0.648	1.00308643396372e-10	COMMD8	Malignant cells	GSE131984_JQ1	ENSG00000169019	54951	COMM domain containing 8	FLJ20502	protein_coding	Q9NX08	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39176
6.48784160783915e-15	-0.263845408505898	0.702	0.783	1.05031667789308e-10	TIMM9	Malignant cells	GSE131984_JQ1	ENSG00000100575	26520	translocase of inner mitochondrial membrane 9	TIM9A	protein_coding	Q9Y5J7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39177
6.64331242170832e-15	-0.264776130511644	0.581	0.693	1.07548584795036e-10	ISCA2	Malignant cells	GSE131984_JQ1	ENSG00000165898	122961	iron-sulfur cluster assembly 2	HBLD1|ISA2	protein_coding	Q86U28	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39178
8.48546794766176e-15	-0.298491199862862	0.537	0.644	1.37371240604696e-10	NMT2	Malignant cells	GSE131984_JQ1	ENSG00000152465	9397	N-myristoyltransferase 2	NA	protein_coding	O60551	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39179
9.79004172585327e-15	-0.254241460775653	0.427	0.558	1.58490985499839e-10	SNX9	Malignant cells	GSE131984_JQ1	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39180
1.07748208993397e-14	-0.253546449274751	0.409	0.537	1.7443357553941e-10	HADH	Malignant cells	GSE131984_JQ1	ENSG00000138796	3033	hydroxyacyl-CoA dehydrogenase	HADH1|HADHSC|SCHAD	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39181
1.11959783772709e-14	-0.275351900730195	0.491	0.613	1.81251693949638e-10	GALK1	Malignant cells	GSE131984_JQ1	ENSG00000108479	2584	galactokinase 1	GALK	protein_coding	P51570	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39182
1.24729980051203e-14	-0.269370688839217	0.514	0.641	2.01925364704893e-10	CYB5B	Malignant cells	GSE131984_JQ1	ENSG00000103018	80777	cytochrome b5 type B	CYB5-M	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39183
1.3669091300097e-14	-0.282021972839153	0.452	0.562	2.2128891905727e-10	WBP4	Malignant cells	GSE131984_JQ1	ENSG00000120688	11193	WW domain binding protein 4	FBP21|MGC117310	protein_coding	O75554	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39184
1.48652474096786e-14	0.269631773271537	0.711	0.6	2.40653490315287e-10	PLOD1	Malignant cells	GSE131984_JQ1	ENSG00000083444	5351	procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	LH1|LLH|PLOD	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39185
1.5123760405873e-14	-0.26106580558813	0.544	0.659	2.44838557210677e-10	CASP4	Malignant cells	GSE131984_JQ1	ENSG00000196954	837	caspase 4	ICE(rel)II|ICH-2|TX	protein_coding	P49662	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39186
1.88304220090991e-14	-0.25382367101401	0.698	0.795	3.04845701905305e-10	IKBIP	Malignant cells	GSE131984_JQ1	ENSG00000166130	121457	IKBKB interacting protein	FLJ31051|IKIP	protein_coding	Q70UQ0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39187
2.09080147988513e-14	-0.252815749226684	0.487	0.645	3.38479851578604e-10	TPX2	Malignant cells	GSE131984_JQ1	ENSG00000088325	22974	TPX2 microtubule nucleation factor	C20orf1|C20orf2|DIL-2|FLS353|HCA519|p100	protein_coding	Q9ULW0	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39188
2.85768357503278e-14	-0.257180223995247	0.64	0.737	4.62630393962057e-10	PIGP	Malignant cells	GSE131984_JQ1	ENSG00000185808	51227	phosphatidylinositol glycan anchor biosynthesis class P	DCRC|DSCR5|DSRC	protein_coding	P57054	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39189
2.96559726709227e-14	-0.254286634442466	0.489	0.619	4.80100541569567e-10	APIP	Malignant cells	GSE131984_JQ1	ENSG00000149089	51074	APAF1 interacting protein	APIP2|CGI-29|Mmrp19	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39190
3.56528792447013e-14	0.269974089754187	0.533	0.402	5.77184462092469e-10	ZBTB16	Malignant cells	GSE131984_JQ1	ENSG00000109906	7704	zinc finger and BTB domain containing 16	PLZF|ZNF145	protein_coding	Q05516	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39191
4.28059657142993e-14	0.277260803594507	0.704	0.58	6.92985778948792e-10	ZFP36	Malignant cells	GSE131984_JQ1	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39192
4.90305526798938e-14	-0.282039465882784	0.496	0.602	7.93755617334801e-10	MPP1	Malignant cells	GSE131984_JQ1	ENSG00000130830	4354	MAGUK p55 scaffold protein 1	DXS552E|PEMP	protein_coding	Q00013	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39193
6.24026180457545e-14	-0.252591055255562	0.512	0.626	1.01023598354272e-09	FAM92A1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39194
6.36087363767073e-14	-0.251980839796255	0.688	0.781	1.02976183320251e-09	MCFD2	Malignant cells	GSE131984_JQ1	ENSG00000180398	90411	multiple coagulation factor deficiency 2, ER cargo receptor complex subunit	F5F8D|LMAN1IP|SDNSF	protein_coding	Q8NI22	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39195
6.53420786237815e-14	0.266023606784118	0.901	0.861	1.0578229108404e-09	METRN	Malignant cells	GSE131984_JQ1	ENSG00000103260	79006	meteorin, glial cell differentiation regulator	C16orf23|MGC2601	protein_coding	Q9UJH8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39196
6.53951928473254e-14	0.341306238285575	0.864	0.803	1.05868277700535e-09	CYBA	Malignant cells	GSE131984_JQ1	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39197
6.71791218975263e-14	-0.253433328143906	0.237	0.369	1.08756280439905e-09	HMMR	Malignant cells	GSE131984_JQ1	ENSG00000072571	3161	hyaluronan mediated motility receptor	CD168|RHAMM	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39198
7.13975302042054e-14	0.277054654373192	0.61	0.493	1.15585461647588e-09	IRF2BP2	Malignant cells	GSE131984_JQ1	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39199
7.77991425732317e-14	0.278506431640771	0.755	0.673	1.25949031911805e-09	C6orf1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39200
7.91905096157171e-14	-0.253709485004592	0.656	0.746	1.28201516016884e-09	RRP36	Malignant cells	GSE131984_JQ1	ENSG00000124541	88745	ribosomal RNA processing 36	C6orf153|dJ20C7.4	protein_coding	Q96EU6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39201
8.89475633808773e-14	-0.277908331354639	0.836	0.893	1.43997210357302e-09	GLRX	Malignant cells	GSE131984_JQ1	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39202
9.09239507633177e-14	-0.255713884018022	0.414	0.542	1.47196783890735e-09	SNX8	Malignant cells	GSE131984_JQ1	ENSG00000106266	29886	sorting nexin 8	Mvp1	protein_coding	Q9Y5X2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39203
1.02641835426608e-13	-0.261411334954986	0.676	0.762	1.66166867372136e-09	ARL4A	Malignant cells	GSE131984_JQ1	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39204
1.04437388764533e-13	0.265081954303208	0.557	0.422	1.69073688670902e-09	MIDN	Malignant cells	GSE131984_JQ1	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39205
1.04793451372513e-13	0.450802547426645	0.705	0.583	1.69650118426962e-09	ARL6IP1	Malignant cells	GSE131984_JQ1	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39206
1.11690167192949e-13	-0.291616265192507	0.456	0.58	1.80815211668665e-09	CNN3	Malignant cells	GSE131984_JQ1	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39207
1.20651052090699e-13	-0.260798281826011	0.964	0.977	1.95321988229633e-09	TSC22D1	Malignant cells	GSE131984_JQ1	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39208
1.80382142566624e-13	-0.499092985523715	0.571	0.63	2.92020650601108e-09	NGFRAP1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39209
2.22793207092455e-13	-0.270172729389216	0.514	0.631	3.60679922961976e-09	PIM3	Malignant cells	GSE131984_JQ1	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39210
2.29003692819147e-13	-0.276693101778884	0.643	0.728	3.70734078304917e-09	TCEAL3	Malignant cells	GSE131984_JQ1	ENSG00000196507	85012	transcription elongation factor A like 3	MGC15737|WEX8	protein_coding	Q969E4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39211
2.93998295160483e-13	-0.302135841386683	0.493	0.614	4.75953840035305e-09	TMEM255B	Malignant cells	GSE131984_JQ1	ENSG00000282107	348013	transmembrane protein 255B	FAM70B|MGC20579	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39212
5.41129311419326e-13	-0.252731552095393	0.539	0.644	8.76034242256746e-09	PPA2	Malignant cells	GSE131984_JQ1	ENSG00000138777	27068	inorganic pyrophosphatase 2	FLJ20459	protein_coding	Q9H2U2	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39213
5.70877465271999e-13	-0.26453486667003	0.677	0.76	9.24193528528839e-09	ARHGAP18	Malignant cells	GSE131984_JQ1	ENSG00000146376	93663	Rho GTPase activating protein 18	bA307O14.2|MacGAP	protein_coding	Q8N392	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39214
7.78519294666108e-13	-0.253360151585719	0.397	0.52	1.26034488613496e-08	PLOD2	Malignant cells	GSE131984_JQ1	ENSG00000152952	5352	procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	LH2|TLH	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39215
8.46559424948719e-13	-0.266343089773999	0.456	0.571	1.37049505304948e-08	CEBPG	Malignant cells	GSE131984_JQ1	ENSG00000153879	1054	CCAAT enhancer binding protein gamma	GPE1BP|IG/EBP-1	protein_coding	P53567	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39216
1.35217254701028e-12	-0.252739292731112	0.745	0.807	2.18903213635495e-08	TRAM1	Malignant cells	GSE131984_JQ1	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39217
1.67582156110435e-12	0.260212263277389	0.592	0.458	2.71298752527183e-08	THBS1	Malignant cells	GSE131984_JQ1	ENSG00000137801	7057	thrombospondin 1	THBS|THBS-1|TSP|TSP-1|TSP1	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39218
1.90062605177583e-12	0.258672736425959	0.819	0.743	3.07692351521989e-08	TAX1BP3	Malignant cells	GSE131984_JQ1	ENSG00000213977	30851	Tax1 binding protein 3	TIP-1	protein_coding	O14907	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39219
2.35408649196668e-12	-0.283865497006268	0.445	0.549	3.81103062184486e-08	SNHG9	Malignant cells	GSE131984_JQ1	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39220
2.67330459282693e-12	-0.254361253294713	0.561	0.664	4.32781280532752e-08	SLC25A11	Malignant cells	GSE131984_JQ1	ENSG00000108528	8402	solute carrier family 25 member 11	OGC|SLC20A4	protein_coding	Q02978	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39221
3.36135556873251e-12	0.255490871785644	0.424	0.304	5.44169853022105e-08	SPRY2	Malignant cells	GSE131984_JQ1	ENSG00000136158	10253	sprouty RTK signaling antagonist 2	hSPRY2	protein_coding	O43597	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39222
3.36665748062647e-12	0.291656663872502	0.336	0.22	5.45028179538619e-08	TXNIP	Malignant cells	GSE131984_JQ1	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39223
4.52137153770083e-12	0.275248539432636	0.827	0.746	7.31964838238387e-08	F3	Malignant cells	GSE131984_JQ1	ENSG00000117525	2152	coagulation factor III, tissue factor	CD142|TF	protein_coding	P13726	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39224
4.54486918634226e-12	-0.254088639170023	0.604	0.689	7.35768872576949e-08	ATXN10	Malignant cells	GSE131984_JQ1	ENSG00000130638	25814	ataxin 10	ATX10|E46L|FLJ37990|SCA10	protein_coding	Q9UBB4	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39225
1.44364396305083e-11	0.272594645757575	0.99	0.992	2.33711521178299e-07	ODC1	Malignant cells	GSE131984_JQ1	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39226
2.09308249529597e-11	-0.263284114893946	0.659	0.719	3.38849125163464e-07	SAR1A	Malignant cells	GSE131984_JQ1	ENSG00000079332	56681	secretion associated Ras related GTPase 1A	SAR1|Sara|SARA1	protein_coding	Q9NR31	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39227
2.16092880112905e-11	0.451575260533636	0.727	0.573	3.49832763614781e-07	SPANXD	Malignant cells	GSE131984_JQ1	ENSG00000196406	64648	SPANX family member D	CT11.4|SPANXE	protein_coding	Q9BXN6	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39228
2.97540522902888e-11	-0.259270447471095	0.468	0.58	4.81688352527485e-07	CTA-29F11.1	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39229
4.11583566632193e-11	0.255674280597464	0.987	0.979	6.66312636020857e-07	S100A13	Malignant cells	GSE131984_JQ1	ENSG00000189171	6284	S100 calcium binding protein A13	NA	protein_coding	Q99584	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39230
3.87941684828463e-10	-0.256200042891923	0.162	0.256	6.28038793568798e-06	DDIT3	Malignant cells	GSE131984_JQ1	ENSG00000175197	1649	DNA damage inducible transcript 3	CHOP|CHOP10|GADD153	protein_coding	P35638	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39231
4.59843416430651e-10	0.267574554588615	0.84	0.75	7.44440506859582e-06	EGR1	Malignant cells	GSE131984_JQ1	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39232
1.10047073537224e-09	0.261286197214902	0.567	0.468	1.78155207349411e-05	DUSP5	Malignant cells	GSE131984_JQ1	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39233
1.16230137895383e-09	-0.271617750890068	0.421	0.512	1.88164970238836e-05	MAD1L1	Malignant cells	GSE131984_JQ1	ENSG00000002822	8379	mitotic arrest deficient 1 like 1	HsMAD1|MAD1|PIG9|TP53I9|TXBP181	protein_coding	Q9Y6D9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39234
1.16569097936683e-09	-0.285875534609622	0.889	0.901	1.88713712649696e-05	GADD45A	Malignant cells	GSE131984_JQ1	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39235
1.71259094880805e-09	0.253821614919896	0.704	0.614	2.77251348702535e-05	SLC20A1	Malignant cells	GSE131984_JQ1	ENSG00000144136	6574	solute carrier family 20 member 1	Glvr-1|GLVR1|PiT-1|PiT1	protein_coding	Q8WUM9	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39236
1.93787954883979e-09	-0.368269518230914	0.572	0.658	3.13723320161674e-05	DKK1	Malignant cells	GSE131984_JQ1	ENSG00000107984	22943	dickkopf WNT signaling pathway inhibitor 1	DKK-1|SK	protein_coding	O94907	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39237
8.23825384209433e-09	-0.349233895711504	0.594	0.659	0.000133369091449665	HERPUD1	Malignant cells	GSE131984_JQ1	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39238
2.49680423491452e-08	-0.306407984168664	0.681	0.746	0.000404207637590311	TSC22D3	Malignant cells	GSE131984_JQ1	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39239
1.32359074949892e-07	-0.420758931252037	0.495	0.551	0.00214276106436381	IL6	Malignant cells	GSE131984_JQ1	ENSG00000136244	3569	interleukin 6	BSF2|HGF|HSF|IFNB2|IL-6	protein_coding	P05231	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39240
4.89488084269894e-07	-0.25848926784826	0.44	0.504	0.00792432259624531	SERPINH1	Malignant cells	GSE131984_JQ1	ENSG00000149257	871	serpin family H member 1	CBP1|CBP2|HSP47|SERPINH2	protein_coding	P50454	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39241
8.70226797728304e-07	0.253826061023816	0.93	0.91	0.0140881016284235	SERPINE1	Malignant cells	GSE131984_JQ1	ENSG00000106366	5054	serpin family E member 1	PAI|PAI1|PLANH1	protein_coding	P05121	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39242
1.19033187237787e-06	0.264567916036432	0.475	0.394	0.0192702826819253	HIST1H2BK	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39243
2.38476931628979e-06	0.334659788147436	0.364	0.292	0.0386070304614154	AC006262.5	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39244
3.06777828694283e-06	0.28629247500882	0.53	0.446	0.0496642626873174	HIST1H1C	Malignant cells	GSE131984_JQ1	NA	NA	NA	NA	NA	NA	GSE131984_JQ1	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1	Homo sapiens	SUM159 cell line	Cell line	resistant 2, sensitive 2	4	2626	Public on Apr 08, 2021	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 2 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39245
3.94200052068993e-217	-2.11611703896033	0.053	0.886	6.07541120248732e-213	IL32	Malignant cells	GSE131984_JQ1Pac	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39246
2.59046169272829e-197	0.961515951755436	1	1	3.99241956083284e-193	GPX4	Malignant cells	GSE131984_JQ1Pac	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39247
2.01980091705188e-169	0.619294681669939	1	1	3.11291717336036e-165	RPL28	Malignant cells	GSE131984_JQ1Pac	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39248
4.06654310920122e-169	-1.17665015509166	0.984	1	6.26735623990093e-165	PLP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39249
9.49426048801768e-158	1.04685585499118	1	1	1.46325542641328e-153	FTL	Malignant cells	GSE131984_JQ1Pac	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39250
3.74701142462335e-149	-1.30070024903724	0.899	0.988	5.77489400762951e-145	SMS	Malignant cells	GSE131984_JQ1Pac	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39251
4.24987122734465e-143	-1.08819563525144	0.882	0.99	6.54990153558358e-139	GTF3C6	Malignant cells	GSE131984_JQ1Pac	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39252
5.03576868595774e-140	-0.952958670745908	0.998	1	7.76112669879807e-136	RBM3	Malignant cells	GSE131984_JQ1Pac	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39253
4.02670691134098e-139	-1.02479475011243	0.978	0.999	6.20596069175872e-135	PPP1R14B	Malignant cells	GSE131984_JQ1Pac	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39254
4.03785147547129e-138	-1.41306584894888	0.768	0.965	6.22313669399636e-134	EBP	Malignant cells	GSE131984_JQ1Pac	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39255
5.28891770820467e-136	0.41001385638966	1	1	8.15127997188504e-132	RPL13	Malignant cells	GSE131984_JQ1Pac	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39256
8.1888226187237e-136	1.40864861452528	0.958	0.721	1.2620613419977e-131	HCFC1R1	Malignant cells	GSE131984_JQ1Pac	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39257
8.7771740606782e-135	-1.06266050398194	0.96	0.997	1.35273806623172e-130	EIF1AX	Malignant cells	GSE131984_JQ1Pac	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39258
2.37184525503697e-132	-1.23726955319822	0.918	0.99	3.65548790706298e-128	PRDX4	Malignant cells	GSE131984_JQ1Pac	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39259
4.69075437325244e-129	1.26065740730247	1	1	7.22939064005666e-125	MALAT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39260
1.77691230052296e-125	-1.0617783431087	0.981	0.998	2.73857723756598e-121	CLIC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39261
2.91062056936977e-125	-1.03177391310916	0.942	1	4.48584842151269e-121	EMP3	Malignant cells	GSE131984_JQ1Pac	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39262
2.12417958901657e-123	1.2892399907367	0.826	0.319	3.27378558259234e-119	VSTM2L	Malignant cells	GSE131984_JQ1Pac	ENSG00000132821	128434	V-set and transmembrane domain containing 2 like	C20orf102|dJ1118M15.2	protein_coding	Q96N03	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39263
4.36309960983395e-123	-0.890761726172045	0.942	0.999	6.72440911867609e-119	OCIAD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000145247	132299	OCIA domain containing 2	MGC45416	protein_coding	Q56VL3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39264
2.88295823969426e-121	-0.917594279951155	0.972	0.998	4.4432152390168e-117	NDUFA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39265
6.36253953341138e-119	0.425210333590191	1	1	9.80594592889362e-115	RPLP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39266
3.19055102523769e-113	-1.01401814167675	0.838	0.99	4.91727724009633e-109	LRRC59	Malignant cells	GSE131984_JQ1Pac	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39267
9.84173553416639e-113	-0.845372182566407	0.998	1	1.51680828052572e-108	SLC25A5	Malignant cells	GSE131984_JQ1Pac	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39268
1.523258236792e-112	-0.870256107936338	0.998	1	2.34764559454383e-108	S100A11	Malignant cells	GSE131984_JQ1Pac	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39269
8.72459377547698e-111	0.742196773944288	1	1	1.34463439267651e-106	GAPDH	Malignant cells	GSE131984_JQ1Pac	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39270
4.17491674871017e-110	0.905792530300821	0.997	0.95	6.43438169311211e-106	CIRBP	Malignant cells	GSE131984_JQ1Pac	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39271
2.67214022089274e-108	-0.890935229333283	0.933	0.994	4.1183025084399e-104	SRM	Malignant cells	GSE131984_JQ1Pac	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39272
1.32270124817581e-106	-1.0662475238127	0.588	0.92	2.03854716368857e-102	IRAK1	Malignant cells	GSE131984_JQ1Pac	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39273
7.56250825352755e-106	-1.06179993000038	0.837	0.98	1.16553377203367e-101	EBNA1BP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39274
7.82533742920468e-106	-0.970936324490126	0.961	0.997	1.20604100458903e-101	NME1	Malignant cells	GSE131984_JQ1Pac	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39275
1.95689213818433e-105	-1.10370307629308	0.062	0.601	3.01596216336969e-101	TNNT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39276
7.26689668144619e-105	-0.894395325472678	0.978	0.997	1.11997411654449e-100	CYCS	Malignant cells	GSE131984_JQ1Pac	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39277
2.84497341188547e-104	-0.750167190088889	0.997	0.998	4.38467302239789e-100	RPL36A	Malignant cells	GSE131984_JQ1Pac	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39278
7.03484545217325e-104	-1.04772111291369	0.877	0.987	1.08421038108894e-99	MORF4L2	Malignant cells	GSE131984_JQ1Pac	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39279
1.63152548112495e-101	-0.540309593945052	1	1	2.51450707150978e-97	RPL39	Malignant cells	GSE131984_JQ1Pac	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39280
1.84081800243387e-101	0.431798445269252	1	1	2.83706870535108e-97	RPL12	Malignant cells	GSE131984_JQ1Pac	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39281
1.10666516839339e-99	0.863024944668668	1	1	1.70559235752789e-95	FTH1	Malignant cells	GSE131984_JQ1Pac	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39282
1.8861085249793e-98	-1.00481713894847	0.712	0.94	2.9068704586981e-94	HSD17B10	Malignant cells	GSE131984_JQ1Pac	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39283
3.07875152586819e-98	-0.76577082764352	1	1	4.74497185166806e-94	TMSB4X	Malignant cells	GSE131984_JQ1Pac	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39284
3.68941828888132e-98	-0.758399210584545	0.981	1	5.68613146682388e-94	NAA10	Malignant cells	GSE131984_JQ1Pac	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39285
7.68795245603148e-97	-0.949481297106975	0.714	0.946	1.18486723252357e-92	PDLIM4	Malignant cells	GSE131984_JQ1Pac	ENSG00000131435	8572	PDZ and LIM domain 4	RIL	protein_coding	P50479	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39286
2.81432345069424e-96	-0.761993844788595	0.974	0.999	4.33743530220996e-92	SNRPB	Malignant cells	GSE131984_JQ1Pac	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39287
9.80046512597789e-96	-0.734033486830718	0.991	0.999	1.51044768521571e-91	COX7B	Malignant cells	GSE131984_JQ1Pac	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39288
2.14021968723924e-95	0.792009214359937	0.998	0.978	3.29850658197312e-91	C9orf16	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39289
8.6822337088463e-95	-0.734806308560635	0.997	0.999	1.33810585920739e-90	H2AFZ	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39290
1.60092600761233e-93	-1.78819772902227	0.622	0.909	2.46734716293212e-89	IL8	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39291
4.10010122369972e-93	0.519273251369269	1	1	6.31907600596601e-89	TMSB10	Malignant cells	GSE131984_JQ1Pac	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39292
6.82468706986851e-93	-1.30894421788635	0.255	0.729	1.05182077120814e-88	S100A2	Malignant cells	GSE131984_JQ1Pac	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39293
1.00756327639359e-92	-1.0315009288077	0.669	0.932	1.5528565215778e-88	HMGB3	Malignant cells	GSE131984_JQ1Pac	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39294
4.52837561019656e-91	1.22537975814165	0.862	0.563	6.97913249043494e-87	PEG10	Malignant cells	GSE131984_JQ1Pac	ENSG00000242265	23089	paternally expressed 10	HB-1|KIAA1051|Mar2|Mart2|MEF3L|RGAG3|RTL2|SIRH1	protein_coding	Q86TG7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39295
3.68489546549982e-89	-0.73883932141477	0.89	0.988	5.67916089142833e-85	MRPS15	Malignant cells	GSE131984_JQ1Pac	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39296
1.14067169330983e-88	-0.627273113875982	1	1	1.7580032137291e-84	PRELID1	Malignant cells	GSE131984_JQ1Pac	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39297
2.24357706165469e-88	-0.626135466722161	0.989	1	3.45780096742221e-84	MRPL23	Malignant cells	GSE131984_JQ1Pac	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39298
1.98722997774855e-87	-0.960255154717911	0.496	0.851	3.06271884170607e-83	PGRMC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000101856	10857	progesterone receptor membrane component 1	HPR6.6	protein_coding	O00264	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39299
4.57485427735997e-85	-0.988640092178231	0.216	0.68	7.05076541226719e-81	S100A3	Malignant cells	GSE131984_JQ1Pac	ENSG00000188015	6274	S100 calcium binding protein A3	S100E	protein_coding	P33764	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39300
5.17095538659154e-85	2.49063341364586	0.358	0.015	7.96947644181488e-81	FABP4	Malignant cells	GSE131984_JQ1Pac	ENSG00000170323	2167	fatty acid binding protein 4	A-FABP|aP2	protein_coding	P15090	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39301
2.76795594170508e-84	-0.905808034200515	0.759	0.957	4.26597369735587e-80	SDF2L1	Malignant cells	GSE131984_JQ1Pac	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39302
4.74628861230458e-84	0.794573488906319	0.994	0.938	7.31498000928381e-80	MMP24-AS1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39303
5.8997558599852e-83	-0.868671227471803	0.518	0.848	9.0927037314092e-79	FAM136A	Malignant cells	GSE131984_JQ1Pac	ENSG00000035141	84908	family with sequence similarity 136 member A	FLJ14668	protein_coding	Q96C01	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39304
1.32105056154358e-82	-0.678153116580414	0.991	1	2.03600312545097e-78	ATP5G1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39305
1.6743489359956e-82	0.371133843280496	1	1	2.58050658015642e-78	RPS25	Malignant cells	GSE131984_JQ1Pac	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39306
2.27720559862521e-82	0.298435223253557	1	1	3.50962926860118e-78	RPS2	Malignant cells	GSE131984_JQ1Pac	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39307
4.81568703815098e-82	-0.806661193607786	0.753	0.955	7.42193686319829e-78	DNPH1	Malignant cells	GSE131984_JQ1Pac	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39308
1.42543342393894e-81	-0.787273140990629	0.956	0.996	2.1968779929747e-77	RANBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39309
1.49157128730538e-81	-0.804834984489812	0.669	0.921	2.29880966799506e-77	UBE2M	Malignant cells	GSE131984_JQ1Pac	ENSG00000130725	9040	ubiquitin conjugating enzyme E2 M	hUbc12|UBC12	protein_coding	P61081	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39310
2.6141052888767e-81	-1.21089230486365	0.157	0.627	4.02885907121677e-77	SCG5	Malignant cells	GSE131984_JQ1Pac	ENSG00000277614	6447	secretogranin V	7B2|SGNE1|SgV	protein_coding	P05408	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39311
2.65686971739895e-81	-0.890099878959575	0.191	0.659	4.09476760845526e-77	PIR	Malignant cells	GSE131984_JQ1Pac	ENSG00000087842	8544	pirin	NA	protein_coding	O00625	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39312
3.11818678814181e-81	-0.844452790019357	0.949	0.992	4.80574947788416e-77	STRA13	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39313
3.54852710222488e-81	-1.03625321060513	0.964	0.995	5.46898996994899e-77	PGK1	Malignant cells	GSE131984_JQ1Pac	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39314
3.44656826434005e-80	-0.660329165389304	0.969	0.997	5.31185100900088e-76	LSM5	Malignant cells	GSE131984_JQ1Pac	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39315
6.61482402193544e-80	-0.845897909287872	0.902	0.983	1.01947667826069e-75	PRSS3	Malignant cells	GSE131984_JQ1Pac	ENSG00000010438	5646	serine protease 3	PRSS4|TRY3|TRY4	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39316
8.55877325249124e-80	-1.24903090745111	0.435	0.809	1.31907813367395e-75	ISG15	Malignant cells	GSE131984_JQ1Pac	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39317
1.8834968685332e-79	-1.01304203552529	0.793	0.959	2.90284537378337e-75	NFKBIA	Malignant cells	GSE131984_JQ1Pac	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39318
2.72312408030271e-79	-1.41555273145157	0.599	0.893	4.19687883256254e-75	CXCL2	Malignant cells	GSE131984_JQ1Pac	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39319
3.37368327568308e-79	-0.811294995893667	0.922	0.989	5.19952066448276e-75	PFDN2	Malignant cells	GSE131984_JQ1Pac	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39320
7.0241805033097e-79	-0.555845874921782	1	1	1.08256669917009e-74	SUB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39321
2.37876749567293e-78	0.926969444078924	0.991	0.952	3.66615646433112e-74	MYC	Malignant cells	GSE131984_JQ1Pac	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39322
3.14863460246954e-78	0.405883043413401	1	1	4.85267564932605e-74	RPL13A	Malignant cells	GSE131984_JQ1Pac	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39323
3.43915156922089e-78	-0.66323292643399	0.981	0.999	5.30042039848323e-74	VDAC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39324
7.65226041218273e-78	-0.714423222579831	0.939	0.992	1.1793663747256e-73	TCEB1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39325
1.34532597824933e-77	1.17364076757318	0.602	0.188	2.07341639767787e-73	STAC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000141750	342667	SH3 and cysteine rich domain 2	24b2	protein_coding	Q6ZMT1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39326
1.79533727832491e-77	-0.971453431876526	0.652	0.893	2.76697381335435e-73	MCTS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39327
7.95584283213312e-77	-0.646042693468232	0.972	0.997	1.22615449728836e-72	JTB	Malignant cells	GSE131984_JQ1Pac	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39328
1.34102114067117e-76	-0.588165985694042	0.995	0.999	2.0667817820024e-72	SEC61G	Malignant cells	GSE131984_JQ1Pac	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39329
1.67325439111399e-76	-0.830356478356863	0.67	0.911	2.57881966758488e-72	MRPL3	Malignant cells	GSE131984_JQ1Pac	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39330
1.72367638566832e-76	1.20788501121033	0.983	0.897	2.65653004559201e-72	TGFBI	Malignant cells	GSE131984_JQ1Pac	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39331
2.66036214548577e-76	0.641404007236475	1	1	4.10015013862267e-72	TPT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39332
6.08223825606703e-76	-0.962369925008245	0.379	0.769	9.3739456002505e-72	LY6K	Malignant cells	GSE131984_JQ1Pac	ENSG00000160886	54742	lymphocyte antigen 6 family member K	CT97|FLJ35226|HSJ001348	protein_coding	Q17RY6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39333
9.89342079626907e-76	-0.769236664219547	0.899	0.988	1.52477401312099e-71	U2AF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000160201	7307	U2 small nuclear RNA auxiliary factor 1	RN|RNU2AF1|U2AF35|U2AFBP	protein_coding	Q01081	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39334
1.00100136624808e-75	0.320698160521062	1	1	1.54274330566155e-71	RPS15	Malignant cells	GSE131984_JQ1Pac	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39335
1.20739692414083e-75	-0.672828228916567	0.994	1	1.86084013948585e-71	HSPE1	Malignant cells	GSE131984_JQ1Pac	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39336
5.7250248812214e-75	-0.925331056963714	0.888	0.975	8.82340834693843e-71	TM4SF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39337
1.88732499912049e-74	-0.708642244299007	0.809	0.964	2.9087452886445e-70	CLPP	Malignant cells	GSE131984_JQ1Pac	ENSG00000125656	8192	caseinolytic mitochondrial matrix peptidase proteolytic subunit	NA	protein_coding	Q16740	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39338
4.58355981661312e-74	0.301203924049601	1	1	7.06418238936414e-70	RPS15A	Malignant cells	GSE131984_JQ1Pac	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39339
5.35556095560574e-74	0.688898230672128	0.984	0.917	8.25399054477956e-70	PHPT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39340
6.81175986162472e-74	-1.20245140247089	0.187	0.61	1.0498284298736e-69	CDA	Malignant cells	GSE131984_JQ1Pac	ENSG00000158825	978	cytidine deaminase	CDD	protein_coding	P32320	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39341
9.48302084224159e-74	1.0959731615035	0.877	0.549	1.46152317220627e-69	FN1	Malignant cells	GSE131984_JQ1Pac	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39342
1.13963762078868e-73	-0.84370928978775	0.571	0.859	1.75640950115951e-69	IFRD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39343
1.19234939934757e-73	-1.03635256660802	0.215	0.664	1.83764889427447e-69	SPANXC	Malignant cells	GSE131984_JQ1Pac	ENSG00000198573	64663	SPANX family member C	CT11.3|CTp11	protein_coding	Q9NY87	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39344
1.37430953414997e-73	-0.831171613701273	0.538	0.83	2.11808585403193e-69	NKAP	Malignant cells	GSE131984_JQ1Pac	ENSG00000101882	79576	NFKB activating protein	FLJ22626	protein_coding	Q8N5F7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39345
1.43398735549566e-73	-0.709634242039544	0.994	0.997	2.21006131228991e-69	S100A16	Malignant cells	GSE131984_JQ1Pac	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39346
1.84426378567449e-73	-0.732905264753204	0.921	0.991	2.84237934648152e-69	PA2G4	Malignant cells	GSE131984_JQ1Pac	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39347
2.95305906993052e-73	0.271718884587667	1	1	4.55125463857692e-69	RPS8	Malignant cells	GSE131984_JQ1Pac	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39348
5.66720673620949e-73	-0.701695490123858	0.894	0.976	8.73429902184607e-69	RAB32	Malignant cells	GSE131984_JQ1Pac	ENSG00000118508	10981	RAB32, member RAS oncogene family	NA	protein_coding	Q13637	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39349
6.47108506655535e-73	-0.700744777709275	0.958	0.993	9.97323630457511e-69	SRSF3	Malignant cells	GSE131984_JQ1Pac	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39350
9.77223669615278e-73	-0.650531758440887	0.913	0.992	1.50609711961107e-68	PRR13	Malignant cells	GSE131984_JQ1Pac	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39351
2.711866954143e-72	-0.857540752224706	0.285	0.694	4.17952934972519e-68	PRPS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000147224	5631	phosphoribosyl pyrophosphate synthetase 1	CMTX5|DFN2|DFNX1|PPRibP|PRS-I	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39352
5.67441629714367e-72	-0.625152782449208	0.966	0.999	8.74541039715783e-68	TIMM13	Malignant cells	GSE131984_JQ1Pac	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39353
9.31293314770183e-72	-0.827635427166105	0.586	0.861	1.43530925672381e-67	COA6	Malignant cells	GSE131984_JQ1Pac	ENSG00000168275	388753	cytochrome c oxidase assembly factor 6	C1orf31	protein_coding	Q5JTJ3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39354
1.59088551293792e-71	-0.79852186845542	0.398	0.757	2.45187275253992e-67	FTSJ1	Malignant cells	GSE131984_JQ1Pac	ENSG00000068438	24140	FtsJ RNA 2'-O-methyltransferase 1	CDLIV|JM23|MRX44|MRX9|SPB1|TRM7|TRMT7	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39355
2.30846415562397e-71	-0.863509967725379	0.281	0.69	3.55780495664766e-67	HCCS	Malignant cells	GSE131984_JQ1Pac	ENSG00000004961	3052	holocytochrome c synthase	CCHL|MLS	protein_coding	P53701	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39356
4.1871604407892e-71	-0.906951294525656	0.767	0.94	6.45325167134431e-67	PSME2	Malignant cells	GSE131984_JQ1Pac	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39357
6.50781825444099e-71	-0.782491991032768	0.485	0.842	1.00298494937444e-66	PSMB8	Malignant cells	GSE131984_JQ1Pac	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39358
8.97623934958841e-71	0.364595902406504	1	1	1.38341800855857e-66	RPS5	Malignant cells	GSE131984_JQ1Pac	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39359
2.14369551030637e-70	-0.693126569996644	0.997	1	3.30386352048418e-66	TUBB	Malignant cells	GSE131984_JQ1Pac	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39360
2.55243062422232e-70	-0.653008591213678	0.882	0.984	3.93380607805143e-66	TMEM167A	Malignant cells	GSE131984_JQ1Pac	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39361
2.69415235805998e-70	-0.79074139096643	0.552	0.862	4.15222761424203e-66	LRR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000165501	122769	leucine rich repeat protein 1	LRR-1|MGC20689|PPIL5	protein_coding	Q96L50	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39362
7.00911313763231e-70	0.413302749411038	1	1	1.08024451677189e-65	RPL36	Malignant cells	GSE131984_JQ1Pac	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39363
1.92569668381971e-69	-0.685205403700011	0.834	0.976	2.96788372910294e-65	MRPL18	Malignant cells	GSE131984_JQ1Pac	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39364
4.79400906558099e-69	-0.744028507448845	0.785	0.942	7.38852677187342e-65	PSMG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39365
6.81584492195267e-69	-0.787776809519719	0.902	0.983	1.05045801937135e-64	EIF5	Malignant cells	GSE131984_JQ1Pac	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39366
1.53242651282488e-68	-0.821828349601968	0.372	0.746	2.3617757415657e-64	TIMM8A	Malignant cells	GSE131984_JQ1Pac	ENSG00000126953	1678	translocase of inner mitochondrial membrane 8A	DDP|DFN1|MTS	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39367
5.74801370874163e-68	-0.683385712790066	0.958	0.993	8.8588387279126e-64	PHB	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39368
6.82379617082189e-68	-0.771907176736759	0.502	0.827	1.05168346584707e-63	TIMM17B	Malignant cells	GSE131984_JQ1Pac	ENSG00000126768	10245	translocase of inner mitochondrial membrane 17B	DXS9822|JM3	protein_coding	O60830	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39369
1.73916693312129e-67	0.380501328773188	1	1	2.68040407732654e-63	RPL23	Malignant cells	GSE131984_JQ1Pac	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39370
3.64937971616009e-67	-0.895255979818372	0.781	0.952	5.62442401854593e-63	CACYBP	Malignant cells	GSE131984_JQ1Pac	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39371
1.12217306930335e-66	-0.703356517333608	0.807	0.963	1.72949313441033e-62	TOMM40	Malignant cells	GSE131984_JQ1Pac	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39372
1.80807361107694e-66	-0.829081229945902	0.129	0.537	2.78660304939177e-62	CASC8	Malignant cells	GSE131984_JQ1Pac	ENSG00000246228	727677	cancer susceptibility 8	CARLo-1|LINC00860	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39373
5.87655761680943e-66	-0.56486717313057	0.986	0.997	9.0569505990267e-62	SF3B5	Malignant cells	GSE131984_JQ1Pac	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39374
7.34176611205467e-66	-0.544493746845175	1	0.999	1.13151299318987e-61	MTDH	Malignant cells	GSE131984_JQ1Pac	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39375
8.43785374899397e-66	-0.928812616781708	0.504	0.805	1.30044201979495e-61	PDHA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000131828	5160	pyruvate dehydrogenase E1 subunit alpha 1	E1alpha|PDHA	protein_coding	P08559	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39376
1.33059914032337e-65	-0.832440674527148	0.208	0.628	2.05071939506638e-61	GYPC	Malignant cells	GSE131984_JQ1Pac	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39377
3.35158536893844e-65	-0.884341382958746	0.575	0.833	5.16546337060793e-61	SH3KBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39378
4.50959022433548e-65	-0.665341154709501	0.964	0.992	6.95018045374584e-61	MRPL12	Malignant cells	GSE131984_JQ1Pac	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39379
5.73199881568777e-65	-0.840794114013308	0.818	0.977	8.83415657473799e-61	NNMT	Malignant cells	GSE131984_JQ1Pac	ENSG00000166741	4837	nicotinamide N-methyltransferase	NA	protein_coding	P40261	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39380
1.63175920812812e-64	-0.644625618028025	0.958	0.992	2.51486729156706e-60	PSMB5	Malignant cells	GSE131984_JQ1Pac	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39381
1.18181287510385e-63	-0.699004600901689	0.793	0.946	1.82141000311006e-59	CAPN2	Malignant cells	GSE131984_JQ1Pac	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39382
1.2460373751181e-63	-0.793903035756713	0.566	0.844	1.92039280253202e-59	DKC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39383
1.50299276007684e-63	-0.623090173743902	0.942	0.992	2.31641244183042e-59	SRSF2	Malignant cells	GSE131984_JQ1Pac	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39384
1.52551722868203e-63	-0.858539818901576	0.11	0.505	2.35112715284474e-59	SLC14A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000141469	6563	solute carrier family 14 member 1 (Kidd blood group)	HsT1341|JK|RACH1|RACH2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39385
2.31848799863519e-63	-0.630897014567115	0.933	0.979	3.57325370349655e-59	RPS19BP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39386
3.14495087104824e-63	-0.587306460576117	0.984	0.999	4.84699828245954e-59	NOP10	Malignant cells	GSE131984_JQ1Pac	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39387
3.60754050879749e-63	0.265701385076126	1	1	5.55994143215869e-59	RPS18	Malignant cells	GSE131984_JQ1Pac	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39388
6.40881720074684e-63	-0.476642801787311	0.998	0.998	9.87726906979103e-59	AURKAIP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39389
1.08588900866817e-62	-0.609045718605362	0.911	0.995	1.67357214015939e-58	NDUFC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39390
2.79016992296045e-62	0.694886969065517	0.944	0.785	4.30020988526664e-58	TTC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39391
4.49352926571757e-62	-0.655065341500159	0.82	0.96	6.92542730432392e-58	MRPL52	Malignant cells	GSE131984_JQ1Pac	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39392
5.10734234119928e-62	-0.697947224204396	0.883	0.98	7.87143601625632e-58	ATP6V0B	Malignant cells	GSE131984_JQ1Pac	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39393
8.50869343720685e-62	-0.649763130197017	0.818	0.946	1.31135983254232e-57	HDGF	Malignant cells	GSE131984_JQ1Pac	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39394
8.53948199450881e-62	-0.503044978192713	1	0.999	1.3161049649937e-57	NDUFS6	Malignant cells	GSE131984_JQ1Pac	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39395
1.33110754178901e-61	-0.778200580357573	0.686	0.912	2.05150294340522e-57	VBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39396
2.41767998178031e-61	-0.618702984359883	0.988	0.997	3.72612838791982e-57	MRPL36	Malignant cells	GSE131984_JQ1Pac	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39397
3.05308983703277e-61	-0.840745957010788	0.477	0.779	4.7054220568349e-57	LYAR	Malignant cells	GSE131984_JQ1Pac	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39398
3.05573795099001e-61	-0.800958783291788	0.824	0.905	4.7095033300658e-57	TCEAL4	Malignant cells	GSE131984_JQ1Pac	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39399
1.52316698295845e-60	-0.450146680556442	1	1	2.34750495413556e-56	TXN	Malignant cells	GSE131984_JQ1Pac	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39400
2.6778234363545e-60	-0.598115250848964	0.918	0.978	4.12706148010956e-56	CUTA	Malignant cells	GSE131984_JQ1Pac	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39401
3.53666868299145e-60	-0.551286478610495	0.97	1	5.45071377422642e-56	SLIRP	Malignant cells	GSE131984_JQ1Pac	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39402
4.59287031784124e-60	-0.682905626933671	0.722	0.92	7.07853173385693e-56	FAM96A	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39403
4.95506905095804e-60	0.493674996749139	0.337	0.043	7.63675242133653e-56	NR2F1	Malignant cells	GSE131984_JQ1Pac	ENSG00000175745	7025	nuclear receptor subfamily 2 group F member 1	COUP-TFI|COUPTF1|EAR-3|ERBAL3|SVP44|TCFCOUP1|TFCOUP1	protein_coding	P10589	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39404
5.06087031807529e-60	0.349728589571041	1	1	7.79981333421764e-56	RPL8	Malignant cells	GSE131984_JQ1Pac	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39405
6.31682017340924e-60	-0.579702172428792	0.978	0.998	9.73548325125831e-56	EIF4EBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39406
6.57221328564413e-60	0.606816625121957	1	1	1.01290951158347e-55	ZFAS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39407
7.13938951402372e-60	-0.610475806768475	0.994	1	1.10032271190134e-55	HMGB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39408
1.10845443180572e-59	-0.692503485692026	0.16	0.553	1.70834997029897e-55	SFN	Malignant cells	GSE131984_JQ1Pac	ENSG00000175793	2810	stratifin	YWHAS	protein_coding	P31947	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39409
1.2907142823312e-59	0.334707666914897	1	1	1.98924885192884e-55	RPL23A	Malignant cells	GSE131984_JQ1Pac	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39410
1.52137015842939e-59	-0.716088916423875	0.653	0.879	2.34473568817137e-55	SLC35B1	Malignant cells	GSE131984_JQ1Pac	ENSG00000121073	10237	solute carrier family 35 member B1	AXER|UGTREL1	protein_coding	P78383	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39411
1.85718539786866e-59	0.390759633333657	1	1	2.86229413519518e-55	UBA52	Malignant cells	GSE131984_JQ1Pac	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39412
2.21102040124669e-59	-0.697692323912823	0.641	0.863	3.4076246424014e-55	ATG3	Malignant cells	GSE131984_JQ1Pac	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39413
2.43417024568784e-59	-0.752779406592926	0.65	0.886	3.75154318265409e-55	DCTPP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39414
3.51828572242476e-59	-0.778668896542107	0.877	0.974	5.42238195540104e-55	C12orf75	Malignant cells	GSE131984_JQ1Pac	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39415
5.568475118045e-59	-0.695256429465559	0.782	0.917	8.58213385193095e-55	TIMM17A	Malignant cells	GSE131984_JQ1Pac	ENSG00000134375	10440	translocase of inner mitochondrial membrane 17A	TIM17|TIM17A	protein_coding	Q99595	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39416
6.66690716673602e-59	-0.638700927800365	0.816	0.962	1.02750373253736e-54	CISD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000122873	55847	CDGSH iron sulfur domain 1	C10orf70|MDS029|mitoNEET|ZCD1	protein_coding	Q9NZ45	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39417
2.04534449268821e-58	-0.656637215358804	0.97	0.996	3.15228493213106e-54	HNRNPDL	Malignant cells	GSE131984_JQ1Pac	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39418
2.60253443370372e-58	-0.637408422808107	0.813	0.959	4.01102606922417e-54	SNRPC	Malignant cells	GSE131984_JQ1Pac	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39419
3.1729214178835e-58	-0.564115432944141	0.998	1	4.89010648924204e-54	EIF5A	Malignant cells	GSE131984_JQ1Pac	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39420
7.42057536228863e-58	-0.758943329978638	0.509	0.811	1.14365907483592e-53	ANP32E	Malignant cells	GSE131984_JQ1Pac	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39421
8.36526240051684e-58	-0.558955103218664	0.989	1	1.28925424116766e-53	GPX1	Malignant cells	GSE131984_JQ1Pac	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39422
8.52922920469393e-58	-0.483429018245857	0.998	1	1.31452480502743e-53	SNRPE	Malignant cells	GSE131984_JQ1Pac	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39423
1.03974930841448e-57	0.334722223378805	1	1	1.6024616341284e-53	RPL18	Malignant cells	GSE131984_JQ1Pac	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39424
1.07077310936062e-57	-0.604363388851731	0.946	0.992	1.65027551614658e-53	ANP32B	Malignant cells	GSE131984_JQ1Pac	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39425
2.46868989066179e-57	0.61716671396996	0.983	0.944	3.80474485948795e-53	COMMD6	Malignant cells	GSE131984_JQ1Pac	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39426
3.15586082673443e-57	-0.570179500525805	0.98	0.993	4.8638127061631e-53	NDUFB11	Malignant cells	GSE131984_JQ1Pac	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39427
4.44439542216356e-57	-0.561678997728662	0.986	0.997	6.84970222463848e-53	SNRPD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39428
1.07553939088771e-56	-0.746253472824915	0.672	0.883	1.65762130923614e-52	PSMC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000100764	5700	proteasome 26S subunit, ATPase 1	p56|RPT2|S4	protein_coding	P62191	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39429
1.20316238146612e-56	-0.58163610660735	0.955	0.992	1.85431386231559e-52	PTGES3	Malignant cells	GSE131984_JQ1Pac	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39430
2.48034940668976e-56	-0.753260310371865	0.563	0.842	3.82271450559026e-52	NOP16	Malignant cells	GSE131984_JQ1Pac	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39431
2.48993885371744e-56	-0.691493245538084	0.551	0.829	3.83749376134931e-52	MRPL15	Malignant cells	GSE131984_JQ1Pac	ENSG00000137547	29088	mitochondrial ribosomal protein L15	HSPC145|L15mt|MRP-L15|MRP-L7|RPML7	protein_coding	Q9P015	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39432
3.33596362491815e-56	-0.62016006510575	0.854	0.957	5.14138713872385e-52	PGP	Malignant cells	GSE131984_JQ1Pac	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39433
3.82240437159022e-56	-0.504236848260205	0.997	1	5.89108961749485e-52	NHP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39434
4.06139755987471e-56	-0.780135369656355	0.336	0.699	6.25942591927891e-52	MAGEA3	Malignant cells	GSE131984_JQ1Pac	ENSG00000221867	4102	MAGE family member A3	CT1.3|HIP8|HYPD|MAGE3|MGC14613	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39435
4.27301196592355e-56	-0.640237940148026	0.829	0.947	6.58556604188138e-52	NAA20	Malignant cells	GSE131984_JQ1Pac	ENSG00000173418	51126	N-alpha-acetyltransferase 20, NatB catalytic subunit	dJ1002M8.1|NAT3|NAT5	protein_coding	P61599	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39436
4.63967109510786e-56	-0.524793266965617	0.98	0.996	7.15066109178023e-52	NDUFAB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39437
5.59415967003996e-56	-0.522772799697632	0.995	1	8.62171888346559e-52	TAGLN2	Malignant cells	GSE131984_JQ1Pac	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39438
5.8218149701691e-56	-0.551168355148828	0.96	0.993	8.97258123202462e-52	UBE2D2	Malignant cells	GSE131984_JQ1Pac	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39439
6.61136484594223e-56	-0.73582217075477	0.384	0.714	1.01894355005662e-51	GAR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000109534	54433	GAR1 ribonucleoprotein	NOLA1	protein_coding	Q9NY12	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39440
7.88763335733144e-56	0.383875283829583	1	1	1.21564205303192e-51	EEF1D	Malignant cells	GSE131984_JQ1Pac	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39441
1.04861249731607e-55	0.290380276111008	1	1	1.61612158086353e-51	RPS16	Malignant cells	GSE131984_JQ1Pac	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39442
1.25436523828148e-55	-0.769739313744311	0.765	0.926	1.93322770523941e-51	PSMD7	Malignant cells	GSE131984_JQ1Pac	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39443
2.11028938772626e-55	-0.490002474117833	0.992	0.999	3.25237800436371e-51	SNRPG	Malignant cells	GSE131984_JQ1Pac	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39444
2.2966570430114e-55	-0.56631864636888	0.95	0.991	3.53960783468917e-51	PYURF	Malignant cells	GSE131984_JQ1Pac	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39445
3.88748932246833e-55	-0.780939097203927	0.703	0.9	5.99139854378819e-51	SNRPA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39446
4.98446871759515e-55	0.619870559686614	0.97	0.886	7.68206318755764e-51	GNAS	Malignant cells	GSE131984_JQ1Pac	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39447
5.58836399229301e-55	-0.700150735769569	0.796	0.936	8.61278658492199e-51	UPP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39448
6.39907436511784e-55	-0.649753838232689	0.227	0.598	9.86225341151962e-51	PRPS2	Malignant cells	GSE131984_JQ1Pac	ENSG00000101911	5634	phosphoribosyl pyrophosphate synthetase 2	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39449
7.69068368271715e-55	-0.618179756068852	0.877	0.971	1.18528816918037e-50	ADRM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39450
8.67033347175011e-55	0.871313206157581	0.762	0.453	1.33627179466613e-50	RAMP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39451
3.82482237475988e-54	-0.686167821799609	0.44	0.769	5.89481624397993e-50	PPIF	Malignant cells	GSE131984_JQ1Pac	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39452
4.01128541662862e-54	-0.824089288506414	0.844	0.949	6.18219308410804e-50	SOD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39453
4.26579872756593e-54	-0.800249495874452	0.445	0.779	6.57444899892462e-50	PBK	Malignant cells	GSE131984_JQ1Pac	ENSG00000168078	55872	PDZ binding kinase	CT84|FLJ14385|Nori-3|SPK|TOPK	protein_coding	Q96KB5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39454
6.34449188814398e-54	-0.630550670975245	0.748	0.919	9.7781308980075e-50	C20orf24	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39455
7.68753128434734e-54	-0.696729685739029	0.348	0.702	1.18480232154361e-49	EMP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000213853	2013	epithelial membrane protein 2	XMP	protein_coding	P54851	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39456
9.01707433521124e-54	-0.550122578398766	0.949	0.993	1.38971149654276e-49	IFITM3	Malignant cells	GSE131984_JQ1Pac	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39457
9.41472659010845e-54	-0.610667912083068	0.846	0.964	1.45099766206751e-49	EMC4	Malignant cells	GSE131984_JQ1Pac	ENSG00000128463	51234	ER membrane protein complex subunit 4	FLJ90746|MGC24415|PIG17|TMEM85	protein_coding	Q5J8M3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39458
1.07233051952223e-53	-0.520879105625235	0.944	0.992	1.65267579668767e-49	MZT2A	Malignant cells	GSE131984_JQ1Pac	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39459
1.13705184887478e-53	-0.626795731705074	0.728	0.928	1.75242430948581e-49	C3orf14	Malignant cells	GSE131984_JQ1Pac	ENSG00000114405	57415	chromosome 3 open reading frame 14	HT021	protein_coding	Q9HBI5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39460
1.16149406713125e-53	-0.603549710791856	0.759	0.915	1.79009465626269e-49	LSM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000175324	27257	LSM1 homolog, mRNA degradation associated	CASM|YJL124C	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39461
1.5196914740665e-53	-0.593111729048896	0.747	0.912	2.34214849983128e-49	HAX1	Malignant cells	GSE131984_JQ1Pac	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39462
1.83159914225618e-53	-0.756529043352514	0.575	0.826	2.82286059804523e-49	TUBA4A	Malignant cells	GSE131984_JQ1Pac	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39463
2.39163939553365e-53	-0.637460681972987	0.848	0.97	3.68599463639646e-49	SELK	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39464
2.90749639258601e-53	-0.693242382015932	0.376	0.704	4.48103344025357e-49	HOMER3	Malignant cells	GSE131984_JQ1Pac	ENSG00000051128	9454	homer scaffold protein 3	HOMER-3	protein_coding	Q9NSC5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39465
8.26597742389448e-53	0.445686122851456	1	1	1.27395244057062e-48	EEF2	Malignant cells	GSE131984_JQ1Pac	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39466
9.4606558904102e-53	-0.563175455844346	0.96	0.992	1.45807628583002e-48	RHEB	Malignant cells	GSE131984_JQ1Pac	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39467
1.21688944664766e-52	-0.707240028948924	0.946	0.981	1.87547001517337e-48	GNG11	Malignant cells	GSE131984_JQ1Pac	ENSG00000127920	2791	G protein subunit gamma 11	GNGT11	protein_coding	P61952	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39468
2.30151954185361e-52	-0.553909695469732	0.975	0.992	3.54710191790478e-48	SERP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39469
3.86770345701561e-52	-0.50938564982857	1	1	5.96090456795246e-48	RAN	Malignant cells	GSE131984_JQ1Pac	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39470
4.06087547587468e-52	0.543650836888906	0.473	0.146	6.25862128341805e-48	CD33	Malignant cells	GSE131984_JQ1Pac	ENSG00000105383	945	CD33 molecule	FLJ00391|p67|SIGLEC-3|SIGLEC3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39471
4.13325106571726e-52	-0.505713750960399	0.988	0.997	6.37016654248343e-48	EIF2S2	Malignant cells	GSE131984_JQ1Pac	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39472
4.32568543682349e-52	-0.721080100445488	1	1	6.66674639523237e-48	AKR1B1	Malignant cells	GSE131984_JQ1Pac	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39473
5.05359890209229e-52	-0.560606702104626	0.952	0.99	7.78860662790464e-48	CNBP	Malignant cells	GSE131984_JQ1Pac	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39474
1.12458728370472e-51	-0.616000607069288	0.799	0.938	1.73321392164571e-47	PAICS	Malignant cells	GSE131984_JQ1Pac	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39475
1.21041207747884e-51	-0.577284978044305	0.862	0.955	1.86548709381038e-47	NPM3	Malignant cells	GSE131984_JQ1Pac	ENSG00000107833	10360	nucleophosmin/nucleoplasmin 3	NA	protein_coding	O75607	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39476
1.54869517843904e-51	-0.473565316623476	0.977	0.994	2.38684900901025e-47	MRPL14	Malignant cells	GSE131984_JQ1Pac	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39477
2.09225362687213e-51	-0.659935623235596	0.677	0.867	3.22458128973532e-47	TARS	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39478
2.44118803895195e-51	-0.610744484154708	0.932	0.985	3.76235900563274e-47	PSMB3	Malignant cells	GSE131984_JQ1Pac	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39479
3.0165696688917e-51	-0.505708635759111	0.037	0.356	4.64913717369589e-47	CDC42EP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000128283	11135	CDC42 effector protein 1	Borg5|CEP1|MSE55	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39480
3.07332181666297e-51	-0.663011892434415	0.617	0.847	4.73660358384097e-47	AP1S1	Malignant cells	GSE131984_JQ1Pac	ENSG00000106367	1174	adaptor related protein complex 1 subunit sigma 1	AP19|CLAPS1|EKV3|SIGMA1A|WUGSC:H_DJ0747G18.2	protein_coding	P61966	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39481
3.58194702897707e-51	0.470871680572972	0.286	0.035	5.52049676105946e-47	CADM3	Malignant cells	GSE131984_JQ1Pac	ENSG00000162706	57863	cell adhesion molecule 3	BIgR|FLJ10698|IGSF4B|Necl-1|NECL1|SynCAM3|TSLL1	protein_coding	Q8N126	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39482
3.71628370657647e-51	-0.569854635591538	0.953	0.994	5.72753644857565e-47	PSMB7	Malignant cells	GSE131984_JQ1Pac	ENSG00000136930	5695	proteasome 20S subunit beta 7	Z	protein_coding	Q99436	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39483
4.02264363035485e-51	-0.610386872203853	0.67	0.868	6.1996983631029e-47	UFC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39484
5.08418103557092e-51	-0.593611728706539	0.207	0.564	7.8357398120219e-47	RAB27A	Malignant cells	GSE131984_JQ1Pac	ENSG00000069974	5873	RAB27A, member RAS oncogene family	GS2|HsT18676|RAB27|RAM	protein_coding	P51159	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39485
5.26526185973665e-51	0.636573708302415	0.927	0.784	8.11482157822612e-47	RNASEH2C	Malignant cells	GSE131984_JQ1Pac	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39486
5.75580838705871e-51	-0.649324583102137	0.46	0.833	8.87085188613488e-47	IFI27	Malignant cells	GSE131984_JQ1Pac	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39487
5.79979672735944e-51	-0.737227930190077	0.594	0.844	8.93864671620637e-47	EXOSC8	Malignant cells	GSE131984_JQ1Pac	ENSG00000120699	11340	exosome component 8	bA421P11.3|CIP3|EAP2|OIP2|p9|RRP43|Rrp43p	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39488
1.36405622205146e-50	0.291803869174281	1	1	2.1022834494257e-46	EEF1A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39489
1.39629390858063e-50	-0.679505528845814	0.571	0.828	2.15196817190447e-46	TSPAN4	Malignant cells	GSE131984_JQ1Pac	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39490
1.58012612210009e-50	-0.607674310956137	0.98	0.995	2.43529037938066e-46	CAV1	Malignant cells	GSE131984_JQ1Pac	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39491
1.6200686657436e-50	-0.597161382829309	0.717	0.895	2.49684982764404e-46	ZNF593	Malignant cells	GSE131984_JQ1Pac	ENSG00000142684	51042	zinc finger protein 593	ZT86	protein_coding	O00488	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39492
2.31240743864362e-50	-0.590565052782328	0.846	0.964	3.56388234443755e-46	DTYMK	Malignant cells	GSE131984_JQ1Pac	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39493
2.86242657709848e-50	-0.669606792304792	0.529	0.792	4.41157184062418e-46	ISOC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39494
2.93829054797048e-50	-0.549669629038044	0.956	0.994	4.52849339253211e-46	PGAM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39495
2.96850997306202e-50	-0.577630974096605	0.955	0.993	4.57506757048318e-46	ERH	Malignant cells	GSE131984_JQ1Pac	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39496
2.98551803724422e-50	0.512294385736988	0.991	0.974	4.60128039900079e-46	POLE4	Malignant cells	GSE131984_JQ1Pac	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39497
3.05826066807032e-50	-0.503817710065424	0.955	0.99	4.71339134162997e-46	STOML2	Malignant cells	GSE131984_JQ1Pac	ENSG00000165283	30968	stomatin like 2	HSPC108|SLP-2	protein_coding	Q9UJZ1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39498
3.1555668956519e-50	-0.56565508607657	0.896	0.972	4.8633596995787e-46	GLRX5	Malignant cells	GSE131984_JQ1Pac	ENSG00000182512	51218	glutaredoxin 5	C14orf87|GRX5|PR01238	protein_coding	Q86SX6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39499
3.85769420089262e-50	-0.758548304159636	0.942	0.985	5.94547830241571e-46	CCT5	Malignant cells	GSE131984_JQ1Pac	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39500
4.29201520995897e-50	0.398786860280564	1	1	6.61485384158877e-46	ATP5E	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39501
4.82500103716548e-50	-0.557708377070933	1	1	7.43629159847944e-46	HMGA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39502
6.43639992579372e-50	-0.520923758511793	0.897	0.978	9.91977956563328e-46	METTL5	Malignant cells	GSE131984_JQ1Pac	ENSG00000138382	29081	methyltransferase 5, N6-adenosine	HSPC133	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39503
8.23593761449094e-50	-0.538174386266552	0.941	0.989	1.26932270514534e-45	GTF2A2	Malignant cells	GSE131984_JQ1Pac	ENSG00000140307	2958	general transcription factor IIA subunit 2	HsT18745|TFIIA	protein_coding	P52657	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39504
1.17135123603455e-49	0.78783615765902	0.947	0.837	1.80528652497645e-45	MXD4	Malignant cells	GSE131984_JQ1Pac	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39505
1.2278643305475e-49	-0.622947198003891	0.851	0.944	1.89238450623981e-45	EIF6	Malignant cells	GSE131984_JQ1Pac	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39506
2.07759051845952e-49	-0.571433330936288	0.778	0.919	3.20198250704982e-45	TRAPPC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000054116	27095	trafficking protein particle complex subunit 3	BET3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39507
2.78352792258616e-49	0.37808808880456	1	0.999	4.28997323428979e-45	MT-ND4	Malignant cells	GSE131984_JQ1Pac	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39508
2.90795561650729e-49	-0.28205606473253	1	1	4.48174119616104e-45	RPS4X	Malignant cells	GSE131984_JQ1Pac	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39509
3.43330429244864e-49	-0.747568086854236	0.669	0.856	5.29140857552184e-45	NUDT4	Malignant cells	GSE131984_JQ1Pac	ENSG00000173598	11163	nudix hydrolase 4	DIPP2|DIPP2alpha|DIPP2beta|HDCMB47P|KIAA0487	protein_coding	Q9NZJ9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39510
5.19258292807057e-49	-0.686561426245348	0.39	0.705	8.00280880874237e-45	MAGOHB	Malignant cells	GSE131984_JQ1Pac	ENSG00000111196	55110	mago homolog B, exon junction complex subunit	FLJ10292|MGN2	protein_coding	Q96A72	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39511
6.06837732043823e-49	-0.654023099182644	0.914	0.973	9.35258312625939e-45	SRSF7	Malignant cells	GSE131984_JQ1Pac	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39512
9.12106006730612e-49	-0.659310077962434	0.533	0.813	1.40573777757322e-44	NXT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39513
9.64947501219347e-49	-0.503353514608031	0.97	0.995	1.48717708887926e-44	ZNF706	Malignant cells	GSE131984_JQ1Pac	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39514
1.17561225605791e-48	0.391310689822118	1	1	1.81185360903645e-44	LGALS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39515
1.3188043132322e-48	-0.673887807524679	0.082	0.404	2.03254120755347e-44	AC003092.1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39516
1.48764152674227e-48	0.304737686608203	1	1	2.29275312101519e-44	RPS28	Malignant cells	GSE131984_JQ1Pac	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39517
1.50910010154533e-48	-0.532348504396372	0.918	0.976	2.32582507650166e-44	BOLA3	Malignant cells	GSE131984_JQ1Pac	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39518
1.87074393597734e-48	-0.548750279150325	0.865	0.972	2.88319055412828e-44	NDUFAF2	Malignant cells	GSE131984_JQ1Pac	ENSG00000164182	91942	NADH:ubiquinone oxidoreductase complex assembly factor 2	B17.2L|mimitin|MMTN|NDUFA12L	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39519
2.31697699043694e-48	-0.493355243253082	0.969	0.993	3.57092493766141e-44	LSM3	Malignant cells	GSE131984_JQ1Pac	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39520
2.87629335015698e-48	-0.622137839402732	0.723	0.88	4.43294331126194e-44	LSM10	Malignant cells	GSE131984_JQ1Pac	ENSG00000181817	84967	LSM10, U7 small nuclear RNA associated	MGC15749	protein_coding	Q969L4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39521
3.07770570326189e-48	-0.479595650180337	0.991	0.999	4.74336002986723e-44	HNRNPA2B1	Malignant cells	GSE131984_JQ1Pac	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39522
3.14713654157241e-48	-0.554128355711271	0.876	0.966	4.8503668378714e-44	CDK4	Malignant cells	GSE131984_JQ1Pac	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39523
3.68270279726504e-48	-0.877517823257279	0.109	0.452	5.67578155114488e-44	KRT75	Malignant cells	GSE131984_JQ1Pac	ENSG00000170454	9119	keratin 75	K6HF	protein_coding	O95678	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39524
4.93723775162954e-48	-0.654932609641906	0.974	0.998	7.60927082281145e-44	UBE2S	Malignant cells	GSE131984_JQ1Pac	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39525
5.59924547888531e-48	0.265666226468041	1	1	8.62955713205804e-44	RPLP0	Malignant cells	GSE131984_JQ1Pac	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39526
9.95460464560755e-48	0.319720129570759	1	1	1.53420366798104e-43	UQCRH	Malignant cells	GSE131984_JQ1Pac	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39527
1.01626838832154e-47	0.490456322915528	0.998	0.999	1.56627284008115e-43	MT-CYB	Malignant cells	GSE131984_JQ1Pac	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39528
1.29309168251938e-47	0.580411291077597	0.6	0.289	1.99291290109887e-43	ITFG3	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39529
1.42002034889042e-47	0.676023130704097	0.826	0.628	2.18853536170992e-43	TMPRSS15	Malignant cells	GSE131984_JQ1Pac	ENSG00000154646	5651	transmembrane serine protease 15	ENTK|MGC133046|PRSS7	protein_coding	P98073	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39530
1.53531080719122e-47	-0.599165607938615	0.557	0.828	2.36622101604311e-43	SPATS2L	Malignant cells	GSE131984_JQ1Pac	ENSG00000196141	26010	spermatogenesis associated serine rich 2 like	DNAPTP6|SGNP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39531
1.624008791506e-47	-0.675336627242897	0.518	0.781	2.50292234946904e-43	PHF19	Malignant cells	GSE131984_JQ1Pac	ENSG00000119403	26147	PHD finger protein 19	DKFZP727G051|MTF2L1|PCL3|TDRD19B	protein_coding	Q5T6S3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39532
7.0540462104373e-47	-0.628338358968341	0.787	0.926	1.0871696019526e-42	MRPS18C	Malignant cells	GSE131984_JQ1Pac	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39533
9.00067629021332e-47	-0.486116094551741	0.989	0.992	1.38718422984768e-42	C19orf10	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39534
9.23992690052477e-47	-0.545954822339084	0.933	0.992	1.42405753390888e-42	DUT	Malignant cells	GSE131984_JQ1Pac	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39535
9.30876621036101e-47	-0.681295192215167	0.664	0.859	1.43466704834084e-42	UBE2A	Malignant cells	GSE131984_JQ1Pac	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39536
9.8487570967944e-47	-0.464001727606121	0.977	0.995	1.51789044375795e-42	GNG5	Malignant cells	GSE131984_JQ1Pac	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39537
1.06605786550897e-46	-0.497457985142109	0.913	0.976	1.64300838232242e-42	MTCH2	Malignant cells	GSE131984_JQ1Pac	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39538
1.08070490739582e-46	-0.508495134615183	0.998	0.999	1.66558240327844e-42	POMP	Malignant cells	GSE131984_JQ1Pac	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39539
1.10165487716533e-46	0.448755045260053	0.379	0.095	1.69787049668721e-42	MRC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000011028	9902	mannose receptor C type 2	CD280|CLEC13E|ENDO180|KIAA0709	protein_coding	Q9UBG0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39540
1.1649196252047e-46	-0.672767267630764	0.487	0.762	1.79537412636549e-42	MRTO4	Malignant cells	GSE131984_JQ1Pac	ENSG00000053372	51154	MRT4 homolog, ribosome maturation factor	C1orf33|dJ657E11.4|MRT4	protein_coding	Q9UKD2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39541
1.29955972271723e-46	-0.622449852295344	0.596	0.842	2.00288144465179e-42	ABRACL	Malignant cells	GSE131984_JQ1Pac	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39542
1.39724172785566e-46	-0.684172414097547	0.733	0.883	2.15342895097115e-42	ILF2	Malignant cells	GSE131984_JQ1Pac	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39543
1.63789901242425e-46	-0.583968064810905	0.697	0.893	2.52432995794825e-42	COA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000106603	55744	cytochrome c oxidase assembly factor 1	C7orf44|FLJ10803|MITRAC15	protein_coding	Q9GZY4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39544
1.64215118407519e-46	-0.577494599729178	0.152	0.494	2.53088340489668e-42	C10orf90	Malignant cells	GSE131984_JQ1Pac	ENSG00000154493	118611	chromosome 10 open reading frame 90	bA422P15.2|FATS|FLJ32938	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39545
1.81128134214814e-46	-0.613974050636262	0.905	0.992	2.79154680451871e-42	PTTG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39546
2.33387251124797e-46	-0.594046358798471	0.826	0.925	3.59696431433537e-42	LINC00116	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39547
2.47387003519953e-46	-0.46781705756183	0.974	0.996	3.81272849824952e-42	TMEM147	Malignant cells	GSE131984_JQ1Pac	ENSG00000105677	10430	transmembrane protein 147	MGC1936|NIFIE14	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39548
2.78175932795572e-46	-0.501386643935066	0.932	0.976	4.28724747624536e-42	TOMM22	Malignant cells	GSE131984_JQ1Pac	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39549
2.97560592791085e-46	-0.764891370702049	0.779	0.916	4.58600385609621e-42	PSMA3	Malignant cells	GSE131984_JQ1Pac	ENSG00000100567	5684	proteasome 20S subunit alpha 3	HC8	protein_coding	P25788	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39550
3.27618670464136e-46	-0.509241823208267	0.966	0.986	5.04925894919326e-42	SIVA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39551
3.32395538868365e-46	-0.712739071639322	0.734	0.89	5.12288004503924e-42	NUDC	Malignant cells	GSE131984_JQ1Pac	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39552
4.49209879932983e-46	-0.479493306292254	0.986	0.997	6.92322266952713e-42	MRPL20	Malignant cells	GSE131984_JQ1Pac	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39553
5.3920928506356e-46	-0.603811786102508	0.776	0.922	8.31029350139958e-42	DCUN1D5	Malignant cells	GSE131984_JQ1Pac	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39554
5.65672358330898e-46	-0.581271513159779	0.672	0.871	8.7181423865958e-42	IER3IP1.1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39555
6.17611269337852e-46	-0.528840801475237	0.862	0.96	9.51862488303497e-42	POLD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39556
6.44612508380435e-46	-0.547649420468921	0.939	0.992	9.93476797915926e-42	EIF3I	Malignant cells	GSE131984_JQ1Pac	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39557
8.97012852488105e-46	-0.546048927000722	0.911	0.969	1.38247620825467e-41	CLTB	Malignant cells	GSE131984_JQ1Pac	ENSG00000175416	1212	clathrin light chain B	Lcb	protein_coding	P09497	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39558
9.67436763854129e-46	-0.592205409205814	0.24	0.576	1.49101354045198e-41	GLA	Malignant cells	GSE131984_JQ1Pac	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39559
1.14454482613342e-45	-0.588816992651388	0.846	0.937	1.76397248603683e-41	CNIH4	Malignant cells	GSE131984_JQ1Pac	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39560
1.32932696241055e-45	-0.640596444535132	0.401	0.696	2.04875871446715e-41	PLEK2	Malignant cells	GSE131984_JQ1Pac	ENSG00000100558	26499	pleckstrin 2	NA	protein_coding	Q9NYT0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39561
1.33813549482511e-45	-0.454634719903556	0.964	1	2.06233442462446e-41	CYC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39562
2.45296697368929e-45	-0.509989088030328	0.955	0.975	3.78051269984994e-41	UXT	Malignant cells	GSE131984_JQ1Pac	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39563
4.65923606547064e-45	-0.630259321361486	0.75	0.895	7.18081462410335e-41	EEF1E1	Malignant cells	GSE131984_JQ1Pac	ENSG00000124802	9521	eukaryotic translation elongation factor 1 epsilon 1	AIMP3|P18	protein_coding	O43324	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39564
5.01858089002895e-45	-0.590426695830506	0.684	0.881	7.73463686771262e-41	VMA21	Malignant cells	GSE131984_JQ1Pac	ENSG00000160131	203547	vacuolar ATPase assembly factor VMA21	MEAX|XMEA	protein_coding	Q3ZAQ7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39565
7.58028460323352e-45	-0.621796947512849	0.6	0.844	1.16827346305035e-40	PDLIM2	Malignant cells	GSE131984_JQ1Pac	ENSG00000120913	64236	PDZ and LIM domain 2	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39566
8.69319430902858e-45	-0.748626244510376	0.179	0.514	1.33979510690748e-40	AKAP12	Malignant cells	GSE131984_JQ1Pac	ENSG00000131016	9590	A-kinase anchoring protein 12	AKAP250|SSeCKS	protein_coding	Q02952	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39567
1.08270848756811e-44	-0.540081673613682	0.796	0.924	1.66867032103997e-40	AUP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39568
1.17268607751236e-44	0.483994169673772	0.347	0.08	1.80734378266205e-40	IFITM10	Malignant cells	GSE131984_JQ1Pac	ENSG00000281618	402778	interferon induced transmembrane protein 10	DSPA3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39569
1.32918890057115e-44	-0.587469582158488	0.297	0.627	2.04854593356026e-40	TSR2	Malignant cells	GSE131984_JQ1Pac	ENSG00000158526	90121	TSR2 ribosome maturation factor	DT1P1A10|RP1-112K5.2|WGG1	protein_coding	Q969E8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39570
1.96797645345148e-44	-0.466113340122911	0.014	0.286	3.03304531005943e-40	IL7R	Malignant cells	GSE131984_JQ1Pac	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39571
2.34937455923817e-44	-0.620610567210241	0.261	0.588	3.62085607069787e-40	FUNDC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000069509	139341	FUN14 domain containing 1	MGC51029	protein_coding	Q8IVP5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39572
2.4027083302086e-44	-0.68373451576514	0.757	0.876	3.70305407851749e-40	PSMD14	Malignant cells	GSE131984_JQ1Pac	ENSG00000115233	10213	proteasome 26S subunit, non-ATPase 14	pad1|POH1|Rpn11	protein_coding	O00487	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39573
2.47210408491976e-44	-0.539566911113866	0.168	0.497	3.81000681567833e-40	C9orf40	Malignant cells	GSE131984_JQ1Pac	ENSG00000135045	55071	chromosome 9 open reading frame 40	FLJ10110	protein_coding	Q8IXQ3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39574
2.99888110615046e-44	-0.597043138291088	0.697	0.874	4.62187556079908e-40	FAM127B	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39575
3.03173511664104e-44	-0.583909699449323	0.871	0.959	4.67251016176717e-40	GLRX3	Malignant cells	GSE131984_JQ1Pac	ENSG00000108010	10539	glutaredoxin 3	bA500G10.4|GLRX4|GRX3|GRX4|PICOT|TXNL2	protein_coding	O76003	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39576
3.76533573495987e-44	-0.592733589388606	0.229	0.551	5.80313543472016e-40	SMAGP	Malignant cells	GSE131984_JQ1Pac	ENSG00000170545	57228	small cell adhesion glycoprotein	hSMAGP|MGC149453|MGC149454	protein_coding	Q0VAQ4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39577
3.77751657823796e-44	-0.463321898692939	0.963	0.991	5.82190855038034e-40	LSM2	Malignant cells	GSE131984_JQ1Pac	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39578
3.9631317748642e-44	-0.505294058740789	0.855	0.968	6.1079786914207e-40	MRPL4	Malignant cells	GSE131984_JQ1Pac	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39579
4.78218245004995e-44	-0.752939339554	0.271	0.596	7.37029959201698e-40	CES1	Malignant cells	GSE131984_JQ1Pac	ENSG00000262243	1066	carboxylesterase 1	CEH|CES1A1|CES1A2|CES2|HMSE|HMSE1|SES1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39580
5.25166236217738e-44	-0.557090997123064	1	1	8.09386203258777e-40	ENO1	Malignant cells	GSE131984_JQ1Pac	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39581
6.36291356874752e-44	-0.516473121600527	0.924	0.984	9.80652239215367e-40	MRPS34	Malignant cells	GSE131984_JQ1Pac	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39582
6.8182803784676e-44	0.554884556844802	0.449	0.153	1.05083337192943e-39	FSTL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000163430	11167	follistatin like 1	FRP|FSL1|OCC-1|OCC1|tsc36	protein_coding	Q12841	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39583
7.97280079463242e-44	-0.623105669848014	0.065	0.365	1.22876805846875e-39	SULT1B1	Malignant cells	GSE131984_JQ1Pac	ENSG00000173597	27284	sulfotransferase family 1B member 1	ST1B2	protein_coding	O43704	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39584
8.03897139235355e-44	-0.575543620096627	0.925	0.979	1.23896627098953e-39	PSMA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000129084	5682	proteasome 20S subunit alpha 1	HC2|MGC14542|MGC14575|MGC14751|MGC1667|MGC21459|MGC22853|MGC23915|NU|PROS30	protein_coding	P25786	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39585
1.1661139286015e-43	-0.479640486540215	0.974	0.993	1.79721478676064e-39	C14orf166	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39586
1.19730615081123e-43	-0.508901775521326	0.12	0.434	1.84528823963027e-39	MTHFD1L	Malignant cells	GSE131984_JQ1Pac	ENSG00000120254	25902	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like	DKFZP586G1517|FLJ21145|FTHFSDC1	protein_coding	Q6UB35	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39587
1.34448150001743e-43	-0.51304830943694	0.913	0.976	2.07211488782686e-39	COPRS	Malignant cells	GSE131984_JQ1Pac	ENSG00000172301	55352	coordinator of PRMT5 and differentiation stimulator	C17orf79|COPR5|HSA272196|TTP1	protein_coding	Q9NQ92	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39588
1.40631487317163e-43	0.28517550929689	1	1	2.16741248253211e-39	RPS3	Malignant cells	GSE131984_JQ1Pac	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39589
1.53232488433026e-43	-0.487421304511408	0.078	0.382	2.3616191117298e-39	ACOX2	Malignant cells	GSE131984_JQ1Pac	ENSG00000168306	8309	acyl-CoA oxidase 2	BRCACOX|BRCOX|THCCox	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39590
2.01669344505428e-43	-0.586538876398969	0.398	0.697	3.10812793751766e-39	AGTRAP	Malignant cells	GSE131984_JQ1Pac	ENSG00000177674	57085	angiotensin II receptor associated protein	ATRAP	protein_coding	Q6RW13	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39591
2.17297986631496e-43	-0.518837439411126	0.844	0.949	3.34899656996461e-39	SSRP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000149136	6749	structure specific recognition protein 1	FACT80	protein_coding	Q08945	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39592
2.41716951748697e-43	-0.463617302270078	0.037	0.319	3.72534166035092e-39	RP11-350J20.12	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39593
2.51502784463462e-43	-0.553707781451182	0.854	0.957	3.87616091415088e-39	ATP1B3	Malignant cells	GSE131984_JQ1Pac	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39594
2.6499733822522e-43	-0.595741930156005	0.557	0.84	4.0841389767271e-39	CRADD	Malignant cells	GSE131984_JQ1Pac	ENSG00000169372	8738	CASP2 and RIPK1 domain containing adaptor with death domain	RAIDD	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39595
2.68956117784924e-43	-0.521884714079629	0.184	0.51	4.14515168730125e-39	ETV4	Malignant cells	GSE131984_JQ1Pac	ENSG00000175832	2118	ETS variant transcription factor 4	E1A-F|E1AF|PEA3	protein_coding	P43268	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39596
3.18013596490486e-43	-0.640413724772558	0.435	0.711	4.90122554911138e-39	UROD	Malignant cells	GSE131984_JQ1Pac	ENSG00000126088	7389	uroporphyrinogen decarboxylase	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39597
3.18099381798905e-43	-0.552227398014901	0.91	0.978	4.90254767228472e-39	DDX21	Malignant cells	GSE131984_JQ1Pac	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39598
3.37731769635386e-43	-0.493464639445496	0.927	0.983	5.20512203362057e-39	UBE2I	Malignant cells	GSE131984_JQ1Pac	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39599
5.31459353635904e-43	-0.543552196495168	0.824	0.938	8.19085155823655e-39	CALD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000122786	800	caldesmon 1	CDM|H-CAD|h-CD|L-CAD	protein_coding	Q05682	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39600
6.30942839520346e-43	-0.525339067777647	0.939	0.984	9.72409104268757e-39	VAPA	Malignant cells	GSE131984_JQ1Pac	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39601
9.14633445470936e-43	-0.647621537481774	0.351	0.662	1.40963306615981e-38	ACOT9	Malignant cells	GSE131984_JQ1Pac	ENSG00000123130	23597	acyl-CoA thioesterase 9	ACATE2|CGI-16|MT-ACT48	protein_coding	Q9Y305	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39602
9.38461204296634e-43	0.474408996299258	0.998	0.992	1.44635640806197e-38	PPDPF	Malignant cells	GSE131984_JQ1Pac	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39603
1.16551454174705e-42	0.254589907850273	1	1	1.79629101174055e-38	RPS9	Malignant cells	GSE131984_JQ1Pac	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39604
1.60991594837786e-42	-0.600783961023543	0.247	0.562	2.48120245963995e-38	UGDH	Malignant cells	GSE131984_JQ1Pac	ENSG00000109814	7358	UDP-glucose 6-dehydrogenase	NA	protein_coding	O60701	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39605
1.79414495912019e-42	-0.592727418351918	0.314	0.633	2.76513621099604e-38	GPANK1	Malignant cells	GSE131984_JQ1Pac	ENSG00000223932	7918	G-patch domain and ankyrin repeats 1	ANKRD59|BAT4|D6S54E|G5|GPATCH10	protein_coding	O95872	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39606
4.15331436629103e-42	-0.730669898963461	0.49	0.749	6.40108810132774e-38	BRIX1	Malignant cells	GSE131984_JQ1Pac	ENSG00000113460	55299	biogenesis of ribosomes BRX1	BRIX|BXDC2|FLJ11100	protein_coding	Q8TDN6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39607
5.30259519128738e-42	-0.628812841504558	0.342	0.64	8.17235970881211e-38	UPF3B	Malignant cells	GSE131984_JQ1Pac	ENSG00000125351	65109	UPF3B regulator of nonsense mediated mRNA decay	HUPF3B|MRX62|MRX82|RENT3B|UPF3BP1|UPF3BP2|UPF3BP3|UPF3X	protein_coding	Q9BZI7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39608
5.72812931713791e-42	-0.603552562782278	0.902	0.973	8.82819290357294e-38	PSMB6	Malignant cells	GSE131984_JQ1Pac	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39609
5.96874273281913e-42	0.685416419742267	0.743	0.47	9.19902629982084e-38	CITED2	Malignant cells	GSE131984_JQ1Pac	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39610
6.24388608671737e-42	0.583001455106831	0.953	0.926	9.62307723684881e-38	DCXR	Malignant cells	GSE131984_JQ1Pac	ENSG00000169738	51181	dicarbonyl and L-xylulose reductase	DCR|HCR2|KIDCR|P34H|SDR20C1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39611
6.48907911994428e-42	-0.521023017747673	0.076	0.369	1.00009687396581e-37	NRG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000157168	3084	neuregulin 1	GGF|HGL|HRG|NDF|NRG1-IT2	protein_coding	Q02297	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39612
7.93466716119147e-42	-0.638710023386397	0.404	0.692	1.22289090288283e-37	GLIPR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39613
8.17394536411741e-42	-0.551431441825628	0.697	0.88	1.25976845951778e-37	ACTR3	Malignant cells	GSE131984_JQ1Pac	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39614
8.5352961817942e-42	-0.539778141898531	0.745	0.91	1.31545984753812e-37	LRRFIP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39615
9.00409050654613e-42	-0.546993534887354	0.946	0.987	1.38771042886889e-37	CCT6A	Malignant cells	GSE131984_JQ1Pac	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39616
9.46914074860173e-42	-0.552800632663977	0.747	0.909	1.4593839721745e-37	RNF126	Malignant cells	GSE131984_JQ1Pac	ENSG00000070423	55658	ring finger protein 126	FLJ20552	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39617
1.1532536298455e-41	0.570252232732606	0.981	0.926	1.77739449431788e-37	LAGE3	Malignant cells	GSE131984_JQ1Pac	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39618
1.3114069866853e-41	-0.392578671302279	0.997	1	2.02114044787938e-37	SEC61B	Malignant cells	GSE131984_JQ1Pac	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39619
1.40023349490673e-41	0.293148505443793	1	1	2.15803986235025e-37	RPS11	Malignant cells	GSE131984_JQ1Pac	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39620
1.88503520389649e-41	-0.377105521959094	0.995	1	2.90521625624526e-37	MZT2B	Malignant cells	GSE131984_JQ1Pac	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39621
2.39845397631771e-41	-0.513889903129608	0.844	0.949	3.69649726830085e-37	PPM1G	Malignant cells	GSE131984_JQ1Pac	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39622
3.21268176972277e-41	-0.614083828960107	0.507	0.747	4.95138514349673e-37	UBE2E1	Malignant cells	GSE131984_JQ1Pac	ENSG00000170142	7324	ubiquitin conjugating enzyme E2 E1	UbcH6	protein_coding	P51965	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39623
3.29412874356209e-41	-0.5735925881141	0.628	0.838	5.0769112195779e-37	ICT1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39624
4.40409495277742e-41	-0.618995299277767	0.253	0.559	6.78759114122056e-37	IQSEC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000124313	23096	IQ motif and Sec7 domain ArfGEF 2	BRAG1|IQ-ArfGEF|KIAA0522|MRX1|MRX18|MRX78	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39625
4.74817018639564e-41	-0.533685909527055	0.759	0.893	7.31787989127297e-37	GSPT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39626
6.0945290940981e-41	0.663732659970631	0.451	0.172	9.392888239824e-37	ASS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39627
6.21050038116428e-41	0.468172786006253	0.997	0.989	9.57162318745039e-37	PTMS	Malignant cells	GSE131984_JQ1Pac	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39628
6.994166793291e-41	-0.604023612344004	0.799	0.922	1.07794098618201e-36	RBBP7	Malignant cells	GSE131984_JQ1Pac	ENSG00000102054	5931	RB binding protein 7, chromatin remodeling factor	RbAp46	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39629
7.82793360473275e-41	-0.592356530560611	0.213	0.531	1.20644112716141e-36	AC074389.9	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39630
9.67264090450922e-41	-0.629383399655199	0.407	0.702	1.49074741620296e-36	MAGEA12	Malignant cells	GSE131984_JQ1Pac	ENSG00000213401	4111	MAGE family member A12	CT1.12|MAGE12	protein_coding	P43365	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39631
1.05740832257413e-40	-0.713109537946871	0.991	0.998	1.62967770675125e-36	HSP90AA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39632
1.4445194965098e-40	-0.608671894888555	0.451	0.709	2.22629344802091e-36	HTATSF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39633
1.5022660301938e-40	0.671856993725007	0.994	0.989	2.31529240573468e-36	CCDC85B	Malignant cells	GSE131984_JQ1Pac	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39634
1.74960984171143e-40	-0.53430756678899	0.907	0.968	2.69649868804566e-36	DAD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39635
2.26585853509404e-40	-0.566972603608167	0.501	0.752	3.49214117428693e-36	SLC30A5	Malignant cells	GSE131984_JQ1Pac	ENSG00000145740	64924	solute carrier family 30 member 5	FLJ12496|FLJ12756|MGC5499|ZnT-5|ZNT5|ZNTL1|ZTL1	protein_coding	Q8TAD4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39636
2.8752496894963e-40	-0.436828944126857	0.966	0.993	4.4313348214517e-36	LSM7	Malignant cells	GSE131984_JQ1Pac	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39637
3.81763689107289e-40	-0.486647200447005	0.848	0.945	5.88374197652154e-36	MRPL11	Malignant cells	GSE131984_JQ1Pac	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39638
3.84329130186318e-40	-0.511711210811953	0.883	0.956	5.92328055443153e-36	CBR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39639
4.35186783393975e-40	-0.911172820985757	0.502	0.769	6.70709870566795e-36	CCNB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000134057	891	cyclin B1	CCNB	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39640
4.70121709134033e-40	-0.564364863281595	0.621	0.822	7.24551578117372e-36	EMC8	Malignant cells	GSE131984_JQ1Pac	ENSG00000131148	10328	ER membrane protein complex subunit 8	C16orf2|C16orf4|COX4NB|FAM158B|NOC4	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39641
4.94933682470413e-40	-0.508721261016486	0.799	0.934	7.62791791423401e-36	YIF1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000174851	10897	Yip1 interacting factor homolog A, membrane trafficking protein	54TM|FinGER7|YIF1|YIF1P	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39642
5.17461710989147e-40	-0.522679115159732	0.852	0.951	7.97511988976473e-36	BCAP31	Malignant cells	GSE131984_JQ1Pac	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39643
5.23217859458925e-40	-0.349304712935482	1	1	8.06383364998095e-36	TSPO	Malignant cells	GSE131984_JQ1Pac	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39644
5.96307449661376e-40	-0.375880627434478	1	1	9.19029041418113e-36	PSMA7	Malignant cells	GSE131984_JQ1Pac	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39645
6.63813895204166e-40	-0.542608055208968	0.235	0.561	1.02306997528866e-35	MAGEA6	Malignant cells	GSE131984_JQ1Pac	ENSG00000197172	4105	MAGE family member A6	CT1.6|MAGE-3b|MAGE3B|MAGE6	protein_coding	P43360	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39646
1.02168224732316e-39	-0.596436727943372	0.852	0.931	1.57461667957445e-35	PCMT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000120265	5110	protein-L-isoaspartate (D-aspartate) O-methyltransferase	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39647
1.06501255151605e-39	-0.489158519092421	0.89	0.954	1.64139734439653e-35	CSNK2B	Malignant cells	GSE131984_JQ1Pac	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39648
1.08183977614478e-39	-0.497564895993926	0.95	0.994	1.66733146299434e-35	DNAJC15	Malignant cells	GSE131984_JQ1Pac	ENSG00000120675	29103	DnaJ heat shock protein family (Hsp40) member C15	DNAJD1|MCJ	protein_coding	Q9Y5T4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39649
1.41831950695004e-39	-0.580995170475036	0.649	0.839	2.1859140241114e-35	WBSCR22	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39650
1.42599689045862e-39	-0.251344662661757	1	1	2.19774640757482e-35	BTF3	Malignant cells	GSE131984_JQ1Pac	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39651
2.07066118203714e-39	-0.57122764695743	0.904	0.972	3.19130301375564e-35	CCT4	Malignant cells	GSE131984_JQ1Pac	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39652
2.1161495581476e-39	-0.667970715237568	0.373	0.649	3.26140969901708e-35	PBDC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000102390	51260	polysaccharide biosynthesis domain containing 1	CXorf26|MGC874	protein_coding	Q9BVG4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39653
2.29274665956716e-39	-0.551961391074044	0.317	0.616	3.53358115172491e-35	PLSCR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39654
2.99412112845261e-39	-0.469358768190439	0.967	0.985	4.61453948317117e-35	HNRNPA3	Malignant cells	GSE131984_JQ1Pac	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39655
3.25769518494225e-39	-0.570846954814126	0.701	0.871	5.02075981903299e-35	CHCHD3	Malignant cells	GSE131984_JQ1Pac	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39656
3.71029193154416e-39	-0.527586379198083	0.768	0.908	5.71830192489585e-35	TMEM126A	Malignant cells	GSE131984_JQ1Pac	ENSG00000171202	84233	transmembrane protein 126A	DKFZp586C1924|OPA7	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39657
4.15915321502767e-39	-0.531871917469085	0.974	0.992	6.41008693500064e-35	SSBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39658
4.75110561769971e-39	-0.626772094589647	0.63	0.815	7.3224039779988e-35	HPRT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000165704	3251	hypoxanthine phosphoribosyltransferase 1	HGPRT|HPRT	protein_coding	P00492	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39659
5.6349939548861e-39	-0.559404349971859	0.238	0.544	8.68465268327045e-35	TRIM7	Malignant cells	GSE131984_JQ1Pac	ENSG00000146054	81786	tripartite motif containing 7	GNIP|RNF90	protein_coding	Q9C029	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39660
6.46065944788677e-39	-0.445845518997592	0.981	0.996	9.95716834108309e-35	PDCD6	Malignant cells	GSE131984_JQ1Pac	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39661
6.92773217642137e-39	-0.464781560544919	0.048	0.315	1.06770208303006e-34	RP11-527H14.3	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39662
6.95169761086889e-39	-0.707008454684826	0.392	0.648	1.07139563578711e-34	KCNMA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000156113	3778	potassium calcium-activated channel subfamily M alpha 1	KCa1.1|mSLO1|SLO	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39663
7.09674549727657e-39	-0.31322937509841	1	1	1.09375041604026e-34	RPS29	Malignant cells	GSE131984_JQ1Pac	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39664
7.34130696825257e-39	-0.423141039361183	0.997	1	1.13144222994709e-34	KRT10	Malignant cells	GSE131984_JQ1Pac	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39665
7.86711004635732e-39	-0.641881652644045	0.639	0.825	1.21247900034459e-34	MRPL13	Malignant cells	GSE131984_JQ1Pac	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39666
8.81325252102714e-39	-0.553546278643619	0.806	0.912	1.3582984785407e-34	MRPL22	Malignant cells	GSE131984_JQ1Pac	ENSG00000082515	29093	mitochondrial ribosomal protein L22	HSPC158|MRP-L25|RPML25	protein_coding	Q9NWU5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39667
9.95081277441569e-39	-0.509527507559647	0.264	0.582	1.53361926479295e-34	TACO1	Malignant cells	GSE131984_JQ1Pac	ENSG00000136463	51204	translational activator of cytochrome c oxidase I	CCDC44	protein_coding	Q9BSH4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39668
1.57154730552765e-38	0.312982263375714	1	1	2.42206870727921e-34	TCEB2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39669
2.09023548643236e-38	-0.564830670304242	0.882	0.961	3.22147093168955e-34	GSTO1	Malignant cells	GSE131984_JQ1Pac	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39670
2.23774397672517e-38	-0.507645701025299	0.868	0.932	3.44881101692883e-34	H2AFY	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39671
2.25084989989487e-38	-0.648554435200232	0.471	0.748	3.46900986571797e-34	UBE2T	Malignant cells	GSE131984_JQ1Pac	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39672
2.26462933748074e-38	-0.509227716952302	0.771	0.918	3.49024673492531e-34	MRPL17	Malignant cells	GSE131984_JQ1Pac	ENSG00000158042	63875	mitochondrial ribosomal protein L17	MRP-L26|RPML26	protein_coding	Q9NRX2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39673
2.91432431780699e-38	-0.528553840750096	0.854	0.943	4.49155663860413e-34	RSL1D1	Malignant cells	GSE131984_JQ1Pac	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39674
3.33542538942215e-38	0.550904450679779	1	0.997	5.14055761017741e-34	IRX2	Malignant cells	GSE131984_JQ1Pac	ENSG00000170561	153572	iroquois homeobox 2	NA	protein_coding	Q9BZI1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39675
3.36516721653026e-38	-0.669126702493394	0.501	0.731	5.18639571411643e-34	NUCB2	Malignant cells	GSE131984_JQ1Pac	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39676
4.11127399984563e-38	-0.474853136251501	0.904	0.961	6.33629548856208e-34	C11orf31	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39677
4.44847825821073e-38	-0.5869493149339	0.603	0.793	6.85599469155437e-34	FAM58A	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39678
5.47659586543113e-38	-0.593623293442597	0.387	0.666	8.44052954780246e-34	HMGN5	Malignant cells	GSE131984_JQ1Pac	ENSG00000198157	79366	high mobility group nucleosome binding domain 5	NSBP1	protein_coding	P82970	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39679
5.71926000905111e-38	-0.549991841224274	0.709	0.896	8.81452352594958e-34	CAV2	Malignant cells	GSE131984_JQ1Pac	ENSG00000105971	858	caveolin 2	CAV	protein_coding	P51636	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39680
6.93052521923219e-38	-0.555260039767671	0.577	0.809	1.06813254678807e-33	JPX	Malignant cells	GSE131984_JQ1Pac	ENSG00000225470	554203	JPX transcript, XIST activator	DCBALD06|ENOX|LINC00183|NCRNA00183	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39681
7.27391322049628e-38	0.382837954952054	1	0.999	1.12105550554289e-33	PFDN5	Malignant cells	GSE131984_JQ1Pac	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39682
7.28242036026704e-38	0.346698376767105	1	0.999	1.12236662592436e-33	MT-CO3	Malignant cells	GSE131984_JQ1Pac	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39683
8.67823677872949e-38	-0.54795954923442	0.694	0.859	1.33748985233779e-33	TIMM10	Malignant cells	GSE131984_JQ1Pac	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39684
9.19044934472039e-38	-0.406182017679447	0.992	0.993	1.41643205300831e-33	VDAC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39685
9.33399657885038e-38	-0.60369421873417	0.434	0.696	1.43855555273242e-33	PYCR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39686
1.0373001322275e-37	-0.665758630459498	0.101	0.383	1.59868696378902e-33	NUPR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39687
1.2528174350194e-37	-0.53522116075413	0.871	0.962	1.93084223085189e-33	PSMB2	Malignant cells	GSE131984_JQ1Pac	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39688
1.30369004702087e-37	-0.543281703623029	0.74	0.89	2.00924710046856e-33	MRPS7	Malignant cells	GSE131984_JQ1Pac	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39689
1.75870648257082e-37	-0.504553695840585	0.137	0.427	2.71051843093815e-33	STEAP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000164647	26872	STEAP family member 1	PRSS24|STEAP	protein_coding	Q9UHE8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39690
2.60628556129783e-37	-0.543730480046384	0.428	0.697	4.01680730707222e-33	UBL4A	Malignant cells	GSE131984_JQ1Pac	ENSG00000102178	8266	ubiquitin like 4A	DXS254E|GDX|GET5|MDY2|TMA24|UBL4	protein_coding	P11441	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39691
3.03019264043164e-37	-0.536200254813351	0.852	0.953	4.67013289743324e-33	RBM8A	Malignant cells	GSE131984_JQ1Pac	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39692
3.61662548693743e-37	-0.552546548909165	0.995	0.997	5.57394320046797e-33	C5orf38	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39693
3.81519463208969e-37	-0.517872280371044	0.232	0.533	5.87997796697664e-33	LDOC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000182195	23641	LDOC1 regulator of NFKB signaling	BCUR1|Mar7|Mart7|RTL7|SIRH7	protein_coding	O95751	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39694
3.84584021411489e-37	-0.636868786719208	0.669	0.849	5.92720893799387e-33	CDC123	Malignant cells	GSE131984_JQ1Pac	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39695
4.64494329679595e-37	-0.465746244865807	0.984	0.998	7.15878660902192e-33	RTN4	Malignant cells	GSE131984_JQ1Pac	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39696
5.10980063830436e-37	-0.503823343524392	0.933	0.978	7.87522474375468e-33	C17orf89	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39697
5.27834502455278e-37	-0.564810799653154	0.574	0.78	8.13498535184075e-33	VAMP8	Malignant cells	GSE131984_JQ1Pac	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39698
6.94355947185481e-37	0.360462924437464	1	0.998	1.07014138580226e-32	MT-ATP6	Malignant cells	GSE131984_JQ1Pac	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39699
7.6813388725959e-37	-0.504722832690146	0.725	0.886	1.18384794704448e-32	ARL5A	Malignant cells	GSE131984_JQ1Pac	ENSG00000162980	26225	ADP ribosylation factor like GTPase 5A	ARL5	protein_coding	Q9Y689	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39700
1.03560788250961e-36	-0.524808651707092	0.322	0.614	1.59607886852381e-32	YRDC	Malignant cells	GSE131984_JQ1Pac	ENSG00000196449	79693	yrdC N6-threonylcarbamoyltransferase domain containing	FLJ23476|IRIP|SUA5	protein_coding	Q86U90	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39701
1.15621646185344e-36	0.304821560147724	1	1	1.78196081100852e-32	SERF2	Malignant cells	GSE131984_JQ1Pac	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39702
1.38111139973153e-36	0.482112176891316	0.49	0.211	2.12856888926623e-32	ZNF22	Malignant cells	GSE131984_JQ1Pac	ENSG00000165512	7570	zinc finger protein 22	HKR-T1|KOX15|Zfp422|ZNF422	protein_coding	P17026	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39703
1.47010446414468e-36	-0.55364181458279	0.653	0.839	2.26572500013979e-32	GPATCH4	Malignant cells	GSE131984_JQ1Pac	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39704
1.70254832172857e-36	-0.492153743024596	0.132	0.419	2.62396747344807e-32	CASP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000137752	834	caspase 1	ICE|IL1BC	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39705
2.302463217247e-36	-0.452668393197162	0.95	0.977	3.54855631042107e-32	CYB5A	Malignant cells	GSE131984_JQ1Pac	ENSG00000166347	1528	cytochrome b5 type A	CYB5	protein_coding	P00167	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39706
2.34068814493523e-36	-0.571463486739186	0.541	0.771	3.60746856897417e-32	ALG5	Malignant cells	GSE131984_JQ1Pac	ENSG00000120697	29880	ALG5 dolichyl-phosphate beta-glucosyltransferase	bA421P11.2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39707
2.38092285383436e-36	-0.533441799548213	0.322	0.615	3.66947830232952e-32	MAP7D3	Malignant cells	GSE131984_JQ1Pac	ENSG00000129680	79649	MAP7 domain containing 3	FLJ12649	protein_coding	Q8IWC1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39708
2.44344567341686e-36	-0.554333915381276	0.72	0.87	3.76583847187006e-32	PSMG3	Malignant cells	GSE131984_JQ1Pac	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39709
2.60231532664732e-36	-0.445747515066159	0.949	0.982	4.01068838142885e-32	MRPL33	Malignant cells	GSE131984_JQ1Pac	ENSG00000243147	9553	mitochondrial ribosomal protein L33	C2orf1|RPL33L	protein_coding	O75394	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39710
2.61648468098259e-36	-0.401117135278819	0.09	0.364	4.03252619033037e-32	IL15RA	Malignant cells	GSE131984_JQ1Pac	ENSG00000134470	3601	interleukin 15 receptor subunit alpha	CD215|IL-15RA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39711
2.90120629965718e-36	-0.541702844487063	0.703	0.876	4.47133914903165e-32	CENPV	Malignant cells	GSE131984_JQ1Pac	ENSG00000166582	201161	centromere protein V	CENP-V|p30|PRR6	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39712
2.99750203458238e-36	-0.557899019982705	0.58	0.799	4.61975013569836e-32	PQBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000102103	10084	polyglutamine binding protein 1	MRX2|MRX55|MRXS3|MRXS8|RENS1|SHS	protein_coding	O60828	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39713
3.08308640424648e-36	-0.515001894010172	0.275	0.577	4.75165276622468e-32	COMTD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000165644	118881	catechol-O-methyltransferase domain containing 1	FLJ23841	protein_coding	Q86VU5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39714
3.09291985240663e-36	-0.684091245875826	0.409	0.673	4.7668080765291e-32	WBP5	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39715
3.29970836136625e-36	-0.530761389046708	0.742	0.941	5.08551052653767e-32	CDKN3	Malignant cells	GSE131984_JQ1Pac	ENSG00000100526	1033	cyclin dependent kinase inhibitor 3	CDI1|KAP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39716
3.62202487205997e-36	-0.513507469261482	0.717	0.873	5.58226473281882e-32	PAFAH1B3	Malignant cells	GSE131984_JQ1Pac	ENSG00000079462	5050	platelet activating factor acetylhydrolase 1b catalytic subunit 3	NA	protein_coding	Q15102	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39717
3.81051414710543e-36	-0.466757061872594	0.938	0.976	5.87276440351889e-32	GHITM	Malignant cells	GSE131984_JQ1Pac	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39718
4.12461934749244e-36	-0.494054484678626	0.844	0.939	6.35686333835534e-32	COX16	Malignant cells	GSE131984_JQ1Pac	ENSG00000133983	51241	cytochrome c oxidase assembly factor COX16	C14orf112|HSPC203	protein_coding	Q9P0S2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39719
4.39457537805124e-36	-0.525800113725593	0.599	0.806	6.77291957265257e-32	RWDD4	Malignant cells	GSE131984_JQ1Pac	ENSG00000182552	201965	RWD domain containing 4	FAM28A|MGC10198|RWDD4A	protein_coding	Q6NW29	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39720
5.01564572698763e-36	0.74362933418645	1	0.992	7.73011319443334e-32	NEAT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39721
5.24526821285122e-36	-0.532120726631003	0.706	0.916	8.0840073696463e-32	BIRC5	Malignant cells	GSE131984_JQ1Pac	ENSG00000089685	332	baculoviral IAP repeat containing 5	API4|EPR-1|survivin	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39722
5.54214729430205e-36	-0.580589679862488	0.44	0.699	8.54155740997832e-32	MCM7	Malignant cells	GSE131984_JQ1Pac	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39723
6.73880854585279e-36	-0.570007039084417	0.981	0.998	1.03858517308683e-31	CALM2	Malignant cells	GSE131984_JQ1Pac	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39724
6.74180559464921e-36	-0.474714370834583	0.862	0.956	1.03904707824734e-31	GGCT	Malignant cells	GSE131984_JQ1Pac	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39725
7.34913553454172e-36	-0.547921301101456	0.986	0.996	1.13264876858357e-31	C1QBP	Malignant cells	GSE131984_JQ1Pac	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39726
7.50459173146212e-36	-0.573022683680416	0.44	0.68	1.15660767765294e-31	TCEAL8	Malignant cells	GSE131984_JQ1Pac	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39727
8.79969395181639e-36	-0.35187792029004	1	1	1.35620883185394e-31	PTMA	Malignant cells	GSE131984_JQ1Pac	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39728
1.01833374466601e-35	-0.572846926688986	0.669	0.841	1.56945596727926e-31	SPCS3	Malignant cells	GSE131984_JQ1Pac	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39729
1.09251165640642e-35	-0.490800162328237	0.854	0.933	1.68377896485357e-31	THOC7	Malignant cells	GSE131984_JQ1Pac	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39730
1.11422256472941e-35	-0.532122398877881	0.585	0.824	1.71723981676096e-31	POLR3K	Malignant cells	GSE131984_JQ1Pac	ENSG00000161980	51728	RNA polymerase III subunit K	C11|RPC11	protein_coding	Q9Y2Y1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39731
1.12132240829691e-35	-0.476068519651978	0.117	0.391	1.72818209566719e-31	ATAD3B	Malignant cells	GSE131984_JQ1Pac	ENSG00000160072	83858	ATPase family AAA domain containing 3B	KIAA1273|TOB3	protein_coding	Q5T9A4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39732
1.38111274195921e-35	-0.601169394047417	0.471	0.73	2.12857095790753e-31	AHSA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39733
1.38565513141453e-35	-0.495477012322749	0.583	0.807	2.13557168853607e-31	CUEDC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000107874	79004	CUE domain containing 2	C10orf66|MGC2491	protein_coding	Q9H467	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39734
1.70570586703357e-35	-0.460687810468953	0.857	0.957	2.62883388227213e-31	COA4	Malignant cells	GSE131984_JQ1Pac	ENSG00000181924	51287	cytochrome c oxidase assembly factor 4 homolog	CHCHD8|CMC3|E2IG2	protein_coding	Q9NYJ1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39735
1.78680383474049e-35	-0.572433664783976	0.736	0.863	2.75382207010204e-31	MRPS23	Malignant cells	GSE131984_JQ1Pac	ENSG00000181610	51649	mitochondrial ribosomal protein S23	CGI-138|HSPC329|MRP-S23	protein_coding	Q9Y3D9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39736
1.89212324689652e-35	-0.538719012127591	0.852	0.944	2.91614034811692e-31	SDHB	Malignant cells	GSE131984_JQ1Pac	ENSG00000117118	6390	succinate dehydrogenase complex iron sulfur subunit B	SDH|SDH1	protein_coding	P21912	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39737
2.25450287741328e-35	-0.542285353861483	0.442	0.714	3.47463983466935e-31	ECHDC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000093144	55862	ethylmalonyl-CoA decarboxylase 1	dJ351K20.2	protein_coding	Q9NTX5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39738
2.44615585971174e-35	-0.495088430180846	0.812	0.925	3.77001541098774e-31	LAPTM4B	Malignant cells	GSE131984_JQ1Pac	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39739
2.45468301300811e-35	-0.391171938980926	0.995	1	3.7831574596481e-31	NHP2L1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39740
2.46571347475125e-35	-0.433756121736772	0.936	0.984	3.80015760728663e-31	EIF5B	Malignant cells	GSE131984_JQ1Pac	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39741
2.66814990463662e-35	-0.441294385322289	0.893	0.963	4.11215263302595e-31	HDDC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39742
2.79526238055437e-35	-0.45816545944967	0.037	0.276	4.30805838091039e-31	TSPAN8	Malignant cells	GSE131984_JQ1Pac	ENSG00000127324	7103	tetraspanin 8	CO-029|TM4SF3	protein_coding	P19075	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39743
3.54059409629864e-35	-0.419006723407573	0.969	0.991	5.45676362121546e-31	CBX3	Malignant cells	GSE131984_JQ1Pac	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39744
3.65072927202489e-35	0.612429585290919	0.966	0.926	5.62650395404477e-31	TXNRD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39745
4.35115338427639e-35	-0.507004558970279	0.143	0.421	6.70599759584677e-31	TPD52L1	Malignant cells	GSE131984_JQ1Pac	ENSG00000111907	7164	TPD52 like 1	D53|hD53|TPD53	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39746
4.58414257931509e-35	-0.55423877139015	0.339	0.633	7.06508054324042e-31	FEN1	Malignant cells	GSE131984_JQ1Pac	ENSG00000168496	2237	flap structure-specific endonuclease 1	FEN-1|MF1|RAD2	protein_coding	P39748	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39747
4.78214018492745e-35	-0.517660739028032	0.818	0.91	7.37023445301019e-31	LINC00152	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39748
5.4631047909317e-35	-0.311353635428507	1	1	8.41973710378394e-31	TMA7	Malignant cells	GSE131984_JQ1Pac	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39749
8.3815609858496e-35	-0.509660573592172	0.319	0.608	1.29176617913914e-30	WDR45	Malignant cells	GSE131984_JQ1Pac	ENSG00000196998	11152	WD repeat domain 45	JM5|NBIA5|WDRX1|WIPI4	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39750
8.89634757595475e-35	-0.586255424002843	0.446	0.688	1.37110508840615e-30	GRPEL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000109519	80273	GrpE like 1, mitochondrial	FLJ25609|GrpE|hMGE	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39751
1.0896631937178e-34	-0.55229430400607	0.319	0.606	1.67938891415787e-30	RP11-1094M14.11	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39752
1.38961403178063e-34	-0.501999222864067	0.334	0.631	2.1416731457803e-30	CDCP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000163814	64866	CUB domain containing protein 1	CD318|SIMA135	protein_coding	Q9H5V8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39753
1.50186955338188e-34	-0.563931486277416	0.513	0.762	2.31468135567216e-30	ARL4A	Malignant cells	GSE131984_JQ1Pac	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39754
1.60004372091074e-34	-0.609356772680145	0.233	0.529	2.46598738266763e-30	TRIB3	Malignant cells	GSE131984_JQ1Pac	ENSG00000101255	57761	tribbles pseudokinase 3	C20orf97|dJ1103G7.3|TRB3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39755
1.6350766721521e-34	-0.524675425085294	0.905	0.971	2.51998016712082e-30	HNRNPD	Malignant cells	GSE131984_JQ1Pac	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39756
1.67685079756956e-34	0.42079607842254	0.383	0.133	2.5843624492142e-30	HTRA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000166033	5654	HtrA serine peptidase 1	ARMD7|HtrA|IGFBP5-protease|PRSS11	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39757
1.74706404559389e-34	-0.537419205666656	0.579	0.799	2.69257510706931e-30	NAA50	Malignant cells	GSE131984_JQ1Pac	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39758
2.31650874789516e-34	-0.500289288075655	0.7	0.919	3.57020328225603e-30	CENPW	Malignant cells	GSE131984_JQ1Pac	ENSG00000203760	387103	centromere protein W	C6orf173|CUG2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39759
2.88961217437197e-34	-0.477970662610309	0.824	0.917	4.45347028314209e-30	POP7	Malignant cells	GSE131984_JQ1Pac	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39760
3.58805786129691e-34	-0.493262737789564	0.669	0.851	5.52991477583079e-30	DDX1	Malignant cells	GSE131984_JQ1Pac	ENSG00000079785	1653	DEAD-box helicase 1	DBP-RB	protein_coding	Q92499	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39761
4.00454553516182e-34	0.392604261798715	0.252	0.05	6.1718055787914e-30	IGFBP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000115457	3485	insulin like growth factor binding protein 2	IBP2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39762
4.04117626319113e-34	-0.550023166365483	0.131	0.403	6.22826085683017e-30	CCAT1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39763
4.44437541269353e-34	0.410261890133127	0.998	0.998	6.84967138604327e-30	NPC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39764
4.60464233957543e-34	-0.277286188925302	1	1	7.09667477375366e-30	CHCHD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39765
4.80690388991942e-34	-0.354424004546034	0.988	1	7.40840027514381e-30	LSM4	Malignant cells	GSE131984_JQ1Pac	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39766
4.93926242389154e-34	-0.467621512329881	0.95	0.976	7.61239124770164e-30	CDC42	Malignant cells	GSE131984_JQ1Pac	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39767
5.70368541126587e-34	-0.323890508522354	0.994	1	8.79051995584296e-30	PDCD5	Malignant cells	GSE131984_JQ1Pac	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39768
5.96876844981936e-34	-0.488827370625337	0.809	0.927	9.19906593486159e-30	PDCD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000071994	5134	programmed cell death 2	RP8|ZMYND7	protein_coding	Q16342	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39769
6.09081925641885e-34	-0.320369795179022	0.998	1	9.38717063799273e-30	RPL36AL	Malignant cells	GSE131984_JQ1Pac	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39770
6.15953725786681e-34	-0.4836691696503	0.888	0.951	9.49307882182433e-30	SSR3	Malignant cells	GSE131984_JQ1Pac	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39771
6.29586644964973e-34	-0.552289846173502	0.625	0.823	9.70318937220016e-30	NAE1	Malignant cells	GSE131984_JQ1Pac	ENSG00000159593	8883	NEDD8 activating enzyme E1 subunit 1	APP-BP1|APPBP1|ula-1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39772
6.65679073630311e-34	-0.517580637960949	0.689	0.847	1.02594458827904e-29	AK2	Malignant cells	GSE131984_JQ1Pac	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39773
7.10631314666816e-34	-0.39916839643816	0.944	0.984	1.0952249821645e-29	EI24	Malignant cells	GSE131984_JQ1Pac	ENSG00000149547	9538	EI24 autophagy associated transmembrane protein	EPG4|PIG8|TP53I8	protein_coding	O14681	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39774
7.41981621718256e-34	-0.340785477726978	1	0.998	1.14354207539218e-29	USMG5	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39775
7.87542298872069e-34	-0.324464193340851	1	1	1.21376019102163e-29	SUMO2	Malignant cells	GSE131984_JQ1Pac	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39776
8.00698126246832e-34	-0.5075403841654	0.998	0.999	1.23403595217162e-29	HSP90AB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39777
8.2517053007395e-34	-0.440870735109768	0.886	0.943	1.27175282094997e-29	SRP72	Malignant cells	GSE131984_JQ1Pac	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39778
9.85048872678827e-34	-0.50856510310053	0.742	0.852	1.51815732257261e-29	COMT	Malignant cells	GSE131984_JQ1Pac	ENSG00000093010	1312	catechol-O-methyltransferase	NA	protein_coding	P21964	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39779
1.15280875232711e-33	-0.517419235769814	0.879	0.958	1.77670884908655e-29	PSMA5	Malignant cells	GSE131984_JQ1Pac	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39780
1.58739444182083e-33	-0.482604726417818	0.672	0.845	2.44649231373427e-29	BCKDK	Malignant cells	GSE131984_JQ1Pac	ENSG00000103507	10295	branched chain keto acid dehydrogenase kinase	NA	protein_coding	O14874	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39781
1.60692693207905e-33	0.577034534858623	0.834	0.665	2.47659578772023e-29	ITGA3	Malignant cells	GSE131984_JQ1Pac	ENSG00000005884	3675	integrin subunit alpha 3	CD49c|GAP-B3|MSK18|VCA-2|VLA3a	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39782
1.70342922191728e-33	-0.547230938711812	0.491	0.734	2.62532511681892e-29	TRIP13	Malignant cells	GSE131984_JQ1Pac	ENSG00000071539	9319	thyroid hormone receptor interactor 13	16E1BP	protein_coding	Q15645	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39783
1.82353853345792e-33	-0.50264679229873	0.638	0.831	2.81043758776534e-29	NTMT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000148335	28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1	AD-003|C9orf32|HOMT1A|METTL11A|NRMT|NRMT1	protein_coding	Q9BV86	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39784
1.86030192261908e-33	-0.494581053750199	0.779	0.925	2.86709732314053e-29	ARPC5L	Malignant cells	GSE131984_JQ1Pac	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39785
2.17294911850314e-33	-0.690869497120589	0.143	0.409	3.34894918143703e-29	PTX3	Malignant cells	GSE131984_JQ1Pac	ENSG00000163661	5806	pentraxin 3	TNFAIP5|TSG-14	protein_coding	P26022	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39786
2.23677166886121e-33	-0.523311688469716	0.516	0.741	3.44731249604889e-29	DNAJC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39787
2.60814898414986e-33	-0.458038232055003	0.09	0.351	4.01967921437177e-29	TMEM98	Malignant cells	GSE131984_JQ1Pac	ENSG00000006042	26022	transmembrane protein 98	DKFZP564K1964	protein_coding	Q9Y2Y6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39788
3.69121995009179e-33	-0.370899701256943	0.076	0.328	5.68890818708146e-29	PACSIN3	Malignant cells	GSE131984_JQ1Pac	ENSG00000165912	29763	protein kinase C and casein kinase substrate in neurons 3	SDPIII	protein_coding	Q9UKS6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39789
4.50023926540569e-33	-0.541007579821505	0.551	0.757	6.93576875584325e-29	ACOT13	Malignant cells	GSE131984_JQ1Pac	ENSG00000112304	55856	acyl-CoA thioesterase 13	HT012|THEM2	protein_coding	Q9NPJ3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39790
5.52332795676202e-33	-0.70854932705185	0.893	0.951	8.51255304696163e-29	PSMA4	Malignant cells	GSE131984_JQ1Pac	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39791
5.7074859279049e-33	-0.432768000617079	0.969	0.992	8.79637731208703e-29	MDH2	Malignant cells	GSE131984_JQ1Pac	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39792
6.10371831680732e-33	-0.502954321042596	0.199	0.475	9.40705066986343e-29	POLR3G	Malignant cells	GSE131984_JQ1Pac	ENSG00000113356	10622	RNA polymerase III subunit G	C31|RPC32|RPC7	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39793
6.4088092414411e-33	-0.506331252268332	0.241	0.512	9.87725680290903e-29	APOO	Malignant cells	GSE131984_JQ1Pac	ENSG00000184831	79135	apolipoprotein O	FAM121B|MGC4825|Mic23|MIC26|MICOS26|My025	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39794
6.70915460731683e-33	-0.509912072413553	0.23	0.52	1.03401490807967e-28	SLC7A11	Malignant cells	GSE131984_JQ1Pac	ENSG00000151012	23657	solute carrier family 7 member 11	xCT	protein_coding	Q9UPY5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39795
6.85256799869531e-33	-0.382593015663551	0.977	0.998	1.05611777995892e-28	UBE2D3	Malignant cells	GSE131984_JQ1Pac	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39796
6.96566815658838e-33	-0.524953959040992	0.68	0.843	1.0735487762934e-28	MRPL47	Malignant cells	GSE131984_JQ1Pac	ENSG00000136522	57129	mitochondrial ribosomal protein L47	CGI-204|NCM1	protein_coding	Q9HD33	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39797
7.30439435836752e-33	-0.551745149414599	0.435	0.684	1.1257532585116e-28	PSME3	Malignant cells	GSE131984_JQ1Pac	ENSG00000131467	10197	proteasome activator subunit 3	Ki|PA28-gamma|PA28G|REG-GAMMA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39798
7.52486919403976e-33	-0.528861337231198	0.404	0.664	1.15973284018541e-28	DYNLT3	Malignant cells	GSE131984_JQ1Pac	ENSG00000165169	6990	dynein light chain Tctex-type 3	TCTE1L|TCTEX1L	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39799
7.9056191711791e-33	-0.468984457555826	0.544	0.774	1.21841402666212e-28	COMMD7	Malignant cells	GSE131984_JQ1Pac	ENSG00000149600	149951	COMM domain containing 7	C20orf92|dJ1085F17.3	protein_coding	Q86VX2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39800
8.08453482326467e-33	-0.412910337934337	0.955	0.981	1.24598850696155e-28	C1orf43	Malignant cells	GSE131984_JQ1Pac	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39801
8.62142064000245e-33	1.22466371954983	0.958	0.936	1.32873334903718e-28	MT1X	Malignant cells	GSE131984_JQ1Pac	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39802
1.0821576568055e-32	-0.421489124412738	0.927	0.975	1.66782138066864e-28	PTP4A2	Malignant cells	GSE131984_JQ1Pac	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39803
1.1149646117473e-32	-0.532030801352838	0.538	0.781	1.71838345962493e-28	PSMB9	Malignant cells	GSE131984_JQ1Pac	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39804
1.17982907847152e-32	0.602014669467761	0.798	0.576	1.81835257574031e-28	ZFP36	Malignant cells	GSE131984_JQ1Pac	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39805
1.29852841571786e-32	-0.496530390031876	0.591	0.804	2.00129199430437e-28	SLC39A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000143570	27173	solute carrier family 39 member 1	ZIP1|ZIRTL	protein_coding	Q9NY26	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39806
1.42187089630976e-32	-0.629922466563239	0.294	0.582	2.19138742539259e-28	CCNA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000145386	890	cyclin A2	CCN1|CCNA	protein_coding	P20248	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39807
1.98421495631118e-32	-0.452882791368982	0.266	0.553	3.05807209066679e-28	UCK2	Malignant cells	GSE131984_JQ1Pac	ENSG00000143179	7371	uridine-cytidine kinase 2	UMPK	protein_coding	Q9BZX2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39808
2.15635809273343e-32	-0.487554744109168	0.33	0.64	3.32337909252076e-28	RP3-460G2.2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39809
2.80894116923887e-32	-0.426734917301989	0.935	0.967	4.32914013003095e-28	GCSH	Malignant cells	GSE131984_JQ1Pac	ENSG00000140905	2653	glycine cleavage system protein H	NA	protein_coding	P23434	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39810
3.65541820015073e-32	-0.49985840774963	0.675	0.826	5.6337305300723e-28	PDZD11	Malignant cells	GSE131984_JQ1Pac	ENSG00000120509	51248	PDZ domain containing 11	PDZK11	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39811
3.83546425033146e-32	-0.428497895007764	0.135	0.401	5.91121750261085e-28	PRR16	Malignant cells	GSE131984_JQ1Pac	ENSG00000184838	51334	proline rich 16	DSC54	protein_coding	Q569H4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39812
4.21840010733869e-32	-0.520946665763158	0.411	0.657	6.50139824543039e-28	EXOSC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000107371	51010	exosome component 3	CGI-102|hRrp-40|hRrp40p|p10|RRP40|Rrp40p	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39813
4.48144473000135e-32	-0.484510443416194	0.742	0.886	6.90680261787808e-28	PTS	Malignant cells	GSE131984_JQ1Pac	ENSG00000150787	5805	6-pyruvoyltetrahydropterin synthase	PTPS	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39814
4.7540713827358e-32	-0.547555149780927	0.677	0.83	7.32697481507242e-28	SEC11C	Malignant cells	GSE131984_JQ1Pac	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39815
6.01068339136541e-32	-0.457412779762284	0.868	0.965	9.26366524277237e-28	HNRNPAB	Malignant cells	GSE131984_JQ1Pac	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39816
6.23158253706956e-32	-0.490775626064777	0.613	0.811	9.6041150061316e-28	LSM6	Malignant cells	GSE131984_JQ1Pac	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39817
6.30113604573749e-32	-0.393415367162775	0.087	0.336	9.71131087369061e-28	L3HYPDH	Malignant cells	GSE131984_JQ1Pac	ENSG00000126790	112849	trans-L-3-hydroxyproline dehydratase	C14orf149|FLJ25436	protein_coding	Q96EM0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39818
9.60686890003388e-32	-0.432304700831826	0.115	0.374	1.48061063487322e-27	UBBP4	Malignant cells	GSE131984_JQ1Pac	ENSG00000263563	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39819
1.11356976775327e-31	0.702444861009951	0.46	0.218	1.71623372606134e-27	TXNIP	Malignant cells	GSE131984_JQ1Pac	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39820
1.14559876611345e-31	-0.524001793929776	0.687	0.838	1.76559681833405e-27	PSMD11	Malignant cells	GSE131984_JQ1Pac	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39821
1.15627745750209e-31	-0.527937890424085	0.706	0.845	1.78205481750223e-27	WDR13	Malignant cells	GSE131984_JQ1Pac	ENSG00000101940	64743	WD repeat domain 13	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39822
1.24418808721136e-31	-0.506841854100359	0.673	0.906	1.91754268001014e-27	CSAG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000198930	158511	chondrosarcoma associated gene 1	CSAGE|CT24.1	protein_coding	Q6PB30	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39823
1.41405212077445e-31	-0.444567532646813	0.925	0.963	2.17933712853759e-27	ARHGDIA	Malignant cells	GSE131984_JQ1Pac	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39824
1.45117407868456e-31	-0.521181248569853	0.638	0.807	2.23654949006865e-27	MRPL19	Malignant cells	GSE131984_JQ1Pac	ENSG00000115364	9801	mitochondrial ribosomal protein L19	KIAA0104|MRP-L15|RLX1|RPML15	protein_coding	P49406	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39825
1.66971477204412e-31	-0.525805663114404	0.314	0.586	2.5733644066744e-27	EXOSC9	Malignant cells	GSE131984_JQ1Pac	ENSG00000123737	5393	exosome component 9	p5|p6|PM/Scl-75|PMSCL1|RRP45|Rrp45p	protein_coding	Q06265	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39826
1.77652360419048e-31	-0.407300759996137	0.989	0.997	2.73797817877837e-27	HN1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39827
1.82063543531923e-31	-0.52287702435236	0.759	0.891	2.805963332914e-27	HNRNPH3	Malignant cells	GSE131984_JQ1Pac	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39828
1.88692994334466e-31	-0.408934708025646	0.978	0.993	2.9081364286828e-27	SF3B14	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39829
1.89910468664484e-31	-0.458745262228865	0.306	0.579	2.92690014305703e-27	TOR3A	Malignant cells	GSE131984_JQ1Pac	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39830
2.03616993314022e-31	-0.35582734589916	0.992	0.997	3.13814510095571e-27	UQCR10	Malignant cells	GSE131984_JQ1Pac	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39831
2.32342541438827e-31	-0.622237315761596	0.624	0.776	3.5808632486552e-27	HDAC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39832
2.39931996080605e-31	-0.488765659893683	0.726	0.861	3.69783192359428e-27	SPTSSA	Malignant cells	GSE131984_JQ1Pac	ENSG00000165389	171546	serine palmitoyltransferase small subunit A	C14orf147|ssSPTa	protein_coding	Q969W0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39833
2.43213678470873e-31	-0.480414600801023	0.653	0.839	3.74840921259309e-27	CCDC34	Malignant cells	GSE131984_JQ1Pac	ENSG00000109881	91057	coiled-coil domain containing 34	L15|NY-REN-41|RAMA3	protein_coding	Q96HJ3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39834
2.50581179206389e-31	-0.417897960298718	0.905	0.965	3.86195713392887e-27	RPL26L1	Malignant cells	GSE131984_JQ1Pac	ENSG00000037241	51121	ribosomal protein L26 like 1	RPL26P1	protein_coding	Q9UNX3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39835
2.52595811023865e-31	-0.437574129495288	0.91	0.973	3.89300663949981e-27	COX17	Malignant cells	GSE131984_JQ1Pac	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39836
2.58699183760941e-31	-0.508254328870687	0.709	0.84	3.98707182012362e-27	EMC7	Malignant cells	GSE131984_JQ1Pac	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39837
2.89828032430965e-31	-0.485595066909188	0.411	0.668	4.46682963582604e-27	ERO1L	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39838
3.16944131920139e-31	-0.431642795865191	0.243	0.516	4.88474296115319e-27	MYO1B	Malignant cells	GSE131984_JQ1Pac	ENSG00000128641	4430	myosin IB	myr1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39839
3.39930641173556e-31	-0.631464428135985	0.403	0.644	5.23901104176684e-27	CTSL	Malignant cells	GSE131984_JQ1Pac	ENSG00000135047	1514	cathepsin L	CTSL1|FLJ31037	protein_coding	P07711	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39840
3.64827653642678e-31	-0.549523772892448	0.653	0.828	5.62272379794095e-27	HSPA9	Malignant cells	GSE131984_JQ1Pac	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39841
3.83362149831359e-31	-0.496715622407266	0.549	0.776	5.9083774532009e-27	USP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39842
3.882856933769e-31	-0.495090739693242	0.593	0.795	5.98425910632479e-27	DAZAP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000071626	26528	DAZ associated protein 1	MGC19907	protein_coding	Q96EP5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39843
4.41936570475769e-31	-0.486334184943263	0.479	0.723	6.81112642417255e-27	TMEM109	Malignant cells	GSE131984_JQ1Pac	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39844
5.12035830655631e-31	-0.462177157235204	0.928	0.977	7.89149622206458e-27	TFDP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39845
5.13159973097797e-31	-0.444416177450382	0.97	0.985	7.90882150538324e-27	PSMD8	Malignant cells	GSE131984_JQ1Pac	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39846
5.31455786349858e-31	-0.493418248151927	0.914	0.972	8.19079657922401e-27	CCT2	Malignant cells	GSE131984_JQ1Pac	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39847
5.51463852978644e-31	-0.383462150822233	0.93	0.981	8.49916090210686e-27	PDAP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39848
5.72825516392006e-31	0.334854629928435	0.334	0.109	8.8283868586336e-27	LYRM9	Malignant cells	GSE131984_JQ1Pac	ENSG00000232859	201229	LYR motif containing 9	C17orf108|HSD24	protein_coding	A8MSI8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39849
5.93636463171412e-31	-0.440067438198295	0.835	0.926	9.14912517039779e-27	DTD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000125821	92675	D-aminoacyl-tRNA deacylase 1	bA379J5.3|bA555E18.1|C20orf88|DUEB|HARS2|MGC119131|MGC41905|pqn-68	protein_coding	Q8TEA8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39850
6.03745273301457e-31	-0.52315849547346	0.23	0.492	9.30492215212205e-27	CD55	Malignant cells	GSE131984_JQ1Pac	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39851
6.13474364696932e-31	-0.568048118076413	0.543	0.747	9.45486690870911e-27	DNAJB11	Malignant cells	GSE131984_JQ1Pac	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39852
6.20170835652731e-31	-0.395111909519186	0.886	0.97	9.55807291907989e-27	TMED3	Malignant cells	GSE131984_JQ1Pac	ENSG00000166557	23423	transmembrane p24 trafficking protein 3	C15orf22|p24B|p24g4|p24gamma4	protein_coding	Q9Y3Q3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39853
6.36453072514003e-31	-0.819957862807914	0.397	0.615	9.80901475358582e-27	PKIB	Malignant cells	GSE131984_JQ1Pac	ENSG00000135549	5570	cAMP-dependent protein kinase inhibitor beta	PRKACN2	protein_coding	Q9C010	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39854
6.55501946511283e-31	-0.497257600007282	0.675	0.837	1.01025959996319e-26	MRPL28	Malignant cells	GSE131984_JQ1Pac	ENSG00000086504	10573	mitochondrial ribosomal protein L28	MAAT1|p15	protein_coding	Q13084	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39855
7.04612715687994e-31	-0.401086377141733	0.964	0.986	1.08594911741834e-26	ARF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39856
7.52798876471029e-31	-0.4714996063693	0.848	0.94	1.16021362841715e-26	TXNL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000091164	9352	thioredoxin like 1	TRP32|Txl|TXNL	protein_coding	O43396	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39857
7.68926335724786e-31	-0.505396591291061	0.53	0.755	1.18506926861904e-26	DDX39A	Malignant cells	GSE131984_JQ1Pac	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39858
8.35503350938599e-31	-0.487889538027591	0.636	0.8	1.28767776446657e-26	NDUFA5	Malignant cells	GSE131984_JQ1Pac	ENSG00000128609	4698	NADH:ubiquinone oxidoreductase subunit A5	B13|CI-13kB|CI-13KD-B|NUFM|UQOR13	protein_coding	Q16718	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39859
8.47027055578733e-31	-0.477886469472745	0.914	0.961	1.30543809805794e-26	TMED9	Malignant cells	GSE131984_JQ1Pac	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39860
8.69245765598395e-31	-0.477652613368198	0.624	0.83	1.33968157394025e-26	TMEM205	Malignant cells	GSE131984_JQ1Pac	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39861
8.73036159548879e-31	-0.489605935762433	0.65	0.826	1.34552332909673e-26	EIF3J	Malignant cells	GSE131984_JQ1Pac	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39862
8.88871247795372e-31	-0.540997102543117	0.275	0.552	1.36992836710223e-26	COL8A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000144810	1295	collagen type VIII alpha 1 chain	C3orf7|MGC9568	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39863
9.02524075284084e-31	-0.523712881209393	0.565	0.766	1.39097010482783e-26	PPP2CA	Malignant cells	GSE131984_JQ1Pac	ENSG00000113575	5515	protein phosphatase 2 catalytic subunit alpha	PP2AC|PP2Calpha	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39864
9.39744522363735e-31	-0.53672740535411	0.393	0.638	1.44833425786699e-26	HSPH1	Malignant cells	GSE131984_JQ1Pac	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39865
1.01181703676946e-30	-0.464106379072623	0.849	0.947	1.55941241706909e-26	SNRPD3	Malignant cells	GSE131984_JQ1Pac	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39866
1.02110426454955e-30	-0.438591600748701	0.218	0.486	1.57372589252377e-26	ANKRD29	Malignant cells	GSE131984_JQ1Pac	ENSG00000154065	147463	ankyrin repeat domain 29	FLJ25053	protein_coding	Q8N6D5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39867
1.07303370786832e-30	-0.479044434971549	0.863	0.945	1.65375955056665e-26	VPS29	Malignant cells	GSE131984_JQ1Pac	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39868
1.09228297226309e-30	0.495200310908946	0.813	0.611	1.68342651685187e-26	NME3	Malignant cells	GSE131984_JQ1Pac	ENSG00000103024	4832	NME/NM23 nucleoside diphosphate kinase 3	DR-nm23|NDPKC|NM23-H3	protein_coding	Q13232	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39869
1.14212985320189e-30	-0.569646737906493	0.641	0.809	1.76025052975475e-26	FDPS	Malignant cells	GSE131984_JQ1Pac	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39870
1.24207804572288e-30	0.411420360528779	0.98	0.944	1.9142906840681e-26	SMDT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39871
1.36978572067143e-30	-0.504977145524327	0.423	0.664	2.11111375269881e-26	FKBP4	Malignant cells	GSE131984_JQ1Pac	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39872
1.58708860020707e-30	-0.479306848808655	0.294	0.569	2.44602095063914e-26	AIFM2	Malignant cells	GSE131984_JQ1Pac	ENSG00000042286	84883	apoptosis inducing factor mitochondria associated 2	AMID|FLJ14497|FSP1|PRG3	protein_coding	Q9BRQ8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39873
1.61754143279471e-30	-0.543098583090038	0.551	0.746	2.49295485622321e-26	TNIP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39874
1.63509153085252e-30	-0.454185072330485	0.89	0.966	2.5200030673499e-26	KPNB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39875
1.81366537725642e-30	-0.521142635636177	0.767	0.896	2.7952210794276e-26	SNRPB2	Malignant cells	GSE131984_JQ1Pac	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39876
1.85563684794245e-30	-0.541628820181619	0.395	0.639	2.8599075100489e-26	GMNN	Malignant cells	GSE131984_JQ1Pac	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39877
1.89183042397353e-30	-0.404342180133257	0.955	0.981	2.915689049428e-26	ATP5J2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39878
1.95613144838613e-30	-0.361378135503591	0.988	0.994	3.01478978825271e-26	NDUFV2	Malignant cells	GSE131984_JQ1Pac	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39879
2.09544653675451e-30	-0.478378680339179	0.47	0.716	3.22950220244605e-26	EXOSC4	Malignant cells	GSE131984_JQ1Pac	ENSG00000178896	54512	exosome component 4	FLJ20591|hRrp41p|p12A|RRP41|RRP41A|Rrp41p|SKI6|Ski6p	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39880
2.14713230334598e-30	-0.520403647525295	0.765	0.866	3.30916030591682e-26	VDAC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39881
2.14972895163208e-30	-0.504296394860877	0.222	0.5	3.31316226025536e-26	TNFAIP3	Malignant cells	GSE131984_JQ1Pac	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39882
2.55043033189626e-30	-0.415556210065831	0.902	0.958	3.93072322751852e-26	MRPS16	Malignant cells	GSE131984_JQ1Pac	ENSG00000182180	51021	mitochondrial ribosomal protein S16	CGI-132	protein_coding	Q9Y3D3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39883
2.74731833674818e-30	-0.473558865275912	0.743	0.888	4.2341670205963e-26	FAM3C	Malignant cells	GSE131984_JQ1Pac	ENSG00000196937	10447	FAM3 metabolism regulating signaling molecule C	GS3876|ILEI	protein_coding	Q92520	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39884
2.85427082332591e-30	-0.442461100077552	0.294	0.574	4.39900219290989e-26	RFC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000049541	5982	replication factor C subunit 2	A1|RFC40	protein_coding	P35250	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39885
2.85483833363566e-30	-0.531356560584323	0.428	0.664	4.39987683979927e-26	GALE	Malignant cells	GSE131984_JQ1Pac	ENSG00000117308	2582	UDP-galactose-4-epimerase	SDR1E1	protein_coding	Q14376	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39886
3.1122905773804e-30	-0.39545767028739	0.908	0.978	4.79666223785867e-26	RAB13	Malignant cells	GSE131984_JQ1Pac	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39887
4.0085859013929e-30	-0.313171999593377	1	1	6.17803259122674e-26	ATP5G3	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39888
4.1501204321392e-30	-0.437640132848051	0.785	0.891	6.39616561001293e-26	SURF4	Malignant cells	GSE131984_JQ1Pac	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39889
4.44605078273704e-30	-0.443640803677563	0.267	0.532	6.85225346635433e-26	PEF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000162517	553115	penta-EF-hand domain containing 1	PEF1A	protein_coding	Q9UBV8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39890
5.60849356735464e-30	-0.430875901072478	0.866	0.941	8.64381028600698e-26	HRAS	Malignant cells	GSE131984_JQ1Pac	ENSG00000276536	3265	HRas proto-oncogene, GTPase	HRAS1	protein_coding	P01112	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39891
5.841155985985e-30	-0.465637587776271	0.353	0.616	9.00238960560008e-26	ATAD3A	Malignant cells	GSE131984_JQ1Pac	ENSG00000197785	55210	ATPase family AAA domain containing 3A	FLJ10709	protein_coding	Q9NVI7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39892
5.89994525135259e-30	-0.509798719827293	0.728	0.852	9.09299562138461e-26	COPS8	Malignant cells	GSE131984_JQ1Pac	ENSG00000198612	10920	COP9 signalosome subunit 8	COP9|CSN8|MGC1297|SGN8	protein_coding	Q99627	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39893
5.95739665446995e-30	-0.508204880331622	0.333	0.576	9.18153972386909e-26	YIPF6	Malignant cells	GSE131984_JQ1Pac	ENSG00000181704	286451	Yip1 domain family member 6	FinGER6|MGC21416	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39894
6.63685288561381e-30	-0.46768078407811	0.474	0.716	1.0228717667308e-25	NIPA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000140157	81614	NIPA magnesium transporter 2	SLC57A2	protein_coding	Q8N8Q9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39895
6.64415653057049e-30	-0.479618762640516	0.751	0.872	1.02399740449152e-25	SYNCRIP	Malignant cells	GSE131984_JQ1Pac	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39896
6.87260672473601e-30	-0.467880667043179	0.351	0.616	1.05920614841631e-25	SNRNP40	Malignant cells	GSE131984_JQ1Pac	ENSG00000060688	9410	small nuclear ribonucleoprotein U5 subunit 40	HPRP8BP|PRP8BP|PRPF8BP|SPF38|WDR57	protein_coding	Q96DI7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39897
7.2107425873002e-30	-0.307023527318586	0.998	1	1.11131964755471e-25	ATP5J	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39898
7.48582460505326e-30	-0.496919529078247	0.434	0.668	1.15371528813081e-25	DNTTIP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000101457	116092	deoxynucleotidyltransferase terminal interacting protein 1	C20orf167|dJ447F3.4|Tdif1	protein_coding	Q9H147	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39899
8.12042095567722e-30	-0.501713964328112	0.619	0.786	1.25151927768897e-25	C4orf32	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39900
8.49979318029173e-30	-0.507128442936856	0.698	0.839	1.30998812494656e-25	COA3	Malignant cells	GSE131984_JQ1Pac	ENSG00000183978	28958	cytochrome c oxidase assembly factor 3	CCDC56|COX25|hCOA3|HSPC009|MITRAC12	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39901
9.85589211437533e-30	-0.624770097181928	0.666	0.86	1.51899009266753e-25	KPNA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39902
1.04745378648523e-29	-0.417064829993944	0.815	0.928	1.61433577573104e-25	MRPL43	Malignant cells	GSE131984_JQ1Pac	ENSG00000055950	84545	mitochondrial ribosomal protein L43	bMRP36a	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39903
1.17062123847983e-29	-0.465696425703193	0.519	0.743	1.80416145274511e-25	MRPL9	Malignant cells	GSE131984_JQ1Pac	ENSG00000143436	65005	mitochondrial ribosomal protein L9	NA	protein_coding	Q9BYD2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39904
1.19943730243647e-29	-0.477323493932325	0.708	0.847	1.84857277051509e-25	NABP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000139579	79035	nucleic acid binding protein 2	hSSB1|MGC2731|OBFC2B|SOSS-B1|SSB1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39905
1.27725772575679e-29	-0.480872257736049	0.642	0.809	1.96850960693637e-25	SREK1IP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000153006	285672	SREK1 interacting protein 1	FLJ36754|P18SRP|SFRS12IP1	protein_coding	Q8N9Q2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39906
1.28637109693519e-29	-0.426788735304833	0.891	0.969	1.98255513459652e-25	ARPC5	Malignant cells	GSE131984_JQ1Pac	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39907
1.42139731734172e-29	-0.992554700269776	0.342	0.601	2.19065754548705e-25	GS1-600G8.5	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39908
1.56130009369967e-29	-0.433907758491873	0.278	0.542	2.40627570440993e-25	METTL21A	Malignant cells	GSE131984_JQ1Pac	ENSG00000144401	151194	methyltransferase 21A, HSPA lysine	FAM119A|HCA557b|HSPA-KMT|LOC151194	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39909
1.86847133562964e-29	-0.492837125897945	0.49	0.722	2.87968802247239e-25	EMG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000126749	10436	EMG1 N1-specific pseudouridine methyltransferase	C2F|Grcc2f|NEP1	protein_coding	Q92979	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39910
2.00419483336034e-29	-0.443491809695812	0.837	0.925	3.08886507717495e-25	BZW1	Malignant cells	GSE131984_JQ1Pac	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39911
2.30789748589579e-29	-0.532056090352613	0.563	0.756	3.55693160526259e-25	RAB9A	Malignant cells	GSE131984_JQ1Pac	ENSG00000123595	9367	RAB9A, member RAS oncogene family	RAB9	protein_coding	P51151	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39912
2.3399363891083e-29	-0.460511075152064	0.663	0.831	3.60630996289372e-25	ETF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39913
2.45001427401914e-29	-0.324019584003362	0.992	0.999	3.7759619991183e-25	SNRPF	Malignant cells	GSE131984_JQ1Pac	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39914
2.5959715401724e-29	-0.525669186360997	0.613	0.785	4.0009113377137e-25	EIF2S1	Malignant cells	GSE131984_JQ1Pac	ENSG00000134001	1965	eukaryotic translation initiation factor 2 subunit alpha	EIF-2alpha|EIF2|EIF2A	protein_coding	P05198	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39915
2.76600423193136e-29	-0.500519360706278	0.552	0.759	4.26296572225262e-25	PFKP	Malignant cells	GSE131984_JQ1Pac	ENSG00000067057	5214	phosphofructokinase, platelet	PFK-C|PFKF	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39916
3.153636543326e-29	-0.48962571308643	0.334	0.596	4.86038464057403e-25	TAF7	Malignant cells	GSE131984_JQ1Pac	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39917
3.1609222004495e-29	-0.486183470852554	0.649	0.822	4.87161329533277e-25	TUBG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39918
3.24244393773633e-29	-0.362692312991443	0.995	1	4.99725459683923e-25	SET	Malignant cells	GSE131984_JQ1Pac	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39919
4.04002337075575e-29	-0.448353839136524	0.527	0.752	6.22648401900875e-25	TYW3	Malignant cells	GSE131984_JQ1Pac	ENSG00000162623	127253	tRNA-yW synthesizing protein 3 homolog	C1orf171|FLJ40918	protein_coding	Q6IPR3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39920
4.4176664287343e-29	-0.47955321637331	0.841	0.914	6.8085074999653e-25	REEP5	Malignant cells	GSE131984_JQ1Pac	ENSG00000129625	7905	receptor accessory protein 5	C5orf18|D5S346|DP1|POB16|TB2|Yip2e	protein_coding	Q00765	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39921
4.4634459644368e-29	0.739675146408211	0.474	0.238	6.87906292039e-25	SEPP1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39922
4.8180009690074e-29	-0.40845129858915	0.104	0.347	7.42550309343421e-25	AP1M2	Malignant cells	GSE131984_JQ1Pac	ENSG00000129354	10053	adaptor related protein complex 1 subunit mu 2	AP1-mu2|HSMU1B|mu2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39923
5.00660251116412e-29	-0.422679234358741	0.356	0.638	7.71617579020614e-25	LITAF	Malignant cells	GSE131984_JQ1Pac	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39924
5.34670034542636e-29	-0.412206402766228	0.868	0.935	8.24033457237111e-25	MTCH1	Malignant cells	GSE131984_JQ1Pac	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39925
6.97898976796489e-29	0.490195114175227	0.82	0.64	1.07560190303875e-24	APLP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39926
7.32207096443204e-29	-0.454244658896558	0.23	0.495	1.12847757703827e-24	AIFM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000156709	9131	apoptosis inducing factor mitochondria associated 1	AIF|AUNX1|CMTX4|DFNX5|NAMSD|PDCD8	protein_coding	O95831	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39927
9.91421814965058e-29	-0.570993655499018	0.393	0.626	1.52797930122415e-24	FHL2	Malignant cells	GSE131984_JQ1Pac	ENSG00000115641	2274	four and a half LIM domains 2	DRAL|SLIM3	protein_coding	Q14192	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39928
9.94694132516542e-29	-0.454969891053373	0.292	0.551	1.53302259703449e-24	PPID	Malignant cells	GSE131984_JQ1Pac	ENSG00000171497	5481	peptidylprolyl isomerase D	CYP-40|CypD	protein_coding	Q08752	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39929
1.05395877717346e-28	-0.376792861202477	0.938	0.977	1.62436126737973e-24	RAB34	Malignant cells	GSE131984_JQ1Pac	ENSG00000109113	83871	RAB34, member RAS oncogene family	NARR|RAB39|RAH	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39930
1.25820182068222e-28	-0.476113502493269	0.759	0.862	1.93914064603543e-24	PLIN3	Malignant cells	GSE131984_JQ1Pac	ENSG00000105355	10226	perilipin 3	M6PRBP1|PP17|TIP47	protein_coding	O60664	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39931
1.32515651879376e-28	-0.394179594770496	0.994	0.997	2.04233122676494e-24	BRI3	Malignant cells	GSE131984_JQ1Pac	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39932
1.51972918902469e-28	-0.510846425320628	0.764	0.867	2.34220662612485e-24	ARL6IP5	Malignant cells	GSE131984_JQ1Pac	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39933
1.54228536781331e-28	-0.480567326842272	0.683	0.836	2.37697020887388e-24	HNRNPF	Malignant cells	GSE131984_JQ1Pac	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39934
1.6499007059814e-28	-0.43142051399979	0.692	0.861	2.54282696805853e-24	MLLT11	Malignant cells	GSE131984_JQ1Pac	ENSG00000213190	10962	MLLT11 transcription factor 7 cofactor	AF1Q	protein_coding	Q13015	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39935
1.86770295224137e-28	-0.316492761706149	0.994	1	2.8785037899944e-24	GADD45GIP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39936
1.96058065231719e-28	-0.475787113541997	0.255	0.516	3.02164690135125e-24	VRK1	Malignant cells	GSE131984_JQ1Pac	ENSG00000100749	7443	VRK serine/threonine kinase 1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39937
2.03034004685998e-28	-0.460097561459508	0.585	0.775	3.12916008022061e-24	SMIM12	Malignant cells	GSE131984_JQ1Pac	ENSG00000163866	113444	small integral membrane protein 12	C1orf212|FLJ90372	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39938
2.08053261626186e-28	-0.49543665855132	0.347	0.616	3.20651686818278e-24	CARD16	Malignant cells	GSE131984_JQ1Pac	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39939
2.33003763342904e-28	0.665897996118598	1	0.997	3.59105400064084e-24	MT2A	Malignant cells	GSE131984_JQ1Pac	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39940
2.40087242258822e-28	-0.423071308660082	0.894	0.962	3.70022457769296e-24	MRPS12	Malignant cells	GSE131984_JQ1Pac	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39941
2.56500118699813e-28	-0.426181336799616	0.823	0.91	3.95317982940153e-24	UBE2N	Malignant cells	GSE131984_JQ1Pac	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39942
2.62499205425907e-28	-0.379287401665959	0.956	0.984	4.04563775402408e-24	TMEM14C	Malignant cells	GSE131984_JQ1Pac	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39943
2.68714164461764e-28	-0.487509489460462	0.507	0.703	4.14142270268471e-24	PIN4	Malignant cells	GSE131984_JQ1Pac	ENSG00000102309	5303	peptidylprolyl cis/trans isomerase, NIMA-interacting 4	EPVH|PAR14|PAR17	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39944
2.95840822101075e-28	-0.466029571215957	0.751	0.863	4.55949875022177e-24	SFT2D1	Malignant cells	GSE131984_JQ1Pac	ENSG00000198818	113402	SFT2 domain containing 1	C6orf83|MGC19825|pRGR1	protein_coding	Q8WV19	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39945
3.14879564438476e-28	-0.303641794067795	1	1	4.8529238471258e-24	ARPC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39946
3.57817284291096e-28	-0.381728003479511	0.997	1	5.51467998549437e-24	MGST1	Malignant cells	GSE131984_JQ1Pac	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39947
3.66090040135427e-28	-0.417913786778661	0.291	0.553	5.6421796985672e-24	IL13RA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000131724	3597	interleukin 13 receptor subunit alpha 1	CD213a1|IL-13Ra|NR4	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39948
3.71083640983509e-28	-0.401523979098166	0.117	0.358	5.71914107483785e-24	MYEOV	Malignant cells	GSE131984_JQ1Pac	ENSG00000172927	26579	myeloma overexpressed	OCIM	protein_coding	Q96EZ4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39949
4.23230251203518e-28	-0.462006354511936	0.663	0.835	6.52282463154862e-24	AP1S2	Malignant cells	GSE131984_JQ1Pac	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39950
4.3347939481474e-28	-0.389264868099391	0.984	0.996	6.68078443288477e-24	GTF3A	Malignant cells	GSE131984_JQ1Pac	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39951
4.93465747303402e-28	-0.452979226117775	0.683	0.855	7.60529409744003e-24	MRPL32	Malignant cells	GSE131984_JQ1Pac	ENSG00000106591	64983	mitochondrial ribosomal protein L32	bMRP-59b|HSPC283|L32mt|MRP-L32	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39952
5.36731763287587e-28	-0.443377925348872	0.524	0.729	8.27210993578829e-24	BRMS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000174744	25855	BRMS1 transcriptional repressor and anoikis regulator	DKFZP564A063	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39953
5.79948663843982e-28	-0.408114760835554	0.946	0.979	8.93816880716345e-24	ATP6V0E1	Malignant cells	GSE131984_JQ1Pac	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39954
5.87684748232758e-28	-0.469102116107666	0.619	0.806	9.05739733976327e-24	CDV3	Malignant cells	GSE131984_JQ1Pac	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39955
6.03602629571191e-28	-0.367211156771287	0.953	0.98	9.30272372695119e-24	FAM96B	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39956
6.60338745555426e-28	-0.379027825579043	0.924	0.977	1.01771407465002e-23	NDUFB8.1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39957
6.99026948949441e-28	-0.49771552575018	0.479	0.701	1.07734033372088e-23	PDCD10	Malignant cells	GSE131984_JQ1Pac	ENSG00000114209	11235	programmed cell death 10	CCM3|TFAR15	protein_coding	Q9BUL8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39958
7.35610956156338e-28	-0.427080867871891	0.812	0.908	1.13372360562815e-23	PRRC2C	Malignant cells	GSE131984_JQ1Pac	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39959
7.36025847623345e-28	-0.330963534905807	0.047	0.254	1.1343630363571e-23	RP11-525A16.4	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39960
8.60749587159488e-28	-0.428770993556552	0.936	0.966	1.3265872637302e-23	PDIA6	Malignant cells	GSE131984_JQ1Pac	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39961
8.75762895579377e-28	-0.49526383367238	0.572	0.772	1.34972577466694e-23	BOD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000145919	91272	biorientation of chromosomes in cell division 1	FAM44B	protein_coding	Q96IK1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39962
9.20191186625823e-28	0.616613537116201	0.991	0.974	1.41819865682772e-23	NQO1	Malignant cells	GSE131984_JQ1Pac	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39963
9.84672103529586e-28	-0.444426016938729	0.639	0.802	1.5175766459598e-23	CDK16	Malignant cells	GSE131984_JQ1Pac	ENSG00000102225	5127	cyclin dependent kinase 16	FLJ16665|PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	protein_coding	Q00536	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39964
1.15858040510577e-27	-0.452340203827228	0.72	0.868	1.78560412034901e-23	CDC26	Malignant cells	GSE131984_JQ1Pac	ENSG00000176386	246184	cell division cycle 26	ANAPC12|APC12|C9orf17	protein_coding	Q8NHZ8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39965
1.1759397732787e-27	-0.489904933720207	0.756	0.865	1.81235837857714e-23	MED10	Malignant cells	GSE131984_JQ1Pac	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39966
1.24977744395021e-27	-0.499526219159425	0.572	0.749	1.92615699661606e-23	YDJC	Malignant cells	GSE131984_JQ1Pac	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39967
1.27124061399048e-27	-0.451678346258593	0.303	0.554	1.95923603428213e-23	PLS3	Malignant cells	GSE131984_JQ1Pac	ENSG00000102024	5358	plastin 3	T-plastin	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39968
1.30581000546883e-27	-0.44437798131908	0.726	0.87	2.01251438042856e-23	DDX18	Malignant cells	GSE131984_JQ1Pac	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39969
1.33824195891614e-27	-0.452352970531571	0.372	0.642	2.06249850708155e-23	GINS2	Malignant cells	GSE131984_JQ1Pac	ENSG00000131153	51659	GINS complex subunit 2	Pfs2|PSF2	protein_coding	Q9Y248	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39970
1.51059661849218e-27	-0.434713445461532	0.398	0.647	2.32813150842015e-23	CHCHD6	Malignant cells	GSE131984_JQ1Pac	ENSG00000159685	84303	coiled-coil-helix-coiled-coil-helix domain containing 6	CHCM1|MGC13016|Mic25|MICOS25|PPP1R23	protein_coding	Q9BRQ6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39971
1.60950992878665e-27	0.478571281828151	0.753	0.553	2.48057670224598e-23	FAM89B	Malignant cells	GSE131984_JQ1Pac	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39972
1.68356202515512e-27	-0.443304857150578	0.747	0.867	2.59470579316907e-23	NT5C	Malignant cells	GSE131984_JQ1Pac	ENSG00000125458	30833	5', 3'-nucleotidase, cytosolic	cdN|DNT-1|DNT1|PN-I|UMPH2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39973
1.74143882237535e-27	0.499883021581896	0.691	0.494	2.68390551304489e-23	EHD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000024422	30846	EH domain containing 2	PAST2	protein_coding	Q9NZN4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39974
1.82159712619482e-27	-0.387513591035369	0.935	0.972	2.80744549089145e-23	HEBP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39975
1.88630308439757e-27	-0.437905779192056	0.683	0.83	2.90717031367354e-23	IMP4	Malignant cells	GSE131984_JQ1Pac	ENSG00000136718	92856	IMP U3 small nucleolar ribonucleoprotein 4	BXDC4|MGC19606	protein_coding	Q96G21	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39976
2.01879756564942e-27	-0.467717579146295	0.401	0.648	3.11137080817889e-23	IFI16	Malignant cells	GSE131984_JQ1Pac	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39977
2.13742160959317e-27	0.258576854247599	1	1	3.29419418470499e-23	RPL26	Malignant cells	GSE131984_JQ1Pac	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39978
2.2809156385091e-27	0.390609622054594	0.308	0.101	3.51534718207023e-23	GTSF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000170627	121355	gametocyte specific factor 1	Cue110|FAM112B|FLJ32942	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39979
2.69654355304693e-27	-0.409748653895321	0.849	0.926	4.15591292395593e-23	MRPL37	Malignant cells	GSE131984_JQ1Pac	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39980
2.75082356761686e-27	-0.468122012784034	0.395	0.632	4.23956928241111e-23	C1D	Malignant cells	GSE131984_JQ1Pac	ENSG00000197223	10438	C1D nuclear receptor corepressor	LRP1|Rrp47|SUN-CoR|SUNCOR	protein_coding	Q13901	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39981
2.84130606362712e-27	-0.480853351342778	0.652	0.808	4.37902090526212e-23	SEC13	Malignant cells	GSE131984_JQ1Pac	ENSG00000157020	6396	SEC13 homolog, nuclear pore and COPII coat complex component	D3S1231E|npp-20|SEC13L1|SEC13R	protein_coding	P55735	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39982
2.90164397193269e-27	-0.439254434543523	0.67	0.83	4.47201368954265e-23	AGPAT2	Malignant cells	GSE131984_JQ1Pac	ENSG00000169692	10555	1-acylglycerol-3-phosphate O-acyltransferase 2	BSCL|LPAAT-beta|LPLAT2	protein_coding	O15120	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39983
2.93919445677019e-27	-0.437337323191572	0.798	0.906	4.52988649677421e-23	HNRNPM	Malignant cells	GSE131984_JQ1Pac	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39984
2.9697164673602e-27	-0.445863518108901	0.616	0.807	4.57692701949554e-23	TMA16	Malignant cells	GSE131984_JQ1Pac	ENSG00000198498	55319	translation machinery associated 16 homolog	C4orf43|FLJ11184	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39985
3.07929177871216e-27	-0.381802646227918	0.179	0.43	4.74580448935118e-23	NME6	Malignant cells	GSE131984_JQ1Pac	ENSG00000172113	10201	NME/NM23 nucleoside diphosphate kinase 6	IPIA-ALPHA|NM23-H6	protein_coding	O75414	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39986
3.10737920986471e-27	-0.454243003747398	0.633	0.805	4.7890928382435e-23	LIMS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000169756	3987	LIM zinc finger domain containing 1	PINCH|PINCH1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39987
3.53487443932993e-27	-0.459693173493593	0.412	0.655	5.44794848589529e-23	GNPNAT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000100522	64841	glucosamine-phosphate N-acetyltransferase 1	FLJ10607|Gpnat1	protein_coding	Q96EK6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39988
3.64735183871078e-27	-0.442947464297118	0.236	0.484	5.62129865382106e-23	LAS1L	Malignant cells	GSE131984_JQ1Pac	ENSG00000001497	81887	LAS1 like ribosome biogenesis factor	FLJ12525|Las1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39989
3.68950525503173e-27	-0.509360744314144	0.787	0.888	5.6862654990549e-23	CTSC	Malignant cells	GSE131984_JQ1Pac	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39990
3.88565814855045e-27	-0.4483325104634	0.255	0.51	5.98857633854595e-23	SCML1	Malignant cells	GSE131984_JQ1Pac	ENSG00000047634	6322	Scm polycomb group protein like 1	NA	protein_coding	Q9UN30	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39991
3.97014416832369e-27	-0.69786648921492	0.695	0.84	6.11878619222048e-23	ANXA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39992
4.47125389604877e-27	-0.413087938274777	0.23	0.484	6.89109650459037e-23	CCDC86	Malignant cells	GSE131984_JQ1Pac	ENSG00000110104	79080	coiled-coil domain containing 86	cyclon|MGC2574	protein_coding	Q9H6F5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39993
4.51420269663487e-27	-0.4046649297061	0.88	0.955	6.95728919605367e-23	NAA38	Malignant cells	GSE131984_JQ1Pac	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39994
4.57658892968854e-27	-0.360390373202768	0.942	0.983	7.05343885843598e-23	PCBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39995
4.80385013834536e-27	-0.357907956284983	0.98	0.995	7.40369383321788e-23	LAMTOR5	Malignant cells	GSE131984_JQ1Pac	ENSG00000134248	10542	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	HBXIP|MGC71071|XIP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39996
4.8368763721094e-27	-0.423170753813705	0.823	0.917	7.454593864695e-23	UFD1L	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39997
5.02904907890136e-27	-0.505972709118705	0.678	0.818	7.75077044040278e-23	SBDS	Malignant cells	GSE131984_JQ1Pac	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39998
5.05297756106233e-27	-0.464064519221553	0.442	0.668	7.78764901710927e-23	RBMX2	Malignant cells	GSE131984_JQ1Pac	ENSG00000134597	51634	RNA binding motif protein X-linked 2	CGI-79|Snu17	protein_coding	Q9Y388	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	39999
5.25941559228635e-27	0.472081330293393	0.922	0.813	8.10581131083173e-23	FKBP5	Malignant cells	GSE131984_JQ1Pac	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40000
5.28927122727682e-27	0.364548631152354	0.983	0.946	8.15182481547903e-23	GLTSCR2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40001
5.43381404728783e-27	-0.486700690101043	0.437	0.666	8.37459420968e-23	STK17A	Malignant cells	GSE131984_JQ1Pac	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40002
5.63663795444213e-27	-0.367811244782691	0.977	0.991	8.68718641538622e-23	CLTA	Malignant cells	GSE131984_JQ1Pac	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40003
5.66889199388142e-27	-0.403787602987042	0.249	0.498	8.73689634097004e-23	CCDC58	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40004
5.74138383229585e-27	-0.428606291844388	0.733	0.856	8.84862076233437e-23	EFHD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40005
5.92015407708104e-27	-0.487398782662936	0.655	0.824	9.1241414635973e-23	BUB3	Malignant cells	GSE131984_JQ1Pac	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40006
6.13245211483501e-27	-0.524511096783713	0.425	0.658	9.45133519938372e-23	CDCA4	Malignant cells	GSE131984_JQ1Pac	ENSG00000170779	55038	cell division cycle associated 4	FLJ20764|Hepp	protein_coding	Q9BXL8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40007
6.90811993818017e-27	-0.500963074756809	0.463	0.684	1.06467944487233e-22	MAGOH	Malignant cells	GSE131984_JQ1Pac	ENSG00000162385	4116	mago homolog, exon junction complex subunit	MAGOH1|MAGOHA	protein_coding	P61326	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40008
7.42094203834635e-27	-0.459136195528594	0.098	0.324	1.14371558694994e-22	DIO2	Malignant cells	GSE131984_JQ1Pac	ENSG00000211448	1734	iodothyronine deiodinase 2	SELENOY|SelY|TXDI2	protein_coding	Q92813	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40009
8.66293757679413e-27	-0.470514446167486	0.272	0.53	1.33513193933551e-22	PAK1IP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000285226	55003	PAK1 interacting protein 1	bA421M1.5|FLJ20624|hPIP1|MAK11|PIP1|WDR84	protein_coding	Q9NWT1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40010
9.37522788655411e-27	-0.429469079858233	0.261	0.516	1.44491012187572e-22	WBSCR27	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40011
9.60157670930878e-27	-0.397926611347374	0.216	0.483	1.47979500243867e-22	CKAP4	Malignant cells	GSE131984_JQ1Pac	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40012
9.76959041002711e-27	0.351188595165269	0.336	0.124	1.50568927399338e-22	AR	Malignant cells	GSE131984_JQ1Pac	ENSG00000169083	367	androgen receptor	AIS|DHTR|HUMARA|NR3C4|SBMA|SMAX1	protein_coding	P10275	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40013
9.77356694773967e-27	-0.334090322974784	0.994	1	1.50630213798564e-22	SNF8	Malignant cells	GSE131984_JQ1Pac	ENSG00000159210	11267	SNF8 subunit of ESCRT-II	Dot3|EAP30|VPS22	protein_coding	Q96H20	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40014
1.07091467961491e-26	-0.433674280426662	0.969	0.992	1.6504937042225e-22	FABP5	Malignant cells	GSE131984_JQ1Pac	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40015
1.08837286605e-26	-0.570009400786054	0.456	0.697	1.67740026115626e-22	PCNA	Malignant cells	GSE131984_JQ1Pac	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40016
1.09187512863893e-26	-0.41542589073556	0.266	0.522	1.68279794825831e-22	RAI14	Malignant cells	GSE131984_JQ1Pac	ENSG00000039560	26064	retinoic acid induced 14	DKFZp564G013|KIAA1334|NORPEG|RAI13	protein_coding	Q9P0K7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40017
1.29346771603387e-26	-0.41138160719255	0.323	0.582	1.9934924439514e-22	MED8	Malignant cells	GSE131984_JQ1Pac	ENSG00000159479	112950	mediator complex subunit 8	ARC32|MGC17544|MGC19641	protein_coding	Q96G25	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40018
1.46601276689798e-26	-0.416126140440676	0.908	0.964	2.25941887634317e-22	PAPOLA	Malignant cells	GSE131984_JQ1Pac	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40019
1.54189010870684e-26	-0.435489588629911	0.208	0.459	2.37636103553898e-22	MRPL39	Malignant cells	GSE131984_JQ1Pac	ENSG00000154719	54148	mitochondrial ribosomal protein L39	C21orf92|FLJ20451|L39mt|MGC104174|MGC3400|MRP-L5|MSTP003|PRED22|PRED66|RPML5	protein_coding	Q9NYK5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40020
1.60593833055077e-26	-0.337498876950859	0.991	0.997	2.47507215504485e-22	PPA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40021
1.62194259315817e-26	-0.418241238011602	0.355	0.603	2.49973792457537e-22	HSPBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000133265	23640	HSPA (Hsp70) binding protein 1	FES1	protein_coding	Q9NZL4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40022
1.83257654686164e-26	-0.425804911525056	0.409	0.653	2.82436697402316e-22	RFK	Malignant cells	GSE131984_JQ1Pac	ENSG00000135002	55312	riboflavin kinase	FLJ11149|RIFK	protein_coding	Q969G6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40023
2.17017185058474e-26	-0.41674356093954	0.784	0.945	3.34466885612119e-22	CKS1B	Malignant cells	GSE131984_JQ1Pac	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40024
2.5413357578662e-26	-0.410835255039972	0.747	0.873	3.91670667002338e-22	POLR2K	Malignant cells	GSE131984_JQ1Pac	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40025
2.54329296001062e-26	-0.438181511194806	0.767	0.892	3.91972310996836e-22	RAB2A	Malignant cells	GSE131984_JQ1Pac	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40026
3.12341949915291e-26	-0.906747872879323	0.135	0.359	4.81381413209447e-22	TFPI2	Malignant cells	GSE131984_JQ1Pac	ENSG00000105825	7980	tissue factor pathway inhibitor 2	PP5|REF1|TFPI-2	protein_coding	P48307	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40027
4.03521180883174e-26	-0.459780968374295	0.285	0.528	6.21906843977148e-22	PRMT5	Malignant cells	GSE131984_JQ1Pac	ENSG00000100462	10419	protein arginine methyltransferase 5	HRMT1L5|SKB1|SKB1Hs	protein_coding	O14744	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40028
4.76614250721497e-26	0.508759795313532	0.712	0.498	7.34557883211971e-22	ABCC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000108846	8714	ATP binding cassette subfamily C member 3	cMOAT2|EST90757|MLP2|MOAT-D|MRP3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40029
5.32606616240183e-26	-0.438856353242544	0.672	0.815	8.20853316949371e-22	STX10	Malignant cells	GSE131984_JQ1Pac	ENSG00000104915	8677	syntaxin 10	hsyn10|SYN10	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40030
5.35582205487167e-26	-0.425795840224902	0.778	0.892	8.25439295096821e-22	SELT	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40031
5.61845958723765e-26	-0.402438873889084	0.275	0.518	8.65916991585067e-22	CHCHD4	Malignant cells	GSE131984_JQ1Pac	ENSG00000163528	131474	coiled-coil-helix-coiled-coil-helix domain containing 4	FLJ31709|MIA40|TIMM40	protein_coding	Q8N4Q1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40032
6.00205105138431e-26	0.594354942668085	0.417	0.2	9.2503610803935e-22	NR4A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40033
6.24916265802691e-26	-0.463376285775811	0.465	0.677	9.63120948855108e-22	BAZ1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40034
6.50383026954542e-26	-0.399664409204585	0.894	0.955	1.00237032114234e-21	EMC6	Malignant cells	GSE131984_JQ1Pac	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40035
6.95393789649652e-26	-0.4534400325283	0.33	0.577	1.07174090860804e-21	EXOSC7	Malignant cells	GSE131984_JQ1Pac	ENSG00000075914	23016	exosome component 7	EAP1|hRrp42p|KIAA0116|p8|RRP42|Rrp42p	protein_coding	Q15024	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40036
7.06337844964546e-26	-0.395096480413282	0.23	0.477	1.08860788665936e-21	PSMD10	Malignant cells	GSE131984_JQ1Pac	ENSG00000101843	5716	proteasome 26S subunit, non-ATPase 10	p28	protein_coding	O75832	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40037
7.39328397869173e-26	-0.427317519654576	0.378	0.616	1.13945292679597e-21	DHRSX	Malignant cells	GSE131984_JQ1Pac	ENSG00000169084	207063	dehydrogenase/reductase X-linked	DHRS5X|DHRS5Y|DHRSXY|DHRSY|SDR46C1|SDR7C6	protein_coding	Q8N5I4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40038
7.72501254057533e-26	-0.470884466129349	0.411	0.642	1.19057893275347e-21	MRPS30	Malignant cells	GSE131984_JQ1Pac	ENSG00000112996	10884	mitochondrial ribosomal protein S30	PAP|PDCD9	protein_coding	Q9NP92	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40039
8.4830159745999e-26	-0.398800250242658	0.255	0.493	1.30740242200534e-21	NDUFAF6	Malignant cells	GSE131984_JQ1Pac	ENSG00000156170	137682	NADH:ubiquinone oxidoreductase complex assembly factor 6	C8orf38|MGC40214	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40040
8.63556783398402e-26	-0.398130094518483	0.796	0.897	1.33091371457362e-21	CHCHD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000172586	118487	coiled-coil-helix-coiled-coil-helix domain containing 1	C10orf34|FLJ25854	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40041
8.93461183201778e-26	-0.278150972597241	1	1	1.37700237555058e-21	TBCA	Malignant cells	GSE131984_JQ1Pac	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40042
9.1415858817118e-26	-0.4569546086423	0.509	0.703	1.40890121608942e-21	ALG3	Malignant cells	GSE131984_JQ1Pac	ENSG00000214160	10195	ALG3 alpha-1,3- mannosyltransferase	CDGS4|D16Ertd36e|Not56|NOT56L	protein_coding	Q92685	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40043
9.15981321427381e-26	-0.470111064355578	0.661	0.814	1.41171041258388e-21	GTF2F2	Malignant cells	GSE131984_JQ1Pac	ENSG00000188342	2963	general transcription factor IIF subunit 2	BTF4|RAP30|TFIIF	protein_coding	P13984	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40044
9.33330591641975e-26	-0.368738291048549	0.938	0.975	1.43844910783861e-21	MRPS21	Malignant cells	GSE131984_JQ1Pac	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40045
9.75869878956596e-26	-0.420398851870127	0.454	0.682	1.50401065744791e-21	MTX1	Malignant cells	GSE131984_JQ1Pac	ENSG00000173171	4580	metaxin 1	MTX|MTXN	protein_coding	Q13505	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40046
1.04378104057756e-25	-0.497992049092332	0.23	0.476	1.60867533973814e-21	SPC25	Malignant cells	GSE131984_JQ1Pac	ENSG00000277909	57405	SPC25 component of NDC80 kinetochore complex	AD024|MGC22228|SPBC25	protein_coding	Q9HBM1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40047
1.09294358965137e-25	-0.335948006169939	0.079	0.292	1.6844446603707e-21	RP5-884M6.1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40048
1.10998764893771e-25	-0.457227197624824	0.806	0.892	1.7107129645428e-21	GLO1	Malignant cells	GSE131984_JQ1Pac	ENSG00000124767	2739	glyoxalase I	GLOD1	protein_coding	Q04760	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40049
1.13493927025096e-25	-0.462775589406368	0.886	0.95	1.74916840331078e-21	CCT7	Malignant cells	GSE131984_JQ1Pac	ENSG00000135624	10574	chaperonin containing TCP1 subunit 7	Ccth|Nip7-1	protein_coding	Q99832	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40050
1.18316844175601e-25	0.401946090687039	0.462	0.241	1.82349920243436e-21	ACYP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000170634	98	acylphosphatase 2	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40051
1.26578662665089e-25	0.577550411977186	0.561	0.344	1.95083034899436e-21	GAMT	Malignant cells	GSE131984_JQ1Pac	ENSG00000130005	2593	guanidinoacetate N-methyltransferase	PIG2|TP53I2	protein_coding	Q14353	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40052
1.28856195477661e-25	-0.435559147895807	0.652	0.822	1.98593168470172e-21	CD47	Malignant cells	GSE131984_JQ1Pac	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40053
1.33814216191842e-25	-0.465954330940729	0.392	0.63	2.06234469994867e-21	SQRDL	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40054
1.40745015738447e-25	-0.395762840897027	0.37	0.617	2.16916218256095e-21	TIMM23	Malignant cells	GSE131984_JQ1Pac	ENSG00000265354	100287932	translocase of inner mitochondrial membrane 23	TIM23	protein_coding	O14925	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40055
1.48307713059565e-25	-0.40973286179697	0.233	0.478	2.28571847367401e-21	C14orf142	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40056
1.55704277253659e-25	-0.422490558875048	0.345	0.597	2.39971432103339e-21	TCOF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000070814	6949	treacle ribosome biogenesis factor 1	TCS|treacle	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40057
1.6562514867419e-25	-0.426450050463135	0.524	0.73	2.55261479136662e-21	DPM3	Malignant cells	GSE131984_JQ1Pac	ENSG00000179085	54344	dolichyl-phosphate mannosyltransferase subunit 3, regulatory	MGC125904|MGC125905|MGC34275	protein_coding	Q9P2X0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40058
1.65926587207695e-25	-0.448230007966894	0.502	0.702	2.55726056204499e-21	TMEM70	Malignant cells	GSE131984_JQ1Pac	ENSG00000175606	54968	transmembrane protein 70	FLJ20533	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40059
1.6757947550353e-25	-0.420423940255226	0.313	0.558	2.5827348764604e-21	WDR74	Malignant cells	GSE131984_JQ1Pac	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40060
1.73694654001758e-25	-0.310505188388553	0.997	1	2.67698200747509e-21	NEDD8	Malignant cells	GSE131984_JQ1Pac	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40061
1.77939752709896e-25	-0.337708180469752	1	1	2.74240746876492e-21	CD63	Malignant cells	GSE131984_JQ1Pac	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40062
1.88637899831651e-25	-0.668622909029443	0.409	0.63	2.90728731220541e-21	SLC3A2	Malignant cells	GSE131984_JQ1Pac	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40063
2.15684657398364e-25	-0.402242439237111	0.215	0.45	3.32413193982358e-21	ALG14	Malignant cells	GSE131984_JQ1Pac	ENSG00000172339	199857	ALG14 UDP-N-acetylglucosaminyltransferase subunit	MGC19780	protein_coding	Q96F25	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40064
2.41178370101445e-25	-0.47630121423016	0.415	0.641	3.71704104000347e-21	CYB5B	Malignant cells	GSE131984_JQ1Pac	ENSG00000103018	80777	cytochrome b5 type B	CYB5-M	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40065
2.42690751883913e-25	-0.287522399316309	0.998	1	3.74034986803487e-21	NDUFB10	Malignant cells	GSE131984_JQ1Pac	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40066
2.43179049081641e-25	-0.444005173016113	0.513	0.721	3.74787550444625e-21	PON2	Malignant cells	GSE131984_JQ1Pac	ENSG00000105854	5445	paraoxonase 2	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40067
2.48666105014035e-25	-0.47421290108263	0.277	0.527	3.8324420104763e-21	MAGED2	Malignant cells	GSE131984_JQ1Pac	ENSG00000102316	10916	MAGE family member D2	11B6|BCG1|HCA10|JCL-1|MAGE-D2|MAGED|MGC8386	protein_coding	Q9UNF1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40068
2.559124820532e-25	-0.43661651626132	0.281	0.527	3.94412317340392e-21	PLAUR	Malignant cells	GSE131984_JQ1Pac	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40069
2.65370680702823e-25	-0.38482694810889	0.222	0.464	4.08989293099192e-21	HDAC8	Malignant cells	GSE131984_JQ1Pac	ENSG00000147099	55869	histone deacetylase 8	HDACL1|KDAC8|MRXS6|RPD3|WTS	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40070
2.71936137002682e-25	-0.453661753687694	0.734	0.855	4.19107974348533e-21	NUDT5	Malignant cells	GSE131984_JQ1Pac	ENSG00000165609	11164	nudix hydrolase 5	hYSAH1|YSA1H	protein_coding	Q9UKK9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40071
2.83050304332632e-25	-0.468482961986632	0.692	0.839	4.36237129037453e-21	PSMC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000165916	5702	proteasome 26S subunit, ATPase 3	RPT5|TBP-1|TBP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40072
2.9977968594669e-25	-0.419274994704195	0.753	0.894	4.62020451981039e-21	HSPB11	Malignant cells	GSE131984_JQ1Pac	ENSG00000081870	51668	heat shock protein family B (small) member 11	C1orf41|FAP232|HSPCO34|IFT25|PP25	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40073
3.00352820452757e-25	-0.518733051101821	0.546	0.784	4.62903766881788e-21	MKI67	Malignant cells	GSE131984_JQ1Pac	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40074
3.09976288741769e-25	-0.460761751223954	0.442	0.669	4.77735456208814e-21	NETO2	Malignant cells	GSE131984_JQ1Pac	ENSG00000171208	81831	neuropilin and tolloid like 2	FLJ10430|NEOT2	protein_coding	Q8NC67	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40075
3.37679962144061e-25	-0.581385828796485	0.134	0.369	5.20432357656428e-21	BEX1	Malignant cells	GSE131984_JQ1Pac	ENSG00000133169	55859	brain expressed X-linked 1	NA	protein_coding	Q9HBH7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40076
3.83554866638178e-25	-0.419413275473421	0.347	0.583	5.9113476046276e-21	OXCT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000083720	5019	3-oxoacid CoA-transferase 1	OXCT|SCOT	protein_coding	P55809	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40077
4.02363854098781e-25	-0.430065111695212	0.597	0.779	6.20123171937041e-21	CMC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000103121	56942	C-X9-C motif containing 2	C16orf61|DC13|MGC45036	protein_coding	Q9NRP2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40078
4.71514246344897e-25	0.263480410159566	1	0.999	7.26697756466755e-21	MT-CO1	Malignant cells	GSE131984_JQ1Pac	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40079
4.72743311332013e-25	-0.501192159615837	0.725	0.85	7.28591991424899e-21	DNAJA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40080
5.37183874857758e-25	-0.486891599634377	0.641	0.793	8.27907787930777e-21	RALA	Malignant cells	GSE131984_JQ1Pac	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40081
5.59286989673505e-25	0.385931020823655	0.995	0.985	8.61973108484806e-21	COX6A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40082
5.65464208759614e-25	-0.401853120510558	0.958	0.985	8.71493438540317e-21	TCP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40083
5.66253462135233e-25	-0.419411664714896	0.857	0.926	8.7270983584282e-21	BID	Malignant cells	GSE131984_JQ1Pac	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40084
5.78172997385345e-25	-0.377293969769755	0.86	0.959	8.91080223570294e-21	COX20	Malignant cells	GSE131984_JQ1Pac	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40085
5.84425577760597e-25	-0.553074073377747	0.456	0.66	9.00716700444633e-21	MAD2L1	Malignant cells	GSE131984_JQ1Pac	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40086
7.30421216216144e-25	0.37909507362608	0.975	0.893	1.12572517843232e-20	NBEAL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000144426	65065	neurobeachin like 1	ALS2CR16|ALS2CR17|MGC164581	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40087
7.7259883921348e-25	-0.362445673782356	0.925	0.962	1.19072933099581e-20	ZC3H15	Malignant cells	GSE131984_JQ1Pac	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40088
8.44563723408753e-25	0.464104774056612	0.616	0.402	1.30164161051757e-20	ZBTB16	Malignant cells	GSE131984_JQ1Pac	ENSG00000109906	7704	zinc finger and BTB domain containing 16	PLZF|ZNF145	protein_coding	Q05516	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40089
8.44719388844538e-25	-0.448648676925546	0.596	0.764	1.3018815220872e-20	MRPS2	Malignant cells	GSE131984_JQ1Pac	ENSG00000122140	51116	mitochondrial ribosomal protein S2	CGI-91	protein_coding	Q9Y399	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40090
8.57782940668272e-25	-0.537912155607399	0.893	0.97	1.32201506815794e-20	HSP90B1	Malignant cells	GSE131984_JQ1Pac	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40091
9.12843054276916e-25	-0.480156950492661	0.446	0.667	1.40687371525158e-20	ACAT2	Malignant cells	GSE131984_JQ1Pac	ENSG00000120437	39	acetyl-CoA acetyltransferase 2	NA	protein_coding	Q9BWD1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40092
9.32807899729739e-25	-0.34557343190881	0.064	0.264	1.43764353506347e-20	HHIP	Malignant cells	GSE131984_JQ1Pac	ENSG00000164161	64399	hedgehog interacting protein	FLJ20992|HIP	protein_coding	Q96QV1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40093
9.39599838755249e-25	-0.387438828438314	0.709	0.849	1.44811127148959e-20	SUPT4H1	Malignant cells	GSE131984_JQ1Pac	ENSG00000213246	6827	SPT4 homolog, DSIF elongation factor subunit	Spt4|SPT4H|Supt4a|SUPT4H	protein_coding	P63272	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40094
1.18883206731593e-24	0.393532536424669	0.967	0.893	1.83222798214731e-20	CHMP2A	Malignant cells	GSE131984_JQ1Pac	ENSG00000130724	27243	charged multivesicular body protein 2A	BC-2|CHMP2|VPS2|VPS2A	protein_coding	O43633	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40095
1.27180326345933e-24	-0.393741375383707	0.829	0.923	1.96010318964351e-20	MRPS26	Malignant cells	GSE131984_JQ1Pac	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40096
1.31076832500868e-24	-0.420194123584335	0.608	0.779	2.02015614250337e-20	MRPS18B	Malignant cells	GSE131984_JQ1Pac	ENSG00000233813	28973	mitochondrial ribosomal protein S18B	C6orf14|HSPC183|MRPS18-2|PTD017	protein_coding	Q9Y676	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40097
1.32941878909473e-24	-0.371419491147251	0.893	0.957	2.0489002377528e-20	CIB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40098
1.36402717905176e-24	-0.42351202454654	0.815	0.902	2.10223868835457e-20	ITGAE	Malignant cells	GSE131984_JQ1Pac	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40099
1.39508412638452e-24	-0.446487609591232	0.625	0.798	2.15010365558382e-20	RRP7A	Malignant cells	GSE131984_JQ1Pac	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40100
1.41118004088874e-24	-0.497642416821648	0.454	0.679	2.17491067901773e-20	CCNB2	Malignant cells	GSE131984_JQ1Pac	ENSG00000157456	9133	cyclin B2	HsT17299	protein_coding	O95067	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40101
1.42475466179929e-24	-0.428699143859612	0.613	0.782	2.19583188476506e-20	DESI1	Malignant cells	GSE131984_JQ1Pac	ENSG00000100418	27351	desumoylating isopeptidase 1	D15Wsu75e|DESI-1|FAM152B|POST|PPPDE2	protein_coding	Q6ICB0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40102
1.71375433975769e-24	-0.439174897614892	0.423	0.642	2.64123818843456e-20	GMPS	Malignant cells	GSE131984_JQ1Pac	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40103
1.86065054370863e-24	-0.420859903274633	0.91	0.958	2.86763461796374e-20	NOL7	Malignant cells	GSE131984_JQ1Pac	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40104
1.87607427460425e-24	-0.400899927661462	0.309	0.562	2.89140567202007e-20	GNA15	Malignant cells	GSE131984_JQ1Pac	ENSG00000060558	2769	G protein subunit alpha 15	GNA16	protein_coding	P30679	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40105
1.88703878298623e-24	-0.38175773114126	0.129	0.353	2.90830417233838e-20	MEST	Malignant cells	GSE131984_JQ1Pac	ENSG00000106484	4232	mesoderm specific transcript	PEG1	protein_coding	Q5EB52	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40106
2.13326173989887e-24	-0.389465284775584	0.759	0.877	3.28778299353215e-20	MRPL42	Malignant cells	GSE131984_JQ1Pac	ENSG00000198015	28977	mitochondrial ribosomal protein L42	HSPC204|MRP-L31|MRPL31|MRPS32|PTD007|RPML31	protein_coding	Q9Y6G3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40107
2.21247749445243e-24	-0.410309073916912	0.285	0.531	3.40987031445008e-20	RP1-276N6.2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40108
2.50906665010495e-24	-0.369691115545053	0.171	0.398	3.86697352114174e-20	FAIM	Malignant cells	GSE131984_JQ1Pac	ENSG00000158234	55179	Fas apoptotic inhibitory molecule	FAIM1|FLJ10582	protein_coding	Q9NVQ4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40109
2.51479540296078e-24	-0.334297209009859	0.18	0.42	3.87580267504315e-20	MSANTD3	Malignant cells	GSE131984_JQ1Pac	ENSG00000066697	91283	Myb/SANT DNA binding domain containing 3	C9orf30|MGC17337	protein_coding	Q96H12	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40110
2.75271412330614e-24	-0.38108861748734	0.207	0.441	4.24248300683942e-20	FAM199X	Malignant cells	GSE131984_JQ1Pac	ENSG00000123575	139231	family with sequence similarity 199, X-linked	CXorf39	protein_coding	Q6PEV8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40111
3.21251242112482e-24	-0.411627767098045	0.747	0.855	4.95112414343757e-20	KARS	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40112
3.42154658390967e-24	-0.3937581213683	0.851	0.913	5.27328759512159e-20	MPLKIP	Malignant cells	GSE131984_JQ1Pac	ENSG00000168303	136647	M-phase specific PLK1 interacting protein	C7orf11|ORF20|TTDN1	protein_coding	Q8TAP9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40113
3.50987340370932e-24	-0.38351691606636	0.922	0.957	5.4094168897968e-20	OSTC	Malignant cells	GSE131984_JQ1Pac	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40114
4.94779506257182e-24	-0.493856263899412	0.138	0.352	7.62554175043569e-20	PRSS23	Malignant cells	GSE131984_JQ1Pac	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40115
4.99853721991092e-24	-0.479989302013528	0.46	0.663	7.70374556332671e-20	NDUFAF4	Malignant cells	GSE131984_JQ1Pac	ENSG00000123545	29078	NADH:ubiquinone oxidoreductase complex assembly factor 4	bA22L21.1|C6orf66|HRPAP20|HSPC125|My013	protein_coding	Q9P032	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40116
5.20319067770373e-24	-0.408853591683072	0.471	0.683	8.01915747247699e-20	RP11-345J4.5	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40117
5.37954283291732e-24	-0.382234854638667	0.844	0.919	8.29095141409217e-20	MRPS6	Malignant cells	GSE131984_JQ1Pac	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40118
6.2612890458165e-24	-0.413918601785516	0.745	0.862	9.64989867741239e-20	PAIP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000172239	10605	poly(A) binding protein interacting protein 1	NA	protein_coding	Q9H074	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40119
6.604636185986e-24	-0.419004155264791	0.565	0.746	1.01790652898416e-19	MRPS5	Malignant cells	GSE131984_JQ1Pac	ENSG00000144029	64969	mitochondrial ribosomal protein S5	MRP-S5|S5mt	protein_coding	P82675	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40120
7.18642942819722e-24	-0.373844776776914	0.179	0.428	1.10757250347376e-19	SFTA1P	Malignant cells	GSE131984_JQ1Pac	ENSG00000225383	207107	surfactant associated 1, lncRNA	SFTPF	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40121
7.57511099725106e-24	-0.407722372364524	0.286	0.527	1.16747610689633e-19	EVA1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000115363	84141	eva-1 homolog A, regulator of programmed cell death	FAM176A|FLJ13391|TMEM166	protein_coding	Q9H8M9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40122
7.69686807869482e-24	-0.504663391511483	0.516	0.701	1.18624130828845e-19	RUVBL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000284901	8607	RuvB like AAA ATPase 1	ECP54|INO80H|NMP238|Pontin52|RVB1|TIH1|TIP49|TIP49a	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40123
7.95313880563299e-24	-0.381023753777032	0.82	0.919	1.22573775272416e-19	WDR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000071127	9948	WD repeat domain 1	AIP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40124
8.05633218304356e-24	-0.370357312799428	0.241	0.473	1.24164191605067e-19	WARS	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40125
9.5661036348566e-24	-0.403843272182738	0.456	0.67	1.4743278922041e-19	NTPCR	Malignant cells	GSE131984_JQ1Pac	ENSG00000135778	84284	nucleoside-triphosphatase, cancer-related	C1orf57|HCR-NTPase|MGC13186|THEP1	protein_coding	Q9BSD7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40126
1.04123989446074e-23	-0.322789976922673	0.087	0.291	1.6047589253429e-19	NMI	Malignant cells	GSE131984_JQ1Pac	ENSG00000123609	9111	N-myc and STAT interactor	NA	protein_coding	Q13287	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40127
1.13486801736653e-23	-0.41511871074662	0.26	0.495	1.74905858836529e-19	CMTM8	Malignant cells	GSE131984_JQ1Pac	ENSG00000170293	152189	CKLF like MARVEL transmembrane domain containing 8	CKLFSF8	protein_coding	Q8IZV2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40128
1.1425493906215e-23	-0.406160028032194	0.473	0.685	1.76089712082585e-19	PHF5A	Malignant cells	GSE131984_JQ1Pac	ENSG00000100410	84844	PHD finger protein 5A	bK223H9.2|INI|MGC1346|Rds3|SAP14b|SF3b14b|SF3B7	protein_coding	Q7RTV0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40129
1.18882209197561e-23	-0.88217944334197	0.628	0.781	1.83221260815282e-19	HSPA5	Malignant cells	GSE131984_JQ1Pac	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40130
1.31754003699067e-23	-0.364805472950875	0.995	0.998	2.03059270501003e-19	MYL12B	Malignant cells	GSE131984_JQ1Pac	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40131
1.32545863329057e-23	-0.423425774931484	0.826	0.921	2.04279684562743e-19	COPS6	Malignant cells	GSE131984_JQ1Pac	ENSG00000168090	10980	COP9 signalosome subunit 6	CSN6|MOV34-34KD	protein_coding	Q7L5N1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40132
1.38168984365217e-23	-0.430573112849467	0.435	0.645	2.12946038703673e-19	YARS	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40133
1.41344861078969e-23	-0.418317803028718	0.722	0.843	2.17840699894907e-19	WTAP	Malignant cells	GSE131984_JQ1Pac	ENSG00000146457	9589	WT1 associated protein	KIAA0105|MGC3925|Mum2	protein_coding	Q15007	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40134
1.42957659877232e-23	-0.420885233637537	0.773	0.876	2.2032634540279e-19	CMSS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000184220	84319	cms1 ribosomal small subunit homolog	C3orf26|MGC4308	protein_coding	Q9BQ75	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40135
1.60749305940928e-23	-0.386255085041289	0.815	0.9	2.47746830316159e-19	DPY30	Malignant cells	GSE131984_JQ1Pac	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40136
1.61008882408846e-23	-0.353709623869998	0.932	0.974	2.48146889568514e-19	NUDCD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000170584	134492	NudC domain containing 2	DKFZp686E10109|NudCL2	protein_coding	Q8WVJ2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40137
1.62675193637954e-23	-0.428050002207637	0.459	0.665	2.50715008434815e-19	CREM	Malignant cells	GSE131984_JQ1Pac	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40138
1.7514259750661e-23	-0.426746677939471	0.547	0.74	2.69929771277187e-19	COMMD4	Malignant cells	GSE131984_JQ1Pac	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40139
1.87801209102486e-23	-0.399114437277235	0.804	0.904	2.89439223468752e-19	GDI2	Malignant cells	GSE131984_JQ1Pac	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40140
2.04436730767135e-23	-0.409028743164983	0.465	0.677	3.15077889458308e-19	MRPL35	Malignant cells	GSE131984_JQ1Pac	ENSG00000132313	51318	mitochondrial ribosomal protein L35	NA	protein_coding	Q9NZE8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40141
2.13320610392037e-23	-0.454755195341939	0.561	0.756	3.28769724736208e-19	SMC1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40142
2.23938897479316e-23	0.440390784805319	0.608	0.404	3.45134628795122e-19	DDX17	Malignant cells	GSE131984_JQ1Pac	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40143
2.25442372608125e-23	-0.360903929558072	0.128	0.343	3.47451784663642e-19	FANCB	Malignant cells	GSE131984_JQ1Pac	ENSG00000181544	2187	FA complementation group B	FAAP95|FAB|FLJ34064	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40144
2.28400650093068e-23	-0.362202209779659	0.216	0.45	3.52011081923437e-19	SFXN4	Malignant cells	GSE131984_JQ1Pac	ENSG00000183605	119559	sideroflexin 4	SLC56A4	protein_coding	Q6P4A7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40145
2.31432802849261e-23	-0.401896127322194	0.426	0.653	3.56684235751282e-19	DPH3	Malignant cells	GSE131984_JQ1Pac	ENSG00000154813	285381	diphthamide biosynthesis 3	DELGIP|DELGIP1|DESR1|DPH3A|KTI11|MGC20197|ZCSL2	protein_coding	Q96FX2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40146
2.36053798964752e-23	0.4563316964193	0.722	0.533	3.63806114964476e-19	MPRIP	Malignant cells	GSE131984_JQ1Pac	ENSG00000133030	23164	myosin phosphatase Rho interacting protein	M-RIP|p116Rip|RHOIP3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40147
2.39773315723658e-23	-0.421096335635577	0.711	0.84	3.69538634193302e-19	RPL7L1	Malignant cells	GSE131984_JQ1Pac	ENSG00000146223	285855	ribosomal protein L7 like 1	dJ475N16.4	protein_coding	Q6DKI1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40148
2.62306444389683e-23	-0.392466831023478	0.846	0.935	4.04266692093379e-19	EMD	Malignant cells	GSE131984_JQ1Pac	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40149
2.73104480350672e-23	-0.424307374742454	0.546	0.727	4.20908625116455e-19	PMVK	Malignant cells	GSE131984_JQ1Pac	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40150
3.12214492170535e-23	-0.410476364515185	0.395	0.616	4.81184975333228e-19	RPUSD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000007376	113000	RNA pseudouridine synthase domain containing 1	C16orf40|MGC19600|RLUCL	protein_coding	Q9UJJ7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40151
3.37126949783702e-23	-0.420898089876902	0.58	0.768	5.19580055006641e-19	NASP	Malignant cells	GSE131984_JQ1Pac	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40152
3.6652159553232e-23	-0.389541956581777	0.77	0.887	5.64883083034412e-19	MSN	Malignant cells	GSE131984_JQ1Pac	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40153
3.88423152673682e-23	-0.359928146605155	0.908	0.961	5.98637762900679e-19	RER1	Malignant cells	GSE131984_JQ1Pac	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40154
3.93245109352109e-23	-0.383194959529455	0.913	0.976	6.0606936253347e-19	PHLDA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40155
4.11501813165835e-23	-0.406980817456967	0.309	0.533	6.34206594451185e-19	ALYREF	Malignant cells	GSE131984_JQ1Pac	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40156
4.4212990064248e-23	-0.38933195028074	0.198	0.422	6.8141060287019e-19	APOBEC3B	Malignant cells	GSE131984_JQ1Pac	ENSG00000179750	9582	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	FLJ21201|PHRBNL	protein_coding	Q9UH17	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40157
4.42564987915807e-23	-0.384723633736363	0.611	0.79	6.82081159375841e-19	FAM204A	Malignant cells	GSE131984_JQ1Pac	ENSG00000165669	63877	family with sequence similarity 204 member A	bA319I23.1|C10orf84|FLJ13188	protein_coding	Q9H8W3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40158
4.56099006407135e-23	-0.454110585661863	0.501	0.693	7.02939788674676e-19	RAD51C	Malignant cells	GSE131984_JQ1Pac	ENSG00000108384	5889	RAD51 paralog C	FANCO|RAD51L2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40159
5.47038838835568e-23	-0.352948682493037	0.879	0.939	8.43096258413378e-19	MRPL21	Malignant cells	GSE131984_JQ1Pac	ENSG00000197345	219927	mitochondrial ribosomal protein L21	NA	protein_coding	Q7Z2W9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40160
5.62703891160843e-23	-0.320432129667418	1	1	8.67239237057092e-19	LDHA	Malignant cells	GSE131984_JQ1Pac	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40161
5.6305203627834e-23	-0.437881319674433	0.705	0.82	8.67775798312177e-19	UFM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000120686	51569	ubiquitin fold modifier 1	bA131P10.1|C13orf20	protein_coding	P61960	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40162
5.77325290005024e-23	-0.394639743838578	0.431	0.646	8.89773736955743e-19	SMIM11	Malignant cells	GSE131984_JQ1Pac	ENSG00000205670	54065	small integral membrane protein 11	C21orf51|FAM165B|SMIM11A	protein_coding	P58511	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40163
6.01577542327588e-23	-0.366641332520639	0.823	0.909	9.27151308235279e-19	C9orf89	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40164
6.04734988979079e-23	-0.401434664726758	0.241	0.473	9.32017565014557e-19	CHORDC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40165
6.20655858168902e-23	-0.485574181743383	0.456	0.653	9.56554808609913e-19	RPF2	Malignant cells	GSE131984_JQ1Pac	ENSG00000197498	84154	ribosome production factor 2 homolog	bA397G5.4|BXDC1|FLJ21087	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40166
6.61598330363316e-23	-0.34323692361604	0.961	0.988	1.01965534675594e-18	TUFM	Malignant cells	GSE131984_JQ1Pac	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40167
6.86531635864539e-23	-0.543154208802097	0.278	0.516	1.05808255719443e-18	AURKA	Malignant cells	GSE131984_JQ1Pac	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40168
6.89327921093343e-23	-0.391888409385921	0.233	0.467	1.06239219198906e-18	SNHG10	Malignant cells	GSE131984_JQ1Pac	ENSG00000247092	283596	small nucleolar RNA host gene 10	C14orf62|FLJ40557|LINC00063|NCRNA00063|TP53LC16	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40169
6.9179325315924e-23	-0.321279293957251	0.953	0.985	1.06619176176902e-18	SRP9	Malignant cells	GSE131984_JQ1Pac	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40170
7.11408277682781e-23	-0.391343231349193	0.428	0.65	1.0964224375647e-18	DNPEP	Malignant cells	GSE131984_JQ1Pac	ENSG00000123992	23549	aspartyl aminopeptidase	ASPEP|DAP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40171
7.49720827062268e-23	-0.348492758274252	0.283	0.511	1.15546973866837e-18	TSPAN17	Malignant cells	GSE131984_JQ1Pac	ENSG00000048140	26262	tetraspanin 17	FBX23|FBXO23|TM4SF17	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40172
7.58996318885339e-23	-0.380953002480811	0.334	0.571	1.16976512666608e-18	FAM103A1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40173
7.66884098478996e-23	-0.309015796117662	0.997	1	1.18192177257583e-18	SHFM1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40174
8.03561408359669e-23	-0.430083384760377	0.515	0.706	1.23844884256392e-18	C14orf119	Malignant cells	GSE131984_JQ1Pac	ENSG00000179933	55017	chromosome 14 open reading frame 119	FLJ20671	protein_coding	Q9NWQ9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40175
8.27381830275577e-23	-0.387423183277455	0.241	0.474	1.27516087682072e-18	RP11-660L16.2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40176
8.90994204330951e-23	-0.375039638949262	0.81	0.894	1.37320026771486e-18	RBM17	Malignant cells	GSE131984_JQ1Pac	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40177
9.93419459865029e-23	-0.45692382973494	0.561	0.717	1.53105807154398e-18	PSMC6	Malignant cells	GSE131984_JQ1Pac	ENSG00000100519	5706	proteasome 26S subunit, ATPase 6	p42|RPT5	protein_coding	P62333	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40178
1.00920394682544e-22	-0.390388966425827	0.742	0.87	1.55538512284736e-18	NELFE	Malignant cells	GSE131984_JQ1Pac	ENSG00000206268	7936	negative elongation factor complex member E	D6S45|NELF-E|RD|RDBP|RDP	protein_coding	P18615	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40179
1.02563952097389e-22	-0.538117740935982	0.319	0.56	1.58071562972496e-18	PLK1	Malignant cells	GSE131984_JQ1Pac	ENSG00000166851	5347	polo like kinase 1	PLK	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40180
1.06431344392023e-22	-0.468742632927487	0.238	0.46	1.64031987976985e-18	PCOLCE	Malignant cells	GSE131984_JQ1Pac	ENSG00000106333	5118	procollagen C-endopeptidase enhancer	PCPE|PCPE1	protein_coding	Q15113	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40181
1.17975957188232e-22	-0.28668031088019	0.994	0.998	1.81824545218503e-18	MINOS1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40182
1.25389929255616e-22	-0.410559235607607	0.46	0.667	1.93250958968755e-18	SMC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000136824	10592	structural maintenance of chromosomes 2	CAP-E|hCAP-E|SMC2L1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40183
1.34567843036093e-22	0.472179239304733	0.477	0.266	2.07395959687226e-18	CRIP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000182809	1397	cysteine rich protein 2	CRP2|ESP1	protein_coding	P52943	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40184
1.37029509663501e-22	-0.383665390245108	0.199	0.419	2.11189880293387e-18	SORD	Malignant cells	GSE131984_JQ1Pac	ENSG00000140263	6652	sorbitol dehydrogenase	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40185
1.38061180426443e-22	0.498398996264994	0.708	0.527	2.12779891273234e-18	AHNAK2	Malignant cells	GSE131984_JQ1Pac	ENSG00000185567	113146	AHNAK nucleoprotein 2	C14orf78	protein_coding	Q8IVF2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40186
1.45294944322495e-22	-0.30285914384158	0.988	0.995	2.2392856818983e-18	ITGB1BP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000119185	9270	integrin subunit beta 1 binding protein 1	ICAP-1A|ICAP-1alpha|ICAP-1B|ICAP1|ICAP1A|ICAP1B	protein_coding	O14713	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40187
1.5383232753428e-22	-0.32868933478187	0.989	0.997	2.37086383195832e-18	UBE2L3	Malignant cells	GSE131984_JQ1Pac	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40188
1.56124420722546e-22	-0.400128625894044	0.381	0.603	2.40618957217588e-18	RDH11	Malignant cells	GSE131984_JQ1Pac	ENSG00000072042	51109	retinol dehydrogenase 11	ARSDR1|MDT1|SDR7C1	protein_coding	Q8TC12	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40189
1.58048779570167e-22	0.391328105111444	0.37	0.17	2.43584779073541e-18	KCNQ1OT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000269821	10984	KCNQ1 opposite strand/antisense transcript 1	KCNQ1-AS2|KvDMR1|KvLQT1-AS|LIT1|NCRNA00012	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40190
1.87875369526598e-22	-0.411723039142463	0.463	0.667	2.89553519514392e-18	ERGIC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000087502	51290	ERGIC and golgi 2	Erv41|PTX1	protein_coding	Q96RQ1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40191
1.88865432754295e-22	-0.401407808413374	0.988	0.996	2.9107940496092e-18	KRT18	Malignant cells	GSE131984_JQ1Pac	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40192
1.91350631603517e-22	-0.466992932598125	0.446	0.657	2.9490959342734e-18	MYBL2	Malignant cells	GSE131984_JQ1Pac	ENSG00000101057	4605	MYB proto-oncogene like 2	B-MYB|BMYB	protein_coding	P10244	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40193
2.1166825707383e-22	-0.37378170497414	0.33	0.565	3.26223117802187e-18	ACYP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000119640	97	acylphosphatase 1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40194
2.23454246849181e-22	-0.317098394233932	0.946	0.989	3.44387685243957e-18	PHB2	Malignant cells	GSE131984_JQ1Pac	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40195
2.24328593217729e-22	-0.368873095573663	0.17	0.395	3.45735227867164e-18	PDGFRA	Malignant cells	GSE131984_JQ1Pac	ENSG00000134853	5156	platelet derived growth factor receptor alpha	CD140a|GAS9|PDGFR2	protein_coding	P16234	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40196
2.44729479116681e-22	-0.390301795648675	0.166	0.387	3.77177073214628e-18	LINC01133	Malignant cells	GSE131984_JQ1Pac	ENSG00000224259	NA	NA	lncRNA-PAGBC	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40197
2.47269149093985e-22	-0.375998787235951	0.725	0.851	3.8109121258365e-18	PFDN1	Malignant cells	GSE131984_JQ1Pac	ENSG00000113068	5201	prefoldin subunit 1	PFD1	protein_coding	O60925	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40198
2.8738791628063e-22	-0.470480862896779	0.537	0.711	4.42922256571707e-18	GCLM	Malignant cells	GSE131984_JQ1Pac	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40199
2.95928064376361e-22	-0.336587060220549	0.97	0.986	4.56084332816847e-18	RNF7	Malignant cells	GSE131984_JQ1Pac	ENSG00000114125	9616	ring finger protein 7	CKBBP1|RBX2|ROC2|SAG	protein_coding	Q9UBF6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40200
2.98119797729671e-22	-0.373481121980075	0.336	0.567	4.59462232260968e-18	PREB	Malignant cells	GSE131984_JQ1Pac	ENSG00000138073	10113	prolactin regulatory element binding	SEC12	protein_coding	Q9HCU5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40201
3.22196729956725e-22	-0.38190759876316	0.353	0.585	4.96569600209304e-18	DAXX	Malignant cells	GSE131984_JQ1Pac	ENSG00000231617	1616	death domain associated protein	DAP6	protein_coding	Q9UER7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40202
3.25207238454914e-22	-0.417100522427814	0.774	0.86	5.01209395906714e-18	RAB7A	Malignant cells	GSE131984_JQ1Pac	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40203
3.25254994602044e-22	-0.334412061210939	0.897	0.961	5.0128299768067e-18	DEF8	Malignant cells	GSE131984_JQ1Pac	ENSG00000140995	54849	differentially expressed in FDCP 8 homolog	FLJ20186	protein_coding	Q6ZN54	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40204
3.59502973225664e-22	0.401309844081017	0.747	0.543	5.54065982335394e-18	LTA4H	Malignant cells	GSE131984_JQ1Pac	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40205
3.74825378083827e-22	-0.351079215178867	0.137	0.346	5.77680872702795e-18	LAMB3	Malignant cells	GSE131984_JQ1Pac	ENSG00000196878	3914	laminin subunit beta 3	BM600-125kDa|kalinin-140kDa|LAMNB1|nicein-125kDa	protein_coding	Q13751	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40206
3.8416445151346e-22	-0.358633088133193	0.882	0.948	5.92074252672545e-18	POLDIP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40207
3.9940739788105e-22	-0.380964537369359	0.311	0.539	6.15566681614275e-18	LACTB	Malignant cells	GSE131984_JQ1Pac	ENSG00000103642	114294	lactamase beta	FLJ14902|MRPL56	protein_coding	P83111	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40208
4.06072574872356e-22	-0.430381889152138	0.319	0.549	6.25839052393275e-18	SNHG9	Malignant cells	GSE131984_JQ1Pac	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40209
4.11413748999877e-22	-0.33463086155	0.96	0.984	6.3407086995861e-18	MYEOV2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40210
4.30777444169232e-22	-0.431541620138368	0.792	0.867	6.63914196953621e-18	VIMP	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40211
4.64617699147081e-22	-0.419182786579571	0.687	0.807	7.16068797925481e-18	MRPL24	Malignant cells	GSE131984_JQ1Pac	ENSG00000143314	79590	mitochondrial ribosomal protein L24	MRP-L18	protein_coding	Q96A35	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40212
4.86269435050415e-22	-0.375686301628314	0.348	0.574	7.49438453299699e-18	TMEM237	Malignant cells	GSE131984_JQ1Pac	ENSG00000155755	65062	transmembrane protein 237	ALS2CR4|JBTS14	protein_coding	Q96Q45	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40213
4.86669270527629e-22	-0.334282360434142	0.241	0.471	7.50054679737182e-18	ALKBH3	Malignant cells	GSE131984_JQ1Pac	ENSG00000166199	221120	alkB homolog 3, alpha-ketoglutarate dependent dioxygenase	DEPC-1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40214
4.95844331683134e-22	-0.47905072703531	0.577	0.73	7.64195283990047e-18	PSMD12	Malignant cells	GSE131984_JQ1Pac	ENSG00000197170	5718	proteasome 26S subunit, non-ATPase 12	p55|Rpn5	protein_coding	O00232	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40215
5.00469679280066e-22	-0.311059472112666	0.989	0.997	7.71323869706438e-18	KDELR2	Malignant cells	GSE131984_JQ1Pac	ENSG00000136240	11014	KDEL endoplasmic reticulum protein retention receptor 2	ELP-1|ERD2.2	protein_coding	P33947	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40216
5.39439298167232e-22	-0.362163150988464	0.25	0.486	8.31383846335338e-18	HSPA14	Malignant cells	GSE131984_JQ1Pac	ENSG00000187522	51182	heat shock protein family A (Hsp70) member 14	HSP70-4|HSP70L1	protein_coding	Q0VDF9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40217
5.44115303969447e-22	-0.330748442225774	0.942	0.975	8.38590506477711e-18	NSA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40218
5.50597303666071e-22	-0.447517501210326	0.552	0.725	8.48580564410149e-18	PSMD13	Malignant cells	GSE131984_JQ1Pac	ENSG00000185627	5719	proteasome 26S subunit, non-ATPase 13	p40.5|Rpn9	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40219
5.72567292045976e-22	-0.365729213282325	0.246	0.475	8.82440710501258e-18	WDR77	Malignant cells	GSE131984_JQ1Pac	ENSG00000116455	79084	WD repeat domain 77	MEP50|p44	protein_coding	Q9BQA1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40220
5.82335145800925e-22	-0.39453910558976	0.801	0.902	8.97494926708386e-18	MALSU1	Malignant cells	GSE131984_JQ1Pac	ENSG00000156928	115416	mitochondrial assembly of ribosomal large subunit 1	C7orf30|mtRsfA	protein_coding	Q96EH3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40221
6.06990432461773e-22	-0.381512311289792	0.219	0.439	9.35493654510085e-18	APEX2	Malignant cells	GSE131984_JQ1Pac	ENSG00000169188	27301	apurinic/apyrimidinic endodeoxyribonuclease 2	APE2|APEXL2|XTH2|ZGRF2	protein_coding	Q9UBZ4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40222
6.87403419588806e-22	-0.391861858342727	0.787	0.9	1.05942615027027e-17	LINC00998	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40223
7.19569400377967e-22	-0.424464591005987	0.519	0.692	1.10900035986252e-17	CHMP2B	Malignant cells	GSE131984_JQ1Pac	ENSG00000083937	25978	charged multivesicular body protein 2B	CHMP2.5|DKFZP564O123|VPS2B	protein_coding	Q9UQN3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40224
8.15807841588114e-22	0.364443893420139	0.994	0.988	1.2573230454556e-17	BSG	Malignant cells	GSE131984_JQ1Pac	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40225
8.26368003900091e-22	0.456584229946198	0.858	0.756	1.27359836761082e-17	SHC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000160691	6464	SHC adaptor protein 1	p66|SHC|ShcA	protein_coding	P29353	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40226
8.98855478622069e-22	-0.388616166317928	0.316	0.532	1.38531606365233e-17	ASB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000065802	51665	ankyrin repeat and SOCS box containing 1	ASB-1	protein_coding	Q9Y576	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40227
9.09317223671804e-22	-0.37148860795932	0.246	0.468	1.40143970512298e-17	UNC50	Malignant cells	GSE131984_JQ1Pac	ENSG00000115446	25972	unc-50 inner nuclear membrane RNA binding protein	GMH1|UNCL|URP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40228
9.13588042539358e-22	-0.33699891426231	0.961	0.985	1.40802189116166e-17	CHCHD10	Malignant cells	GSE131984_JQ1Pac	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40229
9.24631931651016e-22	-0.363439209523035	0.914	0.95	1.42504273306055e-17	KIF5B	Malignant cells	GSE131984_JQ1Pac	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40230
9.26462914937586e-22	-0.378803902598082	0.4	0.631	1.42786464450181e-17	ZWINT	Malignant cells	GSE131984_JQ1Pac	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40231
9.34479573669335e-22	-0.397874897213812	0.575	0.753	1.44021991893918e-17	TMUB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000164897	83590	transmembrane and ubiquitin like domain containing 1	C7orf21|HOPS|SB144	protein_coding	Q9BVT8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40232
9.35134297273053e-22	-0.310632850348382	0.128	0.332	1.44122897895723e-17	DRAM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000136048	55332	DNA damage regulated autophagy modulator 1	DRAM|FLJ11259	protein_coding	Q8N682	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40233
9.81738642335551e-22	-0.269773645923702	1	0.999	1.51305559556755e-17	PARK7	Malignant cells	GSE131984_JQ1Pac	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40234
1.01647944505399e-21	-0.434181713061266	0.439	0.643	1.56659812071721e-17	NMT2	Malignant cells	GSE131984_JQ1Pac	ENSG00000152465	9397	N-myristoyltransferase 2	NA	protein_coding	O60551	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40235
1.08494592077841e-21	-0.413130343043485	0.398	0.609	1.67211865310369e-17	DERL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000136986	79139	derlin 1	DER-1|DER1|derlin-1|FLJ13784|MGC3067|PRO2577	protein_coding	Q9BUN8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40236
1.11594064014388e-21	-0.357539578111053	0.21	0.433	1.71988771458975e-17	RNF113A	Malignant cells	GSE131984_JQ1Pac	ENSG00000125352	7737	ring finger protein 113A	Cwc24|RNF113|ZNF183	protein_coding	O15541	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40237
1.12270968639328e-21	-0.373823527393086	0.205	0.428	1.73032016866932e-17	SLC7A5	Malignant cells	GSE131984_JQ1Pac	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40238
1.13777015596143e-21	-0.498889023975849	0.966	0.987	1.75353136436775e-17	UBB	Malignant cells	GSE131984_JQ1Pac	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40239
1.1753509828688e-21	-0.395389141193601	0.725	0.848	1.8114509347974e-17	PPP4C	Malignant cells	GSE131984_JQ1Pac	ENSG00000149923	5531	protein phosphatase 4 catalytic subunit	PP4|PPX	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40240
1.24229279378296e-21	-0.408526020037639	0.415	0.621	1.91462165377829e-17	BAG2	Malignant cells	GSE131984_JQ1Pac	ENSG00000112208	9532	BAG cochaperone 2	NA	protein_coding	O95816	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40241
1.46462452657765e-21	-0.388272772299117	0.437	0.657	2.25727932036147e-17	CECR5	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40242
1.54471343187185e-21	-0.435328597797696	0.145	0.354	2.3807123412009e-17	BIRC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40243
1.5927539368056e-21	-0.418049176989537	0.406	0.614	2.45475236740479e-17	C1orf35	Malignant cells	GSE131984_JQ1Pac	ENSG00000143793	79169	chromosome 1 open reading frame 35	MGC4174|MMTAG2	protein_coding	Q9BU76	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40244
1.6065705605148e-21	-0.37440964862244	0.725	0.853	2.4760465478654e-17	C11orf73	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40245
1.66222207791914e-21	-0.350821992382444	0.767	0.872	2.56181666648898e-17	MPC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000060762	51660	mitochondrial pyruvate carrier 1	BRP44L|CGI-129|dJ68L15.3|SLC54A1	protein_coding	Q9Y5U8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40246
1.74768652001027e-21	-0.286330499960475	0.981	0.997	2.69353446463983e-17	STRAP	Malignant cells	GSE131984_JQ1Pac	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40247
1.90388943996692e-21	-0.398834167677294	0.499	0.693	2.93427440487702e-17	RAB18	Malignant cells	GSE131984_JQ1Pac	ENSG00000099246	22931	RAB18, member RAS oncogene family	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40248
1.98864944689037e-21	-0.358304263535611	0.717	0.865	3.06490652754744e-17	FDX1	Malignant cells	GSE131984_JQ1Pac	ENSG00000137714	2230	ferredoxin 1	ADX|FDX	protein_coding	P10109	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40249
2.08202129987921e-21	-0.505073075150052	0.521	0.696	3.20881122737383e-17	PSMC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000161057	5701	proteasome 26S subunit, ATPase 2	MSS1|Nbla10058|RPT1|S7	protein_coding	P35998	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40250
2.11905988384939e-21	-0.494696702633852	0.695	0.814	3.26589509298869e-17	ARF4	Malignant cells	GSE131984_JQ1Pac	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40251
2.13780518810855e-21	-0.41387766219913	0.613	0.784	3.2947853559129e-17	SAC3D1	Malignant cells	GSE131984_JQ1Pac	ENSG00000168061	29901	SAC3 domain containing 1	HSU79266|SHD1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40252
2.15694304548268e-21	-0.349910728587126	0.255	0.474	3.3242806216979e-17	CHMP6	Malignant cells	GSE131984_JQ1Pac	ENSG00000176108	79643	charged multivesicular body protein 6	FLJ11749|VPS20	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40253
2.36862970323657e-21	-0.401239841071381	0.411	0.621	3.6505320986282e-17	PELO	Malignant cells	GSE131984_JQ1Pac	ENSG00000152684	53918	pelota mRNA surveillance and ribosome rescue factor	NA	protein_coding	Q9BRX2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40254
2.41698623704769e-21	-0.322043697581791	0.983	0.997	3.7250591885379e-17	SPCS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40255
2.47507602030175e-21	-0.380953002480811	0.355	0.571	3.81458716248905e-17	WDR18	Malignant cells	GSE131984_JQ1Pac	ENSG00000065268	57418	WD repeat domain 18	Ipi3	protein_coding	Q9BV38	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40256
2.55146852828768e-21	-0.325995880340841	0.858	0.947	3.93232329579697e-17	BCL7C	Malignant cells	GSE131984_JQ1Pac	ENSG00000099385	9274	BAF chromatin remodeling complex subunit BCL7C	SMARCJ3	protein_coding	Q8WUZ0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40257
2.63067273367887e-21	-0.3849058847677	0.456	0.664	4.05439281714587e-17	PTDSS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000156471	9791	phosphatidylserine synthase 1	KIAA0024|PSS1|PSSA	protein_coding	P48651	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40258
2.6744705899166e-21	-0.420303383131682	0.467	0.663	4.12189407317947e-17	ECH1	Malignant cells	GSE131984_JQ1Pac	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40259
2.76835233593744e-21	-0.435672389317137	0.544	0.726	4.26658462014679e-17	PSMC4	Malignant cells	GSE131984_JQ1Pac	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40260
2.84965564956881e-21	-0.296784163612962	0.981	0.997	4.39188928711545e-17	ATP5I	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40261
2.86947343384925e-21	0.435344331983235	0.558	0.354	4.42243245624846e-17	RP11-545E17.3	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40262
2.87215553096965e-21	-0.333936881957803	0.137	0.338	4.42656610433042e-17	RNASEH1-AS1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40263
3.03880708075044e-21	-0.368202795586061	0.872	0.929	4.68340947285258e-17	NONO	Malignant cells	GSE131984_JQ1Pac	ENSG00000147140	4841	non-POU domain containing octamer binding	NMT55|NRB54|P54|P54NRB|PPP1R114	protein_coding	Q15233	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40264
3.2228343732416e-21	-0.405335792910779	0.585	0.741	4.96703233603995e-17	RRP36	Malignant cells	GSE131984_JQ1Pac	ENSG00000124541	88745	ribosomal RNA processing 36	C6orf153|dJ20C7.4	protein_coding	Q96EU6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40265
3.37326552109943e-21	-0.315914108726439	0.983	0.992	5.19887682111845e-17	HMGN3	Malignant cells	GSE131984_JQ1Pac	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40266
3.5971482208786e-21	-0.365457630770017	0.781	0.881	5.54392483801809e-17	GNB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000078369	2782	G protein subunit beta 1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40267
3.69982036674594e-21	-0.440468748356832	0.459	0.657	5.70216314922884e-17	SQLE	Malignant cells	GSE131984_JQ1Pac	ENSG00000104549	6713	squalene epoxidase	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40268
3.734606870844e-21	-0.315915123695501	0.159	0.37	5.75577610934477e-17	MAPK3	Malignant cells	GSE131984_JQ1Pac	ENSG00000102882	5595	mitogen-activated protein kinase 3	ERK1|p44erk1|p44mapk|PRKM3	protein_coding	P27361	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40269
3.92488129937554e-21	-0.353000534020496	0.295	0.524	6.04902705859758e-17	MSL3	Malignant cells	GSE131984_JQ1Pac	ENSG00000005302	10943	MSL complex subunit 3	MSL3L1	protein_coding	Q8N5Y2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40270
4.267993680454e-21	-0.316177312894056	0.936	0.98	6.57783186031571e-17	DGUOK	Malignant cells	GSE131984_JQ1Pac	ENSG00000114956	1716	deoxyguanosine kinase	dGK	protein_coding	Q16854	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40271
4.31988472351491e-21	-0.388839520283513	0.613	0.777	6.65780633588117e-17	SRPK1	Malignant cells	GSE131984_JQ1Pac	ENSG00000096063	6732	SRSF protein kinase 1	SFRSK1	protein_coding	Q96SB4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40272
4.34319627898214e-21	-0.432261463002236	0.89	0.941	6.69373410516728e-17	SSB	Malignant cells	GSE131984_JQ1Pac	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40273
4.52134745333295e-21	-0.27294211462624	0.977	0.994	6.96830069507675e-17	UQCRFS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40274
4.67584064340343e-21	0.329718336601451	0.362	0.171	7.20640559961337e-17	NXN	Malignant cells	GSE131984_JQ1Pac	ENSG00000281300	64359	nucleoredoxin	FLJ12614|NRX	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40275
4.86686899019945e-21	-0.392833863195612	0.383	0.598	7.50081848769538e-17	C21orf59	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40276
4.89484539521682e-21	-0.360950971916264	0.356	0.571	7.54393572310816e-17	HDGFRP3	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40277
5.0216318651213e-21	-0.315689750172094	0.994	0.993	7.73933903052495e-17	SSR2	Malignant cells	GSE131984_JQ1Pac	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40278
5.07990341565128e-21	-0.274591518355495	0.998	1	7.82914714420175e-17	SERBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40279
5.15596575971788e-21	0.35620210794559	0.994	0.959	7.9463744288772e-17	AHNAK	Malignant cells	GSE131984_JQ1Pac	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40280
5.17781068749535e-21	-0.285616827534046	0.092	0.281	7.98004183156783e-17	UGT2B7	Malignant cells	GSE131984_JQ1Pac	ENSG00000171234	7364	UDP glucuronosyltransferase family 2 member B7	UGT2B9	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40281
5.23874457631403e-21	0.367899570497085	0.82	0.659	8.07395314101518e-17	TCF25	Malignant cells	GSE131984_JQ1Pac	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40282
5.53272854773053e-21	-0.390158376079841	0.428	0.64	8.52704123776229e-17	BCCIP	Malignant cells	GSE131984_JQ1Pac	ENSG00000107949	56647	BRCA2 and CDKN1A interacting protein	BCCIPalpha|TOK-1	protein_coding	Q9P287	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40283
5.58081197497812e-21	-0.43487071136149	0.448	0.643	8.60114741583628e-17	SNHG15	Malignant cells	GSE131984_JQ1Pac	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40284
5.58489196034863e-21	-0.413760209974215	0.439	0.639	8.6074354892893e-17	FRG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000275145	2483	FSHD region gene 1	FRG1A|FSG1	protein_coding	Q14331	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40285
5.80631680446153e-21	-0.415161243174349	0.614	0.761	8.94869545903611e-17	IDH3G	Malignant cells	GSE131984_JQ1Pac	ENSG00000067829	3421	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma	NA	protein_coding	P51553	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40286
6.14690930656538e-21	-0.381569864979099	0.375	0.602	9.47361662327857e-17	GNL2	Malignant cells	GSE131984_JQ1Pac	ENSG00000134697	29889	G protein nucleolar 2	HUMAUANTIG|Ngp-1|Nog2|Nug2	protein_coding	Q13823	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40287
6.31392792529597e-21	0.476643555016633	0.894	0.791	9.73102571846615e-17	XIST	Malignant cells	GSE131984_JQ1Pac	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40288
6.34205636062872e-21	-0.441664376828537	0.505	0.7	9.77437726300098e-17	ACAA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000167315	10449	acetyl-CoA acyltransferase 2	DSAEC	protein_coding	P42765	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40289
6.41203705184738e-21	-0.338290415097576	0.981	0.994	9.88223150430719e-17	YWHAB	Malignant cells	GSE131984_JQ1Pac	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40290
6.43134718097225e-21	-0.316160765168236	0.933	0.965	9.91199227531443e-17	SSU72	Malignant cells	GSE131984_JQ1Pac	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40291
6.47135725634323e-21	-0.40600786949813	0.453	0.644	9.97365580347618e-17	MTX2	Malignant cells	GSE131984_JQ1Pac	ENSG00000128654	10651	metaxin 2	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40292
7.12668661145027e-21	-0.324626714000734	0.325	0.57	1.09836494055672e-16	SORBS3	Malignant cells	GSE131984_JQ1Pac	ENSG00000120896	10174	sorbin and SH3 domain containing 3	SCAM-1|SH3D4|vinexin	protein_coding	O60504	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40293
7.19771632467446e-21	-0.354542209431823	0.319	0.541	1.10931203995883e-16	TAP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40294
7.25668773371826e-21	-0.420338068106104	0.56	0.738	1.11840071352066e-16	CRELD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40295
7.70623969031324e-21	-0.470773915293446	0.636	0.764	1.18768566107108e-16	GARS	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40296
7.78539529814718e-21	-0.269486649987118	0.992	0.998	1.19988512335044e-16	HSBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40297
7.84699918764885e-21	-0.311619391133352	0.202	0.426	1.20937951480044e-16	RP11-752G15.6	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40298
8.0236101204662e-21	-0.371672156153438	0.314	0.532	1.23659879176625e-16	C8orf88	Malignant cells	GSE131984_JQ1Pac	ENSG00000253250	100127983	chromosome 8 open reading frame 88	NA	protein_coding	P0DMB2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40299
8.21103443286686e-21	-0.419664598511599	0.395	0.596	1.26548462679344e-16	BET1	Malignant cells	GSE131984_JQ1Pac	ENSG00000105829	10282	Bet1 golgi vesicular membrane trafficking protein	hbet1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40300
8.28646533420056e-21	-0.356016634834761	0.25	0.463	1.27711003730699e-16	PIGC	Malignant cells	GSE131984_JQ1Pac	ENSG00000135845	5279	phosphatidylinositol glycan anchor biosynthesis class C	NA	protein_coding	Q92535	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40301
8.37360995037145e-21	0.352042953261236	0.482	0.27	1.29054076555125e-16	PNPLA4	Malignant cells	GSE131984_JQ1Pac	ENSG00000006757	8228	patatin like phospholipase domain containing 4	DXS1283E|GS2|iPLA2eta	protein_coding	P41247	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40302
9.65719800552273e-21	-0.35074938757376	0.75	0.858	1.48836735661116e-16	HIGD1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000181061	25994	HIG1 hypoxia inducible domain family member 1A	DKFZP564K247|HIG1|RCF1A	protein_coding	Q9Y241	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40303
9.87357680131044e-21	-0.417190750079796	0.384	0.594	1.52171565661797e-16	RBM42	Malignant cells	GSE131984_JQ1Pac	ENSG00000126254	79171	RNA binding motif protein 42	MGC10433	protein_coding	Q9BTD8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40304
1.01147041475317e-20	0.404284132639903	0.947	0.863	1.55887820321759e-16	CTSD	Malignant cells	GSE131984_JQ1Pac	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40305
1.04960612667837e-20	-0.423481010018635	0.226	0.439	1.6176529624367e-16	PSAT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40306
1.12927782052959e-20	-0.399276648298774	0.446	0.65	1.74044297700021e-16	EEA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000102189	8411	early endosome antigen 1	ZFYVE2	protein_coding	Q15075	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40307
1.12965298897057e-20	-0.390452134635151	0.686	0.826	1.74102118660144e-16	SMIM15	Malignant cells	GSE131984_JQ1Pac	ENSG00000188725	643155	small integral membrane protein 15	C5orf43|DKFZP686E2158	protein_coding	Q7Z3B0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40308
1.18296202838963e-20	-0.375535813040327	0.476	0.683	1.82318107815409e-16	TIMM44	Malignant cells	GSE131984_JQ1Pac	ENSG00000104980	10469	translocase of inner mitochondrial membrane 44	TIM44	protein_coding	O43615	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40309
1.19612551154421e-20	-0.423143441608818	0.56	0.734	1.84346863839193e-16	EIF4E	Malignant cells	GSE131984_JQ1Pac	ENSG00000151247	1977	eukaryotic translation initiation factor 4E	EIF4E1|EIF4EL1|EIF4F	protein_coding	P06730	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40310
1.32263507299755e-20	-0.362497604981252	0.978	0.988	2.03844517450383e-16	NCL	Malignant cells	GSE131984_JQ1Pac	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40311
1.34357191286594e-20	-0.309557042942904	0.997	0.994	2.07071303210899e-16	ARPC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40312
1.37261051688944e-20	-0.37184865134072	0.384	0.598	2.11546732863001e-16	ENOPH1	Malignant cells	GSE131984_JQ1Pac	ENSG00000145293	58478	enolase-phosphatase 1	E1|MASA|mtnC	protein_coding	Q9UHY7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40313
1.42836612096708e-20	-0.361863455350404	0.719	0.846	2.20139786563446e-16	UBE2K	Malignant cells	GSE131984_JQ1Pac	ENSG00000078140	3093	ubiquitin conjugating enzyme E2 K	HIP2|HYPG|UBC1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40314
1.4927847957852e-20	-0.377405041776004	0.521	0.706	2.30067992726416e-16	LLPH	Malignant cells	GSE131984_JQ1Pac	ENSG00000139233	84298	LLP homolog, long-term synaptic facilitation factor	C12orf31|hLLP|MGC14817	protein_coding	Q9BRT6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40315
1.57316076823495e-20	0.381816170184299	0.526	0.317	2.4245553760037e-16	KANK2	Malignant cells	GSE131984_JQ1Pac	ENSG00000197256	25959	KN motif and ankyrin repeat domains 2	ANKRD25|KIAA1518|MXRA3	protein_coding	Q63ZY3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40316
1.66242957244545e-20	-0.346590347068003	0.222	0.436	2.56213645705292e-16	KIFC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000140859	3801	kinesin family member C3	NA	protein_coding	Q9BVG8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40317
1.7003630594521e-20	-0.382077109493931	0.737	0.845	2.62059954722758e-16	SRP19	Malignant cells	GSE131984_JQ1Pac	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40318
1.76275777240394e-20	-0.311231704483769	0.129	0.329	2.71676227882895e-16	HDHD1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40319
1.84660118493893e-20	-0.346967029848443	0.269	0.484	2.84598174622788e-16	SNX12	Malignant cells	GSE131984_JQ1Pac	ENSG00000147164	29934	sorting nexin 12	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40320
1.85621275671455e-20	-0.387575743330866	0.288	0.496	2.86079510064847e-16	TXLNG	Malignant cells	GSE131984_JQ1Pac	ENSG00000086712	55787	taxilin gamma	CXorf15|FIAT|FLJ11209|LSR5|MGC126621|MGC126625|TXLNGX	protein_coding	Q9NUQ3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40321
1.87690870649184e-20	-0.36842088469905	0.431	0.644	2.89269169844522e-16	ATG5	Malignant cells	GSE131984_JQ1Pac	ENSG00000057663	9474	autophagy related 5	APG5|APG5L|ASP|hAPG5	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40322
1.90003927394431e-20	-0.417572870341834	0.706	0.816	2.92834052900298e-16	RAB11A	Malignant cells	GSE131984_JQ1Pac	ENSG00000103769	8766	RAB11A, member RAS oncogene family	YL8	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40323
1.94731714157866e-20	-0.381263954727428	0.435	0.646	3.00120517860102e-16	NSMCE1	Malignant cells	GSE131984_JQ1Pac	ENSG00000169189	197370	NSE1 homolog, SMC5-SMC6 complex component	NSE1	protein_coding	Q8WV22	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40324
1.98670262830711e-20	-0.311241471751535	0.18	0.393	3.06190609074692e-16	SLC35A2	Malignant cells	GSE131984_JQ1Pac	ENSG00000102100	7355	solute carrier family 35 member A2	UGALT|UGAT|UGT|UGT1|UGT2|UGTL	protein_coding	P78381	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40325
2.00679761452051e-20	-0.366123606233579	0.323	0.541	3.09287648349901e-16	SRPRB	Malignant cells	GSE131984_JQ1Pac	ENSG00000144867	58477	SRP receptor subunit beta	APMCF1|SR-beta	protein_coding	Q9Y5M8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40326
2.11756902686056e-20	0.407310942577346	0.975	0.926	3.26359738419749e-16	SLC38A2	Malignant cells	GSE131984_JQ1Pac	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40327
2.15415227163136e-20	-0.285559668459519	0.098	0.286	3.31997948103825e-16	CSTF2	Malignant cells	GSE131984_JQ1Pac	ENSG00000101811	1478	cleavage stimulation factor subunit 2	CstF-64	protein_coding	P33240	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40328
2.25617506834008e-20	-0.299928783368957	0.084	0.265	3.47721701532573e-16	DLL3	Malignant cells	GSE131984_JQ1Pac	ENSG00000090932	10683	delta like canonical Notch ligand 3	SCDO1	protein_coding	Q9NYJ7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40329
2.30879453017029e-20	-0.317965348692935	0.253	0.474	3.55831412989846e-16	WDYHV1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40330
2.43915451677941e-20	0.28053637023193	0.998	0.997	3.75922494126042e-16	PCBP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40331
2.66085250841846e-20	-0.358879782990717	0.851	0.894	4.10090588597453e-16	CTDNEP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000288307	23399	CTD nuclear envelope phosphatase 1	DULLARD|HSA011916|NET56	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40332
3.04713756754596e-20	-0.381192498178693	0.75	0.844	4.69624841910184e-16	NDUFS3	Malignant cells	GSE131984_JQ1Pac	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40333
3.05171055636914e-20	-0.403041862026989	0.588	0.754	4.70329630947612e-16	TIMM50	Malignant cells	GSE131984_JQ1Pac	ENSG00000105197	92609	translocase of inner mitochondrial membrane 50	TIM50|TIM50L	protein_coding	Q3ZCQ8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40334
3.14868195473402e-20	-0.31913196487152	0.202	0.418	4.85274862863607e-16	ATP6V1C1	Malignant cells	GSE131984_JQ1Pac	ENSG00000155097	528	ATPase H+ transporting V1 subunit C1	ATP6C|ATP6D|VATC|Vma5	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40335
3.17095330683863e-20	-0.316213328058187	0.997	0.993	4.8870732364997e-16	DYNLL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40336
3.40306113337449e-20	-0.389640480352145	0.236	0.451	5.24479781875676e-16	IRF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40337
3.40724724385996e-20	-0.388755406869685	0.407	0.612	5.25124945223697e-16	UBE2L6	Malignant cells	GSE131984_JQ1Pac	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40338
3.58263939092732e-20	-0.273441729854388	0.103	0.293	5.52156382929718e-16	DOCK10	Malignant cells	GSE131984_JQ1Pac	ENSG00000135905	55619	dedicator of cytokinesis 10	KIAA0694|ZIZ3	protein_coding	Q96BY6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40339
3.94855010594308e-20	-0.365993678277166	0.347	0.558	6.08550542327947e-16	EGFLAM	Malignant cells	GSE131984_JQ1Pac	ENSG00000164318	133584	EGF like, fibronectin type III and laminin G domains	AGRINL|AGRNL|FLJ39155|PIKA	protein_coding	Q63HQ2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40340
4.11783852753266e-20	-0.337670620619098	0.925	0.988	6.34641273863333e-16	DEK	Malignant cells	GSE131984_JQ1Pac	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40341
4.24337874808108e-20	-0.347782305269323	0.353	0.565	6.53989532654256e-16	PEMT	Malignant cells	GSE131984_JQ1Pac	ENSG00000133027	10400	phosphatidylethanolamine N-methyltransferase	PEMPT|PEMT2	protein_coding	Q9UBM1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40342
4.52538171333512e-20	-0.392943203833119	0.874	0.939	6.97451829659209e-16	SQSTM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40343
4.77543962549128e-20	-0.355945375105701	0.918	0.975	7.35990755080716e-16	TPM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40344
4.82138585068538e-20	-0.319797484119502	0.21	0.423	7.4307198730763e-16	RFC5	Malignant cells	GSE131984_JQ1Pac	ENSG00000111445	5985	replication factor C subunit 5	RFC36	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40345
5.569367373981e-20	-0.371304399213303	0.792	0.865	8.58350899677952e-16	PDXK	Malignant cells	GSE131984_JQ1Pac	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40346
6.24174351481647e-20	-0.366090885753647	0.291	0.498	9.61977510503514e-16	COMMD9	Malignant cells	GSE131984_JQ1Pac	ENSG00000110442	29099	COMM domain containing 9	FLJ31106|HSPC166	protein_coding	Q9P000	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40347
6.79697616478022e-20	-0.280558581468564	0.081	0.258	1.04754996651593e-15	CLN3.1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40348
7.1617737002202e-20	-0.34997374198055	0.994	0.995	1.10377256267794e-15	SSR4	Malignant cells	GSE131984_JQ1Pac	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40349
7.3013279412121e-20	-0.366809494360127	0.345	0.557	1.12528066229961e-15	HRSP12	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40350
7.50940870349698e-20	-0.387627320987367	0.389	0.588	1.15735006938295e-15	SLC25A33	Malignant cells	GSE131984_JQ1Pac	ENSG00000171612	84275	solute carrier family 25 member 33	BMSC-MCP|MGC4399|PNC1	protein_coding	Q9BSK2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40351
7.53373560621534e-20	-0.38133408076013	0.32	0.535	1.16109933162991e-15	RPA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000117748	6118	replication protein A2	NA	protein_coding	P15927	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40352
7.85670497875645e-20	-0.376516801938734	0.376	0.583	1.21087537132594e-15	TMX2	Malignant cells	GSE131984_JQ1Pac	ENSG00000213593	51075	thioredoxin related transmembrane protein 2	PDIA12|TXNDC14	protein_coding	Q9Y320	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40353
8.30769004124689e-20	-0.326405755860178	0.201	0.408	1.28038118915697e-15	PPIL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000137168	51645	peptidylprolyl isomerase like 1	CYPL1	protein_coding	Q9Y3C6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40354
8.31773509368349e-20	-0.328092059483151	0.159	0.356	1.2819293326385e-15	NSDHL	Malignant cells	GSE131984_JQ1Pac	ENSG00000147383	50814	NAD(P) dependent steroid dehydrogenase-like	H105e3|SDR31E1|XAP104	protein_coding	Q15738	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40355
8.33260381333526e-20	-0.366018417755366	0.477	0.67	1.28422089971123e-15	BCAT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000060982	586	branched chain amino acid transaminase 1	BCATc|BCT1	protein_coding	P54687	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40356
8.52918139932371e-20	-0.367010443152191	0.91	0.954	1.31451743726377e-15	ESD	Malignant cells	GSE131984_JQ1Pac	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40357
9.02516382871062e-20	-0.372218863593999	0.381	0.59	1.39095824928088e-15	CTBP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000175029	1488	C-terminal binding protein 2	ribeye	protein_coding	P56545	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40358
9.4394397767642e-20	-0.282994064677528	0.919	0.977	1.4548064583949e-15	RAD23A	Malignant cells	GSE131984_JQ1Pac	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40359
9.50653969817665e-20	-0.272319013273375	0.087	0.267	1.46514789828299e-15	ACSL5	Malignant cells	GSE131984_JQ1Pac	ENSG00000197142	51703	acyl-CoA synthetase long chain family member 5	ACS2|ACS5|FACL5	protein_coding	Q9ULC5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40360
9.58965012664226e-20	-0.383790825626736	0.683	0.801	1.47795687751811e-15	ITPA	Malignant cells	GSE131984_JQ1Pac	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40361
9.7940133844355e-20	-0.347952895896209	0.638	0.805	1.5094533428092e-15	SRSF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40362
1.00645808781164e-19	-0.32286605238361	0.185	0.39	1.5511532049353e-15	NUDT11	Malignant cells	GSE131984_JQ1Pac	ENSG00000196368	55190	nudix hydrolase 11	DIPP3b|FLJ10628|hDIPP3beta	protein_coding	Q96G61	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40363
1.01100710404089e-19	-0.398686097561609	0.527	0.705	1.55816414874783e-15	PCBD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000166228	5092	pterin-4 alpha-carbinolamine dehydratase 1	DCOH|PCBD|PCD	protein_coding	P61457	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40364
1.09161869381068e-19	-0.329468305867786	0.226	0.439	1.68240273090102e-15	PPARG	Malignant cells	GSE131984_JQ1Pac	ENSG00000132170	5468	peroxisome proliferator activated receptor gamma	NR1C3|PPARG1|PPARG2|PPARgamma	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40365
1.09261196165969e-19	-0.329488198761465	0.33	0.553	1.68393355530991e-15	SPNS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000169682	83985	sphingolipid transporter 1 (putative)	HSpin1|LAT|nrs|PP2030|SLC63A1|SPIN1|SPINL	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40366
1.15954492879451e-19	-0.41885184460384	0.617	0.742	1.78709064425809e-15	NDFIP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40367
1.2400938027625e-19	-0.377183376756337	0.851	0.912	1.91123256881756e-15	XRCC5	Malignant cells	GSE131984_JQ1Pac	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40368
1.25596096223634e-19	-0.312377959521054	0.977	0.989	1.93568703499864e-15	TMED2	Malignant cells	GSE131984_JQ1Pac	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40369
1.27976080316179e-19	-0.302601909937601	0.96	0.982	1.97236734983295e-15	POLR2F	Malignant cells	GSE131984_JQ1Pac	ENSG00000100142	5435	RNA polymerase II, I and III subunit F	HRBP14.4|RPB6	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40370
1.30283200610129e-19	-0.363035594573891	0.994	0.998	2.00792468780331e-15	HSPD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40371
1.30863817376083e-19	-0.344036362381471	0.938	0.963	2.0168731534002e-15	SYAP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40372
1.3220947454057e-19	-0.389826470590721	0.468	0.652	2.03761242161927e-15	POLR2C	Malignant cells	GSE131984_JQ1Pac	ENSG00000102978	5432	RNA polymerase II subunit C	RPB3	protein_coding	P19387	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40373
1.32313111286912e-19	-0.402376594597428	0.655	0.78	2.03920967115389e-15	AIMP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000164022	9255	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	EMAP-2|EMAPII|p43|SCYE1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40374
1.35659964083787e-19	-0.38253410354893	0.614	0.749	2.09079136645933e-15	WBP11	Malignant cells	GSE131984_JQ1Pac	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40375
1.37515176705009e-19	-0.304875926140757	0.958	0.982	2.1193839033776e-15	HNRNPK	Malignant cells	GSE131984_JQ1Pac	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40376
1.4550876874849e-19	0.487852803802264	0.866	0.755	2.24258114395172e-15	ANPEP	Malignant cells	GSE131984_JQ1Pac	ENSG00000166825	290	alanyl aminopeptidase, membrane	AP-N|CD13|gp150|hAPN|LAP1|p150|PEPN	protein_coding	P15144	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40377
1.54621922722792e-19	-0.426738375296931	0.306	0.505	2.38303307300367e-15	SAP30	Malignant cells	GSE131984_JQ1Pac	ENSG00000164105	8819	Sin3A associated protein 30	NA	protein_coding	O75446	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40378
1.60386916923989e-19	-0.345440548663351	0.896	0.957	2.47188316363251e-15	REXO2	Malignant cells	GSE131984_JQ1Pac	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40379
1.62178313142686e-19	-0.304005368602251	0.173	0.381	2.49949216215507e-15	IL20RB	Malignant cells	GSE131984_JQ1Pac	ENSG00000174564	53833	interleukin 20 receptor subunit beta	DIRS1|FNDC6|IL-20R2|MGC34923	protein_coding	Q6UXL0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40380
1.62197739594669e-19	-0.349572628213559	0.882	0.913	2.49979156263303e-15	MMADHC	Malignant cells	GSE131984_JQ1Pac	ENSG00000168288	27249	metabolism of cobalamin associated D	C2orf25|cblD|CL25022	protein_coding	Q9H3L0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40381
1.66374445298446e-19	-0.376228925590567	0.785	0.861	2.56416295093965e-15	ECI2	Malignant cells	GSE131984_JQ1Pac	ENSG00000198721	10455	enoyl-CoA delta isomerase 2	ACBD2|DRS1|HCA88|PECI	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40382
1.70027558074515e-19	0.383279576337898	0.764	0.602	2.62046472504443e-15	TGFB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40383
1.72939948275451e-19	-0.345439614845054	0.801	0.896	2.66535048282126e-15	NDUFA8	Malignant cells	GSE131984_JQ1Pac	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40384
1.8039148346633e-19	-0.359301087114799	0.224	0.431	2.78019354318308e-15	FUOM	Malignant cells	GSE131984_JQ1Pac	ENSG00000148803	282969	fucose mutarotase	C10orf125|FLJ26016|FucM|FucU	protein_coding	A2VDF0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40385
1.83602677060996e-19	-0.319206160164662	0.857	0.921	2.82968445886408e-15	TSR3	Malignant cells	GSE131984_JQ1Pac	ENSG00000007520	115939	TSR3 ribosome maturation factor	C16orf42|MGC24381	protein_coding	Q9UJK0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40386
1.91075088903958e-19	-0.336421792322841	0.807	0.895	2.94484927018781e-15	PCNP	Malignant cells	GSE131984_JQ1Pac	ENSG00000081154	57092	PEST proteolytic signal containing nuclear protein	NA	protein_coding	Q8WW12	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40387
2.08972092968704e-19	-0.316469366044539	0.866	0.93	3.22067789683367e-15	C8orf59	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40388
2.13689123863769e-19	0.486686785309352	0.899	0.746	3.29337677698841e-15	EGR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40389
2.16990275018852e-19	-0.356198422558986	0.588	0.747	3.34425411859054e-15	MVB12A	Malignant cells	GSE131984_JQ1Pac	ENSG00000141971	93343	multivesicular body subunit 12A	FAM125A|FLJ32495	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40390
2.27818499012036e-19	-0.390982020807723	0.93	0.968	3.5111387067735e-15	ATF4	Malignant cells	GSE131984_JQ1Pac	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40391
2.43386449958064e-19	-0.379810199113133	0.516	0.69	3.75107196675368e-15	TSTA3	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40392
2.44663391197281e-19	-0.37272298514532	0.311	0.522	3.77075218513249e-15	LTV1	Malignant cells	GSE131984_JQ1Pac	ENSG00000135521	84946	LTV1 ribosome biogenesis factor	C6orf93|dJ468K18.4|FLJ14909	protein_coding	Q96GA3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40393
2.88132537040588e-19	-0.399321210353643	0.656	0.795	4.44069866086955e-15	TMCO1	Malignant cells	GSE131984_JQ1Pac	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40394
2.92237204093263e-19	-0.319545709655669	0.182	0.386	4.50395978948537e-15	MGST2	Malignant cells	GSE131984_JQ1Pac	ENSG00000085871	4258	microsomal glutathione S-transferase 2	MGST-II	protein_coding	Q99735	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40395
3.00617587825921e-19	-0.318576174376507	0.224	0.431	4.6331182635731e-15	ABHD5	Malignant cells	GSE131984_JQ1Pac	ENSG00000011198	51099	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	CGI-58|NCIE2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40396
3.07762688363039e-19	-0.288707822835096	0.16	0.364	4.74323855305115e-15	GPKOW	Malignant cells	GSE131984_JQ1Pac	ENSG00000068394	27238	G-patch domain and KOW motifs	GPATC5|GPATCH5|Mos2|Spp2|T54	protein_coding	Q92917	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40397
3.21224318023379e-19	-0.387742529120053	0.504	0.671	4.95070918937632e-15	UGP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40398
3.24578195986428e-19	-0.434965978074619	0.532	0.7	5.00239915654282e-15	TWISTNB	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40399
3.42031717293047e-19	-0.360662923149349	0.409	0.616	5.27139282692043e-15	ENDOG	Malignant cells	GSE131984_JQ1Pac	ENSG00000167136	2021	endonuclease G	NA	protein_coding	Q14249	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40400
3.48660238617713e-19	0.277813598514285	0.336	0.155	5.37355159757619e-15	SORT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000134243	6272	sortilin 1	Gp95|NT3	protein_coding	Q99523	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40401
3.69399208716909e-19	-0.333492270882069	0.964	0.984	5.693180604745e-15	MYL12A	Malignant cells	GSE131984_JQ1Pac	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40402
3.7554468629443e-19	-0.345980721204046	0.897	0.957	5.78789470516976e-15	PSMC5	Malignant cells	GSE131984_JQ1Pac	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40403
3.95034799718851e-19	-0.357301021230101	0.907	0.961	6.08827633326694e-15	UBE2E3	Malignant cells	GSE131984_JQ1Pac	ENSG00000170035	10477	ubiquitin conjugating enzyme E2 E3	UbcH9	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40404
4.23667223119886e-19	-0.373283924514314	0.611	0.767	6.52955924272369e-15	MRPS11	Malignant cells	GSE131984_JQ1Pac	ENSG00000181991	64963	mitochondrial ribosomal protein S11	FLJ22512|FLJ23406|HCC-2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40405
4.30391543451302e-19	-0.362912168894829	0.677	0.819	6.63319446767147e-15	PLEKHJ1	Malignant cells	GSE131984_JQ1Pac	ENSG00000104886	55111	pleckstrin homology domain containing J1	FLJ10297	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40406
4.36959298952696e-19	-0.35977633989792	0.451	0.649	6.73441671545894e-15	TNIP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000168884	79155	TNFAIP3 interacting protein 2	ABIN-2|FLIP1|KLIP|MGC4289	protein_coding	Q8NFZ5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40407
4.37954142897075e-19	-0.384557634412454	0.51	0.69	6.74974925032973e-15	PITX1	Malignant cells	GSE131984_JQ1Pac	ENSG00000069011	5307	paired like homeodomain 1	BFT|POTX|PTX1	protein_coding	P78337	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40408
4.39925806895748e-19	-0.3563806893297	0.512	0.694	6.78013653587726e-15	PFDN6	Malignant cells	GSE131984_JQ1Pac	ENSG00000235692	10471	prefoldin subunit 6	H2-KE2|HKE2|KE-2|PFD6	protein_coding	O15212	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40409
5.08799154627661e-19	-0.368517966541086	0.292	0.506	7.84161257112152e-15	PSMC3IP	Malignant cells	GSE131984_JQ1Pac	ENSG00000131470	29893	PSMC3 interacting protein	GT198|Hop2|HUMGT198A|TBPIP	protein_coding	Q9P2W1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40410
5.17004793133233e-19	-0.402350354911994	0.784	0.89	7.96807787176939e-15	GLRX	Malignant cells	GSE131984_JQ1Pac	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40411
5.50162902918044e-19	-0.256301376415141	0.107	0.292	8.47911065977289e-15	C18orf56	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40412
5.62060008048152e-19	-0.257431468829362	0.989	0.999	8.66246884403812e-15	SRSF9	Malignant cells	GSE131984_JQ1Pac	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40413
5.99143164701912e-19	-0.25991599132204	0.081	0.254	9.23399445438587e-15	PODXL2	Malignant cells	GSE131984_JQ1Pac	ENSG00000114631	50512	podocalyxin like 2	endoglycan|PODLX2	protein_coding	Q9NZ53	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40414
6.17755660584868e-19	0.307882726341036	0.314	0.139	9.52085024093399e-15	SOX9	Malignant cells	GSE131984_JQ1Pac	ENSG00000125398	6662	SRY-box transcription factor 9	CMD1|CMPD1|SRA1	protein_coding	P48436	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40415
6.22627851101455e-19	-0.371613140968736	0.263	0.483	9.59594044117562e-15	SGOL1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40416
7.15964310152973e-19	-0.354427968228067	0.289	0.496	1.10344419480776e-14	XIAP	Malignant cells	GSE131984_JQ1Pac	ENSG00000101966	331	X-linked inhibitor of apoptosis	API3|BIRC4|hILP|ILP-1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40417
7.89172004454686e-19	-0.412262764451893	0.446	0.62	1.21627189326556e-14	TXNDC9	Malignant cells	GSE131984_JQ1Pac	ENSG00000115514	10190	thioredoxin domain containing 9	APACD	protein_coding	O14530	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40418
8.10206765986307e-19	-0.36992073184018	0.519	0.696	1.2486906677381e-14	SFXN1	Malignant cells	GSE131984_JQ1Pac	ENSG00000164466	94081	sideroflexin 1	FLJ12876|SLC56A1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40419
8.13146915439631e-19	-0.353530375407005	0.812	0.893	1.25322202607556e-14	DNAJB6	Malignant cells	GSE131984_JQ1Pac	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40420
8.15092915437377e-19	-0.363912998492526	0.894	0.928	1.25622120127209e-14	SEPT7	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40421
8.34501479215141e-19	-0.376739804070667	0.462	0.657	1.28613367976638e-14	NARS	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40422
8.50934259780059e-19	-0.323835949551217	0.802	0.894	1.31145988117303e-14	BAX	Malignant cells	GSE131984_JQ1Pac	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40423
9.01391335120158e-19	-0.309335613857548	0.922	0.976	1.38922432568719e-14	DDX46	Malignant cells	GSE131984_JQ1Pac	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40424
9.40892868477264e-19	-0.351658811849634	0.362	0.554	1.45010408889716e-14	REXO4	Malignant cells	GSE131984_JQ1Pac	ENSG00000280706	57109	REX4 homolog, 3'-5' exonuclease	hPMC2|XPMC2H	protein_coding	Q9GZR2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40425
9.41120460869324e-19	-0.343934247610878	0.97	0.979	1.4504548542918e-14	HPCAL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000115756	3241	hippocalcin like 1	BDR1|HLP2|VILIP-3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40426
9.44102917823773e-19	-0.301626989663982	0.972	0.991	1.45505141695e-14	NDUFB4	Malignant cells	GSE131984_JQ1Pac	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40427
9.84145272807531e-19	-0.35963189228708	0.345	0.548	1.51676469445097e-14	MCMBP	Malignant cells	GSE131984_JQ1Pac	ENSG00000197771	79892	minichromosome maintenance complex binding protein	C10orf119|FLJ13081|MCM-BP	protein_coding	Q9BTE3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40428
9.92364521290897e-19	-0.380876311494709	0.348	0.543	1.52943220021353e-14	GOSR2	Malignant cells	GSE131984_JQ1Pac	ENSG00000108433	9570	golgi SNAP receptor complex member 2	Bos1|GS27	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40429
1.03262634135584e-18	0.337121683417252	0.465	0.271	1.59148371729762e-14	TRIB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40430
1.03929327884726e-18	0.310582494181716	0.456	0.259	1.6017588013594e-14	BEST1	Malignant cells	GSE131984_JQ1Pac	ENSG00000167995	7439	bestrophin 1	BEST|BMD|RP50|VMD2	protein_coding	O76090	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40431
1.048734371472e-18	-0.292854879426609	0.14	0.332	1.61630941331264e-14	SMIM13	Malignant cells	GSE131984_JQ1Pac	ENSG00000224531	221710	small integral membrane protein 13	C6orf228	protein_coding	P0DJ93	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40432
1.07517441498456e-18	-0.360764312439049	0.482	0.665	1.65705880837421e-14	SLC52A2	Malignant cells	GSE131984_JQ1Pac	ENSG00000285112	79581	solute carrier family 52 member 2	D15Ertd747e|FLJ11856|GPCR41|GPR172A|hRFT3|PAR1|RFVT2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40433
1.09391952967087e-18	-0.328561707626561	0.891	0.941	1.68594877912875e-14	HNRNPU	Malignant cells	GSE131984_JQ1Pac	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40434
1.09679258902561e-18	-0.426040541599488	0.812	0.862	1.69037673820628e-14	SPCS2	Malignant cells	GSE131984_JQ1Pac	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40435
1.1384335670452e-18	-0.384870548648569	0.477	0.666	1.75455381353007e-14	LAMP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000005893	3920	lysosomal associated membrane protein 2	CD107b	protein_coding	P13473	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40436
1.33780884828521e-18	-0.341462431021583	0.33	0.539	2.06183099697716e-14	TMEM9	Malignant cells	GSE131984_JQ1Pac	ENSG00000116857	252839	transmembrane protein 9	TMEM9A	protein_coding	Q9P0T7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40437
1.47005672679287e-18	-0.39472420910389	0.619	0.754	2.26565142733317e-14	SSSCA1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40438
1.54005832149131e-18	-0.357086841645126	0.56	0.762	2.3735378850824e-14	MIR4435-1HG	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40439
1.57856661283244e-18	-0.312911007938581	0.942	0.976	2.43288686369736e-14	RSL24D1	Malignant cells	GSE131984_JQ1Pac	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40440
1.59020538120903e-18	-0.337690334873356	0.369	0.587	2.45082453351936e-14	NMT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000136448	4836	N-myristoyltransferase 1	NMT	protein_coding	P30419	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40441
1.61376359497521e-18	0.547989900835657	0.882	0.787	2.4871324525758e-14	ID1	Malignant cells	GSE131984_JQ1Pac	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40442
1.63917432935851e-18	-0.367802723117632	0.339	0.539	2.52629547640734e-14	SNX8	Malignant cells	GSE131984_JQ1Pac	ENSG00000106266	29886	sorting nexin 8	Mvp1	protein_coding	Q9Y5X2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40443
1.66641416964626e-18	-0.363285354874186	0.488	0.663	2.56827751825882e-14	ABCE1	Malignant cells	GSE131984_JQ1Pac	ENSG00000164163	6059	ATP binding cassette subfamily E member 1	OABP|RLI|RLI1|RNASEL1|RNASELI|RNS4I	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40444
1.67732064993154e-18	-0.3341461810023	0.241	0.451	2.58508658567448e-14	RAD51AP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000111247	10635	RAD51 associated protein 1	PIR51	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40445
1.70535850935552e-18	0.372985595896233	0.695	0.528	2.62829853461872e-14	PTPN14	Malignant cells	GSE131984_JQ1Pac	ENSG00000152104	5784	protein tyrosine phosphatase non-receptor type 14	PEZ|PTPD2	protein_coding	Q15678	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40446
1.75422999031531e-18	-0.364928827663522	0.594	0.764	2.70361926107396e-14	MRPS25	Malignant cells	GSE131984_JQ1Pac	ENSG00000131368	64432	mitochondrial ribosomal protein S25	DKFZp313H0817|FLJ00023|MRP-S25|RPMS25	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40447
1.76632560982866e-18	0.481697515384588	0.72	0.545	2.72226102986793e-14	CTGF	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40448
1.77628175592119e-18	-0.392763035860248	0.505	0.684	2.73760544222574e-14	NOP58	Malignant cells	GSE131984_JQ1Pac	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40449
1.84864635621662e-18	-0.396691843626565	0.711	0.818	2.84913376420105e-14	PINK1	Malignant cells	GSE131984_JQ1Pac	ENSG00000158828	65018	PTEN induced kinase 1	BRPK|PARK6	protein_coding	Q9BXM7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40450
1.8494880604006e-18	-0.346836101940828	0.355	0.554	2.8504309986894e-14	TOR1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000136827	1861	torsin family 1 member A	DQ2|DYT1	protein_coding	O14656	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40451
1.96181851353718e-18	-0.35633011755192	0.272	0.477	3.0235546930635e-14	BTG3	Malignant cells	GSE131984_JQ1Pac	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40452
1.99121195353407e-18	-0.36358786893983	0.543	0.713	3.06885586278671e-14	TRIAP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000170855	51499	TP53 regulated inhibitor of apoptosis 1	HSPC132|MDM35|P53CSV|WF-1	protein_coding	O43715	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40453
1.99502563350714e-18	-0.390707044706706	0.306	0.499	3.07473350636121e-14	PNO1	Malignant cells	GSE131984_JQ1Pac	ENSG00000115946	56902	partner of NOB1 homolog	KHRBP1|RRP20	protein_coding	Q9NRX1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40454
2.10369660361282e-18	-0.33904941692924	0.907	0.955	3.24221720548807e-14	C11orf58	Malignant cells	GSE131984_JQ1Pac	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40455
2.13757634771071e-18	-0.353530173467649	0.802	0.882	3.29443266709175e-14	CHPT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40456
2.14343613621335e-18	-0.259444578775142	0.112	0.294	3.30346377313201e-14	PRELID2	Malignant cells	GSE131984_JQ1Pac	ENSG00000186314	153768	PRELI domain containing 2	FLJ38376|MGC21644	protein_coding	Q8N945	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40457
2.17511475660206e-18	-0.340183557026179	0.743	0.871	3.35228686287509e-14	SEP15	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40458
2.22918432786686e-18	-0.383555514274298	0.516	0.69	3.4356188861084e-14	C12orf45	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40459
2.25087242040473e-18	-0.393848111998576	0.549	0.71	3.46904457432777e-14	ANP32A	Malignant cells	GSE131984_JQ1Pac	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40460
2.26837046921104e-18	-0.35275411371742	0.272	0.473	3.49601256714805e-14	KDELR3	Malignant cells	GSE131984_JQ1Pac	ENSG00000100196	11015	KDEL endoplasmic reticulum protein retention receptor 3	NA	protein_coding	O43731	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40461
2.35874429036583e-18	-0.35551905100275	0.691	0.811	3.63529670031181e-14	BTF3L4	Malignant cells	GSE131984_JQ1Pac	ENSG00000134717	91408	basic transcription factor 3 like 4	MGC23908	protein_coding	Q96K17	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40462
2.37116077309233e-18	-0.440597361245096	0.798	0.884	3.6544329834899e-14	PDIA3	Malignant cells	GSE131984_JQ1Pac	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40463
2.85814081991526e-18	-0.284494014042706	0.97	0.99	4.4049666316534e-14	MORF4L1	Malignant cells	GSE131984_JQ1Pac	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40464
2.86015171230846e-18	-0.345180305009528	0.28	0.484	4.4080658190098e-14	ARMCX6	Malignant cells	GSE131984_JQ1Pac	ENSG00000198960	54470	armadillo repeat containing X-linked 6	FLJ20811|GASP10	protein_coding	Q7L4S7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40465
2.89746079406824e-18	-0.286096291556623	0.149	0.336	4.46556657581797e-14	MED27	Malignant cells	GSE131984_JQ1Pac	ENSG00000160563	9442	mediator complex subunit 27	CRSP34|CRSP8|MED3|TRAP37	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40466
2.90648544077864e-18	-0.340019018052347	0.148	0.332	4.47947536132804e-14	C1GALT1C1	Malignant cells	GSE131984_JQ1Pac	ENSG00000288368	29071	C1GALT1 specific chaperone 1	C1GALT2|COSMC	protein_coding	Q96EU7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40467
2.97969868173374e-18	0.395723697319709	0.677	0.514	4.59231160828805e-14	SCPEP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000121064	59342	serine carboxypeptidase 1	RISC	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40468
3.01692973314835e-18	-0.349488406781074	0.384	0.581	4.64969210472824e-14	ZNRD1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40469
3.39867594367646e-18	-0.271287411484058	0.086	0.254	5.23803936439416e-14	POLE2	Malignant cells	GSE131984_JQ1Pac	ENSG00000100479	5427	DNA polymerase epsilon 2, accessory subunit	DPE2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40470
3.79757513056754e-18	-0.369978125202721	0.421	0.615	5.8528227912307e-14	SAR1B	Malignant cells	GSE131984_JQ1Pac	ENSG00000152700	51128	secretion associated Ras related GTPase 1B	SARA2	protein_coding	Q9Y6B6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40471
3.98954300348103e-18	-0.309527195645481	0.215	0.412	6.14868367696496e-14	SPR	Malignant cells	GSE131984_JQ1Pac	ENSG00000116096	6697	sepiapterin reductase	SDR38C1	protein_coding	P35270	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40472
4.30014342295206e-18	-0.364319415996721	0.406	0.587	6.62738104345372e-14	PPT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40473
4.31479621250999e-18	-0.32091624244658	0.886	0.954	6.6499639227204e-14	C20orf27	Malignant cells	GSE131984_JQ1Pac	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40474
4.3577959862906e-18	-0.293023267324744	0.177	0.374	6.71623517407107e-14	SLC25A19	Malignant cells	GSE131984_JQ1Pac	ENSG00000125454	60386	solute carrier family 25 member 19	DNC|MCPHA|MUP1|TPC	protein_coding	Q9HC21	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40475
4.46216824041676e-18	-0.381301797397722	0.79	0.86	6.87709369213032e-14	SEPW1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40476
4.63008190630548e-18	-0.276485561611	0.129	0.312	7.13588223399801e-14	NOTCH2NL	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40477
4.63473482764394e-18	-0.342704781891491	0.722	0.86	7.14305331636484e-14	TMEM14A	Malignant cells	GSE131984_JQ1Pac	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40478
4.7824753195188e-18	-0.272311657812022	0.086	0.253	7.37075096244237e-14	PPAPDC1A	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40479
5.01354493192753e-18	-0.344482739089021	0.554	0.754	7.72687544908671e-14	TROAP	Malignant cells	GSE131984_JQ1Pac	ENSG00000135451	10024	trophinin associated protein	TASTIN	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40480
5.15439899108615e-18	-0.344698227932374	0.449	0.649	7.94395972506197e-14	TRIOBP	Malignant cells	GSE131984_JQ1Pac	ENSG00000100106	11078	TRIO and F-actin binding protein	DFNB28|HRIHFB2122|KIAA1662|TAP68|Tara	protein_coding	Q9H2D6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40481
5.30781480323866e-18	-0.37544114597648	0.594	0.741	8.18040417475143e-14	COX11	Malignant cells	GSE131984_JQ1Pac	ENSG00000166260	1353	cytochrome c oxidase copper chaperone COX11	COX11P	protein_coding	Q9Y6N1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40482
5.51260831664885e-18	-0.311162095360425	0.802	0.894	8.49603193761921e-14	TUBB6	Malignant cells	GSE131984_JQ1Pac	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40483
5.61710909256414e-18	-0.335961635723327	0.4	0.603	8.65708853345985e-14	PET117	Malignant cells	GSE131984_JQ1Pac	ENSG00000232838	100303755	PET117 cytochrome c oxidase chaperone	CSRP2BP	protein_coding	Q6UWS5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40484
5.8065511098706e-18	-0.416071224642689	0.453	0.628	8.94905657053257e-14	BCAS2	Malignant cells	GSE131984_JQ1Pac	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40485
5.82510597217552e-18	-0.323142457606881	0.283	0.493	8.97765332431691e-14	NOL10	Malignant cells	GSE131984_JQ1Pac	ENSG00000115761	79954	nucleolar protein 10	FLJ14075|PQBP5	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40486
6.18291204688779e-18	-0.320985480075925	0.199	0.394	9.52910404666346e-14	COQ3	Malignant cells	GSE131984_JQ1Pac	ENSG00000132423	51805	coenzyme Q3, methyltransferase	bA9819.1	protein_coding	Q9NZJ6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40487
6.33132077448774e-18	-0.326858107840522	0.984	0.997	9.75783157764051e-14	PSMB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40488
6.44419206268472e-18	0.344192175756765	0.837	0.711	9.93178880700969e-14	CRTAP	Malignant cells	GSE131984_JQ1Pac	ENSG00000170275	10491	cartilage associated protein	CASP|LEPREL3|P3H5	protein_coding	O75718	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40489
6.4781353652731e-18	-0.375031536923313	0.949	0.965	9.9841022249589e-14	CCT3	Malignant cells	GSE131984_JQ1Pac	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40490
6.56646809155005e-18	-0.354393064118746	0.602	0.766	1.01202406226969e-13	CCDC59	Malignant cells	GSE131984_JQ1Pac	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40491
6.78532710185734e-18	-0.301043288776409	0.894	0.958	1.04575461293825e-13	SSNA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000176101	8636	SS nuclear autoantigen 1	N14|NA14	protein_coding	O43805	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40492
7.10147419490258e-18	-0.422390722461021	0.747	0.832	1.09447920291839e-13	SNORA76	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40493
7.2040762103778e-18	-0.382632726612746	0.482	0.646	1.11029222554343e-13	DNAJA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000069345	10294	DnaJ heat shock protein family (Hsp40) member A2	CPR3|DNAJ|DNJ3|HIRIP4	protein_coding	O60884	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40494
7.21667005455175e-18	-0.277096585555733	0.983	0.997	1.11223318880752e-13	RPS27L	Malignant cells	GSE131984_JQ1Pac	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40495
7.25013898647302e-18	-0.305157720282231	0.82	0.913	1.11739142059522e-13	TCEA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40496
7.47261271418713e-18	-0.328912751831859	0.336	0.531	1.15167907151052e-13	RPP38	Malignant cells	GSE131984_JQ1Pac	ENSG00000152464	10557	ribonuclease P/MRP subunit p38	NA	protein_coding	P78345	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40497
7.49109703110901e-18	-0.269636296942069	0.975	0.993	1.15452787443452e-13	NDUFC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40498
8.0539814227457e-18	-0.312959080979387	0.603	0.776	1.24127961687357e-13	CRLS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000088766	54675	cardiolipin synthase 1	C20orf155|CLS1|dJ967N21.6|GCD10	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40499
8.10620904465891e-18	-0.326699082879718	0.801	0.91	1.24932893796283e-13	KXD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000105700	79036	KxDL motif containing 1	BORCS4|C19orf50|FLJ25480|KXDL|MGC2749	protein_coding	Q9BQD3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40500
8.32123294405489e-18	-0.312391721836041	0.253	0.455	1.28246842133774e-13	CHAC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000143942	494143	ChaC glutathione specific gamma-glutamylcyclotransferase 2	GCG1	protein_coding	Q8WUX2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40501
8.74127959256272e-18	-0.401194131518453	0.617	0.747	1.34720601080577e-13	PMP22	Malignant cells	GSE131984_JQ1Pac	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40502
8.81072971957059e-18	-0.370229876483556	0.143	0.332	1.35790966438022e-13	ADM	Malignant cells	GSE131984_JQ1Pac	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40503
9.11944334716074e-18	-0.357539578111053	0.541	0.702	1.40548860866441e-13	MRPS35	Malignant cells	GSE131984_JQ1Pac	ENSG00000061794	60488	mitochondrial ribosomal protein S35	MDS023|MRPS28	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40504
9.12597280251518e-18	-0.344816689656002	0.477	0.671	1.40649492832364e-13	STARD3NL	Malignant cells	GSE131984_JQ1Pac	ENSG00000010270	83930	STARD3 N-terminal like	MENTHO|MGC3251	protein_coding	O95772	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40505
9.2288981440063e-18	0.307860509526478	0.392	0.207	1.42235778195425e-13	HOOK2	Malignant cells	GSE131984_JQ1Pac	ENSG00000095066	29911	hook microtubule tethering protein 2	HK2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40506
9.53096130172679e-18	-0.348079439680344	0.565	0.723	1.46891175582213e-13	PPP1R11	Malignant cells	GSE131984_JQ1Pac	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40507
9.77446700836697e-18	-0.335992063019638	0.569	0.741	1.50644085532952e-13	MANBAL	Malignant cells	GSE131984_JQ1Pac	ENSG00000101363	63905	mannosidase beta like	dJ1141E15.2	protein_coding	Q9NQG1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40508
9.80610990438765e-18	0.376564373271765	0.541	0.367	1.51131765846422e-13	PNPLA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000177666	57104	patatin like phospholipase domain containing 2	ATGL|desnutrin|FP17548|iPLA2zeta|TTS-2.2	protein_coding	Q96AD5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40509
9.88226525307635e-18	-0.267169233505754	0.98	0.992	1.52305472080413e-13	NDUFS8	Malignant cells	GSE131984_JQ1Pac	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40510
1.00632533240431e-17	-0.324149777698362	0.348	0.555	1.55094860230152e-13	NEK6	Malignant cells	GSE131984_JQ1Pac	ENSG00000119408	10783	NIMA related kinase 6	SID6-1512	protein_coding	Q9HC98	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40511
1.02631465442851e-17	0.321571699519696	0.936	0.877	1.58175614540522e-13	ADI1	Malignant cells	GSE131984_JQ1Pac	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40512
1.0268220061952e-17	-0.392075938979295	0.166	0.349	1.58253807594805e-13	IFI44	Malignant cells	GSE131984_JQ1Pac	ENSG00000137965	10561	interferon induced protein 44	MTAP44|p44|TLDC5	protein_coding	Q8TCB0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40513
1.03055072528619e-17	-0.344269357097429	0.44	0.623	1.58828477781108e-13	GORASP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000115806	26003	golgi reassembly stacking protein 2	GOLPH6|GRASP55|GRS2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40514
1.06753078429656e-17	-0.364306215969666	0.75	0.836	1.64527844475786e-13	MAPKAPK3	Malignant cells	GSE131984_JQ1Pac	ENSG00000114738	7867	MAPK activated protein kinase 3	3pK|MAPKAP3|MK-3|MK3	protein_coding	Q16644	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40515
1.07822858145606e-17	-0.385417951833479	0.533	0.7	1.66176588974008e-13	NREP	Malignant cells	GSE131984_JQ1Pac	ENSG00000134986	9315	neuronal regeneration related protein	C5orf13|D4S114|P311|PRO1873|PTZ17|SEZ17	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40516
1.1164851264868e-17	-0.465092989588954	0.407	0.592	1.72072687694145e-13	EIF4A3	Malignant cells	GSE131984_JQ1Pac	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40517
1.15134122650806e-17	-0.321134843955315	0.865	0.909	1.77444709829423e-13	PRPF40A	Malignant cells	GSE131984_JQ1Pac	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40518
1.15281748076642e-17	-0.268152235273553	0.165	0.361	1.7767223013572e-13	SLC25A43	Malignant cells	GSE131984_JQ1Pac	ENSG00000077713	203427	solute carrier family 25 member 43	NA	protein_coding	Q8WUT9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40519
1.20869449578577e-17	-0.36071518362629	0.463	0.641	1.86283995690503e-13	APITD1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40520
1.2949875562527e-17	-0.348291899280189	0.362	0.556	1.99583482169665e-13	MSRB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000198736	51734	methionine sulfoxide reductase B1	SELENOR|SELENOX|SelR|SelX|SepR|SEPX1	protein_coding	Q9NZV6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40521
1.32911006226812e-17	0.629647539743703	0.989	0.995	2.04842442796762e-13	RPL22L1	Malignant cells	GSE131984_JQ1Pac	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40522
1.34212981017484e-17	-0.261590227411863	0.115	0.293	2.06849046344146e-13	DNER	Malignant cells	GSE131984_JQ1Pac	ENSG00000187957	92737	delta/notch like EGF repeat containing	bet|UNQ26	protein_coding	Q8NFT8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40523
1.35435341619066e-17	-0.261557217152154	0.992	0.999	2.08732948503304e-13	TXNL4A	Malignant cells	GSE131984_JQ1Pac	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40524
1.43014970041904e-17	0.379889129606401	0.851	0.729	2.20414671828582e-13	SLC25A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000100075	6576	solute carrier family 25 member 1	CTP|SLC20A3	protein_coding	P53007	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40525
1.47219477873091e-17	-0.382453975828547	0.683	0.846	2.26894659298008e-13	SMC4	Malignant cells	GSE131984_JQ1Pac	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40526
1.54278558501136e-17	0.362705466834561	0.457	0.282	2.3777411436195e-13	CPD	Malignant cells	GSE131984_JQ1Pac	ENSG00000108582	1362	carboxypeptidase D	GP180	protein_coding	O75976	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40527
1.58885841497103e-17	-0.387229552638725	0.521	0.683	2.44874858915336e-13	FH	Malignant cells	GSE131984_JQ1Pac	ENSG00000091483	2271	fumarate hydratase	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40528
1.626560341655e-17	-0.347712480282298	0.376	0.568	2.50685479855868e-13	GRK6	Malignant cells	GSE131984_JQ1Pac	ENSG00000198055	2870	G protein-coupled receptor kinase 6	GPRK6	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40529
1.64505711211108e-17	0.267164420272756	0.275	0.117	2.53536202118559e-13	PIK3R3	Malignant cells	GSE131984_JQ1Pac	ENSG00000117461	8503	phosphoinositide-3-kinase regulatory subunit 3	p55	protein_coding	Q92569	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40530
1.74045144309289e-17	-0.349587140734446	0.554	0.723	2.68238376409477e-13	FAM104B	Malignant cells	GSE131984_JQ1Pac	ENSG00000182518	90736	family with sequence similarity 104 member B	CXorf44|FLJ20434	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40531
1.85663083993474e-17	-0.331573391752633	0.299	0.51	2.86143945050742e-13	RFC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000133119	5983	replication factor C subunit 3	MGC5276|RFC38	protein_coding	P40938	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40532
1.91341099000121e-17	-0.356970793247982	0.678	0.81	2.94894901778987e-13	ATP1A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40533
2.05051924096569e-17	-0.36837935558513	0.491	0.666	3.16026025417632e-13	RNF145	Malignant cells	GSE131984_JQ1Pac	ENSG00000145860	153830	ring finger protein 145	FLJ31951	protein_coding	Q96MT1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40534
2.07409972473078e-17	-0.384381190329694	0.754	0.85	3.19660249575508e-13	MTHFD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40535
2.12054465489175e-17	-0.296625564696637	0.154	0.334	3.26818342211916e-13	ICAM3	Malignant cells	GSE131984_JQ1Pac	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40536
2.12228281454134e-17	-0.309193693935475	0.23	0.428	3.27086227377111e-13	CYB561	Malignant cells	GSE131984_JQ1Pac	ENSG00000008283	1534	cytochrome b561	CYB561A1|FRRS2	protein_coding	P49447	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40537
2.16616940983305e-17	-0.377452713599439	0.439	0.628	3.3385002944347e-13	MRPS28	Malignant cells	GSE131984_JQ1Pac	ENSG00000147586	28957	mitochondrial ribosomal protein S28	HSPC007|MRP-S28|MRPS35	protein_coding	Q9Y2Q9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40538
2.17177418331309e-17	-0.366949776195193	0.518	0.679	3.34713837132213e-13	THOC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000125676	57187	THO complex subunit 2	CXorf3|dJ506G2.1|MRX12|MRX35|THO2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40539
2.34822484346969e-17	-0.319451197145698	0.389	0.597	3.61908412875548e-13	INO80E	Malignant cells	GSE131984_JQ1Pac	ENSG00000169592	283899	INO80 complex subunit E	CCDC95|FLJ90652	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40540
2.57758636189115e-17	-0.296732788408384	0.184	0.371	3.97257610094664e-13	MOSPD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000101928	56180	motile sperm domain containing 1	dJ473B4	protein_coding	Q9UJG1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40541
2.70986320380078e-17	-0.295255299856711	0.213	0.408	4.17644116969777e-13	AGAP2-AS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000255737	100130776	AGAP2 antisense RNA 1	LOC100130776|PUNISHER	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40542
2.91067560681334e-17	-0.355528379914553	0.596	0.732	4.48593324522072e-13	MLTK	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40543
3.1462418002339e-17	-0.25846165117428	0.986	0.992	4.84898786252048e-13	HNRNPC	Malignant cells	GSE131984_JQ1Pac	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40544
3.15843860339538e-17	-0.346178736497197	0.47	0.647	4.86778557555295e-13	TSSC4	Malignant cells	GSE131984_JQ1Pac	ENSG00000184281	10078	tumor suppressing subtransferable candidate 4	NA	protein_coding	Q9Y5U2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40545
3.37294946378418e-17	-0.309408878915937	0.204	0.395	5.19838971358418e-13	TRIM47	Malignant cells	GSE131984_JQ1Pac	ENSG00000132481	91107	tripartite motif containing 47	GOA|RNF100	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40546
3.37917519375915e-17	-0.359291030387758	0.782	0.9	5.2079848086216e-13	PRMT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40547
3.50823306430936e-17	-0.293884975115925	0.216	0.412	5.40688879871358e-13	NUDT8	Malignant cells	GSE131984_JQ1Pac	ENSG00000167799	254552	nudix hydrolase 8	FLJ41567	protein_coding	Q8WV74	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40548
4.22410755345456e-17	-0.344515188689508	0.4	0.587	6.51019456138417e-13	WDR43	Malignant cells	GSE131984_JQ1Pac	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40549
4.32984762982396e-17	-0.394438069826245	0.463	0.643	6.67316116708468e-13	UTP11L	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40550
4.41192742334805e-17	-0.297050382731584	0.277	0.482	6.79966254486401e-13	CXorf40B	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40551
4.54380095293766e-17	-0.275429719256664	0.093	0.256	7.00290602866752e-13	MT1F	Malignant cells	GSE131984_JQ1Pac	ENSG00000198417	4494	metallothionein 1F	MT1	protein_coding	P04733	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40552
4.58059471666556e-17	-0.352876738688032	0.389	0.575	7.05961257732495e-13	ARL16	Malignant cells	GSE131984_JQ1Pac	ENSG00000214087	339231	ADP ribosylation factor like GTPase 16	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40553
4.73684718990458e-17	-0.354633846935642	0.305	0.5	7.30042888908093e-13	PPAN	Malignant cells	GSE131984_JQ1Pac	ENSG00000130810	56342	peter pan homolog	BXDC3|SSF|SSF1|SSF2	protein_coding	Q9NQ55	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40554
4.74018620295401e-17	-0.299239642094098	0.229	0.423	7.30557497599272e-13	POLR2D	Malignant cells	GSE131984_JQ1Pac	ENSG00000144231	5433	RNA polymerase II subunit D	RPB4	protein_coding	O15514	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40555
4.94926508145848e-17	0.386818966969379	0.631	0.465	7.62780734354381e-13	PIK3R1	Malignant cells	GSE131984_JQ1Pac	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40556
5.01999007136043e-17	-0.32308860353898	0.644	0.807	7.73680869798069e-13	CENPN	Malignant cells	GSE131984_JQ1Pac	ENSG00000166451	55839	centromere protein N	BM039|C16orf60|FLJ13607|FLJ22660	protein_coding	Q96H22	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40557
5.05879612777327e-17	-0.317605377266397	0.79	0.881	7.79661659212416e-13	UBE2V2	Malignant cells	GSE131984_JQ1Pac	ENSG00000169139	7336	ubiquitin conjugating enzyme E2 V2	DDVit-1|DDVIT1|EDAF-1|EDPF-1|EDPF1|MMS2|UEV-2|UEV2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40558
5.31236695325311e-17	0.353434018492804	0.771	0.616	8.1874199483537e-13	DPYSL2	Malignant cells	GSE131984_JQ1Pac	ENSG00000092964	1808	dihydropyrimidinase like 2	CRMP2|DHPRP2|DRP-2|DRP2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40559
5.33080682392105e-17	-0.31821627728353	0.333	0.532	8.21583947702712e-13	ALG13	Malignant cells	GSE131984_JQ1Pac	ENSG00000101901	79868	ALG13 UDP-N-acetylglucosaminyltransferase subunit	CDG1S|CXorf45|FLJ23018|GLT28D1|MDS031|TDRD13|YGL047W	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40560
5.87452042518405e-17	-0.326015511115025	0.317	0.518	9.05381087929366e-13	MRPS31	Malignant cells	GSE131984_JQ1Pac	ENSG00000102738	10240	mitochondrial ribosomal protein S31	IMOGN38	protein_coding	Q92665	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40561
6.58649836825326e-17	0.298328922763148	0.922	0.814	1.01511112851519e-12	G6PD	Malignant cells	GSE131984_JQ1Pac	ENSG00000160211	2539	glucose-6-phosphate dehydrogenase	G6PD1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40562
6.7303982279016e-17	-0.316100414595974	0.229	0.419	1.03728897488419e-12	CTPS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000171793	1503	CTP synthase 1	CTPS|GATD5A	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40563
7.09242343794387e-17	-0.401341976153891	0.421	0.599	1.09308430025591e-12	ABL2	Malignant cells	GSE131984_JQ1Pac	ENSG00000143322	27	ABL proto-oncogene 2, non-receptor tyrosine kinase	ABLL|ARG	protein_coding	P42684	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40564
7.4099403989086e-17	-0.368647872634216	0.264	0.454	1.14202001427979e-12	TXNRD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000184470	10587	thioredoxin reductase 2	SELZ|TR|TR3|TRXR2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40565
7.41096963639732e-17	-0.313765858671736	0.515	0.688	1.14217864036155e-12	MRPL50	Malignant cells	GSE131984_JQ1Pac	ENSG00000136897	54534	mitochondrial ribosomal protein L50	FLJ20493|MRP-L50	protein_coding	Q8N5N7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40566
7.79865697015363e-17	-0.277197802558727	0.966	0.993	1.20192901224008e-12	TNFRSF12A	Malignant cells	GSE131984_JQ1Pac	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40567
8.34039983170602e-17	-0.328764709158545	0.549	0.725	1.28542242206253e-12	SSBP4	Malignant cells	GSE131984_JQ1Pac	ENSG00000130511	170463	single stranded DNA binding protein 4	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40568
8.36877575364136e-17	-0.350010199008254	0.289	0.487	1.28979571915121e-12	NXT2	Malignant cells	GSE131984_JQ1Pac	ENSG00000101888	55916	nuclear transport factor 2 like export factor 2	P15-2	protein_coding	Q9NPJ8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40569
9.00393147814823e-17	-0.334192413476966	0.649	0.78	1.3876859194122e-12	UBE2J2	Malignant cells	GSE131984_JQ1Pac	ENSG00000160087	118424	ubiquitin conjugating enzyme E2 J2	NCUBE2|Ubc6p	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40570
9.32082276388688e-17	-0.271187539894881	0.21	0.404	1.43652520437025e-12	CMTM7	Malignant cells	GSE131984_JQ1Pac	ENSG00000153551	112616	CKLF like MARVEL transmembrane domain containing 7	CKLFSF7|FLJ30992	protein_coding	Q96FZ5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40571
9.5887144467114e-17	-0.349031704169692	0.33	0.522	1.47781267052716e-12	DCPS	Malignant cells	GSE131984_JQ1Pac	ENSG00000110063	28960	decapping enzyme, scavenger	HINT-5|HINT5|HSL1|HSPC015	protein_coding	Q96C86	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40572
9.67598153959463e-17	-0.34174874803176	0.739	0.832	1.49126227488232e-12	NCBP2-AS2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40573
9.88551595920166e-17	-0.376603070366068	0.672	0.784	1.52355571963216e-12	BAG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000107262	573	BAG cochaperone 1	NA	protein_coding	Q99933	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40574
1.03555519089068e-16	-0.339558757888267	0.341	0.533	1.59599766020072e-12	MCM3	Malignant cells	GSE131984_JQ1Pac	ENSG00000112118	4172	minichromosome maintenance complex component 3	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40575
1.03575411687656e-16	-0.370000109428651	0.44	0.6	1.59630424493016e-12	GRB2	Malignant cells	GSE131984_JQ1Pac	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40576
1.04001568021215e-16	-0.345013684390633	0.477	0.67	1.60287216634297e-12	TMPO	Malignant cells	GSE131984_JQ1Pac	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40577
1.08686740883889e-16	-0.315031467333095	0.227	0.415	1.67508005050249e-12	CXorf38	Malignant cells	GSE131984_JQ1Pac	ENSG00000185753	159013	chromosome X open reading frame 38	MGC39350	protein_coding	Q8TB03	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40578
1.15949224139595e-16	-0.414547731168478	0.361	0.567	1.78700944243943e-12	CENPA	Malignant cells	GSE131984_JQ1Pac	ENSG00000115163	1058	centromere protein A	CenH3|CENP-A	protein_coding	P49450	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40579
1.1726797744566e-16	-0.340861067701692	0.404	0.593	1.80733406839251e-12	FARSB	Malignant cells	GSE131984_JQ1Pac	ENSG00000116120	10056	phenylalanyl-tRNA synthetase subunit beta	FARSLB|FRSB|PheHB	protein_coding	Q9NSD9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40580
1.20734468940628e-16	-0.338173245838682	0.359	0.548	1.86075963531296e-12	RRP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000160214	8568	ribosomal RNA processing 1	D21S2056E|NNP-1|Nop52|RRP1A	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40581
1.28023074340278e-16	-0.338193739612058	0.264	0.453	1.97309162173237e-12	GRB10	Malignant cells	GSE131984_JQ1Pac	ENSG00000106070	2887	growth factor receptor bound protein 10	NA	protein_coding	Q13322	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40582
1.32139398983506e-16	-0.316621175470763	0.246	0.434	2.03653241713379e-12	RRP9	Malignant cells	GSE131984_JQ1Pac	ENSG00000114767	9136	ribosomal RNA processing 9, U3 small nucleolar RNA binding protein	RNU3IP2|U3-55K	protein_coding	O43818	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40583
1.33535519245682e-16	-0.290727885822105	0.159	0.337	2.05804942261444e-12	TRABD2A	Malignant cells	GSE131984_JQ1Pac	ENSG00000186854	129293	TraB domain containing 2A	C2orf89|TIKI1	protein_coding	Q86V40	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40584
1.3859852842592e-16	-0.418973590468961	0.375	0.551	2.13608052010028e-12	NME4	Malignant cells	GSE131984_JQ1Pac	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40585
1.39744049820662e-16	-0.268998889812161	0.14	0.32	2.15373529583604e-12	FAM101B	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40586
1.48305494924445e-16	0.329677634930714	0.897	0.805	2.28568428777555e-12	AKR7A2	Malignant cells	GSE131984_JQ1Pac	ENSG00000053371	8574	aldo-keto reductase family 7 member A2	AFAR	protein_coding	O43488	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40587
1.49032204658926e-16	-0.296222193668832	0.89	0.946	2.29688433820337e-12	SRRM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40588
1.55888512900515e-16	-0.293614140733735	0.253	0.446	2.40255376082274e-12	CYB5R4	Malignant cells	GSE131984_JQ1Pac	ENSG00000065615	51167	cytochrome b5 reductase 4	b5+b5R|dJ676J13.1|NCB5OR	protein_coding	Q7L1T6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40589
1.57740005157594e-16	-0.291201682435155	0.179	0.362	2.43108895948884e-12	PKMYT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000127564	9088	protein kinase, membrane associated tyrosine/threonine 1	MYT1|PPP1R126	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40590
1.5779932373496e-16	-0.349383683038893	0.558	0.707	2.4320031774032e-12	VPS4A	Malignant cells	GSE131984_JQ1Pac	ENSG00000132612	27183	vacuolar protein sorting 4 homolog A	FLJ22197|SKD1|SKD1A|SKD2|VPS4|VPS4-1	protein_coding	Q9UN37	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40591
1.6647936115592e-16	-0.30857066918954	0.865	0.91	2.56577991413504e-12	EIF4E2	Malignant cells	GSE131984_JQ1Pac	ENSG00000135930	9470	eukaryotic translation initiation factor 4E family member 2	4EHP|EIF4EL3|IF4e	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40592
1.6883757268553e-16	-0.293482046767423	0.264	0.455	2.60212467022939e-12	BRCC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000185515	79184	BRCA1/BRCA2-containing complex subunit 3	BRCC36|C6.1A|CXorf53	protein_coding	P46736	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40593
1.71541928827446e-16	-0.343733778586023	0.453	0.633	2.6438042070886e-12	ESRRA	Malignant cells	GSE131984_JQ1Pac	ENSG00000173153	2101	estrogen related receptor alpha	ERR1|ERRa|ERRalpha|ESRL1|NR3B1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40594
1.72363412955906e-16	-0.478619611375291	0.645	0.747	2.65646492047642e-12	PSMD6	Malignant cells	GSE131984_JQ1Pac	ENSG00000163636	9861	proteasome 26S subunit, non-ATPase 6	KIAA0107|p44S10|Rpn7|S10	protein_coding	Q15008	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40595
1.73790289466913e-16	-0.315961086426099	0.314	0.509	2.67845594126406e-12	SNAPC5	Malignant cells	GSE131984_JQ1Pac	ENSG00000174446	10302	small nuclear RNA activating complex polypeptide 5	SNAP19	protein_coding	O75971	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40596
1.74136933326924e-16	-0.317623112885165	0.549	0.708	2.68379841643456e-12	SEC14L1	Malignant cells	GSE131984_JQ1Pac	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40597
1.81918776447107e-16	-0.298505661980082	0.341	0.54	2.80373218260282e-12	TBRG4	Malignant cells	GSE131984_JQ1Pac	ENSG00000136270	9238	transforming growth factor beta regulator 4	Cpr2|FASTKD4|H_TD2522F11.8|KIAA0948	protein_coding	Q969Z0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40598
1.84678872419187e-16	-0.351861412098138	0.454	0.639	2.84627078172452e-12	GEMIN6	Malignant cells	GSE131984_JQ1Pac	ENSG00000152147	79833	gem nuclear organelle associated protein 6	FLJ23459	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40599
1.88011950636455e-16	-0.300837258299511	0.213	0.397	2.89764018320905e-12	C2orf47	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40600
1.89004818235727e-16	-0.339730126124131	0.401	0.586	2.91294225864903e-12	UAP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000117143	6675	UDP-N-acetylglucosamine pyrophosphorylase 1	AgX|AGX1|SPAG2	protein_coding	Q16222	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40601
1.92723550389421e-16	-0.320153465110836	0.849	0.899	2.97025535860176e-12	RBCK1	Malignant cells	GSE131984_JQ1Pac	ENSG00000125826	10616	RANBP2-type and C3HC4-type zinc finger containing 1	C20orf18|HOIL1|RBCK2|RNF54|UBCE7IP3|XAP4|ZRANB4	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40602
1.92976819730565e-16	-0.349858130509008	0.58	0.725	2.97415874568746e-12	MORN2	Malignant cells	GSE131984_JQ1Pac	ENSG00000188010	729967	MORN repeat containing 2	MOPT	protein_coding	Q502X0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40603
1.97197716800323e-16	-0.344716227822378	0.54	0.695	3.03921121132658e-12	SS18L2	Malignant cells	GSE131984_JQ1Pac	ENSG00000008324	51188	SS18 like 2	KIAA-iso	protein_coding	Q9UHA2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40604
2.0081034894354e-16	-0.264258432703441	0.117	0.295	3.09488909791783e-12	AC006262.5	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40605
2.05618431774314e-16	-0.3455442284425	0.35	0.534	3.16899127050573e-12	HSPA4	Malignant cells	GSE131984_JQ1Pac	ENSG00000170606	3308	heat shock protein family A (Hsp70) member 4	HS24/P52|HSPH2	protein_coding	P34932	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40606
2.06003617276011e-16	-0.34536271990537	0.855	0.919	3.17492774945789e-12	XRCC6	Malignant cells	GSE131984_JQ1Pac	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40607
2.08281727412046e-16	0.343608358176167	0.858	0.738	3.21003798287446e-12	TAX1BP3	Malignant cells	GSE131984_JQ1Pac	ENSG00000213977	30851	Tax1 binding protein 3	TIP-1	protein_coding	O14907	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40608
2.12292333591578e-16	-0.259788086034411	0.14	0.314	3.2718494453134e-12	CENPQ	Malignant cells	GSE131984_JQ1Pac	ENSG00000031691	55166	centromere protein Q	C6orf139|CENP-Q|FLJ10545	protein_coding	Q7L2Z9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40609
2.16724117742475e-16	-0.311279464863426	0.868	0.929	3.34015210264703e-12	HNRNPR	Malignant cells	GSE131984_JQ1Pac	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40610
2.20575991098733e-16	-0.352244231180554	0.659	0.778	3.39951717481368e-12	MCFD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000180398	90411	multiple coagulation factor deficiency 2, ER cargo receptor complex subunit	F5F8D|LMAN1IP|SDNSF	protein_coding	Q8NI22	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40611
2.26958501509468e-16	-0.310197188246056	0.249	0.434	3.49788442526392e-12	TMEM185A	Malignant cells	GSE131984_JQ1Pac	ENSG00000269556	84548	transmembrane protein 185A	CXorf13|FAM11A|FRAXF	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40612
2.35436275875332e-16	-0.359272465531792	0.285	0.475	3.62854388379061e-12	NUP37	Malignant cells	GSE131984_JQ1Pac	ENSG00000075188	79023	nucleoporin 37	FLJ22618|MGC5585	protein_coding	Q8NFH4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40613
2.42509511656205e-16	-0.348545213914869	0.757	0.861	3.73755659364543e-12	RNH1	Malignant cells	GSE131984_JQ1Pac	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40614
2.53387288923176e-16	-0.290173839165343	0.969	0.988	3.90520489688399e-12	ATP5C1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40615
2.57545865416669e-16	-0.365989243029815	0.603	0.712	3.96929687780171e-12	HAUS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000152240	115106	HAUS augmin like complex subunit 1	CCDC5|FLJ40084|HEI-C|HsT1461	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40616
2.59044351234004e-16	-0.29122531409808	0.271	0.468	3.99239154121847e-12	WDR46	Malignant cells	GSE131984_JQ1Pac	ENSG00000226916	9277	WD repeat domain 46	BING4|C6orf11|UTP7	protein_coding	O15213	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40617
2.68616866101926e-16	-0.283032662287724	0.176	0.358	4.13992314036289e-12	CCDC51	Malignant cells	GSE131984_JQ1Pac	ENSG00000164051	79714	coiled-coil domain containing 51	FLJ12436	protein_coding	Q96ER9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40618
2.89167070577944e-16	-0.302083742035615	0.753	0.866	4.45664289174727e-12	RNASEH1	Malignant cells	GSE131984_JQ1Pac	ENSG00000171865	246243	ribonuclease H1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40619
2.94159266087282e-16	-0.291158737769087	0.888	0.95	4.53358260893719e-12	YWHAH	Malignant cells	GSE131984_JQ1Pac	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40620
3.06185125891877e-16	-0.34916295170564	0.816	0.895	4.7189251602456e-12	PSMA2.1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40621
3.40878895654014e-16	-0.351384718237099	0.597	0.737	5.25362553981966e-12	POLR3H	Malignant cells	GSE131984_JQ1Pac	ENSG00000100413	171568	RNA polymerase III subunit H	C25|KIAA1665|RPC8	protein_coding	Q9Y535	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40622
3.54919633348071e-16	0.309999021511144	0.527	0.347	5.47002138916047e-12	ESYT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000139641	23344	extended synaptotagmin 1	FAM62A|KIAA0747|MBC2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40623
3.5813008567477e-16	-0.330673739493323	0.834	0.892	5.51950088041956e-12	ETFA	Malignant cells	GSE131984_JQ1Pac	ENSG00000140374	2108	electron transfer flavoprotein subunit alpha	EMA|GA2|MADD	protein_coding	P13804	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40624
3.65270613331859e-16	0.32104178686348	0.935	0.846	5.62955069267061e-12	TMEM256	Malignant cells	GSE131984_JQ1Pac	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40625
3.663131418626e-16	-0.329683506765565	0.4	0.588	5.6456181423864e-12	DEGS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000143753	8560	delta 4-desaturase, sphingolipid 1	DEGS-1|Des-1|DES1|FADS7|MLD	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40626
3.69502242720095e-16	-0.36254748730295	0.372	0.55	5.6947685648021e-12	FTSJ2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40627
3.80839657847362e-16	-0.32131123947592	0.305	0.51	5.86950080674354e-12	DBF4	Malignant cells	GSE131984_JQ1Pac	ENSG00000006634	10926	DBF4 zinc finger	ASK|chif|DBF4A|ZDBF1	protein_coding	Q9UBU7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40628
3.85869011316273e-16	-0.337821948846962	0.434	0.617	5.94701320240639e-12	FARSA	Malignant cells	GSE131984_JQ1Pac	ENSG00000179115	2193	phenylalanyl-tRNA synthetase subunit alpha	CML33|FARSL|FARSLA	protein_coding	Q9Y285	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40629
4.36657622678803e-16	-0.256734544829096	0.171	0.353	6.72976728072571e-12	SLC19A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000173638	6573	solute carrier family 19 member 1	FOLT|RFC1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40630
4.37701254518344e-16	-0.274225187504415	0.907	0.965	6.74585173463672e-12	MKKS	Malignant cells	GSE131984_JQ1Pac	ENSG00000125863	8195	MKKS centrosomal shuttling protein	BBS6|HMCS|KMS|MKS	protein_coding	Q9NPJ1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40631
4.6470689802865e-16	-0.332502872339853	0.762	0.851	7.16206271241755e-12	SUCLG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000163541	8802	succinate-CoA ligase GDP/ADP-forming subunit alpha	NA	protein_coding	P53597	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40632
4.71694044553123e-16	-0.331856743535108	0.334	0.521	7.26974861465274e-12	MAGT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000102158	84061	magnesium transporter 1	DKFZp564K142|IAP|MRX95|OST3B|SLC58A1	protein_coding	Q9H0U3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40633
4.88843381411465e-16	-0.273454236760956	0.952	0.976	7.5340541943135e-12	TPM3	Malignant cells	GSE131984_JQ1Pac	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40634
5.00329810677549e-16	-0.285563454111779	0.869	0.934	7.71108304216238e-12	BAD	Malignant cells	GSE131984_JQ1Pac	ENSG00000002330	572	BCL2 associated agonist of cell death	BBC2|BCL2L8	protein_coding	Q92934	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40635
5.26172297816913e-16	-0.301965515154687	0.807	0.913	8.10936745395426e-12	MRPL40	Malignant cells	GSE131984_JQ1Pac	ENSG00000185608	64976	mitochondrial ribosomal protein L40	MRP-L22|NLVCF	protein_coding	Q9NQ50	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40636
5.67635435023681e-16	-0.408643431638183	0.776	0.846	8.74839732458498e-12	LAPTM4A	Malignant cells	GSE131984_JQ1Pac	ENSG00000068697	9741	lysosomal protein transmembrane 4 alpha	HUMORF13|KIAA0108|LAPTM4|MBNT|Mtrp	protein_coding	Q15012	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40637
5.68052032957896e-16	-0.314167667625981	0.683	0.804	8.75481793194709e-12	PARL	Malignant cells	GSE131984_JQ1Pac	ENSG00000175193	55486	presenilin associated rhomboid like	PRO2207|PSARL|PSARL1|RHBDS1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40638
5.73423371015083e-16	-0.312095551186981	0.286	0.474	8.83760099408447e-12	MIS18A	Malignant cells	GSE131984_JQ1Pac	ENSG00000159055	54069	MIS18 kinetochore protein A	B28|C21orf45|C21orf46|FASP1|hMis18alpha	protein_coding	Q9NYP9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40639
5.91678210350469e-16	0.28388990135564	0.397	0.222	9.11894457792143e-12	MFSD3	Malignant cells	GSE131984_JQ1Pac	ENSG00000167700	113655	major facilitator superfamily domain containing 3	NA	protein_coding	Q96ES6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40640
5.97617056972336e-16	-0.285448948907794	0.215	0.4	9.21047408205765e-12	LINC00511	Malignant cells	GSE131984_JQ1Pac	ENSG00000227036	400619	long intergenic non-protein coding RNA 511	onco-lncRNA-12	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40641
6.03537550387947e-16	-0.299115363925652	0.827	0.89	9.30172072657903e-12	MAP2K2	Malignant cells	GSE131984_JQ1Pac	ENSG00000126934	5605	mitogen-activated protein kinase kinase 2	MEK2|PRKMK2	protein_coding	P36507	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40642
6.46295238910845e-16	-0.300954339335552	0.196	0.375	9.96070222209394e-12	FAM86A	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40643
6.80404399216472e-16	-0.29822454657998	0.233	0.418	1.04863926007243e-11	PUS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000177192	80324	pseudouridine synthase 1	MLASA1	protein_coding	Q9Y606	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40644
7.22871455951791e-16	-0.316888963621367	0.631	0.788	1.1140894879129e-11	SUCLA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000136143	8803	succinate-CoA ligase ADP-forming subunit beta	LINC00444	protein_coding	Q9P2R7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40645
7.27687849319723e-16	-0.319286162107809	0.381	0.575	1.12151251337156e-11	UTP18	Malignant cells	GSE131984_JQ1Pac	ENSG00000011260	51096	UTP18 small subunit processome component	CGI-48|WDR50	protein_coding	Q9Y5J1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40646
7.34267201176151e-16	-0.279248925928538	0.978	0.989	1.13165261045268e-11	NDUFB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40647
7.65626780523065e-16	-0.257506578776097	0.989	0.995	1.17998399414215e-11	RWDD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000111832	51389	RWD domain containing 1	PTD013	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40648
7.70745492976542e-16	-0.318442142580492	0.61	0.767	1.18787295377545e-11	SHISA5	Malignant cells	GSE131984_JQ1Pac	ENSG00000164054	51246	shisa family member 5	hShisa5|SCOTIN	protein_coding	Q8N114	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40649
7.71004579791559e-16	-0.342623048691831	0.194	0.383	1.18827225837475e-11	AKR1C2	Malignant cells	GSE131984_JQ1Pac	ENSG00000151632	1646	aldo-keto reductase family 1 member C2	BABP|DD|DD2|DDH2|HAKRD|MCDR2|TDD	protein_coding	P52895	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40650
7.83128440623489e-16	-0.300340452665769	0.862	0.927	1.20695755268892e-11	BANF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40651
7.97525977989192e-16	-0.340435530732667	0.323	0.51	1.22914703727694e-11	DDX56	Malignant cells	GSE131984_JQ1Pac	ENSG00000136271	54606	DEAD-box helicase 56	NOH61	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40652
8.07769669526352e-16	-0.315089417803572	0.764	0.862	1.24493461467401e-11	IGBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000089289	3476	immunoglobulin binding protein 1	alpha4|IBP1	protein_coding	P78318	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40653
8.56249131967381e-16	-0.320558099629818	0.767	0.855	1.31965116218813e-11	EZR	Malignant cells	GSE131984_JQ1Pac	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40654
8.87143430519862e-16	-0.275530781507469	0.112	0.277	1.36726545511721e-11	KYNU	Malignant cells	GSE131984_JQ1Pac	ENSG00000115919	8942	kynureninase	NA	protein_coding	Q16719	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40655
8.88070486791582e-16	-0.280860564546107	0.244	0.441	1.36869423424319e-11	ASPHD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000174939	253982	aspartate beta-hydroxylase domain containing 1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40656
8.90457195725488e-16	-0.327761102867463	0.3	0.481	1.37237263005212e-11	ETS2	Malignant cells	GSE131984_JQ1Pac	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40657
1.02055148404504e-15	-0.306436739840798	0.383	0.568	1.57287394721021e-11	MRPS18A	Malignant cells	GSE131984_JQ1Pac	ENSG00000096080	55168	mitochondrial ribosomal protein S18A	FLJ10548|MRPS18-3	protein_coding	Q9NVS2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40658
1.04918805346595e-15	-0.253054320373269	0.142	0.313	1.61700862800172e-11	GNB4	Malignant cells	GSE131984_JQ1Pac	ENSG00000114450	59345	G protein subunit beta 4	NA	protein_coding	Q9HAV0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40659
1.05611001930476e-15	-0.329729736505202	0.703	0.809	1.62767676175249e-11	TMEM165	Malignant cells	GSE131984_JQ1Pac	ENSG00000134851	55858	transmembrane protein 165	GDT1|SLC64A1|TMPT27|TPARL	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40660
1.05832386424461e-15	-0.336586853648606	0.414	0.58	1.63108873957379e-11	C8orf33	Malignant cells	GSE131984_JQ1Pac	ENSG00000182307	65265	chromosome 8 open reading frame 33	FLJ20989	protein_coding	Q9H7E9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40661
1.07670839842159e-15	-0.338203619224055	0.801	0.872	1.65942298364735e-11	MLEC	Malignant cells	GSE131984_JQ1Pac	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40662
1.10519205460297e-15	-0.342404718113503	0.404	0.594	1.70332199455409e-11	CENPK	Malignant cells	GSE131984_JQ1Pac	ENSG00000123219	64105	centromere protein K	CENP-K|FKSG14|SOLT	protein_coding	Q9BS16	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40663
1.1335717037785e-15	-0.323150220081618	0.627	0.765	1.74706070986342e-11	APOPT1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40664
1.18726503463548e-15	-0.280481024168614	0.771	0.86	1.82981287138021e-11	LYPLA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000120992	10434	lysophospholipase 1	APT-1|LPL1	protein_coding	O75608	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40665
1.29103291564861e-15	-0.305998684363236	0.184	0.356	1.98973992959764e-11	RPGR	Malignant cells	GSE131984_JQ1Pac	ENSG00000156313	6103	retinitis pigmentosa GTPase regulator	COD1|CORDX1|CRD|RP15|RP3	protein_coding	Q92834	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40666
1.2998397542896e-15	-0.349227212297247	0.339	0.523	2.00331302931114e-11	TYMP	Malignant cells	GSE131984_JQ1Pac	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40667
1.30181183976935e-15	-0.274562204740045	0.143	0.312	2.00635240745253e-11	RELB	Malignant cells	GSE131984_JQ1Pac	ENSG00000104856	5971	RELB proto-oncogene, NF-kB subunit	REL-B	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40668
1.3453734177037e-15	-0.273951502236946	0.23	0.417	2.07348951136494e-11	PDHX	Malignant cells	GSE131984_JQ1Pac	ENSG00000110435	8050	pyruvate dehydrogenase complex component X	DLDBP|E3BP|OPDX|PDX1|proX	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40669
1.49647306218915e-15	-0.324927340119452	0.543	0.698	2.30636428344592e-11	TIPRL	Malignant cells	GSE131984_JQ1Pac	ENSG00000143155	261726	TOR signaling pathway regulator	dJ69E11.3|MGC3794|TIP41|TIPRL1	protein_coding	O75663	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40670
1.51600829377097e-15	-0.30101739947873	0.278	0.466	2.33647198235982e-11	RQCD1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40671
1.52115413526227e-15	-0.333354407543319	0.409	0.593	2.34440275326621e-11	SKP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000145604	6502	S-phase kinase associated protein 2	FBL1|FBXL1|p45	protein_coding	Q13309	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40672
1.57047790638794e-15	-0.304387285728471	0.295	0.479	2.42042054932509e-11	MTMR2	Malignant cells	GSE131984_JQ1Pac	ENSG00000087053	8898	myotubularin related protein 2	CMT4B|KIAA1073	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40673
1.5810888374043e-15	-0.295624209854462	0.233	0.416	2.43677411620751e-11	C16orf80	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40674
1.60436926648028e-15	-0.334946554905127	0.507	0.666	2.47265391349941e-11	TFAM	Malignant cells	GSE131984_JQ1Pac	ENSG00000108064	7019	transcription factor A, mitochondrial	TCF6|TCF6L2	protein_coding	Q00059	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40675
1.60910000212111e-15	-0.521643854871461	0.465	0.658	2.47994492326906e-11	UBE2C	Malignant cells	GSE131984_JQ1Pac	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40676
1.72786448363446e-15	-0.370032105149256	0.437	0.605	2.66298474217743e-11	DCAF13	Malignant cells	GSE131984_JQ1Pac	ENSG00000164934	25879	DDB1 and CUL4 associated factor 13	DKFZP564O0463|Gm83|HSPC064|Sof1|WDSOF1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40677
1.73159540644054e-15	-0.323269676026307	0.415	0.597	2.66873484040616e-11	TRABD	Malignant cells	GSE131984_JQ1Pac	ENSG00000170638	80305	TraB domain containing	PP2447	protein_coding	Q9H4I3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40678
1.75444080742077e-15	-0.336953190740566	0.964	0.985	2.70394417239689e-11	ANXA5	Malignant cells	GSE131984_JQ1Pac	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40679
1.75819151174876e-15	-0.334106483131978	0.384	0.555	2.70972475790719e-11	SNX9	Malignant cells	GSE131984_JQ1Pac	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40680
1.86551505871827e-15	-0.320534708305069	0.495	0.663	2.8751318084966e-11	SLC39A3	Malignant cells	GSE131984_JQ1Pac	ENSG00000141873	29985	solute carrier family 39 member 3	ZIP3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40681
1.89273228574554e-15	-0.304761536384757	0.818	0.892	2.91707899879103e-11	KDELR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40682
1.91150423294463e-15	-0.344055050303308	0.555	0.713	2.94601032381426e-11	TOMM5	Malignant cells	GSE131984_JQ1Pac	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40683
1.93731753434297e-15	-0.270777541235157	0.894	0.93	2.98579378392939e-11	DNAJC19	Malignant cells	GSE131984_JQ1Pac	ENSG00000205981	131118	DnaJ heat shock protein family (Hsp40) member C19	Pam18|Tim14|TIMM14	protein_coding	Q96DA6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40684
1.95217071631159e-15	-0.376052206135232	0.617	0.75	3.00868550797942e-11	SLBP	Malignant cells	GSE131984_JQ1Pac	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40685
1.96527260037124e-15	-0.318361441158504	0.75	0.844	3.02887813169215e-11	PSMD3	Malignant cells	GSE131984_JQ1Pac	ENSG00000108344	5709	proteasome 26S subunit, non-ATPase 3	P58|Rpn3|S3|TSTA2	protein_coding	O43242	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40686
1.99146092885379e-15	0.270246551081201	0.941	0.926	3.06923958354947e-11	FIBP	Malignant cells	GSE131984_JQ1Pac	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40687
2.01841753919e-15	-0.316597231204847	0.387	0.566	3.11078511139963e-11	WDR5	Malignant cells	GSE131984_JQ1Pac	ENSG00000196363	11091	WD repeat domain 5	CFAP89|SWD3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40688
2.10669847283476e-15	-0.310289833384668	0.866	0.925	3.24684368633293e-11	PDLIM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40689
2.20139681818526e-15	-0.339503944871658	0.383	0.561	3.39279277618712e-11	RPP30	Malignant cells	GSE131984_JQ1Pac	ENSG00000148688	10556	ribonuclease P/MRP subunit p30	TSG15	protein_coding	P78346	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40690
2.31033094171076e-15	-0.308510112152173	0.977	0.984	3.56068204736462e-11	CCT8	Malignant cells	GSE131984_JQ1Pac	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40691
2.43531630221438e-15	-0.327467068703043	0.406	0.583	3.7533094849728e-11	AATF	Malignant cells	GSE131984_JQ1Pac	ENSG00000276072	26574	apoptosis antagonizing transcription factor	BFR2|CHE-1|CHE1|DED	protein_coding	Q9NY61	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40692
2.63097086659216e-15	0.412134152812714	0.829	0.733	4.05485229959184e-11	SPARC	Malignant cells	GSE131984_JQ1Pac	ENSG00000113140	6678	secreted protein acidic and cysteine rich	BM-40|ON|ONT	protein_coding	P09486	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40693
2.65774663597284e-15	-0.302075453757184	0.319	0.516	4.09611911536134e-11	RPIA	Malignant cells	GSE131984_JQ1Pac	ENSG00000153574	22934	ribose 5-phosphate isomerase A	NA	protein_coding	P49247	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40694
2.84252440221176e-15	0.377314707910936	0.753	0.647	4.38089860868876e-11	LINC00657	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40695
3.00880624519664e-15	-0.258235872529185	0.18	0.359	4.63717218509707e-11	RP11-879F14.2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40696
3.17982553762112e-15	-0.354574912110949	0.747	0.84	4.90074711858166e-11	BLVRB	Malignant cells	GSE131984_JQ1Pac	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40697
3.22930522645966e-15	-0.312086308019288	0.372	0.543	4.97700521501963e-11	SLC39A6	Malignant cells	GSE131984_JQ1Pac	ENSG00000141424	25800	solute carrier family 39 member 6	LIV-1	protein_coding	Q13433	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40698
3.31503909639863e-15	-0.305719516340623	0.389	0.57	5.10913825536957e-11	TCERG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000113649	10915	transcription elongation regulator 1	CA150|TAF2S|Urn1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40699
3.45520739262418e-15	-0.316736103925741	0.311	0.494	5.32516563351239e-11	CUTC	Malignant cells	GSE131984_JQ1Pac	ENSG00000119929	51076	cutC copper transporter	CGI-32	protein_coding	Q9NTM9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40700
3.69910549060694e-15	-0.289165714426508	0.904	0.936	5.70106138212341e-11	CAST	Malignant cells	GSE131984_JQ1Pac	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40701
3.85660131355061e-15	-0.354087268016095	0.638	0.758	5.9437939444442e-11	ARHGAP18	Malignant cells	GSE131984_JQ1Pac	ENSG00000146376	93663	Rho GTPase activating protein 18	bA307O14.2|MacGAP	protein_coding	Q8N392	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40702
3.87521334821754e-15	-0.304064150590298	0.235	0.414	5.97247881227287e-11	EZH2	Malignant cells	GSE131984_JQ1Pac	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40703
3.87577769214942e-15	-0.334002330104205	0.518	0.663	5.97334857914068e-11	PPIH	Malignant cells	GSE131984_JQ1Pac	ENSG00000171960	10465	peptidylprolyl isomerase H	CYP-20|CYPH|MGC5016|SnuCyp-20|USA-CYP	protein_coding	O43447	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40704
3.92425163815648e-15	-0.32629482924397	0.515	0.672	6.04805662472677e-11	GTPBP4	Malignant cells	GSE131984_JQ1Pac	ENSG00000107937	23560	GTP binding protein 4	CRFG|FLJ10686|FLJ10690|NGB|NOG1	protein_coding	Q9BZE4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40705
3.99975014847284e-15	-0.312749878456521	0.232	0.406	6.16441492882633e-11	PNP	Malignant cells	GSE131984_JQ1Pac	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40706
4.05136295994384e-15	-0.302481953204998	0.734	0.837	6.24396059386544e-11	TRIP6	Malignant cells	GSE131984_JQ1Pac	ENSG00000087077	7205	thyroid hormone receptor interactor 6	MGC10556|MGC10558|MGC29959|MGC3837|MGC4423|OIP1|ZRP-1	protein_coding	Q15654	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40707
4.17535249375544e-15	0.3649028190553	0.582	0.42	6.43505326337588e-11	MIDN	Malignant cells	GSE131984_JQ1Pac	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40708
4.22606660529612e-15	0.302485908782028	0.393	0.23	6.51321385208237e-11	HGSNAT	Malignant cells	GSE131984_JQ1Pac	ENSG00000165102	138050	heparan-alpha-glucosaminide N-acetyltransferase	FLJ32731|HGNAT|TMEM76	protein_coding	Q68CP4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40709
4.33068840172649e-15	-0.325754575107758	0.593	0.733	6.67445696474086e-11	AP2B1	Malignant cells	GSE131984_JQ1Pac	ENSG00000006125	163	adaptor related protein complex 2 subunit beta 1	ADTB2|CLAPB1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40710
4.3335647410285e-15	-0.310792474057166	0.409	0.592	6.67888997887312e-11	EIF2B1	Malignant cells	GSE131984_JQ1Pac	ENSG00000111361	1967	eukaryotic translation initiation factor 2B subunit alpha	EIF-2B|EIF-2Balpha|EIF2B|EIF2BA|EIF2Balpha	protein_coding	Q14232	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40711
4.41160280878357e-15	-0.287637791470474	0.24	0.419	6.79916224889724e-11	C14orf80	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40712
4.57004699914567e-15	-0.344434577572416	0.505	0.661	7.0433564350833e-11	PPP1R2	Malignant cells	GSE131984_JQ1Pac	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40713
4.78978800326633e-15	-0.254274043567666	0.992	0.996	7.38202127063407e-11	YWHAQ	Malignant cells	GSE131984_JQ1Pac	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40714
4.91835734530509e-15	-0.299161057512501	0.266	0.445	7.5801723405842e-11	MPHOSPH6	Malignant cells	GSE131984_JQ1Pac	ENSG00000135698	10200	M-phase phosphoprotein 6	MPP6	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40715
5.5363916951082e-15	-0.270411228879232	0.227	0.408	8.53268688050075e-11	MRPL46	Malignant cells	GSE131984_JQ1Pac	ENSG00000259494	26589	mitochondrial ribosomal protein L46	C15orf4|LIECG2|P2ECSL	protein_coding	Q9H2W6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40716
5.56003971606667e-15	-0.316369465162706	0.459	0.624	8.56913321040195e-11	LEPROTL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40717
5.77712055789809e-15	-0.263846377124055	0.143	0.306	8.90369820383254e-11	PINX1	Malignant cells	GSE131984_JQ1Pac	ENSG00000254093	54984	PIN2 (TERF1) interacting telomerase inhibitor 1	FLJ20565|Gno1|LPTL|LPTS|MGC8850|Pxr1	protein_coding	Q96BK5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40718
5.79560253060834e-15	-0.30140645348041	0.88	0.941	8.93218262017357e-11	EIF3D	Malignant cells	GSE131984_JQ1Pac	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40719
5.82632605710717e-15	-0.31925203930501	0.549	0.696	8.97953371921357e-11	CCDC53	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40720
5.99847485922021e-15	-0.306700928842993	0.373	0.559	9.24484945303019e-11	ORAI1	Malignant cells	GSE131984_JQ1Pac	ENSG00000276045	84876	ORAI calcium release-activated calcium modulator 1	CRACM1|FLJ14466|TMEM142A	protein_coding	Q96D31	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40721
6.26147479162002e-15	-0.335138752310256	0.37	0.551	9.65018494884478e-11	ZNF622	Malignant cells	GSE131984_JQ1Pac	ENSG00000173545	90441	zinc finger protein 622	MGC17552|MGC2485|ZPR9	protein_coding	Q969S3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40722
6.65301773490214e-15	-0.316354999806777	0.327	0.502	1.02536309330312e-10	NIP7	Malignant cells	GSE131984_JQ1Pac	ENSG00000132603	51388	nucleolar pre-rRNA processing protein NIP7	CGI-37|FLJ10296|HSPC031|KD93	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40723
6.75458869342724e-15	-0.315211176021227	0.471	0.635	1.04101720943101e-10	FAM49B	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40724
6.75805406087317e-15	-0.313160410821251	0.353	0.541	1.04155129186177e-10	HAT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000128708	8520	histone acetyltransferase 1	KAT1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40725
6.91618659029979e-15	-0.35436304542553	0.658	0.767	1.065922677297e-10	COPS3	Malignant cells	GSE131984_JQ1Pac	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40726
7.02802465270817e-15	-0.319648488986311	0.238	0.424	1.08315915947538e-10	DEPDC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000024526	55635	DEP domain containing 1	DEP.8|DEPDC1A|FLJ20354|SDP35	protein_coding	Q5TB30	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40727
7.16619838974768e-15	0.355074774423966	0.872	0.713	1.10445449582791e-10	TUBA1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40728
7.24143198460533e-15	0.295840449838258	0.415	0.253	1.11604949746737e-10	SLC48A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000211584	55652	solute carrier family 48 member 1	FLJ20489|hHRG-1|HRG1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40729
7.2939815099514e-15	-0.320643952899732	0.348	0.533	1.12414843031371e-10	GPN3	Malignant cells	GSE131984_JQ1Pac	ENSG00000111231	51184	GPN-loop GTPase 3	ATPBD1C|MGC14560	protein_coding	Q9UHW5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40730
7.60859343293675e-15	-0.300225889413038	0.663	0.794	1.17263641988421e-10	NUDT3	Malignant cells	GSE131984_JQ1Pac	ENSG00000272325	11165	nudix hydrolase 3	DIPP	protein_coding	O95989	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40731
7.67132701794316e-15	-0.333929794017613	0.351	0.515	1.1823049200054e-10	PDCL3	Malignant cells	GSE131984_JQ1Pac	ENSG00000115539	79031	phosducin like 3	VIAF1	protein_coding	Q9H2J4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40732
7.95321134337601e-15	-0.366578942267398	0.361	0.541	1.22574893224111e-10	KNSTRN	Malignant cells	GSE131984_JQ1Pac	ENSG00000128944	90417	kinetochore localized astrin (SPAG5) binding protein	C15orf23|FLJ14502|kinastrin|SKAP|TRAF4AF1	protein_coding	Q9Y448	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40733
8.10861596499871e-15	-0.279983047314923	0.263	0.444	1.2496998925256e-10	BYSL	Malignant cells	GSE131984_JQ1Pac	ENSG00000112578	705	bystin like	Enp1	protein_coding	Q13895	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40734
8.45610203698426e-15	-0.271060098764404	0.194	0.369	1.30325444594001e-10	NFKBIB	Malignant cells	GSE131984_JQ1Pac	ENSG00000282905	4793	NFKB inhibitor beta	IKBB|TRIP9	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40735
8.82087532639005e-15	-0.25471475322118	0.132	0.292	1.35947330530324e-10	RAP2C	Malignant cells	GSE131984_JQ1Pac	ENSG00000123728	57826	RAP2C, member of RAS oncogene family	DKFZp313B211	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40736
9.10905885685156e-15	-0.308790867171888	1	1	1.40388815101796e-10	NPM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40737
9.30390599045417e-15	-0.26165547156572	0.12	0.278	1.4339179912488e-10	ANTXR2	Malignant cells	GSE131984_JQ1Pac	ENSG00000163297	118429	ANTXR cell adhesion molecule 2	CMG-2|CMG2|FLJ31074	protein_coding	P58335	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40738
9.39837646413563e-15	-0.312971013935366	0.538	0.682	1.44847778065258e-10	GIPC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000123159	10755	GIPC PDZ domain containing family member 1	C19orf3|GIPC|GLUT1CBP|Hs.6454|NIP|RGS19IP1|SEMCAP|SYNECTIN|TIP-2	protein_coding	O14908	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40739
9.55625816161748e-15	-0.272288403165092	0.376	0.573	1.47281050786849e-10	HTRA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000115317	27429	HtrA serine peptidase 2	OMI|PARK13|PRSS25	protein_coding	O43464	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40740
9.60086019205197e-15	0.356724029078635	0.768	0.648	1.47968457279905e-10	ACADVL	Malignant cells	GSE131984_JQ1Pac	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40741
9.67234362279134e-15	-0.312660989549755	0.701	0.816	1.4907015991446e-10	SMARCB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40742
9.9316331106914e-15	-0.333556931252012	0.194	0.37	1.53066329501976e-10	NUF2	Malignant cells	GSE131984_JQ1Pac	ENSG00000143228	83540	NUF2 component of NDC80 kinetochore complex	CDCA1|CT106|NUF2R	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40743
1.05059068896617e-14	-0.279934242003932	0.294	0.472	1.61917036983465e-10	RABEPK	Malignant cells	GSE131984_JQ1Pac	ENSG00000136933	10244	Rab9 effector protein with kelch motifs	bA65N13.1|RAB9P40	protein_coding	Q7Z6M1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40744
1.1253284594016e-14	-0.270668824059418	0.255	0.434	1.73435622162975e-10	NGDN	Malignant cells	GSE131984_JQ1Pac	ENSG00000129460	25983	neuroguidin	C14orf120|CANu1|DKFZP564O092|LCP5|lpd-2|NGD	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40745
1.15408867704879e-14	-0.292990909918758	0.597	0.73	1.77868146906759e-10	SIGMAR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000147955	10280	sigma non-opioid intracellular receptor 1	OPRS1|SR-BP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40746
1.19180709383273e-14	-0.309379436059854	0.462	0.63	1.836813093015e-10	FAM192A	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40747
1.37439820701134e-14	-0.335848896548019	0.411	0.577	2.11822251664588e-10	RP6-109B7.3	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40748
1.41427038510039e-14	-0.28655672248404	0.21	0.378	2.17967351751672e-10	RPS6KA3	Malignant cells	GSE131984_JQ1Pac	ENSG00000177189	6197	ribosomal protein S6 kinase A3	CLS|HU-3|MRX19|RSK2	protein_coding	P51812	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40749
1.46101417011649e-14	-0.302730063352073	0.342	0.515	2.25171503898353e-10	CIAPIN1	Malignant cells	GSE131984_JQ1Pac	ENSG00000005194	57019	cytokine induced apoptosis inhibitor 1	CIAE2	protein_coding	Q6FI81	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40750
1.46471694261094e-14	-0.311947131842433	0.714	0.826	2.25742175195199e-10	JAGN1	Malignant cells	GSE131984_JQ1Pac	ENSG00000171135	84522	jagunal homolog 1	FLJ14602|GL009	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40751
1.503131527755e-14	-0.289993084289345	0.285	0.462	2.316626310576e-10	ME2	Malignant cells	GSE131984_JQ1Pac	ENSG00000082212	4200	malic enzyme 2	NA	protein_coding	P23368	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40752
1.50487374054852e-14	-0.340668773711311	0.499	0.641	2.31931140893338e-10	SNW1	Malignant cells	GSE131984_JQ1Pac	ENSG00000100603	22938	SNW domain containing 1	Bx42|FUN20|NCoA-62|Prp45|PRPF45|SKIIP|SKIP|SKIP1	protein_coding	Q13573	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40753
1.51202410956804e-14	-0.326303594327389	0.625	0.737	2.33033155766626e-10	C11orf24	Malignant cells	GSE131984_JQ1Pac	ENSG00000171067	53838	chromosome 11 open reading frame 24	DM4E3	protein_coding	Q96F05	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40754
1.52478533047593e-14	-0.266325428807982	0.176	0.345	2.3499991513295e-10	KIAA0020	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40755
1.54933023891178e-14	-0.265243136903594	0.289	0.479	2.38782776421083e-10	SF3B4	Malignant cells	GSE131984_JQ1Pac	ENSG00000143368	10262	splicing factor 3b subunit 4	Hsh49|SAP49|SF3b49	protein_coding	Q15427	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40756
1.60753394789968e-14	0.261457047832324	0.362	0.2	2.47753132050299e-10	AGRN	Malignant cells	GSE131984_JQ1Pac	ENSG00000188157	375790	agrin	AGRIN	protein_coding	O00468	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40757
1.73401268362327e-14	-0.284952744475205	0.373	0.552	2.67246034800019e-10	ABT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000146109	29777	activator of basal transcription 1	Esf2	protein_coding	Q9ULW3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40758
1.928304495162e-14	0.293913542035049	0.484	0.32	2.97190288794368e-10	GLG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40759
1.96072972444683e-14	-0.325964504104373	0.77	0.847	3.02187665131745e-10	EIF3B	Malignant cells	GSE131984_JQ1Pac	ENSG00000106263	8662	eukaryotic translation initiation factor 3 subunit B	EIF3S9|PRT1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40760
2.03564534312736e-14	-0.328984926847266	0.491	0.635	3.13733660282789e-10	GYG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000163754	2992	glycogenin 1	GYG	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40761
2.0922533282667e-14	-0.325829007974582	0.407	0.575	3.22458082952463e-10	RCC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000180198	1104	regulator of chromosome condensation 1	CHC1	protein_coding	P18754	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40762
2.11064414482755e-14	-0.330577322872745	0.264	0.445	3.25292475600822e-10	SORBS2	Malignant cells	GSE131984_JQ1Pac	ENSG00000154556	8470	sorbin and SH3 domain containing 2	ARGBP2|KIAA0777	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40763
2.1981870482068e-14	-0.321644304679153	0.4	0.575	3.38784587869631e-10	DERL2	Malignant cells	GSE131984_JQ1Pac	ENSG00000072849	51009	derlin 2	CGI-101|derlin-2|F-LAN-1|F-LANa|FLANa	protein_coding	Q9GZP9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40764
2.20869598735422e-14	-0.385812830048919	0.551	0.689	3.40404225571032e-10	AIMP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000106305	7965	aminoacyl tRNA synthetase complex interacting multifunctional protein 2	JTV-1|JTV1|p38|PRO0992	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40765
2.32708267628072e-14	-0.261698670554866	0.323	0.508	3.58649982068385e-10	HDDC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000184508	374659	HD domain containing 3	MESH1|MGC45386	protein_coding	Q8N4P3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40766
2.32974578082455e-14	-0.310205641322682	0.174	0.342	3.5906041974068e-10	ATF3	Malignant cells	GSE131984_JQ1Pac	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40767
2.33283143646655e-14	-0.289744316191619	0.339	0.52	3.59535980988225e-10	RTCA	Malignant cells	GSE131984_JQ1Pac	ENSG00000137996	8634	RNA 3'-terminal phosphate cyclase	RPC|RTC1|RTCD1	protein_coding	O00442	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40768
2.3568895684927e-14	-0.311320684088545	0.776	0.874	3.63243820296095e-10	SLMO2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40769
2.36302111135145e-14	-0.30326974181853	0.344	0.52	3.64188813681485e-10	NSUN5	Malignant cells	GSE131984_JQ1Pac	ENSG00000130305	55695	NOP2/Sun RNA methyltransferase 5	FLJ10267|NOL1R|NSUN5A|p120(NOL1)|WBSCR20|WBSCR20A|Ynl022cL	protein_coding	Q96P11	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40770
2.38288157994704e-14	-0.26698533929703	0.288	0.471	3.67249709101438e-10	DCBLD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000057019	131566	discoidin, CUB and LCCL domain containing 2	CLCP1|ESDN	protein_coding	Q96PD2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40771
2.39583355436398e-14	-0.331269853870132	0.439	0.61	3.69245867398577e-10	C4orf27	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40772
2.5993000989043e-14	-0.262825403695045	0.914	0.958	4.00604131243131e-10	MRPL34	Malignant cells	GSE131984_JQ1Pac	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40773
2.64369348966073e-14	-0.263766314915648	0.456	0.65	4.07446040626512e-10	ITGB3BP	Malignant cells	GSE131984_JQ1Pac	ENSG00000142856	23421	integrin subunit beta 3 binding protein	CENPR|HSU37139|NRIF3|TAP20	protein_coding	Q13352	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40774
2.65556896020324e-14	-0.261425975148915	0.224	0.4	4.09276288146523e-10	PHF6	Malignant cells	GSE131984_JQ1Pac	ENSG00000156531	84295	PHD finger protein 6	BFLS|BORJ|CENP-31|KIAA1823|MGC14797	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40775
2.70858516921925e-14	-0.26782753850745	0.216	0.393	4.17447146280071e-10	CREB5	Malignant cells	GSE131984_JQ1Pac	ENSG00000146592	9586	cAMP responsive element binding protein 5	CRE-BPA|H_GS165L15.1	protein_coding	Q02930	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40776
2.75059700499064e-14	-0.304397581647349	0.801	0.873	4.23922010409158e-10	SNRNP70	Malignant cells	GSE131984_JQ1Pac	ENSG00000104852	6625	small nuclear ribonucleoprotein U1 subunit 70	RNPU1Z|RPU1|Snp1|SNRP70|U1-70K	protein_coding	P08621	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40777
2.80174188673687e-14	-0.295245398974417	0.547	0.717	4.31804459583886e-10	CDC34	Malignant cells	GSE131984_JQ1Pac	ENSG00000099804	997	cell division cycle 34, ubiqiutin conjugating enzyme	E2-CDC34|UBC3|UBE2R1	protein_coding	P49427	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40778
2.82478598149762e-14	-0.289331948089951	0.661	0.801	4.35356015468413e-10	TMEM183A	Malignant cells	GSE131984_JQ1Pac	ENSG00000163444	92703	transmembrane protein 183A	C1orf37	protein_coding	Q8IXX5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40779
2.90638103988975e-14	0.306434537785314	0.639	0.485	4.47931445867808e-10	ADAM15	Malignant cells	GSE131984_JQ1Pac	ENSG00000143537	8751	ADAM metallopeptidase domain 15	MDC15	protein_coding	Q13444	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40780
2.97620026349013e-14	-0.272032100362554	0.205	0.372	4.58691984609099e-10	CD58	Malignant cells	GSE131984_JQ1Pac	ENSG00000116815	965	CD58 molecule	LFA3	protein_coding	P19256	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40781
2.97991269167223e-14	-0.33117657315795	0.516	0.664	4.59264144040524e-10	DRG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000185721	4733	developmentally regulated GTP binding protein 1	NEDD3	protein_coding	Q9Y295	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40782
3.16671434177019e-14	-0.340884028385774	0.442	0.598	4.88054014353621e-10	MPP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000130830	4354	MAGUK p55 scaffold protein 1	DXS552E|PEMP	protein_coding	Q00013	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40783
3.17691462138463e-14	-0.280676336450483	0.855	0.906	4.89626081447799e-10	METTL9	Malignant cells	GSE131984_JQ1Pac	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40784
3.23791659035452e-14	-0.343537627651094	0.571	0.691	4.99027704905439e-10	DIMT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000086189	27292	DIM1 rRNA methyltransferase and ribosome maturation factor	DIMT1L|HSA9761	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40785
3.25438268991556e-14	-0.317783441600671	0.384	0.549	5.01565460169786e-10	PES1	Malignant cells	GSE131984_JQ1Pac	ENSG00000100029	23481	pescadillo ribosomal biogenesis factor 1	NOP7|PES	protein_coding	O00541	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40786
3.27705943782277e-14	-0.318708968645064	0.414	0.567	5.05060400557246e-10	UCHL5	Malignant cells	GSE131984_JQ1Pac	ENSG00000116750	51377	ubiquitin C-terminal hydrolase L5	CGI-70|INO80R|UCH37	protein_coding	Q9Y5K5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40787
3.31024989619654e-14	-0.251119471882557	0.952	0.971	5.1017571400181e-10	ZNHIT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000106400	10467	zinc finger HIT-type containing 1	CG1I|H_DJ0747G18.14|ZNFN4A1	protein_coding	O43257	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40788
3.41988645773401e-14	0.358227316428903	0.418	0.266	5.27072900865966e-10	LINC00936	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40789
3.53963080461892e-14	-0.282927299083348	0.207	0.371	5.45527899607868e-10	FAM122B	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40790
3.60498078837728e-14	-0.291092487157063	0.252	0.42	5.55599639104706e-10	IKBKG	Malignant cells	GSE131984_JQ1Pac	ENSG00000269335	8517	inhibitor of nuclear factor kappa B kinase regulatory subunit gamma	FIP-3|FIP3|Fip3p|IKK-gamma|IKKAP1|IKKG|IP1|IP2|NEMO|ZC2HC9	protein_coding	Q9Y6K9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40791
3.82039476586368e-14	-0.286785291132475	0.4	0.58	5.8879924131491e-10	AKIP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000166452	56672	A-kinase interacting protein 1	BCA3|C11orf17	protein_coding	Q9NQ31	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40792
3.8616933077441e-14	-0.320814249203238	0.826	0.877	5.9516417258952e-10	FAM50A	Malignant cells	GSE131984_JQ1Pac	ENSG00000071859	9130	family with sequence similarity 50 member A	9F|DXS9928E|HXC-26|XAP5	protein_coding	Q14320	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40793
3.86544737354035e-14	-0.314799628003149	0.442	0.601	5.95742749210038e-10	PDS5A	Malignant cells	GSE131984_JQ1Pac	ENSG00000121892	23244	PDS5 cohesin associated factor A	KIAA0648|PIG54|SCC-112	protein_coding	Q29RF7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40794
3.9015917878106e-14	-0.279239428604402	0.224	0.396	6.0131332633737e-10	GMPPA	Malignant cells	GSE131984_JQ1Pac	ENSG00000144591	29926	GDP-mannose pyrophosphorylase A	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40795
3.93497479670618e-14	-0.330947102457209	0.33	0.503	6.06458315668357e-10	USP53	Malignant cells	GSE131984_JQ1Pac	ENSG00000145390	54532	ubiquitin specific peptidase 53	KIAA1350	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40796
3.9654556090558e-14	-0.324806199333338	0.645	0.76	6.1115601846768e-10	SYPL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000008282	6856	synaptophysin like 1	SYPL	protein_coding	Q16563	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40797
4.03140346817121e-14	-0.297252608311992	0.448	0.617	6.21319902514547e-10	THAP4	Malignant cells	GSE131984_JQ1Pac	ENSG00000176946	51078	THAP domain containing 4	CGI-36|Nb(III)	protein_coding	Q8WY91	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40798
4.10224579667105e-14	-0.36184943473155	0.267	0.446	6.32238122182942e-10	AKR1C1	Malignant cells	GSE131984_JQ1Pac	ENSG00000187134	1645	aldo-keto reductase family 1 member C1	DD1|DDH|DDH1|HAKRC|MBAB	protein_coding	Q04828	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40799
4.1075498861911e-14	0.266208305817342	0.966	0.959	6.33055588459773e-10	ENSA	Malignant cells	GSE131984_JQ1Pac	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40800
4.32196625017459e-14	-0.314618984830649	0.325	0.497	6.66101438476908e-10	CA12	Malignant cells	GSE131984_JQ1Pac	ENSG00000074410	771	carbonic anhydrase 12	HsT18816	protein_coding	O43570	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40801
4.48297122482496e-14	-0.289281736660378	0.731	0.808	6.90915525170023e-10	AMZ2	Malignant cells	GSE131984_JQ1Pac	ENSG00000196704	51321	archaelysin family metallopeptidase 2	NA	protein_coding	Q86W34	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40802
4.67161796287052e-14	-0.281728013267342	0.387	0.579	7.19989760437604e-10	VOPP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40803
4.7204608110938e-14	-0.321355855845832	0.547	0.688	7.27517420205777e-10	ISCA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000165898	122961	iron-sulfur cluster assembly 2	HBLD1|ISA2	protein_coding	Q86U28	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40804
4.80239157747408e-14	-0.284373707171054	0.753	0.861	7.40144589920306e-10	RAC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40805
4.8030890156866e-14	-0.337990069809943	0.505	0.636	7.40252079097618e-10	STIP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40806
5.24265707862188e-14	-0.329484785871733	0.56	0.699	8.07998308957204e-10	PSMD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40807
5.25295937631215e-14	-0.289488018698227	0.977	0.993	8.09586099077229e-10	IER3	Malignant cells	GSE131984_JQ1Pac	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40808
5.34391205553249e-14	-0.28981941392474	0.202	0.372	8.23603725998668e-10	ZC3H12A	Malignant cells	GSE131984_JQ1Pac	ENSG00000163874	80149	zinc finger CCCH-type containing 12A	FLJ23231|MCPIP1|Regnase-1	protein_coding	Q5D1E8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40809
5.3655629674466e-14	-0.29224614456105	0.597	0.744	8.2694056454287e-10	COMMD3	Malignant cells	GSE131984_JQ1Pac	ENSG00000148444	23412	COMM domain containing 3	BUP|C10orf8	protein_coding	Q9UBI1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40810
5.37780870856927e-14	0.302739065509159	0.555	0.391	8.28827878164696e-10	SPTAN1	Malignant cells	GSE131984_JQ1Pac	ENSG00000197694	6709	spectrin alpha, non-erythrocytic 1	NA	protein_coding	Q13813	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40811
5.44762024470043e-14	-0.276682551671753	0.325	0.505	8.3958723211323e-10	FXN	Malignant cells	GSE131984_JQ1Pac	ENSG00000165060	2395	frataxin	CyaY|FA|FARR|FRDA|X25	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40812
5.58076509483091e-14	-0.310709278448995	0.577	0.721	8.60107516415339e-10	TMEM126B	Malignant cells	GSE131984_JQ1Pac	ENSG00000171204	55863	transmembrane protein 126B	HT007	protein_coding	Q8IUX1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40813
5.6334760587463e-14	-0.301456932979684	0.68	0.847	8.68231330173979e-10	TYMS	Malignant cells	GSE131984_JQ1Pac	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40814
5.66658640626523e-14	-0.276521505174285	0.171	0.331	8.73334296933597e-10	JMJD6	Malignant cells	GSE131984_JQ1Pac	ENSG00000070495	23210	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	KIAA0585|PTDSR|PTDSR1	protein_coding	Q6NYC1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40815
5.69108585589561e-14	-0.307908927502578	0.771	0.861	8.77110152110631e-10	CCND3	Malignant cells	GSE131984_JQ1Pac	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40816
5.69136592582251e-14	-0.304110758631094	0.607	0.758	8.77153316487765e-10	NSFL1C	Malignant cells	GSE131984_JQ1Pac	ENSG00000088833	55968	NSFL1 cofactor	dJ776F14.1|p47|UBX1|UBXD10|UBXN2C	protein_coding	Q9UNZ2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40817
5.69600858840482e-14	-0.304433034013452	0.563	0.703	8.77868843644951e-10	IMPDH1	Malignant cells	GSE131984_JQ1Pac	ENSG00000106348	3614	inosine monophosphate dehydrogenase 1	LCA11|RP10|sWSS2608	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40818
5.8292059944909e-14	-0.251312034993286	0.989	0.999	8.98397227870937e-10	POLR1D	Malignant cells	GSE131984_JQ1Pac	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40819
5.90741702283755e-14	0.329795181416748	0.46	0.303	9.10451111559724e-10	SPRY2	Malignant cells	GSE131984_JQ1Pac	ENSG00000136158	10253	sprouty RTK signaling antagonist 2	hSPRY2	protein_coding	O43597	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40820
6.20915366038099e-14	-0.356200341241825	0.509	0.651	9.56954762137918e-10	INO80C	Malignant cells	GSE131984_JQ1Pac	ENSG00000153391	125476	INO80 complex subunit C	C18orf37|FLJ38183|hIes6|IES6	protein_coding	Q6PI98	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40821
6.21687315960877e-14	-0.303265455845238	0.403	0.582	9.58144491358903e-10	ACTL6A	Malignant cells	GSE131984_JQ1Pac	ENSG00000136518	86	actin like 6A	Actl6|Arp4|BAF53A|INO80K|SMARCN1	protein_coding	O96019	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40822
6.75273176409749e-14	-0.256663775014452	0.972	0.983	1.04073101948271e-09	RABAC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40823
6.8778127548376e-14	-0.29058811363173	0.378	0.554	1.06000850177557e-09	STAG2	Malignant cells	GSE131984_JQ1Pac	ENSG00000101972	10735	stromal antigen 2	SA-2|SA2|SCC3B	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40824
7.19648450554974e-14	0.306781778082858	0.376	0.222	1.10912219199533e-09	AMOTL2	Malignant cells	GSE131984_JQ1Pac	ENSG00000114019	51421	angiomotin like 2	LCCP	protein_coding	Q9Y2J4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40825
7.67389225616001e-14	-0.276166261063213	0.84	0.923	1.18270027451938e-09	RCN1	Malignant cells	GSE131984_JQ1Pac	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40826
7.721841441424e-14	-0.271435004034547	0.261	0.433	1.19009020295227e-09	UNK	Malignant cells	GSE131984_JQ1Pac	ENSG00000132478	85451	unk zinc finger	KIAA1753|ZC3H5|ZC3HDC5	protein_coding	Q9C0B0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40827
8.07512892795372e-14	-0.280165136014138	0.196	0.365	1.24453887037623e-09	DAB2	Malignant cells	GSE131984_JQ1Pac	ENSG00000153071	1601	DAB adaptor protein 2	DOC-2	protein_coding	P98082	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40828
8.11954775140653e-14	-0.319891652782548	0.445	0.615	1.25138469944677e-09	ATP6V1E1	Malignant cells	GSE131984_JQ1Pac	ENSG00000131100	529	ATPase H+ transporting V1 subunit E1	ATP6E|ATP6E2|ATP6V1E|P31|Vma4	protein_coding	P36543	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40829
8.57194259698642e-14	0.335866312873713	0.479	0.315	1.32110779304755e-09	GAS6	Malignant cells	GSE131984_JQ1Pac	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40830
8.90203671668447e-14	-0.252146671563666	0.188	0.351	1.37198189877541e-09	MIIP	Malignant cells	GSE131984_JQ1Pac	ENSG00000116691	60672	migration and invasion inhibitory protein	FLJ12438|IIp45	protein_coding	Q5JXC2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40831
9.12929773182774e-14	-0.272665000149361	0.311	0.492	1.40700736642929e-09	RPS6KA4	Malignant cells	GSE131984_JQ1Pac	ENSG00000162302	8986	ribosomal protein S6 kinase A4	MSK2|RSK-B	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40832
9.45808349279248e-14	0.270643290859738	0.949	0.906	1.45767982790918e-09	CAMLG	Malignant cells	GSE131984_JQ1Pac	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40833
9.70324044068643e-14	-0.303865894918173	0.691	0.82	1.49546341671859e-09	HLA-B	Malignant cells	GSE131984_JQ1Pac	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40834
9.70915674381589e-14	-0.278211757968114	0.393	0.558	1.4963752373569e-09	ZNF330	Malignant cells	GSE131984_JQ1Pac	ENSG00000109445	27309	zinc finger protein 330	HSA6591|NOA36	protein_coding	Q9Y3S2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40835
9.75603592013475e-14	-0.320269482632681	0.286	0.457	1.50360025601117e-09	ZFAND2A	Malignant cells	GSE131984_JQ1Pac	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40836
9.85693365069717e-14	-0.303510594697571	0.449	0.602	1.51915061424545e-09	NUS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000153989	116150	NUS1 dehydrodolichyl diphosphate synthase subunit	C6orf68|MGC7199|NgBR|TANGO14	protein_coding	Q96E22	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40837
9.91364321188442e-14	-0.312430564985679	0.504	0.651	1.52789069181563e-09	IARS	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40838
1.00331639336675e-13	-0.316861493518882	0.547	0.679	1.54631122545684e-09	WDR45B	Malignant cells	GSE131984_JQ1Pac	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40839
1.00647098705094e-13	-0.444584931723806	0.533	0.661	1.5511730852429e-09	MAGEC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000046774	51438	MAGE family member C2	CT10|HCA587|MAGE-C2|MAGEE1	protein_coding	Q9UBF1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40840
1.0460042563419e-13	-0.28492179133223	0.356	0.534	1.61210175987413e-09	STX4	Malignant cells	GSE131984_JQ1Pac	ENSG00000103496	6810	syntaxin 4	p35-2|STX4A	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40841
1.09845674641078e-13	-0.26272235602688	0.244	0.418	1.6929415375683e-09	HAUS2	Malignant cells	GSE131984_JQ1Pac	ENSG00000137814	55142	HAUS augmin like complex subunit 2	C15orf25|CEP27|FLJ10460|HsT17025	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40842
1.13122203844579e-13	-0.306320849085368	0.675	0.797	1.74343940565265e-09	ASNA1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40843
1.13231537863821e-13	-0.344262049580572	0.563	0.699	1.74512446155722e-09	DPM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000000419	8813	dolichyl-phosphate mannosyltransferase subunit 1, catalytic	CDGIE|MPDS	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40844
1.198632542887e-13	-0.253791430856855	0.173	0.333	1.84733247509745e-09	BCAR3	Malignant cells	GSE131984_JQ1Pac	ENSG00000137936	8412	BCAR3 adaptor protein, NSP family member	AND-34|MIG7|NSP2|SH2D3B	protein_coding	O75815	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40845
1.20298374190394e-13	-0.266678245058099	0.882	0.933	1.85403854302235e-09	PRDX3	Malignant cells	GSE131984_JQ1Pac	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40846
1.20742749661085e-13	-0.306145062419743	0.712	0.817	1.86088725777665e-09	ZNF511	Malignant cells	GSE131984_JQ1Pac	ENSG00000198546	118472	zinc finger protein 511	MGC30006|Zfp511	protein_coding	Q8NB15	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40847
1.2709619299818e-13	-0.30313739401538	0.471	0.628	1.95880652648796e-09	NSMCE4A	Malignant cells	GSE131984_JQ1Pac	ENSG00000107672	54780	NSE4 homolog A, SMC5-SMC6 complex component	bA500G22.3|C10orf86|FLJ20003|NSE4A	protein_coding	Q9NXX6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40848
1.31129709046473e-13	-0.296149166980397	0.367	0.538	2.02097107582424e-09	DYRK4	Malignant cells	GSE131984_JQ1Pac	ENSG00000010219	8798	dual specificity tyrosine phosphorylation regulated kinase 4	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40849
1.34778393124823e-13	-0.289839090048831	0.512	0.674	2.07720459483977e-09	QDPR	Malignant cells	GSE131984_JQ1Pac	ENSG00000151552	5860	quinoid dihydropteridine reductase	DHPR|PKU2|SDR33C1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40850
1.35322649539617e-13	-0.318086378689548	0.306	0.475	2.08559267470458e-09	RFC4	Malignant cells	GSE131984_JQ1Pac	ENSG00000163918	5984	replication factor C subunit 4	A1|RFC37	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40851
1.36933790604342e-13	-0.722552280470104	0.975	0.978	2.11042358079412e-09	HIST1H4C	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40852
1.4033727223443e-13	-0.267728975047896	0.289	0.469	2.16287803967703e-09	FIP1L1	Malignant cells	GSE131984_JQ1Pac	ENSG00000145216	81608	factor interacting with PAPOLA and CPSF1	DKFZp586K0717|FIP1|hFip1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40853
1.40638225058138e-13	-0.271789801880979	0.482	0.66	2.16751632459602e-09	ING2	Malignant cells	GSE131984_JQ1Pac	ENSG00000168556	3622	inhibitor of growth family member 2	ING1L|p33ING2	protein_coding	Q9H160	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40854
1.43728587221404e-13	-0.279569551851559	0.852	0.904	2.21514498625628e-09	CAP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40855
1.49043999243341e-13	0.474044155547966	0.274	0.137	2.29706611633837e-09	AQP3	Malignant cells	GSE131984_JQ1Pac	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40856
1.51640925122305e-13	-0.259009081705621	0.235	0.402	2.33708993798496e-09	CIRH1A	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40857
1.52475427168595e-13	-0.305736552166938	0.793	0.884	2.34995128352238e-09	TMEM50A	Malignant cells	GSE131984_JQ1Pac	ENSG00000183726	23585	transmembrane protein 50A	SMP1	protein_coding	O95807	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40858
1.54595202913413e-13	-0.303435198333051	0.387	0.559	2.38262126730151e-09	CCZ1	Malignant cells	GSE131984_JQ1Pac	ENSG00000122674	51622	CCZ1 homolog, vacuolar protein trafficking and biogenesis associated	C7orf28A|CCZ1A|CGI-43	protein_coding	P86791	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40859
1.63119919542357e-13	-0.260344228031383	0.253	0.431	2.5140041999868e-09	RP11-554I8.2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40860
1.66204673233205e-13	-0.327259911429342	0.502	0.646	2.56154642387016e-09	NDUFA9	Malignant cells	GSE131984_JQ1Pac	ENSG00000139180	4704	NADH:ubiquinone oxidoreductase subunit A9	CI-39k|COQ11|NDUFS2L|SDR22E1	protein_coding	Q16795	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40861
1.73520868815653e-13	-0.255906007973677	0.224	0.391	2.67430363018685e-09	ZCCHC9	Malignant cells	GSE131984_JQ1Pac	ENSG00000131732	84240	zinc finger CCHC-type containing 9	DKFZp761J139|PPP1R41	protein_coding	Q8N567	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40862
1.84212444918627e-13	-0.262153859647368	0.911	0.942	2.83908220108588e-09	LMAN2	Malignant cells	GSE131984_JQ1Pac	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40863
1.84614048434396e-13	-0.284503537153117	0.218	0.385	2.84527171447091e-09	GOT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000120053	2805	glutamic-oxaloacetic transaminase 1	AST|AST1|SGOT	protein_coding	P17174	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40864
1.91839071555586e-13	-0.271248168968032	0.868	0.916	2.95662377081468e-09	CAPZB	Malignant cells	GSE131984_JQ1Pac	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40865
1.97831403872926e-13	-0.267384219034019	0.437	0.615	3.04897759648954e-09	COASY	Malignant cells	GSE131984_JQ1Pac	ENSG00000068120	80347	Coenzyme A synthase	DPCK|NBP|PPAT	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40866
2.09014849770964e-13	-0.261425975148915	0.21	0.377	3.2213368646701e-09	MCM5	Malignant cells	GSE131984_JQ1Pac	ENSG00000100297	4174	minichromosome maintenance complex component 5	CDC46	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40867
2.11596338370682e-13	-0.304155864497914	0.558	0.697	3.26112276696895e-09	RHOG	Malignant cells	GSE131984_JQ1Pac	ENSG00000177105	391	ras homolog family member G	ARHG|MGC125835|MGC125836	protein_coding	P84095	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40868
2.20052237167479e-13	-0.311369602954392	0.7	0.808	3.39144507922519e-09	EWSR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40869
2.21849781299513e-13	-0.250046697487343	0.309	0.488	3.4191488293881e-09	MTFR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000066855	9650	mitochondrial fission regulator 1	CHPPR|FAM54A2|KIAA0009	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40870
2.2197986511569e-13	-0.258879088756352	0.84	0.919	3.42115368116301e-09	MFF	Malignant cells	GSE131984_JQ1Pac	ENSG00000168958	56947	mitochondrial fission factor	C2orf33|GL004	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40871
2.39604716700159e-13	-0.266914583244792	0.291	0.466	3.69278789378286e-09	THOC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000051596	84321	THO complex subunit 3	MGC5469|TEX1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40872
2.43002230400873e-13	-0.341149276871446	0.571	0.695	3.74515037493825e-09	TMEM261	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40873
2.4808706991714e-13	-0.265666590328018	0.208	0.37	3.82351792156296e-09	UTP14A	Malignant cells	GSE131984_JQ1Pac	ENSG00000156697	10813	UTP14A small subunit processome component	NY-CO-16|SDCCAG16|Utp14	protein_coding	Q9BVJ6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40874
2.61636910171409e-13	-0.264355904086921	0.823	0.868	4.03234805956175e-09	RALY	Malignant cells	GSE131984_JQ1Pac	ENSG00000125970	22913	RALY heterogeneous nuclear ribonucleoprotein	HNRPCL2|P542	protein_coding	Q9UKM9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40875
2.67149808525584e-13	-0.277465986413183	0.551	0.696	4.1173128489963e-09	SEC22C	Malignant cells	GSE131984_JQ1Pac	ENSG00000093183	9117	SEC22 homolog C, vesicle trafficking protein	MGC13261|MGC5373|SEC22L3	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40876
2.84685498043618e-13	-0.298959047480822	0.714	0.815	4.38757289584824e-09	RAB5C	Malignant cells	GSE131984_JQ1Pac	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40877
2.89391108267456e-13	-0.278557972115037	0.838	0.897	4.46009576061804e-09	FAM195A	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40878
2.96290572791623e-13	-0.308459131623454	0.731	0.826	4.56643030786449e-09	SRGN	Malignant cells	GSE131984_JQ1Pac	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40879
3.08527503869574e-13	-0.250368546555478	0.918	0.97	4.75502588963787e-09	NDUFA6	Malignant cells	GSE131984_JQ1Pac	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40880
3.13414277083232e-13	-0.310632850348382	0.594	0.727	4.83034083840678e-09	SMC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40881
3.14472923984006e-13	0.286434898780144	0.941	0.877	4.8466567044415e-09	EIF4B	Malignant cells	GSE131984_JQ1Pac	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40882
3.3933338201857e-13	-0.314081579489467	0.512	0.665	5.22980608367021e-09	MRPL16	Malignant cells	GSE131984_JQ1Pac	ENSG00000166902	54948	mitochondrial ribosomal protein L16	FLJ20484|PNAS-111	protein_coding	Q9NX20	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40883
3.42764525327954e-13	-0.269994736982047	0.337	0.513	5.28268686435443e-09	MAFF	Malignant cells	GSE131984_JQ1Pac	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40884
3.43802077598724e-13	-0.253523716652939	0.286	0.465	5.29867761995154e-09	CDC42EP4	Malignant cells	GSE131984_JQ1Pac	ENSG00000179604	23580	CDC42 effector protein 4	BORG4|CEP4|KAIA1777|MGC17125|MGC3740	protein_coding	Q9H3Q1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40885
3.54364058616616e-13	-0.30514867568261	0.546	0.677	5.46145887139928e-09	ZNF259	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40886
3.5537881262776e-13	-0.258066696200559	0.26	0.434	5.47709826021904e-09	WDR12	Malignant cells	GSE131984_JQ1Pac	ENSG00000138442	55759	WD repeat domain 12	FLJ10881|YTM1	protein_coding	Q9GZL7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40887
3.85255580592505e-13	0.354022421400389	0.818	0.719	5.93755900809168e-09	IL18	Malignant cells	GSE131984_JQ1Pac	ENSG00000150782	3606	interleukin 18	IGIF|IL-18|IL-1g|IL1F4	protein_coding	Q14116	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40888
3.86985491227245e-13	-0.276106876523794	0.431	0.611	5.9642203907943e-09	AAMP	Malignant cells	GSE131984_JQ1Pac	ENSG00000127837	14	angio associated migratory cell protein	NA	protein_coding	Q13685	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40889
3.9157591247924e-13	-0.298157317844867	0.448	0.605	6.03496796313005e-09	EXOSC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000171311	51013	exosome component 1	CGI-108|CSL4|Csl4p|hCsl4p|p13|SKI4|Ski4p	protein_coding	Q9Y3B2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40890
3.9666457924618e-13	-0.280529034359742	0.337	0.512	6.11339449534213e-09	PUSL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000169972	126789	pseudouridine synthase like 1	FLJ90811	protein_coding	Q8N0Z8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40891
4.03234878125785e-13	-0.324436852625364	0.401	0.584	6.2146559416746e-09	COL1A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000108821	1277	collagen type I alpha 1 chain	OI4	protein_coding	P02452	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40892
4.08336618853922e-13	-0.273389422409781	0.308	0.474	6.29328396977665e-09	TMEM192	Malignant cells	GSE131984_JQ1Pac	ENSG00000170088	201931	transmembrane protein 192	FLJ38482	protein_coding	Q8IY95	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40893
4.10535687327995e-13	-0.268777405293077	0.328	0.497	6.32717601309905e-09	ACD	Malignant cells	GSE131984_JQ1Pac	ENSG00000102977	65057	ACD shelterin complex subunit and telomerase recruitment factor	Pip1|Ptop|Tint1|Tpp1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40894
4.13299023120872e-13	-0.297450360867337	0.33	0.491	6.36976454433887e-09	ASF1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000111875	25842	anti-silencing function 1A histone chaperone	CIA|DKFZP547E2110	protein_coding	Q9Y294	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40895
4.14811055974927e-13	-0.289478504115162	0.317	0.484	6.39306799468558e-09	JKAMP	Malignant cells	GSE131984_JQ1Pac	ENSG00000050130	51528	JNK1/MAPK8 associated membrane protein	C14orf100|CDA06|HSPC213|HSPC327|JAMP	protein_coding	Q9P055	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40896
4.19384116968557e-13	-0.329347778111378	0.529	0.666	6.46354801071939e-09	MRPS22	Malignant cells	GSE131984_JQ1Pac	ENSG00000175110	56945	mitochondrial ribosomal protein S22	C3orf5|GIBT|GK002|MRP-S22	protein_coding	P82650	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40897
4.28474587594094e-13	-0.288347161438091	0.692	0.801	6.60365034400018e-09	ELAVL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000066044	1994	ELAV like RNA binding protein 1	Hua|HUR|MelG	protein_coding	Q15717	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40898
4.4644740047114e-13	-0.300712330905438	0.378	0.544	6.88064733606121e-09	MRPS9	Malignant cells	GSE131984_JQ1Pac	ENSG00000135972	64965	mitochondrial ribosomal protein S9	MRP-S9|RPMS9|S9mt	protein_coding	P82933	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40899
4.72705938200627e-13	-0.265299170526314	0.17	0.325	7.28534391954806e-09	APOBEC3C	Malignant cells	GSE131984_JQ1Pac	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40900
4.75192757145958e-13	-0.256784223555049	0.448	0.634	7.3236707731335e-09	ERI3	Malignant cells	GSE131984_JQ1Pac	ENSG00000117419	79033	ERI1 exoribonuclease family member 3	FLJ22943|PINT1|PRNPIP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40901
4.91282395502894e-13	-0.267527749357063	0.302	0.469	7.5716442794906e-09	NOL12	Malignant cells	GSE131984_JQ1Pac	ENSG00000273899	79159	nucleolar protein 12	MGC3731|Nop25|RRP17	protein_coding	Q9UGY1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40902
4.91600624666332e-13	-0.308128079691306	0.429	0.593	7.57654882735751e-09	MND1	Malignant cells	GSE131984_JQ1Pac	ENSG00000121211	84057	meiotic nuclear divisions 1	GAJ	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40903
4.92917647512028e-13	-0.49241968868104	0.151	0.291	7.59684678345538e-09	PMAIP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40904
5.01143944137119e-13	-0.324948643000909	0.575	0.722	7.72363046704127e-09	MESDC2	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40905
5.01542696999116e-13	0.321331878401786	0.904	0.797	7.72977604615037e-09	CYBA	Malignant cells	GSE131984_JQ1Pac	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40906
5.03627990112499e-13	-0.29125358721049	0.687	0.808	7.76191458361383e-09	MTIF3	Malignant cells	GSE131984_JQ1Pac	ENSG00000122033	219402	mitochondrial translational initiation factor 3	IF-3mt|IF3(mt)	protein_coding	Q9H2K0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40907
5.32545091038566e-13	-0.289234004996738	0.555	0.714	8.20758494308638e-09	POLE3	Malignant cells	GSE131984_JQ1Pac	ENSG00000148229	54107	DNA polymerase epsilon 3, accessory subunit	CHARAC17|CHRAC17|CHRAC2|p17|Ybl1	protein_coding	Q9NRF9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40908
5.33011118841204e-13	0.270921899408819	0.491	0.329	8.21476736358064e-09	PCYOX1	Malignant cells	GSE131984_JQ1Pac	ENSG00000116005	51449	prenylcysteine oxidase 1	KIAA0908|PCL1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40909
5.37147315654235e-13	-0.296773717514127	0.39	0.549	8.27851442886307e-09	ATIC	Malignant cells	GSE131984_JQ1Pac	ENSG00000138363	471	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	AICARFT|IMPCHASE|PURH	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40910
5.4671538209893e-13	-0.268821892003931	0.238	0.404	8.42597746890871e-09	FAM210A	Malignant cells	GSE131984_JQ1Pac	ENSG00000177150	125228	family with sequence similarity 210 member A	C18orf19|HsT2329|MGC24180	protein_coding	Q96ND0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40911
5.85202493195758e-13	-0.323417050715217	0.953	0.972	9.01914082513303e-09	ATP5F1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40912
5.85999815606235e-13	-0.297033355260682	0.358	0.519	9.0314291581233e-09	PRPSAP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000161542	5635	phosphoribosyl pyrophosphate synthetase associated protein 1	PAP39	protein_coding	Q14558	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40913
5.86177349117549e-13	-0.29159922951563	0.384	0.541	9.03416530459967e-09	FBXO9	Malignant cells	GSE131984_JQ1Pac	ENSG00000112146	26268	F-box protein 9	FBX9|NY-REN-57	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40914
5.90364615322368e-13	-0.308816525579819	0.529	0.666	9.09869945134834e-09	NARF	Malignant cells	GSE131984_JQ1Pac	ENSG00000141562	26502	nuclear prelamin A recognition factor	DKFZp434G0420|FLJ10067|IOP2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40915
5.90453444761772e-13	-0.277465986413183	0.323	0.494	9.10006849066843e-09	RRP15	Malignant cells	GSE131984_JQ1Pac	ENSG00000067533	51018	ribosomal RNA processing 15 homolog	CGI-115|KIAA0507	protein_coding	Q9Y3B9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40916
6.13738541403438e-13	-0.272694113129235	0.795	0.865	9.45893840010979e-09	RNF181	Malignant cells	GSE131984_JQ1Pac	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40917
6.48193878933478e-13	-0.305782794200794	0.414	0.563	9.98996406212277e-09	TMEM33	Malignant cells	GSE131984_JQ1Pac	ENSG00000109133	55161	transmembrane protein 33	FLJ10525|Pom33	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40918
6.54576925952764e-13	0.317583257306876	0.768	0.626	1.0088339582784e-08	GCHFR	Malignant cells	GSE131984_JQ1Pac	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40919
6.612055594993e-13	-0.306866902853742	0.622	0.741	1.01905000830032e-08	AMD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40920
6.81805403073565e-13	-0.281130441116088	0.386	0.554	1.05079848721698e-08	DUSP3	Malignant cells	GSE131984_JQ1Pac	ENSG00000108861	1845	dual specificity phosphatase 3	VHR	protein_coding	P51452	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40921
6.91354720363759e-13	-0.297413395226234	0.75	0.836	1.06551589502463e-08	TMED10	Malignant cells	GSE131984_JQ1Pac	ENSG00000170348	10972	transmembrane p24 trafficking protein 10	p23|P24(DELTA)|p24d1|p24delta1|TMP21	protein_coding	P49755	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40922
6.94110670979576e-13	-0.287293132364938	0.37	0.532	1.06976336611372e-08	MAPK9	Malignant cells	GSE131984_JQ1Pac	ENSG00000050748	5601	mitogen-activated protein kinase 9	JNK2|p54a|PRKM9|SAPK	protein_coding	P45984	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40923
7.2661649173372e-13	-0.29063044561163	0.537	0.679	1.11986133706001e-08	ADK	Malignant cells	GSE131984_JQ1Pac	ENSG00000156110	132	adenosine kinase	AK	protein_coding	P55263	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40924
7.29091025758799e-13	-0.269807899798102	0.258	0.422	1.12367508889946e-08	MOK	Malignant cells	GSE131984_JQ1Pac	ENSG00000080823	5891	MOK protein kinase	RAGE|RAGE1|STK30	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40925
7.63753602280775e-13	0.277984732191429	0.502	0.338	1.17709705183513e-08	C1orf53	Malignant cells	GSE131984_JQ1Pac	ENSG00000203724	388722	chromosome 1 open reading frame 53	NA	protein_coding	Q5VUE5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40926
7.66461817803359e-13	-0.257767261888336	0.26	0.425	1.18127095359854e-08	C1orf174	Malignant cells	GSE131984_JQ1Pac	ENSG00000198912	339448	chromosome 1 open reading frame 174	RP13-531C17.2	protein_coding	Q8IYL3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40927
7.97103201669475e-13	-0.287013969912346	0.149	0.295	1.228495454413e-08	ARHGDIB	Malignant cells	GSE131984_JQ1Pac	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40928
8.05752671994609e-13	-0.324578582251302	0.471	0.627	1.24182601807809e-08	PRC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000198901	9055	protein regulator of cytokinesis 1	ASE1	protein_coding	O43663	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40929
8.08002536503706e-13	-0.290194745917389	0.456	0.615	1.24529350925951e-08	C14orf1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40930
8.40070396465646e-13	-0.258516883612192	0.241	0.408	1.29471649503285e-08	UTP3	Malignant cells	GSE131984_JQ1Pac	ENSG00000132467	57050	UTP3 small subunit processome component	CRLZ1|DKFZp761F222|FLJ23256|SAS10	protein_coding	Q9NQZ2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40931
8.91257859682449e-13	-0.272191044372508	0.361	0.53	1.37360661334259e-08	TPBG	Malignant cells	GSE131984_JQ1Pac	ENSG00000283085	7162	trophoblast glycoprotein	5T4|5T4-AG	protein_coding	Q13641	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40932
9.26165923295602e-13	-0.264149785109495	0.37	0.549	1.42740692098318e-08	TMEM156	Malignant cells	GSE131984_JQ1Pac	ENSG00000121895	80008	transmembrane protein 156	FLJ23235	protein_coding	Q8N614	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40933
9.33066946632241e-13	-0.279386592475696	0.423	0.597	1.43804277814961e-08	IDI1	Malignant cells	GSE131984_JQ1Pac	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40934
1.06054017782151e-12	-0.272930851368848	0.86	0.899	1.63450452205851e-08	CISD2	Malignant cells	GSE131984_JQ1Pac	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40935
1.07071930965708e-12	-0.27013147625451	0.339	0.514	1.65019260004349e-08	GPSM2	Malignant cells	GSE131984_JQ1Pac	ENSG00000121957	29899	G protein signaling modulator 2	DFNB82|LGN|Pins	protein_coding	P81274	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40936
1.14406346883878e-12	-0.274763803490056	0.622	0.751	1.76323061817433e-08	MED28	Malignant cells	GSE131984_JQ1Pac	ENSG00000118579	80306	mediator complex subunit 28	DKFZP434N185|EG1|magicin	protein_coding	Q9H204	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40937
1.24256097139074e-12	0.319060920039254	0.827	0.724	1.91503496910741e-08	PLEC	Malignant cells	GSE131984_JQ1Pac	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40938
1.24781938589285e-12	-0.292631385132851	0.785	0.861	1.92313923753806e-08	BZW2	Malignant cells	GSE131984_JQ1Pac	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40939
1.42306631892581e-12	-0.284977866484254	0.756	0.84	2.19322981072846e-08	ADSL	Malignant cells	GSE131984_JQ1Pac	ENSG00000239900	158	adenylosuccinate lyase	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40940
1.48136091739928e-12	0.320616601604543	0.417	0.272	2.28307344589577e-08	SEMA3C	Malignant cells	GSE131984_JQ1Pac	ENSG00000075223	10512	semaphorin 3C	SEMAE|SemE	protein_coding	Q99985	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40941
1.49319159887276e-12	-0.297660483040484	0.812	0.872	2.3013068921827e-08	IMP3	Malignant cells	GSE131984_JQ1Pac	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40942
1.55064811754692e-12	-0.310430749760969	0.611	0.718	2.38985887876332e-08	UBA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000130985	7317	ubiquitin like modifier activating enzyme 1	A1S9T|CFAP124|GXP1|POC20|UBE1|UBE1X	protein_coding	P22314	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40943
1.59866018070724e-12	-0.284475044932546	0.305	0.475	2.463855070506e-08	CHAF1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000167670	10036	chromatin assembly factor 1 subunit A	CAF-1|CAF1|CAF1B|CAF1P150|MGC71229|P150	protein_coding	Q13111	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40944
1.60443392568118e-12	-0.325251400295174	0.661	0.767	2.47275356625984e-08	ANXA7	Malignant cells	GSE131984_JQ1Pac	ENSG00000138279	310	annexin A7	ANX7	protein_coding	P20073	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40945
1.61225884962501e-12	-0.324069061440215	0.462	0.642	2.48481333904207e-08	TPX2	Malignant cells	GSE131984_JQ1Pac	ENSG00000088325	22974	TPX2 microtubule nucleation factor	C20orf1|C20orf2|DIL-2|FLS353|HCA519|p100	protein_coding	Q9ULW0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40946
1.61474941387228e-12	0.360696080901856	0.477	0.316	2.48865179665996e-08	FOS	Malignant cells	GSE131984_JQ1Pac	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40947
1.65222910118611e-12	-0.298470551362039	0.67	0.777	2.54641549074803e-08	SERPINB6	Malignant cells	GSE131984_JQ1Pac	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40948
1.70148053580246e-12	-0.274744775218053	0.194	0.351	2.62232180177875e-08	SERPINB5	Malignant cells	GSE131984_JQ1Pac	ENSG00000206075	5268	serpin family B member 5	maspin|PI5	protein_coding	P36952	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40949
1.73977320125435e-12	-0.277465986413183	0.294	0.455	2.6813384577732e-08	PYCR2	Malignant cells	GSE131984_JQ1Pac	ENSG00000143811	29920	pyrroline-5-carboxylate reductase 2	P5CR2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40950
1.76835725008288e-12	-0.302981442669616	0.588	0.713	2.72539219382774e-08	RPN1	Malignant cells	GSE131984_JQ1Pac	ENSG00000163902	6184	ribophorin I	OST1	protein_coding	P04843	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40951
1.76986416151569e-12	-0.250498938812913	0.356	0.517	2.72771464572798e-08	FADD	Malignant cells	GSE131984_JQ1Pac	ENSG00000168040	8772	Fas associated via death domain	GIG3|MORT1	protein_coding	Q13158	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40952
1.80756793948276e-12	-0.289007608295874	0.403	0.557	2.78582370833083e-08	WLS	Malignant cells	GSE131984_JQ1Pac	ENSG00000116729	79971	Wnt ligand secretion mediator	C1orf139|EVI|FLJ23091|GPR177|mig-14|MRP	protein_coding	Q5T9L3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40953
1.85045623735364e-12	-0.263202528739127	0.274	0.434	2.85192315300943e-08	MLF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000178053	4291	myeloid leukemia factor 1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40954
1.85890535793905e-12	-0.290512300255328	0.603	0.729	2.86494493765566e-08	PWP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000136045	11137	PWP1 homolog, endonuclein	IEF-SSP-9502	protein_coding	Q13610	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40955
1.85998927671815e-12	-0.331529653538854	0.487	0.619	2.86661547327801e-08	ZNF385D	Malignant cells	GSE131984_JQ1Pac	ENSG00000151789	79750	zinc finger protein 385D	FLJ22419|ZNF659	protein_coding	Q9H6B1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40956
1.87672473204493e-12	-0.278060544443806	0.561	0.696	2.89240815702764e-08	MAPKAP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000119487	79109	MAPK associated protein 1	MGC2745|MIP1|SIN1	protein_coding	Q9BPZ7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40957
1.92330957230293e-12	-0.272707229902047	0.323	0.484	2.96420471283328e-08	SLC7A1	Malignant cells	GSE131984_JQ1Pac	ENSG00000139514	6541	solute carrier family 7 member 1	ATRC1|CAT-1|ERR|HCAT1|REC1L	protein_coding	P30825	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40958
1.9548502427531e-12	-0.290285643924167	0.932	0.97	3.01281519413108e-08	SNHG8	Malignant cells	GSE131984_JQ1Pac	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40959
1.96537704792452e-12	-0.281223705853417	0.594	0.725	3.02903910626126e-08	PUF60	Malignant cells	GSE131984_JQ1Pac	ENSG00000274081	22827	poly(U) binding splicing factor 60	FIR|RoBPI|SIAHBP1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40960
1.99731284733724e-12	0.287541907932329	0.446	0.297	3.07825856031616e-08	HEXIM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000186834	10614	HEXIM P-TEFb complex subunit 1	CLP-1|EDG1|HIS1|MAQ1	protein_coding	O94992	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40961
2.00932442694768e-12	-0.279648581445031	0.607	0.73	3.09677080681177e-08	HTATIP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000109854	10553	HIV-1 Tat interactive protein 2	CC3|FLJ26963|SDR44U1|TIP30	protein_coding	Q9BUP3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40962
2.04702770537626e-12	-0.266890288174992	0.75	0.835	3.15487909952589e-08	CMC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40963
2.0920992293711e-12	-0.271716553648061	0.295	0.455	3.22434333230673e-08	NUP54	Malignant cells	GSE131984_JQ1Pac	ENSG00000138750	53371	nucleoporin 54	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40964
2.12222060153757e-12	-0.274080701228544	0.827	0.872	3.2707663910897e-08	SEC62	Malignant cells	GSE131984_JQ1Pac	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40965
2.13317225532381e-12	-0.293557989828958	0.526	0.667	3.28764507990506e-08	DCTN6	Malignant cells	GSE131984_JQ1Pac	ENSG00000104671	10671	dynactin subunit 6	WS-3	protein_coding	O00399	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40966
2.32068576166906e-12	-0.270086456047585	0.365	0.535	3.57664089588436e-08	SIGIRR	Malignant cells	GSE131984_JQ1Pac	ENSG00000185187	59307	single Ig and TIR domain containing	IL-1R8|TIR8	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40967
2.32876860988325e-12	-0.280749637736843	0.695	0.801	3.58909818155206e-08	ARF6	Malignant cells	GSE131984_JQ1Pac	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40968
2.73253402744046e-12	-0.286071005104582	0.729	0.827	4.21138144309123e-08	MCUR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000050393	63933	mitochondrial calcium uniporter regulator 1	C6orf79|CCDC90A|FLJ20958	protein_coding	Q96AQ8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40969
2.78319969454166e-12	-0.259641506642839	0.392	0.57	4.28946736922761e-08	CFLAR	Malignant cells	GSE131984_JQ1Pac	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40970
2.78846992928555e-12	-0.264906362633938	0.451	0.611	4.29758985501489e-08	SPG20	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40971
2.87483333925765e-12	-0.284349385049076	0.504	0.657	4.43069314246389e-08	YKT6	Malignant cells	GSE131984_JQ1Pac	ENSG00000106636	10652	YKT6 v-SNARE homolog	NA	protein_coding	O15498	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40972
3.0083811473473e-12	-0.252015358756225	0.309	0.478	4.63651702429166e-08	ST3GAL4	Malignant cells	GSE131984_JQ1Pac	ENSG00000110080	6484	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	CGS23|FLJ11867|NANTA3|SAT3|SIAT4|SIAT4C|STZ	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40973
3.11587071517023e-12	-0.433788925244337	0.473	0.63	4.80217994622035e-08	NGFRAP1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40974
3.17604462766367e-12	-0.256826220354146	0.289	0.454	4.89491998015525e-08	CHIC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000109220	26511	cysteine rich hydrophobic domain 2	BTL	protein_coding	Q9UKJ5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40975
3.41443159873051e-12	-0.264097288057038	0.624	0.739	5.26232197996347e-08	FAM32A	Malignant cells	GSE131984_JQ1Pac	ENSG00000105058	26017	family with sequence similarity 32 member A	DKFZP586O0120|OTAG-12	protein_coding	Q9Y421	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40976
3.42810079678212e-12	-0.34204292926648	0.375	0.517	5.2833889480006e-08	CCNH	Malignant cells	GSE131984_JQ1Pac	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40977
3.44227898336731e-12	-0.28189007770863	0.904	0.937	5.3052403691657e-08	MRPL27	Malignant cells	GSE131984_JQ1Pac	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40978
3.49629639671291e-12	-0.268862195421446	0.266	0.432	5.38849200661394e-08	NFKBIZ	Malignant cells	GSE131984_JQ1Pac	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40979
3.56284952462773e-12	-0.317262178834083	0.365	0.525	5.49106368735626e-08	TRMT6	Malignant cells	GSE131984_JQ1Pac	ENSG00000089195	51605	tRNA methyltransferase 6 non-catalytic subunit	CGI-09|GCD10|Gcd10p|MGC5029	protein_coding	Q9UJA5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40980
3.59036985420839e-12	-0.290188247348294	0.51	0.65	5.53347801930598e-08	POP4	Malignant cells	GSE131984_JQ1Pac	ENSG00000105171	10775	POP4 homolog, ribonuclease P/MRP subunit	RPP29	protein_coding	O95707	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40981
3.62692749366747e-12	-0.293001765959212	0.426	0.577	5.58982065324031e-08	KNOP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000103550	400506	lysine rich nucleolar protein 1	101F10.1|C16orf88|FAM191A|TSG118	protein_coding	Q1ED39	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40982
3.67371477053583e-12	-0.252925725988748	0.336	0.5	5.66192920434983e-08	UBE2D1	Malignant cells	GSE131984_JQ1Pac	ENSG00000072401	7321	ubiquitin conjugating enzyme E2 D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UbcH5A	protein_coding	P51668	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40983
3.90443108400913e-12	0.366638091474257	0.649	0.502	6.01750918667488e-08	SOX4	Malignant cells	GSE131984_JQ1Pac	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40984
4.02389126473227e-12	-0.260381831787634	0.213	0.365	6.20162121720538e-08	MSMO1	Malignant cells	GSE131984_JQ1Pac	ENSG00000052802	6307	methylsterol monooxygenase 1	DESP4|ERG25|SC4MOL	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40985
4.29358731016411e-12	-0.290911517478134	0.457	0.606	6.61727676242493e-08	NUDT16	Malignant cells	GSE131984_JQ1Pac	ENSG00000198585	131870	nudix hydrolase 16	FLJ31265	protein_coding	Q96DE0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40986
4.37515708386281e-12	-0.275610429834701	0.723	0.815	6.74299209764936e-08	FAM207A	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40987
4.41335634405471e-12	-0.26289318532591	0.198	0.348	6.80186479745712e-08	RGS17	Malignant cells	GSE131984_JQ1Pac	ENSG00000091844	26575	regulator of G protein signaling 17	RGS-17|RGSZ2	protein_coding	Q9UGC6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40988
4.43183769911219e-12	-0.286938739033465	0.694	0.806	6.83034826187171e-08	GRSF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000132463	2926	G-rich RNA sequence binding factor 1	NA	protein_coding	Q12849	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40989
4.58203757799927e-12	0.278708308570582	0.918	0.844	7.06183631521247e-08	TAF10	Malignant cells	GSE131984_JQ1Pac	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40990
4.70570670922642e-12	-0.266766097755974	0.215	0.368	7.25243518025975e-08	MARS	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40991
4.77272645913031e-12	-0.286477227708151	0.739	0.827	7.35572601881163e-08	ORMDL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000128699	94101	ORMDL sphingolipid biosynthesis regulator 1	NA	protein_coding	Q9P0S3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40992
4.77362803624905e-12	-0.298527601941012	0.751	0.816	7.35711552946703e-08	FUNDC2	Malignant cells	GSE131984_JQ1Pac	ENSG00000165775	65991	FUN14 domain containing 2	DC44|HCBP6	protein_coding	Q9BWH2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40993
4.78670892989899e-12	-0.277904962543418	0.725	0.822	7.37727580276032e-08	RAP1B	Malignant cells	GSE131984_JQ1Pac	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40994
4.90979963142301e-12	-0.31606123172576	0.558	0.682	7.56698319194915e-08	PPP1R7	Malignant cells	GSE131984_JQ1Pac	ENSG00000115685	5510	protein phosphatase 1 regulatory subunit 7	sds22	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40995
5.04681071854772e-12	-0.295258956540037	0.373	0.526	7.77814467942575e-08	DYNC1LI1	Malignant cells	GSE131984_JQ1Pac	ENSG00000144635	51143	dynein cytoplasmic 1 light intermediate chain 1	DNCLI1	protein_coding	Q9Y6G9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40996
5.43334117526406e-12	-0.276520266916263	0.698	0.797	8.37386541931696e-08	RAD23B	Malignant cells	GSE131984_JQ1Pac	ENSG00000119318	5887	RAD23 homolog B, nucleotide excision repair protein	HHR23B|HR23B|P58	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40997
5.73050971742901e-12	-0.315458424721875	0.479	0.626	8.83186157650159e-08	FDFT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40998
5.85173862600353e-12	0.319460130132408	0.83	0.723	9.01869957039664e-08	EIF4A2	Malignant cells	GSE131984_JQ1Pac	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	40999
6.14852887169513e-12	-0.297643868350813	0.593	0.703	9.47611269705653e-08	DARS	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41000
6.36098205795347e-12	-0.282572876846271	0.72	0.812	9.80354554771789e-08	DNAJC7	Malignant cells	GSE131984_JQ1Pac	ENSG00000168259	7266	DnaJ heat shock protein family (Hsp40) member C7	TPR2|TTC2	protein_coding	Q99615	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41001
6.72984570327268e-12	-0.26893259752739	0.801	0.875	1.03720381978838e-07	CTNNAL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000119326	8727	catenin alpha like 1	alpha-CATU|CLLP	protein_coding	Q9UBT7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41002
7.42575920790675e-12	-0.330577322872745	0.549	0.655	1.14445800912259e-07	SARS	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41003
7.64644082827312e-12	-0.260743914234654	0.942	0.983	1.17846946045345e-07	STMN1	Malignant cells	GSE131984_JQ1Pac	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41004
7.66368973437973e-12	-0.349140184546155	0.365	0.51	1.1811278618626e-07	MAD1L1	Malignant cells	GSE131984_JQ1Pac	ENSG00000002822	8379	mitotic arrest deficient 1 like 1	HsMAD1|MAD1|PIG9|TP53I9|TXBP181	protein_coding	Q9Y6D9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41005
7.70262950897026e-12	-0.398944212844774	0.451	0.585	1.1871292599225e-07	HES4	Malignant cells	GSE131984_JQ1Pac	ENSG00000188290	57801	hes family bHLH transcription factor 4	bHLHb42	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41006
8.59668109912017e-12	-0.262327389575261	0.358	0.517	1.3249204909964e-07	LAP3	Malignant cells	GSE131984_JQ1Pac	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41007
9.17910201477624e-12	0.257065736516099	0.407	0.259	1.41468320251731e-07	OPN3	Malignant cells	GSE131984_JQ1Pac	ENSG00000054277	23596	opsin 3	ECPN|encephalopsin|ERO|NMO-1|PPP1R116	protein_coding	Q9H1Y3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41008
9.19823660354307e-12	-0.28365475535957	0.705	0.796	1.41763222533806e-07	ACN9	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41009
9.60077047128362e-12	-0.267144221767404	0.692	0.811	1.47967074503423e-07	BBX	Malignant cells	GSE131984_JQ1Pac	ENSG00000114439	56987	BBX high mobility group box domain containing	HBP2|HSPC339|MDS001	protein_coding	Q8WY36	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41010
9.72680923328261e-12	0.26712533132074	0.488	0.336	1.49909583903352e-07	TP53TG1	Malignant cells	GSE131984_JQ1Pac	ENSG00000182165	NA	NA	H_RG012D21.9|LINC00096|TP53AP1|TP53LC12	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41011
1.00298687273493e-11	-0.316344341559363	0.471	0.605	1.54580336825908e-07	ARL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000120805	400	ADP ribosylation factor like GTPase 1	ARFL1	protein_coding	P40616	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41012
1.00504061808064e-11	-0.263876921665228	0.588	0.728	1.54896860058588e-07	DYNC1I2	Malignant cells	GSE131984_JQ1Pac	ENSG00000077380	1781	dynein cytoplasmic 1 intermediate chain 2	DIC74|DNCI2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41013
1.0359346412389e-11	-0.370182160881486	0.386	0.533	1.5965824690774e-07	SNAPC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000023608	6617	small nuclear RNA activating complex polypeptide 1	PTFgamma|SNAP43	protein_coding	Q16533	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41014
1.0486514966033e-11	0.25440353263039	0.322	0.186	1.616181686565e-07	APPL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000157500	26060	adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1	APPL	protein_coding	Q9UKG1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41015
1.06483459507606e-11	-0.305930266816723	0.471	0.603	1.64112307793122e-07	TMEM11	Malignant cells	GSE131984_JQ1Pac	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41016
1.1549739829358e-11	0.292218209211464	0.591	0.448	1.78004590250065e-07	MGEA5	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41017
1.19843682843369e-11	-0.325049102536602	0.607	0.703	1.847030839982e-07	ADH5	Malignant cells	GSE131984_JQ1Pac	ENSG00000197894	128	alcohol dehydrogenase 5 (class III), chi polypeptide	ADH-3|ADHX|FDH|GSNOR	protein_coding	P11766	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41018
1.23538403324362e-11	-0.269517233297692	0.281	0.442	1.90397387203506e-07	MELK	Malignant cells	GSE131984_JQ1Pac	ENSG00000165304	9833	maternal embryonic leucine zipper kinase	KIAA0175	protein_coding	Q14680	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41019
1.26406971183826e-11	-0.266087678445141	0.456	0.616	1.94818423988513e-07	TMX1	Malignant cells	GSE131984_JQ1Pac	ENSG00000139921	81542	thioredoxin related transmembrane protein 1	PDIA11|TMX|TXNDC|TXNDC1	protein_coding	Q9H3N1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41020
1.27781146446161e-11	-0.28331871265862	0.389	0.54	1.96936302902824e-07	SLC39A7	Malignant cells	GSE131984_JQ1Pac	ENSG00000229802	7922	solute carrier family 39 member 7	D6S2244E|H2-KE4|HKE4|KE4|RING5|ZIP7	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41021
1.32216788412214e-11	-0.300047761130973	0.504	0.645	2.03772514300904e-07	CMAS	Malignant cells	GSE131984_JQ1Pac	ENSG00000111726	55907	cytidine monophosphate N-acetylneuraminic acid synthetase	NA	protein_coding	Q8NFW8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41022
1.32657816474643e-11	-0.279849950118776	0.302	0.454	2.0445222675072e-07	KLF4	Malignant cells	GSE131984_JQ1Pac	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41023
1.3427416866271e-11	-0.254369629938902	0.328	0.487	2.06943348742969e-07	NRAS	Malignant cells	GSE131984_JQ1Pac	ENSG00000213281	4893	NRAS proto-oncogene, GTPase	N-ras	protein_coding	P01111	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41024
1.37070209535556e-11	-0.250199120644189	0.305	0.47	2.11252606936199e-07	SIAH2	Malignant cells	GSE131984_JQ1Pac	ENSG00000181788	6478	siah E3 ubiquitin protein ligase 2	NA	protein_coding	O43255	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41025
1.38083924604269e-11	-0.250902381365294	0.294	0.45	2.12814944600099e-07	ARAF	Malignant cells	GSE131984_JQ1Pac	ENSG00000078061	369	A-Raf proto-oncogene, serine/threonine kinase	ARAF1	protein_coding	P10398	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41026
1.38846408880049e-11	-0.298887241738684	0.627	0.729	2.13990085365932e-07	CCDC107	Malignant cells	GSE131984_JQ1Pac	ENSG00000159884	203260	coiled-coil domain containing 107	MGC31967	protein_coding	Q8WV48	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41027
1.40819682858829e-11	0.255439550923943	0.369	0.224	2.17031295222028e-07	METTL7A	Malignant cells	GSE131984_JQ1Pac	ENSG00000185432	25840	methyltransferase like 7A	DKFZP586A0522	protein_coding	Q9H8H3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41028
1.40891891834724e-11	-0.302587449961367	0.558	0.68	2.17142583695677e-07	IMPAD1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41029
1.4217310561845e-11	-0.257499437494381	0.596	0.73	2.19117190379155e-07	GLRX2	Malignant cells	GSE131984_JQ1Pac	ENSG00000023572	51022	glutaredoxin 2	bA101E13.1|GRX2	protein_coding	Q9NS18	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41030
1.51229783064079e-11	-0.262878450190136	0.389	0.547	2.33075341658358e-07	EID2	Malignant cells	GSE131984_JQ1Pac	ENSG00000176396	163126	EP300 interacting inhibitor of differentiation 2	CRI2|EID-2|MGC20452	protein_coding	Q8N6I1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41031
1.63159646981733e-11	-0.262713487523269	0.731	0.8	2.51461647928246e-07	THRAP3	Malignant cells	GSE131984_JQ1Pac	ENSG00000054118	9967	thyroid hormone receptor associated protein 3	BCLAF2|TRAP150	protein_coding	Q9Y2W1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41032
1.66219873521201e-11	-0.257403646184407	0.571	0.701	2.56178069070875e-07	KRTCAP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41033
1.72359484370436e-11	-0.251192292204074	0.35	0.511	2.65640437311717e-07	ZDHHC6	Malignant cells	GSE131984_JQ1Pac	ENSG00000023041	64429	zinc finger DHHC-type palmitoyltransferase 6	FLJ21952|ZNF376	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41034
1.74297188111501e-11	-0.277465986413183	0.392	0.535	2.68626826317445e-07	DUSP12	Malignant cells	GSE131984_JQ1Pac	ENSG00000081721	11266	dual specificity phosphatase 12	DUSP1|YVH1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41035
1.75095896425404e-11	-0.408854050014479	0.28	0.429	2.69857795570832e-07	CXCL3	Malignant cells	GSE131984_JQ1Pac	ENSG00000163734	2921	C-X-C motif chemokine ligand 3	CINC-2b|GRO3|GROg|MIP-2b|SCYB3	protein_coding	P19876	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41036
1.79947766924289e-11	-0.267911679699934	0.549	0.68	2.77335498383714e-07	MRGBP	Malignant cells	GSE131984_JQ1Pac	ENSG00000101189	55257	MRG domain binding protein	C20orf20|Eaf7|FLJ10914|MRG15BP	protein_coding	Q9NV56	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41037
1.85073861635889e-11	-0.293997199015947	0.911	0.943	2.85235835553232e-07	NT5C3B	Malignant cells	GSE131984_JQ1Pac	ENSG00000141698	115024	5'-nucleotidase, cytosolic IIIB	cN-IIIB|MGC20781|NT5C3L	protein_coding	Q969T7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41038
1.86966399885045e-11	-0.274560255237772	0.386	0.54	2.88152615502831e-07	CCDC28B	Malignant cells	GSE131984_JQ1Pac	ENSG00000160050	79140	coiled-coil domain containing 28B	MGC1203|RP4-622L5.5	protein_coding	Q9BUN5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41039
1.89340527175504e-11	-0.328638638402698	0.551	0.668	2.91811620482887e-07	C19orf33	Malignant cells	GSE131984_JQ1Pac	ENSG00000167644	64073	chromosome 19 open reading frame 33	H2RSP|IMUP|IMUP-1|IMUP-2	protein_coding	Q9GZP8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41040
1.89491084726629e-11	0.252847489520744	0.725	0.586	2.92043659780681e-07	EMP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000134531	2012	epithelial membrane protein 1	CL-20|TMP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41041
2.04512477384356e-11	-0.275155825725982	0.563	0.69	3.15194630144769e-07	SCP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000116171	6342	sterol carrier protein 2	NA	protein_coding	P22307	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41042
2.07187793705679e-11	-0.318079366157112	0.616	0.717	3.19317827659192e-07	SAR1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000079332	56681	secretion associated Ras related GTPase 1A	SAR1|Sara|SARA1	protein_coding	Q9NR31	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41043
2.0943441613205e-11	-0.278678844862833	0.532	0.674	3.22780322142715e-07	SP100	Malignant cells	GSE131984_JQ1Pac	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41044
2.13073570092524e-11	-0.252070395204533	0.25	0.398	3.28388986226598e-07	CNOT11	Malignant cells	GSE131984_JQ1Pac	ENSG00000158435	55571	CCR4-NOT transcription complex subunit 11	C2orf29|C40	protein_coding	Q9UKZ1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41045
2.14409972311343e-11	-0.252671078884812	0.793	0.874	3.30448649326242e-07	HLA-C	Malignant cells	GSE131984_JQ1Pac	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41046
2.15309471387509e-11	0.300154538966806	0.872	0.806	3.31834957302429e-07	PSAP	Malignant cells	GSE131984_JQ1Pac	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41047
2.19817367417286e-11	-0.288256575542104	0.611	0.722	3.38782526663521e-07	CWC27	Malignant cells	GSE131984_JQ1Pac	ENSG00000153015	10283	CWC27 spliceosome associated cyclophilin	NY-CO-10|SDCCAG-10|SDCCAG10	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41048
2.26969293398346e-11	0.276150929201145	0.801	0.693	3.4980507498553e-07	BNIP3L	Malignant cells	GSE131984_JQ1Pac	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41049
2.32349288416634e-11	-0.286377887183071	0.445	0.584	3.58096723307716e-07	UBE2J1	Malignant cells	GSE131984_JQ1Pac	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41050
2.36039889045019e-11	-0.327470531218824	0.641	0.713	3.63784676996183e-07	GPX8	Malignant cells	GSE131984_JQ1Pac	ENSG00000164294	493869	glutathione peroxidase 8 (putative)	EPLA847|UNQ847	protein_coding	Q8TED1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41051
2.48924595864969e-11	-0.273730045505738	0.523	0.652	3.8364258714709e-07	KDSR	Malignant cells	GSE131984_JQ1Pac	ENSG00000119537	2531	3-ketodihydrosphingosine reductase	DHSR|FVT1|SDR35C1	protein_coding	Q06136	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41052
2.53655342209346e-11	-0.27044067494034	0.675	0.77	3.90933613413044e-07	YY1	Malignant cells	GSE131984_JQ1Pac	ENSG00000100811	7528	YY1 transcription factor	DELTA|INO80S|NF-E1|UCRBP|YIN-YANG-1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41053
2.65417409146424e-11	-0.260140567549774	0.677	0.802	4.09061310976468e-07	APH1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000117362	51107	aph-1 homolog A, gamma-secretase subunit	APH-1A|CGI-78	protein_coding	Q96BI3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41054
2.6844681123764e-11	-0.265213725589164	0.344	0.5	4.13730225479451e-07	DNTTIP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41055
2.74015820848725e-11	-0.283866911563605	0.4	0.551	4.22313183092055e-07	MRPL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000169288	65008	mitochondrial ribosomal protein L1	BM022	protein_coding	Q9BYD6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41056
2.83472499224142e-11	-0.362918538377592	0.509	0.655	4.36887815804247e-07	DKK1	Malignant cells	GSE131984_JQ1Pac	ENSG00000107984	22943	dickkopf WNT signaling pathway inhibitor 1	DKK-1|SK	protein_coding	O94907	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41057
3.0788265184109e-11	-0.25563018517271	0.358	0.508	4.74508743017488e-07	TMEM5	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41058
3.19416002543548e-11	-0.262868610200225	0.121	0.251	4.92283943120117e-07	ASNS	Malignant cells	GSE131984_JQ1Pac	ENSG00000070669	440	asparagine synthetase (glutamine-hydrolyzing)	NA	protein_coding	P08243	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41059
3.23336212553168e-11	-0.255361193831178	0.656	0.775	4.98325770786942e-07	NUBP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000095906	10101	NUBP iron-sulfur cluster assembly factor 2, cytosolic	CFD1|CIAO6	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41060
3.25207556783653e-11	-0.271073884503592	0.501	0.632	5.01209886514966e-07	KDM1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000004487	23028	lysine demethylase 1A	AOF2|BHC110|KDM1|KIAA0601|LSD1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41061
3.42548649015548e-11	-0.254175336426963	0.235	0.387	5.27935977862763e-07	CBR3	Malignant cells	GSE131984_JQ1Pac	ENSG00000159231	874	carbonyl reductase 3	SDR21C2	protein_coding	O75828	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41062
3.61000990796489e-11	-0.302922715898923	0.607	0.704	5.56374727015548e-07	SURF2	Malignant cells	GSE131984_JQ1Pac	ENSG00000281024	6835	surfeit 2	NA	protein_coding	Q15527	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41063
3.93863668039012e-11	-0.290698618780409	0.393	0.555	6.07022685181725e-07	HOTAIRM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000233429	NA	NA	HOXA-AS1|HOXA1-AS1|NCRNA00179	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41064
4.37082634112661e-11	-0.251299324431716	0.33	0.484	6.73631755694434e-07	TSR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000167721	55720	TSR1 ribosome maturation factor	FLJ10534	protein_coding	Q2NL82	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41065
4.4748347772125e-11	-0.273470705430336	0.289	0.444	6.8966153586399e-07	CDC6	Malignant cells	GSE131984_JQ1Pac	ENSG00000094804	990	cell division cycle 6	CDC18L	protein_coding	Q99741	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41066
4.63196001209924e-11	-0.304743947608716	0.454	0.576	7.13877677064735e-07	RPF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000117133	80135	ribosome production factor 1 homolog	BXDC5	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41067
4.83533600466352e-11	-0.262854530021159	0.428	0.58	7.45221985038742e-07	KIF9	Malignant cells	GSE131984_JQ1Pac	ENSG00000088727	64147	kinesin family member 9	MGC104186	protein_coding	Q9HAQ2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41068
5.02036679089337e-11	-0.257711752072139	0.471	0.622	7.73738929812487e-07	C12orf44	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41069
5.06399168554294e-11	-0.259784647002627	0.263	0.412	7.80462398575878e-07	SFR1	Malignant cells	GSE131984_JQ1Pac	ENSG00000156384	119392	SWI5 dependent homologous recombination repair protein 1	bA373N18.1|C10orf78|FLJ41960|MEI5|MEIR5	protein_coding	Q86XK3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41070
5.16239882846827e-11	0.293886082789321	0.807	0.709	7.9562890744353e-07	SAT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41071
5.67041215392292e-11	-0.251835943719214	0.53	0.674	8.739239211626e-07	BAZ1B	Malignant cells	GSE131984_JQ1Pac	ENSG00000009954	9031	bromodomain adjacent to zinc finger domain 1B	WBSCR10|WBSCR9|WSTF	protein_coding	Q9UIG0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41072
5.74090663396407e-11	-0.26054466832758	0.449	0.596	8.84788530426542e-07	RILPL2	Malignant cells	GSE131984_JQ1Pac	ENSG00000150977	196383	Rab interacting lysosomal protein like 2	FLJ30380|FLJ32372|MGC7036	protein_coding	Q969X0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41073
6.07942318710856e-11	-0.266113181597636	0.49	0.634	9.36960701597171e-07	RNASEH2A	Malignant cells	GSE131984_JQ1Pac	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41074
6.14958079546727e-11	-0.251957453248634	0.327	0.488	9.47773392197416e-07	ASF1B	Malignant cells	GSE131984_JQ1Pac	ENSG00000288210	55723	anti-silencing function 1B histone chaperone	FLJ10604	protein_coding	Q9NVP2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41075
6.22762890792876e-11	-0.267709769751038	0.561	0.679	9.5980216728998e-07	GTF2E2	Malignant cells	GSE131984_JQ1Pac	ENSG00000197265	2961	general transcription factor IIE subunit 2	FE|TF2E2|TFIIE-B	protein_coding	P29084	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41076
6.86758416250654e-11	-0.267158812630386	0.529	0.676	1.05843207112551e-06	NTAN1	Malignant cells	GSE131984_JQ1Pac	ENSG00000275779	123803	N-terminal asparagine amidase	NA	protein_coding	Q96AB6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41077
6.88078708080941e-11	-0.308878939044644	0.468	0.601	1.06046690489435e-06	ATP6AP2	Malignant cells	GSE131984_JQ1Pac	ENSG00000182220	10159	ATPase H+ transporting accessory protein 2	APT6M8-9|ATP6IP2|ATP6M8-9|M8-9|PRR|RENR	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41078
6.88667463188559e-11	-0.250215952004982	0.355	0.508	1.06137429426621e-06	TM2D1	Malignant cells	GSE131984_JQ1Pac	ENSG00000162604	83941	TM2 domain containing 1	BBP	protein_coding	Q9BX74	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41079
6.94947017652741e-11	-0.294080700264079	0.425	0.568	1.0710523436064e-06	CEBPG	Malignant cells	GSE131984_JQ1Pac	ENSG00000153879	1054	CCAAT enhancer binding protein gamma	GPE1BP|IG/EBP-1	protein_coding	P53567	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41080
7.01349397637441e-11	-0.25022940213938	0.322	0.474	1.08091969163882e-06	PPP1R35	Malignant cells	GSE131984_JQ1Pac	ENSG00000160813	221908	protein phosphatase 1 regulatory subunit 35	C7orf47|MGC22793	protein_coding	Q8TAP8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41081
7.10280175154082e-11	-0.393222714643038	0.322	0.479	1.09468380594747e-06	CDK1	Malignant cells	GSE131984_JQ1Pac	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41082
7.31098997831748e-11	-0.257908140022382	0.737	0.824	1.12676977545829e-06	SKA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000182628	348235	spindle and kinetochore associated complex subunit 2	FAM33A|FLJ12758	protein_coding	Q8WVK7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41083
7.53284578376228e-11	-0.257125538129007	0.575	0.704	1.16096219219344e-06	TMEM203	Malignant cells	GSE131984_JQ1Pac	ENSG00000187713	94107	transmembrane protein 203	HBEBP1|MGC14327	protein_coding	Q969S6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41084
7.74054711039751e-11	-0.270789038768774	0.717	0.798	1.19297312065446e-06	EIF2A	Malignant cells	GSE131984_JQ1Pac	ENSG00000144895	83939	eukaryotic translation initiation factor 2A	EIF-2A	protein_coding	Q9BY44	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41085
8.2452178976809e-11	-0.256512336837949	0.541	0.671	1.27075298239058e-06	CERS2	Malignant cells	GSE131984_JQ1Pac	ENSG00000143418	29956	ceramide synthase 2	FLJ10243|LASS2|SP260	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41086
8.5570333038775e-11	-0.284319657454245	0.636	0.748	1.3188099727936e-06	TEX264	Malignant cells	GSE131984_JQ1Pac	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41087
8.66120482489797e-11	-0.259971247179541	0.535	0.669	1.33486488761327e-06	KCMF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000176407	56888	potassium channel modulatory factor 1	DEBT91|DKFZP434L1021|PCMF|ZZZ1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41088
8.67114761168066e-11	-0.267907157988338	0.437	0.582	1.33639726991222e-06	PCID2	Malignant cells	GSE131984_JQ1Pac	ENSG00000126226	55795	PCI domain containing 2	FLJ11305	protein_coding	Q5JVF3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41089
8.97608365116684e-11	-0.26680891087389	0.872	0.909	1.38339401231783e-06	EIF2S3	Malignant cells	GSE131984_JQ1Pac	ENSG00000130741	1968	eukaryotic translation initiation factor 2 subunit gamma	EIF2|EIF2G|EIF2gamma	protein_coding	P41091	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41090
9.18367716698332e-11	-0.256333174150279	0.291	0.442	1.41538832497547e-06	ACSL4	Malignant cells	GSE131984_JQ1Pac	ENSG00000068366	2182	acyl-CoA synthetase long chain family member 4	ACS4|FACL4|LACS4|MRX63|MRX68	protein_coding	O60488	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41091
9.47949537509464e-11	-0.27258202526303	0.879	0.953	1.46097982720959e-06	DUSP23	Malignant cells	GSE131984_JQ1Pac	ENSG00000158716	54935	dual specificity phosphatase 23	DUSP25|FLJ20442	protein_coding	Q9BVJ7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41092
9.71796882323825e-11	-0.305542083476963	0.888	0.932	1.49773335503748e-06	MANF	Malignant cells	GSE131984_JQ1Pac	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41093
9.84467234780286e-11	-0.257386644507207	0.852	0.906	1.51726090224338e-06	EIF3A	Malignant cells	GSE131984_JQ1Pac	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41094
9.86116619044671e-11	-0.256380692004044	0.32	0.464	1.51980293327165e-06	GOLT1B	Malignant cells	GSE131984_JQ1Pac	ENSG00000111711	51026	golgi transport 1B	CGI-141|GOT1|YMR292W	protein_coding	Q9Y3E0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41095
1.04557279082067e-10	-0.289105901969057	0.507	0.627	1.61143678521282e-06	FAM104A	Malignant cells	GSE131984_JQ1Pac	ENSG00000133193	84923	family with sequence similarity 104 member A	FLJ14775	protein_coding	Q969W3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41096
1.08768752064998e-10	-0.264199731639309	0.631	0.728	1.67634400682575e-06	SMIM20	Malignant cells	GSE131984_JQ1Pac	ENSG00000250317	389203	small integral membrane protein 20	C4orf52|MITRAC7|PNX	protein_coding	Q8N5G0	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41097
1.12916741464744e-10	0.482607074753532	0.557	0.431	1.74027281945463e-06	IGFBP7	Malignant cells	GSE131984_JQ1Pac	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41098
1.13530865342449e-10	0.289316498242953	0.533	0.411	1.74973769665783e-06	JUND	Malignant cells	GSE131984_JQ1Pac	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41099
1.15606165410086e-10	-0.263056307059907	0.641	0.744	1.78172222130024e-06	FUCA2	Malignant cells	GSE131984_JQ1Pac	ENSG00000001036	2519	alpha-L-fucosidase 2	dJ20N2.5|MGC1314	protein_coding	Q9BTY2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41100
1.21458246311792e-10	-0.273979409440485	0.672	0.759	1.87191449215733e-06	DDX3X	Malignant cells	GSE131984_JQ1Pac	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41101
1.32254163335036e-10	-0.260330074099153	0.471	0.615	2.03830116531958e-06	APIP	Malignant cells	GSE131984_JQ1Pac	ENSG00000149089	51074	APAF1 interacting protein	APIP2|CGI-29|Mmrp19	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41102
1.34779004857785e-10	-0.29676849870009	0.537	0.656	2.07721402286819e-06	TRMT10C	Malignant cells	GSE131984_JQ1Pac	ENSG00000174173	54931	tRNA methyltransferase 10C, mitochondrial RNase P subunit	FLJ20432|MRPP1|RG9MTD1	protein_coding	Q7L0Y3	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41103
1.46784470452185e-10	0.315828887482533	0.936	0.9	2.26224225860907e-06	MYH9	Malignant cells	GSE131984_JQ1Pac	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41104
1.51182501529628e-10	-0.259864771255542	0.585	0.692	2.33002471357462e-06	DCTD	Malignant cells	GSE131984_JQ1Pac	ENSG00000129187	1635	dCMP deaminase	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41105
1.5131396937468e-10	-0.270212041317772	0.597	0.701	2.33205089600256e-06	FRA10AC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000148690	118924	FRA10A associated CGG repeat 1	C10orf4	protein_coding	Q70Z53	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41106
1.55063733533557e-10	-0.250295785247712	0.356	0.507	2.38984226121919e-06	ABCF2	Malignant cells	GSE131984_JQ1Pac	ENSG00000033050	10061	ATP binding cassette subfamily F member 2	ABC28|EST133090|HUSSY-18|M-ABC1	protein_coding	Q9UG63	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41107
1.55553692676606e-10	-0.263094804636715	0.291	0.443	2.39739351153186e-06	KIF22	Malignant cells	GSE131984_JQ1Pac	ENSG00000079616	3835	kinesin family member 22	Kid|KNSL4|OBP-1|OBP-2	protein_coding	Q14807	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41108
1.64873600678741e-10	-0.255737112316149	0.375	0.516	2.54103193366076e-06	USB1	Malignant cells	GSE131984_JQ1Pac	ENSG00000103005	79650	U6 snRNA biogenesis phosphodiesterase 1	C16orf57|FLJ13154|HVSL1|Mpn1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41109
1.70339432810201e-10	-0.255741215258467	0.476	0.625	2.62527133847082e-06	TTC1	Malignant cells	GSE131984_JQ1Pac	ENSG00000113312	7265	tetratricopeptide repeat domain 1	TPR1	protein_coding	Q99614	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41110
1.80454351574672e-10	-0.258293677138337	0.32	0.464	2.78116246646885e-06	GNPDA1	Malignant cells	GSE131984_JQ1Pac	ENSG00000113552	10007	glucosamine-6-phosphate deaminase 1	GNPDA|GNPI|GPI|HLN|KIAA0060	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41111
2.21036980840082e-10	-0.252627876936191	0.498	0.648	3.40662194870735e-06	CENPM	Malignant cells	GSE131984_JQ1Pac	ENSG00000100162	79019	centromere protein M	C22orf18|CENP-M|MGC861|Pane1	protein_coding	Q9NSP4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41112
2.39451479755959e-10	-0.28607911671789	0.403	0.534	3.69042620599884e-06	AC010642.1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41113
2.46696286066992e-10	-0.254460456002019	0.868	0.896	3.80208316086448e-06	SF3B2	Malignant cells	GSE131984_JQ1Pac	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41114
2.51603485495963e-10	-0.257824750085068	0.754	0.834	3.87771291846378e-06	SLTM	Malignant cells	GSE131984_JQ1Pac	ENSG00000137776	79811	SAFB like transcription modulator	FLJ13213|Met	protein_coding	Q9NWH9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41115
2.64077700037679e-10	-0.269892766708382	0.495	0.629	4.06996551298071e-06	OPTN	Malignant cells	GSE131984_JQ1Pac	ENSG00000123240	10133	optineurin	FIP-2|FIP2|GLC1E|HIP7|HYPL|NRP|TFIIIA-INTP	protein_coding	Q96CV9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41116
2.6759844584889e-10	-0.256065351957488	0.742	0.811	4.1242272474231e-06	TRAPPC2L	Malignant cells	GSE131984_JQ1Pac	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41117
2.68987205788518e-10	-0.250539205501192	0.583	0.727	4.14563081561264e-06	IFNGR2	Malignant cells	GSE131984_JQ1Pac	ENSG00000262795	3460	interferon gamma receptor 2	AF-1|IFNGT1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41118
2.70906863279601e-10	-0.321414237782523	0.677	0.756	4.17521657686521e-06	PPP1R15A	Malignant cells	GSE131984_JQ1Pac	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41119
2.8095370618819e-10	-0.254302953793865	0.272	0.417	4.33005851977238e-06	SHCBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000171241	79801	SHC binding and spindle associated 1	FLJ22009|PAL	protein_coding	Q8NEM2	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41120
2.8631365119119e-10	0.256314703542039	0.572	0.436	4.41266599215862e-06	PRKCSH	Malignant cells	GSE131984_JQ1Pac	ENSG00000130175	5589	protein kinase C substrate 80K-H	G19P1|GIIB|PCLD|PLD1|VASAP-60	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41121
2.93385665689219e-10	0.2643286551516	0.524	0.397	4.52165987960224e-06	PLD3	Malignant cells	GSE131984_JQ1Pac	ENSG00000105223	23646	phospholipase D family member 3	HU-K4	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41122
3.0795991403628e-10	-0.25547804657099	0.513	0.647	4.74627819512714e-06	KLHDC3	Malignant cells	GSE131984_JQ1Pac	ENSG00000124702	116138	kelch domain containing 3	dJ20C7.3|hPeas|PEAS	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41123
3.17474058118286e-10	0.284688304375247	1	1	4.89291018371902e-06	ALDOA	Malignant cells	GSE131984_JQ1Pac	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41124
3.21905476920067e-10	-0.280768609086026	0.614	0.705	4.96120721029207e-06	CETN2	Malignant cells	GSE131984_JQ1Pac	ENSG00000147400	1069	centrin 2	CALT|CEN2	protein_coding	P41208	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41125
3.27233764418213e-10	-0.265445313227596	0.748	0.815	5.04332677721349e-06	GTPBP6	Malignant cells	GSE131984_JQ1Pac	ENSG00000178605	8225	GTP binding protein 6 (putative)	FLJ20977|PGPL	protein_coding	O43824	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41126
3.62978400423618e-10	-0.263850614555684	0.645	0.74	5.5942231073288e-06	ARPP19	Malignant cells	GSE131984_JQ1Pac	ENSG00000128989	10776	cAMP regulated phosphoprotein 19	ARPP-16|ARPP-19|ARPP16|ENSAL	protein_coding	P56211	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41127
3.6479083121039e-10	-0.25817583649868	0.543	0.662	5.62215629061452e-06	BRD7	Malignant cells	GSE131984_JQ1Pac	ENSG00000166164	29117	bromodomain containing 7	BP75|CELTIX1|SMARCI1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41128
3.77247415399316e-10	-0.255641625078039	0.468	0.614	5.81413716613426e-06	LARS	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41129
3.82766628278658e-10	0.374247904923585	0.714	0.566	5.89919927503067e-06	SPANXD	Malignant cells	GSE131984_JQ1Pac	ENSG00000196406	64648	SPANX family member D	CT11.4|SPANXE	protein_coding	Q9BXN6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41130
4.27162901038999e-10	-0.252767742511973	0.423	0.566	6.58343463081306e-06	ANKRD39	Malignant cells	GSE131984_JQ1Pac	ENSG00000213337	51239	ankyrin repeat domain 39	MGC41816	protein_coding	Q53RE8	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41131
4.67101928915726e-10	0.295729825332012	0.743	0.618	7.19897492844917e-06	N4BP2L2	Malignant cells	GSE131984_JQ1Pac	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41132
4.84472277342735e-10	-0.313892156502261	0.678	0.747	7.46668673840622e-06	HEXB	Malignant cells	GSE131984_JQ1Pac	ENSG00000049860	3074	hexosaminidase subunit beta	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41133
4.97405072232573e-10	0.268020279081646	0.684	0.58	7.66600697324842e-06	TGOLN2	Malignant cells	GSE131984_JQ1Pac	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41134
5.6333720016525e-10	-0.253144114670449	0.63	0.716	8.68215292894683e-06	ACBD6	Malignant cells	GSE131984_JQ1Pac	ENSG00000230124	84320	acyl-CoA binding domain containing 6	MGC2404	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41135
5.7596750514951e-10	-0.286735284280726	0.448	0.588	8.87681118936425e-06	NCOA7	Malignant cells	GSE131984_JQ1Pac	ENSG00000111912	135112	nuclear receptor coactivator 7	dJ187J11.3|ERAP140|TLDC4	protein_coding	Q8NI08	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41136
5.91068817983319e-10	-0.289208297221719	0.589	0.708	9.10955262275891e-06	POLR2G	Malignant cells	GSE131984_JQ1Pac	ENSG00000168002	5436	RNA polymerase II subunit G	hRPB19|hsRPB7|RPB7	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41137
6.24859717553242e-10	-0.256349969594188	0.523	0.644	9.63033796693056e-06	COMMD8	Malignant cells	GSE131984_JQ1Pac	ENSG00000169019	54951	COMM domain containing 8	FLJ20502	protein_coding	Q9NX08	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41138
6.28832113897225e-10	-0.262868610200225	0.323	0.452	9.69156053938404e-06	ANAPC10	Malignant cells	GSE131984_JQ1Pac	ENSG00000164162	10393	anaphase promoting complex subunit 10	APC10|DKFZP564L0562|DOC1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41139
6.36842872185247e-10	-0.268615068830917	0.392	0.526	9.81502234611902e-06	SAP30BP	Malignant cells	GSE131984_JQ1Pac	ENSG00000161526	29115	SAP30 binding protein	HCNGP|HTRG|HTRP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41140
6.55149365533099e-10	-0.253529902827665	0.355	0.494	1.00971620215961e-05	IDH3A	Malignant cells	GSE131984_JQ1Pac	ENSG00000166411	3419	isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41141
6.6303107440907e-10	-0.278133746221859	0.317	0.477	1.02186349187926e-05	AURKB	Malignant cells	GSE131984_JQ1Pac	ENSG00000178999	9212	aurora kinase B	Aik2|AIM-1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5	protein_coding	Q96GD4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41142
7.36638103619513e-10	-0.253458364052639	0.481	0.618	1.13530664529839e-05	COMMD1	Malignant cells	GSE131984_JQ1Pac	ENSG00000173163	150684	copper metabolism domain containing 1	C2orf5|MGC27155|MURR1	protein_coding	Q8N668	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41143
7.73219591165145e-10	-0.268334974661054	0.81	0.868	1.19168603390372e-05	MAP1B	Malignant cells	GSE131984_JQ1Pac	ENSG00000131711	4131	microtubule associated protein 1B	MAP5|PPP1R102	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41144
8.3939226130759e-10	-0.258275166532273	0.532	0.641	1.29367135312726e-05	KIAA1143	Malignant cells	GSE131984_JQ1Pac	ENSG00000281665	57456	KIAA1143	NA	protein_coding	Q96AT1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41145
8.7937043749063e-10	0.437498100437058	0.566	0.447	1.35528571826056e-05	ID2	Malignant cells	GSE131984_JQ1Pac	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41146
9.14370830767791e-10	-0.265234972538973	0.602	0.704	1.40922832437932e-05	GNAI3	Malignant cells	GSE131984_JQ1Pac	ENSG00000065135	2773	G protein subunit alpha i3	87U6	protein_coding	P08754	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41147
9.15681213135235e-10	0.256647372812221	0.705	0.602	1.41124788568402e-05	VAT1	Malignant cells	GSE131984_JQ1Pac	ENSG00000108828	10493	vesicle amine transport 1	FLJ20230|VATI	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41148
9.6212223904557e-10	-0.254591520160596	0.224	0.369	1.48282279481703e-05	HMMR	Malignant cells	GSE131984_JQ1Pac	ENSG00000072571	3161	hyaluronan mediated motility receptor	CD168|RHAMM	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41149
1.06588016162844e-09	-0.251197295147491	0.572	0.692	1.64273450510175e-05	MFSD12	Malignant cells	GSE131984_JQ1Pac	ENSG00000161091	126321	major facilitator superfamily domain containing 12	C19orf28|MGC20700|PP3501	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41150
1.08066783617858e-09	0.310510292385132	0.698	0.585	1.66552526911843e-05	MT-ND6	Malignant cells	GSE131984_JQ1Pac	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41151
1.27484128137045e-09	-0.271492085368549	0.605	0.714	1.96478538284814e-05	EIF1B	Malignant cells	GSE131984_JQ1Pac	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41152
1.2930934179159e-09	-0.251209049884494	0.575	0.697	1.99291557569198e-05	SMIM4	Malignant cells	GSE131984_JQ1Pac	ENSG00000168273	440957	small integral membrane protein 4	C3orf78	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41153
1.52552747977486e-09	-0.275172353114674	0.546	0.669	2.35114295182902e-05	XBP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41154
1.63744333047307e-09	-0.264502015629293	0.731	0.802	2.5236276609251e-05	TRAM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41155
1.87334945468918e-09	-0.254905791892638	0.585	0.703	2.88720617956697e-05	GPS1	Malignant cells	GSE131984_JQ1Pac	ENSG00000169727	2873	G protein pathway suppressor 1	COPS1|CSN1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41156
1.94232235618071e-09	-0.250221150222301	0.523	0.652	2.99350721534571e-05	WSB2	Malignant cells	GSE131984_JQ1Pac	ENSG00000176871	55884	WD repeat and SOCS box containing 2	MGC10210|SBA2	protein_coding	Q9NYS7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41157
2.27252699619898e-09	-0.287917431136141	0.305	0.433	3.50241860654187e-05	ARMCX3	Malignant cells	GSE131984_JQ1Pac	ENSG00000102401	51566	armadillo repeat containing X-linked 3	ALEX3|GASP6	protein_coding	Q9UH62	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41158
2.37157246557903e-09	-0.262801344588198	0.577	0.675	3.65506748395041e-05	CCDC167	Malignant cells	GSE131984_JQ1Pac	ENSG00000198937	154467	coiled-coil domain containing 167	C6orf129|dJ153P14.2	protein_coding	Q9P0B6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41159
2.58857486905209e-09	-0.270567627062581	0.509	0.631	3.98951158818308e-05	VPS25	Malignant cells	GSE131984_JQ1Pac	ENSG00000131475	84313	vacuolar protein sorting 25 homolog	DERP9|EAP20|MGC10540	protein_coding	Q9BRG1	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41160
3.14933163446572e-09	-0.272886805926885	0.628	0.725	4.85374991503857e-05	TCEAL3	Malignant cells	GSE131984_JQ1Pac	ENSG00000196507	85012	transcription elongation factor A like 3	MGC15737|WEX8	protein_coding	Q969E4	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41161
3.28042022541293e-09	-0.278723237073045	0.518	0.624	5.05578365140641e-05	RRM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000167325	6240	ribonucleotide reductase catalytic subunit M1	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41162
3.50324321390374e-09	-0.291249801846282	0.575	0.669	5.39919844126845e-05	HM13	Malignant cells	GSE131984_JQ1Pac	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41163
3.95756206667745e-09	0.28255734461645	0.474	0.352	6.09939465716329e-05	CRIM1	Malignant cells	GSE131984_JQ1Pac	ENSG00000277354	51232	cysteine rich transmembrane BMP regulator 1	S52	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41164
4.0905755235155e-09	-0.267145180735462	0.369	0.495	6.30439499684209e-05	SRPX	Malignant cells	GSE131984_JQ1Pac	ENSG00000101955	8406	sushi repeat containing protein X-linked	ETX1|SRPX1	protein_coding	P78539	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41165
4.28350112500301e-09	0.271739826974573	0.574	0.457	6.60173193385465e-05	SREBF1	Malignant cells	GSE131984_JQ1Pac	ENSG00000072310	6720	sterol regulatory element binding transcription factor 1	bHLHd1|SREBP-1c|SREBP1|SREBP1a	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41166
4.30361466958518e-09	0.250845647378692	0.561	0.446	6.63273092876468e-05	FAM210B	Malignant cells	GSE131984_JQ1Pac	ENSG00000124098	116151	family with sequence similarity 210 member B	C20orf108|dJ1167H4.1|DKFZP434A1114	protein_coding	Q96KR6	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41167
5.28185184837757e-09	-0.293686338871513	0.156	0.273	8.14039006871951e-05	FHL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000022267	2273	four and a half LIM domains 1	bA535K18.1|FHL1B|FLH1A|KYO-T|MGC111107|SLIM1|XMPMA	protein_coding	Q13642	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41168
5.72964890076818e-09	0.250583607688555	0.477	0.357	8.83053488586391e-05	MFGE8	Malignant cells	GSE131984_JQ1Pac	ENSG00000140545	4240	milk fat globule EGF and factor V/VIII domain containing	BA46|EDIL1|hP47|HsT19888|MFG-E8|OAcGD3S|SED1|SPAG10	protein_coding	Q08431	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41169
6.08624982016548e-09	-0.260501979680039	0.747	0.844	9.38012822283903e-05	IGFBP6	Malignant cells	GSE131984_JQ1Pac	ENSG00000167779	3489	insulin like growth factor binding protein 6	NA	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41170
6.11611123768949e-09	-0.308387876026054	0.277	0.408	9.42615063952704e-05	RND3	Malignant cells	GSE131984_JQ1Pac	ENSG00000115963	390	Rho family GTPase 3	ARHE|Rho8|RhoE	protein_coding	P61587	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41171
7.06784948414249e-09	-0.271708806471342	0.574	0.664	0.000108929696249604	SVIP	Malignant cells	GSE131984_JQ1Pac	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41172
7.95127641394404e-09	-0.61447759745075	1	1	0.000122545072091706	TIMP1	Malignant cells	GSE131984_JQ1Pac	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41173
8.77917794429077e-09	-0.258357163465478	0.737	0.817	0.000135304690477409	USP16	Malignant cells	GSE131984_JQ1Pac	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41174
1.25380095653775e-08	0.255161896461236	0.913	0.85	0.000193235803421598	MCL1	Malignant cells	GSE131984_JQ1Pac	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41175
1.39495426000947e-08	-0.25266259541261	0.295	0.418	0.00021499035055266	SLC35F6	Malignant cells	GSE131984_JQ1Pac	ENSG00000213699	54978	solute carrier family 35 member F6	ANT2BP|C2orf18|FLJ20555|TANGO9	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41176
1.6216496110219e-08	-0.250404828012581	0.499	0.611	0.000249928638050695	GALK1	Malignant cells	GSE131984_JQ1Pac	ENSG00000108479	2584	galactokinase 1	GALK	protein_coding	P51570	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41177
1.8026412442044e-08	-0.275718324126915	0.233	0.353	0.000277823068556782	DDX10	Malignant cells	GSE131984_JQ1Pac	ENSG00000178105	1662	DEAD-box helicase 10	Dbp4|HRH-J8	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41178
1.8957909897444e-08	-0.256180341499569	0.684	0.755	0.000292179307339408	TFG	Malignant cells	GSE131984_JQ1Pac	ENSG00000114354	10342	trafficking from ER to golgi regulator	FLJ36137|SPG57|TF6	protein_coding	Q92734	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41179
2.20356999347775e-08	-0.269718468533566	0.617	0.694	0.000339614207394791	PHF14	Malignant cells	GSE131984_JQ1Pac	ENSG00000106443	9678	PHD finger protein 14	KIAA0783	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41180
2.48124657367281e-08	-0.262193243858381	0.63	0.697	0.000382409721934453	PTGES2	Malignant cells	GSE131984_JQ1Pac	ENSG00000148334	80142	prostaglandin E synthase 2	C9orf15|FLJ14038	protein_coding	Q9H7Z7	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41181
2.87044525623614e-08	-0.262128481568326	0.806	0.844	0.000442393022891114	RAB1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000138069	5861	RAB1A, member RAS oncogene family	RAB1|YPT1	protein_coding	P62820	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41182
4.18347319355009e-08	-0.506636940380693	0.451	0.547	0.00064475688858994	IL6	Malignant cells	GSE131984_JQ1Pac	ENSG00000136244	3569	interleukin 6	BSF2|HGF|HSF|IFNB2|IL-6	protein_coding	P05231	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41183
6.65651225975917e-08	-0.260199483281913	0.719	0.762	0.00102590166947408	DDOST	Malignant cells	GSE131984_JQ1Pac	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41184
7.43043949969366e-08	0.267778882158993	0.513	0.398	0.00114517933569279	CDKN1A	Malignant cells	GSE131984_JQ1Pac	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41185
8.37441746009638e-08	-0.26558158980187	0.456	0.573	0.00129066521895005	CTA-29F11.1	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41186
1.44688230344973e-07	-0.332115011200411	0.886	0.9	0.00222993500607672	GADD45A	Malignant cells	GSE131984_JQ1Pac	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41187
3.17395149906228e-07	-0.265705760327022	0.44	0.537	0.00489169405035478	WDR72	Malignant cells	GSE131984_JQ1Pac	ENSG00000166415	256764	WD repeat domain 72	FLJ38736	protein_coding	Q3MJ13	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41188
3.29943290893143e-07	0.275742333131141	0.841	0.758	0.00508508599924512	AXL	Malignant cells	GSE131984_JQ1Pac	ENSG00000167601	558	AXL receptor tyrosine kinase	ARK|JTK11|Tyro7|UFO	protein_coding	P30530	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41189
3.40724340986579e-07	0.26557065054027	0.443	0.343	0.00525124354328515	FGF13	Malignant cells	GSE131984_JQ1Pac	ENSG00000129682	2258	fibroblast growth factor 13	FGF2|FHF2|FLJ30672|LINC00889	protein_coding	Q92913	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41190
3.83130440871256e-07	0.260813976385493	0.726	0.613	0.0059048063547078	PLA2G16	Malignant cells	GSE131984_JQ1Pac	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41191
8.03090248887449e-07	0.263033404439936	0.958	0.929	0.0123772269158534	LY6E	Malignant cells	GSE131984_JQ1Pac	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41192
1.03419278581857e-06	0.262079714648038	0.529	0.446	0.0159389792150358	NRGN	Malignant cells	GSE131984_JQ1Pac	ENSG00000154146	4900	neurogranin	RC3	protein_coding	Q92686	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41193
1.8007934876223e-06	0.254661106899819	0.252	0.166	0.0277538292312349	LINC00632	Malignant cells	GSE131984_JQ1Pac	ENSG00000203930	286411	long intergenic non-protein coding RNA 632	ARST|ASINC	NA	NA	GSE131984_JQ1Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1704	Public on Apr 08, 2023	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41194
4.05046467450779e-306	-2.1762788002263	0.039	0.882	6.40135437159211e-302	IL32	Malignant cells	GSE131984_JQ1Pal	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41195
6.55073329462658e-272	-1.53899501676331	0.987	1	1.03527788988278e-267	RBM3	Malignant cells	GSE131984_JQ1Pal	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41196
2.12146727051268e-271	1.43485750379158	1	1	3.35276687431824e-267	FTH1	Malignant cells	GSE131984_JQ1Pal	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41197
3.98486715515668e-262	1.32075321163411	1	0.979	6.29768405200962e-258	C9orf16	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41198
3.52412370903813e-256	1.7773400676984	0.953	0.326	5.56952510976386e-252	VSTM2L	Malignant cells	GSE131984_JQ1Pal	ENSG00000132821	128434	V-set and transmembrane domain containing 2 like	C20orf102|dJ1118M15.2	protein_coding	Q96N03	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41199
2.51361570754472e-249	0.981234449807785	1	1	3.97251826420368e-245	GPX4	Malignant cells	GSE131984_JQ1Pal	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41200
4.66514041691166e-248	-1.3657378187446	0.982	1	7.37278791488718e-244	PLP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41201
7.39335167274975e-248	1.91264319709748	0.967	0.46	1.16844529836137e-243	RAMP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41202
4.13113507361569e-242	-1.21137614031694	0.999	1	6.52884587034224e-238	TMSB4X	Malignant cells	GSE131984_JQ1Pal	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41203
7.26363636512592e-242	1.47524245571812	0.996	0.849	1.1479450911445e-237	MXD4	Malignant cells	GSE131984_JQ1Pal	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41204
2.17745154279897e-240	-1.40881946895511	0.998	1	3.4412444182395e-236	HMGB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41205
1.16947449950804e-231	1.24108839582191	1	0.991	1.8482374990225e-227	CCDC85B	Malignant cells	GSE131984_JQ1Pal	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41206
3.45281099704085e-227	1.06349514115216	1	0.999	5.45682249972336e-223	MT-CYB	Malignant cells	GSE131984_JQ1Pal	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41207
7.43284691120727e-226	1.00976394597144	1	0.999	1.1746871258472e-221	MT-ND4	Malignant cells	GSE131984_JQ1Pal	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41208
6.09167721049152e-223	1.01972656700972	1	0.999	9.6272866634608e-219	MT-CO3	Malignant cells	GSE131984_JQ1Pal	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41209
4.0778920985619e-210	-1.73157852920417	0.636	0.96	6.44470067256722e-206	NFKBIA	Malignant cells	GSE131984_JQ1Pal	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41210
6.09875552691433e-208	-1.57373003551733	0.012	0.668	9.6384732347354e-204	SPANXC	Malignant cells	GSE131984_JQ1Pal	ENSG00000198573	64663	SPANX family member C	CT11.3|CTp11	protein_coding	Q9NY87	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41211
2.66072967447548e-207	-1.04952576784566	1	0.999	4.20501717754104e-203	H2AFZ	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41212
7.03037163870672e-207	1.65459195186306	0.997	0.907	1.11107993378121e-202	TGFBI	Malignant cells	GSE131984_JQ1Pal	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41213
1.1978052405849e-203	-1.19667550250536	0.996	1	1.89301140222038e-199	SLC25A5	Malignant cells	GSE131984_JQ1Pal	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41214
6.83788225984172e-202	-0.847106683872943	1	1	1.08065891234539e-197	RPL21	Malignant cells	GSE131984_JQ1Pal	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41215
1.83948576089549e-198	-1.18148681617976	0.893	0.998	2.90712329651923e-194	NDUFA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41216
1.05623505544581e-195	-1.09414961880888	0.996	1	1.66927388162656e-191	EIF5A	Malignant cells	GSE131984_JQ1Pal	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41217
8.22993057072082e-195	0.903307537496745	1	0.999	1.30065822739672e-190	MT-CO2	Malignant cells	GSE131984_JQ1Pal	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41218
1.61784936187268e-192	0.55588093348733	1	1	2.55684913150359e-188	RPLP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41219
3.79932241956655e-192	-1.30508745037479	0.881	0.987	6.00444915188298e-188	SMS	Malignant cells	GSE131984_JQ1Pal	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41220
3.05134192118781e-191	-1.22507835413045	0.979	0.998	4.82234077224522e-187	CLIC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41221
9.77128321330358e-188	-1.17072884485214	0.92	1	1.5442535990305e-183	EMP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41222
1.94574511360994e-185	-1.39998309570063	0.997	1	3.07505557754915e-181	AKR1B1	Malignant cells	GSE131984_JQ1Pal	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41223
3.9223549571459e-185	-0.952792989642731	0.984	1	6.19888977427337e-181	SNRPE	Malignant cells	GSE131984_JQ1Pal	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41224
3.64181812688526e-183	-1.08986624813095	0.994	1	5.75552936772947e-179	S100A11	Malignant cells	GSE131984_JQ1Pal	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41225
1.74810059834311e-182	0.569671567194784	1	1	2.76269818562145e-178	TMSB10	Malignant cells	GSE131984_JQ1Pal	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41226
2.47799192363244e-182	-1.44273153261927	0.74	0.963	3.91621843610871e-178	EBP	Malignant cells	GSE131984_JQ1Pal	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41227
6.80284719907803e-182	-1.24907962743172	0.998	1	1.07512197134229e-177	ENO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41228
1.02990792462626e-181	-1.15439759913868	0.989	0.999	1.62766648407935e-177	POMP	Malignant cells	GSE131984_JQ1Pal	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41229
1.50859393834374e-181	1.01924756803564	0.999	0.942	2.38418186015845e-177	MMP24-AS1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41230
2.47440327984373e-180	-1.00950134495773	0.957	0.999	3.91054694346503e-176	VDAC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41231
2.55315036567554e-179	-1.1373674291627	0.921	0.994	4.03499883791363e-175	DNAJC15	Malignant cells	GSE131984_JQ1Pal	ENSG00000120675	29103	DnaJ heat shock protein family (Hsp40) member C15	DNAJD1|MCJ	protein_coding	Q9Y5T4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41232
3.67801242880522e-178	1.23921023259721	0.641	0.049	5.81273084248377e-174	IGFBP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000115457	3485	insulin like growth factor binding protein 2	IBP2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41233
1.16389015170388e-176	0.780672205596947	1	0.999	1.83941199575281e-172	MT-CO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41234
1.92827701318827e-176	0.535294635926319	1	1	3.04744899164274e-172	RPL12	Malignant cells	GSE131984_JQ1Pal	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41235
4.55126282633406e-175	-0.973032033871921	0.982	0.999	7.19281577073835e-171	SNRPB	Malignant cells	GSE131984_JQ1Pal	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41236
1.52436308161911e-174	-1.25509174444866	0.855	0.986	2.40910341419084e-170	MORF4L2	Malignant cells	GSE131984_JQ1Pal	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41237
1.21335808876738e-172	-0.716719031748908	1	1	1.91759112348797e-168	RPL39	Malignant cells	GSE131984_JQ1Pal	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41238
2.32132388408992e-172	-1.0686414471867	0.978	0.996	3.66862026641571e-168	RANBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41239
1.1015988068542e-171	0.836877620873181	1	0.999	1.74096675435238e-167	MT-ND1	Malignant cells	GSE131984_JQ1Pal	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41240
3.57671442479765e-171	0.862103154985852	1	0.998	5.6526394769502e-167	MT-ATP6	Malignant cells	GSE131984_JQ1Pal	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41241
4.81209175895086e-171	-2.5044168975394	0.513	0.911	7.60502981584593e-167	IL8	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41242
1.39975397019782e-169	-1.12157328745841	0.668	0.959	2.21217117450063e-165	SNRPC	Malignant cells	GSE131984_JQ1Pal	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41243
6.58816878384886e-169	-1.10640619922148	0.906	0.99	1.04119419459947e-164	PA2G4	Malignant cells	GSE131984_JQ1Pal	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41244
1.87387600236478e-167	-2.17130178744876	0.498	0.899	2.9614736341373e-163	CXCL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41245
7.08851479736804e-165	-0.907762416445295	1	1	1.12026887857604e-160	RAN	Malignant cells	GSE131984_JQ1Pal	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41246
2.63840158416371e-162	-1.01095675626845	0.979	0.997	4.16972986361232e-158	CYCS	Malignant cells	GSE131984_JQ1Pal	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41247
9.90955687228683e-162	-0.960310495150933	0.856	0.992	1.56610636809621e-157	NDUFC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41248
3.85022359746047e-161	1.03117609784662	0.981	0.796	6.08489337342652e-157	TTC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41249
2.37132959139876e-159	-1.47137564565775	0.196	0.737	3.7476492862466e-155	S100A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41250
2.70593965963945e-158	1.08011734123417	0.995	0.944	4.27646703809418e-154	CCND1	Malignant cells	GSE131984_JQ1Pal	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41251
2.76780252944902e-158	0.467534554190583	1	1	4.37423511754124e-154	RPL28	Malignant cells	GSE131984_JQ1Pal	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41252
1.21827254059501e-157	-1.25564012601713	0.632	0.931	1.92535792315636e-153	HMGB3	Malignant cells	GSE131984_JQ1Pal	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41253
2.28491309398791e-157	-0.953233678352756	0.908	0.99	3.61107665373849e-153	GTF3C6	Malignant cells	GSE131984_JQ1Pal	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41254
8.46949455188785e-156	-1.29084837523952	0.982	1	1.33851891898036e-151	TUBA1B	Malignant cells	GSE131984_JQ1Pal	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41255
1.8454628612434e-154	1.24082673416153	0.972	0.774	2.91656950590908e-150	ANPEP	Malignant cells	GSE131984_JQ1Pal	ENSG00000166825	290	alanyl aminopeptidase, membrane	AP-N|CD13|gp150|hAPN|LAP1|p150|PEPN	protein_coding	P15144	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41256
5.13824197265376e-154	-1.0763797568349	0.966	0.997	8.120477613582e-150	NME1	Malignant cells	GSE131984_JQ1Pal	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41257
8.21158538545084e-154	-0.968027277948153	0.934	0.993	1.29775895431665e-149	PTGES3	Malignant cells	GSE131984_JQ1Pal	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41258
2.51312094921944e-152	-0.806071995464738	0.996	0.999	3.9717363481464e-148	RPL36A	Malignant cells	GSE131984_JQ1Pal	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41259
8.38073374542224e-152	-1.13863592082811	0.893	0.99	1.32449116112653e-147	PRDX4	Malignant cells	GSE131984_JQ1Pal	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41260
1.40817669492414e-151	-1.24356892206458	0.838	0.979	2.22548244865811e-147	TM4SF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41261
7.75291479665873e-151	-0.899778059194135	0.859	0.992	1.22527065446395e-146	PRR13	Malignant cells	GSE131984_JQ1Pal	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41262
2.96756058835697e-150	-1.02553721977566	0.853	0.991	4.68993275383936e-146	LRRC59	Malignant cells	GSE131984_JQ1Pal	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41263
5.09501062361296e-150	-1.1149564040886	0.069	0.607	8.05215478955792e-146	TNNT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41264
9.69251313914898e-150	1.09105457987348	0.921	0.553	1.53180477651111e-145	FAM89B	Malignant cells	GSE131984_JQ1Pal	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41265
8.70240719633386e-149	-1.07394875638704	0.821	0.975	1.3753284333086e-144	TFDP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41266
8.97156106811308e-149	0.967587756727224	0.62	0.08	1.41786551120459e-144	IFITM10	Malignant cells	GSE131984_JQ1Pal	ENSG00000281618	402778	interferon induced transmembrane protein 10	DSPA3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41267
5.36919230360097e-148	-0.812354223029653	0.983	1	8.48547151661097e-144	SNRPF	Malignant cells	GSE131984_JQ1Pal	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41268
1.52798048465254e-147	1.28858055642927	0.972	0.826	2.41482035794488e-143	CYBA	Malignant cells	GSE131984_JQ1Pal	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41269
2.41729219039127e-146	0.650427418109522	1	0.999	3.82028857769436e-142	MT-ND2	Malignant cells	GSE131984_JQ1Pal	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41270
3.42584814295639e-146	-0.875199932471878	0.987	0.999	5.41421040512828e-142	COX7B	Malignant cells	GSE131984_JQ1Pal	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41271
7.10254634713218e-146	-0.941202729958019	0.967	0.993	1.12248642470077e-141	SRSF3	Malignant cells	GSE131984_JQ1Pal	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41272
2.35240537946364e-145	-0.885967353297346	0.965	0.997	3.71774146170434e-141	SNRPD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41273
6.07952472897417e-144	-1.14906474992426	0.706	0.954	9.60808088167078e-140	ESD	Malignant cells	GSE131984_JQ1Pal	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41274
2.55658797605891e-143	-0.928123519103444	0.996	1	4.0404316373635e-139	TUBB	Malignant cells	GSE131984_JQ1Pal	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41275
3.04694771626054e-143	0.411068508985548	1	1	4.81539617077816e-139	RPL8	Malignant cells	GSE131984_JQ1Pal	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41276
5.77325591314768e-143	0.849034440787733	0.995	0.977	9.12405364513859e-139	POLE4	Malignant cells	GSE131984_JQ1Pal	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41277
9.55103558092902e-143	-1.07287908764598	0.467	0.86	1.50944566321002e-138	LRR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000165501	122769	leucine rich repeat protein 1	LRR-1|MGC20689|PPIL5	protein_coding	Q96L50	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41278
1.5462109201311e-142	-1.08896338234431	0.715	0.94	2.44363173817518e-138	HSD17B10	Malignant cells	GSE131984_JQ1Pal	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41279
5.66547654999546e-142	0.472700802246936	1	1	8.95371913961283e-138	RPL13A	Malignant cells	GSE131984_JQ1Pal	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41280
3.46438418776338e-141	-0.897142596764356	0.979	0.996	5.47511277034125e-137	GTF3A	Malignant cells	GSE131984_JQ1Pal	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41281
5.02125501323152e-141	-1.1150682835124	0.778	0.975	7.93559142291109e-137	PSMB6	Malignant cells	GSE131984_JQ1Pal	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41282
6.61317867351196e-141	-0.847186150983872	0.969	1	1.04514675756183e-136	ATP5G1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41283
1.1589191310922e-140	-0.99816979727884	0.948	0.996	1.83155579477811e-136	HNRNPDL	Malignant cells	GSE131984_JQ1Pal	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41284
1.8727663626137e-140	-1.25421633447554	0.93	0.997	2.95971995947468e-136	PGK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41285
1.90115709386936e-139	-0.669428573075695	1	1	3.00458867115113e-135	PTMA	Malignant cells	GSE131984_JQ1Pal	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41286
1.37459528162831e-138	-0.757167023220904	0.995	0.999	2.17241038308538e-134	SNRPG	Malignant cells	GSE131984_JQ1Pal	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41287
2.16762545440715e-138	1.54331035880317	0.915	0.553	3.42571526814506e-134	FN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41288
7.11647525252506e-138	-0.946960227569366	0.915	0.993	1.12468774890906e-133	ERH	Malignant cells	GSE131984_JQ1Pal	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41289
1.49277915984416e-136	-0.836354744840362	0.952	0.993	2.35918818421771e-132	C19orf10	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41290
5.8795150826747e-136	-0.839448834270067	0.861	0.988	9.2919856366591e-132	MRPS15	Malignant cells	GSE131984_JQ1Pal	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41291
6.05838211517757e-136	-0.797497735061494	0.999	1	9.57466709482663e-132	TPI1	Malignant cells	GSE131984_JQ1Pal	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41292
6.06474645627172e-136	-0.869376359546284	0.805	0.963	9.58472529949183e-132	CLPP	Malignant cells	GSE131984_JQ1Pal	ENSG00000125656	8192	caseinolytic mitochondrial matrix peptidase proteolytic subunit	NA	protein_coding	Q16740	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41293
8.42831022232605e-136	-1.39104285520297	0.113	0.614	1.33201014753641e-131	CDA	Malignant cells	GSE131984_JQ1Pal	ENSG00000158825	978	cytidine deaminase	CDD	protein_coding	P32320	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41294
8.50121189604311e-136	-1.06177506748427	0.888	0.99	1.34353152805065e-131	PTTG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41295
1.15779586992506e-135	-0.973459137563719	0.888	0.989	1.82978059282956e-131	PFDN2	Malignant cells	GSE131984_JQ1Pal	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41296
2.24135836142544e-133	-0.762817477890926	0.99	1	3.54224275439677e-129	TAGLN2	Malignant cells	GSE131984_JQ1Pal	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41297
3.31204412066724e-133	-1.04143660971684	0.848	0.98	5.2343545283025e-129	EBNA1BP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41298
7.25408097755694e-133	0.80879082408063	1	1	1.1464349576931e-128	FTL	Malignant cells	GSE131984_JQ1Pal	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41299
1.77652233951126e-132	-0.926192656100745	0.863	0.992	2.80761590536359e-128	EIF3I	Malignant cells	GSE131984_JQ1Pal	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41300
1.85715780186208e-132	-0.756828117221154	0.957	0.996	2.93505219006284e-128	GNG5	Malignant cells	GSE131984_JQ1Pal	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41301
3.62509106370996e-132	0.359429090608043	1	1	5.72909391708722e-128	RPLP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41302
8.27606661271811e-132	0.786831868589561	0.471	0.013	1.30794956747397e-127	SESN3	Malignant cells	GSE131984_JQ1Pal	ENSG00000149212	143686	sestrin 3	MGC29667|SEST3	protein_coding	P58005	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41303
1.72590120230692e-131	-0.871347580250094	0.939	0.992	2.72761426012586e-127	PSMB5	Malignant cells	GSE131984_JQ1Pal	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41304
7.29907179779392e-131	-0.849299574242562	0.977	0.997	1.15354530692335e-126	EIF1AX	Malignant cells	GSE131984_JQ1Pal	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41305
7.94248178979116e-131	-0.805426883914058	0.958	0.996	1.2552298220586e-126	NDUFAB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41306
1.42078856464758e-130	-0.827433859163238	0.962	1	2.24541424756903e-126	SLIRP	Malignant cells	GSE131984_JQ1Pal	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41307
1.63639046728126e-130	0.83497132819252	0.593	0.095	2.5861514944913e-126	MRC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000011028	9902	mannose receptor C type 2	CD280|CLEC13E|ENDO180|KIAA0709	protein_coding	Q9UBG0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41308
2.82947056282256e-130	-0.864890727600828	0.933	0.995	4.47169527748478e-126	PGAM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41309
3.17304429852273e-130	-0.626588452725084	1	1	5.01467920938532e-126	RPL36AL	Malignant cells	GSE131984_JQ1Pal	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41310
1.39471272584555e-129	-0.985158179122196	0.577	0.943	2.20420399192631e-125	H2AFJ	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41311
2.71451908557879e-129	-0.739058841975293	0.992	0.999	4.29002596284872e-125	SEC61G	Malignant cells	GSE131984_JQ1Pal	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41312
2.24568255218005e-128	-1.00854837883858	0.893	0.975	3.54907670546535e-124	SRSF7	Malignant cells	GSE131984_JQ1Pal	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41313
4.00671009284131e-128	1.00985363376215	0.947	0.673	6.33220463072641e-124	ITGA3	Malignant cells	GSE131984_JQ1Pal	ENSG00000005884	3675	integrin subunit alpha 3	CD49c|GAP-B3|MSK18|VCA-2|VLA3a	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41314
6.56403061674669e-128	0.832146271737102	0.514	0.042	1.03737939867065e-123	NR2F1	Malignant cells	GSE131984_JQ1Pal	ENSG00000175745	7025	nuclear receptor subfamily 2 group F member 1	COUP-TFI|COUPTF1|EAR-3|ERBAL3|SVP44|TCFCOUP1|TFCOUP1	protein_coding	P10589	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41315
9.95111767639046e-128	0.647593438723445	1	1	1.57267463757675e-123	ATP5E	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41316
1.00273165630078e-127	-0.840264160568647	0.924	0.995	1.58471710961775e-123	IFITM3	Malignant cells	GSE131984_JQ1Pal	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41317
6.67767872649867e-127	-1.00761160585174	0.657	0.925	1.05534034593585e-122	MRPS18C	Malignant cells	GSE131984_JQ1Pal	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41318
7.56993453905453e-127	-0.97438923950985	0.858	0.987	1.19635245455218e-122	PSMB3	Malignant cells	GSE131984_JQ1Pal	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41319
9.99809672117586e-127	-0.659358084474217	0.996	1	1.58009920581463e-122	MRPL23	Malignant cells	GSE131984_JQ1Pal	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41320
1.08459874739112e-125	0.98863020505334	0.617	0.13	1.71409986037692e-121	HTRA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000166033	5654	HtrA serine peptidase 1	ARMD7|HtrA|IGFBP5-protease|PRSS11	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41321
2.210211701996e-124	-1.09234881076681	0.804	0.978	3.49301857383448e-120	NNMT	Malignant cells	GSE131984_JQ1Pal	ENSG00000166741	4837	nicotinamide N-methyltransferase	NA	protein_coding	P40261	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41322
2.86132850497303e-124	-0.695540723845876	0.993	1	4.52204356925937e-120	SERBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41323
6.5612972321931e-124	-1.01557639272875	0.909	0.983	1.0369474145758e-119	STMN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41324
1.39968770199821e-123	-0.807341462211022	0.948	0.993	2.21206644423797e-119	SRSF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41325
4.34629386824715e-123	-0.824382974031753	0.914	0.983	6.86888282937779e-119	MRPS34	Malignant cells	GSE131984_JQ1Pal	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41326
5.03146692787479e-123	-1.02123832725334	0.21	0.687	7.95173033281331e-119	S100A3	Malignant cells	GSE131984_JQ1Pal	ENSG00000188015	6274	S100 calcium binding protein A3	S100E	protein_coding	P33764	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41327
6.30365994903631e-123	0.890383098350152	0.986	0.874	9.96230418345698e-119	CTSD	Malignant cells	GSE131984_JQ1Pal	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41328
1.59354984424833e-122	-1.00742938128428	0.49	0.854	2.51844617385005e-118	PGRMC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000101856	10857	progesterone receptor membrane component 1	HPR6.6	protein_coding	O00264	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41329
1.95567422668008e-122	-0.944884255022443	0.44	0.833	3.0907475478452e-118	TIMM17B	Malignant cells	GSE131984_JQ1Pal	ENSG00000126768	10245	translocase of inner mitochondrial membrane 17B	DXS9822|JM3	protein_coding	O60830	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41330
2.62993668216741e-122	-1.19801044191525	0.5	0.847	4.15635193249738e-118	EXOSC8	Malignant cells	GSE131984_JQ1Pal	ENSG00000120699	11340	exosome component 8	bA421P11.3|CIP3|EAP2|OIP2|p9|RRP43|Rrp43p	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41331
1.83888058330826e-121	-0.950460983254524	0.824	0.958	2.90616687386038e-117	SDF2L1	Malignant cells	GSE131984_JQ1Pal	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41332
2.12817291320003e-121	-0.663961896884099	0.998	1	3.36336447202133e-117	SUB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41333
4.29593415995257e-121	-0.844499660595672	0.796	0.961	6.78929434638904e-117	MRPL52	Malignant cells	GSE131984_JQ1Pal	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41334
1.06564833564144e-120	-0.75623673094887	0.949	0.993	1.68415062964773e-116	UBE2D2	Malignant cells	GSE131984_JQ1Pal	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41335
4.16577994230439e-120	-1.08646512424336	0.337	0.77	6.58359862081786e-116	LY6K	Malignant cells	GSE131984_JQ1Pal	ENSG00000160886	54742	lymphocyte antigen 6 family member K	CT97|FLJ35226|HSJ001348	protein_coding	Q17RY6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41336
4.57366195672084e-120	0.943260279558825	0.986	0.939	7.22821535640162e-116	TXNRD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41337
4.57870709123961e-120	-0.759693558225133	0.955	0.993	7.23618868699508e-116	LSM3	Malignant cells	GSE131984_JQ1Pal	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41338
2.1110917442097e-119	0.944245380396298	0.931	0.62	3.33636939254901e-115	DPYSL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000092964	1808	dihydropyrimidinase like 2	CRMP2|DHPRP2|DRP-2|DRP2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41339
8.22009639493108e-119	0.940574250462628	0.964	0.806	1.29910403425491e-114	XIST	Malignant cells	GSE131984_JQ1Pal	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41340
8.39464868016317e-119	0.890992388945862	0.968	0.824	1.32669027741299e-114	PSAP	Malignant cells	GSE131984_JQ1Pal	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41341
1.30764092828014e-118	0.971002522600405	0.95	0.731	2.06659572305393e-114	PLEC	Malignant cells	GSE131984_JQ1Pal	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41342
1.69054482706628e-118	-1.08581276099187	0.62	0.893	2.67173704469555e-114	MCTS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41343
4.18629542401933e-118	-0.692430030746135	1	0.999	6.61602128812015e-114	HNRNPA2B1	Malignant cells	GSE131984_JQ1Pal	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41344
4.35755099045417e-118	0.874468668708985	0.927	0.636	6.88667358531378e-114	TMPRSS15	Malignant cells	GSE131984_JQ1Pal	ENSG00000154646	5651	transmembrane serine protease 15	ENTK|MGC133046|PRSS7	protein_coding	P98073	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41345
1.45791865011461e-117	-0.713539809764979	0.976	0.997	2.30409463464113e-113	LSM5	Malignant cells	GSE131984_JQ1Pal	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41346
1.62364153333999e-117	-0.943341108292684	0.785	0.964	2.56600307929052e-113	PSMB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41347
2.60363223703843e-117	0.982930436187539	0.885	0.476	4.11478038741554e-113	MARCKSL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41348
3.99614237428336e-117	-1.11991264083741	0.266	0.728	6.31550340831742e-113	BASP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41349
1.05622313650011e-116	0.851613614478334	0.986	0.936	1.66925504492478e-112	LAGE3	Malignant cells	GSE131984_JQ1Pal	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41350
1.1409426187968e-116	1.00956983013232	0.877	0.525	1.80314571474647e-112	AHNAK2	Malignant cells	GSE131984_JQ1Pal	ENSG00000185567	113146	AHNAK nucleoprotein 2	C14orf78	protein_coding	Q8IVF2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41351
1.49408963954217e-116	-0.774955033402831	0.908	0.987	2.36125926633244e-112	ARF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41352
2.87291564738483e-116	-0.793234400316904	0.934	0.992	4.54035588912699e-112	ANP32B	Malignant cells	GSE131984_JQ1Pal	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41353
4.6051095765487e-116	-1.29960611540975	0.413	0.814	7.27791517477757e-112	ISG15	Malignant cells	GSE131984_JQ1Pal	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41354
1.23570455806041e-115	-0.706435105972654	0.973	0.999	1.95290748355867e-111	TIMM13	Malignant cells	GSE131984_JQ1Pal	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41355
1.59358653997736e-115	-0.644964392817649	1	1	2.51850416778022e-111	SLC25A6	Malignant cells	GSE131984_JQ1Pal	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41356
1.71714279094062e-115	-1.00197434707742	0.438	0.813	2.71377246680255e-111	ANP32E	Malignant cells	GSE131984_JQ1Pal	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41357
2.65979684856264e-115	-1.16358444946938	0.824	0.952	4.2035429394684e-111	SOD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41358
2.86384280704415e-114	0.691010535251158	0.998	0.993	4.52601717225257e-110	PPDPF	Malignant cells	GSE131984_JQ1Pal	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41359
5.67485368043252e-114	-0.699710764882492	1	1	8.96853875655556e-110	ACTG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41360
4.02268559008412e-113	-1.25552334081187	0.172	0.631	6.35745230656894e-109	SCG5	Malignant cells	GSE131984_JQ1Pal	ENSG00000277614	6447	secretogranin V	7B2|SGNE1|SgV	protein_coding	P05408	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41361
1.15980698882717e-112	0.822402015564029	0.981	0.894	1.83295896514246e-108	GNAS	Malignant cells	GSE131984_JQ1Pal	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41362
1.95625357685944e-112	-0.962956234363875	0.62	0.888	3.09166315286866e-108	DCTPP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41363
4.29067882322541e-112	0.696017637030419	0.999	0.985	6.78098881222544e-108	CD44	Malignant cells	GSE131984_JQ1Pal	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41364
9.58557854977878e-112	-0.894174510442022	1	1	1.51490483400704e-107	NPM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41365
5.52929549829701e-111	0.889713734145986	0.921	0.644	8.7384986055086e-107	APLP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41366
2.35040691661031e-110	-0.787859648179101	0.898	0.975	3.71458309101093e-106	RAB32	Malignant cells	GSE131984_JQ1Pal	ENSG00000118508	10981	RAB32, member RAS oncogene family	NA	protein_coding	Q13637	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41367
3.23770868137606e-110	-0.918680559876208	0.207	0.662	5.11687480004673e-106	PIR	Malignant cells	GSE131984_JQ1Pal	ENSG00000087842	8544	pirin	NA	protein_coding	O00625	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41368
1.22624284006486e-109	-0.764924264938894	0.997	1	1.9379541844385e-105	HMGA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41369
3.3718908146776e-109	-0.97126133988893	0.604	0.884	5.32893624351647e-105	PSMC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100764	5700	proteasome 26S subunit, ATPase 1	p56|RPT2|S4	protein_coding	P62191	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41370
1.94674999486323e-108	-0.878599889980068	0.729	0.921	3.07664369188185e-104	TIMM17A	Malignant cells	GSE131984_JQ1Pal	ENSG00000134375	10440	translocase of inner mitochondrial membrane 17A	TIM17|TIM17A	protein_coding	Q99595	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41371
7.72526186141593e-108	0.647596504313167	1	1	1.22090038457817e-103	NPC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41372
9.36079800471492e-108	-0.651285612038397	0.964	0.998	1.47938051666515e-103	HSBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41373
1.09102428201038e-107	-0.869208211384197	0.693	0.915	1.7242547752892e-103	MRPL3	Malignant cells	GSE131984_JQ1Pal	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41374
1.09110477806552e-107	-0.707941179705623	0.908	0.99	1.72438199125476e-103	PHB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41375
1.10187397469864e-107	-0.59591139350856	0.998	1	1.74140162961373e-103	PRELID1	Malignant cells	GSE131984_JQ1Pal	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41376
2.43380346155201e-107	-0.94944058038722	0.735	0.943	3.8463829906368e-103	CDKN3	Malignant cells	GSE131984_JQ1Pal	ENSG00000100526	1033	cyclin dependent kinase inhibitor 3	CDI1|KAP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41377
2.66791832040709e-107	0.865102871072802	0.988	0.959	4.21637811357137e-103	MYC	Malignant cells	GSE131984_JQ1Pal	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41378
3.66227072047259e-107	-0.867223914864922	0.507	0.844	5.78785264663488e-103	PSMB8	Malignant cells	GSE131984_JQ1Pal	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41379
5.79901465954558e-107	-0.833211222287868	0.767	0.947	9.16476276794584e-103	PDLIM4	Malignant cells	GSE131984_JQ1Pal	ENSG00000131435	8572	PDZ and LIM domain 4	RIL	protein_coding	P50479	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41380
1.87860242941192e-106	-0.765043232254577	0.91	0.988	2.9689432794426e-102	TUFM	Malignant cells	GSE131984_JQ1Pal	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41381
7.94891479711202e-106	1.1729025001092	0.993	0.941	1.25624649453558e-101	MT1X	Malignant cells	GSE131984_JQ1Pal	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41382
1.72998668507116e-105	-0.582146836378139	0.994	1	2.73407095708646e-101	TBCA	Malignant cells	GSE131984_JQ1Pal	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41383
2.17233013810947e-105	0.333170902129641	1	1	3.43315055026821e-101	RPS5	Malignant cells	GSE131984_JQ1Pal	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41384
2.25676159832831e-105	-1.0387357816748	0.896	0.985	3.56658602999806e-101	CCT5	Malignant cells	GSE131984_JQ1Pal	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41385
4.77643367166355e-105	0.785206260625394	0.602	0.149	7.54867577469707e-101	FSTL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000163430	11167	follistatin like 1	FRP|FSL1|OCC-1|OCC1|tsc36	protein_coding	Q12841	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41386
3.09178384639509e-104	0.354259091211065	1	1	4.8862551908428e-100	RPS7	Malignant cells	GSE131984_JQ1Pal	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41387
8.07129180017365e-104	-0.704585541368803	0.938	0.992	1.27558695609944e-99	PYURF	Malignant cells	GSE131984_JQ1Pal	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41388
1.5796048294958e-103	0.815565312779268	0.955	0.796	2.49640747253516e-99	RNASEH2C	Malignant cells	GSE131984_JQ1Pal	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41389
1.68983801937845e-103	-0.883497205730955	0.743	0.94	2.67062000582571e-99	VPS29	Malignant cells	GSE131984_JQ1Pal	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41390
2.51534152920523e-103	-0.705507828942946	0.949	0.993	3.97524575275594e-99	C14orf166	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41391
4.77892986837643e-103	-0.865336820138492	0.492	0.831	7.55262076398211e-99	MRPL15	Malignant cells	GSE131984_JQ1Pal	ENSG00000137547	29088	mitochondrial ribosomal protein L15	HSPC145|L15mt|MRP-L15|MRP-L7|RPML7	protein_coding	Q9P015	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41392
7.15158938344768e-103	-0.640542175689928	0.982	0.997	1.13023718616007e-98	UQCR10	Malignant cells	GSE131984_JQ1Pal	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41393
8.56795564059152e-103	-0.55720875637181	0.993	0.998	1.35407970943908e-98	AURKAIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41394
8.69777333618639e-103	0.869823400829246	0.915	0.64	1.3745960980509e-98	GPC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000063660	2817	glypican 1	glypican	protein_coding	P35052	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41395
3.43669506173387e-102	-0.662229693755434	0.997	0.999	5.43135287556421e-98	PPP1R14B	Malignant cells	GSE131984_JQ1Pal	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41396
2.92991567194603e-101	-0.88488930879999	0.59	0.862	4.6304387279435e-97	IFRD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41397
2.21809096840081e-100	-0.738858174958272	0.947	0.993	3.50547096646064e-96	PHB	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41398
2.91572011361553e-100	-0.855023086445523	0.528	0.838	4.60800406755799e-96	NKAP	Malignant cells	GSE131984_JQ1Pal	ENSG00000101882	79576	NFKB activating protein	FLJ22626	protein_coding	Q8N5F7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41399
3.63294992389842e-100	-0.954044870575671	0.708	0.924	5.74151405972907e-96	PSMD7	Malignant cells	GSE131984_JQ1Pal	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41400
5.37972767050641e-100	-0.872821586054735	0.518	0.835	8.50212161046833e-96	MRPL28	Malignant cells	GSE131984_JQ1Pal	ENSG00000086504	10573	mitochondrial ribosomal protein L28	MAAT1|p15	protein_coding	Q13084	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41401
7.39176715802441e-100	1.11715117208106	0.879	0.533	1.16819488165418e-95	PLAT	Malignant cells	GSE131984_JQ1Pal	ENSG00000104368	5327	plasminogen activator, tissue type	NA	protein_coding	P00750	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41402
1.27037437819163e-99	-0.886285128966443	0.698	0.896	2.00769966729406e-95	EEF1E1	Malignant cells	GSE131984_JQ1Pal	ENSG00000124802	9521	eukaryotic translation elongation factor 1 epsilon 1	AIMP3|P18	protein_coding	O43324	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41403
1.42223255507471e-99	-0.649230777226327	0.976	0.998	2.24769633004008e-95	SF3B5	Malignant cells	GSE131984_JQ1Pal	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41404
1.56856728276448e-99	-0.760515852265361	0.787	0.96	2.47896373368098e-95	CISD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000122873	55847	CDGSH iron sulfur domain 1	C10orf70|MDS029|mitoNEET|ZCD1	protein_coding	Q9NZ45	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41405
3.06492150573539e-99	-0.940450865404348	0.662	0.883	4.84380194766421e-95	ILF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41406
3.29038145843234e-99	0.467879298009775	1	1	5.20011885690647e-95	EEF1D	Malignant cells	GSE131984_JQ1Pal	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41407
3.37122714217873e-99	-0.796377146233725	0.969	0.992	5.32788737549926e-95	STRA13	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41408
3.46409549900115e-99	0.825636764162201	0.819	0.431	5.47465652662142e-95	TIMP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41409
1.89029511433608e-98	-0.696828810750385	0.911	0.984	2.98742239869675e-94	UBE2I	Malignant cells	GSE131984_JQ1Pal	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41410
4.49327470451604e-98	-0.982563938273615	0.396	0.779	7.10117134301714e-94	PBK	Malignant cells	GSE131984_JQ1Pal	ENSG00000168078	55872	PDZ binding kinase	CT84|FLJ14385|Nori-3|SPK|TOPK	protein_coding	Q96KB5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41411
4.76009380950547e-98	-0.795937525088789	0.625	0.875	7.52285225654244e-94	IER3IP1.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41412
7.13853842390222e-98	-0.837447070059438	0.784	0.937	1.12817461251351e-93	SDHB	Malignant cells	GSE131984_JQ1Pal	ENSG00000117118	6390	succinate dehydrogenase complex iron sulfur subunit B	SDH|SDH1	protein_coding	P21912	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41413
4.07046428712179e-97	-0.803349122840564	0.768	0.94	6.43296175936727e-93	SNRPD3	Malignant cells	GSE131984_JQ1Pal	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41414
8.98112460207663e-97	-0.8282249649925	0.502	0.841	1.41937693211219e-92	ICT1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41415
1.7974881717847e-96	-0.829649034743651	0.888	0.97	2.84075030668854e-92	HNRNPD	Malignant cells	GSE131984_JQ1Pal	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41416
2.32426577533157e-96	0.663841978754748	1	1	3.67326963133402e-92	ZFAS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41417
3.86025775591509e-96	-0.68188710678979	0.903	0.987	6.1007513574482e-92	SRP9	Malignant cells	GSE131984_JQ1Pal	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41418
4.67996603271113e-96	-0.72270920775877	0.806	0.95	7.39621831809666e-92	SSRP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000149136	6749	structure specific recognition protein 1	FACT80	protein_coding	Q08945	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41419
6.77202952795334e-96	-0.63340643812222	0.972	0.998	1.07025154659775e-91	UBE2D3	Malignant cells	GSE131984_JQ1Pal	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41420
1.04734445523721e-95	-0.490567363848425	0.999	1	1.65522317705688e-91	HNRNPA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41421
1.20208827150034e-95	-0.721277885803048	0.711	0.912	1.89978030427914e-91	HAX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41422
1.53818451158623e-95	0.816036657103881	0.862	0.535	2.43094680211088e-91	MPRIP	Malignant cells	GSE131984_JQ1Pal	ENSG00000133030	23164	myosin phosphatase Rho interacting protein	M-RIP|p116Rip|RHOIP3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41423
1.83095929717737e-95	-0.912145462298184	0.678	0.899	2.89364807325912e-91	SNRPA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41424
2.23224811113796e-95	-0.817653288937944	0.823	0.965	3.52784491484243e-91	TMED9	Malignant cells	GSE131984_JQ1Pal	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41425
2.33005124790163e-95	-0.574566013743201	0.993	1	3.68241299218374e-91	GADD45GIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41426
3.08501560452278e-95	-0.797438241028677	0.759	0.935	4.8755586613878e-91	TXNL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000091164	9352	thioredoxin like 1	TRP32|Txl|TXNL	protein_coding	O43396	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41427
5.96624203185428e-95	-0.694203564875064	0.933	0.994	9.42904890714251e-91	NDUFB11	Malignant cells	GSE131984_JQ1Pal	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41428
1.48726184699921e-94	-0.70588561023982	0.941	0.992	2.35046862299755e-90	DUT	Malignant cells	GSE131984_JQ1Pal	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41429
1.85032505627032e-94	-0.891768954931666	0.552	0.846	2.92425371892962e-90	NOP16	Malignant cells	GSE131984_JQ1Pal	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41430
2.26639703713187e-94	-0.843777851639491	0.972	0.997	3.58181387748321e-90	C1QBP	Malignant cells	GSE131984_JQ1Pal	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41431
8.31016604508601e-94	-0.819632578809248	0.277	0.705	1.31333864176539e-89	IFITM2	Malignant cells	GSE131984_JQ1Pal	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41432
9.75792214992728e-94	-0.728068300886087	0.904	0.985	1.54214201657451e-89	VAPA	Malignant cells	GSE131984_JQ1Pal	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41433
1.22432011144452e-93	0.29309994028599	1	1	1.93491550412692e-89	RPS27A	Malignant cells	GSE131984_JQ1Pal	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41434
1.74008079315228e-93	-0.764411650496635	0.84	0.971	2.75002368549786e-89	DAD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41435
3.29188388206721e-93	-0.708752512736808	0.815	0.95	5.20249328721902e-89	HDGF	Malignant cells	GSE131984_JQ1Pal	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41436
3.56024105850656e-93	-0.925407448754644	0.781	0.951	5.62660496886377e-89	CACYBP	Malignant cells	GSE131984_JQ1Pal	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41437
4.61079941256541e-93	0.605910226449833	0.386	0.025	7.28690739161838e-89	Z83851.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41438
4.74050188304418e-93	-0.79800337855191	0.4	0.761	7.49188917596302e-89	FTSJ1	Malignant cells	GSE131984_JQ1Pal	ENSG00000068438	24140	FtsJ RNA 2'-O-methyltransferase 1	CDLIV|JM23|MRX44|MRX9|SPB1|TRM7|TRMT7	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41439
5.8865655867462e-93	-0.833779032086538	0.497	0.83	9.3031282532937e-89	TSPAN4	Malignant cells	GSE131984_JQ1Pal	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41440
1.03669501454762e-92	-0.68187583035747	0.94	0.99	1.63839280099105e-88	CNBP	Malignant cells	GSE131984_JQ1Pal	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41441
2.16013802472196e-92	-0.690459158953175	0.854	0.976	3.41388213427058e-88	MRPL18	Malignant cells	GSE131984_JQ1Pal	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41442
2.22933095863584e-92	-0.868161042941039	0.302	0.693	3.52323464702808e-88	HCCS	Malignant cells	GSE131984_JQ1Pal	ENSG00000004961	3052	holocytochrome c synthase	CCHL|MLS	protein_coding	P53701	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41443
4.99952932420334e-92	-0.842502705076864	0.688	0.916	7.90125614397095e-88	VBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41444
5.04219792142434e-92	-0.699072206215367	0.996	1	7.96868959501902e-88	MGST1	Malignant cells	GSE131984_JQ1Pal	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41445
6.57748457039078e-92	-0.820546229979162	0.43	0.789	1.03950566150456e-87	SUCLA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000136143	8803	succinate-CoA ligase ADP-forming subunit beta	LINC00444	protein_coding	Q9P2R7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41446
1.634428062027e-91	-0.723315355936052	0.86	0.968	2.58305010922747e-87	ARPC5	Malignant cells	GSE131984_JQ1Pal	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41447
1.93679019170296e-91	-0.402347944512408	1	1	3.06090321896735e-87	BTF3	Malignant cells	GSE131984_JQ1Pal	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41448
2.30237718445005e-91	-0.499100458307548	1	1	3.63867690230487e-87	TXN	Malignant cells	GSE131984_JQ1Pal	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41449
2.78477705015397e-91	-0.798931871201099	0.699	0.914	4.40106165006333e-87	MRPL22	Malignant cells	GSE131984_JQ1Pal	ENSG00000082515	29093	mitochondrial ribosomal protein L22	HSPC158|MRP-L25|RPML25	protein_coding	Q9NWU5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41450
3.71052606224223e-91	-0.966603928807193	0.727	0.916	5.86411538876762e-87	PSMA3	Malignant cells	GSE131984_JQ1Pal	ENSG00000100567	5684	proteasome 20S subunit alpha 3	HC8	protein_coding	P25788	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41451
4.34895974987924e-91	-0.553482245922999	0.015	0.366	6.87309598870915e-87	CDC42EP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000128283	11135	CDC42 effector protein 1	Borg5|CEP1|MSE55	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41452
5.06548977410793e-91	-0.602971001655137	0.979	0.997	8.00550003900018e-87	JTB	Malignant cells	GSE131984_JQ1Pal	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41453
7.2146458727382e-91	-0.498061193170825	0.997	1	1.14020263372754e-86	TSPO	Malignant cells	GSE131984_JQ1Pal	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41454
9.97090011468554e-91	-0.618731868631562	0.957	0.997	1.5758010541249e-86	STRAP	Malignant cells	GSE131984_JQ1Pal	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41455
1.87577445184329e-90	-0.830379304818971	0.981	0.996	2.96447394369314e-86	IER3	Malignant cells	GSE131984_JQ1Pal	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41456
2.34299315583634e-90	-0.597198576497863	1	1	3.70286638348375e-86	ACTB	Malignant cells	GSE131984_JQ1Pal	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41457
3.50164371005859e-90	-0.722652559184312	0.851	0.965	5.5339977193766e-86	DTYMK	Malignant cells	GSE131984_JQ1Pal	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41458
3.91015536480147e-90	0.367241549132436	1	1	6.17960953853225e-86	UBA52	Malignant cells	GSE131984_JQ1Pal	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41459
4.26942832972786e-90	-0.542065495310608	1	1	6.74740453230191e-86	H3F3B	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41460
9.47203725687538e-90	-0.63279075585934	0.976	0.995	1.49696076807658e-85	SRM	Malignant cells	GSE131984_JQ1Pal	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41461
9.94889479871222e-90	-0.61678882347227	0.995	1	1.57232333398848e-85	HSPE1	Malignant cells	GSE131984_JQ1Pal	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41462
1.40484993245457e-89	-0.369646505501743	1	1	2.22022483325121e-85	YBX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41463
1.74602245185182e-89	-0.712059935005684	0.056	0.43	2.75941388290662e-85	SFTA1P	Malignant cells	GSE131984_JQ1Pal	ENSG00000225383	207107	surfactant associated 1, lncRNA	SFTPF	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41464
2.40342225419982e-89	0.861244622568521	0.629	0.179	3.79836853053739e-85	FAM133A	Malignant cells	GSE131984_JQ1Pal	ENSG00000179083	286499	family with sequence similarity 133 member A	CT115|FLJ37659|RP1-32F7.2	protein_coding	Q8N9E0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41465
3.05580863091806e-89	-0.946105546998469	0.492	0.808	4.82939996030291e-85	PDHA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000131828	5160	pyruvate dehydrogenase E1 subunit alpha 1	E1alpha|PDHA	protein_coding	P08559	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41466
3.38367136679039e-89	0.741959980098149	0.908	0.653	5.34755422807554e-85	LINC00657	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41467
3.70740771465266e-89	-0.621731946886079	0.952	0.993	5.85918715223707e-85	LSM7	Malignant cells	GSE131984_JQ1Pal	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41468
4.66549798386234e-89	-0.697961702053064	0.875	0.959	7.37335301369604e-85	PGP	Malignant cells	GSE131984_JQ1Pal	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41469
5.15545482339901e-89	-0.734515965171297	0.8	0.932	8.1476808028998e-85	THOC7	Malignant cells	GSE131984_JQ1Pal	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41470
5.93499449887086e-89	-0.648907365626123	0.914	0.978	9.3796653060155e-85	TOMM22	Malignant cells	GSE131984_JQ1Pal	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41471
7.71266727846689e-89	-0.587650696859912	0.992	1	1.21890993668891e-84	NHP2L1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41472
1.05926207598773e-88	-0.847293869201035	0.321	0.703	1.674057784891e-84	PYCR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41473
1.51677679116985e-88	0.662424681297384	0.508	0.114	2.39711404076483e-84	COL18A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000182871	80781	collagen type XVIII alpha 1 chain	KNO|KNO1|KS	protein_coding	P39060	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41474
2.14066548640279e-88	-0.70735208345173	0.851	0.964	3.38310773471097e-84	TOMM40	Malignant cells	GSE131984_JQ1Pal	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41475
2.58728476611513e-88	-0.786899388713442	0.677	0.889	4.08894484436836e-84	MRPS7	Malignant cells	GSE131984_JQ1Pal	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41476
2.84779683831324e-88	-0.727818361771417	0.628	0.871	4.50065812327024e-84	UFC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41477
8.00649325300545e-88	-0.739948753615038	0.728	0.912	1.26534619370498e-83	UBE2N	Malignant cells	GSE131984_JQ1Pal	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41478
9.53991701584905e-88	-0.685947347196718	0.832	0.941	1.50768848518478e-83	SRP72	Malignant cells	GSE131984_JQ1Pal	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41479
1.35479065178229e-87	-0.78653483365387	0.862	0.968	2.14111114607672e-83	ATF4	Malignant cells	GSE131984_JQ1Pal	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41480
1.40237634539993e-87	-0.572039777584128	0.979	0.995	2.21631557627006e-83	MRPL14	Malignant cells	GSE131984_JQ1Pal	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41481
1.5863380937913e-87	0.758020464878972	0.566	0.168	2.50704872342777e-83	FBLN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000077942	2192	fibulin 1	FBLN	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41482
2.38375341137103e-87	-0.832081046691717	0.734	0.922	3.76728389133078e-83	RBBP7	Malignant cells	GSE131984_JQ1Pal	ENSG00000102054	5931	RB binding protein 7, chromatin remodeling factor	RbAp46	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41483
3.38263559735574e-87	-0.845020221778818	0.442	0.767	5.34591729806101e-83	MRTO4	Malignant cells	GSE131984_JQ1Pal	ENSG00000053372	51154	MRT4 homolog, ribosome maturation factor	C1orf33|dJ657E11.4|MRT4	protein_coding	Q9UKD2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41484
5.5828219840622e-87	-1.14143613702763	0.079	0.457	8.8230918636119e-83	KRT75	Malignant cells	GSE131984_JQ1Pal	ENSG00000170454	9119	keratin 75	K6HF	protein_coding	O95678	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41485
7.31905364656278e-87	-0.71640071110488	0.199	0.601	1.15670323830278e-82	PRPS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000101911	5634	phosphoribosyl pyrophosphate synthetase 2	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41486
9.77951672437746e-87	-0.61339027521456	0.976	0.998	1.54555482312061e-82	MRPL20	Malignant cells	GSE131984_JQ1Pal	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41487
2.35279737903599e-86	-0.754098365813703	0.993	1	3.71836097782848e-82	HSP90AB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41488
1.30899427939253e-85	-0.743748786434352	0.693	0.921	2.06873455915196e-81	CENPW	Malignant cells	GSE131984_JQ1Pal	ENSG00000203760	387103	centromere protein W	C6orf173|CUG2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41489
2.64490976695899e-85	-0.716335410231835	0.026	0.369	4.18001539570199e-81	SULT1B1	Malignant cells	GSE131984_JQ1Pal	ENSG00000173597	27284	sulfotransferase family 1B member 1	ST1B2	protein_coding	O43704	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41490
4.26091453397639e-85	-0.779693053963011	0.565	0.834	6.73394932949628e-81	AP1S2	Malignant cells	GSE131984_JQ1Pal	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41491
4.89950819239063e-85	-0.88092627510622	0.697	0.89	7.74318274725415e-81	NUDC	Malignant cells	GSE131984_JQ1Pal	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41492
5.00043524609704e-85	-0.632380091119491	0.96	0.997	7.90268786293176e-81	UBE2L3	Malignant cells	GSE131984_JQ1Pal	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41493
5.71680943222502e-85	-0.82738334368579	0.448	0.774	9.03484562668842e-81	ALG5	Malignant cells	GSE131984_JQ1Pal	ENSG00000120697	29880	ALG5 dolichyl-phosphate beta-glucosyltransferase	bA421P11.2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41494
5.94581318722492e-85	0.705936901391807	0.573	0.179	9.39676316109026e-81	LAMA5	Malignant cells	GSE131984_JQ1Pal	ENSG00000130702	3911	laminin subunit alpha 5	NA	protein_coding	O15230	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41495
9.30499259572586e-85	-0.636433410658004	0.942	0.992	1.47056102982851e-80	TCEB1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41496
1.02378247094375e-84	-0.797210343057855	0.888	0.987	1.61798581707951e-80	TUBA1C	Malignant cells	GSE131984_JQ1Pal	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41497
1.51498110016974e-84	0.743596623018927	1	0.997	2.39427613070826e-80	MT2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41498
3.89396256225448e-84	-0.726398637748787	0.815	0.938	6.15401843338698e-80	CNIH4	Malignant cells	GSE131984_JQ1Pal	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41499
4.3102830528798e-84	-0.820338631811827	0.282	0.667	6.81197133677123e-80	MYBL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000101057	4605	MYB proto-oncogene like 2	B-MYB|BMYB	protein_coding	P10244	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41500
4.36996018575576e-84	0.358197140046015	1	1	6.9062850775684e-80	RPS21	Malignant cells	GSE131984_JQ1Pal	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41501
4.92986351964045e-84	-0.644035614821302	0.961	0.995	7.79115630643977e-80	PSMB7	Malignant cells	GSE131984_JQ1Pal	ENSG00000136930	5695	proteasome 20S subunit beta 7	Z	protein_coding	Q99436	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41502
5.14716713269241e-84	-0.826420320107464	0.316	0.687	8.13458293650709e-80	MAGOH	Malignant cells	GSE131984_JQ1Pal	ENSG00000162385	4116	mago homolog, exon junction complex subunit	MAGOH1|MAGOHA	protein_coding	P61326	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41503
7.39707695006893e-84	-0.599980307385424	0.941	0.985	1.16903404118889e-79	EI24	Malignant cells	GSE131984_JQ1Pal	ENSG00000149547	9538	EI24 autophagy associated transmembrane protein	EPG4|PIG8|TP53I8	protein_coding	O14681	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41504
9.21438582433472e-84	0.778780370427057	0.9	0.677	1.45624153567786e-79	TFRC	Malignant cells	GSE131984_JQ1Pal	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41505
1.03386633094564e-83	-0.645531735593094	0.999	1	1.63392234942649e-79	LDHA	Malignant cells	GSE131984_JQ1Pal	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41506
1.09519316444665e-83	-0.736153205274521	0.648	0.867	1.73084327709149e-79	SPTSSA	Malignant cells	GSE131984_JQ1Pal	ENSG00000165389	171546	serine palmitoyltransferase small subunit A	C14orf147|ssSPTa	protein_coding	Q969W0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41507
1.22862302880201e-83	0.696200081441178	0.455	0.087	1.94171583471869e-79	SPOCK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000152377	6695	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1	SPOCK|testican-1|TIC1	protein_coding	Q08629	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41508
1.92876508797022e-83	-0.688659632948472	0.925	0.984	3.04822034502813e-79	PSMD8	Malignant cells	GSE131984_JQ1Pal	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41509
2.75179794475564e-83	-0.812721999403606	0.526	0.843	4.34894147189181e-79	CRADD	Malignant cells	GSE131984_JQ1Pal	ENSG00000169372	8738	CASP2 and RIPK1 domain containing adaptor with death domain	RAIDD	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41510
2.7753595433945e-83	-0.658985086957027	0.867	0.975	4.38617822238067e-79	NUDCD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000170584	134492	NudC domain containing 2	DKFZp686E10109|NudCL2	protein_coding	Q8WVJ2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41511
2.90712080269884e-83	-0.725656736166332	0.854	0.959	4.59441371658525e-79	GLRX3	Malignant cells	GSE131984_JQ1Pal	ENSG00000108010	10539	glutaredoxin 3	bA500G10.4|GLRX4|GRX3|GRX4|PICOT|TXNL2	protein_coding	O76003	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41512
3.03891636877544e-83	-0.540486080876783	0.999	1	4.8027034292127e-79	ALDOA	Malignant cells	GSE131984_JQ1Pal	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41513
3.57648119917789e-83	0.32199500888145	1	1	5.65227088718074e-79	RPL27A	Malignant cells	GSE131984_JQ1Pal	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41514
1.38874721882481e-82	-0.515111153432493	0.999	1	2.19477610463073e-78	PFN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41515
1.96998753404654e-82	-0.610495970044733	0.967	1	3.11336829880716e-78	CYC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41516
2.16306178540218e-82	-0.695012146364776	0.165	0.556	3.41850284564961e-78	SFN	Malignant cells	GSE131984_JQ1Pal	ENSG00000175793	2810	stratifin	YWHAS	protein_coding	P31947	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41517
2.20485765875508e-82	-0.72006632503149	0.747	0.924	3.48455704389653e-78	DCUN1D5	Malignant cells	GSE131984_JQ1Pal	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41518
2.53832052089894e-82	-0.812080704326025	0.637	0.865	4.01156175122869e-78	MRPS23	Malignant cells	GSE131984_JQ1Pal	ENSG00000181610	51649	mitochondrial ribosomal protein S23	CGI-138|HSPC329|MRP-S23	protein_coding	Q9Y3D9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41519
2.63450173242367e-82	-1.04917055681563	0.453	0.785	4.16356653792236e-78	CDC20	Malignant cells	GSE131984_JQ1Pal	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41520
4.28086696440305e-82	-0.879294211915704	0.642	0.861	6.76548215054258e-78	NUDT4	Malignant cells	GSE131984_JQ1Pal	ENSG00000173598	11163	nudix hydrolase 4	DIPP2|DIPP2alpha|DIPP2beta|HDCMB47P|KIAA0487	protein_coding	Q9NZJ9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41521
5.10774721854088e-82	-0.749462516220405	0.945	0.997	8.072283704182e-78	ATP5B	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41522
5.87620906178656e-82	-0.749976213902633	0.237	0.646	9.28676080124747e-78	RP3-460G2.2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41523
7.53575857067752e-82	-0.412841252147705	1	1	1.19095128450988e-77	RPS29	Malignant cells	GSE131984_JQ1Pal	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41524
9.54370093853472e-82	-0.823811139406732	0.765	0.942	1.50828649632603e-77	PSME2	Malignant cells	GSE131984_JQ1Pal	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41525
2.21909768074819e-81	0.656116016470958	0.591	0.199	3.50706197465444e-77	AGRN	Malignant cells	GSE131984_JQ1Pal	ENSG00000188157	375790	agrin	AGRIN	protein_coding	O00468	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41526
3.85219800027255e-81	0.698866700849346	0.704	0.32	6.08801371963074e-77	PCYOX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000116005	51449	prenylcysteine oxidase 1	KIAA0908|PCL1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41527
1.05188390773345e-80	0.640738742770305	0.969	0.844	1.66239732778194e-76	HDLBP	Malignant cells	GSE131984_JQ1Pal	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41528
1.90540610422353e-80	-0.75659105134254	0.498	0.807	3.01130380711486e-76	PQBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000102103	10084	polyglutamine binding protein 1	MRX2|MRX55|MRXS3|MRXS8|RENS1|SHS	protein_coding	O60828	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41529
3.25745537926159e-80	-0.578024997446153	0.956	0.991	5.14808248138502e-76	LSM2	Malignant cells	GSE131984_JQ1Pal	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41530
1.14362545289016e-79	0.81906976260022	0.809	0.495	1.80738566574762e-75	ABCC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000108846	8714	ATP binding cassette subfamily C member 3	cMOAT2|EST90757|MLP2|MOAT-D|MRP3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41531
1.44454807732356e-79	-0.7288601552217	0.966	0.996	2.28296378140216e-75	KRT18	Malignant cells	GSE131984_JQ1Pal	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41532
1.63633578711775e-79	-0.608568993031723	0.982	0.994	2.5860650779609e-75	ARPC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41533
2.21597399106305e-79	-0.809129848166488	0.373	0.709	3.50212529547604e-75	MAGOHB	Malignant cells	GSE131984_JQ1Pal	ENSG00000111196	55110	mago homolog B, exon junction complex subunit	FLJ10292|MGN2	protein_coding	Q96A72	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41534
2.49368002735948e-79	-0.722740771216295	0.622	0.865	3.94101191523892e-75	ATG3	Malignant cells	GSE131984_JQ1Pal	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41535
2.65761097626531e-79	-0.576153526949118	0.979	0.992	4.2000883868897e-75	HNRNPC	Malignant cells	GSE131984_JQ1Pal	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41536
8.40996300188768e-79	-0.540692762851519	0.995	0.999	1.32911055281833e-74	PARK7	Malignant cells	GSE131984_JQ1Pal	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41537
8.86758242289974e-79	-0.579490040370644	0.976	0.998	1.40143272611507e-74	EIF4EBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41538
1.41089405181674e-78	-0.309414401906696	1	1	2.22977695949118e-74	RPL29	Malignant cells	GSE131984_JQ1Pal	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41539
1.57346870900201e-78	-0.659218636017961	0.165	0.543	2.48670994770678e-74	LDOC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000182195	23641	LDOC1 regulator of NFKB signaling	BCUR1|Mar7|Mart7|RTL7|SIRH7	protein_coding	O95751	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41540
2.86447805363957e-78	-0.7885383396587	0.516	0.836	4.52702111597197e-74	IFI27	Malignant cells	GSE131984_JQ1Pal	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41541
4.49090658092304e-78	-0.654047793524103	0.757	0.925	7.09742876049076e-74	UBE2M	Malignant cells	GSE131984_JQ1Pal	ENSG00000130725	9040	ubiquitin conjugating enzyme E2 M	hUbc12|UBC12	protein_coding	P61081	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41542
5.1897567736299e-78	-0.793042788203664	0.354	0.694	8.20189160504469e-74	PRPS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000147224	5631	phosphoribosyl pyrophosphate synthetase 1	CMTX5|DFN2|DFNX1|PPRibP|PRS-I	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41543
5.64151840987653e-78	-0.620649496394792	0.925	0.977	8.91585569496886e-74	UXT	Malignant cells	GSE131984_JQ1Pal	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41544
6.97280892683984e-78	0.616959749064237	0.975	0.858	1.10198272279777e-73	TAF10	Malignant cells	GSE131984_JQ1Pal	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41545
7.08119845071388e-78	-0.711277774487264	0.636	0.857	1.11911260315082e-73	COMT	Malignant cells	GSE131984_JQ1Pal	ENSG00000093010	1312	catechol-O-methyltransferase	NA	protein_coding	P21964	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41546
8.34694672223122e-78	-0.598090539536718	0.971	1	1.31915145998142e-73	RHOA	Malignant cells	GSE131984_JQ1Pal	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41547
9.52174455382408e-78	-0.787333330089987	0.452	0.759	1.50481650928636e-73	RAB9A	Malignant cells	GSE131984_JQ1Pal	ENSG00000123595	9367	RAB9A, member RAS oncogene family	RAB9	protein_coding	P51151	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41548
9.88797412553285e-78	-0.830403761863651	0.182	0.557	1.56269543079921e-73	COL8A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000144810	1295	collagen type VIII alpha 1 chain	C3orf7|MGC9568	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41549
1.07642814302874e-77	-0.508901643514396	0.99	1	1.70118703724261e-73	NDUFS5	Malignant cells	GSE131984_JQ1Pal	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41550
1.40172647523053e-77	-0.877183668747426	0.404	0.746	2.21528852145433e-73	UBE2T	Malignant cells	GSE131984_JQ1Pal	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41551
1.72609043325279e-77	-0.547353376406493	0.988	1	2.72791332071272e-73	HMGN2	Malignant cells	GSE131984_JQ1Pal	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41552
1.7825092009229e-77	-0.840229464909783	0.147	0.508	2.81707754113855e-73	SLC14A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000141469	6563	solute carrier family 14 member 1 (Kidd blood group)	HsT1341|JK|RACH1|RACH2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41553
1.94549735514705e-77	-0.837607955961343	0.504	0.779	3.0746640200744e-73	LYAR	Malignant cells	GSE131984_JQ1Pal	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41554
2.0520992574053e-77	-0.626917561069755	0.847	0.968	3.24313766640333e-73	MRPL4	Malignant cells	GSE131984_JQ1Pal	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41555
2.05615007255069e-77	-0.724970085259662	0.46	0.767	3.24953957465911e-73	CCDC59	Malignant cells	GSE131984_JQ1Pal	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41556
2.14901602634805e-77	-0.688292591750926	0.782	0.94	3.39630492804045e-73	EIF3D	Malignant cells	GSE131984_JQ1Pal	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41557
2.85368926058659e-77	-0.497259791594961	0.996	1	4.50997050743104e-73	NDUFB10	Malignant cells	GSE131984_JQ1Pal	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41558
2.88319809712774e-77	-0.633759426967337	0.94	0.989	4.55660627270068e-73	ATP5C1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41559
3.38088907253806e-77	-0.703045084281386	0.998	0.998	5.34315709023916e-73	CALM2	Malignant cells	GSE131984_JQ1Pal	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41560
3.6612095108392e-77	0.690927038125327	0.859	0.552	5.78617551093027e-73	APP	Malignant cells	GSE131984_JQ1Pal	ENSG00000142192	351	amyloid beta precursor protein	AD1|alpha-sAPP	protein_coding	P05067	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41561
5.5559054662152e-77	-0.597251410256685	0.907	0.978	8.7805529988065e-73	CUTA	Malignant cells	GSE131984_JQ1Pal	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41562
6.34619562708409e-77	0.721538278029643	0.873	0.589	1.00295275690437e-72	EMP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000134531	2012	epithelial membrane protein 1	CL-20|TMP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41563
8.35431147168019e-77	0.659301316474476	0.577	0.209	1.32031538498434e-72	EPAS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000116016	2034	endothelial PAS domain protein 1	bHLHe73|HIF2A|HLF|MOP2|PASD2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41564
1.12428875680992e-76	-0.660506133080953	0.808	0.931	1.7768259512624e-72	H2AFY	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41565
3.88248309411538e-76	-0.790904803688991	0.786	0.905	6.13587628193994e-72	TCEAL4	Malignant cells	GSE131984_JQ1Pal	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41566
3.90532431823817e-76	0.672346538786456	0.498	0.133	6.17197455254361e-72	PMEPA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000124225	56937	prostate transmembrane protein, androgen induced 1	STAG1|TMEPAI	protein_coding	Q969W9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41567
6.31379184965013e-76	-0.669883320301365	0.812	0.94	9.97831663918707e-72	PAICS	Malignant cells	GSE131984_JQ1Pal	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41568
8.53846681688383e-76	-0.614014748452262	0.915	0.976	1.34941929574032e-71	GLRX5	Malignant cells	GSE131984_JQ1Pal	ENSG00000182512	51218	glutaredoxin 5	C14orf87|GRX5|PR01238	protein_coding	Q86SX6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41569
1.45934361584896e-75	-0.68169190301327	0.719	0.908	2.30634665048769e-71	RNF126	Malignant cells	GSE131984_JQ1Pal	ENSG00000070423	55658	ring finger protein 126	FLJ20552	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41570
1.7810065084565e-75	0.670118773559259	0.685	0.314	2.81470268596465e-71	KANK2	Malignant cells	GSE131984_JQ1Pal	ENSG00000197256	25959	KN motif and ankyrin repeat domains 2	ANKRD25|KIAA1518|MXRA3	protein_coding	Q63ZY3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41571
2.37402289241659e-75	-0.474409776340494	1	1	3.75190577917518e-71	CFL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41572
4.34234015748594e-75	0.631700485684162	0.442	0.092	6.86263438489078e-71	FAM20C	Malignant cells	GSE131984_JQ1Pal	ENSG00000282147	56975	FAM20C golgi associated secretory pathway kinase	DKFZp547D065|DMP4|G-CK|IMAGE:4942737	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41573
4.84145865124944e-75	-0.795777169353594	0.544	0.828	7.65144125243461e-71	MRPL13	Malignant cells	GSE131984_JQ1Pal	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41574
4.92630669273848e-75	-0.56369214261466	0.979	0.992	7.78553509720389e-71	SSR2	Malignant cells	GSE131984_JQ1Pal	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41575
5.62554349950805e-75	0.72248319346828	0.536	0.172	8.89060894662253e-71	ASS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41576
6.40573886093351e-75	0.588917813471798	0.493	0.127	1.01236296958193e-70	OSBPL5	Malignant cells	GSE131984_JQ1Pal	ENSG00000021762	114879	oxysterol binding protein like 5	KIAA1534|OBPH1|ORP5	protein_coding	Q9H0X9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41577
7.32912908320533e-75	0.531225655341691	0.407	0.07	1.15829556030977e-70	NRCAM	Malignant cells	GSE131984_JQ1Pal	ENSG00000091129	4897	neuronal cell adhesion molecule	Bravo|KIAA0343	protein_coding	Q92823	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41578
7.74180212653117e-75	-0.593416481104731	0.881	0.978	1.22351440807699e-70	RAD23A	Malignant cells	GSE131984_JQ1Pal	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41579
1.82493938435712e-74	0.693133093295171	0.865	0.573	2.884134203038e-70	CD81	Malignant cells	GSE131984_JQ1Pal	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41580
2.47150851622886e-74	-0.524413555279236	0.979	0.997	3.90597205904808e-70	MIF	Malignant cells	GSE131984_JQ1Pal	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41581
3.47189314671407e-74	-0.750262366008501	0.881	0.971	5.48697992906691e-70	CCT2	Malignant cells	GSE131984_JQ1Pal	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41582
3.56124271322625e-74	-0.592686866468972	0.983	0.997	5.62818798398277e-70	MRPL36	Malignant cells	GSE131984_JQ1Pal	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41583
5.90520319001607e-74	-0.730790406865945	0.322	0.671	9.3325831215014e-70	GALE	Malignant cells	GSE131984_JQ1Pal	ENSG00000117308	2582	UDP-galactose-4-epimerase	SDR1E1	protein_coding	Q14376	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41584
6.36477165694663e-74	0.724866289806916	0.796	0.495	1.00588851266385e-69	EHD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000024422	30846	EH domain containing 2	PAST2	protein_coding	Q9NZN4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41585
9.6132781235488e-74	-0.681218445542974	0.398	0.734	1.51928247464565e-69	DPM3	Malignant cells	GSE131984_JQ1Pal	ENSG00000179085	54344	dolichyl-phosphate mannosyltransferase subunit 3, regulatory	MGC125904|MGC125905|MGC34275	protein_coding	Q9P2X0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41586
1.07912304186917e-73	-0.794546975544134	0.54	0.811	1.70544605537004e-69	INSIG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41587
1.46385991869843e-73	-0.717775462185317	0.464	0.775	2.313484215511e-69	PPIF	Malignant cells	GSE131984_JQ1Pal	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41588
1.48613523887562e-73	0.629585252097863	1	1	2.34868813151903e-69	MALAT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41589
1.51237065796811e-73	-0.510011470932545	0.983	0.999	2.3901505878528e-69	SRSF9	Malignant cells	GSE131984_JQ1Pal	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41590
2.02274769952212e-73	-0.620784456430484	0.916	0.977	3.19675046432476e-69	GHITM	Malignant cells	GSE131984_JQ1Pal	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41591
2.21261432343307e-73	0.516144752334649	0.331	0.029	3.49681567675363e-69	KIF5C	Malignant cells	GSE131984_JQ1Pal	ENSG00000276734	3800	kinesin family member 5C	NKHC2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41592
2.93209566539349e-73	-0.703915181124402	0.657	0.863	4.63388398958787e-69	COA6	Malignant cells	GSE131984_JQ1Pal	ENSG00000168275	388753	cytochrome c oxidase assembly factor 6	C1orf31	protein_coding	Q5JTJ3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41593
4.76008662755239e-73	-0.750603679727569	0.664	0.863	7.5228409061838e-69	UBE2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41594
7.69696838078323e-73	-0.541498106997704	0.983	0.999	1.21642888289898e-68	NOP10	Malignant cells	GSE131984_JQ1Pal	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41595
8.9035073653847e-73	-0.524527340140277	0.99	0.998	1.4071103040254e-68	PPA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41596
9.07839506111898e-73	0.570311772225037	0.341	0.035	1.43474955545924e-68	CADM3	Malignant cells	GSE131984_JQ1Pal	ENSG00000162706	57863	cell adhesion molecule 3	BIgR|FLJ10698|IGSF4B|Necl-1|NECL1|SynCAM3|TSLL1	protein_coding	Q8N126	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41597
1.55230580241888e-72	-0.415793994972882	1	1	2.45326409014279e-68	S100A6	Malignant cells	GSE131984_JQ1Pal	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41598
2.08161339287085e-72	-0.672071126756525	0.812	0.942	3.28978180609309e-68	RSL1D1	Malignant cells	GSE131984_JQ1Pal	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41599
2.42224547571978e-72	-0.739985132714471	0.323	0.667	3.82811674982754e-68	HMGN5	Malignant cells	GSE131984_JQ1Pal	ENSG00000198157	79366	high mobility group nucleosome binding domain 5	NSBP1	protein_coding	P82970	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41600
2.49911596060549e-72	-0.716585498897029	0.261	0.626	3.94960286414091e-68	CARD16	Malignant cells	GSE131984_JQ1Pal	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41601
2.62970658672481e-72	-0.568546927152746	0.951	0.991	4.15598828965989e-68	NDUFB4	Malignant cells	GSE131984_JQ1Pal	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41602
4.3039724467672e-72	-0.663832763954735	0.971	0.993	6.80199805487088e-68	HSPB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41603
4.42074345694089e-72	0.56895044672186	0.998	0.961	6.98654295934938e-68	AHNAK	Malignant cells	GSE131984_JQ1Pal	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41604
5.57413379260845e-72	-0.692313525762229	0.688	0.885	8.80936104583839e-68	SLC35B1	Malignant cells	GSE131984_JQ1Pal	ENSG00000121073	10237	solute carrier family 35 member B1	AXER|UGTREL1	protein_coding	P78383	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41605
7.15095317545424e-72	-0.684776561474013	0.487	0.781	1.13013663984879e-67	MRPS18B	Malignant cells	GSE131984_JQ1Pal	ENSG00000233813	28973	mitochondrial ribosomal protein S18B	C6orf14|HSPC183|MRPS18-2|PTD017	protein_coding	Q9Y676	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41606
7.22347254139673e-72	0.925468732929741	0.841	0.554	1.14159760044234e-67	CTGF	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41607
9.26262048601251e-72	-0.582298267942687	0.922	0.98	1.46386454160942e-67	RPS19BP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41608
1.01242514367662e-71	-0.629572251455859	0.837	0.966	1.60003669706654e-67	EMC4	Malignant cells	GSE131984_JQ1Pal	ENSG00000128463	51234	ER membrane protein complex subunit 4	FLJ90746|MGC24415|PIG17|TMEM85	protein_coding	Q5J8M3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41609
1.31005630209449e-71	-0.662724008163623	0.838	0.954	2.07041297983013e-67	RBM8A	Malignant cells	GSE131984_JQ1Pal	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41610
1.49428470700112e-71	0.354735674523227	1	1	2.36156755094458e-67	SERF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41611
2.20020965589625e-71	-0.653130590779063	0.909	0.98	3.47721134017843e-67	PSMA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000129084	5682	proteasome 20S subunit alpha 1	HC2|MGC14542|MGC14575|MGC14751|MGC1667|MGC21459|MGC22853|MGC23915|NU|PROS30	protein_coding	P25786	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41612
2.21479450885079e-71	-0.719370078038489	0.673	0.879	3.50026124178779e-67	CENPV	Malignant cells	GSE131984_JQ1Pal	ENSG00000166582	201161	centromere protein V	CENP-V|p30|PRR6	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41613
2.50740348028942e-71	-0.717907176855148	0.363	0.704	3.9627004602494e-67	EMP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000213853	2013	epithelial membrane protein 2	XMP	protein_coding	P54851	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41614
2.71926633454952e-71	-0.624573136799951	0.752	0.923	4.29752851512206e-67	FAM96A	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41615
3.53730283344497e-71	-0.642772544423178	0.508	0.81	5.59035339797644e-67	CUEDC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000107874	79004	CUE domain containing 2	C10orf66|MGC2491	protein_coding	Q9H467	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41616
5.05364210251985e-71	-0.59678888656148	0.088	0.423	7.98677597882238e-67	CASP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000137752	834	caspase 1	ICE|IL1BC	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41617
5.79745032305101e-71	-0.699397563920828	0.572	0.868	9.16229049054981e-67	BST2	Malignant cells	GSE131984_JQ1Pal	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41618
8.32509726039449e-71	-0.571547709111632	0.895	0.978	1.31569837103274e-66	NDUFB8.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41619
1.56866422361221e-70	0.494167335789542	0.352	0.044	2.47911693899674e-66	ADAMTS7	Malignant cells	GSE131984_JQ1Pal	ENSG00000136378	11173	ADAM metallopeptidase with thrombospondin type 1 motif 7	ADAM-TS7|DKFZp434H204	protein_coding	Q9UKP4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41620
2.13160244900085e-70	-0.408736981961686	1	1	3.36878451040094e-66	TMA7	Malignant cells	GSE131984_JQ1Pal	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41621
4.8736751755192e-70	0.686444648117145	0.688	0.348	7.70235624739054e-66	PILRB	Malignant cells	GSE131984_JQ1Pal	ENSG00000121716	29990	paired immunoglobin like type 2 receptor beta	FDFACT1|FDFACT2	protein_coding	Q9UKJ0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41622
6.73319601225473e-70	-0.306507540116924	1	1	1.06411429777674e-65	RPSA	Malignant cells	GSE131984_JQ1Pal	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41623
1.16902233257035e-69	-0.654327223128093	0.43	0.744	1.84752289439418e-65	MRPL9	Malignant cells	GSE131984_JQ1Pal	ENSG00000143436	65005	mitochondrial ribosomal protein L9	NA	protein_coding	Q9BYD2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41624
1.22288528021737e-69	0.682775941829163	0.744	0.44	1.93264789685553e-65	FAM210B	Malignant cells	GSE131984_JQ1Pal	ENSG00000124098	116151	family with sequence similarity 210 member B	C20orf108|dJ1167H4.1|DKFZP434A1114	protein_coding	Q96KR6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41625
1.370487306455e-69	-0.767869978274964	0.067	0.385	2.16591813912148e-65	NUPR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41626
1.7989671595506e-69	-0.687277480948886	0.692	0.916	2.84308769895377e-65	BIRC5	Malignant cells	GSE131984_JQ1Pal	ENSG00000089685	332	baculoviral IAP repeat containing 5	API4|EPR-1|survivin	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41627
2.02650512562768e-69	-0.711430259596205	0.613	0.824	3.20268870054198e-65	UFM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000120686	51569	ubiquitin fold modifier 1	bA131P10.1|C13orf20	protein_coding	P61960	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41628
2.3481027191758e-69	0.336522963803136	1	1	3.71094153738543e-65	UQCRH	Malignant cells	GSE131984_JQ1Pal	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41629
2.83768554115684e-69	-0.789304841510673	0.641	0.849	4.48467822924428e-65	CDC123	Malignant cells	GSE131984_JQ1Pal	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41630
4.11951534631411e-69	-0.562710050156484	0.934	0.989	6.51048205331482e-65	TMED2	Malignant cells	GSE131984_JQ1Pal	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41631
4.46259740091568e-69	-0.594043093174387	0.978	0.998	7.05268893240715e-65	MYL12B	Malignant cells	GSE131984_JQ1Pal	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41632
5.20053124700004e-69	-0.608625357847684	0.81	0.938	8.21891958275886e-65	LMAN2	Malignant cells	GSE131984_JQ1Pal	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41633
6.52817949425489e-69	-0.670577368565713	0.557	0.814	1.03171348727204e-64	LSM6	Malignant cells	GSE131984_JQ1Pal	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41634
6.64135906699735e-69	-0.607527498402968	0.032	0.327	1.04960038694826e-64	DIO2	Malignant cells	GSE131984_JQ1Pal	ENSG00000211448	1734	iodothyronine deiodinase 2	SELENOY|SelY|TXDI2	protein_coding	Q92813	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41635
7.70721897009724e-69	-0.67772632441092	0.846	0.956	1.21804888603417e-64	PSMA5	Malignant cells	GSE131984_JQ1Pal	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41636
8.36632011634468e-69	-0.634869109326129	0.597	0.847	1.32221323118711e-64	BCKDK	Malignant cells	GSE131984_JQ1Pal	ENSG00000103507	10295	branched chain keto acid dehydrogenase kinase	NA	protein_coding	O14874	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41637
1.58422150728299e-68	-0.623072444817908	0.64	0.874	2.50370367011004e-64	NELFE	Malignant cells	GSE131984_JQ1Pal	ENSG00000206268	7936	negative elongation factor complex member E	D6S45|NELF-E|RD|RDBP|RDP	protein_coding	P18615	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41638
2.21094803985428e-68	0.628200730527341	0.635	0.287	3.49418228218571e-64	ITFG3	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41639
2.67543397851269e-68	-0.641166502227371	0.363	0.692	4.22825585964145e-64	MTX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000173171	4580	metaxin 1	MTX|MTXN	protein_coding	Q13505	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41640
2.710194426846e-68	-0.493026432930026	0.99	0.997	4.28319127218743e-64	APRT	Malignant cells	GSE131984_JQ1Pal	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41641
2.76567427353075e-68	-0.649974115177107	0.948	0.984	4.370871621888e-64	MYL12A	Malignant cells	GSE131984_JQ1Pal	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41642
2.99264377894341e-68	-0.484748102374419	0.014	0.289	4.72957422824216e-64	IL7R	Malignant cells	GSE131984_JQ1Pal	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41643
3.01739159854273e-68	-0.669868393533813	0.915	0.984	4.76868568233693e-64	EIF5	Malignant cells	GSE131984_JQ1Pal	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41644
3.72234576042951e-68	0.814924905879032	0.999	0.992	5.8827952397828e-64	NEAT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41645
3.79804598692904e-68	-0.582366020951488	0.868	0.963	6.00243187774266e-64	C11orf31	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41646
3.88873375713978e-68	-0.714113893720321	0.413	0.716	6.1457548297837e-64	GAR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000109534	54433	GAR1 ribonucleoprotein	NOLA1	protein_coding	Q9NY12	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41647
5.28165200068802e-68	-0.507174661087057	0.986	0.993	8.34712282188734e-64	VDAC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41648
5.30669241492832e-68	0.633312920706909	0.744	0.4	8.38669669255271e-64	DDX17	Malignant cells	GSE131984_JQ1Pal	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41649
5.59550920616489e-68	-1.08452676514216	0.492	0.774	8.84314274942299e-64	CCNB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000134057	891	cyclin B1	CCNB	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41650
6.14864986182992e-68	0.655727874052467	0.937	0.732	9.71732624163601e-64	COL6A3	Malignant cells	GSE131984_JQ1Pal	ENSG00000163359	1293	collagen type VI alpha 3 chain	NA	protein_coding	P12111	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41651
8.01865534286759e-68	-0.567112156752822	0.096	0.426	1.26726829038679e-63	APOBEC3B	Malignant cells	GSE131984_JQ1Pal	ENSG00000179750	9582	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	FLJ21201|PHRBNL	protein_coding	Q9UH17	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41652
1.15161190608549e-67	-0.701809058536807	0.572	0.811	1.82000745637751e-63	SEC13	Malignant cells	GSE131984_JQ1Pal	ENSG00000157020	6396	SEC13 homolog, nuclear pore and COPII coat complex component	D3S1231E|npp-20|SEC13L1|SEC13R	protein_coding	P55735	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41653
1.40302908547544e-67	-0.834323072235234	0.255	0.601	2.21734716668539e-63	CES1	Malignant cells	GSE131984_JQ1Pal	ENSG00000262243	1066	carboxylesterase 1	CEH|CES1A1|CES1A2|CES2|HMSE|HMSE1|SES1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41654
1.63648671527575e-67	-0.544422778052476	0.887	0.979	2.58630360482179e-63	METTL5	Malignant cells	GSE131984_JQ1Pal	ENSG00000138382	29081	methyltransferase 5, N6-adenosine	HSPC133	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41655
1.66425724282281e-67	-0.555998532778499	0.853	0.949	2.63019214655717e-63	MRPL11	Malignant cells	GSE131984_JQ1Pal	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41656
2.81931381963298e-67	0.588510514485737	0.577	0.225	4.45564356054797e-63	RAPH1	Malignant cells	GSE131984_JQ1Pal	ENSG00000173166	65059	Ras association (RalGDS/AF-6) and pleckstrin homology domains 1	ALS2CR18|ALS2CR9|KIAA1681	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41657
3.34924665186354e-67	-0.694464951973029	0.567	0.801	5.29314940860513e-63	RRP7A	Malignant cells	GSE131984_JQ1Pal	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41658
3.43382669254406e-67	-0.512012302668965	0.98	0.994	5.42681970489664e-63	UQCRFS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41659
4.05904447662627e-67	-0.548169894694274	0.955	0.994	6.41491389086016e-63	NDUFC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41660
4.79859125671257e-67	0.653823934698691	0.933	0.76	7.58369362210854e-63	SHC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000160691	6464	SHC adaptor protein 1	p66|SHC|ShcA	protein_coding	P29353	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41661
4.80154031118883e-67	-0.504626197101248	0.01	0.277	7.58835430780283e-63	TSPAN8	Malignant cells	GSE131984_JQ1Pal	ENSG00000127324	7103	tetraspanin 8	CO-029|TM4SF3	protein_coding	P19075	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41662
5.53151262045374e-67	-0.622114935510536	0.867	0.974	8.74200254536509e-63	SELK	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41663
1.10390293688639e-66	-0.684796821891015	0.582	0.821	1.74460820145526e-62	TUBG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41664
1.1263221420218e-66	-0.691043361300825	0.161	0.508	1.78003951325126e-62	TNFAIP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41665
1.3853808874372e-66	0.680293994868229	0.968	0.885	2.18945595450575e-62	LARP6	Malignant cells	GSE131984_JQ1Pal	ENSG00000166173	55323	La ribonucleoprotein 6, translational regulator	acheron|FLJ11196	protein_coding	Q9BRS8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41666
1.50676991867749e-66	-0.635143762039484	0.822	0.938	2.3812991794779e-62	MRPL27	Malignant cells	GSE131984_JQ1Pal	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41667
1.59273541045119e-66	-0.640346193561495	0.536	0.807	2.51715904267706e-62	SLC39A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000143570	27173	solute carrier family 39 member 1	ZIP1|ZIRTL	protein_coding	Q9NY26	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41668
1.84835891586205e-66	0.617754450402123	0.695	0.352	2.92114643062839e-62	RP11-545E17.3	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41669
2.14411197334041e-66	-0.58221974768981	0.885	0.972	3.38855456266718e-62	CLTB	Malignant cells	GSE131984_JQ1Pal	ENSG00000175416	1212	clathrin light chain B	Lcb	protein_coding	P09497	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41670
2.19980367786194e-66	-0.548434543527635	0.912	0.983	3.476569732493e-62	C1orf43	Malignant cells	GSE131984_JQ1Pal	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41671
2.62783213378186e-66	-0.693131086177989	0.311	0.645	4.15302590422885e-62	UPF3B	Malignant cells	GSE131984_JQ1Pal	ENSG00000125351	65109	UPF3B regulator of nonsense mediated mRNA decay	HUPF3B|MRX62|MRX82|RENT3B|UPF3BP1|UPF3BP2|UPF3BP3|UPF3X	protein_coding	Q9BZI7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41672
3.32792360205593e-66	-0.630733528453549	0.657	0.878	5.25945046068919e-62	PAFAH1B3	Malignant cells	GSE131984_JQ1Pal	ENSG00000079462	5050	platelet activating factor acetylhydrolase 1b catalytic subunit 3	NA	protein_coding	Q15102	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41673
3.46202437874993e-66	-0.51323055435058	0.976	0.995	5.47138332817639e-62	NDUFV2	Malignant cells	GSE131984_JQ1Pal	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41674
3.70403603040967e-66	-0.676794609653939	0.621	0.848	5.85385854245945e-62	MRPL47	Malignant cells	GSE131984_JQ1Pal	ENSG00000136522	57129	mitochondrial ribosomal protein L47	CGI-204|NCM1	protein_coding	Q9HD33	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41675
3.89690282285266e-66	0.902186343496408	0.353	0.054	6.15866522123634e-62	RP11-669N7.2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41676
4.83614111034603e-66	-0.578400780386938	0.867	0.953	7.64303741079087e-62	UQCC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000137288	84300	ubiquinol-cytochrome c reductase complex assembly factor 2	bA6B20.2|C6orf125|Cbp6|M19|MGC14833|MNF1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41677
6.84322183717665e-66	-0.607663641921914	0.755	0.909	1.0815027791474e-61	PRRC2C	Malignant cells	GSE131984_JQ1Pal	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41678
7.44192618242974e-66	-0.313556970338088	1	1	1.1761220138712e-61	NACA	Malignant cells	GSE131984_JQ1Pal	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41679
7.58359838142864e-66	-0.497344942694732	0.981	0.997	1.19851188820098e-61	EIF2S2	Malignant cells	GSE131984_JQ1Pal	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41680
8.29325446783996e-66	0.644642053346315	0.955	0.828	1.31066593609743e-61	G6PD	Malignant cells	GSE131984_JQ1Pal	ENSG00000160211	2539	glucose-6-phosphate dehydrogenase	G6PD1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41681
9.98074725957281e-66	-0.611710246506592	0.846	0.949	1.57735729690289e-61	NAA20	Malignant cells	GSE131984_JQ1Pal	ENSG00000173418	51126	N-alpha-acetyltransferase 20, NatB catalytic subunit	dJ1002M8.1|NAT3|NAT5	protein_coding	P61599	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41682
1.33275665543684e-65	-0.53447798615397	0.923	0.985	2.10628861825238e-61	TMEM167A	Malignant cells	GSE131984_JQ1Pal	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41683
1.528563074085e-65	-0.60601399441306	0.191	0.541	2.41574108228393e-61	RP1-276N6.2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41684
2.11905252198479e-65	-0.65167671458681	0.054	0.352	3.34895060574476e-61	PRSS23	Malignant cells	GSE131984_JQ1Pal	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41685
2.33450750610958e-65	-0.6721555929648	0.551	0.811	3.68945566265558e-61	MTIF3	Malignant cells	GSE131984_JQ1Pal	ENSG00000122033	219402	mitochondrial translational initiation factor 3	IF-3mt|IF3(mt)	protein_coding	Q9H2K0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41686
2.8725785578062e-65	-0.533025569357797	0.98	0.992	4.53982315275691e-61	SERP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41687
3.3846870941948e-65	-0.601596205587443	0.749	0.904	5.34915948366545e-61	ZNF593	Malignant cells	GSE131984_JQ1Pal	ENSG00000142684	51042	zinc finger protein 593	ZT86	protein_coding	O00488	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41688
4.04922820541363e-65	-0.707103244590827	0.69	0.869	6.3994002558357e-61	VDAC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41689
5.28891244088908e-65	-0.537799725239238	0.975	0.997	8.35859722158111e-61	SPCS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41690
6.31743728683569e-65	-0.767635002128687	0.289	0.63	9.98407788811512e-61	GYPC	Malignant cells	GSE131984_JQ1Pal	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41691
6.54001840873755e-65	-0.5986832973	0.782	0.926	1.03358450931688e-60	MRPL37	Malignant cells	GSE131984_JQ1Pal	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41692
6.8743182237974e-65	-0.746352191295595	0.618	0.833	1.08641725208894e-60	SRGN	Malignant cells	GSE131984_JQ1Pal	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41693
1.92570295680341e-64	-0.994910845547036	0.68	0.868	3.04338095293211e-60	HMGB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41694
2.47347904051021e-64	-0.553752006656928	0.891	0.966	3.90908627562233e-60	CDK4	Malignant cells	GSE131984_JQ1Pal	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41695
3.99334053316499e-64	-0.629870866367269	0.65	0.851	6.31107537861395e-60	FAM136A	Malignant cells	GSE131984_JQ1Pal	ENSG00000035141	84908	family with sequence similarity 136 member A	FLJ14668	protein_coding	Q96C01	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41696
4.64890879001437e-64	0.639774527040388	0.995	0.98	7.34713545173871e-60	CD59	Malignant cells	GSE131984_JQ1Pal	ENSG00000085063	966	CD59 molecule (CD59 blood group)	16.3A5|EJ16|EJ30|EL32|G344|MIC11|MIN1|MIN2|MIN3|MSK21|p18-20	protein_coding	P13987	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41697
5.10094145849528e-64	0.635073583702347	0.854	0.605	8.06152788100594e-60	VAT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000108828	10493	vesicle amine transport 1	FLJ20230|VATI	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41698
6.74733542046335e-64	-0.639851488504396	0.553	0.822	1.06634888985003e-59	SMARCB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41699
7.28356343068607e-64	-0.871042520333608	0.271	0.593	1.15109436458563e-59	HES4	Malignant cells	GSE131984_JQ1Pal	ENSG00000188290	57801	hes family bHLH transcription factor 4	bHLHb42	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41700
7.34644688492584e-64	-0.695737008377968	0.634	0.841	1.16103246569368e-59	SPCS3	Malignant cells	GSE131984_JQ1Pal	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41701
9.54745190055105e-64	-0.530987404685103	0.994	0.997	1.50887929836309e-59	S100A16	Malignant cells	GSE131984_JQ1Pal	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41702
1.24581622212923e-63	-0.654484006483537	0.318	0.647	1.96888795745304e-59	GINS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000131153	51659	GINS complex subunit 2	Pfs2|PSF2	protein_coding	Q9Y248	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41703
1.26573723730628e-63	-0.432592721133625	0.99	0.996	2.00037112983884e-59	C14orf2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41704
1.31287472056296e-63	-0.510958977054106	0.09	0.405	2.0748672083777e-59	PRR16	Malignant cells	GSE131984_JQ1Pal	ENSG00000184838	51334	proline rich 16	DSC54	protein_coding	Q569H4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41705
1.34690938397847e-63	0.569985982727816	0.602	0.256	2.12865559043957e-59	BEST1	Malignant cells	GSE131984_JQ1Pal	ENSG00000167995	7439	bestrophin 1	BEST|BMD|RP50|VMD2	protein_coding	O76090	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41706
1.75687191559305e-63	-0.470320528338588	0.997	1	2.77656037540326e-59	NHP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41707
1.90036937549693e-63	-0.628979461546185	0.695	0.885	3.00334376103534e-59	CHPT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41708
2.39948316247665e-63	-0.324287430974369	1	1	3.7921431899781e-59	RPL38	Malignant cells	GSE131984_JQ1Pal	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41709
2.45647925155929e-63	-0.617169567994029	0.207	0.547	3.88221980916431e-59	TRIM7	Malignant cells	GSE131984_JQ1Pal	ENSG00000146054	81786	tripartite motif containing 7	GNIP|RNF90	protein_coding	Q9C029	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41710
2.4699786068008e-63	-0.745865938780306	0.339	0.651	3.90355419018799e-59	PBDC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000102390	51260	polysaccharide biosynthesis domain containing 1	CXorf26|MGC874	protein_coding	Q9BVG4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41711
2.57907211329049e-63	-0.60072112541367	0.495	0.779	4.07596556784429e-59	COMMD7	Malignant cells	GSE131984_JQ1Pal	ENSG00000149600	149951	COMM domain containing 7	C20orf92|dJ1085F17.3	protein_coding	Q86VX2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41712
2.76814831471401e-63	-0.633601738198399	0.569	0.809	4.37478159657401e-59	TMA16	Malignant cells	GSE131984_JQ1Pal	ENSG00000198498	55319	translation machinery associated 16 homolog	C4orf43|FLJ11184	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41713
3.2235142775488e-63	-0.58103783796777	0.935	0.978	5.09444196423812e-59	CD99	Malignant cells	GSE131984_JQ1Pal	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41714
4.3799141606807e-63	-0.536059368913299	0.994	0.998	6.92201633953978e-59	HN1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41715
5.24198596908189e-63	-0.620975971918454	0.291	0.622	8.28443462553702e-59	SNRNP40	Malignant cells	GSE131984_JQ1Pal	ENSG00000060688	9410	small nuclear ribonucleoprotein U5 subunit 40	HPRP8BP|PRP8BP|PRPF8BP|SPF38|WDR57	protein_coding	Q96DI7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41716
5.87283750663642e-63	-0.691273178770114	0.666	0.838	9.2814323954882e-59	PSMD11	Malignant cells	GSE131984_JQ1Pal	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41717
7.32356659590778e-63	-0.55477305662834	0.888	0.956	1.15741646481727e-58	NPM3	Malignant cells	GSE131984_JQ1Pal	ENSG00000107833	10360	nucleophosmin/nucleoplasmin 3	NA	protein_coding	O75607	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41718
7.53048551842494e-63	-0.677585615248274	0.727	0.893	1.19011793133188e-58	SNRPB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41719
1.44315631637176e-62	-0.645461388446498	0.814	0.945	2.28076424239392e-58	CKS1B	Malignant cells	GSE131984_JQ1Pal	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41720
2.04607893996958e-62	-0.599121468408333	0.962	0.988	3.23362315672792e-58	NCL	Malignant cells	GSE131984_JQ1Pal	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41721
2.69084090695967e-62	-0.57637319374418	0.848	0.959	4.25260496935907e-58	DNPH1	Malignant cells	GSE131984_JQ1Pal	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41722
3.31096566305329e-62	-0.692193674709475	0.834	0.932	5.23265013388941e-58	PCMT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000120265	5110	protein-L-isoaspartate (D-aspartate) O-methyltransferase	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41723
3.76301891497836e-62	-0.81922466376622	0.262	0.583	5.9470750932318e-58	CCNA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000145386	890	cyclin A2	CCN1|CCNA	protein_coding	P20248	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41724
4.52958017140487e-62	-0.856725834542334	0.107	0.42	7.15854850288825e-58	PLAC8	Malignant cells	GSE131984_JQ1Pal	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41725
5.1080250276232e-62	-0.615234961945033	0.664	0.858	8.07272275365571e-58	KARS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41726
5.16483008107122e-62	-0.640073837924415	0.417	0.708	8.16249746012495e-58	MRPS35	Malignant cells	GSE131984_JQ1Pal	ENSG00000061794	60488	mitochondrial ribosomal protein S35	MDS023|MRPS28	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41727
6.61946024131053e-62	-0.606215298897586	0.838	0.926	1.04613949653672e-57	LINC00116	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41728
7.07761977235325e-62	-0.578087811789424	0.935	0.977	1.11854702882271e-57	CDC42	Malignant cells	GSE131984_JQ1Pal	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41729
8.29033831000353e-62	-0.62450915476189	0.713	0.872	1.31020506651296e-57	NT5C	Malignant cells	GSE131984_JQ1Pal	ENSG00000125458	30833	5', 3'-nucleotidase, cytosolic	cdN|DNT-1|DNT1|PN-I|UMPH2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41730
9.39261977189642e-62	-0.546228417576272	0.861	0.965	1.48440962875051e-57	RPL26L1	Malignant cells	GSE131984_JQ1Pal	ENSG00000037241	51121	ribosomal protein L26 like 1	RPL26P1	protein_coding	Q9UNX3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41731
9.70215753684499e-62	-0.508613464087726	0.979	0.997	1.53332897712298e-57	TKT	Malignant cells	GSE131984_JQ1Pal	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41732
2.17727997172966e-61	0.515127301443269	0.475	0.146	3.44097326732155e-57	CD33	Malignant cells	GSE131984_JQ1Pal	ENSG00000105383	945	CD33 molecule	FLJ00391|p67|SIGLEC-3|SIGLEC3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41733
2.31892841114299e-61	-0.680585697748283	0.434	0.715	3.66483446097038e-57	UROD	Malignant cells	GSE131984_JQ1Pal	ENSG00000126088	7389	uroporphyrinogen decarboxylase	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41734
3.13839252245743e-61	-0.492470709803184	0.116	0.434	4.95991554249173e-57	NME6	Malignant cells	GSE131984_JQ1Pal	ENSG00000172113	10201	NME/NM23 nucleoside diphosphate kinase 6	IPIA-ALPHA|NM23-H6	protein_coding	O75414	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41735
4.1055350203958e-61	-0.644423260995295	0.626	0.841	6.48838754623352e-57	WBSCR22	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41736
4.50629419327585e-61	0.256723819108203	1	1	7.12174734305315e-57	RPS11	Malignant cells	GSE131984_JQ1Pal	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41737
5.92000358361667e-61	-0.251531663824295	1	1	9.35597366354779e-57	RPL41	Malignant cells	GSE131984_JQ1Pal	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41738
6.01965011106988e-61	-0.551905174333794	0.79	0.919	9.51345503553484e-57	LSM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000175324	27257	LSM1 homolog, mRNA degradation associated	CASM|YJL124C	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41739
7.7198818432793e-61	-0.781640748035353	0.478	0.752	1.22005012651186e-56	BRIX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000113460	55299	biogenesis of ribosomes BRX1	BRIX|BXDC2|FLJ11100	protein_coding	Q8TDN6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41740
7.80994489780534e-61	-0.675351745307376	0.609	0.822	1.23428369164916e-56	NAE1	Malignant cells	GSE131984_JQ1Pal	ENSG00000159593	8883	NEDD8 activating enzyme E1 subunit 1	APP-BP1|APPBP1|ula-1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41741
9.84726175674175e-61	-0.569995636274991	0.21	0.537	1.55626124803547e-56	PEF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000162517	553115	penta-EF-hand domain containing 1	PEF1A	protein_coding	Q9UBV8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41742
1.10474469726174e-60	-0.535290943865635	0.875	0.96	1.74593851955245e-56	POLD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41743
1.15844270983094e-60	-0.653068774479757	0.938	1	1.83080285861682e-56	KRT7	Malignant cells	GSE131984_JQ1Pal	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41744
1.19165823870692e-60	-0.580775475028234	0.834	0.945	1.88329668045241e-56	PSMG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41745
1.23717154277365e-60	-0.626782057092959	0.996	0.997	1.95522590619948e-56	C5orf38	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41746
1.99687995301333e-60	-0.634595382259144	0.473	0.762	3.15586907774227e-56	TROAP	Malignant cells	GSE131984_JQ1Pal	ENSG00000135451	10024	trophinin associated protein	TASTIN	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41747
3.50233416021651e-60	-0.613260024113508	0.742	0.893	5.53508890680618e-56	RAB2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41748
3.88039369711656e-60	-0.595857000972083	0.752	0.896	6.13257419892301e-56	GSPT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41749
5.03764374103454e-60	-0.469471632424856	0.949	0.992	7.96149216833099e-56	NDUFS8	Malignant cells	GSE131984_JQ1Pal	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41750
5.98409993959439e-60	-0.715474616547113	0.264	0.586	9.45727154453497e-56	CNN3	Malignant cells	GSE131984_JQ1Pal	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41751
7.22417157506899e-60	0.60843295682714	0.84	0.573	1.1417080757239e-55	PYGB	Malignant cells	GSE131984_JQ1Pal	ENSG00000100994	5834	glycogen phosphorylase B	NA	protein_coding	P11216	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41752
1.0234731715377e-59	-0.625045586202908	0.693	0.868	1.61749700029817e-55	PLIN3	Malignant cells	GSE131984_JQ1Pal	ENSG00000105355	10226	perilipin 3	M6PRBP1|PP17|TIP47	protein_coding	O60664	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41753
1.02720105729877e-59	-0.694779360293662	0.508	0.762	1.62338855095498e-55	PPP1R15A	Malignant cells	GSE131984_JQ1Pal	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41754
1.03119388006277e-59	-0.669321359341479	0.456	0.729	1.62969880805119e-55	EMG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000126749	10436	EMG1 N1-specific pseudouridine methyltransferase	C2F|Grcc2f|NEP1	protein_coding	Q92979	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41755
1.35192813089521e-59	-0.530251871094839	0.065	0.352	2.13658721806678e-55	TMEM98	Malignant cells	GSE131984_JQ1Pal	ENSG00000006042	26022	transmembrane protein 98	DKFZP564K1964	protein_coding	Q9Y2Y6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41756
1.46516450816046e-59	-0.546692615513889	0.959	0.989	2.31554598869678e-55	RBX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41757
1.82891749851955e-59	-0.385304022497612	1	1	2.89042121466029e-55	SUMO2	Malignant cells	GSE131984_JQ1Pal	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41758
2.09676734054244e-59	-0.637172167147283	0.266	0.588	3.31373110499327e-55	EXOSC9	Malignant cells	GSE131984_JQ1Pal	ENSG00000123737	5393	exosome component 9	p5|p6|PM/Scl-75|PMSCL1|RRP45|Rrp45p	protein_coding	Q06265	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41759
2.16917609896311e-59	0.610636349528784	0.542	0.219	3.42816590680129e-55	AMOTL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000114019	51421	angiomotin like 2	LCCP	protein_coding	Q9Y2J4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41760
2.1992243104887e-59	-0.641435203465149	0.925	0.978	3.47565410029635e-55	C12orf75	Malignant cells	GSE131984_JQ1Pal	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41761
2.50592363914546e-59	-0.530592741393565	0.923	0.98	3.96036171930548e-55	CYB5A	Malignant cells	GSE131984_JQ1Pal	ENSG00000166347	1528	cytochrome b5 type A	CYB5	protein_coding	P00167	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41762
3.57906657612362e-59	-0.612009274563426	0.597	0.824	5.65635681690576e-55	EMC8	Malignant cells	GSE131984_JQ1Pal	ENSG00000131148	10328	ER membrane protein complex subunit 8	C16orf2|C16orf4|COX4NB|FAM158B|NOC4	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41763
3.68853456263439e-59	-0.722397189788299	0.611	0.812	5.82936002278739e-55	FDPS	Malignant cells	GSE131984_JQ1Pal	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41764
4.4647037101191e-59	0.803441291734282	0.815	0.571	7.05601774347222e-55	PEG10	Malignant cells	GSE131984_JQ1Pal	ENSG00000242265	23089	paternally expressed 10	HB-1|KIAA1051|Mar2|Mart2|MEF3L|RGAG3|RTL2|SIRH1	protein_coding	Q86TG7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41765
4.63027589960286e-59	-0.544005418709252	0.804	0.927	7.31768803173236e-55	MRPL43	Malignant cells	GSE131984_JQ1Pal	ENSG00000055950	84545	mitochondrial ribosomal protein L43	bMRP36a	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41766
5.23728505566226e-59	-0.56307969480599	0.952	0.997	8.27700530196863e-55	PSMB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41767
5.89043942075251e-59	-0.576879718398695	0.802	0.926	9.30925046055727e-55	BANF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41768
6.48883379807279e-59	-0.588156378345715	0.874	0.954	1.02549529344742e-54	YWHAH	Malignant cells	GSE131984_JQ1Pal	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41769
7.14677696801454e-59	-0.619641156680392	0.67	0.852	1.12947663202502e-54	AP1S1	Malignant cells	GSE131984_JQ1Pal	ENSG00000106367	1174	adaptor related protein complex 1 subunit sigma 1	AP19|CLAPS1|EKV3|SIGMA1A|WUGSC:H_DJ0747G18.2	protein_coding	P61966	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41770
7.7729506240885e-59	0.641365001004599	0.786	0.491	1.22843711663095e-54	EVA1B	Malignant cells	GSE131984_JQ1Pal	ENSG00000142694	55194	eva-1 homolog B	C1orf78|FAM176B|FLJ10647	protein_coding	Q9NVM1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41771
9.92294246071817e-59	-0.90816329316505	0.674	0.859	1.5682218264919e-54	KPNA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41772
9.93466460481035e-59	-0.470599831014857	0.968	0.995	1.57007439414423e-54	ZNF706	Malignant cells	GSE131984_JQ1Pal	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41773
1.4190069587927e-58	0.655326394658959	0.861	0.63	2.24259859767599e-54	GCHFR	Malignant cells	GSE131984_JQ1Pal	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41774
2.70022702060415e-58	0.470665111460614	0.343	0.062	4.26743878336281e-54	CADM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000182985	23705	cell adhesion molecule 1	BL2|IGSF4|IGSF4A|Necl-2|NECL2|RA175|ST17|SYNCAM|SYNCAM1|TSLC1	protein_coding	Q9BY67	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41775
2.98520196940515e-58	-0.481468042602697	0.048	0.32	4.7178131924479e-54	RP11-527H14.3	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41776
3.04323335898334e-58	-0.528227750149317	0.966	0.993	4.80952600053727e-54	MRPL12	Malignant cells	GSE131984_JQ1Pal	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41777
3.2470667002741e-58	-0.9724653512499	0.314	0.62	5.13166421311318e-54	PKIB	Malignant cells	GSE131984_JQ1Pal	ENSG00000135549	5570	cAMP-dependent protein kinase inhibitor beta	PRKACN2	protein_coding	Q9C010	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41778
3.61088186249763e-58	0.578379714565931	0.945	0.776	5.70663769549125e-54	PTRF	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41779
3.8221887648092e-58	-0.558970515275761	0.877	0.957	6.04058712390446e-54	OSTC	Malignant cells	GSE131984_JQ1Pal	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41780
4.58821825822143e-58	-0.453193173856991	0.979	0.998	7.25122013529314e-54	MINOS1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41781
4.83522576353986e-58	0.637390448925082	0.88	0.636	7.6415907966984e-54	YWHAG	Malignant cells	GSE131984_JQ1Pal	ENSG00000170027	7532	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma	14-3-3GAMMA|PPP1R170	protein_coding	P61981	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41782
5.080103056631e-58	0.572531233332823	0.996	0.99	8.02859487069964e-54	ARPC1B	Malignant cells	GSE131984_JQ1Pal	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41783
5.34563543694235e-58	0.544993184886593	0.568	0.247	8.44824224454369e-54	RXRA	Malignant cells	GSE131984_JQ1Pal	ENSG00000186350	6256	retinoid X receptor alpha	NR2B1|RXR-alpha|RXRalpha	protein_coding	P19793	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41784
6.51141458654501e-58	-0.437821045670244	0.993	0.997	1.02906396125757e-53	ATP5I	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41785
6.51769639010754e-58	-0.650081387087668	0.517	0.752	1.03005673749259e-53	UBE2E1	Malignant cells	GSE131984_JQ1Pal	ENSG00000170142	7324	ubiquitin conjugating enzyme E2 E1	UbcH6	protein_coding	P51965	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41786
8.56000127333094e-58	0.590600476596019	0.652	0.348	1.35282260123722e-53	STX16	Malignant cells	GSE131984_JQ1Pal	ENSG00000124222	8675	syntaxin 16	hsyn16|SYN-16|SYN16	protein_coding	O14662	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41787
1.19950100663129e-57	-0.478332585029909	0.99	0.999	1.89569139088009e-53	PRDX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41788
1.24271809276762e-57	-0.599666510765479	0.7	0.878	1.96399167380995e-53	FAM127B	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41789
1.39386734856722e-57	-0.572727092906358	0.634	0.851	2.20286795767563e-53	PFDN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000113068	5201	prefoldin subunit 1	PFD1	protein_coding	O60925	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41790
1.92390674532451e-57	-0.493787152488747	0.069	0.352	3.04054222031086e-53	AP1M2	Malignant cells	GSE131984_JQ1Pal	ENSG00000129354	10053	adaptor related protein complex 1 subunit mu 2	AP1-mu2|HSMU1B|mu2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41791
2.07123424522545e-57	0.277780921257762	1	1	3.27337860115429e-53	RPS20	Malignant cells	GSE131984_JQ1Pal	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41792
2.40161320995184e-57	-0.60251476523996	0.67	0.851	3.79550951700788e-53	PPP4C	Malignant cells	GSE131984_JQ1Pal	ENSG00000149923	5531	protein phosphatase 4 catalytic subunit	PP4|PPX	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41793
3.06380574622417e-57	-0.519250600324279	0.957	0.992	4.84203860133268e-53	MDH2	Malignant cells	GSE131984_JQ1Pal	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41794
3.37906117055184e-57	-0.561730252447642	0.806	0.931	5.34026827394012e-53	C3orf14	Malignant cells	GSE131984_JQ1Pal	ENSG00000114405	57415	chromosome 3 open reading frame 14	HT021	protein_coding	Q9HBI5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41795
4.13020591861161e-57	-0.571053538463636	0.682	0.861	6.52737743377378e-53	HIGD1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000181061	25994	HIG1 hypoxia inducible domain family member 1A	DKFZP564K247|HIG1|RCF1A	protein_coding	Q9Y241	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41796
4.15771130373014e-57	-0.554512119973189	0.838	0.941	6.57084694441512e-53	COX16	Malignant cells	GSE131984_JQ1Pal	ENSG00000133983	51241	cytochrome c oxidase assembly factor COX16	C14orf112|HSPC203	protein_coding	Q9P0S2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41797
4.70315411517422e-57	-0.665448698464736	0.363	0.664	7.43286476362134e-53	ACOT9	Malignant cells	GSE131984_JQ1Pal	ENSG00000123130	23597	acyl-CoA thioesterase 9	ACATE2|CGI-16|MT-ACT48	protein_coding	Q9Y305	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41798
5.27332420803514e-57	-0.616860575758719	0.378	0.675	8.33396157837874e-53	DNTTIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000101457	116092	deoxynucleotidyltransferase terminal interacting protein 1	C20orf167|dJ447F3.4|Tdif1	protein_coding	Q9H147	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41799
7.12419986149815e-57	-0.538525153257236	0.997	0.995	1.12590854611117e-52	CAV1	Malignant cells	GSE131984_JQ1Pal	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41800
1.0317712957213e-56	-0.541877460802977	0.915	0.964	1.63061135575794e-52	ARHGDIA	Malignant cells	GSE131984_JQ1Pal	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41801
1.04759973976014e-56	0.608239248302903	0.71	0.412	1.65562662871693e-52	ITGB5	Malignant cells	GSE131984_JQ1Pal	ENSG00000082781	3693	integrin subunit beta 5	NA	protein_coding	P18084	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41802
1.24187369191288e-56	-0.641467377106645	0.492	0.749	1.96265718269912e-52	TIMM8A	Malignant cells	GSE131984_JQ1Pal	ENSG00000126953	1678	translocase of inner mitochondrial membrane 8A	DDP|DFN1|MTS	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41803
1.64738756611612e-56	0.487387705422827	0.987	0.953	2.60353130948991e-52	COMMD6	Malignant cells	GSE131984_JQ1Pal	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41804
2.66931652528766e-56	-0.571235372254722	0.479	0.751	4.21858783656463e-52	MVB12A	Malignant cells	GSE131984_JQ1Pal	ENSG00000141971	93343	multivesicular body subunit 12A	FAM125A|FLJ32495	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41805
3.19999779454542e-56	-0.547891715535795	0.797	0.929	5.05727651449958e-52	PSMD4	Malignant cells	GSE131984_JQ1Pal	ENSG00000159352	5710	proteasome 26S subunit ubiquitin receptor, non-ATPase 4	AF|AF-1|Rpn10|S5A	protein_coding	P55036	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41806
3.51167626847227e-56	-0.805935969532907	0.27	0.587	5.54985317469357e-52	COL1A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000108821	1277	collagen type I alpha 1 chain	OI4	protein_coding	P02452	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41807
3.86594385735329e-56	-0.58920543003257	0.752	0.872	6.10973767216115e-52	SNRNP70	Malignant cells	GSE131984_JQ1Pal	ENSG00000104852	6625	small nuclear ribonucleoprotein U1 subunit 70	RNPU1Z|RPU1|Snp1|SNRP70|U1-70K	protein_coding	P08621	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41808
4.12583648668692e-56	-0.476458102997424	0.916	0.976	6.52047198356e-52	MTCH2	Malignant cells	GSE131984_JQ1Pal	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41809
4.5870130294835e-56	-0.607307342499508	0.896	0.972	7.24931539179573e-52	CCT4	Malignant cells	GSE131984_JQ1Pal	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41810
4.90203605110138e-56	-0.566207695760497	0.812	0.926	7.74717777516062e-52	PDLIM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41811
5.42457980093835e-56	-0.498770795390744	0.91	0.964	8.57300591740296e-52	HDDC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41812
6.62445541550289e-56	-0.601457871784297	0.963	0.992	1.04692893386608e-51	FABP5	Malignant cells	GSE131984_JQ1Pal	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41813
8.61655561935974e-56	-0.720522071412118	0.866	0.971	1.36176045008361e-51	HSP90B1	Malignant cells	GSE131984_JQ1Pal	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41814
1.06450503784927e-55	0.573435686287958	0.739	0.444	1.68234376181698e-51	MGEA5	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41815
1.14946844451596e-55	0.629640443425526	0.735	0.451	1.81661992971303e-51	SLC6A8	Malignant cells	GSE131984_JQ1Pal	ENSG00000130821	6535	solute carrier family 6 member 8	CRT|CRT-1|CRT1|CRTR|CT1	protein_coding	P48029	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41816
1.35595736936859e-55	-0.546112323060772	0.899	0.963	2.14295502655012e-51	SYAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41817
1.75313943123026e-55	-0.489955093689739	0.913	0.975	2.77066155711629e-51	PTP4A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41818
1.76426674455602e-55	-0.55385945187158	0.807	0.917	2.78824716309633e-51	CAPZB	Malignant cells	GSE131984_JQ1Pal	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41819
1.93908613350821e-55	-0.622144146104457	0.433	0.706	3.06453172539637e-51	TMEM70	Malignant cells	GSE131984_JQ1Pal	ENSG00000175606	54968	transmembrane protein 70	FLJ20533	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41820
2.15987428318949e-55	-0.555580442295191	0.781	0.913	3.41346531715267e-51	TMEM126A	Malignant cells	GSE131984_JQ1Pal	ENSG00000171202	84233	transmembrane protein 126A	DKFZp586C1924|OPA7	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41821
3.1951246232773e-55	-0.530866725344623	0.766	0.903	5.04957495462744e-51	CHCHD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000172586	118487	coiled-coil-helix-coiled-coil-helix domain containing 1	C10orf34|FLJ25854	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41822
3.55274579970338e-55	-0.490915466168676	0.923	0.98	5.61475946185121e-51	RAB34	Malignant cells	GSE131984_JQ1Pal	ENSG00000109113	83871	RAB34, member RAS oncogene family	NARR|RAB39|RAH	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41823
3.87693555603717e-55	-0.585092551765884	0.858	0.959	6.12710895276115e-51	NOL7	Malignant cells	GSE131984_JQ1Pal	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41824
3.8983776855987e-55	-0.44484552209295	0.054	0.32	6.16099609432018e-51	RP11-350J20.12	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41825
4.30990320853291e-55	-0.308992347921918	1	1	6.8113710307654e-51	RPS26	Malignant cells	GSE131984_JQ1Pal	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41826
4.38327235930298e-55	-0.61876158501288	0.741	0.893	6.92732363664242e-51	HNRNPH3	Malignant cells	GSE131984_JQ1Pal	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41827
5.35536107305423e-55	-0.651745171611964	0.655	0.835	8.46361263985491e-51	SEC11C	Malignant cells	GSE131984_JQ1Pal	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41828
9.96189339994872e-55	0.546490937477096	0.724	0.431	1.5743776329279e-50	FAM115A	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41829
9.99021209045238e-55	-0.577884171369445	0.32	0.621	1.57885311877509e-50	PLSCR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41830
1.00148381964395e-54	-0.48864740866205	0.928	0.983	1.5827450285653e-50	MRPL33	Malignant cells	GSE131984_JQ1Pal	ENSG00000243147	9553	mitochondrial ribosomal protein L33	C2orf1|RPL33L	protein_coding	O75394	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41831
1.09912012680175e-54	-0.615618711440064	0.682	0.85	1.73704944839749e-50	WDR13	Malignant cells	GSE131984_JQ1Pal	ENSG00000101940	64743	WD repeat domain 13	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41832
1.15690028291635e-54	-0.583262659585758	0.423	0.697	1.828365207121e-50	AGTRAP	Malignant cells	GSE131984_JQ1Pal	ENSG00000177674	57085	angiotensin II receptor associated protein	ATRAP	protein_coding	Q6RW13	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41833
1.248914176267e-54	-0.420614584455656	0.996	0.999	1.97378396417237e-50	MTDH	Malignant cells	GSE131984_JQ1Pal	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41834
1.41778575547866e-54	0.644518784349441	0.632	0.337	2.24066860795848e-50	DUSP4	Malignant cells	GSE131984_JQ1Pal	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41835
1.76374016311403e-54	-0.512337437458089	0.798	0.921	2.78741495378541e-50	TRAPPC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000054116	27095	trafficking protein particle complex subunit 3	BET3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41836
2.15949255843531e-54	-0.610428506112228	0.805	0.923	3.41286203935117e-50	XRCC6	Malignant cells	GSE131984_JQ1Pal	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41837
2.16565552891784e-54	-0.630392835996408	0.541	0.769	3.42260199790175e-50	COPS3	Malignant cells	GSE131984_JQ1Pal	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41838
2.92169925514715e-54	-0.411377171542014	1	1	4.61745350283455e-50	MYL6	Malignant cells	GSE131984_JQ1Pal	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41839
3.40257425945019e-54	-0.580817543928314	0.718	0.867	5.37742835963508e-50	TARS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41840
3.57490915059819e-54	0.392730298122442	0.263	0.025	5.64978642160538e-50	ITGB4	Malignant cells	GSE131984_JQ1Pal	ENSG00000132470	3691	integrin subunit beta 4	CD104	protein_coding	P16144	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41841
3.60878490029078e-54	-0.585126154385878	0.678	0.851	5.70332365641955e-50	PSMD3	Malignant cells	GSE131984_JQ1Pal	ENSG00000108344	5709	proteasome 26S subunit, non-ATPase 3	P58|Rpn3|S3|TSTA2	protein_coding	O43242	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41842
3.81613452791968e-54	-0.558431010292923	0.731	0.884	6.03101900792427e-50	UBE2V2	Malignant cells	GSE131984_JQ1Pal	ENSG00000169139	7336	ubiquitin conjugating enzyme E2 V2	DDVit-1|DDVIT1|EDAF-1|EDPF-1|EDPF1|MMS2|UEV-2|UEV2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41843
4.11426845658162e-54	-0.647232386625563	0.373	0.648	6.5021898687816e-50	NDUFA9	Malignant cells	GSE131984_JQ1Pal	ENSG00000139180	4704	NADH:ubiquinone oxidoreductase subunit A9	CI-39k|COQ11|NDUFS2L|SDR22E1	protein_coding	Q16795	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41844
4.29590170134627e-54	-0.575975203559009	0.932	0.972	6.78924304880764e-50	ATP5F1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41845
4.59319896911136e-54	-0.555248001162767	0.215	0.523	7.2590916507836e-50	MRPS31	Malignant cells	GSE131984_JQ1Pal	ENSG00000102738	10240	mitochondrial ribosomal protein S31	IMOGN38	protein_coding	Q92665	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41846
7.5780021433228e-54	-0.600016356973421	0.428	0.714	1.19762745873074e-49	C14orf119	Malignant cells	GSE131984_JQ1Pal	ENSG00000179933	55017	chromosome 14 open reading frame 119	FLJ20671	protein_coding	Q9NWQ9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41847
9.63740946225333e-54	-0.560622294926335	0.886	0.963	1.52309619141452e-49	GSTO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41848
1.02442051941633e-53	-0.558398761800043	0.799	0.913	1.61899418888557e-49	EIF2S3	Malignant cells	GSE131984_JQ1Pal	ENSG00000130741	1968	eukaryotic translation initiation factor 2 subunit gamma	EIF2|EIF2G|EIF2gamma	protein_coding	P41091	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41849
1.05877352304105e-53	-0.47707642288556	0.958	0.992	1.67328567581408e-49	YBX3	Malignant cells	GSE131984_JQ1Pal	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41850
1.20911811156762e-53	-0.654701336022658	0.638	0.817	1.91089026352146e-49	HPRT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000165704	3251	hypoxanthine phosphoribosyltransferase 1	HGPRT|HPRT	protein_coding	P00492	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41851
1.240844298623e-53	-0.622397346668911	0.752	0.9	1.96103032954378e-49	PRMT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41852
1.70939023034336e-53	0.616373218581709	1	0.997	2.70152032003465e-49	IRX2	Malignant cells	GSE131984_JQ1Pal	ENSG00000170561	153572	iroquois homeobox 2	NA	protein_coding	Q9BZI1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41853
1.87346918189189e-53	-0.462507572741626	0.98	0.99	2.96083069506194e-49	SIVA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41854
1.97340173298587e-53	-0.638708758803517	0.607	0.827	3.11876409881087e-49	HLA-B	Malignant cells	GSE131984_JQ1Pal	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41855
2.04646416818605e-53	-0.624893798388361	0.646	0.854	3.23423197140123e-49	TYMS	Malignant cells	GSE131984_JQ1Pal	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41856
2.11826801871376e-53	-0.489972546395041	0.889	0.977	3.34771077677522e-49	NDUFAF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000164182	91942	NADH:ubiquinone oxidoreductase complex assembly factor 2	B17.2L|mimitin|MMTN|NDUFA12L	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41857
2.24703445428645e-53	-0.434452204112235	0.95	0.99	3.55121325155431e-49	STOML2	Malignant cells	GSE131984_JQ1Pal	ENSG00000165283	30968	stomatin like 2	HSPC108|SLP-2	protein_coding	Q9UJZ1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41858
3.25937533711373e-53	-0.636767959815738	0.471	0.749	5.15111678277454e-49	DNAJB11	Malignant cells	GSE131984_JQ1Pal	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41859
3.2706912883382e-53	-0.461034015311669	0.956	0.987	5.16900051208969e-49	FBL	Malignant cells	GSE131984_JQ1Pal	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41860
4.47823835191981e-53	-0.602632747725439	0.293	0.589	7.07740789137406e-49	FUNDC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000069509	139341	FUN14 domain containing 1	MGC51029	protein_coding	Q8IVP5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41861
4.61986382219496e-53	-0.745710281255159	0.87	0.953	7.30123278459691e-49	PSMA4	Malignant cells	GSE131984_JQ1Pal	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41862
4.95533238787627e-53	0.588620875732802	0.876	0.666	7.83140730579966e-49	F2R	Malignant cells	GSE131984_JQ1Pal	ENSG00000181104	2149	coagulation factor II thrombin receptor	CF2R|PAR-1|PAR1|TR	protein_coding	P25116	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41863
5.9103782511841e-53	0.519801514977601	0.988	0.959	9.34076178817136e-49	CIRBP	Malignant cells	GSE131984_JQ1Pal	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41864
8.36815531644341e-53	-0.404157758231204	1	0.999	1.32250326621072e-48	NDUFS6	Malignant cells	GSE131984_JQ1Pal	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41865
9.68062770654717e-53	-0.640276547775706	0.519	0.759	1.52992640274272e-48	DDX39A	Malignant cells	GSE131984_JQ1Pal	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41866
1.078958479884e-52	-0.53190276411845	0.741	0.896	1.70518598160868e-48	COA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000106603	55744	cytochrome c oxidase assembly factor 1	C7orf44|FLJ10803|MITRAC15	protein_coding	Q9GZY4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41867
1.14743982675789e-52	-0.481442095141838	0.095	0.376	1.81341390220817e-48	UBBP4	Malignant cells	GSE131984_JQ1Pal	ENSG00000263563	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41868
1.16929827319158e-52	-0.548448161055529	0.93	0.989	1.84795899095197e-48	KRT8	Malignant cells	GSE131984_JQ1Pal	ENSG00000170421	3856	keratin 8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	protein_coding	P05787	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41869
1.42144153744838e-52	-0.545478086268336	0.422	0.708	2.24644620578342e-48	KRTCAP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41870
1.73022284672012e-52	0.47596159502682	0.518	0.206	2.73444418695648e-48	RAB40B	Malignant cells	GSE131984_JQ1Pal	ENSG00000141542	10966	RAB40B, member RAS oncogene family	RAR|SEC4L	protein_coding	Q12829	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41871
1.80779525317409e-52	-0.45594341355638	0.938	0.982	2.85703961811633e-48	FAM96B	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41872
1.92527865914639e-52	-0.570430022444125	0.304	0.605	3.04271039291496e-48	GNL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000134697	29889	G protein nucleolar 2	HUMAUANTIG|Ngp-1|Nog2|Nug2	protein_coding	Q13823	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41873
2.43922734989916e-52	0.473356829356798	0.468	0.169	3.85495490378063e-48	NXN	Malignant cells	GSE131984_JQ1Pal	ENSG00000281300	64359	nucleoredoxin	FLJ12614|NRX	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41874
3.77836072932905e-52	-0.529378740341074	0.709	0.878	5.97132129663164e-48	SEP15	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41875
4.59038399818037e-52	-0.655059856028525	0.421	0.689	7.25464287072426e-48	FH	Malignant cells	GSE131984_JQ1Pal	ENSG00000091483	2271	fumarate hydratase	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41876
5.62497453732589e-52	-0.394490651642203	0.066	0.33	8.88970975878984e-48	PACSIN3	Malignant cells	GSE131984_JQ1Pal	ENSG00000165912	29763	protein kinase C and casein kinase substrate in neurons 3	SDPIII	protein_coding	Q9UKS6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41877
1.00460717550923e-51	-0.571043238041646	0.087	0.357	1.58768118017478e-47	BIRC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41878
1.31813338843075e-51	-0.618870173444342	0.566	0.768	2.08317800707596e-47	PPP2CA	Malignant cells	GSE131984_JQ1Pal	ENSG00000113575	5515	protein phosphatase 2 catalytic subunit alpha	PP2AC|PP2Calpha	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41879
2.18869461674347e-51	-0.454398266000858	0.105	0.386	3.45901297230137e-47	ACOX2	Malignant cells	GSE131984_JQ1Pal	ENSG00000168306	8309	acyl-CoA oxidase 2	BRCACOX|BRCOX|THCCox	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41880
2.33122551950883e-51	0.517057301223929	0.533	0.239	3.68426881103176e-47	ACYP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000170634	98	acylphosphatase 2	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41881
4.31313194252048e-51	-0.555871132626434	0.675	0.861	6.81647372195936e-47	TIMM10	Malignant cells	GSE131984_JQ1Pal	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41882
4.44015379493722e-51	-0.51781201593737	0.204	0.503	7.01721905751878e-47	CUTC	Malignant cells	GSE131984_JQ1Pal	ENSG00000119929	51076	cutC copper transporter	CGI-32	protein_coding	Q9NTM9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41883
4.48326347920616e-51	-0.639777335779936	0.422	0.688	7.08534960253741e-47	GRPEL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000109519	80273	GrpE like 1, mitochondrial	FLJ25609|GrpE|hMGE	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41884
4.66237349780447e-51	-0.547765650179116	0.735	0.879	7.36841507593018e-47	MRPL42	Malignant cells	GSE131984_JQ1Pal	ENSG00000198015	28977	mitochondrial ribosomal protein L42	HSPC204|MRP-L31|MRPL31|MRPS32|PTD007|RPML31	protein_coding	Q9Y6G3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41885
5.29641777584116e-51	-0.613195106813914	0.644	0.832	8.37045865293937e-47	TUBA4A	Malignant cells	GSE131984_JQ1Pal	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41886
5.42397626375281e-51	0.546462286127344	0.71	0.428	8.57205208723494e-47	NSMF	Malignant cells	GSE131984_JQ1Pal	ENSG00000165802	26012	NMDA receptor synaptonuclear signaling and neuronal migration factor	NELF	protein_coding	Q6X4W1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41887
8.91345661366561e-51	-0.554738584935727	0.426	0.692	1.40868268322371e-46	PHF5A	Malignant cells	GSE131984_JQ1Pal	ENSG00000100410	84844	PHD finger protein 5A	bK223H9.2|INI|MGC1346|Rds3|SAP14b|SF3b14b|SF3B7	protein_coding	Q7RTV0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41888
9.17179020666337e-51	-0.58950605521683	0.453	0.717	1.44950972426108e-46	ECHDC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000093144	55862	ethylmalonyl-CoA decarboxylase 1	dJ351K20.2	protein_coding	Q9NTX5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41889
9.45029634555478e-51	0.541211241556498	0.687	0.406	1.49352483445148e-46	PTTG1IP	Malignant cells	GSE131984_JQ1Pal	ENSG00000183255	754	PTTG1 interacting protein	C21orf1|C21orf3|PBF|PTTG1IP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41890
1.03842836394623e-50	-0.50152105258267	0.275	0.587	1.64113218638063e-46	MED8	Malignant cells	GSE131984_JQ1Pal	ENSG00000159479	112950	mediator complex subunit 8	ARC32|MGC17544|MGC19641	protein_coding	Q96G25	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41891
1.21888793782519e-50	-0.523678104963852	0.29	0.587	1.92633049693894e-46	TACO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000136463	51204	translational activator of cytochrome c oxidase I	CCDC44	protein_coding	Q9BSH4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41892
1.47423051337282e-50	0.568569931116142	0.647	0.365	2.3298739033344e-46	PNPLA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000177666	57104	patatin like phospholipase domain containing 2	ATGL|desnutrin|FP17548|iPLA2zeta|TTS-2.2	protein_coding	Q96AD5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41893
1.50375346019846e-50	-0.52853282949135	0.935	0.979	2.37653196849765e-46	DDX21	Malignant cells	GSE131984_JQ1Pal	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41894
1.77085091823114e-50	-0.502415933301929	0.917	0.983	2.79865279117249e-46	ATP6V0B	Malignant cells	GSE131984_JQ1Pal	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41895
1.99350618494539e-50	-0.354824876961736	1	1	3.1505371746877e-46	EIF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41896
2.03695637416456e-50	-0.579800927325828	0.077	0.336	3.21920585372968e-46	APOC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000130208	341	apolipoprotein C1	NA	protein_coding	P02654	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41897
2.18476641762613e-50	-0.510414918401916	0.953	0.987	3.45280484641634e-46	TCP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41898
2.46942354784242e-50	-0.640134036125644	0.474	0.733	3.90267697501016e-46	AHSA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41899
2.6028541100375e-50	0.410643861425195	0.467	0.148	4.11355063550327e-46	AC073236.3	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41900
3.09843687187179e-50	-0.478752170619552	0.15	0.442	4.89676963230617e-46	PPARG	Malignant cells	GSE131984_JQ1Pal	ENSG00000132170	5468	peroxisome proliferator activated receptor gamma	NR1C3|PPARG1|PPARG2|PPARgamma	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41901
3.77937402736317e-50	0.520854835965763	0.61	0.314	5.97292271284475e-46	GLG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41902
3.87559523282233e-50	-0.479305775784015	0.957	0.989	6.12499070595241e-46	DEK	Malignant cells	GSE131984_JQ1Pal	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41903
5.03445875317822e-50	-0.490585700650018	0.86	0.948	7.95645861352285e-46	SRRM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41904
7.13158501766874e-50	-0.731530681888591	0.138	0.415	1.12707569619237e-45	PTX3	Malignant cells	GSE131984_JQ1Pal	ENSG00000163661	5806	pentraxin 3	TNFAIP5|TSG-14	protein_coding	P26022	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41905
8.66562817366334e-50	-0.510030649021654	0.869	0.951	1.36951587656575e-45	NDUFAF3	Malignant cells	GSE131984_JQ1Pal	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41906
8.75338887284766e-50	-0.5372350977001	0.983	0.998	1.38338557746484e-45	HSPD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41907
9.12187290530679e-50	-0.634314382039499	0.493	0.727	1.44162079395469e-45	PSMC4	Malignant cells	GSE131984_JQ1Pal	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41908
9.21786558495145e-50	-0.552773467463883	0.446	0.71	1.45679147704573e-45	LLPH	Malignant cells	GSE131984_JQ1Pal	ENSG00000139233	84298	LLP homolog, long-term synaptic facilitation factor	C12orf31|hLLP|MGC14817	protein_coding	Q9BRT6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41909
9.95303076792165e-50	-0.534442361462297	0.289	0.581	1.57297698256234e-45	COMTD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000165644	118881	catechol-O-methyltransferase domain containing 1	FLJ23841	protein_coding	Q86VU5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41910
1.31446632866629e-49	-0.652757534801099	0.458	0.702	2.07738258582421e-45	RUVBL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000284901	8607	RuvB like AAA ATPase 1	ECP54|INO80H|NMP238|Pontin52|RVB1|TIH1|TIP49|TIP49a	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41911
1.42314484762482e-49	0.46592000167182	0.252	0.028	2.24913811718626e-45	RP11-369E15.3	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41912
1.52468518428068e-49	-0.580644925328856	0.437	0.697	2.40961246523719e-45	PLEK2	Malignant cells	GSE131984_JQ1Pal	ENSG00000100558	26499	pleckstrin 2	NA	protein_coding	Q9NYT0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41913
1.54351703903597e-49	-0.692604810235793	0.515	0.787	2.43937432849245e-45	MKI67	Malignant cells	GSE131984_JQ1Pal	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41914
2.59737441768887e-49	-0.591709694606454	0.465	0.71	4.10489052971548e-45	HTATSF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41915
2.63670421416127e-49	-0.540571432407212	0.261	0.549	4.16704734006047e-45	CCDC28B	Malignant cells	GSE131984_JQ1Pal	ENSG00000160050	79140	coiled-coil domain containing 28B	MGC1203|RP4-622L5.5	protein_coding	Q9BUN5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41916
2.85153281548587e-49	-0.656813857226388	0.37	0.64	4.50656246159388e-45	GMNN	Malignant cells	GSE131984_JQ1Pal	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41917
3.12468367933683e-49	-0.52732174556281	0.705	0.869	4.93825008682393e-45	FDX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000137714	2230	ferredoxin 1	ADX|FDX	protein_coding	P10109	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41918
3.59738466470655e-49	-0.55795621926477	0.771	0.9	5.68530672410223e-45	UQCRC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41919
3.63750584321138e-49	-0.576789195777307	0.958	0.978	5.74871423461127e-45	TSC22D1	Malignant cells	GSE131984_JQ1Pal	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41920
5.13267956833821e-49	0.566449873553199	0.607	0.32	8.11168678980171e-45	EPHA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000142627	1969	EPH receptor A2	ECK	protein_coding	P29317	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41921
5.63994423352203e-49	-0.643936477556814	0.235	0.533	8.91336786665821e-45	TRIB3	Malignant cells	GSE131984_JQ1Pal	ENSG00000101255	57761	tribbles pseudokinase 3	C20orf97|dJ1103G7.3|TRB3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41922
5.89089545924039e-49	0.534068560028612	0.529	0.236	9.30997118378352e-45	TP53I3	Malignant cells	GSE131984_JQ1Pal	ENSG00000115129	9540	tumor protein p53 inducible protein 3	PIG3	protein_coding	Q53FA7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41923
6.07480835082452e-49	-0.653604046647927	0.569	0.767	9.60062711764307e-45	GARS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41924
6.78543922717786e-49	-0.413710170599968	0.983	0.999	1.07237081546319e-44	OCIAD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000145247	132299	OCIA domain containing 2	MGC45416	protein_coding	Q56VL3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41925
7.77981928784383e-49	-0.561846492030906	0.619	0.806	1.22952264025084e-44	NDUFA5	Malignant cells	GSE131984_JQ1Pal	ENSG00000128609	4698	NADH:ubiquinone oxidoreductase subunit A5	B13|CI-13kB|CI-13KD-B|NUFM|UQOR13	protein_coding	Q16718	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41926
7.80453462736496e-49	-0.352246056626666	0.036	0.268	1.23342865250876e-44	ACSL5	Malignant cells	GSE131984_JQ1Pal	ENSG00000197142	51703	acyl-CoA synthetase long chain family member 5	ACS2|ACS5|FACL5	protein_coding	Q9ULC5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41927
7.83313019543266e-49	-0.47912989098759	0.88	0.972	1.23794789608618e-44	NDUFA6	Malignant cells	GSE131984_JQ1Pal	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41928
9.64596462933172e-49	-0.499788267048677	0.213	0.5	1.52444825001959e-44	C9orf40	Malignant cells	GSE131984_JQ1Pal	ENSG00000135045	55071	chromosome 9 open reading frame 40	FLJ10110	protein_coding	Q8IXQ3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41929
9.91784226732986e-49	-0.362817913810743	0.044	0.281	1.56741579192881e-44	UGT2B7	Malignant cells	GSE131984_JQ1Pal	ENSG00000171234	7364	UDP glucuronosyltransferase family 2 member B7	UGT2B9	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41930
1.03523739964113e-48	-0.529782472683428	0.531	0.759	1.63608918639284e-44	MED28	Malignant cells	GSE131984_JQ1Pal	ENSG00000118579	80306	mediator complex subunit 28	DKFZP434N185|EG1|magicin	protein_coding	Q9H204	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41931
1.38141809020409e-48	-0.581486170590493	0.396	0.665	2.18319314975855e-44	ECH1	Malignant cells	GSE131984_JQ1Pal	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41932
1.40602263744507e-48	-0.554023162399866	0.391	0.657	2.22207817621818e-44	POLR2C	Malignant cells	GSE131984_JQ1Pal	ENSG00000102978	5432	RNA polymerase II subunit C	RPB3	protein_coding	P19387	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41933
1.41240784948248e-48	-0.493585640494941	0.948	0.989	2.23216936532211e-44	U2AF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000160201	7307	U2 small nuclear RNA auxiliary factor 1	RN|RNU2AF1|U2AF35|U2AFBP	protein_coding	Q01081	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41934
1.55314149250124e-48	-0.503103346966207	0.896	0.971	2.45458481474896e-44	PRDX2	Malignant cells	GSE131984_JQ1Pal	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41935
2.17143456882307e-48	-0.5235817547491	0.195	0.489	3.43173519256798e-44	CKAP4	Malignant cells	GSE131984_JQ1Pal	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41936
3.47745417444194e-48	-0.477296578086383	0.168	0.451	5.49576857728804e-44	ALG14	Malignant cells	GSE131984_JQ1Pal	ENSG00000172339	199857	ALG14 UDP-N-acetylglucosaminyltransferase subunit	MGC19780	protein_coding	Q96F25	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41937
3.5709941876122e-48	-0.473297666982539	0.972	0.987	5.64359921410231e-44	CHCHD10	Malignant cells	GSE131984_JQ1Pal	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41938
3.85933670891956e-48	-0.570312893120752	0.619	0.808	6.09929573477647e-44	MRPL19	Malignant cells	GSE131984_JQ1Pal	ENSG00000115364	9801	mitochondrial ribosomal protein L19	KIAA0104|MRP-L15|RLX1|RPML15	protein_coding	P49406	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41939
3.9184463789204e-48	-0.657202783760174	0.498	0.736	6.1927126572458e-44	NUCB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41940
4.07550804636565e-48	-0.6043256256494	0.419	0.674	6.44093291647627e-44	XBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41941
4.65385479529911e-48	-0.532286660807732	0.232	0.52	7.35495211849072e-44	APOO	Malignant cells	GSE131984_JQ1Pal	ENSG00000184831	79135	apolipoprotein O	FAM121B|MGC4825|Mic23|MIC26|MICOS26|My025	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41942
5.31117147889175e-48	-0.539327404630983	0.695	0.852	8.39377540524051e-44	NABP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000139579	79035	nucleic acid binding protein 2	hSSB1|MGC2731|OBFC2B|SOSS-B1|SSB1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41943
7.83474613057097e-48	-0.639032127085796	0.057	0.297	1.23820327847544e-43	PMAIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41944
9.22633729212374e-48	-0.508586569516029	0.812	0.918	1.45813034564724e-43	UFD1L	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41945
1.01479568824828e-47	-0.462385229498004	0.919	0.973	1.60378310570758e-43	ADRM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41946
1.18809288025205e-47	-0.552088834179726	0.581	0.795	1.87766198795035e-43	TMCO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41947
1.51238961931144e-47	-0.561970249121865	0.633	0.807	2.3901805543598e-43	MRPL24	Malignant cells	GSE131984_JQ1Pal	ENSG00000143314	79590	mitochondrial ribosomal protein L24	MRP-L18	protein_coding	Q96A35	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41948
1.61808729329009e-47	-0.418709706474738	0.954	0.992	2.55722515831566e-43	MZT2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41949
1.7079976260702e-47	-0.506229131170865	0.718	0.877	2.69931944824134e-43	MPC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000060762	51660	mitochondrial pyruvate carrier 1	BRP44L|CGI-129|dJ68L15.3|SLC54A1	protein_coding	Q9Y5U8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41950
1.7971481180681e-47	0.485166347717576	0.412	0.139	2.84021288579482e-43	PLA2R1	Malignant cells	GSE131984_JQ1Pal	ENSG00000153246	22925	phospholipase A2 receptor 1	CLEC13C|PLA2-R|PLA2G1R|PLA2IR	protein_coding	Q13018	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41951
1.88255327271335e-47	-0.337740831528195	0.999	1	2.97518719219618e-43	COX8A	Malignant cells	GSE131984_JQ1Pal	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41952
2.03235179927274e-47	-0.520697406980945	0.179	0.464	3.21192878357063e-43	MRPL39	Malignant cells	GSE131984_JQ1Pal	ENSG00000154719	54148	mitochondrial ribosomal protein L39	C21orf92|FLJ20451|L39mt|MGC104174|MGC3400|MRP-L5|MSTP003|PRED22|PRED66|RPML5	protein_coding	Q9NYK5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41953
2.18706365925077e-47	-0.601202507111616	0.375	0.649	3.45643540707991e-43	UTP11L	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41954
2.39583715380843e-47	-0.70063878127444	0.537	0.753	3.78638103787884e-43	PSMD6	Malignant cells	GSE131984_JQ1Pal	ENSG00000163636	9861	proteasome 26S subunit, non-ATPase 6	KIAA0107|p44S10|Rpn7|S10	protein_coding	Q15008	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41955
2.46090716229346e-47	-0.53655841148455	0.69	0.851	3.88921767928858e-43	AK2	Malignant cells	GSE131984_JQ1Pal	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41956
2.52110603183762e-47	-0.544886641707372	0.788	0.897	3.98435597271617e-43	TUBB6	Malignant cells	GSE131984_JQ1Pal	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41957
2.83293870593436e-47	-0.560237624177601	0.637	0.818	4.47717633085867e-43	GTF2F2	Malignant cells	GSE131984_JQ1Pal	ENSG00000188342	2963	general transcription factor IIF subunit 2	BTF4|RAP30|TFIIF	protein_coding	P13984	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41958
3.0672023880805e-47	-0.486056817775095	0.242	0.525	4.84740665412242e-43	CHCHD4	Malignant cells	GSE131984_JQ1Pal	ENSG00000163528	131474	coiled-coil-helix-coiled-coil-helix domain containing 4	FLJ31709|MIA40|TIMM40	protein_coding	Q8N4Q1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41959
4.21223124294447e-47	-0.45956073436994	0.92	0.97	6.65701025634944e-43	PPP1CC	Malignant cells	GSE131984_JQ1Pal	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41960
4.34743454606702e-47	-0.547390663460844	0.297	0.581	6.87068555660432e-43	EXOSC7	Malignant cells	GSE131984_JQ1Pal	ENSG00000075914	23016	exosome component 7	EAP1|hRrp42p|KIAA0116|p8|RRP42|Rrp42p	protein_coding	Q15024	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41961
6.60898717736367e-47	-0.749067713098503	0.279	0.563	1.04448433351055e-42	PLK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000166851	5347	polo like kinase 1	PLK	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41962
6.69361111733648e-47	-0.512131324241019	0.787	0.896	1.05785830098386e-42	CTDNEP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000288307	23399	CTD nuclear envelope phosphatase 1	DULLARD|HSA011916|NET56	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41963
8.3736030168022e-47	-0.530046995709909	0.308	0.591	1.32336422077542e-42	PCID2	Malignant cells	GSE131984_JQ1Pal	ENSG00000126226	55795	PCI domain containing 2	FLJ11305	protein_coding	Q5JVF3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41964
8.9681884365842e-47	-0.678070036466983	0.618	0.778	1.41733250051777e-42	HDAC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41965
9.44480332648215e-47	-0.491310891348819	0.824	0.915	1.49265671771724e-42	MPLKIP	Malignant cells	GSE131984_JQ1Pal	ENSG00000168303	136647	M-phase specific PLK1 interacting protein	C7orf11|ORF20|TTDN1	protein_coding	Q8TAP9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41966
1.38606461114189e-46	-0.418276342386455	0.976	0.992	2.19053651144864e-42	RHOC	Malignant cells	GSE131984_JQ1Pal	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41967
2.23861420111857e-46	-0.524884504983808	0.58	0.78	3.53790588344779e-42	SMIM12	Malignant cells	GSE131984_JQ1Pal	ENSG00000163866	113444	small integral membrane protein 12	C1orf212|FLJ90372	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41968
2.24578803557179e-46	-0.532839883372503	0.601	0.811	3.54924341141766e-42	CENPN	Malignant cells	GSE131984_JQ1Pal	ENSG00000166451	55839	centromere protein N	BM039|C16orf60|FLJ13607|FLJ22660	protein_coding	Q96H22	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41969
2.66918925476206e-46	-0.516872147090986	0.803	0.909	4.21838669822595e-42	HNRNPM	Malignant cells	GSE131984_JQ1Pal	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41970
2.93803534390526e-46	-0.515467288872254	0.709	0.875	4.64327105750787e-42	HLA-C	Malignant cells	GSE131984_JQ1Pal	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41971
2.9809407553338e-46	-0.478922084930584	0.822	0.936	4.71107876972954e-42	YIF1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000174851	10897	Yip1 interacting factor homolog A, membrane trafficking protein	54TM|FinGER7|YIF1|YIF1P	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41972
4.6056946185937e-46	-0.564672397410888	0.677	0.844	7.27883977522549e-42	PSMC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000165916	5702	proteasome 26S subunit, ATPase 3	RPT5|TBP-1|TBP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41973
4.67193742777925e-46	-0.546372311294479	0.58	0.788	7.38352991086232e-42	CMC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000103121	56942	C-X9-C motif containing 2	C16orf61|DC13|MGC45036	protein_coding	Q9NRP2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41974
4.81143063018605e-46	-0.349026812203397	0.996	0.999	7.60398496794604e-42	MRPL51	Malignant cells	GSE131984_JQ1Pal	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41975
4.95156279604454e-46	0.479275382882581	0.567	0.28	7.82544984286879e-42	CPD	Malignant cells	GSE131984_JQ1Pal	ENSG00000108582	1362	carboxypeptidase D	GP180	protein_coding	O75976	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41976
7.7807097450419e-46	-0.462178701323885	0.891	0.955	1.22966336810642e-41	CSNK2B	Malignant cells	GSE131984_JQ1Pal	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41977
8.32380123836431e-46	-0.539464697842166	0.648	0.844	1.3154935477111e-41	ABRACL	Malignant cells	GSE131984_JQ1Pal	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41978
9.83771369214454e-46	-0.555721764405008	0.718	0.864	1.55475227190652e-41	MLLT11	Malignant cells	GSE131984_JQ1Pal	ENSG00000213190	10962	MLLT11 transcription factor 7 cofactor	AF1Q	protein_coding	Q13015	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41979
1.00921201447603e-45	-0.455486503009128	0.164	0.438	1.59495866767792e-41	MTHFD1L	Malignant cells	GSE131984_JQ1Pal	ENSG00000120254	25902	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like	DKFZP586G1517|FLJ21145|FTHFSDC1	protein_coding	Q6UB35	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41980
1.05689128586518e-45	0.525995598295488	0.967	0.93	1.67031098818133e-41	DCXR	Malignant cells	GSE131984_JQ1Pal	ENSG00000169738	51181	dicarbonyl and L-xylulose reductase	DCR|HCR2|KIDCR|P34H|SDR20C1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41981
1.12638183136038e-45	-0.502806137285144	0.832	0.924	1.78013384628195e-41	MRPS26	Malignant cells	GSE131984_JQ1Pal	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41982
1.43196687331446e-45	0.534481687743223	0.949	0.871	2.26308044658617e-41	METRN	Malignant cells	GSE131984_JQ1Pal	ENSG00000103260	79006	meteorin, glial cell differentiation regulator	C16orf23|MGC2601	protein_coding	Q9UJH8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41983
1.6074651469461e-45	-0.776902474424622	0.691	0.841	2.54043791823362e-41	ANXA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41984
1.64415897649108e-45	-0.527707497538311	0.247	0.53	2.5984288464465e-41	TYMP	Malignant cells	GSE131984_JQ1Pal	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41985
2.06250960670848e-45	-0.581582084897006	0.56	0.754	3.25959018244208e-41	SSSCA1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41986
2.54374035223978e-45	-0.473110578412259	0.796	0.92	4.02012725267974e-41	MRPL17	Malignant cells	GSE131984_JQ1Pal	ENSG00000158042	63875	mitochondrial ribosomal protein L17	MRP-L26|RPML26	protein_coding	Q9NRX2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41987
2.56814279656885e-45	-0.57274415475054	0.501	0.716	4.05869287569741e-41	HAUS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000152240	115106	HAUS augmin like complex subunit 1	CCDC5|FLJ40084|HEI-C|HsT1461	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41988
3.21714602655288e-45	0.547250130720978	0.61	0.336	5.08437758036416e-41	COL5A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000130635	1289	collagen type V alpha 1 chain	NA	protein_coding	P20908	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41989
3.27859675214155e-45	-0.573823953551059	0.532	0.738	5.18149430708451e-41	EIF4E	Malignant cells	GSE131984_JQ1Pal	ENSG00000151247	1977	eukaryotic translation initiation factor 4E	EIF4E1|EIF4EL1|EIF4F	protein_coding	P06730	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41990
3.72840983345768e-45	-0.53526218175803	0.388	0.656	5.89237890079652e-41	EEA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000102189	8411	early endosome antigen 1	ZFYVE2	protein_coding	Q15075	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41991
3.98234348960083e-45	-0.494706850669691	0.845	0.948	6.29369565096515e-41	CAPN2	Malignant cells	GSE131984_JQ1Pal	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41992
4.10162486548731e-45	-0.490058251331491	0.295	0.579	6.48220793741615e-41	WDR18	Malignant cells	GSE131984_JQ1Pal	ENSG00000065268	57418	WD repeat domain 18	Ipi3	protein_coding	Q9BV38	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41993
4.10261549730638e-45	-0.515178278441366	0.68	0.839	6.48377353194301e-41	SDHC	Malignant cells	GSE131984_JQ1Pal	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41994
4.24020259298572e-45	-0.416363279671493	0.923	0.983	6.70121617795462e-41	PDAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41995
7.19255735311762e-45	0.541675496973477	0.79	0.583	1.13671176408671e-40	TGOLN2	Malignant cells	GSE131984_JQ1Pal	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41996
7.38310499126115e-45	-0.52249538209014	0.654	0.813	1.16682591281891e-40	BTF3L4	Malignant cells	GSE131984_JQ1Pal	ENSG00000134717	91408	basic transcription factor 3 like 4	MGC23908	protein_coding	Q96K17	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41997
7.54609986555351e-45	-0.476038061950104	0.287	0.571	1.19258562275208e-40	ACYP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000119640	97	acylphosphatase 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41998
8.04081604936495e-45	-0.61827035368182	0.604	0.786	1.27077056844164e-40	EIF2S1	Malignant cells	GSE131984_JQ1Pal	ENSG00000134001	1965	eukaryotic translation initiation factor 2 subunit alpha	EIF-2alpha|EIF2|EIF2A	protein_coding	P05198	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	41999
8.46327091554008e-45	-0.468132227587786	0.833	0.933	1.33753533549195e-40	MPST	Malignant cells	GSE131984_JQ1Pal	ENSG00000128309	4357	mercaptopyruvate sulfurtransferase	MST|TST2|TUM1	protein_coding	P25325	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42000
8.81196162982611e-45	-0.52879819505424	0.988	0.999	1.39264241597772e-40	UBE2S	Malignant cells	GSE131984_JQ1Pal	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42001
9.05305352002411e-45	-0.376567242822694	0.994	1	1.43074457830461e-40	NAA10	Malignant cells	GSE131984_JQ1Pal	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42002
1.18570627547015e-44	-0.599799909986247	0.509	0.72	1.87389019775303e-40	PSMC6	Malignant cells	GSE131984_JQ1Pal	ENSG00000100519	5706	proteasome 26S subunit, ATPase 6	p42|RPT5	protein_coding	P62333	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42003
1.23801733977011e-44	-0.392564480386679	0.955	0.986	1.95656260377268e-40	C19orf70	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42004
1.35125302858297e-44	-0.473272456280301	0.277	0.557	2.13552028637252e-40	ABT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000146109	29777	activator of basal transcription 1	Esf2	protein_coding	Q9ULW3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42005
1.48478621219257e-44	-0.500436958057189	0.863	0.948	2.34655612974914e-40	EIF6	Malignant cells	GSE131984_JQ1Pal	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42006
1.52702871527011e-44	-0.447896041482039	0.901	0.978	2.41331618161288e-40	NDUFA12	Malignant cells	GSE131984_JQ1Pal	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42007
1.70256788689677e-44	-0.469109278333676	0.846	0.936	2.69073828845166e-40	PRDX3	Malignant cells	GSE131984_JQ1Pal	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42008
2.38028663101569e-44	-0.479679958388703	0.833	0.932	3.7618049916572e-40	GTF2H5	Malignant cells	GSE131984_JQ1Pal	ENSG00000272047	404672	general transcription factor IIH subunit 5	bA120J8.2|C6orf175|FLJ30544|TFB5|TFIIH|TTD|TTD-A|TTDA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42009
2.40375174707247e-44	0.484094441526533	0.562	0.283	3.79888926107333e-40	DLG5	Malignant cells	GSE131984_JQ1Pal	ENSG00000274429	9231	discs large MAGUK scaffold protein 5	KIAA0583|P-dlg	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42010
2.9650532583924e-44	-0.276573091178953	1	1	4.68597016956336e-40	RPL37	Malignant cells	GSE131984_JQ1Pal	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42011
3.09478698275238e-44	-0.341155827581831	0.992	1	4.89100134754187e-40	TAF9	Malignant cells	GSE131984_JQ1Pal	ENSG00000276463	6880	TATA-box binding protein associated factor 9	AD-004|CGI-137|MGC1603|MGC3647|MGC5067|TAF2G|TAFII31|TAFII32|TAFIID32	protein_coding	Q16594	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42012
3.36242113582158e-44	-0.521138833201933	0.453	0.705	5.31397036305243e-40	CCDC12	Malignant cells	GSE131984_JQ1Pal	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42013
4.29942522871451e-44	0.510045511063161	0.861	0.672	6.79481163146041e-40	IPO7	Malignant cells	GSE131984_JQ1Pal	ENSG00000205339	10527	importin 7	Imp7|RANBP7	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42014
4.6585231987596e-44	0.505523222717583	0.964	0.924	7.36233006331967e-40	PHPT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42015
5.45896249267209e-44	-0.439426177258238	0.148	0.412	8.62734432341896e-40	PPIL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000137168	51645	peptidylprolyl isomerase like 1	CYPL1	protein_coding	Q9Y3C6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42016
5.68797426715143e-44	-0.512891812969915	0.358	0.62	8.98927453180612e-40	C14orf1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42017
5.81257253729319e-44	-0.438816121354124	0.88	0.961	9.18618963793815e-40	RNPS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42018
6.0976779157969e-44	-0.4018785619337	0.998	0.999	9.63677017812542e-40	POLR1D	Malignant cells	GSE131984_JQ1Pal	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42019
6.35844811442136e-44	-0.589067468701989	0.562	0.752	1.00488914000315e-39	PMP22	Malignant cells	GSE131984_JQ1Pal	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42020
6.97993170774475e-44	-0.608347476665025	0.707	0.831	1.10310840709198e-39	HSPA9	Malignant cells	GSE131984_JQ1Pal	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42021
7.05116709340069e-44	-0.506070001120677	0.664	0.834	1.11436644744105e-39	NTMT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000148335	28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1	AD-003|C9orf32|HOMT1A|METTL11A|NRMT|NRMT1	protein_coding	Q9BV86	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42022
8.58352225731863e-44	0.50452743582545	0.691	0.428	1.35653985754664e-39	PURB	Malignant cells	GSE131984_JQ1Pal	ENSG00000146676	5814	purine rich element binding protein B	PURBETA	protein_coding	Q96QR8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42023
8.93362847243631e-44	-0.539446399347244	0.657	0.819	1.41187064378383e-39	GTPBP6	Malignant cells	GSE131984_JQ1Pal	ENSG00000178605	8225	GTP binding protein 6 (putative)	FLJ20977|PGPL	protein_coding	O43824	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42024
9.82741140116073e-44	0.561334962836332	0.696	0.459	1.55312409783944e-39	DCBLD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000057019	131566	discoidin, CUB and LCCL domain containing 2	CLCP1|ESDN	protein_coding	Q96PD2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42025
1.01056294723032e-43	-0.530218407238978	0.836	0.93	1.59709368180279e-39	SEPT7	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42026
1.08883356619767e-43	-0.534916086090801	0.424	0.666	1.72079256801879e-39	PPIH	Malignant cells	GSE131984_JQ1Pal	ENSG00000171960	10465	peptidylprolyl isomerase H	CYP-20|CYPH|MGC5016|SnuCyp-20|USA-CYP	protein_coding	O43447	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42027
1.1324692257028e-43	-0.579795230951703	0.465	0.712	1.78975436430071e-39	NREP	Malignant cells	GSE131984_JQ1Pal	ENSG00000134986	9315	neuronal regeneration related protein	C5orf13|D4S114|P311|PRO1873|PTZ17|SEZ17	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42028
1.30627509670864e-43	-0.536896424146356	0.559	0.772	2.06443716283834e-39	RSRC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42029
1.6865155497269e-43	-0.345737031291801	0.999	1	2.6653691747884e-39	COX7C	Malignant cells	GSE131984_JQ1Pal	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42030
1.84796510151222e-43	0.403661902815586	0.435	0.161	2.92052404642992e-39	ZCCHC24	Malignant cells	GSE131984_JQ1Pal	ENSG00000165424	219654	zinc finger CCHC-type containing 24	C10orf56|FLJ90798|Z3CXXC8	protein_coding	Q8N2G6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42031
1.85688916962227e-43	-0.492663463784744	0.339	0.606	2.93462764367104e-39	HSPBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000133265	23640	HSPA (Hsp70) binding protein 1	FES1	protein_coding	Q9NZL4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42032
2.09268403246718e-43	-0.519343116882225	0.479	0.713	3.30727784491113e-39	VPS4A	Malignant cells	GSE131984_JQ1Pal	ENSG00000132612	27183	vacuolar protein sorting 4 homolog A	FLJ22197|SKD1|SKD1A|SKD2|VPS4|VPS4-1	protein_coding	Q9UN37	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42033
2.11282906523029e-43	-0.543050056192894	0.423	0.665	3.33911505468994e-39	FKBP4	Malignant cells	GSE131984_JQ1Pal	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42034
2.11470268001816e-43	-0.476631775443652	0.84	0.922	3.3420761155007e-39	MAD2L2	Malignant cells	GSE131984_JQ1Pal	ENSG00000116670	10459	mitotic arrest deficient 2 like 2	FANCV|MAD2B|POLZ2|REV7	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42035
2.15999066370582e-43	-0.508741671798318	0.207	0.479	3.41364924492068e-39	POLR3G	Malignant cells	GSE131984_JQ1Pal	ENSG00000113356	10622	RNA polymerase III subunit G	C31|RPC32|RPC7	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42036
2.45740735733154e-43	0.505032156947238	0.605	0.336	3.88368658752677e-39	ABHD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000140526	11057	abhydrolase domain containing 2, acylglycerol lipase	LABH2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42037
2.68754044048727e-43	0.471796244362112	0.553	0.275	4.24738891214608e-39	MTURN	Malignant cells	GSE131984_JQ1Pal	ENSG00000180354	222166	maturin, neural progenitor differentiation regulator homolog	C7orf41|Ells1|FLJ25903	protein_coding	Q8N3F0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42038
2.84374819536606e-43	-0.537425475865683	0.211	0.479	4.49425964795652e-39	NUP37	Malignant cells	GSE131984_JQ1Pal	ENSG00000075188	79023	nucleoporin 37	FLJ22618|MGC5585	protein_coding	Q8NFH4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42039
2.86580178838241e-43	-0.505554133888681	0.731	0.85	4.52911314635956e-39	DCTN2	Malignant cells	GSE131984_JQ1Pal	ENSG00000175203	10540	dynactin subunit 2	DCTN-50|RBP50	protein_coding	Q13561	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42040
3.02955547099724e-43	0.50115841330148	0.629	0.352	4.78790946636404e-39	MFGE8	Malignant cells	GSE131984_JQ1Pal	ENSG00000140545	4240	milk fat globule EGF and factor V/VIII domain containing	BA46|EDIL1|hP47|HsT19888|MFG-E8|OAcGD3S|SED1|SPAG10	protein_coding	Q08431	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42041
3.32823313560448e-43	-0.38823598205781	0.963	0.989	5.25993964750933e-39	TMEM258	Malignant cells	GSE131984_JQ1Pal	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42042
3.66043385434612e-43	-0.517200649262057	0.642	0.811	5.78494966340861e-39	SREK1IP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000153006	285672	SREK1 interacting protein 1	FLJ36754|P18SRP|SFRS12IP1	protein_coding	Q8N9Q2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42043
3.73531490046842e-43	-0.418360930644865	0.963	0.992	5.90329166870028e-39	RHEB	Malignant cells	GSE131984_JQ1Pal	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42044
4.98752174128872e-43	-0.545420830567915	0.397	0.643	7.8822793599327e-39	FRG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000275145	2483	FSHD region gene 1	FRG1A|FSG1	protein_coding	Q14331	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42045
5.03737214027741e-43	-0.511672085955209	0.695	0.857	7.96106293049442e-39	MRPL32	Malignant cells	GSE131984_JQ1Pal	ENSG00000106591	64983	mitochondrial ribosomal protein L32	bMRP-59b|HSPC283|L32mt|MRP-L32	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42046
5.79868447758692e-43	-0.563759907128171	0.204	0.482	9.16424094837837e-39	SPC25	Malignant cells	GSE131984_JQ1Pal	ENSG00000277909	57405	SPC25 component of NDC80 kinetochore complex	AD024|MGC22228|SPBC25	protein_coding	Q9HBM1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42047
6.45922715884601e-43	0.391101316808891	0.41	0.141	1.02081626018402e-38	FBXO25	Malignant cells	GSE131984_JQ1Pal	ENSG00000147364	26260	F-box protein 25	FBX25	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42048
7.066211888562e-43	-0.475122202791165	0.165	0.43	1.11674412686834e-38	STEAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000164647	26872	STEAP family member 1	PRSS24|STEAP	protein_coding	Q9UHE8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42049
7.14208708305092e-43	-0.628429125061891	0.284	0.539	1.12873544260537e-38	CASC8	Malignant cells	GSE131984_JQ1Pal	ENSG00000246228	727677	cancer susceptibility 8	CARLo-1|LINC00860	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42050
7.23567339278838e-43	-0.513600548705134	0.433	0.673	1.14352582299628e-38	ERO1L	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42051
7.54570969224778e-43	-0.368835322444111	1	1	1.19252395976284e-38	GPX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42052
7.7380372465865e-43	-0.504620009725045	0.363	0.629	1.22291940645053e-38	TSR2	Malignant cells	GSE131984_JQ1Pal	ENSG00000158526	90121	TSR2 ribosome maturation factor	DT1P1A10|RP1-112K5.2|WGG1	protein_coding	Q969E8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42053
8.43765066326946e-43	0.406675765003475	0.367	0.117	1.33348631082311e-38	PIK3R3	Malignant cells	GSE131984_JQ1Pal	ENSG00000117461	8503	phosphoinositide-3-kinase regulatory subunit 3	p55	protein_coding	Q92569	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42054
8.47077205612382e-43	0.485884460466491	0.812	0.582	1.33872081574981e-38	FAM120A	Malignant cells	GSE131984_JQ1Pal	ENSG00000048828	23196	family with sequence similarity 120A	C9orf10|KIAA0183|OSSA	protein_coding	Q9NZB2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42055
9.76294002620119e-43	0.519834730201211	0.829	0.616	1.54293504174084e-38	NME3	Malignant cells	GSE131984_JQ1Pal	ENSG00000103024	4832	NME/NM23 nucleoside diphosphate kinase 3	DR-nm23|NDPKC|NM23-H3	protein_coding	Q13232	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42056
1.16341338929356e-42	0.457950298638517	0.455	0.188	1.83865852043954e-38	APCDD1L	Malignant cells	GSE131984_JQ1Pal	ENSG00000198768	164284	APC down-regulated 1 like	FLJ90166	protein_coding	Q8NCL9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42057
1.23863538489246e-42	-0.445728812009167	0.847	0.931	1.95753936228404e-38	C8orf59	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42058
1.5473548680374e-42	-0.587422224599977	0.794	0.877	2.4454396334463e-38	PSMD14	Malignant cells	GSE131984_JQ1Pal	ENSG00000115233	10213	proteasome 26S subunit, non-ATPase 14	pad1|POH1|Rpn11	protein_coding	O00487	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42059
1.60261367446058e-42	-0.498325422378564	0.59	0.786	2.53277065111749e-38	UBE2J2	Malignant cells	GSE131984_JQ1Pal	ENSG00000160087	118424	ubiquitin conjugating enzyme E2 J2	NCUBE2|Ubc6p	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42060
1.97097227793724e-42	0.493972829537505	0.666	0.402	3.11492458805202e-38	PCSK7	Malignant cells	GSE131984_JQ1Pal	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42061
2.29089007450139e-42	0.433456505075939	0.414	0.156	3.620522673742e-38	PTPRS	Malignant cells	GSE131984_JQ1Pal	ENSG00000105426	5802	protein tyrosine phosphatase receptor type S	NA	protein_coding	Q13332	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42062
2.43999586637479e-42	-0.520820608948645	0.623	0.814	3.85616946721872e-38	NCOR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42063
3.90884635784403e-42	-0.491101783889209	0.22	0.482	6.1775407839367e-38	BTG3	Malignant cells	GSE131984_JQ1Pal	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42064
3.90898561529312e-42	0.387791128573337	0.361	0.114	6.17776086640925e-38	LTBP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000168056	4054	latent transforming growth factor beta binding protein 3	LTBP2	protein_coding	Q9NS15	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42065
4.98645711620474e-42	-0.559420547420871	0.415	0.672	7.88059682644997e-38	ACAT2	Malignant cells	GSE131984_JQ1Pal	ENSG00000120437	39	acetyl-CoA acetyltransferase 2	NA	protein_coding	Q9BWD1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42066
5.84601803957694e-42	-0.528051200442208	0.25	0.517	9.23904690974739e-38	VRK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100749	7443	VRK serine/threonine kinase 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42067
5.8731514267347e-42	-0.512691944278562	0.664	0.828	9.28192851481153e-38	POLR3K	Malignant cells	GSE131984_JQ1Pal	ENSG00000161980	51728	RNA polymerase III subunit K	C11|RPC11	protein_coding	Q9Y2Y1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42068
7.66209821069539e-42	0.432184604119976	0.502	0.232	1.2109180012183e-37	PLXNB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000196576	23654	plexin B2	KIAA0315|MM1|PLEXB2	protein_coding	O15031	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42069
8.06613843793592e-42	-0.541451109580504	0.393	0.647	1.27477251873139e-37	SNW1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100603	22938	SNW domain containing 1	Bx42|FUN20|NCoA-62|Prp45|PRPF45|SKIIP|SKIP|SKIP1	protein_coding	Q13573	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42070
8.36383272376757e-42	0.576408444925485	0.698	0.438	1.32182012366423e-37	SERPINE2	Malignant cells	GSE131984_JQ1Pal	ENSG00000135919	5270	serpin family E member 2	GDN|nexin|PI7|PN1|PNI	protein_coding	P07093	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42071
8.3840133745944e-42	0.505436964944522	0.603	0.325	1.3250094737209e-37	COL6A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000142156	1291	collagen type VI alpha 1 chain	NA	protein_coding	P12109	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42072
9.16512392311582e-42	-0.506176436161035	0.546	0.759	1.44845618480922e-37	WBP11	Malignant cells	GSE131984_JQ1Pal	ENSG00000084463	51729	WW domain binding protein 11	BUG13|NPWBP|PPP1R165|SIPP1	protein_coding	Q9Y2W2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42073
9.47828416382016e-42	-0.464143856381893	0.221	0.487	1.49794802925014e-37	CCDC86	Malignant cells	GSE131984_JQ1Pal	ENSG00000110104	79080	coiled-coil domain containing 86	cyclon|MGC2574	protein_coding	Q9H6F5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42074
1.48343616531729e-41	0.486433839562381	0.632	0.366	2.34442251566744e-37	SRD5A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000145545	6715	steroid 5 alpha-reductase 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42075
1.92455251096326e-41	-0.524112602414098	0.616	0.797	3.04156278832633e-37	ISOC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42076
2.2313780463639e-41	-0.656921231485086	0.435	0.664	3.52646986447351e-37	MAD2L1	Malignant cells	GSE131984_JQ1Pal	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42077
2.25695080224821e-41	-0.348818787906284	1	1	3.56688504787306e-37	VIM	Malignant cells	GSE131984_JQ1Pal	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42078
2.32688513461918e-41	-0.535833870247439	0.587	0.779	3.67740926675215e-37	USP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42079
2.97025776196717e-41	0.525177287687918	0.6	0.338	4.69419536701291e-37	SH2B3	Malignant cells	GSE131984_JQ1Pal	ENSG00000111252	10019	SH2B adaptor protein 3	IDDM20|LNK	protein_coding	Q9UQQ2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42080
3.55167325770176e-41	-0.438359444919832	0.864	0.938	5.61306441647186e-37	NUTF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000102898	10204	nuclear transport factor 2	NTF2|PP15	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42081
3.65593443493135e-41	-0.542431450878389	0.742	0.872	5.7778387809655e-37	ARL6IP5	Malignant cells	GSE131984_JQ1Pal	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42082
3.83132291314343e-41	-0.483746890699093	0.814	0.907	6.05502273193187e-37	GDI2	Malignant cells	GSE131984_JQ1Pal	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42083
4.01865903753681e-41	0.41987509562888	0.469	0.201	6.35108874292317e-37	BMPR2	Malignant cells	GSE131984_JQ1Pal	ENSG00000204217	659	bone morphogenetic protein receptor type 2	BMPR-II|BMPR3|BRK-3|PPH1|T-ALK	protein_coding	Q13873	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42084
4.65380657347241e-41	-0.407994565611868	0.104	0.348	7.3548759087158e-37	LAMB3	Malignant cells	GSE131984_JQ1Pal	ENSG00000196878	3914	laminin subunit beta 3	BM600-125kDa|kalinin-140kDa|LAMNB1|nicein-125kDa	protein_coding	Q13751	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42085
4.96513918410985e-41	-0.447220895129951	0.861	0.949	7.8469059665672e-37	POLDIP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42086
5.81350780299725e-41	-0.456427517710297	0.738	0.877	9.18766773185686e-37	POLR2K	Malignant cells	GSE131984_JQ1Pal	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42087
6.27196628819089e-41	-0.529051466337928	0.703	0.849	9.91221552185688e-37	DKC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42088
6.97195556954825e-41	0.401982592835626	0.387	0.136	1.10184785821141e-36	GLCE	Malignant cells	GSE131984_JQ1Pal	ENSG00000138604	26035	glucuronic acid epimerase	HSEPI|KIAA0836	protein_coding	O94923	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42089
6.97966177288073e-41	-0.329319319893857	0.999	0.999	1.10306574658607e-36	DBI	Malignant cells	GSE131984_JQ1Pal	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42090
8.36543957939438e-41	-0.427655631108387	0.286	0.573	1.32207407112749e-36	SORBS3	Malignant cells	GSE131984_JQ1Pal	ENSG00000120896	10174	sorbin and SH3 domain containing 3	SCAM-1|SH3D4|vinexin	protein_coding	O60504	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42091
8.5044088220792e-41	-0.466580944598536	0.406	0.656	1.3440367702414e-36	ITGB3BP	Malignant cells	GSE131984_JQ1Pal	ENSG00000142856	23421	integrin subunit beta 3 binding protein	CENPR|HSU37139|NRIF3|TAP20	protein_coding	Q13352	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42092
8.988968067827e-41	0.466776745305586	0.498	0.24	1.42061651343938e-36	PQLC3	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42093
9.82428204653386e-41	-0.331920179586771	0.998	1	1.55262953463421e-36	PDCD5	Malignant cells	GSE131984_JQ1Pal	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42094
1.04221724215149e-40	-0.526538335137583	0.998	0.999	1.64712012949621e-36	EIF4A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42095
1.24580573530056e-40	-0.503505604055356	0.696	0.841	1.968871384069e-36	GPATCH4	Malignant cells	GSE131984_JQ1Pal	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42096
1.32532885768932e-40	-0.513295664575888	0.904	0.968	2.0945497266922e-36	CCT3	Malignant cells	GSE131984_JQ1Pal	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42097
1.49307013151203e-40	-0.497600983908961	0.692	0.849	2.35964803584162e-36	WTAP	Malignant cells	GSE131984_JQ1Pal	ENSG00000146457	9589	WT1 associated protein	KIAA0105|MGC3925|Mum2	protein_coding	Q15007	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42098
1.62521909449936e-40	0.45525302880108	0.572	0.308	2.5684962569468e-36	EIF4EBP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000148730	1979	eukaryotic translation initiation factor 4E binding protein 2	NA	protein_coding	Q13542	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42099
1.75238279528506e-40	0.405651915462654	0.319	0.089	2.7694657696685e-36	GPAM	Malignant cells	GSE131984_JQ1Pal	ENSG00000119927	57678	glycerol-3-phosphate acyltransferase, mitochondrial	GPAT1|KIAA1560|MGC26846	protein_coding	Q9HCL2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42100
1.81712232166797e-40	0.461606479710603	0.651	0.392	2.87178011716407e-36	ESYT2	Malignant cells	GSE131984_JQ1Pal	ENSG00000117868	57488	extended synaptotagmin 2	CHR2SYT|FAM62B|KIAA1228	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42101
2.22009393514448e-40	-0.44746490733406	0.127	0.373	3.50863645510233e-36	NRG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000157168	3084	neuregulin 1	GGF|HGL|HRG|NDF|NRG1-IT2	protein_coding	Q02297	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42102
2.22310808851964e-40	-0.466479662491933	0.328	0.583	3.51340002309644e-36	ZNRD1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42103
2.68538695614688e-40	-0.481313003990778	0.235	0.5	4.24398554549454e-36	AIFM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000156709	9131	apoptosis inducing factor mitochondria associated 1	AIF|AUNX1|CMTX4|DFNX5|NAMSD|PDCD8	protein_coding	O95831	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42104
2.7244319847753e-40	-0.537688440596054	0.698	0.838	4.30569230873888e-36	BLVRB	Malignant cells	GSE131984_JQ1Pal	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42105
2.76846128276244e-40	-0.503565932946212	0.214	0.479	4.37527621127776e-36	EPHB6	Malignant cells	GSE131984_JQ1Pal	ENSG00000275482	2051	EPH receptor B6	HEP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42106
2.93872861296819e-40	0.426829804567793	0.489	0.221	4.64436669993493e-36	SDC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000162512	9672	syndecan 3	N-syndecan|SYND3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42107
3.16253336402439e-40	-0.470307045146671	0.356	0.618	4.99806772850414e-36	SPG20	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42108
3.71231956516127e-40	0.502618829858571	0.502	0.236	5.86694984078087e-36	SGK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42109
3.99884518858098e-40	-0.400498096332035	0.932	0.98	6.31977493603338e-36	DGUOK	Malignant cells	GSE131984_JQ1Pal	ENSG00000114956	1716	deoxyguanosine kinase	dGK	protein_coding	Q16854	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42110
4.38215584770233e-40	0.538932028073119	0.856	0.644	6.92555910170875e-36	HMOX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100292	3162	heme oxygenase 1	bK286B10|HO-1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42111
4.52137350724154e-40	-0.433230077219358	0.762	0.913	7.14557869084453e-36	MRPL40	Malignant cells	GSE131984_JQ1Pal	ENSG00000185608	64976	mitochondrial ribosomal protein L40	MRP-L22|NLVCF	protein_coding	Q9NQ50	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42112
6.33644705609469e-40	-0.544066653444849	0.418	0.683	1.0014120927452e-35	CCNB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000157456	9133	cyclin B2	HsT17299	protein_coding	O95067	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42113
6.83643365531096e-40	-0.374913333285751	0.999	1	1.08042997488534e-35	KRT10	Malignant cells	GSE131984_JQ1Pal	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42114
6.90717295391206e-40	-0.450425176207495	0.827	0.925	1.09160961363626e-35	LAPTM4B	Malignant cells	GSE131984_JQ1Pal	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42115
7.01142395912862e-40	-0.536162736610425	0.469	0.707	1.10808544250069e-35	ACAA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000167315	10449	acetyl-CoA acyltransferase 2	DSAEC	protein_coding	P42765	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42116
7.08766252322064e-40	-0.509856817157445	0.411	0.655	1.12013418516979e-35	IFI16	Malignant cells	GSE131984_JQ1Pal	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42117
7.23747252235986e-40	-0.510068596678672	0.698	0.844	1.14381015743375e-35	COA3	Malignant cells	GSE131984_JQ1Pal	ENSG00000183978	28958	cytochrome c oxidase assembly factor 3	CCDC56|COX25|hCOA3|HSPC009|MITRAC12	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42118
7.71298590501726e-40	-0.367854542629982	0.12	0.367	1.21896029242893e-35	GPKOW	Malignant cells	GSE131984_JQ1Pal	ENSG00000068394	27238	G-patch domain and KOW motifs	GPATC5|GPATCH5|Mos2|Spp2|T54	protein_coding	Q92917	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42119
9.56406685966831e-40	-0.547142937033571	0.561	0.752	1.51150512650198e-35	HEXB	Malignant cells	GSE131984_JQ1Pal	ENSG00000049860	3074	hexosaminidase subunit beta	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42120
1.1580439443183e-39	-0.49517109748734	0.3	0.565	1.83017264960065e-35	UGDH	Malignant cells	GSE131984_JQ1Pal	ENSG00000109814	7358	UDP-glucose 6-dehydrogenase	NA	protein_coding	O60701	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42121
1.21334373416485e-39	-0.476434578976351	0.788	0.884	1.91756843747413e-35	LSM10	Malignant cells	GSE131984_JQ1Pal	ENSG00000181817	84967	LSM10, U7 small nuclear RNA associated	MGC15749	protein_coding	Q969L4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42122
1.24493283963016e-39	0.300396680885574	1	1	1.9674918597515e-35	EEF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42123
1.25910167047284e-39	0.479142535878629	0.742	0.501	1.98988428001528e-35	LASP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000002834	3927	LIM and SH3 protein 1	Lasp-1|MLN50	protein_coding	Q14847	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42124
1.30292196958794e-39	-0.327705688545102	1	1	2.05913788073678e-35	SNX3	Malignant cells	GSE131984_JQ1Pal	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42125
1.48051211719139e-39	-0.623543300469847	0.677	0.823	2.33980135000927e-35	ARF4	Malignant cells	GSE131984_JQ1Pal	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42126
1.55508046010825e-39	-0.482026559317223	0.341	0.598	2.45764915915508e-35	EIF2B1	Malignant cells	GSE131984_JQ1Pal	ENSG00000111361	1967	eukaryotic translation initiation factor 2B subunit alpha	EIF-2B|EIF-2Balpha|EIF2B|EIF2BA|EIF2Balpha	protein_coding	Q14232	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42127
1.69333818169751e-39	0.538335723160984	0.523	0.265	2.67615166235474e-35	CRIP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000182809	1397	cysteine rich protein 2	CRP2|ESP1	protein_coding	P52943	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42128
1.75455097276571e-39	0.396650077297229	0.338	0.103	2.77289235735893e-35	CXXC5	Malignant cells	GSE131984_JQ1Pal	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42129
2.13884743708691e-39	-0.50442688853688	0.346	0.602	3.38023448957216e-35	RBM42	Malignant cells	GSE131984_JQ1Pal	ENSG00000126254	79171	RNA binding motif protein 42	MGC10433	protein_coding	Q9BTD8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42130
2.40612184542081e-39	-0.484514948304799	0.763	0.874	3.80263496450305e-35	CHCHD3	Malignant cells	GSE131984_JQ1Pal	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42131
3.07847318230499e-39	0.52555226895599	0.639	0.395	4.8652190173148e-35	WEE1	Malignant cells	GSE131984_JQ1Pal	ENSG00000166483	7465	WEE1 G2 checkpoint kinase	WEE1A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42132
3.21778506654959e-39	-0.541955372919179	0.502	0.682	5.08538751917497e-35	TCEAL8	Malignant cells	GSE131984_JQ1Pal	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42133
3.38328295336728e-39	-0.523027153213333	0.283	0.537	5.34694037950165e-35	AC074389.9	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42134
3.55308559820115e-39	0.404696184011571	0.402	0.154	5.6152964793971e-35	RIPK4	Malignant cells	GSE131984_JQ1Pal	ENSG00000183421	54101	receptor interacting serine/threonine kinase 4	ANKK2|ANKRD3|DIK|PKK|RIP4	protein_coding	P57078	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42135
3.58812642829357e-39	-0.425677460941288	0.227	0.491	5.67067500727516e-35	ANKRD29	Malignant cells	GSE131984_JQ1Pal	ENSG00000154065	147463	ankyrin repeat domain 29	FLJ25053	protein_coding	Q8N6D5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42136
3.97899330911772e-39	-0.35606794233533	0.122	0.368	6.28840102572964e-35	IL15RA	Malignant cells	GSE131984_JQ1Pal	ENSG00000134470	3601	interleukin 15 receptor subunit alpha	CD215|IL-15RA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42137
4.0141358165632e-39	0.490622399663157	0.757	0.531	6.34394024449648e-35	PTPN14	Malignant cells	GSE131984_JQ1Pal	ENSG00000152104	5784	protein tyrosine phosphatase non-receptor type 14	PEZ|PTPD2	protein_coding	Q15678	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42138
4.28598702141281e-39	-0.511076339665302	0.411	0.647	6.7735738886408e-35	YARS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42139
4.93484510696751e-39	-0.489929292744674	0.708	0.831	7.79902920705146e-35	PDZD11	Malignant cells	GSE131984_JQ1Pal	ENSG00000120509	51248	PDZ domain containing 11	PDZK11	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42140
5.03921052116891e-39	-0.495756296564609	0.648	0.811	7.96396830765535e-35	DNAJC7	Malignant cells	GSE131984_JQ1Pal	ENSG00000168259	7266	DnaJ heat shock protein family (Hsp40) member C7	TPR2|TTC2	protein_coding	Q99615	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42141
5.04817946380628e-39	0.479898540784824	0.456	0.199	7.97814282459944e-35	PCDH7	Malignant cells	GSE131984_JQ1Pal	ENSG00000169851	5099	protocadherin 7	BH-Pcdh|PPP1R120	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42142
5.09933858980857e-39	0.653243006103566	0.993	0.977	8.05899470733346e-35	NQO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42143
6.41060132462179e-39	-0.473023212273206	0.753	0.869	1.01313143334323e-34	SFT2D1	Malignant cells	GSE131984_JQ1Pal	ENSG00000198818	113402	SFT2 domain containing 1	C6orf83|MGC19825|pRGR1	protein_coding	Q8WV19	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42144
6.51173504460649e-39	-0.432215533344329	0.248	0.512	1.02911460644961e-34	PPIE	Malignant cells	GSE131984_JQ1Pal	ENSG00000084072	10450	peptidylprolyl isomerase E	CyP-33|MGC111222|MGC3736	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42145
7.59053972188251e-39	-0.554731649785442	0.64	0.802	1.19960889764631e-34	FASN	Malignant cells	GSE131984_JQ1Pal	ENSG00000169710	2194	fatty acid synthase	FAS|SDR27X1	protein_coding	P49327	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42146
7.84541739276712e-39	0.424621632505359	0.896	0.749	1.23988976475292e-34	DGCR6L	Malignant cells	GSE131984_JQ1Pal	ENSG00000128185	85359	DiGeorge syndrome critical region gene 6 like	FLJ10666	protein_coding	Q9BY27	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42147
8.46508934276315e-39	-0.319367937399462	0.993	1	1.33782271973029e-34	LSM4	Malignant cells	GSE131984_JQ1Pal	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42148
9.36564004695387e-39	-0.460635151411307	0.838	0.922	1.48014575302059e-34	WDR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000071127	9948	WD repeat domain 1	AIP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42149
1.22189164929596e-38	-0.451875132190009	0.694	0.854	1.93107756254733e-34	DDX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000079785	1653	DEAD-box helicase 1	DBP-RB	protein_coding	Q92499	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42150
1.25628634897366e-38	-0.4599436795098	0.884	0.958	1.98543494591797e-34	PSMC5	Malignant cells	GSE131984_JQ1Pal	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42151
1.28822912846705e-38	-0.335917114662717	0.992	1	2.03591731462933e-34	KIAA0101	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42152
1.30310552817775e-38	-0.542193481739406	0.479	0.707	2.05942797673212e-34	TWISTNB	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42153
1.44549999448067e-38	-0.513176470113462	0.572	0.787	2.28446819127726e-34	PSMB9	Malignant cells	GSE131984_JQ1Pal	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42154
1.59787461192804e-38	-1.23025169447477	0.969	0.979	2.52528103669107e-34	HIST1H4C	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42155
1.91624787330166e-38	-0.468292783061597	0.232	0.486	3.02843813896594e-34	LAS1L	Malignant cells	GSE131984_JQ1Pal	ENSG00000001497	81887	LAS1 like ribosome biogenesis factor	FLJ12525|Las1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42156
2.102970480505e-38	-0.470328179664758	0.719	0.85	3.32353454739011e-34	UQCRC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000140740	7385	ubiquinol-cytochrome c reductase core protein 2	QCR2|UQCR2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42157
2.16623581841625e-38	-0.37407146224399	0.976	0.995	3.42351908742503e-34	LAMTOR5	Malignant cells	GSE131984_JQ1Pal	ENSG00000134248	10542	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	HBXIP|MGC71071|XIP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42158
2.48998879729017e-38	-0.508600082578053	0.649	0.793	3.93517829523739e-34	C4orf32	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42159
2.76581996596418e-38	-0.48750467905141	0.662	0.806	4.37110187420979e-34	THRAP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000054118	9967	thyroid hormone receptor associated protein 3	BCLAF2|TRAP150	protein_coding	Q9Y2W1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42160
3.1996504014799e-38	0.404645158776548	0.399	0.156	5.05672749449884e-34	KLF5	Malignant cells	GSE131984_JQ1Pal	ENSG00000102554	688	KLF transcription factor 5	BTEB2|CKLF|IKLF	protein_coding	Q13887	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42161
3.6165248095934e-38	-0.600703083248257	0.348	0.597	5.71555580908142e-34	EIF4A3	Malignant cells	GSE131984_JQ1Pal	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42162
3.65903846635905e-38	-0.41999526912488	0.919	0.973	5.78274439223385e-34	PRKCDBP	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42163
4.67117140368858e-38	0.471594262812405	0.517	0.253	7.38231928638944e-34	COL6A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000142173	1292	collagen type VI alpha 2 chain	NA	protein_coding	P12110	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42164
5.09173881990767e-38	-0.485052531689678	0.529	0.746	8.04698403098209e-34	COMMD4	Malignant cells	GSE131984_JQ1Pal	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42165
5.60657927883647e-38	-0.527658348522941	0.686	0.828	8.86063789227316e-34	BUB3	Malignant cells	GSE131984_JQ1Pal	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42166
6.75033381726796e-38	-0.455195172455667	0.256	0.512	1.06682275648103e-33	PALLD	Malignant cells	GSE131984_JQ1Pal	ENSG00000129116	23022	palladin, cytoskeletal associated protein	CGI-151|KIAA0992|SIH002	protein_coding	Q8WX93	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42167
7.5345676546943e-38	-0.602648641017459	0.998	0.999	1.19076307214789e-33	HSP90AA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42168
8.03942889751363e-38	-0.403606049652163	0.913	0.963	1.27055134296305e-33	BLOC1S1	Malignant cells	GSE131984_JQ1Pal	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42169
8.53445516248122e-38	-0.395302033137832	0.885	0.963	1.34878529387853e-33	CBR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42170
8.89462248827804e-38	-0.590077166536007	0.602	0.755	1.40570613804746e-33	SLBP	Malignant cells	GSE131984_JQ1Pal	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42171
1.03385141775651e-37	-0.482009984712393	0.562	0.756	1.63389878062238e-33	SLC30A5	Malignant cells	GSE131984_JQ1Pal	ENSG00000145740	64924	solute carrier family 30 member 5	FLJ12496|FLJ12756|MGC5499|ZnT-5|ZNT5|ZNTL1|ZTL1	protein_coding	Q8TAD4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42172
1.2068372413845e-37	-0.488210340394445	0.445	0.681	1.90728557628406e-33	BAZ1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42173
1.49195675567888e-37	-0.483561822666647	0.645	0.799	2.35788845667491e-33	DAZAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000071626	26528	DAZ associated protein 1	MGC19907	protein_coding	Q96EP5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42174
1.57557184218643e-37	-0.463588758417803	0.204	0.455	2.49003373939144e-33	IRF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42175
1.70378556774822e-37	-0.397086320430798	0.94	0.976	2.69266271126929e-33	TPM3	Malignant cells	GSE131984_JQ1Pal	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42176
1.90213876912859e-37	-0.493281831293813	0.747	0.866	3.00614011073082e-33	APEX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100823	328	apurinic/apyrimidinic endodeoxyribonuclease 1	APE|APE-1|APEN|APEX|APX|HAP1|REF-1|REF1	protein_coding	P27695	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42177
1.9299157253076e-37	-0.474407584868463	0.525	0.729	3.05003881227613e-33	TMEM109	Malignant cells	GSE131984_JQ1Pal	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42178
2.01373884814854e-37	-0.51709509105356	0.433	0.661	3.18251287561395e-33	INO80C	Malignant cells	GSE131984_JQ1Pal	ENSG00000153391	125476	INO80 complex subunit C	C18orf37|FLJ38183|hIes6|IES6	protein_coding	Q6PI98	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42179
2.08959461601943e-37	-0.400089395820052	0.935	0.978	3.30239533115711e-33	RSL24D1	Malignant cells	GSE131984_JQ1Pal	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42180
2.12103798418902e-37	-0.413998914875351	0.154	0.396	3.35208843021232e-33	COQ3	Malignant cells	GSE131984_JQ1Pal	ENSG00000132423	51805	coenzyme Q3, methyltransferase	bA9819.1	protein_coding	Q9NZJ6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42181
2.21039847413411e-37	0.530144035180184	0.788	0.593	3.49331374852154e-33	BCL2L1	Malignant cells	GSE131984_JQ1Pal	ENSG00000171552	598	BCL2 like 1	Bcl-X|bcl-xL|bcl-xS|BCL2L|BCLX|PPP1R52	protein_coding	Q07817	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42182
2.31201077905281e-37	-0.385674628419756	0.942	0.984	3.65390183521505e-33	ATP5J2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42183
2.72796670718756e-37	-0.471896121004415	0.995	0.999	4.31127858403923e-33	HSPA8	Malignant cells	GSE131984_JQ1Pal	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42184
2.87865648113824e-37	0.50989246773292	0.734	0.516	4.54942870279087e-33	PXN	Malignant cells	GSE131984_JQ1Pal	ENSG00000089159	5829	paxillin	NA	protein_coding	P49023	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42185
2.97983076012613e-37	0.416510908651954	0.974	0.905	4.70932453330334e-33	MYH9	Malignant cells	GSE131984_JQ1Pal	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42186
3.73207862772141e-37	-0.49949048787175	0.575	0.761	5.89817706325091e-33	PFKP	Malignant cells	GSE131984_JQ1Pal	ENSG00000067057	5214	phosphofructokinase, platelet	PFK-C|PFKF	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42187
4.25291002214711e-37	-0.52175436359737	0.481	0.698	6.72129899900129e-33	GLIPR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42188
4.39101679038954e-37	-0.475470260815455	0.92	0.971	6.93956293553163e-33	SNHG8	Malignant cells	GSE131984_JQ1Pal	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42189
4.48609366866023e-37	-0.510179122791739	0.452	0.668	7.08982243395062e-33	MRPL16	Malignant cells	GSE131984_JQ1Pal	ENSG00000166902	54948	mitochondrial ribosomal protein L16	FLJ20484|PNAS-111	protein_coding	Q9NX20	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42190
5.85640935762746e-37	-0.42351617298527	0.866	0.951	9.25546934879444e-33	MGST3	Malignant cells	GSE131984_JQ1Pal	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42191
6.33391259740182e-37	-0.431152706437612	0.903	0.96	1.00101154689338e-32	EMC6	Malignant cells	GSE131984_JQ1Pal	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42192
6.64717023835918e-37	-0.500254608962989	0.399	0.634	1.05051878447028e-32	MRPS28	Malignant cells	GSE131984_JQ1Pal	ENSG00000147586	28957	mitochondrial ribosomal protein S28	HSPC007|MRP-S28|MRPS35	protein_coding	Q9Y2Q9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42193
6.86411186492486e-37	-0.435054660345081	0.793	0.914	1.08480423913272e-32	SAP18	Malignant cells	GSE131984_JQ1Pal	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42194
7.14917572130436e-37	-0.435373660433765	0.326	0.57	1.12985573099494e-32	PEMT	Malignant cells	GSE131984_JQ1Pal	ENSG00000133027	10400	phosphatidylethanolamine N-methyltransferase	PEMPT|PEMT2	protein_coding	Q9UBM1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42195
7.4316437028834e-37	-0.330260384140923	0.056	0.257	1.17449697080369e-32	SMCO4	Malignant cells	GSE131984_JQ1Pal	ENSG00000166002	56935	single-pass membrane protein with coiled-coil domains 4	C11orf75|FN5	protein_coding	Q9NRQ5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42196
7.95974072159305e-37	-0.505405281807761	0.572	0.771	1.25795742364057e-32	ANXA7	Malignant cells	GSE131984_JQ1Pal	ENSG00000138279	310	annexin A7	ANX7	protein_coding	P20073	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42197
1.01765763435722e-36	-0.484546035722757	0.419	0.657	1.60830612533815e-32	EXOSC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000107371	51010	exosome component 3	CGI-102|hRrp-40|hRrp40p|p10|RRP40|Rrp40p	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42198
1.06047435462363e-36	-0.41327767602978	0.909	0.978	1.67597367004719e-32	DDX46	Malignant cells	GSE131984_JQ1Pal	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42199
1.23084635498555e-36	-0.453830015509442	0.253	0.5	1.94522957941917e-32	TXLNG	Malignant cells	GSE131984_JQ1Pal	ENSG00000086712	55787	taxilin gamma	CXorf15|FIAT|FLJ11209|LSR5|MGC126621|MGC126625|TXLNGX	protein_coding	Q9NUQ3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42200
1.68396191065001e-36	-0.337688420900289	0.058	0.257	2.66133340359127e-32	MT1F	Malignant cells	GSE131984_JQ1Pal	ENSG00000198417	4494	metallothionein 1F	MT1	protein_coding	P04733	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42201
1.73304868301173e-36	-0.419065223809559	0.318	0.566	2.73891013863173e-32	ZNF330	Malignant cells	GSE131984_JQ1Pal	ENSG00000109445	27309	zinc finger protein 330	HSA6591|NOA36	protein_coding	Q9Y3S2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42202
1.95205721672585e-36	-0.474700201111701	0.724	0.842	3.08503122531353e-32	HNRNPF	Malignant cells	GSE131984_JQ1Pal	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42203
2.26374567264792e-36	-0.476482870178693	0.812	0.899	3.57762366105278e-32	PSMA2.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42204
2.52725362817761e-36	-0.426086625934067	0.824	0.911	3.99407163397189e-32	ARL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42205
2.53035391836071e-36	-0.362553529522017	0.088	0.305	3.99897133257727e-32	KRT80	Malignant cells	GSE131984_JQ1Pal	ENSG00000167767	144501	keratin 80	KB20	protein_coding	Q6KB66	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42206
2.69311836714555e-36	0.47554187623795	0.982	0.912	4.25620426743683e-32	SERPINE1	Malignant cells	GSE131984_JQ1Pal	ENSG00000106366	5054	serpin family E member 1	PAI|PAI1|PLANH1	protein_coding	P05121	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42207
2.83442134046923e-36	-0.453484501188335	0.302	0.545	4.47951948647757e-32	DYRK4	Malignant cells	GSE131984_JQ1Pal	ENSG00000010219	8798	dual specificity tyrosine phosphorylation regulated kinase 4	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42208
2.90365456688487e-36	0.460161677732631	0.693	0.455	4.58893567750486e-32	SLC44A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000070214	23446	solute carrier family 44 member 1	CD92|CDW92|CHTL1|CTL1	protein_coding	Q8WWI5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42209
3.10614485481553e-36	-0.446701543811808	0.335	0.581	4.90895132855046e-32	TOR3A	Malignant cells	GSE131984_JQ1Pal	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42210
3.19298084328199e-36	0.352749586901914	0.318	0.099	5.04618692472285e-32	FBN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000166147	2200	fibrillin 1	FBN|MASS|MFS1|OCTD|SGS|WMS	protein_coding	P35555	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42211
3.40924236198595e-36	-0.456281391905819	0.364	0.602	5.3879666288826e-32	ENOPH1	Malignant cells	GSE131984_JQ1Pal	ENSG00000145293	58478	enolase-phosphatase 1	E1|MASA|mtnC	protein_coding	Q9UHY7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42212
3.857661393036e-36	-0.413077435712136	0.877	0.953	6.0966480655541e-32	PPM1G	Malignant cells	GSE131984_JQ1Pal	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42213
4.02208455858479e-36	0.371274291784938	0.389	0.153	6.3565024363874e-32	FAM102A	Malignant cells	GSE131984_JQ1Pal	ENSG00000167106	399665	family with sequence similarity 102 member A	bA203J24.7|C9orf132|Eeig1|SYM-3A	protein_coding	Q5T9C2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42214
4.54319332768801e-36	-0.429063353035835	0.986	0.993	7.18006273507813e-32	NUCKS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42215
4.85559770746583e-36	-0.521319609231598	0.572	0.754	7.673786616879e-32	TNIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42216
4.89974934390702e-36	0.55486404156665	0.861	0.734	7.74356386311065e-32	HCFC1R1	Malignant cells	GSE131984_JQ1Pal	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42217
5.04470271884443e-36	-0.473241647779453	0.839	0.916	7.97264817686174e-32	XRCC5	Malignant cells	GSE131984_JQ1Pal	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42218
5.19388007180555e-36	0.439479530630823	0.665	0.421	8.20840806548149e-32	FAM134A	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42219
5.19581112425775e-36	-0.539821686695224	0.525	0.706	8.21145990077695e-32	MAGEA12	Malignant cells	GSE131984_JQ1Pal	ENSG00000213401	4111	MAGE family member A12	CT1.12|MAGE12	protein_coding	P43365	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42220
5.6303910650933e-36	-0.495574636942321	0.61	0.783	8.89827003927344e-32	PHF19	Malignant cells	GSE131984_JQ1Pal	ENSG00000119403	26147	PHD finger protein 19	DKFZP727G051|MTF2L1|PCL3|TDRD19B	protein_coding	Q5T6S3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42221
5.68394271270688e-36	-0.547318287388194	0.552	0.732	8.98290306316195e-32	PSMD12	Malignant cells	GSE131984_JQ1Pal	ENSG00000197170	5718	proteasome 26S subunit, non-ATPase 12	p55|Rpn5	protein_coding	O00232	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42222
6.11258359687669e-36	-0.450737939254002	0.438	0.676	9.66032711650392e-32	DCTN6	Malignant cells	GSE131984_JQ1Pal	ENSG00000104671	10671	dynactin subunit 6	WS-3	protein_coding	O00399	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42223
6.28928990729208e-36	-0.524820435036384	0.763	0.885	9.93959376948441e-32	PDIA3	Malignant cells	GSE131984_JQ1Pal	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42224
6.3036131874182e-36	-0.467726424751811	0.316	0.563	9.96223028139572e-32	MAGEA6	Malignant cells	GSE131984_JQ1Pal	ENSG00000197172	4105	MAGE family member A6	CT1.6|MAGE-3b|MAGE3B|MAGE6	protein_coding	P43360	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42225
6.86544217332357e-36	0.436082732366265	0.544	0.294	1.08501448107206e-31	NABP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000173559	64859	nucleic acid binding protein 1	DKFZp667M1322|FLJ13624|FLJ22833|hSSB2|MGC111163|NABP1-OT1|OBFC2A|SOSS-B2|SSB2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42226
7.63314890849567e-36	-0.411134273142436	0.127	0.354	1.20634285349866e-31	MEST	Malignant cells	GSE131984_JQ1Pal	ENSG00000106484	4232	mesoderm specific transcript	PEG1	protein_coding	Q5EB52	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42227
7.82698623918411e-36	-0.448228522797545	0.375	0.62	1.23697690524066e-31	ATAD3A	Malignant cells	GSE131984_JQ1Pal	ENSG00000197785	55210	ATPase family AAA domain containing 3A	FLJ10709	protein_coding	Q9NVI7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42228
7.99100150774471e-36	-0.440712414743582	0.768	0.895	1.26289787828397e-31	SELT	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42229
8.78609421726053e-36	-0.461421798723233	0.692	0.826	1.38855433009585e-31	JAGN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000171135	84522	jagunal homolog 1	FLJ14602|GL009	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42230
8.99664500090765e-36	0.454178922871292	0.83	0.646	1.42182977594344e-31	SPTBN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000115306	6711	spectrin beta, non-erythrocytic 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42231
9.32826495242713e-36	-0.506690458686982	0.281	0.53	1.47423899308158e-31	MAGED2	Malignant cells	GSE131984_JQ1Pal	ENSG00000102316	10916	MAGE family member D2	11B6|BCG1|HCA10|JCL-1|MAGE-D2|MAGED|MGC8386	protein_coding	Q9UNF1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42232
1.01196103051866e-35	0.437818031867091	0.354	0.127	1.5993032126317e-31	ARL4C	Malignant cells	GSE131984_JQ1Pal	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42233
1.05099359196029e-35	-0.387603192606779	0.839	0.924	1.66099027273404e-31	MRPS6	Malignant cells	GSE131984_JQ1Pal	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42234
1.05913715942246e-35	0.451554001664251	0.931	0.774	1.67386036675126e-31	AXL	Malignant cells	GSE131984_JQ1Pal	ENSG00000167601	558	AXL receptor tyrosine kinase	ARK|JTK11|Tyro7|UFO	protein_coding	P30530	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42235
1.12070788193737e-35	-0.467647818512116	0.521	0.717	1.77116673661383e-31	TRIAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000170855	51499	TP53 regulated inhibitor of apoptosis 1	HSPC132|MDM35|P53CSV|WF-1	protein_coding	O43715	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42236
1.23534590610774e-35	-0.461556786302303	0.524	0.729	1.95234067001267e-31	PPP1R11	Malignant cells	GSE131984_JQ1Pal	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42237
1.28793372229904e-35	-0.411871377292281	0.966	0.99	2.0354504547214e-31	CCT6A	Malignant cells	GSE131984_JQ1Pal	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42238
1.49100256913467e-35	-0.428221915783143	0.386	0.622	2.35638046026043e-31	TIMM23	Malignant cells	GSE131984_JQ1Pal	ENSG00000265354	100287932	translocase of inner mitochondrial membrane 23	TIM23	protein_coding	O14925	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42239
1.54563997061602e-35	-0.463115040267273	0.877	0.954	2.44272940956156e-31	CCT7	Malignant cells	GSE131984_JQ1Pal	ENSG00000135624	10574	chaperonin containing TCP1 subunit 7	Ccth|Nip7-1	protein_coding	Q99832	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42240
1.64371369552781e-35	-0.44927077756574	0.331	0.574	2.59772512441216e-31	RHNO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000171792	83695	RAD9-HUS1-RAD1 interacting nuclear orphan 1	C12orf32|HKMT1188|MGC13204|RHINO	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42241
1.72606120172208e-35	0.33404258117653	0.313	0.096	2.72786712320157e-31	CHST1	Malignant cells	GSE131984_JQ1Pal	ENSG00000175264	8534	carbohydrate sulfotransferase 1	C6ST|KSGal6ST	protein_coding	O43916	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42242
1.78747307934056e-35	-0.402325271029868	0.868	0.936	2.82492245458982e-31	MTCH1	Malignant cells	GSE131984_JQ1Pal	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42243
2.03508619932031e-35	0.29309753787701	0.257	0.059	3.21625022940582e-31	LINC00960	Malignant cells	GSE131984_JQ1Pal	ENSG00000242516	401074	long intergenic non-protein coding RNA 960	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42244
2.09390539179723e-35	-0.443263025858484	0.674	0.811	3.30920808119635e-31	AMZ2	Malignant cells	GSE131984_JQ1Pal	ENSG00000196704	51321	archaelysin family metallopeptidase 2	NA	protein_coding	Q86W34	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42245
2.64242502603025e-35	-0.498375738782602	0.542	0.732	4.17608851113821e-31	SMC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42246
2.68041609999947e-35	-0.393227011755974	0.87	0.946	4.23612960443916e-31	MLF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000089693	8079	myeloid leukemia factor 2	NTN4	protein_coding	Q15773	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42247
3.06317743284281e-35	-0.53599451560729	0.276	0.526	4.84104561486477e-31	CDCA3	Malignant cells	GSE131984_JQ1Pal	ENSG00000111665	83461	cell division cycle associated 3	GRCC8|TOME-1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42248
3.14676227568418e-35	-0.451258569680275	0.716	0.855	4.97314310049128e-31	SUCLG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000163541	8802	succinate-CoA ligase GDP/ADP-forming subunit alpha	NA	protein_coding	P53597	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42249
3.42122306511334e-35	-0.456099558542364	0.372	0.614	5.40690093210512e-31	YRDC	Malignant cells	GSE131984_JQ1Pal	ENSG00000196449	79693	yrdC N6-threonylcarbamoyltransferase domain containing	FLJ23476|IRIP|SUA5	protein_coding	Q86U90	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42250
3.79439213556898e-35	-0.458104458295055	0.581	0.757	5.99665733105321e-31	TMUB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000164897	83590	transmembrane and ubiquitin like domain containing 1	C7orf21|HOPS|SB144	protein_coding	Q9BVT8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42251
3.85623169243434e-35	0.466246440193609	0.718	0.508	6.09438856672324e-31	ANKH	Malignant cells	GSE131984_JQ1Pal	ENSG00000154122	56172	ANKH inorganic pyrophosphate transport regulator	ANK|CCAL2|CMDJ|CPPDD|HANK|SLC62A1	protein_coding	Q9HCJ1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42252
4.25747251583767e-35	-0.450266182743933	0.739	0.862	6.72850956402986e-31	RAC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42253
4.30278740766482e-35	-0.468251465080104	0.56	0.758	6.80012521907348e-31	NOB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000141101	28987	NIN1 (RPN12) binding protein 1 homolog	ART-4|MST158|NOB1P|PSMD8BP1	protein_coding	Q9ULX3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42254
4.50027945897728e-35	-0.46242711266094	0.64	0.811	7.11224165696769e-31	JPX	Malignant cells	GSE131984_JQ1Pal	ENSG00000225470	554203	JPX transcript, XIST activator	DCBALD06|ENOX|LINC00183|NCRNA00183	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42255
4.65870848324081e-35	-0.458486137526529	0.392	0.634	7.36262288691377e-31	PIM3	Malignant cells	GSE131984_JQ1Pal	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42256
4.66915172101855e-35	-0.435390094356439	0.295	0.54	7.37912737989771e-31	ALYREF	Malignant cells	GSE131984_JQ1Pal	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42257
4.7812663369544e-35	0.440902485963485	0.626	0.38	7.55631331892273e-31	ITGAV	Malignant cells	GSE131984_JQ1Pal	ENSG00000138448	3685	integrin subunit alpha V	CD51|MSK8|VNRA|VTNR	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42258
5.49202738754116e-35	0.447887222212663	0.784	0.596	8.67960008327005e-31	CELF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000149187	10658	CUGBP Elav-like family member 1	BRUNOL2|CUG-BP|CUGBP|CUGBP1|EDEN-BP|hNab50|NAB50|NAPOR	protein_coding	Q92879	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42259
5.49610444690439e-35	-0.370872293871925	0.956	0.991	8.6860434678877e-31	CBX3	Malignant cells	GSE131984_JQ1Pal	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42260
5.62859649313417e-35	-0.314736551834163	0.061	0.257	8.89543389774924e-31	POLE2	Malignant cells	GSE131984_JQ1Pal	ENSG00000100479	5427	DNA polymerase epsilon 2, accessory subunit	DPE2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42261
5.76256683469481e-35	-0.392853199155221	0.233	0.479	9.10716062555167e-31	CHMP6	Malignant cells	GSE131984_JQ1Pal	ENSG00000176108	79643	charged multivesicular body protein 6	FLJ11749|VPS20	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42262
6.20813766939866e-35	-0.376054860697338	0.89	0.957	9.81134077271765e-31	FKBP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42263
6.28606818123777e-35	-0.452784718287122	0.658	0.815	9.93450215362818e-31	TMEM165	Malignant cells	GSE131984_JQ1Pal	ENSG00000134851	55858	transmembrane protein 165	GDT1|SLC64A1|TMPT27|TPARL	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42264
6.30846399203511e-35	-0.477616593290816	0.171	0.402	9.96989649301229e-31	FAM64A	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42265
6.42941805254804e-35	-0.398076397686789	0.892	0.958	1.01610522902469e-30	COA4	Malignant cells	GSE131984_JQ1Pal	ENSG00000181924	51287	cytochrome c oxidase assembly factor 4 homolog	CHCHD8|CMC3|E2IG2	protein_coding	Q9NYJ1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42266
6.66843134812572e-35	-0.389597921630784	0.897	0.96	1.05387889025779e-30	MRPL34	Malignant cells	GSE131984_JQ1Pal	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42267
8.29603057510262e-35	-0.432316304834671	0.701	0.84	1.31110467208922e-30	CMC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42268
8.71032966507332e-35	-0.421896892528515	0.861	0.93	1.37658050026819e-30	HNRNPR	Malignant cells	GSE131984_JQ1Pal	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42269
9.94092007688013e-35	-0.293129805261653	0.998	0.998	1.57106300895014e-30	USMG5	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42270
9.98915900947311e-35	-0.430285541494116	0.334	0.579	1.57868668985713e-30	GLA	Malignant cells	GSE131984_JQ1Pal	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42271
1.06855843665961e-34	-0.442010991178816	0.198	0.433	1.68874975329684e-30	FUOM	Malignant cells	GSE131984_JQ1Pal	ENSG00000148803	282969	fucose mutarotase	C10orf125|FLJ26016|FucM|FucU	protein_coding	A2VDF0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42272
1.27615230398444e-34	-0.479982303365411	0.438	0.652	2.01683110121701e-30	CMAS	Malignant cells	GSE131984_JQ1Pal	ENSG00000111726	55907	cytidine monophosphate N-acetylneuraminic acid synthetase	NA	protein_coding	Q8NFW8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42273
1.32529951745615e-34	-0.389213876783993	0.887	0.96	2.0945033573877e-30	ATP1B3	Malignant cells	GSE131984_JQ1Pal	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42274
1.40225808740252e-34	0.438930022954757	0.913	0.793	2.21612868133094e-30	UROS	Malignant cells	GSE131984_JQ1Pal	ENSG00000188690	7390	uroporphyrinogen III synthase	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42275
1.44506023952874e-34	-0.407787077006387	0.918	0.959	2.28377320255122e-30	NDUFS4	Malignant cells	GSE131984_JQ1Pal	ENSG00000164258	4724	NADH:ubiquinone oxidoreductase subunit S4	AQDQ|CI-18	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42276
1.59347643792583e-34	0.466073527741686	0.758	0.567	2.51833016249798e-30	NPDC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000107281	56654	neural proliferation, differentiation and control 1	CAB-|CAB1|DKFZp586J0523	protein_coding	Q9NQX5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42277
1.78143691762177e-34	0.433171192812656	0.705	0.485	2.81538290460944e-30	ADAM15	Malignant cells	GSE131984_JQ1Pal	ENSG00000143537	8751	ADAM metallopeptidase domain 15	MDC15	protein_coding	Q13444	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42278
1.88124321225615e-34	-0.393982156567161	0.819	0.915	2.97311677264962e-30	TCEA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42279
1.97065789315979e-34	0.367103558926854	0.368	0.139	3.11442773434973e-30	SOX9	Malignant cells	GSE131984_JQ1Pal	ENSG00000125398	6662	SRY-box transcription factor 9	CMD1|CMPD1|SRA1	protein_coding	P48436	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42280
2.02233753324177e-34	-0.456978873445943	0.45	0.662	3.1961022375353e-30	CECR5	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42281
2.27013685249823e-34	-0.382292398649461	0.915	0.963	3.58772428168821e-30	MRPS16	Malignant cells	GSE131984_JQ1Pal	ENSG00000182180	51021	mitochondrial ribosomal protein S16	CGI-132	protein_coding	Q9Y3D3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42282
2.62038622899108e-34	-0.454159467516352	0.343	0.579	4.1412583962975e-30	UTP18	Malignant cells	GSE131984_JQ1Pal	ENSG00000011260	51096	UTP18 small subunit processome component	CGI-48|WDR50	protein_coding	Q9Y5J1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42283
2.62835657361886e-34	-0.42364864454529	0.263	0.508	4.15385472894725e-30	DNTTIP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42284
2.64245371558368e-34	0.465744021577739	0.78	0.595	4.17613385210844e-30	HIPK2	Malignant cells	GSE131984_JQ1Pal	ENSG00000064393	28996	homeodomain interacting protein kinase 2	NA	protein_coding	Q9H2X6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42285
2.85716027726503e-34	-0.460504577775753	0.294	0.532	4.51545610218965e-30	PRMT5	Malignant cells	GSE131984_JQ1Pal	ENSG00000100462	10419	protein arginine methyltransferase 5	HRMT1L5|SKB1|SKB1Hs	protein_coding	O14744	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42286
3.15188426693612e-34	0.911409726029135	0.342	0.121	4.98123789546584e-30	MMP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000196611	4312	matrix metallopeptidase 1	CLG	protein_coding	P03956	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42287
3.25984065350743e-34	-0.482649218858385	0.448	0.669	5.15185216880314e-30	MRPS22	Malignant cells	GSE131984_JQ1Pal	ENSG00000175110	56945	mitochondrial ribosomal protein S22	C3orf5|GIBT|GK002|MRP-S22	protein_coding	P82650	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42288
3.53994088917762e-34	-0.409376064891937	0.955	0.985	5.59452258125631e-30	CCT8	Malignant cells	GSE131984_JQ1Pal	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42289
3.54493696044708e-34	-0.459256609859218	0.824	0.893	5.60241837229057e-30	GLO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000124767	2739	glyoxalase I	GLOD1	protein_coding	Q04760	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42290
3.82745542474777e-34	-0.462141090645552	0.43	0.641	6.04891055327137e-30	GYG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000163754	2992	glycogenin 1	GYG	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42291
3.90642855757971e-34	-0.261429258876618	0.997	1	6.17371969239898e-30	ATP5G3	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42292
4.04851290700892e-34	-0.461492762155876	0.743	0.858	6.3982697982369e-30	NUDT5	Malignant cells	GSE131984_JQ1Pal	ENSG00000165609	11164	nudix hydrolase 5	hYSAH1|YSA1H	protein_coding	Q9UKK9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42293
4.54301792161151e-34	0.436941590941013	0.593	0.363	7.17978552331483e-30	MEF2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000068305	4205	myocyte enhancer factor 2A	RSRFC4|RSRFC9	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42294
4.66512865910647e-34	-0.365540515565684	1	1	7.37276933285186e-30	LDHB	Malignant cells	GSE131984_JQ1Pal	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42295
5.18488896065372e-34	-0.393342352759351	0.851	0.925	8.19419851341714e-30	C20orf24	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42296
5.2016790090078e-34	-0.495685518972872	0.437	0.647	8.22073350583593e-30	MRPS30	Malignant cells	GSE131984_JQ1Pal	ENSG00000112996	10884	mitochondrial ribosomal protein S30	PAP|PDCD9	protein_coding	Q9NP92	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42297
5.88725292276196e-34	-0.261313647738145	1	1	9.304214519133e-30	ATP5G2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42298
5.94230070919133e-34	-0.425167426990298	0.337	0.573	9.39121204080597e-30	MRPS18A	Malignant cells	GSE131984_JQ1Pal	ENSG00000096080	55168	mitochondrial ribosomal protein S18A	FLJ10548|MRPS18-3	protein_coding	Q9NVS2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42299
6.67028862596259e-34	0.424332798460214	0.611	0.374	1.05417241444713e-29	INTS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000164880	26173	integrator complex subunit 1	DKFZp586J0619|INT1|KIAA1440|NET28	protein_coding	Q8N201	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42300
6.82015931429838e-34	0.455924561760133	0.776	0.58	1.07785797803172e-29	UBE2Z	Malignant cells	GSE131984_JQ1Pal	ENSG00000159202	65264	ubiquitin conjugating enzyme E2 Z	FLJ13855|USE1	protein_coding	Q9H832	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42301
6.86453143423558e-34	-0.474355960499398	0.547	0.729	1.08487054786659e-29	CWC27	Malignant cells	GSE131984_JQ1Pal	ENSG00000153015	10283	CWC27 spliceosome associated cyclophilin	NY-CO-10|SDCCAG-10|SDCCAG10	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42302
8.20165773489381e-34	0.421553147103321	0.98	0.955	1.29618998842262e-29	FLNA	Malignant cells	GSE131984_JQ1Pal	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42303
8.46796679918168e-34	-0.394024198941568	0.975	0.993	1.33827747294267e-29	SSBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42304
9.82214421852624e-34	0.401086606696316	0.484	0.244	1.55229167229589e-29	NUDT14	Malignant cells	GSE131984_JQ1Pal	ENSG00000183828	256281	nudix hydrolase 14	UGPP	protein_coding	O95848	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42305
1.01483627659541e-33	0.442273229245876	0.897	0.765	1.60384725153139e-29	SEPT9	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42306
1.28395974172923e-33	-0.472188543598254	0.531	0.728	2.02916997582887e-29	PUF60	Malignant cells	GSE131984_JQ1Pal	ENSG00000274081	22827	poly(U) binding splicing factor 60	FIR|RoBPI|SIAHBP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42307
1.34336245899464e-33	-0.476722614770012	0.573	0.755	2.12305003019514e-29	TIMM50	Malignant cells	GSE131984_JQ1Pal	ENSG00000105197	92609	translocase of inner mitochondrial membrane 50	TIM50|TIM50L	protein_coding	Q3ZCQ8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42308
1.40003107545718e-33	0.399443069509362	0.437	0.2	2.21260911165253e-29	NAV2	Malignant cells	GSE131984_JQ1Pal	ENSG00000166833	89797	neuron navigator 2	FLJ10633|FLJ11030|FLJ23707|HELAD1|KIAA1419|POMFIL2|RAINB1	protein_coding	Q8IVL1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42309
1.66731784109683e-33	-0.409618132623234	0.931	0.97	2.63502911606943e-29	PDIA6	Malignant cells	GSE131984_JQ1Pal	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42310
1.82022368467567e-33	-0.390868443432435	0.799	0.91	2.87668151126142e-29	CCDC124	Malignant cells	GSE131984_JQ1Pal	ENSG00000007080	115098	coiled-coil domain containing 124	Lso2|oxs1	protein_coding	Q96CT7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42311
2.07140087064228e-33	-0.489310883658782	0.517	0.718	3.27364193596306e-29	EIF1B	Malignant cells	GSE131984_JQ1Pal	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42312
2.09907765904115e-33	-0.432322927523026	0.209	0.45	3.31738233234863e-29	KIF22	Malignant cells	GSE131984_JQ1Pal	ENSG00000079616	3835	kinesin family member 22	Kid|KNSL4|OBP-1|OBP-2	protein_coding	Q14807	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42313
2.14561778930865e-33	-0.450949754277609	0.463	0.681	3.39093435422338e-29	ADK	Malignant cells	GSE131984_JQ1Pal	ENSG00000156110	132	adenosine kinase	AK	protein_coding	P55263	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42314
2.16844248065146e-33	-0.529122111074746	0.183	0.404	3.42700649642156e-29	AC003092.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42315
2.18496332851588e-33	-0.552905256943638	0.472	0.663	3.45311604438649e-29	CDCA4	Malignant cells	GSE131984_JQ1Pal	ENSG00000170779	55038	cell division cycle associated 4	FLJ20764|Hepp	protein_coding	Q9BXL8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42316
2.38708616798164e-33	-0.696867368116633	0.463	0.659	3.77255097987818e-29	HERPUD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42317
2.65731620575938e-33	-0.461138264822561	0.541	0.735	4.19962253158213e-29	CUL4A	Malignant cells	GSE131984_JQ1Pal	ENSG00000139842	8451	cullin 4A	NA	protein_coding	Q13619	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42318
2.85325110591597e-33	-0.458705101374945	0.563	0.76	4.5092780477896e-29	COPS5	Malignant cells	GSE131984_JQ1Pal	ENSG00000121022	10987	COP9 signalosome subunit 5	CSN5|JAB1|MOV-34|SGN5	protein_coding	Q92905	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42319
2.87773005663385e-33	-0.478842333749548	0.296	0.534	4.54796458150414e-29	PAK1IP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000285226	55003	PAK1 interacting protein 1	bA421M1.5|FLJ20624|hPIP1|MAK11|PIP1|WDR84	protein_coding	Q9NWT1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42320
3.04130260238085e-33	0.427176875515016	0.971	0.928	4.8064746328027e-29	ITGB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42321
3.06079549730255e-33	-0.448539698450802	0.705	0.828	4.83728120393695e-29	SMIM15	Malignant cells	GSE131984_JQ1Pal	ENSG00000188725	643155	small integral membrane protein 15	C5orf43|DKFZP686E2158	protein_coding	Q7Z3B0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42322
3.23394444202376e-33	-0.387574754107543	0.839	0.917	5.11092579617434e-29	EIF4E2	Malignant cells	GSE131984_JQ1Pal	ENSG00000135930	9470	eukaryotic translation initiation factor 4E family member 2	4EHP|EIF4EL3|IF4e	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42323
3.3514891303019e-33	-0.445959255018491	0.326	0.558	5.29669342152912e-29	PLS3	Malignant cells	GSE131984_JQ1Pal	ENSG00000102024	5358	plastin 3	T-plastin	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42324
3.76829088198691e-33	0.363712023012858	0.42	0.187	5.95540690989211e-29	NFIX	Malignant cells	GSE131984_JQ1Pal	ENSG00000008441	4784	nuclear factor I X	NF1A	protein_coding	Q14938	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42325
4.60252622734137e-33	-0.445254352839956	0.694	0.83	7.2738324496903e-29	DNAJC8	Malignant cells	GSE131984_JQ1Pal	ENSG00000285317	22826	DnaJ heat shock protein family (Hsp40) member C8	SPF31	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42326
5.94252697016663e-33	-0.291929118205591	0.997	1	9.39156962365135e-29	MZT2B	Malignant cells	GSE131984_JQ1Pal	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42327
6.17990170857206e-33	-0.353228964819072	0.985	0.996	9.76671666022728e-29	PRDX6	Malignant cells	GSE131984_JQ1Pal	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42328
6.40491656376742e-33	-0.458843510278942	0.453	0.665	1.0122330137378e-28	DRG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000185721	4733	developmentally regulated GTP binding protein 1	NEDD3	protein_coding	Q9Y295	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42329
6.80262693021396e-33	-0.360670748242514	0.939	0.986	1.07508716005101e-28	TMEM14C	Malignant cells	GSE131984_JQ1Pal	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42330
7.12970476801915e-33	-0.383131696759702	0.283	0.524	1.12677854153775e-28	FADD	Malignant cells	GSE131984_JQ1Pal	ENSG00000168040	8772	Fas associated via death domain	GIG3|MORT1	protein_coding	Q13158	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42331
8.73314493710782e-33	-0.374953774922605	0.887	0.951	1.38018622586052e-28	BCL7C	Malignant cells	GSE131984_JQ1Pal	ENSG00000099385	9274	BAF chromatin remodeling complex subunit BCL7C	SMARCJ3	protein_coding	Q8WUZ0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42332
9.07897168705287e-33	-0.465716039090169	0.591	0.777	1.43484068542184e-28	BOD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000145919	91272	biorientation of chromosomes in cell division 1	FAM44B	protein_coding	Q96IK1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42333
9.10967609865928e-33	-0.48019456943749	0.624	0.764	1.43969321063211e-28	IDH3G	Malignant cells	GSE131984_JQ1Pal	ENSG00000067829	3421	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma	NA	protein_coding	P51553	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42334
1.17334810628526e-32	-0.358153940598372	0.159	0.386	1.85435934717323e-28	MSRA	Malignant cells	GSE131984_JQ1Pal	ENSG00000175806	4482	methionine sulfoxide reductase A	NA	protein_coding	Q9UJ68	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42335
1.17540692041073e-32	0.439974118933067	0.651	0.434	1.85761309701712e-28	FAM168B	Malignant cells	GSE131984_JQ1Pal	ENSG00000152102	130074	family with sequence similarity 168 member B	KIAA0280L|MANI	protein_coding	A1KXE4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42336
1.23118835919841e-32	0.405252922382279	0.969	0.935	1.94577008287716e-28	LY6E	Malignant cells	GSE131984_JQ1Pal	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42337
1.27493408547867e-32	-0.453362242012319	0.436	0.648	2.01490582869049e-28	DNAJA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000069345	10294	DnaJ heat shock protein family (Hsp40) member A2	CPR3|DNAJ|DNJ3|HIRIP4	protein_coding	O60884	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42338
1.30924184327605e-32	-0.438066405664963	0.294	0.53	2.06912580911347e-28	PLAUR	Malignant cells	GSE131984_JQ1Pal	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42339
1.41518589963229e-32	-0.403181698342124	0.822	0.897	2.23655979577887e-28	PCNP	Malignant cells	GSE131984_JQ1Pal	ENSG00000081154	57092	PEST proteolytic signal containing nuclear protein	NA	protein_coding	Q8WW12	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42340
1.50156839846556e-32	0.40462265451689	0.504	0.273	2.37307869693497e-28	LMBR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000105983	64327	limb development membrane protein 1	ACHP|C7orf2|FLJ11665|ZRS	protein_coding	Q8WVP7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42341
1.62381644292404e-32	0.386640042489746	0.515	0.276	2.56627950639716e-28	TEAD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000187079	7003	TEA domain transcription factor 1	AA|TCF13|TEF-1	protein_coding	P28347	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42342
1.67160586605633e-32	-0.476112297952204	0.572	0.742	2.64180591071542e-28	CRELD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42343
1.70447704534072e-32	-0.466874915104185	0.521	0.71	2.69375552245647e-28	PIN4	Malignant cells	GSE131984_JQ1Pal	ENSG00000102309	5303	peptidylprolyl cis/trans isomerase, NIMA-interacting 4	EPVH|PAR14|PAR17	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42344
1.78060129377746e-32	-0.434217886255477	0.549	0.739	2.81406228468589e-28	SDHD	Malignant cells	GSE131984_JQ1Pal	ENSG00000204370	6392	succinate dehydrogenase complex subunit D	cybS|PGL|PGL1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42345
1.79293561763881e-32	-0.420974873778603	0.334	0.566	2.83355545011638e-28	RAB27A	Malignant cells	GSE131984_JQ1Pal	ENSG00000069974	5873	RAB27A, member RAS oncogene family	GS2|HsT18676|RAB27|RAM	protein_coding	P51159	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42346
1.79507121447007e-32	-0.412634736138727	0.289	0.519	2.8369305473485e-28	CIAPIN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000005194	57019	cytokine induced apoptosis inhibitor 1	CIAE2	protein_coding	Q6FI81	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42347
2.20013422557077e-32	-0.454805883790655	0.416	0.636	3.47709213009204e-28	VPS25	Malignant cells	GSE131984_JQ1Pal	ENSG00000131475	84313	vacuolar protein sorting 25 homolog	DERP9|EAP20|MGC10540	protein_coding	Q9BRG1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42348
2.21803500201276e-32	-0.480241265409447	0.677	0.822	3.50538251718097e-28	TK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42349
2.65517833646557e-32	-0.483339032648753	0.475	0.674	4.19624384295019e-28	TMPO	Malignant cells	GSE131984_JQ1Pal	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42350
2.80941806843056e-32	0.410916310739015	0.794	0.607	4.44000431534766e-28	TGFB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42351
2.86801357236402e-32	-0.421902364334552	0.743	0.861	4.53260864976409e-28	TMEM14A	Malignant cells	GSE131984_JQ1Pal	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42352
3.12177789532085e-32	0.392554489629368	0.547	0.309	4.93365778576506e-28	CCNY	Malignant cells	GSE131984_JQ1Pal	ENSG00000108100	219771	cyclin Y	C10orf9|CBCP1|CFP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42353
3.37845392450113e-32	0.428232555595794	0.585	0.345	5.33930858228159e-28	TTL	Malignant cells	GSE131984_JQ1Pal	ENSG00000114999	150465	tubulin tyrosine ligase	MGC46235	protein_coding	Q8NG68	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42354
3.63257583099809e-32	-0.453101394526303	0.236	0.463	5.74092284330938e-28	TXNRD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000184470	10587	thioredoxin reductase 2	SELZ|TR|TR3|TRXR2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42355
4.179932845495e-32	0.533709407972348	0.683	0.472	6.60596586902031e-28	DUSP6	Malignant cells	GSE131984_JQ1Pal	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42356
4.24378220159375e-32	-0.506180133985658	0.469	0.664	6.70687339139877e-28	NDUFAF4	Malignant cells	GSE131984_JQ1Pal	ENSG00000123545	29078	NADH:ubiquinone oxidoreductase complex assembly factor 4	bA22L21.1|C6orf66|HRPAP20|HSPC125|My013	protein_coding	Q9P032	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42357
4.41298878006766e-32	-0.42234502293102	0.261	0.496	6.97428746801893e-28	C10orf90	Malignant cells	GSE131984_JQ1Pal	ENSG00000154493	118611	chromosome 10 open reading frame 90	bA422P15.2|FATS|FLJ32938	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42358
4.43801646303333e-32	-0.455934026439505	0.577	0.76	7.01384121817787e-28	ACOT13	Malignant cells	GSE131984_JQ1Pal	ENSG00000112304	55856	acyl-CoA thioesterase 13	HT012|THEM2	protein_coding	Q9NPJ3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42359
4.60708088891059e-32	-0.439710069891253	0.439	0.651	7.2810306368343e-28	NSMCE1	Malignant cells	GSE131984_JQ1Pal	ENSG00000169189	197370	NSE1 homolog, SMC5-SMC6 complex component	NSE1	protein_coding	Q8WV22	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42360
4.69740304768111e-32	-0.329450276679621	0.104	0.308	7.42377577655523e-28	BNIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000113734	662	BCL2 interacting protein 1	Nip1|SEC20	protein_coding	Q12981	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42361
4.83759106226476e-32	-0.446650867101518	0.354	0.581	7.64532891480323e-28	RCC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000180198	1104	regulator of chromosome condensation 1	CHC1	protein_coding	P18754	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42362
5.02425524465798e-32	-0.359897334003257	0.951	0.99	7.94033298865747e-28	ATPIF1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42363
5.02749114354287e-32	-0.40420563803752	0.522	0.742	7.94544700325516e-28	MRPS14	Malignant cells	GSE131984_JQ1Pal	ENSG00000120333	63931	mitochondrial ribosomal protein S14	HSMRPS14	protein_coding	O60783	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42364
6.81425964117648e-32	-0.458444400091971	0.864	0.943	1.07692559369153e-27	SQSTM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42365
7.26062179988217e-32	-0.351939403578666	0.145	0.363	1.14746866925338e-27	CCDC51	Malignant cells	GSE131984_JQ1Pal	ENSG00000164051	79714	coiled-coil domain containing 51	FLJ12436	protein_coding	Q96ER9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42366
7.48337312523788e-32	0.541959679023059	0.807	0.615	1.18267228871259e-27	SLC20A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000144136	6574	solute carrier family 20 member 1	Glvr-1|GLVR1|PiT-1|PiT1	protein_coding	Q8WUM9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42367
8.04851598332501e-32	-0.443637827070983	0.466	0.669	1.27198746600468e-27	CREM	Malignant cells	GSE131984_JQ1Pal	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42368
8.13941784556073e-32	-0.437219522566141	0.343	0.573	1.28635359631242e-27	AIFM2	Malignant cells	GSE131984_JQ1Pal	ENSG00000042286	84883	apoptosis inducing factor mitochondria associated 2	AMID|FLJ14497|FSP1|PRG3	protein_coding	Q9BRQ8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42369
8.32049084215427e-32	0.3607145359968	0.407	0.183	1.31497037269406e-27	AL589743.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42370
9.00987704191994e-32	-0.428430441805606	0.326	0.556	1.42392096770503e-27	PPID	Malignant cells	GSE131984_JQ1Pal	ENSG00000171497	5481	peptidylprolyl isomerase D	CYP-40|CypD	protein_coding	Q08752	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42371
9.55269578068909e-32	0.411563517218566	0.594	0.356	1.5097080411801e-27	SERINC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42372
9.57700185437971e-32	-0.37741447396953	0.897	0.959	1.51354937306617e-27	GGCT	Malignant cells	GSE131984_JQ1Pal	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42373
1.03748325447225e-31	0.409084780666941	0.702	0.488	1.63963853536794e-27	DAG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000173402	1605	dystroglycan 1	156DAG|A3a|AGRNR|DAG	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42374
1.08788457936188e-31	0.411921074078891	0.693	0.483	1.71929278922351e-27	CENPB	Malignant cells	GSE131984_JQ1Pal	ENSG00000125817	1059	centromere protein B	NA	protein_coding	P07199	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42375
1.16879094834019e-31	-0.43006624298501	0.482	0.688	1.84715721475684e-27	TIMM44	Malignant cells	GSE131984_JQ1Pal	ENSG00000104980	10469	translocase of inner mitochondrial membrane 44	TIM44	protein_coding	O43615	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42376
1.26037716609054e-31	-0.261168384529388	1	1	1.99190007328949e-27	B2M	Malignant cells	GSE131984_JQ1Pal	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42377
1.39703779505236e-31	-0.311927456452049	0.091	0.291	2.20787853130075e-27	TMEM92	Malignant cells	GSE131984_JQ1Pal	ENSG00000167105	162461	transmembrane protein 92	FLJ33318	protein_coding	Q6UXU6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42378
1.52568470637822e-31	-0.3876679690108	0.851	0.931	2.41119210996014e-27	PDCD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000071994	5134	programmed cell death 2	RP8|ZMYND7	protein_coding	Q16342	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42379
1.5641749097967e-31	-0.307113391232997	0.068	0.254	2.4720220274427e-27	RP11-525A16.4	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42380
1.58526415860604e-31	-0.388253795656112	0.822	0.895	2.50535147626099e-27	KDELR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42381
1.66145740454497e-31	-0.431813879622197	0.958	0.987	2.62576728214288e-27	ANXA5	Malignant cells	GSE131984_JQ1Pal	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42382
1.71810026717725e-31	-0.402936691549263	0.294	0.524	2.71528566224693e-27	MRPL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000112651	51069	mitochondrial ribosomal protein L2	CGI-22|MRP-L14|RPML14	protein_coding	Q5T653	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42383
1.76516696387824e-31	-0.48433100108328	0.561	0.734	2.78966986971317e-27	GNL3	Malignant cells	GSE131984_JQ1Pal	ENSG00000163938	26354	G protein nucleolar 3	C77032|E2IG3|MGC800|NS	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42384
1.91052557103398e-31	0.438332909476373	0.63	0.417	3.0193946124621e-27	UBE2H	Malignant cells	GSE131984_JQ1Pal	ENSG00000186591	7328	ubiquitin conjugating enzyme E2 H	GID3|UBC8|UBCH	protein_coding	P62256	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42385
2.13889332756124e-31	-0.387089404563041	0.827	0.916	3.38030701487779e-27	KXD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000105700	79036	KxDL motif containing 1	BORCS4|C19orf50|FLJ25480|KXDL|MGC2749	protein_coding	Q9BQD3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42386
2.18637270765912e-31	-0.421407810943671	0.471	0.681	3.45534342718447e-27	AKR1A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42387
2.24343552450402e-31	-0.425207024396975	0.572	0.762	3.54552550292616e-27	NSFL1C	Malignant cells	GSE131984_JQ1Pal	ENSG00000088833	55968	NSFL1 cofactor	dJ776F14.1|p47|UBX1|UBXD10|UBXN2C	protein_coding	Q9UNZ2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42388
2.35506876673956e-31	0.429313573403258	0.93	0.842	3.7219506789552e-27	EPB41L4A-AS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42389
2.35829900435826e-31	-0.430830614010599	0.339	0.56	3.7270557464878e-27	WDR74	Malignant cells	GSE131984_JQ1Pal	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42390
2.42386329054299e-31	-0.454907613088965	0.455	0.664	3.83067354437414e-27	DYNLT3	Malignant cells	GSE131984_JQ1Pal	ENSG00000165169	6990	dynein light chain Tctex-type 3	TCTE1L|TCTEX1L	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42391
2.43452169066159e-31	-0.405932860982584	0.868	0.931	3.84751807992158e-27	BID	Malignant cells	GSE131984_JQ1Pal	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42392
2.59548996393606e-31	-0.420805842190648	0.72	0.844	4.10191233900455e-27	RPL7L1	Malignant cells	GSE131984_JQ1Pal	ENSG00000146223	285855	ribosomal protein L7 like 1	dJ475N16.4	protein_coding	Q6DKI1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42393
2.6026791901492e-31	-0.436330178054322	0.801	0.875	4.11327419211179e-27	PSMG3	Malignant cells	GSE131984_JQ1Pal	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42394
2.95206896678814e-31	-0.498351172286449	0.78	0.862	4.66544979511197e-27	SPCS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42395
2.96772417441736e-31	0.34753480881325	0.354	0.14	4.6901912852492e-27	PLXNA3	Malignant cells	GSE131984_JQ1Pal	ENSG00000130827	55558	plexin A3	6.3|Plxn3|PLXN4|SEX|XAP-6	protein_coding	P51805	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42396
2.99981797060546e-31	-0.425885668192495	0.826	0.904	4.74091232074487e-27	LINC00998	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42397
3.08480297054896e-31	-0.427668852694051	0.343	0.574	4.87522261465558e-27	RP11-366H4.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42398
3.27899752850125e-31	-0.390561368000351	0.863	0.94	5.18212769404338e-27	RBMX	Malignant cells	GSE131984_JQ1Pal	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42399
3.29951586626998e-31	0.400966878604891	0.64	0.414	5.21455487505308e-27	GLS	Malignant cells	GSE131984_JQ1Pal	ENSG00000115419	2744	glutaminase	GAC|GAM|GLS1|KGA|KIAA0838	protein_coding	O94925	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42400
3.47587088456743e-31	0.405423518169162	0.566	0.336	5.49326634597037e-27	KIF3B	Malignant cells	GSE131984_JQ1Pal	ENSG00000101350	9371	kinesin family member 3B	FLA8|KIAA0359|KLP-11	protein_coding	O15066	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42401
4.13629098241683e-31	-0.418096925020114	0.51	0.702	6.53699426861157e-27	SEC22C	Malignant cells	GSE131984_JQ1Pal	ENSG00000093183	9117	SEC22 homolog C, vesicle trafficking protein	MGC13261|MGC5373|SEC22L3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42402
4.15643723969846e-31	-0.419537990950367	0.284	0.517	6.56883341361945e-27	SCML1	Malignant cells	GSE131984_JQ1Pal	ENSG00000047634	6322	Scm polycomb group protein like 1	NA	protein_coding	Q9UN30	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42403
4.38384045080807e-31	-0.436674678466151	0.512	0.704	6.92822144845708e-27	MRPS10	Malignant cells	GSE131984_JQ1Pal	ENSG00000048544	55173	mitochondrial ribosomal protein S10	FLJ10567	protein_coding	P82664	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42404
4.49052286496315e-31	0.4261456523793	0.551	0.322	7.09682233578776e-27	DDAH1	Malignant cells	GSE131984_JQ1Pal	ENSG00000153904	23576	dimethylarginine dimethylaminohydrolase 1	DDAH	protein_coding	O94760	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42405
4.76344323418767e-31	0.363403589176086	0.401	0.182	7.52814568731019e-27	PCBP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000183570	54039	poly(rC) binding protein 3	FLJ44028|PCBP3-OT1|PCBP3OT	protein_coding	P57721	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42406
5.00332410116051e-31	-0.412399776049786	0.711	0.841	7.90725340947406e-27	EMC7	Malignant cells	GSE131984_JQ1Pal	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42407
5.42079666960872e-31	0.466246440193609	0.648	0.421	8.56702705664961e-27	TSPYL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000189241	7259	TSPY like 1	TSPYL	protein_coding	Q9H0U9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42408
5.56503170580642e-31	-0.452775762982848	0.381	0.601	8.79497610785647e-27	MND1	Malignant cells	GSE131984_JQ1Pal	ENSG00000121211	84057	meiotic nuclear divisions 1	GAJ	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42409
6.84647868757221e-31	-0.371208088729677	0.877	0.942	1.08201749178391e-26	MRPS36	Malignant cells	GSE131984_JQ1Pal	ENSG00000278461	92259	mitochondrial ribosomal protein S36	DC47|MRP-S36	protein_coding	P82909	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42410
7.00550062718497e-31	0.362561200105296	0.4	0.179	1.10714931912031e-26	PDCD4	Malignant cells	GSE131984_JQ1Pal	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42411
8.23626500326318e-31	-0.375810449883754	0.228	0.451	1.30165932111571e-26	SFXN4	Malignant cells	GSE131984_JQ1Pal	ENSG00000183605	119559	sideroflexin 4	SLC56A4	protein_coding	Q6P4A7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42412
9.08227647548711e-31	-0.411194594045605	0.39	0.611	1.43536297418598e-26	PEX2	Malignant cells	GSE131984_JQ1Pal	ENSG00000164751	5828	peroxisomal biogenesis factor 2	PAF-1|PMP35|PXMP3|RNF72|ZWS3	protein_coding	P28328	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42413
9.55081473978682e-31	0.414166914540212	0.754	0.544	1.50941076147591e-26	CHP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000187446	11261	calcineurin like EF-hand protein 1	CHP|p22|p24|Sid470p|SLC9A1BP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42414
9.78827361501095e-31	-0.431321376343846	0.652	0.8	1.54693876211633e-26	EIF2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000144895	83939	eukaryotic translation initiation factor 2A	EIF-2A	protein_coding	Q9BY44	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42415
1.04037590488621e-30	-0.37241094560681	0.191	0.417	1.64421008008216e-26	CXorf38	Malignant cells	GSE131984_JQ1Pal	ENSG00000185753	159013	chromosome X open reading frame 38	MGC39350	protein_coding	Q8TB03	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42416
1.11182092004915e-30	0.337395446309451	0.333	0.124	1.75712178204567e-26	AR	Malignant cells	GSE131984_JQ1Pal	ENSG00000169083	367	androgen receptor	AIS|DHTR|HUMARA|NR3C4|SBMA|SMAX1	protein_coding	P10275	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42417
1.3557690934229e-30	0.380769173002593	0.394	0.178	2.14265747524554e-26	CHPF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000033100	54480	chondroitin polymerizing factor 2	ChSy-3|CSGlcA-T|KIAA1402	protein_coding	Q9P2E5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42418
1.5830585233405e-30	-0.439052839716902	0.388	0.594	2.50186569028732e-26	SLC25A33	Malignant cells	GSE131984_JQ1Pal	ENSG00000171612	84275	solute carrier family 25 member 33	BMSC-MCP|MGC4399|PNC1	protein_coding	Q9BSK2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42419
1.59580767591888e-30	-0.407954444005875	0.575	0.757	2.5220144510222e-26	TYW3	Malignant cells	GSE131984_JQ1Pal	ENSG00000162623	127253	tRNA-yW synthesizing protein 3 homolog	C1orf171|FLJ40918	protein_coding	Q6IPR3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42420
1.62116608459388e-30	0.289368678109529	0.291	0.095	2.56209088009217e-26	ABCA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000107331	20	ATP binding cassette subfamily A member 2	ABC2	protein_coding	Q9BZC7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42421
1.66681368725497e-30	-0.265814436745584	0.999	1	2.63423235133776e-26	COX7A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42422
1.98061225931466e-30	-0.373716842728527	0.936	0.975	3.13015961462089e-26	COX17	Malignant cells	GSE131984_JQ1Pal	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42423
2.13812523121885e-30	0.336492208955254	0.369	0.156	3.37909311541827e-26	UBXN7	Malignant cells	GSE131984_JQ1Pal	ENSG00000163960	26043	UBX domain protein 7	KIAA0794|UBXD7	protein_coding	O94888	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42424
2.14433384410107e-30	0.411550919407356	0.553	0.328	3.38890520721733e-26	QSOX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000116260	5768	quiescin sulfhydryl oxidase 1	QSCN6	protein_coding	O00391	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42425
2.47609814939852e-30	-0.335020163939642	0.132	0.34	3.91322551530942e-26	L3HYPDH	Malignant cells	GSE131984_JQ1Pal	ENSG00000126790	112849	trans-L-3-hydroxyproline dehydratase	C14orf149|FLJ25436	protein_coding	Q96EM0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42426
2.47639582606954e-30	0.492524008402738	0.878	0.74	3.9136959635203e-26	SPARC	Malignant cells	GSE131984_JQ1Pal	ENSG00000113140	6678	secreted protein acidic and cysteine rich	BM-40|ON|ONT	protein_coding	P09486	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42427
2.56027225907736e-30	-0.296258721835713	0.099	0.296	4.04625427824587e-26	PRELID2	Malignant cells	GSE131984_JQ1Pal	ENSG00000186314	153768	PRELI domain containing 2	FLJ38376|MGC21644	protein_coding	Q8N945	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42428
2.62317236604595e-30	-0.43854228615994	0.386	0.614	4.14566160729902e-26	C4orf27	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42429
2.77911511296635e-30	-0.414479801012039	0.932	0.975	4.39211352453202e-26	TUBB4B	Malignant cells	GSE131984_JQ1Pal	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42430
2.81356839477188e-30	0.393231642895387	0.57	0.346	4.44656349109747e-26	ESYT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000139641	23344	extended synaptotagmin 1	FAM62A|KIAA0747|MBC2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42431
2.93030708186832e-30	-0.4517909354088	0.128	0.334	4.63105731218469e-26	ADM	Malignant cells	GSE131984_JQ1Pal	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42432
3.25964524717902e-30	0.412588186520851	0.576	0.341	5.15154334864172e-26	FGF13	Malignant cells	GSE131984_JQ1Pal	ENSG00000129682	2258	fibroblast growth factor 13	FGF2|FHF2|FLJ30672|LINC00889	protein_coding	Q92913	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42433
3.29741097078766e-30	-0.44502464121206	0.583	0.742	5.21122829823282e-26	COX11	Malignant cells	GSE131984_JQ1Pal	ENSG00000166260	1353	cytochrome c oxidase copper chaperone COX11	COX11P	protein_coding	Q9Y6N1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42434
3.3884005359982e-30	-0.483990882504951	0.481	0.662	5.35502820709155e-26	SARS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42435
3.39767139369954e-30	-0.414706940764017	0.736	0.844	5.36967987060275e-26	ADSL	Malignant cells	GSE131984_JQ1Pal	ENSG00000239900	158	adenylosuccinate lyase	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42436
3.52599656105345e-30	-0.506207232920729	0.51	0.698	5.57248496508888e-26	PSMC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000161057	5701	proteasome 26S subunit, ATPase 2	MSS1|Nbla10058|RPT1|S7	protein_coding	P35998	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42437
4.04774994301161e-30	-0.37568871357414	0.213	0.434	6.39706400993556e-26	RNF113A	Malignant cells	GSE131984_JQ1Pal	ENSG00000125352	7737	ring finger protein 113A	Cwc24|RNF113|ZNF183	protein_coding	O15541	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42438
4.07765250125318e-30	0.372272887803311	0.44	0.219	6.44432201298052e-26	LAMB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000091136	3912	laminin subunit beta 1	CLM	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42439
4.16654629713797e-30	-0.36949095155181	0.248	0.474	6.58480976799686e-26	FIP1L1	Malignant cells	GSE131984_JQ1Pal	ENSG00000145216	81608	factor interacting with PAPOLA and CPSF1	DKFZp586K0717|FIP1|hFip1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42440
4.26912626054337e-30	-0.445229772911844	0.318	0.527	6.74692714216274e-26	LTV1	Malignant cells	GSE131984_JQ1Pal	ENSG00000135521	84946	LTV1 ribosome biogenesis factor	C6orf93|dJ468K18.4|FLJ14909	protein_coding	Q96GA3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42441
4.87374920150528e-30	0.366630819008034	0.958	0.9	7.70247323805895e-26	NBEAL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000144426	65065	neurobeachin like 1	ALS2CR16|ALS2CR17|MGC164581	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42442
5.31435194145997e-30	-0.451232341749994	0.882	0.945	8.39880180828334e-26	SSB	Malignant cells	GSE131984_JQ1Pal	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42443
5.36674252363657e-30	0.36346429562204	0.403	0.186	8.48159988435523e-26	PLCD3	Malignant cells	GSE131984_JQ1Pal	ENSG00000161714	113026	phospholipase C delta 3	NA	protein_coding	Q8N3E9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42444
5.8369451303635e-30	-0.399839094129779	0.248	0.477	9.22470808402648e-26	CHORDC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42445
6.18534080605845e-30	-0.433046392045033	0.46	0.67	9.77531260989478e-26	SMC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000136824	10592	structural maintenance of chromosomes 2	CAP-E|hCAP-E|SMC2L1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42446
6.24662148122188e-30	-0.414744397117923	0.374	0.592	9.87216058892306e-26	UAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000117143	6675	UDP-N-acetylglucosamine pyrophosphorylase 1	AgX|AGX1|SPAG2	protein_coding	Q16222	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42447
6.46967390359686e-30	0.419710325917634	0.994	0.992	1.02246726372445e-25	CST3	Malignant cells	GSE131984_JQ1Pal	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42448
6.48289504434957e-30	-0.376875006886638	0.927	0.964	1.02455673280901e-25	MRPS12	Malignant cells	GSE131984_JQ1Pal	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42449
6.50349571703329e-30	-0.419783598355929	0.307	0.529	1.02781246311994e-25	DCPS	Malignant cells	GSE131984_JQ1Pal	ENSG00000110063	28960	decapping enzyme, scavenger	HINT-5|HINT5|HSL1|HSPC015	protein_coding	Q96C86	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42450
6.82921443699339e-30	0.396002537940244	0.877	0.716	1.07928904962243e-25	CRTAP	Malignant cells	GSE131984_JQ1Pal	ENSG00000170275	10491	cartilage associated protein	CASP|LEPREL3|P3H5	protein_coding	O75718	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42451
7.21875217946954e-30	-0.398720809955378	0.507	0.711	1.14085159444337e-25	SRSF4	Malignant cells	GSE131984_JQ1Pal	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42452
7.89547108878758e-30	-0.441395488328524	0.578	0.742	1.24780025087199e-25	DNAJC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42453
7.977531456656e-30	-0.359353099296957	0.09	0.279	1.26076907140991e-25	KYNU	Malignant cells	GSE131984_JQ1Pal	ENSG00000115919	8942	kynureninase	NA	protein_coding	Q16719	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42454
8.00448863242504e-30	0.40636440785464	0.645	0.428	1.26502938346845e-25	CASC4	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42455
8.80480004192121e-30	0.397187649026655	0.699	0.487	1.39151059862523e-25	MGAT4B	Malignant cells	GSE131984_JQ1Pal	ENSG00000284501	11282	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GnT-Ivb	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42456
8.94084209538091e-30	-0.41220713802771	0.826	0.898	1.413010684754e-25	SF3B2	Malignant cells	GSE131984_JQ1Pal	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42457
8.96526805719547e-30	-0.441089362960763	0.643	0.782	1.41687096375917e-25	AIMP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000164022	9255	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	EMAP-2|EMAPII|p43|SCYE1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42458
9.5931884712743e-30	-0.462911669029213	0.514	0.701	1.51610750600019e-25	PDCD10	Malignant cells	GSE131984_JQ1Pal	ENSG00000114209	11235	programmed cell death 10	CCM3|TFAR15	protein_coding	Q9BUL8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42459
9.84888756221858e-30	-0.417681416587967	0.426	0.637	1.55651819033303e-25	RPUSD3	Malignant cells	GSE131984_JQ1Pal	ENSG00000156990	285367	RNA pseudouridine synthase D3	MGC29784	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42460
1.00276838278615e-29	-0.34023447583649	0.954	0.977	1.58477515215523e-25	NSA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42461
1.01516393494878e-29	-0.410219633257699	0.883	0.946	1.60436508279306e-25	NT5C3B	Malignant cells	GSE131984_JQ1Pal	ENSG00000141698	115024	5'-nucleotidase, cytosolic IIIB	cN-IIIB|MGC20781|NT5C3L	protein_coding	Q969T7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42462
1.01973042812918e-29	-0.451901805818104	0.372	0.58	1.61158196861535e-25	YIPF6	Malignant cells	GSE131984_JQ1Pal	ENSG00000181704	286451	Yip1 domain family member 6	FinGER6|MGC21416	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42463
1.09537837230307e-29	-0.404118279389796	0.755	0.863	1.73113597958777e-25	RNH1	Malignant cells	GSE131984_JQ1Pal	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42464
1.14722840773133e-29	0.414647433641103	0.876	0.736	1.8130797755786e-25	RHOBTB3	Malignant cells	GSE131984_JQ1Pal	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42465
1.18075781676454e-29	-0.415374463382973	0.678	0.833	1.86606965361469e-25	TMEM205	Malignant cells	GSE131984_JQ1Pal	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42466
1.18145948362864e-29	0.392674301434325	0.972	0.924	1.8671785679267e-25	SNRNP25	Malignant cells	GSE131984_JQ1Pal	ENSG00000161981	79622	small nuclear ribonucleoprotein U11/U12 subunit 25	C16orf33|U11/U12-25K	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42467
1.23271319322586e-29	-0.411990885059621	0.43	0.653	1.94817993057414e-25	CENPM	Malignant cells	GSE131984_JQ1Pal	ENSG00000100162	79019	centromere protein M	C22orf18|CENP-M|MGC861|Pane1	protein_coding	Q9NSP4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42468
1.24363182077799e-29	0.370425202220031	0.65	0.418	1.96543572955754e-25	ECE1	Malignant cells	GSE131984_JQ1Pal	ENSG00000117298	1889	endothelin converting enzyme 1	ECE	protein_coding	P42892	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42469
1.26737028795292e-29	-0.34832197209657	0.167	0.379	2.0029520030808e-25	HIRIP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000149929	8479	HIRA interacting protein 3	NA	protein_coding	Q9BW71	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42470
1.28771119129728e-29	-0.608047342153705	0.436	0.633	2.03509876672622e-25	SLC3A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42471
1.29365170577943e-29	-0.4127068907333	0.707	0.82	2.04448715581381e-25	STX10	Malignant cells	GSE131984_JQ1Pal	ENSG00000104915	8677	syntaxin 10	hsyn10|SYN10	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42472
1.41190528326864e-29	0.545473131344184	0.413	0.201	2.23137510967776e-25	NR4A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42473
1.56315288032915e-29	-0.42502164538268	0.739	0.849	2.47040681207219e-25	SRSF5	Malignant cells	GSE131984_JQ1Pal	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42474
1.5850290148565e-29	-0.38800911312966	0.265	0.485	2.50497985507921e-25	SUCLG2	Malignant cells	GSE131984_JQ1Pal	ENSG00000172340	8801	succinate-CoA ligase GDP-forming subunit beta	NA	protein_coding	Q96I99	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42475
1.66529505444929e-29	-0.355039389730349	0.196	0.418	2.63183230405165e-25	C16orf80	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42476
1.74078148590355e-29	-0.367749282873949	0.934	0.959	2.75113106032198e-25	FUS	Malignant cells	GSE131984_JQ1Pal	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42477
1.80552794999685e-29	-0.419351776682165	0.569	0.735	2.85345637217503e-25	PMVK	Malignant cells	GSE131984_JQ1Pal	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42478
1.81542859884574e-29	-0.376186304931157	0.3	0.529	2.8691033576158e-25	MSL3	Malignant cells	GSE131984_JQ1Pal	ENSG00000005302	10943	MSL complex subunit 3	MSL3L1	protein_coding	Q8N5Y2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42479
2.03583957411773e-29	-0.316977266398048	0.076	0.259	3.21744086293566e-25	SOCS3	Malignant cells	GSE131984_JQ1Pal	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42480
2.14074061388746e-29	-0.535400660157566	0.257	0.48	3.38322646618773e-25	AURKB	Malignant cells	GSE131984_JQ1Pal	ENSG00000178999	9212	aurora kinase B	Aik2|AIM-1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5	protein_coding	Q96GD4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42481
2.21227908645003e-29	-0.376796690992378	0.256	0.473	3.49628586822563e-25	THOC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000051596	84321	THO complex subunit 3	MGC5469|TEX1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42482
2.22226445858153e-29	0.38019360947346	0.581	0.356	3.51206675034225e-25	SCRN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000136193	9805	secernin 1	KIAA0193	protein_coding	Q12765	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42483
2.24625007991104e-29	-0.350256538790551	0.915	0.963	3.54997362629142e-25	RER1	Malignant cells	GSE131984_JQ1Pal	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42484
2.44888612295735e-29	-0.395426528869406	0.765	0.867	3.8702196287218e-25	PAIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000172239	10605	poly(A) binding protein interacting protein 1	NA	protein_coding	Q9H074	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42485
2.49568395550058e-29	-0.399495695560111	0.41	0.62	3.94417892327312e-25	ENDOG	Malignant cells	GSE131984_JQ1Pal	ENSG00000167136	2021	endonuclease G	NA	protein_coding	Q14249	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42486
2.53393505882201e-29	0.378196827453955	0.562	0.336	4.0046309669623e-25	C1orf53	Malignant cells	GSE131984_JQ1Pal	ENSG00000203724	388722	chromosome 1 open reading frame 53	NA	protein_coding	Q5VUE5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42487
2.54503063973868e-29	-0.431952663290451	0.431	0.636	4.02216642304301e-25	GPANK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000223932	7918	G-patch domain and ankyrin repeats 1	ANKRD59|BAT4|D6S54E|G5|GPATCH10	protein_coding	O95872	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42488
2.65247195606438e-29	-0.335395726702555	0.151	0.363	4.19196667936414e-25	PKMYT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000127564	9088	protein kinase, membrane associated tyrosine/threonine 1	MYT1|PPP1R126	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42489
2.69723892297296e-29	-0.40120107181947	0.423	0.635	4.26271639386647e-25	FAM192A	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42490
2.7073869904952e-29	-0.357989987627359	0.997	0.998	4.27875439977862e-25	S100A4	Malignant cells	GSE131984_JQ1Pal	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42491
2.76947689546951e-29	-0.495594240659123	0.466	0.657	4.37688128560002e-25	RPF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000197498	84154	ribosome production factor 2 homolog	bA397G5.4|BXDC1|FLJ21087	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42492
2.84736073832702e-29	-0.396599556375408	0.561	0.732	4.49996891085203e-25	FBXO7	Malignant cells	GSE131984_JQ1Pal	ENSG00000100225	25793	F-box protein 7	Fbx|FBX7|PARK15	protein_coding	Q9Y3I1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42493
2.85725157501115e-29	0.388243928192335	0.567	0.35	4.51560038914762e-25	C21orf2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42494
3.04544318595876e-29	-0.317010879461961	0.922	0.98	4.81301841108922e-25	NDUFB3	Malignant cells	GSE131984_JQ1Pal	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42495
3.10328342955745e-29	-0.390009096082311	0.385	0.598	4.9044291320726e-25	INO80E	Malignant cells	GSE131984_JQ1Pal	ENSG00000169592	283899	INO80 complex subunit E	CCDC95|FLJ90652	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42496
3.53715763096547e-29	-0.366934469231901	0.284	0.514	5.59012391997783e-25	ETV4	Malignant cells	GSE131984_JQ1Pal	ENSG00000175832	2118	ETS variant transcription factor 4	E1A-F|E1AF|PEA3	protein_coding	P43268	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42497
3.69997110750332e-29	0.349172774403224	0.973	0.953	5.84743433829824e-25	GLTSCR2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42498
3.72991075588781e-29	-0.359934642259588	0.076	0.256	5.89475095860509e-25	PTN	Malignant cells	GSE131984_JQ1Pal	ENSG00000105894	5764	pleiotrophin	HBGF8|HBNF|NEGF1	protein_coding	P21246	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42499
3.81558894127771e-29	-0.460957734207898	0.437	0.631	6.0301567627953e-25	FDFT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42500
3.85457212718474e-29	-0.492088237870394	0.763	0.837	6.09176578980276e-25	SH3KBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42501
3.88449276165804e-29	-0.445522919154806	0.687	0.824	6.13905236052437e-25	SBDS	Malignant cells	GSE131984_JQ1Pal	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42502
4.00530668664082e-29	0.358748703629014	0.969	0.933	6.32998668756715e-25	FIBP	Malignant cells	GSE131984_JQ1Pal	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42503
4.54713221271979e-29	-0.38416685061221	0.654	0.814	7.18628774898236e-25	ATP1A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42504
4.59790529981615e-29	0.509538003104904	0.404	0.191	7.26652953582944e-25	STAC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000141750	342667	SH3 and cysteine rich domain 2	24b2	protein_coding	Q6ZMT1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42505
4.60943295611834e-29	-0.377646199224688	0.89	0.943	7.28474784384943e-25	EMD	Malignant cells	GSE131984_JQ1Pal	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42506
4.6199004743571e-29	-0.403087003212735	0.728	0.83	7.30129070967397e-25	RAP1B	Malignant cells	GSE131984_JQ1Pal	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42507
4.68544820046991e-29	-0.435870142638654	0.519	0.696	7.40488233602264e-25	DIMT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000086189	27292	DIM1 rRNA methyltransferase and ribosome maturation factor	DIMT1L|HSA9761	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42508
4.90080957220754e-29	-0.398166659039016	0.959	0.977	7.74523944791679e-25	TPM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42509
5.05459746340177e-29	-0.373621874688862	0.807	0.898	7.98828583116015e-25	RBM17	Malignant cells	GSE131984_JQ1Pal	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42510
5.22161192178052e-29	-0.396585507524283	0.476	0.674	8.25223548118193e-25	BCAT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000060982	586	branched chain amino acid transaminase 1	BCATc|BCT1	protein_coding	P54687	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42511
5.33322147754614e-29	0.420231980122503	0.827	0.664	8.42862322311392e-25	TUSC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000104723	7991	tumor suppressor candidate 3	MagT2|MGC13453|MRT22|MRT7|N33|OST3A|SLC58A2	protein_coding	Q13454	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42512
5.56970493438073e-29	-0.375742298547901	0.679	0.847	8.80236167829531e-25	IGFBP6	Malignant cells	GSE131984_JQ1Pal	ENSG00000167779	3489	insulin like growth factor binding protein 6	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42513
5.76867557855896e-29	-0.428574155040483	0.3	0.516	9.11681488435457e-25	GPSM2	Malignant cells	GSE131984_JQ1Pal	ENSG00000121957	29899	G protein signaling modulator 2	DFNB82|LGN|Pins	protein_coding	P81274	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42514
6.14129273393576e-29	0.35389580906413	1	0.997	9.70569903671207e-25	BRI3	Malignant cells	GSE131984_JQ1Pal	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42515
6.34365596895435e-29	-0.378050660024703	0.218	0.437	1.00255138933355e-24	PRKAG2	Malignant cells	GSE131984_JQ1Pal	ENSG00000106617	51422	protein kinase AMP-activated non-catalytic subunit gamma 2	AAKG|AAKG2|CMH6|H91620p|WPWS	protein_coding	Q9UGJ0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42516
6.97569864831573e-29	-0.357102695175766	0.22	0.439	1.10243941437982e-24	NGDN	Malignant cells	GSE131984_JQ1Pal	ENSG00000129460	25983	neuroguidin	C14orf120|CANu1|DKFZP564O092|LCP5|lpd-2|NGD	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42517
7.31672938407573e-29	0.389692219023504	0.463	0.252	1.15633591185933e-24	SLC48A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000211584	55652	solute carrier family 48 member 1	FLJ20489|hHRG-1|HRG1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42518
7.35824085647736e-29	-0.316983694904412	0.188	0.409	1.16289638495768e-24	CMTM7	Malignant cells	GSE131984_JQ1Pal	ENSG00000153551	112616	CKLF like MARVEL transmembrane domain containing 7	CKLFSF7|FLJ30992	protein_coding	Q96FZ5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42519
8.17698648598581e-29	-0.30928694787681	0.973	0.99	1.2922909442452e-24	LAMTOR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42520
8.80170899378549e-29	-0.395091128440457	0.841	0.908	1.39102208937786e-24	ITGAE	Malignant cells	GSE131984_JQ1Pal	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42521
9.11119225735241e-29	-0.373736982435667	0.847	0.902	1.43993282435198e-24	CISD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42522
1.01875592446662e-28	0.341952330616601	0.387	0.176	1.61004186302704e-24	ZHX3	Malignant cells	GSE131984_JQ1Pal	ENSG00000174306	23051	zinc fingers and homeoboxes 3	KIAA0395|TIX1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42523
1.02147525499877e-28	-0.410295681251234	0.672	0.802	1.61433949300006e-24	ELAVL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000066044	1994	ELAV like RNA binding protein 1	Hua|HUR|MelG	protein_coding	Q15717	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42524
1.0456288011421e-28	0.303173009846956	0.339	0.136	1.65251175732498e-24	ZMAT3	Malignant cells	GSE131984_JQ1Pal	ENSG00000172667	64393	zinc finger matrin-type 3	FLJ12296|MGC10613|PAG608|WIG-1|WIG1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42525
1.0910007350808e-28	-0.44768455528345	0.446	0.673	1.72421756172169e-24	NUSAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000137804	51203	nucleolar and spindle associated protein 1	ANKT|BM037|FLJ13421|LNP|PRO0310p1|Q0310|SAPL	protein_coding	Q9BXS6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42526
1.22503641349405e-28	-0.400382725419751	0.653	0.806	1.936047547886e-24	C12orf10	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42527
1.35680768943328e-28	-0.456087066216067	0.483	0.654	2.14429887238036e-24	TRAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000126602	10131	TNF receptor associated protein 1	HSP75|HSP90L	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42528
1.36743477592642e-28	-0.40583007967404	0.413	0.618	2.16109391987412e-24	DHRSX	Malignant cells	GSE131984_JQ1Pal	ENSG00000169084	207063	dehydrogenase/reductase X-linked	DHRS5X|DHRS5Y|DHRSXY|DHRSY|SDR46C1|SDR7C6	protein_coding	Q8N5I4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42529
1.40005062131474e-28	-0.389115757625871	0.481	0.697	2.21264000192581e-24	PFDN6	Malignant cells	GSE131984_JQ1Pal	ENSG00000235692	10471	prefoldin subunit 6	H2-KE2|HKE2|KE-2|PFD6	protein_coding	O15212	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42530
1.40705751622259e-28	0.401508355288147	0.485	0.271	2.22371369863818e-24	SEMA3C	Malignant cells	GSE131984_JQ1Pal	ENSG00000075223	10512	semaphorin 3C	SEMAE|SemE	protein_coding	Q99985	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42531
1.4092104202287e-28	-0.398437595294221	0.574	0.748	2.22711614812944e-24	COMMD3	Malignant cells	GSE131984_JQ1Pal	ENSG00000148444	23412	COMM domain containing 3	BUP|C10orf8	protein_coding	Q9UBI1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42532
1.555436340418e-28	-0.431400241243137	0.448	0.646	2.45821159239661e-24	GMPS	Malignant cells	GSE131984_JQ1Pal	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42533
1.58453787735393e-28	0.421540680128285	0.528	0.323	2.50420366137015e-24	UBE2D4	Malignant cells	GSE131984_JQ1Pal	ENSG00000078967	51619	ubiquitin conjugating enzyme E2 D4 (putative)	HBUCE1	protein_coding	Q9Y2X8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42534
1.62937254948607e-28	-0.363946575055289	0.832	0.896	2.57506037720778e-24	CWC15	Malignant cells	GSE131984_JQ1Pal	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42535
1.63960715717474e-28	0.311642633913436	0.319	0.123	2.59123515119896e-24	FLVCR2	Malignant cells	GSE131984_JQ1Pal	ENSG00000119686	55640	FLVCR heme transporter 2	C14orf58|CCT|FLJ20371|MFSD7C|SLC49A2	protein_coding	Q9UPI3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42536
1.71982278148134e-28	0.384678657684818	0.968	0.931	2.7180079238531e-24	SLC38A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42537
1.74135323538306e-28	-0.343810664787121	0.211	0.426	2.75203465319939e-24	RFC5	Malignant cells	GSE131984_JQ1Pal	ENSG00000111445	5985	replication factor C subunit 5	RFC36	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42538
1.76747455103358e-28	-0.43046885380089	0.668	0.819	2.79331678045347e-24	NXT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42539
1.81687621331789e-28	-0.386524805798434	0.282	0.511	2.87139116752759e-24	TSFM	Malignant cells	GSE131984_JQ1Pal	ENSG00000123297	10102	Ts translation elongation factor, mitochondrial	EF-TS|EF-Tsmt	protein_coding	P43897	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42540
1.87761710569842e-28	-0.365379962659248	0.837	0.912	2.96738607384579e-24	GABARAPL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42541
1.92246410025774e-28	0.473008330902501	0.771	0.59	3.03826226404734e-24	VMP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42542
1.96163953144931e-28	0.379528508410924	0.744	0.555	3.10017511550248e-24	GANAB	Malignant cells	GSE131984_JQ1Pal	ENSG00000089597	23193	glucosidase II alpha subunit	G2AN|GIIA|GluII|KIAA0088	protein_coding	Q14697	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42543
2.04371425941521e-28	-0.393536380739052	0.345	0.559	3.22988601557979e-24	WLS	Malignant cells	GSE131984_JQ1Pal	ENSG00000116729	79971	Wnt ligand secretion mediator	C1orf139|EVI|FLJ23091|GPR177|mig-14|MRP	protein_coding	Q5T9L3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42544
2.05707864117667e-28	0.295319219161919	0.334	0.133	3.25100708451561e-24	ZNF217	Malignant cells	GSE131984_JQ1Pal	ENSG00000171940	7764	zinc finger protein 217	ZABC1	protein_coding	O75362	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42545
2.12088748402098e-28	-0.391387794917659	0.285	0.5	3.35185057974676e-24	RRP15	Malignant cells	GSE131984_JQ1Pal	ENSG00000067533	51018	ribosomal RNA processing 15 homolog	CGI-115|KIAA0507	protein_coding	Q9Y3B9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42546
2.17623056301206e-28	-0.38314942353083	0.559	0.747	3.43931478178427e-24	FAM32A	Malignant cells	GSE131984_JQ1Pal	ENSG00000105058	26017	family with sequence similarity 32 member A	DKFZP586O0120|OTAG-12	protein_coding	Q9Y421	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42547
2.22058845323612e-28	-0.402685691661497	0.438	0.649	3.50941799149436e-24	ZC3H13	Malignant cells	GSE131984_JQ1Pal	ENSG00000123200	23091	zinc finger CCCH-type containing 13	DKFZp434D1812|KIAA0853|Xio	protein_coding	Q5T200	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42548
2.22191117987698e-28	0.375158089190165	0.651	0.442	3.51150842867757e-24	DNAJC5	Malignant cells	GSE131984_JQ1Pal	ENSG00000101152	80331	DnaJ heat shock protein family (Hsp40) member C5	CLN4|DNAJC5A|FLJ00118|FLJ13070	protein_coding	Q9H3Z4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42549
2.40576771125401e-28	0.388243928192336	0.609	0.391	3.80207529086584e-24	SPTAN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000197694	6709	spectrin alpha, non-erythrocytic 1	NA	protein_coding	Q13813	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42550
2.49839904416763e-28	-0.276286480807753	0.103	0.294	3.94846984940252e-24	C18orf56	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42551
2.57247589808551e-28	0.410449466454014	0.939	0.828	4.06554090933435e-24	PERP	Malignant cells	GSE131984_JQ1Pal	ENSG00000112378	64065	p53 apoptosis effector related to PMP22	dJ496H19.1|KCP1|KRTCAP1|PIGPC1|THW	protein_coding	Q96FX8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42552
2.68977310906492e-28	0.414385322069644	0.559	0.328	4.2509174215662e-24	GSN	Malignant cells	GSE131984_JQ1Pal	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42553
2.8673933723502e-28	-0.389818938850818	0.237	0.453	4.53162848566226e-24	RAD51AP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000111247	10635	RAD51 associated protein 1	PIR51	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42554
3.04957182351212e-28	-0.388718098581854	0.948	0.97	4.81954330987855e-24	PAPOLA	Malignant cells	GSE131984_JQ1Pal	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42555
3.48260702448194e-28	-0.619577667435027	0.623	0.746	5.50391214149125e-24	TSC22D3	Malignant cells	GSE131984_JQ1Pal	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42556
3.88592652786285e-28	-0.367754973853677	0.917	0.97	6.14131828463444e-24	HNRNPAB	Malignant cells	GSE131984_JQ1Pal	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42557
3.99059738512691e-28	-0.407731380240894	0.542	0.701	6.30674010745457e-24	SS18L2	Malignant cells	GSE131984_JQ1Pal	ENSG00000008324	51188	SS18 like 2	KIAA-iso	protein_coding	Q9UHA2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42558
4.07783716649798e-28	0.356816062776815	0.456	0.238	6.44461385793342e-24	KIDINS220	Malignant cells	GSE131984_JQ1Pal	ENSG00000134313	57498	kinase D interacting substrate 220	ARMS	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42559
4.23116251070102e-28	-0.451291399614418	0.395	0.582	6.6869292319119e-24	RPF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000117133	80135	ribosome production factor 1 homolog	BXDC5	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42560
4.25973436963958e-28	0.375982990025355	0.482	0.265	6.7320841977784e-24	PLEKHA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000169499	59339	pleckstrin homology domain containing A2	TAPP2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42561
4.9297412552527e-28	0.344233998186174	0.501	0.277	7.79096307980137e-24	TBC1D16	Malignant cells	GSE131984_JQ1Pal	ENSG00000167291	125058	TBC1 domain family member 16	FLJ20748|MGC25062	protein_coding	Q8TBP0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42562
5.4369858217306e-28	0.395043889013375	0.523	0.318	8.59261239266304e-24	ATP6V1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000114573	523	ATPase H+ transporting V1 subunit A	ATP6A1|ATP6V1A1|VA68|Vma1|VPP2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42563
5.43818786207979e-28	-0.372511069423558	0.744	0.869	8.5945120972309e-24	TMEM106C	Malignant cells	GSE131984_JQ1Pal	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42564
5.49271386216218e-28	0.356615591727982	0.538	0.317	8.68068498776111e-24	STAT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42565
5.84880802508466e-28	0.389296825625945	0.837	0.68	9.2434562028438e-24	ABI2	Malignant cells	GSE131984_JQ1Pal	ENSG00000138443	10152	abl interactor 2	ABI-2|ABI2B|AblBP3|AIP-1|argBPIA|SSH3BP2	protein_coding	Q9NYB9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42566
5.85111449946773e-28	-0.455263139842509	0.416	0.61	9.2471013549588e-24	DCAF13	Malignant cells	GSE131984_JQ1Pal	ENSG00000164934	25879	DDB1 and CUL4 associated factor 13	DKFZP564O0463|Gm83|HSPC064|Sof1|WDSOF1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42567
6.11756163497991e-28	-0.410609458576421	0.688	0.806	9.66819440792224e-24	RWDD4	Malignant cells	GSE131984_JQ1Pal	ENSG00000182552	201965	RWD domain containing 4	FAM28A|MGC10198|RWDD4A	protein_coding	Q6NW29	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42568
6.41033501033352e-28	0.312694975211804	0.358	0.155	1.01308934503311e-23	LENG8	Malignant cells	GSE131984_JQ1Pal	ENSG00000276458	114823	leukocyte receptor cluster member 8	KIAA1932|MGC40108|pp13842	protein_coding	Q96PV6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42569
6.4281053505403e-28	0.370207704763456	0.524	0.305	1.01589776959939e-23	CYHR1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42570
6.55362471143934e-28	0.341784617099675	0.433	0.214	1.03573484939587e-23	ZNF22	Malignant cells	GSE131984_JQ1Pal	ENSG00000165512	7570	zinc finger protein 22	HKR-T1|KOX15|Zfp422|ZNF422	protein_coding	P17026	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42571
7.90676915411242e-28	0.430569458009338	0.614	0.403	1.24958579711593e-23	B4GALT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42572
8.51829683988044e-28	-0.557326713126969	0.525	0.677	1.3462316325747e-23	WBP5	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42573
8.60586295660117e-28	-0.394653199140056	0.606	0.77	1.36007058166125e-23	APOPT1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42574
8.71792132356501e-28	-0.321651310735271	0.973	0.99	1.37778028597621e-23	MORF4L1	Malignant cells	GSE131984_JQ1Pal	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42575
8.83891860395521e-28	-0.413702429137681	0.476	0.655	1.39690269616908e-23	CINP	Malignant cells	GSE131984_JQ1Pal	ENSG00000100865	51550	cyclin dependent kinase 2 interacting protein	MGC849	protein_coding	Q9BW66	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42576
8.90303918527188e-28	-0.468928253027518	0.792	0.878	1.40703631284037e-23	H1FX	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42577
9.33221393327953e-28	-0.431912502891843	0.971	0.988	1.4748630900155e-23	UBB	Malignant cells	GSE131984_JQ1Pal	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42578
9.57025332059242e-28	0.359331236277097	0.56	0.338	1.51248283478643e-23	MBTPS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000140943	8720	membrane bound transcription factor peptidase, site 1	KIAA0091|PCSK8|S1P|SKI-1	protein_coding	Q14703	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42579
1.01799903186968e-27	-0.360991175864142	0.857	0.907	1.60884566996684e-23	CAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42580
1.07038290510008e-27	-0.429947448877248	0.319	0.525	1.69163314322017e-23	PLOD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000152952	5352	procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	LH2|TLH	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42581
1.17170808577815e-27	0.330858060599455	0.407	0.196	1.85176745876379e-23	EPHB4	Malignant cells	GSE131984_JQ1Pal	ENSG00000196411	2050	EPH receptor B4	HTK|Tyro11	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42582
1.18465886942369e-27	-0.387128646087908	0.685	0.813	1.8722348772372e-23	TRAPPC2L	Malignant cells	GSE131984_JQ1Pal	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42583
1.23702537443299e-27	-0.381396561038608	0.363	0.574	1.95499490175389e-23	TCERG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000113649	10915	transcription elongation regulator 1	CA150|TAF2S|Urn1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42584
1.28289892918875e-27	-0.285826046362806	0.103	0.29	2.0274934676899e-23	CSTF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000101811	1478	cleavage stimulation factor subunit 2	CstF-64	protein_coding	P33240	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42585
1.45069874157793e-27	-0.399437873378123	0.664	0.827	2.29268429118976e-23	CD47	Malignant cells	GSE131984_JQ1Pal	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42586
1.55862096781641e-27	-0.403560414241942	0.526	0.71	2.46324457753706e-23	ALG3	Malignant cells	GSE131984_JQ1Pal	ENSG00000214160	10195	ALG3 alpha-1,3- mannosyltransferase	CDGS4|D16Ertd36e|Not56|NOT56L	protein_coding	Q92685	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42587
1.7407614128761e-27	-0.301955051451765	0.997	0.998	2.75109933690939e-23	PEBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42588
1.77421692919747e-27	-0.327648601680127	0.98	0.99	2.80397243490368e-23	NDUFB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42589
1.83711509343064e-27	0.320705597378255	0.296	0.11	2.90337669365778e-23	TRAPPC6A	Malignant cells	GSE131984_JQ1Pal	ENSG00000007255	79090	trafficking protein particle complex subunit 6A	HSPC289|MGC2650|TRS33	protein_coding	O75865	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42590
2.34371431267393e-27	-0.393093152869274	0.567	0.727	3.70400609974987e-23	ACBD6	Malignant cells	GSE131984_JQ1Pal	ENSG00000230124	84320	acyl-CoA binding domain containing 6	MGC2404	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42591
2.41891386354516e-27	-0.31381525122223	0.187	0.396	3.82285146994677e-23	DMAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000178028	55929	DNA methyltransferase 1 associated protein 1	DNMAP1|DNMTAP1|EAF2|FLJ11543|KIAA1425|MEAF2|SWC4	protein_coding	Q9NPF5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42592
2.44050675494106e-27	-0.437697056046665	0.48	0.665	3.85697687550885e-23	SLC25A11	Malignant cells	GSE131984_JQ1Pal	ENSG00000108528	8402	solute carrier family 25 member 11	OGC|SLC20A4	protein_coding	Q02978	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42593
2.56412570894247e-27	-0.414258759457521	0.477	0.672	4.05234427041267e-23	RBMX2	Malignant cells	GSE131984_JQ1Pal	ENSG00000134597	51634	RNA binding motif protein X-linked 2	CGI-79|Snu17	protein_coding	Q9Y388	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42594
2.5904604814244e-27	-0.371887143414284	0.867	0.926	4.09396374484313e-23	RCN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42595
2.76927911280406e-27	-0.403673379381678	0.523	0.701	4.37656870987553e-23	CCDC53	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42596
2.87424136955929e-27	-0.350440939375025	0.815	0.883	4.5424510604515e-23	TXN2	Malignant cells	GSE131984_JQ1Pal	ENSG00000100348	25828	thioredoxin 2	MT-TRX	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42597
2.89711996762278e-27	0.592691577720541	0.925	0.879	4.57860839683104e-23	MT1E	Malignant cells	GSE131984_JQ1Pal	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42598
2.90764316530287e-27	0.303439482098469	0.361	0.159	4.59523925844466e-23	SMAD7	Malignant cells	GSE131984_JQ1Pal	ENSG00000101665	4092	SMAD family member 7	MADH7|MADH8	protein_coding	O15105	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42599
2.94920491218386e-27	-0.387640697506441	0.282	0.491	4.66092344321538e-23	FHL3	Malignant cells	GSE131984_JQ1Pal	ENSG00000183386	2275	four and a half LIM domains 3	SLIM2	protein_coding	Q13643	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42600
2.95268006211698e-27	-0.391892476781955	0.585	0.754	4.66641557016968e-23	MRPS5	Malignant cells	GSE131984_JQ1Pal	ENSG00000144029	64969	mitochondrial ribosomal protein S5	MRP-S5|S5mt	protein_coding	P82675	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42601
2.96568031151975e-27	-0.426078042280245	0.431	0.633	4.68696116432581e-23	ZWINT	Malignant cells	GSE131984_JQ1Pal	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42602
3.10385817314464e-27	-0.421306154576444	0.299	0.512	4.90533745683779e-23	RFC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000133119	5983	replication factor C subunit 3	MGC5276|RFC38	protein_coding	P40938	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42603
3.32740902878242e-27	-0.34855329402516	0.266	0.483	5.25863722908774e-23	SF3B4	Malignant cells	GSE131984_JQ1Pal	ENSG00000143368	10262	splicing factor 3b subunit 4	Hsh49|SAP49|SF3b49	protein_coding	Q15427	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42604
3.36249260412258e-27	-0.387293998453965	0.489	0.687	5.31408331155532e-23	RP11-345J4.5	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42605
3.41586324779549e-27	-0.373473497441829	0.291	0.501	5.39843027681599e-23	CCDC58	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42606
3.43682113361492e-27	-0.405345199748653	0.778	0.87	5.43155211956501e-23	MED10	Malignant cells	GSE131984_JQ1Pal	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42607
3.44839287436255e-27	-0.415268276878744	0.338	0.536	5.44984009864257e-23	RPA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000117748	6118	replication protein A2	NA	protein_coding	P15927	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42608
3.45048399910601e-27	-0.417884252415055	0.522	0.692	5.45314491218714e-23	ISCA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000165898	122961	iron-sulfur cluster assembly 2	HBLD1|ISA2	protein_coding	Q86U28	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42609
3.61428539115391e-27	-0.335036291744477	0.828	0.916	5.71201663217964e-23	NDUFB6	Malignant cells	GSE131984_JQ1Pal	ENSG00000165264	4712	NADH:ubiquinone oxidoreductase subunit B6	B17|CI	protein_coding	O95139	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42610
4.58073125834943e-27	0.363067618526781	0.479	0.265	7.23938768069544e-23	NBPF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000219481	55672	NBPF member 1	FLJ20719|KIAA1693	protein_coding	Q3BBV0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42611
4.66701952384042e-27	-0.391896591778171	0.71	0.82	7.37575765547741e-23	RAB5C	Malignant cells	GSE131984_JQ1Pal	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42612
5.57390443926579e-27	-0.405455653886992	0.465	0.648	8.80899857581565e-23	COMMD8	Malignant cells	GSE131984_JQ1Pal	ENSG00000169019	54951	COMM domain containing 8	FLJ20502	protein_coding	Q9NX08	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42613
5.59340794855067e-27	-0.747865830938789	0.467	0.658	8.83982192188948e-23	UBE2C	Malignant cells	GSE131984_JQ1Pal	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42614
5.76432338917938e-27	-0.300239150579167	0.96	0.986	9.10993668425909e-23	ZCRB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000139168	85437	zinc finger CCHC-type and RNA binding motif containing 1	MADP-1|MADP1|RBM36|SNRNP31|ZCCHC19	protein_coding	Q8TBF4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42615
6.92785167443383e-27	-0.268858126296082	0.997	1	1.09487767862752e-22	NEDD8	Malignant cells	GSE131984_JQ1Pal	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42616
7.4470948557225e-27	-0.34841586987122	0.256	0.469	1.17693887099838e-22	LZIC	Malignant cells	GSE131984_JQ1Pal	ENSG00000162441	84328	leucine zipper and CTNNBIP1 domain containing	MGC15436	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42617
7.69202902155001e-27	-0.426340617385412	0.515	0.676	1.21564826656576e-22	UGP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42618
8.48178489151718e-27	0.380646264108288	0.894	0.782	1.34046128425537e-22	SEC61A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000058262	29927	SEC61 translocon subunit alpha 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42619
8.61925354760984e-27	-0.428814967632613	0.442	0.637	1.36218683066426e-22	RNASEH2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42620
9.01212191766116e-27	-0.4016036562799	0.512	0.683	1.42427574786717e-22	ZNF259	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42621
9.17778399218781e-27	-0.31661160388071	0.171	0.374	1.45045698212536e-22	MAPK3	Malignant cells	GSE131984_JQ1Pal	ENSG00000102882	5595	mitogen-activated protein kinase 3	ERK1|p44erk1|p44mapk|PRKM3	protein_coding	P27361	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42622
9.41748665087056e-27	-0.39947761990123	0.75	0.854	1.48833959030358e-22	COPS8	Malignant cells	GSE131984_JQ1Pal	ENSG00000198612	10920	COP9 signalosome subunit 8	COP9|CSN8|MGC1297|SGN8	protein_coding	Q99627	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42623
9.52647955541016e-27	0.337415113568166	0.517	0.299	1.50556482893702e-22	NCOA3	Malignant cells	GSE131984_JQ1Pal	ENSG00000124151	8202	nuclear receptor coactivator 3	ACTR|AIB1|bHLHe42|CAGH16|KAT13B|p/CIP|RAC3|SRC-3|SRC3|TNRC16|TRAM-1	protein_coding	Q9Y6Q9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42624
9.59007846739152e-27	0.395903375511209	0.719	0.546	1.51561600098656e-22	LRRC58	Malignant cells	GSE131984_JQ1Pal	ENSG00000163428	116064	leucine rich repeat containing 58	NA	protein_coding	Q96CX6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42625
1.04376488561447e-26	-0.25255157402883	0.999	1	1.64956602522511e-22	CD63	Malignant cells	GSE131984_JQ1Pal	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42626
1.09151695580961e-26	-0.40482627101402	0.69	0.811	1.7250333969615e-22	GRSF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000132463	2926	G-rich RNA sequence binding factor 1	NA	protein_coding	Q12849	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42627
1.11993281716252e-26	-0.332844654475288	0.938	0.978	1.76994182424364e-22	MRPS21	Malignant cells	GSE131984_JQ1Pal	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42628
1.12015202935313e-26	-0.383579991902093	0.523	0.706	1.77028826718968e-22	TIPRL	Malignant cells	GSE131984_JQ1Pal	ENSG00000143155	261726	TOR signaling pathway regulator	dJ69E11.3|MGC3794|TIP41|TIPRL1	protein_coding	O75663	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42629
1.12275366305985e-26	0.281821869056181	0.31	0.121	1.77439988909978e-22	ULK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000177169	8408	unc-51 like autophagy activating kinase 1	ATG1|ATG1A	protein_coding	O75385	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42630
1.12713759542273e-26	-0.436702777418371	0.55	0.697	1.78132825580609e-22	CHMP2B	Malignant cells	GSE131984_JQ1Pal	ENSG00000083937	25978	charged multivesicular body protein 2B	CHMP2.5|DKFZP564O123|VPS2B	protein_coding	Q9UQN3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42631
1.20766791444425e-26	-0.3890738071672	0.594	0.762	1.90859837198769e-22	CCDC109B	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42632
1.26363446552636e-26	-0.282271005084518	0.967	0.994	1.99704790931786e-22	SF3B14	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42633
1.39249990034483e-26	-0.402080927106336	0.688	0.812	2.20070684250496e-22	EWSR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42634
1.39755412963247e-26	-0.320474429429829	0.948	0.968	2.20869454647116e-22	SSU72	Malignant cells	GSE131984_JQ1Pal	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42635
1.46166068861972e-26	-0.397583636856377	0.424	0.625	2.31000855229461e-22	PELO	Malignant cells	GSE131984_JQ1Pal	ENSG00000152684	53918	pelota mRNA surveillance and ribosome rescue factor	NA	protein_coding	Q9BRX2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42636
1.60363085437617e-26	-0.384304515979207	0.449	0.654	2.53437820225611e-22	POP4	Malignant cells	GSE131984_JQ1Pal	ENSG00000105171	10775	POP4 homolog, ribonuclease P/MRP subunit	RPP29	protein_coding	O95707	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42637
1.78640429348277e-26	-0.388473760357731	0.337	0.539	2.82323334542018e-22	DUSP12	Malignant cells	GSE131984_JQ1Pal	ENSG00000081721	11266	dual specificity phosphatase 12	DUSP1|YVH1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42638
2.02026365026914e-26	-0.439698215887846	0.626	0.753	3.19282467288535e-22	YDJC	Malignant cells	GSE131984_JQ1Pal	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42639
2.27459743794618e-26	-0.411265731982646	0.412	0.609	3.59477379093015e-22	WDR45	Malignant cells	GSE131984_JQ1Pal	ENSG00000196998	11152	WD repeat domain 45	JM5|NBIA5|WDRX1|WIPI4	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42640
2.91442709405604e-26	0.365077266008175	0.5	0.287	4.60596057944616e-22	NCS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000107130	23413	neuronal calcium sensor 1	FREQ|NCS-1	protein_coding	P62166	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42641
3.12786948375895e-26	-0.386054664844486	0.492	0.679	4.94328493213265e-22	MLST8	Malignant cells	GSE131984_JQ1Pal	ENSG00000167965	64223	MTOR associated protein, LST8 homolog	GbetaL|GBL|Lst8|Pop3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42642
3.13166434198597e-26	-0.347951649921734	0.225	0.431	4.94928232607463e-22	ERAL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000132591	26284	Era like 12S mitochondrial rRNA chaperone 1	HERA-B	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42643
3.18279325037786e-26	-0.367132621737313	0.841	0.904	5.03008645289717e-22	FAM195A	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42644
3.21219327734944e-26	-0.315806296309953	0.965	0.992	5.07655025552305e-22	DYNLT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000146425	6993	dynein light chain Tctex-type 1	TCTEL1|Tctex-1|TCTEX1	protein_coding	P63172	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42645
3.5685979789723e-26	0.268493539282632	1	0.998	5.63981224596783e-22	GUK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42646
3.57243626364926e-26	-0.34197783714242	0.193	0.399	5.6458782710713e-22	TRIM47	Malignant cells	GSE131984_JQ1Pal	ENSG00000132481	91107	tripartite motif containing 47	GOA|RNF100	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42647
3.93064861469726e-26	0.307119863067614	0.354	0.158	6.21199707066756e-22	METRNL	Malignant cells	GSE131984_JQ1Pal	ENSG00000275031	284207	meteorin like, glial cell differentiation regulator	NA	protein_coding	Q641Q3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42648
4.19748770068641e-26	-0.374820230529418	0.584	0.743	6.63370956216481e-22	GBAS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42649
4.73583289386238e-26	-0.391527152562582	0.576	0.735	7.48451030546011e-22	PWP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000136045	11137	PWP1 homolog, endonuclein	IEF-SSP-9502	protein_coding	Q13610	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42650
4.99809598865532e-26	-0.310142131180782	0.138	0.331	7.89899090047087e-22	HDHD1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42651
5.03060343326837e-26	-0.791851699237403	0.663	0.786	7.95036566593733e-22	HSPA5	Malignant cells	GSE131984_JQ1Pal	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42652
5.42004796566451e-26	0.300801697396929	0.377	0.176	8.56584380493619e-22	TTYH3	Malignant cells	GSE131984_JQ1Pal	ENSG00000136295	80727	tweety family member 3	KIAA1691	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42653
5.4398863343338e-26	0.361773249095462	0.479	0.271	8.59719636278113e-22	TRIB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42654
5.6706897985423e-26	-0.383183694670733	0.8	0.865	8.96195815761624e-22	ECI2	Malignant cells	GSE131984_JQ1Pal	ENSG00000198721	10455	enoyl-CoA delta isomerase 2	ACBD2|DRS1|HCA88|PECI	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42655
5.73171151842211e-26	-0.302311309684268	0.939	0.972	9.0583968837143e-22	VKORC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000167397	79001	vitamin K epoxide reductase complex subunit 1	VKCFD2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42656
6.17559848021518e-26	-0.406205993896022	0.427	0.615	9.75991583813207e-22	MAP7D3	Malignant cells	GSE131984_JQ1Pal	ENSG00000129680	79649	MAP7 domain containing 3	FLJ12649	protein_coding	Q8IWC1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42657
6.46141624934891e-26	-0.366255704025534	0.961	0.984	1.0211622240471e-21	PRSS3	Malignant cells	GSE131984_JQ1Pal	ENSG00000010438	5646	serine protease 3	PRSS4|TRY3|TRY4	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42658
8.08955528459399e-26	0.386424437933355	0.608	0.409	1.27847331717723e-21	JUND	Malignant cells	GSE131984_JQ1Pal	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42659
8.86479483573709e-26	0.330533654378388	0.481	0.272	1.40099217583989e-21	ATM	Malignant cells	GSE131984_JQ1Pal	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42660
9.8999009661166e-26	-0.377523607108654	0.542	0.71	1.56458034868507e-21	SNRPA	Malignant cells	GSE131984_JQ1Pal	ENSG00000077312	6626	small nuclear ribonucleoprotein polypeptide A	Mud1|U1-A|U1A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42661
1.00421183576938e-25	-0.428169369931208	0.41	0.599	1.58705638524993e-21	IDI1	Malignant cells	GSE131984_JQ1Pal	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42662
1.16487986397495e-25	-0.361420369289482	0.764	0.879	1.84097613702601e-21	SRA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000213523	10011	steroid receptor RNA activator 1	SRA|STRAA1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42663
1.32224483725205e-25	-0.331407080671702	0.166	0.359	2.08967574079315e-21	EIF5AL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000253626	143244	eukaryotic translation initiation factor 5A like 1	bA342M3.3|EIF5AP1	protein_coding	Q6IS14	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42664
1.33446193136591e-25	-0.316522843585722	0.203	0.409	2.10898363633069e-21	AGAP2-AS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000255737	100130776	AGAP2 antisense RNA 1	LOC100130776|PUNISHER	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42665
1.34872096362777e-25	0.320113934873059	0.396	0.192	2.13151861091732e-21	CERS6	Malignant cells	GSE131984_JQ1Pal	ENSG00000172292	253782	ceramide synthase 6	LASS6	protein_coding	Q6ZMG9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42666
1.60799164538962e-25	0.349694636630924	0.47	0.261	2.54126999637376e-21	ARRDC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42667
1.62678561750748e-25	-0.381627058890166	0.459	0.658	2.57097198990882e-21	WSB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000176871	55884	WD repeat and SOCS box containing 2	MGC10210|SBA2	protein_coding	Q9NYS7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42668
1.79883007468307e-25	-0.304374708153837	0.93	0.981	2.84287105002912e-21	BOLA3	Malignant cells	GSE131984_JQ1Pal	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42669
1.81412922167096e-25	-0.453825880095331	0.333	0.518	2.86704982192879e-21	CCNH	Malignant cells	GSE131984_JQ1Pal	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42670
1.83563075301787e-25	-0.34710432355445	0.348	0.557	2.90103084206945e-21	SPNS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000169682	83985	sphingolipid transporter 1 (putative)	HSpin1|LAT|nrs|PP2030|SLC63A1|SPIN1|SPINL	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42671
1.84130341443918e-25	-0.339081167265529	0.845	0.928	2.90999591617968e-21	DTD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000125821	92675	D-aminoacyl-tRNA deacylase 1	bA379J5.3|bA555E18.1|C20orf88|DUEB|HARS2|MGC119131|MGC41905|pqn-68	protein_coding	Q8TEA8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42672
1.87840436755878e-25	-0.375478918103004	0.4	0.601	2.96863026248989e-21	C21orf59	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42673
1.97380022326171e-25	0.260128073972941	0.269	0.095	3.11939387284281e-21	MFSD6	Malignant cells	GSE131984_JQ1Pal	ENSG00000151690	54842	major facilitator superfamily domain containing 6	FLJ20160	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42674
2.11829092743191e-25	-0.37182134911761	0.149	0.338	3.34774698171339e-21	PHGDH	Malignant cells	GSE131984_JQ1Pal	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42675
2.13204495278396e-25	-0.392847451835617	0.44	0.635	3.36948384337978e-21	C1D	Malignant cells	GSE131984_JQ1Pal	ENSG00000197223	10438	C1D nuclear receptor corepressor	LRP1|Rrp47|SUN-CoR|SUNCOR	protein_coding	Q13901	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42676
2.3487638124358e-25	-0.372721500560216	0.34	0.543	3.71198632917354e-21	LACTB	Malignant cells	GSE131984_JQ1Pal	ENSG00000103642	114294	lactamase beta	FLJ14902|MRPL56	protein_coding	P83111	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42677
2.4346255518884e-25	-0.594364507271897	0.553	0.703	3.84768222220443e-21	PCNA	Malignant cells	GSE131984_JQ1Pal	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42678
2.4824050599623e-25	-0.270425146422999	0.979	0.99	3.92319295676442e-21	SKP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42679
2.52718282141069e-25	0.365604819890753	0.752	0.549	3.99395973095746e-21	USP22	Malignant cells	GSE131984_JQ1Pal	ENSG00000124422	23326	ubiquitin specific peptidase 22	KIAA1063|USP3L	protein_coding	Q9UPT9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42680
2.59158942741263e-25	0.358777312276862	0.847	0.683	4.09574793108292e-21	GTF2I	Malignant cells	GSE131984_JQ1Pal	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42681
2.61388044687141e-25	-0.327013400840642	0.107	0.284	4.13097665823557e-21	ADAMTS9	Malignant cells	GSE131984_JQ1Pal	ENSG00000163638	56999	ADAM metallopeptidase with thrombospondin type 1 motif 9	KIAA1312	protein_coding	Q9P2N4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42682
2.62247487121193e-25	0.393800159480562	0.787	0.625	4.14455928646333e-21	APMAP	Malignant cells	GSE131984_JQ1Pal	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42683
2.62315985163435e-25	-0.350416224090224	0.433	0.641	4.14564182952293e-21	ERI3	Malignant cells	GSE131984_JQ1Pal	ENSG00000117419	79033	ERI1 exoribonuclease family member 3	FLJ22943|PINT1|PRNPIP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42684
2.71946210618089e-25	-0.345521010105613	0.273	0.483	4.29783791260827e-21	MITD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000158411	129531	microtubule interacting and trafficking domain containing 1	LOC129531	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42685
2.78593238665325e-25	-0.430251105976493	0.528	0.688	4.4028875438668e-21	PSME3	Malignant cells	GSE131984_JQ1Pal	ENSG00000131467	10197	proteasome activator subunit 3	Ki|PA28-gamma|PA28G|REG-GAMMA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42686
2.89422200713232e-25	-0.382519083876	0.434	0.623	4.57402846007191e-21	COQ2	Malignant cells	GSE131984_JQ1Pal	ENSG00000173085	27235	coenzyme Q2, polyprenyltransferase	CL640|FLJ26072	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42687
2.90456131326931e-25	-0.259172400144563	0.095	0.27	4.59036869949081e-21	F2RL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000164251	2150	F2R like trypsin receptor 1	GPR11|PAR2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42688
2.90879489584904e-25	-0.391169078533238	0.993	0.994	4.59705945339982e-21	TNFRSF12A	Malignant cells	GSE131984_JQ1Pal	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42689
2.983843771278e-25	0.303512741092875	0.378	0.181	4.71566669612775e-21	TRAK2	Malignant cells	GSE131984_JQ1Pal	ENSG00000115993	66008	trafficking kinesin protein 2	ALS2CR3|CALS-C|GRIF-1|KIAA0549|MILT2|OIP98	protein_coding	O60296	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42690
3.06356023426861e-25	0.270976848082103	0.281	0.106	4.8416505942381e-21	PCMTD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000280663	55251	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	C20orf36|FLJ10883	protein_coding	Q9NV79	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42691
3.11347662756103e-25	-0.319115497589198	0.183	0.378	4.92053846219745e-21	LACTB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000147592	51110	lactamase beta 2	CGI-83	protein_coding	Q53H82	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42692
3.13073047242016e-25	-0.361045350862823	0.752	0.847	4.94780643861283e-21	NDUFS3	Malignant cells	GSE131984_JQ1Pal	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42693
3.17218134635522e-25	-0.364301495605124	0.354	0.566	5.01331539977979e-21	GNA15	Malignant cells	GSE131984_JQ1Pal	ENSG00000060558	2769	G protein subunit alpha 15	GNA16	protein_coding	P30679	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42694
3.21116610498039e-25	0.382772332614429	0.555	0.352	5.07492691231101e-21	LOXL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000134013	4017	lysyl oxidase like 2	LOR|WS9-14	protein_coding	Q9Y4K0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42695
3.26400359605437e-25	0.483786422465334	0.632	0.443	5.15843128320433e-21	GPR116	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42696
3.64114573077188e-25	0.27153889579432	0.296	0.115	5.75446671291188e-21	ZDHHC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000104219	51201	zinc finger DHHC-type palmitoyltransferase 2	DHHC2|ZNF372	protein_coding	Q9UIJ5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42697
3.71103651320716e-25	-0.328628485808796	0.2	0.398	5.8649221054726e-21	MSRB3	Malignant cells	GSE131984_JQ1Pal	ENSG00000174099	253827	methionine sulfoxide reductase B3	DFNB74|DKFZp686C1178|FLJ36866	protein_coding	Q8IXL7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42698
3.8186616263845e-25	0.37749224528893	0.766	0.58	6.03501283433806e-21	SLC25A37	Malignant cells	GSE131984_JQ1Pal	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42699
3.84653275287346e-25	-0.360361501416514	0.787	0.861	6.07906036264122e-21	EFHD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42700
3.89899438276896e-25	0.320014506940415	0.374	0.178	6.16197072252806e-21	TMEM136	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42701
4.01248143574895e-25	-0.435973932417592	0.534	0.703	6.34132566105764e-21	MCM7	Malignant cells	GSE131984_JQ1Pal	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42702
4.14570587911824e-25	-0.392608146332786	0.399	0.603	6.55187357135846e-21	TXNDC12	Malignant cells	GSE131984_JQ1Pal	ENSG00000117862	51060	thioredoxin domain containing 12	AGR1|ERP18|ERP19|hAG-1|PDIA16|TLP19	protein_coding	O95881	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42703
4.16752675330116e-25	-0.406394861640095	0.28	0.486	6.58635928091716e-21	SGOL1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42704
4.44913790457301e-25	-0.298783707057825	0.899	0.967	7.03141754438719e-21	DEF8	Malignant cells	GSE131984_JQ1Pal	ENSG00000140995	54849	differentially expressed in FDCP 8 homolog	FLJ20186	protein_coding	Q6ZN54	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42705
4.61474592357678e-25	0.294225453171601	0.349	0.156	7.29314445762074e-21	SDC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000169439	6383	syndecan 2	CD362|fibroglycan|HSPG|HSPG1|SYND2	protein_coding	P34741	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42706
4.89045440865415e-25	0.320253925725801	0.54	0.328	7.72887414743701e-21	GNA11	Malignant cells	GSE131984_JQ1Pal	ENSG00000088256	2767	G protein subunit alpha 11	FBH|FBH2|FHH2|HHC2	protein_coding	P29992	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42707
4.94671901331642e-25	0.354574804091077	0.688	0.498	7.81779472864527e-21	RP11-14N7.2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42708
5.07206279601187e-25	-0.393303887608678	0.45	0.643	8.01588804281715e-21	BCCIP	Malignant cells	GSE131984_JQ1Pal	ENSG00000107949	56647	BRCA2 and CDKN1A interacting protein	BCCIPalpha|TOK-1	protein_coding	Q9P287	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42709
5.15344303357131e-25	0.339011251897501	0.631	0.429	8.1445013702561e-21	PFKL	Malignant cells	GSE131984_JQ1Pal	ENSG00000141959	5211	phosphofructokinase, liver type	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42710
5.20252408337556e-25	-0.375436161009723	0.482	0.678	8.22206906136673e-21	QDPR	Malignant cells	GSE131984_JQ1Pal	ENSG00000151552	5860	quinoid dihydropteridine reductase	DHPR|PKU2|SDR33C1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42711
5.24351880696152e-25	-0.340151111239545	0.84	0.91	8.28685712252199e-21	PRPF40A	Malignant cells	GSE131984_JQ1Pal	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42712
5.36941193900843e-25	-0.386677900317553	0.403	0.599	8.48581862840893e-21	SKP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000145604	6502	S-phase kinase associated protein 2	FBL1|FBXL1|p45	protein_coding	Q13309	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42713
6.18937772735741e-25	-0.30734460861736	0.89	0.933	9.78169256031565e-21	METAP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42714
6.56256151516603e-25	-0.326617479267006	0.224	0.426	1.03714722185684e-20	C1orf174	Malignant cells	GSE131984_JQ1Pal	ENSG00000198912	339448	chromosome 1 open reading frame 174	RP13-531C17.2	protein_coding	Q8IYL3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42715
6.63843461026884e-25	-0.376235103231982	0.413	0.609	1.04913820580689e-20	RDH11	Malignant cells	GSE131984_JQ1Pal	ENSG00000072042	51109	retinol dehydrogenase 11	ARSDR1|MDT1|SDR7C1	protein_coding	Q8TC12	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42716
7.13510309882168e-25	-0.396484887927541	0.414	0.604	1.12763169373778e-20	TMEM11	Malignant cells	GSE131984_JQ1Pal	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42717
7.4733721180034e-25	0.2684794671505	0.27	0.099	1.18109172952926e-20	TPRN	Malignant cells	GSE131984_JQ1Pal	ENSG00000176058	286262	taperin	C9orf75|DFNB79|FLJ90254	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42718
7.74108699742747e-25	-0.41743902661084	0.517	0.688	1.22340138907344e-20	RARS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42719
7.97649976992633e-25	-0.391994215930646	0.496	0.667	1.26060602363916e-20	DERA	Malignant cells	GSE131984_JQ1Pal	ENSG00000023697	51071	deoxyribose-phosphate aldolase	CGI-26|DEOC	protein_coding	Q9Y315	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42720
8.25262572401513e-25	-0.360794498274446	0.438	0.644	1.30424496942335e-20	TRAPPC4	Malignant cells	GSE131984_JQ1Pal	ENSG00000280495	51399	trafficking protein particle complex subunit 4	PTD009|SBDN|TRS23	protein_coding	Q9Y296	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42721
8.39290926304269e-25	-0.402087891550431	0.25	0.453	1.32641537993127e-20	SORBS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000154556	8470	sorbin and SH3 domain containing 2	ARGBP2|KIAA0777	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42722
8.4708208571284e-25	-0.292518532257946	0.116	0.295	1.33872852826057e-20	RP5-884M6.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42723
8.89035072500534e-25	-0.278413545762598	0.093	0.261	1.40503102857984e-20	CLN3.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42724
9.66375419729856e-25	-0.38040583821728	0.348	0.54	1.52725971334106e-20	TMEM9	Malignant cells	GSE131984_JQ1Pal	ENSG00000116857	252839	transmembrane protein 9	TMEM9A	protein_coding	Q9P0T7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42725
9.92433468201433e-25	-0.407246706166953	0.525	0.691	1.56844185314554e-20	ATXN10	Malignant cells	GSE131984_JQ1Pal	ENSG00000130638	25814	ataxin 10	ATX10|E46L|FLJ37990|SCA10	protein_coding	Q9UBB4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42726
1.01813364801269e-24	-0.381566835604282	0.329	0.529	1.60905841731926e-20	EVA1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000115363	84141	eva-1 homolog A, regulator of programmed cell death	FAM176A|FLJ13391|TMEM166	protein_coding	Q9H8M9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42727
1.12380881759136e-24	-0.353687301031972	0.722	0.824	1.77606745532138e-20	PSMG2	Malignant cells	GSE131984_JQ1Pal	ENSG00000128789	56984	proteasome assembly chaperone 2	CLAST3|HCCA3|HsT1707|MDS003|MGC15092|PAC2|TNFSF5IP1	protein_coding	Q969U7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42728
1.14714453694117e-24	-0.338098283270661	0.145	0.328	1.81294722618182e-20	AMN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000151743	196394	antagonist of mitotic exit network 1 homolog	NA	protein_coding	Q8IY45	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42729
1.19706963900366e-24	-0.367133703087751	0.669	0.796	1.89184885748138e-20	IKBIP	Malignant cells	GSE131984_JQ1Pal	ENSG00000166130	121457	IKBKB interacting protein	FLJ31051|IKIP	protein_coding	Q70UQ0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42730
1.37160600300586e-24	-0.288317748261788	0.115	0.294	2.16768612715047e-20	NMI	Malignant cells	GSE131984_JQ1Pal	ENSG00000123609	9111	N-myc and STAT interactor	NA	protein_coding	Q13287	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42731
1.4052616764436e-24	-0.291130930308382	0.124	0.303	2.22087555345147e-20	CATSPER1	Malignant cells	GSE131984_JQ1Pal	ENSG00000175294	117144	cation channel sperm associated 1	CATSPER	protein_coding	Q8NEC5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42732
1.44741799460322e-24	-0.32755895643874	0.238	0.434	2.28749939867093e-20	ABHD5	Malignant cells	GSE131984_JQ1Pal	ENSG00000011198	51099	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	CGI-58|NCIE2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42733
1.59343786951586e-24	-0.374872154258874	0.651	0.786	2.51826920898286e-20	VAMP8	Malignant cells	GSE131984_JQ1Pal	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42734
1.70427595411055e-24	-0.303221793659927	0.198	0.398	2.69343771787632e-20	SLC35A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000102100	7355	solute carrier family 35 member A2	UGALT|UGAT|UGT|UGT1|UGT2|UGTL	protein_coding	P78381	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42735
1.70671236822041e-24	-0.390867811116431	0.429	0.613	2.69728822673554e-20	UBE2L6	Malignant cells	GSE131984_JQ1Pal	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42736
1.72353976457317e-24	-0.383469623536115	0.589	0.728	2.72388224393144e-20	TMEM126B	Malignant cells	GSE131984_JQ1Pal	ENSG00000171204	55863	transmembrane protein 126B	HT007	protein_coding	Q8IUX1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42737
1.74973388910575e-24	0.353148358475531	0.49	0.294	2.76527943834273e-20	DPY19L1	Malignant cells	GSE131984_JQ1Pal	ENSG00000173852	23333	dpy-19 like C-mannosyltransferase 1	KIAA0877	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42738
1.80196982875332e-24	0.366082278268177	0.88	0.766	2.84783311736175e-20	STAU1	Malignant cells	GSE131984_JQ1Pal	ENSG00000124214	6780	staufen double-stranded RNA binding protein 1	PPP1R150|STAU	protein_coding	O95793	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42739
1.8038548007716e-24	0.341833709718436	0.463	0.263	2.85081212713944e-20	GALNT10	Malignant cells	GSE131984_JQ1Pal	ENSG00000164574	55568	polypeptide N-acetylgalactosaminyltransferase 10	GalNAc-T10	protein_coding	Q86SR1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42740
1.88283032268912e-24	-0.400080023743428	0.521	0.694	2.97562504197788e-20	C12orf45	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42741
2.00976265560507e-24	-0.364850900469614	0.825	0.899	3.17622890091825e-20	PARP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42742
2.04272020543705e-24	-0.389931168007291	0.475	0.659	3.22831501267271e-20	GNPNAT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100522	64841	glucosamine-phosphate N-acetyltransferase 1	FLJ10607|Gpnat1	protein_coding	Q96EK6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42743
2.09663763690907e-24	-0.368477917982221	0.384	0.577	3.31352612137109e-20	RFC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000049541	5982	replication factor C subunit 2	A1|RFC40	protein_coding	P35250	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42744
2.16854093817622e-24	-0.307949165951225	0.198	0.398	3.4271620986937e-20	TEAD4	Malignant cells	GSE131984_JQ1Pal	ENSG00000197905	7004	TEA domain transcription factor 4	EFTR-2|RTEF-1|TCF13L1|TEF-3|TEFR-1	protein_coding	Q15561	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42745
2.58713265415959e-24	-0.43641245100969	0.455	0.633	4.08870444663382e-20	FEN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000168496	2237	flap structure-specific endonuclease 1	FEN-1|MF1|RAD2	protein_coding	P39748	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42746
2.66359064942194e-24	0.320522409638705	0.495	0.286	4.20953866234643e-20	ZNF664	Malignant cells	GSE131984_JQ1Pal	ENSG00000179195	144348	zinc finger protein 664	DKFZp761B128|ZFOC1|ZNF176	protein_coding	Q8N3J9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42747
2.67872374331848e-24	-0.302182778349282	0.202	0.405	4.23345500394053e-20	VPS72	Malignant cells	GSE131984_JQ1Pal	ENSG00000163159	6944	vacuolar protein sorting 72 homolog	Swc2|TCFL1|YL-1|YL1	protein_coding	Q15906	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42748
2.71500871201841e-24	0.322230471314885	0.998	0.997	4.2907997684739e-20	NDUFB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42749
2.82238324854699e-24	-0.254006448038509	0.999	1	4.46049448600367e-20	SEC61B	Malignant cells	GSE131984_JQ1Pal	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42750
2.86821048999004e-24	-0.356289455490755	0.293	0.488	4.53291985838026e-20	TSEN15	Malignant cells	GSE131984_JQ1Pal	ENSG00000198860	116461	tRNA splicing endonuclease subunit 15	C1orf19	protein_coding	Q8WW01	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42751
3.08509622843685e-24	-0.291845322983806	0.122	0.299	4.8756860794216e-20	XRCC4	Malignant cells	GSE131984_JQ1Pal	ENSG00000152422	7518	X-ray repair cross complementing 4	NA	protein_coding	Q13426	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42752
3.27376347058243e-24	-0.396719988433555	0.402	0.598	5.17385578890847e-20	TAF7	Malignant cells	GSE131984_JQ1Pal	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42753
3.44748837663185e-24	-0.402034562200676	0.59	0.728	5.44841063042898e-20	PSMD13	Malignant cells	GSE131984_JQ1Pal	ENSG00000185627	5719	proteasome 26S subunit, non-ATPase 13	p40.5|Rpn9	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42754
3.57558302723212e-24	-0.327516024375335	0.902	0.944	5.65085141623765e-20	CAST	Malignant cells	GSE131984_JQ1Pal	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42755
3.64516761579747e-24	-0.422079808661024	0.654	0.771	5.76082290000632e-20	NASP	Malignant cells	GSE131984_JQ1Pal	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42756
3.79904776213643e-24	-0.404278478021776	0.386	0.564	6.00401508328041e-20	WBP4	Malignant cells	GSE131984_JQ1Pal	ENSG00000120688	11193	WW domain binding protein 4	FBP21|MGC117310	protein_coding	O75554	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42757
3.90554653276376e-24	-0.317908807849006	0.908	0.967	6.17232574037985e-20	IMPDH2	Malignant cells	GSE131984_JQ1Pal	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42758
4.01068141508016e-24	-0.312785894652514	0.182	0.374	6.33848090839269e-20	SLC25A19	Malignant cells	GSE131984_JQ1Pal	ENSG00000125454	60386	solute carrier family 25 member 19	DNC|MCPHA|MUP1|TPC	protein_coding	Q9HC21	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42759
4.21558734891963e-24	0.342617991378234	0.379	0.187	6.66231424623259e-20	SPRY4	Malignant cells	GSE131984_JQ1Pal	ENSG00000187678	81848	sprouty RTK signaling antagonist 4	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42760
4.30900024008178e-24	-0.346293620478096	0.464	0.663	6.80994397942524e-20	ING2	Malignant cells	GSE131984_JQ1Pal	ENSG00000168556	3622	inhibitor of growth family member 2	ING1L|p33ING2	protein_coding	Q9H160	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42761
4.74565256981856e-24	-0.390921760020337	0.9	0.939	7.50002932134125e-20	UPP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42762
5.02825910763727e-24	0.332927483233097	0.917	0.817	7.94666069370994e-20	MTPN	Malignant cells	GSE131984_JQ1Pal	ENSG00000105887	136319	myotrophin	GCDP|MYOTROPHIN|V-1	protein_coding	P58546	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42763
5.30056875834496e-24	0.266904319148151	0.296	0.12	8.37701886568838e-20	KDM4B	Malignant cells	GSE131984_JQ1Pal	ENSG00000127663	23030	lysine demethylase 4B	JMJD2B|KIAA0876|TDRD14B	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42764
5.45096961334718e-24	-0.409460348008725	0.233	0.428	8.61471237693388e-20	DEPDC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000024526	55635	DEP domain containing 1	DEP.8|DEPDC1A|FLJ20354|SDP35	protein_coding	Q5TB30	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42765
5.68826360785013e-24	-0.326251100547603	0.348	0.548	8.98973180584635e-20	MMAB	Malignant cells	GSE131984_JQ1Pal	ENSG00000139428	326625	metabolism of cobalamin associated B	cblB|CFAP23	protein_coding	Q96EY8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42766
5.73316192016248e-24	-0.300901727933213	0.937	0.968	9.06068909862478e-20	CAMTA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000171735	23261	calmodulin binding transcription activator 1	KIAA0833	protein_coding	Q9Y6Y1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42767
5.78691677454671e-24	-0.365299945580747	0.71	0.805	9.14564327049363e-20	ITPA	Malignant cells	GSE131984_JQ1Pal	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42768
5.82553864953779e-24	-0.278575919698836	0.132	0.313	9.20668128172952e-20	C17orf75	Malignant cells	GSE131984_JQ1Pal	ENSG00000108666	64149	chromosome 17 open reading frame 75	NJMU-R1|SRI2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42769
6.16049159272404e-24	-0.322836130657074	0.226	0.422	9.73604091314108e-20	NME7	Malignant cells	GSE131984_JQ1Pal	ENSG00000143156	29922	NME/NM23 family member 7	CFAP67|FLJ37194|NM23-H7	protein_coding	Q9Y5B8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42770
6.21620277643229e-24	-0.353920257796009	0.611	0.775	9.82408686787359e-20	SHISA5	Malignant cells	GSE131984_JQ1Pal	ENSG00000164054	51246	shisa family member 5	hShisa5|SCOTIN	protein_coding	Q8N114	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42771
6.52407993002573e-24	0.346478113723455	0.449	0.252	1.03106559214127e-19	FAM43A	Malignant cells	GSE131984_JQ1Pal	ENSG00000185112	131583	family with sequence similarity 43 member A	FLJ90022	protein_coding	Q8N2R8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42772
6.77970440460611e-24	-0.341020963586745	0.829	0.916	1.07146448410395e-19	LRRFIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42773
6.83422558360139e-24	-0.279842567894273	0.15	0.336	1.08008101123236e-19	DRAM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000136048	55332	DNA damage regulated autophagy modulator 1	DRAM|FLJ11259	protein_coding	Q8N682	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42774
6.8987852535275e-24	-0.391082167697516	0.463	0.635	1.09028402146749e-19	CDCP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000163814	64866	CUB domain containing protein 1	CD318|SIMA135	protein_coding	Q9H5V8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42775
7.73759193102203e-24	-0.344771075963377	0.665	0.807	1.22284902877872e-19	APH1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000117362	51107	aph-1 homolog A, gamma-secretase subunit	APH-1A|CGI-78	protein_coding	Q96BI3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42776
7.79595353747714e-24	0.376330141628529	0.918	0.817	1.23207249706289e-19	CDC25B	Malignant cells	GSE131984_JQ1Pal	ENSG00000101224	994	cell division cycle 25B	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42777
7.83197741157325e-24	-0.340978412078312	0.692	0.833	1.23776571012504e-19	NANS	Malignant cells	GSE131984_JQ1Pal	ENSG00000095380	54187	N-acetylneuraminate synthase	SAS	protein_coding	Q9NR45	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42778
8.41735252709497e-24	0.394476275879538	0.651	0.44	1.33027839338209e-19	PLK2	Malignant cells	GSE131984_JQ1Pal	ENSG00000145632	10769	polo like kinase 2	SNK	protein_coding	Q9NYY3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42779
8.59333867842813e-24	-0.311554899346022	0.846	0.928	1.35809124473878e-19	AUP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42780
8.85089701098421e-24	0.365053251804515	0.777	0.626	1.39879576361594e-19	TMEM18	Malignant cells	GSE131984_JQ1Pal	ENSG00000151353	129787	transmembrane protein 18	DKFZp434C1714|lncND	protein_coding	Q96B42	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42781
8.85443643349776e-24	-0.374080678386489	0.529	0.702	1.39935513394999e-19	PSENEN	Malignant cells	GSE131984_JQ1Pal	ENSG00000205155	55851	presenilin enhancer, gamma-secretase subunit	PEN2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42782
8.89985153763942e-24	-0.317867102329354	0.904	0.943	1.40653253700853e-19	HNRNPU	Malignant cells	GSE131984_JQ1Pal	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42783
8.95525422785161e-24	0.350939878497022	0.557	0.357	1.41528837816967e-19	ETV1	Malignant cells	GSE131984_JQ1Pal	ENSG00000006468	2115	ETS variant transcription factor 1	ER81	protein_coding	P50549	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42784
9.01703343288563e-24	-0.359171932257752	0.345	0.538	1.42505196373325e-19	TIMM22	Malignant cells	GSE131984_JQ1Pal	ENSG00000278501	29928	translocase of inner mitochondrial membrane 22	TEX4|TIM22	protein_coding	Q9Y584	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42785
9.03958325978332e-24	0.32157882976565	0.518	0.31	1.42861573837616e-19	ZKSCAN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000106261	7586	zinc finger with KRAB and SCAN domains 1	KOX18|PHZ-37|ZNF139|ZNF36|ZSCAN33	protein_coding	P17029	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42786
9.0843420934225e-24	-0.345675502995278	0.82	0.894	1.43568942444449e-19	ETFA	Malignant cells	GSE131984_JQ1Pal	ENSG00000140374	2108	electron transfer flavoprotein subunit alpha	EMA|GA2|MADD	protein_coding	P13804	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42787
9.35158258528249e-24	-0.395432374184603	0.979	0.982	1.47792411177804e-19	GNG11	Malignant cells	GSE131984_JQ1Pal	ENSG00000127920	2791	G protein subunit gamma 11	GNGT11	protein_coding	P61952	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42788
9.75955659391857e-24	-0.379102342424424	0.643	0.767	1.54240032410289e-19	MRPS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000122140	51116	mitochondrial ribosomal protein S2	CGI-91	protein_coding	Q9Y399	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42789
9.84730556257289e-24	-0.348660323732029	0.821	0.924	1.55626817110902e-19	PSME1	Malignant cells	GSE131984_JQ1Pal	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42790
1.03725240973407e-23	0.308768216682408	0.402	0.207	1.63927370834372e-19	VPS13C	Malignant cells	GSE131984_JQ1Pal	ENSG00000129003	54832	vacuolar protein sorting 13 homolog C	BLTP5C|FLJ10381|FLJ20136|KIAA1421	protein_coding	Q709C8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42791
1.0886452816288e-23	-0.371727422547365	0.526	0.69	1.72049500308615e-19	MRPL50	Malignant cells	GSE131984_JQ1Pal	ENSG00000136897	54534	mitochondrial ribosomal protein L50	FLJ20493|MRP-L50	protein_coding	Q8N5N7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42792
1.1094250219819e-23	-0.303329920639793	0.196	0.401	1.75333530474019e-19	DLGAP5	Malignant cells	GSE131984_JQ1Pal	ENSG00000126787	9787	DLG associated protein 5	DLG1|DLG7|HURP|KIAA0008	protein_coding	Q15398	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42793
1.11342331060576e-23	-0.341155057223264	0.342	0.545	1.75965420008134e-19	METTL21A	Malignant cells	GSE131984_JQ1Pal	ENSG00000144401	151194	methyltransferase 21A, HSPA lysine	FAM119A|HCA557b|HSPA-KMT|LOC151194	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42794
1.11347725434805e-23	-0.326360565387186	0.312	0.512	1.75973945277166e-19	HDDC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000184508	374659	HD domain containing 3	MESH1|MGC45386	protein_coding	Q8N4P3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42795
1.11921037489094e-23	0.305886794392932	0.284	0.112	1.76880007647764e-19	PSCA	Malignant cells	GSE131984_JQ1Pal	ENSG00000167653	8000	prostate stem cell antigen	lncPSCA	protein_coding	O43653	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42796
1.18544825838782e-23	0.261821323888392	0.263	0.096	1.87348242755611e-19	FYN	Malignant cells	GSE131984_JQ1Pal	ENSG00000010810	2534	FYN proto-oncogene, Src family tyrosine kinase	MGC45350|SLK|SYN	protein_coding	P06241	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42797
1.20117786766391e-23	-0.342651471359621	0.298	0.501	1.89834150205604e-19	SPRYD7	Malignant cells	GSE131984_JQ1Pal	ENSG00000123178	57213	SPRY domain containing 7	C13orf1|CLLD6	protein_coding	Q5W111	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42798
1.20954897627574e-23	-0.329214803282742	0.11	0.28	1.91157120210619e-19	HIST1H1E	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42799
1.21093212138598e-23	0.300380693366813	0.5	0.291	1.9137571246384e-19	CYBRD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000071967	79901	cytochrome b reductase 1	CYB561A2|DCYTB|FLJ23462|FRRS3	protein_coding	Q53TN4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42800
1.25356037512464e-23	0.389087135388714	0.671	0.484	1.98112681684698e-19	TOR1AIP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000169905	163590	torsin 1A interacting protein 2	IFRG15|LULL1|NET9	protein_coding	Q8NFQ8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42801
1.31676259888961e-23	0.30207653086169	0.368	0.178	2.08101161128514e-19	GABRE	Malignant cells	GSE131984_JQ1Pal	ENSG00000102287	2564	gamma-aminobutyric acid type A receptor subunit epsilon	NA	protein_coding	P78334	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42802
1.32083229461961e-23	-0.335307817940299	0.24	0.44	2.08744335841682e-19	EIF2B3	Malignant cells	GSE131984_JQ1Pal	ENSG00000070785	8891	eukaryotic translation initiation factor 2B subunit gamma	EIF-2B|EIF2Bgamma	protein_coding	Q9NR50	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42803
1.34995895789691e-23	-0.349107052657314	0.858	0.897	2.13347513706028e-19	DNAJB6	Malignant cells	GSE131984_JQ1Pal	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42804
1.3546485523552e-23	-0.333131761141163	0.26	0.454	2.14088657214216e-19	ARAF	Malignant cells	GSE131984_JQ1Pal	ENSG00000078061	369	A-Raf proto-oncogene, serine/threonine kinase	ARAF1	protein_coding	P10398	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42805
1.46355789388487e-23	-0.373691304992823	0.591	0.741	2.31300689549565e-19	TIAL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000151923	7073	TIA1 cytotoxic granule associated RNA binding protein like 1	TIAR	protein_coding	Q01085	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42806
1.5410529920153e-23	-0.339005545400203	0.201	0.391	2.43548014858098e-19	ATAD3B	Malignant cells	GSE131984_JQ1Pal	ENSG00000160072	83858	ATPase family AAA domain containing 3B	KIAA1273|TOB3	protein_coding	Q5T9A4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42807
1.61148016095286e-23	-0.360705164546383	0.104	0.27	2.5467832463699e-19	HIST1H1D	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42808
1.72261572716984e-23	-0.337890002755329	0.276	0.478	2.72242189521921e-19	WDR77	Malignant cells	GSE131984_JQ1Pal	ENSG00000116455	79084	WD repeat domain 77	MEP50|p44	protein_coding	Q9BQA1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42809
1.74080720135528e-23	-0.357841134018542	0.573	0.731	2.75117170102188e-19	SSBP4	Malignant cells	GSE131984_JQ1Pal	ENSG00000130511	170463	single stranded DNA binding protein 4	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42810
1.76080118610483e-23	0.345874955797669	0.669	0.475	2.78277019452008e-19	AFF4	Malignant cells	GSE131984_JQ1Pal	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42811
1.81783206979827e-23	0.392321712218178	0.702	0.522	2.87290180310918e-19	FAM129B	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42812
1.82541531457672e-23	-0.351048212072508	0.343	0.543	2.88488636315705e-19	PMF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000160783	11243	polyamine modulated factor 1	NA	protein_coding	Q6P1K2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42813
1.84654703381971e-23	0.325206213069117	0.996	0.99	2.91828293224866e-19	BSG	Malignant cells	GSE131984_JQ1Pal	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42814
1.88840892981452e-23	-0.382823022384936	0.691	0.801	2.98444147267887e-19	RUVBL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000183207	10856	RuvB like AAA ATPase 2	ECP51|INO80J|Reptin52|RVB2|TIH2|TIP48|TIP49b	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42815
1.939531899129e-23	-0.398693211984785	0.184	0.371	3.06523621338347e-19	NUF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000143228	83540	NUF2 component of NDC80 kinetochore complex	CDCA1|CT106|NUF2R	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42816
1.97068349818193e-23	0.299308105000948	0.408	0.212	3.11446820052672e-19	EPM2AIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000178567	9852	EPM2A interacting protein 1	FLJ11207|KIAA0766	protein_coding	Q7L775	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42817
2.0197056991261e-23	-0.345706716962643	0.8	0.886	3.19194288689889e-19	ACTR3	Malignant cells	GSE131984_JQ1Pal	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42818
2.22186994884988e-23	-0.413617072605943	0.452	0.622	3.51144326716235e-19	TXNDC9	Malignant cells	GSE131984_JQ1Pal	ENSG00000115514	10190	thioredoxin domain containing 9	APACD	protein_coding	O14530	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42819
2.2773453800092e-23	-0.371690676137049	0.423	0.608	3.59911663856655e-19	EXOSC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000171311	51013	exosome component 1	CGI-108|CSL4|Csl4p|hCsl4p|p13|SKI4|Ski4p	protein_coding	Q9Y3B2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42820
2.33749335914077e-23	-0.33450503593796	0.743	0.834	3.69417450478607e-19	IMP4	Malignant cells	GSE131984_JQ1Pal	ENSG00000136718	92856	IMP U3 small nucleolar ribonucleoprotein 4	BXDC4|MGC19606	protein_coding	Q96G21	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42821
2.41812224346014e-23	-0.430756719524083	0.594	0.705	3.82160039356441e-19	ADH5	Malignant cells	GSE131984_JQ1Pal	ENSG00000197894	128	alcohol dehydrogenase 5 (class III), chi polypeptide	ADH-3|ADHX|FDH|GSNOR	protein_coding	P11766	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42822
2.51671685549452e-23	0.31638714728381	0.491	0.288	3.97741931842355e-19	GNB5	Malignant cells	GSE131984_JQ1Pal	ENSG00000069966	10681	G protein subunit beta 5	GB5	protein_coding	O14775	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42823
2.60247440814144e-23	0.329528484141215	0.446	0.255	4.11295055462673e-19	TMEM131	Malignant cells	GSE131984_JQ1Pal	ENSG00000075568	23505	transmembrane protein 131	CC28|KIAA0257|PRO1048|RW1|YR-23	protein_coding	Q92545	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42824
2.74510053605988e-23	0.361143439807539	0.437	0.246	4.33835688718904e-19	CPEB4	Malignant cells	GSE131984_JQ1Pal	ENSG00000113742	80315	cytoplasmic polyadenylation element binding protein 4	KIAA1673	protein_coding	Q17RY0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42825
2.81498660137043e-23	-0.396868091133228	0.524	0.681	4.44880482480583e-19	SHMT2	Malignant cells	GSE131984_JQ1Pal	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42826
2.82314953221908e-23	-0.362599163282535	0.483	0.663	4.46170552071904e-19	SCOC	Malignant cells	GSE131984_JQ1Pal	ENSG00000153130	60592	short coiled-coil protein	HRIHFB2072|SCOCO|UNC-69	protein_coding	Q9UIL1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42827
2.90690160763774e-23	-0.354636027394332	0.708	0.819	4.59406730071068e-19	ARPC4	Malignant cells	GSE131984_JQ1Pal	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42828
2.96744309185965e-23	-0.338821756007387	0.236	0.433	4.68974706237499e-19	RP11-554I8.2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42829
3.03838716373768e-23	-0.373487155330201	0.462	0.645	4.80186707357104e-19	APITD1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42830
3.1852210231609e-23	-0.381132819860725	0.335	0.53	5.03392330500349e-19	DYNC1LI1	Malignant cells	GSE131984_JQ1Pal	ENSG00000144635	51143	dynein cytoplasmic 1 light intermediate chain 1	DNCLI1	protein_coding	Q9Y6G9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42831
3.33624069755874e-23	-0.337631041413636	0.127	0.297	5.27259479842184e-19	ARHGDIB	Malignant cells	GSE131984_JQ1Pal	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42832
3.3725336019696e-23	0.353580476978987	0.793	0.645	5.32995210455276e-19	IQGAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42833
3.46400817987622e-23	-0.35256038048023	0.331	0.522	5.47451852747638e-19	RPIA	Malignant cells	GSE131984_JQ1Pal	ENSG00000153574	22934	ribose 5-phosphate isomerase A	NA	protein_coding	P49247	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42834
3.48469831714208e-23	0.316254836452672	0.386	0.196	5.50721722041134e-19	PHLDB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000019144	23187	pleckstrin homology like domain family B member 1	FLJ00141|KIAA0638|LL5a	protein_coding	Q86UU1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42835
3.49196065697183e-23	-0.392653303623949	0.438	0.621	5.51869462227828e-19	FARSA	Malignant cells	GSE131984_JQ1Pal	ENSG00000179115	2193	phenylalanyl-tRNA synthetase subunit alpha	CML33|FARSL|FARSLA	protein_coding	Q9Y285	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42836
3.71754691144537e-23	-0.370543985730057	0.535	0.708	5.87521113884826e-19	GPS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000169727	2873	G protein pathway suppressor 1	COPS1|CSN1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42837
4.10145400268599e-23	-0.265448658991453	0.987	0.999	6.48193790584494e-19	COX6C	Malignant cells	GSE131984_JQ1Pal	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42838
4.14678545960947e-23	-0.362440684239836	0.382	0.569	6.5535797403668e-19	MGAT2	Malignant cells	GSE131984_JQ1Pal	ENSG00000168282	4247	alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GNT-II	protein_coding	Q10469	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42839
4.14707691745313e-23	-0.348082261632271	0.811	0.874	6.55404036034292e-19	SYNCRIP	Malignant cells	GSE131984_JQ1Pal	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42840
4.37640467738548e-23	-0.374278708979484	0.544	0.695	6.91646995214001e-19	SEPHS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000179918	22928	selenophosphate synthetase 2	SPS2|SPS2b	protein_coding	Q99611	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42841
5.06586265005066e-23	-0.336224758028271	0.721	0.836	8.00608933214007e-19	ARL2BP	Malignant cells	GSE131984_JQ1Pal	ENSG00000102931	23568	ADP ribosylation factor like GTPase 2 binding protein	BART|BART1|RP66	protein_coding	Q9Y2Y0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42842
5.17130475101799e-23	0.306435932807476	0.383	0.197	8.17273002850884e-19	ARFGAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000101199	55738	ADP ribosylation factor GTPase activating protein 1	ARF1GAP|bA261N11.3|FLJ10767	protein_coding	Q8N6T3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42843
5.34845313618973e-23	-0.401870968372976	0.479	0.643	8.45269533643425e-19	CYB5B	Malignant cells	GSE131984_JQ1Pal	ENSG00000103018	80777	cytochrome b5 type B	CYB5-M	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42844
5.37901805664328e-23	0.284375833845388	0.984	0.947	8.50100013671904e-19	SMDT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42845
5.3835141867626e-23	0.338399655364161	0.645	0.461	8.50810582075961e-19	MAN1A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000198162	10905	mannosidase alpha class 1A member 2	MAN1B	protein_coding	O60476	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42846
5.41505392759171e-23	-0.330325337585049	0.699	0.828	8.55795122716593e-19	NDUFV1	Malignant cells	GSE131984_JQ1Pal	ENSG00000167792	4723	NADH:ubiquinone oxidoreductase core subunit V1	CI-51K	protein_coding	P49821	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42847
5.72641270613043e-23	0.309097084313644	0.492	0.289	9.05002264076853e-19	PIEZO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000103335	9780	piezo type mechanosensitive ion channel component 1	FAM38A|KIAA0233	protein_coding	Q92508	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42848
5.89529573539789e-23	0.397853259285979	0.765	0.624	9.31692538022283e-19	C6orf62	Malignant cells	GSE131984_JQ1Pal	ENSG00000112308	81688	chromosome 6 open reading frame 62	DKFZP564G182|FLJ12619|XTP12	protein_coding	Q9GZU0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42849
5.93562070266101e-23	0.361644964675598	0.696	0.517	9.38065495848546e-19	MARCH6	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42850
5.93619425888098e-23	-0.322594033661543	0.229	0.423	9.3815614067355e-19	CTPS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000171793	1503	CTP synthase 1	CTPS|GATD5A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42851
5.94727109710504e-23	-0.37053358224197	0.809	0.862	9.39906724186481e-19	RAB7A	Malignant cells	GSE131984_JQ1Pal	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42852
6.55873187747612e-23	-0.353351734699987	0.485	0.646	1.03654198591633e-18	MLX	Malignant cells	GSE131984_JQ1Pal	ENSG00000108788	6945	MAX dimerization protein MLX	bHLHd13|MAD7|MXD7|TCFL4	protein_coding	Q9UH92	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42853
6.61525389095909e-23	0.358651738981738	0.722	0.568	1.04547472492717e-18	PTPN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42854
6.67346329100883e-23	-0.271744575682642	0.98	0.996	1.05467413851104e-18	HLA-A	Malignant cells	GSE131984_JQ1Pal	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42855
6.83444159588582e-23	-0.373288887613145	0.538	0.697	1.0801151498138e-18	SCP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000116171	6342	sterol carrier protein 2	NA	protein_coding	P22307	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42856
6.95549138952679e-23	-0.331177772073764	0.316	0.514	1.09924585920081e-18	TMEM5	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42857
7.7785526526474e-23	-0.352531898223329	0.491	0.68	1.2293224612244e-18	MRPL35	Malignant cells	GSE131984_JQ1Pal	ENSG00000132313	51318	mitochondrial ribosomal protein L35	NA	protein_coding	Q9NZE8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42858
7.81044132152953e-23	0.365733159371887	0.763	0.608	1.23436214645453e-18	CLIC4	Malignant cells	GSE131984_JQ1Pal	ENSG00000169504	25932	chloride intracellular channel 4	CLIC4L|DKFZP566G223|H1|huH1|P64H1	protein_coding	Q9Y696	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42859
7.97231566990818e-23	0.280027631410646	0.307	0.134	1.25994476847229e-18	MARVELD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000155254	83742	MARVEL domain containing 1	bA548K23.8|FLJ22343|FLJ23440|GB14|MGC4415|MRVLDC1	protein_coding	Q9BSK0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42860
8.40034331016334e-23	-0.352697377767942	0.491	0.672	1.32759025673821e-18	NTPCR	Malignant cells	GSE131984_JQ1Pal	ENSG00000135778	84284	nucleoside-triphosphatase, cancer-related	C1orf57|HCR-NTPase|MGC13186|THEP1	protein_coding	Q9BSD7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42861
9.14365196368069e-23	-0.383503921684621	0.424	0.609	1.4450627563401e-18	ARL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000120805	400	ADP ribosylation factor like GTPase 1	ARFL1	protein_coding	P40616	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42862
1.01039673559453e-22	-0.342486926192866	0.272	0.461	1.5968310009336e-18	NUP54	Malignant cells	GSE131984_JQ1Pal	ENSG00000138750	53371	nucleoporin 54	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42863
1.02511199185826e-22	-0.324322590536153	0.257	0.447	1.6200869919328e-18	NUBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000103274	4682	NUBP iron-sulfur cluster assembly factor 1, cytosolic	CIAO5|NBP1|NBP35	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42864
1.04765011728882e-22	0.347000842851885	0.623	0.422	1.65570624536325e-18	MAP4K4	Malignant cells	GSE131984_JQ1Pal	ENSG00000071054	9448	mitogen-activated protein kinase kinase kinase kinase 4	FLH21957|HGK|NIK	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42865
1.06396268432573e-22	-0.32045313022984	0.196	0.385	1.68148662630838e-18	GOT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000120053	2805	glutamic-oxaloacetic transaminase 1	AST|AST1|SGOT	protein_coding	P17174	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42866
1.11440274592611e-22	-0.372894639390426	0.353	0.538	1.76120209966162e-18	GPN3	Malignant cells	GSE131984_JQ1Pal	ENSG00000111231	51184	GPN-loop GTPase 3	ATPBD1C|MGC14560	protein_coding	Q9UHW5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42867
1.12826946833018e-22	-0.338543153465136	0.268	0.46	1.78311706774902e-18	PYCR2	Malignant cells	GSE131984_JQ1Pal	ENSG00000143811	29920	pyrroline-5-carboxylate reductase 2	P5CR2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42868
1.14296259711533e-22	-0.339884890410085	0.812	0.892	1.80633808848107e-18	MSN	Malignant cells	GSE131984_JQ1Pal	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42869
1.14703663894069e-22	-0.390364479537292	0.318	0.499	1.81277670418187e-18	CMTM8	Malignant cells	GSE131984_JQ1Pal	ENSG00000170293	152189	CKLF like MARVEL transmembrane domain containing 8	CKLFSF8	protein_coding	Q8IZV2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42870
1.15108223558031e-22	-0.363312480719195	0.61	0.754	1.81917036511112e-18	TEX264	Malignant cells	GSE131984_JQ1Pal	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42871
1.19177995888783e-22	0.28403259182482	0.401	0.211	1.88348904702633e-18	SLC12A9	Malignant cells	GSE131984_JQ1Pal	ENSG00000146828	56996	solute carrier family 12 member 9	CIP1	protein_coding	Q9BXP2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42872
1.22394664392554e-22	-0.332010233555244	0.91	0.951	1.93432527605992e-18	CKLF	Malignant cells	GSE131984_JQ1Pal	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42873
1.24617905719762e-22	-0.312452312020346	0.816	0.899	1.96946138199512e-18	BAX	Malignant cells	GSE131984_JQ1Pal	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42874
1.325312132852e-22	-0.343796115000136	0.702	0.809	2.09452329475931e-18	CDK16	Malignant cells	GSE131984_JQ1Pal	ENSG00000102225	5127	cyclin dependent kinase 16	FLJ16665|PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	protein_coding	Q00536	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42875
1.35555672816115e-22	-0.32705252569743	0.243	0.436	2.14232185318588e-18	RRP9	Malignant cells	GSE131984_JQ1Pal	ENSG00000114767	9136	ribosomal RNA processing 9, U3 small nucleolar RNA binding protein	RNU3IP2|U3-55K	protein_coding	O43818	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42876
1.39732699758321e-22	-0.393009583776025	0.628	0.764	2.20833558698051e-18	ARL4A	Malignant cells	GSE131984_JQ1Pal	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42877
1.42250417281142e-22	-0.319535069915644	0.177	0.358	2.24812559471117e-18	RPGR	Malignant cells	GSE131984_JQ1Pal	ENSG00000156313	6103	retinitis pigmentosa GTPase regulator	COD1|CORDX1|CRD|RP15|RP3	protein_coding	Q92834	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42878
1.49842869817021e-22	-0.43617319946315	0.356	0.544	2.36811671458819e-18	KNSTRN	Malignant cells	GSE131984_JQ1Pal	ENSG00000128944	90417	kinetochore localized astrin (SPAG5) binding protein	C15orf23|FLJ14502|kinastrin|SKAP|TRAF4AF1	protein_coding	Q9Y448	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42879
1.59273382285617e-22	-0.374872826713508	0.567	0.724	2.51715653364189e-18	PON2	Malignant cells	GSE131984_JQ1Pal	ENSG00000105854	5445	paraoxonase 2	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42880
1.69909333411927e-22	-0.336130132116318	0.872	0.923	2.6852471052421e-18	COPS6	Malignant cells	GSE131984_JQ1Pal	ENSG00000168090	10980	COP9 signalosome subunit 6	CSN6|MOV34-34KD	protein_coding	Q7L5N1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42881
1.77376050455401e-22	-0.266077509840517	0.142	0.319	2.80325110139716e-18	CENPQ	Malignant cells	GSE131984_JQ1Pal	ENSG00000031691	55166	centromere protein Q	C6orf139|CENP-Q|FLJ10545	protein_coding	Q7L2Z9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42882
1.81377260306943e-22	0.285869876761147	0.998	0.996	2.86648622189092e-18	H2AFV	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42883
1.83991450381437e-22	0.31369800747127	0.388	0.203	2.90780088182823e-18	SPECC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000128487	92521	sperm antigen with calponin homology and coiled-coil domains 1	CYTSB|FLJ36955|HCMOGT-1|NSP	protein_coding	Q5M775	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42884
1.94371084307072e-22	0.315486739163048	1	0.998	3.07184061638897e-18	MT-ND5	Malignant cells	GSE131984_JQ1Pal	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42885
1.94482928148485e-22	0.268340845790517	0.343	0.161	3.07360819645866e-18	PACS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000175115	55690	phosphofurin acidic cluster sorting protein 1	FLJ10209|KIAA1175	protein_coding	Q6VY07	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42886
1.97611640762981e-22	-0.374837081121558	0.369	0.555	3.12305437061816e-18	MRPL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000169288	65008	mitochondrial ribosomal protein L1	BM022	protein_coding	Q9BYD6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42887
2.05167307306415e-22	0.301282298906231	0.434	0.238	3.24246412467058e-18	CACNG8	Malignant cells	GSE131984_JQ1Pal	ENSG00000142408	59283	calcium voltage-gated channel auxiliary subunit gamma 8	NA	protein_coding	Q8WXS5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42888
2.05373718142765e-22	-0.342142630717006	0.485	0.676	3.24572624152825e-18	STARD3NL	Malignant cells	GSE131984_JQ1Pal	ENSG00000010270	83930	STARD3 N-terminal like	MENTHO|MGC3251	protein_coding	O95772	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42889
2.09396428081864e-22	0.334648293369243	0.567	0.378	3.30930114940578e-18	PRRC2B	Malignant cells	GSE131984_JQ1Pal	ENSG00000288701	84726	proline rich coiled-coil 2B	BAT2L|BAT2L1|KIAA0515|LQFBS-1|MGC10526	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42890
2.10263837152108e-22	0.341973356830126	0.769	0.617	3.32300968235191e-18	TGFBR2	Malignant cells	GSE131984_JQ1Pal	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42891
2.234057433145e-22	0.309780632975937	0.483	0.286	3.53070436734235e-18	FOXO3	Malignant cells	GSE131984_JQ1Pal	ENSG00000118689	2309	forkhead box O3	AF6q21|FKHRL1|FOXO2|FOXO3A	protein_coding	O43524	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42892
2.26155581455913e-22	-0.255825146921228	0.998	1	3.57416280932925e-18	SET	Malignant cells	GSE131984_JQ1Pal	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42893
2.2974255522214e-22	0.335829500630174	0.928	0.838	3.63085134273071e-18	ACTR2	Malignant cells	GSE131984_JQ1Pal	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42894
2.31424547995197e-22	-0.444261052751031	0.565	0.701	3.65743355651609e-18	MAGEA3	Malignant cells	GSE131984_JQ1Pal	ENSG00000221867	4102	MAGE family member A3	CT1.3|HIP8|HYPD|MAGE3|MGC14613	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42895
2.35474699812148e-22	-0.337850848603547	0.362	0.549	3.72144215583118e-18	COPS7A	Malignant cells	GSE131984_JQ1Pal	ENSG00000111652	50813	COP9 signalosome subunit 7A	CSN7A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42896
2.37834193037989e-22	0.263638670871613	0.289	0.12	3.75873158677238e-18	TBC1D2B	Malignant cells	GSE131984_JQ1Pal	ENSG00000167202	23102	TBC1 domain family member 2B	KIAA1055	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42897
2.54194152040208e-22	-0.312324878742519	0.979	0.992	4.01728437884345e-18	ATP5A1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42898
2.59309869491625e-22	-0.371562847441468	0.752	0.836	4.09813317744564e-18	FKBP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000100442	2287	FKBP prolyl isomerase 3	FKBP-25|FKBP25	protein_coding	Q00688	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42899
2.59354330600231e-22	-0.370367577712377	0.441	0.619	4.09883584080606e-18	C1orf35	Malignant cells	GSE131984_JQ1Pal	ENSG00000143793	79169	chromosome 1 open reading frame 35	MGC4174|MMTAG2	protein_coding	Q9BU76	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42900
2.65814204621015e-22	-0.403856530166861	0.724	0.814	4.20092768983052e-18	LMAN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000074695	3998	lectin, mannose binding 1	ERGIC-53|ERGIC53|F5F8D|FMFD1|gp58|MCFD1|MR60	protein_coding	P49257	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42901
2.91515046752346e-22	-0.288736550177348	0.949	0.969	4.60710379887407e-18	MRFAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000179010	93621	Morf4 family associated protein 1	PAM14|PGR1	protein_coding	Q9Y605	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42902
3.42010244682559e-22	0.347315168354208	0.612	0.429	5.40512990696316e-18	ARHGAP35	Malignant cells	GSE131984_JQ1Pal	ENSG00000160007	2909	Rho GTPase activating protein 35	GRF-1|GRLF1|KIAA1722|P190A|p190ARhoGAP|p190RhoGAP	protein_coding	Q9NRY4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42903
3.43236493729885e-22	-0.288501251036328	0.972	0.983	5.42450954690711e-18	HNRNPK	Malignant cells	GSE131984_JQ1Pal	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42904
3.69895599574718e-22	-0.353980772407732	0.257	0.441	5.84583005567885e-18	APEX2	Malignant cells	GSE131984_JQ1Pal	ENSG00000169188	27301	apurinic/apyrimidinic endodeoxyribonuclease 2	APE2|APEXL2|XTH2|ZGRF2	protein_coding	Q9UBZ4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42905
3.70513381962739e-22	-0.330443510414157	0.628	0.78	5.85559348853913e-18	CRLS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000088766	54675	cardiolipin synthase 1	C20orf155|CLS1|dJ967N21.6|GCD10	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42906
3.87231149435304e-22	-0.274022101855052	0.976	0.991	6.11980108567554e-18	TMEM160	Malignant cells	GSE131984_JQ1Pal	ENSG00000130748	54958	transmembrane protein 160	FLJ20512	protein_coding	Q9NX00	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42907
4.07039945327178e-22	0.302832945867735	0.406	0.213	6.43285929595072e-18	COL5A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000204262	1290	collagen type V alpha 2 chain	NA	protein_coding	P05997	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42908
4.4198244447829e-22	0.261999479197148	0.285	0.12	6.98509055253489e-18	DMXL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000104093	23312	Dmx like 2	DFNA71|KIAA0856|RC3	protein_coding	Q8TDJ6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42909
4.67752469605845e-22	-0.336018824627161	0.191	0.369	7.39236002965077e-18	MARS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42910
4.69701875353654e-22	-0.474549980290695	0.379	0.571	7.42316843808915e-18	CENPA	Malignant cells	GSE131984_JQ1Pal	ENSG00000115163	1058	centromere protein A	CenH3|CENP-A	protein_coding	P49450	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42911
4.87982058271702e-22	0.346385460540529	0.406	0.23	7.71206844892598e-18	DLC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000164741	10395	DLC1 Rho GTPase activating protein	ARHGAP7|DLC-1|HP|p122-RhoGAP|STARD12	protein_coding	Q96QB1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42912
5.32291983052111e-22	0.253472021418758	0.285	0.119	8.41234250015556e-18	DZIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000134874	22873	DAZ interacting zinc finger protein 1	DZIP|KIAA0996	protein_coding	Q86YF9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42913
5.99972986934744e-22	-0.299265693571647	0.189	0.373	9.48197308551669e-18	MOSPD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000101928	56180	motile sperm domain containing 1	dJ473B4	protein_coding	Q9UJG1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42914
6.02799826834892e-22	-0.312156566050867	0.868	0.93	9.52664846329863e-18	CSNK1A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000113712	1452	casein kinase 1 alpha 1	CK1|CK1a|CK1alpha|CKIa|CKIalpha	protein_coding	P48729	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42915
6.3669554295508e-22	0.354253527531301	0.656	0.474	1.00623363608621e-17	PHC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000134686	1912	polyhomeotic homolog 2	EDR2|HPH2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42916
6.42407442928372e-22	-0.301092803016116	0.123	0.288	1.015260722804e-17	HIST2H2AC	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42917
6.52806109864066e-22	-0.381340244299931	0.297	0.478	1.03169477602917e-17	RFC4	Malignant cells	GSE131984_JQ1Pal	ENSG00000163918	5984	replication factor C subunit 4	A1|RFC37	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42918
6.90710347753995e-22	-0.328607698294878	0.768	0.844	1.09159863359041e-17	SNX7	Malignant cells	GSE131984_JQ1Pal	ENSG00000162627	51375	sorting nexin 7	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42919
7.24744960215752e-22	0.379600956845123	0.777	0.626	1.14538693512497e-17	DST	Malignant cells	GSE131984_JQ1Pal	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42920
7.6532673699745e-22	-0.414163251470241	0.26	0.441	1.20952237515077e-17	PSAT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42921
7.7345694690797e-22	-0.316095947579977	0.267	0.455	1.22237135889336e-17	LYRM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000102897	57149	LYR motif containing 1	A211C6.1	protein_coding	O43325	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42922
7.83878431702805e-22	0.256636267405672	0.305	0.133	1.23884147346311e-17	RALGAPA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000188559	57186	Ral GTPase activating protein catalytic subunit alpha 2	AS250|C20orf74|dJ1049G11.4|KIAA1272|RapGAPalpha2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42923
8.20627186008773e-22	-0.349753373152356	0.33	0.514	1.29691920476826e-17	PUSL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000169972	126789	pseudouridine synthase like 1	FLJ90811	protein_coding	Q8N0Z8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42924
8.47920131238342e-22	0.285179282867416	0.389	0.204	1.34005297540908e-17	NSF	Malignant cells	GSE131984_JQ1Pal	ENSG00000278174	4905	N-ethylmaleimide sensitive factor, vesicle fusing ATPase	SEC18|SKD2	protein_coding	P46459	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42925
8.66670099001913e-22	-0.332616482235433	0.27	0.452	1.36968542446262e-17	MTHFD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100714	4522	methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1	MTHFC|MTHFD	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42926
9.38170712521987e-22	0.358641320287841	0.936	0.889	1.48268499406975e-17	ADI1	Malignant cells	GSE131984_JQ1Pal	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42927
9.84909434254689e-22	0.352390228608132	0.639	0.465	1.55655086989611e-17	RP11-792A8.4	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42928
1.00618713138231e-21	-0.296489672816695	0.281	0.475	1.5901781424366e-17	ALKBH3	Malignant cells	GSE131984_JQ1Pal	ENSG00000166199	221120	alkB homolog 3, alpha-ketoglutarate dependent dioxygenase	DEPC-1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42929
1.03745497970568e-21	-0.353157688407528	0.257	0.441	1.63959384992686e-17	NDUFS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42930
1.06485659006979e-21	0.288248138215614	0.396	0.214	1.6828993549463e-17	MPND	Malignant cells	GSE131984_JQ1Pal	ENSG00000008382	84954	MPN domain containing	FLJ14981	protein_coding	Q8N594	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42931
1.12886797431071e-21	0.263928882097864	0.323	0.149	1.78406294660065e-17	GLIS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000274636	84662	GLIS family zinc finger 2	NPHP7	protein_coding	Q9BZE0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42932
1.17180050965615e-21	0.349346472467376	0.613	0.435	1.85191352546058e-17	UBE2G2	Malignant cells	GSE131984_JQ1Pal	ENSG00000184787	7327	ubiquitin conjugating enzyme E2 G2	UBC7	protein_coding	P60604	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42933
1.2650874351201e-21	0.275241347696528	0.335	0.16	1.9993441824638e-17	TBCD	Malignant cells	GSE131984_JQ1Pal	ENSG00000278759	6904	tubulin folding cofactor D	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42934
1.27202992960194e-21	-0.329395061300205	0.321	0.51	2.0103161007429e-17	GLTP	Malignant cells	GSE131984_JQ1Pal	ENSG00000139433	51228	glycolipid transfer protein	NA	protein_coding	Q9NZD2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42935
1.38650985552796e-21	0.331424826060096	0.537	0.345	2.19124017567639e-17	GFPT2	Malignant cells	GSE131984_JQ1Pal	ENSG00000131459	9945	glutamine-fructose-6-phosphate transaminase 2	GFAT2	protein_coding	O94808	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42936
1.42627709460404e-21	-0.370772512435226	0.559	0.705	2.25408832031222e-17	FRA10AC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000148690	118924	FRA10A associated CGG repeat 1	C10orf4	protein_coding	Q70Z53	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42937
1.45332785041186e-21	0.346664824440936	0.901	0.83	2.2968393347909e-17	ENAH	Malignant cells	GSE131984_JQ1Pal	ENSG00000154380	55740	ENAH actin regulator	FLJ10773|MENA|NDPP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42938
1.59275409842017e-21	-0.38002578589188	0.521	0.667	2.51718857714324e-17	IDH3B	Malignant cells	GSE131984_JQ1Pal	ENSG00000101365	3420	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta	RP46	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42939
1.74068351264564e-21	0.251751052483346	0.281	0.118	2.75097622338517e-17	ENC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000171617	8507	ectodermal-neural cortex 1	ENC-1|KLHL37|NRPB|PIG10|TP53I10	protein_coding	O14682	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42940
1.81622415587022e-21	0.296840300487113	0.44	0.252	2.87036065593729e-17	RYK	Malignant cells	GSE131984_JQ1Pal	ENSG00000163785	6259	receptor like tyrosine kinase	D3S3195|JTK5|JTK5A|RYK1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42941
1.86018234088483e-21	-0.358904679724794	0.494	0.645	2.93983217153439e-17	MTX2	Malignant cells	GSE131984_JQ1Pal	ENSG00000128654	10651	metaxin 2	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42942
1.90045687750453e-21	-0.357022004465877	0.505	0.667	3.00348204920816e-17	IK	Malignant cells	GSE131984_JQ1Pal	ENSG00000113141	3550	IK cytokine	RED|RER	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42943
2.06813488853274e-21	-0.346597735409358	0.353	0.533	3.26848037783714e-17	C8orf88	Malignant cells	GSE131984_JQ1Pal	ENSG00000253250	100127983	chromosome 8 open reading frame 88	NA	protein_coding	P0DMB2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42944
2.15989222864942e-21	-0.271894465679872	0.176	0.354	3.41349367815754e-17	MIIP	Malignant cells	GSE131984_JQ1Pal	ENSG00000116691	60672	migration and invasion inhibitory protein	FLJ12438|IIp45	protein_coding	Q5JXC2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42945
2.18403780483097e-21	-0.346018290896384	0.667	0.779	3.45165334675487e-17	SRPK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000096063	6732	SRSF protein kinase 1	SFRSK1	protein_coding	Q96SB4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42946
2.28146244776252e-21	-0.31433294042895	0.296	0.483	3.60562325244388e-17	GLT8D1	Malignant cells	GSE131984_JQ1Pal	ENSG00000016864	55830	glycosyltransferase 8 domain containing 1	AD-017|FLJ14611	protein_coding	Q68CQ7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42947
2.43149087772841e-21	0.283078141186334	0.503	0.306	3.84272818316198e-17	RUNX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000159216	861	RUNX family transcription factor 1	AML1|AMLCR1|CBFA2|PEBP2A2	protein_coding	Q01196	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42948
2.59608683161374e-21	0.323719712267942	0.544	0.357	4.10285562868236e-17	KIF1C	Malignant cells	GSE131984_JQ1Pal	ENSG00000129250	10749	kinesin family member 1C	SAX2|SPAX2|SPG58	protein_coding	O43896	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42949
2.64692166035825e-21	-0.341718314687485	0.82	0.893	4.18319499203018e-17	SRSF11	Malignant cells	GSE131984_JQ1Pal	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42950
3.08622584444556e-21	-0.384049167741041	0.695	0.796	4.87747132456177e-17	RALA	Malignant cells	GSE131984_JQ1Pal	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42951
3.21909841126295e-21	0.324796523349107	0.626	0.436	5.08746312915997e-17	PRKCSH	Malignant cells	GSE131984_JQ1Pal	ENSG00000130175	5589	protein kinase C substrate 80K-H	G19P1|GIIB|PCLD|PLD1|VASAP-60	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42952
3.28403568766027e-21	-0.313344740592613	0.833	0.887	5.19009000077829e-17	GNB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000078369	2782	G protein subunit beta 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42953
3.6603123609578e-21	-0.345729651059565	0.519	0.697	5.7847576552577e-17	TSTA3	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42954
3.67162499601683e-21	-0.361080768282593	0.453	0.617	5.80263614370499e-17	ATP6V1E1	Malignant cells	GSE131984_JQ1Pal	ENSG00000131100	529	ATPase H+ transporting V1 subunit E1	ATP6E|ATP6E2|ATP6V1E|P31|Vma4	protein_coding	P36543	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42955
3.67220801715561e-21	0.285401344425038	0.395	0.213	5.80355755031272e-17	MOB3A	Malignant cells	GSE131984_JQ1Pal	ENSG00000172081	126308	MOB kinase activator 3A	MOB-LAK|MOB1C|MOBKL2A|moblak	protein_coding	Q96BX8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42956
3.70240827515701e-21	0.291558492725336	0.525	0.333	5.85128603805813e-17	MLXIP	Malignant cells	GSE131984_JQ1Pal	ENSG00000281178	22877	MLX interacting protein	bHLHe36|KIAA0867|MIR|MONDOA	protein_coding	Q9HAP2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42957
3.85243862812931e-21	-0.334658639448774	0.74	0.832	6.08839400789556e-17	MCUR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000050393	63933	mitochondrial calcium uniporter regulator 1	C6orf79|CCDC90A|FLJ20958	protein_coding	Q96AQ8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42958
3.90519111121058e-21	-0.308758144734314	0.763	0.872	6.17176403215719e-17	RNF181	Malignant cells	GSE131984_JQ1Pal	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42959
3.93878512169135e-21	-0.32547276749188	0.713	0.806	6.22485600632101e-17	TMEM183A	Malignant cells	GSE131984_JQ1Pal	ENSG00000163444	92703	transmembrane protein 183A	C1orf37	protein_coding	Q8IXX5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42960
4.07473000225194e-21	-0.351880299520635	0.52	0.672	6.43970329555897e-17	ERGIC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000087502	51290	ERGIC and golgi 2	Erv41|PTX1	protein_coding	Q96RQ1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42961
4.21037588429162e-21	-0.349417364732019	0.335	0.518	6.65407804753448e-17	MAFF	Malignant cells	GSE131984_JQ1Pal	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42962
4.21834951017529e-21	-0.386555142387019	0.466	0.624	6.66667956588102e-17	ZNF385D	Malignant cells	GSE131984_JQ1Pal	ENSG00000151789	79750	zinc finger protein 385D	FLJ22419|ZNF659	protein_coding	Q9H6B1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42963
4.51922801945705e-21	-0.266719996759304	0.12	0.281	7.14218796194993e-17	MIPEP	Malignant cells	GSE131984_JQ1Pal	ENSG00000027001	4285	mitochondrial intermediate peptidase	MIP	protein_coding	Q99797	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42964
4.75921863904183e-21	0.33345049871314	0.717	0.566	7.52146913714171e-17	EMC10	Malignant cells	GSE131984_JQ1Pal	ENSG00000161671	284361	ER membrane protein complex subunit 10	C19orf63|HSM1|HSS1|INM02	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42965
4.8144480949547e-21	0.323437566677914	0.503	0.32	7.6087537692664e-17	IRF2BPL	Malignant cells	GSE131984_JQ1Pal	ENSG00000119669	64207	interferon regulatory factor 2 binding protein like	C14orf4|EAP1|KIAA1865	protein_coding	Q9H1B7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42966
5.01330271960885e-21	-0.472317516193147	0.331	0.518	7.92302361806983e-17	AURKA	Malignant cells	GSE131984_JQ1Pal	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42967
5.03016529658273e-21	-0.34380344764922	0.695	0.804	7.94967323471935e-17	ARF6	Malignant cells	GSE131984_JQ1Pal	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42968
5.53491198459827e-21	-0.296797531735144	0.181	0.356	8.74737490045911e-17	NSDHL	Malignant cells	GSE131984_JQ1Pal	ENSG00000147383	50814	NAD(P) dependent steroid dehydrogenase-like	H105e3|SDR31E1|XAP104	protein_coding	Q15738	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42969
5.62853598147452e-21	-0.281028253311566	0.188	0.369	8.89533826512233e-17	AARS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42970
5.65265300969196e-21	-0.332791699895944	0.371	0.562	8.93345281651718e-17	EGFLAM	Malignant cells	GSE131984_JQ1Pal	ENSG00000164318	133584	EGF like, fibronectin type III and laminin G domains	AGRINL|AGRNL|FLJ39155|PIKA	protein_coding	Q63HQ2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42971
6.05625515750421e-21	-0.382834495610731	0.591	0.741	9.57130565091966e-17	TRIP13	Malignant cells	GSE131984_JQ1Pal	ENSG00000071539	9319	thyroid hormone receptor interactor 13	16E1BP	protein_coding	Q15645	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42972
6.05650860419194e-21	0.332474222524657	0.699	0.528	9.57170619806494e-17	GOLM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000135052	51280	golgi membrane protein 1	bA379P1.3|C9orf155|FLJ23608|GOLPH2|GP73	protein_coding	Q8NBJ4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42973
6.37473682818236e-21	-0.327666493976472	0.376	0.555	1.00746340832594e-16	IL13RA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000131724	3597	interleukin 13 receptor subunit alpha 1	CD213a1|IL-13Ra|NR4	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42974
6.39379629082946e-21	-0.262069136379666	0.128	0.293	1.01047556580269e-16	RAP2C	Malignant cells	GSE131984_JQ1Pal	ENSG00000123728	57826	RAP2C, member of RAS oncogene family	DKFZp313B211	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42975
6.4012169638455e-21	-0.330142401207202	0.882	0.919	1.01164832896614e-16	REEP5	Malignant cells	GSE131984_JQ1Pal	ENSG00000129625	7905	receptor accessory protein 5	C5orf18|D5S346|DP1|POB16|TB2|Yip2e	protein_coding	Q00765	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42976
6.8654179785994e-21	0.308792351444281	0.488	0.285	1.08501065733785e-16	STC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000159167	6781	stanniocalcin 1	STC	protein_coding	P52823	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42977
6.87367320104085e-21	0.329437837668167	0.45	0.272	1.0863153126925e-16	ZBTB44	Malignant cells	GSE131984_JQ1Pal	ENSG00000196323	29068	zinc finger and BTB domain containing 44	BTBD15|HSPC063|ZNF851	protein_coding	Q8NCP5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42978
7.03730097508018e-21	-0.322756015021222	0.927	0.968	1.11217504610167e-16	UBE2E3	Malignant cells	GSE131984_JQ1Pal	ENSG00000170035	10477	ubiquitin conjugating enzyme E2 E3	UbcH9	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42979
7.1797866973256e-21	-0.354945974931384	0.326	0.51	1.13469348964534e-16	PSMC3IP	Malignant cells	GSE131984_JQ1Pal	ENSG00000131470	29893	PSMC3 interacting protein	GT198|Hop2|HUMGT198A|TBPIP	protein_coding	Q9P2W1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42980
7.34501082446649e-21	-0.380420670856656	0.576	0.711	1.16080551069868e-16	ANP32A	Malignant cells	GSE131984_JQ1Pal	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42981
7.61405265452655e-21	-0.320208277255246	0.322	0.501	1.20332488152138e-16	ACD	Malignant cells	GSE131984_JQ1Pal	ENSG00000102977	65057	ACD shelterin complex subunit and telomerase recruitment factor	Pip1|Ptop|Tint1|Tpp1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42982
7.9727759608905e-21	-0.314314758174723	0.846	0.903	1.26001751285913e-16	TRA2B	Malignant cells	GSE131984_JQ1Pal	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42983
8.01025195115804e-21	-0.347697264505846	0.289	0.47	1.26594021836102e-16	SNHG10	Malignant cells	GSE131984_JQ1Pal	ENSG00000247092	283596	small nucleolar RNA host gene 10	C14orf62|FLJ40557|LINC00063|NCRNA00063|TP53LC16	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42984
8.18036681502047e-21	0.305711514291362	0.985	0.971	1.29282517144584e-16	FXYD5	Malignant cells	GSE131984_JQ1Pal	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42985
8.30072854002151e-21	-0.360768758615021	0.502	0.667	1.311847138465e-16	STK17A	Malignant cells	GSE131984_JQ1Pal	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42986
8.33857231714194e-21	0.807310759904115	0.659	0.549	1.31782796900111e-16	HBE1	Malignant cells	GSE131984_JQ1Pal	ENSG00000213931	3046	hemoglobin subunit epsilon 1	HBE	protein_coding	P02100	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42987
8.51377804534627e-21	0.281942854845249	0.42	0.237	1.34551748228652e-16	GNS	Malignant cells	GSE131984_JQ1Pal	ENSG00000135677	2799	glucosamine (N-acetyl)-6-sulfatase	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42988
8.5498209179516e-21	-0.313236412566091	0.866	0.922	1.35121369787307e-16	MMADHC	Malignant cells	GSE131984_JQ1Pal	ENSG00000168288	27249	metabolism of cobalamin associated D	C2orf25|cblD|CL25022	protein_coding	Q9H3L0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42989
8.74530891007175e-21	-0.315613501945728	0.782	0.874	1.38210862014774e-16	DDX18	Malignant cells	GSE131984_JQ1Pal	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42990
8.93568717454814e-21	-0.334382167478234	0.309	0.488	1.41219600106559e-16	ARMCX6	Malignant cells	GSE131984_JQ1Pal	ENSG00000198960	54470	armadillo repeat containing X-linked 6	FLJ20811|GASP10	protein_coding	Q7L4S7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42991
9.51436469421549e-21	-0.293201100972426	0.314	0.506	1.50365019627382e-16	UBE2D1	Malignant cells	GSE131984_JQ1Pal	ENSG00000072401	7321	ubiquitin conjugating enzyme E2 D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UbcH5A	protein_coding	P51668	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42992
9.62303884632886e-21	-0.336081362786925	0.407	0.585	1.52082505927381e-16	GFER	Malignant cells	GSE131984_JQ1Pal	ENSG00000127554	2671	growth factor, augmenter of liver regeneration	ALR|ERV1|HERV1|HPO1|HPO2|HSS	protein_coding	P55789	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42993
9.7565654468443e-21	-0.329448290012191	0.54	0.711	1.54192760321927e-16	COPZ1	Malignant cells	GSE131984_JQ1Pal	ENSG00000111481	22818	COPI coat complex subunit zeta 1	CGI-120|COPZ	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42994
9.76477305476735e-21	-0.279543004359604	0.224	0.408	1.54322473357543e-16	CMTM3	Malignant cells	GSE131984_JQ1Pal	ENSG00000140931	123920	CKLF like MARVEL transmembrane domain containing 3	BNAS2|CKLFSF3|FLJ31762	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42995
9.9180928881614e-21	-0.328999067979625	0.28	0.459	1.56745540004503e-16	ANAPC10	Malignant cells	GSE131984_JQ1Pal	ENSG00000164162	10393	anaphase promoting complex subunit 10	APC10|DKFZP564L0562|DOC1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42996
9.93096983118282e-21	0.328061504516008	0.665	0.488	1.56949047212013e-16	USP34	Malignant cells	GSE131984_JQ1Pal	ENSG00000115464	9736	ubiquitin specific peptidase 34	KIAA0570|KIAA0729	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42997
1.13020565096363e-20	-0.36037299972786	0.632	0.767	1.78617701078292e-16	DDOST	Malignant cells	GSE131984_JQ1Pal	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42998
1.13055598667871e-20	-0.304780990046231	0.337	0.523	1.78673068134703e-16	ELP6	Malignant cells	GSE131984_JQ1Pal	ENSG00000163832	54859	elongator acetyltransferase complex subunit 6	C3orf75|FLJ20211|TMEM103	protein_coding	Q0PNE2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	42999
1.14180800623636e-20	-0.841523952578767	0.261	0.435	1.80451337305595e-16	CXCL3	Malignant cells	GSE131984_JQ1Pal	ENSG00000163734	2921	C-X-C motif chemokine ligand 3	CINC-2b|GRO3|GROg|MIP-2b|SCYB3	protein_coding	P19876	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43000
1.18916366861207e-20	-0.293729132019098	0.188	0.363	1.87935426187452e-16	RP11-879F14.2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43001
1.26219922100618e-20	0.321415002150813	0.653	0.473	1.99477964887816e-16	UBXN6	Malignant cells	GSE131984_JQ1Pal	ENSG00000167671	80700	UBX domain protein 6	UBXD1|UBXDC2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43002
1.31123345679166e-20	-0.288363769164706	0.272	0.459	2.07227335511353e-16	MCAT	Malignant cells	GSE131984_JQ1Pal	ENSG00000100294	27349	malonyl-CoA-acyl carrier protein transacylase	fabD|FASN2C|MCT|MCT1|MT|NET62	protein_coding	Q8IVS2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43003
1.39254154835841e-20	-0.346588108275247	0.284	0.463	2.20077266302563e-16	ZFAND2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43004
1.44056158503079e-20	0.295368177545132	0.427	0.247	2.27666352898265e-16	SPATA20	Malignant cells	GSE131984_JQ1Pal	ENSG00000006282	64847	spermatogenesis associated 20	FLJ21347|SSP411|Tisp78	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43005
1.48966849811571e-20	-0.341879358206616	0.551	0.698	2.35427209442207e-16	SMUG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000123415	23583	single-strand-selective monofunctional uracil-DNA glycosylase 1	FDG|HMUDG|UNG3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43006
1.57752741469824e-20	-0.337072579344268	0.361	0.536	2.4931243261891e-16	MAPK9	Malignant cells	GSE131984_JQ1Pal	ENSG00000050748	5601	mitogen-activated protein kinase 9	JNK2|p54a|PRKM9|SAPK	protein_coding	P45984	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43007
1.70054194199827e-20	-0.303578066405711	0.278	0.461	2.68753648513407e-16	EIF2D	Malignant cells	GSE131984_JQ1Pal	ENSG00000143486	1939	eukaryotic translation initiation factor 2D	LGTN	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43008
1.78818326438008e-20	-0.266780099609232	0.922	0.955	2.82604483102628e-16	NDUFS7	Malignant cells	GSE131984_JQ1Pal	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43009
1.79379765117174e-20	0.289957533236435	0.354	0.184	2.83491780791181e-16	AACS	Malignant cells	GSE131984_JQ1Pal	ENSG00000081760	65985	acetoacetyl-CoA synthetase	ACSF1|FLJ12389|SUR-5	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43010
1.80948448184884e-20	0.320692057207481	0.81	0.666	2.85970927511391e-16	TCF25	Malignant cells	GSE131984_JQ1Pal	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43011
1.82077067087157e-20	0.348870780590744	0.849	0.708	2.87754596824543e-16	CLPTM1L	Malignant cells	GSE131984_JQ1Pal	ENSG00000274811	81037	CLPTM1 like	CRR9|FLJ14400	protein_coding	Q96KA5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43012
1.84486708473982e-20	-0.330705522695155	0.382	0.554	2.91562794072282e-16	UCK2	Malignant cells	GSE131984_JQ1Pal	ENSG00000143179	7371	uridine-cytidine kinase 2	UMPK	protein_coding	Q9BZX2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43013
1.90825820218443e-20	-0.321660719635773	0.524	0.695	3.01581126273227e-16	CFDP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000153774	10428	craniofacial development protein 1	BCNT|CENP-29|CP27|p97|SWC5|Yeti	protein_coding	Q9UEE9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43014
2.00436619935245e-20	0.294341124047535	0.331	0.165	3.16770034145661e-16	FBXW7	Malignant cells	GSE131984_JQ1Pal	ENSG00000109670	55294	F-box and WD repeat domain containing 7	AGO|CDC4|FBW7|FBX30|FBXW6|FLJ11071|SEL-10|SEL10	protein_coding	Q969H0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43015
2.03834942766063e-20	0.324493443442316	0.496	0.314	3.22140743547486e-16	ASAP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000151693	8853	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	CENTB3|DDEF2|KIAA0400|PAP|SHAG1	protein_coding	O43150	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43016
2.11910137045717e-20	-0.340508560686808	0.642	0.794	3.34902780587051e-16	RRM2	Malignant cells	GSE131984_JQ1Pal	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43017
2.30010223858223e-20	-0.381707478472574	0.183	0.35	3.63508157785535e-16	IFI44	Malignant cells	GSE131984_JQ1Pal	ENSG00000137965	10561	interferon induced protein 44	MTAP44|p44|TLDC5	protein_coding	Q8TCB0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43018
2.31074334834666e-20	0.29082465175249	0.765	0.584	3.65189878772707e-16	PRKCA	Malignant cells	GSE131984_JQ1Pal	ENSG00000154229	5578	protein kinase C alpha	PKCA|PKCalpha	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43019
2.34288396438606e-20	0.307351553517394	0.848	0.705	3.70269381731572e-16	ZNF428	Malignant cells	GSE131984_JQ1Pal	ENSG00000131116	126299	zinc finger protein 428	C19orf37|MGC51082|Zfp428	protein_coding	Q96B54	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43020
2.48086952790051e-20	-0.351351781445334	0.479	0.641	3.92076620189397e-16	GEMIN6	Malignant cells	GSE131984_JQ1Pal	ENSG00000152147	79833	gem nuclear organelle associated protein 6	FLJ23459	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43021
2.71678810170626e-20	0.324882825149881	0.736	0.574	4.29361191593658e-16	WNK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43022
2.72575790472751e-20	-0.338284935631905	0.366	0.538	4.30778779263135e-16	HADH	Malignant cells	GSE131984_JQ1Pal	ENSG00000138796	3033	hydroxyacyl-CoA dehydrogenase	HADH1|HADHSC|SCHAD	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43023
2.83673501250553e-20	-0.312726680494173	0.302	0.483	4.48317601376374e-16	PSMD10	Malignant cells	GSE131984_JQ1Pal	ENSG00000101843	5716	proteasome 26S subunit, non-ATPase 10	p28	protein_coding	O75832	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43024
2.93292765798919e-20	0.342548715968704	0.884	0.807	4.63519887068611e-16	ACTN4	Malignant cells	GSE131984_JQ1Pal	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43025
2.9393912545891e-20	-0.331331125214053	0.772	0.866	4.64541393875262e-16	IGBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000089289	3476	immunoglobulin binding protein 1	alpha4|IBP1	protein_coding	P78318	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43026
3.05510101371135e-20	-0.310804822170724	0.317	0.502	4.82828164206942e-16	INTS12	Malignant cells	GSE131984_JQ1Pal	ENSG00000138785	57117	integrator complex subunit 12	INT12|PHF22|SBBI22	protein_coding	Q96CB8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43027
3.530895904835e-20	-0.332977696115628	0.47	0.641	5.58022788800124e-16	FGFR1OP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000111790	26127	FGFR1 oncogene partner 2	DKFZp564O1863	protein_coding	Q9NVK5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43028
3.66049257175384e-20	-0.31849251706652	0.385	0.572	5.78504246039977e-16	FAM103A1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43029
3.68086491008373e-20	-0.357440785017917	0.555	0.694	5.81723890389633e-16	PITX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000069011	5307	paired like homeodomain 1	BFT|POTX|PTX1	protein_coding	P78337	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43030
3.72175450759549e-20	-0.364235811730478	0.468	0.631	5.88186082380391e-16	SQRDL	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43031
3.81681359141325e-20	-0.332010709058923	0.493	0.653	6.0320921998695e-16	RFK	Malignant cells	GSE131984_JQ1Pal	ENSG00000135002	55312	riboflavin kinase	FLJ11149|RIFK	protein_coding	Q969G6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43032
3.90332194101464e-20	0.351309268089322	0.809	0.678	6.16880999557953e-16	C6orf1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43033
4.24325031786862e-20	-0.337007634273029	0.771	0.836	6.70603280235957e-16	NCBP2-AS2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43034
4.61372209251344e-20	0.300520232494583	0.464	0.283	7.29152639500824e-16	PRKACA	Malignant cells	GSE131984_JQ1Pal	ENSG00000288516	5566	protein kinase cAMP-activated catalytic subunit alpha	PKACa	protein_coding	P17612	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43035
4.68336245255656e-20	0.259174291615933	0.283	0.126	7.40158602002038e-16	PNPLA6	Malignant cells	GSE131984_JQ1Pal	ENSG00000032444	10908	patatin like phospholipase domain containing 6	iPLA2delta|NTE|SPG39|sws	protein_coding	Q8IY17	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43036
4.76934842837335e-20	-0.334000991707522	0.309	0.485	7.53747825620124e-16	C14orf142	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43037
4.77742924349323e-20	-0.300320350737944	0.28	0.465	7.5502491764167e-16	ME2	Malignant cells	GSE131984_JQ1Pal	ENSG00000082212	4200	malic enzyme 2	NA	protein_coding	P23368	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43038
5.02394843198379e-20	-0.311900766320218	0.348	0.529	7.93984810190718e-16	SLC50A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000169241	55974	solute carrier family 50 member 1	HsSWEET1|RAG1AP1|RP11-540D14.5|RZPDo834D038D|SCP|slv|SWEET1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43039
5.08883060041316e-20	-0.379614627350734	0.895	0.937	8.04238788089296e-16	MANF	Malignant cells	GSE131984_JQ1Pal	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43040
5.20796042204212e-20	-0.309491908258316	0.279	0.46	8.23066065099537e-16	C1orf131	Malignant cells	GSE131984_JQ1Pal	ENSG00000143633	128061	chromosome 1 open reading frame 131	DKFZp547B1713	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43041
5.21592325162278e-20	-0.318673170168094	0.749	0.829	8.24324510686464e-16	NOSIP	Malignant cells	GSE131984_JQ1Pal	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43042
5.33339999887974e-20	-0.339381323701421	0.408	0.582	8.42890535822954e-16	KNOP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000103550	400506	lysine rich nucleolar protein 1	101F10.1|C16orf88|FAM191A|TSG118	protein_coding	Q1ED39	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43043
5.43683082139452e-20	-0.366648289901438	0.465	0.63	8.5923674301319e-16	BCAS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43044
5.55406938045847e-20	-0.363573191509551	0.799	0.856	8.77765124887656e-16	MTHFD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43045
5.56347319496237e-20	-0.331892036486846	0.444	0.62	8.79251303731853e-16	APIP	Malignant cells	GSE131984_JQ1Pal	ENSG00000149089	51074	APAF1 interacting protein	APIP2|CGI-29|Mmrp19	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43046
5.5899091173136e-20	-0.336049570519509	0.322	0.493	8.83429236900241e-16	COPS4	Malignant cells	GSE131984_JQ1Pal	ENSG00000138663	51138	COP9 signalosome subunit 4	CSN4|SGN4	protein_coding	Q9BT78	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43047
5.73449421311205e-20	-0.291392722237347	0.199	0.372	9.06279465440228e-16	COMMD10	Malignant cells	GSE131984_JQ1Pal	ENSG00000145781	51397	COMM domain containing 10	PTD002	protein_coding	Q9Y6G5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43048
5.79152267123237e-20	-0.326060799641217	0.634	0.768	9.15292242961564e-16	MRPS25	Malignant cells	GSE131984_JQ1Pal	ENSG00000131368	64432	mitochondrial ribosomal protein S25	DKFZp313H0817|FLJ00023|MRP-S25|RPMS25	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43049
5.79944618198053e-20	-0.269977217704824	0.124	0.281	9.16544474600202e-16	CDC45	Malignant cells	GSE131984_JQ1Pal	ENSG00000093009	8318	cell division cycle 45	CDC45L|CDC45L2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43050
5.80750428762637e-20	0.323844117030834	0.692	0.527	9.17817977616472e-16	TMEM259	Malignant cells	GSE131984_JQ1Pal	ENSG00000182087	91304	transmembrane protein 259	ASBABP1|C19orf6|MBRL|MGC4022	protein_coding	Q4ZIN3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43051
6.02135260198877e-20	0.275440361914994	0.409	0.23	9.51614565218305e-16	ATP11B	Malignant cells	GSE131984_JQ1Pal	ENSG00000058063	23200	ATPase phospholipid transporting 11B (putative)	ATPIF|ATPIR|KIAA0956	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43052
6.0820944628058e-20	0.260959922850265	0.38	0.205	9.61214208901829e-16	KIAA1671	Malignant cells	GSE131984_JQ1Pal	ENSG00000197077	85379	KIAA1671	NA	protein_coding	Q9BY89	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43053
6.25960044484967e-20	0.272837263382184	0.412	0.232	9.89267254304042e-16	ANTXR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000169604	84168	ANTXR cell adhesion molecule 1	ATR|FLJ10601|FLJ21776|TEM8	protein_coding	Q9H6X2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43054
7.02519830154241e-20	0.331911707856609	0.528	0.348	1.11026233957576e-15	LPIN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000134324	23175	lipin 1	KIAA0188	protein_coding	Q14693	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43055
7.40421357707822e-20	-0.352752150475018	0.388	0.552	1.17016191372144e-15	SMAGP	Malignant cells	GSE131984_JQ1Pal	ENSG00000170545	57228	small cell adhesion glycoprotein	hSMAGP|MGC149453|MGC149454	protein_coding	Q0VAQ4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43056
7.44870818984491e-20	-0.326989597476432	0.295	0.476	1.17719384232309e-15	RP11-660L16.2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43057
7.5389713488984e-20	-0.287543776613957	0.27	0.454	1.1914590319799e-15	RANGRF	Malignant cells	GSE131984_JQ1Pal	ENSG00000108961	29098	RAN guanine nucleotide release factor	HSPC165|HSPC236|MOG1|RANGNRF	protein_coding	Q9HD47	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43058
7.6079255480376e-20	-0.275990591642714	0.144	0.307	1.20235655361186e-15	BBC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000105327	27113	BCL2 binding component 3	JFY1|PUMA	protein_coding	Q9BXH1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43059
7.68825016740752e-20	0.320436555309854	0.772	0.614	1.21505105645708e-15	MBNL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43060
7.76695067991031e-20	-0.290977992956398	0.283	0.467	1.22748888545303e-15	MRPL44	Malignant cells	GSE131984_JQ1Pal	ENSG00000135900	65080	mitochondrial ribosomal protein L44	FLJ12701|FLJ13990	protein_coding	Q9H9J2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43061
7.79889619752482e-20	-0.302993785001823	0.323	0.504	1.23253755505682e-15	NRBF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000148572	29982	nuclear receptor binding factor 2	COPR1|COPR2|DKFZp564C1664|FLJ30395	protein_coding	Q96F24	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43062
8.20944121049563e-20	-0.266573826064403	0.142	0.303	1.29742008890673e-15	FAM216A	Malignant cells	GSE131984_JQ1Pal	ENSG00000204856	29902	family with sequence similarity 216 member A	C12orf24|HSU79274	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43063
8.32157766482117e-20	0.28997991187747	0.527	0.348	1.31514213414834e-15	SUGP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000064607	10147	SURP and G-patch domain containing 2	KIAA0365|SFRS14	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43064
8.34526032811857e-20	-0.3435872610607	0.617	0.746	1.31888494225586e-15	FUCA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000001036	2519	alpha-L-fucosidase 2	dJ20N2.5|MGC1314	protein_coding	Q9BTY2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43065
8.35803028421152e-20	-0.332222363290112	0.679	0.781	1.32090310611679e-15	SERPINB6	Malignant cells	GSE131984_JQ1Pal	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43066
8.57809276089018e-20	-0.279180732720794	0.163	0.333	1.35568177993108e-15	PTPRF	Malignant cells	GSE131984_JQ1Pal	ENSG00000142949	5792	protein tyrosine phosphatase receptor type F	LAR	protein_coding	P10586	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43067
9.44356938726605e-20	-0.331847594705174	0.295	0.476	1.49246170596353e-15	KDELR3	Malignant cells	GSE131984_JQ1Pal	ENSG00000100196	11015	KDEL endoplasmic reticulum protein retention receptor 3	NA	protein_coding	O43731	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43068
9.92008921979242e-20	0.324817213229874	0.506	0.328	1.56777090029599e-15	MAFK	Malignant cells	GSE131984_JQ1Pal	ENSG00000198517	7975	MAF bZIP transcription factor K	NFE2U|P18	protein_coding	O60675	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43069
1.0278831028751e-19	-0.285609487266512	0.285	0.467	1.6244664557838e-15	GMDS	Malignant cells	GSE131984_JQ1Pal	ENSG00000112699	2762	GDP-mannose 4,6-dehydratase	GMD|SDR3E1	protein_coding	O60547	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43070
1.0736193890162e-19	-0.269805766768369	0.203	0.377	1.6967480824012e-15	RCHY1	Malignant cells	GSE131984_JQ1Pal	ENSG00000163743	25898	ring finger and CHY zinc finger domain containing 1	ARNIP|CHIMP|DKFZp586C1620|PIRH2|PRO1996|RNF199|ZCHY|ZNF363	protein_coding	Q96PM5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43071
1.08081151970872e-19	-0.303480783811079	0.349	0.533	1.70811452574767e-15	RPP38	Malignant cells	GSE131984_JQ1Pal	ENSG00000152464	10557	ribonuclease P/MRP subunit p38	NA	protein_coding	P78345	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43072
1.10365394382107e-19	-0.359331842907868	0.64	0.745	1.74421469281482e-15	NDFIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43073
1.11888373311624e-19	-0.258929700046072	0.113	0.266	1.76828385181691e-15	DLL3	Malignant cells	GSE131984_JQ1Pal	ENSG00000090932	10683	delta like canonical Notch ligand 3	SCDO1	protein_coding	Q9NYJ7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43074
1.15213708647167e-19	-0.326959060796102	0.425	0.592	1.82083745145983e-15	PPT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43075
1.21131689073227e-19	0.260304539637755	0.379	0.205	1.91436521411329e-15	DCTN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000204843	1639	dynactin subunit 1	NA	protein_coding	Q14203	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43076
1.21687193706597e-19	0.322032694854121	0.599	0.422	1.92314440933907e-15	MIDN	Malignant cells	GSE131984_JQ1Pal	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43077
1.21863794801947e-19	-0.259794191906319	0.152	0.315	1.92593541304997e-15	NOTCH2NL	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43078
1.22928282725376e-19	0.275181013170979	0.371	0.2	1.94275858019184e-15	IVD	Malignant cells	GSE131984_JQ1Pal	ENSG00000128928	3712	isovaleryl-CoA dehydrogenase	ACAD2|IVDH	protein_coding	P26440	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43079
1.29257576067698e-19	-0.337698826539425	0.493	0.645	2.04278673217389e-15	ATG5	Malignant cells	GSE131984_JQ1Pal	ENSG00000057663	9474	autophagy related 5	APG5|APG5L|ASP|hAPG5	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43080
1.39397660039622e-19	-0.270505753330113	0.999	0.994	2.20304061926619e-15	DYNLL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43081
1.40390760855146e-19	0.255247662466871	0.354	0.183	2.21873558455473e-15	SKI	Malignant cells	GSE131984_JQ1Pal	ENSG00000157933	6497	SKI proto-oncogene	NA	protein_coding	P12755	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43082
1.46994573150367e-19	-0.277107156803515	0.229	0.406	2.3231022340684e-15	CIRH1A	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43083
1.48112547334568e-19	-0.272107918759018	0.193	0.364	2.34077069807552e-15	SLC25A43	Malignant cells	GSE131984_JQ1Pal	ENSG00000077713	203427	solute carrier family 25 member 43	NA	protein_coding	Q8WUT9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43084
1.48540564349834e-19	-0.306261292949319	0.202	0.375	2.34753507898478e-15	ZC3H12A	Malignant cells	GSE131984_JQ1Pal	ENSG00000163874	80149	zinc finger CCCH-type containing 12A	FLJ23231|MCPIP1|Regnase-1	protein_coding	Q5D1E8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43085
1.49930114321367e-19	0.309508537638525	0.95	0.904	2.36949552673489e-15	ERGIC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000125991	51614	ERGIC and golgi 3	C20orf47|CGI-54|Erv46|NY-BR-84|PRO0989|SDBCAG84	protein_coding	Q9Y282	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43086
1.50745407551727e-19	-0.320944202518861	0.931	0.955	2.38238042094749e-15	SSR3	Malignant cells	GSE131984_JQ1Pal	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43087
1.55664280416575e-19	0.284665971550017	0.509	0.324	2.46011828770355e-15	SPIN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000106723	10927	spindlin 1	SPIN|TDRD24	protein_coding	Q9Y657	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43088
1.58640741682175e-19	0.268643917228263	0.361	0.192	2.5071582815451e-15	FGFRL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000127418	53834	fibroblast growth factor receptor like 1	NA	protein_coding	Q8N441	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43089
1.63830661474709e-19	0.302492341056201	0.967	0.883	2.5891797739463e-15	MAP1B	Malignant cells	GSE131984_JQ1Pal	ENSG00000131711	4131	microtubule associated protein 1B	MAP5|PPP1R102	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43090
1.70789937894909e-19	-0.269336864855747	0.949	0.981	2.69916417849115e-15	ATP6V0E1	Malignant cells	GSE131984_JQ1Pal	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43091
1.98280559543355e-19	0.304994783995193	0.541	0.355	3.13362596302318e-15	CD109	Malignant cells	GSE131984_JQ1Pal	ENSG00000156535	135228	CD109 molecule	CPAMD7|DKFZp762L1111|FLJ38569	protein_coding	Q6YHK3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43092
1.9957791030902e-19	-0.3543714930091	0.633	0.756	3.15412929452376e-15	CSRP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000159176	1465	cysteine and glycine rich protein 1	CSRP|CYRP|D1S181E	protein_coding	P21291	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43093
2.19374290297099e-19	-0.324640336828854	0.35	0.522	3.46699128385535e-15	PRPSAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000161542	5635	phosphoribosyl pyrophosphate synthetase associated protein 1	PAP39	protein_coding	Q14558	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43094
2.24683676916191e-19	-0.350699286420444	0.319	0.49	3.55090082998348e-15	NXT2	Malignant cells	GSE131984_JQ1Pal	ENSG00000101888	55916	nuclear transport factor 2 like export factor 2	P15-2	protein_coding	Q9NPJ8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43095
2.29504668718573e-19	-0.258376885675182	0.943	0.974	3.62709178442832e-15	EIF3G	Malignant cells	GSE131984_JQ1Pal	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43096
2.31416084928539e-19	0.265865713471607	0.377	0.205	3.65729980621063e-15	STIM2	Malignant cells	GSE131984_JQ1Pal	ENSG00000109689	57620	stromal interaction molecule 2	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43097
2.39809825955081e-19	-0.349792765910244	0.557	0.684	3.7899544893941e-15	RAD50	Malignant cells	GSE131984_JQ1Pal	ENSG00000113522	10111	RAD50 double strand break repair protein	hRad50|RAD50-2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43098
2.44436227006868e-19	-0.352168130851816	0.433	0.59	3.86307013161654e-15	ACTL6A	Malignant cells	GSE131984_JQ1Pal	ENSG00000136518	86	actin like 6A	Actl6|Arp4|BAF53A|INO80K|SMARCN1	protein_coding	O96019	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43099
2.67402115519644e-19	-0.317405958937177	0.312	0.488	4.22602303367245e-15	HSPA14	Malignant cells	GSE131984_JQ1Pal	ENSG00000187522	51182	heat shock protein family A (Hsp70) member 14	HSP70-4|HSP70L1	protein_coding	Q0VDF9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43100
2.79116102633018e-19	0.301046290992501	0.572	0.397	4.41115088601222e-15	PLD3	Malignant cells	GSE131984_JQ1Pal	ENSG00000105223	23646	phospholipase D family member 3	HU-K4	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43101
2.89779003011428e-19	-0.285826046362806	0.226	0.399	4.5796673635926e-15	C2orf47	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43102
2.9338487669728e-19	-0.333752894458641	0.514	0.67	4.63665459132381e-15	TFAM	Malignant cells	GSE131984_JQ1Pal	ENSG00000108064	7019	transcription factor A, mitochondrial	TCF6|TCF6L2	protein_coding	Q00059	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43103
2.9467907438494e-19	-0.370401212287565	0.217	0.386	4.65710809157959e-15	HES7	Malignant cells	GSE131984_JQ1Pal	ENSG00000179111	84667	hes family bHLH transcription factor 7	bHLHb37	protein_coding	Q9BYE0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43104
3.02891397607318e-19	-0.357983735889427	0.637	0.762	4.78689564778606e-15	ARHGAP18	Malignant cells	GSE131984_JQ1Pal	ENSG00000146376	93663	Rho GTPase activating protein 18	bA307O14.2|MacGAP	protein_coding	Q8N392	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43105
3.04400270539175e-19	0.289158031868023	0.496	0.314	4.81074187560112e-15	ACAP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000114331	23527	ArfGAP with coiled-coil, ankyrin repeat and PH domains 2	CENTB2|CNT-B2|KIAA0041	protein_coding	Q15057	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43106
3.15934686208468e-19	-0.27825152636987	0.915	0.959	4.99303178083863e-15	REXO2	Malignant cells	GSE131984_JQ1Pal	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43107
3.17014486368262e-19	0.307897415512665	0.462	0.287	5.01009694256401e-15	DNER	Malignant cells	GSE131984_JQ1Pal	ENSG00000187957	92737	delta/notch like EGF repeat containing	bet|UNQ26	protein_coding	Q8NFT8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43108
3.18967515026953e-19	-0.380507299510709	0.344	0.508	5.04096260748597e-15	SAP30	Malignant cells	GSE131984_JQ1Pal	ENSG00000164105	8819	Sin3A associated protein 30	NA	protein_coding	O75446	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43109
3.46557723913672e-19	-0.285753938651138	0.73	0.847	5.47699826873167e-15	DAZAP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43110
3.55717175481437e-19	-0.318334904512549	0.433	0.599	5.62175424130863e-15	TRABD	Malignant cells	GSE131984_JQ1Pal	ENSG00000170638	80305	TraB domain containing	PP2447	protein_coding	Q9H4I3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43111
3.57491798164388e-19	-0.359199811371783	0.468	0.613	5.64980037818998e-15	THYN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000151500	29087	thymocyte nuclear protein 1	THY28	protein_coding	Q9P016	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43112
3.76026101933371e-19	-0.298749193648075	0.289	0.472	5.942716514955e-15	WDR46	Malignant cells	GSE131984_JQ1Pal	ENSG00000226916	9277	WD repeat domain 46	BING4|C6orf11|UTP7	protein_coding	O15213	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43113
3.92715459778936e-19	-0.320981663285197	0.342	0.515	6.2064751263463e-15	TM2D1	Malignant cells	GSE131984_JQ1Pal	ENSG00000162604	83941	TM2 domain containing 1	BBP	protein_coding	Q9BX74	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43114
4.11851704873163e-19	-0.350175806365488	0.521	0.669	6.50890434381547e-15	TWF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000247596	11344	twinfilin actin binding protein 2	A6r|A6RP|PTK9L	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43115
4.25654550857741e-19	-0.283355979650523	0.271	0.448	6.72704452175574e-15	CYB5R4	Malignant cells	GSE131984_JQ1Pal	ENSG00000065615	51167	cytochrome b5 reductase 4	b5+b5R|dJ676J13.1|NCB5OR	protein_coding	Q7L1T6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43116
4.43250671458934e-19	-0.293990537403007	0.308	0.493	7.00513361173699e-15	TSR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000167721	55720	TSR1 ribosome maturation factor	FLJ10534	protein_coding	Q2NL82	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43117
4.63521991147882e-19	-0.492090122124944	0.75	0.828	7.32550154810113e-15	IER2	Malignant cells	GSE131984_JQ1Pal	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43118
4.75617778334002e-19	-0.283052351638531	0.942	0.959	7.51666336879057e-15	KHDRBS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43119
4.77504211484121e-19	-0.269090698541094	0.967	0.972	7.54647655829504e-15	GCSH	Malignant cells	GSE131984_JQ1Pal	ENSG00000140905	2653	glycine cleavage system protein H	NA	protein_coding	P23434	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43120
4.77760068420097e-19	0.270494113492687	0.373	0.199	7.55052012131121e-15	SLFN5	Malignant cells	GSE131984_JQ1Pal	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43121
4.8009670152167e-19	-0.292602946098339	0.76	0.857	7.58744827084848e-15	C11orf73	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43122
5.09177145639964e-19	-0.357882016687429	0.434	0.591	8.04703560969399e-15	AATF	Malignant cells	GSE131984_JQ1Pal	ENSG00000276072	26574	apoptosis antagonizing transcription factor	BFR2|CHE-1|CHE1|DED	protein_coding	Q9NY61	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43123
5.1335087092878e-19	-0.270489589958923	0.909	0.952	8.11299716415843e-15	ISCU	Malignant cells	GSE131984_JQ1Pal	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43124
5.40513123956004e-19	-0.337775032025242	0.643	0.756	8.54226941100069e-15	TFG	Malignant cells	GSE131984_JQ1Pal	ENSG00000114354	10342	trafficking from ER to golgi regulator	FLJ36137|SPG57|TF6	protein_coding	Q92734	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43125
6.06086804320248e-19	-0.35649901656559	0.619	0.761	9.57859585547719e-15	SMC1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43126
6.16841050334817e-19	0.318470045736392	0.805	0.652	9.74855595949144e-15	EIF2AK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000086232	27102	eukaryotic translation initiation factor 2 alpha kinase 1	HCR|hHRI|HRI|KIAA1369	protein_coding	Q9BQI3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43127
6.19713469629087e-19	0.26163677131625	0.344	0.177	9.79395167401809e-15	FARP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000006607	9855	FERM, ARH/RhoGEF and pleckstrin domain protein 2	FIR|FRG|KIAA0793|PLEKHC3	protein_coding	O94887	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43128
6.29851795731997e-19	-0.308440261859059	0.745	0.834	9.95417777974849e-15	ETF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43129
6.32817545853221e-19	0.325692745100351	0.513	0.345	1.00010484946643e-14	ANKIB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000001629	54467	ankyrin repeat and IBR domain containing 1	DKFZP434A0225|KIAA1386	protein_coding	Q9P2G1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43130
6.59545728876471e-19	-0.317313094578497	0.536	0.701	1.04234606991637e-14	MRPL48	Malignant cells	GSE131984_JQ1Pal	ENSG00000175581	51642	mitochondrial ribosomal protein L48	CGI-118	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43131
6.70508589507402e-19	0.263644384617168	0.337	0.174	1.0596717748575e-14	PPP1R12C	Malignant cells	GSE131984_JQ1Pal	ENSG00000125503	54776	protein phosphatase 1 regulatory subunit 12C	AAVS1|DKFZP434D0412|LENG3|MBS85|p84|p85	protein_coding	Q9BZL4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43132
6.80564410369027e-19	0.354130162822706	0.637	0.478	1.07556399414721e-14	ABLIM3	Malignant cells	GSE131984_JQ1Pal	ENSG00000173210	22885	actin binding LIM protein family member 3	KIAA0843	protein_coding	O94929	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43133
6.906193513336e-19	-0.326146213306387	0.56	0.697	1.09145482284762e-14	RAB18	Malignant cells	GSE131984_JQ1Pal	ENSG00000099246	22931	RAB18, member RAS oncogene family	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43134
7.04232989258968e-19	0.314243346748559	0.574	0.398	1.11296981622487e-14	CCDC88A	Malignant cells	GSE131984_JQ1Pal	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43135
7.29588811645887e-19	-0.331108743166315	0.562	0.699	1.15304215792516e-14	UBL4A	Malignant cells	GSE131984_JQ1Pal	ENSG00000102178	8266	ubiquitin like 4A	DXS254E|GDX|GET5|MDY2|TMA24|UBL4	protein_coding	P11441	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43136
7.70993468409753e-19	0.30189815632873	0.335	0.172	1.21847807747477e-14	KCNQ1OT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000269821	10984	KCNQ1 opposite strand/antisense transcript 1	KCNQ1-AS2|KvDMR1|KvLQT1-AS|LIT1|NCRNA00012	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43137
7.75062938124196e-19	-0.359333541146165	0.473	0.609	1.22490946741148e-14	RTCB	Malignant cells	GSE131984_JQ1Pal	ENSG00000100220	51493	RNA 2',3'-cyclic phosphate and 5'-OH ligase	C22orf28|FAAP|HSPC117	protein_coding	Q9Y3I0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43138
8.10830510665086e-19	-0.34244142425127	0.393	0.564	1.2814365390551e-14	RPP30	Malignant cells	GSE131984_JQ1Pal	ENSG00000148688	10556	ribonuclease P/MRP subunit p30	TSG15	protein_coding	P78346	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43139
8.23657786989277e-19	-0.312840795469136	0.763	0.851	1.30170876655785e-14	SRP19	Malignant cells	GSE131984_JQ1Pal	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43140
8.31878197279763e-19	0.326801200079383	0.481	0.315	1.31470030298094e-14	EGFR	Malignant cells	GSE131984_JQ1Pal	ENSG00000146648	1956	epidermal growth factor receptor	ERBB|ERBB1|ERRP	protein_coding	P00533	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43141
8.43135947682466e-19	-0.321190684628565	0.45	0.616	1.33249205171737e-14	TMX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000139921	81542	thioredoxin related transmembrane protein 1	PDIA11|TMX|TXNDC|TXNDC1	protein_coding	Q9H3N1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43142
9.24360725531203e-19	0.251906291151894	0.344	0.18	1.46085969062951e-14	CLASP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000074054	23332	cytoplasmic linker associated protein 1	KIAA0622|MAST1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43143
9.36728690229961e-19	0.301668653977936	0.504	0.327	1.48040602203943e-14	TMEM245	Malignant cells	GSE131984_JQ1Pal	ENSG00000106771	23731	transmembrane protein 245	C9orf5|CG-2	protein_coding	Q9H330	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43144
1.0017223172199e-18	-0.293125567020877	0.2	0.368	1.58312195013434e-14	MSMO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000052802	6307	methylsterol monooxygenase 1	DESP4|ERG25|SC4MOL	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43145
1.0380550056333e-18	-0.315055622027685	0.91	0.934	1.64054213090287e-14	NONO	Malignant cells	GSE131984_JQ1Pal	ENSG00000147140	4841	non-POU domain containing octamer binding	NMT55|NRB54|P54|P54NRB|PPP1R114	protein_coding	Q15233	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43146
1.11361598729436e-18	0.308819426126133	0.649	0.484	1.75995870632e-14	UBE3C	Malignant cells	GSE131984_JQ1Pal	ENSG00000009335	9690	ubiquitin protein ligase E3C	KIAA0010|KIAA10	protein_coding	Q15386	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43147
1.14615865417779e-18	-0.294315866457025	0.309	0.486	1.81138913706257e-14	MTMR2	Malignant cells	GSE131984_JQ1Pal	ENSG00000087053	8898	myotubularin related protein 2	CMT4B|KIAA1073	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43148
1.21035527946334e-18	0.295324895891413	0.993	0.991	1.91284548366387e-14	CD151	Malignant cells	GSE131984_JQ1Pal	ENSG00000177697	977	CD151 molecule (Raph blood group)	PETA-3|RAPH|SFA-1|TSPAN24	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43149
1.21916565787162e-18	-0.300087184887876	0.766	0.843	1.92676940570031e-14	CMPK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000162368	51727	cytidine/uridine monophosphate kinase 1	CMPK|UMP-CMPK	protein_coding	P30085	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43150
1.24319965070654e-18	-0.302973352977224	0.451	0.628	1.96475272797662e-14	TTC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000113312	7265	tetratricopeptide repeat domain 1	TPR1	protein_coding	Q99614	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43151
1.28863660921306e-18	0.26218215556306	0.414	0.241	2.03656129720032e-14	MIB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000101752	57534	MIB E3 ubiquitin protein ligase 1	DIP-1|KIAA1323|MIB|ZZANK2|ZZZ6	protein_coding	Q86YT6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43152
1.51137577962005e-18	0.294516941904548	0.393	0.225	2.38857828211153e-14	METTL7A	Malignant cells	GSE131984_JQ1Pal	ENSG00000185432	25840	methyltransferase like 7A	DKFZP586A0522	protein_coding	Q9H8H3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43153
1.55917205983099e-18	-0.276537442080318	0.811	0.879	2.46411552335689e-14	MRPL54	Malignant cells	GSE131984_JQ1Pal	ENSG00000183617	116541	mitochondrial ribosomal protein L54	NA	protein_coding	Q6P161	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43154
1.56460192178332e-18	0.290574440854926	0.396	0.231	2.47269687718635e-14	HGSNAT	Malignant cells	GSE131984_JQ1Pal	ENSG00000165102	138050	heparan-alpha-glucosaminide N-acetyltransferase	FLJ32731|HGNAT|TMEM76	protein_coding	Q68CP4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43155
1.58510381839355e-18	-0.349656778124307	0.515	0.671	2.50509807458916e-14	NETO2	Malignant cells	GSE131984_JQ1Pal	ENSG00000171208	81831	neuropilin and tolloid like 2	FLJ10430|NEOT2	protein_coding	Q8NC67	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43156
1.73413611080424e-18	-0.331591418595987	0.525	0.675	2.74062870951502e-14	GTPBP4	Malignant cells	GSE131984_JQ1Pal	ENSG00000107937	23560	GTP binding protein 4	CRFG|FLJ10686|FLJ10690|NGB|NOG1	protein_coding	Q9BZE4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43157
1.76364780811301e-18	-0.341496077363812	0.392	0.551	2.78726899594179e-14	ZNF622	Malignant cells	GSE131984_JQ1Pal	ENSG00000173545	90441	zinc finger protein 622	MGC17552|MGC2485|ZPR9	protein_coding	Q969S3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43158
1.83949985548079e-18	-0.346943454594086	0.362	0.518	2.90714557160184e-14	NUPL1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43159
1.87035896422458e-18	-0.312592107009547	0.376	0.55	2.95591530706053e-14	RRP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000160214	8568	ribosomal RNA processing 1	D21S2056E|NNP-1|Nop52|RRP1A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43160
1.88522396141881e-18	0.299620012278376	0.523	0.349	2.97940794862628e-14	CHML	Malignant cells	GSE131984_JQ1Pal	ENSG00000203668	1122	CHM like Rab escort protein	REP-2	protein_coding	P26374	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43161
1.93652016796111e-18	-0.294718473267374	0.591	0.734	3.06047647344574e-14	BRMS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000174744	25855	BRMS1 transcriptional repressor and anoikis regulator	DKFZP564A063	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43162
1.99969396946077e-18	0.284413902462667	0.937	0.885	3.1603163493358e-14	EIF4B	Malignant cells	GSE131984_JQ1Pal	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43163
2.00565612042639e-18	-0.295527577738553	0.222	0.391	3.16973893272186e-14	TGFB1I1	Malignant cells	GSE131984_JQ1Pal	ENSG00000140682	7041	transforming growth factor beta 1 induced transcript 1	ARA55|Hic-5|TSC-5	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43164
2.0312773785655e-18	-0.281262648214067	0.169	0.329	3.21023076908492e-14	APOBEC3C	Malignant cells	GSE131984_JQ1Pal	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43165
2.03190773466532e-18	-0.3202698098033	0.842	0.902	3.21122698386508e-14	CAV2	Malignant cells	GSE131984_JQ1Pal	ENSG00000105971	858	caveolin 2	CAV	protein_coding	P51636	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43166
2.05505371338525e-18	-0.329918436954765	0.624	0.735	3.24780688863405e-14	HTATIP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000109854	10553	HIV-1 Tat interactive protein 2	CC3|FLJ26963|SDR44U1|TIP30	protein_coding	Q9BUP3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43167
2.07691914786018e-18	0.30371186146024	0.756	0.59	3.28236302127822e-14	HADHA	Malignant cells	GSE131984_JQ1Pal	ENSG00000084754	3030	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha	GBP|LCEH|LCHAD|MTPA	protein_coding	P40939	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43168
2.11758202303269e-18	-0.295115808280065	0.217	0.384	3.34662662920086e-14	PHLDA3	Malignant cells	GSE131984_JQ1Pal	ENSG00000174307	23612	pleckstrin homology like domain family A member 3	TIH1	protein_coding	Q9Y5J5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43169
2.16483132443214e-18	0.261098390046382	0.389	0.216	3.42129942513256e-14	CAMK2D	Malignant cells	GSE131984_JQ1Pal	ENSG00000145349	817	calcium/calmodulin dependent protein kinase II delta	CAMKD	protein_coding	Q13557	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43170
2.16627631087231e-18	-0.320944202518861	0.554	0.712	3.42358308170259e-14	POLR2G	Malignant cells	GSE131984_JQ1Pal	ENSG00000168002	5436	RNA polymerase II subunit G	hRPB19|hsRPB7|RPB7	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43171
2.18730645687662e-18	0.306678759500644	0.474	0.308	3.45681912444782e-14	BCAS4	Malignant cells	GSE131984_JQ1Pal	ENSG00000124243	55653	breast carcinoma amplified sequence 4	CNOL|FLJ20495	protein_coding	Q8TDM0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43172
2.25620265808678e-18	-0.305423270850429	0.398	0.571	3.56570268084034e-14	PREB	Malignant cells	GSE131984_JQ1Pal	ENSG00000138073	10113	prolactin regulatory element binding	SEC12	protein_coding	Q9HCU5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43173
2.35568325786847e-18	-0.256777679924414	0.175	0.338	3.72292182073532e-14	ISOC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000066583	51015	isochorismatase domain containing 1	CGI-111	protein_coding	Q96CN7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43174
2.3956277848205e-18	0.265370433194108	0.392	0.224	3.78605015113032e-14	ACAP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000131584	116983	ArfGAP with coiled-coil, ankyrin repeat and PH domains 3	CENTB5|KIAA1716	protein_coding	Q96P50	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43175
2.43196712489027e-18	-0.330785722544576	0.413	0.578	3.84348084417659e-14	DERL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000072849	51009	derlin 2	CGI-101|derlin-2|F-LAN-1|F-LANa|FLANa	protein_coding	Q9GZP9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43176
2.47487351041366e-18	-0.259226836443269	0.938	0.976	3.91129009585776e-14	PPP1CA	Malignant cells	GSE131984_JQ1Pal	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43177
2.54684716829994e-18	0.320510105150917	0.551	0.382	4.02503726478123e-14	WWTR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000018408	25937	WW domain containing transcription regulator 1	DKFZp586I1419|TAZ	protein_coding	Q9GZV5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43178
2.56966515934559e-18	-0.309840911731922	0.336	0.504	4.06109881782977e-14	NIP7	Malignant cells	GSE131984_JQ1Pal	ENSG00000132603	51388	nucleolar pre-rRNA processing protein NIP7	CGI-37|FLJ10296|HSPC031|KD93	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43179
2.59183229215273e-18	-0.32787168058767	0.566	0.699	4.09613175451817e-14	SFXN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000164466	94081	sideroflexin 1	FLJ12876|SLC56A1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43180
2.74881259061473e-18	0.287048059088418	0.365	0.205	4.34422341820751e-14	MYO9B	Malignant cells	GSE131984_JQ1Pal	ENSG00000099331	4650	myosin IXB	CELIAC4	protein_coding	Q13459	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43181
2.75331231548482e-18	-0.284195022941401	0.833	0.881	4.35133478339221e-14	ECHS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43182
2.84999621659861e-18	-0.282390089718944	0.981	0.992	4.50413402071244e-14	LMNA	Malignant cells	GSE131984_JQ1Pal	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43183
2.86689867776066e-18	-0.31420330889331	0.421	0.584	4.53084667033295e-14	OXCT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000083720	5019	3-oxoacid CoA-transferase 1	OXCT|SCOT	protein_coding	P55809	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43184
2.90577319820707e-18	0.30197806529931	0.903	0.844	4.59228396244646e-14	SEPT2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43185
2.91022167071703e-18	0.304774677040636	0.599	0.432	4.59931432840119e-14	ROCK2	Malignant cells	GSE131984_JQ1Pal	ENSG00000134318	9475	Rho associated coiled-coil containing protein kinase 2	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43186
2.96062098197881e-18	0.319303220557368	0.502	0.34	4.67896539991931e-14	TEX261	Malignant cells	GSE131984_JQ1Pal	ENSG00000144043	113419	testis expressed 261	MGC32043|TEG-261	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43187
3.08663967109966e-18	-0.327908984109136	0.636	0.746	4.8781253362059e-14	RRP36	Malignant cells	GSE131984_JQ1Pal	ENSG00000124541	88745	ribosomal RNA processing 36	C6orf153|dJ20C7.4	protein_coding	Q96EU6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43188
3.18901680237463e-18	0.293242045819324	0.438	0.269	5.03992215447286e-14	MBOAT2	Malignant cells	GSE131984_JQ1Pal	ENSG00000143797	129642	membrane bound O-acyltransferase domain containing 2	FLJ14415|FLJ90298|LPLAT13|OACT2	protein_coding	Q6ZWT7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43189
3.19101978258389e-18	0.310720280184861	0.946	0.899	5.04308766439557e-14	CHMP2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000130724	27243	charged multivesicular body protein 2A	BC-2|CHMP2|VPS2|VPS2A	protein_coding	O43633	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43190
3.20337040577161e-18	0.264701662946821	0.453	0.281	5.06260658928145e-14	TFDP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000114126	7029	transcription factor Dp-2	Dp-2	protein_coding	Q14188	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43191
3.25067395779659e-18	-0.343132691359159	0.553	0.687	5.13736512290173e-14	PPP1R7	Malignant cells	GSE131984_JQ1Pal	ENSG00000115685	5510	protein phosphatase 1 regulatory subunit 7	sds22	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43192
3.4810901558601e-18	0.304607368681756	0.856	0.735	5.50151488232131e-14	CTNNA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000044115	1495	catenin alpha 1	CAP102	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43193
3.563876699338e-18	0.289644657166454	0.656	0.473	5.63235073563377e-14	CITED2	Malignant cells	GSE131984_JQ1Pal	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43194
3.60643662317275e-18	0.287933996670358	0.512	0.337	5.69961243926222e-14	TP53TG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000182165	NA	NA	H_RG012D21.9|LINC00096|TP53AP1|TP53LC12	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43195
3.64208962686444e-18	0.296490464489574	0.644	0.468	5.75595844629657e-14	PIK3R1	Malignant cells	GSE131984_JQ1Pal	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43196
3.65615697935282e-18	-0.28511771691129	0.808	0.893	5.77819049016919e-14	ARL5A	Malignant cells	GSE131984_JQ1Pal	ENSG00000162980	26225	ADP ribosylation factor like GTPase 5A	ARL5	protein_coding	Q9Y689	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43197
3.75297706144079e-18	-0.403327867296989	0.246	0.404	5.93120494790103e-14	CCAT1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43198
3.76142644203628e-18	-0.316026782293867	0.522	0.667	5.94455834899413e-14	ABCE1	Malignant cells	GSE131984_JQ1Pal	ENSG00000164163	6059	ATP binding cassette subfamily E member 1	OABP|RLI|RLI1|RNASEL1|RNASELI|RNS4I	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43199
3.76248640052773e-18	-0.272220062971198	0.254	0.427	5.94623350739402e-14	KATNAL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000102781	84056	katanin catalytic subunit A1 like 1	MGC2599	protein_coding	Q9BW62	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43200
3.77509214807171e-18	0.353073479837374	0.634	0.468	5.96615563081252e-14	DUSP5	Malignant cells	GSE131984_JQ1Pal	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43201
4.00609627654622e-18	0.32464009191057	0.521	0.353	6.33123455545364e-14	CRIM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000277354	51232	cysteine rich transmembrane BMP regulator 1	S52	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43202
4.25919030333842e-18	0.296614163727625	0.854	0.748	6.73122435539604e-14	CCM2	Malignant cells	GSE131984_JQ1Pal	ENSG00000136280	83605	CCM2 scaffold protein	C7orf22|MGC4607|OSM	protein_coding	Q9BSQ5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43203
4.3003082795067e-18	-0.310561418360281	0.763	0.845	6.79620720493239e-14	PDLIM2	Malignant cells	GSE131984_JQ1Pal	ENSG00000120913	64236	PDZ and LIM domain 2	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43204
4.45156640563279e-18	-0.324201484243368	0.697	0.795	7.03525554746206e-14	ANXA11	Malignant cells	GSE131984_JQ1Pal	ENSG00000122359	311	annexin A11	ANX11	protein_coding	P50995	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43205
4.5463019985429e-18	0.32487021208086	0.857	0.755	7.1849756784972e-14	ANKRD11	Malignant cells	GSE131984_JQ1Pal	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43206
4.57536771944473e-18	0.281457252881652	0.459	0.285	7.23091114381045e-14	MXRA7	Malignant cells	GSE131984_JQ1Pal	ENSG00000182534	439921	matrix remodeling associated 7	FLJ46603|PS1TP1|TMAP1	protein_coding	P84157	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43207
4.63821592037976e-18	0.259432988113334	0.361	0.199	7.33023644056817e-14	PARVA	Malignant cells	GSE131984_JQ1Pal	ENSG00000197702	55742	parvin alpha	FLJ10793|FLJ12254|MXRA2	protein_coding	Q9NVD7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43208
5.01238044288026e-18	-0.316162124733765	0.429	0.574	7.92156605192796e-14	MIF4GD	Malignant cells	GSE131984_JQ1Pal	ENSG00000125457	57409	MIF4G domain containing	AD023|MGC45027|MIFD|SLIP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43209
5.03773237356389e-18	0.263997365621706	0.412	0.241	7.96163224318037e-14	PLXNA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000114554	5361	plexin A1	NOV|PLXN1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43210
5.21730362252676e-18	-0.391158593773758	0.5	0.648	8.24542664504128e-14	CTSL	Malignant cells	GSE131984_JQ1Pal	ENSG00000135047	1514	cathepsin L	CTSL1|FLJ31037	protein_coding	P07711	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43211
5.52847492498167e-18	0.330585872674855	0.644	0.491	8.73720177144103e-14	C1GALT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000106392	56913	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	C1GALT|T-synthase	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43212
5.5408602355572e-18	0.306558063485581	0.589	0.431	8.7567755162746e-14	MBD3	Malignant cells	GSE131984_JQ1Pal	ENSG00000071655	53615	methyl-CpG binding domain protein 3	NA	protein_coding	O95983	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43213
5.59803004789212e-18	-0.253755644048013	0.192	0.354	8.84712668768871e-14	NUP88	Malignant cells	GSE131984_JQ1Pal	ENSG00000108559	4927	nucleoporin 88	MGC8530	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43214
5.60118637904295e-18	-0.294668530322401	0.414	0.583	8.85211495343948e-14	AKIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000166452	56672	A-kinase interacting protein 1	BCA3|C11orf17	protein_coding	Q9NQ31	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43215
5.70341643744565e-18	-0.290225468324081	0.324	0.509	9.01367933773911e-14	CEP55	Malignant cells	GSE131984_JQ1Pal	ENSG00000138180	55165	centrosomal protein 55	C10orf3|CT111|FLJ10540	protein_coding	Q53EZ4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43216
5.72334731801653e-18	-0.315836091202939	0.431	0.596	9.04517810139332e-14	FARSB	Malignant cells	GSE131984_JQ1Pal	ENSG00000116120	10056	phenylalanyl-tRNA synthetase subunit beta	FARSLB|FRSB|PheHB	protein_coding	Q9NSD9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43217
5.78807496324939e-18	0.377276249761125	0.497	0.334	9.14747367191934e-14	VCAN	Malignant cells	GSE131984_JQ1Pal	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43218
6.53939760459543e-18	-0.294924973078145	0.281	0.45	1.03348639743026e-13	MED30	Malignant cells	GSE131984_JQ1Pal	ENSG00000164758	90390	mediator complex subunit 30	THRAP6|TRAP25	protein_coding	Q96HR3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43219
6.55320255153473e-18	0.274112684262905	0.264	0.119	1.03566813124455e-13	SDPR	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43220
6.8674335952589e-18	-0.257700207502736	0.202	0.369	1.08532920539472e-13	AAAS	Malignant cells	GSE131984_JQ1Pal	ENSG00000094914	8086	aladin WD repeat nucleoporin	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43221
7.38619534599494e-18	0.282267105527816	0.427	0.259	1.16731431248104e-13	SPG7	Malignant cells	GSE131984_JQ1Pal	ENSG00000197912	6687	SPG7 matrix AAA peptidase subunit, paraplegin	CAR|CMAR|SPG5C	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43222
7.64649476792516e-18	0.285771407923402	0.468	0.296	1.20845203312289e-13	RP6-99M1.2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43223
7.95230584789878e-18	-0.279448637689139	0.304	0.477	1.25678241620192e-13	WARS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43224
8.28875912281642e-18	-0.303640770194425	0.822	0.877	1.30995549176991e-13	CTNNAL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000119326	8727	catenin alpha like 1	alpha-CATU|CLLP	protein_coding	Q9UBT7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43225
8.89729639236952e-18	0.276264584360619	0.472	0.303	1.40612872185008e-13	GNA12	Malignant cells	GSE131984_JQ1Pal	ENSG00000146535	2768	G protein subunit alpha 12	gep	protein_coding	Q03113	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43226
9.20168481156057e-18	0.281475317279139	0.502	0.332	1.45423426761903e-13	STK4	Malignant cells	GSE131984_JQ1Pal	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43227
9.52804406288625e-18	0.251228371879979	0.314	0.162	1.50581208369854e-13	TEX2	Malignant cells	GSE131984_JQ1Pal	ENSG00000136478	55852	testis expressed 2	HT008|KIAA1738|TMEM96	protein_coding	Q8IWB9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43228
9.68632227597217e-18	0.345642144139454	0.484	0.316	1.53082637249464e-13	GAS6	Malignant cells	GSE131984_JQ1Pal	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43229
9.90903715368262e-18	0.32616702208259	0.666	0.504	1.566024231768e-13	FADS3	Malignant cells	GSE131984_JQ1Pal	ENSG00000221968	3995	fatty acid desaturase 3	CYB5RP|LLCDL3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43230
9.93677284485883e-18	-0.287921464364999	0.79	0.9	1.57040758040149e-13	HSPB11	Malignant cells	GSE131984_JQ1Pal	ENSG00000081870	51668	heat shock protein family B (small) member 11	C1orf41|FAP232|HSPCO34|IFT25|PP25	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43231
1.09387581003683e-17	0.272149228217301	0.449	0.281	1.7287613301822e-13	CTC-503J8.6	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43232
1.09753025353605e-17	-0.315924785690125	0.349	0.515	1.73453681268837e-13	DDX56	Malignant cells	GSE131984_JQ1Pal	ENSG00000136271	54606	DEAD-box helicase 56	NOH61	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43233
1.1785359962527e-17	-0.30339363267153	0.612	0.742	1.86255828847777e-13	MANBAL	Malignant cells	GSE131984_JQ1Pal	ENSG00000101363	63905	mannosidase beta like	dJ1141E15.2	protein_coding	Q9NQG1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43234
1.20019909335417e-17	-0.303785769257018	0.393	0.56	1.89679464713693e-13	MSRB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000198736	51734	methionine sulfoxide reductase B1	SELENOR|SELENOX|SelR|SelX|SepR|SEPX1	protein_coding	Q9NZV6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43235
1.23832245534175e-17	-0.294565895926965	0.176	0.334	1.9570448084221e-13	C1GALT1C1	Malignant cells	GSE131984_JQ1Pal	ENSG00000288368	29071	C1GALT1 specific chaperone 1	C1GALT2|COSMC	protein_coding	Q96EU7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43236
1.36500888415835e-17	-0.268677426636415	0.783	0.849	2.15726004052386e-13	UBE2K	Malignant cells	GSE131984_JQ1Pal	ENSG00000078140	3093	ubiquitin conjugating enzyme E2 K	HIP2|HYPG|UBC1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43237
1.45688472497905e-17	0.275724534144183	0.462	0.292	2.30246061935689e-13	SRD5A3	Malignant cells	GSE131984_JQ1Pal	ENSG00000128039	79644	steroid 5 alpha-reductase 3	FLJ13352|SRD5A2L|SRD5A2L1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43238
1.470566610083e-17	-0.34074105666377	0.328	0.495	2.32408347057518e-13	CD55	Malignant cells	GSE131984_JQ1Pal	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43239
1.62088206652673e-17	-0.335397211611834	0.527	0.659	2.56164201793884e-13	NARS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43240
1.66218181067392e-17	-0.284726011966477	0.231	0.392	2.62691213358906e-13	COQ5	Malignant cells	GSE131984_JQ1Pal	ENSG00000110871	84274	coenzyme Q5, methyltransferase	MGC4767	protein_coding	Q5HYK3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43241
1.85077040549641e-17	-0.400387818480909	0.783	0.836	2.92495754884653e-13	SNORA76	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43242
1.91629457973751e-17	-0.313787875864483	0.475	0.621	3.02851195381716e-13	NMRAL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000274684	57407	NmrA like redox sensor 1	FLJ25918|HSCARG|SDR48A1	protein_coding	Q9HBL8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43243
2.37214211314586e-17	-0.291195885220647	0.398	0.564	3.74893339561572e-13	CEP57	Malignant cells	GSE131984_JQ1Pal	ENSG00000166037	9702	centrosomal protein 57	KIAA0092|Translokin|TSP57	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43244
2.43032725614713e-17	-0.264685677097324	0.19	0.348	3.84088919561492e-13	C12orf73	Malignant cells	GSE131984_JQ1Pal	ENSG00000204954	728568	chromosome 12 open reading frame 73	BRAWNIN|DKFZp547P055|FLJ13975	protein_coding	Q69YU5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43245
2.44564248356058e-17	0.327418735496292	0.606	0.46	3.86509338101914e-13	TMTC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000133687	83857	transmembrane O-mannosyltransferase targeting cadherins 1	ARG99|FLJ31400|FLJ41625|OLF	protein_coding	Q8IUR5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43246
2.53924930480408e-17	-0.280575715686437	0.248	0.415	4.01302960131237e-13	NKX2-5	Malignant cells	GSE131984_JQ1Pal	ENSG00000183072	1482	NK2 homeobox 5	CSX|CSX1|NKX2.5|NKX2E|NKX4-1	protein_coding	P52952	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43247
2.65194478186812e-17	-0.25941277732496	0.834	0.899	4.19113353326438e-13	NDUFA8	Malignant cells	GSE131984_JQ1Pal	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43248
2.70698051723882e-17	-0.335994350167353	0.532	0.672	4.27811200944423e-13	RABEP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000029725	9135	rabaptin, RAB GTPase binding effector protein 1	neurocrescin|RAB5EP|rabaptin-5|RABPT5	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43249
2.72404584248815e-17	-0.283245082334195	0.314	0.482	4.30508204946828e-13	ASUN	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43250
2.87182292882448e-17	-0.316912597614168	0.47	0.624	4.5386289567142e-13	BAG2	Malignant cells	GSE131984_JQ1Pal	ENSG00000112208	9532	BAG cochaperone 2	NA	protein_coding	O95816	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43251
2.93317722701116e-17	0.29725916711768	0.505	0.343	4.63559328956843e-13	CLSTN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000171603	22883	calsyntenin 1	CDHR12|CSTN1|KIAA0911	protein_coding	O94985	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43252
2.98350275468672e-17	-0.401317762866091	0.85	0.894	4.71512775350689e-13	CEBPD	Malignant cells	GSE131984_JQ1Pal	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43253
3.14510712624134e-17	-0.275539235754587	0.186	0.343	4.97052730231181e-13	FANCB	Malignant cells	GSE131984_JQ1Pal	ENSG00000181544	2187	FA complementation group B	FAAP95|FAB|FLJ34064	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43254
3.34527321060194e-17	0.271545392971936	0.943	0.897	5.2868697820353e-13	RGS10	Malignant cells	GSE131984_JQ1Pal	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43255
3.40126144037391e-17	0.271158186322884	0.603	0.425	5.37535358036692e-13	KLF10	Malignant cells	GSE131984_JQ1Pal	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43256
3.41573878274569e-17	-0.253684596574151	0.879	0.925	5.39823357225129e-13	TSR3	Malignant cells	GSE131984_JQ1Pal	ENSG00000007520	115939	TSR3 ribosome maturation factor	C16orf42|MGC24381	protein_coding	Q9UJK0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43257
3.47542972220388e-17	-0.316189335383449	0.604	0.719	5.49256913297101e-13	EXOSC4	Malignant cells	GSE131984_JQ1Pal	ENSG00000178896	54512	exosome component 4	FLJ20591|hRrp41p|p12A|RRP41|RRP41A|Rrp41p|SKI6|Ski6p	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43258
3.64264214446983e-17	-0.261899067247509	0.302	0.477	5.75683164512013e-13	NOL12	Malignant cells	GSE131984_JQ1Pal	ENSG00000273899	79159	nucleolar protein 12	MGC3731|Nop25|RRP17	protein_coding	Q9UGY1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43259
3.87583197247408e-17	-0.338973369677803	0.669	0.768	6.12536484929804e-13	DNAJC9	Malignant cells	GSE131984_JQ1Pal	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43260
3.95688325781594e-17	-0.342721048186362	0.421	0.572	6.25345830065231e-13	CEBPG	Malignant cells	GSE131984_JQ1Pal	ENSG00000153879	1054	CCAAT enhancer binding protein gamma	GPE1BP|IG/EBP-1	protein_coding	P53567	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43261
4.03231385981306e-17	-0.319207800347157	0.449	0.602	6.37266882404856e-13	TCOF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000070814	6949	treacle ribosome biogenesis factor 1	TCS|treacle	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43262
4.04629756529701e-17	-0.299716850667066	0.736	0.828	6.3947686721954e-13	SKA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000182628	348235	spindle and kinetochore associated complex subunit 2	FAM33A|FLJ12758	protein_coding	Q8WVK7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43263
4.1346575472551e-17	-0.330235586461257	0.562	0.682	6.53441278768196e-13	THOC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000125676	57187	THO complex subunit 2	CXorf3|dJ506G2.1|MRX12|MRX35|THO2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43264
4.13574299526812e-17	-0.272261318781003	0.234	0.398	6.53612822972174e-13	GMPPA	Malignant cells	GSE131984_JQ1Pal	ENSG00000144591	29926	GDP-mannose pyrophosphorylase A	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43265
4.25339790198114e-17	-0.336853570059008	0.458	0.602	6.722070044291e-13	MPP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000130830	4354	MAGUK p55 scaffold protein 1	DXS552E|PEMP	protein_coding	Q00013	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43266
4.37804907927311e-17	0.254025823914452	0.416	0.247	6.91906876488323e-13	RNPEPL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000142327	57140	arginyl aminopeptidase like 1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43267
4.47008390598228e-17	-0.365181658923671	0.517	0.64	7.06452060501439e-13	HSPH1	Malignant cells	GSE131984_JQ1Pal	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43268
4.47708377219513e-17	0.259481284314987	0.965	0.937	7.07558319357719e-13	FIS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43269
4.47776940852514e-17	-0.429716494020536	0.39	0.535	7.07666677323313e-13	SNAPC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000023608	6617	small nuclear RNA activating complex polypeptide 1	PTFgamma|SNAP43	protein_coding	Q16533	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43270
4.55590016356868e-17	-0.304031899402525	0.771	0.834	7.20014461850394e-13	NUDT21	Malignant cells	GSE131984_JQ1Pal	ENSG00000167005	11051	nudix hydrolase 21	CFIM25|CPSF5	protein_coding	O43809	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43271
4.86087998291268e-17	-0.284295103251474	0.286	0.449	7.68213472499521e-13	ELOVL6	Malignant cells	GSE131984_JQ1Pal	ENSG00000170522	79071	ELOVL fatty acid elongase 6	FLJ23378|LCE|MGC5487	protein_coding	Q9H5J4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43272
5.07212338171232e-17	0.296537783513026	0.572	0.418	8.01598379245816e-13	AKAP13	Malignant cells	GSE131984_JQ1Pal	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43273
5.4804682198528e-17	0.333690246636907	0.483	0.312	8.66133197465537e-13	GDA	Malignant cells	GSE131984_JQ1Pal	ENSG00000119125	9615	guanine deaminase	CYPIN|GAH	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43274
5.69613464630018e-17	-0.322474595322043	0.551	0.679	9.00217119501281e-13	CCDC167	Malignant cells	GSE131984_JQ1Pal	ENSG00000198937	154467	coiled-coil domain containing 167	C6orf129|dJ153P14.2	protein_coding	Q9P0B6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43275
5.87207935359599e-17	-0.253853021221465	0.24	0.409	9.2802342104231e-13	MRPL46	Malignant cells	GSE131984_JQ1Pal	ENSG00000259494	26589	mitochondrial ribosomal protein L46	C15orf4|LIECG2|P2ECSL	protein_coding	Q9H2W6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43276
6.12218148818088e-17	0.284445712111762	0.783	0.64	9.67549562392106e-13	C5orf24	Malignant cells	GSE131984_JQ1Pal	ENSG00000181904	134553	chromosome 5 open reading frame 24	FLJ37562	protein_coding	Q7Z6I8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43277
6.16429100832183e-17	-0.298695572723976	0.683	0.794	9.74204550955181e-13	FAM204A	Malignant cells	GSE131984_JQ1Pal	ENSG00000165669	63877	family with sequence similarity 204 member A	bA319I23.1|C10orf84|FLJ13188	protein_coding	Q9H8W3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43278
6.40869734762939e-17	-0.254300306270602	0.911	0.953	1.01283052881935e-12	KIF5B	Malignant cells	GSE131984_JQ1Pal	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43279
6.44018590400185e-17	0.27157368090423	0.447	0.282	1.01780698026845e-12	SERTAD2	Malignant cells	GSE131984_JQ1Pal	ENSG00000179833	9792	SERTA domain containing 2	KIAA0127|Sei-2|TRIP-Br2	protein_coding	Q14140	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43280
6.48714492548353e-17	-0.258235929875987	0.231	0.394	1.02522838402342e-12	TIMM21	Malignant cells	GSE131984_JQ1Pal	ENSG00000075336	29090	translocase of inner mitochondrial membrane 21	C18orf55|HSPC154|TIM21	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43281
6.8233752616566e-17	-0.289364906769997	0.348	0.508	1.07836622635221e-12	NTHL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000065057	4913	nth like DNA glycosylase 1	NTH1|OCTS3	protein_coding	P78549	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43282
7.06681110985258e-17	-0.555110773469844	0.321	0.48	1.1168388278011e-12	CDK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43283
7.23734108986156e-17	-0.293111766015086	0.315	0.474	1.14378938584172e-12	CENPU	Malignant cells	GSE131984_JQ1Pal	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43284
7.69538842839905e-17	0.281619872223766	0.467	0.303	1.21617918722419e-12	WDR26	Malignant cells	GSE131984_JQ1Pal	ENSG00000162923	80232	WD repeat domain 26	FLJ21016|GID7	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43285
7.85915230416251e-17	0.287882760211663	0.442	0.285	1.24206043014984e-12	SLC30A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000170385	7779	solute carrier family 30 member 1	ZNT1|ZRC1	protein_coding	Q9Y6M5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43286
8.38560100158086e-17	-0.291995813603012	0.301	0.464	1.32526038228984e-12	CCDC137	Malignant cells	GSE131984_JQ1Pal	ENSG00000185298	339230	coiled-coil domain containing 137	MGC16597	protein_coding	Q6PK04	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43287
8.61634841934845e-17	-0.291978273344401	0.657	0.764	1.36172770419383e-12	PRPF31	Malignant cells	GSE131984_JQ1Pal	ENSG00000274651	26121	pre-mRNA processing factor 31	hPrp31|NY-BR-99|PRP31|RP11|SNRNP61	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43288
8.68545929368633e-17	-0.313960004366852	0.457	0.628	1.37264998677419e-12	PRC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000198901	9055	protein regulator of cytokinesis 1	ASE1	protein_coding	O43663	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43289
8.97469532159263e-17	-0.289777988353194	0.365	0.528	1.4183608486245e-12	C12orf29	Malignant cells	GSE131984_JQ1Pal	ENSG00000133641	91298	chromosome 12 open reading frame 29	DKFZp434N2030	protein_coding	Q8N999	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43290
9.3489826732739e-17	0.276061447675552	0.438	0.275	1.47751322168421e-12	FMNL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000157827	114793	formin like 2	FHOD2|KIAA1902	protein_coding	Q96PY5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43291
9.35341792117058e-17	0.302043782529167	0.588	0.421	1.4782141682618e-12	ALDH3A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000072210	224	aldehyde dehydrogenase 3 family member A2	ALDH10|FALDH|SLS	protein_coding	P51648	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43292
9.92906796949791e-17	0.25279822010821	0.425	0.262	1.56918990189945e-12	C9orf69	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43293
1.00441866998171e-16	-0.275043844365215	0.302	0.465	1.58738326603909e-12	HDAC8	Malignant cells	GSE131984_JQ1Pal	ENSG00000147099	55869	histone deacetylase 8	HDACL1|KDAC8|MRXS6|RPD3|WTS	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43294
1.02925203024486e-16	-0.335190853154374	0.665	0.764	1.62662990859898e-12	LCP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43295
1.04117986804442e-16	0.290869426893692	0.473	0.311	1.64548066345741e-12	SLC26A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000155850	1836	solute carrier family 26 member 2	DTD|DTDST	protein_coding	P50443	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43296
1.05174386022316e-16	-0.278287005240134	0.308	0.467	1.66217599669668e-12	PIGC	Malignant cells	GSE131984_JQ1Pal	ENSG00000135845	5279	phosphatidylinositol glycan anchor biosynthesis class C	NA	protein_coding	Q92535	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43297
1.09832672213282e-16	-0.381471980685177	0.441	0.582	1.7357955516587e-12	CTA-29F11.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43298
1.12099428883729e-16	0.271639845917927	0.461	0.298	1.77161937407845e-12	KLF13	Malignant cells	GSE131984_JQ1Pal	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43299
1.13907616652032e-16	-0.27236700685408	0.308	0.47	1.80019597356872e-12	THAP11	Malignant cells	GSE131984_JQ1Pal	ENSG00000168286	57215	THAP domain containing 11	CTG-B43a|CTG-B45d|HRIHFB2206|RONIN	protein_coding	Q96EK4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43300
1.16106197782631e-16	-0.291122959579516	0.252	0.408	1.83494234975671e-12	PNP	Malignant cells	GSE131984_JQ1Pal	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43301
1.17153268740103e-16	-0.275642008125138	0.698	0.807	1.85149025916859e-12	PARL	Malignant cells	GSE131984_JQ1Pal	ENSG00000175193	55486	presenilin associated rhomboid like	PRO2207|PSARL|PSARL1|RHBDS1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43302
1.18618007384414e-16	0.257933185515342	0.606	0.436	1.87463898870328e-12	SCARB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000138760	950	scavenger receptor class B member 2	CD36L2|HLGP85|LIMP-2|LIMPII|SR-BII	protein_coding	Q14108	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43303
1.23744752206948e-16	-0.26824319651181	0.215	0.372	1.95566206387861e-12	DRG2	Malignant cells	GSE131984_JQ1Pal	ENSG00000108591	1819	developmentally regulated GTP binding protein 2	NA	protein_coding	P55039	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43304
1.28163562003974e-16	0.275249215132695	0.55	0.384	2.0254969339108e-12	CDH2	Malignant cells	GSE131984_JQ1Pal	ENSG00000170558	1000	cadherin 2	CD325|CDHN|NCAD	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43305
1.37115806318298e-16	0.260350338753357	0.49	0.321	2.16697820305438e-12	WIPF2	Malignant cells	GSE131984_JQ1Pal	ENSG00000171475	147179	WAS/WASL interacting protein family member 2	WICH|WIRE	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43306
1.49043371723767e-16	-0.283368826197333	0.808	0.887	2.35548144672241e-12	TMEM50A	Malignant cells	GSE131984_JQ1Pal	ENSG00000183726	23585	transmembrane protein 50A	SMP1	protein_coding	O95807	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43307
1.55078030644867e-16	0.333805613127077	0.862	0.801	2.45085319631148e-12	ISCA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43308
1.58712021672808e-16	-0.261305123564725	0.35	0.514	2.50828479051706e-12	TSPAN17	Malignant cells	GSE131984_JQ1Pal	ENSG00000048140	26262	tetraspanin 17	FBX23|FBXO23|TM4SF17	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43309
1.60562466180395e-16	-0.269025849739605	0.237	0.404	2.53752921551497e-12	STARD4-AS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000246859	100505678	STARD4 antisense RNA 1	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43310
1.62986707227228e-16	0.278105642281769	0.912	0.841	2.57584192101911e-12	TMEM230	Malignant cells	GSE131984_JQ1Pal	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43311
1.72776935964035e-16	-0.266820561187919	0.254	0.414	2.73056669597562e-12	MED11	Malignant cells	GSE131984_JQ1Pal	ENSG00000161920	400569	mediator complex subunit 11	HSPC296|MGC88387	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43312
1.77712560481798e-16	-0.300875119871095	0.853	0.887	2.80856930585434e-12	SFPQ	Malignant cells	GSE131984_JQ1Pal	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43313
1.81076016211101e-16	-0.300628019653726	0.402	0.561	2.86172536020023e-12	AVPI1	Malignant cells	GSE131984_JQ1Pal	ENSG00000119986	60370	arginine vasopressin induced 1	PP5395|VIP32|VIT32	protein_coding	Q5T686	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43314
1.87048846996172e-16	0.261284682200945	0.403	0.243	2.9561199779275e-12	HIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000127946	3092	huntingtin interacting protein 1	ILWEQ	protein_coding	O00291	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43315
1.87687803937154e-16	-0.321894259731675	0.63	0.736	2.96621805342278e-12	CCDC107	Malignant cells	GSE131984_JQ1Pal	ENSG00000159884	203260	coiled-coil domain containing 107	MGC31967	protein_coding	Q8WV48	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43316
1.90518359256705e-16	-0.273164212018712	0.226	0.382	3.01095214969296e-12	MCM5	Malignant cells	GSE131984_JQ1Pal	ENSG00000100297	4174	minichromosome maintenance complex component 5	CDC46	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43317
1.94212356796118e-16	-0.299788131827232	0.438	0.586	3.06933208680586e-12	SCAMP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000263290	10067	secretory carrier membrane protein 3	C1orf3	protein_coding	O14828	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43318
2.33260766696639e-16	-0.30565877910576	0.688	0.785	3.68645315687368e-12	TIMM9	Malignant cells	GSE131984_JQ1Pal	ENSG00000100575	26520	translocase of inner mitochondrial membrane 9	TIM9A	protein_coding	Q9Y5J7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43319
2.48618913285568e-16	-0.297729272882177	0.69	0.78	3.92917330556512e-12	NUBP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000095906	10101	NUBP iron-sulfur cluster assembly factor 2, cytosolic	CFD1|CIAO6	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43320
2.49808194038799e-16	-0.291861103735297	0.58	0.694	3.94796869858919e-12	DAP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000132676	7818	death associated protein 3	bMRP-10|DAP-3|DKFZp686G12159|MGC126058|MGC126059|MRP-S29|MRPS29	protein_coding	P51398	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43321
2.55032125152633e-16	-0.262518672870737	0.346	0.51	4.03052770591221e-12	RP11-139H15.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43322
2.63250168098012e-16	-0.256652822611032	0.213	0.369	4.16040565662098e-12	NFKBIB	Malignant cells	GSE131984_JQ1Pal	ENSG00000282905	4793	NFKB inhibitor beta	IKBB|TRIP9	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43323
2.66041791438033e-16	0.260265725689734	0.455	0.292	4.20452447188667e-12	B4GALT5	Malignant cells	GSE131984_JQ1Pal	ENSG00000158470	9334	beta-1,4-galactosyltransferase 5	beta4GalT-V	protein_coding	O43286	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43324
2.66378249303538e-16	0.31298390097596	0.882	0.836	4.20984185199312e-12	PROCR	Malignant cells	GSE131984_JQ1Pal	ENSG00000101000	10544	protein C receptor	CCD41|CD201|EPCR	protein_coding	Q9UNN8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43325
2.97703383155155e-16	-0.278466671852214	0.833	0.88	4.70490426738407e-12	SEC62	Malignant cells	GSE131984_JQ1Pal	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43326
3.04369114960421e-16	-0.319067107357329	0.333	0.484	4.81024949283449e-12	ACTR10	Malignant cells	GSE131984_JQ1Pal	ENSG00000131966	55860	actin related protein 10	ACTR11|Arp10|Arp11|HARP11	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43327
3.09063721204819e-16	-0.2939764288422	0.533	0.668	4.88444304992095e-12	BRD7	Malignant cells	GSE131984_JQ1Pal	ENSG00000166164	29117	bromodomain containing 7	BP75|CELTIX1|SMARCI1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43328
3.13933804688713e-16	-0.283829236298859	0.764	0.837	4.96140984930043e-12	AGPAT2	Malignant cells	GSE131984_JQ1Pal	ENSG00000169692	10555	1-acylglycerol-3-phosphate O-acyltransferase 2	BSCL|LPAAT-beta|LPLAT2	protein_coding	O15120	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43329
3.16918413507541e-16	0.266751116773964	0.6	0.441	5.00857860707318e-12	URI1	Malignant cells	GSE131984_JQ1Pal	ENSG00000105176	8725	URI1 prefoldin like chaperone	C19orf2|FLJ10575|NNX3|PPP1R19|RMP|URI	protein_coding	O94763	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43330
3.20398651546904e-16	-0.331571636584388	0.513	0.641	5.06358028904727e-12	STIP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43331
3.33611482470452e-16	-0.319261027737806	0.606	0.726	5.27239586896303e-12	MESDC2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43332
3.69424442953356e-16	0.258294109463364	0.497	0.329	5.83838389643483e-12	MACF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43333
3.70938908837403e-16	-0.278210290165019	0.911	0.941	5.86231851526632e-12	CALD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000122786	800	caldesmon 1	CDM|H-CAD|h-CD|L-CAD	protein_coding	Q05682	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43334
3.72536577766339e-16	-0.275139055897778	0.327	0.486	5.88756807501923e-12	CXorf40B	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43335
3.81847008747517e-16	0.254464479222384	0.991	0.985	6.03471012624576e-12	ACP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000143727	52	acid phosphatase 1	HAAP|LMW-PTP|LMWPTP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43336
4.23883140371111e-16	0.305912072156604	0.813	0.671	6.69904915042504e-12	C9orf3	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43337
4.41590987251015e-16	0.26575992166734	0.548	0.379	6.97890396251503e-12	TNRC6B	Malignant cells	GSE131984_JQ1Pal	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43338
4.5188500880217e-16	0.278058714017975	0.561	0.399	7.14159067910949e-12	LRPPRC	Malignant cells	GSE131984_JQ1Pal	ENSG00000138095	10128	leucine rich pentatricopeptide repeat containing	GP130|LRP130|LSFC	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43339
4.56078682102678e-16	-0.371967903174095	0.591	0.696	7.20786749195073e-12	AIMP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000106305	7965	aminoacyl tRNA synthetase complex interacting multifunctional protein 2	JTV-1|JTV1|p38|PRO0992	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43340
4.58447641251413e-16	0.310072314035223	0.479	0.327	7.24530652233733e-12	MET	Malignant cells	GSE131984_JQ1Pal	ENSG00000105976	4233	MET proto-oncogene, receptor tyrosine kinase	DFNB97|HGFR|RCCP2	protein_coding	P08581	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43341
4.93561280257575e-16	0.259088532552321	0.433	0.272	7.80024247319072e-12	SAMD4B	Malignant cells	GSE131984_JQ1Pal	ENSG00000179134	55095	sterile alpha motif domain containing 4B	FLJ10211|hSmaug2|MGC99832|SMGB	protein_coding	Q5PRF9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43342
4.96905313740833e-16	-0.302386827379055	0.364	0.516	7.85309157836013e-12	PDCL3	Malignant cells	GSE131984_JQ1Pal	ENSG00000115539	79031	phosducin like 3	VIAF1	protein_coding	Q9H2J4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43343
5.00309485469842e-16	-0.318849366898571	0.402	0.544	7.90689110836538e-12	GOSR2	Malignant cells	GSE131984_JQ1Pal	ENSG00000108433	9570	golgi SNAP receptor complex member 2	Bos1|GS27	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43344
5.45960861326578e-16	-0.271821940270676	0.772	0.846	8.62836545240523e-12	CCDC34	Malignant cells	GSE131984_JQ1Pal	ENSG00000109881	91057	coiled-coil domain containing 34	L15|NY-REN-41|RAMA3	protein_coding	Q96HJ3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43345
5.57243041091118e-16	-0.259438896288426	0.275	0.436	8.80666902140403e-12	UNK	Malignant cells	GSE131984_JQ1Pal	ENSG00000132478	85451	unk zinc finger	KIAA1753|ZC3H5|ZC3HDC5	protein_coding	Q9C0B0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43346
5.75580278585028e-16	0.280067957752443	0.439	0.285	9.09647072275778e-12	KMT2C	Malignant cells	GSE131984_JQ1Pal	ENSG00000055609	58508	lysine methyltransferase 2C	HALR|KIAA1506|MLL3	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43347
5.75788449452476e-16	-0.318313899111711	0.488	0.62	9.09976065514692e-12	SAR1B	Malignant cells	GSE131984_JQ1Pal	ENSG00000152700	51128	secretion associated Ras related GTPase 1B	SARA2	protein_coding	Q9Y6B6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43348
5.85809507170204e-16	-0.309414444016042	0.591	0.705	9.25813345131791e-12	GNAI3	Malignant cells	GSE131984_JQ1Pal	ENSG00000065135	2773	G protein subunit alpha i3	87U6	protein_coding	P08754	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43349
5.8880391753155e-16	-0.289753823336935	0.599	0.716	9.30545711266861e-12	MFSD10	Malignant cells	GSE131984_JQ1Pal	ENSG00000109736	10227	major facilitator superfamily domain containing 10	IT10C3|TETRAN	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43350
6.01856535130263e-16	-0.269811513149399	0.203	0.356	9.51174068119868e-12	LMNB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43351
6.04541369706157e-16	-0.255565327554012	0.273	0.434	9.5541718068361e-12	MPDU1	Malignant cells	GSE131984_JQ1Pal	ENSG00000129255	9526	mannose-P-dolichol utilization defect 1	CDGIf|Lec35|PQLC5|SL15|SLC66A5	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43352
6.18928625462531e-16	-0.26601215129507	0.489	0.647	9.78154799680984e-12	CHCHD6	Malignant cells	GSE131984_JQ1Pal	ENSG00000159685	84303	coiled-coil-helix-coiled-coil-helix domain containing 6	CHCM1|MGC13016|Mic25|MICOS25|PPP1R23	protein_coding	Q9BRQ6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43353
6.95281157387458e-16	0.290445050380984	0.946	0.91	1.09882234113514e-11	CAMLG	Malignant cells	GSE131984_JQ1Pal	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43354
7.09106365619178e-16	-0.260944282019524	0.745	0.826	1.12067170022455e-11	TMEM59	Malignant cells	GSE131984_JQ1Pal	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43355
7.11984338609056e-16	-0.287546112771147	0.313	0.472	1.12522004873775e-11	UNC50	Malignant cells	GSE131984_JQ1Pal	ENSG00000115446	25972	unc-50 inner nuclear membrane RNA binding protein	GMH1|UNCL|URP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43356
7.20034451126111e-16	-0.290009557302015	0.801	0.862	1.13794244655971e-11	BZW2	Malignant cells	GSE131984_JQ1Pal	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43357
7.64304332857245e-16	-0.279860256794661	0.243	0.401	1.20790656764759e-11	GLUL	Malignant cells	GSE131984_JQ1Pal	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43358
7.81254708888403e-16	-0.264428164952125	0.256	0.409	1.23469494192723e-11	PPP2R3C	Malignant cells	GSE131984_JQ1Pal	ENSG00000092020	55012	protein phosphatase 2 regulatory subunit B''gamma	C14orf10|FLJ20644|G4-1|G5PR	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43359
8.13941925112598e-16	0.296371895865611	0.615	0.46	1.28635381844795e-11	FYTTD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000122068	84248	forty-two-three domain containing 1	DKFZp761B1514|UIF	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43360
8.14094170009421e-16	-0.306595705658905	0.601	0.722	1.28659442628289e-11	AIG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000146416	51390	androgen induced 1	AIG-1|dJ95L4.1|FLJ10485	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43361
8.23897298184387e-16	-0.30558852767741	0.404	0.551	1.30208729005061e-11	MCMBP	Malignant cells	GSE131984_JQ1Pal	ENSG00000197771	79892	minichromosome maintenance complex binding protein	C10orf119|FLJ13081|MCM-BP	protein_coding	Q9BTE3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43362
8.54303023821385e-16	-0.326334755405047	0.357	0.5	1.35014049884732e-11	PPAN	Malignant cells	GSE131984_JQ1Pal	ENSG00000130810	56342	peter pan homolog	BXDC3|SSF|SSF1|SSF2	protein_coding	Q9NQ55	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43363
8.76672255849196e-16	-0.27727686999476	0.472	0.627	1.38549283314407e-11	C12orf44	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43364
9.17320548168102e-16	0.264789165391625	0.604	0.44	1.44973339432487e-11	PICALM	Malignant cells	GSE131984_JQ1Pal	ENSG00000073921	8301	phosphatidylinositol binding clathrin assembly protein	CALM|CLTH	protein_coding	Q13492	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43365
9.17612026151738e-16	0.283072187988275	0.896	0.778	1.45019404613021e-11	TNPO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000083312	3842	transportin 1	IPO2|KPNB2|MIP|MIP1|TRN	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43366
9.7037372311387e-16	-0.359484597807922	0.65	0.719	1.53357863200916e-11	GPX8	Malignant cells	GSE131984_JQ1Pal	ENSG00000164294	493869	glutathione peroxidase 8 (putative)	EPLA847|UNQ847	protein_coding	Q8TED1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43367
1.04005236541218e-15	-0.282548318656009	0.392	0.551	1.64369875829741e-11	EID2	Malignant cells	GSE131984_JQ1Pal	ENSG00000176396	163126	EP300 interacting inhibitor of differentiation 2	CRI2|EID-2|MGC20452	protein_coding	Q8N6I1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43368
1.14981451348639e-15	-0.33200749213924	0.612	0.703	1.81716685711389e-11	PSMD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43369
1.15760733350182e-15	-0.290299522942114	0.21	0.36	1.82948262986628e-11	PLRG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000171566	5356	pleiotropic regulator 1	Cwc1|PRL1|Prp46|PRPF46|TANGO4	protein_coding	O43660	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43370
1.20207262980932e-15	-0.291136110405909	0.812	0.861	1.89975558415066e-11	EZR	Malignant cells	GSE131984_JQ1Pal	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43371
1.20576017330369e-15	-0.277209774639237	0.76	0.841	1.90558337788914e-11	TRIP6	Malignant cells	GSE131984_JQ1Pal	ENSG00000087077	7205	thyroid hormone receptor interactor 6	MGC10556|MGC10558|MGC29959|MGC3837|MGC4423|OIP1|ZRP-1	protein_coding	Q15654	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43372
1.25385656173885e-15	-0.284169109186428	0.327	0.48	1.98159491017208e-11	MIS18A	Malignant cells	GSE131984_JQ1Pal	ENSG00000159055	54069	MIS18 kinetochore protein A	B28|C21orf45|C21orf46|FASP1|hMis18alpha	protein_coding	Q9NYP9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43373
1.30317747829946e-15	-0.303633776445333	0.438	0.583	2.05954168670447e-11	OGFRL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000119900	79627	opioid growth factor receptor like 1	dJ331H24.1	protein_coding	Q5TC84	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43374
1.31552227480855e-15	-0.430299936569476	0.88	0.902	2.07905140310742e-11	GADD45A	Malignant cells	GSE131984_JQ1Pal	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43375
1.33693519287594e-15	-0.292979854298382	0.357	0.507	2.11289237882113e-11	DRAM2	Malignant cells	GSE131984_JQ1Pal	ENSG00000156171	128338	DNA damage regulated autophagy modulator 2	MGC54289|PRO180|RP5-1180E21.1|TMEM77|WWFQ154	protein_coding	Q6UX65	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43376
1.3836391610596e-15	0.315436149661392	0.983	0.979	2.18670333013859e-11	S100A13	Malignant cells	GSE131984_JQ1Pal	ENSG00000189171	6284	S100 calcium binding protein A13	NA	protein_coding	Q99584	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43377
1.39786682719725e-15	-0.311264743518457	0.455	0.588	2.20918873370253e-11	UBE2J1	Malignant cells	GSE131984_JQ1Pal	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43378
1.41927774147637e-15	-0.278167959747725	0.604	0.736	2.24302654262925e-11	SIGMAR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000147955	10280	sigma non-opioid intracellular receptor 1	OPRS1|SR-BP1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43379
1.43705031938999e-15	-0.274579097639725	0.459	0.603	2.27111432476395e-11	NRD1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43380
1.44512608235919e-15	0.263281932172981	0.409	0.254	2.28387726056047e-11	PAG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000076641	55824	phosphoprotein membrane anchor with glycosphingolipid microdomains 1	CBP|PAG	protein_coding	Q9NWQ8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43381
1.44851204721306e-15	-0.35316260932348	0.777	0.848	2.28922843941553e-11	SMC4	Malignant cells	GSE131984_JQ1Pal	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43382
1.4679972547843e-15	0.308724618991369	0.713	0.582	2.3200228614611e-11	CHPF	Malignant cells	GSE131984_JQ1Pal	ENSG00000123989	79586	chondroitin polymerizing factor	CHSY2|CSS2	protein_coding	Q8IZ52	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43383
1.47452297810302e-15	0.265778774224006	0.449	0.293	2.33033611459401e-11	NBR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000188554	4077	NBR1 autophagy cargo receptor	1A1-3B|CA125|KIAA0049|M17S2	protein_coding	Q14596	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43384
1.57524518919994e-15	-0.272493686841946	0.215	0.367	2.48951749701159e-11	DEPDC1B	Malignant cells	GSE131984_JQ1Pal	ENSG00000035499	55789	DEP domain containing 1B	BRCC3|XTP1	protein_coding	Q8WUY9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43385
1.59598250581068e-15	-0.303899400916604	0.575	0.691	2.52229075218319e-11	CHTOP	Malignant cells	GSE131984_JQ1Pal	ENSG00000160679	26097	chromatin target of PRMT1	C1orf77|DKFZP547E1010|FOP|SRAG	protein_coding	Q9Y3Y2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43386
1.63598540588499e-15	0.265054823133581	0.44	0.287	2.58551133546063e-11	FAT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000083857	2195	FAT atypical cadherin 1	CDHF7|CDHR8|FAT	protein_coding	Q14517	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43387
1.63813961136748e-15	-0.28155617830874	0.38	0.539	2.58891584180517e-11	SIGIRR	Malignant cells	GSE131984_JQ1Pal	ENSG00000185187	59307	single Ig and TIR domain containing	IL-1R8|TIR8	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43388
1.65861977557644e-15	-0.305671752807022	0.328	0.482	2.62128269332101e-11	CHAF1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000167670	10036	chromatin assembly factor 1 subunit A	CAF-1|CAF1|CAF1B|CAF1P150|MGC71229|P150	protein_coding	Q13111	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43389
1.68787134794277e-15	-0.281738154932751	0.513	0.657	2.66751187828875e-11	TAF11	Malignant cells	GSE131984_JQ1Pal	ENSG00000064995	6882	TATA-box binding protein associated factor 11	TAF2I|TAFII28	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43390
1.7474374381655e-15	-0.289496361003226	0.406	0.549	2.76165012727676e-11	MRPS9	Malignant cells	GSE131984_JQ1Pal	ENSG00000135972	64965	mitochondrial ribosomal protein S9	MRP-S9|RPMS9|S9mt	protein_coding	P82933	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43391
1.77111412152448e-15	-0.264906601738676	0.259	0.41	2.79906875765729e-11	LRRC42	Malignant cells	GSE131984_JQ1Pal	ENSG00000116212	115353	leucine rich repeat containing 42	MGC8974	protein_coding	Q9Y546	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43392
1.77604900933204e-15	0.253258145412716	0.468	0.305	2.80686785434836e-11	SPRY2	Malignant cells	GSE131984_JQ1Pal	ENSG00000136158	10253	sprouty RTK signaling antagonist 2	hSPRY2	protein_coding	O43597	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43393
1.84360141504158e-15	-0.276900515503967	0.491	0.638	2.91362767633171e-11	DBNL	Malignant cells	GSE131984_JQ1Pal	ENSG00000136279	28988	drebrin like	ABP1|HIP-55|SH3P7	protein_coding	Q9UJU6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43394
1.98445752622986e-15	0.283446830790828	0.606	0.444	3.13623667445367e-11	KLF9	Malignant cells	GSE131984_JQ1Pal	ENSG00000119138	687	KLF transcription factor 9	BTEB1	protein_coding	Q13886	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43395
1.98986397415115e-15	-0.252092550808065	0.273	0.434	3.14478102474848e-11	AKAP17A	Malignant cells	GSE131984_JQ1Pal	ENSG00000197976	8227	A-kinase anchoring protein 17A	721P|CCDC133|CXYorf3|DXYS155E|MGC39904|SFRS17A|XE7|XE7Y	protein_coding	Q02040	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43396
2.03063274862642e-15	-0.258383378700527	0.195	0.339	3.20921199592919e-11	RNASEH1-AS1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43397
2.10164938887673e-15	-0.300364726203252	0.916	0.965	3.32144669418078e-11	CKS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43398
2.13737721519987e-15	-0.274191345879403	0.304	0.458	3.37791095090188e-11	CHAC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000143942	494143	ChaC glutathione specific gamma-glutamylcyclotransferase 2	GCG1	protein_coding	Q8WUX2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43399
2.19889244846649e-15	-0.28724730797827	0.761	0.82	3.47512962555644e-11	CENPH	Malignant cells	GSE131984_JQ1Pal	ENSG00000153044	64946	centromere protein H	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43400
2.28279371303025e-15	-0.316199103842932	0.582	0.696	3.607727184073e-11	RAD51C	Malignant cells	GSE131984_JQ1Pal	ENSG00000108384	5889	RAD51 paralog C	FANCO|RAD51L2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43401
2.38112623979019e-15	-0.286724512727879	0.462	0.605	3.76313190936442e-11	SCO2	Malignant cells	GSE131984_JQ1Pal	ENSG00000284194	9997	synthesis of cytochrome C oxidase 2	MYP6|SCO1L	protein_coding	O43819	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43402
2.38652783127383e-15	-0.253344734357296	0.275	0.431	3.77166858454516e-11	RP9	Malignant cells	GSE131984_JQ1Pal	ENSG00000164610	6100	RP9 pre-mRNA splicing factor	PAP-1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43403
2.41688477337875e-15	-0.290215329598395	0.503	0.633	3.81964469584777e-11	M6PR	Malignant cells	GSE131984_JQ1Pal	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43404
2.45083230552558e-15	-0.263609502500285	0.384	0.545	3.87329537565263e-11	TAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43405
2.5415499242681e-15	-0.2890333225125	0.529	0.647	4.01666550031331e-11	SMIM11	Malignant cells	GSE131984_JQ1Pal	ENSG00000205670	54065	small integral membrane protein 11	C21orf51|FAM165B|SMIM11A	protein_coding	P58511	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43406
2.55710928822338e-15	0.286180432947843	0.729	0.598	4.04125551910823e-11	SUN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000164828	23353	Sad1 and UNC84 domain containing 1	FLJ12407|KIAA0810|UNC84A	protein_coding	O94901	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43407
2.59486857834732e-15	-0.267116917292402	0.417	0.574	4.1009303012201e-11	BLOC1S4	Malignant cells	GSE131984_JQ1Pal	ENSG00000186222	55330	biogenesis of lysosomal organelles complex 1 subunit 4	BCAS4L|CNO|FLJ11230	protein_coding	Q9NUP1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43408
2.60996980416871e-15	-0.2746189176831	0.257	0.405	4.12479627850822e-11	EIF2B2	Malignant cells	GSE131984_JQ1Pal	ENSG00000119718	8892	eukaryotic translation initiation factor 2B subunit beta	EIF-2Bbeta|EIF2B|EIF2Bbeta	protein_coding	P49770	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43409
2.7693220561897e-15	-0.251147196363925	0.245	0.398	4.3766365776022e-11	ADPRHL2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43410
2.86070101526945e-15	-0.282192494759548	0.838	0.889	4.52105188453183e-11	IFI27L2	Malignant cells	GSE131984_JQ1Pal	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43411
2.86404223050215e-15	0.260713950331764	0.491	0.333	4.5263323410856e-11	TAOK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000160551	57551	TAO kinase 1	FLJ14314|hKFC-B|hTAOK1|KIAA1361|MAP3K16|MARKK|PSK2|TAO1	protein_coding	Q7L7X3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43412
2.975840785836e-15	0.27735489170035	0.852	0.74	4.70301877793522e-11	NAP1L4	Malignant cells	GSE131984_JQ1Pal	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43413
3.04039290890647e-15	0.250867859899358	0.455	0.297	4.80503695323578e-11	HEXIM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000186834	10614	HEXIM P-TEFb complex subunit 1	CLP-1|EDG1|HIS1|MAQ1	protein_coding	O94992	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43414
3.13678774802476e-15	-0.269083445134237	0.296	0.45	4.95737935697833e-11	MPHOSPH6	Malignant cells	GSE131984_JQ1Pal	ENSG00000135698	10200	M-phase phosphoprotein 6	MPP6	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43415
3.22797666192633e-15	-0.3170875465474	0.501	0.631	5.10149431650837e-11	OPTN	Malignant cells	GSE131984_JQ1Pal	ENSG00000123240	10133	optineurin	FIP-2|FIP2|GLC1E|HIP7|HYPL|NRP|TFIIIA-INTP	protein_coding	Q96CV9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43416
3.2934330043812e-15	-0.282195336501422	0.124	0.254	5.20494152012404e-11	ASNS	Malignant cells	GSE131984_JQ1Pal	ENSG00000070669	440	asparagine synthetase (glutamine-hydrolyzing)	NA	protein_coding	P08243	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43417
3.60793535295838e-15	-0.291257323823445	0.446	0.588	5.70198103181543e-11	DAXX	Malignant cells	GSE131984_JQ1Pal	ENSG00000231617	1616	death domain associated protein	DAP6	protein_coding	Q9UER7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43418
3.74234353312207e-15	-0.289662899393846	0.671	0.777	5.91439971974613e-11	GOLGA4	Malignant cells	GSE131984_JQ1Pal	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43419
3.78550244473288e-15	0.254300806292276	0.586	0.428	5.98260806365584e-11	SPATS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000123352	65244	spermatogenesis associated serine rich 2	FLJ13117|SCR59|SPATA10	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43420
4.06904881111243e-15	-0.251989918007491	0.225	0.372	6.43072474108208e-11	PDCD2L	Malignant cells	GSE131984_JQ1Pal	ENSG00000126249	84306	programmed cell death 2 like	MGC13096	protein_coding	Q9BRP1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43421
4.07060582611115e-15	0.271068904016996	0.618	0.474	6.43318544758606e-11	CSNK1G2	Malignant cells	GSE131984_JQ1Pal	ENSG00000133275	1455	casein kinase 1 gamma 2	CK1g2	protein_coding	P78368	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43422
4.21206466530144e-15	-0.27571406389299	0.468	0.622	6.65674699704239e-11	COASY	Malignant cells	GSE131984_JQ1Pal	ENSG00000068120	80347	Coenzyme A synthase	DPCK|NBP|PPAT	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43423
4.56668542981783e-15	-0.27820591203462	0.554	0.69	7.2171896532841e-11	HDAC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000171720	8841	histone deacetylase 3	HD3|KDAC3|RPD3|RPD3-2	protein_coding	O15379	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43424
4.59505713551287e-15	0.292279525856813	0.595	0.443	7.26202829696455e-11	FNDC3B	Malignant cells	GSE131984_JQ1Pal	ENSG00000075420	64778	fibronectin type III domain containing 3B	DKFZp762K137|FAD104|FLJ23399|PRO4979|YVTM2421	protein_coding	Q53EP0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43425
4.80695656129987e-15	-0.290438044341033	0.573	0.691	7.59691414947832e-11	SUPT16H	Malignant cells	GSE131984_JQ1Pal	ENSG00000092201	11198	SPT16 homolog, facilitates chromatin remodeling subunit	CDC68|FACT|FACTP140|FLJ10857|FLJ14010|SPT16/CDC68	protein_coding	Q9Y5B9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43426
4.86922597406757e-15	-0.287576404023354	0.604	0.708	7.69532472941639e-11	RFC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000035928	5981	replication factor C subunit 1	A1|MHCBFB|PO-GA|RFC140	protein_coding	P35251	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43427
5.13031010225351e-15	0.264308608441476	0.537	0.389	8.10794208560145e-11	PSME4	Malignant cells	GSE131984_JQ1Pal	ENSG00000068878	23198	proteasome activator subunit 4	KIAA0077|PA200	protein_coding	Q14997	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43428
5.16268622576333e-15	0.277389622740921	0.457	0.309	8.15910931119636e-11	PREX1	Malignant cells	GSE131984_JQ1Pal	ENSG00000124126	57580	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1	KIAA1415|P-REX1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43429
5.20999495614514e-15	-0.286527121151473	0.391	0.539	8.23387602869179e-11	SHKBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000160410	92799	SH3KBP1 binding protein 1	PP203|Sb1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43430
5.65490039680104e-15	-0.288876540279385	0.32	0.468	8.93700458710436e-11	GNPDA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000113552	10007	glucosamine-6-phosphate deaminase 1	GNPDA|GNPI|GPI|HLN|KIAA0060	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43431
5.73178429691772e-15	0.31662206953129	0.682	0.564	9.05851190284877e-11	MAZ	Malignant cells	GSE131984_JQ1Pal	ENSG00000103495	4150	MYC associated zinc finger protein	Pur-1|ZF87|Zif87|ZNF801	protein_coding	P56270	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43432
5.84859278289328e-15	0.266125466981427	0.396	0.247	9.24311603408453e-11	ZNF281	Malignant cells	GSE131984_JQ1Pal	ENSG00000162702	23528	zinc finger protein 281	ZBP-99	protein_coding	Q9Y2X9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43433
5.88304042093061e-15	-0.269636455954887	0.252	0.402	9.29755708123873e-11	GLOD4	Malignant cells	GSE131984_JQ1Pal	ENSG00000167699	51031	glyoxalase domain containing 4	C17orf25|CGI-150|HC71	protein_coding	Q9HC38	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43434
6.02727143637981e-15	-0.296947751657695	0.48	0.616	9.52549977805465e-11	EPRS	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43435
6.51121513879602e-15	-0.26753087634155	0.272	0.421	1.02903244053532e-10	PUS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000177192	80324	pseudouridine synthase 1	MLASA1	protein_coding	Q9Y606	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43436
6.72764632191552e-15	-0.317747496739085	0.468	0.593	1.06323722471553e-10	THOC6	Malignant cells	GSE131984_JQ1Pal	ENSG00000131652	79228	THO complex subunit 6	fSAP35|MGC2655|WDR58	protein_coding	Q86W42	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43437
6.81785512579991e-15	0.300421350906461	0.578	0.431	1.07749382408142e-10	SLC9A3R1	Malignant cells	GSE131984_JQ1Pal	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43438
7.53030903370419e-15	-0.25325662984831	0.312	0.468	1.19009003968661e-10	CDC42EP4	Malignant cells	GSE131984_JQ1Pal	ENSG00000179604	23580	CDC42 effector protein 4	BORG4|CEP4|KAIA1777|MGC17125|MGC3740	protein_coding	Q9H3Q1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43439
8.00041175048473e-15	-0.257246079320096	0.249	0.4	1.26438507304661e-10	SGCE	Malignant cells	GSE131984_JQ1Pal	ENSG00000127990	8910	sarcoglycan epsilon	DYT11	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43440
8.17948150317614e-15	0.250105564140773	0.462	0.309	1.29268525676196e-10	RNF216	Malignant cells	GSE131984_JQ1Pal	ENSG00000011275	54476	ring finger protein 216	TRIAD3|UBCE7IP1|ZIN	protein_coding	Q9NWF9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43441
8.29907416973403e-15	-0.284973137652839	0.586	0.696	1.31158568178477e-10	DCTD	Malignant cells	GSE131984_JQ1Pal	ENSG00000129187	1635	dCMP deaminase	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43442
8.73109311216547e-15	0.259937742192237	0.422	0.258	1.37986195544663e-10	FOSB	Malignant cells	GSE131984_JQ1Pal	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43443
9.05154796145177e-15	-0.375233321636328	0.735	0.81	1.43050663982784e-10	JUNB	Malignant cells	GSE131984_JQ1Pal	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43444
9.56200090524569e-15	-0.278289651737109	0.778	0.84	1.51117862306503e-10	HNRNPA0	Malignant cells	GSE131984_JQ1Pal	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43445
9.71928685802052e-15	0.251991068295499	0.492	0.335	1.53603609504156e-10	SNTB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000260873	6645	syntrophin beta 2	D16S2531E|EST25263|SNT2B2|SNT3|SNTL	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43446
9.80755076275411e-15	0.251409148193695	0.385	0.239	1.54998532254566e-10	GNAQ	Malignant cells	GSE131984_JQ1Pal	ENSG00000156052	2776	G protein subunit alpha q	G-ALPHA-q|GAQ	protein_coding	P50148	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43447
1.04518159008389e-14	0.252211032228377	0.327	0.187	1.65180498496859e-10	S1PR3	Malignant cells	GSE131984_JQ1Pal	ENSG00000213694	1903	sphingosine-1-phosphate receptor 3	bA791O21.3|C9orf108|C9orf47|EDG-3|EDG3|FLJ37523	protein_coding	Q99500	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43448
1.09189968020541e-14	-0.281019644566895	0.408	0.557	1.72563825459663e-10	TOR1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000136827	1861	torsin family 1 member A	DQ2|DYT1	protein_coding	O14656	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43449
1.16645410866425e-14	-0.312641103505289	0.221	0.37	1.84346407333298e-10	HMMR	Malignant cells	GSE131984_JQ1Pal	ENSG00000072571	3161	hyaluronan mediated motility receptor	CD168|RHAMM	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43450
1.17732202670333e-14	-0.25855453735867	0.337	0.487	1.86063973100194e-10	SNX12	Malignant cells	GSE131984_JQ1Pal	ENSG00000147164	29934	sorting nexin 12	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43451
1.19001804927877e-14	-0.282228902366375	0.395	0.538	1.88070452508017e-10	AC010642.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43452
1.1947706691501e-14	-0.259346122343923	0.462	0.62	1.88821556552481e-10	ATPAF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000123472	64756	ATP synthase mitochondrial F1 complex assembly factor 1	ATP11|Atp11p|FLJ22351	protein_coding	Q5TC12	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43453
1.22356752250087e-14	0.252648591268898	0.523	0.367	1.93372611256038e-10	SH3BP4	Malignant cells	GSE131984_JQ1Pal	ENSG00000130147	23677	SH3 domain binding protein 4	NA	protein_coding	Q9P0V3	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43454
1.2326532773075e-14	-0.269035728996422	0.271	0.418	1.94808523945677e-10	EZH2	Malignant cells	GSE131984_JQ1Pal	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43455
1.28829977140987e-14	0.257725603249893	0.461	0.313	2.03602895873615e-10	EHBP1L1	Malignant cells	GSE131984_JQ1Pal	ENSG00000173442	254102	EH domain binding protein 1 like 1	DKFZp762C186|TANGERIN	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43456
1.35568913222539e-14	-0.25218320253517	0.244	0.392	2.142531104569e-10	NUDT11	Malignant cells	GSE131984_JQ1Pal	ENSG00000196368	55190	nudix hydrolase 11	DIPP3b|FLJ10628|hDIPP3beta	protein_coding	Q96G61	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43457
1.40772998988918e-14	-0.291586901685113	0.504	0.631	2.22477647602085e-10	NSMCE4A	Malignant cells	GSE131984_JQ1Pal	ENSG00000107672	54780	NSE4 homolog A, SMC5-SMC6 complex component	bA500G22.3|C10orf86|FLJ20003|NSE4A	protein_coding	Q9NXX6	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43458
1.48262818397543e-14	0.274747495412497	0.865	0.759	2.34314558195477e-10	TSPAN3	Malignant cells	GSE131984_JQ1Pal	ENSG00000140391	10099	tetraspanin 3	TM4-A|TM4SF8|TSPAN-3	protein_coding	O60637	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43459
1.58883905040039e-14	0.272944845725258	0.64	0.494	2.51100123525277e-10	IRF2BP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43460
1.72201098774334e-14	-0.264551455481639	0.409	0.558	2.72146616502957e-10	GNPAT	Malignant cells	GSE131984_JQ1Pal	ENSG00000116906	8443	glyceronephosphate O-acyltransferase	DAP-AT|DAPAT|DHAPAT	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43461
1.76749671298612e-14	-0.284558061437662	0.448	0.585	2.79335180520326e-10	TMCO3	Malignant cells	GSE131984_JQ1Pal	ENSG00000150403	55002	transmembrane and coiled-coil domains 3	C13orf11|FLJ20623	protein_coding	Q6UWJ1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43462
1.82840796834501e-14	-0.25434513829826	0.854	0.931	2.88961595317246e-10	ARPC5L	Malignant cells	GSE131984_JQ1Pal	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43463
1.94866823311202e-14	0.261382904424909	0.565	0.421	3.07967527561023e-10	UBE2Q2	Malignant cells	GSE131984_JQ1Pal	ENSG00000140367	92912	ubiquitin conjugating enzyme E2 Q2	DKFZp762C143	protein_coding	Q8WVN8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43464
2.08680456265966e-14	-0.272999580164064	0.499	0.63	3.29798593082732e-10	C16orf91	Malignant cells	GSE131984_JQ1Pal	ENSG00000174109	283951	chromosome 16 open reading frame 91	CCSMST1|gs103|URLC5	protein_coding	Q4G0I0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43465
2.31841111909336e-14	-0.286057865782916	0.488	0.628	3.66401693261514e-10	HMOX2	Malignant cells	GSE131984_JQ1Pal	ENSG00000277424	3163	heme oxygenase 2	HO-2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43466
2.32859590483947e-14	-0.261948944344865	0.222	0.365	3.68011296800829e-10	SCO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000133028	6341	synthesis of cytochrome C oxidase 1	SCOD1	protein_coding	O75880	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43467
2.3846339404128e-14	-0.274386452191478	0.351	0.5	3.7686754794284e-10	R3HCC1	Malignant cells	GSE131984_JQ1Pal	ENSG00000104679	203069	R3H domain and coiled-coil containing 1	DKFZp564N123	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43468
2.49499126541298e-14	-0.273850565190233	0.641	0.725	3.94308419585867e-10	TATDN1	Malignant cells	GSE131984_JQ1Pal	ENSG00000147687	83940	TatD DNase domain containing 1	CDA11	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43469
2.62150525524149e-14	-0.281487110638469	0.58	0.696	4.14302690538366e-10	ILK	Malignant cells	GSE131984_JQ1Pal	ENSG00000166333	3611	integrin linked kinase	NA	protein_coding	Q13418	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43470
2.85657944149199e-14	-0.253052741545627	0.64	0.745	4.51453814933394e-10	RAP1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000116473	5906	RAP1A, member of RAS oncogene family	KREV-1|SMGP21	protein_coding	P62834	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43471
2.96866247986222e-14	0.287775943978136	0.63	0.493	4.69167418317426e-10	SSFA2	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43472
2.98750484135995e-14	-0.257123204051697	0.244	0.386	4.72145265128527e-10	MGST2	Malignant cells	GSE131984_JQ1Pal	ENSG00000085871	4258	microsomal glutathione S-transferase 2	MGST-II	protein_coding	Q99735	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43473
3.11317349708492e-14	0.285389548863149	0.75	0.636	4.92005939479301e-10	COLGALT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000130309	79709	collagen beta(1-O)galactosyltransferase 1	FLJ22329|GLT25D1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43474
3.1593424639767e-14	0.252929557250916	0.445	0.303	4.99302483006878e-10	MAN1B1	Malignant cells	GSE131984_JQ1Pal	ENSG00000177239	11253	mannosidase alpha class 1B member 1	ERMan1|ERManI|MANA-ER|MRT15	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43475
3.22639607299018e-14	-0.311090336959831	0.131	0.257	5.09899635375369e-10	DDIT3	Malignant cells	GSE131984_JQ1Pal	ENSG00000175197	1649	DNA damage inducible transcript 3	CHOP|CHOP10|GADD153	protein_coding	P35638	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43476
3.36040778093128e-14	0.269113971258899	0.513	0.367	5.3107884569838e-10	CREG1	Malignant cells	GSE131984_JQ1Pal	ENSG00000143162	8804	cellular repressor of E1A stimulated genes 1	CREG	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43477
3.49686433335118e-14	-0.286241857646809	0.402	0.545	5.5264443924282e-10	SLC39A7	Malignant cells	GSE131984_JQ1Pal	ENSG00000229802	7922	solute carrier family 39 member 7	D6S2244E|H2-KE4|HKE4|KE4|RING5|ZIP7	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43478
3.81170751085241e-14	0.358000156119982	0.661	0.509	6.02402255015115e-10	SOX4	Malignant cells	GSE131984_JQ1Pal	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43479
3.91832641202978e-14	-0.271220873692795	0.483	0.618	6.19252306157186e-10	VASP	Malignant cells	GSE131984_JQ1Pal	ENSG00000125753	7408	vasodilator stimulated phosphoprotein	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43480
4.04310076320278e-14	0.256333354626281	0.564	0.41	6.38971644616567e-10	DKK3	Malignant cells	GSE131984_JQ1Pal	ENSG00000050165	27122	dickkopf WNT signaling pathway inhibitor 3	CRRL|REIC|RIG	protein_coding	Q9UBP4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43481
4.63749225459065e-14	-0.274579914201399	0.417	0.55	7.32909275915505e-10	ATIC	Malignant cells	GSE131984_JQ1Pal	ENSG00000138363	471	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	AICARFT|IMPCHASE|PURH	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43482
4.69829912973351e-14	-0.288144456890842	0.287	0.432	7.42519194463084e-10	IFRD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43483
4.8557884264109e-14	-0.273259110686568	0.778	0.838	7.67408802909979e-10	TMED10	Malignant cells	GSE131984_JQ1Pal	ENSG00000170348	10972	transmembrane p24 trafficking protein 10	p23|P24(DELTA)|p24d1|p24delta1|TMP21	protein_coding	P49755	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43484
4.90386080846911e-14	0.27275226856483	0.8	0.665	7.75006162170458e-10	RTN3	Malignant cells	GSE131984_JQ1Pal	ENSG00000133318	10313	reticulon 3	ASYIP|HAP|NSPL2|NSPLII|RTN3-A1	protein_coding	O95197	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43485
4.9040052540331e-14	0.275198147185542	0.832	0.713	7.75028990347392e-10	PRNP	Malignant cells	GSE131984_JQ1Pal	ENSG00000171867	5621	prion protein	AltPrP|CD230|CJD|GSS|PRIP|PRP	protein_coding	P04156	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43486
4.9666910947311e-14	-0.261725796562312	0.398	0.543	7.84935860611303e-10	TBRG4	Malignant cells	GSE131984_JQ1Pal	ENSG00000136270	9238	transforming growth factor beta regulator 4	Cpr2|FASTKD4|H_TD2522F11.8|KIAA0948	protein_coding	Q969Z0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43487
5.14638624552507e-14	0.260938461268611	0.5	0.352	8.13334882242782e-10	ADAM10	Malignant cells	GSE131984_JQ1Pal	ENSG00000137845	102	ADAM metallopeptidase domain 10	CD156C|HsT18717|kuz|MADM	protein_coding	O14672	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43488
5.67269482216064e-14	-0.261526729691876	0.303	0.451	8.96512689694267e-10	FUBP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000162613	8880	far upstream element binding protein 1	FBP|FUBP	protein_coding	Q96AE4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43489
5.72196640620371e-14	-0.264951250074288	0.412	0.559	9.04299570836434e-10	PET100	Malignant cells	GSE131984_JQ1Pal	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43490
5.86816640991737e-14	-0.277855335254226	0.463	0.598	9.27405019423342e-10	RPP25L	Malignant cells	GSE131984_JQ1Pal	ENSG00000164967	138716	ribonuclease P/MRP subunit p25 like	bA296L22.5|C9orf23|MGC29635	protein_coding	Q8N5L8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43491
5.90492013581444e-14	0.275517977476797	0.394	0.254	9.33213578264113e-10	TFAP2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000137203	7020	transcription factor AP-2 alpha	AP-2|AP-2alpha|AP2TF|TFAP2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43492
5.95010772249692e-14	-0.287749640035635	0.344	0.485	9.40355024463414e-10	SNX2	Malignant cells	GSE131984_JQ1Pal	ENSG00000205302	6643	sorting nexin 2	NA	protein_coding	O60749	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43493
6.00700652473583e-14	-0.269324571900845	0.596	0.72	9.4934731116925e-10	NIPA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000140157	81614	NIPA magnesium transporter 2	SLC57A2	protein_coding	Q8N8Q9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43494
7.14912970292802e-14	-0.255098173384728	0.389	0.533	1.12984845825074e-09	ALG13	Malignant cells	GSE131984_JQ1Pal	ENSG00000101901	79868	ALG13 UDP-N-acetylglucosaminyltransferase subunit	CDG1S|CXorf45|FLJ23018|GLT28D1|MDS031|TDRD13|YGL047W	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43495
7.65139291021996e-14	-0.268823025442317	0.435	0.574	1.20922613553116e-09	SAMM50	Malignant cells	GSE131984_JQ1Pal	ENSG00000100347	25813	SAMM50 sorting and assembly machinery component	CGI-51|OMP85|SAM50|TOB55|TRG-3|YNL026W	protein_coding	Q9Y512	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43496
7.95538457551574e-14	-0.332384389040362	0.427	0.549	1.25726897831451e-09	SNHG9	Malignant cells	GSE131984_JQ1Pal	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43497
8.22221787784214e-14	-0.258162982105504	0.916	0.946	1.29943931341417e-09	RBM39	Malignant cells	GSE131984_JQ1Pal	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43498
8.23152971617659e-14	-0.308382670230844	0.203	0.342	1.30091095634455e-09	ATF3	Malignant cells	GSE131984_JQ1Pal	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43499
8.40039887157137e-14	0.282350982392208	0.426	0.286	1.32759903766314e-09	SIK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000142178	150094	salt inducible kinase 1	msk|SNF1LK	protein_coding	P57059	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43500
8.87417014067657e-14	0.261062577067851	0.646	0.51	1.40247384903253e-09	C5orf55	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43501
8.96173695015842e-14	-0.251999018787646	0.684	0.781	1.41631290760304e-09	PSMF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000125818	9491	proteasome inhibitor subunit 1	PI31	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43502
9.42307899415447e-14	-0.266312052449817	0.521	0.654	1.48922340423617e-09	DPH3	Malignant cells	GSE131984_JQ1Pal	ENSG00000154813	285381	diphthamide biosynthesis 3	DELGIP|DELGIP1|DESR1|DPH3A|KTI11|MGC20197|ZCSL2	protein_coding	Q96FX2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43503
1.01729581335126e-13	-0.291233427631443	0.418	0.549	1.60773430342033e-09	PES1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100029	23481	pescadillo ribosomal biogenesis factor 1	NOP7|PES	protein_coding	O00541	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43504
1.10159717050667e-13	-0.260973114248117	0.356	0.5	1.74096416826875e-09	COMMD9	Malignant cells	GSE131984_JQ1Pal	ENSG00000110442	29099	COMM domain containing 9	FLJ31106|HSPC166	protein_coding	Q9P000	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43505
1.19601782012742e-13	-0.2649210995154	0.516	0.654	1.89018656292937e-09	YIF1B	Malignant cells	GSE131984_JQ1Pal	ENSG00000167645	90522	Yip1 interacting factor homolog B, membrane trafficking protein	FinGER8	protein_coding	Q5BJH7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43506
1.23704400309913e-13	-0.256331599110482	0.312	0.459	1.95502434249787e-09	TXNDC15	Malignant cells	GSE131984_JQ1Pal	ENSG00000113621	79770	thioredoxin domain containing 15	2310047H23Rik|C5orf14|FLJ22625	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43507
1.23995239937267e-13	-0.277627523314775	0.429	0.56	1.95962077196856e-09	HRSP12	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43508
1.29488475954203e-13	-0.369248962228497	0.965	0.981	2.04643587398022e-09	UBC	Malignant cells	GSE131984_JQ1Pal	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43509
1.30009649076486e-13	0.267686034249209	0.51	0.358	2.05467249400479e-09	RP11-307P5.1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43510
1.39540722483607e-13	-0.269407016509807	0.752	0.828	2.20530157813092e-09	EIF3J	Malignant cells	GSE131984_JQ1Pal	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43511
1.44887854925162e-13	0.266793173638316	0.655	0.52	2.28980765923726e-09	EML4	Malignant cells	GSE131984_JQ1Pal	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43512
1.49828698060883e-13	-0.266914945845519	0.806	0.872	2.36789274415419e-09	CDC26	Malignant cells	GSE131984_JQ1Pal	ENSG00000176386	246184	cell division cycle 26	ANAPC12|APC12|C9orf17	protein_coding	Q8NHZ8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43513
1.56022501130388e-13	-0.286206133052806	0.696	0.779	2.46577960786466e-09	DDX24	Malignant cells	GSE131984_JQ1Pal	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43514
2.25981910676393e-13	-0.272019465048356	0.641	0.73	3.57141811632972e-09	EMC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43515
2.42349592199149e-13	-0.286538523556845	0.472	0.592	3.83009295511535e-09	CTBP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000175029	1488	C-terminal binding protein 2	ribeye	protein_coding	P56545	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43516
2.48342569511497e-13	-0.25280651776457	0.853	0.897	3.92480596855971e-09	TMEM219	Malignant cells	GSE131984_JQ1Pal	ENSG00000149932	124446	transmembrane protein 219	IGFBP-3R	protein_coding	Q86XT9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43517
2.64047099747884e-13	-0.27009312009821	0.527	0.648	4.17300036441556e-09	KLHDC3	Malignant cells	GSE131984_JQ1Pal	ENSG00000124702	116138	kelch domain containing 3	dJ20C7.3|hPeas|PEAS	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43518
2.6702048458997e-13	-0.279464181794392	0.542	0.646	4.21999173845989e-09	KIAA1143	Malignant cells	GSE131984_JQ1Pal	ENSG00000281665	57456	KIAA1143	NA	protein_coding	Q96AT1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43519
2.79007247666706e-13	-0.28369145111835	0.354	0.5	4.40943054212462e-09	PNO1	Malignant cells	GSE131984_JQ1Pal	ENSG00000115946	56902	partner of NOB1 homolog	KHRBP1|RRP20	protein_coding	Q9NRX1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43520
2.87425881574504e-13	-0.268168469609528	0.604	0.699	4.54247863240347e-09	IARS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000067704	55699	isoleucyl-tRNA synthetase 2, mitochondrial	FLJ10326	protein_coding	Q9NSE4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43521
3.04871597584983e-13	-0.338910926159749	0.314	0.45	4.81819072823307e-09	AKR1C1	Malignant cells	GSE131984_JQ1Pal	ENSG00000187134	1645	aldo-keto reductase family 1 member C1	DD1|DDH|DDH1|HAKRC|MBAB	protein_coding	Q04828	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43522
3.50571054210885e-13	-0.283458661900452	0.405	0.534	5.54042494074882e-09	HSPA4	Malignant cells	GSE131984_JQ1Pal	ENSG00000170606	3308	heat shock protein family A (Hsp70) member 4	HS24/P52|HSPH2	protein_coding	P34932	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43523
3.57844232259988e-13	-0.255532750157922	0.371	0.515	5.65537024663685e-09	RAB5A	Malignant cells	GSE131984_JQ1Pal	ENSG00000144566	5868	RAB5A, member RAS oncogene family	RAB5	protein_coding	P20339	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43524
3.75104273676475e-13	0.25537495725993	0.672	0.56	5.92814794118301e-09	PLEKHB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000115762	55041	pleckstrin homology domain containing B2	EVT2|FLJ20783	protein_coding	Q96CS7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43525
4.00013773480503e-13	0.261403954429805	0.711	0.602	6.32181767608586e-09	PLOD1	Malignant cells	GSE131984_JQ1Pal	ENSG00000083444	5351	procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	LH1|LLH|PLOD	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43526
4.19665481538856e-13	-0.26012210279258	0.519	0.653	6.63239327024008e-09	TNIP2	Malignant cells	GSE131984_JQ1Pal	ENSG00000168884	79155	TNFAIP3 interacting protein 2	ABIN-2|FLIP1|KLIP|MGC4289	protein_coding	Q8NFZ5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43527
4.21982023858193e-13	-0.260699506077767	0.658	0.762	6.66900390505488e-09	OXA1L	Malignant cells	GSE131984_JQ1Pal	ENSG00000155463	5018	OXA1L mitochondrial inner membrane protein	MGC133129|OXA1|OXA1L1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43528
4.23439971477976e-13	-0.262937990000986	0.44	0.574	6.69204530923794e-09	CFLAR	Malignant cells	GSE131984_JQ1Pal	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43529
4.24347863526549e-13	0.257625008092745	0.851	0.768	6.70639363517358e-09	SURF1	Malignant cells	GSE131984_JQ1Pal	ENSG00000280627	6834	SURF1 cytochrome c oxidase assembly factor	SHY1	protein_coding	Q15526	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43530
4.72087779318478e-13	-0.289056203039219	0.445	0.567	7.46087526434923e-09	OSER1	Malignant cells	GSE131984_JQ1Pal	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43531
5.08824143888384e-13	-0.272213400652928	0.375	0.518	8.04145677001202e-09	WBSCR27	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43532
5.40664749143202e-13	-0.280788411883865	0.39	0.517	8.54466569545917e-09	CDC16	Malignant cells	GSE131984_JQ1Pal	ENSG00000130177	8881	cell division cycle 16	ANAPC6|APC6|CUT9	protein_coding	Q13042	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43533
5.58621068510332e-13	-0.263444172568468	0.437	0.568	8.82844736673729e-09	UCHL5	Malignant cells	GSE131984_JQ1Pal	ENSG00000116750	51377	ubiquitin C-terminal hydrolase L5	CGI-70|INO80R|UCH37	protein_coding	Q9Y5K5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43534
5.60255559312399e-13	-0.271129535156104	0.303	0.44	8.85427885937315e-09	ARV1	Malignant cells	GSE131984_JQ1Pal	ENSG00000173409	64801	ARV1 homolog, fatty acid homeostasis modulator	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43535
5.97720612004212e-13	0.252643658590292	0.514	0.373	9.44637655211457e-09	MAP3K2	Malignant cells	GSE131984_JQ1Pal	ENSG00000169967	10746	mitogen-activated protein kinase kinase kinase 2	MEKK2|MEKK2B	protein_coding	Q9Y2U5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43536
6.11363534767239e-13	-0.254216196742096	0.385	0.52	9.66198930346145e-09	USB1	Malignant cells	GSE131984_JQ1Pal	ENSG00000103005	79650	U6 snRNA biogenesis phosphodiesterase 1	C16orf57|FLJ13154|HVSL1|Mpn1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43537
6.31467809806845e-13	-0.27704312436551	0.852	0.881	9.97971726618738e-09	SCD	Malignant cells	GSE131984_JQ1Pal	ENSG00000099194	6319	stearoyl-CoA desaturase	FADS5|SCD1|SCDOS	protein_coding	O00767	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43538
6.33978033366221e-13	-0.251704161797316	0.38	0.517	1.00193888393198e-08	LAP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43539
6.97902865230018e-13	-0.276127576579888	0.465	0.589	1.10296568820952e-08	WDR43	Malignant cells	GSE131984_JQ1Pal	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43540
7.05866263090254e-13	-0.262545222526897	0.559	0.677	1.11555104218784e-08	SP100	Malignant cells	GSE131984_JQ1Pal	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43541
7.12139652894287e-13	-0.264514004445889	0.424	0.559	1.12546550743413e-08	KIF2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000068796	3796	kinesin family member 2A	HK2|KIF2	protein_coding	O00139	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43542
7.12460291525471e-13	-0.260114053613604	0.317	0.454	1.12597224472685e-08	SUPT20H	Malignant cells	GSE131984_JQ1Pal	ENSG00000102710	55578	SPT20 homolog, SAGA complex component	bA421P11.4|C13orf19|FAM48A|P38IP|SPT20	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43543
7.22496959154604e-13	0.284652093877872	0.402	0.272	1.14183419424794e-08	ABCA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000165029	19	ATP binding cassette subfamily A member 1	ABC1|HDLDT1|TGD	protein_coding	O95477	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43544
7.34240799323473e-13	-0.254363995005704	0.46	0.592	1.16039415925082e-08	FLYWCH2	Malignant cells	GSE131984_JQ1Pal	ENSG00000162076	114984	FLYWCH family member 2	NA	protein_coding	Q96CP2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43545
7.47178289894407e-13	-0.272457245793336	0.524	0.635	1.18084056934912e-08	KDM1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000004487	23028	lysine demethylase 1A	AOF2|BHC110|KDM1|KIAA0601|LSD1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43546
8.49743124041832e-13	-0.296100264039247	0.803	0.859	1.34293403323571e-08	DNAJA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43547
9.53891045907531e-13	-0.263491610123926	0.517	0.639	1.50752940895226e-08	LITAF	Malignant cells	GSE131984_JQ1Pal	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43548
1.06231724552073e-12	0.256486085513413	0.913	0.853	1.67888617482096e-08	CTSZ	Malignant cells	GSE131984_JQ1Pal	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43549
1.1476810608946e-12	0.264804414014054	0.767	0.647	1.81379514863782e-08	WIPI2	Malignant cells	GSE131984_JQ1Pal	ENSG00000157954	26100	WD repeat domain, phosphoinositide interacting 2	ATG18B|ATG21|CGI-50|DKFZP434J154|DKFZp686P02188|FLJ12979|FLJ14217|FLJ42984	protein_coding	Q9Y4P8	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43550
1.14903762479325e-12	0.254651068509853	0.277	0.158	1.81593906222325e-08	IGF2BP3	Malignant cells	GSE131984_JQ1Pal	ENSG00000136231	10643	insulin like growth factor 2 mRNA binding protein 3	CT98|IMP-3|IMP3	protein_coding	O00425	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43551
1.16697312822593e-12	-0.362466882905854	0.389	0.505	1.84428433184825e-08	SERPINH1	Malignant cells	GSE131984_JQ1Pal	ENSG00000149257	871	serpin family H member 1	CBP1|CBP2|HSP47|SERPINH2	protein_coding	P50454	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43552
1.23705933030229e-12	-0.253061758830114	0.625	0.738	1.95504856560974e-08	SAE1	Malignant cells	GSE131984_JQ1Pal	ENSG00000142230	10055	SUMO1 activating enzyme subunit 1	AOS1|FLJ3091|Sua1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43553
1.25050577232089e-12	-0.257480130483399	0.448	0.579	1.97629932257593e-08	RNMT	Malignant cells	GSE131984_JQ1Pal	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43554
1.27103351248571e-12	-0.27177723619156	0.758	0.819	2.00874136313242e-08	RAB11A	Malignant cells	GSE131984_JQ1Pal	ENSG00000103769	8766	RAB11A, member RAS oncogene family	YL8	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43555
1.32958016452417e-12	-0.263577084728578	0.428	0.556	2.10126849201399e-08	STAG2	Malignant cells	GSE131984_JQ1Pal	ENSG00000101972	10735	stromal antigen 2	SA-2|SA2|SCC3B	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43556
1.44045859483813e-12	0.265333746267612	0.695	0.566	2.27650076328218e-08	PTPN12	Malignant cells	GSE131984_JQ1Pal	ENSG00000127947	5782	protein tyrosine phosphatase non-receptor type 12	PTP-PEST|PTPG1	protein_coding	Q05209	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43557
1.47847259813899e-12	-0.262218556575306	0.393	0.524	2.33657809409886e-08	SF3A3	Malignant cells	GSE131984_JQ1Pal	ENSG00000183431	10946	splicing factor 3a subunit 3	PRP9|PRPF9|SAP61|SF3a60	protein_coding	Q12874	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43558
1.61999538916008e-12	-0.254493536636234	0.267	0.399	2.56024071302859e-08	MSC	Malignant cells	GSE131984_JQ1Pal	ENSG00000178860	9242	musculin	ABF-1|bHLHa22	protein_coding	O60682	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43559
1.64732400808075e-12	0.265053184562993	0.911	0.857	2.60343086237082e-08	MCL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43560
1.66498421239384e-12	-0.277040472769316	0.36	0.484	2.63134104926722e-08	ETS2	Malignant cells	GSE131984_JQ1Pal	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43561
1.90459241287602e-12	-0.250547274872837	0.254	0.389	3.01001784930927e-08	CBR3	Malignant cells	GSE131984_JQ1Pal	ENSG00000159231	874	carbonyl reductase 3	SDR21C2	protein_coding	O75828	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43562
1.97784059772845e-12	0.265594709493263	0.789	0.677	3.12577928065004e-08	STARD7	Malignant cells	GSE131984_JQ1Pal	ENSG00000084090	56910	StAR related lipid transfer domain containing 7	GTT1	protein_coding	Q9NQZ5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43563
2.03967160932666e-12	-0.262843668176095	0.664	0.749	3.22349701137986e-08	RTFDC1	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43564
2.10280294098972e-12	-0.379471016368726	0.588	0.652	3.32326976794016e-08	KCNMA1	Malignant cells	GSE131984_JQ1Pal	ENSG00000156113	3778	potassium calcium-activated channel subfamily M alpha 1	KCa1.1|mSLO1|SLO	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43565
2.25068197569118e-12	-0.264422338359027	0.702	0.786	3.55697779438233e-08	DESI1	Malignant cells	GSE131984_JQ1Pal	ENSG00000100418	27351	desumoylating isopeptidase 1	D15Wsu75e|DESI-1|FAM152B|POST|PPPDE2	protein_coding	Q6ICB0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43566
2.98999705578124e-12	-0.277800951333818	0.816	0.844	4.72539134695666e-08	RAB1A	Malignant cells	GSE131984_JQ1Pal	ENSG00000138069	5861	RAB1A, member RAS oncogene family	RAB1|YPT1	protein_coding	P62820	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43567
3.05543156731072e-12	-0.282437105013793	0.724	0.792	4.82880404897785e-08	SAC3D1	Malignant cells	GSE131984_JQ1Pal	ENSG00000168061	29901	SAC3 domain containing 1	HSU79266|SHD1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43568
3.6186726761833e-12	0.270237651142695	0.712	0.598	5.71895029744009e-08	MAT2A	Malignant cells	GSE131984_JQ1Pal	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43569
4.52459138788224e-12	-0.250368626345144	0.474	0.599	7.1506642294091e-08	RILPL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000150977	196383	Rab interacting lysosomal protein like 2	FLJ30380|FLJ32372|MGC7036	protein_coding	Q969X0	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43570
4.70349688433311e-12	-0.260057721057661	0.434	0.558	7.43340647600004e-08	SNX9	Malignant cells	GSE131984_JQ1Pal	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43571
5.02563965209161e-12	-0.30671102955806	0.159	0.275	7.94252090616558e-08	DMKN	Malignant cells	GSE131984_JQ1Pal	ENSG00000161249	93099	dermokine	ZD52F10	protein_coding	Q6E0U4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43572
5.07969215484493e-12	-0.273638113068282	0.371	0.5	8.02794548151693e-08	SRPX	Malignant cells	GSE131984_JQ1Pal	ENSG00000101955	8406	sushi repeat containing protein X-linked	ETX1|SRPX1	protein_coding	P78539	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43573
5.36474898986012e-12	0.256441840225519	0.695	0.571	8.47844930357493e-08	NCKAP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000061676	10787	NCK associated protein 1	HEM2|Nap1|NAP125	protein_coding	Q9Y2A7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43574
5.38862619216766e-12	-0.270556036211003	0.487	0.61	8.51618483410177e-08	CPSF6	Malignant cells	GSE131984_JQ1Pal	ENSG00000111605	11052	cleavage and polyadenylation specific factor 6	CFIM|CFIM68|CFIM72|HPBRII-4|HPBRII-7	protein_coding	Q16630	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43575
5.45637920655167e-12	-0.253574447391954	0.553	0.663	8.62326169803426e-08	CHAMP1	Malignant cells	GSE131984_JQ1Pal	ENSG00000198824	283489	chromosome alignment maintaining phosphoprotein 1	C13orf8|CAMP|CHAMP|ZNF828	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43576
5.77974263664892e-12	0.273141245825406	0.567	0.44	9.13430526295995e-08	NT5E	Malignant cells	GSE131984_JQ1Pal	ENSG00000135318	4907	5'-nucleotidase ecto	CALJA|CD73|eN|eNT|NT5	protein_coding	P21589	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43577
6.45015988493335e-12	-0.252978498386327	0.476	0.609	1.01938326821487e-07	PGM1	Malignant cells	GSE131984_JQ1Pal	ENSG00000079739	5236	phosphoglucomutase 1	NA	protein_coding	P36871	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43578
6.47756704464021e-12	0.253902797923298	0.465	0.335	1.02371469573494e-07	ADAMTS12	Malignant cells	GSE131984_JQ1Pal	ENSG00000281690	81792	ADAM metallopeptidase with thrombospondin type 1 motif 12	NA	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43579
6.66227253790271e-12	0.293217609190969	0.547	0.422	1.05290555189014e-07	PTGR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000106853	22949	prostaglandin reductase 1	LTB4DH|ZADH3	protein_coding	Q14914	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43580
9.76561520066471e-12	-0.300217663886706	0.446	0.559	1.54335782631305e-07	IQSEC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000124313	23096	IQ motif and Sec7 domain ArfGEF 2	BRAG1|IQ-ArfGEF|KIAA0522|MRX1|MRX18|MRX78	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43581
1.06896681952901e-11	-0.271053459394297	0.461	0.581	1.68939516158365e-07	RP6-109B7.3	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43582
1.24449005607733e-11	-0.282885969859466	0.777	0.819	1.96679208462462e-07	PINK1	Malignant cells	GSE131984_JQ1Pal	ENSG00000158828	65018	PTEN induced kinase 1	BRPK|PARK6	protein_coding	Q9BXM7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43583
1.7763994011151e-11	-0.261784985423672	0.442	0.57	2.80742161352231e-07	MZT1	Malignant cells	GSE131984_JQ1Pal	ENSG00000204899	440145	mitotic spindle organizing protein 1	C13orf37|FLJ21869|LOC440145|MGC150539|MOZART1|RP11-11C5.2	protein_coding	Q08AG7	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43584
1.89371143597121e-11	0.298638583724361	0.632	0.526	2.99282155340891e-07	AAMDC	Malignant cells	GSE131984_JQ1Pal	ENSG00000087884	28971	adipogenesis associated Mth938 domain containing	C11orf67|CK067|FLJ21035|PTD015	protein_coding	Q9H7C9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43585
2.11739776174784e-11	-0.258593838086485	0.605	0.7	3.34633542266628e-07	SCAF11	Malignant cells	GSE131984_JQ1Pal	ENSG00000139218	9169	SR-related CTD associated factor 11	CASP11|SFRS2IP|SIP1|SRRP129|SRSF2IP	protein_coding	Q99590	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43586
2.19758604736809e-11	-0.285185958042758	0.759	0.818	3.47306498926054e-07	SDCBP	Malignant cells	GSE131984_JQ1Pal	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43587
2.29915012323726e-11	-0.255752044684394	0.321	0.447	3.63357685476417e-07	ACSL4	Malignant cells	GSE131984_JQ1Pal	ENSG00000068366	2182	acyl-CoA synthetase long chain family member 4	ACS4|FACL4|LACS4|MRX63|MRX68	protein_coding	O60488	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43588
2.33956856249637e-11	-0.254579451317345	0.442	0.552	3.69745415616926e-07	GNL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000229470	2794	G protein nucleolar 1 (putative)	HSR1	protein_coding	P36915	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43589
2.86580480053532e-11	-0.250019225883517	0.485	0.602	4.52911790676602e-07	GRB2	Malignant cells	GSE131984_JQ1Pal	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43590
4.3736441735115e-11	-0.287592972536994	0.555	0.643	6.91210725181757e-07	NMT2	Malignant cells	GSE131984_JQ1Pal	ENSG00000152465	9397	N-myristoyltransferase 2	NA	protein_coding	O60551	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43591
5.65855819556603e-11	-0.309650532118174	0.401	0.512	8.94278537227256e-07	MAD1L1	Malignant cells	GSE131984_JQ1Pal	ENSG00000002822	8379	mitotic arrest deficient 1 like 1	HsMAD1|MAD1|PIG9|TP53I9|TXBP181	protein_coding	Q9Y6D9	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43592
5.90208124551179e-11	-0.276739474412733	0.27	0.388	9.32764920040683e-07	LINC01133	Malignant cells	GSE131984_JQ1Pal	ENSG00000224259	NA	NA	lncRNA-PAGBC	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43593
6.7786455741818e-11	0.275889538846483	0.81	0.73	1.07129714654369e-06	EIF4A2	Malignant cells	GSE131984_JQ1Pal	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43594
7.61307285567101e-11	-0.2742532043869	0.491	0.598	1.20317003411025e-06	BET1	Malignant cells	GSE131984_JQ1Pal	ENSG00000105829	10282	Bet1 golgi vesicular membrane trafficking protein	hbet1	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43595
8.62000392884457e-11	-0.262020644415248	0.569	0.669	1.3623054209146e-06	RNF145	Malignant cells	GSE131984_JQ1Pal	ENSG00000145860	153830	ring finger protein 145	FLJ31951	protein_coding	Q96MT1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43596
8.62650931494938e-11	-0.273818392631484	0.447	0.554	1.3633335321346e-06	ALDH9A1	Malignant cells	GSE131984_JQ1Pal	ENSG00000143149	223	aldehyde dehydrogenase 9 family member A1	ALDH4|ALDH7|ALDH9|E3	protein_coding	P49189	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43597
9.48498371018946e-11	-0.25813119849766	0.607	0.692	1.49900682555834e-06	SPAG7	Malignant cells	GSE131984_JQ1Pal	ENSG00000091640	9552	sperm associated antigen 7	ACRP|FSA-1|MGC20134	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43598
9.59427661121028e-11	-0.252817695086836	0.306	0.423	1.51627947563567e-06	KRR1	Malignant cells	GSE131984_JQ1Pal	ENSG00000111615	11103	KRR1 small subunit processome component homolog	HRB2|RIP-1	protein_coding	Q13601	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43599
1.11343600514111e-10	-0.282118616346881	0.977	0.961	1.75967426252501e-06	HES1	Malignant cells	GSE131984_JQ1Pal	ENSG00000114315	3280	hes family bHLH transcription factor 1	bHLHb39|FLJ20408|HES-1|HRY	protein_coding	Q14469	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43600
1.13613172446008e-10	-0.279117727309622	0.319	0.434	1.79554257733672e-06	NFKBIZ	Malignant cells	GSE131984_JQ1Pal	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43601
1.44705110196502e-10	-0.251393738234174	0.549	0.644	2.28691956154552e-06	PPA2	Malignant cells	GSE131984_JQ1Pal	ENSG00000138777	27068	inorganic pyrophosphatase 2	FLJ20459	protein_coding	Q9H2U2	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43602
1.44972471099731e-10	-0.250378705688422	0.414	0.529	2.29114493326015e-06	SAP30BP	Malignant cells	GSE131984_JQ1Pal	ENSG00000161526	29115	SAP30 binding protein	HCNGP|HTRG|HTRP	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43603
1.73357914470461e-10	-0.264428164952125	0.24	0.354	2.73974848029116e-06	DDX10	Malignant cells	GSE131984_JQ1Pal	ENSG00000178105	1662	DEAD-box helicase 10	Dbp4|HRH-J8	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43604
1.85574355688806e-10	-0.307156866105412	0.643	0.709	2.93281711730589e-06	RP11-304L19.5	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43605
2.01230943507118e-10	-0.257861779240981	0.612	0.697	3.1802538311865e-06	TMEM261	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43606
2.5396774175375e-10	-0.275437390070249	0.629	0.717	4.01370619067627e-06	PDLIM7	Malignant cells	GSE131984_JQ1Pal	ENSG00000196923	9260	PDZ and LIM domain 7	ENIGMA	protein_coding	Q9NR12	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43607
3.70795506538225e-10	-0.260352438414338	0.633	0.699	5.86005218533011e-06	C15orf61	Malignant cells	GSE131984_JQ1Pal	ENSG00000189227	145853	chromosome 15 open reading frame 61	LOC145853	protein_coding	A6NNL5	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43608
4.65320866705291e-10	-0.297780183358457	0.516	0.614	7.35393097741041e-06	TMEM255B	Malignant cells	GSE131984_JQ1Pal	ENSG00000282107	348013	transmembrane protein 255B	FAM70B|MGC20579	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43609
4.92683140771096e-10	-0.267432415336002	0.393	0.506	7.7863643567464e-06	USP53	Malignant cells	GSE131984_JQ1Pal	ENSG00000145390	54532	ubiquitin specific peptidase 53	KIAA1350	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43610
5.77902185416809e-10	0.27164957610339	0.599	0.494	9.13316613832726e-06	ZMYND8	Malignant cells	GSE131984_JQ1Pal	ENSG00000101040	23613	zinc finger MYND-type containing 8	KIAA1125|PRKCBP1|RACK7	protein_coding	Q9ULU4	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43611
9.17221714296457e-10	-0.400436563356642	0.329	0.437	1.44957719727412e-05	JUN	Malignant cells	GSE131984_JQ1Pal	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43612
9.18179563126275e-10	0.280356197331524	0.804	0.688	1.45109098156477e-05	EREG	Malignant cells	GSE131984_JQ1Pal	ENSG00000124882	2069	epiregulin	ER	protein_coding	O14944	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43613
1.09530569166175e-09	-0.263308609801378	0.611	0.695	1.73102111510223e-05	FADS1	Malignant cells	GSE131984_JQ1Pal	ENSG00000149485	3992	fatty acid desaturase 1	D5D|FADS6|FADSD5|LLCDL1|TU12	protein_coding	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43614
1.53049637525786e-09	-0.3554863641887	0.606	0.664	2.41879647145752e-05	MAGEC2	Malignant cells	GSE131984_JQ1Pal	ENSG00000046774	51438	MAGE family member C2	CT10|HCA587|MAGE-C2|MAGEE1	protein_coding	Q9UBF1	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43615
1.6170287362925e-09	-0.271357844327996	0.693	0.756	2.55555221483667e-05	MDH1	Malignant cells	GSE131984_JQ1Pal	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43616
9.18817831322974e-09	-0.49431834663904	0.237	0.337	0.000145209970062283	MGP	Malignant cells	GSE131984_JQ1Pal	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43617
9.65549208771633e-09	-0.251734614951148	0.229	0.333	0.000152595396954269	MGLL	Malignant cells	GSE131984_JQ1Pal	ENSG00000074416	11343	monoglyceride lipase	HU-K5|MAGL|MGL	protein_coding	Q99685	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43618
2.11765873763556e-08	-0.306537765021104	0.185	0.274	0.000334674786895923	FHL1	Malignant cells	GSE131984_JQ1Pal	ENSG00000022267	2273	four and a half LIM domains 1	bA535K18.1|FHL1B|FLH1A|KYO-T|MGC111107|SLIM1|XMPMA	protein_coding	Q13642	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43619
2.31940839848773e-08	-0.252117361825732	0.519	0.601	0.000366559303297	ABL2	Malignant cells	GSE131984_JQ1Pal	ENSG00000143322	27	ABL proto-oncogene 2, non-receptor tyrosine kinase	ABLL|ARG	protein_coding	P42684	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43620
1.15358055031891e-06	0.260709914742141	0.386	0.294	0.0182311870172401	AC006262.5	Malignant cells	GSE131984_JQ1Pal	NA	NA	NA	NA	NA	NA	GSE131984_JQ1Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	JQ1 + palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	2085	Public on Apr 08, 2024	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment samples.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	43621
9.66008158123403e-174	-2.83922665997203	0.395	0.91	1.48948797901047e-169	IL8	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43622
2.06284742659528e-163	1.04603097842519	1	0.993	3.18070444706727e-159	ODC1	Malignant cells	GSE131984_Pac	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43623
1.09072780152308e-151	0.824300828977289	1	0.997	1.68179319716844e-147	SRM	Malignant cells	GSE131984_Pac	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43624
3.04046890755076e-141	0.904662243490569	0.999	0.977	4.68809900855251e-137	TOMM40	Malignant cells	GSE131984_Pac	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43625
1.1278755857443e-140	-2.11349588871237	0.472	0.899	1.73907136565914e-136	CXCL2	Malignant cells	GSE131984_Pac	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43626
3.69718704638836e-129	-1.24080838936102	0.964	0.994	5.70069270682621e-125	IER3	Malignant cells	GSE131984_Pac	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43627
2.48689891476887e-126	-0.598352475201176	1	1	3.83454943668212e-122	LGALS1	Malignant cells	GSE131984_Pac	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43628
3.01525323968378e-113	-1.16498489843189	0.363	0.811	4.64921897026842e-109	INSIG1	Malignant cells	GSE131984_Pac	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43629
7.7324149559914e-107	-1.05924283141362	0.56	0.877	1.19226106206431e-102	SCD	Malignant cells	GSE131984_Pac	ENSG00000099194	6319	stearoyl-CoA desaturase	FADS5|SCD1|SCDOS	protein_coding	O00767	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43630
2.15473581233499e-99	-1.2404661265621	0.301	0.747	3.32238714903931e-95	EGR1	Malignant cells	GSE131984_Pac	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43631
2.82060315835649e-94	0.641902067067469	0.999	0.982	4.34908800986987e-90	RPS19BP1	Malignant cells	GSE131984_Pac	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43632
3.22103334697344e-94	-0.460320240194878	1	1	4.96651131769834e-90	EEF1A1	Malignant cells	GSE131984_Pac	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43633
4.64736567503977e-92	0.563765000013346	1	0.996	7.16577313434382e-88	RANBP1	Malignant cells	GSE131984_Pac	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43634
5.55472478284864e-92	0.774991539038142	0.999	0.993	8.56483014267431e-88	FABP5	Malignant cells	GSE131984_Pac	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43635
2.09078078783478e-90	-1.0335552097349	0.816	0.96	3.22377489676245e-86	NFKBIA	Malignant cells	GSE131984_Pac	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43636
1.7810047969885e-89	0.62970524078204	0.997	0.971	2.74613129647657e-85	MRPS12	Malignant cells	GSE131984_Pac	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43637
1.76929425091609e-88	0.782506390753415	0.969	0.853	2.72807480548752e-84	GPATCH4	Malignant cells	GSE131984_Pac	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43638
1.86784089117365e-87	-1.10849512687319	0.456	0.808	2.88002387010065e-83	JUNB	Malignant cells	GSE131984_Pac	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43639
8.90712690402664e-82	0.525490147690259	1	0.996	1.37338989733187e-77	MRPL20	Malignant cells	GSE131984_Pac	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43640
5.09085785550162e-81	0.614000060637301	0.995	0.949	7.84959372739795e-77	C11orf48	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43641
8.88242058124079e-80	0.526945369032924	1	1	1.36958042942152e-75	NAA10	Malignant cells	GSE131984_Pac	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43642
3.54246454800222e-79	-0.808805048419733	0.971	0.992	5.46212608656462e-75	HSPB1	Malignant cells	GSE131984_Pac	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43643
8.7871103406339e-74	-0.997451048149285	0.348	0.719	1.35488454342234e-69	PNRC1	Malignant cells	GSE131984_Pac	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43644
5.22399722454528e-73	0.888021224248733	0.888	0.648	8.05488132052636e-69	LINC00958	Malignant cells	GSE131984_Pac	ENSG00000251381	100506305	long intergenic non-protein coding RNA 958	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43645
5.81901229310767e-73	0.649315329394204	1	0.999	8.97233505474272e-69	UBE2S	Malignant cells	GSE131984_Pac	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43646
9.13140699654271e-73	0.595872541263069	0.995	0.962	1.40797164479692e-68	EMC6	Malignant cells	GSE131984_Pac	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43647
3.94428252180817e-72	0.667168974684815	0.984	0.919	6.08168922037601e-68	NOP56	Malignant cells	GSE131984_Pac	ENSG00000101361	10528	NOP56 ribonucleoprotein	NOL5A|SCA36	protein_coding	O00567	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43648
4.55691307260584e-72	0.753783490256577	0.989	0.943	7.02630426665094e-68	CCND1	Malignant cells	GSE131984_Pac	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43649
4.63219233404268e-71	0.804521298852204	0.948	0.814	7.1423773598604e-67	LYAR	Malignant cells	GSE131984_Pac	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43650
2.35467146804496e-70	0.587088080701317	0.997	0.973	3.63066793657852e-66	HNRNPAB	Malignant cells	GSE131984_Pac	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43651
5.71457042434627e-70	-0.807582453296922	1	1	8.81129613729951e-66	AKR1B1	Malignant cells	GSE131984_Pac	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43652
8.66748596445463e-69	-0.938831870912373	0.863	0.952	1.33643966085926e-64	SOD2	Malignant cells	GSE131984_Pac	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43653
4.4661444039977e-68	0.639050294066989	0.996	0.979	6.88634805652406e-64	CD59	Malignant cells	GSE131984_Pac	ENSG00000085063	966	CD59 molecule (CD59 blood group)	16.3A5|EJ16|EJ30|EL32|G344|MIC11|MIN1|MIN2|MIN3|MSK21|p18-20	protein_coding	P13987	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43654
5.60274596930401e-68	-0.731492878503283	0.806	0.949	8.63887401006985e-64	H2AFJ	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43655
6.9870924659393e-68	0.515269977510873	1	0.996	1.07733978732318e-63	CYCS	Malignant cells	GSE131984_Pac	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43656
1.72783354407013e-67	0.716266211586822	0.969	0.861	2.66414654160173e-63	DKC1	Malignant cells	GSE131984_Pac	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43657
1.73901829541114e-67	0.6615876142554	0.96	0.834	2.68139230969444e-63	POLR3K	Malignant cells	GSE131984_Pac	ENSG00000161980	51728	RNA polymerase III subunit K	C11|RPC11	protein_coding	Q9Y2Y1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43658
3.75259367829378e-67	0.587546785791039	1	0.996	5.78612419256118e-63	C1QBP	Malignant cells	GSE131984_Pac	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43659
1.86433410412451e-66	0.487697904284955	1	1	2.87461675514958e-62	HSPE1	Malignant cells	GSE131984_Pac	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43660
4.58398135293464e-66	0.664447037189394	0.931	0.747	7.06804084808992e-62	POLR3H	Malignant cells	GSE131984_Pac	ENSG00000100413	171568	RNA polymerase III subunit H	C25|KIAA1665|RPC8	protein_coding	Q9Y535	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43661
1.34312940709699e-65	0.56825469129387	0.993	0.933	2.07097123280285e-61	POP7	Malignant cells	GSE131984_Pac	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43662
1.5826945629065e-65	-1.22691400490399	0.188	0.557	2.44035674654553e-61	IL6	Malignant cells	GSE131984_Pac	ENSG00000136244	3569	interleukin 6	BSF2|HGF|HSF|IFNB2|IL-6	protein_coding	P05231	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43663
1.89603482334424e-65	0.66642446904642	0.908	0.704	2.92349609411448e-61	SURF2	Malignant cells	GSE131984_Pac	ENSG00000281024	6835	surfeit 2	NA	protein_coding	Q15527	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43664
8.67081314184807e-64	0.574718157245621	0.979	0.912	1.33695267834155e-59	ZNF593	Malignant cells	GSE131984_Pac	ENSG00000142684	51042	zinc finger protein 593	ZT86	protein_coding	O00488	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43665
8.95448973085732e-64	0.69927938754218	0.731	0.378	1.38069277160089e-59	ATAD3B	Malignant cells	GSE131984_Pac	ENSG00000160072	83858	ATPase family AAA domain containing 3B	KIAA1273|TOB3	protein_coding	Q5T9A4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43666
3.45319027526549e-63	0.489011176697367	0.999	0.993	5.32447408543185e-59	ITGB1BP1	Malignant cells	GSE131984_Pac	ENSG00000119185	9270	integrin subunit beta 1 binding protein 1	ICAP-1A|ICAP-1alpha|ICAP-1B|ICAP1|ICAP1A|ICAP1B	protein_coding	O14713	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43667
2.49014239873583e-62	-0.74734184227246	0.141	0.507	3.83955056461077e-58	TNFAIP3	Malignant cells	GSE131984_Pac	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43668
6.19070288165529e-62	0.660025193728065	0.957	0.81	9.54544477322429e-58	FAM58A	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43669
7.97552709100914e-62	0.531500586170572	0.999	0.983	1.2297465221627e-57	DDX21	Malignant cells	GSE131984_Pac	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43670
1.80884312005121e-61	0.548812579155988	0.997	0.987	2.78905520680696e-57	EBNA1BP2	Malignant cells	GSE131984_Pac	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43671
1.39839817376189e-60	0.435323083068416	0.999	0.998	2.15619014412346e-56	TIMM13	Malignant cells	GSE131984_Pac	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43672
2.53784118564216e-60	-1.18944048953079	0.657	0.857	3.91309732414165e-56	CYR61	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43673
1.08756518183158e-59	0.376728372142848	1	1	1.67691675386611e-55	AURKAIP1	Malignant cells	GSE131984_Pac	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43674
6.92384562844108e-58	0.397873792830399	1	1	1.06758775744933e-53	PRELID1	Malignant cells	GSE131984_Pac	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43675
9.94904842038661e-58	0.647687856204975	1	0.992	1.53404377593941e-53	NCL	Malignant cells	GSE131984_Pac	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43676
6.50718372961418e-57	0.716413990109481	1	0.999	1.00334265926921e-52	KRT7	Malignant cells	GSE131984_Pac	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43677
1.27706896207001e-56	0.56770318729861	0.979	0.888	1.96911263261575e-52	LSM10	Malignant cells	GSE131984_Pac	ENSG00000181817	84967	LSM10, U7 small nuclear RNA associated	MGC15749	protein_coding	Q969L4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43678
7.23071881015258e-56	-0.84161139253473	0.739	0.892	1.11490453333743e-51	CEBPD	Malignant cells	GSE131984_Pac	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43679
2.89117862300082e-54	0.408717860682586	1	1	4.45790831880496e-50	NHP2L1	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43680
5.58955830096417e-54	0.456525772978641	1	0.993	8.61853994425665e-50	DYNLL1	Malignant cells	GSE131984_Pac	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43681
1.0464513148685e-53	0.502061661141964	0.973	0.938	1.61352328239573e-49	AUP1	Malignant cells	GSE131984_Pac	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43682
1.18913318010124e-52	0.615533891337646	0.96	0.867	1.8335244503981e-48	NOP16	Malignant cells	GSE131984_Pac	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43683
1.45639803499274e-52	0.510386062262386	0.983	0.942	2.24562013015531e-48	ARPC5L	Malignant cells	GSE131984_Pac	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43684
5.35664147005033e-52	0.512763028379861	0.999	0.995	8.25940548267061e-48	TNFRSF12A	Malignant cells	GSE131984_Pac	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43685
9.85791652178695e-52	0.417797485528895	1	0.999	1.51999214849433e-47	JTB	Malignant cells	GSE131984_Pac	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43686
2.26507689608968e-51	0.435226626623045	0.999	0.991	3.49252206608068e-47	SIVA1	Malignant cells	GSE131984_Pac	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43687
7.96318405077501e-51	-0.846188624015304	0.621	0.828	1.227843348789e-46	IER2	Malignant cells	GSE131984_Pac	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43688
3.40455806581104e-50	-0.576773169511556	0.156	0.484	5.24948808167405e-46	SMIM14	Malignant cells	GSE131984_Pac	ENSG00000163683	201895	small integral membrane protein 14	C4orf34|FLJ13289	protein_coding	Q96QK8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43689
7.0144505318538e-50	0.392369076917699	1	1	1.08155812750654e-45	EIF5A	Malignant cells	GSE131984_Pac	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43690
8.96216557466406e-50	-0.285363480830346	1	1	1.38187630995745e-45	RPL3	Malignant cells	GSE131984_Pac	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43691
1.06360040622746e-49	-0.694562056309281	0.936	0.978	1.63996546636213e-45	TM4SF1	Malignant cells	GSE131984_Pac	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43692
8.4151778531822e-49	0.584948634108336	0.92	0.777	1.29753627318216e-44	DNAJC9	Malignant cells	GSE131984_Pac	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43693
2.37473835965143e-47	0.489871753988425	0.981	0.919	3.66160907674654e-43	ITGAE	Malignant cells	GSE131984_Pac	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43694
2.53210892766235e-47	0.471166240979375	0.997	0.989	3.90425875556258e-43	ATP6V0B	Malignant cells	GSE131984_Pac	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43695
3.98433128957585e-47	-0.453642857653199	0.98	0.997	6.14344041539701e-43	EIF3E	Malignant cells	GSE131984_Pac	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43696
5.13152663226161e-47	-0.594072510441466	0.69	0.881	7.91230091428417e-43	IFI27L2	Malignant cells	GSE131984_Pac	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43697
6.53790220117013e-47	-0.501459020565937	0.944	0.984	1.00807914039842e-42	RABAC1	Malignant cells	GSE131984_Pac	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43698
1.00130050603847e-46	0.354364526705819	1	1	1.54390525026071e-42	PFN1	Malignant cells	GSE131984_Pac	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43699
1.09873772858868e-46	0.466491381528952	0.987	0.959	1.69414370371088e-42	MRPL21	Malignant cells	GSE131984_Pac	ENSG00000197345	219927	mitochondrial ribosomal protein L21	NA	protein_coding	Q7Z2W9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43700
3.95664388071695e-46	0.563155399943133	0.878	0.713	6.10074919967746e-42	POLE3	Malignant cells	GSE131984_Pac	ENSG00000148229	54107	DNA polymerase epsilon 3, accessory subunit	CHARAC17|CHRAC17|CHRAC2|p17|Ybl1	protein_coding	Q9NRF9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43701
4.0497714240809e-46	0.586857641326321	0.839	0.611	6.24434255879034e-42	RPUSD1	Malignant cells	GSE131984_Pac	ENSG00000007376	113000	RNA pseudouridine synthase domain containing 1	C16orf40|MGC19600|RLUCL	protein_coding	Q9UJJ7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43702
1.18974666933012e-45	-0.673661705836505	0.924	0.979	1.83447038944011e-41	NNMT	Malignant cells	GSE131984_Pac	ENSG00000166741	4837	nicotinamide N-methyltransferase	NA	protein_coding	P40261	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43703
2.4125877511695e-45	0.563448362280303	0.746	0.47	3.71996905352826e-41	CCDC86	Malignant cells	GSE131984_Pac	ENSG00000110104	79080	coiled-coil domain containing 86	cyclon|MGC2574	protein_coding	Q9H6F5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43704
2.59229863873071e-45	0.466984529808922	0.972	0.904	3.99706527105888e-41	PTS	Malignant cells	GSE131984_Pac	ENSG00000150787	5805	6-pyruvoyltetrahydropterin synthase	PTPS	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43705
2.7113078402586e-45	-0.364416677801149	1	0.999	4.18056555889474e-41	DBI	Malignant cells	GSE131984_Pac	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43706
3.50789567748252e-45	-0.580256433721814	0.136	0.436	5.40882434511029e-41	NFKBIZ	Malignant cells	GSE131984_Pac	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43707
7.75354816651528e-45	0.644943705308308	0.999	0.999	1.19551959179499e-40	HSPA8	Malignant cells	GSE131984_Pac	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43708
1.3409220398951e-44	0.488283197843997	0.963	0.842	2.06756769331425e-40	IMP4	Malignant cells	GSE131984_Pac	ENSG00000136718	92856	IMP U3 small nucleolar ribonucleoprotein 4	BXDC4|MGC19606	protein_coding	Q96G21	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43709
3.55457948751117e-44	0.393480512613629	0.995	0.992	5.48080611179348e-40	LSM2	Malignant cells	GSE131984_Pac	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43710
5.11945074561182e-44	0.693041931707316	0.875	0.633	7.89368110465887e-40	SCG5	Malignant cells	GSE131984_Pac	ENSG00000277614	6447	secretogranin V	7B2|SGNE1|SgV	protein_coding	P05408	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43711
8.56875145368479e-44	0.347558927638081	1	1	1.32121578664366e-39	RAN	Malignant cells	GSE131984_Pac	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43712
2.75232402330783e-43	0.336016645852527	1	1	4.24380841153834e-39	SERBP1	Malignant cells	GSE131984_Pac	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43713
1.22283312857012e-42	0.514900095527339	0.809	0.531	1.88548640094226e-38	AC010642.1	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43714
2.3640296609982e-42	-1.12070793714937	0.149	0.436	3.64509733429312e-38	CXCL3	Malignant cells	GSE131984_Pac	ENSG00000163734	2921	C-X-C motif chemokine ligand 3	CINC-2b|GRO3|GROg|MIP-2b|SCYB3	protein_coding	P19876	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43715
2.80925022403312e-42	0.493099172197568	0.948	0.836	4.33158292043666e-38	ORMDL1	Malignant cells	GSE131984_Pac	ENSG00000128699	94101	ORMDL sphingolipid biosynthesis regulator 1	NA	protein_coding	Q9P0S3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43716
4.35777982131154e-42	0.426601268998553	0.987	0.976	6.71926070648026e-38	MRPL4	Malignant cells	GSE131984_Pac	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43717
6.15597234500949e-42	0.533868601908056	0.892	0.756	9.49189375877014e-38	YDJC	Malignant cells	GSE131984_Pac	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43718
1.58637462046958e-41	-0.536082783004832	0.999	0.997	2.44603102730205e-37	C5orf38	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43719
2.72683145128803e-41	0.416514216255483	1	0.997	4.20450141474102e-37	EIF1AX	Malignant cells	GSE131984_Pac	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43720
4.79210715117758e-41	0.429389074389804	0.993	0.975	7.38895001640071e-37	POLE4	Malignant cells	GSE131984_Pac	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43721
1.03498250695695e-40	-0.749119729572647	0.991	0.992	1.59583952747692e-36	NEAT1	Malignant cells	GSE131984_Pac	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43722
1.24571655049138e-40	0.48343052939804	0.956	0.88	1.92077034920266e-36	IMP3	Malignant cells	GSE131984_Pac	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43723
2.39615939412748e-40	0.574176402292312	0.672	0.415	3.69463816980516e-36	CD3EAP	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43724
2.84222642711046e-40	0.393113465191226	1	0.997	4.38242892796162e-36	HN1	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43725
3.90521748208926e-40	-0.434108517868049	0.985	0.997	6.02145483563343e-36	TKT	Malignant cells	GSE131984_Pac	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43726
1.60346033267872e-39	0.302368874197143	1	1	2.47237548695731e-35	GADD45GIP1	Malignant cells	GSE131984_Pac	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43727
1.61985996468587e-39	0.331979045749728	1	0.999	2.49766207954915e-35	MTDH	Malignant cells	GSE131984_Pac	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43728
1.75919313232037e-39	-0.61426401688233	0.682	0.836	2.71249989072478e-35	IFI27	Malignant cells	GSE131984_Pac	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43729
1.87645416008842e-39	0.45452022539207	0.987	0.967	2.89330466944033e-35	COA4	Malignant cells	GSE131984_Pac	ENSG00000181924	51287	cytochrome c oxidase assembly factor 4 homolog	CHCHD8|CMC3|E2IG2	protein_coding	Q9NYJ1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43730
2.24994326592479e-39	0.435436572785637	0.985	0.934	3.46918752172944e-35	MRPS26	Malignant cells	GSE131984_Pac	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43731
2.70444938149185e-39	0.453519197721281	0.523	0.238	4.16999050132228e-35	TRMT61A	Malignant cells	GSE131984_Pac	ENSG00000166166	115708	tRNA methyltransferase 61A	C14orf172|FLJ40452|GCD14|Gcd14p|hTRM61	protein_coding	Q96FX7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43732
5.59916455463939e-39	0.499439505887602	0.887	0.726	8.63335182679848e-35	BRMS1	Malignant cells	GSE131984_Pac	ENSG00000174744	25855	BRMS1 transcriptional repressor and anoikis regulator	DKFZP564A063	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43733
5.60007442311577e-39	0.584559412219668	0.944	0.812	8.63475475300221e-35	CDC20	Malignant cells	GSE131984_Pac	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43734
6.1479193951747e-39	0.464352016302286	0.976	0.939	9.47947691541987e-35	DCUN1D5	Malignant cells	GSE131984_Pac	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43735
6.28293598014437e-39	0.393779146827872	0.993	0.983	9.6876589877846e-35	C19orf43	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43736
8.8042956018581e-39	0.506247260601307	0.802	0.573	1.3575343388505e-34	PITHD1	Malignant cells	GSE131984_Pac	ENSG00000057757	57095	PITH domain containing 1	C1orf128|HT014|TXNL1CL	protein_coding	Q9GZP4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43737
1.70790153454505e-38	0.486290486343398	0.686	0.406	2.63341337611502e-34	PUS1	Malignant cells	GSE131984_Pac	ENSG00000177192	80324	pseudouridine synthase 1	MLASA1	protein_coding	Q9Y606	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43738
1.72548855698392e-38	-0.591988579128801	0.758	0.893	2.6605308060135e-34	GLRX	Malignant cells	GSE131984_Pac	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43739
2.36591945175351e-38	0.423335663201895	0.985	0.97	3.64801120265873e-34	NOL7	Malignant cells	GSE131984_Pac	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43740
2.92217952007108e-38	0.468759003727069	0.928	0.812	4.5057086019976e-34	NAA50	Malignant cells	GSE131984_Pac	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43741
5.61711547645705e-38	0.41308601054656	0.997	0.992	8.66103035314913e-34	LRRC59	Malignant cells	GSE131984_Pac	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43742
7.1597760969397e-38	0.440798820054054	0.995	0.986	1.10396587638713e-33	EIF5	Malignant cells	GSE131984_Pac	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43743
8.45135364076191e-38	0.389417021192935	1	0.989	1.30311421786908e-33	EI24	Malignant cells	GSE131984_Pac	ENSG00000149547	9538	EI24 autophagy associated transmembrane protein	EPG4|PIG8|TP53I8	protein_coding	O14681	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43744
1.06386764098508e-37	0.40156617129295	0.995	0.967	1.6403775156349e-33	ZC3H15	Malignant cells	GSE131984_Pac	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43745
1.74402979035837e-37	0.370177640108843	0.996	0.993	2.68911953375357e-33	MRPL12	Malignant cells	GSE131984_Pac	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43746
1.86520576898548e-37	-0.605940737531449	0.633	0.801	2.87596077519871e-33	FASN	Malignant cells	GSE131984_Pac	ENSG00000169710	2194	fatty acid synthase	FAS|SDR27X1	protein_coding	P49327	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43747
2.23008553872021e-37	-0.561589155251905	0.6	0.8	3.43856889215269e-33	RRAS	Malignant cells	GSE131984_Pac	ENSG00000126458	6237	RAS related	R-Ras	protein_coding	P10301	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43748
2.49353951487913e-37	0.487971849451462	0.936	0.896	3.84478857799213e-33	CENPV	Malignant cells	GSE131984_Pac	ENSG00000166582	201161	centromere protein V	CENP-V|p30|PRR6	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43749
9.83541264799946e-37	0.326346170177553	1	1	1.51652227619504e-32	TAF9	Malignant cells	GSE131984_Pac	ENSG00000276463	6880	TATA-box binding protein associated factor 9	AD-004|CGI-137|MGC1603|MGC3647|MGC5067|TAF2G|TAFII31|TAFII32|TAFIID32	protein_coding	Q16594	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43750
1.4453662653207e-36	0.461752198934345	0.981	0.955	2.22861024449799e-32	RSL1D1	Malignant cells	GSE131984_Pac	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43751
1.55430335421253e-36	-0.343986486275143	1	0.999	2.3965803418603e-32	UQCRB	Malignant cells	GSE131984_Pac	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43752
1.74249990672441e-36	0.488786431759097	0.811	0.611	2.68676060617836e-32	ATAD3A	Malignant cells	GSE131984_Pac	ENSG00000197785	55210	ATPase family AAA domain containing 3A	FLJ10709	protein_coding	Q9NVI7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43753
1.7931380160479e-36	0.516678948855071	0.835	0.665	2.76483950694425e-32	PTDSS1	Malignant cells	GSE131984_Pac	ENSG00000156471	9791	phosphatidylserine synthase 1	KIAA0024|PSS1|PSSA	protein_coding	P48651	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43754
1.81824402106495e-36	-0.29656260179512	1	1	2.80355045608005e-32	S100A6	Malignant cells	GSE131984_Pac	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43755
3.51270870197101e-36	-0.37025434196371	0.989	0.998	5.41624554756911e-32	EIF3F	Malignant cells	GSE131984_Pac	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43756
4.60590651489785e-36	-0.908403621413697	0.531	0.713	7.101847255321e-32	TUBA1A	Malignant cells	GSE131984_Pac	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43757
4.93290650344871e-36	0.34998616849792	0.997	0.995	7.60604853766757e-32	SNRPD1	Malignant cells	GSE131984_Pac	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43758
5.66948878211845e-36	0.445456653199376	0.964	0.891	8.74178475314843e-32	TOP1	Malignant cells	GSE131984_Pac	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43759
9.77173258155427e-36	0.440701667940729	0.969	0.907	1.50670344674985e-31	CWC15	Malignant cells	GSE131984_Pac	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43760
1.24421244149426e-35	0.521008986097829	0.664	0.42	1.91845116354001e-31	RRP9	Malignant cells	GSE131984_Pac	ENSG00000114767	9136	ribosomal RNA processing 9, U3 small nucleolar RNA binding protein	RNU3IP2|U3-55K	protein_coding	O43818	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43761
5.25407864333528e-35	0.445315898626642	0.973	0.909	8.10126386015867e-31	DCTPP1	Malignant cells	GSE131984_Pac	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43762
5.91828536932926e-35	0.44887950029093	0.935	0.838	9.12540421096878e-31	EMC8	Malignant cells	GSE131984_Pac	ENSG00000131148	10328	ER membrane protein complex subunit 8	C16orf2|C16orf4|COX4NB|FAM158B|NOC4	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43763
6.9127501131414e-35	0.45984504195094	0.906	0.747	1.06587693994527e-30	DNAJC2	Malignant cells	GSE131984_Pac	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43764
7.00309944510986e-35	0.368958509615058	0.997	0.993	1.07980790344149e-30	CNBP	Malignant cells	GSE131984_Pac	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43765
7.56975945450366e-35	0.42381755469292	0.977	0.926	1.16718121028992e-30	CD320	Malignant cells	GSE131984_Pac	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43766
7.76949617090386e-35	-0.318706501376704	1	1	1.19797861459167e-30	PPIA	Malignant cells	GSE131984_Pac	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43767
1.06919481383324e-34	0.395434034047369	0.992	0.95	1.64859148344947e-30	HRAS	Malignant cells	GSE131984_Pac	ENSG00000276536	3265	HRas proto-oncogene, GTPase	HRAS1	protein_coding	P01112	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43768
1.14772050106426e-34	0.397997540113243	0.996	0.983	1.76967024059098e-30	COPRS	Malignant cells	GSE131984_Pac	ENSG00000172301	55352	coordinator of PRMT5 and differentiation stimulator	C17orf79|COPR5|HSA272196|TTP1	protein_coding	Q9NQ92	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43769
1.51996737600792e-34	0.294753641607953	0.997	0.995	2.34363769706661e-30	MRPL14	Malignant cells	GSE131984_Pac	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43770
1.80648480547852e-34	0.461529135433676	1	0.997	2.78541892156733e-30	MT2A	Malignant cells	GSE131984_Pac	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43771
3.32649750552784e-34	-0.336057998394446	1	1	5.12912650377338e-30	GPX4	Malignant cells	GSE131984_Pac	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43772
3.52153172241871e-34	-0.484343130712533	0.515	0.733	5.42984976279741e-30	DPM3	Malignant cells	GSE131984_Pac	ENSG00000179085	54344	dolichyl-phosphate mannosyltransferase subunit 3, regulatory	MGC125904|MGC125905|MGC34275	protein_coding	Q9P2X0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43773
4.30448097021362e-34	-0.556875792075504	0.703	0.841	6.63707920797239e-30	BLVRB	Malignant cells	GSE131984_Pac	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43774
4.57802369986989e-34	0.421782970082379	0.944	0.861	7.05885474282938e-30	FAM136A	Malignant cells	GSE131984_Pac	ENSG00000035141	84908	family with sequence similarity 136 member A	FLJ14668	protein_coding	Q96C01	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43775
5.4201491813677e-34	0.419841177677574	0.972	0.917	8.35732802275085e-30	RBM17	Malignant cells	GSE131984_Pac	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43776
5.80427392577274e-34	0.383325563969846	0.985	0.968	8.94960996614899e-30	SSU72	Malignant cells	GSE131984_Pac	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43777
6.61244965263193e-34	0.453366891283243	0.88	0.725	1.01957361193932e-29	TRIAP1	Malignant cells	GSE131984_Pac	ENSG00000170855	51499	TP53 regulated inhibitor of apoptosis 1	HSPC132|MDM35|P53CSV|WF-1	protein_coding	O43715	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43778
1.16322763312368e-33	0.473062895717657	0.846	0.667	1.7935806875134e-29	TFAM	Malignant cells	GSE131984_Pac	ENSG00000108064	7019	transcription factor A, mitochondrial	TCF6|TCF6L2	protein_coding	Q00059	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43779
1.21376209595747e-33	0.518373877229844	0.843	0.686	1.87149977575682e-29	NIFK	Malignant cells	GSE131984_Pac	ENSG00000155438	84365	nucleolar protein interacting with the FHA domain of MKI67	hNIFK|MKI67IP|Nopp34	protein_coding	Q9BYG3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43780
1.43134596919871e-33	0.330988610584301	1	1	2.20699234990749e-29	HMGA1	Malignant cells	GSE131984_Pac	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43781
1.52957409311739e-33	-0.71849262725295	0.422	0.664	2.35845029417771e-29	AKR1C3	Malignant cells	GSE131984_Pac	ENSG00000196139	8644	aldo-keto reductase family 1 member C3	DDX|HAKRB|HSD17B5|KIAA0119|PGFS	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43782
1.89973839891852e-33	-0.747587046134242	0.524	0.725	2.92920663729246e-29	DUSP1	Malignant cells	GSE131984_Pac	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43783
2.16502800301216e-33	-0.504006488423487	0.384	0.633	3.33825667784445e-29	OPTN	Malignant cells	GSE131984_Pac	ENSG00000123240	10133	optineurin	FIP-2|FIP2|GLC1E|HIP7|HYPL|NRP|TFIIIA-INTP	protein_coding	Q96CV9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43784
3.83571992643826e-33	0.465221787048582	0.735	0.493	5.91429655457516e-29	RRP1B	Malignant cells	GSE131984_Pac	ENSG00000160208	23076	ribosomal RNA processing 1B	KIAA0179|Nnp1|PPP1R136|RRP1	protein_coding	Q14684	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43785
4.45505246115879e-33	0.388732629474366	0.992	0.949	6.86924538986074e-29	MRPL27	Malignant cells	GSE131984_Pac	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43786
4.735536613453e-33	0.422002739676492	0.948	0.884	7.30172390428318e-29	ELOF1	Malignant cells	GSE131984_Pac	ENSG00000130165	84337	elongation factor 1	ELF1|MGC4549	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43787
6.07423305499823e-33	0.331096601526418	0.997	0.994	9.36585994750177e-29	GTF3C6	Malignant cells	GSE131984_Pac	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43788
6.59620750833946e-33	0.38236112423925	0.983	0.943	1.01706923571086e-28	C20orf24	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43789
7.26454981468099e-33	0.481968000603988	0.872	0.729	1.12012093592566e-28	EMG1	Malignant cells	GSE131984_Pac	ENSG00000126749	10436	EMG1 N1-specific pseudouridine methyltransferase	C2F|Grcc2f|NEP1	protein_coding	Q92979	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43790
8.04125854727308e-33	0.304557833128595	1	1	1.23988165540404e-28	MRPL41	Malignant cells	GSE131984_Pac	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43791
8.91670559349278e-33	-0.586045040783365	0.484	0.707	1.37486683546065e-28	RP11-304L19.5	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43792
1.06646599838443e-32	-0.397197039370151	0.177	0.441	1.64438392290895e-28	JUP	Malignant cells	GSE131984_Pac	ENSG00000173801	3728	junction plakoglobin	CTNNG|DP3|DPIII|PDGB|PG|PKGB	protein_coding	P14923	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43793
1.58670663836018e-32	0.397050561923123	0.989	0.958	2.44654296568757e-28	KIF5B	Malignant cells	GSE131984_Pac	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43794
2.19333940365048e-32	0.376214239331136	0.991	0.975	3.38191002648868e-28	PPP1CC	Malignant cells	GSE131984_Pac	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43795
2.34950620191429e-32	0.487963893023143	0.755	0.541	3.62270361273165e-28	RRP1	Malignant cells	GSE131984_Pac	ENSG00000160214	8568	ribosomal RNA processing 1	D21S2056E|NNP-1|Nop52|RRP1A	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43796
2.38331999593272e-32	-0.508042446960699	0.733	0.871	3.67484110172865e-28	BST2	Malignant cells	GSE131984_Pac	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43797
2.86141636088252e-32	0.400547497526502	0.959	0.874	4.41201788684475e-28	IFRD2	Malignant cells	GSE131984_Pac	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43798
3.00141628751825e-32	0.477456084700903	0.669	0.417	4.62788377372439e-28	SLC7A5	Malignant cells	GSE131984_Pac	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43799
5.40450279158416e-32	0.408743971152275	0.973	0.92	8.33320285434361e-28	RNF126	Malignant cells	GSE131984_Pac	ENSG00000070423	55658	ring finger protein 126	FLJ20552	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43800
5.44969340623911e-32	0.368885406061907	0.984	0.975	8.40288226308008e-28	TMED3	Malignant cells	GSE131984_Pac	ENSG00000166557	23423	transmembrane p24 trafficking protein 3	C15orf22|p24B|p24g4|p24gamma4	protein_coding	Q9Y3Q3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43801
5.66972577817483e-32	0.41300163825998	0.951	0.889	8.74215017736777e-28	COA6	Malignant cells	GSE131984_Pac	ENSG00000168275	388753	cytochrome c oxidase assembly factor 6	C1orf31	protein_coding	Q5JTJ3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43802
6.63795170263625e-32	-0.40103765136658	0.952	0.98	1.02350577302948e-27	RAB13	Malignant cells	GSE131984_Pac	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43803
9.14587141937964e-32	0.433344948965202	0.895	0.778	1.41020191415415e-27	MRPS2	Malignant cells	GSE131984_Pac	ENSG00000122140	51116	mitochondrial ribosomal protein S2	CGI-91	protein_coding	Q9Y399	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43804
9.84496205079088e-32	0.378323234753283	0.98	0.926	1.51799469861145e-27	LSM1	Malignant cells	GSE131984_Pac	ENSG00000175324	27257	LSM1 homolog, mRNA degradation associated	CASM|YJL124C	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43805
1.29623502904719e-31	0.4164848133949	0.977	0.936	1.99866479128786e-27	IRAK1	Malignant cells	GSE131984_Pac	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43806
1.33516227470758e-31	0.468915060391833	0.762	0.516	2.05868671137161e-27	TRMT6	Malignant cells	GSE131984_Pac	ENSG00000089195	51605	tRNA methyltransferase 6 non-catalytic subunit	CGI-09|GCD10|Gcd10p|MGC5029	protein_coding	Q9UJA5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43807
1.56749815587222e-31	-0.477058632606913	0.116	0.356	2.41692540653937e-27	BIRC3	Malignant cells	GSE131984_Pac	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43808
1.60333683998409e-31	-0.454811594816226	0.892	0.962	2.47218507357146e-27	BTG1	Malignant cells	GSE131984_Pac	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43809
1.8676928751368e-31	0.435788983519642	0.989	0.96	2.87979564417343e-27	RBM8A	Malignant cells	GSE131984_Pac	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43810
2.36278182315262e-31	0.476744721654319	0.854	0.693	3.64317329311902e-27	MFSD12	Malignant cells	GSE131984_Pac	ENSG00000161091	126321	major facilitator superfamily domain containing 12	C19orf28|MGC20700|PP3501	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43811
2.62039205851191e-31	-0.465073700443486	0.888	0.951	4.04038251501951e-27	MGST3	Malignant cells	GSE131984_Pac	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43812
4.63511951993661e-31	-0.425193557405392	0.134	0.375	7.14689078779026e-27	ZC3H12A	Malignant cells	GSE131984_Pac	ENSG00000163874	80149	zinc finger CCCH-type containing 12A	FLJ23231|MCPIP1|Regnase-1	protein_coding	Q5D1E8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43813
5.63194937206845e-31	0.398797167116658	0.968	0.92	8.68390273679234e-27	C19orf24	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43814
5.98413480575719e-31	0.352191772047285	0.993	0.984	9.22693745699701e-27	MRPL18	Malignant cells	GSE131984_Pac	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43815
8.80105348218398e-31	0.428308824421461	0.656	0.411	1.35703443641795e-26	CLN6	Malignant cells	GSE131984_Pac	ENSG00000128973	54982	CLN6 transmembrane ER protein	FLJ20561|HsT18960|nclf	protein_coding	Q9NWW5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43816
1.53349373679556e-30	0.411095615165209	0.69	0.442	2.36449399276507e-26	RANGRF	Malignant cells	GSE131984_Pac	ENSG00000108961	29098	RAN guanine nucleotide release factor	HSPC165|HSPC236|MOG1|RANGNRF	protein_coding	Q9HD47	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43817
1.56483792284094e-30	-0.391311087171815	0.98	0.992	2.41282359322845e-26	NDUFB1	Malignant cells	GSE131984_Pac	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43818
1.59803924407187e-30	0.567411898660188	0.694	0.469	2.46401671043442e-26	MARCKSL1	Malignant cells	GSE131984_Pac	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43819
1.68239321977823e-30	0.337766112407262	0.996	0.994	2.59408210557605e-26	SRSF3	Malignant cells	GSE131984_Pac	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43820
2.01190625675965e-30	-0.477288797826543	0.999	1	3.10215825729771e-26	MALAT1	Malignant cells	GSE131984_Pac	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43821
2.31505991011246e-30	0.496620089237128	0.856	0.689	3.56959087540239e-26	NOP58	Malignant cells	GSE131984_Pac	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43822
2.6817664501714e-30	0.396246989449683	0.483	0.238	4.13501568951928e-26	MYBBP1A	Malignant cells	GSE131984_Pac	ENSG00000132382	10514	MYB binding protein 1a	FLJ37886|P160|PAP2|Pol5	protein_coding	Q9BQG0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43823
3.09400361316519e-30	0.427237159458589	1	0.999	4.77064417113941e-26	HSP90AA1	Malignant cells	GSE131984_Pac	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43824
4.06279620578433e-30	0.406565468697098	0.904	0.776	6.26442546969886e-26	BCL2L12	Malignant cells	GSE131984_Pac	ENSG00000126453	83596	BCL2 like 12	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43825
5.6230167680555e-30	0.362346463119075	1	0.995	8.67012955466478e-26	PA2G4	Malignant cells	GSE131984_Pac	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43826
6.84218558888819e-30	0.443764086651348	0.86	0.709	1.05499659595067e-25	ALG3	Malignant cells	GSE131984_Pac	ENSG00000214160	10195	ALG3 alpha-1,3- mannosyltransferase	CDGS4|D16Ertd36e|Not56|NOT56L	protein_coding	Q92685	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43827
7.60378004472108e-30	0.372857899604216	0.991	0.954	1.17242684509554e-25	POLDIP2	Malignant cells	GSE131984_Pac	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43828
7.93239947341181e-30	-0.371259955709647	0.963	0.983	1.22309667480537e-25	SCAND1	Malignant cells	GSE131984_Pac	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43829
9.8029682375799e-30	0.415272222498149	0.695	0.463	1.51151967255245e-25	RABEPK	Malignant cells	GSE131984_Pac	ENSG00000136933	10244	Rab9 effector protein with kelch motifs	bA65N13.1|RAB9P40	protein_coding	Q7Z6M1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43830
1.0275358249638e-29	0.447275041199251	0.791	0.587	1.58435748851169e-25	TCOF1	Malignant cells	GSE131984_Pac	ENSG00000070814	6949	treacle ribosome biogenesis factor 1	TCS|treacle	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43831
1.26027693831519e-29	0.416141577523315	0.964	0.904	1.94322101118819e-25	CTDNEP1	Malignant cells	GSE131984_Pac	ENSG00000288307	23399	CTD nuclear envelope phosphatase 1	DULLARD|HSA011916|NET56	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43832
1.48237989416756e-29	-0.498826424476038	0.54	0.73	2.28568155881696e-25	HCFC1R1	Malignant cells	GSE131984_Pac	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43833
1.55200040092373e-29	-0.343849192159514	0.989	0.997	2.39302941818429e-25	PRDX5	Malignant cells	GSE131984_Pac	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43834
1.63732510958848e-29	0.428947613746795	0.91	0.773	2.52459158647447e-25	MRTO4	Malignant cells	GSE131984_Pac	ENSG00000053372	51154	MRT4 homolog, ribosome maturation factor	C1orf33|dJ657E11.4|MRT4	protein_coding	Q9UKD2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43835
2.43059973105594e-29	0.432371961562538	0.818	0.603	3.74774172531516e-25	TMEM11	Malignant cells	GSE131984_Pac	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43836
2.43076588335633e-29	0.446055208245759	0.638	0.402	3.74799791554713e-25	TEX30	Malignant cells	GSE131984_Pac	ENSG00000151287	93081	testis expressed 30	C13orf27	protein_coding	Q5JUR7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43837
3.00355052266569e-29	-0.429523678215198	0.323	0.566	4.63117455089822e-25	WBP2	Malignant cells	GSE131984_Pac	ENSG00000132471	23558	WW domain binding protein 2	GRAMD6|WBP-2	protein_coding	Q969T9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43838
3.1775861078483e-29	0.454184822916731	0.771	0.553	4.8995200196913e-25	CLSPN	Malignant cells	GSE131984_Pac	ENSG00000092853	63967	claspin	NA	protein_coding	Q9HAW4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43839
3.18644424828483e-29	-0.512935308532027	0.738	0.871	4.91317838643039e-25	CTSD	Malignant cells	GSE131984_Pac	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43840
3.8361682430434e-29	0.376964293211364	0.968	0.921	5.91498781394861e-25	MALSU1	Malignant cells	GSE131984_Pac	ENSG00000156928	115416	mitochondrial assembly of ribosomal large subunit 1	C7orf30|mtRsfA	protein_coding	Q96EH3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43841
4.64573391043815e-29	0.330818814076534	0.992	0.97	7.16325711650458e-25	DTYMK	Malignant cells	GSE131984_Pac	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43842
5.49969749874182e-29	0.420955819305055	0.938	0.87	8.47998357331002e-25	MRPL32	Malignant cells	GSE131984_Pac	ENSG00000106591	64983	mitochondrial ribosomal protein L32	bMRP-59b|HSPC283|L32mt|MRP-L32	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43843
5.85197294868775e-29	-0.554594598708769	0.778	0.888	9.02315708958165e-25	KLF6	Malignant cells	GSE131984_Pac	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43844
5.94732732574577e-29	-0.309967143416899	1	1	9.1701840035674e-25	MYL6	Malignant cells	GSE131984_Pac	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43845
6.63798558172853e-29	-0.52821525337279	0.536	0.715	1.02351099684672e-24	RHOB	Malignant cells	GSE131984_Pac	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43846
6.67444429728135e-29	0.446150812224561	1	0.996	1.02913256619781e-24	RPL22L1	Malignant cells	GSE131984_Pac	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43847
7.49186083498585e-29	0.345311969089822	0.995	0.977	1.15517002214647e-24	CDK4	Malignant cells	GSE131984_Pac	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43848
7.8289218036263e-29	-0.437926849274256	0.117	0.342	1.20714145290114e-24	ATF3	Malignant cells	GSE131984_Pac	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43849
8.09421222160805e-29	0.421618418298146	0.826	0.632	1.24804658244975e-24	ZWINT	Malignant cells	GSE131984_Pac	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43850
8.77566473614578e-29	0.411312776612621	0.533	0.294	1.35311974566632e-24	CLUH	Malignant cells	GSE131984_Pac	ENSG00000132361	23277	clustered mitochondria homolog	CLU1|KIAA0664	protein_coding	O75153	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43851
9.24327080796448e-29	-0.435610954755584	0.749	0.893	1.42521992588004e-24	TMEM219	Malignant cells	GSE131984_Pac	ENSG00000149932	124446	transmembrane protein 219	IGFBP-3R	protein_coding	Q86XT9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43852
1.10650084438156e-28	0.415947788083869	0.866	0.672	1.70611365195192e-24	STARD7	Malignant cells	GSE131984_Pac	ENSG00000084090	56910	StAR related lipid transfer domain containing 7	GTT1	protein_coding	Q9NQZ5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43853
1.24783826180804e-28	0.405502791379537	0.959	0.888	1.92404181588181e-24	PSMG3	Malignant cells	GSE131984_Pac	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43854
1.42708534675522e-28	-0.327359419285951	0.977	0.995	2.20042289616188e-24	EIF3L	Malignant cells	GSE131984_Pac	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43855
1.74649290401737e-28	0.325053411812246	0.995	0.992	2.69291740870438e-24	GTF2A2	Malignant cells	GSE131984_Pac	ENSG00000140307	2958	general transcription factor IIA subunit 2	HsT18745|TFIIA	protein_coding	P52657	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43856
1.85008278121552e-28	0.487717833168048	0.932	0.874	2.85264264035621e-24	DNAJA1	Malignant cells	GSE131984_Pac	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43857
1.99545402171335e-28	0.444821623436137	0.943	0.821	3.07679055607982e-24	RRM2	Malignant cells	GSE131984_Pac	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43858
2.09813069066833e-28	0.439860208452866	0.862	0.697	3.23510771194149e-24	DIMT1	Malignant cells	GSE131984_Pac	ENSG00000086189	27292	DIM1 rRNA methyltransferase and ribosome maturation factor	DIMT1L|HSA9761	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43859
2.35846840667935e-28	-0.394689081956509	0.073	0.277	3.63652243625889e-24	TSPAN8	Malignant cells	GSE131984_Pac	ENSG00000127324	7103	tetraspanin 8	CO-029|TM4SF3	protein_coding	P19075	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43860
2.55685942406475e-28	0.444290590343536	0.735	0.526	3.94242154596544e-24	TIMM22	Malignant cells	GSE131984_Pac	ENSG00000278501	29928	translocase of inner mitochondrial membrane 22	TEX4|TIM22	protein_coding	Q9Y584	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43861
2.82111235044527e-28	-0.448873345595139	0.718	0.867	4.34987313315156e-24	IGBP1	Malignant cells	GSE131984_Pac	ENSG00000089289	3476	immunoglobulin binding protein 1	alpha4|IBP1	protein_coding	P78318	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43862
2.83463401706848e-28	-0.527973324884803	0.327	0.585	4.37072219091788e-24	COL1A1	Malignant cells	GSE131984_Pac	ENSG00000108821	1277	collagen type I alpha 1 chain	OI4	protein_coding	P02452	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43863
3.20076219687694e-28	-0.44836580875839	0.13	0.355	4.93525523136455e-24	ITGA10	Malignant cells	GSE131984_Pac	ENSG00000143127	8515	integrin subunit alpha 10	NA	protein_coding	O75578	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43864
4.43485257464378e-28	-0.347832445218246	0.963	0.98	6.83809918484325e-24	CUTA	Malignant cells	GSE131984_Pac	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43865
5.0280321977792e-28	0.429299366280551	0.754	0.542	7.75272284575574e-24	TDG	Malignant cells	GSE131984_Pac	ENSG00000139372	6996	thymine DNA glycosylase	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43866
5.44049970018268e-28	-0.560163331557264	0.706	0.835	8.38870648771168e-24	SNORA76	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43867
5.51936763840855e-28	0.358970480881757	0.993	0.986	8.51031296166215e-24	PRSS3	Malignant cells	GSE131984_Pac	ENSG00000010438	5646	serine protease 3	PRSS4|TRY3|TRY4	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43868
5.70632079058646e-28	0.33129544936562	0.995	0.991	8.79857602700526e-24	YBX3	Malignant cells	GSE131984_Pac	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43869
8.49837661582676e-28	0.413934936473047	0.725	0.505	1.31036469039433e-23	TCEB3	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43870
1.42249478122666e-27	0.384222264749163	0.936	0.837	2.19334470317339e-23	SBDS	Malignant cells	GSE131984_Pac	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43871
1.47272282621998e-27	-0.484647034407755	0.451	0.659	2.27079132574859e-23	NINJ1	Malignant cells	GSE131984_Pac	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43872
1.65560427946914e-27	0.376529864528531	0.987	0.961	2.55277623851347e-23	YWHAH	Malignant cells	GSE131984_Pac	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43873
2.01231150413914e-27	-0.469062454283267	0.77	0.872	3.10278310823214e-23	ARL6IP5	Malignant cells	GSE131984_Pac	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43874
2.52338045286266e-27	-0.371254342317765	0.166	0.396	3.89080032026893e-23	A1BG	Malignant cells	GSE131984_Pac	ENSG00000121410	1	alpha-1-B glycoprotein	NA	protein_coding	P04217	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43875
3.04114850341832e-27	0.346506538019387	0.999	0.994	4.68914687742072e-23	HNRNPDL	Malignant cells	GSE131984_Pac	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43876
3.07834768971035e-27	0.390938237119103	0.569	0.334	4.74650430276439e-23	NOP14	Malignant cells	GSE131984_Pac	ENSG00000087269	8602	NOP14 nucleolar protein	C4orf9|NOL14|RES4-25|UTP2	protein_coding	P78316	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43877
3.18455800853059e-27	-0.487091245336042	0.473	0.673	4.91026999335332e-23	POLD4	Malignant cells	GSE131984_Pac	ENSG00000175482	57804	DNA polymerase delta 4, accessory subunit	p12|POLDS	protein_coding	Q9HCU8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43878
3.49021376201212e-27	0.397722352924504	0.62	0.388	5.3815605996465e-23	SRRD	Malignant cells	GSE131984_Pac	ENSG00000100104	402055	SRR1 domain containing	HC/HCC|SRR1L	protein_coding	Q9UH36	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43879
4.51285762710011e-27	0.42681680585095	0.714	0.501	6.95837517522567e-23	PSMC3IP	Malignant cells	GSE131984_Pac	ENSG00000131470	29893	PSMC3 interacting protein	GT198|Hop2|HUMGT198A|TBPIP	protein_coding	Q9P2W1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43880
4.8454368148019e-27	0.304353588609186	0.992	0.987	7.47117902474306e-23	UBE2I	Malignant cells	GSE131984_Pac	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43881
4.85934186646106e-27	0.394630302933926	0.911	0.818	7.49261922389631e-23	DNMT1	Malignant cells	GSE131984_Pac	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43882
6.49765906590018e-27	-0.472504462677133	0.496	0.682	1.00187405137115e-22	TCEAL8	Malignant cells	GSE131984_Pac	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43883
8.00071143324711e-27	0.435906518858011	0.713	0.491	1.23362969589237e-22	PPAN	Malignant cells	GSE131984_Pac	ENSG00000130810	56342	peter pan homolog	BXDC3|SSF|SSF1|SSF2	protein_coding	Q9NQ55	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43884
9.1227812818244e-27	-0.448964400512166	0.995	0.996	1.4066416458445e-22	S100A4	Malignant cells	GSE131984_Pac	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43885
9.88061108438151e-27	-0.585842070954846	0.469	0.666	1.52349142310078e-22	SPANXC	Malignant cells	GSE131984_Pac	ENSG00000198573	64663	SPANX family member C	CT11.3|CTp11	protein_coding	Q9NY87	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43886
1.62457607766747e-26	-0.422514907662027	0.278	0.51	2.50493385415547e-22	PALLD	Malignant cells	GSE131984_Pac	ENSG00000129116	23022	palladin, cytoskeletal associated protein	CGI-151|KIAA0992|SIH002	protein_coding	Q8WX93	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43887
1.77861039994924e-26	0.299578245337917	0.997	0.989	2.74243937568173e-22	RNF7	Malignant cells	GSE131984_Pac	ENSG00000114125	9616	ring finger protein 7	CKBBP1|RBX2|ROC2|SAG	protein_coding	Q9UBF6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43888
1.79643540218802e-26	0.43988289129245	0.999	0.978	2.76992374663371e-22	TUBB4B	Malignant cells	GSE131984_Pac	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43889
1.96304114649624e-26	-0.332425114951553	0.992	0.998	3.02681314378256e-22	NDUFA1	Malignant cells	GSE131984_Pac	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43890
2.09390817596842e-26	0.655753161649224	1	1	3.22859701652571e-22	TIMP1	Malignant cells	GSE131984_Pac	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43891
2.11055576732799e-26	0.337028275704349	0.985	0.97	3.25426593764303e-22	RPL26L1	Malignant cells	GSE131984_Pac	ENSG00000037241	51121	ribosomal protein L26 like 1	RPL26P1	protein_coding	Q9UNX3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43892
2.47781119884868e-26	-0.474233565103356	0.305	0.522	3.82053708750478e-22	BHLHE40	Malignant cells	GSE131984_Pac	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43893
2.57198197478872e-26	-0.411536349846671	0.556	0.736	3.96573900692672e-22	ACSL3	Malignant cells	GSE131984_Pac	ENSG00000123983	2181	acyl-CoA synthetase long chain family member 3	ACS3|FACL3|PRO2194	protein_coding	O95573	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43894
3.07195963033715e-26	0.375383482153446	0.96	0.893	4.73665455401686e-22	CMSS1	Malignant cells	GSE131984_Pac	ENSG00000184220	84319	cms1 ribosomal small subunit homolog	C3orf26|MGC4308	protein_coding	Q9BQ75	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43895
3.08834939814382e-26	0.391885252357589	0.899	0.771	4.76192593699795e-22	MRPS25	Malignant cells	GSE131984_Pac	ENSG00000131368	64432	mitochondrial ribosomal protein S25	DKFZp313H0817|FLJ00023|MRP-S25|RPMS25	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43896
3.37639043274768e-26	0.410516290491755	0.852	0.684	5.20605640825365e-22	ZNF259	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43897
4.748765814936e-26	-0.42908035614615	0.295	0.518	7.32212201004982e-22	WBSCR27	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43898
5.2803920248323e-26	-0.484175699865721	0.439	0.629	8.14183646308892e-22	FDFT1	Malignant cells	GSE131984_Pac	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43899
5.40038594719931e-26	0.388081301739332	0.59	0.361	8.32685509198662e-22	SLC25A19	Malignant cells	GSE131984_Pac	ENSG00000125454	60386	solute carrier family 25 member 19	DNC|MCPHA|MUP1|TPC	protein_coding	Q9HC21	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43900
5.98121683744776e-26	0.285740943387934	1	1	9.2224382416607e-22	SET	Malignant cells	GSE131984_Pac	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43901
6.93048286168765e-26	-0.485410651719962	0.468	0.672	1.06861115244362e-21	ACAT2	Malignant cells	GSE131984_Pac	ENSG00000120437	39	acetyl-CoA acetyltransferase 2	NA	protein_coding	Q9BWD1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43902
8.00109929079894e-26	-0.470415147415086	0.508	0.697	1.23368949964829e-21	BNIP3L	Malignant cells	GSE131984_Pac	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43903
9.15479291468219e-26	-0.33725982152399	0.992	0.997	1.41157751951485e-21	RPS27L	Malignant cells	GSE131984_Pac	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43904
1.1380044285936e-25	0.330535717090053	0.984	0.978	1.75468902844848e-21	KPNB1	Malignant cells	GSE131984_Pac	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43905
1.34469804249926e-25	0.415742108590686	0.734	0.546	2.07338991172962e-21	UCK2	Malignant cells	GSE131984_Pac	ENSG00000143179	7371	uridine-cytidine kinase 2	UMPK	protein_coding	Q9BZX2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43906
1.50829052397462e-25	0.415856831866739	0.709	0.494	2.32563315891647e-21	PNO1	Malignant cells	GSE131984_Pac	ENSG00000115946	56902	partner of NOB1 homolog	KHRBP1|RRP20	protein_coding	Q9NRX1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43907
1.51891010130371e-25	-0.36226128278764	0.197	0.428	2.34200748520019e-21	JUND	Malignant cells	GSE131984_Pac	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43908
1.64116983834807e-25	-0.340397486990787	0.16	0.381	2.53051977374888e-21	IL20RB	Malignant cells	GSE131984_Pac	ENSG00000174564	53833	interleukin 20 receptor subunit beta	DIRS1|FNDC6|IL-20R2|MGC34923	protein_coding	Q6UXL0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43909
2.04934494549844e-25	0.4118383397097	0.858	0.755	3.15988497146404e-21	RBM25	Malignant cells	GSE131984_Pac	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43910
2.09194569992418e-25	0.416774826263463	0.891	0.797	3.2255710747131e-21	ISCA1	Malignant cells	GSE131984_Pac	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43911
2.11859972178565e-25	0.283140768043251	0.997	0.994	3.2666689110213e-21	COTL1	Malignant cells	GSE131984_Pac	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43912
2.12194979747752e-25	0.393442136767635	0.733	0.52	3.27183439273058e-21	NCLN	Malignant cells	GSE131984_Pac	ENSG00000125912	56926	nicalin	NET59|NICALIN	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43913
2.28884731281357e-25	0.403631965585568	0.908	0.818	3.52917367162725e-21	FAM207A	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43914
2.47505645823792e-25	-0.259952425968306	1	1	3.81628955295704e-21	COX7C	Malignant cells	GSE131984_Pac	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43915
2.57300625938838e-25	0.357958084396392	0.551	0.321	3.96731835135095e-21	DHX33	Malignant cells	GSE131984_Pac	ENSG00000005100	56919	DEAH-box helicase 33	DDX33|DKFZp762F2011|FLJ21972	protein_coding	Q9H6R0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43916
2.63569776645577e-25	0.337359973523025	0.997	0.989	4.06398238609816e-21	TXNDC17	Malignant cells	GSE131984_Pac	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43917
3.35488125692531e-25	0.351282748695414	0.931	0.828	5.17289141005314e-21	EIF3J	Malignant cells	GSE131984_Pac	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43918
4.66008187194235e-25	0.409261124938332	0.832	0.695	7.18538023834792e-21	PLEK2	Malignant cells	GSE131984_Pac	ENSG00000100558	26499	pleckstrin 2	NA	protein_coding	Q9NYT0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43919
5.20265720282652e-25	0.358347538261686	0.955	0.888	8.02197714103821e-21	ANAPC5	Malignant cells	GSE131984_Pac	ENSG00000089053	51433	anaphase promoting complex subunit 5	APC5	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43920
5.28466417183588e-25	0.34479928084392	0.987	0.962	8.14842368655374e-21	C20orf27	Malignant cells	GSE131984_Pac	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43921
5.48186731511379e-25	0.335768885962718	0.996	0.992	8.45249121317395e-21	CCT6A	Malignant cells	GSE131984_Pac	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43922
5.74020547852862e-25	0.319495470400541	0.996	0.982	8.85082282734327e-21	BOLA3	Malignant cells	GSE131984_Pac	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43923
6.39535893048193e-25	0.336053142493049	0.979	0.917	9.86100393491009e-21	MRPL55	Malignant cells	GSE131984_Pac	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43924
6.51214725738111e-25	0.297001913391486	1	0.996	1.00410798561559e-20	PHB	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43925
6.80052716480566e-25	0.264148067845515	0.999	0.999	1.04857328354138e-20	TXNL4A	Malignant cells	GSE131984_Pac	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43926
7.35996387147974e-25	0.385768093863205	0.91	0.827	1.13483282934346e-20	ZNF511	Malignant cells	GSE131984_Pac	ENSG00000198546	118472	zinc finger protein 511	MGC30006|Zfp511	protein_coding	Q8NB15	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43927
7.94851728050275e-25	0.299050611063259	0.989	0.978	1.22558187948072e-20	EIF4G2	Malignant cells	GSE131984_Pac	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43928
1.03021712992763e-24	0.396916572623853	0.686	0.481	1.58849179263541e-20	PRPF19	Malignant cells	GSE131984_Pac	ENSG00000110107	27339	pre-mRNA processing factor 19	hPSO4|NMP200|PRP19|PSO4|SNEV|UBOX4	protein_coding	Q9UMS4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43929
1.08383651889498e-24	0.372148020234019	0.774	0.569	1.67116752848418e-20	RCC1	Malignant cells	GSE131984_Pac	ENSG00000180198	1104	regulator of chromosome condensation 1	CHC1	protein_coding	P18754	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43930
1.13310630935696e-24	0.402785165574188	0.847	0.7	1.7471366183975e-20	PHF14	Malignant cells	GSE131984_Pac	ENSG00000106443	9678	PHD finger protein 14	KIAA0783	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43931
1.2092495414326e-24	0.424451303777069	0.717	0.516	1.86454186793492e-20	SLC10A3	Malignant cells	GSE131984_Pac	ENSG00000126903	8273	solute carrier family 10 member 3	DXS253E|P3	protein_coding	P09131	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43932
1.27700021184372e-24	-0.442818665128112	0.298	0.516	1.96900662664184e-20	ABCC3	Malignant cells	GSE131984_Pac	ENSG00000108846	8714	ATP binding cassette subfamily C member 3	cMOAT2|EST90757|MLP2|MOAT-D|MRP3	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43933
1.32722615616744e-24	0.430664736349373	0.891	0.777	2.04645001019458e-20	ALG5	Malignant cells	GSE131984_Pac	ENSG00000120697	29880	ALG5 dolichyl-phosphate beta-glucosyltransferase	bA421P11.2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43934
1.47332265325379e-24	0.277655312755807	0.996	0.992	2.27171619905203e-20	STOML2	Malignant cells	GSE131984_Pac	ENSG00000165283	30968	stomatin like 2	HSPC108|SLP-2	protein_coding	Q9UJZ1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43935
1.95111244159596e-24	-0.363784747944445	0.892	0.952	3.00842027369681e-20	NDUFAF3	Malignant cells	GSE131984_Pac	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43936
1.99351105892366e-24	0.253368937813099	1	1	3.0737947017544e-20	RPL26	Malignant cells	GSE131984_Pac	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43937
2.34025594697186e-24	-0.255248283637836	1	1	3.60844064463591e-20	DSTN	Malignant cells	GSE131984_Pac	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43938
2.47232783877584e-24	0.38198335831978	0.678	0.464	3.81208229460847e-20	POLR3G	Malignant cells	GSE131984_Pac	ENSG00000113356	10622	RNA polymerase III subunit G	C31|RPC32|RPC7	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43939
3.22871392039178e-24	-0.455775264110486	0.552	0.723	4.97835399385209e-20	IL18	Malignant cells	GSE131984_Pac	ENSG00000150782	3606	interleukin 18	IGIF|IL-18|IL-1g|IL1F4	protein_coding	Q14116	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43940
3.39093999337369e-24	-0.403450112078818	0.299	0.518	5.2284903757829e-20	MAFF	Malignant cells	GSE131984_Pac	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43941
3.45398501466524e-24	0.363189101828499	0.638	0.42	5.32569949411234e-20	PIGH	Malignant cells	GSE131984_Pac	ENSG00000100564	5283	phosphatidylinositol glycan anchor biosynthesis class H	GPI-H	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43942
3.52120899811536e-24	0.323817762700726	1	0.998	5.42935215419407e-20	NME1	Malignant cells	GSE131984_Pac	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43943
4.0281790918598e-24	0.283140768043251	0.992	0.992	6.21104934173863e-20	MRPS15	Malignant cells	GSE131984_Pac	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43944
5.49440792546632e-24	-0.392322367316738	0.818	0.891	8.47182758027652e-20	CHMP2A	Malignant cells	GSE131984_Pac	ENSG00000130724	27243	charged multivesicular body protein 2A	BC-2|CHMP2|VPS2|VPS2A	protein_coding	O43633	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43945
5.5215005328707e-24	0.370114856836824	0.895	0.778	8.51360167163333e-20	COPS3	Malignant cells	GSE131984_Pac	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43946
5.96574491089684e-24	0.366573943450835	0.934	0.887	9.19858207811183e-20	DDX18	Malignant cells	GSE131984_Pac	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43947
6.34880363567594e-24	0.350622546734735	0.525	0.308	9.78922032584873e-20	DPH2	Malignant cells	GSE131984_Pac	ENSG00000132768	1802	diphthamide biosynthesis 2	DPH2L2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43948
7.48888755831023e-24	0.40799102400832	0.656	0.464	1.15471157261585e-19	RRS1	Malignant cells	GSE131984_Pac	ENSG00000179041	23212	ribosome biogenesis regulator 1 homolog	KIAA0112	protein_coding	Q15050	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43949
8.05236488399377e-24	-0.432758619684081	0.781	0.879	1.241594141463e-19	LARP6	Malignant cells	GSE131984_Pac	ENSG00000166173	55323	La ribonucleoprotein 6, translational regulator	acheron|FLJ11196	protein_coding	Q9BRS8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43950
8.26406587139911e-24	-0.436798689296318	0.295	0.507	1.27423631671103e-19	USP53	Malignant cells	GSE131984_Pac	ENSG00000145390	54532	ubiquitin specific peptidase 53	KIAA1350	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43951
8.75209453097461e-24	0.388497588859519	0.812	0.652	1.34948545573098e-19	RFK	Malignant cells	GSE131984_Pac	ENSG00000135002	55312	riboflavin kinase	FLJ11149|RIFK	protein_coding	Q969G6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43952
9.29934554614021e-24	0.287233734104787	0.995	0.988	1.43386608975936e-19	PDAP1	Malignant cells	GSE131984_Pac	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43953
1.05022228063866e-23	-0.499882466526645	0.402	0.599	1.61933773451675e-19	TNNT1	Malignant cells	GSE131984_Pac	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43954
1.1153238947634e-23	-0.460641990100345	0.174	0.385	1.71971791333568e-19	AKR1C2	Malignant cells	GSE131984_Pac	ENSG00000151632	1646	aldo-keto reductase family 1 member C2	BABP|DD|DD2|DDH2|HAKRD|MCDR2|TDD	protein_coding	P52895	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43955
1.16124445972519e-23	0.372349753359185	0.843	0.691	1.79052283245026e-19	PHF5A	Malignant cells	GSE131984_Pac	ENSG00000100410	84844	PHD finger protein 5A	bK223H9.2|INI|MGC1346|Rds3|SAP14b|SF3b14b|SF3B7	protein_coding	Q7RTV0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43956
1.24924753797354e-23	-0.589710782523292	0.398	0.59	1.9262147788014e-19	ZFP36	Malignant cells	GSE131984_Pac	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43957
1.27391791105509e-23	0.322429142511471	0.977	0.974	1.96425402705584e-19	RNPS1	Malignant cells	GSE131984_Pac	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43958
1.7299420572412e-23	0.40847776775967	0.735	0.549	2.66739765806021e-19	REXO4	Malignant cells	GSE131984_Pac	ENSG00000280706	57109	REX4 homolog, 3'-5' exonuclease	hPMC2|XPMC2H	protein_coding	Q9GZR2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43959
1.78450230830656e-23	0.434636048087421	0.818	0.64	2.75152410917789e-19	HSPH1	Malignant cells	GSE131984_Pac	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43960
1.85501645027423e-23	0.437310775924355	0.894	0.758	2.86024986467783e-19	SLBP	Malignant cells	GSE131984_Pac	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43961
1.86668711672001e-23	0.410483236085796	0.743	0.52	2.87824486527059e-19	CDCA3	Malignant cells	GSE131984_Pac	ENSG00000111665	83461	cell division cycle associated 3	GRCC8|TOME-1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43962
2.06764328088093e-23	0.474073003758503	0.717	0.511	3.18809917479031e-19	AURKA	Malignant cells	GSE131984_Pac	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43963
2.55656929245888e-23	-0.339626337891544	0.938	0.974	3.94197419204235e-19	HEBP2	Malignant cells	GSE131984_Pac	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43964
3.12279201934893e-23	-0.320282651657223	1	1	4.81503301463411e-19	LDHB	Malignant cells	GSE131984_Pac	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43965
3.33059122851131e-23	0.388095632458958	0.769	0.58	5.1354386152416e-19	C8orf33	Malignant cells	GSE131984_Pac	ENSG00000182307	65265	chromosome 8 open reading frame 33	FLJ20989	protein_coding	Q9H7E9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43966
3.45459971326088e-23	0.361442433298313	0.863	0.742	5.32664729787695e-19	RRP36	Malignant cells	GSE131984_Pac	ENSG00000124541	88745	ribosomal RNA processing 36	C6orf153|dJ20C7.4	protein_coding	Q96EU6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43967
4.58553739837776e-23	-0.335372112314851	0.116	0.307	7.07044011455867e-19	BBC3	Malignant cells	GSE131984_Pac	ENSG00000105327	27113	BCL2 binding component 3	JFY1|PUMA	protein_coding	Q9BXH1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43968
4.82436156105196e-23	0.350264872116242	0.993	0.972	7.43868309098602e-19	FXYD5	Malignant cells	GSE131984_Pac	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43969
4.86346219006278e-23	-0.475336873581069	0.245	0.452	7.49897235085779e-19	TNFAIP2	Malignant cells	GSE131984_Pac	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43970
5.0554307743772e-23	0.307903758061725	1	0.999	7.79496871101221e-19	HMGN2	Malignant cells	GSE131984_Pac	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43971
5.30267202593231e-23	-0.462657698541836	0.82	0.901	8.17618999678502e-19	IL32	Malignant cells	GSE131984_Pac	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43972
6.00724060449248e-23	0.297503097454137	0.992	0.982	9.26256428806695e-19	TOMM22	Malignant cells	GSE131984_Pac	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43973
6.02056270585159e-23	-0.280841223390826	0.09	0.275	9.28310563615256e-19	SREBF2	Malignant cells	GSE131984_Pac	ENSG00000198911	6721	sterol regulatory element binding transcription factor 2	bHLHd2|SREBP2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43974
6.21725877516687e-23	0.317837664676477	0.511	0.287	9.5863913054298e-19	DOHH	Malignant cells	GSE131984_Pac	ENSG00000129932	83475	deoxyhypusine hydroxylase	HLRC1|MGC4293	protein_coding	Q9BU89	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43975
6.85096913632582e-23	-0.375618056521717	0.79	0.889	1.05635093113008e-18	CCNG1	Malignant cells	GSE131984_Pac	ENSG00000113328	900	cyclin G1	CCNG	protein_coding	P51959	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43976
7.73944934567781e-23	0.309606017340253	0.983	0.96	1.19334569461006e-18	PPM1G	Malignant cells	GSE131984_Pac	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43977
8.2860450007327e-23	0.339228935042521	0.951	0.891	1.27762527866297e-18	POLR2K	Malignant cells	GSE131984_Pac	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43978
1.05391652208593e-22	0.256589204745333	0.999	0.996	1.6250338854043e-18	NDUFAB1	Malignant cells	GSE131984_Pac	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43979
1.21585942542647e-22	-0.513085011026206	0.181	0.385	1.87473364806507e-18	NUPR1	Malignant cells	GSE131984_Pac	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43980
1.24133661468671e-22	0.295188366410412	0.995	0.989	1.91401692618544e-18	LAMTOR1	Malignant cells	GSE131984_Pac	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43981
1.29066872292478e-22	-0.722042026101489	0.473	0.618	1.99008210387772e-18	PKIB	Malignant cells	GSE131984_Pac	ENSG00000135549	5570	cAMP-dependent protein kinase inhibitor beta	PRKACN2	protein_coding	Q9C010	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43982
1.34625436023159e-22	0.337488160825393	0.916	0.798	2.07578959804109e-18	SAC3D1	Malignant cells	GSE131984_Pac	ENSG00000168061	29901	SAC3 domain containing 1	HSU79266|SHD1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43983
1.58214779352645e-22	0.349001540284537	0.957	0.876	2.43951368283843e-18	SEPW1	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43984
1.71298655289046e-22	-0.292657770421074	0.967	0.986	2.6412539659018e-18	TMEM258	Malignant cells	GSE131984_Pac	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43985
1.8166329076899e-22	0.331491817385589	0.981	0.962	2.80106628036706e-18	PSMG1	Malignant cells	GSE131984_Pac	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43986
1.95849020437861e-22	0.394326929655004	0.912	0.843	3.01979604613138e-18	MRPL15	Malignant cells	GSE131984_Pac	ENSG00000137547	29088	mitochondrial ribosomal protein L15	HSPC145|L15mt|MRP-L15|MRP-L7|RPML7	protein_coding	Q9P015	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43987
2.10249195869122e-22	0.409880518765092	0.415	0.218	3.24183235110599e-18	SPHK1	Malignant cells	GSE131984_Pac	ENSG00000176170	8877	sphingosine kinase 1	SPHK	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43988
2.4920591238373e-22	0.361945934977867	0.84	0.691	3.84250596304474e-18	PITX1	Malignant cells	GSE131984_Pac	ENSG00000069011	5307	paired like homeodomain 1	BFT|POTX|PTX1	protein_coding	P78337	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43989
3.16311162171661e-22	0.418283116809901	0.755	0.579	4.87720180952484e-18	AATF	Malignant cells	GSE131984_Pac	ENSG00000276072	26574	apoptosis antagonizing transcription factor	BFR2|CHE-1|CHE1|DED	protein_coding	Q9NY61	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43990
3.3317102359526e-22	-0.377389571655739	0.392	0.587	5.13716401281532e-18	TMCO3	Malignant cells	GSE131984_Pac	ENSG00000150403	55002	transmembrane and coiled-coil domains 3	C13orf11|FLJ20623	protein_coding	Q6UWJ1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43991
3.46737006466143e-22	0.381415567223143	0.828	0.665	5.34633790270146e-18	H2AFX	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43992
3.55317913890403e-22	0.414642787070518	0.839	0.672	5.47864691427613e-18	NDUFAF4	Malignant cells	GSE131984_Pac	ENSG00000123545	29078	NADH:ubiquinone oxidoreductase complex assembly factor 4	bA22L21.1|C6orf66|HRPAP20|HSPC125|My013	protein_coding	Q9P032	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43993
3.86531495041058e-22	-0.339922664441115	0.907	0.957	5.95992912203808e-18	UQCC2	Malignant cells	GSE131984_Pac	ENSG00000137288	84300	ubiquinol-cytochrome c reductase complex assembly factor 2	bA6B20.2|C6orf125|Cbp6|M19|MGC14833|MNF1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43994
3.96664201853821e-22	0.370222142772136	0.727	0.535	6.11616532838406e-18	DUS1L	Malignant cells	GSE131984_Pac	ENSG00000169718	64118	dihydrouridine synthase 1 like	DUS1|PP3111	protein_coding	Q6P1R4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43995
4.33904554682495e-22	0.386323110922872	0.661	0.476	6.69037432864939e-18	TSR1	Malignant cells	GSE131984_Pac	ENSG00000167721	55720	TSR1 ribosome maturation factor	FLJ10534	protein_coding	Q2NL82	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43996
5.65413086202214e-22	0.340931719393192	0.984	0.937	8.71810437615194e-18	LY6E	Malignant cells	GSE131984_Pac	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43997
5.72281048656704e-22	0.276762249578708	0.996	0.994	8.82400148923772e-18	ANP32B	Malignant cells	GSE131984_Pac	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43998
6.39228097591478e-22	0.382093114149987	0.867	0.742	9.85625803676301e-18	TIMM8A	Malignant cells	GSE131984_Pac	ENSG00000126953	1678	translocase of inner mitochondrial membrane 8A	DDP|DFN1|MTS	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	43999
6.66789751693584e-22	0.368708488434032	0.912	0.803	1.02812311813634e-17	RRP7A	Malignant cells	GSE131984_Pac	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44000
7.87638900070874e-22	0.330124868168689	0.547	0.334	1.21446042001928e-17	LUC7L	Malignant cells	GSE131984_Pac	ENSG00000007392	55692	LUC7 like	hLuc7B1|Luc7|LUC7B1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44001
7.96578943918175e-22	0.293261662715231	0.996	0.99	1.22824507362743e-17	PFDN2	Malignant cells	GSE131984_Pac	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44002
8.27298948913485e-22	0.353886546376537	0.648	0.464	1.2756122493297e-17	NOL12	Malignant cells	GSE131984_Pac	ENSG00000273899	79159	nucleolar protein 12	MGC3731|Nop25|RRP17	protein_coding	Q9UGY1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44003
9.01146923438761e-22	-0.626942854960236	0.132	0.32	1.38947844125023e-17	FOS	Malignant cells	GSE131984_Pac	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44004
1.0029479643305e-21	0.357368903200926	0.828	0.646	1.54644546620119e-17	SNHG15	Malignant cells	GSE131984_Pac	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44005
1.06566218233063e-21	0.360874877759551	0.866	0.736	1.64314451893559e-17	GLRX2	Malignant cells	GSE131984_Pac	ENSG00000023572	51022	glutaredoxin 2	bA101E13.1|GRX2	protein_coding	Q9NS18	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44006
1.09540572744061e-21	0.325793797679359	0.959	0.912	1.68900609114067e-17	CDC37	Malignant cells	GSE131984_Pac	ENSG00000105401	11140	cell division cycle 37, HSP90 cochaperone	P50CDC37	protein_coding	Q16543	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44007
1.25997732205407e-21	0.371514693056281	0.549	0.349	1.94275903287517e-17	FAM57A	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44008
1.30683858082886e-21	-0.409026267362928	0.691	0.819	2.01501440778002e-17	PINK1	Malignant cells	GSE131984_Pac	ENSG00000158828	65018	PTEN induced kinase 1	BRPK|PARK6	protein_coding	Q9BXM7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44009
1.57041293035439e-21	0.335855324470592	0.953	0.919	2.42141969731343e-17	SNRPA1	Malignant cells	GSE131984_Pac	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44010
1.6976304685912e-21	-0.269823337361437	0.992	0.999	2.61757641952078e-17	EIF3H	Malignant cells	GSE131984_Pac	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44011
1.70445743740237e-21	-0.414210952770218	0.618	0.748	2.62810292273071e-17	TNIP1	Malignant cells	GSE131984_Pac	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44012
1.87435333666034e-21	-0.403258609016018	0.113	0.296	2.89006540979658e-17	AC006262.5	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44013
1.9075180045914e-21	0.326916941897405	0.96	0.91	2.94120201127948e-17	FAM195A	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44014
2.27577517248671e-21	0.352607804278433	0.94	0.874	3.50901773845726e-17	SNHG7	Malignant cells	GSE131984_Pac	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44015
2.87602881126082e-21	0.308251570753159	0.996	0.978	4.43454882408306e-17	SRSF7	Malignant cells	GSE131984_Pac	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44016
3.02645625997444e-21	-0.416188227306939	0.463	0.658	4.66649290725459e-17	PIR	Malignant cells	GSE131984_Pac	ENSG00000087842	8544	pirin	NA	protein_coding	O00625	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44017
3.49236878429379e-21	0.375798404753171	0.766	0.579	5.38488342850259e-17	TMX2	Malignant cells	GSE131984_Pac	ENSG00000213593	51075	thioredoxin related transmembrane protein 2	PDIA12|TXNDC14	protein_coding	Q9Y320	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44018
3.69993933133695e-21	-0.413538220205302	0.406	0.592	5.70493645498845e-17	NCOA7	Malignant cells	GSE131984_Pac	ENSG00000111912	135112	nuclear receptor coactivator 7	dJ187J11.3|ERAP140|TLDC4	protein_coding	Q8NI08	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44019
3.75337825618443e-21	0.367639450126968	0.646	0.44	5.78733393321078e-17	FJX1	Malignant cells	GSE131984_Pac	ENSG00000179431	24147	four-jointed box kinase 1	FLJ22416|FLJ25593	protein_coding	Q86VR8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44020
4.51106816290491e-21	0.265586856638	1	0.995	6.95561600038309e-17	VDAC2	Malignant cells	GSE131984_Pac	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44021
4.70173608529167e-21	0.38119923479811	0.75	0.583	7.24960686991123e-17	WDR43	Malignant cells	GSE131984_Pac	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44022
5.15928669968314e-21	0.339638787044127	0.854	0.729	7.95510416224144e-17	MESDC2	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44023
5.2268216648485e-21	-0.578125379563001	0.363	0.551	8.0592363250299e-17	HBE1	Malignant cells	GSE131984_Pac	ENSG00000213931	3046	hemoglobin subunit epsilon 1	HBE	protein_coding	P02100	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44024
5.24641828065191e-21	0.321708548517836	0.955	0.891	8.08945234693718e-17	SYNCRIP	Malignant cells	GSE131984_Pac	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44025
5.73020426896743e-21	0.314084217572032	0.991	0.98	8.83540196232088e-17	TFDP1	Malignant cells	GSE131984_Pac	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44026
5.80324700062581e-21	0.346701036710667	0.968	0.922	8.94802655026493e-17	POLR2H	Malignant cells	GSE131984_Pac	ENSG00000163882	5437	RNA polymerase II, I and III subunit H	RPB8	protein_coding	P52434	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44027
5.92440850717914e-21	0.306631667807852	0.983	0.964	9.13484547721952e-17	FUS	Malignant cells	GSE131984_Pac	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44028
6.55290227045205e-21	-0.504378661263743	0.527	0.675	1.010392001081e-16	WBP5	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44029
7.21503730972703e-21	0.580968494149126	0.818	0.676	1.11248660278681e-16	DKK1	Malignant cells	GSE131984_Pac	ENSG00000107984	22943	dickkopf WNT signaling pathway inhibitor 1	DKK-1|SK	protein_coding	O94907	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44030
7.35848824359844e-21	0.346285816152696	0.882	0.744	1.13460530228044e-16	EIF4E	Malignant cells	GSE131984_Pac	ENSG00000151247	1977	eukaryotic translation initiation factor 4E	EIF4E1|EIF4EL1|EIF4F	protein_coding	P06730	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44031
8.17275492885925e-21	0.263432644270357	0.997	0.996	1.26015708248081e-16	PDCD6	Malignant cells	GSE131984_Pac	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44032
8.8348078814999e-21	0.357155625614994	0.851	0.723	1.36223902724847e-16	GAR1	Malignant cells	GSE131984_Pac	ENSG00000109534	54433	GAR1 ribonucleoprotein	NOLA1	protein_coding	Q9NY12	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44033
9.30626610731502e-21	0.339115365325656	0.547	0.347	1.4349331710869e-16	SLC19A1	Malignant cells	GSE131984_Pac	ENSG00000173638	6573	solute carrier family 19 member 1	FOLT|RFC1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44034
1.02170969939485e-20	0.335717754854616	0.876	0.751	1.57537418549692e-16	LUC7L3	Malignant cells	GSE131984_Pac	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44035
1.19065088157174e-20	-0.617559263000224	0.194	0.378	1.83586459429546e-16	CCL20	Malignant cells	GSE131984_Pac	ENSG00000115009	6364	C-C motif chemokine ligand 20	CKb4|exodus-1|LARC|MIP-3a|SCYA20|ST38	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44036
1.19761997927789e-20	0.36114640390569	0.878	0.775	1.84661024604858e-16	PPIF	Malignant cells	GSE131984_Pac	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44037
1.32347589096919e-20	0.353092777859423	0.681	0.5	2.0406674762854e-16	FXN	Malignant cells	GSE131984_Pac	ENSG00000165060	2395	frataxin	CyaY|FA|FARR|FRDA|X25	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44038
1.3708636733815e-20	-0.278040810716774	1	1	2.11373469798694e-16	SLC25A5	Malignant cells	GSE131984_Pac	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44039
1.38891845155715e-20	0.352258985121949	0.864	0.724	2.14157336045596e-16	SSBP4	Malignant cells	GSE131984_Pac	ENSG00000130511	170463	single stranded DNA binding protein 4	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44040
1.5003301464421e-20	0.321060031646992	0.507	0.303	2.31335905279908e-16	PINX1	Malignant cells	GSE131984_Pac	ENSG00000254093	54984	PIN2 (TERF1) interacting telomerase inhibitor 1	FLJ20565|Gno1|LPTL|LPTS|MGC8850|Pxr1	protein_coding	Q96BK5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44041
1.64304674134335e-20	0.337288582227764	0.769	0.608	2.53341377047731e-16	YRDC	Malignant cells	GSE131984_Pac	ENSG00000196449	79693	yrdC N6-threonylcarbamoyltransferase domain containing	FLJ23476|IRIP|SUA5	protein_coding	Q86U90	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44042
1.68951364078195e-20	0.360874163723934	0.81	0.67	2.60506108272168e-16	NETO2	Malignant cells	GSE131984_Pac	ENSG00000171208	81831	neuropilin and tolloid like 2	FLJ10430|NEOT2	protein_coding	Q8NC67	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44043
1.87845061660272e-20	-0.369974036195153	0.874	0.939	2.89638300573973e-16	MMP24-AS1	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44044
1.8847915923478e-20	0.322197012823779	0.977	0.926	2.90616015624108e-16	SNRNP25	Malignant cells	GSE131984_Pac	ENSG00000161981	79622	small nuclear ribonucleoprotein U11/U12 subunit 25	C16orf33|U11/U12-25K	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44045
1.9367911030639e-20	0.34110251161584	0.888	0.775	2.98633820181423e-16	CCDC59	Malignant cells	GSE131984_Pac	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44046
2.06580832314592e-20	0.376355193795167	0.751	0.595	3.1852698534587e-16	MAT2A	Malignant cells	GSE131984_Pac	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44047
2.07703875721748e-20	0.314633167683159	0.916	0.833	3.20258605975363e-16	NTMT1	Malignant cells	GSE131984_Pac	ENSG00000148335	28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1	AD-003|C9orf32|HOMT1A|METTL11A|NRMT|NRMT1	protein_coding	Q9BV86	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44048
2.12579692733328e-20	0.374749861766683	0.826	0.666	3.27776628225518e-16	FKBP4	Malignant cells	GSE131984_Pac	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44049
2.18518767811403e-20	0.345402267464764	0.855	0.721	3.36934088088402e-16	EXOSC4	Malignant cells	GSE131984_Pac	ENSG00000178896	54512	exosome component 4	FLJ20591|hRrp41p|p12A|RRP41|RRP41A|Rrp41p|SKI6|Ski6p	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44050
2.62402975596215e-20	0.41056230761593	0.757	0.566	4.04599148071804e-16	PLK1	Malignant cells	GSE131984_Pac	ENSG00000166851	5347	polo like kinase 1	PLK	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44051
4.23599088662112e-20	-0.377418951155814	0.188	0.374	6.5314743480811e-16	MAOA	Malignant cells	GSE131984_Pac	ENSG00000189221	4128	monoamine oxidase A	NA	protein_coding	P21397	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44052
4.35082608739405e-20	0.261397714070847	1	0.996	6.70853874415288e-16	TMEM147	Malignant cells	GSE131984_Pac	ENSG00000105677	10430	transmembrane protein 147	MGC1936|NIFIE14	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44053
4.68890557688408e-20	0.355360554209057	0.802	0.684	7.22982350899756e-16	TIMM44	Malignant cells	GSE131984_Pac	ENSG00000104980	10469	translocase of inner mitochondrial membrane 44	TIM44	protein_coding	O43615	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44054
4.79818023238044e-20	0.367886775114924	0.648	0.465	7.39831410030739e-16	WDR77	Malignant cells	GSE131984_Pac	ENSG00000116455	79084	WD repeat domain 77	MEP50|p44	protein_coding	Q9BQA1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44055
4.990836583995e-20	-0.33393830521749	0.795	0.894	7.6953709288619e-16	KDELR1	Malignant cells	GSE131984_Pac	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44056
5.13621375146431e-20	0.318167358461992	0.949	0.879	7.91952798338281e-16	CHCHD3	Malignant cells	GSE131984_Pac	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44057
6.42203767600689e-20	0.287842580040482	0.945	0.874	9.90213989263503e-16	SMC4	Malignant cells	GSE131984_Pac	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44058
6.69617093945197e-20	0.281583611521447	0.963	0.949	1.0324825971541e-15	PDCD2	Malignant cells	GSE131984_Pac	ENSG00000071994	5134	programmed cell death 2	RP8|ZMYND7	protein_coding	Q16342	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44059
7.03870385584489e-20	-0.374205305367951	0.883	0.93	1.08529774753272e-15	SLC38A2	Malignant cells	GSE131984_Pac	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44060
7.03940104270294e-20	0.330218154358512	0.941	0.876	1.08540524677437e-15	C11orf83	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44061
8.7369064877006e-20	-0.367450724601854	0.642	0.765	1.34714361133855e-15	ALKBH7	Malignant cells	GSE131984_Pac	ENSG00000125652	84266	alkB homolog 7	MGC10974|SPATA11	protein_coding	Q9BT30	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44062
9.28686001909482e-20	0.278256105646433	0.985	0.965	1.43194094634423e-15	SSNA1	Malignant cells	GSE131984_Pac	ENSG00000176101	8636	SS nuclear autoantigen 1	N14|NA14	protein_coding	O43805	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44063
9.82937594332476e-20	0.368153062721816	0.674	0.495	1.51559147670124e-15	NIP7	Malignant cells	GSE131984_Pac	ENSG00000132603	51388	nucleolar pre-rRNA processing protein NIP7	CGI-37|FLJ10296|HSPC031|KD93	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44064
1.08387874579495e-19	-0.399723440395176	0.726	0.848	1.67123263814124e-15	IGFBP6	Malignant cells	GSE131984_Pac	ENSG00000167779	3489	insulin like growth factor binding protein 6	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44065
1.23530176660726e-19	-0.268146849027401	1	1	1.90471179393174e-15	TMSB4X	Malignant cells	GSE131984_Pac	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44066
1.34169863398851e-19	-0.313078848744871	1	1	2.06876512374688e-15	FTH1	Malignant cells	GSE131984_Pac	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44067
1.35326482126889e-19	0.328892643499061	0.601	0.407	2.0865990279145e-15	BCS1L	Malignant cells	GSE131984_Pac	ENSG00000074582	617	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	BCS|BJS|h-BCS|Hs.6719	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44068
1.56135261607411e-19	0.310924358844914	0.995	0.98	2.40744959872466e-15	PHLDA2	Malignant cells	GSE131984_Pac	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44069
1.63380412862007e-19	0.342814753158092	0.703	0.514	2.51916258591929e-15	NOLC1	Malignant cells	GSE131984_Pac	ENSG00000166197	9221	nucleolar and coiled-body phosphoprotein 1	KIAA0035|NOPP130|NOPP140|P130|Srp40	protein_coding	Q14978	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44070
1.71563874041641e-19	0.263193884680203	0.997	1	2.64534337384806e-15	CYC1	Malignant cells	GSE131984_Pac	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44071
1.72571769216947e-19	0.328041693037754	0.874	0.744	2.66088410955611e-15	C11orf24	Malignant cells	GSE131984_Pac	ENSG00000171067	53838	chromosome 11 open reading frame 24	DM4E3	protein_coding	Q96F05	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44072
1.76407205371888e-19	-0.284031892070898	0.94	0.972	2.72002269962915e-15	CAMTA1	Malignant cells	GSE131984_Pac	ENSG00000171735	23261	calmodulin binding transcription activator 1	KIAA0833	protein_coding	Q9Y6Y1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44073
1.81510802953835e-19	-0.330166884391731	0.174	0.362	2.79871507074517e-15	TSPAN13	Malignant cells	GSE131984_Pac	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44074
1.84912823783098e-19	0.325317813188173	0.714	0.549	2.85117082991159e-15	E2F4	Malignant cells	GSE131984_Pac	ENSG00000205250	1874	E2F transcription factor 4	E2F-4	protein_coding	Q16254	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44075
2.05942957992929e-19	-0.336641592446088	0.61	0.75	3.17543446929298e-15	MVB12A	Malignant cells	GSE131984_Pac	ENSG00000141971	93343	multivesicular body subunit 12A	FAM125A|FLJ32495	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44076
2.13071062136844e-19	-0.293362882286007	0.936	0.962	3.28534270708799e-15	BLOC1S1	Malignant cells	GSE131984_Pac	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44077
2.50540439021843e-19	0.337775824653896	0.666	0.485	3.86308302927779e-15	NOL10	Malignant cells	GSE131984_Pac	ENSG00000115761	79954	nucleolar protein 10	FLJ14075|PQBP5	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44078
2.51835466816596e-19	-0.421701087147795	0.553	0.694	3.88305106284509e-15	FADS1	Malignant cells	GSE131984_Pac	ENSG00000149485	3992	fatty acid desaturase 1	D5D|FADS6|FADSD5|LLCDL1|TU12	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44079
2.69340960093219e-19	-0.383477116892244	0.568	0.717	4.15296826367734e-15	POLR3GL	Malignant cells	GSE131984_Pac	ENSG00000121851	84265	RNA polymerase III subunit GL	flj32422|MGC3200	protein_coding	Q9BT43	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44080
2.78145549659764e-19	-0.462937814737047	0.269	0.45	4.2887262302039e-15	AKR1C1	Malignant cells	GSE131984_Pac	ENSG00000187134	1645	aldo-keto reductase family 1 member C1	DD1|DDH|DDH1|HAKRC|MBAB	protein_coding	Q04828	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44081
3.25737136099297e-19	0.357770932941888	0.71	0.554	5.02254090151506e-15	WDR74	Malignant cells	GSE131984_Pac	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44082
3.4715193927188e-19	0.273025722450095	1	0.996	5.35273575163312e-15	PTGES3	Malignant cells	GSE131984_Pac	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44083
4.14774799940962e-19	-0.403508895706348	0.52	0.683	6.3954126402897e-15	CCNL1	Malignant cells	GSE131984_Pac	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44084
4.20654126310003e-19	0.300123195810719	0.995	0.997	6.48606597357394e-15	KRT18	Malignant cells	GSE131984_Pac	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44085
4.34449497820769e-19	0.318534754710565	0.898	0.809	6.69877680689844e-15	SRSF1	Malignant cells	GSE131984_Pac	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44086
4.66699790556384e-19	0.335779195944691	0.989	0.97	7.19604407058889e-15	CKS2	Malignant cells	GSE131984_Pac	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44087
5.78822773161752e-19	0.328579138056307	0.864	0.74	8.92486833938106e-15	LSM12	Malignant cells	GSE131984_Pac	ENSG00000161654	124801	LSM12 homolog	FLJ30656	protein_coding	Q3MHD2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44088
6.02421243806816e-19	0.299296968817612	0.935	0.865	9.2887331582573e-15	DHX29	Malignant cells	GSE131984_Pac	ENSG00000067248	54505	DExH-box helicase 29	DDX29	protein_coding	Q7Z478	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44089
6.02781492831157e-19	0.303975011294731	0.573	0.37	9.29428783796361e-15	TTLL12	Malignant cells	GSE131984_Pac	ENSG00000100304	23170	tubulin tyrosine ligase like 12	KIAA0153	protein_coding	Q14166	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44090
6.341182181401e-19	0.330460279251358	0.855	0.705	9.7774688055022e-15	PTGES2	Malignant cells	GSE131984_Pac	ENSG00000148334	80142	prostaglandin E synthase 2	C9orf15|FLJ14038	protein_coding	Q9H7Z7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44091
6.52017627410286e-19	0.311044584619522	0.956	0.931	1.00534597970392e-14	MRPL17	Malignant cells	GSE131984_Pac	ENSG00000158042	63875	mitochondrial ribosomal protein L17	MRP-L26|RPML26	protein_coding	Q9NRX2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44092
6.65068682326384e-19	0.386664245258605	0.801	0.662	1.02546940127905e-14	TRMT10C	Malignant cells	GSE131984_Pac	ENSG00000174173	54931	tRNA methyltransferase 10C, mitochondrial RNase P subunit	FLJ20432|MRPP1|RG9MTD1	protein_coding	Q7L0Y3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44093
6.69378830542119e-19	-0.37980522564434	0.38	0.559	1.03211521881289e-14	LTA4H	Malignant cells	GSE131984_Pac	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44094
7.32301282715138e-19	-0.473522628481123	0.406	0.589	1.12913534781847e-14	HES4	Malignant cells	GSE131984_Pac	ENSG00000188290	57801	hes family bHLH transcription factor 4	bHLHb42	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44095
7.83646508010637e-19	0.356308428145139	0.795	0.654	1.2083045507016e-14	EXOSC3	Malignant cells	GSE131984_Pac	ENSG00000107371	51010	exosome component 3	CGI-102|hRrp-40|hRrp40p|p10|RRP40|Rrp40p	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44096
8.08027847542527e-19	0.33475367284502	0.894	0.852	1.24589813812582e-14	ICT1	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44097
8.54897526222721e-19	-0.371677597045784	0.634	0.763	1.31816649568281e-14	TCEA2	Malignant cells	GSE131984_Pac	ENSG00000171703	6919	transcription elongation factor A2	TFIIS	protein_coding	Q15560	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44098
8.56839414375511e-19	-0.34933133376745	0.775	0.854	1.3211606930256e-14	DCTN2	Malignant cells	GSE131984_Pac	ENSG00000175203	10540	dynactin subunit 2	DCTN-50|RBP50	protein_coding	Q13561	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44099
8.59121790066739e-19	0.329633966466198	0.678	0.5	1.3246798881039e-14	ABCF2	Malignant cells	GSE131984_Pac	ENSG00000033050	10061	ATP binding cassette subfamily F member 2	ABC28|EST133090|HUSSY-18|M-ABC1	protein_coding	Q9UG63	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44100
9.47407838794685e-19	0.437864794834812	0.334	0.165	1.46080814663753e-14	ANGPTL4	Malignant cells	GSE131984_Pac	ENSG00000167772	51129	angiopoietin like 4	ARP4|FIAF|HFARP|NL2|PGAR|pp1158	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44101
1.08251774367459e-18	0.263816834195906	0.999	0.986	1.66913410897185e-14	POLR2F	Malignant cells	GSE131984_Pac	ENSG00000100142	5435	RNA polymerase II, I and III subunit F	HRBP14.4|RPB6	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44102
1.29016083288452e-18	-0.329089716759159	0.273	0.459	1.98929898822464e-14	IDH1	Malignant cells	GSE131984_Pac	ENSG00000138413	3417	isocitrate dehydrogenase (NADP(+)) 1	NA	protein_coding	O75874	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44103
1.30079061225514e-18	0.354139769910584	0.874	0.752	2.0056890450362e-14	PMP22	Malignant cells	GSE131984_Pac	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44104
1.42389529703049e-18	0.596343479272711	0.838	0.685	2.19550415849131e-14	UBE2C	Malignant cells	GSE131984_Pac	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44105
1.63661403603993e-18	0.331424132200684	0.562	0.386	2.52349518216997e-14	GRWD1	Malignant cells	GSE131984_Pac	ENSG00000105447	83743	glutamate rich WD repeat containing 1	GRWD|RRB1|WDR28	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44106
1.66557415384271e-18	-0.417129432911917	0.445	0.614	2.56814878781007e-14	TMEM255B	Malignant cells	GSE131984_Pac	ENSG00000282107	348013	transmembrane protein 255B	FAM70B|MGC20579	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44107
1.68656651039923e-18	0.274832191287228	0.993	0.962	2.60051690238457e-14	CKS1B	Malignant cells	GSE131984_Pac	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44108
1.76002492502365e-18	0.330705108178121	0.484	0.294	2.71378243189397e-14	SAPCD2	Malignant cells	GSE131984_Pac	ENSG00000186193	89958	suppressor APC domain containing 2	C9orf140|p42.3	protein_coding	Q86UD0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44109
1.77626822150396e-18	0.315298047047294	0.602	0.409	2.73882797073695e-14	POLR2D	Malignant cells	GSE131984_Pac	ENSG00000144231	5433	RNA polymerase II subunit D	RPB4	protein_coding	O15514	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44110
1.91962321013156e-18	0.310741432600268	0.504	0.318	2.95986702770185e-14	POP1	Malignant cells	GSE131984_Pac	ENSG00000104356	10940	POP1 homolog, ribonuclease P/MRP subunit	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44111
1.94676577388307e-18	0.346131863595888	0.766	0.628	3.00171814675031e-14	M6PR	Malignant cells	GSE131984_Pac	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44112
2.07643387811479e-18	-0.381414493980627	0.1	0.26	3.20165339666519e-14	FOSB	Malignant cells	GSE131984_Pac	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44113
2.10101122594213e-18	0.258337807482796	0.993	0.992	3.23954920928018e-14	DEK	Malignant cells	GSE131984_Pac	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44114
2.10828247549648e-18	0.276413155977608	0.984	0.962	3.25076074896802e-14	NPM3	Malignant cells	GSE131984_Pac	ENSG00000107833	10360	nucleophosmin/nucleoplasmin 3	NA	protein_coding	O75607	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44115
2.5128650823446e-18	0.356843298125337	0.787	0.654	3.87458667046714e-14	GNPNAT1	Malignant cells	GSE131984_Pac	ENSG00000100522	64841	glucosamine-phosphate N-acetyltransferase 1	FLJ10607|Gpnat1	protein_coding	Q96EK6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44116
2.56283995641002e-18	0.320993595184577	0.915	0.856	3.95164292878862e-14	EIF3B	Malignant cells	GSE131984_Pac	ENSG00000106263	8662	eukaryotic translation initiation factor 3 subunit B	EIF3S9|PRT1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44117
2.58913486651549e-18	0.279207635016306	0.981	0.966	3.99218705068023e-14	COX20	Malignant cells	GSE131984_Pac	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44118
2.94305643637195e-18	-0.273363678159337	0.105	0.269	4.53789871924191e-14	LINC00936	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44119
3.08924747670576e-18	0.295304668647269	0.984	0.969	4.7633106843326e-14	CACYBP	Malignant cells	GSE131984_Pac	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44120
3.29293226659913e-18	0.255142919763213	0.999	0.992	5.07737226186919e-14	STRA13	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44121
3.35394170466701e-18	0.320409942757161	0.457	0.276	5.17144271442607e-14	SLC25A22	Malignant cells	GSE131984_Pac	ENSG00000177542	79751	solute carrier family 25 member 22	EIEE3|FLJ13044|GC-1|GC1|NET44	protein_coding	Q9H936	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44122
3.42361047476795e-18	0.330419546911542	0.735	0.566	5.2788649910447e-14	WDR5	Malignant cells	GSE131984_Pac	ENSG00000196363	11091	WD repeat domain 5	CFAP89|SWD3	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44123
3.47161533216592e-18	0.32356281666413	0.682	0.509	5.35288368066664e-14	RPIA	Malignant cells	GSE131984_Pac	ENSG00000153574	22934	ribose 5-phosphate isomerase A	NA	protein_coding	P49247	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44124
3.90105256678851e-18	-0.32899579643035	0.791	0.87	6.01503295273121e-14	RNF181	Malignant cells	GSE131984_Pac	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44125
4.03513778239001e-18	0.330270795211142	0.633	0.45	6.22177894666716e-14	CCDC137	Malignant cells	GSE131984_Pac	ENSG00000185298	339230	coiled-coil domain containing 137	MGC16597	protein_coding	Q6PK04	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44126
4.1467885252594e-18	0.271431068932624	0.43	0.239	6.39393322709747e-14	POLR2A	Malignant cells	GSE131984_Pac	ENSG00000284832	5430	RNA polymerase II subunit A	POLR2|POLRA|RPB1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44127
5.09837122409866e-18	0.521298580163549	0.882	0.861	7.86117859043772e-14	IGFBP4	Malignant cells	GSE131984_Pac	ENSG00000141753	3487	insulin like growth factor binding protein 4	BP-4|HT29-IGFBP|IBP4|IGFBP-4	protein_coding	P22692	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44128
5.40531619452725e-18	0.327743177227682	0.852	0.719	8.33445704034157e-14	NIPA2	Malignant cells	GSE131984_Pac	ENSG00000140157	81614	NIPA magnesium transporter 2	SLC57A2	protein_coding	Q8N8Q9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44129
6.56412315094519e-18	-0.370222792403352	0.438	0.621	1.01212214864424e-13	NME3	Malignant cells	GSE131984_Pac	ENSG00000103024	4832	NME/NM23 nucleoside diphosphate kinase 3	DR-nm23|NDPKC|NM23-H3	protein_coding	Q13232	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44130
6.91993654273624e-18	-0.377491128642227	0.555	0.699	1.0669850155245e-13	BLVRA	Malignant cells	GSE131984_Pac	ENSG00000106605	644	biliverdin reductase A	BLVR	protein_coding	P53004	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44131
7.06252042594984e-18	-0.314676625001852	0.916	0.952	1.08897002447721e-13	CKLF	Malignant cells	GSE131984_Pac	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44132
7.31541945695002e-18	0.275807837873426	0.941	0.868	1.12796452606712e-13	TIMM10	Malignant cells	GSE131984_Pac	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44133
8.04054725801184e-18	-0.341838492913314	0.908	0.94	1.23977198171285e-13	ETFB	Malignant cells	GSE131984_Pac	ENSG00000105379	2109	electron transfer flavoprotein subunit beta	NA	protein_coding	P38117	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44134
8.45262968673319e-18	-0.626748389407453	0.496	0.63	1.30331097139739e-13	NGFRAP1	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44135
8.7009779239704e-18	0.301640930473547	0.902	0.8	1.341603786097e-13	DAZAP1	Malignant cells	GSE131984_Pac	ENSG00000071626	26528	DAZ associated protein 1	MGC19907	protein_coding	Q96EP5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44136
8.70731103872232e-18	0.398413476158733	0.858	0.765	1.34258028906059e-13	DDX39A	Malignant cells	GSE131984_Pac	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44137
9.14192038256937e-18	-0.41339283635825	0.734	0.828	1.40959270378837e-13	MAP1LC3B	Malignant cells	GSE131984_Pac	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44138
9.82665103273792e-18	0.316686063044285	0.868	0.744	1.51517132273786e-13	PTBP1	Malignant cells	GSE131984_Pac	ENSG00000011304	5725	polypyrimidine tract binding protein 1	HNRNP-I|HNRPI|pPTB|PTB|PTB-1|PTB2|PTB3|PTB4	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44139
1.07879956306419e-17	0.300004409917419	0.802	0.654	1.66340104628868e-13	CECR5	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44140
1.10557950055625e-17	-0.281255523805438	0.168	0.345	1.70469303190768e-13	WIPI1	Malignant cells	GSE131984_Pac	ENSG00000070540	55062	WD repeat domain, phosphoinositide interacting 1	ATG18|ATG18A|FLJ10055|WIPI49	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44141
1.18022005102142e-17	0.305280499611927	0.803	0.661	1.81978129666992e-13	SLC52A2	Malignant cells	GSE131984_Pac	ENSG00000285112	79581	solute carrier family 52 member 2	D15Ertd747e|FLJ11856|GPCR41|GPR172A|hRFT3|PAR1|RFVT2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44142
1.42804503882844e-17	-0.274573984712231	0.993	0.998	2.20190264536958e-13	EID1	Malignant cells	GSE131984_Pac	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44143
1.44639671577917e-17	-0.418339691500014	0.71	0.81	2.23019909605991e-13	FDPS	Malignant cells	GSE131984_Pac	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44144
1.5204848552961e-17	-0.260339030101044	1	1	2.34443559838106e-13	S100A11	Malignant cells	GSE131984_Pac	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44145
1.66325863802e-17	-0.359202709874952	0.918	0.959	2.56457849396304e-13	ESD	Malignant cells	GSE131984_Pac	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44146
1.9947329474078e-17	-0.387627343587184	0.456	0.617	3.07567873160809e-13	CARD16	Malignant cells	GSE131984_Pac	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44147
2.40622569584425e-17	0.324733571461529	0.565	0.382	3.71015940042225e-13	RPP40	Malignant cells	GSE131984_Pac	ENSG00000124787	10799	ribonuclease P/MRP subunit p40	bA428J1.3|RNASEP1	protein_coding	O75818	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44148
2.46164275515665e-17	0.344071110307636	0.908	0.794	3.79560696417604e-13	ID1	Malignant cells	GSE131984_Pac	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44149
2.64050566951935e-17	0.298750232954636	0.979	0.968	4.07139569183189e-13	ATP1B3	Malignant cells	GSE131984_Pac	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44150
2.64218527372791e-17	0.28263990771688	0.555	0.359	4.07398547356107e-13	SCO1	Malignant cells	GSE131984_Pac	ENSG00000133028	6341	synthesis of cytochrome C oxidase 1	SCOD1	protein_coding	O75880	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44151
2.81284335933206e-17	-0.374728240908872	0.4	0.57	4.3371231757541e-13	TFPI	Malignant cells	GSE131984_Pac	ENSG00000003436	7035	tissue factor pathway inhibitor	EPI|LACI|TFI|TFPI1	protein_coding	P10646	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44152
3.05331317151473e-17	0.299805369545777	0.899	0.791	4.70790357915856e-13	BAG1	Malignant cells	GSE131984_Pac	ENSG00000107262	573	BAG cochaperone 1	NA	protein_coding	Q99933	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44153
3.06492774646885e-17	0.328283084698007	0.715	0.545	4.72581209228031e-13	PES1	Malignant cells	GSE131984_Pac	ENSG00000100029	23481	pescadillo ribosomal biogenesis factor 1	NOP7|PES	protein_coding	O00541	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44154
4.1747317730925e-17	-0.358351185379869	0.632	0.759	6.43701892093133e-13	SERPINB1	Malignant cells	GSE131984_Pac	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44155
4.23204454016124e-17	0.346620211559369	0.947	0.91	6.52538947647461e-13	CTSC	Malignant cells	GSE131984_Pac	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44156
4.60838704281547e-17	-0.257562327771147	1	1	7.10567198131717e-13	VIM	Malignant cells	GSE131984_Pac	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44157
4.82387591799405e-17	-0.422828153363409	0.379	0.553	7.43793427795502e-13	COL8A1	Malignant cells	GSE131984_Pac	ENSG00000144810	1295	collagen type VIII alpha 1 chain	C3orf7|MGC9568	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44158
4.89466176269239e-17	0.348490588056175	0.993	0.987	7.54707897189539e-13	TUBA1C	Malignant cells	GSE131984_Pac	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44159
5.12012420970379e-17	0.290328881410824	0.927	0.877	7.89471951894227e-13	FDX1	Malignant cells	GSE131984_Pac	ENSG00000137714	2230	ferredoxin 1	ADX|FDX	protein_coding	P10109	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44160
5.20607441741142e-17	0.382917736898388	0.481	0.31	8.02724614420668e-13	HTRA3	Malignant cells	GSE131984_Pac	ENSG00000170801	94031	HtrA serine peptidase 3	Prsp|Tasp	protein_coding	P83110	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44161
5.45480841980933e-17	-0.250575651722254	0.984	0.992	8.41076910250401e-13	TMEM160	Malignant cells	GSE131984_Pac	ENSG00000130748	54958	transmembrane protein 160	FLJ20512	protein_coding	Q9NX00	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44162
5.96524100572352e-17	0.290169211769701	0.447	0.267	9.19780510672509e-13	NBPF1	Malignant cells	GSE131984_Pac	ENSG00000219481	55672	NBPF member 1	FLJ20719|KIAA1693	protein_coding	Q3BBV0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44163
6.1797869679756e-17	0.326216661313598	0.775	0.646	9.52861352592158e-13	TSSC4	Malignant cells	GSE131984_Pac	ENSG00000184281	10078	tumor suppressing subtransferable candidate 4	NA	protein_coding	Q9Y5U2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44164
6.56696010194034e-17	0.310322118060615	0.836	0.713	1.01255957811818e-12	BCL7B	Malignant cells	GSE131984_Pac	ENSG00000106635	9275	BAF chromatin remodeling complex subunit BCL7B	SMARCJ2	protein_coding	Q9BQE9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44165
6.8154305109363e-17	0.308132636768388	0.543	0.362	1.05087123048127e-12	REEP4	Malignant cells	GSE131984_Pac	ENSG00000168476	80346	receptor accessory protein 4	C8orf20|FLJ22246|FLJ22277|PP432|Yip2c	protein_coding	Q9H6H4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44166
6.87141089944331e-17	0.326125108602709	0.928	0.851	1.05950284658516e-12	HNRNPA0	Malignant cells	GSE131984_Pac	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44167
7.26345524080528e-17	-0.322684141422112	0.411	0.572	1.11995216357977e-12	MIF4GD	Malignant cells	GSE131984_Pac	ENSG00000125457	57409	MIF4G domain containing	AD023|MGC45027|MIFD|SLIP1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44168
7.89825536139091e-17	-0.337681596911211	0.348	0.525	1.21783199417286e-12	TYMP	Malignant cells	GSE131984_Pac	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44169
8.3410827892369e-17	0.325086091326561	0.782	0.639	1.28611155527244e-12	BCCIP	Malignant cells	GSE131984_Pac	ENSG00000107949	56647	BRCA2 and CDKN1A interacting protein	BCCIPalpha|TOK-1	protein_coding	Q9P287	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44170
8.50879522843369e-17	-0.361183855507834	0.37	0.536	1.31197113627219e-12	FAM114A1	Malignant cells	GSE131984_Pac	ENSG00000197712	92689	family with sequence similarity 114 member A1	Noxp20	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44171
8.56564977346762e-17	0.326404192534047	0.654	0.49	1.32073753857097e-12	RRP15	Malignant cells	GSE131984_Pac	ENSG00000067533	51018	ribosomal RNA processing 15 homolog	CGI-115|KIAA0507	protein_coding	Q9Y3B9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44172
8.87131435821939e-17	0.292873420698079	0.826	0.669	1.36786796089385e-12	RABEP1	Malignant cells	GSE131984_Pac	ENSG00000029725	9135	rabaptin, RAB GTPase binding effector protein 1	neurocrescin|RAB5EP|rabaptin-5|RABPT5	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44173
9.18300161178496e-17	0.347641128225678	0.662	0.474	1.41592701852112e-12	AURKB	Malignant cells	GSE131984_Pac	ENSG00000178999	9212	aurora kinase B	Aik2|AIM-1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5	protein_coding	Q96GD4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44174
9.68662491572808e-17	0.292573203229326	0.774	0.623	1.49358069575611e-12	TMEM9B	Malignant cells	GSE131984_Pac	ENSG00000175348	56674	TMEM9 domain family member B	C11orf15	protein_coding	Q9NQ34	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44175
1.0286634719547e-16	-0.374145791275617	0.523	0.663	1.58609620740695e-12	ECH1	Malignant cells	GSE131984_Pac	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44176
1.04269506061521e-16	0.31254267446085	0.493	0.317	1.60773151396259e-12	MYO10	Malignant cells	GSE131984_Pac	ENSG00000145555	4651	myosin X	KIAA0799|MyoX	protein_coding	Q9HD67	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44177
1.14021405453142e-16	0.313603712492508	0.838	0.698	1.758096050682e-12	SS18L2	Malignant cells	GSE131984_Pac	ENSG00000008324	51188	SS18 like 2	KIAA-iso	protein_coding	Q9UHA2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44178
1.1754414892599e-16	0.261025604713849	0.989	0.989	1.81241323228984e-12	CHCHD10	Malignant cells	GSE131984_Pac	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44179
1.20032448204319e-16	-0.3507128987415	0.217	0.387	1.8507803188624e-12	LINC01133	Malignant cells	GSE131984_Pac	ENSG00000224259	NA	NA	lncRNA-PAGBC	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44180
1.20172489930585e-16	0.292632088234451	0.742	0.566	1.85293962223968e-12	POP5	Malignant cells	GSE131984_Pac	ENSG00000167272	51367	POP5 homolog, ribonuclease P/MRP subunit	NA	protein_coding	Q969H6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44181
1.44049003216159e-16	-0.35729932252764	0.781	0.879	2.22109158058996e-12	H1FX	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44182
1.45995940805988e-16	0.29994678896921	0.614	0.448	2.25111141128753e-12	PGAM5	Malignant cells	GSE131984_Pac	ENSG00000247077	192111	PGAM family member 5, mitochondrial serine/threonine protein phosphatase	BXLBv68|MGC5352	protein_coding	Q96HS1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44183
1.58316425395597e-16	0.309430654698616	0.822	0.705	2.44108096317471e-12	ABCF1	Malignant cells	GSE131984_Pac	ENSG00000225989	23	ATP binding cassette subfamily F member 1	ABC50|EST123147	protein_coding	Q8NE71	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44184
1.6280319553419e-16	0.268676698986743	0.525	0.335	2.51026247194168e-12	TRMU	Malignant cells	GSE131984_Pac	ENSG00000100416	55687	tRNA mitochondrial 2-thiouridylase	FLJ10140|MTO2|MTU1|TRMT	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44185
1.65371512216867e-16	-0.298189579501363	0.96	0.972	2.54986334687187e-12	TALDO1	Malignant cells	GSE131984_Pac	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44186
1.754708553399e-16	0.321985741312518	0.789	0.647	2.70558511848591e-12	TNIP2	Malignant cells	GSE131984_Pac	ENSG00000168884	79155	TNFAIP3 interacting protein 2	ABIN-2|FLIP1|KLIP|MGC4289	protein_coding	Q8NFZ5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44187
1.92960587369852e-16	-0.378222638687806	0.274	0.451	2.97525929665574e-12	SORBS2	Malignant cells	GSE131984_Pac	ENSG00000154556	8470	sorbin and SH3 domain containing 2	ARGBP2|KIAA0777	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44188
1.98937752776107e-16	-0.433902008159788	0.858	0.907	3.0674212100548e-12	GADD45A	Malignant cells	GSE131984_Pac	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44189
2.06745608136984e-16	0.356842195948409	0.618	0.447	3.18781053186416e-12	TXNRD2	Malignant cells	GSE131984_Pac	ENSG00000184470	10587	thioredoxin reductase 2	SELZ|TR|TR3|TRXR2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44190
2.07318965470242e-16	-0.293957998898037	0.822	0.893	3.19665112858566e-12	PNKD	Malignant cells	GSE131984_Pac	ENSG00000127838	25953	PNKD metallo-beta-lactamase domain containing	BRP17|DKFZp564N1362|DYT8|FKSG19|FPD1|KIAA1184|KIPP1184|MGC31943|MR-1|MR-1S|PDC|PKND1|TAHCCP2	protein_coding	Q8N490	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44191
2.16821629223116e-16	0.329055647428446	0.931	0.881	3.34317270099123e-12	MRPS23	Malignant cells	GSE131984_Pac	ENSG00000181610	51649	mitochondrial ribosomal protein S23	CGI-138|HSPC329|MRP-S23	protein_coding	Q9Y3D9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44192
2.30267368693455e-16	0.35049148137011	0.646	0.484	3.55049255788439e-12	SLC25A4	Malignant cells	GSE131984_Pac	ENSG00000151729	291	solute carrier family 25 member 4	AAC1|ANT1|PEO2|PEO3|T1	protein_coding	P12235	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44193
2.43978760234233e-16	-0.383764752153434	0.299	0.472	3.76190850405164e-12	DUSP5	Malignant cells	GSE131984_Pac	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44194
2.48134893338812e-16	0.253441668334121	0.34	0.178	3.82599192039115e-12	SLC5A6	Malignant cells	GSE131984_Pac	ENSG00000138074	8884	solute carrier family 5 member 6	SMVT	protein_coding	Q9Y289	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44195
2.52952446009278e-16	0.307602153471522	0.662	0.487	3.90027376501706e-12	NDUFAF6	Malignant cells	GSE131984_Pac	ENSG00000156170	137682	NADH:ubiquinone oxidoreductase complex assembly factor 6	C8orf38|MGC40214	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44196
2.77806121665855e-16	0.287021564277269	0.529	0.341	4.28349258996582e-12	RBM14	Malignant cells	GSE131984_Pac	ENSG00000239306	10432	RNA binding motif protein 14	COAA|DKFZp779J0927|SIP|SYTIP1	protein_coding	Q96PK6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44197
2.80266461836707e-16	0.271913802062433	0.96	0.916	4.32142857506018e-12	EIF3A	Malignant cells	GSE131984_Pac	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44198
2.93856303743237e-16	0.301923598804537	0.812	0.688	4.53097034741697e-12	PSME3	Malignant cells	GSE131984_Pac	ENSG00000131467	10197	proteasome activator subunit 3	Ki|PA28-gamma|PA28G|REG-GAMMA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44199
2.94926580037561e-16	0.297598939787008	0.812	0.654	4.54747293759916e-12	TPX2	Malignant cells	GSE131984_Pac	ENSG00000088325	22974	TPX2 microtubule nucleation factor	C20orf1|C20orf2|DIL-2|FLS353|HCA519|p100	protein_coding	Q9ULW0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44200
3.17345254889906e-16	-0.310734832820477	0.229	0.399	4.89314648514747e-12	MSC	Malignant cells	GSE131984_Pac	ENSG00000178860	9242	musculin	ABF-1|bHLHa22	protein_coding	O60682	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44201
3.35074280741614e-16	0.30023498115396	0.811	0.664	5.16651033475494e-12	SLC25A11	Malignant cells	GSE131984_Pac	ENSG00000108528	8402	solute carrier family 25 member 11	OGC|SLC20A4	protein_coding	Q02978	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44202
3.36180206071129e-16	0.344775542420171	0.702	0.535	5.18356259741074e-12	MPRIP	Malignant cells	GSE131984_Pac	ENSG00000133030	23164	myosin phosphatase Rho interacting protein	M-RIP|p116Rip|RHOIP3	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44203
3.41506393870136e-16	0.311636713002798	0.854	0.746	5.26568708708363e-12	AMD1	Malignant cells	GSE131984_Pac	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44204
3.56623505586935e-16	0.291782062738002	0.847	0.736	5.49877783264496e-12	SF1	Malignant cells	GSE131984_Pac	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44205
3.6489413753085e-16	0.256354705830762	0.963	0.916	5.62630270658818e-12	CISD2	Malignant cells	GSE131984_Pac	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44206
4.03061421893045e-16	0.327528774637367	0.795	0.695	6.21480406416887e-12	C12orf45	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44207
4.06242168529282e-16	-0.337870334940383	0.743	0.847	6.26384799655299e-12	MXD4	Malignant cells	GSE131984_Pac	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44208
4.71026255257425e-16	0.322083378889002	0.741	0.587	7.26275382981423e-12	EIF2B1	Malignant cells	GSE131984_Pac	ENSG00000111361	1967	eukaryotic translation initiation factor 2B subunit alpha	EIF-2B|EIF-2Balpha|EIF2B|EIF2BA|EIF2Balpha	protein_coding	Q14232	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44209
5.01079701379365e-16	0.298531557317421	0.604	0.429	7.72614791556844e-12	TMEM138	Malignant cells	GSE131984_Pac	ENSG00000149483	51524	transmembrane protein 138	HSPC196|JBTS16	protein_coding	Q9NPI0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44210
5.25048374730859e-16	0.30637943895096	0.86	0.73	8.09572088997511e-12	DPM2	Malignant cells	GSE131984_Pac	ENSG00000136908	8818	dolichyl-phosphate mannosyltransferase subunit 2, regulatory	MGC111193|MGC21559	protein_coding	O94777	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44211
5.58461901255893e-16	0.332689347655949	0.84	0.735	8.61092405546461e-12	C9orf78	Malignant cells	GSE131984_Pac	ENSG00000136819	51759	chromosome 9 open reading frame 78	CSU2|HCA59|HSPC220	protein_coding	Q9NZ63	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44212
6.19650041849013e-16	-0.398495813814094	0.719	0.818	9.55438399526993e-12	SDCBP	Malignant cells	GSE131984_Pac	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44213
7.35699228372414e-16	0.343725718043376	0.678	0.535	1.13437464022743e-11	SRPRB	Malignant cells	GSE131984_Pac	ENSG00000144867	58477	SRP receptor subunit beta	APMCF1|SR-beta	protein_coding	Q9Y5M8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44214
7.36913733355928e-16	0.297265610932174	0.794	0.663	1.13624728546151e-11	SLC39A3	Malignant cells	GSE131984_Pac	ENSG00000141873	29985	solute carrier family 39 member 3	ZIP3	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44215
7.77625133352287e-16	0.30259729827497	0.642	0.479	1.19902019311589e-11	NSUN2	Malignant cells	GSE131984_Pac	ENSG00000037474	54888	NOP2/Sun RNA methyltransferase 2	FLJ20303|Misu|MRT5|SAKI|TRM4	protein_coding	Q08J23	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44216
7.87149080276953e-16	0.30532786467802	0.576	0.405	1.21370516687903e-11	NKX2-5	Malignant cells	GSE131984_Pac	ENSG00000183072	1482	NK2 homeobox 5	CSX|CSX1|NKX2.5|NKX2E|NKX4-1	protein_coding	P52952	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44217
8.2414682674595e-16	-0.318551844995242	0.971	0.986	1.27075199215958e-11	MYL12A	Malignant cells	GSE131984_Pac	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44218
8.4661057643036e-16	0.269559925825705	0.983	0.974	1.30538884779797e-11	SRRM2	Malignant cells	GSE131984_Pac	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44219
8.73931799457852e-16	0.296918130184557	0.678	0.506	1.34751544158406e-11	SDAD1	Malignant cells	GSE131984_Pac	ENSG00000198301	55153	SDA1 domain containing 1	FLJ10498	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44220
9.04192709317224e-16	0.289395648726562	0.455	0.283	1.39417473849623e-11	LRFN4	Malignant cells	GSE131984_Pac	ENSG00000173621	78999	leucine rich repeat and fibronectin type III domain containing 4	FIGLER6|MGC3103|SALM3.	protein_coding	Q6PJG9	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44221
9.06387633242577e-16	-0.330562418522105	0.464	0.64	1.39755909169673e-11	RP3-460G2.2	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44222
9.83819450740887e-16	0.26120572878118	0.955	0.896	1.51695121109737e-11	MRPL42	Malignant cells	GSE131984_Pac	ENSG00000198015	28977	mitochondrial ribosomal protein L42	HSPC204|MRP-L31|MRPL31|MRPS32|PTD007|RPML31	protein_coding	Q9Y6G3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44223
1.0103185141644e-15	-0.259104371527975	0.285	0.452	1.55781011699008e-11	IRF1	Malignant cells	GSE131984_Pac	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44224
1.03506891553717e-15	0.290191130730509	0.971	0.915	1.59597276086676e-11	NUDC	Malignant cells	GSE131984_Pac	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44225
1.0681646224671e-15	0.272188522627081	0.993	0.977	1.64700303138202e-11	C17orf89	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44226
1.07045930892247e-15	0.260561775943454	1	0.999	1.65054120842755e-11	TPM2	Malignant cells	GSE131984_Pac	ENSG00000198467	7169	tropomyosin 2	AMCD1|DA1|NEM4	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44227
1.32568485204944e-15	0.312327457835572	0.831	0.686	2.04407347337503e-11	MRPL50	Malignant cells	GSE131984_Pac	ENSG00000136897	54534	mitochondrial ribosomal protein L50	FLJ20493|MRP-L50	protein_coding	Q8N5N7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44228
1.52467547223794e-15	0.307425060864498	0.684	0.526	2.35089711064368e-11	AAED1	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44229
1.66646606636441e-15	0.307066281045883	0.584	0.424	2.56952402772729e-11	MPDU1	Malignant cells	GSE131984_Pac	ENSG00000129255	9526	mannose-P-dolichol utilization defect 1	CDGIf|Lec35|PQLC5|SL15|SLC66A5	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44230
1.84815836178126e-15	0.285678328638682	0.874	0.762	2.84967537803053e-11	TIMM50	Malignant cells	GSE131984_Pac	ENSG00000105197	92609	translocase of inner mitochondrial membrane 50	TIM50|TIM50L	protein_coding	Q3ZCQ8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44231
1.94211501701088e-15	0.311303246748557	0.741	0.594	2.99454714472908e-11	TRABD	Malignant cells	GSE131984_Pac	ENSG00000170638	80305	TraB domain containing	PP2447	protein_coding	Q9H4I3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44232
2.01349444494879e-15	0.283120744785138	0.923	0.807	3.10460708466654e-11	MKI67	Malignant cells	GSE131984_Pac	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44233
2.23682421230251e-15	-0.410062759947115	0.472	0.626	3.44895925294924e-11	GYPC	Malignant cells	GSE131984_Pac	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44234
2.35498261589871e-15	0.292613259055382	0.83	0.713	3.63114769545422e-11	SZRD1	Malignant cells	GSE131984_Pac	ENSG00000055070	26099	SUZ RNA binding domain containing 1	C1orf144|DKFZp566C0424	protein_coding	Q7Z422	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44235
2.4266991034794e-15	0.289568750050046	0.935	0.857	3.74172734765489e-11	C19orf48	Malignant cells	GSE131984_Pac	ENSG00000167747	84798	multidrug resistance-related protein	BC006151|MGC13170	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44236
2.4652530002621e-15	0.268465166636878	0.971	0.93	3.80117360110414e-11	BIRC5	Malignant cells	GSE131984_Pac	ENSG00000089685	332	baculoviral IAP repeat containing 5	API4|EPR-1|survivin	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44237
2.49624145173983e-15	0.269174013641818	0.945	0.917	3.84895469443765e-11	SLC25A39	Malignant cells	GSE131984_Pac	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44238
2.50452814727833e-15	0.310788696885454	0.705	0.546	3.86173195028845e-11	MAP2K3	Malignant cells	GSE131984_Pac	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44239
2.53493297763104e-15	0.338809281172238	0.628	0.468	3.9086131582093e-11	CHORDC1	Malignant cells	GSE131984_Pac	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44240
2.53872323984977e-15	0.266548515431165	0.391	0.226	3.91445736352435e-11	NOP2	Malignant cells	GSE131984_Pac	ENSG00000111641	4839	NOP2 nucleolar protein	NOL1|NOP120|NSUN1|p120	protein_coding	P46087	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44241
2.83666318592686e-15	-0.297175353091313	0.9	0.951	4.37385096638063e-11	GLTSCR2	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44242
2.88144353516135e-15	-0.458551487093743	0.64	0.746	4.44289778686529e-11	TSC22D3	Malignant cells	GSE131984_Pac	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44243
3.45156616483745e-15	0.294615116800893	0.691	0.545	5.32196986956287e-11	LRRC58	Malignant cells	GSE131984_Pac	ENSG00000163428	116064	leucine rich repeat containing 58	NA	protein_coding	Q96CX6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44244
3.48370318369655e-15	0.314792570406445	0.677	0.52	5.37152193894171e-11	PRMT5	Malignant cells	GSE131984_Pac	ENSG00000100462	10419	protein arginine methyltransferase 5	HRMT1L5|SKB1|SKB1Hs	protein_coding	O14744	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44245
3.5205590007748e-15	-0.256103756326644	0.293	0.472	5.42834992329467e-11	TMTC1	Malignant cells	GSE131984_Pac	ENSG00000133687	83857	transmembrane O-mannosyltransferase targeting cadherins 1	ARG99|FLJ31400|FLJ41625|OLF	protein_coding	Q8IUR5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44246
3.72050336841454e-15	0.30178079788182	0.771	0.631	5.73664414375838e-11	ELOVL1	Malignant cells	GSE131984_Pac	ENSG00000066322	64834	ELOVL fatty acid elongase 1	Ssc1	protein_coding	Q9BW60	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44247
3.95106638218259e-15	0.287730698265965	0.945	0.898	6.09214925468734e-11	SFPQ	Malignant cells	GSE131984_Pac	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44248
4.04405947262855e-15	0.34143808512457	0.805	0.691	6.23553530084595e-11	GRPEL1	Malignant cells	GSE131984_Pac	ENSG00000109519	80273	GrpE like 1, mitochondrial	FLJ25609|GrpE|hMGE	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44249
4.3250293142604e-15	0.270604872834139	0.471	0.297	6.66876269965812e-11	ECE2	Malignant cells	GSE131984_Pac	ENSG00000145194	9718	endothelin converting enzyme 2	KIAA0604|MGC2408	protein_coding	P0DPD6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44250
4.33384962616026e-15	0.262322211322885	0.515	0.34	6.6823627385765e-11	TARBP2	Malignant cells	GSE131984_Pac	ENSG00000139546	6895	TARBP2 subunit of RISC loading complex	Trbp	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44251
4.33829377998865e-15	0.254725762986227	0.939	0.906	6.6892151793645e-11	SRSF11	Malignant cells	GSE131984_Pac	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44252
4.55438288153993e-15	-0.291732396519253	0.293	0.469	7.02240296504642e-11	SREBF1	Malignant cells	GSE131984_Pac	ENSG00000072310	6720	sterol regulatory element binding transcription factor 1	bHLHd1|SREBP-1c|SREBP1|SREBP1a	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44253
4.6293794756175e-15	0.351819681950431	0.737	0.58	7.13804021345463e-11	CENPA	Malignant cells	GSE131984_Pac	ENSG00000115163	1058	centromere protein A	CenH3|CENP-A	protein_coding	P49450	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44254
5.36374673151684e-15	0.290409530770946	0.6	0.414	8.27036108532581e-11	GTSE1	Malignant cells	GSE131984_Pac	ENSG00000075218	51512	G2 and S-phase expressed 1	B99|GTSE-1|Lnc_bc060912	protein_coding	Q9NYZ3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44255
5.37537058082537e-15	0.281696338804529	0.613	0.451	8.28828389857463e-11	ALKBH5	Malignant cells	GSE131984_Pac	ENSG00000091542	54890	alkB homolog 5, RNA demethylase	FLJ20308|OFOXD1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44256
5.60050942257083e-15	0.294197439069758	0.902	0.842	8.63542547866196e-11	BUB3	Malignant cells	GSE131984_Pac	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44257
5.7615253130601e-15	0.333414260222108	0.848	0.734	8.88369588020737e-11	RHOBTB3	Malignant cells	GSE131984_Pac	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44258
5.78859031191377e-15	0.312501206212061	0.733	0.583	8.92542740193984e-11	SLC25A33	Malignant cells	GSE131984_Pac	ENSG00000171612	84275	solute carrier family 25 member 33	BMSC-MCP|MGC4399|PNC1	protein_coding	Q9BSK2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44259
5.96234716751332e-15	0.334149649970618	0.745	0.614	9.19334309758879e-11	FARSA	Malignant cells	GSE131984_Pac	ENSG00000179115	2193	phenylalanyl-tRNA synthetase subunit alpha	CML33|FARSL|FARSLA	protein_coding	Q9Y285	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44260
6.46858332762764e-15	0.309904972218312	0.67	0.507	9.97390863286906e-11	DBF4	Malignant cells	GSE131984_Pac	ENSG00000006634	10926	DBF4 zinc finger	ASK|chif|DBF4A|ZDBF1	protein_coding	Q9UBU7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44261
6.72215936344174e-15	0.313547950071049	0.843	0.739	1.03648975224908e-10	GNL3	Malignant cells	GSE131984_Pac	ENSG00000163938	26354	G protein nucleolar 3	C77032|E2IG3|MGC800|NS	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44262
6.82686404280278e-15	0.374081676634017	0.649	0.52	1.05263416675976e-10	CPED1	Malignant cells	GSE131984_Pac	ENSG00000106034	79974	cadherin like and PC-esterase domain containing 1	C7orf58|FLJ21986	protein_coding	A4D0V7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44263
7.1689141871371e-15	0.295074951971499	0.816	0.678	1.10537487851467e-10	MRGBP	Malignant cells	GSE131984_Pac	ENSG00000101189	55257	MRG domain binding protein	C20orf20|Eaf7|FLJ10914|MRG15BP	protein_coding	Q9NV56	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44264
7.19223830954759e-15	0.292643239260363	0.677	0.528	1.10897122494914e-10	GOLM1	Malignant cells	GSE131984_Pac	ENSG00000135052	51280	golgi membrane protein 1	bA379P1.3|C9orf155|FLJ23608|GOLPH2|GP73	protein_coding	Q8NBJ4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44265
7.75970088555499e-15	0.298577529316428	0.565	0.403	1.19646827954372e-10	ELAC2	Malignant cells	GSE131984_Pac	ENSG00000006744	60528	elaC ribonuclease Z 2	FLJ10530|HPC2	protein_coding	Q9BQ52	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44266
7.93126145839943e-15	0.279327570157371	0.469	0.303	1.22292120427061e-10	DLEU1	Malignant cells	GSE131984_Pac	ENSG00000176124	10301	deleted in lymphocytic leukemia 1	BCMS|BCMS1|DLB1|LEU1|LINC00021|NCRNA00021|XTP6	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44267
8.03754636693342e-15	0.276992470918533	0.77	0.613	1.23930927431746e-10	ZFR	Malignant cells	GSE131984_Pac	ENSG00000056097	51663	zinc finger RNA binding protein	SPG71|ZFR1	protein_coding	Q96KR1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44268
8.97193967732074e-15	0.259030699960797	0.96	0.923	1.38338337884608e-10	TMEM126A	Malignant cells	GSE131984_Pac	ENSG00000171202	84233	transmembrane protein 126A	DKFZp586C1924|OPA7	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44269
9.26753456463857e-15	0.252087898663974	0.529	0.348	1.42896115452162e-10	TSEN54	Malignant cells	GSE131984_Pac	ENSG00000182173	283989	tRNA splicing endonuclease subunit 54	SEN54|SEN54L	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44270
9.335834092815e-15	-0.274511863688218	0.88	0.937	1.43949225877114e-10	LINC00493	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44271
9.62212774115365e-15	0.293718172380781	0.799	0.668	1.48363587640848e-10	TMPO	Malignant cells	GSE131984_Pac	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44272
9.75408180163014e-15	-0.295070237657184	0.209	0.366	1.50398187299335e-10	MSMO1	Malignant cells	GSE131984_Pac	ENSG00000052802	6307	methylsterol monooxygenase 1	DESP4|ERG25|SC4MOL	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44273
1.0705799734989e-14	0.283523253653242	0.68	0.517	1.65072726113795e-10	C12orf29	Malignant cells	GSE131984_Pac	ENSG00000133641	91298	chromosome 12 open reading frame 29	DKFZp434N2030	protein_coding	Q8N999	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44274
1.15582740596858e-14	0.297661237362529	0.77	0.63	1.78217027726295e-10	ESRRA	Malignant cells	GSE131984_Pac	ENSG00000173153	2101	estrogen related receptor alpha	ERR1|ERRa|ERRalpha|ESRL1|NR3B1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44275
1.30951105600928e-14	0.305142460748201	0.816	0.691	2.01913509726071e-10	MAGOH	Malignant cells	GSE131984_Pac	ENSG00000162385	4116	mago homolog, exon junction complex subunit	MAGOH1|MAGOHA	protein_coding	P61326	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44276
1.32045702266039e-14	0.31005221921173	0.895	0.828	2.03601268324005e-10	VTI1B	Malignant cells	GSE131984_Pac	ENSG00000100568	10490	vesicle transport through interaction with t-SNAREs 1B	VTI2	protein_coding	Q9UEU0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44277
1.34145585531763e-14	0.282245135504568	0.883	0.836	2.06839078331425e-10	ARL2BP	Malignant cells	GSE131984_Pac	ENSG00000102931	23568	ADP ribosylation factor like GTPase 2 binding protein	BART|BART1|RP66	protein_coding	Q9Y2Y0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44278
1.42475549023316e-14	-0.331802109006034	0.644	0.74	2.1968304903905e-10	SLC25A1	Malignant cells	GSE131984_Pac	ENSG00000100075	6576	solute carrier family 25 member 1	CTP|SLC20A3	protein_coding	P53007	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44279
1.4516591223559e-14	0.281649155980974	0.657	0.503	2.23831320076056e-10	TMEM5	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44280
1.49656669136141e-14	0.282398876049643	0.887	0.782	2.30755618141016e-10	DDX24	Malignant cells	GSE131984_Pac	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44281
1.70795612651923e-14	0.288702155753273	0.456	0.303	2.63349755148001e-10	FTSJ3	Malignant cells	GSE131984_Pac	ENSG00000108592	117246	FtsJ RNA 2'-O-methyltransferase 3	SPB1	protein_coding	Q8IY81	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44282
1.73550677738457e-14	0.284430767953815	0.856	0.758	2.67597790004926e-10	CNOT7	Malignant cells	GSE131984_Pac	ENSG00000198791	29883	CCR4-NOT transcription complex subunit 7	CAF1	protein_coding	Q9UIV1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44283
1.81275981624929e-14	-0.364186624369129	0.419	0.559	2.79509436067478e-10	IQSEC2	Malignant cells	GSE131984_Pac	ENSG00000124313	23096	IQ motif and Sec7 domain ArfGEF 2	BRAG1|IQ-ArfGEF|KIAA0522|MRX1|MRX18|MRX78	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44284
1.94788163493231e-14	0.271647279015876	0.852	0.774	3.00343869290213e-10	CRLS1	Malignant cells	GSE131984_Pac	ENSG00000088766	54675	cardiolipin synthase 1	C20orf155|CLS1|dJ967N21.6|GCD10	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44285
2.12144817040886e-14	0.330370745938213	0.585	0.426	3.27106093395342e-10	RP11-554I8.2	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44286
2.58483932423272e-14	0.301994647166491	0.725	0.598	3.98556375403443e-10	GNL2	Malignant cells	GSE131984_Pac	ENSG00000134697	29889	G protein nucleolar 2	HUMAUANTIG|Ngp-1|Nog2|Nug2	protein_coding	Q13823	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44287
2.70390984514956e-14	0.261691958043756	0.979	0.958	4.1691585902361e-10	HNRNPU	Malignant cells	GSE131984_Pac	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44288
2.81140777452623e-14	0.275816076188794	0.826	0.714	4.334909647542e-10	ZCCHC17	Malignant cells	GSE131984_Pac	ENSG00000121766	51538	zinc finger CCHC-type containing 17	HSPC251|pNO40|PS1D	protein_coding	Q9NP64	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44289
2.91437514410576e-14	0.27422766790068	0.576	0.405	4.49367503469667e-10	DDX17	Malignant cells	GSE131984_Pac	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44290
3.13580357505455e-14	0.292323768089854	0.822	0.704	4.83509553237662e-10	C9orf142	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44291
3.46590252172438e-14	0.297039469297694	0.685	0.524	5.34407509824682e-10	CCAR1	Malignant cells	GSE131984_Pac	ENSG00000060339	55749	cell division cycle and apoptosis regulator 1	CARP-1|CARP1|FLJ10590	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44292
4.0133904683882e-14	0.270604872834139	0.452	0.288	6.18824676320776e-10	SLC29A1	Malignant cells	GSE131984_Pac	ENSG00000112759	2030	solute carrier family 29 member 1 (Augustine blood group)	ENT1	protein_coding	Q99808	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44293
4.14799259255424e-14	0.263439161162728	0.419	0.26	6.39578977845938e-10	KAT2A	Malignant cells	GSE131984_Pac	ENSG00000108773	2648	lysine acetyltransferase 2A	GCN5|GCN5L2|PCAF-b	protein_coding	Q92830	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44294
4.20091517950551e-14	-0.73700847990107	0.48	0.601	6.47739111527955e-10	GS1-600G8.5	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44295
4.55041679965611e-14	0.259984207413948	0.961	0.932	7.01628766338976e-10	TSR3	Malignant cells	GSE131984_Pac	ENSG00000007520	115939	TSR3 ribosome maturation factor	C16orf42|MGC24381	protein_coding	Q9UJK0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44296
4.6571692980378e-14	-0.282173818776135	0.279	0.441	7.18088934064448e-10	SHISA4	Malignant cells	GSE131984_Pac	ENSG00000198892	149345	shisa family member 4	C1orf40|hShisa4|TMEM58	protein_coding	Q96DD7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44297
4.69718615285408e-14	0.259018108609115	0.944	0.905	7.2425913290857e-10	CNPY2	Malignant cells	GSE131984_Pac	ENSG00000257727	10330	canopy FGF signaling regulator 2	HP10390|TMEM4|ZSIG9	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44298
4.83227975768816e-14	0.278715058892993	0.888	0.798	7.45089215837938e-10	BLOC1S2	Malignant cells	GSE131984_Pac	ENSG00000196072	282991	biogenesis of lysosomal organelles complex 1 subunit 2	BLOS2|BORCS2|FLJ30135|MGC10120	protein_coding	Q6QNY1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44299
5.98578190827325e-14	0.270833489083279	0.987	0.961	9.22947712436652e-10	EIF6	Malignant cells	GSE131984_Pac	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44300
5.99484544350143e-14	-0.291348001032147	0.481	0.639	9.24345218933485e-10	LITAF	Malignant cells	GSE131984_Pac	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44301
6.40229119698434e-14	-0.302813851879603	0.396	0.54	9.87169279663016e-10	LACTB	Malignant cells	GSE131984_Pac	ENSG00000103642	114294	lactamase beta	FLJ14902|MRPL56	protein_coding	P83111	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44302
6.4034799271792e-14	-0.307984221804442	0.239	0.397	9.87352569971761e-10	PDGFRA	Malignant cells	GSE131984_Pac	ENSG00000134853	5156	platelet derived growth factor receptor alpha	CD140a|GAS9|PDGFR2	protein_coding	P16234	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44303
6.42280213521135e-14	0.281562600211499	0.6	0.432	9.90331861228238e-10	UBTF	Malignant cells	GSE131984_Pac	ENSG00000108312	7343	upstream binding transcription factor	NOR-90|UBF|UBF1|UBF2	protein_coding	P17480	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44304
7.17489356782635e-14	0.306883368345562	0.685	0.549	1.10629683922315e-09	MRPL1	Malignant cells	GSE131984_Pac	ENSG00000169288	65008	mitochondrial ribosomal protein L1	BM022	protein_coding	Q9BYD6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44305
7.28077414718553e-14	0.258858547251035	0.972	0.938	1.12262256575454e-09	MRPS18C	Malignant cells	GSE131984_Pac	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44306
7.753570805782e-14	0.278607770061059	0.598	0.433	1.19552308254353e-09	BRI3BP	Malignant cells	GSE131984_Pac	ENSG00000184992	140707	BRI3 binding protein	BNAS1|HCCR-2|HCCRBP-3|KG19	protein_coding	Q8WY22	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44307
7.83018180930421e-14	0.26827064416444	0.501	0.336	1.20733573317662e-09	SRRT	Malignant cells	GSE131984_Pac	ENSG00000087087	51593	serrate, RNA effector molecule	ARS2|Asr2|serrate	protein_coding	Q9BXP5	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44308
8.01413375805432e-14	-0.266844730268997	0.92	0.943	1.2356992841544e-09	CALD1	Malignant cells	GSE131984_Pac	ENSG00000122786	800	caldesmon 1	CDM|H-CAD|h-CD|L-CAD	protein_coding	Q05682	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44309
9.85428366892544e-14	-0.289230611228565	0.415	0.572	1.51943199891161e-09	CFLAR	Malignant cells	GSE131984_Pac	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44310
1.06554464325367e-13	-0.251234517529504	0.935	0.964	1.64296328543284e-09	MPG	Malignant cells	GSE131984_Pac	ENSG00000103152	4350	N-methylpurine DNA glycosylase	MDG	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44311
1.10117912043508e-13	0.275971916941938	0.626	0.464	1.69790808579885e-09	NF2	Malignant cells	GSE131984_Pac	ENSG00000186575	4771	NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor	ACN|BANF|merlin|merlin-1|SCH	protein_coding	P35240	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44312
1.23394985792559e-13	0.290279303344472	0.82	0.754	1.90262728593547e-09	DNAJB11	Malignant cells	GSE131984_Pac	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44313
1.26006166981563e-13	0.282202050474799	0.741	0.613	1.94288908868873e-09	TMX1	Malignant cells	GSE131984_Pac	ENSG00000139921	81542	thioredoxin related transmembrane protein 1	PDIA11|TMX|TXNDC|TXNDC1	protein_coding	Q9H3N1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44314
1.28380197469292e-13	-0.323171936058699	0.412	0.561	1.97949426477902e-09	UGDH	Malignant cells	GSE131984_Pac	ENSG00000109814	7358	UDP-glucose 6-dehydrogenase	NA	protein_coding	O60701	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44315
1.28431652184902e-13	0.2768143024634	0.463	0.304	1.980287645039e-09	FERMT1	Malignant cells	GSE131984_Pac	ENSG00000101311	55612	FERM domain containing kindlin 1	C20orf42|FLJ20116|KIND1|UNC112A|URP1	protein_coding	Q9BQL6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44316
1.30613982964943e-13	-0.264328008224404	0.141	0.281	2.01393700333645e-09	MAP3K8	Malignant cells	GSE131984_Pac	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44317
1.32321185789188e-13	0.293306643323461	0.537	0.372	2.04026036368349e-09	CHD1	Malignant cells	GSE131984_Pac	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44318
1.37655091507889e-13	-0.283550003494246	0.862	0.93	2.12250385596014e-09	PDLIM1	Malignant cells	GSE131984_Pac	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44319
1.37920613383668e-13	0.254893959762401	0.963	0.953	2.12659793776278e-09	CAPN2	Malignant cells	GSE131984_Pac	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44320
1.39609187157426e-13	-0.335425025397508	0.654	0.759	2.15263405678035e-09	PPP1R15A	Malignant cells	GSE131984_Pac	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44321
1.47569683886162e-13	-0.297267336741923	0.249	0.403	2.27537695584073e-09	UBALD2	Malignant cells	GSE131984_Pac	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44322
1.51965558058858e-13	0.281944925748422	0.569	0.416	2.34315693970953e-09	RP9	Malignant cells	GSE131984_Pac	ENSG00000164610	6100	RP9 pre-mRNA splicing factor	PAP-1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44323
1.59268140409603e-13	0.335997432939552	0.823	0.692	2.45575545697568e-09	GLIPR1	Malignant cells	GSE131984_Pac	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44324
1.64159573777101e-13	0.266500305876069	0.594	0.423	2.53117646806911e-09	GTF2H2	Malignant cells	GSE131984_Pac	ENSG00000276910	2966	general transcription factor IIH subunit 2	BTF2|BTF2P44|p44|T-BTF2P44|TFIIH	protein_coding	Q13888	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44325
1.67118351936652e-13	0.283524613598984	0.785	0.641	2.57679786851124e-09	GMNN	Malignant cells	GSE131984_Pac	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44326
1.7391295510998e-13	0.318985179133874	0.785	0.677	2.68156385484079e-09	GTPBP4	Malignant cells	GSE131984_Pac	ENSG00000107937	23560	GTP binding protein 4	CRFG|FLJ10686|FLJ10690|NGB|NOG1	protein_coding	Q9BZE4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44327
1.7504854948068e-13	-0.333380165640341	0.964	0.96	2.6990735844426e-09	HES1	Malignant cells	GSE131984_Pac	ENSG00000114315	3280	hes family bHLH transcription factor 1	bHLHb39|FLJ20408|HES-1|HRY	protein_coding	Q14469	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44328
1.76744911569308e-13	-0.307720299062696	0.674	0.774	2.72522979148717e-09	CYSTM1	Malignant cells	GSE131984_Pac	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44329
1.80919771439864e-13	0.311984728744627	0.765	0.631	2.78960195583127e-09	FOSL1	Malignant cells	GSE131984_Pac	ENSG00000175592	8061	FOS like 1, AP-1 transcription factor subunit	fra-1	protein_coding	P15407	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44330
1.88036137468607e-13	0.266888565581235	0.867	0.804	2.89932920362845e-09	PARL	Malignant cells	GSE131984_Pac	ENSG00000175193	55486	presenilin associated rhomboid like	PRO2207|PSARL|PSARL1|RHBDS1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44331
1.9076986782272e-13	0.276986943725774	0.875	0.77	2.94148059195852e-09	LARP1	Malignant cells	GSE131984_Pac	ENSG00000155506	23367	La ribonucleoprotein 1, translational regulator	KIAA0731|Lar1|LARP|Lhp1|MGC19556	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44332
2.25178846162255e-13	-0.418330729481587	0.662	0.736	3.4720326289758e-09	ZFP36L2	Malignant cells	GSE131984_Pac	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44333
2.29957667927801e-13	0.275204772605073	0.592	0.442	3.54571728177876e-09	SFXN4	Malignant cells	GSE131984_Pac	ENSG00000183605	119559	sideroflexin 4	SLC56A4	protein_coding	Q6P4A7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44334
2.39093506915584e-13	0.250192736058762	0.951	0.907	3.68658278313139e-09	MRPS7	Malignant cells	GSE131984_Pac	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44335
2.41642055108993e-13	0.285190717656884	0.624	0.461	3.72587884772556e-09	RAMP1	Malignant cells	GSE131984_Pac	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44336
3.49180584017696e-13	-0.329058437894228	0.609	0.713	5.38401542496886e-09	PGD	Malignant cells	GSE131984_Pac	ENSG00000142657	5226	phosphogluconate dehydrogenase	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44337
3.54823840741746e-13	-0.346952338368641	0.475	0.598	5.47102880039698e-09	IDI1	Malignant cells	GSE131984_Pac	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44338
3.64465266258187e-13	0.318738363966472	0.947	0.934	5.61968994043499e-09	SAP18	Malignant cells	GSE131984_Pac	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44339
3.74191985350121e-13	-0.287718180095505	0.551	0.679	5.76966622211352e-09	NTAN1	Malignant cells	GSE131984_Pac	ENSG00000275779	123803	N-terminal asparagine amidase	NA	protein_coding	Q96AB6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44340
3.88831632581159e-13	-0.266018647372754	0.14	0.278	5.99539494276888e-09	KYNU	Malignant cells	GSE131984_Pac	ENSG00000115919	8942	kynureninase	NA	protein_coding	Q16719	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44341
4.13305117518598e-13	0.281755250505197	0.759	0.633	6.37275160701926e-09	CEBPZ	Malignant cells	GSE131984_Pac	ENSG00000115816	10153	CCAAT enhancer binding protein zeta	CBF2|CTF2	protein_coding	Q03701	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44342
4.29516824961747e-13	0.26296670677566	0.557	0.407	6.62271992408517e-09	TMEM97	Malignant cells	GSE131984_Pac	ENSG00000109084	27346	transmembrane protein 97	σ2R|MAC30	protein_coding	Q5BJF2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44343
4.311100362195e-13	-0.283350893778487	0.59	0.699	6.64728564846847e-09	CCDC53	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44344
4.72568625056305e-13	-0.285694492103952	0.318	0.475	7.28653562974316e-09	KDELR3	Malignant cells	GSE131984_Pac	ENSG00000100196	11015	KDEL endoplasmic reticulum protein retention receptor 3	NA	protein_coding	O43731	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44345
4.84121834642857e-13	0.256169457287142	0.726	0.582	7.46467456835822e-09	SRSF6	Malignant cells	GSE131984_Pac	ENSG00000124193	6431	serine and arginine rich splicing factor 6	B52|SFRS6|SRP55	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44346
5.26911917327486e-13	0.253415270556134	0.882	0.78	8.12445485327251e-09	USP1	Malignant cells	GSE131984_Pac	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44347
6.0036167567786e-13	-0.262371811259078	0.242	0.394	9.25697667727693e-09	CREB5	Malignant cells	GSE131984_Pac	ENSG00000146592	9586	cAMP responsive element binding protein 5	CRE-BPA|H_GS165L15.1	protein_coding	Q02930	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44348
6.00799460715814e-13	0.280680255156899	0.887	0.797	9.26372688477714e-09	SNX5	Malignant cells	GSE131984_Pac	ENSG00000089006	27131	sorting nexin 5	NA	protein_coding	Q9Y5X3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44349
6.35104951351181e-13	-0.441632772693846	0.269	0.409	9.79268324488386e-09	PTX3	Malignant cells	GSE131984_Pac	ENSG00000163661	5806	pentraxin 3	TNFAIP5|TSG-14	protein_coding	P26022	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44350
6.52953495204469e-13	0.254874520295867	0.54	0.376	1.00678899425577e-08	RMDN3	Malignant cells	GSE131984_Pac	ENSG00000137824	55177	regulator of microtubule dynamics 3	FAM82A2|FAM82C|FLJ10579|PTPIP51|RMD3	protein_coding	Q96TC7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44351
6.93135138911515e-13	0.283156539787177	0.774	0.667	1.06874507068767e-08	DRG1	Malignant cells	GSE131984_Pac	ENSG00000185721	4733	developmentally regulated GTP binding protein 1	NEDD3	protein_coding	Q9Y295	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44352
7.11880201471149e-13	0.263140748063299	0.626	0.476	1.09764808264837e-08	TGS1	Malignant cells	GSE131984_Pac	ENSG00000137574	96764	trimethylguanosine synthase 1	NCOA6IP|PIMT	protein_coding	Q96RS0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44353
7.16175168143991e-13	0.280534541511512	0.621	0.473	1.10427049176122e-08	NBL1	Malignant cells	GSE131984_Pac	ENSG00000158747	4681	NBL1, DAN family BMP antagonist	D1S1733E|DAN|DAND1|NB|NO3	protein_coding	P41271	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44354
7.18225989239731e-13	0.269731227246481	0.632	0.483	1.10743265280874e-08	ZNF639	Malignant cells	GSE131984_Pac	ENSG00000121864	51193	zinc finger protein 639	ANC-2H01|ZASC1	protein_coding	Q9UID6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44355
7.53653858712071e-13	0.259713136447099	0.685	0.535	1.16205888474814e-08	RITA1	Malignant cells	GSE131984_Pac	ENSG00000139405	84934	RBPJ interacting and tubulin associated 1	C12orf52|FLJ14827|RITA	protein_coding	Q96K30	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44356
8.62867442850744e-13	0.26553257234106	0.517	0.364	1.33045531013156e-08	SAFB2	Malignant cells	GSE131984_Pac	ENSG00000130254	9667	scaffold attachment factor B2	KIAA0138	protein_coding	Q14151	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44357
8.84487873850323e-13	-0.2562870487981	0.344	0.501	1.36379185268981e-08	IFI27L1	Malignant cells	GSE131984_Pac	ENSG00000276880	122509	interferon alpha inducible protein 27 like 1	FAM14B	protein_coding	Q96BM0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44358
9.27007158507082e-13	0.268866974168009	0.431	0.283	1.42935233770207e-08	LYSMD2	Malignant cells	GSE131984_Pac	ENSG00000140280	256586	LysM domain containing 2	MGC35274	protein_coding	Q8IV50	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44359
9.96463461339259e-13	0.27422766790068	0.648	0.501	1.536447011039e-08	RFC3	Malignant cells	GSE131984_Pac	ENSG00000133119	5983	replication factor C subunit 3	MGC5276|RFC38	protein_coding	P40938	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44360
1.02399055629556e-12	0.27098829089138	0.738	0.62	1.57889103875212e-08	SGTA	Malignant cells	GSE131984_Pac	ENSG00000104969	6449	small glutamine rich tetratricopeptide repeat co-chaperone alpha	alphaSGT|hSGT|SGT|SGT1|UBP|Vpu	protein_coding	O43765	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44361
1.1265118705369e-12	0.2637301471429	0.699	0.562	1.73696865318085e-08	ANKRD39	Malignant cells	GSE131984_Pac	ENSG00000213337	51239	ankyrin repeat domain 39	MGC41816	protein_coding	Q53RE8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44362
1.15497928453161e-12	0.260430670422212	0.507	0.35	1.78086255881929e-08	UMPS	Malignant cells	GSE131984_Pac	ENSG00000114491	7372	uridine monophosphate synthetase	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44363
1.16313258016987e-12	0.270790404761028	0.658	0.511	1.79343412536392e-08	CHCHD4	Malignant cells	GSE131984_Pac	ENSG00000163528	131474	coiled-coil-helix-coiled-coil-helix domain containing 4	FLJ31709|MIA40|TIMM40	protein_coding	Q8N4Q1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44364
1.25947914804531e-12	-0.278431281381367	0.455	0.604	1.94199089837107e-08	FLOT1	Malignant cells	GSE131984_Pac	ENSG00000223654	10211	flotillin 1	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44365
1.315715492421e-12	0.29052429300233	0.866	0.811	2.02870171776393e-08	CDV3	Malignant cells	GSE131984_Pac	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44366
1.37709270434376e-12	-0.439629426012853	0.698	0.81	2.12333924082764e-08	ISG15	Malignant cells	GSE131984_Pac	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44367
1.40350601818801e-12	0.260552731003603	0.577	0.421	2.16406592944409e-08	CRK	Malignant cells	GSE131984_Pac	ENSG00000167193	1398	CRK proto-oncogene, adaptor protein	NA	protein_coding	P46108	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44368
1.58256114375911e-12	0.255997912492205	0.58	0.428	2.44015102756217e-08	DNAJA3	Malignant cells	GSE131984_Pac	ENSG00000276726	9093	DnaJ heat shock protein family (Hsp40) member A3	hTid-1|TID1	protein_coding	Q96EY1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44369
1.66677981631786e-12	-0.297849706613794	0.758	0.832	2.57000779878051e-08	TMEM205	Malignant cells	GSE131984_Pac	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44370
2.08743665706755e-12	-0.302028626235177	0.287	0.429	3.21861858153245e-08	MVP	Malignant cells	GSE131984_Pac	ENSG00000013364	9961	major vault protein	LRP|VAULT1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44371
2.11770872616833e-12	-0.295324949447692	0.722	0.81	3.26529508487895e-08	PSAP	Malignant cells	GSE131984_Pac	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44372
2.13069849762726e-12	-0.262371811259078	0.404	0.553	3.28532401349147e-08	PMM1	Malignant cells	GSE131984_Pac	ENSG00000100417	5372	phosphomannomutase 1	Sec53	protein_coding	Q92871	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44373
2.64482117747905e-12	0.293129139218455	0.685	0.556	4.07804977355495e-08	OAF	Malignant cells	GSE131984_Pac	ENSG00000184232	220323	out at first homolog	MGC52117	protein_coding	Q86UD1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44374
2.65409428640673e-12	0.261305288068861	0.831	0.718	4.09234798021054e-08	UBE2F	Malignant cells	GSE131984_Pac	ENSG00000184182	140739	ubiquitin conjugating enzyme E2 F (putative)	NCE2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44375
2.86286485603458e-12	0.253814786105899	0.89	0.831	4.41425132151972e-08	U2SURP	Malignant cells	GSE131984_Pac	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44376
2.89287109588069e-12	-0.310240030524277	0.786	0.845	4.46051794273844e-08	TMEM256	Malignant cells	GSE131984_Pac	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44377
3.01010527949232e-12	-0.305581731589138	0.386	0.538	4.64128133044921e-08	AHNAK2	Malignant cells	GSE131984_Pac	ENSG00000185567	113146	AHNAK nucleoprotein 2	C14orf78	protein_coding	Q8IVF2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44378
3.05545434143266e-12	0.265317948116695	0.797	0.664	4.71120504905503e-08	CDCA4	Malignant cells	GSE131984_Pac	ENSG00000170779	55038	cell division cycle associated 4	FLJ20764|Hepp	protein_coding	Q9BXL8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44379
3.15371242381531e-12	0.259095534962382	0.549	0.388	4.86270918628082e-08	SGOL2	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44380
3.35719969857248e-12	0.268095213829943	0.532	0.386	5.17646621522891e-08	UTP23	Malignant cells	GSE131984_Pac	ENSG00000147679	84294	UTP23 small subunit processome component	C8orf53|MGC14595	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44381
3.37561099088884e-12	0.268532748157582	0.801	0.68	5.2048545868515e-08	BAZ1A	Malignant cells	GSE131984_Pac	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44382
3.50467141218137e-12	-0.278699312831154	0.439	0.591	5.40385285044246e-08	THOC6	Malignant cells	GSE131984_Pac	ENSG00000131652	79228	THO complex subunit 6	fSAP35|MGC2655|WDR58	protein_coding	Q86W42	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44383
3.61143872233624e-12	0.253287597845882	0.66	0.514	5.56847736597025e-08	SF3A3	Malignant cells	GSE131984_Pac	ENSG00000183431	10946	splicing factor 3a subunit 3	PRP9|PRPF9|SAP61|SF3a60	protein_coding	Q12874	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44384
3.65506485428478e-12	-0.281581557806607	0.459	0.583	5.6357444988217e-08	HAGH	Malignant cells	GSE131984_Pac	ENSG00000063854	3029	hydroxyacylglutathione hydrolase	GLO2|GLXII|HAGH1	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44385
3.66627761324458e-12	0.26678628433175	0.874	0.809	5.65303345186182e-08	GRSF1	Malignant cells	GSE131984_Pac	ENSG00000132463	2926	G-rich RNA sequence binding factor 1	NA	protein_coding	Q12849	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44386
3.80018790482142e-12	-0.257780098265099	0.261	0.409	5.85950973044414e-08	HEG1	Malignant cells	GSE131984_Pac	ENSG00000173706	57493	heart development protein with EGF like domains 1	HEG|KIAA1237	protein_coding	Q9ULI3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44387
3.98418025565682e-12	0.264472085587756	0.955	0.907	6.14320753619726e-08	TUBB6	Malignant cells	GSE131984_Pac	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44388
4.25853475889678e-12	0.277475013316675	0.645	0.502	6.56623474474294e-08	DDX56	Malignant cells	GSE131984_Pac	ENSG00000136271	54606	DEAD-box helicase 56	NOH61	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44389
4.28205397481989e-12	0.310351574342396	0.702	0.582	6.60249902377479e-08	NR2F6	Malignant cells	GSE131984_Pac	ENSG00000160113	2063	nuclear receptor subfamily 2 group F member 6	EAR-2|EAR2|ERBAL2	protein_coding	P10588	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44390
4.45072012498629e-12	0.316719750014758	0.775	0.658	6.86256536071636e-08	RPF2	Malignant cells	GSE131984_Pac	ENSG00000197498	84154	ribosome production factor 2 homolog	bA397G5.4|BXDC1|FLJ21087	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44391
4.76466687478713e-12	-0.256024652053308	0.967	0.991	7.34663985423427e-08	RPA3	Malignant cells	GSE131984_Pac	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44392
4.81259809124306e-12	-0.315376214971345	0.509	0.622	7.42054499688768e-08	ZNF385D	Malignant cells	GSE131984_Pac	ENSG00000151789	79750	zinc finger protein 385D	FLJ22419|ZNF659	protein_coding	Q9H6B1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44393
5.48650511205919e-12	-0.250497122204703	0.952	0.975	8.45964223228407e-08	COPE	Malignant cells	GSE131984_Pac	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44394
5.64188973405687e-12	0.259106045790672	0.699	0.547	8.69922978094229e-08	FTSJ2	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44395
5.97802514080341e-12	0.266370057598917	0.581	0.425	9.21751696460477e-08	MAP4K4	Malignant cells	GSE131984_Pac	ENSG00000071054	9448	mitogen-activated protein kinase kinase kinase kinase 4	FLH21957|HGK|NIK	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44396
6.2297586708528e-12	0.289471704052539	0.715	0.596	9.60566489458794e-08	C21orf59	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44397
6.27568277025973e-12	0.267717818581855	0.638	0.498	9.67647526346347e-08	RP11-14N7.2	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44398
6.45599140376088e-12	0.270930077800104	0.684	0.532	9.9544931454589e-08	HELLS	Malignant cells	GSE131984_Pac	ENSG00000119969	3070	helicase, lymphoid specific	LSH|Nbla10143|PASG|SMARCA6	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44399
6.62797565674083e-12	0.319385352307966	0.848	0.756	1.02196756651287e-07	BRIX1	Malignant cells	GSE131984_Pac	ENSG00000113460	55299	biogenesis of ribosomes BRX1	BRIX|BXDC2|FLJ11100	protein_coding	Q8TDN6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44400
6.67499648550703e-12	0.265173795303276	0.707	0.556	1.02921770810033e-07	RPP30	Malignant cells	GSE131984_Pac	ENSG00000148688	10556	ribonuclease P/MRP subunit p30	TSG15	protein_coding	P78346	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44401
6.74486253865583e-12	-0.342191575311632	0.295	0.437	1.03999035483534e-07	JUN	Malignant cells	GSE131984_Pac	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44402
6.98596364209794e-12	0.285282856409675	0.604	0.466	1.07716573397508e-07	ARHGAP11A	Malignant cells	GSE131984_Pac	ENSG00000275568	9824	Rho GTPase activating protein 11A	KIAA0013	protein_coding	Q6P4F7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44403
7.67732218657827e-12	-0.272274931102059	0.641	0.741	1.1837663079485e-07	AHCYL1	Malignant cells	GSE131984_Pac	ENSG00000168710	10768	adenosylhomocysteinase like 1	IRBIT|PPP1R78|XPVKONA	protein_coding	O43865	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44404
9.06267953009077e-12	-0.277944897702807	0.703	0.782	1.3973745567447e-07	SERPINB6	Malignant cells	GSE131984_Pac	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44405
1.02211630973782e-11	-0.295647207319616	0.359	0.495	1.57600113798474e-07	CMTM8	Malignant cells	GSE131984_Pac	ENSG00000170293	152189	CKLF like MARVEL transmembrane domain containing 8	CKLFSF8	protein_coding	Q8IZV2	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44406
1.09106856902677e-11	-0.274348543176478	0.504	0.625	1.68231862658237e-07	SH3BGRL	Malignant cells	GSE131984_Pac	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44407
1.15782146985088e-11	0.274901792972937	0.61	0.471	1.78524492436308e-07	ILKAP	Malignant cells	GSE131984_Pac	ENSG00000132323	80895	ILK associated serine/threonine phosphatase	DKFZP434J2031|FLJ10181|PPM1O	protein_coding	Q9H0C8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44408
1.22222983217649e-11	-0.255637156881669	0.864	0.906	1.88455617823292e-07	CAMLG	Malignant cells	GSE131984_Pac	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44409
1.25791209104912e-11	0.273313438792125	0.862	0.792	1.93957465318863e-07	PABPC4	Malignant cells	GSE131984_Pac	ENSG00000090621	8761	poly(A) binding protein cytoplasmic 4	APP-1|iPABP	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44410
1.33174567311416e-11	0.25307128750776	0.678	0.543	2.05341865337472e-07	HGS	Malignant cells	GSE131984_Pac	ENSG00000185359	9146	hepatocyte growth factor-regulated tyrosine kinase substrate	Hrs|Vps27|ZFYVE8	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44411
1.35081630677331e-11	0.255611989733333	0.769	0.677	2.08282366341377e-07	BAZ1B	Malignant cells	GSE131984_Pac	ENSG00000009954	9031	bromodomain adjacent to zinc finger domain 1B	WBSCR10|WBSCR9|WSTF	protein_coding	Q9UIG0	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44412
1.55241253258465e-11	0.297766301206454	0.592	0.451	2.39366488399227e-07	ID2	Malignant cells	GSE131984_Pac	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44413
1.72393294194491e-11	-0.29024545728752	0.949	0.973	2.65813220318486e-07	SNHG8	Malignant cells	GSE131984_Pac	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44414
1.75922885136721e-11	0.262483184577713	0.609	0.466	2.7125549659231e-07	CENPU	Malignant cells	GSE131984_Pac	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44415
1.85436232203887e-11	-0.306695129740877	0.968	0.977	2.85924126435174e-07	EBP	Malignant cells	GSE131984_Pac	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44416
1.94596971889536e-11	0.261390744439416	0.775	0.656	3.00049070956476e-07	ABCE1	Malignant cells	GSE131984_Pac	ENSG00000164163	6059	ATP binding cassette subfamily E member 1	OABP|RLI|RLI1|RNASEL1|RNASELI|RNS4I	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44417
1.99408935850075e-11	0.29747530284727	0.766	0.651	3.07468638187231e-07	PBDC1	Malignant cells	GSE131984_Pac	ENSG00000102390	51260	polysaccharide biosynthesis domain containing 1	CXorf26|MGC874	protein_coding	Q9BVG4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44418
2.02268664088493e-11	0.306202194942253	0.944	0.905	3.11878053158047e-07	TGFBI	Malignant cells	GSE131984_Pac	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44419
2.10161201324897e-11	0.257980609434524	0.812	0.697	3.24047556322859e-07	UBL4A	Malignant cells	GSE131984_Pac	ENSG00000102178	8266	ubiquitin like 4A	DXS254E|GDX|GET5|MDY2|TMA24|UBL4	protein_coding	P11441	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44420
2.12323454804804e-11	0.25287397689014	0.926	0.858	3.27381534963527e-07	CCDC34	Malignant cells	GSE131984_Pac	ENSG00000109881	91057	coiled-coil domain containing 34	L15|NY-REN-41|RAMA3	protein_coding	Q96HJ3	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44421
2.12498751099786e-11	0.254550403930547	0.839	0.76	3.2765182432076e-07	TIMMDC1	Malignant cells	GSE131984_Pac	ENSG00000113845	51300	translocase of inner mitochondrial membrane domain containing 1	C3orf1|FLJ22597	protein_coding	Q9NPL8	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44422
2.30201788105857e-11	-0.280171485422267	0.415	0.549	3.54948137080421e-07	RNF213	Malignant cells	GSE131984_Pac	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44423
2.47206918485481e-11	0.251706213971418	0.533	0.388	3.81168347612763e-07	TEAD4	Malignant cells	GSE131984_Pac	ENSG00000197905	7004	TEA domain transcription factor 4	EFTR-2|RTEF-1|TCF13L1|TEF-3|TEFR-1	protein_coding	Q15561	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44424
2.651145048777e-11	-0.388078244266224	0.577	0.711	4.08780055070925e-07	SAT1	Malignant cells	GSE131984_Pac	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44425
2.66899514590927e-11	-0.279058288207054	0.625	0.721	4.1153236154775e-07	AIG1	Malignant cells	GSE131984_Pac	ENSG00000146416	51390	androgen induced 1	AIG-1|dJ95L4.1|FLJ10485	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44426
2.85389360761609e-11	-0.299220844803436	0.484	0.6	4.40041855358325e-07	GRN	Malignant cells	GSE131984_Pac	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44427
3.06867528764282e-11	0.251899194841983	0.569	0.41	4.73159042601646e-07	CENPE	Malignant cells	GSE131984_Pac	ENSG00000138778	1062	centromere protein E	KIF10|PPP1R61	protein_coding	Q02224	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44428
3.12218737510659e-11	-0.440577387723064	0.782	0.849	4.81410071367684e-07	ANXA1	Malignant cells	GSE131984_Pac	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44429
3.66448659207858e-11	-0.286485425513286	0.685	0.786	5.65027187632596e-07	PSMB9	Malignant cells	GSE131984_Pac	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44430
3.80217249289204e-11	0.276339444380531	0.646	0.525	5.86256976679024e-07	PAK1IP1	Malignant cells	GSE131984_Pac	ENSG00000285226	55003	PAK1 interacting protein 1	bA421M1.5|FLJ20624|hPIP1|MAK11|PIP1|WDR84	protein_coding	Q9NWT1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44431
4.02128187224274e-11	0.278427656429965	0.765	0.671	6.20041451881107e-07	HMBS	Malignant cells	GSE131984_Pac	ENSG00000256269	3145	hydroxymethylbilane synthase	PBGD|PORC|UPS	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44432
4.28715795545515e-11	-0.295995918079135	0.984	0.987	6.6103688515163e-07	STMN1	Malignant cells	GSE131984_Pac	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44433
4.60219695729658e-11	-0.323970659977171	0.16	0.292	7.09612748845559e-07	PMAIP1	Malignant cells	GSE131984_Pac	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44434
4.69038585367073e-11	0.272260110952984	0.902	0.863	7.23210594777489e-07	MRPL47	Malignant cells	GSE131984_Pac	ENSG00000136522	57129	mitochondrial ribosomal protein L47	CGI-204|NCM1	protein_coding	Q9HD33	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44435
4.78499593093122e-11	-0.271796596174199	0.87	0.924	7.37798522590285e-07	PSME1	Malignant cells	GSE131984_Pac	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44436
4.93549914149864e-11	-0.322930129790782	0.388	0.527	7.61004612627675e-07	MAGED2	Malignant cells	GSE131984_Pac	ENSG00000102316	10916	MAGE family member D2	11B6|BCG1|HCA10|JCL-1|MAGE-D2|MAGED|MGC8386	protein_coding	Q9UNF1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44437
5.42509997797667e-11	-0.254911618063743	0.347	0.481	8.36496165604223e-07	ACSL1	Malignant cells	GSE131984_Pac	ENSG00000151726	2180	acyl-CoA synthetase long chain family member 1	ACS1|FACL1|FACL2|LACS|LACS1|LACS2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44438
5.47741999160742e-11	0.251018878432854	0.625	0.496	8.44563388505948e-07	TRAF4	Malignant cells	GSE131984_Pac	ENSG00000076604	9618	TNF receptor associated factor 4	CART1|MLN62|RNF83	protein_coding	Q9BUZ4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44439
6.32626143501887e-11	0.260360810447609	0.854	0.762	9.75446250665559e-07	FTSJ1	Malignant cells	GSE131984_Pac	ENSG00000068438	24140	FtsJ RNA 2'-O-methyltransferase 1	CDLIV|JM23|MRX44|MRX9|SPB1|TRM7|TRMT7	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44440
6.86065320636735e-11	-0.545391666703567	0.438	0.555	1.05784411788978e-06	CTGF	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44441
7.41981653089727e-11	-0.259214018882992	0.438	0.566	1.14406151089905e-06	LRP10	Malignant cells	GSE131984_Pac	ENSG00000197324	26020	LDL receptor related protein 10	DKFZP564C1940|LRP9|MGC8675|MST087|MSTP087	protein_coding	Q7Z4F1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44442
7.5542561922115e-11	0.276945306421521	0.822	0.74	1.16479076227709e-06	TRIP13	Malignant cells	GSE131984_Pac	ENSG00000071539	9319	thyroid hormone receptor interactor 13	16E1BP	protein_coding	Q15645	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44443
7.5844296122389e-11	-0.261382441214476	0.613	0.72	1.16944320191112e-06	WDR54	Malignant cells	GSE131984_Pac	ENSG00000005448	84058	WD repeat domain 54	FLJ12953	protein_coding	Q9H977	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44444
8.19702908935922e-11	0.256863395048241	0.802	0.707	1.2638999152883e-06	TMEM70	Malignant cells	GSE131984_Pac	ENSG00000175606	54968	transmembrane protein 70	FLJ20533	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44445
8.38401062377147e-11	-0.371844740073357	0.668	0.765	1.29273059807932e-06	DDIT4	Malignant cells	GSE131984_Pac	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44446
8.53682780498519e-11	0.329530017064051	0.741	0.619	1.31629347925067e-06	FHL2	Malignant cells	GSE131984_Pac	ENSG00000115641	2274	four and a half LIM domains 2	DRAL|SLIM3	protein_coding	Q14192	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44447
1.17928642202667e-10	0.264724195212238	0.652	0.516	1.81834173412292e-06	SPDL1	Malignant cells	GSE131984_Pac	ENSG00000040275	54908	spindle apparatus coiled-coil protein 1	CCDC99|FLJ20364|hSpindly	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44448
1.34722543377139e-10	0.266322469815333	0.501	0.368	2.0772868963321e-06	UTP14A	Malignant cells	GSE131984_Pac	ENSG00000156697	10813	UTP14A small subunit processome component	NY-CO-16|SDCCAG16|Utp14	protein_coding	Q9BVJ6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44449
1.37449064228297e-10	-0.250467802358215	0.314	0.448	2.11932712133611e-06	TIPARP	Malignant cells	GSE131984_Pac	ENSG00000163659	25976	TCDD inducible poly(ADP-ribose) polymerase	ARTD14|DDF1|DKFZP434J214|DKFZp686N0351|PARP-1|PARP-7|PARP7|pART14|RM1	protein_coding	Q7Z3E1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44450
1.40340216569257e-10	-0.25508160976473	0.948	0.971	2.16390579928138e-06	PRKCDBP	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44451
1.76912124826777e-10	0.254908107281905	0.852	0.775	2.72780805270408e-06	BOD1	Malignant cells	GSE131984_Pac	ENSG00000145919	91272	biorientation of chromosomes in cell division 1	FAM44B	protein_coding	Q96IK1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44452
2.22512532645176e-10	-0.278287076769233	0.562	0.663	3.43092074085597e-06	USP9X	Malignant cells	GSE131984_Pac	ENSG00000124486	8239	ubiquitin specific peptidase 9 X-linked	DFFRX|FAF|MRX99	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44453
2.73174010305685e-10	-0.302950356090318	0.521	0.632	4.21207006490336e-06	GCHFR	Malignant cells	GSE131984_Pac	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44454
2.82974550731584e-10	-0.274637374034113	0.561	0.669	4.36318459773029e-06	LAMP2	Malignant cells	GSE131984_Pac	ENSG00000005893	3920	lysosomal associated membrane protein 2	CD107b	protein_coding	P13473	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44455
3.10274736448175e-10	-0.294556179074861	0.428	0.55	4.78412616129441e-06	GBE1	Malignant cells	GSE131984_Pac	ENSG00000114480	2632	1,4-alpha-glucan branching enzyme 1	NA	protein_coding	Q04446	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44456
4.39407914965699e-10	-0.32158941630855	0.81	0.856	6.77523064085611e-06	CEBPB	Malignant cells	GSE131984_Pac	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44457
4.46105028583996e-10	0.292184853090785	0.797	0.71	6.87849343573663e-06	RUVBL1	Malignant cells	GSE131984_Pac	ENSG00000284901	8607	RuvB like AAA ATPase 1	ECP54|INO80H|NMP238|Pontin52|RVB1|TIH1|TIP49|TIP49a	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44458
4.55824859733879e-10	-0.25791162238941	0.612	0.698	7.02836351223668e-06	PSENEN	Malignant cells	GSE131984_Pac	ENSG00000205155	55851	presenilin enhancer, gamma-secretase subunit	PEN2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44459
5.0092793897478e-10	0.364644522226036	0.543	0.403	7.72380789105214e-06	TIMP3	Malignant cells	GSE131984_Pac	ENSG00000100234	7078	TIMP metallopeptidase inhibitor 3	SFD	protein_coding	P35625	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44460
5.06523506629425e-10	0.262721026580165	0.912	0.871	7.81008594871911e-06	CDC123	Malignant cells	GSE131984_Pac	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44461
5.25609164543677e-10	0.271638801786479	0.714	0.588	8.10436770809895e-06	MT-ND6	Malignant cells	GSE131984_Pac	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44462
6.089400362033e-10	-0.267378463626095	0.427	0.551	9.38924641821868e-06	CHP1	Malignant cells	GSE131984_Pac	ENSG00000187446	11261	calcineurin like EF-hand protein 1	CHP|p22|p24|Sid470p|SLC9A1BP	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44463
7.24701245134866e-10	0.267619596076916	0.636	0.512	1.11741684987345e-05	FADD	Malignant cells	GSE131984_Pac	ENSG00000168040	8772	Fas associated via death domain	GIG3|MORT1	protein_coding	Q13158	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44464
7.36675230750683e-10	-0.258703399110436	0.633	0.73	1.13587953829448e-05	EIF4A2	Malignant cells	GSE131984_Pac	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44465
7.58932263938213e-10	0.414417231681824	0.577	0.446	1.17019765776633e-05	KRT75	Malignant cells	GSE131984_Pac	ENSG00000170454	9119	keratin 75	K6HF	protein_coding	O95678	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44466
7.99239832680919e-10	-0.252293961606413	0.267	0.391	1.23234789801071e-05	TGFB1I1	Malignant cells	GSE131984_Pac	ENSG00000140682	7041	transforming growth factor beta 1 induced transcript 1	ARA55|Hic-5|TSC-5	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44467
8.94238176573552e-10	0.285727988920682	0.828	0.742	1.37882584445876e-05	UCHL3	Malignant cells	GSE131984_Pac	ENSG00000118939	7347	ubiquitin C-terminal hydrolase L3	NA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44468
9.64293100091044e-10	0.270243000181059	0.999	0.998	1.48684353103038e-05	HSPD1	Malignant cells	GSE131984_Pac	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44469
1.04132813676611e-09	-0.254151304454109	0.476	0.59	1.60562385407967e-05	HIBADH	Malignant cells	GSE131984_Pac	ENSG00000106049	11112	3-hydroxyisobutyrate dehydrogenase	NS5ATP1	protein_coding	P31937	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44470
1.09748369408905e-09	0.269167950303563	0.854	0.773	1.69221010791591e-05	LY6K	Malignant cells	GSE131984_Pac	ENSG00000160886	54742	lymphocyte antigen 6 family member K	CT97|FLJ35226|HSJ001348	protein_coding	Q17RY6	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44471
1.09878359422933e-09	-0.260247388785834	0.636	0.727	1.6942144239422e-05	TCEAL3	Malignant cells	GSE131984_Pac	ENSG00000196507	85012	transcription elongation factor A like 3	MGC15737|WEX8	protein_coding	Q969E4	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44472
1.14581076260027e-09	-0.267946297066523	0.448	0.578	1.76672561485336e-05	PEG10	Malignant cells	GSE131984_Pac	ENSG00000242265	23089	paternally expressed 10	HB-1|KIAA1051|Mar2|Mart2|MEF3L|RGAG3|RTL2|SIRH1	protein_coding	Q86TG7	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44473
1.38454707196124e-09	-0.324705324113353	0.246	0.363	2.13483313025704e-05	SULT1B1	Malignant cells	GSE131984_Pac	ENSG00000173597	27284	sulfotransferase family 1B member 1	ST1B2	protein_coding	O43704	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44474
1.57044074572796e-09	-0.388566957831702	0.515	0.611	2.42146258583794e-05	CDA	Malignant cells	GSE131984_Pac	ENSG00000158825	978	cytidine deaminase	CDD	protein_coding	P32320	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44475
1.76054814132611e-09	0.257136888233226	0.747	0.657	2.71458917911073e-05	TAF12	Malignant cells	GSE131984_Pac	ENSG00000120656	6883	TATA-box binding protein associated factor 12	TAF2J|TAFII20	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44476
1.93664652665528e-09	-0.254161625969975	0.983	0.982	2.98611527944977e-05	GNG11	Malignant cells	GSE131984_Pac	ENSG00000127920	2791	G protein subunit gamma 11	GNGT11	protein_coding	P61952	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44477
3.50240498905498e-09	-0.253077590131384	0.334	0.455	5.40035825262388e-05	KLF9	Malignant cells	GSE131984_Pac	ENSG00000119138	687	KLF transcription factor 9	BTEB1	protein_coding	Q13886	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44478
6.37594965739944e-09	0.272704069659075	0.862	0.769	9.83107677674419e-05	PPP2CA	Malignant cells	GSE131984_Pac	ENSG00000113575	5515	protein phosphatase 2 catalytic subunit alpha	PP2AC|PP2Calpha	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44479
6.47965427753899e-09	-0.251008487991952	0.742	0.818	9.99097893053737e-05	RAB11A	Malignant cells	GSE131984_Pac	ENSG00000103769	8766	RAB11A, member RAS oncogene family	YL8	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44480
7.25216969898054e-09	-0.260186170704153	0.391	0.501	0.000111821204588581	ARID5B	Malignant cells	GSE131984_Pac	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44481
7.65435012935653e-09	-0.319050727574893	0.867	0.91	0.000118022424644548	SERPINE1	Malignant cells	GSE131984_Pac	ENSG00000106366	5054	serpin family E member 1	PAI|PAI1|PLANH1	protein_coding	P05121	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44482
8.18144101832536e-09	-0.285981008308673	0.535	0.617	0.000126149639061559	PLA2G16	Malignant cells	GSE131984_Pac	NA	NA	NA	NA	NA	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44483
9.63883206961519e-09	-0.268198659682606	0.318	0.435	0.000148621151681397	ARMCX3	Malignant cells	GSE131984_Pac	ENSG00000102401	51566	armadillo repeat containing X-linked 3	ALEX3|GASP6	protein_coding	Q9UH62	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44484
1.73559593069671e-08	-0.32289062392277	0.689	0.736	0.000267611536554126	NUCB2	Malignant cells	GSE131984_Pac	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44485
2.03137622017825e-08	0.280445118658249	0.91	0.849	0.000313217899389284	HSPA9	Malignant cells	GSE131984_Pac	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44486
3.61881559344595e-08	-0.322238217692743	0.412	0.502	0.000557985176353432	SLC14A1	Malignant cells	GSE131984_Pac	ENSG00000141469	6563	solute carrier family 14 member 1 (Kidd blood group)	HsT1341|JK|RACH1|RACH2	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44487
1.04679288117972e-07	0.254237384156168	0.928	0.883	0.00161404994349101	KPNA2	Malignant cells	GSE131984_Pac	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44488
1.9174942931615e-07	-0.326850860383888	0.31	0.413	0.00295658445062572	PLAC8	Malignant cells	GSE131984_Pac	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44489
2.54233901011615e-07	-0.313182514294299	0.703	0.755	0.00392003251969809	MDH1	Malignant cells	GSE131984_Pac	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44490
2.54656095087773e-06	-0.276580485693425	0.588	0.676	0.0392654233015838	SDC4	Malignant cells	GSE131984_Pac	ENSG00000124145	6385	syndecan 4	amphiglycan|ryudocan|SYND4	protein_coding	P31431	GSE131984_Pac	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Chemotherapy	NA	paclitaxel	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1813	Public on Apr 08, 2020	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Chemotherapy	44491
4.470018293056e-150	1.17021774993397	0.987	0.85	7.06620491766292e-146	MXD4	Malignant cells	GSE131984_Pal	ENSG00000123933	10608	MAX dimerization protein 4	bHLHc12|MAD4|MST149|MSTP149	protein_coding	Q14582	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44492
5.79757986412657e-135	-1.0147715003481	0.994	1	9.16481424921128e-131	HMGA1	Malignant cells	GSE131984_Pal	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44493
3.93177008122602e-121	-0.741609089590784	1	1	6.2153421444021e-117	PTMA	Malignant cells	GSE131984_Pal	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44494
5.95096823442555e-119	0.678140352360111	1	0.999	9.40729058497991e-115	MT-CO1	Malignant cells	GSE131984_Pal	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44495
6.28322500393011e-118	-0.906142081829063	0.994	1	9.93252208621272e-114	HMGB1	Malignant cells	GSE131984_Pal	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44496
8.54031081503269e-116	1.50890421440627	0.918	0.551	1.35005233364037e-111	FN1	Malignant cells	GSE131984_Pal	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44497
1.42970297232127e-111	-0.780929908651827	0.997	0.999	2.26007445864547e-107	H2AFZ	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44498
5.56110195607242e-111	0.737473578359143	1	0.999	8.79098997215928e-107	MT-CO3	Malignant cells	GSE131984_Pal	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44499
6.98853035501147e-111	0.769277230812442	1	0.999	1.10474687852021e-106	MT-CYB	Malignant cells	GSE131984_Pal	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44500
6.95346766580367e-110	-0.795592215816517	0.987	0.999	1.09920416861024e-105	SNRPB	Malignant cells	GSE131984_Pal	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44501
2.52965701790536e-107	0.658170942829094	1	0.999	3.99888181390479e-103	MT-ND4	Malignant cells	GSE131984_Pal	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44502
7.0943883629065e-105	-0.875584876398105	0.977	0.996	1.12148091240826e-100	RANBP1	Malignant cells	GSE131984_Pal	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44503
2.53069794520507e-104	1.03949142508882	0.967	0.724	4.00052731178017e-100	PNRC1	Malignant cells	GSE131984_Pal	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44504
3.84707239421125e-104	-0.883050894415089	0.984	0.997	6.08145204076915e-100	CYCS	Malignant cells	GSE131984_Pal	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44505
4.65199539654187e-104	1.24473788620984	0.996	0.907	7.35387432285339e-100	TGFBI	Malignant cells	GSE131984_Pal	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44506
1.21794671919613e-100	-0.995064525031268	0.879	0.974	1.92533017370524e-96	SRSF7	Malignant cells	GSE131984_Pal	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44507
2.75722884989542e-98	-0.881480831561081	0.887	0.991	4.35862736591468e-94	LRRC59	Malignant cells	GSE131984_Pal	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44508
4.59841522487217e-96	0.892779121472153	0.635	0.172	7.26917478747792e-92	ASS1	Malignant cells	GSE131984_Pal	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44509
6.23265257217325e-96	-0.773438486800057	0.955	0.992	9.85257718609147e-92	SRSF2	Malignant cells	GSE131984_Pal	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44510
8.31065455448236e-96	1.08444323915878	0.654	0.194	1.31374827197257e-91	NR4A1	Malignant cells	GSE131984_Pal	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44511
2.46920843030059e-95	-0.813648801908613	0.971	0.994	3.90332468661918e-91	SRSF3	Malignant cells	GSE131984_Pal	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44512
7.0220247772164e-95	0.822018543636009	1	1	1.11004167678237e-90	FTH1	Malignant cells	GSE131984_Pal	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44513
5.06979692460713e-94	-0.944505874880925	0.886	0.982	8.01433497841895e-90	EBNA1BP2	Malignant cells	GSE131984_Pal	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44514
8.13337552121829e-94	1.47989840132363	0.996	0.937	1.28572400239419e-89	MT1X	Malignant cells	GSE131984_Pal	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44515
1.18349023201527e-92	-0.884238218166569	0.941	0.991	1.87086135876974e-88	SMS	Malignant cells	GSE131984_Pal	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44516
2.1493176665896e-92	-0.778739995363058	0.97	0.994	3.39764136734484e-88	PTGES3	Malignant cells	GSE131984_Pal	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44517
5.31382200649274e-92	1.10400315696905	0.997	0.958	8.40008982786372e-88	SOD2	Malignant cells	GSE131984_Pal	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44518
5.81372423687053e-91	-0.840547643720834	0.818	0.965	9.19033527364493e-87	TOMM40	Malignant cells	GSE131984_Pal	ENSG00000130204	10452	translocase of outer mitochondrial membrane 40	C19orf1|D19S1177E|PER-EC1|PEREC1|TOM40	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44519
1.35115488897508e-90	0.6614023795055	1	0.998	2.13590564849181e-86	MT-ATP6	Malignant cells	GSE131984_Pal	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44520
1.38733431786847e-90	-0.907757176092675	0.89	0.984	2.19309808968648e-86	EIF5	Malignant cells	GSE131984_Pal	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44521
9.53051726598822e-90	-1.02329625028442	0.99	1	1.50658416940742e-85	TUBA1B	Malignant cells	GSE131984_Pal	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44522
3.38560134167643e-87	-0.967015631253909	0.853	0.971	5.35195860092209e-83	EBP	Malignant cells	GSE131984_Pal	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44523
5.44612885017133e-87	-1.12141185630365	0.837	0.974	8.60924048635084e-83	TUBB4B	Malignant cells	GSE131984_Pal	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44524
4.24447771330126e-86	-0.690511522222717	1	1	6.70967036918664e-82	ACTB	Malignant cells	GSE131984_Pal	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44525
1.92063723738379e-85	0.369867165709303	1	1	3.0361433448563e-81	RPL13A	Malignant cells	GSE131984_Pal	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44526
7.55999889284814e-85	1.12888057383743	1	0.993	1.19508462498143e-80	NEAT1	Malignant cells	GSE131984_Pal	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44527
1.23301173728865e-84	-0.696985301989947	0.978	0.997	1.94914495430589e-80	SNRPD1	Malignant cells	GSE131984_Pal	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44528
1.65241469878064e-83	-0.604028086970658	1	1	2.61213715583243e-79	H3F3B	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44529
4.0445344063245e-83	-0.793777733173219	0.958	0.996	6.39359998951776e-79	HNRNPDL	Malignant cells	GSE131984_Pal	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44530
3.12484739229158e-80	-0.731963292624702	0.986	0.998	4.93975875773453e-76	CLIC1	Malignant cells	GSE131984_Pal	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44531
5.12736123432413e-80	-0.668892310031662	0.98	1	8.10533263921959e-76	HMGN2	Malignant cells	GSE131984_Pal	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44532
1.44163975237836e-79	-0.710221595221499	0.98	0.997	2.27894412055971e-75	EIF1AX	Malignant cells	GSE131984_Pal	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44533
1.03664604531049e-77	-0.880804176327806	0.638	0.888	1.63873006842682e-73	DCTPP1	Malignant cells	GSE131984_Pal	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44534
1.93270007005692e-77	-0.657817322238651	0.978	0.996	3.05521227074598e-73	SRM	Malignant cells	GSE131984_Pal	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44535
1.15982928303707e-76	-0.862960122482145	0.938	0.992	1.83345813062501e-72	FABP5	Malignant cells	GSE131984_Pal	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44536
4.45633805046293e-76	-0.818729818976564	0.925	0.99	7.04457919017181e-72	MORF4L2	Malignant cells	GSE131984_Pal	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44537
1.02495997062417e-74	-0.721449287290423	0.957	0.992	1.62025672156268e-70	PA2G4	Malignant cells	GSE131984_Pal	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44538
1.08423202137157e-73	-0.749599059992158	0.971	0.992	1.71395397938418e-69	STRA13	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44539
4.21849432275789e-73	-0.596923530593485	0.999	1	6.66859582541568e-69	TPI1	Malignant cells	GSE131984_Pal	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44540
2.69233926031951e-72	-0.701629379254587	0.988	0.997	4.25604990271308e-68	HN1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44541
9.14949800575352e-72	-0.720837159693333	0.987	0.998	1.44635264474952e-67	NME1	Malignant cells	GSE131984_Pal	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44542
1.09031357459299e-71	-0.610764630746945	0.996	0.999	1.7235676987166e-67	PPP1R14B	Malignant cells	GSE131984_Pal	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44543
2.20290743414502e-71	-1.02607930382963	0.997	1	3.48235607189645e-67	HSP90AA1	Malignant cells	GSE131984_Pal	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44544
6.14899817053723e-71	-0.591450999551706	0.999	1	9.72033630798526e-67	RAN	Malignant cells	GSE131984_Pal	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44545
9.58538085535444e-71	-0.723090324049821	0.941	0.99	1.51525700561443e-66	PFDN2	Malignant cells	GSE131984_Pal	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44546
1.85656113308646e-70	0.323539949142494	1	1	2.93485183918308e-66	RPS18	Malignant cells	GSE131984_Pal	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44547
1.85701536334346e-70	0.821606890746664	0.955	0.74	2.93556988637334e-66	DUSP1	Malignant cells	GSE131984_Pal	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44548
1.18351680896025e-69	0.893893988327695	0.582	0.191	1.87090337160436e-65	STAC2	Malignant cells	GSE131984_Pal	ENSG00000141750	342667	SH3 and cysteine rich domain 2	24b2	protein_coding	Q6ZMT1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44549
1.76656434900926e-69	-0.720415823948615	0.786	0.946	2.79258492291384e-65	PSMG1	Malignant cells	GSE131984_Pal	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44550
3.28797873522864e-69	-0.757068901959592	0.771	0.922	5.19763678464943e-65	TIMM17A	Malignant cells	GSE131984_Pal	ENSG00000134375	10440	translocase of inner mitochondrial membrane 17A	TIM17|TIM17A	protein_coding	Q99595	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44551
1.94939023573019e-68	-0.79082399742463	0.921	0.986	3.08159608464229e-64	STMN1	Malignant cells	GSE131984_Pal	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44552
6.28328693328334e-68	-0.560906891593977	1	1	9.93261998413431e-64	RBM3	Malignant cells	GSE131984_Pal	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44553
7.27526127895718e-68	-0.784722494181498	0.991	0.998	1.15007330297755e-63	CALM2	Malignant cells	GSE131984_Pal	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44554
1.36561176470297e-67	-0.52226698309488	0.996	0.999	2.15875907764246e-63	SNRPG	Malignant cells	GSE131984_Pal	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44555
8.47690035811405e-67	1.74785261476088	0.593	0.199	1.34002840861067e-62	SAA1	Malignant cells	GSE131984_Pal	ENSG00000288411	6288	serum amyloid A1	PIG4|SAA|TP53I4	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44556
3.16100521190727e-66	-0.771341550429298	0.955	0.994	4.99691703898301e-62	TNFRSF12A	Malignant cells	GSE131984_Pal	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44557
5.90838839140869e-66	-0.72497844221533	0.81	0.955	9.33998036913886e-62	YWHAH	Malignant cells	GSE131984_Pal	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44558
9.99221036632321e-66	-0.727416117895911	0.945	0.99	1.57956861470837e-61	PRDX4	Malignant cells	GSE131984_Pal	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44559
1.03014251218415e-65	-0.677439734949087	0.932	0.99	1.62844928326071e-61	U2AF1	Malignant cells	GSE131984_Pal	ENSG00000160201	7307	U2 small nuclear RNA auxiliary factor 1	RN|RNU2AF1|U2AF35|U2AFBP	protein_coding	Q01081	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44560
1.26879518786085e-65	-0.623968194498433	0.893	0.98	2.00571143297043e-61	MRPL18	Malignant cells	GSE131984_Pal	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44561
7.70391429696974e-65	0.804974640037237	0.812	0.495	1.21783477206498e-60	ABCC3	Malignant cells	GSE131984_Pal	ENSG00000108846	8714	ATP binding cassette subfamily C member 3	cMOAT2|EST90757|MLP2|MOAT-D|MRP3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44562
1.04687286016053e-64	-0.680658477980698	0.908	0.983	1.65489661734177e-60	ATP6V0B	Malignant cells	GSE131984_Pal	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44563
4.47451453970742e-64	-0.653134718794671	0.824	0.96	7.07331258436949e-60	SNRPC	Malignant cells	GSE131984_Pal	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44564
8.42282928498048e-64	-0.724395745093392	0.605	0.864	1.33148085336971e-59	LRR1	Malignant cells	GSE131984_Pal	ENSG00000165501	122769	leucine rich repeat protein 1	LRR-1|MGC20689|PPIL5	protein_coding	Q96L50	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44565
9.60327132360573e-64	-0.659826540989996	0.848	0.966	1.51808513083559e-59	DTYMK	Malignant cells	GSE131984_Pal	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44566
1.70102941216819e-63	-0.653657996605087	0.88	0.973	2.68898729475548e-59	ADRM1	Malignant cells	GSE131984_Pal	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44567
2.81171060347667e-63	-0.560881560544785	0.997	1	4.44475212197593e-59	PLP2	Malignant cells	GSE131984_Pal	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44568
3.61052881210489e-63	-0.625252627796388	0.964	0.993	5.7075239461754e-59	PHB	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44569
5.81438132267709e-63	0.417820566816105	0.276	0.013	9.19137399488795e-59	SESN3	Malignant cells	GSE131984_Pal	ENSG00000149212	143686	sestrin 3	MGC29667|SEST3	protein_coding	P58005	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44570
1.7264769327718e-62	-0.644692281291144	0.864	0.961	2.72921473532566e-58	PGP	Malignant cells	GSE131984_Pal	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44571
2.33585667648555e-62	0.403715163185742	1	1	3.69252223418836e-58	SERF2	Malignant cells	GSE131984_Pal	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44572
8.20604617440228e-62	0.292184203110339	1	1	1.29721177924951e-57	RPS12	Malignant cells	GSE131984_Pal	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44573
1.15745471711551e-61	-0.673363714913253	0.925	0.977	1.82970441681619e-57	TFDP1	Malignant cells	GSE131984_Pal	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44574
5.30941521026391e-61	-0.808424281782156	0.818	0.959	8.39312356438519e-57	CACYBP	Malignant cells	GSE131984_Pal	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44575
1.16947938521454e-60	-0.631805511725827	0.96	0.993	1.84871301214714e-56	ERH	Malignant cells	GSE131984_Pal	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44576
1.48541869685034e-60	-0.674430881660409	0.948	0.99	2.34814987598102e-56	NCL	Malignant cells	GSE131984_Pal	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44577
1.57970674791646e-60	-0.540838783717176	0.999	1	2.49720042710633e-56	EIF5A	Malignant cells	GSE131984_Pal	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44578
2.57926211042868e-60	-0.661732095843528	1	1	4.07729754416566e-56	ENO1	Malignant cells	GSE131984_Pal	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44579
4.13937508342761e-60	0.850057864874698	0.782	0.458	6.54352413188237e-56	RAMP1	Malignant cells	GSE131984_Pal	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44580
7.07176207612325e-60	-0.738850800261327	0.791	0.947	1.11790414899356e-55	CDKN3	Malignant cells	GSE131984_Pal	ENSG00000100526	1033	cyclin dependent kinase inhibitor 3	CDI1|KAP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44581
1.00849683109708e-59	0.433060576827148	1	0.999	1.59423179059826e-55	TOMM7	Malignant cells	GSE131984_Pal	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44582
1.17649851660864e-59	-0.591669028281112	0.991	0.997	1.85980885505494e-55	S100A16	Malignant cells	GSE131984_Pal	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44583
1.28658399306388e-59	-0.556471035606482	0.98	0.999	2.03383197623538e-55	EIF4EBP1	Malignant cells	GSE131984_Pal	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44584
1.88275599139832e-59	-0.722028072322769	0.668	0.878	2.97626067120246e-55	CENPV	Malignant cells	GSE131984_Pal	ENSG00000166582	201161	centromere protein V	CENP-V|p30|PRR6	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44585
2.7428271515719e-59	0.742400776722832	0.873	0.666	4.33586116120486e-55	F2R	Malignant cells	GSE131984_Pal	ENSG00000181104	2149	coagulation factor II thrombin receptor	CF2R|PAR-1|PAR1|TR	protein_coding	P25116	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44586
3.29082859592606e-59	-0.720166684037273	0.802	0.948	5.20214184443991e-55	CKS1B	Malignant cells	GSE131984_Pal	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44587
7.58635911808042e-59	0.282269767292391	1	1	1.19925164938615e-54	RPS11	Malignant cells	GSE131984_Pal	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44588
8.63745428083131e-59	-0.855012806486424	0.595	0.845	1.36540877271381e-54	EXOSC8	Malignant cells	GSE131984_Pal	ENSG00000120699	11340	exosome component 8	bA421P11.3|CIP3|EAP2|OIP2|p9|RRP43|Rrp43p	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44589
2.81396472791036e-58	-0.580816445720296	0.951	0.986	4.4483154418807e-54	MRPS34	Malignant cells	GSE131984_Pal	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44590
3.06050971624218e-58	-0.538865717085577	0.997	1	4.83805375943563e-54	HSPE1	Malignant cells	GSE131984_Pal	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44591
3.60350601372422e-58	-0.596057877022612	0.975	1	5.69642230649524e-54	EMP3	Malignant cells	GSE131984_Pal	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44592
3.95732873836746e-58	-0.754630557384662	0.971	0.999	6.25574526961128e-54	UBE2S	Malignant cells	GSE131984_Pal	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44593
6.40696684751446e-58	-0.72628469347337	0.778	0.935	1.01281331925509e-53	HMGB3	Malignant cells	GSE131984_Pal	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44594
7.94818945909433e-58	0.503558602987434	1	0.999	1.25644978969363e-53	MT-CO2	Malignant cells	GSE131984_Pal	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44595
2.90794292245637e-57	0.695644042168564	0.986	0.959	4.59687617181902e-53	MYC	Malignant cells	GSE131984_Pal	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44596
6.69984843119232e-57	-0.570206914552918	0.99	0.996	1.05911204000288e-52	GTF3A	Malignant cells	GSE131984_Pal	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44597
1.30137103426319e-56	-0.63739030117929	0.745	0.914	2.05720733096326e-52	UBE2N	Malignant cells	GSE131984_Pal	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44598
2.37316943281621e-56	-0.470136007103527	1	1	3.75150623939587e-52	CFL1	Malignant cells	GSE131984_Pal	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44599
3.05166062997e-56	-0.609540995402457	0.913	0.966	4.82406512385658e-52	ARHGDIA	Malignant cells	GSE131984_Pal	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44600
5.01644864592295e-56	-0.715292813882782	0.726	0.915	7.930002019475e-52	VBP1	Malignant cells	GSE131984_Pal	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44601
7.76140790490419e-56	0.575316371408485	0.492	0.153	1.22692336160725e-51	FSTL1	Malignant cells	GSE131984_Pal	ENSG00000163430	11167	follistatin like 1	FRP|FSL1|OCC-1|OCC1|tsc36	protein_coding	Q12841	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44602
3.26981822817801e-55	-0.497965247557223	0.994	1	5.16892865510379e-51	SET	Malignant cells	GSE131984_Pal	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44603
4.55026921062866e-55	-0.52256390264902	0.996	0.999	7.19306556816178e-51	NOP10	Malignant cells	GSE131984_Pal	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44604
1.63195326955002e-54	-0.664414103178234	0.709	0.897	2.57979172850468e-50	TUBB6	Malignant cells	GSE131984_Pal	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44605
3.89358654310871e-54	0.313855068536044	1	1	6.15498160734625e-50	UQCRH	Malignant cells	GSE131984_Pal	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44606
9.94304855424741e-54	-0.778293012926561	0.43	0.748	1.57179711545543e-49	UBE2T	Malignant cells	GSE131984_Pal	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44607
1.00047343983374e-53	-0.564764537495527	0.928	0.989	1.58154841368917e-49	DEK	Malignant cells	GSE131984_Pal	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44608
1.49706711050073e-53	-0.546080512372158	0.997	1	2.36656368827955e-49	TUBB	Malignant cells	GSE131984_Pal	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44609
2.17775755959518e-53	-0.554991228976159	0.962	0.992	3.44259915020806e-49	PSMB5	Malignant cells	GSE131984_Pal	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44610
3.14871936684242e-53	-0.545589740820994	0.941	0.992	4.97749557510449e-49	CNBP	Malignant cells	GSE131984_Pal	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44611
3.4799490476595e-53	-0.464939185245982	0.996	1	5.50110345454013e-49	SERBP1	Malignant cells	GSE131984_Pal	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44612
3.51164289388154e-53	-0.622641607928083	0.75	0.913	5.55120508664794e-49	RNF126	Malignant cells	GSE131984_Pal	ENSG00000070423	55658	ring finger protein 126	FLJ20552	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44613
3.89821526302308e-53	0.500376347225965	0.994	0.981	6.16229868778688e-49	C9orf16	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44614
6.99044552497586e-53	0.86779248683632	0.439	0.117	1.10504962858818e-48	IL13RA2	Malignant cells	GSE131984_Pal	ENSG00000123496	3598	interleukin 13 receptor subunit alpha 2	CD213a2|CT19|IL-13R|IL13BP	protein_coding	Q14627	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44615
8.35780402095054e-53	0.462848376276213	1	0.999	1.32120165963186e-48	MT-ND2	Malignant cells	GSE131984_Pal	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44616
1.22108131733636e-52	-0.609091783341658	0.949	0.985	1.93028534644532e-48	PSMD8	Malignant cells	GSE131984_Pal	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44617
1.363192809617e-52	-0.555390401106221	0.954	0.995	2.15493519344255e-48	DNAJC15	Malignant cells	GSE131984_Pal	ENSG00000120675	29103	DnaJ heat shock protein family (Hsp40) member C15	DNAJD1|MCJ	protein_coding	Q9Y5T4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44618
2.39669355534466e-52	-0.530799229895722	0.952	0.985	3.78869317228884e-48	UBE2I	Malignant cells	GSE131984_Pal	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44619
2.93604425770812e-52	-0.591828369637125	0.758	0.924	4.64129876258499e-48	MRPS6	Malignant cells	GSE131984_Pal	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44620
9.17459990387702e-52	-0.769507949687505	0.949	0.986	1.45032075280488e-47	CCT5	Malignant cells	GSE131984_Pal	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44621
1.05170759388425e-51	0.537191672610102	0.342	0.065	1.66253936441222e-47	EGR3	Malignant cells	GSE131984_Pal	ENSG00000179388	1960	early growth response 3	PILOT	protein_coding	Q06889	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44622
1.32200194845878e-51	-0.689052166794957	0.932	0.977	2.08982068012364e-47	C12orf75	Malignant cells	GSE131984_Pal	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44623
4.16996116316719e-51	-0.655485581793416	0.671	0.87	6.59187460673469e-47	MED10	Malignant cells	GSE131984_Pal	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44624
4.39152988889895e-51	-0.706961450686618	0.502	0.767	6.94213044837145e-47	MRTO4	Malignant cells	GSE131984_Pal	ENSG00000053372	51154	MRT4 homolog, ribosome maturation factor	C1orf33|dJ657E11.4|MRT4	protein_coding	Q9UKD2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44625
6.3294836314933e-51	-0.739413441939707	0.544	0.783	1.00056477246646e-46	LYAR	Malignant cells	GSE131984_Pal	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44626
7.94623685164069e-51	-0.490501980681757	0.991	1	1.25614112150736e-46	SLIRP	Malignant cells	GSE131984_Pal	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44627
1.05414926258438e-50	0.754256896467854	0.833	0.583	1.66639915429338e-46	ZFP36	Malignant cells	GSE131984_Pal	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44628
1.15698782961006e-50	-0.455387818772167	1	0.999	1.82896636104759e-46	HNRNPA2B1	Malignant cells	GSE131984_Pal	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44629
2.95856146187771e-50	0.898638356610495	0.827	0.555	4.67689395893629e-46	IL6	Malignant cells	GSE131984_Pal	ENSG00000136244	3569	interleukin 6	BSF2|HGF|HSF|IFNB2|IL-6	protein_coding	P05231	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44630
3.51029394917761e-50	-0.539983488391016	0.887	0.964	5.54907267485996e-46	MRPL52	Malignant cells	GSE131984_Pal	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44631
3.84374525240842e-50	0.566644275515719	0.528	0.2	6.07619249500723e-46	AGRN	Malignant cells	GSE131984_Pal	ENSG00000188157	375790	agrin	AGRIN	protein_coding	O00468	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44632
8.49192637898229e-50	0.670760561597308	0.593	0.254	1.34240372198952e-45	FOSB	Malignant cells	GSE131984_Pal	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44633
1.33484409622326e-49	0.682051314075562	0.938	0.756	2.11012154730973e-45	EGR1	Malignant cells	GSE131984_Pal	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44634
2.37046395788812e-49	-0.630057412590638	0.872	0.959	3.74722942462954e-45	SDF2L1	Malignant cells	GSE131984_Pal	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44635
4.14939687219253e-49	-0.600531856299304	0.951	0.985	6.55936657556195e-45	MYL12A	Malignant cells	GSE131984_Pal	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44636
1.09969899936394e-48	-0.69605483847948	0.472	0.781	1.73840417819452e-44	PBK	Malignant cells	GSE131984_Pal	ENSG00000168078	55872	PDZ binding kinase	CT84|FLJ14385|Nori-3|SPK|TOPK	protein_coding	Q96KB5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44637
1.9042405014115e-48	0.501959060028998	0.436	0.134	3.0102233846313e-44	HTRA1	Malignant cells	GSE131984_Pal	ENSG00000166033	5654	HtrA serine peptidase 1	ARMD7|HtrA|IGFBP5-protease|PRSS11	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44638
3.61881480476299e-48	-0.590235647359372	0.944	0.992	5.72062244336933e-44	PTTG1	Malignant cells	GSE131984_Pal	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44639
3.72395724787839e-48	-0.526554812494002	0.973	0.994	5.88683161744615e-44	MRPL12	Malignant cells	GSE131984_Pal	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44640
4.52849068181947e-48	-0.647332754030652	0.668	0.861	7.15863806982022e-44	IFRD2	Malignant cells	GSE131984_Pal	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44641
1.61793897131294e-47	-0.640812813982617	0.583	0.824	2.5576379258515e-43	TUBG1	Malignant cells	GSE131984_Pal	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44642
2.12301044278388e-47	-0.482144491753428	0.962	0.989	3.35605490795276e-43	ARF1	Malignant cells	GSE131984_Pal	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44643
2.36413502907831e-47	-0.668330876420871	0.622	0.855	3.737224653967e-43	TYMS	Malignant cells	GSE131984_Pal	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44644
2.44008731466513e-47	-0.419335337564311	0.997	1	3.85729002702264e-43	TAF9	Malignant cells	GSE131984_Pal	ENSG00000276463	6880	TATA-box binding protein associated factor 9	AD-004|CGI-137|MGC1603|MGC3647|MGC5067|TAF2G|TAFII31|TAFII32|TAFIID32	protein_coding	Q16594	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44645
3.5959089443175e-47	-0.481123965859952	0.967	0.997	5.68441285917711e-43	UBE2L3	Malignant cells	GSE131984_Pal	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44646
8.84978574912752e-47	-0.540316912754279	0.877	0.965	1.39897413122208e-42	CBR1	Malignant cells	GSE131984_Pal	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44647
9.06365629182978e-47	-0.65953956792085	0.674	0.868	1.43278278661245e-42	MRPS23	Malignant cells	GSE131984_Pal	ENSG00000181610	51649	mitochondrial ribosomal protein S23	CGI-138|HSPC329|MRP-S23	protein_coding	Q9Y3D9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44648
9.46704637805144e-47	-0.393926230638929	1	1	1.49655069144237e-42	SUB1	Malignant cells	GSE131984_Pal	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44649
9.71779131840652e-47	-0.688616050826348	0.746	0.895	1.5361884516137e-42	NUDC	Malignant cells	GSE131984_Pal	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44650
1.14665663479538e-46	-0.581146064220685	0.84	0.94	1.81263480828454e-42	MRPL27	Malignant cells	GSE131984_Pal	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44651
1.4196405847422e-46	-0.653811949096917	0.736	0.886	2.24416783636047e-42	PSMC1	Malignant cells	GSE131984_Pal	ENSG00000100764	5700	proteasome 26S subunit, ATPase 1	p56|RPT2|S4	protein_coding	P62191	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44652
1.53205581782081e-46	-0.602138625731346	0.964	0.992	2.42187383681113e-42	ODC1	Malignant cells	GSE131984_Pal	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44653
1.664721356783e-46	-0.504189375118275	0.97	0.994	2.63159152080256e-42	PGAM1	Malignant cells	GSE131984_Pal	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44654
2.52521157466282e-46	-0.589819959603801	0.753	0.925	3.99185445722698e-42	CENPW	Malignant cells	GSE131984_Pal	ENSG00000203760	387103	centromere protein W	C6orf173|CUG2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44655
2.55997456264087e-46	0.670856109070967	0.569	0.253	4.04680778862269e-42	COL6A2	Malignant cells	GSE131984_Pal	ENSG00000142173	1292	collagen type VI alpha 2 chain	NA	protein_coding	P12110	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44656
3.25054694507348e-46	-0.585351512045013	0.942	0.981	5.13846461077215e-42	CALM1	Malignant cells	GSE131984_Pal	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44657
3.6111839031052e-46	0.695644861912577	1	0.997	5.7085595140287e-42	MT2A	Malignant cells	GSE131984_Pal	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44658
3.98734459684601e-46	0.575348947006191	0.978	0.937	6.30319433869417e-42	LY6E	Malignant cells	GSE131984_Pal	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44659
4.23786088865229e-46	0.601054145683909	0.364	0.093	6.69921049278153e-42	FAM20C	Malignant cells	GSE131984_Pal	ENSG00000282147	56975	FAM20C golgi associated secretory pathway kinase	DKFZp547D065|DMP4|G-CK|IMAGE:4942737	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44660
4.24304224511604e-46	-0.473852729811534	0.98	0.994	6.70740118107943e-42	UBE2D2	Malignant cells	GSE131984_Pal	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44661
5.79392243721085e-46	-0.360931432920503	1	1	9.15903258874292e-42	RPL36AL	Malignant cells	GSE131984_Pal	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44662
6.68019473462997e-46	-0.617715289680127	0.769	0.902	1.0560051836503e-41	EEF1E1	Malignant cells	GSE131984_Pal	ENSG00000124802	9521	eukaryotic translation elongation factor 1 epsilon 1	AIMP3|P18	protein_coding	O43324	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44663
7.00996349723552e-46	-0.599821722023215	0.231	0.555	1.10813502964299e-41	SFN	Malignant cells	GSE131984_Pal	ENSG00000175793	2810	stratifin	YWHAS	protein_coding	P31947	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44664
8.49666113253097e-46	0.609472332600399	0.984	0.956	1.34315219183049e-41	DUSP23	Malignant cells	GSE131984_Pal	ENSG00000158716	54935	dual specificity phosphatase 23	DUSP25|FLJ20442	protein_coding	Q9BVJ7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44665
1.17329949181996e-45	-0.448656845969901	0.994	1	1.85475183666899e-41	NHP2L1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44666
1.22605932939582e-45	0.629499562116798	0.876	0.668	1.93815458790891e-41	ITGA3	Malignant cells	GSE131984_Pal	ENSG00000005884	3675	integrin subunit alpha 3	CD49c|GAP-B3|MSK18|VCA-2|VLA3a	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44667
1.28379549194695e-45	-0.508688894455996	0.967	0.992	2.02942391366973e-41	DUT	Malignant cells	GSE131984_Pal	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44668
1.34937475735365e-45	-0.373112531072116	1	1	2.13309161642465e-41	EIF1	Malignant cells	GSE131984_Pal	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44669
1.40197333607624e-45	-0.638384429427975	0.478	0.75	2.21623944966933e-41	TIMM8A	Malignant cells	GSE131984_Pal	ENSG00000126953	1678	translocase of inner mitochondrial membrane 8A	DDP|DFN1|MTS	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44670
1.42065921072893e-45	0.554438985286849	0.984	0.943	2.24577808032029e-41	MMP24-AS1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44671
1.67965594175794e-45	-0.466465676237356	0.996	1	2.65520011273095e-41	S100A11	Malignant cells	GSE131984_Pal	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44672
1.79095861574125e-45	-0.761605287119729	0.485	0.751	2.83114737976378e-41	BRIX1	Malignant cells	GSE131984_Pal	ENSG00000113460	55299	biogenesis of ribosomes BRX1	BRIX|BXDC2|FLJ11100	protein_coding	Q8TDN6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44673
2.09235836990431e-45	0.669169485889807	0.323	0.066	3.30760011114473e-41	SLPI	Malignant cells	GSE131984_Pal	ENSG00000124107	6590	secretory leukocyte peptidase inhibitor	ALK1|ALP|BLPI|HUSI|HUSI-I|WAP4|WFDC4	protein_coding	P03973	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44674
2.38082989318666e-45	0.5930312304673	0.948	0.861	3.76361589514947e-41	MCL1	Malignant cells	GSE131984_Pal	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44675
2.40670646204814e-45	0.4706616262039	0.423	0.129	3.8045215752057e-41	OSBPL5	Malignant cells	GSE131984_Pal	ENSG00000021762	114879	oxysterol binding protein like 5	KIAA1534|OBPH1|ORP5	protein_coding	Q9H0X9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44676
2.63870122429037e-45	-0.636151325861164	0.612	0.844	4.17125889535821e-41	NOP16	Malignant cells	GSE131984_Pal	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44677
2.76323569181758e-45	0.425515217946408	1	0.999	4.36812298162522e-41	MT-ND1	Malignant cells	GSE131984_Pal	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44678
2.79583801268248e-45	-0.582002837915802	0.857	0.958	4.41966073044847e-41	RBM8A	Malignant cells	GSE131984_Pal	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44679
3.45672700287304e-45	-0.620267760284289	0.597	0.828	5.46439404614171e-41	POLR3K	Malignant cells	GSE131984_Pal	ENSG00000161980	51728	RNA polymerase III subunit K	C11|RPC11	protein_coding	Q9Y2Y1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44680
4.0529551925621e-45	-0.863531630167963	0.675	0.862	6.40691156840216e-41	KPNA2	Malignant cells	GSE131984_Pal	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44681
7.47333259091146e-45	-0.669585546462412	0.322	0.64	1.18138441597128e-40	GMNN	Malignant cells	GSE131984_Pal	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44682
7.7907483769381e-45	-0.479460622047536	0.939	0.979	1.23156150342638e-40	TOMM22	Malignant cells	GSE131984_Pal	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44683
1.11399102425251e-44	-0.548307304949838	0.827	0.949	1.76099701113836e-40	SNRPD3	Malignant cells	GSE131984_Pal	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44684
1.21980873943369e-44	-0.516294288660976	0.908	0.983	1.92827365529678e-40	COPRS	Malignant cells	GSE131984_Pal	ENSG00000172301	55352	coordinator of PRMT5 and differentiation stimulator	C17orf79|COPR5|HSA272196|TTP1	protein_coding	Q9NQ92	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44685
1.30978810372397e-44	-0.580863767273428	0.981	0.999	2.07051303436684e-40	PRDX1	Malignant cells	GSE131984_Pal	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44686
1.82277225512658e-44	0.531748505991791	0.348	0.085	2.88143838090409e-40	LIF	Malignant cells	GSE131984_Pal	ENSG00000128342	3976	LIF interleukin 6 family cytokine	CDF|DIA|HILDA	protein_coding	P15018	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44687
2.18899569152195e-44	-0.593767649204382	0.638	0.836	3.4603643891579e-40	AP1S2	Malignant cells	GSE131984_Pal	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44688
2.51561863499779e-44	0.558847774564906	1	1	3.97668993820451e-40	MALAT1	Malignant cells	GSE131984_Pal	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44689
2.883916742451e-44	-0.490758045394873	0.96	0.987	4.55889558646653e-40	HNRNPA3	Malignant cells	GSE131984_Pal	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44690
4.38837565672944e-44	-0.567199117790053	0.812	0.926	6.93714423815789e-40	DCUN1D5	Malignant cells	GSE131984_Pal	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44691
5.98543556590465e-44	-0.380248711103547	1	1	9.46177654258206e-40	PRELID1	Malignant cells	GSE131984_Pal	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44692
6.34804577902123e-44	-0.472368651999812	0.965	0.992	1.00349907674768e-39	RHEB	Malignant cells	GSE131984_Pal	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44693
8.66801568768533e-44	-0.664658499317627	0.948	0.988	1.3702399199093e-39	TUBA1C	Malignant cells	GSE131984_Pal	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44694
1.20329680111017e-43	-0.667468025976176	0.661	0.858	1.90217158319496e-39	NUDT4	Malignant cells	GSE131984_Pal	ENSG00000173598	11163	nudix hydrolase 4	DIPP2|DIPP2alpha|DIPP2beta|HDCMB47P|KIAA0487	protein_coding	Q9NZJ9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44695
2.26013128360306e-43	-0.630418601359252	0.833	0.936	3.57281553311971e-39	PCMT1	Malignant cells	GSE131984_Pal	ENSG00000120265	5110	protein-L-isoaspartate (D-aspartate) O-methyltransferase	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44696
2.34231234686301e-43	-0.522310179449535	0.86	0.955	3.70272735792105e-39	PPM1G	Malignant cells	GSE131984_Pal	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44697
2.4101265999424e-43	0.715534341199525	0.638	0.315	3.80992812918894e-39	FOS	Malignant cells	GSE131984_Pal	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44698
2.55065287286933e-43	-0.554073221159039	0.804	0.923	4.03207206143184e-39	MRPL3	Malignant cells	GSE131984_Pal	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44699
3.06301264101091e-43	-0.616112885978369	0.938	0.975	4.84201038291005e-39	CCT2	Malignant cells	GSE131984_Pal	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44700
3.88817380381444e-43	-0.63986346365126	0.759	0.903	6.14642514906986e-39	PRMT1	Malignant cells	GSE131984_Pal	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44701
4.05225102799019e-43	-0.569538428016332	0.71	0.921	6.4057984250469e-39	BIRC5	Malignant cells	GSE131984_Pal	ENSG00000089685	332	baculoviral IAP repeat containing 5	API4|EPR-1|survivin	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44702
4.72175020940611e-43	-0.547823678501426	0.824	0.948	7.46414273102918e-39	HSD17B10	Malignant cells	GSE131984_Pal	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44703
1.05542759648161e-42	-0.461454737975935	0.997	1	1.66841994451813e-38	POMP	Malignant cells	GSE131984_Pal	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44704
1.44461720576467e-42	-0.631625440282428	0.931	0.978	2.2836508788728e-38	TM4SF1	Malignant cells	GSE131984_Pal	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44705
1.67225753567927e-42	-0.416920344544925	0.986	0.999	2.64350471240179e-38	SRSF9	Malignant cells	GSE131984_Pal	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44706
1.7034590612094e-42	0.25074232112678	1	1	2.69282808395981e-38	RPL34	Malignant cells	GSE131984_Pal	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44707
1.70620353538826e-42	-0.485952023543289	0.974	0.999	2.69716654874177e-38	RHOA	Malignant cells	GSE131984_Pal	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44708
1.89080256422171e-42	-0.560980280756626	0.818	0.941	2.98898069352169e-38	TXNL1	Malignant cells	GSE131984_Pal	ENSG00000091164	9352	thioredoxin like 1	TRP32|Txl|TXNL	protein_coding	O43396	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44709
2.32876673791135e-42	-0.486120972791074	0.934	0.976	3.68131445929026e-38	RAB32	Malignant cells	GSE131984_Pal	ENSG00000118508	10981	RAB32, member RAS oncogene family	NA	protein_coding	Q13637	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44710
2.47127440535516e-42	-0.584784375472147	0.957	0.986	3.90659057998543e-38	ANXA5	Malignant cells	GSE131984_Pal	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44711
2.81043897177198e-42	-0.504457433183499	0.86	0.95	4.44274192657715e-38	SRRM1	Malignant cells	GSE131984_Pal	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44712
3.00199341115836e-42	-0.513456877500065	0.968	0.986	4.74555118435913e-38	TCP1	Malignant cells	GSE131984_Pal	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44713
3.56284618422082e-42	-0.573789811992275	0.622	0.833	5.63214724801627e-38	MRPL15	Malignant cells	GSE131984_Pal	ENSG00000137547	29088	mitochondrial ribosomal protein L15	HSPC145|L15mt|MRP-L15|MRP-L7|RPML7	protein_coding	Q9P015	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44714
4.31846074775094e-42	-0.507966248958492	0.951	0.988	6.82662275004468e-38	PSMB3	Malignant cells	GSE131984_Pal	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44715
4.4735882924527e-42	-0.631707722026884	0.602	0.822	7.07184837270923e-38	TK1	Malignant cells	GSE131984_Pal	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44716
4.62351755002684e-42	-0.573664786140974	0.522	0.761	7.30885654308243e-38	FTSJ1	Malignant cells	GSE131984_Pal	ENSG00000068438	24140	FtsJ RNA 2'-O-methyltransferase 1	CDLIV|JM23|MRX44|MRX9|SPB1|TRM7|TRMT7	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44717
7.89169697611022e-42	-0.452814834973266	0.98	0.994	1.2475194579835e-37	C19orf10	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44718
1.01388686628743e-41	-0.625102174474822	0.429	0.695	1.60275235822716e-37	PRPS1	Malignant cells	GSE131984_Pal	ENSG00000147224	5631	phosphoribosyl pyrophosphate synthetase 1	CMTX5|DFN2|DFNX1|PPRibP|PRS-I	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44719
1.20805050765671e-41	-0.459259920206881	0.931	0.981	1.90968624250372e-37	RAD23A	Malignant cells	GSE131984_Pal	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44720
1.409212381001e-41	-0.603847695889027	0.987	1	2.22768293188638e-37	HSPA8	Malignant cells	GSE131984_Pal	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44721
1.49958868929277e-41	0.535899803223677	0.906	0.761	2.37054980003401e-37	SHC1	Malignant cells	GSE131984_Pal	ENSG00000160691	6464	SHC adaptor protein 1	p66|SHC|ShcA	protein_coding	P29353	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44722
2.34829738273221e-41	-0.626534525463314	0.81	0.935	3.71218850262309e-37	PSMD7	Malignant cells	GSE131984_Pal	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44723
2.84168500695391e-41	-0.610426289180513	0.645	0.847	4.49213565899273e-37	IGFBP6	Malignant cells	GSE131984_Pal	ENSG00000167779	3489	insulin like growth factor binding protein 6	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44724
2.8870331463493e-41	-0.564135016084527	0.931	0.972	4.56382199774898e-37	HNRNPD	Malignant cells	GSE131984_Pal	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44725
3.04058409943105e-41	-0.864194803259939	0.486	0.732	4.8065553443806e-37	S100A2	Malignant cells	GSE131984_Pal	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44726
4.99056665736883e-41	-0.559370472134217	0.877	0.959	7.88908777196864e-37	NOL7	Malignant cells	GSE131984_Pal	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44727
5.36452274863634e-41	-0.583875657805533	0.453	0.728	8.48023756104432e-37	PUF60	Malignant cells	GSE131984_Pal	ENSG00000274081	22827	poly(U) binding splicing factor 60	FIR|RoBPI|SIAHBP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44728
7.02969025902942e-41	-0.442992378192586	0.981	0.992	1.11125343614737e-36	HNRNPC	Malignant cells	GSE131984_Pal	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44729
7.30776771788689e-41	0.590130400825042	0.566	0.281	1.15521192084356e-36	CPD	Malignant cells	GSE131984_Pal	ENSG00000108582	1362	carboxypeptidase D	GP180	protein_coding	O75976	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44730
1.02956435410475e-40	-0.545623548172627	0.693	0.868	1.62753533096879e-36	ATG3	Malignant cells	GSE131984_Pal	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44731
1.03152303898294e-40	-0.445969774558651	0.98	0.989	1.63063162002422e-36	SIVA1	Malignant cells	GSE131984_Pal	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44732
1.17192062187701e-40	-0.547774030121326	0.887	0.954	1.85257211906317e-36	EIF6	Malignant cells	GSE131984_Pal	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44733
1.31537201914759e-40	-0.427159722528138	0.98	0.999	2.07934008786852e-36	UBE2D3	Malignant cells	GSE131984_Pal	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44734
1.38842634894452e-40	-0.553253886657803	0.645	0.827	2.1948243724115e-36	EMC8	Malignant cells	GSE131984_Pal	ENSG00000131148	10328	ER membrane protein complex subunit 8	C16orf2|C16orf4|COX4NB|FAM158B|NOC4	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44735
1.40212512641033e-40	0.319151733182149	1	1	2.21647939982946e-36	ATP5E	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44736
1.94256753585308e-40	-0.625497631430086	0.504	0.756	3.07081076067655e-36	DDX39A	Malignant cells	GSE131984_Pal	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44737
2.61900940995901e-40	0.338706505557922	1	0.999	4.14013007526321e-36	PFDN5	Malignant cells	GSE131984_Pal	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44738
2.74075719317565e-40	-0.55522944387853	0.68	0.861	4.33258897097207e-36	TIMM10	Malignant cells	GSE131984_Pal	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44739
3.44162957945663e-40	-0.598589928859683	0.593	0.815	5.44052803920504e-36	ANP32E	Malignant cells	GSE131984_Pal	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44740
4.21920531198367e-40	-0.472402488342729	0.909	0.969	6.66971975718379e-36	CDK4	Malignant cells	GSE131984_Pal	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44741
4.39188111534123e-40	-0.504171944142564	0.092	0.37	6.94268566713141e-36	NRG1	Malignant cells	GSE131984_Pal	ENSG00000157168	3084	neuregulin 1	GGF|HGL|HRG|NDF|NRG1-IT2	protein_coding	Q02297	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44742
4.41604990720793e-40	-0.518458770520414	0.794	0.932	6.9808916933143e-36	C3orf14	Malignant cells	GSE131984_Pal	ENSG00000114405	57415	chromosome 3 open reading frame 14	HT021	protein_coding	Q9HBI5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44743
5.04062976819925e-40	-0.593846365522833	0.563	0.769	7.96822753756938e-36	PPP2CA	Malignant cells	GSE131984_Pal	ENSG00000113575	5515	protein phosphatase 2 catalytic subunit alpha	PP2AC|PP2Calpha	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44744
5.18995498359683e-40	-0.946246630859735	0.57	0.785	8.20428083806988e-36	HSPA5	Malignant cells	GSE131984_Pal	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44745
6.2106157811547e-40	-0.441053953753382	0.971	0.992	9.81774142684935e-36	PYURF	Malignant cells	GSE131984_Pal	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44746
9.80783483497689e-40	-0.533085688711623	0.866	0.949	1.55042253071315e-35	RSL1D1	Malignant cells	GSE131984_Pal	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44747
1.25223133544985e-39	0.573460642067894	0.576	0.294	1.97952729507913e-35	NABP1	Malignant cells	GSE131984_Pal	ENSG00000173559	64859	nucleic acid binding protein 1	DKFZp667M1322|FLJ13624|FLJ22833|hSSB2|MGC111163|NABP1-OT1|OBFC2A|SOSS-B2|SSB2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44748
1.34138730423788e-39	-0.402754216767984	0.987	0.995	2.12046505053924e-35	GNG5	Malignant cells	GSE131984_Pal	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44749
1.55650657602167e-39	-0.523152006467113	0.951	0.984	2.46052559537505e-35	PRSS3	Malignant cells	GSE131984_Pal	ENSG00000010438	5646	serine protease 3	PRSS4|TRY3|TRY4	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44750
2.759589490153e-39	-0.447362902403839	0.967	0.99	4.36235906603386e-35	GTF2A2	Malignant cells	GSE131984_Pal	ENSG00000140307	2958	general transcription factor IIA subunit 2	HsT18745|TFIIA	protein_coding	P52657	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44751
3.55103280965539e-39	-0.616090384571386	0.691	0.877	5.61347266550323e-35	H1FX	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44752
3.90811337549847e-39	-0.476079547379713	0.919	0.977	6.17794562398797e-35	TPM3	Malignant cells	GSE131984_Pal	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44753
5.23918853990278e-39	-0.735579434977569	0.543	0.785	8.28210924387831e-35	CDC20	Malignant cells	GSE131984_Pal	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44754
5.24357525715572e-39	-0.591693197537973	0.665	0.839	8.28904376651176e-35	PSMD11	Malignant cells	GSE131984_Pal	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44755
8.35452060666973e-39	-0.565939088443362	0.841	0.939	1.32068261750235e-34	UPP1	Malignant cells	GSE131984_Pal	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44756
8.52060900408456e-39	0.557806702453855	0.798	0.578	1.34693787136569e-34	CD81	Malignant cells	GSE131984_Pal	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44757
1.05209015831671e-38	-0.524125928923375	0.635	0.834	1.66314412226705e-34	NTMT1	Malignant cells	GSE131984_Pal	ENSG00000148335	28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1	AD-003|C9orf32|HOMT1A|METTL11A|NRMT|NRMT1	protein_coding	Q9BV86	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44758
1.29012670156674e-38	0.575975466154575	0.618	0.322	2.03943228983671e-34	VSTM2L	Malignant cells	GSE131984_Pal	ENSG00000132821	128434	V-set and transmembrane domain containing 2 like	C20orf102|dJ1118M15.2	protein_coding	Q96N03	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44759
1.51144140194162e-38	0.502217290789873	0.359	0.107	2.38928656818932e-34	C3	Malignant cells	GSE131984_Pal	ENSG00000125730	718	complement C3	ARMD9|C3a|C3b|CPAMD1	protein_coding	P01024	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44760
2.00110317436636e-38	-0.432431230083557	0.973	0.993	3.16334389803834e-34	NDUFC2	Malignant cells	GSE131984_Pal	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44761
2.98400555097312e-38	0.443310748771327	0.455	0.179	4.7171159749783e-34	PDCD4	Malignant cells	GSE131984_Pal	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44762
3.16160003575067e-38	-0.574702435638851	0.677	0.848	4.99785733651466e-34	DKC1	Malignant cells	GSE131984_Pal	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44763
3.54277917889846e-38	-0.474754594139106	0.981	0.998	5.60042532600268e-34	MYL12B	Malignant cells	GSE131984_Pal	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44764
3.56250925491312e-38	-0.493689782711907	0.771	0.92	5.63161463016667e-34	MRPL17	Malignant cells	GSE131984_Pal	ENSG00000158042	63875	mitochondrial ribosomal protein L17	MRP-L26|RPML26	protein_coding	Q9NRX2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44765
3.63809486136923e-38	-0.458249498443787	0.905	0.971	5.75110035685247e-34	MRPL4	Malignant cells	GSE131984_Pal	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44766
4.04156764318758e-38	-0.420359103407414	0.968	0.986	6.38891013035093e-34	EI24	Malignant cells	GSE131984_Pal	ENSG00000149547	9538	EI24 autophagy associated transmembrane protein	EPG4|PIG8|TP53I8	protein_coding	O14681	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44767
5.01904332643248e-38	-0.53636501065323	0.83	0.949	7.93410369042446e-34	VPS29	Malignant cells	GSE131984_Pal	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44768
5.14296571961243e-38	-0.490166232242013	0.883	0.971	8.13000020956332e-34	HNRNPAB	Malignant cells	GSE131984_Pal	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44769
5.7670487814609e-38	-0.481380641193041	0.827	0.927	9.11655071373339e-34	UBE2M	Malignant cells	GSE131984_Pal	ENSG00000130725	9040	ubiquitin conjugating enzyme E2 M	hUbc12|UBC12	protein_coding	P61081	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44770
6.51478407352833e-38	-0.66803141062439	0.571	0.754	1.02985706634336e-33	SLBP	Malignant cells	GSE131984_Pal	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44771
6.65054871794654e-38	-0.369320347410283	1	0.999	1.05131874133299e-33	MTDH	Malignant cells	GSE131984_Pal	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44772
7.98204452747868e-38	-0.4054125219925	1	1	1.26180159890383e-33	KRT10	Malignant cells	GSE131984_Pal	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44773
8.25225463625071e-38	-0.563188218693511	0.602	0.803	1.30451641289851e-33	RRP7A	Malignant cells	GSE131984_Pal	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44774
1.05348531378259e-37	-0.459746313027876	0.994	0.994	1.66534958402752e-33	DYNLL1	Malignant cells	GSE131984_Pal	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44775
1.23029360311444e-37	-0.532156069306457	0.792	0.935	1.9448481278033e-33	MRPS18C	Malignant cells	GSE131984_Pal	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44776
1.57406211504779e-37	-0.401682849383003	1	1	2.48827739146755e-33	TMSB4X	Malignant cells	GSE131984_Pal	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44777
2.04673231618482e-37	0.579907469613671	0.916	0.765	3.23547444542496e-33	ANPEP	Malignant cells	GSE131984_Pal	ENSG00000166825	290	alanyl aminopeptidase, membrane	AP-N|CD13|gp150|hAPN|LAP1|p150|PEPN	protein_coding	P15144	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44778
2.34515533736438e-37	-0.529183046544856	0.332	0.622	3.70722155730561e-33	SNRNP40	Malignant cells	GSE131984_Pal	ENSG00000060688	9410	small nuclear ribonucleoprotein U5 subunit 40	HPRP8BP|PRP8BP|PRPF8BP|SPF38|WDR57	protein_coding	Q96DI7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44779
2.55087635247273e-37	-0.608072683422478	0.446	0.691	4.0324253379889e-33	HCCS	Malignant cells	GSE131984_Pal	ENSG00000004961	3052	holocytochrome c synthase	CCHL|MLS	protein_coding	P53701	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44780
3.16610870933182e-37	-0.578568179631516	0.403	0.659	5.00498464771175e-33	INO80C	Malignant cells	GSE131984_Pal	ENSG00000153391	125476	INO80 complex subunit C	C18orf37|FLJ38183|hIes6|IES6	protein_coding	Q6PI98	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44781
3.34473487365953e-37	-0.537251676700316	0.659	0.848	5.28735688828098e-33	MRPL47	Malignant cells	GSE131984_Pal	ENSG00000136522	57129	mitochondrial ribosomal protein L47	CGI-204|NCM1	protein_coding	Q9HD33	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44782
3.59182821055753e-37	-0.491071222340568	0.954	0.99	5.67796203524935e-33	CCT6A	Malignant cells	GSE131984_Pal	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44783
3.63901668176867e-37	0.631227718167399	0.395	0.137	5.75255757053991e-33	AQP3	Malignant cells	GSE131984_Pal	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44784
4.18014591431154e-37	-0.562742986166522	0.57	0.779	6.60797466134368e-33	USP1	Malignant cells	GSE131984_Pal	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44785
4.84258578824505e-37	-0.531454776982732	0.759	0.873	7.65515961405777e-33	CHCHD3	Malignant cells	GSE131984_Pal	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44786
6.93656212629382e-37	-0.536207401110866	0.681	0.841	1.09653174092453e-32	GPATCH4	Malignant cells	GSE131984_Pal	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44787
7.75513797848874e-37	-0.41661993490162	0.954	0.99	1.2259322116395e-32	POLR2E	Malignant cells	GSE131984_Pal	ENSG00000099817	5434	RNA polymerase II, I and III subunit E	hRPB25|hsRPB5|RPABC1|RPB5|XAP4	protein_coding	P19388	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44788
1.04884573000367e-36	0.527795563872321	0.431	0.168	1.6580153299898e-32	NR4A2	Malignant cells	GSE131984_Pal	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44789
1.2619301985796e-36	-0.630868358963236	0.551	0.771	1.99485925791463e-32	LY6K	Malignant cells	GSE131984_Pal	ENSG00000160886	54742	lymphocyte antigen 6 family member K	CT97|FLJ35226|HSJ001348	protein_coding	Q17RY6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44790
1.40638076609936e-36	-0.600357413767454	0.978	0.996	2.22320671504987e-32	PGK1	Malignant cells	GSE131984_Pal	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44791
1.85652808141599e-36	-0.600308528087089	0.642	0.827	2.9347995911024e-32	MRPL13	Malignant cells	GSE131984_Pal	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44792
1.89625813714531e-36	-0.45308989853477	0.957	0.993	2.99760486319931e-32	EIF3I	Malignant cells	GSE131984_Pal	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44793
1.95618516859801e-36	-0.389551409436574	0.986	0.997	3.09233751451973e-32	ZNF706	Malignant cells	GSE131984_Pal	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44794
2.92315986539478e-36	0.386334189583155	0.31	0.08	4.62093111521607e-32	IFITM10	Malignant cells	GSE131984_Pal	ENSG00000281618	402778	interferon induced transmembrane protein 10	DSPA3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44795
3.360388925385e-36	-0.488762069736056	0.909	0.97	5.31210281324861e-32	PRKCDBP	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44796
3.41981681770163e-36	-0.571598893335907	0.747	0.867	5.40604642542274e-32	VDAC3	Malignant cells	GSE131984_Pal	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44797
5.02421530200355e-36	-0.445078803531743	0.984	0.994	7.94227954940721e-32	PSMB7	Malignant cells	GSE131984_Pal	ENSG00000136930	5695	proteasome 20S subunit beta 7	Z	protein_coding	Q99436	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44798
5.16453415627216e-36	-0.75315259797151	0.457	0.703	8.16409559423503e-32	PCNA	Malignant cells	GSE131984_Pal	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44799
6.64441822347516e-36	-0.405940348614767	0.975	0.992	1.05034963276695e-31	RHOC	Malignant cells	GSE131984_Pal	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44800
6.90874629797852e-36	0.556883005743608	0.544	0.285	1.09213461478445e-31	SIK1	Malignant cells	GSE131984_Pal	ENSG00000142178	150094	salt inducible kinase 1	msk|SNF1LK	protein_coding	P57059	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44801
7.53808098319369e-36	-0.611030181433175	0.491	0.787	1.19161984182326e-31	MKI67	Malignant cells	GSE131984_Pal	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44802
8.21216880503717e-36	-0.47414545393204	0.874	0.959	1.29817964470028e-31	ATP1B3	Malignant cells	GSE131984_Pal	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44803
1.058650225262e-35	-0.49569468752781	0.898	0.974	1.67351427609417e-31	PSMB6	Malignant cells	GSE131984_Pal	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44804
1.10242594386202e-35	-0.570662116359922	0.351	0.633	1.74271493205709e-31	FEN1	Malignant cells	GSE131984_Pal	ENSG00000168496	2237	flap structure-specific endonuclease 1	FEN-1|MF1|RAD2	protein_coding	P39748	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44805
1.20885401293742e-35	-0.327102901230679	1	1	1.91095642365148e-31	DSTN	Malignant cells	GSE131984_Pal	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44806
1.20915009796726e-35	0.328739239705574	1	1	1.91142447486665e-31	ZFAS1	Malignant cells	GSE131984_Pal	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44807
1.31492836827087e-35	-0.378215370849903	0.997	1	2.07863876456259e-31	NAA10	Malignant cells	GSE131984_Pal	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44808
1.80249941578536e-35	-0.396188080740546	0.981	0.996	2.84939107647349e-31	ITGB1BP1	Malignant cells	GSE131984_Pal	ENSG00000119185	9270	integrin subunit beta 1 binding protein 1	ICAP-1A|ICAP-1alpha|ICAP-1B|ICAP1|ICAP1A|ICAP1B	protein_coding	O14713	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44809
2.0754238634759e-35	0.764209044725487	0.949	0.877	3.2808300433827e-31	MT1E	Malignant cells	GSE131984_Pal	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44810
2.10846281560435e-35	-0.37327629888919	0.993	0.999	3.33305801890735e-31	JTB	Malignant cells	GSE131984_Pal	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44811
2.27140375930277e-35	-0.435176034830521	1	1	3.59063506270581e-31	LDHA	Malignant cells	GSE131984_Pal	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44812
2.37231892915337e-35	-0.335978343986407	1	1	3.75016176320565e-31	RAC1	Malignant cells	GSE131984_Pal	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44813
2.60998698970371e-35	-0.578095009722096	0.576	0.794	4.12586743332362e-31	RRM2	Malignant cells	GSE131984_Pal	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44814
3.12072621792222e-35	-0.594818445280639	0.638	0.875	4.93324400529144e-31	HMGB2	Malignant cells	GSE131984_Pal	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44815
3.48936255486264e-35	0.298502878518374	1	1	5.51598432672686e-31	EEF2	Malignant cells	GSE131984_Pal	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44816
3.788389426159e-35	-0.492307822669619	0.736	0.884	5.98868600487215e-31	UBE2V2	Malignant cells	GSE131984_Pal	ENSG00000169139	7336	ubiquitin conjugating enzyme E2 V2	DDVit-1|DDVIT1|EDAF-1|EDPF-1|EDPF1|MMS2|UEV-2|UEV2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44817
3.82937185203494e-35	-0.54221634427242	0.71	0.862	6.05347102369683e-31	UBE2A	Malignant cells	GSE131984_Pal	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44818
3.90104676704276e-35	-0.569673675119486	0.794	0.892	6.1667747293412e-31	ILF2	Malignant cells	GSE131984_Pal	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44819
4.15557503007333e-35	0.551804923090628	0.874	0.74	6.56913300753992e-31	SPARC	Malignant cells	GSE131984_Pal	ENSG00000113140	6678	secreted protein acidic and cysteine rich	BM-40|ON|ONT	protein_coding	P09486	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44820
5.07372731821905e-35	-0.550482378406441	0.837	0.929	8.02054814464068e-31	RBBP7	Malignant cells	GSE131984_Pal	ENSG00000102054	5931	RB binding protein 7, chromatin remodeling factor	RbAp46	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44821
6.06489676589756e-35	-0.501475828769284	0.973	0.993	9.58738880753087e-31	LMNA	Malignant cells	GSE131984_Pal	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44822
6.52636529727508e-35	-0.630185076475532	0.287	0.582	1.03168782619325e-30	CCNA2	Malignant cells	GSE131984_Pal	ENSG00000145386	890	cyclin A2	CCN1|CCNA	protein_coding	P20248	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44823
7.31207042065062e-35	-0.431597365473797	0.987	0.997	1.15589209209645e-30	MRPL36	Malignant cells	GSE131984_Pal	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44824
9.08816183421675e-35	0.557315738130274	0.691	0.436	1.43665662275298e-30	TNFAIP2	Malignant cells	GSE131984_Pal	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44825
1.12015588312202e-34	-0.539693253905263	0.765	0.896	1.77074242003929e-30	HNRNPH3	Malignant cells	GSE131984_Pal	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44826
1.18073589369768e-34	-0.583668906879008	0.405	0.663	1.8665073007573e-30	MYBL2	Malignant cells	GSE131984_Pal	ENSG00000101057	4605	MYB proto-oncogene like 2	B-MYB|BMYB	protein_coding	P10244	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44827
2.28598793381763e-34	0.467277697861639	0.955	0.89	3.61368972577891e-30	GNAS	Malignant cells	GSE131984_Pal	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44828
2.33204520735823e-34	-0.469970826684422	0.811	0.929	3.68649706379189e-30	BANF1	Malignant cells	GSE131984_Pal	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44829
2.5528154584548e-34	-0.507493125601059	0.758	0.884	4.03549067672535e-30	SLC35B1	Malignant cells	GSE131984_Pal	ENSG00000121073	10237	solute carrier family 35 member B1	AXER|UGTREL1	protein_coding	P78383	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44830
2.91858708893317e-34	-0.56076877350435	0.57	0.764	4.61370247018556e-30	ARL4A	Malignant cells	GSE131984_Pal	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44831
3.19309689608233e-34	-0.454208831461287	0.913	0.964	5.04764757332695e-30	MRPS12	Malignant cells	GSE131984_Pal	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44832
3.26690108022693e-34	0.267185048962726	1	1	5.16431722762273e-30	RPS21	Malignant cells	GSE131984_Pal	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44833
4.08773110392334e-34	-1.27974699182124	0.977	0.979	6.46188532908202e-30	HIST1H4C	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44834
4.3698857255504e-34	-0.341634749856167	0.999	1	6.90791535495008e-30	KIAA0101	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44835
5.17861427497849e-34	-0.450023637064251	0.913	0.971	8.186353445886e-30	DAD1	Malignant cells	GSE131984_Pal	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44836
8.0518355502754e-34	-0.483756208985341	0.912	0.964	1.27283416378754e-29	GLRX3	Malignant cells	GSE131984_Pal	ENSG00000108010	10539	glutaredoxin 3	bA500G10.4|GLRX4|GRX3|GRX4|PICOT|TXNL2	protein_coding	O76003	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44837
9.90087842123386e-34	-0.45842371398277	0.883	0.947	1.56513086082865e-29	HRAS	Malignant cells	GSE131984_Pal	ENSG00000276536	3265	HRas proto-oncogene, GTPase	HRAS1	protein_coding	P01112	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44838
1.00025781469029e-33	-0.497997784424348	0.879	0.96	1.58120755346241e-29	PSMA5	Malignant cells	GSE131984_Pal	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44839
1.03635370985206e-33	-0.484916830685503	0.82	0.932	1.63826794453414e-29	SEPT7	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44840
1.17519727434555e-33	-0.479866289402334	0.659	0.83	1.85775185128544e-29	WDR34	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44841
1.35659753707061e-33	0.578907953399643	0.733	0.492	2.14450938660123e-29	TNFAIP3	Malignant cells	GSE131984_Pal	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44842
1.44020673647141e-33	-0.367458425752687	0.988	0.996	2.27667880901401e-29	NDUFAB1	Malignant cells	GSE131984_Pal	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44843
1.44653421581152e-33	0.496736218649247	0.997	0.997	2.28668128835484e-29	IRX2	Malignant cells	GSE131984_Pal	ENSG00000170561	153572	iroquois homeobox 2	NA	protein_coding	Q9BZI1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44844
1.45092461250987e-33	-0.526858450467991	0.297	0.563	2.2936216274556e-29	UGDH	Malignant cells	GSE131984_Pal	ENSG00000109814	7358	UDP-glucose 6-dehydrogenase	NA	protein_coding	O60701	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44845
1.49622946309575e-33	0.523523738730061	0.983	0.918	2.36523953526177e-29	SELM	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44846
1.72495587414261e-33	0.517382999119286	0.948	0.838	2.72681024584464e-29	HIF1A	Malignant cells	GSE131984_Pal	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44847
1.79312722107178e-33	-0.360082608717917	0.99	0.999	2.83457551107027e-29	SF3B5	Malignant cells	GSE131984_Pal	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44848
2.08466726644045e-33	-0.448639078736116	0.893	0.948	3.29544201478906e-29	PAICS	Malignant cells	GSE131984_Pal	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44849
2.16547017320024e-33	-0.494208860664949	0.687	0.834	3.42317524979493e-29	IMP4	Malignant cells	GSE131984_Pal	ENSG00000136718	92856	IMP U3 small nucleolar ribonucleoprotein 4	BXDC4|MGC19606	protein_coding	Q96G21	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44850
2.18738450855436e-33	-0.572465533021299	0.505	0.735	3.45781743112273e-29	AHSA1	Malignant cells	GSE131984_Pal	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44851
2.25149746896832e-33	0.648958313652153	0.307	0.089	3.55916719894513e-29	C11orf96	Malignant cells	GSE131984_Pal	ENSG00000187479	387763	chromosome 11 open reading frame 96	AG2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44852
2.350107314022e-33	-0.302755513478087	1	1	3.71504964200598e-29	SUMO2	Malignant cells	GSE131984_Pal	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44853
2.49468664241444e-33	-0.463650847355963	0.905	0.945	3.94360064432874e-29	CNIH4	Malignant cells	GSE131984_Pal	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44854
2.95137354656669e-33	-0.523128237210883	0.381	0.642	4.66553130241263e-29	GINS2	Malignant cells	GSE131984_Pal	ENSG00000131153	51659	GINS complex subunit 2	Pfs2|PSF2	protein_coding	Q9Y248	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44855
3.50899758916031e-33	0.534248334021951	0.59	0.335	5.54702338894462e-29	SNX10	Malignant cells	GSE131984_Pal	ENSG00000086300	29887	sorting nexin 10	NA	protein_coding	Q9Y5X0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44856
3.58864241615763e-33	-0.430954027363945	0.804	0.916	5.67292593146199e-29	HAX1	Malignant cells	GSE131984_Pal	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44857
3.69146502935309e-33	-0.481504421099803	0.206	0.477	5.83546791840136e-29	CHORDC1	Malignant cells	GSE131984_Pal	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44858
4.27716753558933e-33	-0.599458185410257	0.646	0.81	6.76134644025961e-29	PDHA1	Malignant cells	GSE131984_Pal	ENSG00000131828	5160	pyruvate dehydrogenase E1 subunit alpha 1	E1alpha|PDHA	protein_coding	P08559	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44859
5.19337798329779e-33	-0.361258982445261	1	1	8.20969191599715e-29	MYL6	Malignant cells	GSE131984_Pal	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44860
6.63393348757298e-33	-0.477238664205237	0.815	0.931	1.04869220571554e-28	ARPC5L	Malignant cells	GSE131984_Pal	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44861
7.74670317772147e-33	-0.537003800405735	0.659	0.832	1.22459883833421e-28	TUBA4A	Malignant cells	GSE131984_Pal	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44862
8.21770390017409e-33	-0.463245384611118	0.887	0.951	1.29905463253952e-28	CAPN2	Malignant cells	GSE131984_Pal	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44863
8.37459780031401e-33	-0.540530075845312	0.651	0.828	1.32385642027364e-28	BUB3	Malignant cells	GSE131984_Pal	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44864
8.76239214676374e-33	-0.378584038120711	0.98	0.991	1.38515895056041e-28	GTF3C6	Malignant cells	GSE131984_Pal	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44865
9.54162313949206e-33	0.587452575763322	0.746	0.528	1.5083397858909e-28	AHNAK2	Malignant cells	GSE131984_Pal	ENSG00000185567	113146	AHNAK nucleoprotein 2	C14orf78	protein_coding	Q8IVF2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44866
9.56215132800291e-33	-0.38788132400518	0.942	0.988	1.5115848819307e-28	SRP9	Malignant cells	GSE131984_Pal	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44867
1.44526510772523e-32	-0.493174088778495	0.76	0.877	2.28467508229205e-28	CTNNAL1	Malignant cells	GSE131984_Pal	ENSG00000119326	8727	catenin alpha like 1	alpha-CATU|CLLP	protein_coding	Q9UBT7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44868
1.55507169670505e-32	-0.47204318567638	0.811	0.9	2.45825733815134e-28	GSPT1	Malignant cells	GSE131984_Pal	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44869
1.61616931883707e-32	-0.436031506753004	0.83	0.927	2.55484045921764e-28	AUP1	Malignant cells	GSE131984_Pal	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44870
1.7142758896919e-32	-0.46078324382459	0.935	0.982	2.70992732642495e-28	DDX21	Malignant cells	GSE131984_Pal	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44871
1.75856569102598e-32	-0.381288407161789	0.951	0.992	2.77994064437388e-28	PRR13	Malignant cells	GSE131984_Pal	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44872
1.79400473310956e-32	0.404929017798687	0.294	0.082	2.83596268209959e-28	BTG2	Malignant cells	GSE131984_Pal	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44873
3.11228262882036e-32	0.489294364676216	0.595	0.333	4.91989637963923e-28	VCAN	Malignant cells	GSE131984_Pal	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44874
3.22877483107328e-32	-0.463369817226541	0.81	0.921	5.10404725296064e-28	UFD1L	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44875
3.50451744074956e-32	-0.379225677575711	0.988	0.998	5.53994117033691e-28	MRPL20	Malignant cells	GSE131984_Pal	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44876
4.01856687994788e-32	-0.484524883000359	0.649	0.822	6.35255052382161e-28	ZNF511	Malignant cells	GSE131984_Pal	ENSG00000198546	118472	zinc finger protein 511	MGC30006|Zfp511	protein_coding	Q8NB15	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44877
4.04193505838568e-32	-0.567482697711185	0.473	0.698	6.38949094029609e-28	PYCR1	Malignant cells	GSE131984_Pal	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44878
4.31200523073566e-32	-0.630232414706985	0.407	0.667	6.81641786874694e-28	SPANXC	Malignant cells	GSE131984_Pal	ENSG00000198573	64663	SPANX family member C	CT11.3|CTp11	protein_coding	Q9NY87	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44879
4.41591666420679e-32	-0.371063943817048	0.983	0.998	6.98068106277809e-28	STRAP	Malignant cells	GSE131984_Pal	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44880
4.79505903907919e-32	-0.400040050635148	0.909	0.971	7.58002932897638e-28	PIN1	Malignant cells	GSE131984_Pal	ENSG00000127445	5300	peptidylprolyl cis/trans isomerase, NIMA-interacting 1	dod	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44881
8.45903348799002e-32	-0.371902039633593	0.993	1	1.33720401378146e-27	VDAC1	Malignant cells	GSE131984_Pal	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44882
8.64774979862262e-32	-0.483879017948523	0.457	0.691	1.36703628816626e-27	PHF5A	Malignant cells	GSE131984_Pal	ENSG00000100410	84844	PHD finger protein 5A	bK223H9.2|INI|MGC1346|Rds3|SAP14b|SF3b14b|SF3B7	protein_coding	Q7RTV0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44883
9.46682399444135e-32	-0.485060440924671	0.962	0.977	1.49651553704129e-27	PHLDA2	Malignant cells	GSE131984_Pal	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44884
1.0309969703641e-31	-0.433931893498119	0.84	0.926	1.62980001075156e-27	C20orf24	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44885
1.12383394754603e-31	-0.45096072564275	0.96	0.982	1.77655670428076e-27	HPCAL1	Malignant cells	GSE131984_Pal	ENSG00000115756	3241	hippocalcin like 1	BDR1|HLP2|VILIP-3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44886
1.18550799960091e-31	-0.290653764265485	1	1	1.87405104576912e-27	TXN	Malignant cells	GSE131984_Pal	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44887
1.40860846025756e-31	-0.510244000172837	0.899	0.959	2.22672825397515e-27	ESD	Malignant cells	GSE131984_Pal	ENSG00000139684	2098	esterase D	NA	protein_coding	P10768	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44888
1.41998889966877e-31	0.556521476476253	1	0.998	2.24471845259639e-27	MT-ND5	Malignant cells	GSE131984_Pal	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44889
1.452357543445e-31	-0.481761903098244	0.664	0.842	2.29588680467786e-27	ICT1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44890
1.66486845505442e-31	-0.50446406496298	0.319	0.587	2.63182405375003e-27	EXOSC9	Malignant cells	GSE131984_Pal	ENSG00000123737	5393	exosome component 9	p5|p6|PM/Scl-75|PMSCL1|RRP45|Rrp45p	protein_coding	Q06265	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44891
1.77667208281408e-31	-0.473456420757356	0.771	0.895	2.8085632285125e-27	MRPS7	Malignant cells	GSE131984_Pal	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44892
1.82766176696704e-31	-0.452068488934331	0.825	0.927	2.8891677212215e-27	MRPS26	Malignant cells	GSE131984_Pal	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44893
2.61842375184439e-31	-0.408227449541485	0.876	0.955	4.13920426691561e-27	SSRP1	Malignant cells	GSE131984_Pal	ENSG00000149136	6749	structure specific recognition protein 1	FACT80	protein_coding	Q08945	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44894
2.63474292357751e-31	-0.675572969368646	0.388	0.632	4.16500161359132e-27	SLC3A2	Malignant cells	GSE131984_Pal	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44895
3.1389198755298e-31	-0.460208599536716	0.912	0.968	4.9620045392375e-27	TMED9	Malignant cells	GSE131984_Pal	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44896
3.83126363796124e-31	-0.400231474440664	0.911	0.962	6.05646155888913e-27	RNPS1	Malignant cells	GSE131984_Pal	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44897
5.53779178424796e-31	0.500915223060392	0.932	0.839	8.75414125253917e-27	EPB41L4A-AS1	Malignant cells	GSE131984_Pal	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44898
6.32307283471276e-31	-0.435118206703647	0.89	0.977	9.99551353711392e-27	DDX46	Malignant cells	GSE131984_Pal	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44899
6.51857238868373e-31	-0.4471551981119	0.805	0.903	1.03045592320312e-26	CISD2	Malignant cells	GSE131984_Pal	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44900
7.18655310337521e-31	0.495898398093915	0.678	0.442	1.13605031458155e-26	KLF9	Malignant cells	GSE131984_Pal	ENSG00000119138	687	KLF transcription factor 9	BTEB1	protein_coding	Q13886	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44901
8.22780657724841e-31	-0.463028976242209	0.893	0.968	1.30065166373143e-26	PSMB2	Malignant cells	GSE131984_Pal	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44902
1.18476703507781e-30	-0.487559894530792	0.685	0.855	1.872879729051e-26	PGRMC1	Malignant cells	GSE131984_Pal	ENSG00000101856	10857	progesterone receptor membrane component 1	HPR6.6	protein_coding	O00264	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44903
1.18610214551686e-30	-0.481036969530532	0.724	0.847	1.87499027163305e-26	PSMD3	Malignant cells	GSE131984_Pal	ENSG00000108344	5709	proteasome 26S subunit, non-ATPase 3	P58|Rpn3|S3|TSTA2	protein_coding	O43242	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44904
1.31281677352266e-30	-0.384997721063005	0.949	0.976	2.07530075558461e-26	PTP4A2	Malignant cells	GSE131984_Pal	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44905
1.35342761157505e-30	-0.323441633090197	0.999	1	2.13949836837784e-26	GADD45GIP1	Malignant cells	GSE131984_Pal	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44906
2.13402789352063e-30	-0.418392210416546	0.892	0.968	3.37347129407741e-26	EMC4	Malignant cells	GSE131984_Pal	ENSG00000128463	51234	ER membrane protein complex subunit 4	FLJ90746|MGC24415|PIG17|TMEM85	protein_coding	Q5J8M3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44907
3.14714850047809e-30	-0.427108878833097	0.968	0.98	4.97501234955576e-26	CDC42	Malignant cells	GSE131984_Pal	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44908
3.96837451873897e-30	-0.597918900077901	0.343	0.595	6.27320643922256e-26	EIF4A3	Malignant cells	GSE131984_Pal	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44909
4.06426340688522e-30	-0.455668134024452	0.648	0.831	6.42478759360416e-26	SPATS2L	Malignant cells	GSE131984_Pal	ENSG00000196141	26010	spermatogenesis associated serine rich 2 like	DNAPTP6|SGNP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44910
4.13022216558494e-30	0.349485343503315	0.296	0.09	6.52905519935667e-26	GPAM	Malignant cells	GSE131984_Pal	ENSG00000119927	57678	glycerol-3-phosphate acyltransferase, mitochondrial	GPAT1|KIAA1560|MGC26846	protein_coding	Q9HCL2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44911
4.32414094408764e-30	-0.51802148759203	0.623	0.789	6.83560200441375e-26	SAC3D1	Malignant cells	GSE131984_Pal	ENSG00000168061	29901	SAC3 domain containing 1	HSU79266|SHD1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44912
4.67096940092455e-30	-0.524491848994176	0.442	0.664	7.38386842898152e-26	GALE	Malignant cells	GSE131984_Pal	ENSG00000117308	2582	UDP-galactose-4-epimerase	SDR1E1	protein_coding	Q14376	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44913
4.71266554555662e-30	-0.488452720766222	0.293	0.559	7.44978169441591e-26	CLSPN	Malignant cells	GSE131984_Pal	ENSG00000092853	63967	claspin	NA	protein_coding	Q9HAW4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44914
5.46009553441075e-30	-0.46316226744243	0.749	0.877	8.63131902079651e-26	IMP3	Malignant cells	GSE131984_Pal	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44915
7.0733380189735e-30	-0.71449519721119	0.548	0.752	1.11815327403933e-25	H1F0	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44916
7.12034939802855e-30	-0.417480341928901	0.964	0.986	1.12558483284035e-25	VAPA	Malignant cells	GSE131984_Pal	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44917
7.91068249935739e-30	-0.307199373184371	1	1	1.25052068949842e-25	ARPC2	Malignant cells	GSE131984_Pal	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44918
8.19466748807113e-30	-0.526058064849187	0.462	0.685	1.29541303651428e-25	MAGOH	Malignant cells	GSE131984_Pal	ENSG00000162385	4116	mago homolog, exon junction complex subunit	MAGOH1|MAGOHA	protein_coding	P61326	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44919
8.51594124330633e-30	-0.354035363542844	0.986	1	1.34619999174186e-25	CYC1	Malignant cells	GSE131984_Pal	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44920
1.0611367284876e-29	-0.458258943657763	0.707	0.853	1.67744494039319e-25	AK2	Malignant cells	GSE131984_Pal	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44921
1.06579408830215e-29	0.500434588373738	0.939	0.816	1.68480729478804e-25	JUNB	Malignant cells	GSE131984_Pal	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44922
1.07258586204624e-29	0.485146251444109	0.857	0.704	1.69554373072269e-25	IFITM2	Malignant cells	GSE131984_Pal	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44923
1.14017985030078e-29	-0.495780655313761	0.641	0.818	1.80239630735547e-25	NXT1	Malignant cells	GSE131984_Pal	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44924
1.14865742769323e-29	0.484585416937908	0.623	0.381	1.81579766169745e-25	ITGAV	Malignant cells	GSE131984_Pal	ENSG00000138448	3685	integrin subunit alpha V	CD51|MSK8|VNRA|VTNR	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44925
1.19583725517615e-29	-0.541218803340302	0.711	0.856	1.89037953298245e-25	CDC123	Malignant cells	GSE131984_Pal	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44926
1.19680361635468e-29	0.441850638536631	0.645	0.391	1.89190715673347e-25	FAM229B	Malignant cells	GSE131984_Pal	ENSG00000203778	619208	family with sequence similarity 229 member B	C6orf225|DKFZp586F0922|LOC619208	protein_coding	Q4G0N7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44927
1.28175492786795e-29	-0.451985503568577	0.356	0.614	2.02619818997365e-25	YRDC	Malignant cells	GSE131984_Pal	ENSG00000196449	79693	yrdC N6-threonylcarbamoyltransferase domain containing	FLJ23476|IRIP|SUA5	protein_coding	Q86U90	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44928
1.3133415468133e-29	-0.455557494531917	0.739	0.872	2.07613031720246e-25	TARS	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44929
1.48209582345795e-29	-0.512682681703623	0.522	0.725	2.34289707772232e-25	EMG1	Malignant cells	GSE131984_Pal	ENSG00000126749	10436	EMG1 N1-specific pseudouridine methyltransferase	C2F|Grcc2f|NEP1	protein_coding	Q92979	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44930
1.57285192893807e-29	-0.505667702672562	0.864	0.916	2.4863643292653e-25	TCEAL4	Malignant cells	GSE131984_Pal	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44931
1.67519654835782e-29	0.379393925691549	0.33	0.117	2.64815070364404e-25	PIK3R3	Malignant cells	GSE131984_Pal	ENSG00000117461	8503	phosphoinositide-3-kinase regulatory subunit 3	p55	protein_coding	Q92569	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44932
1.67567176856632e-29	-0.555963621634661	0.444	0.664	2.64890193174964e-25	CDCA4	Malignant cells	GSE131984_Pal	ENSG00000170779	55038	cell division cycle associated 4	FLJ20764|Hepp	protein_coding	Q9BXL8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44933
2.03877937444891e-29	-0.545393009285956	0.672	0.811	3.22290243512884e-25	FDPS	Malignant cells	GSE131984_Pal	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44934
2.24366128918832e-29	-0.469652631594374	0.983	0.998	3.54677976594889e-25	HSPD1	Malignant cells	GSE131984_Pal	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44935
2.5880566104878e-29	-0.450864810036776	0.769	0.894	4.09119988985912e-25	RAB2A	Malignant cells	GSE131984_Pal	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44936
2.6764091993763e-29	-0.419421427301328	0.968	0.993	4.23086766237406e-25	SSBP1	Malignant cells	GSE131984_Pal	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44937
2.83267093548778e-29	-0.423693238662002	0.752	0.875	4.47788621481908e-25	IER3IP1.1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44938
3.04225372385105e-29	0.506002103554609	0.564	0.322	4.80919468666374e-25	CSF1	Malignant cells	GSE131984_Pal	ENSG00000184371	1435	colony stimulating factor 1	M-CSF|MCSF|MGC31930	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44939
3.39214594798352e-29	-0.475108438153023	0.413	0.658	5.36230431457235e-25	GNPNAT1	Malignant cells	GSE131984_Pal	ENSG00000100522	64841	glucosamine-phosphate N-acetyltransferase 1	FLJ10607|Gpnat1	protein_coding	Q96EK6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44940
3.46373977096907e-29	-0.315629905401348	1	1	5.47547982994791e-25	SNRPE	Malignant cells	GSE131984_Pal	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44941
4.32679566093462e-29	-0.490502172890455	0.514	0.719	6.83979858080545e-25	GAR1	Malignant cells	GSE131984_Pal	ENSG00000109534	54433	GAR1 ribonucleoprotein	NOLA1	protein_coding	Q9NY12	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44942
5.24178084133705e-29	-0.509282905156267	0.772	0.899	8.28620715398562e-25	MCTS1	Malignant cells	GSE131984_Pal	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44943
5.40049729918961e-29	-0.381601665882545	0.964	0.989	8.53710613055893e-25	TMED2	Malignant cells	GSE131984_Pal	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44944
6.11182962074812e-29	-0.391888834472699	0.938	0.977	9.66158026447863e-25	GLRX5	Malignant cells	GSE131984_Pal	ENSG00000182512	51218	glutaredoxin 5	C14orf87|GRX5|PR01238	protein_coding	Q86SX6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44945
6.30276195710088e-29	0.498171179503839	0.965	0.897	9.96340610178507e-25	CEBPD	Malignant cells	GSE131984_Pal	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44946
6.35577202534676e-29	-0.360277917455189	0.945	0.977	1.00472044176682e-24	MTCH2	Malignant cells	GSE131984_Pal	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44947
6.76033045408008e-29	-0.505463225263362	0.696	0.844	1.06867303818098e-24	PSMC3	Malignant cells	GSE131984_Pal	ENSG00000165916	5702	proteasome 26S subunit, ATPase 3	RPT5|TBP-1|TBP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44948
8.60470313480647e-29	-0.461901775975429	0.494	0.709	1.36023147155021e-24	LLPH	Malignant cells	GSE131984_Pal	ENSG00000139233	84298	LLP homolog, long-term synaptic facilitation factor	C12orf31|hLLP|MGC14817	protein_coding	Q9BRT6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44949
9.19764680938826e-29	-0.372062344283741	0.981	0.993	1.4539640076281e-24	TCEB1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44950
9.56092834628508e-29	-0.525249282406895	0.645	0.788	1.51139155298075e-24	EIF2S1	Malignant cells	GSE131984_Pal	ENSG00000134001	1965	eukaryotic translation initiation factor 2 subunit alpha	EIF-2alpha|EIF2|EIF2A	protein_coding	P05198	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44951
1.13070034874652e-28	0.368180387888691	0.416	0.182	1.7874111112985e-24	LAMA5	Malignant cells	GSE131984_Pal	ENSG00000130702	3911	laminin subunit alpha 5	NA	protein_coding	O15230	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44952
1.13388809608219e-28	-0.408374340801872	0.874	0.937	1.79245030228673e-24	H2AFY	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44953
1.1623309416238e-28	-0.506933995648943	0.58	0.757	1.8374127525189e-24	SSSCA1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44954
1.19279582006317e-28	0.502344566525981	0.742	0.553	1.88557163235587e-24	ELL2	Malignant cells	GSE131984_Pal	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44955
1.20750164146842e-28	-0.43614447227034	0.937	0.982	1.90881859483328e-24	PSMA1	Malignant cells	GSE131984_Pal	ENSG00000129084	5682	proteasome 20S subunit alpha 1	HC2|MGC14542|MGC14575|MGC14751|MGC1667|MGC21459|MGC22853|MGC23915|NU|PROS30	protein_coding	P25786	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44956
1.21220308885236e-28	-0.426207136177906	0.903	0.967	1.9162506428578e-24	UBE2E3	Malignant cells	GSE131984_Pal	ENSG00000170035	10477	ubiquitin conjugating enzyme E2 E3	UbcH9	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44957
1.49981385394175e-28	0.401479477067974	0.473	0.237	2.37090574031111e-24	GNS	Malignant cells	GSE131984_Pal	ENSG00000135677	2799	glucosamine (N-acetyl)-6-sulfatase	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44958
1.60439869215658e-28	-0.480936345052498	0.476	0.698	2.53623345256112e-24	PLEK2	Malignant cells	GSE131984_Pal	ENSG00000100558	26499	pleckstrin 2	NA	protein_coding	Q9NYT0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44959
1.96616926712065e-28	-0.479089008442177	0.439	0.657	3.10812037746433e-24	EXOSC3	Malignant cells	GSE131984_Pal	ENSG00000107371	51010	exosome component 3	CGI-102|hRrp-40|hRrp40p|p10|RRP40|Rrp40p	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44960
2.05371140265963e-28	-0.555337188410924	0.739	0.837	3.24650698532434e-24	SH3KBP1	Malignant cells	GSE131984_Pal	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44961
2.09208790788642e-28	0.423675056441973	0.531	0.281	3.30717256478685e-24	HSBP1L1	Malignant cells	GSE131984_Pal	ENSG00000226742	440498	heat shock factor binding protein 1 like 1	FLJ10967|MGC189743	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44962
2.51540716284563e-28	-0.44309317058719	0.348	0.597	3.97635564302637e-24	EIF2B1	Malignant cells	GSE131984_Pal	ENSG00000111361	1967	eukaryotic translation initiation factor 2B subunit alpha	EIF-2B|EIF-2Balpha|EIF2B|EIF2BA|EIF2Balpha	protein_coding	Q14232	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44963
2.67192630960787e-28	0.439282950380241	0.799	0.596	4.22378111022813e-24	TAPBP	Malignant cells	GSE131984_Pal	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44964
2.76860851113089e-28	-0.337945829925992	1	1	4.37661633439572e-24	SLC25A5	Malignant cells	GSE131984_Pal	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44965
2.86928154305821e-28	0.318488483067321	0.297	0.095	4.53576026326642e-24	MRC2	Malignant cells	GSE131984_Pal	ENSG00000011028	9902	mannose receptor C type 2	CD280|CLEC13E|ENDO180|KIAA0709	protein_coding	Q9UBG0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44966
3.02307555639058e-28	0.453549852024004	0.593	0.361	4.77887783954223e-24	VEGFA	Malignant cells	GSE131984_Pal	ENSG00000112715	7422	vascular endothelial growth factor A	VEGF|VEGF-A|VPF	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44967
3.02688901945118e-28	-0.504486503163091	0.599	0.767	4.78490616194843e-24	DNAJC9	Malignant cells	GSE131984_Pal	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44968
3.09435066535909e-28	-0.46634585138479	0.693	0.828	4.89154953179966e-24	NOSIP	Malignant cells	GSE131984_Pal	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44969
3.11728146758733e-28	-0.705606643616085	0.587	0.773	4.92779854396205e-24	CCNB1	Malignant cells	GSE131984_Pal	ENSG00000134057	891	cyclin B1	CCNB	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44970
3.17149152128815e-28	-0.468901382892108	0.263	0.509	5.01349379685231e-24	PSMC3IP	Malignant cells	GSE131984_Pal	ENSG00000131470	29893	PSMC3 interacting protein	GT198|Hop2|HUMGT198A|TBPIP	protein_coding	Q9P2W1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44971
3.81679864875337e-28	-0.393189306270978	0.918	0.977	6.03359530394933e-24	PPP1CA	Malignant cells	GSE131984_Pal	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44972
4.26194264131546e-28	-0.297707668814189	0.999	1	6.73727892739148e-24	HMGN1	Malignant cells	GSE131984_Pal	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44973
4.31859051973658e-28	-0.581100996554192	0.449	0.663	6.82682789359959e-24	MAD2L1	Malignant cells	GSE131984_Pal	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44974
4.32458795480567e-28	-0.51891771971163	0.841	0.937	6.8363086389568e-24	MANF	Malignant cells	GSE131984_Pal	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44975
4.3348613687041e-28	-0.526785148912237	0.74	0.856	6.85254885164745e-24	DNAJA1	Malignant cells	GSE131984_Pal	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44976
4.6357166347715e-28	-0.500584267124844	0.55	0.75	7.32814085624679e-24	DNAJB11	Malignant cells	GSE131984_Pal	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44977
4.8937676631621e-28	-0.532175727571743	0.554	0.73	7.73606792192664e-24	PSMC4	Malignant cells	GSE131984_Pal	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44978
5.65023732343632e-28	0.493800374510454	0.332	0.123	8.93189516088814e-24	PDPN	Malignant cells	GSE131984_Pal	ENSG00000162493	10630	podoplanin	aggrus|D2-40|Gp38|GP40|PA2.26|T1A-2	protein_coding	Q86YL7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44979
6.36856954184939e-28	-0.459503182666226	0.183	0.43	1.00674347317555e-23	SFTA1P	Malignant cells	GSE131984_Pal	ENSG00000225383	207107	surfactant associated 1, lncRNA	SFTPF	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44980
6.57115912392089e-28	-0.443578667674995	0.802	0.909	1.03876883430941e-23	HNRNPM	Malignant cells	GSE131984_Pal	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44981
6.8553219783899e-28	-0.502803937030408	0.439	0.672	1.08368929834388e-23	ACAT2	Malignant cells	GSE131984_Pal	ENSG00000120437	39	acetyl-CoA acetyltransferase 2	NA	protein_coding	Q9BWD1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44982
7.43320063407537e-28	-0.443202708279527	0.733	0.861	1.17504035623463e-23	EZR	Malignant cells	GSE131984_Pal	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44983
8.69395061613059e-28	0.418418445915342	0.439	0.211	1.37433971339792e-23	EPAS1	Malignant cells	GSE131984_Pal	ENSG00000116016	2034	endothelial PAS domain protein 1	bHLHe73|HIF2A|HLF|MOP2|PASD2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44984
8.76401019871862e-28	0.551105201584165	0.674	0.467	1.38541473221344e-23	DUSP5	Malignant cells	GSE131984_Pal	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44985
8.80077829781979e-28	0.343071722684617	0.31	0.105	1.39122703331935e-23	CXXC5	Malignant cells	GSE131984_Pal	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44986
9.57651465125431e-28	-0.419242813047679	0.797	0.899	1.51385543607028e-23	RBM17	Malignant cells	GSE131984_Pal	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44987
1.07773965196197e-27	-0.416859519729309	0.84	0.923	1.70369084182148e-23	WDR1	Malignant cells	GSE131984_Pal	ENSG00000071127	9948	WD repeat domain 1	AIP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44988
1.22880263307637e-27	-0.445530930555414	0.886	0.948	1.94249120236713e-23	SDHB	Malignant cells	GSE131984_Pal	ENSG00000117118	6390	succinate dehydrogenase complex iron sulfur subunit B	SDH|SDH1	protein_coding	P21912	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44989
1.42648649835892e-27	-0.311417672611079	0.999	0.999	2.25498985660579e-23	SEC61G	Malignant cells	GSE131984_Pal	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44990
1.49991097666022e-27	-0.449927549917067	0.782	0.88	2.37105927190447e-23	CMSS1	Malignant cells	GSE131984_Pal	ENSG00000184220	84319	cms1 ribosomal small subunit homolog	C3orf26|MGC4308	protein_coding	Q9BQ75	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44991
1.57068392295327e-27	-0.430627606173762	0.244	0.485	2.48293714540454e-23	CCDC86	Malignant cells	GSE131984_Pal	ENSG00000110104	79080	coiled-coil domain containing 86	cyclon|MGC2574	protein_coding	Q9H6F5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44992
1.83632335923767e-27	-0.466080117069479	0.44	0.656	2.90285996628291e-23	POLR2C	Malignant cells	GSE131984_Pal	ENSG00000102978	5432	RNA polymerase II subunit C	RPB3	protein_coding	P19387	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44993
1.85814849287751e-27	-0.325452443136302	0.994	0.997	2.93736113754077e-23	EIF2S2	Malignant cells	GSE131984_Pal	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44994
1.99128952982112e-27	-0.391850193660431	0.905	0.956	3.14783048874123e-23	NAA20	Malignant cells	GSE131984_Pal	ENSG00000173418	51126	N-alpha-acetyltransferase 20, NatB catalytic subunit	dJ1002M8.1|NAT3|NAT5	protein_coding	P61599	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44995
2.08643352923618e-27	-0.520332226686223	0.677	0.847	3.29823412301655e-23	SMC4	Malignant cells	GSE131984_Pal	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44996
2.40874047009791e-27	-0.513318823220153	0.457	0.664	3.80773693513078e-23	NDUFAF4	Malignant cells	GSE131984_Pal	ENSG00000123545	29078	NADH:ubiquinone oxidoreductase complex assembly factor 4	bA22L21.1|C6orf66|HRPAP20|HSPC125|My013	protein_coding	Q9P032	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44997
2.42004175648921e-27	-0.525443600580051	0.434	0.641	3.82560200865814e-23	HSPH1	Malignant cells	GSE131984_Pal	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44998
2.45974477436331e-27	-0.591016912488033	0.374	0.602	3.88836453931353e-23	CD9	Malignant cells	GSE131984_Pal	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	44999
3.05308929542808e-27	0.487352118749477	0.788	0.621	4.8263235582127e-23	DPYSL2	Malignant cells	GSE131984_Pal	ENSG00000092964	1808	dihydropyrimidinase like 2	CRMP2|DHPRP2|DRP-2|DRP2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45000
3.5058774048536e-27	0.464750279272869	0.631	0.418	5.54209100159256e-23	NAMPT	Malignant cells	GSE131984_Pal	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45001
3.55257026363462e-27	-0.396756129740427	0.861	0.953	5.61590307275361e-23	NDUFAF3	Malignant cells	GSE131984_Pal	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45002
3.59137598136589e-27	-0.389265315547438	0.983	0.995	5.67724715134319e-23	CAV1	Malignant cells	GSE131984_Pal	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45003
3.80939611283129e-27	-0.330955099102379	0.99	0.999	6.0218933751637e-23	TIMM13	Malignant cells	GSE131984_Pal	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45004
4.71954653824588e-27	0.505519236872412	0.844	0.673	7.46065916765909e-23	CCNL1	Malignant cells	GSE131984_Pal	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45005
5.09650841671572e-27	0.471607328480557	0.649	0.425	8.05656050514421e-23	KLF10	Malignant cells	GSE131984_Pal	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45006
5.54809107728347e-27	0.466877636651398	0.962	0.931	8.7704223749697e-23	SLC38A2	Malignant cells	GSE131984_Pal	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45007
5.67365393672371e-27	-0.340952802845368	0.983	0.997	8.96891214317284e-23	TRMT112	Malignant cells	GSE131984_Pal	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45008
6.47211891945641e-27	-0.450470157236278	0.837	0.905	1.02311255878767e-22	SNRPB2	Malignant cells	GSE131984_Pal	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45009
6.85510857762268e-27	-0.495045448128745	0.511	0.705	1.08365556395059e-22	MAGOHB	Malignant cells	GSE131984_Pal	ENSG00000111196	55110	mago homolog B, exon junction complex subunit	FLJ10292|MGN2	protein_coding	Q96A72	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45010
7.03342888318993e-27	-0.378935645945656	0.863	0.937	1.11184443785467e-22	MTCH1	Malignant cells	GSE131984_Pal	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45011
7.35897329441533e-27	-0.402297843765427	0.198	0.435	1.16330649838118e-22	RRP9	Malignant cells	GSE131984_Pal	ENSG00000114767	9136	ribosomal RNA processing 9, U3 small nucleolar RNA binding protein	RNU3IP2|U3-55K	protein_coding	O43818	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45012
8.05208944213437e-27	-0.462949749905964	0.661	0.833	1.2728742990126e-22	NANS	Malignant cells	GSE131984_Pal	ENSG00000095380	54187	N-acetylneuraminate synthase	SAS	protein_coding	Q9NR45	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45013
9.58233539695468e-27	-0.437940220448542	0.691	0.84	1.5147755795506e-22	MRPL28	Malignant cells	GSE131984_Pal	ENSG00000086504	10573	mitochondrial ribosomal protein L28	MAAT1|p15	protein_coding	Q13084	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45014
1.05163385010087e-26	-0.386731368046486	0.911	0.972	1.66242279023945e-22	ARPC5	Malignant cells	GSE131984_Pal	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45015
1.19874153542571e-26	-0.460680190829132	0.75	0.864	1.89497061920095e-22	MLLT11	Malignant cells	GSE131984_Pal	ENSG00000213190	10962	MLLT11 transcription factor 7 cofactor	AF1Q	protein_coding	Q13015	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45016
1.22003516715034e-26	0.56615915672195	0.88	0.8	1.92863159223125e-22	XIST	Malignant cells	GSE131984_Pal	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45017
1.24080836420311e-26	-0.445794928331163	0.364	0.598	1.96146986213228e-22	PRPS2	Malignant cells	GSE131984_Pal	ENSG00000101911	5634	phosphoribosyl pyrophosphate synthetase 2	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45018
1.25811272029675e-26	-0.51564626070376	0.424	0.652	1.9888245882451e-22	PBDC1	Malignant cells	GSE131984_Pal	ENSG00000102390	51260	polysaccharide biosynthesis domain containing 1	CXorf26|MGC874	protein_coding	Q9BVG4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45019
1.26328761042383e-26	-0.428030332478795	0.782	0.895	1.99700505455798e-22	SELT	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45020
1.27941724215321e-26	0.509318491795395	0.915	0.806	2.02250277639579e-22	CYBA	Malignant cells	GSE131984_Pal	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45021
1.28262436952816e-26	-0.499287230511643	0.885	0.946	2.02757260335011e-22	SSB	Malignant cells	GSE131984_Pal	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45022
1.44139863251311e-26	-0.333757700043365	0.991	0.995	2.27856295827673e-22	UQCRFS1	Malignant cells	GSE131984_Pal	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45023
1.48637474199711e-26	-0.344886921436354	0.96	0.989	2.34966119214903e-22	MRPS15	Malignant cells	GSE131984_Pal	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45024
1.78712762979278e-26	0.41203297049176	0.772	0.567	2.82509135717643e-22	NPDC1	Malignant cells	GSE131984_Pal	ENSG00000107281	56654	neural proliferation, differentiation and control 1	CAB-|CAB1|DKFZp586J0523	protein_coding	Q9NQX5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45025
2.15464901668202e-26	-0.35151105510637	0.981	0.992	3.40606916557093e-22	ANP32B	Malignant cells	GSE131984_Pal	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45026
2.37044195979039e-26	-0.444700128943242	0.802	0.903	3.74719465003665e-22	NOP56	Malignant cells	GSE131984_Pal	ENSG00000101361	10528	NOP56 ribonucleoprotein	NOL5A|SCA36	protein_coding	O00567	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45027
2.74775020268589e-26	-0.385502601222449	0.879	0.963	4.34364352040585e-22	COX20	Malignant cells	GSE131984_Pal	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45028
2.77973182376422e-26	-0.426045264178956	0.648	0.831	4.39420006700648e-22	TIMM17B	Malignant cells	GSE131984_Pal	ENSG00000126768	10245	translocase of inner mitochondrial membrane 17B	DXS9822|JM3	protein_coding	O60830	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45029
2.95417011714335e-26	-0.402919654299858	0.319	0.566	4.66995212118021e-22	ACYP1	Malignant cells	GSE131984_Pal	ENSG00000119640	97	acylphosphatase 1	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45030
3.05048718918994e-26	-0.375402011253479	0.908	0.961	4.82221014867146e-22	SSNA1	Malignant cells	GSE131984_Pal	ENSG00000176101	8636	SS nuclear autoantigen 1	N14|NA14	protein_coding	O43805	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45031
3.40198757400082e-26	0.407963824050586	0.446	0.221	5.3778619569805e-22	SDC3	Malignant cells	GSE131984_Pal	ENSG00000162512	9672	syndecan 3	N-syndecan|SYND3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45032
3.47768790869857e-26	-0.437326926056391	0.782	0.908	5.4975290460707e-22	SNRPA1	Malignant cells	GSE131984_Pal	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45033
3.647032052368e-26	-0.388358771428381	0.937	0.967	5.76522826838334e-22	PDIA6	Malignant cells	GSE131984_Pal	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45034
4.02906808362283e-26	-0.502898551523809	0.447	0.662	6.36915082659097e-22	ACOT9	Malignant cells	GSE131984_Pal	ENSG00000123130	23597	acyl-CoA thioesterase 9	ACATE2|CGI-16|MT-ACT48	protein_coding	Q9Y305	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45035
4.07491013505754e-26	-0.561298190789262	0.915	0.957	6.44161794149896e-22	PSMA4	Malignant cells	GSE131984_Pal	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45036
4.51141557113149e-26	-0.394290618492434	0.801	0.903	7.13164573484465e-22	ZNF593	Malignant cells	GSE131984_Pal	ENSG00000142684	51042	zinc finger protein 593	ZT86	protein_coding	O00488	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45037
4.85045288788859e-26	-0.433271447361559	0.709	0.843	7.66759592517428e-22	ADSL	Malignant cells	GSE131984_Pal	ENSG00000239900	158	adenylosuccinate lyase	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45038
4.93458513914616e-26	0.36372088091432	0.999	0.985	7.80059218796224e-22	CD44	Malignant cells	GSE131984_Pal	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45039
5.20525571332235e-26	-0.477316577140314	0.426	0.645	8.22846823161997e-22	NMT2	Malignant cells	GSE131984_Pal	ENSG00000152465	9397	N-myristoyltransferase 2	NA	protein_coding	O60551	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45040
6.12664207564018e-26	0.454480168483988	0.756	0.559	9.68499579317199e-22	MSRB2	Malignant cells	GSE131984_Pal	ENSG00000148450	22921	methionine sulfoxide reductase B2	CBS-1|CBS1|CGI-131|MSRB|PILB	protein_coding	Q9Y3D2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45041
6.27005882507384e-26	-0.497123748930931	0.486	0.69	9.91170899067673e-22	GRPEL1	Malignant cells	GSE131984_Pal	ENSG00000109519	80273	GrpE like 1, mitochondrial	FLJ25609|GrpE|hMGE	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45042
6.67823434387807e-26	0.503769310356432	0.893	0.816	1.05569528508025e-21	PSAP	Malignant cells	GSE131984_Pal	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45043
6.91162265117017e-26	-0.398012037042342	0.872	0.932	1.09258930869698e-21	HNRNPR	Malignant cells	GSE131984_Pal	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45044
6.98356743608126e-26	-0.411563029575973	0.785	0.88	1.10396234029573e-21	MRPL42	Malignant cells	GSE131984_Pal	ENSG00000198015	28977	mitochondrial ribosomal protein L42	HSPC204|MRP-L31|MRPL31|MRPS32|PTD007|RPML31	protein_coding	Q9Y6G3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45045
7.67685890029966e-26	-0.592230427395604	0.397	0.627	1.21355785495937e-21	SCG5	Malignant cells	GSE131984_Pal	ENSG00000277614	6447	secretogranin V	7B2|SGNE1|SgV	protein_coding	P05408	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45046
7.83219655596313e-26	-0.397634949417543	0.734	0.869	1.23811363156665e-21	FDX1	Malignant cells	GSE131984_Pal	ENSG00000137714	2230	ferredoxin 1	ADX|FDX	protein_coding	P10109	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45047
1.00403342743277e-25	-0.418112531013702	0.645	0.811	1.58717604208573e-21	TMA16	Malignant cells	GSE131984_Pal	ENSG00000198498	55319	translation machinery associated 16 homolog	C4orf43|FLJ11184	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45048
1.00863586464447e-25	-0.465801206566595	0.618	0.777	1.59445157482998e-21	ALG5	Malignant cells	GSE131984_Pal	ENSG00000120697	29880	ALG5 dolichyl-phosphate beta-glucosyltransferase	bA421P11.2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45049
1.01345945334992e-25	0.371640874881388	0.387	0.172	1.60207670385556e-21	TSHZ2	Malignant cells	GSE131984_Pal	ENSG00000182463	128553	teashirt zinc finger homeobox 2	C20orf17|OVC10-2|TSH2|ZABC2|ZNF218	protein_coding	Q9NRE2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45050
1.06439692383355e-25	-0.444020469598224	0.33	0.581	1.68259865719608e-21	PEG10	Malignant cells	GSE131984_Pal	ENSG00000242265	23089	paternally expressed 10	HB-1|KIAA1051|Mar2|Mart2|MEF3L|RGAG3|RTL2|SIRH1	protein_coding	Q86TG7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45051
1.16059461773155e-25	-0.300445649624319	0.988	0.996	1.83466797171003e-21	MRPL14	Malignant cells	GSE131984_Pal	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45052
1.17749617745631e-25	-0.27387052211517	1	1	1.86138595732293e-21	ATP5G3	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45053
1.19032364774091e-25	-0.407846755284527	0.994	0.996	1.88166362234884e-21	C1QBP	Malignant cells	GSE131984_Pal	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45054
1.27750952790945e-25	-0.395534569755943	0.812	0.911	2.01948706171925e-21	PRRC2C	Malignant cells	GSE131984_Pal	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45055
1.31743859770839e-25	-0.388174259469082	0.384	0.622	2.08260693525742e-21	TIMM23	Malignant cells	GSE131984_Pal	ENSG00000265354	100287932	translocase of inner mitochondrial membrane 23	TIM23	protein_coding	O14925	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45056
1.36404541791386e-25	-0.325666491487957	0.975	0.991	2.15628299663823e-21	PHB2	Malignant cells	GSE131984_Pal	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45057
1.4788364689009e-25	-0.331903877572332	0.994	0.997	2.33774469003855e-21	YWHAQ	Malignant cells	GSE131984_Pal	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45058
1.53502744598591e-25	-0.468966285259495	0.558	0.737	2.42657138661453e-21	EIF4E	Malignant cells	GSE131984_Pal	ENSG00000151247	1977	eukaryotic translation initiation factor 4E	EIF4E1|EIF4EL1|EIF4F	protein_coding	P06730	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45059
1.62640222287581e-25	-0.366584693025529	0.152	0.374	2.57101663392208e-21	SLC25A19	Malignant cells	GSE131984_Pal	ENSG00000125454	60386	solute carrier family 25 member 19	DNC|MCPHA|MUP1|TPC	protein_coding	Q9HC21	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45060
1.65424452508565e-25	0.429148911476053	0.659	0.437	2.6150297452554e-21	TIMP2	Malignant cells	GSE131984_Pal	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45061
1.73603539471241e-25	-0.493502373475483	0.812	0.885	2.74432475196137e-21	PSMD14	Malignant cells	GSE131984_Pal	ENSG00000115233	10213	proteasome 26S subunit, non-ATPase 14	pad1|POH1|Rpn11	protein_coding	O00487	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45062
1.97091628821912e-25	-0.416479530205964	0.747	0.879	3.11562446841678e-21	FAM127B	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45063
1.99370025793438e-25	-0.363552652877395	0.911	0.962	3.15164136774266e-21	POLD2	Malignant cells	GSE131984_Pal	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45064
2.21964722311987e-25	0.383084972116982	0.514	0.285	3.50881833030789e-21	DLG5	Malignant cells	GSE131984_Pal	ENSG00000274429	9231	discs large MAGUK scaffold protein 5	KIAA0583|P-dlg	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45065
2.41424723422336e-25	-0.445183895067457	0.853	0.926	3.81644202786029e-21	XRCC6	Malignant cells	GSE131984_Pal	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45066
2.4834399289442e-25	-0.420633602054703	0.67	0.842	3.92582183967499e-21	WBSCR22	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45067
2.60067982439483e-25	-0.345431559707129	0.947	0.985	4.11115466640335e-21	EIF5B	Malignant cells	GSE131984_Pal	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45068
2.76777436420189e-25	-0.446091234396319	0.518	0.708	4.37529771493035e-21	TMEM70	Malignant cells	GSE131984_Pal	ENSG00000175606	54968	transmembrane protein 70	FLJ20533	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45069
2.79571277675757e-25	-0.307816333090966	1	1	4.41946275749837e-21	VIM	Malignant cells	GSE131984_Pal	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45070
3.56288924576977e-25	-0.317673636451815	0.993	1	5.63221531971286e-21	ATP5G1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45071
3.68010245556276e-25	-0.313349404158584	0.997	0.994	5.81750596175361e-21	VDAC2	Malignant cells	GSE131984_Pal	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45072
3.72884309456569e-25	-0.386048766302184	0.89	0.956	5.89455516388945e-21	C20orf27	Malignant cells	GSE131984_Pal	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45073
3.74042822968688e-25	-0.47064400176184	0.274	0.526	5.91286894548902e-21	CDCA3	Malignant cells	GSE131984_Pal	ENSG00000111665	83461	cell division cycle associated 3	GRCC8|TOME-1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45074
3.78908282995736e-25	0.326086430042964	0.27	0.088	5.98978213759659e-21	SPOCK1	Malignant cells	GSE131984_Pal	ENSG00000152377	6695	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1	SPOCK|testican-1|TIC1	protein_coding	Q08629	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45075
4.00375155324345e-25	-0.366829749256735	0.892	0.94	6.32913045536724e-21	NUTF2	Malignant cells	GSE131984_Pal	ENSG00000102898	10204	nuclear transport factor 2	NTF2|PP15	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45076
4.09130111054507e-25	-0.405885018761411	0.999	1	6.46752879554965e-21	HSP90AB1	Malignant cells	GSE131984_Pal	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45077
4.4756276808669e-25	0.398211252135236	0.434	0.219	7.07507223791439e-21	LAMB1	Malignant cells	GSE131984_Pal	ENSG00000091136	3912	laminin subunit beta 1	CLM	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45078
4.60614576889648e-25	-0.778567044887952	0.447	0.66	7.28139523147155e-21	DKK1	Malignant cells	GSE131984_Pal	ENSG00000107984	22943	dickkopf WNT signaling pathway inhibitor 1	DKK-1|SK	protein_coding	O94907	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45079
6.01758290845995e-25	0.321528921110474	0.253	0.077	9.51259506169348e-21	RP11-91K9.1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45080
6.15008046833928e-25	-0.426354969594234	0.68	0.819	9.72204720435073e-21	RAB5C	Malignant cells	GSE131984_Pal	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45081
7.72909852395901e-25	-0.397080786185121	0.45	0.672	1.22181589466744e-20	SLC52A2	Malignant cells	GSE131984_Pal	ENSG00000285112	79581	solute carrier family 52 member 2	D15Ertd747e|FLJ11856|GPCR41|GPR172A|hRFT3|PAR1|RFVT2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45082
8.77561887073865e-25	-0.354464391367101	0.919	0.963	1.38724983108637e-20	ZC3H15	Malignant cells	GSE131984_Pal	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45083
9.14865686660425e-25	-0.436493885807642	0.557	0.744	1.4462196774728e-20	DNAJC2	Malignant cells	GSE131984_Pal	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45084
9.266274112423e-25	-0.430643135208687	0.364	0.59	1.46481261169183e-20	ACTL6A	Malignant cells	GSE131984_Pal	ENSG00000136518	86	actin like 6A	Actl6|Arp4|BAF53A|INO80K|SMARCN1	protein_coding	O96019	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45085
1.0124176989875e-24	-0.43330094030365	0.377	0.593	1.60042989855945e-20	SLC25A33	Malignant cells	GSE131984_Pal	ENSG00000171612	84275	solute carrier family 25 member 33	BMSC-MCP|MGC4399|PNC1	protein_coding	Q9BSK2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45086
1.13028185923126e-24	-0.464551121180032	0.69	0.821	1.78674956307278e-20	SBDS	Malignant cells	GSE131984_Pal	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45087
1.13228863108708e-24	-0.274775783355919	1	1	1.78992186802246e-20	PSMA7	Malignant cells	GSE131984_Pal	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45088
1.26843497602362e-24	-0.463304752826082	0.444	0.641	2.00514201009815e-20	STIP1	Malignant cells	GSE131984_Pal	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45089
1.27441284208749e-24	-0.395407596840314	0.786	0.879	2.01459182077191e-20	PAFAH1B3	Malignant cells	GSE131984_Pal	ENSG00000079462	5050	platelet activating factor acetylhydrolase 1b catalytic subunit 3	NA	protein_coding	Q15102	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45090
1.27833400745741e-24	-0.423494258466757	0.642	0.806	2.02079039898867e-20	PQBP1	Malignant cells	GSE131984_Pal	ENSG00000102103	10084	polyglutamine binding protein 1	MRX2|MRX55|MRXS3|MRXS8|RENS1|SHS	protein_coding	O60828	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45091
1.32784307366892e-24	-0.366696254312223	0.853	0.921	2.09905433085583e-20	LSM1	Malignant cells	GSE131984_Pal	ENSG00000175324	27257	LSM1 homolog, mRNA degradation associated	CASM|YJL124C	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45092
1.41004847216246e-24	-0.41942332620142	0.515	0.719	2.22900462479442e-20	NIPA2	Malignant cells	GSE131984_Pal	ENSG00000140157	81614	NIPA magnesium transporter 2	SLC57A2	protein_coding	Q8N8Q9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45093
1.5527150767843e-24	-0.380614866312817	0.227	0.458	2.45453199338063e-20	CHAC2	Malignant cells	GSE131984_Pal	ENSG00000143942	494143	ChaC glutathione specific gamma-glutamylcyclotransferase 2	GCG1	protein_coding	Q8WUX2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45094
1.66665773479395e-24	-0.377350548074151	0.737	0.853	2.63465254716227e-20	PFDN1	Malignant cells	GSE131984_Pal	ENSG00000113068	5201	prefoldin subunit 1	PFD1	protein_coding	O60925	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45095
2.10443200584791e-24	0.431674777544765	0.688	0.493	3.32668611484438e-20	IRF2BP2	Malignant cells	GSE131984_Pal	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45096
2.28311949798009e-24	-0.375792117172028	0.835	0.928	3.60915530240692e-20	FAM96A	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45097
2.41233023603858e-24	-0.328073396277266	0.983	0.99	3.81341163712978e-20	MORF4L1	Malignant cells	GSE131984_Pal	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45098
2.41629641107256e-24	0.393436274357129	0.903	0.794	3.81968136662351e-20	TTC3	Malignant cells	GSE131984_Pal	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45099
2.42837838922963e-24	0.398882046060381	0.736	0.516	3.83878055769419e-20	BHLHE40	Malignant cells	GSE131984_Pal	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45100
2.58719950245146e-24	-0.407405703330187	0.759	0.872	4.08984497347527e-20	DDX18	Malignant cells	GSE131984_Pal	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45101
2.61251389975807e-24	-0.440415336153246	0.993	1	4.12986197273756e-20	KRT7	Malignant cells	GSE131984_Pal	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45102
2.97594774976216e-24	-0.491970988935248	0.67	0.814	4.70437820282402e-20	INSIG1	Malignant cells	GSE131984_Pal	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45103
3.17253662934791e-24	-0.416529496843073	0.42	0.653	5.01514590367318e-20	CENPM	Malignant cells	GSE131984_Pal	ENSG00000100162	79019	centromere protein M	C22orf18|CENP-M|MGC861|Pane1	protein_coding	Q9NSP4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45104
3.26210311628439e-24	-0.402522401926983	0.531	0.733	5.15673260622237e-20	BRMS1	Malignant cells	GSE131984_Pal	ENSG00000174744	25855	BRMS1 transcriptional repressor and anoikis regulator	DKFZP564A063	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45105
3.41694922332082e-24	-0.39699119824688	0.834	0.926	5.40151333222555e-20	COPS6	Malignant cells	GSE131984_Pal	ENSG00000168090	10980	COP9 signalosome subunit 6	CSN6|MOV34-34KD	protein_coding	Q7L5N1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45106
4.11308150799388e-24	-0.435878347646079	0.687	0.817	6.50195924783673e-20	GTPBP6	Malignant cells	GSE131984_Pal	ENSG00000178605	8225	GTP binding protein 6 (putative)	FLJ20977|PGPL	protein_coding	O43824	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45107
4.16125814245274e-24	-0.32998619174669	0.99	0.994	6.57811687158929e-20	SSR2	Malignant cells	GSE131984_Pal	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45108
4.58453379604433e-24	-0.448998563888786	0.304	0.533	7.24723102478687e-20	PAK1IP1	Malignant cells	GSE131984_Pal	ENSG00000285226	55003	PAK1 interacting protein 1	bA421M1.5|FLJ20624|hPIP1|MAK11|PIP1|WDR84	protein_coding	Q9NWT1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45109
4.76624305242277e-24	0.408667669822336	0.491	0.272	7.53447701726992e-20	SEMA3C	Malignant cells	GSE131984_Pal	ENSG00000075223	10512	semaphorin 3C	SEMAE|SemE	protein_coding	Q99985	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45110
4.97608861287005e-24	-0.418171560696184	0.76	0.872	7.86620087922498e-20	VIMP	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45111
5.29970849156421e-24	0.449163079066782	0.869	0.731	8.3777791834647e-20	COL6A3	Malignant cells	GSE131984_Pal	ENSG00000163359	1293	collagen type VI alpha 3 chain	NA	protein_coding	P12111	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45112
5.68930242723179e-24	-0.485038274773363	0.244	0.479	8.99364927696802e-20	AURKB	Malignant cells	GSE131984_Pal	ENSG00000178999	9212	aurora kinase B	Aik2|AIM-1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5	protein_coding	Q96GD4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45113
6.10275614447923e-24	0.466433974312682	0.957	0.87	9.64723691319277e-20	CTSD	Malignant cells	GSE131984_Pal	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45114
6.28094952939948e-24	-0.40048204835324	0.672	0.809	9.92892501607469e-20	SLC39A1	Malignant cells	GSE131984_Pal	ENSG00000143570	27173	solute carrier family 39 member 1	ZIP1|ZIRTL	protein_coding	Q9NY26	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45115
6.87073138837996e-24	-0.417296165919333	0.626	0.782	1.0861252178751e-19	CMC2	Malignant cells	GSE131984_Pal	ENSG00000103121	56942	C-X9-C motif containing 2	C16orf61|DC13|MGC45036	protein_coding	Q9NRP2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45116
7.31599590862962e-24	-0.53865938928387	0.659	0.778	1.15651263323617e-19	HDAC2	Malignant cells	GSE131984_Pal	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45117
8.23685274746771e-24	-0.408468101024123	0.752	0.852	1.3020816823197e-19	FAM136A	Malignant cells	GSE131984_Pal	ENSG00000035141	84908	family with sequence similarity 136 member A	FLJ14668	protein_coding	Q96C01	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45118
8.33380056371637e-24	-0.34576959189382	0.899	0.95	1.31740719311228e-19	MRPL11	Malignant cells	GSE131984_Pal	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45119
8.57533779423783e-24	-0.482021219340938	0.954	0.959	1.35558939851312e-19	NFKBIA	Malignant cells	GSE131984_Pal	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45120
8.89353730528432e-24	-0.367337677925291	0.807	0.912	1.40589037721935e-19	CCDC124	Malignant cells	GSE131984_Pal	ENSG00000007080	115098	coiled-coil domain containing 124	Lso2|oxs1	protein_coding	Q96CT7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45121
9.17686728222596e-24	-0.441764289305562	0.463	0.667	1.45067917997428e-19	STK17A	Malignant cells	GSE131984_Pal	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45122
1.0292397617123e-23	-0.366162603679715	0.913	0.954	1.62702221531481e-19	KIF5B	Malignant cells	GSE131984_Pal	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45123
1.04148635932609e-23	-0.309648846703195	0.97	0.985	1.64638163682268e-19	PCBP1	Malignant cells	GSE131984_Pal	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45124
1.14190869260806e-23	0.469404250315175	0.545	0.328	1.80512926127482e-19	COL6A1	Malignant cells	GSE131984_Pal	ENSG00000142156	1291	collagen type VI alpha 1 chain	NA	protein_coding	P12109	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45125
1.19631331459031e-23	-0.274248092226093	1	1	1.89113208770436e-19	PFN1	Malignant cells	GSE131984_Pal	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45126
1.22282029504245e-23	-0.51227021580531	0.861	0.926	1.9330343224031e-19	PSMA3	Malignant cells	GSE131984_Pal	ENSG00000100567	5684	proteasome 20S subunit alpha 3	HC8	protein_coding	P25788	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45127
1.2314087504762e-23	0.362451703426727	0.53	0.302	1.94661095275278e-19	RNF130	Malignant cells	GSE131984_Pal	ENSG00000113269	55819	ring finger protein 130	G1RZFP|GOLIATH|GP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45128
1.46620865545744e-23	-0.28584503209959	0.996	1	2.31778264254712e-19	SNRPF	Malignant cells	GSE131984_Pal	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45129
1.50790425942158e-23	-0.411478032947801	0.786	0.874	2.38369505329363e-19	SYNCRIP	Malignant cells	GSE131984_Pal	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45130
1.63272328468525e-23	-0.319484343959089	0.968	0.994	2.58100896843045e-19	MDH2	Malignant cells	GSE131984_Pal	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45131
1.63956039613995e-23	-0.319270877635829	0.988	0.997	2.59181707421803e-19	KDELR2	Malignant cells	GSE131984_Pal	ENSG00000136240	11014	KDEL endoplasmic reticulum protein retention receptor 2	ELP-1|ERD2.2	protein_coding	P33947	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45132
1.73795682079255e-23	-0.389097656760532	0.32	0.55	2.74736214230886e-19	RRP1	Malignant cells	GSE131984_Pal	ENSG00000160214	8568	ribosomal RNA processing 1	D21S2056E|NNP-1|Nop52|RRP1A	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45133
1.77348220689844e-23	0.327417518977106	0.502	0.277	2.80352067266505e-19	TBC1D16	Malignant cells	GSE131984_Pal	ENSG00000167291	125058	TBC1 domain family member 16	FLJ20748|MGC25062	protein_coding	Q8TBP0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45134
1.79067990968962e-23	-0.401773770396932	0.377	0.599	2.83070680123735e-19	ENOPH1	Malignant cells	GSE131984_Pal	ENSG00000145293	58478	enolase-phosphatase 1	E1|MASA|mtnC	protein_coding	Q9UHY7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45135
1.87350547094957e-23	-0.401644812042331	0.567	0.762	2.96163744847708e-19	TROAP	Malignant cells	GSE131984_Pal	ENSG00000135451	10024	trophinin associated protein	TASTIN	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45136
1.89165935871473e-23	-0.341004477607677	0.913	0.957	2.99033511425624e-19	HDGF	Malignant cells	GSE131984_Pal	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45137
2.07207500867757e-23	0.291387251353034	0.33	0.134	3.27553617371751e-19	PTGFRN	Malignant cells	GSE131984_Pal	ENSG00000134247	5738	prostaglandin F2 receptor inhibitor	CD315|CD9P-1|EWI-F|FLJ11001|FPRP|KIAA1436|SMAP-6	protein_coding	Q9P2B2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45138
2.22789679695551e-23	-0.398934476027991	0.424	0.644	3.52185925662727e-19	TRAPPC4	Malignant cells	GSE131984_Pal	ENSG00000280495	51399	trafficking protein particle complex subunit 4	PTD009|SBDN|TRS23	protein_coding	Q9Y296	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45139
2.37119592443031e-23	-0.367544376365305	0.732	0.869	3.74838651733944e-19	RNASEH1	Malignant cells	GSE131984_Pal	ENSG00000171865	246243	ribonuclease H1	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45140
2.40912801141291e-23	-0.351018207477973	0.983	0.998	3.80834956044153e-19	RTN4	Malignant cells	GSE131984_Pal	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45141
2.47396765924084e-23	-0.317071634528873	0.954	0.984	3.91084807572792e-19	PDAP1	Malignant cells	GSE131984_Pal	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45142
2.54614876521155e-23	-0.424796056177779	0.313	0.538	4.02495196804642e-19	AC010642.1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45143
2.54888411624587e-23	0.430785445605163	0.551	0.337	4.02927601096147e-19	COL5A1	Malignant cells	GSE131984_Pal	ENSG00000130635	1289	collagen type V alpha 1 chain	NA	protein_coding	P20908	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45144
2.6458609862953e-23	-0.323123709960358	1	1	4.18257704713561e-19	ACTG1	Malignant cells	GSE131984_Pal	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45145
2.87415344511668e-23	-0.264582698749303	1	0.995	4.54346176604045e-19	POLR2L	Malignant cells	GSE131984_Pal	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45146
3.38224759991858e-23	-0.414873114252366	0.381	0.599	5.34665700595129e-19	RBM42	Malignant cells	GSE131984_Pal	ENSG00000126254	79171	RNA binding motif protein 42	MGC10433	protein_coding	Q9BTD8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45147
3.70361062000583e-23	-0.421901982908599	0.32	0.544	5.85466766810522e-19	TRIM7	Malignant cells	GSE131984_Pal	ENSG00000146054	81786	tripartite motif containing 7	GNIP|RNF90	protein_coding	Q9C029	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45148
3.79515565205073e-23	-0.393633535994222	0.544	0.727	5.9993820547618e-19	TMEM109	Malignant cells	GSE131984_Pal	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45149
3.88248387206316e-23	0.335763838552791	0.447	0.232	6.13743050495744e-19	PLXNB2	Malignant cells	GSE131984_Pal	ENSG00000196576	23654	plexin B2	KIAA0315|MM1|PLEXB2	protein_coding	O15031	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45150
4.04080664072002e-23	-0.450622746948898	0.468	0.665	6.38770713765021e-19	H2AFX	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45151
4.14587769924884e-23	-0.40231656703353	0.284	0.516	6.55380346697257e-19	GPSM2	Malignant cells	GSE131984_Pal	ENSG00000121957	29899	G protein signaling modulator 2	DFNB82|LGN|Pins	protein_coding	P81274	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45152
4.35143007375964e-23	-0.43053513979313	0.9	0.958	6.87874066059925e-19	CCT7	Malignant cells	GSE131984_Pal	ENSG00000135624	10574	chaperonin containing TCP1 subunit 7	Ccth|Nip7-1	protein_coding	Q99832	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45153
4.64294751692992e-23	-0.409428440467929	0.232	0.451	7.33957143476281e-19	CDC6	Malignant cells	GSE131984_Pal	ENSG00000094804	990	cell division cycle 6	CDC18L	protein_coding	Q99741	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45154
5.05060082029685e-23	-0.614178796282302	0.717	0.844	7.98398977672525e-19	ANXA1	Malignant cells	GSE131984_Pal	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45155
5.09976366707224e-23	0.290105263938708	0.277	0.1	8.0617064049078e-19	MUC1	Malignant cells	GSE131984_Pal	ENSG00000185499	4582	mucin 1, cell surface associated	ADMCKD|ADMCKD1|Ca15-3|CD227|EMA|KL-6|MCD|MCKD|MCKD1|PEM|PUM	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45156
5.24994395731204e-23	0.411861874691255	0.652	0.451	8.29911140771887e-19	MMP2	Malignant cells	GSE131984_Pal	ENSG00000087245	4313	matrix metallopeptidase 2	CLG4|CLG4A|TBE-1	protein_coding	P08253	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45157
5.26650262433474e-23	-0.382301945354192	0.75	0.87	8.32528734854835e-19	TMEM106C	Malignant cells	GSE131984_Pal	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45158
6.21885524922996e-23	-0.375440437143001	0.818	0.92	9.83076637798272e-19	MRPL22	Malignant cells	GSE131984_Pal	ENSG00000082515	29093	mitochondrial ribosomal protein L22	HSPC158|MRP-L25|RPML25	protein_coding	Q9NWU5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45159
6.27957144814084e-23	-0.357942320934936	0.201	0.427	9.92674654522103e-19	CD3EAP	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45160
6.77473346426962e-23	-0.441355835955966	0.557	0.739	1.07094986603174e-18	TRIP13	Malignant cells	GSE131984_Pal	ENSG00000071539	9319	thyroid hormone receptor interactor 13	16E1BP	protein_coding	Q15645	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45161
6.82325686480281e-23	-0.343648246945693	0.906	0.96	1.07862044518803e-18	MRPL34	Malignant cells	GSE131984_Pal	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45162
7.19528952003646e-23	-0.423568924953331	0.817	0.903	1.13743136732736e-18	CAV2	Malignant cells	GSE131984_Pal	ENSG00000105971	858	caveolin 2	CAV	protein_coding	P51636	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45163
7.80429627126368e-23	-0.504958101756641	0.677	0.817	1.23370315456136e-18	ARF4	Malignant cells	GSE131984_Pal	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45164
8.76233039286123e-23	-0.428571323114335	0.368	0.58	1.3851491885035e-18	EXOSC7	Malignant cells	GSE131984_Pal	ENSG00000075914	23016	exosome component 7	EAP1|hRrp42p|KIAA0116|p8|RRP42|Rrp42p	protein_coding	Q15024	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45165
9.14765179603506e-23	-0.261666017678465	0.997	0.999	1.44606079591722e-18	AURKAIP1	Malignant cells	GSE131984_Pal	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45166
9.91803106260398e-23	-0.428662064929263	0.444	0.64	1.56784235037644e-18	UPF3B	Malignant cells	GSE131984_Pal	ENSG00000125351	65109	UPF3B regulator of nonsense mediated mRNA decay	HUPF3B|MRX62|MRX82|RENT3B|UPF3BP1|UPF3BP2|UPF3BP3|UPF3X	protein_coding	Q9BZI7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45167
9.9425692007414e-23	-0.434025108854041	0.928	0.973	1.5717213392532e-18	HSP90B1	Malignant cells	GSE131984_Pal	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45168
1.15367233682598e-22	0.37913314967046	0.39	0.188	1.82372523005452e-18	ICAM1	Malignant cells	GSE131984_Pal	ENSG00000090339	3383	intercellular adhesion molecule 1	BB2|CD54	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45169
1.19926585162936e-22	-0.41860604302154	0.371	0.581	1.89579945825568e-18	RCC1	Malignant cells	GSE131984_Pal	ENSG00000180198	1104	regulator of chromosome condensation 1	CHC1	protein_coding	P18754	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45170
1.3163031396463e-22	-0.382779678034359	0.681	0.815	2.08081200315287e-18	LSM6	Malignant cells	GSE131984_Pal	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45171
1.3636514924808e-22	-0.434746120242298	0.71	0.843	2.15566027931366e-18	SPCS3	Malignant cells	GSE131984_Pal	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45172
1.37340110836009e-22	-0.42631366805704	0.418	0.633	2.17107247209563e-18	ZWINT	Malignant cells	GSE131984_Pal	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45173
1.45784998437565e-22	-0.41603462796222	0.665	0.798	2.30456925530103e-18	FAM58A	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45174
1.70855944697452e-22	0.441461364773683	0.677	0.475	2.70089077377732e-18	DUSP6	Malignant cells	GSE131984_Pal	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45175
1.92645301222e-22	-0.427161752859664	0.524	0.718	3.04533692171738e-18	ECHDC1	Malignant cells	GSE131984_Pal	ENSG00000093144	55862	ethylmalonyl-CoA decarboxylase 1	dJ351K20.2	protein_coding	Q9NTX5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45176
1.92772832246216e-22	0.303964584824539	0.302	0.12	3.04735293214819e-18	SH3BP2	Malignant cells	GSE131984_Pal	ENSG00000087266	6452	SH3 domain binding protein 2	CRBM|RES4-23	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45177
2.03740630215256e-22	-0.418634841169145	0.765	0.863	3.22073188244276e-18	RAB7A	Malignant cells	GSE131984_Pal	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45178
2.0682119403965e-22	-0.412356959481878	0.515	0.713	3.26942943537878e-18	C14orf119	Malignant cells	GSE131984_Pal	ENSG00000179933	55017	chromosome 14 open reading frame 119	FLJ20671	protein_coding	Q9NWQ9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45179
2.47869196260935e-22	-0.523907688657147	0.297	0.505	3.91831625449286e-18	SLC14A1	Malignant cells	GSE131984_Pal	ENSG00000141469	6563	solute carrier family 14 member 1 (Kidd blood group)	HsT1341|JK|RACH1|RACH2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45180
2.50972248518681e-22	-0.361576761976969	0.821	0.901	3.96736930458331e-18	TRA2B	Malignant cells	GSE131984_Pal	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45181
2.99575164766995e-22	-0.395397145694642	0.762	0.868	4.73568420463665e-18	COA6	Malignant cells	GSE131984_Pal	ENSG00000168275	388753	cytochrome c oxidase assembly factor 6	C1orf31	protein_coding	Q5JTJ3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45182
3.07058009685012e-22	-0.317410431312386	0.964	0.983	4.85397301710066e-18	HNRNPK	Malignant cells	GSE131984_Pal	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45183
4.22188224685593e-22	0.375309734898125	0.456	0.243	6.67395145582985e-18	SERTAD4-AS1	Malignant cells	GSE131984_Pal	ENSG00000280963	NA	NA	C1orf133	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45184
4.62689496621451e-22	-0.397905683047389	0.733	0.862	7.31419556259189e-18	RNH1	Malignant cells	GSE131984_Pal	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45185
4.6281620316297e-22	-0.43622757369543	0.258	0.477	7.31619853960023e-18	SPC25	Malignant cells	GSE131984_Pal	ENSG00000277909	57405	SPC25 component of NDC80 kinetochore complex	AD024|MGC22228|SPBC25	protein_coding	Q9HBM1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45186
4.73968160157423e-22	-0.396837670765505	0.462	0.653	7.49248867576854e-18	RFK	Malignant cells	GSE131984_Pal	ENSG00000135002	55312	riboflavin kinase	FLJ11149|RIFK	protein_coding	Q969G6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45187
4.91403668488693e-22	-0.436715553194393	0.553	0.733	7.76810919146926e-18	GNL3	Malignant cells	GSE131984_Pal	ENSG00000163938	26354	G protein nucleolar 3	C77032|E2IG3|MGC800|NS	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45188
4.91568118636885e-22	-0.288940709700349	0.984	0.995	7.77070881941187e-18	COTL1	Malignant cells	GSE131984_Pal	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45189
4.98589242100795e-22	-0.268756306247925	1	0.999	7.88169873912937e-18	RPL36A	Malignant cells	GSE131984_Pal	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45190
5.0950944093253e-22	-0.327107495106336	0.954	0.979	8.05432524226143e-18	BOLA3	Malignant cells	GSE131984_Pal	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45191
5.26944224928744e-22	-0.397696609714975	0.768	0.868	8.32993430767359e-18	PLIN3	Malignant cells	GSE131984_Pal	ENSG00000105355	10226	perilipin 3	M6PRBP1|PP17|TIP47	protein_coding	O60664	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45192
5.35355514193136e-22	-0.430296931885209	0.294	0.508	8.46289996836509e-18	SAP30	Malignant cells	GSE131984_Pal	ENSG00000164105	8819	Sin3A associated protein 30	NA	protein_coding	O75446	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45193
5.50740306138319e-22	-0.431484337589541	0.547	0.695	8.70610275943455e-18	DIMT1	Malignant cells	GSE131984_Pal	ENSG00000086189	27292	DIM1 rRNA methyltransferase and ribosome maturation factor	DIMT1L|HSA9761	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45194
5.63687564184774e-22	-0.401679072617437	0.939	0.975	8.91077301463291e-18	CCT4	Malignant cells	GSE131984_Pal	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45195
6.01753809115619e-22	-0.342504220385716	0.896	0.95	9.51252421449971e-18	POLDIP2	Malignant cells	GSE131984_Pal	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45196
7.40179626918201e-22	-0.352020555739222	0.931	0.962	1.17007595423229e-17	OSTC	Malignant cells	GSE131984_Pal	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45197
7.54101061989028e-22	-0.319210922513266	0.947	0.982	1.19208295879226e-17	DGUOK	Malignant cells	GSE131984_Pal	ENSG00000114956	1716	deoxyguanosine kinase	dGK	protein_coding	Q16854	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45198
7.80496479370178e-22	-0.386329597542537	0.74	0.851	1.23380883458838e-17	NABP2	Malignant cells	GSE131984_Pal	ENSG00000139579	79035	nucleic acid binding protein 2	hSSB1|MGC2731|OBFC2B|SOSS-B1|SSB1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45199
8.85835942991693e-22	-0.404377049213763	0.489	0.682	1.40032945868127e-17	ADK	Malignant cells	GSE131984_Pal	ENSG00000156110	132	adenosine kinase	AK	protein_coding	P55263	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45200
9.12761350673938e-22	0.413864069206552	0.719	0.556	1.44289314314536e-17	APP	Malignant cells	GSE131984_Pal	ENSG00000142192	351	amyloid beta precursor protein	AD1|alpha-sAPP	protein_coding	P05067	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45201
9.51158721936995e-22	-0.383348788867869	0.771	0.889	1.503591707638e-17	PTS	Malignant cells	GSE131984_Pal	ENSG00000150787	5805	6-pyruvoyltetrahydropterin synthase	PTPS	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45202
9.98206256816529e-22	-0.40326404038679	0.532	0.71	1.57796445077557e-17	HTATSF1	Malignant cells	GSE131984_Pal	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45203
1.10123715906493e-21	-0.516496610069057	0.473	0.65	1.74083570104985e-17	KCNMA1	Malignant cells	GSE131984_Pal	ENSG00000156113	3778	potassium calcium-activated channel subfamily M alpha 1	KCa1.1|mSLO1|SLO	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45204
1.1051754490238e-21	-0.439800424739426	0.395	0.579	1.74706134981682e-17	RPF1	Malignant cells	GSE131984_Pal	ENSG00000117133	80135	ribosome production factor 1 homolog	BXDC5	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45205
1.17468876432029e-21	-0.344917314178133	0.843	0.926	1.85694799863752e-17	TRAPPC3	Malignant cells	GSE131984_Pal	ENSG00000054116	27095	trafficking protein particle complex subunit 3	BET3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45206
1.19266351312652e-21	0.352654810476129	0.482	0.272	1.8853624815504e-17	TRIB1	Malignant cells	GSE131984_Pal	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45207
1.22775374591619e-21	-0.391103330137441	0.6	0.762	1.94083312154431e-17	NSFL1C	Malignant cells	GSE131984_Pal	ENSG00000088833	55968	NSFL1 cofactor	dJ776F14.1|p47|UBX1|UBXD10|UBXN2C	protein_coding	Q9UNZ2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45208
1.24294218843677e-21	-0.361492437953006	0.364	0.582	1.96484301148084e-17	MED8	Malignant cells	GSE131984_Pal	ENSG00000159479	112950	mediator complex subunit 8	ARC32|MGC17544|MGC19641	protein_coding	Q96G25	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45209
1.24879068803766e-21	-0.32604392973609	0.994	0.995	1.97408831964993e-17	YWHAB	Malignant cells	GSE131984_Pal	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45210
1.28723893647894e-21	-0.404611424170154	0.41	0.617	2.0348673107859e-17	C1orf35	Malignant cells	GSE131984_Pal	ENSG00000143793	79169	chromosome 1 open reading frame 35	MGC4174|MMTAG2	protein_coding	Q9BU76	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45211
1.40150891177247e-21	-0.335534141948364	0.814	0.917	2.21550528772992e-17	MRPL40	Malignant cells	GSE131984_Pal	ENSG00000185608	64976	mitochondrial ribosomal protein L40	MRP-L22|NLVCF	protein_coding	Q9NQ50	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45212
1.46385852428735e-21	-0.377155258508929	0.354	0.576	2.31406755519345e-17	RFC2	Malignant cells	GSE131984_Pal	ENSG00000049541	5982	replication factor C subunit 2	A1|RFC40	protein_coding	P35250	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45213
1.46707353878761e-21	-0.364643996324785	0.372	0.582	2.31914985011546e-17	TACO1	Malignant cells	GSE131984_Pal	ENSG00000136463	51204	translational activator of cytochrome c oxidase I	CCDC44	protein_coding	Q9BSH4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45214
1.55505233144864e-21	0.399713343565907	0.797	0.653	2.458226725554e-17	LINC00657	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45215
1.57164337023522e-21	-0.433912665909014	0.524	0.7	2.48445383966784e-17	MCM7	Malignant cells	GSE131984_Pal	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45216
1.64226676729711e-21	-0.397629157511817	0.345	0.554	2.59609530574327e-17	PPID	Malignant cells	GSE131984_Pal	ENSG00000171497	5481	peptidylprolyl isomerase D	CYP-40|CypD	protein_coding	Q08752	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45217
1.64505088146626e-21	0.283870211895597	0.306	0.125	2.60049643342187e-17	C1RL	Malignant cells	GSE131984_Pal	ENSG00000288124	51279	complement C1r subcomponent like	C1r-LP|C1RL1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45218
1.67439555328507e-21	-0.421004184733952	0.704	0.825	2.64688449063304e-17	NAE1	Malignant cells	GSE131984_Pal	ENSG00000159593	8883	NEDD8 activating enzyme E1 subunit 1	APP-BP1|APPBP1|ula-1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45219
1.81710850780494e-21	-0.328631940794055	0.89	0.96	2.87248512913805e-17	CIB1	Malignant cells	GSE131984_Pal	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45220
1.9460213217611e-21	-0.389853432607629	0.743	0.845	3.07627050543994e-17	COA3	Malignant cells	GSE131984_Pal	ENSG00000183978	28958	cytochrome c oxidase assembly factor 3	CCDC56|COX25|hCOA3|HSPC009|MITRAC12	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45221
2.00223583225159e-21	-0.399213928918778	0.556	0.719	3.16513440362331e-17	EXOSC4	Malignant cells	GSE131984_Pal	ENSG00000178896	54512	exosome component 4	FLJ20591|hRrp41p|p12A|RRP41|RRP41A|Rrp41p|SKI6|Ski6p	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45222
2.07951986320117e-21	-0.341679055350131	0.221	0.432	3.2873049997484e-17	NME6	Malignant cells	GSE131984_Pal	ENSG00000172113	10201	NME/NM23 nucleoside diphosphate kinase 6	IPIA-ALPHA|NM23-H6	protein_coding	O75414	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45223
2.08993202590016e-21	-0.385900202173261	0.762	0.853	3.30376454654298e-17	PPP4C	Malignant cells	GSE131984_Pal	ENSG00000149923	5531	protein phosphatase 4 catalytic subunit	PP4|PPX	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45224
2.2130159032675e-21	-0.387102337155228	0.566	0.735	3.49833553988527e-17	GLRX2	Malignant cells	GSE131984_Pal	ENSG00000023572	51022	glutaredoxin 2	bA101E13.1|GRX2	protein_coding	Q9NS18	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45225
2.31146577623147e-21	-0.329035649563421	0.948	0.979	3.65396509906671e-17	GHITM	Malignant cells	GSE131984_Pal	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45226
2.31576042424483e-21	0.439297455294564	0.72	0.54	3.66075407864623e-17	LPP	Malignant cells	GSE131984_Pal	ENSG00000145012	4026	LIM domain containing preferred translocation partner in lipoma	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45227
2.61612296131224e-21	-0.408407043086285	0.558	0.732	4.13556717724239e-17	SMC3	Malignant cells	GSE131984_Pal	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45228
3.0514582670898e-21	-0.372320524367086	0.773	0.879	4.82374522861556e-17	SNRNP70	Malignant cells	GSE131984_Pal	ENSG00000104852	6625	small nuclear ribonucleoprotein U1 subunit 70	RNPU1Z|RPU1|Snp1|SNRP70|U1-70K	protein_coding	P08621	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45229
3.42680671899984e-21	-0.408937250557576	0.626	0.773	5.41709606139495e-17	PPIF	Malignant cells	GSE131984_Pal	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45230
3.54186858262155e-21	-0.412384610922111	0.72	0.823	5.59898585540815e-17	UFM1	Malignant cells	GSE131984_Pal	ENSG00000120686	51569	ubiquitin fold modifier 1	bA131P10.1|C13orf20	protein_coding	P61960	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45231
3.55808819834389e-21	-0.348665833042078	0.296	0.51	5.62462582394202e-17	ETV4	Malignant cells	GSE131984_Pal	ENSG00000175832	2118	ETS variant transcription factor 4	E1A-F|E1AF|PEA3	protein_coding	P43268	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45232
3.77295703839809e-21	-0.386420054379529	0.684	0.805	5.9642904862997e-17	ARF6	Malignant cells	GSE131984_Pal	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45233
3.78125994583193e-21	-0.373514886184407	0.815	0.884	5.97741572237111e-17	LSM10	Malignant cells	GSE131984_Pal	ENSG00000181817	84967	LSM10, U7 small nuclear RNA associated	MGC15749	protein_coding	Q969L4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45234
3.96474810986737e-21	0.309037659924448	0.957	0.906	6.26747381207835e-17	C6orf48	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45235
3.99178220977978e-21	-0.28767102197783	0.986	0.993	6.31020931721987e-17	LSM7	Malignant cells	GSE131984_Pal	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45236
4.10090472913749e-21	0.362644642753928	0.996	0.994	6.48271019582054e-17	IFITM3	Malignant cells	GSE131984_Pal	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45237
4.70169544182615e-21	-0.319193256174683	0.915	0.967	7.43244015443879e-17	CISD1	Malignant cells	GSE131984_Pal	ENSG00000122873	55847	CDGSH iron sulfur domain 1	C10orf70|MDS029|mitoNEET|ZCD1	protein_coding	Q9NZ45	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45238
4.74287553464761e-21	0.357022518285658	0.545	0.341	7.49753764517094e-17	MBTPS1	Malignant cells	GSE131984_Pal	ENSG00000140943	8720	membrane bound transcription factor peptidase, site 1	KIAA0091|PCSK8|S1P|SKI-1	protein_coding	Q14703	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45239
4.81531803217376e-21	-0.432246981257733	0.786	0.866	7.61205474526029e-17	SPCS2	Malignant cells	GSE131984_Pal	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45240
5.0514583199268e-21	-0.315416994433855	0.922	0.966	7.98534531214028e-17	HDDC2	Malignant cells	GSE131984_Pal	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45241
5.25833817826133e-21	-0.367395449027556	0.586	0.745	8.31238099219551e-17	MRPL9	Malignant cells	GSE131984_Pal	ENSG00000143436	65005	mitochondrial ribosomal protein L9	NA	protein_coding	Q9BYD2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45242
5.32525859662322e-21	-0.490281485781138	0.304	0.514	8.41816878954199e-17	AKAP12	Malignant cells	GSE131984_Pal	ENSG00000131016	9590	A-kinase anchoring protein 12	AKAP250|SSeCKS	protein_coding	Q02952	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45243
5.46710618325852e-21	-0.389181383600547	0.434	0.642	8.64240145449506e-17	BCCIP	Malignant cells	GSE131984_Pal	ENSG00000107949	56647	BRCA2 and CDKN1A interacting protein	BCCIPalpha|TOK-1	protein_coding	Q9P287	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45244
5.92095292592505e-21	0.356419009637853	0.496	0.293	9.35984238530231e-17	NBR1	Malignant cells	GSE131984_Pal	ENSG00000188554	4077	NBR1 autophagy cargo receptor	1A1-3B|CA125|KIAA0049|M17S2	protein_coding	Q14596	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45245
6.27907791454771e-21	-0.445887962000382	0.509	0.697	9.92596636731702e-17	PSMC2	Malignant cells	GSE131984_Pal	ENSG00000161057	5701	proteasome 26S subunit, ATPase 2	MSS1|Nbla10058|RPT1|S7	protein_coding	P35998	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45246
6.46781289542725e-21	-0.378311085158157	0.733	0.842	1.02243186250914e-16	HNRNPF	Malignant cells	GSE131984_Pal	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45247
6.9753732833507e-21	0.272190223285349	0.294	0.117	1.10266700863208e-16	YPEL3	Malignant cells	GSE131984_Pal	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45248
7.02179953626059e-21	-0.263341519306324	0.99	1	1.11000607069207e-16	MRPL41	Malignant cells	GSE131984_Pal	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45249
7.06996229591331e-21	-0.370029854308707	0.622	0.786	1.11761963973798e-16	UBE2J2	Malignant cells	GSE131984_Pal	ENSG00000160087	118424	ubiquitin conjugating enzyme E2 J2	NCUBE2|Ubc6p	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45250
7.83926372667473e-21	-0.412230700317707	0.768	0.856	1.23923080991274e-16	MTHFD2	Malignant cells	GSE131984_Pal	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45251
8.05627201714701e-21	0.36326643955764	0.392	0.2	1.2735354804706e-16	PCDH7	Malignant cells	GSE131984_Pal	ENSG00000169851	5099	protocadherin 7	BH-Pcdh|PPP1R120	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45252
9.2117063610256e-21	-0.404892714451008	0.642	0.786	1.45618654155093e-16	PHF19	Malignant cells	GSE131984_Pal	ENSG00000119403	26147	PHD finger protein 19	DKFZP727G051|MTF2L1|PCL3|TDRD19B	protein_coding	Q5T6S3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45253
9.28951933946067e-21	-0.317379880302996	0.916	0.975	1.46848721718194e-16	NDUFA6	Malignant cells	GSE131984_Pal	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45254
9.34052867785657e-21	-0.398139426900374	0.358	0.554	1.47655077339557e-16	FTSJ2	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45255
9.68376008928896e-21	-0.390114310128262	0.264	0.476	1.5308087949148e-16	POLR3G	Malignant cells	GSE131984_Pal	ENSG00000113356	10622	RNA polymerase III subunit G	C31|RPC32|RPC7	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45256
1.00506557672022e-20	-0.400548895270072	0.498	0.682	1.58880766367932e-16	BAZ1A	Malignant cells	GSE131984_Pal	ENSG00000198604	11177	bromodomain adjacent to zinc finger domain 1A	ACF1|hACF1|WALp1|WCRF180	protein_coding	Q9NRL2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45257
1.01512707535671e-20	-0.344149493478016	0.916	0.959	1.60471288072389e-16	C11orf58	Malignant cells	GSE131984_Pal	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45258
1.02044453289423e-20	0.394542477562038	0.545	0.356	1.6131187175992e-16	PRR24	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45259
1.07808892731797e-20	0.284250729061512	0.332	0.143	1.70424297630425e-16	FBXO25	Malignant cells	GSE131984_Pal	ENSG00000147364	26260	F-box protein 25	FBX25	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45260
1.099255544246e-20	-0.440628885488197	0.452	0.646	1.73770316434408e-16	UTP11L	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45261
1.17521532110986e-20	-0.389056039080204	0.668	0.819	1.85778037961046e-16	SMARCB1	Malignant cells	GSE131984_Pal	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45262
1.22598408362124e-20	-0.39812100563665	0.573	0.736	1.93803563938845e-16	SAE1	Malignant cells	GSE131984_Pal	ENSG00000142230	10055	SUMO1 activating enzyme subunit 1	AOS1|FLJ3091|Sua1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45263
1.26346205578607e-20	-0.41843217514236	0.618	0.756	1.99728081778662e-16	TIMM50	Malignant cells	GSE131984_Pal	ENSG00000105197	92609	translocase of inner mitochondrial membrane 50	TIM50|TIM50L	protein_coding	Q3ZCQ8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45264
1.3048108026777e-20	-0.370086897781143	0.408	0.604	2.06264491687291e-16	HSPBP1	Malignant cells	GSE131984_Pal	ENSG00000133265	23640	HSPA (Hsp70) binding protein 1	FES1	protein_coding	Q9NZL4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45265
1.3166269297903e-20	-0.354198408322825	1	1	2.08132385061251e-16	NPM1	Malignant cells	GSE131984_Pal	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45266
1.36612430547864e-20	-0.373333927890756	0.333	0.547	2.15956930210064e-16	DUSP14	Malignant cells	GSE131984_Pal	ENSG00000275932	11072	dual specificity phosphatase 14	MKP-L|MKP6	protein_coding	O95147	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45267
1.38909445728896e-20	0.300182488000064	0.401	0.203	2.19588051808238e-16	SPECC1	Malignant cells	GSE131984_Pal	ENSG00000128487	92521	sperm antigen with calponin homology and coiled-coil domains 1	CYTSB|FLJ36955|HCMOGT-1|NSP	protein_coding	Q5M775	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45268
1.47206581998798e-20	-0.405797363440296	0.727	0.836	2.327041648237e-16	SEC11C	Malignant cells	GSE131984_Pal	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45269
1.54653216794976e-20	-0.33920275806755	0.893	0.946	2.44475805109498e-16	C11orf48	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45270
1.55121931707397e-20	-0.43288869122247	0.711	0.817	2.45216749643053e-16	HPRT1	Malignant cells	GSE131984_Pal	ENSG00000165704	3251	hypoxanthine phosphoribosyltransferase 1	HGPRT|HPRT	protein_coding	P00492	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45271
1.59080409816754e-20	-0.392838832767806	0.557	0.704	2.51474311838325e-16	CCDC12	Malignant cells	GSE131984_Pal	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45272
1.66897353983391e-20	-0.303792208292525	0.922	0.981	2.63831337176945e-16	NDUFA12	Malignant cells	GSE131984_Pal	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45273
1.79801860251238e-20	-0.380725460960577	0.491	0.68	2.84230780685156e-16	MRPL35	Malignant cells	GSE131984_Pal	ENSG00000132313	51318	mitochondrial ribosomal protein L35	NA	protein_coding	Q9NZE8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45274
1.81536379205824e-20	-0.383847944496866	0.834	0.898	2.86972708248567e-16	GLO1	Malignant cells	GSE131984_Pal	ENSG00000124767	2739	glyoxalase I	GLOD1	protein_coding	Q04760	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45275
1.89329588991712e-20	-0.401078407476903	0.644	0.773	2.99292214278098e-16	RSRC2	Malignant cells	GSE131984_Pal	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45276
1.9399433162781e-20	0.337022261929737	0.957	0.886	3.06666239437243e-16	EIF4B	Malignant cells	GSE131984_Pal	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45277
1.94546519340397e-20	0.305000453439002	0.388	0.194	3.07539137773299e-16	IL1R1	Malignant cells	GSE131984_Pal	ENSG00000115594	3554	interleukin 1 receptor type 1	CD121A|D2S1473|IL1R|IL1RA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45278
1.96314552736449e-20	-0.323657123620041	0.176	0.382	3.10334044965778e-16	ACOX2	Malignant cells	GSE131984_Pal	ENSG00000168306	8309	acyl-CoA oxidase 2	BRCACOX|BRCOX|THCCox	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45279
1.98187092471748e-20	-0.317506705061628	0.926	0.949	3.1329415577934e-16	SRP72	Malignant cells	GSE131984_Pal	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45280
2.18284186442546e-20	0.352461052506834	0.991	0.98	3.45063641928377e-16	S100A13	Malignant cells	GSE131984_Pal	ENSG00000189171	6284	S100 calcium binding protein A13	NA	protein_coding	Q99584	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45281
2.24886325954335e-20	0.323392227357089	0.286	0.115	3.55500304068613e-16	SAMD11	Malignant cells	GSE131984_Pal	ENSG00000187634	148398	sterile alpha motif domain containing 11	MGC45873	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45282
2.26154536763752e-20	-0.356356255562932	0.838	0.916	3.57505091716139e-16	TMEM126A	Malignant cells	GSE131984_Pal	ENSG00000171202	84233	transmembrane protein 126A	DKFZp586C1924|OPA7	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45283
2.32817687050717e-20	0.280324902599553	0.354	0.162	3.68038199689773e-16	ZCCHC24	Malignant cells	GSE131984_Pal	ENSG00000165424	219654	zinc finger CCHC-type containing 24	C10orf56|FLJ90798|Z3CXXC8	protein_coding	Q8N2G6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45284
2.60641104342279e-20	-0.329562229558228	0.926	0.958	4.12021457744275e-16	C7orf50	Malignant cells	GSE131984_Pal	ENSG00000146540	84310	chromosome 7 open reading frame 50	MGC11257|YCR016W	protein_coding	Q9BRJ6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45285
2.75198790469669e-20	-0.327653840336171	0.834	0.915	4.35034247974453e-16	TCEA1	Malignant cells	GSE131984_Pal	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45286
2.89562154409882e-20	-0.373765613179165	0.791	0.872	4.57739853691141e-16	NT5C	Malignant cells	GSE131984_Pal	ENSG00000125458	30833	5', 3'-nucleotidase, cytosolic	cdN|DNT-1|DNT1|PN-I|UMPH2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45287
2.9918307710687e-20	-0.361161543500442	0.358	0.572	4.72948608290541e-16	FAM103A1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45288
3.32374648202547e-20	-0.298528130391075	0.932	0.973	5.25417843878586e-16	CLPP	Malignant cells	GSE131984_Pal	ENSG00000125656	8192	caseinolytic mitochondrial matrix peptidase proteolytic subunit	NA	protein_coding	Q16740	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45289
3.37245662389151e-20	0.293154694460561	0.317	0.139	5.3311794310477e-16	MEF2D	Malignant cells	GSE131984_Pal	ENSG00000116604	4209	myocyte enhancer factor 2D	NA	protein_coding	Q14814	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45290
3.59420815352674e-20	-0.325421997218438	0.091	0.265	5.68172424909507e-16	HHIP	Malignant cells	GSE131984_Pal	ENSG00000164161	64399	hedgehog interacting protein	FLJ20992|HIP	protein_coding	Q96QV1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45291
4.26666720897781e-20	-0.351387656132746	0.772	0.869	6.74474752395212e-16	SPTSSA	Malignant cells	GSE131984_Pal	ENSG00000165389	171546	serine palmitoyltransferase small subunit A	C14orf147|ssSPTa	protein_coding	Q969W0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45292
4.32708983449817e-20	-0.311957718017051	0.987	0.992	6.84026361037471e-16	SERP1	Malignant cells	GSE131984_Pal	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45293
4.34120326462407e-20	-0.270645764392975	0.999	1	6.86257412071772e-16	GPX1	Malignant cells	GSE131984_Pal	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45294
4.50128816185253e-20	-0.39645290078299	0.67	0.794	7.11563632625648e-16	BAG1	Malignant cells	GSE131984_Pal	ENSG00000107262	573	BAG cochaperone 1	NA	protein_coding	Q99933	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45295
4.56891469917926e-20	-0.252293881063682	0.994	1	7.22254035646258e-16	LSM4	Malignant cells	GSE131984_Pal	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45296
4.80618460857581e-20	-0.415916271211111	0.654	0.769	7.59761662923664e-16	ANXA7	Malignant cells	GSE131984_Pal	ENSG00000138279	310	annexin A7	ANX7	protein_coding	P20073	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45297
4.8075204146122e-20	-0.372044527502666	0.387	0.589	7.59972827141896e-16	PCID2	Malignant cells	GSE131984_Pal	ENSG00000126226	55795	PCI domain containing 2	FLJ11305	protein_coding	Q5JVF3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45298
4.83425014313019e-20	-0.384188072620443	0.404	0.602	7.6419826262602e-16	GNL2	Malignant cells	GSE131984_Pal	ENSG00000134697	29889	G protein nucleolar 2	HUMAUANTIG|Ngp-1|Nog2|Nug2	protein_coding	Q13823	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45299
5.13545725829315e-20	-0.394587612610578	0.98	0.988	8.11813083390982e-16	UBB	Malignant cells	GSE131984_Pal	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45300
5.50506258723727e-20	-0.384297845377165	0.486	0.668	8.70240293790468e-16	CREM	Malignant cells	GSE131984_Pal	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45301
5.69799499674884e-20	-0.393770217206049	0.289	0.49	9.00739049086056e-16	ASF1B	Malignant cells	GSE131984_Pal	ENSG00000288210	55723	anti-silencing function 1B histone chaperone	FLJ10604	protein_coding	Q9NVP2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45302
5.76893642725448e-20	-0.299912590991235	0.162	0.362	9.11953470420389e-16	PKMYT1	Malignant cells	GSE131984_Pal	ENSG00000127564	9088	protein kinase, membrane associated tyrosine/threonine 1	MYT1|PPP1R126	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45303
6.05162947025847e-20	-0.451124595245985	0.586	0.733	9.56641586658459e-16	PSMD12	Malignant cells	GSE131984_Pal	ENSG00000197170	5718	proteasome 26S subunit, non-ATPase 12	p55|Rpn5	protein_coding	O00232	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45304
6.06692650009434e-20	0.361745224047807	0.759	0.582	9.59059741134914e-16	NCOA7	Malignant cells	GSE131984_Pal	ENSG00000111912	135112	nuclear receptor coactivator 7	dJ187J11.3|ERAP140|TLDC4	protein_coding	Q8NI08	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45305
6.17240923605341e-20	-0.33857224615504	0.911	0.942	9.75734452035324e-16	THOC7	Malignant cells	GSE131984_Pal	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45306
6.53902221958376e-20	-0.347117472939566	0.219	0.42	1.0336886324718e-15	TEX30	Malignant cells	GSE131984_Pal	ENSG00000151287	93081	testis expressed 30	C13orf27	protein_coding	Q5JUR7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45307
6.94084446571926e-20	-0.411443457652579	0.47	0.641	1.0972086931409e-15	FRG1	Malignant cells	GSE131984_Pal	ENSG00000275145	2483	FSHD region gene 1	FRG1A|FSG1	protein_coding	Q14331	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45308
7.0398046635724e-20	-0.391883394644171	0.418	0.614	1.11285232121752e-15	C4orf27	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45309
8.40792713157883e-20	0.399308042141886	0.67	0.492	1.32912512095998e-15	ZMYND8	Malignant cells	GSE131984_Pal	ENSG00000101040	23613	zinc finger MYND-type containing 8	KIAA1125|PRKCBP1|RACK7	protein_coding	Q9ULU4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45310
9.10933495146721e-20	-0.399886519385105	0.317	0.516	1.44000366912794e-15	VRK1	Malignant cells	GSE131984_Pal	ENSG00000100749	7443	VRK serine/threonine kinase 1	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45311
9.35127495793182e-20	-0.312306720947191	0.912	0.953	1.47824954534986e-15	BCL7C	Malignant cells	GSE131984_Pal	ENSG00000099385	9274	BAF chromatin remodeling complex subunit BCL7C	SMARCJ3	protein_coding	Q8WUZ0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45312
9.89026994790865e-20	-0.355740986083217	0.378	0.58	1.5634538733654e-15	TOR3A	Malignant cells	GSE131984_Pal	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45313
1.05522972954859e-19	-0.383366856878458	0.328	0.528	1.66810715647041e-15	PLAUR	Malignant cells	GSE131984_Pal	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45314
1.22154811988849e-19	-0.367077126752265	0.32	0.516	1.93102326791972e-15	PDCL3	Malignant cells	GSE131984_Pal	ENSG00000115539	79031	phosducin like 3	VIAF1	protein_coding	Q9H2J4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45315
1.24728407377977e-19	0.357102658237928	0.582	0.379	1.97170666383106e-15	TNRC6B	Malignant cells	GSE131984_Pal	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45316
1.37212711473769e-19	-0.382696346610952	0.898	0.945	2.16905854297734e-15	NT5C3B	Malignant cells	GSE131984_Pal	ENSG00000141698	115024	5'-nucleotidase, cytosolic IIIB	cN-IIIB|MGC20781|NT5C3L	protein_coding	Q969T7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45317
1.43582699946501e-19	0.392423558659333	0.784	0.636	2.26975532075429e-15	TMPRSS15	Malignant cells	GSE131984_Pal	ENSG00000154646	5651	transmembrane serine protease 15	ENTK|MGC133046|PRSS7	protein_coding	P98073	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45318
1.64597812695569e-19	-0.36561250429722	0.375	0.578	2.60196222309155e-15	UTP18	Malignant cells	GSE131984_Pal	ENSG00000011260	51096	UTP18 small subunit processome component	CGI-48|WDR50	protein_coding	Q9Y5J1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45319
1.69580987243045e-19	-0.408135974694117	0.444	0.621	2.68073624633806e-15	TXNDC9	Malignant cells	GSE131984_Pal	ENSG00000115514	10190	thioredoxin domain containing 9	APACD	protein_coding	O14530	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45320
1.6975313685159e-19	-0.298612508020796	0.126	0.308	2.68345758734993e-15	PINX1	Malignant cells	GSE131984_Pal	ENSG00000254093	54984	PIN2 (TERF1) interacting telomerase inhibitor 1	FLJ20565|Gno1|LPTL|LPTS|MGC8850|Pxr1	protein_coding	Q96BK5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45321
2.08947855429738e-19	-0.335319178094895	0.908	0.959	3.3030476986333e-15	PSMC5	Malignant cells	GSE131984_Pal	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45322
2.0996271216769e-19	-0.340157963274289	0.848	0.913	3.31909055394685e-15	PRPF40A	Malignant cells	GSE131984_Pal	ENSG00000196504	55660	pre-mRNA processing factor 40 homolog A	FBP-11|FBP11|FLAF1|FLJ20585|FNBP3|HIP10|HYPA|NY-REN-6|Prp40	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45323
2.12289299555576e-19	0.323349356734843	0.426	0.233	3.35586924737454e-15	SSH1	Malignant cells	GSE131984_Pal	ENSG00000084112	54434	slingshot protein phosphatase 1	KIAA1298|SSH1L	protein_coding	Q8WYL5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45324
2.17910660118997e-19	-0.329205862448695	0.286	0.509	3.44473171516111e-15	CEP55	Malignant cells	GSE131984_Pal	ENSG00000138180	55165	centrosomal protein 55	C10orf3|CT111|FLJ10540	protein_coding	Q53EZ4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45325
2.22539678108722e-19	-0.332708336052586	0.823	0.88	3.51790723154268e-15	MRPL54	Malignant cells	GSE131984_Pal	ENSG00000183617	116541	mitochondrial ribosomal protein L54	NA	protein_coding	Q6P161	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45326
2.28122711897405e-19	-0.343115291258228	0.221	0.423	3.60616382967417e-15	APOBEC3B	Malignant cells	GSE131984_Pal	ENSG00000179750	9582	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	FLJ21201|PHRBNL	protein_coding	Q9UH17	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45327
2.30086149348822e-19	-0.375550652992515	0.397	0.595	3.63720184890618e-15	FARSB	Malignant cells	GSE131984_Pal	ENSG00000116120	10056	phenylalanyl-tRNA synthetase subunit beta	FARSLB|FRSB|PheHB	protein_coding	Q9NSD9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45328
2.32810850338569e-19	-0.304283100661531	0.977	0.99	3.6802739221521e-15	SKP1	Malignant cells	GSE131984_Pal	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45329
2.45786051005471e-19	-0.432427935958819	0.534	0.687	3.88538589429448e-15	FH	Malignant cells	GSE131984_Pal	ENSG00000091483	2271	fumarate hydratase	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45330
2.6911206031558e-19	-0.341606171309644	0.863	0.912	4.25412344946869e-15	ARL2	Malignant cells	GSE131984_Pal	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45331
2.82680694789792e-19	-0.315859301982109	0.209	0.411	4.46861642323703e-15	PPIL1	Malignant cells	GSE131984_Pal	ENSG00000137168	51645	peptidylprolyl isomerase like 1	CYPL1	protein_coding	Q9Y3C6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45332
3.015083023825e-19	0.334663704075451	0.511	0.311	4.76624324406255e-15	ZKSCAN1	Malignant cells	GSE131984_Pal	ENSG00000106261	7586	zinc finger with KRAB and SCAN domains 1	KOX18|PHZ-37|ZNF139|ZNF36|ZSCAN33	protein_coding	P17029	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45333
3.49871923925018e-19	-0.454496643344368	0.392	0.581	5.53077537340669e-15	CNN3	Malignant cells	GSE131984_Pal	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45334
3.79123569273299e-19	-0.365324719284818	0.654	0.777	5.99318538307232e-15	SMIM12	Malignant cells	GSE131984_Pal	ENSG00000163866	113444	small integral membrane protein 12	C1orf212|FLJ90372	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45335
4.06217634108743e-19	-0.360057584664986	0.43	0.627	6.42148835999101e-15	TSR2	Malignant cells	GSE131984_Pal	ENSG00000158526	90121	TSR2 ribosome maturation factor	DT1P1A10|RP1-112K5.2|WGG1	protein_coding	Q969E8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45336
4.18962470691293e-19	-0.358559536384203	0.421	0.619	6.62295873668795e-15	ATAD3A	Malignant cells	GSE131984_Pal	ENSG00000197785	55210	ATPase family AAA domain containing 3A	FLJ10709	protein_coding	Q9NVI7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45337
4.2193106309868e-19	-0.330086183884149	0.805	0.888	6.66988624546394e-15	SUMO3	Malignant cells	GSE131984_Pal	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45338
4.47419342046704e-19	-0.364128950429882	0.312	0.514	7.07280495907429e-15	DDX56	Malignant cells	GSE131984_Pal	ENSG00000136271	54606	DEAD-box helicase 56	NOH61	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45339
4.8241470304375e-19	-0.317505483034709	0.276	0.483	7.62601162571559e-15	SF3B4	Malignant cells	GSE131984_Pal	ENSG00000143368	10262	splicing factor 3b subunit 4	Hsh49|SAP49|SF3b49	protein_coding	Q15427	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45340
4.85144364583767e-19	-0.400530810454781	0.44	0.63	7.66916211534019e-15	MRPS28	Malignant cells	GSE131984_Pal	ENSG00000147586	28957	mitochondrial ribosomal protein S28	HSPC007|MRP-S28|MRPS35	protein_coding	Q9Y2Q9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45341
4.95701730862475e-19	-0.388546721503706	0.723	0.811	7.836052961474e-15	MRPL19	Malignant cells	GSE131984_Pal	ENSG00000115364	9801	mitochondrial ribosomal protein L19	KIAA0104|MRP-L15|RLX1|RPML15	protein_coding	P49406	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45342
5.03662378968947e-19	-0.354852388382264	0.307	0.513	7.96189488674111e-15	APOO	Malignant cells	GSE131984_Pal	ENSG00000184831	79135	apolipoprotein O	FAM121B|MGC4825|Mic23|MIC26|MICOS26|My025	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45343
5.2684449984086e-19	-0.370705599294368	0.403	0.589	8.32835785348431e-15	WDR43	Malignant cells	GSE131984_Pal	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45344
5.51714885426893e-19	0.334605802720179	0.457	0.266	8.72150890882833e-15	LINC00936	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45345
5.67090034277443e-19	0.366939128617359	0.498	0.312	8.96455926185781e-15	SLC39A14	Malignant cells	GSE131984_Pal	ENSG00000104635	23516	solute carrier family 39 member 14	KIAA0062|NET34|ZIP14	protein_coding	Q15043	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45346
5.71887950386418e-19	0.364182244596352	0.658	0.488	9.04040471970849e-15	MGAT4B	Malignant cells	GSE131984_Pal	ENSG00000284501	11282	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GnT-Ivb	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45347
6.84150501812562e-19	0.341678069858825	0.517	0.32	1.0815051132653e-14	IRF2BPL	Malignant cells	GSE131984_Pal	ENSG00000119669	64207	interferon regulatory factor 2 binding protein like	C14orf4|EAP1|KIAA1865	protein_coding	Q9H1B7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45348
7.17829401213703e-19	-0.359783247877039	0.861	0.921	1.13474471743862e-14	XRCC5	Malignant cells	GSE131984_Pal	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45349
7.42988380601903e-19	-0.354285691459531	0.505	0.687	1.17451603205549e-14	TIMM44	Malignant cells	GSE131984_Pal	ENSG00000104980	10469	translocase of inner mitochondrial membrane 44	TIM44	protein_coding	O43615	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45350
8.07563490681203e-19	-0.371409481745796	0.479	0.657	1.27659636606885e-14	CECR5	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45351
8.10338014453611e-19	-0.351203450505704	0.698	0.836	1.28098233324827e-14	ARL2BP	Malignant cells	GSE131984_Pal	ENSG00000102931	23568	ADP ribosylation factor like GTPase 2 binding protein	BART|BART1|RP66	protein_coding	Q9Y2Y0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45352
8.33500912029836e-19	-0.328530415784526	0.455	0.673	1.31759824173676e-14	NUSAP1	Malignant cells	GSE131984_Pal	ENSG00000137804	51203	nucleolar and spindle associated protein 1	ANKT|BM037|FLJ13421|LNP|PRO0310p1|Q0310|SAPL	protein_coding	Q9BXS6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45353
8.70143542089216e-19	-0.367711293410724	0.755	0.851	1.37552291133463e-14	WDR13	Malignant cells	GSE131984_Pal	ENSG00000101940	64743	WD repeat domain 13	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45354
8.83193579739791e-19	-0.371415635782985	0.716	0.831	1.39615241085266e-14	TSPAN4	Malignant cells	GSE131984_Pal	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45355
9.28234368143479e-19	-0.360270056047507	0.232	0.427	1.46735288916121e-14	STEAP1	Malignant cells	GSE131984_Pal	ENSG00000164647	26872	STEAP family member 1	PRSS24|STEAP	protein_coding	Q9UHE8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45356
9.34971157055519e-19	-0.257798103900796	0.111	0.288	1.47800240507336e-14	CSTF2	Malignant cells	GSE131984_Pal	ENSG00000101811	1478	cleavage stimulation factor subunit 2	CstF-64	protein_coding	P33240	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45357
1.02209015359443e-18	-0.279375699431331	0.981	0.988	1.61572011480207e-14	FBL	Malignant cells	GSE131984_Pal	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45358
1.04414131930686e-18	-0.360337437697943	0.719	0.827	1.65057859756029e-14	RAP1B	Malignant cells	GSE131984_Pal	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45359
1.0571845448471e-18	0.304888660699892	0.405	0.216	1.6711973284943e-14	CAMK2D	Malignant cells	GSE131984_Pal	ENSG00000145349	817	calcium/calmodulin dependent protein kinase II delta	CAMKD	protein_coding	Q13557	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45360
1.06160865103577e-18	-0.416798731711988	0.433	0.608	1.67819095555734e-14	DCAF13	Malignant cells	GSE131984_Pal	ENSG00000164934	25879	DDB1 and CUL4 associated factor 13	DKFZP564O0463|Gm83|HSPC064|Sof1|WDSOF1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45361
1.07079136336269e-18	-0.337869364800949	0.772	0.875	1.69270698720375e-14	POLR2K	Malignant cells	GSE131984_Pal	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45362
1.07223239697393e-18	-0.338891658930859	0.476	0.665	1.69498497313639e-14	SLC39A3	Malignant cells	GSE131984_Pal	ENSG00000141873	29985	solute carrier family 39 member 3	ZIP3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45363
1.13443096432907e-18	-0.323769431411952	0.247	0.452	1.79330846841139e-14	RAD51AP1	Malignant cells	GSE131984_Pal	ENSG00000111247	10635	RAD51 associated protein 1	PIR51	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45364
1.16085038396203e-18	-0.3654084352427	0.734	0.829	1.83507228696718e-14	SMIM15	Malignant cells	GSE131984_Pal	ENSG00000188725	643155	small integral membrane protein 15	C5orf43|DKFZP686E2158	protein_coding	Q7Z3B0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45365
1.17802724926329e-18	0.366015748572442	0.701	0.53	1.86222547563541e-14	PTPN14	Malignant cells	GSE131984_Pal	ENSG00000152104	5784	protein tyrosine phosphatase non-receptor type 14	PEZ|PTPD2	protein_coding	Q15678	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45366
1.23188443150928e-18	-0.381220333190027	0.68	0.809	1.94736290932987e-14	SEC13	Malignant cells	GSE131984_Pal	ENSG00000157020	6396	SEC13 homolog, nuclear pore and COPII coat complex component	D3S1231E|npp-20|SEC13L1|SEC13R	protein_coding	P55735	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45367
1.23580613090587e-18	-0.299908401719718	0.212	0.409	1.95356233173601e-14	MRPL46	Malignant cells	GSE131984_Pal	ENSG00000259494	26589	mitochondrial ribosomal protein L46	C15orf4|LIECG2|P2ECSL	protein_coding	Q9H2W6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45368
1.24523900957193e-18	0.352765866103999	0.814	0.665	1.9684738263313e-14	FKBP10	Malignant cells	GSE131984_Pal	ENSG00000141756	60681	FKBP prolyl isomerase 10	FKBP6|FKBP65|FLJ20683|FLJ22041|FLJ23833|hFKBP65	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45369
1.40219191233708e-18	-0.312973142222379	0.232	0.425	2.21658497502246e-14	RFC5	Malignant cells	GSE131984_Pal	ENSG00000111445	5985	replication factor C subunit 5	RFC36	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45370
1.521224509732e-18	-0.371113619701649	0.73	0.807	2.40475170498434e-14	THRAP3	Malignant cells	GSE131984_Pal	ENSG00000054118	9967	thyroid hormone receptor associated protein 3	BCLAF2|TRAP150	protein_coding	Q9Y2W1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45371
1.56275293832629e-18	-0.30600468090808	0.199	0.392	2.4703998449062e-14	NUDT11	Malignant cells	GSE131984_Pal	ENSG00000196368	55190	nudix hydrolase 11	DIPP3b|FLJ10628|hDIPP3beta	protein_coding	Q96G61	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45372
1.6554732403009e-18	0.333166727066752	0.408	0.225	2.61697209826766e-14	METTL7A	Malignant cells	GSE131984_Pal	ENSG00000185432	25840	methyltransferase like 7A	DKFZP586A0522	protein_coding	Q9H8H3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45373
1.68507243379835e-18	-0.367065352965773	0.263	0.461	2.66376250334843e-14	MRPL39	Malignant cells	GSE131984_Pal	ENSG00000154719	54148	mitochondrial ribosomal protein L39	C21orf92|FLJ20451|L39mt|MGC104174|MGC3400|MRP-L5|MSTP003|PRED22|PRED66|RPML5	protein_coding	Q9NYK5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45374
1.68930694410692e-18	-0.354936851535394	0.687	0.803	2.67045641724422e-14	ELAVL1	Malignant cells	GSE131984_Pal	ENSG00000066044	1994	ELAV like RNA binding protein 1	Hua|HUR|MelG	protein_coding	Q15717	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45375
1.7103086555777e-18	0.270723289367584	0.315	0.145	2.70365592273724e-14	SMARCD3	Malignant cells	GSE131984_Pal	ENSG00000082014	6604	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3	BAF60C|CRACD3|Rsc6p	protein_coding	Q6STE5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45376
1.76558377557356e-18	-0.391631595745144	0.388	0.571	2.79103483242668e-14	CEBPG	Malignant cells	GSE131984_Pal	ENSG00000153879	1054	CCAAT enhancer binding protein gamma	GPE1BP|IG/EBP-1	protein_coding	P53567	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45377
1.77417785299812e-18	-0.431740048613314	0.354	0.571	2.80462035001943e-14	CENPA	Malignant cells	GSE131984_Pal	ENSG00000115163	1058	centromere protein A	CenH3|CENP-A	protein_coding	P49450	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45378
1.81897833259219e-18	0.345189835489524	0.902	0.821	2.87544094816173e-14	FKBP5	Malignant cells	GSE131984_Pal	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45379
1.83090743152359e-18	-0.353412479589909	0.167	0.351	2.89429846775249e-14	TMEM98	Malignant cells	GSE131984_Pal	ENSG00000006042	26022	transmembrane protein 98	DKFZP564K1964	protein_coding	Q9Y2Y6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45380
1.89081301482472e-18	-0.398486444849896	0.595	0.727	2.98899721383491e-14	PSMD13	Malignant cells	GSE131984_Pal	ENSG00000185627	5719	proteasome 26S subunit, non-ATPase 13	p40.5|Rpn9	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45381
2.02073227210465e-18	-0.392370254644129	0.619	0.752	3.19437357574303e-14	YDJC	Malignant cells	GSE131984_Pal	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45382
2.23420472184273e-18	-0.297371690943784	0.948	0.978	3.53183082428899e-14	CISD3	Malignant cells	GSE131984_Pal	ENSG00000274768	284106	CDGSH iron sulfur domain 3	Miner2|MiNT	protein_coding	P0C7P0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45383
2.26674073188835e-18	-0.387723841139127	0.543	0.693	3.58326374896911e-14	C12orf45	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45384
2.29830794478942e-18	0.333705863842012	0.413	0.232	3.63316519912312e-14	RP11-640M9.1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45385
2.40679433833093e-18	-0.277115589787202	0.965	0.977	3.80466049003353e-14	UXT	Malignant cells	GSE131984_Pal	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45386
2.55604059171094e-18	-0.404809406198855	0.795	0.888	4.04058896737665e-14	PDIA3	Malignant cells	GSE131984_Pal	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45387
2.56795886588964e-18	-0.376451787090636	0.67	0.791	4.05942937519835e-14	C4orf32	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45388
3.12887413945368e-18	0.356566270429491	0.453	0.272	4.94612423964838e-14	ABCA1	Malignant cells	GSE131984_Pal	ENSG00000165029	19	ATP binding cassette subfamily A member 1	ABC1|HDLDT1|TGD	protein_coding	O95477	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45389
3.35786153874714e-18	-0.411136327679197	0.532	0.688	5.30810752045148e-14	PSME3	Malignant cells	GSE131984_Pal	ENSG00000131467	10197	proteasome activator subunit 3	Ki|PA28-gamma|PA28G|REG-GAMMA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45390
3.3602585782647e-18	-0.337408313021404	0.375	0.571	5.31189676052084e-14	PREB	Malignant cells	GSE131984_Pal	ENSG00000138073	10113	prolactin regulatory element binding	SEC12	protein_coding	Q9HCU5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45391
3.45545088496489e-18	0.277004921392805	0.387	0.199	5.46237675895249e-14	SLFN5	Malignant cells	GSE131984_Pal	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45392
3.58047869343044e-18	0.402203424940573	0.632	0.457	5.66002071857484e-14	SREBF1	Malignant cells	GSE131984_Pal	ENSG00000072310	6720	sterol regulatory element binding transcription factor 1	bHLHd1|SREBP-1c|SREBP1|SREBP1a	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45393
3.60906013375454e-18	0.365032501274722	0.343	0.173	5.70520225943918e-14	FBLN1	Malignant cells	GSE131984_Pal	ENSG00000077942	2192	fibulin 1	FBLN	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45394
3.67523960793798e-18	-0.376457461619442	0.472	0.652	5.80981877222836e-14	EEA1	Malignant cells	GSE131984_Pal	ENSG00000102189	8411	early endosome antigen 1	ZFYVE2	protein_coding	Q15075	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45395
3.80720714003793e-18	-0.345213742425285	0.704	0.818	6.01843304697195e-14	ARPC4	Malignant cells	GSE131984_Pal	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45396
4.39273381908682e-18	-0.315922869919443	0.912	0.971	6.94403362121244e-14	KPNB1	Malignant cells	GSE131984_Pal	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45397
4.39390533024811e-18	-0.294628728613886	0.999	1	6.94588554605621e-14	MGST1	Malignant cells	GSE131984_Pal	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45398
4.62065157237114e-18	-0.322363012410439	0.886	0.929	7.30432600560429e-14	BZW1	Malignant cells	GSE131984_Pal	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45399
4.89630053689147e-18	-0.439523167456723	0.583	0.702	7.74007188871803e-14	RUVBL1	Malignant cells	GSE131984_Pal	ENSG00000284901	8607	RuvB like AAA ATPase 1	ECP54|INO80H|NMP238|Pontin52|RVB1|TIH1|TIP49|TIP49a	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45400
5.07565873929334e-18	0.337423539674449	0.468	0.29	8.02360133507492e-14	ACO1	Malignant cells	GSE131984_Pal	ENSG00000122729	48	aconitase 1	IREB1|IREBP|IRP1	protein_coding	P21399	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45401
5.57101321241447e-18	-0.372719143802953	0.68	0.802	8.8066576861848e-14	NAA50	Malignant cells	GSE131984_Pal	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45402
5.65093229934705e-18	-0.291202035314926	0.908	0.967	8.93299377880782e-14	RPL26L1	Malignant cells	GSE131984_Pal	ENSG00000037241	51121	ribosomal protein L26 like 1	RPL26P1	protein_coding	Q9UNX3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45403
5.90665712183144e-18	0.262785834867536	0.33	0.158	9.33724357819113e-14	PTPRS	Malignant cells	GSE131984_Pal	ENSG00000105426	5802	protein tyrosine phosphatase receptor type S	NA	protein_coding	Q13332	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45404
6.06254634269264e-18	-0.409153869287094	0.299	0.479	9.58367325852852e-14	NUP37	Malignant cells	GSE131984_Pal	ENSG00000075188	79023	nucleoporin 37	FLJ22618|MGC5585	protein_coding	Q8NFH4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45405
6.2894751871483e-18	0.289546801032489	0.377	0.196	9.94240237584404e-14	PHLDB1	Malignant cells	GSE131984_Pal	ENSG00000019144	23187	pleckstrin homology like domain family B member 1	FLJ00141|KIAA0638|LL5a	protein_coding	Q86UU1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45406
6.44009915657471e-18	-0.354523296525013	0.492	0.674	1.01805087467133e-13	TMPO	Malignant cells	GSE131984_Pal	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45407
6.47105438344335e-18	-0.33177548178013	0.697	0.815	1.02294427693472e-13	DNMT1	Malignant cells	GSE131984_Pal	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45408
6.69395426862801e-18	-0.331259556438462	0.398	0.59	1.05818029078472e-13	RAB8A	Malignant cells	GSE131984_Pal	ENSG00000167461	4218	RAB8A, member RAS oncogene family	MEL|RAB8	protein_coding	P61006	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45409
6.87121366603044e-18	-0.252103475805251	0.993	0.994	1.08620145632609e-13	NDUFV2	Malignant cells	GSE131984_Pal	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45410
6.95094299117087e-18	-0.354388422064491	0.678	0.817	1.09880506804429e-13	NCOR1	Malignant cells	GSE131984_Pal	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45411
7.00916716612532e-18	-0.351004406544317	0.472	0.654	1.10800914562109e-13	POP4	Malignant cells	GSE131984_Pal	ENSG00000105171	10775	POP4 homolog, ribonuclease P/MRP subunit	RPP29	protein_coding	O95707	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45412
7.02905353259628e-18	0.29202601823478	0.392	0.211	1.11115278243282e-13	EVL	Malignant cells	GSE131984_Pal	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45413
7.06012930956864e-18	-0.368785206277515	0.411	0.589	1.11606524125661e-13	PAQR5	Malignant cells	GSE131984_Pal	ENSG00000137819	54852	progestin and adipoQ receptor family member 5	FLJ20190|MPRG	protein_coding	Q9NXK6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45414
7.36434077841901e-18	-0.376820358122648	0.508	0.666	1.16415499025248e-13	FKBP4	Malignant cells	GSE131984_Pal	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45415
7.52874456826744e-18	-0.381508979181923	0.62	0.754	1.19014394135172e-13	CSRP1	Malignant cells	GSE131984_Pal	ENSG00000159176	1465	cysteine and glycine rich protein 1	CSRP|CYRP|D1S181E	protein_coding	P21291	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45416
7.56158954373017e-18	-0.323267182154025	0.782	0.893	1.19533607507287e-13	ARL5A	Malignant cells	GSE131984_Pal	ENSG00000162980	26225	ADP ribosylation factor like GTPase 5A	ARL5	protein_coding	Q9Y689	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45417
7.79724253249577e-18	0.355481888044375	0.55	0.365	1.23258809953693e-13	ZC3H12A	Malignant cells	GSE131984_Pal	ENSG00000163874	80149	zinc finger CCCH-type containing 12A	FLJ23231|MCPIP1|Regnase-1	protein_coding	Q5D1E8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45418
8.0358588959043e-18	0.304204004373592	0.304	0.142	1.27030857426455e-13	CCNG2	Malignant cells	GSE131984_Pal	ENSG00000138764	901	cyclin G2	NA	protein_coding	Q16589	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45419
8.13420842054686e-18	0.357231118582774	0.68	0.504	1.28585566712005e-13	FADS3	Malignant cells	GSE131984_Pal	ENSG00000221968	3995	fatty acid desaturase 3	CYB5RP|LLCDL3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45420
8.30156791323605e-18	-0.253960555207062	0.974	0.988	1.31231185572435e-13	GNB2	Malignant cells	GSE131984_Pal	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45421
8.47061132397235e-18	-0.282023141619682	0.932	0.973	1.33903423809355e-13	COPE	Malignant cells	GSE131984_Pal	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45422
8.793160187988e-18	-0.295868545063717	0.918	0.959	1.39002276251714e-13	FUS	Malignant cells	GSE131984_Pal	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45423
8.93748728736706e-18	-0.367341409136775	0.561	0.706	1.41283799038698e-13	MRPS35	Malignant cells	GSE131984_Pal	ENSG00000061794	60488	mitochondrial ribosomal protein S35	MDS023|MRPS28	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45424
9.03866682745785e-18	-0.299454336490892	0.981	0.997	1.42883245208454e-13	PSMB1	Malignant cells	GSE131984_Pal	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45425
9.15168047534784e-18	-0.355604038639208	0.538	0.701	1.44669764954299e-13	MRPL48	Malignant cells	GSE131984_Pal	ENSG00000175581	51642	mitochondrial ribosomal protein L48	CGI-118	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45426
9.80427477828095e-18	-0.262487682643653	0.987	0.993	1.54985975695065e-13	SUMO1	Malignant cells	GSE131984_Pal	ENSG00000116030	7341	small ubiquitin like modifier 1	GMP1|OFC10|PIC1|SMT3C|SMT3H3|SUMO-1|UBL1	protein_coding	P63165	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45427
1.01532690843456e-17	-0.350366738833036	0.569	0.718	1.60502877685335e-13	TRIAP1	Malignant cells	GSE131984_Pal	ENSG00000170855	51499	TP53 regulated inhibitor of apoptosis 1	HSPC132|MDM35|P53CSV|WF-1	protein_coding	O43715	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45428
1.05985386526593e-17	-0.396442163688714	0.755	0.832	1.67541699021238e-13	HSPA9	Malignant cells	GSE131984_Pal	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45429
1.08044910809888e-17	0.333791966616702	0.431	0.254	1.70797395008272e-13	ADAM12	Malignant cells	GSE131984_Pal	ENSG00000148848	8038	ADAM metallopeptidase domain 12	MCMPMltna|MLTN	protein_coding	O43184	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45430
1.28988734242888e-17	-0.452999789740563	0.356	0.56	2.03905391091158e-13	PLK1	Malignant cells	GSE131984_Pal	ENSG00000166851	5347	polo like kinase 1	PLK	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45431
1.31007164008086e-17	-0.402274951357384	0.485	0.658	2.07096124863982e-13	PIR	Malignant cells	GSE131984_Pal	ENSG00000087842	8544	pirin	NA	protein_coding	O00625	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45432
1.31725872847825e-17	-0.324495515267726	0.867	0.925	2.08232259797841e-13	POP7	Malignant cells	GSE131984_Pal	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45433
1.32183945095112e-17	-0.362093279199168	0.616	0.743	2.08956380406354e-13	COX11	Malignant cells	GSE131984_Pal	ENSG00000166260	1353	cytochrome c oxidase copper chaperone COX11	COX11P	protein_coding	Q9Y6N1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45434
1.32294580566515e-17	-0.354920638540089	0.713	0.807	2.09131272959546e-13	RWDD4	Malignant cells	GSE131984_Pal	ENSG00000182552	201965	RWD domain containing 4	FAM28A|MGC10198|RWDD4A	protein_coding	Q6NW29	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45435
1.36378578540852e-17	-0.500704416323922	0.281	0.48	2.15587256957378e-13	CDK1	Malignant cells	GSE131984_Pal	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45436
1.3670709734254e-17	-0.384856087637402	0.433	0.601	2.16106579479088e-13	C21orf59	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45437
1.38531981077843e-17	0.308238023431451	0.512	0.327	2.18991355687855e-13	ZSCAN16-AS1	Malignant cells	GSE131984_Pal	ENSG00000269293	100129195	ZSCAN16 antisense RNA 1	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45438
1.39461636559907e-17	-0.33289602579014	0.097	0.256	2.20460955073902e-13	PTN	Malignant cells	GSE131984_Pal	ENSG00000105894	5764	pleiotrophin	HBGF8|HBNF|NEGF1	protein_coding	P21246	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45439
1.44641158561925e-17	-0.346076153227981	0.333	0.519	2.28648743454691e-13	RPIA	Malignant cells	GSE131984_Pal	ENSG00000153574	22934	ribose 5-phosphate isomerase A	NA	protein_coding	P49247	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45440
1.452483978013e-17	-0.363223611637423	0.429	0.619	2.29608667244295e-13	FARSA	Malignant cells	GSE131984_Pal	ENSG00000179115	2193	phenylalanyl-tRNA synthetase subunit alpha	CML33|FARSL|FARSLA	protein_coding	Q9Y285	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45441
1.47277996069296e-17	-0.348455614467129	0.381	0.57	2.32817056186343e-13	RHNO1	Malignant cells	GSE131984_Pal	ENSG00000171792	83695	RAD9-HUS1-RAD1 interacting nuclear orphan 1	C12orf32|HKMT1188|MGC13204|RHINO	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45442
1.70822572878178e-17	0.340736586350699	0.424	0.246	2.70036323205824e-13	CPEB4	Malignant cells	GSE131984_Pal	ENSG00000113742	80315	cytoplasmic polyadenylation element binding protein 4	KIAA1673	protein_coding	Q17RY0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45443
1.79078893199758e-17	-0.553625360030776	0.511	0.66	2.83087914370178e-13	HERPUD1	Malignant cells	GSE131984_Pal	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45444
1.98584139049437e-17	0.29176280333389	0.394	0.215	3.1392180700935e-13	SYNPO	Malignant cells	GSE131984_Pal	ENSG00000171992	11346	synaptopodin	KIAA1029	protein_coding	Q8N3V7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45445
2.03806562564078e-17	-0.359331925036541	0.459	0.645	3.22177414101294e-13	GMPS	Malignant cells	GSE131984_Pal	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45446
2.06109820055997e-17	-0.328772673237417	0.763	0.881	3.2581840354452e-13	SRA1	Malignant cells	GSE131984_Pal	ENSG00000213523	10011	steroid receptor RNA activator 1	SRA|STRAA1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45447
2.29061864297585e-17	-0.3495332717139	0.613	0.746	3.62100995081622e-13	RRP36	Malignant cells	GSE131984_Pal	ENSG00000124541	88745	ribosomal RNA processing 36	C6orf153|dJ20C7.4	protein_coding	Q96EU6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45448
2.33111133489845e-17	-0.392969431410525	0.579	0.711	3.68502079820747e-13	ANP32A	Malignant cells	GSE131984_Pal	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45449
2.40814930818593e-17	-0.324953880610829	0.928	0.975	3.80680242638032e-13	SELK	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45450
2.41710046813132e-17	-0.376368377696579	0.632	0.743	3.82095242002199e-13	POLR3H	Malignant cells	GSE131984_Pal	ENSG00000100413	171568	RNA polymerase III subunit H	C25|KIAA1665|RPC8	protein_coding	Q9Y535	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45451
2.53672788589881e-17	-0.377099270368292	0.257	0.441	4.01005944202883e-13	PSAT1	Malignant cells	GSE131984_Pal	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45452
2.83446643640941e-17	-0.290249267315391	0.97	0.981	4.480724542676e-13	RPS19BP1	Malignant cells	GSE131984_Pal	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45453
3.06767974023845e-17	-0.350806859961204	0.284	0.485	4.84938813336893e-13	SGOL1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45454
3.24115175236305e-17	-0.353333320898232	0.303	0.493	5.12361269013552e-13	C10orf90	Malignant cells	GSE131984_Pal	ENSG00000154493	118611	chromosome 10 open reading frame 90	bA422P15.2|FATS|FLJ32938	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45455
3.27348144784388e-17	0.368253244835233	0.548	0.372	5.17471947275161e-13	LPCAT1	Malignant cells	GSE131984_Pal	ENSG00000275079	79888	lysophosphatidylcholine acyltransferase 1	AGPAT10|AGPAT9|AYTL2|FLJ12443|LPLAT8	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45456
3.43132561345199e-17	-0.295179817585308	0.909	0.961	5.42423952974491e-13	BUD31	Malignant cells	GSE131984_Pal	ENSG00000106245	8896	BUD31 homolog	Cwc14|EDG-2|EDG2|fSAP17|G10|YCR063W	protein_coding	P41223	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45457
3.81164723547668e-17	-0.332928948491412	0.348	0.532	6.02545194984154e-13	PEF1	Malignant cells	GSE131984_Pal	ENSG00000162517	553115	penta-EF-hand domain containing 1	PEF1A	protein_coding	Q9UBV8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45458
3.83241258377984e-17	0.356375440175756	0.69	0.518	6.05827781243917e-13	MARCH6	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45459
3.95000786742818e-17	-0.343228533738365	0.296	0.476	6.24417243683047e-13	WDR77	Malignant cells	GSE131984_Pal	ENSG00000116455	79084	WD repeat domain 77	MEP50|p44	protein_coding	Q9BQA1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45460
3.99678414222247e-17	0.32758289349298	0.827	0.684	6.31811637202528e-13	GTF2I	Malignant cells	GSE131984_Pal	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45461
4.09467155782184e-17	-0.356483707750912	0.444	0.623	6.47285679860477e-13	BAG2	Malignant cells	GSE131984_Pal	ENSG00000112208	9532	BAG cochaperone 2	NA	protein_coding	O95816	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45462
4.479098163057e-17	-0.315269063519733	0.267	0.458	7.0805583761605e-13	NUP54	Malignant cells	GSE131984_Pal	ENSG00000138750	53371	nucleoporin 54	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45463
5.01789616756054e-17	-0.3396676143299	0.649	0.769	7.9322902616797e-13	CCDC59	Malignant cells	GSE131984_Pal	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45464
5.06887677038891e-17	-0.275583918173196	0.945	0.972	8.01288039863079e-13	PPP1CC	Malignant cells	GSE131984_Pal	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45465
5.70335438332678e-17	-0.319607824793191	0.791	0.887	9.01586260916298e-13	ACTR3	Malignant cells	GSE131984_Pal	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45466
5.82642091169408e-17	0.381314863045562	0.426	0.253	9.21040617720601e-13	FBXO32	Malignant cells	GSE131984_Pal	ENSG00000156804	114907	F-box protein 32	ATROGIN1|Fbx32|MAFbx	protein_coding	Q969P5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45467
5.92718577757288e-17	-0.26650575521887	0.977	0.994	9.36969527718721e-13	SF3B14	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45468
6.10572088841196e-17	-0.349188901834366	0.38	0.559	9.65192358040162e-13	WDR74	Malignant cells	GSE131984_Pal	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45469
6.17166402136847e-17	-0.304811248176594	0.231	0.42	9.75616648497927e-13	C14orf80	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45470
6.6853292763362e-17	-0.305073428842727	0.212	0.396	1.05681685200323e-12	COQ3	Malignant cells	GSE131984_Pal	ENSG00000132423	51805	coenzyme Q3, methyltransferase	bA9819.1	protein_coding	Q9NZJ6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45471
6.76445304498587e-17	-0.371634871494542	0.639	0.771	1.06932473735137e-12	COPS3	Malignant cells	GSE131984_Pal	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45472
6.96039005866259e-17	-0.327056328838892	0.652	0.79	1.10029846047338e-12	SUCLA2	Malignant cells	GSE131984_Pal	ENSG00000136143	8803	succinate-CoA ligase ADP-forming subunit beta	LINC00444	protein_coding	Q9P2R7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45473
7.33688852139362e-17	-0.319645519083265	0.208	0.391	1.1598153374619e-12	ATAD3B	Malignant cells	GSE131984_Pal	ENSG00000160072	83858	ATPase family AAA domain containing 3B	KIAA1273|TOB3	protein_coding	Q5T9A4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45474
8.01200772505862e-17	0.272617897072412	0.317	0.154	1.26653818117727e-12	RIPK4	Malignant cells	GSE131984_Pal	ENSG00000183421	54101	receptor interacting serine/threonine kinase 4	ANKK2|ANKRD3|DIK|PKK|RIP4	protein_coding	P57078	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45475
8.04952489367832e-17	-0.257397775474764	0.097	0.254	1.27246889519267e-12	PPAPDC1A	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45476
8.15269088237124e-17	-0.318733589009748	0.341	0.521	1.28877737468524e-12	CHCHD4	Malignant cells	GSE131984_Pal	ENSG00000163528	131474	coiled-coil-helix-coiled-coil-helix domain containing 4	FLJ31709|MIA40|TIMM40	protein_coding	Q8N4Q1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45477
8.35184451519736e-17	-0.362771509807164	0.82	0.872	1.3202595809624e-12	PSMG3	Malignant cells	GSE131984_Pal	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45478
8.39735444744292e-17	-0.37077035754233	0.548	0.702	1.32745379105178e-12	PDCD10	Malignant cells	GSE131984_Pal	ENSG00000114209	11235	programmed cell death 10	CCM3|TFAR15	protein_coding	Q9BUL8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45479
8.4461911581601e-17	0.293634416556426	0.391	0.213	1.33517389828195e-12	COL5A2	Malignant cells	GSE131984_Pal	ENSG00000204262	1290	collagen type V alpha 2 chain	NA	protein_coding	P05997	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45480
8.5393221471723e-17	0.337318810623487	0.609	0.447	1.349896045025e-12	FAM210B	Malignant cells	GSE131984_Pal	ENSG00000124098	116151	family with sequence similarity 210 member B	C20orf108|dJ1167H4.1|DKFZP434A1114	protein_coding	Q96KR6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45481
8.60497604662748e-17	-0.32083207541864	0.762	0.847	1.36027461345087e-12	CCDC34	Malignant cells	GSE131984_Pal	ENSG00000109881	91057	coiled-coil domain containing 34	L15|NY-REN-41|RAMA3	protein_coding	Q96HJ3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45482
8.65153669667591e-17	-0.328668583222517	0.439	0.619	1.36763492101053e-12	ENDOG	Malignant cells	GSE131984_Pal	ENSG00000167136	2021	endonuclease G	NA	protein_coding	Q14249	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45483
9.22983639436594e-17	-0.326394400973646	0.824	0.921	1.45905253722137e-12	CD320	Malignant cells	GSE131984_Pal	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45484
9.43798032882052e-17	0.318269814221539	0.986	0.981	1.49195593037995e-12	RAB13	Malignant cells	GSE131984_Pal	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45485
9.452151589853e-17	0.294828811072314	0.547	0.36	1.49419612332396e-12	SERINC1	Malignant cells	GSE131984_Pal	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45486
9.80381743177051e-17	-0.354109992738389	0.427	0.598	1.54978745961428e-12	SKP2	Malignant cells	GSE131984_Pal	ENSG00000145604	6502	S-phase kinase associated protein 2	FBL1|FBXL1|p45	protein_coding	Q13309	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45487
1.05073844824767e-16	-0.393208201211061	0.359	0.531	1.66100733898991e-12	AC074389.9	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45488
1.08328758482859e-16	0.376206166797034	0.582	0.405	1.71246101409703e-12	DDX17	Malignant cells	GSE131984_Pal	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45489
1.18642590471928e-16	-0.253773813563114	0.961	0.984	1.87550207018023e-12	ATP5J2	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45490
1.22235379142467e-16	-0.315864481388059	0.33	0.516	1.93229687348412e-12	CIAPIN1	Malignant cells	GSE131984_Pal	ENSG00000005194	57019	cytokine induced apoptosis inhibitor 1	CIAE2	protein_coding	Q6FI81	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45491
1.29466652894031e-16	-0.338521233352133	0.463	0.631	2.04660884894884e-12	NSMCE4A	Malignant cells	GSE131984_Pal	ENSG00000107672	54780	NSE4 homolog A, SMC5-SMC6 complex component	bA500G22.3|C10orf86|FLJ20003|NSE4A	protein_coding	Q9NXX6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45492
1.45653161660231e-16	-0.335439437908185	0.641	0.778	2.30248517952493e-12	SRPK1	Malignant cells	GSE131984_Pal	ENSG00000096063	6732	SRSF protein kinase 1	SFRSK1	protein_coding	Q96SB4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45493
1.48778275729793e-16	-0.32685539729417	0.724	0.829	2.35188698273657e-12	ORMDL1	Malignant cells	GSE131984_Pal	ENSG00000128699	94101	ORMDL sphingolipid biosynthesis regulator 1	NA	protein_coding	Q9P0S3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45494
1.53373999138486e-16	-0.264960328719656	0.916	0.958	2.42453617838119e-12	TBCB	Malignant cells	GSE131984_Pal	ENSG00000105254	1155	tubulin folding cofactor B	CG22|CKAP1|CKAPI	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45495
1.54360623339444e-16	-0.325307819303703	0.375	0.554	2.44013273374993e-12	UCK2	Malignant cells	GSE131984_Pal	ENSG00000143179	7371	uridine-cytidine kinase 2	UMPK	protein_coding	Q9BZX2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45496
1.59110745315634e-16	-0.322505407561086	0.649	0.792	2.51522266194955e-12	PRKRA	Malignant cells	GSE131984_Pal	ENSG00000180228	8575	protein activator of interferon induced protein kinase EIF2AK2	DYT16|HSD14|PACT|RAX	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45497
1.59175692360914e-16	-0.364782102368714	0.661	0.774	2.51624934484133e-12	NASP	Malignant cells	GSE131984_Pal	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45498
1.60556658237919e-16	0.373262371229106	0.779	0.625	2.53807965342503e-12	DST	Malignant cells	GSE131984_Pal	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45499
1.62449102027898e-16	-0.336134046693355	0.752	0.86	2.56799540485701e-12	MRPL32	Malignant cells	GSE131984_Pal	ENSG00000106591	64983	mitochondrial ribosomal protein L32	bMRP-59b|HSPC283|L32mt|MRP-L32	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45500
1.63963071995816e-16	0.294086067696506	0.455	0.275	2.59192824210985e-12	TNS3	Malignant cells	GSE131984_Pal	ENSG00000136205	64759	tensin 3	FLJ13732|H_NH0549I23.2|TEM6|TENS1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45501
1.6879953040429e-16	0.28431941698684	0.44	0.259	2.66838297663102e-12	BEST1	Malignant cells	GSE131984_Pal	ENSG00000167995	7439	bestrophin 1	BEST|BMD|RP50|VMD2	protein_coding	O76090	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45502
1.71076737883291e-16	-0.402894818960195	0.499	0.656	2.70438107245906e-12	RPF2	Malignant cells	GSE131984_Pal	ENSG00000197498	84154	ribosome production factor 2 homolog	bA397G5.4|BXDC1|FLJ21087	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45503
1.75736854905907e-16	-0.37253181875612	0.494	0.644	2.77804820235257e-12	SNW1	Malignant cells	GSE131984_Pal	ENSG00000100603	22938	SNW domain containing 1	Bx42|FUN20|NCoA-62|Prp45|PRPF45|SKIIP|SKIP|SKIP1	protein_coding	Q13573	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45504
1.98238669411874e-16	-0.345416033494577	0.42	0.593	3.13375688606291e-12	THOC6	Malignant cells	GSE131984_Pal	ENSG00000131652	79228	THO complex subunit 6	fSAP35|MGC2655|WDR58	protein_coding	Q86W42	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45505
2.08006894165158e-16	-0.332297984050705	0.437	0.612	3.28817298296281e-12	PSIP1	Malignant cells	GSE131984_Pal	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45506
2.103551786365e-16	-0.380336275053722	0.38	0.563	3.32529466388579e-12	TUBB2A	Malignant cells	GSE131984_Pal	ENSG00000137267	7280	tubulin beta 2A class IIa	dJ40E16.7|TUBB|TUBB2	protein_coding	Q13885	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45507
2.29215186656724e-16	-0.344437352810995	0.625	0.758	3.62343367066949e-12	CCDC109B	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45508
2.29891841340155e-16	-0.258374564211667	0.952	0.98	3.63413022790516e-12	NDUFB8.1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45509
2.43076484629299e-16	-0.314355020847465	0.706	0.827	3.84255306901997e-12	PDZD11	Malignant cells	GSE131984_Pal	ENSG00000120509	51248	PDZ domain containing 11	PDZK11	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45510
2.55783469684184e-16	-0.323356901311696	0.183	0.354	4.04342508876758e-12	MEST	Malignant cells	GSE131984_Pal	ENSG00000106484	4232	mesoderm specific transcript	PEG1	protein_coding	Q5EB52	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45511
2.5781484350005e-16	-0.371549218960766	0.323	0.5	4.0755370460488e-12	PNO1	Malignant cells	GSE131984_Pal	ENSG00000115946	56902	partner of NOB1 homolog	KHRBP1|RRP20	protein_coding	Q9NRX1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45512
2.75051080385827e-16	-0.307957579328352	0.375	0.557	4.34800747873916e-12	REXO4	Malignant cells	GSE131984_Pal	ENSG00000280706	57109	REX4 homolog, 3'-5' exonuclease	hPMC2|XPMC2H	protein_coding	Q9GZR2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45513
2.7909056909593e-16	-0.318523901493703	0.361	0.543	4.41186371626846e-12	METTL21A	Malignant cells	GSE131984_Pal	ENSG00000144401	151194	methyltransferase 21A, HSPA lysine	FAM119A|HCA557b|HSPA-KMT|LOC151194	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45514
2.80748186070011e-16	-0.339627858638742	0.975	0.99	4.43806732539473e-12	CCDC85B	Malignant cells	GSE131984_Pal	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45515
2.8250975808766e-16	0.37030647131524	0.949	0.898	4.46591425584972e-12	GLRX	Malignant cells	GSE131984_Pal	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45516
2.86449640719981e-16	-0.285538383173837	0.857	0.921	4.52819592050146e-12	SAP18	Malignant cells	GSE131984_Pal	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45517
2.99133544189466e-16	0.299237597214254	0.466	0.287	4.72870306654707e-12	FOXO3	Malignant cells	GSE131984_Pal	ENSG00000118689	2309	forkhead box O3	AF6q21|FKHRL1|FOXO2|FOXO3A	protein_coding	O43524	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45518
2.9964917094742e-16	-0.306130138457435	0.222	0.401	4.73685409433682e-12	PRR16	Malignant cells	GSE131984_Pal	ENSG00000184838	51334	proline rich 16	DSC54	protein_coding	Q569H4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45519
3.055249850746e-16	0.257911654089978	0.367	0.194	4.82973896405928e-12	BCOR	Malignant cells	GSE131984_Pal	ENSG00000183337	54880	BCL6 corepressor	FLJ20285|KIAA1575	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45520
3.14056525863896e-16	-0.370359114961907	0.525	0.671	4.96460556085646e-12	NETO2	Malignant cells	GSE131984_Pal	ENSG00000171208	81831	neuropilin and tolloid like 2	FLJ10430|NEOT2	protein_coding	Q8NC67	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45521
3.1510089472212e-16	0.356017677203191	0.703	0.535	4.98111494376728e-12	MPRIP	Malignant cells	GSE131984_Pal	ENSG00000133030	23164	myosin phosphatase Rho interacting protein	M-RIP|p116Rip|RHOIP3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45522
3.21703248098724e-16	-0.335979777591958	0.724	0.828	5.08548494594462e-12	EIF3J	Malignant cells	GSE131984_Pal	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45523
3.25967870388437e-16	-0.317407724234798	0.271	0.446	5.15290009510041e-12	NUBP1	Malignant cells	GSE131984_Pal	ENSG00000103274	4682	NUBP iron-sulfur cluster assembly factor 1, cytosolic	CIAO5|NBP1|NBP35	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45524
3.30933410008209e-16	0.282000062180002	0.414	0.237	5.23139534540977e-12	BCL3	Malignant cells	GSE131984_Pal	ENSG00000069399	602	BCL3 transcription coactivator	BCL4|D19S37	protein_coding	P20749	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45525
3.51860823041916e-16	-0.466765762765822	0.872	0.905	5.56221589064661e-12	GADD45A	Malignant cells	GSE131984_Pal	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45526
3.54371152577955e-16	-0.40041981726414	0.56	0.687	5.60189917995232e-12	NOP58	Malignant cells	GSE131984_Pal	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45527
3.62091854176692e-16	0.329413199323818	0.584	0.403	5.72394803082514e-12	ZBTB16	Malignant cells	GSE131984_Pal	ENSG00000109906	7704	zinc finger and BTB domain containing 16	PLZF|ZNF145	protein_coding	Q05516	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45528
3.70339577039534e-16	-0.25416656702193	0.986	0.994	5.85432803384095e-12	C14orf166	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45529
3.74099133588446e-16	0.35692037058685	0.6	0.425	5.91375910376616e-12	NFKBIZ	Malignant cells	GSE131984_Pal	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45530
3.92640571830537e-16	-0.338790295641711	0.734	0.818	6.20686215949714e-12	GTF2F2	Malignant cells	GSE131984_Pal	ENSG00000188342	2963	general transcription factor IIF subunit 2	BTF4|RAP30|TFIIF	protein_coding	P13984	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45531
4.01269930313995e-16	0.279941695562439	0.426	0.25	6.34327505840363e-12	RXRA	Malignant cells	GSE131984_Pal	ENSG00000186350	6256	retinoid X receptor alpha	NR2B1|RXR-alpha|RXRalpha	protein_coding	P19793	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45532
4.05175089478319e-16	-0.28323137971242	0.913	0.961	6.40500781447326e-12	COA4	Malignant cells	GSE131984_Pal	ENSG00000181924	51287	cytochrome c oxidase assembly factor 4 homolog	CHCHD8|CMC3|E2IG2	protein_coding	Q9NYJ1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45533
4.08294955057397e-16	-0.40705750107441	0.486	0.634	6.45432664954732e-12	FOSL1	Malignant cells	GSE131984_Pal	ENSG00000175592	8061	FOS like 1, AP-1 transcription factor subunit	fra-1	protein_coding	P15407	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45534
4.25546867355989e-16	0.356123556346627	0.755	0.617	6.72704487916347e-12	TGFBR2	Malignant cells	GSE131984_Pal	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45535
4.4169616159872e-16	-0.297366033660047	0.811	0.9	6.98233292255256e-12	BAX	Malignant cells	GSE131984_Pal	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45536
4.81390429390113e-16	0.335765571868552	0.478	0.304	7.60981990779891e-12	PHLDB2	Malignant cells	GSE131984_Pal	ENSG00000144824	90102	pleckstrin homology like domain family B member 2	FLJ21791|LL5b|LL5beta	protein_coding	Q86SQ0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45537
4.99135173563568e-16	-0.367260769719964	0.569	0.707	7.89032882369288e-12	SURF2	Malignant cells	GSE131984_Pal	ENSG00000281024	6835	surfeit 2	NA	protein_coding	Q15527	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45538
4.99968396665938e-16	0.257865834547217	0.452	0.267	7.90350041449514e-12	PLEKHA2	Malignant cells	GSE131984_Pal	ENSG00000169499	59339	pleckstrin homology domain containing A2	TAPP2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45539
5.00490987419348e-16	-0.396629591949482	0.43	0.599	7.91176152912505e-12	TNNT1	Malignant cells	GSE131984_Pal	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45540
5.26290884608218e-16	0.308604743737106	0.846	0.715	8.31960630388671e-12	AES	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45541
5.47804396680762e-16	0.347632900552751	0.612	0.46	8.65969190272949e-12	OSMR	Malignant cells	GSE131984_Pal	ENSG00000145623	9180	oncostatin M receptor	OSMRB|OSMRbeta	protein_coding	Q99650	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45542
5.55271039484862e-16	0.326211772868724	0.563	0.391	8.7777245921767e-12	PDGFRA	Malignant cells	GSE131984_Pal	ENSG00000134853	5156	platelet derived growth factor receptor alpha	CD140a|GAS9|PDGFR2	protein_coding	P16234	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45543
5.56761334010435e-16	-0.262451997756751	0.977	0.99	8.80128316803696e-12	TUFM	Malignant cells	GSE131984_Pal	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45544
5.65305060635199e-16	-0.289424251115754	0.215	0.401	8.93634239852122e-12	CDCA5	Malignant cells	GSE131984_Pal	ENSG00000146670	113130	cell division cycle associated 5	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45545
6.39490624002223e-16	-0.348588303564542	0.628	0.762	1.01090677842271e-11	PFKP	Malignant cells	GSE131984_Pal	ENSG00000067057	5214	phosphofructokinase, platelet	PFK-C|PFKF	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45546
6.60052300846385e-16	-0.363843720092676	0.645	0.761	1.04341067717796e-11	RAB9A	Malignant cells	GSE131984_Pal	ENSG00000123595	9367	RAB9A, member RAS oncogene family	RAB9	protein_coding	P51151	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45547
7.76647175776715e-16	-0.308656867346139	0.284	0.463	1.22772385546783e-11	CCDC137	Malignant cells	GSE131984_Pal	ENSG00000185298	339230	coiled-coil domain containing 137	MGC16597	protein_coding	Q6PK04	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45548
8.6673236194251e-16	-0.404638103936789	0.582	0.704	1.37013051775872e-11	MAGEA3	Malignant cells	GSE131984_Pal	ENSG00000221867	4102	MAGE family member A3	CT1.3|HIP8|HYPD|MAGE3|MGC14613	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45549
8.67374672237067e-16	-0.314831744392527	0.338	0.518	1.37114588187235e-11	MRPS31	Malignant cells	GSE131984_Pal	ENSG00000102738	10240	mitochondrial ribosomal protein S31	IMOGN38	protein_coding	Q92665	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45550
9.15325027289449e-16	-0.351570925495804	0.394	0.562	1.44694580313916e-11	WBP4	Malignant cells	GSE131984_Pal	ENSG00000120688	11193	WW domain binding protein 4	FBP21|MGC117310	protein_coding	O75554	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45551
9.32003510182059e-16	-0.305890981890126	0.781	0.853	1.4733111488958e-11	DDX1	Malignant cells	GSE131984_Pal	ENSG00000079785	1653	DEAD-box helicase 1	DBP-RB	protein_coding	Q92499	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45552
9.42558736860414e-16	-0.530561664113631	0.465	0.61	1.48999685122894e-11	CDA	Malignant cells	GSE131984_Pal	ENSG00000158825	978	cytidine deaminase	CDD	protein_coding	P32320	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45553
9.98409295894444e-16	-0.344799458369008	0.574	0.721	1.57828541494994e-11	POLE3	Malignant cells	GSE131984_Pal	ENSG00000148229	54107	DNA polymerase epsilon 3, accessory subunit	CHARAC17|CHRAC17|CHRAC2|p17|Ybl1	protein_coding	Q9NRF9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45554
1.00648141483981e-15	-0.316954955953035	0.753	0.855	1.59104582057876e-11	SUCLG1	Malignant cells	GSE131984_Pal	ENSG00000163541	8802	succinate-CoA ligase GDP/ADP-forming subunit alpha	NA	protein_coding	P53597	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45555
1.01841348546839e-15	-0.323991424677504	0.724	0.833	1.60990803782843e-11	MCUR1	Malignant cells	GSE131984_Pal	ENSG00000050393	63933	mitochondrial calcium uniporter regulator 1	C6orf79|CCDC90A|FLJ20958	protein_coding	Q96AQ8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45556
1.01954427395945e-15	0.339497045902709	0.732	0.598	1.6116955882751e-11	HIPK2	Malignant cells	GSE131984_Pal	ENSG00000064393	28996	homeodomain interacting protein kinase 2	NA	protein_coding	Q9H2X6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45557
1.03241949651239e-15	-0.32867515023368	1	1	1.63204874008678e-11	ANXA2	Malignant cells	GSE131984_Pal	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45558
1.04603737792707e-15	0.320714542687739	0.625	0.462	1.65357588702711e-11	STAT3	Malignant cells	GSE131984_Pal	ENSG00000168610	6774	signal transducer and activator of transcription 3	APRF	protein_coding	P40763	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45559
1.09689806956763e-15	0.30571698376029	0.615	0.444	1.73397646837251e-11	FNDC3B	Malignant cells	GSE131984_Pal	ENSG00000075420	64778	fibronectin type III domain containing 3B	DKFZp762K137|FAD104|FLJ23399|PRO4979|YVTM2421	protein_coding	Q53EP0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45560
1.0973338968116e-15	-0.291537341565517	0.745	0.867	1.73466542407978e-11	HIGD1A	Malignant cells	GSE131984_Pal	ENSG00000181061	25994	HIG1 hypoxia inducible domain family member 1A	DKFZP564K247|HIG1|RCF1A	protein_coding	Q9Y241	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45561
1.11753268913894e-15	0.288013562072515	0.391	0.223	1.76659567499084e-11	AMOTL2	Malignant cells	GSE131984_Pal	ENSG00000114019	51421	angiomotin like 2	LCCP	protein_coding	Q9Y2J4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45562
1.12617438935449e-15	0.369601966472197	0.589	0.424	1.78025647469157e-11	MIDN	Malignant cells	GSE131984_Pal	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45563
1.14152663416417e-15	-0.254649342649182	0.124	0.284	1.80452530328672e-11	MTERFD1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45564
1.14691279846697e-15	-0.282529393990403	0.86	0.914	1.81303975181659e-11	EIF4E2	Malignant cells	GSE131984_Pal	ENSG00000135930	9470	eukaryotic translation initiation factor 4E family member 2	4EHP|EIF4EL3|IF4e	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45565
1.20504342957294e-15	0.299425387567644	0.449	0.281	1.90493265346891e-11	TFDP2	Malignant cells	GSE131984_Pal	ENSG00000114126	7029	transcription factor Dp-2	Dp-2	protein_coding	Q14188	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45566
1.2172351015549e-15	0.338359405669577	0.547	0.363	1.92420524853798e-11	MAOA	Malignant cells	GSE131984_Pal	ENSG00000189221	4128	monoamine oxidase A	NA	protein_coding	P21397	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45567
1.2393470070696e-15	-0.322409745465854	0.726	0.805	1.95915974877563e-11	ITPA	Malignant cells	GSE131984_Pal	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45568
1.27732881356704e-15	-0.331359187830241	0.494	0.67	2.01920138848678e-11	SMC2	Malignant cells	GSE131984_Pal	ENSG00000136824	10592	structural maintenance of chromosomes 2	CAP-E|hCAP-E|SMC2L1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45569
1.31024367578857e-15	-0.326878852302681	0.691	0.796	2.07123320268657e-11	TMCO1	Malignant cells	GSE131984_Pal	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45570
1.35584372700483e-15	-0.31171234050809	0.716	0.828	2.14331776364923e-11	DNAJC8	Malignant cells	GSE131984_Pal	ENSG00000285317	22826	DnaJ heat shock protein family (Hsp40) member C8	SPF31	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45571
1.54955454580334e-15	-0.324748570143353	0.502	0.67	2.44953582600592e-11	TFAM	Malignant cells	GSE131984_Pal	ENSG00000108064	7019	transcription factor A, mitochondrial	TCF6|TCF6L2	protein_coding	Q00059	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45572
1.56532793838172e-15	0.262218274889802	0.41	0.236	2.47447040499382e-11	CD99L2	Malignant cells	GSE131984_Pal	ENSG00000102181	83692	CD99 molecule like 2	CD99B|MIC2L1	protein_coding	Q8TCZ2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45573
1.61762471409729e-15	-0.340809483906222	0.427	0.601	2.557141148045e-11	TXNDC12	Malignant cells	GSE131984_Pal	ENSG00000117862	51060	thioredoxin domain containing 12	AGR1|ERP18|ERP19|hAG-1|PDIA16|TLP19	protein_coding	O95881	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45574
1.63938748128832e-15	-0.299263750284993	0.957	0.98	2.59154373042058e-11	C17orf89	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45575
1.6436573035177e-15	-0.454737208489438	0.648	0.752	2.59829346540077e-11	PSMD6	Malignant cells	GSE131984_Pal	ENSG00000163636	9861	proteasome 26S subunit, non-ATPase 6	KIAA0107|p44S10|Rpn7|S10	protein_coding	Q15008	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45576
1.66692197669363e-15	-0.313654955550242	0.473	0.628	2.63507026075729e-11	C16orf91	Malignant cells	GSE131984_Pal	ENSG00000174109	283951	chromosome 16 open reading frame 91	CCSMST1|gs103|URLC5	protein_coding	Q4G0I0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45577
1.67886060819586e-15	0.312821727916638	0.59	0.419	2.65394284943601e-11	UBE2H	Malignant cells	GSE131984_Pal	ENSG00000186591	7328	ubiquitin conjugating enzyme E2 H	GID3|UBC8|UBCH	protein_coding	P62256	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45578
1.79404743822084e-15	0.299258478752561	0.652	0.487	2.8360301903395e-11	ADAM15	Malignant cells	GSE131984_Pal	ENSG00000143537	8751	ADAM metallopeptidase domain 15	MDC15	protein_coding	Q13444	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45579
1.79633501142962e-15	0.294712754414203	0.964	0.953	2.83964638606795e-11	COMMD6	Malignant cells	GSE131984_Pal	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45580
1.85304729532317e-15	-0.287632536908944	0.856	0.912	2.92929716444686e-11	MRPL55	Malignant cells	GSE131984_Pal	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45581
1.889162025346e-15	-0.322374622656985	0.3	0.48	2.98638732966696e-11	CHAF1A	Malignant cells	GSE131984_Pal	ENSG00000167670	10036	chromatin assembly factor 1 subunit A	CAF-1|CAF1|CAF1B|CAF1P150|MGC71229|P150	protein_coding	Q13111	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45582
1.91655547162884e-15	-0.352362470941917	0.483	0.637	3.02969088955088e-11	RNASEH2A	Malignant cells	GSE131984_Pal	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45583
1.92924878265449e-15	0.292919090542621	0.962	0.91	3.04975647562021e-11	CAMLG	Malignant cells	GSE131984_Pal	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45584
1.94337341042086e-15	-0.410638190628385	0.583	0.695	3.0720846871933e-11	AIMP2	Malignant cells	GSE131984_Pal	ENSG00000106305	7965	aminoacyl tRNA synthetase complex interacting multifunctional protein 2	JTV-1|JTV1|p38|PRO0992	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45585
1.95256759972359e-15	-0.285348722116808	0.258	0.438	3.08661886164305e-11	NGDN	Malignant cells	GSE131984_Pal	ENSG00000129460	25983	neuroguidin	C14orf120|CANu1|DKFZP564O092|LCP5|lpd-2|NGD	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45586
1.98521218837192e-15	-0.324140751826748	0.701	0.792	3.13822342737834e-11	PPIG	Malignant cells	GSE131984_Pal	ENSG00000138398	9360	peptidylprolyl isomerase G	CARS-Cyp|SCAF10|SRCyp	protein_coding	Q13427	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45587
2.16494144240947e-15	-0.328971248948414	0.418	0.591	3.42233943216089e-11	UAP1	Malignant cells	GSE131984_Pal	ENSG00000117143	6675	UDP-N-acetylglucosamine pyrophosphorylase 1	AgX|AGX1|SPAG2	protein_coding	Q16222	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45588
2.19045425354014e-15	-0.373877276102822	0.502	0.657	3.46267008399626e-11	SQLE	Malignant cells	GSE131984_Pal	ENSG00000104549	6713	squalene epoxidase	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45589
2.21177859877303e-15	0.353172685074586	0.996	0.98	3.4963796089404e-11	NNMT	Malignant cells	GSE131984_Pal	ENSG00000166741	4837	nicotinamide N-methyltransferase	NA	protein_coding	P40261	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45590
2.22184557390502e-15	-0.349863775212788	0.509	0.646	3.51229348322906e-11	YARS	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45591
2.248064508565e-15	-0.337695210340319	0.652	0.784	3.55374037513955e-11	CBX1	Malignant cells	GSE131984_Pal	ENSG00000108468	10951	chromobox 1	CBX|HP1-BETA|HP1Hs-beta|M31|MOD1	protein_coding	P83916	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45592
2.26306265906998e-15	-0.322395510342627	0.335	0.506	3.57744945145782e-11	DNTTIP2	Malignant cells	GSE131984_Pal	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45593
2.43062197533998e-15	-0.299669656691236	0.206	0.376	3.84232721861744e-11	FAM86A	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45594
2.47741915004208e-15	-0.27768025585287	0.284	0.473	3.91630419238652e-11	CENPU	Malignant cells	GSE131984_Pal	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45595
2.53062110550301e-15	-0.329917314152191	0.414	0.577	4.00040584357916e-11	DERL2	Malignant cells	GSE131984_Pal	ENSG00000072849	51009	derlin 2	CGI-101|derlin-2|F-LAN-1|F-LANa|FLANa	protein_coding	Q9GZP9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45596
2.66657664270503e-15	-0.344475332962394	0.426	0.58	4.21532435678812e-11	KNOP1	Malignant cells	GSE131984_Pal	ENSG00000103550	400506	lysine rich nucleolar protein 1	101F10.1|C16orf88|FAM191A|TSG118	protein_coding	Q1ED39	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45597
2.72355839695776e-15	0.279297868261652	0.463	0.287	4.30540111391083e-11	PTPRE	Malignant cells	GSE131984_Pal	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45598
2.78860629042437e-15	-0.315406474234588	0.626	0.761	4.40822882390284e-11	PRPF31	Malignant cells	GSE131984_Pal	ENSG00000274651	26121	pre-mRNA processing factor 31	hPrp31|NY-BR-99|PRP31|RP11|SNRNP61	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45599
2.85946092666418e-15	0.268676638902891	0.348	0.187	4.52023583287074e-11	SPRY4	Malignant cells	GSE131984_Pal	ENSG00000187678	81848	sprouty RTK signaling antagonist 4	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45600
3.01025472583117e-15	-0.254886720636565	0.993	0.998	4.75861067059392e-11	PEBP1	Malignant cells	GSE131984_Pal	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45601
3.03218478379407e-15	0.329714886460152	0.786	0.673	4.79327770622167e-11	POLD4	Malignant cells	GSE131984_Pal	ENSG00000175482	57804	DNA polymerase delta 4, accessory subunit	p12|POLDS	protein_coding	Q9HCU8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45602
3.1305094105534e-15	-0.300375781798293	0.658	0.783	4.94870927620281e-11	MRPS18B	Malignant cells	GSE131984_Pal	ENSG00000233813	28973	mitochondrial ribosomal protein S18B	C6orf14|HSPC183|MRPS18-2|PTD017	protein_coding	Q9Y676	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45603
3.20642909483762e-15	-0.314243918052627	0.328	0.504	5.06872311311931e-11	NIP7	Malignant cells	GSE131984_Pal	ENSG00000132603	51388	nucleolar pre-rRNA processing protein NIP7	CGI-37|FLJ10296|HSPC031|KD93	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45604
3.31543017425543e-15	-0.338368625631354	0.716	0.82	5.24103201946298e-11	FUNDC2	Malignant cells	GSE131984_Pal	ENSG00000165775	65991	FUN14 domain containing 2	DC44|HCBP6	protein_coding	Q9BWH2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45605
3.38109055597623e-15	0.37293845707729	0.551	0.402	5.34482795088723e-11	HEG1	Malignant cells	GSE131984_Pal	ENSG00000173706	57493	heart development protein with EGF like domains 1	HEG|KIAA1237	protein_coding	Q9ULI3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45606
3.39981400277017e-15	-0.27087178748821	0.281	0.459	5.37442597557908e-11	MCAT	Malignant cells	GSE131984_Pal	ENSG00000100294	27349	malonyl-CoA-acyl carrier protein transacylase	fabD|FASN2C|MCT|MCT1|MT|NET62	protein_coding	Q8IVS2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45607
3.44573702504053e-15	-0.299552988403834	0.121	0.276	5.44702108918406e-11	TSPAN8	Malignant cells	GSE131984_Pal	ENSG00000127324	7103	tetraspanin 8	CO-029|TM4SF3	protein_coding	P19075	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45608
3.53666755329677e-15	-0.323918456960091	0.984	0.997	5.59076406825153e-11	ATP5B	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45609
3.5410120748402e-15	-0.319195733331756	0.482	0.637	5.59763188790739e-11	FAM49B	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45610
3.6001132323186e-15	-0.296829126408202	0.691	0.809	5.69105899764925e-11	SRSF1	Malignant cells	GSE131984_Pal	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45611
3.66065502131528e-15	-0.265440237489307	0.911	0.957	5.7867634576952e-11	UQCC2	Malignant cells	GSE131984_Pal	ENSG00000137288	84300	ubiquinol-cytochrome c reductase complex assembly factor 2	bA6B20.2|C6orf125|Cbp6|M19|MGC14833|MNF1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45612
3.82253779962582e-15	-0.323283451516563	0.569	0.708	6.04266775364849e-11	SRSF4	Malignant cells	GSE131984_Pal	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45613
3.87019960841734e-15	-0.303188668200121	0.446	0.616	6.11801154098612e-11	TMX1	Malignant cells	GSE131984_Pal	ENSG00000139921	81542	thioredoxin related transmembrane protein 1	PDIA11|TMX|TXNDC|TXNDC1	protein_coding	Q9H3N1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45614
3.89601210499356e-15	-0.319329191208068	0.115	0.267	6.15881593557382e-11	HIST1H1D	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45615
3.9269977964036e-15	-0.327830916325786	0.32	0.5	6.20779811655481e-11	PPAN	Malignant cells	GSE131984_Pal	ENSG00000130810	56342	peter pan homolog	BXDC3|SSF|SSF1|SSF2	protein_coding	Q9NQ55	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45616
4.06444254972598e-15	-0.300578503503183	0.505	0.666	6.42507078260683e-11	ABCE1	Malignant cells	GSE131984_Pal	ENSG00000164163	6059	ATP binding cassette subfamily E member 1	OABP|RLI|RLI1|RNASEL1|RNASELI|RNS4I	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45617
4.17398131143316e-15	-0.28617467409581	0.889	0.938	6.59822965711354e-11	PRDX3	Malignant cells	GSE131984_Pal	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45618
4.35381530040016e-15	0.330809732579273	0.615	0.45	6.88251122687257e-11	MGEA5	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45619
4.54022097135233e-15	-0.313677872012733	0.413	0.574	7.17718131151376e-11	WDR18	Malignant cells	GSE131984_Pal	ENSG00000065268	57418	WD repeat domain 18	Ipi3	protein_coding	Q9BV38	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45620
4.77127399073572e-15	0.314269003692702	0.759	0.615	7.54242992455503e-11	NME3	Malignant cells	GSE131984_Pal	ENSG00000103024	4832	NME/NM23 nucleoside diphosphate kinase 3	DR-nm23|NDPKC|NM23-H3	protein_coding	Q13232	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45621
4.80928592531018e-15	-0.258560770330883	0.973	0.988	7.60251919073032e-11	RBX1	Malignant cells	GSE131984_Pal	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45622
4.90504036260892e-15	-0.36347629489245	0.495	0.641	7.75388780521219e-11	CYB5B	Malignant cells	GSE131984_Pal	ENSG00000103018	80777	cytochrome b5 type B	CYB5-M	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45623
4.90661571054462e-15	-0.351128773654569	0.426	0.598	7.75637811522894e-11	IDI1	Malignant cells	GSE131984_Pal	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45624
4.9620185306084e-15	-0.294812608836675	0.315	0.498	7.84395889318575e-11	SPRYD7	Malignant cells	GSE131984_Pal	ENSG00000123178	57213	SPRY domain containing 7	C13orf1|CLLD6	protein_coding	Q5W111	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45625
5.01146357442563e-15	-0.319594080485968	0.545	0.692	7.92212161845204e-11	MRPL50	Malignant cells	GSE131984_Pal	ENSG00000136897	54534	mitochondrial ribosomal protein L50	FLJ20493|MRP-L50	protein_coding	Q8N5N7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45626
5.06205035625226e-15	-0.542176758150235	0.527	0.66	8.00208920316358e-11	UBE2C	Malignant cells	GSE131984_Pal	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45627
5.30458272405062e-15	-0.327902334599521	0.378	0.535	8.38548437017921e-11	DUSP12	Malignant cells	GSE131984_Pal	ENSG00000081721	11266	dual specificity phosphatase 12	DUSP1|YVH1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45628
5.63682439301605e-15	-0.28665490815233	0.955	0.978	8.91069200047977e-11	CD99	Malignant cells	GSE131984_Pal	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45629
5.83951134319435e-15	-0.289339872853414	0.299	0.473	9.23109953132163e-11	RUSC1	Malignant cells	GSE131984_Pal	ENSG00000160753	23623	RUN and SH3 domain containing 1	NESCA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45630
5.92979660428439e-15	-0.313352815466613	0.857	0.911	9.37382247205276e-11	ITGAE	Malignant cells	GSE131984_Pal	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45631
5.95405894401753e-15	-0.319335677256703	0.557	0.699	9.41217637870291e-11	RHOG	Malignant cells	GSE131984_Pal	ENSG00000177105	391	ras homolog family member G	ARHG|MGC125835|MGC125836	protein_coding	P84095	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45632
5.97235572199716e-15	-0.274437619945131	0.183	0.354	9.4410999253331e-11	LMNB1	Malignant cells	GSE131984_Pal	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45633
6.21843012874989e-15	-0.277827083696303	0.949	0.965	9.83009434752782e-11	SYAP1	Malignant cells	GSE131984_Pal	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45634
6.24660882113696e-15	0.332644354126002	0.7	0.55	9.87463922445331e-11	USP22	Malignant cells	GSE131984_Pal	ENSG00000124422	23326	ubiquitin specific peptidase 22	KIAA1063|USP3L	protein_coding	Q9UPT9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45635
6.44092294127103e-15	-0.311129759412553	0.687	0.805	1.01818109855612e-10	ACN9	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45636
6.53263495442469e-15	-0.289906029206437	0.367	0.541	1.03267893359545e-10	TBRG4	Malignant cells	GSE131984_Pal	ENSG00000136270	9238	transforming growth factor beta regulator 4	Cpr2|FASTKD4|H_TD2522F11.8|KIAA0948	protein_coding	Q969Z0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45637
6.73319322270178e-15	-0.314861910835269	0.778	0.858	1.0643831846447e-10	COPS8	Malignant cells	GSE131984_Pal	ENSG00000198612	10920	COP9 signalosome subunit 8	COP9|CSN8|MGC1297|SGN8	protein_coding	Q99627	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45638
7.10332095302158e-15	-0.316239938785335	0.859	0.91	1.12289297625365e-10	GDI2	Malignant cells	GSE131984_Pal	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45639
7.35501079225038e-15	0.269025253959238	0.42	0.254	1.16268010603894e-10	DNAJC4	Malignant cells	GSE131984_Pal	ENSG00000110011	3338	DnaJ heat shock protein family (Hsp40) member C4	HSPF2|MCG18	protein_coding	Q9NNZ3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45640
7.54889370860656e-15	-0.295705930871803	0.423	0.598	1.19332911745652e-10	INO80E	Malignant cells	GSE131984_Pal	ENSG00000169592	283899	INO80 complex subunit E	CCDC95|FLJ90652	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45641
7.85178022467368e-15	-0.265408755732143	0.293	0.47	1.24120941791642e-10	USP39	Malignant cells	GSE131984_Pal	ENSG00000168883	10713	ubiquitin specific peptidase 39	CGI-21|SAD1|SNRNP65	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45642
7.89703669854639e-15	-0.303843667464135	0.182	0.348	1.24836356130621e-10	AP1M2	Malignant cells	GSE131984_Pal	ENSG00000129354	10053	adaptor related protein complex 1 subunit mu 2	AP1-mu2|HSMU1B|mu2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45643
8.10263161785065e-15	-0.305919559704192	0.694	0.805	1.28086400614983e-10	RAD23B	Malignant cells	GSE131984_Pal	ENSG00000119318	5887	RAD23 homolog B, nucleotide excision repair protein	HHR23B|HR23B|P58	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45644
8.35501038957092e-15	-0.319220592947684	0.554	0.709	1.32076004238337e-10	CETN2	Malignant cells	GSE131984_Pal	ENSG00000147400	1069	centrin 2	CALT|CEN2	protein_coding	P41208	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45645
9.23369314944021e-15	-0.317915002557076	0.798	0.869	1.45966221306351e-10	APEX1	Malignant cells	GSE131984_Pal	ENSG00000100823	328	apurinic/apyrimidinic endodeoxyribonuclease 1	APE|APE-1|APEN|APEX|APX|HAP1|REF-1|REF1	protein_coding	P27695	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45646
9.61082144715684e-15	-0.318388405363912	0.528	0.679	1.51927865436655e-10	AKR1A1	Malignant cells	GSE131984_Pal	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45647
9.69242290129305e-15	0.293200818472778	0.596	0.437	1.5321782122364e-10	FAM115A	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45648
9.71863363366321e-15	-0.306476961329048	0.994	0.998	1.53632160480948e-10	KRT18	Malignant cells	GSE131984_Pal	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45649
9.84409781899326e-15	0.269136019546809	0.421	0.254	1.55615498322645e-10	PDE4DIP	Malignant cells	GSE131984_Pal	ENSG00000178104	9659	phosphodiesterase 4D interacting protein	CMYA2|KIAA0454|KIAA0477|MMGL	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45650
1.01651127797638e-14	-0.322880327746714	0.426	0.591	1.60690102822506e-10	DEGS1	Malignant cells	GSE131984_Pal	ENSG00000143753	8560	delta 4-desaturase, sphingolipid 1	DEGS-1|Des-1|DES1|FADS7|MLD	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45651
1.02932512808224e-14	-0.299475610909285	0.737	0.838	1.62715716247241e-10	NKAP	Malignant cells	GSE131984_Pal	ENSG00000101882	79576	NFKB activating protein	FLJ22626	protein_coding	Q8N5F7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45652
1.04913916771646e-14	-0.279723377711786	0.885	0.933	1.65847919632618e-10	PSMD4	Malignant cells	GSE131984_Pal	ENSG00000159352	5710	proteasome 26S subunit ubiquitin receptor, non-ATPase 4	AF|AF-1|Rpn10|S5A	protein_coding	P55036	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45653
1.05731460188126e-14	0.26205153666655	0.338	0.184	1.6714029226539e-10	AACS	Malignant cells	GSE131984_Pal	ENSG00000081760	65985	acetoacetyl-CoA synthetase	ACSF1|FLJ12389|SUR-5	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45654
1.07521698319012e-14	-0.314069716508534	0.704	0.8	1.69970300702693e-10	DAZAP1	Malignant cells	GSE131984_Pal	ENSG00000071626	26528	DAZ associated protein 1	MGC19907	protein_coding	Q96EP5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45655
1.12858145699857e-14	-0.289599981939287	0.916	0.96	1.78406156722334e-10	REXO2	Malignant cells	GSE131984_Pal	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45656
1.19948296958152e-14	-0.386407963687611	0.674	0.771	1.89614267831447e-10	GARS	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45657
1.26687232736005e-14	-0.285036156645128	0.818	0.882	2.00267177509077e-10	ECHS1	Malignant cells	GSE131984_Pal	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45658
1.36306275320748e-14	-0.255696525005906	0.931	0.961	2.15472960027039e-10	NPM3	Malignant cells	GSE131984_Pal	ENSG00000107833	10360	nucleophosmin/nucleoplasmin 3	NA	protein_coding	O75607	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45659
1.40938490427706e-14	-0.302222059477975	0.455	0.618	2.22795565668118e-10	VASP	Malignant cells	GSE131984_Pal	ENSG00000125753	7408	vasodilator stimulated phosphoprotein	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45660
1.41573819401321e-14	-0.304960950248193	0.746	0.847	2.23799893709608e-10	EMC7	Malignant cells	GSE131984_Pal	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45661
1.5009268003405e-14	-0.308725946086838	0.335	0.509	2.37266508597826e-10	TSFM	Malignant cells	GSE131984_Pal	ENSG00000123297	10102	Ts translation elongation factor, mitochondrial	EF-TS|EF-Tsmt	protein_coding	P43897	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45662
1.55338883923069e-14	-0.299087849404976	0.329	0.496	2.45559707705588e-10	C9orf40	Malignant cells	GSE131984_Pal	ENSG00000135045	55071	chromosome 9 open reading frame 40	FLJ10110	protein_coding	Q8IXQ3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45663
1.55651535936787e-14	-0.377052459681501	0.368	0.544	2.46053948008873e-10	KNSTRN	Malignant cells	GSE131984_Pal	ENSG00000128944	90417	kinetochore localized astrin (SPAG5) binding protein	C15orf23|FLJ14502|kinastrin|SKAP|TRAF4AF1	protein_coding	Q9Y448	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45664
1.62522048351409e-14	-0.278480037585625	1	1	2.56914854033907e-10	PKM	Malignant cells	GSE131984_Pal	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45665
1.63911196242585e-14	-0.284477946993456	0.928	0.96	2.59110819020279e-10	GGCT	Malignant cells	GSE131984_Pal	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45666
1.70605690116884e-14	0.263289019840941	0.369	0.211	2.6969347493677e-10	ARL5B	Malignant cells	GSE131984_Pal	ENSG00000165997	221079	ADP ribosylation factor like GTPase 5B	ARL8	protein_coding	Q96KC2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45667
1.76922330294468e-14	-0.298848218968267	0.551	0.704	2.79678819729495e-10	TIPRL	Malignant cells	GSE131984_Pal	ENSG00000143155	261726	TOR signaling pathway regulator	dJ69E11.3|MGC3794|TIP41|TIPRL1	protein_coding	O75663	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45668
1.79013145553302e-14	0.326995856891139	0.896	0.813	2.82983980490659e-10	ERRFI1	Malignant cells	GSE131984_Pal	ENSG00000116285	54206	ERBB receptor feedback inhibitor 1	GENE-33|MIG-6|RALT	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45669
1.85226306081732e-14	0.320848079408255	0.58	0.421	2.92805744654002e-10	ECE1	Malignant cells	GSE131984_Pal	ENSG00000117298	1889	endothelin converting enzyme 1	ECE	protein_coding	P42892	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45670
1.88509766483891e-14	-0.277613140341654	0.841	0.899	2.97996238857735e-10	CDC37	Malignant cells	GSE131984_Pal	ENSG00000105401	11140	cell division cycle 37, HSP90 cochaperone	P50CDC37	protein_coding	Q16543	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45671
1.90024862944258e-14	-0.288205399867534	0.88	0.933	3.00391303342282e-10	MRPL37	Malignant cells	GSE131984_Pal	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45672
1.91568669167395e-14	0.311741613165034	0.368	0.205	3.02831752219818e-10	DCN	Malignant cells	GSE131984_Pal	ENSG00000011465	1634	decorin	DSPG2|SLRR1B	protein_coding	P07585	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45673
2.058510974248e-14	-0.325189378585071	0.358	0.523	3.25409414809125e-10	LTV1	Malignant cells	GSE131984_Pal	ENSG00000135521	84946	LTV1 ribosome biogenesis factor	C6orf93|dJ468K18.4|FLJ14909	protein_coding	Q96GA3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45674
2.10733907365985e-14	0.267290606442689	0.335	0.184	3.33128160764148e-10	PCBP3	Malignant cells	GSE131984_Pal	ENSG00000183570	54039	poly(rC) binding protein 3	FLJ44028|PCBP3-OT1|PCBP3OT	protein_coding	P57721	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45675
2.17819835770454e-14	0.378223935731456	0.784	0.68	3.44329596385934e-10	TFRC	Malignant cells	GSE131984_Pal	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45676
2.25884591554978e-14	-0.33863370642314	0.518	0.681	3.5707836233011e-10	CCNB2	Malignant cells	GSE131984_Pal	ENSG00000157456	9133	cyclin B2	HsT17299	protein_coding	O95067	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45677
2.35962966323977e-14	-0.263274341811433	0.9	0.948	3.73010257164942e-10	MLF2	Malignant cells	GSE131984_Pal	ENSG00000089693	8079	myeloid leukemia factor 2	NTN4	protein_coding	Q15773	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45678
2.41423512296663e-14	-0.306437932269245	0.651	0.769	3.81642288238565e-10	APOPT1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45679
2.56748059638105e-14	0.319085883342687	0.964	0.926	4.05867332675917e-10	ITGB1	Malignant cells	GSE131984_Pal	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45680
2.82585560583359e-14	-0.332986204191144	0.414	0.57	4.46711254170173e-10	AIFM2	Malignant cells	GSE131984_Pal	ENSG00000042286	84883	apoptosis inducing factor mitochondria associated 2	AMID|FLJ14497|FSP1|PRG3	protein_coding	Q9BRQ8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45681
2.91914344711575e-14	-0.289633017634426	0.469	0.627	4.61458196120058e-10	SGTA	Malignant cells	GSE131984_Pal	ENSG00000104969	6449	small glutamine rich tetratricopeptide repeat co-chaperone alpha	alphaSGT|hSGT|SGT|SGT1|UBP|Vpu	protein_coding	O43765	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45682
2.99644316216169e-14	-0.30571603875993	0.81	0.865	4.7367773507452e-10	PAIP1	Malignant cells	GSE131984_Pal	ENSG00000172239	10605	poly(A) binding protein interacting protein 1	NA	protein_coding	Q9H074	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45683
3.02719390551721e-14	-0.316773315477918	0.38	0.542	4.78538812584161e-10	SNX8	Malignant cells	GSE131984_Pal	ENSG00000106266	29886	sorting nexin 8	Mvp1	protein_coding	Q9Y5X2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45684
3.10429603658562e-14	-0.296206249942167	0.378	0.551	4.90727117463455e-10	EID2	Malignant cells	GSE131984_Pal	ENSG00000176396	163126	EP300 interacting inhibitor of differentiation 2	CRI2|EID-2|MGC20452	protein_coding	Q8N6I1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45685
3.65956208186927e-14	0.302104406154006	0.921	0.853	5.78503573901895e-10	TMEM256	Malignant cells	GSE131984_Pal	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45686
3.90106907862918e-14	-0.333886255030278	0.403	0.554	6.16680999949701e-10	MRPL1	Malignant cells	GSE131984_Pal	ENSG00000169288	65008	mitochondrial ribosomal protein L1	BM022	protein_coding	Q9BYD6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45687
3.91064498314413e-14	-0.285548815788913	0.317	0.486	6.18194758935424e-10	HSPA14	Malignant cells	GSE131984_Pal	ENSG00000187522	51182	heat shock protein family A (Hsp70) member 14	HSP70-4|HSP70L1	protein_coding	Q0VDF9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45688
4.2971912689397e-14	-0.307787954625265	0.786	0.86	6.79299995793988e-10	NUDT5	Malignant cells	GSE131984_Pal	ENSG00000165609	11164	nudix hydrolase 5	hYSAH1|YSA1H	protein_coding	Q9UKK9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45689
4.31305584142805e-14	-0.34176505814661	0.567	0.693	6.81807867412947e-10	CHMP2B	Malignant cells	GSE131984_Pal	ENSG00000083937	25978	charged multivesicular body protein 2B	CHMP2.5|DKFZP564O123|VPS2B	protein_coding	Q9UQN3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45690
4.45692473611446e-14	-0.279396745246923	0.928	0.967	7.04550662284974e-10	GSTO1	Malignant cells	GSE131984_Pal	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45691
4.58917296149216e-14	0.275279131700581	0.427	0.261	7.25456461752681e-10	ARRDC3	Malignant cells	GSE131984_Pal	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45692
4.75682010331855e-14	-0.295560475909651	0.257	0.42	7.51958121932597e-10	CTPS1	Malignant cells	GSE131984_Pal	ENSG00000171793	1503	CTP synthase 1	CTPS|GATD5A	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45693
4.90275287576986e-14	-0.289710775777648	0.784	0.859	7.75027174601699e-10	KARS	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45694
4.99837960853352e-14	-0.294904018673446	0.71	0.817	7.90143848516979e-10	FAM207A	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45695
5.00358013133568e-14	-0.333379870146316	0.407	0.564	7.90965947161545e-10	RPP30	Malignant cells	GSE131984_Pal	ENSG00000148688	10556	ribonuclease P/MRP subunit p30	TSG15	protein_coding	P78346	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45696
5.24823259547656e-14	-0.304025857905683	0.294	0.458	8.29640608692934e-10	PYCR2	Malignant cells	GSE131984_Pal	ENSG00000143811	29920	pyrroline-5-carboxylate reductase 2	P5CR2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45697
5.25721141739605e-14	0.360814143645813	0.916	0.83	8.31059980861968e-10	HLA-B	Malignant cells	GSE131984_Pal	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45698
5.42183527681697e-14	-0.282033901951825	0.333	0.507	8.57083720559227e-10	FXN	Malignant cells	GSE131984_Pal	ENSG00000165060	2395	frataxin	CyaY|FA|FARR|FRDA|X25	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45699
5.43680880694841e-14	-0.29924686787203	0.342	0.513	8.59450736202404e-10	PUSL1	Malignant cells	GSE131984_Pal	ENSG00000169972	126789	pseudouridine synthase like 1	FLJ90811	protein_coding	Q8N0Z8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45700
5.85219269817577e-14	-0.318870670132196	0.319	0.486	9.25114621727627e-10	FSTL3	Malignant cells	GSE131984_Pal	ENSG00000070404	10272	follistatin like 3	FLRG|FSRP	protein_coding	O95633	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45701
6.02426705155404e-14	-0.300255314603938	0.759	0.834	9.52316135509663e-10	AGPAT2	Malignant cells	GSE131984_Pal	ENSG00000169692	10555	1-acylglycerol-3-phosphate O-acyltransferase 2	BSCL|LPAAT-beta|LPLAT2	protein_coding	O15120	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45702
6.22065499331894e-14	0.314639561995264	0.625	0.478	9.83361141343858e-10	PHC2	Malignant cells	GSE131984_Pal	ENSG00000134686	1912	polyhomeotic homolog 2	EDR2|HPH2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45703
6.2750000451552e-14	-0.253448103949312	0.14	0.29	9.91952007138134e-10	PTPLAD1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45704
6.29615295765886e-14	-0.290724376470349	0.355	0.521	9.95295859546713e-10	NSUN5	Malignant cells	GSE131984_Pal	ENSG00000130305	55695	NOP2/Sun RNA methyltransferase 5	FLJ10267|NOL1R|NSUN5A|p120(NOL1)|WBSCR20|WBSCR20A|Ynl022cL	protein_coding	Q96P11	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45705
6.42100180897783e-14	-0.28442981852055	0.535	0.685	1.01503196596322e-09	MTX1	Malignant cells	GSE131984_Pal	ENSG00000173171	4580	metaxin 1	MTX|MTXN	protein_coding	Q13505	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45706
6.48112147843542e-14	-0.331324901719702	0.6	0.727	1.02453568331107e-09	MESDC2	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45707
6.70748584194972e-14	-0.290204292037213	0.883	0.955	1.06031936189541e-09	PSME2	Malignant cells	GSE131984_Pal	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45708
6.85028057523132e-14	-0.327854942222633	0.563	0.694	1.08289235333257e-09	URM1	Malignant cells	GSE131984_Pal	ENSG00000167118	81605	ubiquitin related modifier 1	C9orf74|MGC2668	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45709
6.96133798126911e-14	-0.311876017199014	0.315	0.476	1.10044830807902e-09	RFC4	Malignant cells	GSE131984_Pal	ENSG00000163918	5984	replication factor C subunit 4	A1|RFC37	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45710
7.16206802970508e-14	-0.275597044818817	0.856	0.894	1.13217971413578e-09	CTDNEP1	Malignant cells	GSE131984_Pal	ENSG00000288307	23399	CTD nuclear envelope phosphatase 1	DULLARD|HSA011916|NET56	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45711
7.19067398391907e-14	-0.317677236434168	0.625	0.758	1.13670174337793e-09	COPS5	Malignant cells	GSE131984_Pal	ENSG00000121022	10987	COP9 signalosome subunit 5	CSN5|JAB1|MOV-34|SGN5	protein_coding	Q92905	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45712
7.22905333453755e-14	-0.254561123305229	0.892	0.927	1.1427687511237e-09	TSR3	Malignant cells	GSE131984_Pal	ENSG00000007520	115939	TSR3 ribosome maturation factor	C16orf42|MGC24381	protein_coding	Q9UJK0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45713
7.2525056521732e-14	-0.256326414966626	0.921	0.958	1.14647609349554e-09	PDLIM4	Malignant cells	GSE131984_Pal	ENSG00000131435	8572	PDZ and LIM domain 4	RIL	protein_coding	P50479	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45714
7.35939991055141e-14	-0.288710715321274	0.199	0.359	1.16337393785997e-09	RAE1	Malignant cells	GSE131984_Pal	ENSG00000101146	8480	ribonucleic acid export 1	Gle2|Mnrp41	protein_coding	P78406	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45715
8.00614930001277e-14	-0.300290129653613	0.404	0.576	1.26561208134602e-09	COX19	Malignant cells	GSE131984_Pal	ENSG00000240230	90639	cytochrome c oxidase assembly factor COX19	MGC104475	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45716
8.04872236572685e-14	-0.311502019778672	0.343	0.498	1.2723420315741e-09	RRP15	Malignant cells	GSE131984_Pal	ENSG00000067533	51018	ribosomal RNA processing 15 homolog	CGI-115|KIAA0507	protein_coding	Q9Y3B9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45717
8.57889122111863e-14	-0.312145362059518	0.473	0.619	1.35615112423443e-09	COQ2	Malignant cells	GSE131984_Pal	ENSG00000173085	27235	coenzyme Q2, polyprenyltransferase	CL640|FLJ26072	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45718
8.63528842087752e-14	-0.272177696660144	0.955	0.97	1.36506639357232e-09	TALDO1	Malignant cells	GSE131984_Pal	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45719
8.90202589859925e-14	-0.289582294741774	0.388	0.56	1.40723225405057e-09	EGFLAM	Malignant cells	GSE131984_Pal	ENSG00000164318	133584	EGF like, fibronectin type III and laminin G domains	AGRINL|AGRNL|FLJ39155|PIKA	protein_coding	Q63HQ2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45720
9.25626741767144e-14	-0.269320495411645	0.203	0.362	1.4632307533855e-09	MPV17L2	Malignant cells	GSE131984_Pal	ENSG00000254858	84769	MPV17 mitochondrial inner membrane protein like 2	FKSG24|MGC12972	protein_coding	Q567V2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45721
9.51836662293059e-14	0.296987975157194	0.893	0.829	1.50466339575287e-09	ENAH	Malignant cells	GSE131984_Pal	ENSG00000154380	55740	ENAH actin regulator	FLJ10773|MENA|NDPP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45722
9.61339851014305e-14	-0.264851188415354	0.31	0.482	1.51968603648341e-09	GEMIN7	Malignant cells	GSE131984_Pal	ENSG00000142252	79760	gem nuclear organelle associated protein 7	FLJ13956	protein_coding	Q9H840	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45723
9.7210351978162e-14	0.325295646085975	0.726	0.583	1.53670124407078e-09	GALNT2	Malignant cells	GSE131984_Pal	ENSG00000143641	2590	polypeptide N-acetylgalactosaminyltransferase 2	GalNAc-T2	protein_coding	Q10471	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45724
9.85382511989334e-14	-0.282048797177797	0.605	0.744	1.55769267495274e-09	FAM32A	Malignant cells	GSE131984_Pal	ENSG00000105058	26017	family with sequence similarity 32 member A	DKFZP586O0120|OTAG-12	protein_coding	Q9Y421	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45725
1.02062432746529e-13	-0.277023500089501	0.333	0.5	1.61340293685713e-09	ACD	Malignant cells	GSE131984_Pal	ENSG00000102977	65057	ACD shelterin complex subunit and telomerase recruitment factor	Pip1|Ptop|Tint1|Tpp1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45726
1.03023574086624e-13	-0.297468960739781	0.544	0.694	1.62859665916136e-09	ORMDL2	Malignant cells	GSE131984_Pal	ENSG00000123353	29095	ORMDL sphingolipid biosynthesis regulator 2	adoplin-2|HSPC160|MST095|MSTP095	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45727
1.03235792065154e-13	-0.316161362763917	0.491	0.643	1.63195140096595e-09	APITD1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45728
1.17424837048447e-13	0.299350145215636	0.812	0.686	1.85625182406185e-09	LTBR	Malignant cells	GSE131984_Pal	ENSG00000111321	4055	lymphotoxin beta receptor	D12S370|TNF-R-III|TNFCR|TNFR-RP|TNFR2-RP|TNFRSF3	protein_coding	P36941	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45729
1.17961163512531e-13	-0.27785949868258	0.861	0.901	1.8647300728061e-09	PCNP	Malignant cells	GSE131984_Pal	ENSG00000081154	57092	PEST proteolytic signal containing nuclear protein	NA	protein_coding	Q8WW12	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45730
1.2069475452573e-13	-0.254841624689907	0.916	0.961	1.90794267954274e-09	FKBP2	Malignant cells	GSE131984_Pal	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45731
1.24986937040974e-13	-0.261696399608051	0.26	0.425	1.97579350074371e-09	POLR2D	Malignant cells	GSE131984_Pal	ENSG00000144231	5433	RNA polymerase II subunit D	RPB4	protein_coding	O15514	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45732
1.25863789200496e-13	-0.300059665092236	0.808	0.877	1.98965477968145e-09	MLEC	Malignant cells	GSE131984_Pal	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45733
1.27031348868057e-13	-0.273765013849094	0.255	0.418	2.00811156290625e-09	HAUS2	Malignant cells	GSE131984_Pal	ENSG00000137814	55142	HAUS augmin like complex subunit 2	C15orf25|CEP27|FLJ10460|HsT17025	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45734
1.27824178604428e-13	-0.327664009670457	0.434	0.596	2.0206446153788e-09	CENPK	Malignant cells	GSE131984_Pal	ENSG00000123219	64105	centromere protein K	CENP-K|FKSG14|SOLT	protein_coding	Q9BS16	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45735
1.2899201186538e-13	-0.278537203514825	0.843	0.916	2.03910572356793e-09	LRRFIP1	Malignant cells	GSE131984_Pal	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45736
1.37780219426261e-13	-0.278679491081519	0.494	0.651	2.17802970869034e-09	ITGB3BP	Malignant cells	GSE131984_Pal	ENSG00000142856	23421	integrin subunit beta 3 binding protein	CENPR|HSU37139|NRIF3|TAP20	protein_coding	Q13352	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45737
1.45808895238635e-13	-0.269178483255217	0.185	0.343	2.30494701593234e-09	FANCB	Malignant cells	GSE131984_Pal	ENSG00000181544	2187	FA complementation group B	FAAP95|FAB|FLJ34064	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45738
1.47544211418101e-13	-0.263111041765161	0.929	0.962	2.33237889409735e-09	EMC6	Malignant cells	GSE131984_Pal	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45739
1.49787275093308e-13	-0.278701331761348	0.781	0.864	2.36783724467502e-09	TMEM14A	Malignant cells	GSE131984_Pal	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45740
1.50502057337408e-13	-0.331731344781468	0.443	0.588	2.37913652238975e-09	FUNDC1	Malignant cells	GSE131984_Pal	ENSG00000069509	139341	FUN14 domain containing 1	MGC51029	protein_coding	Q8IVP5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45741
1.50588761453774e-13	-0.291676329715155	0.547	0.689	2.38050714106125e-09	SUPT16H	Malignant cells	GSE131984_Pal	ENSG00000092201	11198	SPT16 homolog, facilitates chromatin remodeling subunit	CDC68|FACT|FACTP140|FLJ10857|FLJ14010|SPT16/CDC68	protein_coding	Q9Y5B9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45742
1.56651453215741e-13	-0.313718855639157	0.375	0.535	2.47634617243444e-09	RPA2	Malignant cells	GSE131984_Pal	ENSG00000117748	6118	replication protein A2	NA	protein_coding	P15927	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45743
1.65042272993086e-13	-0.27428037137601	0.382	0.555	2.60898825147471e-09	ABT1	Malignant cells	GSE131984_Pal	ENSG00000146109	29777	activator of basal transcription 1	Esf2	protein_coding	Q9ULW3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45744
1.65936921942731e-13	-0.326174150330507	0.303	0.459	2.62313086207069e-09	TXNRD2	Malignant cells	GSE131984_Pal	ENSG00000184470	10587	thioredoxin reductase 2	SELZ|TR|TR3|TRXR2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45745
1.67052992115539e-13	-0.310475555814425	0.576	0.708	2.64077369936244e-09	C9orf142	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45746
1.71461647933765e-13	-0.35306990990111	0.583	0.704	2.71046573053696e-09	DPM1	Malignant cells	GSE131984_Pal	ENSG00000000419	8813	dolichyl-phosphate mannosyltransferase subunit 1, catalytic	CDGIE|MPDS	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45747
1.7481422792968e-13	-0.282210605933993	0.573	0.71	2.76346331511239e-09	TMEM203	Malignant cells	GSE131984_Pal	ENSG00000187713	94107	transmembrane protein 203	HBEBP1|MGC14327	protein_coding	Q969S6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45748
1.79315178564716e-13	0.268968747550327	0.46	0.285	2.83461434275102e-09	STC1	Malignant cells	GSE131984_Pal	ENSG00000159167	6781	stanniocalcin 1	STC	protein_coding	P52823	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45749
1.81603837678164e-13	-0.308785989447861	0.683	0.795	2.87079346601641e-09	ISOC2	Malignant cells	GSE131984_Pal	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45750
1.82969515568275e-13	-0.303537001734389	0.577	0.703	2.89238210210329e-09	MRPS10	Malignant cells	GSE131984_Pal	ENSG00000048544	55173	mitochondrial ribosomal protein S10	FLJ10567	protein_coding	P82664	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45751
1.9334954344963e-13	-0.269201692634897	0.267	0.439	3.05646958285174e-09	EIF2B3	Malignant cells	GSE131984_Pal	ENSG00000070785	8891	eukaryotic translation initiation factor 2B subunit gamma	EIF-2B|EIF2Bgamma	protein_coding	Q9NR50	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45752
2.09746595173249e-13	-0.273386147721328	0.877	0.926	3.31567417649873e-09	MAD2L2	Malignant cells	GSE131984_Pal	ENSG00000116670	10459	mitotic arrest deficient 2 like 2	FANCV|MAD2B|POLZ2|REV7	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45753
2.14229466130025e-13	-0.291980349484928	0.274	0.439	3.38653940058343e-09	APEX2	Malignant cells	GSE131984_Pal	ENSG00000169188	27301	apurinic/apyrimidinic endodeoxyribonuclease 2	APE2|APEXL2|XTH2|ZGRF2	protein_coding	Q9UBZ4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45754
2.15884956110204e-13	-0.299655420611072	0.338	0.497	3.4127093861901e-09	TXLNG	Malignant cells	GSE131984_Pal	ENSG00000086712	55787	taxilin gamma	CXorf15|FIAT|FLJ11209|LSR5|MGC126621|MGC126625|TXLNGX	protein_coding	Q9NUQ3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45755
2.16228283821515e-13	0.30817608395499	0.502	0.343	3.41813671065052e-09	PER1	Malignant cells	GSE131984_Pal	ENSG00000179094	5187	period circadian regulator 1	PER|RIGUI	protein_coding	O15534	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45756
2.17377626361429e-13	-0.284158740767932	0.837	0.896	3.43630551752147e-09	FAM3C	Malignant cells	GSE131984_Pal	ENSG00000196937	10447	FAM3 metabolism regulating signaling molecule C	GS3876|ILEI	protein_coding	Q92520	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45757
2.27391993543397e-13	-0.30410187663293	0.378	0.534	3.59461263393403e-09	ALYREF	Malignant cells	GSE131984_Pal	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45758
2.27415586459019e-13	-0.316455986977833	0.628	0.732	3.59498559074418e-09	PWP1	Malignant cells	GSE131984_Pal	ENSG00000136045	11137	PWP1 homolog, endonuclein	IEF-SSP-9502	protein_coding	Q13610	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45759
2.4746117053718e-13	-0.265811785527183	0.993	0.995	3.91186618385175e-09	PPIB	Malignant cells	GSE131984_Pal	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45760
2.48690942350146e-13	-0.285417434219495	0.522	0.665	3.93130641667111e-09	DRG1	Malignant cells	GSE131984_Pal	ENSG00000185721	4733	developmentally regulated GTP binding protein 1	NEDD3	protein_coding	Q9Y295	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45761
2.51574528100813e-13	-0.299516680511912	0.622	0.742	3.97689014021765e-09	C11orf24	Malignant cells	GSE131984_Pal	ENSG00000171067	53838	chromosome 11 open reading frame 24	DM4E3	protein_coding	Q96F05	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45762
2.57479327846741e-13	0.283376958017896	0.902	0.799	4.07023321460129e-09	RAB31	Malignant cells	GSE131984_Pal	ENSG00000168461	11031	RAB31, member RAS oncogene family	Rab22B	protein_coding	Q13636	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45763
2.59027321581791e-13	-0.318521024295006	0.661	0.751	4.09470389956495e-09	UBE2E1	Malignant cells	GSE131984_Pal	ENSG00000170142	7324	ubiquitin conjugating enzyme E2 E1	UbcH6	protein_coding	P51965	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45764
2.72347670580753e-13	-0.272989380080498	0.333	0.5	4.30527197654054e-09	TMEM242	Malignant cells	GSE131984_Pal	ENSG00000215712	729515	transmembrane protein 242	BM033|C6orf35	protein_coding	Q9NWH2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45765
2.78044735189148e-13	-0.335961034811861	0.618	0.721	4.39533117387005e-09	PSMC6	Malignant cells	GSE131984_Pal	ENSG00000100519	5706	proteasome 26S subunit, ATPase 6	p42|RPT5	protein_coding	P62333	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45766
2.84654431270552e-13	0.305980223149749	0.605	0.461	4.49981724952489e-09	TMTC1	Malignant cells	GSE131984_Pal	ENSG00000133687	83857	transmembrane O-mannosyltransferase targeting cadherins 1	ARG99|FLJ31400|FLJ41625|OLF	protein_coding	Q8IUR5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45767
2.9051395502207e-13	-0.27118219726284	0.752	0.846	4.59244460098888e-09	BCKDK	Malignant cells	GSE131984_Pal	ENSG00000103507	10295	branched chain keto acid dehydrogenase kinase	NA	protein_coding	O14874	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45768
2.97875093996731e-13	-0.295249016304893	0.805	0.871	4.70880948590033e-09	PDXK	Malignant cells	GSE131984_Pal	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45769
3.02184606154817e-13	0.285164522668437	0.472	0.32	4.77693425409534e-09	ATP6V1A	Malignant cells	GSE131984_Pal	ENSG00000114573	523	ATPase H+ transporting V1 subunit A	ATP6A1|ATP6V1A1|VA68|Vma1|VPP2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45770
3.04886852616107e-13	-0.277110427757463	0.521	0.676	4.81965136615542e-09	QDPR	Malignant cells	GSE131984_Pal	ENSG00000151552	5860	quinoid dihydropteridine reductase	DHPR|PKU2|SDR33C1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45771
3.07353995345546e-13	-0.296532927191891	0.771	0.835	4.8586519584224e-09	CAPZA2	Malignant cells	GSE131984_Pal	ENSG00000198898	830	capping actin protein of muscle Z-line subunit alpha 2	CAPPA2|CAPZ	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45772
3.24875472462978e-13	-0.308904908292633	0.43	0.585	5.13563146869476e-09	PITHD1	Malignant cells	GSE131984_Pal	ENSG00000057757	57095	PITH domain containing 1	C1orf128|HT014|TXNL1CL	protein_coding	Q9GZP4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45773
3.4391046240481e-13	0.301437532680298	0.358	0.211	5.43653658969523e-09	SYT12	Malignant cells	GSE131984_Pal	ENSG00000173227	91683	synaptotagmin 12	SRG1	protein_coding	Q8IV01	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45774
3.48278949849633e-13	-0.271565901878295	0.364	0.519	5.505593639223e-09	FADD	Malignant cells	GSE131984_Pal	ENSG00000168040	8772	Fas associated via death domain	GIG3|MORT1	protein_coding	Q13158	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45775
3.63600348869555e-13	-0.306704621099237	0.633	0.73	5.74779431492992e-09	PMVK	Malignant cells	GSE131984_Pal	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45776
3.7558921398057e-13	-0.277361744808101	0.391	0.561	5.93731429460485e-09	ORAI1	Malignant cells	GSE131984_Pal	ENSG00000276045	84876	ORAI calcium release-activated calcium modulator 1	CRACM1|FLJ14466|TMEM142A	protein_coding	Q96D31	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45777
3.79427386571615e-13	-0.283267512262201	0.39	0.55	5.9979881269241e-09	MCMBP	Malignant cells	GSE131984_Pal	ENSG00000197771	79892	minichromosome maintenance complex binding protein	C10orf119|FLJ13081|MCM-BP	protein_coding	Q9BTE3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45778
3.91858511282801e-13	-0.309101161441188	0.62	0.747	6.19449934635851e-09	FUCA2	Malignant cells	GSE131984_Pal	ENSG00000001036	2519	alpha-L-fucosidase 2	dJ20N2.5|MGC1314	protein_coding	Q9BTY2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45779
3.94099884924785e-13	-0.281926197779899	0.812	0.863	6.229930980891e-09	BZW2	Malignant cells	GSE131984_Pal	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45780
4.06406063409811e-13	-0.259172546950138	0.952	0.975	6.42446705038228e-09	CLTB	Malignant cells	GSE131984_Pal	ENSG00000175416	1212	clathrin light chain B	Lcb	protein_coding	P09497	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45781
4.25145972411999e-13	-0.269106344295052	0.879	0.907	6.72070753188889e-09	CAP1	Malignant cells	GSE131984_Pal	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45782
4.51914769512882e-13	-0.306225470010537	0.584	0.708	7.14386867645963e-09	ALG3	Malignant cells	GSE131984_Pal	ENSG00000214160	10195	ALG3 alpha-1,3- mannosyltransferase	CDGS4|D16Ertd36e|Not56|NOT56L	protein_coding	Q92685	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45783
4.59898139946555e-13	-0.308229744881676	0.485	0.628	7.27006979627514e-09	HMOX2	Malignant cells	GSE131984_Pal	ENSG00000277424	3163	heme oxygenase 2	HO-2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45784
4.68846466678522e-13	-0.317263909504725	0.371	0.525	7.41152494525407e-09	DCPS	Malignant cells	GSE131984_Pal	ENSG00000110063	28960	decapping enzyme, scavenger	HINT-5|HINT5|HSL1|HSPC015	protein_coding	Q96C86	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45785
4.71702135923003e-13	-0.294287524505323	0.45	0.602	7.45666736467083e-09	GRB2	Malignant cells	GSE131984_Pal	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45786
4.79665645688412e-13	0.290324362837843	0.759	0.624	7.58255452704241e-09	CSNK1E	Malignant cells	GSE131984_Pal	ENSG00000213923	1454	casein kinase 1 epsilon	CKIE|CKIepsilon|HCKIE	protein_coding	P49674	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45787
4.92911062164597e-13	-0.272040691690193	0.688	0.81	7.79193807069794e-09	CENPN	Malignant cells	GSE131984_Pal	ENSG00000166451	55839	centromere protein N	BM039|C16orf60|FLJ13607|FLJ22660	protein_coding	Q96H22	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45788
4.94700474876199e-13	-0.325443744368189	0.719	0.796	7.82022510684295e-09	RALA	Malignant cells	GSE131984_Pal	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45789
5.0954249971873e-13	0.286082254246458	0.44	0.271	8.05484783555368e-09	FHL1	Malignant cells	GSE131984_Pal	ENSG00000022267	2273	four and a half LIM domains 1	bA535K18.1|FHL1B|FLH1A|KYO-T|MGC111107|SLIM1|XMPMA	protein_coding	Q13642	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45790
5.10153242859432e-13	-0.342935529268122	0.343	0.517	8.0645024631219e-09	AURKA	Malignant cells	GSE131984_Pal	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45791
5.28172350101243e-13	-0.3044815921009	0.524	0.645	8.34934851040045e-09	MTX2	Malignant cells	GSE131984_Pal	ENSG00000128654	10651	metaxin 2	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45792
5.32486800000588e-13	-0.257314332052959	0.489	0.657	8.41755133440929e-09	TSG101	Malignant cells	GSE131984_Pal	ENSG00000074319	7251	tumor susceptibility 101	TSG10|VPS23	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45793
5.63115030877413e-13	-0.266926574624457	0.472	0.636	8.90172240811015e-09	DBNL	Malignant cells	GSE131984_Pal	ENSG00000136279	28988	drebrin like	ABP1|HIP-55|SH3P7	protein_coding	Q9UJU6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45794
5.78031398680454e-13	-0.265577690990848	0.274	0.434	9.13752035034061e-09	MTHFD1L	Malignant cells	GSE131984_Pal	ENSG00000120254	25902	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like	DKFZP586G1517|FLJ21145|FTHFSDC1	protein_coding	Q6UB35	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45795
5.82276247733897e-13	-0.300502173734377	0.599	0.711	9.20462292417744e-09	VPS4A	Malignant cells	GSE131984_Pal	ENSG00000132612	27183	vacuolar protein sorting 4 homolog A	FLJ22197|SKD1|SKD1A|SKD2|VPS4|VPS4-1	protein_coding	Q9UN37	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45796
5.85077861104508e-13	-0.280352521964408	0.837	0.9	9.24891082834007e-09	SF3B2	Malignant cells	GSE131984_Pal	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45797
6.07799687632537e-13	-0.269489364832613	0.905	0.927	9.60809746209515e-09	LINC00116	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45798
6.14169413654123e-13	-0.280667392034094	0.346	0.509	9.70879009104438e-09	PAWR	Malignant cells	GSE131984_Pal	ENSG00000177425	5074	pro-apoptotic WT1 regulator	par-4|PAR4	protein_coding	Q96IZ0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45799
6.17309936791358e-13	-0.394011148242162	0.561	0.676	9.75843548079779e-09	WBP5	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45800
6.29508008889833e-13	-0.326254920008869	0.336	0.493	9.95126260453048e-09	CD55	Malignant cells	GSE131984_Pal	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45801
6.32822429078038e-13	-0.313049053808481	0.737	0.802	1.00036569588656e-08	RUVBL2	Malignant cells	GSE131984_Pal	ENSG00000183207	10856	RuvB like AAA ATPase 2	ECP51|INO80J|Reptin52|RVB2|TIH2|TIP48|TIP49b	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45802
6.410043212095e-13	-0.260646916904876	0.28	0.452	1.01329963096798e-08	TCF19	Malignant cells	GSE131984_Pal	ENSG00000224472	6941	transcription factor 19	SC1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45803
6.67212116998493e-13	-0.290345368182109	0.352	0.499	1.05472891455122e-08	CCDC58	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45804
7.04900508158128e-13	-0.267168957475023	0.851	0.899	1.11430672329637e-08	DNAJB6	Malignant cells	GSE131984_Pal	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45805
7.12331225756434e-13	-0.311924385306358	0.583	0.695	1.12605320167577e-08	RAD51C	Malignant cells	GSE131984_Pal	ENSG00000108384	5889	RAD51 paralog C	FANCO|RAD51L2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45806
7.61738655490481e-13	-0.281629855353794	0.745	0.815	1.20415646659935e-08	BTF3L4	Malignant cells	GSE131984_Pal	ENSG00000134717	91408	basic transcription factor 3 like 4	MGC23908	protein_coding	Q96K17	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45807
7.6294577700408e-13	-0.293465433997298	0.374	0.535	1.20606468428805e-08	GPN3	Malignant cells	GSE131984_Pal	ENSG00000111231	51184	GPN-loop GTPase 3	ATPBD1C|MGC14560	protein_coding	Q9UHW5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45808
7.88034652071986e-13	-0.27122156768289	0.817	0.895	1.2457251779954e-08	SRSF11	Malignant cells	GSE131984_Pal	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45809
8.18386278248835e-13	0.355728456459436	0.423	0.277	1.29370502865576e-08	ADAMTS9	Malignant cells	GSE131984_Pal	ENSG00000163638	56999	ADAM metallopeptidase with thrombospondin type 1 motif 9	KIAA1312	protein_coding	Q9P2N4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45810
8.26071159897924e-13	-0.281488822552383	0.599	0.738	1.30585328956664e-08	SDHD	Malignant cells	GSE131984_Pal	ENSG00000204370	6392	succinate dehydrogenase complex subunit D	cybS|PGL|PGL1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45811
8.41915865329682e-13	-0.321983756644884	0.941	0.967	1.33090059991316e-08	CKS2	Malignant cells	GSE131984_Pal	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45812
8.51146201465868e-13	-0.252430170125971	0.312	0.473	1.34549191527724e-08	ALKBH3	Malignant cells	GSE131984_Pal	ENSG00000166199	221120	alkB homolog 3, alpha-ketoglutarate dependent dioxygenase	DEPC-1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45813
8.89431936622287e-13	0.314790509018422	0.397	0.24	1.40601400541251e-08	SEPP1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45814
9.05110370107919e-13	-0.279862426147999	0.511	0.648	1.4307984730666e-08	TSSC4	Malignant cells	GSE131984_Pal	ENSG00000184281	10078	tumor suppressing subtransferable candidate 4	NA	protein_coding	Q9Y5U2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45815
9.31997788716345e-13	-0.281799118964899	0.416	0.574	1.4733021044028e-08	GLA	Malignant cells	GSE131984_Pal	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45816
9.38717875160857e-13	-0.277116010089269	0.281	0.445	1.48392521705428e-08	KIF22	Malignant cells	GSE131984_Pal	ENSG00000079616	3835	kinesin family member 22	Kid|KNSL4|OBP-1|OBP-2	protein_coding	Q14807	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45817
9.835112753814e-13	-0.304126048744827	0.395	0.55	1.55473462412292e-08	TMEM156	Malignant cells	GSE131984_Pal	ENSG00000121895	80008	transmembrane protein 156	FLJ23235	protein_coding	Q8N614	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45818
9.90676805505208e-13	-0.292613944293855	0.566	0.683	1.56606189414263e-08	WDR45B	Malignant cells	GSE131984_Pal	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45819
1.11027638793486e-12	-0.262803309921753	0.351	0.513	1.75512491404743e-08	ZDHHC6	Malignant cells	GSE131984_Pal	ENSG00000023041	64429	zinc finger DHHC-type palmitoyltransferase 6	FLJ21952|ZNF376	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45820
1.12348080450948e-12	-0.300426862343065	0.478	0.617	1.77599845576858e-08	RPUSD1	Malignant cells	GSE131984_Pal	ENSG00000007376	113000	RNA pseudouridine synthase domain containing 1	C16orf40|MGC19600|RLUCL	protein_coding	Q9UJJ7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45821
1.1932370961629e-12	-0.27663053699793	0.544	0.68	1.88626920161431e-08	ZNF259	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45822
1.19400061450937e-12	-0.308060698522151	0.505	0.632	1.88747617141641e-08	C1D	Malignant cells	GSE131984_Pal	ENSG00000197223	10438	C1D nuclear receptor corepressor	LRP1|Rrp47|SUN-CoR|SUNCOR	protein_coding	Q13901	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45823
1.1990050585211e-12	-0.286142769592758	0.468	0.615	1.89538719651015e-08	C14orf1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45824
1.23589007563661e-12	0.281113353503439	0.424	0.267	1.95369503156636e-08	CRIP2	Malignant cells	GSE131984_Pal	ENSG00000182809	1397	cysteine rich protein 2	CRP2|ESP1	protein_coding	P52943	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45825
1.26216713555715e-12	-0.275337312249065	0.527	0.669	1.99523380788874e-08	ERO1L	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45826
1.27711524671207e-12	-0.283562212721229	0.736	0.805	2.01886378200244e-08	NDUFA5	Malignant cells	GSE131984_Pal	ENSG00000128609	4698	NADH:ubiquinone oxidoreductase subunit A5	B13|CI-13kB|CI-13KD-B|NUFM|UQOR13	protein_coding	Q16718	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45827
1.35830131645978e-12	0.285557198724817	0.711	0.584	2.14720272105963e-08	FAM120A	Malignant cells	GSE131984_Pal	ENSG00000048828	23196	family with sequence similarity 120A	C9orf10|KIAA0183|OSSA	protein_coding	Q9NZB2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45828
1.39258777605133e-12	-0.30345134819386	0.508	0.641	2.20140275638195e-08	GEMIN6	Malignant cells	GSE131984_Pal	ENSG00000152147	79833	gem nuclear organelle associated protein 6	FLJ23459	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45829
1.40881479135923e-12	-0.300816418944962	0.768	0.843	2.22705442218067e-08	RPL7L1	Malignant cells	GSE131984_Pal	ENSG00000146223	285855	ribosomal protein L7 like 1	dJ475N16.4	protein_coding	Q6DKI1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45830
1.46066022904892e-12	0.263422958230672	0.394	0.245	2.30901169008053e-08	DGKD	Malignant cells	GSE131984_Pal	ENSG00000280873	8527	diacylglycerol kinase delta	DGKdelta|KIAA0145	protein_coding	Q16760	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45831
1.46715616914932e-12	-0.265374299420601	0.755	0.85	2.31928047219125e-08	SRP19	Malignant cells	GSE131984_Pal	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45832
1.52591541316444e-12	-0.255246215271107	0.407	0.573	2.41216708513035e-08	TCERG1	Malignant cells	GSE131984_Pal	ENSG00000113649	10915	transcription elongation regulator 1	CA150|TAF2S|Urn1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45833
1.55470157386577e-12	-0.303877252455234	0.551	0.674	2.457672247967e-08	GTPBP4	Malignant cells	GSE131984_Pal	ENSG00000107937	23560	GTP binding protein 4	CRFG|FLJ10686|FLJ10690|NGB|NOG1	protein_coding	Q9BZE4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45834
1.56081634127182e-12	-0.289415497031072	0.574	0.698	2.4673384722825e-08	UBL4A	Malignant cells	GSE131984_Pal	ENSG00000102178	8266	ubiquitin like 4A	DXS254E|GDX|GET5|MDY2|TMA24|UBL4	protein_coding	P11441	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45835
1.62529137844827e-12	-0.322698559083122	0.247	0.402	2.56926061105102e-08	FAM64A	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45836
1.69635135896975e-12	0.266827103578316	0.701	0.549	2.68159222825938e-08	CTGF	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45837
1.71853238768574e-12	-0.295629798920393	0.483	0.631	2.71665599845361e-08	GPANK1	Malignant cells	GSE131984_Pal	ENSG00000223932	7918	G-patch domain and ankyrin repeats 1	ANKRD59|BAT4|D6S54E|G5|GPATCH10	protein_coding	O95872	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45838
1.74918996505083e-12	-0.309654312761538	0.566	0.683	2.76511949675235e-08	NIFK	Malignant cells	GSE131984_Pal	ENSG00000155438	84365	nucleolar protein interacting with the FHA domain of MKI67	hNIFK|MKI67IP|Nopp34	protein_coding	Q9BYG3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45839
1.81712269099248e-12	-0.275986477690711	0.999	0.997	2.87250754992091e-08	S100A4	Malignant cells	GSE131984_Pal	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45840
1.85687718522084e-12	-0.29752343606291	0.346	0.51	2.93535145439711e-08	RFC3	Malignant cells	GSE131984_Pal	ENSG00000133119	5983	replication factor C subunit 3	MGC5276|RFC38	protein_coding	P40938	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45841
1.87553527973508e-12	-0.251108907370777	0.283	0.446	2.96484617020521e-08	BYSL	Malignant cells	GSE131984_Pal	ENSG00000112578	705	bystin like	Enp1	protein_coding	Q13895	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45842
1.88021185382644e-12	-0.286743474765311	0.488	0.623	2.97223889852884e-08	GORASP2	Malignant cells	GSE131984_Pal	ENSG00000115806	26003	golgi reassembly stacking protein 2	GOLPH6|GRASP55|GRS2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45843
2.07376480525356e-12	0.250039259976889	0.429	0.28	3.27820740414482e-08	ABL1	Malignant cells	GSE131984_Pal	ENSG00000097007	25	ABL proto-oncogene 1, non-receptor tyrosine kinase	ABL|c-ABL|JTK7|p150	protein_coding	P00519	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45844
2.07529666547422e-12	0.309230795244077	0.417	0.272	3.28062896878164e-08	PNPLA4	Malignant cells	GSE131984_Pal	ENSG00000006757	8228	patatin like phospholipase domain containing 4	DXS1283E|GS2|iPLA2eta	protein_coding	P41247	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45845
2.11796895662179e-12	-0.29232745393224	0.652	0.746	3.34808532662772e-08	UBA2	Malignant cells	GSE131984_Pal	ENSG00000126261	10054	ubiquitin like modifier activating enzyme 2	FLJ13058|HRIHFB2115|SAE2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45846
2.44193606519516e-12	-0.298114400789618	0.502	0.637	3.86021253186051e-08	ELOVL1	Malignant cells	GSE131984_Pal	ENSG00000066322	64834	ELOVL fatty acid elongase 1	Ssc1	protein_coding	Q9BW60	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45847
2.45496124115555e-12	-0.286649214296163	0.468	0.607	3.8808027300187e-08	ARL1	Malignant cells	GSE131984_Pal	ENSG00000120805	400	ADP ribosylation factor like GTPase 1	ARFL1	protein_coding	P40616	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45848
2.61682718325671e-12	-0.282488809442307	0.71	0.811	4.13668041129221e-08	CDV3	Malignant cells	GSE131984_Pal	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45849
2.67243789003738e-12	-0.259401371220156	0.26	0.416	4.2245898165711e-08	C16orf80	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45850
2.72087135937976e-12	-0.27475553571491	0.141	0.277	4.30115344490753e-08	HIST1H1E	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45851
2.86594619838691e-12	-0.287445994435109	0.439	0.585	4.53048775041003e-08	TMX2	Malignant cells	GSE131984_Pal	ENSG00000213593	51075	thioredoxin related transmembrane protein 2	PDIA12|TXNDC14	protein_coding	Q9Y320	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45852
2.94576091517906e-12	0.302417089846536	0.61	0.477	4.65665885471506e-08	AFF4	Malignant cells	GSE131984_Pal	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45853
2.98200862919446e-12	-0.260781085241663	0.319	0.472	4.7139592410306e-08	FIP1L1	Malignant cells	GSE131984_Pal	ENSG00000145216	81608	factor interacting with PAPOLA and CPSF1	DKFZp586K0717|FIP1|hFip1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45854
2.99338559939107e-12	-0.31727138149846	0.469	0.604	4.7319439555174e-08	TMEM11	Malignant cells	GSE131984_Pal	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45855
2.9953854134179e-12	0.300997925960769	0.716	0.579	4.73510526153101e-08	SLC25A37	Malignant cells	GSE131984_Pal	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45856
3.1235085913845e-12	-0.310446169560629	0.495	0.633	4.93764238126061e-08	VPS25	Malignant cells	GSE131984_Pal	ENSG00000131475	84313	vacuolar protein sorting 25 homolog	DERP9|EAP20|MGC10540	protein_coding	Q9BRG1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45857
3.17294744781287e-12	0.272317988210046	0.636	0.493	5.01579532550259e-08	EVA1B	Malignant cells	GSE131984_Pal	ENSG00000142694	55194	eva-1 homolog B	C1orf78|FAM176B|FLJ10647	protein_coding	Q9NVM1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45858
3.41054432341792e-12	-0.280573668901316	0.348	0.497	5.39138846645905e-08	IDH3A	Malignant cells	GSE131984_Pal	ENSG00000166411	3419	isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45859
3.44898710716071e-12	-0.26381809842909	0.797	0.882	5.45215881899964e-08	ELOF1	Malignant cells	GSE131984_Pal	ENSG00000130165	84337	elongation factor 1	ELF1|MGC4549	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45860
3.55410058304112e-12	-0.25041497818927	0.253	0.404	5.6183222016714e-08	VPS72	Malignant cells	GSE131984_Pal	ENSG00000163159	6944	vacuolar protein sorting 72 homolog	Swc2|TCFL1|YL-1|YL1	protein_coding	Q15906	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45861
3.60847296308033e-12	-0.292009960000214	0.325	0.478	5.70427406003738e-08	BTG3	Malignant cells	GSE131984_Pal	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45862
3.97398355578584e-12	-0.314593085737677	0.658	0.752	6.28207320498626e-08	PMP22	Malignant cells	GSE131984_Pal	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45863
4.04180613634152e-12	-0.291518571135256	0.739	0.821	6.38928714032867e-08	USP16	Malignant cells	GSE131984_Pal	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45864
4.0830674743861e-12	-0.289031882942157	0.296	0.444	6.45451306350954e-08	MELK	Malignant cells	GSE131984_Pal	ENSG00000165304	9833	maternal embryonic leucine zipper kinase	KIAA0175	protein_coding	Q14680	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45865
4.30662462612325e-12	-0.307028543199364	0.222	0.371	6.80791220897563e-08	NUF2	Malignant cells	GSE131984_Pal	ENSG00000143228	83540	NUF2 component of NDC80 kinetochore complex	CDCA1|CT106|NUF2R	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45866
4.45992203968273e-12	-0.255499975795913	0.299	0.447	7.05024476033045e-08	CYB5R4	Malignant cells	GSE131984_Pal	ENSG00000065615	51167	cytochrome b5 reductase 4	b5+b5R|dJ676J13.1|NCB5OR	protein_coding	Q7L1T6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45867
4.61440962629312e-12	-0.286248456610058	0.698	0.811	7.29445873724416e-08	JPX	Malignant cells	GSE131984_Pal	ENSG00000225470	554203	JPX transcript, XIST activator	DCBALD06|ENOX|LINC00183|NCRNA00183	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45868
4.65177234872164e-12	-0.405251862270718	0.378	0.529	7.35352172885917e-08	TRIB3	Malignant cells	GSE131984_Pal	ENSG00000101255	57761	tribbles pseudokinase 3	C20orf97|dJ1103G7.3|TRB3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45869
4.97804110281345e-12	0.287395257552252	0.554	0.411	7.8692873753275e-08	ZBTB38	Malignant cells	GSE131984_Pal	ENSG00000177311	253461	zinc finger and BTB domain containing 38	CIBZ|FLJ35036|PPP1R171|ZNF921	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45870
5.03904191283771e-12	0.284480483913014	0.73	0.607	7.96571745581386e-08	VAT1	Malignant cells	GSE131984_Pal	ENSG00000108828	10493	vesicle amine transport 1	FLJ20230|VATI	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45871
5.10987034031182e-12	-0.312200440315952	0.616	0.718	8.07768303396493e-08	EIF1B	Malignant cells	GSE131984_Pal	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45872
5.41164001264159e-12	-0.263179562860024	0.338	0.497	8.55472053198382e-08	CUTC	Malignant cells	GSE131984_Pal	ENSG00000119929	51076	cutC copper transporter	CGI-32	protein_coding	Q9NTM9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45873
5.60972112644657e-12	-0.253836017494798	0.797	0.893	8.86784715668674e-08	MEA1	Malignant cells	GSE131984_Pal	ENSG00000124733	4201	male-enhanced antigen 1	MEA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45874
6.62544004459264e-12	-0.267434801240943	0.264	0.416	1.0473495622492e-07	EZH2	Malignant cells	GSE131984_Pal	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45875
6.65491747514974e-12	-0.263726726340734	0.828	0.903	1.05200935447167e-07	UQCRC1	Malignant cells	GSE131984_Pal	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45876
6.73755552853746e-12	-0.287294636262343	0.635	0.742	1.0650727779512e-07	COMMD4	Malignant cells	GSE131984_Pal	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45877
6.7901726718047e-12	0.267809935554189	0.968	0.937	1.07339049595889e-07	CCND1	Malignant cells	GSE131984_Pal	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45878
7.03431994771855e-12	-0.289911169086841	0.628	0.727	1.11198529733535e-07	TMEM126B	Malignant cells	GSE131984_Pal	ENSG00000171204	55863	transmembrane protein 126B	HT007	protein_coding	Q8IUX1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45879
7.19537441927529e-12	-0.296376710749465	0.411	0.544	1.13744478819904e-07	GOSR2	Malignant cells	GSE131984_Pal	ENSG00000108433	9570	golgi SNAP receptor complex member 2	Bos1|GS27	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45880
7.22412185097938e-12	-0.26224427677451	0.83	0.889	1.14198918220282e-07	CHPT1	Malignant cells	GSE131984_Pal	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45881
9.03655171882093e-12	-0.282836748787709	0.854	0.902	1.42849809571121e-07	IL32	Malignant cells	GSE131984_Pal	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45882
9.17436581573531e-12	-0.274990150569522	0.606	0.729	1.45028374815144e-07	RSRC1	Malignant cells	GSE131984_Pal	ENSG00000174891	51319	arginine and serine rich coiled-coil 1	BM-011|MGC12197|SFRS21|SRrp53	protein_coding	Q96IZ7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45883
9.23969018784804e-12	-0.277857703901805	0.476	0.621	1.46061022489502e-07	PELO	Malignant cells	GSE131984_Pal	ENSG00000152684	53918	pelota mRNA surveillance and ribosome rescue factor	NA	protein_coding	Q9BRX2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45884
9.45443295533778e-12	-0.262383581011362	0.626	0.747	1.4945567615798e-07	COMMD3	Malignant cells	GSE131984_Pal	ENSG00000148444	23412	COMM domain containing 3	BUP|C10orf8	protein_coding	Q9UBI1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45885
9.4906497655374e-12	-0.271184268145404	0.375	0.524	1.50028191493615e-07	C12orf29	Malignant cells	GSE131984_Pal	ENSG00000133641	91298	chromosome 12 open reading frame 29	DKFZp434N2030	protein_coding	Q8N999	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45886
9.55712609532034e-12	-0.252605376655866	0.833	0.904	1.51079049314824e-07	DAP	Malignant cells	GSE131984_Pal	ENSG00000112977	1611	death associated protein	DAP1	protein_coding	P51397	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45887
9.90479200423899e-12	-0.254018676084211	0.214	0.356	1.5657495200301e-07	NSDHL	Malignant cells	GSE131984_Pal	ENSG00000147383	50814	NAD(P) dependent steroid dehydrogenase-like	H105e3|SDR31E1|XAP104	protein_coding	Q15738	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45888
1.01286884586596e-11	-0.276865803974088	0.248	0.394	1.60114307154491e-07	RPP40	Malignant cells	GSE131984_Pal	ENSG00000124787	10799	ribonuclease P/MRP subunit p40	bA428J1.3|RNASEP1	protein_coding	O75818	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45889
1.02412148293618e-11	-0.276927600711345	0.545	0.674	1.61893124022552e-07	UGP2	Malignant cells	GSE131984_Pal	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45890
1.03225290586341e-11	-0.276478707467594	0.518	0.647	1.63178539358887e-07	COMMD8	Malignant cells	GSE131984_Pal	ENSG00000169019	54951	COMM domain containing 8	FLJ20502	protein_coding	Q9NX08	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45891
1.04879369684176e-11	-0.289832154473559	0.53	0.657	1.65793307596745e-07	NARS	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45892
1.0598862711628e-11	0.276830656448038	0.837	0.735	1.67546821745415e-07	RHOBTB3	Malignant cells	GSE131984_Pal	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45893
1.0935758892044e-11	-0.2786189064853	0.968	0.97	1.72872476565431e-07	CCT3	Malignant cells	GSE131984_Pal	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45894
1.10484209869325e-11	-0.273502146283995	0.786	0.841	1.7465343896143e-07	FKBP3	Malignant cells	GSE131984_Pal	ENSG00000100442	2287	FKBP prolyl isomerase 3	FKBP-25|FKBP25	protein_coding	Q00688	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45895
1.15349966831225e-11	-0.270957056447671	0.698	0.804	1.82345227566801e-07	ASNA1	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45896
1.16324301241772e-11	-0.251590221376526	0.792	0.877	1.83885455402993e-07	NELFE	Malignant cells	GSE131984_Pal	ENSG00000206268	7936	negative elongation factor complex member E	D6S45|NELF-E|RD|RDBP|RDP	protein_coding	P18615	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45897
1.24784340254826e-11	-0.320492609989825	0.548	0.667	1.97259085074829e-07	MRPS22	Malignant cells	GSE131984_Pal	ENSG00000175110	56945	mitochondrial ribosomal protein S22	C3orf5|GIBT|GK002|MRP-S22	protein_coding	P82650	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45898
1.25866240622846e-11	-0.264821118799986	0.599	0.707	1.98969353176595e-07	IMPDH1	Malignant cells	GSE131984_Pal	ENSG00000106348	3614	inosine monophosphate dehydrogenase 1	LCA11|RP10|sWSS2608	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45899
1.3710683953659e-11	-0.288205399867534	0.587	0.707	2.16738491939441e-07	GPS1	Malignant cells	GSE131984_Pal	ENSG00000169727	2873	G protein pathway suppressor 1	COPS1|CSN1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45900
1.4244906699522e-11	-0.269797148994663	0.518	0.664	2.25183485106044e-07	DYNLT3	Malignant cells	GSE131984_Pal	ENSG00000165169	6990	dynein light chain Tctex-type 3	TCTE1L|TCTEX1L	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45901
1.43976089910641e-11	-0.254391875069278	0.906	0.946	2.27597402930741e-07	COX16	Malignant cells	GSE131984_Pal	ENSG00000133983	51241	cytochrome c oxidase assembly factor COX16	C14orf112|HSPC203	protein_coding	Q9P0S2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45902
1.44836887122431e-11	-0.26278948378607	0.41	0.56	2.28958151163138e-07	PPAP2A	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45903
1.48282583841197e-11	-0.27275689936931	0.684	0.774	2.34405108536164e-07	BCL2L12	Malignant cells	GSE131984_Pal	ENSG00000126453	83596	BCL2 like 12	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45904
1.51427045604629e-11	-0.26984839857983	0.333	0.484	2.39375873691798e-07	LAS1L	Malignant cells	GSE131984_Pal	ENSG00000001497	81887	LAS1 like ribosome biogenesis factor	FLJ12525|Las1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45905
1.59054910357553e-11	-0.268811709094031	0.329	0.48	2.5143400229322e-07	C14orf142	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45906
1.60743985397955e-11	0.314416006188437	0.541	0.406	2.54104092117088e-07	B4GALT1	Malignant cells	GSE131984_Pal	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45907
1.61498160393392e-11	-0.252279280992934	0.847	0.915	2.55296291949874e-07	KXD1	Malignant cells	GSE131984_Pal	ENSG00000105700	79036	KxDL motif containing 1	BORCS4|C19orf50|FLJ25480|KXDL|MGC2749	protein_coding	Q9BQD3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45908
1.63392917197031e-11	-0.257904820445677	0.465	0.645	2.58291523505067e-07	TPX2	Malignant cells	GSE131984_Pal	ENSG00000088325	22974	TPX2 microtubule nucleation factor	C20orf1|C20orf2|DIL-2|FLS353|HCA519|p100	protein_coding	Q9ULW0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45909
1.64309735048481e-11	-0.256554744005065	0.381	0.531	2.59740829164638e-07	RABIF	Malignant cells	GSE131984_Pal	ENSG00000183155	5877	RAB interacting factor	mss4|RASGRF3	protein_coding	P47224	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45910
1.64370564010517e-11	0.252294814788294	0.745	0.626	2.59836987587825e-07	TMEM134	Malignant cells	GSE131984_Pal	ENSG00000172663	80194	transmembrane protein 134	FLJ21749	protein_coding	Q9H6X4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45911
1.64797577723141e-11	-0.271213160981508	0.73	0.819	2.60512010864741e-07	STX10	Malignant cells	GSE131984_Pal	ENSG00000104915	8677	syntaxin 10	hsyn10|SYN10	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45912
1.6570601267019e-11	-0.329577186624457	0.545	0.661	2.61948064829037e-07	TRMT10C	Malignant cells	GSE131984_Pal	ENSG00000174173	54931	tRNA methyltransferase 10C, mitochondrial RNase P subunit	FLJ20432|MRPP1|RG9MTD1	protein_coding	Q7L0Y3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45913
1.6751856919743e-11	-0.269099332650048	0.303	0.449	2.64813354187297e-07	FJX1	Malignant cells	GSE131984_Pal	ENSG00000179431	24147	four-jointed box kinase 1	FLJ22416|FLJ25593	protein_coding	Q86VR8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45914
1.70010732551786e-11	-0.251282415378341	0.879	0.923	2.68752966017863e-07	FSCN1	Malignant cells	GSE131984_Pal	ENSG00000075618	6624	fascin actin-bundling protein 1	FLJ38511|p55|SNL	protein_coding	Q16658	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45915
1.71119515332037e-11	-0.265242494343397	0.28	0.419	2.70505729836884e-07	PUS1	Malignant cells	GSE131984_Pal	ENSG00000177192	80324	pseudouridine synthase 1	MLASA1	protein_coding	Q9Y606	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45916
1.7523016521883e-11	-0.350580610899925	0.156	0.292	2.77003845177926e-07	PMAIP1	Malignant cells	GSE131984_Pal	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45917
1.76312793396148e-11	0.357947026513956	0.283	0.158	2.7871526380063e-07	DUSP2	Malignant cells	GSE131984_Pal	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45918
1.83424993879817e-11	-0.261596680873236	0.615	0.734	2.89958230325214e-07	SIGMAR1	Malignant cells	GSE131984_Pal	ENSG00000147955	10280	sigma non-opioid intracellular receptor 1	OPRS1|SR-BP1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45919
1.96846755349897e-11	-0.252145260574799	0.359	0.509	3.11175350857118e-07	PPIE	Malignant cells	GSE131984_Pal	ENSG00000084072	10450	peptidylprolyl isomerase E	CyP-33|MGC111222|MGC3736	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45920
1.97382992889174e-11	-0.253114678255601	0.42	0.57	3.12023035159206e-07	MRPS18A	Malignant cells	GSE131984_Pal	ENSG00000096080	55168	mitochondrial ribosomal protein S18A	FLJ10548|MRPS18-3	protein_coding	Q9NVS2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45921
2.45203113559496e-11	0.26038170015949	0.463	0.324	3.87617081914851e-07	GLG1	Malignant cells	GSE131984_Pal	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45922
2.47570140803003e-11	-0.27598199982282	0.53	0.654	3.91358878581387e-07	CINP	Malignant cells	GSE131984_Pal	ENSG00000100865	51550	cyclin dependent kinase 2 interacting protein	MGC849	protein_coding	Q9BW66	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45923
2.49986187686888e-11	-0.26542888359889	0.773	0.858	3.95178165495432e-07	PSMD2	Malignant cells	GSE131984_Pal	ENSG00000175166	5708	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	MGC14274|P97|Rpn1|S2|TRAP2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45924
2.6801833085956e-11	-0.284608137798649	0.505	0.628	4.23683377422792e-07	FAM104A	Malignant cells	GSE131984_Pal	ENSG00000133193	84923	family with sequence similarity 104 member A	FLJ14775	protein_coding	Q969W3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45925
2.68090051616075e-11	-0.299054432414045	0.387	0.528	4.23796753594692e-07	PRMT5	Malignant cells	GSE131984_Pal	ENSG00000100462	10419	protein arginine methyltransferase 5	HRMT1L5|SKB1|SKB1Hs	protein_coding	O14744	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45926
2.78237853643198e-11	0.287984293074934	0.98	0.953	4.39838399039168e-07	FLNA	Malignant cells	GSE131984_Pal	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45927
2.8774723795857e-11	0.254548226550249	0.609	0.475	4.54870833764907e-07	UBXN6	Malignant cells	GSE131984_Pal	ENSG00000167671	80700	UBX domain protein 6	UBXD1|UBXDC2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45928
3.02299368681647e-11	-0.278828892961152	0.271	0.407	4.77874842011948e-07	PNP	Malignant cells	GSE131984_Pal	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45929
3.16613468382885e-11	-0.281564735624569	0.794	0.843	5.00502570819665e-07	MAPKAPK3	Malignant cells	GSE131984_Pal	ENSG00000114738	7867	MAPK activated protein kinase 3	3pK|MAPKAP3|MK-3|MK3	protein_coding	Q16644	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45930
3.24922794481145e-11	-0.28348166428194	0.622	0.718	5.13637953515794e-07	HAUS1	Malignant cells	GSE131984_Pal	ENSG00000152240	115106	HAUS augmin like complex subunit 1	CCDC5|FLJ40084|HEI-C|HsT1461	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45931
3.30200819865421e-11	-0.259289174279907	0.303	0.449	5.21981456043258e-07	MPHOSPH6	Malignant cells	GSE131984_Pal	ENSG00000135698	10200	M-phase phosphoprotein 6	MPP6	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45932
3.35527679671814e-11	-0.258903790650528	0.732	0.814	5.30402156025204e-07	DENR	Malignant cells	GSE131984_Pal	ENSG00000139726	8562	density regulated re-initiation and release factor	DRP|DRP1|SMAP-3	protein_coding	O43583	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45933
3.54278145514574e-11	-0.262380627764528	0.413	0.556	5.60042892429438e-07	TOR1A	Malignant cells	GSE131984_Pal	ENSG00000136827	1861	torsin family 1 member A	DQ2|DYT1	protein_coding	O14656	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45934
3.54490412300295e-11	-0.255677604842547	0.369	0.518	5.60378443764306e-07	MRPL2	Malignant cells	GSE131984_Pal	ENSG00000112651	51069	mitochondrial ribosomal protein L2	CGI-22|MRP-L14|RPML14	protein_coding	Q5T653	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45935
3.65867099832736e-11	0.274076199310763	0.921	0.841	5.78362711415589e-07	PDLIM2	Malignant cells	GSE131984_Pal	ENSG00000120913	64236	PDZ and LIM domain 2	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45936
3.66890722915163e-11	0.25247173262228	0.473	0.329	5.79980854784289e-07	MACF1	Malignant cells	GSE131984_Pal	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45937
3.863136861955e-11	-0.291030602749211	0.665	0.739	6.10684675137846e-07	LSM12	Malignant cells	GSE131984_Pal	ENSG00000161654	124801	LSM12 homolog	FLJ30656	protein_coding	Q3MHD2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45938
4.01453576058619e-11	-0.275953139043515	0.768	0.828	6.34617813033465e-07	JAGN1	Malignant cells	GSE131984_Pal	ENSG00000171135	84522	jagunal homolog 1	FLJ14602|GL009	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45939
4.07826873973281e-11	-0.275905882757199	0.519	0.666	6.44692722376962e-07	HMGN5	Malignant cells	GSE131984_Pal	ENSG00000198157	79366	high mobility group nucleosome binding domain 5	NSBP1	protein_coding	P82970	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45940
4.12465440217649e-11	-0.270600506409647	0.368	0.517	6.5202536789606e-07	WBSCR27	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45941
4.24386866204668e-11	0.291388367796068	0.911	0.851	6.70870758096339e-07	CEBPB	Malignant cells	GSE131984_Pal	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45942
5.24664271324958e-11	-0.270835659050372	0.571	0.686	8.29389280110493e-07	GIPC1	Malignant cells	GSE131984_Pal	ENSG00000123159	10755	GIPC PDZ domain containing family member 1	C19orf3|GIPC|GLUT1CBP|Hs.6454|NIP|RGS19IP1|SEMCAP|SYNECTIN|TIP-2	protein_coding	O14908	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45943
5.29668306300403e-11	0.252977833036377	0.916	0.84	8.37299658599677e-07	HDLBP	Malignant cells	GSE131984_Pal	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45944
5.3492450272691e-11	0.250458467362325	0.574	0.424	8.456086539107e-07	TSPYL1	Malignant cells	GSE131984_Pal	ENSG00000189241	7259	TSPY like 1	TSPYL	protein_coding	Q9H0U9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45945
5.35706982190209e-11	-0.283390816036892	0.388	0.528	8.46845597446282e-07	DYNC1LI1	Malignant cells	GSE131984_Pal	ENSG00000144635	51143	dynein cytoplasmic 1 light intermediate chain 1	DNCLI1	protein_coding	Q9Y6G9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45946
5.40673170631192e-11	-0.277708265602708	0.567	0.692	8.54696148133788e-07	ATXN10	Malignant cells	GSE131984_Pal	ENSG00000130638	25814	ataxin 10	ATX10|E46L|FLJ37990|SCA10	protein_coding	Q9UBB4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45947
5.52514702533629e-11	-0.263860111559384	0.547	0.674	8.7341524176516e-07	STARD3NL	Malignant cells	GSE131984_Pal	ENSG00000010270	83930	STARD3 N-terminal like	MENTHO|MGC3251	protein_coding	O95772	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45948
5.76770103350407e-11	0.289986498610179	0.59	0.468	9.11758179376324e-07	SVIL	Malignant cells	GSE131984_Pal	ENSG00000197321	6840	supervillin	NA	protein_coding	O95425	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45949
6.02460093765832e-11	-0.253566538085556	0.29	0.434	9.52368916225027e-07	GTF2H2	Malignant cells	GSE131984_Pal	ENSG00000276910	2966	general transcription factor IIH subunit 2	BTF2|BTF2P44|p44|T-BTF2P44|TFIIH	protein_coding	Q13888	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45950
6.09123748542182e-11	-0.263262258078162	0.538	0.665	9.62902821695481e-07	BRD7	Malignant cells	GSE131984_Pal	ENSG00000166164	29117	bromodomain containing 7	BP75|CELTIX1|SMARCI1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45951
6.13685558735833e-11	-0.260186709831319	0.511	0.643	9.70114131249606e-07	MLX	Malignant cells	GSE131984_Pal	ENSG00000108788	6945	MAX dimerization protein MLX	bHLHd13|MAD7|MXD7|TCFL4	protein_coding	Q9UH92	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45952
6.14365065342455e-11	-0.254974390686109	0.73	0.795	9.71188295293353e-07	FAM204A	Malignant cells	GSE131984_Pal	ENSG00000165669	63877	family with sequence similarity 204 member A	bA319I23.1|C10orf84|FLJ13188	protein_coding	Q9H8W3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45953
6.19979083120691e-11	0.263243418059836	0.623	0.469	9.80062934597189e-07	MARCKSL1	Malignant cells	GSE131984_Pal	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45954
6.54946097299751e-11	-0.256121678197509	0.274	0.416	1.03533879061145e-06	CXorf38	Malignant cells	GSE131984_Pal	ENSG00000185753	159013	chromosome X open reading frame 38	MGC39350	protein_coding	Q8TB03	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45955
7.04738083300163e-11	-0.261412253497805	0.499	0.647	1.1140499620809e-06	RAD1	Malignant cells	GSE131984_Pal	ENSG00000113456	5810	RAD1 checkpoint DNA exonuclease	HRAD1|REC1	protein_coding	O60671	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45956
7.33410720060749e-11	-0.253522468162351	0.411	0.56	1.15937566627203e-06	AVPI1	Malignant cells	GSE131984_Pal	ENSG00000119986	60370	arginine vasopressin induced 1	PP5395|VIP32|VIT32	protein_coding	Q5T686	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45957
7.65969741718769e-11	-0.30109669494975	0.496	0.629	1.21084496770903e-06	FDFT1	Malignant cells	GSE131984_Pal	ENSG00000284967	2222	farnesyl-diphosphate farnesyltransferase 1	SQS	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45958
7.76592838336781e-11	-0.275487048603697	0.654	0.752	1.22763795884278e-06	TEX264	Malignant cells	GSE131984_Pal	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45959
7.96228773190032e-11	-0.25883475395965	0.426	0.567	1.2586784446588e-06	OSER1	Malignant cells	GSE131984_Pal	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45960
8.0134740876489e-11	0.254783370977947	0.502	0.36	1.26676998377554e-06	MFGE8	Malignant cells	GSE131984_Pal	ENSG00000140545	4240	milk fat globule EGF and factor V/VIII domain containing	BA46|EDIL1|hP47|HsT19888|MFG-E8|OAcGD3S|SED1|SPAG10	protein_coding	Q08431	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45961
8.22777026268182e-11	-0.290273144956598	0.592	0.692	1.30064592312474e-06	PITX1	Malignant cells	GSE131984_Pal	ENSG00000069011	5307	paired like homeodomain 1	BFT|POTX|PTX1	protein_coding	P78337	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45962
8.258872647854e-11	-0.271611634694464	0.739	0.827	1.30556258817276e-06	SKA2	Malignant cells	GSE131984_Pal	ENSG00000182628	348235	spindle and kinetochore associated complex subunit 2	FAM33A|FLJ12758	protein_coding	Q8WVK7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45963
8.40182073012373e-11	-0.278516574545515	0.681	0.771	1.32815982101796e-06	MRPS2	Malignant cells	GSE131984_Pal	ENSG00000122140	51116	mitochondrial ribosomal protein S2	CGI-91	protein_coding	Q9Y399	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45964
8.70989443860262e-11	-0.261015008354278	0.447	0.583	1.3768601128543e-06	GFER	Malignant cells	GSE131984_Pal	ENSG00000127554	2671	growth factor, augmenter of liver regeneration	ALR|ERV1|HERV1|HPO1|HPO2|HSS	protein_coding	P55789	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45965
8.84580311431291e-11	-0.269526025851839	0.489	0.629	1.39834455631058e-06	TMEM9B	Malignant cells	GSE131984_Pal	ENSG00000175348	56674	TMEM9 domain family member B	C11orf15	protein_coding	Q9NQ34	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45966
8.88023779757345e-11	-0.286057240046968	0.433	0.57	1.40378799104041e-06	MZT1	Malignant cells	GSE131984_Pal	ENSG00000204899	440145	mitotic spindle organizing protein 1	C13orf37|FLJ21869|LOC440145|MGC150539|MOZART1|RP11-11C5.2	protein_coding	Q08AG7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45967
8.9306506261416e-11	-0.326547193915106	0.573	0.666	1.41175725098046e-06	SVIP	Malignant cells	GSE131984_Pal	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45968
9.34101552034907e-11	-0.262402545393352	0.459	0.601	1.47662773345678e-06	TCOF1	Malignant cells	GSE131984_Pal	ENSG00000070814	6949	treacle ribosome biogenesis factor 1	TCS|treacle	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45969
9.40028562914827e-11	-0.291604035198631	0.537	0.648	1.48599715225576e-06	NDUFA9	Malignant cells	GSE131984_Pal	ENSG00000139180	4704	NADH:ubiquinone oxidoreductase subunit A9	CI-39k|COQ11|NDUFS2L|SDR22E1	protein_coding	Q16795	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45970
9.62057939915802e-11	-0.250300338615869	0.698	0.803	1.5208211914189e-06	TSEN34	Malignant cells	GSE131984_Pal	ENSG00000274078	79042	tRNA splicing endonuclease subunit 34	LENG5|SEN34|SEN34L	protein_coding	Q9BSV6	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45971
9.80685486273793e-11	-0.256769287100246	0.651	0.759	1.55026761670161e-06	SLC30A5	Malignant cells	GSE131984_Pal	ENSG00000145740	64924	solute carrier family 30 member 5	FLJ12496|FLJ12756|MGC5499|ZnT-5|ZNT5|ZNTL1|ZTL1	protein_coding	Q8TAD4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45972
1.10191588829015e-10	-0.275227342124608	0.325	0.467	1.74190863620907e-06	SNHG10	Malignant cells	GSE131984_Pal	ENSG00000247092	283596	small nucleolar RNA host gene 10	C14orf62|FLJ40557|LINC00063|NCRNA00063|TP53LC16	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45973
1.23201694268965e-10	-0.255460756045973	0.641	0.737	1.94757238300379e-06	DPM2	Malignant cells	GSE131984_Pal	ENSG00000136908	8818	dolichyl-phosphate mannosyltransferase subunit 2, regulatory	MGC111193|MGC21559	protein_coding	O94777	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45974
1.27930282859264e-10	-0.266620095147956	0.742	0.813	2.02232191143924e-06	DNAJC7	Malignant cells	GSE131984_Pal	ENSG00000168259	7266	DnaJ heat shock protein family (Hsp40) member C7	TPR2|TTC2	protein_coding	Q99615	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45975
1.30700438051838e-10	-0.260435086748447	0.442	0.567	2.06611252472346e-06	MGAT2	Malignant cells	GSE131984_Pal	ENSG00000168282	4247	alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GNT-II	protein_coding	Q10469	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45976
1.69140778348306e-10	0.268425946908379	0.939	0.879	2.67377742413003e-06	ZFP36L1	Malignant cells	GSE131984_Pal	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45977
1.73503040347929e-10	0.257867400006345	0.543	0.407	2.74273606182006e-06	PCSK7	Malignant cells	GSE131984_Pal	ENSG00000160613	9159	proprotein convertase subtilisin/kexin type 7	LPC|PC7|PC8|SPC7	protein_coding	Q16549	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45978
1.76551547677539e-10	-0.261747781213063	0.421	0.565	2.79092686568653e-06	FERMT2	Malignant cells	GSE131984_Pal	ENSG00000073712	10979	FERM domain containing kindlin 2	KIND2|mig-2|PLEKHC1|UNC112B	protein_coding	Q96AC1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45979
1.79447771862618e-10	-0.263288260923054	0.628	0.727	2.83671037760427e-06	PPP1R11	Malignant cells	GSE131984_Pal	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45980
1.80194538183854e-10	-0.271753861836936	0.528	0.648	2.84851525961036e-06	DNAJA2	Malignant cells	GSE131984_Pal	ENSG00000069345	10294	DnaJ heat shock protein family (Hsp40) member A2	CPR3|DNAJ|DNJ3|HIRIP4	protein_coding	O60884	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45981
1.87405275693166e-10	0.404415620293699	0.473	0.33	2.96250259815756e-06	MGP	Malignant cells	GSE131984_Pal	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45982
1.92094538892016e-10	-0.269913853900955	0.683	0.777	3.03663047080499e-06	BOD1	Malignant cells	GSE131984_Pal	ENSG00000145919	91272	biorientation of chromosomes in cell division 1	FAM44B	protein_coding	Q96IK1	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45983
1.93125267723447e-10	-0.264024374790858	0.58	0.687	3.05292423217224e-06	RP11-345J4.5	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45984
1.95511193898094e-10	-0.289443595185205	0.502	0.629	3.09064095314107e-06	BCAS2	Malignant cells	GSE131984_Pal	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45985
1.97879147582336e-10	-0.315331846930574	0.618	0.717	3.12807356498157e-06	PDLIM7	Malignant cells	GSE131984_Pal	ENSG00000196923	9260	PDZ and LIM domain 7	ENIGMA	protein_coding	Q9NR12	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45986
2.01563037230664e-10	-0.277387741535123	0.325	0.466	3.18630849254234e-06	ATP1B1	Malignant cells	GSE131984_Pal	ENSG00000143153	481	ATPase Na+/K+ transporting subunit beta 1	ATP1B	protein_coding	P05026	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45987
2.05448856186889e-10	-0.254383978439113	0.586	0.694	3.24773551860235e-06	SEPHS2	Malignant cells	GSE131984_Pal	ENSG00000179918	22928	selenophosphate synthetase 2	SPS2|SPS2b	protein_coding	Q99611	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45988
2.11089767786261e-10	-0.254110762474247	0.466	0.598	3.33690704916521e-06	TRABD	Malignant cells	GSE131984_Pal	ENSG00000170638	80305	TraB domain containing	PP2447	protein_coding	Q9H4I3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45989
2.37684769050987e-10	-0.293506817141676	0.528	0.643	3.75732082915801e-06	MRPS30	Malignant cells	GSE131984_Pal	ENSG00000112996	10884	mitochondrial ribosomal protein S30	PAP|PDCD9	protein_coding	Q9NP92	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45990
2.37977060060437e-10	-0.250630399585684	0.333	0.466	3.76194136543539e-06	THUMPD3	Malignant cells	GSE131984_Pal	ENSG00000134077	25917	THUMP domain containing 3	DKFZP434F091	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45991
2.44357807017607e-10	-0.259524024785614	0.491	0.615	3.86280821333433e-06	AAMP	Malignant cells	GSE131984_Pal	ENSG00000127837	14	angio associated migratory cell protein	NA	protein_coding	Q13685	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45992
2.46489249253834e-10	-0.278189577079815	0.42	0.549	3.89650205220461e-06	SMAGP	Malignant cells	GSE131984_Pal	ENSG00000170545	57228	small cell adhesion glycoprotein	hSMAGP|MGC149453|MGC149454	protein_coding	Q0VAQ4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45993
2.66540094357946e-10	0.264300057118235	0.397	0.262	4.21346581161041e-06	MIR24-2	Malignant cells	GSE131984_Pal	ENSG00000288126	407013	microRNA 24-2	hsa-mir-24-2|MIRN24-2	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45994
2.72254920553848e-10	-0.258286186895421	0.681	0.78	4.30380578411523e-06	DDX24	Malignant cells	GSE131984_Pal	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45995
2.87426024011478e-10	-0.284219265385267	0.623	0.706	4.54363058757344e-06	GNAI3	Malignant cells	GSE131984_Pal	ENSG00000065135	2773	G protein subunit alpha i3	87U6	protein_coding	P08754	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45996
2.91156020447644e-10	-0.308419647567617	0.541	0.644	4.60259437123636e-06	SNHG15	Malignant cells	GSE131984_Pal	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45997
2.946929713132e-10	-0.257238716643397	0.582	0.694	4.65850649051906e-06	ISCA2	Malignant cells	GSE131984_Pal	ENSG00000165898	122961	iron-sulfur cluster assembly 2	HBLD1|ISA2	protein_coding	Q86U28	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45998
3.15103815512574e-10	-0.251322364992056	0.342	0.485	4.98116111562277e-06	ARMCX6	Malignant cells	GSE131984_Pal	ENSG00000198960	54470	armadillo repeat containing X-linked 6	FLJ20811|GASP10	protein_coding	Q7L4S7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	45999
3.26090356824017e-10	-0.262203385468947	0.74	0.811	5.15483636067406e-06	GRSF1	Malignant cells	GSE131984_Pal	ENSG00000132463	2926	G-rich RNA sequence binding factor 1	NA	protein_coding	Q12849	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46000
3.3927664306913e-10	-0.280579611718102	0.456	0.588	5.36328517363681e-06	AATF	Malignant cells	GSE131984_Pal	ENSG00000276072	26574	apoptosis antagonizing transcription factor	BFR2|CHE-1|CHE1|DED	protein_coding	Q9NY61	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46001
3.62577931397842e-10	0.264501316860851	0.485	0.358	5.73163193953709e-06	ETV1	Malignant cells	GSE131984_Pal	ENSG00000006468	2115	ETS variant transcription factor 1	ER81	protein_coding	P50549	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46002
3.81739211186828e-10	-0.250633854559254	0.861	0.901	6.03453345044137e-06	PARP1	Malignant cells	GSE131984_Pal	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46003
4.15755806209692e-10	0.273812261258382	0.701	0.607	6.57226778456282e-06	CLIC4	Malignant cells	GSE131984_Pal	ENSG00000169504	25932	chloride intracellular channel 4	CLIC4L|DKFZP566G223|H1|huH1|P64H1	protein_coding	Q9Y696	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46004
4.69557697067298e-10	-0.252975174881356	0.519	0.644	7.42276807523984e-06	ATG5	Malignant cells	GSE131984_Pal	ENSG00000057663	9474	autophagy related 5	APG5|APG5L|ASP|hAPG5	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46005
5.03935329985503e-10	-0.25632743723166	0.365	0.495	7.96620969641084e-06	AIFM1	Malignant cells	GSE131984_Pal	ENSG00000156709	9131	apoptosis inducing factor mitochondria associated 1	AIF|AUNX1|CMTX4|DFNX5|NAMSD|PDCD8	protein_coding	O95831	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46006
5.07734899893744e-10	-0.251707526735323	0.548	0.673	8.02627329752031e-06	HMBS	Malignant cells	GSE131984_Pal	ENSG00000256269	3145	hydroxymethylbilane synthase	PBGD|PORC|UPS	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46007
5.19220651733166e-10	-0.273296418876111	0.684	0.762	8.20784006259789e-06	ARHGAP18	Malignant cells	GSE131984_Pal	ENSG00000146376	93663	Rho GTPase activating protein 18	bA307O14.2|MacGAP	protein_coding	Q8N392	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46008
5.42799683123037e-10	-0.277734075842706	0.597	0.696	8.58057739080897e-06	ILK	Malignant cells	GSE131984_Pal	ENSG00000166333	3611	integrin linked kinase	NA	protein_coding	Q13418	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46009
5.58750554581835e-10	-0.269648777004931	0.724	0.783	8.83272876682964e-06	AIMP1	Malignant cells	GSE131984_Pal	ENSG00000164022	9255	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	EMAP-2|EMAPII|p43|SCYE1	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46010
6.21110404819266e-10	-0.267785699371323	0.475	0.591	9.81851327938295e-06	CTBP2	Malignant cells	GSE131984_Pal	ENSG00000175029	1488	C-terminal binding protein 2	ribeye	protein_coding	P56545	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46011
7.54357386430488e-10	-0.28202063546748	0.633	0.73	1.19248815646932e-05	GGH	Malignant cells	GSE131984_Pal	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46012
7.91926470675927e-10	-0.31183068934175	0.639	0.736	1.2518773648445e-05	NUCB2	Malignant cells	GSE131984_Pal	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46013
8.50175669518335e-10	-0.260724663445427	0.478	0.6	1.34395769837458e-05	MPP1	Malignant cells	GSE131984_Pal	ENSG00000130830	4354	MAGUK p55 scaffold protein 1	DXS552E|PEMP	protein_coding	Q00013	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46014
9.76509998642714e-10	-0.260384743773787	0.502	0.625	1.5436670058544e-05	RRM1	Malignant cells	GSE131984_Pal	ENSG00000167325	6240	ribonucleotide reductase catalytic subunit M1	NA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46015
1.01801080673753e-09	0.25450126305667	0.96	0.91	1.60927148329069e-05	CXCL2	Malignant cells	GSE131984_Pal	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46016
1.08179817171656e-09	-0.260047836744374	0.726	0.793	1.71010654984954e-05	ANXA11	Malignant cells	GSE131984_Pal	ENSG00000122359	311	annexin A11	ANX11	protein_coding	P50995	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46017
1.15943362931188e-09	-0.296214907783376	0.615	0.713	1.83283268121622e-05	GCLM	Malignant cells	GSE131984_Pal	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46018
1.21702069145735e-09	-0.307828833677626	0.404	0.517	1.92386630905578e-05	CCNH	Malignant cells	GSE131984_Pal	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46019
1.23994316880059e-09	0.263100938951756	0.635	0.493	1.96010216123997e-05	SRPX	Malignant cells	GSE131984_Pal	ENSG00000101955	8406	sushi repeat containing protein X-linked	ETX1|SRPX1	protein_coding	P78539	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46020
1.25454904791084e-09	-0.256539749175468	0.747	0.811	1.98319113493745e-05	EWSR1	Malignant cells	GSE131984_Pal	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46021
1.50806185233266e-09	0.252225120000958	0.671	0.562	2.38394417616747e-05	FAM89B	Malignant cells	GSE131984_Pal	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46022
1.58191059128237e-09	0.271640870457158	0.837	0.747	2.50068426269917e-05	F3	Malignant cells	GSE131984_Pal	ENSG00000117525	2152	coagulation factor III, tissue factor	CD142|TF	protein_coding	P13726	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46023
1.62222035972898e-09	-0.278231944260495	0.863	0.897	2.56440594465957e-05	CTSC	Malignant cells	GSE131984_Pal	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46024
1.87844692753169e-09	0.255876410610791	0.579	0.466	2.96944890304209e-05	RP11-792A8.4	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46025
2.00912390013002e-09	-0.262248033210794	0.141	0.253	3.17602306132554e-05	ASNS	Malignant cells	GSE131984_Pal	ENSG00000070669	440	asparagine synthetase (glutamine-hydrolyzing)	NA	protein_coding	P08243	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46026
2.44358051875123e-09	-0.262645853436915	0.671	0.744	3.86281208404194e-05	NDFIP1	Malignant cells	GSE131984_Pal	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46027
2.4493988553586e-09	-0.309515520269096	0.447	0.584	3.87200971055087e-05	COL1A1	Malignant cells	GSE131984_Pal	ENSG00000108821	1277	collagen type I alpha 1 chain	OI4	protein_coding	P02452	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46028
2.56617487077445e-09	0.266479121851342	0.341	0.22	4.05660923572025e-05	TXNIP	Malignant cells	GSE131984_Pal	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46029
2.67595160833463e-09	-0.251017269035429	0.264	0.392	4.23014430245538e-05	TACC3	Malignant cells	GSE131984_Pal	ENSG00000013810	10460	transforming acidic coiled-coil containing protein 3	ERIC-1|ERIC1|maskin|Tacc4	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46030
2.89824846940235e-09	-0.26244970062126	0.189	0.314	4.58155118043124e-05	FAM83D	Malignant cells	GSE131984_Pal	ENSG00000101447	81610	family with sequence similarity 83 member D	C20orf129|CHICA|dJ616B8.3	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46031
3.23659279602528e-09	0.271671962996923	0.707	0.58	5.11640589195677e-05	ITGA5	Malignant cells	GSE131984_Pal	ENSG00000161638	3678	integrin subunit alpha 5	CD49e|FNRA	protein_coding	P08648	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46032
3.40734735584128e-09	-0.286315026368093	0.234	0.354	5.38633470011389e-05	DDX10	Malignant cells	GSE131984_Pal	ENSG00000178105	1662	DEAD-box helicase 10	Dbp4|HRH-J8	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46033
4.17926569774138e-09	0.280978119170614	0.587	0.473	6.60658321498957e-05	ACSL1	Malignant cells	GSE131984_Pal	ENSG00000151726	2180	acyl-CoA synthetase long chain family member 1	ACS1|FACL1|FACL2|LACS|LACS1|LACS2	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46034
4.43960087991183e-09	-0.253399065215104	0.358	0.481	7.01812107096462e-05	ACTR10	Malignant cells	GSE131984_Pal	ENSG00000131966	55860	actin related protein 10	ACTR11|Arp10|Arp11|HARP11	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46035
4.47330434726384e-09	-0.307881704099975	0.24	0.362	7.07139951215468e-05	SULT1B1	Malignant cells	GSE131984_Pal	ENSG00000173597	27284	sulfotransferase family 1B member 1	ST1B2	protein_coding	O43704	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46036
4.77121362250392e-09	-0.26019212935075	0.489	0.588	7.5423344944542e-05	SUGT1	Malignant cells	GSE131984_Pal	ENSG00000165416	10910	SGT1 homolog, MIS12 kinetochore complex assembly cochaperone	SGT1	protein_coding	Q9Y2Z0	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46037
4.98642203573869e-09	0.262630371769503	0.556	0.448	7.88253595409572e-05	ZNF581	Malignant cells	GSE131984_Pal	ENSG00000171425	51545	zinc finger protein 581	FLJ22550|HSPC189	protein_coding	Q9P0T4	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46038
4.99774606109512e-09	-0.266103208720423	0.714	0.799	7.90043697337917e-05	FASN	Malignant cells	GSE131984_Pal	ENSG00000169710	2194	fatty acid synthase	FAS|SDR27X1	protein_coding	P49327	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46039
5.93206625541371e-09	-0.253022977062009	0.619	0.711	9.377410336558e-05	BCL7B	Malignant cells	GSE131984_Pal	ENSG00000106635	9275	BAF chromatin remodeling complex subunit BCL7B	SMARCJ2	protein_coding	Q9BQE9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46040
6.10808251432947e-09	0.265859032127723	0.739	0.646	9.65565683865202e-05	APLP2	Malignant cells	GSE131984_Pal	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46041
6.39098362459556e-09	0.250486895669517	0.59	0.468	0.000101028669137607	PIK3R1	Malignant cells	GSE131984_Pal	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46042
7.26847014723535e-09	0.263602371878287	0.537	0.42	0.000114899976087496	ITGB5	Malignant cells	GSE131984_Pal	ENSG00000082781	3693	integrin subunit beta 5	NA	protein_coding	P18084	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46043
1.19530047018413e-08	-0.286347134562888	0.57	0.657	0.000188953098326707	SARS	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46044
1.59421837826904e-08	-0.266449929578686	0.631	0.701	0.000252014041236769	PSMD1	Malignant cells	GSE131984_Pal	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46045
1.60208586231734e-08	-0.254065078171868	0.385	0.495	0.000253257733115124	CMTM8	Malignant cells	GSE131984_Pal	ENSG00000170293	152189	CKLF like MARVEL transmembrane domain containing 8	CKLFSF8	protein_coding	Q8IZV2	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46046
2.10899415338409e-08	0.25444236913137	0.593	0.456	0.000333389795766956	PCOLCE	Malignant cells	GSE131984_Pal	ENSG00000106333	5118	procollagen C-endopeptidase enhancer	PCPE|PCPE1	protein_coding	Q15113	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46047
2.47003130252787e-08	-0.263548281344409	0.481	0.579	0.000390462548303606	RP6-109B7.3	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46048
2.55447446191261e-08	-0.287505764355024	0.58	0.673	0.000403811322939146	C19orf33	Malignant cells	GSE131984_Pal	ENSG00000167644	64073	chromosome 19 open reading frame 33	H2RSP|IMUP|IMUP-1|IMUP-2	protein_coding	Q9GZP8	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46049
2.62177008430499e-08	0.318886570020763	0.74	0.615	0.000414449414926932	GS1-600G8.5	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46050
3.88477663040131e-08	0.313854523733545	0.779	0.713	0.000614105489733839	SAT1	Malignant cells	GSE131984_Pal	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46051
4.31009851778869e-08	0.28691008380849	0.701	0.59	0.000681340373692036	VMP1	Malignant cells	GSE131984_Pal	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46052
4.35298980731693e-08	-0.384637416764202	0.872	0.911	0.00068812062874066	SERPINE1	Malignant cells	GSE131984_Pal	ENSG00000106366	5054	serpin family E member 1	PAI|PAI1|PLANH1	protein_coding	P05121	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46053
5.37575427601245e-08	0.264331876538811	0.437	0.326	0.000849799235952047	DDAH1	Malignant cells	GSE131984_Pal	ENSG00000153904	23576	dimethylarginine dimethylaminohydrolase 1	DDAH	protein_coding	O94760	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46054
5.87979350380135e-08	0.251736385692076	0.696	0.587	0.000929477757080917	NRP1	Malignant cells	GSE131984_Pal	ENSG00000099250	8829	neuropilin 1	CD304|NRP|VEGF165R	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46055
1.06144650192321e-07	-0.2534660566962	0.631	0.702	0.00167793463024022	ACAA2	Malignant cells	GSE131984_Pal	ENSG00000167315	10449	acetyl-CoA acyltransferase 2	DSAEC	protein_coding	P42765	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46056
1.16456170264855e-07	-0.266809149192144	0.701	0.76	0.00184093913954682	PPP1R15A	Malignant cells	GSE131984_Pal	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46057
1.94421730838744e-07	0.270529374055944	0.893	0.84	0.00307341872109886	SNORA76	Malignant cells	GSE131984_Pal	NA	NA	NA	NA	NA	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46058
2.29576310818224e-07	0.254314492966027	0.84	0.769	0.00362914232141449	PNISR	Malignant cells	GSE131984_Pal	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46059
3.50016326114842e-07	0.301177117963177	0.678	0.591	0.00553305808322341	MT-ND6	Malignant cells	GSE131984_Pal	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46060
1.37600602685224e-06	0.364154690786619	0.639	0.545	0.0217519032724802	COL8A1	Malignant cells	GSE131984_Pal	ENSG00000144810	1295	collagen type VIII alpha 1 chain	C3orf7|MGC9568	protein_coding	NA	GSE131984_Pal	GSE131984	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	NA	palbociclib	Homo sapiens	SUM159 cell line	Cell line	resistant 1, sensitive 2	3	1754	Public on Apr 08, 2022	32393766	This dataset has 1 cell line with 2 sensitive pre-treatment samples and 1 resistant post-treatment sample.	PRJNA545508	10x genomics	CellRanger 2.1.0	Breast_cancer	Targeted_therapy	46061
3.38145391871202e-66	-0.921862041841132	0.58	0.86	5.34168275538938e-62	FOS	Malignant cells	GSE150930	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46062
9.86817550180065e-60	0.605514260258191	1	0.998	1.55887568401945e-55	IGKC	Malignant cells	GSE150930	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46063
4.89803463854395e-56	0.506350722406263	1	1	7.73742531850788e-52	B2M	Malignant cells	GSE150930	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46064
8.32774867751937e-54	-0.769776292799606	0.352	0.685	1.31553445858774e-49	EGR1	Malignant cells	GSE150930	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46065
7.46993551329438e-49	0.418210756765427	1	1	1.18002571303511e-44	RPLP1	Malignant cells	GSE150930	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46066
3.99091727689868e-44	0.488181433607838	0.989	0.975	6.30445202231685e-40	HLA-B	Malignant cells	GSE150930	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46067
8.81819656963964e-44	0.445017532897416	0.995	0.995	1.39301051210597e-39	TMSB10	Malignant cells	GSE150930	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46068
5.9977139129101e-43	-0.571276702672211	0.793	0.915	9.47458866822409e-39	GAPDH	Malignant cells	GSE150930	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46069
1.21306987762093e-42	-0.481215442974306	0.927	0.969	1.91628648567779e-38	BTG1	Malignant cells	GSE150930	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46070
1.82008308400125e-40	-0.63543170055042	0.536	0.758	2.87518524779677e-36	IER2	Malignant cells	GSE150930	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46071
3.82573563409626e-39	0.344375049552681	0.999	1	6.04351458118185e-35	RPS14	Malignant cells	GSE150930	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46072
1.25597489520114e-38	-0.679787071685163	0.396	0.669	1.98406354194924e-34	DUSP2	Malignant cells	GSE150930	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46073
9.03113081719411e-37	-0.47658635570039	0.448	0.707	1.42664773519215e-32	RPL9P9	Malignant cells	GSE150930	NA	NA	NA	NA	NA	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46074
1.0251733188242e-36	-0.63553929368439	0.66	0.813	1.61946629174659e-32	DUSP1	Malignant cells	GSE150930	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46075
3.01392371312285e-36	-0.58889334021706	0.647	0.818	4.76109528962017e-32	KLF2	Malignant cells	GSE150930	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46076
3.28665513792225e-36	0.342522379694997	1	1	5.19192912137579e-32	RPS12	Malignant cells	GSE150930	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46077
1.18796773555498e-34	0.630465867224087	0.634	0.374	1.87663263185621e-30	LTB	Malignant cells	GSE150930	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46078
1.2590197928413e-34	0.333775667042399	0.999	1	1.9888735667514e-30	RPS18	Malignant cells	GSE150930	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46079
5.1917174777467e-33	0.586197573499633	0.626	0.397	8.20135609959647e-29	SYNE2	Malignant cells	GSE150930	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46080
6.56013147230684e-33	-0.53017504748289	0.482	0.713	1.03630396868031e-28	ID3	Malignant cells	GSE150930	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46081
1.78481567805015e-32	-0.585340764162767	0.649	0.8	2.81947332661582e-28	JUNB	Malignant cells	GSE150930	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46082
5.50199465099185e-32	0.447032028960517	0.993	0.975	8.69150095017183e-28	IGHM	Malignant cells	GSE150930	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46083
1.43395344700901e-30	0.365890973231958	0.997	0.992	2.26521626024013e-26	RPL27A	Malignant cells	GSE150930	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46084
1.07271805546137e-28	-0.507534525829036	0.821	0.912	1.69457271221232e-24	JUN	Malignant cells	GSE150930	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46085
2.17194894350385e-28	0.334780076381622	0.337	0.123	3.43102774605303e-24	ADTRP	Malignant cells	GSE150930	ENSG00000111863	84830	androgen dependent TFPI regulating protein	AIG1L|C6orf105|dJ413H6.1	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46086
1.22242163806798e-27	-0.431372062689375	0.128	0.323	1.93105946165599e-23	ID1	Malignant cells	GSE150930	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46087
1.55711671805891e-27	0.334874717014097	0.983	0.939	2.45977727951766e-23	SERF2	Malignant cells	GSE150930	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46088
5.49271523878226e-27	-0.417282507845977	0.216	0.436	8.67684226270433e-23	NR4A1	Malignant cells	GSE150930	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46089
5.68407062339282e-27	-0.311823099457626	0.982	0.995	8.97912636377364e-23	RPL21	Malignant cells	GSE150930	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46090
1.5296726719822e-26	0.259302292233389	1	1	2.41642391993027e-22	RPL23A	Malignant cells	GSE150930	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46091
1.59702389903006e-26	-0.450111123617496	0.441	0.638	2.52281865329778e-22	TPI1	Malignant cells	GSE150930	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46092
1.59802205731084e-25	-0.265027211253849	0.992	0.999	2.52439544393394e-21	RPL32	Malignant cells	GSE150930	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46093
2.03165786218248e-25	-0.397857835610406	0.929	0.972	3.20940992488966e-21	H3F3B	Malignant cells	GSE150930	NA	NA	NA	NA	NA	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46094
2.9380386051116e-25	-0.445879382480659	0.259	0.465	4.6412195844948e-21	RGCC	Malignant cells	GSE150930	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46095
5.10010270911551e-25	0.352050307148179	0.976	0.938	8.05663224958978e-21	DDX5	Malignant cells	GSE150930	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46096
2.44818961262612e-24	0.278218431379136	0.994	0.988	3.86740513106548e-20	RPL35	Malignant cells	GSE150930	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46097
1.33241621737807e-23	0.263080256477259	0.999	0.995	2.10481789859213e-19	RPS29	Malignant cells	GSE150930	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46098
1.43947080282537e-23	-0.480603440453814	0.649	0.766	2.27393202722324e-19	BTG2	Malignant cells	GSE150930	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46099
1.74560892151748e-23	0.394518106805057	0.809	0.673	2.75753841332116e-19	HLA-C	Malignant cells	GSE150930	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46100
2.95341616099131e-23	0.270635635971295	0.998	0.995	4.66551150951798e-19	RPS15A	Malignant cells	GSE150930	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46101
3.02519434483742e-23	0.269553503070179	0.999	0.999	4.77889950653968e-19	CD74	Malignant cells	GSE150930	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46102
3.36434709691485e-23	0.274885111775829	0.999	0.999	5.31465910899639e-19	RPL18A	Malignant cells	GSE150930	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46103
1.49623135813402e-22	0.401043355849292	0.924	0.835	2.36359667644432e-18	DBI	Malignant cells	GSE150930	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46104
2.42636984986181e-22	-0.422037257550452	0.516	0.686	3.83293645182671e-18	ENO1	Malignant cells	GSE150930	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46105
6.5967948384241e-22	0.287201645226155	0.255	0.088	1.04209568062586e-17	AC007364.1	Malignant cells	GSE150930	NA	NA	NA	NA	NA	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46106
1.0391600761568e-21	0.34823375024357	0.796	0.638	1.6415611723049e-17	PEBP1	Malignant cells	GSE150930	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46107
2.45059246078753e-21	0.324302127080671	0.574	0.373	3.87120091030606e-17	ARPC1B	Malignant cells	GSE150930	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46108
2.57195411443315e-21	0.340183406407803	0.831	0.718	4.06291591457005e-17	YWHAZ	Malignant cells	GSE150930	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46109
3.67466298992517e-21	-0.425875053235834	0.643	0.779	5.80486512518479e-17	FOSB	Malignant cells	GSE150930	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46110
3.87362512125983e-21	-0.341312749631375	0.92	0.96	6.11916560405416e-17	JUND	Malignant cells	GSE150930	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46111
7.54755508660368e-21	0.250178339167739	0.999	1	1.19228727703078e-16	RPS15	Malignant cells	GSE150930	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46112
2.0086178904673e-20	0.369051021358578	0.94	0.88	3.17301368157119e-16	CD52	Malignant cells	GSE150930	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46113
2.09032528328804e-20	0.321779553529603	0.285	0.118	3.30208685001011e-16	STAT1	Malignant cells	GSE150930	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46114
7.13159619512162e-20	0.308699766441555	0.478	0.283	1.12657825094336e-15	CXXC5	Malignant cells	GSE150930	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46115
7.33360190825522e-20	-0.396369752383442	0.413	0.589	1.15848909344708e-15	ZFP36L2	Malignant cells	GSE150930	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46116
2.92269861576903e-19	-0.379986557380001	0.394	0.561	4.61698700333033e-15	LDHA	Malignant cells	GSE150930	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46117
3.02388691000144e-19	0.3456823252023	0.784	0.639	4.77683415172927e-15	TPM3	Malignant cells	GSE150930	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46118
2.01710094060397e-18	0.315970294085334	0.877	0.785	3.1864143558721e-14	ATP5F1E	Malignant cells	GSE150930	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46119
2.41233522327387e-18	-0.280705042972708	0.209	0.383	3.81076595220573e-14	P4HA1	Malignant cells	GSE150930	ENSG00000122884	5033	prolyl 4-hydroxylase subunit alpha 1	C-P4Halpha(I)|P4HA	protein_coding	P13674	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46120
4.42439986258477e-18	0.350670805920966	0.689	0.522	6.98922446292517e-14	XIST	Malignant cells	GSE150930	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46121
5.17943198644437e-18	0.287418829964545	0.372	0.197	8.18194870898617e-14	PXDNL	Malignant cells	GSE150930	ENSG00000147485	137902	peroxidasin like	FLJ25471|PMR1	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46122
6.65368294733543e-18	-0.257557031881509	0.955	0.984	1.05108229519058e-13	RPL14	Malignant cells	GSE150930	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46123
1.70888088073756e-17	-0.308030944419732	0.336	0.512	2.69951912730113e-13	NR4A2	Malignant cells	GSE150930	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46124
1.83804331154221e-17	-0.306841846030697	0.863	0.932	2.90355701924323e-13	HLA-DQB1	Malignant cells	GSE150930	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46125
2.35069673319651e-17	-0.422800200365774	0.472	0.625	3.71339562943053e-13	CD69	Malignant cells	GSE150930	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46126
5.75607559695895e-17	-0.310114034483661	0.262	0.428	9.09287262051605e-13	MARCKSL1	Malignant cells	GSE150930	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46127
5.82264536284076e-17	0.281750463797797	0.449	0.273	9.19803287967955e-13	ETS1	Malignant cells	GSE150930	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46128
1.06589678951667e-16	0.360507848266452	0.484	0.323	1.68379715839948e-12	BIRC3	Malignant cells	GSE150930	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46129
1.54828167562132e-16	0.340878298605301	0.781	0.645	2.44582056297899e-12	S100A6	Malignant cells	GSE150930	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46130
2.14911719017031e-16	0.288376714830783	0.83	0.714	3.39496042531204e-12	COX4I1	Malignant cells	GSE150930	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46131
2.4354564167178e-16	0.280914706116657	0.834	0.692	3.8472905014891e-12	ARPC3	Malignant cells	GSE150930	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46132
4.61622464662752e-16	-0.288914658841103	0.239	0.409	7.29225007427749e-12	SLC2A3	Malignant cells	GSE150930	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46133
6.91376615076452e-16	-0.382840132051418	0.546	0.669	1.09216763883627e-11	RNASET2	Malignant cells	GSE150930	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46134
8.54931638079515e-16	0.285992153772471	0.65	0.485	1.35053550867421e-11	ABCA6	Malignant cells	GSE150930	ENSG00000154262	23460	ATP binding cassette subfamily A member 6	EST155051	protein_coding	Q8N139	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46135
1.79466953693608e-15	0.286705973636936	0.644	0.484	2.83503946749793e-11	ATP5MG	Malignant cells	GSE150930	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46136
2.02653222942075e-15	0.269852837800997	0.445	0.284	3.20131296281597e-11	CTSH	Malignant cells	GSE150930	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46137
2.04986463577131e-15	-0.398986077368435	0.65	0.743	3.23817116512794e-11	HSP90AA1	Malignant cells	GSE150930	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46138
2.86589670292616e-15	0.272369861150931	0.454	0.286	4.52725702161246e-11	ISG20	Malignant cells	GSE150930	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46139
6.98548518137465e-15	-0.322649192915178	0.716	0.804	1.10349709410175e-10	TSC22D3	Malignant cells	GSE150930	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46140
7.96177190383497e-15	-0.291508638597196	0.627	0.744	1.25772110764881e-10	UBB	Malignant cells	GSE150930	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46141
1.24484020000481e-14	0.347988792585469	0.445	0.295	1.9664740639476e-10	IRF1	Malignant cells	GSE150930	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46142
1.28516072614611e-14	0.268486100964503	0.612	0.454	2.03016839909301e-10	ISCU	Malignant cells	GSE150930	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46143
2.41938988056067e-14	-0.374914328809594	0.432	0.559	3.82191019432169e-10	PGK1	Malignant cells	GSE150930	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46144
3.24809918343213e-14	0.250883423308276	0.292	0.152	5.13102228006773e-10	TLE1	Malignant cells	GSE150930	ENSG00000196781	7088	TLE family member 1, transcriptional corepressor	ESG|ESG1|GRG1|TLE-1	protein_coding	Q04724	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46145
5.88557175727766e-14	-0.303843118643387	0.644	0.739	9.29743770497152e-10	HIST1H4C	Malignant cells	GSE150930	NA	NA	NA	NA	NA	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46146
6.96059772762476e-14	-0.259556973937836	0.223	0.364	1.09956562303288e-09	ARHGAP9	Malignant cells	GSE150930	ENSG00000123329	64333	Rho GTPase activating protein 9	10C|MGC1295	protein_coding	Q9BRR9	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46147
4.31955694195465e-13	-0.287833050091158	0.398	0.539	6.82360410120576e-09	WNT3	Malignant cells	GSE150930	ENSG00000277626	7473	Wnt family member 3	INT4|MGC131950|MGC138321|MGC138323	protein_coding	P56703	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46148
4.98579196933887e-13	-0.273143075312861	0.463	0.6	7.87605557396461e-09	RHOH	Malignant cells	GSE150930	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46149
5.77251993863746e-13	0.263703632163839	0.683	0.55	9.1188497470656e-09	LIMD2	Malignant cells	GSE150930	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46150
5.93239487853481e-13	0.30475464446748	0.492	0.344	9.37140418962144e-09	AC103591.3	Malignant cells	GSE150930	NA	NA	NA	NA	NA	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46151
1.08413548260486e-12	0.270672474143344	0.518	0.374	1.71260882187089e-08	CFLAR	Malignant cells	GSE150930	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46152
1.44957417153465e-12	0.252619249825034	0.594	0.438	2.28989231877329e-08	PRKCB	Malignant cells	GSE150930	ENSG00000166501	5579	protein kinase C beta	PKCB|PKCbeta|PRKCB1|PRKCB2	protein_coding	P05771	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46153
1.67875141013364e-11	-0.281862514703281	0.617	0.716	2.65192360258812e-07	SRGN	Malignant cells	GSE150930	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46154
2.08427093510775e-11	-0.282060564678318	0.289	0.417	3.29252279618972e-07	PKM	Malignant cells	GSE150930	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46155
2.98810421951863e-11	-0.267364961533621	0.568	0.664	4.72030823557357e-07	ZNF292	Malignant cells	GSE150930	ENSG00000188994	23036	zinc finger protein 292	bA393I2.3|KIAA0530|ZFP292|Zn-15|Zn-16	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46156
1.79127742197155e-10	-0.26004770295746	0.209	0.331	2.82968094348846e-06	ATF5	Malignant cells	GSE150930	ENSG00000169136	22809	activating transcription factor 5	NA	protein_coding	Q9Y2D1	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46157
2.94725985926578e-10	-0.259216169323816	0.338	0.452	4.65578639968215e-06	SCIMP	Malignant cells	GSE150930	ENSG00000161929	388325	SLP adaptor and CSK interacting membrane protein	C17orf87|DTFT5783|FLJ32580|MGC163426|MGC163428|UNQ5783	protein_coding	Q6UWF3	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46158
7.64436058060713e-10	-0.264970584672818	0.645	0.729	1.20757964091851e-05	ARID5B	Malignant cells	GSE150930	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46159
8.41060195652515e-10	0.252602497273448	0.547	0.414	1.32862279107228e-05	TTN	Malignant cells	GSE150930	ENSG00000155657	7273	titin	CMD1G|CMH9|CMPD4|FLJ32040|LGMD2J|MYLK5|TMD	protein_coding	Q8WZ42	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46160
1.43578061484902e-09	-0.258930518130225	0.454	0.571	2.26810263727699e-05	HERPUD1	Malignant cells	GSE150930	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46161
2.45319750315297e-09	0.303078869819483	0.616	0.492	3.87531609573075e-05	S100A4	Malignant cells	GSE150930	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46162
1.10264901387609e-08	-0.487351704094734	0.019	0.429	0.000174185464722005	MRPL36	CD4+ T cells	GSE150930	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46163
2.86826933410835e-08	-0.426897654488905	0.01	0.357	0.000453100506709096	HPS3	CD4+ T cells	GSE150930	ENSG00000163755	84343	HPS3 biogenesis of lysosomal organelles complex 2 subunit 1	BLOC2S1|SUTAL	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46164
2.77525950283661e-06	-0.736965594166206	0	0.667	0.0438407743663099	AC093495.1	Mono/Macro	GSE150930	NA	NA	NA	NA	NA	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46165
2.77525950283661e-06	-0.736965594166206	0	0.667	0.0438407743663099	SLC25A46	Mono/Macro	GSE150930	ENSG00000164209	91137	solute carrier family 25 member 46	NA	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46166
2.77525950283661e-06	-0.736965594166206	0	0.667	0.0438407743663099	MTURN	Mono/Macro	GSE150930	ENSG00000180354	222166	maturin, neural progenitor differentiation regulator homolog	C7orf41|Ells1|FLJ25903	protein_coding	Q8N3F0	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46167
2.77525950283661e-06	-0.736965594166206	0	0.667	0.0438407743663099	NUDCD1	Mono/Macro	GSE150930	ENSG00000120526	84955	NudC domain containing 1	CML66|FLJ14991	protein_coding	Q96RS6	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46168
2.77525950283661e-06	-0.736965594166206	0	0.667	0.0438407743663099	MMS19	Mono/Macro	GSE150930	ENSG00000155229	64210	MMS19 homolog, cytosolic iron-sulfur assembly component	CIAO4|hMMS19|MET18|MMS19L	protein_coding	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46169
2.77525950283661e-06	-0.736965594166206	0	0.667	0.0438407743663099	ARMH3	Mono/Macro	GSE150930	ENSG00000120029	79591	armadillo like helical domain containing 3	C10orf76|FLJ13114	protein_coding	Q5T2E6	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46170
2.77525950283661e-06	-0.736965594166206	0	0.667	0.0438407743663099	AC063950.1	Mono/Macro	GSE150930	NA	NA	NA	NA	NA	NA	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46171
2.77525950283661e-06	-0.736965594166206	0	0.667	0.0438407743663099	TNFAIP8L1	Mono/Macro	GSE150930	ENSG00000185361	126282	TNF alpha induced protein 8 like 1	MGC17791	protein_coding	Q8WVP5	GSE150930	GSE150930	Chronic lymphocytic leukemia	Mucosa-assisted lymphoid tissue (MALT) lymphoma	Immunotherapy	NA	rituximab + cyclophosphamide + fludarabine	Homo sapiens	patients	Peripheral blood mononuclear cells	resistant 1, sensitive 1	2	2630	Public on Oct 27, 2020	33194728	This dataset has 1 patient with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA634108	10x genomics	CellRanger	Chronic_lymphocytic_leukemia	Immunotherapy	46172
0	-1.20946535027292	0.634	0.855	0	ENO1	Malignant cells	GSE158457	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46173
0	-0.514034446450344	0.185	0.408	0	S100A10	Malignant cells	GSE158457	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46174
0	0.511007825886185	0.939	0.87	0	MAL	Malignant cells	GSE158457	ENSG00000172005	4118	mal, T cell differentiation protein	MVP17|VIP17	protein_coding	P21145	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46175
0	-1.52797468483104	0.38	0.682	0	IGFBP2	Malignant cells	GSE158457	ENSG00000115457	3485	insulin like growth factor binding protein 2	IBP2	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46176
0	-0.549441077677639	1	1	0	PTMA	Malignant cells	GSE158457	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46177
0	-0.31885092796843	0.999	1	0	RPSA	Malignant cells	GSE158457	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46178
0	0.697278265948582	0.859	0.748	0	LTB	Malignant cells	GSE158457	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46179
0	-0.861257943954201	0.704	0.853	0	PGK1	Malignant cells	GSE158457	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46180
0	-1.29774768618398	0.778	0.905	0	LDHA	Malignant cells	GSE158457	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46181
0	0.701108829132577	1	1	0	MALAT1	Malignant cells	GSE158457	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46182
0	0.570475550919457	0.919	0.814	0	DNTT	Malignant cells	GSE158457	ENSG00000107447	1791	DNA nucleotidylexotransferase	TDT	protein_coding	P04053	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46183
0	-0.590331256411028	0.559	0.758	0	PGAM1	Malignant cells	GSE158457	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46184
0	-0.557620740351486	0.141	0.328	0	BNIP3	Malignant cells	GSE158457	ENSG00000176171	664	BCL2 interacting protein 3	HABON|Nip3	protein_coding	Q12983	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46185
0	-0.798415576817649	1	1	0	GAPDH	Malignant cells	GSE158457	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46186
0	-1.38899776176801	0.502	0.788	0	TPI1	Malignant cells	GSE158457	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46187
0	-0.717969451748124	0.524	0.763	0	PKM	Malignant cells	GSE158457	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46188
0	0.515230590019984	0.883	0.794	0	FAM173A	Malignant cells	GSE158457	NA	NA	NA	NA	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46189
0	-0.727893797309507	0.818	0.921	0	ALDOA	Malignant cells	GSE158457	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46190
0	-0.46197333920878	0.432	0.648	0	MIF	Malignant cells	GSE158457	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46191
3.16095993725095e-300	-0.260381816792418	1	1	6.00708826475171e-296	TMSB4X	Malignant cells	GSE158457	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46192
6.90062092844255e-296	-0.351643026063601	0.866	0.934	1.31139400124122e-291	NAP1L1	Malignant cells	GSE158457	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46193
2.29940309958791e-292	-0.318902931970391	0.987	0.995	4.36978565045687e-288	YBX1	Malignant cells	GSE158457	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46194
2.57409375104516e-291	-0.326331333973494	1	1	4.89180776448622e-287	MT-CO3	Malignant cells	GSE158457	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46195
6.38436266856753e-286	-0.278527862654533	0.992	0.997	1.21328428153457e-281	RPL4	Malignant cells	GSE158457	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46196
5.73539923161735e-273	-0.343909876019548	0.114	0.279	1.08995526997656e-268	GPI	Malignant cells	GSE158457	ENSG00000282019	2821	glucose-6-phosphate isomerase	AMF|NLK	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46197
9.99641400979119e-271	-0.286318313730704	0.999	1	1.89971851842072e-266	RPS6	Malignant cells	GSE158457	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46198
1.32488191501532e-261	0.305707659426177	0.99	0.98	2.51780559129512e-257	CD3G	Malignant cells	GSE158457	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46199
1.93649159376507e-261	-0.552742942377672	0.295	0.501	3.68010862479113e-257	KIAA0101	Malignant cells	GSE158457	NA	NA	NA	NA	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46200
7.33563453858719e-252	-0.294760546541787	0.996	0.999	1.39406398771311e-247	RPLP0	Malignant cells	GSE158457	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46201
1.78436364208267e-251	-0.478699134172997	0.503	0.679	3.3910046654139e-247	DEK	Malignant cells	GSE158457	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46202
5.45343781512344e-251	-0.417501541168622	0.477	0.649	1.03637132238606e-246	BNIP3L	Malignant cells	GSE158457	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46203
2.19236027673878e-250	-0.405159465908289	0.1	0.254	4.16636146991439e-246	ANXA1	Malignant cells	GSE158457	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46204
1.64238144345173e-246	-0.34096864995163	0.834	0.92	3.12118169513567e-242	ANP32B	Malignant cells	GSE158457	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46205
1.30110932182786e-238	-0.257742490358211	1	1	2.47262815520167e-234	RPL23A	Malignant cells	GSE158457	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46206
2.09191885281915e-235	-0.293325811267552	0.874	0.959	3.97548258789752e-231	VIM	Malignant cells	GSE158457	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46207
7.7013938038884e-235	0.470374607376991	0.793	0.697	1.46357287849095e-230	MDM4	Malignant cells	GSE158457	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46208
2.04676092977512e-233	-0.501091296092789	0.329	0.529	3.88966447094463e-229	TYMS	Malignant cells	GSE158457	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46209
2.76347779820077e-233	-0.580411713301212	0.213	0.398	5.25171320770075e-229	MKI67	Malignant cells	GSE158457	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46210
1.14850295549514e-220	-0.3238737792596	0.317	0.495	2.18261501662297e-216	DARS	Malignant cells	GSE158457	NA	NA	NA	NA	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46211
9.11900125714444e-219	-0.443442927908065	0.403	0.583	1.73297499890773e-214	ANP32E	Malignant cells	GSE158457	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46212
2.00504705032565e-217	-0.436973436164285	0.33	0.512	3.81039141443887e-213	SMC2	Malignant cells	GSE158457	ENSG00000136824	10592	structural maintenance of chromosomes 2	CAP-E|hCAP-E|SMC2L1	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46213
1.44348816714017e-215	-0.255941151385255	0.941	0.976	2.74320491283317e-211	RPS20	Malignant cells	GSE158457	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46214
4.16519375459308e-215	-0.279940234262625	0.237	0.416	7.91553421122869e-211	PAICS	Malignant cells	GSE158457	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46215
1.43810547506732e-214	0.327501917479342	0.95	0.918	2.73297564481794e-210	MZB1	Malignant cells	GSE158457	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46216
6.51411123789216e-214	-0.269223039775672	0.989	0.995	1.23794169964903e-209	NPM1	Malignant cells	GSE158457	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46217
3.53571940670193e-213	0.271817935048839	0.984	0.966	6.71928116049635e-209	PNISR	Malignant cells	GSE158457	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46218
1.24334334319143e-212	-0.380532695265857	0.771	0.86	2.36284968940099e-208	RAN	Malignant cells	GSE158457	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46219
1.39855814368926e-210	-0.706736436624181	0.546	0.682	2.65781989626706e-206	HMGB2	Malignant cells	GSE158457	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46220
8.5688529783051e-208	-0.352141694988479	0.784	0.877	1.6284248199971e-203	H2AFV	Malignant cells	GSE158457	NA	NA	NA	NA	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46221
5.95212717251868e-200	0.404725355475992	0.688	0.566	1.13114224786545e-195	ARPP21	Malignant cells	GSE158457	ENSG00000172995	10777	cAMP regulated phosphoprotein 21	ARPP-21|R3HDM3|TARPP	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46222
7.75855265156694e-200	-0.338257262971771	0.343	0.511	1.47443534590378e-195	HMGA1	Malignant cells	GSE158457	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46223
1.20220707457507e-198	-0.259924505071244	0.125	0.27	2.28467432452246e-194	SKAP1	Malignant cells	GSE158457	ENSG00000141293	8631	src kinase associated phosphoprotein 1	SCAP1|SKAP55	protein_coding	Q86WV1	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46224
1.72396313236188e-197	-0.330977717751673	0.171	0.329	3.27621953674052e-193	CENPM	Malignant cells	GSE158457	ENSG00000100162	79019	centromere protein M	C22orf18|CENP-M|MGC861|Pane1	protein_coding	Q9NSP4	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46225
2.04191552028906e-197	-0.326141064349572	0.617	0.755	3.88045625475734e-193	SNRPB	Malignant cells	GSE158457	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46226
5.28323221703888e-196	-0.36859808329411	1	1	1.00402545052607e-191	ACTB	Malignant cells	GSE158457	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46227
1.69993033923657e-192	-0.531004165921575	0.197	0.361	3.23054761668517e-188	CENPF	Malignant cells	GSE158457	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46228
5.96124146937763e-188	-0.400775410028095	0.444	0.603	1.13287432884052e-183	RANBP1	Malignant cells	GSE158457	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46229
1.31350083865594e-187	0.279561820263005	0.939	0.907	2.49617699378175e-183	DDX17	Malignant cells	GSE158457	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46230
1.29258761499359e-185	-0.339922128147899	0.483	0.639	2.45643350353383e-181	LSM4	Malignant cells	GSE158457	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46231
7.83958757877855e-183	-0.335314060356016	0.219	0.375	1.48983522347107e-178	HMGB3	Malignant cells	GSE158457	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46232
1.16330750206289e-179	-0.297453437491208	0.383	0.557	2.21074957692031e-175	FABP5	Malignant cells	GSE158457	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46233
2.01358955797535e-178	-0.270958696873862	0.392	0.556	3.82662559597635e-174	VDAC1	Malignant cells	GSE158457	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46234
7.18347094869413e-177	-0.479502925737809	0.181	0.33	1.36514681908983e-172	PTTG1	Malignant cells	GSE158457	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46235
1.14053810310606e-176	-0.304727607263302	0.274	0.437	2.16747861114275e-172	LMNB1	Malignant cells	GSE158457	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46236
2.31288342780988e-176	0.318637213307937	0.806	0.723	4.3954036662099e-172	BTG1	Malignant cells	GSE158457	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46237
3.60871193861696e-176	-0.322934881941318	0.958	0.977	6.85799616814766e-172	PPIA	Malignant cells	GSE158457	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46238
5.00462133998487e-175	-0.577791719383417	0.182	0.336	9.51078239450724e-171	TOP2A	Malignant cells	GSE158457	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46239
5.28478018461824e-175	0.356070502443593	0.696	0.594	1.00431962628485e-170	MYO7B	Malignant cells	GSE158457	ENSG00000169994	4648	myosin VIIB	NA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46240
1.48635939221932e-173	-0.311836684228256	0.217	0.369	2.8246773889736e-169	RRM1	Malignant cells	GSE158457	ENSG00000167325	6240	ribonucleotide reductase catalytic subunit M1	NA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46241
3.92073646146927e-172	-0.2984733329701	0.193	0.342	7.4509675713762e-168	UBE2T	Malignant cells	GSE158457	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46242
9.17734643856264e-168	-0.544664945885514	0.849	0.895	1.74406291718444e-163	TUBB	Malignant cells	GSE158457	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46243
1.63298768042917e-166	-0.389352444537049	0.437	0.591	3.10332978788759e-162	SMC4	Malignant cells	GSE158457	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46244
5.45080346228398e-163	0.312460961712988	0.624	0.493	1.03587068997245e-158	MED13L	Malignant cells	GSE158457	ENSG00000123066	23389	mediator complex subunit 13L	KIAA1025|THRAP2|TRAP240L	protein_coding	Q71F56	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46245
1.50673855517089e-161	-0.388343154315906	0.17	0.309	2.86340595024675e-157	CDK1	Malignant cells	GSE158457	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46246
3.07821647485219e-161	-0.381307330489935	0.142	0.276	5.84984258880911e-157	RRM2	Malignant cells	GSE158457	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46247
1.56486137013886e-160	-0.330079297409307	0.157	0.299	2.9738625478119e-156	BIRC5	Malignant cells	GSE158457	ENSG00000089685	332	baculoviral IAP repeat containing 5	API4|EPR-1|survivin	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46248
3.46690804077475e-160	-0.357703708626498	0.148	0.283	6.58851204068833e-156	CDKN3	Malignant cells	GSE158457	ENSG00000100526	1033	cyclin dependent kinase inhibitor 3	CDI1|KAP	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46249
6.77479203003895e-160	-0.404381489505672	0.271	0.421	1.2874814773886e-155	H2AFX	Malignant cells	GSE158457	NA	NA	NA	NA	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46250
7.96877662712768e-159	-0.462535259945396	0.237	0.386	1.51438631021935e-154	NUSAP1	Malignant cells	GSE158457	ENSG00000137804	51203	nucleolar and spindle associated protein 1	ANKT|BM037|FLJ13421|LNP|PRO0310p1|Q0310|SAPL	protein_coding	Q9BXS6	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46251
1.53592464491567e-158	-0.519960179580739	0.887	0.914	2.91887119519773e-154	H2AFZ	Malignant cells	GSE158457	NA	NA	NA	NA	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46252
8.84320145445546e-157	0.286585361777087	1	0.998	1.68056200440472e-152	TRBC1	Malignant cells	GSE158457	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46253
2.46941585654371e-156	-0.269697041568753	0.206	0.349	4.69287789377567e-152	ZWINT	Malignant cells	GSE158457	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46254
1.4393444083703e-155	-0.286809914464654	0.177	0.316	2.73533011366692e-151	CASC5	Malignant cells	GSE158457	NA	NA	NA	NA	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46255
3.53389884561208e-155	-0.417763587170544	0.152	0.289	6.7158213662012e-151	ASPM	Malignant cells	GSE158457	ENSG00000066279	259266	assembly factor for spindle microtubules	ASP|Calmbp1|FLJ10517|FLJ10549|MCPH5	protein_coding	Q8IZT6	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46256
5.94707399185839e-155	-0.333840170034591	0.22	0.354	1.13018194141277e-150	FAM162A	Malignant cells	GSE158457	ENSG00000114023	26355	family with sequence similarity 162 member A	C3orf28|E2IG5	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46257
8.19325053257643e-155	-0.287843975323265	0.178	0.318	1.55704533121082e-150	CLSPN	Malignant cells	GSE158457	ENSG00000092853	63967	claspin	NA	protein_coding	Q9HAW4	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46258
2.17568873963885e-154	-0.373826556138878	0.997	0.996	4.13467888080966e-150	STMN1	Malignant cells	GSE158457	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46259
5.76561686186622e-154	-0.27137824271171	0.384	0.54	1.09569782842906e-149	RPA3	Malignant cells	GSE158457	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46260
2.05598712562044e-153	-0.716281859712808	0.849	0.874	3.90719793352908e-149	TUBA1B	Malignant cells	GSE158457	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46261
1.05050185657691e-148	-0.271162127573638	1	1	1.99637372823876e-144	RPS2	Malignant cells	GSE158457	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46262
2.18225501415084e-148	-0.305475643433377	0.26	0.41	4.14715742889226e-144	CKS1B	Malignant cells	GSE158457	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46263
5.30046251450036e-147	-0.333063627781875	0.589	0.71	1.00729989625565e-142	NASP	Malignant cells	GSE158457	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46264
1.59035253279965e-144	-0.347364721185133	0.979	0.982	3.02230595333245e-140	HNRNPA2B1	Malignant cells	GSE158457	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46265
3.2864948545877e-144	0.305536684521556	0.853	0.807	6.24565482165846e-140	ARL4C	Malignant cells	GSE158457	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46266
1.73758342471644e-143	-0.349509325966168	0.648	0.776	3.30210354033113e-139	RCBTB2	Malignant cells	GSE158457	ENSG00000136161	1102	RCC1 and BTB domain containing protein 2	CHC1L	protein_coding	O95199	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46267
3.19030544052832e-143	-0.284515353458765	0.308	0.454	6.06285645918003e-139	MAD2L1	Malignant cells	GSE158457	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46268
1.38130708145844e-142	-0.278584238392906	0.196	0.328	2.62503597760363e-138	FEN1	Malignant cells	GSE158457	ENSG00000168496	2237	flap structure-specific endonuclease 1	FEN-1|MF1|RAD2	protein_coding	P39748	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46269
2.28379227942348e-141	-0.457567322703217	0.923	0.938	4.34011884781638e-137	HMGN2	Malignant cells	GSE158457	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46270
5.60469687015539e-141	-0.425631761603168	0.138	0.263	1.06511659320433e-136	UBE2C	Malignant cells	GSE158457	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46271
1.03753165451602e-138	-0.271840742222982	0.655	0.762	1.97172515624225e-134	ERH	Malignant cells	GSE158457	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46272
1.2339008465495e-136	-0.268491468830518	0.166	0.292	2.34490516878267e-132	FBXO5	Malignant cells	GSE158457	ENSG00000112029	26271	F-box protein 5	EMI1|FBX5|Fbxo31	protein_coding	Q9UKT4	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46273
1.37313653405895e-136	-0.29409097936634	0.532	0.661	2.60950866932563e-132	CARHSP1	Malignant cells	GSE158457	ENSG00000153048	23589	calcium regulated heat stable protein 1	CRHSP-24|CSDC1	protein_coding	Q9Y2V2	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46274
4.7345333592762e-136	-0.257430942358865	0.25	0.391	8.99750719596848e-132	DHFR	Malignant cells	GSE158457	ENSG00000228716	1719	dihydrofolate reductase	NA	protein_coding	P00374	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46275
2.69370902414524e-135	-0.294349254185056	0.342	0.484	5.11912462948561e-131	USP1	Malignant cells	GSE158457	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46276
4.79867102505493e-135	-0.328989709502708	0.186	0.318	9.11939441601439e-131	TPX2	Malignant cells	GSE158457	ENSG00000088325	22974	TPX2 microtubule nucleation factor	C20orf1|C20orf2|DIL-2|FLS353|HCA519|p100	protein_coding	Q9ULW0	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46277
9.59043158113056e-132	-0.2601725143367	0.145	0.267	1.82256561767805e-127	KIF11	Malignant cells	GSE158457	ENSG00000138160	3832	kinesin family member 11	Eg5|HKSP|KNSL1|TRIP5	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46278
1.0313597656391e-131	-0.279968355754651	0.17	0.297	1.95999609862054e-127	GTSE1	Malignant cells	GSE158457	ENSG00000075218	51512	G2 and S-phase expressed 1	B99|GTSE-1|Lnc_bc060912	protein_coding	Q9NYZ3	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46279
6.94631107108824e-131	0.291921449751239	0.606	0.479	1.32007695594961e-126	MIR181A1HG	Malignant cells	GSE158457	ENSG00000229989	NA	NA	NA	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46280
8.76372839719565e-131	0.28476348467166	0.579	0.46	1.66545894460306e-126	BCL7A	Malignant cells	GSE158457	ENSG00000282873	605	BAF chromatin remodeling complex subunit BCL7A	BCL7|SMARCJ1	protein_coding	Q4VC05	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46281
1.49535768317182e-130	-0.283623929192148	0.577	0.705	2.84177774109973e-126	RAD21	Malignant cells	GSE158457	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46282
5.70809870493383e-130	-0.266552852597512	0.297	0.433	1.08476707788562e-125	ALYREF	Malignant cells	GSE158457	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46283
1.30104598583675e-129	-0.263056366084446	0.244	0.385	2.47250779148417e-125	ATAD2	Malignant cells	GSE158457	ENSG00000156802	29028	ATPase family AAA domain containing 2	ANCCA|CT137|DKFZp667N1320|MGC29843|MGC5254|PRO2000	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46284
1.31730152348054e-129	-0.312521552022055	0.587	0.707	2.50339981522241e-125	TMPO	Malignant cells	GSE158457	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46285
1.15663835480338e-128	-0.284945721057229	0.621	0.731	2.19807552946835e-124	PRDX2	Malignant cells	GSE158457	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46286
2.58843242875213e-127	-0.399354945429889	0.195	0.313	4.91905698760054e-123	PKIB	Malignant cells	GSE158457	ENSG00000135549	5570	cAMP-dependent protein kinase inhibitor beta	PRKACN2	protein_coding	Q9C010	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46287
4.24335551019259e-127	-0.391428804452366	0.304	0.434	8.06407281157e-123	PCNA	Malignant cells	GSE158457	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46288
1.78345297704876e-126	-0.284264953939152	0.432	0.566	3.38927403758346e-122	HNRNPAB	Malignant cells	GSE158457	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46289
3.36310965536414e-121	-0.258712301072884	0.719	0.818	6.39125358905401e-117	HNRNPU	Malignant cells	GSE158457	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46290
5.30490150588344e-121	-0.309741539519452	0.73	0.805	1.00814348217809e-116	NUCKS1	Malignant cells	GSE158457	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46291
6.85033300549469e-121	-0.25925814941064	0.23	0.354	1.30183728436421e-116	TMEM106C	Malignant cells	GSE158457	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46292
6.81126739041527e-120	0.331216772161396	0.495	0.37	1.29441325487452e-115	TXNIP	Malignant cells	GSE158457	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46293
4.37596239158764e-118	-0.279058004137691	0.737	0.814	8.31607892897314e-114	HNRNPD	Malignant cells	GSE158457	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46294
4.76099685146798e-117	-0.394408073043944	0.626	0.729	9.04779841652975e-113	DUT	Malignant cells	GSE158457	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46295
5.41194333941273e-113	-0.264791992467664	0.69	0.786	1.028485712222e-108	SRSF2	Malignant cells	GSE158457	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46296
2.95663091176538e-111	0.595284250008117	0.569	0.511	5.61878138471892e-107	PTCRA	Malignant cells	GSE158457	ENSG00000171611	171558	pre T cell antigen receptor alpha	PT-ALPHA|PTA	protein_coding	Q6ISU1	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46297
6.7312978376173e-111	0.255072691981968	0.476	0.351	1.27921584106079e-106	BTG2	Malignant cells	GSE158457	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46298
1.18013329119119e-108	-0.268553531912204	0.284	0.405	2.24272530657973e-104	MCM3	Malignant cells	GSE158457	ENSG00000112118	4172	minichromosome maintenance complex component 3	NA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46299
3.28746856921677e-107	-0.259063594593759	0.404	0.527	6.24750526893955e-103	DNMT1	Malignant cells	GSE158457	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46300
4.18825182355016e-106	-0.412097391923125	0.309	0.427	7.95935376547472e-102	TUBB4B	Malignant cells	GSE158457	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46301
1.75535108563843e-101	-0.258101056854073	0.347	0.471	3.33586920314728e-97	MCM7	Malignant cells	GSE158457	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46302
1.85314996597627e-100	-0.285416232588195	0.207	0.314	3.52172619534131e-96	SPINK2	Malignant cells	GSE158457	ENSG00000128040	6691	serine peptidase inhibitor Kazal type 2	HUSI-II	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46303
4.17716510999567e-99	0.368029729651651	0.652	0.586	7.93828457503577e-95	ACSF3	Malignant cells	GSE158457	ENSG00000176715	197322	acyl-CoA synthetase family member 3	NA	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46304
5.91336552252828e-98	-0.261766627665033	0.331	0.447	1.12377598390127e-93	SLBP	Malignant cells	GSE158457	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46305
1.7958893949859e-92	0.2555070123676	0.914	0.892	3.41290820623121e-88	RP11-620J15.3	Malignant cells	GSE158457	NA	NA	NA	NA	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46306
1.56230981943496e-89	-0.276144897186176	0.304	0.415	2.9690135808542e-85	CKS2	Malignant cells	GSE158457	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46307
9.01411092657428e-89	-0.28640125413207	0.22	0.325	1.71304164048618e-84	TUBA1C	Malignant cells	GSE158457	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46308
1.00763832015139e-86	0.272038729179338	0.457	0.354	1.9149158636157e-82	RP11-356I2.4	Malignant cells	GSE158457	NA	NA	NA	NA	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46309
1.22652372045302e-74	-0.335079347790323	0.217	0.309	2.33088567834892e-70	KPNA2	Malignant cells	GSE158457	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46310
1.23007324249744e-73	-0.257526175085731	0.292	0.395	2.33763119004213e-69	KRT1	Malignant cells	GSE158457	ENSG00000167768	3848	keratin 1	EHK1|KRT1A	protein_coding	P04264	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46311
2.5683545074282e-72	-0.269556010422693	0.608	0.683	4.88090090591655e-68	PSIP1	Malignant cells	GSE158457	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46312
2.38110741878299e-64	-0.388509725552299	0.456	0.534	4.5250565386552e-60	UBE2S	Malignant cells	GSE158457	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46313
8.21211310172294e-51	0.33276984436668	0.637	0.623	1.56062997385143e-46	PRMT7	Malignant cells	GSE158457	ENSG00000132600	54496	protein arginine methyltransferase 7	FLJ10640|KIAA1933	protein_coding	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46314
1.16264817838014e-46	-0.253318065227402	0.827	0.848	2.20949659819362e-42	HIST1H4C	Malignant cells	GSE158457	NA	NA	NA	NA	NA	NA	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46315
5.16092630785997e-42	0.259635502517188	0.31	0.248	9.80782435545708e-38	PMEPA1	Malignant cells	GSE158457	ENSG00000124225	56937	prostate transmembrane protein, androgen induced 1	STAG1|TMEPAI	protein_coding	Q969W9	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46316
2.04166037134985e-40	-0.272978193362122	0.999	0.997	3.87997136971326e-36	HMGB1	Malignant cells	GSE158457	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46317
1.0414066976044e-16	0.260741121726186	0.398	0.374	1.97908928812741e-12	LPAR6	Malignant cells	GSE158457	ENSG00000139679	10161	lysophosphatidic acid receptor 6	P2RY5|P2Y5	protein_coding	P43657	GSE158457	GSE158457	Acute lymphoblastic leukemia	T-cell acute lymphoblastic leukemia (ALL)	Targeted therapy	NA	dasatinib	Homo sapiens	PDX cells	Cell line	resistant 2, sensitive 2	4	26026	Public on Jan 05, 2021	34151288	The dataset has 2 patient-derived PDX cell groups, each with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA665257	10x genomics	CellRanger 3.1.0	Acute_lymphoblastic_leukemia	Targeted_therapy	46318
0	0.849568703291892	0.49	0.082	0	S100A4	Malignant cells	GSE161195_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46319
1.15572315135249e-303	3.88358002196735	0.252	0.007	2.13531409443885e-299	IGHD	Malignant cells	GSE161195_post	ENSG00000278801	NA	NA	FLJ00382|FLJ46727|MGC29633	IG_C_gene	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46320
9.41372415044466e-286	-1.76624659938193	0.333	0.714	1.73927967403616e-281	IGHGP	Malignant cells	GSE161195_post	ENSG00000282094	NA	NA	IGHGP1	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46321
6.9564452671305e-281	-1.37327306104601	0.385	0.754	1.28527282755503e-276	IGLC2	Malignant cells	GSE161195_post	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46322
7.44247294702696e-278	-1.93340194605782	0.352	0.719	1.3750713016927e-273	IGHG1	Malignant cells	GSE161195_post	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46323
7.71595416541245e-273	0.708800557345082	0.498	0.134	1.4255996916016e-268	S100A6	Malignant cells	GSE161195_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46324
3.43255722456442e-268	0.972238219951232	0.94	0.64	6.34199272810522e-264	JCHAIN	Malignant cells	GSE161195_post	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46325
7.07598685413361e-258	-1.60184761410145	0.271	0.675	1.30735933116973e-253	IGLC3	Malignant cells	GSE161195_post	ENSG00000211679	NA	NA	IGLC	IG_C_gene	P0DOY3	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46326
5.4533990910224e-228	0.832327047122693	0.606	0.288	1.0075700160573e-223	COX6C	Malignant cells	GSE161195_post	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46327
1.56272366354735e-223	-0.993348377939089	0.275	0.658	2.88728824077008e-219	IGHG3	Malignant cells	GSE161195_post	ENSG00000282184	NA	NA	NA	IG_C_gene	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46328
1.46569908139909e-216	0.543520793244311	0.341	0.071	2.70802562279297e-212	STMN1	Malignant cells	GSE161195_post	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46329
1.60512583466975e-204	-2.73966105932447	0.157	0.512	2.96563049213583e-200	IGHG4	Malignant cells	GSE161195_post	ENSG00000277016	NA	NA	NA	IG_C_gene	P01861	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46330
1.47239548577828e-202	0.750432423351715	0.959	0.908	2.72039789952395e-198	RPS24	Malignant cells	GSE161195_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46331
3.76430649793166e-201	0.606174503282577	0.943	0.839	6.95493268557853e-197	RPLP0	Malignant cells	GSE161195_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46332
5.8960562493782e-195	0.525653693606742	0.365	0.093	1.08935535263512e-190	CREG1	Malignant cells	GSE161195_post	ENSG00000143162	8804	cellular repressor of E1A stimulated genes 1	CREG	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46333
3.15171562201617e-182	0.765431781812401	0.691	0.436	5.82310978323708e-178	MIF	Malignant cells	GSE161195_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46334
3.61603498872162e-180	0.7300356798901	0.69	0.437	6.68098624516206e-176	KRTCAP2	Malignant cells	GSE161195_post	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46335
1.4888088941151e-174	0.45781104782569	0.362	0.101	2.75072331276706e-170	S100A10	Malignant cells	GSE161195_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46336
2.89523393978929e-172	-0.386844910294303	0.229	0.574	5.34923422715469e-168	IGHG2	Malignant cells	GSE161195_post	ENSG00000274497	NA	NA	NA	IG_C_gene	P01859	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46337
1.13454514380459e-170	0.414615373149287	0.298	0.068	2.09618560769337e-166	HSPB1	Malignant cells	GSE161195_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46338
5.49949679533321e-170	0.572227440273406	0.382	0.122	1.01608702790576e-165	HDGF	Malignant cells	GSE161195_post	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46339
2.60146124972217e-164	0.503825900526576	0.551	0.245	4.80645980498668e-160	RPS24P8	Malignant cells	GSE161195_post	ENSG00000224094	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46340
2.79223045522341e-163	0.602078617256797	0.87	0.668	5.15892498907077e-159	MTND1P23	Malignant cells	GSE161195_post	ENSG00000225972	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46341
1.55803282918025e-162	0.420620247958182	0.322	0.086	2.87862145519344e-158	CCT3	Malignant cells	GSE161195_post	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46342
3.15340236151943e-152	0.458141371215122	0.375	0.121	5.82622620314329e-148	S100A11	Malignant cells	GSE161195_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46343
3.20628394241696e-145	0.493210848268347	0.392	0.147	5.92393021200957e-141	SSBP1	Malignant cells	GSE161195_post	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46344
4.84083974639304e-145	-0.978105968546919	0.073	0.358	8.94393551543578e-141	IGLJ2	Malignant cells	GSE161195_post	ENSG00000211676	NA	NA	NA	IG_J_gene	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46345
5.79072968076689e-143	-0.786410419784984	0.111	0.389	1.06989521581849e-138	BIRC3	Malignant cells	GSE161195_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46346
1.75899068822615e-136	0.482118103264826	0.502	0.241	3.24991119556664e-132	PSMB4	Malignant cells	GSE161195_post	ENSG00000159377	5692	proteasome 20S subunit beta 4	HN3|PROS26	protein_coding	P28070	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46347
1.79620891602815e-136	0.717851709967416	0.494	0.234	3.31867559325362e-132	TUBA1B	Malignant cells	GSE161195_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46348
2.33701962562326e-136	-0.702461634360833	0.27	0.554	4.31787746030154e-132	PSAP	Malignant cells	GSE161195_post	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46349
1.41130570603471e-135	0.566037199713388	0.916	0.824	2.60752842246973e-131	RPL27	Malignant cells	GSE161195_post	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46350
1.52621216878991e-135	0.391485973419858	0.297	0.085	2.81982960305623e-131	LILRB4	Malignant cells	GSE161195_post	ENSG00000278555	11006	leukocyte immunoglobulin like receptor B4	CD85k|HM18|ILT3|LIR-5|LIR5	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46351
5.44861622795674e-132	0.556078295861767	0.638	0.392	1.00668633427729e-127	YBX1	Malignant cells	GSE161195_post	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46352
2.35860514293428e-130	0.522194240492632	0.597	0.342	4.35775886208538e-126	UQCRH	Malignant cells	GSE161195_post	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46353
7.40309490909202e-130	-0.470237129494897	0.745	0.922	1.36779581540384e-125	TPT1	Malignant cells	GSE161195_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46354
2.39528907903703e-124	0.551747405061694	0.831	0.657	4.42553610242882e-120	SEC11C	Malignant cells	GSE161195_post	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46355
3.15395930911065e-124	0.504666583591632	0.491	0.241	5.82725521951283e-120	LDHA	Malignant cells	GSE161195_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46356
1.32782602199135e-122	-0.600850545962218	0.719	0.864	2.45329135823122e-118	MTATP6P1	Malignant cells	GSE161195_post	ENSG00000248527	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46357
1.50022812667816e-121	-0.489768062219505	0.062	0.301	2.77182148685057e-117	CD79A	Malignant cells	GSE161195_post	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46358
4.40989315673004e-120	0.738801415865665	0.697	0.54	8.14771859637442e-116	PTMA	Malignant cells	GSE161195_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46359
9.16396738103233e-120	-0.58026854657908	0.357	0.61	1.69313461331953e-115	HLA-E	Malignant cells	GSE161195_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46360
2.72148961534007e-118	0.580538827695321	0.505	0.26	5.02822421330231e-114	IGHA2	Malignant cells	GSE161195_post	ENSG00000276173	NA	NA	NA	IG_C_gene	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46361
4.67726829521174e-118	0.394188227600818	0.356	0.136	8.64172090223322e-114	HSPE1	Malignant cells	GSE161195_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46362
1.3273418618776e-116	0.348286052047365	0.288	0.089	2.45239682400506e-112	HMGB2	Malignant cells	GSE161195_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46363
1.8417512038343e-114	0.4399883704166	0.421	0.19	3.40281952420425e-110	ENO1	Malignant cells	GSE161195_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46364
3.57225956476619e-114	0.416392848968272	0.451	0.213	6.60010677186202e-110	SLC25A5	Malignant cells	GSE161195_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46365
9.9699713038886e-113	0.467444546452887	0.499	0.26	1.84205189810646e-108	RAN	Malignant cells	GSE161195_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46366
2.29114444414601e-112	0.48264947379728	0.45	0.214	4.23311847500417e-108	H2AFZ	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46367
8.83665423246374e-112	0.371036841486139	0.352	0.139	1.63266023599e-107	BX679664.3	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46368
2.19749155331899e-111	0.495527953536589	0.617	0.391	4.06008539391217e-107	HINT1	Malignant cells	GSE161195_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46369
1.10099926710646e-110	0.408949743884349	0.997	0.99	2.03420624590589e-106	RPLP1	Malignant cells	GSE161195_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46370
7.45589279449519e-109	0.349400214475073	0.348	0.137	1.37755075271093e-104	PDCD5	Malignant cells	GSE161195_post	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46371
1.23539953784184e-108	0.834113815677426	0.414	0.199	2.28252418611659e-104	HIST1H4C	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46372
2.41739627934419e-106	0.415554297997311	0.38	0.167	4.46638136571632e-102	CBX3	Malignant cells	GSE161195_post	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46373
8.92425332764978e-105	0.383710082376561	0.345	0.141	1.64884504481657e-100	NDUFB2	Malignant cells	GSE161195_post	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46374
9.94960232445789e-102	0.809728380755949	0.689	0.561	1.83828852546684e-97	PABPC1	Malignant cells	GSE161195_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46375
2.90296774629369e-99	0.331670930353671	0.273	0.095	5.36352320805222e-95	SNRPE	Malignant cells	GSE161195_post	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46376
3.98297593094993e-99	0.437306665660111	0.455	0.234	7.35894633002309e-95	LDHB	Malignant cells	GSE161195_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46377
7.78559877110493e-99	0.701846101454781	0.932	0.894	1.43846722894935e-94	SNORD100	Malignant cells	GSE161195_post	ENSG00000221500	594838	small nucleolar RNA, C/D box 100	HBII-429	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46378
1.68635248934947e-96	0.280776269042369	0.25	0.08	3.11570485932209e-92	AP1S2	Malignant cells	GSE161195_post	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46379
5.71685554596004e-96	0.513539678241075	0.595	0.401	1.05624623067158e-91	NME2	Malignant cells	GSE161195_post	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46380
4.03567324723202e-95	-0.503849430275217	0.973	0.987	7.45630989158588e-91	MT-ND3	Malignant cells	GSE161195_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46381
8.54051064359447e-95	0.414452266504595	0.958	0.919	1.57794474651052e-90	RPS19	Malignant cells	GSE161195_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46382
1.02396434842093e-94	0.484538968385473	0.389	0.192	1.89187653014251e-90	RPL22L1	Malignant cells	GSE161195_post	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46383
2.26816676359621e-93	0.444220563597888	0.586	0.37	4.19066491242036e-89	NPM1	Malignant cells	GSE161195_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46384
6.65385410058963e-93	0.410005945103718	0.514	0.289	1.22936608362494e-88	MIR1244-1	Malignant cells	GSE161195_post	ENSG00000284378	100302285	microRNA 1244-1	hsa-mir-1244|MIR1244|MIRN1244	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46385
1.27977965558555e-92	0.489956340773748	0.866	0.793	2.36452089165986e-88	RPL38	Malignant cells	GSE161195_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46386
2.49171245869089e-92	0.369964988016851	0.379	0.177	4.60368793867729e-88	PPA1	Malignant cells	GSE161195_post	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46387
4.94793631824719e-92	0.512026162481319	0.972	0.946	9.1418071415935e-88	RPL37A	Malignant cells	GSE161195_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46388
7.02762061638743e-92	0.30847903795627	0.301	0.117	1.29842318508374e-87	NME1	Malignant cells	GSE161195_post	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46389
7.5490027284198e-92	0.432420555855371	0.585	0.375	1.39475374410284e-87	PPIA	Malignant cells	GSE161195_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46390
7.91587702276255e-92	0.311244670698926	0.261	0.092	1.46253743872561e-87	ANP32E	Malignant cells	GSE161195_post	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46391
1.39435296807257e-90	-0.422203846356281	0.144	0.367	2.57620654381087e-86	SEL1L3	Malignant cells	GSE161195_post	ENSG00000091490	23231	SEL1L family member 3	KIAA0746	protein_coding	Q68CR1	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46392
2.58008757469364e-90	0.313800539733337	0.324	0.134	4.76696980300396e-86	HSPD1	Malignant cells	GSE161195_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46393
2.7271402816429e-89	0.345976501199756	0.387	0.182	5.03866438436343e-85	COX7B	Malignant cells	GSE161195_post	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46394
2.12815684486308e-88	0.46575985418312	0.675	0.485	3.93198258656902e-84	COX7C	Malignant cells	GSE161195_post	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46395
3.25747008713128e-87	0.376593826348176	0.378	0.182	6.01850173298376e-83	SNHG6	Malignant cells	GSE161195_post	ENSG00000245910	NA	NA	HBII-276HG|NCRNA00058|U87HG	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46396
6.2738730722322e-87	0.39210149706133	0.544	0.329	1.15916078882562e-82	AC026403.1	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46397
1.60600854872287e-86	0.406466807875669	0.921	0.834	2.96726139462037e-82	RPS13	Malignant cells	GSE161195_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46398
2.84007848124293e-86	0.376181543490647	0.494	0.284	5.24732900194444e-82	JTB	Malignant cells	GSE161195_post	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46399
4.23299817397345e-85	0.524818411371093	0.91	0.861	7.82088742623334e-81	RPS21	Malignant cells	GSE161195_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46400
5.6299842692278e-84	0.414106510948215	0.56	0.36	1.04019589358253e-79	TXN	Malignant cells	GSE161195_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46401
8.64725943942534e-83	-0.433901927952131	0.814	0.915	1.59766765402823e-78	BLOC1S5-TXNDC5	Malignant cells	GSE161195_post	ENSG00000259040	NA	NA	MUTED-TXNDC5	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46402
2.28521424178541e-82	0.569094119888948	0.967	0.938	4.22216183312273e-78	RPS8	Malignant cells	GSE161195_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46403
3.06629354947788e-82	0.334223127802803	0.471	0.26	5.66528396201534e-78	COX6B1	Malignant cells	GSE161195_post	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46404
3.57589803406025e-82	0.325283499935706	0.353	0.165	6.60682920772972e-78	NDUFB9	Malignant cells	GSE161195_post	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46405
1.95789028537286e-81	-1.85832754470782	0.318	0.521	3.61739809125489e-77	IGHM	Malignant cells	GSE161195_post	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46406
6.14971130926844e-81	0.447010929990532	0.514	0.312	1.13622066150044e-76	HSP90AA1	Malignant cells	GSE161195_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46407
2.12577411685653e-80	0.372771649192452	0.928	0.849	3.92758025830413e-76	RPS17	Malignant cells	GSE161195_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46408
3.14373238754561e-79	0.426910608196809	0.486	0.293	5.80835995922926e-75	HNRNPA2B1	Malignant cells	GSE161195_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46409
9.2988397118272e-79	0.285768372546342	0.329	0.148	1.71805362515719e-74	SEM1	Malignant cells	GSE161195_post	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46410
1.83581363391157e-78	0.275479634484384	0.271	0.108	3.39184927001501e-74	IER3IP1	Malignant cells	GSE161195_post	ENSG00000134049	51124	immediate early response 3 interacting protein 1	NA	protein_coding	Q9Y5U9	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46411
8.39883728289861e-78	0.289764622358043	0.31	0.135	1.55176917638835e-73	DBI	Malignant cells	GSE161195_post	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46412
5.02014581767335e-77	0.282754622465034	0.263	0.104	9.27522141273328e-73	CCT6A	Malignant cells	GSE161195_post	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46413
1.26663390619781e-76	-0.430669407892402	1	1	2.34023280509107e-72	MT-RNR2	Malignant cells	GSE161195_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46414
5.23778604709124e-75	-0.532071743698767	0.215	0.41	9.67733350060578e-71	LAPTM5	Malignant cells	GSE161195_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46415
6.58730152818406e-75	0.257573008721204	0.256	0.101	1.21706983034729e-70	NHP2	Malignant cells	GSE161195_post	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46416
8.82157093847601e-75	0.291417659192562	0.297	0.13	1.62987344659283e-70	IFI16	Malignant cells	GSE161195_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46417
1.43341427226978e-74	0.368770718952152	0.75	0.587	2.64837620944565e-70	SNORA33	Malignant cells	GSE161195_post	ENSG00000200534	594839	small nucleolar RNA, H/ACA box 33	ACA33	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46418
2.45034859517321e-74	0.352776662638922	0.484	0.286	4.52726406444202e-70	UQCRQ	Malignant cells	GSE161195_post	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46419
5.24740359881509e-74	0.310876992186117	0.35	0.172	9.69510288917076e-70	C1orf43	Malignant cells	GSE161195_post	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46420
1.93760991228643e-73	0.343696136669532	0.394	0.21	3.57992807394041e-69	SOD1	Malignant cells	GSE161195_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46421
5.80489710200341e-73	0.443619096508431	0.879	0.809	1.07251278856615e-68	RPL35	Malignant cells	GSE161195_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46422
8.97019828763536e-73	0.579217357334086	0.907	0.855	1.65733383562351e-68	RPL30	Malignant cells	GSE161195_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46423
1.92609167799144e-72	0.300148931204395	0.399	0.211	3.55864698425699e-68	ATP5J2	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46424
1.30188969171569e-71	0.285132174390887	0.279	0.119	2.40537139441391e-67	MDH1	Malignant cells	GSE161195_post	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46425
3.96486050094981e-71	0.378992399352411	0.411	0.234	7.32547626155487e-67	EIF3H	Malignant cells	GSE161195_post	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46426
4.35221986469583e-71	0.359637337235598	0.643	0.457	8.04116142201202e-67	GAPDH	Malignant cells	GSE161195_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46427
2.69553405462688e-69	0.273993154326222	0.327	0.155	4.98026871932863e-65	SNORD49A	Malignant cells	GSE161195_post	ENSG00000277370	26800	small nucleolar RNA, C/D box 49A	RNU49|U49|U49A	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46428
2.71261978402707e-69	0.262469559304901	0.267	0.113	5.01183631296841e-65	SNRPF	Malignant cells	GSE161195_post	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46429
8.60182259351285e-69	0.276930569612334	0.298	0.136	1.58927274237743e-64	TOMM5	Malignant cells	GSE161195_post	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46430
3.03592124860316e-68	0.304306589169078	0.324	0.158	5.6091680989192e-64	ENSA	Malignant cells	GSE161195_post	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46431
4.74599613393106e-66	0.251373325083167	0.28	0.125	8.76870245705103e-62	TXNL4A	Malignant cells	GSE161195_post	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46432
1.8478097911721e-65	0.270020058969795	0.346	0.175	3.41401337016958e-61	ATP5H	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46433
1.91980040198735e-65	0.27529770856908	0.323	0.159	3.54702322271182e-61	C8orf59	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46434
1.63231439496747e-64	0.389507169756097	0.356	0.195	3.0158640761419e-60	CYCS	Malignant cells	GSE161195_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46435
3.0334343432213e-64	-0.438798136040763	0.256	0.436	5.60457329253568e-60	SEC62	Malignant cells	GSE161195_post	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46436
1.56391233479973e-63	0.265343702670777	0.353	0.183	2.88948442977598e-59	MZT2B	Malignant cells	GSE161195_post	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46437
2.90082190664873e-63	0.276668620795963	0.374	0.201	5.35955855472419e-59	COX5B	Malignant cells	GSE161195_post	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46438
2.84392114495962e-62	0.357561804288586	0.856	0.777	5.2544287074274e-58	UBA52	Malignant cells	GSE161195_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46439
3.1023369579299e-62	-1.23677052386206	0.814	0.808	5.73187776347128e-58	IGLC1	Malignant cells	GSE161195_post	ENSG00000211675	NA	NA	IGLC	IG_C_gene	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46440
6.1789456478633e-62	0.331061626455678	0.321	0.162	1.14162199789922e-57	TUBB	Malignant cells	GSE161195_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46441
1.4886047598806e-61	0.26639300201111	0.262	0.116	2.75034615435539e-57	SMC4	Malignant cells	GSE161195_post	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46442
8.5418404468754e-61	0.293696266128609	0.386	0.216	1.5781904409647e-56	COX5A	Malignant cells	GSE161195_post	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46443
1.17532487339557e-60	-0.427215408596043	0.17	0.335	2.17153023608565e-56	MIR3648-1	Malignant cells	GSE161195_post	ENSG00000275708	100500862	microRNA 3648-1	hsa-mir-3648|MIR3648	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46444
1.2427587270019e-60	0.340236430643363	0.418	0.248	2.29612102400871e-56	H3F3AP6	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46445
2.5524623353164e-60	0.342349995581126	0.546	0.378	4.71592941073058e-56	UQCRB	Malignant cells	GSE161195_post	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46446
2.65572039623827e-60	0.26878869366664	0.323	0.163	4.90670900408982e-56	H2AFV	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46447
3.00649753366691e-60	0.303661608932733	0.391	0.222	5.55480484320298e-56	SERBP1	Malignant cells	GSE161195_post	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46448
8.09016404757945e-60	0.27277291939093	0.397	0.22	1.49473870943078e-55	SRM	Malignant cells	GSE161195_post	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46449
2.0971250107181e-59	0.333788104041152	0.487	0.31	3.87464816980276e-55	SEC61G	Malignant cells	GSE161195_post	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46450
2.33739497899157e-59	0.39166516276542	0.502	0.343	4.31857096318483e-55	NDUFA4	Malignant cells	GSE161195_post	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46451
2.79775701187805e-59	0.321133710433691	0.503	0.328	5.16913585514589e-55	NDUFA1	Malignant cells	GSE161195_post	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46452
1.0011848781191e-58	0.280759662077447	0.423	0.249	1.84978918081286e-54	SNRPD2	Malignant cells	GSE161195_post	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46453
1.58873002045534e-58	0.25234773346093	0.273	0.129	2.93533758579328e-54	SLIRP	Malignant cells	GSE161195_post	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46454
3.96405465981611e-58	0.314705843160971	0.267	0.124	7.32398738947624e-54	HIST1H1C	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46455
3.99789369787252e-58	0.274069944615454	0.303	0.152	7.38650839618927e-54	NDUFS6	Malignant cells	GSE161195_post	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46456
4.18300856662683e-58	-0.585680076236099	0.263	0.44	7.72852662769972e-54	MALAT1	Malignant cells	GSE161195_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46457
1.43620716913158e-57	0.312745285098836	0.42	0.248	2.65353636568752e-53	CALM2	Malignant cells	GSE161195_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46458
2.88427835259656e-56	0.313764053535901	0.482	0.313	5.3289926842574e-52	CHCHD2	Malignant cells	GSE161195_post	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46459
1.07815132249066e-55	0.298827715739836	0.409	0.243	1.99199238343374e-51	ATP5O	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46460
1.77852782855382e-55	0.356669348848807	0.942	0.889	3.28600801603603e-51	RPL31	Malignant cells	GSE161195_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46461
5.10897649883625e-55	0.303173022653994	0.439	0.272	9.43934497924985e-51	SLC25A3	Malignant cells	GSE161195_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46462
2.19476519395734e-54	-0.267965644685513	0.106	0.259	4.05504817235558e-50	CFLAR	Malignant cells	GSE161195_post	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46463
2.27033123183114e-54	-0.259256637936796	0.099	0.252	4.19466398393121e-50	ADA2	Malignant cells	GSE161195_post	ENSG00000093072	51816	adenosine deaminase 2	ADGF|CECR1|IDGFL	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46464
2.52090310655049e-54	-0.253810908560611	0.12	0.281	4.65762057966269e-50	ST6GAL1	Malignant cells	GSE161195_post	ENSG00000073849	6480	ST6 beta-galactoside alpha-2,6-sialyltransferase 1	CDw75|SIAT1	protein_coding	P15907	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46465
2.54836934836462e-53	0.316164237309691	0.5	0.335	4.70836720803847e-49	PTMAP4	Malignant cells	GSE161195_post	ENSG00000231503	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46466
2.97925905144862e-53	0.336686627215258	0.946	0.912	5.50447902345647e-49	RPS27A	Malignant cells	GSE161195_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46467
3.8692683867144e-53	-0.426237954834483	0.492	0.651	7.14886027129353e-49	ACTB	Malignant cells	GSE161195_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46468
5.63384241720174e-52	0.273222245114331	0.378	0.221	1.04090872500219e-47	C14orf2	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46469
4.12500463265875e-51	0.329681860118872	0.398	0.247	7.62135855930031e-47	EIF3E	Malignant cells	GSE161195_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46470
5.89283274746302e-51	-0.319184059474585	0.303	0.473	1.08875977842127e-46	TAPBP	Malignant cells	GSE161195_post	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46471
6.02476337364305e-50	0.398118209259942	0.936	0.895	1.11313528091429e-45	RPL23	Malignant cells	GSE161195_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46472
7.08780964061619e-50	-0.371752861788962	0.998	0.996	1.30954370920025e-45	MT-ATP6	Malignant cells	GSE161195_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46473
9.49629070222153e-50	0.271541955215299	0.505	0.335	1.75453467014245e-45	COX7A2	Malignant cells	GSE161195_post	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46474
7.0357278690101e-49	0.265643329873126	0.431	0.27	1.29992108107831e-44	ATP5J	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46475
1.34193441561175e-48	0.269686965067395	0.862	0.766	2.47935802628427e-44	MIR6797	Malignant cells	GSE161195_post	ENSG00000276926	102465478	microRNA 6797	hsa-mir-6797	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46476
4.6165940676862e-48	0.291946263750012	0.501	0.345	8.52961919945703e-44	ATP5A1	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46477
7.07898404101131e-48	-0.283654695699098	0.257	0.434	1.30791309141725e-43	ITM2C	Malignant cells	GSE161195_post	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46478
8.68616410624263e-48	0.349980448588153	0.495	0.345	1.60485568026939e-43	NAP1L1	Malignant cells	GSE161195_post	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46479
1.59780439054558e-47	-0.663544386411651	0.846	0.936	2.95210339197202e-43	CD74	Malignant cells	GSE161195_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46480
5.29260685508988e-47	-0.281205551329501	0.139	0.285	9.77862042546406e-43	SDC1	Malignant cells	GSE161195_post	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46481
2.78426039372769e-46	-0.257949571462655	0.123	0.267	5.14419950345128e-42	PNRC1	Malignant cells	GSE161195_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46482
3.66755333755252e-46	-0.372876680432285	0.143	0.283	6.77617154646204e-42	MTRNR2L1	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46483
6.97501920016075e-46	-0.427435820291941	0.783	0.817	1.2887045474217e-41	RPS25	Malignant cells	GSE161195_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46484
1.73056898231146e-45	-0.287775212230836	0.325	0.509	3.19739925171866e-41	AC012181.2	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46485
2.63480404522179e-45	-0.319750714391612	0.223	0.374	4.86806395395179e-41	ISCU	Malignant cells	GSE161195_post	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46486
6.05762177177801e-45	-0.367450990608768	0.316	0.464	1.11920619855371e-40	ITM2B	Malignant cells	GSE161195_post	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46487
3.43167085868388e-44	0.26636138057947	0.811	0.7	6.34035507850434e-40	AC116533.1	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46488
3.8799694626236e-44	0.255121593179696	0.411	0.263	7.16863157914337e-40	COX8A	Malignant cells	GSE161195_post	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46489
2.76329162032619e-43	-0.310282112811404	0.312	0.466	5.10545759771467e-39	FAM46C	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46490
4.33145959039308e-41	0.403375997648083	0.955	0.932	8.00280473921026e-37	RPS6	Malignant cells	GSE161195_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46491
6.82645981268103e-41	0.287268039399795	0.722	0.607	1.26125671499095e-36	ATP5E	Malignant cells	GSE161195_post	NA	NA	NA	NA	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46492
7.17891445343503e-40	0.274518572375687	0.491	0.338	1.32637623441666e-35	ARPC2	Malignant cells	GSE161195_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46493
7.79049031738177e-39	0.321288845531802	0.65	0.526	1.43937099103946e-34	ACTG1	Malignant cells	GSE161195_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46494
4.21970209523003e-38	0.259385015594779	0.743	0.633	7.79632159114701e-34	RPL10A	Malignant cells	GSE161195_post	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46495
1.06059038800882e-37	0.265831747898012	0.806	0.72	1.95954680088509e-33	RPL36	Malignant cells	GSE161195_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46496
2.71452019497797e-34	-0.307032518407484	0.226	0.358	5.0153475122413e-30	TXNIP	Malignant cells	GSE161195_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46497
1.83573862629212e-33	0.458563180527897	0.622	0.622	3.39171068593732e-29	IGHA1	Malignant cells	GSE161195_post	ENSG00000282633	NA	NA	AL928768.3	IG_C_gene	P01876	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46498
3.10617084576646e-33	-0.251737161423816	0.52	0.644	5.73896125463812e-29	SNORD36B	Malignant cells	GSE161195_post	ENSG00000281243	NA	NA	RNU36B|U36b	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46499
3.15713563995905e-32	0.250835367469602	0.78	0.711	5.83312380838833e-28	RPL14	Malignant cells	GSE161195_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46500
3.04757795635758e-30	0.460521737587775	0.589	0.528	5.63070503216627e-26	MT-ATP8	Malignant cells	GSE161195_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46501
4.35266190948574e-30	0.263367026317963	0.838	0.777	8.04197814396586e-26	RACK1	Malignant cells	GSE161195_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46502
2.09119094420491e-27	-0.333248282567723	0.534	0.648	3.863684388513e-23	FTH1	Malignant cells	GSE161195_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46503
5.75899597025477e-27	0.270314692954444	0.935	0.908	1.06403209546427e-22	RPL34	Malignant cells	GSE161195_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46504
2.57619395770724e-25	0.324870219040537	0.785	0.742	4.7597759562599e-21	RPS5	Malignant cells	GSE161195_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46505
1.38380195413531e-24	0.295905707706501	0.86	0.825	2.5567124904604e-20	GNAS	Malignant cells	GSE161195_post	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46506
9.25311871824562e-21	0.274566041413784	0.886	0.859	1.70960621438306e-16	SNORA70	Malignant cells	GSE161195_post	ENSG00000207165	26778	small nucleolar RNA, H/ACA box 70	DXS648E|RNU70|U70	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46507
5.26051767393679e-20	0.271782955335618	0.79	0.779	9.71933245436562e-16	RPL5	Malignant cells	GSE161195_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46508
2.81818760558302e-15	-0.266059674657861	0.993	0.995	5.20688342007519e-11	MT-RNR1	Malignant cells	GSE161195_post	ENSG00000211459	NA	NA	12S|MOTS-c|MTRNR1	NA	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46509
8.20444606938964e-15	0.255835133728705	0.732	0.719	1.51585345578043e-10	RPL8	Malignant cells	GSE161195_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46510
1.9020732405811e-11	0.302130697197681	0.353	0.307	3.51427051929764e-07	NUCB2	Malignant cells	GSE161195_post	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46511
8.26784945253677e-09	-0.311965395134285	0.38	0.417	0.000152756786485069	GSTP1	Malignant cells	GSE161195_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE161195	GSE161195	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	post	DARA-KRD (daratumumab + carfilzomib + lenalidomide + dexamethasone)	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 7, sensitive 21); post (resistant 5, sensitive 15)	48	36505	Public on Jan 27, 2021	33619369	This dataset has 28 patients, 19 of whom have both pre- and post-treatment samples.	PRJNA675855	MARS-seq v2.0	NA	Multiple_myeloma	Targeted_therapy	46512
1.5496598240066e-238	-1.58869874950552	0.565	0.985	2.86439121869379e-234	RPS26	CD4+ T cells	GSE162117_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46513
1.58548462779517e-139	-0.611935707421188	1	1	2.93060978601659e-135	TPT1	CD4+ T cells	GSE162117_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46514
8.80983384322296e-112	-0.489347974435894	1	1	1.62840968758133e-107	RPLP2	CD4+ T cells	GSE162117_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46515
9.80420294694785e-77	-0.388213837620241	1	1	1.81220887271384e-72	EEF1A1	CD4+ T cells	GSE162117_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46516
1.10867260262822e-75	-0.46107550898415	1	1	2.049270438698e-71	RPS4X	CD4+ T cells	GSE162117_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46517
1.87708247544961e-74	-0.385918502105342	1	1	3.46959924762106e-70	RPL30	CD4+ T cells	GSE162117_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46518
2.82423335612892e-65	-0.397667739273684	1	1	5.22031293546869e-61	RPL37	CD4+ T cells	GSE162117_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46519
7.78112820701123e-64	0.43709125936375	1	1	1.43826373778396e-59	TMSB4X	CD4+ T cells	GSE162117_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46520
4.18759872608936e-61	-0.408977799952503	1	1	7.74035748530358e-57	RPL37A	CD4+ T cells	GSE162117_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46521
3.55199160888476e-60	0.711301212035027	0.992	0.871	6.56550128986259e-56	S100A4	CD4+ T cells	GSE162117_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46522
1.75015781583977e-59	-0.329873506867472	1	1	3.23499170679822e-55	RPS14	CD4+ T cells	GSE162117_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46523
1.34172089296863e-57	-0.361243001771325	1	1	2.48003689856322e-53	RPL9	CD4+ T cells	GSE162117_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46524
9.2292210937838e-57	-0.550391353894311	0.849	0.975	1.705929226975e-52	RPS10	CD4+ T cells	GSE162117_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46525
3.35142410054753e-56	-0.326800143338577	1	1	6.19477230745205e-52	RPS27	CD4+ T cells	GSE162117_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46526
4.83703712513302e-55	-0.414648412725982	0.998	1	8.94077942209587e-51	RPL38	CD4+ T cells	GSE162117_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46527
1.4361233088926e-54	-0.337885522545863	1	1	2.65453032415709e-50	RPS16	CD4+ T cells	GSE162117_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46528
2.61781636626701e-54	-0.301476771709972	1	1	4.83877177140794e-50	RPL28	CD4+ T cells	GSE162117_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46529
1.06387570852783e-53	0.642360263007138	0.996	0.974	1.96646785964284e-49	ACTB	CD4+ T cells	GSE162117_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46530
7.25509666362641e-53	1.45234353748028	0.368	0.134	1.3410320673047e-48	PPBP	CD4+ T cells	GSE162117_post	ENSG00000163736	5473	pro-platelet basic protein	b-TG1|Beta-TG|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|NAP-2-L1|PBP|SCYB7|TGB|TGB1|THBGB1	protein_coding	P02775	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46531
1.42942797488021e-47	-0.324984096105886	1	1	2.64215466876858e-43	RPS29	CD4+ T cells	GSE162117_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46532
1.27219481334834e-46	-0.277620212262885	1	1	2.35152489299307e-42	RPL19	CD4+ T cells	GSE162117_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46533
2.08498275932359e-45	-0.391803710861737	0.996	0.999	3.85388213233373e-41	RPS21	CD4+ T cells	GSE162117_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46534
4.08790162501981e-44	0.792535263729385	0.28	0.09	7.55607736368661e-40	PF4	CD4+ T cells	GSE162117_post	ENSG00000163737	5196	platelet factor 4	CXCL4|SCYB4	protein_coding	P02776	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46535
5.07232780500251e-43	-0.279576955830613	1	1	9.37569071476665e-39	RPS3	CD4+ T cells	GSE162117_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46536
4.99345869605544e-42	-0.307480176699892	0.998	1	9.22990905378887e-38	RPL3	CD4+ T cells	GSE162117_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46537
2.79947336969055e-41	-0.304682462434217	1	1	5.17454657653601e-37	RPS28	CD4+ T cells	GSE162117_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46538
1.70269810569814e-40	0.493802704403837	0.683	0.376	3.14726717857244e-36	RPS4Y1	CD4+ T cells	GSE162117_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46539
1.54245867732997e-39	-0.290671881000873	1	1	2.85108061917672e-35	RPS3A	CD4+ T cells	GSE162117_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46540
7.78950969488609e-37	-0.299543670969181	1	1	1.43981297200274e-32	RPL7	CD4+ T cells	GSE162117_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46541
5.95642758442646e-36	0.731307714933772	0.422	0.197	1.10098607470539e-31	KLRB1	CD4+ T cells	GSE162117_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46542
1.65447967594538e-35	0.45645611362474	0.956	0.902	3.05814023301744e-31	MT-ND5	CD4+ T cells	GSE162117_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46543
3.8530335116789e-34	-0.312123712039848	1	0.999	7.12194714298727e-30	RPL8	CD4+ T cells	GSE162117_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46544
8.86871597727354e-34	0.557218756393774	0.863	0.777	1.63929346123924e-29	IL32	CD4+ T cells	GSE162117_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46545
1.62153156302829e-33	-0.291453661135026	0.998	1	2.99723894110149e-29	RPL5	CD4+ T cells	GSE162117_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46546
1.89075259297968e-31	0.494582235266541	0.839	0.73	3.49486709286364e-27	SH3BGRL3	CD4+ T cells	GSE162117_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46547
7.03625363058663e-29	-0.269197733306505	0.998	0.999	1.30058112107763e-24	RPL7A	CD4+ T cells	GSE162117_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46548
9.32124944487259e-29	-0.285490742032692	0.998	0.998	1.72293974739025e-24	RPL22	CD4+ T cells	GSE162117_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46549
2.56400735554918e-25	-0.388829169960736	0.598	0.83	4.7393111959971e-21	GLTSCR2	CD4+ T cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46550
3.09140683977414e-25	-0.347256638391301	0.832	0.958	5.71415640263852e-21	TOMM7	CD4+ T cells	GSE162117_post	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46551
3.21182583340365e-24	-0.333433416350159	0.878	0.971	5.93673887046331e-20	EEF1B2	CD4+ T cells	GSE162117_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46552
3.14386352165637e-23	0.578140636299848	0.319	0.164	5.81111733342964e-19	CCL5	CD4+ T cells	GSE162117_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46553
3.50004372793459e-23	0.279052868500464	0.998	1	6.4694808267143e-19	PTMA	CD4+ T cells	GSE162117_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46554
1.00818791532598e-22	0.353108821278706	0.888	0.848	1.86353454268854e-18	SERF2	CD4+ T cells	GSE162117_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46555
2.39137792840121e-22	0.408703357130852	0.867	0.775	4.4202229628568e-18	H3F3A	CD4+ T cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46556
7.88242285389254e-22	0.43015947123883	0.758	0.712	1.4569870403135e-17	MYL6	CD4+ T cells	GSE162117_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46557
2.03694727385807e-21	-0.251597754307763	0.994	0.999	3.76509334099925e-17	RPS5	CD4+ T cells	GSE162117_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46558
2.46723556035333e-21	0.748100521207599	0.41	0.277	4.5604382097571e-17	GPX1	CD4+ T cells	GSE162117_post	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46559
3.24532018711795e-20	0.403910519051251	0.986	0.967	5.99864983386882e-16	FTH1	CD4+ T cells	GSE162117_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46560
2.36255795486637e-19	0.344290780899511	0.994	0.973	4.366952123775e-15	FTL	CD4+ T cells	GSE162117_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46561
8.06712388506186e-19	0.387771536184198	0.807	0.775	1.49112717891484e-14	PFN1	CD4+ T cells	GSE162117_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46562
8.39609061405961e-19	-0.3659814987589	0.296	0.505	1.55193338910278e-14	CXCR4	CD4+ T cells	GSE162117_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46563
8.71148670865677e-19	0.390897464337751	0.795	0.759	1.61023120322812e-14	MYL12A	CD4+ T cells	GSE162117_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46564
1.47672737478798e-18	0.335710830316982	0.961	0.853	2.7295828795581e-14	S100A6	CD4+ T cells	GSE162117_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46565
1.62390946883086e-18	-0.29173342395441	0.255	0.451	3.00163426218696e-14	LEPROTL1	CD4+ T cells	GSE162117_post	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46566
2.41761070248745e-18	0.353784018263315	0.77	0.729	4.46871162247781e-14	CALM1	CD4+ T cells	GSE162117_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46567
1.97916763342546e-17	-0.283549994421684	0.304	0.508	3.65829345362361e-13	SMDT1	CD4+ T cells	GSE162117_post	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46568
1.99508220666056e-17	-0.284519061504144	0.201	0.384	3.68770995079138e-13	CD7	CD4+ T cells	GSE162117_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46569
1.13121338130148e-15	0.353796175253722	0.704	0.656	2.09093481399765e-11	HMGB1	CD4+ T cells	GSE162117_post	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46570
1.89036133530138e-15	-0.289503132865561	0.47	0.672	3.49414389217107e-11	TMEM66	CD4+ T cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46571
8.54957275573199e-15	0.386812111984436	0.569	0.486	1.5803030281695e-10	IFITM2	CD4+ T cells	GSE162117_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46572
4.33058826940802e-14	0.33173441561261	0.691	0.503	8.00465935717379e-10	S100A9	CD4+ T cells	GSE162117_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46573
5.65010593234041e-14	0.32071386118917	0.731	0.686	1.0443655805338e-09	PTPRC	CD4+ T cells	GSE162117_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46574
7.98445007161612e-14	-0.265978900481421	0.47	0.673	1.47584575123752e-09	CD48	CD4+ T cells	GSE162117_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46575
8.14349187567128e-14	0.366157417588387	0.677	0.632	1.50524303829908e-09	CYBA	CD4+ T cells	GSE162117_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46576
1.29698011039749e-13	0.371897859005921	0.549	0.443	2.39733803605871e-09	ANXA1	CD4+ T cells	GSE162117_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46577
2.00713689919599e-13	0.412283613775425	0.662	0.641	3.70999184447386e-09	OAZ1	CD4+ T cells	GSE162117_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46578
2.5962308892909e-13	0.320436323369731	0.747	0.703	4.7988731757653e-09	GAPDH	CD4+ T cells	GSE162117_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46579
2.79089670725796e-12	0.326255273828045	0.52	0.429	5.15869347369561e-08	TPM3	CD4+ T cells	GSE162117_post	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46580
3.34176102667532e-12	0.310724729890655	0.3	0.187	6.17691108170665e-08	TLN1	CD4+ T cells	GSE162117_post	ENSG00000137076	7094	talin 1	ILWEQ|TLN	protein_coding	Q9Y490	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46581
4.56535848394505e-12	0.34452051772385	0.462	0.368	8.43860862172403e-08	MT-ND4L	CD4+ T cells	GSE162117_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46582
7.63757910132149e-12	0.397301090597935	0.658	0.579	1.41173012108826e-07	FOS	CD4+ T cells	GSE162117_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46583
8.65303486926397e-12	0.350858982916346	0.323	0.21	1.59942696523475e-07	ISG15	CD4+ T cells	GSE162117_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46584
5.71171349225788e-11	0.39265170567435	0.714	0.677	1.05575312190895e-06	IL7R	CD4+ T cells	GSE162117_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46585
5.84379778876492e-11	0.271218422498697	0.356	0.243	1.08016758327531e-06	TIMP1	CD4+ T cells	GSE162117_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46586
1.08819746938795e-10	0.325079198235185	0.435	0.338	2.01142420241668e-06	S100A11	CD4+ T cells	GSE162117_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46587
1.51282062978468e-10	0.507554184608313	0.393	0.302	2.796297652094e-06	LGALS1	CD4+ T cells	GSE162117_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46588
3.20883062915663e-10	0.284853753977837	0.681	0.653	5.93120253493311e-06	HSP90AA1	CD4+ T cells	GSE162117_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46589
4.71921425139927e-10	0.305269440608119	0.53	0.458	8.72299562228641e-06	SEPT7	CD4+ T cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46590
2.6282148539486e-09	0.31608632382727	0.497	0.441	4.85799233603859e-05	ARPC1B	CD4+ T cells	GSE162117_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46591
2.77453975873608e-09	0.453738322716027	0.253	0.166	5.12845929004777e-05	NKG7	CD4+ T cells	GSE162117_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46592
2.02619709432685e-08	0.314454340587847	0.509	0.432	0.000374522270915375	KLF6	CD4+ T cells	GSE162117_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46593
5.47847477112045e-08	0.274083449299319	0.679	0.693	0.0010126412766939	UBB	CD4+ T cells	GSE162117_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46594
7.24703970789674e-08	0.26330527595591	0.723	0.734	0.00133954281960763	OST4	CD4+ T cells	GSE162117_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46595
7.90988013578992e-08	0.271055936327491	0.364	0.285	0.00146206224429941	CLIC1	CD4+ T cells	GSE162117_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46596
6.48534355409869e-07	0.263652391132792	0.594	0.564	0.011987509025396	EMP3	CD4+ T cells	GSE162117_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46597
1.72923789593635e-06	0.290133239172155	0.526	0.493	0.0319632332684874	NCL	CD4+ T cells	GSE162117_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46598
2.34025778461224e-06	0.251916113917703	0.532	0.499	0.0432573248907726	MYL12B	CD4+ T cells	GSE162117_post	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46599
0	-1.04059911651555	0.589	0.886	0	S100A10	Malignant cells	GSE162117_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46600
0	-0.702851305590349	0.746	0.958	0	S100A11	Malignant cells	GSE162117_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46601
0	-0.65012358376813	0.927	0.997	0	S100A6	Malignant cells	GSE162117_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46602
0	-1.43259501026739	0.072	0.707	0	HLA-DRB5	Malignant cells	GSE162117_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46603
0	0.49475158089552	1	1	0	RPS18	Malignant cells	GSE162117_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46604
0	-0.50141762861692	0.026	0.309	0	XIST	Malignant cells	GSE162117_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46605
0	-0.791400290329439	0.627	0.87	0	RPS26	Malignant cells	GSE162117_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46606
0	-1.67902525528816	0.745	0.951	0	LYZ	Malignant cells	GSE162117_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46607
0	-0.464131712976355	0.971	0.993	0	ATP5E	Malignant cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46608
0	0.596935877972183	0.643	0.267	0	RPS4Y1	Malignant cells	GSE162117_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46609
0	-0.593664321919459	0.994	1	0	MT-ND1	Malignant cells	GSE162117_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46610
0	-0.589586572477447	0.984	0.998	0	MT-ND3	Malignant cells	GSE162117_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46611
3.03525554147309e-282	-0.579602773118183	0.797	0.966	5.61036634285885e-278	LGALS1	Malignant cells	GSE162117_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46612
6.93589021094123e-280	-0.711998067788673	0.202	0.501	1.28202994659038e-275	LGALS2	Malignant cells	GSE162117_post	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46613
3.94883906990847e-278	-0.673179516864281	0.054	0.311	7.29903413681881e-274	IER3	Malignant cells	GSE162117_post	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46614
2.41029101815578e-257	-0.460896425127059	0.105	0.375	4.45518191795915e-253	TMEM176B	Malignant cells	GSE162117_post	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46615
8.76763875757653e-242	-0.541131483298704	0.591	0.874	1.62061034795045e-237	FCN1	Malignant cells	GSE162117_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46616
3.27535081877499e-239	0.372631422162364	1	0.999	6.05415845342369e-235	RPL12	Malignant cells	GSE162117_post	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46617
5.39944300629921e-237	-0.55991051242971	0.236	0.522	9.98033045284347e-233	RGS2	Malignant cells	GSE162117_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46618
8.23049686736101e-227	-0.371199296619921	0.986	0.997	1.52132504096301e-222	EIF1	Malignant cells	GSE162117_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46619
2.38424627870189e-225	0.777110512793307	0.623	0.382	4.40704082155258e-221	ISG15	Malignant cells	GSE162117_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46620
2.16213612716604e-217	-0.319491474900738	1	1	3.99649241745371e-213	TPT1	Malignant cells	GSE162117_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46621
1.00400944625424e-211	-0.370641937309172	0.968	0.992	1.85581106045634e-207	H3F3A	Malignant cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46622
4.9632471549262e-207	-0.357454767959024	0.999	1	9.17406604116558e-203	MT-ND2	Malignant cells	GSE162117_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46623
4.48053602078222e-206	0.577930598838852	0.608	0.362	8.28182278081385e-202	IFI6	Malignant cells	GSE162117_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46624
1.46499365702766e-205	-0.495604808347491	0.94	0.972	2.70789427564993e-201	NEAT1	Malignant cells	GSE162117_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46625
6.46455031256488e-202	-0.416669346491181	0.978	0.997	1.19490747977449e-197	MT-CYB	Malignant cells	GSE162117_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46626
1.021412933538e-188	0.651933475898545	0.793	0.765	1.88797966635164e-184	CFD	Malignant cells	GSE162117_post	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46627
6.24596726671346e-183	-0.485049172448242	0.445	0.665	1.15450458957932e-178	ITGB2	Malignant cells	GSE162117_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46628
3.13600237069727e-181	0.279611782874366	1	1	5.79658678199684e-177	RPL32	Malignant cells	GSE162117_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46629
6.3089649035698e-180	-0.359680357818078	0.084	0.295	1.16614907277584e-175	HLA-DQA1	Malignant cells	GSE162117_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46630
5.67943424104943e-175	-0.325575002288099	0.999	1	1.04978662511558e-170	TMSB10	Malignant cells	GSE162117_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46631
6.35169527292913e-175	-0.477755084077559	0.681	0.878	1.17404735424822e-170	COTL1	Malignant cells	GSE162117_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46632
1.03183560259023e-158	-0.630642445347246	0.511	0.688	1.90724492782779e-154	CD52	Malignant cells	GSE162117_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46633
1.72161729128103e-152	-0.392695793448149	0.285	0.509	3.18223740120386e-148	CAST	Malignant cells	GSE162117_post	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46634
1.5739559829242e-151	0.277895938851452	1	0.999	2.90930023883709e-147	RPL23A	Malignant cells	GSE162117_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46635
1.29325430065869e-149	0.43036851240632	1	1	2.39045124933753e-145	RPS6	Malignant cells	GSE162117_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46636
9.75848646524062e-145	-0.466280729926511	0.271	0.48	1.80375863823508e-140	IRF1	Malignant cells	GSE162117_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46637
1.49933340772518e-143	0.320629600960897	1	1	2.77136787083922e-139	B2M	Malignant cells	GSE162117_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46638
1.82225807003743e-140	0.362333052446449	1	1	3.36826181665718e-136	RPS8	Malignant cells	GSE162117_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46639
6.03521564623204e-140	-0.338795086363739	0.959	0.997	1.11554926004953e-135	S100A4	Malignant cells	GSE162117_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46640
1.50692083880639e-134	-0.267189028781478	1	1	2.78539247844972e-130	MT-CO3	Malignant cells	GSE162117_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46641
1.77935319517035e-133	-0.279367019392676	0.102	0.285	3.28895644595287e-129	MYADM	Malignant cells	GSE162117_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46642
2.62427836941366e-133	0.524545684537607	0.691	0.498	4.85071613802421e-129	JUN	Malignant cells	GSE162117_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46643
4.42888690070668e-132	-0.289346057568267	0.966	0.983	8.18635454726623e-128	PFDN5	Malignant cells	GSE162117_post	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46644
3.32626813202483e-130	-0.28083403416185	0.088	0.259	6.14827401523469e-126	RNASE6	Malignant cells	GSE162117_post	ENSG00000169413	6039	ribonuclease A family member k6	RAD1|RNaseK6|RNS6	protein_coding	Q93091	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46645
2.56210391961744e-129	0.358145680670965	0.981	0.957	4.73579288502088e-125	RPS5	Malignant cells	GSE162117_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46646
1.17508762529378e-126	0.385164680740706	0.255	0.093	2.17203196659302e-122	CLU	Malignant cells	GSE162117_post	ENSG00000120885	1191	clusterin	APOJ|CLI|CLU1|CLU2|KUB1|SGP-2|SP-40|TRPM-2	protein_coding	P10909	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46647
3.54386516278952e-125	-0.59245712818654	0.31	0.521	6.55048036690015e-121	S100A12	Malignant cells	GSE162117_post	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46648
1.31647343274278e-124	-0.366163696502428	0.631	0.824	2.43336949308176e-120	JUNB	Malignant cells	GSE162117_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46649
9.53183141576871e-124	-0.253478081932847	0.974	0.994	1.76186371889069e-119	RPL23	Malignant cells	GSE162117_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46650
7.71367207272476e-123	0.280537046576543	1	1	1.42579514592244e-118	RPS15A	Malignant cells	GSE162117_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46651
8.43022169177142e-123	0.279012713978136	1	1	1.55824217750703e-118	RPS2	Malignant cells	GSE162117_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46652
5.19971859776797e-120	0.256632502148328	0.999	0.998	9.61115985611431e-116	RPS25	Malignant cells	GSE162117_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46653
5.69382963675063e-120	0.548274775522026	0.332	0.165	1.05244747005699e-115	ANKRD28	Malignant cells	GSE162117_post	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46654
3.12093626728009e-118	-0.25097133041588	0.095	0.259	5.76873859644051e-114	TGFBI	Malignant cells	GSE162117_post	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46655
3.94195716723509e-118	-0.459302756443278	0.804	0.97	7.28631362791734e-114	LST1	Malignant cells	GSE162117_post	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46656
3.9716565849821e-118	0.321433805778276	0.351	0.174	7.34121003168091e-114	LIPA	Malignant cells	GSE162117_post	ENSG00000107798	3988	lipase A, lysosomal acid type	CESD|LAL	protein_coding	P38571	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46657
1.40579160665197e-116	-0.276193522996603	0.995	1	2.59846520573551e-112	ACTB	Malignant cells	GSE162117_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46658
1.92299983525769e-115	-0.701276829149498	0.174	0.345	3.55447289549031e-111	IL1B	Malignant cells	GSE162117_post	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46659
1.45650876303449e-113	0.336013950030438	0.424	0.238	2.69221079759296e-109	LDHB	Malignant cells	GSE162117_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46660
1.95537278092133e-113	0.422786682858717	0.637	0.461	3.61431104825499e-109	HSP90AB1	Malignant cells	GSE162117_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46661
2.13942900003012e-113	0.476384474641827	0.625	0.446	3.95452056365567e-109	PLAC8	Malignant cells	GSE162117_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46662
4.66029216022063e-112	0.336811179853401	0.422	0.239	8.61408402895182e-108	HMGN1	Malignant cells	GSE162117_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46663
2.22882764915833e-108	0.262668473104438	0.258	0.104	4.11976502670426e-104	IFI44L	Malignant cells	GSE162117_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46664
4.22638263252356e-108	-0.515406327111987	0.425	0.608	7.81204565795654e-104	RP11-1143G9.4	Malignant cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46665
1.2971633596429e-107	-0.30461062260795	0.847	0.942	2.39767675396394e-103	HLA-C	Malignant cells	GSE162117_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46666
1.35250868471174e-105	-0.304345153238342	0.16	0.329	2.49997705282118e-101	BTG2	Malignant cells	GSE162117_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46667
1.18969174752964e-104	0.460152931276833	0.416	0.25	2.19902622613379e-100	MGST1	Malignant cells	GSE162117_post	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46668
3.00632096478139e-103	-0.347219270893162	0.416	0.597	5.55688367130192e-99	MCL1	Malignant cells	GSE162117_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46669
2.26734274423955e-101	-0.322634782207622	0.733	0.847	4.19095632845238e-97	TSPO	Malignant cells	GSE162117_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46670
7.75631243148202e-101	-0.277984911449819	0.353	0.554	1.43367678983514e-96	ANXA5	Malignant cells	GSE162117_post	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46671
3.47907339244033e-100	-0.284727310340005	0.215	0.394	6.4307192585867e-96	NAMPT	Malignant cells	GSE162117_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46672
3.94204579098545e-98	-0.337897935593387	0.578	0.742	7.2864774400575e-94	AP1S2	Malignant cells	GSE162117_post	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46673
7.41869947104836e-95	0.270143899974611	0.463	0.287	1.37127241022858e-90	ELF1	Malignant cells	GSE162117_post	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46674
6.03142929700225e-94	-0.299721007771522	0.14	0.296	1.1148493912579e-89	CRIP1	Malignant cells	GSE162117_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46675
1.24860872325142e-92	0.512954261731967	0.803	0.871	2.30792836405793e-88	HLA-DRB1	Malignant cells	GSE162117_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46676
4.85993052867661e-91	0.281323366513465	0.494	0.321	8.98309558920585e-87	IFI16	Malignant cells	GSE162117_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46677
4.07352940089339e-90	0.320873598462053	0.796	0.661	7.52951174461134e-86	HSP90AA1	Malignant cells	GSE162117_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46678
3.82045540854978e-89	0.421083456936771	0.684	0.562	7.06172977716342e-85	NPM1	Malignant cells	GSE162117_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46679
1.57089045239105e-88	-0.297545807912717	0.858	0.919	2.90363391219962e-84	VIM	Malignant cells	GSE162117_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46680
8.78070928347466e-87	0.321523555099702	0.603	0.446	1.62302630395746e-82	NCL	Malignant cells	GSE162117_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46681
4.55179841412133e-86	-0.275296557337797	0.895	0.949	8.41354418866187e-82	MYL6	Malignant cells	GSE162117_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46682
1.15902152976101e-85	0.311830669802372	0.917	0.846	2.14233539561026e-81	RPLP0	Malignant cells	GSE162117_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46683
6.45123833347392e-85	0.348443680158678	0.381	0.225	1.19244689355932e-80	NKG7	Malignant cells	GSE162117_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46684
6.08562442584703e-81	-0.301152270197247	0.269	0.431	1.12486681887357e-76	SOD2	Malignant cells	GSE162117_post	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46685
7.00051329693555e-81	-0.304713628470841	0.29	0.453	1.29397487780557e-76	MARCKS	Malignant cells	GSE162117_post	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46686
7.37039129280329e-80	-0.411511742315102	0.39	0.551	1.36234312656176e-75	VCAN	Malignant cells	GSE162117_post	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46687
5.23131291362492e-78	-0.282643872085357	0.851	0.994	9.66955878954429e-74	TYROBP	Malignant cells	GSE162117_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46688
3.13830443436815e-77	0.307188525857398	0.832	0.725	5.8008419164861e-73	HCST	Malignant cells	GSE162117_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46689
6.23316913614527e-77	0.304644415681723	0.912	0.914	1.15213898312509e-72	HLA-A	Malignant cells	GSE162117_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46690
1.49372895662798e-75	-0.276176593249615	0.455	0.617	2.76100860343117e-71	CD48	Malignant cells	GSE162117_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46691
1.75968071252492e-74	-0.276064225445582	0.502	0.657	3.25259382903106e-70	ANXA2	Malignant cells	GSE162117_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46692
1.80095602165058e-74	0.31130609879573	0.998	0.998	3.32888711041893e-70	RPS3	Malignant cells	GSE162117_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46693
5.58889257704726e-74	0.526976504080505	0.79	0.799	1.03305090394141e-69	HLA-DPA1	Malignant cells	GSE162117_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46694
1.28071628766381e-69	0.256469789345056	0.994	0.988	2.36727598611779e-65	RPL10A	Malignant cells	GSE162117_post	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46695
1.6280321075799e-69	-0.263185714728753	0.292	0.435	3.0092545476507e-65	MYO1F	Malignant cells	GSE162117_post	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46696
3.04337563231739e-69	-0.271070952171302	0.237	0.38	5.62537551877547e-65	CEBPD	Malignant cells	GSE162117_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46697
7.90257678739269e-69	0.345258256328915	0.994	0.993	1.46071229338166e-64	RPL31	Malignant cells	GSE162117_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46698
1.42708135512269e-68	0.354497464303398	0.853	0.795	2.63781717680877e-64	EEF1B2	Malignant cells	GSE162117_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46699
9.22027562213452e-68	-0.379774474355603	0.532	0.657	1.70427574599534e-63	IER2	Malignant cells	GSE162117_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46700
4.53079315355556e-66	-0.256667795508389	0.351	0.501	8.37471806503211e-62	CEBPB	Malignant cells	GSE162117_post	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46701
1.12209224460725e-65	-0.26827612874779	0.531	0.684	2.07407530493203e-61	SERPINA1	Malignant cells	GSE162117_post	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46702
1.99669924319416e-65	-0.270972079812655	0.713	0.793	3.69069888112008e-61	C14orf2	Malignant cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46703
1.27858904332114e-64	-0.266094077903052	0.606	0.758	2.3633439876748e-60	CSTA	Malignant cells	GSE162117_post	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46704
5.20109803795001e-64	-0.279303632831304	0.427	0.569	9.6137096133468e-60	FOSB	Malignant cells	GSE162117_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46705
7.72682157821432e-64	-0.273663847828551	0.388	0.54	1.42822570051713e-59	DUSP6	Malignant cells	GSE162117_post	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46706
1.46414380433326e-63	0.281060090782881	0.897	0.862	2.70632340792959e-59	RPSA	Malignant cells	GSE162117_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46707
1.88246691171755e-63	-0.272522452957934	0.229	0.367	3.47955183961872e-59	RP11-290F20.3	Malignant cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46708
1.59622407897934e-61	-0.431705111457873	0.565	0.67	2.95046058758542e-57	IFITM3	Malignant cells	GSE162117_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46709
4.31626471782093e-61	-0.252928568296143	0.68	0.766	7.9781837044202e-57	TCEB2	Malignant cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46710
7.99598128273936e-55	-0.258715866616015	0.347	0.491	1.47797718030154e-50	CD14	Malignant cells	GSE162117_post	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46711
6.159392226964e-48	0.301761883250932	0.667	0.603	1.13850205923203e-43	PSME2	Malignant cells	GSE162117_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46712
2.23792229610077e-47	-0.266426199817604	0.339	0.455	4.13657557211266e-43	VAMP5	Malignant cells	GSE162117_post	ENSG00000168899	10791	vesicle associated membrane protein 5	NA	protein_coding	O95183	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46713
2.88921097451722e-43	0.383651346760796	0.398	0.302	5.34041756529762e-39	CD99	Malignant cells	GSE162117_post	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46714
6.05645031268728e-40	0.267189800184996	0.818	0.794	1.11947427579712e-35	UBC	Malignant cells	GSE162117_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46715
1.9478029008045e-38	0.296411567192064	0.462	0.374	3.60031888184704e-34	SERPINB1	Malignant cells	GSE162117_post	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46716
3.47947394144198e-34	0.455959375290858	0.639	0.605	6.43145963336136e-30	HINT1	Malignant cells	GSE162117_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46717
7.62381725791416e-33	-0.26413779297547	0.678	0.783	1.40918638195285e-28	NFKBIA	Malignant cells	GSE162117_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46718
1.01139538609818e-23	-0.320441927962208	0.267	0.331	1.86946323166388e-19	FCGR3A	Malignant cells	GSE162117_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46719
2.70695545815826e-62	-1.21488999859539	0.721	0.955	5.00353646885973e-58	RPS26	CD8+ T cells	GSE162117_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46720
8.40002067845876e-30	-0.464823984332588	1	1	1.55265982220632e-25	RPL37	CD8+ T cells	GSE162117_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46721
8.38529662125834e-22	-0.509264881848524	0.941	0.985	1.54993822747339e-17	HLA-C	CD8+ T cells	GSE162117_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46722
2.4056821120683e-20	-0.483821337798393	1	1	4.44666281594704e-16	TPT1	CD8+ T cells	GSE162117_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46723
4.99491408125995e-17	-0.404909150314066	1	1	9.23259918780089e-13	RPS27	CD8+ T cells	GSE162117_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46724
6.25973244077033e-16	0.593815433584113	0.712	0.469	1.15704894435199e-11	FOS	CD8+ T cells	GSE162117_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46725
9.99991974139198e-16	-0.592572477462471	0.829	0.945	1.84838516499889e-11	CD52	CD8+ T cells	GSE162117_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46726
1.58799549445399e-15	-0.362582907404129	0.991	0.998	2.93525087194875e-11	RPS21	CD8+ T cells	GSE162117_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46727
1.98418500433061e-15	-0.341822554652978	1	1	3.6675675620047e-11	RPS29	CD8+ T cells	GSE162117_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46728
3.33129344855136e-15	-0.364124022528203	0.991	0.998	6.15756281030233e-11	RPL38	CD8+ T cells	GSE162117_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46729
3.24251716929505e-14	0.398036082968594	0.68	0.408	5.99346873572497e-10	RPS4Y1	CD8+ T cells	GSE162117_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46730
2.65716344244603e-13	-0.30348384994685	1	1	4.91150090701724e-09	RPL37A	CD8+ T cells	GSE162117_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46731
3.25940959527935e-13	-0.322917128016118	1	1	6.02469269591434e-09	EEF1A1	CD8+ T cells	GSE162117_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46732
3.56233489005508e-13	0.558361739618185	0.275	0.103	6.58461981077782e-09	PPBP	CD8+ T cells	GSE162117_post	ENSG00000163736	5473	pro-platelet basic protein	b-TG1|Beta-TG|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|NAP-2-L1|PBP|SCYB7|TGB|TGB1|THBGB1	protein_coding	P02775	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46733
2.91095240716122e-12	-0.359758948823102	0.095	0.333	5.3806044293968e-08	HBG2	CD8+ T cells	GSE162117_post	ENSG00000196565	3048	hemoglobin subunit gamma 2	HBG-T1	protein_coding	P69892	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46734
5.33744877556748e-11	-0.264298363526854	1	1	9.86574031675892e-07	RPS28	CD8+ T cells	GSE162117_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46735
6.43004807591157e-11	0.340799648305935	1	0.997	1.18853008635149e-06	PTMA	CD8+ T cells	GSE162117_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46736
1.4983449289766e-10	-0.288349623514412	1	1	2.76954076672035e-06	RPLP2	CD8+ T cells	GSE162117_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46737
1.55362846704619e-10	-0.333221308483104	1	1	2.87172685848817e-06	RPS4X	CD8+ T cells	GSE162117_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46738
4.85058804893316e-10	0.421297170377336	0.725	0.555	8.96582694964806e-06	HSP90AB1	CD8+ T cells	GSE162117_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46739
1.14257033616508e-09	0.277357319841356	0.423	0.232	2.11192700936753e-05	SLFN5	CD8+ T cells	GSE162117_post	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46740
1.48625582373076e-09	-0.358588241345478	0.851	0.91	2.74719526458395e-05	RPS10	CD8+ T cells	GSE162117_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46741
1.92396286816538e-09	-0.306653203837689	0.964	0.993	3.5562529655169e-05	MT-ND3	CD8+ T cells	GSE162117_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46742
2.91321685130682e-09	-0.294632083766926	1	1	5.38479002795552e-05	RPL34	CD8+ T cells	GSE162117_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46743
5.09744196536947e-09	-0.325827798308425	0.153	0.354	9.42211172878893e-05	HBA2	CD8+ T cells	GSE162117_post	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46744
7.81095349875865e-09	0.340949552442633	1	0.995	0.000144377664471055	ACTB	CD8+ T cells	GSE162117_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46745
3.33674546595231e-08	0.345017330174314	0.878	0.836	0.000616764031926624	MYL12A	CD8+ T cells	GSE162117_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46746
4.66860184051913e-08	0.296332439047147	0.365	0.207	0.000862944364201555	EIF5A	CD8+ T cells	GSE162117_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46747
4.75490073995349e-08	0.41923398031413	0.824	0.761	0.000878895852773003	NPM1	CD8+ T cells	GSE162117_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46748
5.46457064308018e-08	-0.377076266758104	0.878	0.919	0.00101007123766694	CCL5	CD8+ T cells	GSE162117_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46749
6.49434347327386e-08	-0.327309437860124	1	1	0.00120041444759994	MALAT1	CD8+ T cells	GSE162117_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46750
8.08433321484145e-08	0.355947707247821	0.874	0.778	0.00149430815143129	HSP90AA1	CD8+ T cells	GSE162117_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46751
3.95786632280903e-07	0.297178121978399	0.293	0.156	0.00731572011108021	RGS1	CD8+ T cells	GSE162117_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46752
5.27072523965566e-07	0.303544772366975	0.302	0.165	0.00974240853297952	AIF1	CD8+ T cells	GSE162117_post	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46753
5.88241316413387e-07	-0.275583046143049	0.239	0.411	0.010873052492585	MYO1F	CD8+ T cells	GSE162117_post	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46754
2.1906870354443e-06	0.486162254599866	0.423	0.284	0.0404926591631525	HIST1H1C	CD8+ T cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46755
2.41155686804918e-06	0.265801276131199	0.869	0.807	0.044575217149021	UBB	CD8+ T cells	GSE162117_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46756
2.52778071525636e-06	0.375674415769229	0.523	0.39	0.0467234987407985	IFI16	CD8+ T cells	GSE162117_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46757
2.37476498479914e-47	-1.17035780838675	0.611	0.928	4.38951559790273e-43	RPS26	NK cells	GSE162117_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46758
1.45482197150121e-22	0.637313343907953	0.63	0.272	2.68909293212284e-18	RPS4Y1	NK cells	GSE162117_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46759
3.18580528729811e-17	-0.468409970407557	1	1	5.88864249304183e-13	TPT1	NK cells	GSE162117_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46760
1.78753338634293e-13	0.739275754853407	0.341	0.122	3.30407671131627e-09	PPBP	NK cells	GSE162117_post	ENSG00000163736	5473	pro-platelet basic protein	b-TG1|Beta-TG|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|NAP-2-L1|PBP|SCYB7|TGB|TGB1|THBGB1	protein_coding	P02775	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46761
2.41334067477496e-12	-0.448351248322364	0.058	0.291	4.46081890325403e-08	XIST	NK cells	GSE162117_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46762
1.04566042842754e-11	-0.299373125088169	1	1	1.93279873590547e-07	MT-CO3	NK cells	GSE162117_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46763
1.18609915746698e-10	0.542777111667685	0.462	0.254	2.19238568266197e-06	GPX1	NK cells	GSE162117_post	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46764
1.50222897364775e-09	0.425264174149774	0.611	0.41	2.7767200348905e-05	MT-ND4L	NK cells	GSE162117_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46765
1.65149391578256e-09	-0.316709736750798	0.947	0.989	3.05262135393248e-05	HLA-C	NK cells	GSE162117_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46766
2.54916222079318e-09	-0.277017578754188	1	1	4.71187144891412e-05	EEF1A1	NK cells	GSE162117_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46767
1.39013521942325e-08	0.323078998749723	0.317	0.146	0.000256952593958194	TIMP1	NK cells	GSE162117_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46768
5.13740693360275e-08	-0.298705851740551	0.082	0.259	0.000949598297607133	TNFAIP3	NK cells	GSE162117_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46769
6.69685100616123e-08	0.482303101806815	0.62	0.445	0.00123784593997884	CD3D	NK cells	GSE162117_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46770
7.85768367053429e-08	-0.362974303394543	0.101	0.28	0.00145241424966156	HBG2	NK cells	GSE162117_post	ENSG00000196565	3048	hemoglobin subunit gamma 2	HBG-T1	protein_coding	P69892	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46771
2.56440296386596e-07	-0.352376844952407	0.861	0.925	0.00474004243840984	H3F3B	NK cells	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46772
2.97774867605458e-07	-0.252127064988337	1	1	0.00550407065281929	RPL37	NK cells	GSE162117_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46773
3.28797921411764e-07	0.309805429421866	0.976	0.941	0.00607750077937505	MT-ND5	NK cells	GSE162117_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46774
3.82451866617112e-07	-0.526171517040806	0.476	0.63	0.0070692403025507	GZMH	NK cells	GSE162117_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46775
5.84363025437002e-07	0.376420657724262	0.986	0.958	0.0108013661621775	S100A4	NK cells	GSE162117_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46776
7.97280769983317e-07	-0.270963429651431	1	1	0.0147369377523716	RPS4X	NK cells	GSE162117_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46777
1.1486574553641e-06	-0.3077577789901	0.971	0.974	0.02123178440495	NKG7	NK cells	GSE162117_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46778
1.17233308715383e-06	0.387540837483081	0.26	0.125	0.0216694047829514	AIF1	NK cells	GSE162117_post	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46779
1.4976460441469e-06	-0.322639286175398	0.356	0.555	0.0276824894800112	FUS	NK cells	GSE162117_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46780
9.23048364762349e-12	-2.13988295984667	0.242	1	1.70616259742673e-07	GZMB	pDCs	GSE162117_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46781
2.4872618237415e-10	-1.52450782144484	0.606	1	4.59745475500379e-06	IGJ	pDCs	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46782
1.2984656620694e-09	-0.795059418781595	1	1	2.40008392976907e-05	TPT1	pDCs	GSE162117_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46783
1.54374980753961e-07	-0.982937916237063	0.333	0.878	0.00285346714425621	PPP1R14B	pDCs	GSE162117_post	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46784
2.28679907728174e-07	0.829402946073886	0.758	0.204	0.00422691941444757	RPS4Y1	pDCs	GSE162117_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46785
1.14592421025871e-06	-0.993585160436572	0.636	0.918	0.021181263102422	RPS26	pDCs	GSE162117_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46786
1.67446484848654e-06	-0.661499950466319	1	1	0.0309508082594252	RPS28	pDCs	GSE162117_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46787
1.99379040104554e-06	0.895608053677493	0.97	0.98	0.0368532217729258	PLAC8	pDCs	GSE162117_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46788
2.39965897473456e-06	-0.471716362665763	1	1	0.0443552964889937	RPL28	pDCs	GSE162117_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46789
2.43018868498485e-06	-0.954525783526831	0.364	0.816	0.04491960765326	CCDC50	pDCs	GSE162117_post	ENSG00000152492	152137	coiled-coil domain containing 50	C3orf6|DFNA44|Ymer	protein_coding	Q8IVM0	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46790
8.62272894465601e-147	-1.81420885005746	0.437	0.988	1.59382521813022e-142	S100A10	cDCs	GSE162117_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46791
3.61573184207544e-139	-1.45404236380405	0.781	0.997	6.68331873689225e-135	HLA-DRB5	cDCs	GSE162117_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46792
3.13913752306337e-118	-0.763979653102053	1	1	5.80238179763033e-114	TPT1	cDCs	GSE162117_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46793
3.82025686062632e-114	-1.53871176143036	0.226	0.841	7.06136278118168e-110	FCER1A	cDCs	GSE162117_post	ENSG00000179639	2205	Fc epsilon receptor Ia	FCE1A|FcepsilonRIalpha|FCERIA	protein_coding	P12319	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46794
8.60124103015706e-108	1.05242882274787	0.777	0.145	1.58985339201423e-103	RPS4Y1	cDCs	GSE162117_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46795
2.90410820541173e-100	-0.95304234455925	0.612	0.957	5.36795360688304e-96	RPS26	cDCs	GSE162117_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46796
2.78481798017543e-94	0.778415713392313	1	1	5.14745755455626e-90	MALAT1	cDCs	GSE162117_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46797
4.64471974624555e-93	-0.781721415445188	0.026	0.55	8.58529997896028e-89	XIST	cDCs	GSE162117_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46798
1.68521864633076e-89	-0.508267186283647	1	1	3.11495814587778e-85	EEF1A1	cDCs	GSE162117_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46799
1.51064467524638e-85	-1.06322816941877	0.15	0.721	2.7922756177254e-81	GPR183	cDCs	GSE162117_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46800
3.13182657593523e-84	-0.577676082381461	1	1	5.78886824295868e-80	RPS4X	cDCs	GSE162117_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46801
4.3200413651659e-77	-0.81602211741227	0.297	0.823	7.98516445937266e-73	CPVL	cDCs	GSE162117_post	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46802
5.40544039131325e-76	-0.741466027543564	0.834	0.991	9.99141601930342e-72	GAPDH	cDCs	GSE162117_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46803
9.64009034894048e-76	-0.76154475632996	0.171	0.69	1.78187430009816e-71	CD48	cDCs	GSE162117_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46804
8.66475501664564e-74	1.47442781173498	0.786	0.404	1.60159331727678e-69	JUN	cDCs	GSE162117_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46805
1.13177088240983e-73	-0.725702683826876	0.823	0.985	2.09196529904633e-69	RPS10	cDCs	GSE162117_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46806
8.66864926113838e-71	-0.475406614298386	1	1	1.60231312942882e-66	RPS2	cDCs	GSE162117_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46807
6.45325698161544e-70	-0.485441734531669	1	1	1.1928200204818e-65	RPLP1	cDCs	GSE162117_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46808
4.85319396551375e-63	-0.851359496453516	0.86	0.992	8.97064372585562e-59	LYZ	cDCs	GSE162117_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46809
1.99335807480579e-62	-0.755418683403222	0.884	0.991	3.68452306547103e-58	S100A6	cDCs	GSE162117_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46810
5.56234048501836e-62	-0.644105985471114	0.089	0.518	1.02814301525079e-57	CEBPD	cDCs	GSE162117_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46811
4.39827275687354e-59	-0.373237200556475	1	1	8.12976736380504e-55	RPS14	cDCs	GSE162117_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46812
1.36296987213195e-57	-0.592216685964671	0.89	0.995	2.51931351164869e-53	RPLP0	cDCs	GSE162117_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46813
9.50161250525195e-57	-0.481324598150799	0.997	1	1.75627805547077e-52	RPL37A	cDCs	GSE162117_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46814
2.23081008705089e-54	-0.540633137479079	0.121	0.525	4.12342936490487e-50	ALDH2	cDCs	GSE162117_post	ENSG00000111275	217	aldehyde dehydrogenase 2 family member	NA	protein_coding	P05091	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46815
4.35533274915948e-54	-0.708937330123823	0.203	0.65	8.05039705354639e-50	CSTA	cDCs	GSE162117_post	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46816
1.34530918319229e-52	-0.691293735780924	0.466	0.823	2.48666949421263e-48	AP1S2	cDCs	GSE162117_post	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46817
1.45300899746596e-50	-0.669696461083203	0.903	0.965	2.68574183091609e-46	S100A4	cDCs	GSE162117_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46818
3.67686828665005e-50	0.72515775407461	0.971	0.94	6.79632334104395e-46	AIF1	cDCs	GSE162117_post	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46819
4.13621268511933e-48	-0.41926280112945	0.997	1	7.64537552717457e-44	RPL8	cDCs	GSE162117_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46820
1.22699812553666e-46	0.813240657343729	0.839	0.558	2.26798333524196e-42	TXNIP	cDCs	GSE162117_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46821
1.32298826891702e-46	-0.647655671466878	0.952	0.998	2.44541151626622e-42	HLA-DQB1	cDCs	GSE162117_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46822
1.63451742672059e-46	-0.669011969403089	0.069	0.41	3.02124201155033e-42	FCN1	cDCs	GSE162117_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46823
1.70158592710283e-46	-0.650264014250585	0.574	0.877	3.14521142765688e-42	ANXA2	cDCs	GSE162117_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46824
4.97214997210288e-46	-0.483516231342564	0.026	0.333	9.19052200843497e-42	NR4A1	cDCs	GSE162117_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46825
1.01357158916989e-45	-0.464392609094669	0.069	0.41	1.87348572542163e-41	ENHO	cDCs	GSE162117_post	ENSG00000168913	375704	energy homeostasis associated	C9orf165|UNQ470	protein_coding	Q6UWT2	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46826
1.65948100004415e-44	0.429934668143824	1	1	3.06738468048161e-40	TMSB4X	cDCs	GSE162117_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46827
3.06495338566931e-44	-0.377841416572424	0.998	1	5.66525983807115e-40	RPS11	cDCs	GSE162117_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46828
9.51579652475257e-44	-0.710706261636043	0.47	0.789	1.75889982963527e-39	DBI	cDCs	GSE162117_post	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46829
1.1273780705605e-42	-0.641990483974175	0.443	0.767	2.08384562562404e-38	TSPO	cDCs	GSE162117_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46830
8.86136892993056e-42	-0.570420013962947	0.236	0.604	1.63793543300837e-37	PHACTR1	cDCs	GSE162117_post	ENSG00000112137	221692	phosphatase and actin regulator 1	dJ257A7.2|KIAA1733|RPEL1	protein_coding	Q9C0D0	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46831
6.56711510252445e-41	-0.337351790747033	1	1	1.21386555555062e-36	RPS16	cDCs	GSE162117_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46832
9.83769852371627e-41	-0.397113945442102	0.035	0.324	1.81840019512371e-36	PLBD1	cDCs	GSE162117_post	ENSG00000121316	79887	phospholipase B domain containing 1	FLJ22662	protein_coding	Q6P4A8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46833
5.70249717373963e-40	-0.383632122808458	0.99	1	1.05404957759403e-35	RPL7A	cDCs	GSE162117_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46834
7.03022820609534e-40	-0.462497580048852	0.158	0.507	1.29946738161466e-35	KLF4	cDCs	GSE162117_post	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46835
1.35740538017522e-39	-0.499224559216985	0.287	0.65	2.50902810471588e-35	ANXA5	cDCs	GSE162117_post	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46836
1.35210139538671e-38	-0.533975865584946	0.199	0.544	2.49922421923279e-34	NR4A2	cDCs	GSE162117_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46837
1.44716209327621e-38	-0.361566533384373	1	1	2.67493441321175e-34	RPL37	cDCs	GSE162117_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46838
1.79846117386713e-38	-0.689609062910354	0.941	0.992	3.32427563377599e-34	VIM	cDCs	GSE162117_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46839
3.53101999490367e-38	-0.484816096462995	0.166	0.498	6.52673735857995e-34	HERPUD1	cDCs	GSE162117_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46840
3.81971640492439e-38	-0.369175887906006	1	1	7.06036380286224e-34	RPS28	cDCs	GSE162117_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46841
4.58670182170452e-38	-0.394343832286548	0.987	1	8.47805964723863e-34	RPL5	cDCs	GSE162117_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46842
4.74794733146997e-37	-0.310180232711748	1	1	8.7761058474891e-33	RPS3A	cDCs	GSE162117_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46843
5.83599108573193e-37	-0.604958988960918	0.278	0.629	1.07872459228669e-32	CD1C	cDCs	GSE162117_post	ENSG00000158481	911	CD1c molecule	CD1	protein_coding	P29017	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46844
2.00081606242728e-36	-0.379297152689547	0.986	1	3.69830840979059e-32	RPL22	cDCs	GSE162117_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46845
9.69746532046667e-35	-0.482398318138787	0.759	0.969	1.79247948983506e-30	SLC25A6	cDCs	GSE162117_post	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46846
2.41839870866504e-34	0.596504744514573	0.745	0.476	4.47016817309646e-30	IFITM2	cDCs	GSE162117_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46847
1.79287612944396e-32	-0.308508471895947	1	1	3.31395223766421e-28	RPL15	cDCs	GSE162117_post	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46848
4.74690360467691e-32	-0.583143942587758	0.297	0.598	8.77417662288481e-28	ARL4C	cDCs	GSE162117_post	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46849
7.46043251848201e-32	-0.357671279971869	0.059	0.316	1.37898634671621e-27	FCGR2B	cDCs	GSE162117_post	ENSG00000072694	2213	Fc gamma receptor IIb	CD32|CD32B|FCG2|FcgammaRIIb|FCGR2|FcGRIIB	protein_coding	P31994	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46850
3.40132017708296e-31	-0.536277732911548	0.27	0.582	6.28700021532014e-27	RP11-1143G9.4	cDCs	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46851
5.63177254284164e-31	-0.455482273053323	0.464	0.744	1.04097683681885e-26	EIF3L	cDCs	GSE162117_post	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46852
7.87280423382817e-31	-0.385124313499124	1	1	1.4552091345808e-26	MT-CO3	cDCs	GSE162117_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46853
2.00673620984995e-30	-1.07286625146686	0.466	0.698	3.70925121028664e-26	S100A9	cDCs	GSE162117_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46854
4.01257135855981e-30	-0.409174056405544	0.986	0.998	7.41683689916195e-26	MT-ND1	cDCs	GSE162117_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46855
5.0119656123655e-30	0.292498821064279	1	1	9.26411723789639e-26	RPS19	cDCs	GSE162117_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46856
5.20894574776865e-30	-0.27275868114087	1	1	9.62821532017557e-26	RPL19	cDCs	GSE162117_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46857
5.87794220000661e-30	-0.254041313696594	1	1	1.08647883624922e-25	RPL28	cDCs	GSE162117_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46858
1.40783946135769e-29	-0.316240644844474	1	1	2.60225046037355e-25	RPL3	cDCs	GSE162117_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46859
1.67227681768005e-29	-0.414432113410832	0.734	0.921	3.09103646979981e-25	TOMM7	cDCs	GSE162117_post	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46860
2.00766696294632e-29	-0.394363392509963	0.169	0.462	3.71097161430998e-25	MYADM	cDCs	GSE162117_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46861
3.3932197787521e-29	-0.660831114542475	0.293	0.569	6.27202743904538e-25	CXCR4	cDCs	GSE162117_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46862
3.85185507484894e-29	-0.428900563377716	0.193	0.493	7.11976892035078e-25	LGALS3	cDCs	GSE162117_post	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46863
9.44456619631307e-29	-0.45420974341057	0.075	0.324	1.74573361572651e-24	VCAN	cDCs	GSE162117_post	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46864
9.73623602676193e-29	-0.6153889095276	0.585	0.826	1.79964586718667e-24	LGALS2	cDCs	GSE162117_post	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46865
1.14423320647847e-28	-0.371257375821399	0.96	0.995	2.1150006588548e-24	RPS21	cDCs	GSE162117_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46866
2.07260547882613e-28	-0.540236282598889	0.179	0.456	3.83100396706221e-24	CRIP1	cDCs	GSE162117_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46867
7.42808819925804e-28	-0.697119724051567	0.426	0.69	1.37300782275086e-23	ID2	cDCs	GSE162117_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46868
3.01662106197673e-27	-0.322678896366098	0.979	0.997	5.57592237095778e-23	NACA	cDCs	GSE162117_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46869
5.02051492133635e-27	0.642110196089378	0.954	0.951	9.27991978059811e-23	FCER1G	cDCs	GSE162117_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46870
6.4974679270362e-27	-0.553729553494855	0.287	0.564	1.20099197163337e-22	RGS2	cDCs	GSE162117_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46871
1.13334911207948e-26	-0.398546918213493	0.088	0.327	2.09488249876771e-22	CTA-29F11.1	cDCs	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46872
3.061740461185e-26	0.281379979096937	1	1	5.65932106845436e-22	B2M	cDCs	GSE162117_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46873
1.07912714787319e-25	-0.418395800541307	0.464	0.726	1.9946586201288e-21	SLC25A3	cDCs	GSE162117_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46874
1.3747877589389e-25	0.533292135515231	0.553	0.308	2.54115769362267e-21	FAM65B	cDCs	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46875
1.38283593297791e-25	0.549324044687611	0.365	0.12	2.55603393851638e-21	LTB	cDCs	GSE162117_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46876
1.77029783727008e-25	-0.356704118575149	0.866	0.986	3.27221852241002e-21	BTF3	cDCs	GSE162117_post	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46877
2.67070028551688e-25	-0.375224173644538	0.874	0.98	4.93652240774941e-21	EEF1B2	cDCs	GSE162117_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46878
6.39420303322351e-25	-0.261315389952883	1	1	1.18190448866103e-20	RPS7	cDCs	GSE162117_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46879
9.10352370026998e-25	-0.436969431971214	0.22	0.482	1.6826953207579e-20	MAP3K8	cDCs	GSE162117_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46880
1.20615975652552e-24	-0.281122959208247	0.994	1	2.22946569396177e-20	RPL18	cDCs	GSE162117_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46881
1.55211185929332e-24	-0.374590626303426	0.118	0.367	2.86892356071778e-20	SGK1	cDCs	GSE162117_post	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46882
1.56177066959762e-24	0.472656939139165	0.909	0.857	2.88677690568425e-20	DDX5	cDCs	GSE162117_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46883
2.19732226007069e-24	-0.498550994945208	0.767	0.892	4.06153046551467e-20	JUNB	cDCs	GSE162117_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46884
2.86208736176567e-24	-0.278227729812521	0.056	0.267	5.29028227948767e-20	IGFBP7	cDCs	GSE162117_post	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46885
4.27448390311896e-24	-0.312141467007907	0.121	0.367	7.90095604652508e-20	FGR	cDCs	GSE162117_post	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46886
4.5946891690759e-24	-0.28104197686265	0.994	1	8.49282346011989e-20	RPL23	cDCs	GSE162117_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46887
5.12728599930437e-23	0.605327988101039	0.6	0.351	9.47727544111419e-19	IFITM3	cDCs	GSE162117_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46888
7.77914195901127e-23	-0.301998219347769	0.107	0.336	1.43789659970364e-18	OGFRL1	cDCs	GSE162117_post	ENSG00000119900	79627	opioid growth factor receptor like 1	dJ331H24.1	protein_coding	Q5TC84	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46889
1.03917596116666e-22	-0.362545342239582	0.657	0.846	1.92081284662046e-18	LSP1	cDCs	GSE162117_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46890
3.99639034356218e-22	-0.324916521762236	0.156	0.402	7.38692791104033e-18	IFI30	cDCs	GSE162117_post	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46891
2.21046731924394e-21	0.528587185056913	0.456	0.225	4.08582779289051e-17	PLAC8	cDCs	GSE162117_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46892
2.36832683833106e-21	0.542767095690867	0.791	0.641	4.37761532797113e-17	KLF6	cDCs	GSE162117_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46893
2.57925605292441e-21	-0.370492755084506	0.931	0.992	4.76749688822548e-17	ACTG1	cDCs	GSE162117_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46894
2.64297923009363e-21	0.631466953052976	0.898	0.812	4.88528280890507e-17	SAT1	cDCs	GSE162117_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46895
6.54771977657158e-21	-0.312113805060407	0.086	0.29	1.21028052350149e-16	BHLHE40	cDCs	GSE162117_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46896
1.12680309379611e-20	-0.358281076343982	0.874	0.957	2.08278283857273e-16	HLA-C	cDCs	GSE162117_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46897
1.42723909809019e-20	0.438090607063314	0.608	0.404	2.63810874890991e-16	IFI16	cDCs	GSE162117_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46898
2.08278149116143e-20	0.50580270396581	0.333	0.117	3.84981330826279e-16	PPBP	cDCs	GSE162117_post	ENSG00000163736	5473	pro-platelet basic protein	b-TG1|Beta-TG|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|NAP-2-L1|PBP|SCYB7|TGB|TGB1|THBGB1	protein_coding	P02775	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46899
2.35727726864084e-20	-0.413484873487777	0.477	0.712	4.35719130335572e-16	MNDA	cDCs	GSE162117_post	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46900
3.2787048177755e-20	0.421818637754623	0.962	0.938	6.06035798517623e-16	MT-ND5	cDCs	GSE162117_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46901
3.67022125182568e-20	0.425461732493557	0.364	0.151	6.78403696187459e-16	OFD1	cDCs	GSE162117_post	ENSG00000046651	8481	OFD1 centriole and centriolar satellite protein	71-7A|CXorf5|JBTS10|RP23	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46902
4.23638622514882e-20	-0.35739589110159	0.774	0.915	7.83053629856508e-16	S100A11	cDCs	GSE162117_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46903
8.32372018341524e-20	-0.268772666529414	0.973	0.997	1.53855643870247e-15	HLA-B	cDCs	GSE162117_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46904
2.08004311362212e-19	0.413966275398261	0.729	0.538	3.84475169121913e-15	PNRC1	cDCs	GSE162117_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46905
2.33308111837383e-19	-0.28827836787418	0.217	0.459	4.31246713920219e-15	PRCP	cDCs	GSE162117_post	ENSG00000137509	5547	prolylcarboxypeptidase	HUMPCP|PCP	protein_coding	P42785	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46906
2.60301351975788e-19	-0.356752830460627	0.293	0.521	4.81141018992047e-15	CAST	cDCs	GSE162117_post	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46907
3.05153447103754e-19	-0.301936770338781	0.947	0.994	5.64045631626579e-15	RPSA	cDCs	GSE162117_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46908
5.36914992441261e-19	0.299966480824427	0.254	0.074	9.92433672028426e-15	DHRS9	cDCs	GSE162117_post	ENSG00000073737	10170	dehydrogenase/reductase 9	3alpha-HSD|RDH15|RDHL|RETSDR8|SDR9C4	protein_coding	Q9BPW9	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46909
7.20658928156403e-19	-0.328244451744075	0.821	0.969	1.3320659628043e-14	HLA-DMA	cDCs	GSE162117_post	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46910
1.13567461893129e-18	-0.329176518256798	0.499	0.723	2.0991809656326e-14	SMDT1	cDCs	GSE162117_post	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46911
1.25947309622438e-18	-0.330696681544309	0.88	0.965	2.32801007106115e-14	TYROBP	cDCs	GSE162117_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46912
1.26612980633083e-18	-0.305156228671965	0.877	0.965	2.34031433402191e-14	COX4I1	cDCs	GSE162117_post	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46913
3.39511426975993e-18	-0.268786782344549	0.939	0.991	6.27552921622426e-14	RPL4	cDCs	GSE162117_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46914
6.48290329845445e-18	-0.38965915176242	0.282	0.507	1.19829984568632e-13	GADD45B	cDCs	GSE162117_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46915
1.31443759219306e-17	-0.282935754528047	0.185	0.398	2.42960644540964e-13	TGFBI	cDCs	GSE162117_post	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46916
2.33026131603255e-17	-0.317544612724593	0.376	0.59	4.30725501655456e-13	ATP5A1	cDCs	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46917
2.37173011846165e-17	-0.29990845522972	0.364	0.616	4.38390595096451e-13	PPA1	cDCs	GSE162117_post	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46918
2.61717561573148e-17	-0.34037276670817	0.608	0.86	4.83758740811807e-13	ANXA1	cDCs	GSE162117_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46919
3.48023279041986e-17	-0.312627103427557	0.278	0.504	6.43286228981206e-13	CD44	cDCs	GSE162117_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46920
5.13944840680649e-17	-0.311851061532913	0.565	0.764	9.49975643514111e-13	COX8A	cDCs	GSE162117_post	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46921
8.79248513354362e-17	-0.347752297073767	0.722	0.9	1.6252029520842e-12	HNRNPA1	cDCs	GSE162117_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46922
1.17446890368671e-16	-0.315098706913528	0.667	0.867	2.17088832157451e-12	COMMD6	cDCs	GSE162117_post	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46923
2.23331565790734e-16	0.357325837107392	0.421	0.225	4.12806066207593e-12	ITGA4	cDCs	GSE162117_post	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46924
3.07988147809092e-16	0.385150147134072	0.909	0.852	5.69285292410326e-12	UBC	cDCs	GSE162117_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46925
4.52932196588286e-16	0.390306232980396	0.383	0.193	8.37199872173788e-12	MARCKS	cDCs	GSE162117_post	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46926
4.72860324037558e-16	-0.26945897158168	0.402	0.633	8.74035022951023e-12	RNH1	cDCs	GSE162117_post	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46927
5.24691756477632e-16	-0.31372927630203	0.802	0.935	9.69840242673255e-12	SRGN	cDCs	GSE162117_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46928
1.783576184979e-15	0.389050019103615	0.869	0.824	3.29676222031518e-11	DUSP1	cDCs	GSE162117_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46929
2.11879761221533e-15	0.305883400997262	0.994	1	3.91638550641881e-11	HLA-DPA1	cDCs	GSE162117_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46930
2.33078159451325e-15	-0.263731489193423	0.185	0.384	4.3082166992983e-11	CAPN2	cDCs	GSE162117_post	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46931
2.37544398267609e-15	-0.274645126402546	0.265	0.476	4.39077065757849e-11	RAB31	cDCs	GSE162117_post	ENSG00000168461	11031	RAB31, member RAS oncogene family	Rab22B	protein_coding	Q13636	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46932
2.76331987848092e-15	-0.272175059690263	0.284	0.498	5.10772046338413e-11	PTRHD1	cDCs	GSE162117_post	ENSG00000184924	391356	peptidyl-tRNA hydrolase domain containing 1	C2orf79|LOC391356	protein_coding	Q6GMV3	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46933
3.65737402356367e-15	-0.318255555676603	0.359	0.559	6.7602901451551e-11	PKM	cDCs	GSE162117_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46934
3.844529513031e-15	-0.269315405551022	0.239	0.448	7.10622835188651e-11	CASP1	cDCs	GSE162117_post	ENSG00000137752	834	caspase 1	ICE|IL1BC	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46935
7.79190027008008e-15	-0.266968509081243	0.71	0.895	1.4402548459216e-10	EIF3K	cDCs	GSE162117_post	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46936
1.01541801431357e-14	-0.276699982503332	0.563	0.757	1.8768986576572e-10	GRN	cDCs	GSE162117_post	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46937
1.31347257804267e-14	-0.759710576698848	0.305	0.492	2.42782271325407e-10	S100A8	cDCs	GSE162117_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46938
1.39651263279231e-14	-0.300867735585974	0.659	0.832	2.58131395045331e-10	EEF2	cDCs	GSE162117_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46939
1.4145094436781e-14	0.368767574652846	0.809	0.721	2.6145792556946e-10	PSAP	cDCs	GSE162117_post	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46940
1.81348779477444e-14	0.480045760131321	1	1	3.35205083986107e-10	CST3	cDCs	GSE162117_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46941
1.98527356466486e-14	0.31811162284585	0.959	0.934	3.66957965692653e-10	MYL12A	cDCs	GSE162117_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46942
2.28389980870473e-14	0.374802721726172	0.351	0.171	4.22156040640983e-10	NKG7	cDCs	GSE162117_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46943
2.44316877803764e-14	-0.336378587635367	0.203	0.407	4.51595316932478e-10	IL1B	cDCs	GSE162117_post	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46944
2.64122922934673e-14	0.294745463536588	0.305	0.136	4.8820481075245e-10	PKIB	cDCs	GSE162117_post	ENSG00000135549	5570	cAMP-dependent protein kinase inhibitor beta	PRKACN2	protein_coding	Q9C010	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46945
4.18934259411558e-14	-0.273700913921223	0.187	0.371	7.74358085096323e-10	PTGER4	cDCs	GSE162117_post	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46946
6.92172405157288e-14	-0.2505264963855	0.179	0.364	1.27941147369273e-09	PLD4	cDCs	GSE162117_post	ENSG00000166428	122618	phospholipase D family member 4	C14orf175	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46947
8.74799383340923e-14	-0.257239116306545	0.276	0.476	1.61697918016736e-09	EIF4B	cDCs	GSE162117_post	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46948
9.49810031720457e-14	-0.289910541229274	0.459	0.661	1.75562886263209e-09	LAPTM5	cDCs	GSE162117_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46949
1.23686870746298e-13	0.371497218421151	0.847	0.777	2.28622811887457e-09	TPM3	cDCs	GSE162117_post	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46950
1.51568077016324e-13	-0.33442451288657	0.923	0.986	2.80158433556974e-09	HLA-DQA1	cDCs	GSE162117_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46951
1.73094158481894e-13	-0.373825135784697	0.172	0.348	3.19947242537933e-09	LMNA	cDCs	GSE162117_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46952
1.91290851953845e-13	-0.271938726650028	0.589	0.775	3.53582010751487e-09	SLC25A5	cDCs	GSE162117_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46953
2.62828334170454e-13	-0.251703414593299	0.509	0.727	4.85811892880667e-09	FCGRT	cDCs	GSE162117_post	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46954
2.74738460925117e-13	0.394850294538643	0.346	0.18	5.07826571173986e-09	IFI6	cDCs	GSE162117_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46955
2.90860034570139e-13	0.314093638531518	0.526	0.348	5.37625687899445e-09	N4BP2L2	cDCs	GSE162117_post	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46956
3.6494792632943e-13	-0.250175986610369	0.396	0.607	6.74569747027319e-09	CAPG	cDCs	GSE162117_post	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46957
1.19966397739876e-12	0.326301226580453	0.668	0.521	2.21745889582388e-08	MEF2C	cDCs	GSE162117_post	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46958
2.60685531029145e-12	0.286079262361922	0.254	0.106	4.81851135554272e-08	DUSP6	cDCs	GSE162117_post	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46959
3.28249034935456e-12	0.313169662530252	0.748	0.626	6.06735516174697e-08	RNASET2	cDCs	GSE162117_post	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46960
4.03888287785965e-12	-0.413647485643143	0.343	0.525	7.46547111143578e-08	MS4A6A	cDCs	GSE162117_post	ENSG00000110077	64231	membrane spanning 4-domains A6A	CD20L3|MS4A6	protein_coding	Q9H2W1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46961
4.03962025857071e-12	-0.303563035287967	0.199	0.37	7.46683408594209e-08	DUSP2	cDCs	GSE162117_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46962
4.49590605244762e-12	0.317799704465882	0.766	0.622	8.31023274734418e-08	ZFAS1	cDCs	GSE162117_post	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46963
8.02430221593223e-12	0.351481515738801	0.927	0.904	1.48321202159291e-07	CALM2	cDCs	GSE162117_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46964
1.17502177486038e-11	-0.28345212492857	0.394	0.569	2.17191024865193e-07	ATP5B	cDCs	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46965
2.06175151632287e-11	-0.276370976484742	0.263	0.433	3.81094150277119e-07	PLAUR	cDCs	GSE162117_post	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46966
2.41202137169228e-11	0.265481726252537	0.876	0.858	4.45838030343601e-07	RPL36AL	cDCs	GSE162117_post	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46967
2.52138706303591e-11	-0.252475994543862	0.718	0.863	4.66053184731558e-07	EIF4A1	cDCs	GSE162117_post	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46968
7.89899324660306e-11	0.305407910665296	0.636	0.496	1.46004991170211e-06	MORF4L1	cDCs	GSE162117_post	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46969
8.95014188727037e-11	0.294525234638165	0.349	0.196	1.65434422644305e-06	NCF1	cDCs	GSE162117_post	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46970
1.97984113681472e-10	-0.316641200367199	0.557	0.701	3.65953835728832e-06	TAGLN2	cDCs	GSE162117_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46971
3.95242360886283e-10	-0.272175059690263	0.191	0.337	7.30565979862206e-06	IRF1	cDCs	GSE162117_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46972
7.35368938370724e-10	0.29873406849481	0.781	0.718	1.35925594568445e-05	PTPRC	cDCs	GSE162117_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46973
7.56223345840404e-10	0.272402095338972	0.359	0.219	1.3978032324514e-05	EMB	cDCs	GSE162117_post	ENSG00000170571	133418	embigin	MGC71745	protein_coding	Q6PCB8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46974
1.32880124595242e-09	0.280876742257248	0.614	0.478	2.45615622301846e-05	SEPT7	cDCs	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46975
8.64699726451122e-09	0.289387008450816	0.877	0.834	0.000159831097437225	HLA-A	cDCs	GSE162117_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46976
1.1688817372997e-08	0.29925411182983	0.968	0.974	0.000216056100322476	FOS	cDCs	GSE162117_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46977
1.24963911199516e-08	0.377621371606443	0.388	0.251	0.000230983293461185	ISG15	cDCs	GSE162117_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46978
3.3137115026705e-08	0.254111533703286	0.633	0.513	0.000612506434153615	SH3BGRL	cDCs	GSE162117_post	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46979
3.58328955909173e-08	0.2558364874643	0.954	0.935	0.000662335242102515	LST1	cDCs	GSE162117_post	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46980
4.33114569665186e-08	0.259586045890264	0.738	0.63	0.00080056897056913	LCP1	cDCs	GSE162117_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46981
5.42743899338781e-08	0.276805249071969	0.378	0.251	0.0010032078235378	C12orf57	cDCs	GSE162117_post	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46982
8.97222083054163e-08	0.326514814036327	0.646	0.579	0.00165842529831731	CKLF	cDCs	GSE162117_post	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46983
1.90336620897249e-07	0.284473159436479	0.373	0.257	0.00351818210066476	RP11-386I14.4	cDCs	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46984
2.53002138555061e-07	0.279748955493829	0.777	0.775	0.00467649152905175	NPM1	cDCs	GSE162117_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46985
1.85070245134993e-06	0.306469717274415	1	1	0.0342083841107521	FTL	cDCs	GSE162117_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46986
2.31465546708999e-06	0.284856508283101	0.254	0.153	0.0427840916536914	CCL5	cDCs	GSE162117_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46987
1.36564012826492e-15	1.61367379736268	0.73	0.252	2.52424921308487e-11	HLA-DRB1	Erythrocytes	GSE162117_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46988
3.45242410619708e-14	-1.06441672849577	0.513	0.843	6.38146071789468e-10	RPS26	Erythrocytes	GSE162117_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46989
2.82049495601622e-13	1.66985139830767	0.739	0.339	5.21340287670039e-09	HLA-DRA	Erythrocytes	GSE162117_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46990
4.48690162862235e-13	1.63346101841235	0.67	0.261	8.29358897034556e-09	HLA-DPA1	Erythrocytes	GSE162117_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46991
5.20133827941347e-13	1.2910821279346	0.722	0.287	9.61415367566785e-09	HLA-DPB1	Erythrocytes	GSE162117_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46992
6.67991312415008e-13	0.838478346592434	0.991	0.983	1.2347151418679e-08	TMSB4X	Erythrocytes	GSE162117_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46993
7.18687001067847e-13	0.982273831103627	0.974	0.878	1.32842105277381e-08	ACTB	Erythrocytes	GSE162117_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46994
9.90527456429528e-13	0.769892993179698	0.991	0.991	1.83089095046434e-08	B2M	Erythrocytes	GSE162117_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46995
3.16565849816857e-12	1.46369544495654	0.687	0.313	5.85140316801478e-08	FCER1G	Erythrocytes	GSE162117_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46996
3.57615041000907e-12	1.6316557361692	0.739	0.365	6.61015641786077e-08	CST3	Erythrocytes	GSE162117_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46997
4.11133534974105e-12	1.4943007778035	0.809	0.487	7.59939226046137e-08	FOS	Erythrocytes	GSE162117_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46998
1.96468517322832e-11	1.06950451029795	0.722	0.278	3.63152407419522e-07	LST1	Erythrocytes	GSE162117_post	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	46999
2.79368779666585e-11	0.667855509069501	0.957	0.887	5.16385252335717e-07	SERF2	Erythrocytes	GSE162117_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47000
4.46844696493838e-11	0.801564833854091	0.843	0.496	8.25947736999209e-07	UBC	Erythrocytes	GSE162117_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47001
4.96875186230853e-11	0.872331474850747	0.878	0.6	9.18424094229108e-07	CYBA	Erythrocytes	GSE162117_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47002
5.24510436388328e-11	0.836788342644123	0.8	0.417	9.69505090620185e-07	HCST	Erythrocytes	GSE162117_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47003
5.6887303905554e-11	0.795104030217728	0.939	0.739	1.05150492539026e-06	OAZ1	Erythrocytes	GSE162117_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47004
7.21347515279153e-11	1.46358924411095	0.696	0.348	1.33333874724199e-06	CTSS	Erythrocytes	GSE162117_post	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47005
7.84462338338906e-11	1.33026739580009	0.687	0.33	1.45000018618563e-06	AIF1	Erythrocytes	GSE162117_post	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47006
8.34355614675789e-11	1.31354030939464	0.757	0.435	1.54222291816673e-06	CD74	Erythrocytes	GSE162117_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47007
9.6035733452073e-11	0.794576317336301	0.67	0.304	1.77512449712812e-06	ARPC1B	Erythrocytes	GSE162117_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47008
1.28723868783247e-10	0.96636922211872	0.757	0.391	2.37933199058953e-06	SRGN	Erythrocytes	GSE162117_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47009
2.55422651981341e-10	-1.33686863717343	0.983	1	4.72123229922311e-06	HBA1	Erythrocytes	GSE162117_post	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47010
5.00631741728304e-10	1.28540221886225	0.548	0.191	9.25367711410596e-06	CFD	Erythrocytes	GSE162117_post	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47011
5.30184943507346e-10	0.861363024542512	0.739	0.383	9.79993849578979e-06	CALM2	Erythrocytes	GSE162117_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47012
8.29928118812861e-10	-1.0389189892923	0.096	0.435	1.53403913481369e-05	NUDT4	Erythrocytes	GSE162117_post	ENSG00000173598	11163	nudix hydrolase 4	DIPP2|DIPP2alpha|DIPP2beta|HDCMB47P|KIAA0487	protein_coding	Q9NZJ9	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47013
8.86129240298177e-10	0.903367529044821	0.965	0.748	1.63792128776715e-05	S100A4	Erythrocytes	GSE162117_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47014
1.20584459338456e-09	-3.33143038839713	0.391	0.687	2.22888314641203e-05	HBG2	Erythrocytes	GSE162117_post	ENSG00000196565	3048	hemoglobin subunit gamma 2	HBG-T1	protein_coding	P69892	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47015
1.66500359503215e-09	1.24188859696225	0.704	0.357	3.07759264505742e-05	TYROBP	Erythrocytes	GSE162117_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47016
2.84906512457027e-09	0.968597900860866	0.722	0.391	5.26621197625568e-05	DUSP1	Erythrocytes	GSE162117_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47017
3.49416345635863e-09	0.736965594166206	0.861	0.6	6.4586117327333e-05	SH3BGRL3	Erythrocytes	GSE162117_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47018
3.63737395477373e-09	0.618570893363976	0.948	0.704	6.72332201800376e-05	PFN1	Erythrocytes	GSE162117_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47019
6.62563841492191e-09	0.625039940096491	0.548	0.191	0.000122468300461417	PYCARD	Erythrocytes	GSE162117_post	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47020
7.4814011574679e-09	0.839535327806754	0.539	0.2	0.000138286218994637	TYMP	Erythrocytes	GSE162117_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47021
1.03717565694716e-08	0.756505780561851	0.965	0.904	0.000191711548430112	HLA-B	Erythrocytes	GSE162117_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47022
1.21935416899319e-08	-0.850856560694191	0.357	0.652	0.000225385424596701	GYPC	Erythrocytes	GSE162117_post	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47023
1.3214699825929e-08	0.777607578663552	0.478	0.139	0.000244260511582471	MS4A6A	Erythrocytes	GSE162117_post	ENSG00000110077	64231	membrane spanning 4-domains A6A	CD20L3|MS4A6	protein_coding	Q9H2W1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47024
3.45300456584422e-08	-2.65167383292041	0.435	0.67	0.000638253363950646	HBG1	Erythrocytes	GSE162117_post	ENSG00000213934	3047	hemoglobin subunit gamma 1	HBG-T2	protein_coding	P69891	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47025
3.63454019548679e-08	0.7079733908265	0.643	0.287	0.000671808409733779	COTL1	Erythrocytes	GSE162117_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47026
4.38203340499099e-08	0.478653598574815	0.348	0.061	0.000809975054578535	LAP3	Erythrocytes	GSE162117_post	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47027
4.75764486563669e-08	0.641889568805992	0.73	0.443	0.000879403076964286	SAT1	Erythrocytes	GSE162117_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47028
4.98515733661408e-08	0.398549376490275	0.452	0.122	0.000921456482099747	ACTR2	Erythrocytes	GSE162117_post	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47029
5.42732491790795e-08	0.679903720129609	0.991	0.948	0.00100318673782611	TMSB10	Erythrocytes	GSE162117_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47030
8.53568878995441e-08	0.893084796083488	0.661	0.365	0.00157773671593517	PSAP	Erythrocytes	GSE162117_post	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47031
1.10842677370433e-07	0.469885976274463	0.539	0.226	0.00204881604851509	ISG15	Erythrocytes	GSE162117_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47032
1.37430123373785e-07	0.651513693629762	0.783	0.522	0.00254025840044104	CFL1	Erythrocytes	GSE162117_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47033
1.43307102828715e-07	0.409520494311278	0.426	0.113	0.00264888848868598	SPI1	Erythrocytes	GSE162117_post	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47034
1.50638003974335e-07	0.720957717965814	0.504	0.2	0.0027843928654616	IFI6	Erythrocytes	GSE162117_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47035
1.5321834002687e-07	0.555646933896601	0.974	0.957	0.00283208779705666	RPS24	Erythrocytes	GSE162117_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47036
1.95027605738763e-07	0.496675968303201	0.47	0.148	0.0036048902644753	FGL2	Erythrocytes	GSE162117_post	ENSG00000127951	10875	fibrinogen like 2	pT49|T49	protein_coding	Q14314	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47037
2.01429705231431e-07	-0.943676393270384	0.461	0.73	0.00372322667149777	SLC25A37	Erythrocytes	GSE162117_post	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47038
2.07353704846233e-07	0.652076696579693	0.635	0.33	0.00383272588037778	TPM3	Erythrocytes	GSE162117_post	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47039
2.13459458930554e-07	0.66347452889968	0.478	0.157	0.00394558463887235	IFITM3	Erythrocytes	GSE162117_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47040
2.54051442592195e-07	0.647045009492013	0.783	0.557	0.00469588686487414	ARPC3	Erythrocytes	GSE162117_post	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47041
2.62811694864252e-07	0.675160309692735	0.861	0.722	0.00485781136787084	H3F3B	Erythrocytes	GSE162117_post	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47042
3.1766825938067e-07	0.658740426860704	0.739	0.478	0.0058717801063923	EMP3	Erythrocytes	GSE162117_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47043
3.30063944812593e-07	-0.501061243112211	0.026	0.261	0.00610090195591596	HBQ1	Erythrocytes	GSE162117_post	ENSG00000086506	3049	hemoglobin subunit theta 1	HBQ	protein_coding	P09105	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47044
4.00659577150154e-07	0.492239308362737	0.939	0.748	0.00740579162404344	PFDN5	Erythrocytes	GSE162117_post	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47045
4.06001322053568e-07	0.582180060049829	0.652	0.339	0.00750452843683814	EIF4A1	Erythrocytes	GSE162117_post	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47046
4.58799949788507e-07	0.569760094077486	0.609	0.304	0.00848045827189077	LCP1	Erythrocytes	GSE162117_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47047
5.57026182643752e-07	0.808573929346766	0.557	0.27	0.0102960719599871	NPC2	Erythrocytes	GSE162117_post	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47048
6.81757265083484e-07	0.780092842053147	0.748	0.409	0.0126016012878031	LGALS1	Erythrocytes	GSE162117_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47049
6.83634818549984e-07	0.519608762727057	0.504	0.209	0.0126363059860779	CARD16	Erythrocytes	GSE162117_post	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47050
6.96099276442528e-07	0.365284464081744	0.252	0.026	0.0128666990257637	IFI44L	Erythrocytes	GSE162117_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47051
6.98219091157522e-07	0.660025449695184	0.626	0.313	0.0129058816809556	KLF6	Erythrocytes	GSE162117_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47052
7.91739298985341e-07	0.599559876934114	0.817	0.522	0.014634509202445	GPX1	Erythrocytes	GSE162117_post	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47053
8.67203100877577e-07	0.409390936137702	0.348	0.078	0.0160293821166211	IGSF6	Erythrocytes	GSE162117_post	ENSG00000283934	10261	immunoglobulin superfamily member 6	DORA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47054
8.72856420545434e-07	-0.966313523259517	1	1	0.0161338780773618	HBA2	Erythrocytes	GSE162117_post	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47055
8.87987358725655e-07	-1.24911965925517	0.339	0.591	0.016413558338685	AHSP	Erythrocytes	GSE162117_post	ENSG00000169877	51327	alpha hemoglobin stabilizing protein	EDRF|ERAF	protein_coding	Q9NZD4	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47056
9.35195124285905e-07	0.353636954614701	0.357	0.087	0.0172861466773007	HSBP1	Erythrocytes	GSE162117_post	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47057
9.76803850551031e-07	0.632857190825467	0.47	0.174	0.0180552423735852	MNDA	Erythrocytes	GSE162117_post	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47058
1.21119273408335e-06	0.467778961350817	0.47	0.174	0.0223876864967966	ENY2	Erythrocytes	GSE162117_post	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47059
1.37802029064554e-06	1.04564266555571	0.357	0.096	0.0254713270522922	PPBP	Erythrocytes	GSE162117_post	ENSG00000163736	5473	pro-platelet basic protein	b-TG1|Beta-TG|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|NAP-2-L1|PBP|SCYB7|TGB|TGB1|THBGB1	protein_coding	P02775	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47060
1.39799513915959e-06	0.484121811214329	0.548	0.226	0.0258405421522259	RPS4Y1	Erythrocytes	GSE162117_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47061
1.47981854030157e-06	0.584962500721156	0.33	0.078	0.0273529658989342	MS4A7	Erythrocytes	GSE162117_post	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47062
1.53601492260822e-06	0.647118976783725	0.548	0.278	0.0283916998294903	TIMP1	Erythrocytes	GSE162117_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47063
1.55895095855351e-06	0.642610159720972	0.417	0.148	0.0288156495179032	SERPINA1	Erythrocytes	GSE162117_post	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47064
1.56390812578581e-06	0.450392775726806	0.383	0.113	0.0289072777970249	GLRX	Erythrocytes	GSE162117_post	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47065
1.75891039519311e-06	0.561629996890533	0.896	0.757	0.0325116997447495	HLA-A	Erythrocytes	GSE162117_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47066
1.91750913375098e-06	0.461331151552779	0.417	0.13	0.0354432388282531	HLA-DMA	Erythrocytes	GSE162117_post	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47067
1.96076080138807e-06	0.369233809665719	0.27	0.043	0.0362427026528571	CFP	Erythrocytes	GSE162117_post	ENSG00000126759	5199	complement factor properdin	PFC	protein_coding	P27918	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47068
1.97910107978073e-06	0.443301351497565	0.435	0.148	0.036581704358667	PLEK	Erythrocytes	GSE162117_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47069
2.13816430553421e-06	1.13819273672895	0.991	0.965	0.0395218290234943	FTL	Erythrocytes	GSE162117_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47070
2.25923012464906e-06	0.725560830893957	0.878	0.67	0.0417596096240132	S100A6	Erythrocytes	GSE162117_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47071
2.38688242269682e-06	0.622930350920177	0.504	0.235	0.044119134701128	LY6E	Erythrocytes	GSE162117_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47072
2.52277480951148e-06	0.423599512782268	0.348	0.096	0.0466309695790102	LY96	Erythrocytes	GSE162117_post	ENSG00000154589	23643	lymphocyte antigen 96	MD-2	protein_coding	Q9Y6Y9	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	post	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47073
4.82709692732272e-179	0.555904411687486	1	1	8.92240596046331e-175	RPS29	CD4+ T cells	GSE162117_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47074
2.31615509176027e-163	0.803812565506098	0.805	0.324	4.28118107160969e-159	RPS4Y1	CD4+ T cells	GSE162117_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47075
4.74997857181679e-125	0.411968594500394	1	0.999	8.77986039214615e-121	RPL37A	CD4+ T cells	GSE162117_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47076
3.28856246452151e-122	-0.478771771407507	1	1	6.07857885942155e-118	RPS4X	CD4+ T cells	GSE162117_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47077
7.78844038380945e-105	0.365860409440462	1	1	1.43961532054334e-100	RPL37	CD4+ T cells	GSE162117_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47078
6.87977268158454e-78	0.549370775645786	0.999	0.992	1.27165718246409e-73	MT-ND3	CD4+ T cells	GSE162117_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47079
2.34616552016748e-77	0.373600290961013	1	0.997	4.33665234747758e-73	RPS21	CD4+ T cells	GSE162117_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47080
2.51336731858812e-73	0.280263365949777	1	1	4.64570815167828e-69	RPS27	CD4+ T cells	GSE162117_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47081
3.31643684825167e-70	0.294330320200382	1	1	6.13010187030839e-66	RPS28	CD4+ T cells	GSE162117_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47082
1.30362820059083e-60	0.264935631729707	1	1	2.4096263659721e-56	RPL39	CD4+ T cells	GSE162117_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47083
5.87673374924241e-54	0.2942838249962	1	1	1.08625546620997e-49	RPL38	CD4+ T cells	GSE162117_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47084
4.37785482114536e-51	0.258277742421753	1	1	8.09202685140509e-47	RPL36	CD4+ T cells	GSE162117_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47085
4.35366160931194e-45	-0.435776619169428	0.749	0.879	8.04730811865219e-41	RPS26	CD4+ T cells	GSE162117_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47086
3.02457685582014e-44	-0.250779536250429	0.999	1	5.59062786029794e-40	RPL7	CD4+ T cells	GSE162117_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47087
1.51811347620978e-43	0.303210728562942	0.406	0.2	2.80608094942616e-39	AAK1	CD4+ T cells	GSE162117_pre	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47088
5.59729968610993e-42	0.326892358045592	0.526	0.305	1.03460487398056e-37	DONSON	CD4+ T cells	GSE162117_pre	ENSG00000159147	29980	DNA replication fork stabilization factor DONSON	B17|C21orf60|C2TA|DKFZP434M035	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47089
1.85752908591272e-39	0.302656420100645	0.323	0.144	3.43345676240107e-35	IFI6	CD4+ T cells	GSE162117_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47090
1.0305285097695e-37	0.312302470945748	0.381	0.199	1.90482889745795e-33	IFITM1	CD4+ T cells	GSE162117_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47091
3.09913856415577e-35	0.259709089926355	0.383	0.2	5.72844772198552e-31	EIF5A	CD4+ T cells	GSE162117_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47092
2.38574924621627e-32	0.297882702147003	0.533	0.329	4.40981890670616e-28	ATP5I	CD4+ T cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47093
5.96730498590178e-32	0.343894738396736	0.73	0.545	1.10299665359409e-27	SON	CD4+ T cells	GSE162117_pre	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47094
1.02973193337546e-31	0.319858725888738	0.949	0.861	1.9033565056512e-27	RPL36A	CD4+ T cells	GSE162117_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47095
5.1912320822992e-26	0.326375082054107	0.581	0.405	9.59547338092184e-22	TRA2B	CD4+ T cells	GSE162117_pre	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47096
2.05359921865985e-23	0.255727416851113	0.976	0.951	3.79587279577087e-19	ATP5E	CD4+ T cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47097
1.24551620228642e-22	0.268779526913601	0.46	0.287	2.30221214830622e-18	S100A8	CD4+ T cells	GSE162117_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47098
1.33292998345203e-20	-0.51943761708115	0.531	0.622	2.46378778141273e-16	FOS	CD4+ T cells	GSE162117_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47099
2.71114434042593e-18	0.274216140263939	0.365	0.232	5.0112791988433e-14	ISG15	CD4+ T cells	GSE162117_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47100
1.20301781682648e-14	0.301359800155411	0.858	0.774	2.22365813262207e-10	IL32	CD4+ T cells	GSE162117_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47101
2.21251149664169e-14	0.408011354795718	0.277	0.175	4.08960625039251e-10	KLRB1	CD4+ T cells	GSE162117_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47102
3.71647983548805e-09	-0.302645208661538	0.557	0.599	6.86954132791611e-05	JUNB	CD4+ T cells	GSE162117_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47103
4.05147747330566e-07	0.287871917071746	0.906	0.882	0.00748875096165817	LTB	CD4+ T cells	GSE162117_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47104
0	-1.14847476284838	0.108	0.392	0	C1QA	Malignant cells	GSE162117_pre	ENSG00000173372	712	complement C1q A chain	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47105
0	-1.28145847834834	0.665	0.861	0	TXNIP	Malignant cells	GSE162117_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47106
0	-0.686111420041917	0.657	0.919	0	S100A11	Malignant cells	GSE162117_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47107
0	-0.84994762552197	0.631	0.952	0	S100A9	Malignant cells	GSE162117_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47108
0	0.545498163596877	1	1	0	RPS27	Malignant cells	GSE162117_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47109
0	-0.752482909980237	0.565	0.96	0	FCER1G	Malignant cells	GSE162117_pre	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47110
0	-0.714667919938087	0.138	0.502	0	RGS2	Malignant cells	GSE162117_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47111
0	-0.504731823410724	0.973	0.991	0	H3F3A	Malignant cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47112
0	0.625954245440143	0.995	0.985	0	RPL31	Malignant cells	GSE162117_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47113
0	0.56752341028542	1	0.998	0	RPL37A	Malignant cells	GSE162117_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47114
0	0.492911798187898	1	0.999	0	RPL35A	Malignant cells	GSE162117_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47115
0	0.561766460819228	0.339	0.051	0	HOPX	Malignant cells	GSE162117_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47116
0	-1.37300850014356	0.084	0.498	0	IL8	Malignant cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47117
0	0.600987138952326	1	0.999	0	RPL37	Malignant cells	GSE162117_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47118
0	-0.718004241918429	0.198	0.52	0	CD14	Malignant cells	GSE162117_pre	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47119
0	-0.878859734448615	0.811	0.96	0	DUSP1	Malignant cells	GSE162117_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47120
0	-0.943334592384887	0.059	0.554	0	HLA-DRB5	Malignant cells	GSE162117_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47121
0	-0.705504381050549	0.074	0.382	0	TNFAIP3	Malignant cells	GSE162117_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47122
0	-0.687879308453479	0.224	0.513	0	ARL4A	Malignant cells	GSE162117_pre	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47123
0	-0.60675863858754	0.171	0.529	0	NAMPT	Malignant cells	GSE162117_pre	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47124
0	-0.614286289657913	0.117	0.436	0	TMEM176B	Malignant cells	GSE162117_pre	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47125
0	-0.972059455816765	0.782	0.967	0	SAT1	Malignant cells	GSE162117_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47126
0	0.534745283737343	1	0.999	0	RPL39	Malignant cells	GSE162117_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47127
0	0.392851308949345	1	0.999	0	RPL27A	Malignant cells	GSE162117_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47128
0	-0.673592486459919	0.965	1	0	FTH1	Malignant cells	GSE162117_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47129
0	0.426546387507732	0.999	0.997	0	RPS25	Malignant cells	GSE162117_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47130
0	-1.16602859434639	0.058	0.395	0	CD163	Malignant cells	GSE162117_pre	ENSG00000177575	9332	CD163 molecule	M130|MM130|SCARI1	protein_coding	Q86VB7	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47131
0	0.343411352619635	1	1	0	RPL41	Malignant cells	GSE162117_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47132
0	0.736125546279805	0.387	0.043	0	RP11-620J15.3	Malignant cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47133
0	-1.89776659875369	0.565	0.914	0	LYZ	Malignant cells	GSE162117_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47134
0	-0.758902365937827	0.512	0.744	0	BTG1	Malignant cells	GSE162117_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47135
0	-0.539262776747105	0.077	0.39	0	RNASE6	Malignant cells	GSE162117_pre	ENSG00000169413	6039	ribonuclease A family member k6	RAD1|RNaseK6|RNS6	protein_coding	Q93091	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47136
0	-1.23835627179024	0.421	0.823	0	NFKBIA	Malignant cells	GSE162117_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47137
0	0.749428221949386	1	0.997	0	RPS29	Malignant cells	GSE162117_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47138
0	-1.09386971383736	0.87	0.979	0	FOS	Malignant cells	GSE162117_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47139
0	0.330006776649105	1	0.999	0	RPLP1	Malignant cells	GSE162117_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47140
0	0.61716082839206	0.999	0.998	0	RPS2	Malignant cells	GSE162117_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47141
0	0.418434671032855	1	0.997	0	RPL23A	Malignant cells	GSE162117_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47142
0	-0.807945819329184	0.074	0.318	0	CCL3	Malignant cells	GSE162117_pre	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47143
0	-0.479429580028807	0.98	0.995	0	EIF1	Malignant cells	GSE162117_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47144
0	0.466615094936846	0.998	0.99	0	RPL38	Malignant cells	GSE162117_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47145
0	-0.76461786584289	0.612	0.974	0	CST3	Malignant cells	GSE162117_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47146
0	0.726499369625011	0.993	0.955	0	RPS21	Malignant cells	GSE162117_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47147
0	0.591988049907662	0.334	0.027	0	PRSS57	Malignant cells	GSE162117_pre	ENSG00000185198	400668	serine protease 57	PRSSL1|UNQ782	protein_coding	Q6UWY2	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47148
0	0.466587168927329	0.999	0.993	0	RPL36	Malignant cells	GSE162117_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47149
0	0.504502525479927	0.999	0.999	0	RPS28	Malignant cells	GSE162117_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47150
0	-0.802721264637208	0.475	0.789	0	JUNB	Malignant cells	GSE162117_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47151
0	0.422017938681075	0.999	0.999	0	RPS19	Malignant cells	GSE162117_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47152
0	-0.598424257213359	0.435	0.739	0	ITGB2	Malignant cells	GSE162117_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47153
1.33710754678619e-297	-0.423781618221996	0.06	0.291	2.47150958947958e-293	LMNA	Malignant cells	GSE162117_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47154
7.91974390957972e-294	-0.486674086434162	0.999	1	1.46388546424672e-289	TMSB4X	Malignant cells	GSE162117_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47155
8.79285375655929e-290	0.536077412703232	0.366	0.085	1.62527108836242e-285	CDK6	Malignant cells	GSE162117_pre	ENSG00000105810	1021	cyclin dependent kinase 6	PLSTIRE	protein_coding	Q00534	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47156
4.55796522248219e-289	0.616920618701429	0.387	0.106	8.42494291723607e-285	NUCB2	Malignant cells	GSE162117_pre	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47157
4.36430340672879e-287	-0.52575375346494	0.811	0.974	8.0669784169975e-283	CYBA	Malignant cells	GSE162117_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47158
1.8227318104123e-283	0.465333016991061	0.946	0.822	3.3691374783661e-279	RPL36A	Malignant cells	GSE162117_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47159
1.98514298332862e-283	-0.693978019642366	0.318	0.628	3.66933829038461e-279	VCAN	Malignant cells	GSE162117_pre	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47160
3.58524327449345e-279	0.419210013783734	0.278	0.031	6.6269636685737e-275	NPDC1	Malignant cells	GSE162117_pre	ENSG00000107281	56654	neural proliferation, differentiation and control 1	CAB-|CAB1|DKFZp586J0523	protein_coding	Q9NQX5	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47161
6.61981371837029e-277	-0.563254069457422	0.904	0.995	1.22360636770356e-272	S100A4	Malignant cells	GSE162117_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47162
7.54027472400293e-276	-0.555618694244355	0.401	0.686	1.3937443799847e-271	ZFP36	Malignant cells	GSE162117_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47163
2.01830500672125e-275	0.588453979361529	0.401	0.123	3.73063497442357e-271	IGFBP7	Malignant cells	GSE162117_pre	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47164
1.42585356790084e-274	0.392586186343874	0.275	0.03	2.63554773490791e-270	EGFL7	Malignant cells	GSE162117_pre	ENSG00000172889	51162	EGF like domain multiple 7	ZNEU1	protein_coding	Q9UHF1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47165
2.00226355583669e-273	-0.806562126001473	0.648	0.811	3.70098395660855e-269	S100A10	Malignant cells	GSE162117_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47166
6.73711151516802e-271	-0.311805760328788	0.046	0.254	1.24528769246366e-266	FPR1	Malignant cells	GSE162117_pre	ENSG00000171051	2357	formyl peptide receptor 1	FMLP|FPR	protein_coding	P21462	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47167
6.82176105305849e-269	-0.523454015933881	0.694	0.862	1.26093431304733e-264	ITM2B	Malignant cells	GSE162117_pre	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47168
4.62325342048043e-267	0.377796128079191	0.999	0.998	8.54562162241603e-263	RPL30	Malignant cells	GSE162117_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47169
1.44420228696854e-264	0.321930415993871	1	1	2.66946350723265e-260	RPL32	Malignant cells	GSE162117_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47170
9.6820718348664e-261	-0.592443990961198	0.782	0.892	1.78963415795671e-256	GPX1	Malignant cells	GSE162117_pre	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47171
6.05475699493134e-260	0.416956852708486	0.252	0.022	1.11916128294311e-255	KIAA0125	Malignant cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47172
9.24114754767821e-256	0.598998052757793	0.926	0.851	1.70813371271284e-251	RPLP0	Malignant cells	GSE162117_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47173
1.52151402711192e-255	-0.68835627520448	0.237	0.486	2.81236652771367e-251	RHOB	Malignant cells	GSE162117_pre	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47174
2.48558298614815e-255	0.396616125548337	1	0.999	4.59435159159624e-251	RPS18	Malignant cells	GSE162117_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47175
4.92283240360677e-254	0.573021212054575	0.972	0.946	9.09936341482675e-250	RPS5	Malignant cells	GSE162117_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47176
2.08570955195254e-252	0.378800799305831	1	0.999	3.85522553582908e-248	RPS15A	Malignant cells	GSE162117_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47177
1.67164772544437e-249	-0.545521703717714	0.573	0.766	3.08987365571137e-245	CCNL1	Malignant cells	GSE162117_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47178
2.61869449684523e-245	-0.466156886875533	0.844	0.95	4.84039490796873e-241	MYL6	Malignant cells	GSE162117_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47179
5.75113493622831e-244	0.36346892949632	0.999	1	1.06303978161244e-239	RPS24	Malignant cells	GSE162117_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47180
3.19259943426169e-242	0.330695028823251	0.999	0.998	5.90120079428931e-238	RPL19	Malignant cells	GSE162117_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47181
2.37025569823146e-241	-0.497770788460246	0.224	0.485	4.38118063261103e-237	SOD2	Malignant cells	GSE162117_pre	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47182
2.88966692013617e-238	0.391623398780788	0.284	0.052	5.3412603351797e-234	CD82	Malignant cells	GSE162117_pre	ENSG00000085117	3732	CD82 molecule	IA4|KAI1|R2|ST6|TSPAN27	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47183
2.35345018752937e-235	-0.598593890911688	0.958	0.971	4.3501173266293e-231	NEAT1	Malignant cells	GSE162117_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47184
1.54688582481836e-230	0.324167785528191	1	1	2.85926375859426e-226	RPS12	Malignant cells	GSE162117_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47185
4.66750277506119e-230	0.39561462347492	0.318	0.077	8.62741212942311e-226	GYPC	Malignant cells	GSE162117_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47186
1.93337493548258e-229	0.581099756248674	0.923	0.854	3.573650230746e-225	RPSA	Malignant cells	GSE162117_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47187
1.95185689664124e-228	-0.592441465683974	0.477	0.772	3.60781228775167e-224	FCN1	Malignant cells	GSE162117_pre	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47188
6.28007186375207e-223	-0.510790752808044	0.849	0.982	1.16080848329593e-218	S100A6	Malignant cells	GSE162117_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47189
5.33482600166255e-219	0.394357699739659	0.995	0.993	9.86089238147306e-215	RPL14	Malignant cells	GSE162117_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47190
4.15012973663479e-218	0.315434215492729	0.999	1	7.67109980519575e-214	RPS14	Malignant cells	GSE162117_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47191
2.74714268780531e-216	-0.489430033328303	0.739	0.929	5.07781854413933e-212	SRGN	Malignant cells	GSE162117_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47192
6.88674314470688e-211	0.844363247011193	0.551	0.352	1.27294560286762e-206	IFI6	Malignant cells	GSE162117_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47193
6.01316795644983e-208	-0.654507506544368	0.457	0.664	1.11147396507019e-203	IER2	Malignant cells	GSE162117_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47194
1.23760324274081e-207	0.30379656646071	0.999	0.999	2.28758583388211e-203	RPL18A	Malignant cells	GSE162117_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47195
3.38718764150484e-207	0.700025896094493	0.506	0.273	6.26087763655754e-203	MGST1	Malignant cells	GSE162117_pre	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47196
1.2512311819378e-206	-0.459840419448087	0.781	0.93	2.31277571669383e-202	HLA-C	Malignant cells	GSE162117_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47197
6.55435134711574e-206	-0.669610713281374	0.609	0.863	1.21150630300087e-201	S100A8	Malignant cells	GSE162117_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47198
5.31144217878355e-202	-0.351872061973603	0.089	0.287	9.81766972326352e-198	TMEM176A	Malignant cells	GSE162117_pre	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47199
1.57320740075713e-198	-0.459844665933258	0.498	0.718	2.90791655955947e-194	AP1S2	Malignant cells	GSE162117_pre	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47200
1.77501015386845e-197	0.309930431340672	0.999	0.999	3.28092876841045e-193	RPL12	Malignant cells	GSE162117_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47201
6.50867730707268e-195	0.28311636369048	1	1	1.20306391343931e-190	RPLP2	Malignant cells	GSE162117_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47202
7.40176204829817e-194	0.296671578133432	0.999	0.999	1.36814169700743e-189	RPS15	Malignant cells	GSE162117_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47203
8.49402977592538e-190	0.649272202417009	0.997	0.998	1.57003646378205e-185	RPS3	Malignant cells	GSE162117_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47204
2.21398948786012e-188	0.640085239074446	0.627	0.439	4.09233816936064e-184	SERPINB1	Malignant cells	GSE162117_pre	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47205
3.70826770867596e-184	0.81520669962419	0.48	0.287	6.85436203271664e-180	ANKRD28	Malignant cells	GSE162117_pre	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47206
3.11833320060049e-182	0.295407543364195	0.997	0.998	5.76392708798995e-178	RPL35	Malignant cells	GSE162117_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47207
5.51501126643123e-182	-0.398008080646029	0.25	0.486	1.01939468248715e-177	LGALS3	Malignant cells	GSE162117_pre	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47208
1.46784290618712e-181	-0.444302308746019	0.527	0.718	2.71316082779626e-177	PNRC1	Malignant cells	GSE162117_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47209
2.43790773391247e-181	0.256688428959182	1	1	4.50622865536381e-177	RPL11	Malignant cells	GSE162117_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47210
1.14632551505109e-178	0.323843041221223	0.999	1	2.11886808202044e-174	RPL34	Malignant cells	GSE162117_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47211
3.0304948289567e-178	-0.426222072697265	0.171	0.377	5.60156664184357e-174	RNASE2	Malignant cells	GSE162117_pre	ENSG00000169385	6036	ribonuclease A family member 2	EDN|RAF3|RNS2	protein_coding	P10153	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47212
4.67559160394967e-177	0.42020476917996	0.997	0.997	8.64236352074058e-173	RPL15	Malignant cells	GSE162117_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47213
1.89770275651966e-175	-0.587740711252347	0.72	0.899	3.50771377515095e-171	LGALS1	Malignant cells	GSE162117_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47214
1.91737903376798e-173	-0.393168819404369	0.305	0.535	3.54408340601673e-169	CLEC12A	Malignant cells	GSE162117_pre	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47215
4.48310020665397e-172	-0.345416199745957	0.161	0.364	8.2865624219792e-168	UPP1	Malignant cells	GSE162117_pre	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47216
3.97979162441002e-171	0.456091372292383	0.999	0.999	7.35624683855948e-167	RPS23	Malignant cells	GSE162117_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47217
3.12531988787839e-168	-0.402317194076895	0.202	0.412	5.77684128075442e-164	IGSF6	Malignant cells	GSE162117_pre	ENSG00000283934	10261	immunoglobulin superfamily member 6	DORA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47218
1.07948502927699e-167	0.337849422296046	0.352	0.139	1.99532012811558e-163	SEPT6	Malignant cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47219
1.30066937459263e-166	-0.604535854829569	0.417	0.635	2.40415727199701e-162	MNDA	Malignant cells	GSE162117_pre	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47220
1.14062472171053e-163	-0.342606516612281	0.326	0.57	2.10833073560975e-159	ANXA5	Malignant cells	GSE162117_pre	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47221
4.9254558902543e-162	0.295768920770058	0.28	0.085	9.10421266754604e-158	EBPL	Malignant cells	GSE162117_pre	ENSG00000123179	84650	EBP like	EBRP	protein_coding	Q9BY08	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47222
6.49916200460929e-161	0.418314982191568	0.528	0.309	1.20130510493198e-156	HMGN1	Malignant cells	GSE162117_pre	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47223
7.83107554641443e-159	-0.361043888856245	0.437	0.706	1.44749600399924e-154	CSTA	Malignant cells	GSE162117_pre	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47224
1.74814556181773e-157	0.286304299957535	0.998	0.998	3.23127225646389e-153	RPL29	Malignant cells	GSE162117_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47225
3.0242500586598e-157	-0.402042888066853	0.5	0.695	5.59002380842678e-153	CALM1	Malignant cells	GSE162117_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47226
1.05933707006627e-154	-0.376557111606166	0.556	0.732	1.95807864031049e-150	RAC1	Malignant cells	GSE162117_pre	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47227
1.1204044886959e-154	-0.355653010410138	0.979	0.999	2.0709556569055e-150	ACTB	Malignant cells	GSE162117_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47228
1.22206224008677e-154	0.73933728858288	0.544	0.377	2.25885984457639e-150	CD99	Malignant cells	GSE162117_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47229
2.76680285345075e-153	-0.271356784607272	0.091	0.258	5.11415839431836e-149	TRIB1	Malignant cells	GSE162117_pre	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47230
1.19311055053989e-152	-0.348111364970987	0.386	0.645	2.20534554161793e-148	MS4A6A	Malignant cells	GSE162117_pre	ENSG00000110077	64231	membrane spanning 4-domains A6A	CD20L3|MS4A6	protein_coding	Q9H2W1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47231
4.24509375486934e-151	0.509362694845732	1	0.999	7.84663129650049e-147	RPS6	Malignant cells	GSE162117_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47232
6.65604677019324e-151	0.771682669455782	0.535	0.373	1.23030368500252e-146	ISG15	Malignant cells	GSE162117_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47233
6.56607754492626e-149	0.340630840227587	0.391	0.185	1.21367377340417e-144	PEBP1	Malignant cells	GSE162117_pre	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47234
7.54081356937593e-149	-0.35297693519748	0.345	0.554	1.39384398016345e-144	CAST	Malignant cells	GSE162117_pre	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47235
3.88355409869859e-148	0.292992550618247	0.329	0.13	7.17836139603448e-144	MBOAT7	Malignant cells	GSE162117_pre	ENSG00000275118	79143	membrane bound O-acyltransferase domain containing 7	BB1|hMBOA-7|LENG4|LPIAT1|LPLAT|LPLAT11	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47236
6.86665850974816e-148	-0.354234778362051	0.13	0.311	1.26923315894185e-143	LGALS2	Malignant cells	GSE162117_pre	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47237
3.14125040489174e-146	-0.352890342218169	0.115	0.285	5.80628724840189e-142	CXCR4	Malignant cells	GSE162117_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47238
2.03168491191402e-145	-0.386843335969461	0.43	0.647	3.75536639118187e-141	ANXA2	Malignant cells	GSE162117_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47239
2.19535656716567e-145	-0.309206755352842	0.917	0.984	4.05789707874902e-141	OAZ1	Malignant cells	GSE162117_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47240
3.38775579533291e-144	0.474078965201534	0.358	0.162	6.26192781209336e-140	SOX4	Malignant cells	GSE162117_pre	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47241
5.65860949779175e-144	0.370450001911889	0.711	0.503	1.04593737957183e-139	RPS4Y1	Malignant cells	GSE162117_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47242
6.88864633616007e-143	0.427541333935128	0.849	0.764	1.27329738877583e-138	NAP1L1	Malignant cells	GSE162117_pre	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47243
1.35374593231183e-142	-0.300326410960816	0.116	0.285	2.50226398128518e-138	BTG2	Malignant cells	GSE162117_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47244
1.05365184582279e-140	0.585197183215707	0.878	0.829	1.94757007181884e-136	EEF1B2	Malignant cells	GSE162117_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47245
5.38724674652855e-140	0.310589471255614	1	0.999	9.95778688628337e-136	RPL13A	Malignant cells	GSE162117_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47246
1.17814134113338e-138	0.287652246195122	0.996	0.994	2.17767645495093e-134	RPL18	Malignant cells	GSE162117_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47247
1.79137868596184e-138	-0.421669304097948	0.79	0.864	3.31118436313187e-134	KLF6	Malignant cells	GSE162117_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47248
6.38491723378755e-137	-0.318631618935312	0.389	0.614	1.18018810149329e-132	C10orf54	Malignant cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47249
6.79375199361204e-136	-0.392144940209614	0.675	0.975	1.25575711849925e-131	TYROBP	Malignant cells	GSE162117_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47250
2.82924509100405e-135	-0.331265686052334	0.281	0.482	5.22957662621188e-131	SMAP2	Malignant cells	GSE162117_pre	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47251
1.94123108981859e-134	-0.27916769038113	0.958	0.984	3.58817154642069e-130	SERF2	Malignant cells	GSE162117_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47252
2.27349545589543e-134	0.463610345637029	0.692	0.486	4.20232900067711e-130	PLAC8	Malignant cells	GSE162117_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47253
4.3482352067219e-134	0.416536279690305	0.999	0.999	8.03727795610476e-130	RPS8	Malignant cells	GSE162117_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47254
1.52682731516947e-133	0.551662258238627	0.969	0.97	2.82218760935925e-129	RPL5	Malignant cells	GSE162117_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47255
3.53802334562051e-132	-0.318733663883829	0.253	0.442	6.53968235204495e-128	MAP1LC3B	Malignant cells	GSE162117_pre	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47256
5.15767054798073e-129	-0.325951529745577	0.201	0.383	9.53343824088759e-125	MAP3K8	Malignant cells	GSE162117_pre	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47257
7.63524149551975e-128	-0.341734271811515	0.387	0.59	1.41129803803187e-123	CARD16	Malignant cells	GSE162117_pre	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47258
5.71296324155436e-126	0.29701372928749	0.283	0.108	1.05598412556891e-121	IFI44L	Malignant cells	GSE162117_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47259
8.25114325883446e-126	-0.350341870107069	0.804	0.868	1.52514131996296e-121	DDX5	Malignant cells	GSE162117_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47260
1.22871939078137e-123	-0.411788207121328	0.146	0.308	2.27116492192028e-119	IL1B	Malignant cells	GSE162117_pre	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47261
1.28351648799637e-123	-0.579071653512632	0.208	0.393	2.37245187641249e-119	S100A12	Malignant cells	GSE162117_pre	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47262
6.16620661546811e-123	0.439976547567057	0.753	0.637	1.13976163080313e-118	EIF3E	Malignant cells	GSE162117_pre	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47263
1.26720117094344e-122	0.347528233853529	0.975	0.942	2.34229464437186e-118	GAPDH	Malignant cells	GSE162117_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47264
1.05821029425282e-120	0.401145086799438	0.967	0.959	1.95599590789691e-116	GNB2L1	Malignant cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47265
2.37904802927639e-120	0.328317887878397	0.374	0.192	4.39743237731448e-116	DONSON	Malignant cells	GSE162117_pre	ENSG00000159147	29980	DNA replication fork stabilization factor DONSON	B17|C21orf60|C2TA|DKFZP434M035	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47266
2.74947308956638e-120	0.27032739628576	0.413	0.217	5.0821260587545e-116	SPN	Malignant cells	GSE162117_pre	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47267
2.09705624429287e-119	-0.307736816799424	0.278	0.466	3.87619876195093e-115	FAM65B	Malignant cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47268
1.19626601784176e-118	-0.301435191257872	0.209	0.39	2.21117810737871e-114	BCL2A1	Malignant cells	GSE162117_pre	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47269
4.80416688864499e-118	-0.3614592280068	0.189	0.348	8.8800220769714e-114	FKBP5	Malignant cells	GSE162117_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47270
4.21630182749737e-117	-0.413135529205296	0.384	0.54	7.79341229794615e-113	VAPA	Malignant cells	GSE162117_pre	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47271
4.98020466376058e-117	0.30895914453502	0.441	0.251	9.20541030049505e-113	MIR142	Malignant cells	GSE162117_pre	ENSG00000284353	406934	microRNA 142	hsa-mir-142|MIRN142	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47272
5.666434955928e-117	0.687510392673092	0.729	0.699	1.04738383725373e-112	HINT1	Malignant cells	GSE162117_pre	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47273
9.99146373056882e-116	0.305078125875594	0.994	0.996	1.84682215595834e-111	RPS7	Malignant cells	GSE162117_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47274
2.65206025387693e-115	-0.296373116949664	0.6	0.94	4.90206817326611e-111	LST1	Malignant cells	GSE162117_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47275
1.88772795920859e-112	0.377551299021447	0.302	0.137	3.48927635980116e-108	HIST1H4C	Malignant cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47276
3.73910023879303e-111	-0.303143789831432	0.866	0.912	6.91135288138504e-107	ARPC3	Malignant cells	GSE162117_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47277
7.83433082943365e-111	-0.303014200180286	0.96	0.978	1.44809771051252e-106	SH3BGRL3	Malignant cells	GSE162117_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47278
7.98393770766448e-111	-0.338046152990765	0.436	0.609	1.4757510458847e-106	MCL1	Malignant cells	GSE162117_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47279
7.99925778038702e-111	0.276685445961619	0.278	0.115	1.47858280812674e-106	F13A1	Malignant cells	GSE162117_pre	ENSG00000124491	2162	coagulation factor XIII A chain	F13A	protein_coding	P00488	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47280
8.06258412318937e-111	-0.300002905382373	0.472	0.68	1.49028804933032e-106	C1orf162	Malignant cells	GSE162117_pre	ENSG00000143110	128346	chromosome 1 open reading frame 162	MGC24133	protein_coding	Q8NEQ5	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47281
2.05610373474748e-110	-0.316285258910539	0.623	0.936	3.80050214330725e-106	CTSS	Malignant cells	GSE162117_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47282
7.60536131225235e-110	-0.303383601130997	0.446	0.635	1.40577498495672e-105	GRN	Malignant cells	GSE162117_pre	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47283
2.68077176808143e-107	-0.361590952801379	0.74	0.865	4.95513853612172e-103	EMP3	Malignant cells	GSE162117_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47284
4.88576565439007e-107	0.369223317984019	0.996	0.997	9.03084923557461e-103	RPS4X	Malignant cells	GSE162117_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47285
6.83205760136955e-106	-0.325249634199497	0.708	0.802	1.26283752703715e-101	MYL12A	Malignant cells	GSE162117_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47286
3.63858587875223e-105	0.303942365255881	0.912	0.845	6.72556213828562e-101	RPS10	Malignant cells	GSE162117_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47287
5.17058041314667e-105	0.295484338917807	0.354	0.186	9.5573008356603e-101	CAT	Malignant cells	GSE162117_pre	ENSG00000121691	847	catalase	NA	protein_coding	P04040	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47288
1.71149507334004e-103	-0.28281689177198	0.307	0.48	3.16352749356173e-99	ZFAND5	Malignant cells	GSE162117_pre	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47289
1.39779634781678e-102	0.330663815150141	0.912	0.871	2.58368676930453e-98	RPL4	Malignant cells	GSE162117_pre	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47290
2.92226735224152e-101	-0.302491142218132	0.513	0.712	5.40151897388323e-97	PTPRC	Malignant cells	GSE162117_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47291
1.06320751075274e-100	-0.421024219774249	0.497	0.657	1.96523276287536e-96	ID2	Malignant cells	GSE162117_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47292
1.44354997623757e-100	0.430950573111985	0.588	0.446	2.66825777607752e-96	LY6E	Malignant cells	GSE162117_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47293
2.75484985617995e-100	0.336699028666053	0.345	0.187	5.09206447416301e-96	LIPA	Malignant cells	GSE162117_pre	ENSG00000107798	3988	lipase A, lysosomal acid type	CESD|LAL	protein_coding	P38571	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47294
4.9306232990082e-100	0.286701328478989	0.651	0.485	9.11376410588675e-96	GLTSCR2	Malignant cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47295
4.25977779382662e-99	-0.263715781389384	0.324	0.502	7.87377327410912e-95	GLRX	Malignant cells	GSE162117_pre	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47296
5.26802640551128e-98	-0.264846021075064	0.839	0.927	9.73742000794705e-94	PFN1	Malignant cells	GSE162117_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47297
4.94608158700436e-97	-0.339257770240252	0.549	0.738	9.14233720541885e-93	TIMP1	Malignant cells	GSE162117_pre	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47298
6.20250092933865e-96	0.264361134068663	0.506	0.334	1.14647027177896e-91	ST13	Malignant cells	GSE162117_pre	ENSG00000100380	6767	ST13 Hsp70 interacting protein	FAM10A1|HIP|HSPABP1|P48|SNC6	protein_coding	P50502	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47299
6.2272303523865e-96	-0.326363752742123	0.717	0.794	1.15104125833512e-91	RPS26	Malignant cells	GSE162117_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47300
1.07752972549973e-95	0.279952624110336	0.444	0.274	1.99170594461369e-91	TPM4	Malignant cells	GSE162117_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47301
1.48083051006647e-95	0.266904074849063	0.987	0.987	2.73716711480687e-91	RPL22	Malignant cells	GSE162117_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47302
1.08285667524817e-93	0.253967159748376	0.292	0.141	2.00155227852871e-89	SNHG7	Malignant cells	GSE162117_pre	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47303
2.58966675799896e-93	-0.291681199886904	0.937	0.958	4.78674003548528e-89	MT-ND5	Malignant cells	GSE162117_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47304
1.28871917359044e-92	-0.262454300452262	0.343	0.511	2.38206852046456e-88	BLVRB	Malignant cells	GSE162117_pre	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47305
9.96061209909751e-92	0.310962360163481	0.773	0.662	1.84111954039718e-87	EEF2	Malignant cells	GSE162117_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47306
2.14600265835928e-91	0.493654097762768	0.985	0.991	3.9666713137113e-87	RPL3	Malignant cells	GSE162117_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47307
1.61097080166758e-90	0.251062926163497	1	1	2.97771842980235e-86	RPS27A	Malignant cells	GSE162117_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47308
1.17868496932218e-89	0.339078788188649	0.339	0.182	2.17868129729511e-85	CLU	Malignant cells	GSE162117_pre	ENSG00000120885	1191	clusterin	APOJ|CLI|CLU1|CLU2|KUB1|SGP-2|SP-40|TRPM-2	protein_coding	P10909	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47309
4.91849341511333e-89	-0.262784853301754	0.608	0.762	9.09134322849548e-85	CDC42	Malignant cells	GSE162117_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47310
4.72097274348597e-88	0.388739510293788	0.987	0.987	8.72624601905947e-84	RPL7A	Malignant cells	GSE162117_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47311
3.76004509901513e-87	-0.30819116048543	0.348	0.531	6.95006736101956e-83	RP11-1143G9.4	Malignant cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47312
8.55904124912689e-87	0.313202742863059	0.809	0.713	1.58205318448861e-82	HNRNPA1	Malignant cells	GSE162117_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47313
2.82623570141042e-86	0.279013689147254	0.999	0.998	5.22401407048702e-82	RPS20	Malignant cells	GSE162117_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47314
7.03730617411185e-83	0.277417018505166	0.608	0.464	1.30077567322284e-78	ANP32B	Malignant cells	GSE162117_pre	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47315
5.05901454385794e-82	-0.259536474631119	0.188	0.325	9.35108248286702e-78	SAMSN1	Malignant cells	GSE162117_pre	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47316
1.97237803202377e-79	0.298001837390966	0.986	0.982	3.64574355439273e-75	RPL10A	Malignant cells	GSE162117_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47317
2.19826485016914e-79	-0.292169545869925	0.688	0.779	4.06327274905265e-75	TSPO	Malignant cells	GSE162117_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47318
3.39521862968554e-79	-0.299936341174971	0.187	0.322	6.27572211511075e-75	EGR1	Malignant cells	GSE162117_pre	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47319
5.0801742017831e-78	-0.305775817879786	0.539	0.657	9.39019399457588e-74	GPX4	Malignant cells	GSE162117_pre	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47320
3.32417637868415e-77	0.274844446004201	0.609	0.466	6.14440761835978e-73	PNISR	Malignant cells	GSE162117_pre	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47321
9.05323205742569e-77	-0.48082708848267	0.574	0.66	1.67339941349456e-72	CD52	Malignant cells	GSE162117_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47322
2.89373165281314e-74	-0.252358274246395	0.597	0.717	5.3487735870598e-70	ATP6V0E1	Malignant cells	GSE162117_pre	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47323
4.78195621084668e-74	0.306786420415215	0.885	0.852	8.83896786012901e-70	BTF3	Malignant cells	GSE162117_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47324
7.58489372381719e-72	0.420067709869892	0.999	0.999	1.40199175591037e-67	RPS3A	Malignant cells	GSE162117_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47325
3.54176872981079e-71	-0.559203001830471	0.532	0.679	6.54660532018226e-67	MT2A	Malignant cells	GSE162117_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47326
1.92862824261439e-70	-0.266268970007312	0.314	0.474	3.56487644364844e-66	MS4A7	Malignant cells	GSE162117_pre	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47327
5.57962213581928e-69	0.390351786614646	0.584	0.484	1.03133735558484e-64	TAGLN2	Malignant cells	GSE162117_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47328
7.67415202419176e-67	-0.271617370836054	0.759	0.823	1.41849026015161e-62	GSTP1	Malignant cells	GSE162117_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47329
4.96629869021023e-64	-0.282529507702339	0.774	0.914	9.1797064989846e-60	HLA-DRA	Malignant cells	GSE162117_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47330
1.8922534789054e-62	-0.350217693489584	0.319	0.441	3.49764133040875e-58	IRF1	Malignant cells	GSE162117_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47331
5.73034186281157e-58	-0.263346349458871	0.257	0.377	1.05919638992209e-53	HSPA5	Malignant cells	GSE162117_pre	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47332
1.61009864723584e-55	0.534295079460649	0.618	0.583	2.97610633955073e-51	IFITM2	Malignant cells	GSE162117_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47333
2.62185387315965e-55	-0.312580296543293	0.281	0.406	4.84623469914829e-51	FCGR3A	Malignant cells	GSE162117_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47334
2.61491591402082e-53	0.34428696072984	0.703	0.659	4.83341057547608e-49	NPM1	Malignant cells	GSE162117_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47335
1.626064173345e-45	0.344677065611953	0.298	0.202	3.00561701801091e-41	APOBEC3A	Malignant cells	GSE162117_pre	ENSG00000262156	200315	apolipoprotein B mRNA editing enzyme catalytic subunit 3A	ARP3|PHRBN	protein_coding	P31941	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47336
1.71753807768672e-43	-0.330160305503739	0.623	0.696	3.17469738279613e-39	JUN	Malignant cells	GSE162117_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47337
3.53443509297117e-38	0.26742341716685	0.779	0.739	6.53304982584791e-34	ZFAS1	Malignant cells	GSE162117_pre	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47338
2.92280804746233e-35	0.274055644159574	0.661	0.608	5.40251839492938e-31	CD44	Malignant cells	GSE162117_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47339
1.99090278004356e-34	0.318895506358455	0.422	0.354	3.67998469863251e-30	STXBP2	Malignant cells	GSE162117_pre	ENSG00000076944	6813	syntaxin binding protein 2	Hunc18b|MUNC18-2|Unc18-2|UNC18B	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47340
1.10464860860362e-18	0.386208114399636	0.641	0.656	2.04183248814294e-14	HLA-DPA1	Malignant cells	GSE162117_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47341
2.39234005868733e-18	0.254092338365572	0.346	0.298	4.42200136447766e-14	IFI30	Malignant cells	GSE162117_pre	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47342
3.27655880400854e-12	0.305668167246212	0.289	0.34	6.05639129332939e-08	HBG2	Malignant cells	GSE162117_pre	ENSG00000196565	3048	hemoglobin subunit gamma 2	HBG-T1	protein_coding	P69892	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47343
7.26244892808946e-10	0.50311896131978	1	0.991	1.34239105986806e-05	RPS29	B cells	GSE162117_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47344
1.42891537110644e-09	0.468507731249591	1	1	2.64120717195314e-05	RPL36	B cells	GSE162117_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47345
2.22122175137269e-09	0.451412170301178	1	1	4.10570628523728e-05	RPL37	B cells	GSE162117_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47346
4.52885551376748e-09	0.787293147724631	0.688	0.228	8.37113653164781e-05	CRIP1	B cells	GSE162117_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47347
5.44069685633506e-09	0.508438621667125	1	0.991	0.000100565840692497	RPS21	B cells	GSE162117_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47348
8.33100623875905e-09	0.499210913585022	1	1	0.000153990319317222	RPL37A	B cells	GSE162117_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47349
2.21883531579178e-08	0.450999712456042	1	1	0.000410129519770952	RPS28	B cells	GSE162117_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47350
1.16813755817457e-07	0.658211482751795	0.688	0.263	0.00215918546252987	NDUFB1	B cells	GSE162117_pre	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47351
1.54245981209644e-07	0.52210247688258	0.5	0.123	0.00285108271667907	PTPN2	B cells	GSE162117_pre	ENSG00000175354	5771	protein tyrosine phosphatase non-receptor type 2	PTPT|TC-PTP|TCELLPTP|TCPTP	protein_coding	P17706	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47352
1.70197234922759e-07	0.740631506312753	0.979	0.833	0.00314592569031228	HLA-DRB1	B cells	GSE162117_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47353
6.48879477075833e-07	0.707096274279137	1	0.991	0.0119938882542697	MT-ND3	B cells	GSE162117_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47354
1.70615679276434e-06	-0.346477625274917	1	1	0.0315366021574561	RPL13	B cells	GSE162117_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47355
2.08521361124053e-06	0.308300131423067	0.271	0.026	0.03854308839017	FXYD1	B cells	GSE162117_pre	ENSG00000266964	5348	FXYD domain containing ion transport regulator 1	PLM	protein_coding	O00168	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47356
2.23665111771176e-06	0.486015562147148	1	1	0.0413422592597842	RPL38	B cells	GSE162117_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47357
7.46895788027709e-35	0.438040355956814	1	0.998	1.38056217459042e-30	RPL37A	CD8+ T cells	GSE162117_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47358
7.3978170163641e-33	0.589831491781932	1	1	1.36741249730474e-28	RPS29	CD8+ T cells	GSE162117_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47359
4.40755519952122e-29	0.570969828884359	0.735	0.392	8.14692503079502e-25	RPS4Y1	CD8+ T cells	GSE162117_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47360
8.42113100304087e-29	0.630367857844639	1	0.982	1.55656185460207e-24	MT-ND3	CD8+ T cells	GSE162117_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47361
5.40555400451058e-28	0.453594032297814	0.993	0.99	9.99162602193735e-24	RPL38	CD8+ T cells	GSE162117_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47362
9.74030049118574e-28	0.480502160472005	1	0.992	1.80039714279077e-23	RPS21	CD8+ T cells	GSE162117_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47363
1.9759003688387e-23	0.405868450021855	1	1	3.65225424176146e-19	RPS28	CD8+ T cells	GSE162117_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47364
2.3208117778841e-23	0.363730664084874	1	1	4.28978849024098e-19	RPL37	CD8+ T cells	GSE162117_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47365
1.56789444373436e-22	-0.685210905908372	0.832	0.904	2.8980960897986e-18	CCL5	CD8+ T cells	GSE162117_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47366
7.43943975957408e-21	0.288630010319104	1	1	1.37510604515967e-16	RPL41	CD8+ T cells	GSE162117_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47367
2.08911497037973e-17	0.405536019130958	1	0.998	3.8615201112499e-13	MT-ND2	CD8+ T cells	GSE162117_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47368
2.24384147886617e-16	0.30218584395074	1	0.999	4.14751658953623e-12	RPL36	CD8+ T cells	GSE162117_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47369
5.59674142979387e-16	0.317696049440055	1	0.999	1.0345016858831e-11	RPL39	CD8+ T cells	GSE162117_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47370
9.11249514698756e-16	0.329624422869684	0.413	0.202	1.68435360296918e-11	AAK1	CD8+ T cells	GSE162117_pre	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47371
1.82450656675104e-15	0.409818034212035	1	1	3.37241793798262e-11	RPS27	CD8+ T cells	GSE162117_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47372
2.3573281267882e-15	0.484230837118584	0.43	0.219	4.35728530955531e-11	IFI6	CD8+ T cells	GSE162117_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47373
4.22032561132334e-15	-0.347976166676443	1	1	7.80084985997006e-11	RPS4X	CD8+ T cells	GSE162117_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47374
9.6429981809251e-15	-0.651432849683906	0.359	0.584	1.7824117837622e-10	GZMH	CD8+ T cells	GSE162117_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47375
2.41746751578128e-14	0.397016865205956	0.379	0.192	4.46844695617012e-10	IFITM1	CD8+ T cells	GSE162117_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47376
3.8304354581559e-14	0.415316581800325	0.886	0.751	7.08017690085537e-10	RPL36A	CD8+ T cells	GSE162117_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47377
3.06171378678319e-13	0.369716531881005	0.46	0.263	5.65927176349005e-09	EIF5A	CD8+ T cells	GSE162117_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47378
6.65174363170397e-13	-0.448074749742134	0.272	0.486	1.22950829288416e-08	HLA-DPB1	CD8+ T cells	GSE162117_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47379
1.4817028973586e-12	0.30337180188415	0.497	0.287	2.73877963547763e-08	DONSON	CD8+ T cells	GSE162117_pre	ENSG00000159147	29980	DNA replication fork stabilization factor DONSON	B17|C21orf60|C2TA|DKFZP434M035	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47380
5.51437720980342e-12	0.2660806101933	1	1	1.01927748346006e-07	MT-CO2	CD8+ T cells	GSE162117_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47381
7.62794201439301e-10	0.349479581962283	0.265	0.129	1.4099488019404e-05	LST1	CD8+ T cells	GSE162117_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47382
1.28481802333733e-09	0.265595151081194	0.997	0.993	2.37485763433673e-05	MT-ND1	CD8+ T cells	GSE162117_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47383
1.40727738721942e-09	0.390980475475287	0.433	0.264	2.60121152253638e-05	S100A8	CD8+ T cells	GSE162117_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47384
1.69983091742785e-09	0.340429182503347	0.742	0.589	3.14196746777363e-05	SON	CD8+ T cells	GSE162117_pre	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47385
4.98115520504087e-09	-0.371102994199672	0.832	0.878	9.20716728099755e-05	PTPRC	CD8+ T cells	GSE162117_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47386
1.47937382563464e-08	0.287831341722056	0.587	0.418	0.000273447457930307	ATP5I	CD8+ T cells	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47387
1.77546844453456e-08	-0.322663863326968	0.799	0.877	0.000328177587287768	RPS26	CD8+ T cells	GSE162117_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47388
2.15841965066314e-08	0.31369556006076	0.654	0.479	0.000398962288228574	IFITM2	CD8+ T cells	GSE162117_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47389
6.61516914750772e-08	-0.321420334008245	0.144	0.293	0.00122274786522533	KLRD1	CD8+ T cells	GSE162117_pre	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47390
1.10953074601681e-07	-0.295121169375451	0.138	0.281	0.00205085663093748	HOPX	CD8+ T cells	GSE162117_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47391
1.32339271965539e-07	-0.2864236399937	0.936	0.947	0.00244615910301103	CD52	CD8+ T cells	GSE162117_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47392
4.22488629600098e-07	-0.321044856245807	0.836	0.873	0.00780927982952822	NKG7	CD8+ T cells	GSE162117_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47393
8.17077506261286e-07	-0.27143287257626	0.621	0.739	0.0151028606257336	EMP3	CD8+ T cells	GSE162117_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47394
9.47765385614839e-07	0.583881607415157	0.453	0.318	0.0175184953877047	KLRB1	CD8+ T cells	GSE162117_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47395
1.54330360954876e-06	-0.309988840611584	0.386	0.528	0.0285264239188993	GIMAP7	CD8+ T cells	GSE162117_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47396
2.11116037492881e-06	-0.342070534238973	0.752	0.8	0.0390226883701842	GZMA	CD8+ T cells	GSE162117_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47397
6.35960515721059e-18	-1.53318885099711	0.246	0.987	1.17550941725881e-13	HLA-DRB5	cDCs	GSE162117_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47398
8.30499519709156e-16	-1.72202871262253	0.154	0.831	1.5350953122304e-11	FCER1A	cDCs	GSE162117_pre	ENSG00000179639	2205	Fc epsilon receptor Ia	FCE1A|FcepsilonRIalpha|FCERIA	protein_coding	P12319	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47399
9.15829175750745e-14	0.928556633478439	0.738	0.117	1.69281864845768e-09	DONSON	cDCs	GSE162117_pre	ENSG00000159147	29980	DNA replication fork stabilization factor DONSON	B17|C21orf60|C2TA|DKFZP434M035	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47400
1.21136133671719e-13	0.575391962156816	1	1	2.23908029478805e-09	RPL39	cDCs	GSE162117_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47401
7.22666182338958e-13	-1.57149820789458	0.862	0.935	1.33577617143533e-08	LYZ	cDCs	GSE162117_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47402
8.8124118005627e-13	0.583183485548432	1	1	1.62888619721601e-08	RPS29	cDCs	GSE162117_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47403
5.41044866866353e-12	-1.06968986276162	0.523	0.935	1.00006733191577e-07	DUSP1	cDCs	GSE162117_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47404
1.99403007374116e-11	-0.577377706779643	1	1	3.68576518830317e-07	TPT1	cDCs	GSE162117_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47405
7.47555856475505e-11	0.624266798482991	0.585	0.078	1.38178224510932e-06	RP1-3J17.3	cDCs	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47406
6.48287118123541e-10	-0.949591892300179	0.015	0.481	1.19829390913955e-05	HLA-DQA2	cDCs	GSE162117_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47407
2.25425479817974e-09	1.27298787986322	0.677	0.273	4.16676456895543e-05	IFI6	cDCs	GSE162117_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47408
1.95184438521587e-08	-0.934689595941201	0.169	0.623	0.000360778916163301	CD1C	cDCs	GSE162117_pre	ENSG00000158481	911	CD1c molecule	CD1	protein_coding	P29017	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47409
2.21702486798345e-08	1.06754096558237	0.646	0.247	0.000409794876598061	ISG15	cDCs	GSE162117_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47410
2.53907473763937e-08	0.893157138820918	0.754	0.39	0.000469322574505261	HCST	cDCs	GSE162117_pre	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47411
4.85172625565065e-08	0.663795162669628	0.908	0.688	0.000896793081094465	TPM3	cDCs	GSE162117_pre	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47412
9.32802132321167e-08	0.589915293692214	0.492	0.091	0.00172419146138245	IFI44L	cDCs	GSE162117_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47413
1.11894500161676e-07	0.369066262660717	1	1	0.00206825794098841	RPL37A	cDCs	GSE162117_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47414
1.27812398647747e-07	0.399465941392753	1	1	0.00236248437660496	RPS27	cDCs	GSE162117_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47415
1.35272957585175e-07	-0.999506855219642	0.108	0.506	0.00250038534800438	FCN1	cDCs	GSE162117_pre	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47416
1.8008604376962e-07	-0.584309845183724	0.031	0.403	0.00332871043303766	HBA2	cDCs	GSE162117_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47417
2.80593158650254e-07	0.371302347815555	1	1	0.00518648394449129	RPL37	cDCs	GSE162117_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47418
2.83420043310426e-07	-0.912764604884284	0.646	0.909	0.00523873608054992	JUNB	cDCs	GSE162117_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47419
9.24208964441904e-07	-0.63427497611142	0.4	0.844	0.0170830784987441	CD52	cDCs	GSE162117_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47420
1.39946565546816e-06	0.427207946531147	1	0.987	0.0258677231756735	RPS21	cDCs	GSE162117_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47421
1.44706496892645e-06	0.641489680415842	0.631	0.273	0.0267475488856365	LY6E	cDCs	GSE162117_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47422
1.75474493772621e-06	0.586810925113525	0.723	0.377	0.0324347054289313	STK17B	cDCs	GSE162117_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47423
1.97769271900966e-06	0.425150484065342	1	1	0.0365556722181746	RPL38	cDCs	GSE162117_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47424
2.3549466507769e-06	-0.42747940982599	1	1	0.0435288338929603	H3F3A	cDCs	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47425
2.63473123606731e-06	-0.444379584039249	0.031	0.351	0.0487003721674682	ILF3-AS1	cDCs	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47426
7.08634980623483e-33	0.560697222850254	1	1	1.30984089818445e-28	RPS28	NK cells	GSE162117_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47427
1.21673106519439e-32	0.619981170910642	1	1	2.24900570090531e-28	RPS29	NK cells	GSE162117_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47428
3.21304769077607e-29	0.479432150442829	1	1	5.93899735163049e-25	RPL37	NK cells	GSE162117_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47429
6.66002219246336e-24	0.596178613991422	1	0.987	1.23103850205493e-19	MT-ND3	NK cells	GSE162117_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47430
2.88211094071148e-22	0.506809260655299	1	0.992	5.32729386281111e-18	RPS21	NK cells	GSE162117_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47431
8.94383640944159e-22	0.429866430627625	1	1	1.65317872192118e-17	RPL39	NK cells	GSE162117_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47432
1.09869981081434e-21	0.351874553352078	1	1	2.03083673030923e-17	RPL41	NK cells	GSE162117_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47433
2.82888593587466e-21	0.4220903766882	1	1	5.22891276387073e-17	RPL37A	NK cells	GSE162117_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47434
4.56634825868347e-20	0.624920443542994	0.884	0.7	8.44043812135053e-16	RPL36A	NK cells	GSE162117_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47435
1.37571054925183e-18	0.482523654180211	0.489	0.195	2.54286337923708e-14	DONSON	NK cells	GSE162117_pre	ENSG00000159147	29980	DNA replication fork stabilization factor DONSON	B17|C21orf60|C2TA|DKFZP434M035	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47436
5.90883120966859e-18	0.401736336490552	1	0.99	1.09218836079514e-13	RPL36	NK cells	GSE162117_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47437
7.74369992624769e-18	0.441247378601692	0.996	0.99	1.43134549436762e-13	RPL38	NK cells	GSE162117_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47438
7.71717302948873e-16	0.406283568268258	1	1	1.4264422627707e-11	RPS27	NK cells	GSE162117_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47439
1.00892801431338e-15	-0.617981503552484	0.827	0.936	1.86490254165686e-11	CCL5	NK cells	GSE162117_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47440
2.80160407250773e-12	-0.550692851604356	0.271	0.54	5.17848496762328e-08	FGFBP2	NK cells	GSE162117_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47441
4.93190401585745e-12	0.422801711280874	0.689	0.429	9.11613138291091e-08	RPS4Y1	NK cells	GSE162117_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47442
7.99646203220011e-12	-0.514776799330042	0.809	0.941	1.47806604203187e-07	GZMA	NK cells	GSE162117_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47443
1.96671256036508e-11	0.573961300946932	0.378	0.173	3.63527149657882e-07	IFITM3	NK cells	GSE162117_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47444
2.68440894973155e-11	0.317908412749543	1	0.998	4.9618615026838e-07	MT-ND2	NK cells	GSE162117_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47445
9.53001170913883e-11	0.342228583914928	0.991	0.98	1.76152736431722e-06	RPL23	NK cells	GSE162117_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47446
2.51272815501624e-10	0.29828942475965	1	1	4.64452672173203e-06	RPL31	NK cells	GSE162117_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47447
3.20281910092322e-10	0.279524190272167	1	0.998	5.92009082614648e-06	RPS24	NK cells	GSE162117_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47448
1.94966532607009e-09	-0.50304318881202	0.547	0.738	3.60376138870795e-05	GZMH	NK cells	GSE162117_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47449
3.29316348424367e-09	0.26177768940703	0.996	1	6.087083384276e-05	RPL35A	NK cells	GSE162117_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47450
1.05428942361286e-08	-0.370116888438056	0.267	0.489	0.000194874857060601	GIMAP7	NK cells	GSE162117_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47451
1.09111716897413e-08	0.330288470671617	0.427	0.234	0.000201682097513177	EIF5A	NK cells	GSE162117_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47452
1.74426463056446e-08	0.29999171999065	0.489	0.277	0.000322409874313534	CD44	NK cells	GSE162117_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47453
2.35764143415899e-08	0.257070046892636	1	1	0.000435786442689947	RPS19	NK cells	GSE162117_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47454
2.37752407057508e-08	-0.424886955109057	0.649	0.766	0.000439461549205097	SUB1	NK cells	GSE162117_pre	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47455
1.1493069466505e-07	-0.390270481601172	0.422	0.625	0.00212437896018879	ANXA1	NK cells	GSE162117_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47456
1.6331869593743e-07	0.288125111244893	0.449	0.264	0.00301878277570745	S100A8	NK cells	GSE162117_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47457
1.66233236210933e-07	0.390678554199055	0.827	0.723	0.00307265513812289	IFITM2	NK cells	GSE162117_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47458
2.75291267257069e-07	0.349942471056959	0.413	0.255	0.00508848378397967	IFITM1	NK cells	GSE162117_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47459
5.12944586387687e-07	-0.578070798598087	0.6	0.74	0.00948126773479001	LGALS1	NK cells	GSE162117_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47460
6.95346004514322e-07	-0.362687482492205	0.662	0.766	0.0128527755474427	EMP3	NK cells	GSE162117_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47461
1.14107903636603e-06	0.419312408097807	0.302	0.164	0.0210917049081896	XCL2	NK cells	GSE162117_pre	ENSG00000143185	6846	X-C motif chemokine ligand 2	SCM-1b|SCYC2	protein_coding	Q9UBD3	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47462
1.16298855592133e-06	0.355207547535001	0.347	0.2	0.0214966804676498	IL2RB	NK cells	GSE162117_pre	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47463
1.34915916285761e-06	0.270640413052666	0.631	0.442	0.0249378579662601	FXYD5	NK cells	GSE162117_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47464
5.88460740284539e-13	0.693658547586429	0.469	0.047	1.08771083234194e-08	RP11-620J15.3	Erythrocytes	GSE162117_pre	NA	NA	NA	NA	NA	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47465
5.7874732701233e-12	0.911217186308996	0.469	0.061	1.06975655924959e-07	MGST1	Erythrocytes	GSE162117_pre	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47466
3.33941206989751e-11	-1.28806145557046	0.878	0.986	6.17256926999855e-07	TMSB4X	Erythrocytes	GSE162117_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47467
5.75133676666592e-11	0.666002204683563	0.449	0.061	1.06307708795053e-06	IGFBP7	Erythrocytes	GSE162117_pre	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47468
1.03543239619359e-10	0.468366235744186	0.388	0.034	1.91389324112424e-06	RAB13	Erythrocytes	GSE162117_pre	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47469
1.77090499210382e-09	0.477704100323522	0.347	0.034	3.27334078740469e-05	PRSS57	Erythrocytes	GSE162117_pre	ENSG00000185198	400668	serine protease 57	PRSSL1|UNQ782	protein_coding	Q6UWY2	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47470
3.27124056960131e-09	-1.16014398064973	0.898	0.986	6.04656106885105e-05	B2M	Erythrocytes	GSE162117_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47471
4.00713552438119e-09	-1.18815835681932	0.347	0.784	7.40678930326619e-05	TXNIP	Erythrocytes	GSE162117_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47472
6.81771787711861e-09	0.926365012604948	0.469	0.101	0.00012601869724066	ANKRD28	Erythrocytes	GSE162117_pre	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47473
2.00816167580572e-08	-1.00020306778004	0.469	0.899	0.000371188604155929	HLA-B	Erythrocytes	GSE162117_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47474
9.97152650433439e-08	0.50163411712226	0.388	0.074	0.00184313695906117	CAT	Erythrocytes	GSE162117_pre	ENSG00000121691	847	catalase	NA	protein_coding	P04040	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47475
1.09323242933939e-07	-0.967135366094374	0.265	0.649	0.00202073082239093	BTG1	Erythrocytes	GSE162117_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47476
1.23720131829164e-07	0.473280009028074	0.367	0.068	0.00228684291673026	CDK6	Erythrocytes	GSE162117_pre	ENSG00000105810	1021	cyclin dependent kinase 6	PLSTIRE	protein_coding	Q00534	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47477
3.45255546520346e-07	-0.950535277734933	0.388	0.777	0.00638170352188208	HLA-C	Erythrocytes	GSE162117_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47478
8.42414259849881e-07	0.32795698081884	0.286	0.041	0.0155711851790652	NPDC1	Erythrocytes	GSE162117_pre	ENSG00000107281	56654	neural proliferation, differentiation and control 1	CAB-|CAB1|DKFZp586J0523	protein_coding	Q9NQX5	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47479
1.26389374894989e-06	0.457239997763807	0.408	0.108	0.0233618120555897	NFE2	Erythrocytes	GSE162117_pre	ENSG00000123405	4778	nuclear factor, erythroid 2	NF-E2	protein_coding	Q16621	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47480
1.432985308714e-06	0.413573762903807	0.327	0.061	0.0264873004462695	SOX4	Erythrocytes	GSE162117_pre	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47481
1.48397417185872e-06	-1.2687544785814	0.082	0.453	0.0274297785926366	IL32	Erythrocytes	GSE162117_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47482
2.34101682846692e-06	-0.807945585337457	0.204	0.601	0.0432713550573826	CALM1	Erythrocytes	GSE162117_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47483
2.66695304890972e-06	-0.965127998244584	0.102	0.486	0.0492959601560474	LTB	Erythrocytes	GSE162117_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE162117	GSE162117	Acute myeloid leukemia	Tefractory acute myeloid leukemia (AML)	Targeted therapy	pre	ficlatuzumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 7); post (resistant 3, sensitive 6)	20	43486	Public on Sep 03, 2021	34514432	This dataset has 11 patients, 9 of whom have both pre- and post-treatment samples.	PRJNA680611	10x genomics	CellRanger 2.0.1	Acute_myeloid_leukemia	Targeted_therapy	47484
0	0.543530661476595	0.549	0.207	0	EPHA2	Malignant cells	GSE164897_Vem	ENSG00000142627	1969	EPH receptor A2	ECK	protein_coding	P29317	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47485
0	-1.04673651179411	0.326	0.73	0	ID3	Malignant cells	GSE164897_Vem	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47486
0	1.02081820354224	0.65	0.231	0	SERINC2	Malignant cells	GSE164897_Vem	ENSG00000168528	347735	serine incorporator 2	FKSG84|PRO0899|TDE2|TDE2L	protein_coding	Q96SA4	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47487
0	0.827719368813548	0.817	0.468	0	TINAGL1	Malignant cells	GSE164897_Vem	ENSG00000142910	64129	tubulointerstitial nephritis antigen like 1	ARG1|LCN7|LIECG3|P3ECSL|TINAGRP	protein_coding	Q9GZM7	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47488
0	0.858887957043544	0.672	0.211	0	ARHGAP29	Malignant cells	GSE164897_Vem	ENSG00000137962	9411	Rho GTPase activating protein 29	PARG1	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47489
0	0.731432036979125	1	0.999	0	S100A10	Malignant cells	GSE164897_Vem	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47490
0	0.54543859787397	0.999	0.996	0	S100A11	Malignant cells	GSE164897_Vem	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47491
0	0.621239390038656	1	1	0	S100A6	Malignant cells	GSE164897_Vem	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47492
0	1.06031464342094	0.839	0.632	0	S100A4	Malignant cells	GSE164897_Vem	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47493
0	1.2680454159891	0.874	0.547	0	S100A2	Malignant cells	GSE164897_Vem	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47494
0	0.702645698561483	0.978	0.908	0	LMNA	Malignant cells	GSE164897_Vem	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47495
0	0.873924228513435	0.969	0.922	0	CALM2	Malignant cells	GSE164897_Vem	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47496
0	0.403232128149654	1	1	0	TMSB10	Malignant cells	GSE164897_Vem	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47497
0	0.575812857492219	0.525	0.194	0	LINC00973	Malignant cells	GSE164897_Vem	ENSG00000240476	105374003	uncharacterized LOC105374003	CTD-2021J15.2	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47498
0	1.06255678549134	0.795	0.367	0	TM4SF1	Malignant cells	GSE164897_Vem	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47499
0	0.730062981113016	0.435	0.112	0	AREG	Malignant cells	GSE164897_Vem	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47500
0	1.28442764899234	0.931	0.802	0	AP3S1	Malignant cells	GSE164897_Vem	ENSG00000177879	1176	adaptor related protein complex 3 subunit sigma 1	CLAPS3	protein_coding	Q92572	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47501
0	-1.22163723992679	0.599	0.834	0	CD74	Malignant cells	GSE164897_Vem	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47502
0	0.64263354373437	1	0.999	0	HMGA1	Malignant cells	GSE164897_Vem	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47503
0	1.11771422870468	0.82	0.375	0	CAV1	Malignant cells	GSE164897_Vem	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47504
0	0.497401931043734	0.423	0.106	0	GAGE1	Malignant cells	GSE164897_Vem	ENSG00000205777	2543	G antigen 1	CT4.1	protein_coding	P0DTW1	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47505
0	0.95844886325952	0.474	0.037	0	GAGE2A	Malignant cells	GSE164897_Vem	ENSG00000189064	26749	G antigen 2E	CT4.2|GAGE2	protein_coding	Q6NT46	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47506
0	-0.638240094664573	0.871	0.963	0	RBMX	Malignant cells	GSE164897_Vem	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47507
0	2.2965085131995	0.965	0.458	0	SPANXB1	Malignant cells	GSE164897_Vem	ENSG00000227234	728695	SPANX family member B1	CT11.2|SPANXB2|SPANXF1|SPANXF2	protein_coding	Q9NS25	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47508
0	1.15455784599364	0.727	0.183	0	SPANXC	Malignant cells	GSE164897_Vem	ENSG00000198573	64663	SPANX family member C	CT11.3|CTp11	protein_coding	Q9NY87	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47509
0	-1.47164685729506	0.001	0.688	0	LINC01419	Malignant cells	GSE164897_Vem	ENSG00000253898	103352670	long intergenic non-protein coding RNA 1419	PRLH1|TCONS_00014497	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47510
0	0.844329852766637	0.646	0.224	0	PRSS23	Malignant cells	GSE164897_Vem	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47511
0	0.626866045863539	0.495	0.164	0	DKK1	Malignant cells	GSE164897_Vem	ENSG00000107984	22943	dickkopf WNT signaling pathway inhibitor 1	DKK-1|SK	protein_coding	O94907	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47512
0	1.42990802224724	0.914	0.452	0	KRT7	Malignant cells	GSE164897_Vem	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47513
0	0.981717011223787	0.999	0.991	0	KRT18	Malignant cells	GSE164897_Vem	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47514
0	-0.312311823485985	1	1	0	RPL41	Malignant cells	GSE164897_Vem	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47515
0	-0.263157409932038	1	1	0	RPL6	Malignant cells	GSE164897_Vem	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47516
0	0.605484383813714	0.584	0.216	0	RHOF	Malignant cells	GSE164897_Vem	ENSG00000139725	54509	ras homolog family member F, filopodia associated	ARHF|FLJ20247|RIF	protein_coding	Q9HBH0	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47517
0	-0.345821413048857	1	1	0	RPS29	Malignant cells	GSE164897_Vem	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47518
0	0.551542800528644	0.476	0.154	0	MOK	Malignant cells	GSE164897_Vem	ENSG00000080823	5891	MOK protein kinase	RAGE|RAGE1|STK30	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47519
0	-0.686422553857734	0.938	0.989	0	EIF3J	Malignant cells	GSE164897_Vem	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47520
0	0.868523877488293	0.987	0.925	0	RPS27L	Malignant cells	GSE164897_Vem	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47521
0	0.627734041714892	0.999	0.999	0	PKM	Malignant cells	GSE164897_Vem	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47522
0	1.11138200096479	0.999	0.995	0	MT2A	Malignant cells	GSE164897_Vem	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47523
0	0.708224968429369	0.514	0.139	0	IGFBP4	Malignant cells	GSE164897_Vem	ENSG00000141753	3487	insulin like growth factor binding protein 4	BP-4|HT29-IGFBP|IBP4|IGFBP-4	protein_coding	P22692	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47524
0	0.916088734692008	0.623	0.19	0	SLC14A1	Malignant cells	GSE164897_Vem	ENSG00000141469	6563	solute carrier family 14 member 1 (Kidd blood group)	HsT1341|JK|RACH1|RACH2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47525
0	-1.13331076727449	0.902	0.963	0	SNRPB2	Malignant cells	GSE164897_Vem	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47526
0	-0.517908655130747	0.976	0.997	0	DSTN	Malignant cells	GSE164897_Vem	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47527
0	0.826096300819952	0.643	0.23	0	TGM2	Malignant cells	GSE164897_Vem	ENSG00000198959	7052	transglutaminase 2	TGC	protein_coding	P21980	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47528
0	-0.859671900176344	0.423	0.77	0	PMEPA1	Malignant cells	GSE164897_Vem	ENSG00000124225	56937	prostate transmembrane protein, androgen induced 1	STAG1|TMEPAI	protein_coding	Q969W9	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47529
0	-0.31267900550204	1	1	0	RPS21	Malignant cells	GSE164897_Vem	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47530
0	0.669806648097299	0.589	0.203	0	DMKN	Malignant cells	GSE164897_Vem	ENSG00000161249	93099	dermokine	ZD52F10	protein_coding	Q6E0U4	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47531
0	2.16717817605068	0.977	0.449	0	C19orf33	Malignant cells	GSE164897_Vem	ENSG00000167644	64073	chromosome 19 open reading frame 33	H2RSP|IMUP|IMUP-1|IMUP-2	protein_coding	Q9GZP8	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47532
0	0.594693139449082	0.386	0.096	0	RUNX1	Malignant cells	GSE164897_Vem	ENSG00000159216	861	RUNX family transcription factor 1	AML1|AMLCR1|CBFA2|PEBP2A2	protein_coding	Q01196	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47533
1.21100255264116e-306	0.598457624485758	0.812	0.515	1.91738034159674e-302	PLAAT3	Malignant cells	GSE164897_Vem	ENSG00000176485	11145	phospholipase A and acyltransferase 3	AdPLA|H-REV107-1|HRASLS3|HREV107|HREV107-3|MGC118754.|PLA2G16|PLAAT-3	protein_coding	P53816	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47534
4.07427095343688e-299	-0.893147450329454	0.29	0.619	6.45079320057661e-295	SLC26A2	Malignant cells	GSE164897_Vem	ENSG00000155850	1836	solute carrier family 26 member 2	DTD|DTDST	protein_coding	P50443	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47535
1.8373237236389e-294	-0.580459418563644	0.74	0.889	2.90903465163747e-290	NMT1	Malignant cells	GSE164897_Vem	ENSG00000136448	4836	N-myristoyltransferase 1	NMT	protein_coding	P30419	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47536
2.32381799228118e-285	0.416073779963554	1	0.999	3.67930102717879e-281	ALDOA	Malignant cells	GSE164897_Vem	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47537
2.88793073466207e-281	0.820774228077812	0.829	0.611	4.57246073219045e-277	FOSL1	Malignant cells	GSE164897_Vem	ENSG00000175592	8061	FOS like 1, AP-1 transcription factor subunit	fra-1	protein_coding	P15407	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47538
4.87961701732268e-274	-0.424330715499631	1	1	7.725897623527e-270	NPM1	Malignant cells	GSE164897_Vem	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47539
1.07969539140267e-270	0.562256182506614	0.597	0.286	1.70948171320785e-266	CTNNAL1	Malignant cells	GSE164897_Vem	ENSG00000119326	8727	catenin alpha like 1	alpha-CATU|CLLP	protein_coding	Q9UBT7	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47540
1.82886547621298e-268	0.577895466918911	0.866	0.664	2.89564270848801e-264	MGST1	Malignant cells	GSE164897_Vem	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47541
1.62607150446918e-265	0.527461691072148	0.625	0.31	2.57455901302605e-261	MIR4435-2HG	Malignant cells	GSE164897_Vem	ENSG00000172965	541471	MIR4435-2 host gene	AGD2|AK001796|LINC00978|lncRNA-AWPPH|MIR4435-1HG|MORRBID	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47542
9.33029386899191e-261	0.513643554844198	0.672	0.366	1.47726542827749e-256	CAPN2	Malignant cells	GSE164897_Vem	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47543
1.24467704851305e-257	-0.606248640474612	0.733	0.887	1.97069717091071e-253	CYBA	Malignant cells	GSE164897_Vem	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47544
2.16025481512486e-255	-0.401909791446984	0.99	0.998	3.42033144878719e-251	SNHG8	Malignant cells	GSE164897_Vem	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47545
5.88669741319421e-253	0.443465457398009	1	0.999	9.3204080143104e-249	TXN	Malignant cells	GSE164897_Vem	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47546
2.5562902217597e-252	0.396600028403721	0.322	0.074	4.04737430811213e-248	BIK	Malignant cells	GSE164897_Vem	ENSG00000100290	638	BCL2 interacting killer	NBK	protein_coding	Q13323	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47547
9.7454273031335e-252	0.516600119644395	0.578	0.276	1.54299350490513e-247	PDLIM1	Malignant cells	GSE164897_Vem	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47548
7.69964037865945e-247	0.563913105937748	0.983	0.939	1.21908406115315e-242	TNFRSF12A	Malignant cells	GSE164897_Vem	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47549
1.56461503599051e-246	0.586072157246586	0.837	0.541	2.47725498648378e-242	IGFBP6	Malignant cells	GSE164897_Vem	ENSG00000167779	3489	insulin like growth factor binding protein 6	NA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47550
1.73228671207418e-245	-0.684092424190559	0.565	0.766	2.74272955122705e-241	GNAS	Malignant cells	GSE164897_Vem	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47551
1.36393747697017e-244	0.3635432035836	1	0.999	2.15952220728687e-240	SH3BGRL3	Malignant cells	GSE164897_Vem	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47552
5.22201197380838e-244	0.543888797791373	0.738	0.465	8.2680115581308e-240	ANXA5	Malignant cells	GSE164897_Vem	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47553
7.64653736802069e-240	0.491098321726812	0.987	0.985	1.21067626147872e-235	SNRPG	Malignant cells	GSE164897_Vem	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47554
3.84352731565677e-238	-0.694342356722588	0.241	0.543	6.08545679887937e-234	CAPS	Malignant cells	GSE164897_Vem	ENSG00000105519	828	calcyphosine	CAPS1|MGC126562	protein_coding	Q13938	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47555
1.25855881410674e-233	0.469305629370497	0.36	0.109	1.99267617037519e-229	APOBEC3G	Malignant cells	GSE164897_Vem	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47556
1.80960696403982e-232	-0.561971890288	0.703	0.861	2.86515070616425e-228	SNHG25	Malignant cells	GSE164897_Vem	ENSG00000266402	NA	NA	NA	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47557
5.74932018971693e-232	0.637144438434452	0.638	0.353	9.10289865637881e-228	AKAP12	Malignant cells	GSE164897_Vem	ENSG00000131016	9590	A-kinase anchoring protein 12	AKAP250|SSeCKS	protein_coding	Q02952	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47558
1.46420662072241e-227	0.394864997857084	0.999	0.988	2.3182783425898e-223	POLR2L	Malignant cells	GSE164897_Vem	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47559
1.58696419916566e-224	0.628163181123782	0.734	0.498	2.51264041653898e-220	ATG12	Malignant cells	GSE164897_Vem	ENSG00000145782	9140	autophagy related 12	APG12|APG12L	protein_coding	O94817	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47560
1.33264905748089e-223	-0.820829770514692	0.68	0.839	2.10998325270949e-219	HES1	Malignant cells	GSE164897_Vem	ENSG00000114315	3280	hes family bHLH transcription factor 1	bHLHb39|FLJ20408|HES-1|HRY	protein_coding	Q14469	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47561
1.51790149224826e-223	0.501432732755394	0.999	0.999	2.40329343267666e-219	ACTB	Malignant cells	GSE164897_Vem	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47562
1.82251381709229e-222	0.441412663844732	0.5	0.218	2.88558612660223e-218	ANPEP	Malignant cells	GSE164897_Vem	ENSG00000166825	290	alanyl aminopeptidase, membrane	AP-N|CD13|gp150|hAPN|LAP1|p150|PEPN	protein_coding	P15144	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47563
1.57832833626529e-216	-0.57728462224347	0.43	0.678	2.49896725480884e-212	LMO4	Malignant cells	GSE164897_Vem	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47564
2.25506308817827e-216	0.438967965057399	0.963	0.886	3.57044138751266e-212	SUB1	Malignant cells	GSE164897_Vem	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47565
1.07772306138326e-215	-0.504172014323762	0.126	0.399	1.70635892308812e-211	ERBB3	Malignant cells	GSE164897_Vem	ENSG00000065361	2065	erb-b2 receptor tyrosine kinase 3	HER3|LCCS2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47566
2.98604587510979e-215	0.477663758742613	0.464	0.188	4.72780643406134e-211	THBS1	Malignant cells	GSE164897_Vem	ENSG00000137801	7057	thrombospondin 1	THBS|THBS-1|TSP|TSP-1|TSP1	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47567
3.03288545356962e-214	0.381943146638422	0.37	0.122	4.80196753863677e-210	CAV2	Malignant cells	GSE164897_Vem	ENSG00000105971	858	caveolin 2	CAV	protein_coding	P51636	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47568
5.6064597835908e-212	0.569707830851453	0.792	0.56	8.87670777535931e-208	DUSP4	Malignant cells	GSE164897_Vem	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47569
1.61370150079207e-211	-0.712418000725433	0.616	0.783	2.55497358620408e-207	NQO1	Malignant cells	GSE164897_Vem	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47570
1.43825774429002e-207	0.92225803849185	0.365	0.125	2.2771934865344e-203	GDF15	Malignant cells	GSE164897_Vem	ENSG00000130513	9518	growth differentiation factor 15	MIC-1|MIC1|NAG-1|PDF|PLAB|PTGFB	protein_coding	Q99988	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47571
1.11561269853784e-206	0.474828494526067	0.93	0.779	1.76634958559496e-202	NPC2	Malignant cells	GSE164897_Vem	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47572
2.6010246593473e-204	-0.650074691163247	0.149	0.422	4.11820234314458e-200	HLA-DRA	Malignant cells	GSE164897_Vem	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47573
3.10643130436166e-201	0.368418805881771	0.363	0.124	4.91841268419581e-197	DSCR8	Malignant cells	GSE164897_Vem	ENSG00000198054	84677	Down syndrome critical region 8	C21orf65|CT25.1a|CT25.1b|MMA-1a|MMA-1b|MTAG2	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47574
3.33924573919814e-199	0.388248735057789	0.35	0.114	5.28702777887242e-195	C5orf46	Malignant cells	GSE164897_Vem	ENSG00000178776	389336	chromosome 5 open reading frame 46	AP-64|MGC23985|SSSP1	protein_coding	Q6UWT4	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47575
8.25085798091231e-197	0.52865719622982	0.792	0.575	1.30635834411785e-192	BAX	Malignant cells	GSE164897_Vem	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47576
1.66930017846156e-193	0.364267272466588	0.999	0.994	2.64300297255818e-189	S100A16	Malignant cells	GSE164897_Vem	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47577
1.38116086123619e-192	0.459650143943538	0.679	0.41	2.18679199159526e-188	C12orf75	Malignant cells	GSE164897_Vem	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47578
1.81544013408218e-192	0.394939919179433	0.981	0.937	2.87438636429231e-188	COX17	Malignant cells	GSE164897_Vem	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47579
3.10166915032045e-192	-0.561356873654241	0.236	0.498	4.91087276570237e-188	CTHRC1	Malignant cells	GSE164897_Vem	ENSG00000164932	115908	collagen triple helix repeat containing 1	NA	protein_coding	Q96CG8	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47580
4.77437616739278e-192	0.538213066015759	0.699	0.458	7.55926978583299e-188	GPRC5A	Malignant cells	GSE164897_Vem	ENSG00000013588	9052	G protein-coupled receptor class C group 5 member A	PEIG-1|RAI3|RAIG1|TIG1	protein_coding	Q8NFJ5	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47581
8.52191211783206e-192	-0.258720451062207	1	1	1.34927434561635e-187	ATP5ME	Malignant cells	GSE164897_Vem	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47582
2.71635361696303e-190	0.331755745750461	0.33	0.104	4.30080268173757e-186	DLC1	Malignant cells	GSE164897_Vem	ENSG00000164741	10395	DLC1 Rho GTPase activating protein	ARHGAP7|DLC-1|HP|p122-RhoGAP|STARD12	protein_coding	Q96QB1	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47583
3.02548640987616e-190	0.343682693645783	0.996	0.991	4.79025263275693e-186	MIF	Malignant cells	GSE164897_Vem	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47584
1.1209907399642e-189	0.498215184077793	0.427	0.172	1.77486463858532e-185	CCN1	Malignant cells	GSE164897_Vem	ENSG00000142871	3491	cellular communication network factor 1	CYR61|GIG1|IGFBP10	protein_coding	O00622	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47585
2.10325711622351e-188	0.377515364365176	0.422	0.172	3.33008699211669e-184	BCL2L1	Malignant cells	GSE164897_Vem	ENSG00000171552	598	BCL2 like 1	Bcl-X|bcl-xL|bcl-xS|BCL2L|BCLX|PPP1R52	protein_coding	Q07817	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47586
1.26372972913339e-185	-0.60926788646637	0.523	0.732	2.00086328013689e-181	ID1	Malignant cells	GSE164897_Vem	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47587
1.45485289738347e-185	0.406371264621049	0.47	0.216	2.30346859242725e-181	SLC9A3R2	Malignant cells	GSE164897_Vem	ENSG00000065054	9351	SLC9A3 regulator 2	E3KARP|NHERF-2|SIP-1|TKA-1	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47588
2.13042171236116e-185	0.307516187870534	0.292	0.083	3.37309669718142e-181	ADORA2B	Malignant cells	GSE164897_Vem	ENSG00000170425	136	adenosine A2b receptor	NA	protein_coding	P29275	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47589
8.69491219580696e-183	0.408605361697516	0.963	0.899	1.37666544796212e-178	DRAP1	Malignant cells	GSE164897_Vem	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47590
3.16537660901722e-182	0.340540898023651	0.313	0.098	5.01174078505697e-178	AMOTL2	Malignant cells	GSE164897_Vem	ENSG00000114019	51421	angiomotin like 2	LCCP	protein_coding	Q9Y2J4	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47591
4.08076699489744e-180	0.365167520208718	0.448	0.189	6.46107838302112e-176	KRT80	Malignant cells	GSE164897_Vem	ENSG00000167767	144501	keratin 80	KB20	protein_coding	Q6KB66	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47592
1.21346134094411e-179	-0.443861669564491	0.865	0.943	1.92127334111681e-175	SNHG7	Malignant cells	GSE164897_Vem	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47593
1.17445080726323e-178	0.436732726789474	0.543	0.287	1.85950796313987e-174	PLAUR	Malignant cells	GSE164897_Vem	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47594
1.45212858849629e-176	0.424070912156284	0.717	0.475	2.29915519416618e-172	C4orf48	Malignant cells	GSE164897_Vem	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47595
1.47675021794937e-175	0.426167176430293	0.61	0.35	2.33813862007924e-171	CD9	Malignant cells	GSE164897_Vem	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47596
6.4227453048664e-175	0.580277563217119	0.623	0.37	1.0169132641195e-170	SORBS2	Malignant cells	GSE164897_Vem	ENSG00000154556	8470	sorbin and SH3 domain containing 2	ARGBP2|KIAA0777	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47597
8.40758000878022e-175	0.871850493690221	0.56	0.306	1.33117214279017e-170	CDKN1A	Malignant cells	GSE164897_Vem	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47598
2.46609221984506e-173	0.37349380530007	0.356	0.135	3.90456381168069e-169	F2R	Malignant cells	GSE164897_Vem	ENSG00000181104	2149	coagulation factor II thrombin receptor	CF2R|PAR-1|PAR1|TR	protein_coding	P25116	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47599
4.18157183073803e-173	0.404907227399501	0.36	0.137	6.62068267960753e-169	PLAT	Malignant cells	GSE164897_Vem	ENSG00000104368	5327	plasminogen activator, tissue type	NA	protein_coding	P00750	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47600
3.81765761508303e-171	0.540531679648912	0.708	0.466	6.04449730196096e-167	AXL	Malignant cells	GSE164897_Vem	ENSG00000167601	558	AXL receptor tyrosine kinase	ARK|JTK11|Tyro7|UFO	protein_coding	P30530	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47601
2.85682214553431e-170	0.537195354795068	0.599	0.35	4.52320650302448e-166	FHL2	Malignant cells	GSE164897_Vem	ENSG00000115641	2274	four and a half LIM domains 2	DRAL|SLIM3	protein_coding	Q14192	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47602
1.23748492738432e-167	-0.407618997745621	0.855	0.931	1.9593098855276e-163	SYF2	Malignant cells	GSE164897_Vem	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47603
1.44184991886267e-167	0.41007329629123	0.899	0.776	2.28288097653526e-163	CSTB	Malignant cells	GSE164897_Vem	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47604
1.90046989595786e-166	0.360532918148114	0.998	0.998	3.00901398627008e-162	TPI1	Malignant cells	GSE164897_Vem	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47605
5.76592439577736e-166	0.389386154815941	0.494	0.249	9.1291880958343e-162	CD68	Malignant cells	GSE164897_Vem	ENSG00000129226	968	CD68 molecule	DKFZp686M18236|GP110|LAMP4|SCARD1	protein_coding	P34810	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47606
2.23077637570498e-165	0.394751943646698	0.574	0.305	3.53198823565369e-161	TPST1	Malignant cells	GSE164897_Vem	ENSG00000169902	8460	tyrosylprotein sulfotransferase 1	TANGO13A	protein_coding	O60507	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47607
3.42989452103791e-165	0.34084874550534	0.384	0.158	5.43055199515932e-161	PTPRF	Malignant cells	GSE164897_Vem	ENSG00000142949	5792	protein tyrosine phosphatase receptor type F	LAR	protein_coding	P10586	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47608
2.29802542379951e-164	0.346810135475766	0.989	0.979	3.63846365350177e-160	YBX1	Malignant cells	GSE164897_Vem	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47609
5.22929376114923e-164	0.350703478820383	1	1	8.27954081202758e-160	H3-3B	Malignant cells	GSE164897_Vem	ENSG00000132475	3021	H3.3 histone B	H3.3B|H3F3B	protein_coding	P84243	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47610
7.93466027810659e-164	0.336079767137302	0.323	0.114	1.25629476183262e-159	ITGB4	Malignant cells	GSE164897_Vem	ENSG00000132470	3691	integrin subunit beta 4	CD104	protein_coding	P16144	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47611
6.17700330428802e-163	0.526640495248587	0.896	0.775	9.78004933167923e-159	CCND1	Malignant cells	GSE164897_Vem	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47612
2.58824916698954e-162	0.366904713163181	0.49	0.248	4.09797490609454e-158	LDOC1	Malignant cells	GSE164897_Vem	ENSG00000182195	23641	LDOC1 regulator of NFKB signaling	BCUR1|Mar7|Mart7|RTL7|SIRH7	protein_coding	O95751	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47613
2.19229298177318e-160	0.353028652719675	0.388	0.162	3.47105747804148e-156	TXNRD2	Malignant cells	GSE164897_Vem	ENSG00000184470	10587	thioredoxin reductase 2	SELZ|TR|TR3|TRXR2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47614
5.09853242704492e-158	-0.420373836034541	0.772	0.877	8.07250639174022e-154	CIRBP	Malignant cells	GSE164897_Vem	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47615
8.99780941400958e-158	0.330109545344205	0.989	0.964	1.42462316452014e-153	SUMO2	Malignant cells	GSE164897_Vem	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47616
2.27869621204324e-157	-0.358683581057493	0.964	0.991	3.60785971252806e-153	RAB13	Malignant cells	GSE164897_Vem	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47617
9.78088969497039e-157	-0.558721445873094	0.311	0.526	1.54860826540466e-152	UBE2F	Malignant cells	GSE164897_Vem	ENSG00000184182	140739	ubiquitin conjugating enzyme E2 F (putative)	NCE2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47618
5.27867736477597e-153	0.409110986368875	0.432	0.204	8.35772987164979e-149	PLK2	Malignant cells	GSE164897_Vem	ENSG00000145632	10769	polo like kinase 2	SNK	protein_coding	Q9NYY3	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47619
2.33431352474565e-150	0.544763331222271	0.745	0.536	3.69591860372978e-146	BNIP3	Malignant cells	GSE164897_Vem	ENSG00000176171	664	BCL2 interacting protein 3	HABON|Nip3	protein_coding	Q12983	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47620
2.79659582770696e-150	0.447593297854938	0.43	0.207	4.42785017400843e-146	DDB2	Malignant cells	GSE164897_Vem	ENSG00000134574	1643	damage specific DNA binding protein 2	DDBB|FLJ34321|UV-DDB2|XPE	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47621
4.95627834937334e-150	0.365828496686177	0.979	0.94	7.84727551056281e-146	TAGLN2	Malignant cells	GSE164897_Vem	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47622
1.06432645191537e-149	0.32095574655977	0.394	0.175	1.6851480713176e-145	NF2	Malignant cells	GSE164897_Vem	ENSG00000186575	4771	NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor	ACN|BANF|merlin|merlin-1|SCH	protein_coding	P35240	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47623
1.35072389430758e-149	0.369272846085395	0.605	0.361	2.1386011418572e-145	CD99	Malignant cells	GSE164897_Vem	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47624
6.04324549048167e-149	0.336262754454697	0.419	0.198	9.56827058507963e-145	DAP	Malignant cells	GSE164897_Vem	ENSG00000112977	1611	death associated protein	DAP1	protein_coding	P51397	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47625
7.39953011243069e-149	0.755422553762415	0.64	0.396	1.17156760270115e-144	IL24	Malignant cells	GSE164897_Vem	ENSG00000162892	11009	interleukin 24	C49A|FISP|IL-24|IL10B|mda-7|Mob-5|ST16	protein_coding	Q13007	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47626
1.10818295064827e-148	0.289409813702812	0.309	0.112	1.75458606576141e-144	SRGAP1	Malignant cells	GSE164897_Vem	ENSG00000196935	57522	SLIT-ROBO Rho GTPase activating protein 1	ARHGAP13|KIAA1304	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47627
1.93908268326484e-147	-0.256812699767334	1	1	3.07014961241322e-143	EIF1	Malignant cells	GSE164897_Vem	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47628
7.48548230961739e-144	-0.365401453253932	0.911	0.958	1.18517641408172e-139	METAP2	Malignant cells	GSE164897_Vem	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47629
9.30092458922219e-144	0.297949209570161	0.312	0.118	1.47261539021155e-139	LASTR	Malignant cells	GSE164897_Vem	ENSG00000242147	102723629	long intergenic non-protein coding RNA 2677	LINC02657	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47630
1.18648690182104e-143	-0.293582588863096	1	1	1.87856471165326e-139	ATP5F1E	Malignant cells	GSE164897_Vem	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47631
6.02262255919145e-143	0.31428354087261	0.994	0.983	9.53561829796783e-139	FKBP1A	Malignant cells	GSE164897_Vem	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47632
3.43590587479676e-142	-0.332909226524756	0.99	0.998	5.44006977156571e-138	EIF2S2	Malignant cells	GSE164897_Vem	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47633
1.67002002090908e-141	-0.491378612742657	0.856	0.927	2.64414269910534e-137	CTSC	Malignant cells	GSE164897_Vem	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47634
2.47619502393588e-140	0.365181528581792	0.818	0.592	3.92055958139769e-136	MDK	Malignant cells	GSE164897_Vem	ENSG00000110492	4192	midkine	FLJ27379|MK|NEGF2	protein_coding	P21741	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47635
8.08850423177594e-139	-0.410703689819109	0.726	0.837	1.28065287501708e-134	CBX3	Malignant cells	GSE164897_Vem	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47636
2.11068489640355e-137	-0.376401329133081	0.123	0.325	3.34184739647573e-133	TSPAN13	Malignant cells	GSE164897_Vem	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47637
8.6177148703199e-137	-0.892002234759491	0.936	0.961	1.36444279541775e-132	TIMP1	Malignant cells	GSE164897_Vem	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47638
9.67223073583915e-137	0.343328105826497	0.562	0.32	1.53140429240541e-132	AMIGO2	Malignant cells	GSE164897_Vem	ENSG00000139211	347902	adhesion molecule with Ig like domain 2	ALI1|DEGA	protein_coding	Q86SJ2	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47639
4.55084578547252e-136	0.414170740872401	0.796	0.639	7.20535413213864e-132	RHEB	Malignant cells	GSE164897_Vem	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47640
8.711851332593e-136	0.437267095427272	0.868	0.721	1.37934742148945e-131	ANXA1	Malignant cells	GSE164897_Vem	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47641
2.06345855382694e-135	0.281110957770974	0.316	0.124	3.2670739282742e-131	MANCR	Malignant cells	GSE164897_Vem	ENSG00000231298	100216001	mitotically associated long non coding RNA	CR749391|LINC00704	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47642
1.02959717322111e-134	0.285065070459949	0.306	0.119	1.63016120436098e-130	PPARG	Malignant cells	GSE164897_Vem	ENSG00000132170	5468	peroxisome proliferator activated receptor gamma	NR1C3|PPARG1|PPARG2|PPARgamma	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47643
4.06780993855959e-134	0.394770159824238	0.642	0.431	6.4405634757214e-130	MLLT11	Malignant cells	GSE164897_Vem	ENSG00000213190	10962	MLLT11 transcription factor 7 cofactor	AF1Q	protein_coding	Q13015	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47644
1.44034633855658e-133	0.290275243575282	0.359	0.156	2.28050035783663e-129	FSTL3	Malignant cells	GSE164897_Vem	ENSG00000070404	10272	follistatin like 3	FLRG|FSRP	protein_coding	O95633	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47645
1.88294388605039e-133	0.364753672772495	0.796	0.587	2.98126505478359e-129	PDLIM2	Malignant cells	GSE164897_Vem	ENSG00000120913	64236	PDZ and LIM domain 2	NA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47646
2.83320036452212e-133	0.38191464499996	0.914	0.821	4.48580613714788e-129	PLP2	Malignant cells	GSE164897_Vem	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47647
3.25083782208776e-133	0.339292638548288	0.44	0.224	5.14705152371155e-129	CNN3	Malignant cells	GSE164897_Vem	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47648
6.52093978760279e-133	0.363418013912626	0.595	0.366	1.03246039657115e-128	CYTOR	Malignant cells	GSE164897_Vem	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47649
5.98357535462047e-132	-0.296189100407837	0.997	1	9.47379485897059e-128	MALAT1	Malignant cells	GSE164897_Vem	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47650
3.7064045714399e-131	0.356588062820405	0.889	0.693	5.86835035796079e-127	HCFC1R1	Malignant cells	GSE164897_Vem	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47651
5.36942105401223e-131	0.293996858302264	0.277	0.1	8.50140435481756e-127	TMEM156	Malignant cells	GSE164897_Vem	ENSG00000121895	80008	transmembrane protein 156	FLJ23235	protein_coding	Q8N614	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47652
4.06011226478634e-130	0.408011820090463	0.512	0.279	6.4283757488362e-126	SCG5	Malignant cells	GSE164897_Vem	ENSG00000277614	6447	secretogranin V	7B2|SGNE1|SgV	protein_coding	P05408	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47653
1.45285211023865e-129	0.56567740868147	0.389	0.176	2.30030074614085e-125	ANKRD1	Malignant cells	GSE164897_Vem	ENSG00000148677	27063	ankyrin repeat domain 1	ALRP|C-193|CARP|CVARP|MCARP	protein_coding	Q15327	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47654
1.51336973446824e-129	0.300969979271422	0.99	0.974	2.39611830058357e-125	GUK1	Malignant cells	GSE164897_Vem	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47655
9.64659627526848e-129	0.350290211560825	0.389	0.189	1.52734558826326e-124	APOBEC3C	Malignant cells	GSE164897_Vem	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47656
1.39665660483352e-128	0.442542824724098	1	1	2.21132640243291e-124	FTH1	Malignant cells	GSE164897_Vem	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47657
2.26793832340211e-128	0.367364156607867	0.867	0.736	3.59082674744256e-124	ENY2	Malignant cells	GSE164897_Vem	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47658
1.10818432279671e-126	-0.393044058329804	0.15	0.351	1.75458823828403e-122	NHSL1-AS1	Malignant cells	GSE164897_Vem	ENSG00000225177	NA	NA	FLJ46906	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47659
6.68098323234316e-126	0.268532489341277	0.295	0.116	1.05780007517689e-121	ALDH3B1	Malignant cells	GSE164897_Vem	ENSG00000006534	221	aldehyde dehydrogenase 3 family member B1	ALDH7	protein_coding	P43353	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47660
8.32635310260609e-126	0.326150059121273	0.525	0.304	1.31831148673562e-121	ITGA3	Malignant cells	GSE164897_Vem	ENSG00000005884	3675	integrin subunit alpha 3	CD49c|GAP-B3|MSK18|VCA-2|VLA3a	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47661
1.24841429375861e-124	-0.464434988265956	0.282	0.49	1.976614351308e-120	RAMP1	Malignant cells	GSE164897_Vem	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47662
5.29119995417763e-124	-0.412785634500899	0.579	0.724	8.37755688744945e-120	RDX	Malignant cells	GSE164897_Vem	ENSG00000137710	5962	radixin	DFNB24	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47663
1.52695294775501e-123	0.382950147515568	0.532	0.312	2.41762460218051e-119	GCHFR	Malignant cells	GSE164897_Vem	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47664
2.04166127495262e-123	0.41889260872001	0.69	0.508	3.23256229663249e-119	LY6K	Malignant cells	GSE164897_Vem	ENSG00000160886	54742	lymphocyte antigen 6 family member K	CT97|FLJ35226|HSJ001348	protein_coding	Q17RY6	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47665
1.73291055120907e-122	0.441379604455807	0.478	0.278	2.74371727572933e-118	UBE2T	Malignant cells	GSE164897_Vem	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47666
2.84349360112489e-122	0.26216720069566	0.314	0.131	4.50210341866104e-118	MYOF	Malignant cells	GSE164897_Vem	ENSG00000138119	26509	myoferlin	FER1L3|KIAA1207	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47667
9.39489893529284e-122	0.343854721178247	0.636	0.418	1.48749434842492e-117	PLEC	Malignant cells	GSE164897_Vem	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47668
1.06690882448807e-121	-0.397468762244255	0.674	0.792	1.68923674181196e-117	CNPY2	Malignant cells	GSE164897_Vem	ENSG00000257727	10330	canopy FGF signaling regulator 2	HP10390|TMEM4|ZSIG9	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47669
2.42418156219214e-120	0.352146954407675	0.924	0.841	3.83820666741882e-116	MRPL33	Malignant cells	GSE164897_Vem	ENSG00000243147	9553	mitochondrial ribosomal protein L33	C2orf1|RPL33L	protein_coding	O75394	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47670
2.9315126587598e-120	0.303139752200861	0.457	0.248	4.64146399261439e-116	TAX1BP3	Malignant cells	GSE164897_Vem	ENSG00000213977	30851	Tax1 binding protein 3	TIP-1	protein_coding	O14907	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47671
8.63128904248316e-120	0.260909466579396	0.309	0.129	1.36659199409636e-115	ACYP1	Malignant cells	GSE164897_Vem	ENSG00000119640	97	acylphosphatase 1	NA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47672
3.26407784696208e-119	0.263874056639005	0.318	0.136	5.16801445509506e-115	NBPF14	Malignant cells	GSE164897_Vem	ENSG00000270629	25832	NBPF member 14	DJ328E19.C1.1	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47673
4.80645256601384e-119	0.269891837902495	0.366	0.169	7.61005634776971e-115	MYEOV	Malignant cells	GSE164897_Vem	ENSG00000172927	26579	myeloma overexpressed	OCIM	protein_coding	Q96EZ4	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47674
7.95041665417427e-119	0.349075867010327	0.516	0.306	1.25878946885541e-114	PPP1R14B-AS1	Malignant cells	GSE164897_Vem	ENSG00000256940	105369340	PPP1R14B antisense RNA 1	NA	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47675
1.65866255898487e-118	0.338045582130231	0.441	0.242	2.62616042964075e-114	TUBB6	Malignant cells	GSE164897_Vem	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47676
1.09755051256614e-116	-0.350326238055113	0.928	0.976	1.73775172654597e-112	EIF4EBP1	Malignant cells	GSE164897_Vem	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47677
7.53022061510811e-115	0.367855763165893	0.955	0.952	1.19225982999007e-110	SNRPD1	Malignant cells	GSE164897_Vem	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47678
1.81839569643689e-114	0.313313953157435	0.949	0.866	2.87906590616853e-110	EMP3	Malignant cells	GSE164897_Vem	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47679
2.30828637254608e-113	-0.276038457763422	0.993	0.998	3.65470981365221e-109	H3-3A	Malignant cells	GSE164897_Vem	ENSG00000163041	3020	H3.3 histone A	H3.3A|H3F3|H3F3A	protein_coding	P84243	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47680
1.15552066632496e-112	0.473803221031434	0.437	0.244	1.82953587099232e-108	SNAPC1	Malignant cells	GSE164897_Vem	ENSG00000023608	6617	small nuclear RNA activating complex polypeptide 1	PTFgamma|SNAP43	protein_coding	Q16533	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47681
1.48942937312029e-112	0.316614143071934	0.896	0.776	2.35821352646136e-108	RPL17	Malignant cells	GSE164897_Vem	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47682
2.18251329305846e-112	0.337228925622997	0.888	0.782	3.45557329689946e-108	NDUFV2	Malignant cells	GSE164897_Vem	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47683
5.74070770075056e-112	-0.379686114231376	0.844	0.918	9.08926250259836e-108	NCL	Malignant cells	GSE164897_Vem	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47684
1.1878405289582e-110	0.319295348548064	0.693	0.487	1.88070790949952e-106	BAD	Malignant cells	GSE164897_Vem	ENSG00000002330	572	BCL2 associated agonist of cell death	BBC2|BCL2L8	protein_coding	Q92934	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47685
4.74252203996701e-110	-0.380465946716505	0.238	0.43	7.50883514587977e-106	NFKB1	Malignant cells	GSE164897_Vem	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47686
6.96928350289555e-110	-0.36835907408124	0.592	0.767	1.10344665701345e-105	COL9A3	Malignant cells	GSE164897_Vem	ENSG00000092758	1299	collagen type IX alpha 3 chain	DJ885L7.4.1|EDM3|FLJ90759|IDD|MED	protein_coding	Q14050	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47687
8.37117045783115e-107	0.371070138929851	0.796	0.648	1.32540741858841e-102	KRT8	Malignant cells	GSE164897_Vem	ENSG00000170421	3856	keratin 8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	protein_coding	P05787	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47688
2.94547233670833e-106	0.337238200308678	0.575	0.378	4.66356635071029e-102	DYNC2I2	Malignant cells	GSE164897_Vem	ENSG00000119333	89891	dynein 2 intermediate chain 2	bA216B9.3|CFAP133|DIC5|FAP133|MGC20486|WDR34	protein_coding	Q96EX3	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47689
5.30063195782975e-106	0.295441217009944	0.969	0.942	8.39249057883184e-102	ATP5IF1	Malignant cells	GSE164897_Vem	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47690
7.00654642368349e-106	0.424296418855912	0.739	0.591	1.10934649526181e-101	RPA3	Malignant cells	GSE164897_Vem	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47691
7.31543682015445e-106	0.301189473539385	0.935	0.854	1.15825311173505e-101	ANAPC11	Malignant cells	GSE164897_Vem	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47692
7.45478223685173e-105	-0.394727089617179	0.401	0.571	1.18031567156074e-100	NFE2L2	Malignant cells	GSE164897_Vem	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47693
2.12582151441332e-104	0.339206179713524	0.891	0.809	3.36581320377061e-100	TOMM5	Malignant cells	GSE164897_Vem	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47694
5.25865222153421e-104	0.321401117224505	0.593	0.398	8.32602406235512e-100	CHCHD7	Malignant cells	GSE164897_Vem	ENSG00000170791	79145	coiled-coil-helix-coiled-coil-helix domain containing 7	COX23|MGC2217	protein_coding	Q9BUK0	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47695
5.59301137046369e-103	0.30834236765409	0.95	0.897	8.85541490285517e-99	MYL12B	Malignant cells	GSE164897_Vem	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47696
9.62161173767136e-103	0.304411684064614	0.449	0.261	1.52338978642551e-98	HPRT1	Malignant cells	GSE164897_Vem	ENSG00000165704	3251	hypoxanthine phosphoribosyltransferase 1	HGPRT|HPRT	protein_coding	P00492	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47697
6.58615508687879e-102	0.262290774090263	0.997	0.993	1.04278593490552e-97	EEF2	Malignant cells	GSE164897_Vem	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47698
8.59832753623934e-102	0.261228839982931	0.354	0.177	1.36137319881277e-97	VCL	Malignant cells	GSE164897_Vem	ENSG00000035403	7414	vinculin	NA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47699
2.06228222799759e-101	-0.360419235521974	0.306	0.496	3.26521145158859e-97	SOX10	Malignant cells	GSE164897_Vem	ENSG00000100146	6663	SRY-box transcription factor 10	DOM|SOX-10|WS2E|WS4	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47700
5.95049023948849e-101	0.288649876322438	0.476	0.284	9.42141119618212e-97	BNIP3L	Malignant cells	GSE164897_Vem	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47701
8.56175115812024e-101	0.252317923143508	0.277	0.12	1.35558206086518e-96	TNFRSF21	Malignant cells	GSE164897_Vem	ENSG00000146072	27242	TNF receptor superfamily member 21	CD358|DR6	protein_coding	O75509	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47702
2.13841196052134e-100	0.309122211098705	0.846	0.703	3.38574765709344e-96	SELENOH	Malignant cells	GSE164897_Vem	ENSG00000211450	280636	selenoprotein H	C11orf31|SELH	protein_coding	Q8IZQ5	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47703
2.3536409667498e-100	0.464560285109012	0.734	0.581	3.72651974265497e-96	PTTG1	Malignant cells	GSE164897_Vem	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47704
4.49363080812542e-100	0.273612148270892	0.387	0.207	7.11476565850497e-96	METTL27	Malignant cells	GSE164897_Vem	ENSG00000165171	155368	methyltransferase like 27	WBSCR27	protein_coding	Q8N6F8	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47705
1.65528662986695e-99	0.299913944914242	0.918	0.834	2.62081532106834e-95	CST3	Malignant cells	GSE164897_Vem	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47706
2.07094690754694e-97	0.311770100618871	0.609	0.425	3.27893023871907e-93	SPCS3	Malignant cells	GSE164897_Vem	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47707
2.46173598181007e-97	0.294579661301239	0.569	0.374	3.89766657999988e-93	AHNAK	Malignant cells	GSE164897_Vem	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47708
3.73136846024068e-97	0.253725015115328	0.307	0.144	5.90787568309906e-93	ENO2	Malignant cells	GSE164897_Vem	ENSG00000111674	2026	enolase 2	NSE	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47709
1.44428213565254e-96	0.27398124940035	0.993	0.972	2.28673190537866e-92	SEC61G	Malignant cells	GSE164897_Vem	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47710
3.39520972530625e-96	0.423003602492473	0.479	0.29	5.37563555807738e-92	CDC20	Malignant cells	GSE164897_Vem	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47711
4.25472029370262e-96	0.317539915822777	0.763	0.6	6.73649864101936e-92	ARPC5	Malignant cells	GSE164897_Vem	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47712
1.84776537439543e-95	0.294327416113993	0.54	0.348	2.92556691728028e-91	CATSPER1	Malignant cells	GSE164897_Vem	ENSG00000175294	117144	cation channel sperm associated 1	CATSPER	protein_coding	Q8NEC5	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47713
5.59142218915736e-94	0.315618577289863	0.835	0.694	8.85289875209286e-90	MYL12A	Malignant cells	GSE164897_Vem	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47714
1.27946412294881e-93	0.299234295011565	0.605	0.421	2.02577554586485e-89	MCFD2	Malignant cells	GSE164897_Vem	ENSG00000180398	90411	multiple coagulation factor deficiency 2, ER cargo receptor complex subunit	F5F8D|LMAN1IP|SDNSF	protein_coding	Q8NI22	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47715
5.89568946735241e-93	0.287336304192921	0.571	0.385	9.33464513365907e-89	AMZ2	Malignant cells	GSE164897_Vem	ENSG00000196704	51321	archaelysin family metallopeptidase 2	NA	protein_coding	Q86W34	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47716
9.21112822850352e-93	0.27779606658455	0.937	0.873	1.45839793241896e-88	NDUFB4	Malignant cells	GSE164897_Vem	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47717
1.75606884653378e-92	0.286760659693558	0.58	0.39	2.78038380471693e-88	TPGS2	Malignant cells	GSE164897_Vem	ENSG00000134779	25941	tubulin polyglutamylase complex subunit 2	C18orf10|DKFZP586M1523|HsT3006|PGs2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47718
2.32828517229508e-91	0.256560812104426	0.43	0.249	3.6863739132948e-87	ASPH	Malignant cells	GSE164897_Vem	ENSG00000198363	444	aspartate beta-hydroxylase	BAH|CASQ2BP1|HAAH|JCTN	protein_coding	Q12797	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47719
1.32938883895851e-90	0.265439589869488	0.993	0.981	2.10482134872301e-86	HSPB1	Malignant cells	GSE164897_Vem	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47720
1.87689918394497e-90	0.292775332899284	0.604	0.412	2.97169447794008e-86	RRAS	Malignant cells	GSE164897_Vem	ENSG00000126458	6237	RAS related	R-Ras	protein_coding	P10301	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47721
5.28079213739726e-90	0.315891287346028	0.883	0.798	8.36107819114107e-86	PGAM1	Malignant cells	GSE164897_Vem	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47722
5.40769150910396e-90	0.259277055533629	0.411	0.237	8.5619979663643e-86	CYRIB	Malignant cells	GSE164897_Vem	ENSG00000153310	51571	CYFIP related Rac1 interactor B	BM-009|CYRI|CYRI-B|FAM49B	protein_coding	Q9NUQ9	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47723
1.44253875895908e-89	0.268381564330384	0.512	0.321	2.28397161705991e-85	CAVIN1	Malignant cells	GSE164897_Vem	ENSG00000177469	284119	caveolae associated protein 1	cavin-1|CGL4|PTRF	protein_coding	Q6NZI2	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47724
2.11785618216227e-89	0.282916179550341	0.454	0.278	3.35320169321751e-85	HAUS1	Malignant cells	GSE164897_Vem	ENSG00000152240	115106	HAUS augmin like complex subunit 1	CCDC5|FLJ40084|HEI-C|HsT1461	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47725
2.34963152364537e-89	0.324021634537296	0.386	0.217	3.72017159138772e-85	PHLDA3	Malignant cells	GSE164897_Vem	ENSG00000174307	23612	pleckstrin homology like domain family A member 3	TIH1	protein_coding	Q9Y5J5	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47726
4.58144579185693e-89	0.294460035045087	0.379	0.21	7.25380312224707e-85	PCNA	Malignant cells	GSE164897_Vem	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47727
5.16637126364048e-89	0.278159578160676	0.632	0.446	8.17991562172197e-85	FLNA	Malignant cells	GSE164897_Vem	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47728
8.78914867237654e-89	0.301581013215408	0.31	0.153	1.39158590929738e-84	FDXR	Malignant cells	GSE164897_Vem	ENSG00000161513	2232	ferredoxin reductase	ADR|ADXR	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47729
9.80881953080868e-89	0.328969697172022	0.902	0.853	1.55303039631294e-84	JPT1	Malignant cells	GSE164897_Vem	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47730
4.01703691271958e-88	0.260341131871339	0.478	0.296	6.36017454390892e-84	SBDS	Malignant cells	GSE164897_Vem	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47731
4.2620924347981e-88	0.283774297838138	0.252	0.108	6.74817095201583e-84	IL1B	Malignant cells	GSE164897_Vem	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47732
1.37604798969622e-87	0.256163839709126	0.999	0.998	2.17869678208603e-83	B2M	Malignant cells	GSE164897_Vem	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47733
2.36833776435943e-86	0.2960842498028	0.442	0.271	3.74978918231028e-82	FERMT1	Malignant cells	GSE164897_Vem	ENSG00000101311	55612	FERM domain containing kindlin 1	C20orf42|FLJ20116|KIND1|UNC112A|URP1	protein_coding	Q9BQL6	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47734
4.42034289503214e-85	0.302819634960331	0.991	0.988	6.99872890570438e-81	LDHA	Malignant cells	GSE164897_Vem	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47735
5.39082464771046e-85	0.271348125404518	0.55	0.373	8.53529266471996e-81	GTF2H5	Malignant cells	GSE164897_Vem	ENSG00000272047	404672	general transcription factor IIH subunit 5	bA120J8.2|C6orf175|FLJ30544|TFB5|TFIIH|TTD|TTD-A|TTDA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47736
6.7969484378671e-85	0.272253007479399	0.603	0.425	1.0761608461675e-80	GAMT	Malignant cells	GSE164897_Vem	ENSG00000130005	2593	guanidinoacetate N-methyltransferase	PIG2|TP53I2	protein_coding	Q14353	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47737
4.44228215217171e-84	0.288313429350148	0.718	0.542	7.03346533153346e-80	DCBLD2	Malignant cells	GSE164897_Vem	ENSG00000057019	131566	discoidin, CUB and LCCL domain containing 2	CLCP1|ESDN	protein_coding	Q96PD2	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47738
8.04887306537905e-84	0.282730442292506	0.673	0.5	1.27437807244147e-79	PFN2	Malignant cells	GSE164897_Vem	ENSG00000070087	5217	profilin 2	NA	protein_coding	P35080	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47739
3.77488114696736e-83	-0.263578386661413	0.917	0.954	5.97676931999341e-79	PHB2	Malignant cells	GSE164897_Vem	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47740
7.65021832894546e-83	-0.323152967171358	0.844	0.875	1.21125906802194e-78	NDUFB8	Malignant cells	GSE164897_Vem	ENSG00000166136	4714	NADH:ubiquinone oxidoreductase subunit B8	ASHI|CI-ASHI	protein_coding	O95169	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47741
9.77953635041206e-83	0.309565508263733	0.746	0.597	1.54839399036074e-78	ACADVL	Malignant cells	GSE164897_Vem	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47742
1.10656627131616e-82	0.405622764501603	0.89	0.832	1.75202637737488e-78	PGK1	Malignant cells	GSE164897_Vem	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47743
2.74488873098842e-82	0.261979017450661	0.409	0.241	4.34598232777396e-78	ABL2	Malignant cells	GSE164897_Vem	ENSG00000143322	27	ABL proto-oncogene 2, non-receptor tyrosine kinase	ABLL|ARG	protein_coding	P42684	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47744
3.04274028501175e-82	0.277126740676097	0.651	0.473	4.81757069325911e-78	TSPAN4	Malignant cells	GSE164897_Vem	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47745
3.82067808881658e-82	0.255332319668036	0.969	0.935	6.0492796180233e-78	PRDX2	Malignant cells	GSE164897_Vem	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47746
4.85323786711183e-82	0.281632028488311	0.726	0.568	7.68413151499817e-78	SLC25A39	Malignant cells	GSE164897_Vem	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47747
3.30889921955808e-81	0.274245607541264	0.727	0.568	5.2389801343263e-77	PCBP1	Malignant cells	GSE164897_Vem	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47748
7.80175293157466e-81	0.258986839489084	0.407	0.243	1.23525154165622e-76	LYRM1	Malignant cells	GSE164897_Vem	ENSG00000102897	57149	LYR motif containing 1	A211C6.1	protein_coding	O43325	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47749
4.12376858676595e-80	0.418857792815473	0.9	0.862	6.52916280342652e-76	UBE2S	Malignant cells	GSE164897_Vem	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47750
4.21268001449156e-80	0.2825237328468	0.918	0.858	6.66993626694449e-76	RAD23A	Malignant cells	GSE164897_Vem	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47751
1.12634689924727e-79	0.26322849245911	0.903	0.816	1.7833450455782e-75	NDUFAF3	Malignant cells	GSE164897_Vem	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47752
1.14912281986379e-79	-0.263036300288199	0.76	0.84	1.81940616069034e-75	EPB41L4A-AS1	Malignant cells	GSE164897_Vem	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47753
1.30494039007485e-79	-0.282594095798978	0.8	0.872	2.06611211960551e-75	ERP29	Malignant cells	GSE164897_Vem	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47754
2.52951069441937e-79	-0.333772173584414	0.705	0.811	4.00497428247419e-75	MIA	Malignant cells	GSE164897_Vem	ENSG00000261857	8190	MIA SH3 domain containing	CD-RAP	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47755
2.76231381551364e-79	-0.282598832453414	0.188	0.349	4.37357146410274e-75	INPP5F	Malignant cells	GSE164897_Vem	ENSG00000198825	22876	inositol polyphosphate-5-phosphatase F	hSac2|KIAA0966|SAC2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47756
1.04364802365853e-78	0.277703914183174	0.411	0.248	1.65240791585855e-74	MMP24OS	Malignant cells	GSE164897_Vem	ENSG00000126005	101410538	MMP24 opposite strand	MMP24-AS1	protein_coding	A0A0U1RRL7	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47757
2.23656398747668e-78	0.260204003128969	0.44	0.27	3.54115176137183e-74	NMT2	Malignant cells	GSE164897_Vem	ENSG00000152465	9397	N-myristoyltransferase 2	NA	protein_coding	O60551	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47758
2.42632184909623e-78	-0.255899874212795	0.115	0.259	3.84159538367406e-74	TNC	Malignant cells	GSE164897_Vem	ENSG00000041982	3371	tenascin C	DFNA56|HXB|MGC167029|TN	protein_coding	P24821	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47759
2.57616704774237e-78	0.275833192047372	0.941	0.891	4.0788452866905e-74	CLIC1	Malignant cells	GSE164897_Vem	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47760
3.18531279085693e-78	0.321456592269789	0.744	0.597	5.04330574176378e-74	AKR1B1	Malignant cells	GSE164897_Vem	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47761
5.19478235618027e-78	0.298280941255216	0.907	0.857	8.22489890454022e-74	LSM4	Malignant cells	GSE164897_Vem	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47762
1.38008190166323e-77	0.302802222102317	0.962	0.948	2.18508367490339e-73	PRDX1	Malignant cells	GSE164897_Vem	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47763
1.69643131551707e-77	0.283465574646006	0.64	0.47	2.68595970185818e-73	POP7	Malignant cells	GSE164897_Vem	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47764
1.80813575838498e-77	0.26757267593144	0.589	0.419	2.86282134625094e-73	RTL8A	Malignant cells	GSE164897_Vem	ENSG00000203950	26071	retrotransposon Gag like 8A	CXX1b|DKFZP564B147|FAM127B|MAR8A|SIRH6	protein_coding	Q9BWD3	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47765
6.19202118673396e-77	0.290225185999822	0.981	0.961	9.80382714495588e-73	TUBB	Malignant cells	GSE164897_Vem	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47766
9.62250741856334e-77	0.273016169636659	0.509	0.343	1.52353159958113e-72	PSMD2	Malignant cells	GSE164897_Vem	ENSG00000175166	5708	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	MGC14274|P97|Rpn1|S2|TRAP2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47767
1.66355990046867e-76	-0.406902171222261	0.543	0.663	2.63391439041204e-72	TRIB3	Malignant cells	GSE164897_Vem	ENSG00000101255	57761	tribbles pseudokinase 3	C20orf97|dJ1103G7.3|TRB3	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47768
2.00044859269373e-76	0.294998647779125	0.425	0.262	3.16731025681198e-72	CENPU	Malignant cells	GSE164897_Vem	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47769
3.87965807588702e-76	0.255234287817313	0.541	0.372	6.14266263155192e-72	LMAN1	Malignant cells	GSE164897_Vem	ENSG00000074695	3998	lectin, mannose binding 1	ERGIC-53|ERGIC53|F5F8D|FMFD1|gp58|MCFD1|MR60	protein_coding	P49257	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47770
2.79011369931404e-75	-0.264698906037494	0.875	0.911	4.41758702012391e-71	NSA2	Malignant cells	GSE164897_Vem	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47771
4.33894284108407e-75	0.301796265446474	0.539	0.363	6.8698482002884e-71	TK1	Malignant cells	GSE164897_Vem	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47772
5.60288497376995e-75	0.253009764439755	0.981	0.972	8.87104777896997e-71	MT-ND5	Malignant cells	GSE164897_Vem	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47773
6.84814244902473e-74	0.253275838581691	0.461	0.3	1.08426639395409e-69	LSM6	Malignant cells	GSE164897_Vem	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47774
1.62317751647624e-73	0.389642230015687	0.758	0.647	2.56997696183683e-69	STMN1	Malignant cells	GSE164897_Vem	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47775
2.43119368326334e-73	0.259599920666481	0.915	0.839	3.84930895871084e-69	PPDPF	Malignant cells	GSE164897_Vem	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47776
3.08630255504271e-73	0.281266587415524	0.916	0.839	4.88654283539912e-69	SMS	Malignant cells	GSE164897_Vem	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47777
3.55957690307967e-73	0.260639222604623	0.636	0.476	5.63587811064605e-69	PERP	Malignant cells	GSE164897_Vem	ENSG00000112378	64065	p53 apoptosis effector related to PMP22	dJ496H19.1|KCP1|KRTCAP1|PIGPC1|THW	protein_coding	Q96FX8	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47778
4.26609233787684e-73	-0.272680041589038	0.873	0.928	6.75450399856041e-69	DDX21	Malignant cells	GSE164897_Vem	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47779
4.66390413081152e-73	0.265119778807879	0.643	0.48	7.38435941031387e-69	SLC25A4	Malignant cells	GSE164897_Vem	ENSG00000151729	291	solute carrier family 25 member 4	AAC1|ANT1|PEO2|PEO3|T1	protein_coding	P12235	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47780
5.67299034097769e-73	-0.275376127755053	0.905	0.938	8.98204560686998e-69	IFITM3	Malignant cells	GSE164897_Vem	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47781
1.54314935774657e-72	0.283273620735264	0.756	0.599	2.44326837812015e-68	HMGA2	Malignant cells	GSE164897_Vem	ENSG00000149948	8091	high mobility group AT-hook 2	BABL|HMGIC|LIPO	protein_coding	P52926	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47782
4.36959336475073e-72	0.284069853433496	0.744	0.603	6.91837717440984e-68	MKKS	Malignant cells	GSE164897_Vem	ENSG00000125863	8195	MKKS centrosomal shuttling protein	BBS6|HMCS|KMS|MKS	protein_coding	Q9NPJ1	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47783
4.4135011400173e-72	0.256268806138654	0.993	0.984	6.98789635498938e-68	GPX1	Malignant cells	GSE164897_Vem	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47784
2.79586535662319e-71	-0.261244813765354	0.846	0.897	4.42669361914149e-67	NDUFA13	Malignant cells	GSE164897_Vem	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47785
4.32856976964219e-71	0.272326298411942	0.489	0.329	6.85342451627448e-67	MAGOHB	Malignant cells	GSE164897_Vem	ENSG00000111196	55110	mago homolog B, exon junction complex subunit	FLJ10292|MGN2	protein_coding	Q96A72	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47786
6.38284695911262e-71	0.299854936152569	0.522	0.361	1.0105961590363e-66	PMAIP1	Malignant cells	GSE164897_Vem	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47787
1.75851486446646e-70	-0.260246655201806	0.871	0.913	2.78425658490974e-66	RBM3	Malignant cells	GSE164897_Vem	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47788
3.32822289661707e-70	0.382352876737991	0.493	0.338	5.26957531221381e-66	CKS2	Malignant cells	GSE164897_Vem	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47789
3.76098226223204e-70	0.255377455089548	0.546	0.379	5.95476321579199e-66	KCNN4	Malignant cells	GSE164897_Vem	ENSG00000104783	3783	potassium calcium-activated channel subfamily N member 4	hIKCa1|hKCa4|hSK4|IK|KCa3.1	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47790
3.99204910272174e-70	0.355317129068155	0.581	0.431	6.32061134433933e-66	CD70	Malignant cells	GSE164897_Vem	ENSG00000125726	970	CD70 molecule	CD27L|CD27LG|TNFSF7	protein_coding	P32970	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47791
9.88701531419499e-70	0.250171613490705	0.915	0.863	1.56541113469649e-65	UQCR10	Malignant cells	GSE164897_Vem	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47792
1.41981303745104e-69	0.285811291970385	0.501	0.346	2.24798998219623e-65	RNASEH2A	Malignant cells	GSE164897_Vem	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47793
1.53407942526577e-69	0.257234463983143	0.548	0.389	2.42890795402329e-65	MAGEA3	Malignant cells	GSE164897_Vem	ENSG00000221867	4102	MAGE family member A3	CT1.3|HIP8|HYPD|MAGE3|MGC14613	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47794
2.71451973572583e-69	0.268239155863587	0.796	0.683	4.2978990975747e-65	DBI	Malignant cells	GSE164897_Vem	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47795
5.45499584958784e-69	0.267816064050276	0.62	0.467	8.63689492865242e-65	HSPB11	Malignant cells	GSE164897_Vem	ENSG00000081870	51668	heat shock protein family B (small) member 11	C1orf41|FAP232|HSPCO34|IFT25|PP25	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47796
7.16925442997106e-69	0.341912411655053	0.77	0.642	1.13510805389732e-64	PLIN2	Malignant cells	GSE164897_Vem	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47797
4.63908055659107e-68	0.44263480595535	0.918	0.978	7.34505624525065e-64	ANXA2	Malignant cells	GSE164897_Vem	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47798
6.51581688821887e-68	0.260812450585987	0.321	0.178	1.03164928791169e-63	FST	Malignant cells	GSE164897_Vem	ENSG00000134363	10468	follistatin	FS	protein_coding	P19883	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47799
6.61392911094721e-68	-0.287616217807171	0.429	0.567	1.04718339613627e-63	PABPC4	Malignant cells	GSE164897_Vem	ENSG00000090621	8761	poly(A) binding protein cytoplasmic 4	APP-1|iPABP	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47800
7.67022636344459e-68	0.27562507851798	0.608	0.448	1.21442694012418e-63	TMEM106C	Malignant cells	GSE164897_Vem	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47801
9.5728276092167e-68	0.270960498804881	0.735	0.604	1.51566579536728e-63	MRPL14	Malignant cells	GSE164897_Vem	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47802
2.05757421757289e-67	0.271798925318292	0.661	0.522	3.25775725868315e-63	UBE2V2	Malignant cells	GSE164897_Vem	ENSG00000169139	7336	ubiquitin conjugating enzyme E2 V2	DDVit-1|DDVIT1|EDAF-1|EDPF-1|EDPF1|MMS2|UEV-2|UEV2	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47803
6.47133612449204e-67	0.259506227000013	0.626	0.475	1.02460664859082e-62	IER3IP1	Malignant cells	GSE164897_Vem	ENSG00000134049	51124	immediate early response 3 interacting protein 1	NA	protein_coding	Q9Y5U9	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47804
7.00125601544767e-67	0.321589079993548	0.891	0.871	1.10850886492583e-62	HNRNPA2B1	Malignant cells	GSE164897_Vem	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47805
9.99062775471186e-67	0.302542575312901	0.784	0.682	1.58181609240353e-62	CCT5	Malignant cells	GSE164897_Vem	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47806
2.03671033447069e-66	0.260727543509868	0.608	0.454	3.22472347256745e-62	TUBG1	Malignant cells	GSE164897_Vem	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47807
3.15042124865885e-66	0.252701679563716	0.662	0.509	4.98806196300155e-62	GALE	Malignant cells	GSE164897_Vem	ENSG00000117308	2582	UDP-galactose-4-epimerase	SDR1E1	protein_coding	Q14376	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47808
6.0281879342446e-66	0.259246254415767	0.998	0.998	9.54442995628947e-62	ENO1	Malignant cells	GSE164897_Vem	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47809
4.81343316379786e-65	0.398107032378308	0.784	0.706	7.62110872824115e-61	CKS1B	Malignant cells	GSE164897_Vem	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47810
5.54748959695444e-65	0.270507064485789	0.857	0.774	8.78334027885797e-61	PSMB2	Malignant cells	GSE164897_Vem	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47811
5.56217320926406e-64	0.252754906750406	0.554	0.407	8.80658884222778e-60	MRPL13	Malignant cells	GSE164897_Vem	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47812
6.30491842877213e-64	0.268292141333425	0.569	0.424	9.98257734827492e-60	C4orf3	Malignant cells	GSE164897_Vem	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47813
1.58845201508918e-63	0.258464587358756	0.902	0.842	2.51499607549069e-59	NDUFC1	Malignant cells	GSE164897_Vem	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47814
3.64794371428938e-60	0.26121459508847	0.798	0.685	5.77578928283438e-56	TXNL4A	Malignant cells	GSE164897_Vem	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47815
1.50330813714333e-59	-0.403716382955358	0.72	0.796	2.38018777353904e-55	INHBA	Malignant cells	GSE164897_Vem	ENSG00000122641	3624	inhibin subunit beta A	NA	protein_coding	P08476	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47816
4.77256770528405e-59	0.252613578248015	0.514	0.369	7.55640644777624e-55	TOMM34	Malignant cells	GSE164897_Vem	ENSG00000025772	10953	translocase of outer mitochondrial membrane 34	HTOM34P|TOM34	protein_coding	Q15785	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47817
5.39412279358353e-59	0.320633759611862	0.708	0.579	8.54051461908081e-55	IER2	Malignant cells	GSE164897_Vem	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47818
1.74609392197746e-58	0.279666581225863	0.803	0.707	2.76459050666691e-54	H2AZ2	Malignant cells	GSE164897_Vem	ENSG00000105968	94239	H2A.Z variant histone 2	H2AFV|H2AV|MGC10170|MGC10831|MGC1947	protein_coding	Q71UI9	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47819
7.69042600431284e-58	-0.28789037896157	0.621	0.702	1.21762514926285e-53	SNRPN	Malignant cells	GSE164897_Vem	ENSG00000128739	6638	small nuclear ribonucleoprotein polypeptide N	HCERN3|PWCR|RT-LI|SM-D|SMN|SNRNP-N|SNURF-SNRPN	protein_coding	P63162	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47820
1.22714240461469e-57	0.377852001018797	0.477	0.337	1.94293456922644e-53	HMGB2	Malignant cells	GSE164897_Vem	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47821
2.84524190858338e-56	-0.357014171777871	0.178	0.302	4.50487151386007e-52	TFPI2	Malignant cells	GSE164897_Vem	ENSG00000105825	7980	tissue factor pathway inhibitor 2	PP5|REF1|TFPI-2	protein_coding	P48307	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47822
1.25765574672861e-55	0.256305240184563	0.798	0.684	1.9912463437954e-51	PDLIM4	Malignant cells	GSE164897_Vem	ENSG00000131435	8572	PDZ and LIM domain 4	RIL	protein_coding	P50479	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47823
6.10452407986077e-55	0.451400520742482	0.46	0.316	9.66529297564356e-51	UBE2C	Malignant cells	GSE164897_Vem	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47824
3.72952341950303e-52	0.253400077256183	0.764	0.66	5.90495443009915e-48	POLD2	Malignant cells	GSE164897_Vem	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47825
3.43204783155556e-51	0.375797320960529	0.602	0.491	5.43396133170192e-47	MT1X	Malignant cells	GSE164897_Vem	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47826
1.98311811550621e-49	-0.265393455646335	0.907	0.929	3.13987091228098e-45	HSPD1	Malignant cells	GSE164897_Vem	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47827
2.11430959270263e-49	0.285377340620378	0.695	0.589	3.34758637812607e-45	EBNA1BP2	Malignant cells	GSE164897_Vem	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47828
4.02316867853605e-49	0.290977507178965	0.68	0.558	6.36988296872612e-45	TUBB4B	Malignant cells	GSE164897_Vem	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47829
3.96361162973147e-46	0.316485930864598	0.61	0.493	6.27558629335383e-42	TSC22D1	Malignant cells	GSE164897_Vem	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47830
1.30182410312598e-45	-0.255808450346322	0.642	0.71	2.06117810247937e-41	SHMT2	Malignant cells	GSE164897_Vem	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47831
1.398548263247e-45	0.302768029875349	0.939	0.957	2.21432146519898e-41	H2AZ1	Malignant cells	GSE164897_Vem	ENSG00000164032	3015	H2A.Z variant histone 1	H2A.Z|H2AFZ|H2AZ	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47832
1.76690227590175e-44	0.478740599490519	0.547	0.415	2.79753637343525e-40	GADD45A	Malignant cells	GSE164897_Vem	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47833
7.7926559524856e-43	-0.270880979680132	0.352	0.459	1.23381121695704e-38	PCOLCE	Malignant cells	GSE164897_Vem	ENSG00000106333	5118	procollagen C-endopeptidase enhancer	PCPE|PCPE1	protein_coding	Q15113	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47834
5.23954642343125e-42	-0.286978795868625	0.357	0.463	8.29577385221869e-38	HLA-DPA1	Malignant cells	GSE164897_Vem	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47835
2.34647988626518e-39	0.413896892970804	0.405	0.295	3.71518160392367e-35	H1-2	Malignant cells	GSE164897_Vem	ENSG00000187837	3006	H1.2 linker histone, cluster member	H1.2|H1c|H1F2|H1s-1|HIST1H1C	protein_coding	P16403	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47836
6.8528428595198e-39	-0.255453371862965	0.339	0.439	1.08501060994777e-34	DYNLT3	Malignant cells	GSE164897_Vem	ENSG00000165169	6990	dynein light chain Tctex-type 3	TCTE1L|TCTEX1L	protein_coding	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47837
2.5449632583416e-30	-0.729540629327918	0.618	0.655	4.02944032693226e-26	KRT81	Malignant cells	GSE164897_Vem	ENSG00000205426	3887	keratin 81	Hb-1|KRTHB1	protein_coding	Q14533	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47838
9.13124619035694e-19	0.252445050705016	0.444	0.374	1.44575020931921e-14	SLCO4A1-AS1	Malignant cells	GSE164897_Vem	ENSG00000232803	100127888	SLCO4A1 antisense RNA 1	NA	NA	NA	GSE164897_Vem	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	11008	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47839
0	-0.604282318373117	0.088	0.524	0	NOC2L	Malignant cells	GSE164897_VemCob	ENSG00000188976	26155	NOC2 like nucleolar associated transcriptional repressor	DKFZP564C186|NET15|NET7|NIR|PPP1R112	protein_coding	Q9Y3T9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47840
0	-0.446940366478152	0.038	0.366	0	UBE2J2	Malignant cells	GSE164897_VemCob	ENSG00000160087	118424	ubiquitin conjugating enzyme E2 J2	NCUBE2|Ubc6p	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47841
0	-0.462018837771186	0.035	0.375	0	INTS11	Malignant cells	GSE164897_VemCob	ENSG00000127054	54973	integrator complex subunit 11	CPSF3L|CPSF73L|FLJ20542|INT11|RC-68	protein_coding	Q5TA45	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47842
0	-1.1867602177514	0.218	0.875	0	AURKAIP1	Malignant cells	GSE164897_VemCob	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47843
0	-0.998903981627946	0.052	0.709	0	FAAP20	Malignant cells	GSE164897_VemCob	ENSG00000162585	199990	FA core complex associated protein 20	C1orf86|FLJ31031	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47844
0	-0.761583999848132	0.153	0.678	0	RER1	Malignant cells	GSE164897_VemCob	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47845
0	-0.457071942691121	0.999	1	0	RPL22	Malignant cells	GSE164897_VemCob	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47846
0	-0.779246945663789	0.089	0.613	0	ACOT7	Malignant cells	GSE164897_VemCob	ENSG00000097021	11332	acyl-CoA thioesterase 7	ACH1|ACT|BACH|CTE-II|hBACH|LACH1|MGC1126	protein_coding	O00154	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47847
0	-0.444834230959566	0.214	0.568	0	CAMTA1	Malignant cells	GSE164897_VemCob	ENSG00000171735	23261	calmodulin binding transcription activator 1	KIAA0833	protein_coding	Q9Y6Y1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47848
0	5.61081632911048	0.972	0.017	0	UTS2	Malignant cells	GSE164897_VemCob	ENSG00000049247	10911	urotensin 2	PRO1068|U-II|UCN2|UII	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47849
0	0.486391828131527	0.983	0.955	0	PARK7	Malignant cells	GSE164897_VemCob	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47850
0	-0.519507849543443	0.025	0.389	0	MAD2L2	Malignant cells	GSE164897_VemCob	ENSG00000116670	10459	mitotic arrest deficient 2 like 2	FANCV|MAD2B|POLZ2|REV7	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47851
0	-0.568948520963307	0.015	0.412	0	MFAP2	Malignant cells	GSE164897_VemCob	ENSG00000117122	4237	microfibril associated protein 2	MAGP|MAGP-1	protein_coding	P55001	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47852
0	-0.683528743150026	0.182	0.644	0	SDHB	Malignant cells	GSE164897_VemCob	ENSG00000117118	6390	succinate dehydrogenase complex iron sulfur subunit B	SDH|SDH1	protein_coding	P21912	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47853
0	-0.406896809227561	0.047	0.345	0	AKR7A2	Malignant cells	GSE164897_VemCob	ENSG00000053371	8574	aldo-keto reductase family 7 member A2	AFAR	protein_coding	O43488	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47854
0	-0.673514106227192	0.181	0.667	0	CAPZB	Malignant cells	GSE164897_VemCob	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47855
0	1.16138649219251	0.939	0.676	0	MICOS10	Malignant cells	GSE164897_VemCob	ENSG00000173436	440574	mitochondrial contact site and cristae organizing system subunit 10	C1orf151|FLJ36999|Mic10|MINOS1|MIO10|RP5-1056L3.2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47856
0	-0.688790522415498	0.099	0.584	0	DDOST	Malignant cells	GSE164897_VemCob	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47857
0	-1.3000074448908	0.075	0.698	0	ID3	Malignant cells	GSE164897_VemCob	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47858
0	-0.616711092691225	0.078	0.525	0	LYPLA2	Malignant cells	GSE164897_VemCob	ENSG00000011009	11313	lysophospholipase 2	APT-2	protein_coding	O95372	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47859
0	-0.468969944599206	0.138	0.48	0	GALE	Malignant cells	GSE164897_VemCob	ENSG00000117308	2582	UDP-galactose-4-epimerase	SDR1E1	protein_coding	Q14376	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47860
0	-1.1874471720858	0.234	0.886	0	SYF2	Malignant cells	GSE164897_VemCob	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47861
0	-0.869143336809398	0.036	0.621	0	ZNF593	Malignant cells	GSE164897_VemCob	ENSG00000142684	51042	zinc finger protein 593	ZT86	protein_coding	O00488	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47862
0	-1.73895590287528	0.887	0.998	0	SH3BGRL3	Malignant cells	GSE164897_VemCob	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47863
0	-1.6446501946017	0.426	0.911	0	HMGN2	Malignant cells	GSE164897_VemCob	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47864
0	-0.602420802766773	0.28	0.687	0	NUDC	Malignant cells	GSE164897_VemCob	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47865
0	-0.428663470592265	0.143	0.474	0	WASF2	Malignant cells	GSE164897_VemCob	ENSG00000158195	10163	WASP family member 2	SCAR2|WAVE2	protein_coding	Q9Y6W5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47866
0	-1.23673400393282	0.245	0.889	0	ATP5IF1	Malignant cells	GSE164897_VemCob	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47867
0	-0.708337482807408	0.014	0.454	0	TINAGL1	Malignant cells	GSE164897_VemCob	ENSG00000142910	64129	tubulointerstitial nephritis antigen like 1	ARG1|LCN7|LIECG3|P3ECSL|TINAGRP	protein_coding	Q9GZM7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47868
0	-0.735975330975889	0.176	0.651	0	MARCKSL1	Malignant cells	GSE164897_VemCob	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47869
0	-0.458787071074189	0.157	0.495	0	YARS1	Malignant cells	GSE164897_VemCob	ENSG00000134684	8565	tyrosyl-tRNA synthetase 1	tyrRS|YARS|YRS|YTS	protein_coding	P54577	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47870
0	0.867069164081491	0.848	0.662	0	PSMB2	Malignant cells	GSE164897_VemCob	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47871
0	-0.659225435666526	0.113	0.59	0	TRAPPC3	Malignant cells	GSE164897_VemCob	ENSG00000054116	27095	trafficking protein particle complex subunit 3	BET3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47872
0	-0.599360028322753	0.08	0.51	0	LSM10	Malignant cells	GSE164897_VemCob	ENSG00000181817	84967	LSM10, U7 small nuclear RNA associated	MGC15749	protein_coding	Q969L4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47873
0	-0.915437943295377	0.124	0.729	0	MRPS15	Malignant cells	GSE164897_VemCob	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47874
0	-0.517437372082941	0.154	0.531	0	C1orf122	Malignant cells	GSE164897_VemCob	ENSG00000197982	127687	chromosome 1 open reading frame 122	FLJ45459	protein_coding	Q6ZSJ8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47875
0	0.585676893891106	0.971	0.919	0	NDUFS5	Malignant cells	GSE164897_VemCob	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47876
0	-0.505089952550895	0.149	0.531	0	PABPC4	Malignant cells	GSE164897_VemCob	ENSG00000090621	8761	poly(A) binding protein cytoplasmic 4	APP-1|iPABP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47877
0	-0.33334914126296	0.059	0.303	0	PPT1	Malignant cells	GSE164897_VemCob	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47878
0	-0.498185818349364	0.21	0.555	0	EBNA1BP2	Malignant cells	GSE164897_VemCob	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47879
0	-0.872420632861303	0.212	0.768	0	ATP6V0B	Malignant cells	GSE164897_VemCob	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47880
0	-0.503844107310355	0.032	0.393	0	ERI3	Malignant cells	GSE164897_VemCob	ENSG00000117419	79033	ERI1 exoribonuclease family member 3	FLJ22943|PINT1|PRNPIP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47881
0	1.32328713623974	0.985	0.861	0	PRDX1	Malignant cells	GSE164897_VemCob	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47882
0	0.525393848551952	1	1	0	UQCRH	Malignant cells	GSE164897_VemCob	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47883
0	-0.368571550015052	0.079	0.351	0	TXNDC12	Malignant cells	GSE164897_VemCob	ENSG00000117862	51060	thioredoxin domain containing 12	AGR1|ERP18|ERP19|hAG-1|PDIA16|TLP19	protein_coding	O95881	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47884
0	-0.433534289706615	0.261	0.598	0	TMEM59	Malignant cells	GSE164897_VemCob	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47885
0	-0.69543454202509	0.191	0.672	0	MRPL37	Malignant cells	GSE164897_VemCob	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47886
0	-1.10816764479875	0.672	0.966	0	SERBP1	Malignant cells	GSE164897_VemCob	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47887
0	-0.528144012595347	0.055	0.398	0	GADD45A	Malignant cells	GSE164897_VemCob	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47888
0	-0.577747953689511	0.386	0.801	0	GNG5	Malignant cells	GSE164897_VemCob	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47889
0	-0.799778720415709	0.133	0.644	0	LMO4	Malignant cells	GSE164897_VemCob	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47890
0	-0.353567358129975	0.056	0.322	0	RTCA	Malignant cells	GSE164897_VemCob	ENSG00000137996	8634	RNA 3'-terminal phosphate cyclase	RPC|RTC1|RTCD1	protein_coding	O00442	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47891
0	-0.592473469429272	0.322	0.722	0	SARS1	Malignant cells	GSE164897_VemCob	ENSG00000031698	6301	seryl-tRNA synthetase 1	SARS|SERS	protein_coding	P49591	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47892
0	1.10255507549636	0.952	0.706	0	LAMTOR5	Malignant cells	GSE164897_VemCob	ENSG00000134248	10542	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	HBXIP|MGC71071|XIP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47893
0	-0.367247842163923	0.037	0.303	0	SIKE1	Malignant cells	GSE164897_VemCob	ENSG00000052723	80143	suppressor of IKBKE 1	FLJ21168|SIKE	protein_coding	Q9BRV8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47894
0	-0.510809481966156	0.131	0.496	0	ATP1A1	Malignant cells	GSE164897_VemCob	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47895
0	-0.978615646149589	0.048	0.627	0	PHGDH	Malignant cells	GSE164897_VemCob	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47896
0	0.726105113179353	0.935	0.817	0	RBM8A	Malignant cells	GSE164897_VemCob	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47897
0	0.728255588037704	0.557	0.283	0	ANP32E	Malignant cells	GSE164897_VemCob	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47898
0	-0.537209321368203	0.314	0.727	0	ENSA	Malignant cells	GSE164897_VemCob	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47899
0	1.45333195615613	0.856	0.327	0	MLLT11	Malignant cells	GSE164897_VemCob	ENSG00000213190	10962	MLLT11 transcription factor 7 cofactor	AF1Q	protein_coding	Q13015	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47900
0	-0.417659789045346	0.044	0.348	0	VPS72	Malignant cells	GSE164897_VemCob	ENSG00000163159	6944	vacuolar protein sorting 72 homolog	Swc2|TCFL1|YL-1|YL1	protein_coding	Q15906	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47901
0	-0.661668510367763	0.074	0.547	0	MRPL9	Malignant cells	GSE164897_VemCob	ENSG00000143436	65005	mitochondrial ribosomal protein L9	NA	protein_coding	Q9BYD2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47902
0	-1.45293456312281	0.816	0.991	0	S100A10	Malignant cells	GSE164897_VemCob	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47903
0	0.473372258852829	0.996	0.975	0	S100A11	Malignant cells	GSE164897_VemCob	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47904
0	-0.804836733677671	1	1	0	S100A6	Malignant cells	GSE164897_VemCob	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47905
0	-0.571736782123078	0.256	0.57	0	S100A4	Malignant cells	GSE164897_VemCob	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47906
0	-0.571067116915453	0.913	0.979	0	S100A16	Malignant cells	GSE164897_VemCob	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47907
0	-0.429038124136741	0.085	0.408	0	SNAPIN	Malignant cells	GSE164897_VemCob	ENSG00000143553	23557	SNAP associated protein	BLOC1S7|BORCS3|SNAPAP	protein_coding	O95295	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47908
0	-0.535201175168494	0.152	0.552	0	SLC39A1	Malignant cells	GSE164897_VemCob	ENSG00000143570	27173	solute carrier family 39 member 1	ZIP1|ZIRTL	protein_coding	Q9NY26	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47909
0	-1.14783749131722	0.285	0.896	0	JTB	Malignant cells	GSE164897_VemCob	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47910
0	-0.777106382579206	0.847	0.972	0	RAB13	Malignant cells	GSE164897_VemCob	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47911
0	-0.941672279377002	1	1	0	RPS27	Malignant cells	GSE164897_VemCob	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47912
0	-0.941353829755391	0.404	0.893	0	C1orf43	Malignant cells	GSE164897_VemCob	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47913
0	1.31771414427914	0.933	0.595	0	CKS1B	Malignant cells	GSE164897_VemCob	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47914
0	-0.365977106022921	0.025	0.291	0	ADAM15	Malignant cells	GSE164897_VemCob	ENSG00000143537	8751	ADAM metallopeptidase domain 15	MDC15	protein_coding	Q13444	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47915
0	-0.913604678205536	0.056	0.637	0	DPM3	Malignant cells	GSE164897_VemCob	ENSG00000179085	54344	dolichyl-phosphate mannosyltransferase subunit 3, regulatory	MGC125904|MGC125905|MGC34275	protein_coding	Q9P2X0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47916
0	-0.683898163975631	0.111	0.591	0	MTX1	Malignant cells	GSE164897_VemCob	ENSG00000173171	4580	metaxin 1	MTX|MTXN	protein_coding	Q13505	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47917
0	-0.539983122839715	0.082	0.464	0	ARHGEF2	Malignant cells	GSE164897_VemCob	ENSG00000116584	9181	Rho/Rac guanine nucleotide exchange factor 2	GEF-H1|GEFH1|KIAA0651|Lfc|LFP40|P40	protein_coding	Q92974	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47918
0	-1.1208831839864	0.288	0.855	0	LMNA	Malignant cells	GSE164897_VemCob	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47919
0	-0.318790137286415	0.057	0.288	0	PMF1	Malignant cells	GSE164897_VemCob	ENSG00000160783	11243	polyamine modulated factor 1	NA	protein_coding	Q6P1K2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47920
0	-0.743465168839663	0.342	0.806	0	NAXE	Malignant cells	GSE164897_VemCob	ENSG00000163382	128240	NAD(P)HX epimerase	AIBP|APOA1BP|MGC119143|MGC119144|MGC119145|YJEFN1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47921
0	-0.380424205448347	0.028	0.303	0	DUSP23	Malignant cells	GSE164897_VemCob	ENSG00000158716	54935	dual specificity phosphatase 23	DUSP25|FLJ20442	protein_coding	Q9BVJ7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47922
0	0.75346550074725	0.979	0.858	0	TAGLN2	Malignant cells	GSE164897_VemCob	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47923
0	-1.59538385026907	0.514	0.966	0	PFDN2	Malignant cells	GSE164897_VemCob	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47924
0	-0.845222131959613	0.128	0.677	0	NDUFS2	Malignant cells	GSE164897_VemCob	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47925
0	-0.376348740263107	0.023	0.268	0	FCGR2A	Malignant cells	GSE164897_VemCob	ENSG00000143226	2212	Fc gamma receptor IIa	CD32|CD32A|CDw32|Fc-gamma-RIIa|FCG2|FcgammaRIIa|FCGR2|FCGR2A1|IGFR2	protein_coding	P12318	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47926
0	-0.51612287732555	0.056	0.436	0	DUSP12	Malignant cells	GSE164897_VemCob	ENSG00000081721	11266	dual specificity phosphatase 12	DUSP1|YVH1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47927
0	1.42074251941678	0.879	0.383	0	MGST3	Malignant cells	GSE164897_VemCob	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47928
0	0.634753371383572	0.888	0.767	0	TMCO1	Malignant cells	GSE164897_VemCob	ENSG00000143183	54499	transmembrane and coiled-coil domains 1	HP10122|TMCC4	protein_coding	Q9UM00	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47929
0	-0.509781161326984	0.079	0.454	0	MPC2	Malignant cells	GSE164897_VemCob	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47930
0	-0.590695306879365	0.448	0.777	0	CACYBP	Malignant cells	GSE164897_VemCob	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47931
0	-0.574000890720557	0.041	0.434	0	GLRX2	Malignant cells	GSE164897_VemCob	ENSG00000023572	51022	glutaredoxin 2	bA101E13.1|GRX2	protein_coding	Q9NS18	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47932
0	0.724493950260677	0.523	0.237	0	UBE2T	Malignant cells	GSE164897_VemCob	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47933
0	-0.423448191328725	0.246	0.601	0	ADIPOR1	Malignant cells	GSE164897_VemCob	ENSG00000159346	51094	adiponectin receptor 1	ACDCR1|PAQR1	protein_coding	Q96A54	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47934
0	-0.437789813131081	0.103	0.433	0	TMEM183A	Malignant cells	GSE164897_VemCob	ENSG00000163444	92703	transmembrane protein 183A	C1orf37	protein_coding	Q8IXX5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47935
0	0.576168911243559	0.994	0.987	0	SNRPE	Malignant cells	GSE164897_VemCob	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47936
0	-1.00494057731897	0.019	0.382	0	IL24	Malignant cells	GSE164897_VemCob	ENSG00000162892	11009	interleukin 24	C49A|FISP|IL-24|IL10B|mda-7|Mob-5|ST16	protein_coding	Q13007	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47937
0	-0.693184411262199	0.018	0.419	0	CD55	Malignant cells	GSE164897_VemCob	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47938
0	-0.543282119675221	0.006	0.371	0	SERTAD4-AS1	Malignant cells	GSE164897_VemCob	ENSG00000280963	NA	NA	C1orf133	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47939
0	0.818195854871663	0.564	0.262	0	CENPF	Malignant cells	GSE164897_VemCob	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47940
0	-0.36580569327491	0.147	0.436	0	IARS2	Malignant cells	GSE164897_VemCob	ENSG00000067704	55699	isoleucyl-tRNA synthetase 2, mitochondrial	FLJ10326	protein_coding	Q9NSE4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47941
0	0.994921039593483	0.879	0.646	0	CNIH4	Malignant cells	GSE164897_VemCob	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47942
0	-0.79594090346731	0.922	0.992	0	H3-3A	Malignant cells	GSE164897_VemCob	ENSG00000163041	3020	H3.3 histone A	H3.3A|H3F3|H3F3A	protein_coding	P84243	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47943
0	-0.885200998200616	0.23	0.793	0	ARF1	Malignant cells	GSE164897_VemCob	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47944
0	-0.389771843155784	0.072	0.359	0	C1orf35	Malignant cells	GSE164897_VemCob	ENSG00000143793	79169	chromosome 1 open reading frame 35	MGC4174|MMTAG2	protein_coding	Q9BU76	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47945
0	-0.83815298488347	0.068	0.641	0	MRPL55	Malignant cells	GSE164897_VemCob	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47946
0	-1.31084621522789	0.357	0.935	0	GUK1	Malignant cells	GSE164897_VemCob	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47947
0	-0.707323342586987	0.027	0.492	0	H2AC25	Malignant cells	GSE164897_VemCob	ENSG00000284841	92815	H2A clustered histone 25	H2AW|HIST3H2A|MGC3165	protein_coding	Q7L7L0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47948
0	-0.467618215419076	0.056	0.397	0	RAB4A	Malignant cells	GSE164897_VemCob	ENSG00000168118	5867	RAB4A, member RAS oncogene family	HRES-1/RAB4|RAB4	protein_coding	P20338	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47949
0	-0.741570502590015	0.409	0.854	0	TOMM20	Malignant cells	GSE164897_VemCob	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47950
0	-0.357343400398225	0.051	0.312	0	FH	Malignant cells	GSE164897_VemCob	ENSG00000091483	2271	fumarate hydratase	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47951
0	0.889629985210636	0.938	0.741	0	COX20	Malignant cells	GSE164897_VemCob	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47952
0	-0.521867901007971	0.08	0.446	0	SCCPDH	Malignant cells	GSE164897_VemCob	ENSG00000143653	51097	saccharopine dehydrogenase (putative)	CGI-49|NET11	protein_coding	Q8NBX0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47953
0	-0.560302096041977	0.09	0.489	0	ADI1	Malignant cells	GSE164897_VemCob	ENSG00000280830	55256	acireductone dioxygenase 1	APL1|ARD|FLJ10913|HMFT1638|MTCBP-1|mtnD|SIPL	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47954
0	-0.452689318209128	0.124	0.468	0	RNASEH1	Malignant cells	GSE164897_VemCob	ENSG00000171865	246243	ribonuclease H1	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47955
0	0.457278067873964	1	1	0	RPS7	Malignant cells	GSE164897_VemCob	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47956
0	-0.400208271208658	0.242	0.57	0	ITGB1BP1	Malignant cells	GSE164897_VemCob	ENSG00000119185	9270	integrin subunit beta 1 binding protein 1	ICAP-1A|ICAP-1alpha|ICAP-1B|ICAP1|ICAP1A|ICAP1B	protein_coding	O14713	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47957
0	-0.459874890655222	0.43	0.762	0	YWHAQ	Malignant cells	GSE164897_VemCob	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47958
0	1.10340049501878	0.977	0.799	0	SF3B6	Malignant cells	GSE164897_VemCob	ENSG00000115128	51639	splicing factor 3b subunit 6	CGI-110|Ht006|P14|SAP14a|SF3B14a	protein_coding	Q9Y3B4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47959
0	-0.868017095532542	0.071	0.66	0	PTRHD1	Malignant cells	GSE164897_VemCob	ENSG00000184924	391356	peptidyl-tRNA hydrolase domain containing 1	C2orf79|LOC391356	protein_coding	Q6GMV3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47960
0	1.25372112099289	1	0.989	0	OST4	Malignant cells	GSE164897_VemCob	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47961
0	0.749045923011219	0.909	0.736	0	MRPL33	Malignant cells	GSE164897_VemCob	ENSG00000243147	9553	mitochondrial ribosomal protein L33	C2orf1|RPL33L	protein_coding	O75394	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47962
0	-0.432474034403821	0.12	0.439	0	WDR43	Malignant cells	GSE164897_VemCob	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47963
0	-0.341930977569035	0.077	0.334	0	FEZ2	Malignant cells	GSE164897_VemCob	ENSG00000171055	9637	fasciculation and elongation protein zeta 2	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47964
0	-0.386026137915901	0.085	0.359	0	CDC42EP3	Malignant cells	GSE164897_VemCob	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47965
0	0.707558967651162	0.845	0.639	0	SRSF7	Malignant cells	GSE164897_VemCob	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47966
0	1.34730560555073	0.995	0.812	0	CALM2	Malignant cells	GSE164897_VemCob	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47967
0	-0.344697893814428	0.038	0.286	0	ACYP2	Malignant cells	GSE164897_VemCob	ENSG00000170634	98	acylphosphatase 2	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47968
0	-0.308256840540977	0.054	0.285	0	NFU1	Malignant cells	GSE164897_VemCob	ENSG00000169599	27247	NFU1 iron-sulfur cluster scaffold	CGI-33|HIRIP5|NifU|NIFUC	protein_coding	Q9UMS0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47969
0	-0.565243686598041	0.105	0.51	0	AAK1	Malignant cells	GSE164897_VemCob	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47970
0	1.15835753353108	0.844	0.459	0	PCBP1	Malignant cells	GSE164897_VemCob	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47971
0	1.20797645725103	0.999	0.936	0	SNRPG	Malignant cells	GSE164897_VemCob	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47972
0	-0.628640947767484	0.024	0.421	0	TGFA	Malignant cells	GSE164897_VemCob	ENSG00000163235	7039	transforming growth factor alpha	NA	protein_coding	P01135	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47973
0	-0.765861951195683	0.257	0.758	0	CCT7	Malignant cells	GSE164897_VemCob	ENSG00000135624	10574	chaperonin containing TCP1 subunit 7	Ccth|Nip7-1	protein_coding	Q99832	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47974
0	-0.684106158740122	0.235	0.706	0	BOLA3	Malignant cells	GSE164897_VemCob	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47975
0	-1.12579565034891	0.194	0.766	0	MTHFD2	Malignant cells	GSE164897_VemCob	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47976
0	-0.614378711814686	0.193	0.631	0	AUP1	Malignant cells	GSE164897_VemCob	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47977
0	-0.503937985689102	0.062	0.431	0	POLE4	Malignant cells	GSE164897_VemCob	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47978
0	-0.433883024915464	0.054	0.373	0	MRPL19	Malignant cells	GSE164897_VemCob	ENSG00000115364	9801	mitochondrial ribosomal protein L19	KIAA0104|MRP-L15|RLX1|RPML15	protein_coding	P49406	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47979
0	1.07390156408902	1	1	0	TMSB10	Malignant cells	GSE164897_VemCob	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47980
0	0.909607462375368	0.602	0.211	0	VAMP8	Malignant cells	GSE164897_VemCob	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47981
0	0.727612778363171	0.853	0.667	0	RNF181	Malignant cells	GSE164897_VemCob	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47982
0	-1.5071700164964	0.374	0.958	0	COX5B	Malignant cells	GSE164897_VemCob	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47983
0	-0.643212912863715	1	1	0	RPL31	Malignant cells	GSE164897_VemCob	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47984
0	0.732498537581091	0.552	0.256	0	MIR4435-2HG	Malignant cells	GSE164897_VemCob	ENSG00000172965	541471	MIR4435-2 host gene	AGD2|AK001796|LINC00978|lncRNA-AWPPH|MIR4435-1HG|MORRBID	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47985
0	-0.33794548918303	0.117	0.392	0	CHCHD5	Malignant cells	GSE164897_VemCob	ENSG00000125611	84269	coiled-coil-helix-coiled-coil-helix domain containing 5	C2orf9|MGC11104|MIC14|MIX14	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47986
0	1.17014671533529	0.896	0.555	0	DBI	Malignant cells	GSE164897_VemCob	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47987
0	-0.760559689078111	0.188	0.688	0	GYPC	Malignant cells	GSE164897_VemCob	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47988
0	-1.46486762460641	0.166	0.913	0	MZT2B	Malignant cells	GSE164897_VemCob	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47989
0	-0.686726768190046	0.086	0.559	0	IMP4	Malignant cells	GSE164897_VemCob	ENSG00000136718	92856	IMP U3 small nucleolar ribonucleoprotein 4	BXDC4|MGC19606	protein_coding	Q96G21	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47990
0	-1.08680547554561	0.068	0.752	0	MZT2A	Malignant cells	GSE164897_VemCob	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47991
0	-0.348912387974605	0.112	0.385	0	UBXN4	Malignant cells	GSE164897_VemCob	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47992
0	-0.309450156472848	0.031	0.256	0	ARL5A	Malignant cells	GSE164897_VemCob	ENSG00000162980	26225	ADP ribosylation factor like GTPase 5A	ARL5	protein_coding	Q9Y689	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47993
0	-0.405279395638019	0.218	0.557	0	OLA1	Malignant cells	GSE164897_VemCob	ENSG00000138430	29789	Obg like ATPase 1	GTPBP9|PTD004	protein_coding	Q9NTK5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47994
0	1.3369152825907	0.985	0.775	0	ATP5MC3	Malignant cells	GSE164897_VemCob	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47995
0	1.54192403177971	0.989	0.769	0	HSPE1	Malignant cells	GSE164897_VemCob	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47996
0	0.874671362079991	0.89	0.661	0	SUMO1	Malignant cells	GSE164897_VemCob	ENSG00000116030	7341	small ubiquitin like modifier 1	GMP1|OFC10|PIC1|SMT3C|SMT3H3|SUMO-1|UBL1	protein_coding	P63165	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47997
0	0.880945679202114	0.745	0.494	0	XRCC5	Malignant cells	GSE164897_VemCob	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47998
0	0.607204541363811	1	1	0	RPL37A	Malignant cells	GSE164897_VemCob	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	47999
0	-0.634703757983935	0.624	0.897	0	ARPC2	Malignant cells	GSE164897_VemCob	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48000
0	-1.5927915663036	0.646	0.973	0	SERPINE2	Malignant cells	GSE164897_VemCob	ENSG00000135919	5270	serpin family E member 2	GDN|nexin|PI7|PN1|PNI	protein_coding	P07093	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48001
0	0.502874729762473	0.28	0.025	0	IRS1	Malignant cells	GSE164897_VemCob	ENSG00000169047	3667	insulin receptor substrate 1	HIRS-1	protein_coding	P35568	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48002
0	-0.460793483484566	0.144	0.496	0	MFF	Malignant cells	GSE164897_VemCob	ENSG00000168958	56947	mitochondrial fission factor	C2orf33|GL004	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48003
0	-0.369763381006423	0.116	0.398	0	ITM2C	Malignant cells	GSE164897_VemCob	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48004
0	0.860017322878577	0.958	0.831	0	NCL	Malignant cells	GSE164897_VemCob	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48005
0	-0.795428834946506	0.995	0.999	0	PTMA	Malignant cells	GSE164897_VemCob	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48006
0	1.18991049398797	0.531	0.054	0	ARL4C	Malignant cells	GSE164897_VemCob	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48007
0	-0.846525844398231	0.01	0.474	0	RAMP1	Malignant cells	GSE164897_VemCob	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48008
0	-0.587638379386641	0.146	0.488	0	UBE2F	Malignant cells	GSE164897_VemCob	ENSG00000184182	140739	ubiquitin conjugating enzyme E2 F (putative)	NCE2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48009
0	-0.33748031444486	0.051	0.297	0	STK25	Malignant cells	GSE164897_VemCob	ENSG00000115694	10494	serine/threonine kinase 25	SOK1|YSK1	protein_coding	O00506	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48010
0	-0.446152156175592	0.147	0.443	0	DTYMK	Malignant cells	GSE164897_VemCob	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48011
0	-0.498438199710974	0.088	0.446	0	RPUSD3	Malignant cells	GSE164897_VemCob	ENSG00000156990	285367	RNA pseudouridine synthase D3	MGC29784	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48012
0	-0.642658396701427	0.084	0.554	0	JAGN1	Malignant cells	GSE164897_VemCob	ENSG00000171135	84522	jagunal homolog 1	FLJ14602|GL009	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48013
0	1.05777510774511	0.981	0.82	0	BRK1	Malignant cells	GSE164897_VemCob	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48014
0	0.308574650860421	1	1	0	RPL32	Malignant cells	GSE164897_VemCob	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48015
0	0.577652042448653	0.794	0.654	0	LSM3	Malignant cells	GSE164897_VemCob	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48016
0	-0.552226098256612	0.084	0.476	0	MRPS25	Malignant cells	GSE164897_VemCob	ENSG00000131368	64432	mitochondrial ribosomal protein S25	DKFZp313H0817|FLJ00023|MRP-S25|RPMS25	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48017
0	-0.381477050997515	0.111	0.406	0	UBE2E1	Malignant cells	GSE164897_VemCob	ENSG00000170142	7324	ubiquitin conjugating enzyme E2 E1	UbcH6	protein_coding	P51965	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48018
0	0.482300998507406	1	1	0	RPL15	Malignant cells	GSE164897_VemCob	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48019
0	-0.376783501612535	0.115	0.405	0	CMC1	Malignant cells	GSE164897_VemCob	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48020
0	-1.35846606822272	0.037	0.798	0	CMTM7	Malignant cells	GSE164897_VemCob	ENSG00000153551	112616	CKLF like MARVEL transmembrane domain containing 7	CKLFSF7|FLJ30992	protein_coding	Q96FZ5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48021
0	-0.345061422413804	0.075	0.328	0	DYNC1LI1	Malignant cells	GSE164897_VemCob	ENSG00000144635	51143	dynein cytoplasmic 1 light intermediate chain 1	DNCLI1	protein_coding	Q9Y6G9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48022
0	0.343357672642826	1	1	0	RPSA	Malignant cells	GSE164897_VemCob	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48023
0	-0.339568126922198	0.042	0.292	0	TMEM42	Malignant cells	GSE164897_VemCob	ENSG00000280516	131616	transmembrane protein 42	MGC29956	protein_coding	Q69YG0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48024
0	1.25233592649468	0.592	0.045	0	TMEM158	Malignant cells	GSE164897_VemCob	ENSG00000249992	25907	transmembrane protein 158	p40BBp|RIS1	protein_coding	Q8WZ71	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48025
0	0.716252258782741	1	1	0	TMA7	Malignant cells	GSE164897_VemCob	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48026
0	-0.871566527367962	0.195	0.759	0	NDUFAF3	Malignant cells	GSE164897_VemCob	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48027
0	-0.798194509852998	0.694	0.943	0	IMPDH2	Malignant cells	GSE164897_VemCob	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48028
0	-2.00143492363862	0.081	0.959	0	GPX1	Malignant cells	GSE164897_VemCob	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48029
0	-0.420823503325389	0.02	0.307	0	SEMA3B	Malignant cells	GSE164897_VemCob	ENSG00000012171	7869	semaphorin 3B	LUCA-1|SemA|sema5|SEMAA|semaV	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48030
0	-0.688648959234325	0.122	0.597	0	IFRD2	Malignant cells	GSE164897_VemCob	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48031
0	-0.496787225957986	0.076	0.441	0	TUSC2	Malignant cells	GSE164897_VemCob	ENSG00000114383	11334	tumor suppressor 2, mitochondrial calcium regulator	C3orf11|FUS1|PAP|PDAP2	protein_coding	O75896	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48032
0	-0.521648705285015	0.102	0.481	0	MANF	Malignant cells	GSE164897_VemCob	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48033
0	-0.512710287068807	0.092	0.475	0	TEX264	Malignant cells	GSE164897_VemCob	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48034
0	-0.322894300082048	0.022	0.252	0	RRP9	Malignant cells	GSE164897_VemCob	ENSG00000114767	9136	ribosomal RNA processing 9, U3 small nucleolar RNA binding protein	RNU3IP2|U3-55K	protein_coding	O43818	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48035
0	-0.611581884462648	0.119	0.564	0	PCBP4	Malignant cells	GSE164897_VemCob	ENSG00000090097	57060	poly(rC) binding protein 4	LIP4|MCG10	protein_coding	P57723	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48036
0	-0.660062750027974	0.168	0.628	0	ABHD14B	Malignant cells	GSE164897_VemCob	ENSG00000114779	84836	abhydrolase domain containing 14B	CIB|MGC15429	protein_coding	Q96IU4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48037
0	-1.54179410064798	1	1	0	RPL29	Malignant cells	GSE164897_VemCob	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48038
0	-0.578299695817039	0.052	0.468	0	TWF2	Malignant cells	GSE164897_VemCob	ENSG00000247596	11344	twinfilin actin binding protein 2	A6r|A6RP|PTK9L	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48039
0	-0.458516149986209	0.461	0.778	0	SMIM4	Malignant cells	GSE164897_VemCob	ENSG00000168273	440957	small integral membrane protein 4	C3orf78	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48040
0	-0.796479507101529	0.476	0.889	0	SPCS1	Malignant cells	GSE164897_VemCob	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48041
0	-0.894746537603449	0.531	0.915	0	TKT	Malignant cells	GSE164897_VemCob	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48042
0	-0.558420941246365	0.119	0.525	0	PSMD6	Malignant cells	GSE164897_VemCob	ENSG00000163636	9861	proteasome 26S subunit, non-ATPase 6	KIAA0107|p44S10|Rpn7|S10	protein_coding	Q15008	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48043
0	0.686606304898087	0.654	0.464	0	DCBLD2	Malignant cells	GSE164897_VemCob	ENSG00000057019	131566	discoidin, CUB and LCCL domain containing 2	CLCP1|ESDN	protein_coding	Q96PD2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48044
0	-0.504213849745472	0.004	0.354	0	CD96	Malignant cells	GSE164897_VemCob	ENSG00000153283	10225	CD96 molecule	TACTILE	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48045
0	0.701000857666223	0.398	0.081	0	CCDC80	Malignant cells	GSE164897_VemCob	ENSG00000091986	151887	coiled-coil domain containing 80	CL2|DRO1|LINC01279|SSG1|TCONS_00006930|URB	protein_coding	Q76M96	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48046
0	1.23556458725556	0.993	0.853	0	COX17	Malignant cells	GSE164897_VemCob	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48047
0	0.960129229533035	0.946	0.768	0	NDUFB4	Malignant cells	GSE164897_VemCob	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48048
0	0.521586075482242	0.271	0.006	0	SLC12A8	Malignant cells	GSE164897_VemCob	ENSG00000221955	84561	solute carrier family 12 member 8	CCC9	protein_coding	A0AV02	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48049
0	-0.586147422618593	0.111	0.459	0	MGLL	Malignant cells	GSE164897_VemCob	ENSG00000074416	11343	monoglyceride lipase	HU-K5|MAGL|MGL	protein_coding	Q99685	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48050
0	-0.503943983708916	0.439	0.776	0	CNBP	Malignant cells	GSE164897_VemCob	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48051
0	-0.482526457530472	0.137	0.497	0	MRPL3	Malignant cells	GSE164897_VemCob	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48052
0	-0.576117771035192	0.19	0.596	0	ATP1B3	Malignant cells	GSE164897_VemCob	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48053
0	-0.329700171812354	0.067	0.319	0	GYG1	Malignant cells	GSE164897_VemCob	ENSG00000163754	2992	glycogenin 1	GYG	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48054
0	-0.861264644372654	0.312	0.846	0	SERP1	Malignant cells	GSE164897_VemCob	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48055
0	-0.462614491957802	0.184	0.542	0	EIF2A	Malignant cells	GSE164897_VemCob	ENSG00000144895	83939	eukaryotic translation initiation factor 2A	EIF-2A	protein_coding	Q9BY44	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48056
0	-0.329422907275977	0.074	0.319	0	GMPS	Malignant cells	GSE164897_VemCob	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48057
0	1.09411996194866	0.973	0.801	0	RPL22L1	Malignant cells	GSE164897_VemCob	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48058
0	-0.380748849265483	0.047	0.324	0	PARL	Malignant cells	GSE164897_VemCob	ENSG00000175193	55486	presenilin associated rhomboid like	PRO2207|PSARL|PSARL1|RHBDS1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48059
0	-0.485495894256958	0.104	0.462	0	ALG3	Malignant cells	GSE164897_VemCob	ENSG00000214160	10195	ALG3 alpha-1,3- mannosyltransferase	CDGS4|D16Ertd36e|Not56|NOT56L	protein_coding	Q92685	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48060
0	0.686076327698655	0.674	0.488	0	POLR2H	Malignant cells	GSE164897_VemCob	ENSG00000163882	5437	RNA polymerase II, I and III subunit H	RPB8	protein_coding	P52434	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48061
0	-0.437792907376593	0.098	0.417	0	IGF2BP2	Malignant cells	GSE164897_VemCob	ENSG00000073792	10644	insulin like growth factor 2 mRNA binding protein 2	IMP-2|p62	protein_coding	Q9Y6M1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48062
0	-0.351034545888005	0.042	0.289	0	RPL39L	Malignant cells	GSE164897_VemCob	ENSG00000163923	116832	ribosomal protein L39 like	RPL39L1	protein_coding	Q96EH5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48063
0	-1.02736585001296	0.383	0.778	0	HES1	Malignant cells	GSE164897_VemCob	ENSG00000114315	3280	hes family bHLH transcription factor 1	bHLHb39|FLJ20408|HES-1|HRY	protein_coding	Q14469	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48064
0	-0.579823776026694	0.04	0.45	0	NCBP2AS2	Malignant cells	GSE164897_VemCob	ENSG00000270170	152217	NCBP2 antisense 2 (head to head)	HIAR|KRASIM|NCBP2-AS2	protein_coding	Q69YL0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48065
0	-0.331075458145572	0.026	0.267	0	MYL5	Malignant cells	GSE164897_VemCob	ENSG00000215375	4636	myosin light chain 5	NA	protein_coding	Q02045	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48066
0	-0.501427646947458	0.09	0.454	0	C4orf48	Malignant cells	GSE164897_VemCob	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48067
0	-0.537520463561616	0.048	0.439	0	MFSD10	Malignant cells	GSE164897_VemCob	ENSG00000109736	10227	major facilitator superfamily domain containing 10	IT10C3|TETRAN	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48068
0	-0.564698829168646	0.072	0.474	0	LRPAP1	Malignant cells	GSE164897_VemCob	ENSG00000163956	4043	LDL receptor related protein associated protein 1	A2MRAP|HBP44|RAP	protein_coding	P30533	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48069
0	-0.425584545031592	0.274	0.62	0	MRFAP1	Malignant cells	GSE164897_VemCob	ENSG00000179010	93621	Morf4 family associated protein 1	PAM14|PGR1	protein_coding	Q9Y605	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48070
0	-0.467338650288059	0.078	0.424	0	QDPR	Malignant cells	GSE164897_VemCob	ENSG00000151552	5860	quinoid dihydropteridine reductase	DHPR|PKU2|SDR33C1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48071
0	-0.416701572704786	0.125	0.448	0	SMIM20	Malignant cells	GSE164897_VemCob	ENSG00000250317	389203	small integral membrane protein 20	C4orf52|MITRAC7|PNX	protein_coding	Q8N5G0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48072
0	-0.325779771284984	0.013	0.25	0	NOA1	Malignant cells	GSE164897_VemCob	ENSG00000084092	84273	nitric oxide associated 1	C4orf14|hAtNOS1|hNOA1|MGC3232|MTG3	protein_coding	Q8NC60	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48073
0	-0.382593817870052	0.072	0.361	0	YTHDC1	Malignant cells	GSE164897_VemCob	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48074
0	2.15518989172142	0.847	0.207	0	CXCL8	Malignant cells	GSE164897_VemCob	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48075
0	-0.621536177762522	0.457	0.841	0	CCNI	Malignant cells	GSE164897_VemCob	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48076
0	-0.441325637633822	0.172	0.513	0	MRPL1	Malignant cells	GSE164897_VemCob	ENSG00000169288	65008	mitochondrial ribosomal protein L1	BM022	protein_coding	Q9BYD6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48077
0	-0.609184947787679	0.568	0.847	0	HNRNPDL	Malignant cells	GSE164897_VemCob	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48078
0	-0.570402272481133	0.118	0.535	0	PYURF	Malignant cells	GSE164897_VemCob	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48079
0	1.60885596907504	0.997	0.869	0	H2AZ1	Malignant cells	GSE164897_VemCob	ENSG00000164032	3015	H2A.Z variant histone 1	H2A.Z|H2AFZ|H2AZ	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48080
0	-0.482437530669923	0.089	0.411	0	NFKB1	Malignant cells	GSE164897_VemCob	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48081
0	-0.593846312785935	0.368	0.783	0	UBE2D3	Malignant cells	GSE164897_VemCob	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48082
0	-0.936970042142337	1	1	0	RPL34	Malignant cells	GSE164897_VemCob	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48083
0	-1.55813745732372	0.659	0.99	0	SNHG8	Malignant cells	GSE164897_VemCob	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48084
0	1.40821692853687	0.835	0.323	0	C4orf3	Malignant cells	GSE164897_VemCob	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48085
0	-0.989975049235089	0.162	0.786	0	NDUFC1	Malignant cells	GSE164897_VemCob	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48086
0	-0.793941379546994	1	1	0	RPS3A	Malignant cells	GSE164897_VemCob	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48087
0	-0.510509142940833	0.401	0.761	0	TMA16	Malignant cells	GSE164897_VemCob	ENSG00000198498	55319	translation machinery associated 16 homolog	C4orf43|FLJ11184	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48088
0	-0.331049435576715	0.05	0.288	0	RWDD4	Malignant cells	GSE164897_VemCob	ENSG00000182552	201965	RWD domain containing 4	FAM28A|MGC10198|RWDD4A	protein_coding	Q6NW29	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48089
0	-0.522846861359011	0.084	0.458	0	SLC25A4	Malignant cells	GSE164897_VemCob	ENSG00000151729	291	solute carrier family 25 member 4	AAC1|ANT1|PEO2|PEO3|T1	protein_coding	P12235	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48090
0	-0.552650858617323	0.085	0.477	0	CFAP97	Malignant cells	GSE164897_VemCob	ENSG00000164323	57587	cilia and flagella associated protein 97	DKFZp434F1728|hmw|KIAA1430	protein_coding	Q9P2B7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48091
0	-0.648062547558272	0.009	0.362	0	SORBS2	Malignant cells	GSE164897_VemCob	ENSG00000154556	8470	sorbin and SH3 domain containing 2	ARGBP2|KIAA0777	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48092
0	-0.775926377037908	0.174	0.696	0	PDCD6	Malignant cells	GSE164897_VemCob	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48093
0	-0.383079972755768	0.042	0.325	0	BRD9	Malignant cells	GSE164897_VemCob	ENSG00000028310	65980	bromodomain containing 9	FLJ13441|SMARCI2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48094
0	-1.05042619557194	0.144	0.779	0	NDUFS6	Malignant cells	GSE164897_VemCob	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48095
0	-0.42405577033683	0.111	0.428	0	MED10	Malignant cells	GSE164897_VemCob	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48096
0	0.984235542435004	0.959	0.784	0	SUB1	Malignant cells	GSE164897_VemCob	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48097
0	-0.402635875979889	0.053	0.351	0	WDR70	Malignant cells	GSE164897_VemCob	ENSG00000082068	55100	WD repeat domain 70	FLJ10233	protein_coding	Q9NW82	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48098
0	-0.445850807818134	0.042	0.36	0	MRPS30	Malignant cells	GSE164897_VemCob	ENSG00000112996	10884	mitochondrial ribosomal protein S30	PAP|PDCD9	protein_coding	Q9NP92	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48099
0	0.709094050130336	0.414	0.113	0	ITGA2	Malignant cells	GSE164897_VemCob	ENSG00000164171	3673	integrin subunit alpha 2	CD49B	protein_coding	P17301	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48100
0	-0.326255479871764	0.041	0.281	0	DIMT1	Malignant cells	GSE164897_VemCob	ENSG00000086189	27292	DIM1 rRNA methyltransferase and ribosome maturation factor	DIMT1L|HSA9761	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48101
0	-0.362574259307149	0.082	0.343	0	CENPH	Malignant cells	GSE164897_VemCob	ENSG00000153044	64946	centromere protein H	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48102
0	0.899682696186637	0.675	0.419	0	MAP1B	Malignant cells	GSE164897_VemCob	ENSG00000131711	4131	microtubule associated protein 1B	MAP5|PPP1R102	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48103
0	0.54421298585222	0.311	0.039	0	FOXD1	Malignant cells	GSE164897_VemCob	ENSG00000251493	2297	forkhead box D1	FKHL8|FREAC4	protein_coding	Q16676	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48104
0	0.453903973226562	1	1	0	RPS23	Malignant cells	GSE164897_VemCob	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48105
0	0.672592971162509	0.745	0.563	0	TMEM167A	Malignant cells	GSE164897_VemCob	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48106
0	0.596550605904253	1	1	0	COX7C	Malignant cells	GSE164897_VemCob	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48107
0	0.776704110217487	0.47	0.174	0	RHOBTB3	Malignant cells	GSE164897_VemCob	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48108
0	-1.27670648037781	0.032	0.797	0	EPB41L4A-AS1	Malignant cells	GSE164897_VemCob	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48109
0	-1.15329865264644	0.161	0.72	0	AP3S1	Malignant cells	GSE164897_VemCob	ENSG00000177879	1176	adaptor related protein complex 3 subunit sigma 1	CLAPS3	protein_coding	Q92572	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48110
0	0.921944065470021	1	0.998	0	HINT1	Malignant cells	GSE164897_VemCob	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48111
0	-0.921967544907508	0.064	0.644	0	PDLIM4	Malignant cells	GSE164897_VemCob	ENSG00000131435	8572	PDZ and LIM domain 4	RIL	protein_coding	P50479	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48112
0	0.705794353218804	1	0.999	0	UQCRQ	Malignant cells	GSE164897_VemCob	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48113
0	-0.777237768375767	0.4	0.845	0	VDAC1	Malignant cells	GSE164897_VemCob	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48114
0	0.989933951726238	0.969	0.857	0	SKP1	Malignant cells	GSE164897_VemCob	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48115
0	-0.359511738969111	0.046	0.312	0	CDKN2AIPNL	Malignant cells	GSE164897_VemCob	ENSG00000237190	91368	CDKN2A interacting protein N-terminal like	C2AIL|MGC13017	protein_coding	Q96HQ2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48116
0	-0.749006432011678	0.147	0.667	0	CAMLG	Malignant cells	GSE164897_VemCob	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48117
0	0.593871579477657	0.831	0.695	0	DDX46	Malignant cells	GSE164897_VemCob	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48118
0	1.17827542472814	0.922	0.605	0	TGFBI	Malignant cells	GSE164897_VemCob	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48119
0	-0.506217224244873	0.176	0.552	0	HNRNPA0	Malignant cells	GSE164897_VemCob	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48120
0	-0.717084733548876	0.226	0.719	0	UBE2D2	Malignant cells	GSE164897_VemCob	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48121
0	-0.5354117146696	0.171	0.567	0	SRA1	Malignant cells	GSE164897_VemCob	ENSG00000213523	10011	steroid receptor RNA activator 1	SRA|STRAA1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48122
0	0.686903450371997	0.932	0.793	0	NDUFA2	Malignant cells	GSE164897_VemCob	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48123
0	-0.349604922795978	0.092	0.362	0	NDFIP1	Malignant cells	GSE164897_VemCob	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48124
0	-1.21270598806859	0.065	0.594	0	SLC26A2	Malignant cells	GSE164897_VemCob	ENSG00000155850	1836	solute carrier family 26 member 2	DTD|DTDST	protein_coding	P50443	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48125
0	-1.68729173776945	0.601	0.769	0	CD74	Malignant cells	GSE164897_VemCob	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48126
0	-0.781342096385758	0.484	0.79	0	SPARC	Malignant cells	GSE164897_VemCob	ENSG00000113140	6678	secreted protein acidic and cysteine rich	BM-40|ON|ONT	protein_coding	P09486	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48127
0	0.965816479387713	0.797	0.484	0	PTTG1	Malignant cells	GSE164897_VemCob	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48128
0	-0.341754647489781	0.08	0.337	0	NUDCD2	Malignant cells	GSE164897_VemCob	ENSG00000170584	134492	NudC domain containing 2	DKFZp686E10109|NudCL2	protein_coding	Q8WVJ2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48129
0	1.30368549315385	0.658	0.156	0	SPDL1	Malignant cells	GSE164897_VemCob	ENSG00000040275	54908	spindle apparatus coiled-coil protein 1	CCDC99|FLJ20364|hSpindly	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48130
0	-0.605266185676864	0.997	1	0	NPM1	Malignant cells	GSE164897_VemCob	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48131
0	1.14351563474067	0.857	0.494	0	RPL26L1	Malignant cells	GSE164897_VemCob	ENSG00000037241	51121	ribosomal protein L26 like 1	RPL26P1	protein_coding	Q9UNX3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48132
0	1.26394557932812	0.88	0.458	0	ATP6V0E1	Malignant cells	GSE164897_VemCob	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48133
0	-0.420182486403769	0.054	0.359	0	BOD1	Malignant cells	GSE164897_VemCob	ENSG00000145919	91272	biorientation of chromosomes in cell division 1	FAM44B	protein_coding	Q96IK1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48134
0	-0.911684299929087	0.231	0.824	0	HIGD2A	Malignant cells	GSE164897_VemCob	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48135
0	-1.22358851631306	0.56	0.963	0	PRELID1	Malignant cells	GSE164897_VemCob	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48136
0	-0.715555103867011	0.103	0.607	0	LMAN2	Malignant cells	GSE164897_VemCob	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48137
0	-0.732307440687091	0.03	0.523	0	PDLIM7	Malignant cells	GSE164897_VemCob	ENSG00000196923	9260	PDZ and LIM domain 7	ENIGMA	protein_coding	Q9NR12	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48138
0	-1.1324819693874	0.731	0.969	0	NHP2	Malignant cells	GSE164897_VemCob	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48139
0	-0.528655387936449	0.47	0.78	0	SQSTM1	Malignant cells	GSE164897_VemCob	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48140
0	0.551458698208304	0.365	0.087	0	GFPT2	Malignant cells	GSE164897_VemCob	ENSG00000131459	9945	glutamine-fructose-6-phosphate transaminase 2	GFAT2	protein_coding	O94808	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48141
0	-0.580479048963152	0.042	0.452	0	PSMG4	Malignant cells	GSE164897_VemCob	ENSG00000180822	389362	proteasome assembly chaperone 4	C6orf86|PAC4	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48142
0	0.898033625890744	0.725	0.428	0	TMEM14B	Malignant cells	GSE164897_VemCob	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48143
0	-0.756249211287064	0.081	0.598	0	NOL7	Malignant cells	GSE164897_VemCob	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48144
0	-0.58920596555057	0.255	0.611	0	DEK	Malignant cells	GSE164897_VemCob	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48145
0	1.0106289875005	0.552	0.205	0	SOX4	Malignant cells	GSE164897_VemCob	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48146
0	0.969585825643619	0.999	0.971	0	H4C3	Malignant cells	GSE164897_VemCob	ENSG00000197061	8364	H4 clustered histone 3	dJ221C16.1|H4/g|H4FG|HIST1H4C	protein_coding	P62805	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48147
0	0.59180014450015	0.982	0.887	0	TUBB	Malignant cells	GSE164897_VemCob	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48148
0	-0.588238552639122	0.288	0.641	0	IER3	Malignant cells	GSE164897_VemCob	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48149
0	1.01121578352488	0.812	0.471	0	HLA-B	Malignant cells	GSE164897_VemCob	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48150
0	-0.356293606150304	0.014	0.272	0	NFKBIL1	Malignant cells	GSE164897_VemCob	ENSG00000236346	4795	NFKB inhibitor like 1	IKBL|NFKBIL	protein_coding	Q9UBC1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48151
0	0.826036604569633	0.958	0.793	0	CLIC1	Malignant cells	GSE164897_VemCob	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48152
0	-1.12231467322644	0.105	0.789	0	SNHG32	Malignant cells	GSE164897_VemCob	ENSG00000229300	50854	small nucleolar RNA host gene 32	C6orf48|D6S57|G8	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48153
0	-0.516028337457376	0.186	0.57	0	NELFE	Malignant cells	GSE164897_VemCob	ENSG00000206268	7936	negative elongation factor complex member E	D6S45|NELF-E|RD|RDBP|RDP	protein_coding	P18615	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48154
0	-0.782210362047254	0.052	0.409	0	HLA-DRA	Malignant cells	GSE164897_VemCob	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48155
0	0.283165565124205	1	1	0	RPS18	Malignant cells	GSE164897_VemCob	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48156
0	-0.579837259315493	0.206	0.641	0	CUTA	Malignant cells	GSE164897_VemCob	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48157
0	1.02776470695484	0.769	0.442	0	UQCC2	Malignant cells	GSE164897_VemCob	ENSG00000137288	84300	ubiquinol-cytochrome c reductase complex assembly factor 2	bA6B20.2|C6orf125|Cbp6|M19|MGC14833|MNF1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48158
0	-1.5628816766503	0.817	0.991	0	HMGA1	Malignant cells	GSE164897_VemCob	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48159
0	-0.37339587530538	0.1	0.383	0	SMIM29	Malignant cells	GSE164897_VemCob	ENSG00000186577	221491	small integral membrane protein 29	C6orf1|LBH|MGC57858	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48160
0	0.554134304786988	1	0.996	0	RPS10	Malignant cells	GSE164897_VemCob	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48161
0	0.741018655683624	0.747	0.535	0	MEA1	Malignant cells	GSE164897_VemCob	ENSG00000124733	4201	male-enhanced antigen 1	MEA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48162
0	-0.780422288158011	0.048	0.583	0	DNPH1	Malignant cells	GSE164897_VemCob	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48163
0	0.913250605281567	0.999	0.99	0	HSP90AB1	Malignant cells	GSE164897_VemCob	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48164
0	-0.298946961813911	0.05	0.275	0	SMAP1	Malignant cells	GSE164897_VemCob	ENSG00000112305	60682	small ArfGAP 1	FLJ13159|SMAP-1	protein_coding	Q8IYB5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48165
0	-0.416746189635865	1	1	0	EEF1A1	Malignant cells	GSE164897_VemCob	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48166
0	1.09719461655548	1	0.993	0	COX7A2	Malignant cells	GSE164897_VemCob	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48167
0	-0.508791135117346	0.233	0.624	0	SNX3	Malignant cells	GSE164897_VemCob	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48168
0	0.82665503378251	0.535	0.172	0	CENPW	Malignant cells	GSE164897_VemCob	ENSG00000203760	387103	centromere protein W	C6orf173|CUG2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48169
0	0.610301656157462	1	1	0	RPS12	Malignant cells	GSE164897_VemCob	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48170
0	0.678797735393784	0.334	0.059	0	SGK1	Malignant cells	GSE164897_VemCob	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48171
0	-0.441688585316521	0.119	0.45	0	PERP	Malignant cells	GSE164897_VemCob	ENSG00000112378	64065	p53 apoptosis effector related to PMP22	dJ496H19.1|KCP1|KRTCAP1|PIGPC1|THW	protein_coding	Q96FX8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48172
0	-0.54990884165164	0.005	0.34	0	NHSL1-AS1	Malignant cells	GSE164897_VemCob	ENSG00000225177	NA	NA	FLJ46906	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48173
0	0.67468044370223	0.731	0.558	0	SF3B5	Malignant cells	GSE164897_VemCob	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48174
0	1.31279592504007	0.886	0.462	0	DYNLT1	Malignant cells	GSE164897_VemCob	ENSG00000146425	6993	dynein light chain Tctex-type 1	TCTEL1|Tctex-1|TCTEX1	protein_coding	P63172	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48175
0	0.722796259267649	0.612	0.361	0	MRPL18	Malignant cells	GSE164897_VemCob	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48176
0	-0.395392230950842	0.102	0.407	0	SFT2D1	Malignant cells	GSE164897_VemCob	ENSG00000198818	113402	SFT2 domain containing 1	C6orf83|MGC19825|pRGR1	protein_coding	Q8WV19	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48177
0	1.13683612992148	0.977	0.833	0	PSMB1	Malignant cells	GSE164897_VemCob	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48178
0	-0.570960747746032	0.051	0.461	0	C7orf50	Malignant cells	GSE164897_VemCob	ENSG00000146540	84310	chromosome 7 open reading frame 50	MGC11257|YCR016W	protein_coding	Q9BRJ6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48179
0	-0.81420395376619	0.058	0.594	0	FSCN1	Malignant cells	GSE164897_VemCob	ENSG00000075618	6624	fascin actin-bundling protein 1	FLJ38511|p55|SNL	protein_coding	Q16658	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48180
0	1.08851342563978	0.848	0.496	0	RPA3	Malignant cells	GSE164897_VemCob	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48181
0	1.29840717354195	1	0.971	0	NDUFA4	Malignant cells	GSE164897_VemCob	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48182
0	-0.41735687655604	0.042	0.313	0	TSPAN13	Malignant cells	GSE164897_VemCob	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48183
0	0.961758983698974	1	0.999	0	TOMM7	Malignant cells	GSE164897_VemCob	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48184
0	-0.474621194006957	0.045	0.39	0	MALSU1	Malignant cells	GSE164897_VemCob	ENSG00000156928	115416	mitochondrial assembly of ribosomal large subunit 1	C7orf30|mtRsfA	protein_coding	Q96EH3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48185
0	0.80456105756539	0.935	0.769	0	HNRNPA2B1	Malignant cells	GSE164897_VemCob	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48186
0	-0.626654569151073	0.203	0.625	0	GARS1	Malignant cells	GSE164897_VemCob	ENSG00000106105	2617	glycyl-tRNA synthetase 1	CMT2D|DSMAV|GARS|GlyRS|SMAD1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48187
0	0.866809535835252	0.947	0.795	0	LSM5	Malignant cells	GSE164897_VemCob	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48188
0	-0.502237711547269	0.093	0.46	0	RALA	Malignant cells	GSE164897_VemCob	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48189
0	-0.64997674077023	0.068	0.537	0	MPLKIP	Malignant cells	GSE164897_VemCob	ENSG00000168303	136647	M-phase specific PLK1 interacting protein	C7orf11|ORF20|TTDN1	protein_coding	Q8TAP9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48190
0	-1.00600383855068	0.23	0.734	0	INHBA	Malignant cells	GSE164897_VemCob	ENSG00000122641	3624	inhibin subunit beta A	NA	protein_coding	P08476	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48191
0	0.75401498236287	0.689	0.487	0	PSMA2	Malignant cells	GSE164897_VemCob	ENSG00000106588	5683	proteasome 20S subunit alpha 2	HC3|MU|PMSA2	protein_coding	P25787	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48192
0	-0.401186292986883	0.079	0.363	0	STK17A	Malignant cells	GSE164897_VemCob	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48193
0	-0.806740625054203	0.086	0.621	0	POLD2	Malignant cells	GSE164897_VemCob	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48194
0	-0.459786017329549	0.322	0.652	0	H2AZ2	Malignant cells	GSE164897_VemCob	ENSG00000105968	94239	H2A.Z variant histone 2	H2AFV|H2AV|MGC10170|MGC10831|MGC1947	protein_coding	Q71UI9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48195
0	-0.480293022734726	0.03	0.34	0	UPP1	Malignant cells	GSE164897_VemCob	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48196
0	1.29804421906717	0.997	0.913	0	SEC61G	Malignant cells	GSE164897_VemCob	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48197
0	-0.333543849953369	0.065	0.316	0	NIPSNAP2	Malignant cells	GSE164897_VemCob	ENSG00000146729	2631	nipsnap homolog 2	GBAS	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48198
0	-0.454119645311317	0.383	0.732	0	CCT6A	Malignant cells	GSE164897_VemCob	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48199
0	-1.56844185367541	0.791	0.997	0	CHCHD2	Malignant cells	GSE164897_VemCob	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48200
0	-1.23973001950026	0.517	0.952	0	MDH2	Malignant cells	GSE164897_VemCob	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48201
0	-0.84579910595849	0.69	0.944	0	HSPB1	Malignant cells	GSE164897_VemCob	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48202
0	-0.326796509160027	0.07	0.318	0	RSBN1L	Malignant cells	GSE164897_VemCob	ENSG00000187257	222194	round spermatid basic protein 1 like	FLJ42526|FLJ45813|MGC71764	protein_coding	Q6PCB5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48203
0	1.15410434398533	0.995	0.886	0	SEM1	Malignant cells	GSE164897_VemCob	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48204
0	-0.523391405649955	0.038	0.396	0	ASNS	Malignant cells	GSE164897_VemCob	ENSG00000070669	440	asparagine synthetase (glutamine-hydrolyzing)	NA	protein_coding	P08243	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48205
0	-1.45866654157227	0.259	0.907	0	ARPC1B	Malignant cells	GSE164897_VemCob	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48206
0	-0.544796758999035	0.406	0.789	0	PDAP1	Malignant cells	GSE164897_VemCob	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48207
0	-0.800170430574084	0.218	0.746	0	BUD31	Malignant cells	GSE164897_VemCob	ENSG00000106245	8896	BUD31 homolog	Cwc14|EDG-2|EDG2|fSAP17|G10|YCR063W	protein_coding	P41223	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48208
0	1.02405780196988	0.996	0.928	0	ATP5MF	Malignant cells	GSE164897_VemCob	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48209
0	-0.536213706933138	0.147	0.539	0	GNB2	Malignant cells	GSE164897_VemCob	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48210
0	-0.517010204636325	0.095	0.45	0	POP7	Malignant cells	GSE164897_VemCob	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48211
0	-0.401177080629452	0.117	0.418	0	TRIP6	Malignant cells	GSE164897_VemCob	ENSG00000087077	7205	thyroid hormone receptor interactor 6	MGC10556|MGC10558|MGC29959|MGC3837|MGC4423|OIP1|ZRP-1	protein_coding	Q15654	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48212
0	-0.725039996549714	0.177	0.671	0	AP1S1	Malignant cells	GSE164897_VemCob	ENSG00000106367	1174	adaptor related protein complex 1 subunit sigma 1	AP19|CLAPS1|EKV3|SIGMA1A|WUGSC:H_DJ0747G18.2	protein_coding	P61966	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48213
0	-1.08102889103322	0.195	0.838	0	ZNHIT1	Malignant cells	GSE164897_VemCob	ENSG00000106400	10467	zinc finger HIT-type containing 1	CG1I|H_DJ0747G18.14|ZNFN4A1	protein_coding	O43257	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48214
0	-0.703026602753123	0.322	0.8	0	POLR2J	Malignant cells	GSE164897_VemCob	ENSG00000005075	5439	RNA polymerase II subunit J	hRPB14|POLR2J1|RPB11|RPB11A|RPB11m	protein_coding	P52435	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48215
0	-0.74333220086031	0.002	0.521	0	POLR2J3	Malignant cells	GSE164897_VemCob	ENSG00000168255	NA	NA	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48216
0	0.84500130505699	0.395	0.003	0	LRRC17	Malignant cells	GSE164897_VemCob	ENSG00000128606	10234	leucine rich repeat containing 17	H_RG318M05.3|P37NB	protein_coding	Q8N6Y2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48217
0	-0.521550585470126	0.105	0.481	0	DNAJC2	Malignant cells	GSE164897_VemCob	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48218
0	-0.351507669915281	0.131	0.414	0	SRPK2	Malignant cells	GSE164897_VemCob	ENSG00000135250	6733	SRSF protein kinase 2	SFRSK2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48219
0	-0.372754828255302	0.048	0.321	0	IFRD1	Malignant cells	GSE164897_VemCob	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48220
0	1.38305454628947	0.811	0.316	0	CAV1	Malignant cells	GSE164897_VemCob	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48221
0	-0.780199949018269	0.12	0.612	0	FAM3C	Malignant cells	GSE164897_VemCob	ENSG00000196937	10447	FAM3 metabolism regulating signaling molecule C	GS3876|ILEI	protein_coding	Q92520	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48222
0	0.601283756328528	0.876	0.743	0	ATP6V1F	Malignant cells	GSE164897_VemCob	ENSG00000128524	9296	ATPase H+ transporting V1 subunit F	ATP6S14|VATF|Vma7	protein_coding	Q16864	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48223
0	-0.392690295909811	0.162	0.46	0	CHCHD3	Malignant cells	GSE164897_VemCob	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48224
0	1.25722726836379	0.77	0.491	0	AKR1B1	Malignant cells	GSE164897_VemCob	ENSG00000085662	231	aldo-keto reductase family 1 member B	ALDR1|AR	protein_coding	P15121	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48225
0	0.689770536666295	0.837	0.659	0	STMP1	Malignant cells	GSE164897_VemCob	ENSG00000243317	647087	short transmembrane mitochondrial protein 1	C7orf73|Mm47|PL-5283	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48226
0	-0.710961771721131	0.668	0.929	0	NDUFB2	Malignant cells	GSE164897_VemCob	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48227
0	-0.354187530537637	0.09	0.355	0	ZYX	Malignant cells	GSE164897_VemCob	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48228
0	-0.31225386537933	0.057	0.29	0	CDK5	Malignant cells	GSE164897_VemCob	ENSG00000164885	1020	cyclin dependent kinase 5	PSSALRE	protein_coding	Q00535	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48229
0	-0.39667335219926	0.031	0.316	0	FASTK	Malignant cells	GSE164897_VemCob	ENSG00000164896	10922	Fas activated serine/threonine kinase	FAST	protein_coding	Q14296	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48230
0	-0.364055431173168	0.024	0.288	0	TMUB1	Malignant cells	GSE164897_VemCob	ENSG00000164897	83590	transmembrane and ubiquitin like domain containing 1	C7orf21|HOPS|SB144	protein_coding	Q9BVT8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48231
0	-0.580258102618187	0.188	0.601	0	RHEB	Malignant cells	GSE164897_VemCob	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48232
0	-2.26735370601139	0.576	0.999	0	SLC25A6	Malignant cells	GSE164897_VemCob	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48233
0	-0.418985874300851	0.057	0.348	0	CD99	Malignant cells	GSE164897_VemCob	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48234
0	2.11429858850084	0.997	0.809	0	TMSB4X	Malignant cells	GSE164897_VemCob	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48235
0	-0.72974609426526	0.059	0.561	0	AP1S2	Malignant cells	GSE164897_VemCob	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48236
0	-0.599076751500043	0.203	0.637	0	SYAP1	Malignant cells	GSE164897_VemCob	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48237
0	-0.848023601041854	0.271	0.78	0	SMS	Malignant cells	GSE164897_VemCob	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48238
0	-0.685378227009462	0.132	0.608	0	PRDX4	Malignant cells	GSE164897_VemCob	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48239
0	-0.501225528866159	0.092	0.419	0	DYNLT3	Malignant cells	GSE164897_VemCob	ENSG00000165169	6990	dynein light chain Tctex-type 3	TCTE1L|TCTEX1L	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48240
0	-0.536174237847817	0.137	0.51	0	SRPX	Malignant cells	GSE164897_VemCob	ENSG00000101955	8406	sushi repeat containing protein X-linked	ETX1|SRPX1	protein_coding	P78539	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48241
0	-0.332740321530003	0.02	0.254	0	MID1IP1	Malignant cells	GSE164897_VemCob	ENSG00000165175	58526	MID1 interacting protein 1	FLJ10386|G12-like|MIG12|STRAIT11499|THRSPL	protein_coding	Q9NPA3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48242
0	-1.38720392263355	0.247	0.928	0	NDUFB11	Malignant cells	GSE164897_VemCob	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48243
0	0.831420813771537	0.994	0.883	0	TIMP1	Malignant cells	GSE164897_VemCob	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48244
0	-0.482133746031574	0.056	0.41	0	WDR13	Malignant cells	GSE164897_VemCob	ENSG00000101940	64743	WD repeat domain 13	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48245
0	-0.606442306092781	0.144	0.58	0	TIMM17B	Malignant cells	GSE164897_VemCob	ENSG00000126768	10245	translocase of inner mitochondrial membrane 17B	DXS9822|JM3	protein_coding	O60830	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48246
0	-0.757011014564818	0.108	0.634	0	PQBP1	Malignant cells	GSE164897_VemCob	ENSG00000102103	10084	polyglutamine binding protein 1	MRX2|MRX55|MRXS3|MRXS8|RENS1|SHS	protein_coding	O60828	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48247
0	-0.485731535283674	0.242	0.595	0	PRAF2	Malignant cells	GSE164897_VemCob	ENSG00000243279	11230	PRA1 domain family member 2	JM4|Yip6a	protein_coding	O60831	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48248
0	-0.630165472963024	0.114	0.573	0	WDR45	Malignant cells	GSE164897_VemCob	ENSG00000196998	11152	WD repeat domain 45	JM5|NBIA5|WDRX1|WIPI4	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48249
0	-0.694004185491634	0.156	0.637	0	HSD17B10	Malignant cells	GSE164897_VemCob	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48250
0	0.934933529412556	0.995	0.943	0	PAGE5	Malignant cells	GSE164897_VemCob	ENSG00000158639	90737	PAGE family member 5	CT16.1|CT16.2|PAGE-5	protein_coding	Q96GU1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48251
0	0.91239023782259	0.803	0.525	0	NBDY	Malignant cells	GSE164897_VemCob	ENSG00000204272	550643	negative regulator of P-body association	LINC01420|NoBody	protein_coding	A0A0U1RRE5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48252
0	-0.250704734028065	1	1	0	RPS4X	Malignant cells	GSE164897_VemCob	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48253
0	0.943613434178746	0.932	0.71	0	PGK1	Malignant cells	GSE164897_VemCob	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48254
0	-0.790330119084325	0.876	0.983	0	SLC25A5	Malignant cells	GSE164897_VemCob	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48255
0	-0.676946415299104	1	1	0	RPL39	Malignant cells	GSE164897_VemCob	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48256
0	-0.521189252463765	0.065	0.455	0	NKAP	Malignant cells	GSE164897_VemCob	ENSG00000101882	79576	NFKB activating protein	FLJ22626	protein_coding	Q8N5F7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48257
0	-0.478039607433862	0.117	0.471	0	MAP7D3	Malignant cells	GSE164897_VemCob	ENSG00000129680	79649	MAP7 domain containing 3	FLJ12649	protein_coding	Q8IWC1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48258
0	-0.948193020600259	0.591	0.923	0	RBMX	Malignant cells	GSE164897_VemCob	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48259
0	-1.21453187706561	0.001	0.364	0	SPANXB1	Malignant cells	GSE164897_VemCob	ENSG00000227234	728695	SPANX family member B1	CT11.2|SPANXB2|SPANXF1|SPANXF2	protein_coding	Q9NS25	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48260
0	-0.529576740107157	0.155	0.552	0	VMA21	Malignant cells	GSE164897_VemCob	ENSG00000160131	203547	vacuolar ATPase assembly factor VMA21	MEAX|XMEA	protein_coding	Q3ZAQ7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48261
0	1.13943702572181	0.973	0.763	0	MAGEA4	Malignant cells	GSE164897_VemCob	ENSG00000147381	4103	MAGE family member A4	CT1.4|MAGE-41|MAGE-X2|MAGE4|MAGE4A|MAGE4B|MGC21336	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48262
0	0.66144035582096	0.807	0.654	0	CSAG1	Malignant cells	GSE164897_VemCob	ENSG00000198930	158511	chondrosarcoma associated gene 1	CSAGE|CT24.1	protein_coding	Q6PB30	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48263
0	-0.401545836070201	0.033	0.324	0	CCNQ	Malignant cells	GSE164897_VemCob	ENSG00000262919	92002	cyclin Q	CycM|FAM58A	protein_coding	Q8N1B3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48264
0	0.712938475336906	0.836	0.659	0	BCAP31	Malignant cells	GSE164897_VemCob	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48265
0	-0.373202979068786	0.089	0.366	0	IDH3G	Malignant cells	GSE164897_VemCob	ENSG00000067829	3421	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma	NA	protein_coding	P51553	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48266
0	-0.980170567415773	0.339	0.869	0	NAA10	Malignant cells	GSE164897_VemCob	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48267
0	-0.419191790305151	0.115	0.425	0	FLNA	Malignant cells	GSE164897_VemCob	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48268
0	0.385499969736425	1	1	0	RPL10	Malignant cells	GSE164897_VemCob	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48269
0	-0.455392446932302	0.161	0.501	0	LAGE3	Malignant cells	GSE164897_VemCob	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48270
0	-0.450556578556152	0.066	0.394	0	POLR3D	Malignant cells	GSE164897_VemCob	ENSG00000168495	661	RNA polymerase III subunit D	BN51T|C53|RPC4|TSBN51	protein_coding	P05423	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48271
0	-0.786391556209095	0.058	0.56	0	PDLIM2	Malignant cells	GSE164897_VemCob	ENSG00000120913	64236	PDZ and LIM domain 2	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48272
0	-0.402870575221716	0.044	0.329	0	BIN3	Malignant cells	GSE164897_VemCob	ENSG00000147439	55909	bridging integrator 3	NA	protein_coding	Q9NQY0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48273
0	0.751664476666524	0.382	0.08	0	NEFL	Malignant cells	GSE164897_VemCob	ENSG00000277586	4747	neurofilament light chain	CMT1F|CMT2E|NF68|NFL|PPP1R110	protein_coding	P07196	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48274
0	-0.76374773657946	0.063	0.532	0	DUSP4	Malignant cells	GSE164897_VemCob	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48275
0	-1.7597585341336	0.388	0.943	0	EIF4EBP1	Malignant cells	GSE164897_VemCob	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48276
0	-0.620008485247949	0.16	0.577	0	TCEA1	Malignant cells	GSE164897_VemCob	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48277
0	1.01860114304027	1	1	0	RPS20	Malignant cells	GSE164897_VemCob	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48278
0	0.655156565060094	0.567	0.332	0	CHCHD7	Malignant cells	GSE164897_VemCob	ENSG00000170791	79145	coiled-coil-helix-coiled-coil-helix domain containing 7	COX23|MGC2217	protein_coding	Q9BUK0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48279
0	-0.884921991474386	1	1	0	RPL7	Malignant cells	GSE164897_VemCob	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48280
0	0.57585508591928	0.885	0.777	0	ELOC	Malignant cells	GSE164897_VemCob	ENSG00000154582	6921	elongin C	SIII|TCEB1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48281
0	0.864216766712461	0.666	0.427	0	FABP5	Malignant cells	GSE164897_VemCob	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48282
0	-0.386493816683193	0.145	0.459	0	ZFAND1	Malignant cells	GSE164897_VemCob	ENSG00000104231	79752	zinc finger AN1-type containing 1	FLJ14007	protein_coding	Q8TCF1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48283
0	1.37868330518798	0.899	0.59	0	LINC01419	Malignant cells	GSE164897_VemCob	ENSG00000253898	103352670	long intergenic non-protein coding RNA 1419	PRLH1|TCONS_00014497	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48284
0	0.7818892316957	1	1	0	RPL30	Malignant cells	GSE164897_VemCob	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48285
0	1.19351789950124	0.996	0.907	0	COX6C	Malignant cells	GSE164897_VemCob	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48286
0	-1.0274638555676	0.823	0.984	0	PABPC1	Malignant cells	GSE164897_VemCob	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48287
0	0.590112952363652	0.852	0.728	0	YWHAZ	Malignant cells	GSE164897_VemCob	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48288
0	-0.642726333020793	0.312	0.758	0	ZNF706	Malignant cells	GSE164897_VemCob	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48289
0	-0.487331862675865	0.161	0.465	0	CTHRC1	Malignant cells	GSE164897_VemCob	ENSG00000164932	115908	collagen triple helix repeat containing 1	NA	protein_coding	Q96CG8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48290
0	-0.668494892707385	0.545	0.899	0	EIF3E	Malignant cells	GSE164897_VemCob	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48291
0	0.671158400105962	0.311	0.009	0	HAS2	Malignant cells	GSE164897_VemCob	ENSG00000170961	3037	hyaluronan synthase 2	NA	protein_coding	Q92819	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48292
0	0.619608160269723	0.975	0.91	0	NDUFB9	Malignant cells	GSE164897_VemCob	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48293
0	-0.565955239866029	0.085	0.488	0	LY6K	Malignant cells	GSE164897_VemCob	ENSG00000160886	54742	lymphocyte antigen 6 family member K	CT97|FLJ35226|HSJ001348	protein_coding	Q17RY6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48294
0	-1.43744215161505	0.071	0.866	0	LY6E	Malignant cells	GSE164897_VemCob	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48295
0	-0.348547686954747	0.063	0.315	0	MINCR	Malignant cells	GSE164897_VemCob	ENSG00000253716	100507316	MYC-induced long non-coding RNA	LINC01604|TCONS_00015189	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48296
0	-1.80798208296599	0.537	0.99	0	EEF1D	Malignant cells	GSE164897_VemCob	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48297
0	-0.493440266336394	0.037	0.393	0	GFUS	Malignant cells	GSE164897_VemCob	ENSG00000278243	7264	GDP-L-fucose synthase	FX|P35B|SDR4E1|TSTA3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48298
0	-0.433406580942618	0.095	0.418	0	PUF60	Malignant cells	GSE164897_VemCob	ENSG00000274081	22827	poly(U) binding splicing factor 60	FIR|RoBPI|SIAHBP1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48299
0	-0.443388119499659	0.083	0.399	0	PLEC	Malignant cells	GSE164897_VemCob	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48300
0	-0.361872767522889	0.075	0.348	0	GRINA	Malignant cells	GSE164897_VemCob	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48301
0	-0.846398394316057	0.057	0.624	0	EXOSC4	Malignant cells	GSE164897_VemCob	ENSG00000178896	54512	exosome component 4	FLJ20591|hRrp41p|p12A|RRP41|RRP41A|Rrp41p|SKI6|Ski6p	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48302
0	-0.508206488187831	0.147	0.523	0	GPAA1	Malignant cells	GSE164897_VemCob	ENSG00000197858	8733	glycosylphosphatidylinositol anchor attachment 1	GAA1|hGAA1	protein_coding	O43292	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48303
0	-1.13932150096613	0.389	0.919	0	CYC1	Malignant cells	GSE164897_VemCob	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48304
0	-0.368479879515637	0.053	0.327	0	SHARPIN	Malignant cells	GSE164897_VemCob	ENSG00000179526	81858	SHANK associated RH domain interactor	DKFZP434N1923|SIPL1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48305
0	-0.66632941004578	0.063	0.541	0	MAF1	Malignant cells	GSE164897_VemCob	ENSG00000179632	84232	MAF1 homolog, negative regulator of RNA polymerase III	DKFZp586G1123	protein_coding	Q9H063	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48306
0	-0.519267941752235	0.044	0.419	0	HSF1	Malignant cells	GSE164897_VemCob	ENSG00000284774	3297	heat shock transcription factor 1	HSTF1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48307
0	-0.393669342778249	0.078	0.375	0	SLC52A2	Malignant cells	GSE164897_VemCob	ENSG00000285112	79581	solute carrier family 52 member 2	D15Ertd747e|FLJ11856|GPCR41|GPR172A|hRFT3|PAR1|RFVT2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48308
0	-0.569102987258169	0.116	0.539	0	VPS28	Malignant cells	GSE164897_VemCob	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48309
0	-0.335990953201023	0.027	0.273	0	ZFTRAF1	Malignant cells	GSE164897_VemCob	ENSG00000187954	50626	zinc finger TRAF-type containing 1	CHRP|CYHR1|KIAA0496|MGC13010	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48310
0	-2.3141664255302	0.998	1	0	RPL8	Malignant cells	GSE164897_VemCob	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48311
0	-0.347209684282259	0.077	0.342	0	COMMD5	Malignant cells	GSE164897_VemCob	ENSG00000170619	28991	COMM domain containing 5	FLJ13008|HCaRG|HT002	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48312
0	-0.745773840961365	0.104	0.609	0	C8orf33	Malignant cells	GSE164897_VemCob	ENSG00000182307	65265	chromosome 8 open reading frame 33	FLJ20989	protein_coding	Q9H7E9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48313
0	-0.88072971652938	0.202	0.756	0	DMAC1	Malignant cells	GSE164897_VemCob	ENSG00000137038	90871	distal membrane arm assembly component 1	C9orf123|MGC4730|TMEM261	protein_coding	Q96GE9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48314
0	-0.868028041543102	1	1	0	RPS6	Malignant cells	GSE164897_VemCob	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48315
0	-0.457016185672622	0.066	0.408	0	BAG1	Malignant cells	GSE164897_VemCob	ENSG00000107262	573	BAG cochaperone 1	NA	protein_coding	Q99933	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48316
0	-0.367955026636373	0.041	0.308	0	RPP25L	Malignant cells	GSE164897_VemCob	ENSG00000164967	138716	ribonuclease P/MRP subunit p25 like	bA296L22.5|C9orf23|MGC29635	protein_coding	Q8N5L8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48317
0	-0.55672556743165	0.145	0.549	0	DCTN3	Malignant cells	GSE164897_VemCob	ENSG00000137100	11258	dynactin subunit 3	DCTN-22	protein_coding	O75935	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48318
0	-0.451903588037155	0.226	0.567	0	SIGMAR1	Malignant cells	GSE164897_VemCob	ENSG00000147955	10280	sigma non-opioid intracellular receptor 1	OPRS1|SR-BP1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48319
0	-0.879000808269878	0.513	0.905	0	STOML2	Malignant cells	GSE164897_VemCob	ENSG00000165283	30968	stomatin like 2	HSPC108|SLP-2	protein_coding	Q9UJZ1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48320
0	-1.22589326676555	0.517	0.951	0	TPM2	Malignant cells	GSE164897_VemCob	ENSG00000198467	7169	tropomyosin 2	AMCD1|DA1|NEM4	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48321
0	-0.896854706010363	0.061	0.66	0	HINT2	Malignant cells	GSE164897_VemCob	ENSG00000137133	84681	histidine triad nucleotide binding protein 2	NA	protein_coding	Q9BX68	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48322
0	-1.14156241086254	0.299	0.894	0	CLTA	Malignant cells	GSE164897_VemCob	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48323
0	-0.532540704704035	0.208	0.603	0	GRHPR	Malignant cells	GSE164897_VemCob	ENSG00000137106	9380	glyoxylate and hydroxypyruvate reductase	GLXR|PH2	protein_coding	Q9UBQ7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48324
0	-0.468046425070253	0.066	0.409	0	EXOSC3	Malignant cells	GSE164897_VemCob	ENSG00000107371	51010	exosome component 3	CGI-102|hRrp-40|hRrp40p|p10|RRP40|Rrp40p	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48325
0	-0.750384486234142	0.081	0.552	0	PSAT1	Malignant cells	GSE164897_VemCob	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48326
0	-0.423215674374028	0.065	0.374	0	ISCA1	Malignant cells	GSE164897_VemCob	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48327
0	1.41015870348626	0.733	0.27	0	CKS2	Malignant cells	GSE164897_VemCob	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48328
0	-0.688902843245804	0.053	0.527	0	CARD19	Malignant cells	GSE164897_VemCob	ENSG00000165233	84270	caspase recruitment domain family member 19	bA370F5.1|BinCARD|C9orf89|MGC11115	protein_coding	Q96LW7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48329
0	-0.347392661818512	0.097	0.358	0	NINJ1	Malignant cells	GSE164897_VemCob	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48330
0	-0.983752410154911	0.363	0.862	0	ANP32B	Malignant cells	GSE164897_VemCob	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48331
0	-0.549741525263966	0.055	0.448	0	NANS	Malignant cells	GSE164897_VemCob	ENSG00000095380	54187	N-acetylneuraminate synthase	SAS	protein_coding	Q9NR45	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48332
0	-0.320546192156977	0.052	0.277	0	CTNNAL1	Malignant cells	GSE164897_VemCob	ENSG00000119326	8727	catenin alpha like 1	alpha-CATU|CLLP	protein_coding	Q9UBT7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48333
0	0.843609916353356	1	0.994	0	TXN	Malignant cells	GSE164897_VemCob	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48334
0	-0.378775340988106	0.065	0.311	0	PHF19	Malignant cells	GSE164897_VemCob	ENSG00000119403	26147	PHD finger protein 19	DKFZP727G051|MTF2L1|PCL3|TDRD19B	protein_coding	Q5T6S3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48335
0	0.390968539975968	1	1	0	RPL35	Malignant cells	GSE164897_VemCob	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48336
0	-0.62863458804341	0.142	0.591	0	ARPC5L	Malignant cells	GSE164897_VemCob	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48337
0	0.294991955426157	1	1	0	RPL12	Malignant cells	GSE164897_VemCob	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48338
0	-0.31853934618704	0.02	0.251	0	PTRH1	Malignant cells	GSE164897_VemCob	ENSG00000187024	138428	peptidyl-tRNA hydrolase 1 homolog	C9orf115|PTH1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48339
0	-0.537693260811176	0.033	0.412	0	AK1	Malignant cells	GSE164897_VemCob	ENSG00000106992	203	adenylate kinase 1	NA	protein_coding	P00568	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48340
0	-0.836637941998511	0.129	0.681	0	DPM2	Malignant cells	GSE164897_VemCob	ENSG00000136908	8818	dolichyl-phosphate mannosyltransferase subunit 2, regulatory	MGC111193|MGC21559	protein_coding	O94777	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48341
0	-0.475133565080433	0.056	0.405	0	PTGES2	Malignant cells	GSE164897_VemCob	ENSG00000148334	80142	prostaglandin E synthase 2	C9orf15|FLJ14038	protein_coding	Q9H7Z7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48342
0	-0.779007653701142	0.04	0.296	0	LCN2	Malignant cells	GSE164897_VemCob	ENSG00000148346	3934	lipocalin 2	24p3|NGAL	protein_coding	P80188	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48343
0	-1.40958048685151	0.066	0.831	0	BBLN	Malignant cells	GSE164897_VemCob	ENSG00000171159	79095	bublin coiled coil protein	C9orf16|EST00098|FLJ12823|MGC4639	protein_coding	Q9BUW7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48344
0	-0.369595606644051	0.031	0.304	0	CIZ1	Malignant cells	GSE164897_VemCob	ENSG00000148337	25792	CDKN1A interacting zinc finger protein 1	LSFR1|ZNF356	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48345
0	-0.521548577715305	0.099	0.488	0	COQ4	Malignant cells	GSE164897_VemCob	ENSG00000167113	51117	coenzyme Q4	CGI-92	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48346
0	-0.766075164872503	0.087	0.621	0	URM1	Malignant cells	GSE164897_VemCob	ENSG00000167118	81605	ubiquitin related modifier 1	C9orf74|MGC2668	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48347
0	-0.467008914378201	0.046	0.363	0	DYNC2I2	Malignant cells	GSE164897_VemCob	ENSG00000119333	89891	dynein 2 intermediate chain 2	bA216B9.3|CFAP133|DIC5|FAP133|MGC20486|WDR34	protein_coding	Q96EX3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48348
0	-0.601286024874488	0.074	0.5	0	ZDHHC12	Malignant cells	GSE164897_VemCob	ENSG00000160446	84885	zinc finger DHHC-type palmitoyltransferase 12	FLJ14524|ZNF400	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48349
0	-0.463646466345518	0.103	0.441	0	NTMT1	Malignant cells	GSE164897_VemCob	ENSG00000148335	28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1	AD-003|C9orf32|HOMT1A|METTL11A|NRMT|NRMT1	protein_coding	Q9BV86	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48350
0	-0.545735548644134	0.072	0.461	0	SURF6	Malignant cells	GSE164897_VemCob	ENSG00000281309	6838	surfeit 6	FLJ30322|RRP14	protein_coding	O75683	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48351
0	-0.650953915614876	0.046	0.511	0	SURF1	Malignant cells	GSE164897_VemCob	ENSG00000280627	6834	SURF1 cytochrome c oxidase assembly factor	SHY1	protein_coding	Q15526	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48352
0	-0.952601769996253	0.052	0.672	0	SURF2	Malignant cells	GSE164897_VemCob	ENSG00000281024	6835	surfeit 2	NA	protein_coding	Q15527	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48353
0	-0.669360365725131	0.037	0.493	0	REXO4	Malignant cells	GSE164897_VemCob	ENSG00000280706	57109	REX4 homolog, 3'-5' exonuclease	hPMC2|XPMC2H	protein_coding	Q9GZR2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48354
0	-0.475869717914615	0.081	0.429	0	MRPS2	Malignant cells	GSE164897_VemCob	ENSG00000122140	51116	mitochondrial ribosomal protein S2	CGI-91	protein_coding	Q9Y399	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48355
0	-0.601625929254668	0.029	0.452	0	AGPAT2	Malignant cells	GSE164897_VemCob	ENSG00000169692	10555	1-acylglycerol-3-phosphate O-acyltransferase 2	BSCL|LPAAT-beta|LPLAT2	protein_coding	O15120	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48356
0	-1.65145078373402	0.078	0.903	0	SNHG7	Malignant cells	GSE164897_VemCob	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48357
0	-1.19853077442977	0.126	0.806	0	PHPT1	Malignant cells	GSE164897_VemCob	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48358
0	-0.557124130827198	0.733	0.933	0	EDF1	Malignant cells	GSE164897_VemCob	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48359
0	-0.467058382660973	0.031	0.372	0	FBXW5	Malignant cells	GSE164897_VemCob	ENSG00000159069	54461	F-box and WD repeat domain containing 5	DKFZP434B205|Fbw5|MGC20962	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48360
0	-0.569629718887954	0.032	0.43	0	PAXX	Malignant cells	GSE164897_VemCob	ENSG00000148362	286257	PAXX non-homologous end joining factor	C9orf142|XLS	protein_coding	Q9BUH6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48361
0	-0.510049821102127	0.038	0.404	0	DPP7	Malignant cells	GSE164897_VemCob	ENSG00000176978	29952	dipeptidyl peptidase 7	DPP2|DPPII	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48362
0	-0.608159430579747	0.123	0.566	0	SSNA1	Malignant cells	GSE164897_VemCob	ENSG00000176101	8636	SS nuclear autoantigen 1	N14|NA14	protein_coding	O43805	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48363
0	-1.42664118453531	0.223	0.921	0	MRPL41	Malignant cells	GSE164897_VemCob	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48364
0	1.10590838960545	0.609	0.271	0	IFITM2	Malignant cells	GSE164897_VemCob	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48365
0	-0.618823582182683	0.018	0.447	0	SIGIRR	Malignant cells	GSE164897_VemCob	ENSG00000185187	59307	single Ig and TIR domain containing	IL-1R8|TIR8	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48366
0	-0.610874999284006	0.088	0.529	0	RNH1	Malignant cells	GSE164897_VemCob	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48367
0	-2.68732064519899	0.994	1	0	RPLP2	Malignant cells	GSE164897_VemCob	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48368
0	-0.319042258669691	0.03	0.261	0	PNPLA2	Malignant cells	GSE164897_VemCob	ENSG00000177666	57104	patatin like phospholipase domain containing 2	ATGL|desnutrin|FP17548|iPLA2zeta|TTS-2.2	protein_coding	Q96AD5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48369
0	-0.705037358412698	0.181	0.658	0	CD151	Malignant cells	GSE164897_VemCob	ENSG00000177697	977	CD151 molecule (Raph blood group)	PETA-3|RAPH|SFA-1|TSPAN24	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48370
0	-1.38416308705173	0.58	0.966	0	POLR2L	Malignant cells	GSE164897_VemCob	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48371
0	-0.603805324607979	0.038	0.455	0	TSPAN4	Malignant cells	GSE164897_VemCob	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48372
0	-0.460284045181878	0.075	0.404	0	CTSD	Malignant cells	GSE164897_VemCob	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48373
0	-0.577754215829851	0.031	0.449	0	MRPL23	Malignant cells	GSE164897_VemCob	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48374
0	-0.38339325711634	0.019	0.298	0	TSSC4	Malignant cells	GSE164897_VemCob	ENSG00000184281	10078	tumor suppressing subtransferable candidate 4	NA	protein_coding	Q9Y5U2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48375
0	-1.13589360544982	0.07	0.693	0	PHLDA2	Malignant cells	GSE164897_VemCob	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48376
0	-0.639081004313412	0.03	0.372	0	HBE1	Malignant cells	GSE164897_VemCob	ENSG00000213931	3046	hemoglobin subunit epsilon 1	HBE	protein_coding	P02100	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48377
0	-0.965668778866324	0.09	0.674	0	CAVIN3	Malignant cells	GSE164897_VemCob	ENSG00000170955	112464	caveolae associated protein 3	cavin-3|HSRBC|MGC20400|PRKCDBP|SRBC	protein_coding	Q969G5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48378
0	-1.27801707988474	0.279	0.922	0	EIF3F	Malignant cells	GSE164897_VemCob	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48379
0	-0.550626066505446	1	1	0	RPL27A	Malignant cells	GSE164897_VemCob	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48380
0	0.702790774129405	0.992	0.952	0	LDHA	Malignant cells	GSE164897_VemCob	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48381
0	-0.589666466923708	0.584	0.884	0	EIF3M	Malignant cells	GSE164897_VemCob	ENSG00000149100	10480	eukaryotic translation initiation factor 3 subunit M	FLJ29030|GA17|hfl-B5|PCID1|TANGO7	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48382
0	-0.571494601847411	0.647	0.905	0	CD44	Malignant cells	GSE164897_VemCob	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48383
0	-0.481301035727543	0.017	0.358	0	PEX16	Malignant cells	GSE164897_VemCob	ENSG00000121680	9409	peroxisomal biogenesis factor 16	NA	protein_coding	Q9Y5Y5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48384
0	-0.83991694044592	0.131	0.556	0	MDK	Malignant cells	GSE164897_VemCob	ENSG00000110492	4192	midkine	FLJ27379|MK|NEGF2	protein_coding	P21741	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48385
0	-0.452649730062208	0.042	0.37	0	PACSIN3	Malignant cells	GSE164897_VemCob	ENSG00000165912	29763	protein kinase C and casein kinase substrate in neurons 3	SDPIII	protein_coding	Q9UKS6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48386
0	-0.84072885788577	0.092	0.668	0	NDUFS3	Malignant cells	GSE164897_VemCob	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48387
0	-0.355895426887589	0.061	0.326	0	PTPMT1	Malignant cells	GSE164897_VemCob	ENSG00000285206	114971	protein tyrosine phosphatase mitochondrial 1	DUSP23|MOSP|PLIP	protein_coding	Q8WUK0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48388
0	-0.804984136274852	0.109	0.658	0	SELENOH	Malignant cells	GSE164897_VemCob	ENSG00000211450	280636	selenoprotein H	C11orf31|SELH	protein_coding	Q8IZQ5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48389
0	-0.357581710699909	0.125	0.402	0	MRPL16	Malignant cells	GSE164897_VemCob	ENSG00000166902	54948	mitochondrial ribosomal protein L16	FLJ20484|PNAS-111	protein_coding	Q9NX20	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48390
0	-1.6621482280865	0.998	1	0	FTH1	Malignant cells	GSE164897_VemCob	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48391
0	-0.371368635724237	0.082	0.357	0	B3GAT3	Malignant cells	GSE164897_VemCob	ENSG00000149541	26229	beta-1,3-glucuronyltransferase 3	GlcAT-I	protein_coding	O94766	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48392
0	-0.672245425806494	0.085	0.556	0	CSKMT	Malignant cells	GSE164897_VemCob	ENSG00000214756	751071	citrate synthase lysine methyltransferase	CS-KMT|METTL12|U99HG	protein_coding	A8MUP2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48393
0	-0.541372483204581	0.042	0.434	0	UQCC3	Malignant cells	GSE164897_VemCob	ENSG00000204922	790955	ubiquinol-cytochrome c reductase complex assembly factor 3	C11orf83|UNQ655	protein_coding	Q6UW78	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48394
0	-1.25804234375734	0.166	0.871	0	UBXN1	Malignant cells	GSE164897_VemCob	ENSG00000162191	51035	UBX domain protein 1	2B28|LOC51035|SAKS1|UBXD10	protein_coding	Q04323	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48395
0	-0.730770560159873	0.084	0.594	0	TMEM223	Malignant cells	GSE164897_VemCob	ENSG00000168569	79064	transmembrane protein 223	MGC3196|Mrx15	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48396
0	-0.826554390439811	0.125	0.676	0	TMEM179B	Malignant cells	GSE164897_VemCob	ENSG00000185475	374395	transmembrane protein 179B	NA	protein_coding	Q7Z7N9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48397
0	-0.54025085422912	0.084	0.474	0	WDR74	Malignant cells	GSE164897_VemCob	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48398
0	-0.986606166803345	0.028	0.632	0	SLC3A2	Malignant cells	GSE164897_VemCob	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48399
0	-1.37113674543876	0.582	0.979	0	COX8A	Malignant cells	GSE164897_VemCob	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48400
0	-0.361694821780647	0.156	0.449	0	OTUB1	Malignant cells	GSE164897_VemCob	ENSG00000167770	55611	OTU deubiquitinase, ubiquitin aldehyde binding 1	FLJ20113|FLJ40710	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48401
0	-0.385872464867749	0.058	0.345	0	TRPT1	Malignant cells	GSE164897_VemCob	ENSG00000149743	83707	tRNA phosphotransferase 1	MGC11134	protein_coding	Q86TN4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48402
0	-0.532312169881888	0.059	0.44	0	NUDT22	Malignant cells	GSE164897_VemCob	ENSG00000149761	84304	nudix hydrolase 22	MGC13045	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48403
0	-0.44138076409616	0.022	0.333	0	DNAJC4	Malignant cells	GSE164897_VemCob	ENSG00000110011	3338	DnaJ heat shock protein family (Hsp40) member C4	HSPF2|MCG18	protein_coding	Q9NNZ3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48404
0	-0.60124298738637	0.045	0.469	0	BAD	Malignant cells	GSE164897_VemCob	ENSG00000002330	572	BCL2 associated agonist of cell death	BBC2|BCL2L8	protein_coding	Q92934	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48405
0	-0.401366465594056	0.069	0.372	0	ESRRA	Malignant cells	GSE164897_VemCob	ENSG00000173153	2101	estrogen related receptor alpha	ERR1|ERRa|ERRalpha|ESRL1|NR3B1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48406
0	0.99457773254103	0.998	0.966	0	TRMT112	Malignant cells	GSE164897_VemCob	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48407
0	-0.703301200442269	0.529	0.891	0	PRDX5	Malignant cells	GSE164897_VemCob	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48408
0	-1.07061179004242	0.089	0.771	0	ARL2	Malignant cells	GSE164897_VemCob	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48409
0	-0.443119208415634	1	1	0	FAU	Malignant cells	GSE164897_VemCob	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48410
0	1.31712713269455	0.971	0.698	0	NEAT1	Malignant cells	GSE164897_VemCob	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48411
0	0.964400379707611	1	1	0	MALAT1	Malignant cells	GSE164897_VemCob	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48412
0	-0.339776632985617	0.065	0.303	0	LTBP3	Malignant cells	GSE164897_VemCob	ENSG00000168056	4054	latent transforming growth factor beta binding protein 3	LTBP2	protein_coding	Q9NS15	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48413
0	-0.74172461910139	0.068	0.579	0	ZNRD2	Malignant cells	GSE164897_VemCob	ENSG00000173465	10534	zinc ribbon domain containing 2	p27|SSSCA1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48414
0	-0.678153513206909	0.102	0.577	0	RNASEH2C	Malignant cells	GSE164897_VemCob	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48415
0	-1.05033637046258	0.979	0.999	0	CFL1	Malignant cells	GSE164897_VemCob	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48416
0	-0.844151789171238	0.476	0.898	0	FIBP	Malignant cells	GSE164897_VemCob	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48417
0	-1.61659973680065	0.352	0.958	0	CCDC85B	Malignant cells	GSE164897_VemCob	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48418
0	-1.17593711862357	0.183	0.842	0	DRAP1	Malignant cells	GSE164897_VemCob	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48419
0	-0.791694005251378	0.062	0.616	0	YIF1A	Malignant cells	GSE164897_VemCob	ENSG00000174851	10897	Yip1 interacting factor homolog A, membrane trafficking protein	54TM|FinGER7|YIF1|YIF1P	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48420
0	-0.320894570118321	0.05	0.283	0	BRMS1	Malignant cells	GSE164897_VemCob	ENSG00000174744	25855	BRMS1 transcriptional repressor and anoikis regulator	DKFZP564A063	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48421
0	-0.507761675931166	0.179	0.561	0	MRPL11	Malignant cells	GSE164897_VemCob	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48422
0	-0.318482015168659	0.036	0.267	0	ZDHHC24	Malignant cells	GSE164897_VemCob	ENSG00000174165	254359	zinc finger DHHC-type containing 24	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48423
0	-0.955800142284732	0.071	0.696	0	PPP1CA	Malignant cells	GSE164897_VemCob	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48424
0	-0.50746548988902	0.031	0.399	0	RPS6KB2	Malignant cells	GSE164897_VemCob	ENSG00000175634	6199	ribosomal protein S6 kinase B2	KLS|P70-BETA|p70S6Kb|S6KB|S6Kbeta|STK14B	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48425
0	-0.602033225702295	0.023	0.448	0	CORO1B	Malignant cells	GSE164897_VemCob	ENSG00000172725	57175	coronin 1B	coronin-2	protein_coding	Q9BR76	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48426
0	-0.52303520556035	0.043	0.412	0	TMEM134	Malignant cells	GSE164897_VemCob	ENSG00000172663	80194	transmembrane protein 134	FLJ21749	protein_coding	Q9H6X4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48427
0	-0.65706585861124	0.03	0.504	0	AIP	Malignant cells	GSE164897_VemCob	ENSG00000110711	9049	aryl hydrocarbon receptor interacting protein	ARA9|FKBP16|FKBP37|XAP2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48428
0	-0.684668927551611	0.96	0.996	0	GSTP1	Malignant cells	GSE164897_VemCob	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48429
0	-0.639056748985701	0.054	0.507	0	NDUFV1	Malignant cells	GSE164897_VemCob	ENSG00000167792	4723	NADH:ubiquinone oxidoreductase core subunit V1	CI-51K	protein_coding	P49821	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48430
0	-1.10022726574978	0.239	0.859	0	NDUFS8	Malignant cells	GSE164897_VemCob	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48431
0	-0.898829625791095	0.21	0.713	0	CCND1	Malignant cells	GSE164897_VemCob	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48432
0	-0.580173892218856	0.341	0.754	0	LAMTOR1	Malignant cells	GSE164897_VemCob	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48433
0	-0.753254640412057	0.334	0.808	0	CLNS1A	Malignant cells	GSE164897_VemCob	ENSG00000074201	1207	chloride nucleotide-sensitive channel 1A	CLCI|ICln	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48434
0	-1.59509836924712	0.257	0.877	0	CTSC	Malignant cells	GSE164897_VemCob	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48435
0	-0.367293904794316	0.085	0.362	0	BIRC2	Malignant cells	GSE164897_VemCob	ENSG00000110330	329	baculoviral IAP repeat containing 2	API1|c-IAP1|cIAP1|hiap-2|MIHB|RNF48	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48436
0	2.939820789033	0.702	0.014	0	MMP1	Malignant cells	GSE164897_VemCob	ENSG00000196611	4312	matrix metallopeptidase 1	CLG	protein_coding	P03956	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48437
0	1.35058385850157	0.273	0	0	MMP3	Malignant cells	GSE164897_VemCob	ENSG00000149968	4314	matrix metallopeptidase 3	STMY|STMY1	protein_coding	P08254	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48438
0	-0.479713472393617	0.165	0.522	0	DCUN1D5	Malignant cells	GSE164897_VemCob	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48439
0	-0.32818314558521	0.076	0.321	0	ACAT1	Malignant cells	GSE164897_VemCob	ENSG00000075239	38	acetyl-CoA acetyltransferase 1	ACAT|THIL	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48440
0	-0.788159416449919	0.159	0.684	0	RDX	Malignant cells	GSE164897_VemCob	ENSG00000137710	5962	radixin	DFNB24	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48441
0	-0.518492461263383	0.17	0.557	0	REXO2	Malignant cells	GSE164897_VemCob	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48442
0	-0.510154585222624	0.12	0.496	0	ZPR1	Malignant cells	GSE164897_VemCob	ENSG00000109917	8882	ZPR1 zinc finger	ZNF259	protein_coding	O75312	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48443
0	0.91037977080126	1	0.992	0	ATP5MG	Malignant cells	GSE164897_VemCob	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48444
0	1.01808937424425	0.73	0.377	0	TRAPPC4	Malignant cells	GSE164897_VemCob	ENSG00000280495	51399	trafficking protein particle complex subunit 4	PTD009|SBDN|TRS23	protein_coding	Q9Y296	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48445
0	-0.323070959916798	0.045	0.289	0	TLCD5	Malignant cells	GSE164897_VemCob	ENSG00000181264	219902	TLC domain containing 5	MGC17839|TMEM136	protein_coding	Q6ZRR5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48446
0	0.723361194807751	0.909	0.704	0	HSPA8	Malignant cells	GSE164897_VemCob	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48447
0	-0.379082780480907	0.085	0.373	0	TBRG1	Malignant cells	GSE164897_VemCob	ENSG00000154144	84897	transforming growth factor beta regulator 1	FLJ14621|NIAM|TB-5	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48448
0	-0.627927455943531	0.051	0.482	0	DCPS	Malignant cells	GSE164897_VemCob	ENSG00000110063	28960	decapping enzyme, scavenger	HINT-5|HINT5|HSL1|HSPC015	protein_coding	Q96C86	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48449
0	-1.61430674343352	0.071	0.854	0	ST3GAL4	Malignant cells	GSE164897_VemCob	ENSG00000110080	6484	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	CGS23|FLJ11867|NANTA3|SAT3|SIAT4|SIAT4C|STZ	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48450
0	-0.433164847746084	0.17	0.509	0	GDI2	Malignant cells	GSE164897_VemCob	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48451
0	-1.82726060653925	0.97	1	0	VIM	Malignant cells	GSE164897_VemCob	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48452
0	-0.341585856251704	0.038	0.284	0	MSRB2	Malignant cells	GSE164897_VemCob	ENSG00000148450	22921	methionine sulfoxide reductase B2	CBS-1|CBS1|CGI-131|MSRB|PILB	protein_coding	Q9Y3D2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48453
0	-0.577778087717687	0.19	0.583	0	KIF5B	Malignant cells	GSE164897_VemCob	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48454
0	-1.01491645637876	0.106	0.742	0	PPA1	Malignant cells	GSE164897_VemCob	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48455
0	-0.359172070417697	0.125	0.395	0	PCBD1	Malignant cells	GSE164897_VemCob	ENSG00000166228	5092	pterin-4 alpha-carbinolamine dehydratase 1	DCOH|PCBD|PCD	protein_coding	P61457	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48456
0	-1.05954502708261	0.071	0.665	0	DDIT4	Malignant cells	GSE164897_VemCob	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48457
0	-0.620560219446897	0.267	0.719	0	MRPS16	Malignant cells	GSE164897_VemCob	ENSG00000182180	51021	mitochondrial ribosomal protein S16	CGI-132	protein_coding	Q9Y3D3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48458
0	0.643337988683223	0.428	0.144	0	VCL	Malignant cells	GSE164897_VemCob	ENSG00000035403	7414	vinculin	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48459
0	-0.969351249643762	0.185	0.803	0	VDAC2	Malignant cells	GSE164897_VemCob	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48460
0	-0.844899528669872	1	1	0	RPS24	Malignant cells	GSE164897_VemCob	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48461
0	-0.405745195659902	0.17	0.487	0	ANXA11	Malignant cells	GSE164897_VemCob	ENSG00000122359	311	annexin A11	ANX11	protein_coding	P50995	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48462
0	-0.44175476605774	0.042	0.363	0	FRA10AC1	Malignant cells	GSE164897_VemCob	ENSG00000148690	118924	FRA10A associated CGG repeat 1	C10orf4	protein_coding	Q70Z53	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48463
0	-0.523844001919892	0.027	0.362	0	AVPI1	Malignant cells	GSE164897_VemCob	ENSG00000119986	60370	arginine vasopressin induced 1	PP5395|VIP32|VIT32	protein_coding	Q5T686	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48464
0	-0.585954456304495	0.133	0.559	0	MRPL43	Malignant cells	GSE164897_VemCob	ENSG00000055950	84545	mitochondrial ribosomal protein L43	bMRP36a	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48465
0	0.748755713655759	0.598	0.313	0	ARL3	Malignant cells	GSE164897_VemCob	ENSG00000138175	403	ADP ribosylation factor like GTPase 3	ARFL3	protein_coding	P36405	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48466
0	0.593493219056454	1	0.998	0	ATP5MK	Malignant cells	GSE164897_VemCob	ENSG00000173915	84833	ATP synthase membrane subunit k	AGP|ATP5MD|bA792D24.4|DAPIT|MGC14697|USMG5	protein_coding	Q96IX5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48467
0	-0.806105413721154	0.249	0.767	0	GSTO1	Malignant cells	GSE164897_VemCob	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48468
0	-0.509842232792867	0.024	0.388	0	RGS10	Malignant cells	GSE164897_VemCob	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48469
0	-0.475213433373249	0.022	0.334	0	INPP5F	Malignant cells	GSE164897_VemCob	ENSG00000198825	22876	inositol polyphosphate-5-phosphatase F	hSac2|KIAA0966|SAC2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48470
0	-0.453447732264303	0.072	0.407	0	UROS	Malignant cells	GSE164897_VemCob	ENSG00000188690	7390	uroporphyrinogen III synthase	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48471
0	-0.757794814132874	0.135	0.654	0	GLRX3	Malignant cells	GSE164897_VemCob	ENSG00000108010	10539	glutaredoxin 3	bA500G10.4|GLRX4|GRX3|GRX4|PICOT|TXNL2	protein_coding	O76003	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48472
0	-0.477823870734612	0.093	0.446	0	ZNF511	Malignant cells	GSE164897_VemCob	ENSG00000198546	118472	zinc finger protein 511	MGC30006|Zfp511	protein_coding	Q8NB15	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48473
0	-0.473673209397736	0.014	0.35	0	FUOM	Malignant cells	GSE164897_VemCob	ENSG00000148803	282969	fucose mutarotase	C10orf125|FLJ26016|FucM|FucU	protein_coding	A2VDF0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48474
0	-0.660240207368464	0.191	0.652	0	ECHS1	Malignant cells	GSE164897_VemCob	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48475
0	-0.397084989013408	0.089	0.388	0	LTBR	Malignant cells	GSE164897_VemCob	ENSG00000111321	4055	lymphotoxin beta receptor	D12S370|TNF-R-III|TNFCR|TNFR-RP|TNFR2-RP|TNFRSF3	protein_coding	P36941	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48476
0	1.25680356285584	0.998	0.908	0	MRPL51	Malignant cells	GSE164897_VemCob	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48477
0	-0.586137224514001	1	1	0	GAPDH	Malignant cells	GSE164897_VemCob	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48478
0	-0.565119859923814	0.314	0.72	0	MLF2	Malignant cells	GSE164897_VemCob	ENSG00000089693	8079	myeloid leukemia factor 2	NTN4	protein_coding	Q15773	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48479
0	1.35389843782961	1	0.985	0	TPI1	Malignant cells	GSE164897_VemCob	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48480
0	-1.20995628984559	0.25	0.882	0	C12orf57	Malignant cells	GSE164897_VemCob	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48481
0	-0.562600804359783	0.647	0.909	0	PHB2	Malignant cells	GSE164897_VemCob	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48482
0	-0.51917716282293	0.06	0.436	0	SMIM10L1	Malignant cells	GSE164897_VemCob	ENSG00000262986	100129361	small integral membrane protein 10 like 1	NA	protein_coding	P0DMW3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48483
0	-0.569686997320472	0.056	0.442	0	GPRC5A	Malignant cells	GSE164897_VemCob	ENSG00000013588	9052	G protein-coupled receptor class C group 5 member A	PEIG-1|RAI3|RAIG1|TIG1	protein_coding	Q8NFJ5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48484
0	-0.719807966615741	0.255	0.733	0	STRAP	Malignant cells	GSE164897_VemCob	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48485
0	1.42811617063256	0.91	0.536	0	MGST1	Malignant cells	GSE164897_VemCob	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48486
0	-0.454303613464593	0.157	0.504	0	PRKAG1	Malignant cells	GSE164897_VemCob	ENSG00000181929	5571	protein kinase AMP-activated non-catalytic subunit gamma 1	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48487
0	1.43666645755598	0.999	0.848	0	TUBA1B	Malignant cells	GSE164897_VemCob	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48488
0	1.01393450802333	0.569	0.222	0	TUBA1A	Malignant cells	GSE164897_VemCob	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48489
0	0.712335652775936	0.882	0.747	0	TUBA1C	Malignant cells	GSE164897_VemCob	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48490
0	0.844789866934061	0.867	0.698	0	TMBIM6	Malignant cells	GSE164897_VemCob	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48491
0	0.885885372631189	0.888	0.649	0	COX14	Malignant cells	GSE164897_VemCob	ENSG00000178449	84987	cytochrome c oxidase assembly factor COX14	C12orf62|MGC14288	protein_coding	Q96I36	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48492
0	-0.585382231055402	0.068	0.49	0	LETMD1	Malignant cells	GSE164897_VemCob	ENSG00000050426	25875	LETM1 domain containing 1	HCCR|HCCR-1|HCCR-2|HCCR1|HCCR2|SLC55A3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48493
0	-0.62543272625059	0.069	0.499	0	SMAGP	Malignant cells	GSE164897_VemCob	ENSG00000170545	57228	small cell adhesion glycoprotein	hSMAGP|MGC149453|MGC149454	protein_coding	Q0VAQ4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48494
0	-0.509757341495997	0.115	0.462	0	ATG101	Malignant cells	GSE164897_VemCob	ENSG00000123395	60673	autophagy related 101	C12orf44|FLJ11773	protein_coding	Q9BSB4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48495
0	-1.10598994854995	0.007	0.408	0	KRT7	Malignant cells	GSE164897_VemCob	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48496
0	-3.05894605812784	0.042	0.571	0	KRT81	Malignant cells	GSE164897_VemCob	ENSG00000205426	3887	keratin 81	Hb-1|KRTHB1	protein_coding	Q14533	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48497
0	-1.977003697509	0.384	0.96	0	KRT18	Malignant cells	GSE164897_VemCob	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48498
0	-0.533544603507369	0.327	0.722	0	EIF4B	Malignant cells	GSE164897_VemCob	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48499
0	-0.725559808708293	0.165	0.51	0	IGFBP6	Malignant cells	GSE164897_VemCob	ENSG00000167779	3489	insulin like growth factor binding protein 6	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48500
0	0.674319682512206	0.999	0.988	0	PFDN5	Malignant cells	GSE164897_VemCob	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48501
0	-0.913758011310119	0.086	0.695	0	MYG1	Malignant cells	GSE164897_VemCob	ENSG00000139637	60314	MYG1 exonuclease	C12orf10|Gamm1|MYG	protein_coding	Q9HB07	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48502
0	0.418760451804959	0.999	0.997	0	ATP5MC2	Malignant cells	GSE164897_VemCob	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48503
0	-0.8832109438167	0.989	0.999	0	HNRNPA1	Malignant cells	GSE164897_VemCob	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48504
0	0.577022421352646	0.837	0.714	0	GTSF1	Malignant cells	GSE164897_VemCob	ENSG00000170627	121355	gametocyte specific factor 1	Cue110|FAM112B|FLJ32942	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48505
0	0.732555509772659	0.809	0.614	0	BLOC1S1	Malignant cells	GSE164897_VemCob	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48506
0	0.775023618168245	1	1	0	RPS26	Malignant cells	GSE164897_VemCob	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48507
0	-0.612387982190825	0.001	0.385	0	ERBB3	Malignant cells	GSE164897_VemCob	ENSG00000065361	2065	erb-b2 receptor tyrosine kinase 3	HER3|LCCS2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48508
0	1.40722877491957	1	1	0	RPL41	Malignant cells	GSE164897_VemCob	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48509
0	0.778452128701232	0.893	0.716	0	MYL6B	Malignant cells	GSE164897_VemCob	ENSG00000196465	140465	myosin light chain 6B	MLC1SA	protein_coding	P14649	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48510
0	2.24945324725254	1	0.906	0	MYL6	Malignant cells	GSE164897_VemCob	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48511
0	-0.827149088072241	0.207	0.739	0	CNPY2	Malignant cells	GSE164897_VemCob	ENSG00000257727	10330	canopy FGF signaling regulator 2	HP10390|TMEM4|ZSIG9	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48512
0	-0.592847488844947	0.796	0.927	0	ATP5F1B	Malignant cells	GSE164897_VemCob	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48513
0	-0.623132932833008	0.242	0.662	0	SHMT2	Malignant cells	GSE164897_VemCob	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48514
0	-0.52594206354736	0.107	0.458	0	DDIT3	Malignant cells	GSE164897_VemCob	ENSG00000175197	1649	DNA damage inducible transcript 3	CHOP|CHOP10|GADD153	protein_coding	P35638	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48515
0	-0.606576228809512	0.49	0.838	0	CDK4	Malignant cells	GSE164897_VemCob	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48516
0	0.704562307576496	0.549	0.258	0	TMBIM4	Malignant cells	GSE164897_VemCob	ENSG00000155957	51643	transmembrane BAX inhibitor motif containing 4	CGI-119|GAAP|LFG4|S1R|ZPRO	protein_coding	Q9HC24	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48517
0	0.508598603790834	0.311	0.049	0	GLIPR1	Malignant cells	GSE164897_VemCob	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48518
0	-0.640110815674221	0.516	0.824	0	PHLDA1	Malignant cells	GSE164897_VemCob	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48519
0	-0.493168509884281	0.961	0.994	0	NAP1L1	Malignant cells	GSE164897_VemCob	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48520
0	2.28402370815583	0.59	0.003	0	NTS	Malignant cells	GSE164897_VemCob	ENSG00000133636	4922	neurotensin	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48521
0	-0.512748386510624	0.163	0.529	0	BTG1	Malignant cells	GSE164897_VemCob	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48522
0	0.744822325419181	0.829	0.649	0	NDUFA12	Malignant cells	GSE164897_VemCob	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48523
0	0.704461205932009	0.964	0.894	0	SNRPF	Malignant cells	GSE164897_VemCob	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48524
0	-1.46103558927963	0.578	0.987	0	SLC25A3	Malignant cells	GSE164897_VemCob	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48525
0	0.723314199985972	0.562	0.268	0	CKAP4	Malignant cells	GSE164897_VemCob	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48526
0	-0.537771619003377	0.096	0.491	0	ISCU	Malignant cells	GSE164897_VemCob	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48527
0	-0.396238575296487	0.038	0.326	0	MMAB	Malignant cells	GSE164897_VemCob	ENSG00000139428	326625	metabolism of cobalamin associated B	cblB|CFAP23	protein_coding	Q96EY8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48528
0	0.72152548870473	0.963	0.903	0	ARPC3	Malignant cells	GSE164897_VemCob	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48529
0	-0.36683431328105	0.071	0.337	0	FAM216A	Malignant cells	GSE164897_VemCob	ENSG00000204856	29902	family with sequence similarity 216 member A	C12orf24|HSU79274	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48530
0	0.739610266012861	0.662	0.437	0	VPS29	Malignant cells	GSE164897_VemCob	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48531
0	-0.412251666544584	0.279	0.615	0	PPP1CC	Malignant cells	GSE164897_VemCob	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48532
0	-0.951177530030319	0.228	0.82	0	ERP29	Malignant cells	GSE164897_VemCob	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48533
0	-0.856334466425863	0.262	0.791	0	PEBP1	Malignant cells	GSE164897_VemCob	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48534
0	-0.569054225629915	0.932	0.99	0	COX6A1	Malignant cells	GSE164897_VemCob	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48535
0	1.62625119938722	0.999	0.895	0	DYNLL1	Malignant cells	GSE164897_VemCob	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48536
0	-1.52159464277547	0.196	0.934	0	ARL6IP4	Malignant cells	GSE164897_VemCob	ENSG00000182196	51329	ADP ribosylation factor like GTPase 6 interacting protein 4	SFRS20|SR-25|SRp25|SRrp37	protein_coding	Q66PJ3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48537
0	-0.443946965757019	0.232	0.594	0	TMED2	Malignant cells	GSE164897_VemCob	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48538
0	0.718821663313303	0.993	0.955	0	RAN	Malignant cells	GSE164897_VemCob	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48539
0	0.74506168093005	0.833	0.642	0	SAP18	Malignant cells	GSE164897_VemCob	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48540
0	-0.850378863378271	0.084	0.648	0	MRPL57	Malignant cells	GSE164897_VemCob	ENSG00000173141	78988	mitochondrial ribosomal protein L57	MRP63	protein_coding	Q9BQC6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48541
0	-1.00240718601437	1	1	0	RPL21	Malignant cells	GSE164897_VemCob	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48542
0	-0.833912784795246	0.135	0.671	0	GTF3A	Malignant cells	GSE164897_VemCob	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48543
0	1.27537592093334	0.993	0.848	0	POMP	Malignant cells	GSE164897_VemCob	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48544
0	1.20830916854081	0.991	0.847	0	HMGB1	Malignant cells	GSE164897_VemCob	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48545
0	0.61865282815345	0.27	0.002	0	ALOX5AP	Malignant cells	GSE164897_VemCob	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48546
0	-0.456629186354463	0.061	0.395	0	ALG5	Malignant cells	GSE164897_VemCob	ENSG00000120697	29880	ALG5 dolichyl-phosphate beta-glucosyltransferase	bA421P11.2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48547
0	-0.469221194200223	0.157	0.471	0	TSC22D1	Malignant cells	GSE164897_VemCob	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48548
0	-0.737827827751087	0.998	1	0	TPT1	Malignant cells	GSE164897_VemCob	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48549
0	0.548316492854821	0.952	0.877	0	COMMD6	Malignant cells	GSE164897_VemCob	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48550
0	-0.408708015047034	0.111	0.423	0	COL4A2	Malignant cells	GSE164897_VemCob	ENSG00000134871	1284	collagen type IV alpha 2 chain	DKFZp686I14213|FLJ22259	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48551
0	-0.381591292348745	0.073	0.355	0	CCNB1IP1	Malignant cells	GSE164897_VemCob	ENSG00000100814	57820	cyclin B1 interacting protein 1	C14orf18|HEI10	protein_coding	Q9NPC3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48552
0	1.23979497277993	0.835	0.396	0	DAD1	Malignant cells	GSE164897_VemCob	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48553
0	-0.423165977708255	0.184	0.519	0	OXA1L	Malignant cells	GSE164897_VemCob	ENSG00000155463	5018	OXA1L mitochondrial inner membrane protein	MGC133129|OXA1|OXA1L1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48554
0	-0.702107945703862	0.162	0.651	0	MRPL52	Malignant cells	GSE164897_VemCob	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48555
0	1.09905249174847	0.97	0.789	0	PSMB5	Malignant cells	GSE164897_VemCob	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48556
0	1.39811021699686	0.993	0.804	0	NEDD8	Malignant cells	GSE164897_VemCob	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48557
0	-0.345030168481501	0.074	0.339	0	FAM177A1	Malignant cells	GSE164897_VemCob	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48558
0	-0.366475821938156	1	1	0	RPS29	Malignant cells	GSE164897_VemCob	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48559
0	1.25229209319482	0.995	0.859	0	RPL36AL	Malignant cells	GSE164897_VemCob	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48560
0	-0.315583074789671	0.065	0.302	0	KLHDC2	Malignant cells	GSE164897_VemCob	ENSG00000165516	23588	kelch domain containing 2	HCLP-1|LCP	protein_coding	Q9Y2U9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48561
0	-0.640144752750121	0.071	0.508	0	LGALS3	Malignant cells	GSE164897_VemCob	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48562
0	-0.585534571969542	0.308	0.733	0	KTN1	Malignant cells	GSE164897_VemCob	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48563
0	-0.486920275610439	0.072	0.431	0	VTI1B	Malignant cells	GSE164897_VemCob	ENSG00000100568	10490	vesicle transport through interaction with t-SNAREs 1B	VTI2	protein_coding	Q9UEU0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48564
0	0.876289542533117	0.891	0.684	0	ERH	Malignant cells	GSE164897_VemCob	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48565
0	0.707678401130357	0.996	0.978	0	SLIRP	Malignant cells	GSE164897_VemCob	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48566
0	0.736035951995148	0.58	0.296	0	DDX24	Malignant cells	GSE164897_VemCob	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48567
0	-0.532574132645608	0.179	0.565	0	IFI27L2	Malignant cells	GSE164897_VemCob	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48568
0	1.35759690594104	0.964	0.82	0	HSP90AA1	Malignant cells	GSE164897_VemCob	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48569
0	-0.337320523676098	0.039	0.284	0	CINP	Malignant cells	GSE164897_VemCob	ENSG00000100865	51550	cyclin dependent kinase 2 interacting protein	MGC849	protein_coding	Q9BW66	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48570
0	-0.697560655792246	0.22	0.675	0	EIF5	Malignant cells	GSE164897_VemCob	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48571
0	-0.682093454981113	0.026	0.455	0	CKB	Malignant cells	GSE164897_VemCob	ENSG00000166165	1152	creatine kinase B	CKBB	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48572
0	-0.315721065854646	0.05	0.286	0	COA8	Malignant cells	GSE164897_VemCob	ENSG00000256053	84334	cytochrome c oxidase assembly factor 8	APOP-1|APOPT1|C14orf153|MGC2562	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48573
0	-0.731445878215384	0.09	0.585	0	SIVA1	Malignant cells	GSE164897_VemCob	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48574
0	-0.899438337695169	0.062	0.636	0	CRIP2	Malignant cells	GSE164897_VemCob	ENSG00000182809	1397	cysteine rich protein 2	CRP2|ESP1	protein_coding	P52943	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48575
0	1.79102061473652	0.796	0.221	0	SCG5	Malignant cells	GSE164897_VemCob	ENSG00000277614	6447	secretogranin V	7B2|SGNE1|SgV	protein_coding	P05408	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48576
0	1.74821174475551	0.998	0.795	0	NOP10	Malignant cells	GSE164897_VemCob	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48577
0	0.958569031070269	0.487	0.069	0	MEIS2	Malignant cells	GSE164897_VemCob	ENSG00000134138	4212	Meis homeobox 2	HsT18361|MRG1	protein_coding	O14770	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48578
0	1.58630656390167	1	0.995	0	SRP14	Malignant cells	GSE164897_VemCob	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48579
0	-0.453156322650987	0.027	0.305	0	GCHFR	Malignant cells	GSE164897_VemCob	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48580
0	-0.527968765593104	0.205	0.607	0	RTF1	Malignant cells	GSE164897_VemCob	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48581
0	1.09792930385443	1	0.998	0	SERF2	Malignant cells	GSE164897_VemCob	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48582
0	-1.93393830120452	0.305	0.97	0	EIF3J	Malignant cells	GSE164897_VemCob	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48583
0	1.68659389791352	1	0.988	0	B2M	Malignant cells	GSE164897_VemCob	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48584
0	1.30204475381227	0.416	0.065	0	C15orf48	Malignant cells	GSE164897_VemCob	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48585
0	-0.856538343939234	0.14	0.665	0	DUT	Malignant cells	GSE164897_VemCob	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48586
0	-0.367913925069272	0.018	0.282	0	GABPB1	Malignant cells	GSE164897_VemCob	ENSG00000104064	2553	GA binding protein transcription factor subunit beta 1	E4TF1-47|GABPB|GABPB2	protein_coding	Q06547	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48587
0	-0.674632207334397	0.478	0.861	0	RSL24D1	Malignant cells	GSE164897_VemCob	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48588
0	0.904674850799245	0.856	0.621	0	GTF2A2	Malignant cells	GSE164897_VemCob	ENSG00000140307	2958	general transcription factor IIA subunit 2	HsT18745|TFIIA	protein_coding	P52657	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48589
0	0.692270443139695	0.969	0.828	0	RPS27L	Malignant cells	GSE164897_VemCob	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48590
0	0.614347180473644	0.839	0.623	0	PCLAF	Malignant cells	GSE164897_VemCob	ENSG00000166803	9768	PCNA clamp associated factor	KIAA0101|NS5ATP9|OEATC-1|p15(PAF)|PAF15	protein_coding	Q15004	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48591
0	-0.569899595252915	1	1	0	RPL4	Malignant cells	GSE164897_VemCob	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48592
0	-0.36571764577646	0.078	0.352	0	C15orf61	Malignant cells	GSE164897_VemCob	ENSG00000189227	145853	chromosome 15 open reading frame 61	LOC145853	protein_coding	A6NNL5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48593
0	-2.4207442350502	1	1	0	RPLP1	Malignant cells	GSE164897_VemCob	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48594
0	-0.821931837304668	0.109	0.656	0	LARP6	Malignant cells	GSE164897_VemCob	ENSG00000166173	55323	La ribonucleoprotein 6, translational regulator	acheron|FLJ11196	protein_coding	Q9BRS8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48595
0	-0.35229236957981	0.076	0.328	0	STRA6	Malignant cells	GSE164897_VemCob	ENSG00000288257	64220	signaling receptor and transporter of retinol STRA6	FLJ12541	protein_coding	Q9BX79	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48596
0	-0.611238917863933	0.047	0.484	0	UBL7	Malignant cells	GSE164897_VemCob	ENSG00000288408	84993	ubiquitin like 7	BMSC-UbP|MGC14421	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48597
0	-1.59734486656424	0.335	0.966	0	COX5A	Malignant cells	GSE164897_VemCob	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48598
0	-0.570328751042595	0.101	0.514	0	IMP3	Malignant cells	GSE164897_VemCob	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48599
0	-0.456004608140861	0.147	0.499	0	TSPAN3	Malignant cells	GSE164897_VemCob	ENSG00000140391	10099	tetraspanin 3	TM4-A|TM4SF8|TSPAN-3	protein_coding	O60637	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48600
0	0.778714342235844	0.822	0.654	0	PSMA4	Malignant cells	GSE164897_VemCob	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48601
0	0.66889575556238	0.821	0.66	0	MORF4L1	Malignant cells	GSE164897_VemCob	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48602
0	-0.506215990532784	0.121	0.493	0	TMED3	Malignant cells	GSE164897_VemCob	ENSG00000166557	23423	transmembrane p24 trafficking protein 3	C15orf22|p24B|p24g4|p24gamma4	protein_coding	Q9Y3Q3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48603
0	-1.72381296618622	1	1	0	RPS17	Malignant cells	GSE164897_VemCob	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48604
0	-0.371521927228839	0.059	0.331	0	NMB	Malignant cells	GSE164897_VemCob	ENSG00000197696	4828	neuromedin B	MGC17211|MGC2277|MGC3936	protein_coding	P08949	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48605
0	-0.417408384967439	0.14	0.468	0	MRPS11	Malignant cells	GSE164897_VemCob	ENSG00000181991	64963	mitochondrial ribosomal protein S11	FLJ22512|FLJ23406|HCC-2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48606
0	-0.814980319993051	0.042	0.533	0	ISG20	Malignant cells	GSE164897_VemCob	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48607
0	-0.600051501777132	0.093	0.524	0	CIB1	Malignant cells	GSE164897_VemCob	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48608
0	-0.396275517429182	0.059	0.35	0	HDDC3	Malignant cells	GSE164897_VemCob	ENSG00000184508	374659	HD domain containing 3	MESH1|MGC45386	protein_coding	Q8N4P3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48609
0	-0.703347030110498	0.133	0.628	0	SELENOS	Malignant cells	GSE164897_VemCob	ENSG00000131871	55829	selenoprotein S	AD-015|MGC2553|SBBI8|SELS|SEPS1|VIMP	protein_coding	Q9BQE4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48610
0	-0.387076312110078	0.189	0.487	0	SNRPA1	Malignant cells	GSE164897_VemCob	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48611
0	-1.11939254709422	0.073	0.762	0	MPG	Malignant cells	GSE164897_VemCob	ENSG00000103152	4350	N-methylpurine DNA glycosylase	MDG	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48612
0	-0.736447598377951	0.06	0.566	0	MRPL28	Malignant cells	GSE164897_VemCob	ENSG00000086504	10573	mitochondrial ribosomal protein L28	MAAT1|p15	protein_coding	Q13084	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48613
0	-1.00001541266756	0.265	0.824	0	NME4	Malignant cells	GSE164897_VemCob	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48614
0	-1.22311234200445	0.139	0.85	0	METTL26	Malignant cells	GSE164897_VemCob	ENSG00000130731	84326	methyltransferase like 26	C16orf13|MGC13114	protein_coding	Q96S19	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48615
0	-0.597027497092863	0.022	0.443	0	MCRIP2	Malignant cells	GSE164897_VemCob	ENSG00000172366	84331	MAPK regulated corepressor interacting protein 2	C16orf14|FAM195A|MGC15416	protein_coding	Q9BUT9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48616
0	-0.296895523509524	0.04	0.258	0	RHOT2	Malignant cells	GSE164897_VemCob	ENSG00000140983	89941	ras homolog family member T2	ARHT2|C16orf39|MIRO-2|MIRO2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48617
0	-0.647696982877241	0.295	0.745	0	STUB1	Malignant cells	GSE164897_VemCob	ENSG00000103266	10273	STIP1 homology and U-box containing protein 1	CHIP|HSPABP2|NY-CO-7|SDCCAG7|UBOX1	protein_coding	Q9UNE7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48618
0	-0.662133501481255	0.042	0.478	0	HAGHL	Malignant cells	GSE164897_VemCob	ENSG00000103253	84264	hydroxyacylglutathione hydrolase like	MGC2605	protein_coding	Q6PII5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48619
0	-0.326555994220185	0.019	0.252	0	RPUSD1	Malignant cells	GSE164897_VemCob	ENSG00000007376	113000	RNA pseudouridine synthase domain containing 1	C16orf40|MGC19600|RLUCL	protein_coding	Q9UJJ7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48620
0	-0.573406216390975	0.248	0.657	0	UBE2I	Malignant cells	GSE164897_VemCob	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48621
0	-0.57221466980998	0.056	0.448	0	NME3	Malignant cells	GSE164897_VemCob	ENSG00000103024	4832	NME/NM23 nucleoside diphosphate kinase 3	DR-nm23|NDPKC|NM23-H3	protein_coding	Q13232	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48622
0	-1.12108581906375	0.176	0.828	0	MRPS34	Malignant cells	GSE164897_VemCob	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48623
0	-0.48451392680391	0.015	0.359	0	SPSB3	Malignant cells	GSE164897_VemCob	ENSG00000162032	90864	splA/ryanodine receptor domain and SOCS box containing 3	C16orf31|SSB-3	protein_coding	Q6PJ21	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48624
0	-0.524524339065909	0.103	0.492	0	NUBP2	Malignant cells	GSE164897_VemCob	ENSG00000095906	10101	NUBP iron-sulfur cluster assembly factor 2, cytosolic	CFD1|CIAO6	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48625
0	-0.340326208604388	0.054	0.302	0	HAGH	Malignant cells	GSE164897_VemCob	ENSG00000063854	3029	hydroxyacylglutathione hydrolase	GLO2|GLXII|HAGH1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48626
0	-1.1989817669826	0.549	0.958	0	NDUFB10	Malignant cells	GSE164897_VemCob	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48627
0	-3.25819919612004	1	1	0	RPS2	Malignant cells	GSE164897_VemCob	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48628
0	-0.464813496219478	0.016	0.348	0	NTHL1	Malignant cells	GSE164897_VemCob	ENSG00000065057	4913	nth like DNA glycosylase 1	NTH1|OCTS3	protein_coding	P78549	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48629
0	-0.894437582484844	0.15	0.699	0	SNHG19	Malignant cells	GSE164897_VemCob	ENSG00000260260	NA	NA	SNORD60HG	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48630
0	-0.30822986934552	0.041	0.268	0	TRAF7	Malignant cells	GSE164897_VemCob	ENSG00000131653	84231	TNF receptor associated factor 7	DKFZp586I021|MGC7807|RFWD1|RNF119	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48631
0	-0.623334113211958	0.022	0.464	0	MLST8	Malignant cells	GSE164897_VemCob	ENSG00000167965	64223	MTOR associated protein, LST8 homolog	GbetaL|GBL|Lst8|Pop3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48632
0	-0.410042198892889	0.21	0.535	0	SRRM2	Malignant cells	GSE164897_VemCob	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48633
0	-1.40844623754582	0.802	0.997	0	ELOB	Malignant cells	GSE164897_VemCob	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48634
0	-0.369710091271511	0.031	0.302	0	FLYWCH2	Malignant cells	GSE164897_VemCob	ENSG00000162076	114984	FLYWCH family member 2	NA	protein_coding	Q96CP2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48635
0	-1.54445218430936	0.306	0.877	0	TNFRSF12A	Malignant cells	GSE164897_VemCob	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48636
0	-0.445844871986228	0.021	0.334	0	THOC6	Malignant cells	GSE164897_VemCob	ENSG00000131652	79228	THO complex subunit 6	fSAP35|MGC2655|WDR58	protein_coding	Q86W42	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48637
0	-0.551650955412189	0.046	0.434	0	TRAP1	Malignant cells	GSE164897_VemCob	ENSG00000126602	10131	TNF receptor associated protein 1	HSP75|HSP90L	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48638
0	-0.557400588603545	0.081	0.485	0	NMRAL1	Malignant cells	GSE164897_VemCob	ENSG00000274684	57407	NmrA like redox sensor 1	FLJ25918|HSCARG|SDR48A1	protein_coding	Q9HBL8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48639
0	-0.67799955577898	0.122	0.559	0	CARHSP1	Malignant cells	GSE164897_VemCob	ENSG00000153048	23589	calcium regulated heat stable protein 1	CRHSP-24|CSDC1	protein_coding	Q9Y2V2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48640
0	-0.324193366456334	0.078	0.326	0	NUBP1	Malignant cells	GSE164897_VemCob	ENSG00000103274	4682	NUBP iron-sulfur cluster assembly factor 1, cytosolic	CIAO5|NBP1|NBP35	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48641
0	0.40558849375638	1	1	0	RPS15A	Malignant cells	GSE164897_VemCob	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48642
0	0.730402032687153	0.446	0.155	0	ARL6IP1	Malignant cells	GSE164897_VemCob	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48643
0	-0.353301773457426	0.073	0.33	0	MOSMO	Malignant cells	GSE164897_VemCob	ENSG00000284487	730094	modulator of smoothened	ATTHOG|BC030336|C16orf52	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48644
0	-1.26148384769584	0.177	0.871	0	NDUFAB1	Malignant cells	GSE164897_VemCob	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48645
0	-1.07462888113868	0.451	0.923	0	TUFM	Malignant cells	GSE164897_VemCob	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48646
0	-0.476372196109751	0.164	0.523	0	MAZ	Malignant cells	GSE164897_VemCob	ENSG00000103495	4150	MYC associated zinc finger protein	Pur-1|ZF87|Zif87|ZNF801	protein_coding	P56270	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48647
0	-0.348928169324748	0.103	0.375	0	CDIPT	Malignant cells	GSE164897_VemCob	ENSG00000103502	10423	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	PIS|PIS1	protein_coding	O14735	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48648
0	-0.364782187957954	0.087	0.353	0	SEZ6L2	Malignant cells	GSE164897_VemCob	ENSG00000174938	26470	seizure related 6 homolog like 2	FLJ90517|PSK-1	protein_coding	Q6UXD5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48649
0	-0.39056112755144	0.159	0.457	0	TMEM219	Malignant cells	GSE164897_VemCob	ENSG00000149932	124446	transmembrane protein 219	IGFBP-3R	protein_coding	Q86XT9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48650
0	-0.293335764138371	0.046	0.265	0	INO80E	Malignant cells	GSE164897_VemCob	ENSG00000169592	283899	INO80 complex subunit E	CCDC95|FLJ90652	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48651
0	-2.38962979064323	0.223	0.99	0	ALDOA	Malignant cells	GSE164897_VemCob	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48652
0	-0.532176751087387	0.156	0.556	0	PPP4C	Malignant cells	GSE164897_VemCob	ENSG00000149923	5531	protein phosphatase 4 catalytic subunit	PP4|PPX	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48653
0	-0.61221795709582	0.302	0.736	0	VKORC1	Malignant cells	GSE164897_VemCob	ENSG00000167397	79001	vitamin K epoxide reductase complex subunit 1	VKCFD2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48654
0	-0.538675631646722	0.081	0.466	0	BCKDK	Malignant cells	GSE164897_VemCob	ENSG00000103507	10295	branched chain keto acid dehydrogenase kinase	NA	protein_coding	O14874	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48655
0	-0.45314270684253	0.031	0.353	0	TGFB1I1	Malignant cells	GSE164897_VemCob	ENSG00000140682	7041	transforming growth factor beta 1 induced transcript 1	ARA55|Hic-5|TSC-5	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48656
0	0.640100998330418	0.514	0.259	0	MMP2	Malignant cells	GSE164897_VemCob	ENSG00000087245	4313	matrix metallopeptidase 2	CLG4|CLG4A|TBE-1	protein_coding	P08253	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48657
0	-0.426802337870464	0.26	0.598	0	NUDT21	Malignant cells	GSE164897_VemCob	ENSG00000167005	11051	nudix hydrolase 21	CFIM25|CPSF5	protein_coding	O43809	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48658
0	-1.00202115769356	0.993	0.987	0	MT2A	Malignant cells	GSE164897_VemCob	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48659
0	1.29302816371355	0.819	0.391	0	MT1X	Malignant cells	GSE164897_VemCob	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48660
0	-0.385510796923644	0.093	0.374	0	HERPUD1	Malignant cells	GSE164897_VemCob	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48661
0	1.08084847466133	0.848	0.517	0	CKLF	Malignant cells	GSE164897_VemCob	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48662
0	-0.782396994467315	0.433	0.867	0	CIAO2B	Malignant cells	GSE164897_VemCob	ENSG00000166595	51647	cytosolic iron-sulfur assembly component 2B	CGI-128|CIA2B|FAM96B|MIP18	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48663
0	-0.416706237283164	0.147	0.471	0	E2F4	Malignant cells	GSE164897_VemCob	ENSG00000205250	1874	E2F transcription factor 4	E2F-4	protein_coding	Q16254	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48664
0	0.881394121979042	0.809	0.526	0	TMEM208	Malignant cells	GSE164897_VemCob	ENSG00000168701	29100	transmembrane protein 208	hSND2|HSPC171	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48665
0	-0.353269039701078	0.077	0.34	0	ACD	Malignant cells	GSE164897_VemCob	ENSG00000102977	65057	ACD shelterin complex subunit and telomerase recruitment factor	Pip1|Ptop|Tint1|Tpp1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48666
0	-0.909566841161212	0.085	0.684	0	NOB1	Malignant cells	GSE164897_VemCob	ENSG00000141101	28987	NIN1 (RPN12) binding protein 1 homolog	ART-4|MST158|NOB1P|PSMD8BP1	protein_coding	Q9ULX3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48667
0	-0.539979744690348	0.205	0.604	0	GABARAPL2	Malignant cells	GSE164897_VemCob	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48668
0	-0.404547226035682	0.308	0.644	0	KARS1	Malignant cells	GSE164897_VemCob	ENSG00000065427	3735	lysyl-tRNA synthetase 1	DFNB89|KARS|KARS2	protein_coding	Q15046	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48669
0	-0.873003438280221	0.078	0.656	0	GCSH	Malignant cells	GSE164897_VemCob	ENSG00000140905	2653	glycine cleavage system protein H	NA	protein_coding	P23434	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48670
0	-0.350855011406401	0.054	0.308	0	CDH13	Malignant cells	GSE164897_VemCob	ENSG00000140945	1012	cadherin 13	CDHH	protein_coding	P55290	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48671
0	0.774061171877558	0.981	0.886	0	HSBP1	Malignant cells	GSE164897_VemCob	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48672
0	0.687515608222625	1	0.999	0	COX4I1	Malignant cells	GSE164897_VemCob	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48673
0	-0.530590608877495	0.112	0.488	0	MAP1LC3B	Malignant cells	GSE164897_VemCob	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48674
0	-0.744516656832374	0.027	0.51	0	SLC7A5	Malignant cells	GSE164897_VemCob	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48675
0	-1.33713380260988	0.146	0.843	0	CYBA	Malignant cells	GSE164897_VemCob	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48676
0	-1.2520341444401	0.254	0.898	0	APRT	Malignant cells	GSE164897_VemCob	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48677
0	-3.16811748441125	0.995	1	0	RPL13	Malignant cells	GSE164897_VemCob	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48678
0	-0.419512495670537	0.088	0.401	0	TCF25	Malignant cells	GSE164897_VemCob	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48679
0	0.556590384715431	0.966	0.906	0	YWHAE	Malignant cells	GSE164897_VemCob	ENSG00000274474	7531	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon	FLJ45465	protein_coding	P62258	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48680
0	-0.440279783132577	0.063	0.385	0	PITPNA-AS1	Malignant cells	GSE164897_VemCob	ENSG00000236618	100306951	PITPNA antisense RNA 1	NA	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48681
0	-0.721848973126741	0.084	0.595	0	EMC6	Malignant cells	GSE164897_VemCob	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48682
0	0.958123687428471	0.953	0.774	0	PSMB6	Malignant cells	GSE164897_VemCob	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48683
0	-0.558353329046204	0.107	0.52	0	SLC25A11	Malignant cells	GSE164897_VemCob	ENSG00000108528	8402	solute carrier family 25 member 11	OGC|SLC20A4	protein_coding	Q02978	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48684
0	-2.3121885318113	0.892	1	0	PFN1	Malignant cells	GSE164897_VemCob	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48685
0	-0.575764915026404	0.017	0.405	0	CAMTA2	Malignant cells	GSE164897_VemCob	ENSG00000108509	23125	calmodulin binding transcription activator 2	KIAA0909	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48686
0	-0.379523566005039	0.076	0.355	0	RABEP1	Malignant cells	GSE164897_VemCob	ENSG00000029725	9135	rabaptin, RAB GTPase binding effector protein 1	neurocrescin|RAB5EP|rabaptin-5|RABPT5	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48687
0	-0.982913715864342	0.426	0.878	0	C1QBP	Malignant cells	GSE164897_VemCob	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48688
0	1.04640205104008	0.972	0.817	0	TXNDC17	Malignant cells	GSE164897_VemCob	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48689
0	0.698685234485663	0.49	0.16	0	MED31	Malignant cells	GSE164897_VemCob	ENSG00000108590	51003	mediator complex subunit 31	CGI-125|Soh1	protein_coding	Q9Y3C7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48690
0	-0.48997979657469	0.193	0.558	0	ACADVL	Malignant cells	GSE164897_VemCob	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48691
0	-0.848524042608925	0.8	0.952	0	EIF5A	Malignant cells	GSE164897_VemCob	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48692
0	-0.494831992449714	0.307	0.675	0	TMEM256	Malignant cells	GSE164897_VemCob	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48693
0	-0.520451881636753	0.753	0.919	0	NAA38	Malignant cells	GSE164897_VemCob	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48694
0	-0.416247685615979	1	1	0	RPL26	Malignant cells	GSE164897_VemCob	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48695
0	-0.488992686832872	0.101	0.441	0	PMP22	Malignant cells	GSE164897_VemCob	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48696
0	-0.434179586194862	0.052	0.378	0	ZSWIM7	Malignant cells	GSE164897_VemCob	ENSG00000214941	125150	zinc finger SWIM-type containing 7	SWS1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48697
0	1.43211724962388	0.998	0.907	0	UBB	Malignant cells	GSE164897_VemCob	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48698
0	-0.501283120119269	0.028	0.391	0	PEMT	Malignant cells	GSE164897_VemCob	ENSG00000133027	10400	phosphatidylethanolamine N-methyltransferase	PEMPT|PEMT2	protein_coding	Q9UBM1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48699
0	-0.320398168508508	0.054	0.292	0	DRG2	Malignant cells	GSE164897_VemCob	ENSG00000108591	1819	developmentally regulated GTP binding protein 2	NA	protein_coding	P55039	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48700
0	-0.559541321739886	0.064	0.471	0	IFT20	Malignant cells	GSE164897_VemCob	ENSG00000109083	90410	intraflagellar transport 20	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48701
0	-0.470986660046718	0.203	0.569	0	POLDIP2	Malignant cells	GSE164897_VemCob	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48702
0	-0.570423758927434	0.266	0.688	0	RAB34	Malignant cells	GSE164897_VemCob	ENSG00000109113	83871	RAB34, member RAS oncogene family	NARR|RAB39|RAH	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48703
0	0.269554173756004	1	1	0	RPL23A	Malignant cells	GSE164897_VemCob	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48704
0	-0.752037754050166	0.145	0.661	0	CISD3	Malignant cells	GSE164897_VemCob	ENSG00000274768	284106	CDGSH iron sulfur domain 3	Miner2|MiNT	protein_coding	P0C7P0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48705
0	1.10279374058006	0.966	0.788	0	PSMB3	Malignant cells	GSE164897_VemCob	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48706
0	0.305402486258018	1	1	0	RPL23	Malignant cells	GSE164897_VemCob	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48707
0	0.398445148877533	1	1	0	RPL19	Malignant cells	GSE164897_VemCob	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48708
0	-0.74756649962419	0.198	0.709	0	MIEN1	Malignant cells	GSE164897_VemCob	ENSG00000141741	84299	migration and invasion enhancer 1	C17orf37|C35|MGC14832|ORB3|Rdx12|XTP4	protein_coding	Q9BRT3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48709
0	-0.378583634524998	0.099	0.387	0	PSMD3	Malignant cells	GSE164897_VemCob	ENSG00000108344	5709	proteasome 26S subunit, non-ATPase 3	P58|Rpn3|S3|TSTA2	protein_coding	O43242	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48710
0	-0.80150782182054	0.287	0.797	0	KRT10	Malignant cells	GSE164897_VemCob	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48711
0	-2.59438729538933	0.884	1	0	EIF1	Malignant cells	GSE164897_VemCob	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48712
0	-0.714477325139226	0.048	0.551	0	NT5C3B	Malignant cells	GSE164897_VemCob	ENSG00000141698	115024	5'-nucleotidase, cytosolic IIIB	cN-IIIB|MGC20781|NT5C3L	protein_coding	Q969T7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48713
0	-0.631501058776636	0.191	0.651	0	RAB5C	Malignant cells	GSE164897_VemCob	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48714
0	0.938366338942994	1	1	0	RPL27	Malignant cells	GSE164897_VemCob	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48715
0	-0.51161562860199	0.082	0.46	0	ETV4	Malignant cells	GSE164897_VemCob	ENSG00000175832	2118	ETS variant transcription factor 4	E1A-F|E1AF|PEA3	protein_coding	P43268	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48716
0	-0.370816617299719	0.076	0.359	0	TMEM101	Malignant cells	GSE164897_VemCob	ENSG00000091947	84336	transmembrane protein 101	FLJ23987|MGC4251	protein_coding	Q96IK0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48717
0	-0.465984031878901	0.128	0.472	0	G6PC3	Malignant cells	GSE164897_VemCob	ENSG00000141349	92579	glucose-6-phosphatase catalytic subunit 3	UGRP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48718
0	-0.690318949378079	0.059	0.546	0	SLC25A39	Malignant cells	GSE164897_VemCob	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48719
0	-0.38021032577354	0.153	0.45	0	GRN	Malignant cells	GSE164897_VemCob	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48720
0	-0.488688194511549	0.115	0.486	0	MRPL10	Malignant cells	GSE164897_VemCob	ENSG00000159111	124995	mitochondrial ribosomal protein L10	L10MT|MGC17973|MRP-L10|MRP-L8|MRPL8|RPML8	protein_coding	Q7Z7H8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48721
0	1.35482435953309	0.979	0.729	0	ATP5MC1	Malignant cells	GSE164897_VemCob	ENSG00000159199	516	ATP synthase membrane subunit c locus 1	ATP5G|ATP5G1	protein_coding	P05496	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48722
0	-0.870749679293375	0.213	0.777	0	SNF8	Malignant cells	GSE164897_VemCob	ENSG00000159210	11267	SNF8 subunit of ESCRT-II	Dot3|EAP30|VPS22	protein_coding	Q96H20	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48723
0	-1.03719000974581	0.187	0.798	0	PHB1	Malignant cells	GSE164897_VemCob	ENSG00000167085	5245	prohibitin 1	PHB	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48724
0	0.831367052175168	0.823	0.592	0	MRPL27	Malignant cells	GSE164897_VemCob	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48725
0	0.772513830610075	0.974	0.9	0	NME1	Malignant cells	GSE164897_VemCob	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48726
0	-0.696594592889404	0.008	0.501	0	NME2	Malignant cells	GSE164897_VemCob	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48727
0	0.629259188083428	0.667	0.484	0	SUPT4H1	Malignant cells	GSE164897_VemCob	ENSG00000213246	6827	SPT4 homolog, DSIF elongation factor subunit	Spt4|SPT4H|Supt4a|SUPT4H	protein_coding	P63272	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48728
0	-0.340837795950606	0.032	0.263	0	LIMD2	Malignant cells	GSE164897_VemCob	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48729
0	0.759181912080926	0.899	0.729	0	PSMC5	Malignant cells	GSE164897_VemCob	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48730
0	-0.97780900284193	0.255	0.807	0	SNHG25	Malignant cells	GSE164897_VemCob	ENSG00000266402	NA	NA	NA	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48731
0	-0.295160820325207	0.046	0.267	0	FAM104A	Malignant cells	GSE164897_VemCob	ENSG00000133193	84923	family with sequence similarity 104 member A	FLJ14775	protein_coding	Q969W3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48732
0	-0.483758040609513	0.059	0.417	0	MRPL58	Malignant cells	GSE164897_VemCob	ENSG00000167862	3396	mitochondrial ribosomal protein L58	DS-1|ICT1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48733
0	-1.02083962010846	0.078	0.727	0	NT5C	Malignant cells	GSE164897_VemCob	ENSG00000125458	30833	5', 3'-nucleotidase, cytosolic	cdN|DNT-1|DNT1|PN-I|UMPH2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48734
0	1.10322527975976	0.993	0.892	0	SUMO2	Malignant cells	GSE164897_VemCob	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48735
0	-0.394561093297103	0.023	0.305	0	GALK1	Malignant cells	GSE164897_VemCob	ENSG00000108479	2584	galactokinase 1	GALK	protein_coding	P51570	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48736
0	-0.776546612660333	0.976	0.997	0	H3-3B	Malignant cells	GSE164897_VemCob	ENSG00000132475	3021	H3.3 histone B	H3.3B|H3F3B	protein_coding	P84243	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48737
0	-0.377018173898213	0.082	0.372	0	WBP2	Malignant cells	GSE164897_VemCob	ENSG00000132471	23558	WW domain binding protein 2	GRAMD6|WBP-2	protein_coding	Q969T9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48738
0	-0.386408354822615	0.112	0.405	0	SYNGR2	Malignant cells	GSE164897_VemCob	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48739
0	-0.299667390767275	0.033	0.254	0	ENDOV	Malignant cells	GSE164897_VemCob	ENSG00000173818	284131	endonuclease V	FLJ35220	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48740
0	-0.884399910898769	0.196	0.765	0	NDUFAF8	Malignant cells	GSE164897_VemCob	ENSG00000224877	284184	NADH:ubiquinone oxidoreductase complex assembly factor 8	C17orf89	protein_coding	A1L188	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48741
0	-0.641302047831793	0.991	0.999	0	ACTG1	Malignant cells	GSE164897_VemCob	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48742
0	-0.961077558843032	0.042	0.678	0	OXLD1	Malignant cells	GSE164897_VemCob	ENSG00000204237	339229	oxidoreductase like domain containing 1	C17orf90|MGC104712	protein_coding	Q5BKU9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48743
0	-0.363505989754554	0.066	0.331	0	CCDC137	Malignant cells	GSE164897_VemCob	ENSG00000185298	339230	coiled-coil domain containing 137	MGC16597	protein_coding	Q6PK04	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48744
0	-0.462272465852087	0.071	0.414	0	HGS	Malignant cells	GSE164897_VemCob	ENSG00000185359	9146	hepatocyte growth factor-regulated tyrosine kinase substrate	Hrs|Vps27|ZFYVE8	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48745
0	-1.12084175590884	0.08	0.779	0	MRPL12	Malignant cells	GSE164897_VemCob	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48746
0	-0.472248627571873	0.04	0.383	0	MCRIP1	Malignant cells	GSE164897_VemCob	ENSG00000288213	348262	MAPK regulated corepressor interacting protein 1	FAM195B|GRAN2|MCRIP	protein_coding	C9JLW8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48747
0	-0.545306644766591	0.245	0.656	0	P4HB	Malignant cells	GSE164897_VemCob	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48748
0	-0.731880588111584	0.125	0.636	0	ARHGDIA	Malignant cells	GSE164897_VemCob	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48749
0	-0.586403502033439	0.398	0.791	0	ANAPC11	Malignant cells	GSE164897_VemCob	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48750
0	-0.621693804072417	0.054	0.477	0	PYCR1	Malignant cells	GSE164897_VemCob	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48751
0	-0.538594114536092	0.042	0.431	0	DCXR	Malignant cells	GSE164897_VemCob	ENSG00000169738	51181	dicarbonyl and L-xylulose reductase	DCR|HCR2|KIDCR|P34H|SDR20C1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48752
0	-0.712093049731235	0.052	0.554	0	GPS1	Malignant cells	GSE164897_VemCob	ENSG00000169727	2873	G protein pathway suppressor 1	COPS1|CSN1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48753
0	-0.405076596384794	0.076	0.378	0	WDR45B	Malignant cells	GSE164897_VemCob	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48754
0	0.687446577446755	0.786	0.597	0	MYL12A	Malignant cells	GSE164897_VemCob	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48755
0	-0.458999337114947	0.37	0.713	0	NDUFV2	Malignant cells	GSE164897_VemCob	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48756
0	-0.390794040676781	0.209	0.526	0	VAPA	Malignant cells	GSE164897_VemCob	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48757
0	-0.374831296767031	0.13	0.423	0	PSMG2	Malignant cells	GSE164897_VemCob	ENSG00000128789	56984	proteasome assembly chaperone 2	CLAST3|HCCA3|HsT1707|MDS003|MGC15092|PAC2|TNFSF5IP1	protein_coding	Q969U7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48758
0	-0.381625610252626	0.056	0.344	0	PTPN2	Malignant cells	GSE164897_VemCob	ENSG00000175354	5771	protein tyrosine phosphatase non-receptor type 2	PTPT|TC-PTP|TCELLPTP|TCPTP	protein_coding	P17706	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48759
0	0.53393225469411	0.955	0.881	0	SNRPD1	Malignant cells	GSE164897_VemCob	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48760
0	-0.560085216856078	0.127	0.487	0	COSMOC	Malignant cells	GSE164897_VemCob	ENSG00000260552	101927809	cell fate and sterol metabolism associated divergent transcript of MOCOS	NA	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48761
0	-0.362505540114817	0.034	0.298	0	MOCOS	Malignant cells	GSE164897_VemCob	ENSG00000075643	55034	molybdenum cofactor sulfurase	FLJ20733|HMCS|MOS	protein_coding	Q96EN8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48762
0	-0.517475610511227	0.504	0.831	0	ATP5F1A	Malignant cells	GSE164897_VemCob	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48763
0	-0.625415297279315	0.109	0.56	0	TXNL1	Malignant cells	GSE164897_VemCob	ENSG00000091164	9352	thioredoxin like 1	TRP32|Txl|TXNL	protein_coding	O43396	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48764
0	-0.382119772798426	0.047	0.327	0	SEC11C	Malignant cells	GSE164897_VemCob	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48765
0	-0.576066366076679	0.225	0.636	0	TXNL4A	Malignant cells	GSE164897_VemCob	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48766
0	-1.16129807688886	0.041	0.633	0	TRIB3	Malignant cells	GSE164897_VemCob	ENSG00000101255	57761	tribbles pseudokinase 3	C20orf97|dJ1103G7.3|TRB3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48767
0	-1.18257483792044	0.08	0.771	0	RBCK1	Malignant cells	GSE164897_VemCob	ENSG00000125826	10616	RANBP2-type and C3HC4-type zinc finger containing 1	C20orf18|HOIL1|RBCK2|RNF54|UBCE7IP3|XAP4|ZRANB4	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48768
0	-0.363363200800791	0.084	0.352	0	PSMF1	Malignant cells	GSE164897_VemCob	ENSG00000125818	9491	proteasome inhibitor subunit 1	PI31	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48769
0	-1.28554427487527	0.469	0.953	0	FKBP1A	Malignant cells	GSE164897_VemCob	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48770
0	-1.20988897542636	0.412	0.9	0	SNRPB	Malignant cells	GSE164897_VemCob	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48771
0	-0.587550031011121	0.085	0.502	0	IDH3B	Malignant cells	GSE164897_VemCob	ENSG00000101365	3420	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta	RP46	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48772
0	-0.972029308454613	0.092	0.711	0	MRPS26	Malignant cells	GSE164897_VemCob	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48773
0	-0.543710992764294	0.022	0.414	0	DDRGK1	Malignant cells	GSE164897_VemCob	ENSG00000198171	65992	DDRGK domain containing 1	C20orf116|dJ1187M17.3|UFBP1	protein_coding	Q96HY6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48774
0	-0.644898249047665	0.075	0.535	0	ITPA	Malignant cells	GSE164897_VemCob	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48775
0	-0.728431499526584	0.045	0.549	0	C20orf27	Malignant cells	GSE164897_VemCob	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48776
0	-0.918573851846116	0.165	0.762	0	TMEM230	Malignant cells	GSE164897_VemCob	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48777
0	-0.410618464553931	0.065	0.364	0	TRMT6	Malignant cells	GSE164897_VemCob	ENSG00000089195	51605	tRNA methyltransferase 6 non-catalytic subunit	CGI-09|GCD10|Gcd10p|MGC5029	protein_coding	Q9UJA5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48778
0	-0.312697453932371	0.043	0.26	0	FERMT1	Malignant cells	GSE164897_VemCob	ENSG00000101311	55612	FERM domain containing kindlin 1	C20orf42|FLJ20116|KIND1|UNC112A|URP1	protein_coding	Q9BQL6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48779
0	-0.832041071729509	0.023	0.579	0	MKKS	Malignant cells	GSE164897_VemCob	ENSG00000125863	8195	MKKS centrosomal shuttling protein	BBS6|HMCS|KMS|MKS	protein_coding	Q9NPJ1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48780
0	-1.31184548037913	0.752	0.92	0	SNRPB2	Malignant cells	GSE164897_VemCob	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48781
0	-1.68227899464269	0.46	0.987	0	DSTN	Malignant cells	GSE164897_VemCob	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48782
0	-0.32131798740563	0.073	0.315	0	RRBP1	Malignant cells	GSE164897_VemCob	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48783
0	-0.536476153111407	0.126	0.524	0	SNX5	Malignant cells	GSE164897_VemCob	ENSG00000089006	27131	sorting nexin 5	NA	protein_coding	Q9Y5X3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48784
0	-0.496048413956356	0.112	0.481	0	DTD1	Malignant cells	GSE164897_VemCob	ENSG00000125821	92675	D-aminoacyl-tRNA deacylase 1	bA379J5.3|bA555E18.1|C20orf88|DUEB|HARS2|MGC119131|MGC41905|pqn-68	protein_coding	Q8TEA8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48785
0	-0.48656585311315	0.232	0.603	0	NAA20	Malignant cells	GSE164897_VemCob	ENSG00000173418	51126	N-alpha-acetyltransferase 20, NatB catalytic subunit	dJ1002M8.1|NAT3|NAT5	protein_coding	P61599	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48786
0	-0.401283698322664	0.038	0.318	0	NXT1	Malignant cells	GSE164897_VemCob	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48787
0	-1.02904367112262	0.149	0.777	0	CST3	Malignant cells	GSE164897_VemCob	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48788
0	-0.661369954935902	0.043	0.486	0	PYGB	Malignant cells	GSE164897_VemCob	ENSG00000100994	5834	glycogen phosphorylase B	NA	protein_coding	P11216	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48789
0	-0.657621423199251	0.128	0.593	0	HM13	Malignant cells	GSE164897_VemCob	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48790
0	-1.1606724433119	0.112	0.692	0	ID1	Malignant cells	GSE164897_VemCob	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48791
0	-0.346238679279684	0.059	0.314	0	COMMD7	Malignant cells	GSE164897_VemCob	ENSG00000149600	149951	COMM domain containing 7	C20orf92|dJ1085F17.3	protein_coding	Q86VX2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48792
0	-0.68436767813487	0.073	0.551	0	RALY	Malignant cells	GSE164897_VemCob	ENSG00000125970	22913	RALY heterogeneous nuclear ribonucleoprotein	HNRPCL2|P542	protein_coding	Q9UKM9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48793
0	-1.9133720997457	0.569	0.987	0	EIF2S2	Malignant cells	GSE164897_VemCob	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48794
0	-0.781917741404037	0.102	0.647	0	AHCY	Malignant cells	GSE164897_VemCob	ENSG00000101444	191	adenosylhomocysteinase	AdoHcyase|SAHH	protein_coding	P23526	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48795
0	-0.360896437835816	0.078	0.348	0	GSS	Malignant cells	GSE164897_VemCob	ENSG00000100983	2937	glutathione synthetase	NA	protein_coding	P48637	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48796
0	-2.00624611699532	0.487	0.994	0	ROMO1	Malignant cells	GSE164897_VemCob	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48797
0	-0.465754345618279	0.354	0.716	0	RBM39	Malignant cells	GSE164897_VemCob	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48798
0	-1.04008111857771	0.063	0.717	0	SCAND1	Malignant cells	GSE164897_VemCob	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48799
0	-0.340109808498461	0.019	0.265	0	DLGAP4	Malignant cells	GSE164897_VemCob	ENSG00000080845	22839	DLG associated protein 4	DAP4|KIAA0964|SAPAP4	protein_coding	Q9Y2H0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48800
0	-0.689014739103133	0.178	0.615	0	TOP1	Malignant cells	GSE164897_VemCob	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48801
0	-0.454016832106277	0.045	0.377	0	PKIG	Malignant cells	GSE164897_VemCob	ENSG00000168734	11142	cAMP-dependent protein kinase inhibitor gamma	NA	protein_coding	Q9Y2B9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48802
0	-0.482078256834604	0.643	0.883	0	YWHAB	Malignant cells	GSE164897_VemCob	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48803
0	-0.300715974089433	0.053	0.279	0	SYS1	Malignant cells	GSE164897_VemCob	ENSG00000204070	90196	SYS1 golgi trafficking protein	C20orf169|dJ453C12.4	protein_coding	Q8N2H4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48804
0	-0.526364160525888	0.078	0.462	0	PIGT	Malignant cells	GSE164897_VemCob	ENSG00000124155	51604	phosphatidylinositol glycan anchor biosynthesis class T	NA	protein_coding	Q969N2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48805
0	0.710591653435825	0.403	0.075	0	WFDC3	Malignant cells	GSE164897_VemCob	ENSG00000124116	140686	WAP four-disulfide core domain 3	dJ447F3.3|WAP14	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48806
0	-0.431872988655734	0.166	0.497	0	DNTTIP1	Malignant cells	GSE164897_VemCob	ENSG00000101457	116092	deoxynucleotidyltransferase terminal interacting protein 1	C20orf167|dJ447F3.4|Tdif1	protein_coding	Q9H147	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48807
0	-0.563336064937389	0.043	0.43	0	PLTP	Malignant cells	GSE164897_VemCob	ENSG00000100979	5360	phospholipid transfer protein	BPIFE	protein_coding	P55058	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48808
0	-0.475533503783471	0.058	0.409	0	SLC35C2	Malignant cells	GSE164897_VemCob	ENSG00000080189	51006	solute carrier family 35 member C2	bA394O2.1|C20orf5|CGI-15|OVCOV1	protein_coding	Q9NQQ7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48809
0	-0.552648233215768	0.958	0.991	0	ZFAS1	Malignant cells	GSE164897_VemCob	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48810
0	-0.568020213995753	0.08	0.492	0	RNF114	Malignant cells	GSE164897_VemCob	ENSG00000124226	55905	ring finger protein 114	PSORS12|ZNF313	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48811
0	-0.609816544320622	0.006	0.415	0	KCNG1	Malignant cells	GSE164897_VemCob	ENSG00000026559	3755	potassium voltage-gated channel modifier subfamily G member 1	K13|KCNG|kH2|Kv6.1	protein_coding	Q9UIX4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48812
0	-0.871415740354804	0.394	0.867	0	PFDN4	Malignant cells	GSE164897_VemCob	ENSG00000101132	5203	prefoldin subunit 4	C-1|C1|PFD4	protein_coding	Q9NQP4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48813
0	-0.986581235763225	0.182	0.724	0	PMEPA1	Malignant cells	GSE164897_VemCob	ENSG00000124225	56937	prostate transmembrane protein, androgen induced 1	STAG1|TMEPAI	protein_coding	Q969W9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48814
0	-0.418797912244127	0.187	0.485	0	CTSZ	Malignant cells	GSE164897_VemCob	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48815
0	-0.522750093258913	0.278	0.631	0	PRELID3B	Malignant cells	GSE164897_VemCob	ENSG00000101166	51012	PRELI domain containing 3B	C20orf45|dJ543J19.5|SLMO2	protein_coding	Q9Y3B1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48816
0	-1.36271815346371	0.915	0.996	0	PSMA7	Malignant cells	GSE164897_VemCob	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48817
0	-1.24302190543757	0.153	0.853	0	ADRM1	Malignant cells	GSE164897_VemCob	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48818
0	-0.603280821677725	1	1	0	RPS21	Malignant cells	GSE164897_VemCob	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48819
0	-0.897144201146597	0.02	0.505	0	SLCO4A1	Malignant cells	GSE164897_VemCob	ENSG00000101187	28231	solute carrier organic anion transporter family member 4A1	OATP-E|OATP4A1|SLC21A12	protein_coding	Q96BD0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48820
0	-0.655016134117838	0	0.364	0	SLCO4A1-AS1	Malignant cells	GSE164897_VemCob	ENSG00000232803	100127888	SLCO4A1 antisense RNA 1	NA	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48821
0	-0.359425050723785	0.082	0.354	0	MRGBP	Malignant cells	GSE164897_VemCob	ENSG00000101189	55257	MRG domain binding protein	C20orf20|Eaf7|FLJ10914|MRG15BP	protein_coding	Q9NV56	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48822
0	-0.39779385806858	0.04	0.329	0	OGFR	Malignant cells	GSE164897_VemCob	ENSG00000060491	11054	opioid growth factor receptor	7-60	protein_coding	Q9NZT2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48823
0	-1.38107120010534	0	0.731	0	COL9A3	Malignant cells	GSE164897_VemCob	ENSG00000092758	1299	collagen type IX alpha 3 chain	DJ885L7.4.1|EDM3|FLJ90759|IDD|MED	protein_coding	Q14050	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48824
0	-1.24302865153079	0.036	0.792	0	PPDPF	Malignant cells	GSE164897_VemCob	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48825
0	-0.339356423273065	0.011	0.255	0	ARFRP1	Malignant cells	GSE164897_VemCob	ENSG00000101246	10139	ADP ribosylation factor related protein 1	ARL18|ARP|Arp1	protein_coding	Q13795	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48826
0	-0.324691475591034	0.063	0.304	0	TPD52L2	Malignant cells	GSE164897_VemCob	ENSG00000101150	7165	TPD52 like 2	D54|hD54|TPD54	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48827
0	-0.387488784077534	0.099	0.391	0	TCEA2	Malignant cells	GSE164897_VemCob	ENSG00000171703	6919	transcription elongation factor A2	TFIIS	protein_coding	Q15560	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48828
0	-0.771467459469498	0.073	0.594	0	PLPP2	Malignant cells	GSE164897_VemCob	ENSG00000141934	8612	phospholipid phosphatase 2	LPP2|PAP-2c|PPAP2C	protein_coding	O43688	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48829
0	-1.18679823359484	0.145	0.841	0	BSG	Malignant cells	GSE164897_VemCob	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48830
0	-0.594590429187181	0.032	0.447	0	RNF126	Malignant cells	GSE164897_VemCob	ENSG00000070423	55658	ring finger protein 126	FLJ20552	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48831
0	-0.698718883076716	0.026	0.505	0	WDR18	Malignant cells	GSE164897_VemCob	ENSG00000065268	57418	WD repeat domain 18	Ipi3	protein_coding	Q9BV38	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48832
0	-0.66308431960409	0.063	0.534	0	POLR2E	Malignant cells	GSE164897_VemCob	ENSG00000099817	5434	RNA polymerase II, I and III subunit E	hRPB25|hsRPB5|RPABC1|RPB5|XAP4	protein_coding	P19388	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48833
0	-1.50919355289818	0.102	0.897	0	GPX4	Malignant cells	GSE164897_VemCob	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48834
0	-0.646200700953247	0.085	0.541	0	ATP5F1D	Malignant cells	GSE164897_VemCob	ENSG00000099624	513	ATP synthase F1 subunit delta	ATP5D	protein_coding	P30049	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48835
0	-0.985107057799011	0.238	0.826	0	CIRBP	Malignant cells	GSE164897_VemCob	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48836
0	-0.369122232443837	0.042	0.313	0	FAM174C	Malignant cells	GSE164897_VemCob	ENSG00000228300	55009	family with sequence similarity 174 member C	C19orf24|FLJ20640	protein_coding	Q9BVV8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48837
0	-0.877869283853655	0.039	0.632	0	NDUFS7	Malignant cells	GSE164897_VemCob	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48838
0	-0.50314460099002	0.045	0.408	0	GAMT	Malignant cells	GSE164897_VemCob	ENSG00000130005	2593	guanidinoacetate N-methyltransferase	PIG2|TP53I2	protein_coding	Q14353	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48839
0	-2.9132911669066	0.928	1	0	RPS15	Malignant cells	GSE164897_VemCob	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48840
0	-1.41015770862279	0.384	0.952	0	UQCR11	Malignant cells	GSE164897_VemCob	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48841
0	-1.00853055779623	0.642	0.962	0	OAZ1	Malignant cells	GSE164897_VemCob	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48842
0	-1.11531516422996	0.046	0.736	0	LSM7	Malignant cells	GSE164897_VemCob	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48843
0	-1.19674012522551	0.116	0.828	0	TIMM13	Malignant cells	GSE164897_VemCob	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48844
0	-0.65421374594051	0.029	0.472	0	HMG20B	Malignant cells	GSE164897_VemCob	ENSG00000064961	10362	high mobility group 20B	BRAF25|BRAF35|HMGX2|HMGXB2|SMARCE1r|SOXL	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48845
0	-0.458761093515661	0.218	0.573	0	MRPL54	Malignant cells	GSE164897_VemCob	ENSG00000183617	116541	mitochondrial ribosomal protein L54	NA	protein_coding	Q6P161	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48846
0	-1.32853356750412	0.713	0.973	0	EEF2	Malignant cells	GSE164897_VemCob	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48847
0	-0.758517508338275	0.215	0.732	0	MYDGF	Malignant cells	GSE164897_VemCob	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48848
0	-2.13270096218941	1	1	0	RPL36	Malignant cells	GSE164897_VemCob	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48849
0	-1.36847421044985	0.189	0.898	0	MICOS13	Malignant cells	GSE164897_VemCob	ENSG00000174917	125988	mitochondrial contact site and cristae organizing system subunit 13	C19orf70|MIC12|MIC13|P117|QIL1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48850
0	-0.349220337860026	0.02	0.271	0	HSD11B1L	Malignant cells	GSE164897_VemCob	ENSG00000167733	374875	hydroxysteroid 11-beta dehydrogenase 1 like	HSD1L|SCDR10|SDR26C2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48851
0	-0.41892129666274	0.037	0.339	0	LONP1	Malignant cells	GSE164897_VemCob	ENSG00000196365	9361	lon peptidase 1, mitochondrial	hLON|LonHS|PIM1|PRSS15	protein_coding	P36776	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48852
0	-1.26757337404259	0.182	0.889	0	NDUFA11	Malignant cells	GSE164897_VemCob	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48853
0	-0.997992402554295	0.005	0.523	0	CAPS	Malignant cells	GSE164897_VemCob	ENSG00000105519	828	calcyphosine	CAPS1|MGC126562	protein_coding	Q13938	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48854
0	-0.753468992498075	0.108	0.625	0	CLPP	Malignant cells	GSE164897_VemCob	ENSG00000125656	8192	caseinolytic mitochondrial matrix peptidase proteolytic subunit	NA	protein_coding	Q16740	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48855
0	-0.638752997183236	0.024	0.471	0	ALKBH7	Malignant cells	GSE164897_VemCob	ENSG00000125652	84266	alkB homolog 7	MGC10974|SPATA11	protein_coding	Q9BT30	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48856
0	-0.428747717097373	0.114	0.414	0	CD70	Malignant cells	GSE164897_VemCob	ENSG00000125726	970	CD70 molecule	CD27L|CD27LG|TNFSF7	protein_coding	P32970	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48857
0	-0.323937385806888	0.075	0.321	0	GPR108	Malignant cells	GSE164897_VemCob	ENSG00000125734	56927	G protein-coupled receptor 108	LUSTR2	protein_coding	Q9NPR9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48858
0	-0.383441247736818	0.028	0.306	0	SNAPC2	Malignant cells	GSE164897_VemCob	ENSG00000104976	6618	small nuclear RNA activating complex polypeptide 2	PTFdelta|SNAP45	protein_coding	Q13487	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48859
0	-0.72873379419702	0.054	0.56	0	CD320	Malignant cells	GSE164897_VemCob	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48860
0	-2.37799293914173	0.999	1	0	RPS28	Malignant cells	GSE164897_VemCob	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48861
0	-0.333625046589899	0.062	0.311	0	RAB11B	Malignant cells	GSE164897_VemCob	ENSG00000185236	9230	RAB11B, member RAS oncogene family	H-YPT3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48862
0	-0.626577319180985	0.221	0.67	0	HNRNPM	Malignant cells	GSE164897_VemCob	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48863
0	0.975872254108444	1	0.992	0	UBL5	Malignant cells	GSE164897_VemCob	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48864
0	-0.81994429571889	0.091	0.652	0	PIN1	Malignant cells	GSE164897_VemCob	ENSG00000127445	5300	peptidylprolyl cis/trans isomerase, NIMA-interacting 1	dod	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48865
0	-0.376642986459322	0.013	0.284	0	PPAN	Malignant cells	GSE164897_VemCob	ENSG00000130810	56342	peter pan homolog	BXDC3|SSF|SSF1|SSF2	protein_coding	Q9NQ55	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48866
0	-1.07812623038457	0.213	0.85	0	EIF3G	Malignant cells	GSE164897_VemCob	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48867
0	-0.746476844815838	0.085	0.594	0	MRPL4	Malignant cells	GSE164897_VemCob	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48868
0	-0.969272167495483	0.239	0.819	0	CDC37	Malignant cells	GSE164897_VemCob	ENSG00000105401	11140	cell division cycle 37, HSP90 cochaperone	P50CDC37	protein_coding	Q16543	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48869
0	-0.389725754343677	0.013	0.292	0	QTRT1	Malignant cells	GSE164897_VemCob	ENSG00000213339	81890	queuine tRNA-ribosyltransferase catalytic subunit 1	TGT	protein_coding	Q9BXR0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48870
0	-0.356138988965691	0.073	0.339	0	TMED1	Malignant cells	GSE164897_VemCob	ENSG00000099203	11018	transmembrane p24 trafficking protein 1	Il1rl1l|IL1RL1LG|MGC1270|p24g1|p24gamma1|ST2L	protein_coding	Q13445	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48871
0	-0.350628846564537	0.056	0.314	0	CARM1	Malignant cells	GSE164897_VemCob	ENSG00000142453	10498	coactivator associated arginine methyltransferase 1	PRMT4	protein_coding	Q86X55	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48872
0	-0.439179792475258	0.038	0.362	0	YIPF2	Malignant cells	GSE164897_VemCob	ENSG00000130733	78992	Yip1 domain family member 2	FinGER2|MGC3262	protein_coding	Q9BWQ6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48873
0	-0.928962655286122	0.071	0.687	0	PRKCSH	Malignant cells	GSE164897_VemCob	ENSG00000130175	5589	protein kinase C substrate 80K-H	G19P1|GIIB|PCLD|PLD1|VASAP-60	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48874
0	-0.544518636929307	0.033	0.425	0	ECSIT	Malignant cells	GSE164897_VemCob	ENSG00000130159	51295	ECSIT signaling integrator	SITPEC	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48875
0	-0.889880369701133	0.192	0.757	0	ELOF1	Malignant cells	GSE164897_VemCob	ENSG00000130165	84337	elongation factor 1	ELF1|MGC4549	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48876
0	-0.353932038899911	0.028	0.286	0	WDR83	Malignant cells	GSE164897_VemCob	ENSG00000123154	84292	WD repeat domain 83	MORG1	protein_coding	Q9BRX9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48877
0	0.734199792817591	0.987	0.917	0	WDR83OS	Malignant cells	GSE164897_VemCob	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48878
0	-0.643358828075416	0.144	0.608	0	DHPS	Malignant cells	GSE164897_VemCob	ENSG00000095059	1725	deoxyhypusine synthase	MIG13	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48879
0	-1.04862676220826	0.36	0.905	0	TRIR	Malignant cells	GSE164897_VemCob	ENSG00000123144	79002	telomerase RNA component interacting RNase	C19orf43|fSAP18|MGC2803|TERCIR	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48880
0	-0.737607563954379	0.051	0.497	0	JUNB	Malignant cells	GSE164897_VemCob	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48881
0	-0.460609087285464	0.022	0.335	0	RNASEH2A	Malignant cells	GSE164897_VemCob	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48882
0	-0.634182337579566	0.376	0.799	0	RAD23A	Malignant cells	GSE164897_VemCob	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48883
0	-1.21383099159049	0.52	0.953	0	GADD45GIP1	Malignant cells	GSE164897_VemCob	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48884
0	-0.650862451106721	0.114	0.579	0	STX10	Malignant cells	GSE164897_VemCob	ENSG00000104915	8677	syntaxin 10	hsyn10|SYN10	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48885
0	1.35420182345384	1	0.985	0	C19orf53	Malignant cells	GSE164897_VemCob	ENSG00000104979	28974	chromosome 19 open reading frame 53	HSPC023|LYDG10	protein_coding	Q9UNZ5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48886
0	-0.548215402169423	0.083	0.477	0	GIPC1	Malignant cells	GSE164897_VemCob	ENSG00000123159	10755	GIPC PDZ domain containing family member 1	C19orf3|GIPC|GLUT1CBP|Hs.6454|NIP|RGS19IP1|SEMCAP|SYNECTIN|TIP-2	protein_coding	O14908	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48887
0	-0.637026583742695	0.244	0.691	0	TECR	Malignant cells	GSE164897_VemCob	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48888
0	-1.42779615626133	0.311	0.942	0	NDUFB7	Malignant cells	GSE164897_VemCob	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48889
0	-0.379946926455741	0.137	0.434	0	BRD4	Malignant cells	GSE164897_VemCob	ENSG00000141867	23476	bromodomain containing 4	CAP|HUNK1|HUNKI|MCAP	protein_coding	O60885	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48890
0	-0.750328650825863	0.134	0.658	0	MRPL34	Malignant cells	GSE164897_VemCob	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48891
0	-0.632482126209177	0.101	0.56	0	DDA1	Malignant cells	GSE164897_VemCob	ENSG00000130311	79016	DET1 and DDB1 associated 1	C19orf58|MGC2594|PCIA1	protein_coding	Q9BW61	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48892
0	-0.789236901637388	0.041	0.586	0	MVB12A	Malignant cells	GSE164897_VemCob	ENSG00000141971	93343	multivesicular body subunit 12A	FAM125A|FLJ32495	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48893
0	-1.12477865616018	0.075	0.773	0	PGLS	Malignant cells	GSE164897_VemCob	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48894
0	-2.84538269467843	0.997	1	0	RPL18A	Malignant cells	GSE164897_VemCob	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48895
0	-0.86906371213196	0.041	0.631	0	CCDC124	Malignant cells	GSE164897_VemCob	ENSG00000007080	115098	coiled-coil domain containing 124	Lso2|oxs1	protein_coding	Q96CT7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48896
0	-1.04813120286954	0.197	0.8	0	LSM4	Malignant cells	GSE164897_VemCob	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48897
0	-1.15915309014023	0.037	0.769	0	FKBP8	Malignant cells	GSE164897_VemCob	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48898
0	-0.498531448712338	0.28	0.665	0	KXD1	Malignant cells	GSE164897_VemCob	ENSG00000105700	79036	KxDL motif containing 1	BORCS4|C19orf50|FLJ25480|KXDL|MGC2749	protein_coding	Q9BQD3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48899
0	0.606228833710696	1	1	0	UBA52	Malignant cells	GSE164897_VemCob	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48900
0	-0.920628718650528	0.091	0.711	0	REX1BD	Malignant cells	GSE164897_VemCob	ENSG00000006015	55049	required for excision 1-B domain containing	C19orf60|FLJ20850|FLJ30108|FLJ34606|FLJ37391	protein_coding	Q96EN9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48901
0	-1.23460297267564	0.145	0.852	0	COPE	Malignant cells	GSE164897_VemCob	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48902
0	-0.603898015589118	0.046	0.48	0	DDX49	Malignant cells	GSE164897_VemCob	ENSG00000105671	54555	DEAD-box helicase 49	Dbp8|FLJ10432	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48903
0	-0.668362220681148	0.248	0.711	0	UQCRFS1	Malignant cells	GSE164897_VemCob	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48904
0	-0.864975000456242	0.416	0.86	0	PDCD5	Malignant cells	GSE164897_VemCob	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48905
0	-0.443192050789958	0.025	0.336	0	CEBPG	Malignant cells	GSE164897_VemCob	ENSG00000153879	1054	CCAAT enhancer binding protein gamma	GPE1BP|IG/EBP-1	protein_coding	P53567	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48906
0	-0.905819568873945	0.401	0.876	0	FXYD5	Malignant cells	GSE164897_VemCob	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48907
0	-0.565770196823166	0.068	0.478	0	USF2	Malignant cells	GSE164897_VemCob	ENSG00000105698	7392	upstream transcription factor 2, c-fos interacting	bHLHb12|FIP	protein_coding	Q15853	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48908
0	-0.986449787797455	0.218	0.827	0	TMEM147	Malignant cells	GSE164897_VemCob	ENSG00000105677	10430	transmembrane protein 147	MGC1936|NIFIE14	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48909
0	1.07518311586108	1	0.973	0	COX6B1	Malignant cells	GSE164897_VemCob	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48910
0	0.662169835608285	0.573	0.322	0	PSENEN	Malignant cells	GSE164897_VemCob	ENSG00000205155	55851	presenilin enhancer, gamma-secretase subunit	PEN2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48911
0	-0.897803037722161	0.2	0.773	0	POLR2I	Malignant cells	GSE164897_VemCob	ENSG00000105258	5438	RNA polymerase II subunit I	hRPB14.5|RPB9	protein_coding	P36954	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48912
0	-0.95851682756909	0.122	0.735	0	TBCB	Malignant cells	GSE164897_VemCob	ENSG00000105254	1155	tubulin folding cofactor B	CG22|CKAP1|CKAPI	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48913
0	-0.857611215162367	0.018	0.386	0	C19orf33	Malignant cells	GSE164897_VemCob	ENSG00000167644	64073	chromosome 19 open reading frame 33	H2RSP|IMUP|IMUP-1|IMUP-2	protein_coding	Q9GZP8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48914
0	-0.468698801706904	0.019	0.358	0	YIF1B	Malignant cells	GSE164897_VemCob	ENSG00000167645	90522	Yip1 interacting factor homolog B, membrane trafficking protein	FinGER8	protein_coding	Q5BJH7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48915
0	-0.971974949659509	0.305	0.834	0	PSMD8	Malignant cells	GSE164897_VemCob	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48916
0	-0.569659546563352	0.279	0.674	0	ACTN4	Malignant cells	GSE164897_VemCob	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48917
0	-0.781639118116068	0.135	0.65	0	ECH1	Malignant cells	GSE164897_VemCob	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48918
0	-0.921483359241062	0.09	0.685	0	MRPS12	Malignant cells	GSE164897_VemCob	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48919
0	-0.964678294563053	1	1	0	RPS16	Malignant cells	GSE164897_VemCob	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48920
0	-0.629134334420821	0.079	0.522	0	TIMM50	Malignant cells	GSE164897_VemCob	ENSG00000105197	92609	translocase of inner mitochondrial membrane 50	TIM50|TIM50L	protein_coding	Q3ZCQ8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48921
0	-0.831936991057081	0.056	0.613	0	SNRPA	Malignant cells	GSE164897_VemCob	ENSG00000077312	6626	small nuclear ribonucleoprotein polypeptide A	Mud1|U1-A|U1A	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48922
0	-1.44899058092477	0.008	0.769	0	MIA	Malignant cells	GSE164897_VemCob	ENSG00000261857	8190	MIA SH3 domain containing	CD-RAP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48923
0	-0.354332902567723	0.002	0.251	0	EGLN2	Malignant cells	GSE164897_VemCob	ENSG00000269858	112398	egl-9 family hypoxia inducible factor 2	HIFPH1|PHD1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48924
0	-0.890962229251423	0.076	0.649	0	EXOSC5	Malignant cells	GSE164897_VemCob	ENSG00000077348	56915	exosome component 5	hRrp46p|MGC12901|p12B|RRP41B|RRP46|Rrp46p	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48925
0	-0.576338587433729	1	1	0	RPS19	Malignant cells	GSE164897_VemCob	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48926
0	-0.709467661324281	0.073	0.551	0	RABAC1	Malignant cells	GSE164897_VemCob	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48927
0	-0.466962660738686	0.082	0.427	0	PAFAH1B3	Malignant cells	GSE164897_VemCob	ENSG00000079462	5050	platelet activating factor acetylhydrolase 1b catalytic subunit 3	NA	protein_coding	Q15102	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48928
0	-0.975684306893947	0.127	0.731	0	ETHE1	Malignant cells	GSE164897_VemCob	ENSG00000105755	23474	ETHE1 persulfide dioxygenase	HSCO|YF13H12	protein_coding	O95571	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48929
0	-0.501243221499135	0.032	0.394	0	ZNF428	Malignant cells	GSE164897_VemCob	ENSG00000131116	126299	zinc finger protein 428	C19orf37|MGC51082|Zfp428	protein_coding	Q96B54	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48930
0	-0.459677949143635	0.051	0.364	0	KCNN4	Malignant cells	GSE164897_VemCob	ENSG00000104783	3783	potassium calcium-activated channel subfamily N member 4	hIKCa1|hKCa4|hSK4|IK|KCa3.1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48931
0	-0.321244918565111	0.021	0.254	0	CLPTM1	Malignant cells	GSE164897_VemCob	ENSG00000104853	1209	CLPTM1 regulator of GABA type A receptor forward trafficking	NA	protein_coding	O96005	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48932
0	-0.586568597106444	0.211	0.638	0	ERCC1	Malignant cells	GSE164897_VemCob	ENSG00000012061	2067	ERCC excision repair 1, endonuclease non-catalytic subunit	RAD10	protein_coding	P07992	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48933
0	0.611336045160597	1	0.996	0	SNRPD2	Malignant cells	GSE164897_VemCob	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48934
0	-0.538823007381992	0.088	0.471	0	SLC1A5	Malignant cells	GSE164897_VemCob	ENSG00000105281	6510	solute carrier family 1 member 5	AAAT|ASCT2|M7V1|RDRC	protein_coding	Q15758	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48935
0	-1.82375295417506	0.434	0.987	0	AP2S1	Malignant cells	GSE164897_VemCob	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48936
0	-0.609866748622131	0.041	0.47	0	TMEM160	Malignant cells	GSE164897_VemCob	ENSG00000130748	54958	transmembrane protein 160	FLJ20512	protein_coding	Q9NX00	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48937
0	-1.49225692051659	0.073	0.892	0	NOP53	Malignant cells	GSE164897_VemCob	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48938
0	-1.19772237170071	0.151	0.81	0	EMP3	Malignant cells	GSE164897_VemCob	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48939
0	-2.9152721846057	0.916	1	0	RPL18	Malignant cells	GSE164897_VemCob	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48940
0	-0.288816658978263	0.039	0.253	0	BCAT2	Malignant cells	GSE164897_VemCob	ENSG00000105552	587	branched chain amino acid transaminase 2	BCAM|BCATm|BCT2	protein_coding	O15382	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48941
0	-0.604314876631046	0.041	0.413	0	PPP1R15A	Malignant cells	GSE164897_VemCob	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48942
0	-0.387779296296904	0.06	0.349	0	NUCB1	Malignant cells	GSE164897_VemCob	ENSG00000104805	4924	nucleobindin 1	Calnuc|NUC	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48943
0	-0.629939540161565	0.132	0.542	0	BAX	Malignant cells	GSE164897_VemCob	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48944
0	3.03532714183483	1	0.999	0	FTL	Malignant cells	GSE164897_VemCob	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48945
0	-0.558201729109457	0.279	0.668	0	RUVBL2	Malignant cells	GSE164897_VemCob	ENSG00000183207	10856	RuvB like AAA ATPase 2	ECP51|INO80J|Reptin52|RVB2|TIH2|TIP48|TIP49b	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48946
0	-0.425523502138893	0.089	0.406	0	SNRNP70	Malignant cells	GSE164897_VemCob	ENSG00000104852	6625	small nuclear ribonucleoprotein U1 subunit 70	RNPU1Z|RPU1|Snp1|SNRP70|U1-70K	protein_coding	P08621	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48947
0	-1.30207199484957	1	1	0	RPL13A	Malignant cells	GSE164897_VemCob	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48948
0	0.850883864907916	1	1	0	RPS11	Malignant cells	GSE164897_VemCob	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48949
0	-0.767993464273405	0.064	0.6	0	NOSIP	Malignant cells	GSE164897_VemCob	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48950
0	-0.413983021035126	0.106	0.391	0	RRAS	Malignant cells	GSE164897_VemCob	ENSG00000126458	6237	RAS related	R-Ras	protein_coding	P10301	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48951
0	-1.11758001793097	0.094	0.761	0	PRMT1	Malignant cells	GSE164897_VemCob	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48952
0	0.467174780795435	0.293	0.043	0	CPT1C	Malignant cells	GSE164897_VemCob	ENSG00000169169	126129	carnitine palmitoyltransferase 1C	CATL1|CPT1P|CPTIC|FLJ23809	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48953
0	-0.322685110432669	0.032	0.264	0	FUZ	Malignant cells	GSE164897_VemCob	ENSG00000010361	80199	fuzzy planar cell polarity protein	CPLANE3|FLJ22688|Fy	protein_coding	Q9BT04	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48954
0	-0.524284924441027	0.072	0.459	0	AKT1S1	Malignant cells	GSE164897_VemCob	ENSG00000204673	84335	AKT1 substrate 1	Lobe|MGC2865|PRAS40	protein_coding	Q96B36	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48955
0	-0.448045021231046	0.04	0.363	0	NR1H2	Malignant cells	GSE164897_VemCob	ENSG00000131408	7376	nuclear receptor subfamily 1 group H member 2	LXR-b|LXRb|NER|NER-I|RIP15|UNR	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48956
0	-0.608967735860235	0.048	0.488	0	JOSD2	Malignant cells	GSE164897_VemCob	ENSG00000161677	126119	Josephin domain containing 2	SBBI54	protein_coding	Q8TAC2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48957
0	-1.2568498833654	0.088	0.745	0	C19orf48	Malignant cells	GSE164897_VemCob	ENSG00000167747	84798	multidrug resistance-related protein	BC006151|MGC13170	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48958
0	-0.890277359197332	0.415	0.86	0	ETFB	Malignant cells	GSE164897_VemCob	ENSG00000105379	2109	electron transfer flavoprotein subunit beta	NA	protein_coding	P38117	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48959
0	-0.53421608767808	0.064	0.443	0	TFPT	Malignant cells	GSE164897_VemCob	ENSG00000276504	29844	TCF3 fusion partner	amida|FB1|INO80F	protein_coding	P0C1Z6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48960
0	-0.345825945278581	0.023	0.272	0	LENG1	Malignant cells	GSE164897_VemCob	ENSG00000276628	79165	leukocyte receptor cluster member 1	NA	protein_coding	Q96BZ8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48961
0	-0.440458049914737	0.077	0.404	0	TSEN34	Malignant cells	GSE164897_VemCob	ENSG00000274078	79042	tRNA splicing endonuclease subunit 34	LENG5|SEN34|SEN34L	protein_coding	Q9BSV6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48962
0	-0.950067199596276	1	1	0	RPS9	Malignant cells	GSE164897_VemCob	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48963
0	-0.413499367994065	0.068	0.372	0	HSPBP1	Malignant cells	GSE164897_VemCob	ENSG00000133265	23640	HSPA (Hsp70) binding protein 1	FES1	protein_coding	Q9NZL4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48964
0	-2.21457019281298	0.999	1	0	RPL28	Malignant cells	GSE164897_VemCob	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48965
0	-1.24744843167852	0.35	0.778	0	UBE2S	Malignant cells	GSE164897_VemCob	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48966
0	-0.381355142910733	0.035	0.309	0	ISOC2	Malignant cells	GSE164897_VemCob	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48967
0	-0.462858921570398	0.161	0.51	0	ZNF580	Malignant cells	GSE164897_VemCob	ENSG00000213015	51157	zinc finger protein 580	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48968
0	-0.764004819984122	0.034	0.562	0	ZNF581	Malignant cells	GSE164897_VemCob	ENSG00000171425	51545	zinc finger protein 581	FLJ22550|HSPC189	protein_coding	Q9P0T4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48969
0	-0.447424662949643	0.108	0.449	0	EPN1	Malignant cells	GSE164897_VemCob	ENSG00000063245	29924	epsin 1	NA	protein_coding	Q9Y6I3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48970
0	-0.429515001139439	0.015	0.319	0	A1BG	Malignant cells	GSE164897_VemCob	ENSG00000121410	1	alpha-1-B glycoprotein	NA	protein_coding	P04217	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48971
0	-1.31599266856844	1	1	0	RPS5	Malignant cells	GSE164897_VemCob	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48972
0	-0.360993512252737	0.066	0.333	0	BID	Malignant cells	GSE164897_VemCob	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48973
0	-0.318598621363828	0.038	0.272	0	SLC25A1	Malignant cells	GSE164897_VemCob	ENSG00000100075	6576	solute carrier family 25 member 1	CTP|SLC20A3	protein_coding	P53007	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48974
0	-0.86086297688232	0.345	0.798	0	RANBP1	Malignant cells	GSE164897_VemCob	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48975
0	-0.383070124867794	0.037	0.316	0	DGCR6L	Malignant cells	GSE164897_VemCob	ENSG00000128185	85359	DiGeorge syndrome critical region gene 6 like	FLJ10666	protein_coding	Q9BY27	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48976
0	-0.343247093896166	0.025	0.274	0	THAP7	Malignant cells	GSE164897_VemCob	ENSG00000184436	80764	THAP domain containing 7	MGC10963	protein_coding	Q9BT49	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48977
0	-0.548965396289699	0.054	0.443	0	YDJC	Malignant cells	GSE164897_VemCob	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48978
0	-0.302475771666036	0.046	0.267	0	SDF2L1	Malignant cells	GSE164897_VemCob	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48979
0	-0.512360334641273	0.03	0.398	0	SMARCB1	Malignant cells	GSE164897_VemCob	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48980
0	-1.89132089782726	0.211	0.973	0	MIF	Malignant cells	GSE164897_VemCob	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48981
0	-1.28153223243842	0.094	0.841	0	DDT	Malignant cells	GSE164897_VemCob	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48982
0	-0.44364699605092	0.076	0.391	0	XBP1	Malignant cells	GSE164897_VemCob	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48983
0	1.51526816270965	0.99	0.736	0	UQCR10	Malignant cells	GSE164897_VemCob	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48984
0	-0.439749715471802	0.08	0.395	0	SELENOM	Malignant cells	GSE164897_VemCob	ENSG00000198832	140606	selenoprotein M	SELM|SEPM	protein_coding	Q8WWX9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48985
0	-0.610735879925623	0.302	0.741	0	EIF3D	Malignant cells	GSE164897_VemCob	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48986
0	-0.528017858146836	0.039	0.419	0	MPST	Malignant cells	GSE164897_VemCob	ENSG00000128309	4357	mercaptopyruvate sulfurtransferase	MST|TST2|TUM1	protein_coding	P25325	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48987
0	-0.523322125523527	0.173	0.466	0	H1-0	Malignant cells	GSE164897_VemCob	ENSG00000189060	3005	H1.0 linker histone	H1.0|H1F0|H1FV	protein_coding	P07305	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48988
0	-0.703085403269572	0.823	0.978	0	EIF3L	Malignant cells	GSE164897_VemCob	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48989
0	-0.742349996329078	0	0.48	0	SOX10	Malignant cells	GSE164897_VemCob	ENSG00000100146	6663	SRY-box transcription factor 10	DOM|SOX-10|WS2E|WS4	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48990
0	-1.3145044030536	1	1	0	RPL3	Malignant cells	GSE164897_VemCob	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48991
0	-1.21809027084034	0.158	0.841	0	ATF4	Malignant cells	GSE164897_VemCob	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48992
0	-0.890125888029103	0.076	0.678	0	RPS19BP1	Malignant cells	GSE164897_VemCob	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48993
0	-0.455894830669877	0.127	0.466	0	ADSL	Malignant cells	GSE164897_VemCob	ENSG00000239900	158	adenylosuccinate lyase	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48994
0	-0.575160200542243	0.513	0.847	0	ST13	Malignant cells	GSE164897_VemCob	ENSG00000100380	6767	ST13 Hsp70 interacting protein	FAM10A1|HIP|HSPABP1|P48|SNC6	protein_coding	P50502	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48995
0	1.51273734057939	0.928	0.454	0	RBX1	Malignant cells	GSE164897_VemCob	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48996
0	-0.387436904352591	0.058	0.342	0	DESI1	Malignant cells	GSE164897_VemCob	ENSG00000100418	27351	desumoylating isopeptidase 1	D15Wsu75e|DESI-1|FAM152B|POST|PPPDE2	protein_coding	Q6ICB0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48997
0	0.867690188694516	0.987	0.898	0	SNU13	Malignant cells	GSE164897_VemCob	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48998
0	-0.64213171579185	0.063	0.534	0	SMDT1	Malignant cells	GSE164897_VemCob	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	48999
0	-0.400058917991872	0.056	0.343	0	RRP7A	Malignant cells	GSE164897_VemCob	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49000
0	-1.39216034730315	0.164	0.893	0	TSPO	Malignant cells	GSE164897_VemCob	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49001
0	0.86025773224436	0.993	0.955	0	ATP5PF	Malignant cells	GSE164897_VemCob	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49002
0	0.929787106480199	0.946	0.775	0	SOD1	Malignant cells	GSE164897_VemCob	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49003
0	-0.624974693714795	0.075	0.44	0	MRPS6	Malignant cells	GSE164897_VemCob	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49004
0	-0.440431583505525	0.031	0.319	0	RCAN1	Malignant cells	GSE164897_VemCob	ENSG00000159200	1827	regulator of calcineurin 1	DSCR1	protein_coding	P53805	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49005
0	-0.423391543169041	0.048	0.351	0	PSMG1	Malignant cells	GSE164897_VemCob	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49006
0	-0.804031715716546	0.373	0.837	0	HMGN1	Malignant cells	GSE164897_VemCob	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49007
0	-0.493449115173937	0.014	0.363	0	SLX9	Malignant cells	GSE164897_VemCob	ENSG00000160256	85395	SLX9 ribosome biogenesis factor	C21orf70|FAM207A|PRED56	protein_coding	Q9NSI2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49008
0	0.708276194879105	1	0.999	0	MT-ND1	Malignant cells	GSE164897_VemCob	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49009
0	-0.284818613239296	1	1	0	MT-CO1	Malignant cells	GSE164897_VemCob	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49010
0	0.822936119012848	1	0.999	0	MT-ATP6	Malignant cells	GSE164897_VemCob	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49011
0	0.900952734031994	1	1	0	MT-CO3	Malignant cells	GSE164897_VemCob	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49012
0	-0.577945602966425	0.999	1	0	MT-ND3	Malignant cells	GSE164897_VemCob	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49013
0	-0.454611546344613	0.338	0.69	0	MT-ND4L	Malignant cells	GSE164897_VemCob	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49014
0	0.740424619016639	0.289	0	0	COL3A1	Malignant cells	GSE164897_VemCob	ENSG00000168542	1281	collagen type III alpha 1 chain	EDS4A	protein_coding	P02461	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49015
0	1.27015811492793	0.417	0	0	SUCNR1	Malignant cells	GSE164897_VemCob	ENSG00000198829	56670	succinate receptor 1	GPR91	protein_coding	Q9BXA5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49016
6.38213059925126e-308	-0.292869413598015	0.039	0.251	1.01622665531878e-303	ZFPL1	Malignant cells	GSE164897_VemCob	ENSG00000162300	7542	zinc finger protein like 1	D11S750|MCG4	protein_coding	O95159	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49017
9.80735930817731e-308	-0.376259494314479	0.193	0.492	1.56162582264107e-303	NABP2	Malignant cells	GSE164897_VemCob	ENSG00000139579	79035	nucleic acid binding protein 2	hSSB1|MGC2731|OBFC2B|SOSS-B1|SSB1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49018
1.53529006903073e-307	0.620814579151137	0.539	0.301	2.44464237691763e-303	ITGAE	Malignant cells	GSE164897_VemCob	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49019
3.08753067960776e-307	-0.358253651177199	0.108	0.368	4.91627510113943e-303	EMP2	Malignant cells	GSE164897_VemCob	ENSG00000213853	2013	epithelial membrane protein 2	XMP	protein_coding	P54851	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49020
9.50132342330814e-307	0.634442746513783	0.604	0.399	1.51289572869335e-302	DPY30	Malignant cells	GSE164897_VemCob	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49021
5.01945938114519e-306	-0.369370911203834	0.17	0.461	7.99248517259749e-302	CHTOP	Malignant cells	GSE164897_VemCob	ENSG00000160679	26097	chromatin target of PRMT1	C1orf77|DKFZP547E1010|FOP|SRAG	protein_coding	Q9Y3Y2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49022
5.58085255140935e-306	-0.358492124461626	0.164	0.455	8.88639151760912e-302	PAIP2	Malignant cells	GSE164897_VemCob	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49023
2.18172547661073e-305	0.492711728073948	0.993	0.982	3.47396147640726e-301	EIF3K	Malignant cells	GSE164897_VemCob	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49024
2.3424244167714e-305	-0.315684732894569	0.063	0.294	3.7298423988251e-301	TMEM54	Malignant cells	GSE164897_VemCob	ENSG00000121900	113452	transmembrane protein 54	BCLP|CAC-1	protein_coding	Q969K7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49025
1.74887006989517e-303	-0.347492638592625	0.042	0.253	2.78472581229407e-299	CENPU	Malignant cells	GSE164897_VemCob	ENSG00000151725	79682	centromere protein U	CENP-50|CENP-U|KLIP1|MLF1IP|PBIP1	protein_coding	Q71F23	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49026
3.02993971833955e-303	-0.313195344588041	0.069	0.305	4.82457301351207e-299	OCEL1	Malignant cells	GSE164897_VemCob	ENSG00000099330	79629	occludin/ELL domain containing 1	FLJ22709	protein_coding	Q9H607	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49027
6.93338987580354e-303	-0.300109763417917	0.05	0.269	1.1040036699242e-298	SECISBP2	Malignant cells	GSE164897_VemCob	ENSG00000187742	79048	SECIS binding protein 2	SBP2	protein_coding	Q96T21	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49028
3.42723748775854e-302	-0.351456287264017	0.137	0.414	5.45719025175792e-298	PRMT2	Malignant cells	GSE164897_VemCob	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49029
3.57395883918506e-302	-0.357140592100751	0.161	0.447	5.69081465963438e-298	ARPC4	Malignant cells	GSE164897_VemCob	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49030
5.0069979780864e-302	0.610518641468551	0.703	0.518	7.97264288050697e-298	PAGE2	Malignant cells	GSE164897_VemCob	ENSG00000234068	203569	PAGE family member 2	CT16.4|GAGEC2|MGC62094|PAGE-2	protein_coding	Q7Z2X7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49031
8.9361047609429e-302	-0.359575488253052	0.132	0.403	1.42289596108494e-297	RUVBL1	Malignant cells	GSE164897_VemCob	ENSG00000284901	8607	RuvB like AAA ATPase 1	ECP54|INO80H|NMP238|Pontin52|RVB1|TIH1|TIP49|TIP49a	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49032
2.17722492140194e-301	-0.354138635058456	0.156	0.439	3.46679524234831e-297	UPF3A	Malignant cells	GSE164897_VemCob	ENSG00000169062	65110	UPF3A regulator of nonsense mediated mRNA decay	HUPF3A|RENT3A|UPF3	protein_coding	Q9H1J1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49033
4.96597491469441e-300	-0.386393896020387	0.214	0.52	7.90732185666791e-296	TPR	Malignant cells	GSE164897_VemCob	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49034
2.33075642369888e-299	0.462993221484167	0.289	0.058	3.71126345345572e-295	MARCKS	Malignant cells	GSE164897_VemCob	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49035
2.43292486564955e-299	0.541965182625389	0.83	0.713	3.87394626357378e-295	BANF1	Malignant cells	GSE164897_VemCob	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49036
5.65403386932221e-299	-0.303545082496282	0.062	0.289	9.00291813012176e-295	HCCS	Malignant cells	GSE164897_VemCob	ENSG00000004961	3052	holocytochrome c synthase	CCHL|MLS	protein_coding	P53701	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49037
2.48833589406405e-298	-0.318772906846098	0.087	0.333	3.96217724411819e-294	B4GALT3	Malignant cells	GSE164897_VemCob	ENSG00000158850	8703	beta-1,4-galactosyltransferase 3	beta4Gal-T3	protein_coding	O60512	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49038
3.47788765369765e-298	-0.332806468494743	0.117	0.38	5.53784051098276e-294	VPS4A	Malignant cells	GSE164897_VemCob	ENSG00000132612	27183	vacuolar protein sorting 4 homolog A	FLJ22197|SKD1|SKD1A|SKD2|VPS4|VPS4-1	protein_coding	Q9UN37	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49039
1.22235098575845e-297	-0.325946509117846	0.093	0.342	1.94634947462319e-293	CLIC4	Malignant cells	GSE164897_VemCob	ENSG00000169504	25932	chloride intracellular channel 4	CLIC4L|DKFZP566G223|H1|huH1|P64H1	protein_coding	Q9Y696	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49040
1.48832032357231e-297	-0.372874177189025	0.176	0.467	2.36985245122419e-293	ZBTB38	Malignant cells	GSE164897_VemCob	ENSG00000177311	253461	zinc finger and BTB domain containing 38	CIBZ|FLJ35036|PPP1R171|ZNF921	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49041
3.38303453308001e-297	-0.316980184326322	0.076	0.313	5.38680588702331e-293	COMT	Malignant cells	GSE164897_VemCob	ENSG00000093010	1312	catechol-O-methyltransferase	NA	protein_coding	P21964	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49042
2.4870559106826e-296	-0.299854404826221	0.065	0.295	3.96013912657991e-292	PPA2	Malignant cells	GSE164897_VemCob	ENSG00000138777	27068	inorganic pyrophosphatase 2	FLJ20459	protein_coding	Q9H2U2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49043
3.51629261612574e-296	-0.293978680124315	0.997	1	5.59899273265701e-292	PPIA	Malignant cells	GSE164897_VemCob	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49044
4.17633258820782e-295	0.608144776066724	0.837	0.722	6.64997438020331e-291	SET	Malignant cells	GSE164897_VemCob	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49045
1.1517247750031e-294	-0.306878968032286	0.064	0.292	1.83389135923743e-290	POLR1F	Malignant cells	GSE164897_VemCob	ENSG00000105849	221830	RNA polymerase I subunit F	A43|RPA43|TWISTNB	protein_coding	Q3B726	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49046
3.15528978341857e-294	-0.345587516920862	0.128	0.394	5.02416792213739e-290	NELFCD	Malignant cells	GSE164897_VemCob	ENSG00000101158	51497	negative elongation factor complex member C/D	HSPC130|NELF-C|NELF-D|TH1|TH1L	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49047
5.44289776087146e-294	-0.33213925105808	0.097	0.346	8.66672610463563e-290	PRPF31	Malignant cells	GSE164897_VemCob	ENSG00000274651	26121	pre-mRNA processing factor 31	hPrp31|NY-BR-99|PRP31|RP11|SNRNP61	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49048
8.18395387804368e-294	0.616248890382332	0.69	0.544	1.3031309760009e-289	UBE2L3	Malignant cells	GSE164897_VemCob	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49049
8.41556063567851e-294	-0.330937541536801	0.118	0.382	1.34000972001909e-289	TNFRSF1A	Malignant cells	GSE164897_VemCob	ENSG00000067182	7132	TNF receptor superfamily member 1A	CD120a|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR60	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49050
1.34756385097082e-293	-0.343288695279054	0.134	0.402	2.14572591990084e-289	TADA3	Malignant cells	GSE164897_VemCob	ENSG00000171148	10474	transcriptional adaptor 3	ADA3|FLJ20221|FLJ21329|hADA3|NGG1|TADA3L	protein_coding	O75528	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49051
3.77219849134795e-293	-0.30773735765924	0.075	0.31	6.00647165777334e-289	GID8	Malignant cells	GSE164897_VemCob	ENSG00000101193	54994	GID complex subunit 8 homolog	bA305P22.1|C20orf11|FLJ20602|TWA1	protein_coding	Q9NWU2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49052
7.19585621016309e-293	-0.278560418540754	0.045	0.257	1.14579618434427e-288	ARF5	Malignant cells	GSE164897_VemCob	ENSG00000004059	381	ADP ribosylation factor 5	NA	protein_coding	P84085	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49053
1.22493014084445e-292	-0.322911880676106	0.106	0.361	1.95045626326662e-288	TOR1A	Malignant cells	GSE164897_VemCob	ENSG00000136827	1861	torsin family 1 member A	DQ2|DYT1	protein_coding	O14656	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49054
1.55032638128493e-292	-0.446072642372726	1	1	2.46858469691999e-288	LGALS1	Malignant cells	GSE164897_VemCob	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49055
2.29752684856188e-292	-0.29132316900953	0.047	0.259	3.65835200096509e-288	SNAP47	Malignant cells	GSE164897_VemCob	ENSG00000143740	116841	synaptosome associated protein 47	C1orf142|SNAP-47|SVAP1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49056
4.86452499221694e-292	-0.365411275514966	0.202	0.499	7.74578314510703e-288	AKAP9	Malignant cells	GSE164897_VemCob	ENSG00000127914	10142	A-kinase anchoring protein 9	AKAP350|AKAP450|CG-NAP|HYPERION|KIAA0803|LQT11|MU-RMS-40.16A|PPP1R45|PRKA9|YOTIAO	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49057
7.29971239188132e-292	-0.287806060213776	0.044	0.253	1.16233320415926e-287	FAM234A	Malignant cells	GSE164897_VemCob	ENSG00000167930	83986	family with sequence similarity 234 member A	C16orf9|DKFZP761D0211|FLJ32603|ITFG3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49058
1.21402898029152e-291	-0.399854882248756	0.366	0.705	1.93309834531818e-287	CSNK2B	Malignant cells	GSE164897_VemCob	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49059
1.55561433890786e-291	-0.302959575674627	0.077	0.311	2.47700471184298e-287	BORCS8	Malignant cells	GSE164897_VemCob	ENSG00000254901	729991	BLOC-1 related complex subunit 8	MEF2BNB	protein_coding	Q96FH0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49060
2.25815041177713e-291	-0.342716821479904	0.103	0.354	3.59565290067272e-287	CCDC144NL-AS1	Malignant cells	GSE164897_VemCob	ENSG00000233098	339260	uncharacterized LOC339260	NA	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49061
3.13853895549148e-291	-0.37923207407786	0.238	0.545	4.99749557882909e-287	CENPX	Malignant cells	GSE164897_VemCob	ENSG00000169689	201254	centromere protein X	CENP-X|FAAP10|MGC14480|MHF2|STRA13	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49062
8.68441848083547e-291	-0.369890814593117	0.245	0.558	1.38281995470343e-286	NUTF2	Malignant cells	GSE164897_VemCob	ENSG00000102898	10204	nuclear transport factor 2	NTF2|PP15	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49063
8.98631744719161e-291	-0.312715258651966	0.081	0.317	1.43089132711632e-286	CCNDBP1	Malignant cells	GSE164897_VemCob	ENSG00000166946	23582	cyclin D1 binding protein 1	DIP1|GCIP|HHM	protein_coding	O95273	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49064
1.46736742051547e-290	-0.349326872596323	0.159	0.439	2.33648914368678e-286	BZW2	Malignant cells	GSE164897_VemCob	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49065
1.94884732102359e-290	0.431905599482803	0.27	0.048	3.10314958926586e-286	SMIM3	Malignant cells	GSE164897_VemCob	ENSG00000256235	85027	small integral membrane protein 3	C5orf62|MSTP150|NID67	protein_coding	Q9BZL3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49066
2.16857627143761e-290	-0.321860292568924	0.105	0.357	3.4530239970101e-286	PMVK	Malignant cells	GSE164897_VemCob	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49067
3.81122872622726e-290	-0.287306382078137	0.048	0.259	6.06861950077167e-286	SUDS3	Malignant cells	GSE164897_VemCob	ENSG00000111707	64426	SDS3 homolog, SIN3A corepressor complex component	FLJ00052|SAP45|SDS3	protein_coding	Q9H7L9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49068
2.18221054167268e-289	-0.328758007845525	0.109	0.364	3.47473384550541e-285	YAF2	Malignant cells	GSE164897_VemCob	ENSG00000015153	10138	YY1 associated factor 2	NA	protein_coding	Q8IY57	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49069
3.10375995386273e-289	-0.316402706195136	0.099	0.347	4.94211697453562e-285	COPRS	Malignant cells	GSE164897_VemCob	ENSG00000172301	55352	coordinator of PRMT5 and differentiation stimulator	C17orf79|COPR5|HSA272196|TTP1	protein_coding	Q9NQ92	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49070
5.24473898353977e-287	-0.282278748539275	0.047	0.257	8.35119788349038e-283	NSUN5	Malignant cells	GSE164897_VemCob	ENSG00000130305	55695	NOP2/Sun RNA methyltransferase 5	FLJ10267|NOL1R|NSUN5A|p120(NOL1)|WBSCR20|WBSCR20A|Ynl022cL	protein_coding	Q96P11	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49071
1.32678682706813e-286	-0.352208703193323	0.191	0.482	2.11264266474058e-282	ZCCHC9	Malignant cells	GSE164897_VemCob	ENSG00000131732	84240	zinc finger CCHC-type containing 9	DKFZp761J139|PPP1R41	protein_coding	Q8N567	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49072
1.60820645454825e-285	-0.398205968492896	0.185	0.465	2.56074713757718e-281	DNMT1	Malignant cells	GSE164897_VemCob	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49073
2.02478404782383e-285	0.579619849560969	0.78	0.665	3.22406363934989e-281	PSMB4	Malignant cells	GSE164897_VemCob	ENSG00000159377	5692	proteasome 20S subunit beta 4	HN3|PROS26	protein_coding	P28070	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49074
2.85501320814566e-285	-0.315126195876839	0.088	0.327	4.54603753133033e-281	PHF14	Malignant cells	GSE164897_VemCob	ENSG00000106443	9678	PHD finger protein 14	KIAA0783	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49075
4.07335633207631e-285	-0.287976267942464	0.052	0.264	6.48600528756511e-281	MGMT	Malignant cells	GSE164897_VemCob	ENSG00000170430	4255	O-6-methylguanine-DNA methyltransferase	NA	protein_coding	P16455	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49076
6.81645455311541e-285	-0.306918944786846	0.069	0.295	1.08538405849257e-280	TLCD1	Malignant cells	GSE164897_VemCob	ENSG00000160606	116238	TLC domain containing 1	NA	protein_coding	Q96CP7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49077
7.39187214980359e-285	0.617976915616207	0.652	0.483	1.17700780241323e-280	SNRPD3	Malignant cells	GSE164897_VemCob	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49078
9.97966839336553e-285	-0.322812571260498	0.112	0.364	1.58906259827559e-280	PRPF6	Malignant cells	GSE164897_VemCob	ENSG00000101161	24148	pre-mRNA processing factor 6	ANT-1|bB152O15.1|C20orf14|hPrp6|Prp6|RP60|SNRNP102|TOM|U5-102K	protein_coding	O94906	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49079
1.62025437326004e-284	-0.291431715064833	0.061	0.281	2.57993103854197e-280	CPNE1	Malignant cells	GSE164897_VemCob	ENSG00000214078	8904	copine 1	CPN1	protein_coding	Q99829	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49080
2.6828054448206e-284	-0.396156733641756	0.287	0.603	4.27183110978785e-280	AK2	Malignant cells	GSE164897_VemCob	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49081
9.0707224620741e-284	-0.337694757333302	0.163	0.44	1.44433113763606e-279	GTF2F1	Malignant cells	GSE164897_VemCob	ENSG00000125651	2962	general transcription factor IIF subunit 1	BTF4|RAP74|TF2F1|TFIIF	protein_coding	P35269	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49082
2.21459071573758e-283	-0.407617352349903	0.355	0.676	3.52629279666894e-279	UQCRC1	Malignant cells	GSE164897_VemCob	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49083
1.10007339871496e-282	-0.287479011528947	0.053	0.266	1.75164687277383e-278	TSEN15	Malignant cells	GSE164897_VemCob	ENSG00000198860	116461	tRNA splicing endonuclease subunit 15	C1orf19	protein_coding	Q8WW01	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49084
1.50462834337498e-282	-0.346990782889591	0.149	0.419	2.39581971115599e-278	MRPL15	Malignant cells	GSE164897_VemCob	ENSG00000137547	29088	mitochondrial ribosomal protein L15	HSPC145|L15mt|MRP-L15|MRP-L7|RPML7	protein_coding	Q9P015	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49085
1.8448096542503e-282	-0.321749070129251	0.051	0.26	2.93749041246276e-278	NMT2	Malignant cells	GSE164897_VemCob	ENSG00000152465	9397	N-myristoyltransferase 2	NA	protein_coding	O60551	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49086
2.16694359176165e-281	0.542084008749178	0.418	0.172	3.45042428116207e-277	TXNRD1	Malignant cells	GSE164897_VemCob	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49087
3.6099035806e-281	0.569042241302505	0.394	0.146	5.74804947138938e-277	NUSAP1	Malignant cells	GSE164897_VemCob	ENSG00000137804	51203	nucleolar and spindle associated protein 1	ANKT|BM037|FLJ13421|LNP|PRO0310p1|Q0310|SAPL	protein_coding	Q9BXS6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49088
3.31941960314291e-280	-0.311850715820759	0.089	0.326	5.28551183408445e-276	SMIM27	Malignant cells	GSE164897_VemCob	ENSG00000235453	100129250	small integral membrane protein 27	C9orf133|TOPORS-AS1	protein_coding	A0A1B0GUW7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49089
3.84110432633571e-280	-0.349750134541082	0.202	0.496	6.11619041882436e-276	DHX36	Malignant cells	GSE164897_VemCob	ENSG00000281763	170506	DEAH-box helicase 36	DDX36|KIAA1488|MLEL1|RHAU	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49090
9.43493604698401e-280	-0.362558681373373	0.275	0.595	1.50232486676126e-275	KRTCAP2	Malignant cells	GSE164897_VemCob	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49091
1.65075365830154e-279	0.459236756113437	0.294	0.068	2.62849505011354e-275	WNT5A	Malignant cells	GSE164897_VemCob	ENSG00000114251	7474	Wnt family member 5A	hWNT5A	protein_coding	P41221	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49092
1.67552023724107e-279	-0.308379110212648	0.09	0.327	2.66793087375896e-275	THOC5	Malignant cells	GSE164897_VemCob	ENSG00000100296	8563	THO complex subunit 5	C22orf19|Fmip|fSAP79|KIAA0983|PK1.3	protein_coding	Q13769	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49093
2.70098325072134e-279	0.630196993238334	0.624	0.454	4.30077563012359e-275	TCEAL4	Malignant cells	GSE164897_VemCob	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49094
1.11979374127126e-277	-0.277446441260944	0.051	0.259	1.78304757422623e-273	MTX2	Malignant cells	GSE164897_VemCob	ENSG00000128654	10651	metaxin 2	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49095
4.14132768950566e-277	-0.317815440808098	0.1	0.34	6.59423607999986e-273	AATF	Malignant cells	GSE164897_VemCob	ENSG00000276072	26574	apoptosis antagonizing transcription factor	BFR2|CHE-1|CHE1|DED	protein_coding	Q9NY61	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49096
7.29477947209241e-277	-0.329143248340231	0.123	0.376	1.16154773534127e-272	RFXANK	Malignant cells	GSE164897_VemCob	ENSG00000064490	8625	regulatory factor X associated ankyrin containing protein	ANKRA1|BLS|F14150_1|MGC138628|RFX-B	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49097
1.17364917054928e-276	-0.320966284838091	0.094	0.332	1.86880157426562e-272	FHL2	Malignant cells	GSE164897_VemCob	ENSG00000115641	2274	four and a half LIM domains 2	DRAL|SLIM3	protein_coding	Q14192	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49098
2.75871771728965e-276	-0.282273842600967	0.049	0.254	4.39270622124031e-272	LRRFIP2	Malignant cells	GSE164897_VemCob	ENSG00000093167	9209	LRR binding FLII interacting protein 2	HUFI-2	protein_coding	Q9Y608	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49099
6.18182859598466e-276	0.440886742190593	0.297	0.071	9.84332567338638e-272	CENPL	Malignant cells	GSE164897_VemCob	ENSG00000120334	91687	centromere protein L	C1orf155|dJ383J4.3|FLJ31044	protein_coding	Q8N0S6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49100
5.28017234247018e-274	-0.315734815071769	0.115	0.364	8.40761842091527e-270	EMD	Malignant cells	GSE164897_VemCob	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49101
1.24869283144407e-273	-0.289143506830881	0.05	0.253	1.98829359550839e-269	NIPAL3	Malignant cells	GSE164897_VemCob	ENSG00000001461	57185	NIPA like domain containing 3	DJ462O23.2|NPAL3|SLC57A5	protein_coding	Q6P499	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49102
1.30858259210327e-273	-0.279104902745788	0.051	0.256	2.08365606140604e-269	BOP1	Malignant cells	GSE164897_VemCob	ENSG00000285301	23246	BOP1 ribosomal biogenesis factor	KIAA0124	protein_coding	Q14137	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49103
7.32162392762178e-273	-0.375884946311764	0.333	0.662	1.16582217799522e-268	CCT8	Malignant cells	GSE164897_VemCob	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49104
2.15718853843466e-272	0.581418146661928	0.397	0.159	3.43489130974951e-268	NIBAN1	Malignant cells	GSE164897_VemCob	ENSG00000135842	116496	niban apoptosis regulator 1	C1orf24|FAM129A|GIG39|NIBAN	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49105
8.04252937548434e-272	-0.287491258992527	0.067	0.284	1.28061195245837e-267	HEXB	Malignant cells	GSE164897_VemCob	ENSG00000049860	3074	hexosaminidase subunit beta	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49106
4.66527571862419e-271	-0.310770834126213	0.124	0.379	7.4285185267653e-267	MED19	Malignant cells	GSE164897_VemCob	ENSG00000156603	219541	mediator complex subunit 19	LCMR1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49107
7.324350065557e-271	-0.294800858052512	0.072	0.292	1.16625626093864e-266	RBM42	Malignant cells	GSE164897_VemCob	ENSG00000126254	79171	RNA binding motif protein 42	MGC10433	protein_coding	Q9BTD8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49108
1.27000078920962e-270	-0.34152687124777	0.181	0.458	2.02222225665848e-266	NCOR1	Malignant cells	GSE164897_VemCob	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49109
1.7550623378482e-270	-0.33497293109981	0.156	0.423	2.79458576055569e-266	DCTN2	Malignant cells	GSE164897_VemCob	ENSG00000175203	10540	dynactin subunit 2	DCTN-50|RBP50	protein_coding	Q13561	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49110
5.07654240136882e-270	0.456789256803546	0.319	0.089	8.08337846569957e-266	RAI14	Malignant cells	GSE164897_VemCob	ENSG00000039560	26064	retinoic acid induced 14	DKFZp564G013|KIAA1334|NORPEG|RAI13	protein_coding	Q9P0K7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49111
5.8052966366947e-270	0.736856483028912	0.379	0.143	9.24377383460897e-266	DKK1	Malignant cells	GSE164897_VemCob	ENSG00000107984	22943	dickkopf WNT signaling pathway inhibitor 1	DKK-1|SK	protein_coding	O94907	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49112
2.07515966800924e-268	-0.296906198818917	0.07	0.288	3.30427673937111e-264	FLOT1	Malignant cells	GSE164897_VemCob	ENSG00000223654	10211	flotillin 1	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49113
4.31786185480762e-268	-0.278747581490539	0.062	0.274	6.87533143141017e-264	RNF115	Malignant cells	GSE164897_VemCob	ENSG00000265491	27246	ring finger protein 115	CL469780|ZNF364	protein_coding	Q9Y4L5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49114
6.36573921403757e-268	-0.34813583895877	0.194	0.475	1.0136166550512e-263	RPF2	Malignant cells	GSE164897_VemCob	ENSG00000197498	84154	ribosome production factor 2 homolog	bA397G5.4|BXDC1|FLJ21087	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49115
7.27855447312094e-267	-0.37051352610974	0.302	0.615	1.15896422875505e-262	PRKDC	Malignant cells	GSE164897_VemCob	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49116
7.9962072313763e-267	-0.390725421227834	0.244	0.542	1.27323607745205e-262	IER2	Malignant cells	GSE164897_VemCob	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49117
9.45788682322969e-267	-0.2825450016221	0.064	0.276	1.50597931886286e-262	CHID1	Malignant cells	GSE164897_VemCob	ENSG00000177830	66005	chitinase domain containing 1	FLJ42707|MGC3234|SI-CLP	protein_coding	Q9BWS9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49118
1.01426329827863e-266	-0.302338579772186	0.094	0.327	1.61501144984907e-262	PPCS	Malignant cells	GSE164897_VemCob	ENSG00000127125	79717	phosphopantothenoylcysteine synthetase	FLJ11838	protein_coding	Q9HAB8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49119
9.59353139648275e-266	0.474810782624571	0.271	0.058	1.52757800426195e-261	ADAMTS6	Malignant cells	GSE164897_VemCob	ENSG00000049192	11174	ADAM metallopeptidase with thrombospondin type 1 motif 6	ADAM-TS6	protein_coding	Q9UKP5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49120
1.3914322418286e-265	-0.390882130348532	0.443	0.764	2.21557755866369e-261	COPS6	Malignant cells	GSE164897_VemCob	ENSG00000168090	10980	COP9 signalosome subunit 6	CSN6|MOV34-34KD	protein_coding	Q7L5N1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49121
1.83624709246703e-265	-0.367737459628134	0.29	0.598	2.92385624533526e-261	IGBP1	Malignant cells	GSE164897_VemCob	ENSG00000089289	3476	immunoglobulin binding protein 1	alpha4|IBP1	protein_coding	P78318	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49122
5.21599453210831e-265	-0.304653963188455	0.097	0.33	8.30542809347607e-261	EIF2AK4	Malignant cells	GSE164897_VemCob	ENSG00000128829	440275	eukaryotic translation initiation factor 2 alpha kinase 4	GCN2|KIAA1338	protein_coding	Q9P2K8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49123
6.62178805235141e-265	-0.295227401545248	0.08	0.302	1.05438731157591e-260	CIAO1	Malignant cells	GSE164897_VemCob	ENSG00000144021	9391	cytosolic iron-sulfur assembly component 1	CIA1|WDR39	protein_coding	O76071	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49124
1.18340559476194e-264	-0.284729640555853	0.071	0.288	1.88433672853944e-260	FTSJ1	Malignant cells	GSE164897_VemCob	ENSG00000068438	24140	FtsJ RNA 2'-O-methyltransferase 1	CDLIV|JM23|MRX44|MRX9|SPB1|TRM7|TRMT7	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49125
1.33126463784693e-264	0.540559241786334	0.451	0.213	2.11977268284367e-260	CD68	Malignant cells	GSE164897_VemCob	ENSG00000129226	968	CD68 molecule	DKFZp686M18236|GP110|LAMP4|SCARD1	protein_coding	P34810	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49126
2.00041925192023e-264	-0.297527045373838	0.091	0.321	3.18526757483258e-260	MAPKAP1	Malignant cells	GSE164897_VemCob	ENSG00000119487	79109	MAPK associated protein 1	MGC2745|MIP1|SIN1	protein_coding	Q9BPZ7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49127
2.33929198126975e-264	-0.275594056764012	0.053	0.255	3.72485462177582e-260	PMPCA	Malignant cells	GSE164897_VemCob	ENSG00000165688	23203	peptidase, mitochondrial processing subunit alpha	Alpha-MPP|CLA1|INPP5E|KIAA0123|MAS2|SCAR2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49128
5.43549104689378e-264	-0.328344192633907	0.143	0.4	8.65493239396896e-260	LINC01029	Malignant cells	GSE164897_VemCob	ENSG00000265843	NA	NA	NA	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49129
7.26714179417233e-264	-0.384105913971413	0.127	0.372	1.15714698788606e-259	NNMT	Malignant cells	GSE164897_VemCob	ENSG00000166741	4837	nicotinamide N-methyltransferase	NA	protein_coding	P40261	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49130
1.40837714412658e-263	0.556165898191226	0.438	0.193	2.24255892659275e-259	PBK	Malignant cells	GSE164897_VemCob	ENSG00000168078	55872	PDZ binding kinase	CT84|FLJ14385|Nori-3|SPK|TOPK	protein_coding	Q96KB5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49131
1.43027673008121e-263	-0.310908551291691	0.108	0.349	2.27742963730831e-259	NDUFA10	Malignant cells	GSE164897_VemCob	ENSG00000130414	4705	NADH:ubiquinone oxidoreductase subunit A10	CI-42k	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49132
1.63025800668299e-263	-0.320310415974813	0.168	0.438	2.59585982404132e-259	MRPL45	Malignant cells	GSE164897_VemCob	ENSG00000277936	84311	mitochondrial ribosomal protein L45	Mba1|MGC11321	protein_coding	Q9BRJ2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49133
2.78006048469288e-263	-0.323337877391404	0.159	0.425	4.42669030977647e-259	ERLEC1	Malignant cells	GSE164897_VemCob	ENSG00000068912	27248	endoplasmic reticulum lectin 1	C2orf30|CL25084|ERLECTIN|XTP3-B|XTP3TPB	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49134
3.16680620441509e-263	-0.320384063915996	0.129	0.379	5.04250551929015e-259	TLE5	Malignant cells	GSE164897_VemCob	ENSG00000104964	166	TLE family member 5, transcriptional modulator	AES|GRG5	protein_coding	Q08117	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49135
3.13499586725418e-262	-0.31972762721022	0.127	0.375	4.99185391942883e-258	RNF145	Malignant cells	GSE164897_VemCob	ENSG00000145860	153830	ring finger protein 145	FLJ31951	protein_coding	Q96MT1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49136
3.97033834851836e-262	-0.287185123349895	0.081	0.303	6.32196975234578e-258	AP1M1	Malignant cells	GSE164897_VemCob	ENSG00000072958	8907	adaptor related protein complex 1 subunit mu 1	AP47|CLAPM2|mu1A	protein_coding	Q9BXS5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49137
4.01583871820477e-262	-0.285846892895051	0.063	0.273	6.39441999099746e-258	LINC00511	Malignant cells	GSE164897_VemCob	ENSG00000227036	400619	long intergenic non-protein coding RNA 511	onco-lncRNA-12	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49138
4.40658620027526e-262	-0.326134642126715	0.184	0.461	7.0166072066983e-258	ETF1	Malignant cells	GSE164897_VemCob	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49139
4.99575514972294e-262	-0.287988432445977	0.082	0.305	7.95474092490384e-258	FAM120AOS	Malignant cells	GSE164897_VemCob	ENSG00000188938	158293	family with sequence similarity 120A opposite strand	C9orf10OS	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49140
6.23317638412368e-262	-0.282315505420497	0.073	0.29	9.92508675644014e-258	RHBDD2	Malignant cells	GSE164897_VemCob	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49141
1.34312214178234e-261	-0.464511914434966	0.502	0.779	2.13865338636002e-257	JPT1	Malignant cells	GSE164897_VemCob	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49142
2.94894634480208e-261	0.58800468437333	0.666	0.52	4.69560726482836e-257	KPNB1	Malignant cells	GSE164897_VemCob	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49143
5.80243957177938e-261	-0.308259503066453	0.122	0.367	9.2392245301443e-257	THEM4	Malignant cells	GSE164897_VemCob	ENSG00000159445	117145	thioesterase superfamily member 4	CTMP	protein_coding	Q5T1C6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49144
1.40626975208818e-260	-0.318631850288029	0.106	0.345	2.23920332625001e-256	PMAIP1	Malignant cells	GSE164897_VemCob	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49145
6.68667545102764e-260	-0.330243929640302	0.177	0.447	1.06471933206713e-255	ITM2B	Malignant cells	GSE164897_VemCob	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49146
6.8102059215285e-260	-0.313255887961885	0.126	0.372	1.08438908888498e-255	DEF8	Malignant cells	GSE164897_VemCob	ENSG00000140995	54849	differentially expressed in FDCP 8 homolog	FLJ20186	protein_coding	Q6ZN54	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49147
1.01337832423611e-259	-0.335252489488227	0.171	0.437	1.61360230568115e-255	TMEM205	Malignant cells	GSE164897_VemCob	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49148
1.74516320183558e-259	-0.314945573108407	0.136	0.389	2.77882336628279e-255	DCTD	Malignant cells	GSE164897_VemCob	ENSG00000129187	1635	dCMP deaminase	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49149
5.23975120983639e-259	-0.334746310258666	0.224	0.515	8.34325585142248e-255	TIPRL	Malignant cells	GSE164897_VemCob	ENSG00000143155	261726	TOR signaling pathway regulator	dJ69E11.3|MGC3794|TIP41|TIPRL1	protein_coding	O75663	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49150
6.11413339705465e-258	0.374106320641097	0.262	0.054	9.73553460813012e-254	CDCP1	Malignant cells	GSE164897_VemCob	ENSG00000163814	64866	CUB domain containing protein 1	CD318|SIMA135	protein_coding	Q9H5V8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49151
2.36587992716359e-256	-0.275178164384544	0.058	0.259	3.76719060802258e-252	MELTF	Malignant cells	GSE164897_VemCob	ENSG00000163975	4241	melanotransferrin	CD228|FLJ38863|MAP97|MFI2|MGC4856|MTf|MTF1	protein_coding	P08582	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49152
3.28230568404798e-256	-0.295385819130419	0.094	0.323	5.22641534070959e-252	ILF3-DT	Malignant cells	GSE164897_VemCob	ENSG00000267100	147727	ILF3 divergent transcript	ILF3-AS1	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49153
4.18169154228762e-256	0.65559373328957	0.482	0.261	6.65850744278457e-252	PPP1CB	Malignant cells	GSE164897_VemCob	ENSG00000213639	5500	protein phosphatase 1 catalytic subunit beta	MP|PP-1B|PP1B|PP1beta|PP1c|PPP1beta	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49154
8.44099650112742e-256	-0.306986415031428	0.141	0.396	1.34405987287452e-251	LCMT1	Malignant cells	GSE164897_VemCob	ENSG00000205629	51451	leucine carboxyl methyltransferase 1	CGI-68|PPMT1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49155
1.13489812481589e-255	-0.301386568218235	0.107	0.344	1.80709828414434e-251	SERPINB1	Malignant cells	GSE164897_VemCob	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49156
2.15698967642439e-255	-0.291834553786993	0.084	0.304	3.43457466177056e-251	PON2	Malignant cells	GSE164897_VemCob	ENSG00000105854	5445	paraoxonase 2	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49157
2.71039937909321e-255	0.575646317868695	0.391	0.151	4.31576893133012e-251	CCNB1	Malignant cells	GSE164897_VemCob	ENSG00000134057	891	cyclin B1	CCNB	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49158
2.87538067723225e-255	-0.28894305594487	0.093	0.32	4.57846865235692e-251	DNAJA2	Malignant cells	GSE164897_VemCob	ENSG00000069345	10294	DnaJ heat shock protein family (Hsp40) member A2	CPR3|DNAJ|DNJ3|HIRIP4	protein_coding	O60884	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49159
5.05159974910846e-255	-0.313495508230525	0.118	0.358	8.0436622805054e-251	DALRD3	Malignant cells	GSE164897_VemCob	ENSG00000178149	55152	DALR anticodon binding domain containing 3	FLJ10496	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49160
9.27913778764012e-255	-0.281429400644802	0.067	0.274	1.47751710992594e-250	SHISA4	Malignant cells	GSE164897_VemCob	ENSG00000198892	149345	shisa family member 4	C1orf40|hShisa4|TMEM58	protein_coding	Q96DD7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49161
2.39611021222131e-253	0.584430445998962	0.664	0.529	3.81532629091999e-249	POLR2K	Malignant cells	GSE164897_VemCob	ENSG00000147669	5440	RNA polymerase II, I and III subunit K	RPB10alpha|RPB12	protein_coding	P53803	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49162
1.97251612993716e-252	-0.390729957743396	0.526	0.803	3.14083743369893e-248	FBL	Malignant cells	GSE164897_VemCob	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49163
2.38062908727652e-251	-0.285888223900969	0.079	0.294	3.7906756956704e-247	COA5	Malignant cells	GSE164897_VemCob	ENSG00000183513	493753	cytochrome c oxidase assembly factor 5	C2orf64|FLJ27524|MGC52110|Pet191	protein_coding	Q86WW8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49164
3.33885050908576e-251	-0.297920922334269	0.12	0.36	5.31645166561725e-247	LTA4H	Malignant cells	GSE164897_VemCob	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49165
1.08740410220132e-250	-0.288309530831654	0.098	0.326	1.73147355193515e-246	ADSS2	Malignant cells	GSE164897_VemCob	ENSG00000035687	159	adenylosuccinate synthase 2	ADSS	protein_coding	P30520	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49166
2.40389116714349e-250	-0.271350145242547	0.058	0.256	3.82771590544258e-246	WIPF1	Malignant cells	GSE164897_VemCob	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49167
1.59129304196447e-249	-0.331970393375507	0.214	0.494	2.53381591072002e-245	SLC25A37	Malignant cells	GSE164897_VemCob	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49168
6.63207837516881e-249	0.530001170772997	0.756	0.641	1.05602583967813e-244	ENY2	Malignant cells	GSE164897_VemCob	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49169
1.58116619283906e-247	-0.318505759344802	0.182	0.446	2.51769092885763e-243	STAU1	Malignant cells	GSE164897_VemCob	ENSG00000124214	6780	staufen double-stranded RNA binding protein 1	PPP1R150|STAU	protein_coding	O95793	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49170
3.72942629452287e-247	-0.279550168168054	0.076	0.287	5.93836548876877e-243	TMEM11	Malignant cells	GSE164897_VemCob	ENSG00000178307	8834	transmembrane protein 11	C17orf35|PM1|PMI	protein_coding	P17152	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49171
1.92577043403953e-246	-0.269273062825251	0.063	0.264	3.06640426212115e-242	MZT1	Malignant cells	GSE164897_VemCob	ENSG00000204899	440145	mitotic spindle organizing protein 1	C13orf37|FLJ21869|LOC440145|MGC150539|MOZART1|RP11-11C5.2	protein_coding	Q08AG7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49172
2.03957829438529e-246	-0.399632437365955	0.664	0.881	3.2476205181497e-242	PSMD4	Malignant cells	GSE164897_VemCob	ENSG00000159352	5710	proteasome 26S subunit ubiquitin receptor, non-ATPase 4	AF|AF-1|Rpn10|S5A	protein_coding	P55036	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49173
5.09175529949481e-246	-0.321084953739683	0.174	0.433	8.10760196338559e-242	EIF2B1	Malignant cells	GSE164897_VemCob	ENSG00000111361	1967	eukaryotic translation initiation factor 2B subunit alpha	EIF-2B|EIF-2Balpha|EIF2B|EIF2BA|EIF2Balpha	protein_coding	Q14232	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49174
1.10140739611812e-245	0.487759556288516	0.93	0.865	1.75377099683889e-241	SSBP1	Malignant cells	GSE164897_VemCob	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49175
1.10276034705067e-245	-0.297805010177313	0.116	0.35	1.75592530060879e-241	UTP4	Malignant cells	GSE164897_VemCob	ENSG00000262788	84916	UTP4 small subunit processome component	CIRH1A|CIRHIN|FLJ14728|KIAA1988|NAIC|TEX292	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49176
1.90839397593499e-245	0.512931704335633	0.751	0.638	3.03873572788128e-241	FIS1	Malignant cells	GSE164897_VemCob	ENSG00000214253	51024	fission, mitochondrial 1	CGI-135|H_NH0132A01.6|TTC11	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49177
2.12072128702191e-245	-0.308080870690241	0.144	0.392	3.37682450532498e-241	TIAL1	Malignant cells	GSE164897_VemCob	ENSG00000151923	7073	TIA1 cytotoxic granule associated RNA binding protein like 1	TIAR	protein_coding	Q01085	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49178
4.56508716290756e-245	0.585085783335337	0.576	0.396	7.2689882894977e-241	PRDX3	Malignant cells	GSE164897_VemCob	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49179
1.2993708865462e-244	-0.324187957715719	0.237	0.52	2.06898826264752e-240	APH1A	Malignant cells	GSE164897_VemCob	ENSG00000117362	51107	aph-1 homolog A, gamma-secretase subunit	APH-1A|CGI-78	protein_coding	Q96BI3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49180
2.38305521011825e-244	0.527609204571609	0.783	0.672	3.79453881107129e-240	DDX5	Malignant cells	GSE164897_VemCob	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49181
5.17127576747103e-244	0.639260858733051	0.334	0.12	8.23422240454412e-240	NCAPD2	Malignant cells	GSE164897_VemCob	ENSG00000010292	9918	non-SMC condensin I complex subunit D2	CAP-D2|CNAP1|hCAP-D2|KIAA0159	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49182
2.79210416547699e-243	0.495128802355268	0.806	0.699	4.44586746268901e-239	PGAM1	Malignant cells	GSE164897_VemCob	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49183
7.51999756228623e-242	-0.323176698518343	0.205	0.474	1.19740921184284e-237	QARS1	Malignant cells	GSE164897_VemCob	ENSG00000172053	5859	glutaminyl-tRNA synthetase 1	QARS	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49184
4.28504228855882e-241	-0.323851159921636	0.192	0.453	6.82307283607221e-237	PSMG3	Malignant cells	GSE164897_VemCob	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49185
6.68428644526272e-241	0.504274682183942	0.855	0.792	1.06433893067918e-236	ATP5PO	Malignant cells	GSE164897_VemCob	ENSG00000241837	539	ATP synthase peripheral stalk subunit OSCP	ATP5O|ATPO|OSCP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49186
1.57075311940236e-240	-0.287666260264363	0.083	0.293	2.50111019202438e-236	NIBAN2	Malignant cells	GSE164897_VemCob	ENSG00000136830	64855	niban apoptosis regulator 2	bA356B19.6|C9orf88|DKFZP434H0820|FAM129B|FLJ13518|FLJ22151|FLJ22298|MINERVA	protein_coding	Q96TA1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49187
3.35967328814274e-240	-0.391312024293495	0.716	0.901	5.34960777670968e-236	EIF3H	Malignant cells	GSE164897_VemCob	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49188
1.30006829004524e-239	-0.317450596236139	0.235	0.517	2.07009873823903e-235	TATDN1	Malignant cells	GSE164897_VemCob	ENSG00000147687	83940	TatD DNase domain containing 1	CDA11	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49189
1.45714911182214e-239	-0.263812705371646	0.058	0.251	2.3202185307544e-235	YEATS4	Malignant cells	GSE164897_VemCob	ENSG00000127337	8089	YEATS domain containing 4	GAS41|NuBI-1|YAF9	protein_coding	O95619	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49190
2.68356386661013e-239	0.379152417212782	0.275	0.07	4.27303874480331e-235	COX16	Malignant cells	GSE164897_VemCob	ENSG00000133983	51241	cytochrome c oxidase assembly factor COX16	C14orf112|HSPC203	protein_coding	Q9P0S2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49191
6.67906713851875e-239	-0.354245971833134	0.261	0.543	1.06350786046634e-234	NOP56	Malignant cells	GSE164897_VemCob	ENSG00000101361	10528	NOP56 ribonucleoprotein	NOL5A|SCA36	protein_coding	O00567	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49192
1.34527764061782e-238	-0.256391306192018	0.058	0.251	2.14208558715575e-234	TIMM22	Malignant cells	GSE164897_VemCob	ENSG00000278501	29928	translocase of inner mitochondrial membrane 22	TEX4|TIM22	protein_coding	Q9Y584	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49193
1.97224281525801e-238	-0.344825195876524	0.315	0.616	3.14040223473533e-234	EI24	Malignant cells	GSE164897_VemCob	ENSG00000149547	9538	EI24 autophagy associated transmembrane protein	EPG4|PIG8|TP53I8	protein_coding	O14681	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49194
2.25326088094052e-238	0.400707660575834	0.267	0.065	3.58786730072159e-234	EDEM3	Malignant cells	GSE164897_VemCob	ENSG00000116406	80267	ER degradation enhancing alpha-mannosidase like protein 3	C1orf22	protein_coding	Q9BZQ6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49195
3.40366782404576e-238	-0.334587886906977	0.235	0.51	5.41966027622806e-234	PARP1	Malignant cells	GSE164897_VemCob	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49196
7.99088079619611e-238	-0.26350045265618	0.064	0.261	1.27238794917831e-233	C16orf91	Malignant cells	GSE164897_VemCob	ENSG00000174109	283951	chromosome 16 open reading frame 91	CCSMST1|gs103|URLC5	protein_coding	Q4G0I0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49197
2.4405051913017e-237	-0.281849573915138	0.099	0.319	3.88601641610969e-233	DBNL	Malignant cells	GSE164897_VemCob	ENSG00000136279	28988	drebrin like	ABP1|HIP-55|SH3P7	protein_coding	Q9UJU6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49198
1.67324868019206e-236	-0.297881880312205	0.15	0.396	2.66431387346982e-232	EWSR1	Malignant cells	GSE164897_VemCob	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49199
3.42981364367766e-236	-0.273468554869346	0.064	0.259	5.46129226482794e-232	DLGAP1-AS1	Malignant cells	GSE164897_VemCob	ENSG00000177337	NA	NA	FLJ35776|HsT914	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49200
2.6033246333168e-235	-0.264402832040176	0.066	0.263	4.14527381363034e-231	FKBP11	Malignant cells	GSE164897_VemCob	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49201
8.10520945680511e-235	-0.314132499831074	0.168	0.419	1.29059250180708e-230	ATIC	Malignant cells	GSE164897_VemCob	ENSG00000138363	471	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	AICARFT|IMPCHASE|PURH	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49202
7.83463878292841e-234	-0.351224560974742	0.356	0.66	1.24750953340569e-229	PPM1G	Malignant cells	GSE164897_VemCob	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49203
1.37327304005514e-233	0.53911763884167	0.684	0.56	2.18666266167979e-229	PRRC2C	Malignant cells	GSE164897_VemCob	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49204
1.81165118860593e-233	-0.270824048602162	0.089	0.3	2.88469218761722e-229	CYREN	Malignant cells	GSE164897_VemCob	ENSG00000122783	78996	cell cycle regulator of NHEJ	C7orf49|FLJ22450|FLJ27285|MGC5242|MRI|MRI-2	protein_coding	Q9BWK5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49205
6.74182158428031e-233	-0.350281443048103	0.252	0.528	1.07350025086495e-228	NFE2L2	Malignant cells	GSE164897_VemCob	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49206
1.51284609074748e-232	-0.25099493614304	0.061	0.254	2.40890483029721e-228	TMEM69	Malignant cells	GSE164897_VemCob	ENSG00000159596	51249	transmembrane protein 69	C1orf154|FLJ21029	protein_coding	Q5SWH9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49207
3.13807873817999e-232	-0.263594664479107	0.079	0.284	4.996762774804e-228	HDAC3	Malignant cells	GSE164897_VemCob	ENSG00000171720	8841	histone deacetylase 3	HD3|KDAC3|RPD3|RPD3-2	protein_coding	O15379	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49208
5.31194616902791e-232	-0.251745609552892	0.06	0.25	8.45821188494314e-228	ACOT8	Malignant cells	GSE164897_VemCob	ENSG00000101473	10005	acyl-CoA thioesterase 8	hACTE-III|hTE|NAP1|PTE-2|PTE1	protein_coding	O14734	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49209
1.7043403149321e-231	-0.332895811973379	0.355	0.664	2.71382108346638e-227	USE1	Malignant cells	GSE164897_VemCob	ENSG00000053501	55850	unconventional SNARE in the ER 1	D12|MDS032|p31|SLT1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49210
4.23304906209243e-231	0.544755510331845	0.524	0.313	6.74028402156977e-227	CYTOR	Malignant cells	GSE164897_VemCob	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49211
4.59377348926433e-231	0.624376922169068	0.499	0.3	7.31466552695559e-227	MT-ND6	Malignant cells	GSE164897_VemCob	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49212
6.23025672231741e-231	-0.325931830412766	0.104	0.321	9.92043777894601e-227	FRMD4A	Malignant cells	GSE164897_VemCob	ENSG00000151474	55691	FERM domain containing 4A	bA295P9.4|FLJ10210|FRMD4|KIAA1294	protein_coding	Q9P2Q2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49213
6.77919364067647e-231	-0.294023182026048	0.17	0.424	1.07945100340491e-226	C5orf24	Malignant cells	GSE164897_VemCob	ENSG00000181904	134553	chromosome 5 open reading frame 24	FLJ37562	protein_coding	Q7Z6I8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49214
8.20214398571868e-231	-0.262855305014209	0.076	0.278	1.30602738684599e-226	DHX29	Malignant cells	GSE164897_VemCob	ENSG00000067248	54505	DExH-box helicase 29	DDX29	protein_coding	Q7Z478	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49215
6.42983596867793e-230	-0.318781883055924	0.196	0.453	1.02382278129259e-225	SRSF10	Malignant cells	GSE164897_VemCob	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49216
2.75552124163001e-229	0.479524805964596	0.875	0.785	4.38761647304746e-225	CYCS	Malignant cells	GSE164897_VemCob	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49217
3.15544153866039e-229	-0.280464513997371	0.103	0.32	5.02440956200894e-225	CARS1	Malignant cells	GSE164897_VemCob	ENSG00000278191	833	cysteinyl-tRNA synthetase 1	CARS	protein_coding	P49589	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49218
9.1573013827317e-229	-0.301739155967253	0.187	0.445	1.45811709917237e-224	MRPS35	Malignant cells	GSE164897_VemCob	ENSG00000061794	60488	mitochondrial ribosomal protein S35	MDS023|MRPS28	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49219
1.03388241283006e-228	-0.266214278031373	0.085	0.292	1.64625096594931e-224	MKRN1	Malignant cells	GSE164897_VemCob	ENSG00000133606	23608	makorin ring finger protein 1	RNF61	protein_coding	Q9UHC7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49220
2.21506570820663e-228	-0.275074417938239	0.111	0.333	3.52704912717742e-224	SH3GLB1	Malignant cells	GSE164897_VemCob	ENSG00000097033	51100	SH3 domain containing GRB2 like, endophilin B1	Bif-1|CGI-61|KIAA0491|PPP1R70	protein_coding	Q9Y371	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49221
2.47291198173551e-228	-0.293510519988622	0.163	0.412	3.93761774851745e-224	ETFA	Malignant cells	GSE164897_VemCob	ENSG00000140374	2108	electron transfer flavoprotein subunit alpha	EMA|GA2|MADD	protein_coding	P13804	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49222
3.49301986166218e-228	-0.324339930822946	0.322	0.618	5.56193552572468e-224	TXN2	Malignant cells	GSE164897_VemCob	ENSG00000100348	25828	thioredoxin 2	MT-TRX	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49223
3.93257898072317e-228	-0.312124599362268	0.197	0.458	6.2618455110055e-224	PDIA3	Malignant cells	GSE164897_VemCob	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49224
1.1516674068344e-227	0.480818804741793	0.366	0.147	1.83380001190241e-223	MYEOV	Malignant cells	GSE164897_VemCob	ENSG00000172927	26579	myeloma overexpressed	OCIM	protein_coding	Q96EZ4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49225
1.57668213545182e-227	-0.251364181352334	0.067	0.261	2.51055096427994e-223	SFXN4	Malignant cells	GSE164897_VemCob	ENSG00000183605	119559	sideroflexin 4	SLC56A4	protein_coding	Q6P4A7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49226
2.59072492082234e-226	-0.297771685002994	0.192	0.451	4.12521129142542e-222	PTS	Malignant cells	GSE164897_VemCob	ENSG00000150787	5805	6-pyruvoyltetrahydropterin synthase	PTPS	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49227
3.49323813298464e-226	-0.26760781735287	0.099	0.314	5.56228307915145e-222	ARL16	Malignant cells	GSE164897_VemCob	ENSG00000214087	339231	ADP ribosylation factor like GTPase 16	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49228
6.08934103651114e-226	-0.252492272530236	0.062	0.251	9.69605773243668e-222	SNRNP40	Malignant cells	GSE164897_VemCob	ENSG00000060688	9410	small nuclear ribonucleoprotein U5 subunit 40	HPRP8BP|PRP8BP|PRPF8BP|SPF38|WDR57	protein_coding	Q96DI7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49229
6.63072321074475e-226	-0.258525271197814	0.079	0.28	1.05581005684689e-221	HEBP1	Malignant cells	GSE164897_VemCob	ENSG00000013583	50865	heme binding protein 1	HBP|HEBP	protein_coding	Q9NRV9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49230
1.49661806226363e-225	-0.259916092055829	0.085	0.291	2.38306494054238e-221	SLC25A26	Malignant cells	GSE164897_VemCob	ENSG00000282739	115286	solute carrier family 25 member 26	NA	protein_coding	Q70HW3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49231
3.62966589894617e-225	-0.270725044489662	0.103	0.319	5.77951701089198e-221	MEAF6	Malignant cells	GSE164897_VemCob	ENSG00000163875	64769	MYST/Esa1 associated factor 6	C1orf149|CENP-28|Eaf6|FLJ11730|NY-SAR-91	protein_coding	Q9HAF1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49232
1.36085615639727e-224	-0.279570626632883	0.11	0.327	2.16689125783137e-220	RNASEH1-DT	Malignant cells	GSE164897_VemCob	ENSG00000234171	100506054	RNASEH1 divergent transcript	LOC100506054|RNASEH1-AS1	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49233
2.30207088117335e-224	-0.277634480735569	0.105	0.32	3.66558746409233e-220	TRIM28	Malignant cells	GSE164897_VemCob	ENSG00000130726	10155	tripartite motif containing 28	KAP-1|KAP1|PPP1R157|RNF96|TF1B|TIF1-beta|TIF1B|TIF1beta	protein_coding	Q13263	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49234
2.50466817165291e-224	0.52326023677935	0.507	0.306	3.98818312972292e-220	CDC26	Malignant cells	GSE164897_VemCob	ENSG00000176386	246184	cell division cycle 26	ANAPC12|APC12|C9orf17	protein_coding	Q8NHZ8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49235
4.26581842069863e-224	-0.250194934291102	0.062	0.25	6.79246267127843e-220	RNASEH2B	Malignant cells	GSE164897_VemCob	ENSG00000136104	79621	ribonuclease H2 subunit B	AGS2|DLEU8|FLJ11712	protein_coding	Q5TBB1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49236
6.367892947039e-224	-0.271762533344924	0.11	0.329	1.01395959395702e-219	TIMM23	Malignant cells	GSE164897_VemCob	ENSG00000265354	100287932	translocase of inner mitochondrial membrane 23	TIM23	protein_coding	O14925	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49237
1.77515317085071e-223	-0.296495253365403	0.194	0.451	2.82657639394558e-219	METTL9	Malignant cells	GSE164897_VemCob	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49238
2.35817369600228e-223	-0.316287847107654	0.278	0.56	3.75491997614444e-219	SCAMP3	Malignant cells	GSE164897_VemCob	ENSG00000263290	10067	secretory carrier membrane protein 3	C1orf3	protein_coding	O14828	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49239
3.25220823700729e-223	-0.260068226617407	0.083	0.284	5.17849117578671e-219	EIPR1	Malignant cells	GSE164897_VemCob	ENSG00000032389	7260	EARP complex and GARP complex interacting protein 1	EIPR-1|TSSC1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49240
7.51600842844358e-223	-0.267191432058931	0.087	0.291	1.19677402206107e-218	APMAP	Malignant cells	GSE164897_VemCob	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49241
1.89801384737836e-222	0.579486788525331	0.635	0.5	3.02220744918056e-218	CDC42	Malignant cells	GSE164897_VemCob	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49242
6.25456557812512e-222	-0.315184441805418	0.308	0.603	9.95914477004863e-218	KDELR2	Malignant cells	GSE164897_VemCob	ENSG00000136240	11014	KDEL endoplasmic reticulum protein retention receptor 2	ELP-1|ERD2.2	protein_coding	P33947	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49243
2.91650050935379e-221	-0.304086251777968	0.168	0.41	4.64394376104404e-217	SEPTIN9	Malignant cells	GSE164897_VemCob	ENSG00000282302	10801	septin 9	AF17q25|KIAA0991|MSF|MSF1|PNUTL4|SEPT9|SeptD1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49244
3.28304928295143e-221	-0.331204062110601	0.362	0.664	5.22759937324356e-217	MTCH2	Malignant cells	GSE164897_VemCob	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49245
4.46724511594867e-221	0.317753810674078	1	0.999	7.11319439812506e-217	RPL36A	Malignant cells	GSE164897_VemCob	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49246
7.06815884919588e-220	-0.259340738331303	0.08	0.278	1.12546293355746e-215	RMDN1	Malignant cells	GSE164897_VemCob	ENSG00000176623	51115	regulator of microtubule dynamics 1	CGI-90|FAM82B|FLJ20665|RMD1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49247
1.24975446323253e-219	-0.324506570817609	0.292	0.576	1.98998403180515e-215	DNAJB6	Malignant cells	GSE164897_VemCob	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49248
2.79491491648304e-219	0.575947670771348	0.574	0.419	4.45034302151595e-215	NUDT5	Malignant cells	GSE164897_VemCob	ENSG00000165609	11164	nudix hydrolase 5	hYSAH1|YSA1H	protein_coding	Q9UKK9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49249
4.76232790300051e-218	-0.253097924074731	0.067	0.255	7.58305471994771e-214	DUSP14	Malignant cells	GSE164897_VemCob	ENSG00000275932	11072	dual specificity phosphatase 14	MKP-L|MKP6	protein_coding	O95147	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49250
5.28085523158923e-218	-0.282990833412672	0.146	0.381	8.40870578525953e-214	ARGLU1	Malignant cells	GSE164897_VemCob	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49251
8.42324512982703e-218	0.389407636049707	0.252	0.064	1.34123332202236e-213	IQSEC2	Malignant cells	GSE164897_VemCob	ENSG00000124313	23096	IQ motif and Sec7 domain ArfGEF 2	BRAG1|IQ-ArfGEF|KIAA0522|MRX1|MRX18|MRX78	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49252
3.26921740221945e-217	-0.260548650586861	0.068	0.255	5.20557486955404e-213	CDCA4	Malignant cells	GSE164897_VemCob	ENSG00000170779	55038	cell division cycle associated 4	FLJ20764|Hepp	protein_coding	Q9BXL8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49253
8.89482046829998e-217	-0.283596003907343	0.178	0.424	1.41632226316741e-212	YIPF3	Malignant cells	GSE164897_VemCob	ENSG00000137207	25844	Yip1 domain family member 3	C6orf109|dJ337H4.3|DKFZp566C243|FinGER3|KLIP1	protein_coding	Q9GZM5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49254
1.29875938483153e-216	-0.281975296140543	0.134	0.36	2.06801456846724e-212	LARP7	Malignant cells	GSE164897_VemCob	ENSG00000174720	51574	La ribonucleoprotein 7, transcriptional regulator	DKFZP564K112|HDCMA18P|PIP7S	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49255
9.6472403100618e-216	-0.250435267227894	0.069	0.257	1.53613007457114e-211	UBXN6	Malignant cells	GSE164897_VemCob	ENSG00000167671	80700	UBX domain protein 6	UBXD1|UBXDC2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49256
1.1448921974001e-215	-0.251409948020125	0.075	0.268	1.82301184592018e-211	RXYLT1	Malignant cells	GSE164897_VemCob	ENSG00000118600	10329	ribitol xylosyltransferase 1	HP10481|TMEM5	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49257
2.26870544519271e-215	0.547507021618276	0.655	0.543	3.61245968038034e-211	NDUFA6	Malignant cells	GSE164897_VemCob	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49258
4.84619496622174e-215	0.562198594879346	0.505	0.32	7.71659624471488e-211	ORMDL2	Malignant cells	GSE164897_VemCob	ENSG00000123353	29095	ORMDL sphingolipid biosynthesis regulator 2	adoplin-2|HSPC160|MST095|MSTP095	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49259
4.95394009338702e-215	-0.254434665193631	0.082	0.28	7.88815881070015e-211	BLVRB	Malignant cells	GSE164897_VemCob	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49260
5.82935692208293e-215	-0.282077577120139	0.166	0.405	9.28208502703265e-211	SUMF2	Malignant cells	GSE164897_VemCob	ENSG00000129103	25870	sulfatase modifying factor 2	DKFZp566I1024	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49261
6.21265114886892e-215	-0.320878470581797	0.309	0.591	9.89240442434398e-211	EIF4H	Malignant cells	GSE164897_VemCob	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49262
1.00409863412729e-214	-0.318148670577961	0.298	0.579	1.59882625512088e-210	DAP3	Malignant cells	GSE164897_VemCob	ENSG00000132676	7818	death associated protein 3	bMRP-10|DAP-3|DKFZp686G12159|MGC126058|MGC126059|MRP-S29|MRPS29	protein_coding	P51398	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49263
1.74051902615629e-214	-0.294134686959124	0.193	0.444	2.77142844534866e-210	PMPCB	Malignant cells	GSE164897_VemCob	ENSG00000105819	9512	peptidase, mitochondrial processing subunit beta	beta-MPP|MAS1|MPPB|MPPP52	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49264
5.37413094778198e-214	0.595179140982417	0.566	0.408	8.55722870815325e-210	MDH1	Malignant cells	GSE164897_VemCob	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49265
7.64837336870132e-214	-0.291145017280743	0.177	0.422	1.21785049149831e-209	CMTM6	Malignant cells	GSE164897_VemCob	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49266
3.76367028892448e-213	0.576568962218369	0.581	0.423	5.99289220105445e-209	ARF4	Malignant cells	GSE164897_VemCob	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49267
5.95021782822162e-213	-0.307016770896718	0.246	0.513	9.47453184787728e-209	PWP1	Malignant cells	GSE164897_VemCob	ENSG00000136045	11137	PWP1 homolog, endonuclein	IEF-SSP-9502	protein_coding	Q13610	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49268
2.72008797994173e-212	-0.296179446429317	0.177	0.416	4.33119609046122e-208	PLOD3	Malignant cells	GSE164897_VemCob	ENSG00000106397	8985	procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	LH3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49269
3.96146893424729e-212	-0.272811529814711	0.115	0.329	6.30784698400197e-208	DNPEP	Malignant cells	GSE164897_VemCob	ENSG00000123992	23549	aspartyl aminopeptidase	ASPEP|DAP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49270
5.598221376011e-212	-0.255737991817023	0.083	0.277	8.91404789702231e-208	ARMC6	Malignant cells	GSE164897_VemCob	ENSG00000105676	93436	armadillo repeat containing 6	MGC19595	protein_coding	Q6NXE6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49271
1.68841673378663e-211	-0.250388596781672	0.085	0.282	2.68846596520846e-207	FBXO22	Malignant cells	GSE164897_VemCob	ENSG00000167196	26263	F-box protein 22	FBX22|FISTC1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49272
2.8687826013403e-211	-0.271682405757761	0.12	0.336	4.56796253611416e-207	PTPN12	Malignant cells	GSE164897_VemCob	ENSG00000127947	5782	protein tyrosine phosphatase non-receptor type 12	PTP-PEST|PTPG1	protein_coding	Q05209	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49273
4.4959006996933e-211	0.525283696177807	0.893	0.841	7.15882268412165e-207	PPIB	Malignant cells	GSE164897_VemCob	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49274
9.85321938022845e-211	0.526175432382732	0.5	0.312	1.56892812191378e-206	TIMM10	Malignant cells	GSE164897_VemCob	ENSG00000134809	26519	translocase of inner mitochondrial membrane 10	TIM10|TIM10A|TIMM10A	protein_coding	P62072	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49275
1.9756216058962e-210	-0.280859885853176	0.144	0.371	3.14578228306852e-206	PTMS	Malignant cells	GSE164897_VemCob	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49276
3.69268746879381e-210	-0.253909034600366	0.074	0.261	5.87986625656038e-206	CCDC86	Malignant cells	GSE164897_VemCob	ENSG00000110104	79080	coiled-coil domain containing 86	cyclon|MGC2574	protein_coding	Q9H6F5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49277
4.53999455381241e-210	-0.353577819912268	0.491	0.769	7.22903332803551e-206	POLR1D	Malignant cells	GSE164897_VemCob	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49278
1.82655568418715e-209	-0.321540060398288	0.377	0.672	2.9084246159312e-205	MACROH2A1	Malignant cells	GSE164897_VemCob	ENSG00000113648	9555	macroH2A.1 histone	H2AFY|macroH2A1.2	protein_coding	O75367	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49279
5.25657950796475e-209	0.513328226571916	0.428	0.224	8.37005155053227e-205	HPCAL1	Malignant cells	GSE164897_VemCob	ENSG00000115756	3241	hippocalcin like 1	BDR1|HLP2|VILIP-3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49280
1.53505550564799e-208	-0.257088350522047	0.103	0.309	2.4442688816433e-204	PPP6C	Malignant cells	GSE164897_VemCob	ENSG00000119414	5537	protein phosphatase 6 catalytic subunit	PP6	protein_coding	O00743	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49281
1.73625455551362e-208	-0.275370475124156	0.139	0.363	2.76463812874434e-204	SLC35B1	Malignant cells	GSE164897_VemCob	ENSG00000121073	10237	solute carrier family 35 member B1	AXER|UGTREL1	protein_coding	P78383	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49282
2.10516498037179e-208	-0.271774163105354	0.152	0.383	3.35205419824601e-204	TSG101	Malignant cells	GSE164897_VemCob	ENSG00000074319	7251	tumor susceptibility 101	TSG10|VPS23	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49283
3.87759523813401e-208	-0.293778528661962	0.275	0.549	6.17429489768079e-204	CYB5R3	Malignant cells	GSE164897_VemCob	ENSG00000100243	1727	cytochrome b5 reductase 3	DIA1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49284
5.42791994849596e-208	-0.369778848602122	0.474	0.744	8.64287693399011e-204	RNPS1	Malignant cells	GSE164897_VemCob	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49285
7.00563162512992e-208	-0.31472116166245	0.231	0.483	1.11550672366944e-203	PLAAT3	Malignant cells	GSE164897_VemCob	ENSG00000176485	11145	phospholipase A and acyltransferase 3	AdPLA|H-REV107-1|HRASLS3|HREV107|HREV107-3|MGC118754.|PLA2G16|PLAAT-3	protein_coding	P53816	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49286
8.90340344247767e-208	0.515634187040441	0.664	0.548	1.41768893014572e-203	SELENOK	Malignant cells	GSE164897_VemCob	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49287
6.38761519403793e-207	-0.272238991149113	0.135	0.354	1.01709996734666e-202	GLO1	Malignant cells	GSE164897_VemCob	ENSG00000124767	2739	glyoxalase I	GLOD1	protein_coding	Q04760	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49288
2.9966671425279e-206	-0.262257421352484	0.102	0.306	4.77159309104718e-202	GNL2	Malignant cells	GSE164897_VemCob	ENSG00000134697	29889	G protein nucleolar 2	HUMAUANTIG|Ngp-1|Nog2|Nug2	protein_coding	Q13823	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49289
6.00724342792826e-206	0.405033299466752	0.977	0.952	9.56533371029017e-202	MRPS21	Malignant cells	GSE164897_VemCob	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49290
4.31700902180925e-205	-0.306932660320384	0.158	0.387	6.87397346542687e-201	PTP4A1	Malignant cells	GSE164897_VemCob	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49291
2.37240388194661e-204	-0.283040316493612	0.177	0.415	3.77757870122359e-200	WARS1	Malignant cells	GSE164897_VemCob	ENSG00000140105	7453	tryptophanyl-tRNA synthetase 1	IFI53|IFP53|WARS	protein_coding	P23381	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49292
2.97547292471026e-204	-0.272666250726277	0.12	0.332	4.73784553801615e-200	CCDC28B	Malignant cells	GSE164897_VemCob	ENSG00000160050	79140	coiled-coil domain containing 28B	MGC1203|RP4-622L5.5	protein_coding	Q9BUN5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49293
4.80593373766448e-204	-0.283417083355231	0.17	0.402	7.65248829048316e-200	RCN1	Malignant cells	GSE164897_VemCob	ENSG00000049449	5954	reticulocalbin 1	FLJ37041|PIG20|Rcal|RCN	protein_coding	Q15293	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49294
7.78753164295836e-204	-0.280174775470722	0.216	0.471	1.24000866350826e-199	CNIH1	Malignant cells	GSE164897_VemCob	ENSG00000100528	10175	cornichon family AMPA receptor auxiliary protein 1	CNIH|CNIL|TGAM77	protein_coding	O95406	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49295
1.10945213993572e-203	-0.256409446365367	0.087	0.281	1.76658064241965e-199	NUMB	Malignant cells	GSE164897_VemCob	ENSG00000133961	8650	NUMB endocytic adaptor protein	C14orf41	protein_coding	P49757	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49296
1.63509525603556e-203	-0.321830219238386	0.381	0.672	2.60356217618542e-199	CCT4	Malignant cells	GSE164897_VemCob	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49297
8.18139736743457e-203	-0.255933528876988	0.118	0.328	1.30272390281661e-198	NKIRAS2	Malignant cells	GSE164897_VemCob	ENSG00000168256	28511	NFKB inhibitor interacting Ras like 2	DKFZP434N1526|kappaB-Ras2|KBRAS2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49298
1.12647086741111e-202	-0.259372649061519	0.121	0.333	1.79367956217872e-198	TMEM18	Malignant cells	GSE164897_VemCob	ENSG00000151353	129787	transmembrane protein 18	DKFZp434C1714|lncND	protein_coding	Q96B42	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49299
1.56749953012963e-202	-0.277041276747622	0.163	0.392	2.4959295018254e-198	RTL8A	Malignant cells	GSE164897_VemCob	ENSG00000203950	26071	retrotransposon Gag like 8A	CXX1b|DKFZP564B147|FAM127B|MAR8A|SIRH6	protein_coding	Q9BWD3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49300
1.29088159028223e-201	0.44367593249814	0.881	0.806	2.05547075620639e-197	SRSF3	Malignant cells	GSE164897_VemCob	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49301
1.30086316613104e-200	-0.266002889125089	0.135	0.351	2.07136441943046e-196	SZRD1	Malignant cells	GSE164897_VemCob	ENSG00000055070	26099	SUZ RNA binding domain containing 1	C1orf144|DKFZp566C0424	protein_coding	Q7Z422	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49302
3.28864090283131e-199	0.525154200808596	0.523	0.351	5.2365029095783e-195	HNRNPAB	Malignant cells	GSE164897_VemCob	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49303
8.24429718548897e-199	-0.28412173386822	0.218	0.468	1.31273944084541e-194	XRN2	Malignant cells	GSE164897_VemCob	ENSG00000088930	22803	5'-3' exoribonuclease 2	NA	protein_coding	Q9H0D6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49304
1.39897305894131e-198	-0.267466906596723	0.098	0.295	2.22758480175226e-194	GSN	Malignant cells	GSE164897_VemCob	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49305
2.51616277507754e-198	0.495458323467323	0.502	0.32	4.00648598675597e-194	HMGN3	Malignant cells	GSE164897_VemCob	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49306
2.84776343479832e-198	-0.305340133483226	0.363	0.648	4.53449371722936e-194	BABAM1	Malignant cells	GSE164897_VemCob	ENSG00000105393	29086	BRISC and BRCA1 A complex member 1	C19orf62|FLJ20571|HSPC142|MERIT40|NBA1	protein_coding	Q9NWV8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49307
1.32425796148323e-197	-0.255521413393605	0.096	0.289	2.10861595206974e-193	HLA-E	Malignant cells	GSE164897_VemCob	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49308
1.75426736920811e-197	-0.252638006617492	0.093	0.286	2.79331993199007e-193	TRUB2	Malignant cells	GSE164897_VemCob	ENSG00000167112	26995	TruB pseudouridine synthase family member 2	CLONE24922	protein_coding	O95900	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49309
4.58342759466731e-197	-0.252410773748244	0.113	0.317	7.29819175898876e-193	MRPS27	Malignant cells	GSE164897_VemCob	ENSG00000113048	23107	mitochondrial ribosomal protein S27	KIAA0264	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49310
6.30718451873612e-197	-0.270220479806818	0.144	0.362	1.00429299091835e-192	CTSA	Malignant cells	GSE164897_VemCob	ENSG00000064601	5476	cathepsin A	GSL|PPGB	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49311
4.59592905100898e-196	-0.287339279050239	0.198	0.437	7.3180978279216e-192	ANXA5	Malignant cells	GSE164897_VemCob	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49312
9.64494478255932e-196	-0.268892868931006	0.159	0.383	1.53576455772692e-191	SUMO3	Malignant cells	GSE164897_VemCob	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49313
1.93484889885191e-194	-0.255905558918629	0.117	0.32	3.08085990164189e-190	IFT57	Malignant cells	GSE164897_VemCob	ENSG00000114446	55081	intraflagellar transport 57	ESRRBL1|FLJ10147|HIPPI|MHS4R2	protein_coding	Q9NWB7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49314
3.04876873626893e-194	0.388053164419353	0.261	0.077	4.85455445876102e-190	SPP1	Malignant cells	GSE164897_VemCob	ENSG00000118785	6696	secreted phosphoprotein 1	BNSP|BSPI|ETA-1|OPN	protein_coding	P10451	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49315
2.64451638473317e-193	-0.262239160401228	0.146	0.365	4.21086343941062e-189	ESF1	Malignant cells	GSE164897_VemCob	ENSG00000089048	51575	ESF1 nucleolar pre-rRNA processing protein homolog	bA526K24.1|C20orf6	protein_coding	Q9H501	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49316
3.34851338491553e-193	-0.261885806087312	0.114	0.315	5.331837862801e-189	SLC43A3	Malignant cells	GSE164897_VemCob	ENSG00000134802	29015	solute carrier family 43 member 3	DKFZp762A227|Eeg1|FOAP-13|PRO1659|SEEEG-1	protein_coding	Q8NBI5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49317
3.47873772419798e-193	0.460899952619764	0.416	0.218	5.53919407824044e-189	GLRX	Malignant cells	GSE164897_VemCob	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49318
8.09117679444705e-193	-0.317674872364797	0.431	0.719	1.2883580809798e-188	TAF1D	Malignant cells	GSE164897_VemCob	ENSG00000166012	79101	TATA-box binding protein associated factor, RNA polymerase I subunit D	JOSD3|MGC5306|TAF(I)41	protein_coding	Q9H5J8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49319
1.17941582484105e-192	-0.268950296510733	0.142	0.353	1.87798381789441e-188	COMMD4	Malignant cells	GSE164897_VemCob	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49320
1.95458963508128e-192	-0.271265093367992	0.125	0.329	3.11229307593991e-188	CNP	Malignant cells	GSE164897_VemCob	ENSG00000173786	1267	2',3'-cyclic nucleotide 3' phosphodiesterase	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49321
7.0839480024953e-191	0.455655517650767	0.421	0.227	1.12797704043733e-186	SS18L2	Malignant cells	GSE164897_VemCob	ENSG00000008324	51188	SS18 like 2	KIAA-iso	protein_coding	Q9UHA2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49322
9.08584731650898e-190	-0.264175072157701	0.167	0.39	1.44673946820773e-185	NFIC	Malignant cells	GSE164897_VemCob	ENSG00000141905	4782	nuclear factor I C	CTF|CTF5|NF-I|NFI	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49323
1.19704302627367e-189	0.419536082956899	0.352	0.157	1.90605161073557e-185	PTPN14	Malignant cells	GSE164897_VemCob	ENSG00000152104	5784	protein tyrosine phosphatase non-receptor type 14	PEZ|PTPD2	protein_coding	Q15678	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49324
1.67754200351967e-189	-0.298456272385546	0.396	0.689	2.67115013220437e-185	RTRAF	Malignant cells	GSE164897_VemCob	ENSG00000087302	51637	RNA transcription, translation and transport factor	C14orf166|CGI-99|CLE|CLE7|hCLE1|LCRP369|RLLM1	protein_coding	Q9Y224	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49325
2.44802295567211e-189	-0.254041102146867	0.12	0.322	3.8979869523167e-185	KDSR	Malignant cells	GSE164897_VemCob	ENSG00000119537	2531	3-ketodihydrosphingosine reductase	DHSR|FVT1|SDR35C1	protein_coding	Q06136	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49326
2.014163759335e-188	-0.28441798648664	0.273	0.532	3.20715295398912e-184	RARS1	Malignant cells	GSE164897_VemCob	ENSG00000113643	5917	arginyl-tRNA synthetase 1	DALRD1|RARS	protein_coding	P54136	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49327
3.7007578309723e-188	-0.3770156213407	0.211	0.434	5.89271669425719e-184	HLA-DPA1	Malignant cells	GSE164897_VemCob	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49328
8.50038203520996e-188	-0.272468474522971	0.164	0.382	1.35351583146648e-183	ATG3	Malignant cells	GSE164897_VemCob	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49329
8.58794912787836e-187	0.578185903024989	0.586	0.467	1.36745913963207e-182	SPCS2	Malignant cells	GSE164897_VemCob	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49330
6.78230764651068e-186	-0.289340487581834	0.256	0.504	1.0799468465539e-181	TCP1	Malignant cells	GSE164897_VemCob	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49331
6.89611065776025e-186	0.518107140132703	0.594	0.471	1.09806770003516e-181	COA1	Malignant cells	GSE164897_VemCob	ENSG00000106603	55744	cytochrome c oxidase assembly factor 1	C7orf44|FLJ10803|MITRAC15	protein_coding	Q9GZY4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49332
6.26820314315552e-185	-0.305761060056588	0.389	0.669	9.98085986484653e-181	FKBP2	Malignant cells	GSE164897_VemCob	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49333
7.07006648426818e-185	-0.270678540344987	0.224	0.467	1.12576668629002e-180	COPS3	Malignant cells	GSE164897_VemCob	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49334
1.20753218893763e-184	-0.259438039490091	0.143	0.352	1.92275350444538e-180	RSF1	Malignant cells	GSE164897_VemCob	ENSG00000048649	51773	remodeling and spacing factor 1	HBXAP|p325|RSF-1|XAP8	protein_coding	Q96T23	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49335
2.06205589926185e-184	-0.260438913821251	0.172	0.394	3.28341160839464e-180	TDG	Malignant cells	GSE164897_VemCob	ENSG00000139372	6996	thymine DNA glycosylase	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49336
1.46646854685445e-183	-0.268122045095888	0.215	0.452	2.33505786715634e-179	HDDC2	Malignant cells	GSE164897_VemCob	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49337
3.47440099282621e-183	-0.329246605336347	0.522	0.779	5.53228870087718e-179	MTDH	Malignant cells	GSE164897_VemCob	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49338
1.65613035007707e-182	0.347135151171206	0.281	0.099	2.63705635642772e-178	BRI3	Malignant cells	GSE164897_VemCob	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49339
6.87987164746078e-182	-0.266041602319629	0.201	0.43	1.09548196242518e-177	BFAR	Malignant cells	GSE164897_VemCob	ENSG00000275618	51283	bifunctional apoptosis regulator	BAR|RNF47	protein_coding	Q9NZS9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49340
4.1639897250354e-181	-0.252700399708304	0.15	0.36	6.63032083917388e-177	SAT2	Malignant cells	GSE164897_VemCob	ENSG00000141504	112483	spermidine/spermine N1-acetyltransferase family member 2	SSAT2	protein_coding	Q96F10	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49341
4.45449784363379e-181	-0.273791530145476	0.126	0.324	7.09289691641808e-177	CREM	Malignant cells	GSE164897_VemCob	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49342
5.08322527037887e-181	-0.291694612347051	0.246	0.487	8.09401959802427e-177	TMED9	Malignant cells	GSE164897_VemCob	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49343
3.54765325242181e-180	-0.259607670627276	0.264	0.522	5.64892827383124e-176	AIMP1	Malignant cells	GSE164897_VemCob	ENSG00000164022	9255	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	EMAP-2|EMAPII|p43|SCYE1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49344
5.53063643894932e-180	-0.258338852217223	0.157	0.369	8.806432401739e-176	CDK2AP2	Malignant cells	GSE164897_VemCob	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49345
7.20777386584316e-180	0.445805331214977	0.852	0.805	1.14769383265821e-175	ATP5PD	Malignant cells	GSE164897_VemCob	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49346
9.75189452362774e-180	0.480431606366088	0.471	0.295	1.55279416499724e-175	SAR1A	Malignant cells	GSE164897_VemCob	ENSG00000079332	56681	secretion associated Ras related GTPase 1A	SAR1|Sara|SARA1	protein_coding	Q9NR31	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49347
1.29208273543218e-179	-0.252847123845226	0.173	0.392	2.05738333962866e-175	RAB5IF	Malignant cells	GSE164897_VemCob	ENSG00000101084	55969	RAB5 interacting factor	C20orf24|PNAS-11|RCAF1|RIP5	protein_coding	Q9BUV8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49348
1.56990623046848e-179	-0.252773755855504	0.12	0.315	2.49976169077496e-175	LINC00662	Malignant cells	GSE164897_VemCob	ENSG00000261824	148189	long intergenic non-protein coding RNA 662	NA	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49349
2.79416945180285e-179	-0.302356401000477	0.326	0.586	4.44915601810568e-175	TRA2B	Malignant cells	GSE164897_VemCob	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49350
1.52152901779269e-178	0.496933386179547	0.528	0.369	2.42273065503129e-174	RFC1	Malignant cells	GSE164897_VemCob	ENSG00000035928	5981	replication factor C subunit 1	A1|MHCBFB|PO-GA|RFC140	protein_coding	P35251	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49351
1.76788782851563e-178	-0.259622143734773	0.169	0.386	2.81500778934543e-174	SLU7	Malignant cells	GSE164897_VemCob	ENSG00000164609	10569	SLU7 homolog, splicing factor	9G8	protein_coding	O95391	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49352
2.06362083294999e-178	-0.305386286380426	0.498	0.772	3.28590345230628e-174	SEC61B	Malignant cells	GSE164897_VemCob	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49353
4.47623692468423e-178	0.398862261674313	0.347	0.159	7.1275120551747e-174	RECQL	Malignant cells	GSE164897_VemCob	ENSG00000004700	5965	RecQ like helicase	RecQ1|RecQL1	protein_coding	P46063	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49354
3.10362958767623e-177	-0.256866239119884	0.167	0.383	4.94190939245687e-173	HP1BP3	Malignant cells	GSE164897_VemCob	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49355
6.21152291599516e-175	-0.262287528567856	0.284	0.541	9.89060793913909e-171	KDELR1	Malignant cells	GSE164897_VemCob	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49356
2.29210170885629e-174	-0.283031981171323	0.177	0.39	3.64971355101188e-170	C12orf75	Malignant cells	GSE164897_VemCob	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49357
3.67923473559885e-174	-0.25017688172054	0.2	0.428	5.85844546949406e-170	PPP1R11	Malignant cells	GSE164897_VemCob	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49358
4.29959836020134e-173	0.563715116933577	0.275	0.105	6.84625046894859e-169	FABP6	Malignant cells	GSE164897_VemCob	ENSG00000170231	2172	fatty acid binding protein 6	I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP	protein_coding	P51161	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49359
4.51541025822259e-173	-0.269511445511281	0.135	0.332	7.18988775416782e-169	CD9	Malignant cells	GSE164897_VemCob	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49360
4.99421227172976e-173	0.39175707607184	0.957	0.929	7.9522842002753e-169	NDUFA1	Malignant cells	GSE164897_VemCob	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49361
1.0942034033961e-172	0.508128593999777	0.461	0.278	1.7423000792276e-168	KPNA2	Malignant cells	GSE164897_VemCob	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49362
5.21500251989822e-171	-0.257026462123415	0.251	0.493	8.30384851243394e-167	MTCH1	Malignant cells	GSE164897_VemCob	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49363
5.41798725409025e-171	0.337686393131051	0.255	0.085	8.62706110468791e-167	GTSE1	Malignant cells	GSE164897_VemCob	ENSG00000075218	51512	G2 and S-phase expressed 1	B99|GTSE-1|Lnc_bc060912	protein_coding	Q9NYZ3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49364
3.2767074332572e-170	0.341405163528474	0.278	0.103	5.21750124597543e-166	SNHG30	Malignant cells	GSE164897_VemCob	ENSG00000267321	NA	NA	LINC02001|RP11-1094M14.11	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49365
3.74970462711819e-170	-0.25587595511838	0.235	0.469	5.9706546777603e-166	ZDHHC4	Malignant cells	GSE164897_VemCob	ENSG00000136247	55146	zinc finger DHHC-type palmitoyltransferase 4	FLJ10479|ZNF374	protein_coding	Q9NPG8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49366
1.10518920991848e-169	-0.25383609709636	0.172	0.384	1.7597927789532e-165	HSPA5	Malignant cells	GSE164897_VemCob	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49367
2.2139034647328e-169	0.372656753189445	0.895	0.837	3.52519848689403e-165	RBM3	Malignant cells	GSE164897_VemCob	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49368
1.77292942015352e-168	-0.256131110680833	0.232	0.468	2.82303551571045e-164	UBE2E3	Malignant cells	GSE164897_VemCob	ENSG00000170035	10477	ubiquitin conjugating enzyme E2 E3	UbcH9	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49369
4.15521744325144e-168	-0.263658172314716	0.285	0.532	6.61635273488927e-164	SCNM1	Malignant cells	GSE164897_VemCob	ENSG00000163156	79005	sodium channel modifier 1	MGC3180	protein_coding	Q9BWG6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49370
1.02976989024863e-166	0.442845924888198	0.453	0.28	1.63970259624289e-162	TGOLN2	Malignant cells	GSE164897_VemCob	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49371
1.19213859252531e-166	-0.284006967169306	0.327	0.58	1.89824228087805e-162	FARSA	Malignant cells	GSE164897_VemCob	ENSG00000179115	2193	phenylalanyl-tRNA synthetase subunit alpha	CML33|FARSL|FARSLA	protein_coding	Q9Y285	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49372
3.0776407123299e-166	0.325276476529373	0.255	0.088	4.9005273062429e-162	RAP1B	Malignant cells	GSE164897_VemCob	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49373
3.17203153148166e-165	-0.330925398959313	0.157	0.347	5.05082580757824e-161	TK1	Malignant cells	GSE164897_VemCob	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49374
9.838029067545e-165	0.478029747069759	0.558	0.428	1.56650936842519e-160	NDUFB3	Malignant cells	GSE164897_VemCob	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49375
7.68155143708735e-164	0.441223269701809	0.389	0.211	1.22313343532742e-159	RNF213	Malignant cells	GSE164897_VemCob	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49376
8.3916806526983e-164	-0.292552914606154	0.37	0.625	1.33620731032915e-159	FUS	Malignant cells	GSE164897_VemCob	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49377
3.57916006805886e-163	0.494675514563655	0.589	0.48	5.69909657637013e-159	OSTC	Malignant cells	GSE164897_VemCob	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49378
7.98891757082771e-163	0.48093062934811	0.464	0.298	1.2720753448029e-158	ARL6IP5	Malignant cells	GSE164897_VemCob	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49379
6.96383553249002e-162	0.392624667270446	0.476	0.266	1.10885153183839e-157	TOP2A	Malignant cells	GSE164897_VemCob	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49380
2.24040810606253e-161	0.408756448846793	0.848	0.757	3.56740182728337e-157	CMSS1	Malignant cells	GSE164897_VemCob	ENSG00000184220	84319	cms1 ribosomal small subunit homolog	C3orf26|MGC4308	protein_coding	Q9BQ75	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49381
4.48336092698711e-160	-0.415165128236285	0.406	0.63	7.13885560404158e-156	HCFC1R1	Malignant cells	GSE164897_VemCob	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49382
1.39562042971007e-159	0.465284732761568	0.818	0.762	2.22224641022735e-155	CCT2	Malignant cells	GSE164897_VemCob	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49383
2.59098388931647e-159	-0.281507184102434	0.43	0.701	4.12562364695861e-155	CSTB	Malignant cells	GSE164897_VemCob	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49384
5.13047572068388e-159	0.52270868911523	0.383	0.211	8.16925649004494e-155	CTNNB1	Malignant cells	GSE164897_VemCob	ENSG00000168036	1499	catenin beta 1	armadillo|beta-catenin|CTNNB	protein_coding	P35222	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49385
7.5167243564574e-159	0.362358803711019	0.308	0.135	1.19688801927871e-154	MFAP1	Malignant cells	GSE164897_VemCob	ENSG00000140259	4236	microfibril associated protein 1	AMP	protein_coding	P55081	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49386
6.84025787717273e-158	0.464425326595198	0.515	0.366	1.08917426178221e-153	DPCD	Malignant cells	GSE164897_VemCob	ENSG00000166171	25911	deleted in primary ciliary dyskinesia homolog (mouse)	DKFZP566F084|RP11-529I10.4	protein_coding	Q9BVM2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49387
3.51638150204877e-153	0.440265867738977	0.437	0.273	5.59913426571226e-149	YWHAG	Malignant cells	GSE164897_VemCob	ENSG00000170027	7532	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma	14-3-3GAMMA|PPP1R170	protein_coding	P61981	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49388
1.53147675210464e-152	0.39190846965346	0.304	0.133	2.43857043237622e-148	EGR1	Malignant cells	GSE164897_VemCob	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49389
2.02852426819347e-152	0.470510424132804	0.733	0.667	3.23001919224445e-148	PSME2	Malignant cells	GSE164897_VemCob	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49390
3.14688846688583e-152	0.402397683853984	0.802	0.726	5.01079050582231e-148	PLP2	Malignant cells	GSE164897_VemCob	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49391
1.04258343371338e-150	0.512134924093439	0.509	0.376	1.66010560150182e-146	PSMA3	Malignant cells	GSE164897_VemCob	ENSG00000100567	5684	proteasome 20S subunit alpha 3	HC8	protein_coding	P25788	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49392
3.51791560050781e-150	0.416787621680722	0.756	0.677	5.60157701068859e-146	RTN4	Malignant cells	GSE164897_VemCob	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49393
4.22512204191082e-150	-0.254194550138281	0.214	0.424	6.7276618273346e-146	DDX39A	Malignant cells	GSE164897_VemCob	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49394
4.67127953297548e-150	0.459492402002555	0.439	0.281	7.43807840035686e-146	TRMT10C	Malignant cells	GSE164897_VemCob	ENSG00000174173	54931	tRNA methyltransferase 10C, mitochondrial RNase P subunit	FLJ20432|MRPP1|RG9MTD1	protein_coding	Q7L0Y3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49395
5.43398737576942e-150	-0.271276026636154	0.248	0.466	8.65253809843765e-146	MCL1	Malignant cells	GSE164897_VemCob	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49396
3.59340419618719e-149	0.328488033093358	0.265	0.103	5.72177750158886e-145	KIF20B	Malignant cells	GSE164897_VemCob	ENSG00000138182	9585	kinesin family member 20B	CT90|KRMP1|MPHOSPH1|MPP1	protein_coding	Q96Q89	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49397
5.71341265205437e-149	-0.300340953380626	0.444	0.693	9.09746696586618e-145	NARS1	Malignant cells	GSE164897_VemCob	ENSG00000134440	4677	asparaginyl-tRNA synthetase 1	NARS	protein_coding	O43776	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49398
1.96602492046147e-148	0.331509197834365	0.288	0.122	3.1305014808508e-144	TIMP2	Malignant cells	GSE164897_VemCob	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49399
5.96358056840303e-145	0.422339137132765	0.435	0.277	9.49580933906815e-141	DPH3	Malignant cells	GSE164897_VemCob	ENSG00000154813	285381	diphthamide biosynthesis 3	DELGIP|DELGIP1|DESR1|DPH3A|KTI11|MGC20197|ZCSL2	protein_coding	Q96FX2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49400
7.75644790503501e-144	0.386566259352724	0.382	0.215	1.23505919991872e-139	MSN	Malignant cells	GSE164897_VemCob	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49401
1.07902118265529e-143	0.438539161847323	0.651	0.578	1.71812542914202e-139	C11orf58	Malignant cells	GSE164897_VemCob	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49402
9.18759721847457e-143	0.378627409205255	0.351	0.186	1.46294110509771e-138	ACLY	Malignant cells	GSE164897_VemCob	ENSG00000131473	47	ATP citrate lyase	ACL|ATPCL|CLATP	protein_coding	P53396	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49403
3.17178250273003e-141	0.519111061305888	0.478	0.338	5.05042927909703e-137	HNRNPH1	Malignant cells	GSE164897_VemCob	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49404
8.94526018262186e-141	0.450127900884052	0.51	0.375	1.42435377887888e-136	THRAP3	Malignant cells	GSE164897_VemCob	ENSG00000054118	9967	thyroid hormone receptor associated protein 3	BCLAF2|TRAP150	protein_coding	Q9Y2W1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49405
1.6245999135494e-140	0.3598865316416	0.328	0.16	2.58685044234471e-136	TNFAIP2	Malignant cells	GSE164897_VemCob	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49406
2.04584686435467e-140	0.331754933970877	0.281	0.121	3.25760196211194e-136	ADGRE1	Malignant cells	GSE164897_VemCob	ENSG00000174837	2015	adhesion G protein-coupled receptor E1	EMR1|TM7LN3	protein_coding	Q14246	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49407
9.63069146732572e-140	0.471238617529898	0.514	0.38	1.53349500234227e-135	FAM162A	Malignant cells	GSE164897_VemCob	ENSG00000114023	26355	family with sequence similarity 162 member A	C3orf28|E2IG5	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49408
1.01561717320806e-139	0.357089958219497	0.969	0.94	1.6171672248992e-135	SSR2	Malignant cells	GSE164897_VemCob	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49409
2.23436081353433e-139	0.429383604585517	0.434	0.281	3.55777272339071e-135	EMC3	Malignant cells	GSE164897_VemCob	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49410
3.20578477763256e-139	0.444921786105179	0.633	0.559	5.10457110142432e-135	PET100	Malignant cells	GSE164897_VemCob	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49411
3.67895983672005e-139	-0.28282351767029	0.273	0.496	5.85800774800934e-135	BNIP3	Malignant cells	GSE164897_VemCob	ENSG00000176171	664	BCL2 interacting protein 3	HABON|Nip3	protein_coding	Q12983	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49412
3.76653757007879e-139	-0.27793216262235	0.439	0.684	5.99745777283646e-135	PTGES3	Malignant cells	GSE164897_VemCob	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49413
2.14887629780115e-138	0.466138444519603	0.542	0.427	3.42165572898877e-134	SRRM1	Malignant cells	GSE164897_VemCob	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49414
8.20841732514333e-137	0.359383878294353	0.888	0.858	1.30702629068257e-132	SEC11A	Malignant cells	GSE164897_VemCob	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49415
1.79131264825537e-136	0.357272362246963	0.336	0.174	2.85230712981702e-132	C3orf14	Malignant cells	GSE164897_VemCob	ENSG00000114405	57415	chromosome 3 open reading frame 14	HT021	protein_coding	Q9HBI5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49416
4.34579718330836e-136	0.459374912663892	0.467	0.324	6.91981285498191e-132	AHNAK	Malignant cells	GSE164897_VemCob	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49417
1.19605394891095e-135	-0.252406210230072	0.376	0.618	1.9044767028509e-131	GGCT	Malignant cells	GSE164897_VemCob	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49418
7.33771634432949e-135	0.369018561902735	0.364	0.203	1.16838457350758e-130	TFAM	Malignant cells	GSE164897_VemCob	ENSG00000108064	7019	transcription factor A, mitochondrial	TCF6|TCF6L2	protein_coding	Q00059	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49419
1.987501848342e-133	0.307808379739131	0.265	0.112	3.16469919311497e-129	AAMDC	Malignant cells	GSE164897_VemCob	ENSG00000087884	28971	adipogenesis associated Mth938 domain containing	C11orf67|CK067|FLJ21035|PTD015	protein_coding	Q9H7C9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49420
3.97281476775296e-131	0.413389656727054	0.36	0.205	6.32591295469303e-127	CDC42SE1	Malignant cells	GSE164897_VemCob	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49421
5.84102683726652e-131	0.445509782502602	0.597	0.515	9.30066703297948e-127	SSR3	Malignant cells	GSE164897_VemCob	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49422
8.16813041842391e-130	-0.252381091405212	0.46	0.708	1.30061140652564e-125	EIF1AX	Malignant cells	GSE164897_VemCob	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49423
1.65736960917279e-129	-0.36546934201546	0.345	0.549	2.63902962868583e-125	FOSL1	Malignant cells	GSE164897_VemCob	ENSG00000175592	8061	FOS like 1, AP-1 transcription factor subunit	fra-1	protein_coding	P15407	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49424
4.66596514005765e-129	0.454361874638418	0.51	0.392	7.4296162925138e-125	PSMD11	Malignant cells	GSE164897_VemCob	ENSG00000108671	5717	proteasome 26S subunit, non-ATPase 11	MGC3844|p44.5|Rpn6|S9	protein_coding	O00231	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49425
5.55284960942533e-129	0.438393018207268	0.53	0.417	8.84180243308796e-125	TRAPPC2L	Malignant cells	GSE164897_VemCob	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49426
1.03828570646712e-128	0.35310664647335	0.335	0.179	1.6532623304076e-124	DHX15	Malignant cells	GSE164897_VemCob	ENSG00000109606	1665	DEAH-box helicase 15	DBP1|DDX15|HRH2|PRP43|PRPF43|PrPp43p	protein_coding	O43143	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49427
2.18689752517502e-128	0.422175550579774	0.501	0.371	3.48219692933618e-124	VPS35	Malignant cells	GSE164897_VemCob	ENSG00000069329	55737	VPS35 retromer complex component	FLJ10752|MEM3|PARK17	protein_coding	Q96QK1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49428
2.47428514910479e-128	-0.264675993638818	0.618	0.822	3.93980424291956e-124	ERGIC3	Malignant cells	GSE164897_VemCob	ENSG00000125991	51614	ERGIC and golgi 3	C20orf47|CGI-54|Erv46|NY-BR-84|PRO0989|SDBCAG84	protein_coding	Q9Y282	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49429
4.2478066477206e-128	0.450961848068074	0.469	0.306	6.76378252516551e-124	HMGB2	Malignant cells	GSE164897_VemCob	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49430
1.53741338934524e-127	0.369086042515863	0.347	0.192	2.44802333985442e-123	SMC1A	Malignant cells	GSE164897_VemCob	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49431
6.84133163759893e-127	-0.251887399790768	0.131	0.291	1.08934523665488e-122	TPST1	Malignant cells	GSE164897_VemCob	ENSG00000169902	8460	tyrosylprotein sulfotransferase 1	TANGO13A	protein_coding	O60507	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49432
9.00225003524918e-127	0.356106820099745	0.758	0.708	1.43342827311273e-122	DYNLRB1	Malignant cells	GSE164897_VemCob	ENSG00000125971	83658	dynein light chain roadblock-type 1	DNCL2A|DNLC2A|ROBLD1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49433
2.23470798144056e-126	0.325731528754913	0.275	0.123	3.55832551884781e-122	CDK1	Malignant cells	GSE164897_VemCob	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49434
8.4057855979222e-126	-0.278470086895963	0.986	0.991	1.33845324075715e-121	PKM	Malignant cells	GSE164897_VemCob	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49435
1.25288271195279e-125	0.438122137763969	0.499	0.378	1.99496514224243e-121	DNAJC8	Malignant cells	GSE164897_VemCob	ENSG00000285317	22826	DnaJ heat shock protein family (Hsp40) member C8	SPF31	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49436
2.49179797140782e-124	0.37204403550106	0.741	0.69	3.96768990987267e-120	TRAPPC1	Malignant cells	GSE164897_VemCob	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49437
1.38417958106127e-123	0.413888910507616	0.634	0.56	2.20402914692386e-119	LSM8	Malignant cells	GSE164897_VemCob	ENSG00000128534	51691	LSM8 homolog, U6 small nuclear RNA associated	YJR022W	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49438
2.4394776283302e-122	0.408929785018941	0.436	0.296	3.88438022759018e-118	DNAJA1	Malignant cells	GSE164897_VemCob	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49439
3.58920333924032e-121	0.382101733877922	0.411	0.265	5.71508847707236e-117	GIHCG	Malignant cells	GSE164897_VemCob	ENSG00000262349	NA	NA	lncRNA-GIHCG	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49440
1.52633469973238e-119	0.441603326572931	0.545	0.454	2.43038274238386e-115	CCDC25	Malignant cells	GSE164897_VemCob	ENSG00000147419	55246	coiled-coil domain containing 25	FLJ10853	protein_coding	Q86WR0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49441
1.94274109055686e-119	0.346214302329477	0.337	0.182	3.09342663849368e-115	DMKN	Malignant cells	GSE164897_VemCob	ENSG00000161249	93099	dermokine	ZD52F10	protein_coding	Q6E0U4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49442
1.16198285646323e-118	0.457914873964945	0.522	0.427	1.8502253023464e-114	PSMA5	Malignant cells	GSE164897_VemCob	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49443
4.86910000253583e-118	0.41684488118149	0.652	0.599	7.75306793403781e-114	CEBPZ	Malignant cells	GSE164897_VemCob	ENSG00000115816	10153	CCAAT enhancer binding protein zeta	CBF2|CTF2	protein_coding	Q03701	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49444
5.01224708092326e-118	0.318595042348971	0.942	0.898	7.98100102695411e-114	METAP2	Malignant cells	GSE164897_VemCob	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49445
9.77227545626892e-116	0.366933246415272	0.375	0.231	1.5560394209017e-111	MORN2	Malignant cells	GSE164897_VemCob	ENSG00000188010	729967	MORN repeat containing 2	MOPT	protein_coding	Q502X0	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49446
1.06203273476952e-115	0.41218789626526	0.485	0.364	1.6910747235735e-111	MCFD2	Malignant cells	GSE164897_VemCob	ENSG00000180398	90411	multiple coagulation factor deficiency 2, ER cargo receptor complex subunit	F5F8D|LMAN1IP|SDNSF	protein_coding	Q8NI22	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49447
1.09000209304175e-115	0.432312356325217	0.594	0.526	1.73561033275037e-111	MRPS18C	Malignant cells	GSE164897_VemCob	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49448
2.56534803249113e-115	0.389940792309737	0.682	0.636	4.08480367213563e-111	ATP6V1G1	Malignant cells	GSE164897_VemCob	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49449
4.16732802304945e-115	0.409539135135906	0.447	0.319	6.63563641110164e-111	SUPT16H	Malignant cells	GSE164897_VemCob	ENSG00000092201	11198	SPT16 homolog, facilitates chromatin remodeling subunit	CDC68|FACT|FACTP140|FLJ10857|FLJ14010|SPT16/CDC68	protein_coding	Q9Y5B9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49450
1.31660537958689e-114	0.419735133214394	0.51	0.403	2.0964307459162e-110	MTPN	Malignant cells	GSE164897_VemCob	ENSG00000105887	136319	myotrophin	GCDP|MYOTROPHIN|V-1	protein_coding	P58546	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49451
7.76161247657869e-113	0.395324116787036	0.466	0.34	1.23588155464562e-108	BZW1	Malignant cells	GSE164897_VemCob	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49452
5.39392097448853e-110	0.323613386406071	0.334	0.191	8.58874036767809e-106	PHAX	Malignant cells	GSE164897_VemCob	ENSG00000164902	51808	phosphorylated adaptor for RNA export	FLJ13193|RNUXA	protein_coding	Q9H814	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49453
7.77775338814088e-110	0.320590236925683	0.872	0.839	1.23845167199367e-105	NSA2	Malignant cells	GSE164897_VemCob	ENSG00000164346	10412	NSA2 ribosome biogenesis factor	FLJ94393|HCLG1|HUSSY-29|TINP1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49454
1.35104515718987e-109	0.293402529080977	0.283	0.142	2.15126920379342e-105	KANK2	Malignant cells	GSE164897_VemCob	ENSG00000197256	25959	KN motif and ankyrin repeat domains 2	ANKRD25|KIAA1518|MXRA3	protein_coding	Q63ZY3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49455
1.55575656592442e-109	0.381580057080167	0.668	0.623	2.47723117992145e-105	MRPS33	Malignant cells	GSE164897_VemCob	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49456
1.60829219541401e-109	0.42720730301951	0.574	0.507	2.56088366275773e-105	MCTS1	Malignant cells	GSE164897_VemCob	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49457
4.51392475721889e-108	0.322031953925316	0.315	0.174	7.18752239091964e-104	CHORDC1	Malignant cells	GSE164897_VemCob	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49458
3.25372775222616e-107	0.3448594119162	0.979	0.96	5.18091069986972e-103	CD63	Malignant cells	GSE164897_VemCob	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49459
4.98536175367077e-107	0.282942811256873	0.256	0.122	7.93819152036997e-103	TMEM107	Malignant cells	GSE164897_VemCob	ENSG00000179029	84314	transmembrane protein 107	JBTS29|MGC10744|MKS13	protein_coding	Q6UX40	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49460
2.18218071965254e-106	0.337192293386243	0.364	0.224	3.47468635990274e-102	PSMD1	Malignant cells	GSE164897_VemCob	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49461
3.32902112705284e-106	0.32598722951813	0.301	0.159	5.30080034060623e-102	CLSPN	Malignant cells	GSE164897_VemCob	ENSG00000092853	63967	claspin	NA	protein_coding	Q9HAW4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49462
3.75132654978902e-106	-0.332830258710097	0.137	0.278	5.97323726522906e-102	CDC20	Malignant cells	GSE164897_VemCob	ENSG00000117399	991	cell division cycle 20	CDC20A|p55CDC	protein_coding	Q12834	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49463
4.97125917367743e-105	-0.267220649370937	0.641	0.808	7.91573598224657e-101	NDUFB8	Malignant cells	GSE164897_VemCob	ENSG00000166136	4714	NADH:ubiquinone oxidoreductase subunit B8	ASHI|CI-ASHI	protein_coding	O95169	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49464
1.05663444157414e-104	0.402527016863615	0.343	0.204	1.6824790213185e-100	PRSS23	Malignant cells	GSE164897_VemCob	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49465
1.81965976018464e-102	0.388385668010888	0.482	0.371	2.89744423614201e-98	HNRNPR	Malignant cells	GSE164897_VemCob	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49466
9.61890265404051e-102	0.275879829018773	0.263	0.129	1.53161786960287e-97	BRCA1	Malignant cells	GSE164897_VemCob	ENSG00000012048	672	BRCA1 DNA repair associated	BRCC1|FANCS|PPP1R53|RNF53	protein_coding	P38398	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49467
2.97024992104415e-101	0.404539538079505	0.583	0.517	4.7295289492786e-97	ANKRD11	Malignant cells	GSE164897_VemCob	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49468
4.77873277510109e-101	0.388930217500104	0.71	0.664	7.60917619779346e-97	GPATCH4	Malignant cells	GSE164897_VemCob	ENSG00000160818	54865	G-patch domain containing 4 (gene/pseudogene)	DKFZP434F1735|FLJ20249|GPATC4	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49469
1.40859719796424e-100	0.328644214649269	0.86	0.837	2.24290931831846e-96	HNRNPC	Malignant cells	GSE164897_VemCob	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49470
4.99682626439496e-100	0.37349499950902	0.441	0.322	7.9564464607961e-96	LAPTM4B	Malignant cells	GSE164897_VemCob	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49471
1.23121936331965e-98	0.280661532967697	0.268	0.136	1.96047059221388e-94	FOXP1	Malignant cells	GSE164897_VemCob	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49472
3.33905145229483e-97	0.374536050527272	0.466	0.354	5.31677162748906e-93	RSRC2	Malignant cells	GSE164897_VemCob	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49473
5.45808510795084e-97	0.272913821605224	0.256	0.128	8.69090891739013e-93	ENO2	Malignant cells	GSE164897_VemCob	ENSG00000111674	2026	enolase 2	NSE	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49474
2.17508471520892e-96	0.353749161451187	0.373	0.245	3.46338739202716e-92	TIMM8A	Malignant cells	GSE164897_VemCob	ENSG00000126953	1678	translocase of inner mitochondrial membrane 8A	DDP|DFN1|MTS	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49475
5.22224451883479e-95	0.265557833021206	0.259	0.131	8.31537994734064e-91	ZWINT	Malignant cells	GSE164897_VemCob	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49476
1.59700824153279e-94	0.368418918693809	0.475	0.371	2.54291622299266e-90	PDZD11	Malignant cells	GSE164897_VemCob	ENSG00000120509	51248	PDZ domain containing 11	PDZK11	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49477
7.61471092199675e-94	0.298347457953574	0.854	0.818	1.21249042010954e-89	NDUFA13	Malignant cells	GSE164897_VemCob	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49478
2.58174993565959e-93	0.261814280354572	0.262	0.134	4.11092042255076e-89	FOXM1	Malignant cells	GSE164897_VemCob	ENSG00000111206	2305	forkhead box M1	FKHL16|HFH-11|HNF-3|INS-1|MPHOSPH2|MPP2|TGT3|trident	protein_coding	Q08050	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49479
3.29402557266157e-93	0.267243969001282	0.27	0.143	5.24507691934902e-89	HSPH1	Malignant cells	GSE164897_VemCob	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49480
5.66828931891069e-92	0.383461353262587	0.601	0.562	9.02561708250149e-88	GTF3C6	Malignant cells	GSE164897_VemCob	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49481
5.85593146819691e-91	0.372213559098699	0.62	0.59	9.32439967680994e-87	NDUFS4	Malignant cells	GSE164897_VemCob	ENSG00000164258	4724	NADH:ubiquinone oxidoreductase subunit S4	AQDQ|CI-18	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49482
2.23374247123544e-90	0.272622900526426	0.255	0.128	3.5567881369482e-86	AURKA	Malignant cells	GSE164897_VemCob	ENSG00000087586	6790	aurora kinase A	AIK|ARK1|AurA|BTAK|PPP1R47|STK15|STK6|STK7	protein_coding	O14965	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49483
2.85998395508206e-89	0.381187665709495	0.487	0.395	4.55395245167716e-85	CALU	Malignant cells	GSE164897_VemCob	ENSG00000128595	813	calumenin	NA	protein_coding	O43852	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49484
2.482363628747e-88	0.277584883202502	0.294	0.167	3.95266760605385e-84	MBNL1	Malignant cells	GSE164897_VemCob	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49485
3.04455385164279e-88	0.312938396872751	0.376	0.251	4.84784309797082e-84	ATP6V1E1	Malignant cells	GSE164897_VemCob	ENSG00000131100	529	ATPase H+ transporting V1 subunit E1	ATP6E|ATP6E2|ATP6V1E|P31|Vma4	protein_coding	P36543	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49486
1.12475054131617e-87	0.364381545394509	0.524	0.449	1.79094028693774e-83	SMIM7	Malignant cells	GSE164897_VemCob	ENSG00000214046	79086	small integral membrane protein 7	C19orf42|MGC2747	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49487
5.60814990210929e-87	0.350731214839625	0.435	0.328	8.92985708912863e-83	CHCHD1	Malignant cells	GSE164897_VemCob	ENSG00000172586	118487	coiled-coil-helix-coiled-coil-helix domain containing 1	C10orf34|FLJ25854	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49488
1.14796707684391e-86	0.347259680796021	0.451	0.345	1.82790797645856e-82	ANAPC15	Malignant cells	GSE164897_VemCob	ENSG00000110200	25906	anaphase promoting complex subunit 15	APC15|C11orf51|DKFZP564M082|HSPC020	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49489
2.43445761944431e-83	0.271157214176656	0.276	0.154	3.87638686744117e-79	LIMA1	Malignant cells	GSE164897_VemCob	ENSG00000050405	51474	LIM domain and actin binding 1	EPLIN	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49490
6.72730293922063e-83	0.317871739106311	0.411	0.287	1.0711884470121e-78	AMIGO2	Malignant cells	GSE164897_VemCob	ENSG00000139211	347902	adhesion molecule with Ig like domain 2	ALI1|DEGA	protein_coding	Q86SJ2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49491
1.01878230479221e-82	0.364459869963051	0.516	0.444	1.62220706392063e-78	TIMMDC1	Malignant cells	GSE164897_VemCob	ENSG00000113845	51300	translocase of inner mitochondrial membrane domain containing 1	C3orf1|FLJ22597	protein_coding	Q9NPL8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49492
1.11061997182293e-82	0.268159389052372	0.251	0.135	1.76844018113365e-78	MGST2	Malignant cells	GSE164897_VemCob	ENSG00000085871	4258	microsomal glutathione S-transferase 2	MGST-II	protein_coding	Q99735	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49493
5.4376629532779e-82	0.354099130733667	0.543	0.477	8.6583907205044e-78	CHD4	Malignant cells	GSE164897_VemCob	ENSG00000111642	1108	chromodomain helicase DNA binding protein 4	Mi-2b|Mi2-BETA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49494
3.66133799405399e-81	0.348484583794408	0.486	0.392	5.82994848793217e-77	TMEM106C	Malignant cells	GSE164897_VemCob	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49495
2.15853614343154e-80	0.398106596074418	0.562	0.468	3.43703710118605e-76	S100A2	Malignant cells	GSE164897_VemCob	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49496
1.38088670104155e-79	0.3040325002551	0.355	0.238	2.19878589406846e-75	FTSJ3	Malignant cells	GSE164897_VemCob	ENSG00000108592	117246	FtsJ RNA 2'-O-methyltransferase 3	SPB1	protein_coding	Q8IY81	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49497
1.70633966429547e-79	0.354838703564071	0.474	0.388	2.71700464745768e-75	TMEM126A	Malignant cells	GSE164897_VemCob	ENSG00000171202	84233	transmembrane protein 126A	DKFZp586C1924|OPA7	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49498
2.17930866608289e-79	0.341762712198043	0.418	0.315	3.47011318900379e-75	TOR1AIP2	Malignant cells	GSE164897_VemCob	ENSG00000169905	163590	torsin 1A interacting protein 2	IFRG15|LULL1|NET9	protein_coding	Q8NFQ8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49499
2.66366766612354e-78	0.302726089511612	0.383	0.27	4.24135802476851e-74	JPX	Malignant cells	GSE164897_VemCob	ENSG00000225470	554203	JPX transcript, XIST activator	DCBALD06|ENOX|LINC00183|NCRNA00183	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49500
5.76330107913345e-78	0.29577632464111	0.326	0.211	9.17690430830419e-74	CSTF3	Malignant cells	GSE164897_VemCob	ENSG00000176102	1479	cleavage stimulation factor subunit 3	CstF-77	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49501
1.58860451739965e-77	0.306431209130122	0.703	0.682	2.52953497305546e-73	ACP1	Malignant cells	GSE164897_VemCob	ENSG00000143727	52	acid phosphatase 1	HAAP|LMW-PTP|LMWPTP	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49502
2.4591205071894e-77	0.276582660358802	0.953	0.949	3.91565758359768e-73	PSMB7	Malignant cells	GSE164897_VemCob	ENSG00000136930	5695	proteasome 20S subunit beta 7	Z	protein_coding	Q99436	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49503
1.08638865309636e-76	0.296999313677239	0.337	0.223	1.72985665232533e-72	RAD51C	Malignant cells	GSE164897_VemCob	ENSG00000108384	5889	RAD51 paralog C	FANCO|RAD51L2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49504
2.14526153610017e-76	0.338996325627705	0.445	0.347	3.4158999439323e-72	SHC1	Malignant cells	GSE164897_VemCob	ENSG00000160691	6464	SHC adaptor protein 1	p66|SHC|ShcA	protein_coding	P29353	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49505
3.35515923245849e-75	0.35070531867439	0.558	0.51	5.34242004584366e-71	MRPL22	Malignant cells	GSE164897_VemCob	ENSG00000082515	29093	mitochondrial ribosomal protein L22	HSPC158|MRP-L25|RPML25	protein_coding	Q9NWU5	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49506
1.58686686524436e-74	0.303372754553171	0.715	0.698	2.5267681095286e-70	TOMM22	Malignant cells	GSE164897_VemCob	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49507
2.41084854518391e-73	0.306314477809755	0.35	0.243	3.83879413849634e-69	RTL8C	Malignant cells	GSE164897_VemCob	ENSG00000134590	8933	retrotransposon Gag like 8C	CXX1|FAM127A|Mar8|MAR8C|Mart8|SIRH5	protein_coding	A6ZKI3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49508
7.42492775189643e-72	0.354017164984931	0.589	0.557	1.18227124593447e-67	VAMP5	Malignant cells	GSE164897_VemCob	ENSG00000168899	10791	vesicle associated membrane protein 5	NA	protein_coding	O95183	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49509
1.96429330349803e-71	0.337076464675941	0.39	0.29	3.12774422715991e-67	MAGOHB	Malignant cells	GSE164897_VemCob	ENSG00000111196	55110	mago homolog B, exon junction complex subunit	FLJ10292|MGN2	protein_coding	Q96A72	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49510
2.08201500459798e-71	0.362619721634509	0.563	0.522	3.31519249182137e-67	MRPS23	Malignant cells	GSE164897_VemCob	ENSG00000181610	51649	mitochondrial ribosomal protein S23	CGI-138|HSPC329|MRP-S23	protein_coding	Q9Y3D9	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49511
4.15396891437173e-71	0.339302097708463	0.531	0.475	6.61436470235411e-67	RAC1	Malignant cells	GSE164897_VemCob	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49512
1.11774487775267e-70	-0.372241929940382	0.414	0.557	1.77978516884558e-66	TPM1	Malignant cells	GSE164897_VemCob	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49513
1.02020833354222e-69	0.267439129624361	0.885	0.855	1.62447772949928e-65	PRDX2	Malignant cells	GSE164897_VemCob	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49514
3.54915222802377e-69	0.325893146321442	0.484	0.406	5.65131509268225e-65	TIMM17A	Malignant cells	GSE164897_VemCob	ENSG00000134375	10440	translocase of inner mitochondrial membrane 17A	TIM17|TIM17A	protein_coding	Q99595	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49515
4.08181747078836e-69	0.325664889031219	0.461	0.378	6.4994779587363e-65	HIKESHI	Malignant cells	GSE164897_VemCob	ENSG00000149196	51501	heat shock protein nuclear import factor hikeshi	C11orf73|HSPC138|HSPC179|OPI10	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49516
8.05669258270104e-69	0.310062889531313	0.423	0.33	1.28286715994349e-64	SRP19	Malignant cells	GSE164897_VemCob	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49517
5.05306023861193e-67	0.305614494886366	0.673	0.659	8.04598781794178e-63	PRR13	Malignant cells	GSE164897_VemCob	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49518
9.15136892204476e-67	0.321760157115371	0.413	0.321	1.45717247345719e-62	XIST	Malignant cells	GSE164897_VemCob	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49519
1.1402134818877e-66	0.28745834584252	0.733	0.715	1.81556192720978e-62	TOMM5	Malignant cells	GSE164897_VemCob	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49520
1.68556783449808e-66	0.264349446858806	0.251	0.147	2.68392966287129e-62	B4GALT1	Malignant cells	GSE164897_VemCob	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49521
8.17713954249161e-65	0.306562733299035	0.416	0.324	1.30204592935094e-60	GTF2H5	Malignant cells	GSE164897_VemCob	ENSG00000272047	404672	general transcription factor IIH subunit 5	bA120J8.2|C6orf175|FLJ30544|TFB5|TFIIH|TTD|TTD-A|TTDA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49522
2.29613770663369e-64	0.271740753849782	0.331	0.227	3.65614007027283e-60	GLG1	Malignant cells	GSE164897_VemCob	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49523
3.9260171059226e-64	0.371740570264535	0.491	0.399	6.25139703776056e-60	SAT1	Malignant cells	GSE164897_VemCob	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49524
9.06847926864014e-64	0.298283318171142	0.38	0.284	1.44397395394557e-59	EBP	Malignant cells	GSE164897_VemCob	ENSG00000147155	10682	EBP cholestenol delta-isomerase	CDPX2|CHO2|CPX|CPXD	protein_coding	Q15125	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49525
9.91110157695584e-64	0.437777266601138	0.499	0.444	1.57814470409868e-59	ERRFI1	Malignant cells	GSE164897_VemCob	ENSG00000116285	54206	ERBB receptor feedback inhibitor 1	GENE-33|MIG-6|RALT	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49526
1.28347295667591e-62	0.339250766666279	0.513	0.462	2.04367398891505e-58	IK	Malignant cells	GSE164897_VemCob	ENSG00000113141	3550	IK cytokine	RED|RER	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49527
1.09287590130476e-60	0.333562798620882	0.465	0.4	1.74018629764757e-56	SNRNP27	Malignant cells	GSE164897_VemCob	ENSG00000124380	11017	small nuclear ribonucleoprotein U4/U6.U5 subunit 27	RY1|U4/U6.U5-27K	protein_coding	Q8WVK2	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49528
1.55929662632493e-60	0.324115985922959	0.572	0.548	2.48286801809718e-56	UBE2N	Malignant cells	GSE164897_VemCob	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49529
8.41953141213135e-60	0.276343636546217	0.391	0.297	1.34064198675368e-55	PSMD2	Malignant cells	GSE164897_VemCob	ENSG00000175166	5708	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	MGC14274|P97|Rpn1|S2|TRAP2	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49530
3.47636676001165e-59	0.313855156066616	0.417	0.334	5.53541879196655e-55	CAPZA1	Malignant cells	GSE164897_VemCob	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49531
2.25680951955571e-57	0.287196941716949	0.371	0.283	3.59351779798855e-53	CBX5	Malignant cells	GSE164897_VemCob	ENSG00000094916	23468	chromobox 5	HP1|HP1-ALPHA|HP1Hs-alpha	protein_coding	P45973	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49532
3.18700698674952e-57	0.355012113345842	0.403	0.327	5.07467122500126e-53	NASP	Malignant cells	GSE164897_VemCob	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49533
1.97931971426464e-55	0.250943811215021	0.324	0.229	3.15167078102358e-51	IFT43	Malignant cells	GSE164897_VemCob	ENSG00000119650	112752	intraflagellar transport 43	C14orf179|FLJ32173|MGC16028	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49534
2.53760279190028e-55	0.250201719405529	0.283	0.189	4.04062492554281e-51	AIG1	Malignant cells	GSE164897_VemCob	ENSG00000146416	51390	androgen induced 1	AIG-1|dJ95L4.1|FLJ10485	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49535
1.35514278272711e-54	0.261181631736422	0.369	0.279	2.15779385293638e-50	OAF	Malignant cells	GSE164897_VemCob	ENSG00000184232	220323	out at first homolog	MGC52117	protein_coding	Q86UD1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49536
2.12990025950877e-54	0.296148901179267	0.428	0.354	3.39144018321582e-50	RBM25	Malignant cells	GSE164897_VemCob	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49537
4.86381405928283e-54	0.3174115300563	0.424	0.356	7.74465112659605e-50	MRPL13	Malignant cells	GSE164897_VemCob	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49538
4.14997250579138e-53	0.306494529554822	0.464	0.406	6.60800122097161e-49	VPS25	Malignant cells	GSE164897_VemCob	ENSG00000131475	84313	vacuolar protein sorting 25 homolog	DERP9|EAP20|MGC10540	protein_coding	Q9BRG1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49539
4.28092990777636e-53	0.258757122637147	0.706	0.701	6.8165246921523e-49	LAMTOR4	Malignant cells	GSE164897_VemCob	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49540
1.80890408386656e-52	0.273926856414901	0.371	0.289	2.88031797274072e-48	SELENOT	Malignant cells	GSE164897_VemCob	ENSG00000198843	51714	selenoprotein T	SELT	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49541
3.24702063257913e-52	0.30363679865744	0.557	0.535	5.17023095325575e-48	SRP9	Malignant cells	GSE164897_VemCob	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49542
4.16532944263711e-52	0.30008686293191	0.553	0.532	6.63245407151107e-48	MRPL14	Malignant cells	GSE164897_VemCob	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49543
6.16348461427054e-52	0.270265520106767	0.321	0.233	9.81411655130299e-48	ABRACL	Malignant cells	GSE164897_VemCob	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49544
1.02571534396797e-51	0.293425675209243	0.475	0.418	1.6332465422002e-47	MRPS14	Malignant cells	GSE164897_VemCob	ENSG00000120333	63931	mitochondrial ribosomal protein S14	HSMRPS14	protein_coding	O60783	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49545
5.59034393551663e-50	0.290391329119776	0.418	0.348	8.90150464852313e-46	VBP1	Malignant cells	GSE164897_VemCob	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49546
1.05935372950318e-49	0.270250737784698	0.422	0.335	1.68680894348791e-45	SMC4	Malignant cells	GSE164897_VemCob	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49547
1.16694485299403e-49	0.280129876829742	0.426	0.355	1.85812628942239e-45	IFT22	Malignant cells	GSE164897_VemCob	ENSG00000128581	64792	intraflagellar transport 22	DKFZp761N0823|FAP9|FLJ13225|FLJ14117|RABL5	protein_coding	Q9H7X7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49548
2.14950665978879e-49	0.297644444769353	0.691	0.689	3.42265945438168e-45	CALR	Malignant cells	GSE164897_VemCob	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49549
7.97282120678945e-48	0.273140896091935	0.639	0.634	1.26951232075708e-43	SDHC	Malignant cells	GSE164897_VemCob	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49550
9.27965648703621e-47	0.284186628545952	0.493	0.446	1.47759970243078e-42	PNKD	Malignant cells	GSE164897_VemCob	ENSG00000127838	25953	PNKD metallo-beta-lactamase domain containing	BRP17|DKFZp564N1362|DYT8|FKSG19|FPD1|KIAA1184|KIPP1184|MGC31943|MR-1|MR-1S|PDC|PKND1|TAHCCP2	protein_coding	Q8N490	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49551
2.17212265681825e-46	0.259222063597131	0.344	0.265	3.45867090645171e-42	LSM6	Malignant cells	GSE164897_VemCob	ENSG00000164167	11157	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated	YDR378C	protein_coding	P62312	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49552
7.75782337132413e-46	0.297169820697023	0.468	0.424	1.23527821541594e-41	FDPS	Malignant cells	GSE164897_VemCob	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49553
8.70147149469619e-46	0.267940582735556	0.366	0.292	1.38553530610047e-41	MRPS10	Malignant cells	GSE164897_VemCob	ENSG00000048544	55173	mitochondrial ribosomal protein S10	FLJ10567	protein_coding	P82664	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49554
8.86315618705141e-46	0.253763312212835	0.339	0.259	1.4112803596642e-41	PNN	Malignant cells	GSE164897_VemCob	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49555
5.92986687700273e-45	0.313659055991619	0.522	0.502	9.44212702825145e-41	PSMA1	Malignant cells	GSE164897_VemCob	ENSG00000129084	5682	proteasome 20S subunit alpha 1	HC2|MGC14542|MGC14575|MGC14751|MGC1667|MGC21459|MGC22853|MGC23915|NU|PROS30	protein_coding	P25786	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49556
2.64935169795081e-42	0.277910561102132	0.553	0.548	4.21856270864708e-38	MRPL36	Malignant cells	GSE164897_VemCob	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49557
1.24013619223322e-40	0.260222706792869	0.607	0.601	1.97466885889296e-36	HLA-A	Malignant cells	GSE164897_VemCob	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49558
6.29080596850366e-39	0.272657385956258	0.432	0.38	1.00168503436484e-34	TCEAL9	Malignant cells	GSE164897_VemCob	ENSG00000185222	51186	transcription elongation factor A like 9	DKFZp313K1940|WBP5|WEX6	protein_coding	Q9UHQ7	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49559
7.54212516615184e-38	0.278712174370184	0.406	0.354	1.20093259020636e-33	LAPTM4A	Malignant cells	GSE164897_VemCob	ENSG00000068697	9741	lysosomal protein transmembrane 4 alpha	HUMORF13|KIAA0108|LAPTM4|MBNT|Mtrp	protein_coding	Q15012	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49560
1.27176350908389e-37	0.275882085105499	0.626	0.655	2.02502903551428e-33	DDX1	Malignant cells	GSE164897_VemCob	ENSG00000079785	1653	DEAD-box helicase 1	DBP-RB	protein_coding	Q92499	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49561
2.97499174621882e-37	0.251408483092692	0.421	0.366	4.73707935750423e-33	MORF4L2	Malignant cells	GSE164897_VemCob	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49562
1.48519923984154e-36	0.27706550629234	0.472	0.445	2.36488274959969e-32	SMUG1	Malignant cells	GSE164897_VemCob	ENSG00000123415	23583	single-strand-selective monofunctional uracil-DNA glycosylase 1	FDG|HMUDG|UNG3	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49563
8.00314252905461e-36	0.255261011999801	0.377	0.322	1.27434038490137e-31	NIT2	Malignant cells	GSE164897_VemCob	ENSG00000114021	56954	nitrilase family member 2	NA	protein_coding	Q9NQR4	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49564
2.90195318438661e-33	0.250525592275398	0.418	0.373	4.62078005549879e-29	UFM1	Malignant cells	GSE164897_VemCob	ENSG00000120686	51569	ubiquitin fold modifier 1	bA131P10.1|C13orf20	protein_coding	P61960	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49565
3.73621588154163e-31	0.25223085633208	0.415	0.375	5.94917654817874e-27	SEC13	Malignant cells	GSE164897_VemCob	ENSG00000157020	6396	SEC13 homolog, nuclear pore and COPII coat complex component	D3S1231E|npp-20|SEC13L1|SEC13R	protein_coding	P55735	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49566
3.1624714289278e-30	0.258775904865744	0.497	0.488	5.03560325628173e-26	KNOP1	Malignant cells	GSE164897_VemCob	ENSG00000103550	400506	lysine rich nucleolar protein 1	101F10.1|C16orf88|FAM191A|TSG118	protein_coding	Q1ED39	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49567
2.22960797026189e-29	0.258983758846241	0.47	0.452	3.55020477104801e-25	PSMD14	Malignant cells	GSE164897_VemCob	ENSG00000115233	10213	proteasome 26S subunit, non-ATPase 14	pad1|POH1|Rpn11	protein_coding	O00487	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49568
4.88610755127551e-29	0.262354540182138	0.481	0.466	7.78014905389599e-25	CISD1	Malignant cells	GSE164897_VemCob	ENSG00000122873	55847	CDGSH iron sulfur domain 1	C10orf70|MDS029|mitoNEET|ZCD1	protein_coding	Q9NZ45	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49569
2.73025325724269e-26	0.272835237367955	0.519	0.535	4.34738226150753e-22	POLR2G	Malignant cells	GSE164897_VemCob	ENSG00000168002	5436	RNA polymerase II subunit G	hRPB19|hsRPB7|RPB7	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49570
7.53915845056228e-26	0.262542345649238	0.469	0.465	1.20046020008303e-21	EIF4A2	Malignant cells	GSE164897_VemCob	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49571
5.63161418054972e-21	0.297357112261313	0.566	0.604	8.96721925968932e-17	CCT5	Malignant cells	GSE164897_VemCob	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE164897_VemCob	GSE164897	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + combimetinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	14851	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49572
0	-0.47757497577805	0.067	0.433	0	NOC2L	Malignant cells	GSE164897_VemTra	ENSG00000188976	26155	NOC2 like nucleolar associated transcriptional repressor	DKFZP564C186|NET15|NET7|NIR|PPP1R112	protein_coding	Q9Y3T9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49573
0	-0.359165420952927	0.035	0.309	0	UBE2J2	Malignant cells	GSE164897_VemTra	ENSG00000160087	118424	ubiquitin conjugating enzyme E2 J2	NCUBE2|Ubc6p	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49574
0	-0.365646388901243	0.034	0.316	0	INTS11	Malignant cells	GSE164897_VemTra	ENSG00000127054	54973	integrator complex subunit 11	CPSF3L|CPSF73L|FLJ20542|INT11|RC-68	protein_coding	Q5TA45	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49575
0	-0.985969152268371	0.173	0.801	0	AURKAIP1	Malignant cells	GSE164897_VemTra	ENSG00000175756	54998	aurora kinase A interacting protein 1	AIP|AKIP|FLJ20608	protein_coding	Q9NWT8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49576
0	-0.591052138613511	0.414	0.827	0	MRPL20	Malignant cells	GSE164897_VemTra	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49577
0	-0.691650848573044	0.099	0.598	0	FAAP20	Malignant cells	GSE164897_VemTra	ENSG00000162585	199990	FA core complex associated protein 20	C1orf86|FLJ31031	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49578
0	-0.578550311436264	0.136	0.57	0	RER1	Malignant cells	GSE164897_VemTra	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49579
0	-0.615707644892659	0.071	0.512	0	ACOT7	Malignant cells	GSE164897_VemTra	ENSG00000097021	11332	acyl-CoA thioesterase 7	ACH1|ACT|BACH|CTE-II|hBACH|LACH1|MGC1126	protein_coding	O00154	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49580
0	-1.55234887629473	0.66	0.985	0	ENO1	Malignant cells	GSE164897_VemTra	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49581
0	-0.439568407419613	0.011	0.334	0	MAD2L2	Malignant cells	GSE164897_VemTra	ENSG00000116670	10459	mitotic arrest deficient 2 like 2	FANCV|MAD2B|POLZ2|REV7	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49582
0	-0.311115178248813	0.057	0.3	0	AGTRAP	Malignant cells	GSE164897_VemTra	ENSG00000177674	57085	angiotensin II receptor associated protein	ATRAP	protein_coding	Q6RW13	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49583
0	0.589275668790462	0.433	0.155	0	PLOD1	Malignant cells	GSE164897_VemTra	ENSG00000083444	5351	procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	LH1|LLH|PLOD	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49584
0	-0.482833000756496	0.001	0.354	0	MFAP2	Malignant cells	GSE164897_VemTra	ENSG00000117122	4237	microfibril associated protein 2	MAGP|MAGP-1	protein_coding	P55001	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49585
0	-0.561338999227017	0.13	0.546	0	SDHB	Malignant cells	GSE164897_VemTra	ENSG00000117118	6390	succinate dehydrogenase complex iron sulfur subunit B	SDH|SDH1	protein_coding	P21912	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49586
0	-0.358204423748176	0.056	0.329	0	MRTO4	Malignant cells	GSE164897_VemTra	ENSG00000053372	51154	MRT4 homolog, ribosome maturation factor	C1orf33|dJ657E11.4|MRT4	protein_coding	Q9UKD2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49587
0	-0.295677830485276	0.055	0.285	0	AKR7A2	Malignant cells	GSE164897_VemTra	ENSG00000053371	8574	aldo-keto reductase family 7 member A2	AFAR	protein_coding	O43488	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49588
0	-0.585697148586601	0.117	0.558	0	CAPZB	Malignant cells	GSE164897_VemTra	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49589
0	-0.449679943272811	0.123	0.473	0	DDOST	Malignant cells	GSE164897_VemTra	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49590
0	0.945242304103117	1	1	0	RPL11	Malignant cells	GSE164897_VemTra	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49591
0	-0.494242874472486	0.057	0.436	0	LYPLA2	Malignant cells	GSE164897_VemTra	ENSG00000011009	11313	lysophospholipase 2	APT-2	protein_coding	O95372	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49592
0	-0.977229397742317	0.197	0.818	0	SYF2	Malignant cells	GSE164897_VemTra	ENSG00000117614	25949	SYF2 pre-mRNA splicing factor	CBPIN|DKFZp564O2082|fSAP29|NTC31|p29	protein_coding	O95926	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49593
0	-0.53913895902976	0.187	0.519	0	STMN1	Malignant cells	GSE164897_VemTra	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49594
0	-0.671140601808476	0.035	0.519	0	ZNF593	Malignant cells	GSE164897_VemTra	ENSG00000142684	51042	zinc finger protein 593	ZT86	protein_coding	O00488	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49595
0	-1.45831064858674	0.826	0.996	0	SH3BGRL3	Malignant cells	GSE164897_VemTra	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49596
0	-1.60443111680616	0.232	0.855	0	HMGN2	Malignant cells	GSE164897_VemTra	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49597
0	-0.638290668702905	0.153	0.597	0	NUDC	Malignant cells	GSE164897_VemTra	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49598
0	-1.02850760426593	0.193	0.824	0	ATP5IF1	Malignant cells	GSE164897_VemTra	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49599
0	-0.558142780593418	0.019	0.392	0	TINAGL1	Malignant cells	GSE164897_VemTra	ENSG00000142910	64129	tubulointerstitial nephritis antigen like 1	ARG1|LCN7|LIECG3|P3ECSL|TINAGRP	protein_coding	Q9GZM7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49600
0	-0.274118939863492	0.041	0.251	0	TMEM54	Malignant cells	GSE164897_VemTra	ENSG00000121900	113452	transmembrane protein 54	BCLP|CAC-1	protein_coding	Q969K7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49601
0	-0.467300857090038	0.156	0.508	0	AK2	Malignant cells	GSE164897_VemTra	ENSG00000004455	204	adenylate kinase 2	NA	protein_coding	P54819	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49602
0	-0.407958591071533	0.137	0.468	0	TRAPPC3	Malignant cells	GSE164897_VemTra	ENSG00000054116	27095	trafficking protein particle complex subunit 3	BET3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49603
0	-0.408555668953381	0.097	0.412	0	LSM10	Malignant cells	GSE164897_VemTra	ENSG00000181817	84967	LSM10, U7 small nuclear RNA associated	MGC15749	protein_coding	Q969L4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49604
0	-0.741077795942169	0.096	0.629	0	MRPS15	Malignant cells	GSE164897_VemTra	ENSG00000116898	64960	mitochondrial ribosomal protein S15	FLJ11564	protein_coding	P82914	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49605
0	-0.282101251606861	0.046	0.261	0	GNL2	Malignant cells	GSE164897_VemTra	ENSG00000134697	29889	G protein nucleolar 2	HUMAUANTIG|Ngp-1|Nog2|Nug2	protein_coding	Q13823	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49606
0	1.00840328390516	0.973	0.825	0	NDUFS5	Malignant cells	GSE164897_VemTra	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49607
0	-0.330488550972847	0.113	0.385	0	PPIE	Malignant cells	GSE164897_VemTra	ENSG00000084072	10450	peptidylprolyl isomerase E	CyP-33|MGC111222|MGC3736	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49608
0	-0.514681300238024	0.109	0.471	0	EBNA1BP2	Malignant cells	GSE164897_VemTra	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49609
0	-0.782984675875883	0.132	0.672	0	ATP6V0B	Malignant cells	GSE164897_VemTra	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49610
0	-0.434060053003589	0.01	0.335	0	ERI3	Malignant cells	GSE164897_VemTra	ENSG00000117419	79033	ERI1 exoribonuclease family member 3	FLJ22943|PINT1|PRNPIP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49611
0	0.350327533647155	1	1	0	RPS8	Malignant cells	GSE164897_VemTra	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49612
0	0.81366224332789	0.883	0.774	0	PRDX1	Malignant cells	GSE164897_VemTra	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49613
0	0.786926436944547	1	1	0	UQCRH	Malignant cells	GSE164897_VemTra	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49614
0	-0.563829243276787	0.148	0.568	0	MRPL37	Malignant cells	GSE164897_VemTra	ENSG00000116221	51253	mitochondrial ribosomal protein L37	MRP-L2|RPML2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49615
0	-1.19281945551841	0.403	0.941	0	SERBP1	Malignant cells	GSE164897_VemTra	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49616
0	-0.469290474645852	0.021	0.34	0	GADD45A	Malignant cells	GSE164897_VemTra	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49617
0	-0.604165661981006	0.247	0.706	0	GNG5	Malignant cells	GSE164897_VemTra	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49618
0	-0.43748677560664	0.198	0.529	0	LMO4	Malignant cells	GSE164897_VemTra	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49619
0	0.366774116716084	1	0.999	0	RPL5	Malignant cells	GSE164897_VemTra	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49620
0	-0.653462456383175	0.177	0.628	0	SARS1	Malignant cells	GSE164897_VemTra	ENSG00000031698	6301	seryl-tRNA synthetase 1	SARS|SERS	protein_coding	P49591	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49621
0	1.2047814160824	0.893	0.551	0	LAMTOR5	Malignant cells	GSE164897_VemTra	ENSG00000134248	10542	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	HBXIP|MGC71071|XIP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49622
0	-0.278415599330427	0.039	0.253	0	SIKE1	Malignant cells	GSE164897_VemTra	ENSG00000052723	80143	suppressor of IKBKE 1	FLJ21168|SIKE	protein_coding	Q9BRV8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49623
0	-0.83408361971444	0.016	0.541	0	PHGDH	Malignant cells	GSE164897_VemTra	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49624
0	1.60004288881388	0.758	0.076	0	TXNIP	Malignant cells	GSE164897_VemTra	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49625
0	-0.356503490885077	0.061	0.338	0	SF3B4	Malignant cells	GSE164897_VemTra	ENSG00000143368	10262	splicing factor 3b subunit 4	Hsh49|SAP49|SF3b49	protein_coding	Q15427	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49626
0	0.683648626679684	0.963	0.891	0	MRPS21	Malignant cells	GSE164897_VemTra	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49627
0	-0.564176748330255	0.19	0.621	0	ENSA	Malignant cells	GSE164897_VemTra	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49628
0	0.815535044290898	0.582	0.241	0	MLLT11	Malignant cells	GSE164897_VemTra	ENSG00000213190	10962	MLLT11 transcription factor 7 cofactor	AF1Q	protein_coding	Q13015	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49629
0	-0.363255406878017	0.021	0.297	0	VPS72	Malignant cells	GSE164897_VemTra	ENSG00000163159	6944	vacuolar protein sorting 72 homolog	Swc2|TCFL1|YL-1|YL1	protein_coding	Q15906	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49630
0	-0.75682914942778	0.328	0.815	0	PSMD4	Malignant cells	GSE164897_VemTra	ENSG00000159352	5710	proteasome 26S subunit ubiquitin receptor, non-ATPase 4	AF|AF-1|Rpn10|S5A	protein_coding	P55036	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49631
0	0.680420249011756	0.691	0.513	0	PSMB4	Malignant cells	GSE164897_VemTra	ENSG00000159377	5692	proteasome 20S subunit beta 4	HN3|PROS26	protein_coding	P28070	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49632
0	-0.500203103725299	0.066	0.448	0	MRPL9	Malignant cells	GSE164897_VemTra	ENSG00000143436	65005	mitochondrial ribosomal protein L9	NA	protein_coding	Q9BYD2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49633
0	-1.41130798081895	0.629	0.979	0	S100A10	Malignant cells	GSE164897_VemTra	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49634
0	-2.41100396537578	0.993	1	0	S100A6	Malignant cells	GSE164897_VemTra	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49635
0	-1.51675303569112	0.362	0.966	0	S100A16	Malignant cells	GSE164897_VemTra	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49636
0	-0.305240425031216	0.082	0.329	0	SNAPIN	Malignant cells	GSE164897_VemTra	ENSG00000143553	23557	SNAP associated protein	BLOC1S7|BORCS3|SNAPAP	protein_coding	O95295	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49637
0	-0.744201861920789	0.326	0.828	0	JTB	Malignant cells	GSE164897_VemTra	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49638
0	-1.27882838348086	1	1	0	RPS27	Malignant cells	GSE164897_VemTra	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49639
0	-0.64810186153667	0.371	0.823	0	C1orf43	Malignant cells	GSE164897_VemTra	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49640
0	-0.318047748419956	0.051	0.3	0	PMVK	Malignant cells	GSE164897_VemTra	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49641
0	0.923177189780661	0.618	0.203	0	SHC1	Malignant cells	GSE164897_VemTra	ENSG00000160691	6464	SHC adaptor protein 1	p66|SHC|ShcA	protein_coding	P29353	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49642
0	-0.753152383332718	0.032	0.547	0	DPM3	Malignant cells	GSE164897_VemTra	ENSG00000179085	54344	dolichyl-phosphate mannosyltransferase subunit 3, regulatory	MGC125904|MGC125905|MGC34275	protein_coding	Q9P2X0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49643
0	-0.563126938532443	0.079	0.502	0	KRTCAP2	Malignant cells	GSE164897_VemTra	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49644
0	-0.611145130290936	0.05	0.494	0	MTX1	Malignant cells	GSE164897_VemTra	ENSG00000173171	4580	metaxin 1	MTX|MTXN	protein_coding	Q13505	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49645
0	-0.370612029793822	0.093	0.377	0	ARHGEF2	Malignant cells	GSE164897_VemTra	ENSG00000116584	9181	Rho/Rac guanine nucleotide exchange factor 2	GEF-H1|GEFH1|KIAA0651|Lfc|LFP40|P40	protein_coding	Q92974	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49646
0	-0.830271223861591	0.277	0.771	0	LMNA	Malignant cells	GSE164897_VemTra	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49647
0	-0.383319069742539	0.297	0.623	0	MRPL24	Malignant cells	GSE164897_VemTra	ENSG00000143314	79590	mitochondrial ribosomal protein L24	MRP-L18	protein_coding	Q96A35	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49648
0	-1.72835232402659	0.21	0.946	0	PFDN2	Malignant cells	GSE164897_VemTra	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49649
0	-0.61197078737743	0.133	0.572	0	NDUFS2	Malignant cells	GSE164897_VemTra	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49650
0	-0.408553534851357	0.046	0.359	0	DUSP12	Malignant cells	GSE164897_VemTra	ENSG00000081721	11266	dual specificity phosphatase 12	DUSP1|YVH1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49651
0	1.23296941276234	0.716	0.261	0	MGST3	Malignant cells	GSE164897_VemTra	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49652
0	-0.350551197555402	0.089	0.369	0	MPC2	Malignant cells	GSE164897_VemTra	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49653
0	-0.360082241199211	0.125	0.42	0	TIPRL	Malignant cells	GSE164897_VemTra	ENSG00000143155	261726	TOR signaling pathway regulator	dJ69E11.3|MGC3794|TIP41|TIPRL1	protein_coding	O75663	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49654
0	0.709829944489419	0.421	0.09	0	ATP1B1	Malignant cells	GSE164897_VemTra	ENSG00000143153	481	ATPase Na+/K+ transporting subunit beta 1	ATP1B	protein_coding	P05026	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49655
0	-0.931072129714876	0.151	0.701	0	CACYBP	Malignant cells	GSE164897_VemTra	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49656
0	0.753191823781747	0.527	0.199	0	TOR1AIP2	Malignant cells	GSE164897_VemTra	ENSG00000169905	163590	torsin 1A interacting protein 2	IFRG15|LULL1|NET9	protein_coding	Q8NFQ8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49657
0	-0.46326786968146	0.029	0.363	0	GLRX2	Malignant cells	GSE164897_VemTra	ENSG00000023572	51022	glutaredoxin 2	bA101E13.1|GRX2	protein_coding	Q9NS18	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49658
0	-0.435638131523659	0.01	0.323	0	SERTAD4-AS1	Malignant cells	GSE164897_VemTra	ENSG00000280963	NA	NA	C1orf133	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49659
0	0.456984580562431	0.264	0.005	0	TGFB2	Malignant cells	GSE164897_VemTra	ENSG00000092969	7042	transforming growth factor beta 2	NA	protein_coding	P61812	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49660
0	-0.750934065576881	0.17	0.699	0	ARF1	Malignant cells	GSE164897_VemTra	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49661
0	-0.373491123929076	0.027	0.308	0	C1orf35	Malignant cells	GSE164897_VemTra	ENSG00000143793	79169	chromosome 1 open reading frame 35	MGC4174|MMTAG2	protein_coding	Q9BU76	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49662
0	-0.661956277361784	0.057	0.537	0	MRPL55	Malignant cells	GSE164897_VemTra	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49663
0	-1.10333239448556	0.262	0.891	0	GUK1	Malignant cells	GSE164897_VemTra	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49664
0	-0.535820118295739	0.034	0.415	0	H2AC25	Malignant cells	GSE164897_VemTra	ENSG00000284841	92815	H2A clustered histone 25	H2AW|HIST3H2A|MGC3165	protein_coding	Q7L7L0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49665
0	-0.345965472491982	0.063	0.334	0	RAB4A	Malignant cells	GSE164897_VemTra	ENSG00000168118	5867	RAB4A, member RAS oncogene family	HRES-1/RAB4|RAB4	protein_coding	P20338	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49666
0	-0.286902882947377	0.041	0.262	0	FH	Malignant cells	GSE164897_VemTra	ENSG00000091483	2271	fumarate hydratase	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49667
0	-0.407007699949587	0.066	0.368	0	SCCPDH	Malignant cells	GSE164897_VemTra	ENSG00000143653	51097	saccharopine dehydrogenase (putative)	CGI-49|NET11	protein_coding	Q8NBX0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49668
0	-0.383555860020228	0.083	0.384	0	RNASEH1	Malignant cells	GSE164897_VemTra	ENSG00000171865	246243	ribonuclease H1	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49669
0	-0.348616943210628	0.023	0.285	0	RNASEH1-DT	Malignant cells	GSE164897_VemTra	ENSG00000234171	100506054	RNASEH1 divergent transcript	LOC100506054|RNASEH1-AS1	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49670
0	0.827386578332492	1	1	0	RPS7	Malignant cells	GSE164897_VemTra	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49671
0	-0.482665712016531	0.105	0.474	0	ITGB1BP1	Malignant cells	GSE164897_VemTra	ENSG00000119185	9270	integrin subunit beta 1 binding protein 1	ICAP-1A|ICAP-1alpha|ICAP-1B|ICAP1|ICAP1A|ICAP1B	protein_coding	O14713	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49672
0	-0.608275975456464	0.234	0.666	0	YWHAQ	Malignant cells	GSE164897_VemTra	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49673
0	-0.488609440395932	0.032	0.288	0	RRM2	Malignant cells	GSE164897_VemTra	ENSG00000171848	6241	ribonucleotide reductase regulatory subunit M2	C2orf48|FLJ25102	protein_coding	P31350	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49674
0	0.600042841007232	0.791	0.688	0	SF3B6	Malignant cells	GSE164897_VemTra	ENSG00000115128	51639	splicing factor 3b subunit 6	CGI-110|Ht006|P14|SAP14a|SF3B14a	protein_coding	Q9Y3B4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49675
0	-0.33091226107443	0.073	0.323	0	TP53I3	Malignant cells	GSE164897_VemTra	ENSG00000115129	9540	tumor protein p53 inducible protein 3	PIG3	protein_coding	Q53FA7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49676
0	-0.634671114524356	0.08	0.551	0	PTRHD1	Malignant cells	GSE164897_VemTra	ENSG00000184924	391356	peptidyl-tRNA hydrolase domain containing 1	C2orf79|LOC391356	protein_coding	Q6GMV3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49677
0	0.848389818315962	0.996	0.968	0	OST4	Malignant cells	GSE164897_VemTra	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49678
0	-0.522886024704265	0.171	0.562	0	PPM1G	Malignant cells	GSE164897_VemTra	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49679
0	1.01756837210994	0.583	0.165	0	PPP1CB	Malignant cells	GSE164897_VemTra	ENSG00000213639	5500	protein phosphatase 1 catalytic subunit beta	MP|PP-1B|PP1B|PP1beta|PP1c|PPP1beta	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49680
0	-0.431792927503758	0.049	0.372	0	WDR43	Malignant cells	GSE164897_VemTra	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49681
0	-0.328847980319788	0.056	0.301	0	CDC42EP3	Malignant cells	GSE164897_VemTra	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49682
0	-0.405599071635185	0.098	0.417	0	AAK1	Malignant cells	GSE164897_VemTra	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49683
0	0.761914811575	0.622	0.338	0	PCBP1	Malignant cells	GSE164897_VemTra	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49684
0	-0.454028471490993	0.094	0.44	0	FAM136A	Malignant cells	GSE164897_VemTra	ENSG00000035141	84908	family with sequence similarity 136 member A	FLJ14668	protein_coding	Q96C01	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49685
0	-0.485295146480026	0.033	0.363	0	TGFA	Malignant cells	GSE164897_VemTra	ENSG00000163235	7039	transforming growth factor alpha	NA	protein_coding	P01135	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49686
0	-0.904960038538457	0.069	0.677	0	CCT7	Malignant cells	GSE164897_VemTra	ENSG00000135624	10574	chaperonin containing TCP1 subunit 7	Ccth|Nip7-1	protein_coding	Q99832	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49687
0	-0.479566998496247	0.21	0.591	0	DGUOK	Malignant cells	GSE164897_VemTra	ENSG00000114956	1716	deoxyguanosine kinase	dGK	protein_coding	Q16854	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49688
0	-0.718995412792195	0.099	0.609	0	BOLA3	Malignant cells	GSE164897_VemTra	ENSG00000163170	388962	bolA family member 3	NA	protein_coding	Q53S33	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49689
0	-1.0717277568472	0.09	0.695	0	MTHFD2	Malignant cells	GSE164897_VemTra	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49690
0	-0.347241700782755	0.106	0.38	0	WDR54	Malignant cells	GSE164897_VemTra	ENSG00000005448	84058	WD repeat domain 54	FLJ12953	protein_coding	Q9H977	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49691
0	-0.485855496157108	0.154	0.52	0	AUP1	Malignant cells	GSE164897_VemTra	ENSG00000115307	550	AUP1 lipid droplet regulating VLDL assembly factor	NA	protein_coding	Q9Y679	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49692
0	-0.353761033899336	0.075	0.352	0	POLE4	Malignant cells	GSE164897_VemTra	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49693
0	-0.338456769346605	0.048	0.311	0	MRPL19	Malignant cells	GSE164897_VemTra	ENSG00000115364	9801	mitochondrial ribosomal protein L19	KIAA0104|MRP-L15|RLX1|RPML15	protein_coding	P49406	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49694
0	-0.317666237522536	0.086	0.344	0	SUCLG1	Malignant cells	GSE164897_VemTra	ENSG00000163541	8802	succinate-CoA ligase GDP/ADP-forming subunit alpha	NA	protein_coding	P53597	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49695
0	0.617721803009728	0.472	0.182	0	TGOLN2	Malignant cells	GSE164897_VemTra	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49696
0	-0.347221789811022	0.068	0.33	0	CAPG	Malignant cells	GSE164897_VemTra	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49697
0	0.562571629772763	0.43	0.155	0	VAMP8	Malignant cells	GSE164897_VemTra	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49698
0	-0.366112476729849	0.189	0.484	0	VAMP5	Malignant cells	GSE164897_VemTra	ENSG00000168899	10791	vesicle associated membrane protein 5	NA	protein_coding	O95183	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49699
0	-1.32168626323362	0.252	0.931	0	COX5B	Malignant cells	GSE164897_VemTra	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49700
0	-0.817004557444249	0.361	0.845	0	EIF5B	Malignant cells	GSE164897_VemTra	ENSG00000158417	9669	eukaryotic translation initiation factor 5B	DKFZp434I036|FLJ10524|IF2|KIAA0741	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49701
0	-0.365563221426675	0.999	1	0	RPL31	Malignant cells	GSE164897_VemTra	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49702
0	-0.324767332732836	0.039	0.281	0	FHL2	Malignant cells	GSE164897_VemTra	ENSG00000115641	2274	four and a half LIM domains 2	DRAL|SLIM3	protein_coding	Q14192	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49703
0	-0.381894827687269	0.034	0.331	0	CHCHD5	Malignant cells	GSE164897_VemTra	ENSG00000125611	84269	coiled-coil-helix-coiled-coil-helix domain containing 5	C2orf9|MGC11104|MIC14|MIX14	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49704
0	-0.605180356856557	0.269	0.685	0	DDX18	Malignant cells	GSE164897_VemTra	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49705
0	-0.828244053331853	0.039	0.599	0	GYPC	Malignant cells	GSE164897_VemTra	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49706
0	-1.28976752383684	0.101	0.859	0	MZT2B	Malignant cells	GSE164897_VemTra	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49707
0	-0.581509764333911	0.046	0.469	0	IMP4	Malignant cells	GSE164897_VemTra	ENSG00000136718	92856	IMP U3 small nucleolar ribonucleoprotein 4	BXDC4|MGC19606	protein_coding	Q96G21	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49708
0	-0.885785223922072	0.052	0.659	0	MZT2A	Malignant cells	GSE164897_VemTra	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49709
0	-0.346538627403379	0.16	0.449	0	OLA1	Malignant cells	GSE164897_VemTra	ENSG00000138430	29789	Obg like ATPase 1	GTPBP9|PTD004	protein_coding	Q9NTK5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49710
0	-0.484557010020707	0.233	0.592	0	ZC3H15	Malignant cells	GSE164897_VemTra	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49711
0	-0.59808262518973	0.438	0.794	0	HSPD1	Malignant cells	GSE164897_VemTra	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49712
0	-0.438782851003529	0.066	0.37	0	SPATS2L	Malignant cells	GSE164897_VemTra	ENSG00000196141	26010	spermatogenesis associated serine rich 2 like	DNAPTP6|SGNP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49713
0	-0.512507398561874	0.05	0.418	0	NOP58	Malignant cells	GSE164897_VemTra	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49714
0	-0.365102336422684	0.026	0.292	0	NRP2	Malignant cells	GSE164897_VemTra	ENSG00000118257	8828	neuropilin 2	VEGF165R2	protein_coding	O60462	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49715
0	-0.362063674850112	0.075	0.353	0	ATIC	Malignant cells	GSE164897_VemTra	ENSG00000138363	471	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	AICARFT|IMPCHASE|PURH	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49716
0	-0.681464050065403	1	1	0	RPL37A	Malignant cells	GSE164897_VemTra	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49717
0	-0.875697816244066	0.31	0.838	0	ARPC2	Malignant cells	GSE164897_VemTra	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49718
0	-0.290190936595837	0.057	0.281	0	DNPEP	Malignant cells	GSE164897_VemTra	ENSG00000123992	23549	aspartyl aminopeptidase	ASPEP|DAP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49719
0	-0.361044307715371	0.112	0.404	0	MFF	Malignant cells	GSE164897_VemTra	ENSG00000168958	56947	mitochondrial fission factor	C2orf33|GL004	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49720
0	-0.72269790354751	0.363	0.782	0	NCL	Malignant cells	GSE164897_VemTra	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49721
0	-1.78031091013341	0.847	0.995	0	PTMA	Malignant cells	GSE164897_VemTra	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49722
0	-0.697835033737614	0.006	0.422	0	RAMP1	Malignant cells	GSE164897_VemTra	ENSG00000132329	10267	receptor activity modifying protein 1	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49723
0	-0.537752069993793	0.081	0.419	0	UBE2F	Malignant cells	GSE164897_VemTra	ENSG00000184182	140739	ubiquitin conjugating enzyme E2 F (putative)	NCE2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49724
0	-1.00522160504147	0.151	0.784	0	COPS9	Malignant cells	GSE164897_VemTra	ENSG00000172428	150678	COP9 signalosome subunit 9	CSNAP|MYEOV2	protein_coding	Q8WXC6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49725
0	-0.302664981753962	0.026	0.255	0	STK25	Malignant cells	GSE164897_VemTra	ENSG00000115694	10494	serine/threonine kinase 25	SOK1|YSK1	protein_coding	O00506	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49726
0	-0.531344523980558	0.025	0.387	0	DTYMK	Malignant cells	GSE164897_VemTra	ENSG00000168393	1841	deoxythymidylate kinase	CDC8|TMPK|TYMK	protein_coding	P23919	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49727
0	-0.389820711453423	0.071	0.373	0	ARPC4	Malignant cells	GSE164897_VemTra	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49728
0	-0.414944764303868	0.058	0.371	0	RPUSD3	Malignant cells	GSE164897_VemTra	ENSG00000156990	285367	RNA pseudouridine synthase D3	MGC29784	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49729
0	-0.503176295797096	0.07	0.452	0	JAGN1	Malignant cells	GSE164897_VemTra	ENSG00000171135	84522	jagunal homolog 1	FLJ14602|GL009	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49730
0	1.12414422276397	0.94	0.684	0	BRK1	Malignant cells	GSE164897_VemTra	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49731
0	0.624891525687193	1	1	0	RPL32	Malignant cells	GSE164897_VemTra	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49732
0	-0.360425118957592	0.102	0.381	0	MRPS25	Malignant cells	GSE164897_VemTra	ENSG00000131368	64432	mitochondrial ribosomal protein S25	DKFZp313H0817|FLJ00023|MRP-S25|RPMS25	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49733
0	0.403718061295073	1	1	0	RPL15	Malignant cells	GSE164897_VemTra	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49734
0	-0.316093664605845	0.076	0.33	0	CMC1	Malignant cells	GSE164897_VemTra	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49735
0	-1.08738722232921	0.049	0.71	0	CMTM7	Malignant cells	GSE164897_VemTra	ENSG00000153551	112616	CKLF like MARVEL transmembrane domain containing 7	CKLFSF7|FLJ30992	protein_coding	Q96FZ5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49736
0	-0.318335553131397	0.037	0.277	0	DYNC1LI1	Malignant cells	GSE164897_VemTra	ENSG00000144635	51143	dynein cytoplasmic 1 light intermediate chain 1	DNCLI1	protein_coding	Q9Y6G9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49737
0	0.444523200073752	1	1	0	RPSA	Malignant cells	GSE164897_VemTra	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49738
0	0.904307912112635	1	1	0	RPL14	Malignant cells	GSE164897_VemTra	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49739
0	0.844047910436927	0.464	0.14	0	CTNNB1	Malignant cells	GSE164897_VemTra	ENSG00000168036	1499	catenin beta 1	armadillo|beta-catenin|CTNNB	protein_coding	P35222	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49740
0	-0.292919498412608	0.048	0.276	0	CCDC12	Malignant cells	GSE164897_VemTra	ENSG00000160799	151903	coiled-coil domain containing 12	MGC23918	protein_coding	Q8WUD4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49741
0	-0.276967313715019	0.053	0.269	0	KIF9	Malignant cells	GSE164897_VemTra	ENSG00000088727	64147	kinesin family member 9	MGC104186	protein_coding	Q9HAQ2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49742
0	-0.470631241398025	0.213	0.571	0	UQCRC1	Malignant cells	GSE164897_VemTra	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49743
0	-0.676935052206217	0.172	0.655	0	NDUFAF3	Malignant cells	GSE164897_VemTra	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49744
0	-1.81448877114493	0	0.932	0	GPX1	Malignant cells	GSE164897_VemTra	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49745
0	-0.350924475337379	0.132	0.414	0	GNAI2	Malignant cells	GSE164897_VemTra	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49746
0	-0.305500047598504	0.041	0.267	0	SEMA3B	Malignant cells	GSE164897_VemTra	ENSG00000012171	7869	semaphorin 3B	LUCA-1|SemA|sema5|SEMAA|semaV	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49747
0	-0.589493258155304	0.076	0.503	0	IFRD2	Malignant cells	GSE164897_VemTra	ENSG00000214706	7866	interferon related developmental regulator 2	IFNRP|SKMc15|SM15	protein_coding	Q12894	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49748
0	-0.358627101103269	0.074	0.357	0	TUSC2	Malignant cells	GSE164897_VemTra	ENSG00000114383	11334	tumor suppressor 2, mitochondrial calcium regulator	C3orf11|FUS1|PAP|PDAP2	protein_coding	O75896	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49749
0	-0.398728722937049	0.083	0.391	0	MANF	Malignant cells	GSE164897_VemTra	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49750
0	-0.41106763223876	0.07	0.39	0	TEX264	Malignant cells	GSE164897_VemTra	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49751
0	-0.524144590678725	0.069	0.462	0	PCBP4	Malignant cells	GSE164897_VemTra	ENSG00000090097	57060	poly(rC) binding protein 4	LIP4|MCG10	protein_coding	P57723	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49752
0	-0.52528928088947	0.135	0.526	0	ABHD14B	Malignant cells	GSE164897_VemTra	ENSG00000114779	84836	abhydrolase domain containing 14B	CIB|MGC15429	protein_coding	Q96IU4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49753
0	-2.15127281798582	0.987	1	0	RPL29	Malignant cells	GSE164897_VemTra	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49754
0	-0.489678657706709	0.024	0.39	0	TWF2	Malignant cells	GSE164897_VemTra	ENSG00000247596	11344	twinfilin actin binding protein 2	A6r|A6RP|PTK9L	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49755
0	-0.819051340151809	0.149	0.7	0	SMIM4	Malignant cells	GSE164897_VemTra	ENSG00000168273	440957	small integral membrane protein 4	C3orf78	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49756
0	-0.69939060428411	0.345	0.817	0	SPCS1	Malignant cells	GSE164897_VemTra	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49757
0	-0.506044699647165	0.063	0.44	0	PSMD6	Malignant cells	GSE164897_VemTra	ENSG00000163636	9861	proteasome 26S subunit, non-ATPase 6	KIAA0107|p44S10|Rpn7|S10	protein_coding	Q15008	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49758
0	-0.812931144436872	0.212	0.702	0	CMSS1	Malignant cells	GSE164897_VemTra	ENSG00000184220	84319	cms1 ribosomal small subunit homolog	C3orf26|MGC4308	protein_coding	Q9BQ75	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49759
0	0.642670276204983	1	1	0	RPL24	Malignant cells	GSE164897_VemTra	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49760
0	-0.325976767699126	0.068	0.322	0	ATG3	Malignant cells	GSE164897_VemTra	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49761
0	0.500358607763331	0.314	0.031	0	ZBTB20	Malignant cells	GSE164897_VemTra	ENSG00000181722	26137	zinc finger and BTB domain containing 20	DKFZp566F123|DPZF|ODA-8S|ZNF288	protein_coding	Q9HC78	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49762
0	0.405670254871343	0.253	0.027	0	FSTL1	Malignant cells	GSE164897_VemTra	ENSG00000163430	11167	follistatin like 1	FRP|FSL1|OCC-1|OCC1|tsc36	protein_coding	Q12841	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49763
0	0.726138551643934	0.797	0.652	0	NDUFB4	Malignant cells	GSE164897_VemTra	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49764
0	-0.617766323555784	0.013	0.401	0	MGLL	Malignant cells	GSE164897_VemTra	ENSG00000074416	11343	monoglyceride lipase	HU-K5|MAGL|MGL	protein_coding	Q99685	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49765
0	-0.407001172530993	0.042	0.346	0	RUVBL1	Malignant cells	GSE164897_VemTra	ENSG00000284901	8607	RuvB like AAA ATPase 1	ECP54|INO80H|NMP238|Pontin52|RVB1|TIH1|TIP49|TIP49a	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49766
0	-0.599986624169817	0.263	0.682	0	CNBP	Malignant cells	GSE164897_VemTra	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49767
0	-0.432298083337878	0.079	0.41	0	MRPL3	Malignant cells	GSE164897_VemTra	ENSG00000114686	11222	mitochondrial ribosomal protein L3	MRL3|RPML3	protein_coding	P09001	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49768
0	-0.272295012941047	0.044	0.257	0	MRPS22	Malignant cells	GSE164897_VemTra	ENSG00000175110	56945	mitochondrial ribosomal protein S22	C3orf5|GIBT|GK002|MRP-S22	protein_coding	P82650	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49769
0	-0.493155427408993	0.129	0.493	0	ATP1B3	Malignant cells	GSE164897_VemTra	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49770
0	-0.457236631778923	0.204	0.524	0	WWTR1	Malignant cells	GSE164897_VemTra	ENSG00000018408	25937	WW domain containing transcription regulator 1	DKFZp586I1419|TAZ	protein_coding	Q9GZV5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49771
0	-0.574276902387292	0.314	0.751	0	SERP1	Malignant cells	GSE164897_VemTra	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49772
0	-0.357219795242173	0.143	0.435	0	EIF2A	Malignant cells	GSE164897_VemTra	ENSG00000144895	83939	eukaryotic translation initiation factor 2A	EIF-2A	protein_coding	Q9BY44	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49773
0	-0.286263774875859	0.049	0.27	0	GMPS	Malignant cells	GSE164897_VemTra	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49774
0	-0.350728279783877	0.13	0.411	0	DNAJC19	Malignant cells	GSE164897_VemTra	ENSG00000205981	131118	DnaJ heat shock protein family (Hsp40) member C19	Pam18|Tim14|TIMM14	protein_coding	Q96DA6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49775
0	-0.306832329850302	0.041	0.277	0	PARL	Malignant cells	GSE164897_VemTra	ENSG00000175193	55486	presenilin associated rhomboid like	PRO2207|PSARL|PSARL1|RHBDS1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49776
0	-0.513888411143399	0.335	0.723	0	AP2M1	Malignant cells	GSE164897_VemTra	ENSG00000161203	1173	adaptor related protein complex 2 subunit mu 1	AP50|CLAPM1|mu2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49777
0	-0.425364119699199	0.058	0.381	0	ALG3	Malignant cells	GSE164897_VemTra	ENSG00000214160	10195	ALG3 alpha-1,3- mannosyltransferase	CDGS4|D16Ertd36e|Not56|NOT56L	protein_coding	Q92685	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49778
0	-0.414945691425819	0.171	0.495	0	TRA2B	Malignant cells	GSE164897_VemTra	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49779
0	-1.26173841960205	0.194	0.712	0	HES1	Malignant cells	GSE164897_VemTra	ENSG00000114315	3280	hes family bHLH transcription factor 1	bHLHb39|FLJ20408|HES-1|HRY	protein_coding	Q14469	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49780
0	-0.437397364965116	0.042	0.375	0	NCBP2AS2	Malignant cells	GSE164897_VemTra	ENSG00000270170	152217	NCBP2 antisense 2 (head to head)	HIAR|KRASIM|NCBP2-AS2	protein_coding	Q69YL0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49781
0	-1.17012362944841	0.957	1	0	ATP5ME	Malignant cells	GSE164897_VemTra	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49782
0	-0.366175581569082	0.086	0.373	0	C4orf48	Malignant cells	GSE164897_VemTra	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49783
0	-0.419382592438194	0.043	0.364	0	MFSD10	Malignant cells	GSE164897_VemTra	ENSG00000109736	10227	major facilitator superfamily domain containing 10	IT10C3|TETRAN	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49784
0	-0.390518353020591	0.083	0.387	0	LRPAP1	Malignant cells	GSE164897_VemTra	ENSG00000163956	4043	LDL receptor related protein associated protein 1	A2MRAP|HBP44|RAP	protein_coding	P30533	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49785
0	-0.431218878601162	0.059	0.385	0	LYAR	Malignant cells	GSE164897_VemTra	ENSG00000145220	55646	Ly1 antibody reactive	ZC2HC2|ZLYAR	protein_coding	Q9NX58	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49786
0	-0.367436033629029	0.066	0.351	0	QDPR	Malignant cells	GSE164897_VemTra	ENSG00000151552	5860	quinoid dihydropteridine reductase	DHPR|PKU2|SDR33C1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49787
0	-0.332975296777358	0.095	0.364	0	SMIM20	Malignant cells	GSE164897_VemTra	ENSG00000250317	389203	small integral membrane protein 20	C4orf52|MITRAC7|PNX	protein_coding	Q8N5G0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49788
0	-0.519188985866445	0.123	0.514	0	PAICS	Malignant cells	GSE164897_VemTra	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49789
0	-0.772192988668166	0.032	0.292	0	CXCL1	Malignant cells	GSE164897_VemTra	ENSG00000163739	2919	C-X-C motif chemokine ligand 1	FSP|GRO1|GROa|MGSA|MGSA-a|NAP-3|SCYB1	protein_coding	P09341	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49790
0	-0.495389504831535	0.059	0.429	0	MRPL1	Malignant cells	GSE164897_VemTra	ENSG00000169288	65008	mitochondrial ribosomal protein L1	BM022	protein_coding	Q9BYD6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49791
0	-0.672524756125681	0.355	0.771	0	HNRNPDL	Malignant cells	GSE164897_VemTra	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49792
0	-0.36333550684694	0.132	0.43	0	PYURF	Malignant cells	GSE164897_VemTra	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49793
0	0.635902960880009	0.396	0.086	0	PPP3CA	Malignant cells	GSE164897_VemTra	ENSG00000138814	5530	protein phosphatase 3 catalytic subunit alpha	CALN|CALNA|CNA1|PPP2B	protein_coding	Q08209	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49794
0	-0.412794620977881	0.06	0.35	0	NFKB1	Malignant cells	GSE164897_VemTra	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49795
0	-0.522738213258773	0.283	0.68	0	UBE2D3	Malignant cells	GSE164897_VemTra	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49796
0	-0.67943753937684	1	1	0	RPL34	Malignant cells	GSE164897_VemTra	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49797
0	-1.74047513391075	0.325	0.981	0	SNHG8	Malignant cells	GSE164897_VemTra	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49798
0	1.22088272908475	0.74	0.207	0	C4orf3	Malignant cells	GSE164897_VemTra	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49799
0	-0.870463343120309	0.096	0.693	0	NDUFC1	Malignant cells	GSE164897_VemTra	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49800
0	-0.80103434258778	0.141	0.678	0	TMA16	Malignant cells	GSE164897_VemTra	ENSG00000198498	55319	translation machinery associated 16 homolog	C4orf43|FLJ11184	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49801
0	-0.375285736231338	0.085	0.373	0	SLC25A4	Malignant cells	GSE164897_VemTra	ENSG00000151729	291	solute carrier family 25 member 4	AAC1|ANT1|PEO2|PEO3|T1	protein_coding	P12235	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49802
0	-0.388766304392555	0.086	0.39	0	CFAP97	Malignant cells	GSE164897_VemTra	ENSG00000164323	57587	cilia and flagella associated protein 97	DKFZp434F1728|hmw|KIAA1430	protein_coding	Q9P2B7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49803
0	-0.510426623315591	0.02	0.321	0	SORBS2	Malignant cells	GSE164897_VemTra	ENSG00000154556	8470	sorbin and SH3 domain containing 2	ARGBP2|KIAA0777	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49804
0	-0.565325146325978	0.153	0.553	0	FRG1	Malignant cells	GSE164897_VemTra	ENSG00000275145	2483	FSHD region gene 1	FRG1A|FSG1	protein_coding	Q14331	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49805
0	-0.311028364536379	0.037	0.276	0	BRD9	Malignant cells	GSE164897_VemTra	ENSG00000028310	65980	bromodomain containing 9	FLJ13441|SMARCI2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49806
0	-0.824063776946581	0.129	0.683	0	NDUFS6	Malignant cells	GSE164897_VemTra	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49807
0	-0.412028887797562	0.049	0.361	0	MED10	Malignant cells	GSE164897_VemTra	ENSG00000133398	84246	mediator complex subunit 10	L6|MGC5309|NUT2|TRG20	protein_coding	Q9BTT4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49808
0	0.842022594468881	0.464	0.017	0	BASP1	Malignant cells	GSE164897_VemTra	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49809
0	0.613572620394862	0.785	0.669	0	SUB1	Malignant cells	GSE164897_VemTra	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49810
0	-0.360523535080752	0.024	0.297	0	WDR70	Malignant cells	GSE164897_VemTra	ENSG00000082068	55100	WD repeat domain 70	FLJ10233	protein_coding	Q9NW82	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49811
0	-0.635972922694452	1	1	0	RPL37	Malignant cells	GSE164897_VemTra	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49812
0	-0.365901734210992	0.033	0.308	0	MRPS30	Malignant cells	GSE164897_VemTra	ENSG00000112996	10884	mitochondrial ribosomal protein S30	PAP|PDCD9	protein_coding	Q9NP92	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49813
0	-0.47329046384021	0.193	0.552	0	NDUFAF2	Malignant cells	GSE164897_VemTra	ENSG00000164182	91942	NADH:ubiquinone oxidoreductase complex assembly factor 2	B17.2L|mimitin|MMTN|NDUFA12L	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49814
0	-0.382863130898451	0.021	0.295	0	CENPH	Malignant cells	GSE164897_VemTra	ENSG00000153044	64946	centromere protein H	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49815
0	-0.350175003727047	0.109	0.394	0	ZCCHC9	Malignant cells	GSE164897_VemTra	ENSG00000131732	84240	zinc finger CCHC-type containing 9	DKFZp761J139|PPP1R41	protein_coding	Q8N567	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49816
0	1.24100517514496	1	1	0	RPS23	Malignant cells	GSE164897_VemTra	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49817
0	0.826783637814676	0.691	0.401	0	TMEM167A	Malignant cells	GSE164897_VemTra	ENSG00000174695	153339	transmembrane protein 167A	FLJ30508|MGC23909|TMEM167	protein_coding	Q8TBQ9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49818
0	1.08209042899748	1	0.999	0	COX7C	Malignant cells	GSE164897_VemTra	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49819
0	0.634828510323923	0.424	0.118	0	RHOBTB3	Malignant cells	GSE164897_VemTra	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49820
0	0.61925869980768	0.439	0.146	0	GLRX	Malignant cells	GSE164897_VemTra	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49821
0	0.434499269620457	0.303	0.059	0	PAM	Malignant cells	GSE164897_VemTra	ENSG00000145730	5066	peptidylglycine alpha-amidating monooxygenase	PAL|PHM	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49822
0	-0.820656245306227	0.141	0.696	0	EPB41L4A-AS1	Malignant cells	GSE164897_VemTra	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49823
0	-0.628836596049019	0.284	0.608	0	AP3S1	Malignant cells	GSE164897_VemTra	ENSG00000177879	1176	adaptor related protein complex 3 subunit sigma 1	CLAPS3	protein_coding	Q92572	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49824
0	1.61358146639754	1	0.989	0	HINT1	Malignant cells	GSE164897_VemTra	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49825
0	-0.749466053164327	0.047	0.545	0	PDLIM4	Malignant cells	GSE164897_VemTra	ENSG00000131435	8572	PDZ and LIM domain 4	RIL	protein_coding	P50479	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49826
0	-0.497163377107366	0.979	0.999	0	UQCRQ	Malignant cells	GSE164897_VemTra	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49827
0	-0.580982772394354	0.344	0.757	0	VDAC1	Malignant cells	GSE164897_VemTra	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49828
0	1.07042135027079	0.908	0.749	0	SKP1	Malignant cells	GSE164897_VemTra	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49829
0	-0.289632513570127	0.042	0.266	0	CDKN2AIPNL	Malignant cells	GSE164897_VemTra	ENSG00000237190	91368	CDKN2A interacting protein N-terminal like	C2AIL|MGC13017	protein_coding	Q96HQ2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49830
0	-0.487412485929284	0.259	0.627	0	DDX46	Malignant cells	GSE164897_VemTra	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49831
0	-0.495363399141546	0.223	0.608	0	UBE2D2	Malignant cells	GSE164897_VemTra	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49832
0	-0.404578608729479	0.14	0.46	0	SRA1	Malignant cells	GSE164897_VemTra	ENSG00000213523	10011	steroid receptor RNA activator 1	SRA|STRAA1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49833
0	-0.557663212677586	1	1	0	RPS14	Malignant cells	GSE164897_VemTra	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49834
0	-0.326929119777378	0.054	0.292	0	TNIP1	Malignant cells	GSE164897_VemTra	ENSG00000145901	10318	TNFAIP3 interacting protein 1	ABIN-1|KIAA0113|NAF1|VAN	protein_coding	Q15025	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49835
0	1.42240969122274	0.975	0.603	0	SPARC	Malignant cells	GSE164897_VemTra	ENSG00000113140	6678	secreted protein acidic and cysteine rich	BM-40|ON|ONT	protein_coding	P09486	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49836
0	-0.910111530773233	0.992	0.999	0	NPM1	Malignant cells	GSE164897_VemTra	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49837
0	1.26675655499246	0.762	0.303	0	ATP6V0E1	Malignant cells	GSE164897_VemTra	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49838
0	-0.318449936848184	0.054	0.301	0	BOD1	Malignant cells	GSE164897_VemTra	ENSG00000145919	91272	biorientation of chromosomes in cell division 1	FAM44B	protein_coding	Q96IK1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49839
0	-0.450521752725082	0.094	0.427	0	NOP16	Malignant cells	GSE164897_VemTra	ENSG00000048162	51491	NOP16 nucleolar protein	HSPC111|HSPC185|LOC51491	protein_coding	Q9Y3C1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49840
0	-0.738172422853871	0.197	0.729	0	HIGD2A	Malignant cells	GSE164897_VemTra	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49841
0	-1.13056446357943	0.391	0.936	0	PRELID1	Malignant cells	GSE164897_VemTra	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49842
0	-0.586859266679902	0.073	0.505	0	LMAN2	Malignant cells	GSE164897_VemTra	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49843
0	-0.592742654654201	0.022	0.44	0	PDLIM7	Malignant cells	GSE164897_VemTra	ENSG00000196923	9260	PDZ and LIM domain 7	ENIGMA	protein_coding	Q9NR12	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49844
0	-1.72639264205483	0.2	0.955	0	NHP2	Malignant cells	GSE164897_VemTra	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49845
0	-0.485951947480404	0.022	0.383	0	PSMG4	Malignant cells	GSE164897_VemTra	ENSG00000180822	389362	proteasome assembly chaperone 4	C6orf86|PAC4	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49846
0	-0.637127543803284	0.043	0.504	0	NOL7	Malignant cells	GSE164897_VemTra	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49847
0	-0.706354243781301	0.092	0.533	0	DEK	Malignant cells	GSE164897_VemTra	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49848
0	0.815156797893209	0.463	0.148	0	SOX4	Malignant cells	GSE164897_VemTra	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49849
0	-2.53120882221253	0.734	0.967	0	H4C3	Malignant cells	GSE164897_VemTra	ENSG00000197061	8364	H4 clustered histone 3	dJ221C16.1|H4/g|H4FG|HIST1H4C	protein_coding	P62805	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49850
0	-0.691794023946995	0.143	0.553	0	IER3	Malignant cells	GSE164897_VemTra	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49851
0	1.24598143875614	0.798	0.335	0	HLA-B	Malignant cells	GSE164897_VemTra	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49852
0	-0.500354177344889	0.209	0.601	0	CSNK2B	Malignant cells	GSE164897_VemTra	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49853
0	-0.412702728377742	0.089	0.414	0	LSM2	Malignant cells	GSE164897_VemTra	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49854
0	-0.73874443933769	0.177	0.68	0	SNHG32	Malignant cells	GSE164897_VemTra	ENSG00000229300	50854	small nucleolar RNA host gene 32	C6orf48|D6S57|G8	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49855
0	-0.490491113440377	0.103	0.475	0	NELFE	Malignant cells	GSE164897_VemTra	ENSG00000206268	7936	negative elongation factor complex member E	D6S45|NELF-E|RD|RDBP|RDP	protein_coding	P18615	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49856
0	0.530335910993793	1	1	0	RPS18	Malignant cells	GSE164897_VemTra	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49857
0	-0.543577154260711	0.12	0.534	0	CUTA	Malignant cells	GSE164897_VemTra	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49858
0	-2.40778913992359	0.183	0.986	0	HMGA1	Malignant cells	GSE164897_VemTra	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49859
0	-0.398808242121173	0.027	0.328	0	SMIM29	Malignant cells	GSE164897_VemTra	ENSG00000186577	221491	small integral membrane protein 29	C6orf1|LBH|MGC57858	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49860
0	1.19371927569731	1	0.985	0	RPS10	Malignant cells	GSE164897_VemTra	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49861
0	-0.466199532731718	0.116	0.476	0	SNRPC	Malignant cells	GSE164897_VemTra	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49862
0	0.75165242766104	1	1	0	RPL10A	Malignant cells	GSE164897_VemTra	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49863
0	-0.582109954109654	0.058	0.487	0	DNPH1	Malignant cells	GSE164897_VemTra	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49864
0	0.595120466067589	1	1	0	EEF1A1	Malignant cells	GSE164897_VemTra	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49865
0	0.935513132620593	0.998	0.972	0	COX7A2	Malignant cells	GSE164897_VemTra	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49866
0	-0.443336361425128	0.064	0.398	0	RPF2	Malignant cells	GSE164897_VemTra	ENSG00000197498	84154	ribosome production factor 2 homolog	bA397G5.4|BXDC1|FLJ21087	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49867
0	0.923828739489162	0.504	0.029	0	MARCKS	Malignant cells	GSE164897_VemTra	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49868
0	0.747554442200696	0.476	0.104	0	NCOA7	Malignant cells	GSE164897_VemTra	ENSG00000111912	135112	nuclear receptor coactivator 7	dJ187J11.3|ERAP140|TLDC4	protein_coding	Q8NI08	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49869
0	0.842135153982388	1	1	0	RPS12	Malignant cells	GSE164897_VemTra	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49870
0	-0.433115535508344	0.014	0.301	0	NHSL1-AS1	Malignant cells	GSE164897_VemTra	ENSG00000225177	NA	NA	FLJ46906	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49871
0	-0.388098441542473	0.066	0.363	0	PCMT1	Malignant cells	GSE164897_VemTra	ENSG00000120265	5110	protein-L-isoaspartate (D-aspartate) O-methyltransferase	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49872
0	-0.347647043027008	0.136	0.416	0	TCP1	Malignant cells	GSE164897_VemTra	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49873
0	-0.335850468260945	0.068	0.335	0	SFT2D1	Malignant cells	GSE164897_VemTra	ENSG00000198818	113402	SFT2 domain containing 1	C6orf83|MGC19825|pRGR1	protein_coding	Q8WV19	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49874
0	-0.457608207655652	0.036	0.382	0	C7orf50	Malignant cells	GSE164897_VemTra	ENSG00000146540	84310	chromosome 7 open reading frame 50	MGC11257|YCR016W	protein_coding	Q9BRJ6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49875
0	-0.446208561061701	0.051	0.386	0	PSMG3	Malignant cells	GSE164897_VemTra	ENSG00000157778	84262	proteasome assembly chaperone 3	C7orf48|MGC10911|PAC3	protein_coding	Q9BT73	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49876
0	-0.320995446598244	0.026	0.264	0	NUDT1	Malignant cells	GSE164897_VemTra	ENSG00000106268	4521	nudix hydrolase 1	MTH1	protein_coding	P36639	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49877
0	-0.874997188610921	0.847	0.983	0	ACTB	Malignant cells	GSE164897_VemTra	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49878
0	-0.709214198375526	0.01	0.502	0	FSCN1	Malignant cells	GSE164897_VemTra	ENSG00000075618	6624	fascin actin-bundling protein 1	FLJ38511|p55|SNL	protein_coding	Q16658	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49879
0	1.38852850263674	0.998	0.92	0	NDUFA4	Malignant cells	GSE164897_VemTra	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49880
0	-0.322428023515206	0.098	0.363	0	BZW2	Malignant cells	GSE164897_VemTra	ENSG00000136261	28969	basic leucine zipper and W2 domains 2	5MP1|HSPC028|MST017|MSTP017	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49881
0	-0.387976501324539	0.012	0.285	0	TSPAN13	Malignant cells	GSE164897_VemTra	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49882
0	0.456231982135963	0.3	0.057	0	AHR	Malignant cells	GSE164897_VemTra	ENSG00000106546	196	aryl hydrocarbon receptor	bHLHe76	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49883
0	0.701730183615629	0.999	0.994	0	TOMM7	Malignant cells	GSE164897_VemTra	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49884
0	-0.374062930593155	0.041	0.328	0	MALSU1	Malignant cells	GSE164897_VemTra	ENSG00000156928	115416	mitochondrial assembly of ribosomal large subunit 1	C7orf30|mtRsfA	protein_coding	Q96EH3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49885
0	-0.640981745997519	0.091	0.54	0	GGCT	Malignant cells	GSE164897_VemTra	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49886
0	-0.533241141421228	0.142	0.525	0	GARS1	Malignant cells	GSE164897_VemTra	ENSG00000106105	2617	glycyl-tRNA synthetase 1	CMT2D|DSMAV|GARS|GlyRS|SMAD1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49887
0	-0.418003677892779	0.059	0.377	0	RALA	Malignant cells	GSE164897_VemTra	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49888
0	-0.431616899447783	0.096	0.432	0	MPLKIP	Malignant cells	GSE164897_VemTra	ENSG00000168303	136647	M-phase specific PLK1 interacting protein	C7orf11|ORF20|TTDN1	protein_coding	Q8TAP9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49889
0	-1.17108782029595	0.108	0.656	0	INHBA	Malignant cells	GSE164897_VemTra	ENSG00000122641	3624	inhibin subunit beta A	NA	protein_coding	P08476	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49890
0	-0.338904056926262	0.059	0.311	0	STK17A	Malignant cells	GSE164897_VemTra	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49891
0	-0.725293208983663	0.027	0.531	0	POLD2	Malignant cells	GSE164897_VemTra	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49892
0	-0.598798392401068	0.98	0.999	0	PPIA	Malignant cells	GSE164897_VemTra	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49893
0	-0.539894425432413	0.175	0.554	0	H2AZ2	Malignant cells	GSE164897_VemTra	ENSG00000105968	94239	H2A.Z variant histone 2	H2AFV|H2AV|MGC10170|MGC10831|MGC1947	protein_coding	Q71UI9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49894
0	-0.435811089476976	0.003	0.298	0	UPP1	Malignant cells	GSE164897_VemTra	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49895
0	-0.545303870583543	0.228	0.634	0	CCT6A	Malignant cells	GSE164897_VemTra	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49896
0	-1.4854611888121	0.622	0.993	0	CHCHD2	Malignant cells	GSE164897_VemTra	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49897
0	-0.46590182630484	0.133	0.492	0	EIF4H	Malignant cells	GSE164897_VemTra	ENSG00000106682	7458	eukaryotic translation initiation factor 4H	KIAA0038|WBSCR1|WSCR1	protein_coding	Q15056	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49898
0	-1.40827851697549	0.211	0.927	0	MDH2	Malignant cells	GSE164897_VemTra	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49899
0	-1.53289015436035	0.131	0.915	0	HSPB1	Malignant cells	GSE164897_VemTra	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49900
0	0.652340201130411	0.487	0.175	0	YWHAG	Malignant cells	GSE164897_VemTra	ENSG00000170027	7532	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma	14-3-3GAMMA|PPP1R170	protein_coding	P61981	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49901
0	-0.286708754379247	0.045	0.267	0	RSBN1L	Malignant cells	GSE164897_VemTra	ENSG00000187257	222194	round spermatid basic protein 1 like	FLJ42526|FLJ45813|MGC71764	protein_coding	Q6PCB5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49902
0	0.550439456178505	0.348	0.064	0	SEMA3C	Malignant cells	GSE164897_VemTra	ENSG00000075223	10512	semaphorin 3C	SEMAE|SemE	protein_coding	Q99985	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49903
0	-0.44664192892626	0.019	0.262	0	TFPI2	Malignant cells	GSE164897_VemTra	ENSG00000105825	7980	tissue factor pathway inhibitor 2	PP5|REF1|TFPI-2	protein_coding	P48307	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49904
0	-0.441066560418839	0.019	0.336	0	ASNS	Malignant cells	GSE164897_VemTra	ENSG00000070669	440	asparagine synthetase (glutamine-hydrolyzing)	NA	protein_coding	P08243	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49905
0	-0.428306520626112	0.27	0.62	0	ARPC1A	Malignant cells	GSE164897_VemTra	ENSG00000241685	10552	actin related protein 2/3 complex subunit 1A	Arc40|SOP2Hs|SOP2L	protein_coding	Q92747	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49906
0	-1.28235202985773	0.179	0.851	0	ARPC1B	Malignant cells	GSE164897_VemTra	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49907
0	-0.769021614842684	0.172	0.703	0	PDAP1	Malignant cells	GSE164897_VemTra	ENSG00000106244	11333	PDGFA associated protein 1	HASPP28|PAP|PAP1	protein_coding	Q13442	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49908
0	-0.809822449342465	0.097	0.659	0	BUD31	Malignant cells	GSE164897_VemTra	ENSG00000106245	8896	BUD31 homolog	Cwc14|EDG-2|EDG2|fSAP17|G10|YCR063W	protein_coding	P41223	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49909
0	-0.70175497703146	0.179	0.678	0	COPS6	Malignant cells	GSE164897_VemTra	ENSG00000168090	10980	COP9 signalosome subunit 6	CSN6|MOV34-34KD	protein_coding	Q7L5N1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49910
0	-0.412619872891799	0.038	0.324	0	MCM7	Malignant cells	GSE164897_VemTra	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49911
0	-0.456634993821377	0.252	0.614	0	LAMTOR4	Malignant cells	GSE164897_VemTra	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49912
0	-0.445354957343589	0.101	0.441	0	GNB2	Malignant cells	GSE164897_VemTra	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49913
0	-0.491662884495638	0.031	0.381	0	POP7	Malignant cells	GSE164897_VemTra	ENSG00000172336	10248	POP7 homolog, ribonuclease P/MRP subunit	RPP2|RPP20	protein_coding	O75817	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49914
0	-0.702366332788695	0.081	0.574	0	AP1S1	Malignant cells	GSE164897_VemTra	ENSG00000106367	1174	adaptor related protein complex 1 subunit sigma 1	AP19|CLAPS1|EKV3|SIGMA1A|WUGSC:H_DJ0747G18.2	protein_coding	P61966	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49915
0	-0.37633474633685	0.067	0.354	0	PLOD3	Malignant cells	GSE164897_VemTra	ENSG00000106397	8985	procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	LH3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49916
0	-0.902122692214028	0.15	0.749	0	ZNHIT1	Malignant cells	GSE164897_VemTra	ENSG00000106400	10467	zinc finger HIT-type containing 1	CG1I|H_DJ0747G18.14|ZNFN4A1	protein_coding	O43257	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49917
0	-0.773386483958427	0.163	0.703	0	POLR2J	Malignant cells	GSE164897_VemTra	ENSG00000005075	5439	RNA polymerase II subunit J	hRPB14|POLR2J1|RPB11|RPB11A|RPB11m	protein_coding	P52435	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49918
0	-0.592879163816278	0.001	0.435	0	POLR2J3	Malignant cells	GSE164897_VemTra	ENSG00000168255	NA	NA	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49919
0	-0.463942407553882	0.058	0.402	0	DNAJC2	Malignant cells	GSE164897_VemTra	ENSG00000105821	27000	DnaJ heat shock protein family (Hsp40) member C2	MPHOSPH11|MPP11|ZRF1|ZUO1|zuotin	protein_coding	Q99543	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49920
0	-0.293684279769212	0.046	0.273	0	IFRD1	Malignant cells	GSE164897_VemTra	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49921
0	-0.574159262479763	0.118	0.505	0	FAM3C	Malignant cells	GSE164897_VemTra	ENSG00000196937	10447	FAM3 metabolism regulating signaling molecule C	GS3876|ILEI	protein_coding	Q92520	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49922
0	-0.35184899869024	0.102	0.378	0	CHCHD3	Malignant cells	GSE164897_VemTra	ENSG00000106554	54927	coiled-coil-helix-coiled-coil-helix domain containing 3	FLJ20420|Mic19|MICOS19|MINOS3|PPP1R22	protein_coding	Q9NX63	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49923
0	-0.302066771391789	0.057	0.296	0	FMC1	Malignant cells	GSE164897_VemTra	ENSG00000164898	154791	formation of mitochondrial complex V assembly factor 1 homolog	C7orf55|HSPC268	protein_coding	Q96HJ9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49924
0	-1.03634766191048	0.296	0.887	0	NDUFB2	Malignant cells	GSE164897_VemTra	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49925
0	-0.304651736287556	0.059	0.294	0	ZYX	Malignant cells	GSE164897_VemTra	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49926
0	-0.295453131756954	0.027	0.252	0	CDK5	Malignant cells	GSE164897_VemTra	ENSG00000164885	1020	cyclin dependent kinase 5	PSSALRE	protein_coding	Q00535	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49927
0	-0.321139225822843	0.029	0.272	0	FASTK	Malignant cells	GSE164897_VemTra	ENSG00000164896	10922	Fas activated serine/threonine kinase	FAST	protein_coding	Q14296	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49928
0	-0.446003582832212	0.155	0.496	0	RHEB	Malignant cells	GSE164897_VemTra	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49929
0	-1.90458597961457	0.522	0.998	0	SLC25A6	Malignant cells	GSE164897_VemTra	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49930
0	1.29569618473287	0.97	0.722	0	TMSB4X	Malignant cells	GSE164897_VemTra	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49931
0	-0.535570493693994	0.068	0.458	0	AP1S2	Malignant cells	GSE164897_VemTra	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49932
0	-0.407458049633175	0.19	0.52	0	SYAP1	Malignant cells	GSE164897_VemTra	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49933
0	-0.546373411956306	0.12	0.52	0	SH3KBP1	Malignant cells	GSE164897_VemTra	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49934
0	-0.877035291041233	0.132	0.697	0	SMS	Malignant cells	GSE164897_VemTra	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49935
0	-0.595635590558707	0.076	0.507	0	PRDX4	Malignant cells	GSE164897_VemTra	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49936
0	0.939065697246241	0.683	0.281	0	SAT1	Malignant cells	GSE164897_VemTra	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49937
0	-0.389049424548211	0.079	0.358	0	DYNLT3	Malignant cells	GSE164897_VemTra	ENSG00000165169	6990	dynein light chain Tctex-type 3	TCTE1L|TCTEX1L	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49938
0	-0.412341804005418	0.116	0.421	0	SRPX	Malignant cells	GSE164897_VemTra	ENSG00000101955	8406	sushi repeat containing protein X-linked	ETX1|SRPX1	protein_coding	P78539	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49939
0	-1.1741926053708	0.182	0.877	0	NDUFB11	Malignant cells	GSE164897_VemTra	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49940
0	-1.15448919627891	0.601	0.854	0	TIMP1	Malignant cells	GSE164897_VemTra	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49941
0	-0.565029250444415	0.277	0.713	0	UXT	Malignant cells	GSE164897_VemTra	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49942
0	-0.378214145490081	0.047	0.339	0	WDR13	Malignant cells	GSE164897_VemTra	ENSG00000101940	64743	WD repeat domain 13	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49943
0	-0.604112663455466	0.047	0.487	0	TIMM17B	Malignant cells	GSE164897_VemTra	ENSG00000126768	10245	translocase of inner mitochondrial membrane 17B	DXS9822|JM3	protein_coding	O60830	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49944
0	-0.67188298120129	0.04	0.528	0	PQBP1	Malignant cells	GSE164897_VemTra	ENSG00000102103	10084	polyglutamine binding protein 1	MRX2|MRX55|MRXS3|MRXS8|RENS1|SHS	protein_coding	O60828	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49945
0	-0.431823818612424	0.122	0.465	0	WDR45	Malignant cells	GSE164897_VemTra	ENSG00000196998	11152	WD repeat domain 45	JM5|NBIA5|WDRX1|WIPI4	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49946
0	-0.6636983639936	0.205	0.659	0	PLP2	Malignant cells	GSE164897_VemTra	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49947
0	0.777814606444574	0.466	0.07	0	GAGE1	Malignant cells	GSE164897_VemTra	ENSG00000205777	2543	G antigen 1	CT4.1	protein_coding	P0DTW1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49948
0	0.595926650085881	0.337	0.026	0	GAGE2A	Malignant cells	GSE164897_VemTra	ENSG00000189064	26749	G antigen 2E	CT4.2|GAGE2	protein_coding	Q6NT46	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49949
0	-0.523014901030519	0.136	0.527	0	HSD17B10	Malignant cells	GSE164897_VemTra	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49950
0	-0.7055496672941	0.011	0.492	0	PAGE2	Malignant cells	GSE164897_VemTra	ENSG00000234068	203569	PAGE family member 2	CT16.4|GAGEC2|MGC62094|PAGE-2	protein_coding	Q7Z2X7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49951
0	1.20511793445532	0.989	0.863	0	PAGE5	Malignant cells	GSE164897_VemTra	ENSG00000158639	90737	PAGE family member 5	CT16.1|CT16.2|PAGE-5	protein_coding	Q96GU1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49952
0	0.967550027665457	0.73	0.372	0	NBDY	Malignant cells	GSE164897_VemTra	ENSG00000204272	550643	negative regulator of P-body association	LINC01420|NoBody	protein_coding	A0A0U1RRE5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49953
0	0.792276810020199	1	1	0	RPS4X	Malignant cells	GSE164897_VemTra	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49954
0	0.633256075472788	0.493	0.205	0	XIST	Malignant cells	GSE164897_VemTra	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49955
0	-0.647676744923415	0.144	0.541	0	IL13RA2	Malignant cells	GSE164897_VemTra	ENSG00000123496	3598	interleukin 13 receptor subunit alpha 2	CD213a2|CT19|IL-13R|IL13BP	protein_coding	Q14627	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49956
0	-0.936907671764293	0.681	0.964	0	SLC25A5	Malignant cells	GSE164897_VemTra	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49957
0	-0.864660094655427	1	1	0	RPL39	Malignant cells	GSE164897_VemTra	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49958
0	-0.367908929456278	0.077	0.37	0	NKAP	Malignant cells	GSE164897_VemTra	ENSG00000101882	79576	NFKB activating protein	FLJ22626	protein_coding	Q8N5F7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49959
0	0.637654125396045	0.463	0.153	0	RTL8C	Malignant cells	GSE164897_VemTra	ENSG00000134590	8933	retrotransposon Gag like 8C	CXX1|FAM127A|Mar8|MAR8C|Mart8|SIRH5	protein_coding	A6ZKI3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49960
0	-0.400103492356935	0.081	0.387	0	MAP7D3	Malignant cells	GSE164897_VemTra	ENSG00000129680	79649	MAP7 domain containing 3	FLJ12649	protein_coding	Q8IWC1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49961
0	-1.19123939654599	0.248	0.88	0	RBMX	Malignant cells	GSE164897_VemTra	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49962
0	2.2589731250768	0.976	0.275	0	SPANXB1	Malignant cells	GSE164897_VemTra	ENSG00000227234	728695	SPANX family member B1	CT11.2|SPANXB2|SPANXF1|SPANXF2	protein_coding	Q9NS25	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49963
0	1.31424504565912	0.662	0.098	0	SPANXC	Malignant cells	GSE164897_VemTra	ENSG00000198573	64663	SPANX family member C	CT11.3|CTp11	protein_coding	Q9NY87	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49964
0	0.704761581672455	0.817	0.647	0	MAGEA4	Malignant cells	GSE164897_VemTra	ENSG00000147381	4103	MAGE family member A4	CT1.4|MAGE-41|MAGE-X2|MAGE4|MAGE4A|MAGE4B|MGC21336	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49965
0	0.754207607986536	0.71	0.495	0	CSAG1	Malignant cells	GSE164897_VemTra	ENSG00000198930	158511	chondrosarcoma associated gene 1	CSAGE|CT24.1	protein_coding	Q6PB30	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49966
0	-0.331743042911553	0.027	0.279	0	CCNQ	Malignant cells	GSE164897_VemTra	ENSG00000262919	92002	cyclin Q	CycM|FAM58A	protein_coding	Q8N1B3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49967
0	-0.346543724667983	0.044	0.307	0	IDH3G	Malignant cells	GSE164897_VemTra	ENSG00000067829	3421	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma	NA	protein_coding	P51553	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49968
0	-0.414501693967771	0.308	0.648	0	SSR4	Malignant cells	GSE164897_VemTra	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49969
0	-1.03680769105253	0.154	0.806	0	NAA10	Malignant cells	GSE164897_VemTra	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49970
0	-0.330976375875052	0.05	0.307	0	EMD	Malignant cells	GSE164897_VemTra	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49971
0	0.676987077714496	1	1	0	RPL10	Malignant cells	GSE164897_VemTra	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49972
0	-0.281568144351095	0.061	0.282	0	GDI1	Malignant cells	GSE164897_VemTra	ENSG00000203879	2664	GDP dissociation inhibitor 1	FLJ41411|GDIL|MRX41|MRX48|OPHN2|RABGDIA|XAP-4	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49973
0	-0.345583355088288	0.138	0.408	0	LAGE3	Malignant cells	GSE164897_VemTra	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49974
0	-0.348405910873991	0.129	0.402	0	DKC1	Malignant cells	GSE164897_VemTra	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49975
0	-0.38138950484283	0.039	0.33	0	POLR3D	Malignant cells	GSE164897_VemTra	ENSG00000168495	661	RNA polymerase III subunit D	BN51T|C53|RPC4|TSBN51	protein_coding	P05423	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49976
0	-0.584870451741467	0.067	0.467	0	PDLIM2	Malignant cells	GSE164897_VemTra	ENSG00000120913	64236	PDZ and LIM domain 2	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49977
0	-0.375152620511698	0.014	0.288	0	BIN3	Malignant cells	GSE164897_VemTra	ENSG00000147439	55909	bridging integrator 3	NA	protein_coding	Q9NQY0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49978
0	-0.371430615633137	0.111	0.406	0	SLC25A37	Malignant cells	GSE164897_VemTra	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49979
0	-0.550114105424056	0.079	0.439	0	DUSP4	Malignant cells	GSE164897_VemTra	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49980
0	-1.99302063110424	0.034	0.919	0	EIF4EBP1	Malignant cells	GSE164897_VemTra	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49981
0	-0.495554241530109	0.127	0.482	0	TCEA1	Malignant cells	GSE164897_VemTra	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49982
0	-0.402571026488782	0.05	0.354	0	MRPL15	Malignant cells	GSE164897_VemTra	ENSG00000137547	29088	mitochondrial ribosomal protein L15	HSPC145|L15mt|MRP-L15|MRP-L7|RPML7	protein_coding	Q9P015	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49983
0	1.22467532145558	1	1	0	RPS20	Malignant cells	GSE164897_VemTra	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49984
0	-0.467371023328477	1	1	0	RPL7	Malignant cells	GSE164897_VemTra	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49985
0	-0.401061147004183	0.365	0.705	0	ELOC	Malignant cells	GSE164897_VemTra	ENSG00000154582	6921	elongin C	SIII|TCEB1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49986
0	-0.563532600527993	0.031	0.414	0	FABP5	Malignant cells	GSE164897_VemTra	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49987
0	-0.98283974079542	0.001	0.582	0	LINC01419	Malignant cells	GSE164897_VemTra	ENSG00000253898	103352670	long intergenic non-protein coding RNA 1419	PRLH1|TCONS_00014497	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49988
0	-0.495293787385829	0.315	0.69	0	MTDH	Malignant cells	GSE164897_VemTra	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49989
0	0.907723530282534	1	1	0	RPL30	Malignant cells	GSE164897_VemTra	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49990
0	0.751392961608871	0.936	0.828	0	COX6C	Malignant cells	GSE164897_VemTra	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49991
0	-0.476071585399537	0.27	0.644	0	ZNF706	Malignant cells	GSE164897_VemTra	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49992
0	-0.531575060689322	0.064	0.404	0	CTHRC1	Malignant cells	GSE164897_VemTra	ENSG00000164932	115908	collagen triple helix repeat containing 1	NA	protein_coding	Q96CG8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49993
0	0.48279271748617	0.312	0.054	0	EXT1	Malignant cells	GSE164897_VemTra	ENSG00000182197	2131	exostosin glycosyltransferase 1	LGCR|LGS|ttv	protein_coding	Q16394	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49994
0	-0.431844916448442	0.072	0.399	0	LY6K	Malignant cells	GSE164897_VemTra	ENSG00000160886	54742	lymphocyte antigen 6 family member K	CT97|FLJ35226|HSJ001348	protein_coding	Q17RY6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49995
0	-1.09100088644669	0.113	0.787	0	LY6E	Malignant cells	GSE164897_VemTra	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49996
0	-0.348818432405338	0.017	0.274	0	MINCR	Malignant cells	GSE164897_VemTra	ENSG00000253716	100507316	MYC-induced long non-coding RNA	LINC01604|TCONS_00015189	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49997
0	-1.58580343845328	0.421	0.979	0	EEF1D	Malignant cells	GSE164897_VemTra	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49998
0	-0.371362592266111	0.041	0.328	0	GFUS	Malignant cells	GSE164897_VemTra	ENSG00000278243	7264	GDP-L-fucose synthase	FX|P35B|SDR4E1|TSTA3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	49999
0	-0.356825009023739	0.07	0.347	0	PUF60	Malignant cells	GSE164897_VemTra	ENSG00000274081	22827	poly(U) binding splicing factor 60	FIR|RoBPI|SIAHBP1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50000
0	-0.362826904238885	0.023	0.298	0	GRINA	Malignant cells	GSE164897_VemTra	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50001
0	-0.714046589999346	0.024	0.526	0	EXOSC4	Malignant cells	GSE164897_VemTra	ENSG00000178896	54512	exosome component 4	FLJ20591|hRrp41p|p12A|RRP41|RRP41A|Rrp41p|SKI6|Ski6p	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50002
0	-0.450816186273579	0.085	0.432	0	GPAA1	Malignant cells	GSE164897_VemTra	ENSG00000197858	8733	glycosylphosphatidylinositol anchor attachment 1	GAA1|hGAA1	protein_coding	O43292	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50003
0	-1.133010762479	0.209	0.869	0	CYC1	Malignant cells	GSE164897_VemTra	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50004
0	-0.321013470533633	0.028	0.273	0	SHARPIN	Malignant cells	GSE164897_VemTra	ENSG00000179526	81858	SHANK associated RH domain interactor	DKFZP434N1923|SIPL1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50005
0	-0.53662373542536	0.044	0.448	0	MAF1	Malignant cells	GSE164897_VemTra	ENSG00000179632	84232	MAF1 homolog, negative regulator of RNA polymerase III	DKFZp586G1123	protein_coding	Q9H063	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50006
0	-0.426298773196033	0.027	0.353	0	HSF1	Malignant cells	GSE164897_VemTra	ENSG00000284774	3297	heat shock transcription factor 1	HSTF1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50007
0	-0.38859467380526	0.024	0.318	0	SLC52A2	Malignant cells	GSE164897_VemTra	ENSG00000285112	79581	solute carrier family 52 member 2	D15Ertd747e|FLJ11856|GPCR41|GPR172A|hRFT3|PAR1|RFVT2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50008
0	-0.51883819028053	0.053	0.449	0	VPS28	Malignant cells	GSE164897_VemTra	ENSG00000285339	51160	VPS28 subunit of ESCRT-I	NA	protein_coding	Q9UK41	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50009
0	-2.58432883816042	0.974	1	0	RPL8	Malignant cells	GSE164897_VemTra	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50010
0	-0.289709535036657	0.056	0.284	0	COMMD5	Malignant cells	GSE164897_VemTra	ENSG00000170619	28991	COMM domain containing 5	FLJ13008|HCaRG|HT002	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50011
0	-0.604005936438505	0.075	0.506	0	C8orf33	Malignant cells	GSE164897_VemTra	ENSG00000182307	65265	chromosome 8 open reading frame 33	FLJ20989	protein_coding	Q9H7E9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50012
0	-0.71177807594897	0.166	0.661	0	DMAC1	Malignant cells	GSE164897_VemTra	ENSG00000137038	90871	distal membrane arm assembly component 1	C9orf123|MGC4730|TMEM261	protein_coding	Q96GE9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50013
0	-0.347022534771863	0.024	0.282	0	SMIM27	Malignant cells	GSE164897_VemTra	ENSG00000235453	100129250	small integral membrane protein 27	C9orf133|TOPORS-AS1	protein_coding	A0A1B0GUW7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50014
0	-0.493912561611689	0.223	0.605	0	NDUFB6	Malignant cells	GSE164897_VemTra	ENSG00000165264	4712	NADH:ubiquinone oxidoreductase subunit B6	B17|CI	protein_coding	O95139	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50015
0	0.695789832806297	0.406	0.095	0	B4GALT1	Malignant cells	GSE164897_VemTra	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50016
0	-0.363526192483191	0.15	0.439	0	DCTN3	Malignant cells	GSE164897_VemTra	ENSG00000137100	11258	dynactin subunit 3	DCTN-22	protein_coding	O75935	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50017
0	-0.496793845753409	0.107	0.475	0	SIGMAR1	Malignant cells	GSE164897_VemTra	ENSG00000147955	10280	sigma non-opioid intracellular receptor 1	OPRS1|SR-BP1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50018
0	-0.813969574942847	0.348	0.849	0	STOML2	Malignant cells	GSE164897_VemTra	ENSG00000165283	30968	stomatin like 2	HSPC108|SLP-2	protein_coding	Q9UJZ1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50019
0	-0.886397588118927	0.469	0.912	0	TPM2	Malignant cells	GSE164897_VemTra	ENSG00000198467	7169	tropomyosin 2	AMCD1|DA1|NEM4	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50020
0	-0.716972555269712	0.048	0.563	0	HINT2	Malignant cells	GSE164897_VemTra	ENSG00000137133	84681	histidine triad nucleotide binding protein 2	NA	protein_coding	Q9BX68	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50021
0	-0.867449237554657	0.274	0.827	0	CLTA	Malignant cells	GSE164897_VemTra	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50022
0	-0.689389351938062	0.174	0.647	0	TOMM5	Malignant cells	GSE164897_VemTra	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50023
0	-0.397469666703625	0.043	0.347	0	EXOSC3	Malignant cells	GSE164897_VemTra	ENSG00000107371	51010	exosome component 3	CGI-102|hRrp-40|hRrp40p|p10|RRP40|Rrp40p	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50024
0	0.531875673109943	0.336	0.064	0	KLF9	Malignant cells	GSE164897_VemTra	ENSG00000119138	687	KLF transcription factor 9	BTEB1	protein_coding	Q13886	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50025
0	-0.645068312936393	0.045	0.479	0	PSAT1	Malignant cells	GSE164897_VemTra	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50026
0	-0.577012409540883	0.024	0.442	0	CARD19	Malignant cells	GSE164897_VemTra	ENSG00000165233	84270	caspase recruitment domain family member 19	bA370F5.1|BinCARD|C9orf89|MGC11115	protein_coding	Q96LW7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50027
0	-0.321325910149689	0.054	0.302	0	NINJ1	Malignant cells	GSE164897_VemTra	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50028
0	-1.07719429080355	0.158	0.794	0	ANP32B	Malignant cells	GSE164897_VemTra	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50029
0	-0.475602308741327	0.023	0.375	0	NANS	Malignant cells	GSE164897_VemTra	ENSG00000095380	54187	N-acetylneuraminate synthase	SAS	protein_coding	Q9NR45	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50030
0	-0.588842620671174	0.233	0.676	0	SEC61B	Malignant cells	GSE164897_VemTra	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50031
0	-0.354039105763419	0.059	0.325	0	POLE3	Malignant cells	GSE164897_VemTra	ENSG00000148229	54107	DNA polymerase epsilon 3, accessory subunit	CHARAC17|CHRAC17|CHRAC2|p17|Ybl1	protein_coding	Q9NRF9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50032
0	-0.37287657014112	0.016	0.272	0	PHF19	Malignant cells	GSE164897_VemTra	ENSG00000119403	26147	PHD finger protein 19	DKFZP727G051|MTF2L1|PCL3|TDRD19B	protein_coding	Q5T6S3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50033
0	-1.56452628835855	0.998	1	0	RPL35	Malignant cells	GSE164897_VemTra	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50034
0	-0.466048101343865	0.122	0.483	0	ARPC5L	Malignant cells	GSE164897_VemTra	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50035
0	0.467436837733842	1	1	0	RPL12	Malignant cells	GSE164897_VemTra	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50036
0	-0.277116675047886	0.042	0.251	0	NIBAN2	Malignant cells	GSE164897_VemTra	ENSG00000136830	64855	niban apoptosis regulator 2	bA356B19.6|C9orf88|DKFZP434H0820|FAM129B|FLJ13518|FLJ22151|FLJ22298|MINERVA	protein_coding	Q96TA1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50037
0	-0.437625617573643	0.026	0.35	0	AK1	Malignant cells	GSE164897_VemTra	ENSG00000106992	203	adenylate kinase 1	NA	protein_coding	P00568	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50038
0	-0.777553349637601	0.044	0.588	0	DPM2	Malignant cells	GSE164897_VemTra	ENSG00000136908	8818	dolichyl-phosphate mannosyltransferase subunit 2, regulatory	MGC111193|MGC21559	protein_coding	O94777	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50039
0	-0.404677269343737	0.033	0.34	0	PTGES2	Malignant cells	GSE164897_VemTra	ENSG00000148334	80142	prostaglandin E synthase 2	C9orf15|FLJ14038	protein_coding	Q9H7Z7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50040
0	-0.730995268200406	0	0.268	0	LCN2	Malignant cells	GSE164897_VemTra	ENSG00000148346	3934	lipocalin 2	24p3|NGAL	protein_coding	P80188	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50041
0	-0.954238709484002	0.165	0.735	0	BBLN	Malignant cells	GSE164897_VemTra	ENSG00000171159	79095	bublin coiled coil protein	C9orf16|EST00098|FLJ12823|MGC4639	protein_coding	Q9BUW7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50042
0	-0.302982907189804	0.025	0.257	0	CIZ1	Malignant cells	GSE164897_VemTra	ENSG00000148337	25792	CDKN1A interacting zinc finger protein 1	LSFR1|ZNF356	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50043
0	-0.440993733961374	0.066	0.405	0	COQ4	Malignant cells	GSE164897_VemTra	ENSG00000167113	51117	coenzyme Q4	CGI-92	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50044
0	-0.617319368926023	0.061	0.517	0	URM1	Malignant cells	GSE164897_VemTra	ENSG00000167118	81605	ubiquitin related modifier 1	C9orf74|MGC2668	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50045
0	-0.407244677614286	0.02	0.309	0	DYNC2I2	Malignant cells	GSE164897_VemTra	ENSG00000119333	89891	dynein 2 intermediate chain 2	bA216B9.3|CFAP133|DIC5|FAP133|MGC20486|WDR34	protein_coding	Q96EX3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50046
0	-0.452917955003103	0.069	0.41	0	ZDHHC12	Malignant cells	GSE164897_VemTra	ENSG00000160446	84885	zinc finger DHHC-type palmitoyltransferase 12	FLJ14524|ZNF400	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50047
0	0.573992115951309	0.383	0.075	0	ZDHHC12-DT	Malignant cells	GSE164897_VemTra	ENSG00000223478	100506100	ZDHHC12 divergent transcript	NA	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50048
0	-0.452319440927233	0.037	0.374	0	NTMT1	Malignant cells	GSE164897_VemTra	ENSG00000148335	28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1	AD-003|C9orf32|HOMT1A|METTL11A|NRMT|NRMT1	protein_coding	Q9BV86	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50049
0	-0.462908076558843	0.039	0.385	0	SURF6	Malignant cells	GSE164897_VemTra	ENSG00000281309	6838	surfeit 6	FLJ30322|RRP14	protein_coding	O75683	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50050
0	1.09263543669244	1	1	0	RPL7A	Malignant cells	GSE164897_VemTra	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50051
0	-0.376795170395741	0.11	0.407	0	SURF1	Malignant cells	GSE164897_VemTra	ENSG00000280627	6834	SURF1 cytochrome c oxidase assembly factor	SHY1	protein_coding	Q15526	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50052
0	-0.762038632021347	0.043	0.576	0	SURF2	Malignant cells	GSE164897_VemTra	ENSG00000281024	6835	surfeit 2	NA	protein_coding	Q15527	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50053
0	-0.53230924719828	0.024	0.414	0	REXO4	Malignant cells	GSE164897_VemTra	ENSG00000280706	57109	REX4 homolog, 3'-5' exonuclease	hPMC2|XPMC2H	protein_coding	Q9GZR2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50054
0	-0.419653553721024	0.041	0.358	0	MRPS2	Malignant cells	GSE164897_VemTra	ENSG00000122140	51116	mitochondrial ribosomal protein S2	CGI-91	protein_coding	Q9Y399	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50055
0	-0.487293217775415	0.022	0.381	0	AGPAT2	Malignant cells	GSE164897_VemTra	ENSG00000169692	10555	1-acylglycerol-3-phosphate O-acyltransferase 2	BSCL|LPAAT-beta|LPLAT2	protein_coding	O15120	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50056
0	-1.30492874332347	0.108	0.841	0	SNHG7	Malignant cells	GSE164897_VemTra	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50057
0	-0.886798951968656	0.154	0.712	0	PHPT1	Malignant cells	GSE164897_VemTra	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50058
0	-1.09501426540317	0.256	0.892	0	EDF1	Malignant cells	GSE164897_VemTra	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50059
0	-0.348570077355835	0.042	0.312	0	FBXW5	Malignant cells	GSE164897_VemTra	ENSG00000159069	54461	F-box and WD repeat domain containing 5	DKFZP434B205|Fbw5|MGC20962	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50060
0	-0.466692066273267	0.019	0.363	0	PAXX	Malignant cells	GSE164897_VemTra	ENSG00000148362	286257	PAXX non-homologous end joining factor	C9orf142|XLS	protein_coding	Q9BUH6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50061
0	-0.37406642767686	0.051	0.336	0	DPP7	Malignant cells	GSE164897_VemTra	ENSG00000176978	29952	dipeptidyl peptidase 7	DPP2|DPPII	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50062
0	-0.530602736162843	0.068	0.471	0	SSNA1	Malignant cells	GSE164897_VemTra	ENSG00000176101	8636	SS nuclear autoantigen 1	N14|NA14	protein_coding	O43805	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50063
0	-0.429924840341535	0.148	0.433	0	TUBB4B	Malignant cells	GSE164897_VemTra	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50064
0	-1.23690719661633	0.148	0.874	0	MRPL41	Malignant cells	GSE164897_VemTra	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50065
0	0.677876055878102	0.518	0.202	0	IFITM2	Malignant cells	GSE164897_VemTra	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50066
0	-0.466917887990278	0.028	0.377	0	SIGIRR	Malignant cells	GSE164897_VemTra	ENSG00000185187	59307	single Ig and TIR domain containing	IL-1R8|TIR8	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50067
0	-0.516021158176731	0.05	0.44	0	RNH1	Malignant cells	GSE164897_VemTra	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50068
0	-0.406750524895631	0.134	0.465	0	TALDO1	Malignant cells	GSE164897_VemTra	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50069
0	-2.72271874431211	0.961	1	0	RPLP2	Malignant cells	GSE164897_VemTra	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50070
0	-0.605500588103034	0.121	0.553	0	CD151	Malignant cells	GSE164897_VemTra	ENSG00000177697	977	CD151 molecule (Raph blood group)	PETA-3|RAPH|SFA-1|TSPAN24	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50071
0	-1.55373068226182	0.267	0.942	0	POLR2L	Malignant cells	GSE164897_VemTra	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50072
0	-0.479657714738325	0.032	0.382	0	TSPAN4	Malignant cells	GSE164897_VemTra	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50073
0	-0.476652922004355	0.017	0.378	0	MRPL23	Malignant cells	GSE164897_VemTra	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50074
0	-0.318870460971	0.013	0.252	0	TSSC4	Malignant cells	GSE164897_VemTra	ENSG00000184281	10078	tumor suppressing subtransferable candidate 4	NA	protein_coding	Q9Y5U2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50075
0	-0.999373046467641	0.021	0.603	0	PHLDA2	Malignant cells	GSE164897_VemTra	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50076
0	-0.398368126331204	0.09	0.326	0	HBE1	Malignant cells	GSE164897_VemTra	ENSG00000213931	3046	hemoglobin subunit epsilon 1	HBE	protein_coding	P02100	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50077
0	-0.701520107455735	0.109	0.566	0	CAVIN3	Malignant cells	GSE164897_VemTra	ENSG00000170955	112464	caveolae associated protein 3	cavin-3|HSRBC|MGC20400|PRKCDBP|SRBC	protein_coding	Q969G5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50078
0	-0.338352306039728	0.083	0.344	0	MRPL17	Malignant cells	GSE164897_VemTra	ENSG00000158042	63875	mitochondrial ribosomal protein L17	MRP-L26|RPML26	protein_coding	Q9NRX2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50079
0	-0.935093832726721	0.28	0.862	0	EIF3F	Malignant cells	GSE164897_VemTra	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50080
0	-1.09592857830397	0.995	1	0	RPL27A	Malignant cells	GSE164897_VemTra	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50081
0	0.423367856765213	1	1	0	RPS13	Malignant cells	GSE164897_VemTra	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50082
0	-0.670558405672084	0.688	0.931	0	LDHA	Malignant cells	GSE164897_VemTra	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50083
0	-0.547975564559025	0.094	0.466	0	SVIP	Malignant cells	GSE164897_VemTra	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50084
0	-0.376352014692524	0.021	0.303	0	PEX16	Malignant cells	GSE164897_VemTra	ENSG00000121680	9409	peroxisomal biogenesis factor 16	NA	protein_coding	Q9Y5Y5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50085
0	-0.369238890579847	0.031	0.311	0	PACSIN3	Malignant cells	GSE164897_VemTra	ENSG00000165912	29763	protein kinase C and casein kinase substrate in neurons 3	SDPIII	protein_coding	Q9UKS6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50086
0	-0.629944492140888	0.123	0.564	0	PSMC3	Malignant cells	GSE164897_VemTra	ENSG00000165916	5702	proteasome 26S subunit, ATPase 3	RPT5|TBP-1|TBP1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50087
0	-0.627776740842277	0.093	0.558	0	NDUFS3	Malignant cells	GSE164897_VemTra	ENSG00000285387	4722	NADH:ubiquinone oxidoreductase core subunit S3	CI-30	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50088
0	-0.469923082845909	0.191	0.56	0	MTCH2	Malignant cells	GSE164897_VemTra	ENSG00000285121	23788	mitochondrial carrier 2	SLC25A50	protein_coding	Q9Y6C9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50089
0	-0.293675113074457	0.05	0.266	0	SLC43A3	Malignant cells	GSE164897_VemTra	ENSG00000134802	29015	solute carrier family 43 member 3	DKFZp762A227|Eeg1|FOAP-13|PRO1659|SEEEG-1	protein_coding	Q8NBI5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50090
0	-0.537102886131263	0.141	0.543	0	SELENOH	Malignant cells	GSE164897_VemTra	ENSG00000211450	280636	selenoprotein H	C11orf31|SELH	protein_coding	Q8IZQ5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50091
0	0.758069079710088	0.555	0.215	0	AHNAK	Malignant cells	GSE164897_VemTra	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50092
0	-0.30331334432414	0.065	0.302	0	B3GAT3	Malignant cells	GSE164897_VemTra	ENSG00000149541	26229	beta-1,3-glucuronyltransferase 3	GlcAT-I	protein_coding	O94766	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50093
0	-0.579495270999017	0.041	0.467	0	CSKMT	Malignant cells	GSE164897_VemTra	ENSG00000214756	751071	citrate synthase lysine methyltransferase	CS-KMT|METTL12|U99HG	protein_coding	A8MUP2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50094
0	-0.45770033961956	0.021	0.367	0	UQCC3	Malignant cells	GSE164897_VemTra	ENSG00000204922	790955	ubiquinol-cytochrome c reductase complex assembly factor 3	C11orf83|UNQ655	protein_coding	Q6UW78	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50095
0	-1.00704009725599	0.154	0.797	0	UBXN1	Malignant cells	GSE164897_VemTra	ENSG00000162191	51035	UBX domain protein 1	2B28|LOC51035|SAKS1|UBXD10	protein_coding	Q04323	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50096
0	-0.491595644668702	0.111	0.484	0	TMEM223	Malignant cells	GSE164897_VemTra	ENSG00000168569	79064	transmembrane protein 223	MGC3196|Mrx15	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50097
0	-0.525026221549766	0.174	0.561	0	TMEM179B	Malignant cells	GSE164897_VemTra	ENSG00000185475	374395	transmembrane protein 179B	NA	protein_coding	Q7Z7N9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50098
0	-0.44882309403465	0.055	0.39	0	WDR74	Malignant cells	GSE164897_VemTra	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50099
0	-0.681936736982477	0.078	0.528	0	SLC3A2	Malignant cells	GSE164897_VemTra	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50100
0	-1.33989863701749	0.367	0.96	0	COX8A	Malignant cells	GSE164897_VemTra	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50101
0	-0.406747187906437	0.062	0.38	0	OTUB1	Malignant cells	GSE164897_VemTra	ENSG00000167770	55611	OTU deubiquitinase, ubiquitin aldehyde binding 1	FLJ20113|FLJ40710	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50102
0	-0.397708447677027	0.061	0.365	0	NUDT22	Malignant cells	GSE164897_VemTra	ENSG00000149761	84304	nudix hydrolase 22	MGC13045	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50103
0	-0.305760632470001	0.049	0.282	0	DNAJC4	Malignant cells	GSE164897_VemTra	ENSG00000110011	3338	DnaJ heat shock protein family (Hsp40) member C4	HSPF2|MCG18	protein_coding	Q9NNZ3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50104
0	-0.395334767818021	0.241	0.56	0	FKBP2	Malignant cells	GSE164897_VemTra	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50105
0	-0.461234113126793	0.044	0.391	0	BAD	Malignant cells	GSE164897_VemTra	ENSG00000002330	572	BCL2 associated agonist of cell death	BBC2|BCL2L8	protein_coding	Q92934	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50106
0	-0.305850220965039	0.066	0.309	0	ESRRA	Malignant cells	GSE164897_VemTra	ENSG00000173153	2101	estrogen related receptor alpha	ERR1|ERRa|ERRalpha|ESRL1|NR3B1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50107
0	-0.650163099838221	0.375	0.821	0	PRDX5	Malignant cells	GSE164897_VemTra	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50108
0	-0.89058778100878	0.058	0.671	0	ARL2	Malignant cells	GSE164897_VemTra	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50109
0	-1.48512552267211	0.892	1	0	FAU	Malignant cells	GSE164897_VemTra	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50110
0	3.65584601819093	1	0.473	0	NEAT1	Malignant cells	GSE164897_VemTra	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50111
0	0.678120958756275	1	0.999	0	MALAT1	Malignant cells	GSE164897_VemTra	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50112
0	-0.637741963947747	0.024	0.487	0	ZNRD2	Malignant cells	GSE164897_VemTra	ENSG00000173465	10534	zinc ribbon domain containing 2	p27|SSSCA1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50113
0	-0.506586173890584	0.096	0.477	0	RNASEH2C	Malignant cells	GSE164897_VemTra	ENSG00000172922	84153	ribonuclease H2 subunit C	AGS3|AYP1	protein_coding	Q8TDP1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50114
0	-1.35446766366119	0.847	0.997	0	CFL1	Malignant cells	GSE164897_VemTra	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50115
0	-1.10076498009518	0.172	0.843	0	FIBP	Malignant cells	GSE164897_VemTra	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50116
0	-1.44574018100913	0.233	0.924	0	CCDC85B	Malignant cells	GSE164897_VemTra	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50117
0	-0.808167485792575	0.042	0.489	0	FOSL1	Malignant cells	GSE164897_VemTra	ENSG00000175592	8061	FOS like 1, AP-1 transcription factor subunit	fra-1	protein_coding	P15407	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50118
0	-1.16266980456377	0.053	0.773	0	DRAP1	Malignant cells	GSE164897_VemTra	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50119
0	-0.619514703217285	0.053	0.511	0	YIF1A	Malignant cells	GSE164897_VemTra	ENSG00000174851	10897	Yip1 interacting factor homolog A, membrane trafficking protein	54TM|FinGER7|YIF1|YIF1P	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50120
0	-0.499695908535939	0.085	0.468	0	MRPL11	Malignant cells	GSE164897_VemTra	ENSG00000174547	65003	mitochondrial ribosomal protein L11	NA	protein_coding	Q9Y3B7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50121
0	-0.814646452880564	0.033	0.602	0	PPP1CA	Malignant cells	GSE164897_VemTra	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50122
0	-0.414102280552732	0.021	0.335	0	RPS6KB2	Malignant cells	GSE164897_VemTra	ENSG00000175634	6199	ribosomal protein S6 kinase B2	KLS|P70-BETA|p70S6Kb|S6KB|S6Kbeta|STK14B	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50123
0	-0.460729563152596	0.032	0.377	0	CORO1B	Malignant cells	GSE164897_VemTra	ENSG00000172725	57175	coronin 1B	coronin-2	protein_coding	Q9BR76	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50124
0	-0.368331083778725	0.062	0.341	0	TMEM134	Malignant cells	GSE164897_VemTra	ENSG00000172663	80194	transmembrane protein 134	FLJ21749	protein_coding	Q9H6X4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50125
0	-0.510411841784682	0.031	0.416	0	AIP	Malignant cells	GSE164897_VemTra	ENSG00000110711	9049	aryl hydrocarbon receptor interacting protein	ARA9|FKBP16|FKBP37|XAP2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50126
0	-0.356515569556176	0.044	0.315	0	CDK2AP2	Malignant cells	GSE164897_VemTra	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50127
0	-1.48873943452716	0.649	0.99	0	GSTP1	Malignant cells	GSE164897_VemTra	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50128
0	-0.530003133188681	0.031	0.429	0	NDUFV1	Malignant cells	GSE164897_VemTra	ENSG00000167792	4723	NADH:ubiquinone oxidoreductase core subunit V1	CI-51K	protein_coding	P49821	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50129
0	-0.941008530517256	0.18	0.783	0	NDUFS8	Malignant cells	GSE164897_VemTra	ENSG00000110717	4728	NADH:ubiquinone oxidoreductase core subunit S8	CI-23k|TYKY	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50130
0	-0.498566164193316	0.254	0.634	0	MRPL21	Malignant cells	GSE164897_VemTra	ENSG00000197345	219927	mitochondrial ribosomal protein L21	NA	protein_coding	Q7Z2W9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50131
0	-0.925777568698905	0.084	0.624	0	CCND1	Malignant cells	GSE164897_VemTra	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50132
0	-0.501232928457232	0.26	0.647	0	LAMTOR1	Malignant cells	GSE164897_VemTra	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50133
0	-0.481672457524495	0.185	0.554	0	COA4	Malignant cells	GSE164897_VemTra	ENSG00000181924	51287	cytochrome c oxidase assembly factor 4 homolog	CHCHD8|CMC3|E2IG2	protein_coding	Q9NYJ1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50134
0	0.512501438305201	1	1	0	RPS3	Malignant cells	GSE164897_VemTra	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50135
0	-0.756648087421285	0.2	0.723	0	CLNS1A	Malignant cells	GSE164897_VemTra	ENSG00000074201	1207	chloride nucleotide-sensitive channel 1A	CLCI|ICln	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50136
0	-0.715313425368589	0.164	0.673	0	NDUFC2	Malignant cells	GSE164897_VemTra	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50137
0	-0.995206935384517	0.362	0.814	0	CTSC	Malignant cells	GSE164897_VemTra	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50138
0	-0.428181683371802	0.267	0.61	0	TAF1D	Malignant cells	GSE164897_VemTra	ENSG00000166012	79101	TATA-box binding protein associated factor, RNA polymerase I subunit D	JOSD3|MGC5306|TAF(I)41	protein_coding	Q9H5J8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50139
0	-0.302192096342139	0.066	0.302	0	BIRC2	Malignant cells	GSE164897_VemTra	ENSG00000110330	329	baculoviral IAP repeat containing 2	API1|c-IAP1|cIAP1|hiap-2|MIHB|RNF48	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50140
0	-0.464146623392899	0.085	0.432	0	DCUN1D5	Malignant cells	GSE164897_VemTra	ENSG00000137692	84259	defective in cullin neddylation 1 domain containing 5	FLJ32431|MGC2714	protein_coding	Q9BTE7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50141
0	-0.376919461815349	0.152	0.451	0	REXO2	Malignant cells	GSE164897_VemTra	ENSG00000076043	25996	RNA exonuclease 2	CGI-114|DKFZP566E144|SFN	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50142
0	-0.435653860652474	0.077	0.407	0	ZPR1	Malignant cells	GSE164897_VemTra	ENSG00000109917	8882	ZPR1 zinc finger	ZNF259	protein_coding	O75312	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50143
0	1.14888889917993	0.999	0.977	0	ATP5MG	Malignant cells	GSE164897_VemTra	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50144
0	-0.335515964581349	0.061	0.321	0	HMBS	Malignant cells	GSE164897_VemTra	ENSG00000256269	3145	hydroxymethylbilane synthase	PBGD|PORC|UPS	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50145
0	0.767288540103837	0.839	0.589	0	HSPA8	Malignant cells	GSE164897_VemTra	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50146
0	-0.315244821464141	0.057	0.305	0	TBRG1	Malignant cells	GSE164897_VemTra	ENSG00000154144	84897	transforming growth factor beta regulator 1	FLJ14621|NIAM|TB-5	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50147
0	-0.558000274953862	0.012	0.413	0	DCPS	Malignant cells	GSE164897_VemTra	ENSG00000110063	28960	decapping enzyme, scavenger	HINT-5|HINT5|HSL1|HSPC015	protein_coding	Q96C86	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50148
0	-1.37949484050735	0.047	0.789	0	ST3GAL4	Malignant cells	GSE164897_VemTra	ENSG00000110080	6484	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	CGS23|FLJ11867|NANTA3|SAT3|SIAT4|SIAT4C|STZ	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50149
0	-0.362584247874913	0.1	0.382	0	CDC123	Malignant cells	GSE164897_VemTra	ENSG00000151465	8872	cell division cycle 123	C10orf7|D123	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50150
0	-0.390507153691674	0.021	0.284	0	FRMD4A	Malignant cells	GSE164897_VemTra	ENSG00000151474	55691	FERM domain containing 4A	bA295P9.4|FLJ10210|FRMD4|KIAA1294	protein_coding	Q9P2Q2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50151
0	-2.2576061244086	0.794	0.999	0	VIM	Malignant cells	GSE164897_VemTra	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50152
0	-0.474290431371968	0.141	0.486	0	KIF5B	Malignant cells	GSE164897_VemTra	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50153
0	-0.322679822687972	0.033	0.28	0	TIMM23	Malignant cells	GSE164897_VemTra	ENSG00000265354	100287932	translocase of inner mitochondrial membrane 23	TIM23	protein_coding	O14925	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50154
0	0.510459164215721	0.355	0.102	0	ARID5B	Malignant cells	GSE164897_VemTra	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50155
0	-0.598778956846674	0.43	0.807	0	DDX21	Malignant cells	GSE164897_VemTra	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50156
0	-0.799912347791724	0.096	0.647	0	PPA1	Malignant cells	GSE164897_VemTra	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50157
0	-0.347170825697556	0.066	0.334	0	PCBD1	Malignant cells	GSE164897_VemTra	ENSG00000166228	5092	pterin-4 alpha-carbinolamine dehydratase 1	DCOH|PCBD|PCD	protein_coding	P61457	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50158
0	-0.74156953291779	0.116	0.57	0	DDIT4	Malignant cells	GSE164897_VemTra	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50159
0	-0.566532113818565	0.187	0.612	0	MRPS16	Malignant cells	GSE164897_VemTra	ENSG00000182180	51021	mitochondrial ribosomal protein S16	CGI-132	protein_coding	Q9Y3D3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50160
0	-0.77678480852253	0.158	0.71	0	VDAC2	Malignant cells	GSE164897_VemTra	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50161
0	-0.477460312552413	1	1	0	RPS24	Malignant cells	GSE164897_VemTra	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50162
0	-0.329985062177801	0.047	0.3	0	FRA10AC1	Malignant cells	GSE164897_VemTra	ENSG00000148690	118924	FRA10A associated CGG repeat 1	C10orf4	protein_coding	Q70Z53	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50163
0	-0.383536315760579	0.045	0.309	0	AVPI1	Malignant cells	GSE164897_VemTra	ENSG00000119986	60370	arginine vasopressin induced 1	PP5395|VIP32|VIT32	protein_coding	Q5T686	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50164
0	-0.852710737824272	0.203	0.738	0	NDUFB8	Malignant cells	GSE164897_VemTra	ENSG00000166136	4714	NADH:ubiquinone oxidoreductase subunit B8	ASHI|CI-ASHI	protein_coding	O95169	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50165
0	-0.476484153460654	0.095	0.461	0	MRPL43	Malignant cells	GSE164897_VemTra	ENSG00000055950	84545	mitochondrial ribosomal protein L43	bMRP36a	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50166
0	-0.867424102307379	0.102	0.686	0	GSTO1	Malignant cells	GSE164897_VemTra	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50167
0	-0.315438376151808	0.09	0.333	0	SMC3	Malignant cells	GSE164897_VemTra	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50168
0	-0.399571156718857	0.026	0.329	0	RGS10	Malignant cells	GSE164897_VemTra	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50169
0	-0.408805625091746	0.013	0.299	0	INPP5F	Malignant cells	GSE164897_VemTra	ENSG00000198825	22876	inositol polyphosphate-5-phosphatase F	hSac2|KIAA0966|SAC2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50170
0	-0.32150617097481	0.078	0.337	0	UROS	Malignant cells	GSE164897_VemTra	ENSG00000188690	7390	uroporphyrinogen III synthase	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50171
0	-0.695849239794986	0.062	0.555	0	GLRX3	Malignant cells	GSE164897_VemTra	ENSG00000108010	10539	glutaredoxin 3	bA500G10.4|GLRX4|GRX3|GRX4|PICOT|TXNL2	protein_coding	O76003	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50172
0	-0.42213513424579	0.123	0.413	0	BNIP3	Malignant cells	GSE164897_VemTra	ENSG00000176171	664	BCL2 interacting protein 3	HABON|Nip3	protein_coding	Q12983	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50173
0	-0.447801476262382	0.034	0.375	0	ZNF511	Malignant cells	GSE164897_VemTra	ENSG00000198546	118472	zinc finger protein 511	MGC30006|Zfp511	protein_coding	Q8NB15	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50174
0	-0.371915244259896	0.017	0.297	0	FUOM	Malignant cells	GSE164897_VemTra	ENSG00000148803	282969	fucose mutarotase	C10orf125|FLJ26016|FucM|FucU	protein_coding	A2VDF0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50175
0	-0.568318716519916	0.129	0.555	0	ECHS1	Malignant cells	GSE164897_VemTra	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50176
0	-0.321547125970853	0.07	0.32	0	LTBR	Malignant cells	GSE164897_VemTra	ENSG00000111321	4055	lymphotoxin beta receptor	D12S370|TNF-R-III|TNFCR|TNFR-RP|TNFR2-RP|TNFRSF3	protein_coding	P36941	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50177
0	0.635367496523414	0.917	0.833	0	MRPL51	Malignant cells	GSE164897_VemTra	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50178
0	-1.74667048755327	1	1	0	GAPDH	Malignant cells	GSE164897_VemTra	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50179
0	-0.490197034841689	0.24	0.611	0	MLF2	Malignant cells	GSE164897_VemTra	ENSG00000089693	8079	myeloid leukemia factor 2	NTN4	protein_coding	Q15773	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50180
0	-1.07984425894757	0.165	0.812	0	C12orf57	Malignant cells	GSE164897_VemTra	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50181
0	-0.942992333114811	0.27	0.856	0	PHB2	Malignant cells	GSE164897_VemTra	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50182
0	-0.359366340557985	0.07	0.352	0	SMIM10L1	Malignant cells	GSE164897_VemTra	ENSG00000262986	100129361	small integral membrane protein 10 like 1	NA	protein_coding	P0DMW3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50183
0	0.645061782580683	0.276	0.01	0	MGP	Malignant cells	GSE164897_VemTra	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50184
0	-0.522848147047845	0.237	0.631	0	STRAP	Malignant cells	GSE164897_VemTra	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50185
0	1.61584594510815	0.873	0.372	0	MGST1	Malignant cells	GSE164897_VemTra	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50186
0	-0.360076829670097	0.083	0.369	0	MRPS35	Malignant cells	GSE164897_VemTra	ENSG00000061794	60488	mitochondrial ribosomal protein S35	MDS023|MRPS28	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50187
0	-0.351368474319118	0.044	0.309	0	YAF2	Malignant cells	GSE164897_VemTra	ENSG00000015153	10138	YY1 associated factor 2	NA	protein_coding	Q8IY57	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50188
0	-0.877303185583524	0.633	0.809	0	TUBA1B	Malignant cells	GSE164897_VemTra	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50189
0	-0.275637850722456	0.046	0.26	0	MCRS1	Malignant cells	GSE164897_VemTra	ENSG00000187778	10445	microspherule protein 1	ICP22BP|INO80Q|MCRS2|MSP58|P78	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50190
0	1.11529400660926	0.839	0.485	0	COX14	Malignant cells	GSE164897_VemTra	ENSG00000178449	84987	cytochrome c oxidase assembly factor COX14	C12orf62|MGC14288	protein_coding	Q96I36	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50191
0	0.512724517968606	0.359	0.105	0	LIMA1	Malignant cells	GSE164897_VemTra	ENSG00000050405	51474	LIM domain and actin binding 1	EPLIN	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50192
0	-0.535907620759521	0.032	0.417	0	SMAGP	Malignant cells	GSE164897_VemTra	ENSG00000170545	57228	small cell adhesion glycoprotein	hSMAGP|MGC149453|MGC149454	protein_coding	Q0VAQ4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50193
0	-0.478064438606282	0.054	0.389	0	ATG101	Malignant cells	GSE164897_VemTra	ENSG00000123395	60673	autophagy related 101	C12orf44|FLJ11773	protein_coding	Q9BSB4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50194
0	-0.792773115260918	0.077	0.367	0	KRT7	Malignant cells	GSE164897_VemTra	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50195
0	-2.3348655063525	0.209	0.518	0	KRT81	Malignant cells	GSE164897_VemTra	ENSG00000205426	3887	keratin 81	Hb-1|KRTHB1	protein_coding	Q14533	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50196
0	-1.51317799302756	0.342	0.93	0	KRT18	Malignant cells	GSE164897_VemTra	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50197
0	-0.548139194932225	0.158	0.437	0	IGFBP6	Malignant cells	GSE164897_VemTra	ENSG00000167779	3489	insulin like growth factor binding protein 6	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50198
0	1.25755562913001	0.999	0.954	0	PFDN5	Malignant cells	GSE164897_VemTra	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50199
0	-0.778186857512556	0.046	0.596	0	MYG1	Malignant cells	GSE164897_VemTra	ENSG00000139637	60314	MYG1 exonuclease	C12orf10|Gamm1|MYG	protein_coding	Q9HB07	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50200
0	0.664704539092753	0.998	0.987	0	ATP5MC2	Malignant cells	GSE164897_VemTra	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50201
0	-0.360940075692112	0.993	0.999	0	HNRNPA1	Malignant cells	GSE164897_VemTra	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50202
0	-0.592870949982215	0.747	0.936	0	CD63	Malignant cells	GSE164897_VemTra	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50203
0	-0.508277120975261	0.002	0.346	0	ERBB3	Malignant cells	GSE164897_VemTra	ENSG00000065361	2065	erb-b2 receptor tyrosine kinase 3	HER3|LCCS2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50204
0	-1.2828829394338	0.23	0.889	0	PA2G4	Malignant cells	GSE164897_VemTra	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50205
0	1.41894534177334	1	1	0	RPL41	Malignant cells	GSE164897_VemTra	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50206
0	2.21383180877722	1	0.806	0	MYL6	Malignant cells	GSE164897_VemTra	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50207
0	-0.41539466495806	0.091	0.414	0	NABP2	Malignant cells	GSE164897_VemTra	ENSG00000139579	79035	nucleic acid binding protein 2	hSSB1|MGC2731|OBFC2B|SOSS-B1|SSB1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50208
0	-0.599960992945655	0.2	0.629	0	CNPY2	Malignant cells	GSE164897_VemTra	ENSG00000257727	10330	canopy FGF signaling regulator 2	HP10390|TMEM4|ZSIG9	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50209
0	-0.505832039592687	0.655	0.878	0	ATP5F1B	Malignant cells	GSE164897_VemTra	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50210
0	0.324334407656554	1	1	0	NACA	Malignant cells	GSE164897_VemTra	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50211
0	-0.659646545227466	0.114	0.571	0	SHMT2	Malignant cells	GSE164897_VemTra	ENSG00000182199	6472	serine hydroxymethyltransferase 2	mSHMT|SHMT	protein_coding	P34897	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50212
0	-0.635202009368076	0.319	0.756	0	CDK4	Malignant cells	GSE164897_VemTra	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50213
0	-0.491279708560413	0.127	0.461	0	HMGA2	Malignant cells	GSE164897_VemTra	ENSG00000149948	8091	high mobility group AT-hook 2	BABL|HMGIC|LIPO	protein_coding	P52926	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50214
0	-0.298995718891702	0.064	0.292	0	DUSP6	Malignant cells	GSE164897_VemTra	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50215
0	-0.578628705097338	0.483	0.847	0	METAP2	Malignant cells	GSE164897_VemTra	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50216
0	-1.06979026681893	0.552	0.973	0	SLC25A3	Malignant cells	GSE164897_VemTra	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50217
0	-0.376254472155782	0.047	0.337	0	TDG	Malignant cells	GSE164897_VemTra	ENSG00000139372	6996	thymine DNA glycosylase	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50218
0	1.26036327697926	0.643	0.082	0	TXNRD1	Malignant cells	GSE164897_VemTra	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50219
0	-0.412792945104612	0.106	0.427	0	PWP1	Malignant cells	GSE164897_VemTra	ENSG00000136045	11137	PWP1 homolog, endonuclein	IEF-SSP-9502	protein_coding	Q13610	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50220
0	-0.297797127564087	0.043	0.274	0	MMAB	Malignant cells	GSE164897_VemTra	ENSG00000139428	326625	metabolism of cobalamin associated B	cblB|CFAP23	protein_coding	Q96EY8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50221
0	-0.336869650395303	0.033	0.283	0	FAM216A	Malignant cells	GSE164897_VemTra	ENSG00000204856	29902	family with sequence similarity 216 member A	C12orf24|HSU79274	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50222
0	-0.37658257760014	0.198	0.506	0	PPP1CC	Malignant cells	GSE164897_VemTra	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50223
0	-0.759179693657619	0.199	0.727	0	ERP29	Malignant cells	GSE164897_VemTra	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50224
0	-0.578153106068391	0.277	0.692	0	PEBP1	Malignant cells	GSE164897_VemTra	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50225
0	-1.33609225327169	0.506	0.981	0	COX6A1	Malignant cells	GSE164897_VemTra	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50226
0	1.60195321954159	0.991	0.789	0	DYNLL1	Malignant cells	GSE164897_VemTra	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50227
0	-1.32092130762997	0.129	0.883	0	ARL6IP4	Malignant cells	GSE164897_VemTra	ENSG00000182196	51329	ADP ribosylation factor like GTPase 6 interacting protein 4	SFRS20|SR-25|SRp25|SRrp37	protein_coding	Q66PJ3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50228
0	-0.695322714549324	0.058	0.552	0	MRPL57	Malignant cells	GSE164897_VemTra	ENSG00000173141	78988	mitochondrial ribosomal protein L57	MRP63	protein_coding	Q9BQC6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50229
0	-0.778337357861005	1	1	0	RPL21	Malignant cells	GSE164897_VemTra	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50230
0	-0.726214004294328	0.075	0.571	0	GTF3A	Malignant cells	GSE164897_VemTra	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50231
0	0.642574867283811	0.886	0.768	0	POMP	Malignant cells	GSE164897_VemTra	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50232
0	-0.370115953014815	0.045	0.33	0	ALG5	Malignant cells	GSE164897_VemTra	ENSG00000120697	29880	ALG5 dolichyl-phosphate beta-glucosyltransferase	bA421P11.2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50233
0	-0.345495933765886	0.056	0.318	0	EXOSC8	Malignant cells	GSE164897_VemTra	ENSG00000120699	11340	exosome component 8	bA421P11.3|CIP3|EAP2|OIP2|p9|RRP43|Rrp43p	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50234
0	0.725823150450596	0.906	0.769	0	COMMD6	Malignant cells	GSE164897_VemTra	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50235
0	-0.706800165073413	0.044	0.548	0	MRPL52	Malignant cells	GSE164897_VemTra	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50236
0	0.661365672716506	0.812	0.683	0	PSMB5	Malignant cells	GSE164897_VemTra	ENSG00000100804	5693	proteasome 20S subunit beta 5	MB1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50237
0	1.07943430510668	0.924	0.675	0	NEDD8	Malignant cells	GSE164897_VemTra	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50238
0	-1.62726098643335	1	1	0	RPS29	Malignant cells	GSE164897_VemTra	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50239
0	1.06026763965348	0.961	0.757	0	RPL36AL	Malignant cells	GSE164897_VemTra	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50240
0	-0.389570024522159	0.252	0.584	0	RTRAF	Malignant cells	GSE164897_VemTra	ENSG00000087302	51637	RNA transcription, translation and transport factor	C14orf166|CGI-99|CLE|CLE7|hCLE1|LCRP369|RLLM1	protein_coding	Q9Y224	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50241
0	-0.521454056800297	0.044	0.422	0	LGALS3	Malignant cells	GSE164897_VemTra	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50242
0	-0.383430778986726	0.058	0.358	0	VTI1B	Malignant cells	GSE164897_VemTra	ENSG00000100568	10490	vesicle transport through interaction with t-SNAREs 1B	VTI2	protein_coding	Q9UEU0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50243
0	-0.689230807981086	0.757	0.958	0	SLIRP	Malignant cells	GSE164897_VemTra	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50244
0	-0.336917826266011	0.158	0.445	0	PSMC1	Malignant cells	GSE164897_VemTra	ENSG00000100764	5700	proteasome 26S subunit, ATPase 1	p56|RPT2|S4	protein_coding	P62191	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50245
0	-0.515098884242219	0.141	0.513	0	CALM1	Malignant cells	GSE164897_VemTra	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50246
0	-0.496211704310574	0.808	0.969	0	NDUFB1	Malignant cells	GSE164897_VemTra	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50247
0	-0.548368279054237	0.078	0.474	0	IFI27L2	Malignant cells	GSE164897_VemTra	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50248
0	-0.658877293103673	0.125	0.577	0	EIF5	Malignant cells	GSE164897_VemTra	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50249
0	-0.508462139934553	0.047	0.39	0	CKB	Malignant cells	GSE164897_VemTra	ENSG00000166165	1152	creatine kinase B	CKBB	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50250
0	-0.396636312938095	0.745	0.952	0	ATP5MJ	Malignant cells	GSE164897_VemTra	ENSG00000156411	9556	ATP synthase membrane subunit j	6.8PL|ATP5MPL|C14orf2|MLQ|MP68	protein_coding	P56378	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50251
0	-0.589797946763632	0.064	0.491	0	SIVA1	Malignant cells	GSE164897_VemTra	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50252
0	-0.70752982600344	0.053	0.535	0	CRIP2	Malignant cells	GSE164897_VemTra	ENSG00000182809	1397	cysteine rich protein 2	CRP2|ESP1	protein_coding	P52943	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50253
0	-0.513488935303268	0.174	0.553	0	SNRPN	Malignant cells	GSE164897_VemTra	ENSG00000128739	6638	small nuclear ribonucleoprotein polypeptide N	HCERN3|PWCR|RT-LI|SM-D|SMN|SNRNP-N|SNURF-SNRPN	protein_coding	P63162	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50254
0	3.16577956215453	0.978	0.12	0	SCG5	Malignant cells	GSE164897_VemTra	ENSG00000277614	6447	secretogranin V	7B2|SGNE1|SgV	protein_coding	P05408	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50255
0	0.752485387992548	0.865	0.708	0	NOP10	Malignant cells	GSE164897_VemTra	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50256
0	1.65865409844238	0.67	0.089	0	THBS1	Malignant cells	GSE164897_VemTra	ENSG00000137801	7057	thrombospondin 1	THBS|THBS-1|TSP|TSP-1|TSP1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50257
0	1.71445816149754	1	0.981	0	SRP14	Malignant cells	GSE164897_VemTra	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50258
0	-0.389326742543693	0.016	0.27	0	GCHFR	Malignant cells	GSE164897_VemTra	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50259
0	-0.461770806834016	0.138	0.5	0	RTF1	Malignant cells	GSE164897_VemTra	ENSG00000137815	23168	RTF1 homolog, Paf1/RNA polymerase II complex component	KIAA0252	protein_coding	Q92541	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50260
0	0.710750997325338	0.999	0.991	0	SERF2	Malignant cells	GSE164897_VemTra	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50261
0	-1.87942884771778	0.114	0.949	0	EIF3J	Malignant cells	GSE164897_VemTra	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50262
0	1.99668388537175	1	0.96	0	B2M	Malignant cells	GSE164897_VemTra	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50263
0	-0.599587572494521	0.161	0.564	0	DUT	Malignant cells	GSE164897_VemTra	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50264
0	-0.519863419181536	0.39	0.774	0	RSL24D1	Malignant cells	GSE164897_VemTra	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50265
0	-0.400754807593287	0.109	0.435	0	CIAO2A	Malignant cells	GSE164897_VemTra	ENSG00000166797	84191	cytosolic iron-sulfur assembly component 2A	CIA2A|FAM96A|FLJ22875	protein_coding	Q9H5X1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50266
0	-0.790466326737562	0.073	0.587	0	PCLAF	Malignant cells	GSE164897_VemTra	ENSG00000166803	9768	PCNA clamp associated factor	KIAA0101|NS5ATP9|OEATC-1|p15(PAF)|PAF15	protein_coding	Q15004	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50267
0	-0.289955437543896	1	1	0	RPL4	Malignant cells	GSE164897_VemTra	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50268
0	-0.327932539597896	0.044	0.297	0	C15orf61	Malignant cells	GSE164897_VemTra	ENSG00000189227	145853	chromosome 15 open reading frame 61	LOC145853	protein_coding	A6NNL5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50269
0	-2.81062217259238	1	1	0	RPLP1	Malignant cells	GSE164897_VemTra	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50270
0	-0.647627476265988	0.09	0.551	0	LARP6	Malignant cells	GSE164897_VemTra	ENSG00000166173	55323	La ribonucleoprotein 6, translational regulator	acheron|FLJ11196	protein_coding	Q9BRS8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50271
0	-0.356657581437567	0.026	0.288	0	STRA6	Malignant cells	GSE164897_VemTra	ENSG00000288257	64220	signaling receptor and transporter of retinol STRA6	FLJ12541	protein_coding	Q9BX79	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50272
0	-0.451214082420674	0.054	0.396	0	UBL7	Malignant cells	GSE164897_VemTra	ENSG00000288408	84993	ubiquitin like 7	BMSC-UbP|MGC14421	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50273
0	-1.41505506380272	0.214	0.942	0	COX5A	Malignant cells	GSE164897_VemTra	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50274
0	-0.326045451660853	0.049	0.299	0	COMMD4	Malignant cells	GSE164897_VemTra	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50275
0	-0.458034835811422	0.075	0.422	0	IMP3	Malignant cells	GSE164897_VemTra	ENSG00000177971	55272	IMP U3 small nucleolar ribonucleoprotein 3	BRMS2|C15orf12|FLJ10968|MRPS4	protein_coding	Q9NV31	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50276
0	0.665446954831569	0.692	0.52	0	MORF4L1	Malignant cells	GSE164897_VemTra	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50277
0	-1.41264178081382	1	1	0	RPS17	Malignant cells	GSE164897_VemTra	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50278
0	-0.353507122470597	0.098	0.38	0	MRPS11	Malignant cells	GSE164897_VemTra	ENSG00000181991	64963	mitochondrial ribosomal protein S11	FLJ22512|FLJ23406|HCC-2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50279
0	-0.673180215765092	0.026	0.455	0	ISG20	Malignant cells	GSE164897_VemTra	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50280
0	-0.535286229098881	0.04	0.437	0	CIB1	Malignant cells	GSE164897_VemTra	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50281
0	-0.34617908177886	0.033	0.293	0	HDDC3	Malignant cells	GSE164897_VemTra	ENSG00000184508	374659	HD domain containing 3	MESH1|MGC45386	protein_coding	Q8N4P3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50282
0	0.503945101314008	0.344	0.095	0	NR2F2	Malignant cells	GSE164897_VemTra	ENSG00000185551	7026	nuclear receptor subfamily 2 group F member 2	ARP1|COUP-TFII|COUPTF2|COUPTFB|NF-E3|SVP40|TFCOUP2	protein_coding	P24468	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50283
0	-0.555111091524363	0.103	0.52	0	SELENOS	Malignant cells	GSE164897_VemTra	ENSG00000131871	55829	selenoprotein S	AD-015|MGC2553|SBBI8|SELS|SEPS1|VIMP	protein_coding	Q9BQE4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50284
0	-0.483447884398067	0.059	0.415	0	SNRPA1	Malignant cells	GSE164897_VemTra	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50285
0	-0.393938022482837	0.131	0.432	0	POLR3K	Malignant cells	GSE164897_VemTra	ENSG00000161980	51728	RNA polymerase III subunit K	C11|RPC11	protein_coding	Q9Y2Y1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50286
0	-0.812079935565829	0.107	0.656	0	MPG	Malignant cells	GSE164897_VemTra	ENSG00000103152	4350	N-methylpurine DNA glycosylase	MDG	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50287
0	-0.587402996945053	0.046	0.473	0	MRPL28	Malignant cells	GSE164897_VemTra	ENSG00000086504	10573	mitochondrial ribosomal protein L28	MAAT1|p15	protein_coding	Q13084	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50288
0	-0.821439059969276	0.221	0.739	0	NME4	Malignant cells	GSE164897_VemTra	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50289
0	-1.02999009202095	0.106	0.773	0	METTL26	Malignant cells	GSE164897_VemTra	ENSG00000130731	84326	methyltransferase like 26	C16orf13|MGC13114	protein_coding	Q96S19	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50290
0	-0.458111048443416	0.03	0.372	0	MCRIP2	Malignant cells	GSE164897_VemTra	ENSG00000172366	84331	MAPK regulated corepressor interacting protein 2	C16orf14|FAM195A|MGC15416	protein_coding	Q9BUT9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50291
0	-0.423158431052211	0.292	0.636	0	STUB1	Malignant cells	GSE164897_VemTra	ENSG00000103266	10273	STIP1 homology and U-box containing protein 1	CHIP|HSPABP2|NY-CO-7|SDCCAG7|UBOX1	protein_coding	Q9UNE7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50292
0	-0.449343077656684	0.074	0.398	0	HAGHL	Malignant cells	GSE164897_VemTra	ENSG00000103253	84264	hydroxyacylglutathione hydrolase like	MGC2605	protein_coding	Q6PII5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50293
0	-0.486939605095664	0.182	0.556	0	UBE2I	Malignant cells	GSE164897_VemTra	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50294
0	-0.36836748094334	0.086	0.366	0	NME3	Malignant cells	GSE164897_VemTra	ENSG00000103024	4832	NME/NM23 nucleoside diphosphate kinase 3	DR-nm23|NDPKC|NM23-H3	protein_coding	Q13232	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50295
0	-1.08281113611202	0.064	0.754	0	MRPS34	Malignant cells	GSE164897_VemTra	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50296
0	-0.373387254111578	0.024	0.306	0	SPSB3	Malignant cells	GSE164897_VemTra	ENSG00000162032	90864	splA/ryanodine receptor domain and SOCS box containing 3	C16orf31|SSB-3	protein_coding	Q6PJ21	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50297
0	-0.49053267275366	0.039	0.407	0	NUBP2	Malignant cells	GSE164897_VemTra	ENSG00000095906	10101	NUBP iron-sulfur cluster assembly factor 2, cytosolic	CFD1|CIAO6	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50298
0	-0.282491051394514	0.041	0.261	0	HAGH	Malignant cells	GSE164897_VemTra	ENSG00000063854	3029	hydroxyacylglutathione hydrolase	GLO2|GLXII|HAGH1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50299
0	-1.05569543402837	0.396	0.92	0	NDUFB10	Malignant cells	GSE164897_VemTra	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50300
0	-2.74739754496622	1	1	0	RPS2	Malignant cells	GSE164897_VemTra	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50301
0	-0.437340873570355	0.09	0.419	0	SNHG9	Malignant cells	GSE164897_VemTra	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50302
0	-0.386849193712632	0.009	0.299	0	NTHL1	Malignant cells	GSE164897_VemTra	ENSG00000065057	4913	nth like DNA glycosylase 1	NTH1|OCTS3	protein_coding	P78549	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50303
0	-0.93929845667413	0.011	0.61	0	SNHG19	Malignant cells	GSE164897_VemTra	ENSG00000260260	NA	NA	SNORD60HG	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50304
0	-0.499043381084843	0.015	0.386	0	MLST8	Malignant cells	GSE164897_VemTra	ENSG00000167965	64223	MTOR associated protein, LST8 homolog	GbetaL|GBL|Lst8|Pop3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50305
0	-0.528407556134061	0.273	0.652	0	RNPS1	Malignant cells	GSE164897_VemTra	ENSG00000205937	10921	RNA binding protein with serine rich domain 1	NA	protein_coding	Q15287	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50306
0	-1.90131488186568	0.347	0.993	0	ELOB	Malignant cells	GSE164897_VemTra	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50307
0	-0.290742272020388	0.033	0.256	0	FLYWCH2	Malignant cells	GSE164897_VemTra	ENSG00000162076	114984	FLYWCH family member 2	NA	protein_coding	Q96CP2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50308
0	-1.53761746009467	0.117	0.822	0	TNFRSF12A	Malignant cells	GSE164897_VemTra	ENSG00000006327	51330	TNF receptor superfamily member 12A	CD266|FN14|TweakR	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50309
0	-0.587360057397749	0.23	0.551	0	HCFC1R1	Malignant cells	GSE164897_VemTra	ENSG00000103145	54985	host cell factor C1 regulator 1	FLJ20568|HPIP	protein_coding	Q9NWW0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50310
0	-0.378146646258924	0.009	0.285	0	THOC6	Malignant cells	GSE164897_VemTra	ENSG00000131652	79228	THO complex subunit 6	fSAP35|MGC2655|WDR58	protein_coding	Q86W42	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50311
0	-0.479730317528811	0.016	0.366	0	TRAP1	Malignant cells	GSE164897_VemTra	ENSG00000126602	10131	TNF receptor associated protein 1	HSP75|HSP90L	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50312
0	-0.495850437147236	0.038	0.411	0	NMRAL1	Malignant cells	GSE164897_VemTra	ENSG00000274684	57407	NmrA like redox sensor 1	FLJ25918|HSCARG|SDR48A1	protein_coding	Q9HBL8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50313
0	-0.551839486878427	0.095	0.474	0	CARHSP1	Malignant cells	GSE164897_VemTra	ENSG00000153048	23589	calcium regulated heat stable protein 1	CRHSP-24|CSDC1	protein_coding	Q9Y2V2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50314
0	-0.31897861097053	0.069	0.308	0	EMP2	Malignant cells	GSE164897_VemTra	ENSG00000213853	2013	epithelial membrane protein 2	XMP	protein_coding	P54851	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50315
0	-0.314745740454751	0.038	0.282	0	NUBP1	Malignant cells	GSE164897_VemTra	ENSG00000103274	4682	NUBP iron-sulfur cluster assembly factor 1, cytosolic	CIAO5|NBP1|NBP35	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50316
0	0.552226127891518	1	1	0	RPS15A	Malignant cells	GSE164897_VemTra	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50317
0	-1.09574243778337	0.122	0.804	0	NDUFAB1	Malignant cells	GSE164897_VemTra	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50318
0	-1.08174285354741	0.251	0.872	0	TUFM	Malignant cells	GSE164897_VemTra	ENSG00000178952	7284	Tu translation elongation factor, mitochondrial	EF-TuMT|EFTu	protein_coding	P49411	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50319
0	-0.357248591066411	0.136	0.42	0	MAZ	Malignant cells	GSE164897_VemTra	ENSG00000103495	4150	MYC associated zinc finger protein	Pur-1|ZF87|Zif87|ZNF801	protein_coding	P56270	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50320
0	-2.27420830580016	0.06	0.984	0	ALDOA	Malignant cells	GSE164897_VemTra	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50321
0	-0.454072176767243	0.106	0.456	0	PPP4C	Malignant cells	GSE164897_VemTra	ENSG00000149923	5531	protein phosphatase 4 catalytic subunit	PP4|PPX	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50322
0	-0.356532587459223	0.066	0.333	0	DCTPP1	Malignant cells	GSE164897_VemTra	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50323
0	-0.672945423282719	0.16	0.64	0	VKORC1	Malignant cells	GSE164897_VemTra	ENSG00000167397	79001	vitamin K epoxide reductase complex subunit 1	VKCFD2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50324
0	-0.445145719842833	0.052	0.389	0	BCKDK	Malignant cells	GSE164897_VemTra	ENSG00000103507	10295	branched chain keto acid dehydrogenase kinase	NA	protein_coding	O14874	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50325
0	-0.409926021335126	0.208	0.528	0	FUS	Malignant cells	GSE164897_VemTra	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50326
0	-0.375682029685209	0.024	0.307	0	TGFB1I1	Malignant cells	GSE164897_VemTra	ENSG00000140682	7041	transforming growth factor beta 1 induced transcript 1	ARA55|Hic-5|TSC-5	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50327
0	1.0649545603382	0.647	0.154	0	MMP2	Malignant cells	GSE164897_VemTra	ENSG00000087245	4313	matrix metallopeptidase 2	CLG4|CLG4A|TBE-1	protein_coding	P08253	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50328
0	-0.413004642889397	0.163	0.491	0	NUDT21	Malignant cells	GSE164897_VemTra	ENSG00000167005	11051	nudix hydrolase 21	CFIM25|CPSF5	protein_coding	O43809	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50329
0	-3.00953114493078	0.503	0.98	0	MT2A	Malignant cells	GSE164897_VemTra	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50330
0	-0.968722747624772	0.181	0.796	0	CIAO2B	Malignant cells	GSE164897_VemTra	ENSG00000166595	51647	cytosolic iron-sulfur assembly component 2B	CGI-128|CIA2B|FAM96B|MIP18	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50331
0	-0.399982562054177	0.08	0.389	0	E2F4	Malignant cells	GSE164897_VemTra	ENSG00000205250	1874	E2F transcription factor 4	E2F-4	protein_coding	Q16254	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50332
0	-0.341183564453763	0.031	0.288	0	ACD	Malignant cells	GSE164897_VemTra	ENSG00000102977	65057	ACD shelterin complex subunit and telomerase recruitment factor	Pip1|Ptop|Tint1|Tpp1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50333
0	-0.453444194758017	0.114	0.468	0	NUTF2	Malignant cells	GSE164897_VemTra	ENSG00000102898	10204	nuclear transport factor 2	NTF2|PP15	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50334
0	-0.295759118208593	0.061	0.291	0	UTP4	Malignant cells	GSE164897_VemTra	ENSG00000262788	84916	UTP4 small subunit processome component	CIRH1A|CIRHIN|FLJ14728|KIAA1988|NAIC|TEX292	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50335
0	-0.332259685181718	0.059	0.318	0	VPS4A	Malignant cells	GSE164897_VemTra	ENSG00000132612	27183	vacuolar protein sorting 4 homolog A	FLJ22197|SKD1|SKD1A|SKD2|VPS4|VPS4-1	protein_coding	Q9UN37	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50336
0	-0.745589171312914	0.058	0.582	0	NOB1	Malignant cells	GSE164897_VemTra	ENSG00000141101	28987	NIN1 (RPN12) binding protein 1 homolog	ART-4|MST158|NOB1P|PSMD8BP1	protein_coding	Q9ULX3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50337
0	-0.385479362504903	0.045	0.327	0	CENPN	Malignant cells	GSE164897_VemTra	ENSG00000166451	55839	centromere protein N	BM039|C16orf60|FLJ13607|FLJ22660	protein_coding	Q96H22	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50338
0	-0.671474810339865	0.072	0.554	0	GCSH	Malignant cells	GSE164897_VemTra	ENSG00000140905	2653	glycine cleavage system protein H	NA	protein_coding	P23434	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50339
0	0.634577050178347	0.905	0.803	0	HSBP1	Malignant cells	GSE164897_VemTra	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50340
0	1.16131009131359	1	0.996	0	COX4I1	Malignant cells	GSE164897_VemTra	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50341
0	-1.20413067446458	0.074	0.77	0	CYBA	Malignant cells	GSE164897_VemTra	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50342
0	-1.07667713142967	0.181	0.84	0	APRT	Malignant cells	GSE164897_VemTra	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50343
0	-2.59530318253255	0.997	1	0	RPL13	Malignant cells	GSE164897_VemTra	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50344
0	-0.359940749653157	0.061	0.341	0	TCF25	Malignant cells	GSE164897_VemTra	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50345
0	-0.295827274935478	0.076	0.312	0	DEF8	Malignant cells	GSE164897_VemTra	ENSG00000140995	54849	differentially expressed in FDCP 8 homolog	FLJ20186	protein_coding	Q6ZN54	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50346
0	-0.380729375975283	0.034	0.324	0	PITPNA-AS1	Malignant cells	GSE164897_VemTra	ENSG00000236618	100306951	PITPNA antisense RNA 1	NA	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50347
0	-0.580440633789878	0.06	0.492	0	EMC6	Malignant cells	GSE164897_VemTra	ENSG00000127774	83460	ER membrane protein complex subunit 6	MGC2963|RAB5IFL|TMEM93	protein_coding	Q9BV81	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50348
0	-0.514579840025725	0.045	0.431	0	SLC25A11	Malignant cells	GSE164897_VemTra	ENSG00000108528	8402	solute carrier family 25 member 11	OGC|SLC20A4	protein_coding	Q02978	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50349
0	-2.34778247558953	0.736	0.999	0	PFN1	Malignant cells	GSE164897_VemTra	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50350
0	-0.374472670241963	0.066	0.355	0	SPAG7	Malignant cells	GSE164897_VemTra	ENSG00000091640	9552	sperm associated antigen 7	ACRP|FSA-1|MGC20134	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50351
0	-0.471393068242728	0.009	0.347	0	CAMTA2	Malignant cells	GSE164897_VemTra	ENSG00000108509	23125	calmodulin binding transcription activator 2	KIAA0909	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50352
0	-0.30103922393483	0.062	0.297	0	RABEP1	Malignant cells	GSE164897_VemTra	ENSG00000029725	9135	rabaptin, RAB GTPase binding effector protein 1	neurocrescin|RAB5EP|rabaptin-5|RABPT5	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50353
0	-0.940133644585797	0.268	0.818	0	C1QBP	Malignant cells	GSE164897_VemTra	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50354
0	0.82269151441889	0.87	0.704	0	TXNDC17	Malignant cells	GSE164897_VemTra	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50355
0	-0.389762962142898	0.15	0.453	0	ACADVL	Malignant cells	GSE164897_VemTra	ENSG00000072778	37	acyl-CoA dehydrogenase very long chain	ACAD6|LCACD|VLCAD	protein_coding	P49748	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50356
0	0.601522401150692	0.381	0.056	0	GABARAP	Malignant cells	GSE164897_VemTra	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50357
0	-1.36015986959927	0.363	0.924	0	EIF5A	Malignant cells	GSE164897_VemTra	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50358
0	-0.54742336811451	0.17	0.577	0	TMEM256	Malignant cells	GSE164897_VemTra	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50359
0	-0.457529190084255	0.37	0.703	0	EIF4A1	Malignant cells	GSE164897_VemTra	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50360
0	-1.19163403356146	0.237	0.879	0	NAA38	Malignant cells	GSE164897_VemTra	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50361
0	0.402219686010858	1	1	0	RPL26	Malignant cells	GSE164897_VemTra	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50362
0	-0.394296830252216	0.077	0.365	0	PMP22	Malignant cells	GSE164897_VemTra	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50363
0	-0.309169181188433	0.063	0.31	0	ZSWIM7	Malignant cells	GSE164897_VemTra	ENSG00000214941	125150	zinc finger SWIM-type containing 7	SWS1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50364
0	1.11820138308765	0.979	0.822	0	UBB	Malignant cells	GSE164897_VemTra	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50365
0	0.600393423224046	0.316	0.064	0	LRRC75A	Malignant cells	GSE164897_VemTra	ENSG00000181350	388341	leucine rich repeat containing 75A	C17orf76|FAM211A|FLJ35696	protein_coding	Q8NAA5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50366
0	-0.425907700005627	0.068	0.394	0	COPS3	Malignant cells	GSE164897_VemTra	ENSG00000141030	8533	COP9 signalosome subunit 3	CSN3|SGN3	protein_coding	Q9UNS2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50367
0	-0.419050030450213	0.015	0.333	0	PEMT	Malignant cells	GSE164897_VemTra	ENSG00000133027	10400	phosphatidylethanolamine N-methyltransferase	PEMPT|PEMT2	protein_coding	Q9UBM1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50368
0	-0.301871141386845	0.022	0.253	0	DRG2	Malignant cells	GSE164897_VemTra	ENSG00000108591	1819	developmentally regulated GTP binding protein 2	NA	protein_coding	P55039	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50369
0	-0.369732352310232	0.085	0.38	0	IFT20	Malignant cells	GSE164897_VemTra	ENSG00000109083	90410	intraflagellar transport 20	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50370
0	-0.374355588200436	0.254	0.571	0	RAB34	Malignant cells	GSE164897_VemTra	ENSG00000109113	83871	RAB34, member RAS oncogene family	NARR|RAB39|RAH	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50371
0	0.564592752940433	1	1	0	RPL23A	Malignant cells	GSE164897_VemTra	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50372
0	-0.369990367335405	0.214	0.517	0	NSRP1	Malignant cells	GSE164897_VemTra	ENSG00000126653	84081	nuclear speckle splicing regulatory protein 1	CCDC55|DKFZP434K1421|NSrp70	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50373
0	-0.340332757035721	0.036	0.293	0	AATF	Malignant cells	GSE164897_VemTra	ENSG00000276072	26574	apoptosis antagonizing transcription factor	BFR2|CHE-1|CHE1|DED	protein_coding	Q9NY61	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50374
0	-0.617251141403637	0.1	0.552	0	CISD3	Malignant cells	GSE164897_VemTra	ENSG00000274768	284106	CDGSH iron sulfur domain 3	Miner2|MiNT	protein_coding	P0C7P0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50375
0	0.750499574777129	1	1	0	RPL23	Malignant cells	GSE164897_VemTra	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50376
0	0.598409151158051	1	1	0	RPL19	Malignant cells	GSE164897_VemTra	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50377
0	-0.402353097985572	0.254	0.588	0	MIEN1	Malignant cells	GSE164897_VemTra	ENSG00000141741	84299	migration and invasion enhancer 1	C17orf37|C35|MGC14832|ORB3|Rdx12|XTP4	protein_coding	Q9BRT3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50378
0	-0.373216913358876	0.04	0.325	0	PSMD3	Malignant cells	GSE164897_VemTra	ENSG00000108344	5709	proteasome 26S subunit, non-ATPase 3	P58|Rpn3|S3|TSTA2	protein_coding	O43242	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50379
0	0.580425631612433	0.368	0.083	0	IGFBP4	Malignant cells	GSE164897_VemTra	ENSG00000141753	3487	insulin like growth factor binding protein 4	BP-4|HT29-IGFBP|IBP4|IGFBP-4	protein_coding	P22692	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50380
0	-0.53200573987457	0.29	0.69	0	KRT10	Malignant cells	GSE164897_VemTra	ENSG00000186395	3858	keratin 10	CK10|K10|KPP	protein_coding	P13645	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50381
0	-2.37994506561404	0.818	1	0	EIF1	Malignant cells	GSE164897_VemTra	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50382
0	-0.552734129757925	0.044	0.459	0	NT5C3B	Malignant cells	GSE164897_VemTra	ENSG00000141698	115024	5'-nucleotidase, cytosolic IIIB	cN-IIIB|MGC20781|NT5C3L	protein_coding	Q969T7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50383
0	-0.502123047366496	0.149	0.538	0	RAB5C	Malignant cells	GSE164897_VemTra	ENSG00000108774	5878	RAB5C, member RAS oncogene family	RAB5CL|RABL	protein_coding	P51148	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50384
0	-0.412161652163109	0.054	0.36	0	TUBG1	Malignant cells	GSE164897_VemTra	ENSG00000131462	7283	tubulin gamma 1	TUBG|TUBGCP1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50385
0	0.81301655541645	1	1	0	RPL27	Malignant cells	GSE164897_VemTra	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50386
0	-0.46208421586295	0.038	0.388	0	ETV4	Malignant cells	GSE164897_VemTra	ENSG00000175832	2118	ETS variant transcription factor 4	E1A-F|E1AF|PEA3	protein_coding	P43268	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50387
0	-0.384878413624123	0.091	0.391	0	G6PC3	Malignant cells	GSE164897_VemTra	ENSG00000141349	92579	glucose-6-phosphatase catalytic subunit 3	UGRP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50388
0	-0.559191169219419	0.038	0.452	0	SLC25A39	Malignant cells	GSE164897_VemTra	ENSG00000013306	51629	solute carrier family 25 member 39	CGI-69|FLJ22407	protein_coding	Q9BZJ4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50389
0	-0.752467952139946	0.246	0.761	0	NMT1	Malignant cells	GSE164897_VemTra	ENSG00000136448	4836	N-myristoyltransferase 1	NMT	protein_coding	P30419	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50390
0	-0.367202179882608	0.099	0.392	0	MRPL10	Malignant cells	GSE164897_VemTra	ENSG00000159111	124995	mitochondrial ribosomal protein L10	L10MT|MGC17973|MRP-L10|MRP-L8|MRPL8|RPML8	protein_coding	Q7Z7H8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50391
0	1.10929884502662	0.899	0.598	0	ATP5MC1	Malignant cells	GSE164897_VemTra	ENSG00000159199	516	ATP synthase membrane subunit c locus 1	ATP5G|ATP5G1	protein_coding	P05496	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50392
0	-0.545808918966211	0.252	0.672	0	SNF8	Malignant cells	GSE164897_VemTra	ENSG00000159210	11267	SNF8 subunit of ESCRT-II	Dot3|EAP30|VPS22	protein_coding	Q96H20	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50393
0	-0.993759237634933	0.081	0.718	0	PHB1	Malignant cells	GSE164897_VemTra	ENSG00000167085	5245	prohibitin 1	PHB	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50394
0	-0.555052403798818	0.006	0.422	0	NME2	Malignant cells	GSE164897_VemTra	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50395
0	1.18337976709324	0.717	0.194	0	VMP1	Malignant cells	GSE164897_VemTra	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50396
0	-1.05090427974921	0.087	0.726	0	SNHG25	Malignant cells	GSE164897_VemTra	ENSG00000266402	NA	NA	NA	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50397
0	-0.991881257403823	0.999	1	0	RPL38	Malignant cells	GSE164897_VemTra	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50398
0	-0.412036822985722	0.033	0.348	0	MRPL58	Malignant cells	GSE164897_VemTra	ENSG00000167862	3396	mitochondrial ribosomal protein L58	DS-1|ICT1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50399
0	-0.836077256614011	0.056	0.629	0	NT5C	Malignant cells	GSE164897_VemTra	ENSG00000125458	30833	5', 3'-nucleotidase, cytosolic	cdN|DNT-1|DNT1|PN-I|UMPH2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50400
0	-0.943995621007011	0.131	0.703	0	JPT1	Malignant cells	GSE164897_VemTra	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50401
0	0.950368970881052	0.957	0.806	0	SUMO2	Malignant cells	GSE164897_VemTra	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50402
0	-0.337705916597211	0.122	0.398	0	MRPS7	Malignant cells	GSE164897_VemTra	ENSG00000125445	51081	mitochondrial ribosomal protein S7	MRP-S|RP-S7|RPMS7	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50403
0	-0.313479783445308	0.026	0.262	0	GALK1	Malignant cells	GSE164897_VemTra	ENSG00000108479	2584	galactokinase 1	GALK	protein_coding	P51570	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50404
0	-1.45485252631249	0.756	0.993	0	H3-3B	Malignant cells	GSE164897_VemTra	ENSG00000132475	3021	H3.3 histone B	H3.3B|H3F3B	protein_coding	P84243	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50405
0	-0.343469482259455	0.046	0.314	0	WBP2	Malignant cells	GSE164897_VemTra	ENSG00000132471	23558	WW domain binding protein 2	GRAMD6|WBP-2	protein_coding	Q969T9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50406
0	-0.412876627692472	0.035	0.347	0	SYNGR2	Malignant cells	GSE164897_VemTra	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50407
0	-0.478362994056469	0.013	0.311	0	TK1	Malignant cells	GSE164897_VemTra	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50408
0	-0.776609030048007	0.129	0.669	0	NDUFAF8	Malignant cells	GSE164897_VemTra	ENSG00000224877	284184	NADH:ubiquinone oxidoreductase complex assembly factor 8	C17orf89	protein_coding	A1L188	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50409
0	-0.860598164263234	0.941	0.996	0	ACTG1	Malignant cells	GSE164897_VemTra	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50410
0	-0.700372695567238	0.066	0.567	0	OXLD1	Malignant cells	GSE164897_VemTra	ENSG00000204237	339229	oxidoreductase like domain containing 1	C17orf90|MGC104712	protein_coding	Q5BKU9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50411
0	-0.326833129995628	0.033	0.282	0	CCDC137	Malignant cells	GSE164897_VemTra	ENSG00000185298	339230	coiled-coil domain containing 137	MGC16597	protein_coding	Q6PK04	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50412
0	-0.395987014522626	0.043	0.345	0	HGS	Malignant cells	GSE164897_VemTra	ENSG00000185359	9146	hepatocyte growth factor-regulated tyrosine kinase substrate	Hrs|Vps27|ZFYVE8	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50413
0	-0.94546280331183	0.053	0.693	0	MRPL12	Malignant cells	GSE164897_VemTra	ENSG00000262814	6182	mitochondrial ribosomal protein L12	MRPL7|MRPL7/L12|RPML12	protein_coding	P52815	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50414
0	-0.392837431034608	0.023	0.321	0	MCRIP1	Malignant cells	GSE164897_VemTra	ENSG00000288213	348262	MAPK regulated corepressor interacting protein 1	FAM195B|GRAN2|MCRIP	protein_coding	C9JLW8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50415
0	-0.486947897735106	0.172	0.548	0	P4HB	Malignant cells	GSE164897_VemTra	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50416
0	-0.69251366168373	0.041	0.537	0	ARHGDIA	Malignant cells	GSE164897_VemTra	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50417
0	-0.799935857941673	0.167	0.705	0	ANAPC11	Malignant cells	GSE164897_VemTra	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50418
0	-0.502885170729078	0.038	0.399	0	PYCR1	Malignant cells	GSE164897_VemTra	ENSG00000183010	5831	pyrroline-5-carboxylate reductase 1	P5C	protein_coding	P32322	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50419
0	-0.564479004605548	0.05	0.466	0	CENPX	Malignant cells	GSE164897_VemTra	ENSG00000169689	201254	centromere protein X	CENP-X|FAAP10|MGC14480|MHF2|STRA13	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50420
0	-0.438204558579534	0.033	0.364	0	DCXR	Malignant cells	GSE164897_VemTra	ENSG00000169738	51181	dicarbonyl and L-xylulose reductase	DCR|HCR2|KIDCR|P34H|SDR20C1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50421
0	-0.584716251669292	0.031	0.459	0	GPS1	Malignant cells	GSE164897_VemTra	ENSG00000169727	2873	G protein pathway suppressor 1	COPS1|CSN1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50422
0	-0.322751951250853	0.064	0.315	0	WDR45B	Malignant cells	GSE164897_VemTra	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50423
0	-0.493394738798362	0.233	0.61	0	NDUFV2	Malignant cells	GSE164897_VemTra	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50424
0	0.966844295435632	0.663	0.307	0	COSMOC	Malignant cells	GSE164897_VemTra	ENSG00000260552	101927809	cell fate and sterol metabolism associated divergent transcript of MOCOS	NA	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50425
0	0.748002155111911	0.723	0.512	0	RPL17	Malignant cells	GSE164897_VemTra	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50426
0	-0.433763323723837	0.117	0.456	0	TXNL1	Malignant cells	GSE164897_VemTra	ENSG00000091164	9352	thioredoxin like 1	TRP32|Txl|TXNL	protein_coding	O43396	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50427
0	-0.356475998741914	0.038	0.299	0	PMAIP1	Malignant cells	GSE164897_VemTra	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50428
0	0.57189285336906	0.357	0.058	0	CCDC102B	Malignant cells	GSE164897_VemTra	ENSG00000150636	79839	coiled-coil domain containing 102B	ACY1L|AN|C18orf14|FLJ23594|HsT1731	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50429
0	-0.397229478619649	0.204	0.522	0	TXNL4A	Malignant cells	GSE164897_VemTra	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50430
0	-0.939016672662794	0.041	0.556	0	TRIB3	Malignant cells	GSE164897_VemTra	ENSG00000101255	57761	tribbles pseudokinase 3	C20orf97|dJ1103G7.3|TRB3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50431
0	-0.848358828444592	0.127	0.675	0	RBCK1	Malignant cells	GSE164897_VemTra	ENSG00000125826	10616	RANBP2-type and C3HC4-type zinc finger containing 1	C20orf18|HOIL1|RBCK2|RNF54|UBCE7IP3|XAP4|ZRANB4	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50432
0	-1.30986447281657	0.163	0.847	0	SNRPB	Malignant cells	GSE164897_VemTra	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50433
0	-0.404481873393324	0.146	0.449	0	NOP56	Malignant cells	GSE164897_VemTra	ENSG00000101361	10528	NOP56 ribonucleoprotein	NOL5A|SCA36	protein_coding	O00567	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50434
0	-0.410779207393457	0.093	0.408	0	IDH3B	Malignant cells	GSE164897_VemTra	ENSG00000101365	3420	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta	RP46	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50435
0	-0.793525061031614	0.066	0.606	0	MRPS26	Malignant cells	GSE164897_VemTra	ENSG00000125901	64949	mitochondrial ribosomal protein S26	C20orf193|dJ534B8.3|MRP-S13|MRP-S26|RPMS13	protein_coding	Q9BYN8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50436
0	-0.408811150192767	0.029	0.341	0	DDRGK1	Malignant cells	GSE164897_VemTra	ENSG00000198171	65992	DDRGK domain containing 1	C20orf116|dJ1187M17.3|UFBP1	protein_coding	Q96HY6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50437
0	-0.500226269822321	0.063	0.439	0	ITPA	Malignant cells	GSE164897_VemTra	ENSG00000125877	3704	inosine triphosphatase	C20orf37|dJ794I6.3|HLC14-06-P	protein_coding	Q9BY32	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50438
0	-0.601862235500571	0.018	0.458	0	C20orf27	Malignant cells	GSE164897_VemTra	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50439
0	-0.390563438328821	0.309	0.638	0	TMEM230	Malignant cells	GSE164897_VemTra	ENSG00000089063	29058	transmembrane protein 230	C20orf30|HSPC274	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50440
0	-0.367851461358421	0.032	0.306	0	TRMT6	Malignant cells	GSE164897_VemTra	ENSG00000089195	51605	tRNA methyltransferase 6 non-catalytic subunit	CGI-09|GCD10|Gcd10p|MGC5029	protein_coding	Q9UJA5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50441
0	-0.644368184916763	0.03	0.488	0	MKKS	Malignant cells	GSE164897_VemTra	ENSG00000125863	8195	MKKS centrosomal shuttling protein	BBS6|HMCS|KMS|MKS	protein_coding	Q9NPJ1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50442
0	-1.53794003643633	0.449	0.875	0	SNRPB2	Malignant cells	GSE164897_VemTra	ENSG00000125870	6629	small nuclear ribonucleoprotein polypeptide B2	Msl1|U2B''	protein_coding	P08579	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50443
0	-1.13409650507498	0.518	0.97	0	DSTN	Malignant cells	GSE164897_VemTra	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50444
0	-0.440704518899529	0.065	0.401	0	DTD1	Malignant cells	GSE164897_VemTra	ENSG00000125821	92675	D-aminoacyl-tRNA deacylase 1	bA379J5.3|bA555E18.1|C20orf88|DUEB|HARS2|MGC119131|MGC41905|pqn-68	protein_coding	Q8TEA8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50445
0	-0.408927133705961	0.171	0.497	0	NAA20	Malignant cells	GSE164897_VemTra	ENSG00000173418	51126	N-alpha-acetyltransferase 20, NatB catalytic subunit	dJ1002M8.1|NAT3|NAT5	protein_coding	P61599	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50446
0	-0.314439565784483	0.037	0.272	0	NXT1	Malignant cells	GSE164897_VemTra	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50447
0	-0.538484671774747	0.271	0.665	0	CST3	Malignant cells	GSE164897_VemTra	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50448
0	-0.537091567129705	0.029	0.411	0	PYGB	Malignant cells	GSE164897_VemTra	ENSG00000100994	5834	glycogen phosphorylase B	NA	protein_coding	P11216	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50449
0	-0.470544836556945	0.126	0.485	0	HM13	Malignant cells	GSE164897_VemTra	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50450
0	-0.552688799336269	0.054	0.462	0	RALY	Malignant cells	GSE164897_VemTra	ENSG00000125970	22913	RALY heterogeneous nuclear ribonucleoprotein	HNRPCL2|P542	protein_coding	Q9UKM9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50451
0	-1.73158432698014	0.421	0.977	0	EIF2S2	Malignant cells	GSE164897_VemTra	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50452
0	-0.494358724270785	0.144	0.527	0	AHCY	Malignant cells	GSE164897_VemTra	ENSG00000101444	191	adenosylhomocysteinase	AdoHcyase|SAHH	protein_coding	P23526	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50453
0	-0.283480398467235	0.064	0.289	0	GSS	Malignant cells	GSE164897_VemTra	ENSG00000100983	2937	glutathione synthetase	NA	protein_coding	P48637	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50454
0	-0.680783267399268	0.373	0.817	0	EIF6	Malignant cells	GSE164897_VemTra	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50455
0	0.839402847911083	0.874	0.667	0	ERGIC3	Malignant cells	GSE164897_VemTra	ENSG00000125991	51614	ERGIC and golgi 3	C20orf47|CGI-54|Erv46|NY-BR-84|PRO0989|SDBCAG84	protein_coding	Q9Y282	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50456
0	-2.01389169856779	0.245	0.986	0	ROMO1	Malignant cells	GSE164897_VemTra	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50457
0	-0.460947626598027	0.247	0.604	0	RBM39	Malignant cells	GSE164897_VemTra	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50458
0	-0.684069631775879	0.128	0.605	0	SCAND1	Malignant cells	GSE164897_VemTra	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50459
0	-0.588801721176427	0.123	0.516	0	TOP1	Malignant cells	GSE164897_VemTra	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50460
0	-0.354069788183741	0.044	0.32	0	PKIG	Malignant cells	GSE164897_VemTra	ENSG00000168734	11142	cAMP-dependent protein kinase inhibitor gamma	NA	protein_coding	Q9Y2B9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50461
0	-0.418655350500813	0.087	0.406	0	DNTTIP1	Malignant cells	GSE164897_VemTra	ENSG00000101457	116092	deoxynucleotidyltransferase terminal interacting protein 1	C20orf167|dJ447F3.4|Tdif1	protein_coding	Q9H147	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50462
0	-0.683877007381038	0.045	0.281	0	UBE2C	Malignant cells	GSE164897_VemTra	ENSG00000175063	11065	ubiquitin conjugating enzyme E2 C	UBCH10	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50463
0	-0.471189491958943	0.024	0.368	0	PLTP	Malignant cells	GSE164897_VemTra	ENSG00000100979	5360	phospholipid transfer protein	BPIFE	protein_coding	P55058	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50464
0	-0.373668778416029	0.051	0.341	0	SLC35C2	Malignant cells	GSE164897_VemTra	ENSG00000080189	51006	solute carrier family 35 member C2	bA394O2.1|C20orf5|CGI-15|OVCOV1	protein_coding	Q9NQQ7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50465
0	-0.496905133378915	0.004	0.356	0	KCNG1	Malignant cells	GSE164897_VemTra	ENSG00000026559	3755	potassium voltage-gated channel modifier subfamily G member 1	K13|KCNG|kH2|Kv6.1	protein_coding	Q9UIX4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50466
0	-0.596202849489187	0.371	0.79	0	PFDN4	Malignant cells	GSE164897_VemTra	ENSG00000101132	5203	prefoldin subunit 4	C-1|C1|PFD4	protein_coding	Q9NQP4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50467
0	-1.00043265018069	0.055	0.641	0	PMEPA1	Malignant cells	GSE164897_VemTra	ENSG00000124225	56937	prostate transmembrane protein, androgen induced 1	STAG1|TMEPAI	protein_coding	Q969W9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50468
0	0.725586036648589	0.777	0.53	0	GNAS	Malignant cells	GSE164897_VemTra	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50469
0	-1.62033343828793	0.713	0.993	0	PSMA7	Malignant cells	GSE164897_VemTra	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50470
0	-1.1161367250891	0.081	0.774	0	ADRM1	Malignant cells	GSE164897_VemTra	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50471
0	-2.04377300220318	0.982	1	0	RPS21	Malignant cells	GSE164897_VemTra	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50472
0	-0.765782846931941	0.001	0.443	0	SLCO4A1	Malignant cells	GSE164897_VemTra	ENSG00000101187	28231	solute carrier organic anion transporter family member 4A1	OATP-E|OATP4A1|SLC21A12	protein_coding	Q96BD0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50473
0	-0.546440730391039	0	0.331	0	SLCO4A1-AS1	Malignant cells	GSE164897_VemTra	ENSG00000232803	100127888	SLCO4A1 antisense RNA 1	NA	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50474
0	-0.290972001085587	0.064	0.295	0	MRGBP	Malignant cells	GSE164897_VemTra	ENSG00000101189	55257	MRG domain binding protein	C20orf20|Eaf7|FLJ10914|MRG15BP	protein_coding	Q9NV56	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50475
0	-0.340865344684697	0.023	0.281	0	OGFR	Malignant cells	GSE164897_VemTra	ENSG00000060491	11054	opioid growth factor receptor	7-60	protein_coding	Q9NZT2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50476
0	-0.985340928663631	0.081	0.647	0	COL9A3	Malignant cells	GSE164897_VemTra	ENSG00000092758	1299	collagen type IX alpha 3 chain	DJ885L7.4.1|EDM3|FLJ90759|IDD|MED	protein_coding	Q14050	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50477
0	-0.963794996534021	0.054	0.697	0	PPDPF	Malignant cells	GSE164897_VemTra	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50478
0	-0.338861982934879	0.046	0.308	0	PRPF6	Malignant cells	GSE164897_VemTra	ENSG00000101161	24148	pre-mRNA processing factor 6	ANT-1|bB152O15.1|C20orf14|hPrp6|Prp6|RP60|SNRNP102|TOM|U5-102K	protein_coding	O94906	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50479
0	-0.639298599629706	0.042	0.501	0	PLPP2	Malignant cells	GSE164897_VemTra	ENSG00000141934	8612	phospholipid phosphatase 2	LPP2|PAP-2c|PPAP2C	protein_coding	O43688	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50480
0	-0.991036409323234	0.117	0.761	0	BSG	Malignant cells	GSE164897_VemTra	ENSG00000172270	682	basigin (Ok blood group)	CD147|EMMPRIN|EMPRIN|OK	protein_coding	P35613	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50481
0	-0.493059302091167	0.016	0.379	0	RNF126	Malignant cells	GSE164897_VemTra	ENSG00000070423	55658	ring finger protein 126	FLJ20552	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50482
0	-0.5757684670197	0.012	0.427	0	WDR18	Malignant cells	GSE164897_VemTra	ENSG00000065268	57418	WD repeat domain 18	Ipi3	protein_coding	Q9BV38	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50483
0	-0.521851447531395	0.053	0.443	0	POLR2E	Malignant cells	GSE164897_VemTra	ENSG00000099817	5434	RNA polymerase II, I and III subunit E	hRPB25|hsRPB5|RPABC1|RPB5|XAP4	protein_coding	P19388	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50484
0	-1.14873342556714	0.145	0.829	0	GPX4	Malignant cells	GSE164897_VemTra	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50485
0	-0.44595123862632	0.097	0.44	0	ATP5F1D	Malignant cells	GSE164897_VemTra	ENSG00000099624	513	ATP synthase F1 subunit delta	ATP5D	protein_coding	P30049	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50486
0	-0.721620537616911	0.242	0.729	0	CIRBP	Malignant cells	GSE164897_VemTra	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50487
0	-0.302884989745681	0.032	0.264	0	FAM174C	Malignant cells	GSE164897_VemTra	ENSG00000228300	55009	family with sequence similarity 174 member C	C19orf24|FLJ20640	protein_coding	Q9BVV8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50488
0	-0.687124948371941	0.035	0.532	0	NDUFS7	Malignant cells	GSE164897_VemTra	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50489
0	-0.405728435667959	0.034	0.343	0	GAMT	Malignant cells	GSE164897_VemTra	ENSG00000130005	2593	guanidinoacetate N-methyltransferase	PIG2|TP53I2	protein_coding	Q14353	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50490
0	-2.74283022372494	0.848	1	0	RPS15	Malignant cells	GSE164897_VemTra	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50491
0	-1.35812675695944	0.199	0.918	0	UQCR11	Malignant cells	GSE164897_VemTra	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50492
0	-1.01629611937186	0.405	0.926	0	OAZ1	Malignant cells	GSE164897_VemTra	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50493
0	-0.928766966943261	0.024	0.642	0	LSM7	Malignant cells	GSE164897_VemTra	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50494
0	-1.06049262760028	0.06	0.748	0	TIMM13	Malignant cells	GSE164897_VemTra	ENSG00000099800	26517	translocase of inner mitochondrial membrane 13	Tim13|TIMM13B	protein_coding	Q9Y5L4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50495
0	-0.449142269718112	0.06	0.392	0	HMG20B	Malignant cells	GSE164897_VemTra	ENSG00000064961	10362	high mobility group 20B	BRAF25|BRAF35|HMGX2|HMGXB2|SMARCE1r|SOXL	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50496
0	-0.598486837635268	0.046	0.487	0	MRPL54	Malignant cells	GSE164897_VemTra	ENSG00000183617	116541	mitochondrial ribosomal protein L54	NA	protein_coding	Q6P161	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50497
0	-1.0213438176199	0.653	0.949	0	EEF2	Malignant cells	GSE164897_VemTra	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50498
0	-0.653502881880468	0.152	0.625	0	MYDGF	Malignant cells	GSE164897_VemTra	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50499
0	-3.31444826634394	0.927	1	0	RPL36	Malignant cells	GSE164897_VemTra	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50500
0	-1.26076654723289	0.093	0.846	0	MICOS13	Malignant cells	GSE164897_VemTra	ENSG00000174917	125988	mitochondrial contact site and cristae organizing system subunit 13	C19orf70|MIC12|MIC13|P117|QIL1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50501
0	-0.362004651982005	0.019	0.29	0	LONP1	Malignant cells	GSE164897_VemTra	ENSG00000196365	9361	lon peptidase 1, mitochondrial	hLON|LonHS|PIM1|PRSS15	protein_coding	P36776	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50502
0	-1.07852353060984	0.133	0.822	0	NDUFA11	Malignant cells	GSE164897_VemTra	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50503
0	-0.803486270342609	0.013	0.459	0	CAPS	Malignant cells	GSE164897_VemTra	ENSG00000105519	828	calcyphosine	CAPS1|MGC126562	protein_coding	Q13938	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50504
0	-0.672493645709015	0.043	0.532	0	CLPP	Malignant cells	GSE164897_VemTra	ENSG00000125656	8192	caseinolytic mitochondrial matrix peptidase proteolytic subunit	NA	protein_coding	Q16740	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50505
0	-0.477909972449804	0.034	0.39	0	ALKBH7	Malignant cells	GSE164897_VemTra	ENSG00000125652	84266	alkB homolog 7	MGC10974|SPATA11	protein_coding	Q9BT30	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50506
0	-0.426746117652986	0.045	0.35	0	CD70	Malignant cells	GSE164897_VemTra	ENSG00000125726	970	CD70 molecule	CD27L|CD27LG|TNFSF7	protein_coding	P32970	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50507
0	0.454900812845444	0.311	0.062	0	C3	Malignant cells	GSE164897_VemTra	ENSG00000125730	718	complement C3	ARMD9|C3a|C3b|CPAMD1	protein_coding	P01024	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50508
0	-0.324030151123981	0.017	0.26	0	SNAPC2	Malignant cells	GSE164897_VemTra	ENSG00000104976	6618	small nuclear RNA activating complex polypeptide 2	PTFdelta|SNAP45	protein_coding	Q13487	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50509
0	-0.467031255373552	0.048	0.398	0	TIMM44	Malignant cells	GSE164897_VemTra	ENSG00000104980	10469	translocase of inner mitochondrial membrane 44	TIM44	protein_coding	O43615	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50510
0	-0.591148512014955	0.038	0.475	0	CD320	Malignant cells	GSE164897_VemTra	ENSG00000167775	51293	CD320 molecule	8D6|8D6A|TCblR	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50511
0	-3.33193782028909	0.905	1	0	RPS28	Malignant cells	GSE164897_VemTra	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50512
0	-0.628650909737045	0.113	0.568	0	HNRNPM	Malignant cells	GSE164897_VemTra	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50513
0	0.578722870928959	0.993	0.977	0	UBL5	Malignant cells	GSE164897_VemTra	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50514
0	-0.657348060623224	0.066	0.548	0	PIN1	Malignant cells	GSE164897_VemTra	ENSG00000127445	5300	peptidylprolyl cis/trans isomerase, NIMA-interacting 1	dod	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50515
0	-1.00098783341942	0.114	0.77	0	EIF3G	Malignant cells	GSE164897_VemTra	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50516
0	-0.454547721392525	0.074	0.396	0	DNMT1	Malignant cells	GSE164897_VemTra	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50517
0	-0.654930759374568	0.032	0.499	0	MRPL4	Malignant cells	GSE164897_VemTra	ENSG00000105364	51073	mitochondrial ribosomal protein L4	CGI-28	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50518
0	-0.928075483902219	0.125	0.741	0	CDC37	Malignant cells	GSE164897_VemTra	ENSG00000105401	11140	cell division cycle 37, HSP90 cochaperone	P50CDC37	protein_coding	Q16543	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50519
0	-0.320351101866742	0.013	0.254	0	QTRT1	Malignant cells	GSE164897_VemTra	ENSG00000213339	81890	queuine tRNA-ribosyltransferase catalytic subunit 1	TGT	protein_coding	Q9BXR0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50520
0	-0.323011294509849	0.04	0.289	0	TMED1	Malignant cells	GSE164897_VemTra	ENSG00000099203	11018	transmembrane p24 trafficking protein 1	Il1rl1l|IL1RL1LG|MGC1270|p24g1|p24gamma1|ST2L	protein_coding	Q13445	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50521
0	-0.31843786472641	0.025	0.266	0	CARM1	Malignant cells	GSE164897_VemTra	ENSG00000142453	10498	coactivator associated arginine methyltransferase 1	PRMT4	protein_coding	Q86X55	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50522
0	-0.356438239672393	0.032	0.306	0	YIPF2	Malignant cells	GSE164897_VemTra	ENSG00000130733	78992	Yip1 domain family member 2	FinGER2|MGC3262	protein_coding	Q9BWQ6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50523
0	-0.415102086114889	0.058	0.371	0	TMEM205	Malignant cells	GSE164897_VemTra	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50524
0	-0.78632409466414	0.034	0.587	0	PRKCSH	Malignant cells	GSE164897_VemTra	ENSG00000130175	5589	protein kinase C substrate 80K-H	G19P1|GIIB|PCLD|PLD1|VASAP-60	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50525
0	-0.451137351961872	0.021	0.363	0	ECSIT	Malignant cells	GSE164897_VemTra	ENSG00000130159	51295	ECSIT signaling integrator	SITPEC	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50526
0	-0.931118243929485	0.046	0.671	0	ELOF1	Malignant cells	GSE164897_VemTra	ENSG00000130165	84337	elongation factor 1	ELF1|MGC4549	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50527
0	-0.52729444466474	0.106	0.502	0	DHPS	Malignant cells	GSE164897_VemTra	ENSG00000095059	1725	deoxyhypusine synthase	MIG13	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50528
0	-0.992649666647753	0.225	0.848	0	TRIR	Malignant cells	GSE164897_VemTra	ENSG00000123144	79002	telomerase RNA component interacting RNase	C19orf43|fSAP18|MGC2803|TERCIR	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50529
0	-0.418922587778879	0.07	0.39	0	GET3	Malignant cells	GSE164897_VemTra	ENSG00000198356	439	guided entry of tail-anchored proteins factor 3, ATPase	ARSA-I|ASNA1|TRC40	protein_coding	O43681	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50530
0	-0.592142435420291	0.04	0.421	0	JUNB	Malignant cells	GSE164897_VemTra	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50531
0	-0.51860638150276	0.423	0.797	0	PRDX2	Malignant cells	GSE164897_VemTra	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50532
0	-0.401325574020188	0.006	0.293	0	RNASEH2A	Malignant cells	GSE164897_VemTra	ENSG00000104889	10535	ribonuclease H2 subunit A	AGS4|RNASEHI|RNHIA|RNHL	protein_coding	O75792	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50533
0	-0.566445708978158	0.089	0.499	0	FARSA	Malignant cells	GSE164897_VemTra	ENSG00000179115	2193	phenylalanyl-tRNA synthetase subunit alpha	CML33|FARSL|FARSLA	protein_coding	Q9Y285	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50534
0	0.677272079930563	0.686	0.534	0	CALR	Malignant cells	GSE164897_VemTra	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50535
0	-0.811118986504707	0.161	0.709	0	RAD23A	Malignant cells	GSE164897_VemTra	ENSG00000179262	5886	RAD23 homolog A, nucleotide excision repair protein	HHR23A|MGC111083	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50536
0	-1.39846375717147	0.194	0.923	0	GADD45GIP1	Malignant cells	GSE164897_VemTra	ENSG00000179271	90480	GADD45G interacting protein 1	CKBBP2|CKbetaBP2|CRIF1|MGC4667|MGC4758|PLINP-1|Plinp1|PRG6	protein_coding	Q8TAE8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50537
0	-0.575078194116292	0.054	0.48	0	STX10	Malignant cells	GSE164897_VemTra	ENSG00000104915	8677	syntaxin 10	hsyn10|SYN10	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50538
0	-0.478757780010578	0.117	0.457	0	IER2	Malignant cells	GSE164897_VemTra	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50539
0	-0.483510392112842	0.024	0.367	0	DDX39A	Malignant cells	GSE164897_VemTra	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50540
0	-0.47215708406362	0.047	0.399	0	GIPC1	Malignant cells	GSE164897_VemTra	ENSG00000123159	10755	GIPC PDZ domain containing family member 1	C19orf3|GIPC|GLUT1CBP|Hs.6454|NIP|RGS19IP1|SEMCAP|SYNECTIN|TIP-2	protein_coding	O14908	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50541
0	-0.801099262022438	0.049	0.601	0	TECR	Malignant cells	GSE164897_VemTra	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50542
0	-1.38711231902015	0.14	0.904	0	NDUFB7	Malignant cells	GSE164897_VemTra	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50543
0	-0.441175817666332	0.197	0.557	0	USE1	Malignant cells	GSE164897_VemTra	ENSG00000053501	55850	unconventional SNARE in the ER 1	D12|MDS032|p31|SLT1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50544
0	-0.604314187215058	0.101	0.554	0	MRPL34	Malignant cells	GSE164897_VemTra	ENSG00000130312	64981	mitochondrial ribosomal protein L34	L34mt|MGC24974|MGC2633	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50545
0	-0.554682787018697	0.053	0.47	0	DDA1	Malignant cells	GSE164897_VemTra	ENSG00000130311	79016	DET1 and DDB1 associated 1	C19orf58|MGC2594|PCIA1	protein_coding	Q9BW61	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50546
0	-0.619891830387847	0.034	0.49	0	MVB12A	Malignant cells	GSE164897_VemTra	ENSG00000141971	93343	multivesicular body subunit 12A	FAM125A|FLJ32495	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50547
0	-0.865312694000266	0.086	0.678	0	PGLS	Malignant cells	GSE164897_VemTra	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50548
0	-2.92424685899347	0.977	1	0	RPL18A	Malignant cells	GSE164897_VemTra	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50549
0	-0.723536948025514	0.016	0.537	0	CCDC124	Malignant cells	GSE164897_VemTra	ENSG00000007080	115098	coiled-coil domain containing 124	Lso2|oxs1	protein_coding	Q96CT7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50550
0	-0.978708639274068	0.105	0.716	0	LSM4	Malignant cells	GSE164897_VemTra	ENSG00000130520	25804	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated	YER112W	protein_coding	Q9Y4Z0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50551
0	-0.945263676525532	0.026	0.669	0	FKBP8	Malignant cells	GSE164897_VemTra	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50552
0	-0.487517472409013	0.178	0.559	0	KXD1	Malignant cells	GSE164897_VemTra	ENSG00000105700	79036	KxDL motif containing 1	BORCS4|C19orf50|FLJ25480|KXDL|MGC2749	protein_coding	Q9BQD3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50553
0	0.796645020843727	1	1	0	UBA52	Malignant cells	GSE164897_VemTra	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50554
0	-0.741065457517694	0.067	0.603	0	REX1BD	Malignant cells	GSE164897_VemTra	ENSG00000006015	55049	required for excision 1-B domain containing	C19orf60|FLJ20850|FLJ30108|FLJ34606|FLJ37391	protein_coding	Q96EN9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50555
0	-1.0856539915281	0.086	0.777	0	COPE	Malignant cells	GSE164897_VemTra	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50556
0	-0.496090352867535	0.027	0.394	0	DDX49	Malignant cells	GSE164897_VemTra	ENSG00000105671	54555	DEAD-box helicase 49	Dbp8|FLJ10432	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50557
0	-0.377061338537788	0.037	0.321	0	RFXANK	Malignant cells	GSE164897_VemTra	ENSG00000064490	8625	regulatory factor X associated ankyrin containing protein	ANKRA1|BLS|F14150_1|MGC138628|RFX-B	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50558
0	-0.610425739408495	0.306	0.757	0	NDUFA13	Malignant cells	GSE164897_VemTra	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50559
0	-0.573648544778726	0.177	0.604	0	UQCRFS1	Malignant cells	GSE164897_VemTra	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50560
0	-1.06471475426625	0.156	0.802	0	PDCD5	Malignant cells	GSE164897_VemTra	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50561
0	-0.358619577707197	0.02	0.284	0	CEBPG	Malignant cells	GSE164897_VemTra	ENSG00000153879	1054	CCAAT enhancer binding protein gamma	GPE1BP|IG/EBP-1	protein_coding	P53567	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50562
0	-1.11541596349648	0.128	0.805	0	FXYD5	Malignant cells	GSE164897_VemTra	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50563
0	-0.444233342117072	0.053	0.388	0	USF2	Malignant cells	GSE164897_VemTra	ENSG00000105698	7392	upstream transcription factor 2, c-fos interacting	bHLHb12|FIP	protein_coding	Q15853	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50564
0	-0.721246398856816	0.221	0.733	0	TMEM147	Malignant cells	GSE164897_VemTra	ENSG00000105677	10430	transmembrane protein 147	MGC1936|NIFIE14	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50565
0	-0.276443065372173	0.04	0.251	0	RBM42	Malignant cells	GSE164897_VemTra	ENSG00000126254	79171	RNA binding motif protein 42	MGC10433	protein_coding	Q9BTD8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50566
0	1.09833993175078	0.998	0.926	0	COX6B1	Malignant cells	GSE164897_VemTra	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50567
0	-0.936890316010294	0.062	0.688	0	POLR2I	Malignant cells	GSE164897_VemTra	ENSG00000105258	5438	RNA polymerase II subunit I	hRPB14.5|RPB9	protein_coding	P36954	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50568
0	-0.829730994019978	0.07	0.637	0	TBCB	Malignant cells	GSE164897_VemTra	ENSG00000105254	1155	tubulin folding cofactor B	CG22|CKAP1|CKAPI	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50569
0	-0.379890877633847	0.252	0.564	0	CAPNS1	Malignant cells	GSE164897_VemTra	ENSG00000126247	826	calpain small subunit 1	30K|CANP|CANPS|CAPN4|CDPS	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50570
0	-0.614838444187729	0.069	0.358	0	C19orf33	Malignant cells	GSE164897_VemTra	ENSG00000167644	64073	chromosome 19 open reading frame 33	H2RSP|IMUP|IMUP-1|IMUP-2	protein_coding	Q9GZP8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50571
0	-0.39174271812931	0.01	0.303	0	YIF1B	Malignant cells	GSE164897_VemTra	ENSG00000167645	90522	Yip1 interacting factor homolog B, membrane trafficking protein	FinGER8	protein_coding	Q5BJH7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50572
0	-0.873236427186053	0.205	0.754	0	PSMD8	Malignant cells	GSE164897_VemTra	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50573
0	0.823678487310159	0.993	0.953	0	EIF3K	Malignant cells	GSE164897_VemTra	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50574
0	-0.571631949734936	0.159	0.568	0	ACTN4	Malignant cells	GSE164897_VemTra	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50575
0	-0.620205066143698	0.11	0.547	0	ECH1	Malignant cells	GSE164897_VemTra	ENSG00000282853	1891	enoyl-CoA hydratase 1	HPXEL	protein_coding	Q13011	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50576
0	-0.745050977348918	0.067	0.584	0	MRPS12	Malignant cells	GSE164897_VemTra	ENSG00000283018	6183	mitochondrial ribosomal protein S12	RPMS12|RPS12|RPSM12	protein_coding	O15235	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50577
0	-1.70860612921966	0.997	1	0	RPS16	Malignant cells	GSE164897_VemTra	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50578
0	-0.545563802210191	0.035	0.439	0	TIMM50	Malignant cells	GSE164897_VemTra	ENSG00000105197	92609	translocase of inner mitochondrial membrane 50	TIM50|TIM50L	protein_coding	Q3ZCQ8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50579
0	-0.495368969745471	0.326	0.712	0	FBL	Malignant cells	GSE164897_VemTra	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50580
0	-0.396911463160739	0.131	0.441	0	PSMC4	Malignant cells	GSE164897_VemTra	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50581
0	-0.704143416567483	0.021	0.52	0	SNRPA	Malignant cells	GSE164897_VemTra	ENSG00000077312	6626	small nuclear ribonucleoprotein polypeptide A	Mud1|U1-A|U1A	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50582
0	-0.685732414269071	0.26	0.662	0	MIA	Malignant cells	GSE164897_VemTra	ENSG00000261857	8190	MIA SH3 domain containing	CD-RAP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50583
0	-0.794449626457814	0.015	0.561	0	EXOSC5	Malignant cells	GSE164897_VemTra	ENSG00000077348	56915	exosome component 5	hRrp46p|MGC12901|p12B|RRP41B|RRP46|Rrp46p	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50584
0	-2.0239805428697	0.999	1	0	RPS19	Malignant cells	GSE164897_VemTra	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50585
0	-0.517486849043039	0.085	0.454	0	RABAC1	Malignant cells	GSE164897_VemTra	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50586
0	-0.434364212526405	0.032	0.353	0	PAFAH1B3	Malignant cells	GSE164897_VemTra	ENSG00000079462	5050	platelet activating factor acetylhydrolase 1b catalytic subunit 3	NA	protein_coding	Q15102	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50587
0	-0.849959151478962	0.077	0.632	0	ETHE1	Malignant cells	GSE164897_VemTra	ENSG00000105755	23474	ETHE1 persulfide dioxygenase	HSCO|YF13H12	protein_coding	O95571	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50588
0	-0.380457116677604	0.039	0.33	0	ZNF428	Malignant cells	GSE164897_VemTra	ENSG00000131116	126299	zinc finger protein 428	C19orf37|MGC51082|Zfp428	protein_coding	Q96B54	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50589
0	-0.394785348183046	0.032	0.314	0	KCNN4	Malignant cells	GSE164897_VemTra	ENSG00000104783	3783	potassium calcium-activated channel subfamily N member 4	hIKCa1|hKCa4|hSK4|IK|KCa3.1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50590
0	-0.561793623116558	0.122	0.54	0	ERCC1	Malignant cells	GSE164897_VemTra	ENSG00000012061	2067	ERCC excision repair 1, endonuclease non-catalytic subunit	RAD10	protein_coding	P07992	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50591
0	-0.468599071376313	0.046	0.396	0	SLC1A5	Malignant cells	GSE164897_VemTra	ENSG00000105281	6510	solute carrier family 1 member 5	AAAT|ASCT2|M7V1|RDRC	protein_coding	Q15758	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50592
0	-1.79291829013911	0.215	0.975	0	AP2S1	Malignant cells	GSE164897_VemTra	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50593
0	-0.479346290910798	0.034	0.397	0	TMEM160	Malignant cells	GSE164897_VemTra	ENSG00000130748	54958	transmembrane protein 160	FLJ20512	protein_coding	Q9NX00	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50594
0	-0.34508343451023	0.064	0.325	0	SAE1	Malignant cells	GSE164897_VemTra	ENSG00000142230	10055	SUMO1 activating enzyme subunit 1	AOS1|FLJ3091|Sua1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50595
0	-1.16011298586921	0.104	0.827	0	NOP53	Malignant cells	GSE164897_VemTra	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50596
0	-1.09293285542871	0.076	0.727	0	EMP3	Malignant cells	GSE164897_VemTra	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50597
0	-2.5776509838062	0.888	1	0	RPL18	Malignant cells	GSE164897_VemTra	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50598
0	-0.497823209666742	0.025	0.355	0	PPP1R15A	Malignant cells	GSE164897_VemTra	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50599
0	-0.327384135389478	0.045	0.296	0	NUCB1	Malignant cells	GSE164897_VemTra	ENSG00000104805	4924	nucleobindin 1	Calnuc|NUC	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50600
0	-0.56531903057704	0.071	0.451	0	BAX	Malignant cells	GSE164897_VemTra	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50601
0	3.60778946847207	1	0.995	0	FTL	Malignant cells	GSE164897_VemTra	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50602
0	-0.624971428203624	0.137	0.576	0	RUVBL2	Malignant cells	GSE164897_VemTra	ENSG00000183207	10856	RuvB like AAA ATPase 2	ECP51|INO80J|Reptin52|RVB2|TIH2|TIP48|TIP49b	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50603
0	-0.383335754875782	0.044	0.337	0	SNRNP70	Malignant cells	GSE164897_VemTra	ENSG00000104852	6625	small nuclear ribonucleoprotein U1 subunit 70	RNPU1Z|RPU1|Snp1|SNRP70|U1-70K	protein_coding	P08621	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50604
0	-0.372901544194841	0.077	0.363	0	PIH1D1	Malignant cells	GSE164897_VemTra	ENSG00000104872	55011	PIH1 domain containing 1	DNAAF14|FLJ20643|MOT48|NOP17|Pih1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50605
0	-1.51105489711	1	1	0	RPL13A	Malignant cells	GSE164897_VemTra	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50606
0	1.22112913417581	1	1	0	RPS11	Malignant cells	GSE164897_VemTra	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50607
0	-0.584206937128622	0.059	0.493	0	NOSIP	Malignant cells	GSE164897_VemTra	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50608
0	-1.02800353110898	0.018	0.683	0	PRMT1	Malignant cells	GSE164897_VemTra	ENSG00000126457	3276	protein arginine methyltransferase 1	ANM1|HCP1|HRMT1L2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50609
0	-0.439058410310995	0.045	0.379	0	AKT1S1	Malignant cells	GSE164897_VemTra	ENSG00000204673	84335	AKT1 substrate 1	Lobe|MGC2865|PRAS40	protein_coding	Q96B36	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50610
0	-0.363876176230303	0.029	0.305	0	NR1H2	Malignant cells	GSE164897_VemTra	ENSG00000131408	7376	nuclear receptor subfamily 1 group H member 2	LXR-b|LXRb|NER|NER-I|RIP15|UNR	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50611
0	-0.460305910290342	0.051	0.404	0	JOSD2	Malignant cells	GSE164897_VemTra	ENSG00000161677	126119	Josephin domain containing 2	SBBI54	protein_coding	Q8TAC2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50612
0	-1.14218159731325	0.022	0.673	0	C19orf48	Malignant cells	GSE164897_VemTra	ENSG00000167747	84798	multidrug resistance-related protein	BC006151|MGC13170	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50613
0	-1.11496683562845	0.141	0.796	0	ETFB	Malignant cells	GSE164897_VemTra	ENSG00000105379	2109	electron transfer flavoprotein subunit beta	NA	protein_coding	P38117	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50614
0	-1.12556443949351	0.12	0.818	0	NDUFA3	Malignant cells	GSE164897_VemTra	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50615
0	-0.413969247044197	0.055	0.365	0	TFPT	Malignant cells	GSE164897_VemTra	ENSG00000276504	29844	TCF3 fusion partner	amida|FB1|INO80F	protein_coding	P0C1Z6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50616
0	-0.28948876431803	0.064	0.29	0	PRPF31	Malignant cells	GSE164897_VemTra	ENSG00000274651	26121	pre-mRNA processing factor 31	hPrp31|NY-BR-99|PRP31|RP11|SNRNP61	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50617
0	-0.324730971025798	0.072	0.327	0	TSEN34	Malignant cells	GSE164897_VemTra	ENSG00000274078	79042	tRNA splicing endonuclease subunit 34	LENG5|SEN34|SEN34L	protein_coding	Q9BSV6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50618
0	-1.50521889362149	0.987	1	0	RPS9	Malignant cells	GSE164897_VemTra	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50619
0	-0.350850514350362	0.117	0.387	0	TNNT1	Malignant cells	GSE164897_VemTra	ENSG00000105048	7138	troponin T1, slow skeletal type	ANM|FLJ98147|MGC104241|NEM5|STNT|TNT|TNTS	protein_coding	P13805	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50620
0	-0.393919086367552	0.022	0.319	0	HSPBP1	Malignant cells	GSE164897_VemTra	ENSG00000133265	23640	HSPA (Hsp70) binding protein 1	FES1	protein_coding	Q9NZL4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50621
0	-0.410407261274301	0.017	0.259	0	IL11	Malignant cells	GSE164897_VemTra	ENSG00000095752	3589	interleukin 11	AGIF|IL-11	protein_coding	P20809	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50622
0	-2.22063548581918	0.987	1	0	RPL28	Malignant cells	GSE164897_VemTra	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50623
0	-1.44326294581854	0.085	0.7	0	UBE2S	Malignant cells	GSE164897_VemTra	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50624
0	-0.313486695944593	0.028	0.266	0	ISOC2	Malignant cells	GSE164897_VemTra	ENSG00000063241	79763	isochorismatase domain containing 2	FLJ23469	protein_coding	Q96AB3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50625
0	-0.516086449258914	0.07	0.458	0	ZNF581	Malignant cells	GSE164897_VemTra	ENSG00000171425	51545	zinc finger protein 581	FLJ22550|HSPC189	protein_coding	Q9P0T4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50626
0	-0.384911007511287	0.068	0.367	0	EPN1	Malignant cells	GSE164897_VemTra	ENSG00000063245	29924	epsin 1	NA	protein_coding	Q9Y6I3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50627
0	-0.337627641980187	0.022	0.273	0	A1BG	Malignant cells	GSE164897_VemTra	ENSG00000121410	1	alpha-1-B glycoprotein	NA	protein_coding	P04217	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50628
0	-1.83481670658526	0.999	1	0	RPS5	Malignant cells	GSE164897_VemTra	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50629
0	-0.351017172208781	0.058	0.326	0	SLC27A5	Malignant cells	GSE164897_VemTra	ENSG00000083807	10998	solute carrier family 27 member 5	ACSB|ACSVL6|FACVL3|FATP5|FLJ22987|VLACSR|VLCS-H2|VLCSH2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50630
0	-0.347633144081732	0.024	0.289	0	BID	Malignant cells	GSE164897_VemTra	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50631
0	-1.09298352810945	0.093	0.726	0	RANBP1	Malignant cells	GSE164897_VemTra	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50632
0	-0.315947120012144	0.029	0.268	0	DGCR6L	Malignant cells	GSE164897_VemTra	ENSG00000128185	85359	DiGeorge syndrome critical region gene 6 like	FLJ10666	protein_coding	Q9BY27	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50633
0	-0.463143863543896	0.033	0.374	0	YDJC	Malignant cells	GSE164897_VemTra	ENSG00000161179	150223	YdjC chitooligosaccharide deacetylase homolog	NA	protein_coding	A8MPS7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50634
0	-0.432798128337447	0.012	0.338	0	SMARCB1	Malignant cells	GSE164897_VemTra	ENSG00000275837	6598	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	BAF47|hSNFS|INI-1|Ini1|PPP1R144|RDT|Sfh1p|SNF5|SNF5L1|Snr1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50635
0	-1.78339151937234	0.061	0.949	0	MIF	Malignant cells	GSE164897_VemTra	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50636
0	-1.00485846067268	0.103	0.757	0	DDT	Malignant cells	GSE164897_VemTra	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50637
0	-0.371932131312451	0.051	0.328	0	XBP1	Malignant cells	GSE164897_VemTra	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50638
0	0.926286538907115	0.854	0.616	0	UQCR10	Malignant cells	GSE164897_VemTra	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50639
0	-0.29782282444878	0.072	0.31	0	DRG1	Malignant cells	GSE164897_VemTra	ENSG00000185721	4733	developmentally regulated GTP binding protein 1	NEDD3	protein_coding	Q9Y295	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50640
0	-0.512581413822698	0.131	0.524	0	TXN2	Malignant cells	GSE164897_VemTra	ENSG00000100348	25828	thioredoxin 2	MT-TRX	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50641
0	-0.512818283922408	0.242	0.635	0	EIF3D	Malignant cells	GSE164897_VemTra	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50642
0	-0.436856085070502	0.021	0.351	0	MPST	Malignant cells	GSE164897_VemTra	ENSG00000128309	4357	mercaptopyruvate sulfurtransferase	MST|TST2|TUM1	protein_coding	P25325	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50643
0	-1.9487292176361	0.87	0.999	0	LGALS1	Malignant cells	GSE164897_VemTra	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50644
0	-0.469997121665583	0.115	0.393	0	H1-0	Malignant cells	GSE164897_VemTra	ENSG00000189060	3005	H1.0 linker histone	H1.0|H1F0|H1FV	protein_coding	P07305	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50645
0	-0.948909608503888	0.244	0.824	0	POLR2F	Malignant cells	GSE164897_VemTra	ENSG00000100142	5435	RNA polymerase II, I and III subunit F	HRBP14.4|RPB6	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50646
0	-0.496908097274908	0.058	0.41	0	SOX10	Malignant cells	GSE164897_VemTra	ENSG00000100146	6663	SRY-box transcription factor 10	DOM|SOX-10|WS2E|WS4	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50647
0	-0.423769025119397	0.267	0.61	0	TOMM22	Malignant cells	GSE164897_VemTra	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50648
0	-1.62220782092997	1	1	0	RPL3	Malignant cells	GSE164897_VemTra	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50649
0	-0.901818045771541	0.185	0.757	0	ATF4	Malignant cells	GSE164897_VemTra	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50650
0	-0.696198774231872	0.068	0.57	0	RPS19BP1	Malignant cells	GSE164897_VemTra	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50651
0	-0.425303162900167	0.067	0.389	0	ADSL	Malignant cells	GSE164897_VemTra	ENSG00000239900	158	adenylosuccinate lyase	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50652
0	0.802675344627872	0.638	0.346	0	RBX1	Malignant cells	GSE164897_VemTra	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50653
0	-0.284993370847787	0.062	0.285	0	DESI1	Malignant cells	GSE164897_VemTra	ENSG00000100418	27351	desumoylating isopeptidase 1	D15Wsu75e|DESI-1|FAM152B|POST|PPPDE2	protein_coding	Q6ICB0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50654
0	-0.368522291395603	0.084	0.373	0	XRCC6	Malignant cells	GSE164897_VemTra	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50655
0	-0.47196786281804	0.067	0.433	0	SMDT1	Malignant cells	GSE164897_VemTra	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50656
0	-0.358755579122633	0.024	0.292	0	RRP7A	Malignant cells	GSE164897_VemTra	ENSG00000189306	27341	ribosomal RNA processing 7 homolog A	CGI-96|Rrp7	protein_coding	Q9Y3A4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50657
0	-1.07380616827086	0.176	0.832	0	TSPO	Malignant cells	GSE164897_VemTra	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50658
0	-0.392770516570101	0.095	0.401	0	PRR34-AS1	Malignant cells	GSE164897_VemTra	ENSG00000241990	NA	NA	NA	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50659
0	0.682730134752326	0.963	0.903	0	ATP5PF	Malignant cells	GSE164897_VemTra	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50660
0	-0.400046175191368	0.229	0.557	0	CCT8	Malignant cells	GSE164897_VemTra	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50661
0	0.593401254578203	0.773	0.672	0	ATP5PO	Malignant cells	GSE164897_VemTra	ENSG00000241837	539	ATP synthase peripheral stalk subunit OSCP	ATP5O|ATPO|OSCP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50662
0	-0.503563508719073	0.064	0.374	0	MRPS6	Malignant cells	GSE164897_VemTra	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50663
0	-0.318714764635185	0.041	0.274	0	RCAN1	Malignant cells	GSE164897_VemTra	ENSG00000159200	1827	regulator of calcineurin 1	DSCR1	protein_coding	P53805	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50664
0	-0.364880187962622	0.028	0.301	0	PSMG1	Malignant cells	GSE164897_VemTra	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50665
0	-0.558603108612728	0.34	0.748	0	HMGN1	Malignant cells	GSE164897_VemTra	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50666
0	-0.502049191488628	0.22	0.599	0	CSTB	Malignant cells	GSE164897_VemTra	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50667
0	-0.403811549826642	0.007	0.309	0	SLX9	Malignant cells	GSE164897_VemTra	ENSG00000160256	85395	SLX9 ribosome biogenesis factor	C21orf70|FAM207A|PRED56	protein_coding	Q9NSI2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50668
0	-0.338296444033145	0.077	0.343	0	PRMT2	Malignant cells	GSE164897_VemTra	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50669
0	1.93347133935408	1	0.994	0	MT-ND1	Malignant cells	GSE164897_VemTra	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50670
0	0.396162804245914	1	1	0	MT-ND2	Malignant cells	GSE164897_VemTra	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50671
0	0.702657385776563	1	1	0	MT-CO1	Malignant cells	GSE164897_VemTra	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50672
0	0.705336697750261	1	1	0	MT-CO2	Malignant cells	GSE164897_VemTra	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50673
0	1.16084218458447	1	0.992	0	MT-ATP6	Malignant cells	GSE164897_VemTra	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50674
0	1.2006196266605	1	1	0	MT-CO3	Malignant cells	GSE164897_VemTra	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50675
0	-1.15446964475026	0.963	0.998	0	MT-ND3	Malignant cells	GSE164897_VemTra	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50676
0	-0.612676645299779	0.149	0.589	0	MT-ND4L	Malignant cells	GSE164897_VemTra	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50677
0	1.00840182380775	1	1	0	MT-ND4	Malignant cells	GSE164897_VemTra	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50678
0	0.651051511779321	0.927	0.838	0	MT-ND5	Malignant cells	GSE164897_VemTra	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50679
0	0.476755229387471	1	1	0	MT-CYB	Malignant cells	GSE164897_VemTra	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50680
0	0.66027228637329	0.254	0	0	DIO2	Malignant cells	GSE164897_VemTra	ENSG00000211448	1734	iodothyronine deiodinase 2	SELENOY|SelY|TXDI2	protein_coding	Q92813	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50681
5.28589255407176e-308	-0.309829644572892	0.102	0.352	8.44632771215126e-304	LRRC59	Malignant cells	GSE164897_VemTra	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50682
1.53206239469259e-307	0.550836879868245	0.438	0.182	2.44808250047928e-303	LEPROT	Malignant cells	GSE164897_VemTra	ENSG00000213625	54741	leptin receptor overlapping transcript	FLJ90360|OB-RGRP|OBRGRP|VPS55	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50683
1.80274346403544e-307	-0.452791482734371	0.272	0.578	2.88060378118223e-303	SRSF7	Malignant cells	GSE164897_VemTra	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50684
9.64954388315721e-307	-0.28108996802939	0.063	0.285	1.54190061708969e-302	COX19	Malignant cells	GSE164897_VemTra	ENSG00000240230	90639	cytochrome c oxidase assembly factor COX19	MGC104475	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50685
2.14464069171218e-306	-0.311911606776987	0.114	0.371	3.42692136128689e-302	PIGT	Malignant cells	GSE164897_VemTra	ENSG00000124155	51604	phosphatidylinositol glycan anchor biosynthesis class T	NA	protein_coding	Q969N2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50686
2.26844003679113e-305	0.52216035308847	0.391	0.138	3.62474033478855e-301	NR3C1	Malignant cells	GSE164897_VemTra	ENSG00000113580	2908	nuclear receptor subfamily 3 group C member 1	GR|GRL	protein_coding	P04150	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50687
3.70960759706142e-305	-0.308410086006686	0.099	0.346	5.92758197934445e-301	TRIP6	Malignant cells	GSE164897_VemTra	ENSG00000087077	7205	thyroid hormone receptor interactor 6	MGC10556|MGC10558|MGC29959|MGC3837|MGC4423|OIP1|ZRP-1	protein_coding	Q15654	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50688
4.90807299787453e-304	-0.2706088361043	0.05	0.26	7.84260984330372e-300	DMAC2	Malignant cells	GSE164897_VemTra	ENSG00000105341	55101	distal membrane arm assembly component 2	ATP5SL|FLJ10241	protein_coding	Q9NW81	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50689
2.74408296165316e-303	-0.267947326009761	0.051	0.261	4.38477016442559e-299	RAB11B	Malignant cells	GSE164897_VemTra	ENSG00000185236	9230	RAB11B, member RAS oncogene family	H-YPT3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50690
4.71016430227489e-303	-0.30235753793006	0.091	0.333	7.52637153860505e-299	CTSD	Malignant cells	GSE164897_VemTra	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50691
5.40818563591232e-303	-0.300086450713322	0.09	0.329	8.64173982762429e-299	TADA3	Malignant cells	GSE164897_VemTra	ENSG00000171148	10474	transcriptional adaptor 3	ADA3|FLJ20221|FLJ21329|hADA3|NGG1|TADA3L	protein_coding	O75528	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50692
5.78721777410954e-303	-0.30495139206114	0.102	0.351	9.24739528124963e-299	PSMG2	Malignant cells	GSE164897_VemTra	ENSG00000128789	56984	proteasome assembly chaperone 2	CLAST3|HCCA3|HsT1707|MDS003|MGC15092|PAC2|TNFSF5IP1	protein_coding	Q969U7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50693
1.17821298938823e-301	-0.374036217429185	0.301	0.626	1.88266653574345e-297	RNF7	Malignant cells	GSE164897_VemTra	ENSG00000114125	9616	ring finger protein 7	CKBBP1|RBX2|ROC2|SAG	protein_coding	Q9UBF6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50694
1.34838920471931e-301	-0.46861249019709	0.406	0.731	2.15459111022098e-297	PHLDA1	Malignant cells	GSE164897_VemTra	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50695
3.68312049513704e-301	-0.314840661195998	0.131	0.396	5.88525823917948e-297	FKBP3	Malignant cells	GSE164897_VemTra	ENSG00000100442	2287	FKBP prolyl isomerase 3	FKBP-25|FKBP25	protein_coding	Q00688	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50696
4.29080311937048e-301	-0.267508450860495	0.049	0.256	6.85627430444209e-297	TPD52L2	Malignant cells	GSE164897_VemTra	ENSG00000101150	7165	TPD52 like 2	D54|hD54|TPD54	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50697
6.71451083437538e-301	-0.331016986747973	0.169	0.449	1.07291168622484e-296	CYB5R3	Malignant cells	GSE164897_VemTra	ENSG00000100243	1727	cytochrome b5 reductase 3	DIA1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50698
1.14585935917498e-300	-0.358798794967582	0.21	0.507	1.8309686700257e-296	PRKDC	Malignant cells	GSE164897_VemTra	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50699
1.84507676725356e-300	-0.430898985094248	0.523	0.83	2.94824816639446e-296	CD44	Malignant cells	GSE164897_VemTra	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50700
3.31403751071715e-300	-0.353165644714798	0.231	0.534	5.29550053837494e-296	KARS1	Malignant cells	GSE164897_VemTra	ENSG00000065427	3735	lysyl-tRNA synthetase 1	DFNB89|KARS|KARS2	protein_coding	Q15046	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50701
1.12962148308885e-299	-0.301172413672227	0.105	0.354	1.80502216782768e-295	BRD4	Malignant cells	GSE164897_VemTra	ENSG00000141867	23476	bromodomain containing 4	CAP|HUNK1|HUNKI|MCAP	protein_coding	O60885	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50702
1.78392054513573e-298	-0.313039289297148	0.993	0.999	2.85052663907239e-294	TMA7	Malignant cells	GSE164897_VemTra	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50703
2.92429798759062e-297	-0.29380056569846	0.091	0.331	4.67273575437105e-293	MRPL16	Malignant cells	GSE164897_VemTra	ENSG00000166902	54948	mitochondrial ribosomal protein L16	FLJ20484|PNAS-111	protein_coding	Q9NX20	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50704
6.60185405901316e-297	-0.337391586424947	0.138	0.4	1.05491026008971e-292	PLAAT3	Malignant cells	GSE164897_VemTra	ENSG00000176485	11145	phospholipase A and acyltransferase 3	AdPLA|H-REV107-1|HRASLS3|HREV107|HREV107-3|MGC118754.|PLA2G16|PLAAT-3	protein_coding	P53816	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50705
8.83902388559117e-297	-0.334283283580222	0.174	0.456	1.41238762667861e-292	CAMTA1	Malignant cells	GSE164897_VemTra	ENSG00000171735	23261	calmodulin binding transcription activator 1	KIAA0833	protein_coding	Q9Y6Y1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50706
7.00387127257222e-296	-0.369724238893162	0.254	0.562	1.11914859064431e-291	CCT4	Malignant cells	GSE164897_VemTra	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50707
8.10066011645576e-296	-0.263145234664954	0.047	0.251	1.29440448000847e-291	POLR1F	Malignant cells	GSE164897_VemTra	ENSG00000105849	221830	RNA polymerase I subunit F	A43|RPA43|TWISTNB	protein_coding	Q3B726	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50708
1.0910137962563e-295	-0.311890726689326	0.099	0.341	1.74333094503794e-291	BRIX1	Malignant cells	GSE164897_VemTra	ENSG00000113460	55299	biogenesis of ribosomes BRX1	BRIX|BXDC2|FLJ11100	protein_coding	Q8TDN6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50709
1.69079854342863e-295	-0.318980299960038	0.135	0.398	2.7017269925446e-291	TMED3	Malignant cells	GSE164897_VemTra	ENSG00000166557	23423	transmembrane p24 trafficking protein 3	C15orf22|p24B|p24g4|p24gamma4	protein_coding	Q9Y3Q3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50710
1.7804565700578e-295	-0.281947844187011	0.076	0.303	2.84499155329536e-291	MRPS5	Malignant cells	GSE164897_VemTra	ENSG00000144029	64969	mitochondrial ribosomal protein S5	MRP-S5|S5mt	protein_coding	P82675	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50711
2.89394023500247e-295	-0.314610178103583	0.139	0.406	4.62422710151044e-291	GDI2	Malignant cells	GSE164897_VemTra	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50712
3.071491512562e-295	-0.264181347286121	0.058	0.272	4.90793628792282e-291	SEC11C	Malignant cells	GSE164897_VemTra	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50713
5.63752936018854e-295	-0.419166166834057	0.616	0.879	9.00820816464527e-291	EIF3I	Malignant cells	GSE164897_VemTra	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50714
8.54498894343866e-295	-0.302405442268517	0.113	0.365	1.36540378327206e-290	PTS	Malignant cells	GSE164897_VemTra	ENSG00000150787	5805	6-pyruvoyltetrahydropterin synthase	PTPS	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50715
1.39756974836881e-294	-0.262279641529583	0.05	0.255	2.23317670091852e-290	DUSP23	Malignant cells	GSE164897_VemTra	ENSG00000158716	54935	dual specificity phosphatase 23	DUSP25|FLJ20442	protein_coding	Q9BVJ7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50716
3.06702706535676e-294	-0.261196573232667	0.053	0.261	4.90080254773356e-290	TGS1	Malignant cells	GSE164897_VemTra	ENSG00000137574	96764	trimethylguanosine synthase 1	NCOA6IP|PIMT	protein_coding	Q96RS0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50717
4.21852389186597e-294	-0.27037340801862	0.055	0.265	6.74077932681264e-290	CMC2	Malignant cells	GSE164897_VemTra	ENSG00000103121	56942	C-X9-C motif containing 2	C16orf61|DC13|MGC45036	protein_coding	Q9NRP2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50718
4.41818447405351e-294	-0.264732032687387	0.049	0.254	7.0598169710901e-290	CIAO1	Malignant cells	GSE164897_VemTra	ENSG00000144021	9391	cytosolic iron-sulfur assembly component 1	CIA1|WDR39	protein_coding	O76071	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50719
1.17841613209035e-293	-0.263129432972938	0.053	0.259	1.88299113746716e-289	BORCS8	Malignant cells	GSE164897_VemTra	ENSG00000254901	729991	BLOC-1 related complex subunit 8	MEF2BNB	protein_coding	Q96FH0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50720
3.87705738682296e-292	-0.273094833439133	0.06	0.273	6.1951499984044e-288	TRIM28	Malignant cells	GSE164897_VemTra	ENSG00000130726	10155	tripartite motif containing 28	KAP-1|KAP1|PPP1R157|RNF96|TF1B|TIF1-beta|TIF1B|TIF1beta	protein_coding	Q13263	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50721
4.92785358637647e-292	-0.272716076237476	0.058	0.268	7.87421724567096e-288	AIMP2	Malignant cells	GSE164897_VemTra	ENSG00000106305	7965	aminoacyl tRNA synthetase complex interacting multifunctional protein 2	JTV-1|JTV1|p38|PRO0992	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50722
1.46892189517022e-291	-0.254434475934449	0.118	0.371	2.34719029629249e-287	DDIT3	Malignant cells	GSE164897_VemTra	ENSG00000175197	1649	DNA damage inducible transcript 3	CHOP|CHOP10|GADD153	protein_coding	P35638	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50723
4.26442322235495e-291	-0.325095870481447	0.169	0.445	6.81412186700097e-287	VMA21	Malignant cells	GSE164897_VemTra	ENSG00000160131	203547	vacuolar ATPase assembly factor VMA21	MEAX|XMEA	protein_coding	Q3ZAQ7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50724
5.70045482747237e-291	-0.267172841399093	0.056	0.266	9.10875676881809e-287	COMT	Malignant cells	GSE164897_VemTra	ENSG00000093010	1312	catechol-O-methyltransferase	NA	protein_coding	P21964	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50725
6.97531420118559e-291	0.486829503543172	0.368	0.124	1.11458545620745e-286	MARCHF6	Malignant cells	GSE164897_VemTra	ENSG00000145495	10299	membrane associated ring-CH-type finger 6	MARCH-VI|MARCH6|RNF176|TEB4	protein_coding	O60337	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50726
1.25812305971077e-290	0.510131210230887	0.427	0.177	2.01035483711185e-286	COPA	Malignant cells	GSE164897_VemTra	ENSG00000122218	1314	COPI coat complex subunit alpha	HEP-COP	protein_coding	P53621	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50727
1.54760902579111e-290	-0.341880779325478	0.081	0.306	2.47292446231161e-286	SMC4	Malignant cells	GSE164897_VemTra	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50728
3.8925174057727e-289	0.427570224247708	0.305	0.074	6.2198535626842e-285	STAT1	Malignant cells	GSE164897_VemTra	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50729
6.17392207818628e-289	0.402095374861021	0.262	0.045	9.86531008873385e-285	RHOQ	Malignant cells	GSE164897_VemTra	ENSG00000119729	23433	ras homolog family member Q	ARHQ|RASL7A|TC10	protein_coding	P17081	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50730
3.27649830805582e-288	-0.26420092480268	0.059	0.269	5.23551664644239e-284	MAPKAP1	Malignant cells	GSE164897_VemTra	ENSG00000119487	79109	MAPK associated protein 1	MGC2745|MIP1|SIN1	protein_coding	Q9BPZ7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50731
1.70199616232148e-287	-0.332356257797245	0.198	0.485	2.7196196677735e-283	GRHPR	Malignant cells	GSE164897_VemTra	ENSG00000137106	9380	glyoxylate and hydroxypyruvate reductase	GLXR|PH2	protein_coding	Q9UBQ7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50732
1.84086408145714e-287	-0.306102730652696	0.121	0.37	2.94151671576036e-283	POLR2C	Malignant cells	GSE164897_VemTra	ENSG00000102978	5432	RNA polymerase II subunit C	RPB3	protein_coding	P19387	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50733
3.80997322359468e-287	0.496025648527055	0.885	0.82	6.08795621398194e-283	SNU13	Malignant cells	GSE164897_VemTra	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50734
3.81047908140141e-287	-0.264550335822417	0.065	0.28	6.08876452417132e-283	FAM177A1	Malignant cells	GSE164897_VemTra	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50735
3.81236231155472e-286	-0.276907516358989	0.075	0.296	6.09177373763329e-282	TOR1A	Malignant cells	GSE164897_VemTra	ENSG00000136827	1861	torsin family 1 member A	DQ2|DYT1	protein_coding	O14656	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50736
7.54487219798437e-286	-0.264504774918165	0.051	0.252	1.20559512851592e-281	CWF19L2	Malignant cells	GSE164897_VemTra	ENSG00000152404	143884	CWF19 like cell cycle control factor 2	FLJ32343	protein_coding	Q2TBE0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50737
2.32237981233738e-285	-0.335820329407148	0.189	0.47	3.71093070213389e-281	DNAJB6	Malignant cells	GSE164897_VemTra	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50738
4.84730120603209e-285	0.501417695017408	0.869	0.811	7.74550259711867e-281	SEM1	Malignant cells	GSE164897_VemTra	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50739
5.87972524611026e-284	0.427894226165949	0.306	0.076	9.39521297075959e-280	PTGFRN	Malignant cells	GSE164897_VemTra	ENSG00000134247	5738	prostaglandin F2 receptor inhibitor	CD315|CD9P-1|EWI-F|FLJ11001|FPRP|KIAA1436|SMAP-6	protein_coding	Q9P2B2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50740
7.8763740101086e-283	-0.294043608408536	0.091	0.321	1.25856580307525e-278	SELENOM	Malignant cells	GSE164897_VemTra	ENSG00000198832	140606	selenoprotein M	SELM|SEPM	protein_coding	Q8WWX9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50741
8.40520438810173e-283	-0.277304412470398	0.087	0.316	1.34306760917478e-278	COASY	Malignant cells	GSE164897_VemTra	ENSG00000068120	80347	Coenzyme A synthase	DPCK|NBP|PPAT	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50742
1.05370606146455e-282	-0.270720762750076	0.072	0.29	1.6837169156142e-278	MECP2	Malignant cells	GSE164897_VemTra	ENSG00000169057	4204	methyl-CpG binding protein 2	MRX16|MRX79|RTT	protein_coding	P51608	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50743
1.30096250295138e-282	-0.287291226157185	0.092	0.324	2.07880798346601e-278	NELFCD	Malignant cells	GSE164897_VemTra	ENSG00000101158	51497	negative elongation factor complex member C/D	HSPC130|NELF-C|NELF-D|TH1|TH1L	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50744
1.38918314828428e-282	-0.350990202982329	0.221	0.512	2.21977575264345e-278	SRI	Malignant cells	GSE164897_VemTra	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50745
1.64771719301527e-282	-0.323395192376474	0.142	0.4	2.6328873027191e-278	YARS1	Malignant cells	GSE164897_VemTra	ENSG00000134684	8565	tyrosyl-tRNA synthetase 1	tyrRS|YARS|YRS|YTS	protein_coding	P54577	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50746
1.79664252301681e-282	-0.39079616673059	0.132	0.377	2.87085508752857e-278	HLA-DPA1	Malignant cells	GSE164897_VemTra	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50747
3.3244740189365e-281	-0.299443438249133	0.11	0.352	5.31217703485864e-277	EIF2B1	Malignant cells	GSE164897_VemTra	ENSG00000111361	1967	eukaryotic translation initiation factor 2B subunit alpha	EIF-2B|EIF-2Balpha|EIF2B|EIF2BA|EIF2Balpha	protein_coding	Q14232	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50748
1.03042971883699e-280	-0.374974436726937	0.348	0.668	1.64652364772963e-276	ATP6V1F	Malignant cells	GSE164897_VemTra	ENSG00000128524	9296	ATPase H+ transporting V1 subunit F	ATP6S14|VATF|Vma7	protein_coding	Q16864	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50749
8.39280555297859e-280	-0.269049680989972	0.065	0.275	1.34108639931045e-275	NMB	Malignant cells	GSE164897_VemTra	ENSG00000197696	4828	neuromedin B	MGC17211|MGC2277|MGC3936	protein_coding	P08949	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50750
1.92038983486766e-279	-0.400368961507909	0.418	0.735	3.06859091713504e-275	SRSF3	Malignant cells	GSE164897_VemTra	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50751
2.94256121761074e-279	-0.301863088168416	0.142	0.403	4.70191856962021e-275	TSPAN3	Malignant cells	GSE164897_VemTra	ENSG00000140391	10099	tetraspanin 3	TM4-A|TM4SF8|TSPAN-3	protein_coding	O60637	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50752
9.78981812981573e-278	-0.379488720749312	0.285	0.585	1.56431503896326e-273	PTGES3	Malignant cells	GSE164897_VemTra	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50753
1.95082567759396e-277	-0.381445531298443	0.381	0.703	3.11722435022739e-273	RSL1D1	Malignant cells	GSE164897_VemTra	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50754
2.95343360341751e-277	-0.281867003092503	0.089	0.316	4.71929155490083e-273	TNFRSF1A	Malignant cells	GSE164897_VemTra	ENSG00000067182	7132	TNF receptor superfamily member 1A	CD120a|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR60	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50755
4.13769164904023e-275	-0.426471738090462	0.807	0.939	6.61161748600138e-271	RAB13	Malignant cells	GSE164897_VemTra	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50756
1.18672074849412e-274	-0.265977631592722	0.065	0.272	1.89626108401875e-270	RPF1	Malignant cells	GSE164897_VemTra	ENSG00000117133	80135	ribosome production factor 1 homolog	BXDC5	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50757
3.90879951170702e-274	-0.26344430549748	0.071	0.285	6.24587073975665e-270	PTPN2	Malignant cells	GSE164897_VemTra	ENSG00000175354	5771	protein tyrosine phosphatase non-receptor type 2	PTPT|TC-PTP|TCELLPTP|TCPTP	protein_coding	P17706	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50758
6.52157322252579e-274	0.590334765104988	0.525	0.306	1.0420821852274e-269	TAX1BP1	Malignant cells	GSE164897_VemTra	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50759
1.23644352365136e-273	0.544753863587269	0.504	0.275	1.97571310644251e-269	MTPN	Malignant cells	GSE164897_VemTra	ENSG00000105887	136319	myotrophin	GCDP|MYOTROPHIN|V-1	protein_coding	P58546	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50760
1.76799543422518e-272	0.489166070670647	0.404	0.165	2.82507990434842e-268	CLTC	Malignant cells	GSE164897_VemTra	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50761
1.78657722112246e-272	-0.295456372597229	0.111	0.348	2.85477174163158e-268	FLNA	Malignant cells	GSE164897_VemTra	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50762
1.49746252868855e-271	-0.391147508608428	0.297	0.592	2.39279537459143e-267	NARS1	Malignant cells	GSE164897_VemTra	ENSG00000134440	4677	asparaginyl-tRNA synthetase 1	NARS	protein_coding	O43776	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50763
1.52918532670043e-271	-0.399429476049495	0.349	0.653	2.44348523353462e-267	RHOC	Malignant cells	GSE164897_VemTra	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50764
1.92636953478184e-271	-0.268541410867126	0.077	0.292	3.0781458796279e-267	SZRD1	Malignant cells	GSE164897_VemTra	ENSG00000055070	26099	SUZ RNA binding domain containing 1	C1orf144|DKFZp566C0424	protein_coding	Q7Z422	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50765
7.7926057426245e-271	-0.300503856544339	0.135	0.385	1.24518047161397e-266	RNF114	Malignant cells	GSE164897_VemTra	ENSG00000124226	55905	ring finger protein 114	PSORS12|ZNF313	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50766
1.1069083709998e-270	0.415598942334347	0.305	0.081	1.76872888602058e-266	RAB5B	Malignant cells	GSE164897_VemTra	ENSG00000111540	5869	RAB5B, member RAS oncogene family	NA	protein_coding	P61020	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50767
1.43171018846566e-270	-0.255388913086641	0.061	0.265	2.28772971014929e-266	BLOC1S2	Malignant cells	GSE164897_VemTra	ENSG00000196072	282991	biogenesis of lysosomal organelles complex 1 subunit 2	BLOS2|BORCS2|FLJ30135|MGC10120	protein_coding	Q6QNY1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50768
1.59714847507343e-270	-0.336922465379138	0.235	0.525	2.55208354831983e-266	ZCRB1	Malignant cells	GSE164897_VemTra	ENSG00000139168	85437	zinc finger CCHC-type and RNA binding motif containing 1	MADP-1|MADP1|RBM36|SNRNP31|ZCCHC19	protein_coding	Q8TBF4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50769
3.01033383833959e-270	-0.258396526359815	0.068	0.277	4.81021244028283e-266	TMEM18	Malignant cells	GSE164897_VemTra	ENSG00000151353	129787	transmembrane protein 18	DKFZp434C1714|lncND	protein_coding	Q96B42	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50770
4.61004093174816e-270	-0.308074825187218	0.135	0.383	7.36638440484038e-266	GALE	Malignant cells	GSE164897_VemTra	ENSG00000117308	2582	UDP-galactose-4-epimerase	SDR1E1	protein_coding	Q14376	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50771
1.70731847516933e-269	-0.310816860008441	0.141	0.392	2.72812419147307e-265	MAP1LC3B	Malignant cells	GSE164897_VemTra	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50772
1.83540199658733e-268	-0.26784604283261	0.082	0.3	2.9327888503469e-264	ELP5	Malignant cells	GSE164897_VemTra	ENSG00000288485	23587	elongator acetyltransferase complex subunit 5	C17orf81|DERP6	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50773
3.75540116512566e-268	-0.260853351731235	0.069	0.277	6.00075552175429e-264	CEP57	Malignant cells	GSE164897_VemTra	ENSG00000166037	9702	centrosomal protein 57	KIAA0092|Translokin|TSP57	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50774
9.31635747844561e-268	-0.252990587525174	0.058	0.257	1.48866076148082e-263	AP1M1	Malignant cells	GSE164897_VemTra	ENSG00000072958	8907	adaptor related protein complex 1 subunit mu 1	AP47|CLAPM2|mu1A	protein_coding	Q9BXS5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50775
7.68578705063131e-267	-0.272509168688166	0.085	0.304	1.22811191282038e-262	ESF1	Malignant cells	GSE164897_VemTra	ENSG00000089048	51575	ESF1 nucleolar pre-rRNA processing protein homolog	bA526K24.1|C20orf6	protein_coding	Q9H501	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50776
1.26857869405412e-266	-0.254103480464319	0.062	0.264	2.02706189522908e-262	ARL16	Malignant cells	GSE164897_VemTra	ENSG00000214087	339231	ADP ribosylation factor like GTPase 16	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50777
1.78103534109035e-266	-0.267724320449611	0.077	0.29	2.84591637152827e-262	PSMF1	Malignant cells	GSE164897_VemTra	ENSG00000125818	9491	proteasome inhibitor subunit 1	PI31	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50778
1.95334894572175e-265	0.418071883475264	0.304	0.083	3.12125628036878e-261	DSCR8	Malignant cells	GSE164897_VemTra	ENSG00000198054	84677	Down syndrome critical region 8	C21orf65|CT25.1a|CT25.1b|MMA-1a|MMA-1b|MTAG2	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50779
3.76188437319358e-265	-0.286652265531889	0.123	0.365	6.01111503992602e-261	PAIP2	Malignant cells	GSE164897_VemTra	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50780
3.80920813626567e-265	-0.261527038480396	0.081	0.298	6.08673368093892e-261	YTHDC1	Malignant cells	GSE164897_VemTra	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50781
1.69783909278355e-264	-0.405391520786373	0.691	0.901	2.71297708635883e-260	FKBP1A	Malignant cells	GSE164897_VemTra	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50782
1.78665809377335e-264	-0.298372611304294	0.131	0.374	2.85490096804043e-260	CHTOP	Malignant cells	GSE164897_VemTra	ENSG00000160679	26097	chromatin target of PRMT1	C1orf77|DKFZP547E1010|FOP|SRAG	protein_coding	Q9Y3Y2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50783
3.89441807762885e-264	-0.278215744967424	0.112	0.346	6.22289064624314e-260	PPP1R11	Malignant cells	GSE164897_VemTra	ENSG00000236560	6992	protein phosphatase 1 regulatory inhibitor subunit 11	CFAP255|HCG-V|HCGV|TCTE5|Tctex5	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50784
4.98337560153513e-263	0.585561043347894	0.574	0.377	7.96293587369299e-259	SSR3	Malignant cells	GSE164897_VemTra	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50785
9.5561151509769e-263	-0.265127407726978	0.078	0.29	1.5269716399746e-258	CCNB1IP1	Malignant cells	GSE164897_VemTra	ENSG00000100814	57820	cyclin B1 interacting protein 1	C14orf18|HEI10	protein_coding	Q9NPC3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50786
1.06652101946432e-262	0.428416345692387	0.31	0.088	1.70419393700204e-258	SPOCK1	Malignant cells	GSE164897_VemTra	ENSG00000152377	6695	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1	SPOCK|testican-1|TIC1	protein_coding	Q08629	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50787
1.09963316194047e-262	-0.266905731131968	0.09	0.31	1.75710382946468e-258	MED19	Malignant cells	GSE164897_VemTra	ENSG00000156603	219541	mediator complex subunit 19	LCMR1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50788
6.36994578999829e-262	-0.26747756380351	0.082	0.296	1.01785363778383e-257	GLO1	Malignant cells	GSE164897_VemTra	ENSG00000124767	2739	glyoxalase I	GLOD1	protein_coding	Q04760	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50789
6.65608627971179e-262	-0.301904981689164	0.15	0.402	1.06357602663515e-257	PRKAG1	Malignant cells	GSE164897_VemTra	ENSG00000181929	5571	protein kinase AMP-activated non-catalytic subunit gamma 1	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50790
8.75179417009805e-262	-0.337947445542488	0.248	0.533	1.39844919043997e-257	AP2B1	Malignant cells	GSE164897_VemTra	ENSG00000006125	163	adaptor related protein complex 2 subunit beta 1	ADTB2|CLAPB1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50791
1.24794023793282e-261	0.514591650650147	0.435	0.201	1.99408370619286e-257	LAMC1	Malignant cells	GSE164897_VemTra	ENSG00000135862	3915	laminin subunit gamma 1	LAMB2	protein_coding	P11047	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50792
2.17110549392787e-261	-0.27727916939824	0.103	0.329	3.46920946874734e-257	UBE2E1	Malignant cells	GSE164897_VemTra	ENSG00000170142	7324	ubiquitin conjugating enzyme E2 E1	UbcH6	protein_coding	P51965	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50793
2.17753249892723e-261	-0.576535845763505	0.108	0.33	3.47947918003583e-257	IL24	Malignant cells	GSE164897_VemTra	ENSG00000162892	11009	interleukin 24	C49A|FISP|IL-24|IL10B|mda-7|Mob-5|ST16	protein_coding	Q13007	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50794
1.14408716876745e-260	-0.281683358290918	0.121	0.358	1.82813688697351e-256	PFDN6	Malignant cells	GSE164897_VemTra	ENSG00000235692	10471	prefoldin subunit 6	H2-KE2|HKE2|KE-2|PFD6	protein_coding	O15212	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50795
3.58768860624281e-260	0.371318365686138	0.997	0.995	5.73276762391539e-256	RPL36A	Malignant cells	GSE164897_VemTra	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50796
4.12830254174434e-260	-0.322307519613309	0.237	0.522	6.59661463145329e-256	THOC7	Malignant cells	GSE164897_VemTra	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50797
5.54232297686754e-260	-0.278778469106256	0.103	0.329	8.85607788473665e-256	BUD23	Malignant cells	GSE164897_VemTra	ENSG00000071462	114049	BUD23 rRNA methyltransferase and ribosome maturation factor	MERM1|MGC19709|MGC2022|MGC5140|PP3381|WBMT|WBSCR22	protein_coding	O43709	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50798
1.80517447045417e-259	-0.269540274456167	0.086	0.301	2.88448828633872e-255	UPF2	Malignant cells	GSE164897_VemTra	ENSG00000151461	26019	UPF2 regulator of nonsense mediated mRNA decay	DKFZP434D222|KIAA1408|RENT2|smg-3	protein_coding	Q9HAU5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50799
1.82308351153604e-259	-0.37706039961551	0.555	0.845	2.91310514308343e-255	SNRPF	Malignant cells	GSE164897_VemTra	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50800
1.8804936712385e-259	-0.288921942883206	0.139	0.386	3.004840837272e-255	LETMD1	Malignant cells	GSE164897_VemTra	ENSG00000050426	25875	LETM1 domain containing 1	HCCR|HCCR-1|HCCR-2|HCCR1|HCCR2|SLC55A3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50801
4.6566896744317e-259	-0.291850504206245	0.141	0.388	7.44092443077441e-255	ISCU	Malignant cells	GSE164897_VemTra	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50802
1.74618803882848e-258	-0.299663427605528	0.101	0.323	2.79023386724403e-254	RRAS	Malignant cells	GSE164897_VemTra	ENSG00000126458	6237	RAS related	R-Ras	protein_coding	P10301	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50803
1.88295687560216e-258	-0.309544305452443	0.18	0.442	3.0087767915247e-254	ILF3	Malignant cells	GSE164897_VemTra	ENSG00000129351	3609	interleukin enhancer binding factor 3	DRBP76|MPHOSPH4|MPP4|MPP4110|NF110|NF110b|NF90|NF90a|NF90c|NF90ctv|NFAR-1|NFAR-2|NFAR110|NFAR90|TCP110	protein_coding	Q12906	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50804
6.75380695488192e-258	0.515215792281076	0.433	0.204	1.07919081332058e-253	GNG12	Malignant cells	GSE164897_VemTra	ENSG00000172380	55970	G protein subunit gamma 12	NA	protein_coding	Q9UBI6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50805
1.18214220538289e-257	-0.370086575613301	0.422	0.74	1.88894502998132e-253	ATP5F1A	Malignant cells	GSE164897_VemTra	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50806
1.34069758875421e-256	-0.259924612888812	0.085	0.3	2.14230067707035e-252	PSME3	Malignant cells	GSE164897_VemTra	ENSG00000131467	10197	proteasome activator subunit 3	Ki|PA28-gamma|PA28G|REG-GAMMA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50807
1.24073336094547e-255	-0.273019548939377	0.114	0.347	1.98256783745477e-251	DYNC1I2	Malignant cells	GSE164897_VemTra	ENSG00000077380	1781	dynein cytoplasmic 1 intermediate chain 2	DIC74|DNCI2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50808
2.09499684349466e-255	-0.282923249276994	0.113	0.343	3.34759545622011e-251	COL4A2	Malignant cells	GSE164897_VemTra	ENSG00000134871	1284	collagen type IV alpha 2 chain	DKFZp686I14213|FLJ22259	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50809
2.62821014152718e-255	0.396006895839303	0.259	0.055	4.19961698514627e-251	TNS3	Malignant cells	GSE164897_VemTra	ENSG00000136205	64759	tensin 3	FLJ13732|H_NH0549I23.2|TEM6|TENS1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50810
3.41239324852423e-255	-0.267284404134742	0.093	0.312	5.45266317181686e-251	GRPEL1	Malignant cells	GSE164897_VemTra	ENSG00000109519	80273	GrpE like 1, mitochondrial	FLJ25609|GrpE|hMGE	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50811
1.04583153490331e-254	-0.263795765860118	0.081	0.292	1.671134209622e-250	CD96	Malignant cells	GSE164897_VemTra	ENSG00000153283	10225	CD96 molecule	TACTILE	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50812
3.10120416581893e-254	-0.277890642616977	0.114	0.345	4.95541413656207e-250	TMEM183A	Malignant cells	GSE164897_VemTra	ENSG00000163444	92703	transmembrane protein 183A	C1orf37	protein_coding	Q8IXX5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50813
4.53895924310008e-254	-0.361596491898513	0.394	0.7	7.25280297454962e-250	NAXE	Malignant cells	GSE164897_VemTra	ENSG00000163382	128240	NAD(P)HX epimerase	AIBP|APOA1BP|MGC119143|MGC119144|MGC119145|YJEFN1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50814
4.79221447130473e-254	-0.397535223762149	0.921	0.975	7.65747950369782e-250	PKM	Malignant cells	GSE164897_VemTra	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50815
2.15878206820934e-253	0.556567131483554	0.683	0.563	3.4495178667917e-249	MICOS10	Malignant cells	GSE164897_VemTra	ENSG00000173436	440574	mitochondrial contact site and cristae organizing system subunit 10	C1orf151|FLJ36999|Mic10|MINOS1|MIO10|RP5-1056L3.2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50816
6.62644519123945e-252	-0.346201860047591	0.303	0.599	1.05883967710815e-247	PSMD7	Malignant cells	GSE164897_VemTra	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50817
6.76244040453081e-252	-0.344450699519371	0.306	0.603	1.08057035223998e-247	EIF1AX	Malignant cells	GSE164897_VemTra	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50818
9.1314804438062e-252	-0.251962546484559	0.069	0.269	1.45911926011579e-247	RRBP1	Malignant cells	GSE164897_VemTra	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50819
9.16920201404456e-252	-0.266769936515898	0.106	0.332	1.46514678982418e-247	MTAP	Malignant cells	GSE164897_VemTra	ENSG00000099810	4507	methylthioadenosine phosphorylase	c86fus|MSAP	protein_coding	Q13126	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50820
2.7282289372685e-251	-0.251253349858063	0.069	0.268	4.35943701886133e-247	CD47	Malignant cells	GSE164897_VemTra	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50821
3.0819570309097e-251	-0.286969765918755	0.151	0.398	4.92465913969061e-247	TMEM141	Malignant cells	GSE164897_VemTra	ENSG00000244187	85014	transmembrane protein 141	MGC14141	protein_coding	Q96I45	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50822
1.38303498147456e-250	-0.255039251535072	0.08	0.287	2.2099515968982e-246	TRPT1	Malignant cells	GSE164897_VemTra	ENSG00000149743	83707	tRNA phosphotransferase 1	MGC11134	protein_coding	Q86TN4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50823
8.66441639175485e-250	-0.251113877130373	0.07	0.269	1.38448709523851e-245	RANGRF	Malignant cells	GSE164897_VemTra	ENSG00000108961	29098	RAN guanine nucleotide release factor	HSPC165|HSPC236|MOG1|RANGNRF	protein_coding	Q9HD47	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50824
1.65630387469796e-249	-0.354515319257362	0.742	0.928	2.64660796137987e-245	PRDX6	Malignant cells	GSE164897_VemTra	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50825
2.38615463513119e-249	-0.380287954243697	0.573	0.849	3.81283649147613e-245	TKT	Malignant cells	GSE164897_VemTra	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50826
1.26647848504783e-248	-0.272172219750572	0.121	0.352	2.02370597125793e-244	GTF2F1	Malignant cells	GSE164897_VemTra	ENSG00000125651	2962	general transcription factor IIF subunit 1	BTF4|RAP74|TF2F1|TFIIF	protein_coding	P35269	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50827
2.29278163393559e-247	-0.327652924182612	0.118	0.346	3.66363577286569e-243	CD55	Malignant cells	GSE164897_VemTra	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50828
7.05656642066207e-247	0.577524108453576	0.506	0.301	1.12756874835759e-242	DAD1	Malignant cells	GSE164897_VemTra	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50829
2.80171350717408e-246	-0.280378810972526	0.133	0.368	4.47685801311346e-242	HDDC2	Malignant cells	GSE164897_VemTra	ENSG00000111906	51020	HD domain containing 2	C6orf74|CGI-130|dJ167O5.2	protein_coding	Q7Z4H3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50830
4.59381641353732e-246	-0.26403073658894	0.096	0.311	7.34045924719129e-242	GPANK1	Malignant cells	GSE164897_VemTra	ENSG00000223932	7918	G-patch domain and ankyrin repeats 1	ANKRD59|BAT4|D6S54E|G5|GPATCH10	protein_coding	O95872	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50831
2.82261600054177e-245	-0.333351442733659	0.264	0.543	4.51025810726569e-241	NPM3	Malignant cells	GSE164897_VemTra	ENSG00000107833	10360	nucleophosmin/nucleoplasmin 3	NA	protein_coding	O75607	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50832
8.78394562155001e-244	-0.274662417678176	0.131	0.364	1.40358667086748e-239	METTL9	Malignant cells	GSE164897_VemTra	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50833
1.09899311689516e-243	-0.293679375830649	0.171	0.423	1.75608110148677e-239	COA3	Malignant cells	GSE164897_VemTra	ENSG00000183978	28958	cytochrome c oxidase assembly factor 3	CCDC56|COX25|hCOA3|HSPC009|MITRAC12	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50834
4.25463282571967e-243	-0.256613034110965	0.094	0.306	6.79847779221746e-239	ISCA1	Malignant cells	GSE164897_VemTra	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50835
4.27089478774295e-242	-0.316471804344003	0.184	0.437	6.82446278133445e-238	PTTG1	Malignant cells	GSE164897_VemTra	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50836
1.08100579467498e-241	-0.29772040857865	0.192	0.45	1.72733915931116e-237	SCAMP3	Malignant cells	GSE164897_VemTra	ENSG00000263290	10067	secretory carrier membrane protein 3	C1orf3	protein_coding	O14828	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50837
1.39587423366836e-241	-0.273216483584578	0.116	0.34	2.23046743797867e-237	IGF2BP2	Malignant cells	GSE164897_VemTra	ENSG00000073792	10644	insulin like growth factor 2 mRNA binding protein 2	IMP-2|p62	protein_coding	Q9Y6M1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50838
1.76996814542934e-241	-0.292996526578051	0.174	0.427	2.82823209958154e-237	RARS1	Malignant cells	GSE164897_VemTra	ENSG00000113643	5917	arginyl-tRNA synthetase 1	DALRD1|RARS	protein_coding	P54136	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50839
6.64506713615061e-241	-0.279686105598005	0.136	0.37	1.06181527768551e-236	HNRNPUL1	Malignant cells	GSE164897_VemTra	ENSG00000105323	11100	heterogeneous nuclear ribonucleoprotein U like 1	E1B-AP5|E1BAP5|FLJ12944|HNRPUL1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50840
7.28071726047618e-241	-0.318687940227077	0.194	0.449	1.16338581105149e-236	TARS1	Malignant cells	GSE164897_VemTra	ENSG00000113407	6897	threonyl-tRNA synthetase 1	TARS	protein_coding	P26639	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50841
1.31503364066778e-240	0.366302124640783	0.254	0.057	2.10129225442304e-236	ABCC3	Malignant cells	GSE164897_VemTra	ENSG00000108846	8714	ATP binding cassette subfamily C member 3	cMOAT2|EST90757|MLP2|MOAT-D|MRP3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50842
3.95106922867141e-238	-0.275280976065393	0.091	0.298	6.31341352049405e-234	TM4SF1	Malignant cells	GSE164897_VemTra	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50843
1.22363042624161e-237	-0.265556780633052	0.109	0.326	1.95523905809147e-233	ITM2C	Malignant cells	GSE164897_VemTra	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50844
1.70221966829482e-237	-0.27959540330455	0.153	0.394	2.71997680796829e-233	COPS5	Malignant cells	GSE164897_VemTra	ENSG00000121022	10987	COP9 signalosome subunit 5	CSN5|JAB1|MOV-34|SGN5	protein_coding	Q92905	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50845
3.58826121866055e-236	-0.404826164869273	0.889	0.956	5.7336826012977e-232	ATOX1	Malignant cells	GSE164897_VemTra	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50846
9.97909579258776e-236	-0.361240349385049	0.301	0.577	1.5945597166976e-231	RBIS	Malignant cells	GSE164897_VemTra	ENSG00000176731	401466	ribosomal biogenesis factor	C8orf59	protein_coding	Q8N0T1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50847
1.1800322114544e-235	-0.252141045981132	0.09	0.296	1.88557347068299e-231	LARP7	Malignant cells	GSE164897_VemTra	ENSG00000174720	51574	La ribonucleoprotein 7, transcriptional regulator	DKFZP564K112|HDCMA18P|PIP7S	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50848
2.29118512699953e-233	-0.292314685365514	0.144	0.376	3.66108471443255e-229	PUM3	Malignant cells	GSE164897_VemTra	ENSG00000080608	9933	pumilio RNA binding family member 3	HA-8|hPUF-A|KIAA0020|PEN|Puf-A|PUF6|XTP5	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50849
1.95070211357467e-232	-0.29550978241251	0.226	0.496	3.11702690728096e-228	EMC4	Malignant cells	GSE164897_VemTra	ENSG00000128463	51234	ER membrane protein complex subunit 4	FLJ90746|MGC24415|PIG17|TMEM85	protein_coding	Q5J8M3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50850
5.17583664990875e-232	-0.29280540683542	0.184	0.431	8.27046938288919e-228	SRRM2	Malignant cells	GSE164897_VemTra	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50851
8.72640174378956e-232	-0.28553728835757	0.175	0.42	1.39439173464013e-227	AIMP1	Malignant cells	GSE164897_VemTra	ENSG00000164022	9255	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	EMAP-2|EMAPII|p43|SCYE1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50852
6.47197253122979e-231	-0.253511742454941	0.087	0.289	1.03415649076521e-226	SLC20A1	Malignant cells	GSE164897_VemTra	ENSG00000144136	6574	solute carrier family 20 member 1	Glvr-1|GLVR1|PiT-1|PiT1	protein_coding	Q8WUM9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50853
2.1478998832979e-230	-0.303538521390342	0.261	0.534	3.43212922352171e-226	BABAM1	Malignant cells	GSE164897_VemTra	ENSG00000105393	29086	BRISC and BRCA1 A complex member 1	C19orf62|FLJ20571|HSPC142|MERIT40|NBA1	protein_coding	Q9NWV8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50854
5.0101704100336e-230	-0.487915556403332	0.602	0.805	8.00575129819269e-226	HMGB1	Malignant cells	GSE164897_VemTra	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50855
9.45515285897759e-230	-0.264686743281063	0.135	0.365	1.51083887533603e-225	GNL3	Malignant cells	GSE164897_VemTra	ENSG00000163938	26354	G protein nucleolar 3	C77032|E2IG3|MGC800|NS	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50856
3.32839122773974e-229	-0.251457035832715	0.113	0.331	5.31843634280533e-225	SRPK2	Malignant cells	GSE164897_VemTra	ENSG00000135250	6733	SRSF protein kinase 2	SFRSK2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50857
6.55155178041523e-229	-0.290346390702228	0.202	0.455	1.04687245899255e-224	POLDIP2	Malignant cells	GSE164897_VemTra	ENSG00000004142	26073	DNA polymerase delta interacting protein 2	DKFZP586F1524|PDIP38	protein_coding	Q9Y2S7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50858
8.26223451676634e-229	-0.262429761134924	0.116	0.334	1.32022245343409e-224	NIFK	Malignant cells	GSE164897_VemTra	ENSG00000155438	84365	nucleolar protein interacting with the FHA domain of MKI67	hNIFK|MKI67IP|Nopp34	protein_coding	Q9BYG3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50859
2.16411900225777e-228	-0.26559013748603	0.111	0.324	3.45804575370768e-224	PLEC	Malignant cells	GSE164897_VemTra	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50860
8.57867260500169e-228	-0.261339986647004	0.097	0.302	1.37078609555322e-223	PPFIBP1	Malignant cells	GSE164897_VemTra	ENSG00000110841	8496	PPFIA binding protein 1	hSGT2|hSgt2p|L2|SGT2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50861
3.37714974641371e-227	0.351737502214047	0.254	0.062	5.39634757979447e-223	RAP1B	Malignant cells	GSE164897_VemTra	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50862
5.12015411804025e-226	-0.309770448425123	0.322	0.611	8.18149426521651e-222	KTN1	Malignant cells	GSE164897_VemTra	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50863
1.28245310378422e-224	-0.321523659297051	0.266	0.533	2.0492318145368e-220	SRSF2	Malignant cells	GSE164897_VemTra	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50864
1.54103156694907e-224	-0.347868108207528	0.257	0.519	2.46241434082792e-220	PRELID3B	Malignant cells	GSE164897_VemTra	ENSG00000101166	51012	PRELI domain containing 3B	C20orf45|dJ543J19.5|SLMO2	protein_coding	Q9Y3B1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50865
2.73370131157763e-224	0.434545586884147	0.372	0.159	4.3681813257699e-220	PABPN1	Malignant cells	GSE164897_VemTra	ENSG00000100836	8106	poly(A) binding protein nuclear 1	OPMD|PAB2|PABP2	protein_coding	Q86U42	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50866
1.05544250392642e-223	-0.328507186016287	0.064	0.251	1.68649157702403e-219	TOP2A	Malignant cells	GSE164897_VemTra	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50867
3.61034831098292e-222	-0.274907549884955	0.174	0.413	5.76897556611961e-218	OXA1L	Malignant cells	GSE164897_VemTra	ENSG00000155463	5018	OXA1L mitochondrial inner membrane protein	MGC133129|OXA1|OXA1L1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50868
4.71923393308421e-222	-0.26988435046241	0.171	0.413	7.54086390167526e-218	SNX5	Malignant cells	GSE164897_VemTra	ENSG00000089006	27131	sorting nexin 5	NA	protein_coding	Q9Y5X3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50869
7.0596049716716e-222	0.359723472148902	0.282	0.084	1.1280542784234e-217	TCAF1	Malignant cells	GSE164897_VemTra	ENSG00000198420	9747	TRPM8 channel associated factor 1	FAM115A|GATD9A|KIAA0738	protein_coding	Q9Y4C2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50870
1.07725289314932e-221	-0.325053569128454	0.388	0.682	1.7213423979633e-217	CCT2	Malignant cells	GSE164897_VemTra	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50871
8.58300997951738e-221	0.439788561612688	0.386	0.174	1.37147916462708e-216	DDX17	Malignant cells	GSE164897_VemTra	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50872
1.04641766650656e-220	0.442237623661402	0.377	0.166	1.67207078931082e-216	ATRX	Malignant cells	GSE164897_VemTra	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50873
1.16405325521795e-218	0.633709517972514	0.481	0.27	1.86004069651275e-214	CAV1	Malignant cells	GSE164897_VemTra	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50874
1.71523292096997e-218	-0.254624379226194	0.137	0.36	2.74077068441792e-214	CUEDC2	Malignant cells	GSE164897_VemTra	ENSG00000107874	79004	CUE domain containing 2	C10orf66|MGC2491	protein_coding	Q9H467	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50875
2.37064954276243e-218	0.351805946279071	0.277	0.081	3.78806090438008e-214	EHD2	Malignant cells	GSE164897_VemTra	ENSG00000024422	30846	EH domain containing 2	PAST2	protein_coding	Q9NZN4	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50876
2.56784071765651e-217	0.502450774928444	0.689	0.552	4.10315268274334e-213	NPC2	Malignant cells	GSE164897_VemTra	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50877
7.00460386559134e-217	-0.277723778453271	0.174	0.411	1.11926565168284e-212	PARP1	Malignant cells	GSE164897_VemTra	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50878
1.61069703028575e-215	0.54990823522777	0.532	0.357	2.57373278469359e-211	PSMA2	Malignant cells	GSE164897_VemTra	ENSG00000106588	5683	proteasome 20S subunit alpha 2	HC3|MU|PMSA2	protein_coding	P25787	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50879
2.13173317424761e-215	-0.338564945102074	0.269	0.525	3.40629643913026e-211	MARCKSL1	Malignant cells	GSE164897_VemTra	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50880
1.22583778630593e-214	-0.461307001762937	0.374	0.622	1.95876619873825e-210	NQO1	Malignant cells	GSE164897_VemTra	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50881
7.632103572939e-214	-0.257363072376352	0.144	0.367	1.21953382991992e-209	NCOR1	Malignant cells	GSE164897_VemTra	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50882
8.69908088855864e-214	-0.317778992220139	0.456	0.757	1.39002613518278e-209	TOMM20	Malignant cells	GSE164897_VemTra	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50883
6.58883484461608e-213	-0.337979888400797	0.595	0.854	1.0528299198212e-208	NME1	Malignant cells	GSE164897_VemTra	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50884
2.8007171056433e-212	0.476908361106534	0.425	0.222	4.47526586310742e-208	HMGN3	Malignant cells	GSE164897_VemTra	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50885
8.6473823674406e-212	-0.272845948072192	0.16	0.386	1.38176522849333e-207	PDCD11	Malignant cells	GSE164897_VemTra	ENSG00000148843	22984	programmed cell death 11	ALG-4|KIAA0185|NFBP|RRP5	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50886
9.39669116404472e-212	-0.250358769513116	0.134	0.35	1.50149728110271e-207	UPF3A	Malignant cells	GSE164897_VemTra	ENSG00000169062	65110	UPF3A regulator of nonsense mediated mRNA decay	HUPF3A|RENT3A|UPF3	protein_coding	Q9H1J1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50887
2.65444999294497e-209	-0.258725521185189	0.156	0.381	4.24154564372677e-205	PSMD14	Malignant cells	GSE164897_VemTra	ENSG00000115233	10213	proteasome 26S subunit, non-ATPase 14	pad1|POH1|Rpn11	protein_coding	O00487	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50888
2.73635229533248e-209	-0.32381154554791	0.801	0.927	4.37241733271177e-205	RAN	Malignant cells	GSE164897_VemTra	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50889
1.08867648723411e-208	-0.287007678181138	0.268	0.533	1.73959615895138e-204	CAMLG	Malignant cells	GSE164897_VemTra	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50890
6.63013897909764e-208	0.482979075641565	0.317	0.117	1.05942990747001e-203	ARL6IP1	Malignant cells	GSE164897_VemTra	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50891
1.68998124842217e-206	-0.306278231731094	0.374	0.656	2.70042103685378e-202	TPM3	Malignant cells	GSE164897_VemTra	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50892
2.41302028855398e-206	0.408987161762823	0.372	0.166	3.85576511908041e-202	ADAR	Malignant cells	GSE164897_VemTra	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50893
8.80571708488394e-205	-0.255585452483334	0.172	0.401	1.4070655329936e-200	MTCH1	Malignant cells	GSE164897_VemTra	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50894
5.96943746509086e-203	-0.273416470083994	0.243	0.497	9.53856412546869e-199	SNX3	Malignant cells	GSE164897_VemTra	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50895
1.6240445429667e-202	-0.300500552840774	0.164	0.384	2.59506077520649e-198	TSC22D1	Malignant cells	GSE164897_VemTra	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50896
1.95788312916434e-202	-0.277549833313009	0.221	0.467	3.1285014520917e-198	MRPL36	Malignant cells	GSE164897_VemTra	ENSG00000171421	64979	mitochondrial ribosomal protein L36	L36mt|MRP-L36|PRPL36|RPMJ	protein_coding	Q9P0J6	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50897
3.80040465783469e-201	0.540809586133703	0.498	0.319	6.07266660275405e-197	MAP1B	Malignant cells	GSE164897_VemTra	ENSG00000131711	4131	microtubule associated protein 1B	MAP5|PPP1R102	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50898
9.64909242930966e-200	-0.261508029263116	0.159	0.379	1.54182847927939e-195	BUB3	Malignant cells	GSE164897_VemTra	ENSG00000154473	9184	BUB3 mitotic checkpoint protein	BUB3L	protein_coding	O43684	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50899
8.59741776750614e-199	0.510330179679501	0.695	0.601	1.37378138506981e-194	SET	Malignant cells	GSE164897_VemTra	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50900
3.48497037988923e-197	-0.26047171586766	0.078	0.254	5.56863417002501e-193	TPST1	Malignant cells	GSE164897_VemTra	ENSG00000169902	8460	tyrosylprotein sulfotransferase 1	TANGO13A	protein_coding	O60507	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50901
5.15138305388292e-196	-0.263696094348436	0.97	0.992	8.23139498179951e-192	LDHB	Malignant cells	GSE164897_VemTra	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50902
9.22627601118681e-195	0.477325263544892	0.488	0.306	1.47426664382754e-190	CANX	Malignant cells	GSE164897_VemTra	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50903
1.09899827624839e-193	-0.251018568242178	0.085	0.262	1.75608934561731e-189	AMIGO2	Malignant cells	GSE164897_VemTra	ENSG00000139211	347902	adhesion molecule with Ig like domain 2	ALI1|DEGA	protein_coding	Q86SJ2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50904
3.21170433311718e-191	-0.262673325012775	0.099	0.283	5.13198235388794e-187	AKAP12	Malignant cells	GSE164897_VemTra	ENSG00000131016	9590	A-kinase anchoring protein 12	AKAP250|SSeCKS	protein_coding	Q02952	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50905
7.53647806953131e-191	0.513802280184497	0.618	0.502	1.20425383073041e-186	ENY2	Malignant cells	GSE164897_VemTra	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50906
1.15161287669661e-190	-0.250736974965187	0.075	0.251	1.84016221567351e-186	CENPF	Malignant cells	GSE164897_VemTra	ENSG00000117724	1063	centromere protein F	hcp-1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50907
3.25969033973249e-190	-0.292879360405656	0.385	0.66	5.20865919385855e-186	POLR1D	Malignant cells	GSE164897_VemTra	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50908
3.26853574846738e-190	0.396241798107263	0.875	0.852	5.22279327247602e-186	WDR83OS	Malignant cells	GSE164897_VemTra	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50909
8.75395848928915e-189	0.398453360298029	0.261	0.08	1.39879502700351e-184	STC1	Malignant cells	GSE164897_VemTra	ENSG00000159167	6781	stanniocalcin 1	STC	protein_coding	P52823	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50910
1.07251635369282e-188	0.363988080656331	0.292	0.107	1.71377388156576e-184	KANK2	Malignant cells	GSE164897_VemTra	ENSG00000197256	25959	KN motif and ankyrin repeat domains 2	ANKRD25|KIAA1518|MXRA3	protein_coding	Q63ZY3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50911
2.057164749669e-188	-0.255508613954054	0.204	0.433	3.2871435534961e-184	SLC39A1	Malignant cells	GSE164897_VemTra	ENSG00000143570	27173	solute carrier family 39 member 1	ZIP1|ZIRTL	protein_coding	Q9NY26	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50912
5.74909092132241e-188	-0.32379664651798	0.542	0.806	9.18647238318108e-184	EIF3M	Malignant cells	GSE164897_VemTra	ENSG00000149100	10480	eukaryotic translation initiation factor 3 subunit M	FLJ29030|GA17|hfl-B5|PCID1|TANGO7	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50913
5.33916466485948e-187	0.40125453993679	0.841	0.799	8.53145121797896e-183	EIF3H	Malignant cells	GSE164897_VemTra	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50914
2.08193220997136e-185	-0.300090292156287	0.922	0.975	3.32671947831323e-181	H3-3A	Malignant cells	GSE164897_VemTra	ENSG00000163041	3020	H3.3 histone A	H3.3A|H3F3|H3F3A	protein_coding	P84243	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50915
3.82948244101856e-184	-0.256938225469545	0.256	0.502	6.11912999250356e-180	RWDD1	Malignant cells	GSE164897_VemTra	ENSG00000111832	51389	RWD domain containing 1	PTD013	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50916
5.8174653548783e-183	0.470543596774094	0.605	0.458	9.29572789056004e-179	HLA-A	Malignant cells	GSE164897_VemTra	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50917
4.54228380164864e-181	-0.26660086987546	0.268	0.515	7.25811528665436e-177	CEBPZ	Malignant cells	GSE164897_VemTra	ENSG00000115816	10153	CCAAT enhancer binding protein zeta	CBF2|CTF2	protein_coding	Q03701	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50918
1.07574749177394e-179	0.457834462884081	0.847	0.73	1.71893691710558e-175	CALM2	Malignant cells	GSE164897_VemTra	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50919
7.80218572404008e-179	0.330279373972676	0.256	0.084	1.24671125684436e-174	CDKN2C	Malignant cells	GSE164897_VemTra	ENSG00000123080	1031	cyclin dependent kinase inhibitor 2C	INK4C|p18	protein_coding	P42773	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50920
7.89571957379746e-177	0.410099941295181	0.389	0.203	1.2616570306971e-172	PTP4A2	Malignant cells	GSE164897_VemTra	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50921
5.29374266633745e-175	-0.250095377377673	0.187	0.403	8.45887140654062e-171	SLC7A5	Malignant cells	GSE164897_VemTra	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50922
6.21007599667133e-175	0.475312954671523	0.524	0.369	9.92308043508112e-171	DYNLT1	Malignant cells	GSE164897_VemTra	ENSG00000146425	6993	dynein light chain Tctex-type 1	TCTEL1|Tctex-1|TCTEX1	protein_coding	P63172	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50923
2.17033747385427e-174	0.430240120288818	0.408	0.226	3.46798224947174e-170	SRP19	Malignant cells	GSE164897_VemTra	ENSG00000153037	6728	signal recognition particle 19	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50924
3.00060155345361e-174	0.323032286503409	0.263	0.091	4.79466122226353e-170	FAM151B-DT	Malignant cells	GSE164897_VemTra	ENSG00000249042	NA	NA	NA	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50925
3.4679548360407e-174	0.49063918075141	0.526	0.374	5.54144503250944e-170	CDC42	Malignant cells	GSE164897_VemTra	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50926
1.67468285755525e-173	-0.285823832011534	0.406	0.668	2.67597573808753e-169	CBX3	Malignant cells	GSE164897_VemTra	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50927
3.60563165924248e-173	0.441172093321251	0.442	0.266	5.76143882830355e-169	EIF4G2	Malignant cells	GSE164897_VemTra	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50928
9.20271548666656e-173	-0.318680192875903	0.422	0.675	1.47050190761445e-168	SQSTM1	Malignant cells	GSE164897_VemTra	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50929
3.00354655961975e-172	0.469204840356927	0.515	0.36	4.79936704761639e-168	CAST	Malignant cells	GSE164897_VemTra	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50930
8.27889567588967e-169	0.332013019563831	0.268	0.098	1.32288474005041e-164	LOXL3	Malignant cells	GSE164897_VemTra	ENSG00000115318	84695	lysyl oxidase like 3	NA	protein_coding	P58215	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50931
1.32780261041751e-168	-0.256680360790749	0.33	0.585	2.12169579118615e-164	TIMM8B	Malignant cells	GSE164897_VemTra	ENSG00000150779	26521	translocase of inner mitochondrial membrane 8 homolog B	DDP2|FLJ21744|MGC102866|MGC117373|TIM8B	protein_coding	Q9Y5J9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50932
3.38054047318967e-168	0.372292686636141	0.342	0.163	5.40176562210978e-164	MORN2	Malignant cells	GSE164897_VemTra	ENSG00000188010	729967	MORN repeat containing 2	MOPT	protein_coding	Q502X0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50933
2.9300838962071e-166	0.406306566577448	0.409	0.229	4.68198105774932e-162	NORAD	Malignant cells	GSE164897_VemTra	ENSG00000260032	647979	non-coding RNA activated by DNA damage	LINC00657	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50934
1.63152619113931e-163	-0.259595769382983	0.338	0.589	2.60701570082151e-159	PSME1	Malignant cells	GSE164897_VemTra	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50935
2.34295283761399e-161	0.351439056913466	0.298	0.127	3.7438043392234e-157	CTBP2	Malignant cells	GSE164897_VemTra	ENSG00000175029	1488	C-terminal binding protein 2	ribeye	protein_coding	P56545	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50936
6.0046395716023e-161	0.465136841934449	0.526	0.388	9.59481357146332e-157	RPL26L1	Malignant cells	GSE164897_VemTra	ENSG00000037241	51121	ribosomal protein L26 like 1	RPL26P1	protein_coding	Q9UNX3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50937
9.93786145204251e-158	0.355987787458317	0.306	0.137	1.58797088142187e-153	ACLY	Malignant cells	GSE164897_VemTra	ENSG00000131473	47	ATP citrate lyase	ACL|ATPCL|CLATP	protein_coding	P53396	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50938
2.24947078561454e-157	0.363055229093755	0.337	0.164	3.59442936833348e-153	GLG1	Malignant cells	GSE164897_VemTra	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50939
6.23138662530909e-157	-0.402402233500566	0.664	0.835	9.95713268858139e-153	TUBB	Malignant cells	GSE164897_VemTra	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50940
4.52004566172277e-156	0.336434519847375	0.313	0.142	7.22258096286681e-152	KDM5B	Malignant cells	GSE164897_VemTra	ENSG00000117139	10765	lysine demethylase 5B	CT31|JARID1B|PLU-1|PPP1R98|RBBP2H1A	protein_coding	Q9UGL1	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50941
9.14559254280404e-155	0.325705425600965	0.294	0.127	1.46137423241466e-150	UBE2Z	Malignant cells	GSE164897_VemTra	ENSG00000159202	65264	ubiquitin conjugating enzyme E2 Z	FLJ13855|USE1	protein_coding	Q9H832	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50942
9.95297610559366e-155	0.408318351015376	0.36	0.191	1.59038605191281e-150	TMBIM4	Malignant cells	GSE164897_VemTra	ENSG00000155957	51643	transmembrane BAX inhibitor motif containing 4	CGI-119|GAAP|LFG4|S1R|ZPRO	protein_coding	Q9HC24	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50943
3.16599219680093e-154	-0.264547078987	0.457	0.716	5.0589389312682e-150	RHOA	Malignant cells	GSE164897_VemTra	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50944
6.56341830211902e-154	0.448619500692358	0.543	0.415	1.0487686104956e-149	MEA1	Malignant cells	GSE164897_VemTra	ENSG00000124733	4201	male-enhanced antigen 1	MEA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50945
1.2281785781154e-153	0.322771778950048	0.285	0.119	1.9625065499706e-149	NENF	Malignant cells	GSE164897_VemTra	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50946
3.12935929622186e-153	0.414333651969298	0.36	0.193	5.00040321943291e-149	SPTSSA	Malignant cells	GSE164897_VemTra	ENSG00000165389	171546	serine palmitoyltransferase small subunit A	C14orf147|ssSPTa	protein_coding	Q969W0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50947
8.91506659904682e-150	0.429447952544059	0.438	0.28	1.42453849186169e-145	CALU	Malignant cells	GSE164897_VemTra	ENSG00000128595	813	calumenin	NA	protein_coding	O43852	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50948
6.2914267201467e-148	0.395175717827879	0.411	0.247	1.00530707561224e-143	CTNNA1	Malignant cells	GSE164897_VemTra	ENSG00000044115	1495	catenin alpha 1	CAP102	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50949
1.11736425916574e-147	0.406412989676405	0.43	0.269	1.78543634972094e-143	PNISR	Malignant cells	GSE164897_VemTra	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50950
1.49538268058304e-147	0.449655027964627	0.631	0.468	2.38947198530364e-143	SLC26A2	Malignant cells	GSE164897_VemTra	ENSG00000155850	1836	solute carrier family 26 member 2	DTD|DTDST	protein_coding	P50443	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50951
8.22424869096944e-147	0.344897627885762	0.303	0.14	1.31415269833001e-142	SLC39A6	Malignant cells	GSE164897_VemTra	ENSG00000141424	25800	solute carrier family 39 member 6	LIV-1	protein_coding	Q13433	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50952
9.37694670472591e-146	0.424534798119121	0.471	0.321	1.49834231394815e-141	TMEM14B	Malignant cells	GSE164897_VemTra	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50953
3.52350689449294e-145	0.370166143977308	0.348	0.184	5.63021166671027e-141	AHCYL1	Malignant cells	GSE164897_VemTra	ENSG00000168710	10768	adenosylhomocysteinase like 1	IRBIT|PPP1R78|XPVKONA	protein_coding	O43865	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50954
6.03784103979267e-145	-0.442561141564853	0.287	0.479	9.64786619748471e-141	TPM1	Malignant cells	GSE164897_VemTra	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50955
1.57053654956666e-144	0.336963869628899	0.313	0.15	2.50956035255256e-140	BPTF	Malignant cells	GSE164897_VemTra	ENSG00000171634	2186	bromodomain PHD finger transcription factor	FAC1|FALZ|NURF301	protein_coding	Q12830	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50956
5.91628242592145e-144	0.348268561262646	0.886	0.873	9.45362768837989e-140	YBX1	Malignant cells	GSE164897_VemTra	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50957
3.46145075291979e-142	0.341395730641638	0.322	0.16	5.53105215809053e-138	RNF213	Malignant cells	GSE164897_VemTra	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50958
1.0573894671387e-140	0.301585012689647	0.26	0.107	1.68960262954093e-136	YIPF5	Malignant cells	GSE164897_VemTra	ENSG00000145817	81555	Yip1 domain family member 5	FinGER5|SMAP-5	protein_coding	Q969M3	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50959
1.11875593525545e-138	0.386664960998848	0.386	0.229	1.78766010894469e-134	GTF2H5	Malignant cells	GSE164897_VemTra	ENSG00000272047	404672	general transcription factor IIH subunit 5	bA120J8.2|C6orf175|FLJ30544|TFB5|TFIIH|TTD|TTD-A|TTDA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50960
1.33070993937709e-138	0.355477289968729	0.357	0.196	2.12634141213066e-134	GTF2I	Malignant cells	GSE164897_VemTra	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50961
4.26679593747158e-134	0.388554622900028	0.395	0.241	6.81791322848583e-130	CAPZA1	Malignant cells	GSE164897_VemTra	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50962
6.25501907144434e-134	0.364830260248435	0.379	0.222	9.99489497426091e-130	CELF1	Malignant cells	GSE164897_VemTra	ENSG00000149187	10658	CUGBP Elav-like family member 1	BRUNOL2|CUG-BP|CUGBP|CUGBP1|EDEN-BP|hNab50|NAB50|NAPOR	protein_coding	Q92879	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50963
3.34555721833484e-128	0.353810465631703	0.359	0.205	5.34586587917724e-124	CKAP4	Malignant cells	GSE164897_VemTra	ENSG00000136026	10970	cytoskeleton associated protein 4	CLIMP-63|ERGIC-63|P63	protein_coding	Q07065	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50964
2.08213751918582e-125	0.320924520962814	0.896	0.88	3.32704754190703e-121	SSR2	Malignant cells	GSE164897_VemTra	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50965
2.4583043826759e-125	0.306157096748551	0.301	0.151	3.92812457307783e-121	DCAF7	Malignant cells	GSE164897_VemTra	ENSG00000136485	10238	DDB1 and CUL4 associated factor 7	HAN11|SWAN-1|WDR68	protein_coding	P61962	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50966
8.8429446578667e-125	-0.259259392170877	0.74	0.826	1.41301412688052e-120	H2AZ1	Malignant cells	GSE164897_VemTra	ENSG00000164032	3015	H2A.Z variant histone 1	H2A.Z|H2AFZ|H2AZ	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50967
3.40032143002357e-124	0.324333455088362	0.841	0.743	5.43337361303467e-120	RPS27L	Malignant cells	GSE164897_VemTra	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50968
9.85127528766041e-124	0.372398924570336	0.407	0.261	1.57413527821526e-119	SERINC3	Malignant cells	GSE164897_VemTra	ENSG00000132824	10955	serine incorporator 3	AIGP1|DIFF33|SBBI99|TDE|TDE1|TMS-1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50969
3.27853607032436e-122	-0.257733534163304	0.725	0.892	5.2387727867713e-118	IMPDH2	Malignant cells	GSE164897_VemTra	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50970
5.13225330326051e-119	0.376807542535159	0.338	0.193	8.20082755327998e-115	ALDH1A3	Malignant cells	GSE164897_VemTra	ENSG00000184254	220	aldehyde dehydrogenase 1 family member A3	ALDH6|RALDH3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50971
2.10336852163017e-118	0.38672449023627	0.455	0.323	3.36097256071285e-114	CRIPT	Malignant cells	GSE164897_VemTra	ENSG00000119878	9419	CXXC repeat containing interactor of PDZ3 domain	HSPC139	protein_coding	Q9P021	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50972
3.11503334794785e-118	0.405879587962344	0.623	0.569	4.97751178668587e-114	DYNLRB1	Malignant cells	GSE164897_VemTra	ENSG00000125971	83658	dynein light chain roadblock-type 1	DNCL2A|DNLC2A|ROBLD1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50973
1.84750279163544e-117	0.374114018065324	0.444	0.308	2.95212471075426e-113	BBX	Malignant cells	GSE164897_VemTra	ENSG00000114439	56987	BBX high mobility group box domain containing	HBP2|HSPC339|MDS001	protein_coding	Q8WY36	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50974
5.91715069063968e-117	0.322415847238595	0.338	0.191	9.45501508857315e-113	JPX	Malignant cells	GSE164897_VemTra	ENSG00000225470	554203	JPX transcript, XIST activator	DCBALD06|ENOX|LINC00183|NCRNA00183	NA	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50975
1.5160475091498e-116	0.412343484245322	0.54	0.448	2.42249231487046e-112	NDUFS4	Malignant cells	GSE164897_VemTra	ENSG00000164258	4724	NADH:ubiquinone oxidoreductase subunit S4	AQDQ|CI-18	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50976
2.37070745900909e-116	0.322553484741844	0.311	0.167	3.78815344875062e-112	CEBPB	Malignant cells	GSE164897_VemTra	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50977
2.46106975562186e-116	0.360663534386085	0.412	0.274	3.93254336250817e-112	GANAB	Malignant cells	GSE164897_VemTra	ENSG00000089597	23193	glucosidase II alpha subunit	G2AN|GIIA|GluII|KIAA0088	protein_coding	Q14697	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50978
1.39345843316126e-115	0.288775850902344	0.278	0.136	2.22660723034838e-111	STAT3	Malignant cells	GSE164897_VemTra	ENSG00000168610	6774	signal transducer and activator of transcription 3	APRF	protein_coding	P40763	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50979
2.15318818973926e-115	0.35505810064887	0.341	0.196	3.44057940838436e-111	H1-2	Malignant cells	GSE164897_VemTra	ENSG00000187837	3006	H1.2 linker histone, cluster member	H1.2|H1c|H1F2|H1s-1|HIST1H1C	protein_coding	P16403	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50980
4.5566742519508e-115	0.403178997920169	0.534	0.436	7.28110978719219e-111	PRRC2C	Malignant cells	GSE164897_VemTra	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50981
2.12160765879545e-113	0.374204532727584	0.439	0.308	3.39011687798925e-109	PFN2	Malignant cells	GSE164897_VemTra	ENSG00000070087	5217	profilin 2	NA	protein_coding	P35080	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50982
8.61784924836794e-113	0.279635192898211	0.263	0.125	1.37704613139671e-108	IRF2BP2	Malignant cells	GSE164897_VemTra	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50983
5.47427920822105e-109	0.383554680291285	0.535	0.443	8.74735074681641e-105	NONO	Malignant cells	GSE164897_VemTra	ENSG00000147140	4841	non-POU domain containing octamer binding	NMT55|NRB54|P54|P54NRB|PPP1R114	protein_coding	Q15233	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50984
4.97503250767877e-108	0.276389375812534	0.26	0.126	7.94960444401991e-104	MBNL1	Malignant cells	GSE164897_VemTra	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50985
1.17171723830025e-106	0.352615794524975	0.416	0.286	1.87228697507997e-102	HDGF	Malignant cells	GSE164897_VemTra	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50986
3.01237255337067e-104	0.272495848311038	0.258	0.127	4.81347010303099e-100	ZFAND5	Malignant cells	GSE164897_VemTra	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50987
2.56114902880226e-103	0.269724712064094	0.271	0.138	4.09246003312314e-99	SDCBP	Malignant cells	GSE164897_VemTra	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50988
3.03262349141307e-103	0.354107669492734	0.456	0.335	4.84582907692895e-99	EIF4A2	Malignant cells	GSE164897_VemTra	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50989
6.74995726590652e-103	0.407581281930799	0.596	0.546	1.0785756715192e-98	ACP1	Malignant cells	GSE164897_VemTra	ENSG00000143727	52	acid phosphatase 1	HAAP|LMW-PTP|LMWPTP	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50990
1.53699254073553e-101	0.474907801635229	0.608	0.545	2.45596038084131e-97	HSP90B1	Malignant cells	GSE164897_VemTra	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50991
1.43267045999969e-100	0.418334571065625	0.514	0.427	2.28926412803351e-96	EIF2S3	Malignant cells	GSE164897_VemTra	ENSG00000130741	1968	eukaryotic translation initiation factor 2 subunit gamma	EIF2|EIF2G|EIF2gamma	protein_coding	P41091	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50992
1.59721608395422e-100	0.35124108773239	0.421	0.299	2.55219158055045e-96	PRDX3	Malignant cells	GSE164897_VemTra	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50993
1.69334179894626e-100	0.338562144231995	0.371	0.241	2.70579086053624e-96	ARL3	Malignant cells	GSE164897_VemTra	ENSG00000138175	403	ADP ribosylation factor like GTPase 3	ARFL3	protein_coding	P36405	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50994
7.39499186493191e-100	-0.31627608317073	0.208	0.355	1.18164575009747e-95	HLA-DRA	Malignant cells	GSE164897_VemTra	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50995
9.59172756739429e-98	0.366042136654853	0.692	0.692	1.53266214799393e-93	ATP5PD	Malignant cells	GSE164897_VemTra	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50996
6.00911085178859e-97	0.431861714713634	0.565	0.483	9.60195823007298e-93	MYL12A	Malignant cells	GSE164897_VemTra	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50997
5.13029217883631e-95	0.3146785675875	0.359	0.232	8.19769387256254e-91	LARP1	Malignant cells	GSE164897_VemTra	ENSG00000155506	23367	La ribonucleoprotein 1, translational regulator	KIAA0731|Lar1|LARP|Lhp1|MGC19556	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50998
6.19799495261489e-91	0.255602489230827	0.259	0.136	9.90377613478333e-87	KMT2A	Malignant cells	GSE164897_VemTra	ENSG00000118058	4297	lysine methyltransferase 2A	ALL-1|ALL1|CXXC7|HRX|HTRX|HTRX1|MLL|MLL1|MLL1A|TRX1	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	50999
1.29861330180677e-90	0.268811202430182	0.27	0.148	2.07505419495704e-86	PPIC	Malignant cells	GSE164897_VemTra	ENSG00000168938	5480	peptidylprolyl isomerase C	CYPC	protein_coding	P45877	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51000
2.22070854905879e-90	0.362399930834922	0.551	0.487	3.54847019054104e-86	MRPS33	Malignant cells	GSE164897_VemTra	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51001
1.09467857068329e-88	0.300042993676513	0.337	0.214	1.74918688809484e-84	TAF7	Malignant cells	GSE164897_VemTra	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51002
2.43712138072869e-88	0.334611064699341	0.723	0.69	3.89427625426637e-84	HSPE1	Malignant cells	GSE164897_VemTra	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51003
1.43098107958849e-87	-0.257302122602369	0.891	0.934	2.28656466707446e-83	SERPINE2	Malignant cells	GSE164897_VemTra	ENSG00000135919	5270	serpin family E member 2	GDN|nexin|PI7|PN1|PNI	protein_coding	P07093	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51004
6.67515824822733e-85	0.292319724000091	0.658	0.56	1.06662353648425e-80	ID3	Malignant cells	GSE164897_VemTra	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51005
5.89962272797644e-83	0.337747336120343	0.649	0.637	9.42700715703355e-79	COX20	Malignant cells	GSE164897_VemTra	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51006
3.65545915467381e-82	0.3173536554359	0.341	0.226	5.84105818325327e-78	ARL6IP5	Malignant cells	GSE164897_VemTra	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51007
1.81637350090796e-81	0.297230408889927	0.331	0.214	2.90238321710083e-77	CAVIN1	Malignant cells	GSE164897_VemTra	ENSG00000177469	284119	caveolae associated protein 1	cavin-1|CGL4|PTRF	protein_coding	Q6NZI2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51008
1.83186709893595e-81	0.355860734709699	0.452	0.356	2.92714043738976e-77	OSTC	Malignant cells	GSE164897_VemTra	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51009
3.52366502486067e-81	0.35309796772521	0.53	0.467	5.63046434322487e-77	MRPL27	Malignant cells	GSE164897_VemTra	ENSG00000108826	51264	mitochondrial ribosomal protein L27	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51010
7.95498978146258e-79	0.324364484901422	0.654	0.646	1.27112781717991e-74	UFC1	Malignant cells	GSE164897_VemTra	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51011
2.39510378937346e-78	0.345828379073497	0.552	0.496	3.82713634503985e-74	ATP6V1G1	Malignant cells	GSE164897_VemTra	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51012
5.61940677666955e-78	0.285952907606839	0.343	0.23	8.97925008844028e-74	DDX24	Malignant cells	GSE164897_VemTra	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51013
1.35416164094602e-77	0.300403061275627	0.369	0.261	2.16381488606764e-73	ZMAT2	Malignant cells	GSE164897_VemTra	ENSG00000146007	153527	zinc finger matrin-type 2	FLJ31121|hSNU23|Snu23	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51014
2.53945702663435e-75	0.344211823314607	0.587	0.546	4.05779838285903e-71	EID1	Malignant cells	GSE164897_VemTra	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51015
2.87579913945078e-75	0.283833991530556	0.867	0.878	4.5952394449284e-71	ATP5MF	Malignant cells	GSE164897_VemTra	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51016
9.50549590601796e-75	0.290078878260266	0.346	0.237	1.51888319082261e-70	CETN2	Malignant cells	GSE164897_VemTra	ENSG00000147400	1069	centrin 2	CALT|CEN2	protein_coding	P41208	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51017
4.716429400004e-73	0.392022262757928	0.254	0.147	7.53638253826639e-69	IGFBP3	Malignant cells	GSE164897_VemTra	ENSG00000146674	3486	insulin like growth factor binding protein 3	BP-53|IBP3	protein_coding	P17936	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51018
6.34187820420523e-73	0.262503872510531	0.846	0.846	1.01336871824995e-68	COX7B	Malignant cells	GSE164897_VemTra	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51019
1.04791842432598e-71	0.296185758240448	0.379	0.274	1.67446885023048e-67	DPCD	Malignant cells	GSE164897_VemTra	ENSG00000166171	25911	deleted in primary ciliary dyskinesia homolog (mouse)	DKFZP566F084|RP11-529I10.4	protein_coding	Q9BVM2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51020
4.11847301000571e-71	0.327554121530403	0.394	0.298	6.58090802268812e-67	MAT2A	Malignant cells	GSE164897_VemTra	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51021
5.63624990011766e-71	0.293581829008616	0.378	0.276	9.00616371539801e-67	HNRNPR	Malignant cells	GSE164897_VemTra	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51022
1.98439553327646e-70	0.332045019995692	0.577	0.541	3.17086562262245e-66	STMP1	Malignant cells	GSE164897_VemTra	ENSG00000243317	647087	short transmembrane mitochondrial protein 1	C7orf73|Mm47|PL-5283	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51023
6.96414181036922e-70	0.303063463010609	0.292	0.186	1.1128002198789e-65	TUBA1A	Malignant cells	GSE164897_VemTra	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51024
2.92678672646706e-69	0.298757953568195	0.366	0.265	4.67671251022172e-65	MORF4L2	Malignant cells	GSE164897_VemTra	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51025
7.13656536500873e-69	0.250900884734575	0.292	0.186	1.14035177967474e-64	DDX3X	Malignant cells	GSE164897_VemTra	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51026
8.22197871979594e-68	0.269829191709341	0.828	0.843	1.31378997963619e-63	NDUFB9	Malignant cells	GSE164897_VemTra	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51027
1.44322302937676e-67	-0.272679761991157	0.325	0.462	2.30612607864112e-63	S100A4	Malignant cells	GSE164897_VemTra	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51028
8.3756019346524e-67	0.305553118559567	0.452	0.37	1.33833743313811e-62	SUPT4H1	Malignant cells	GSE164897_VemTra	ENSG00000213246	6827	SPT4 homolog, DSIF elongation factor subunit	Spt4|SPT4H|Supt4a|SUPT4H	protein_coding	P63272	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51029
3.04233006739169e-64	0.32934710027112	0.515	0.458	4.86133921468517e-60	DBI	Malignant cells	GSE164897_VemTra	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51030
8.47045235254386e-64	0.262081086406835	0.338	0.238	1.35349358141298e-59	KHDRBS1	Malignant cells	GSE164897_VemTra	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51031
1.55072918120494e-63	0.30232878099601	0.448	0.362	2.47791015864737e-59	DCBLD2	Malignant cells	GSE164897_VemTra	ENSG00000057019	131566	discoidin, CUB and LCCL domain containing 2	CLCP1|ESDN	protein_coding	Q96PD2	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51032
2.13966547536479e-61	0.272446065288716	0.73	0.755	3.4189714630854e-57	SEC11A	Malignant cells	GSE164897_VemTra	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51033
4.65299070957654e-61	0.25546399598466	0.331	0.233	7.43501385483235e-57	CDC26	Malignant cells	GSE164897_VemTra	ENSG00000176386	246184	cell division cycle 26	ANAPC12|APC12|C9orf17	protein_coding	Q8NHZ8	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51034
9.72889303873806e-60	0.295054721062797	0.362	0.272	1.55457981865995e-55	ZFP36L1	Malignant cells	GSE164897_VemTra	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51035
2.50551074409487e-59	0.29703085944385	0.447	0.375	4.0035556179892e-55	CSDE1	Malignant cells	GSE164897_VemTra	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51036
1.77866707291629e-58	0.284230984926874	0.434	0.357	2.84213211581294e-54	RAC1	Malignant cells	GSE164897_VemTra	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51037
4.00662310991118e-57	0.293901545990212	0.347	0.258	6.40218306732708e-53	HNRNPH1	Malignant cells	GSE164897_VemTra	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51038
4.52361577327538e-56	0.28009699390456	0.69	0.699	7.22828564411672e-52	LSM5	Malignant cells	GSE164897_VemTra	ENSG00000106355	23658	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated	YER146W	protein_coding	Q9Y4Y9	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51039
7.2747368590937e-55	0.271766899617254	0.366	0.281	1.16243020271458e-50	TMEM126A	Malignant cells	GSE164897_VemTra	ENSG00000171202	84233	transmembrane protein 126A	DKFZp586C1924|OPA7	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51040
7.19092358955548e-53	0.281618652627985	0.34	0.255	1.14903768037507e-48	LAPTM4A	Malignant cells	GSE164897_VemTra	ENSG00000068697	9741	lysosomal protein transmembrane 4 alpha	HUMORF13|KIAA0108|LAPTM4|MBNT|Mtrp	protein_coding	Q15012	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51041
1.54863225350734e-52	0.250331934183765	0.337	0.251	2.47455947787938e-48	MAGEA3	Malignant cells	GSE164897_VemTra	ENSG00000221867	4102	MAGE family member A3	CT1.3|HIP8|HYPD|MAGE3|MGC14613	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51042
6.73430973017526e-49	0.259415097988618	0.987	0.986	1.0760753517847e-44	TXN	Malignant cells	GSE164897_VemTra	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51043
1.1331048678965e-48	-0.705601998060313	0.796	0.7	1.81058826841181e-44	CD74	Malignant cells	GSE164897_VemTra	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51044
5.68200042287409e-47	0.274433564480606	0.415	0.348	9.0792684757105e-43	TCEAL4	Malignant cells	GSE164897_VemTra	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51045
8.50476042528098e-45	0.282366402966668	0.532	0.502	1.35897566835565e-40	SDHC	Malignant cells	GSE164897_VemTra	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51046
3.57190451208545e-43	0.260742953409728	0.672	0.695	5.70754621986134e-39	ATP5MC3	Malignant cells	GSE164897_VemTra	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51047
3.33861397273435e-40	0.262816074465399	0.487	0.448	5.33477126703221e-36	EIF3A	Malignant cells	GSE164897_VemTra	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51048
2.41546835371417e-37	0.253956174397137	0.609	0.612	3.85967688239988e-33	PGK1	Malignant cells	GSE164897_VemTra	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51049
2.1205996146287e-35	0.262082997847285	0.465	0.434	3.3885061242152e-31	UBE2L3	Malignant cells	GSE164897_VemTra	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51050
2.14010389072864e-30	0.256679046974551	0.639	0.681	3.41967200699529e-26	SOD1	Malignant cells	GSE164897_VemTra	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51051
2.63039538533734e-24	0.256696871833203	0.365	0.327	4.20310878623053e-20	ARF4	Malignant cells	GSE164897_VemTra	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE164897_VemTra	GSE164897	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	NA	vemurafenib + trametinib	Homo sapiens	A375 cell line	Cell line	resistant 1, sensitive 1	2	15718	Public on Jan 16, 2021	34591417	This dataset has 1 cell line with a sensitive pre-treatment sample and a resistant post-treatment sample.	PRJNA692421	10x genomics	CellRanger	Melanoma	Targeted_therapy	51052
0	-1.07657057324201	0.362	0.859	0	HES4	Malignant cells	GSE168668	ENSG00000188290	57801	hes family bHLH transcription factor 4	bHLHb42	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51053
0	-0.751707603886091	0.72	0.958	0	SLC25A33	Malignant cells	GSE168668	ENSG00000171612	84275	solute carrier family 25 member 33	BMSC-MCP|MGC4399|PNC1	protein_coding	Q9BSK2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51054
0	0.736316801651982	0.996	0.955	0	ATP5IF1	Malignant cells	GSE168668	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51055
0	1.25965248179942	0.997	0.914	0	MARCKSL1	Malignant cells	GSE168668	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51056
0	0.665713555609409	1	0.998	0	PRDX1	Malignant cells	GSE168668	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51057
0	-0.497361121087247	0.052	0.399	0	RAB3B	Malignant cells	GSE168668	ENSG00000169213	5865	RAB3B, member RAS oncogene family	NA	protein_coding	P20337	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51058
0	-0.821055109810835	0	0.461	0	PTGFR	Malignant cells	GSE168668	ENSG00000122420	5737	prostaglandin F receptor	FP	protein_coding	P43088	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51059
0	0.84484662908068	0.999	0.973	0	GNG5	Malignant cells	GSE168668	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51060
0	1.32283709287626	0.938	0.628	0	SELENBP1	Malignant cells	GSE168668	ENSG00000143416	8991	selenium binding protein 1	hSBP|hSP56|LPSB	protein_coding	Q13228	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51061
0	-1.04552359575011	0.379	0.813	0	UAP1	Malignant cells	GSE168668	ENSG00000117143	6675	UDP-N-acetylglucosamine pyrophosphorylase 1	AgX|AGX1|SPAG2	protein_coding	Q16222	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51062
0	-1.16226567716802	0.952	0.997	0	MPC2	Malignant cells	GSE168668	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51063
0	1.40794204971329	0.988	0.74	0	ATP1B1	Malignant cells	GSE168668	ENSG00000143153	481	ATPase Na+/K+ transporting subunit beta 1	ATP1B	protein_coding	P05026	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51064
0	0.777904832757016	0.925	0.716	0	CACYBP	Malignant cells	GSE168668	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51065
0	0.839516731482822	0.931	0.746	0	ARPC5	Malignant cells	GSE168668	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51066
0	-0.707017494624835	0.008	0.451	0	SLC45A3	Malignant cells	GSE168668	ENSG00000158715	85414	solute carrier family 45 member 3	IPCA-2|IPCA-6|IPCA-8|PCANAP2|PCANAP6|PCANAP8|prostein	protein_coding	Q96JT2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51067
0	1.25999614995605	0.927	0.588	0	AIDA	Malignant cells	GSE168668	ENSG00000186063	64853	axin interactor, dorsalization associated	C1orf80|FLJ12806	protein_coding	Q96BJ3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51068
0	-1.51965457355952	0.389	0.887	0	DEGS1	Malignant cells	GSE168668	ENSG00000143753	8560	delta 4-desaturase, sphingolipid 1	DEGS-1|Des-1|DES1|FADS7|MLD	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51069
0	1.85300702193105	0.957	0.384	0	EPHX1	Malignant cells	GSE168668	ENSG00000143819	2052	epoxide hydrolase 1	EPHX	protein_coding	P07099	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51070
0	0.804935530479267	1	1	0	H3F3A	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51071
0	0.649347887951943	0.996	0.974	0	GUK1	Malignant cells	GSE168668	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51072
0	-0.640568149890818	0.053	0.502	0	SCCPDH	Malignant cells	GSE168668	ENSG00000143653	51097	saccharopine dehydrogenase (putative)	CGI-49|NET11	protein_coding	Q8NBX0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51073
0	-0.692188655193491	0.164	0.547	0	MBOAT2	Malignant cells	GSE168668	ENSG00000143797	129642	membrane bound O-acyltransferase domain containing 2	FLJ14415|FLJ90298|LPLAT13|OACT2	protein_coding	Q6ZWT7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51074
0	1.04770124414751	0.965	0.854	0	TMSB10	Malignant cells	GSE168668	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51075
0	0.660778628346397	0.997	0.974	0	DBI	Malignant cells	GSE168668	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51076
0	-0.748620570582947	0.074	0.526	0	SCHLAP1	Malignant cells	GSE168668	ENSG00000281131	101669767	SWI/SNF complex antagonist associated with prostate cancer 1	LINC00913|PCAT11	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51077
0	-1.05326974183247	0.003	0.63	0	TFPI	Malignant cells	GSE168668	ENSG00000003436	7035	tissue factor pathway inhibitor	EPI|LACI|TFI|TFPI1	protein_coding	P10646	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51078
0	-1.74637178796887	0.002	0.775	0	GULP1	Malignant cells	GSE168668	ENSG00000144366	51454	GULP PTB domain containing engulfment adaptor 1	CED-6|CED6|GULP	protein_coding	Q9UBP9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51079
0	0.623691927436143	1	0.998	0	HSPD1	Malignant cells	GSE168668	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51080
0	0.571902956403662	1	0.997	0	HSPE1	Malignant cells	GSE168668	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51081
0	0.998535732114638	0.896	0.552	0	BZW1	Malignant cells	GSE168668	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51082
0	-0.384379256784167	1	1	0	RPL37A	Malignant cells	GSE168668	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51083
0	-0.451710051939056	1	1	0	RPL32	Malignant cells	GSE168668	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51084
0	1.50062184735241	0.893	0.358	0	ATG3	Malignant cells	GSE168668	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51085
0	-0.913584408440802	0.179	0.664	0	ARHGEF26	Malignant cells	GSE168668	ENSG00000277101	26084	Rho guanine nucleotide exchange factor 26	DKFZP434D146|SGEF	protein_coding	Q96DR7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51086
0	-1.09190130823715	0.861	0.991	0	LIMCH1	Malignant cells	GSE168668	ENSG00000064042	22998	LIM and calponin homology domains 1	DKFZP686A01247|LIMCH1A|LMO7B	protein_coding	Q9UPQ0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51087
0	-0.672519955443024	0.056	0.386	0	SLC4A4	Malignant cells	GSE168668	ENSG00000080493	8671	solute carrier family 4 member 4	hhNMC|HNBC1|NBC1|NBC2|pNBC|SLC4A5	protein_coding	Q9Y6R1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51088
0	-0.800130269300369	0.956	0.994	0	PPP3CA	Malignant cells	GSE168668	ENSG00000138814	5530	protein phosphatase 3 catalytic subunit alpha	CALN|CALNA|CNA1|PPP2B	protein_coding	Q08209	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51089
0	-0.482741516444019	1	1	0	RPL34	Malignant cells	GSE168668	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51090
0	-1.08479347347112	0.429	0.81	0	SLC7A11	Malignant cells	GSE168668	ENSG00000151012	23657	solute carrier family 7 member 11	xCT	protein_coding	Q9UPY5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51091
0	-0.393367074190144	1	1	0	RPS3A	Malignant cells	GSE168668	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51092
0	-0.642450338513399	0.035	0.472	0	AADAT	Malignant cells	GSE168668	ENSG00000109576	51166	aminoadipate aminotransferase	KAT2|KATII|KYAT2	protein_coding	Q8N5Z0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51093
0	-0.580013614085544	0.038	0.443	0	GALNT7	Malignant cells	GSE168668	ENSG00000109586	51809	polypeptide N-acetylgalactosaminyltransferase 7	GALNAC-T7	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51094
0	-0.663598175101137	0.189	0.602	0	ANKH	Malignant cells	GSE168668	ENSG00000154122	56172	ANKH inorganic pyrophosphate transport regulator	ANK|CCAL2|CMDJ|CPPDD|HANK|SLC62A1	protein_coding	Q9HCJ1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51095
0	-0.377556439869546	1	1	0	RPL37	Malignant cells	GSE168668	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51096
0	-1.02500360539372	0.883	0.986	0	BDP1	Malignant cells	GSE168668	ENSG00000274803	55814	B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB	HSA238520|KIAA1241|KIAA1689|TAF3B1|TFC5|TFIIIB150|TFIIIB90|TFNR	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51097
0	-0.555186849047719	0.054	0.421	0	IQGAP2	Malignant cells	GSE168668	ENSG00000145703	10788	IQ motif containing GTPase activating protein 2	NA	protein_coding	Q13576	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51098
0	-0.333642781903333	1	1	0	RPS23	Malignant cells	GSE168668	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51099
0	-0.795162947380713	0.077	0.471	0	KCNN2	Malignant cells	GSE168668	ENSG00000080709	3781	potassium calcium-activated channel subfamily N member 2	hSK2|KCa2.2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51100
0	-0.696597528464881	0	0.485	0	ADRB2	Malignant cells	GSE168668	ENSG00000169252	154	adrenoceptor beta 2	ADRB2R|ADRBR|B2AR|BAR	protein_coding	P07550	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51101
0	1.47342193297987	0.986	0.667	0	SQSTM1	Malignant cells	GSE168668	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51102
0	-1.12694622165321	0.529	0.853	0	HIST1H1C	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51103
0	0.962908217724777	1	0.997	0	HSP90AB1	Malignant cells	GSE168668	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51104
0	0.331383504058239	1	1	0	EEF1A1	Malignant cells	GSE168668	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51105
0	-1.20676976641884	0.814	0.997	0	MYO6	Malignant cells	GSE168668	ENSG00000196586	4646	myosin VI	DFNA22|DFNB37|KIAA0389	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51106
0	1.17800257398569	0.998	0.902	0	GTF3C6	Malignant cells	GSE168668	ENSG00000155115	112495	general transcription factor IIIC subunit 6	bA397G5.3|C6orf51|TFIIIC35	protein_coding	Q969F1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51107
0	-1.00965373065037	0.944	0.992	0	HEBP2	Malignant cells	GSE168668	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51108
0	-0.709739433856262	0.002	0.413	0	ADGRG6	Malignant cells	GSE168668	ENSG00000112414	57211	adhesion G protein-coupled receptor G6	FLJ14937|GPR126	protein_coding	Q86SQ4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51109
0	0.707684660940534	0.95	0.823	0	SF3B5	Malignant cells	GSE168668	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51110
0	-0.868085784765206	0.366	0.771	0	UTRN	Malignant cells	GSE168668	ENSG00000152818	7402	utrophin	DMDL|DRP|DRP1	protein_coding	P46939	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51111
0	-0.909920906933931	0	0.493	0	SLC22A3	Malignant cells	GSE168668	ENSG00000146477	6581	solute carrier family 22 member 3	EMT|OCT3	protein_coding	O75751	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51112
0	-1.26515183742759	0	0.627	0	ETV1	Malignant cells	GSE168668	ENSG00000006468	2115	ETS variant transcription factor 1	ER81	protein_coding	P50549	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51113
0	0.927750716607722	0.956	0.765	0	TAX1BP1	Malignant cells	GSE168668	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51114
0	-0.863383511435838	0.896	0.987	0	GGCT	Malignant cells	GSE168668	ENSG00000006625	79017	gamma-glutamylcyclotransferase	C7orf24|CRF21|GCTG|Ggc|MGC3077	protein_coding	O75223	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51115
0	0.524391843257191	1	1	0	PPIA	Malignant cells	GSE168668	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51116
0	-0.930168807859362	0.549	0.926	0	STEAP1	Malignant cells	GSE168668	ENSG00000164647	26872	STEAP family member 1	PRSS24|STEAP	protein_coding	Q9UHE8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51117
0	-1.22759397936942	0.545	0.95	0	STEAP2	Malignant cells	GSE168668	ENSG00000157214	261729	STEAP2 metalloreductase	IPCA-1|PCANAP1|STAMP1|STMP	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51118
0	-0.383059016459029	0.026	0.273	0	CFAP69	Malignant cells	GSE168668	ENSG00000105792	79846	cilia and flagella associated protein 69	C7orf63|FAP69|FLJ21062	protein_coding	A5D8W1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51119
0	0.906540065328817	0.929	0.655	0	AP1S1	Malignant cells	GSE168668	ENSG00000106367	1174	adaptor related protein complex 1 subunit sigma 1	AP19|CLAPS1|EKV3|SIGMA1A|WUGSC:H_DJ0747G18.2	protein_coding	P61966	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51120
0	-0.810027615614338	0.271	0.706	0	ARHGAP6	Malignant cells	GSE168668	ENSG00000047648	395	Rho GTPase activating protein 6	rhoGAPX-1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51121
0	1.51056400163365	0.814	0.168	0	TMSB4X	Malignant cells	GSE168668	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51122
0	-1.70416901628537	0.496	0.975	0	SAT1	Malignant cells	GSE168668	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51123
0	-1.03702922484545	0.233	0.747	0	MAOA	Malignant cells	GSE168668	ENSG00000189221	4128	monoamine oxidase A	NA	protein_coding	P21397	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51124
0	1.69734218177989	0.652	0.14	0	PAGE1	Malignant cells	GSE168668	ENSG00000068985	8712	PAGE family member 1	CT16.3|GAGE-9|GAGEB1|PAGE-1	protein_coding	O75459	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51125
0	-0.367522263600652	1	1	0	RPL39	Malignant cells	GSE168668	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51126
0	-0.867436039541023	0.524	0.87	0	SLC25A37	Malignant cells	GSE168668	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51127
0	-1.40621308087342	0.334	0.818	0	NKX3-1	Malignant cells	GSE168668	ENSG00000167034	4824	NK3 homeobox 1	BAPX2|NKX3.1|NKX3A	protein_coding	Q99801	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51128
0	-0.706221776917672	0.062	0.495	0	DUSP4	Malignant cells	GSE168668	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51129
0	-0.897545424194609	0.848	0.984	0	EIF4EBP1	Malignant cells	GSE168668	ENSG00000187840	1978	eukaryotic translation initiation factor 4E binding protein 1	4E-BP1|PHAS-I	protein_coding	Q13541	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51130
0	-0.553045614965676	0.035	0.435	0	CEBPD	Malignant cells	GSE168668	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51131
0	-0.550709479979834	0.126	0.49	0	ZBTB10	Malignant cells	GSE168668	ENSG00000205189	65986	zinc finger and BTB domain containing 10	FLJ12752|RINZF	protein_coding	Q96DT7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51132
0	-0.839683004653185	0.117	0.634	0	NFIB	Malignant cells	GSE168668	ENSG00000147862	4781	nuclear factor I B	NFI-RED|NFIB2|NFIB3	protein_coding	O00712	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51133
0	-0.350522848821939	1	1	0	RPS6	Malignant cells	GSE168668	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51134
0	-0.354185814444062	1	1	0	RPL35	Malignant cells	GSE168668	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51135
0	-0.406655713740523	1	1	0	RPL7A	Malignant cells	GSE168668	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51136
0	-0.510343035671092	0.049	0.416	0	IFITM2	Malignant cells	GSE168668	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51137
0	-0.745043910813671	1	1	0	RPLP2	Malignant cells	GSE168668	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51138
0	-0.600645300702428	0.961	0.997	0	EIF3F	Malignant cells	GSE168668	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51139
0	-0.499052229516688	1	1	0	RPL27A	Malignant cells	GSE168668	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51140
0	-0.678958173918277	1	1	0	RPS13	Malignant cells	GSE168668	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51141
0	-1.15307185936509	0.597	0.961	0	EHF	Malignant cells	GSE168668	ENSG00000135373	26298	ETS homologous factor	ESE3|ESEJ	protein_coding	Q9NZC4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51142
0	-0.526468720759648	0.064	0.427	0	SLC43A1	Malignant cells	GSE168668	ENSG00000149150	8501	solute carrier family 43 member 1	PB39|POV1|R00504	protein_coding	O75387	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51143
0	-1.28496342905212	0.994	0.997	0	NEAT1	Malignant cells	GSE168668	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51144
0	-0.559608765853598	1	1	0	RPS3	Malignant cells	GSE168668	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51145
0	-0.876425028349548	0.262	0.685	0	ENDOD1	Malignant cells	GSE168668	ENSG00000149218	23052	endonuclease domain containing 1	KIAA0830	protein_coding	O94919	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51146
0	-0.744519577032179	0.072	0.478	0	COLCA1	Malignant cells	GSE168668	ENSG00000196167	399948	colorectal cancer associated 1	C11orf92|CASC12|FLJ45803	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51147
0	-0.80240488821391	0.002	0.518	0	ZBTB16	Malignant cells	GSE168668	ENSG00000109906	7704	zinc finger and BTB domain containing 16	PLZF|ZNF145	protein_coding	Q05516	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51148
0	-0.776674417712631	1	1	0	RPS25	Malignant cells	GSE168668	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51149
0	0.948848174281551	1	0.971	0	HSPA8	Malignant cells	GSE168668	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51150
0	-0.406971104818658	0.031	0.331	0	AP000842.3	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51151
0	1.4578940994639	0.554	0.051	0	VIM	Malignant cells	GSE168668	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51152
0	-0.665261556391888	0.036	0.437	0	GPR158	Malignant cells	GSE168668	ENSG00000151025	57512	G protein-coupled receptor 158	KIAA1136	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51153
0	1.49322973395196	0.846	0.293	0	BAMBI	Malignant cells	GSE168668	ENSG00000095739	25805	BMP and activin membrane bound inhibitor	NMA	protein_coding	Q13145	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51154
0	-0.736768541722323	0.034	0.52	0	KCNMA1	Malignant cells	GSE168668	ENSG00000156113	3778	potassium calcium-activated channel subfamily M alpha 1	KCa1.1|mSLO1|SLO	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51155
0	-0.448063077781939	1	1	0	RPS24	Malignant cells	GSE168668	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51156
0	-0.607335558149336	0.005	0.423	0	FAM213A	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51157
0	-0.58740469031139	0.049	0.472	0	FUOM	Malignant cells	GSE168668	ENSG00000148803	282969	fucose mutarotase	C10orf125|FLJ26016|FucM|FucU	protein_coding	A2VDF0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51158
0	0.771820772697482	0.912	0.711	0	FKBP4	Malignant cells	GSE168668	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51159
0	0.648890896061971	0.997	0.966	0	CD9	Malignant cells	GSE168668	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51160
0	0.728794116514931	1	1	0	GAPDH	Malignant cells	GSE168668	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51161
0	0.704011609458187	1	0.994	0	TPI1	Malignant cells	GSE168668	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51162
0	-2.71294486179911	0	0.909	0	H2AFJ	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51163
0	1.27839730003662	0.999	0.895	0	LDHB	Malignant cells	GSE168668	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51164
0	0.750226620601476	1	0.975	0	KRT18	Malignant cells	GSE168668	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51165
0	1.15354288384924	1	0.974	0	MYL6	Malignant cells	GSE168668	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51166
0	0.665756620667454	1	0.994	0	ATP5F1B	Malignant cells	GSE168668	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51167
0	0.322081255204812	1	1	0	NACA	Malignant cells	GSE168668	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51168
0	-1.0799275936581	0.167	0.738	0	RASSF3	Malignant cells	GSE168668	ENSG00000153179	283349	Ras association domain family member 3	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51169
0	0.796405967576217	0.968	0.824	0	CCT2	Malignant cells	GSE168668	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51170
0	-0.773583932297452	0.999	0.999	0	NAP1L1	Malignant cells	GSE168668	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51171
0	1.18145022112446	0.72	0.333	0	ATP2B1	Malignant cells	GSE168668	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51172
0	-2.45381734618784	0.517	0.95	0	BTG1	Malignant cells	GSE168668	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51173
0	1.03177689664208	0.896	0.565	0	ARL1	Malignant cells	GSE168668	ENSG00000120805	400	ADP ribosylation factor like GTPase 1	ARFL1	protein_coding	P40616	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51174
0	1.89274911348272	0.985	0.715	0	CHPT1	Malignant cells	GSE168668	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51175
0	0.923117814050905	0.998	0.976	0	HSP90B1	Malignant cells	GSE168668	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51176
0	-1.02464810171281	0.83	0.978	0	TXNRD1	Malignant cells	GSE168668	ENSG00000198431	7296	thioredoxin reductase 1	GRIM-12|Trxr1|TXNR	protein_coding	Q16881	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51177
0	-0.369680405312334	0	0.263	0	ADGRD1-AS1	Malignant cells	GSE168668	ENSG00000256151	NA	NA	LACAT8	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51178
0	0.761335924670254	0.98	0.849	0	SAP18	Malignant cells	GSE168668	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51179
0	0.942952220727184	0.986	0.818	0	POMP	Malignant cells	GSE168668	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51180
0	-0.591237720599205	0.044	0.421	0	DGKH	Malignant cells	GSE168668	ENSG00000102780	160851	diacylglycerol kinase eta	DGKeta	protein_coding	Q86XP1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51181
0	-0.450568352148673	1	1	0	TPT1	Malignant cells	GSE168668	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51182
0	-1.11508737876525	0.337	0.799	0	MYCBP2	Malignant cells	GSE168668	ENSG00000005810	23077	MYC binding protein 2	FLJ10106|KIAA0916|PAM|PHR1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51183
0	-0.736863310748997	0.049	0.512	0	ABCC4	Malignant cells	GSE168668	ENSG00000125257	10257	ATP binding cassette subfamily C member 4	EST170205|MOAT-B|MOATB|MRP4	protein_coding	O15439	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51184
0	-0.389948557398142	1	1	0	RPS29	Malignant cells	GSE168668	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51185
0	0.827067752065749	0.997	0.936	0	CALM1	Malignant cells	GSE168668	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51186
0	1.58191597852387	1	0.99	0	HSP90AA1	Malignant cells	GSE168668	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51187
0	-0.77716892097392	0.486	0.864	0	TJP1	Malignant cells	GSE168668	ENSG00000277401	7082	tight junction protein 1	DKFZp686M05161|MGC133289|ZO-1	protein_coding	Q07157	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51188
0	-0.950232730238302	0.65	0.953	0	SORD	Malignant cells	GSE168668	ENSG00000140263	6652	sorbitol dehydrogenase	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51189
0	-0.830910274793851	0.429	0.818	0	MAPK6	Malignant cells	GSE168668	ENSG00000069956	5597	mitogen-activated protein kinase 6	ERK3|HsT17250|p97MAPK|PRKM6	protein_coding	Q16659	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51190
0	-0.613738582623713	0.165	0.544	0	FAM214A	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51191
0	-0.368663718566778	0.021	0.29	0	WDR72	Malignant cells	GSE168668	ENSG00000166415	256764	WD repeat domain 72	FLJ38736	protein_coding	Q3MJ13	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51192
0	-0.686393478018659	0.824	0.976	0	RSL24D1	Malignant cells	GSE168668	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51193
0	-0.401861056818984	1	1	0	RPL4	Malignant cells	GSE168668	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51194
0	-0.79407640434351	0.593	0.901	0	TMED3	Malignant cells	GSE168668	ENSG00000166557	23423	transmembrane p24 trafficking protein 3	C15orf22|p24B|p24g4|p24gamma4	protein_coding	Q9Y3Q3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51195
0	-0.730624248234852	0.098	0.594	0	HOMER2	Malignant cells	GSE168668	ENSG00000103942	9455	homer scaffold protein 2	CPD|Cupidin|DFNA68|HOMER-2|HOMER-2A|HOMER-2B|Vesl-2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51196
0	-0.498057964853772	0.122	0.478	0	HDGFL3	Malignant cells	GSE168668	ENSG00000166503	50810	HDGF like 3	Hdgfrp3|HRP-3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51197
0	-0.713220322172319	0.844	0.991	0	SEC11A	Malignant cells	GSE168668	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51198
0	-1.1408222094857	0.476	0.95	0	ABHD2	Malignant cells	GSE168668	ENSG00000140526	11057	abhydrolase domain containing 2, acylglycerol lipase	LABH2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51199
0	-0.405709276875102	0.021	0.315	0	ALDH1A3	Malignant cells	GSE168668	ENSG00000184254	220	aldehyde dehydrogenase 1 family member A3	ALDH6|RALDH3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51200
0	-0.899654761802877	0.188	0.602	0	NUP93	Malignant cells	GSE168668	ENSG00000102900	9688	nucleoporin 93	KIAA0095	protein_coding	Q8N1F7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51201
0	0.362096809552047	1	1	0	RPL13	Malignant cells	GSE168668	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51202
0	-0.5245952615358	1	1	0	RPL23A	Malignant cells	GSE168668	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51203
0	-1.75594514869708	0.578	0.996	0	PRAC1	Malignant cells	GSE168668	ENSG00000159182	84366	PRAC1 small nuclear protein	C17orf92|PRAC	protein_coding	Q96KF2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51204
0	1.71908838673197	0.982	0.494	0	SNHG25	Malignant cells	GSE168668	ENSG00000266402	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51205
0	1.01278078195253	0.857	0.472	0	SLC9A3R1	Malignant cells	GSE168668	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51206
0	-0.816444830152524	0.094	0.544	0	DSC2	Malignant cells	GSE168668	ENSG00000134755	1824	desmocollin 2	CDHF2|DSC3	protein_coding	Q02487	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51207
0	-0.70588549057481	0.234	0.651	0	NEDD4L	Malignant cells	GSE168668	ENSG00000049759	23327	NEDD4 like E3 ubiquitin protein ligase	KIAA0439|NEDD4-2|RSP5	protein_coding	Q96PU5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51208
0	-1.27907350363003	0.2	0.631	0	DSEL	Malignant cells	GSE168668	ENSG00000262102	92126	dermatan sulfate epimerase like	C18orf4|DE-epi2|FLJ11477|NCAG1	protein_coding	Q8IZU8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51209
0	-0.540898694188198	0.003	0.386	0	MAP1LC3A	Malignant cells	GSE168668	ENSG00000101460	84557	microtubule associated protein 1 light chain 3 alpha	ATG8E|LC3|LC3A|MAP1ALC3|MAP1BLC3	protein_coding	Q9H492	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51210
0	-1.11575739425086	0.976	1	0	ZFAS1	Malignant cells	GSE168668	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51211
0	-0.416783270723919	1	1	0	RPS21	Malignant cells	GSE168668	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51212
0	0.776575170790307	1	0.994	0	GPX4	Malignant cells	GSE168668	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51213
0	-0.576943071233715	1	1	0	RPS28	Malignant cells	GSE168668	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51214
0	0.879840630587363	0.926	0.642	0	HNRNPM	Malignant cells	GSE168668	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51215
0	-0.768863563783587	0.503	0.926	0	TMEM205	Malignant cells	GSE168668	ENSG00000105518	374882	transmembrane protein 205	MBC3205|UNQ501	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51216
0	0.587117494611012	1	0.997	0	PRDX2	Malignant cells	GSE168668	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51217
0	0.967842449222482	0.995	0.959	0	CALR	Malignant cells	GSE168668	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51218
0	-0.382736892949411	1	1	0	RPL18A	Malignant cells	GSE168668	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51219
0	-3.54420008986851	0.819	0.996	0	GDF15	Malignant cells	GSE168668	ENSG00000130513	9518	growth differentiation factor 15	MIC-1|MIC1|NAG-1|PDF|PLAB|PTGFB	protein_coding	Q99988	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51220
0	-0.561468850836542	1	1	0	RPS16	Malignant cells	GSE168668	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51221
0	-0.301104137431642	1	1	0	RPL18	Malignant cells	GSE168668	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51222
0	-0.95524859184596	0.115	0.628	0	TRPM4	Malignant cells	GSE168668	ENSG00000130529	54795	transient receptor potential cation channel subfamily M member 4	FLJ20041	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51223
0	-0.316355512894566	1	1	0	RPS11	Malignant cells	GSE168668	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51224
0	-1.52392474452904	0.684	0.978	0	C19orf48	Malignant cells	GSE168668	ENSG00000167747	84798	multidrug resistance-related protein	BC006151|MGC13170	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51225
0	-3.4898971239682	0.076	0.633	0	KLK3	Malignant cells	GSE168668	ENSG00000142515	354	kallikrein related peptidase 3	APS|PSA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51226
0	-2.4950939700074	0.081	0.76	0	KLK2	Malignant cells	GSE168668	ENSG00000167751	3817	kallikrein related peptidase 2	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51227
0	-1.2643406962867	0.204	0.743	0	KLK4	Malignant cells	GSE168668	ENSG00000167749	9622	kallikrein related peptidase 4	EMSP|EMSP1|KLK-L1|PRSS17|PSTS	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51228
0	-0.748772031976238	0.038	0.569	0	ZNF677	Malignant cells	GSE168668	ENSG00000197928	342926	zinc finger protein 677	MGC48625	protein_coding	Q86XU0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51229
0	-2.62600711135145	0.033	0.636	0	PEG3	Malignant cells	GSE168668	ENSG00000198300	5178	paternally expressed 3	KIAA0287|ZKSCAN22|ZNF904|ZSCAN24	protein_coding	Q9GZU2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51230
0	0.965529873169987	0.932	0.71	0	XBP1	Malignant cells	GSE168668	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51231
0	-1.17079342281934	0.106	0.449	0	HMOX1	Malignant cells	GSE168668	ENSG00000100292	3162	heme oxygenase 1	bK286B10|HO-1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51232
0	-0.671657875039366	0.216	0.619	0	PRR34-AS1	Malignant cells	GSE168668	ENSG00000241990	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51233
0	-1.45040510124497	0.448	0.936	0	NCAM2	Malignant cells	GSE168668	ENSG00000154654	4685	neural cell adhesion molecule 2	MGC51008|NCAM21	protein_coding	O15394	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51234
0	0.680674328335955	0.999	0.982	0	ATP5PF	Malignant cells	GSE168668	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51235
0	1.0212223812797	0.999	0.956	0	SOD1	Malignant cells	GSE168668	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51236
0	0.687057063581621	0.998	0.98	0	HMGN1	Malignant cells	GSE168668	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51237
0	-1.2474126194364	0.141	0.647	0	TMPRSS2	Malignant cells	GSE168668	ENSG00000184012	7113	transmembrane serine protease 2	PRSS10	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51238
0	1.15506758384336	0.99	0.803	0	CSTB	Malignant cells	GSE168668	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51239
0	0.417621743423214	1	1	0	MT-CO2	Malignant cells	GSE168668	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51240
4.19795850927905e-306	-0.380185450519902	0.04	0.3	7.75908671270047e-302	GNB4	Malignant cells	GSE168668	ENSG00000114450	59345	G protein subunit beta 4	NA	protein_coding	Q9HAV0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51241
1.14028785014181e-303	0.836824354726755	0.649	0.218	2.1075940334171e-299	KLHL35	Malignant cells	GSE168668	ENSG00000149243	283212	kelch like family member 35	FLJ33790	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51242
2.91163222965311e-301	-0.354673840290374	1	1	5.38156985006785e-297	RPS19	Malignant cells	GSE168668	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51243
1.63578213752974e-299	-0.75472672844859	1	1	3.02341612479621e-295	MALAT1	Malignant cells	GSE168668	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51244
5.37117756046476e-298	-0.767711286501276	0.674	0.924	9.92754748500702e-294	ARFGEF3	Malignant cells	GSE168668	ENSG00000112379	57221	ARFGEF family member 3	BIG3|C6orf92|dJ171N11.1|KIAA1244|PPP1R33	protein_coding	Q5TH69	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51245
7.99546251278395e-297	0.609535556157363	0.995	0.967	1.47780133623786e-292	CD63	Malignant cells	GSE168668	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51246
3.94685663776323e-296	0.481650215327615	1	0.995	7.29497512357778e-292	NDUFS5	Malignant cells	GSE168668	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51247
9.41912077503201e-296	-0.391125559463695	0.065	0.357	1.74093609284917e-291	CORO2A	Malignant cells	GSE168668	ENSG00000106789	7464	coronin 2A	IR10|WDR2	protein_coding	Q92828	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51248
5.44507970498957e-295	0.774625357798585	0.848	0.555	1.00641408187322e-290	HMGN3	Malignant cells	GSE168668	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51249
8.57522958403068e-295	-0.369840453633953	1	1	1.58495968401639e-290	RPL22	Malignant cells	GSE168668	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51250
3.6687957272596e-294	0.631741445990063	0.982	0.913	6.78103514269392e-290	AKR1A1	Malignant cells	GSE168668	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51251
2.12665254201887e-293	1.32726431751556	0.812	0.545	3.93069189341347e-289	EIF1B	Malignant cells	GSE168668	ENSG00000114784	10289	eukaryotic translation initiation factor 1B	GC20	protein_coding	O60739	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51252
3.80588395250814e-293	1.79558031594155	0.819	0.521	7.03441530942079e-289	LMO4	Malignant cells	GSE168668	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51253
2.76539805871488e-292	-0.740784572503382	0.612	0.913	5.11128523192272e-288	PRKACB	Malignant cells	GSE168668	ENSG00000142875	5567	protein kinase cAMP-activated catalytic subunit beta	PKACb	protein_coding	P22694	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51254
4.08013435103308e-291	0.676672962177689	0.955	0.821	7.54131232101444e-287	CUTA	Malignant cells	GSE168668	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51255
1.05054190035625e-290	0.606851661470306	0.985	0.934	1.94171659442846e-286	ATP5PO	Malignant cells	GSE168668	ENSG00000241837	539	ATP synthase peripheral stalk subunit OSCP	ATP5O|ATPO|OSCP	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51256
1.3421485135668e-290	0.775621066863907	0.82	0.5	2.48069309762552e-286	MINOS1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51257
1.7853933671478e-290	-0.696043145519031	0.316	0.688	3.29994256049928e-286	RNF41	Malignant cells	GSE168668	ENSG00000181852	10193	ring finger protein 41	NRDP1|SBBI03	protein_coding	Q9H4P4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51258
9.3606589392457e-289	-0.321726044272765	1	1	1.73013059174078e-284	RPSA	Malignant cells	GSE168668	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51259
3.30122791507545e-287	1.88388545801811	0.655	0.346	6.10165955543396e-283	ASPH	Malignant cells	GSE168668	ENSG00000198363	444	aspartate beta-hydroxylase	BAH|CASQ2BP1|HAAH|JCTN	protein_coding	Q12797	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51260
1.46271847833119e-286	-0.542134476771163	0.094	0.402	2.70354256349953e-282	MMP16	Malignant cells	GSE168668	ENSG00000156103	4325	matrix metallopeptidase 16	C8orf57|DKFZp761D112|MT3-MMP	protein_coding	P51512	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51261
2.41142114042568e-285	-0.346875060788333	0.039	0.286	4.45702969384878e-281	FAM174B	Malignant cells	GSE168668	ENSG00000185442	400451	family with sequence similarity 174 member B	LOC400451|MGC102891	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51262
5.89792110524801e-285	-0.472674104904204	0.085	0.39	1.09011275788299e-280	SLPI	Malignant cells	GSE168668	ENSG00000124107	6590	secretory leukocyte peptidase inhibitor	ALK1|ALP|BLPI|HUSI|HUSI-I|WAP4|WFDC4	protein_coding	P03973	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51263
1.59405361823426e-282	-0.480720463227696	0.037	0.278	2.94628930258238e-278	RLN1	Malignant cells	GSE168668	ENSG00000107018	6013	relaxin 1	H1	protein_coding	P04808	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51264
2.09561315141767e-280	0.674893739816333	0.965	0.842	3.87332178776529e-276	TTC3	Malignant cells	GSE168668	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51265
5.99718176923808e-280	0.578698746261983	0.995	0.967	1.10845910640827e-275	SUB1	Malignant cells	GSE168668	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51266
1.69614245887012e-279	-0.283294952129446	1	1	3.13498010672963e-275	RPS5	Malignant cells	GSE168668	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51267
2.03001835693465e-279	-0.657749123989179	0.483	0.821	3.75208292912231e-275	ST8SIA6-AS1	Malignant cells	GSE168668	ENSG00000204832	100128098	ST8SIA6 antisense RNA 1	APAL	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51268
3.08989501817252e-278	0.709166572740286	0.996	0.826	5.71105296208826e-274	DYNLL1	Malignant cells	GSE168668	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51269
7.54675324152611e-277	-0.482657502493887	0.121	0.449	1.39486640163127e-272	GUCY1A1	Malignant cells	GSE168668	ENSG00000164116	2982	guanylate cyclase 1 soluble subunit alpha 1	GC-SA3|GUC1A3|GUCY1A3	protein_coding	Q02108	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51270
4.58990476330425e-276	1.8959864700094	0.446	0.032	8.48352097401524e-272	IGFBP5	Malignant cells	GSE168668	ENSG00000115461	3488	insulin like growth factor binding protein 5	NA	protein_coding	P24593	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51271
2.36718093373749e-275	1.04291986900758	0.439	0.022	4.375260519827e-271	TUBA1A	Malignant cells	GSE168668	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51272
3.00280520640377e-274	-0.669750496480645	0.49	0.814	5.55008486299608e-270	EIF2AK4	Malignant cells	GSE168668	ENSG00000128829	440275	eukaryotic translation initiation factor 2 alpha kinase 4	GCN2|KIAA1338	protein_coding	Q9P2K8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51273
2.29248931534158e-272	-0.295230489773116	1	1	4.23720800154584e-268	RPL26	Malignant cells	GSE168668	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51274
6.30944322630989e-271	-0.410632884636448	0.089	0.388	1.16617439151886e-266	CLDN12	Malignant cells	GSE168668	ENSG00000157224	9069	claudin 12	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51275
5.92876513807007e-268	-0.458564160701745	0.996	0.999	1.09581366046949e-263	ATP5MG	Malignant cells	GSE168668	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51276
2.91089091740072e-267	-0.293584708265266	1	1	5.38019968263176e-263	RPS27A	Malignant cells	GSE168668	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51277
5.3253724815034e-267	-0.452103360664233	0.086	0.378	9.84288595756274e-263	CNTLN	Malignant cells	GSE168668	ENSG00000044459	54875	centlein	bA340N12.1|C9orf101|C9orf39|FLJ20276|OTTHUMG00000019597	protein_coding	Q9NXG0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51278
3.75527189099116e-265	-0.490826144508026	0.128	0.454	6.94086903611896e-261	LPAR3	Malignant cells	GSE168668	ENSG00000171517	23566	lysophosphatidic acid receptor 3	Edg-7|EDG7|HOFNH30|LP-A3|LPA3|RP4-678I3	protein_coding	Q9UBY5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51279
7.03787150416393e-262	0.81064112227052	0.649	0.249	1.30080979011462e-257	ARHGAP29	Malignant cells	GSE168668	ENSG00000137962	9411	Rho GTPase activating protein 29	PARG1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51280
1.14960271358341e-261	-0.781196862551308	0.641	0.884	2.12481069551622e-257	PURA	Malignant cells	GSE168668	ENSG00000185129	5813	purine rich element binding protein A	PUR-ALPHA|PUR1|PURALPHA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51281
8.1176125834082e-260	-1.15076589734739	0.04	0.269	1.50037833379134e-255	S100P	Malignant cells	GSE168668	ENSG00000163993	6286	S100 calcium binding protein P	NA	protein_coding	P25815	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51282
1.70884139920369e-259	0.845913702877285	0.723	0.385	3.15845155814819e-255	BROX	Malignant cells	GSE168668	ENSG00000162819	148362	BRO1 domain and CAAX motif containing	C1orf58|FLJ32421	protein_coding	Q5VW32	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51283
2.32002155265503e-259	0.409249030688396	1	1	4.2880958357723e-255	PTMA	Malignant cells	GSE168668	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51284
1.40400998018797e-258	-0.587618595467581	0.204	0.556	2.59503164638143e-254	AL139246.5	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51285
5.78533796248136e-257	0.458402351625645	1	0.996	1.06930401560543e-252	COX7A2	Malignant cells	GSE168668	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51286
7.07819884691703e-255	0.863883123129106	0.423	0.028	1.30826349287567e-250	TOX3	Malignant cells	GSE168668	ENSG00000103460	27324	TOX high mobility group box family member 3	CAGF9|TNRC9	protein_coding	O15405	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51287
1.28667861661051e-254	0.667636261162406	0.974	0.889	2.3781680870812e-250	GSTM3	Malignant cells	GSE168668	ENSG00000134202	2947	glutathione S-transferase mu 3	GST5	protein_coding	P21266	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51288
3.34418410237105e-254	-0.67061954108846	0.528	0.845	6.18105547641241e-250	MESP1	Malignant cells	GSE168668	ENSG00000166823	55897	mesoderm posterior bHLH transcription factor 1	bHLHc5|MGC10676	protein_coding	Q9BRJ9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51289
2.55812974656226e-248	-0.337109219394254	0.042	0.271	4.72819121057103e-244	ZNF43	Malignant cells	GSE168668	ENSG00000279566	7594	zinc finger protein 43	HTF6|KOX27|ZNF39L1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51290
8.09583837395516e-248	0.744555141803414	0.518	0.118	1.49635380665813e-243	TMEM144	Malignant cells	GSE168668	ENSG00000164124	55314	transmembrane protein 144	FLJ11155	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51291
1.15038155512957e-247	-0.560016117756235	0.25	0.605	2.12625022834598e-243	MBP	Malignant cells	GSE168668	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51292
1.02754102749596e-244	-0.622999122875212	0.925	0.987	1.89920408112079e-240	EIF4A2	Malignant cells	GSE168668	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51293
5.92557833813305e-244	-0.607705096635906	0.324	0.667	1.09522464423713e-239	LINC00665	Malignant cells	GSE168668	ENSG00000232677	100506930	long intergenic non-protein coding RNA 665	CIP2A-BP	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51294
4.95552478751497e-243	-0.259575794940003	1	1	9.15929646476392e-239	RPL13A	Malignant cells	GSE168668	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51295
8.91708346161428e-243	0.729817107565517	0.382	0.007	1.64814453621017e-238	CCDC80	Malignant cells	GSE168668	ENSG00000091986	151887	coiled-coil domain containing 80	CL2|DRO1|LINC01279|SSG1|TCONS_00006930|URB	protein_coding	Q76M96	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51296
1.69511022903805e-242	-0.36140759002558	0.059	0.307	3.13307223633102e-238	ST3GAL4	Malignant cells	GSE168668	ENSG00000110080	6484	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	CGS23|FLJ11867|NANTA3|SAT3|SIAT4|SIAT4C|STZ	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51297
6.30760836699934e-242	0.679362530955058	0.872	0.666	1.16583525447249e-237	BCLAF1	Malignant cells	GSE168668	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51298
2.18517485961198e-241	-0.65105358631361	0.581	0.862	4.03885869302082e-237	CALM3	Malignant cells	GSE168668	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51299
5.31561441025272e-240	0.551255622030737	0.988	0.959	9.82485011447011e-236	PDCD5	Malignant cells	GSE168668	ENSG00000105185	9141	programmed cell death 5	MGC9294|TFAR19	protein_coding	O14737	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51300
1.49160603709046e-239	-0.352960663145814	0.072	0.335	2.7569354383543e-235	PDE9A	Malignant cells	GSE168668	ENSG00000160191	5152	phosphodiesterase 9A	NA	protein_coding	O76083	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51301
9.57227406278426e-237	-0.747861931651394	0.385	0.697	1.76924341502441e-232	TAOK3	Malignant cells	GSE168668	ENSG00000135090	51347	TAO kinase 3	DPK|JIK|MAP3K18	protein_coding	Q9H2K8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51302
1.9733731770161e-236	0.762344733456162	0.751	0.435	3.64738564307887e-232	ANK3	Malignant cells	GSE168668	ENSG00000151150	288	ankyrin 3	NA	protein_coding	Q12955	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51303
9.95358443665124e-236	-0.465341978454539	0.989	0.999	1.83972101142625e-231	UQCR10	Malignant cells	GSE168668	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51304
7.04774841136467e-235	-0.340612867828644	0.059	0.302	1.30263533887253e-230	TNFAIP8	Malignant cells	GSE168668	ENSG00000145779	25816	TNF alpha induced protein 8	GG2-1|MDC-3.13|SCC-S2	protein_coding	O95379	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51305
1.3118944018714e-234	0.75744404407896	0.974	0.76	2.42477442297891e-230	NQO1	Malignant cells	GSE168668	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51306
2.51158068153763e-234	-0.568853405299703	0.314	0.667	4.642154573686e-230	IFITM3	Malignant cells	GSE168668	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51307
9.61130902785237e-234	0.703399496515452	0.698	0.359	1.77645824761795e-229	MRPS6	Malignant cells	GSE168668	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51308
7.07030727531142e-233	-0.284385854027334	1	1	1.30680489369581e-228	RPLP1	Malignant cells	GSE168668	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51309
3.46253290454765e-232	-0.467409016793231	0.133	0.436	6.39979956747542e-228	JDP2	Malignant cells	GSE168668	ENSG00000140044	122953	Jun dimerization protein 2	JUNDM2	protein_coding	Q8WYK2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51310
4.30254465378478e-231	0.699652270144105	0.844	0.629	7.95239328359041e-227	PSME2	Malignant cells	GSE168668	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51311
4.73543606292181e-231	0.518500050419468	0.996	0.975	8.75250647509838e-227	CCT3	Malignant cells	GSE168668	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51312
6.87738103773901e-231	-0.344096120900656	0.076	0.337	1.2711463372053e-226	HLA-DMA	Malignant cells	GSE168668	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51313
2.16499681330069e-230	0.563881290952021	0.998	0.963	4.00156361002367e-226	ENO1	Malignant cells	GSE168668	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51314
2.50739790897092e-230	0.380990116331216	1	0.999	4.63442355515094e-226	COX4I1	Malignant cells	GSE168668	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51315
5.51513731321511e-229	-0.60353790827679	0.653	0.901	1.01936282960155e-224	CCNG1	Malignant cells	GSE168668	ENSG00000113328	900	cyclin G1	CCNG	protein_coding	P51959	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51316
5.5541234736763e-229	0.597633987648396	0.961	0.87	1.02656864163959e-224	ECHS1	Malignant cells	GSE168668	ENSG00000127884	1892	enoyl-CoA hydratase, short chain 1	SCEH	protein_coding	P30084	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51317
1.99287036600325e-228	0.535336952729012	1	0.994	3.68342229748381e-224	APRT	Malignant cells	GSE168668	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51318
7.16760025916543e-228	0.541615079076882	0.992	0.974	1.32478755590155e-223	CCT8	Malignant cells	GSE168668	ENSG00000156261	10694	chaperonin containing TCP1 subunit 8	C21orf112|Cctq|PRED71	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51319
7.53556370201191e-228	0.609868119846283	0.949	0.837	1.39279823904286e-223	RBM8A	Malignant cells	GSE168668	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51320
1.81568686718423e-226	-0.375432788454283	0.089	0.358	3.35593403661662e-222	AL353622.1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51321
6.92460209094884e-226	-0.503619896509367	0.138	0.439	1.27987420447007e-221	NRP1	Malignant cells	GSE168668	ENSG00000099250	8829	neuropilin 1	CD304|NRP|VEGF165R	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51322
1.21753488526491e-224	0.47159456337439	0.999	0.992	2.25036972843513e-220	PFN1	Malignant cells	GSE168668	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51323
6.25535487193686e-224	0.489023155667361	0.995	0.978	1.15617724098009e-219	PSMB1	Malignant cells	GSE168668	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51324
6.6047741691262e-224	0.715195777518768	0.56	0.192	1.2207604096796e-219	PPP1R16A	Malignant cells	GSE168668	ENSG00000160972	84988	protein phosphatase 1 regulatory subunit 16A	MGC14333|MYPT3	protein_coding	Q96I34	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51325
3.46429148800024e-219	0.475249020189804	0.998	0.989	6.40304995727084e-215	NDUFB2	Malignant cells	GSE168668	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51326
3.61576099649167e-219	0.738853121138165	0.51	0.135	6.68301104981556e-215	ANKRD29	Malignant cells	GSE168668	ENSG00000154065	147463	ankyrin repeat domain 29	FLJ25053	protein_coding	Q8N6D5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51327
4.64827746067179e-219	-0.340349097341533	0.076	0.328	8.59141123055967e-215	ZNF518B	Malignant cells	GSE168668	ENSG00000178163	85460	zinc finger protein 518B	KIAA1729	protein_coding	Q9C0D4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51328
1.5516761613558e-218	0.480387248346071	0.999	0.985	2.86796304903393e-214	UBB	Malignant cells	GSE168668	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51329
2.38639821007074e-218	0.461417891691876	0.999	0.993	4.41077981167374e-214	SNRPE	Malignant cells	GSE168668	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51330
6.96387987053815e-217	-0.609332282119911	0.75	0.941	1.28713391647157e-212	TBL1XR1	Malignant cells	GSE168668	ENSG00000177565	79718	TBL1X/Y related 1	C21|DC42|FLJ12894|IRA1|TBLR1	protein_coding	Q9BZK7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51331
1.14302757922266e-216	0.78405063836434	0.747	0.46	2.11265787467723e-212	TUBA4A	Malignant cells	GSE168668	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51332
1.4372478550496e-216	-0.512508876250121	0.211	0.532	2.65646521048817e-212	SLC1A5	Malignant cells	GSE168668	ENSG00000105281	6510	solute carrier family 1 member 5	AAAT|ASCT2|M7V1|RDRC	protein_coding	Q15758	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51333
8.24410336900373e-216	-0.564275388802748	0.655	0.898	1.52375762569296e-211	SNRPN	Malignant cells	GSE168668	ENSG00000128739	6638	small nuclear ribonucleoprotein polypeptide N	HCERN3|PWCR|RT-LI|SM-D|SMN|SNRNP-N|SNURF-SNRPN	protein_coding	P63162	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51334
1.41021825918692e-215	-0.317958886424519	0.047	0.263	2.60650640845518e-211	ASRGL1	Malignant cells	GSE168668	ENSG00000162174	80150	asparaginase and isoaspartyl peptidase 1	ALP|ALP1|FLJ22316	protein_coding	Q7L266	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51335
3.89220074687017e-214	-0.308208833549208	0.051	0.273	7.19395464044014e-210	MGLL	Malignant cells	GSE168668	ENSG00000074416	11343	monoglyceride lipase	HU-K5|MAGL|MGL	protein_coding	Q99685	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51336
1.5544015830762e-213	-0.30873940688618	1	1	2.87300044599974e-209	SERF2	Malignant cells	GSE168668	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51337
1.74276002962209e-212	-0.315361019080024	0.052	0.273	3.22114336275052e-208	HERC3	Malignant cells	GSE168668	ENSG00000287542	8916	HECT and RLD domain containing E3 ubiquitin protein ligase 3	KIAA0032	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51338
3.2469275313583e-212	-0.66438246187771	0.425	0.757	6.00129615620955e-208	PRAC2	Malignant cells	GSE168668	ENSG00000229637	360205	PRAC2 small nuclear protein	C17orf93|HOXB-AS5|HOXB13-AS1|NCRNA00253	protein_coding	D3DTV9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51339
1.15444482548333e-210	-0.418048450434677	0.137	0.429	2.13376037094084e-206	ALCAM	Malignant cells	GSE168668	ENSG00000170017	214	activated leukocyte cell adhesion molecule	CD166|MEMD	protein_coding	Q13740	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51340
4.9192030994156e-209	-0.262764365138584	1	1	9.09216308864985e-205	FAU	Malignant cells	GSE168668	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51341
1.11283173322674e-207	-0.341203306396766	0.07	0.308	2.05684689252298e-203	SMAD9	Malignant cells	GSE168668	ENSG00000120693	4093	SMAD family member 9	MADH6|MADH9|SMAD8|SMAD8/9	protein_coding	O15198	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51342
1.49869033295012e-207	-0.368506416067281	0.093	0.353	2.7700293423917e-203	BBC3	Malignant cells	GSE168668	ENSG00000105327	27113	BCL2 binding component 3	JFY1|PUMA	protein_coding	Q9BXH1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51343
2.70956534600936e-207	0.860484004501671	0.374	0.03	5.0080896290291e-203	UGT2B11	Malignant cells	GSE168668	ENSG00000213759	10720	UDP glucuronosyltransferase family 2 member B11	NA	protein_coding	O75310	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51344
1.07152898588969e-205	0.807746858431347	0.435	0.079	1.98050702461991e-201	UGT2B15	Malignant cells	GSE168668	ENSG00000277132	7366	UDP glucuronosyltransferase family 2 member B15	UGT2B8	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51345
4.12828978622947e-205	-0.640903813310578	0.539	0.812	7.63031801188793e-201	LUZP2	Malignant cells	GSE168668	ENSG00000187398	338645	leucine zipper protein 2	NA	protein_coding	Q86TE4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51346
1.60863212879885e-204	-0.440757174713633	0.981	0.998	2.97323476365892e-200	TMEM258	Malignant cells	GSE168668	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51347
2.2365945805405e-204	-0.603559720295844	0.299	0.669	4.13389776321301e-200	PRUNE2	Malignant cells	GSE168668	ENSG00000106772	158471	prune homolog 2 with BCH domain	A214N16.3|bA214N16.3|BMCC1|BNIPXL|C9orf65|KIAA0367	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51348
1.91870096428309e-202	-0.627168820349004	0.265	0.569	3.54633499228444e-198	DBNDD1	Malignant cells	GSE168668	ENSG00000003249	79007	dysbindin domain containing 1	FLJ12582|MGC3101	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51349
4.75545270304674e-202	-0.57111101614129	0.443	0.75	8.78950323104128e-198	GOLM1	Malignant cells	GSE168668	ENSG00000135052	51280	golgi membrane protein 1	bA379P1.3|C9orf155|FLJ23608|GOLPH2|GP73	protein_coding	Q8NBJ4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51350
1.39550110210114e-201	-0.53717423515965	0.272	0.591	2.57930468701353e-197	NAALADL2	Malignant cells	GSE168668	ENSG00000177694	254827	N-acetylated alpha-linked acidic dipeptidase like 2	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51351
3.44999149764534e-201	-0.575165286686727	0.749	0.939	6.37661928509787e-197	TAF1D	Malignant cells	GSE168668	ENSG00000166012	79101	TATA-box binding protein associated factor, RNA polymerase I subunit D	JOSD3|MGC5306|TAF(I)41	protein_coding	Q9H5J8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51352
6.16590221388562e-201	-0.648814584187428	0.481	0.769	1.13964370619248e-196	UBE2E3	Malignant cells	GSE168668	ENSG00000170035	10477	ubiquitin conjugating enzyme E2 E3	UbcH9	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51353
1.0324543808327e-200	0.522870725539575	0.974	0.907	1.90828543209308e-196	COPE	Malignant cells	GSE168668	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51354
6.75030618554496e-200	-0.39653567026595	0.133	0.414	1.24765909227428e-195	DGKD	Malignant cells	GSE168668	ENSG00000280873	8527	diacylglycerol kinase delta	DGKdelta|KIAA0145	protein_coding	Q16760	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51355
8.49747085303603e-200	-0.411647582357968	0.132	0.41	1.57058753776665e-195	PSD3	Malignant cells	GSE168668	ENSG00000156011	23362	pleckstrin and Sec7 domain containing 3	DKFZp761K1423|EFA6D|EFA6R|HCA67|KIAA0942	protein_coding	Q9NYI0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51356
1.10890981696915e-199	-0.567939072625819	0.953	0.986	2.04959801470409e-195	NUPR1	Malignant cells	GSE168668	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51357
1.28785159574101e-199	-0.411667376198209	0.994	1	2.38033610440812e-195	UQCR11	Malignant cells	GSE168668	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51358
6.05417999346413e-199	-0.347893681051028	0.085	0.332	1.11899408819197e-194	AC245297.3	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51359
6.78031981852725e-199	-0.494016446313456	0.954	0.993	1.25320651205839e-194	EIF3H	Malignant cells	GSE168668	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51360
7.14018795782781e-199	-0.457791545070803	0.215	0.53	1.31972094024531e-194	GCHFR	Malignant cells	GSE168668	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51361
3.15180569554318e-198	0.65346701797773	0.66	0.344	5.82548246707246e-194	ABRACL	Malignant cells	GSE168668	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51362
1.71016464151493e-197	0.713479423130167	0.998	0.992	3.16089730691205e-193	CKB	Malignant cells	GSE168668	ENSG00000166165	1152	creatine kinase B	CKBB	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51363
4.2593995519039e-197	0.51629657401407	0.994	0.96	7.87264819178398e-193	JPT1	Malignant cells	GSE168668	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51364
7.40116242514296e-197	0.616924473156933	0.921	0.721	1.36795685103917e-192	SFPQ	Malignant cells	GSE168668	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51365
1.21201354390606e-196	0.721345290230715	0.906	0.747	2.24016463320157e-192	MIA3	Malignant cells	GSE168668	ENSG00000154305	375056	MIA SH3 domain ER export factor 3	FLJ39207|KIAA0268|TANGO|TANGO1|UNQ6077	protein_coding	Q5JRA6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51366
2.20914364882639e-196	-0.575217630324329	0.417	0.724	4.08316020612582e-192	TAGLN2	Malignant cells	GSE168668	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51367
2.29647181901896e-196	-0.875829324066319	0.321	0.612	4.24456886309275e-192	H1F0	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51368
2.66606116772896e-195	0.793265922307175	0.486	0.141	4.92768085631344e-191	INSIG2	Malignant cells	GSE168668	ENSG00000125629	51141	insulin induced gene 2	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51369
6.01981498085682e-195	-0.546726440211381	0.529	0.81	1.11264240291177e-190	ARL2	Malignant cells	GSE168668	ENSG00000213465	402	ADP ribosylation factor like GTPase 2	ARFL2	protein_coding	P36404	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51370
9.56430627218997e-195	-0.333681451086954	1	1	1.76777072828887e-190	EIF1	Malignant cells	GSE168668	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51371
1.15299503864745e-194	0.5701713069907	0.907	0.78	2.13108072993207e-190	LAGE3	Malignant cells	GSE168668	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51372
3.05275202887827e-194	-0.582120165077201	0.881	0.971	5.64240157497571e-190	FOLH1	Malignant cells	GSE168668	ENSG00000086205	2346	folate hydrolase 1	FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA	protein_coding	Q04609	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51373
7.63303984673715e-194	-0.384147451866141	0.998	1	1.41081475487243e-189	EEF1D	Malignant cells	GSE168668	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51374
1.61640504647833e-193	1.13834639469464	0.946	0.861	2.9876014474059e-189	HSPA5	Malignant cells	GSE168668	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51375
2.02973349658065e-193	0.575217561027651	0.386	0.052	3.75155642173001e-189	CD24	Malignant cells	GSE168668	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51376
4.5002135345681e-193	-0.554999006201197	0.359	0.66	8.31774467594222e-189	CCNB1IP1	Malignant cells	GSE168668	ENSG00000100814	57820	cyclin B1 interacting protein 1	C14orf18|HEI10	protein_coding	Q9NPC3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51377
4.83502760937986e-192	-0.403687215697203	0.154	0.44	8.93658153041679e-188	TP53I11	Malignant cells	GSE168668	ENSG00000175274	9537	tumor protein p53 inducible protein 11	PIG11	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51378
8.79572065523475e-192	-0.259875290711983	1	1	1.62571304870704e-187	RPL10	Malignant cells	GSE168668	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51379
3.52867764372687e-191	-0.252179227768274	1	1	6.52205488890037e-187	COX7C	Malignant cells	GSE168668	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51380
2.03813702394163e-189	-0.579829877881503	0.982	0.997	3.76708866135131e-185	SNHG8	Malignant cells	GSE168668	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51381
2.11535330901355e-189	0.542090563973951	0.922	0.804	3.90980752104974e-185	MSRB2	Malignant cells	GSE168668	ENSG00000148450	22921	methionine sulfoxide reductase B2	CBS-1|CBS1|CGI-131|MSRB|PILB	protein_coding	Q9Y3D2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51382
1.80683673438768e-187	0.553641687482082	0.916	0.798	3.33957633616875e-183	RHOC	Malignant cells	GSE168668	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51383
1.18532139216355e-186	-0.541679671016615	0.507	0.79	2.1908295291359e-182	ASAH1	Malignant cells	GSE168668	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51384
1.80078819368437e-186	0.610647931682717	0.844	0.652	3.32839681838682e-182	SRSF2	Malignant cells	GSE168668	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51385
2.71560588775691e-186	0.550654987232416	0.924	0.78	5.0192543623411e-182	COX20	Malignant cells	GSE168668	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51386
3.00837487489494e-186	0.471791407168976	0.992	0.951	5.56037928126831e-182	MRPL57	Malignant cells	GSE168668	ENSG00000173141	78988	mitochondrial ribosomal protein L57	MRP63	protein_coding	Q9BQC6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51387
5.99020500339126e-186	-0.370300936071324	0.134	0.405	1.10716959077681e-181	EPB41L4B	Malignant cells	GSE168668	ENSG00000095203	54566	erythrocyte membrane protein band 4.1 like 4B	EHM2|LULU2	protein_coding	Q9H329	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51388
4.93753301743359e-185	-0.540719305836498	0.52	0.791	9.12604227612251e-181	PIR	Malignant cells	GSE168668	ENSG00000087842	8544	pirin	NA	protein_coding	O00625	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51389
1.44780234967956e-184	0.634869944613931	0.529	0.195	2.67597308291274e-180	RHOB	Malignant cells	GSE168668	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51390
3.49883448340347e-184	0.754079230143038	0.454	0.118	6.46689577567463e-180	ENC1	Malignant cells	GSE168668	ENSG00000171617	8507	ectodermal-neural cortex 1	ENC-1|KLHL37|NRPB|PIG10|TP53I10	protein_coding	O14682	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51391
1.51095966062721e-183	-0.583016844604601	0.898	0.985	2.79270674073727e-179	BLVRB	Malignant cells	GSE168668	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51392
6.14203265502425e-182	0.260242233989093	1	1	1.13523189562813e-177	MT-CO1	Malignant cells	GSE168668	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51393
8.98248504925667e-182	0.543738704287741	0.921	0.781	1.66023271165411e-177	TOP1	Malignant cells	GSE168668	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51394
9.14167028739298e-182	-0.601774768835327	0.827	0.949	1.68965491921885e-177	CCND1	Malignant cells	GSE168668	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51395
9.9702120868311e-182	-0.552232985516648	0.48	0.75	1.84279430000899e-177	C15orf61	Malignant cells	GSE168668	ENSG00000189227	145853	chromosome 15 open reading frame 61	LOC145853	protein_coding	A6NNL5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51396
2.08949144901571e-181	-0.52834402819221	0.54	0.801	3.86200704521574e-177	CALU	Malignant cells	GSE168668	ENSG00000128595	813	calumenin	NA	protein_coding	O43852	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51397
4.81033830232852e-181	0.409402774376336	1	0.996	8.89094828419381e-177	C1QBP	Malignant cells	GSE168668	ENSG00000108561	708	complement C1q binding protein	gC1Q-R|gC1qR|HABP1|p32|SF2p32	protein_coding	Q07021	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51398
1.2117240873562e-180	-0.511923889779838	0.376	0.671	2.23962963066046e-176	TOMM5	Malignant cells	GSE168668	ENSG00000175768	401505	translocase of outer mitochondrial membrane 5	bA613M10.3|C9orf105|Tom5	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51399
1.99879799821631e-180	0.581649787008213	0.877	0.738	3.69437834010321e-176	OCIAD2	Malignant cells	GSE168668	ENSG00000145247	132299	OCIA domain containing 2	MGC45416	protein_coding	Q56VL3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51400
2.39960204706059e-180	-0.543098434542289	0.516	0.792	4.4351844635821e-176	EPB41L4A-AS1	Malignant cells	GSE168668	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51401
2.49169843212416e-179	-0.479329909072822	0.186	0.467	4.60540621209509e-175	STK39	Malignant cells	GSE168668	ENSG00000198648	27347	serine/threonine kinase 39	DCHT|SPAK	protein_coding	Q9UEW8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51402
5.15038744067676e-179	-0.337391350400375	0.11	0.361	9.51946110660286e-175	EVA1B	Malignant cells	GSE168668	ENSG00000142694	55194	eva-1 homolog B	C1orf78|FAM176B|FLJ10647	protein_coding	Q9NVM1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51403
3.81251647320576e-178	-0.352560189971371	0.099	0.339	7.0466741974262e-174	FNIP2	Malignant cells	GSE168668	ENSG00000052795	57600	folliculin interacting protein 2	FNIPL|KIAA1450|MAPO1	protein_coding	Q9P278	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51404
1.11899984397135e-177	0.649424357542257	0.757	0.496	2.06824741161225e-173	TMEM14A	Malignant cells	GSE168668	ENSG00000096092	28978	transmembrane protein 14A	C6orf73|PTD011	protein_coding	Q9Y6G1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51405
8.52527628796542e-176	0.866149554120378	0.431	0.1	1.57572681630465e-171	GSTA1	Malignant cells	GSE168668	ENSG00000243955	2938	glutathione S-transferase alpha 1	NA	protein_coding	P08263	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51406
8.76952324716985e-176	0.634916241687673	0.658	0.361	1.6208709817744e-171	IRF2BP2	Malignant cells	GSE168668	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51407
9.50302586579306e-176	-0.387367285978967	0.145	0.411	1.75644427077453e-171	MFHAS1	Malignant cells	GSE168668	ENSG00000147324	9258	multifunctional ROCO family signaling regulator 1	LRRC65|MASL1	protein_coding	Q9Y4C4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51408
1.22226305432687e-175	0.567886076956835	0.927	0.831	2.25910880331235e-171	TMEM59	Malignant cells	GSE168668	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51409
6.11181402841981e-175	-0.556373285835386	0.474	0.742	1.12964658687283e-170	SLC39A6	Malignant cells	GSE168668	ENSG00000141424	25800	solute carrier family 39 member 6	LIV-1	protein_coding	Q13433	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51410
1.48445294568885e-174	0.828527181397339	0.37	0.06	2.74371437951669e-170	GNAI1	Malignant cells	GSE168668	ENSG00000127955	2770	G protein subunit alpha i1	NA	protein_coding	P63096	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51411
1.86390146705649e-174	-0.480989054671967	0.329	0.629	3.44504908156052e-170	SH3GLB2	Malignant cells	GSE168668	ENSG00000148341	56904	SH3 domain containing GRB2 like, endophilin B2	KIAA1848	protein_coding	Q9NR46	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51412
4.4097044394212e-174	0.527990111945944	0.916	0.794	8.15045671538221e-170	TPM3	Malignant cells	GSE168668	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51413
7.16726181712453e-174	0.734775728327772	0.955	0.69	1.32472500165913e-169	TUBA1B	Malignant cells	GSE168668	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51414
7.54371786517449e-174	-0.467821386585809	0.84	0.97	1.3943053730202e-169	RCN2	Malignant cells	GSE168668	ENSG00000117906	5955	reticulocalbin 2	E6BP|ERC-55|ERC55|TCBP49	protein_coding	Q14257	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51415
5.61246635012598e-173	0.610220127745561	0.833	0.643	1.03735215549378e-168	ENAH	Malignant cells	GSE168668	ENSG00000154380	55740	ENAH actin regulator	FLJ10773|MENA|NDPP1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51416
2.3983808878204e-172	-0.520520300040973	0.594	0.834	4.43292739495845e-168	PHF20	Malignant cells	GSE168668	ENSG00000025293	51230	PHD finger protein 20	C20orf104|dJ1121G12.1|TDRD20A	protein_coding	Q9BVI0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51417
4.23640833633163e-172	0.636939806047865	0.602	0.288	7.83015352804175e-168	CITED2	Malignant cells	GSE168668	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51418
1.02065382767993e-169	-0.505444906817962	0.369	0.663	1.88647446970081e-165	TMEM87A	Malignant cells	GSE168668	ENSG00000103978	25963	transmembrane protein 87A	DKFZP564G2022	protein_coding	Q8NBN3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51419
1.61194220796944e-169	-0.290738063021914	0.057	0.254	2.97935278298991e-165	REPS2	Malignant cells	GSE168668	ENSG00000169891	9185	RALBP1 associated Eps domain containing 2	POB1	protein_coding	Q8NFH8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51420
3.82743026580792e-169	-0.507071828665111	0.395	0.684	7.07423936029279e-165	CTBS	Malignant cells	GSE168668	ENSG00000117151	1486	chitobiase	CTB	protein_coding	Q01459	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51421
8.45537516922658e-168	0.452889366217432	0.984	0.949	1.56280699252815e-163	SCAND1	Malignant cells	GSE168668	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51422
1.01349438003029e-166	0.602881586519161	0.946	0.798	1.87324166260999e-162	HMGN2	Malignant cells	GSE168668	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51423
1.63831028647359e-166	0.544488935712524	0.868	0.708	3.02808890248913e-162	GTF3A	Malignant cells	GSE168668	ENSG00000122034	2971	general transcription factor IIIA	AP2|TFIIIA	protein_coding	Q92664	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51424
2.98063764930429e-166	-0.586984822352555	0.901	0.973	5.50911256720911e-162	SNHG19	Malignant cells	GSE168668	ENSG00000260260	NA	NA	SNORD60HG	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51425
1.07654333716316e-165	0.562148296020876	0.812	0.599	1.98977505007867e-161	FUS	Malignant cells	GSE168668	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51426
1.85151484087776e-165	-0.50612031465187	0.597	0.845	3.42215488039436e-161	PLPP5	Malignant cells	GSE168668	ENSG00000147535	84513	phospholipid phosphatase 5	DPPL1|HTPAP|PPAPDC1B	protein_coding	Q8NEB5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51427
4.10075115579266e-165	-0.276879945188329	0.059	0.254	7.57941836125158e-161	C9orf3	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51428
3.3773462101146e-164	0.444649733749474	0.993	0.971	6.24234900015481e-160	PRELID1	Malignant cells	GSE168668	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51429
1.6518629990763e-163	-0.41835153721579	0.152	0.406	3.05313838119272e-159	GLMP	Malignant cells	GSE168668	ENSG00000198715	112770	glycosylated lysosomal membrane protein	C1orf85|MGC31963|NCU-G1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51430
3.50504064110321e-163	0.45223906379334	0.978	0.943	6.47836661695106e-159	NDUFB9	Malignant cells	GSE168668	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51431
4.26933509566314e-163	0.494432163063943	0.978	0.913	7.89101205731418e-159	HNRNPU	Malignant cells	GSE168668	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51432
1.11851760469924e-162	-0.394277725500879	0.203	0.483	2.06735608876561e-158	BRAF	Malignant cells	GSE168668	ENSG00000157764	673	B-Raf proto-oncogene, serine/threonine kinase	BRAF-1|BRAF1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51433
1.82550128975194e-162	0.499210107280605	0.93	0.843	3.3740740338485e-158	NUDC	Malignant cells	GSE168668	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51434
1.2127246742602e-161	-0.355102080738266	0.115	0.355	2.24147901543512e-157	EGFR	Malignant cells	GSE168668	ENSG00000146648	1956	epidermal growth factor receptor	ERBB|ERBB1|ERRP	protein_coding	P00533	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51435
6.3276748095048e-161	-0.264623733291414	0.061	0.257	1.16954413504077e-156	TRIP10	Malignant cells	GSE168668	ENSG00000125733	9322	thyroid hormone receptor interactor 10	CIP4|HSTP|STOT|STP	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51436
6.36285492674431e-161	0.491333648869207	0.919	0.822	1.17604647611015e-156	AP2M1	Malignant cells	GSE168668	ENSG00000161203	1173	adaptor related protein complex 2 subunit mu 1	AP50|CLAPM1|mu2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51437
7.16552259972165e-161	-0.751265940695423	0.352	0.623	1.32440354210655e-156	HES6	Malignant cells	GSE168668	ENSG00000144485	55502	hes family bHLH transcription factor 6	bHLHb41	protein_coding	Q96HZ4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51438
8.29731756907629e-161	0.549836180350573	0.533	0.22	1.53359320629237e-156	GNPTAB	Malignant cells	GSE168668	ENSG00000111670	79158	N-acetylglucosamine-1-phosphate transferase subunits alpha and beta	GNPTA|KIAA1208|MGC4170	protein_coding	Q3T906	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51439
8.64481901671269e-161	0.540517738910099	0.83	0.66	1.59782189885901e-156	SDCCAG8	Malignant cells	GSE168668	ENSG00000276111	10806	SHH signaling and ciliogenesis regulator SDCCAG8	BBS16|CCCAP|NPHP10|NY-CO-8|SLSN7	protein_coding	Q86SQ7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51440
1.39466236825126e-159	-0.292739455804323	0.082	0.296	2.57775445523881e-155	SORBS2	Malignant cells	GSE168668	ENSG00000154556	8470	sorbin and SH3 domain containing 2	ARGBP2|KIAA0777	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51441
1.68644889027121e-159	0.559582645888799	0.882	0.739	3.11706348388827e-155	NOP56	Malignant cells	GSE168668	ENSG00000101361	10528	NOP56 ribonucleoprotein	NOL5A|SCA36	protein_coding	O00567	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51442
3.30405279744451e-159	-0.473320022327389	0.571	0.822	6.10688078551668e-155	RPS17	Malignant cells	GSE168668	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51443
4.11491386187855e-159	-0.3333572893306	0.129	0.375	7.60559529091012e-155	SBF2	Malignant cells	GSE168668	ENSG00000133812	81846	SET binding factor 2	CMT4B2|DENND7B|KIAA1766|MTMR13	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51444
1.82236943504423e-158	0.539206028094365	0.267	0	3.36828542679225e-154	NR2F1	Malignant cells	GSE168668	ENSG00000175745	7025	nuclear receptor subfamily 2 group F member 1	COUP-TFI|COUPTF1|EAR-3|ERBAL3|SVP44|TCFCOUP1|TFCOUP1	protein_coding	P10589	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51445
2.84403901169759e-158	-0.473198708702925	0.29	0.568	5.25663730532066e-154	TSPAN13	Malignant cells	GSE168668	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51446
3.72870442428564e-158	-0.398746904951572	0.231	0.515	6.89176438740715e-154	TMEM245	Malignant cells	GSE168668	ENSG00000106771	23731	transmembrane protein 245	C9orf5|CG-2	protein_coding	Q9H330	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51447
4.31574722622867e-158	0.412904265405228	0.995	0.98	7.97679559823844e-154	TMBIM6	Malignant cells	GSE168668	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51448
6.50653032820475e-158	-0.349694211745852	0.126	0.367	1.20260200056208e-153	USP9Y	Malignant cells	GSE168668	ENSG00000114374	8287	ubiquitin specific peptidase 9 Y-linked	AZFA|DFFRY	protein_coding	O00507	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51449
8.00120154617569e-158	-0.300291662317043	0.084	0.298	1.47886208177965e-153	AC091138.1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51450
1.04715754294845e-157	0.507960941952128	0.957	0.878	1.93546128663163e-153	PRKDC	Malignant cells	GSE168668	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51451
3.25143065803715e-157	0.56131021473655	0.917	0.802	6.00961928525006e-153	SVIP	Malignant cells	GSE168668	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51452
1.15142609663082e-156	-0.485005863429687	0.211	0.474	2.12818085440274e-152	NUDT4	Malignant cells	GSE168668	ENSG00000173598	11163	nudix hydrolase 4	DIPP2|DIPP2alpha|DIPP2beta|HDCMB47P|KIAA0487	protein_coding	Q9NZJ9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51453
1.34783284794337e-156	-0.524087179437417	0.101	0.323	2.49119945285374e-152	ADAMTS1	Malignant cells	GSE168668	ENSG00000154734	9510	ADAM metallopeptidase with thrombospondin type 1 motif 1	C3-C5|KIAA1346|METH1	protein_coding	Q9UHI8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51454
3.40528551198358e-156	0.418380104532253	0.99	0.968	6.29398921179925e-152	SSBP1	Malignant cells	GSE168668	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51455
6.76155445553063e-156	-0.542314689747718	0.461	0.71	1.24973811001573e-151	OSBPL8	Malignant cells	GSE168668	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51456
4.25491885514774e-155	-0.481330790633403	0.597	0.83	7.86436651996956e-151	TPD52	Malignant cells	GSE168668	ENSG00000076554	7163	tumor protein D52	D52|hD52|N8L	protein_coding	P55327	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51457
9.75634393673962e-155	-0.627404269932977	0.928	0.967	1.80326504982758e-150	AMD1	Malignant cells	GSE168668	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51458
1.44547507763579e-154	-0.265920291148015	0.073	0.276	2.67167158599423e-150	TUSC1	Malignant cells	GSE168668	ENSG00000198680	286319	tumor suppressor candidate 1	CCDC89B|TSG-9	protein_coding	Q2TAM9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51459
2.68046397123668e-154	0.397672757636676	0.998	0.987	4.95430155803675e-150	ATP5MC3	Malignant cells	GSE168668	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51460
4.48223594384555e-154	0.787713805351927	0.651	0.385	8.28451669500974e-150	SESN3	Malignant cells	GSE168668	ENSG00000149212	143686	sestrin 3	MGC29667|SEST3	protein_coding	P58005	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51461
1.23133105806488e-153	-0.786476316658754	0.347	0.591	2.27586919462132e-149	NETO1	Malignant cells	GSE168668	ENSG00000166342	81832	neuropilin and tolloid like 1	BCTL1|BTCL1	protein_coding	Q8TDF5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51462
1.36017015589984e-153	0.410875508127317	0.994	0.982	2.51400249914967e-149	PPDPF	Malignant cells	GSE168668	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51463
1.72478412678437e-153	-0.373214185888496	0.145	0.391	3.18791850153555e-149	PDLIM5	Malignant cells	GSE168668	ENSG00000163110	10611	PDZ and LIM domain 5	Enh|LIM	protein_coding	Q96HC4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51464
1.72508493823947e-153	0.525454979201722	0.83	0.668	3.18847449134801e-149	HADHA	Malignant cells	GSE168668	ENSG00000084754	3030	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha	GBP|LCEH|LCHAD|MTPA	protein_coding	P40939	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51465
5.260060964428e-153	0.57944883912331	0.916	0.791	9.72217068055227e-149	MKNK2	Malignant cells	GSE168668	ENSG00000099875	2872	MAPK interacting serine/threonine kinase 2	GPRK7|MNK2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51466
5.28406999043713e-153	-0.363382282150696	0.163	0.422	9.76654656332495e-149	HSD17B12	Malignant cells	GSE168668	ENSG00000149084	51144	hydroxysteroid 17-beta dehydrogenase 12	KAR|SDR12C1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51467
1.61769685558761e-152	-0.473134704857632	0.474	0.742	2.98998909818258e-148	RAC3	Malignant cells	GSE168668	ENSG00000169750	5881	Rac family small GTPase 3	NA	protein_coding	P60763	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51468
1.23096012455566e-151	0.354338904919497	1	0.998	2.27518359821623e-147	NDUFB10	Malignant cells	GSE168668	ENSG00000140990	4716	NADH:ubiquinone oxidoreductase subunit B10	PDSW	protein_coding	O96000	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51469
1.56780396620671e-151	-0.478693973369001	0.286	0.557	2.89777207073986e-147	TTTY15	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51470
1.80225142555289e-151	-0.473572150670008	0.528	0.774	3.3311013098494e-147	CDV3	Malignant cells	GSE168668	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51471
2.12568095151326e-151	-0.376322364540101	0.96	0.995	3.92889610268196e-147	RPL36A	Malignant cells	GSE168668	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51472
3.99931750942756e-150	-0.31093529928003	0.109	0.336	7.39193855267496e-146	CAB39L	Malignant cells	GSE168668	ENSG00000102547	81617	calcium binding protein 39 like	bA103J18.3|FLJ12577|MO2L	protein_coding	Q9H9S4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51473
2.05140874721944e-149	0.499677699581308	0.455	0.156	3.79161878748568e-145	MAPKAPK2	Malignant cells	GSE168668	ENSG00000162889	9261	MAPK activated protein kinase 2	MK2	protein_coding	P49137	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51474
2.20093891730112e-149	-0.367969872570116	0.201	0.47	4.06799540084765e-145	ADAM9	Malignant cells	GSE168668	ENSG00000282230	8754	ADAM metallopeptidase domain 9	CORD9|KIAA0021|MCMP|MDC9|Mltng	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51475
1.67621855628564e-148	0.406476062600071	0.28	0.017	3.09815475758274e-144	PRKAG2-AS1	Malignant cells	GSE168668	ENSG00000239911	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51476
2.25836566548166e-148	-0.671018449628398	0.862	0.953	4.17413725950975e-144	TXNIP	Malignant cells	GSE168668	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51477
5.91080250502214e-148	-0.430629866994227	0.682	0.897	1.09249362700324e-143	CLNS1A	Malignant cells	GSE168668	ENSG00000074201	1207	chloride nucleotide-sensitive channel 1A	CLCI|ICln	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51478
2.31716078953637e-147	0.555235743982251	0.728	0.471	4.28280828730007e-143	MARCKS	Malignant cells	GSE168668	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51479
5.39895973523495e-147	0.469040229692744	0.969	0.91	9.97889727863475e-143	EIF5	Malignant cells	GSE168668	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51480
1.45869927009089e-145	-0.503843786985753	0.369	0.634	2.69611386090899e-141	TBRG1	Malignant cells	GSE168668	ENSG00000154144	84897	transforming growth factor beta regulator 1	FLJ14621|NIAM|TB-5	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51481
1.83830301133531e-145	-0.468567103824319	0.349	0.616	3.39773545585105e-141	DSG2	Malignant cells	GSE168668	ENSG00000046604	1829	desmoglein 2	CDHF5	protein_coding	Q14126	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51482
5.90377577466087e-145	0.457695711832066	0.959	0.891	1.09119487643057e-140	PARP1	Malignant cells	GSE168668	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51483
1.0206908429845e-144	0.358231536643256	1	0.997	1.88654288508825e-140	RAN	Malignant cells	GSE168668	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51484
8.94772519903826e-144	0.492800615025867	0.847	0.694	1.65380804853824e-139	SNX3	Malignant cells	GSE168668	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51485
5.74909972531591e-143	-0.474232684448827	0.374	0.645	1.06260610223014e-138	HIST3H2A	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51486
1.16808923473975e-142	0.445996365786293	0.959	0.897	2.15897933256947e-138	MLF2	Malignant cells	GSE168668	ENSG00000089693	8079	myeloid leukemia factor 2	NTN4	protein_coding	Q15773	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51487
1.18764755045409e-142	-0.338415744012003	0.179	0.435	2.19512896750429e-138	TMX3	Malignant cells	GSE168668	ENSG00000166479	54495	thioredoxin related transmembrane protein 3	FLJ20793|KIAA1830|PDIA13|TXNDC10	protein_coding	Q96JJ7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51488
1.45833185294833e-142	-0.481887722028703	0.411	0.672	2.6954347638044e-138	SPDEF	Malignant cells	GSE168668	ENSG00000124664	25803	SAM pointed domain containing ETS transcription factor	bA375E1.3|PDEF	protein_coding	O95238	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51489
3.4906965014092e-142	-0.433157866588127	0.593	0.832	6.45185434355462e-138	CHMP5	Malignant cells	GSE168668	ENSG00000086065	51510	charged multivesicular body protein 5	C9orf83|CGI-34|HSPC177|SNF7DC2|Vps60	protein_coding	Q9NZZ3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51490
1.57138295007259e-141	0.334427252709475	1	0.998	2.90438710661917e-137	SERBP1	Malignant cells	GSE168668	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51491
2.42445644928568e-141	0.455862655201991	0.988	0.955	4.48112285521473e-137	EPRS	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51492
4.42472307553554e-141	-0.351708611434034	0.175	0.423	8.17821566051234e-137	CBFA2T2	Malignant cells	GSE168668	ENSG00000078699	9139	CBFA2/RUNX1 partner transcriptional co-repressor 2	MTGR1|ZMYND3	protein_coding	O43439	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51493
1.09578297791212e-140	-0.456142637605606	0.442	0.692	2.02533567807497e-136	ZFAND1	Malignant cells	GSE168668	ENSG00000104231	79752	zinc finger AN1-type containing 1	FLJ14007	protein_coding	Q8TCF1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51494
1.38802590704994e-140	-0.379624203196937	0.155	0.392	2.56548828400041e-136	TTC6	Malignant cells	GSE168668	ENSG00000139865	319089	tetratricopeptide repeat domain 6	C14orf25|NCRNA00291	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51495
2.3679984870252e-140	0.498886693483423	0.375	0.096	4.37677160356869e-136	FAM198B	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51496
5.11358152649352e-140	-0.38938118107129	0.254	0.522	9.45143273541798e-136	SYNGR1	Malignant cells	GSE168668	ENSG00000100321	9145	synaptogyrin 1	NA	protein_coding	O43759	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51497
1.25194847982457e-139	-0.254446288128455	0.076	0.27	2.31397637525975e-135	ZNF814	Malignant cells	GSE168668	ENSG00000204514	730051	zinc finger protein 814	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51498
1.26250370194232e-139	0.373858287224913	0.997	0.982	2.33348559229999e-135	YWHAB	Malignant cells	GSE168668	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51499
3.35283047904812e-139	-0.457970326040092	0.607	0.827	6.19703657442464e-135	SNRPA1	Malignant cells	GSE168668	ENSG00000131876	6627	small nuclear ribonucleoprotein polypeptide A'	Lea1|U2A'	protein_coding	P09661	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51500
1.07435371141932e-138	0.503473051890697	0.587	0.306	1.98572796481634e-134	TOP2B	Malignant cells	GSE168668	ENSG00000077097	7155	DNA topoisomerase II beta	top2beta|TOPIIB	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51501
2.42708989832202e-138	-0.337677470668688	0.158	0.397	4.48599025906858e-134	JARID2	Malignant cells	GSE168668	ENSG00000008083	3720	jumonji and AT-rich interaction domain containing 2	JMJ	protein_coding	Q92833	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51502
9.40560602611664e-138	-0.275543454235506	0.102	0.313	1.73843816180714e-133	POLR2M	Malignant cells	GSE168668	ENSG00000255529	81488	RNA polymerase II subunit M	Gdown|Gdown1|GRINL1A	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51503
1.36872648760771e-137	0.520977922362841	0.58	0.308	2.52981716704533e-133	PSMG1	Malignant cells	GSE168668	ENSG00000183527	8624	proteasome assembly chaperone 1	c21-LRP|DSCR2|LRPC21|PAC1	protein_coding	O95456	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51504
1.50029573015723e-137	0.400757674552079	0.982	0.942	2.77299659804961e-133	ARPC3	Malignant cells	GSE168668	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51505
4.06431943297435e-137	0.426855923735289	0.98	0.944	7.51208160796649e-133	SRP9	Malignant cells	GSE168668	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51506
2.13197341818746e-136	-0.389717601173464	0.188	0.433	3.94052646883588e-132	ELK4	Malignant cells	GSE168668	ENSG00000158711	2005	ETS transcription factor ELK4	SAP1	protein_coding	P28324	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51507
2.99997566853788e-136	0.429887072889994	0.972	0.93	5.54485502815856e-132	EIF5A	Malignant cells	GSE168668	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51508
6.65766537576808e-136	-0.281963093175423	0.109	0.323	1.23053629140321e-131	ZNF587	Malignant cells	GSE168668	ENSG00000198466	84914	zinc finger protein 587	FLJ14710|FLJ20813|UBF-fl|ZF6	protein_coding	Q96SQ5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51509
2.06016710991375e-135	-0.265988449253431	0.085	0.282	3.80780686925358e-131	AEN	Malignant cells	GSE168668	ENSG00000181026	64782	apoptosis enhancing nuclease	FLJ12484|FLJ12562|ISG20L1	protein_coding	Q8WTP8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51510
2.11513696107622e-135	-0.275779075104637	0.092	0.294	3.90940764515717e-131	CFD	Malignant cells	GSE168668	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51511
2.63197099138542e-135	0.630096499286257	0.853	0.577	4.86467198337768e-131	STMN1	Malignant cells	GSE168668	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51512
5.70203340949956e-135	0.381536186894657	0.994	0.983	1.0539068350778e-130	TXNDC17	Malignant cells	GSE168668	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51513
5.7888416638774e-135	0.415010244480763	0.97	0.937	1.06995160473446e-130	PSMB3	Malignant cells	GSE168668	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51514
6.26530406133819e-135	0.509273479266306	0.755	0.549	1.15801614965714e-130	SYNCRIP	Malignant cells	GSE168668	ENSG00000135316	10492	synaptotagmin binding cytoplasmic RNA interacting protein	dJ3J17.2|GRY-RBP|hnRNP-Q|HNRNPQ|HNRPQ1|NSAP1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51515
8.86743491276583e-135	0.523897019023722	0.974	0.847	1.63896799492651e-130	TUBB	Malignant cells	GSE168668	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51516
1.46934617240614e-134	0.67032594250154	0.665	0.449	2.71579253045827e-130	PITX1	Malignant cells	GSE168668	ENSG00000069011	5307	paired like homeodomain 1	BFT|POTX|PTX1	protein_coding	P78337	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51517
1.95227910518752e-134	0.272110408635973	1	1	3.6083974701181e-130	RPS26	Malignant cells	GSE168668	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51518
7.73551163925302e-134	0.659953809576979	0.326	0.066	1.42975461628314e-129	RDH10	Malignant cells	GSE168668	ENSG00000121039	157506	retinol dehydrogenase 10	SDR16C4	protein_coding	Q8IZV5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51519
1.10862513293931e-133	-0.254540857885955	0.079	0.269	2.04907183321172e-129	PTK2B	Malignant cells	GSE168668	ENSG00000120899	2185	protein tyrosine kinase 2 beta	CADTK|CAKB|FAK2|PTK|PYK2|RAFTK	protein_coding	Q14289	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51520
1.55628685597872e-133	0.43125140423035	0.302	0.046	2.87648499590547e-129	LAMA3	Malignant cells	GSE168668	ENSG00000053747	3909	laminin subunit alpha 3	BM600-150kDa|epiligrin|kalinin-165kDa|LAMNA|nicein-150kDa	protein_coding	Q16787	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51521
5.32252368623909e-133	-0.405099468276207	0.999	1	9.83762052927572e-129	H3F3B	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51522
1.01771232733937e-132	-0.374550687694	0.214	0.467	1.88103769462135e-128	RAB26	Malignant cells	GSE168668	ENSG00000167964	25837	RAB26, member RAS oncogene family	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51523
1.0583507455477e-132	-0.409515726230912	0.556	0.801	1.95614968299582e-128	DCTN6	Malignant cells	GSE168668	ENSG00000104671	10671	dynactin subunit 6	WS-3	protein_coding	O00399	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51524
4.08901938061642e-132	0.417852186476735	0.964	0.908	7.55773452119333e-128	POLR1D	Malignant cells	GSE168668	ENSG00000186184	51082	RNA polymerase I and III subunit D	AC19|MGC9850|RPA16|RPA9|RPAC2|RPO1-3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51525
5.86530905761079e-132	0.616482477784497	0.511	0.238	1.0840850731182e-127	GOLIM4	Malignant cells	GSE168668	ENSG00000173905	27333	golgi integral membrane protein 4	GIMPC|GOLPH4|GPP130|P138	protein_coding	O00461	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51526
1.76774851758673e-131	-0.335394549757596	0.154	0.385	3.26732958505555e-127	CWF19L2	Malignant cells	GSE168668	ENSG00000152404	143884	CWF19 like cell cycle control factor 2	FLJ32343	protein_coding	Q2TBE0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51527
2.7734522884922e-131	0.577279273399144	0.585	0.321	5.12617186482014e-127	HMGN5	Malignant cells	GSE168668	ENSG00000198157	79366	high mobility group nucleosome binding domain 5	NSBP1	protein_coding	P82970	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51528
3.71002115839893e-131	0.365741640071012	0.265	0.023	6.85723210706874e-127	GPRC5C	Malignant cells	GSE168668	ENSG00000170412	55890	G protein-coupled receptor class C group 5 member C	RAIG-3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51529
1.64528856388132e-130	-0.306467968184912	0.151	0.384	3.04098685262184e-126	CCDC32	Malignant cells	GSE168668	ENSG00000128891	90416	coiled-coil domain containing 32	C15orf57|MGC20481	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51530
3.0036634312582e-130	-0.269812448205747	0.095	0.294	5.55167111999453e-126	ZNF419	Malignant cells	GSE168668	ENSG00000105136	79744	zinc finger protein 419	ZAPHIR|ZNF419A	protein_coding	Q96HQ0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51531
4.07485473222664e-130	-0.545753339192484	0.631	0.827	7.53155400157451e-126	GABPB1-AS1	Malignant cells	GSE168668	ENSG00000244879	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51532
4.39713257122606e-130	0.491181167332864	0.333	0.073	8.12722013139713e-126	ZNF503	Malignant cells	GSE168668	ENSG00000165655	84858	zinc finger protein 503	FLJ45745|MGC2555|Nlz2	protein_coding	Q96F45	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51533
4.44750863644817e-130	-0.440059545186208	0.375	0.626	8.22033021274715e-126	A1BG	Malignant cells	GSE168668	ENSG00000121410	1	alpha-1-B glycoprotein	NA	protein_coding	P04217	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51534
4.69617927054365e-130	-0.402246671654916	0.846	0.965	8.67994814574583e-126	SARAF	Malignant cells	GSE168668	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51535
8.2835868193505e-130	-0.264296299859864	0.077	0.262	1.53105535182055e-125	RFX3	Malignant cells	GSE168668	ENSG00000080298	5991	regulatory factor X3	NA	protein_coding	P48380	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51536
3.87728791745285e-129	-0.272815804043841	0.088	0.281	7.1663912578281e-125	RCCD1	Malignant cells	GSE168668	ENSG00000166965	91433	RCC1 domain containing 1	MGC14386	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51537
4.71474536361873e-129	-0.267608395321057	0.098	0.299	8.71426385557649e-125	SUN2	Malignant cells	GSE168668	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51538
6.68782872538003e-129	0.542461950220803	0.432	0.145	1.23611138331199e-124	DDC	Malignant cells	GSE168668	ENSG00000132437	1644	dopa decarboxylase	AADC	protein_coding	P20711	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51539
1.12252486088793e-128	-0.318949467539157	0.175	0.415	2.07476270037916e-124	DRAM2	Malignant cells	GSE168668	ENSG00000156171	128338	DNA damage regulated autophagy modulator 2	MGC54289|PRO180|RP5-1180E21.1|TMEM77|WWFQ154	protein_coding	Q6UX65	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51540
1.31211501725536e-128	0.503137948097489	0.465	0.195	2.42518218639309e-124	C1orf53	Malignant cells	GSE168668	ENSG00000203724	388722	chromosome 1 open reading frame 53	NA	protein_coding	Q5VUE5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51541
5.33214717223769e-128	0.466752922913382	0.849	0.726	9.85540761844693e-124	EPCAM	Malignant cells	GSE168668	ENSG00000119888	4072	epithelial cell adhesion molecule	17-1A|323/A3|Ber-Ep4|BerEp4|CD326|CO-17A|EGP-2|EGP34|EGP40|Ep-CAM|ESA|GA733-2|HEA125|KS1/4|KSA|Ly74|M4S1|MH99|MIC18|MK-1|MOC-31|MOC31|TACST-1|TACSTD1|TROP1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51542
1.22203809565994e-127	0.513991425837252	0.515	0.241	2.25869301220827e-123	OGFRL1	Malignant cells	GSE168668	ENSG00000119900	79627	opioid growth factor receptor like 1	dJ331H24.1	protein_coding	Q5TC84	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51543
2.01104364639139e-127	0.419440114511434	0.348	0.088	3.71701197162521e-123	IRX4	Malignant cells	GSE168668	ENSG00000113430	50805	iroquois homeobox 4	NA	protein_coding	P78413	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51544
3.48068085955835e-127	0.469569721297797	0.94	0.885	6.4333424327217e-123	SELENOM	Malignant cells	GSE168668	ENSG00000198832	140606	selenoprotein M	SELM|SEPM	protein_coding	Q8WWX9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51545
4.89356915277846e-127	0.497116209901589	0.847	0.734	9.04478386508043e-123	TIMM17A	Malignant cells	GSE168668	ENSG00000134375	10440	translocase of inner mitochondrial membrane 17A	TIM17|TIM17A	protein_coding	Q99595	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51546
6.98637351044701e-127	0.393006030129082	0.973	0.933	1.29129141593592e-122	HSBP1	Malignant cells	GSE168668	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51547
1.79133333279326e-126	-0.311439826539227	0.121	0.331	3.31092139900177e-122	CTSV	Malignant cells	GSE168668	ENSG00000136943	1515	cathepsin V	CTSL2|CTSU	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51548
2.34585772249296e-126	0.368003938959764	0.994	0.979	4.33584882848375e-122	DSTN	Malignant cells	GSE168668	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51549
2.92227068193564e-126	0.306726676354156	0.873	0.634	5.40123290142165e-122	TUBB4B	Malignant cells	GSE168668	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51550
2.94338640214921e-126	-0.449724014688109	0.688	0.881	5.44026108709238e-122	ERGIC1	Malignant cells	GSE168668	ENSG00000113719	57222	endoplasmic reticulum-golgi intermediate compartment 1	ERGIC-32|ERGIC32|KIAA1181|NET24	protein_coding	Q969X5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51551
5.46185028889172e-126	0.397683555087202	0.312	0.061	1.00951378889586e-121	PPIC	Malignant cells	GSE168668	ENSG00000168938	5480	peptidylprolyl isomerase C	CYPC	protein_coding	P45877	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51552
1.33672891123493e-125	-0.420272884780037	0.459	0.707	2.47067604663552e-121	PDLIM2	Malignant cells	GSE168668	ENSG00000120913	64236	PDZ and LIM domain 2	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51553
1.6360480599381e-125	-0.325595770486812	0.104	0.302	3.02390762918358e-121	COLEC12	Malignant cells	GSE168668	ENSG00000158270	81035	collectin subfamily member 12	CL-P1|SCARA4|SRCL	protein_coding	Q5KU26	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51554
4.31146873819477e-125	0.399998788051745	0.97	0.933	7.9688876688054e-121	METTL26	Malignant cells	GSE168668	ENSG00000130731	84326	methyltransferase like 26	C16orf13|MGC13114	protein_coding	Q96S19	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51555
6.08115717403011e-125	-0.493876344679903	0.534	0.769	1.12398028047598e-120	NUDT8	Malignant cells	GSE168668	ENSG00000167799	254552	nudix hydrolase 8	FLJ41567	protein_coding	Q8WV74	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51556
6.54450322822284e-125	-0.432348603122772	0.506	0.737	1.20962053167243e-120	SINHCAF	Malignant cells	GSE168668	ENSG00000276371	58516	SIN3-HDAC complex associated factor	C12orf14|FAM60A|TERA	protein_coding	Q9NP50	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51557
8.75978558721414e-125	-0.290556135232362	0.138	0.359	1.61907117008479e-120	AP3M2	Malignant cells	GSE168668	ENSG00000070718	10947	adaptor related protein complex 3 subunit mu 2	AP47B|CLA20	protein_coding	P53677	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51558
1.12063013130851e-124	0.52678256276825	0.274	0.035	2.07126067169752e-120	HMGCS2	Malignant cells	GSE168668	ENSG00000134240	3158	3-hydroxy-3-methylglutaryl-CoA synthase 2	NA	protein_coding	P54868	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51559
1.99093210715941e-124	0.562051712324328	0.808	0.656	3.67983981366273e-120	FDPS	Malignant cells	GSE168668	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51560
2.22640889918059e-123	-0.290721078070593	0.114	0.319	4.11507156835548e-119	LRIG1	Malignant cells	GSE168668	ENSG00000144749	26018	leucine rich repeats and immunoglobulin like domains 1	DKFZP586O1624|LIG-1|LIG1	protein_coding	Q96JA1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51561
2.67957245635428e-123	-0.411318356319371	0.898	0.976	4.95265377107962e-119	NAA20	Malignant cells	GSE168668	ENSG00000173418	51126	N-alpha-acetyltransferase 20, NatB catalytic subunit	dJ1002M8.1|NAT3|NAT5	protein_coding	P61599	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51562
5.71171391066839e-123	-0.299085889702909	0.14	0.358	1.05569608210884e-118	RALGDS	Malignant cells	GSE168668	ENSG00000160271	5900	ral guanine nucleotide dissociation stimulator	RalGEF|RGDS|RGF	protein_coding	Q12967	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51563
1.34204404765334e-122	-0.250441433652867	1	1	2.48050001327768e-118	RPL31	Malignant cells	GSE168668	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51564
1.9129364268196e-122	-0.353700215606607	0.248	0.497	3.53568039769066e-118	CMTM4	Malignant cells	GSE168668	ENSG00000183723	146223	CKLF like MARVEL transmembrane domain containing 4	CKLFSF4	protein_coding	Q8IZR5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51565
3.07685727306642e-122	0.469454213847937	0.873	0.776	5.68695529780866e-118	PGLS	Malignant cells	GSE168668	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51566
3.53287851318599e-122	-0.350899349933385	0.936	0.986	6.52981935592166e-118	EIF3L	Malignant cells	GSE168668	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51567
3.88735869306007e-122	0.480630094216637	0.833	0.689	7.18500507238292e-118	VPS29	Malignant cells	GSE168668	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51568
4.10451365107299e-122	-0.330635144474958	0.188	0.423	7.58637258127822e-118	KAT6A	Malignant cells	GSE168668	ENSG00000083168	7994	lysine acetyltransferase 6A	MOZ|MYST3|RUNXBP2|ZC2HC6A|ZNF220	protein_coding	Q92794	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51569
4.53149399098063e-122	0.487332246943418	0.484	0.22	8.3755603435295e-118	USP54	Malignant cells	GSE168668	ENSG00000166348	159195	ubiquitin specific peptidase 54	bA137L10.3|bA137L10.4|C10orf29|FLJ37318	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51570
6.55032074803559e-122	-0.397084655671332	0.808	0.958	1.21069578385942e-117	TSTD1	Malignant cells	GSE168668	ENSG00000215845	100131187	thiosulfate sulfurtransferase like domain containing 1	KAT	protein_coding	Q8NFU3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51571
7.28573883587504e-122	0.536071143033302	0.61	0.334	1.34662310903478e-117	JUN	Malignant cells	GSE168668	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51572
1.04719122413594e-121	0.39164809992762	0.267	0.033	1.93552353957047e-117	IFI27L2	Malignant cells	GSE168668	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51573
2.23687479505611e-121	0.377735811635762	0.283	0.044	4.1344156837022e-117	TLE1	Malignant cells	GSE168668	ENSG00000196781	7088	TLE family member 1, transcriptional corepressor	ESG|ESG1|GRG1|TLE-1	protein_coding	Q04724	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51574
3.03111324934271e-121	0.48259763107572	0.721	0.516	5.60240661876013e-117	POP5	Malignant cells	GSE168668	ENSG00000167272	51367	POP5 homolog, ribonuclease P/MRP subunit	NA	protein_coding	Q969H6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51575
1.32636856278617e-120	0.391634458300815	0.338	0.086	2.45152701459769e-116	BAG2	Malignant cells	GSE168668	ENSG00000112208	9532	BAG cochaperone 2	NA	protein_coding	O95816	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51576
1.38652079232195e-120	-0.370298757037349	0.234	0.477	2.56270638044865e-116	CHTF18	Malignant cells	GSE168668	ENSG00000127586	63922	chromosome transmission fidelity factor 18	C16orf41|C321D2.4|CHL12|Ctf18	protein_coding	Q8WVB6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51577
6.3870804104246e-120	-0.292328290130822	0.156	0.38	1.18052407225878e-115	FKBP14	Malignant cells	GSE168668	ENSG00000106080	55033	FKBP prolyl isomerase 14	FKBP22|FLJ20731	protein_coding	Q9NWM8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51578
2.02323385886831e-119	0.266332498610484	1	1	3.7395431413463e-115	GNAS	Malignant cells	GSE168668	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51579
2.48513389215674e-119	-0.367343575571083	0.255	0.502	4.59327297287331e-115	TANC1	Malignant cells	GSE168668	ENSG00000115183	85461	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	KIAA1728|ROLSB	protein_coding	Q9C0D5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51580
6.3391245888994e-119	0.344803918749412	0.994	0.988	1.17166039776628e-114	NDUFS6	Malignant cells	GSE168668	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51581
9.70945178694235e-119	-0.254059691841003	0.099	0.292	1.79459797378055e-114	NAV1	Malignant cells	GSE168668	ENSG00000134369	89796	neuron navigator 1	DKFZp781D0314|FLJ12560|FLJ14203|KIAA1151|MGC14961|POMFIL3|steerin-1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51582
1.68252654731057e-118	-0.300257894518377	0.17	0.4	3.10981381739412e-114	PRPF39	Malignant cells	GSE168668	ENSG00000185246	55015	pre-mRNA processing factor 39	FLJ11128|FLJ20666	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51583
3.33598880879621e-118	-0.394435532494338	0.191	0.419	6.16590811529804e-114	PMAIP1	Malignant cells	GSE168668	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51584
3.69583636773468e-118	1.32390985755382	0.421	0.159	6.83101435848402e-114	CAMK2N1	Malignant cells	GSE168668	ENSG00000162545	55450	calcium/calmodulin dependent protein kinase II inhibitor 1	CaMKIINalpha	protein_coding	Q7Z7J9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51585
6.2133570799915e-118	0.309439888963975	0.999	0.998	1.14841478909483e-113	SKP1	Malignant cells	GSE168668	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51586
6.32616993212954e-118	-0.467271919578836	0.582	0.796	1.1692659885555e-113	LEO1	Malignant cells	GSE168668	ENSG00000166477	123169	LEO1 homolog, Paf1/RNA polymerase II complex component	NA	protein_coding	Q8WVC0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51587
6.63834590138682e-118	-0.39390764231088	0.367	0.615	1.22696547295333e-113	UFM1	Malignant cells	GSE168668	ENSG00000120686	51569	ubiquitin fold modifier 1	bA131P10.1|C13orf20	protein_coding	P61960	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51588
6.86791969023405e-118	-0.305536012460915	0.192	0.426	1.26939759634596e-113	ZNF226	Malignant cells	GSE168668	ENSG00000167380	7769	zinc finger protein 226	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51589
1.25922955044048e-117	-0.475502230078458	0.325	0.566	2.32743397807913e-113	PLCB4	Malignant cells	GSE168668	ENSG00000101333	5332	phospholipase C beta 4	NA	protein_coding	Q15147	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51590
2.10819021271305e-117	0.456312414497386	0.911	0.844	3.89656797015753e-113	GAMT	Malignant cells	GSE168668	ENSG00000130005	2593	guanidinoacetate N-methyltransferase	PIG2|TP53I2	protein_coding	Q14353	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51591
2.53532682187537e-117	-0.371722268284479	0.258	0.503	4.68604456487224e-113	SLC39A10	Malignant cells	GSE168668	ENSG00000196950	57181	solute carrier family 39 member 10	DKFZp564L2123|FLJ90515|KIAA1265	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51592
3.74504742985623e-117	0.396698852299227	0.968	0.934	6.92197116460326e-113	MRPS34	Malignant cells	GSE168668	ENSG00000074071	65993	mitochondrial ribosomal protein S34	MGC2616|MRP-S12	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51593
9.59353078171498e-117	-0.28915275850932	0.137	0.347	1.77317229438438e-112	RFX5	Malignant cells	GSE168668	ENSG00000143390	5993	regulatory factor X5	NA	protein_coding	P48382	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51594
1.20099760213782e-116	0.474263021286629	0.511	0.245	2.21980386803133e-112	MAFB	Malignant cells	GSE168668	ENSG00000204103	9935	MAF bZIP transcription factor B	KRML	protein_coding	Q9Y5Q3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51595
1.25177638893221e-116	0.441047512266597	0.873	0.784	2.3136582996634e-112	ZNHIT1	Malignant cells	GSE168668	ENSG00000106400	10467	zinc finger HIT-type containing 1	CG1I|H_DJ0747G18.14|ZNFN4A1	protein_coding	O43257	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51596
1.32982221723367e-116	-0.416680235658121	0.52	0.748	2.457910404113e-112	FNBP4	Malignant cells	GSE168668	ENSG00000285182	23360	formin binding protein 4	KIAA1014	protein_coding	Q8N3X1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51597
2.12105822332527e-115	-0.251128611049439	0.102	0.292	3.9203519141721e-111	IKBKB	Malignant cells	GSE168668	ENSG00000104365	3551	inhibitor of nuclear factor kappa B kinase subunit beta	IKK-beta|IKK2|IKKB|NFKBIKB	protein_coding	O14920	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51598
3.43902955533149e-115	0.384948232811104	0.999	0.987	6.35635832711919e-111	NCL	Malignant cells	GSE168668	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51599
3.97104572333208e-115	-0.567678994274403	0.555	0.736	7.33968381043468e-111	PLGRKT	Malignant cells	GSE168668	ENSG00000107020	55848	plasminogen receptor with a C-terminal lysine	AD025|C9orf46|FLJ14688|MDS030|Plg-RKT	protein_coding	Q9HBL7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51600
6.13532296512976e-115	0.375429930344205	0.978	0.953	1.13399174364493e-110	PCBD1	Malignant cells	GSE168668	ENSG00000166228	5092	pterin-4 alpha-carbinolamine dehydratase 1	DCOH|PCBD|PCD	protein_coding	P61457	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51601
8.29104128160313e-115	-0.418618461282833	0.572	0.805	1.53243316007871e-110	AARS	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51602
1.46857763148949e-114	0.482246279382298	0.596	0.363	2.71437203628203e-110	TSTA3	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51603
1.53047835522782e-114	0.412826674577869	0.91	0.829	2.82878314396758e-110	SERPINB6	Malignant cells	GSE168668	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51604
3.50259280583538e-114	-0.305384635580457	0.187	0.414	6.47384228302553e-110	C20orf96	Malignant cells	GSE168668	ENSG00000196476	140680	chromosome 20 open reading frame 96	dJ1103G7.2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51605
5.05387096501019e-114	-0.310019375800096	0.197	0.427	9.34106970462833e-110	METTL27	Malignant cells	GSE168668	ENSG00000165171	155368	methyltransferase like 27	WBSCR27	protein_coding	Q8N6F8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51606
8.37178421074687e-114	0.405097201501998	0.929	0.867	1.54735687567234e-109	NDUFA12	Malignant cells	GSE168668	ENSG00000184752	55967	NADH:ubiquinone oxidoreductase subunit A12	B17.2|DAP13	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51607
8.45152489421253e-114	0.390637585501319	0.352	0.103	1.5620953461973e-109	HTATIP2	Malignant cells	GSE168668	ENSG00000109854	10553	HIV-1 Tat interactive protein 2	CC3|FLJ26963|SDR44U1|TIP30	protein_coding	Q9BUP3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51608
1.65859035727939e-113	-0.276525320068491	0.146	0.36	3.0655725573595e-109	LIN7C	Malignant cells	GSE168668	ENSG00000148943	55327	lin-7 homolog C, crumbs cell polarity complex component	FLJ11215|LIN-7-C|LIN-7C|MALS-3|VELI3	protein_coding	Q9NUP9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51609
1.71002391080669e-113	-0.409999312894975	0.722	0.903	3.16063719434401e-109	FOXA1	Malignant cells	GSE168668	ENSG00000129514	3169	forkhead box A1	HNF3A	protein_coding	P55317	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51610
2.27549482347279e-113	0.599522646520989	0.55	0.254	4.20579708222476e-109	CDK1	Malignant cells	GSE168668	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51611
3.49553840065735e-113	-0.251804117083136	0.095	0.278	6.46080362593499e-109	TARSL2	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51612
7.7548793975908e-113	-0.476370083036637	0.626	0.819	1.43333435905671e-108	MTHFD2	Malignant cells	GSE168668	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51613
1.62253808613095e-112	-0.3588922540048	0.197	0.422	2.99893714459583e-108	ZMAT3	Malignant cells	GSE168668	ENSG00000172667	64393	zinc finger matrin-type 3	FLJ12296|MGC10613|PAG608|WIG-1|WIG1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51614
6.49616311096825e-112	0.50135730169171	0.975	0.856	1.20068582780026e-107	AR	Malignant cells	GSE168668	ENSG00000169083	367	androgen receptor	AIS|DHTR|HUMARA|NR3C4|SBMA|SMAX1	protein_coding	P10275	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51615
9.2452426741704e-112	0.448130614918226	0.832	0.703	1.70879820346691e-107	MRPL14	Malignant cells	GSE168668	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51616
1.52072121870873e-111	-0.286179810189508	0.133	0.337	2.81074902853934e-107	ITGA6	Malignant cells	GSE168668	ENSG00000091409	3655	integrin subunit alpha 6	CD49f	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51617
2.01425154994501e-111	0.458696644871433	0.522	0.259	3.72294113976336e-107	SYNE2	Malignant cells	GSE168668	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51618
2.98497690817565e-111	-0.424282284831312	0.309	0.546	5.51713281938105e-107	PLPP1	Malignant cells	GSE168668	ENSG00000067113	8611	phospholipid phosphatase 1	LPP1|PAP-2a|PPAP2A	protein_coding	O14494	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51619
3.23401985242682e-111	0.449531274554888	0.85	0.717	5.97743889324049e-107	TMED2	Malignant cells	GSE168668	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51620
1.82848827946648e-110	-0.457797856062561	0.421	0.645	3.3795948869379e-106	HAGHL	Malignant cells	GSE168668	ENSG00000103253	84264	hydroxyacylglutathione hydrolase like	MGC2605	protein_coding	Q6PII5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51621
2.42810912072222e-110	-0.286291213688417	0.138	0.34	4.48787408783087e-106	ABCC1	Malignant cells	GSE168668	ENSG00000278183	4363	ATP binding cassette subfamily C member 1	GS-X|MRP|MRP1	protein_coding	P33527	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51622
2.48204210903889e-110	0.36954562193071	0.997	0.978	4.58755843013658e-106	MGST1	Malignant cells	GSE168668	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51623
2.85102457076239e-110	-0.406864352777892	0.26	0.491	5.26954871414012e-106	ELOVL5	Malignant cells	GSE168668	ENSG00000012660	60481	ELOVL fatty acid elongase 5	dJ483K16.1|HELO1|SCA38	protein_coding	Q9NYP7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51624
6.64241289864175e-110	0.475205473536198	0.385	0.142	1.22771717605595e-105	SSFA2	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51625
8.57588758515183e-109	0.593470184918238	0.396	0.147	1.58508130236361e-104	ID3	Malignant cells	GSE168668	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51626
1.92121997699835e-108	-0.39951320038374	0.578	0.787	3.55099088348605e-104	CAST	Malignant cells	GSE168668	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51627
2.03013058562636e-108	-0.261610564309874	0.117	0.309	3.75229036141321e-104	DUSP8	Malignant cells	GSE168668	ENSG00000278165	1850	dual specificity phosphatase 8	C11orf81|FLJ42958|HB5|HVH-5	protein_coding	Q13202	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51628
9.99986900018737e-108	-0.420806427385929	0.646	0.833	1.84827578730463e-103	HOXB13	Malignant cells	GSE168668	ENSG00000159184	10481	homeobox B13	NA	protein_coding	Q92826	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51629
1.08483889552224e-107	0.285511039363123	1	1	2.00510773059375e-103	PARK7	Malignant cells	GSE168668	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51630
1.09022242567921e-107	0.43987920047487	0.554	0.31	2.01505810938288e-103	DECR1	Malignant cells	GSE168668	ENSG00000104325	1666	2,4-dienoyl-CoA reductase 1	DECR|SDR18C1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51631
1.36323148853752e-107	-0.289261557144962	0.154	0.362	2.5196607602639e-103	PASK	Malignant cells	GSE168668	ENSG00000115687	23178	PAS domain containing serine/threonine kinase	KIAA0135|PASKIN|STK37	protein_coding	Q96RG2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51632
1.8136735571781e-107	-0.288739415604406	0.115	0.304	3.35221283573228e-103	FN1	Malignant cells	GSE168668	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51633
2.17309914570825e-107	0.444753105908053	0.606	0.361	4.01653915101256e-103	MAP1LC3B	Malignant cells	GSE168668	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51634
2.35416298178679e-107	-0.303182096380553	0.157	0.366	4.35119943923652e-103	DDB2	Malignant cells	GSE168668	ENSG00000134574	1643	damage specific DNA binding protein 2	DDBB|FLJ34321|UV-DDB2|XPE	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51635
1.13048461263346e-106	0.775497106054682	0.895	0.793	2.08947470953043e-102	SOX4	Malignant cells	GSE168668	ENSG00000124766	6659	SRY-box transcription factor 4	NA	protein_coding	Q06945	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51636
1.175402360038e-106	0.392791161388171	0.952	0.907	2.17249618205823e-102	STUB1	Malignant cells	GSE168668	ENSG00000103266	10273	STIP1 homology and U-box containing protein 1	CHIP|HSPABP2|NY-CO-7|SDCCAG7|UBOX1	protein_coding	Q9UNE7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51637
2.1629794759405e-106	-0.256895540885675	0.129	0.325	3.99783496538082e-102	RGMB	Malignant cells	GSE168668	ENSG00000174136	285704	repulsive guidance molecule BMP co-receptor b	DRAGON|FLJ90406	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51638
3.12227749513203e-106	-0.467032160050754	0.94	0.966	5.77090549425253e-102	HIST1H4C	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51639
3.62080083470845e-106	-0.337461249275574	0.277	0.515	6.69232618279163e-102	BNIP2	Malignant cells	GSE168668	ENSG00000140299	663	BCL2 interacting protein 2	BNIP-2|Nip2	protein_coding	Q12982	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51640
5.38918475900299e-106	-0.277569396249994	0.175	0.392	9.96083019006523e-102	FAM219B	Malignant cells	GSE168668	ENSG00000178761	57184	family with sequence similarity 219 member B	C15orf17|FLJ00005	protein_coding	Q5XKK7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51641
5.70407485629879e-106	0.423459395601691	0.491	0.238	1.05428415568971e-101	ODF2L	Malignant cells	GSE168668	ENSG00000122417	57489	outer dense fiber of sperm tails 2 like	KIAA1229	protein_coding	Q9ULJ1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51642
7.44130817000734e-106	0.39793607089001	0.927	0.866	1.37537698906246e-101	POLD2	Malignant cells	GSE168668	ENSG00000106628	5425	DNA polymerase delta 2, accessory subunit	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51643
1.09633007905672e-105	0.460032576649417	0.721	0.552	2.02634688512053e-101	TRAPPC2L	Malignant cells	GSE168668	ENSG00000167515	51693	trafficking protein particle complex subunit 2L	HSPC176	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51644
2.6230316313191e-105	-0.381149751503648	0.474	0.701	4.84814936416709e-101	MACROD1	Malignant cells	GSE168668	ENSG00000133315	28992	mono-ADP ribosylhydrolase 1	LRP16	protein_coding	Q9BQ69	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51645
2.91408309328655e-105	0.430571037483923	0.868	0.783	5.38609978132153e-101	SRSF7	Malignant cells	GSE168668	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51646
3.49198184937295e-105	0.449099119337532	0.581	0.349	6.45423005219603e-101	FNDC10	Malignant cells	GSE168668	ENSG00000228594	643988	fibronectin type III domain containing 10	C1orf233	protein_coding	F2Z333	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51647
3.6512353130404e-105	-0.377677677909766	0.413	0.658	6.74857822909258e-101	ZNF667-AS1	Malignant cells	GSE168668	ENSG00000166770	100128252	ZNF667 antisense RNA 1 (head to head)	MORT	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51648
4.83375512254605e-105	-0.382611812794582	0.67	0.864	8.93422959300186e-101	SCOC	Malignant cells	GSE168668	ENSG00000153130	60592	short coiled-coil protein	HRIHFB2072|SCOCO|UNC-69	protein_coding	Q9UIL1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51649
5.40400056503273e-105	-0.250312321093741	0.104	0.285	9.98821424435e-101	GNB5	Malignant cells	GSE168668	ENSG00000069966	10681	G protein subunit beta 5	GB5	protein_coding	O14775	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51650
1.50484947333063e-104	0.573983354122244	0.491	0.255	2.781413281557e-100	NIPSNAP3A	Malignant cells	GSE168668	ENSG00000136783	25934	nipsnap homolog 3A	DKFZp564D177|FLJ13953|HSPC299|MGC14553|NIPSNAP4|TassC	protein_coding	Q9UFN0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51651
3.08974345449692e-104	-0.404093881821163	0.491	0.699	5.71077282694666e-100	CCNH	Malignant cells	GSE168668	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51652
3.39958002848916e-104	0.407551376757849	0.888	0.814	6.28344376665651e-100	PSMD2	Malignant cells	GSE168668	ENSG00000175166	5708	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	MGC14274|P97|Rpn1|S2|TRAP2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51653
4.01064889732565e-104	-0.329911309854756	0.268	0.5	7.412882356927e-100	ELP2	Malignant cells	GSE168668	ENSG00000134759	55250	elongator acetyltransferase complex subunit 2	FLJ10879|STATIP1|StIP	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51654
5.02373153479775e-104	-0.317088859830562	0.275	0.512	9.28536299576667e-100	DEAF1	Malignant cells	GSE168668	ENSG00000282712	10522	DEAF1 transcription factor	NUDR|SPN|ZMYND5	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51655
2.07554323736707e-103	-0.26636743442049	0.144	0.346	3.83622656562555e-99	CEP164	Malignant cells	GSE168668	ENSG00000110274	22897	centrosomal protein 164	KIAA1052|NPHP15	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51656
2.09552226624201e-103	0.397029514108693	0.944	0.891	3.87315380469511e-99	ARL6IP5	Malignant cells	GSE168668	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51657
2.78316260812726e-103	0.333652488315276	0.991	0.982	5.14411944860162e-99	ATP6V1F	Malignant cells	GSE168668	ENSG00000128524	9296	ATPase H+ transporting V1 subunit F	ATP6S14|VATF|Vma7	protein_coding	Q16864	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51658
3.07429503163833e-103	-0.27342414806138	0.995	1	5.68221950697713e-99	MZT2B	Malignant cells	GSE168668	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51659
3.55290982196874e-103	-0.27048558727699	0.145	0.347	6.56684322394482e-99	SMIM1	Malignant cells	GSE168668	ENSG00000235169	388588	small integral membrane protein 1 (Vel blood group)	Vel	protein_coding	B2RUZ4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51660
5.51929670365347e-103	-0.360675049302292	0.124	0.312	1.02013160973627e-98	LRRC75A	Malignant cells	GSE168668	ENSG00000181350	388341	leucine rich repeat containing 75A	C17orf76|FAM211A|FLJ35696	protein_coding	Q8NAA5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51661
8.69123610115821e-103	-0.374075305250407	0.344	0.577	1.60640116857707e-98	CTNNAL1	Malignant cells	GSE168668	ENSG00000119326	8727	catenin alpha like 1	alpha-CATU|CLLP	protein_coding	Q9UBT7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51662
8.74142343409167e-103	-0.29692795636904	0.192	0.408	1.61567729332316e-98	DPH6	Malignant cells	GSE168668	ENSG00000134146	89978	diphthamine biosynthesis 6	ATPBD4|MGC14798	protein_coding	Q7L8W6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51663
1.58486346496791e-102	-0.274498479184962	0.178	0.397	2.92930314230019e-98	DNAJC15	Malignant cells	GSE168668	ENSG00000120675	29103	DnaJ heat shock protein family (Hsp40) member C15	DNAJD1|MCJ	protein_coding	Q9Y5T4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51664
1.65921118786307e-102	-0.36044918691561	0.701	0.879	3.06672003852731e-98	EIF2S3	Malignant cells	GSE168668	ENSG00000130741	1968	eukaryotic translation initiation factor 2 subunit gamma	EIF2|EIF2G|EIF2gamma	protein_coding	P41091	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51665
1.88400603017758e-102	0.455683673296362	0.734	0.565	3.48220834557722e-98	ADAM15	Malignant cells	GSE168668	ENSG00000143537	8751	ADAM metallopeptidase domain 15	MDC15	protein_coding	Q13444	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51666
2.0094686273523e-102	0.392304588838791	0.896	0.826	3.71410086393526e-98	ARPC2	Malignant cells	GSE168668	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51667
4.54630769790584e-102	0.258330234809902	1	0.999	8.40294051803937e-98	SLC25A3	Malignant cells	GSE168668	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51668
5.49959219189806e-102	-0.269314304528046	0.133	0.325	1.01648962482852e-97	TOLLIP-AS1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51669
7.18953640663752e-102	0.420071382515878	0.511	0.272	1.32884201403881e-97	FAM229B	Malignant cells	GSE168668	ENSG00000203778	619208	family with sequence similarity 229 member B	C6orf225|DKFZp586F0922|LOC619208	protein_coding	Q4G0N7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51670
7.32079598233662e-102	0.437330199815548	0.678	0.474	1.35310272141528e-97	PCMT1	Malignant cells	GSE168668	ENSG00000120265	5110	protein-L-isoaspartate (D-aspartate) O-methyltransferase	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51671
8.02282380409184e-102	0.486004568481338	0.551	0.314	1.48285852371029e-97	HSPH1	Malignant cells	GSE168668	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51672
9.7591970064185e-102	-0.326452136685605	0.254	0.482	1.80379238269633e-97	JOSD1	Malignant cells	GSE168668	ENSG00000100221	9929	Josephin domain containing 1	KIAA0063	protein_coding	Q15040	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51673
1.1617362048727e-101	-0.374972374640169	0.364	0.593	2.14723702746622e-97	EPN2	Malignant cells	GSE168668	ENSG00000072134	22905	epsin 2	EHB21|KIAA1065	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51674
1.53239422866676e-101	-0.3122918384742	0.222	0.445	2.83232425284478e-97	MLPH	Malignant cells	GSE168668	ENSG00000115648	79083	melanophilin	exophilin-3|l(1)-3Rk|l1Rk3|ln|Slac-2a	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51675
2.12975743551169e-101	-0.298529961612596	0.192	0.406	3.93643066805625e-97	SNAPC3	Malignant cells	GSE168668	ENSG00000164975	6619	small nuclear RNA activating complex polypeptide 3	MGC132011|MGC33124|PTFbeta|SNAP50	protein_coding	Q92966	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51676
3.78474886753085e-101	-0.394181344990819	0.369	0.597	6.99535133185726e-97	C12orf75	Malignant cells	GSE168668	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51677
4.27366410076775e-101	-0.300204072383824	0.185	0.396	7.89901335744903e-97	WWC1	Malignant cells	GSE168668	ENSG00000113645	23286	WW and C2 domain containing 1	KIAA0869|KIBRA|PPP1R168	protein_coding	Q8IX03	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51678
4.63252311465099e-101	0.406278069727642	0.849	0.747	8.56229247280943e-97	STRAP	Malignant cells	GSE168668	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51679
5.48445220063092e-101	0.41157168040071	0.549	0.307	1.01369130024261e-96	CDC5L	Malignant cells	GSE168668	ENSG00000096401	988	cell division cycle 5 like	CDC5|CEF1|hCDC5|PCDC5RP	protein_coding	Q99459	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51680
5.99426823390026e-101	-0.267955237511933	0.153	0.356	1.10792059767178e-96	PRKCD	Malignant cells	GSE168668	ENSG00000163932	5580	protein kinase C delta	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51681
1.59270674719144e-100	0.45860290411938	0.833	0.709	2.94379988083394e-96	BEX2	Malignant cells	GSE168668	ENSG00000133134	84707	brain expressed X-linked 2	DJ79P11.1	protein_coding	Q9BXY8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51682
2.71497501250074e-100	-0.357841219732689	0.376	0.615	5.01808831560512e-96	ACACA	Malignant cells	GSE168668	ENSG00000275176	31	acetyl-CoA carboxylase alpha	ACAC|Acac1|ACACalpha|ACC|ACC-alpha|ACC1|ACCA|ACCalpha|hACC1	protein_coding	Q13085	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51683
6.66724165686542e-100	-0.328130364742198	0.259	0.483	1.23230627543844e-95	TLK1	Malignant cells	GSE168668	ENSG00000198586	9874	tousled like kinase 1	KIAA0137|PKU-BETA	protein_coding	Q9UKI8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51684
1.01592005053773e-99	0.340221800650319	0.984	0.959	1.87772502940889e-95	CCT6A	Malignant cells	GSE168668	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51685
1.5196941152195e-99	-0.282089466902711	0.189	0.402	2.80885063316019e-95	SMIM27	Malignant cells	GSE168668	ENSG00000235453	100129250	small integral membrane protein 27	C9orf133|TOPORS-AS1	protein_coding	A0A1B0GUW7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51686
1.82302611529169e-99	0.457289659093541	0.838	0.708	3.36949916889362e-95	IDH1	Malignant cells	GSE168668	ENSG00000138413	3417	isocitrate dehydrogenase (NADP(+)) 1	NA	protein_coding	O75874	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51687
2.54365705860705e-99	-0.439814515388619	0.358	0.597	4.70144134142341e-95	EFNA5	Malignant cells	GSE168668	ENSG00000184349	1946	ephrin A5	AF1|EPLG7|LERK7	protein_coding	P52803	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51688
2.54706292575106e-99	0.421272439877446	0.571	0.338	4.70773640566569e-95	DAAM1	Malignant cells	GSE168668	ENSG00000100592	23002	dishevelled associated activator of morphogenesis 1	KIAA0666	protein_coding	Q9Y4D1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51689
2.82902356551073e-99	0.462136233152379	0.808	0.692	5.22888425613349e-95	LTBP3	Malignant cells	GSE168668	ENSG00000168056	4054	latent transforming growth factor beta binding protein 3	LTBP2	protein_coding	Q9NS15	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51690
3.20050333985489e-99	-0.34663344366226	0.851	0.961	5.9154903230538e-95	FBL	Malignant cells	GSE168668	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51691
3.30292240485366e-99	0.477555849752286	0.746	0.558	6.10479148089101e-95	BARD1	Malignant cells	GSE168668	ENSG00000138376	580	BRCA1 associated RING domain 1	NA	protein_coding	Q99728	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51692
4.62177315146423e-99	-0.266566207941962	0.17	0.378	8.54242331585134e-95	MTFMT	Malignant cells	GSE168668	ENSG00000103707	123263	mitochondrial methionyl-tRNA formyltransferase	FMT1	protein_coding	Q96DP5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51693
1.28377815825318e-98	-0.350298266191944	0.31	0.539	2.37280716989934e-94	AL441992.1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51694
2.11001116628919e-98	0.411072953023446	0.869	0.781	3.89993363865232e-94	ZNF706	Malignant cells	GSE168668	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51695
2.20215564012596e-98	0.399380736854019	0.866	0.766	4.07024426964482e-94	ENY2	Malignant cells	GSE168668	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51696
3.24545521948541e-98	0.427030764061519	0.821	0.716	5.99857488217488e-94	MTX1	Malignant cells	GSE168668	ENSG00000173171	4580	metaxin 1	MTX|MTXN	protein_coding	Q13505	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51697
3.30706269973782e-98	0.412359628862523	0.811	0.682	6.11244398792542e-94	VPS35	Malignant cells	GSE168668	ENSG00000069329	55737	VPS35 retromer complex component	FLJ10752|MEM3|PARK17	protein_coding	Q96QK1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51698
3.74127034954799e-98	0.447604255068623	0.516	0.272	6.91498998706954e-94	LIN7A	Malignant cells	GSE168668	ENSG00000111052	8825	lin-7 homolog A, crumbs cell polarity complex component	LIN-7A|MALS-1|TIP-33|VELI1	protein_coding	O14910	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51699
4.11140415431836e-98	-0.296938180919355	0.2	0.413	7.59910829842663e-94	NDFIP2	Malignant cells	GSE168668	ENSG00000102471	54602	Nedd4 family interacting protein 2	KIAA1165|N4wbp5a	protein_coding	Q9NV92	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51700
4.29645944758104e-98	0.400074627885185	0.43	0.194	7.94114599696404e-94	SMARCD3	Malignant cells	GSE168668	ENSG00000082014	6604	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3	BAF60C|CRACD3|Rsc6p	protein_coding	Q6STE5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51701
4.69580119520586e-98	0.429891104007123	0.698	0.478	8.67924934909899e-94	KIF22	Malignant cells	GSE168668	ENSG00000079616	3835	kinesin family member 22	Kid|KNSL4|OBP-1|OBP-2	protein_coding	Q14807	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51702
6.737325919563e-98	-0.361917619630082	0.941	0.986	1.24525994971283e-93	UQCC2	Malignant cells	GSE168668	ENSG00000137288	84300	ubiquinol-cytochrome c reductase complex assembly factor 2	bA6B20.2|C6orf125|Cbp6|M19|MGC14833|MNF1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51703
1.0583117825813e-97	-0.376607212679345	0.494	0.703	1.95607766774501e-93	NPM3	Malignant cells	GSE168668	ENSG00000107833	10360	nucleophosmin/nucleoplasmin 3	NA	protein_coding	O75607	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51704
1.38500333092063e-97	0.524569557274722	0.878	0.781	2.5599016565406e-93	TM7SF2	Malignant cells	GSE168668	ENSG00000149809	7108	transmembrane 7 superfamily member 2	ANG1|DHCR14A|NET47	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51705
1.71139688645705e-97	-0.377085804920884	0.443	0.661	3.16317486523857e-93	RABGGTB	Malignant cells	GSE168668	ENSG00000137955	5876	Rab geranylgeranyltransferase subunit beta	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51706
1.86367550865045e-97	-0.344708047691254	0.345	0.574	3.44463144263863e-93	COA1	Malignant cells	GSE168668	ENSG00000106603	55744	cytochrome c oxidase assembly factor 1	C7orf44|FLJ10803|MITRAC15	protein_coding	Q9GZY4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51707
2.58326261324419e-97	-0.34475675505322	0.549	0.772	4.77464428805925e-93	PSMD13	Malignant cells	GSE168668	ENSG00000185627	5719	proteasome 26S subunit, non-ATPase 13	p40.5|Rpn9	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51708
3.11308365692923e-97	-0.294855092896852	0.197	0.409	5.7539125231023e-93	PPM1K	Malignant cells	GSE168668	ENSG00000163644	152926	protein phosphatase, Mg2+/Mn2+ dependent 1K	BDP|DKFZp761G058|hPTMP|PP2Ckappa|PP2Cm	protein_coding	Q8N3J5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51709
3.18339100558027e-97	0.369074517648034	0.958	0.91	5.88386159561402e-93	ERP29	Malignant cells	GSE168668	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51710
4.28838087240486e-97	0.320144661809316	0.996	0.988	7.9262143664659e-93	MRPL20	Malignant cells	GSE168668	ENSG00000242485	55052	mitochondrial ribosomal protein L20	FLJ10024	protein_coding	Q9BYC9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51711
7.92084433801325e-97	-0.37741327255493	0.336	0.559	1.46400965899499e-92	WSB1	Malignant cells	GSE168668	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51712
8.41226707109992e-97	-0.273735175477282	0.169	0.372	1.5548393227514e-92	DTNB	Malignant cells	GSE168668	ENSG00000138101	1838	dystrobrevin beta	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51713
8.78485743922292e-97	0.417070272318797	0.446	0.214	1.62370520049157e-92	SAYSD1	Malignant cells	GSE168668	ENSG00000112167	55776	SAYSVFN motif domain containing 1	C6orf64|FLJ11101	protein_coding	Q9NPB0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51714
1.60907925580125e-96	0.422591645707934	0.632	0.431	2.97406118849745e-92	CFAP298	Malignant cells	GSE168668	ENSG00000159079	56683	cilia and flagella associated protein 298	C21orf48|C21orf59|CILD26|DNAAF16|FBB18|FLJ20467|Kur	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51715
1.70059765495263e-96	0.327032916517372	0.275	0.064	3.14321464564895e-92	SH3BGRL	Malignant cells	GSE168668	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51716
1.96628441288927e-96	-0.255876658062833	0.135	0.325	3.63428348034323e-92	RHOBTB3	Malignant cells	GSE168668	ENSG00000164292	22836	Rho related BTB domain containing 3	KIAA0878	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51717
2.34118096232136e-96	0.369147985956879	0.914	0.865	4.32720477265858e-92	PSMC5	Malignant cells	GSE168668	ENSG00000087191	5705	proteasome 26S subunit, ATPase 5	p45|p45/SUG|RPT6|S8|SUG-1|SUG1|TBP10|TRIP1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51718
2.39369834970137e-96	0.289353256516378	0.999	0.998	4.42427265975304e-92	CFL1	Malignant cells	GSE168668	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51719
2.43172522327068e-96	-0.393200748211381	0.415	0.631	4.49455773017119e-92	NAAA	Malignant cells	GSE168668	ENSG00000138744	27163	N-acylethanolamine acid amidase	ASAHL	protein_coding	Q02083	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51720
2.49525692609537e-96	-0.379523123343839	0.83	0.94	4.61198337650208e-92	CIB1	Malignant cells	GSE168668	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51721
2.56221662962758e-96	0.430176958299388	0.791	0.661	4.73574499654065e-92	DCTPP1	Malignant cells	GSE168668	ENSG00000179958	79077	dCTP pyrophosphatase 1	CDA03|MGC5627|RS21C6|XTP3TPA	protein_coding	Q9H773	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51722
2.76171862263898e-96	-0.3687817843314	0.637	0.829	5.10448453022363e-92	C6orf48	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51723
3.44521900623187e-96	0.307548714841055	0.994	0.985	6.36779828921837e-92	MRPL51	Malignant cells	GSE168668	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51724
6.41927398124309e-96	-0.370139272192546	0.456	0.673	1.18647440995316e-91	PRKD1	Malignant cells	GSE168668	ENSG00000184304	5587	protein kinase D1	PKC-mu|PKCM|PKD|PRKCM	protein_coding	Q15139	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51725
7.24168408349162e-96	-0.347481461291008	0.331	0.555	1.33848046915176e-91	SPINT1	Malignant cells	GSE168668	ENSG00000166145	6692	serine peptidase inhibitor, Kunitz type 1	HAI|HAI-1|MANSC2	protein_coding	O43278	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51726
8.78949166684716e-96	0.426684061763474	0.612	0.399	1.62456174478336e-91	CSKMT	Malignant cells	GSE168668	ENSG00000214756	751071	citrate synthase lysine methyltransferase	CS-KMT|METTL12|U99HG	protein_coding	A8MUP2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51727
1.13357802583042e-95	0.437834436347249	0.503	0.273	2.09519226514236e-91	ACAT2	Malignant cells	GSE168668	ENSG00000120437	39	acetyl-CoA acetyltransferase 2	NA	protein_coding	Q9BWD1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51728
2.03052421356153e-95	-0.263564307193552	0.158	0.356	3.75301790392578e-91	TTC39C	Malignant cells	GSE168668	ENSG00000168234	125488	tetratricopeptide repeat domain 39C	C18orf17|FLJ33761|HsT2697	protein_coding	Q8N584	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51729
2.69836802806816e-95	-0.475236604868402	0.626	0.8	4.98739362627839e-91	CEBPB	Malignant cells	GSE168668	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51730
2.81233836721779e-95	-0.352983297261802	0.668	0.852	5.19804500412863e-91	NUDT2	Malignant cells	GSE168668	ENSG00000164978	318	nudix hydrolase 2	APAH1	protein_coding	P50583	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51731
5.3827777980992e-95	-0.410719769227181	0.541	0.737	9.94898820422675e-91	FAM118A	Malignant cells	GSE168668	ENSG00000100376	55007	family with sequence similarity 118 member A	bK268H5.C22.4|C22orf8|FLJ20635	protein_coding	Q9NWS6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51732
6.132583201756e-95	-0.622505976833803	0.787	0.88	1.13348535318056e-90	H1FX	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51733
7.50722359027192e-95	0.415127883791897	0.588	0.373	1.38756013618996e-90	DHX9	Malignant cells	GSE168668	ENSG00000135829	1660	DExH-box helicase 9	DDX9|LKP|RHA	protein_coding	Q08211	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51734
8.61862197224183e-95	-0.363602183857996	0.419	0.644	1.59297989912946e-90	FECH	Malignant cells	GSE168668	ENSG00000066926	2235	ferrochelatase	NA	protein_coding	P22830	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51735
1.30726798272334e-94	0.363611563254125	0.261	0.057	2.41622341246754e-90	LGALS3BP	Malignant cells	GSE168668	ENSG00000108679	3959	galectin 3 binding protein	90K|BTBD17B|CyCAP|gp90|M2BP|MAC-2-BP|TANGO10B	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51736
1.76457129739016e-94	-0.408795275428185	0.326	0.54	3.26145712896624e-90	TPM4	Malignant cells	GSE168668	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51737
1.94360121100751e-94	-0.383296059294054	0.675	0.849	3.59235811830517e-90	GSTO1	Malignant cells	GSE168668	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51738
2.06933585671546e-94	0.357232182008997	0.953	0.913	3.82475346396719e-90	PSMB6	Malignant cells	GSE168668	ENSG00000142507	5694	proteasome 20S subunit beta 6	DELTA|Y	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51739
5.6025463738536e-94	0.428218191824211	0.736	0.585	1.03551864627936e-89	GTF2H5	Malignant cells	GSE168668	ENSG00000272047	404672	general transcription factor IIH subunit 5	bA120J8.2|C6orf175|FLJ30544|TFB5|TFIIH|TTD|TTD-A|TTDA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51740
7.2028891963855e-94	-0.277874305594742	0.178	0.38	1.33131001016793e-89	AC062017.1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51741
1.2729085120038e-93	-0.492675939033625	0.786	0.878	2.35271680273662e-89	PSAT1	Malignant cells	GSE168668	ENSG00000135069	29968	phosphoserine aminotransferase 1	PSA|PSAT	protein_coding	Q9Y617	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51742
2.84263138368269e-93	-0.290395787503534	0.214	0.425	5.25403558646071e-89	DRG1	Malignant cells	GSE168668	ENSG00000185721	4733	developmentally regulated GTP binding protein 1	NEDD3	protein_coding	Q9Y295	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51743
7.88701166832808e-93	0.331155087644825	0.988	0.969	1.45775636665708e-88	NME1	Malignant cells	GSE168668	ENSG00000239672	4830	NME/NM23 nucleoside diphosphate kinase 1	NDPKA|NM23|NM23-H1	protein_coding	P15531	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51744
1.43532923309113e-92	0.380189603554588	0.962	0.89	2.65291902152233e-88	PKM	Malignant cells	GSE168668	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51745
2.20362470045664e-92	-0.33894283844856	0.609	0.805	4.07295953385401e-88	DHPS	Malignant cells	GSE168668	ENSG00000095059	1725	deoxyhypusine synthase	MIG13	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51746
2.31495451227485e-92	-0.351299805096219	0.772	0.915	4.2787304250376e-88	NDUFA3	Malignant cells	GSE168668	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51747
3.16946158078985e-92	0.400780576934228	0.834	0.734	5.85811583977388e-88	SCP2	Malignant cells	GSE168668	ENSG00000116171	6342	sterol carrier protein 2	NA	protein_coding	P22307	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51748
3.2712624614601e-92	0.425423684887663	0.77	0.641	6.04627440751671e-88	HDAC2	Malignant cells	GSE168668	ENSG00000196591	3066	histone deacetylase 2	KDAC2|RPD3|YAF1	protein_coding	Q92769	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51749
3.75717776821257e-92	-0.33351493707957	0.839	0.951	6.9443916689873e-88	SMDT1	Malignant cells	GSE168668	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51750
4.31236329037308e-92	-0.273607630386375	0.181	0.383	7.97054106959656e-88	LARP1B	Malignant cells	GSE168668	ENSG00000138709	55132	La ribonucleoprotein 1B	DKFZp434K245|DKFZp686E0316|FLJ10378|LARP2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51751
4.82615298409473e-92	0.357789540456791	0.93	0.879	8.92017856050229e-88	TCEAL4	Malignant cells	GSE168668	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51752
8.75689964999107e-92	0.317357033915498	0.261	0.059	1.61853776230785e-87	DPYSL2	Malignant cells	GSE168668	ENSG00000092964	1808	dihydropyrimidinase like 2	CRMP2|DHPRP2|DRP-2|DRP2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51753
1.2377609499825e-91	0.370237937833712	0.935	0.891	2.28775356385265e-87	XRCC5	Malignant cells	GSE168668	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51754
1.28614718600558e-91	0.322997218755409	0.986	0.975	2.37718584389412e-87	DAD1	Malignant cells	GSE168668	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51755
3.76451030131468e-91	0.413250668166672	0.571	0.355	6.95794438991992e-87	SLC52A2	Malignant cells	GSE168668	ENSG00000285112	79581	solute carrier family 52 member 2	D15Ertd747e|FLJ11856|GPCR41|GPR172A|hRFT3|PAR1|RFVT2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51756
5.52088510936895e-91	0.396719203834702	0.875	0.795	1.02042519476466e-86	DNAJA1	Malignant cells	GSE168668	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51757
2.01575053433554e-90	-0.394897523993527	0.795	0.908	3.72571171261237e-86	FAM177A1	Malignant cells	GSE168668	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51758
2.18796651228535e-90	0.292491384702248	1	0.999	4.04401850465702e-86	FTL	Malignant cells	GSE168668	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51759
2.66264439197931e-90	-0.332241508786961	0.293	0.51	4.92136562969536e-86	JMY	Malignant cells	GSE168668	ENSG00000152409	133746	junction mediating and regulatory protein, p53 cofactor	FLJ37870|WHAMM2	protein_coding	Q8N9B5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51760
2.73137536574537e-90	-0.263566123136741	0.162	0.356	5.04840108850717e-86	IFI6	Malignant cells	GSE168668	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51761
3.62337681798198e-90	-0.287474889482341	0.199	0.405	6.69708737267609e-86	BBS4	Malignant cells	GSE168668	ENSG00000140463	585	Bardet-Biedl syndrome 4	NA	protein_coding	Q96RK4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51762
3.76930837751288e-90	0.351809506493201	0.379	0.157	6.96681267415706e-86	HIBCH	Malignant cells	GSE168668	ENSG00000198130	26275	3-hydroxyisobutyryl-CoA hydrolase	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51763
6.96843054370612e-90	0.41308843470628	0.746	0.597	1.2879750173932e-85	MRPL15	Malignant cells	GSE168668	ENSG00000137547	29088	mitochondrial ribosomal protein L15	HSPC145|L15mt|MRP-L15|MRP-L7|RPML7	protein_coding	Q9P015	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51764
7.07413659381146e-90	-0.327565223710772	0.238	0.443	1.30751266663417e-85	ESRP1	Malignant cells	GSE168668	ENSG00000104413	54845	epithelial splicing regulatory protein 1	FLJ20171|RBM35A	protein_coding	Q6NXG1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51765
1.3640007606785e-89	-0.34703613871742	0.362	0.587	2.52108260596208e-85	PHLDA3	Malignant cells	GSE168668	ENSG00000174307	23612	pleckstrin homology like domain family A member 3	TIH1	protein_coding	Q9Y5J5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51766
2.07935183232674e-89	-0.330488650554937	0.215	0.417	3.84326599168952e-85	PLEKHA5	Malignant cells	GSE168668	ENSG00000052126	54477	pleckstrin homology domain containing A5	FLJ10667|KIAA1686|PEPP2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51767
2.75390816232722e-89	0.387518225106265	0.631	0.429	5.0900484564294e-85	ACOT13	Malignant cells	GSE168668	ENSG00000112304	55856	acyl-CoA thioesterase 13	HT012|THEM2	protein_coding	Q9NPJ3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51768
2.88872869806169e-89	-0.33063962381118	0.282	0.502	5.33923725262742e-85	SYCE3	Malignant cells	GSE168668	ENSG00000217442	644186	synaptonemal complex central element protein 3	C22orf41	protein_coding	A1L190	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51769
8.61321980858606e-89	-0.279881964304963	0.184	0.382	1.59198141722096e-84	ERICH1	Malignant cells	GSE168668	ENSG00000282665	157697	glutamate rich 1	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51770
9.60259790166917e-89	0.337194466760344	0.965	0.939	1.77484817016551e-84	ATP5F1C	Malignant cells	GSE168668	ENSG00000165629	509	ATP synthase F1 subunit gamma	ATP5C|ATP5C1|ATP5CL1	protein_coding	P36542	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51771
1.04445383715828e-88	0.403831926247036	0.466	0.243	1.93046402721965e-84	HSPA1B	Malignant cells	GSE168668	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51772
1.10105789488577e-88	-0.366563169970183	0.424	0.629	2.03508530711737e-84	APMAP	Malignant cells	GSE168668	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51773
1.16470931718309e-88	-0.32904027695369	0.675	0.856	2.1527322309495e-84	EIF2A	Malignant cells	GSE168668	ENSG00000144895	83939	eukaryotic translation initiation factor 2A	EIF-2A	protein_coding	Q9BY44	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51774
1.5057911151991e-88	-0.287660270059834	0.268	0.486	2.7831537182225e-84	C22orf39	Malignant cells	GSE168668	ENSG00000242259	128977	chromosome 22 open reading frame 39	MGC74441	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51775
1.80493433175698e-88	-0.28312904436849	0.211	0.417	3.33606012538642e-84	RNF169	Malignant cells	GSE168668	ENSG00000166439	254225	ring finger protein 169	KIAA1991	protein_coding	Q8NCN4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51776
1.9344950220631e-88	0.413276806016821	0.792	0.63	3.57552714927923e-84	ST3GAL1	Malignant cells	GSE168668	ENSG00000008513	6482	ST3 beta-galactoside alpha-2,3-sialyltransferase 1	SIAT4A|SIATFL|ST3GalA.1|ST3O	protein_coding	Q11201	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51777
2.43550732736967e-88	-0.370441526202725	0.451	0.655	4.50154819317736e-84	RNF213	Malignant cells	GSE168668	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51778
2.43812725730861e-88	-0.300654631820708	0.24	0.45	4.50639060968351e-84	SEL1L3	Malignant cells	GSE168668	ENSG00000091490	23231	SEL1L family member 3	KIAA0746	protein_coding	Q68CR1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51779
2.58859719852176e-88	0.339764677042535	0.964	0.942	4.78450420202778e-84	PHB	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51780
3.03650583405326e-88	-0.335552233153536	0.951	0.981	5.61237373308064e-84	KTN1	Malignant cells	GSE168668	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51781
3.76553965999557e-88	-0.321829219699059	0.28	0.493	6.9598469535698e-84	KLF9	Malignant cells	GSE168668	ENSG00000119138	687	KLF transcription factor 9	BTEB1	protein_coding	Q13886	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51782
3.90533123383554e-88	0.40721122616123	0.709	0.545	7.21822371949822e-84	FH	Malignant cells	GSE168668	ENSG00000091483	2271	fumarate hydratase	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51783
4.35418728455569e-88	0.400414033998511	0.941	0.897	8.04784435804428e-84	P4HB	Malignant cells	GSE168668	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51784
1.37567607407865e-87	0.280353792222433	0.999	0.994	2.54266208771957e-83	PSMA7	Malignant cells	GSE168668	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51785
2.62906861814278e-87	0.379778715709538	0.431	0.212	4.85930752691331e-83	REEP6	Malignant cells	GSE168668	ENSG00000115255	92840	receptor accessory protein 6	C19orf32|DP1L1|FLJ25383|Yip2f	protein_coding	Q96HR9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51786
2.65592411083857e-87	-0.320144901659356	0.334	0.551	4.90894453406293e-83	ECSIT	Malignant cells	GSE168668	ENSG00000130159	51295	ECSIT signaling integrator	SITPEC	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51787
2.78798036884991e-87	0.41349849410004	0.638	0.439	5.15302411574528e-83	CXXC5	Malignant cells	GSE168668	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51788
4.10865366622714e-87	-0.341625945937062	0.373	0.586	7.59402457128762e-83	IMPACT	Malignant cells	GSE168668	ENSG00000154059	55364	impact RWD domain protein	RWDD5	protein_coding	Q9P2X3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51789
6.474679293439e-87	0.637545596999465	0.306	0.108	1.19671497380633e-82	LTN1	Malignant cells	GSE168668	ENSG00000198862	26046	listerin E3 ubiquitin protein ligase 1	C21orf10|C21orf98|FLJ11053|KIAA0714|LISTERIN|RNF160|ZNF294	protein_coding	O94822	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51790
8.16199286405574e-87	0.378995207791846	0.861	0.767	1.50858114106342e-82	RPL7L1	Malignant cells	GSE168668	ENSG00000146223	285855	ribosomal protein L7 like 1	dJ475N16.4	protein_coding	Q6DKI1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51791
9.912282635525e-87	-0.350659434554057	0.395	0.608	1.83208719952409e-82	IPO7	Malignant cells	GSE168668	ENSG00000205339	10527	importin 7	Imp7|RANBP7	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51792
1.73788871733944e-86	0.317339128842104	0.29	0.087	3.21213971625849e-82	KCNG1	Malignant cells	GSE168668	ENSG00000026559	3755	potassium voltage-gated channel modifier subfamily G member 1	K13|KCNG|kH2|Kv6.1	protein_coding	Q9UIX4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51793
1.88509443855589e-86	0.368379252761123	0.371	0.154	3.48422005078286e-82	SLFN5	Malignant cells	GSE168668	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51794
2.27251021082487e-86	-0.312354219170017	0.333	0.547	4.2002806226676e-82	NT5C	Malignant cells	GSE168668	ENSG00000125458	30833	5', 3'-nucleotidase, cytosolic	cdN|DNT-1|DNT1|PN-I|UMPH2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51795
2.83785327006114e-86	-0.258728684223693	0.17	0.362	5.245204199054e-82	TMEM136	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51796
3.42949939987704e-86	0.813615752881961	0.384	0.18	6.33874374079273e-82	ADD3	Malignant cells	GSE168668	ENSG00000148700	120	adducin 3	ADDL	protein_coding	Q9UEY8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51797
3.9963474604407e-86	-0.355730416232064	0.312	0.523	7.38644901113254e-82	LRBA	Malignant cells	GSE168668	ENSG00000198589	987	LPS responsive beige-like anchor protein	BGL|CDC4L|LAB300|LBA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51798
4.32198239450311e-86	-0.348324100411851	0.677	0.845	7.9883200597601e-82	TMEM123	Malignant cells	GSE168668	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51799
4.75831941175394e-86	-0.254758492730643	0.179	0.373	8.7948017687448e-82	TFPT	Malignant cells	GSE168668	ENSG00000276504	29844	TCF3 fusion partner	amida|FB1|INO80F	protein_coding	P0C1Z6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51800
1.02115437205608e-85	-0.279933647388231	0.203	0.404	1.88739962587125e-81	UNKL	Malignant cells	GSE168668	ENSG00000059145	64718	unk like zinc finger	C16orf28|FLJ23360|ZC3H5L|ZC3HDC5L	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51801
1.58203469481555e-85	0.42861086086537	0.525	0.308	2.92407472642758e-81	EFNA1	Malignant cells	GSE168668	ENSG00000169242	1942	ephrin A1	ECKLG|EPLG1|GMAN|LERK1|TNFAIP4	protein_coding	P20827	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51802
1.60526516912269e-85	0.362795795561928	0.894	0.794	2.96701161208947e-81	DNPH1	Malignant cells	GSE168668	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51803
2.0054889393496e-85	-0.325286317564262	0.334	0.55	3.70674520659986e-81	CDC42SE1	Malignant cells	GSE168668	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51804
2.40606690399502e-85	0.360448607775329	0.405	0.189	4.447133458654e-81	AGA	Malignant cells	GSE168668	ENSG00000038002	175	aspartylglucosaminidase	ASRG	protein_coding	P20933	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51805
2.50223181037877e-85	-0.386641353264449	0.565	0.763	4.62487505512308e-81	PLA2G16	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51806
2.88363400217395e-85	0.250334041482453	1	0.998	5.3298207262181e-81	COX6A1	Malignant cells	GSE168668	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51807
3.9812001714869e-85	0.394933523591624	0.749	0.594	7.35845227695923e-81	BCAS2	Malignant cells	GSE168668	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51808
4.20578446374683e-85	0.278922866438021	0.996	0.987	7.77355142434326e-81	NDUFAB1	Malignant cells	GSE168668	ENSG00000004779	4706	NADH:ubiquinone oxidoreductase subunit AB1	ACP|ACP1|FASN2A|SDAP	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51809
4.91478303831974e-85	-0.324916464536626	0.342	0.569	9.08399348972637e-81	VPS13A	Malignant cells	GSE168668	ENSG00000197969	23230	vacuolar protein sorting 13 homolog A	BLTP5A|CHAC|KIAA0986	protein_coding	Q96RL7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51810
5.8103903519728e-85	0.407229624707937	0.667	0.493	1.07393444875513e-80	SH3BGRL3	Malignant cells	GSE168668	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51811
7.84268888858628e-85	-0.364036015669044	0.413	0.616	1.4495641872774e-80	IRF2BPL	Malignant cells	GSE168668	ENSG00000119669	64207	interferon regulatory factor 2 binding protein like	C14orf4|EAP1|KIAA1865	protein_coding	Q9H1B7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51812
1.15694110210751e-84	-0.351596052307422	0.694	0.86	2.1383742390253e-80	PRR7	Malignant cells	GSE168668	ENSG00000131188	80758	proline rich 7, synaptic	MGC10772	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51813
1.67574984646808e-84	-0.401033133421225	0.308	0.521	3.09728844122695e-80	TSC22D3	Malignant cells	GSE168668	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51814
4.02802073225157e-84	-0.265854982791234	0.197	0.393	7.44499071942058e-80	EIF3J-DT	Malignant cells	GSE168668	ENSG00000179523	645212	EIF3J divergent transcript	EIF3J-AS1	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51815
5.74041218950722e-84	0.393413233976543	0.79	0.686	1.06100038498662e-79	ATP6V0E2	Malignant cells	GSE168668	ENSG00000171130	155066	ATPase H+ transporting V0 subunit e2	ATP6V0E2L|C7orf32	protein_coding	Q8NHE4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51816
7.74938058235535e-84	0.416475887208526	0.638	0.446	1.43231801303674e-79	IMPA2	Malignant cells	GSE168668	ENSG00000141401	3613	inositol monophosphatase 2	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51817
1.12570908881718e-83	0.344997369053596	0.935	0.89	2.0806481088608e-79	PDCD6	Malignant cells	GSE168668	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51818
3.00933943399433e-83	0.404811386780107	0.631	0.439	5.56216207585172e-79	PPIF	Malignant cells	GSE168668	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51819
4.28781101350106e-83	0.638027340631123	0.653	0.462	7.925161096254e-79	MAP1B	Malignant cells	GSE168668	ENSG00000131711	4131	microtubule associated protein 1B	MAP5|PPP1R102	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51820
7.6791340363142e-83	0.387381505542535	0.768	0.625	1.41933434393195e-78	BLOC1S1	Malignant cells	GSE168668	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51821
8.70664078983365e-83	-0.270645952097884	0.213	0.412	1.60924841718495e-78	TXNRD2	Malignant cells	GSE168668	ENSG00000184470	10587	thioredoxin reductase 2	SELZ|TR|TR3|TRXR2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51822
2.37887120562675e-82	-0.405506582644264	0.383	0.574	4.39686764935992e-78	FAM111A	Malignant cells	GSE168668	ENSG00000166801	63901	FAM111 trypsin like peptidase A	FLJ22794|KIAA1895	protein_coding	Q96PZ2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51823
3.14270606219876e-82	0.342606169519741	0.974	0.932	5.80866361476196e-78	ATP5MC1	Malignant cells	GSE168668	ENSG00000159199	516	ATP synthase membrane subunit c locus 1	ATP5G|ATP5G1	protein_coding	P05496	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51824
4.39191558468464e-82	-0.269430218966991	0.24	0.446	8.11757757517261e-78	ASMTL	Malignant cells	GSE168668	ENSG00000169093	8623	acetylserotonin O-methyltransferase like	NA	protein_coding	O95671	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51825
5.87288612634203e-82	0.34109313731968	0.943	0.914	1.0854855427318e-77	CCT5	Malignant cells	GSE168668	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51826
7.69022925070618e-82	-0.376013852231829	0.677	0.837	1.42138507240802e-77	COPB1	Malignant cells	GSE168668	ENSG00000129083	1315	COPI coat complex subunit beta 1	COPB	protein_coding	P53618	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51827
8.1563009059801e-82	0.355527610669344	0.955	0.893	1.5075290964523e-77	SRM	Malignant cells	GSE168668	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51828
9.54731506353506e-82	0.366564531002776	0.508	0.295	1.76463024319318e-77	RAP1B	Malignant cells	GSE168668	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51829
9.63430979704706e-82	-0.267331580348786	0.225	0.425	1.78070947978821e-77	PUS3	Malignant cells	GSE168668	ENSG00000110060	83480	pseudouridine synthase 3	DEG1|FKSG32	protein_coding	Q9BZE2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51830
1.42121998782005e-81	0.356655553749374	0.891	0.827	2.62684090348779e-77	SNF8	Malignant cells	GSE168668	ENSG00000159210	11267	SNF8 subunit of ESCRT-II	Dot3|EAP30|VPS22	protein_coding	Q96H20	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51831
1.65746394071188e-81	0.402189399050928	0.517	0.308	3.06349060161777e-77	CCDC28B	Malignant cells	GSE168668	ENSG00000160050	79140	coiled-coil domain containing 28B	MGC1203|RP4-622L5.5	protein_coding	Q9BUN5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51832
1.67976762302747e-81	-0.313962642633998	0.288	0.493	3.10471449764167e-77	MINDY2	Malignant cells	GSE168668	ENSG00000128923	54629	MINDY lysine 48 deubiquitinase 2	FAM63B|KIAA1164	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51833
1.72572756973041e-81	-0.327190271013545	0.929	0.968	3.18966226713272e-77	DDX21	Malignant cells	GSE168668	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51834
2.32153249118719e-81	-0.278963279221809	0.234	0.434	4.29088850346129e-77	CTSB	Malignant cells	GSE168668	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51835
2.3277027794235e-81	-0.320058136320499	0.3	0.511	4.30229304720846e-77	TCEAL3	Malignant cells	GSE168668	ENSG00000196507	85012	transcription elongation factor A like 3	MGC15737|WEX8	protein_coding	Q969E4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51836
3.18749034511499e-81	0.434299192243339	0.343	0.144	5.89143840487603e-77	ARRDC3	Malignant cells	GSE168668	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51837
3.37249587891316e-81	-0.322484618109241	0.544	0.741	6.2333841329952e-77	CCDC25	Malignant cells	GSE168668	ENSG00000147419	55246	coiled-coil domain containing 25	FLJ10853	protein_coding	Q86WR0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51838
4.71975954634915e-81	0.325824592005453	0.98	0.952	8.72353156951713e-77	JTB	Malignant cells	GSE168668	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51839
7.17646142966e-81	-0.262890572404126	0.213	0.412	1.32642536604406e-76	GALK1	Malignant cells	GSE168668	ENSG00000108479	2584	galactokinase 1	GALK	protein_coding	P51570	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51840
7.66230118845182e-81	-0.340081848159378	0.446	0.645	1.41622312866155e-76	MID1IP1	Malignant cells	GSE168668	ENSG00000165175	58526	MID1 interacting protein 1	FLJ10386|G12-like|MIG12|STRAIT11499|THRSPL	protein_coding	Q9NPA3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51841
9.95957560196946e-81	0.345491495703284	0.921	0.853	1.84082835851202e-76	DDX24	Malignant cells	GSE168668	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51842
1.07226796163754e-80	0.404192719990076	0.284	0.092	1.98187287349466e-76	LRRN1	Malignant cells	GSE168668	ENSG00000175928	57633	leucine rich repeat neuronal 1	FIGLER3	protein_coding	Q6UXK5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51843
3.57428338175225e-80	0.415497643428599	0.529	0.331	6.60634797449268e-76	SDSL	Malignant cells	GSE168668	ENSG00000139410	113675	serine dehydratase like	cSDH|SDS-RS1	protein_coding	Q96GA7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51844
4.06461072339087e-80	-0.291910877513004	0.258	0.461	7.51262000004335e-76	LPIN2	Malignant cells	GSE168668	ENSG00000101577	9663	lipin 2	KIAA0249	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51845
8.30372173317768e-80	-0.398763545932831	0.372	0.567	1.53477688794323e-75	CLGN	Malignant cells	GSE168668	ENSG00000153132	1047	calmegin	NA	protein_coding	O14967	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51846
1.28063276008291e-79	0.336545406097159	0.313	0.115	2.36699353046124e-75	TMEM116	Malignant cells	GSE168668	ENSG00000198270	89894	transmembrane protein 116	FLJ90167	protein_coding	Q8NCL8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51847
1.38833619363155e-79	-0.315635132068173	0.366	0.577	2.5660617866892e-75	FKBP10	Malignant cells	GSE168668	ENSG00000141756	60681	FKBP prolyl isomerase 10	FKBP6|FKBP65|FLJ20683|FLJ22041|FLJ23833|hFKBP65	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51848
1.66183030255205e-79	0.325386445595627	0.321	0.122	3.07156094820696e-75	PRR15L	Malignant cells	GSE168668	ENSG00000167183	79170	proline rich 15 like	ATAD4|MGC11242	protein_coding	Q9BU68	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51849
2.6885524071188e-79	-0.319415927112019	0.609	0.791	4.96925141407767e-75	CHCHD5	Malignant cells	GSE168668	ENSG00000125611	84269	coiled-coil-helix-coiled-coil-helix domain containing 5	C2orf9|MGC11104|MIC14|MIX14	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51850
5.1630628515208e-79	-0.323951148909958	0.693	0.859	9.5428890684659e-75	EIF3J	Malignant cells	GSE168668	ENSG00000104131	8669	eukaryotic translation initiation factor 3 subunit J	eIF3-alpha|eIF3-p35|EIF3S1	protein_coding	O75822	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51851
5.34013457345578e-79	-0.349811424861747	0.63	0.806	9.87017073211831e-75	UBE2R2	Malignant cells	GSE168668	ENSG00000107341	54926	ubiquitin conjugating enzyme E2 R2	CDC34B|FLJ20419|MGC10481|UBC3B	protein_coding	Q712K3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51852
8.82804201184168e-79	-0.303503170644918	0.752	0.901	1.6316870050487e-74	NOP53	Malignant cells	GSE168668	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51853
1.94789466372029e-78	-0.313345351078442	0.375	0.578	3.60029370695421e-74	HMGXB4	Malignant cells	GSE168668	ENSG00000100281	10042	HMG-box containing 4	HMG2L1|P53N|THC211630	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51854
1.98138397584045e-78	-0.338929383303663	0.605	0.796	3.66219200254591e-74	ARGLU1	Malignant cells	GSE168668	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51855
2.0565559514692e-78	0.373552808721827	0.615	0.419	3.80113236510053e-74	PTGR1	Malignant cells	GSE168668	ENSG00000106853	22949	prostaglandin reductase 1	LTB4DH|ZADH3	protein_coding	Q14914	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51856
2.12630985656236e-78	0.353891060481205	0.949	0.92	3.93005850788421e-74	HAX1	Malignant cells	GSE168668	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51857
2.4368050317942e-78	-0.2809679526422	0.882	0.999	4.50394674026522e-74	NDUFB4	Malignant cells	GSE168668	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51858
4.48964090933954e-78	0.352354821256722	0.478	0.256	8.29820329273226e-74	STXBP5L	Malignant cells	GSE168668	ENSG00000145087	9515	syntaxin binding protein 5L	KIAA1006|LLGL4|tomosyn-2	protein_coding	Q9Y2K9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51859
6.60604165795528e-78	-0.309245722723013	0.917	0.976	1.22099467963987e-73	MORF4L1	Malignant cells	GSE168668	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51860
8.54595663875963e-78	0.359508198953906	0.268	0.082	1.57954916554194e-73	SEMA3C	Malignant cells	GSE168668	ENSG00000075223	10512	semaphorin 3C	SEMAE|SemE	protein_coding	Q99985	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51861
8.87628182686262e-78	-0.299663338021908	0.318	0.522	1.64060317005902e-73	PCID2	Malignant cells	GSE168668	ENSG00000126226	55795	PCI domain containing 2	FLJ11305	protein_coding	Q5JVF3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51862
1.47616163779065e-77	-0.34101479733634	0.531	0.716	2.72838955512846e-73	UBE2H	Malignant cells	GSE168668	ENSG00000186591	7328	ubiquitin conjugating enzyme E2 H	GID3|UBC8|UBCH	protein_coding	P62256	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51863
2.09166323182246e-77	-0.262584816206532	0.222	0.416	3.86602115137745e-73	TLE6	Malignant cells	GSE168668	ENSG00000104953	79816	TLE family member 6, subcortical maternal complex member	FLJ14009|GRG6	protein_coding	Q9H808	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51864
2.58134295515125e-77	0.364510063112683	0.566	0.36	4.77109618400606e-73	DNAJC1	Malignant cells	GSE168668	ENSG00000136770	64215	DnaJ heat shock protein family (Hsp40) member C1	DNAJL1|ERdj1|MTJ1	protein_coding	Q96KC8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51865
2.79976066995606e-77	0.38163378252026	0.508	0.306	5.17479764627979e-73	PEX2	Malignant cells	GSE168668	ENSG00000164751	5828	peroxisomal biogenesis factor 2	PAF-1|PMP35|PXMP3|RNF72|ZWS3	protein_coding	P28328	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51866
3.20658613718821e-77	-0.274159312392993	0.255	0.455	5.92673315736497e-73	PRKCI	Malignant cells	GSE168668	ENSG00000163558	5584	protein kinase C iota	DXS1179E|PKCI	protein_coding	P41743	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51867
4.17020775238976e-77	0.376722099443632	0.592	0.406	7.707794988742e-73	TMEM70	Malignant cells	GSE168668	ENSG00000175606	54968	transmembrane protein 70	FLJ20533	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51868
4.45286992502614e-77	0.323777825990838	0.969	0.952	8.23023948242582e-73	GHITM	Malignant cells	GSE168668	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51869
7.93152353376149e-77	-0.53518361697432	0.698	0.83	1.46598349474514e-72	MT1X	Malignant cells	GSE168668	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51870
7.97006295662282e-77	0.366245743145838	0.608	0.411	1.4731067362726e-72	SDHAF3	Malignant cells	GSE168668	ENSG00000196636	57001	succinate dehydrogenase complex assembly factor 3	ACN9|DC11|LYRM10|Sdh7	protein_coding	Q9NRP4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51871
8.27651588097889e-77	0.362106688012538	0.794	0.683	1.52974843028133e-72	PSMC1	Malignant cells	GSE168668	ENSG00000100764	5700	proteasome 26S subunit, ATPase 1	p56|RPT2|S4	protein_coding	P62191	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51872
1.01885206604839e-76	0.333336940051409	0.366	0.162	1.88314427367724e-72	ELOVL6	Malignant cells	GSE168668	ENSG00000170522	79071	ELOVL fatty acid elongase 6	FLJ23378|LCE|MGC5487	protein_coding	Q9H5J4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51873
1.20274038970496e-76	-0.302493717012668	0.326	0.528	2.22302506229168e-72	GSR	Malignant cells	GSE168668	ENSG00000104687	2936	glutathione-disulfide reductase	NA	protein_coding	P00390	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51874
1.33165450711969e-76	-0.338884289945002	0.365	0.562	2.46129702550932e-72	SLC31A1	Malignant cells	GSE168668	ENSG00000136868	1317	solute carrier family 31 member 1	COPT1|CTR1|hCTR1	protein_coding	O15431	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51875
1.39477757207378e-76	-0.256177183389103	0.189	0.372	2.57796738646396e-72	HACD2	Malignant cells	GSE168668	ENSG00000206527	201562	3-hydroxyacyl-CoA dehydratase 2	PTPLB	protein_coding	Q6Y1H2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51876
1.73771155552142e-76	-0.3304159430734	0.474	0.669	3.21181226807025e-72	TMOD3	Malignant cells	GSE168668	ENSG00000138594	29766	tropomodulin 3	UTMOD	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51877
4.03855748615164e-76	0.379508057392649	0.748	0.609	7.46446580165407e-72	LINC00467	Malignant cells	GSE168668	ENSG00000153363	NA	NA	ASAP|C1orf97|MGC14801	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51878
4.43719204078858e-76	-0.298501506893546	0.258	0.455	8.20126204898953e-72	GOLPH3L	Malignant cells	GSE168668	ENSG00000143457	55204	golgi phosphoprotein 3 like	GPP34R	protein_coding	Q9H4A5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51879
4.46520907869757e-76	0.362318097108247	0.935	0.911	8.25304594015672e-72	ATP6V1G1	Malignant cells	GSE168668	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51880
4.59072958776729e-76	-0.255226503952404	0.225	0.418	8.48504549707027e-72	FAM69B	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51881
6.26111336417313e-76	0.35225014985377	0.409	0.207	1.15724158310012e-71	RRP36	Malignant cells	GSE168668	ENSG00000124541	88745	ribosomal RNA processing 36	C6orf153|dJ20C7.4	protein_coding	Q96EU6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51882
8.2857912019718e-76	-0.319832628662954	0.441	0.638	1.53146278786045e-71	DNAJC4	Malignant cells	GSE168668	ENSG00000110011	3338	DnaJ heat shock protein family (Hsp40) member C4	HSPF2|MCG18	protein_coding	Q9NNZ3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51883
9.06092771539473e-76	-0.27734662281525	0.291	0.496	1.67473126963641e-71	EPHX2	Malignant cells	GSE168668	ENSG00000120915	2053	epoxide hydrolase 2	ABHD20|sEH	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51884
9.72682317744608e-76	-0.297965034894595	0.338	0.544	1.79780872788736e-71	SIPA1	Malignant cells	GSE168668	ENSG00000213445	6494	signal-induced proliferation-associated 1	SPA1	protein_coding	Q96FS4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51885
1.06129695818648e-75	-0.269672086133926	0.241	0.436	1.96159516781608e-71	LCOR	Malignant cells	GSE168668	ENSG00000196233	84458	ligand dependent nuclear receptor corepressor	C10orf12|DKFZP564P1916|FLJ13022|FLJ38026|KIAA1795|MLR2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51886
1.11431425108843e-75	-0.255245467891087	0.233	0.428	2.05958703028674e-71	C16orf87	Malignant cells	GSE168668	ENSG00000155330	388272	chromosome 16 open reading frame 87	NA	protein_coding	Q6PH81	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51887
1.18765926691851e-75	-0.301503394615618	0.276	0.474	2.19515062304548e-71	MIPOL1	Malignant cells	GSE168668	ENSG00000151338	145282	mirror-image polydactyly 1	CCDC193	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51888
1.26525099897487e-75	-0.375343203979255	0.565	0.752	2.33856342140525e-71	FBXL17	Malignant cells	GSE168668	ENSG00000145743	64839	F-box and leucine rich repeat protein 17	DKFZP434C1715|Fbl17|Fbx13|FBXO13	protein_coding	Q9UF56	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51889
1.46689439967007e-75	-0.273462143513641	0.24	0.434	2.71126091891018e-71	UTP23	Malignant cells	GSE168668	ENSG00000147679	84294	UTP23 small subunit processome component	C8orf53|MGC14595	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51890
1.85707126402122e-75	0.411508390710982	0.915	0.882	3.43242481729043e-71	PDIA6	Malignant cells	GSE168668	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51891
2.29739158435719e-75	-0.345098486272064	0.74	0.887	4.24626886536739e-71	CMBL	Malignant cells	GSE168668	ENSG00000164237	134147	carboxymethylenebutenolidase homolog	FLJ23617	protein_coding	Q96DG6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51892
3.38380543868495e-75	0.355075059971664	0.804	0.687	6.2542875923214e-71	RAB4A	Malignant cells	GSE168668	ENSG00000168118	5867	RAB4A, member RAS oncogene family	HRES-1/RAB4|RAB4	protein_coding	P20338	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51893
4.77911785539371e-75	0.355513281922846	0.459	0.256	8.8332435321242e-71	MPC1	Malignant cells	GSE168668	ENSG00000060762	51660	mitochondrial pyruvate carrier 1	BRP44L|CGI-129|dJ68L15.3|SLC54A1	protein_coding	Q9Y5U8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51894
5.31162629439003e-75	0.37261009193394	0.578	0.369	9.8174788799211e-71	ELF3	Malignant cells	GSE168668	ENSG00000163435	1999	E74 like ETS transcription factor 3	EPR-1|ERT|ESE-1|ESX	protein_coding	P78545	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51895
5.86590705095543e-75	-0.271757727107388	0.261	0.458	1.08419560022809e-70	GALNT11	Malignant cells	GSE168668	ENSG00000178234	63917	polypeptide N-acetylgalactosaminyltransferase 11	GalNAc-T11	protein_coding	Q8NCW6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51896
7.41897674893601e-75	0.372359443416323	0.685	0.529	1.37124947250584e-70	GRINA	Malignant cells	GSE168668	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51897
1.11072214703962e-74	0.303356729274791	0.32	0.126	2.05294774437333e-70	LASP1	Malignant cells	GSE168668	ENSG00000002834	3927	LIM and SH3 protein 1	Lasp-1|MLN50	protein_coding	Q14847	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51898
1.28146848649868e-74	-0.266906227648981	0.199	0.382	2.36853820359552e-70	NSMF	Malignant cells	GSE168668	ENSG00000165802	26012	NMDA receptor synaptonuclear signaling and neuronal migration factor	NELF	protein_coding	Q6X4W1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51899
2.75863310461968e-74	-0.304707183753312	0.285	0.485	5.09878156726855e-70	ZNF91	Malignant cells	GSE168668	ENSG00000167232	7644	zinc finger protein 91	HPF7|HTF10	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51900
3.16676236710812e-74	-0.302625728981342	0.504	0.698	5.85312688312595e-70	CHID1	Malignant cells	GSE168668	ENSG00000177830	66005	chitinase domain containing 1	FLJ42707|MGC3234|SI-CLP	protein_coding	Q9BWS9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51901
3.16948958254708e-74	0.375422714362396	0.717	0.581	5.85816759542177e-70	USP16	Malignant cells	GSE168668	ENSG00000156256	10600	ubiquitin specific peptidase 16	Ubp-M	protein_coding	Q9Y5T5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51902
3.18258883966559e-74	0.361862939631038	0.799	0.696	5.88237895235391e-70	MRPL18	Malignant cells	GSE168668	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51903
4.99523908376202e-74	-0.270248737277674	0.181	0.356	9.23270039851735e-70	SPIRE1	Malignant cells	GSE168668	ENSG00000134278	56907	spire type actin nucleation factor 1	KIAA1135|spir-1	protein_coding	Q08AE8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51904
5.11745924213013e-74	-0.34292950342997	0.462	0.647	9.45859991722913e-70	CHD3	Malignant cells	GSE168668	ENSG00000170004	1107	chromodomain helicase DNA binding protein 3	Mi-2a|Mi2-ALPHA|ZFH	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51905
5.6273277571523e-74	-0.275668468115644	0.99	0.996	1.04009898935446e-69	MRPL41	Malignant cells	GSE168668	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51906
7.14561874613275e-74	0.363044732599015	0.831	0.777	1.32072471284772e-69	TMEM208	Malignant cells	GSE168668	ENSG00000168701	29100	transmembrane protein 208	hSND2|HSPC171	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51907
9.30116514137293e-74	0.35691586698429	0.39	0.19	1.71913435307996e-69	TCEA3	Malignant cells	GSE168668	ENSG00000282941	6920	transcription elongation factor A3	TFIIS.H	protein_coding	O75764	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51908
1.29206837897113e-73	-0.31499685280609	0.364	0.559	2.38812998485234e-69	FNTA	Malignant cells	GSE168668	ENSG00000168522	2339	farnesyltransferase, CAAX box, alpha	FPTA|PGGT1A|PTAR2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51909
2.46247271064638e-73	0.441193357102339	0.275	0.092	4.5513883110877e-69	CBLN2	Malignant cells	GSE168668	ENSG00000141668	147381	cerebellin 2 precursor	NA	protein_coding	Q8IUK8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51910
2.6859640504366e-73	0.348129208944786	0.484	0.281	4.96446735442196e-69	MCCC1	Malignant cells	GSE168668	ENSG00000078070	56922	methylcrotonyl-CoA carboxylase subunit 1	MCCA|MCCCalpha	protein_coding	Q96RQ3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51911
2.69377667866185e-73	0.378136154195979	0.552	0.358	4.9789074351707e-69	SNHG9	Malignant cells	GSE168668	ENSG00000255198	NA	NA	DKFZp686N06141|NCRNA00062	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51912
3.51273146862709e-73	0.33699718217639	0.937	0.905	6.49258157346345e-69	SNRPB	Malignant cells	GSE168668	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51913
4.25500582383131e-73	0.372714328080498	0.611	0.442	7.86452726418741e-69	SAMM50	Malignant cells	GSE168668	ENSG00000100347	25813	SAMM50 sorting and assembly machinery component	CGI-51|OMP85|SAM50|TOB55|TRG-3|YNL026W	protein_coding	Q9Y512	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51914
5.82984530580681e-73	0.351663936053074	0.485	0.287	1.07753030787227e-68	DNPEP	Malignant cells	GSE168668	ENSG00000123992	23549	aspartyl aminopeptidase	ASPEP|DAP	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51915
6.50384727922262e-73	0.377223954345278	0.829	0.757	1.20210609261872e-68	MRPL55	Malignant cells	GSE168668	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51916
6.58792682144792e-73	0.362417472791015	0.798	0.696	1.21764651440822e-68	NR2F6	Malignant cells	GSE168668	ENSG00000160113	2063	nuclear receptor subfamily 2 group F member 6	EAR-2|EAR2|ERBAL2	protein_coding	P10588	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51917
6.60987436605531e-73	-0.313253149070839	0.883	0.962	1.221703079078e-68	COX17	Malignant cells	GSE168668	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51918
7.4263050308133e-73	0.312608514576024	0.961	0.938	1.37260395884522e-68	LAMTOR5	Malignant cells	GSE168668	ENSG00000134248	10542	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	HBXIP|MGC71071|XIP	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51919
9.83012542240771e-73	0.399690456573868	0.499	0.309	1.81690208182362e-68	FAM174A	Malignant cells	GSE168668	ENSG00000174132	345757	family with sequence similarity 174 member A	NS5ATP6|TMEM157|UNQ1912	protein_coding	Q8TBP5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51920
1.53826756033265e-72	-0.423223871514887	0.714	0.845	2.84317993176283e-68	RDH11	Malignant cells	GSE168668	ENSG00000072042	51109	retinol dehydrogenase 11	ARSDR1|MDT1|SDR7C1	protein_coding	Q8TC12	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51921
2.06137775395124e-72	-0.319302568018467	0.312	0.506	3.81004450262808e-68	AL355338.1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51922
2.23139045868807e-72	0.366607050913782	0.904	0.841	4.12427898479316e-68	TARS	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51923
2.98233589409562e-72	-0.272726835693981	0.3	0.505	5.51225143305694e-68	NVL	Malignant cells	GSE168668	ENSG00000143748	4931	nuclear VCP like	NVL2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51924
3.15419479272704e-72	-0.310861177829624	0.585	0.757	5.82989823539739e-68	CSNK2A1	Malignant cells	GSE168668	ENSG00000101266	1457	casein kinase 2 alpha 1	Cka1|Cka2	protein_coding	P68400	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51925
4.60533363351047e-72	0.302886654770147	0.965	0.938	8.5120381548174e-68	PRDX3	Malignant cells	GSE168668	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51926
5.18635252925074e-72	0.364203235129391	0.77	0.661	9.58593537981415e-68	PSMD12	Malignant cells	GSE168668	ENSG00000197170	5718	proteasome 26S subunit, non-ATPase 12	p55|Rpn5	protein_coding	O00232	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51927
6.48218047807093e-72	0.366460515135252	0.796	0.711	1.19810141776185e-67	MRPL58	Malignant cells	GSE168668	ENSG00000167862	3396	mitochondrial ribosomal protein L58	DS-1|ICT1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51928
7.09717301383158e-72	-0.274588626614977	0.176	0.347	1.31177048814649e-67	PALLD	Malignant cells	GSE168668	ENSG00000129116	23022	palladin, cytoskeletal associated protein	CGI-151|KIAA0992|SIH002	protein_coding	Q8WX93	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51929
7.46298207416352e-72	-0.270628760381221	0.208	0.388	1.37938297676764e-67	MPHOSPH9	Malignant cells	GSE168668	ENSG00000051825	10198	M-phase phosphoprotein 9	MPP9	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51930
1.42412479512623e-71	-0.252610137813345	0.251	0.445	2.63220985883182e-67	CYFIP1	Malignant cells	GSE168668	ENSG00000280618	23191	cytoplasmic FMR1 interacting protein 1	KIAA0068|P140SRA-1|SHYC	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51931
1.72153950948126e-71	-0.252327618644164	0.993	0.998	3.1819214753742e-67	EIF2S2	Malignant cells	GSE168668	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51932
3.21459929386679e-71	0.334365969488189	0.927	0.884	5.94154387485399e-67	KRT8	Malignant cells	GSE168668	ENSG00000170421	3856	keratin 8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	protein_coding	P05787	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51933
3.69478849659399e-71	0.365439562275052	0.53	0.338	6.82907757825468e-67	RNASEH2B	Malignant cells	GSE168668	ENSG00000136104	79621	ribonuclease H2 subunit B	AGS2|DLEU8|FLJ11712	protein_coding	Q5TBB1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51934
6.88686127959064e-71	-0.303896787127548	0.718	0.868	1.27289857030674e-66	TAF7	Malignant cells	GSE168668	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51935
7.16645564865267e-71	0.317057137046312	0.907	0.82	1.32457599754047e-66	NFIX	Malignant cells	GSE168668	ENSG00000008441	4784	nuclear factor I X	NF1A	protein_coding	Q14938	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51936
7.82467294074989e-71	-0.303836695154775	0.952	0.982	1.4462342996388e-66	ATF4	Malignant cells	GSE168668	ENSG00000128272	468	activating transcription factor 4	CREB-2|TAXREB67|TXREB	protein_coding	P18848	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51937
1.08550963769037e-70	-0.295306809802559	0.31	0.499	2.00634746334312e-66	ZFYVE16	Malignant cells	GSE168668	ENSG00000039319	9765	zinc finger FYVE-type containing 16	KIAA0305|PPP1R69	protein_coding	Q7Z3T8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51938
1.14279254798754e-70	0.346281452360686	0.938	0.914	2.11222346644536e-66	MLEC	Malignant cells	GSE168668	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51939
1.24928493743147e-70	-0.317175749895498	0.641	0.806	2.30905334985459e-66	USP14	Malignant cells	GSE168668	ENSG00000101557	9097	ubiquitin specific peptidase 14	TGT|Ubp6	protein_coding	P54578	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51940
1.33843433042667e-70	0.361805170491453	0.604	0.422	2.47382817292762e-66	MEA1	Malignant cells	GSE168668	ENSG00000124733	4201	male-enhanced antigen 1	MEA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51941
2.17648847282244e-70	-0.263660941777406	0.972	0.994	4.02280364431772e-66	SPINT2	Malignant cells	GSE168668	ENSG00000167642	10653	serine peptidase inhibitor, Kunitz type 2	HAI-2|HAI2|Kop	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51942
2.46520549948742e-70	0.365084820530461	0.624	0.45	4.5564393247026e-66	HTATSF1	Malignant cells	GSE168668	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51943
1.0511613524357e-69	-0.399013840696081	0.663	0.814	1.94286152770691e-65	BLOC1S6	Malignant cells	GSE168668	ENSG00000104164	26258	biogenesis of lysosomal organelles complex 1 subunit 6	HPS9|PA|PLDN	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51944
1.25029870293348e-69	-0.258312497177528	0.248	0.437	2.31092709263195e-65	USP8	Malignant cells	GSE168668	ENSG00000138592	9101	ubiquitin specific peptidase 8	HumORF8|KIAA0055|SPG59|UBPY	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51945
1.45013559096686e-69	0.285931645224103	0.985	0.958	2.68028561278404e-65	DDX5	Malignant cells	GSE168668	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51946
1.74375560758538e-69	0.369193227881079	0.629	0.466	3.22298348950006e-65	EMG1	Malignant cells	GSE168668	ENSG00000126749	10436	EMG1 N1-specific pseudouridine methyltransferase	C2F|Grcc2f|NEP1	protein_coding	Q92979	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51947
2.0352200426486e-69	-0.334365164019307	0.529	0.705	3.7616972048274e-65	IVD	Malignant cells	GSE168668	ENSG00000128928	3712	isovaleryl-CoA dehydrogenase	ACAD2|IVDH	protein_coding	P26440	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51948
3.34621390616809e-69	0.359524983007059	0.646	0.488	6.18480716277047e-65	NDUFA9	Malignant cells	GSE168668	ENSG00000139180	4704	NADH:ubiquinone oxidoreductase subunit A9	CI-39k|COQ11|NDUFS2L|SDR22E1	protein_coding	Q16795	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51949
3.41560594921284e-69	0.35278388315153	0.605	0.424	6.31306447593009e-65	UFD1	Malignant cells	GSE168668	ENSG00000070010	7353	ubiquitin recognition factor in ER associated degradation 1	UFD1L	protein_coding	Q92890	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51950
3.97412762730152e-69	0.362346943335428	0.717	0.591	7.34538009354139e-65	PSMD6	Malignant cells	GSE168668	ENSG00000163636	9861	proteasome 26S subunit, non-ATPase 6	KIAA0107|p44S10|Rpn7|S10	protein_coding	Q15008	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51951
4.13300286404047e-69	0.359751013830467	0.603	0.405	7.63902919360601e-65	HMGB3	Malignant cells	GSE168668	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51952
8.42845285324396e-69	-0.253105441367343	0.982	0.994	1.55783094086508e-64	NDUFA1	Malignant cells	GSE168668	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51953
1.0499574774345e-68	-0.273464530432847	0.304	0.497	1.94063640554218e-64	FBXO25	Malignant cells	GSE168668	ENSG00000147364	26260	F-box protein 25	FBX25	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51954
1.15797987861552e-68	0.35539345968409	0.438	0.246	2.14029420964506e-64	ABHD10	Malignant cells	GSE168668	ENSG00000144827	55347	abhydrolase domain containing 10, depalmitoylase	FLJ11342	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51955
1.17604525377621e-68	0.371576827554732	0.705	0.572	2.17368444255458e-64	ALDH9A1	Malignant cells	GSE168668	ENSG00000143149	223	aldehyde dehydrogenase 9 family member A1	ALDH4|ALDH7|ALDH9|E3	protein_coding	P49189	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51956
1.20056986291782e-68	0.353964184441595	0.584	0.408	2.219013277631e-64	GSTK1	Malignant cells	GSE168668	ENSG00000197448	373156	glutathione S-transferase kappa 1	GST13	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51957
1.40383156233623e-68	-0.303440987327547	0.633	0.804	2.59470187666605e-64	VTI1B	Malignant cells	GSE168668	ENSG00000100568	10490	vesicle transport through interaction with t-SNAREs 1B	VTI2	protein_coding	Q9UEU0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51958
2.03830166563144e-68	0.344275394764631	0.344	0.156	3.76739296858658e-64	IER5L	Malignant cells	GSE168668	ENSG00000188483	389792	immediate early response 5 like	bA247A12.2	protein_coding	Q5T953	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51959
2.37479395837726e-68	0.254126855534972	0.996	0.99	4.38933167326869e-64	BEX3	Malignant cells	GSE168668	ENSG00000166681	27018	brain expressed X-linked 3	Bex|DXS6984E|HGR74|NADE|NGFRAP1	protein_coding	Q00994	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51960
3.48141810940755e-68	0.352855840357543	0.42	0.232	6.43470509161798e-64	VWA1	Malignant cells	GSE168668	ENSG00000179403	64856	von Willebrand factor A domain containing 1	FLJ22215|VWA-1|WARP	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51961
5.8135584719239e-68	-0.250164512927658	0.241	0.428	1.07452001236569e-63	NCOR2	Malignant cells	GSE168668	ENSG00000196498	9612	nuclear receptor corepressor 2	CTG26|SMRT|SMRTE|TNRC14|TRAC-1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51962
5.82216407486588e-68	-0.311601161859271	0.45	0.634	1.07611058595746e-63	DESI1	Malignant cells	GSE168668	ENSG00000100418	27351	desumoylating isopeptidase 1	D15Wsu75e|DESI-1|FAM152B|POST|PPPDE2	protein_coding	Q6ICB0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51963
1.01292890423159e-67	-0.336800843381939	0.598	0.76	1.87219649369125e-63	TPM1	Malignant cells	GSE168668	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51964
1.04539049381514e-67	0.34680959204619	0.752	0.622	1.93219524971853e-63	DYNLT1	Malignant cells	GSE168668	ENSG00000146425	6993	dynein light chain Tctex-type 1	TCTEL1|Tctex-1|TCTEX1	protein_coding	P63172	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51965
1.65391954053791e-67	-0.312591941007582	0.387	0.572	3.05693948677623e-63	KDM6B	Malignant cells	GSE168668	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51966
2.36792942273753e-67	-0.318841141087893	0.54	0.711	4.37664395204577e-63	ARPP19	Malignant cells	GSE168668	ENSG00000128989	10776	cAMP regulated phosphoprotein 19	ARPP-16|ARPP-19|ARPP16|ENSAL	protein_coding	P56211	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51967
2.5576512040356e-67	0.416212414347973	0.603	0.442	4.72730672041899e-63	TERF1	Malignant cells	GSE168668	ENSG00000147601	7013	telomeric repeat binding factor 1	PIN2|TRBF1|TRF|TRF1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51968
3.94717924550126e-67	0.363041847366467	0.641	0.48	7.29557139945998e-63	MRPL1	Malignant cells	GSE168668	ENSG00000169288	65008	mitochondrial ribosomal protein L1	BM022	protein_coding	Q9BYD6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51969
6.03848303712348e-67	-0.295166960778789	0.457	0.651	1.11609281975153e-62	PCMTD1	Malignant cells	GSE168668	ENSG00000168300	115294	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1	FLJ10883	protein_coding	Q96MG8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51970
6.33789481144952e-67	0.525107471026553	0.581	0.434	1.17143309800022e-62	ZFP36L1	Malignant cells	GSE168668	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51971
6.69140287737884e-67	0.325483270300329	0.851	0.796	1.23677199382593e-62	POLR2E	Malignant cells	GSE168668	ENSG00000099817	5434	RNA polymerase II, I and III subunit E	hRPB25|hsRPB5|RPABC1|RPB5|XAP4	protein_coding	P19388	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51972
9.47279422853869e-67	-0.251399002264208	0.98	0.994	1.75085655726081e-62	EIF4B	Malignant cells	GSE168668	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51973
1.01290218208389e-66	0.371602461567239	0.681	0.542	1.87214710314566e-62	MYO1C	Malignant cells	GSE168668	ENSG00000197879	4641	myosin IC	MyoIC|myr2|NMI	protein_coding	O00159	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51974
1.07780118494552e-66	-0.302518791037149	0.332	0.518	1.99209993013481e-62	DBP	Malignant cells	GSE168668	ENSG00000105516	1628	D-box binding PAR bZIP transcription factor	DABP	protein_coding	Q10586	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51975
1.54547223808823e-66	-0.250740604052719	0.205	0.38	2.85649633765848e-62	MZT1	Malignant cells	GSE168668	ENSG00000204899	440145	mitotic spindle organizing protein 1	C13orf37|FLJ21869|LOC440145|MGC150539|MOZART1|RP11-11C5.2	protein_coding	Q08AG7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51976
1.80260843265715e-66	-0.287459064528634	0.471	0.66	3.3317611660802e-62	SPG21	Malignant cells	GSE168668	ENSG00000090487	51324	SPG21 abhydrolase domain containing, maspardin	ABHD21|ACP33|BM-019|GL010|MAST	protein_coding	Q9NZD8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51977
2.65868885313748e-66	0.30929852482178	0.947	0.926	4.914054607254e-62	PSMD7	Malignant cells	GSE168668	ENSG00000103035	5713	proteasome 26S subunit, non-ATPase 7	MOV34|P40|Rpn8|S12	protein_coding	P51665	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51978
2.71383783713687e-66	0.285038110428776	0.964	0.942	5.01598647438008e-62	ATP5PD	Malignant cells	GSE168668	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51979
2.99609300359659e-66	0.296798403093905	0.284	0.107	5.53767869854757e-62	HES1	Malignant cells	GSE168668	ENSG00000114315	3280	hes family bHLH transcription factor 1	bHLHb39|FLJ20408|HES-1|HRY	protein_coding	Q14469	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51980
3.16042836746845e-66	0.320694617614373	0.897	0.86	5.84141975159193e-62	MGST3	Malignant cells	GSE168668	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51981
3.16690562678208e-66	0.31387837065822	0.924	0.852	5.85339166998132e-62	SRSF3	Malignant cells	GSE168668	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51982
3.29022298248295e-66	0.317658089781627	0.407	0.214	6.08131913852323e-62	TEDC1	Malignant cells	GSE168668	ENSG00000185347	283643	tubulin epsilon and delta complex 1	C14orf80	protein_coding	Q86SX3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51983
8.27496393268564e-66	-0.250702976915365	0.172	0.337	1.52946158367829e-61	CTDSPL2	Malignant cells	GSE168668	ENSG00000137770	51496	CTD small phosphatase like 2	FLJ10523|HSPC129	protein_coding	Q05D32	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51984
8.35102245445782e-66	-0.259204174053583	0.259	0.44	1.54351948025744e-61	RBL2	Malignant cells	GSE168668	ENSG00000103479	5934	RB transcriptional corepressor like 2	p130|Rb2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51985
8.95726244613993e-66	0.337893328170522	0.793	0.683	1.65557081792004e-61	CD164	Malignant cells	GSE168668	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51986
8.96119537375508e-66	-0.257416455554279	0.3	0.488	1.65629774093115e-61	GLT8D1	Malignant cells	GSE168668	ENSG00000016864	55830	glycosyltransferase 8 domain containing 1	AD-017|FLJ14611	protein_coding	Q68CQ7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51987
1.13924171588883e-65	0.273372127103622	0.979	0.961	2.10566046347732e-61	NHP2	Malignant cells	GSE168668	ENSG00000145912	55651	NHP2 ribonucleoprotein	FLJ20479|NOLA2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51988
1.29214952462316e-65	0.341087732689169	0.799	0.718	2.38827996636098e-61	TCEAL8	Malignant cells	GSE168668	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51989
1.44311913027592e-65	-0.383701340629381	1	1	2.66731708848899e-61	FTH1	Malignant cells	GSE168668	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51990
2.37952685259029e-65	-0.29900416092053	0.619	0.785	4.39807948164263e-61	RALBP1	Malignant cells	GSE168668	ENSG00000017797	10928	ralA binding protein 1	RIP|RIP1|RLIP76	protein_coding	Q15311	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51991
3.33119513636462e-65	-0.297185602787132	0.407	0.59	6.15704797054274e-61	CTBP2	Malignant cells	GSE168668	ENSG00000175029	1488	C-terminal binding protein 2	ribeye	protein_coding	P56545	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51992
3.62503601782922e-65	0.334036857642144	0.478	0.286	6.70015407175375e-61	DDAH2	Malignant cells	GSE168668	ENSG00000226634	23564	dimethylarginine dimethylaminohydrolase 2	G6A	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51993
4.86161957566606e-65	0.346366810719748	0.365	0.184	8.98573146170357e-61	ARMT1	Malignant cells	GSE168668	ENSG00000146476	79624	acidic residue methyltransferase 1	C6orf211|FLJ12910	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51994
7.70645025100768e-65	0.303433006881765	0.921	0.886	1.42438319989375e-60	TMEM147	Malignant cells	GSE168668	ENSG00000105677	10430	transmembrane protein 147	MGC1936|NIFIE14	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51995
1.72426726857016e-64	-0.266155912687128	0.829	0.938	3.18696319249822e-60	LMAN1	Malignant cells	GSE168668	ENSG00000074695	3998	lectin, mannose binding 1	ERGIC-53|ERGIC53|F5F8D|FMFD1|gp58|MCFD1|MR60	protein_coding	P49257	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51996
2.57051538917224e-64	-0.274151396986102	0.955	0.985	4.75108359380705e-60	VDAC1	Malignant cells	GSE168668	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51997
2.81962173843538e-64	0.312034621621884	0.892	0.834	5.21150685915011e-60	PSMA5	Malignant cells	GSE168668	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51998
3.1701099760903e-64	-0.292261207251455	0.64	0.809	5.85931426880771e-60	IARS	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	51999
3.51726366846392e-64	0.337007181242051	0.784	0.686	6.50095843842187e-60	GPAA1	Malignant cells	GSE168668	ENSG00000197858	8733	glycosylphosphatidylinositol anchor attachment 1	GAA1|hGAA1	protein_coding	O43292	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52000
3.88384514099201e-64	0.355960981615351	0.744	0.624	7.17851097409553e-60	RBMX	Malignant cells	GSE168668	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52001
4.62398519245926e-64	0.362568185515682	0.635	0.483	8.54651183122245e-60	C8orf82	Malignant cells	GSE168668	ENSG00000213563	414919	chromosome 8 open reading frame 82	MGC70857	protein_coding	Q6P1X6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52002
4.66266870396885e-64	-0.300583921131996	0.89	0.952	8.61801056554562e-60	YBX3	Malignant cells	GSE168668	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52003
6.08873476855433e-64	0.432630290253041	0.814	0.707	1.1253808472719e-59	NUCB2	Malignant cells	GSE168668	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52004
7.27859257727551e-64	0.321313708537044	0.458	0.27	1.34530226605783e-59	RAB21	Malignant cells	GSE168668	ENSG00000080371	23011	RAB21, member RAS oncogene family	KIAA0118	protein_coding	Q9UL25	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52005
8.35401384564762e-64	0.344000836040532	0.738	0.567	1.54407237909105e-59	FASN	Malignant cells	GSE168668	ENSG00000169710	2194	fatty acid synthase	FAS|SDR27X1	protein_coding	P49327	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52006
8.70030290769652e-64	-0.268613897439277	0.359	0.549	1.60807698642955e-59	CREG1	Malignant cells	GSE168668	ENSG00000143162	8804	cellular repressor of E1A stimulated genes 1	CREG	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52007
8.8431743346618e-64	-0.297624096635148	0.469	0.65	1.63448391227554e-59	AC100810.1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52008
1.02297650879111e-63	0.322632312978226	0.426	0.241	1.89076748119861e-59	PGM2	Malignant cells	GSE168668	ENSG00000169299	55276	phosphoglucomutase 2	FLJ10983	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52009
1.08823681555591e-63	0.304480362594879	0.386	0.202	2.01138810619199e-59	SLC5A3	Malignant cells	GSE168668	ENSG00000198743	6526	solute carrier family 5 member 3	SMIT|SMIT1	protein_coding	P53794	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52010
1.16158198202915e-63	0.326600599202251	0.828	0.744	2.14695197738448e-59	TECR	Malignant cells	GSE168668	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52011
1.44932232601647e-63	0.338037148756827	0.56	0.383	2.67878245517624e-59	DDX1	Malignant cells	GSE168668	ENSG00000079785	1653	DEAD-box helicase 1	DBP-RB	protein_coding	Q92499	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52012
4.13816459818594e-63	0.33236127719572	0.513	0.333	7.64856962682707e-59	FAHD1	Malignant cells	GSE168668	ENSG00000180185	81889	fumarylacetoacetate hydrolase domain containing 1	C16orf36|DKFZP566J2046	protein_coding	Q6P587	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52013
7.658153591387e-63	-0.303434808005384	0.562	0.733	1.41545652829606e-58	ACTR3	Malignant cells	GSE168668	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52014
7.66462486241423e-63	0.349993690039513	0.658	0.522	1.41665261332002e-58	NUDT14	Malignant cells	GSE168668	ENSG00000183828	256281	nudix hydrolase 14	UGPP	protein_coding	O95848	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52015
8.03359714131385e-63	-0.261672753320425	0.29	0.471	1.48484975962904e-58	OSER1	Malignant cells	GSE168668	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52016
1.1331891361753e-62	-0.25324983598309	0.256	0.436	2.09447348039281e-58	NFATC3	Malignant cells	GSE168668	ENSG00000072736	4775	nuclear factor of activated T cells 3	NFAT4|NFATX	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52017
2.71927992748266e-62	-0.332681796333313	0.807	0.915	5.02604508996621e-58	MYL12A	Malignant cells	GSE168668	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52018
2.91839436989369e-62	-0.450381552073759	0.37	0.519	5.39406831387451e-58	SLC30A4	Malignant cells	GSE168668	ENSG00000104154	7782	solute carrier family 30 member 4	ZNT4	protein_coding	O14863	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52019
3.41554367111174e-62	0.316940954283285	0.433	0.252	6.31294936731583e-58	FAIM	Malignant cells	GSE168668	ENSG00000158234	55179	Fas apoptotic inhibitory molecule	FAIM1|FLJ10582	protein_coding	Q9NVQ4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52020
3.91835382860764e-62	-0.305400359666916	0.47	0.641	7.2422933814155e-58	FBXO22	Malignant cells	GSE168668	ENSG00000167196	26263	F-box protein 22	FBX22|FISTC1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52021
5.14216752078671e-62	-0.271810713987474	0.38	0.568	9.50426822867008e-58	CCDC107	Malignant cells	GSE168668	ENSG00000159884	203260	coiled-coil domain containing 107	MGC31967	protein_coding	Q8WV48	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52022
7.02779130557072e-62	-0.257836066503169	0.255	0.431	1.29894666700864e-57	ADAM10	Malignant cells	GSE168668	ENSG00000137845	102	ADAM metallopeptidase domain 10	CD156C|HsT18717|kuz|MADM	protein_coding	O14672	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52023
1.22671387282706e-61	-0.275093561105149	0.907	0.966	2.26733525114625e-57	SSR3	Malignant cells	GSE168668	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52024
3.29603582710811e-61	0.326681960705405	0.779	0.676	6.09206301924393e-57	CFDP1	Malignant cells	GSE168668	ENSG00000153774	10428	craniofacial development protein 1	BCNT|CENP-29|CP27|p97|SWC5|Yeti	protein_coding	Q9UEE9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52025
5.92734377637877e-61	-0.258288710347288	0.305	0.489	1.09555095018809e-56	SNHG7	Malignant cells	GSE168668	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52026
1.0275537777572e-60	-0.266046570885727	0.241	0.41	1.89922764742864e-56	TRIM16L	Malignant cells	GSE168668	ENSG00000108448	NA	NA	TRIM70	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52027
1.41933848565209e-60	-0.250709590537994	0.199	0.362	2.62336332303076e-56	ACYP1	Malignant cells	GSE168668	ENSG00000119640	97	acylphosphatase 1	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52028
1.71479829091919e-60	-0.318969935109226	0.412	0.585	3.16946168110594e-56	CCPG1	Malignant cells	GSE168668	ENSG00000260916	9236	cell cycle progression 1	CPR8|KIAA1254	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52029
1.73067939674472e-60	-0.265012651311534	0.607	0.786	3.19881472900327e-56	SEPT11	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52030
2.03563123423192e-60	-0.443071935882409	0.468	0.62	3.76245721023086e-56	TRIB3	Malignant cells	GSE168668	ENSG00000101255	57761	tribbles pseudokinase 3	C20orf97|dJ1103G7.3|TRB3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52031
2.56238252403538e-60	-0.268703488389603	0.331	0.511	4.7360516191746e-56	LAMC1	Malignant cells	GSE168668	ENSG00000135862	3915	laminin subunit gamma 1	LAMB2	protein_coding	P11047	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52032
2.98279530900774e-60	-0.27807689622996	0.727	0.867	5.51310056963901e-56	NPDC1	Malignant cells	GSE168668	ENSG00000107281	56654	neural proliferation, differentiation and control 1	CAB-|CAB1|DKFZp586J0523	protein_coding	Q9NQX5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52033
5.63685992105254e-60	0.449834584771687	0.47	0.28	1.04186081920814e-55	TK1	Malignant cells	GSE168668	ENSG00000167900	7083	thymidine kinase 1	NA	protein_coding	P04183	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52034
7.7762678752144e-60	0.340114467889899	0.668	0.539	1.43728759137588e-55	HADHB	Malignant cells	GSE168668	ENSG00000138029	3032	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta	MTPB	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52035
9.29256834336231e-60	0.342671062542347	0.671	0.527	1.71754540690365e-55	CDC42	Malignant cells	GSE168668	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52036
1.0436437347311e-59	-0.274840706444877	0.504	0.677	1.92896671490349e-55	SUCLG2	Malignant cells	GSE168668	ENSG00000172340	8801	succinate-CoA ligase GDP-forming subunit beta	NA	protein_coding	Q96I99	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52037
1.29440675908244e-59	0.285670692498131	0.303	0.135	2.39245201281208e-55	FUCA2	Malignant cells	GSE168668	ENSG00000001036	2519	alpha-L-fucosidase 2	dJ20N2.5|MGC1314	protein_coding	Q9BTY2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52038
1.57035789369121e-59	0.317099410660927	0.501	0.322	2.90249249490946e-55	ADSS	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52039
1.58377377182351e-59	0.332459863499934	0.762	0.669	2.92728906246139e-55	HOOK2	Malignant cells	GSE168668	ENSG00000095066	29911	hook microtubule tethering protein 2	HK2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52040
2.03203650560071e-59	0.31387963215471	0.869	0.821	3.7558130733018e-55	RER1	Malignant cells	GSE168668	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52041
2.53550238475861e-59	0.398482616197319	0.804	0.739	4.68636905774935e-55	ATXN7L3B	Malignant cells	GSE168668	ENSG00000253719	552889	ataxin 7 like 3B	lnc-SCA7	protein_coding	Q96GX2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52042
3.01406799914204e-59	0.316373089931392	0.459	0.281	5.57090188281423e-55	DNAJB1	Malignant cells	GSE168668	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52043
5.96587532140908e-59	0.33226856059682	0.658	0.518	1.10267273565604e-54	LAP3	Malignant cells	GSE168668	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52044
6.24422141029409e-59	0.311183811597343	0.523	0.341	1.15411944326466e-54	CERS6	Malignant cells	GSE168668	ENSG00000172292	253782	ceramide synthase 6	LASS6	protein_coding	Q6ZMG9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52045
7.50247084791901e-59	-0.264958818905332	0.827	0.941	1.38668168682087e-54	RPS19BP1	Malignant cells	GSE168668	ENSG00000187051	91582	ribosomal protein S19 binding protein 1	FLJ21770|MGC52010	protein_coding	Q86WX3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52046
9.50092710769988e-59	0.328119711653867	0.779	0.692	1.75605635731617e-54	SNRPC	Malignant cells	GSE168668	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52047
1.06777348083484e-58	-0.283213089516512	0.901	0.96	1.97356572462704e-54	GNL3	Malignant cells	GSE168668	ENSG00000163938	26354	G protein nucleolar 3	C77032|E2IG3|MGC800|NS	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52048
1.53963247146021e-58	-0.269683025628243	0.645	0.821	2.84570269699991e-54	RGS10	Malignant cells	GSE168668	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52049
1.7381828752019e-58	-0.27297279308621	0.502	0.674	3.21268340823567e-54	SETD5	Malignant cells	GSE168668	ENSG00000168137	55209	SET domain containing 5	FLJ10707|SETD5A	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52050
3.06008172949434e-58	-0.280539474259584	0.308	0.48	5.65594906062439e-54	FBXO28	Malignant cells	GSE168668	ENSG00000143756	23219	F-box protein 28	CENP-30|Fbx28|FLJ10766|KIAA0483	protein_coding	Q9NVF7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52051
3.34187992396114e-58	0.343893269538837	0.852	0.789	6.17679666345737e-54	MMP24OS	Malignant cells	GSE168668	ENSG00000126005	101410538	MMP24 opposite strand	MMP24-AS1	protein_coding	A0A0U1RRL7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52052
4.12934423527524e-58	0.280218181111827	0.967	0.943	7.63226695005922e-54	CYC1	Malignant cells	GSE168668	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52053
4.85461181812353e-58	-0.287280824026481	0.85	0.927	8.97277902343772e-54	NARS	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52054
6.44256930760069e-58	-0.266626225831026	0.342	0.521	1.19078008512384e-53	TRIM16	Malignant cells	GSE168668	ENSG00000221926	10626	tripartite motif containing 16	EBBP	protein_coding	O95361	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52055
6.76370480860087e-58	0.330493665726707	0.76	0.668	1.2501355597737e-53	DPY30	Malignant cells	GSE168668	ENSG00000162961	84661	dpy-30 histone methyltransferase complex regulatory subunit	Cps25|HDPY-30|Saf19	protein_coding	Q9C005	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52056
7.34341024171772e-58	-0.295037352571809	0.185	0.335	1.35728251497669e-53	CENPBD1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52057
7.6990419277518e-58	0.331657305284446	0.69	0.564	1.42301391950636e-53	PRR13	Malignant cells	GSE168668	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52058
8.2582552683641e-58	0.303313691393353	0.858	0.79	1.52637332125174e-53	CNPY2	Malignant cells	GSE168668	ENSG00000257727	10330	canopy FGF signaling regulator 2	HP10390|TMEM4|ZSIG9	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52059
8.32710220698843e-58	-0.264346200058083	0.146	0.291	1.53909830091767e-53	KNSTRN	Malignant cells	GSE168668	ENSG00000128944	90417	kinetochore localized astrin (SPAG5) binding protein	C15orf23|FLJ14502|kinastrin|SKAP|TRAF4AF1	protein_coding	Q9Y448	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52060
8.35569312933843e-58	0.501976345113082	0.555	0.396	1.54438276109562e-53	PCNA	Malignant cells	GSE168668	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52061
8.52923404010773e-58	0.310714826233518	0.448	0.276	1.57645832763311e-53	MRPL2	Malignant cells	GSE168668	ENSG00000112651	51069	mitochondrial ribosomal protein L2	CGI-22|MRP-L14|RPML14	protein_coding	Q5T653	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52062
8.65114106050874e-58	-0.257399159872581	0.321	0.497	1.59899040221383e-53	LEPROTL1	Malignant cells	GSE168668	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52063
1.23134512434661e-57	-0.301699771648486	0.54	0.702	2.27589519332983e-53	SLC25A36	Malignant cells	GSE168668	ENSG00000114120	55186	solute carrier family 25 member 36	FLJ10618|PNC2	protein_coding	Q96CQ1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52064
2.57943060940668e-57	-0.271687415802295	0.41	0.589	4.76756159536637e-53	USP47	Malignant cells	GSE168668	ENSG00000170242	55031	ubiquitin specific peptidase 47	NA	protein_coding	Q96K76	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52065
3.82966054699808e-57	0.344970580729048	0.3	0.138	7.07836158901655e-53	RAP2B	Malignant cells	GSE168668	ENSG00000181467	5912	RAP2B, member of RAS oncogene family	NA	protein_coding	P61225	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52066
4.57157270505791e-57	-0.259421910516421	0.53	0.705	8.44963783075854e-53	RPL17	Malignant cells	GSE168668	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52067
5.15134639309996e-57	-0.269423467748065	0.928	0.975	9.52123353836665e-53	PFDN2	Malignant cells	GSE168668	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52068
6.57609475003342e-57	-0.283566597750425	0.699	0.843	1.21545959264868e-52	N4BP2L2	Malignant cells	GSE168668	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52069
7.9682686537819e-57	-0.270794727475558	0.407	0.586	1.47277509527851e-52	RFK	Malignant cells	GSE168668	ENSG00000135002	55312	riboflavin kinase	FLJ11149|RIFK	protein_coding	Q969G6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52070
9.98253267933033e-57	-0.297229374790318	0.514	0.669	1.84507151512063e-52	KMT2A	Malignant cells	GSE168668	ENSG00000118058	4297	lysine methyltransferase 2A	ALL-1|ALL1|CXXC7|HRX|HTRX|HTRX1|MLL|MLL1|MLL1A|TRX1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52071
1.19745655502544e-56	-0.329229383994921	0.74	0.852	2.21325895065353e-52	DHRS7	Malignant cells	GSE168668	ENSG00000100612	51635	dehydrogenase/reductase 7	retDSR4|SDR34C1	protein_coding	Q9Y394	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52072
1.71011948932614e-56	-0.261488774282272	0.747	0.89	3.1608138521215e-52	CAMLG	Malignant cells	GSE168668	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52073
2.00327561566198e-56	0.338581385717219	0.666	0.518	3.70265432042804e-52	KDM5B	Malignant cells	GSE168668	ENSG00000117139	10765	lysine demethylase 5B	CT31|JARID1B|PLU-1|PPP1R98|RBBP2H1A	protein_coding	Q9UGL1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52074
3.44528924347191e-56	0.278276838738415	0.95	0.911	6.36792810870912e-52	KIF5B	Malignant cells	GSE168668	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52075
3.78933560789837e-56	0.330474517745887	0.801	0.71	7.00382900407856e-52	HNRNPDL	Malignant cells	GSE168668	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52076
4.16269813637623e-56	-0.28256867588464	0.389	0.555	7.69391496546419e-52	TFDP1	Malignant cells	GSE168668	ENSG00000198176	7027	transcription factor Dp-1	DILC|Dp-1|DP1|DRTF1	protein_coding	Q14186	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52077
4.52245257425068e-56	0.268765948651358	0.963	0.94	8.35884909298754e-52	ATP5PB	Malignant cells	GSE168668	ENSG00000116459	515	ATP synthase peripheral stalk-membrane subunit b	ATP5F1	protein_coding	P24539	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52078
7.65032140372759e-56	0.282549198741185	0.966	0.903	1.41400890505097e-51	RNF187	Malignant cells	GSE168668	ENSG00000285426	149603	ring finger protein 187	RACO-1|RACO1	protein_coding	Q5TA31	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52079
1.02948591375201e-55	-0.265366744647889	0.847	0.936	1.90279881438784e-51	ITGB1	Malignant cells	GSE168668	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52080
1.27362399021976e-55	-0.259917193573243	0.291	0.47	2.35403922112319e-51	BTG3	Malignant cells	GSE168668	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52081
1.33772529210102e-55	-0.430319208167213	0.882	0.921	2.47251765739032e-51	DDIT4	Malignant cells	GSE168668	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52082
1.36382902139618e-55	-0.266035866429903	0.381	0.552	2.52076518024656e-51	DCAF6	Malignant cells	GSE168668	ENSG00000143164	55827	DDB1 and CUL4 associated factor 6	IQWD1|PC326	protein_coding	Q58WW2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52083
1.69810386878272e-55	0.292063992616379	0.872	0.82	3.13860538067111e-51	FKBP3	Malignant cells	GSE168668	ENSG00000100442	2287	FKBP prolyl isomerase 3	FKBP-25|FKBP25	protein_coding	Q00688	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52084
1.93174575436147e-55	0.313343561969272	0.408	0.238	3.5704456777863e-51	LDOC1	Malignant cells	GSE168668	ENSG00000182195	23641	LDOC1 regulator of NFKB signaling	BCUR1|Mar7|Mart7|RTL7|SIRH7	protein_coding	O95751	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52085
1.93306356679582e-55	-0.278483271183199	0.7	0.849	3.57288139050871e-51	NSRP1	Malignant cells	GSE168668	ENSG00000126653	84081	nuclear speckle splicing regulatory protein 1	CCDC55|DKFZP434K1421|NSrp70	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52086
2.25765544130497e-55	0.336912531650363	0.635	0.462	4.17282455216398e-51	KCNQ1OT1	Malignant cells	GSE168668	ENSG00000269821	10984	KCNQ1 opposite strand/antisense transcript 1	KCNQ1-AS2|KvDMR1|KvLQT1-AS|LIT1|NCRNA00012	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52087
2.41186711771617e-55	-0.303868035475752	0.284	0.444	4.45785399367479e-51	MCCC2	Malignant cells	GSE168668	ENSG00000281742	64087	methylcrotonyl-CoA carboxylase subunit 2	MCCB|MCCCbeta	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52088
2.6206638012586e-55	-0.346706488833297	0.224	0.38	4.84377290386627e-51	UBALD2	Malignant cells	GSE168668	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52089
2.71775742204511e-55	0.277932511006114	0.389	0.216	5.02323104316597e-51	SMAP1	Malignant cells	GSE168668	ENSG00000112305	60682	small ArfGAP 1	FLJ13159|SMAP-1	protein_coding	Q8IYB5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52090
2.81278048441611e-55	0.278697094630354	0.373	0.203	5.19886216934629e-51	PPP2R5A	Malignant cells	GSE168668	ENSG00000066027	5525	protein phosphatase 2 regulatory subunit B'alpha	B56A|B56alpha|PR61A	protein_coding	Q15172	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52091
3.49082928716692e-55	-0.252949733957208	0.559	0.722	6.45209977147061e-51	NOB1	Malignant cells	GSE168668	ENSG00000141101	28987	NIN1 (RPN12) binding protein 1 homolog	ART-4|MST158|NOB1P|PSMD8BP1	protein_coding	Q9ULX3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52092
3.6042394407054e-55	0.325675332543224	0.641	0.511	6.6617157582558e-51	CBR1	Malignant cells	GSE168668	ENSG00000159228	873	carbonyl reductase 1	CBR|SDR21C1	protein_coding	P16152	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52093
3.78254068650679e-55	0.289417722723791	0.522	0.333	6.99126995087049e-51	GRB10	Malignant cells	GSE168668	ENSG00000106070	2887	growth factor receptor bound protein 10	NA	protein_coding	Q13322	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52094
5.98231752835379e-55	-0.355810355926344	0.344	0.501	1.10571174876563e-50	SKA2	Malignant cells	GSE168668	ENSG00000182628	348235	spindle and kinetochore associated complex subunit 2	FAM33A|FLJ12758	protein_coding	Q8WVK7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52095
6.99804364176768e-55	-0.280627764209918	0.785	0.889	1.29344840630792e-50	EBPL	Malignant cells	GSE168668	ENSG00000123179	84650	EBP like	EBRP	protein_coding	Q9BY08	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52096
7.84878615063587e-55	-0.267578535345363	0.717	0.859	1.45069114422203e-50	COX7A2L	Malignant cells	GSE168668	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52097
7.99923239659444e-55	0.322889591529437	0.77	0.693	1.47849812386255e-50	MDH1	Malignant cells	GSE168668	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52098
1.0271727006882e-54	0.264795919161777	0.95	0.922	1.898523302682e-50	SSB	Malignant cells	GSE168668	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52099
1.19237061268811e-54	-0.296894547844905	0.334	0.498	2.20385860343144e-50	STC2	Malignant cells	GSE168668	ENSG00000113739	8614	stanniocalcin 2	STC-2	protein_coding	O76061	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52100
1.51065593698768e-54	0.388024576866158	0.767	0.68	2.79214536833432e-50	AP001816.1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52101
1.54634220988987e-54	0.253968977384522	0.984	0.958	2.85810430653944e-50	EIF3A	Malignant cells	GSE168668	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52102
1.66664512067794e-54	0.289301106528966	0.86	0.803	3.08046017654903e-50	NOL7	Malignant cells	GSE168668	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52103
1.90743949651196e-54	-0.254447951582092	0.824	0.926	3.52552042140305e-50	TMEM256	Malignant cells	GSE168668	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52104
1.97433994587211e-54	0.322065798370908	0.605	0.465	3.64917252195542e-50	TSFM	Malignant cells	GSE168668	ENSG00000123297	10102	Ts translation elongation factor, mitochondrial	EF-TS|EF-Tsmt	protein_coding	P43897	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52105
3.19142770513879e-54	-0.251307179119268	0.381	0.557	5.89871582740802e-50	AL451165.2	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52106
3.4647625007566e-54	-0.262430287490442	0.281	0.447	6.40392053014843e-50	SCML1	Malignant cells	GSE168668	ENSG00000047634	6322	Scm polycomb group protein like 1	NA	protein_coding	Q9UN30	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52107
3.78352891515325e-54	0.299185498972612	0.364	0.197	6.99309649387774e-50	SPATS2L	Malignant cells	GSE168668	ENSG00000196141	26010	spermatogenesis associated serine rich 2 like	DNAPTP6|SGNP	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52108
8.32919980698131e-54	0.320571105817943	0.781	0.677	1.53948600032436e-49	RBBP4	Malignant cells	GSE168668	ENSG00000162521	5928	RB binding protein 4, chromatin remodeling factor	lin-53|NURF55|RbAp48	protein_coding	Q09028	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52109
8.48073738586873e-54	0.28629617620007	0.808	0.701	1.56749469103012e-49	SEPT7	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52110
1.30858553809637e-53	-0.272796306644568	0.527	0.678	2.41865865006353e-49	FMC1	Malignant cells	GSE168668	ENSG00000164898	154791	formation of mitochondrial complex V assembly factor 1 homolog	C7orf55|HSPC268	protein_coding	Q96HJ9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52111
1.61910641297243e-53	0.293108755982344	0.856	0.807	2.99259438309695e-49	DNAJC8	Malignant cells	GSE168668	ENSG00000285317	22826	DnaJ heat shock protein family (Hsp40) member C8	SPF31	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52112
2.016486387889e-53	-0.252991244584464	0.224	0.379	3.72707179073524e-49	ZNF714	Malignant cells	GSE168668	ENSG00000160352	148206	zinc finger protein 714	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52113
2.47778608968425e-53	0.323277471465505	0.511	0.342	4.57969202956341e-49	SQLE	Malignant cells	GSE168668	ENSG00000104549	6713	squalene epoxidase	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52114
2.77967469640269e-53	0.335096022017235	0.775	0.694	5.13767274136109e-49	C1orf122	Malignant cells	GSE168668	ENSG00000197982	127687	chromosome 1 open reading frame 122	FLJ45459	protein_coding	Q6ZSJ8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52115
3.15053712895973e-53	0.333606786672803	0.594	0.451	5.82313777545627e-49	THYN1	Malignant cells	GSE168668	ENSG00000151500	29087	thymocyte nuclear protein 1	THY28	protein_coding	Q9P016	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52116
4.62873154299141e-53	0.287043570052329	0.901	0.811	8.55528451091103e-49	HNRNPA3	Malignant cells	GSE168668	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52117
7.39909401427244e-53	-0.263820237971926	0.351	0.514	1.36757454665797e-48	DNAJB14	Malignant cells	GSE168668	ENSG00000164031	79982	DnaJ heat shock protein family (Hsp40) member B14	FLJ14281	protein_coding	Q8TBM8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52118
1.56233845160127e-52	0.280274352022416	0.4	0.234	2.88767016009462e-48	LINC01184	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52119
1.93581988870843e-52	0.300271171368286	0.428	0.263	3.57797590029979e-48	SSBP3	Malignant cells	GSE168668	ENSG00000157216	23648	single stranded DNA binding protein 3	CSDP|FLJ10355|SSDP|SSDP1	protein_coding	Q9BWW4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52120
2.39655156097557e-52	0.284350857755346	0.949	0.928	4.42954625015114e-48	ARF1	Malignant cells	GSE168668	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52121
3.29962077407793e-52	0.358932449142828	0.574	0.429	6.09868907672823e-48	VGLL4	Malignant cells	GSE168668	ENSG00000144560	9686	vestigial like family member 4	KIAA0121	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52122
3.60310620742129e-52	-0.340159621921641	0.194	0.339	6.65962120317677e-48	ATF3	Malignant cells	GSE168668	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52123
3.81454413098833e-52	-0.258552938609229	0.605	0.759	7.05042191730574e-48	TRAF4	Malignant cells	GSE168668	ENSG00000076604	9618	TNF receptor associated factor 4	CART1|MLN62|RNF83	protein_coding	Q9BUZ4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52124
4.30663958369172e-52	0.302791937916454	0.55	0.392	7.9599619425374e-48	PSMC2	Malignant cells	GSE168668	ENSG00000161057	5701	proteasome 26S subunit, ATPase 2	MSS1|Nbla10058|RPT1|S7	protein_coding	P35998	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52125
6.48211940330062e-52	-0.278925689252788	0.487	0.645	1.19809012931205e-47	NAMPT	Malignant cells	GSE168668	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52126
7.91056684466878e-52	-0.264724918709716	0.567	0.722	1.46211006990013e-47	EXOSC7	Malignant cells	GSE168668	ENSG00000075914	23016	exosome component 7	EAP1|hRrp42p|KIAA0116|p8|RRP42|Rrp42p	protein_coding	Q15024	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52127
2.4128589989646e-51	-0.257000275832149	0.816	0.921	4.45968728778627e-47	DDX17	Malignant cells	GSE168668	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52128
2.58221431265978e-51	-0.252152810855951	0.386	0.55	4.77270671408908e-47	HDHD5	Malignant cells	GSE168668	ENSG00000069998	27440	haloacid dehalogenase like hydrolase domain containing 5	CECR5	protein_coding	Q9BXW7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52129
2.92354521797841e-51	-0.2598924981602	0.487	0.647	5.40358862638949e-47	SUMF2	Malignant cells	GSE168668	ENSG00000129103	25870	sulfatase modifying factor 2	DKFZp566I1024	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52130
3.22578304189774e-51	0.373797233370237	0.372	0.219	5.96221479633959e-47	IRF6	Malignant cells	GSE168668	ENSG00000117595	3664	interferon regulatory factor 6	LPS|OFC6|VWS|VWS1	protein_coding	O14896	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52131
3.5056928472257e-51	-0.273105237786232	0.379	0.538	6.47957208952727e-47	CASC4	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52132
3.75616470752898e-51	-0.250430363699438	0.977	0.988	6.94251922892581e-47	RPS27L	Malignant cells	GSE168668	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52133
4.03998540447723e-51	0.30675375260892	0.508	0.348	7.46710502309527e-47	RXYLT1	Malignant cells	GSE168668	ENSG00000118600	10329	ribitol xylosyltransferase 1	HP10481|TMEM5	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52134
5.68532931905365e-51	-0.260125237521512	0.425	0.589	1.05081941804069e-46	CYSTM1	Malignant cells	GSE168668	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52135
7.50777800378118e-51	0.258148340113075	0.945	0.913	1.38766260843888e-46	HDLBP	Malignant cells	GSE168668	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52136
8.43239738425041e-51	0.29980633722559	0.808	0.735	1.558560008531e-46	COPS6	Malignant cells	GSE168668	ENSG00000168090	10980	COP9 signalosome subunit 6	CSN6|MOV34-34KD	protein_coding	Q7L5N1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52137
8.46788292904442e-51	0.311896379350193	0.65	0.511	1.56511880177528e-46	FAM89B	Malignant cells	GSE168668	ENSG00000176973	23625	family with sequence similarity 89 member B	LRAP25|MTVR1	protein_coding	Q8N5H3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52138
1.0877266049859e-50	0.299061108336061	0.473	0.311	2.01044508399543e-46	MAGT1	Malignant cells	GSE168668	ENSG00000102158	84061	magnesium transporter 1	DKFZp564K142|IAP|MRX95|OST3B|SLC58A1	protein_coding	Q9H0U3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52139
1.45888857582358e-50	0.293261770810693	0.562	0.404	2.69646375469472e-46	WASHC3	Malignant cells	GSE168668	ENSG00000120860	51019	WASH complex subunit 3	CCDC53|CGI-116	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52140
2.14626756984186e-50	-0.347663305099039	0.299	0.451	3.96694634933871e-46	PMEPA1	Malignant cells	GSE168668	ENSG00000124225	56937	prostate transmembrane protein, androgen induced 1	STAG1|TMEPAI	protein_coding	Q969W9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52141
2.17781478208101e-50	-0.259593069944889	0.93	0.964	4.02525506172034e-46	ANP32B	Malignant cells	GSE168668	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52142
2.3722892505943e-50	0.288170339085073	0.458	0.293	4.38470222187345e-46	MICU2	Malignant cells	GSE168668	ENSG00000165487	221154	mitochondrial calcium uptake 2	EFHA1	protein_coding	Q8IYU8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52143
2.83635390479266e-50	0.259851027620669	0.935	0.897	5.24243292222827e-46	GSPT1	Malignant cells	GSE168668	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52144
3.15829403791307e-50	-0.267406135887758	0.536	0.696	5.83747487027472e-46	ZNF106	Malignant cells	GSE168668	ENSG00000103994	64397	zinc finger protein 106	SH3BP3|ZFP106|ZNF474	protein_coding	Q9H2Y7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52145
4.75425562629185e-50	-0.253361858764758	0.597	0.749	8.78729067407523e-46	RAB11A	Malignant cells	GSE168668	ENSG00000103769	8766	RAB11A, member RAS oncogene family	YL8	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52146
5.64677466077005e-50	-0.260473179551856	0.421	0.584	1.04369336055013e-45	MAP9	Malignant cells	GSE168668	ENSG00000164114	79884	microtubule associated protein 9	ASAP|FLJ21159	protein_coding	Q49MG5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52147
6.04314745262003e-50	-0.27246521681801	0.452	0.615	1.11695494366776e-45	LINC00662	Malignant cells	GSE168668	ENSG00000261824	148189	long intergenic non-protein coding RNA 662	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52148
8.0968808771353e-50	0.298521865628007	0.463	0.3	1.49654649252092e-45	PFKL	Malignant cells	GSE168668	ENSG00000141959	5211	phosphofructokinase, liver type	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52149
1.08499546355444e-49	0.302914048653779	0.507	0.347	2.00539711528767e-45	TOR1AIP2	Malignant cells	GSE168668	ENSG00000169905	163590	torsin 1A interacting protein 2	IFRG15|LULL1|NET9	protein_coding	Q8NFQ8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52150
1.86477912061366e-49	0.328959569173861	0.651	0.516	3.44667124863023e-45	TOB1	Malignant cells	GSE168668	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52151
4.835475454099e-49	0.298257260975962	0.466	0.313	8.93740928181118e-45	MOCS2	Malignant cells	GSE168668	ENSG00000164172	4338	molybdenum cofactor synthesis 2	MOCO1|MOCS2A|MOCS2B	protein_coding	O96033	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52152
6.25043538648238e-49	0.311698478173502	0.713	0.618	1.15526797248354e-44	SELENOF	Malignant cells	GSE168668	ENSG00000183291	9403	selenoprotein F	SEP15	protein_coding	O60613	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52153
1.03665070495338e-48	0.290422090195477	0.526	0.367	1.91604149796534e-44	GLRX2	Malignant cells	GSE168668	ENSG00000023572	51022	glutaredoxin 2	bA101E13.1|GRX2	protein_coding	Q9NS18	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52154
1.28535950668265e-48	0.319171182718367	0.439	0.282	2.37572997620155e-44	DAXX	Malignant cells	GSE168668	ENSG00000231617	1616	death domain associated protein	DAP6	protein_coding	Q9UER7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52155
1.36313562576223e-48	0.342428521505567	0.702	0.612	2.51948357709633e-44	LAMP2	Malignant cells	GSE168668	ENSG00000005893	3920	lysosomal associated membrane protein 2	CD107b	protein_coding	P13473	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52156
1.57842680987926e-48	-0.276781119371968	0.895	0.953	2.91740627269984e-44	MT-ND6	Malignant cells	GSE168668	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52157
1.75655626577892e-48	0.272395008190165	0.871	0.83	3.24664294603917e-44	OLA1	Malignant cells	GSE168668	ENSG00000138430	29789	Obg like ATPase 1	GTPBP9|PTD004	protein_coding	Q9NTK5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52158
2.08605974134793e-48	0.294359987297765	0.813	0.746	3.85566421993338e-44	UQCRC1	Malignant cells	GSE168668	ENSG00000010256	7384	ubiquinol-cytochrome c reductase core protein 1	D3S3191|QCR1|UQCR1	protein_coding	P31930	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52159
2.53455339339708e-48	-0.263554360178006	0.736	0.859	4.68461503701582e-44	NCOR1	Malignant cells	GSE168668	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52160
2.79820059546821e-48	0.318028986124634	0.437	0.282	5.17191416060389e-44	GSTA4	Malignant cells	GSE168668	ENSG00000170899	2941	glutathione S-transferase alpha 4	NA	protein_coding	O15217	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52161
6.65839797463017e-48	0.303134709420555	0.624	0.495	1.23067169765089e-43	DLD	Malignant cells	GSE168668	ENSG00000091140	1738	dihydrolipoamide dehydrogenase	DLDH|E3|GCSL|LAD|OGDC-E3	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52162
6.87136484318504e-48	-0.255491667527382	0.603	0.758	1.27003436396589e-43	MAP4	Malignant cells	GSE168668	ENSG00000047849	4134	microtubule associated protein 4	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52163
1.37004778212722e-47	-0.256935033992019	0.199	0.34	2.53225931570574e-43	SAPCD2	Malignant cells	GSE168668	ENSG00000186193	89958	suppressor APC domain containing 2	C9orf140|p42.3	protein_coding	Q86UD0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52164
1.52943762541132e-47	0.273346443398991	0.872	0.813	2.82685956304775e-43	TPR	Malignant cells	GSE168668	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52165
1.65187308842697e-47	0.302341588600602	0.655	0.534	3.05315702933956e-43	ASNA1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52166
2.44355122951837e-47	0.330089295493327	0.629	0.51	4.5164157375188e-43	MAN1A2	Malignant cells	GSE168668	ENSG00000198162	10905	mannosidase alpha class 1A member 2	MAN1B	protein_coding	O60476	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52167
3.23472297690822e-47	0.295620570301682	0.76	0.688	5.97873847821945e-43	ARL3	Malignant cells	GSE168668	ENSG00000138175	403	ADP ribosylation factor like GTPase 3	ARFL3	protein_coding	P36405	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52168
3.39931661439499e-47	-0.394709986424988	0.737	0.807	6.28295689838626e-43	MYC	Malignant cells	GSE168668	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52169
3.44922832224387e-47	0.322526829711548	0.85	0.81	6.37520870800335e-43	ITM2B	Malignant cells	GSE168668	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52170
4.78972166959167e-47	0.309368258087955	0.644	0.515	8.85284256190628e-43	MMAB	Malignant cells	GSE168668	ENSG00000139428	326625	metabolism of cobalamin associated B	cblB|CFAP23	protein_coding	Q96EY8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52171
5.03191638850063e-47	-0.251520619120665	0.401	0.556	9.30049106086572e-43	CARS	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52172
6.67687853812224e-47	0.291475854555597	0.583	0.438	1.23408746020113e-42	SNX2	Malignant cells	GSE168668	ENSG00000205302	6643	sorting nexin 2	NA	protein_coding	O60749	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52173
7.90886530542216e-47	0.260124255607663	0.836	0.748	1.46179557440118e-42	TUBA1C	Malignant cells	GSE168668	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52174
8.92056342476734e-47	0.252599184387744	0.924	0.887	1.64878773779975e-42	EIF1AX	Malignant cells	GSE168668	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52175
1.43769369355027e-46	0.280140681431453	0.509	0.351	2.65728925378896e-42	PTTG1IP	Malignant cells	GSE168668	ENSG00000183255	754	PTTG1 interacting protein	C21orf1|C21orf3|PBF|PTTG1IP1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52176
1.55397596887881e-46	-0.254067173327087	0.567	0.719	2.8722137832787e-42	SMCO4	Malignant cells	GSE168668	ENSG00000166002	56935	single-pass membrane protein with coiled-coil domains 4	C11orf75|FN5	protein_coding	Q9NRQ5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52177
1.56442677440143e-46	0.257111902372706	0.991	0.962	2.89153000712617e-42	PHGDH	Malignant cells	GSE168668	ENSG00000092621	26227	phosphoglycerate dehydrogenase	PDG|PGDH|SERA	protein_coding	O43175	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52178
2.3169298162644e-46	0.371582483810794	0.559	0.423	4.28238137940149e-42	CRELD2	Malignant cells	GSE168668	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52179
2.37551845559759e-46	-0.262854918988176	0.525	0.674	4.39067076148102e-42	VMP1	Malignant cells	GSE168668	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52180
2.43233078006119e-46	-0.260329278637941	0.449	0.601	4.49567698078709e-42	KDM6A	Malignant cells	GSE168668	ENSG00000147050	7403	lysine demethylase 6A	UTX	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52181
2.60926335058469e-46	0.299751653676835	0.528	0.381	4.82270145088569e-42	EBNA1BP2	Malignant cells	GSE168668	ENSG00000117395	10969	EBNA1 binding protein 2	EBP2|NOBP|P40	protein_coding	Q99848	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52182
2.62865532136039e-46	0.252940583926217	0.94	0.915	4.8585436304704e-42	MORF4L2	Malignant cells	GSE168668	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52183
2.73329545746179e-46	0.278658490584297	0.574	0.43	5.05194999402663e-42	NSL1	Malignant cells	GSE168668	ENSG00000117697	25936	NSL1 component of MIS12 kinetochore complex	C1orf48|DC8|DKFZP566O1646|MIS14	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52184
3.44593933625719e-46	-0.290049720624847	0.433	0.579	6.36912967520417e-42	FAM43A	Malignant cells	GSE168668	ENSG00000185112	131583	family with sequence similarity 43 member A	FLJ90022	protein_coding	Q8N2R8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52185
3.53844855031859e-46	0.29287349768594	0.553	0.404	6.54011445555384e-42	SLC35B1	Malignant cells	GSE168668	ENSG00000121073	10237	solute carrier family 35 member B1	AXER|UGTREL1	protein_coding	P78383	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52186
3.53982545785753e-46	0.264593206102573	0.891	0.859	6.54265939375806e-42	PSMA3	Malignant cells	GSE168668	ENSG00000100567	5684	proteasome 20S subunit alpha 3	HC8	protein_coding	P25788	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52187
3.98865017942768e-46	0.260713141823127	0.905	0.878	7.37222212663619e-42	ATP6V0E1	Malignant cells	GSE168668	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52188
4.85292368707285e-46	0.279362028029269	0.407	0.252	8.96965885081675e-42	GLYATL1	Malignant cells	GSE168668	ENSG00000166840	92292	glycine-N-acyltransferase like 1	FLJ34646|MGC15397	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52189
5.10320238406339e-46	0.286385992283952	0.834	0.799	9.43224896646437e-42	UFC1	Malignant cells	GSE168668	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52190
8.55286741037846e-46	0.31874206325376	0.556	0.402	1.58082648346025e-41	DNMT1	Malignant cells	GSE168668	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52191
8.9441062354821e-46	0.311074034990119	0.785	0.731	1.65313915550416e-41	COA3	Malignant cells	GSE168668	ENSG00000183978	28958	cytochrome c oxidase assembly factor 3	CCDC56|COX25|hCOA3|HSPC009|MITRAC12	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52192
1.27847614281824e-45	0.269947546507969	0.424	0.269	2.36300745477096e-41	RETREG1	Malignant cells	GSE168668	ENSG00000154153	54463	reticulophagy regulator 1	FAM134B|FLJ20152|JK1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52193
1.60359670432523e-45	0.251607065018167	0.909	0.89	2.96392778860432e-41	NENF	Malignant cells	GSE168668	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52194
1.83174354289697e-45	0.251038722395004	0.352	0.202	3.38561159033647e-41	PEPD	Malignant cells	GSE168668	ENSG00000124299	5184	peptidase D	NA	protein_coding	P12955	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52195
2.15469162476292e-45	-0.254038403856046	0.39	0.541	3.98251653004931e-41	TMEM33	Malignant cells	GSE168668	ENSG00000109133	55161	transmembrane protein 33	FLJ10525|Pom33	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52196
1.09932122267e-44	-0.266954547230397	0.803	0.908	2.03187541586097e-40	GTF2H2	Malignant cells	GSE168668	ENSG00000276910	2966	general transcription factor IIH subunit 2	BTF2|BTF2P44|p44|T-BTF2P44|TFIIH	protein_coding	Q13888	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52197
1.26094330437214e-44	-0.254422512284156	0.547	0.692	2.33060150947102e-40	POLR2J3.1	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52198
2.03567506834583e-44	0.320924158000115	0.712	0.628	3.76253822882359e-40	PAFAH1B3	Malignant cells	GSE168668	ENSG00000079462	5050	platelet activating factor acetylhydrolase 1b catalytic subunit 3	NA	protein_coding	Q15102	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52199
3.34981984142321e-44	0.274592530653155	0.482	0.333	6.19147201290251e-40	YIPF3	Malignant cells	GSE168668	ENSG00000137207	25844	Yip1 domain family member 3	C6orf109|dJ337H4.3|DKFZp566C243|FinGER3|KLIP1	protein_coding	Q9GZM5	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52200
3.51825068792461e-44	0.288159337816721	0.779	0.71	6.50278274649105e-40	ANXA7	Malignant cells	GSE168668	ENSG00000138279	310	annexin A7	ANX7	protein_coding	P20073	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52201
4.38841096959466e-44	0.259256046406974	0.469	0.315	8.1110999951018e-40	CHMP3	Malignant cells	GSE168668	ENSG00000115561	51652	charged multivesicular body protein 3	CGI-149|NEDF|VPS24	protein_coding	Q9Y3E7	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52202
5.01464749548684e-44	-0.260796054942083	0.534	0.679	9.26857296590832e-40	NSD3	Malignant cells	GSE168668	ENSG00000147548	54904	nuclear receptor binding SET domain protein 3	FLJ20353|KMT3F|WHISTLE|WHSC1L1	protein_coding	Q9BZ95	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52203
1.35677213669853e-43	0.260961980628954	0.421	0.27	2.50772194025989e-39	VAT1	Malignant cells	GSE168668	ENSG00000108828	10493	vesicle amine transport 1	FLJ20230|VATI	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52204
1.51361532311872e-43	0.27955207770049	0.46	0.317	2.79761520172033e-39	C6orf203	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52205
1.52343511635649e-43	0.303134123937936	0.645	0.531	2.8157651255617e-39	ERBB3	Malignant cells	GSE168668	ENSG00000065361	2065	erb-b2 receptor tyrosine kinase 3	HER3|LCCS2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52206
1.64842453374399e-43	0.274564530651121	0.672	0.541	3.04678306571902e-39	CHD4	Malignant cells	GSE168668	ENSG00000111642	1108	chromodomain helicase DNA binding protein 4	Mi-2b|Mi2-BETA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52207
1.96865467308492e-43	-0.306183162168449	0.617	0.749	3.63866443226285e-39	GCLM	Malignant cells	GSE168668	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52208
2.09280430202104e-43	0.334916830001248	0.416	0.273	3.86813019142549e-39	GGH	Malignant cells	GSE168668	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52209
3.03667096143293e-43	0.298106191597525	0.737	0.661	5.61267893801649e-39	ATIC	Malignant cells	GSE168668	ENSG00000138363	471	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	AICARFT|IMPCHASE|PURH	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52210
5.09488800629523e-43	0.292230064933178	0.73	0.646	9.41688150203548e-39	APPL1	Malignant cells	GSE168668	ENSG00000157500	26060	adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1	APPL	protein_coding	Q9UKG1	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52211
5.21535399042762e-43	0.271246315256184	0.499	0.353	9.63953878050736e-39	CCDC91	Malignant cells	GSE168668	ENSG00000123106	55297	coiled-coil domain containing 91	DKFZp779L1558|FLJ11088|p56	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52212
6.18752945221576e-43	0.305102376157417	0.656	0.555	1.14364106865304e-38	PHYH	Malignant cells	GSE168668	ENSG00000107537	5264	phytanoyl-CoA 2-hydroxylase	PAHX|PHYH1|RD	protein_coding	O14832	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52213
6.54305558017654e-43	0.262788566485449	0.925	0.916	1.20935296288403e-38	RPN2	Malignant cells	GSE168668	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52214
7.53876279153792e-43	0.273760814135263	0.795	0.729	1.39338952675995e-38	CSNK2B	Malignant cells	GSE168668	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52215
9.81446858665666e-43	0.280074977186684	0.585	0.453	1.81400822887175e-38	C1orf131	Malignant cells	GSE168668	ENSG00000143633	128061	chromosome 1 open reading frame 131	DKFZp547B1713	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52216
1.2950547324139e-42	0.269790739380006	0.803	0.747	2.3936496619206e-38	IK	Malignant cells	GSE168668	ENSG00000113141	3550	IK cytokine	RED|RER	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52217
1.34855402715411e-42	0.262904583477994	0.787	0.713	2.49253240838894e-38	NDUFS2	Malignant cells	GSE168668	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52218
2.09498340423775e-42	0.272283862653709	0.475	0.332	3.87215782605263e-38	CSRP1	Malignant cells	GSE168668	ENSG00000159176	1465	cysteine and glycine rich protein 1	CSRP|CYRP|D1S181E	protein_coding	P21291	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52219
2.32415779182911e-42	-0.285394317396548	0.747	0.859	4.29574084663775e-38	DHX36	Malignant cells	GSE168668	ENSG00000281763	170506	DEAH-box helicase 36	DDX36|KIAA1488|MLEL1|RHAU	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52220
2.40188481176855e-42	0.271171122803016	0.625	0.501	4.43940369759182e-38	PRPF4B	Malignant cells	GSE168668	ENSG00000112739	8899	pre-mRNA processing factor 4B	KIAA0536|PR4H|Prp4	protein_coding	Q13523	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52221
2.58715201728986e-42	0.271102293574649	0.461	0.313	4.78183307355686e-38	FUBP1	Malignant cells	GSE168668	ENSG00000162613	8880	far upstream element binding protein 1	FBP|FUBP	protein_coding	Q96AE4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52222
2.95343903095269e-42	0.255205110590435	0.389	0.244	5.45884136090985e-38	LYRM2	Malignant cells	GSE168668	ENSG00000083099	57226	LYR motif containing 2	DJ122O8.2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52223
3.97708296312081e-42	0.276064102901088	0.872	0.841	7.3508424407362e-38	CLIC1	Malignant cells	GSE168668	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52224
4.66745838215077e-42	0.283115194780341	0.588	0.464	8.62686332772927e-38	GLOD4	Malignant cells	GSE168668	ENSG00000167699	51031	glyoxalase domain containing 4	C17orf25|CGI-150|HC71	protein_coding	Q9HC38	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52225
4.74701997164421e-42	0.25602337612636	0.841	0.779	8.77391701358999e-38	CCAR1	Malignant cells	GSE168668	ENSG00000060339	55749	cell division cycle and apoptosis regulator 1	CARP-1|CARP1|FLJ10590	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52226
5.61738079212534e-42	0.291057100224484	0.843	0.809	1.03826049180853e-37	ARF4	Malignant cells	GSE168668	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52227
1.05850527337804e-41	0.261710793553949	0.513	0.372	1.95643529678464e-37	VPS26A	Malignant cells	GSE168668	ENSG00000122958	9559	VPS26 retromer complex component A	Hbeta58|PEP8A|VPS26	protein_coding	O75436	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52228
1.87892507487733e-41	0.282143334914899	0.745	0.685	3.47281721589577e-37	EIF6	Malignant cells	GSE168668	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52229
3.80991619494041e-41	-0.268387412490725	0.241	0.373	7.04186810310835e-37	ARHGAP21	Malignant cells	GSE168668	ENSG00000107863	57584	Rho GTPase activating protein 21	ARHGAP10|KIAA1424	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52230
4.80503822274376e-41	0.296927472167792	0.706	0.614	8.88115214709729e-37	SLC50A1	Malignant cells	GSE168668	ENSG00000169241	55974	solute carrier family 50 member 1	HsSWEET1|RAG1AP1|RP11-540D14.5|RZPDo834D038D|SCP|slv|SWEET1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52231
5.58345308266213e-41	0.257352712729904	0.485	0.338	1.03198963326844e-36	PUS7L	Malignant cells	GSE168668	ENSG00000129317	83448	pseudouridine synthase 7 like	DKFZP434G1415	protein_coding	Q9H0K6	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52232
5.68172483980476e-41	0.281240227303726	0.733	0.653	1.05015320214111e-36	MRPL13	Malignant cells	GSE168668	ENSG00000172172	28998	mitochondrial ribosomal protein L13	L13|L13A|L13mt|RPL13|RPML13	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52233
8.78657583335973e-41	0.251413140691066	0.865	0.844	1.62402281127988e-36	DNAJC7	Malignant cells	GSE168668	ENSG00000168259	7266	DnaJ heat shock protein family (Hsp40) member C7	TPR2|TTC2	protein_coding	Q99615	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52234
1.04895001611218e-40	0.253180077170196	0.449	0.305	1.93877431478014e-36	UROD	Malignant cells	GSE168668	ENSG00000126088	7389	uroporphyrinogen decarboxylase	NA	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52235
1.09632359382113e-40	0.25034107007182	0.865	0.842	2.0263348984596e-36	NDUFA8	Malignant cells	GSE168668	ENSG00000119421	4702	NADH:ubiquinone oxidoreductase subunit A8	MGC793|PGIV	protein_coding	P51970	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52236
1.38535887316233e-40	-0.281495630762327	0.905	0.961	2.56055880526594e-36	RBCK1	Malignant cells	GSE168668	ENSG00000125826	10616	RANBP2-type and C3HC4-type zinc finger containing 1	C20orf18|HOIL1|RBCK2|RNF54|UBCE7IP3|XAP4|ZRANB4	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52237
2.54761110907084e-40	0.262381081543248	0.827	0.776	4.70874961289564e-36	GDI2	Malignant cells	GSE168668	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52238
2.59039644862673e-40	0.324129602541501	0.609	0.495	4.78782975599679e-36	SLC16A1	Malignant cells	GSE168668	ENSG00000281917	6566	solute carrier family 16 member 1	MCT|MCT1	protein_coding	P53985	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52239
4.04452944054488e-40	0.287807565282797	0.686	0.599	7.47550376495911e-36	RRAGA	Malignant cells	GSE168668	ENSG00000155876	10670	Ras related GTP binding A	FIP-1|RAGA	protein_coding	Q7L523	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52240
5.01359220171454e-40	0.266413611601739	0.566	0.432	9.26662246642898e-36	CDC73	Malignant cells	GSE168668	ENSG00000134371	79577	cell division cycle 73	C1orf28|FIHP|HRPT1|HRPT2|parafibromin	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52241
5.29206935401309e-40	0.297120997069113	0.697	0.619	9.78133178702239e-36	PPA2	Malignant cells	GSE168668	ENSG00000138777	27068	inorganic pyrophosphatase 2	FLJ20459	protein_coding	Q9H2U2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52242
5.44806944213063e-40	-0.256382222536615	0.795	0.891	1.006966674989e-35	GOLGA4	Malignant cells	GSE168668	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52243
6.04254384257838e-40	0.26132725107106	0.836	0.796	1.11684337842376e-35	PSME1	Malignant cells	GSE168668	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52244
6.67470319009564e-40	0.283751509298802	0.875	0.875	1.23368539062538e-35	FIBP	Malignant cells	GSE168668	ENSG00000172500	9158	FGF1 intracellular binding protein	FGFIBP	protein_coding	O43427	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52245
7.95701954647581e-40	-0.489994331132584	0.517	0.634	1.47069592277512e-35	MME	Malignant cells	GSE168668	ENSG00000196549	4311	membrane metalloendopeptidase	CALLA|CD10|NEP	protein_coding	P08473	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52246
9.19336491325171e-40	0.257893772535623	0.766	0.682	1.69920963691631e-35	MRPS35	Malignant cells	GSE168668	ENSG00000061794	60488	mitochondrial ribosomal protein S35	MDS023|MRPS28	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52247
1.0026279663572e-39	0.254628226043883	0.431	0.288	1.85315727021802e-35	LTV1	Malignant cells	GSE168668	ENSG00000135521	84946	LTV1 ribosome biogenesis factor	C6orf93|dJ468K18.4|FLJ14909	protein_coding	Q96GA3	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52248
1.01603305012888e-39	0.291554758821817	0.454	0.316	1.87793388655321e-35	NREP	Malignant cells	GSE168668	ENSG00000134986	9315	neuronal regeneration related protein	C5orf13|D4S114|P311|PRO1873|PTZ17|SEZ17	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52249
1.64579368947081e-39	0.287942069263938	0.302	0.172	3.0419204762489e-35	ADGRV1	Malignant cells	GSE168668	ENSG00000164199	84059	adhesion G protein-coupled receptor V1	DKFZp761P0710|FEB4|GPR98|KIAA0686|MASS1|USH2C|VLGR1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52250
3.80767761967979e-39	0.256715070722432	0.913	0.887	7.03773054445415e-35	XRCC6	Malignant cells	GSE168668	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52251
4.57175909222918e-39	-0.298472074596911	0.154	0.267	8.44998233016719e-35	CDKN2D	Malignant cells	GSE168668	ENSG00000129355	1032	cyclin dependent kinase inhibitor 2D	INK4D|p19	protein_coding	P55273	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52252
8.06071981747283e-39	0.255765647581641	0.473	0.336	1.4898628438635e-34	DPM1	Malignant cells	GSE168668	ENSG00000000419	8813	dolichyl-phosphate mannosyltransferase subunit 1, catalytic	CDGIE|MPDS	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52253
8.24309199018271e-39	0.263219863462519	0.766	0.701	1.52357069254547e-34	HSD17B10	Malignant cells	GSE168668	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52254
8.50315031717753e-39	0.276971614462937	0.666	0.567	1.57163727312392e-34	PSMD1	Malignant cells	GSE168668	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52255
2.07810144918576e-38	0.271770286523411	0.489	0.342	3.84095490853003e-34	ARID5B	Malignant cells	GSE168668	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52256
3.16898769567046e-38	0.312415318811722	0.579	0.455	5.85723995790771e-34	SERINC2	Malignant cells	GSE168668	ENSG00000168528	347735	serine incorporator 2	FKSG84|PRO0899|TDE2|TDE2L	protein_coding	Q96SA4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52257
3.38972109637174e-38	0.253970804750358	0.443	0.3	6.26522150242388e-34	PNRC1	Malignant cells	GSE168668	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52258
5.55950750169649e-38	0.258159934635113	0.553	0.422	1.02756377153856e-33	DCAF13	Malignant cells	GSE168668	ENSG00000164934	25879	DDB1 and CUL4 associated factor 13	DKFZP564O0463|Gm83|HSPC064|Sof1|WDSOF1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52259
6.08812960500645e-38	0.260085398740181	0.421	0.283	1.12526899489334e-33	PAPSS1	Malignant cells	GSE168668	ENSG00000138801	9061	3'-phosphoadenosine 5'-phosphosulfate synthase 1	ATPSK1|PAPSS	protein_coding	O43252	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52260
1.42052788962076e-37	0.261282503498588	0.554	0.425	2.62556169838606e-33	BOLA1	Malignant cells	GSE168668	ENSG00000178096	51027	bolA family member 1	CGI-143	protein_coding	Q9Y3E2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52261
1.6164236118426e-37	0.260819115174684	0.83	0.768	2.98763576176867e-33	HNRNPD	Malignant cells	GSE168668	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52262
1.91335840730474e-37	0.253467014235181	0.471	0.337	3.53646034422134e-33	FAM207A	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52263
2.32358035351398e-37	0.268045768396508	0.651	0.545	4.29467356739989e-33	MTIF3	Malignant cells	GSE168668	ENSG00000122033	219402	mitochondrial translational initiation factor 3	IF-3mt|IF3(mt)	protein_coding	Q9H2K0	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52264
2.36037306714402e-37	0.257256552010885	0.535	0.406	4.36267754000229e-33	UBA1	Malignant cells	GSE168668	ENSG00000130985	7317	ubiquitin like modifier activating enzyme 1	A1S9T|CFAP124|GXP1|POC20|UBE1|UBE1X	protein_coding	P22314	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52265
7.90334574938866e-37	0.2935322250597	0.621	0.505	1.46077539485951e-32	SDCBP	Malignant cells	GSE168668	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52266
8.0710824410023e-37	0.252955166398695	0.506	0.371	1.49177816757046e-32	ZNRF1	Malignant cells	GSE168668	ENSG00000186187	84937	zinc and ring finger 1	DKFZp434E229|FLJ14846|nin283	protein_coding	Q8ND25	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52267
1.10430511666341e-36	0.254203869666622	0.568	0.436	2.04108714712898e-32	LAD1	Malignant cells	GSE168668	ENSG00000159166	3898	ladinin 1	NA	protein_coding	O00515	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52268
2.30249734899822e-36	0.267268717559633	0.42	0.286	4.25570585015342e-32	DDX39A	Malignant cells	GSE168668	ENSG00000123136	10212	DExD-box helicase 39A	BAT1L|DDX39|DDXL|URH49	protein_coding	O00148	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52269
2.33634393334472e-36	0.264250983888657	0.685	0.602	4.31826449200105e-32	ATP6AP2	Malignant cells	GSE168668	ENSG00000182220	10159	ATPase H+ transporting accessory protein 2	APT6M8-9|ATP6IP2|ATP6M8-9|M8-9|PRR|RENR	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52270
2.41766897086851e-36	0.252792100262949	0.789	0.747	4.46857755885627e-32	PSMC4	Malignant cells	GSE168668	ENSG00000281221	5704	proteasome 26S subunit, ATPase 4	MGC13687|MGC23214|MGC8570|MIP224|RPT3|S6|TBP-7|TBP7	protein_coding	P43686	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52271
4.25095924094811e-36	0.262080181800526	0.459	0.321	7.85704796504438e-32	CTXN1	Malignant cells	GSE168668	ENSG00000178531	404217	cortexin 1	FLJ25968	protein_coding	P60606	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52272
8.87739125329212e-36	0.256884330474185	0.617	0.508	1.64080822534598e-31	EIF4A3	Malignant cells	GSE168668	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52273
9.84607472743807e-36	-0.295784018767458	0.72	0.806	1.81984999187238e-31	TBX3	Malignant cells	GSE168668	ENSG00000135111	6926	T-box transcription factor 3	TBX3-ISO|UMS|XHL	protein_coding	O15119	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52274
1.58121429051502e-35	0.261349951672334	0.749	0.673	2.92255837315891e-31	CDK4	Malignant cells	GSE168668	ENSG00000135446	1019	cyclin dependent kinase 4	PSK-J3	protein_coding	P11802	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52275
5.24503520925856e-35	0.252547855997147	0.524	0.391	9.69439857727259e-31	PTP4A1	Malignant cells	GSE168668	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52276
1.67590752994945e-34	0.25745891209694	0.629	0.535	3.09757988760557e-30	FASTK	Malignant cells	GSE168668	ENSG00000164896	10922	Fas activated serine/threonine kinase	FAST	protein_coding	Q14296	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52277
4.33790248249039e-34	0.302636548883898	0.455	0.333	8.01774515838698e-30	SEL1L	Malignant cells	GSE168668	ENSG00000071537	6400	SEL1L adaptor subunit of ERAD E3 ubiquitin ligase	Hrd3|IBD2|SEL1L1	protein_coding	Q9UBV2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52278
6.03183440792648e-34	0.252236847936862	0.764	0.693	1.11486395361705e-29	GTF2I	Malignant cells	GSE168668	ENSG00000263001	2969	general transcription factor IIi	BAP-135|BTKAP1|DIWS|IB291|SPIN|TFII-I|WBSCR6	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52279
7.02053848230201e-34	0.270372421669015	0.465	0.34	1.29760612768388e-29	NADK2	Malignant cells	GSE168668	ENSG00000152620	133686	NAD kinase 2, mitochondrial	C5orf33|FLJ30596|MNADK|NADKD1	protein_coding	Q4G0N4	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52280
1.44661571991041e-33	0.266616421909192	0.675	0.606	2.6737798351104e-29	SDF4	Malignant cells	GSE168668	ENSG00000078808	51150	stromal cell derived factor 4	Cab45	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52281
7.03506456862499e-33	0.299792726552928	0.302	0.187	1.30029098421896e-28	ATP11A	Malignant cells	GSE168668	ENSG00000068650	23250	ATPase phospholipid transporting 11A	ATPIH|ATPIS|KIAA1021	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52282
1.83976648432e-32	-0.277888577334024	0.331	0.445	3.40044039296866e-28	ACKR3	Malignant cells	GSE168668	ENSG00000144476	57007	atypical chemokine receptor 3	CMKOR1|CXCR7|GPR159|RDC1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52283
2.12353524394202e-32	0.365883602812722	0.74	0.693	3.92493019137804e-28	TSC22D1	Malignant cells	GSE168668	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52284
2.51006858519899e-32	0.252676889143551	0.688	0.609	4.6393597660233e-28	RNF181	Malignant cells	GSE168668	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52285
5.71739336962151e-32	0.266541365589903	0.646	0.549	1.05674581650714e-27	SELENOW	Malignant cells	GSE168668	ENSG00000178980	6415	selenoprotein W	SELW|SEPW1	protein_coding	P63302	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52286
4.57336052098012e-31	0.279453029254193	0.74	0.671	8.45294225092756e-27	FKBP1A	Malignant cells	GSE168668	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52287
9.6192960798626e-31	-0.282488255343471	0.779	0.858	1.777934494441e-26	SLC3A2	Malignant cells	GSE168668	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52288
9.77489973074498e-31	0.254920884806899	0.595	0.475	1.80669471723359e-26	SMC1A	Malignant cells	GSE168668	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52289
4.00171951465953e-29	0.304990545274253	0.616	0.542	7.3963781789452e-25	LYPLAL1	Malignant cells	GSE168668	ENSG00000143353	127018	lysophospholipase like 1	Q96AV0	protein_coding	Q5VWZ2	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52290
5.23934736079176e-29	-0.400744753840368	0.939	0.911	9.68388572695141e-25	MT2A	Malignant cells	GSE168668	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52291
1.32528210663402e-28	0.255002366775315	0.788	0.759	2.44951891769166e-24	CWC15	Malignant cells	GSE168668	ENSG00000150316	51503	CWC15 spliceosome associated protein homolog	AD002|C11orf5|Cwf15|HSPC148	protein_coding	Q9P013	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52292
1.46824748178217e-28	-0.290267682963609	0.609	0.69	2.71376182057798e-24	GATA2	Malignant cells	GSE168668	ENSG00000179348	2624	GATA binding protein 2	NFE1B	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52293
1.95672459983133e-27	0.253343545828999	0.744	0.713	3.61661407786825e-23	MRPS18C	Malignant cells	GSE168668	ENSG00000163319	51023	mitochondrial ribosomal protein S18C	CGI-134|FLJ11146|FLJ22967|MRPS18-1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52294
2.35021937469608e-27	0.256244805907869	0.726	0.658	4.34391047025077e-23	DKC1	Malignant cells	GSE168668	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52295
1.59282667505049e-26	0.259242081354242	0.529	0.433	2.94402154349582e-22	CREB3L4	Malignant cells	GSE168668	ENSG00000143578	148327	cAMP responsive element binding protein 3 like 4	AIbZIP|ATCE1|CREB3|CREB4|hJAL	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52296
4.11768110510026e-26	0.250072549635227	0.567	0.476	7.61070998655681e-22	TST	Malignant cells	GSE168668	ENSG00000128311	7263	thiosulfate sulfurtransferase	RDS	protein_coding	Q16762	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52297
7.86321458286903e-26	0.268980791736039	0.507	0.399	1.45335795135168e-21	FADS2	Malignant cells	GSE168668	ENSG00000134824	9415	fatty acid desaturase 2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	protein_coding	O95864	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52298
3.05477687596758e-24	0.261440309364567	0.934	0.892	5.64614409985087e-20	MAT2A	Malignant cells	GSE168668	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52299
4.99582953477221e-23	0.263943492025186	0.589	0.497	9.23379172911947e-19	ICK	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52300
1.89761402241871e-22	0.334420757609531	0.714	0.695	3.5073599976365e-18	PDIA4	Malignant cells	GSE168668	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52301
1.17124124136289e-21	-0.277663002273799	0.447	0.543	2.16480518641102e-17	PCLAF	Malignant cells	GSE168668	ENSG00000166803	9768	PCNA clamp associated factor	KIAA0101|NS5ATP9|OEATC-1|p15(PAF)|PAF15	protein_coding	Q15004	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52302
2.62119955564546e-21	0.399450546158557	0.862	0.859	4.8447631386995e-17	MANF	Malignant cells	GSE168668	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52303
8.08468742692025e-21	-0.398412141418474	0.228	0.32	1.49429277711767e-16	CDKN1A	Malignant cells	GSE168668	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52304
4.39939021568188e-19	-0.378447327004567	0.317	0.388	8.13139293564481e-15	MAD2L1	Malignant cells	GSE168668	ENSG00000164109	4085	mitotic arrest deficient 2 like 1	HSMAD2|MAD2	protein_coding	Q13257	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52305
2.19538025884106e-12	-0.295550418824161	0.267	0.34	4.05772133241594e-08	ATAD2	Malignant cells	GSE168668	ENSG00000156802	29028	ATPase family AAA domain containing 2	ANCCA|CT137|DKFZp667N1320|MGC29843|MGC5254|PRO2000	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52306
2.12798146749253e-09	-0.456982366544145	0.382	0.422	3.93314814636644e-05	SMC4	Malignant cells	GSE168668	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52307
8.11420773005749e-07	-0.335590479958462	0.303	0.344	0.0149974901474653	H2AFX	Malignant cells	GSE168668	NA	NA	NA	NA	NA	NA	GSE168668	GSE168668	Prostate cancer	Prostate cancer	Targeted therapy	NA	enzalutamide	Homo sapiens	LNCaP cell line	Cell line	resistant 2, sensitive 1	3	10698	Public on Aug 17, 2021	34489465	This dataset has 1 cell line with 1 sensitive pre-treatment sample and 2 resistant post-treatment samples.	PRJNA713356	10x genomics	CellRanger 3.0.2	Prostate_cancer	Targeted_therapy	52308
0	0.827639361846551	0.998	0.987	0	HLA-B	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52309
0	0.453118328206127	1	1	0	EEF1A1	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52310
0	-1.04073580371603	0.012	0.286	0	HBB	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52311
0	-0.488950065022104	0.056	0.261	0	LYZ	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52312
0	0.441152550539385	0.995	0.99	0	RPL3	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52313
3.76629859229562e-269	0.337172948400831	0.999	0.997	7.29607363299507e-265	RPS3	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52314
2.79676649302688e-246	0.26470389031603	1	1	5.41789605029168e-242	B2M	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52315
1.73165233078992e-244	0.560737655549239	0.995	0.996	3.35455689520624e-240	HLA-C	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52316
3.50934787233441e-224	0.413767393376769	0.883	0.665	6.79830869828621e-220	CD3E	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52317
2.20580711964254e-216	0.323485366463561	0.996	0.987	4.27308955217154e-212	RPL14	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52318
4.80529541194004e-206	0.312078166872267	0.997	0.993	9.30881827201024e-202	RPS6	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52319
3.89598223880002e-187	0.304223759683246	0.971	0.97	7.5472967930034e-183	PTMA	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52320
5.70207267167495e-183	0.282494166073814	0.998	0.997	1.10460551795687e-178	RPS4X	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52321
9.55183427318463e-179	0.250156149592289	0.998	0.999	1.85038133540133e-174	TMSB4X	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52322
9.45033061271405e-147	0.29125852409152	0.98	0.969	1.83071804629497e-142	IL32	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52323
1.11847465172891e-142	0.332830596625821	0.456	0.245	2.16670909532924e-138	EFHD2	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52324
3.12870552040925e-140	0.267773863167261	0.977	0.964	6.06092833413681e-136	NACA	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52325
1.85594747264401e-138	0.254267928972541	0.997	0.997	3.59534144400598e-134	HLA-A	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52326
6.50919670701319e-132	0.301364701031696	0.558	0.34	1.2609615860826e-127	KLRG1	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52327
6.58401021772492e-124	0.293748751166904	0.747	0.523	1.27545445937767e-119	HSP90AA1	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52328
1.2279414631426e-123	0.318207563627098	0.671	0.439	2.37876820239984e-119	PRF1	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52329
4.8452814772012e-123	0.269778815137085	0.947	0.888	9.38627927763416e-119	CALM1	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52330
9.92779525930215e-121	0.587486318477773	0.927	0.964	1.92321249763201e-116	RPS26	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52331
3.38061720850228e-120	0.25980746415037	0.986	0.975	6.54893165631062e-116	RPL5	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52332
1.22563368575089e-117	0.276841275289839	0.996	0.977	2.37429757603662e-113	MT-ND3	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52333
7.0195634436949e-115	0.310157720164339	0.73	0.525	1.35982983031258e-110	SRGN	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52334
8.85440166535577e-114	0.287391378919769	0.365	0.191	1.71527469061272e-109	ALOX5AP	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52335
1.14613566336148e-113	0.274908796702003	0.734	0.529	2.22029400706385e-109	UQCRB	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52336
1.49845885038267e-110	0.281010422206794	0.985	0.978	2.9028144849613e-106	MT-ATP6	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52337
8.26906654351783e-108	0.256137510713221	0.739	0.541	1.60188357081027e-103	RPL36A	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52338
1.50696431840514e-106	0.253707116968071	0.483	0.288	2.91929127761444e-102	TGFB1	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52339
3.81156361142468e-106	0.25060848264057	0.994	0.99	7.38376102805189e-102	RPS3A	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52340
1.56654212983007e-104	0.310959213717445	0.85	0.699	3.03470541390682e-100	GZMA	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52341
6.61434164648185e-104	0.261754363756663	0.666	0.459	1.28133026375646e-99	CD3G	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52342
1.20992370846509e-99	-0.271570251154218	0.974	0.991	2.34386420803857e-95	FTL	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52343
3.27243522702384e-99	0.266959893290181	0.813	0.646	6.33936152179058e-95	UBC	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52344
9.8088193591284e-99	0.252281406543825	0.84	0.679	1.90016448625035e-94	RPL36AL	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52345
1.81799741645798e-95	0.267823253491459	0.632	0.44	3.5218245951624e-91	LITAF	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52346
2.58300362510755e-83	-0.322091453950066	0.21	0.336	5.00379462255834e-79	COTL1	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52347
2.56135929421484e-82	-0.386071350030938	0.222	0.341	4.96186522475298e-78	HIST1H1E	CD8+ T cells	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52348
3.12272193874638e-73	0.370387293295915	0.526	0.391	6.04933693973948e-69	GZMB	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52349
5.63356269194354e-71	0.250647255801913	0.47	0.313	1.0913337646833e-66	CD8A	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52350
4.7587016318937e-64	0.309400280870335	0.482	0.338	9.21855680130447e-60	IL7R	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52351
7.43824204834593e-55	-0.250067258893656	0.999	0.999	1.44093624960557e-50	RPL28	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52352
3.33419954775297e-40	0.321311146834598	0.329	0.236	6.45901136390705e-36	GZMK	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52353
7.23858641200014e-39	0.258416780260304	0.692	0.63	1.40225895973267e-34	GZMH	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52354
2.25298398318128e-37	-0.282691799099952	0.998	0.991	4.36448057221878e-33	RPL39	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52355
7.86563203048504e-37	-0.480353624049447	0.368	0.418	1.52373023694556e-32	NEAT1	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52356
2.45179632774205e-31	-0.257014519120748	0.51	0.583	4.74961984610189e-27	LGALS1	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52357
6.78599621007801e-20	-0.281374076430797	0.254	0.299	1.31458318581631e-15	STAT1	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52358
3.19341571276238e-17	-0.383517090919473	0.995	0.926	6.18628491876329e-13	RPS29	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52359
5.27252450680619e-13	-0.2921476964527	0.994	0.95	1.02139344745849e-08	RPL41	CD8+ T cells	GSE169246_PacAteBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52360
9.26334277690251e-204	0.569335365809373	0.992	0.958	1.79449476274155e-199	HLA-DRB1	B cells	GSE169246_PacAteBlood_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52361
5.51516071074196e-197	0.462470990932961	1	1	1.06839693288493e-192	EEF1A1	B cells	GSE169246_PacAteBlood_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52362
2.07533557047456e-158	0.437985207321643	0.992	0.98	4.02034006712333e-154	HLA-DRA	B cells	GSE169246_PacAteBlood_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52363
3.24379562158849e-150	0.451845124839208	0.998	0.99	6.28388087814122e-146	RPL3	B cells	GSE169246_PacAteBlood_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52364
7.59697535891523e-132	-0.419251922018946	0.126	0.372	1.47168606652906e-127	NKG7	B cells	GSE169246_PacAteBlood_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52365
1.38848769062954e-120	-0.466237473675595	0.404	0.715	2.68977835428755e-116	S100A4	B cells	GSE169246_PacAteBlood_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52366
2.49641548484944e-102	-0.304763543521788	0.095	0.291	4.83605607725034e-98	IL32	B cells	GSE169246_PacAteBlood_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52367
1.86480478236617e-101	0.387585268651388	0.979	0.91	3.61249982439974e-97	HLA-DPA1	B cells	GSE169246_PacAteBlood_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52368
2.6095562219587e-93	0.31736036894094	0.999	0.996	5.0552323131784e-89	RPS6	B cells	GSE169246_PacAteBlood_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52369
1.4662225950977e-89	0.29104718949369	1	0.998	2.84036641122326e-85	RPS3	B cells	GSE169246_PacAteBlood_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52370
2.64864223078822e-83	0.368025102661348	0.978	0.934	5.13094972948294e-79	EEF1B2	B cells	GSE169246_PacAteBlood_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52371
7.76750279486898e-80	0.410943805841108	0.944	0.843	1.50472064142202e-75	LTB	B cells	GSE169246_PacAteBlood_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52372
9.92855483386467e-80	0.298115059734882	0.999	0.996	1.92335964241626e-75	RPS3A	B cells	GSE169246_PacAteBlood_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52373
2.50413312457913e-77	0.346605561945702	0.991	0.971	4.8510066889347e-73	MT-ATP6	B cells	GSE169246_PacAteBlood_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52374
8.59177949607262e-75	0.367609307614209	0.885	0.732	1.66439952397919e-70	EEF1G	B cells	GSE169246_PacAteBlood_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52375
1.07113441016955e-74	0.291875336251854	0.986	0.942	2.07500157938046e-70	PTMA	B cells	GSE169246_PacAteBlood_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52376
3.84028781632467e-72	0.265381824078457	0.999	0.999	7.43940555778414e-68	RPS4X	B cells	GSE169246_PacAteBlood_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52377
2.98608398691246e-67	0.759737736482034	0.857	0.854	5.78464189944682e-63	RPS26	B cells	GSE169246_PacAteBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52378
1.18706243984007e-65	0.313832682660798	0.684	0.418	2.29957735845819e-61	NPM1	B cells	GSE169246_PacAteBlood_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52379
9.56934072421716e-65	0.267315224088187	0.996	0.99	1.85377268509535e-60	RPL5	B cells	GSE169246_PacAteBlood_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52380
7.68074601431999e-64	0.310793417934179	0.97	0.971	1.48791411789407e-59	HLA-B	B cells	GSE169246_PacAteBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52381
4.26907145563747e-59	0.29541012027295	0.974	0.912	8.2700452238609e-55	HLA-DPB1	B cells	GSE169246_PacAteBlood_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52382
1.09533129591806e-56	0.292969263545418	0.95	0.869	2.12187578645246e-52	RPL4	B cells	GSE169246_PacAteBlood_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52383
3.48673776234018e-55	0.304783046572848	0.719	0.489	6.7545083932054e-51	HSP90AB1	B cells	GSE169246_PacAteBlood_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52384
6.16683039553396e-55	0.253335692684542	0.989	0.965	1.19463838422284e-50	NACA	B cells	GSE169246_PacAteBlood_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52385
1.44449921022769e-51	0.261723723316478	0.45	0.252	2.79828387005308e-47	LY86	B cells	GSE169246_PacAteBlood_post	ENSG00000112799	9450	lymphocyte antigen 86	dJ80N2.1|MD-1	protein_coding	O95711	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52386
1.53433131300328e-49	0.295058743646709	0.9	0.775	2.97230661954995e-45	HLA-DQB1	B cells	GSE169246_PacAteBlood_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52387
1.25276109757114e-47	0.257932925334037	0.587	0.377	2.42684879821482e-43	ERP29	B cells	GSE169246_PacAteBlood_post	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52388
6.2891991376643e-43	0.261425537424614	0.802	0.635	1.21834365694833e-38	RPL36A	B cells	GSE169246_PacAteBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52389
7.89102153683318e-41	0.272995369595368	0.925	0.829	1.52864869211532e-36	HLA-DQA1	B cells	GSE169246_PacAteBlood_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52390
6.17429804674786e-36	-0.281346496351962	0.498	0.64	1.196085017616e-31	S100A6	B cells	GSE169246_PacAteBlood_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52391
4.16865385862167e-35	0.344029273104379	0.342	0.192	8.07551625492189e-31	JCHAIN	B cells	GSE169246_PacAteBlood_post	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52392
3.73120660199888e-34	-0.273794452028404	0.866	0.931	7.22809342939223e-30	SH3BGRL3	B cells	GSE169246_PacAteBlood_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52393
1.43541780611874e-30	-0.26656832662308	0.618	0.704	2.78069137401323e-26	IFITM2	B cells	GSE169246_PacAteBlood_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52394
1.25324861194156e-26	-0.262626322572814	0.999	0.998	2.4277932110532e-22	RPL39	B cells	GSE169246_PacAteBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52395
2.12590310148575e-12	-0.257789473602344	0.714	0.726	4.11829948819819e-08	PTPRC	B cells	GSE169246_PacAteBlood_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52396
5.67685539290633e-12	-0.282003432377598	0.999	0.972	1.09972042671381e-07	RPL41	B cells	GSE169246_PacAteBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52397
0	0.937063995390978	0.996	0.946	0	RPS27	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52398
0	0.678818348837081	0.973	0.85	0	RPL37A	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52399
0	0.609401844649173	0.992	0.945	0	RPL37	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52400
0	0.772753339123368	0.993	0.996	0	HLA-C	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52401
0	-1.24983628841599	0.418	0.876	0	HLA-DRB5	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52402
0	0.800967579931687	0.825	0.56	0	BRI3	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52403
0	1.00151584217281	0.701	0.213	0	TMEM176B	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52404
0	0.653904271097038	0.5	0.111	0	TMEM176A	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52405
0	0.781849251176632	0.771	0.393	0	RPL36A	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52406
0	-1.03083680480458	0.04	0.657	0	HBB	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52407
0	-0.777915800098113	0.851	0.952	0	RPS26	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52408
0	0.964118100839213	0.983	0.841	0	RPL41	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52409
0	1.40518753920432	0.967	0.577	0	RPS29	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52410
0	0.790620897827274	0.931	0.668	0	RPL38	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52411
0	0.764112521269433	0.987	0.851	0	RPS21	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52412
0	0.994833124392061	0.918	0.759	0	LGALS1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52413
0	-0.564980273955164	1	1	0	MT-CO2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52414
0	-0.529774214387568	0.999	0.997	0	MT-CO3	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52415
1.43495211541285e-284	0.593501402515035	0.618	0.252	2.77978923797777e-280	NDUFB1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52416
1.46350181836509e-270	0.801535680903664	0.582	0.24	2.83509572253686e-266	LGALS2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52417
1.90102427943372e-267	-0.810508476791823	0.87	0.96	3.68266423411901e-263	MT-ND4L	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52418
4.52360845837657e-257	0.558559942659874	0.653	0.299	8.76313430556709e-253	ATP5ME	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52419
1.11586177701466e-250	0.518565586298371	0.975	0.913	2.1616474344328e-246	ATP5F1E	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52420
1.42224673631907e-244	0.714833399501774	0.251	0.012	2.7551763775973e-240	G0S2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52421
1.69115997373558e-236	0.515621406322146	0.614	0.275	3.27611510112056e-232	PET100	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52422
1.46043883690959e-231	0.414575044387409	0.999	0.997	2.82916211486126e-227	HLA-B	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52423
1.22683321828462e-223	0.554988107247308	0.383	0.097	2.37662131046097e-219	FOLR3	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000110203	2352	folate receptor gamma	FR-G|FRgamma	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52424
1.22500539123184e-222	0.492138135203793	0.995	0.963	2.37308044389432e-218	RPS28	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52425
7.50518774161703e-212	0.495632719789363	1	0.966	1.45390496930605e-207	MT-ND3	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52426
6.31518282168895e-208	0.726710954430996	0.872	0.651	1.22337721621758e-203	CD52	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52427
5.08725496965131e-201	0.474045747862341	0.992	0.992	9.85503032720852e-197	S100A6	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52428
1.8040917371782e-191	0.457707509355157	0.465	0.174	3.49488651326161e-187	HEBP2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52429
4.94567805289406e-180	-0.650246308030674	0.354	0.63	9.58076752406637e-176	STAT1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52430
6.87510388544148e-178	0.411029201139148	0.994	0.964	1.33184512468772e-173	RPL34	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52431
3.82935076856675e-172	0.497740249881081	0.716	0.48	7.41821830886751e-168	EFHD2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52432
1.5067918388269e-169	-0.652110868115734	0.32	0.6	2.91895715017546e-165	ITGA4	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52433
2.21935337137934e-167	-0.393004116913938	1	1	4.29933135103606e-163	MT-CO1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52434
7.55404689956587e-162	0.545859636920808	0.493	0.23	1.4633699653839e-157	AC020656.1	Mono/Macro	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52435
1.22436023368819e-156	0.407711953522864	0.98	0.895	2.37183064470077e-152	RPL36	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52436
1.09750184679861e-155	0.389225017673133	0.994	0.96	2.12608057761827e-151	RPL39	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52437
8.32740567176922e-154	-0.450610441307343	0.138	0.403	1.61318502673513e-149	HIST1H1E	Mono/Macro	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52438
1.94294744777347e-153	0.422081388498511	0.853	0.663	3.76387779582677e-149	TMA7	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52439
1.34285181962027e-149	0.461708165350392	0.689	0.457	2.60137254496839e-145	IFI30	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52440
1.72043211279988e-147	0.397552913989992	0.546	0.275	3.33282108891593e-143	NDUFA3	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52441
2.51796125403486e-144	-0.496003465985315	0.199	0.462	4.87779454131633e-140	GBP1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52442
2.97277791545647e-143	0.368929218125799	0.43	0.179	5.75886537782227e-139	ANPEP	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000166825	290	alanyl aminopeptidase, membrane	AP-N|CD13|gp150|hAPN|LAP1|p150|PEPN	protein_coding	P15144	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52443
3.06437185907453e-127	-0.462462831039824	0.887	0.956	5.93630116539918e-123	MT-ND5	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52444
7.75702482067715e-126	0.428450900527478	0.738	0.564	1.50269084826158e-121	CTSZ	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52445
2.31403945742783e-124	0.366004341617963	0.964	0.889	4.4827572369292e-120	RPL21	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52446
1.88905906985853e-123	0.36534646639439	0.365	0.144	3.65948523012995e-119	NRGN	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000154146	4900	neurogranin	RC3	protein_coding	Q92686	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52447
8.67462609396279e-120	-0.392928284682763	0.991	0.99	1.68044856692247e-115	MT-CYB	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52448
9.50693760957854e-120	-0.450637272898645	0.171	0.407	1.84168395372755e-115	MX1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52449
2.43168549276001e-119	-0.417223486471587	0.11	0.327	4.71066113657469e-115	GBP5	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52450
2.29052797549137e-118	1.21789950944568	0.924	0.944	4.43721079412188e-114	S100A9	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52451
1.37273024354677e-116	-0.469587767595707	0.486	0.678	2.6592530277988e-112	DOCK8	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000107099	81704	dedicator of cytokinesis 8	FLJ00026|FLJ00152|FLJ00346|ZIR8	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52452
1.65030505726837e-115	0.301869731534134	0.341	0.132	3.19697095694029e-111	TAF10	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52453
3.16464272135449e-115	0.360738545278822	0.732	0.517	6.13054587980792e-111	UBL5	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52454
5.87495873969476e-113	-0.638976083070746	0.949	0.972	1.13809700705367e-108	NEAT1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52455
2.47301104835389e-112	0.431958237358571	0.96	0.944	4.79071700287116e-108	FCER1G	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52456
3.72269167210394e-112	-0.418832663869047	0.551	0.748	7.21159830719974e-108	HSPA8	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52457
7.90798675393639e-109	-0.396571130431746	0.547	0.731	1.53193519397256e-104	PSMB9	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52458
6.67426740131741e-106	0.335779997273361	0.412	0.199	1.29293908098321e-101	YPEL3	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52459
1.22263272651799e-105	0.433805746828358	0.688	0.502	2.36848411781065e-101	HCST	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52460
1.33663006018605e-104	0.275927199345009	0.994	0.981	2.58931975259242e-100	CYBA	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52461
4.20041875961742e-104	0.256498815785038	0.28	0.097	8.13705122113087e-100	BX284668.5	Mono/Macro	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52462
4.67946948459831e-103	0.397725174059694	0.703	0.523	9.06506828556384e-99	FPR1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000171051	2357	formyl peptide receptor 1	FMLP|FPR	protein_coding	P21462	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52463
8.056648692466e-103	0.337564467226775	0.915	0.791	1.56073398470451e-98	RPL27	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52464
3.87798070016682e-101	-0.394858876072331	0.234	0.445	7.51242421236316e-97	JAK2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000096968	3717	Janus kinase 2	JTK10	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52465
7.3849389917441e-100	-0.313527008728101	0.959	0.976	1.43061038148067e-95	PABPC1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52466
8.01931726169469e-100	0.280997240285334	0.99	0.996	1.55350213993549e-95	S100A4	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52467
7.28863378604799e-99	0.339192849582283	0.527	0.319	1.41195413703322e-94	SULT1A1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000196502	6817	sulfotransferase family 1A member 1	P-PST|STP|STP1	protein_coding	P50225	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52468
7.75424449813642e-99	0.297394071042411	0.969	0.974	1.50215224417899e-94	H3F3A	Mono/Macro	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52469
2.79593418395408e-98	-0.405816801089081	0.585	0.775	5.41628370115585e-94	IRF1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52470
2.13414780596274e-97	-0.360477455379638	0.239	0.454	4.13427112971103e-93	APOL6	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000221963	80830	apolipoprotein L6	APOL-VI|APOLVI	protein_coding	Q9BWW8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52471
2.60011513885779e-97	-0.385524306976576	0.792	0.873	5.0369430469953e-93	SAMHD1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52472
3.48709997877951e-97	0.274190178642233	0.978	0.988	6.75521007889166e-93	TYROBP	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52473
4.23506889315759e-97	-0.435760730393868	0.276	0.485	8.20417545982488e-93	PARP14	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000173193	54625	poly(ADP-ribose) polymerase family member 14	ARTD8|BAL2|KIAA1268|pART8	protein_coding	Q460N5	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52474
6.39729884958647e-97	0.287908960912614	0.978	0.923	1.23928473314189e-92	UBA52	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52475
2.66828774272063e-93	-0.481435711703822	0.693	0.841	5.1690070151984e-89	HLA-DPB1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52476
1.7056226064394e-92	0.365135986677998	0.901	0.874	3.30413211319441e-88	TSPO	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52477
1.26845030968936e-91	0.272624729970719	0.33	0.144	2.45724193993023e-87	SNHG8	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52478
2.85065050366311e-90	0.315225900731552	0.55	0.338	5.52228015569617e-86	RPS10	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52479
6.78936505064001e-90	-0.305535822367433	0.158	0.357	1.31523579760998e-85	GBP4	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52480
7.41089679254307e-90	0.313720916715063	0.798	0.641	1.43563892665144e-85	UQCR11	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52481
8.69972929149544e-90	0.295160116506879	0.422	0.222	1.6853115583485e-85	CKLF	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52482
3.02547607229208e-86	0.330006701808752	0.761	0.599	5.86095224724422e-82	RPL23	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52483
3.95909897962643e-86	0.283070900604004	0.484	0.276	7.66956654333233e-82	ROMO1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52484
3.98128457677907e-86	-0.425493097236543	0.527	0.7	7.71254448213642e-82	WARS	Mono/Macro	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52485
4.02495834663443e-85	0.383550650290001	1	0.999	7.79714930910021e-81	MALAT1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52486
6.72493456932366e-85	0.336028210958262	0.743	0.587	1.30275432476938e-80	PCBP2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52487
5.47610387018367e-84	-0.267918388553924	0.091	0.258	1.06083084173198e-79	NSF	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000278174	4905	N-ethylmaleimide sensitive factor, vesicle fusing ATPase	SEC18|SKD2	protein_coding	P46459	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52488
1.99191518466013e-83	1.0365197428251	0.849	0.905	3.85873809572361e-79	S100A8	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52489
8.11761367637921e-82	0.318231806513316	0.72	0.537	1.57254412138818e-77	GPX4	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52490
1.11058610596354e-81	0.390411109430329	0.918	0.913	2.15142740447256e-77	SRGN	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52491
2.23106352311805e-81	-0.328027569673984	0.327	0.524	4.32201625698429e-77	GBP2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52492
3.93170557304337e-81	-0.348683181645232	0.51	0.683	7.61650003609961e-77	UCP2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52493
2.36367717222696e-80	-0.360548327630043	0.325	0.514	4.57891541803807e-76	PIK3AP1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000155629	118788	phosphoinositide-3-kinase adaptor protein 1	BCAP|FLJ35564	protein_coding	Q6ZUJ8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52494
3.12596420088886e-80	0.290748568602262	0.948	0.952	6.05561784996191e-76	S100A11	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52495
4.79860295292295e-79	-0.288789576851662	0.197	0.385	9.29585364040233e-75	TAP1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52496
7.70081941166715e-79	0.323415565147183	0.887	0.794	1.49180273642816e-74	EMP3	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52497
2.83436626664636e-76	0.285342594584688	0.557	0.364	5.49073433174733e-72	ATP5MD	Mono/Macro	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52498
5.51639814609218e-76	0.301742161026984	0.629	0.449	1.06863664886098e-71	POLR2L	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52499
1.22811217817267e-75	-0.324906345281769	0.284	0.473	2.3790989115561e-71	LAP3	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52500
3.42332083816899e-75	-0.32389925645484	0.969	0.959	6.63165712770097e-71	RPS3A	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52501
1.26997762735972e-73	0.253509583553283	0.998	0.998	2.46020065972125e-69	TMSB10	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52502
4.16964365301374e-73	0.354810138821999	0.721	0.597	8.07743368461821e-69	CSTA	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52503
5.01690340013684e-73	-0.311788837267925	0.355	0.539	9.71874526674509e-69	ADAR	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52504
1.78688032003366e-71	-0.383093187859202	0.617	0.754	3.46154455596921e-67	RNF213	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52505
6.1189635188745e-71	0.35477854454993	0.597	0.435	1.18536561287637e-66	CTSD	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52506
7.10689315808443e-71	-0.327151562075327	0.186	0.358	1.37674734258412e-66	KIAA1551	Mono/Macro	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52507
3.95763507827505e-70	-0.29609543438466	0.269	0.451	7.66673067363442e-66	AC004687.1	Mono/Macro	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52508
3.30656945300671e-69	-0.297922492006331	0.399	0.578	6.40548634436461e-65	PPDPF	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52509
4.91972850478718e-69	0.268635529104925	0.682	0.51	9.53049805947373e-65	NDUFA1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52510
1.71751526720141e-68	0.474387704917291	0.762	0.702	3.32717057562257e-64	CD14	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52511
1.56401143899074e-67	0.368085138692842	0.4	0.239	3.02980295961285e-63	H1FX	Mono/Macro	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52512
2.65453593413418e-66	-0.292387557578423	0.455	0.62	5.14236701160473e-62	SARAF	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52513
2.81199551879059e-65	-0.425056178128807	0.796	0.854	5.44739771900112e-61	AHNAK	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52514
1.01553479469678e-63	0.332390889102032	0.733	0.585	1.9672940042866e-59	TIMP1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52515
2.55796054845029e-62	0.298546044790882	0.938	0.926	4.95528117445789e-58	AIF1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52516
2.97134112406421e-62	0.251352809381011	0.867	0.725	5.75608202553719e-58	RPL31	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52517
4.85475138812643e-62	-0.431995388757403	0.853	0.875	9.40462438907852e-58	CYBB	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52518
1.41417143322831e-61	-0.314579952760451	0.506	0.637	2.73953290044988e-57	EIF4G2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52519
1.60762450588988e-61	0.26324146220964	0.709	0.55	3.11429019280987e-57	OST4	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52520
3.42715315782809e-61	-0.334466582510696	0.449	0.615	6.63908109734457e-57	KLF2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52521
4.29161146400556e-60	0.28359718467026	0.52	0.357	8.31370972807157e-56	PLP2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52522
9.73718347419223e-60	0.293239039273612	0.286	0.143	1.88628718262052e-55	RETN	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52523
1.07717245426923e-59	-0.2632495359627	0.247	0.408	2.08669847841035e-55	RBM47	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000163694	54502	RNA binding motif protein 47	FLJ20273|NET18	protein_coding	A0AV96	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52524
1.80832408902916e-58	-0.265971177721771	0.347	0.528	3.5030854252673e-54	CALHM6	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000188820	441168	calcium homeostasis modulator family member 6	C6orf187|dJ93H18.5|FAM26F|INAM|OTTHUMP00000017061|OTTHUMP00000017062|RP1-93H18.5	protein_coding	Q5R3K3	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52525
6.64224753389387e-58	-0.426723417682843	0.834	0.879	1.28673619226592e-53	PTPRC	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52526
7.33749785730805e-58	-0.261475444176649	0.249	0.415	1.42142008491772e-53	XAF1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52527
3.09397020494102e-56	-0.251989088557747	0.216	0.371	5.99363908101175e-52	LPGAT1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000123684	9926	lysophosphatidylglycerol acyltransferase 1	FAM34A|FAM34A1|KIAA0205|LPLAT7|NET8	protein_coding	Q92604	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52528
6.47847455491981e-56	0.621013881671218	0.615	0.518	1.25501009077907e-51	S100A12	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52529
9.87049109293185e-55	-0.323287855402242	0.759	0.811	1.91211153452276e-50	HNRNPA2B1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52530
2.31747156912042e-54	0.267492168785136	0.328	0.184	4.48940592370007e-50	CYP1B1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000138061	1545	cytochrome P450 family 1 subfamily B member 1	CP1B|GLC3A	protein_coding	Q16678	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52531
2.67645658804409e-54	-0.369746647410114	0.826	0.869	5.18483170235902e-50	FGL2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000127951	10875	fibrinogen like 2	pT49|T49	protein_coding	Q14314	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52532
6.1210541305451e-54	-0.282881163073289	0.653	0.748	1.1857706061692e-49	GRB2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52533
6.243759947793e-53	-0.303457635184178	0.365	0.51	1.20954117708646e-48	BACH1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000156273	571	BTB domain and CNC homolog 1	BACH-1|BTBD24	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52534
2.07718075571449e-52	-0.302180961694916	0.534	0.655	4.0239145599701e-48	HNRNPU	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52535
3.47954076249115e-52	-0.269440157652553	0.374	0.523	6.74056636509786e-48	RAB10	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000084733	10890	RAB10, member RAS oncogene family	NA	protein_coding	P61026	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52536
9.3589121408354e-52	-0.286822208127918	0.503	0.638	1.81300845992263e-47	AKAP13	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52537
1.43925344408545e-51	0.26977888265519	0.775	0.691	2.78812177188233e-47	TALDO1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52538
1.43278398353019e-50	-0.383960046066918	0.646	0.732	2.77558913289468e-46	ZEB2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52539
1.68343319662117e-49	0.2561731507166	0.69	0.56	3.26114678849454e-45	SRRM2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52540
1.23220057834797e-48	0.278220180112019	0.752	0.658	2.38701896037569e-44	LGALS3	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52541
1.10734501588684e-47	0.251488204677703	0.938	0.899	2.14514876477598e-43	SERPINA1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52542
1.74728377144706e-47	-0.331624752109737	0.985	0.979	3.38483812204725e-43	PSAP	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52543
5.90157223435046e-47	-0.256025619622747	0.359	0.502	1.14325257323837e-42	LCP2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52544
3.46943139690402e-46	-0.278868352412411	0.481	0.608	6.72098250208247e-42	WSB1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52545
3.48401653357466e-46	-0.329005879981447	0.311	0.451	6.74923682884083e-42	MT-ND6	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52546
7.79111948992423e-45	-0.300008902684662	0.391	0.518	1.50929566758812e-40	IL10RA	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52547
1.88654179454866e-44	0.253546156764023	0.839	0.752	3.65460876439967e-40	UBC	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52548
1.7787353296171e-43	-0.268915020915332	0.318	0.455	3.44576608053424e-39	SSH2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52549
1.43750784012119e-42	-0.265842196434265	0.541	0.656	2.78474018788277e-38	TNFSF10	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000121858	8743	TNF superfamily member 10	Apo-2L|CD253|TL2|TRAIL	protein_coding	P50591	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52550
3.11919065717012e-42	-0.3032489384514	0.767	0.856	6.04249614106995e-38	HLA-DPA1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52551
4.65394302134126e-42	-0.285734456844014	0.423	0.548	9.01561842094228e-38	CDC42EP3	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52552
1.94247757435587e-41	-0.285471225959827	0.646	0.734	3.7629675570422e-37	LYN	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52553
2.26855252780654e-41	-0.270056832611995	0.464	0.589	4.39463995686683e-37	DDX17	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52554
1.78692791441256e-40	-0.270386220574642	0.329	0.451	3.46163675580002e-36	VPS13C	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000129003	54832	vacuolar protein sorting 13 homolog C	BLTP5C|FLJ10381|FLJ20136|KIAA1421	protein_coding	Q709C8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52555
2.85861795843033e-39	-0.253949365404569	0.424	0.541	5.53771470907123e-35	NOTCH2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000134250	4853	notch receptor 2	NA	protein_coding	Q04721	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52556
1.32109360163723e-38	-0.319390392256756	0.494	0.596	2.55922252509164e-34	LRRK2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000188906	120892	leucine rich repeat kinase 2	DKFZp434H2111|FLJ45829|PARK8|RIPK7|ROCO2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52557
3.02549353485433e-38	-0.292565168903791	0.496	0.598	5.86098607571981e-34	RNF149	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000163162	284996	ring finger protein 149	FLJ90504	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52558
1.35081511913222e-37	-0.301329225988342	0.465	0.565	2.61679904878293e-33	DMXL2	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000104093	23312	Dmx like 2	DFNA71|KIAA0856|RC3	protein_coding	Q8TDJ6	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52559
1.52177804791195e-35	-0.266801015184836	0.347	0.461	2.94798843441503e-31	CD55	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52560
2.78667443887178e-35	-0.250165209784809	0.408	0.524	5.3983457229824e-31	VAMP5	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000168899	10791	vesicle associated membrane protein 5	NA	protein_coding	O95183	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52561
3.21062333767127e-35	0.271614831615255	0.931	0.897	6.21961952973678e-31	LST1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52562
6.14343735091416e-35	-0.278530812313273	0.408	0.512	1.19010668361909e-30	DPYD	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000188641	1806	dihydropyrimidine dehydrogenase	DHPDHase|DPD	protein_coding	Q12882	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52563
8.41445988869417e-34	0.251999892484925	0.89	0.878	1.63004916963783e-29	S100A10	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52564
9.31864987124662e-33	-0.25420022188972	0.508	0.599	1.8052088530579e-28	MBNL1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52565
6.61158611987e-32	-0.321693581813783	0.43	0.538	1.28079646314122e-27	NFKBIZ	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52566
4.46461527061948e-28	0.27087669527321	0.534	0.441	8.64885270224405e-24	NAMPT	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52567
6.94328570868862e-27	-0.408767591583377	0.275	0.396	1.34505330748716e-22	FCGR3A	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52568
2.19264398968943e-26	-0.256669438067016	0.95	0.971	4.24758993682636e-22	COTL1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52569
5.58067875854595e-21	0.398683671041828	0.615	0.619	1.08108908910552e-16	NFKBIA	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52570
2.00054138945099e-13	0.263088894697548	0.724	0.767	3.87544877964445e-09	JUNB	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52571
5.33494555833879e-10	0.338517904947097	0.631	0.666	1.03348565356139e-05	FOS	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52572
2.59618576986659e-09	0.276876939895075	0.661	0.691	5.02933107338556e-05	DUSP1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52573
2.87143584275407e-09	0.26315166614822	0.638	0.619	5.56254551458319e-05	CRIP1	Mono/Macro	GSE169246_PacAteBlood_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52574
0	0.482323460180961	0.987	0.908	0	PTMA	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52575
0	0.635316327256263	0.988	0.954	0	HLA-B	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52576
0	0.311069658467576	1	1	0	EEF1A1	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52577
0	0.933215323564635	0.936	0.898	0	RPS26	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52578
0	-0.411428011466233	1	1	0	RPL28	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52579
0	0.386894215658791	0.998	0.986	0	RPL3	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52580
1.3626333777752e-298	-0.438700644176847	1	0.998	2.63969337942612e-294	RPL39	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52581
5.4618160619717e-290	0.359907032979638	0.998	0.968	1.05806300752516e-285	MT-CO3	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52582
5.36684462536988e-250	0.423076815815033	0.979	0.931	1.03966514082665e-245	MT-ATP6	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52583
3.4847013421087e-232	-0.332040913996304	1	1	6.75056343993298e-228	RPS19	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52584
4.05219136429163e-229	-0.550928054685468	0.999	0.995	7.84990511090574e-225	RPL41	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52585
1.50127890921953e-221	0.343035240211943	1	0.996	2.90827750294008e-217	MT-CO2	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52586
9.36568452655946e-219	0.366454074977085	0.974	0.909	1.8143204064851e-214	MT-ND1	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52587
1.66738972096185e-211	0.34620360447156	0.999	0.994	3.2300673674473e-207	MT-ND3	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52588
3.03258357634282e-211	-0.530965413998215	1	0.992	5.87472090409131e-207	RPS29	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52589
3.12773955920033e-209	0.263504959362748	1	0.999	6.05905707408288e-205	TMSB4X	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52590
2.61980542824079e-192	0.372428609786219	0.797	0.621	5.07508707558805e-188	GIMAP7	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52591
5.14521771074525e-175	-0.330177084700981	1	0.999	9.96731574925569e-171	RPL18A	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52592
4.33194475349296e-174	0.309976757898779	1	0.996	8.39184337646655e-170	MT-CO1	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52593
8.5025114617439e-173	-0.291420038003462	0.222	0.404	1.64710652036903e-168	NKG7	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52594
1.49798213156332e-168	0.26675106289168	0.988	0.944	2.90189098526447e-164	HLA-A	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52595
2.85397222319519e-168	0.323616484825914	0.755	0.549	5.52871499077371e-164	LDHB	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52596
7.48143738591947e-168	0.279630597141465	0.696	0.442	1.44930405040032e-163	NPM1	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52597
6.11997195093889e-166	-0.356241941614739	1	1	1.18556096633588e-161	RPS27	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52598
4.44089510134782e-157	0.281840909642329	0.997	0.979	8.602901990331e-153	MT-CYB	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52599
3.11253077637154e-149	0.350395026981386	0.903	0.805	6.02959461998695e-145	LTB	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52600
5.65341893930104e-149	-0.322117554058486	0.969	0.988	1.0951803169214e-144	FTL	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52601
4.28551326288121e-144	-0.263625055541726	1	1	8.30189629285347e-140	RPS15A	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52602
1.58073457104441e-140	0.276180476127153	0.642	0.435	3.06219901102724e-136	HSP90AA1	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52603
5.94568904388543e-140	0.345221164240112	1	1	1.15179888158148e-135	MALAT1	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52604
6.80255074059419e-137	0.316531359758669	0.967	0.951	1.31779012946791e-132	MT-ND4	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52605
1.63823142605921e-128	0.326791897262366	0.947	0.888	3.17358191856189e-124	MT-ATP8	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52606
1.11059370263212e-125	0.3012107386892	0.445	0.274	2.15144212073894e-121	CCR7	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52607
4.93311105585292e-125	0.25604319951307	0.603	0.409	9.55642273739827e-121	HSP90AB1	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52608
7.06183463648434e-124	-0.256381822576426	1	0.997	1.36801860577975e-119	RPL36	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52609
8.0877127170196e-123	-0.288978118366843	1	0.999	1.56675170754104e-118	RPS21	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52610
1.68562389671389e-117	-0.311756295276806	0.91	0.959	3.26539061271416e-113	SH3BGRL3	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52611
3.37634290165761e-117	-0.256395062715763	1	0.998	6.54065146909112e-113	FAU	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52612
1.22336151634995e-115	0.259876615252949	0.825	0.672	2.36989592947313e-111	CD3E	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52613
1.30172510923163e-114	-0.267670300709246	0.997	0.998	2.52170188160352e-110	RPLP0	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52614
1.59435885048546e-114	0.281200600893194	0.796	0.704	3.08859196516043e-110	EEF1G	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52615
3.31097246378936e-99	-0.375313298980431	0.781	0.878	6.41401585685274e-95	S100A4	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52616
2.34450491534469e-95	-0.250720807551118	1	0.998	4.54177492200572e-91	RPL35A	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52617
1.06972696430281e-92	-0.264057032745529	0.607	0.741	2.07227507524741e-88	CD74	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52618
2.34582591615555e-89	-0.330763082688322	0.234	0.366	4.54433396477653e-85	CCL5	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52619
6.13762655240242e-89	-0.283337669809003	0.993	0.996	1.1889810157314e-84	RPS5	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52620
1.33210607107209e-79	-0.354012437821857	0.181	0.288	2.58055588088085e-75	LGALS1	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52621
1.2676239319932e-74	0.26750344809847	0.861	0.785	2.45564108105722e-70	IL7R	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52622
9.42522069293852e-74	-0.257191767010696	0.772	0.82	1.82585375263605e-69	MIF	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52623
1.06311036433683e-41	-0.251672981583626	0.677	0.748	2.05945739779331e-37	CRIP1	CD4+ T cells	GSE169246_PacAteBlood_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52624
0	-0.66885549627636	0.065	0.414	0	S100A9	NK cells	GSE169246_PacAteBlood_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52625
0	-0.582641947947358	0.069	0.387	0	S100A8	NK cells	GSE169246_PacAteBlood_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52626
0	0.56250917657977	0.999	0.997	0	HLA-B	NK cells	GSE169246_PacAteBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52627
0	0.776432062146671	0.256	0.025	0	MYOM2	NK cells	GSE169246_PacAteBlood_post	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52628
0	-1.0916012983662	0.016	0.496	0	HBB	NK cells	GSE169246_PacAteBlood_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52629
0	-0.809376766665187	0.061	0.459	0	LYZ	NK cells	GSE169246_PacAteBlood_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52630
2.63552432432203e-299	-0.432813448947854	0.104	0.353	5.10553772107664e-295	COTL1	NK cells	GSE169246_PacAteBlood_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52631
2.20418225176912e-242	-0.512643982638021	0.629	0.882	4.26994185812714e-238	IL32	NK cells	GSE169246_PacAteBlood_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52632
3.43643406879973e-241	-0.564805693573008	0.984	0.992	6.65706007807883e-237	MT-ND4L	NK cells	GSE169246_PacAteBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52633
2.58368107429983e-238	0.264887588058464	0.99	0.868	5.00510697713362e-234	RPS29	NK cells	GSE169246_PacAteBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52634
1.29779896906985e-234	-0.585768689314394	0.602	0.725	2.51409616288212e-230	KLF2	NK cells	GSE169246_PacAteBlood_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52635
1.04237094625894e-224	-0.47032219150811	0.93	0.975	2.01928099709282e-220	FTH1	NK cells	GSE169246_PacAteBlood_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52636
2.69236978687846e-214	-0.392772729724938	0.974	0.993	5.21565875114095e-210	FTL	NK cells	GSE169246_PacAteBlood_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52637
4.9034364144723e-213	-0.516504532384266	0.251	0.475	9.49893702211575e-209	HIST1H1E	NK cells	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52638
2.26670057278006e-212	0.372896985729258	0.986	0.937	4.39105234958954e-208	RPL37A	NK cells	GSE169246_PacAteBlood_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52639
2.25026021192701e-210	0.497458388716097	0.75	0.551	4.35920408254501e-206	LINC00861	NK cells	GSE169246_PacAteBlood_post	ENSG00000245164	100130231	long intergenic non-protein coding RNA 861	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52640
7.95396834991489e-190	-0.295059844751831	0.093	0.271	1.54084274874551e-185	CST3	NK cells	GSE169246_PacAteBlood_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52641
1.95939136198603e-163	0.263435059337802	0.991	0.932	3.79573294643934e-159	RPS21	NK cells	GSE169246_PacAteBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52642
1.24976071820517e-161	0.296826438696568	0.934	0.795	2.42103646330706e-157	RPL38	NK cells	GSE169246_PacAteBlood_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52643
3.90740067226797e-157	0.442837597201104	1	1	7.56941658231751e-153	MALAT1	NK cells	GSE169246_PacAteBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52644
4.86284174384835e-156	0.304319131213418	0.999	0.996	9.42029702618302e-152	RPS27	NK cells	GSE169246_PacAteBlood_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52645
1.12862480085479e-153	-0.3222795609439	0.201	0.394	2.18637196421591e-149	HLA-DRB5	NK cells	GSE169246_PacAteBlood_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52646
1.02635400168507e-137	0.397517020678594	0.42	0.235	1.98825297206432e-133	ALOX5AP	NK cells	GSE169246_PacAteBlood_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52647
5.92111572837626e-134	0.34810910176759	0.972	0.951	1.14703853890105e-129	MT-ND4	NK cells	GSE169246_PacAteBlood_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52648
5.4373953958851e-124	0.251365717748923	0.997	0.982	1.05333223609086e-119	RPL34	NK cells	GSE169246_PacAteBlood_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52649
1.36516536203347e-120	-0.358085082103573	0.741	0.814	2.64459833933124e-116	DDX5	NK cells	GSE169246_PacAteBlood_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52650
4.91799961149064e-120	-0.300924925172424	0.691	0.824	9.52714884737967e-116	PABPC1	NK cells	GSE169246_PacAteBlood_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52651
4.7966387903877e-119	-0.377815751061312	0.955	0.98	9.29204866473906e-115	MT-ND5	NK cells	GSE169246_PacAteBlood_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52652
2.25603661548363e-117	0.3066242480628	0.997	0.982	4.37039413151488e-113	MT-ND3	NK cells	GSE169246_PacAteBlood_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52653
3.09533457993962e-116	0.349663816242703	0.896	0.886	5.99628214825904e-112	GZMA	NK cells	GSE169246_PacAteBlood_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52654
7.57045697021804e-114	0.390927984489345	0.719	0.576	1.46654892427064e-109	KLRB1	NK cells	GSE169246_PacAteBlood_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52655
9.70005984920168e-105	0.30159085620958	0.624	0.469	1.87909559398735e-100	RPL36A	NK cells	GSE169246_PacAteBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52656
6.27909125788307e-102	0.257210186260561	0.868	0.778	1.21638555847711e-97	TMA7	NK cells	GSE169246_PacAteBlood_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52657
3.28793517754995e-100	-0.270904606400133	0.838	0.9	6.36938802594976e-96	ITGB2	NK cells	GSE169246_PacAteBlood_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52658
3.80791229033623e-100	-0.310966984591529	0.356	0.504	7.37668768883935e-96	EIF4G2	NK cells	GSE169246_PacAteBlood_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52659
1.45533738863748e-98	0.279947270815963	0.952	0.929	2.81927958926853e-94	MYL12A	NK cells	GSE169246_PacAteBlood_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52660
1.97365624535386e-97	-0.435855182856633	0.45	0.594	3.8233668784995e-93	NEAT1	NK cells	GSE169246_PacAteBlood_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52661
2.38294063544882e-89	-0.254639201722324	0.153	0.283	4.61623259899145e-85	HIST1H1D	NK cells	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52662
1.59998848084265e-88	-0.289042246593165	0.225	0.366	3.09949768508838e-84	STAT1	NK cells	GSE169246_PacAteBlood_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52663
2.09059727482938e-88	-0.250524787590345	0.144	0.272	4.04990504079947e-84	ITGAX	NK cells	GSE169246_PacAteBlood_post	ENSG00000140678	3687	integrin subunit alpha X	CD11C	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52664
8.32063632258543e-86	0.346942606882993	0.666	0.557	1.61187366841125e-81	EFHD2	NK cells	GSE169246_PacAteBlood_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52665
9.24988135587362e-82	-0.268669630580611	0.291	0.428	1.79188701625984e-77	RASA3	NK cells	GSE169246_PacAteBlood_post	ENSG00000280477	22821	RAS p21 protein activator 3	GAP1IP4BP|GAPIII	protein_coding	Q14644	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52666
3.9208743151901e-76	-0.339072837852272	0.406	0.528	7.59551772338627e-72	MT-ND6	NK cells	GSE169246_PacAteBlood_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52667
6.18812824147224e-75	-0.30145516854438	0.567	0.716	1.198764202938e-70	LGALS1	NK cells	GSE169246_PacAteBlood_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52668
6.13131284415783e-69	-0.254280979459419	0.561	0.66	1.18775792417025e-64	SLC9A3R1	NK cells	GSE169246_PacAteBlood_post	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52669
1.01540030743402e-67	-0.26087532788607	0.999	0.998	1.96703347556119e-63	MT-CO3	NK cells	GSE169246_PacAteBlood_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52670
2.75093671784324e-61	0.279001496969972	0.39	0.266	5.32911460980593e-57	CD3E	NK cells	GSE169246_PacAteBlood_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52671
2.30792363552789e-60	0.263808350774769	0.545	0.431	4.47090966674463e-56	TGFB1	NK cells	GSE169246_PacAteBlood_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52672
2.64183711892811e-60	0.35986912769663	0.665	0.591	5.11776686678754e-56	CLIC3	NK cells	GSE169246_PacAteBlood_post	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52673
2.13290420938322e-57	-0.262457446422428	0.695	0.741	4.13186203441718e-53	HNRNPA2B1	NK cells	GSE169246_PacAteBlood_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52674
2.56176852124499e-57	0.349056632043921	0.999	0.999	4.96265797935579e-53	HLA-C	NK cells	GSE169246_PacAteBlood_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52675
3.89953046914623e-53	-0.272463584781223	0.363	0.46	7.55417042483008e-49	PRSS23	NK cells	GSE169246_PacAteBlood_post	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52676
2.7817384718168e-49	-0.265797496305983	0.714	0.753	5.38878376760351e-45	FCGR3A	NK cells	GSE169246_PacAteBlood_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52677
1.17171144750299e-46	0.251472156639648	0.521	0.431	2.2698394161028e-42	CD2	NK cells	GSE169246_PacAteBlood_post	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52678
2.29817566256161e-46	0.306395034615847	0.59	0.522	4.45202589351435e-42	TRBC1	NK cells	GSE169246_PacAteBlood_post	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52679
5.07071044662667e-27	-0.269846302975862	0.365	0.435	9.82298027720518e-23	KLF6	NK cells	GSE169246_PacAteBlood_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52680
1.65321009423898e-41	-1.13379365542114	0.941	0.984	3.20259859455974e-37	MT-ND4L	cDCs	GSE169246_PacAteBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52681
1.51607369926754e-40	0.905561566830511	0.973	0.759	2.93693797022108e-36	RPS29	cDCs	GSE169246_PacAteBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52682
3.76811624199716e-37	0.725565236779771	0.986	0.898	7.2995947839969e-33	RPL41	cDCs	GSE169246_PacAteBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52683
3.66740076640647e-34	0.70821084221637	0.991	0.965	7.10448876468262e-30	RPS27	cDCs	GSE169246_PacAteBlood_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52684
1.80572219101013e-33	-0.746384167751601	1	0.997	3.49804502842483e-29	MT-CO3	cDCs	GSE169246_PacAteBlood_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52685
3.48066112736826e-33	-0.726549739152228	0.005	0.48	6.74273673593779e-29	HBB	cDCs	GSE169246_PacAteBlood_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52686
2.89754718811249e-32	-0.797188291444997	0.977	0.992	5.61312841281151e-28	MT-CYB	cDCs	GSE169246_PacAteBlood_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52687
5.19526284137616e-32	-0.706903047951159	1	1	1.00642631763139e-27	MT-CO2	cDCs	GSE169246_PacAteBlood_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52688
4.2798474456196e-31	0.757338384514506	1	0.944	8.29092047165429e-27	HLA-B	cDCs	GSE169246_PacAteBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52689
4.3549255869085e-29	0.523116676982348	0.986	0.981	8.43636184695915e-25	RPL37	cDCs	GSE169246_PacAteBlood_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52690
2.28436693527337e-28	-0.611060143515584	1	1	4.42527562701158e-24	MT-CO1	cDCs	GSE169246_PacAteBlood_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52691
7.56160365809837e-28	0.476932482443046	0.995	0.965	1.46483386064682e-23	RPS21	cDCs	GSE169246_PacAteBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52692
2.2655932040584e-26	-0.563998389842601	0.982	0.992	4.38890715490194e-22	PABPC1	cDCs	GSE169246_PacAteBlood_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52693
2.2367672597291e-25	0.443164973890882	0.986	0.952	4.33306553554721e-21	RPS28	cDCs	GSE169246_PacAteBlood_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52694
1.03153356700857e-24	-0.761372582166632	0.923	0.971	1.99828682600901e-20	MT-ND5	cDCs	GSE169246_PacAteBlood_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52695
2.7209999990863e-24	0.770108943879218	0.827	0.44	5.27112119822997e-20	LGALS2	cDCs	GSE169246_PacAteBlood_post	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52696
3.20869123641588e-23	0.412782533107229	0.995	0.973	6.21587666318484e-19	RPL39	cDCs	GSE169246_PacAteBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52697
4.51680735994129e-23	0.644594054512766	0.709	0.343	8.74995921767828e-19	EFHD2	cDCs	GSE169246_PacAteBlood_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52698
6.39978683756841e-23	0.565216474577756	0.945	0.777	1.23976670617375e-18	RPL38	cDCs	GSE169246_PacAteBlood_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52699
3.05690790060237e-21	0.399262095585343	0.986	0.941	5.92184198504692e-17	RPL36	cDCs	GSE169246_PacAteBlood_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52700
3.28368854749686e-21	0.635038668199561	0.845	0.574	6.36116145421091e-17	RPL36A	cDCs	GSE169246_PacAteBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52701
4.02487530112342e-21	0.413382125193953	0.982	0.981	7.79698843333629e-17	RPL34	cDCs	GSE169246_PacAteBlood_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52702
5.31536210494323e-21	0.583884987515295	0.618	0.263	1.0296919469696e-16	BRI3	cDCs	GSE169246_PacAteBlood_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52703
4.74083835802525e-20	-0.691306009497181	0.927	0.968	9.18395206716651e-16	HLA-DRB5	cDCs	GSE169246_PacAteBlood_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52704
1.04672411835755e-19	0.471786481247353	0.445	0.121	2.02771396208225e-15	TAF10	cDCs	GSE169246_PacAteBlood_post	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52705
1.40847433697328e-19	0.373391289885697	0.995	1	2.72849648558464e-15	TMSB10	cDCs	GSE169246_PacAteBlood_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52706
7.36729050543148e-19	0.639430853286184	0.818	0.598	1.42719151671219e-14	CTSZ	cDCs	GSE169246_PacAteBlood_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52707
7.15877394811874e-18	-0.579934998012299	0.818	0.962	1.38679768922956e-13	MT-ATP8	cDCs	GSE169246_PacAteBlood_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52708
1.46323374613576e-16	-0.740114911143337	0.355	0.662	2.8345764130142e-12	MT-ND6	cDCs	GSE169246_PacAteBlood_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52709
2.06006759129197e-16	0.391936308768865	0.986	0.973	3.99076293785081e-12	RPL35A	cDCs	GSE169246_PacAteBlood_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52710
5.14335752173439e-16	0.406655171489923	0.986	0.949	9.96371219110386e-12	RPL37A	cDCs	GSE169246_PacAteBlood_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52711
2.72015757173612e-15	0.479314020577565	1	1	5.26948924796721e-11	HLA-DRB1	cDCs	GSE169246_PacAteBlood_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52712
1.85353485293519e-14	0.444945596301689	0.955	0.903	3.59066771710605e-10	TYROBP	cDCs	GSE169246_PacAteBlood_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52713
1.95166857784888e-14	0.459109336710147	0.314	0.075	3.78077236900886e-10	RETN	cDCs	GSE169246_PacAteBlood_post	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52714
6.90338196243125e-14	-0.484278144477667	0.336	0.745	1.33732315376218e-09	FOS	cDCs	GSE169246_PacAteBlood_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52715
1.31209306181403e-13	0.400854998449621	0.495	0.206	2.54178667934615e-09	NDUFB1	cDCs	GSE169246_PacAteBlood_post	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52716
1.73683189201051e-13	0.357558256487971	0.973	0.92	3.36459074120277e-09	ATP5F1E	cDCs	GSE169246_PacAteBlood_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52717
3.74441013563368e-13	-0.408518706788191	1	1	7.25367131474957e-09	EEF1A1	cDCs	GSE169246_PacAteBlood_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52718
3.81854124527228e-13	0.501177657610755	0.45	0.19	7.39727810034146e-09	AC020656.1	cDCs	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52719
5.23771280957106e-13	0.358441566774003	0.991	0.987	1.01464972547011e-08	RPL30	cDCs	GSE169246_PacAteBlood_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52720
1.38097558236478e-12	-0.516805732123387	0.736	0.89	2.67522589815705e-08	HNRNPA1	cDCs	GSE169246_PacAteBlood_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52721
2.19339057287621e-12	-0.37061056075156	0.877	0.954	4.24903621777579e-08	H3F3B	cDCs	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52722
2.53797222980148e-12	0.312420838084575	0.995	0.954	4.91655980357143e-08	RPL21	cDCs	GSE169246_PacAteBlood_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52723
3.14253173584452e-12	0.283650806070572	0.977	0.968	6.087712478678e-08	UBA52	cDCs	GSE169246_PacAteBlood_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52724
3.3307578013018e-12	0.4238821374687	0.564	0.311	6.45234401268184e-08	CKLF	cDCs	GSE169246_PacAteBlood_post	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52725
4.18235560289557e-12	0.357281851651243	0.541	0.255	8.1020592739293e-08	NDUFA3	cDCs	GSE169246_PacAteBlood_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52726
4.77557241777838e-12	0.438780752386236	0.986	0.979	9.25123888772028e-08	HLA-DQA1	cDCs	GSE169246_PacAteBlood_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52727
1.13732254123593e-11	0.329561094092793	0.886	0.751	2.20322122688225e-07	TMA7	cDCs	GSE169246_PacAteBlood_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52728
4.02019112186339e-11	-0.378073754983592	0.736	0.893	7.78791424127375e-07	RHOA	cDCs	GSE169246_PacAteBlood_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52729
4.0874672689246e-11	0.322048969173461	0.386	0.153	7.91824159336073e-07	PET100	cDCs	GSE169246_PacAteBlood_post	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52730
4.29277472924357e-11	0.301946845577177	0.991	0.984	8.31596320549065e-07	FAU	cDCs	GSE169246_PacAteBlood_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52731
4.64826462039119e-11	0.397903277762244	0.582	0.332	9.00461822262181e-07	IFI30	cDCs	GSE169246_PacAteBlood_post	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52732
5.66080068347067e-11	0.397542778298235	0.577	0.338	1.09661030840194e-06	ATP5ME	cDCs	GSE169246_PacAteBlood_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52733
1.01496054087477e-10	-0.395869170255902	0.477	0.721	1.9661815597826e-06	SARAF	cDCs	GSE169246_PacAteBlood_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52734
1.125872435877e-10	0.322020188662944	0.986	0.952	2.18104008278092e-06	RPL12	cDCs	GSE169246_PacAteBlood_post	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52735
3.55308403100414e-10	0.313682580873764	0.986	0.933	6.88303438486121e-06	RPL35	cDCs	GSE169246_PacAteBlood_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52736
3.57506641764266e-10	-0.794820734572778	0.255	0.477	6.92561866425736e-06	HIST1H1E	cDCs	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52737
7.9879122486142e-10	0.324603472897794	0.995	1	1.54741836080154e-05	HLA-DRA	cDCs	GSE169246_PacAteBlood_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52738
1.18971853598123e-09	0.326615641386177	0.977	0.928	2.30472274790284e-05	FCER1G	cDCs	GSE169246_PacAteBlood_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52739
1.62879966086616e-09	0.32673505001403	0.364	0.15	3.15531070302993e-05	HIST1H4C	cDCs	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52740
1.88960871673426e-09	0.420585915682477	0.968	0.903	3.66055000605761e-05	LGALS1	cDCs	GSE169246_PacAteBlood_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52741
1.99323623456146e-09	-0.371222163766767	0.427	0.665	3.86129723359247e-05	EIF4B	cDCs	GSE169246_PacAteBlood_post	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52742
3.72993743797845e-09	0.254776207169924	0.995	1	7.22563480485186e-05	RPL11	cDCs	GSE169246_PacAteBlood_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52743
5.42106256865556e-09	0.512152507371266	0.495	0.298	0.000105016824079996	H1FX	cDCs	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52744
9.52562140972373e-09	-0.289410943683989	0.982	0.989	0.000184530337949168	RPL3	cDCs	GSE169246_PacAteBlood_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52745
1.15783284485143e-08	0.299941372003693	0.745	0.523	0.000224295378704618	LY86	cDCs	GSE169246_PacAteBlood_post	ENSG00000112799	9450	lymphocyte antigen 86	dJ80N2.1|MD-1	protein_coding	O95711	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52746
1.21170073217461e-08	-0.334879708381515	0.7	0.842	0.000234730665836866	SLC25A3	cDCs	GSE169246_PacAteBlood_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52747
1.21486186927702e-08	0.281928918063919	0.973	0.917	0.000235343041316344	RPL27	cDCs	GSE169246_PacAteBlood_post	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52748
1.25472997742523e-08	-0.438933094829797	0.295	0.512	0.000243066291226816	MCL1	cDCs	GSE169246_PacAteBlood_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52749
1.34294164228703e-08	0.252360152962742	0.991	1	0.000260154654943843	RPL28	cDCs	GSE169246_PacAteBlood_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52750
2.0802402743721e-08	0.306269239778338	0.336	0.142	0.000402984145951362	IFI6	cDCs	GSE169246_PacAteBlood_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52751
2.1548681637772e-08	0.255962557994406	0.991	0.984	0.00041744106068692	RPS15A	cDCs	GSE169246_PacAteBlood_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52752
2.65123408522037e-08	0.262345689190281	0.968	0.949	0.00051359706698889	RPS11	cDCs	GSE169246_PacAteBlood_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52753
4.12337719771461e-08	0.273808294114503	0.455	0.241	0.000798780630741275	IL18	cDCs	GSE169246_PacAteBlood_post	ENSG00000150782	3606	interleukin 18	IGIF|IL-18|IL-1g|IL1F4	protein_coding	Q14116	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52754
4.27385957744358e-08	-0.350161939458171	0.45	0.657	0.000827932077342371	HNRNPU	cDCs	GSE169246_PacAteBlood_post	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52755
4.31590008849229e-08	-0.36024526052518	0.718	0.836	0.000836076165142726	HNRNPA2B1	cDCs	GSE169246_PacAteBlood_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52756
7.65941046941599e-08	-0.288121818285581	0.3	0.525	0.00148378099613527	ARF6	cDCs	GSE169246_PacAteBlood_post	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52757
8.28442977306429e-08	-0.289832401791065	0.973	0.971	0.00160485973563801	COTL1	cDCs	GSE169246_PacAteBlood_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52758
8.42783497142898e-08	0.284880965896359	0.568	0.354	0.00163264019066522	ATP5MD	cDCs	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52759
9.20667651156051e-08	0.2788900008159	0.595	0.378	0.0017835173738195	C8orf59	cDCs	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52760
1.03612545794578e-07	0.277036664682149	0.8	0.617	0.00200718223713256	UQCR11	cDCs	GSE169246_PacAteBlood_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52761
1.12889926901266e-07	-0.271204049516111	0.209	0.429	0.00218690366393132	KLF10	cDCs	GSE169246_PacAteBlood_post	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52762
1.20185198907702e-07	-0.428763547834208	0.859	0.877	0.00232822767323999	PSAP	cDCs	GSE169246_PacAteBlood_post	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52763
1.34918505342973e-07	0.277510246796914	0.391	0.196	0.00261364128550407	CLEC12A	cDCs	GSE169246_PacAteBlood_post	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52764
1.55801629920739e-07	0.303796513814018	0.759	0.59	0.00301818917482456	OST4	cDCs	GSE169246_PacAteBlood_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52765
1.87164264272468e-07	-0.280994358072158	1	0.995	0.00362574612748624	ACTG1	cDCs	GSE169246_PacAteBlood_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52766
1.9176351963025e-07	-0.270440078423175	0.286	0.515	0.0037148429022772	AC004687.1	cDCs	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52767
2.91183905334752e-07	0.272246851535711	0.95	0.928	0.00564081461414481	HLA-DMA	cDCs	GSE169246_PacAteBlood_post	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52768
3.24949449486653e-07	0.25649763190307	0.836	0.724	0.00629492073545544	ATP5MF	cDCs	GSE169246_PacAteBlood_post	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52769
3.4598159404077e-07	-0.319166170391851	0.4	0.582	0.0067023554397578	GRB2	cDCs	GSE169246_PacAteBlood_post	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52770
4.36783904087011e-07	-0.331338857140863	0.623	0.796	0.00846137778997357	DDX5	cDCs	GSE169246_PacAteBlood_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52771
5.09171742670032e-07	0.259211967810384	1	1	0.00986367499900385	HLA-DPB1	cDCs	GSE169246_PacAteBlood_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52772
5.18044915733155e-07	-0.295539792692995	0.345	0.536	0.0100355661075827	MOB1A	cDCs	GSE169246_PacAteBlood_post	ENSG00000114978	55233	MOB kinase activator 1A	C2orf6|FLJ10788|FLJ11595|Mats1|MOB1|Mob4B|MOBK1B|MOBKL1B	protein_coding	Q9H8S9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52773
5.29712148727509e-07	-0.274062105002635	0.341	0.555	0.0102615837451493	SRSF5	cDCs	GSE169246_PacAteBlood_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52774
5.41505176507287e-07	-0.266561573998366	0.145	0.327	0.0104900382792992	TNFRSF1A	cDCs	GSE169246_PacAteBlood_post	ENSG00000067182	7132	TNF receptor superfamily member 1A	CD120a|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR60	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52775
7.60873604249723e-07	-0.251916958017377	0.368	0.574	0.0147396434615256	SRSF2	cDCs	GSE169246_PacAteBlood_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52776
7.6330258668409e-07	-0.278266638639566	0.264	0.456	0.0147866977092442	CAPZA1	cDCs	GSE169246_PacAteBlood_post	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52777
7.93382774323329e-07	-0.330468906649214	0.441	0.598	0.0153694111041915	LYN	cDCs	GSE169246_PacAteBlood_post	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52778
8.91828254283118e-07	0.260594776385043	0.814	0.678	0.0172764969419726	COMMD6	cDCs	GSE169246_PacAteBlood_post	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52779
9.58660110007953e-07	-0.267865215985466	0.818	0.893	0.0185711636510741	GRN	cDCs	GSE169246_PacAteBlood_post	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52780
1.22124865813228e-06	-0.262575439516099	0.291	0.493	0.0236580290053386	HNRNPF	cDCs	GSE169246_PacAteBlood_post	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52781
1.22624837485246e-06	-0.344899557467466	0.286	0.472	0.0237548835176419	CYBB	cDCs	GSE169246_PacAteBlood_post	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52782
1.56168342344531e-06	-0.419030293184495	0.759	0.879	0.0302529312789825	AHNAK	cDCs	GSE169246_PacAteBlood_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52783
1.59793304397025e-06	0.261004535926038	0.641	0.458	0.0309551589277917	TMEM258	cDCs	GSE169246_PacAteBlood_post	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52784
1.65977173176405e-06	0.267528743513693	1	1	0.0321530979877332	MALAT1	cDCs	GSE169246_PacAteBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52785
1.76482756033653e-06	0.283098950601399	0.636	0.466	0.0341882394988392	BST2	cDCs	GSE169246_PacAteBlood_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52786
1.87614860187526e-06	-0.309136061355629	0.4	0.579	0.0363447507155276	HNRNPA3	cDCs	GSE169246_PacAteBlood_post	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52787
2.27433957216612e-06	-0.299990913153226	0.691	0.804	0.0440585061920022	H2AFY	cDCs	GSE169246_PacAteBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52788
7.21351477095475e-08	-0.807837812539723	0.853	0.887	0.00139740208142935	MT-ND4L	Plasma cells	GSE169246_PacAteBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52789
4.81950707826559e-18	-3.50682918644709	0.025	0.69	9.3363491120161e-14	HBB	pDCs	GSE169246_PacAteBlood_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52790
1.31847147525869e-14	1.21643846114826	0.949	0.736	2.55414294187113e-10	RPS29	pDCs	GSE169246_PacAteBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52791
4.6673849195795e-12	-0.794494757499679	0.076	0.609	9.0416580662094e-08	LYZ	pDCs	GSE169246_PacAteBlood_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52792
4.96964835484187e-11	-0.955448681885088	0.873	1	9.62720279299966e-07	MT-ND4L	pDCs	GSE169246_PacAteBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52793
4.04065545797558e-09	0.697564422121646	0.987	0.989	7.82755775319029e-05	HLA-B	pDCs	GSE169246_PacAteBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52794
2.15539125533144e-08	0.733640171857387	0.987	0.977	0.000417542393982806	RPS28	pDCs	GSE169246_PacAteBlood_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52795
3.32227011392139e-08	0.7458203194921	0.975	0.954	0.000643590166468852	RPS21	pDCs	GSE169246_PacAteBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52796
3.45557819958621e-08	-0.673210249152604	1	1	0.000669414608823841	MT-CO3	pDCs	GSE169246_PacAteBlood_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52797
4.25063607781868e-08	-0.652542813464886	1	1	0.000823433220995034	MT-CO1	pDCs	GSE169246_PacAteBlood_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52798
5.17840723464133e-08	0.704996936018726	0.962	0.885	0.00100316104949472	RPL41	pDCs	GSE169246_PacAteBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52799
6.8037881560273e-08	-0.562495977758628	0.076	0.46	0.00131802984158561	S100A9	pDCs	GSE169246_PacAteBlood_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52800
1.09175863845201e-07	-0.701898111672948	0.443	0.816	0.00211495483440923	ZFP36L2	pDCs	GSE169246_PacAteBlood_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52801
1.5522677665349e-07	-0.600594710047783	1	1	0.00300705311733141	MT-CO2	pDCs	GSE169246_PacAteBlood_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52802
2.48857361543703e-07	-0.952897805317143	0.342	0.701	0.00482086480782461	AHNAK	pDCs	GSE169246_PacAteBlood_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52803
5.03426548605833e-07	-0.71408988433482	0.684	0.943	0.00975237909959219	MT-ATP8	pDCs	GSE169246_PacAteBlood_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52804
7.63698514156233e-07	0.701709498129823	0.962	0.931	0.0147943676162346	RPL39	pDCs	GSE169246_PacAteBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52805
1.54108075159658e-06	0.569548211283905	0.899	0.885	0.0298538163199289	TYROBP	pDCs	GSE169246_PacAteBlood_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52806
2.34284226421183e-06	0.60178970546873	0.797	0.517	0.0453855403423115	CD4	pDCs	GSE169246_PacAteBlood_post	ENSG00000010610	920	CD4 molecule	NA	protein_coding	P01730	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52807
2.43896812993663e-06	0.696348205498974	1	0.966	0.0472476906131325	RPS27	pDCs	GSE169246_PacAteBlood_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52808
0	0.818860102878382	0.462	0.1	0	CXCR4	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52809
0	0.800089053866854	0.812	0.571	0	BTG1	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52810
0	0.619078369537201	0.991	0.923	0	MT-ND4L	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52811
5.57635406932394e-304	0.464341781040677	1	1	1.08025131030943e-299	EEF1A1	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52812
2.36275483726556e-271	0.772697467796754	0.927	0.819	4.57712867075084e-267	TXNIP	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52813
1.10665597942349e-244	0.704885172916811	0.587	0.288	2.14381396333919e-240	TSC22D3	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52814
8.26213717496615e-219	0.537897976066199	0.986	0.956	1.60054121353444e-214	MT-ATP6	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52815
1.13706632689995e-217	0.416198564937684	0.997	0.992	2.20272488847058e-213	RPL3	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52816
2.37513937926727e-205	0.439436096908652	0.999	0.992	4.60112000551655e-201	MT-CO3	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52817
1.37515658308094e-203	0.486725766746993	0.31	0.068	2.66395333274439e-199	DDIT4	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52818
7.33129852306916e-192	0.658076474361218	0.749	0.538	1.42021914988896e-187	ZFP36L2	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52819
2.6181901090608e-179	0.822122131320695	0.51	0.254	5.07195787927257e-175	IL7R	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52820
1.58154351854782e-163	0.630365486939564	0.923	0.897	3.06376610413083e-159	RPS26	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52821
3.20211376889951e-147	0.399668780267327	0.258	0.066	6.20313479311214e-143	FKBP5	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52822
9.52175144810654e-147	0.642876592663334	0.381	0.163	1.8445536905272e-142	DUSP2	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52823
3.59850303010085e-144	0.372203292395397	0.979	0.936	6.97102006991137e-140	MT-ND1	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52824
1.33159565017231e-141	0.698557477092725	0.406	0.207	2.57956709351381e-137	TUBA4A	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52825
4.39328777981972e-130	0.45500413610414	0.971	0.929	8.51067708706677e-126	MT-ATP8	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52826
2.67695068906682e-116	0.324770405000441	0.447	0.239	5.18578887486023e-112	CYTIP	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52827
1.12234824809504e-111	-0.341125183468543	0.991	0.995	2.1742130262097e-107	SH3BGRL3	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52828
2.36040304955578e-111	-0.552713466530787	0.435	0.612	4.57257278759945e-107	LGALS1	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52829
7.49271161494657e-110	0.282000514185902	0.981	0.946	1.45148809404745e-105	PTMA	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52830
5.9150792024366e-109	0.305100491123835	0.424	0.22	1.14586914309602e-104	PARP8	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000151883	79668	poly(ADP-ribose) polymerase family member 8	ARTD16|FLJ21308|pART16	protein_coding	Q8N3A8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52831
7.4428994060035e-109	0.31254511534258	0.448	0.24	1.441838472931e-104	SPOCK2	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52832
9.92432407370046e-101	0.345001310685388	0.367	0.181	1.92254005955725e-96	CD69	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52833
2.84424849282921e-99	-0.26986325239967	0.965	0.979	5.50987818030874e-95	ATP5F1E	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52834
1.98196882021714e-96	-0.337358405855456	0.821	0.895	3.83946999852465e-92	EMP3	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52835
8.94900687027447e-96	0.28152225856947	0.279	0.113	1.73360161090957e-91	NFKBIA	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52836
1.39588633659737e-94	-0.431985145787235	0.758	0.848	2.70411101125642e-90	CRIP1	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52837
2.16321035489676e-92	0.30557366986922	0.996	0.994	4.190571099506e-88	MT-CYB	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52838
4.47955427015302e-91	-0.294221796292571	0.996	0.998	8.67779253214044e-87	PFN1	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52839
1.03392384531205e-89	0.325641605136618	0.749	0.589	2.00291727313851e-85	HNRNPA1	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52840
7.29881186908184e-78	0.283588633672637	0.958	0.904	1.41392583527853e-73	MT-ND5	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52841
1.29253175930221e-76	-0.326709707871578	0.976	0.985	2.50389252412024e-72	S100A4	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52842
1.14208884928308e-72	0.278590728815575	0.613	0.437	2.21245451883118e-68	SARAF	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52843
4.47111381412217e-71	0.25576799696752	0.651	0.48	8.66144168071747e-67	NPM1	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52844
5.26994885941064e-68	0.261336779760007	0.625	0.463	1.02089449304503e-63	NOP53	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52845
6.09925636265496e-67	0.25250830098755	0.536	0.366	1.18154794257352e-62	ETS1	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52846
3.24699226497143e-63	-0.348285122013667	0.873	0.904	6.29007341570265e-59	IFITM2	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52847
2.86811691842032e-61	-0.286128855514732	0.927	0.951	5.55611609436384e-57	CYBA	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52848
3.48984525399686e-56	0.303237308454816	0.855	0.781	6.76052822604273e-52	H3F3B	CD8+ T cells	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52849
1.31166961323312e-55	0.351879962004942	0.305	0.177	2.5409663747552e-51	ZFP36	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52850
1.01875805099006e-51	0.250096866901391	0.999	0.997	1.97353809637795e-47	MALAT1	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52851
1.01039031570673e-50	0.414017613299444	0.334	0.211	1.95732811958708e-46	JUNB	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52852
1.17671712701176e-47	0.261073275933971	0.286	0.171	2.27953641844718e-43	H1FX	CD8+ T cells	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52853
1.20634781401272e-38	0.254858405855604	0.348	0.232	2.33693698530545e-34	GZMK	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52854
4.29574557695861e-33	-0.288935789263885	0.42	0.499	8.32171833168422e-29	MT2A	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52855
4.96880479806811e-28	-0.343725541135525	0.537	0.638	9.62556865481754e-24	GNLY	CD8+ T cells	GSE169246_PacAteBlood_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52856
0	0.794164807777993	0.95	0.89	0	RPS26	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52857
1.36039944394279e-146	0.371474036426215	1	1	2.63536580280597e-142	MALAT1	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52858
2.02804100855451e-134	0.406380768846683	0.961	0.929	3.9287210417718e-130	MT-ATP6	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52859
6.60955058593988e-117	-0.495313785094895	0.627	0.792	1.28040213950827e-112	CRIP1	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52860
1.31774665561386e-101	-0.46403322347788	0.738	0.862	2.55273882125517e-97	S100A4	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52861
3.18408659048499e-101	0.487459360095635	0.89	0.873	6.16821254308752e-97	TXNIP	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52862
6.93892440337454e-100	-0.423097580484396	0.162	0.307	1.34420843542172e-95	LGALS1	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52863
2.37120835916225e-89	0.375733364793857	0.815	0.761	4.59350483336912e-85	BTG1	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52864
3.46330599608508e-78	0.320772434429311	0.292	0.155	6.70911637561601e-74	CXCR4	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52865
2.05030903133322e-66	-0.285816279252742	0.892	0.948	3.97185865549872e-62	SH3BGRL3	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52866
1.55245689826901e-53	-0.3058207995117	0.15	0.25	3.00741950332672e-49	KLRB1	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52867
1.00343800978559e-51	-0.27903583063674	0.551	0.668	1.94386011255665e-47	CD74	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52868
3.0069864121927e-49	-0.253790788755835	0.362	0.475	5.8251340776997e-45	ANXA1	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52869
4.50225849631474e-49	-0.265486021116686	0.794	0.873	8.72177515906092e-45	S100A6	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52870
1.90414323706186e-33	-0.254211274853956	0.46	0.519	3.68870627883624e-29	PCBP1	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52871
2.59568768196879e-27	0.254483333264879	0.573	0.496	5.02836617750993e-23	ZFP36L2	CD4+ T cells	GSE169246_PacAteBlood_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52872
1.11948983481524e-268	0.77132983850846	0.387	0.051	2.16867570800408e-264	CXCR4	NK cells	GSE169246_PacAteBlood_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52873
2.3842434468376e-261	0.643740585918338	0.992	0.973	4.6187564052138e-257	MT-ATP6	NK cells	GSE169246_PacAteBlood_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52874
9.26164656772533e-217	1.2691609539964	0.349	0.064	1.79416617309975e-212	MYOM2	NK cells	GSE169246_PacAteBlood_pre	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52875
5.77313014522519e-193	0.653638895658514	0.435	0.145	1.11837077173302e-188	DDIT4	NK cells	GSE169246_PacAteBlood_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52876
8.13708378369485e-176	0.679006687964745	0.831	0.699	1.57631587057737e-171	BTG1	NK cells	GSE169246_PacAteBlood_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52877
2.11619086810585e-143	0.565182903952407	0.537	0.282	4.09948494969466e-139	TSC22D3	NK cells	GSE169246_PacAteBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52878
1.65735641582006e-139	0.685124423245377	0.382	0.144	3.21063084872661e-135	DUSP2	NK cells	GSE169246_PacAteBlood_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52879
3.19302901944457e-125	-0.557533385824113	0.617	0.825	6.18553581646802e-121	IL32	NK cells	GSE169246_PacAteBlood_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52880
6.19727139828706e-113	0.340772285671006	0.996	0.995	1.20053541527617e-108	RPL3	NK cells	GSE169246_PacAteBlood_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52881
2.33976754017041e-103	0.271172420336721	0.999	0.999	4.53259767881811e-99	HLA-A	NK cells	GSE169246_PacAteBlood_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52882
3.43968848510359e-100	0.462857454430902	0.373	0.174	6.66336453334268e-96	CD69	NK cells	GSE169246_PacAteBlood_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52883
3.71039865454516e-99	0.36095561172576	0.468	0.254	7.18778427358489e-95	CYTIP	NK cells	GSE169246_PacAteBlood_pre	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52884
4.73559466961885e-96	0.512312216036648	0.724	0.547	9.17379399398564e-92	ZFP36L2	NK cells	GSE169246_PacAteBlood_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52885
1.18689966857442e-89	0.496622425416608	0.954	0.92	2.29926203796237e-85	TXNIP	NK cells	GSE169246_PacAteBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52886
1.89985925373449e-89	0.377353516505377	0.89	0.78	3.68040734633445e-85	SRGN	NK cells	GSE169246_PacAteBlood_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52887
2.14164250535407e-85	0.296234003705146	1	1	4.1487898613719e-81	EEF1A1	NK cells	GSE169246_PacAteBlood_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52888
1.49406120951857e-82	0.32759382598035	0.5	0.291	2.89429537507937e-78	ALOX5AP	NK cells	GSE169246_PacAteBlood_pre	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52889
1.70215964148611e-80	0.429708841444136	0.335	0.164	3.29742365748689e-76	MAP3K8	NK cells	GSE169246_PacAteBlood_pre	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52890
1.79754565840498e-71	0.374970806447137	0.307	0.145	3.48220544946212e-67	NFKBIA	NK cells	GSE169246_PacAteBlood_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52891
3.83061610812037e-70	0.295531675195434	0.549	0.356	7.42066952465077e-66	TCF25	NK cells	GSE169246_PacAteBlood_pre	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52892
9.11322631993674e-70	0.419006259153764	0.692	0.517	1.76541420269814e-65	CLIC3	NK cells	GSE169246_PacAteBlood_pre	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52893
2.25038449747024e-67	0.286764335411515	0.396	0.222	4.35944484849934e-63	PIK3R1	NK cells	GSE169246_PacAteBlood_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52894
3.03921141157898e-65	0.437769771614206	0.901	0.855	5.8875603465108e-61	H3F3B	NK cells	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52895
9.47668258679777e-65	0.267542477268765	0.482	0.303	1.83582295071447e-60	YPEL3	NK cells	GSE169246_PacAteBlood_pre	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52896
2.008002440487e-62	0.303695316609353	0.719	0.554	3.88990232771142e-58	EFHD2	NK cells	GSE169246_PacAteBlood_pre	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52897
2.96587722462704e-61	0.808209756187083	0.366	0.23	5.7454973595475e-57	JUNB	NK cells	GSE169246_PacAteBlood_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52898
2.32895167292288e-60	0.250978324705466	0.894	0.803	4.51164518078621e-56	RPL27A	NK cells	GSE169246_PacAteBlood_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52899
2.44418642234984e-60	0.252641002344985	0.389	0.221	4.73487793737611e-56	SYTL3	NK cells	GSE169246_PacAteBlood_pre	ENSG00000164674	94120	synaptotagmin like 3	exophilin-6|SLP3	protein_coding	Q4VX76	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52900
1.55417100234845e-57	-0.259398282728869	0.153	0.281	3.01074006574943e-53	HLA-DRB5	NK cells	GSE169246_PacAteBlood_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52901
2.96473203648987e-54	0.252188140457857	0.545	0.376	5.74327890108818e-50	APMAP	NK cells	GSE169246_PacAteBlood_pre	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52902
7.27229953410425e-50	0.260947383088257	0.564	0.403	1.40878986574668e-45	ID2	NK cells	GSE169246_PacAteBlood_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52903
1.323232959019e-47	0.252693987783919	0.476	0.325	2.56336688821161e-43	SRSF5	NK cells	GSE169246_PacAteBlood_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52904
5.18140735190865e-47	0.251978733167767	0.662	0.475	1.00374223221174e-42	SPON2	NK cells	GSE169246_PacAteBlood_pre	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52905
5.4117767890531e-47	0.271877827208676	0.773	0.618	1.04836939957537e-42	KLRB1	NK cells	GSE169246_PacAteBlood_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52906
1.82355677308301e-45	0.291635558919512	0.258	0.139	3.53259418081641e-41	TUBA4A	NK cells	GSE169246_PacAteBlood_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52907
1.27103567953812e-44	-0.304199933465713	0.735	0.836	2.46225031840125e-40	CRIP1	NK cells	GSE169246_PacAteBlood_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52908
9.48734585225488e-44	0.264757343198781	0.762	0.66	1.83788863849881e-39	PNRC1	NK cells	GSE169246_PacAteBlood_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52909
2.91210130589781e-41	0.256567446048846	0.746	0.641	5.64132264978523e-37	HNRNPA1	NK cells	GSE169246_PacAteBlood_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52910
5.25071525467626e-30	0.294832548468319	0.344	0.235	1.01716855913588e-25	ZFP36	NK cells	GSE169246_PacAteBlood_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52911
1.05265548038552e-09	0.279695364407039	0.998	1	2.03920419660283e-05	HLA-C	NK cells	GSE169246_PacAteBlood_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52912
6.05187015590782e-195	0.51787736033857	0.99	0.956	1.17236828660246e-190	MT-ND4L	B cells	GSE169246_PacAteBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52913
1.2896432991706e-191	0.383827160115534	1	1	2.49829699915329e-187	EEF1A1	B cells	GSE169246_PacAteBlood_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52914
2.03885524498474e-186	0.478131888834652	0.989	0.951	3.94967038058444e-182	PTMA	B cells	GSE169246_PacAteBlood_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52915
8.54722367187277e-167	0.892810670553537	0.862	0.745	1.65576816971519e-162	TXNIP	B cells	GSE169246_PacAteBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52916
4.00534321550622e-165	0.905026508235945	0.86	0.787	7.75915087707865e-161	RPS26	B cells	GSE169246_PacAteBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52917
5.9406864810315e-150	0.716527644659994	0.868	0.745	1.15082978510542e-145	BTG1	B cells	GSE169246_PacAteBlood_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52918
4.9741838948103e-143	0.366916535907677	0.999	0.994	9.63598904102651e-139	RPL3	B cells	GSE169246_PacAteBlood_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52919
2.38525160874889e-137	0.727735015186974	0.513	0.265	4.62070941646835e-133	CXCR4	B cells	GSE169246_PacAteBlood_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52920
1.21364208962143e-99	0.381563740883841	0.708	0.494	2.35106745601463e-95	NPM1	B cells	GSE169246_PacAteBlood_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52921
1.23459776286089e-87	0.360285983439434	0.43	0.225	2.39166278621412e-83	SMAP2	B cells	GSE169246_PacAteBlood_pre	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52922
2.86119497225816e-87	0.542489209823643	0.517	0.322	5.5427069002585e-83	TSC22D3	B cells	GSE169246_PacAteBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52923
1.06867807162519e-86	0.374704778938221	0.986	0.974	2.07024316035233e-82	MT-ATP6	B cells	GSE169246_PacAteBlood_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52924
4.61769109010739e-80	0.316467827255734	0.899	0.813	8.94539117975604e-76	EEF1G	B cells	GSE169246_PacAteBlood_pre	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52925
8.07252047664526e-80	0.359124182968233	0.723	0.548	1.56380866673572e-75	HNRNPA1	B cells	GSE169246_PacAteBlood_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52926
4.88197879631557e-74	0.399954721541127	0.513	0.322	9.45736932422252e-70	ZFP36L2	B cells	GSE169246_PacAteBlood_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52927
5.3594102776953e-74	-0.261870764496761	1	1	1.03822495899513e-69	TMSB10	B cells	GSE169246_PacAteBlood_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52928
9.83518352586311e-73	0.321245666523526	0.674	0.485	1.9052717526302e-68	HSP90AB1	B cells	GSE169246_PacAteBlood_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52929
1.88035360412259e-67	0.388162742589586	0.754	0.628	3.64262100190627e-63	H3F3B	B cells	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52930
2.91549103353143e-62	0.254970882953956	0.44	0.257	5.64788923015709e-58	NCL	B cells	GSE169246_PacAteBlood_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52931
6.62466741811547e-62	0.251605365971774	0.971	0.928	1.28333057223733e-57	HLA-A	B cells	GSE169246_PacAteBlood_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52932
1.35161603379095e-59	0.257666840039083	0.581	0.397	2.61835058065982e-55	EIF3E	B cells	GSE169246_PacAteBlood_pre	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52933
9.46027376313918e-58	0.312747436797473	0.276	0.131	1.83264423339532e-53	YBX3	B cells	GSE169246_PacAteBlood_pre	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52934
1.71676102317731e-52	0.275415532805213	0.617	0.461	3.32570945409908e-48	FAM129C	B cells	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52935
1.16285199417267e-51	-0.286226684159054	0.837	0.902	2.2526768831113e-47	SH3BGRL3	B cells	GSE169246_PacAteBlood_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52936
2.54982274488528e-49	0.310788446810719	0.808	0.696	4.93951662139176e-45	RPL36A	B cells	GSE169246_PacAteBlood_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52937
2.4440559810007e-47	0.269733762242073	0.609	0.458	4.73462524639456e-43	ISG20	B cells	GSE169246_PacAteBlood_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52938
7.65714823863424e-40	0.293010457459245	0.361	0.231	1.48334275678823e-35	JCHAIN	B cells	GSE169246_PacAteBlood_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52939
1.97052652976796e-219	-0.557359295089245	1	1	3.81730399346649e-215	RPL39	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52940
5.58754418210987e-205	-0.69482188300763	0.991	1	1.08241905895832e-200	RPS27	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52941
2.38717217007665e-194	-0.553273588844286	0.986	0.998	4.62442992787249e-190	RPS21	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52942
2.88173908541165e-194	-0.516819221555325	1	1	5.58250495625944e-190	RPS28	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52943
7.7294958140376e-194	-0.531633769620543	0.998	1	1.49735792909536e-189	RPL30	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52944
1.00251283421366e-181	-0.475274528937435	1	1	1.9420678624387e-177	RPS12	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52945
1.92335950392699e-169	-0.455428522428384	1	1	3.72593203100737e-165	RPL34	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52946
7.76206320772079e-161	-0.562546999377493	0.995	0.998	1.50366688459967e-156	RPL41	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52947
4.37215238589213e-156	-0.744320311208534	0.055	0.374	8.46973360195023e-152	PPBP	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000163736	5473	pro-platelet basic protein	b-TG1|Beta-TG|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|NAP-2-L1|PBP|SCYB7|TGB|TGB1|THBGB1	protein_coding	P02775	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52948
1.32239502097359e-154	-0.466691038731521	0.997	0.999	2.56174363463004e-150	RPS15A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52949
1.37100439290793e-151	-0.603945335687008	0.874	0.99	2.65590970994123e-147	RPS29	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52950
5.24249022661511e-147	-0.48337322378499	0.998	1	1.01557520669988e-142	RPS13	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52951
2.04188155294423e-146	-0.469821252595376	0.999	1	3.95553294436357e-142	RPL10	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52952
3.03454814052897e-137	0.817614909996418	0.435	0.123	5.87852665783273e-133	CD163	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000177575	9332	CD163 molecule	M130|MM130|SCARI1	protein_coding	Q86VB7	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52953
1.49277229346206e-134	1.46087494401709	0.921	0.843	2.8917984868947e-130	S100A9	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52954
3.12898533440554e-131	0.614648980675629	0.707	0.413	6.0614703898104e-127	SLC11A1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000018280	6556	solute carrier family 11 member 1	LSH|NRAMP|NRAMP1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52955
6.20101632849944e-127	-0.39290171563686	1	0.999	1.20126088315691e-122	RPL37	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52956
1.42764373264044e-126	-0.560847096817611	0.784	0.936	2.76563143887107e-122	RPS5	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52957
6.94451551951346e-124	-0.39344630051809	0.998	1	1.34529154644015e-119	RPS23	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52958
2.19965795988248e-118	-0.391088269507226	1	1	4.26117739988434e-114	RPL11	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52959
2.8797699121444e-117	0.728342500988495	0.359	0.088	5.57869027380613e-113	FKBP5	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52960
2.12628311534236e-116	-0.730588586005778	0.999	1	4.11903565104123e-112	RPS19	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52961
8.90900434171289e-115	0.454768429233717	0.998	0.99	1.72585232107662e-110	HLA-B	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52962
2.8923327073754e-113	0.738624890853617	0.76	0.524	5.60302692072762e-109	CEBPD	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52963
9.8795054225868e-109	-0.374964404067951	0.996	0.999	1.91385779046351e-104	RPS27A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52964
4.51702239586435e-108	0.904402893069286	0.715	0.455	8.75037578526842e-104	VCAN	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52965
6.81255953569055e-108	-0.40621895257574	0.994	0.995	1.31972903325397e-103	RPL35A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52966
1.08227587157872e-106	-0.380659676899352	0.998	1	2.09658481842229e-102	RPL26	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52967
6.47380718850705e-106	-0.619717100104692	0.673	0.837	1.25410592855759e-101	OST4	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52968
8.36109743570931e-105	-0.356815552699745	0.998	1	1.61971179524561e-100	FAU	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52969
3.71773644827109e-103	-0.357869847276022	0.999	1	7.20199904759076e-99	RPS24	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52970
8.45720703472554e-103	-0.385493531758841	0.999	1	1.63833014676703e-98	RPS8	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52971
3.2007931851783e-102	0.858369817168627	0.335	0.088	6.20057655832741e-98	TNFAIP3	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52972
2.9447464355441e-98	-0.294457395250647	1	1	5.70456279493603e-94	RPL28	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52973
1.41190636821127e-97	0.461658570276312	0.329	0.083	2.73514501649888e-93	CXCR4	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52974
4.74501769465822e-96	-0.32214698822685	1	1	9.1920482780919e-92	RPL32	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52975
1.62358373878865e-94	-0.341028059812868	0.994	0.998	3.14520641878138e-90	ATP5F1E	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52976
5.86473780168379e-94	0.544734186854631	0.801	0.607	1.13611700694218e-89	GRN	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52977
1.65517249500451e-91	0.651074289675795	0.95	0.872	3.20640015732275e-87	NEAT1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52978
8.7364439099331e-91	-0.323694035351094	0.999	1	1.69242391423224e-86	RPS15	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52979
8.77858336689942e-90	1.69400894298899	0.583	0.348	1.70058716983576e-85	NFKBIA	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52980
1.25093345357892e-89	-0.333220659996734	0.997	1	2.42330828627308e-85	RPL18A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52981
2.19591145207557e-89	0.662396949231228	0.962	0.793	4.25391966496078e-85	LYZ	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52982
1.0410939420416e-87	-0.451339317899086	1	1	2.016807184523e-83	FTH1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52983
1.61602612482785e-85	0.527596717039732	0.991	0.989	3.1305658090165e-81	HLA-C	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52984
5.7588682175159e-83	1.30678365212272	0.831	0.71	1.11560795109718e-78	S100A8	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52985
6.9810962811934e-83	0.568473401789095	0.394	0.149	1.35237797159279e-78	LGALS2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52986
3.63777031385434e-81	0.471124356331813	0.62	0.376	7.04708865199863e-77	FPR1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000171051	2357	formyl peptide receptor 1	FMLP|FPR	protein_coding	P21462	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52987
7.03178848877189e-81	0.491931640162706	0.748	0.535	1.36219806604489e-76	APLP2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52988
2.83954860509224e-80	-0.36942117457934	0.989	0.996	5.50077355778468e-76	RPS7	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52989
1.22664523830046e-79	0.523129238240212	0.944	0.911	2.37625715563565e-75	FCN1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52990
1.34616049398309e-79	-0.488929391472193	0.415	0.669	2.60778210894405e-75	HLA-DQB1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52991
2.01925933322722e-77	-0.363417592008044	0.988	0.997	3.91170918032778e-73	RPS4X	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52992
2.59535249729144e-77	-0.320166922646645	1	0.998	5.02771685775297e-73	RPL19	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52993
4.31512920771919e-77	0.457614496645065	0.829	0.693	8.35926830119362e-73	VSIR	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000107738	64115	V-set immunoregulatory receptor	B7-H5|B7H5|C10orf54|Dies1|GI24|PD-1H|SISP1|VISTA	protein_coding	Q9H7M9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52994
3.04081830524515e-76	-0.374183174048608	0.938	0.981	5.89067322092091e-72	RPL21	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52995
4.92141790480136e-73	0.337175847824608	0.275	0.076	9.53377076518119e-69	ARL4A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52996
8.56840667063305e-73	-0.390577350451984	0.965	0.986	1.65987174023504e-68	NACA	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52997
2.1703241170718e-70	0.477055694998164	0.777	0.629	4.2043518795915e-66	ANXA2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52998
3.18681262217321e-70	0.525722913112173	0.401	0.181	6.17349341167394e-66	SELL	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	52999
8.05090090410621e-69	-0.313910902808028	0.999	0.999	1.55962052314346e-64	RPL8	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53000
1.00984588437802e-68	-0.603078384722483	0.134	0.347	1.9562734472171e-64	EGR1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53001
8.1404151631175e-68	0.330864578199405	0.323	0.115	1.57696122539912e-63	ACSL1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000151726	2180	acyl-CoA synthetase long chain family member 1	ACS1|FACL1|FACL2|LACS|LACS1|LACS2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53002
3.0994946436615e-67	0.392788148229961	0.286	0.091	6.00434102370105e-63	CLEC4E	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000166523	26253	C-type lectin domain family 4 member E	CLECSF9|MINCLE	protein_coding	Q9ULY5	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53003
3.13796078373431e-67	-0.302614092783361	0.996	0.998	6.07885763025011e-63	RPL36	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53004
4.24382808667739e-67	-0.393763417518882	0.668	0.831	8.22114376951143e-63	EEF1B2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53005
2.24414146399626e-66	0.381599314222678	0.399	0.177	4.34735084405356e-62	AC020656.1	Mono/Macro	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53006
2.62694554179784e-65	-0.389282269815921	0.762	0.866	5.08891890357077e-61	RPL36A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53007
3.25316443070716e-63	-0.271683882132995	0.999	0.999	6.30203013516591e-59	RPS14	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53008
6.91477192588548e-63	-0.3568386624771	0.797	0.901	1.33952961748253e-58	TMA7	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53009
8.34477628925348e-63	0.532805187205735	0.948	0.901	1.61655006275418e-58	MT-ND4L	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53010
3.40894716008149e-61	0.448239997428271	0.928	0.868	6.60381243850986e-57	S100A10	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53011
1.1499704705598e-60	0.409183920794027	0.402	0.191	2.22772279556845e-56	RBP7	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000162444	116362	retinol binding protein 7	CRBPIV	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53012
8.51579426517509e-60	-0.390691510342676	0.736	0.843	1.64967966504972e-55	UQCRB	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53013
4.56240944040397e-59	0.465077528560167	0.591	0.377	8.83829956795057e-55	CSF3R	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000119535	1441	colony stimulating factor 3 receptor	CD114|GCSFR	protein_coding	Q99062	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53014
5.66064025885835e-59	0.378609670413448	0.759	0.593	1.09657923094604e-54	LRRFIP1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53015
3.35824537971554e-57	0.401057253477354	0.992	0.99	6.50559294958495e-53	MT-CYB	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53016
3.13947342087451e-56	0.28811953037762	0.991	0.971	6.08178791091809e-52	HLA-A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53017
1.95648147574656e-55	-0.288555118879352	0.986	0.993	3.79009591481624e-51	RPS3A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53018
1.86660591548718e-54	0.796106640885448	0.542	0.332	3.61598897948177e-50	S100A12	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53019
2.24388198134312e-54	0.359382435657341	0.55	0.347	4.3468481742579e-50	IL17RA	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000177663	23765	interleukin 17 receptor A	CD217|CDw217|hIL-17R|IL-17RA|IL17R	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53020
3.49875044214689e-54	-0.310961931106805	0.948	0.977	6.77777935652696e-50	RPL23A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53021
3.97285194639331e-54	-0.388697208332382	0.507	0.679	7.69620879055311e-50	PSMB9	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53022
5.78794951677643e-54	-0.359232787738322	0.659	0.789	1.12124158038993e-49	COMMD6	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53023
1.12343033464045e-53	0.417970327550039	0.918	0.857	2.17630924426547e-49	SRGN	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53024
1.42637047566353e-53	-0.527167102239167	0.327	0.531	2.76316488545538e-49	HLA-DQA1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53025
6.87396112121181e-53	0.394062287200681	0.418	0.221	1.33162374840115e-48	PLBD1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000121316	79887	phospholipase B domain containing 1	FLJ22662	protein_coding	Q6P4A8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53026
1.26258459887973e-52	0.35740885941083	0.835	0.699	2.44587888494982e-48	TPM3	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53027
1.60597664010288e-52	0.567243874306065	0.621	0.446	3.11109794720729e-48	CD14	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53028
2.37852186587359e-51	0.324148140230761	0.979	0.957	4.60767255857031e-47	VIM	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53029
5.68174801086299e-50	-0.265338830531364	0.978	0.987	1.10066822466438e-45	PFDN5	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53030
8.21489992722149e-50	-0.324348248218867	0.899	0.95	1.59139041390135e-45	RPL10A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53031
8.45364020371362e-50	0.354650701361662	0.851	0.757	1.6376391802634e-45	UBC	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53032
2.78447762182301e-49	0.411240359161073	0.613	0.428	5.39409004899553e-45	CTSD	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53033
9.92632920460253e-49	0.358472201152128	0.257	0.096	1.9229284935156e-44	RETN	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53034
1.8787761271571e-48	-0.48808993239145	0.931	0.957	3.63956511352874e-44	LST1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53035
2.07868233866192e-48	-0.318188202173153	0.694	0.823	4.02682342645587e-44	TOMM7	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53036
3.71325791626115e-48	0.353676842804288	0.735	0.571	7.1933232353811e-44	CTSB	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53037
3.51546962335145e-47	0.258731234906209	0.993	0.992	6.81016775435643e-43	PTMA	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53038
6.83836487615345e-47	0.432952462368999	0.439	0.256	1.32472804380845e-42	ID2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53039
9.74832153236926e-47	0.34439693701121	0.477	0.281	1.88844484725057e-42	PLEC	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53040
2.99391254266832e-46	0.336390919461855	0.724	0.568	5.79980737765708e-42	HCLS1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53041
1.31723305983563e-45	-0.280434169338617	0.998	1	2.55174388351357e-41	TMSB4X	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53042
1.67182554979131e-45	0.35123787802256	0.735	0.585	3.23866045505573e-41	ZEB2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53043
1.80906977259278e-45	-0.283949862898569	0.97	0.99	3.50452996346673e-41	EIF1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53044
1.88373110388234e-45	-0.330725980980123	0.181	0.361	3.64916389444087e-41	CX3CR1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000168329	1524	C-X3-C motif chemokine receptor 1	CCRL1|CMKBRL1|CMKDR1|GPR13|V28	protein_coding	P49238	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53045
4.11766546323725e-45	-0.374919143429382	0.995	0.995	7.97674153538319e-41	MT-ND2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53046
1.72899549703136e-44	0.680278239932052	0.274	0.123	3.34941007684916e-40	GADD45B	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53047
2.49829932027009e-44	-0.341264640758422	0.947	0.967	4.83970544322721e-40	RPLP0	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53048
3.03712450934179e-43	0.255068938041829	0.314	0.147	5.88351759949691e-39	ETS2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53049
4.04846235197948e-43	0.431498188679036	0.419	0.258	7.84268126825464e-39	NUDT16	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000198585	131870	nudix hydrolase 16	FLJ31265	protein_coding	Q96DE0	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53050
8.78217460459525e-42	-0.399295610813026	0.501	0.677	1.70128286440219e-37	MS4A7	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53051
1.87783472872923e-41	0.339544205853181	0.46	0.292	3.63774143649425e-37	IFNGR1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53052
1.05275717278049e-40	0.295219366346828	0.708	0.556	2.03940119511037e-36	ENO1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53053
3.3779715951409e-40	-0.402307900827995	0.641	0.736	6.54380657410694e-36	IFI30	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53054
8.84525976657913e-40	0.263778913173955	0.344	0.179	1.71350372198171e-35	UPP1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53055
8.85826851908618e-40	0.266633687741143	0.916	0.843	1.71602377751737e-35	LAPTM5	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53056
1.1840245234991e-39	0.291073627309632	0.464	0.28	2.29369230692246e-35	CAPG	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53057
1.62622076793887e-39	0.313627273246225	0.385	0.218	3.15031487165118e-35	HMGB2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53058
2.69157258918106e-39	0.336364555556566	0.52	0.347	5.21411441976155e-35	KCTD12	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000178695	115207	potassium channel tetramerization domain containing 12	C13orf2|KIAA1778|PFET1	protein_coding	Q96CX2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53059
4.03212796953041e-39	-0.268950505754832	0.977	0.982	7.81103830257432e-35	RPL22	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53060
5.23814641955942e-39	0.295570386005392	1	0.998	1.01473372439705e-34	MALAT1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53061
6.53415393097952e-39	-0.294715939410889	0.495	0.646	1.26579629950935e-34	COX7A2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53062
1.41775386882948e-38	0.285289400027608	0.791	0.666	2.74647279469647e-34	FGR	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53063
2.77243431783778e-38	-0.269866886670199	0.985	0.993	5.37075976051535e-34	RPS3	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53064
3.285998707784e-38	-0.323518435468436	0.341	0.57	6.36563669671917e-34	FCGR3A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53065
3.72900977478606e-38	0.341852502344309	0.534	0.378	7.22383773571556e-34	SMAP2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53066
7.1297571938256e-38	-0.299266628293779	0.383	0.561	1.38117656358789e-33	HSPA8	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53067
8.27052848437855e-38	-0.324546864024561	0.486	0.638	1.60216677799381e-33	UCP2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53068
1.6134798262095e-37	0.537330549426982	0.271	0.131	3.12563311933304e-33	IER3	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53069
1.89825401578451e-37	0.293710719786071	0.673	0.517	3.67729767937776e-33	MYO1F	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53070
4.95702718805351e-37	-0.255270689913282	1	1	9.60275306869726e-33	FTL	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53071
8.02588257209032e-37	0.270874536187546	0.91	0.854	1.55477397186534e-32	TSPO	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53072
8.05727064713871e-37	0.275535768306674	0.519	0.344	1.56085446976371e-32	PGD	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000142657	5226	phosphogluconate dehydrogenase	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53073
1.00509943218957e-36	0.274907450698951	0.37	0.21	1.94707862003764e-32	SPTLC2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000100596	9517	serine palmitoyltransferase long chain base subunit 2	hLCB2a|KIAA0526|LCB2|LCB2A	protein_coding	O15270	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53074
1.64730148825664e-36	0.303950690461787	0.76	0.65	3.19115244305076e-32	ANXA5	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53075
6.446525147854e-36	0.274000668757219	0.714	0.565	1.24882085164228e-31	FCGRT	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53076
1.3735179542291e-35	0.265655193948103	0.333	0.178	2.66077898093261e-31	ITGAM	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000169896	3684	integrin subunit alpha M	CD11B|CR3A|MAC-1	protein_coding	P11215	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53077
2.38263157131645e-34	0.301239932192492	0.522	0.368	4.61563387995423e-30	CELF2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53078
9.50458682627948e-34	0.25577512323509	0.62	0.465	1.84122855998686e-29	H2AFY	Mono/Macro	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53079
1.03631610980319e-33	-0.257474116867281	0.139	0.283	2.00755156791074e-29	GBP1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53080
1.46567862126958e-33	0.336126416507836	0.895	0.844	2.83931262512343e-29	TXNIP	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53081
5.56656461354086e-33	0.326210687673082	0.643	0.494	1.07835489693514e-28	MS4A6A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000110077	64231	membrane spanning 4-domains A6A	CD20L3|MS4A6	protein_coding	Q9H2W1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53082
2.14941759531697e-32	-0.283149180944876	0.286	0.438	4.16385176564804e-28	RGS18	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000150681	64407	regulator of G protein signaling 18	RGS13	protein_coding	Q9NS28	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53083
2.88290901616551e-32	-0.325305684891391	0.572	0.696	5.58477134611583e-28	NAP1L1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53084
4.87369929386798e-32	0.276116529633294	0.68	0.545	9.44133027208105e-28	PKM	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53085
1.16162963507818e-31	0.387484578013776	0.742	0.632	2.25030892907345e-27	AHNAK	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53086
2.89733621996575e-31	0.25642656906132	0.665	0.528	5.61271972531766e-27	NCF2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000116701	4688	neutrophil cytosolic factor 2	NOXA2|p67phox	protein_coding	P19878	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53087
4.00817049740285e-31	0.254298899047312	0.825	0.716	7.7646278875688e-27	TKT	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53088
1.70946528841366e-30	0.268360141969219	0.441	0.285	3.31157615671495e-26	CD36	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000135218	948	CD36 molecule	FAT|GP3B|GP4|GPIV|SCARB3	protein_coding	P16671	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53089
2.09026405957673e-30	0.27035589915498	0.92	0.88	4.04925953621205e-26	ITM2B	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53090
2.4400839175941e-30	0.254209720769251	0.497	0.341	4.7269305651633e-26	USP15	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53091
6.66488921807008e-30	-0.253199350912146	0.496	0.637	1.29112233932454e-25	NDUFA3	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53092
1.30506568746519e-29	0.293403496494988	0.455	0.316	2.52817324975757e-25	GLUL	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53093
1.88798438639524e-29	-0.372101054766593	0.734	0.823	3.65740335332485e-25	CD52	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53094
3.29865961987705e-29	0.253403983783672	0.659	0.514	6.39016341562582e-25	CLEC12A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53095
1.4979823859029e-28	-0.320147124010335	0.694	0.798	2.90189147797111e-24	HLA-DPB1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53096
1.81424718401296e-28	0.285985321244561	0.547	0.404	3.51455964486991e-24	MYH9	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53097
3.32120059993465e-28	0.28952377575361	0.881	0.848	6.4338298021934e-24	SPI1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53098
5.57521679868535e-27	-0.261227756264794	0.545	0.656	1.08003099824133e-22	COX6C	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53099
7.08141729323376e-27	-0.356753941130389	0.322	0.455	1.37181215804524e-22	PLAC8	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53100
1.40312813456771e-26	-0.268230069430751	0.271	0.42	2.71813982228458e-22	IFITM1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53101
1.6404949750391e-26	0.263147922833182	0.443	0.305	3.17796686564575e-22	CDC42EP3	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53102
2.97315763766304e-26	0.253146547791484	1	1	5.75960097568085e-22	MT-CO1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53103
1.47188911846997e-25	0.297319215683234	0.463	0.331	2.85134360030002e-21	SQSTM1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53104
1.83410450503665e-25	0.313136607714025	0.512	0.383	3.553027247157e-21	IFI6	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53105
2.77289254639971e-25	0.259025664518966	0.562	0.434	5.37164744088552e-21	LRP1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000123384	4035	LDL receptor related protein 1	A2MR|APOER|APR|CD91|IGFBP-3R|IGFBP3R1|LRP|LRP1A	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53106
6.61199935255003e-25	0.266903535086829	0.562	0.433	1.28087651457599e-20	SERPINB1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53107
2.49398491192821e-24	0.484912330968193	0.334	0.224	4.83134757138733e-20	PPP1R15A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53108
2.77048548094385e-24	0.255948498172935	0.438	0.307	5.36698447368443e-20	GCA	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000115271	25801	grancalcin	GCL	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53109
1.02177236460123e-22	0.291292466658955	0.641	0.536	1.97937742470551e-18	PNRC1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53110
9.84454246078306e-21	0.324544763419672	0.526	0.421	1.90708476550289e-16	PLEK	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53111
3.28114398262155e-19	0.321919235311149	0.694	0.568	6.35623212313446e-15	DUSP1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53112
3.47384595040872e-19	0.270123119196707	0.512	0.409	6.72953437513177e-15	TSC22D3	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53113
5.91412300978235e-19	0.258847765765398	0.532	0.427	1.14568390945504e-14	MAFB	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000204103	9935	MAF bZIP transcription factor B	KRML	protein_coding	Q9Y5Q3	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53114
9.79058993883285e-19	-0.273062124695866	0.293	0.408	1.8966330829507e-14	APOBEC3A	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000262156	200315	apolipoprotein B mRNA editing enzyme catalytic subunit 3A	ARP3|PHRBN	protein_coding	P31941	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53115
1.41760706857772e-17	0.298464514523958	0.473	0.381	2.74618841324876e-13	NAMPT	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53116
1.98781702657543e-17	0.313098606399577	0.414	0.316	3.85079914388193e-13	PLAUR	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53117
1.34343698874378e-15	-0.368632411983285	0.465	0.544	2.60250613459446e-11	IER2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53118
1.77370823925226e-15	0.282994320379762	0.89	0.861	3.43602760107948e-11	SERPINA1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53119
1.82287339682252e-15	-0.423827589487478	0.897	0.916	3.53127034432458e-11	RPS26	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53120
1.32506753972774e-14	0.382940632721016	0.472	0.411	2.56692083796058e-10	NFKBIZ	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53121
1.76384821414702e-12	0.306552882069755	0.55	0.492	3.41692676044561e-08	TNFAIP2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53122
1.76657998745607e-11	-0.250458589366941	0.593	0.642	3.4222187516999e-07	SMIM25	Mono/Macro	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53123
3.89781214940555e-11	0.298665687060971	0.945	0.95	7.55084169582843e-07	SAT1	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53124
4.0259649347505e-10	-0.26454237186898	0.857	0.849	7.79909927159868e-06	IFITM2	Mono/Macro	GSE169246_PacAteBlood_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53125
1.9881103743902e-09	-0.730878264287291	0.023	0.333	3.85136741726869e-05	PPBP	Plasma cells	GSE169246_PacAteBlood_pre	ENSG00000163736	5473	pro-platelet basic protein	b-TG1|Beta-TG|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|NAP-2-L1|PBP|SCYB7|TGB|TGB1|THBGB1	protein_coding	P02775	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53126
4.96827491490334e-08	-0.565894004115249	0.209	0.596	0.000962454216515076	FXYD5	Plasma cells	GSE169246_PacAteBlood_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53127
1.87451677266959e-06	-0.664357892286033	0.837	0.86	0.0363131389201552	OST4	Plasma cells	GSE169246_PacAteBlood_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53128
5.15109990827038e-63	-0.964495074456702	1	1	9.97871074230138e-59	RPL41	cDCs	GSE169246_PacAteBlood_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53129
7.75119413939972e-61	-0.92348793788689	1	1	1.50156132868451e-56	RPL39	cDCs	GSE169246_PacAteBlood_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53130
4.00305801739715e-54	1.23273578124448	0.983	0.463	7.75472399130176e-50	HLA-DRB5	cDCs	GSE169246_PacAteBlood_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53131
9.94548169480404e-48	-1.09787872736623	0.928	0.981	1.92663871391744e-43	MT-ND2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53132
1.21024519465061e-47	0.90332320513692	1	0.901	2.34448699107716e-43	HLA-B	cDCs	GSE169246_PacAteBlood_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53133
8.15445915505947e-46	0.838971737951755	0.983	0.907	1.57968182751812e-41	RPS26	cDCs	GSE169246_PacAteBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53134
1.89327370505859e-45	-0.869109956391328	0.919	0.998	3.6676498214395e-41	RPS29	cDCs	GSE169246_PacAteBlood_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53135
3.55571617461712e-43	-0.554114859655364	1	1	6.88813337346829e-39	RPL34	cDCs	GSE169246_PacAteBlood_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53136
6.98844078406487e-43	-0.652907890456539	1	1	1.35380074868905e-38	RPS27	cDCs	GSE169246_PacAteBlood_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53137
1.30555766025229e-42	-0.606568278179034	1	1	2.52912629944073e-38	RPS21	cDCs	GSE169246_PacAteBlood_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53138
3.55031683315035e-42	-0.561436380699906	1	1	6.87767376917885e-38	RPS28	cDCs	GSE169246_PacAteBlood_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53139
1.50493882753601e-41	-0.816076716663069	0.009	0.541	2.91536749670277e-37	PPBP	cDCs	GSE169246_PacAteBlood_pre	ENSG00000163736	5473	pro-platelet basic protein	b-TG1|Beta-TG|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|NAP-2-L1|PBP|SCYB7|TGB|TGB1|THBGB1	protein_coding	P02775	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53140
2.84480381035004e-41	0.643691162232548	0.991	0.965	5.5109539414101e-37	RPL3	cDCs	GSE169246_PacAteBlood_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53141
4.41680348494764e-40	-0.518709898205131	1	1	8.55623171104056e-36	B2M	cDCs	GSE169246_PacAteBlood_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53142
1.48706751474855e-39	-0.597556982822398	0.991	0.998	2.8807471895709e-35	ATP5F1E	cDCs	GSE169246_PacAteBlood_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53143
4.24596768757631e-37	0.741078173182682	0.885	0.49	8.22528860437283e-33	UBC	cDCs	GSE169246_PacAteBlood_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53144
3.32658407044123e-34	0.672462366216322	0.936	0.723	6.44425866125874e-30	EEF2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53145
4.98998834033813e-34	-0.469361014810606	1	1	9.66660541290302e-30	RPL30	cDCs	GSE169246_PacAteBlood_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53146
7.93872395838201e-34	-0.75966980996252	0.677	0.901	1.53788960521776e-29	OST4	cDCs	GSE169246_PacAteBlood_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53147
6.70647736931241e-33	0.791997647818733	0.911	0.661	1.2991787959832e-28	ANXA2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53148
8.52838015509985e-32	0.649863343046658	0.902	0.601	1.65211780364594e-27	LAPTM5	cDCs	GSE169246_PacAteBlood_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53149
1.49646901951322e-30	0.614826787779901	0.957	0.808	2.898959784601e-26	SPI1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53150
2.25314927216266e-29	-0.667446747141108	0.991	0.998	4.36480077003351e-25	MT-ND4	cDCs	GSE169246_PacAteBlood_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53151
2.99773994616722e-29	0.621474822764007	0.962	0.847	5.80722182371514e-25	LSP1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53152
2.99836046597401e-29	-0.418468815650345	1	1	5.80842389468484e-25	RPS13	cDCs	GSE169246_PacAteBlood_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53153
4.25877825816811e-29	0.783237938356877	0.962	0.924	8.25010524172326e-25	MT-ND4L	cDCs	GSE169246_PacAteBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53154
8.34530001123932e-29	-0.457824169439693	1	0.998	1.61665151817728e-24	RPL36	cDCs	GSE169246_PacAteBlood_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53155
9.38459327712743e-29	-0.354852565451686	1	1	1.81798340964512e-24	RPL28	cDCs	GSE169246_PacAteBlood_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53156
3.02799907946226e-28	0.63947796879311	0.404	0.079	5.86583981673429e-24	DDIT4	cDCs	GSE169246_PacAteBlood_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53157
8.67544348485761e-28	0.730937635675225	0.987	0.963	1.68060691188662e-23	VIM	cDCs	GSE169246_PacAteBlood_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53158
1.3955496937074e-27	0.79504912804587	1	0.969	2.70345886664998e-23	LYZ	cDCs	GSE169246_PacAteBlood_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53159
1.79088881803026e-27	-0.389267777794232	1	1	3.46930981828822e-23	RPL37	cDCs	GSE169246_PacAteBlood_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53160
2.00615419462992e-27	0.776468514582809	0.855	0.556	3.88632190583708e-23	LGALS2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53161
2.1930787522305e-27	-0.409410361686195	1	0.996	4.24843215882092e-23	RPL35A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53162
5.74367186195886e-27	0.595228703472283	0.945	0.758	1.11266411309867e-22	CORO1A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53163
9.9150340854092e-27	-0.416046681228356	1	1	1.92074040302547e-22	RPS19	cDCs	GSE169246_PacAteBlood_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53164
8.10956732140271e-26	-0.371354794325027	1	1	1.57098538150213e-21	RPS12	cDCs	GSE169246_PacAteBlood_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53165
1.40896388291026e-25	0.588373447035939	0.915	0.793	2.72944483397375e-21	GRN	cDCs	GSE169246_PacAteBlood_pre	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53166
6.28216725275689e-25	0.587691881110699	0.991	0.992	1.21698144020406e-20	MT-CYB	cDCs	GSE169246_PacAteBlood_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53167
9.39937478676031e-24	0.51729828181992	0.928	0.754	1.82084688369121e-19	ANXA5	cDCs	GSE169246_PacAteBlood_pre	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53168
1.39865663468815e-23	0.66684590130513	0.945	0.744	2.70947763271787e-19	PSAP	cDCs	GSE169246_PacAteBlood_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53169
9.74968903594275e-23	-0.348206350003057	1	1	1.88870976004283e-18	RPS15A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53170
1.25037958169805e-22	-0.540854740643808	1	1	2.42223532566547e-18	MT-ND3	cDCs	GSE169246_PacAteBlood_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53171
1.34167742696696e-22	0.584513226297775	0.498	0.172	2.59909751152039e-18	MAP3K8	cDCs	GSE169246_PacAteBlood_pre	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53172
2.91722487093257e-22	0.539694143473175	0.804	0.484	5.65124801997057e-18	PKM	cDCs	GSE169246_PacAteBlood_pre	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53173
8.16874614383151e-22	0.672560213741291	0.804	0.486	1.58244950298304e-17	AHNAK	cDCs	GSE169246_PacAteBlood_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53174
1.18398694657529e-21	0.374346062286214	1	1	2.29361951290565e-17	EEF1A1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53175
1.72183180224124e-21	0.539061129339851	0.74	0.421	3.33553256730174e-17	TKT	cDCs	GSE169246_PacAteBlood_pre	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53176
2.36824731111786e-21	-0.329442497671339	1	1	4.58776869109751e-17	RPL10	cDCs	GSE169246_PacAteBlood_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53177
3.34398348238237e-21	-0.450252191862902	0.013	0.326	6.47796480207113e-17	MAP3K7CL	cDCs	GSE169246_PacAteBlood_pre	ENSG00000156265	56911	MAP3K7 C-terminal like	C21orf7|TAK1L|TAKL|TAKL-1|TAKL-2|TAKL-4	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53178
1.27266681557953e-20	-0.506231863922066	0.366	0.705	2.46541015514066e-16	NDUFA3	cDCs	GSE169246_PacAteBlood_pre	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53179
3.68018360510925e-20	0.308762713904121	1	1	7.12925167981765e-16	RPS2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53180
4.04844696229416e-20	-0.268720570772606	1	1	7.84265145535625e-16	RPS24	cDCs	GSE169246_PacAteBlood_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53181
6.11211019619027e-20	0.548917480033091	0.745	0.461	1.18403798720598e-15	CAPG	cDCs	GSE169246_PacAteBlood_pre	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53182
6.34344249848381e-20	0.459370781533752	0.97	0.874	1.22885168080628e-15	SLC25A6	cDCs	GSE169246_PacAteBlood_pre	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53183
6.5404772756512e-20	0.468484646593725	0.796	0.488	1.26702125783915e-15	LRRFIP1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53184
1.63111218593403e-19	0.406156954508248	0.928	0.748	3.15979052659141e-15	YWHAB	cDCs	GSE169246_PacAteBlood_pre	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53185
1.88674445593294e-19	0.413024511183035	1	0.963	3.65500136003329e-15	RPL13A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53186
3.22458156082835e-19	-0.263381891635518	1	1	6.24665939963669e-15	RPL32	cDCs	GSE169246_PacAteBlood_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53187
3.6507194609664e-19	-0.496706140617536	0.991	0.998	7.07217373978411e-15	HLA-DQA1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53188
4.54262481799525e-19	-0.487425135051409	0.877	0.926	8.79997279742041e-15	RPL36A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53189
5.48446983113152e-19	0.524879265058438	0.834	0.622	1.0624514956868e-14	CFP	cDCs	GSE169246_PacAteBlood_pre	ENSG00000126759	5199	complement factor properdin	PFC	protein_coding	P27918	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53190
2.37642218728071e-18	0.497892088502663	0.838	0.622	4.6036050612002e-14	HNRNPA2B1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53191
9.45627951546363e-18	0.509946800079123	0.991	0.984	1.83187046773561e-13	ACTG1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53192
1.19467214828381e-17	-0.375613390970146	0.009	0.275	2.3143188856554e-13	PF4	cDCs	GSE169246_PacAteBlood_pre	ENSG00000163737	5196	platelet factor 4	CXCL4|SCYB4	protein_coding	P02776	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53193
1.20475243995162e-17	0.411006614100971	0.698	0.399	2.33384642667428e-13	SMDT1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53194
1.21684345878161e-17	0.394323977959883	0.323	0.081	2.35726914835174e-13	HLA-DQA2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53195
1.37113058677126e-17	0.454385952014238	0.511	0.219	2.65615417269328e-13	CSF3R	cDCs	GSE169246_PacAteBlood_pre	ENSG00000119535	1441	colony stimulating factor 3 receptor	CD114|GCSFR	protein_coding	Q99062	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53196
1.8584980426489e-17	0.438012570366793	0.894	0.678	3.60028240821944e-13	TPM3	cDCs	GSE169246_PacAteBlood_pre	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53197
3.05123859719938e-17	0.481441794746189	0.881	0.665	5.91085941049463e-13	TSPO	cDCs	GSE169246_PacAteBlood_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53198
4.33670009522391e-17	0.46466630724733	0.549	0.252	8.40105542446777e-13	SELL	cDCs	GSE169246_PacAteBlood_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53199
4.70604169184768e-17	-0.419809870851315	0.953	0.986	9.11654396544732e-13	RPL38	cDCs	GSE169246_PacAteBlood_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53200
4.98095925130052e-17	0.454277844111986	0.643	0.351	9.64911426161938e-13	PLD4	cDCs	GSE169246_PacAteBlood_pre	ENSG00000166428	122618	phospholipase D family member 4	C14orf175	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53201
5.13492700165819e-17	0.4522694342435	0.826	0.576	9.94738058761224e-13	H2AFY	cDCs	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53202
6.63425071645615e-17	0.482123375300337	0.723	0.457	1.28518704879189e-12	ALDH2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000111275	217	aldehyde dehydrogenase 2 family member	NA	protein_coding	P05091	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53203
7.5590376985666e-17	0.325624498721534	1	0.921	1.46433678296632e-12	PABPC1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53204
8.03860279123924e-17	-0.269553665417386	1	1	1.55723813271886e-12	RPS27A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53205
1.19493731166466e-16	0.452485053031594	0.843	0.607	2.31483256015678e-12	EIF3L	cDCs	GSE169246_PacAteBlood_pre	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53206
1.21574120889885e-16	-0.745750992943207	0.651	0.853	2.35513386987886e-12	IFITM3	cDCs	GSE169246_PacAteBlood_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53207
1.72245688255504e-16	0.454799404081835	0.706	0.426	3.33674347288562e-12	VSIR	cDCs	GSE169246_PacAteBlood_pre	ENSG00000107738	64115	V-set immunoregulatory receptor	B7-H5|B7H5|C10orf54|Dies1|GI24|PD-1H|SISP1|VISTA	protein_coding	Q9H7M9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53208
1.81986961945541e-16	0.428323920877435	0.97	0.967	3.52545142680903e-12	COTL1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53209
2.0841612392269e-16	0.553984801023569	0.915	0.826	4.03743715263035e-12	CPVL	cDCs	GSE169246_PacAteBlood_pre	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53210
2.12626913865085e-16	0.748803031147248	0.77	0.595	4.11900857539442e-12	FCER1A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000179639	2205	Fc epsilon receptor Ia	FCE1A|FcepsilonRIalpha|FCERIA	protein_coding	P12319	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53211
2.33212077636974e-16	0.390295908916921	0.63	0.324	4.51778436798345e-12	FGR	cDCs	GSE169246_PacAteBlood_pre	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53212
3.05821617566864e-16	-0.27496722439944	1	1	5.92437637550528e-12	FAU	cDCs	GSE169246_PacAteBlood_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53213
4.22818694595459e-16	0.363308800164734	0.974	0.924	8.19084375170323e-12	RPL4	cDCs	GSE169246_PacAteBlood_pre	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53214
4.5876236046061e-16	-0.449354714359067	0.8	0.868	8.88714444684293e-12	COMMD6	cDCs	GSE169246_PacAteBlood_pre	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53215
5.0758679732123e-16	0.587222513555761	0.668	0.384	9.83297143770687e-12	JUNB	cDCs	GSE169246_PacAteBlood_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53216
6.01049459393244e-16	0.369409367704587	0.923	0.785	1.16435301273659e-11	ARHGDIB	cDCs	GSE169246_PacAteBlood_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53217
8.51931303709393e-16	-0.383672109905134	0.911	0.953	1.65036132154584e-11	TMA7	cDCs	GSE169246_PacAteBlood_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53218
9.73704447536842e-16	0.450052110733667	0.809	0.589	1.88626025576837e-11	ENO1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53219
1.04497096979588e-15	0.425671151143786	0.906	0.731	2.02431776268857e-11	HNRNPA1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53220
1.08609178316053e-15	0.280297340085358	1	0.996	2.10397700233857e-11	RACK1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53221
2.33693060381482e-15	0.41061451494309	0.809	0.554	4.52710196571006e-11	RNASET2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53222
3.78816939814798e-15	0.49131797620744	0.983	0.903	7.33844175809228e-11	S100A10	cDCs	GSE169246_PacAteBlood_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53223
4.66717105182149e-15	0.404494784782229	0.826	0.558	9.04124376158858e-11	ATP5F1B	cDCs	GSE169246_PacAteBlood_pre	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53224
6.43801497124729e-15	0.437273078878686	0.685	0.44	1.24717226023003e-10	GSN	cDCs	GSE169246_PacAteBlood_pre	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53225
7.07553863275687e-15	0.534029574390168	0.417	0.165	1.37067334393766e-10	DUSP1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53226
8.71695196239778e-15	0.587482754016969	0.953	0.938	1.6886479341557e-10	HLA-C	cDCs	GSE169246_PacAteBlood_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53227
1.12511856248713e-14	-0.258414121015486	1	1	2.17957967925007e-10	RPL26	cDCs	GSE169246_PacAteBlood_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53228
1.69988506478501e-14	0.434943332646298	0.689	0.419	3.29301734750152e-10	ZYX	cDCs	GSE169246_PacAteBlood_pre	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53229
3.73941019256083e-14	0.392206531150618	0.579	0.304	7.24398542502885e-10	STK17B	cDCs	GSE169246_PacAteBlood_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53230
6.29450412662557e-14	0.337148123819057	0.46	0.2	1.21937133940991e-09	ODF3B	cDCs	GSE169246_PacAteBlood_pre	ENSG00000177989	440836	outer dense fiber of sperm tails 3B	FAP123	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53231
6.75474193904415e-14	0.394690582742476	0.928	0.742	1.30852860843163e-09	FXYD5	cDCs	GSE169246_PacAteBlood_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53232
1.18360932611828e-13	0.363721132403169	0.791	0.529	2.29288798655634e-09	HCLS1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53233
1.55351672498558e-13	0.372870046053019	0.911	0.777	3.00947259964207e-09	EEF1G	cDCs	GSE169246_PacAteBlood_pre	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53234
1.70836310707429e-13	-0.31635514241149	1	1	3.30944101102431e-09	TMSB4X	cDCs	GSE169246_PacAteBlood_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53235
1.98130914603805e-13	0.388651566069524	0.83	0.676	3.8381920777049e-09	CTSH	cDCs	GSE169246_PacAteBlood_pre	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53236
2.32200238016508e-13	0.338582642223905	0.97	0.924	4.49818301085579e-09	ARPC1B	cDCs	GSE169246_PacAteBlood_pre	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53237
3.1976716325845e-13	0.335968517105358	0.757	0.5	6.19452948664269e-09	GNB2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000172354	2783	G protein subunit beta 2	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53238
6.1349653136807e-13	-0.28190822624007	0.996	0.998	1.18846548056623e-08	UBA52	cDCs	GSE169246_PacAteBlood_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53239
8.00846406984554e-13	0.404236705785797	0.685	0.438	1.55139965961048e-08	CNN2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53240
9.28559320388844e-13	0.341541293043961	0.928	0.802	1.79880511545727e-08	RAC1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53241
9.34768771780754e-13	-0.419878542819383	0.417	0.676	1.81083406469368e-08	CALHM6	cDCs	GSE169246_PacAteBlood_pre	ENSG00000188820	441168	calcium homeostasis modulator family member 6	C6orf187|dJ93H18.5|FAM26F|INAM|OTTHUMP00000017061|OTTHUMP00000017062|RP1-93H18.5	protein_coding	Q5R3K3	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53242
1.27574580192853e-12	-0.386499770631565	0.426	0.661	2.47137476749595e-08	RBX1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53243
1.32843476687246e-12	-0.405629200442274	0.557	0.74	2.57344383038533e-08	ATP5ME	cDCs	GSE169246_PacAteBlood_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53244
1.38399301989886e-12	0.969108104077383	0.506	0.258	2.68107127814807e-08	S100A9	cDCs	GSE169246_PacAteBlood_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53245
1.46471569206396e-12	-0.280327190420589	0.996	1	2.83744723866631e-08	RPS5	cDCs	GSE169246_PacAteBlood_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53246
1.86068337819943e-12	0.338582642223904	0.779	0.556	3.60451584024794e-08	CNPY3	cDCs	GSE169246_PacAteBlood_pre	ENSG00000137161	10695	canopy FGF signaling regulator 3	CAG4A|TNRC5	protein_coding	Q9BT09	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53247
2.03366428534637e-12	0.844843423203191	0.532	0.322	3.93961445357298e-08	FCN1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53248
2.60662105935364e-12	0.413525297382627	0.651	0.434	5.04954631617988e-08	ETV6	cDCs	GSE169246_PacAteBlood_pre	ENSG00000139083	2120	ETS variant transcription factor 6	TEL	protein_coding	P41212	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53249
3.19200528994336e-12	0.282755388734621	0.991	0.977	6.18355264767827e-08	CFL1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53250
3.47602548844004e-12	0.387829245826965	0.574	0.322	6.73375657620605e-08	HNRNPU	cDCs	GSE169246_PacAteBlood_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53251
3.95727313841034e-12	0.313459160687573	0.485	0.234	7.6660295237285e-08	NRROS	cDCs	GSE169246_PacAteBlood_pre	ENSG00000174004	375387	negative regulator of reactive oxygen species	ELLP3030|GARPL1|LRRC33|MGC50789|UNQ3030	protein_coding	Q86YC3	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53252
4.64314598308483e-12	0.346338490168223	0.868	0.7	8.99470239843193e-08	FCGRT	cDCs	GSE169246_PacAteBlood_pre	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53253
4.66604506276468e-12	-0.371845846397582	0.574	0.742	9.03906249558774e-08	ATP5MD	cDCs	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53254
7.62210276144655e-12	0.322643259451329	0.915	0.8	1.47655374694743e-07	ITGB2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53255
8.65173300611322e-12	0.332741933347709	0.685	0.455	1.67601371794425e-07	ERP29	cDCs	GSE169246_PacAteBlood_pre	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53256
9.4521263598539e-12	-0.390955008179129	0.247	0.496	1.8310659184309e-07	RGS18	cDCs	GSE169246_PacAteBlood_pre	ENSG00000150681	64407	regulator of G protein signaling 18	RGS13	protein_coding	Q9NS28	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53257
9.64574074491229e-12	0.317060054555294	0.489	0.238	1.86857289710441e-07	MYO1F	cDCs	GSE169246_PacAteBlood_pre	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53258
1.13640720378302e-11	-0.386121854443186	0.336	0.576	2.20144803516847e-07	DDT	cDCs	GSE169246_PacAteBlood_pre	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53259
1.73570265733111e-11	0.321364948958267	0.6	0.353	3.36240318778183e-07	PARVG	cDCs	GSE169246_PacAteBlood_pre	ENSG00000138964	64098	parvin gamma	NA	protein_coding	Q9HBI0	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53260
2.29058049366525e-11	0.340029216835761	0.774	0.607	4.43731253232833e-07	RNH1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53261
2.46903178595541e-11	-0.371540215848861	0.906	0.911	4.78300837575282e-07	MYL12A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53262
3.26392647353126e-11	0.295865100672835	0.494	0.254	6.32287836452475e-07	EIF3D	cDCs	GSE169246_PacAteBlood_pre	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53263
4.15405823605869e-11	0.418615893026881	0.719	0.517	8.04724161489289e-07	DDX5	cDCs	GSE169246_PacAteBlood_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53264
4.68368004959123e-11	-0.484145145050782	0.668	0.833	9.07322499206814e-07	CD52	cDCs	GSE169246_PacAteBlood_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53265
4.79380898574324e-11	0.593164293087409	0.362	0.153	9.28656676718181e-07	VCAN	cDCs	GSE169246_PacAteBlood_pre	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53266
4.79918430862831e-11	0.321902830765604	0.604	0.368	9.29697984267476e-07	ZNF385A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000161642	25946	zinc finger protein 385A	DKFZp586G1122|Hzf|ZFP385|ZNF385	protein_coding	Q96PM9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53267
5.30566987128445e-11	0.318977629459705	0.579	0.329	1.02781436746522e-06	SRSF5	cDCs	GSE169246_PacAteBlood_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53268
5.93318964318971e-11	0.312855817105535	0.545	0.31	1.14937749767871e-06	GRB2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53269
6.92122276720813e-11	-0.348580773967996	0.357	0.609	1.34077927446356e-06	NDUFB1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53270
7.00742742067743e-11	0.317385098045722	0.583	0.341	1.35747883993363e-06	MSN	cDCs	GSE169246_PacAteBlood_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53271
7.77572642534759e-11	0.283033055815356	0.43	0.205	1.50631372311834e-06	CNPPD1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000115649	27013	cyclin Pas1/PHO80 domain containing 1	C2orf24|CGI-57	protein_coding	Q9BV87	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53272
8.76185297803861e-11	0.344513508261008	0.809	0.655	1.69734615890564e-06	CTSZ	cDCs	GSE169246_PacAteBlood_pre	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53273
1.43007905687035e-10	0.45114622010984	0.809	0.649	2.77034914896925e-06	ANXA1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53274
1.66795591756143e-10	-0.300074214304004	0.983	0.977	3.23116420350001e-06	PFDN5	cDCs	GSE169246_PacAteBlood_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53275
1.82665929076769e-10	0.438445286979647	0.655	0.382	3.53860437807518e-06	FOS	cDCs	GSE169246_PacAteBlood_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53276
1.94499194079543e-10	0.306380435759381	0.791	0.579	3.76783838770891e-06	EIF3H	cDCs	GSE169246_PacAteBlood_pre	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53277
2.17384865401173e-10	0.298209041141134	0.413	0.2	4.21117961255152e-06	TMEM109	cDCs	GSE169246_PacAteBlood_pre	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53278
2.44629860665966e-10	0.349130324983748	0.468	0.246	4.7389696608211e-06	MYH9	cDCs	GSE169246_PacAteBlood_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53279
3.22573239656967e-10	0.536472577421464	0.694	0.516	6.24888879863477e-06	CEBPD	cDCs	GSE169246_PacAteBlood_pre	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53280
3.86565618193401e-10	0.255862750431539	0.374	0.169	7.48854915564257e-06	RNPEP	cDCs	GSE169246_PacAteBlood_pre	ENSG00000176393	6051	arginyl aminopeptidase	APB	protein_coding	Q9H4A4	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53281
4.37000842966332e-10	0.326388108828855	0.6	0.38	8.46558032994379e-06	LDHA	cDCs	GSE169246_PacAteBlood_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53282
5.09579757204984e-10	0.305072027434487	0.579	0.347	9.87157905657495e-06	PTPN6	cDCs	GSE169246_PacAteBlood_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53283
7.38470738445382e-10	0.285284283770505	0.953	0.888	1.43056551451639e-05	HLA-A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53284
7.68910125739282e-10	0.304635310300567	0.711	0.494	1.48953269558214e-05	ATP5F1A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53285
7.73388735203476e-10	0.260999506355572	0.438	0.223	1.49820865783617e-05	MTMR14	cDCs	GSE169246_PacAteBlood_pre	ENSG00000163719	64419	myotubularin related protein 14	C3orf29|FLJ22405|FLJ90311|hEDTP|hJumpy	protein_coding	Q8NCE2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53286
7.87880628482067e-10	0.365883615736912	0.511	0.297	1.52628235349546e-05	APLP2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53287
9.48943622539344e-10	0.32735538680065	0.617	0.39	1.83829358558322e-05	CTSB	cDCs	GSE169246_PacAteBlood_pre	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53288
9.77814733954118e-10	0.298939704636564	0.715	0.506	1.89422270261592e-05	LGALS9	cDCs	GSE169246_PacAteBlood_pre	ENSG00000168961	3965	galectin 9	LGALS9A	protein_coding	O00182	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53289
9.93560642462871e-10	0.34554850356662	0.643	0.43	1.92472567657907e-05	NCL	cDCs	GSE169246_PacAteBlood_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53290
9.99067243975061e-10	0.284735752862862	0.562	0.326	1.93539306502849e-05	BLVRB	cDCs	GSE169246_PacAteBlood_pre	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53291
1.48642766559161e-09	0.279406425355969	0.489	0.271	2.87950767378408e-05	PLCB2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000137841	5330	phospholipase C beta 2	FLJ38135	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53292
1.52078144677941e-09	0.318283481304174	0.485	0.273	2.94605781870107e-05	CLEC12A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53293
1.67995931596643e-09	0.286313708426004	0.57	0.347	3.25441718689018e-05	VASP	cDCs	GSE169246_PacAteBlood_pre	ENSG00000125753	7408	vasodilator stimulated phosphoprotein	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53294
1.79110433106405e-09	0.504213102404848	0.455	0.256	3.46972731013727e-05	NFKBIA	cDCs	GSE169246_PacAteBlood_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53295
1.79994801855369e-09	0.25629400642545	0.489	0.262	3.48685930154221e-05	NOP53	cDCs	GSE169246_PacAteBlood_pre	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53296
2.12059017793737e-09	-0.365943972505556	0.145	0.357	4.10800729270028e-05	MARCKS	cDCs	GSE169246_PacAteBlood_pre	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53297
2.32405501925512e-09	0.299125328908289	0.655	0.45	4.50215938330102e-05	RAB7A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53298
2.58123482504894e-09	-0.318286851654397	0.213	0.424	5.0003681030848e-05	CHURC1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000258289	91612	churchill domain containing 1	C14orf52|FLJ33064|My015	protein_coding	Q8WUH1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53299
2.85301058132747e-09	0.375405176218777	0.796	0.61	5.52685209814758e-05	EMP3	cDCs	GSE169246_PacAteBlood_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53300
3.95629248506061e-09	0.271111276161031	0.315	0.136	7.66412980205942e-05	MYADM	cDCs	GSE169246_PacAteBlood_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53301
5.62614718314317e-09	0.348305781957543	0.57	0.372	0.000108989723231849	NBPF26	cDCs	GSE169246_PacAteBlood_pre	ENSG00000273136	101060684	NBPF member 26	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53302
5.6901536241483e-09	-0.34300567664837	0.4	0.578	0.000110229656007001	SEC61G	cDCs	GSE169246_PacAteBlood_pre	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53303
6.48244018686401e-09	-0.360173402405551	0.506	0.68	0.00012557783129993	PSMB9	cDCs	GSE169246_PacAteBlood_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53304
6.51754928838965e-09	-0.260149308482959	0.123	0.329	0.000126257964814684	AL034397.3	cDCs	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53305
8.37982449795519e-09	-0.324416975838269	0.651	0.767	0.000162333960174388	UBL5	cDCs	GSE169246_PacAteBlood_pre	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53306
8.95622808936325e-09	-0.31219421190288	0.438	0.612	0.000173500050547145	SNRPG	cDCs	GSE169246_PacAteBlood_pre	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53307
9.44262736403178e-09	0.278924054197742	0.634	0.421	0.000182922577296024	CAPZB	cDCs	GSE169246_PacAteBlood_pre	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53308
1.13765631757418e-08	-0.472819948768177	0.136	0.337	0.00022038678184047	IFITM1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53309
1.27858675631933e-08	0.306546924520744	0.689	0.496	0.00024768782643418	TALDO1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53310
2.01808393014379e-08	-0.31588155759793	0.77	0.831	0.000390943218947455	TOMM7	cDCs	GSE169246_PacAteBlood_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53311
2.0940106516974e-08	0.309739843883679	0.528	0.333	0.000405651743446819	ITGAX	cDCs	GSE169246_PacAteBlood_pre	ENSG00000140678	3687	integrin subunit alpha X	CD11C	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53312
2.10297767969974e-08	0.261980598369441	1	1	0.000407388836111434	MT-CO1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53313
2.19463464072478e-08	-0.292927227200223	0.8	0.843	0.000425144622601205	UQCR11	cDCs	GSE169246_PacAteBlood_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53314
2.41245271505543e-08	0.253673140539297	0.779	0.566	0.000467340339960538	PCBP1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53315
2.46657993590047e-08	0.277337609494169	0.587	0.376	0.000477825865182638	NCF2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000116701	4688	neutrophil cytosolic factor 2	NOXA2|p67phox	protein_coding	P19878	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53316
2.55411654563423e-08	0.409149477964298	0.353	0.174	0.000494783457220262	GADD45B	cDCs	GSE169246_PacAteBlood_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53317
2.64092857945684e-08	0.25133453812647	0.485	0.281	0.000511600684412379	DBNL	cDCs	GSE169246_PacAteBlood_pre	ENSG00000136279	28988	drebrin like	ABP1|HIP-55|SH3P7	protein_coding	Q9UJU6	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53318
2.65167472677795e-08	0.27286619302667	0.817	0.628	0.000513682428071425	EIF3F	cDCs	GSE169246_PacAteBlood_pre	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53319
2.67426198990704e-08	-0.324721309779043	0.643	0.756	0.000518058032684792	UQCR10	cDCs	GSE169246_PacAteBlood_pre	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53320
5.20684919986443e-08	0.303914143056913	0.43	0.24	0.00100867082699774	CD99	cDCs	GSE169246_PacAteBlood_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53321
5.31835696457126e-08	0.459452634897497	0.447	0.279	0.00103027211117674	ID2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53322
5.4367911052288e-08	0.32842735839738	0.753	0.599	0.00105321517290492	ALDOA	cDCs	GSE169246_PacAteBlood_pre	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53323
6.42367794590061e-08	0.340540761269865	1	1	0.00124439489167987	MT-CO3	cDCs	GSE169246_PacAteBlood_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53324
7.01226502419872e-08	0.381217388766539	0.898	0.789	0.00135841598048778	TAGLN2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53325
8.03147813328234e-08	-0.267271037595143	0.34	0.55	0.00155585794397946	ROMO1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53326
8.03876222977143e-08	0.253354805356874	0.515	0.318	0.00155726901915132	PGAM1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53327
1.06684092742781e-07	0.255223116175489	0.834	0.638	0.00206668424461316	CD37	cDCs	GSE169246_PacAteBlood_pre	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53328
1.09163635955726e-07	0.324220227926372	0.468	0.289	0.00211471795573433	TUBA1A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53329
1.09272731902796e-07	-0.25509764200427	0.162	0.347	0.00211683136242097	BLOC1S1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53330
1.12296556393292e-07	0.281723839382128	0.63	0.459	0.00217540889045086	CIITA	cDCs	GSE169246_PacAteBlood_pre	ENSG00000179583	4261	class II major histocompatibility complex transactivator	C2TA|MHC2TA|NLRA	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53331
1.30091280014187e-07	0.262324505442602	0.821	0.595	0.00252012827643482	HSP90AB1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53332
1.56471438298235e-07	-0.369520919750045	0.174	0.359	0.00303116470271341	PLAC8	cDCs	GSE169246_PacAteBlood_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53333
1.8884767315536e-07	-0.273754536497103	0.132	0.308	0.00365835712436564	MS4A7	cDCs	GSE169246_PacAteBlood_pre	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53334
1.9925262407387e-07	-0.298520307186559	0.545	0.69	0.00385992183355901	COX7A2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53335
2.15840784159069e-07	0.251574066549153	0.37	0.196	0.00418126767072949	IL17RA	cDCs	GSE169246_PacAteBlood_pre	ENSG00000177663	23765	interleukin 17 receptor A	CD217|CDw217|hIL-17R|IL-17RA|IL17R	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53336
2.37785836327438e-07	0.28250115101639	0.455	0.281	0.00460638722133514	HERPUD1	cDCs	GSE169246_PacAteBlood_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53337
2.57794091457991e-07	0.266813844865599	0.532	0.349	0.0049939871397242	PLP2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53338
3.46954359622236e-07	0.263074635468388	0.609	0.421	0.00672119985460195	HADHA	cDCs	GSE169246_PacAteBlood_pre	ENSG00000084754	3030	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha	GBP|LCEH|LCHAD|MTPA	protein_coding	P40939	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53339
6.03789476408387e-07	0.252014218262528	0.668	0.483	0.0116966097369833	GNAI2	cDCs	GSE169246_PacAteBlood_pre	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53340
7.14710497279828e-07	-0.346955825297169	0.63	0.717	0.0138453717533048	CKLF	cDCs	GSE169246_PacAteBlood_pre	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53341
7.82404255830805e-07	-0.277784995858136	0.196	0.368	0.0151567352439544	CLEC7A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000172243	64581	C-type lectin domain containing 7A	CD369|CLECSF12|DECTIN-1|hDectin-1|SCARE2	protein_coding	Q9BXN2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53342
8.69034353797342e-07	0.254253121102516	0.664	0.475	0.0168349335017621	TYMP	cDCs	GSE169246_PacAteBlood_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53343
8.89415513642132e-07	-0.260149308482959	0.643	0.758	0.0172297573302754	ATP5MPL	cDCs	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53344
9.51383357609471e-07	0.266049734433768	0.396	0.229	0.0184301984036107	H1FX	cDCs	GSE169246_PacAteBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53345
1.07464102923653e-06	0.286117616607912	0.991	0.957	0.0208179460183701	S100A6	cDCs	GSE169246_PacAteBlood_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53346
1.13872736786749e-06	0.27949991207073	0.834	0.742	0.022059426570329	JAML	cDCs	GSE169246_PacAteBlood_pre	ENSG00000160593	120425	junction adhesion molecule like	AMICA|AMICA1|Gm638	protein_coding	Q86YT9	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53347
1.22614174424088e-06	0.260358114864041	1	1	0.0237528178694343	ACTB	cDCs	GSE169246_PacAteBlood_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53348
1.47674459541059e-06	0.262970983697685	0.783	0.647	0.028607496302294	CCDC88A	cDCs	GSE169246_PacAteBlood_pre	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53349
2.04684546358376e-06	0.263225049380935	0.37	0.213	0.0396514903205445	HSPA5	cDCs	GSE169246_PacAteBlood_pre	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53350
1.36583186320882e-08	-1.25143665278922	0.962	1	0.000264588948540812	RPL39	pDCs	GSE169246_PacAteBlood_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53351
1.73738451995765e-08	-1.4007835155986	0	0.685	0.000336566129206196	PPBP	pDCs	GSE169246_PacAteBlood_pre	ENSG00000163736	5473	pro-platelet basic protein	b-TG1|Beta-TG|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|NAP-2-L1|PBP|SCYB7|TGB|TGB1|THBGB1	protein_coding	P02775	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53352
3.75830086599636e-07	-1.05902825683257	1	1	0.00728058043760814	RPL41	pDCs	GSE169246_PacAteBlood_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53353
4.98542078536755e-07	-1.22212774307292	0.923	1	0.00965775714541403	MT-ND2	pDCs	GSE169246_PacAteBlood_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53354
7.29969954361573e-07	0.532932875256262	0.5	0.079	0.0141409779558924	P2RX1	pDCs	GSE169246_PacAteBlood_pre	ENSG00000108405	5023	purinergic receptor P2X 1	P2X1	protein_coding	P51575	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53355
1.60924455989351e-06	-0.878148525778617	0.962	0.989	0.0311742856142571	RPS21	pDCs	GSE169246_PacAteBlood_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53356
1.88097352571678e-06	0.918251666667349	0.462	0.079	0.0364382191401854	MAP3K8	pDCs	GSE169246_PacAteBlood_pre	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53357
2.57239779937503e-06	-0.95129364610001	1	1	0.049832490169493	RPS28	pDCs	GSE169246_PacAteBlood_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacAteBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 7, sensitive 4); post (resistant 7, sensitive 4)	22	129562	Public on Sep 15, 2021	34653365	This dataset has 11 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53358
0	0.961673110416096	0.526	0.026	0	IFI44L	B cells	GSE169246_PacAteTissue_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53359
0	1.07548051830638	0.651	0.084	0	XAF1	B cells	GSE169246_PacAteTissue_post	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53360
1.23227247820683e-244	1.67009907625437	0.858	0.257	2.53909744134516e-240	IFITM1	B cells	GSE169246_PacAteTissue_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53361
2.46815786022611e-231	1.72980870016293	1	0.805	5.0856392709959e-227	HLA-B	B cells	GSE169246_PacAteTissue_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53362
1.70948591213309e-228	0.734802084658174	0.402	0.037	3.52239572195024e-224	IFI6	B cells	GSE169246_PacAteTissue_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53363
1.0864850482031e-191	0.940308326281807	0.478	0.071	2.23870244182249e-187	ISG15	B cells	GSE169246_PacAteTissue_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53364
8.04829715711115e-188	1.06249342725223	0.672	0.166	1.65835162922275e-183	LY6E	B cells	GSE169246_PacAteTissue_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53365
4.03801395006691e-173	0.955159167148573	0.681	0.182	8.32032774411287e-169	IRF7	B cells	GSE169246_PacAteTissue_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53366
8.14896300844945e-125	0.628027742792847	0.49	0.112	1.67909382789101e-120	TAP1	B cells	GSE169246_PacAteTissue_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53367
1.6124183624975e-123	0.478408633395991	0.362	0.059	3.32238803592609e-119	SAMD9L	B cells	GSE169246_PacAteTissue_post	ENSG00000177409	219285	sterile alpha motif domain containing 9 like	C7orf6|FLJ39885|KIAA2005	protein_coding	Q8IVG5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53368
2.22355532237795e-123	0.591165430743269	0.455	0.097	4.58163574175976e-119	PLSCR1	B cells	GSE169246_PacAteTissue_post	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53369
1.69109742005348e-115	0.58840149641242	0.488	0.118	3.48450623402019e-111	EIF2AK2	B cells	GSE169246_PacAteTissue_post	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53370
1.07279958691685e-107	0.596435021507247	0.459	0.109	2.21050354884217e-103	STAT1	B cells	GSE169246_PacAteTissue_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53371
1.03588102247102e-104	0.391028099982307	0.321	0.055	2.13443284680154e-100	ERAP2	B cells	GSE169246_PacAteTissue_post	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53372
1.01914110614681e-97	0.503937332699081	0.355	0.072	2.09994024921551e-93	MX2	B cells	GSE169246_PacAteTissue_post	ENSG00000183486	4600	MX dynamin like GTPase 2	MXB	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53373
1.33163115182536e-96	0.447383388288803	0.374	0.08	2.74382598833616e-92	TYMP	B cells	GSE169246_PacAteTissue_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53374
4.58279477530441e-94	0.794451382425878	0.996	0.792	9.44284863451473e-90	HLA-C	B cells	GSE169246_PacAteTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53375
4.68881663737294e-90	0.968989640326433	0.989	0.897	9.66130668130694e-86	TMSB10	B cells	GSE169246_PacAteTissue_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53376
1.29786606225697e-89	0.630231271228084	0.596	0.215	2.67425302128049e-85	TRIM22	B cells	GSE169246_PacAteTissue_post	ENSG00000132274	10346	tripartite motif containing 22	GPSTAF50|RNF94|STAF50	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53377
1.09582972790182e-85	0.81571908701959	0.727	0.35	2.2579571543417e-81	IFITM2	B cells	GSE169246_PacAteTissue_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53378
2.11797311343202e-83	0.646000100256012	0.507	0.167	4.36408360022667e-79	MX1	B cells	GSE169246_PacAteTissue_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53379
9.99475937321818e-80	0.712707276473251	1	0.962	2.05942016885161e-75	B2M	B cells	GSE169246_PacAteTissue_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53380
4.1504248014109e-76	0.503311757726257	0.433	0.131	8.55195030330716e-72	UBE2L6	B cells	GSE169246_PacAteTissue_post	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53381
2.74661325565654e-75	-1.02559299629589	0.33	0.733	5.6593966132803e-71	UCP2	B cells	GSE169246_PacAteTissue_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53382
1.54405340632542e-72	0.395244806749879	0.376	0.101	3.18152204373354e-68	C19orf66	B cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53383
3.11731937816535e-68	-0.881770769359123	0.829	0.921	6.42323657870971e-64	RPS26	B cells	GSE169246_PacAteTissue_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53384
8.39025291598681e-63	0.292395229656399	0.266	0.059	1.72881161333908e-58	PARP9	B cells	GSE169246_PacAteTissue_post	ENSG00000138496	83666	poly(ADP-ribose) polymerase family member 9	ARTD9|BAL|BAL1	protein_coding	Q8IXQ6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53385
1.86393720731393e-62	0.375168609818219	0.359	0.103	3.84064261567035e-58	NRROS	B cells	GSE169246_PacAteTissue_post	ENSG00000174004	375387	negative regulator of reactive oxygen species	ELLP3030|GARPL1|LRRC33|MGC50789|UNQ3030	protein_coding	Q86YC3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53386
7.04034388046625e-62	0.800926462677408	0.567	0.263	1.45066285657007e-57	WDR74	B cells	GSE169246_PacAteTissue_post	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53387
1.07806606754534e-60	0.357708827362299	0.307	0.08	2.22135513217717e-56	IFI35	B cells	GSE169246_PacAteTissue_post	ENSG00000068079	3430	interferon induced protein 35	IFP35	protein_coding	P80217	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53388
1.19545653295741e-60	0.353755208951415	0.296	0.074	2.46323818615874e-56	OAS1	B cells	GSE169246_PacAteTissue_post	ENSG00000089127	4938	2'-5'-oligoadenylate synthetase 1	IFI-4|OIAS|OIASI	protein_coding	P00973	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53389
5.59845752545713e-59	0.569619155331022	0.467	0.176	1.15356217312044e-54	RNF213	B cells	GSE169246_PacAteTissue_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53390
3.57261176964353e-58	0.833871491121501	0.649	0.342	7.3613665513505e-54	CDKN1A	B cells	GSE169246_PacAteTissue_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53391
5.98975521697869e-58	0.493677163826859	0.497	0.196	1.23418906245846e-53	RARA	B cells	GSE169246_PacAteTissue_post	ENSG00000131759	5914	retinoic acid receptor alpha	NR1B1|RAR|RAR-alpha|RARalpha	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53392
2.87331778119511e-57	0.695163887788104	0.277	0.072	5.92047128815253e-53	TNFSF9	B cells	GSE169246_PacAteTissue_post	ENSG00000125657	8744	TNF superfamily member 9	4-1BB-L|4-1BBL|CD137L	protein_coding	P41273	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53393
8.6899344677644e-57	0.435123735873345	0.44	0.158	1.79056099708285e-52	CSRNP1	B cells	GSE169246_PacAteTissue_post	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53394
8.83396425657281e-57	0.428280796185883	0.448	0.164	1.82023833506683e-52	EPSTI1	B cells	GSE169246_PacAteTissue_post	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53395
2.99979522933044e-56	0.327432918286388	0.332	0.096	6.18107807003537e-52	ODF3B	B cells	GSE169246_PacAteTissue_post	ENSG00000177989	440836	outer dense fiber of sperm tails 3B	FAP123	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53396
1.05781465605368e-54	-1.26427757268443	0.818	0.935	2.1796270987986e-50	ACTG1	B cells	GSE169246_PacAteTissue_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53397
1.99690853787407e-54	0.477914856630676	0.283	0.075	4.11463004228953e-50	MT2A	B cells	GSE169246_PacAteTissue_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53398
4.04173341683488e-54	0.455382714842099	0.497	0.207	8.32799170538827e-50	ADAR	B cells	GSE169246_PacAteTissue_post	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53399
9.56441235528661e-53	-1.3039280728257	0.273	0.587	1.97074716580681e-48	KLF2	B cells	GSE169246_PacAteTissue_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53400
4.56998123188693e-51	-0.936933653897871	0.334	0.627	9.41644632830301e-47	BASP1	B cells	GSE169246_PacAteTissue_post	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53401
1.08476726820659e-49	-0.747929745969166	0.239	0.568	2.23516295613968e-45	FAM107B	B cells	GSE169246_PacAteTissue_post	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53402
9.8661352880258e-49	-1.67790566414851	0.362	0.675	2.03291717609772e-44	HIST1H4C	B cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53403
3.34663874931964e-45	-0.535594098027693	0.116	0.45	6.89574914297311e-41	MZT2B	B cells	GSE169246_PacAteTissue_post	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53404
5.80620768101444e-45	0.569165195182253	0.979	0.884	1.19636909267303e-40	MT-ND5	B cells	GSE169246_PacAteTissue_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53405
9.73323066845299e-45	-0.739950451994455	0.385	0.663	2.00553217923474e-40	SWAP70	B cells	GSE169246_PacAteTissue_post	ENSG00000133789	23075	switching B cell complex subunit SWAP70	KIAA0640|SWAP-70	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53406
1.28240463062979e-43	-1.1966606206753	0.027	0.334	2.64239474141269e-39	RGS13	B cells	GSE169246_PacAteTissue_post	ENSG00000127074	6003	regulator of G protein signaling 13	NA	protein_coding	O14921	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53407
6.59295916403438e-43	0.441650216715177	0.535	0.262	1.35847923574928e-38	PSME2	B cells	GSE169246_PacAteTissue_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53408
1.88474237766433e-42	-0.765936488941544	0.027	0.329	3.88351166917735e-38	HMCES	B cells	GSE169246_PacAteTissue_post	ENSG00000183624	56941	5-hydroxymethylcytosine binding, ES cell specific	C3orf37|DC12|SRAPD1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53409
7.5150940040435e-42	-0.774572485958453	0.998	1	1.54848511953316e-37	ACTB	B cells	GSE169246_PacAteTissue_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53410
3.57419795147461e-40	0.318591541243113	0.368	0.141	7.36463487901342e-36	LGALS9	B cells	GSE169246_PacAteTissue_post	ENSG00000168961	3965	galectin 9	LGALS9A	protein_coding	O00182	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53411
6.41156991394024e-40	0.660744315557927	0.647	0.396	1.32110398076739e-35	ISG20	B cells	GSE169246_PacAteTissue_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53412
2.07723597541661e-39	1.01914136047138	0.848	0.673	4.28014472734593e-35	JUNB	B cells	GSE169246_PacAteTissue_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53413
3.82358317722327e-39	-0.50016848991791	0.48	0.742	7.87849313666854e-35	PCBP1	B cells	GSE169246_PacAteTissue_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53414
4.22228081326353e-39	-0.605474794647956	0.702	0.847	8.70000961572951e-35	PNRC1	B cells	GSE169246_PacAteTissue_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53415
5.62563974110106e-39	0.876308791893368	0.74	0.492	1.15916306865387e-34	NR4A2	B cells	GSE169246_PacAteTissue_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53416
1.72273586587022e-38	-0.939154573487893	0.433	0.659	3.54969725162558e-34	LCP1	B cells	GSE169246_PacAteTissue_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53417
2.1118153302786e-38	-0.625731429703502	0.199	0.493	4.35139548803905e-34	RBM38	B cells	GSE169246_PacAteTissue_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53418
2.20123093180715e-37	0.415218851802557	0.702	0.431	4.53563633498863e-33	RNASET2	B cells	GSE169246_PacAteTissue_post	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53419
4.1470815372276e-36	0.47322354687633	0.52	0.267	8.54506150745747e-32	CD24	B cells	GSE169246_PacAteTissue_post	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53420
4.79923291478947e-36	0.306538511459084	0.383	0.159	9.8888194209237e-32	BAG1	B cells	GSE169246_PacAteTissue_post	ENSG00000107262	573	BAG cochaperone 1	NA	protein_coding	Q99933	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53421
8.25136988546234e-36	-1.29324874466567	0.091	0.358	1.70019476489952e-31	PRPSAP2	B cells	GSE169246_PacAteTissue_post	ENSG00000141127	5636	phosphoribosyl pyrophosphate synthetase associated protein 2	PAP41	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53422
9.11200031402506e-36	0.444008547692153	0.977	0.828	1.87752766470486e-31	HLA-E	B cells	GSE169246_PacAteTissue_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53423
1.0001535595934e-35	0.552487734782572	0.56	0.303	2.06081640954219e-31	NFKBID	B cells	GSE169246_PacAteTissue_post	ENSG00000167604	84807	NFKB inhibitor delta	IkappaBNS|IkBNS|TA-NFKBH	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53424
1.45762050502048e-35	1.22715170675057	0.641	0.405	3.00342705059469e-31	FOS	B cells	GSE169246_PacAteTissue_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53425
1.63286446680546e-35	-0.677724952972373	0.397	0.629	3.36451723385265e-31	TCEA1	B cells	GSE169246_PacAteTissue_post	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53426
2.95927836631812e-35	-0.727578052413327	0.03	0.294	6.09759307379848e-31	MEF2B	B cells	GSE169246_PacAteTissue_post	ENSG00000213999	4207	BORCS8-MEF2B readthrough	RSRFR2	protein_coding	Q02080	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53427
3.00692456404089e-35	0.28559370556071	0.309	0.115	6.19576806420625e-31	TCIRG1	B cells	GSE169246_PacAteTissue_post	ENSG00000110719	10312	T cell immune regulator 1, ATPase H+ transporting V0 subunit a3	a3|Atp6i|ATP6N1C|ATP6V0A3|OC-116|OC116|TIRC7	protein_coding	Q13488	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53428
3.65365680576793e-35	-0.45220045196732	0.159	0.442	7.52835984828482e-31	HNRNPL	B cells	GSE169246_PacAteTissue_post	ENSG00000282947	3191	heterogeneous nuclear ribonucleoprotein L	HNRPL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53429
8.39422623816305e-35	-0.506412370721062	0.634	0.799	1.7296303163735e-30	SFPQ	B cells	GSE169246_PacAteTissue_post	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53430
5.39361719960445e-34	0.408523742906852	0.603	0.341	1.1113548239785e-29	SP110	B cells	GSE169246_PacAteTissue_post	ENSG00000135899	3431	SP110 nuclear body protein	IFI41|IFI75	protein_coding	Q9HB58	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53431
6.09825608420185e-34	0.352644141047231	0.507	0.255	1.25654566614979e-29	NFKB2	B cells	GSE169246_PacAteTissue_post	ENSG00000077150	4791	nuclear factor kappa B subunit 2	LYT-10|NF-kB2|p105|p49/p100|p52	protein_coding	Q00653	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53432
7.23745451303142e-34	0.694561308400181	0.888	0.745	1.49127750241012e-29	ZFP36	B cells	GSE169246_PacAteTissue_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53433
1.45891632783621e-33	0.787865398819976	0.383	0.176	3.0060970935065e-29	GLA	B cells	GSE169246_PacAteTissue_post	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53434
2.11632872635565e-33	0.509495285240224	0.998	0.987	4.36069534065582e-29	TMSB4X	B cells	GSE169246_PacAteTissue_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53435
3.36275449493305e-33	0.26379264147174	0.277	0.099	6.92895563680955e-29	HOOK2	B cells	GSE169246_PacAteTissue_post	ENSG00000095066	29911	hook microtubule tethering protein 2	HK2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53436
8.73602711834502e-33	-0.398390363218622	0.985	0.993	1.80005838773499e-28	RPS2	B cells	GSE169246_PacAteTissue_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53437
9.7108837956094e-33	-0.665181089866489	0.34	0.588	2.00092760608532e-28	ANP32B	B cells	GSE169246_PacAteTissue_post	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53438
1.11309736701523e-32	-0.510915924751917	0.285	0.545	2.29353712473487e-28	SMAP2	B cells	GSE169246_PacAteTissue_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53439
1.20135866462199e-32	0.357883793165864	0.336	0.138	2.47539952845362e-28	FAM210A	B cells	GSE169246_PacAteTissue_post	ENSG00000177150	125228	family with sequence similarity 210 member A	C18orf19|HsT2329|MGC24180	protein_coding	Q96ND0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53440
2.14066790051453e-32	0.647504982472237	0.3	0.117	4.41084620901018e-28	TNF	B cells	GSE169246_PacAteTissue_post	ENSG00000228978	7124	tumor necrosis factor	DIF|TNF-alpha|TNFA|TNFSF2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53441
2.20396294750804e-32	0.439182370861147	0.575	0.346	4.54126565334031e-28	BST2	B cells	GSE169246_PacAteTissue_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53442
2.6775071796234e-32	-0.604315106072204	0.423	0.657	5.51700354361402e-28	SLC25A5	B cells	GSE169246_PacAteTissue_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53443
3.06230901997974e-32	-0.584648267945189	0.524	0.704	6.30988773566826e-28	ACTR3	B cells	GSE169246_PacAteTissue_post	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53444
3.14651250169284e-32	-0.415007887007762	0.159	0.431	6.48338900973811e-28	PTP4A2	B cells	GSE169246_PacAteTissue_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53445
6.89354782432882e-32	-1.07044645789981	0.216	0.454	1.42041552920295e-27	LRMP	B cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53446
7.48047362216403e-32	0.386872103870072	0.6	0.359	1.5413515898469e-27	TAPBP	B cells	GSE169246_PacAteTissue_post	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53447
9.18249337607408e-32	-0.413430217129936	0.342	0.604	1.89205276014007e-27	KHDRBS1	B cells	GSE169246_PacAteTissue_post	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53448
2.47826930396328e-31	0.348991488017147	0.979	0.974	5.10647390081633e-27	RPL23A	B cells	GSE169246_PacAteTissue_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53449
3.17944749534535e-31	0.414195368784016	0.493	0.251	6.55125156415909e-27	VPS37B	B cells	GSE169246_PacAteTissue_post	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53450
3.28880916999853e-31	0.830290594230303	0.619	0.396	6.77659129478197e-27	FOSB	B cells	GSE169246_PacAteTissue_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53451
8.99937494788353e-31	0.251099864197996	0.307	0.121	1.8543212080114e-26	GAPT	B cells	GSE169246_PacAteTissue_post	ENSG00000175857	202309	GRB2 binding adaptor protein, transmembrane	C5orf29|FLJ33641	protein_coding	Q8N292	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53452
8.40882732232642e-30	-0.450635318672322	0.803	0.911	1.73263886976536e-25	NPM1	B cells	GSE169246_PacAteTissue_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53453
8.88178131037265e-30	0.397444720739408	0.336	0.144	1.83009103900228e-25	S100A4	B cells	GSE169246_PacAteTissue_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53454
3.3502441073987e-29	0.918681146565474	0.49	0.281	6.90317798329501e-25	GADD45B	B cells	GSE169246_PacAteTissue_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53455
4.65880123541513e-29	0.385378793449545	0.522	0.296	9.59945994557288e-25	PPM1K	B cells	GSE169246_PacAteTissue_post	ENSG00000163644	152926	protein phosphatase, Mg2+/Mn2+ dependent 1K	BDP|DKFZp761G058|hPTMP|PP2Ckappa|PP2Cm	protein_coding	Q8N3J5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53456
1.70511133116981e-28	0.445990371407592	0.41	0.204	3.51338189787539e-24	SERTAD1	B cells	GSE169246_PacAteTissue_post	ENSG00000197019	29950	SERTA domain containing 1	SEI1|TRIP-Br1	protein_coding	Q9UHV2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53457
3.23019313895763e-28	0.409280934470952	0.666	0.429	6.6558129628222e-24	SUB1	B cells	GSE169246_PacAteTissue_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53458
9.89333656627818e-28	-0.806105262990357	0.142	0.368	2.03852199948162e-23	MYO1E	B cells	GSE169246_PacAteTissue_post	ENSG00000157483	4643	myosin IE	HuncM-IC|MGC104638|MYO1C	protein_coding	Q12965	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53459
1.46860930767463e-27	0.322687009851254	0.393	0.191	3.02606947846357e-23	ARID5A	B cells	GSE169246_PacAteTissue_post	ENSG00000196843	10865	AT-rich interaction domain 5A	MRF-1|RP11-363D14	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53460
1.83622195977953e-27	0.422041982296154	0.658	0.465	3.78353534812573e-23	PSMB9	B cells	GSE169246_PacAteTissue_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53461
1.88924311008791e-27	0.628884081919575	0.66	0.434	3.89278542833614e-23	NFKBIA	B cells	GSE169246_PacAteTissue_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53462
2.00937877378059e-27	0.417580961507048	0.389	0.192	4.1403249633749e-23	ATP1B3	B cells	GSE169246_PacAteTissue_post	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53463
5.01457134437667e-27	0.328653362004569	0.304	0.126	1.03325242550881e-22	S1PR1	B cells	GSE169246_PacAteTissue_post	ENSG00000170989	1901	sphingosine-1-phosphate receptor 1	CD363|D1S3362|edg-1|EDG1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53464
5.98562200517429e-27	-0.641849915820422	0.224	0.438	1.23333741416616e-22	RFTN1	B cells	GSE169246_PacAteTissue_post	ENSG00000131378	23180	raftlin, lipid raft linker 1	FLJ23866|KIAA0084|MIG2|Raftlin	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53465
1.02344875660724e-26	-0.490298176788669	0.057	0.279	2.10881616298922e-22	ELL3	B cells	GSE169246_PacAteTissue_post	ENSG00000128886	80237	elongation factor for RNA polymerase II 3	FLJ22637	protein_coding	Q9HB65	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53466
1.0313126840001e-26	0.314302041119984	0.55	0.317	2.1250197853822e-22	SASH3	B cells	GSE169246_PacAteTissue_post	ENSG00000122122	54440	SAM and SH3 domain containing 3	753P9|CXorf9|HACS2|SH3D6C|SLY	protein_coding	O75995	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53467
1.49176390138129e-26	-0.423932244806049	0.053	0.274	3.07377951879614e-22	CCNG2	B cells	GSE169246_PacAteTissue_post	ENSG00000138764	901	cyclin G2	NA	protein_coding	Q16589	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53468
1.56392568916095e-26	0.280189868344572	0.351	0.163	3.22246888251614e-22	NARF	B cells	GSE169246_PacAteTissue_post	ENSG00000141562	26502	nuclear prelamin A recognition factor	DKFZp434G0420|FLJ10067|IOP2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53469
1.78328656335727e-26	-0.559297322500274	0.275	0.498	3.67446196379766e-22	TERF2IP	B cells	GSE169246_PacAteTissue_post	ENSG00000166848	54386	TERF2 interacting protein	RAP1	protein_coding	Q9NYB0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53470
2.09411021516053e-26	0.295495682559013	0.296	0.125	4.31491409833827e-22	BHLHE40	B cells	GSE169246_PacAteTissue_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53471
2.81601034055284e-26	0.291144375673908	0.283	0.116	5.80238930670912e-22	SOCS3	B cells	GSE169246_PacAteTissue_post	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53472
3.06139060366521e-26	-0.359312064532889	0.089	0.318	6.30799533885216e-22	CD81	B cells	GSE169246_PacAteTissue_post	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53473
5.12498347702097e-26	0.348913701337561	0.427	0.224	1.05600284544017e-21	TRAF4	B cells	GSE169246_PacAteTissue_post	ENSG00000076604	9618	TNF receptor associated factor 4	CART1|MLN62|RNF83	protein_coding	Q9BUZ4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53474
9.91263343793782e-26	-0.468673947682893	0.161	0.39	2.04249811988709e-21	NUCKS1	B cells	GSE169246_PacAteTissue_post	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53475
1.38463647969911e-25	-0.475316210285227	0.812	0.893	2.85304346642002e-21	CORO1A	B cells	GSE169246_PacAteTissue_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53476
3.05222013828246e-25	-0.314717806739906	0.087	0.315	6.28909959493101e-21	TXNL4A	B cells	GSE169246_PacAteTissue_post	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53477
4.91524083128985e-25	-0.390583688592167	0.146	0.375	1.01278537328727e-20	ETS1	B cells	GSE169246_PacAteTissue_post	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53478
6.80619514223351e-25	0.49553096480681	0.964	0.843	1.40241650905721e-20	FTL	B cells	GSE169246_PacAteTissue_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53479
9.78321400396432e-25	0.266073333944648	0.273	0.113	2.01583124551685e-20	ICAM1	B cells	GSE169246_PacAteTissue_post	ENSG00000090339	3383	intercellular adhesion molecule 1	BB2|CD54	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53480
1.150410231897e-24	0.341207920484818	0.985	0.99	2.37042028282377e-20	EIF1	B cells	GSE169246_PacAteTissue_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53481
1.53335042376793e-24	0.31580483231631	0.397	0.207	3.15946854817381e-20	ZBTB1	B cells	GSE169246_PacAteTissue_post	ENSG00000126804	22890	zinc finger and BTB domain containing 1	KIAA0997|ZNF909	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53482
2.02363206308659e-24	0.272033481809115	0.315	0.143	4.16969386598991e-20	IRF2BP2	B cells	GSE169246_PacAteTissue_post	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53483
2.13395215536116e-24	0.435375485749367	0.687	0.488	4.39700841612167e-20	DDX3X	B cells	GSE169246_PacAteTissue_post	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53484
2.16760018535145e-24	0.576469627493864	0.41	0.22	4.46634018191666e-20	LMNA	B cells	GSE169246_PacAteTissue_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53485
2.78134854885744e-24	0.589340752219187	0.797	0.602	5.73096868492075e-20	ZFP36L2	B cells	GSE169246_PacAteTissue_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53486
6.1563804031743e-24	-0.68504170176085	0.224	0.441	1.26852218207407e-19	TCL1A	B cells	GSE169246_PacAteTissue_post	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53487
6.33876193778756e-24	-0.401701934040811	0.277	0.502	1.30610189728113e-19	SRSF9	B cells	GSE169246_PacAteTissue_post	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53488
7.299566102671e-24	0.364199254017552	0.947	0.739	1.50407559545536e-19	MT-ND2	B cells	GSE169246_PacAteTissue_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53489
1.61394120610552e-23	-0.395612369862776	0.313	0.532	3.32552585518042e-19	CSK	B cells	GSE169246_PacAteTissue_post	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53490
1.78157640891827e-23	-0.492051724118465	0.165	0.377	3.67093819057609e-19	SIAH2	B cells	GSE169246_PacAteTissue_post	ENSG00000181788	6478	siah E3 ubiquitin protein ligase 2	NA	protein_coding	O43255	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53491
2.27760905476329e-23	0.284639389968738	0.467	0.261	4.69301345733975e-19	SSU72	B cells	GSE169246_PacAteTissue_post	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53492
2.938662180202e-23	-0.445129331777802	0.837	0.896	6.05511342230621e-19	HNRNPA1	B cells	GSE169246_PacAteTissue_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53493
3.39052889054401e-23	-0.743963523666483	0.588	0.705	6.98618477896593e-19	HMGN1	B cells	GSE169246_PacAteTissue_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53494
3.49029792473569e-23	-0.480064980736855	0.131	0.342	7.19175887391789e-19	FAM76B	B cells	GSE169246_PacAteTissue_post	ENSG00000077458	143684	family with sequence similarity 76 member B	MGC33371	protein_coding	Q5HYJ3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53495
3.87923411516561e-23	-0.695920367953193	0.144	0.346	7.99316189429874e-19	LPP	B cells	GSE169246_PacAteTissue_post	ENSG00000145012	4026	LIM domain containing preferred translocation partner in lipoma	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53496
6.11587013867074e-23	0.497257803659283	0.651	0.445	1.26017504207311e-18	SQSTM1	B cells	GSE169246_PacAteTissue_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53497
1.69866685062848e-22	-0.57012076197201	0.233	0.429	3.50010304571999e-18	METAP2	B cells	GSE169246_PacAteTissue_post	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53498
1.91005395610671e-22	-0.337694209579833	0.055	0.252	3.93566617655787e-18	MDFIC	B cells	GSE169246_PacAteTissue_post	ENSG00000135272	29969	MyoD family inhibitor domain containing	HIC|MDFIC1	protein_coding	Q9P1T7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53499
2.34150954728557e-22	-0.378400910906849	0.577	0.731	4.82468042218193e-18	SLC25A3	B cells	GSE169246_PacAteTissue_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53500
2.97018087352216e-22	0.360477530715752	0.977	0.923	6.12005768989242e-18	MT-ND1	B cells	GSE169246_PacAteTissue_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53501
6.38532043800193e-22	0.275360317491919	0.355	0.181	1.3156952762503e-17	DRAP1	B cells	GSE169246_PacAteTissue_post	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53502
6.66687826043657e-22	-0.421788644069421	0.438	0.614	1.37371026556296e-17	SET	B cells	GSE169246_PacAteTissue_post	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53503
7.0768548656891e-22	0.297063257535189	0.326	0.157	1.45818594507524e-17	PRNP	B cells	GSE169246_PacAteTissue_post	ENSG00000171867	5621	prion protein	AltPrP|CD230|CJD|GSS|PRIP|PRP	protein_coding	P04156	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53504
1.13306389801695e-21	-0.434776156767834	0.087	0.29	2.33467816186393e-17	SYNE2	B cells	GSE169246_PacAteTissue_post	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53505
1.56775016120049e-21	0.270843157860931	0.364	0.187	3.2303492071536e-17	TOR3A	B cells	GSE169246_PacAteTissue_post	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53506
1.59654324981268e-21	0.559315524496197	0.545	0.355	3.28967736623904e-17	ZNF331	B cells	GSE169246_PacAteTissue_post	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53507
2.52940937690181e-21	-0.33228158776031	0.307	0.526	5.21184802110618e-17	ARF6	B cells	GSE169246_PacAteTissue_post	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53508
5.16946342641802e-21	-0.393918084250456	0.106	0.305	1.06516793901343e-16	BRWD1	B cells	GSE169246_PacAteTissue_post	ENSG00000185658	54014	bromodomain and WD repeat domain containing 1	C21orf107|DCAF19|FLJ11315|N143|WDR9	protein_coding	Q9NSI6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53509
1.00343656844754e-20	0.30054665039759	0.543	0.348	2.06758104928615e-16	CD47	B cells	GSE169246_PacAteTissue_post	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53510
1.27348968131451e-20	0.267509923136067	0.412	0.229	2.62402548834856e-16	NDUFS5	B cells	GSE169246_PacAteTissue_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53511
1.27692789199706e-20	0.318710852370292	0.719	0.503	2.63110992145995e-16	FXYD5	B cells	GSE169246_PacAteTissue_post	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53512
1.4346465376852e-20	0.301418425562857	0.97	0.948	2.95608919090036e-16	HLA-DPA1	B cells	GSE169246_PacAteTissue_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53513
2.14528331771104e-20	0.309526582199827	0.345	0.179	4.42035627614359e-16	S100A6	B cells	GSE169246_PacAteTissue_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53514
2.6907606269744e-20	0.439194193970355	0.643	0.49	5.54431227188076e-16	MCL1	B cells	GSE169246_PacAteTissue_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53515
2.9361076586303e-20	0.261592183280776	0.983	0.977	6.04984983060774e-16	RPS25	B cells	GSE169246_PacAteTissue_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53516
2.97605410006554e-20	-0.308843408815246	0.163	0.369	6.13215947318505e-16	STRBP	B cells	GSE169246_PacAteTissue_post	ENSG00000165209	55342	spermatid perinuclear RNA binding protein	FLJ11307|ILF3L|SPNR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53517
3.0812082133831e-20	-0.355434337529821	0.814	0.867	6.34882952367587e-16	CCNI	B cells	GSE169246_PacAteTissue_post	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53518
4.12641925975876e-20	-0.347716531691326	0.239	0.453	8.50248688473293e-16	LDHB	B cells	GSE169246_PacAteTissue_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53519
4.56838088238321e-20	-0.322676425498916	0.442	0.635	9.41314880815061e-16	JAK1	B cells	GSE169246_PacAteTissue_post	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53520
4.69891219672809e-20	0.25270151974879	0.34	0.173	9.68210858135823e-16	NXT1	B cells	GSE169246_PacAteTissue_post	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53521
6.04541926585399e-20	-0.46101921291217	0.755	0.83	1.24565863972921e-15	ARPC2	B cells	GSE169246_PacAteTissue_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53522
6.3130167058656e-20	-0.293229575267029	0.099	0.291	1.30079709224361e-15	TAF10	B cells	GSE169246_PacAteTissue_post	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53523
6.82756810237832e-20	-0.437902306789986	0.364	0.551	1.40682040749505e-15	VPREB3	B cells	GSE169246_PacAteTissue_post	ENSG00000128218	29802	V-set pre-B cell surrogate light chain 3	8HS20	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53524
7.50320066581393e-20	0.397669243893559	0.48	0.291	1.54603449719096e-15	IGKC	B cells	GSE169246_PacAteTissue_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53525
9.75888199888943e-20	-0.903716711036016	0.837	0.867	2.01081763587117e-15	GAPDH	B cells	GSE169246_PacAteTissue_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53526
9.92643068437809e-20	0.26921833720867	0.406	0.23	2.04534104251611e-15	NAPA	B cells	GSE169246_PacAteTissue_post	ENSG00000105402	8775	NSF attachment protein alpha	NA	protein_coding	P54920	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53527
1.29918465248615e-19	0.463831120509453	0.981	0.975	2.67696997644771e-15	H3F3B	B cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53528
1.96283295512642e-19	0.324464075064494	0.996	0.966	4.044417304038e-15	MT-ND4L	B cells	GSE169246_PacAteTissue_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53529
3.47085209098857e-19	-0.358208668722157	0.165	0.357	7.15169073348196e-15	TACC1	B cells	GSE169246_PacAteTissue_post	ENSG00000147526	6867	transforming acidic coiled-coil containing protein 1	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53530
3.4799519118998e-19	0.268987235712129	0.531	0.325	7.17044091446954e-15	SELL	B cells	GSE169246_PacAteTissue_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53531
4.08940086869118e-19	-0.470058458720747	0.133	0.317	8.42621048993818e-15	KLHL6	B cells	GSE169246_PacAteTissue_post	ENSG00000172578	89857	kelch like family member 6	FLJ00029	protein_coding	Q8WZ60	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53532
5.45039327590633e-19	0.505218439372117	0.738	0.583	1.1230535345005e-14	SAT1	B cells	GSE169246_PacAteTissue_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53533
6.57463609478484e-19	-0.314073313682695	0.939	0.968	1.35470376733042e-14	HSP90AB1	B cells	GSE169246_PacAteTissue_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53534
7.34899909237232e-19	0.710541449407524	0.252	0.118	1.51426126298332e-14	EGR1	B cells	GSE169246_PacAteTissue_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53535
8.47899470699067e-19	-0.342976131996525	0.082	0.261	1.74709685937543e-14	OTULIN	B cells	GSE169246_PacAteTissue_post	ENSG00000154124	90268	OTU deubiquitinase with linear linkage specificity	FAM105B|FLJ34884	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53536
8.67267754243072e-19	-0.327270103753307	0.77	0.854	1.78700520761785e-14	RHOA	B cells	GSE169246_PacAteTissue_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53537
9.51036818223005e-19	0.28795962369757	0.338	0.176	1.9596113639485e-14	KLF10	B cells	GSE169246_PacAteTissue_post	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53538
1.06551957027696e-18	0.311266767373577	0.975	0.935	2.19550307455568e-14	MT-ATP6	B cells	GSE169246_PacAteTissue_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53539
1.19443646830125e-18	0.252266917055418	0.465	0.278	2.46113634293473e-14	HLA-F	B cells	GSE169246_PacAteTissue_post	ENSG00000234487	3134	major histocompatibility complex, class I, F	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53540
1.38042431189118e-18	-0.354712842777582	0.264	0.459	2.84436429465178e-14	RAD21	B cells	GSE169246_PacAteTissue_post	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53541
1.6142293223997e-18	-0.643281363216954	0.326	0.486	3.32611951880459e-14	UBE2J1	B cells	GSE169246_PacAteTissue_post	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53542
2.0872019871742e-18	-0.58653007183732	0.865	0.885	4.30067969457244e-14	SERF2	B cells	GSE169246_PacAteTissue_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53543
2.66533741364263e-18	-0.303392059850912	0.953	0.974	5.49192774081063e-14	RPL5	B cells	GSE169246_PacAteTissue_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53544
3.61468183247369e-18	-0.367332793162199	0.979	0.984	7.44805191581204e-14	RPS3A	B cells	GSE169246_PacAteTissue_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53545
3.85914557952997e-18	-0.299944495474053	0.288	0.488	7.9517694666215e-14	CCT2	B cells	GSE169246_PacAteTissue_post	ENSG00000166226	10576	chaperonin containing TCP1 subunit 2	Cctb	protein_coding	P78371	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53546
5.40432923412118e-18	-0.416459361248412	0.222	0.404	1.11356203869067e-13	PRDX6	B cells	GSE169246_PacAteTissue_post	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53547
6.13417508957034e-18	0.280748808088777	0.607	0.425	1.26394677720597e-13	ATP6V0E1	B cells	GSE169246_PacAteTissue_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53548
6.41960941891505e-18	0.383967369433868	0.374	0.209	1.32276052076745e-13	DDIT4	B cells	GSE169246_PacAteTissue_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53549
7.33007628996022e-18	-0.283001760289939	0.095	0.272	1.5103622195463e-13	GRHPR	B cells	GSE169246_PacAteTissue_post	ENSG00000137106	9380	glyoxylate and hydroxypyruvate reductase	GLXR|PH2	protein_coding	Q9UBQ7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53550
7.83917472810435e-18	0.35851412049273	0.471	0.295	1.6152619527259e-13	LITAF	B cells	GSE169246_PacAteTissue_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53551
1.04912216314002e-17	-0.331718135213648	0.353	0.534	2.16171621715001e-13	NAP1L1	B cells	GSE169246_PacAteTissue_post	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53552
1.16829800417914e-17	-0.389537941094711	0.499	0.655	2.40727803761112e-13	POLD4	B cells	GSE169246_PacAteTissue_post	ENSG00000175482	57804	DNA polymerase delta 4, accessory subunit	p12|POLDS	protein_coding	Q9HCU8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53553
1.37493282423238e-17	0.250785188531771	0.427	0.252	2.83304908433082e-13	HSH2D	B cells	GSE169246_PacAteTissue_post	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53554
1.48517121365029e-17	0.634989126196267	0.645	0.525	3.06019528572642e-13	CREM	B cells	GSE169246_PacAteTissue_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53555
1.53541817224918e-17	0.251167866827617	0.389	0.222	3.16372914391943e-13	VOPP1	B cells	GSE169246_PacAteTissue_post	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53556
2.31001538192761e-17	-0.430195024159842	0.182	0.353	4.75978669446184e-13	FAM3C	B cells	GSE169246_PacAteTissue_post	ENSG00000196937	10447	FAM3 metabolism regulating signaling molecule C	GS3876|ILEI	protein_coding	Q92520	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53557
2.98262981508198e-17	0.471881726319591	0.985	0.959	6.14570873397642e-13	FTH1	B cells	GSE169246_PacAteTissue_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53558
3.97859199595358e-17	0.394941069877631	0.423	0.257	8.19788880766236e-13	NR4A3	B cells	GSE169246_PacAteTissue_post	ENSG00000119508	8013	nuclear receptor subfamily 4 group A member 3	CHN|CSMF|MINOR|NOR1	protein_coding	Q92570	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53559
5.02909281772267e-17	-0.285287092774992	0.211	0.402	1.03624457509176e-12	ATP5F1A	B cells	GSE169246_PacAteTissue_post	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53560
6.09054526505379e-17	-0.316716720793791	0.123	0.299	1.25495685186433e-12	LBR	B cells	GSE169246_PacAteTissue_post	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53561
6.9132740816409e-17	-0.321962817151105	0.429	0.587	1.42448012452211e-12	ATP5F1B	B cells	GSE169246_PacAteTissue_post	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53562
8.05341496747422e-17	0.33460841724277	0.691	0.55	1.65940615404806e-12	CLIC1	B cells	GSE169246_PacAteTissue_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53563
1.20412517500015e-16	0.253647176477636	0.345	0.191	2.48109992308781e-12	ELL2	B cells	GSE169246_PacAteTissue_post	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53564
1.21717813853239e-16	-0.304057440780184	0.416	0.59	2.50799555444599e-12	ACTR2	B cells	GSE169246_PacAteTissue_post	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53565
1.65089865297998e-16	-0.385536066048351	0.224	0.41	3.40167667446524e-12	GSTP1	B cells	GSE169246_PacAteTissue_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53566
1.68398403652834e-16	-0.38844828189984	0.114	0.285	3.46984910726665e-12	NEIL1	B cells	GSE169246_PacAteTissue_post	ENSG00000140398	79661	nei like DNA glycosylase 1	FLJ22402|FPG1|hFPG1|NEI1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53567
1.71686362944137e-16	-0.484387621300178	0.658	0.745	3.53759750846395e-12	CD53	B cells	GSE169246_PacAteTissue_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53568
2.25378416750803e-16	-0.313748428948779	0.169	0.345	4.64392227715029e-12	TKT	B cells	GSE169246_PacAteTissue_post	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53569
2.34635826442391e-16	-0.339679739868549	0.484	0.638	4.83467120384546e-12	LYN	B cells	GSE169246_PacAteTissue_post	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53570
2.36432997155297e-16	0.252166472957239	0.495	0.321	4.8717019063849e-12	CNPY3	B cells	GSE169246_PacAteTissue_post	ENSG00000137161	10695	canopy FGF signaling regulator 3	CAG4A|TNRC5	protein_coding	Q9BT09	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53571
3.12673211633841e-16	-0.439338683812232	0.182	0.348	6.4426315257153e-12	SEC14L1	B cells	GSE169246_PacAteTissue_post	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53572
3.34565556526528e-16	-0.259509391184566	0.095	0.26	6.8937232922291e-12	PTEN	B cells	GSE169246_PacAteTissue_post	ENSG00000284792	5728	phosphatase and tensin homolog	BZS|MHAM|MMAC1|PTEN1|TEP1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53573
3.37758732416933e-16	0.289779397915527	0.584	0.411	6.95951868145091e-12	CD48	B cells	GSE169246_PacAteTissue_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53574
3.38370903010661e-16	-0.323600094340248	0.106	0.273	6.97213245653466e-12	PELI1	B cells	GSE169246_PacAteTissue_post	ENSG00000197329	57162	pellino E3 ubiquitin protein ligase 1	NA	protein_coding	Q96FA3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53575
3.94795995319304e-16	0.575624916758691	0.554	0.395	8.13477148355426e-12	ID3	B cells	GSE169246_PacAteTissue_post	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53576
4.75949724492382e-16	0.537712579288765	0.634	0.478	9.80694407316554e-12	CD69	B cells	GSE169246_PacAteTissue_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53577
5.28535322417652e-16	-0.329662460717607	0.319	0.492	1.08904703184157e-11	RAB11FIP1	B cells	GSE169246_PacAteTissue_post	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53578
5.32065550430131e-16	-0.372300393304034	0.421	0.572	1.09632106666129e-11	GDI2	B cells	GSE169246_PacAteTissue_post	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53579
5.48802538060864e-16	0.289183984972536	0.617	0.436	1.13080762967441e-11	IDS	B cells	GSE169246_PacAteTissue_post	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53580
5.83745753938136e-16	0.288816431944216	0.998	0.977	1.20280812598953e-11	MT-CO2	B cells	GSE169246_PacAteTissue_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53581
6.07114361273665e-16	-0.390692139883148	0.144	0.309	1.25095914140439e-11	PAG1	B cells	GSE169246_PacAteTissue_post	ENSG00000076641	55824	phosphoprotein membrane anchor with glycosphingolipid microdomains 1	CBP|PAG	protein_coding	Q9NWQ8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53582
6.79235112302662e-16	0.256555758631776	0.262	0.132	1.39956394889964e-11	PNP	B cells	GSE169246_PacAteTissue_post	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53583
7.07077855106456e-16	-0.282253707155622	0.336	0.51	1.45693392044685e-11	CCT3	B cells	GSE169246_PacAteTissue_post	ENSG00000163468	7203	chaperonin containing TCP1 subunit 3	Cctg|TRIC5	protein_coding	P49368	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53584
7.71508372556937e-16	0.258231536956069	0.96	0.953	1.58969300165357e-11	RPL37A	B cells	GSE169246_PacAteTissue_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53585
8.58577831789701e-16	0.350759882676191	0.596	0.44	1.76909962240268e-11	KDM6B	B cells	GSE169246_PacAteTissue_post	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53586
8.74308988745441e-16	-0.291239913162235	0.129	0.297	1.80151367130998e-11	H2AFY	B cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53587
9.19360201017138e-16	-0.279316158228976	0.342	0.52	1.89434169419581e-11	CCT6A	B cells	GSE169246_PacAteTissue_post	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53588
1.18063063721454e-15	0.286654756399271	0.315	0.173	2.43268942798055e-11	INSIG1	B cells	GSE169246_PacAteTissue_post	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53589
1.39956320033342e-15	0.369094440906671	0.431	0.275	2.88379997428701e-11	MAP3K8	B cells	GSE169246_PacAteTissue_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53590
1.44179101527247e-15	-0.401250395900826	0.7	0.771	2.97081038696892e-11	PTPRC	B cells	GSE169246_PacAteTissue_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53591
1.56368901824309e-15	0.286713626773056	0.636	0.483	3.22198122208989e-11	PSME1	B cells	GSE169246_PacAteTissue_post	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53592
2.3043582569057e-15	0.312056389535943	0.59	0.433	4.74813018835419e-11	LSM7	B cells	GSE169246_PacAteTissue_post	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53593
3.24927717875014e-15	-0.411600714479945	0.317	0.476	6.69513562681466e-11	DEK	B cells	GSE169246_PacAteTissue_post	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53594
4.04841413743026e-15	-0.266248977894684	0.288	0.466	8.34175733017504e-11	CCT5	B cells	GSE169246_PacAteTissue_post	ENSG00000150753	22948	chaperonin containing TCP1 subunit 5	KIAA0098	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53595
4.07605006318825e-15	-0.285729815939901	0.685	0.796	8.39870115519939e-11	SLC25A6	B cells	GSE169246_PacAteTissue_post	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53596
4.28560262171338e-15	-0.270949313440217	0.395	0.566	8.83048420204043e-11	CCT4	B cells	GSE169246_PacAteTissue_post	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53597
4.44608589115511e-15	0.286538788790118	0.655	0.493	9.16115997872511e-11	BIRC3	B cells	GSE169246_PacAteTissue_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53598
4.49386591077077e-15	-0.25129841665476	0.207	0.387	9.25961070914317e-11	GNAI2	B cells	GSE169246_PacAteTissue_post	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53599
4.58958694071519e-15	-0.302325901573203	0.127	0.292	9.45684389134365e-11	NSMCE3	B cells	GSE169246_PacAteTissue_post	ENSG00000282130	56160	NSE3 homolog, SMC5-SMC6 complex component	HCA4|MAGEG1|MAGEL3|NDNL2|NSE3	protein_coding	Q96MG7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53600
6.24031481599235e-15	-0.344308707711045	0.23	0.393	1.28581686783522e-10	RBBP4	B cells	GSE169246_PacAteTissue_post	ENSG00000162521	5928	RB binding protein 4, chromatin remodeling factor	lin-53|NURF55|RbAp48	protein_coding	Q09028	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53601
7.32539985331503e-15	0.387798566271948	0.594	0.449	1.50939863977556e-10	CDC37	B cells	GSE169246_PacAteTissue_post	ENSG00000105401	11140	cell division cycle 37, HSP90 cochaperone	P50CDC37	protein_coding	Q16543	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53602
8.21268091400301e-15	0.535964096371966	0.641	0.502	1.69222290233032e-10	TUBB4B	B cells	GSE169246_PacAteTissue_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53603
9.07019560988948e-15	0.256626093507724	0.852	0.657	1.86891380541773e-10	SARAF	B cells	GSE169246_PacAteTissue_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53604
9.51480640620576e-15	-0.382973284177828	0.106	0.26	1.9605258599987e-10	CD38	B cells	GSE169246_PacAteTissue_post	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53605
1.00348961661762e-14	0.27922444783443	0.376	0.227	2.06769035504061e-10	IFRD1	B cells	GSE169246_PacAteTissue_post	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53606
1.00988870202143e-14	-0.250028983134753	0.104	0.26	2.08087567051515e-10	UBE2H	B cells	GSE169246_PacAteTissue_post	ENSG00000186591	7328	ubiquitin conjugating enzyme E2 H	GID3|UBC8|UBCH	protein_coding	P62256	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53607
1.22544122517882e-14	0.290827100476107	0.856	0.765	2.52502164448096e-10	CD52	B cells	GSE169246_PacAteTissue_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53608
1.41227722630522e-14	-0.310779490194809	0.197	0.359	2.9099972248019e-10	SNX5	B cells	GSE169246_PacAteTissue_post	ENSG00000089006	27131	sorting nexin 5	NA	protein_coding	Q9Y5X3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53609
1.69601113423247e-14	-0.458377310677922	0.366	0.502	3.49463094208601e-10	CD22	B cells	GSE169246_PacAteTissue_post	ENSG00000012124	933	CD22 molecule	SIGLEC-2|SIGLEC2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53610
1.71704600489708e-14	0.393409450945936	0.687	0.561	3.53797329309044e-10	ATP6V0C	B cells	GSE169246_PacAteTissue_post	ENSG00000185883	527	ATPase H+ transporting V0 subunit c	ATP6C|ATP6L|ATPL|VATL|Vma3	protein_coding	P27449	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53611
1.86405510940037e-14	-0.347247080975905	0.182	0.344	3.84088555291946e-10	IER5	B cells	GSE169246_PacAteTissue_post	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53612
2.41081651850945e-14	-0.418768236946929	0.148	0.302	4.96748743638873e-10	DNMT1	B cells	GSE169246_PacAteTissue_post	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53613
5.30118829636395e-14	-0.335691185718964	0.951	0.963	1.09230984846579e-09	BTG1	B cells	GSE169246_PacAteTissue_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53614
5.57039231357384e-14	-0.252389412407134	0.279	0.447	1.14777933621189e-09	PHB2	B cells	GSE169246_PacAteTissue_post	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53615
6.16286550145352e-14	0.29262196826105	0.556	0.39	1.2698584365745e-09	PDE4B	B cells	GSE169246_PacAteTissue_post	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53616
6.24041875247034e-14	0.567106523726889	0.499	0.365	1.28583828394651e-09	RGS2	B cells	GSE169246_PacAteTissue_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53617
8.11746218512589e-14	0.265634347128592	0.288	0.159	1.67260308324519e-09	NFKBIZ	B cells	GSE169246_PacAteTissue_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53618
9.48011978881764e-14	-0.30774426194086	0.197	0.358	1.95337868248587e-09	YWHAH	B cells	GSE169246_PacAteTissue_post	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53619
1.07735776027225e-13	0.430824783868335	0.738	0.641	2.21989566504096e-09	YPEL5	B cells	GSE169246_PacAteTissue_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53620
1.53825242881849e-13	-0.383276587354639	0.381	0.501	3.1695691295805e-09	PARP1	B cells	GSE169246_PacAteTissue_post	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53621
2.21009991955326e-13	-0.29516484245626	0.884	0.92	4.5539108842395e-09	HNRNPA2B1	B cells	GSE169246_PacAteTissue_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53622
2.26185017918142e-13	0.369490281324125	0.662	0.539	4.66054229420332e-09	SAP18	B cells	GSE169246_PacAteTissue_post	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53623
2.41242287827028e-13	-0.297227849944826	0.108	0.252	4.97079734067592e-09	MCTP2	B cells	GSE169246_PacAteTissue_post	ENSG00000140563	55784	multiple C2 and transmembrane domain containing 2	FLJ11175|FLJ33303	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53624
2.56179632036805e-13	-0.29795538047395	0.505	0.638	5.27858131811837e-09	HCLS1	B cells	GSE169246_PacAteTissue_post	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53625
3.16020142957007e-13	-0.302555561019228	0.334	0.484	6.51159504562914e-09	TNFRSF13C	B cells	GSE169246_PacAteTissue_post	ENSG00000159958	115650	TNF receptor superfamily member 13C	BAFFR|CD268	protein_coding	Q96RJ3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53626
3.42641183382931e-13	-0.270960495339432	0.245	0.401	7.0601215836053e-09	HNRNPD	B cells	GSE169246_PacAteTissue_post	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53627
4.38348294963657e-13	-0.251809411272238	0.116	0.261	9.03216661772616e-09	SSBP2	B cells	GSE169246_PacAteTissue_post	ENSG00000145687	23635	single stranded DNA binding protein 2	HSPC116	protein_coding	P81877	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53628
4.52646956352811e-13	-0.280605226640074	0.423	0.581	9.32679053564967e-09	STK17B	B cells	GSE169246_PacAteTissue_post	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53629
4.71966829856499e-13	-0.296098779183844	0.655	0.762	9.72487652919316e-09	YWHAB	B cells	GSE169246_PacAteTissue_post	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53630
5.16236824889574e-13	-0.635495178883484	0.751	0.816	1.06370597768497e-08	HMGB1	B cells	GSE169246_PacAteTissue_post	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53631
5.16283990627329e-13	-0.423326910979336	0.279	0.422	1.06380316268761e-08	H2AFV	B cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53632
7.51550870239924e-13	-0.263139585365127	0.469	0.622	1.54857056812936e-08	CDC42	B cells	GSE169246_PacAteTissue_post	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53633
7.52542954613845e-13	-0.263486496211596	0.125	0.268	1.55061475798183e-08	CPNE3	B cells	GSE169246_PacAteTissue_post	ENSG00000085719	8895	copine 3	NA	protein_coding	O75131	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53634
1.10846219569909e-12	-0.27590896614282	0.52	0.655	2.28398635423796e-08	CACYBP	B cells	GSE169246_PacAteTissue_post	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53635
1.27223316021901e-12	0.313685460852366	0.723	0.592	2.62143642663128e-08	BRD2	B cells	GSE169246_PacAteTissue_post	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53636
1.42942346957313e-12	-0.340850000859622	0.966	0.983	2.94532705905544e-08	HSP90AA1	B cells	GSE169246_PacAteTissue_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53637
1.64474833380253e-12	-0.311741559268193	0.397	0.529	3.38900394180012e-08	SYPL1	B cells	GSE169246_PacAteTissue_post	ENSG00000008282	6856	synaptophysin like 1	SYPL	protein_coding	Q16563	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53638
1.81468129798257e-12	-0.281391477766169	0.302	0.452	3.73915081449308e-08	EIF3A	B cells	GSE169246_PacAteTissue_post	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53639
2.25261780433968e-12	-0.304883379534583	0.463	0.594	4.64151898584192e-08	HNRNPA3	B cells	GSE169246_PacAteTissue_post	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53640
2.61886283742222e-12	-0.306393475832783	0.44	0.57	5.39616687650848e-08	RAP1B	B cells	GSE169246_PacAteTissue_post	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53641
2.66250824041899e-12	-0.251911836480208	0.427	0.569	5.48609822938333e-08	EIF3L	B cells	GSE169246_PacAteTissue_post	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53642
3.13617268292747e-12	0.265935141884262	0.433	0.288	6.46208381317205e-08	PARP14	B cells	GSE169246_PacAteTissue_post	ENSG00000173193	54625	poly(ADP-ribose) polymerase family member 14	ARTD8|BAL2|KIAA1268|pART8	protein_coding	Q460N5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53643
3.15410050547449e-12	-0.292681856191405	0.66	0.757	6.49902409153018e-08	RAN	B cells	GSE169246_PacAteTissue_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53644
3.50328956762057e-12	-0.304489070952334	0.313	0.462	7.21852815408219e-08	ARPC5	B cells	GSE169246_PacAteTissue_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53645
3.61952105285711e-12	0.383864655077054	0.395	0.257	7.45802312941208e-08	CHMP1B	B cells	GSE169246_PacAteTissue_post	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53646
3.80077943589991e-12	-0.251197541349516	0.144	0.286	7.83150602767177e-08	CUL3	B cells	GSE169246_PacAteTissue_post	ENSG00000036257	8452	cullin 3	NA	protein_coding	Q13618	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53647
4.41815180725902e-12	-0.328681110781872	0.159	0.299	9.10360179885722e-08	IL4R	B cells	GSE169246_PacAteTissue_post	ENSG00000077238	3566	interleukin 4 receptor	CD124	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53648
5.06532746995549e-12	0.275895061853442	0.397	0.257	1.04371072518433e-07	H2AFX	B cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53649
5.59687652351086e-12	0.482645759084204	0.719	0.607	1.15323640766941e-07	IER2	B cells	GSE169246_PacAteTissue_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53650
6.91410423351813e-12	-0.292398455675138	0.233	0.372	1.42465117731641e-07	MBD4	B cells	GSE169246_PacAteTissue_post	ENSG00000129071	8930	methyl-CpG binding domain 4, DNA glycosylase	MED1	protein_coding	O95243	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53651
8.65068009950879e-12	-0.268887878039525	0.408	0.549	1.78247263450379e-07	CAP1	B cells	GSE169246_PacAteTissue_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53652
8.90522690130572e-12	-0.262226430964448	0.49	0.621	1.83492200301404e-07	RPS17	B cells	GSE169246_PacAteTissue_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53653
9.02763822788769e-12	-0.715241724611136	0.152	0.282	1.86014485685626e-07	HMGB2	B cells	GSE169246_PacAteTissue_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53654
9.23717451464415e-12	-0.279012460524977	0.161	0.298	1.90331980874243e-07	BLOC1S6	B cells	GSE169246_PacAteTissue_post	ENSG00000104164	26258	biogenesis of lysosomal organelles complex 1 subunit 6	HPS9|PA|PLDN	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53655
1.09478144043076e-11	-0.326131568183069	0.841	0.901	2.25579715800758e-07	EZR	B cells	GSE169246_PacAteTissue_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53656
1.31778984424651e-11	-0.263609346018976	0.457	0.602	2.71530597406993e-07	HNRNPU	B cells	GSE169246_PacAteTissue_post	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53657
2.32632857635124e-11	-0.270154554075802	0.328	0.463	4.79340003157172e-07	ACAP2	B cells	GSE169246_PacAteTissue_post	ENSG00000114331	23527	ArfGAP with coiled-coil, ankyrin repeat and PH domains 2	CENTB2|CNT-B2|KIAA0041	protein_coding	Q15057	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53658
2.44726165607132e-11	0.340467863710508	0.288	0.172	5.04258264233496e-07	XIST	B cells	GSE169246_PacAteTissue_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53659
2.66963409909882e-11	-0.261573965856894	0.235	0.373	5.50078106119313e-07	ANKRD13A	B cells	GSE169246_PacAteTissue_post	ENSG00000076513	88455	ankyrin repeat domain 13A	ANKRD13|NY-REN-25	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53660
4.55870862840775e-11	-0.276996980940498	0.328	0.473	9.39321912883417e-07	ARID5B	B cells	GSE169246_PacAteTissue_post	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53661
4.71760345002103e-11	-0.267713901988837	0.448	0.583	9.72062190876833e-07	RPL22L1	B cells	GSE169246_PacAteTissue_post	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53662
5.09521385743892e-11	-0.686712046537024	0.596	0.687	1.04986881532529e-06	TUBA1B	B cells	GSE169246_PacAteTissue_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53663
5.63121522853786e-11	0.256799806655615	0.469	0.325	1.16031189784023e-06	IRF1	B cells	GSE169246_PacAteTissue_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53664
5.81493159143458e-11	-0.314788795613235	0.323	0.454	1.1981666544151e-06	TPD52	B cells	GSE169246_PacAteTissue_post	ENSG00000076554	7163	tumor protein D52	D52|hD52|N8L	protein_coding	P55327	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53665
5.84484719869207e-11	-0.283972963301204	0.431	0.553	1.2043307652905e-06	ITSN2	B cells	GSE169246_PacAteTissue_post	ENSG00000198399	50618	intersectin 2	KIAA1256|PRO2015|SH3D1B|SH3P18|SWA|SWAP	protein_coding	Q9NZM3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53666
6.85531693751767e-11	-0.328135644224687	0.748	0.805	1.41253805497552e-06	HSPH1	B cells	GSE169246_PacAteTissue_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53667
9.87429096104139e-11	0.315475240838381	0.499	0.357	2.03459765252258e-06	SRGN	B cells	GSE169246_PacAteTissue_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53668
1.37547787214009e-10	0.303637729464808	0.431	0.302	2.83417215554465e-06	SOCS1	B cells	GSE169246_PacAteTissue_post	ENSG00000185338	8651	suppressor of cytokine signaling 1	Cish1|JAB|SOCS-1|SSI-1|TIP3	protein_coding	O15524	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53669
1.42802254701906e-10	-0.31925436427385	0.66	0.74	2.94244045813277e-06	ATP5MG	B cells	GSE169246_PacAteTissue_post	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53670
1.57958040627261e-10	-0.40478108145366	0.374	0.486	3.25472542712472e-06	HMGA1	B cells	GSE169246_PacAteTissue_post	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53671
2.05106678331008e-10	-0.760070241056572	0.564	0.64	4.22622310701042e-06	HMGN2	B cells	GSE169246_PacAteTissue_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53672
3.53299518156182e-10	-0.350555030082274	0.376	0.496	7.27973657160814e-06	PKM	B cells	GSE169246_PacAteTissue_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53673
3.9372176667596e-10	-0.258794971419864	0.165	0.292	8.11263700235816e-06	CR2	B cells	GSE169246_PacAteTissue_post	ENSG00000117322	1380	complement C3d receptor 2	C3DR|CD21	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53674
4.2740886364268e-10	-0.307405559725446	0.603	0.697	8.80675963535743e-06	CYTIP	B cells	GSE169246_PacAteTissue_post	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53675
4.38191628627919e-10	-0.402137922155407	0.41	0.499	9.02893850787828e-06	POU2AF1	B cells	GSE169246_PacAteTissue_post	ENSG00000110777	5450	POU class 2 homeobox associating factor 1	BOB1|OBF1|OCA-B	protein_coding	Q16633	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53676
4.42349617301066e-10	-0.264540135286502	0.273	0.4	9.11461386448847e-06	SPI1	B cells	GSE169246_PacAteTissue_post	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53677
6.78917420551149e-10	-0.574829814892919	0.469	0.55	1.39890934504564e-05	MARCKSL1	B cells	GSE169246_PacAteTissue_post	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53678
7.49976453177097e-10	0.356434356252639	0.873	0.818	1.54532648177141e-05	CD83	B cells	GSE169246_PacAteTissue_post	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53679
1.64252307360245e-09	-0.278192747711309	0.939	0.932	3.38441879315784e-05	MS4A1	B cells	GSE169246_PacAteTissue_post	ENSG00000156738	931	membrane spanning 4-domains A1	B1|Bp35|CD20|FMC7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53680
2.3073143538835e-09	0.330337766942135	0.393	0.284	4.75422122617696e-05	NEAT1	B cells	GSE169246_PacAteTissue_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53681
4.77341849500033e-09	-0.289722391539024	0.744	0.826	9.83562880894819e-05	HSPD1	B cells	GSE169246_PacAteTissue_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53682
6.47094151939872e-09	-0.255705600203307	0.264	0.388	0.000133333750007211	NFKB1	B cells	GSE169246_PacAteTissue_post	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53683
8.86213777747994e-09	0.252586322559329	0.476	0.358	0.000182604348904974	MRPS6	B cells	GSE169246_PacAteTissue_post	ENSG00000243927	64968	mitochondrial ribosomal protein S6	C21orf101|MRP-S6|RPMS6	protein_coding	P82932	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53684
1.52487124757411e-08	0.514743910364203	0.619	0.558	0.000314199720562645	PPP1R15A	B cells	GSE169246_PacAteTissue_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53685
1.87317941489658e-08	-0.296531273073309	0.224	0.33	0.00038596861843944	CLIC4	B cells	GSE169246_PacAteTissue_post	ENSG00000169504	25932	chloride intracellular channel 4	CLIC4L|DKFZP566G223|H1|huH1|P64H1	protein_coding	Q9Y696	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53686
2.10956953074678e-08	-0.369628090266568	0.628	0.726	0.000434676801810374	KLF6	B cells	GSE169246_PacAteTissue_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53687
2.3835081253612e-08	-0.331391768542963	0.247	0.367	0.000491121849230675	UBE2S	B cells	GSE169246_PacAteTissue_post	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53688
5.21299723050656e-08	-0.273094568127153	0.734	0.783	0.00107413807934588	LIMD2	B cells	GSE169246_PacAteTissue_post	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53689
6.05765736934259e-08	-0.363217758662578	0.884	0.904	0.00124818030095304	CFL1	B cells	GSE169246_PacAteTissue_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53690
6.25738853379365e-08	-0.684775797803244	0.391	0.474	0.00128933490738818	TUBB	B cells	GSE169246_PacAteTissue_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53691
7.7368396381385e-08	-0.328812485825526	0.438	0.525	0.00159417580743844	IRF8	B cells	GSE169246_PacAteTissue_post	ENSG00000140968	3394	interferon regulatory factor 8	ICSBP|ICSBP1|IRF-8	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53692
8.32296975014443e-08	0.284409920545515	0.529	0.424	0.00171494791701726	RSRP1	B cells	GSE169246_PacAteTissue_post	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53693
1.18873914084695e-07	-0.400028826384206	0.275	0.381	0.00244939699971514	BACH2	B cells	GSE169246_PacAteTissue_post	ENSG00000112182	60468	BTB domain and CNC homolog 2	BTBD25	protein_coding	Q9BYV9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53694
1.65078714036791e-07	0.264297138771252	0.575	0.485	0.00340144690272807	MAP1LC3B	B cells	GSE169246_PacAteTissue_post	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53695
1.6510375447201e-07	-0.275488857511422	0.218	0.312	0.00340196286089578	SYVN1	B cells	GSE169246_PacAteTissue_post	ENSG00000162298	84447	synoviolin 1	DER3|HRD1	protein_coding	Q86TM6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53696
2.0542215760872e-07	-0.638725730002679	0.207	0.293	0.00423272355752768	STMN1	B cells	GSE169246_PacAteTissue_post	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53697
2.1313450485861e-07	-0.310098334132045	0.245	0.358	0.00439163647261166	RGS1	B cells	GSE169246_PacAteTissue_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53698
2.30399196975477e-07	0.260678045642429	0.514	0.41	0.00474737545367971	AC016831.7	B cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53699
3.71069501113748e-07	-0.311090967226793	0.34	0.429	0.00764588707044878	RAB30	B cells	GSE169246_PacAteTissue_post	ENSG00000137502	27314	RAB30, member RAS oncogene family	NA	protein_coding	Q15771	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53700
4.61547231465053e-07	0.267103118178581	0.71	0.63	0.00951018070433741	DYNLL1	B cells	GSE169246_PacAteTissue_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53701
6.55547826205136e-07	-0.261813326263912	0.52	0.596	0.0135075629589568	SMIM14	B cells	GSE169246_PacAteTissue_post	ENSG00000163683	201895	small integral membrane protein 14	C4orf34|FLJ13289	protein_coding	Q96QK8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53702
7.32388589767275e-07	-0.25811844453879	0.218	0.32	0.0150908668921547	FCER2	B cells	GSE169246_PacAteTissue_post	ENSG00000104921	2208	Fc epsilon receptor II	CD23|CD23A|CLEC4J|FCE2|FcepsilonRII|FCErII	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53703
7.41721270081791e-07	-0.275251609389708	0.323	0.414	0.0152831667700353	ST6GAL1	B cells	GSE169246_PacAteTissue_post	ENSG00000073849	6480	ST6 beta-galactoside alpha-2,6-sialyltransferase 1	CDw75|SIAT1	protein_coding	P15907	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53704
2.01811855981336e-06	-0.320433808295465	0.404	0.484	0.0415833329249543	TPM4	B cells	GSE169246_PacAteTissue_post	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53705
0	0.833186616185667	0.998	0.983	0	TMSB10	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53706
0	1.07850502352895	0.999	0.996	0	HLA-B	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53707
0	0.499187718800694	1	1	0	RPL28	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53708
0	-0.916932173911826	0.95	0.997	0	MT-ATP8	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53709
0	-0.735435586684507	0.976	0.999	0	MT-ND3	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53710
0	-0.926894041136708	0.798	0.962	0	MT-ND4	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53711
5.5105590641733e-274	-0.637528326175405	0.976	0.999	1.13545069517291e-269	MT-CYB	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53712
1.12115345856051e-258	1.07943035606129	0.515	0.15	2.31013670136393e-254	IFI6	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53713
2.74861607658741e-257	-0.630293593906837	0.973	0.999	5.66352342580836e-253	MT-CO3	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53714
9.82699973042494e-257	0.734467495281631	0.497	0.129	2.02485329445406e-252	XAF1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53715
2.24052590384545e-256	-1.04548417467477	1	1	4.61660362487355e-252	MALAT1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53716
2.64248438625381e-249	-0.774187635892229	0.103	0.471	5.44483907787597e-245	HLA-DQA1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53717
4.67531979689491e-249	1.22135858705541	0.579	0.221	9.63349644150197e-245	ISG15	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53718
7.33096073174019e-245	0.671148612130586	0.38	0.054	1.51054445877507e-240	IFI44L	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53719
9.7835307126178e-242	-0.797517059624337	0.857	0.978	2.0158965033349e-237	CD74	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53720
7.53432327920219e-229	-0.747862756769284	0.913	0.975	1.55244731167961e-224	CCL5	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53721
2.12359327276905e-226	-0.540390533334035	0.997	1	4.37566393854063e-222	MT-CO1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53722
1.11829112565199e-220	1.23897060905257	0.751	0.455	2.30423886440592e-216	MT2A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53723
8.5931434838739e-217	0.793220554803812	0.866	0.609	1.77061721485222e-212	CD52	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53724
1.00734385964935e-215	0.501822222575007	1	1	2.07563202280748e-211	TMSB4X	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53725
2.59958491801482e-205	0.644851928292839	0.496	0.162	5.35644472356954e-201	IRF7	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53726
8.85883542507767e-201	0.74226939643291	0.647	0.304	1.82536303933725e-196	S100A11	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53727
1.27928896316136e-199	1.18546553067256	0.993	0.98	2.63597490859399e-195	FTH1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53728
3.9164723621111e-199	-0.490173342565646	0.988	0.999	8.06989130212992e-195	MT-ND4L	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53729
3.34511392685309e-198	0.677956619129642	0.737	0.401	6.89260724628079e-194	S100A10	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53730
2.98819641798727e-197	-0.47440502256813	0.998	0.999	6.15717871926277e-193	HLA-A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53731
1.89356783626141e-193	0.881284932789942	0.728	0.471	3.90169652661664e-189	LY6E	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53732
7.26193914411776e-186	0.44976258864901	1	1	1.49632256064546e-181	RPLP1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53733
1.92382013898923e-181	0.827534733588548	0.645	0.344	3.96403139638731e-177	ISG20	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53734
2.33529424049736e-181	-0.626161788263385	0.288	0.606	4.81187378254482e-177	CTSW	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53735
8.14389959040282e-179	-0.564193021177407	0.944	0.967	1.6780505106025e-174	IL32	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53736
3.27862094499206e-178	0.795516419700269	0.944	0.791	6.75559845715613e-174	VIM	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53737
7.59760332963183e-177	0.666781913207845	0.839	0.6	1.56548616607064e-172	S100A6	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53738
9.61504406550659e-173	0.365931113271006	0.283	0.037	1.98117982969763e-168	ERAP2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53739
4.83190948242713e-170	0.426794419044467	1	0.997	9.95614948854111e-166	HLA-C	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53740
9.38519994574518e-167	0.611779427791205	0.929	0.723	1.93382044882079e-162	PABPC1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53741
3.5735588221234e-155	0.513626655085474	0.57	0.259	7.36331795298526e-151	SPOCK2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53742
2.67177574474983e-153	0.549538711036538	0.763	0.502	5.50519392205702e-149	NDUFS5	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53743
3.32787472886862e-153	-0.660208134776568	0.634	0.858	6.8570858788338e-149	GZMK	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53744
2.48633130166355e-151	0.579434977146913	0.457	0.178	5.12308564707774e-147	ITM2C	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53745
1.24932774547861e-145	-0.698937274011748	0.453	0.705	2.57423981955868e-141	HLA-DRB1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53746
1.16936750223282e-143	0.527412788513532	0.329	0.087	2.40948173835073e-139	MX2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000183486	4600	MX dynamin like GTPase 2	MXB	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53747
1.46511441955772e-143	0.45734762124132	0.407	0.14	3.01886826149868e-139	EIF2AK2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53748
2.778640533393e-140	0.473261556571817	0.991	0.96	5.72538881905628e-136	RPLP0	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53749
1.59746431194298e-138	0.36874854517866	1	1	3.2915752147585e-134	RPS12	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53750
1.01895823116587e-137	0.419378666264461	1	0.996	2.09956343531728e-133	TPT1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53751
1.66714453091515e-136	0.543541277167277	0.436	0.173	3.43515130595066e-132	STAT1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53752
8.46239561149029e-136	-0.77571449372957	0.971	0.988	1.74367661574757e-131	HSP90AA1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53753
3.26100614618043e-135	0.472682735735956	0.613	0.334	6.71930316420478e-131	PLP2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53754
9.05361055709305e-135	0.472968961715139	0.472	0.203	1.86549645528902e-130	UBE2L6	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53755
1.94917449487287e-134	0.520605032521124	0.541	0.26	4.01627404668554e-130	CSRNP1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53756
1.31070463276244e-132	-0.540188404860456	0.815	0.892	2.700706895807e-128	PNRC1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53757
9.43260483619322e-132	0.425194652181764	0.526	0.254	1.94358822649761e-127	OCIAD2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000145247	132299	OCIA domain containing 2	MGC45416	protein_coding	Q56VL3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53758
4.5395167752757e-129	0.542412224238448	0.459	0.193	9.35367431545557e-125	CDKN1A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53759
4.03836295723242e-124	0.721332604394122	0.556	0.284	8.32104687337739e-120	IL7R	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53760
5.4472909174404e-124	-0.650936958634073	0.244	0.497	1.12241429353859e-119	HLA-DRA	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53761
3.12743182457066e-121	0.511134386813092	0.364	0.132	6.44407327452784e-117	PLSCR1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53762
2.39023947454206e-119	-0.415737488495997	0.882	0.95	4.92508843729391e-115	MT-ND2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53763
9.96877907354487e-117	0.669802192080867	0.444	0.208	2.05406692810392e-112	MX1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53764
6.63631403961221e-114	-0.471554201963923	0.849	0.902	1.3674125078621e-109	PTPRC	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53765
8.80206081787584e-114	0.369308534123458	0.395	0.154	1.81366463152332e-109	TMEM123	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53766
7.89670417501855e-112	0.400491505256601	0.486	0.235	1.62711589526257e-107	TAP1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53767
3.41784150004768e-110	0.51599116659745	0.666	0.367	7.04246241084825e-106	ANXA1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53768
5.15058258259079e-105	0.313648578725201	0.998	0.991	1.06127754114283e-100	RPS25	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53769
6.13670727652279e-104	-0.602085542810556	0.553	0.72	1.26446853432752e-99	HIST1H4C	CD8+ T cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53770
7.07763605591798e-104	0.661706713200805	0.961	0.911	1.4583469093219e-99	IFITM1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53771
7.7713794389266e-104	0.724738291058938	0.766	0.613	1.60129273339082e-99	S100A4	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53772
1.58343835209929e-101	0.87003673526469	0.268	0.079	3.26267472450058e-97	KLRB1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53773
2.11790482240995e-101	-0.294867335572052	0.997	1	4.36394288657571e-97	MT-CO2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53774
2.66206353425321e-101	-0.386883532410242	0.09	0.313	5.48518191232874e-97	CXCL13	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000156234	10563	C-X-C motif chemokine ligand 13	ANGIE|ANGIE2|BCA-1|BLC|BLR1L|SCYB13	protein_coding	O43927	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53775
2.8397549932765e-100	0.41059992636966	0.422	0.19	5.85131516364622e-96	CD55	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53776
1.45666471561094e-99	-0.402204099196441	0.148	0.37	3.00145764651634e-95	HLA-DQB1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53777
1.13895080122026e-95	0.610911226336912	0.26	0.074	2.34680812591435e-91	TNF	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000228978	7124	tumor necrosis factor	DIF|TNF-alpha|TNFA|TNFSF2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53778
3.88590836034557e-95	0.45043828477848	0.704	0.465	8.00691417649204e-91	MCL1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53779
4.75446568867843e-95	0.452580999357221	0.97	0.89	9.7965765515219e-91	SH3BGRL3	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53780
2.36751094536331e-94	0.316111479645861	0.337	0.128	4.8782563029211e-90	PRNP	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000171867	5621	prion protein	AltPrP|CD230|CJD|GSS|PRIP|PRP	protein_coding	P04156	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53781
4.03289336471932e-92	0.360779721019983	0.372	0.163	8.30977677800416e-88	C19orf66	CD8+ T cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53782
7.8333654254054e-91	0.301592526178116	0.996	0.981	1.61406494590478e-86	RPL23A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53783
1.59183487794645e-90	0.338015215926772	0.993	0.964	3.27997576600866e-86	RPL15	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53784
2.19816165177419e-89	0.329270483092428	0.518	0.284	4.52931208348072e-85	NDUFB2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53785
2.40491229990458e-87	0.407028679667363	0.473	0.256	4.95532179395338e-83	TRIM22	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000132274	10346	tripartite motif containing 22	GPSTAF50|RNF94|STAF50	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53786
3.59860996910142e-84	0.285353936317991	1	1	7.41493584133348e-80	EEF1A1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53787
4.52569415402916e-83	0.311938397551783	0.287	0.106	9.32519280437709e-79	IFI35	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000068079	3430	interferon induced protein 35	IFP35	protein_coding	P80217	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53788
2.79429591256131e-82	-0.548325938139591	0.904	0.936	5.75764672783259e-78	HSP90AB1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53789
2.32036548124886e-80	0.36040779925923	0.358	0.162	4.78111307411327e-76	WDR74	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53790
2.01063698007657e-79	0.381007987253139	0.49	0.282	4.14291749744777e-75	BST2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53791
1.77357406208695e-78	-0.357487843262677	0.989	0.986	3.65444935493016e-74	RPS29	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53792
4.82048712415687e-78	0.273211203679445	0.292	0.113	9.93261371932524e-74	FLT3LG	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000090554	2323	fms related receptor tyrosine kinase 3 ligand	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53793
6.27260299144643e-78	0.596266396817501	0.413	0.218	1.29246984638754e-73	LTB	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53794
2.72303815434649e-77	-0.424451712050301	0.508	0.668	5.61082011703093e-73	HLA-DPB1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53795
3.11231132605303e-77	0.287667186763252	0.268	0.097	6.41291748733226e-73	PIM1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53796
9.3463532401019e-77	-0.665439477817424	0.514	0.745	1.925816085123e-72	CCL4	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53797
2.3789433313087e-76	0.338568997345773	0.448	0.244	4.90181273416158e-72	ADAR	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53798
2.90665363725116e-76	0.27747560563651	1	0.999	5.98915981955601e-72	RPL10	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53799
5.93031183604255e-75	0.45964200791238	0.843	0.691	1.22194075381657e-70	IFITM2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53800
9.76423038047154e-75	0.329405467617111	0.471	0.264	2.01191966989616e-70	CD6	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000013725	923	CD6 molecule	Tp120	protein_coding	P30203	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53801
1.21246562090177e-74	-0.323194831646586	0.955	0.981	2.4982854118681e-70	MT-ND1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53802
2.50546885955973e-73	0.35379500482163	0.509	0.306	5.16251858512283e-69	SP100	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53803
7.02645334656302e-73	0.266850423080009	0.284	0.111	1.44780071205931e-68	RORA	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53804
1.86058350317839e-72	0.304881104063786	0.473	0.27	3.83373230829908e-68	ABRACL	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53805
2.11948800224758e-71	0.354198465760676	0.331	0.151	4.36720502863114e-67	LDLRAD4	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000168675	753	low density lipoprotein receptor class A domain containing 4	C18orf1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53806
6.90553116237583e-70	-0.383381907196555	0.774	0.88	1.42288469600754e-65	CST7	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53807
2.82829790037104e-69	0.279819618122325	0.996	0.982	5.82770782371453e-65	RPL14	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53808
3.45747137563327e-69	0.319719633197072	0.597	0.398	7.12411976949236e-65	DRAP1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53809
3.0915433782109e-68	0.291762152190203	0.989	0.963	6.37012513080355e-64	RPS16	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53810
2.0628529535463e-67	-0.300563946225009	0.991	0.992	4.25050851078215e-63	RPS3A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53811
1.20633615704757e-65	0.317962236837417	0.418	0.231	2.48565565159652e-61	PPM1K	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000163644	152926	protein phosphatase, Mg2+/Mn2+ dependent 1K	BDP|DKFZp761G058|hPTMP|PP2Ckappa|PP2Cm	protein_coding	Q8N3J5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53812
1.62367674139615e-65	0.28709676201034	0.86	0.652	3.34558592564677e-61	EEF2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53813
1.27862033887839e-64	0.272332242375925	0.513	0.315	2.63459720825893e-60	COX7B	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53814
4.1795529776099e-64	0.267115771413717	0.995	0.98	8.6119689103652e-60	RPL36	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53815
4.8891548538575e-64	0.324460315468665	0.416	0.229	1.00741035763734e-59	PTGER4	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53816
5.31768631013553e-64	0.312392947176165	0.925	0.795	1.09570926420343e-59	MYL6	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53817
5.4179421429539e-64	0.276540889508817	0.314	0.144	1.11636697855565e-59	ZC3H12A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000163874	80149	zinc finger CCCH-type containing 12A	FLJ23231|MCPIP1|Regnase-1	protein_coding	Q5D1E8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53818
2.42070505611431e-62	0.262635772334479	0.488	0.293	4.98786276812353e-58	SEC61G	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53819
1.17260888759397e-61	0.305025708889356	0.966	0.91	2.41616061288738e-57	RPSA	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53820
1.67972392412604e-61	0.276661710397053	0.527	0.332	3.46107114566171e-57	CSTB	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53821
1.73646202688628e-61	0.265496434490395	0.267	0.113	3.57798000639918e-57	SAMD9L	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000177409	219285	sterile alpha motif domain containing 9 like	C7orf6|FLJ39885|KIAA2005	protein_coding	Q8IVG5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53822
1.90228826728831e-60	0.276982711336076	0.642	0.448	3.91966497474757e-56	NDUFA4	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53823
7.21877254826178e-60	0.321736053747671	0.627	0.446	1.48742808356934e-55	SRSF5	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53824
9.52662368270512e-60	0.266834738880801	0.998	0.996	1.96296080982139e-55	RPL18A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53825
3.12464791293558e-58	0.31185229650209	0.318	0.159	6.43833702460375e-54	EPSTI1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53826
3.34417894688488e-58	0.284100674498094	0.485	0.302	6.89068072005629e-54	ARID5A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000196843	10865	AT-rich interaction domain 5A	MRF-1|RP11-363D14	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53827
5.25339369507224e-58	-0.32526784951539	0.297	0.466	1.08246177086964e-53	ETS1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53828
2.73831054011979e-57	0.287794501591926	0.388	0.22	5.64228886791683e-53	ATP8A1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000124406	10396	ATPase phospholipid transporting 8A1	ATPIA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53829
3.96051342907068e-57	0.263165477740282	0.263	0.113	8.16063792060013e-53	MAP3K8	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53830
1.22768194327562e-56	-0.312421857761752	0.253	0.425	2.52963864411941e-52	SH2D1A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000183918	4068	SH2 domain containing 1A	DSHP|EBVS|IMD5|LYP|MTCP1|SAP|XLP|XLPD	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53831
2.05561880938602e-56	0.26040533461673	0.424	0.242	4.23560255673989e-52	FOSL2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53832
1.16025012690168e-55	0.263822823022407	0.342	0.179	2.39069538648092e-51	C12orf75	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53833
1.31547758117501e-54	0.518968949001148	0.959	0.919	2.7105415560111e-50	ZFP36L2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53834
1.60898875725374e-54	-0.353511086204012	0.491	0.633	3.31532133432132e-50	HLA-DPA1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53835
1.72716812569658e-54	0.25693602982153	0.547	0.36	3.55882992299781e-50	CIB1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53836
5.21154426566634e-54	-0.349192250937053	0.14	0.286	1.07383869594055e-49	HLA-DRB5	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53837
1.20718938225764e-53	0.267607956720714	0.907	0.776	2.48741372214187e-49	RPL36AL	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53838
9.45691068091567e-53	-0.257554654418645	0.12	0.261	1.94859644580267e-48	CD81	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53839
6.5184766648962e-51	0.260207096964076	0.498	0.326	1.34313211680186e-46	GNG5	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53840
1.17824837793988e-49	0.306111341139868	0.41	0.236	2.42778078274513e-45	LMNA	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53841
3.47486137259628e-49	0.289308353353185	0.764	0.605	7.15995185823464e-45	FXYD5	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53842
4.65439888384468e-49	-0.283067397245706	0.927	0.949	9.59038890016195e-45	MT-ND5	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53843
5.90029748187342e-49	-0.45221301880369	0.651	0.742	1.21575629614002e-44	HSPH1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53844
7.44239370854073e-49	0.272562965463068	0.756	0.605	1.53350522364482e-44	SUB1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53845
2.56559109264774e-48	0.252265326859614	0.735	0.581	5.28640044640067e-44	UBE2D3	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53846
4.80546170436915e-48	-0.382493175565876	0.158	0.305	9.90165384185264e-44	CRTAM	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000109943	56253	cytotoxic and regulatory T cell molecule	CD355	protein_coding	O95727	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53847
6.89344040885591e-48	0.335284704281156	0.583	0.429	1.42039339624476e-43	ALOX5AP	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53848
6.17751964934192e-47	0.326698240525614	0.465	0.302	1.2728779237469e-42	MT1X	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53849
6.68911982893998e-47	0.250281648055799	0.59	0.418	1.37829314075308e-42	PSME2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53850
6.83037015835903e-47	0.30741085862652	0.548	0.377	1.40739777112988e-42	NEAT1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53851
3.26677955333313e-46	0.268122237700503	0.38	0.228	6.73119926964291e-42	SP110	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000135899	3431	SP110 nuclear body protein	IFI41|IFI75	protein_coding	Q9HB58	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53852
8.74575213307057e-46	0.258436538891322	0.384	0.233	1.80206222701919e-41	PLK3	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000173846	1263	polo like kinase 3	CNK|FNK|PRK	protein_coding	Q9H4B4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53853
3.18514980709996e-45	0.506836309966183	0.945	0.908	6.56300117752946e-41	ZFP36	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53854
8.83062753993727e-44	0.399287577825962	0.52	0.35	1.81955080460407e-39	GADD45B	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53855
4.14204322701154e-43	0.268090061665713	0.49	0.334	8.53468006925728e-39	VPS37B	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53856
1.27378439384467e-42	0.294013710531229	0.279	0.145	2.62463274351694e-38	EGR1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53857
1.0203065981662e-41	0.314342302429147	0.377	0.234	2.10234174552145e-37	CHMP1B	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53858
5.89507452745329e-41	0.310881247430308	0.969	0.943	1.21468010638175e-36	GAPDH	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53859
5.94658786019015e-40	-0.287562156338965	0.233	0.369	1.22529442859218e-35	UCP2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53860
7.0912859036255e-40	-0.25776034861891	0.723	0.832	1.46115946044203e-35	NKG7	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53861
4.70316595794348e-39	-0.25473576210739	0.414	0.55	9.69087345634254e-35	ITGB2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53862
8.10286897343572e-38	0.324843054443208	0.535	0.393	1.66959615197643e-33	SLC7A5	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53863
5.04191597126842e-37	-0.26682102943919	0.301	0.438	1.03888678587986e-32	CD27	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53864
1.28291092992655e-35	0.298712660068418	0.837	0.734	2.64343797111367e-31	LDHA	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53865
1.84198442502835e-33	0.336219834729204	0.729	0.611	3.79540890777092e-29	H2AFZ	CD8+ T cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53866
8.64837186893162e-33	-0.279175361710783	0.956	0.96	1.78199702359336e-28	MT-ATP6	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53867
2.55128552841141e-32	-0.286521624902226	0.508	0.605	5.25692383129172e-28	CD3G	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53868
1.03632290927905e-31	0.324373379891387	0.415	0.291	2.13534335456948e-27	OASL	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000135114	8638	2'-5'-oligoadenylate synthetase like	OASL1|p59OASL|TRIP14	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53869
1.20825505845979e-31	0.27305978101495	0.516	0.382	2.48960954795639e-27	RGS2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53870
2.03332644292027e-31	-0.6197279780317	0.337	0.465	4.18966913563722e-27	CCL4L2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53871
2.23914577522467e-31	-0.27071709315351	0.69	0.755	4.61375986985042e-27	FUS	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53872
2.97717562609317e-31	-0.250374843720464	0.59	0.669	6.13447037756497e-27	PCBP1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53873
1.01870077011232e-30	-0.297846991350901	0.627	0.685	2.09903293681644e-26	SFPQ	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53874
1.84394001432604e-29	0.251310902883522	0.727	0.604	3.7994383995188e-25	DYNLL1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53875
2.79572110176203e-29	-0.33123939615466	0.367	0.468	5.76058333018066e-25	RNF19A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53876
9.06619486122746e-27	-0.287316891837316	0.5	0.576	1.86808945115592e-22	JUND	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53877
2.20210561797094e-26	-0.482150874651432	0.719	0.764	4.53743862582912e-22	DUSP1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53878
1.4097263554424e-25	-0.378644466347497	0.899	0.869	2.90474115538907e-21	CXCR4	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53879
1.73684505925052e-25	0.263944996558848	0.805	0.711	3.57876924458569e-21	CREM	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53880
2.26417253291422e-25	-0.260397222201543	0.249	0.347	4.66532750406976e-21	RBM38	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53881
5.79586504404846e-25	-0.274517013542616	0.432	0.529	1.19423799232618e-20	ITM2A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53882
2.86980499605163e-24	-0.28143376981385	0.613	0.689	5.91323319436438e-20	SAMSN1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53883
2.05328176900593e-23	-0.428427846294586	0.475	0.568	4.23078708503672e-19	HSPA1B	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53884
4.89442383340035e-20	-0.621777423942865	0.29	0.361	1.00849603087214e-15	KLF2	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53885
6.18524033943628e-20	-0.250319517422732	0.941	0.942	1.27446877194084e-15	UBB	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53886
6.89987532395505e-19	-0.369621951000789	0.879	0.888	1.42171931050094e-14	DNAJB1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53887
1.80680661676179e-18	-0.333957891213129	0.199	0.291	3.72292503383766e-14	IFNG	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000111537	3458	interferon gamma	NA	protein_coding	P01579	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53888
6.33473923081607e-16	0.335846283588031	0.873	0.821	1.30527301850965e-11	JUNB	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53889
1.13327359082406e-15	0.265582040070155	0.674	0.617	2.33511023389297e-11	ELF1	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53890
1.68865837818407e-13	-0.297773246641852	0.609	0.657	3.47948058824827e-09	KLF6	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53891
2.42605030488549e-13	-0.342749078275018	0.511	0.543	4.99887665321655e-09	MYADM	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53892
4.14077337560898e-13	-0.413913998378912	0.59	0.632	8.5320635404423e-09	HSPA1A	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53893
9.83271401824624e-10	0.283120406933365	0.329	0.275	2.02603072345964e-05	TNFSF9	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000125657	8744	TNF superfamily member 9	4-1BB-L|4-1BBL|CD137L	protein_coding	P41273	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53894
1.54605564650058e-07	-0.273985032125643	0.679	0.654	0.00318564765961445	EZR	CD8+ T cells	GSE169246_PacAteTissue_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53895
8.93934523606579e-50	-2.36845561221042	0.016	0.284	1.84195208589136e-45	PTGDS	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000107317	5730	prostaglandin D2 synthase	L-PGDS|PGDS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53896
3.11056397328368e-45	-1.45965484526619	0.035	0.335	6.40931706695103e-41	PLA2G2D	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000117215	26279	phospholipase A2 group IID	sPLA2S	protein_coding	Q9UNK4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53897
2.57931227967564e-42	-0.755578395140594	0.072	0.432	5.31467295227167e-38	CFP	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000126759	5199	complement factor properdin	PFC	protein_coding	P27918	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53898
6.18618537575497e-39	1.64115133120482	0.828	0.419	1.27466349667431e-34	IFI30	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53899
8.28957353956882e-37	1.12785504208038	0.959	0.826	1.70806662782815e-32	S100A11	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53900
7.18143129839616e-32	0.820063494195616	0.997	0.974	1.47973391903453e-27	HLA-C	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53901
4.59526618811039e-31	-0.78762657932107	0.107	0.458	9.46854598060146e-27	CLEC10A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000132514	10462	C-type lectin domain containing 10A	CD301|CLECSF13|CLECSF14|HML|HML2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53902
8.57719549564871e-31	-1.08265899660935	0.816	0.981	1.76733113187842e-26	RPS3A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53903
5.13504640291877e-29	1.02929754244514	0.934	0.574	1.05807631132141e-24	LGALS1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53904
2.459690019277e-27	1.75010706576828	0.998	0.994	5.06819128472026e-23	FTL	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53905
4.55510281154827e-27	-2.31489175508247	0.128	0.439	9.38578934319521e-23	MMP9	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000100985	4318	matrix metallopeptidase 9	CLG4B	protein_coding	P14780	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53906
2.04277318064897e-26	0.940938986949531	0.946	0.832	4.20913413872721e-22	TYROBP	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53907
4.48465245750434e-25	1.2553593497142	0.532	0.084	9.24062638868769e-21	IFI6	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53908
2.53435964997288e-24	0.609787554095993	0.993	0.987	5.22204805876911e-20	SERF2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53909
8.85853576350069e-24	1.1043970287531	0.763	0.394	1.82530129406932e-19	GLUL	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53910
1.04529000293291e-21	0.623737892314671	0.999	0.974	2.15382005104326e-17	HLA-B	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53911
6.90726672956521e-21	1.56932737250212	0.723	0.348	1.42324230962691e-16	CTSD	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53912
1.04996855722383e-20	0.783320984967639	0.473	0.052	2.16346021215971e-16	ALOX5AP	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53913
1.98211636336495e-20	0.684397497595359	0.39	0.006	4.08415076671349e-16	C3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000125730	718	complement C3	ARMD9|C3a|C3b|CPAMD1	protein_coding	P01024	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53914
5.58506930927608e-20	0.806476585596456	0.585	0.181	1.15080353117634e-15	OLR1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000173391	4973	oxidized low density lipoprotein receptor 1	CLEC8A|LOX-1|SCARE1	protein_coding	P78380	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53915
8.19801193897573e-20	0.873000227538894	0.528	0.116	1.68920036002595e-15	TREM2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000095970	54209	triggering receptor expressed on myeloid cells 2	TREM-2|Trem2a|Trem2b|Trem2c	protein_coding	Q9NZC2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53916
8.77203107492042e-20	0.890463986564869	0.515	0.11	1.80747700298735e-15	FCGR3A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53917
1.0062730718873e-19	1.19145032231601	0.566	0.155	2.07342566462378e-15	CD9	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53918
1.24881374918282e-19	0.791917788621085	1	1	2.5731807301912e-15	FTH1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53919
1.73429796466344e-19	-0.752597203955817	0.366	0.671	3.57352095618902e-15	UCP2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53920
5.41422903064343e-19	-0.713403032929213	1	1	1.11560189176408e-14	EEF1A1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53921
6.91799074066067e-19	-0.588582783122258	0.142	0.406	1.42545199211313e-14	JAML	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000160593	120425	junction adhesion molecule like	AMICA|AMICA1|Gm638	protein_coding	Q86YT9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53922
7.97970985619249e-19	1.0996029348349	0.371	0.006	1.64421921586846e-14	FN1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53923
2.78440896265246e-18	1.22039973039461	0.844	0.606	5.7372746675454e-14	CSTB	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53924
9.89807255482016e-18	-0.609355939482326	0.16	0.419	2.0394978499207e-13	NBPF26	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000273136	101060684	NBPF member 26	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53925
1.25202605604648e-17	-0.692693939477483	0.689	0.871	2.57979968848376e-13	RPL13A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53926
2.32470051578858e-16	1.13431499079787	0.598	0.213	4.79004541278237e-12	C15orf48	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53927
3.76379625073732e-16	0.928473745725269	0.881	0.684	7.75530217464425e-12	CTSB	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53928
4.57006657413245e-16	-0.300613328185188	0.076	0.284	9.41662217599991e-12	PRKCB	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000166501	5579	protein kinase C beta	PKCB|PKCbeta|PRKCB1|PRKCB2	protein_coding	P05771	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53929
7.30966967526924e-16	1.01017441800109	0.379	0.052	1.50615743658923e-11	GCHFR	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53930
1.26249926521173e-15	0.585399841966358	0.726	0.413	2.60137973596878e-11	TSPO	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53931
2.03024678661507e-15	0.641014793565301	0.883	0.568	4.18332350382035e-11	S100A6	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53932
2.23639315524228e-15	1.67395362075942	0.306	0	4.60808809637672e-11	SPP1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000118785	6696	secreted phosphoprotein 1	BNSP|BSPI|ETA-1|OPN	protein_coding	P10451	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53933
2.45300693954906e-15	-0.66517212190833	0.595	0.794	5.05442079894083e-11	EEF1G	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53934
3.04889710666685e-15	-0.650586883103432	0.6	0.794	6.28225248828705e-11	SLC25A6	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53935
4.54573960010738e-15	1.44100657995518	0.687	0.387	9.36649644602126e-11	APOC1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000130208	341	apolipoprotein C1	NA	protein_coding	P02654	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53936
6.55203181075905e-15	-0.650643009031902	0.913	0.968	1.3500461546069e-10	RPL6	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53937
7.19252000360226e-15	0.967537847626036	0.517	0.161	1.48201874674225e-10	NUPR1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53938
1.31111134754364e-14	0.492062454476705	0.76	0.497	2.70154493161367e-10	UQCR11	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53939
1.47060843131078e-14	-0.507860846626728	0.999	0.994	3.03018867271586e-10	TPT1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53940
1.6601836948288e-14	0.617748922044407	0.905	0.735	3.42080850319475e-10	FCER1G	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53941
2.17866658316455e-14	0.487821144631761	0.494	0.174	4.48914249461055e-10	PLXDC2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000120594	84898	plexin domain containing 2	FLJ14623|TEM7R	protein_coding	Q6UX71	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53942
7.86925430520913e-14	-0.634720136052475	0.605	0.774	1.62145984958834e-09	HNRNPA1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53943
8.2903676885336e-14	-0.59692554295147	0.873	0.935	1.70823026222235e-09	RPL5	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53944
1.53721205262382e-13	-0.439706771171982	0.401	0.677	3.16742543443138e-09	NAP1L1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53945
2.22971389592823e-13	0.521822454762165	0.836	0.529	4.59432548256013e-09	S100A10	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53946
2.31147419052643e-13	-0.567006746108897	0.329	0.581	4.7627925695797e-09	LCP1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53947
2.44159291289555e-13	-0.550389869891813	0.97	0.981	5.03090219702127e-09	RPS27A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53948
3.05992718742895e-13	-0.594632116639546	0.635	0.774	6.30497996969735e-09	RPL7	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53949
3.44953497704566e-13	-0.46772711154072	0.565	0.794	7.10776682020257e-09	HNRNPA2B1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53950
3.71498087939026e-13	0.621396309935942	0.59	0.29	7.65471810198363e-09	YWHAH	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53951
4.23955781716916e-13	-0.620318214199032	0.933	0.981	8.73560888227706e-09	RPS7	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53952
6.92144400960221e-13	-0.636396060465627	0.961	0.987	1.42616353817854e-08	RPS2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53953
7.27614471118699e-13	0.467952670715896	0.459	0.148	1.49924961774008e-08	CKLF	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53954
1.18117258403976e-12	-0.364553951095945	0.16	0.387	2.43380610941393e-08	VSIR	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000107738	64115	V-set immunoregulatory receptor	B7-H5|B7H5|C10orf54|Dies1|GI24|PD-1H|SISP1|VISTA	protein_coding	Q9H7M9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53955
1.36236850813039e-12	-0.440533234105264	0.191	0.439	2.80716031100267e-08	LIMD2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53956
1.38110262137675e-12	-0.559537571163726	0.906	0.981	2.8457619513468e-08	RACK1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53957
3.80167769258673e-12	0.420214090198974	0.346	0.071	7.83335688557495e-08	SLC16A3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000141526	9123	solute carrier family 16 member 3	MCT3|MCT4	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53958
3.91891641840774e-12	0.381785028258091	0.45	0.142	8.07492728012916e-08	NDUFS5	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53959
8.15577790744581e-12	0.346720591485294	0.99	0.955	1.68049803782921e-07	ATP5F1E	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53960
9.90418663861026e-12	0.436846617763334	0.683	0.413	2.04075765688564e-07	NDUFB2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53961
1.04908819403631e-11	0.89765785849302	0.345	0.077	2.16164622381182e-07	ISG15	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53962
1.17240562897451e-11	-0.538379435866061	0.335	0.574	2.41574179850197e-07	FGL2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000127951	10875	fibrinogen like 2	pT49|T49	protein_coding	Q14314	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53963
1.52617028595875e-11	0.853831586449828	0.66	0.387	3.14467387421801e-07	C1QB	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000173369	713	complement C1q B chain	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53964
1.52623356870977e-11	0.500055300061736	0.775	0.465	3.14480426832648e-07	S100A4	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53965
1.8324729544947e-11	-0.643394358036624	0.363	0.587	3.77581052273632e-07	HSPD1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53966
2.66359137796931e-11	-0.455606192859926	0.993	0.987	5.48833003430575e-07	RPL19	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53967
3.61091292589881e-11	-0.497449322987555	0.906	0.961	7.44028608381451e-07	NACA	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53968
3.95622366830229e-11	-0.519657355695243	0.983	0.987	8.15179886853687e-07	RPS4X	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53969
4.40174013764833e-11	0.688333644402263	0.473	0.206	9.06978555362438e-07	LY6E	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53970
4.51063867200235e-11	0.545416454530987	0.992	0.968	9.29417098366085e-07	RPL41	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53971
4.84331378317805e-11	-0.427341579821402	0.383	0.613	9.97964805023837e-07	CDC42	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53972
6.49888310115837e-11	0.35345218626643	1	1	1.33909486299368e-06	B2M	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53973
6.54165807172052e-11	-0.608309926864792	0.93	0.935	1.34790864567801e-06	RPS6	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53974
6.61257917552129e-11	-0.542247214252222	0.976	0.987	1.36252193911616e-06	RPS13	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53975
7.07963446433259e-11	-0.542910570416808	0.992	1	1.45875868137573e-06	RPS8	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53976
8.09600362657904e-11	1.02354930264827	0.677	0.419	1.66818154725661e-06	APOE	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000130203	348	apolipoprotein E	AD2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53977
1.06468367363036e-10	0.451594998966486	0.367	0.103	2.19378070951535e-06	FCGR2B	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000072694	2213	Fc gamma receptor IIb	CD32|CD32B|FCG2|FcgammaRIIb|FCGR2|FcGRIIB	protein_coding	P31994	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53978
1.11636376226182e-10	-0.50477488505561	0.954	0.968	2.30026753214048e-06	RPL7A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53979
1.13661168800168e-10	0.41347380317168	0.424	0.155	2.34198838312746e-06	SELENOW	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000178980	6415	selenoprotein W	SELW|SEPW1	protein_coding	P63302	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53980
1.44218952196531e-10	-0.450368004251881	0.723	0.845	2.97163151000953e-06	RPL31	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53981
1.44683973345752e-10	0.543079731583943	0.397	0.135	2.98121327078923e-06	SDS	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000135094	10993	serine dehydratase	SDH	protein_coding	P20132	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53982
1.48978602497896e-10	0.532409531893417	0.628	0.335	3.06970410446914e-06	ATF3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53983
1.79165278780388e-10	-0.419302366444501	0.218	0.439	3.6917005692699e-06	MPEG1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000197629	219972	macrophage expressed 1	MPG1	protein_coding	Q2M385	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53984
1.96245770415457e-10	0.648867106075068	0.451	0.168	4.04364409941049e-06	EGR1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53985
2.00745259292774e-10	-0.507882756052382	0.358	0.594	4.13635606772762e-06	PTPRC	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53986
2.12032570945776e-10	0.670476675843014	0.522	0.226	4.3689311243377e-06	CXCL8	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53987
2.18798578688485e-10	0.519562778357916	0.702	0.406	4.50834471387622e-06	PLAUR	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53988
2.49616966900937e-10	0.748435973363381	0.426	0.148	5.1433576029938e-06	CXCL2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53989
2.55529252496106e-10	0.413666759388649	0.855	0.574	5.26518024768227e-06	NEAT1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53990
2.70067917725639e-10	-0.884650420821401	0.906	0.929	5.56474944473679e-06	HSP90AA1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53991
2.78665094746228e-10	-0.325045385398937	0.143	0.335	5.74189427724603e-06	AOAH	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000136250	313	acyloxyacyl hydrolase	NA	protein_coding	P28039	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53992
3.33891956731508e-10	0.31326293877801	1	1	6.87984376845272e-06	TMSB10	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53993
3.63025956040661e-10	0.4851096792633	0.77	0.561	7.48014982421781e-06	DBI	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53994
3.8842007987481e-10	0.562171912990107	0.529	0.258	8.00339574582047e-06	FABP5	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53995
3.96328808659758e-10	0.393839918301055	0.979	0.871	8.16635510243432e-06	CYBA	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53996
4.36106058920117e-10	1.37226290635792	0.393	0.142	8.98596534404902e-06	IFI27	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53997
5.16509553141174e-10	0.398867469986477	0.429	0.155	1.06426793424739e-05	MSR1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000038945	4481	macrophage scavenger receptor 1	CD204|SCARA1|SR-A|SR-AI|SR-AII|SR-AIII	protein_coding	P21757	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53998
9.39795757698032e-10	-0.777300428395722	0.49	0.645	1.93644915873679e-05	PLEK	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	53999
1.06471600840751e-09	0.487352117142957	0.736	0.555	2.19384733532368e-05	ATP6V1F	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000128524	9296	ATPase H+ transporting V1 subunit F	ATP6S14|VATF|Vma7	protein_coding	Q16864	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54000
1.09479673612816e-09	-0.267567348664227	0.144	0.335	2.25582867479208e-05	RASSF2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000101265	9770	Ras association domain family member 2	CENP-34|KIAA0168	protein_coding	P50749	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54001
1.27613479723912e-09	0.253822455198196	0.695	0.406	2.62947574971121e-05	SGK1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54002
1.62138177438043e-09	-0.537400284023573	0.808	0.845	3.34085714611088e-05	RPL10A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54003
1.64435850522907e-09	0.437956561020948	0.506	0.258	3.38820070002449e-05	TIMP2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54004
1.71692564872973e-09	0.568964378948649	0.757	0.503	3.53772529920762e-05	FOSB	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54005
1.85479591804985e-09	-0.503786492083069	0.647	0.794	3.82180698914172e-05	TAGLN2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54006
2.56440274472288e-09	1.00052295581702	0.638	0.419	5.28395185550149e-05	IFITM3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54007
2.99653894129619e-09	0.304320127059168	0.981	0.961	6.17436848854079e-05	OAZ1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54008
3.15019306888476e-09	-0.515920556613122	0.717	0.858	6.49097281843704e-05	EEF1B2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54009
3.70226234875031e-09	0.368100824216092	0.627	0.387	7.62851156960001e-05	PPT1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54010
4.57151035181465e-09	0.374726959951093	0.478	0.232	9.41959707991409e-05	CD99	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54011
5.03938168817585e-09	0.41260459754344	0.657	0.387	0.000103836459684863	MS4A7	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54012
5.10537979953723e-09	-0.295437007696756	0.159	0.342	0.000105196350769465	IQGAP2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000145703	10788	IQ motif containing GTPase activating protein 2	NA	protein_coding	Q13576	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54013
5.61578505095193e-09	0.664430814830558	0.894	0.781	0.000115713250974865	CTSZ	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54014
5.66199405903139e-09	0.363697631046686	0.396	0.148	0.000116665387586342	FCGR1A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000150337	2209	Fc gamma receptor Ia	CD64|CD64A|FCG1|FcgammaRI|FcgammaRIa|FCGR1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54015
6.34465129524068e-09	-0.39704576319632	0.785	0.897	0.000130731539938434	PABPC1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54016
6.4158497982562e-09	0.30892523026535	0.797	0.542	0.000132198585093069	SOD2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54017
7.20300524629648e-09	0.383299530827501	0.761	0.568	0.000148417923099939	ATP6V0B	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54018
7.5474832856862e-09	0.344739813564425	0.364	0.135	0.000155515893101564	TMED2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54019
7.69593428888128e-09	0.457931155641006	0.664	0.439	0.000158574726022399	MIF	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54020
8.63413678901586e-09	-0.542208455129351	0.903	0.961	0.000177906388537672	ACTG1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54021
9.24036501718515e-09	-0.435984437723755	0.993	0.987	0.0001903977211791	RPL34	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54022
9.5417834594106e-09	0.379621538413393	0.579	0.31	0.000196608448181155	CFD	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54023
9.55385925088028e-09	-0.391597437055151	0.948	0.974	0.000196857269864388	RPLP2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54024
1.01946658129055e-08	0.261421026723632	0.986	0.948	0.000210061089074917	VIM	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54025
1.02516272085861e-08	-0.3105898088306	0.233	0.432	0.000211234778632917	ATP5F1A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54026
1.21932016289212e-08	0.350746235534112	0.662	0.439	0.000251240919563921	UQCR10	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54027
1.24464008404403e-08	-0.392760578992009	0.099	0.252	0.000256458089317273	HIST1H4C	Mono/Macro	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54028
1.29140976994557e-08	0.430127458703318	0.554	0.316	0.000266094983097286	NOP10	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54029
1.37610971558767e-08	0.358517795294789	0.429	0.2	0.000283547406896839	NENF	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54030
1.43120368870559e-08	0.322432210566904	0.333	0.11	0.000294899520057788	NDUFA11	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54031
1.45137494639077e-08	0.306408825567944	0.599	0.284	0.000299055807703818	LGMN	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000100600	5641	legumain	LGMN1|PRSC1	protein_coding	Q99538	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54032
1.54402690530499e-08	0.421561966560481	0.479	0.239	0.000318146743838093	ID2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54033
1.75773582739389e-08	-0.554903568537062	0.968	0.974	0.00036218146723451	HLA-A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54034
1.93124454657008e-08	-0.442821806605817	0.981	0.994	0.000397932938820764	RPL26	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54035
2.08743278970457e-08	-0.426505287129888	0.965	0.961	0.000430115526318627	MT-ND4L	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54036
2.27607410794442e-08	0.423032631596524	0.502	0.284	0.000468985069941948	SNX10	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000086300	29887	sorting nexin 10	NA	protein_coding	Q9Y5X0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54037
2.28116232341943e-08	0.398336145897936	0.628	0.342	0.000470033496740573	CCL3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54038
2.29224956403449e-08	0.365456610660259	0.949	0.897	0.000472318022669306	MYL6	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54039
2.46777120463498e-08	-0.376118662672064	0.943	0.981	0.000508484256715037	RPL18	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54040
2.70554978227949e-08	-0.412675492172208	0.537	0.703	0.00055747853263869	UQCRB	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54041
2.78279830582606e-08	0.334123183600387	0.455	0.219	0.000573395590915459	C4orf48	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54042
2.82118690225306e-08	0.295705848041489	0.346	0.123	0.000581305561209243	BLOC1S1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54043
2.8447692555848e-08	0.405923232451791	0.715	0.51	0.000586164705113249	TYMP	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54044
3.14723156527003e-08	0.37606750272403	0.391	0.168	0.000648487064023889	FPR3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000187474	2359	formyl peptide receptor 3	FMLPY|FPRH1|FPRL2|RMLP-R-I	protein_coding	P25089	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54045
3.15963359074809e-08	0.474509047760426	0.755	0.626	0.000651042501373644	BRI3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54046
3.29586365176618e-08	0.315714758205203	0.785	0.535	0.000679112705446422	ANXA2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54047
3.73758655797542e-08	-0.546331869509216	0.884	0.903	0.000770129710270835	RPL3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54048
4.1080671954558e-08	-0.506762751485573	0.855	0.923	0.000846467245623667	RPL23A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54049
4.54272253251041e-08	-0.31169397570822	0.208	0.4	0.000936027977823771	RILPL2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000150977	196383	Rab interacting lysosomal protein like 2	FLJ30380|FLJ32372|MGC7036	protein_coding	Q969X0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54050
4.58147180819511e-08	-0.370759071676044	0.391	0.561	0.000944012266078602	RBM3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54051
5.35082739585188e-08	0.270778799747898	0.38	0.148	0.00110253798491528	CD164	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54052
6.20029779570798e-08	0.435405115763876	0.592	0.329	0.00127757136080563	GPNMB	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000136235	10457	glycoprotein nmb	HGFIN|NMB	protein_coding	Q14956	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54053
6.37726261623948e-08	-0.44721363036441	0.986	0.987	0.00131403496207614	RPS23	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54054
6.76865247575082e-08	-0.478674481979287	0.98	0.923	0.00139468084262846	CST3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54055
7.27035330462272e-08	-0.261516045713757	0.211	0.4	0.00149805629841751	WASF2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000158195	10163	WASP family member 2	SCAR2|WAVE2	protein_coding	Q9Y6W5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54056
7.41239330310061e-08	-0.437779785242438	0.981	0.961	0.00152732364010388	MT-CYB	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54057
8.14857953104652e-08	-0.399186393820048	0.931	0.942	0.00167901481237214	RPL14	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54058
8.38088190312662e-08	-0.500174909926545	0.92	0.974	0.00172688071613924	RPL35A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54059
9.43464395111808e-08	-1.55481733710098	0.22	0.368	0.00194400838612788	SLC40A1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000138449	30061	solute carrier family 40 member 1	FPN1|HFE4|IREG1|MTP1|SLC11A3	protein_coding	Q9NP59	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54060
1.10870756122642e-07	0.349748205561292	0.493	0.271	0.00228449192990704	SEC61G	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54061
1.1509791829003e-07	0.428033539616653	0.437	0.2	0.00237159260636606	RGS1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54062
1.22100739285728e-07	-0.453831718663309	0.988	0.987	0.00251588573298242	RPL37	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54063
1.43178049928427e-07	0.520032588788176	0.952	0.852	0.00295018371877524	PSAP	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54064
1.54471673747218e-07	0.365380161614581	0.91	0.845	0.00318288883756142	NPC2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54065
1.60619823852957e-07	-0.280164258413582	0.231	0.419	0.00330957147049019	PAK2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000180370	5062	p21 (RAC1) activated kinase 2	PAK65|PAKgamma	protein_coding	Q13177	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54066
1.80086312061976e-07	-0.498168536570216	0.818	0.942	0.00371067846003702	HSP90AB1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54067
1.87461497419238e-07	0.327658287406876	0.399	0.181	0.00386264415432339	JPT1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54068
1.90024842586769e-07	0.286290646288301	0.71	0.477	0.00391546188150037	UBL5	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54069
2.10495903941238e-07	-0.471382718176164	0.655	0.819	0.0043372681007092	ARHGDIB	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54070
2.82046163850999e-07	-0.406754118519707	0.975	0.974	0.00581156120614984	RPL30	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54071
3.03788261951955e-07	0.31351855675081	0.476	0.258	0.00625955713752004	GUK1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54072
3.47978136268431e-07	0.330358692056187	0.543	0.316	0.00717008949781102	CXCL16	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000161921	58191	C-X-C motif chemokine ligand 16	CXCLG16|SR-PSOX|SRPSOX	protein_coding	Q9H2A7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54073
3.93325290679048e-07	-0.350129068332816	0.288	0.458	0.00810446761444178	EIF3L	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54074
4.00616018939127e-07	-0.361887599287175	0.294	0.465	0.00825469307024071	NAGK	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000124357	55577	N-acetylglucosamine kinase	GNK	protein_coding	Q9UJ70	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54075
4.10740268262817e-07	0.36772354373988	0.862	0.729	0.00846330322755534	GRN	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54076
4.2156288030282e-07	-0.252216600922023	0.217	0.4	0.0086863031486396	RBM39	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54077
4.62754928578749e-07	-0.452313843646332	0.496	0.632	0.00953506530336512	CYBB	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54078
4.66206592642233e-07	0.281431689153674	0.31	0.116	0.00960618684139321	PDXK	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54079
4.69782989231188e-07	0.295316423030517	0.528	0.316	0.00967987849310862	COX7B	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54080
4.78998434583143e-07	-0.350856011659254	0.361	0.542	0.00986976274458567	ATP5F1B	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54081
4.83999533526702e-07	-0.36202521293145	0.308	0.484	0.00997281038831769	RPS20	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54082
5.515307446617e-07	-0.309152579380783	0.247	0.419	0.0113642909937543	CAST	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54083
5.75497562788175e-07	0.320543330828245	0.658	0.4	0.0118581272812504	C1QC	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000159189	714	complement C1q C chain	C1QG	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54084
6.41682368780577e-07	-0.382899634548256	0.968	0.981	0.0132218652087238	RPL8	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54085
7.20168588774221e-07	-0.251761604847597	0.158	0.316	0.0148390737716928	JAK1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54086
7.49770082522117e-07	-0.494310346184144	0.626	0.697	0.0154490125503682	RPL27A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54087
7.60554638452699e-07	-0.513448764121832	0.149	0.297	0.0156712283253179	UBD	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000228913	10537	ubiquitin D	FAT10	protein_coding	O15205	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54088
8.07129623435064e-07	-0.345573244741876	0.248	0.413	0.0166309058908795	CD48	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54089
9.48578445168917e-07	-0.452155782578119	0.998	1	0.0195454588627055	ACTB	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54090
9.96438087609909e-07	-0.361948061852393	0.987	0.981	0.0205316067952022	RPS14	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54091
1.07180392318e-06	-0.317339564012932	0.7	0.845	0.0220845198371238	PNRC1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54092
1.07860483485517e-06	-0.663709738733391	0.144	0.284	0.0222246526221908	FCN1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54093
1.10058975115708e-06	0.293877939108664	0.436	0.232	0.0226776518225915	KRTCAP2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54094
1.12398110891954e-06	-0.390046727760379	0.938	0.929	0.0231596307492872	RPS3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54095
1.13443425352583e-06	0.326233253572277	0.349	0.161	0.0233750177938997	SLC15A3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000110446	51296	solute carrier family 15 member 3	hPTR3|PHT2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54096
1.20442466217912e-06	-0.469840755278399	0.668	0.723	0.0248171701642007	EEF2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54097
1.24727938568708e-06	0.251414755799145	0.468	0.245	0.0257001917420822	RPS27L	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54098
1.31020783651789e-06	0.357406702810577	0.697	0.529	0.026996832471451	NR4A2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54099
1.43070329918291e-06	-0.419806232699824	0.926	0.923	0.0294796414796638	RPL22	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54100
1.52460975679331e-06	0.260483630025673	0.399	0.194	0.0314145840387262	REX1BD	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000006015	55049	required for excision 1-B domain containing	C19orf60|FLJ20850|FLJ30108|FLJ34606|FLJ37391	protein_coding	Q96EN9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54101
1.58122084847444e-06	-0.402779822062352	0.919	0.948	0.0325810555828159	RPL21	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54102
1.58764420649136e-06	0.290338264493938	0.44	0.239	0.0327134088747545	RBX1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54103
1.65436746932302e-06	-0.344875785196801	0.515	0.652	0.0340882417054008	SLC25A3	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54104
1.85322957116931e-06	-0.313307924668918	0.905	0.948	0.0381857953139436	RPL9	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54105
1.96198731949797e-06	0.257921086013178	0.405	0.2	0.0404267487182557	ANAPC11	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54106
2.03424663114125e-06	-0.460817223659019	0.867	0.916	0.0419156518346654	HLA-DQA1	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54107
2.09892419698854e-06	-0.42947790814472	0.338	0.497	0.0432483330789489	CORO1A	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54108
2.27006143903557e-06	-0.365217091385874	0.188	0.335	0.0467746159513279	RAC2	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54109
2.3319862372032e-06	0.275335592316462	0.83	0.665	0.048050576417572	ATP6V0C	Mono/Macro	GSE169246_PacAteTissue_post	ENSG00000185883	527	ATPase H+ transporting V0 subunit c	ATP6C|ATP6L|ATPL|VATL|Vma3	protein_coding	P27449	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54110
0	0.742268430189272	0.35	0.036	0	IFI44L	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54111
0	-0.810081416441063	0.973	0.979	0	RPS3A	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54112
0	0.777333860971424	0.999	0.991	0	HLA-C	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54113
0	1.47193346920406	1	0.981	0	HLA-B	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54114
0	0.911725932868719	0.619	0.307	0	LY6E	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54115
0	0.785953684179868	0.434	0.101	0	XAF1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54116
2.06491934010914e-281	0.876206975191316	0.413	0.117	4.25476630029488e-277	IFI6	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54117
7.63790442722307e-251	0.85117260060211	0.417	0.134	1.57379020722931e-246	ISG15	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54118
3.16609991725084e-244	0.383305005026196	0.284	0.044	6.52374887949535e-240	ERAP2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54119
2.22806260077867e-226	0.889406489305282	0.774	0.561	4.59092298890444e-222	S100A4	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54120
1.39001461174223e-221	0.686414468708891	0.693	0.448	2.86412510749487e-217	S100A6	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54121
3.10467875000292e-216	0.661928236701337	0.984	0.939	6.39719056438102e-212	TMSB10	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54122
3.97482904524175e-195	1.09180257624027	0.608	0.346	8.19013524772063e-191	NEAT1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54123
1.49639487439441e-187	-0.494676886159217	0.963	0.982	3.08332163868967e-183	MT-ATP8	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54124
9.30697193707702e-179	-0.64882557234632	1	0.998	1.91770156763472e-174	MALAT1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54125
6.41963888548337e-176	0.527996060718213	0.987	0.968	1.32276659235385e-171	H3F3B	CD4+ T cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54126
2.82406374499685e-174	0.627549642022444	0.65	0.406	5.81898334656601e-170	S100A11	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54127
8.3046871723309e-168	-0.502332637410313	0.987	0.989	1.71118079185878e-163	RPS8	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54128
1.66043025858122e-167	0.450280217542173	0.369	0.14	3.42131654780661e-163	IRF7	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54129
1.95274305687544e-162	0.498097338366322	0.296	0.085	4.02362706869185e-158	GZMA	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54130
1.30158615828245e-158	-0.542534254393012	0.262	0.514	2.68191827914099e-154	UCP2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54131
3.46035423484825e-158	-0.456352242920784	0.359	0.611	7.13005990090482e-154	HIST1H4C	CD4+ T cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54132
3.8042801777538e-156	-0.496485921646789	0.938	0.957	7.8387193062617e-152	RPS29	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54133
7.71953535054336e-156	0.432961945864908	0.338	0.124	1.59061025897946e-151	EIF2AK2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54134
2.61830747598382e-148	0.573484119220108	0.393	0.176	5.39502255426466e-144	MX1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54135
1.39489675769505e-145	0.742825385348976	0.894	0.794	2.87418476923066e-141	ZFP36	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54136
1.65972913441313e-144	-0.476870847818833	0.89	0.931	3.41987188145825e-140	RPL22	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54137
1.99075183144366e-140	-0.432089468055121	0.979	0.982	4.10194414868966e-136	RPL37	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54138
7.78772370797598e-140	-0.484088685673201	0.226	0.454	1.60466047002845e-135	TCF7	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54139
9.00887769335846e-140	-0.375403678004702	0.982	0.99	1.85627924871651e-135	MT-CO3	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54140
7.20349690100095e-139	0.564142419793951	0.434	0.215	1.48428053645125e-134	CDKN1A	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54141
2.48724117854128e-138	-0.451863091861914	0.746	0.859	5.12496044838431e-134	PNRC1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54142
2.9303581011492e-138	-0.406193392827774	0.985	0.986	6.03800286741793e-134	MT-ND3	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54143
4.45772004617277e-138	-0.365130106064036	0.983	0.993	9.185132155139e-134	MT-CYB	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54144
1.99961551947807e-137	0.544765159054822	0.621	0.419	4.12020777788457e-133	S100A10	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54145
1.61184800565524e-135	0.545097320234092	0.398	0.17	3.32121281565261e-131	CCL5	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54146
1.58802111914312e-132	0.25915343921333	1	1	3.27211751599439e-128	B2M	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54147
6.56490474002135e-130	0.551859929158634	0.902	0.76	1.3526986216814e-125	VIM	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54148
7.12337466045169e-130	0.382605346633273	0.407	0.193	1.46777134878607e-125	TAP1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54149
8.96767110901508e-123	-0.38971218497436	0.837	0.918	1.84778863201256e-118	MT-ND4	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54150
1.26954776946224e-119	0.665817197054182	0.522	0.322	2.61590317897695e-115	MT2A	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54151
2.13265916553753e-119	0.479342821648547	0.429	0.229	4.39434421059008e-115	STAT1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54152
5.64970936004245e-115	0.490179288807354	0.307	0.125	1.16412261363675e-110	ID2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54153
6.90171425798188e-115	0.510659898781049	0.936	0.884	1.42209822285717e-110	IFITM1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54154
4.77721331872334e-110	0.431913048775548	0.826	0.723	9.84344804322945e-106	MYL6	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54155
5.92818836551196e-110	-0.403682740916568	0.974	0.979	1.22150321271374e-105	RPS13	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54156
1.99619995967718e-107	-0.41326718572527	0.343	0.544	4.11317001691483e-103	ETS1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54157
6.55925765619774e-105	-0.389489129166766	0.725	0.807	1.35153504005954e-100	RPL7	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54158
7.06026551488683e-104	-0.347803285005082	0.494	0.695	1.45476770934243e-99	PCBP1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54159
2.64273089514895e-102	0.387925209288434	0.635	0.432	5.44534700945442e-98	MCL1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54160
1.3900902232574e-101	0.56774339627913	0.558	0.382	2.86428090502187e-97	TUBB4B	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54161
3.29595367120368e-101	-0.359609697405592	0.975	0.989	6.79131253951519e-97	RPS2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54162
1.79085554965062e-100	0.385095779464877	0.295	0.13	3.69005786005509e-96	MX2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000183486	4600	MX dynamin like GTPase 2	MXB	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54163
2.31632294260475e-99	0.535115311279487	0.597	0.431	4.77278342323709e-95	SQSTM1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54164
1.21517915956442e-98	0.757051327199225	0.423	0.244	2.50387665828249e-94	GADD45B	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54165
3.13242002484605e-98	0.472749536348133	0.717	0.587	6.45435146119528e-94	IFITM2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54166
6.86696059783279e-97	0.373184695790891	0.423	0.239	1.41493723118345e-92	CSRNP1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54167
7.67026814628319e-97	-0.373038669013432	0.917	0.951	1.58045875154165e-92	RPS5	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54168
4.30058005551268e-96	0.38874546931823	0.348	0.174	8.86134520438388e-92	H2AFX	CD4+ T cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54169
7.18574405498774e-95	0.470207434892576	0.843	0.794	1.48062256253022e-90	SH3BGRL3	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54170
1.21658929978919e-94	-0.416145121925174	0.655	0.785	2.50678225221562e-90	FYB1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54171
1.51502864089103e-94	0.30801678791696	0.335	0.165	3.12171651455597e-90	UBE2L6	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54172
2.78566720066918e-93	-0.330694456717262	0.964	0.976	5.73986726697884e-89	RPLP2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54173
2.09543799170802e-92	-0.425929224986695	0.826	0.895	4.31764998191438e-88	PTPRC	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54174
5.64812420376188e-92	-0.369939096264343	0.984	0.985	1.16379599218513e-87	RPL34	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54175
2.57663778882161e-90	0.362282169740673	0.446	0.269	5.30916216386693e-86	BST2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54176
2.13887913870173e-88	-0.335802805576707	0.926	0.939	4.40716046529492e-84	RPL9	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54177
4.53912213793295e-88	0.392963170851155	0.618	0.465	9.35286116521085e-84	NDUFS5	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54178
5.44841994269039e-88	0.359616197734058	0.997	0.992	1.12264692919136e-83	TMSB4X	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54179
1.29634495413947e-87	-0.307920282667716	0.989	0.99	2.67111877800437e-83	RPL19	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54180
4.75961108433995e-86	0.324422739945884	0.452	0.276	9.80717863928247e-82	PLP2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54181
6.78861645319162e-85	-0.321376552271495	0.989	0.988	1.39879442018013e-80	RPL11	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54182
1.62342443122743e-82	0.360487315812787	0.451	0.286	3.34506604054412e-78	SP100	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54183
1.58845076255419e-81	0.269120312306277	0.291	0.14	3.2730027962429e-77	C19orf66	CD4+ T cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54184
2.76540568151286e-80	-0.374250710132332	0.282	0.452	5.69811840675725e-76	FAM107B	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54185
6.75592039948484e-80	0.360688661979608	0.336	0.178	1.39205739831385e-75	GBP5	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54186
3.66800168349966e-79	-0.801422636991728	0.357	0.488	7.55791746885104e-75	KLF2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54187
5.2027518173663e-78	-0.335930273575266	0.99	0.988	1.07202701196833e-73	RPL32	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54188
6.86459984991635e-78	0.34630509752041	0.564	0.403	1.41445079907526e-73	TPI1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54189
4.51241756143102e-76	0.264975913055715	0.265	0.122	9.29783638532861e-72	BHLHE40	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54190
1.17552808444645e-75	0.32327917148921	0.399	0.239	2.42217561800192e-71	TRIM22	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000132274	10346	tripartite motif containing 22	GPSTAF50|RNF94|STAF50	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54191
2.86371993453205e-75	0.727000919451277	0.602	0.428	5.90069492510328e-71	FOS	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54192
4.77303005847964e-75	-0.30933362453397	0.213	0.377	9.83482843549731e-71	RBM38	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54193
4.30994328316368e-74	-0.306133187798481	0.912	0.941	8.88063813495876e-70	NACA	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54194
1.39134805784048e-73	-0.30614317088042	0.93	0.956	2.86687267318032e-69	RPL21	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54195
7.84155212310289e-73	0.615315485814048	0.395	0.239	1.61575181496535e-68	DUSP4	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54196
4.42435168666274e-72	0.470656980611218	0.925	0.904	9.11637665036858e-68	GAPDH	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54197
4.548821623926e-72	0.358704971858806	0.46	0.303	9.37284695609953e-68	HERPUD1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54198
6.45219516041619e-70	0.289518987701018	0.357	0.205	1.32947481280376e-65	TXN	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54199
9.22418583334711e-70	0.341687873154773	0.628	0.483	1.90064349096117e-65	BRD2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54200
1.03422750062516e-68	-0.323345753243886	0.831	0.883	2.13102576503815e-64	EEF1B2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54201
1.68016898420096e-68	0.345755740099007	0.415	0.268	3.46198819194608e-64	ADAR	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54202
2.5650055591221e-68	-0.323068076488652	0.7	0.786	5.28519395457109e-64	EEF1G	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54203
3.28412034291138e-68	0.440261874981445	0.336	0.192	6.7669299665689e-64	NEU1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000184494	4758	neuraminidase 1	NEU	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54204
4.15676955171023e-68	-0.30208603706627	0.862	0.898	8.56502366129894e-64	RPL13A	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54205
2.1798543595149e-66	-0.259288436142392	0.117	0.254	4.49158990778046e-62	PASK	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000115687	23178	PAS domain containing serine/threonine kinase	KIAA0135|PASKIN|STK37	protein_coding	Q96RG2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54206
2.96805437940528e-66	0.382680577865455	0.499	0.355	6.11567604876458e-62	ISG20	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54207
5.63372141172216e-66	-0.281531588055411	0.982	0.987	1.16082829688535e-61	RPS4X	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54208
7.49153890750833e-66	-0.360916233508578	0.423	0.566	1.54363159189209e-61	LAT	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000213658	27040	linker for activation of T cells	LAT1	protein_coding	O43561	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54209
6.58396851551603e-64	0.409110505813917	0.613	0.489	1.35662671262208e-59	DDX3X	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54210
6.05779664792319e-63	0.284474093583653	0.478	0.335	1.24820899930457e-58	PSME2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54211
6.42621212924407e-63	0.356540270010952	0.481	0.339	1.32412100923074e-58	ZC3HAV1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54212
6.67995859527493e-63	0.403016553590756	0.726	0.576	1.3764054685564e-58	DUSP2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54213
3.66196986756992e-61	-0.267694541592277	0.337	0.497	7.54548891212782e-57	FCMR	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000162894	9214	Fc mu receptor	FAIM3|FcmuR|TOSO	protein_coding	O60667	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54214
4.82961537736461e-61	0.25321994544026	0.384	0.24	9.95142248505977e-57	PAXX	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000148362	286257	PAXX non-homologous end joining factor	C9orf142|XLS	protein_coding	Q9BUH6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54215
6.91773156013135e-61	0.480436118751908	0.933	0.889	1.42539858796507e-56	ZFP36L2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54216
1.05507081089384e-60	-0.257685600405559	0.963	0.973	2.17397340584676e-56	RPL29	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54217
8.82474141538286e-60	0.312953232499586	0.37	0.228	1.81833796863964e-55	SERTAD1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000197019	29950	SERTA domain containing 1	SEI1|TRIP-Br1	protein_coding	Q9UHV2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54218
1.32605747339717e-59	0.333353686791787	0.597	0.471	2.73234142393487e-55	HCST	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54219
2.800511958306e-59	-0.258236949381629	0.988	0.993	5.77045489008952e-55	RPS15A	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54220
5.31879435432975e-59	-0.256465429243107	0.307	0.457	1.09593757670965e-54	SET	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54221
7.44383624202715e-58	0.305888720264281	0.557	0.435	1.53380245766969e-53	PSMB9	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54222
1.10899272410274e-57	-0.279491288773842	0.963	0.974	2.2850795080137e-53	RPS21	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54223
1.19617631319225e-57	0.297165193942748	0.573	0.394	2.46472129333263e-53	ANXA1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54224
2.13010433000557e-57	-0.431534631068571	0.38	0.511	4.38907997197647e-53	ITM2A	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54225
3.15041319259087e-57	-0.428962321108518	0.376	0.517	6.49142638333349e-53	CCR7	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54226
4.904445221701e-57	-0.319066540075427	0.343	0.489	1.01056093793149e-52	GIMAP7	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54227
6.17715015316879e-57	-0.267225400710867	0.973	0.983	1.27280178906043e-52	RPS6	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54228
1.09502976606157e-56	0.34346063611692	0.526	0.385	2.25630883296986e-52	IRF1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54229
1.45838934041e-56	0.396862527103377	0.559	0.415	3.0050112359148e-52	RGS1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54230
4.56398489924906e-56	-0.252418210310289	0.978	0.986	9.40409088490269e-52	RPS23	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54231
3.36594019752646e-55	-0.305121166919684	0.986	0.984	6.93551977700327e-51	RPL39	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54232
4.45694277617063e-55	-0.278362046981964	0.893	0.941	9.18353059029958e-51	ACTG1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54233
5.4609365154278e-55	-0.312402150807067	0.544	0.656	1.1252259690039e-50	LDHB	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54234
2.879726096479e-54	-0.263404528238418	0.939	0.954	5.93367562179498e-50	RPL5	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54235
3.93119164831568e-54	-0.254006851695278	0.42	0.564	8.10022039135446e-50	CD3G	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54236
3.21208803960207e-53	-0.396871043720574	0.182	0.306	6.61850740560006e-49	SH2D1A	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000183918	4068	SH2 domain containing 1A	DSHP|EBVS|IMD5|LYP|MTCP1|SAP|XLP|XLPD	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54237
4.33532538231054e-53	0.304426400173367	0.565	0.441	8.93293795025087e-49	SRSF5	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54238
1.09541264038065e-52	-0.314472714923465	0.283	0.427	2.25709774550433e-48	IL6ST	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000134352	3572	interleukin 6 cytokine family signal transducer	CD130|GP130|IL-6RB|sGP130	protein_coding	P40189	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54239
2.56355825413751e-52	0.25034922036061	0.994	0.99	5.28221178265035e-48	EIF1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54240
4.06309851767877e-52	0.35262907993097	0.606	0.491	8.37201449567711e-48	LDHA	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54241
5.39734586486452e-52	0.312037812033025	0.817	0.74	1.11212311545533e-47	CD52	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54242
1.3198399844365e-51	0.275540576970956	0.582	0.458	2.7195302879314e-47	CLIC1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54243
2.4829094431743e-51	0.507964521759055	0.503	0.385	5.11603490766065e-47	IER2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54244
1.05398332719827e-50	0.290896115829714	0.264	0.147	2.17173264569203e-46	PHLDA1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54245
1.35716044391563e-50	0.261094280970471	0.274	0.158	2.79642909468815e-46	ATP8A1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000124406	10396	ATPase phospholipid transporting 8A1	ATPIA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54246
1.35802729473158e-50	-0.273087489349189	0.521	0.647	2.79821524079443e-46	C12orf57	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54247
2.51221697479244e-50	0.282687632818563	0.362	0.234	5.17642307655983e-46	IFRD1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54248
5.3579334960992e-50	0.396319070106207	0.723	0.613	1.10400219687124e-45	CREM	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54249
2.31647137876349e-49	0.366062112205773	0.541	0.414	4.77308927594217e-45	PPP1R15A	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54250
4.77111988938407e-47	0.30460877085458	0.357	0.23	9.83089253207587e-43	RGS2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54251
5.09356502379798e-47	-0.25956995204193	0.818	0.859	1.04952907315357e-42	RPL38	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54252
8.11040170169369e-47	0.311633396270375	0.765	0.671	1.67114827063399e-42	TNFAIP3	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54253
1.39481658340672e-46	0.289290160439271	0.991	0.969	2.87401957010954e-42	HSPA8	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54254
1.55211307127162e-46	0.251637097034971	0.459	0.326	3.19812898335518e-42	PDE4B	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54255
2.01430859973256e-45	0.467579458260347	0.336	0.22	4.15048286974893e-41	NR4A1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54256
3.78840016133567e-45	0.260325418510137	0.444	0.303	7.80599853243215e-41	LMNA	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54257
6.12815475639921e-45	0.352304677725643	0.544	0.438	1.26270628755606e-40	RSRP1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54258
6.51300987659026e-45	0.321670119649566	0.532	0.415	1.34200568507142e-40	AC016831.7	CD4+ T cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54259
7.99246781737044e-45	0.339441718551158	0.606	0.514	1.64684799376918e-40	DYNLL1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54260
8.56474807086155e-44	0.367263479994468	0.545	0.436	1.76476634000102e-39	RNF213	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54261
1.4970336447585e-43	0.281010840166898	0.331	0.217	3.0846378250249e-39	EPSTI1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54262
5.69495123731464e-43	0.289852575067478	0.616	0.501	1.17344470244868e-38	SAMSN1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54263
5.84837922965091e-43	0.38802459069553	0.605	0.524	1.20505854026957e-38	SAP18	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54264
3.8046633848481e-42	-0.322687603270474	0.294	0.413	7.83950890447952e-38	RNF19A	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54265
6.29558060103528e-41	0.536987986586186	0.981	0.978	1.29720438284332e-36	FTH1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54266
3.34903782225261e-38	0.294578373155563	0.338	0.233	6.9006924327515e-34	SNHG12	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000197989	85028	small nucleolar RNA host gene 12	ASLNC04080|C1orf79|LINC00100|PNAS-123	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54267
4.41629237664454e-38	0.388311865694665	0.304	0.204	9.09977044207608e-34	XIST	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54268
8.74393702135824e-36	0.280136829204336	0.826	0.754	1.80168822325086e-31	HSPE1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54269
6.91928300178751e-35	0.283498850954728	0.859	0.765	1.42571826251832e-30	DNAJA1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54270
8.30655234329865e-35	0.45000488000759	0.445	0.347	1.71156511033669e-30	FOSB	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54271
1.35246034070444e-34	-0.317718274420476	0.181	0.274	2.7867445320215e-30	PFKFB3	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000170525	5209	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	NA	protein_coding	Q16875	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54272
4.12651791697484e-34	0.341147144656717	0.302	0.206	8.50269016792666e-30	CARD16	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54273
2.95175462048323e-30	0.321841513525215	0.609	0.53	6.0820903955057e-26	H2AFZ	CD4+ T cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54274
5.83148652192438e-26	0.276069626949064	0.558	0.474	1.20157779784252e-21	BIRC3	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54275
3.48918723895989e-24	0.265426636058954	0.46	0.385	7.18947030587686e-20	CLEC2D	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54276
5.56168494066877e-24	0.294365851086125	0.78	0.707	1.1459851820248e-19	CRIP1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54277
6.23292674078714e-23	0.330946265504193	0.388	0.305	1.28429455493919e-18	CITED2	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54278
3.45918633307918e-21	-0.317108084223694	0.593	0.637	7.12765343930966e-17	EZR	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54279
1.20845566947096e-19	0.309288972420618	0.295	0.229	2.49002290694492e-15	BATF	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000156127	10538	basic leucine zipper ATF-like transcription factor	B-ATF|BATF1|SFA-2	protein_coding	Q16520	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54280
1.85293706242928e-17	0.391643734512774	0.552	0.504	3.81797681713552e-13	SAT1	CD4+ T cells	GSE169246_PacAteTissue_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54281
2.43390775428527e-09	0.688571244599502	1	1	5.01506692770479e-05	HLA-C	pDCs	GSE169246_PacAteTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54282
1.24415395532402e-08	0.64056845856739	1	0.96	0.000256357922494514	RPS12	pDCs	GSE169246_PacAteTissue_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54283
2.09884048809636e-08	0.880605632622748	1	0.94	0.000432466082572255	TMSB10	pDCs	GSE169246_PacAteTissue_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54284
2.81876598155639e-08	-0.635459279137506	0.984	1	0.000580806730499693	HLA-DRA	pDCs	GSE169246_PacAteTissue_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54285
1.00365726964173e-07	0.716408922146023	1	0.92	0.00206803580409679	ATP5F1E	pDCs	GSE169246_PacAteTissue_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54286
1.52220633417355e-07	-1.00147892892591	0.705	0.98	0.0031365061515646	HSP90AB1	pDCs	GSE169246_PacAteTissue_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54287
1.68479057188437e-07	1.06283010361274	0.984	0.9	0.00347151097336775	FTL	pDCs	GSE169246_PacAteTissue_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54288
4.11480935544619e-07	1.3171901758807	0.41	0	0.00847856467689687	ISG15	pDCs	GSE169246_PacAteTissue_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54289
4.2423194762089e-07	0.510375802750882	1	0.94	0.00874129928072843	RPL28	pDCs	GSE169246_PacAteTissue_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54290
4.72709335895963e-07	-0.426637051502174	1	1	0.00974017586613632	CD74	pDCs	GSE169246_PacAteTissue_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54291
6.42961419184559e-07	-1.30502849449842	0.852	0.96	0.0132482200422978	HSP90AA1	pDCs	GSE169246_PacAteTissue_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54292
8.3603668242253e-07	0.70489834540687	0.869	0.56	0.0172265358413162	GNG5	pDCs	GSE169246_PacAteTissue_post	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54293
8.66048850931277e-07	0.657024290140912	0.984	0.78	0.017844936573439	ATP5MG	pDCs	GSE169246_PacAteTissue_post	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54294
1.11845359674816e-06	-0.951460816572686	0.344	0.76	0.0230457363609958	HSPD1	pDCs	GSE169246_PacAteTissue_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54295
1.54758097264691e-06	-1.16602675291378	0.328	0.78	0.0318879059413897	HSPA1A	pDCs	GSE169246_PacAteTissue_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54296
2.38690155172943e-63	1.55118688416941	0.717	0.053	4.91821064733848e-59	IFI6	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54297
2.61078126609914e-40	-2.10088482972199	0.651	0.947	5.37951479879728e-36	CD74	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54298
1.35662770648988e-33	1.09080222767495	0.945	0.694	2.79533138922239e-29	HLA-B	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54299
2.99212502386008e-30	-1.37532646250359	0.042	0.434	6.1652736116637e-26	HLA-DRB1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54300
4.77274787388924e-29	-1.22061820939402	0.016	0.372	9.83424699414879e-25	RGS13	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000127074	6003	regulator of G protein signaling 13	NA	protein_coding	O14921	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54301
1.03125707669994e-28	0.866397437084787	0.524	0.102	2.12490520654022e-24	IFITM1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54302
1.99469142710308e-26	-0.959025777734133	0.023	0.362	4.11006168554591e-22	HLA-DRB5	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54303
4.3599370893717e-25	1.06842244957033	0.342	0.02	8.98365037265039e-21	IFI27	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54304
1.01116965510763e-23	0.512269092188107	0.42	0.072	2.08351507434928e-19	PECAM1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000261371	5175	platelet and endothelial cell adhesion molecule 1	CD31	protein_coding	P16284	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54305
4.99251259332516e-22	0.583946536445867	0.528	0.171	1.02870721985465e-17	SDC1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54306
7.89804161560606e-22	0.719152789571213	0.332	0.033	1.62739147489563e-17	ISG15	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54307
3.07846077703401e-20	0.451917772942642	0.492	0.148	6.34316843107859e-16	GAS6	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54308
2.46345852761069e-19	-0.685303189828855	0.244	0.586	5.07595629614182e-15	TNFRSF17	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000048462	608	TNF receptor superfamily member 17	BCM|BCMA|CD269|TNFRSF13A	protein_coding	Q02223	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54309
4.17835273032789e-19	-0.591847156704054	0.042	0.322	8.60949580084061e-15	HLA-DPA1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54310
5.86181011884585e-19	-0.87611515061504	0.309	0.628	1.20782597498819e-14	HSP90AB1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54311
1.07414421516025e-18	0.465204809104374	0.251	0.01	2.2132741553377e-14	PTP4A3	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000275575	11156	protein tyrosine phosphatase 4A3	PRL-3|PRL-R|PRL3	protein_coding	O75365	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54312
7.21386241299347e-18	-0.70388757386088	0.326	0.632	1.4864163501973e-13	RPS26	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54313
1.4369595776482e-17	-0.773757075531384	0.039	0.293	2.96085520974412e-13	HLA-DRA	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54314
1.88998334194507e-17	-0.666244028506287	0.026	0.266	3.89431067607782e-13	NSMCE3	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000282130	56160	NSE3 homolog, SMC5-SMC6 complex component	HCA4|MAGEG1|MAGEL3|NDNL2|NSE3	protein_coding	Q96MG7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54315
3.02110098593191e-17	-1.20312736306113	0.081	0.352	6.2249785815127e-13	PRPSAP2	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000141127	5636	phosphoribosyl pyrophosphate synthetase associated protein 2	PAP41	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54316
4.83808351098235e-17	-0.643252385880058	0.033	0.276	9.96887107437914e-13	LAPTM5	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54317
6.73942244752418e-17	-0.687499588546338	0.101	0.372	1.38865799531236e-12	CCDC88A	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54318
2.93502366224027e-16	-0.695956218940678	0.482	0.724	6.04761625604608e-12	UBE2J1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54319
3.80379846809799e-16	-0.67061987774053	0.879	0.934	7.83772674351591e-12	HSP90B1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54320
1.06178695825633e-15	-0.451434778588903	0.046	0.283	2.18781202748717e-11	YWHAB	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54321
1.11167281941195e-15	1.03767159959302	0.544	0.22	2.29060184439831e-11	IGHG4	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000277016	NA	NA	NA	IG_C_gene	P01861	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54322
1.25567609642868e-15	1.08391254428496	0.394	0.099	2.5873205966913e-11	IGHGP	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000282094	NA	NA	IGHGP1	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54323
7.99163245396827e-15	-0.338789535983219	0.042	0.27	1.64667586714016e-10	YPEL3	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54324
1.23731495126807e-14	0.370209614650454	0.29	0.056	2.54948745708787e-10	TYMP	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54325
2.0632513519549e-14	-0.861729757213123	0.117	0.372	4.25132941070306e-10	KLF2	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54326
4.89890913716422e-14	-0.362730553317423	0.049	0.27	1.00942022771269e-09	PDXK	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54327
5.17223655274006e-14	-0.449382713143068	0.3	0.586	1.06573934169209e-09	SSR2	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54328
7.96960677400703e-14	-0.629344445694758	0.726	0.836	1.64213747578415e-09	PPIB	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54329
8.26460948055747e-14	-0.510086532914478	0.557	0.789	1.70292278346887e-09	RPS7	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54330
1.08189005485564e-13	-0.304844492829516	0.062	0.296	2.22923445803004e-09	MZT2B	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54331
1.62002342229837e-13	-0.5098858016055	0.306	0.579	3.3380582616458e-09	ATP5MG	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54332
1.81198020205439e-13	-0.649240446318258	0.762	0.885	3.73358520633307e-09	RPS15A	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54333
2.35082569162208e-13	-0.438893887373871	0.153	0.421	4.8438763375873e-09	PDIA3	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54334
2.473160656598e-13	-0.348443819241601	0.121	0.375	5.09594753292019e-09	SPATS2	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000123352	65244	spermatogenesis associated serine rich 2	FLJ13117|SCR59|SPATA10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54335
3.31299425061588e-13	-0.669871424010777	0.052	0.26	6.82642465339403e-09	STAP1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000035720	26228	signal transducing adaptor family member 1	BRDG1|STAP-1	protein_coding	Q9ULZ2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54336
3.50449042911841e-13	0.522658647750292	0.469	0.211	7.22100252919849e-09	TRIB1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54337
4.20410972451213e-13	-0.732205644356876	0.339	0.579	8.66256808735724e-09	PDIA4	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54338
4.30689839276141e-13	-0.454533011151462	0.153	0.408	8.87436413828488e-09	MEF2C	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54339
4.50111186878212e-13	-0.519945994037267	0.153	0.398	9.27454100562556e-09	AC012236.1	Plasma cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54340
6.10921906363712e-13	-1.64087553513149	0.645	0.724	1.25880458806243e-08	CD79A	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54341
6.52045578906775e-13	-0.588343277421513	0.104	0.339	1.34353991533741e-08	HIST1H4C	Plasma cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54342
1.56794012767043e-12	-0.751684520456579	0.476	0.664	3.23074063306492e-08	CD38	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54343
2.01807580061639e-12	-0.856626054940114	0.264	0.487	4.15824518717008e-08	EZR	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54344
2.64108171421229e-12	0.380463956690413	0.407	0.161	5.44194887213443e-08	SPAG4	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000061656	6676	sperm associated antigen 4	CT127|SUN4	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54345
2.67919976047419e-12	-0.57879393545921	0.391	0.664	5.52049110645707e-08	PTMA	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54346
3.62715137311209e-12	-0.373376442893416	0.208	0.464	7.47374540429745e-08	SRPRA	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000182934	6734	SRP receptor subunit alpha	SR-alpha|Sralpha|SRP-alpha|SRPR	protein_coding	P08240	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54347
3.89371756034443e-12	0.772763911841472	0.384	0.141	8.02300503308971e-08	MIR155HG	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000234883	114614	MIR155 host gene	BIC|miPEP155|MIRHG2|NCRNA00172	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54348
5.59740937415621e-12	-0.510204553318924	0.065	0.266	1.15334620154489e-07	FAM107B	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54349
7.50830184110071e-12	1.36471946601089	0.824	0.868	1.5470855943588e-07	IGHG1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54350
7.85193748611468e-12	-0.430881409012821	0.208	0.474	1.61789171901393e-07	DNAJA1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54351
1.11283070303008e-11	-0.43106277742602	0.221	0.474	2.29298766359348e-07	PRDX1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54352
1.2860809937171e-11	-0.999004400575012	0.635	0.737	2.64996988755408e-07	HSP90AA1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54353
1.66221312225264e-11	-0.368516904506333	0.117	0.345	3.42499013840156e-07	BTF3	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54354
1.85124443150925e-11	-0.317843722257733	0.13	0.359	3.8144891511248e-07	GNG7	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000176533	2788	G protein subunit gamma 7	FLJ00058	protein_coding	O60262	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54355
2.03255388704617e-11	-0.343826469647855	0.081	0.289	4.18807728425863e-07	SRSF9	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54356
2.56547991868189e-11	-0.488609118403033	0.081	0.283	5.28617137244403e-07	BASP1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54357
2.65699096042374e-11	-0.459814257111481	0.28	0.536	5.47472987395311e-07	RPS29	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54358
3.91692254372945e-11	-0.823866194452497	0.479	0.678	8.07081890135453e-07	HSPA5	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54359
8.33027103409176e-11	-0.322289627288926	0.078	0.28	1.71645234657461e-06	PCBP1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54360
1.51370375999444e-10	-0.323949996951867	0.075	0.27	3.11898659746854e-06	AC007384.1	Plasma cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54361
1.80776470010377e-10	-0.335286967817799	0.15	0.368	3.72489916456382e-06	ADA2	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000093072	51816	adenosine deaminase 2	ADGF|CECR1|IDGFL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54362
2.43933707261561e-10	0.494395994041583	0.528	0.286	5.02625403812446e-06	ANKRD28	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54363
2.86562290323688e-10	-0.406567027525706	0.84	0.914	5.9046159921196e-06	CYBA	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54364
3.20049786226522e-10	-0.275834901996482	0.121	0.336	6.59462584519748e-06	TRMT112	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54365
3.67007464466431e-10	-0.298115953647343	0.078	0.266	7.56218880533082e-06	TCEA1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54366
3.70996139187695e-10	-0.531890495180002	0.586	0.783	7.64437544796246e-06	RPS13	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54367
3.84904603933318e-10	-1.09467535503597	0.508	0.664	7.93095936404601e-06	JCHAIN	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54368
4.47935121636796e-10	0.422108963726589	0.332	0.128	9.22970318132619e-06	MIR4435-2HG	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000172965	541471	MIR4435-2 host gene	AGD2|AK001796|LINC00978|lncRNA-AWPPH|MIR4435-1HG|MORRBID	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54369
5.40068346472366e-10	-0.448496169814198	0.199	0.421	1.11281082790631e-05	H3F3A	Plasma cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54370
5.4129492766047e-10	0.855622965490612	0.638	0.48	1.1153381984444e-05	SQSTM1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54371
5.80270939557625e-10	0.598569834896167	0.508	0.289	1.19564827095849e-05	PPP1R15A	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54372
7.88730621829059e-10	0.587697228704982	0.42	0.211	1.62517944627878e-05	CDKN1A	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54373
9.09558170432648e-10	-0.559763672911425	0.87	0.944	1.87414461017647e-05	TPT1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54374
1.09839700322524e-09	-0.450700971622117	0.339	0.539	2.26324702514561e-05	TMBIM6	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54375
1.12610414724548e-09	-0.682448382293312	0.274	0.493	2.32033759539932e-05	HSPD1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54376
1.1355595551089e-09	-0.387245069129696	0.261	0.513	2.33982046330188e-05	HLA-A	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54377
1.3055213461522e-09	-0.405069191182901	0.857	0.911	2.6900267337466e-05	RPS4X	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54378
1.50837390417485e-09	-0.385423139177524	0.166	0.372	3.10800442955227e-05	SEL1L3	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000091490	23231	SEL1L family member 3	KIAA0746	protein_coding	Q68CR1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54379
2.09230317919008e-09	0.650994464298657	0.541	0.345	4.31119070072117e-05	JSRP1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000167476	126306	junctional sarcoplasmic reticulum protein 1	FLJ32416|JP-45	protein_coding	Q96MG2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54380
3.21261316517665e-09	-0.415157056719805	0.179	0.395	6.61958942684649e-05	HMGB1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54381
3.87055993203299e-09	-0.374698266037704	0.205	0.424	7.97528873995397e-05	HSPH1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54382
4.10262761012439e-09	-0.257513402838275	0.075	0.25	8.45346419066131e-05	RBM3	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54383
4.57462877816422e-09	-0.587552798281625	0.958	0.957	9.42602259740737e-05	MZB1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54384
5.4461725949808e-09	-0.292610282624219	0.147	0.349	0.000112218386319579	EAF2	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000145088	55840	ELL associated factor 2	BM040|TRAITS|U19	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54385
6.99123305692266e-09	-0.346391948988913	0.143	0.339	0.000144054357137891	CCNI	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54386
7.52452184464026e-09	-0.253837744694877	0.081	0.253	0.000155042772608813	CTSS	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54387
8.59185946422922e-09	-0.306694510373397	0.107	0.293	0.000177035264260443	NCF1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54388
8.92627268192252e-09	-0.25159109408135	0.101	0.283	0.000183925848611013	MANEA	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000172469	79694	mannosidase endo-alpha	FLJ12838|mandaselin	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54389
1.53263168444148e-08	-0.323214135517224	0.127	0.312	0.000315798758579166	EHMT1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000181090	79813	euchromatic histone lysine methyltransferase 1	bA188C12.1|EHMT1-IT1|Eu-HMTase1|FLJ12879|FLJ40292|GLP|KIAA1876|KMT1D	protein_coding	Q9H9B1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54390
1.5359829796482e-08	-0.365639702427972	0.13	0.322	0.000316489292956511	PPIA	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54391
1.54680810182388e-08	0.571418767265862	0.795	0.622	0.000318719809380811	MT-ND5	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54392
1.81984069593267e-08	-0.573712104383743	0.645	0.77	0.000374978175396926	RPL39	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54393
2.08842308662786e-08	-0.601774553903314	0.306	0.51	0.00043031957699967	HSPE1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54394
2.32379733843046e-08	0.545641691566224	0.564	0.378	0.000478818441583597	CYTOR	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54395
2.8704708045285e-08	0.290687249601827	0.287	0.112	0.000591460509273098	IRF7	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54396
2.8710007981674e-08	-0.530919254288318	0.655	0.796	0.000591569714462392	RPS23	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54397
2.92242053979124e-08	-0.289244928586158	0.085	0.25	0.000602164752223985	RNGTT	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000111880	8732	RNA guanylyltransferase and 5'-phosphatase	hCAP|HCE|HCE1	protein_coding	O60942	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54398
3.13642084287434e-08	-0.498329191860258	0.531	0.688	0.000646259514674257	RPS2	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54399
3.31594028997463e-08	-0.452697133368221	0.883	0.951	0.000683249496749273	RPL10	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54400
3.51993389782215e-08	-0.559085113752348	0.404	0.609	0.000725282379646255	BTG2	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54401
3.53735274365131e-08	-0.278582968158748	0.098	0.273	0.000728871532829351	HINT1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54402
4.1633698261371e-08	-0.324382006250166	0.176	0.365	0.00085786235267555	UBXN4	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54403
4.23160032514033e-08	-0.38055912226371	0.101	0.276	0.000871921246995164	ZFAND2A	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54404
4.90074395027399e-08	0.838952007240944	0.651	0.48	0.00100979829095396	NEAT1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54405
4.92773808602584e-08	-0.513738341417105	0.319	0.484	0.00101536043262563	CYTIP	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54406
5.90811999938586e-08	-0.269208947006857	0.156	0.342	0.00121736812587346	SEC14L1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54407
6.28236568198536e-08	-0.253238494409672	0.104	0.276	0.00129448144877308	PTGES3	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54408
6.86674133427193e-08	-0.311233366335179	0.231	0.428	0.00141489205192673	CANX	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54409
7.10683785500741e-08	0.364041871235705	0.371	0.191	0.00146436394002428	CFLAR	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54410
7.30815990874285e-08	0.347528320556043	0.964	0.964	0.00150584634919646	HLA-C	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54411
8.3256325332061e-08	-0.440626010285263	0.114	0.273	0.00171549658346712	RASSF6	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000169435	166824	Ras association domain family member 6	NA	protein_coding	Q6ZTQ3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54412
9.10931321749406e-08	-0.658985500229291	0.088	0.263	0.00187697398846465	IGKV1-39	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000282120	NA	NA	NA	IG_V_gene	P01597	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54413
9.2975563285189e-08	-0.434816877896632	0.365	0.539	0.00191576148149132	ARF4	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54414
1.55321053381247e-07	0.435849899140025	0.541	0.319	0.0032003903049206	FOSB	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54415
1.6364681222819e-07	-0.418094554011218	0.489	0.635	0.00337194256596186	RACK1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54416
1.80658069639022e-07	-0.285580155559709	0.199	0.382	0.00372245952491204	REEP5	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000129625	7905	receptor accessory protein 5	C5orf18|D5S346|DP1|POB16|TB2|Yip2e	protein_coding	Q00765	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54417
1.85390954345873e-07	-0.286898236370752	0.091	0.25	0.00381998061429672	PNRC1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54418
2.22804342645967e-07	-0.271818541063484	0.156	0.329	0.00459088348022015	EIF2AK4	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000128829	440275	eukaryotic translation initiation factor 2 alpha kinase 4	GCN2|KIAA1338	protein_coding	Q9P2K8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54419
2.34310451777027e-07	-0.292045584999408	0.322	0.513	0.00482796685886564	TMED9	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54420
2.43641070368489e-07	-0.307017392195949	0.358	0.543	0.00502022425494271	LMAN2	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000169223	10960	lectin, mannose binding 2	C5orf8|GP36B|VIP36	protein_coding	Q12907	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54421
3.84003595753485e-07	-0.32675756223462	0.303	0.493	0.00791239409050055	RPS11	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54422
5.24344019024018e-07	-0.267123284734837	0.163	0.342	0.0108041085119899	JUND	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54423
5.5781879420447e-07	-0.264767455401556	0.134	0.306	0.0114938562545831	NPM1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54424
5.59771909648563e-07	-0.291789273983434	0.29	0.47	0.0115341001983087	RPN1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000163902	6184	ribophorin I	OST1	protein_coding	P04843	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54425
5.65515819800704e-07	-0.340678174101938	0.779	0.865	0.0116524534669935	MT-CO1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54426
6.07050589750745e-07	-0.310216794988351	0.137	0.299	0.0125082774018141	HNRNPA1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54427
7.33394579968975e-07	-0.34871491334507	0.199	0.372	0.0151115953202607	EIF5	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54428
1.29190889253308e-06	-0.322497823413234	0.453	0.605	0.026619782730644	NACA	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54429
1.32598945635276e-06	-0.365911081249518	0.309	0.48	0.0273220127481487	MTDH	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54430
1.37237265482036e-06	-0.486801132544874	0.127	0.273	0.0282777385525735	H1FX	Plasma cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54431
1.70484784386386e-06	-0.332885870338066	0.137	0.289	0.0351283898228149	CHST2	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000175040	9435	carbohydrate sulfotransferase 2	C6ST	protein_coding	Q9Y4C5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54432
1.81095464796305e-06	-0.328457050051467	0.818	0.905	0.0373147205212787	RPLP0	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54433
1.91457506288025e-06	-0.332381924014892	0.127	0.283	0.0394498191706475	RGS2	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54434
1.95850444863632e-06	0.30612967738184	0.264	0.112	0.0403549841641514	LGALS1	Plasma cells	GSE169246_PacAteTissue_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54435
2.15912091905991e-41	0.85850748203531	1	1	4.44886865372295e-37	HLA-B	NK cells	GSE169246_PacAteTissue_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54436
1.94604975771386e-32	-0.612483440469334	0.996	1	4.00983552576941e-28	HLA-A	NK cells	GSE169246_PacAteTissue_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54437
1.36192742586896e-29	0.607409998524926	1	0.994	2.80625146100298e-25	HLA-C	NK cells	GSE169246_PacAteTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54438
8.25526382698568e-29	0.623163469442032	1	1	1.7009971115504e-24	TMSB4X	NK cells	GSE169246_PacAteTissue_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54439
3.69881180185776e-25	-0.59346521574624	0.973	1	7.62140171772791e-21	MT-CO3	NK cells	GSE169246_PacAteTissue_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54440
6.89801361749779e-25	0.496359284425464	1	0.994	1.42133570588542e-20	RPL28	NK cells	GSE169246_PacAteTissue_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54441
1.0160380478791e-24	-0.651207933167929	0.849	0.955	2.09354639765489e-20	MT-ND4	NK cells	GSE169246_PacAteTissue_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54442
1.081843159899e-23	-0.808861614454194	0.621	0.904	2.2291378309719e-19	CTSW	NK cells	GSE169246_PacAteTissue_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54443
4.63790548947463e-23	-0.607146399703167	0.987	1	9.55640426106247e-19	MT-CYB	NK cells	GSE169246_PacAteTissue_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54444
4.03355644312922e-21	-0.82844084031423	0.218	0.511	8.31114305106775e-17	KLF2	NK cells	GSE169246_PacAteTissue_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54445
1.3829139564995e-19	-0.58630580628897	0.964	0.989	2.84949420736721e-15	MT-ATP8	NK cells	GSE169246_PacAteTissue_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54446
4.58163631680079e-19	-0.556864776318998	0.775	0.921	9.44046163076804e-15	PNRC1	NK cells	GSE169246_PacAteTissue_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54447
4.02990461595636e-18	0.542295642030303	0.998	0.989	8.30361846117809e-14	TMSB10	NK cells	GSE169246_PacAteTissue_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54448
7.3714405773859e-18	-0.408868739499854	0.16	0.421	1.51888533097036e-13	SMAP2	NK cells	GSE169246_PacAteTissue_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54449
1.02360718269725e-17	0.430712427125146	1	1	2.10914259994769e-13	RPLP1	NK cells	GSE169246_PacAteTissue_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54450
7.74292776621812e-17	-0.588414885446581	0.368	0.64	1.59543026622924e-12	AHNAK	NK cells	GSE169246_PacAteTissue_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54451
2.60353742306644e-15	1.09739815833416	0.556	0.287	5.36458886022839e-11	ISG15	NK cells	GSE169246_PacAteTissue_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54452
2.87734313310531e-15	0.864260470509895	0.28	0.006	5.9287655257635e-11	FDCSP	NK cells	GSE169246_PacAteTissue_post	ENSG00000181617	260436	follicular dendritic cell secreted protein	C4orf7|FDC-SP	protein_coding	Q8NFU4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54453
3.34510393752697e-15	-0.518629871728055	0.982	1	6.89258666327433e-11	MT-ND3	NK cells	GSE169246_PacAteTissue_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54454
4.81647184511633e-15	0.748280848110139	0.733	0.522	9.92434023686219e-11	LY6E	NK cells	GSE169246_PacAteTissue_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54455
8.61489780776362e-15	-0.441048371616083	0.169	0.416	1.77509969328969e-10	SELL	NK cells	GSE169246_PacAteTissue_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54456
1.00053813820237e-14	-0.327426783290475	0.158	0.393	2.06160883376599e-10	CD81	NK cells	GSE169246_PacAteTissue_post	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54457
2.55953191656736e-14	-0.575078555262701	0.848	0.955	5.27391551408704e-10	HSP90AB1	NK cells	GSE169246_PacAteTissue_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54458
3.45381693530693e-14	-0.443990074514297	0.557	0.803	7.11658979519993e-10	JAK1	NK cells	GSE169246_PacAteTissue_post	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54459
9.21858656504235e-14	-0.73152679380681	0.597	0.803	1.89948976172698e-09	NFKBIA	NK cells	GSE169246_PacAteTissue_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54460
2.01709059032867e-13	-0.38357466635395	0.415	0.68	4.15621516137222e-09	CDC42	NK cells	GSE169246_PacAteTissue_post	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54461
2.32905326201209e-13	0.565066237880246	0.423	0.146	4.79901424637591e-09	XAF1	NK cells	GSE169246_PacAteTissue_post	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54462
2.41213385216357e-13	-0.760496570468947	0.445	0.68	4.97020180238303e-09	MYADM	NK cells	GSE169246_PacAteTissue_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54463
3.88601917024077e-13	0.85475147107368	0.387	0.124	8.0071425002811e-09	IFI6	NK cells	GSE169246_PacAteTissue_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54464
5.36229027145702e-13	0.35924882122624	0.999	0.994	1.10489991043372e-08	RPS15A	NK cells	GSE169246_PacAteTissue_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54465
1.51495280944943e-12	-0.577774632669525	0.524	0.708	3.12156026387055e-08	ADGRE5	NK cells	GSE169246_PacAteTissue_post	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54466
1.56933081793249e-12	0.506234790666471	0.262	0.022	3.2336061503499e-08	IFI44L	NK cells	GSE169246_PacAteTissue_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54467
2.3299947661066e-12	-0.417264562801997	0.929	0.944	4.80095421556264e-08	MT-ND5	NK cells	GSE169246_PacAteTissue_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54468
5.62301660989296e-12	-0.575319189025459	0.426	0.657	1.15862257246844e-07	NFKB1	NK cells	GSE169246_PacAteTissue_post	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54469
8.65732697417247e-12	-0.439524855718124	0.861	0.916	1.78384222302824e-07	MT-ND2	NK cells	GSE169246_PacAteTissue_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54470
9.10241065268388e-12	0.624892256684305	0.436	0.185	1.87555171498551e-07	IRF7	NK cells	GSE169246_PacAteTissue_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54471
1.52931097356692e-11	-0.345718894185462	0.998	1	3.15114526103464e-07	MT-CO1	NK cells	GSE169246_PacAteTissue_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54472
2.22394616698294e-11	-0.437113321541483	0.481	0.697	4.58244107706835e-07	HIST1H4C	NK cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54473
2.59422100778709e-11	-0.847639413801072	0.362	0.573	5.3453923865453e-07	LMNA	NK cells	GSE169246_PacAteTissue_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54474
3.48384892145877e-11	0.405886928076054	0.997	0.989	7.17847070266579e-07	H3F3B	NK cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54475
4.51666539239499e-11	0.505722009537285	0.98	0.949	9.30658904102989e-07	GAPDH	NK cells	GSE169246_PacAteTissue_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54476
4.60195763817126e-11	-0.336395679144907	0.132	0.315	9.48233371345189e-07	IGF2R	NK cells	GSE169246_PacAteTissue_post	ENSG00000197081	3482	insulin like growth factor 2 receptor	CD222|CI-M6PR|CI-MPR|CIMPR|M6P-R|MPR1|MPR300|MPRI	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54477
5.11432106006327e-11	-0.430047655211993	0.268	0.483	1.05380585442604e-06	UCP2	NK cells	GSE169246_PacAteTissue_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54478
5.33497702087148e-11	-0.500117090810634	0.948	0.978	1.09927201515057e-06	HSP90AA1	NK cells	GSE169246_PacAteTissue_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54479
6.20241660067548e-11	-0.641358526267424	1	1	1.27800794056918e-06	MALAT1	NK cells	GSE169246_PacAteTissue_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54480
6.8524795387152e-11	-0.274422046801343	0.178	0.388	1.41195340895227e-06	OTULIN	NK cells	GSE169246_PacAteTissue_post	ENSG00000154124	90268	OTU deubiquitinase with linear linkage specificity	FAM105B|FLJ34884	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54481
9.86872118804447e-11	-0.334966434534031	0.99	1	2.03345000079656e-06	MT-ND4L	NK cells	GSE169246_PacAteTissue_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54482
1.23869169502179e-10	0.412820760912271	0.955	0.871	2.55232423759241e-06	ATP5F1E	NK cells	GSE169246_PacAteTissue_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54483
1.56703177457181e-10	-0.440547980766192	0.954	0.972	3.22886897150522e-06	MT-ND1	NK cells	GSE169246_PacAteTissue_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54484
1.93665114168908e-10	-0.39676674844367	0.811	0.916	3.99046967745034e-06	PTPRC	NK cells	GSE169246_PacAteTissue_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54485
2.71556308933601e-10	-0.288326691521224	0.203	0.404	5.59541774557686e-06	TAF10	NK cells	GSE169246_PacAteTissue_post	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54486
3.49783079096892e-10	0.508935366473978	0.731	0.517	7.20728034479145e-06	DYNLL1	NK cells	GSE169246_PacAteTissue_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54487
4.60128588867665e-10	0.467900494369577	0.744	0.612	9.48094957361824e-06	NDUFS5	NK cells	GSE169246_PacAteTissue_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54488
5.52812942755263e-10	-0.408625919719876	0.421	0.635	1.13907106854722e-05	BCL3	NK cells	GSE169246_PacAteTissue_post	ENSG00000069399	602	BCL3 transcription coactivator	BCL4|D19S37	protein_coding	P20749	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54489
5.60212791225068e-10	-0.379752889052654	0.994	0.972	1.15431845631925e-05	RPS3A	NK cells	GSE169246_PacAteTissue_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54490
7.03314464048285e-10	0.560201322777688	0.56	0.354	1.44917945317149e-05	ALOX5AP	NK cells	GSE169246_PacAteTissue_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54491
1.01815944943907e-09	0.869227911468841	0.633	0.421	2.09791754556921e-05	MT2A	NK cells	GSE169246_PacAteTissue_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54492
1.05415995307728e-09	-0.594499346000763	0.608	0.747	2.17209658331573e-05	EZR	NK cells	GSE169246_PacAteTissue_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54493
1.29862158558435e-09	-0.291623423159287	0.119	0.281	2.67580977709655e-05	TRAF1	NK cells	GSE169246_PacAteTissue_post	ENSG00000056558	7185	TNF receptor associated factor 1	EBI6	protein_coding	Q13077	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54494
2.58875432881906e-09	-0.270336246730093	0.156	0.337	5.33412829453168e-05	TCF7	NK cells	GSE169246_PacAteTissue_post	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54495
2.71686320194773e-09	-0.439172439538735	0.345	0.545	5.59809662761329e-05	TUBA1A	NK cells	GSE169246_PacAteTissue_post	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54496
2.80712220694994e-09	-0.284828482844282	0.186	0.371	5.78407530742035e-05	SRPRA	NK cells	GSE169246_PacAteTissue_post	ENSG00000182934	6734	SRP receptor subunit alpha	SR-alpha|Sralpha|SRP-alpha|SRPR	protein_coding	P08240	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54497
2.86982348020787e-09	-0.375634298159641	0.525	0.742	5.91327128096832e-05	BTG2	NK cells	GSE169246_PacAteTissue_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54498
3.76544819845852e-09	-0.576452516208476	0.263	0.472	7.75870601292378e-05	IL7R	NK cells	GSE169246_PacAteTissue_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54499
4.58675261447758e-09	-0.450599913154968	0.49	0.685	9.45100376213106e-05	ITGB2	NK cells	GSE169246_PacAteTissue_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54500
5.17053538429891e-09	-0.402047543264216	0.609	0.77	0.000106538881593479	SFPQ	NK cells	GSE169246_PacAteTissue_post	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54501
9.11791544838621e-09	-0.531098280201265	0.744	0.831	0.000187874647813998	TAGLN2	NK cells	GSE169246_PacAteTissue_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54502
1.01004181047068e-08	0.259575291026699	0.999	0.989	0.000208119115047484	FAU	NK cells	GSE169246_PacAteTissue_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54503
1.66659255417968e-08	0.707446705689676	0.443	0.264	0.000343401395788722	DUSP4	NK cells	GSE169246_PacAteTissue_post	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54504
1.92834549388296e-08	-0.307839438068463	0.377	0.596	0.000397335589014584	RBM38	NK cells	GSE169246_PacAteTissue_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54505
2.15637759525397e-08	-0.310338740914781	0.317	0.511	0.00044432160350208	ETS1	NK cells	GSE169246_PacAteTissue_post	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54506
2.26008850011349e-08	-0.342031482496926	0.49	0.708	0.000465691235448384	BHLHE40	NK cells	GSE169246_PacAteTissue_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54507
2.69447886774356e-08	-0.319487953354554	0.415	0.607	0.00055519737069856	DDX17	NK cells	GSE169246_PacAteTissue_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54508
2.77379599695665e-08	0.369165268200001	0.577	0.376	0.000571540665172918	GNG5	NK cells	GSE169246_PacAteTissue_post	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54509
3.0764471030579e-08	-0.33835717667836	0.613	0.792	0.00063390192558508	NCL	NK cells	GSE169246_PacAteTissue_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54510
3.21550227701561e-08	-0.258419201649476	0.986	0.994	0.000662554244179067	RPL3	NK cells	GSE169246_PacAteTissue_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54511
3.39107904581277e-08	0.262990790823231	1	1	0.000698731837389721	RPS12	NK cells	GSE169246_PacAteTissue_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54512
3.43331671010283e-08	-0.385909980507678	0.232	0.404	0.000707434908116688	PHLDA1	NK cells	GSE169246_PacAteTissue_post	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54513
3.65024882428267e-08	-0.409563487653782	0.303	0.489	0.000752133770243443	NFKBIZ	NK cells	GSE169246_PacAteTissue_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54514
3.82534418585004e-08	-0.528959005134135	0.67	0.792	0.0007882121694944	IL32	NK cells	GSE169246_PacAteTissue_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54515
4.60727033933827e-08	-0.250717973055614	0.254	0.444	0.000949328053420651	ATM	NK cells	GSE169246_PacAteTissue_post	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54516
5.62272581848944e-08	-0.58880974633789	0.775	0.899	0.00115856265489975	TNFAIP3	NK cells	GSE169246_PacAteTissue_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54517
7.70059684224876e-08	-0.382554948503538	0.278	0.461	0.00158670797934536	FAM107B	NK cells	GSE169246_PacAteTissue_post	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54518
1.18146414445808e-07	0.302222280033214	0.616	0.416	0.00243440686965587	NDUFA4	NK cells	GSE169246_PacAteTissue_post	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54519
1.26657803755234e-07	0.468756947372402	0.74	0.59	0.0026097840463766	S100A6	NK cells	GSE169246_PacAteTissue_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54520
1.37209892749253e-07	0.468031173003294	0.337	0.157	0.00282720984009836	PLSCR1	NK cells	GSE169246_PacAteTissue_post	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54521
1.38887655813988e-07	-0.289849242545236	0.175	0.337	0.00286178014804722	RASGEF1B	NK cells	GSE169246_PacAteTissue_post	ENSG00000138670	153020	RasGEF domain family member 1B	FLJ31695|GPIG4	protein_coding	Q0VAM2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54522
1.98082780278706e-07	0.489591329922658	0.978	0.955	0.00408149568764274	IFITM1	NK cells	GSE169246_PacAteTissue_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54523
2.19564802062072e-07	0.54556191651079	0.345	0.169	0.004524132746489	MX1	NK cells	GSE169246_PacAteTissue_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54524
2.39241870804366e-07	-0.295361663322905	0.851	0.933	0.00492957874792396	RPL13A	NK cells	GSE169246_PacAteTissue_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54525
2.83943647387895e-07	0.30892047952994	0.959	0.893	0.00585065885442758	SERF2	NK cells	GSE169246_PacAteTissue_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54526
3.18834532246015e-07	0.4051427983504	0.951	0.904	0.00656958553692914	SH3BGRL3	NK cells	GSE169246_PacAteTissue_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54527
3.51510644547475e-07	-0.259782675671585	0.429	0.629	0.00724287683090072	ACTR3	NK cells	GSE169246_PacAteTissue_post	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54528
4.18424636559769e-07	0.344994698289648	0.747	0.646	0.00862163963631403	SUB1	NK cells	GSE169246_PacAteTissue_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54529
4.52056440714598e-07	-0.300853532251342	0.859	0.916	0.0093146229609243	YWHAZ	NK cells	GSE169246_PacAteTissue_post	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54530
4.85752277112354e-07	-0.290042387339807	0.402	0.596	0.0100089256699001	HNRNPU	NK cells	GSE169246_PacAteTissue_post	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54531
5.08506210606903e-07	-0.566301254414237	0.85	0.843	0.0104777704695552	CXCR4	NK cells	GSE169246_PacAteTissue_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54532
5.68265826693195e-07	0.605160927134446	0.518	0.348	0.0117091173590133	IFITM3	NK cells	GSE169246_PacAteTissue_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54533
5.76141191665258e-07	0.353867885583914	0.804	0.697	0.0118713892542626	MIF	NK cells	GSE169246_PacAteTissue_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54534
5.765373560172e-07	-0.299840782212187	0.353	0.545	0.0118795522207344	CAST	NK cells	GSE169246_PacAteTissue_post	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54535
6.21723350681382e-07	-0.285402000447898	0.289	0.461	0.0128106096407899	RNF19A	NK cells	GSE169246_PacAteTissue_post	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54536
7.46862336608665e-07	-0.318335164736645	0.2	0.36	0.0153890984458215	GPR183	NK cells	GSE169246_PacAteTissue_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54537
8.84458115905158e-07	0.383116595910102	0.665	0.534	0.0182242594782258	RARRES3	NK cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54538
9.33121498882868e-07	0.346643558816002	0.441	0.27	0.0192269684844815	UBE2L6	NK cells	GSE169246_PacAteTissue_post	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54539
1.00204280627661e-06	-0.298890855703383	0.991	0.989	0.0206470920233295	RPS2	NK cells	GSE169246_PacAteTissue_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54540
1.03763269662612e-06	0.466541640405104	0.837	0.758	0.0213804217139812	CREM	NK cells	GSE169246_PacAteTissue_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54541
1.04572900673255e-06	-0.267051492913652	0.337	0.506	0.0215472461837243	EIF4B	NK cells	GSE169246_PacAteTissue_post	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54542
1.19456815120836e-06	-0.279979841446402	0.371	0.539	0.0246140767556483	KHDRBS1	NK cells	GSE169246_PacAteTissue_post	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54543
1.30228408119196e-06	-0.531266293329831	0.311	0.455	0.0268335634929604	GZMK	NK cells	GSE169246_PacAteTissue_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54544
1.35959579090149e-06	0.281513789295738	0.55	0.371	0.0280144712715253	ATP5MD	NK cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54545
1.42051248998446e-06	-0.258731865428103	0.332	0.5	0.0292696598561299	RAB8B	NK cells	GSE169246_PacAteTissue_post	ENSG00000166128	51762	RAB8B, member RAS oncogene family	NA	protein_coding	Q92930	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54546
1.92506052821714e-06	-0.267109841381472	0.351	0.522	0.0396658721839142	IQGAP1	NK cells	GSE169246_PacAteTissue_post	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54547
2.15278441169548e-06	0.290498985370289	0.939	0.86	0.0443581228029854	OAZ1	NK cells	GSE169246_PacAteTissue_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54548
2.16343974136646e-06	0.547090850592274	0.364	0.213	0.044577675870856	ZNF683	NK cells	GSE169246_PacAteTissue_post	ENSG00000176083	257101	zinc finger protein 683	Hobit|MGC33414	protein_coding	Q8IZ20	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54549
2.1914625953346e-06	0.454965762905112	0.452	0.275	0.0451550867768694	LDLRAD4	NK cells	GSE169246_PacAteTissue_post	ENSG00000168675	753	low density lipoprotein receptor class A domain containing 4	C18orf1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54550
2.2514169878729e-06	-0.455911479923599	0.591	0.736	0.0463904470351212	ANXA1	NK cells	GSE169246_PacAteTissue_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54551
2.31969908600424e-06	-0.387757717170632	0.371	0.539	0.0477973996671174	BIRC3	NK cells	GSE169246_PacAteTissue_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54552
8.28350050903461e-12	-1.13750352374994	0	0.8	1.70681527988658e-07	AC068446.2	Mast cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54553
6.00932115984528e-07	-1.03796785019902	0.054	0.8	0.0123822062498612	ADD1	Mast cells	GSE169246_PacAteTissue_post	ENSG00000087274	118	adducin 1	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54554
6.81971276337321e-07	-0.6525368130055	0.018	0.6	0.0140520181489305	UBE4B	Mast cells	GSE169246_PacAteTissue_post	ENSG00000130939	10277	ubiquitination factor E4B	E4|KIAA0684|UBOX3|UFD2	protein_coding	O95155	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54555
6.81971276337321e-07	-0.6525368130055	0.018	0.6	0.0140520181489305	NSD1	Mast cells	GSE169246_PacAteTissue_post	ENSG00000165671	64324	nuclear receptor binding SET domain protein 1	ARA267|FLJ22263|KMT3B|STO	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54556
6.81971276337321e-07	-0.6525368130055	0.018	0.6	0.0140520181489305	HDHD2	Mast cells	GSE169246_PacAteTissue_post	ENSG00000167220	84064	haloacid dehalogenase like hydrolase domain containing 2	DKFZP564D1378	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54557
6.81971276337321e-07	-0.6525368130055	0.018	0.6	0.0140520181489305	ZNF264	Mast cells	GSE169246_PacAteTissue_post	ENSG00000083844	9422	zinc finger protein 264	KIAA0412	protein_coding	O43296	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54558
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	AGO1	Mast cells	GSE169246_PacAteTissue_post	ENSG00000092847	26523	argonaute RISC component 1	EIF2C1|hAGO1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54559
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	P3H1	Mast cells	GSE169246_PacAteTissue_post	ENSG00000117385	64175	prolyl 3-hydroxylase 1	GROS1|LEPRE1|LEPRECAN|MGC117314	protein_coding	Q32P28	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54560
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	RNF144A	Mast cells	GSE169246_PacAteTissue_post	ENSG00000151692	9781	ring finger protein 144A	hUIP4|KIAA0161|RNF144|UBCE7IP4	protein_coding	P50876	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54561
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	CAMKMT	Mast cells	GSE169246_PacAteTissue_post	ENSG00000143919	79823	calmodulin-lysine N-methyltransferase	C2orf34|CLNMT	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54562
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	PUS10	Mast cells	GSE169246_PacAteTissue_post	ENSG00000162927	150962	pseudouridine synthase 10	CCDC139|FLJ32312	protein_coding	Q3MIT2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54563
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	OXCT1	Mast cells	GSE169246_PacAteTissue_post	ENSG00000083720	5019	3-oxoacid CoA-transferase 1	OXCT|SCOT	protein_coding	P55809	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54564
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	JMY	Mast cells	GSE169246_PacAteTissue_post	ENSG00000152409	133746	junction mediating and regulatory protein, p53 cofactor	FLJ37870|WHAMM2	protein_coding	Q8N9B5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54565
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	HIST1H1E	Mast cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54566
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	POLH	Mast cells	GSE169246_PacAteTissue_post	ENSG00000170734	5429	DNA polymerase eta	RAD30A|XP-V	protein_coding	Q9Y253	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54567
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	GSAP	Mast cells	GSE169246_PacAteTissue_post	ENSG00000186088	54103	gamma-secretase activating protein	LOC54103|PION	protein_coding	A4D1B5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54568
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	WDYHV1	Mast cells	GSE169246_PacAteTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54569
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	RNF38	Mast cells	GSE169246_PacAteTissue_post	ENSG00000137075	152006	ring finger protein 38	NA	protein_coding	Q9H0F5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54570
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	ZNF79	Mast cells	GSE169246_PacAteTissue_post	ENSG00000196152	7633	zinc finger protein 79	pT7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54571
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	CCDC7	Mast cells	GSE169246_PacAteTissue_post	ENSG00000216937	79741	coiled-coil domain containing 7	BIOT2|C10orf68|FLJ13031|FLJ32762	protein_coding	Q96M83	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54572
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	TLNRD1	Mast cells	GSE169246_PacAteTissue_post	ENSG00000140406	59274	talin rod domain containing 1	MESDC1|MGC99595	protein_coding	Q9H1K6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54573
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	LRRC28	Mast cells	GSE169246_PacAteTissue_post	ENSG00000168904	123355	leucine rich repeat containing 28	FLJ34269|FLJ45242|MGC24976	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54574
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	DHX38	Mast cells	GSE169246_PacAteTissue_post	ENSG00000140829	9785	DEAH-box helicase 38	DDX38|hPrp16|KIAA0224|PRP16|PRPF16	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54575
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	NUP88	Mast cells	GSE169246_PacAteTissue_post	ENSG00000108559	4927	nucleoporin 88	MGC8530	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54576
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	ZNF333	Mast cells	GSE169246_PacAteTissue_post	ENSG00000160961	84449	zinc finger protein 333	KIAA1806	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54577
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	ZNF230	Mast cells	GSE169246_PacAteTissue_post	ENSG00000159882	7773	zinc finger protein 230	FDZF2	protein_coding	Q9UIE0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54578
2.24309816930898e-06	-0.485426827170242	0	0.4	0.0462190377786116	PPIL2	Mast cells	GSE169246_PacAteTissue_post	ENSG00000100023	23759	peptidylprolyl isomerase like 2	CYC4|Cyp-60|UBOX7	protein_coding	Q13356	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54579
2.25036905831376e-06	-0.678071905112637	0	0.4	0.0463688544465549	IGKC	Mast cells	GSE169246_PacAteTissue_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54580
2.25036905831376e-06	-0.678071905112637	0	0.4	0.0463688544465549	KIF2A	Mast cells	GSE169246_PacAteTissue_post	ENSG00000068796	3796	kinesin family member 2A	HK2|KIF2	protein_coding	O00139	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	post	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54581
0	-0.647354526075696	0.929	0.988	0	RPL22	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54582
0	-0.733420943001134	0.992	1	0	RPL11	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54583
0	-0.753463879567401	0.993	1	0	RPS8	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54584
0	0.488645622913504	0.356	0.107	0	GBP5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54585
0	-0.550349947918824	0.951	0.99	0	RPL5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54586
0	0.688871000660721	0.763	0.464	0	S100A6	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54587
0	1.06089207399541	0.812	0.558	0	S100A4	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54588
0	0.384946114996046	0.289	0.068	0	FAM129A	CD4+ T cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54589
0	-0.579044530426227	0.985	0.999	0	RPS7	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54590
0	-0.56274610382639	0.992	1	0	RPS27A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54591
0	1.5801617317886	0.358	0.12	0	IGKC	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54592
0	0.941687026734724	0.33	0.112	0	IGKV1-5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000282801	NA	NA	NA	IG_V_gene	P01602	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54593
0	0.764043598931137	0.251	0.015	0	IGKV1-9	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000282758	NA	NA	IGKV19|L8	IG_V_gene	A0A0C4DH69	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54594
0	1.28042336357585	0.327	0.026	0	IGKV1-39	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000282120	NA	NA	NA	IG_V_gene	P01597	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54595
0	-0.736200217385448	0.992	1	0	RPL32	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54596
0	-0.555850378454989	0.976	0.997	0	RPL14	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54597
0	-0.613320059674786	0.976	0.998	0	RPL29	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54598
0	0.490804904722567	0.275	0.033	0	MTRNR2L12	CD4+ T cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54599
0	-0.563518520409199	0.982	0.999	0	RPL35A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54600
0	-0.687379072204086	0.99	1	0	RPL34	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54601
0	-0.968383111109544	0.983	0.999	0	RPS3A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54602
0	-0.47524800129966	0.99	0.999	0	RPL37	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54603
0	-0.57136357893037	0.988	1	0	RPS23	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54604
0	-0.565424592491185	0.988	0.999	0	RPS14	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54605
0	1.1967883328882	0.999	0.975	0	HLA-B	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54606
0	-0.737025606361348	0.996	1	0	RPS12	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54607
0	-0.551158290216198	0.99	1	0	RPS4X	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54608
0	-0.719595841241179	0.993	1	0	RPL39	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54609
0	-0.558652781299275	0.998	1	0	RPL10	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54610
0	-0.588276329981861	0.995	1	0	RPL30	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54611
0	-0.438977201003051	0.987	0.998	0	RPL8	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54612
0	-0.667360994835145	0.979	0.998	0	RPL12	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54613
0	-0.414967356255413	0.982	0.998	0	RPL7A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54614
0	-0.650582838310411	0.978	0.999	0	RPLP2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54615
0	-0.749162817325354	0.983	0.999	0	RPS13	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54616
0	0.664172500260124	0.482	0.176	0	AHNAK	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54617
0	-0.455788482372777	0.987	0.999	0	FAU	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54618
0	0.9454597921805	0.551	0.211	0	NEAT1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54619
0	-0.423502505521117	0.992	1	0	RPS3	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54620
0	-0.593137099565268	0.947	0.986	0	RPL41	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54621
0	-0.479084575851396	0.94	0.984	0	NACA	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54622
0	-0.437132216678407	0.975	0.997	0	RPL6	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54623
0	0.446187993084547	0.339	0.059	0	ANXA2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54624
0	-0.429379363296696	0.999	1	0	RPLP1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54625
0	-0.602278159709713	0.993	1	0	RPS15A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54626
0	-0.436871740754259	0.986	0.999	0	RPL26	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54627
0	-0.657669918893814	0.992	1	0	RPL19	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54628
0	-0.53335426103388	0.954	0.994	0	RPS21	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54629
0	-0.507661104841346	0.99	1	0	RPS15	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54630
0	-0.565790409891911	0.992	0.999	0	RPS28	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54631
0	-0.623801262998534	0.989	1	0	RPL18A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54632
0	-0.578944551819762	0.985	0.999	0	RPL18	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54633
0	-0.514254107518683	0.997	1	0	RPL28	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54634
0	-0.676823356884886	0.94	0.989	0	RPS5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54635
0	0.759651096463643	0.269	0.05	0	IGLV1-51	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000211644	NA	NA	NA	IG_V_gene	P01701	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54636
0	0.766840974741994	0.257	0.009	0	IGLV1-44	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000274854	NA	NA	NA	IG_V_gene	P01699	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54637
0	0.844161524385894	0.262	0.021	0	IGLV3-19	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000211663	NA	NA	NA	IG_V_gene	P01714	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54638
0	0.895252085539127	0.29	0.015	0	IGLV3-1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000211673	NA	NA	NA	IG_V_gene	P01715	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54639
0	0.787853505272535	0.266	0.022	0	IGLC2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54640
0	0.438509219487567	0.334	0.09	0	IL2RB	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54641
0	0.716737782841626	0.607	0.316	0	SAMSN1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54642
0	1.00932003714218	0.274	0.004	0	MGP	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54643
0	0.892748209100588	0.282	0.001	0	IGKV1D-13	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000276566	NA	NA	NA	IG_V_gene	A0A0B4J2D9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54644
7.66536971398225e-306	0.94249575093671	0.711	0.492	1.57944942956604e-301	TNFAIP3	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54645
3.44269777240003e-303	-0.424914132908372	0.995	1	7.09367876003027e-299	RPL13	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54646
7.57194755828052e-300	0.676881110034259	0.251	0.062	1.5601997943837e-295	IGLV3-21	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000211662	NA	NA	NA	IG_V_gene	P80748	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54647
2.07936221519255e-299	0.326580556752445	0.312	0.092	4.28452584440425e-295	CAPN2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54648
1.54671808331695e-298	2.01800292165935	0.366	0.16	3.18701261067458e-294	IGHG1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54649
5.53284151744147e-293	-0.500815720898036	0.846	0.936	1.14004199466882e-288	EEF1B2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54650
8.00487013251495e-292	0.983646285442603	0.334	0.122	1.64940349080471e-287	IGLV2-14	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000211666	NA	NA	NA	IG_V_gene	P01704	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54651
4.48253222599772e-290	0.526191491212804	0.573	0.29	9.23625765166831e-286	MT-ND6	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54652
5.37565819485286e-285	0.497163974517732	0.993	0.983	1.10765437104943e-280	HLA-C	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54653
1.91372341031711e-284	0.550534543328867	0.533	0.262	3.94322708695839e-280	RNF213	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54654
2.20171057814036e-283	0.315320845290234	0.277	0.076	4.53662464625821e-279	CASP1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000137752	834	caspase 1	ICE|IL1BC	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54655
3.24559244921781e-282	0.810182465034412	0.399	0.164	6.68754324161329e-278	IFI6	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54656
1.17228964146492e-280	0.448352086910036	0.297	0.09	2.41550280623847e-276	PMAIP1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54657
2.70518023529208e-279	1.48676345298998	0.358	0.158	5.57402387481934e-275	IGKV3-20	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000282402	NA	NA	NA	IG_V_gene	P01619	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54658
3.01884400367847e-277	0.309403036061044	0.294	0.087	6.22032806957948e-273	ACTN4	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54659
1.71775499092867e-272	-0.433428535769906	0.986	0.999	3.53943415880853e-268	RPS24	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54660
4.240305733582e-268	0.516774895975867	0.33	0.115	8.73714996404572e-264	PHLDA1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54661
7.27813428119254e-268	0.561128195427393	0.706	0.454	1.49965956863972e-263	CD2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54662
1.97746542992167e-267	0.59785574189375	0.436	0.195	4.07456751835361e-263	TXNIP	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54663
2.55058453012362e-266	-0.649834258295515	0.289	0.55	5.25547942431972e-262	CCR7	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54664
1.12068767022373e-265	0.357781360461577	0.29	0.087	2.309176944496e-261	LGALS3	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54665
1.34930378491618e-265	0.613289625675519	0.345	0.126	2.78024044881979e-261	LGALS1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54666
1.03819204609571e-264	-0.400474639422299	0.994	1	2.13919471098022e-260	RPS19	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54667
2.93505052258868e-263	-0.422621742764953	0.985	0.999	6.04767160179398e-259	RPS18	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54668
8.01924120509216e-263	0.733148370136573	0.985	0.982	1.65236465030924e-258	MT-ATP8	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54669
2.79036859681952e-262	0.49959034846227	0.45	0.203	5.74955449374661e-258	PDE4B	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54670
2.94433245832683e-259	0.470812047569589	0.414	0.175	6.06679703038243e-255	SYNE2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54671
6.25186100283957e-259	-0.451805409135415	0.952	0.99	1.28819595963509e-254	RPL21	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54672
7.39700442128852e-259	0.484191058546224	0.637	0.36	1.5241527610065e-254	CLIC1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54673
1.84573670068153e-258	0.671478645353432	0.466	0.216	3.80314047175429e-254	DUSP4	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54674
4.27238257934031e-258	0.506373203938051	0.426	0.186	8.80324430473071e-254	CTSC	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54675
9.9788431561386e-258	1.00879236042184	0.439	0.207	2.05614063232236e-253	ISG15	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54676
8.45499962429233e-257	0.542481836660555	0.423	0.184	1.74215267258543e-252	CARD16	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54677
1.2678448201925e-256	-0.351612512683615	0.999	1	2.61239425200665e-252	EEF1A1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54678
1.72804013725674e-256	0.381150688664535	0.366	0.142	3.56062670281751e-252	IL10RA	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54679
5.14944270416015e-255	0.692123849870479	0.578	0.329	1.0610426691922e-250	LY6E	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54680
4.29859948927734e-252	0.367447488588179	0.361	0.138	8.85726424765596e-248	RORA	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54681
1.03271240460626e-251	0.448649897515187	0.443	0.199	2.12790390969119e-247	TENT5C	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54682
1.57137717236758e-251	-0.42006085142803	0.973	0.997	3.2378226636634e-247	RPL36	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54683
2.94967132439187e-249	-0.42155599234484	0.943	0.985	6.07779776390945e-245	RPS9	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54684
3.6688504626681e-248	0.614846234805081	0.594	0.338	7.55966637832762e-244	SQSTM1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54685
4.59440351745281e-248	0.714251277959335	0.44	0.203	9.46676844771151e-244	LMNA	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54686
9.15591391187784e-248	0.455246335288464	0.336	0.127	1.88657606154243e-243	XAF1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54687
5.92575158432359e-244	0.52801145280229	0.951	0.864	1.22100111394988e-239	MT-ND5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54688
8.80256172241703e-244	-0.408437969838571	0.973	0.993	1.81376784290403e-239	RPLP0	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54689
1.09516762084587e-243	0.610958594837401	0.321	0.117	2.25659288275292e-239	TNFRSF18	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000186891	8784	TNF receptor superfamily member 18	AITR|CD357|GITR	protein_coding	Q9Y5U5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54690
8.56324877998994e-241	0.419555774244206	0.478	0.233	1.76445741111693e-236	GNG2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000186469	54331	G protein subunit gamma 2	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54691
1.07859354110948e-240	0.568280914947256	0.261	0.081	2.22244199145609e-236	FOXP3	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000049768	50943	forkhead box P3	AIID|DIETER|IPEX|JM2|PIDX|SCURFIN|XPID	protein_coding	Q9BZS1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54692
2.87500311830717e-240	0.360172407070337	0.297	0.102	5.92394392527193e-236	SLFN5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54693
5.15326702011026e-240	0.445879774803646	0.296	0.099	1.06183066949372e-235	ID2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54694
3.51710530950087e-238	0.359596532045454	0.318	0.114	7.24699549022654e-234	GLUD1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000148672	2746	glutamate dehydrogenase 1	GDH|GDH1|GLUD|hGDH1	protein_coding	P00367	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54695
6.706895515123e-238	0.491187672455281	0.252	0.075	1.38195582089109e-233	GZMA	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54696
6.84462263146763e-234	0.75123001223578	0.666	0.427	1.41033449321391e-229	KLF6	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54697
1.15982942906427e-232	0.392348633409015	0.56	0.298	2.38982853858692e-228	EIF4G2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54698
3.39644552193399e-232	0.407117755162111	0.338	0.129	6.99837599794498e-228	NFKBIZ	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54699
2.70581031434113e-231	-0.385968375751733	0.938	0.976	5.5753221526999e-227	RPL9	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54700
2.83169350730427e-228	0.376463907517244	0.377	0.158	5.83470447180045e-224	SLC38A2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54701
1.09111978293733e-226	-0.442001448360822	0.937	0.96	2.24825231274236e-222	SARAF	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54702
5.9939564065165e-225	-0.361178078344905	0.984	0.998	1.23505471756273e-220	RPS25	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54703
7.02772884127999e-222	0.469522991758073	0.643	0.391	1.44806352774574e-217	CD44	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54704
7.92554889061155e-220	0.345843154722137	0.376	0.158	1.63305934891051e-215	ITGB1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54705
4.36733669703946e-219	-0.399753954582767	0.916	0.971	8.99889726424981e-215	RPL10A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54706
1.89830518447744e-218	0.379291905896518	0.38	0.167	3.91145783261576e-214	ADAR	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54707
1.70359687927097e-217	0.397627040736435	0.439	0.213	3.51026136973784e-213	SP100	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54708
1.85500169649666e-217	0.500082926892304	0.443	0.22	3.82223099563138e-213	STAT1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54709
7.63764783720798e-216	0.6096216286636	0.386	0.177	1.5737373368567e-211	BATF	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000156127	10538	basic leucine zipper ATF-like transcription factor	B-ATF|BATF1|SFA-2	protein_coding	Q16520	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54710
1.34581009603705e-215	0.348513461534453	0.397	0.178	2.77304170288435e-211	TAP1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54711
1.36881898268961e-215	0.351472748587123	0.289	0.103	2.82045151383195e-211	GLRX	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54712
3.77502452512893e-215	0.335522373226008	0.349	0.142	7.77843803402817e-211	FLNA	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54713
3.58443078792931e-213	0.407387109152318	0.552	0.302	7.38571963852834e-209	LCP1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54714
4.51732757378005e-213	-0.364827372073372	0.955	0.99	9.30795346577379e-209	RPL24	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54715
2.85898141305093e-212	0.710334703214563	0.918	0.807	5.89093120159143e-208	VIM	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54716
8.72272410163796e-212	0.34596661504405	0.399	0.18	1.7973173011425e-207	CAST	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54717
1.07524207777781e-211	-0.379898826882358	0.984	0.997	2.21553630126117e-207	RPS6	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54718
3.29246760104786e-211	0.34579355598544	0.294	0.108	6.78412949195911e-207	GATA3	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000107485	2625	GATA binding protein 3	HDR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54719
7.33322920471136e-211	0.306436469689105	0.283	0.1	1.51101187763078e-206	MACF1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54720
2.79755943602228e-207	0.337514304795975	0.293	0.107	5.7643712179239e-203	CYTOR	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54721
2.14380269747268e-205	0.42785742690745	0.253	0.086	4.41730545814246e-201	IFI44L	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54722
4.16302828737956e-203	0.396521025530725	0.4	0.188	8.57791978614557e-199	TNFRSF1B	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000028137	7133	TNF receptor superfamily member 1B	CD120b|p75|TNF-R-II|TNF-R75|TNFBR|TNFR2|TNFR80	protein_coding	P20333	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54723
6.32045554280628e-202	0.367213735765244	0.424	0.204	1.30232986459523e-197	TXN	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54724
5.96714609172543e-196	0.269767944303652	0.29	0.109	1.22953045220002e-191	PRNP	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000171867	5621	prion protein	AltPrP|CD230|CJD|GSS|PRIP|PRP	protein_coding	P04156	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54725
8.57161700228915e-195	0.329738641019458	0.376	0.17	1.76618168332168e-190	SAMHD1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54726
5.574914642994e-192	-0.343125797083456	0.994	0.999	1.14871116218891e-187	RPS2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54727
7.03189711074993e-192	0.878764027383689	0.386	0.193	1.44892239967002e-187	FOSB	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54728
8.11040355390884e-192	0.466088988766007	0.453	0.239	1.67114865228292e-187	ARID5B	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54729
9.13687459907345e-192	0.460167628311916	0.45	0.237	1.88265301113908e-187	AC016831.7	CD4+ T cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54730
1.11227550870463e-186	-0.377846763207144	0.872	0.925	2.29184368568589e-182	EEF1D	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54731
3.56976252747953e-185	0.382913442095725	0.436	0.225	7.35549568787157e-181	IDS	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54732
3.02649583440265e-181	0.300258153792839	0.345	0.153	6.23609466678666e-177	IQGAP1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54733
4.57028788221669e-179	0.300252000682726	0.304	0.126	9.41707818130748e-175	CDK17	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000059758	5128	cyclin dependent kinase 17	PCTAIRE2|PCTK2	protein_coding	Q00537	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54734
6.27072400031968e-179	0.495095985813392	0.351	0.162	1.29208268026587e-174	RGS2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54735
3.2927987328981e-178	0.269711592874154	0.257	0.094	6.78481178913653e-174	PARP8	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000151883	79668	poly(ADP-ribose) polymerase family member 8	ARTD16|FLJ21308|pART16	protein_coding	Q8N3A8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54736
4.4769204549456e-178	0.645732149867722	0.948	0.875	9.22469459741541e-174	GAPDH	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54737
2.79607030808967e-177	0.325641539353621	0.269	0.105	5.76130286981876e-173	EIF2AK2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54738
8.47823022935656e-176	0.380468386821258	0.665	0.434	1.74693933875892e-171	LSP1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54739
8.84281428958763e-176	0.348685217417516	0.369	0.176	1.82206188436953e-171	IFI16	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54740
3.14699577834055e-175	0.798793578224499	0.553	0.366	6.48438480127069e-171	RGS1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54741
8.60251173633977e-175	0.287734425170849	0.369	0.174	1.77254754327281e-170	FMNL1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54742
7.97424237568787e-174	0.256478681120288	0.291	0.117	1.64309264151049e-169	TMEM173	CD4+ T cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54743
2.11109814783057e-173	0.270554323436797	0.301	0.125	4.34991773360489e-169	WNK1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54744
4.43641855480664e-173	0.77409893473273	0.581	0.374	9.14124043217909e-169	SAT1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54745
1.08606847617914e-172	0.422740667747004	0.505	0.29	2.23784409516712e-168	DDX3X	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54746
1.39954448954911e-171	0.374243148174581	0.533	0.311	2.88376142071593e-167	MBNL1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54747
1.1684652061329e-170	0.26953215178559	0.326	0.143	2.40762255723684e-166	ANXA5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54748
1.98374409339445e-166	0.309492013893536	0.449	0.239	4.08750470443926e-162	LCP2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54749
8.92497131508555e-165	-0.326308114377514	0.956	0.985	1.83899033947338e-160	RACK1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54750
5.50633777241554e-163	0.276681275424618	0.327	0.149	1.13458089800622e-158	EMB	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000170571	133418	embigin	MGC71745	protein_coding	Q6PCB8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54751
1.41253515936777e-162	0.297574102234397	0.328	0.15	2.9105286958773e-158	TANK	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000136560	10010	TRAF family member associated NFKB activator	I-TRAF|TRAF2	protein_coding	Q92844	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54752
2.30874017309913e-162	-0.367122293283167	0.822	0.886	4.75715912667076e-158	PFDN5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54753
4.02873062385401e-162	-0.34560260217999	0.92	0.963	8.30119945045118e-158	UBA52	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54754
9.73165831934009e-161	0.282118662190853	0.378	0.187	2.00520819670003e-156	CD96	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000153283	10225	CD96 molecule	TACTILE	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54755
8.62788054543881e-160	-0.365418885269072	0.787	0.862	1.77777478638767e-155	RPL7	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54756
1.82905450595811e-159	0.296105007351448	0.316	0.142	3.76876680952668e-155	STAT4	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000138378	6775	signal transducer and activator of transcription 4	NA	protein_coding	Q14765	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54757
4.43730371806002e-158	0.38221389629221	0.319	0.151	9.14306431106268e-154	PTGER4	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54758
7.72657401390239e-158	0.278114057251272	0.408	0.209	1.59206057556459e-153	MSN	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54759
4.73215527302427e-156	0.311825379722809	0.37	0.185	9.75060594006651e-152	USP15	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54760
6.82814341115971e-156	0.425309862818412	0.34	0.166	1.40693894986946e-151	CTLA4	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163599	1493	cytotoxic T-lymphocyte associated protein 4	CD|CD152|CELIAC3|CTLA-4|GSE|IDDM12	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54761
1.52242932444982e-154	0.43927701529566	0.531	0.317	3.13696562302886e-150	TAGAP	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54762
1.88558682293576e-154	0.315073924022051	0.507	0.294	3.88525164865913e-150	MYH9	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54763
5.32608570221719e-153	0.372825571284065	0.602	0.383	1.09743995894185e-148	MCL1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54764
1.08269340078891e-152	0.359373381000086	0.426	0.228	2.23088975232554e-148	HERPUD1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54765
2.61958206389e-152	-0.485374736516607	0.527	0.68	5.39764884264534e-148	YPEL5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54766
1.2050422905911e-151	0.312800616343042	0.36	0.174	2.48298963976296e-147	CST7	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54767
2.49878751229277e-150	-0.296367866813688	0.996	0.999	5.14875166907926e-146	RPS27	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54768
4.01152551316406e-149	0.417454489525899	0.505	0.299	8.26574831987455e-145	PPP1R15A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54769
9.45436849632383e-149	0.336432192135176	0.521	0.309	1.94807262866753e-144	ENO1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54770
1.5203139717528e-147	0.271025660965113	0.318	0.149	3.13260693879664e-143	CCND2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54771
1.85980189580908e-147	0.277841840897498	0.385	0.197	3.83212180631462e-143	PLP2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54772
2.45812638432669e-147	0.305396740779853	0.536	0.321	5.06496941490514e-143	ARL6IP5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54773
1.52831220721828e-146	0.270632172280849	0.283	0.123	3.14908730297327e-142	PTPN22	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000134242	26191	protein tyrosine phosphatase non-receptor type 22	Lyp|Lyp1|Lyp2|PTPN8	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54774
5.08655666969767e-141	0.39324230430549	0.995	0.991	1.04808500179121e-136	HLA-A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54775
1.71928066560662e-140	0.26574547128699	0.411	0.22	3.54257781148244e-136	TAPBP	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54776
3.76260181552262e-140	0.445434954113479	0.325	0.152	7.75284104088435e-136	CCL5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54777
2.82234774584826e-138	-0.499782452023101	0.326	0.487	5.81544753032034e-134	FAM177A1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54778
9.56541526302708e-138	0.360170566157412	0.65	0.434	1.97095381494673e-133	S100A11	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54779
3.92496725459989e-137	-0.386263335147658	0.499	0.647	8.08739502810308e-133	RPL36A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54780
4.53113987724943e-135	0.295906478562157	0.381	0.204	9.33641371707245e-131	ZC3HAV1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54781
1.70529077105931e-134	0.282512413478766	0.419	0.23	3.5137516337677e-130	HSP90B1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54782
1.75520159970685e-133	0.258753241117642	0.333	0.167	3.61659289619596e-129	ITK	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000113263	3702	IL2 inducible T cell kinase	EMT|LYK|PSCTK2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54783
8.51259724527544e-133	0.417549121808819	0.688	0.495	1.754020662389e-128	S100A10	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54784
9.20731882357009e-133	0.281248178340068	0.289	0.136	1.89716804359662e-128	RALGAPA1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000174373	253959	Ral GTPase activating protein catalytic subunit alpha 1	DKFZp667F074|GARNL1|GRIPE|KIAA0884|RalGAPalpha1|Tulip1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54785
2.54934257175064e-131	0.506515967420756	0.342	0.184	5.2529203690922e-127	MX1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54786
1.40861468148911e-130	-0.340428340104686	0.789	0.858	2.90245055120831e-126	RPL31	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54787
2.43861557827905e-130	-0.329126403383345	0.924	0.955	5.02476739904399e-126	RPL13A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54788
7.8577696409431e-128	0.344928435512413	0.37	0.198	1.61909343451633e-123	CDKN1A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54789
1.55659418152749e-125	0.291681462749781	0.419	0.237	3.2073623110374e-121	BST2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54790
1.21550822837053e-124	-0.421738514894328	0.988	0.996	2.50455470455748e-120	FTH1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54791
6.80962520504682e-123	0.254675747110215	0.346	0.184	1.4031232734999e-118	TTC39C	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000168234	125488	tetratricopeptide repeat domain 39C	C18orf17|FLJ33761|HsT2697	protein_coding	Q8N584	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54792
1.05173531585473e-121	0.325723970596014	0.454	0.271	2.16710061831868e-117	RSRP1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54793
3.76180291026271e-121	0.328029520909093	0.366	0.204	7.75119489659632e-117	TRIM22	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000132274	10346	tripartite motif containing 22	GPSTAF50|RNF94|STAF50	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54794
5.19978830634102e-120	-0.362635490474558	0.782	0.822	1.07141638052157e-115	FXYD5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54795
9.03240668996098e-120	0.250426034079589	0.485	0.293	1.86112739846646e-115	SRSF5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54796
1.1860005147355e-119	-0.415896356424413	0.713	0.77	2.44375406061249e-115	OAZ1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54797
2.2669321218113e-119	0.268982941588469	0.43	0.249	4.67101363699218e-115	AKAP13	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54798
3.62106039977874e-117	0.265407778032723	0.408	0.234	7.46119495374409e-113	WSB1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54799
2.16211421181781e-116	-0.258881258055901	0.97	0.994	4.4550363334506e-112	RPL15	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54800
2.49959930381573e-114	0.296355220028706	0.564	0.373	5.1504243655123e-110	STK17B	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54801
5.00021869273217e-114	-0.509005879843371	0.468	0.612	1.03029506163746e-109	KLF2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54802
3.80201325941626e-112	0.268018154764716	0.331	0.177	7.8340483210272e-108	ADGRE5	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54803
4.00023582040796e-112	0.262453784114006	0.408	0.241	8.24248590795061e-108	PBXIP1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163346	57326	PBX homeobox interacting protein 1	HPIP	protein_coding	Q96AQ6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54804
7.7118726830633e-112	0.303289228526062	0.345	0.189	1.58903136634519e-107	PIM2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54805
1.15783142480163e-111	0.297792114808603	0.571	0.379	2.38571165080375e-107	TPI1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54806
4.86498721667869e-111	0.26015108376443	0.467	0.287	1.00243061599664e-106	WIPF1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54807
1.45491444091e-110	0.435382524485763	0.437	0.279	2.99785120549506e-106	HLA-DRB1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54808
2.12505299960166e-110	0.257942901911761	0.261	0.126	4.37867170567923e-106	LDLRAD4	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000168675	753	low density lipoprotein receptor class A domain containing 4	C18orf1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54809
7.84192756987486e-110	0.458907002086472	0.999	1	1.61582917577271e-105	MALAT1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54810
1.34574982542193e-109	0.312051124261277	0.528	0.348	2.77291751528188e-105	BRD2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54811
3.77200071326467e-109	-0.313313325884384	0.733	0.801	7.77220746968186e-105	EEF1G	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54812
4.07587314306137e-109	0.322888626545734	0.421	0.254	8.39833661127794e-105	SMCHD1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54813
8.81748864857374e-109	0.333076117499447	0.815	0.684	1.81684353603862e-104	MYL12A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54814
3.9017717701335e-107	0.276713713788467	0.47	0.296	8.03960073236007e-103	FYN	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000010810	2534	FYN proto-oncogene, Src family tyrosine kinase	MGC45350|SLK|SYN	protein_coding	P06241	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54815
1.35485996164621e-106	0.367669529737951	0.957	0.919	2.79168895097201e-102	MT-ND1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54816
4.51435891795907e-106	0.262131445925455	0.354	0.201	9.30183655045467e-102	UBE2L6	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54817
1.13612904685928e-105	0.284230133757546	0.544	0.356	2.34099390105354e-101	CALR	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54818
1.43026364837744e-104	-0.391048158820338	0.559	0.648	2.94705824748172e-100	LEPROTL1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54819
7.87783589504063e-104	0.369678078815487	0.462	0.295	1.62322808617312e-99	REL	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54820
9.00970727593072e-104	-0.309815022302985	0.791	0.829	1.85645018420552e-99	COX4I1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54821
1.23150248292002e-103	0.261464752376678	0.406	0.243	2.5375108660567e-99	CCNL1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54822
1.39334130825208e-100	0.619924445273919	0.338	0.196	2.87097976565341e-96	TNFRSF4	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000186827	7293	TNF receptor superfamily member 4	ACT35|CD134|OX40|TXGP1L	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54823
7.31426910621362e-98	0.294019194235596	0.317	0.178	1.50710514933532e-93	PIK3R1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54824
9.14291813467532e-98	0.31297962491446	0.617	0.439	1.88389828164985e-93	DYNLL1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54825
3.89914440439039e-97	0.291697509206173	0.43	0.27	8.03418704524639e-93	COX5A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54826
2.19959951170869e-96	-0.252020722187491	0.961	0.984	4.53227479387576e-92	RPL17	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54827
7.42910812606838e-96	-0.278479266459329	0.82	0.867	1.53076772937639e-91	BTF3	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54828
1.663457059707e-94	0.260140861776553	0.446	0.285	3.42755327152628e-90	STAT3	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000168610	6774	signal transducer and activator of transcription 3	APRF	protein_coding	P40763	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54829
2.11027885612763e-94	-0.327042240652189	0.209	0.355	4.34822958305099e-90	TCF7	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54830
1.15068270032509e-92	0.325615002458427	0.516	0.344	2.37098170401985e-88	PKM	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54831
4.65870014983283e-92	0.26241068521184	0.361	0.215	9.59925165873054e-88	KIAA1551	CD4+ T cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54832
4.89256626215656e-91	0.456444328017073	0.512	0.352	1.00811327831736e-86	CD69	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54833
8.67483082777728e-91	0.336225717781911	0.692	0.519	1.78744889206351e-86	SRSF7	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54834
9.98818694606805e-91	0.307582658615315	0.867	0.764	2.05806592023732e-86	MYL6	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54835
2.77388131845258e-89	0.268030732498094	0.375	0.228	5.71558245667155e-85	HLA-DPA1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54836
1.44053559819223e-88	0.45483979626298	0.9	0.855	2.96822360007509e-84	IL32	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54837
2.95405245744861e-88	-0.280341652329425	0.895	0.91	6.08682508857286e-84	PABPC1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54838
1.54202182917567e-86	0.571177722251721	0.537	0.383	3.17733597901647e-82	FOS	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54839
4.45229424720417e-85	0.258371637177286	0.325	0.192	9.17395229636419e-81	CCNH	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54840
5.90981039347755e-84	0.263845365537225	0.474	0.319	1.21771643157605e-79	EML4	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54841
1.47041044247861e-81	0.39253613870927	0.47	0.335	3.02978071672718e-77	ICOS	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163600	29851	inducible T cell costimulator	AILIM|CD278	protein_coding	Q9Y6W8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54842
6.10986870321757e-80	0.276998604176212	0.312	0.182	1.25893844629798e-75	CITED2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54843
1.80209942200872e-79	-0.280475890958404	0.747	0.839	3.71322585904897e-75	MT-ATP6	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54844
6.87440285004553e-79	-0.297533114725203	0.751	0.783	1.41647070725188e-74	PNRC1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54845
4.10625922215091e-75	0.258410423815592	0.792	0.652	8.46094712724194e-71	CORO1A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54846
5.89268896793122e-74	-0.267706929779318	0.753	0.799	1.21418856184223e-69	COX7C	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54847
3.28363348291736e-68	0.296004878391153	0.828	0.683	6.76592679155122e-64	PTPRC	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54848
1.0163556353594e-67	0.503389889249531	0.607	0.467	2.09420078665805e-63	MT2A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54849
2.59553998772419e-64	-0.326097280816468	0.338	0.453	5.34811014470569e-60	GIMAP7	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54850
1.0956897893827e-62	0.272664481001646	0.617	0.467	2.25766881102305e-58	FUS	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54851
2.61995575911753e-61	0.38300323564584	0.26	0.159	5.39841884166166e-57	NR4A1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54852
6.99260036449079e-61	0.296094200093795	0.649	0.519	1.44082530510333e-56	DUSP1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54853
5.01798491773918e-60	0.314770018370801	0.519	0.393	1.03395579230016e-55	BIRC3	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54854
7.35561176341429e-60	0.259875393748897	0.378	0.255	1.51562380385151e-55	MYADM	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54855
1.44328104608265e-58	0.254173398993665	0.937	0.902	2.9738805954533e-54	UBC	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54856
3.04702004383299e-58	0.309539437359636	0.53	0.404	6.27838480031788e-54	SLC2A3	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54857
7.07811323741671e-57	0.33347978694394	0.669	0.554	1.45844523256971e-52	ZFP36L1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54858
3.9056137324292e-55	0.469671172515476	0.767	0.738	8.04751709567037e-51	ZFP36	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54859
7.33491300299438e-55	0.278093661681053	0.66	0.534	1.51135882426699e-50	DUSP2	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54860
1.43965808209691e-49	0.529549543795033	0.438	0.327	2.96641547816068e-45	HSPA1B	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54861
1.69335890447525e-48	0.260173018817824	0.471	0.351	3.48916602267125e-44	TUBB4B	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54862
3.05903604102661e-48	0.323843611391788	0.786	0.739	6.30314376253533e-44	CD52	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54863
1.79334138607152e-47	0.369256871717885	0.76	0.667	3.69517992600038e-43	CRIP1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54864
4.95323001054197e-44	-0.25971848470123	0.594	0.636	1.02061304367217e-39	C12orf57	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54865
1.35818562676164e-33	0.308615395542324	0.531	0.437	2.79854148394236e-29	ISG20	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54866
1.01443297697635e-26	0.311929123414997	0.762	0.728	2.09023914905976e-22	DNAJB1	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54867
5.1151790990416e-20	0.346312274089215	0.507	0.443	1.05398265335752e-15	HSPA1A	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54868
3.48635762812131e-11	0.340808778880191	0.83	0.893	7.18363989274397e-07	CD74	CD4+ T cells	GSE169246_PacAteTissue_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54869
5.26759371961965e-166	0.776430433806338	0.999	0.998	1.08538768592763e-161	HLA-C	NK cells	GSE169246_PacAteTissue_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54870
7.58039252849274e-91	-1.08608247587067	0.358	0.674	1.56193988049593e-86	HSPA1A	NK cells	GSE169246_PacAteTissue_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54871
3.15062098059639e-89	0.703683110809753	0.256	0.004	6.49185453051887e-85	MYOM2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54872
4.40514266648301e-89	0.985339463436231	0.256	0.004	9.07679646428825e-85	MGP	NK cells	GSE169246_PacAteTissue_pre	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54873
4.16010890104643e-84	-0.459306103629555	0.992	0.998	8.57190439060618e-80	RPS3A	NK cells	GSE169246_PacAteTissue_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54874
3.32259438861142e-81	0.580414747863531	0.59	0.253	6.84620573773383e-77	ALOX5AP	NK cells	GSE169246_PacAteTissue_pre	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54875
9.69432155015058e-80	0.534829530037241	0.645	0.301	1.99751495540853e-75	MT-ND6	NK cells	GSE169246_PacAteTissue_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54876
6.8328463133025e-76	0.744515673010997	0.981	0.996	1.40790798285598e-71	MT-ATP8	NK cells	GSE169246_PacAteTissue_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54877
1.97440387917504e-74	0.58865369365132	0.883	0.632	4.06825919304016e-70	GZMA	NK cells	GSE169246_PacAteTissue_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54878
2.73388012300643e-74	0.761535583137913	0.586	0.305	5.63315999345475e-70	IL2RB	NK cells	GSE169246_PacAteTissue_pre	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54879
7.47321940748397e-73	0.426919832765729	0.288	0.046	1.53985685891207e-68	CD160	NK cells	GSE169246_PacAteTissue_pre	ENSG00000117281	11126	CD160 molecule	BY55|NK1|NK28	protein_coding	O95971	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54880
1.54465246009684e-71	-0.552416413368687	0.862	0.982	3.18275639402953e-67	HSP90AA1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54881
6.65815394424251e-69	0.55963830500368	0.668	0.346	1.37191262021117e-64	GNG2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000186469	54331	G protein subunit gamma 2	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54882
2.70914344822422e-68	-0.366854905620746	0.997	0.999	5.58219007506601e-64	RPL11	NK cells	GSE169246_PacAteTissue_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54883
1.36586224717898e-66	0.712746485817649	0.605	0.35	2.81435916031229e-62	FCER1G	NK cells	GSE169246_PacAteTissue_pre	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54884
6.81638765970974e-66	0.688355932233943	0.421	0.159	1.40451667728319e-61	SPON2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54885
1.10773341605823e-65	0.513462770984949	0.703	0.407	2.28248470378798e-61	GZMM	NK cells	GSE169246_PacAteTissue_pre	ENSG00000197540	3004	granzyme M	LMET1|MET1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54886
5.66434377432563e-64	-0.661247265539094	0.717	0.803	1.1671380346998e-59	LDHA	NK cells	GSE169246_PacAteTissue_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54887
1.12613820359253e-61	0.605881366138163	0.438	0.179	2.32040776850241e-57	CEMIP2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000135048	23670	cell migration inducing hyaluronidase 2	TMEM2	protein_coding	Q9UHN6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54888
7.46807318642338e-61	-0.55141718710906	0.786	0.957	1.53879648006254e-56	HSP90AB1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54889
1.70022441483724e-58	-0.827019232242252	0.375	0.628	3.50331240677213e-54	JUN	NK cells	GSE169246_PacAteTissue_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54890
5.31181707078471e-58	0.364706389996005	0.602	0.299	1.09449990743519e-53	MSN	NK cells	GSE169246_PacAteTissue_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54891
6.09054359314961e-58	0.416032281180252	0.375	0.138	1.25495650736848e-53	S1PR5	NK cells	GSE169246_PacAteTissue_pre	ENSG00000180739	53637	sphingosine-1-phosphate receptor 5	Edg-8|EDG8	protein_coding	Q9H228	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54892
8.35822228000583e-58	0.491361705013016	0.427	0.171	1.7222117007952e-53	PTGER4	NK cells	GSE169246_PacAteTissue_pre	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54893
1.70221306574745e-57	0.406295758370162	0.735	0.419	3.50741002197261e-53	LCP1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54894
4.25562864303538e-56	0.380328470535239	0.394	0.142	8.76872281897441e-52	PLEK	NK cells	GSE169246_PacAteTissue_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54895
6.48975823761569e-56	-0.54332952709054	0.569	0.838	1.33721468486071e-51	DNAJB1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54896
6.59585863632216e-56	0.356479905648589	0.387	0.135	1.35907667201418e-51	RORA	NK cells	GSE169246_PacAteTissue_pre	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54897
7.42461936029408e-56	0.528362403841149	0.51	0.245	1.52984281918859e-51	MAP3K8	NK cells	GSE169246_PacAteTissue_pre	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54898
2.66597060192812e-55	-0.369092081151984	0.985	0.995	5.49323242527289e-51	RPL12	NK cells	GSE169246_PacAteTissue_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54899
7.7688967049792e-55	0.463329664271158	0.959	0.931	1.60078116606096e-50	ACTG1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54900
8.80373601950958e-55	-0.316058286512734	0.998	1	1.81400980681995e-50	RPL32	NK cells	GSE169246_PacAteTissue_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54901
1.30406270749445e-54	0.532956764288912	0.549	0.272	2.68702120879232e-50	NEAT1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54902
6.49179857835368e-54	0.435782928697077	0.953	0.798	1.33763509706978e-49	MYL12A	NK cells	GSE169246_PacAteTissue_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54903
3.61736369196554e-53	0.351778591603671	0.998	1	7.453577887295e-49	MT-CO1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54904
8.27013569402995e-52	0.337695637044163	0.424	0.171	1.70406145975487e-47	RHOC	NK cells	GSE169246_PacAteTissue_pre	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54905
1.42409821842312e-51	0.332644155182707	0.454	0.194	2.93435437906083e-47	PRKCH	NK cells	GSE169246_PacAteTissue_pre	ENSG00000027075	5583	protein kinase C eta	PKC-L|PKCL|PRKCL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54906
5.49162672161499e-51	-0.281219329088024	0.999	1	1.13154968598877e-46	RPL28	NK cells	GSE169246_PacAteTissue_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54907
9.23320438944927e-51	-0.308209735171558	0.998	1	1.90250176444602e-46	RPL19	NK cells	GSE169246_PacAteTissue_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54908
1.01515653177806e-50	0.719159467641731	0.424	0.201	2.09173003372869e-46	TXNIP	NK cells	GSE169246_PacAteTissue_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54909
4.39266908321684e-49	-0.30167991725322	0.997	1	9.05109464596831e-45	RPL34	NK cells	GSE169246_PacAteTissue_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54910
1.21776008786921e-48	-0.331380978552283	0.998	1	2.50919466105451e-44	RPL39	NK cells	GSE169246_PacAteTissue_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54911
3.16730523845227e-48	-0.287525295714294	0.999	1	6.5262324438309e-44	RPS12	NK cells	GSE169246_PacAteTissue_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54912
5.94209153917483e-48	0.551784274975401	0.55	0.302	1.22436796164697e-43	CLIC3	NK cells	GSE169246_PacAteTissue_pre	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54913
2.38763553592855e-47	0.315608565428311	1	0.994	4.91972302178078e-43	HLA-B	NK cells	GSE169246_PacAteTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54914
3.05399790696061e-47	0.300934329382632	0.333	0.117	6.29276268729234e-43	MACF1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54915
3.48070824253202e-47	0.475382894696733	0.735	0.477	7.17199933373723e-43	GSTP1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54916
3.51985263005641e-47	0.274609978976586	0.297	0.089	7.25265634423123e-43	SAMHD1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54917
8.64535240803788e-47	0.331830722275043	0.334	0.116	1.7813748636762e-42	IFNGR1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54918
1.46659679201089e-46	0.46252778903577	0.452	0.214	3.02192268993843e-42	CEBPD	NK cells	GSE169246_PacAteTissue_pre	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54919
2.46399062114194e-46	0.393746212564118	0.958	0.927	5.07705267486297e-42	MT-ND5	NK cells	GSE169246_PacAteTissue_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54920
3.36791867532678e-46	0.56907816217154	0.672	0.478	6.93959643051082e-42	KLRB1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54921
8.09674217617664e-46	0.364222682994016	0.39	0.177	1.6683337254012e-41	AOAH	NK cells	GSE169246_PacAteTissue_pre	ENSG00000136250	313	acyloxyacyl hydrolase	NA	protein_coding	P28039	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54922
1.13018423996832e-45	-0.315897681140178	0.997	1	2.32874462645472e-41	RPS19	NK cells	GSE169246_PacAteTissue_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54923
1.87251845415836e-45	0.27940775172406	0.346	0.126	3.8583242747933e-41	UTRN	NK cells	GSE169246_PacAteTissue_pre	ENSG00000152818	7402	utrophin	DMDL|DRP|DRP1	protein_coding	P46939	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54924
2.14056238147439e-45	0.308953660438055	0.519	0.255	4.41062878702797e-41	CD164	NK cells	GSE169246_PacAteTissue_pre	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54925
2.88135285659378e-45	0.349703637986704	0.291	0.093	5.93702756101148e-41	CD38	NK cells	GSE169246_PacAteTissue_pre	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54926
5.50028417516791e-45	0.326364157176189	0.449	0.205	1.13333355429335e-40	STAT4	NK cells	GSE169246_PacAteTissue_pre	ENSG00000138378	6775	signal transducer and activator of transcription 4	NA	protein_coding	Q14765	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54927
8.95203976485104e-45	0.373799664087333	0.821	0.541	1.84456779354756e-40	CLIC1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54928
1.5284239930723e-44	-0.296502644258909	0.995	1	3.14931763772546e-40	RPS7	NK cells	GSE169246_PacAteTissue_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54929
1.88158410612327e-44	0.277554860755183	0.341	0.125	3.87700405066701e-40	LPXN	NK cells	GSE169246_PacAteTissue_pre	ENSG00000110031	9404	leupaxin	LDPL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54930
4.56820656586224e-44	-0.564170699116105	0.691	0.726	9.41278962895915e-40	TGFB1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54931
2.6934432457352e-43	-0.532726037263768	0.733	0.86	5.54983980783737e-39	CRIP1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54932
2.82924595282515e-42	0.326473339456697	0.388	0.172	5.82966128579623e-38	SLA2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000101082	84174	Src like adaptor 2	C20orf156|FLJ21992|SLAP-2	protein_coding	Q9H6Q3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54933
2.88394525756406e-42	0.259673567523177	0.452	0.207	5.94236920321074e-38	IQGAP1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54934
3.79936259814539e-42	0.322566914863877	0.432	0.201	7.82858663347858e-38	PTPN22	NK cells	GSE169246_PacAteTissue_pre	ENSG00000134242	26191	protein tyrosine phosphatase non-receptor type 22	Lyp|Lyp1|Lyp2|PTPN8	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54935
6.6050183437682e-42	0.45110855678655	0.507	0.27	1.36096402973344e-37	TAGAP	NK cells	GSE169246_PacAteTissue_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54936
8.2397873657796e-42	0.332724771480281	0.367	0.165	1.69780818671889e-37	SH2D1B	NK cells	GSE169246_PacAteTissue_pre	ENSG00000198574	117157	SH2 domain containing 1B	EAT2	protein_coding	O14796	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54937
1.08112052433506e-41	0.382995656770366	0.527	0.287	2.2276488403924e-37	GPR65	NK cells	GSE169246_PacAteTissue_pre	ENSG00000140030	8477	G protein-coupled receptor 65	hTDAG8|TDAG8	protein_coding	Q8IYL9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54938
3.04264819298222e-41	-0.287385773978281	0.997	1	6.26937660163985e-37	RPS8	NK cells	GSE169246_PacAteTissue_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54939
4.30773846623366e-41	0.324113760338675	0.561	0.3	8.87609510967446e-37	HSP90B1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54940
2.68205604658301e-40	0.3051897787287	0.51	0.267	5.52637648398429e-36	APMAP	NK cells	GSE169246_PacAteTissue_pre	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54941
3.36902417476417e-40	0.306472623192135	0.684	0.415	6.94187431210157e-36	EVL	NK cells	GSE169246_PacAteTissue_pre	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54942
4.15306338076867e-40	-0.26082536054249	0.998	1	8.55738709607384e-36	RPS15A	NK cells	GSE169246_PacAteTissue_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54943
1.02618997800158e-39	-0.262555737212804	0.996	0.999	2.11446444967227e-35	FAU	NK cells	GSE169246_PacAteTissue_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54944
1.03363056825131e-39	0.301043489638049	0.514	0.266	2.12979578588182e-35	MYH9	NK cells	GSE169246_PacAteTissue_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54945
1.11239775459555e-39	-0.332912230425776	0.218	0.425	2.29209557334414e-35	HLA-DRA	NK cells	GSE169246_PacAteTissue_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54946
1.26486528638912e-39	0.282534656587276	0.558	0.301	2.60625492260479e-35	CD63	NK cells	GSE169246_PacAteTissue_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54947
4.6474682346965e-39	0.475640880463241	0.513	0.344	9.57610829759214e-35	KLRF1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000150045	51348	killer cell lectin like receptor F1	CLEC5C|NKp80	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54948
6.98122688667683e-39	0.295422340669405	0.584	0.325	1.43848179999976e-34	CTSC	NK cells	GSE169246_PacAteTissue_pre	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54949
7.60281679608141e-39	0.286566217022102	0.545	0.293	1.56656040083257e-34	MBNL1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54950
1.1476537427828e-38	0.278668425664313	0.422	0.199	2.36474053700395e-34	LBH	NK cells	GSE169246_PacAteTissue_pre	ENSG00000213626	81606	LBH regulator of WNT signaling pathway	NA	protein_coding	Q53QV2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54951
1.16358601817386e-38	-0.441567405574619	0.797	0.841	2.39756899044724e-34	OAZ1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54952
3.3965095618528e-38	0.36342732017759	0.686	0.438	6.9985079521977e-34	CALR	NK cells	GSE169246_PacAteTissue_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54953
4.14955308121309e-38	0.297127239698492	0.326	0.133	8.55015412383958e-34	PPP1R10	NK cells	GSE169246_PacAteTissue_pre	ENSG00000230995	5514	protein phosphatase 1 regulatory subunit 10	CAT53|FB19|p99|PNUTS	protein_coding	Q96QC0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54954
4.1958231359367e-38	0.525381566992114	0.424	0.221	8.64549357159757e-34	RANBP2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54955
5.1286372866767e-38	0.359781274176952	0.272	0.1	1.05675571291973e-33	FASLG	NK cells	GSE169246_PacAteTissue_pre	ENSG00000117560	356	Fas ligand	APT1LG1|CD178|FasL|TNFSF6	protein_coding	P48023	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54956
8.59796117917915e-38	0.297628274332622	0.571	0.323	1.77160990096986e-33	EIF4G2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54957
1.98692036608083e-37	0.37675434754309	0.57	0.339	4.09404941430955e-33	FYN	NK cells	GSE169246_PacAteTissue_pre	ENSG00000010810	2534	FYN proto-oncogene, Src family tyrosine kinase	MGC45350|SLK|SYN	protein_coding	P06241	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54958
3.5730723460714e-37	0.286496134712491	0.327	0.135	7.36231556908012e-33	POLR2A	NK cells	GSE169246_PacAteTissue_pre	ENSG00000284832	5430	RNA polymerase II subunit A	POLR2|POLRA|RPB1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54959
1.20499108951515e-36	0.274071330582014	1	0.999	2.48288413994597e-32	TMSB4X	NK cells	GSE169246_PacAteTissue_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54960
1.31522681856957e-36	0.281788316477325	0.594	0.338	2.7100248596626e-32	WIPF1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54961
1.39012203462398e-36	0.39337389065964	0.611	0.376	2.86434645234271e-32	ID2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54962
2.01883927103276e-36	-0.275161596380862	0.994	0.998	4.159818317963e-32	RPL18	NK cells	GSE169246_PacAteTissue_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54963
2.21365443088894e-36	0.332091564967023	0.909	0.745	4.56123495484665e-32	HCST	NK cells	GSE169246_PacAteTissue_pre	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54964
2.77028167703676e-36	0.25786736079036	0.473	0.242	5.70816539553424e-32	ABRACL	NK cells	GSE169246_PacAteTissue_pre	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54965
3.36343227841943e-36	-0.343615767349842	0.687	0.838	6.93035220968324e-32	HSPE1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54966
3.601517758446e-36	0.252482203870801	0.283	0.104	7.42092734127799e-32	PYHIN1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000163564	149628	pyrin and HIN domain family member 1	IFIX|MGC23885	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54967
6.54178718040512e-36	0.520017543559756	0.843	0.706	1.34793524852248e-31	CD7	NK cells	GSE169246_PacAteTissue_pre	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54968
7.77841348265485e-36	0.265387151278328	0.446	0.224	1.60274209810103e-31	AKNA	NK cells	GSE169246_PacAteTissue_pre	ENSG00000106948	80709	AT-hook transcription factor	KIAA1968	protein_coding	Q7Z591	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54969
1.13877889201049e-35	0.250055104449925	0.997	0.998	2.34645390698762e-31	MT-ND4L	NK cells	GSE169246_PacAteTissue_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54970
3.64102170151693e-35	-0.364757876995595	0.958	0.991	7.50232521597563e-31	HSPA8	NK cells	GSE169246_PacAteTissue_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54971
4.2875492939817e-35	0.260783188576132	0.364	0.168	8.8344953202493e-31	SAMD3	NK cells	GSE169246_PacAteTissue_pre	ENSG00000164483	154075	sterile alpha motif domain containing 3	bA73O6.2|FLJ34032	protein_coding	Q8N6K7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54972
4.30971667161933e-35	0.253369773365637	0.389	0.179	8.88017120187162e-31	GLIPR1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54973
5.23384446106039e-35	0.320970676353309	0.548	0.311	1.07843365120149e-30	IFITM3	NK cells	GSE169246_PacAteTissue_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54974
6.75169818311576e-35	-0.323411022386807	0.376	0.59	1.391187410631e-30	HLA-DRB1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54975
7.31592987592768e-35	-0.260318780083678	0.994	1	1.5074473509349e-30	RPL18A	NK cells	GSE169246_PacAteTissue_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54976
1.39656631666576e-34	0.267283340020619	0.533	0.29	2.87762489548979e-30	RNF213	NK cells	GSE169246_PacAteTissue_pre	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54977
3.2879836752241e-34	0.25948905068082	1	0.999	6.77489036279926e-30	MALAT1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54978
6.24987287628411e-34	0.2851535727426	0.262	0.096	1.28778630615834e-29	KLRG1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54979
7.89429800843573e-34	-0.523031981875571	0.48	0.6	1.62662010463818e-29	TUBA4A	NK cells	GSE169246_PacAteTissue_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54980
1.23245293143312e-33	0.279798464944445	0.432	0.222	2.53946926521794e-29	MAPRE2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000166974	10982	microtubule associated protein RP/EB family member 2	EB1|EB2|RP1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54981
1.48616150736751e-33	0.342843413179965	0.999	1	3.06223578593076e-29	ACTB	NK cells	GSE169246_PacAteTissue_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54982
2.578442072693e-33	0.581664341153685	0.427	0.245	5.31287989078393e-29	ATP1B3	NK cells	GSE169246_PacAteTissue_pre	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54983
2.87115481716047e-33	-0.329345336542846	0.957	0.985	5.91601450075916e-29	RPS5	NK cells	GSE169246_PacAteTissue_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54984
3.76217013358497e-33	-0.257398859674848	0.995	1	7.75195156025183e-29	RPS14	NK cells	GSE169246_PacAteTissue_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54985
2.29828227349022e-32	0.463090821066972	0.518	0.332	4.7356106245266e-28	SYTL3	NK cells	GSE169246_PacAteTissue_pre	ENSG00000164674	94120	synaptotagmin like 3	exophilin-6|SLP3	protein_coding	Q4VX76	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54986
3.43716099115225e-32	0.250715403127014	0.474	0.253	7.08227022226921e-28	ETS1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54987
9.48547341002303e-32	0.28541831743319	0.305	0.132	1.95448179613525e-27	USP36	NK cells	GSE169246_PacAteTissue_pre	ENSG00000055483	57602	ubiquitin specific peptidase 36	FLJ12851|KIAA1453	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54988
1.01912750427299e-31	0.94113819886693	0.514	0.326	2.09991222255449e-27	XCL2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000143185	6846	X-C motif chemokine ligand 2	SCM-1b|SCYC2	protein_coding	Q9UBD3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54989
1.1349869249116e-31	-0.266840071075988	0.995	0.999	2.33864055878036e-27	RPLP2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54990
3.97264074592226e-31	0.400449662658324	0.755	0.552	8.18562625697281e-27	PRF1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54991
4.91866405013591e-31	0.332296276254266	0.744	0.536	1.0134907275305e-26	CD247	NK cells	GSE169246_PacAteTissue_pre	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54992
7.12133259752961e-31	0.256020835009064	0.48	0.268	1.46735058172098e-26	ARHGAP9	NK cells	GSE169246_PacAteTissue_pre	ENSG00000123329	64333	Rho GTPase activating protein 9	10C|MGC1295	protein_coding	Q9BRR9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54993
4.82650060138752e-30	0.258899213967612	0.466	0.254	9.94500448915899e-26	ITGB1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54994
5.06967250341782e-30	0.432630852313339	0.367	0.191	1.04460601932924e-25	CD8A	NK cells	GSE169246_PacAteTissue_pre	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54995
3.26793798067261e-29	0.333578056228583	0.639	0.416	6.73358620917591e-25	LY6E	NK cells	GSE169246_PacAteTissue_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54996
6.68572068228681e-29	0.25778181907993	0.584	0.354	1.3775927465852e-24	HNRNPC	NK cells	GSE169246_PacAteTissue_pre	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54997
6.76205691542734e-29	0.270750648131376	0.939	0.841	1.3933218274238e-24	ARHGDIB	NK cells	GSE169246_PacAteTissue_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54998
8.42656552334954e-29	0.439710315269919	0.504	0.321	1.73629382608617e-24	PIK3R1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	54999
4.50849342572173e-28	0.252178598060682	0.368	0.187	9.28975070369963e-24	ITGA4	NK cells	GSE169246_PacAteTissue_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55000
6.91268080238024e-28	0.276851398377224	0.257	0.109	1.42435787933045e-23	STX11	NK cells	GSE169246_PacAteTissue_pre	ENSG00000135604	8676	syntaxin 11	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55001
7.05607947758518e-28	-0.306328966643292	0.7	0.863	1.45390517635643e-23	JUNB	NK cells	GSE169246_PacAteTissue_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55002
9.44999648168759e-28	-0.319145239078814	0.988	0.996	1.94717177505173e-23	FTH1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55003
2.015732164231e-27	0.26233561921243	0.377	0.194	4.15341612439798e-23	TIGIT	NK cells	GSE169246_PacAteTissue_pre	ENSG00000181847	201633	T cell immunoreceptor with Ig and ITIM domains	DKFZp667A205|FLJ39873|VSIG9|VSTM3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55004
1.75772353365597e-25	0.266717566719617	0.492	0.3	3.62178934109812e-21	TPM4	NK cells	GSE169246_PacAteTissue_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55005
2.09163656866598e-25	0.264907564616951	0.472	0.284	4.30981714973625e-21	RUNX3	NK cells	GSE169246_PacAteTissue_pre	ENSG00000020633	864	RUNX family transcription factor 3	AML2|CBFA3|PEBP2A3	protein_coding	Q13761	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55006
3.25966314641805e-25	0.314844194628087	0.733	0.533	6.71653591319439e-21	ITGB2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55007
1.78307920247195e-24	0.258748032230286	0.584	0.379	3.67403469669346e-20	AES	NK cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55008
3.75113438835338e-24	0.252409665120671	0.86	0.668	7.72921240720215e-20	CORO1A	NK cells	GSE169246_PacAteTissue_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55009
4.7303406471465e-24	0.257750396383019	0.382	0.228	9.74686690344537e-20	LINC01871	NK cells	GSE169246_PacAteTissue_pre	ENSG00000235576	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55010
8.07998487252115e-24	0.308059862542536	0.422	0.249	1.66488088298298e-19	RGS2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55011
5.90736225028875e-23	-0.651298651091033	0.238	0.37	1.217211991672e-18	HSPA1B	NK cells	GSE169246_PacAteTissue_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55012
6.6224625398979e-22	0.408802663167737	0.63	0.438	1.36455840634596e-17	MT2A	NK cells	GSE169246_PacAteTissue_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55013
1.3365588255446e-21	0.293508779306153	0.71	0.561	2.75397946003464e-17	KLRD1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55014
1.44799412952569e-21	0.272452766679361	0.277	0.148	2.98359190388768e-17	TNFSF14	NK cells	GSE169246_PacAteTissue_pre	ENSG00000125735	8740	TNF superfamily member 14	CD258|HVEM-L|LIGHT|LTg	protein_coding	O43557	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55015
1.87766959418204e-21	-0.311746517431055	0.168	0.289	3.86893819881209e-17	SELL	NK cells	GSE169246_PacAteTissue_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55016
6.56700793901691e-21	0.294630703682822	0.971	0.95	1.35313198583443e-16	NKG7	NK cells	GSE169246_PacAteTissue_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55017
6.77494554777172e-21	0.276304454570657	0.528	0.345	1.39597753011836e-16	DDX3X	NK cells	GSE169246_PacAteTissue_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55018
8.04052054310196e-21	0.252090977300764	0.991	0.986	1.65674925790616e-16	RPS29	NK cells	GSE169246_PacAteTissue_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55019
1.39505376506981e-20	-0.274202157055351	0.923	0.963	2.87450828292634e-16	UBB	NK cells	GSE169246_PacAteTissue_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55020
1.61204735953334e-20	0.269348995743462	0.469	0.301	3.32162358431845e-16	ARL4C	NK cells	GSE169246_PacAteTissue_pre	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55021
3.19387575493966e-20	0.274981527560733	0.507	0.336	6.58098099305317e-16	CD2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55022
3.7166127241683e-20	0.368659145232353	0.328	0.199	7.65808051814878e-16	CD3D	NK cells	GSE169246_PacAteTissue_pre	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55023
1.09202100508504e-19	0.329210170854593	0.381	0.226	2.25010928097772e-15	ISG15	NK cells	GSE169246_PacAteTissue_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55024
9.53864285469251e-19	-0.284961073367483	0.682	0.84	1.96543736020939e-14	IL32	NK cells	GSE169246_PacAteTissue_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55025
8.59306049126552e-18	0.357629134349499	0.691	0.657	1.77060011422526e-13	TYROBP	NK cells	GSE169246_PacAteTissue_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55026
1.07937923514914e-17	0.262735714018237	0.255	0.138	2.2240609140248e-13	TWISTNB	NK cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55027
1.33520535232903e-17	-0.297505999349829	0.751	0.838	2.75119062847396e-13	DUSP2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55028
3.95604394603289e-17	-0.256853977231683	0.682	0.789	8.15142855080076e-13	DNAJA1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55029
2.05193763123247e-16	-0.416357439938976	0.336	0.418	4.2280174891545e-12	UBE2S	NK cells	GSE169246_PacAteTissue_pre	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55030
2.45962474404582e-16	0.256487105722385	0.529	0.377	5.06805678510641e-12	NFE2L2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55031
4.98185767245361e-16	-0.333649280882795	0.394	0.49	1.02651177340907e-11	HSPH1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55032
8.64984692252842e-16	0.25287685395495	0.792	0.65	1.78230095838698e-11	LITAF	NK cells	GSE169246_PacAteTissue_pre	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55033
2.84678536360764e-14	0.3009081582814	0.527	0.399	5.86580124171353e-10	CMC1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55034
6.86577005751323e-14	0.335198156770783	0.524	0.409	1.4146919203506e-09	VPS37B	NK cells	GSE169246_PacAteTissue_pre	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55035
2.14666067246573e-13	0.488910023971473	0.782	0.737	4.42319431561563e-09	S100A4	NK cells	GSE169246_PacAteTissue_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55036
6.41220386132226e-13	0.494357167220569	0.588	0.504	1.32123460562545e-08	REL	NK cells	GSE169246_PacAteTissue_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55037
7.95355140377448e-12	0.379295331351147	0.7	0.623	1.63882926674773e-07	GZMB	NK cells	GSE169246_PacAteTissue_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55038
1.63586872301288e-11	0.617961606079759	0.49	0.385	3.37070750376804e-07	XCL1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000143184	6375	X-C motif chemokine ligand 1	ATAC|LPTN|LTN|SCM-1|SCM-1a|SCYC1	protein_coding	P47992	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55039
2.39720586113908e-11	-0.260501708684449	0.76	0.722	4.93944267687707e-07	FXYD5	NK cells	GSE169246_PacAteTissue_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55040
3.91529932599313e-11	0.320438049877525	0.385	0.29	8.06747426120885e-07	KDM6B	NK cells	GSE169246_PacAteTissue_pre	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55041
8.3753333826296e-11	0.349199764491715	0.974	0.983	1.72573744349083e-06	SRGN	NK cells	GSE169246_PacAteTissue_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55042
8.50874832400372e-11	-0.252194506891275	0.688	0.699	1.75322759216097e-06	IER2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55043
1.89195200177441e-10	0.302769498821561	0.647	0.528	3.89836709965617e-06	SQSTM1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55044
6.30184970254754e-10	0.479290601172158	0.414	0.364	1.29849613120992e-05	FGFBP2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55045
7.32936337432535e-09	-0.321486724750566	0.445	0.467	0.000151021532327974	TRBC2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55046
2.25108073322288e-08	-0.354537823069293	0.287	0.187	0.000463835185080575	CCL4L2	NK cells	GSE169246_PacAteTissue_pre	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55047
2.74483852957889e-08	0.316547195607089	0.448	0.363	0.000565573979019729	NFKB1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55048
3.18597921320658e-08	0.35846538820697	0.527	0.46	0.000656471016881216	ZNF331	NK cells	GSE169246_PacAteTissue_pre	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55049
1.94017684962939e-07	0.250071618837831	0.886	0.876	0.00399773439866136	PABPC1	NK cells	GSE169246_PacAteTissue_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55050
0	0.57671468017534	0.851	0.565	0	S100A6	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55051
0	0.740375556891142	0.297	0.039	0	IGKV1-39	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000282120	NA	NA	NA	IG_V_gene	P01597	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55052
0	0.492234745596875	0.477	0.169	0	ARL4C	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55053
0	0.442516026722153	0.271	0.032	0	MTRNR2L12	CD8+ T cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55054
0	0.727588270285259	0.511	0.138	0	PTGER4	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55055
0	1.33719926541461	1	0.984	0	HLA-B	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55056
0	0.676303270540678	0.317	0.065	0	TNF	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000228978	7124	tumor necrosis factor	DIF|TNF-alpha|TNFA|TNFSF2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55057
0	1.17557086517928	0.393	0.105	0	KLRB1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55058
0	0.477174072212039	0.999	0.999	0	TPT1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55059
0	0.735522805103157	0.992	0.988	0	RPS29	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55060
0	0.540273264263124	0.619	0.276	0	GNG2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000186469	54331	G protein subunit gamma 2	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55061
0	0.423893347450447	0.416	0.113	0	ANXA2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55062
0	0.554133421710066	0.408	0.088	0	RORA	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55063
0	-0.804537413389821	0.856	0.92	0	CCL5	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55064
0	0.468001304605316	0.385	0.1	0	PRNP	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000171867	5621	prion protein	AltPrP|CD230|CJD|GSS|PRIP|PRP	protein_coding	P04156	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55065
0	0.446319734485797	0.251	0.018	0	IGLV3-1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000211673	NA	NA	NA	IG_V_gene	P01715	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55066
0	0.694465441416104	0.99	0.987	0	MT-ATP8	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55067
0	-1.22829894076553	0.051	0.33	0	CXCL13	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000156234	10563	C-X-C motif chemokine ligand 13	ANGIE|ANGIE2|BCA-1|BLC|BLR1L|SCYB13	protein_coding	O43927	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55068
0	0.993707628073462	0.28	0.007	0	MGP	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55069
7.10784511495543e-308	0.590412311377628	0.432	0.148	1.46457148593657e-303	GPR65	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000140030	8477	G protein-coupled receptor 65	hTDAG8|TDAG8	protein_coding	Q8IYL9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55070
6.47423693444511e-295	-0.647370639237271	0.696	0.814	1.33401652034241e-290	OAZ1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55071
6.07480971560956e-292	0.627981243411244	0.468	0.184	1.25171454190135e-287	NFKB1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55072
4.34977890363977e-291	0.407353043432245	0.414	0.137	8.96271943094975e-287	STAT4	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000138378	6775	signal transducer and activator of transcription 4	NA	protein_coding	Q14765	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55073
7.19165670879244e-286	0.497302672044572	0.551	0.24	1.48184086484668e-281	AHNAK	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55074
1.75487926277339e-281	0.484221498126079	0.728	0.393	3.61592872094457e-277	LCP1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55075
1.85915376229931e-275	0.600946582980694	0.329	0.09	3.83078632721773e-271	AQP3	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55076
3.30840203509204e-275	-0.546922966610899	0.875	0.977	6.81696239330714e-271	CD74	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55077
1.08984308873233e-267	0.730424459776885	0.815	0.617	2.24562168433296e-263	S100A4	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55078
1.3338982421683e-263	0.402672419956832	0.623	0.298	2.74849732798778e-259	EIF4G2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55079
1.24992805281332e-259	0.621701579317148	0.893	0.706	2.57547675282185e-255	CD52	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55080
1.02404041921191e-257	-0.716777447671426	0.952	0.987	2.11003528378613e-253	HSP90AA1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55081
1.09724755741487e-257	0.470616864923563	0.575	0.278	2.26087859205334e-253	SPOCK2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55082
1.17865993820653e-254	0.499473412306813	0.435	0.167	2.42862880267455e-250	GPR183	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55083
2.11081298020221e-254	0.39195289451268	0.468	0.191	4.34933014570666e-250	FLNA	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55084
8.29171031450954e-252	0.779275387976818	0.925	0.847	1.70850691030469e-247	VIM	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55085
5.19817944286689e-245	0.463447826438179	0.618	0.312	1.07108487420272e-240	MT-ND6	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55086
8.16722627970933e-241	0.542495275620116	0.758	0.455	1.68285697493411e-236	S100A10	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55087
3.0075808376575e-238	0.464502601565707	0.739	0.446	6.19712031599327e-234	CD44	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55088
8.5555508273303e-237	0.566726638943627	0.392	0.15	1.76287124797141e-232	NFKBIZ	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55089
3.23600290911022e-233	0.409110884134253	0.972	0.934	6.66778399422161e-229	RPL37A	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55090
1.2306317694432e-220	0.623109626488239	0.606	0.338	2.53571676093771e-216	REL	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55091
8.00326666284856e-214	0.367338103343298	0.449	0.194	1.64907309587995e-209	RUNX3	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000020633	864	RUNX family transcription factor 3	AML2|CBFA3|PEBP2A3	protein_coding	Q13761	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55092
8.578806817281e-213	-0.575401647651349	0.921	0.954	1.76766314470075e-208	UBB	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55093
9.91358553080686e-213	0.457856710744125	0.416	0.173	2.04269429862275e-208	CDKN1A	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55094
3.9409675275925e-207	0.329384195562874	0.287	0.085	8.12036359060434e-203	IFNGR1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55095
2.0252830185337e-202	0.604370942658778	0.435	0.193	4.1730956596887e-198	LMNA	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55096
2.66024802412886e-202	0.326463452965979	1	1	5.48144105371751e-198	TMSB4X	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55097
1.51916950270755e-199	0.287813044977461	0.305	0.098	3.1302487603289e-195	SAMHD1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55098
2.85761946187475e-198	0.915880726362378	0.751	0.524	5.88812490119293e-194	MT2A	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55099
3.04704949871122e-197	0.416436363679471	0.62	0.342	6.27844549209446e-193	DDX3X	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55100
3.35397581204581e-196	0.504965728151593	0.652	0.383	6.9108671607204e-192	S100A11	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55101
1.31866712834437e-193	0.511152211391927	0.499	0.252	2.71711361795357e-189	ID2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55102
8.20569693036897e-193	0.592120687329482	0.684	0.402	1.69078385250253e-188	ANXA1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55103
7.02948061056299e-188	0.395611179085732	0.423	0.191	1.4484244798065e-183	STAT1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55104
6.21692414963e-186	0.304467539170793	0.387	0.161	1.28099722103126e-181	CDK17	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000059758	5128	cyclin dependent kinase 17	PCTAIRE2|PCTK2	protein_coding	Q00537	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55105
1.1563296238358e-184	-0.563402648382886	0.884	0.945	2.38261718991367e-180	HSP90AB1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55106
2.6847481961948e-184	0.267202748454351	0.279	0.089	5.53192365825939e-180	B4GALT1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55107
2.35898129106196e-181	0.339754393096084	0.257	0.079	4.86068095023317e-177	LINC01871	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000235576	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55108
7.05890364799256e-181	0.397362508411281	0.46	0.226	1.45448709666887e-176	NFE2L2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55109
1.0535744320999e-180	0.292434173678176	0.412	0.18	2.17089011734185e-176	CAST	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55110
1.06142582712335e-178	0.346753484547454	0.991	0.979	2.18706791678766e-174	RPL3	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55111
2.33592897957698e-178	0.331784215417939	0.452	0.211	4.81318166241836e-174	SLC38A2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55112
7.11503213362861e-178	0.338191472150949	0.509	0.261	1.46605237113417e-173	IDS	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55113
1.33765984559208e-177	0.363682899814721	0.528	0.278	2.75624811184248e-173	PDE4B	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55114
5.13198486990917e-176	0.32875025528901	0.308	0.112	1.05744548244479e-171	MAP3K8	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55115
5.29525925521203e-176	0.301817694715413	0.402	0.174	1.09108816953644e-171	TPM4	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55116
1.96023574670969e-175	0.369353255586297	0.534	0.279	4.03906575609531e-171	NEAT1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55117
1.84858754277545e-174	0.506949088884564	0.522	0.282	3.80901463188881e-170	MT1X	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55118
7.99200867333557e-174	0.290833249397518	0.346	0.138	1.64675338714079e-169	TMEM123	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55119
5.53838930433533e-173	0.344390348285892	0.274	0.093	1.1411851161583e-168	SATB1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000182568	6304	SATB homeobox 1	NA	protein_coding	Q01826	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55120
1.43800376075386e-172	0.272834007338234	0.321	0.121	2.96300674903332e-168	MACF1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55121
3.10067994061923e-171	0.270659520339693	0.39	0.169	6.38895101764593e-167	RASSF5	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000266094	83593	Ras association domain family member 5	Maxp1|NORE1|RAPL	protein_coding	Q8WWW0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55122
5.28158375738212e-171	0.272050574032024	0.46	0.218	1.08827033320859e-166	EIF4B	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55123
7.24893327383977e-171	0.286982569109813	0.525	0.269	1.49364270107468e-166	MSN	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55124
1.16465250047899e-169	0.341845435069489	0.593	0.332	2.39976647723696e-165	MYH9	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55125
3.32317059679427e-169	0.400585279787661	0.578	0.319	6.84739301469459e-165	MYADM	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55126
5.64098069528061e-169	-0.758498218104985	0.456	0.683	1.16232407226257e-164	HSPA1A	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55127
1.29506895803929e-167	0.330902501213971	0.431	0.206	2.66848958803995e-163	CCNH	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55128
2.20041519212662e-165	0.256282727462155	0.261	0.085	4.53395550337691e-161	ELL2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55129
3.54976577402413e-165	0.309908170980673	0.565	0.305	7.31429237737672e-161	MBNL1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55130
1.97411969516906e-164	0.266401974904186	0.415	0.189	4.06767363189584e-160	FMNL1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55131
3.30004951493007e-164	0.306830917162221	0.323	0.127	6.79975202551341e-160	BHLHE40	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55132
1.30416120464871e-162	0.347737564983319	0.573	0.315	2.68722416217866e-158	ALOX5AP	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55133
5.45812510586821e-162	0.279281481550599	0.365	0.158	1.12464667806414e-157	CAMK4	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000152495	814	calcium/calmodulin dependent protein kinase IV	CaMK-GR|CaMKIV	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55134
3.11764275706752e-161	0.309363119654482	0.538	0.292	6.42390290093763e-157	EML4	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55135
3.2164658289143e-161	0.26487504682644	0.37	0.159	6.62752784047791e-157	ATP1A1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55136
3.58588483319429e-161	0.327404354418128	0.326	0.133	7.38871569879684e-157	ZC3H12A	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163874	80149	zinc finger CCCH-type containing 12A	FLJ23231|MCPIP1|Regnase-1	protein_coding	Q5D1E8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55137
2.39036873954221e-159	0.265918675998695	0.313	0.123	4.92535478782672e-155	GYG1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163754	2992	glycogenin 1	GYG	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55138
2.23690444667794e-157	0.254327166450406	0.354	0.152	4.6091416123799e-153	CAPN2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55139
4.3638587179098e-157	0.334022618658027	0.479	0.251	8.99173088825315e-153	G3BP2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55140
2.58550855930267e-156	0.277114628836134	0.408	0.193	5.32744038644315e-152	HNRNPUL1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000105323	11100	heterogeneous nuclear ribonucleoprotein U like 1	E1B-AP5|E1BAP5|FLJ12944|HNRPUL1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55141
2.59818993491597e-156	0.285770944277452	0.433	0.21	5.35357036089436e-152	AMD1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55142
1.69438599666897e-155	0.41025800972761	0.635	0.388	3.49128234613641e-151	SLC2A3	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55143
4.73275332551073e-155	0.391053975095932	0.727	0.478	9.75183822721486e-151	MCL1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55144
6.55738675177184e-155	0.297155191773649	0.531	0.287	1.35114954020259e-150	SRSF5	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55145
5.94351488544824e-154	0.26002665103443	0.469	0.236	1.22466124214661e-149	CSDE1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55146
1.46163596298815e-153	0.269265661100062	0.455	0.228	3.01170090173708e-149	SUN2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55147
1.55225009952647e-153	0.281429701327546	0.502	0.269	3.19841133007428e-149	CD96	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000153283	10225	CD96 molecule	TACTILE	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55148
2.68412823983557e-153	0.259614864140989	0.386	0.176	5.53064623818119e-149	AAK1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55149
8.14589612966154e-153	0.269314224556115	0.347	0.15	1.67846189751676e-148	PBXIP1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000163346	57326	PBX homeobox interacting protein 1	HPIP	protein_coding	Q96AQ6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55150
3.08003595991475e-150	0.284963141308565	0.442	0.221	6.34641409540435e-146	FNBP1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000187239	23048	formin binding protein 1	FBP17|KIAA0554	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55151
5.52204019297699e-149	0.354140652601161	0.961	0.9	1.13781638176291e-144	MT-ND5	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55152
1.45481341775843e-148	-0.352190527682513	0.99	0.996	2.99764304729125e-144	RPL12	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55153
1.10507456479327e-147	0.302004981505906	0.324	0.138	2.27700614075653e-143	PNP	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55154
5.64986485952236e-147	0.612779969969766	0.581	0.376	1.16415465430458e-142	IL7R	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55155
1.10746233029689e-146	0.40123827564056	0.388	0.193	2.28192613157674e-142	KDM6B	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55156
2.66230791742511e-143	0.278937903038796	0.481	0.258	5.48568546385444e-139	CD6	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000013725	923	CD6 molecule	Tp120	protein_coding	P30203	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55157
5.7743856853928e-142	0.290243046667825	0.284	0.113	1.18981217047519e-137	PFKFB3	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000170525	5209	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	NA	protein_coding	Q16875	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55158
7.30164675175249e-142	0.262183515698825	0.517	0.281	1.5045043131986e-137	BZW1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55159
5.88956660290435e-140	0.254424164129233	0.456	0.236	1.21354519852844e-135	TAP1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55160
9.30867625099465e-140	-0.366723998684394	0.912	0.965	1.91805274151745e-135	FTL	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55161
1.33255005161981e-139	0.290989682448336	0.483	0.263	2.74571938136262e-135	CSRNP1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55162
1.34710673853783e-138	0.287977046763481	0.642	0.389	2.7757134347572e-134	HNRNPC	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55163
7.77998608461818e-137	0.270375750013656	0.378	0.178	1.60306613273558e-132	GLIPR1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55164
4.75479224954924e-135	-0.345303832059335	0.946	0.988	9.79724943019622e-131	RPS26	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55165
1.35481341606961e-134	0.327359923258475	0.539	0.317	2.79159304381144e-130	ADGRE5	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55166
1.63689775623079e-134	0.598819564518949	0.524	0.318	3.37282782671354e-130	FOSB	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55167
2.0773025205513e-133	0.287787510661051	0.287	0.119	4.28028184359594e-129	SERPINB9	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000170542	5272	serpin family B member 9	CAP3|PI9	protein_coding	P50453	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55168
1.4689917757106e-132	0.258694513843486	0.386	0.188	3.02685755385169e-128	MAT2A	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55169
3.14428328599367e-131	0.407948260476207	0.656	0.425	6.47879571078997e-127	SQSTM1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55170
3.53145039050848e-131	0.256868790742822	0.379	0.185	7.27655352964273e-127	IL2RB	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55171
2.15021958649803e-130	0.292503069236107	0.612	0.383	4.4305274579792e-126	FYN	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000010810	2534	FYN proto-oncogene, Src family tyrosine kinase	MGC45350|SLK|SYN	protein_coding	P06241	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55172
4.02085534782079e-129	0.257404048323762	0.382	0.188	8.28497244418473e-125	DDX21	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55173
3.43529276589674e-128	0.250563557798771	1	1	7.07842074413024e-124	EEF1A1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55174
1.49377422617589e-125	0.634827395879526	0.526	0.333	3.07792179303542e-121	LTB	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55175
1.28269493559954e-123	0.304683868940679	0.502	0.289	2.64299291480286e-119	AC016831.7	CD8+ T cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55176
1.29722106409243e-122	0.523530203347589	0.803	0.634	2.67292400256245e-118	TNFAIP3	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55177
4.45913504212755e-122	0.250239133623447	0.375	0.19	9.18804775430382e-118	TTC39C	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000168234	125488	tetratricopeptide repeat domain 39C	C18orf17|FLJ33761|HsT2697	protein_coding	Q8N584	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55178
4.58354847410349e-122	-0.431566373255317	0.25	0.42	9.44440163089025e-118	CD8B	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000172116	926	CD8b molecule	CD8B1	protein_coding	P10966	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55179
4.00374005944624e-120	0.276041092068533	0.611	0.379	8.24970639248897e-116	SRSF3	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55180
4.75630392650637e-119	-0.641846541545641	0.845	0.897	9.80036424056638e-115	DNAJB1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55181
1.96407241270647e-118	0.251583216733649	0.571	0.339	4.04697120638168e-114	RNF213	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55182
9.53889064141111e-118	0.255133948341848	0.483	0.273	1.96548841666276e-113	HSP90B1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55183
1.53115362664218e-117	0.388457440539066	0.385	0.211	3.1549420476962e-113	ITM2C	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55184
3.18699199920256e-116	0.332007435341582	0.715	0.493	6.56679701435687e-112	TAGLN2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55185
1.00085427213859e-115	0.735604258673406	0.324	0.189	2.06226022774157e-111	IGKC	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55186
2.16216291786499e-113	0.265991196476379	0.6	0.376	4.45513669226081e-109	JUND	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55187
1.82015344050966e-110	0.276585843672345	0.795	0.56	3.75042616417015e-106	MYL12B	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55188
3.93442363575164e-109	0.264905552292169	0.681	0.442	8.10687990146626e-105	CALR	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55189
8.48390749131193e-108	-0.555659036755568	0.447	0.612	1.74810913858482e-103	HSPA1B	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55190
1.48202530585146e-107	0.250520558700427	0.604	0.377	3.05371314270693e-103	KMT2E	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55191
3.1863648836544e-106	-0.436902878153637	0.979	0.988	6.56550484276989e-102	HSPA8	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55192
3.00569241067883e-104	0.395635472522754	0.892	0.789	6.19322921220373e-100	PABPC1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55193
2.2822803919626e-103	0.281669857016559	0.926	0.822	4.70263874763895e-99	RPL38	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55194
2.7791867094988e-102	-0.347395453595632	0.73	0.83	5.72651421492228e-98	MT-ATP6	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55195
3.46142629623325e-101	-0.339789492519962	0.821	0.882	7.13226888338861e-97	MT-ND4	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55196
1.25354866012316e-99	-0.30056032498901	0.326	0.483	2.58293701418378e-95	CTSW	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55197
8.82096557435223e-99	0.321189091990124	0.259	0.116	1.81755995659528e-94	CD83	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55198
4.68675401580798e-93	0.56382911190929	0.918	0.888	9.65705664957234e-89	ZFP36L2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55199
1.35515266385935e-92	0.285185828506916	0.839	0.662	2.7922920638822e-88	RPL27A	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55200
2.71555815278804e-91	0.336222463357309	0.526	0.338	5.59540757381976e-87	RGS2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55201
5.33892681313087e-91	0.396703227730495	0.689	0.497	1.10008586984562e-86	CD69	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55202
1.3129796865378e-87	0.92096958819605	0.335	0.199	2.70539464411113e-83	IFNG	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000111537	3458	interferon gamma	NA	protein_coding	P01579	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55203
3.42624662162743e-87	0.2742522441898	0.411	0.248	7.05978116386331e-83	PIK3R1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55204
6.22083898554942e-87	-0.516323630386293	0.662	0.72	1.28180387297246e-82	GZMK	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55205
1.08551714090142e-81	0.323008325840908	0.996	0.996	2.23670806882738e-77	HLA-C	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55206
1.4798472993847e-81	0.258359139096327	0.349	0.2	3.04922536038217e-77	ATP1B3	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55207
3.23635464810524e-80	-0.268128935188631	0.921	0.948	6.66850875242086e-76	IFITM1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55208
1.82658956483216e-79	0.276347645759302	0.312	0.173	3.76368779833666e-75	PHLDA1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55209
1.46742598232133e-74	0.263507086190021	0.545	0.363	3.0236312365731e-70	PPP1R15A	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55210
7.64454734359609e-73	0.309342754067996	0.465	0.299	1.57515898014798e-68	ISG15	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55211
8.81822215236848e-73	0.29528605825141	0.6	0.421	1.81699467449552e-68	TAGAP	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55212
1.02865843223746e-71	-0.358371459877538	0.231	0.352	2.11955069962528e-67	TIGIT	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000181847	201633	T cell immunoreceptor with Ig and ITIM domains	DKFZp667A205|FLJ39873|VSIG9|VSTM3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55213
1.26940697000898e-71	-0.31182941053795	0.555	0.649	2.6156130617035e-67	COTL1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55214
1.59822394548722e-70	0.462434906662135	0.888	0.861	3.29314043967641e-66	ZFP36	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55215
2.02071269996977e-69	0.645672523154336	0.325	0.234	4.16367851828771e-65	IGKV3-20	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000282402	NA	NA	NA	IG_V_gene	P01619	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55216
9.23022279704402e-69	0.79612587525124	0.33	0.248	1.90188740733092e-64	IGHG1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55217
2.08286540030683e-66	-0.361352584674219	0.54	0.624	4.29174415733221e-62	HSPH1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55218
3.92249577514046e-65	0.250179240967624	0.957	0.94	8.08230254467691e-61	SRGN	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55219
5.0182103777853e-64	-0.269668730918824	0.907	0.876	1.03400224834266e-59	PTPRCAP	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55220
5.08722154776751e-64	-0.335731711833769	0.699	0.792	1.0482219999175e-59	NKG7	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55221
1.65096804299087e-62	-0.279903778332262	0.755	0.813	3.40181965258268e-58	CST7	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55222
3.41896976893296e-61	0.315246451796534	0.637	0.482	7.04478720888636e-57	FOS	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55223
2.48014470713045e-55	0.419033078169785	0.657	0.521	5.1103381690423e-51	NFKBIA	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55224
4.19103716165958e-53	0.370260591244717	0.697	0.559	8.63563207159957e-49	KLF6	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55225
3.16591571311672e-52	0.264806565584118	0.965	0.914	6.52336932687701e-48	SH3BGRL3	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55226
7.93960039694551e-51	-0.281537725790049	0.742	0.783	1.63595466179062e-46	HSPE1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55227
1.76045085456549e-50	0.346085819887432	0.307	0.215	3.62740898583218e-46	IGLV2-14	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000211666	NA	NA	NA	IG_V_gene	P01704	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55228
1.97125691221747e-50	-0.281912140522669	0.162	0.257	4.06177486762409e-46	PDCD1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000276977	5133	programmed cell death 1	CD279|hSLE1|PD-1|PD1|SLEB2	protein_coding	Q15116	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55229
4.38926807101577e-48	-0.250127886783245	0.189	0.286	9.044086860328e-44	HLA-DQA1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55230
2.10958003969616e-44	-0.419294432293332	0.726	0.766	4.34678967179393e-40	JUN	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55231
2.89990768776422e-43	-0.475247869890217	0.975	0.975	5.97525979063817e-39	RPL41	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55232
2.08434702153093e-38	-0.291300677929885	0.685	0.651	4.29479703786448e-34	SOD1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55233
1.34242523595393e-36	-0.349276542683558	0.435	0.492	2.76606719868308e-32	UBE2S	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55234
6.09703640970314e-34	-0.304383169237093	0.702	0.698	1.25629435221933e-29	YPEL5	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55235
6.14689597764191e-33	0.313378579451601	0.736	0.687	1.26656791619312e-28	CREM	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55236
6.0516552442245e-32	-0.282066661460568	0.389	0.462	1.24694356307246e-27	DUSP4	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55237
1.32386671401781e-30	-0.314416210419708	0.283	0.348	2.72782736423369e-26	LAG3	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000089692	3902	lymphocyte activating 3	CD223	protein_coding	P18627	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55238
1.626986387149e-30	-0.286352197337154	0.435	0.468	3.35240545072051e-26	CACYBP	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55239
1.52210809406339e-24	-0.309579881419194	0.589	0.654	3.13630372781762e-20	CCL4	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55240
9.42011210190561e-18	0.313402973329883	0.803	0.763	1.94101409859765e-13	CRIP1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55241
2.14979776823341e-15	-0.270174040761822	0.221	0.267	4.42965830144493e-11	AREG	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55242
4.02942873007739e-15	0.256763995775951	0.993	0.994	8.30263789832447e-11	FTH1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55243
4.6933182555384e-15	-0.297678239226485	0.412	0.448	9.67058226553688e-11	KLF2	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55244
1.44601593182485e-10	-0.268779396810034	0.748	0.731	2.97951582752511e-06	DUSP1	CD8+ T cells	GSE169246_PacAteTissue_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55245
1.41200401726155e-15	-1.33671271805477	0.657	1	2.90943427756742e-11	HSP90AA1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55246
1.97933030112231e-15	-0.877381353445796	0.181	0.775	4.07841008546253e-11	DNAJB6	pDCs	GSE169246_PacAteTissue_pre	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55247
2.54787482026162e-15	-1.30554516913946	0.171	0.845	5.24989606714906e-11	HSPA1A	pDCs	GSE169246_PacAteTissue_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55248
1.02133577001302e-14	1.40674260885714	0.657	0.07	2.10446235411183e-10	IGHG1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55249
3.85430834133578e-14	1.053414524361	0.838	0.366	7.94180233732237e-10	CD4	pDCs	GSE169246_PacAteTissue_pre	ENSG00000010610	920	CD4 molecule	NA	protein_coding	P01730	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55250
1.79326240615624e-13	-1.11383698915188	0.39	0.873	3.69501718788493e-09	HSPE1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55251
2.89807094100586e-13	-1.28182111935657	0.638	0.944	5.97147517394257e-09	HSPA8	pDCs	GSE169246_PacAteTissue_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55252
1.61651339005608e-11	0.902201220939896	0.495	0.014	3.33082584021056e-07	IGKV1-39	pDCs	GSE169246_PacAteTissue_pre	ENSG00000282120	NA	NA	NA	IG_V_gene	P01597	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55253
3.5638070722532e-11	1.34851830024392	0.819	0.535	7.34322447237772e-07	ZC3HAV1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55254
4.44581429132749e-11	0.763354530683027	0.924	0.887	9.1606003472803e-07	TYROBP	pDCs	GSE169246_PacAteTissue_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55255
5.43241754986583e-11	-0.995132752491303	0.676	0.958	1.11934963614985e-06	HSP90AB1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55256
1.54544941127879e-10	-0.826419183684526	0.143	0.648	3.18439851193994e-06	HSPA1B	pDCs	GSE169246_PacAteTissue_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55257
2.85126817676468e-10	0.824198708938623	0.524	0.07	5.87503807822362e-06	IGKV1-5	pDCs	GSE169246_PacAteTissue_pre	ENSG00000282801	NA	NA	NA	IG_V_gene	P01602	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55258
3.04559982880614e-10	1.01444031493195	0.581	0.127	6.27545844725505e-06	IGKV3-20	pDCs	GSE169246_PacAteTissue_pre	ENSG00000282402	NA	NA	NA	IG_V_gene	P01619	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55259
1.62422311367684e-09	0.762796206475737	0.943	0.718	3.34671172573113e-05	IGKC	pDCs	GSE169246_PacAteTissue_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55260
3.11726691727931e-09	-0.747459212297364	0.819	0.986	6.42312848305402e-05	RPS26	pDCs	GSE169246_PacAteTissue_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55261
5.68212474825693e-09	0.734074300059891	0.914	0.915	0.000117080180437834	PLAC8	pDCs	GSE169246_PacAteTissue_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55262
6.84901554632228e-09	0.682160687967691	1	1	0.000141123965331971	HLA-B	pDCs	GSE169246_PacAteTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55263
7.93407928718052e-09	1.11464654161642	0.543	0.127	0.000163481703712355	HIST2H2AA4	pDCs	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55264
9.38538332657964e-09	-0.723854157893566	0.238	0.662	0.000193385823444173	FAM177A1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55265
1.39189773009493e-08	-0.558960214620011	0.933	1	0.000286800527286061	RPS21	pDCs	GSE169246_PacAteTissue_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55266
2.87547768515358e-08	0.901819606061097	0.457	0.07	0.000592492177025896	IGLV2-14	pDCs	GSE169246_PacAteTissue_pre	ENSG00000211666	NA	NA	NA	IG_V_gene	P01704	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55267
3.70496852509354e-08	-0.638027433583406	0.286	0.704	0.000763408764595524	HSPD1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55268
6.92205960664411e-08	0.70109171257611	0.914	0.62	0.00142629038194902	LILRB4	pDCs	GSE169246_PacAteTissue_pre	ENSG00000278555	11006	leukocyte immunoglobulin like receptor B4	CD85k|HM18|ILT3|LIR-5|LIR5	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55269
9.30819190007211e-08	0.571963844387831	0.962	0.915	0.00191795294100986	TCF4	pDCs	GSE169246_PacAteTissue_pre	ENSG00000196628	6925	transcription factor 4	bHLHb19|E2-2|ITF2|SEF2-1B	protein_coding	P15884	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55270
1.070376878531e-07	0.742162940072611	1	0.887	0.00220551155821313	MT-ND1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55271
1.32665961747848e-07	0.599802054086994	0.952	0.817	0.00273358214181441	IRF8	pDCs	GSE169246_PacAteTissue_pre	ENSG00000140968	3394	interferon regulatory factor 8	ICSBP|ICSBP1|IRF-8	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55272
1.42257684316815e-07	-0.439477753055805	0.933	1	0.00293121958534797	RPL18	pDCs	GSE169246_PacAteTissue_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55273
1.43136521337246e-07	-0.378331792148369	1	1	0.00294932802215396	B2M	pDCs	GSE169246_PacAteTissue_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55274
1.43345072839167e-07	0.81553265128949	0.838	0.648	0.00295362522585103	MPEG1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000197629	219972	macrophage expressed 1	MPG1	protein_coding	Q2M385	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55275
2.18980293572898e-07	0.527424091279599	0.371	0.028	0.00451208894906957	IGLV3-1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000211673	NA	NA	NA	IG_V_gene	P01715	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55276
2.34704238235899e-07	0.589624747157979	0.714	0.338	0.00483608082885069	RUBCN	pDCs	GSE169246_PacAteTissue_pre	ENSG00000145016	9711	rubicon autophagy regulator	KIAA0226|rubicon|rundataxin	protein_coding	Q92622	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55277
2.49632997211246e-07	-0.620860840780553	0.705	0.944	0.00514368790753771	OAZ1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55278
2.79366417844045e-07	-0.487615308184543	0.924	1	0.00575634503967655	RPL8	pDCs	GSE169246_PacAteTissue_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55279
3.55788997269077e-07	0.918392193299846	0.752	0.451	0.00733103228872934	PDE4B	pDCs	GSE169246_PacAteTissue_pre	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55280
4.24270238398452e-07	0.898350581033591	0.952	0.831	0.0087420882622001	CTSB	pDCs	GSE169246_PacAteTissue_pre	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55281
4.30648879396777e-07	0.711443491451742	0.686	0.31	0.00887352015997058	C12orf45	pDCs	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55282
4.48197518710922e-07	0.64586146768011	0.552	0.197	0.00923510987303854	GRAMD1B	pDCs	GSE169246_PacAteTissue_pre	ENSG00000023171	57476	GRAM domain containing 1B	KIAA1201|LINC01059	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55283
6.24207811420524e-07	0.608447955256109	0.752	0.38	0.0128618019543199	ZFAT	pDCs	GSE169246_PacAteTissue_pre	ENSG00000066827	57623	zinc finger and AT-hook domain containing	KIAA1485|ZFAT1|ZNF406	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55284
9.0959671066179e-07	-0.720617600078723	0.552	0.817	0.0187422402231862	DNAJA1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55285
1.01073659741618e-06	-0.658713739779091	0.295	0.662	0.0208262275897605	HSPH1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55286
1.0268811803803e-06	-0.422545988947201	0.971	1	0.021158886721736	RPLP2	pDCs	GSE169246_PacAteTissue_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55287
1.06396271661607e-06	-0.843343318842696	0.924	1	0.0219229517758741	RPL41	pDCs	GSE169246_PacAteTissue_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55288
1.19168469847021e-06	-0.585458016797087	0.648	0.901	0.0245546632119788	ATP6V0C	pDCs	GSE169246_PacAteTissue_pre	ENSG00000185883	527	ATPase H+ transporting V0 subunit c	ATP6C|ATP6L|ATPL|VATL|Vma3	protein_coding	P27449	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55289
1.26082427841213e-06	-0.432815289095987	0.962	1	0.0259792842566819	RPL18A	pDCs	GSE169246_PacAteTissue_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55290
1.33142782659743e-06	0.689849664556948	0.99	0.887	0.02743407036704	MT-ND2	pDCs	GSE169246_PacAteTissue_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55291
1.42426191801681e-06	0.869258298463992	0.857	0.887	0.0293469168207363	IRF4	pDCs	GSE169246_PacAteTissue_pre	ENSG00000137265	3662	interferon regulatory factor 4	LSIRF|MUM1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55292
1.47433517235093e-06	0.485426827170242	0.276	0	0.0303786762262909	IGKV1D-13	pDCs	GSE169246_PacAteTissue_pre	ENSG00000276566	NA	NA	NA	IG_V_gene	A0A0B4J2D9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55293
1.50103798966621e-06	0.615684508646311	0.743	0.465	0.0309288877770723	ETV6	pDCs	GSE169246_PacAteTissue_pre	ENSG00000139083	2120	ETS variant transcription factor 6	TEL	protein_coding	P41212	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55294
1.81627261332015e-06	0.482194837286601	0.39	0.07	0.0374242971974618	SLC7A11	pDCs	GSE169246_PacAteTissue_pre	ENSG00000151012	23657	solute carrier family 7 member 11	xCT	protein_coding	Q9UPY5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55295
1.86085093022029e-06	0.605426603280872	0.771	0.423	0.038342833417189	TPM2	pDCs	GSE169246_PacAteTissue_pre	ENSG00000198467	7169	tropomyosin 2	AMCD1|DA1|NEM4	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55296
1.93474911681641e-06	-0.586976266372145	0.981	1	0.0398655055520021	RPL39	pDCs	GSE169246_PacAteTissue_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55297
1.99886956052411e-06	0.600723984315583	0.962	0.859	0.0411867072945993	PLD4	pDCs	GSE169246_PacAteTissue_pre	ENSG00000166428	122618	phospholipase D family member 4	C14orf175	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55298
2.07247574473331e-06	0.680614099675091	0.819	0.62	0.0427033627202298	SEL1L3	pDCs	GSE169246_PacAteTissue_pre	ENSG00000091490	23231	SEL1L family member 3	KIAA0746	protein_coding	Q68CR1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55299
2.07874212677691e-06	-0.385780278261122	0.952	1	0.0428324815222382	RPL30	pDCs	GSE169246_PacAteTissue_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55300
2.1073993206179e-06	0.899327665058081	0.819	0.592	0.0434229630013318	SLC20A1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000144136	6574	solute carrier family 20 member 1	Glvr-1|GLVR1|PiT-1|PiT1	protein_coding	Q8WUM9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55301
2.27386513032583e-06	-0.337989868352761	0.067	0.352	0.0468529910103638	MRPL18	pDCs	GSE169246_PacAteTissue_pre	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55302
2.27550179821021e-06	-0.419927473137084	0.971	1	0.0468867145521214	FAU	pDCs	GSE169246_PacAteTissue_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55303
2.27735926424464e-06	-0.417156682086254	0.181	0.549	0.0469249876397608	DNAJB1	pDCs	GSE169246_PacAteTissue_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55304
0	0.593443522556589	0.427	0.036	0	IGKV1-9	B cells	GSE169246_PacAteTissue_pre	ENSG00000282758	NA	NA	IGKV19|L8	IG_V_gene	A0A0C4DH69	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55305
0	0.610101884283454	0.36	0.036	0	IGKV2D-28	B cells	GSE169246_PacAteTissue_pre	ENSG00000242534	NA	NA	NA	IG_V_gene	P01615	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55306
0	0.569738133940549	0.422	0.036	0	IGHV1-46	B cells	GSE169246_PacAteTissue_pre	ENSG00000282131	NA	NA	NA	IG_V_gene	P01743	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55307
0	0.543462241284296	0.321	0.028	0	IGHV3-53	B cells	GSE169246_PacAteTissue_pre	ENSG00000282593	NA	NA	NA	IG_V_gene	P01767	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55308
0	0.758632293760821	0.43	0.049	0	IGLV1-44	B cells	GSE169246_PacAteTissue_pre	ENSG00000274854	NA	NA	NA	IG_V_gene	P01699	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55309
0	0.515516802574009	0.269	0.01	0	IGLV7-43	B cells	GSE169246_PacAteTissue_pre	ENSG00000278293	NA	NA	NA	IG_V_gene	P04211	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55310
0	0.971692965910063	0.41	0.026	0	IGLV2-11	B cells	GSE169246_PacAteTissue_pre	ENSG00000211668	NA	NA	NA	IG_V_gene	P01706	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55311
0	0.754785789246437	0.497	0.059	0	IGLV3-1	B cells	GSE169246_PacAteTissue_pre	ENSG00000211673	NA	NA	NA	IG_V_gene	P01715	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55312
0	1.00905218276958	0.455	0.004	0	IGKV1D-13	B cells	GSE169246_PacAteTissue_pre	ENSG00000276566	NA	NA	NA	IG_V_gene	A0A0B4J2D9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55313
1.19568913325622e-292	0.736271857058409	0.506	0.084	2.46371745907443e-288	IGLC2	B cells	GSE169246_PacAteTissue_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55314
1.67283357304465e-284	0.508765014099221	0.417	0.054	3.44687357725849e-280	IGLV3-19	B cells	GSE169246_PacAteTissue_pre	ENSG00000211663	NA	NA	NA	IG_V_gene	P01714	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55315
4.03815991290716e-264	1.55077130451259	0.999	0.916	8.32062850054521e-260	HLA-B	B cells	GSE169246_PacAteTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55316
2.07482864526548e-255	1.30352715856528	0.587	0.122	4.27518442356953e-251	IGKV1-39	B cells	GSE169246_PacAteTissue_pre	ENSG00000282120	NA	NA	NA	IG_V_gene	P01597	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55317
4.58048433863308e-255	1.15424579904051	0.478	0.084	9.43808797975345e-251	IGHA1	B cells	GSE169246_PacAteTissue_pre	ENSG00000282633	NA	NA	AL928768.3	IG_C_gene	P01876	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55318
1.06493698391118e-254	-1.78450318561516	0.667	0.98	2.19430265534898e-250	HSP90AA1	B cells	GSE169246_PacAteTissue_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55319
7.96175925863577e-218	0.430707842729164	0.317	0.042	1.6405204952419e-213	MTRNR2L12	B cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55320
1.4595414305996e-208	-1.25269227594071	0.794	0.97	3.00738511775047e-204	RPS26	B cells	GSE169246_PacAteTissue_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55321
3.77910634202033e-180	-1.33617228167407	0.773	0.952	7.78684861773289e-176	HSP90AB1	B cells	GSE169246_PacAteTissue_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55322
1.83355088959898e-170	0.365776367961072	0.317	0.053	3.77803160801869e-166	IGHG2	B cells	GSE169246_PacAteTissue_pre	ENSG00000274497	NA	NA	NA	IG_C_gene	P01859	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55323
2.18938907679997e-167	1.66524079870043	0.327	0.055	4.51123619274634e-163	IGKV1-12	B cells	GSE169246_PacAteTissue_pre	ENSG00000282694	NA	NA	IGKV112|L19	IG_V_gene	A0A0C4DH73	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55324
3.84499372617874e-152	-1.19525950227039	0.815	0.959	7.9226095727913e-148	HSPA8	B cells	GSE169246_PacAteTissue_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55325
5.34009513301756e-151	1.23917602670111	0.728	0.355	1.10032660215827e-146	IGKC	B cells	GSE169246_PacAteTissue_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55326
3.17370125195437e-139	1.29336396506734	0.663	0.325	6.53941142965198e-135	IGHG1	B cells	GSE169246_PacAteTissue_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55327
1.00245681471889e-137	-1.26222233664242	0.174	0.663	2.06556226672827e-133	HSPH1	B cells	GSE169246_PacAteTissue_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55328
1.52734670386527e-136	0.262962690036261	0.385	0.09	3.1470978833144e-132	IGLV4-69	B cells	GSE169246_PacAteTissue_pre	ENSG00000211637	NA	NA	NA	IG_V_gene	A0A075B6H9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55329
7.3731439731952e-132	-1.10362830189891	0.49	0.818	1.51923631567687e-127	HSPE1	B cells	GSE169246_PacAteTissue_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55330
3.52403295731944e-123	0.270920633649401	0.407	0.103	7.26126990855671e-119	IGLV1-40	B cells	GSE169246_PacAteTissue_pre	ENSG00000274575	NA	NA	NA	IG_V_gene	P01703	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55331
1.08185647916361e-122	0.39933695583381	0.317	0.069	2.22916527531662e-118	ANXA2	B cells	GSE169246_PacAteTissue_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55332
6.99034342338066e-120	1.21662153453983	0.586	0.215	1.44036026238758e-115	IGKV1-5	B cells	GSE169246_PacAteTissue_pre	ENSG00000282801	NA	NA	NA	IG_V_gene	P01602	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55333
1.10534216574138e-115	-1.17021918491504	0.244	0.687	2.27755753251011e-111	DNAJB1	B cells	GSE169246_PacAteTissue_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55334
1.88405423123331e-115	-1.11288567335931	0.291	0.689	3.88209374345624e-111	HSPD1	B cells	GSE169246_PacAteTissue_pre	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55335
1.51752763432273e-112	-1.03559400298195	0.451	0.791	3.12686569052199e-108	DNAJA1	B cells	GSE169246_PacAteTissue_pre	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55336
3.01261862759081e-110	-0.509145888088292	0.276	0.056	6.20750068215086e-106	IGLV2-8	B cells	GSE169246_PacAteTissue_pre	ENSG00000278196	NA	NA	NA	IG_V_gene	P01709	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55337
4.749103569788e-103	2.38245711951248	0.65	0.304	9.78552790554818e-99	IGKV3-20	B cells	GSE169246_PacAteTissue_pre	ENSG00000282402	NA	NA	NA	IG_V_gene	P01619	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55338
1.69231471908512e-102	-0.855599435154554	0.927	0.983	3.48701447867489e-98	BTG1	B cells	GSE169246_PacAteTissue_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55339
9.69527486634369e-99	-0.852271050584636	0.747	0.907	1.99771138621012e-94	UBB	B cells	GSE169246_PacAteTissue_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55340
2.38393280829177e-96	0.292964392056876	0.417	0.128	4.91209355148519e-92	IGLV3-21	B cells	GSE169246_PacAteTissue_pre	ENSG00000211662	NA	NA	NA	IG_V_gene	P80748	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55341
7.01559716469699e-95	2.69640203589227	0.253	0.055	1.44556379578582e-90	IGHV4-59	B cells	GSE169246_PacAteTissue_pre	ENSG00000282691	NA	NA	NA	IG_V_gene	P01825	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55342
1.21061587210336e-90	0.419692836696512	1	1	2.49447400446896e-86	EEF1A1	B cells	GSE169246_PacAteTissue_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55343
2.19360996765074e-89	0.306660313263845	0.295	0.074	4.51993333834435e-85	IGLV1-47	B cells	GSE169246_PacAteTissue_pre	ENSG00000211648	NA	NA	NA	IG_V_gene	P01700	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55344
3.04053540392522e-89	0.452426216829895	0.56	0.237	6.26502319978791e-85	IGLV2-14	B cells	GSE169246_PacAteTissue_pre	ENSG00000211666	NA	NA	NA	IG_V_gene	P01704	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55345
9.137214997386e-88	0.540773249529326	0.538	0.214	1.88272315021138e-83	S100A6	B cells	GSE169246_PacAteTissue_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55346
1.15827431403934e-86	0.444804393541471	0.315	0.087	2.38662422407806e-82	IGLC3	B cells	GSE169246_PacAteTissue_pre	ENSG00000211679	NA	NA	IGLC	IG_C_gene	P0DOY3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55347
4.70535409100957e-79	0.455574777573033	0.981	0.991	9.69538210452522e-75	RPL23A	B cells	GSE169246_PacAteTissue_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55348
7.14078343106186e-79	-1.37988967435621	0.121	0.495	1.4713584259703e-74	HSPA1A	B cells	GSE169246_PacAteTissue_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55349
3.33168611692887e-78	0.688542556836754	0.974	0.964	6.86493924393194e-74	RPS29	B cells	GSE169246_PacAteTissue_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55350
6.33886393883755e-78	0.498104394524661	0.404	0.141	1.30612291459748e-73	JCHAIN	B cells	GSE169246_PacAteTissue_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55351
4.75641066255882e-72	0.460041263472263	0.334	0.104	9.80058417020245e-68	IGHV3-23	B cells	GSE169246_PacAteTissue_pre	ENSG00000281962	NA	NA	NA	IG_V_gene	P01764	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55352
2.5140746134578e-71	0.596552812006281	0.468	0.195	5.1802507410298e-67	S100A4	B cells	GSE169246_PacAteTissue_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55353
3.75255077752244e-70	0.31164694993407	0.314	0.101	7.73213087708499e-66	GAPT	B cells	GSE169246_PacAteTissue_pre	ENSG00000175857	202309	GRB2 binding adaptor protein, transmembrane	C5orf29|FLJ33641	protein_coding	Q8N292	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55354
4.38040040654246e-68	0.30125756236173	0.295	0.091	9.02581503768074e-64	IGHG3	B cells	GSE169246_PacAteTissue_pre	ENSG00000282184	NA	NA	NA	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55355
1.20919207829296e-67	0.771227109570223	0.488	0.226	2.49154027732265e-63	TXNIP	B cells	GSE169246_PacAteTissue_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55356
1.61190373456167e-67	0.446737357700693	0.427	0.177	3.32132764506432e-63	LINC00926	B cells	GSE169246_PacAteTissue_pre	ENSG00000247982	283663	long intergenic non-protein coding RNA 926	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55357
9.04763836754976e-63	-0.976674472024843	0.1	0.427	1.86426588563363e-58	HSPA1B	B cells	GSE169246_PacAteTissue_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55358
2.20329356524009e-61	0.623278792490405	0.926	0.794	4.5398863911772e-57	CD52	B cells	GSE169246_PacAteTissue_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55359
4.20159128950957e-60	0.463468456236095	0.977	0.951	8.65737885203446e-56	RPL37A	B cells	GSE169246_PacAteTissue_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55360
9.72056983816085e-59	0.453408006471085	0.994	0.998	2.00292341515304e-54	RPS27	B cells	GSE169246_PacAteTissue_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55361
3.96980887370671e-58	0.440552828067247	0.326	0.121	8.17979118427268e-54	AHNAK	B cells	GSE169246_PacAteTissue_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55362
3.16331138742244e-57	1.75801490872499	0.439	0.184	6.51800311378394e-53	IGHV4-39	B cells	GSE169246_PacAteTissue_pre	ENSG00000282579	NA	NA	NA	IG_V_gene	P01824	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55363
2.36865653879924e-56	-0.628199438399975	0.201	0.49	4.88061679819584e-52	CACYBP	B cells	GSE169246_PacAteTissue_pre	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55364
6.38809412057815e-54	0.297454512427566	0.353	0.139	1.31626679354513e-49	MARCH1	B cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55365
2.07458299077496e-53	-0.614041012297856	0.259	0.531	4.2746782524918e-49	DNAJB6	B cells	GSE169246_PacAteTissue_pre	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55366
6.47463631410507e-53	0.33402526210953	0.452	0.208	1.33409881252135e-48	LY86	B cells	GSE169246_PacAteTissue_pre	ENSG00000112799	9450	lymphocyte antigen 86	dJ80N2.1|MD-1	protein_coding	O95711	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55367
2.92503288046293e-52	0.597719909247228	0.523	0.278	6.02703025019387e-48	GPR183	B cells	GSE169246_PacAteTissue_pre	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55368
4.74167289260889e-52	-0.483008094957707	0.98	0.994	9.77021699522062e-48	EIF1	B cells	GSE169246_PacAteTissue_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55369
1.46878333211969e-50	0.495420572820727	0.987	0.978	3.02642805583261e-46	TMSB10	B cells	GSE169246_PacAteTissue_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55370
1.9061379658059e-50	0.712696523526058	0.769	0.547	3.92759727854305e-46	VIM	B cells	GSE169246_PacAteTissue_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55371
1.38869503474016e-48	0.497377333277684	0.99	0.996	2.86140611908209e-44	TMSB4X	B cells	GSE169246_PacAteTissue_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55372
2.8001343907465e-48	0.447609544714474	0.628	0.362	5.76967691213316e-44	MT-ND6	B cells	GSE169246_PacAteTissue_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55373
1.0939123955517e-47	0.373300381223373	0.398	0.181	2.25400649103427e-43	TNFRSF13B	B cells	GSE169246_PacAteTissue_pre	ENSG00000240505	23495	TNF receptor superfamily member 13B	CD267|IGAD2|TACI	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55374
6.16748688757137e-47	0.310079483350303	0.333	0.138	1.27081067318408e-42	ODF3B	B cells	GSE169246_PacAteTissue_pre	ENSG00000177989	440836	outer dense fiber of sperm tails 3B	FAP123	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55375
2.86330510994118e-46	0.323074067457344	0.985	0.995	5.89984017903381e-42	RPS25	B cells	GSE169246_PacAteTissue_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55376
6.10228928575925e-46	0.487032384636943	0.629	0.367	1.25737670733069e-41	LY6E	B cells	GSE169246_PacAteTissue_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55377
2.59491768853972e-44	-0.62669503489913	0.77	0.844	5.34682789723608e-40	SARAF	B cells	GSE169246_PacAteTissue_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55378
8.87309550321756e-44	-0.456801830393299	0.781	0.856	1.82830132843798e-39	OAZ1	B cells	GSE169246_PacAteTissue_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55379
2.67154248558369e-42	-0.503180953954091	0.952	0.984	5.5047132915452e-38	H3F3B	B cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55380
4.9358632639554e-42	-0.543718447144699	0.453	0.634	1.01703462553801e-37	SFPQ	B cells	GSE169246_PacAteTissue_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55381
1.07941632616509e-41	0.309015158820006	0.983	0.988	2.22413734006317e-37	RPL36	B cells	GSE169246_PacAteTissue_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55382
2.34642912073354e-41	-0.59594894060357	0.555	0.733	4.83481720327145e-37	YPEL5	B cells	GSE169246_PacAteTissue_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55383
2.6436302643862e-41	-0.552040385937246	0.714	0.822	5.44720015976777e-37	EZR	B cells	GSE169246_PacAteTissue_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55384
2.89764947213179e-41	0.385405490426775	0.331	0.148	5.97060673732755e-37	ITGB1	B cells	GSE169246_PacAteTissue_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55385
2.27252152206899e-40	0.515368432463693	0.99	0.979	4.68253059622315e-36	MT-ATP8	B cells	GSE169246_PacAteTissue_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55386
6.1264652971969e-40	0.566449122905278	0.442	0.23	1.26235817448742e-35	ISG15	B cells	GSE169246_PacAteTissue_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55387
4.00833684996365e-39	0.306489492441896	0.99	0.999	8.2591780793501e-35	RPL39	B cells	GSE169246_PacAteTissue_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55388
2.40794736117763e-37	0.484868602664741	0.321	0.149	4.9615755377065e-33	IFI6	B cells	GSE169246_PacAteTissue_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55389
8.12865713483645e-37	0.27553537480017	0.442	0.227	1.67490980263305e-32	CAPG	B cells	GSE169246_PacAteTissue_pre	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55390
9.7532049438318e-37	-0.571355204351567	0.435	0.614	2.00964787867654e-32	TUBA1B	B cells	GSE169246_PacAteTissue_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55391
1.45107358791123e-36	0.275298370473548	0.529	0.291	2.98993712789108e-32	EIF2S3	B cells	GSE169246_PacAteTissue_pre	ENSG00000130741	1968	eukaryotic translation initiation factor 2 subunit gamma	EIF2|EIF2G|EIF2gamma	protein_coding	P41091	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55392
1.77090330339226e-36	-0.764277597960496	0.485	0.669	3.64894625663976e-32	JUN	B cells	GSE169246_PacAteTissue_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55393
6.65032089946776e-36	0.43085104817374	0.326	0.151	1.37029862133533e-31	LMNA	B cells	GSE169246_PacAteTissue_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55394
7.47956285765026e-36	-0.422147945651193	0.15	0.376	1.54116392681884e-31	AHSA1	B cells	GSE169246_PacAteTissue_pre	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55395
3.79655767936367e-35	0.561023803078277	0.776	0.61	7.82280709832884e-31	LTB	B cells	GSE169246_PacAteTissue_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55396
5.33445074810624e-35	0.313503591218998	0.999	0.997	1.09916357664729e-30	RPS18	B cells	GSE169246_PacAteTissue_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55397
1.61699969946519e-34	0.254116176282454	0.299	0.135	3.33182788074803e-30	TRAF3IP3	B cells	GSE169246_PacAteTissue_pre	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55398
1.76057754603371e-34	-0.558719698334267	0.116	0.332	3.62767003360246e-30	UBE2S	B cells	GSE169246_PacAteTissue_pre	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55399
5.92063243744482e-33	0.329760199977288	0.968	0.96	1.2199463137355e-28	HLA-DPA1	B cells	GSE169246_PacAteTissue_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55400
2.10954131758777e-32	-0.450207614712658	0.156	0.365	4.3467098848896e-28	MRPL18	B cells	GSE169246_PacAteTissue_pre	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55401
3.66033809643822e-32	0.277937650455194	0.375	0.192	7.54212664771094e-28	EIF2AK2	B cells	GSE169246_PacAteTissue_pre	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55402
4.69447830963265e-32	0.258382552828106	0.478	0.267	9.67297255699808e-28	EIF4B	B cells	GSE169246_PacAteTissue_pre	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55403
1.09044897792227e-31	-0.554584292952746	0.304	0.49	2.24687011900884e-27	TUBA1A	B cells	GSE169246_PacAteTissue_pre	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55404
1.93767079819738e-31	0.290315580312856	0.987	0.981	3.99257067968569e-27	RPL3	B cells	GSE169246_PacAteTissue_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55405
2.21501827748573e-31	0.280500165043072	0.269	0.119	4.56404516075934e-27	CD70	B cells	GSE169246_PacAteTissue_pre	ENSG00000125726	970	CD70 molecule	CD27L|CD27LG|TNFSF7	protein_coding	P32970	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55406
4.25429639031943e-30	-0.355206204048232	0.126	0.329	8.76597771225318e-26	STIP1	B cells	GSE169246_PacAteTissue_pre	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55407
5.40142908824952e-30	0.31314657564424	0.972	0.956	1.11296446363381e-25	RPL9	B cells	GSE169246_PacAteTissue_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55408
1.33856217507048e-29	0.271665914714155	0.488	0.285	2.75810736173272e-25	PNISR	B cells	GSE169246_PacAteTissue_pre	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55409
6.98715739425199e-29	0.363668156590185	0.503	0.312	1.43970378108562e-24	IGHM	B cells	GSE169246_PacAteTissue_pre	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55410
3.64760586323349e-28	0.326287192047418	0.369	0.2	7.51589188119261e-24	IFI44L	B cells	GSE169246_PacAteTissue_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55411
4.13832363089648e-28	0.309500364666682	0.411	0.231	8.52701584146219e-24	PIM2	B cells	GSE169246_PacAteTissue_pre	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55412
6.45064769634762e-28	0.360941930739329	0.298	0.144	1.32915595783243e-23	MT2A	B cells	GSE169246_PacAteTissue_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55413
1.33142455083897e-27	0.345668638037654	0.908	0.848	2.7434002870037e-23	HLA-DQB1	B cells	GSE169246_PacAteTissue_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55414
2.92303070056113e-27	-0.390788920663472	0.169	0.357	6.02290475850621e-23	CHORDC1	B cells	GSE169246_PacAteTissue_pre	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55415
4.1192660526033e-27	-0.753364730744338	0.545	0.647	8.48774770138909e-23	KLF2	B cells	GSE169246_PacAteTissue_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55416
6.1262960478587e-27	0.325097098500626	0.462	0.281	1.26232330066129e-22	CD24	B cells	GSE169246_PacAteTissue_pre	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55417
7.42630932391717e-27	0.294794143468523	0.932	0.817	1.53019103619313e-22	RPL4	B cells	GSE169246_PacAteTissue_pre	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55418
1.02512535172986e-26	0.298527521153402	0.762	0.571	2.11227078723938e-22	CLIC1	B cells	GSE169246_PacAteTissue_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55419
1.92727346496173e-26	-0.571409280757041	0.858	0.902	3.97114697455365e-22	UBC	B cells	GSE169246_PacAteTissue_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55420
1.98682836746464e-26	0.34251372930971	0.958	0.88	4.09385985116089e-22	MT-ND5	B cells	GSE169246_PacAteTissue_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55421
2.9368697624801e-26	0.294434941674287	0.378	0.202	6.05142014559025e-22	S100A11	B cells	GSE169246_PacAteTissue_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55422
5.85154833945092e-26	0.322026626599396	0.637	0.432	1.20571153534386e-21	SELL	B cells	GSE169246_PacAteTissue_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55423
7.39264738730792e-26	0.37975139391532	0.484	0.296	1.5232549941548e-21	S100A10	B cells	GSE169246_PacAteTissue_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55424
7.15959595555991e-25	0.294391710121956	0.988	0.943	1.47523474664312e-20	HLA-C	B cells	GSE169246_PacAteTissue_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55425
8.51027042509923e-25	-0.452952573514596	0.422	0.548	1.7535412210917e-20	EIF5	B cells	GSE169246_PacAteTissue_pre	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55426
1.08421533873737e-24	-0.317808426373715	0.987	0.994	2.23402570546836e-20	MT-CO3	B cells	GSE169246_PacAteTissue_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55427
1.44260816588769e-24	-0.464696691345216	0.432	0.566	2.97249412581159e-20	SELENOK	B cells	GSE169246_PacAteTissue_pre	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55428
2.36928658749338e-24	-0.44000603913965	0.281	0.439	4.88191501353011e-20	TGFB1	B cells	GSE169246_PacAteTissue_pre	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55429
6.12015496405169e-24	-0.528583015621751	0.993	0.993	1.26105793034285e-19	FTH1	B cells	GSE169246_PacAteTissue_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55430
9.48696419407147e-24	0.254023465800461	0.981	0.975	1.95478897218843e-19	RPL17	B cells	GSE169246_PacAteTissue_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55431
1.40678071540855e-23	-0.359418073008384	0.865	0.901	2.89867166409931e-19	MT-ND4	B cells	GSE169246_PacAteTissue_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55432
2.15375369239858e-23	0.276042233661101	0.99	0.997	4.43780948318727e-19	RPL37	B cells	GSE169246_PacAteTissue_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55433
3.77454894396465e-23	-0.379113300506219	0.513	0.676	7.77745809903915e-19	NR4A1	B cells	GSE169246_PacAteTissue_pre	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55434
7.09615024412232e-23	0.664153834974529	0.786	0.705	1.4621617578014e-18	ZFP36	B cells	GSE169246_PacAteTissue_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55435
1.24340761388389e-22	0.288303559174313	0.901	0.82	2.56204138840776e-18	RPL38	B cells	GSE169246_PacAteTissue_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55436
1.91312744692433e-22	0.261181990391138	0.977	0.974	3.94199910438759e-18	RPSA	B cells	GSE169246_PacAteTissue_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55437
3.49809456620011e-21	-0.404860704965991	0.395	0.543	7.20782385365532e-17	RBM38	B cells	GSE169246_PacAteTissue_pre	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55438
1.54084733421914e-20	0.332679899582976	0.295	0.162	3.17491593215855e-16	LGALS1	B cells	GSE169246_PacAteTissue_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55439
7.48699612215522e-20	-0.888175564544669	0.388	0.505	1.54269555097008e-15	HIST1H4C	B cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55440
1.08166971712333e-19	0.310703401187815	0.35	0.203	2.22878045213262e-15	NEAT1	B cells	GSE169246_PacAteTissue_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55441
1.50820080015462e-19	-0.373768888364144	0.302	0.438	3.10764774871858e-15	SRSF2	B cells	GSE169246_PacAteTissue_pre	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55442
2.33796497070938e-19	0.358136623876937	0.257	0.134	4.81737682214669e-15	TXN	B cells	GSE169246_PacAteTissue_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55443
4.96171115520659e-19	-0.285361600658734	0.105	0.25	1.02236058353032e-14	FKBP4	B cells	GSE169246_PacAteTissue_pre	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55444
1.41169127709297e-18	-0.489888013214787	0.432	0.534	2.90878987645006e-14	BASP1	B cells	GSE169246_PacAteTissue_pre	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55445
1.10810254931958e-17	-0.343418568236994	0.701	0.773	2.28324530287299e-13	CALM1	B cells	GSE169246_PacAteTissue_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55446
1.83582589099889e-17	-0.341291503633238	0.398	0.513	3.78271924840322e-13	UBE2B	B cells	GSE169246_PacAteTissue_pre	ENSG00000119048	7320	ubiquitin conjugating enzyme E2 B	HHR6B|RAD6B|UBC2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55447
3.58554030600168e-17	-0.282861352763106	0.167	0.307	7.38800580051646e-13	HSPA4	B cells	GSE169246_PacAteTissue_pre	ENSG00000170606	3308	heat shock protein family A (Hsp70) member 4	HS24/P52|HSPH2	protein_coding	P34932	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55448
5.89030185176102e-17	0.30320868580211	0.35	0.221	1.21369669655536e-12	SAMSN1	B cells	GSE169246_PacAteTissue_pre	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55449
7.56326498358235e-17	0.26641442636242	0.858	0.719	1.55841074986714e-12	MYL12A	B cells	GSE169246_PacAteTissue_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55450
3.11739690068661e-16	0.251128472808928	0.693	0.503	6.42339631386477e-12	LSP1	B cells	GSE169246_PacAteTissue_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55451
4.08821862223167e-16	-0.287978304529503	0.493	0.631	8.42377447110835e-12	CREM	B cells	GSE169246_PacAteTissue_pre	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55452
6.51097108733115e-16	-0.332508343860352	0.654	0.761	1.34158559254458e-11	HERPUD1	B cells	GSE169246_PacAteTissue_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55453
1.16956056634669e-15	-0.377401517816811	0.142	0.274	2.40987954695736e-11	AREG	B cells	GSE169246_PacAteTissue_pre	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55454
1.26067534663958e-15	-0.268364755540779	0.203	0.339	2.59762155175086e-11	TCP1	B cells	GSE169246_PacAteTissue_pre	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55455
7.40080787679874e-15	-0.427214407446655	0.172	0.299	1.52493646301438e-10	CHMP1B	B cells	GSE169246_PacAteTissue_pre	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55456
2.80355350532829e-14	-0.305211481912053	0.15	0.28	5.77672199772894e-10	RGS16	B cells	GSE169246_PacAteTissue_pre	ENSG00000143333	6004	regulator of G protein signaling 16	A28-RGS14|RGS-r	protein_coding	O15492	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55457
2.19074661972647e-13	-0.317441334282514	0.552	0.646	4.51403340994639e-09	CYTIP	B cells	GSE169246_PacAteTissue_pre	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55458
4.6059279494655e-13	-0.286380219359591	0.358	0.455	9.49051453987367e-09	POMP	B cells	GSE169246_PacAteTissue_pre	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55459
4.979080483352e-13	-0.319816424887165	0.219	0.342	1.02593953359468e-08	MYADM	B cells	GSE169246_PacAteTissue_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55460
7.08358544873408e-13	0.426583786515776	0.571	0.449	1.45957278171166e-08	RPL36A	B cells	GSE169246_PacAteTissue_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55461
7.15280237380595e-13	-0.300300990675538	0.997	0.999	1.47383492912272e-08	ACTB	B cells	GSE169246_PacAteTissue_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55462
1.94306158071042e-12	-0.332974035286219	0.269	0.374	4.00367838705381e-08	BCAS2	B cells	GSE169246_PacAteTissue_pre	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55463
2.71993407680565e-12	-0.292278294644956	0.767	0.768	5.60442416525805e-08	PNRC1	B cells	GSE169246_PacAteTissue_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55464
7.09515337878999e-12	-0.252465624172257	0.782	0.855	1.46195635369968e-07	CXCR4	B cells	GSE169246_PacAteTissue_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55465
8.78013064803728e-12	-0.303750140266226	0.307	0.409	1.80914592002808e-07	TUBA4A	B cells	GSE169246_PacAteTissue_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55466
4.79238563262135e-11	-0.353658960472439	0.513	0.605	9.87471059601629e-07	KLF6	B cells	GSE169246_PacAteTissue_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55467
6.6931314211799e-11	-0.308264215664856	0.451	0.517	1.37911972933412e-06	ATP6V0C	B cells	GSE169246_PacAteTissue_pre	ENSG00000185883	527	ATPase H+ transporting V0 subunit c	ATP6C|ATP6L|ATPL|VATL|Vma3	protein_coding	P27449	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55468
6.90083016807194e-11	-0.291349803055112	0.375	0.455	1.42191605613122e-06	TAF1D	B cells	GSE169246_PacAteTissue_pre	ENSG00000166012	79101	TATA-box binding protein associated factor, RNA polymerase I subunit D	JOSD3|MGC5306|TAF(I)41	protein_coding	Q9H5J8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55469
1.34972239156105e-10	-0.294947632530626	0.549	0.593	2.78110298781155e-06	SRSF7	B cells	GSE169246_PacAteTissue_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55470
1.84640958220445e-10	-0.275737309251552	0.516	0.572	3.80452694413227e-06	PTGES3	B cells	GSE169246_PacAteTissue_pre	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55471
2.3328438099028e-10	-0.259422137692687	0.344	0.438	4.80682467030473e-06	SKIL	B cells	GSE169246_PacAteTissue_pre	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55472
3.39078009085069e-10	-0.264422728529998	0.182	0.283	6.98670237719786e-06	ANKRD37	B cells	GSE169246_PacAteTissue_pre	ENSG00000186352	353322	ankyrin repeat domain 37	Lrp2bp	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55473
4.4469459277824e-10	-0.271653224950077	0.304	0.4	9.16293208419563e-06	TUBB4B	B cells	GSE169246_PacAteTissue_pre	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55474
1.77764773000878e-09	-0.458062919367252	0.17	0.266	3.6628431476831e-05	RGCC	B cells	GSE169246_PacAteTissue_pre	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55475
1.99913204634779e-09	-0.382514346689775	0.209	0.299	4.11921158149961e-05	DUSP5	B cells	GSE169246_PacAteTissue_pre	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55476
2.75305268984053e-09	-0.296918494290247	0.233	0.324	5.67266506741641e-05	CKS2	B cells	GSE169246_PacAteTissue_pre	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55477
2.7549233831333e-09	0.293846451943146	0.344	0.248	5.67651963094616e-05	NFKBID	B cells	GSE169246_PacAteTissue_pre	ENSG00000167604	84807	NFKB inhibitor delta	IkappaBNS|IkBNS|TA-NFKBH	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55478
2.8282920090921e-09	-0.282313292933673	0.459	0.52	5.82769568473426e-05	SMAP2	B cells	GSE169246_PacAteTissue_pre	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55479
5.02784465567935e-09	0.275988312158972	0.651	0.541	0.000103598739130273	CRIP1	B cells	GSE169246_PacAteTissue_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55480
4.26415794500814e-08	-0.44352910190692	0.57	0.623	0.000878629744568926	DUSP1	B cells	GSE169246_PacAteTissue_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55481
1.05480308020071e-07	-0.389970594463432	0.283	0.366	0.00217342174675357	ID3	B cells	GSE169246_PacAteTissue_pre	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55482
1.48461461482774e-07	-0.279802949321245	0.471	0.509	0.00305904841385255	PRDX1	B cells	GSE169246_PacAteTissue_pre	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55483
6.73898776991343e-07	-0.320255593482509	0.469	0.497	0.0138856842999066	SLC25A5	B cells	GSE169246_PacAteTissue_pre	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55484
6.79630765104032e-07	-0.256280855241986	0.35	0.422	0.0140037919149686	IRF1	B cells	GSE169246_PacAteTissue_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55485
2.1825300704255e-06	-0.274949644950689	0.314	0.369	0.0449710321011175	MARCKSL1	B cells	GSE169246_PacAteTissue_pre	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55486
1.14044416493512e-13	-0.598637437618233	0	0.429	2.34988520184882e-09	AC068446.2	Mast cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55487
2.48427952119458e-13	-0.92934834007026	0.137	0.771	5.11885795342144e-09	TPSD1	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000095917	23430	tryptase delta 1	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55488
3.97574610295612e-12	-1.57736185072283	0.615	0.971	8.19202484514109e-08	HLA-C	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55489
7.87032051121772e-12	2.30501471195102	0.94	0.686	1.62167954133641e-07	HPGD	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000164120	3248	15-hydroxyprostaglandin dehydrogenase	SDR36C1	protein_coding	P15428	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55490
5.40506018420681e-11	-1.05221039667328	0.761	1	1.11371265095581e-06	HLA-A	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55491
6.06206432959975e-10	-0.586359107839796	0.009	0.343	1.24908835511403e-05	IGKV3-11	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000282823	NA	NA	NA	IG_V_gene	P04433	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55492
7.81789577995444e-10	1.00982308248564	1	1	1.61087742545961e-05	MT-ND3	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55493
1.52683434346436e-09	0.798077108469593	1	1	3.14604216470832e-05	MT-CO2	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55494
6.16536126149875e-09	0.800343288196167	1	1	0.000127037268793182	MALAT1	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55495
7.50759374452643e-09	-0.787034275652371	1	1	0.000154693969105967	B2M	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55496
8.15479414922546e-09	-0.868316890934546	0.145	0.6	0.000168029533444791	YPEL5	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55497
1.13539734488612e-08	-1.15386322797691	0.513	0.914	0.000233948622913784	JUNB	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55498
1.54043990009659e-08	0.96193655960443	0.744	0.171	0.000317407641414903	SEC61G	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55499
2.86648732414821e-08	-0.586359107839796	0.009	0.286	0.00059063971314074	CD3E	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55500
3.62349552798157e-08	-0.431226440051651	0.017	0.314	0.000746621253540603	CORO1B	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000172725	57175	coronin 1B	coronin-2	protein_coding	Q9BR76	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55501
4.63082751334796e-08	1.30816181638141	0.795	0.343	0.000954182009125346	NSMCE1	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000169189	197370	NSE1 homolog, SMC5-SMC6 complex component	NSE1	protein_coding	Q8WV22	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55502
5.2731451655779e-08	-0.345780421420856	0.017	0.314	0.00108653156136733	IGKV4-1	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000211598	NA	NA	B3|IGKV41	IG_V_gene	P06312	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55503
6.25097315783024e-08	0.906059789342605	1	1	0.00128801301917092	MT-ATP8	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55504
1.49831290791575e-07	-1.09263037593189	0.795	0.971	0.0030872737467604	NFKBIA	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55505
1.49974152651246e-07	-0.815082284082215	0.197	0.629	0.00309021741537892	PSMB9	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55506
1.5570355106206e-07	-0.498061319915261	1	1	0.00320827166963374	RPL19	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55507
2.55519202942784e-07	-0.605922119356802	0.051	0.371	0.00526497317663606	PTPRCAP	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55508
4.72255197380247e-07	-0.937572260532129	0.675	0.943	0.00973081834201999	HLA-E	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55509
5.54909731671564e-07	1.59750029018297	0.983	1	0.0114339150210926	TPSAB1	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000172236	7177	tryptase alpha/beta 1	TPS1|TPS2|TPSB1	protein_coding	Q15661	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55510
8.63341833113884e-07	1.79141337818858	0.718	0.257	0.0177891584713116	MT2A	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55511
8.79066370437668e-07	-0.494643807335339	0.034	0.314	0.0181131625628681	HLA-F	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000234487	3134	major histocompatibility complex, class I, F	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55512
9.50542732491692e-07	-0.868915370591717	0.778	0.971	0.0195859330029913	RPL13A	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55513
9.71452214921416e-07	1.00102719480373	0.641	0.2	0.0200167728884558	SLC18A2	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000165646	6571	solute carrier family 18 member A2	SVAT|SVMT|VMAT2	protein_coding	Q05940	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55514
2.31047155843754e-06	-0.617631130995627	0.991	1	0.0476072664616056	RPL18A	Mast cells	GSE169246_PacAteTissue_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55515
3.764619547525e-111	1.24183901704717	0.912	0.673	7.75699857767526e-107	HLA-B	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55516
1.44003476284355e-106	0.949820701052195	0.451	0.107	2.96719162883913e-102	GADD45A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55517
2.96108627170355e-100	3.59974146914215	0.273	0.022	6.10131826284516e-96	IGHV1-46	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000282131	NA	NA	NA	IG_V_gene	P01743	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55518
4.5918113984742e-100	-1.37146942616787	0.319	0.734	9.46142738655608e-96	HSP90AA1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55519
8.10679174882229e-98	1.03184697027259	0.686	0.339	1.67040443984483e-93	IFI6	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55520
2.28835178947943e-89	1.20227944863414	0.384	0.085	4.71514886222236e-85	DNAAF1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000154099	123872	dynein axonemal assembly factor 1	CILD13|DAU1|FLJ25330|LRRC50|ODA7|swt	protein_coding	Q8NEP3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55521
1.45433436215498e-85	3.91167265041933	0.329	0.059	2.99665595322034e-81	IGKV1D-13	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000276566	NA	NA	NA	IG_V_gene	A0A0B4J2D9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55522
2.93316909938958e-82	-0.966645254302128	0.367	0.746	6.04379492929222e-78	RPS26	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55523
5.06766066049045e-82	0.733701509130268	0.573	0.229	1.04419147909406e-77	MT-ND6	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55524
1.50285434985683e-78	1.3844681638272	0.504	0.169	3.09663138788e-74	IGHG4	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000277016	NA	NA	NA	IG_C_gene	P01861	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55525
2.6616861576919e-78	0.730723074383601	0.365	0.077	5.48440432792417e-74	IGHGP	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000282094	NA	NA	IGHGP1	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55526
3.12624620312529e-77	0.738999277955022	0.381	0.1	6.44163030153967e-73	HIST2H2AA4	Plasma cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55527
1.62847172016302e-76	1.23376827896678	0.658	0.324	3.35546597939591e-72	NEAT1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55528
4.07634260379522e-73	1.81246235970076	0.629	0.307	8.39930393512004e-69	IGLV3-1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000211673	NA	NA	NA	IG_V_gene	P01715	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55529
8.60886950163312e-72	-1.01737609318166	0.189	0.545	1.77385756081151e-67	HSP90AB1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55530
4.7009276060828e-69	-1.48188480262247	0.254	0.596	9.68626133233361e-65	HSPA1A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55531
1.27887527342981e-67	1.71756110910971	0.406	0.116	2.63512250090213e-63	IGHG2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000274497	NA	NA	NA	IG_C_gene	P01859	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55532
2.2015619030355e-66	-1.25520512263123	0.242	0.576	4.53631830120465e-62	HSPA1B	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55533
2.05266431484011e-65	2.09011557263345	0.261	0.045	4.22951482072805e-61	IGLV1-44	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000274854	NA	NA	NA	IG_V_gene	P01699	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55534
6.71262699109781e-64	1.57974036850717	0.406	0.141	1.3831367915157e-59	MT1X	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55535
3.99135479627909e-60	0.805043047666641	0.848	0.598	8.22418655773306e-56	MT-ND5	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55536
2.90834437696339e-59	0.413276079040036	0.451	0.174	5.99264358873306e-55	SDC1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55537
3.87499766863469e-58	-1.68426776489407	0.709	0.846	7.98443269622178e-54	CD74	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55538
3.68160148966467e-57	-0.719921230621487	0.187	0.512	7.58593986945406e-53	HSPE1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55539
1.86457009974423e-54	-1.10246415786178	0.082	0.362	3.84194669052299e-50	HLA-DRB1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55540
1.2769367533733e-53	-1.05527695423925	0.295	0.587	2.63112818032569e-49	HSPA8	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55541
1.37590160453293e-53	2.23262481569257	0.375	0.129	2.8350452561401e-49	IGHA1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000282633	NA	NA	AL928768.3	IG_C_gene	P01876	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55542
1.97683438466876e-52	0.328685087503146	0.277	0.071	4.07326724960999e-48	TP53INP1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000164938	94241	tumor protein p53 inducible nuclear protein 1	DKFZp434M1317|FLJ22139|P53DINP1|SIP|Teap|TP53INP1A|TP53INP1B	protein_coding	Q96A56	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55543
2.07198272603613e-52	-0.692148255297618	0.597	0.838	4.26932040699745e-48	RPL11	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55544
3.52002952389538e-52	0.376612731607423	0.349	0.117	7.25302083398644e-48	PECAM1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000261371	5175	platelet and endothelial cell adhesion molecule 1	CD31	protein_coding	P16284	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55545
1.15246621582205e-51	-0.693205820267437	0.293	0.591	2.37465663770134e-47	UBB	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55546
5.68228643907073e-51	0.7419223635556	0.538	0.254	1.17083512077052e-46	IGKV3-20	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000282402	NA	NA	NA	IG_V_gene	P01619	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55547
1.4227540309547e-50	-0.723476810396935	0.582	0.835	2.93158468078216e-46	RPS27A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55548
1.66620069080838e-49	-1.05491112313552	0.043	0.295	3.43320652341068e-45	HLA-DRA	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55549
1.03578816735285e-48	0.467464986463479	0.263	0.069	2.13424151883055e-44	CCND2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55550
2.60845536169356e-47	0.465093825073235	0.405	0.167	5.37472227276958e-43	ANKRD28	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55551
4.01131561472135e-47	-0.714277116143477	0.513	0.764	8.26531582413334e-43	RPL39	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55552
7.06800983395079e-47	0.432925178480112	0.26	0.071	1.45636342628556e-42	RBM33	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000184863	155435	RNA binding motif protein 33	DKFZp434D1319|DKFZp686F102|MGC20460|PRR8	protein_coding	Q96EV2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55553
2.94940632854062e-46	0.825484755222207	0.686	0.441	6.07725173995794e-42	SQSTM1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55554
3.9982271820136e-46	-0.616504468496074	0.709	0.893	8.23834710853903e-42	RPS15A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55555
8.15007567469296e-46	-0.656803915394371	0.572	0.811	1.67932309277048e-41	RPL34	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55556
9.16782578930183e-46	-0.749011496178233	0.452	0.718	1.88903050388564e-41	RPLP2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55557
2.11080663490537e-45	-0.577189594524194	0.853	0.974	4.34931707122251e-41	RPL10	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55558
5.23818989199476e-45	-0.59673624267882	0.149	0.417	1.07932902724552e-40	HSPD1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55559
1.83004806401088e-44	-0.587558122209957	0.595	0.818	3.77081403589442e-40	FAU	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55560
5.20347490999622e-44	0.754115386848795	0.689	0.476	1.07217600520472e-39	BTG2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55561
6.67165656804473e-44	0.602756513607901	0.478	0.249	1.37469483584562e-39	JSRP1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000167476	126306	junctional sarcoplasmic reticulum protein 1	FLJ32416|JP-45	protein_coding	Q96MG2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55562
1.81930767999992e-43	-0.711053571964907	0.073	0.312	3.74868347463984e-39	HLA-DPA1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55563
3.16179694273637e-41	-0.676557043177163	0.633	0.833	6.51488260050828e-37	RPL19	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55564
1.29177612697145e-40	-0.639996988856739	0.241	0.517	2.66170470962468e-36	RPS21	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55565
3.69843530924823e-40	0.379575753887178	0.445	0.211	7.62062595470598e-36	TRIB1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55566
4.73473420246205e-40	0.30997889788656	0.386	0.166	9.75591982417306e-36	GAS6	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55567
1.35567550999346e-39	1.13929248955018	0.285	0.095	2.79336938834153e-35	IGKV1-9	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000282758	NA	NA	IGKV19|L8	IG_V_gene	A0A0C4DH69	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55568
1.47670155436294e-39	-0.613969223975523	0.55	0.771	3.04274355276485e-35	RPS7	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55569
4.67308192900311e-39	0.403236257534841	0.343	0.138	9.6288853147109e-35	LINC02362	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000249096	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55570
6.3495088405937e-39	0.915304408465121	0.376	0.171	1.30831629660433e-34	ISG15	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55571
2.60342415612369e-38	-0.644667214112069	0.583	0.786	5.36435547369286e-34	RPL30	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55572
6.04780916617972e-38	0.914343587982913	0.824	0.649	1.24615107869133e-33	MT-ATP8	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55573
8.56002642227278e-38	1.36757241358938	0.506	0.254	1.76379344430931e-33	IGLC2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55574
1.2227227404763e-37	-0.677385410387695	0.234	0.505	2.51942020675142e-33	DNAJB1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55575
2.34051612213371e-37	-0.481057774501952	0.265	0.513	4.8226334696565e-33	OAZ1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55576
3.57660202137824e-36	0.617439865796815	0.837	0.542	7.36958846504987e-32	JCHAIN	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55577
1.91886189225359e-35	-0.636518222233122	0.55	0.76	3.95381492898852e-31	RPS23	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55578
2.04621311789428e-35	-0.554073179095612	0.108	0.331	4.21622212942116e-31	DNAJA1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55579
2.20539053801611e-35	-0.673266872313478	0.674	0.847	4.54420720358219e-31	RPS12	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55580
2.66692139074712e-35	-0.491464904618683	0.779	0.922	5.49519152563444e-31	RPL8	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55581
5.73832223269009e-35	-0.549157336810294	0.682	0.865	1.18238129604579e-30	RPS14	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55582
7.58366757514736e-35	-0.686590282353369	0.143	0.378	1.56261470385911e-30	BTG1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55583
2.24356106293851e-34	0.472434320228668	0.616	0.395	4.6228575701848e-30	PIM2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55584
4.36702877187123e-34	-0.553173806849089	0.79	0.929	8.99826278444068e-30	RPS8	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55585
2.87898470659409e-33	-0.364441540226776	0.987	0.996	5.93214798793712e-29	B2M	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55586
4.64682784019335e-33	0.367761252181239	0.721	0.526	9.57478876471841e-29	SPCS3	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55587
1.26049754104059e-32	-0.512257178098333	0.343	0.579	2.59725518331414e-28	RPL22	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55588
1.94723140243261e-32	-0.598094900336057	0.586	0.776	4.01227030471239e-28	RPS13	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55589
1.78057326127622e-31	0.270364322823982	0.465	0.252	3.66887120485966e-27	TXNDC15	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000113621	79770	thioredoxin domain containing 15	2310047H23Rik|C5orf14|FLJ22625	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55590
2.94805420756406e-31	-0.441422061555498	0.284	0.538	6.07446569468574e-27	HLA-A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55591
3.64814603847814e-31	0.785092896012805	0.472	0.276	7.51700491228421e-27	MIR155HG	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000234883	114614	MIR155 host gene	BIC|miPEP155|MIRHG2|NCRNA00172	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55592
8.15803970210358e-31	0.406405131301928	0.393	0.199	1.68096408061844e-26	FNDC3B	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000075420	64778	fibronectin type III domain containing 3B	DKFZp762K137|FAD104|FLJ23399|PRO4979|YVTM2421	protein_coding	Q53EP0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55593
1.17549146781225e-30	-0.459369336409348	0.405	0.627	2.42210016942715e-26	NACA	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55594
1.57468821957046e-30	-0.586416288344678	0.661	0.823	3.24464507642493e-26	RPL32	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55595
3.26410254232126e-30	0.562328027071142	0.422	0.234	6.72568328845295e-26	RHOB	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55596
7.0766736787009e-30	-0.513233701995258	0.547	0.759	1.45814861149632e-25	RPL26	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55597
6.50260185529744e-29	-0.63723999726974	0.428	0.643	1.33986111228404e-24	PTMA	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55598
8.12414789847889e-29	1.28608157951318	0.317	0.152	1.67398067448157e-24	MT2A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55599
9.07963104979035e-29	-0.514915821840889	0.293	0.506	1.8708579778093e-24	RPL13A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55600
3.33115298547667e-28	-0.45093060811845	0.665	0.841	6.86384072657468e-24	RPL18	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55601
8.36388256349253e-28	0.566839254532581	0.594	0.402	1.72337800220764e-23	RGS1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55602
1.28497059408239e-27	0.431909597091168	0.463	0.266	2.64768190910676e-23	PRDM1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000057657	639	PR/SET domain 1	BLIMP1|PRDI-BF1	protein_coding	O75626	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55603
2.31624939601315e-27	-0.491700813429661	0.528	0.718	4.77263188048509e-23	RPS27	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55604
1.34108853864481e-26	0.278895538395323	0.269	0.112	2.76331293387764e-22	HIST1H1C	Plasma cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55605
1.79588900690763e-26	-0.466092428326062	0.885	0.963	3.70042929873316e-22	EEF1A1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55606
3.79354555023657e-26	0.902825519131403	0.258	0.107	7.81660060626246e-22	IGLV6-57	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000211640	NA	NA	NA	IG_V_gene	P01721	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55607
6.4771220381002e-26	-0.301022025884487	0.1	0.279	1.33461099595055e-21	HSPH1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55608
9.88487748364515e-26	-0.466145607967476	0.483	0.685	2.03677900550508e-21	RPL37	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55609
1.26659861865579e-25	-0.579149094746275	0.363	0.57	2.60982645374025e-21	RPL41	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55610
2.30288226848854e-25	0.284133890757616	0.435	0.251	4.74508891422064e-21	CRELD2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55611
2.81086037261156e-25	-0.416170473109857	0.576	0.768	5.79177779776612e-21	RPL35A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55612
4.33878890782641e-25	0.386500703379368	0.254	0.108	8.94007454457632e-21	HIST1H2AC	Plasma cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55613
5.30327679185091e-25	-0.418510524710849	0.711	0.826	1.09274018296088e-20	EIF1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55614
5.39132085733659e-25	0.258341214922674	0.277	0.123	1.1108816626542e-20	ODF3B	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000177989	440836	outer dense fiber of sperm tails 3B	FAP123	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55615
7.76099235129834e-25	-0.54230467586172	0.464	0.643	1.59915247398502e-20	RPL12	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55616
9.5404499498474e-25	0.356475528667178	0.854	0.776	1.96580971216606e-20	FKBP11	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55617
9.92677855777157e-25	0.396182498874356	0.399	0.223	2.04541272182883e-20	ELL2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55618
1.00795385065296e-24	-0.353356744487058	0.273	0.497	2.07688890927042e-20	TMSB10	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55619
1.59627497840529e-24	-0.586406578278353	0.481	0.644	3.28912459300411e-20	FTH1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55620
4.4132533439644e-24	-0.477098925467614	0.722	0.861	9.09350851523865e-20	RPL18A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55621
4.66828126189213e-24	0.409654535483327	0.427	0.205	9.61899354012874e-20	IGKV1-39	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000282120	NA	NA	NA	IG_V_gene	P01597	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55622
4.70312568652283e-24	-0.39774526742157	0.912	0.993	9.69079047708028e-20	RPLP1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55623
6.81743807459915e-24	-0.453759573834096	0.586	0.753	1.40473311527115e-19	RPS5	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55624
1.32128959165958e-23	0.521792971996284	0.53	0.35	2.72251720361456e-19	CYTOR	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55625
1.52642105475289e-23	0.354301617743651	0.396	0.225	3.14519058331832e-19	ZBP1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000124256	81030	Z-DNA binding protein 1	C20orf183|DAI|dJ718J7.3|DLM-1|DLM1	protein_coding	Q9H171	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55626
2.52559863169569e-23	-0.440208177498088	0.62	0.785	5.20399598060897e-19	RPL29	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55627
2.94224542521539e-23	-0.390614102857945	0.803	0.924	6.06249669865631e-19	RPS4X	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55628
3.83024750868876e-23	-0.520914887348927	0.529	0.694	7.89222499165319e-19	RPS3A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55629
4.62634954616145e-23	-0.509895689874668	0.685	0.821	9.53259323986566e-19	RPS28	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55630
4.82501154869703e-23	0.65064747878639	0.373	0.212	9.94193629609023e-19	IFI27	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55631
8.75403709860908e-23	-0.414621450521839	0.622	0.787	1.8037693441684e-18	RPL6	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55632
1.43819018152463e-22	0.41895226679509	0.615	0.417	2.96339086903151e-18	KLF6	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55633
1.47209007088999e-22	0.275618558079223	0.365	0.2	3.03324159106883e-18	HDLBP	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000115677	3069	high density lipoprotein binding protein	HBP|VGL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55634
1.8514302351898e-22	-0.400198359259056	0.165	0.347	3.81487199960859e-18	SARAF	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55635
1.8697930195103e-22	0.477558883172614	0.48	0.308	3.85270851670097e-18	NFKBIA	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55636
2.42331639768033e-22	-0.416298083559722	0.42	0.612	4.99324343742031e-18	RACK1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55637
6.48395299670141e-22	0.43904906818282	0.906	0.801	1.33601851497033e-17	HSP90B1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55638
7.34851273054805e-22	-0.522920304823558	0.728	0.84	1.51416104812943e-17	RPL28	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55639
8.77354527987285e-22	-0.418770983319426	0.448	0.641	1.8077890049178e-17	RPL14	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55640
9.15236763074735e-22	-0.401004615939288	0.187	0.363	1.88584535031549e-17	EZR	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55641
9.86224978584835e-22	0.426656627234255	0.837	0.729	2.03211656837405e-17	DERL3	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000274437	91319	derlin 3	C22orf14|derlin-3|FLJ43842|IZP6|MGC71803	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55642
1.53080480408163e-21	0.577475139398268	0.492	0.321	3.1542232988102e-17	ZFP36	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55643
2.26184586697225e-21	-0.524046558450011	0.548	0.702	4.66053340889632e-17	RPS3	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55644
2.3123955985053e-21	-0.376118956673445	0.119	0.284	4.76469113072017e-17	CXCR4	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55645
2.38971915294145e-21	-0.283310734135769	0.138	0.302	4.92401631463587e-17	TRMT112	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55646
3.13032329946754e-21	0.340536791999685	0.843	0.747	6.45003115855286e-17	ITM2C	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55647
7.65391133517529e-21	0.38102545594273	0.94	0.882	1.57708843061287e-16	XBP1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55648
8.80717850885244e-21	0.409613183153694	0.54	0.373	1.81471913174905e-16	TPM4	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55649
1.16024472789157e-20	-0.400540356877869	0.308	0.487	2.39068426182058e-16	ATP5MG	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55650
1.88025895383731e-20	-0.340966867887295	0.171	0.342	3.87427357438178e-16	BTF3	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55651
2.0160136870118e-20	-0.370554299477476	0.212	0.382	4.15399620208781e-16	EIF5	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55652
6.36574998125296e-20	-0.407106179642248	0.549	0.713	1.31166278363717e-15	RPS24	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55653
2.21337529096581e-19	-0.390653595806163	0.476	0.638	4.56065978703505e-15	RPS25	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55654
2.71020162030845e-19	0.266407054226771	0.402	0.243	5.58437043864557e-15	RRBP1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55655
2.9809460581163e-19	-0.379660816335873	0.47	0.651	6.14223935274863e-15	RPL5	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55656
3.79426208422979e-19	-0.341270174915751	0.167	0.33	7.81807702455548e-15	HNRNPA1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55657
8.0154022367853e-19	-0.345098155860971	0.265	0.426	1.65157363088961e-14	PRDX1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55658
1.60420438107263e-18	-0.334850724451611	0.129	0.278	3.30546312720015e-14	PNRC1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55659
2.49007086506021e-18	-0.299864283182792	0.157	0.316	5.13079101745656e-14	RPL31	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55660
2.74357243646637e-18	-0.352642176460457	0.119	0.263	5.65313100533895e-14	BASP1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55661
3.00669179048934e-18	-0.299767808461508	0.255	0.418	6.19528843430328e-14	ATP5MC2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55662
3.76949439941372e-18	-0.327408627331713	0.511	0.68	7.76704320999198e-14	EEF1B2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55663
4.29888949269121e-18	-0.350016965162944	0.649	0.791	8.85786179969024e-14	RPS15	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55664
4.43982137898076e-18	-0.409880262142869	0.318	0.482	9.14825195138986e-14	RPL10A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55665
5.59266877744349e-18	-0.343640031868083	0.146	0.291	1.15236940159223e-13	CCNI	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55666
5.95791418495299e-18	-0.286651431035549	0.234	0.4	1.22762821780956e-13	PFDN5	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55667
7.79703544835581e-18	-0.252915116916564	0.24	0.412	1.60657915413371e-13	HLA-E	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55668
8.07989900449833e-18	-0.346481652166913	0.241	0.405	1.66486318987688e-13	RPL7	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55669
2.42954396567274e-17	-0.381572065319771	0.724	0.855	5.00607534126869e-13	RPS19	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55670
3.54449590405608e-17	-0.354756383434229	0.122	0.264	7.30343381030755e-13	BCAS2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55671
5.57702067883579e-17	-0.3340505184028	0.279	0.439	1.14914511087411e-12	YPEL5	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55672
6.34562997729818e-17	-0.263762319508881	0.281	0.437	1.30751705682229e-12	GABARAP	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55673
7.24265978757787e-17	-0.308567361694354	0.266	0.418	1.49235004923042e-12	COX4I1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55674
7.32208166454943e-17	-0.911961398535178	0.59	0.666	1.50871492698041e-12	CD79A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55675
7.94230730227152e-17	0.291261681395177	0.257	0.135	1.63651241963305e-12	EHMT1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000181090	79813	euchromatic histone lysine methyltransferase 1	bA188C12.1|EHMT1-IT1|Eu-HMTase1|FLJ12879|FLJ40292|GLP|KIAA1876|KMT1D	protein_coding	Q9H9B1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55676
1.32098248570401e-16	-0.340052523846016	0.753	0.876	2.72188441179311e-12	RPL13	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55677
1.32939576346795e-16	-0.407977937196612	0.458	0.595	2.73921997062572e-12	RPS9	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55678
1.68504464292161e-16	0.50108039750543	0.412	0.278	3.47203448673997e-12	PDE4B	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55679
2.50952862469975e-16	-0.296196638966908	0.282	0.453	5.17088373119384e-12	RPS29	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55680
1.18433885825587e-15	0.331166886346142	0.48	0.335	2.44033021743623e-11	PPP1R15A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55681
4.10929021273829e-15	-0.323085826149114	0.482	0.626	8.46719248334724e-11	RPL24	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55682
5.0952035673151e-15	-0.281048094026277	0.218	0.372	1.04986669504528e-10	MT-ATP6	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55683
5.73548948597906e-15	-0.362800970895173	0.646	0.778	1.18179760858598e-10	RPS18	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55684
6.99401492328321e-15	-0.394975425574844	0.194	0.343	1.44111677494251e-10	HMGB1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55685
9.15704475973392e-15	-0.287727573246169	0.171	0.312	1.88680907274317e-10	NPM1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55686
9.36131557723446e-15	0.313585926991254	0.305	0.175	1.92889907468916e-10	ATF3	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55687
1.35805907728497e-14	-0.442039650589194	0.604	0.741	2.79828072874568e-10	MT-CO3	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55688
1.41739227318757e-14	-0.399153584447919	0.44	0.573	2.920536778903e-10	RPL21	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55689
3.34567528439519e-14	-0.332650893570876	0.267	0.416	6.89376392349628e-10	UBA52	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55690
4.23230869574363e-14	-0.250740423953704	0.132	0.258	8.72067206757974e-10	RAC2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55691
5.2618084839253e-14	-0.254823131787418	0.14	0.269	1.08419563811281e-09	ARPC3	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55692
7.83277558995571e-14	-0.494179284800227	0.186	0.32	1.61394341031037e-09	PFN1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55693
9.66615257015786e-14	-0.34279512483166	0.51	0.647	1.99171073708103e-09	RPS16	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55694
1.07977567905138e-13	-0.274783834926071	0.139	0.264	2.22487778668538e-09	PTPRCAP	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55695
1.21832027068177e-13	-0.278618824494202	0.598	0.706	2.51034891773978e-09	SERP1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55696
1.90460788337111e-13	0.273498919993807	0.305	0.185	3.92444454368616e-09	LGALS1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55697
2.82646509147081e-13	0.406504301791838	0.896	0.898	5.8239313209756e-09	IGHG1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55698
2.98264947326235e-13	-0.359081159395231	0.245	0.388	6.14574923965708e-09	PPIA	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55699
3.08192343019399e-13	-0.279778574109228	0.749	0.884	6.35030322791471e-09	RPL7A	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55700
3.4901045730305e-13	-0.602703568801744	0.812	0.795	7.19136047272935e-09	UBC	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55701
6.09906608725817e-13	-0.367129982036638	0.516	0.643	1.25671256727955e-08	RPL15	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55702
6.63069303016119e-13	-0.579460195526207	0.158	0.285	1.36625429886471e-08	HIST1H4C	Plasma cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55703
9.45163357236723e-13	-0.251779652318429	0.287	0.417	1.94750909758627e-08	ARF4	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55704
2.26600274271784e-12	-0.473758876384029	0.235	0.362	4.6690986513701e-08	ANKRD37	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000186352	353322	ankyrin repeat domain 37	Lrp2bp	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55705
2.50564981792528e-12	-0.341933231310813	0.133	0.251	5.16289144983504e-08	H2AFZ	Plasma cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55706
2.85338302680416e-12	-0.356919830487971	0.291	0.423	5.87939572672998e-08	KLF2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55707
7.22405541256072e-12	0.307901555754205	0.586	0.467	1.48851661775814e-07	IGLL5	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000254709	100423062	immunoglobulin lambda like polypeptide 5	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55708
9.13478878666913e-12	-0.301322195304223	0.308	0.437	1.88222322949317e-07	H3F3A	Plasma cells	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55709
9.29478299014416e-12	-1.71143649099525	0.219	0.336	1.9151900351192e-07	IGKV3-11	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000282823	NA	NA	NA	IG_V_gene	P04433	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55710
1.97805281759007e-11	-0.317032102662887	0.147	0.26	4.07577783064434e-07	CFL1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55711
2.03829281234408e-11	-0.357962793043067	0.526	0.644	4.19990233983499e-07	RPS6	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55712
2.76106327309971e-11	-0.26557596507848	0.45	0.581	5.68917087422194e-07	RPL36	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55713
4.29869265996856e-11	-0.308391874561115	0.209	0.323	8.85745622586521e-07	PABPC1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55714
6.82468288727313e-11	-0.258186546649153	0.349	0.473	1.40622590892263e-06	RPL9	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55715
8.98602301953831e-11	-0.2997889715496	0.706	0.77	1.85157004317587e-06	SERF2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55716
2.30990978597803e-10	-0.310238462033997	0.791	0.896	4.75956911400772e-06	RPLP0	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55717
9.68846445744053e-09	0.269522208422264	0.308	0.213	0.000199630810145562	TAGAP	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55718
3.91087106188564e-08	-0.404601837656472	0.644	0.694	0.000805834982301536	RPS2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55719
4.61560022644254e-08	-0.359371436152932	0.878	0.868	0.000951044426658486	HERPUD1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55720
6.70258033423682e-08	-0.294554102600322	0.333	0.428	0.0013810666778695	RPSA	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55721
8.59598920206254e-08	-0.944849873914193	0.367	0.248	0.00177120357508499	IGLV2-14	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000211666	NA	NA	NA	IG_V_gene	P01704	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55722
1.19166254471045e-07	0.255487976494211	0.363	0.27	0.00245542067337588	IER2	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55723
4.30670552438412e-07	0.334521392404306	0.914	0.848	0.00887396673299348	MT-ND4L	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55724
5.60261404462934e-07	0.770867271357091	0.963	0.915	0.0115441862389588	MALAT1	Plasma cells	GSE169246_PacAteTissue_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55725
5.84178103904158e-259	-1.47791474040937	0.008	0.314	1.20369898309452e-254	PLA2G2D	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000117215	26279	phospholipase A2 group IID	sPLA2S	protein_coding	Q9UNK4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55726
5.83101684850654e-242	-0.885240380590124	0.029	0.39	1.20148102163477e-237	ADAMDEC1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000134028	27299	ADAM like decysin 1	M12.219	protein_coding	O15204	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55727
2.100736053323e-210	-2.55440520951846	0.08	0.494	4.32856663787204e-206	MMP9	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000100985	4318	matrix metallopeptidase 9	CLG4B	protein_coding	P14780	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55728
2.28094774977206e-198	-1.45428363719401	0.052	0.422	4.69989283840532e-194	UBD	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000228913	10537	ubiquitin D	FAT10	protein_coding	O15205	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55729
2.76299194811024e-156	-0.808002190516341	0.069	0.406	5.69314490908115e-152	NR1H3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000025434	10062	nuclear receptor subfamily 1 group H member 3	LXR-a|LXRa|RLD-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55730
5.85545842234823e-128	-0.875696435113785	0.107	0.443	1.20651720792485e-123	PLA2G7	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000146070	7941	phospholipase A2 group VII	LDL-PLA2|PAFAH	protein_coding	Q13093	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55731
5.16488794540633e-127	1.4096679245444	0.892	0.485	1.06422516115097e-122	S100A4	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55732
1.54738287256454e-100	-0.456621476271991	0.056	0.301	3.18838240891923e-96	SMPDL3A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000172594	10924	sphingomyelin phosphodiesterase acid like 3A	ASM3A|ASML3a|FLJ20177|yR36GH4.1	protein_coding	Q92484	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55733
7.41188625846201e-91	1.07884142356879	0.653	0.294	1.5272191635561e-86	FCGR2A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000143226	2212	Fc gamma receptor IIa	CD32|CD32A|CDw32|Fc-gamma-RIIa|FCG2|FcgammaRIIa|FCGR2|FCGR2A1|IGFR2	protein_coding	P12318	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55734
2.46944438780942e-90	-0.468227184071023	0.117	0.406	5.08829016108132e-86	SLAMF8	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000158714	56833	SLAM family member 8	BLAME|CD353|SBBI42	protein_coding	Q9P0V8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55735
1.27812906181805e-85	1.08302331056043	0.918	0.744	2.63358493187609e-81	LGALS1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55736
2.43369016874008e-85	0.966582093430476	0.708	0.399	5.01461859268893e-81	YWHAH	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55737
3.42272282918376e-85	0.840171930858666	0.969	0.908	7.05252038953314e-81	MT-ND1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55738
7.47241011714774e-83	-1.07645355904433	0.751	0.915	1.53969010463829e-78	LYZ	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55739
1.91466779441966e-81	-0.426165611538811	0.06	0.286	3.94517299040171e-77	BIRC3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55740
4.21728045225025e-78	1.15432532433372	0.66	0.321	8.68970637186164e-74	FCGR3A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55741
5.34189942048995e-78	-0.686232448502047	0.104	0.367	1.10069837559196e-73	MARCKSL1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55742
9.07789133275707e-74	-0.569372398618321	0.135	0.401	1.87049950911459e-69	PIM3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55743
3.48560064759769e-73	0.888031953212309	0.418	0.059	7.18208013437503e-69	F13A1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000124491	2162	coagulation factor XIII A chain	F13A	protein_coding	P00488	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55744
8.47530864172719e-73	0.599149423184269	0.993	0.974	1.74633734562789e-68	HLA-B	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55745
1.46120142136566e-72	1.23094502532873	0.361	0.012	3.01080552872394e-68	MGP	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55746
4.85170630922796e-72	-0.514158402160829	0.188	0.488	9.99694085016421e-68	WARS	Mono/Macro	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55747
8.23583719874169e-70	-1.11975331300635	0.521	0.704	1.69699425480073e-65	ATOX1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55748
1.7928290192888e-69	0.753511833774209	0.944	0.879	3.69412419424457e-65	MT-ATP6	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55749
2.18270653629501e-69	0.93748870536427	0.374	0.035	4.49746681803587e-65	HTRA1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000166033	5654	HtrA serine peptidase 1	ARMD7|HtrA|IGFBP5-protease|PRSS11	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55750
4.91796379198493e-66	-0.544627310402278	1	1	1.0133464393385e-61	B2M	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55751
3.23121175804522e-65	0.98984361387343	0.431	0.096	6.65791182745217e-61	C3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000125730	718	complement C3	ARMD9|C3a|C3b|CPAMD1	protein_coding	P01024	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55752
3.876762250805e-65	-0.451188071472883	0.157	0.423	7.98806861778371e-61	UBE2D1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000072401	7321	ubiquitin conjugating enzyme E2 D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UbcH5A	protein_coding	P51668	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55753
9.47576128484748e-65	0.733676079972705	0.933	0.816	1.95248061274282e-60	MT-ND5	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55754
4.05348230996765e-61	-0.66116999529175	0.686	0.845	8.35220029968833e-57	ATP6V0C	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000185883	527	ATPase H+ transporting V0 subunit c	ATP6C|ATP6L|ATPL|VATL|Vma3	protein_coding	P27449	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55755
4.78138492573127e-61	-0.554966388136589	0.072	0.265	9.85204363946929e-57	CYP27A1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000135929	1593	cytochrome P450 family 27 subfamily A member 1	CP27|CTX|CYP27	protein_coding	Q02318	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55756
2.93835268459258e-60	-0.458672002521683	0.121	0.353	6.054475706603e-56	TOR3A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55757
4.67958611977566e-59	-0.551088202319687	0.144	0.397	9.64228719979775e-55	ZNF331	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55758
3.66615756647239e-57	-0.370669732865868	0.189	0.471	7.55411766571637e-53	CD48	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55759
4.27774856713832e-56	0.723260068417254	0.445	0.137	8.81430092258851e-52	MSR1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000038945	4481	macrophage scavenger receptor 1	CD204|SCARA1|SR-A|SR-AI|SR-AII|SR-AIII	protein_coding	P21757	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55760
9.76104567204966e-55	-0.738555872201557	0.169	0.41	2.01126346072583e-50	GPR183	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55761
1.04920631764072e-54	-1.19858123697514	0.247	0.488	2.1618896174987e-50	ACP5	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000102575	54	acid phosphatase 5, tartrate resistant	HPAP|TRAcP|TRAP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55762
4.71894127814787e-54	0.835764037025262	0.53	0.237	9.72337850362368e-50	TREM2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000095970	54209	triggering receptor expressed on myeloid cells 2	TREM-2|Trem2a|Trem2b|Trem2c	protein_coding	Q9NZC2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55763
1.45186069693429e-53	-0.606324978296757	0.9	0.918	2.9915589660331e-49	SRGN	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55764
2.59337317983678e-52	2.21212091815447	0.384	0.091	5.34364543705368e-48	SPP1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000118785	6696	secreted phosphoprotein 1	BNSP|BSPI|ETA-1|OPN	protein_coding	P10451	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55765
7.2347803007458e-52	0.96815974223694	0.868	0.76	1.49072648096867e-47	S100A6	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55766
1.62969957081461e-50	-0.895256694323646	0.111	0.319	3.35799596566351e-46	CXCL9	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000138755	4283	C-X-C motif chemokine ligand 9	CMK|crg-10|Humig|MIG|SCYB9	protein_coding	Q07325	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55767
2.33524553015626e-50	1.67446141593814	0.51	0.217	4.81177341488697e-46	CCL2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000108691	6347	C-C motif chemokine ligand 2	GDCF-2|HC11|MCAF|MCP-1|MCP1|MGC9434|SCYA2|SMC-CF	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55768
9.92275248870986e-50	-0.622702260562744	0.561	0.767	2.04458315029867e-45	SYNGR2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55769
1.85955570594756e-48	0.637182049402769	0.56	0.256	3.83161453210494e-44	ALOX5AP	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55770
5.68644368334281e-48	-0.374990843921239	0.109	0.305	1.17169172095279e-43	TCN2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000185339	6948	transcobalamin 2	D22S676|D22S750|TC2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55771
1.25612058091443e-47	-0.806027644171271	0.33	0.538	2.58823645697419e-43	IL18	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000150782	3606	interleukin 18	IGIF|IL-18|IL-1g|IL1F4	protein_coding	Q14116	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55772
3.78658913871414e-45	0.56298986375138	0.276	0.03	7.80226692032049e-41	MTRNR2L12	Mono/Macro	GSE169246_PacAteTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55773
5.13432801721028e-45	-0.408756354009934	0.193	0.423	1.05792828794618e-40	STX11	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000135604	8676	syntaxin 11	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55774
3.72047017769072e-44	0.556229510006524	0.571	0.314	7.66602880113172e-40	CSF1R	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000182578	1436	colony stimulating factor 1 receptor	C-FMS|CD115|CSFR|FMS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55775
2.18021577476282e-43	-0.444004982189538	0.176	0.394	4.49233460389878e-39	IL4I1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000104951	259307	interleukin 4 induced 1	FIG1	protein_coding	Q96RQ9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55776
3.30976121966708e-43	-0.552208128629453	0.668	0.863	6.81976299312402e-39	GSTP1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55777
7.19628411649957e-43	0.541380091461298	0.313	0.06	1.48279434220474e-38	VSIG4	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000155659	11326	V-set and immunoglobulin domain containing 4	CRIg|Z39IG	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55778
1.25941572345883e-41	0.635146811606809	0.513	0.265	2.59502609818692e-37	TXNIP	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55779
1.77479630693699e-41	-0.497526679421716	0.286	0.512	3.65696779044367e-37	STAT1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55780
2.39521828724198e-41	0.410188572946111	0.785	0.545	4.9353472808621e-37	FXYD5	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55781
2.56676033015746e-41	0.505093144081049	0.392	0.137	5.28880966028944e-37	MEF2C	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55782
2.66803282714976e-41	-0.906096883417399	0.503	0.689	5.49748164034207e-37	TXN	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55783
7.03131920454041e-41	0.552195253044465	0.342	0.095	1.44880332209555e-36	STAB1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000010327	23166	stabilin 1	CLEVER-1|FEEL-1|FELE-1|FEX1|KIAA0246|SCARH2|STAB-1	protein_coding	Q9NY15	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55784
7.66982809053681e-40	-0.776595909365228	0.363	0.584	1.58036807805511e-35	DUSP2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55785
2.11578655343194e-39	0.607788728318559	0.477	0.223	4.35957819334651e-35	MT-ND6	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55786
5.06672477453026e-39	-0.727532904031426	0.403	0.639	1.04399863979196e-34	C15orf48	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55787
2.29662979097359e-38	0.475616141155394	0.912	0.845	4.73220568430109e-34	AIF1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55788
2.83611673318375e-38	0.480554233975649	0.314	0.076	5.84381852872512e-34	OLFML3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000116774	56944	olfactomedin like 3	HNOEL-iso|OLF44	protein_coding	Q9NRN5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55789
4.49069438395898e-38	0.435462012253073	0.997	0.994	9.25307577814748e-34	TPT1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55790
5.0195913281812e-38	-0.326319129125404	0.213	0.432	1.03428679317174e-33	RAB20	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000139832	55647	RAB20, member RAS oncogene family	FLJ20429	protein_coding	Q9NX57	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55791
1.18051509266326e-37	-0.564625689155657	0.37	0.603	2.43245134843265e-33	BCL2A1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55792
1.44259926660134e-37	-0.398705488697917	0.237	0.459	2.97247578883207e-33	PPA1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55793
1.5829263941017e-37	0.648389493113953	0.617	0.377	3.26161983504655e-33	MS4A7	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55794
1.80466921237632e-37	0.778888880367931	0.321	0.082	3.71852091210141e-33	FN1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55795
2.59671796683016e-37	-0.373442686467309	0.938	0.981	5.35053737065354e-33	HLA-C	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55796
3.48430536192135e-37	0.403001872635641	0.971	0.892	7.17941119823894e-33	TYROBP	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55797
1.45810056952331e-36	-0.447953498301297	0.265	0.486	3.00441622350279e-32	SELENOK	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55798
2.7028183706381e-36	-0.333809429620088	0.151	0.344	5.5691572526998e-32	BCL3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000069399	602	BCL3 transcription coactivator	BCL4|D19S37	protein_coding	P20749	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55799
7.76408082659876e-36	-0.450031419679673	0.479	0.698	1.59978885432067e-31	PLEK	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55800
9.12707183455939e-36	-0.623092961155699	0.624	0.817	1.88063315151096e-31	NFKBIA	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55801
1.2599767654025e-35	0.372035930491736	0.254	0.042	2.59618212511186e-31	LTC4S	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000283887	4056	leukotriene C4 synthase	MGC33147	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55802
1.58090887802744e-35	-0.483423143043401	0.238	0.45	3.25746274317555e-31	CHMP1B	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55803
2.67939642944044e-35	0.482694313466453	0.436	0.196	5.52089634286203e-31	AHNAK	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55804
1.19498687662013e-34	0.400777704289501	0.96	0.881	2.46227045927578e-30	RPL37A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55805
1.21120000838068e-34	0.436066792220829	0.466	0.237	2.49567761726838e-30	KCTD12	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000178695	115207	potassium channel tetramerization domain containing 12	C13orf2|KIAA1778|PFET1	protein_coding	Q96CX2	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55806
1.64900931370543e-34	0.50473442313133	0.357	0.129	3.39778369089003e-30	GPR34	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000171659	2857	G protein-coupled receptor 34	NA	protein_coding	Q9UPC5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55807
1.67520819398745e-34	-0.399783161745264	0.467	0.681	3.45176648371114e-30	SUB1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55808
2.47508284797384e-34	-0.315109754252466	0.18	0.376	5.09990820825011e-30	SELENOS	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000131871	55829	selenoprotein S	AD-015|MGC2553|SBBI8|SELS|SEPS1|VIMP	protein_coding	Q9BQE4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55809
2.49841473582326e-34	-0.37830150469393	0.155	0.338	5.14798356316384e-30	YPEL5	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55810
2.69945806003206e-34	0.379631633283727	0.267	0.056	5.56223333269605e-30	RUNX1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000159216	861	RUNX family transcription factor 1	AML1|AMLCR1|CBFA2|PEBP2A2	protein_coding	Q01196	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55811
2.90404406898315e-34	-0.354640261888016	0.194	0.396	5.98378280413977e-30	EPSTI1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55812
3.99693004638357e-34	0.48066748472033	0.956	0.931	8.23567436057334e-30	MT-ND4	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55813
8.29431756523064e-34	-0.334938239912808	0.215	0.436	1.70904413431577e-29	NR4A3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000119508	8013	nuclear receptor subfamily 4 group A member 3	CHN|CSMF|MINOR|NOR1	protein_coding	Q92570	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55814
1.24768941128275e-33	0.378655564659742	0.325	0.104	2.57086403194811e-29	OGFRL1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000119900	79627	opioid growth factor receptor like 1	dJ331H24.1	protein_coding	Q5TC84	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55815
2.90889597444025e-33	-0.551824985462655	0.121	0.282	5.99378015533413e-29	ENPP2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000136960	5168	ectonucleotide pyrophosphatase/phosphodiesterase 2	ATX|PD-IALPHA|PDNP2	protein_coding	Q13822	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55816
5.7398253251812e-33	0.734160902999826	0.826	0.715	1.18269100825359e-28	S100A10	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55817
9.03943051127378e-33	0.385498508763157	0.384	0.154	1.86257465684796e-28	RHOC	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55818
1.83941958188765e-32	0.373025595619662	0.801	0.609	3.7901240484795e-28	CALM1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55819
9.16070307594079e-32	0.44457684135036	0.474	0.259	1.8875628687976e-27	PLXDC2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000120594	84898	plexin domain containing 2	FLJ14623|TEM7R	protein_coding	Q6UX71	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55820
1.60143770071306e-31	-0.779942875088737	0.752	0.81	3.29976238231927e-27	PRDX1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55821
1.05109543604324e-30	-0.283546569197478	0.128	0.294	2.16578214596711e-26	GTF2B	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000137947	2959	general transcription factor IIB	TFIIB	protein_coding	Q00403	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55822
1.26088290013536e-30	-0.361036007362654	0.385	0.612	2.5980492157289e-26	PSMB9	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55823
1.88793557510215e-30	-0.373402144509309	0.316	0.531	3.89009125249798e-26	ICAM1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000090339	3383	intercellular adhesion molecule 1	BB2|CD54	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55824
1.95685786531536e-30	-0.407330088800053	0.275	0.472	4.0321056314823e-26	GLA	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55825
2.04447496601084e-30	1.37606102640016	0.399	0.199	4.21264066746535e-26	RNASE1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000129538	6035	ribonuclease A family member 1, pancreatic	RAC1|RNS1	protein_coding	P07998	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55826
2.22809190184705e-30	0.668999526716685	0.995	0.984	4.59098336375585e-26	GAPDH	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55827
2.41818369959575e-30	-1.06968028365629	0.637	0.698	4.98266751301704e-26	CTSC	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55828
2.75065456883955e-30	-0.391948518602727	0.244	0.437	5.6677237390939e-26	PPIF	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55829
3.07956360293292e-30	0.334188388155631	0.257	0.063	6.34544080384328e-26	TGFBR1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000106799	7046	transforming growth factor beta receptor 1	ACVRLK4|ALK-5|ALK5|ESS1|MSSE|TBR-i|TBRI	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55830
6.28805904594365e-30	-1.64930308295435	0.555	0.632	1.29565456641669e-25	APOC1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000130208	341	apolipoprotein C1	NA	protein_coding	P02654	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55831
7.52357795828347e-30	0.386550690939136	0.871	0.729	1.55023323830431e-25	RPL38	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55832
2.38920777546891e-29	-0.340183430912801	0.514	0.75	4.9229626213537e-25	PSME2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55833
2.44109594425948e-29	-0.28521125565614	0.13	0.292	5.02987819314666e-25	FOSL2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55834
3.80346722526604e-29	-0.505873489293002	0.683	0.797	7.83704421766068e-25	PNRC1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55835
5.91977741803117e-29	0.442397701054622	0.936	0.882	1.21977013698532e-24	MT-ND2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55836
8.11945976842963e-29	-0.391822411832394	0.215	0.406	1.67301468528492e-24	IRF1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55837
8.99809437567035e-29	-0.420281347874664	0.142	0.305	1.85405734610688e-24	MX1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55838
1.19007605012904e-28	0.790220779048292	0.697	0.563	2.45215170129089e-24	MIF	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55839
2.49176281884769e-28	0.388416321245218	0.986	0.944	5.13427728823566e-24	S100A11	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55840
2.86709767320385e-28	0.372555261692045	0.972	0.947	5.90765475563653e-24	MYL6	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55841
3.10720011264176e-28	-0.284228826553042	0.152	0.314	6.40238583209836e-24	ACP2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000134575	53	acid phosphatase 2, lysosomal	LAP	protein_coding	P11117	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55842
7.45355011968249e-28	0.337091834424386	0.992	0.98	1.53580400216058e-23	MT-CO1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55843
1.15606819727299e-27	-0.371281727675847	0.22	0.387	2.38207852048099e-23	TSPAN4	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55844
1.65019950159378e-27	0.325096023171254	0.331	0.131	3.40023607303399e-23	LRP1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000123384	4035	LDL receptor related protein 1	A2MR|APOER|APR|CD91|IGFBP-3R|IGFBP3R1|LRP|LRP1A	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55845
1.68540560030823e-27	0.402727486737348	0.471	0.268	3.47277823943511e-23	ADAP2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000184060	55803	ArfGAP with dual PH domains 2	CENTA2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55846
2.76103951045714e-27	-0.490043676265609	0.468	0.671	5.68912191129695e-23	NR4A2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55847
3.36097175652845e-27	-0.321411936967567	0.34	0.54	6.92528230432686e-23	NFE2L2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55848
6.11619540680875e-27	0.350954277986129	0.503	0.299	1.26024206357294e-22	GNAS	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55849
7.13419110880862e-27	0.481754436155655	0.543	0.34	1.47000007797002e-22	CD9	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55850
8.1419675562109e-27	-0.432155293396523	0.368	0.553	1.67765241495726e-22	HERPUD1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55851
1.10377306455735e-26	-0.32740764407045	0.112	0.253	2.27432439952042e-22	CD55	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55852
9.37722641636364e-26	0.348575474968635	0.308	0.119	1.93217750309173e-21	HLA-DQA2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55853
1.34793194567563e-25	-0.468539604938981	0.64	0.774	2.77741377406464e-21	SOD2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55854
1.48800342215276e-25	0.38190505544983	0.329	0.14	3.06603105134577e-21	GAL3ST4	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000197093	79690	galactose-3-O-sulfotransferase 4	FLJ12116	protein_coding	Q96RP7	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55855
2.39565915575494e-25	0.317239223920369	0.376	0.18	4.93625569043305e-21	CMTM3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000140931	123920	CKLF like MARVEL transmembrane domain containing 3	BNAS2|CKLFSF3|FLJ31762	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55856
4.48214711514737e-25	-0.554067280092902	0.27	0.426	9.23546413076116e-21	IFITM1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55857
6.57667931289185e-25	-0.571781234115139	0.171	0.328	1.35512477242137e-20	IL1RN	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000136689	3557	interleukin 1 receptor antagonist	ICIL-1RA|IL-1RN|IL1F3|IL1RA|IRAP|MGC10430	protein_coding	P18510	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55858
8.15201554189973e-25	-0.378801797739444	0.864	0.944	1.67972280240844e-20	HSPA8	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55859
9.16837678906392e-25	0.494716572593793	0.878	0.824	1.88914403738662e-20	RPS29	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55860
1.17511295438273e-24	-0.366205017971094	0.553	0.718	2.42132024250561e-20	DNAJA1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55861
1.38764968339557e-24	-0.536944933822578	0.345	0.514	2.85925217263656e-20	CDKN1A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55862
1.44739689708906e-24	0.258512121506015	0.253	0.078	2.98236130645201e-20	GAS6	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55863
1.84879615034307e-24	0.756299494183938	0.375	0.194	3.8094444677819e-20	FOLR2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000165457	2350	folate receptor beta	FRbeta	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55864
2.30289686065952e-24	0.310725308972992	0.257	0.082	4.74511898138893e-20	SLC11A1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000018280	6556	solute carrier family 11 member 1	LSH|NRAMP|NRAMP1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55865
4.16604405185808e-24	0.333523391856629	0.369	0.181	8.58413376885358e-20	DSE	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000111817	29940	dermatan sulfate epimerase	DS-Epi1|DSEPI|SART2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55866
4.89628165365543e-24	-0.353984489563605	0.158	0.306	1.0088788347357e-19	EZR	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55867
9.48252324314939e-24	-0.333182043237282	0.176	0.334	1.95387391425093e-19	GBP1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55868
1.15939879333885e-23	-0.402186660979925	0.234	0.394	2.3889412136747e-19	GM2A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000196743	2760	ganglioside GM2 activator	GM2-AP|GM2AP|SAP-3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55869
1.89217502553989e-23	-0.524828589081436	0.195	0.358	3.89882664012495e-19	G0S2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55870
2.6940124941047e-23	0.278307774555081	0.278	0.102	5.55101274410273e-19	PECAM1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000261371	5175	platelet and endothelial cell adhesion molecule 1	CD31	protein_coding	P16284	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55871
3.01107501928024e-23	0.293904375667562	0.411	0.217	6.20432007722693e-19	MSN	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55872
5.0818093374434e-23	-0.251963068689804	0.21	0.376	1.04710681398021e-18	VOPP1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55873
7.42733207496598e-23	-0.384437628955276	0.981	0.974	1.53040177404674e-18	HLA-A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55874
1.03333253968498e-22	-0.282951918674158	0.179	0.331	2.12918169802091e-18	RILPL2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000150977	196383	Rab interacting lysosomal protein like 2	FLJ30380|FLJ32372|MGC7036	protein_coding	Q969X0	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55875
2.3307564962884e-22	-0.74186029009221	0.911	0.924	4.80252376060225e-18	PSAP	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55876
3.97970991946718e-22	-0.471045500844456	0.675	0.788	8.20019228906212e-18	JUNB	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55877
4.1915288996626e-22	0.281348957000033	0.925	0.858	8.6366452977548e-18	LAPTM5	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55878
4.68520649617689e-22	-0.381134396787641	0.252	0.414	9.65386798537249e-18	BASP1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55879
5.41582231728959e-22	0.286660318092446	0.399	0.216	1.11593018847752e-17	FLOT1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000223654	10211	flotillin 1	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55880
5.73045059469493e-22	-0.26929906946346	0.177	0.334	1.18075934503689e-17	LIMD2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55881
1.03221053734902e-21	0.336038334507376	0.545	0.355	2.12686981220767e-17	TGFBI	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55882
1.43777208468244e-21	-0.476458983148766	0.911	0.921	2.96252938048817e-17	SAT1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55883
1.64732289867708e-21	-0.648529475835877	0.569	0.681	3.39430883272413e-17	BTG1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55884
1.75268460044786e-21	0.328791925047398	0.981	0.976	3.61140661922281e-17	MT-ND3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55885
2.14609209869174e-21	0.4440045195652	0.39	0.226	4.42202276935434e-17	SLCO2B1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000137491	11309	solute carrier organic anion transporter family member 2B1	OATP-B|OATP2B1|SLC21A9	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55886
2.41451320674742e-21	-0.254610588026592	0.252	0.419	4.97510446250305e-17	REL	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55887
3.06593249673527e-21	0.325405660318636	0.421	0.252	6.31735390952303e-17	ARHGAP18	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000146376	93663	Rho GTPase activating protein 18	bA307O14.2|MacGAP	protein_coding	Q8N392	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55888
4.48365372103575e-21	-0.630426340638423	0.815	0.849	9.23856849219417e-17	CTSZ	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55889
4.81922743986827e-21	0.443473772765746	0.484	0.304	9.93001813984856e-17	A2M	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000175899	2	alpha-2-macroglobulin	CPAMD5|FWP007|S863-7	protein_coding	P01023	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55890
5.49849267849891e-21	0.329045002738387	0.493	0.296	1.1329644164047e-16	FCGR1A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000150337	2209	Fc gamma receptor Ia	CD64|CD64A|FCG1|FcgammaRI|FcgammaRIa|FCGR1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55891
5.55240275857502e-21	-0.277781236074792	0.424	0.588	1.14407258840438e-16	LGALS9	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000168961	3965	galectin 9	LGALS9A	protein_coding	O00182	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55892
1.11439802815667e-20	0.342906254469623	0.829	0.788	2.29621713701681e-16	CLIC1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55893
1.41124882508363e-20	0.319329520555378	0.565	0.396	2.90787820408482e-16	C1orf162	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000143110	128346	chromosome 1 open reading frame 162	MGC24133	protein_coding	Q8NEQ5	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55894
1.46324164212371e-20	-0.401040566930798	0.556	0.688	3.01500940359591e-16	FYB1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55895
1.77498723758054e-20	0.305631805553169	0.986	0.983	3.65736120303471e-16	MT-CO3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55896
3.72545592244496e-20	-0.488367880878949	0.953	0.958	7.67630192819784e-16	CST3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55897
5.07957189116926e-20	-0.345018922900352	0.271	0.42	1.04664578817543e-15	C1orf54	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000118292	79630	chromosome 1 open reading frame 54	FLJ23221	protein_coding	Q8WWF1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55898
5.24296565547178e-20	0.313254195395481	0.762	0.614	1.08031307330996e-15	TSPO	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55899
1.09454205752562e-19	0.273816724663894	0.337	0.17	2.25530390953155e-15	RBPJ	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55900
1.26184077243702e-19	0.556380156962094	0.452	0.299	2.60002291160649e-15	DAB2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000153071	1601	DAB adaptor protein 2	DOC-2	protein_coding	P98082	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55901
1.89184676386047e-19	-0.340171619274409	0.546	0.656	3.89815025693451e-15	GRINA	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55902
2.47619358532664e-19	0.385453609494545	0.78	0.662	5.10219688256554e-15	ANXA2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55903
2.87447961666816e-19	0.279284115007195	0.506	0.338	5.92286525014474e-15	ARRB2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000141480	409	arrestin beta 2	ARR2|BARR2|DKFZp686L0365	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55904
2.92408640786832e-19	-0.359049461765027	0.228	0.364	6.02508004341267e-15	DNASE2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000105612	1777	deoxyribonuclease 2, lysosomal	DNL|DNL2	protein_coding	O00115	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55905
3.91754547911262e-19	0.273809028974665	0.316	0.157	8.07210245971155e-15	AP1B1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000100280	162	adaptor related protein complex 1 subunit beta 1	ADTB1|AP105A|BAM22|CLAPB2	protein_coding	Q10567	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55906
5.17040025480799e-19	-0.29649454984484	0.169	0.305	1.06536097250319e-14	TAGAP	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55907
5.52484752899172e-19	0.590454429905429	0.418	0.253	1.13839483334874e-14	PLTP	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000100979	5360	phospholipid transfer protein	BPIFE	protein_coding	P55058	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55908
6.09561762444326e-19	-0.307668647608611	0.475	0.623	1.25600201151653e-14	LAP3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55909
6.96428870712109e-19	-0.333942190026321	0.25	0.399	1.4349916881023e-14	EIF4A3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55910
7.02019845879954e-19	-0.274756647636138	0.412	0.594	1.44651189243565e-14	HSPD1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55911
7.31904878625058e-19	-0.340721211758048	0.627	0.758	1.50809000240693e-14	HSPE1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55912
7.71388066820222e-19	-0.339347870349354	0.23	0.384	1.58944511168307e-14	INSIG1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55913
1.16998449389523e-18	0.268502351934758	0.356	0.194	2.41075304967113e-14	TBXAS1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000059377	6916	thromboxane A synthase 1	CYP5|CYP5A1|THAS|TS|TXAS|TXS	protein_coding	P24557	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55914
1.29958233804943e-18	-0.529766178636224	0.146	0.271	2.67778940755086e-14	CCL5	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55915
1.73403287074351e-18	0.274817472462558	0.424	0.258	3.57297473016701e-14	LY86	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000112799	9450	lymphocyte antigen 86	dJ80N2.1|MD-1	protein_coding	O95711	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55916
1.89904116803717e-18	0.281795083150524	0.447	0.282	3.91297432674059e-14	TIMP2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55917
1.96918117083375e-18	-0.293017217365207	0.654	0.747	4.05749780250294e-14	ATP6V0E1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55918
2.29423957134054e-18	-0.27391520351549	0.434	0.609	4.72728063674718e-14	MCL1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55919
3.15923587102672e-18	-0.269383884917142	0.998	0.999	6.50960551225055e-14	RPL28	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55920
3.61749072739638e-18	-0.277162344998115	0.485	0.649	7.45383964380023e-14	ATP6V1G1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55921
5.03847994784052e-18	0.260755849910443	0.379	0.216	1.03817879325254e-13	CD302	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000241399	9936	CD302 molecule	BIMLEC|CLEC13A|DCL-1|KIAA0022	protein_coding	Q8IX05	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55922
5.2576006738811e-18	-0.332221971582383	0.274	0.435	1.0833286188532e-13	CSTA	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55923
7.55893401316274e-18	0.511318654654563	0.783	0.731	1.55751835341218e-13	TUBA1B	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55924
8.48265395022832e-18	0.253981034695603	0.343	0.18	1.74785084644455e-13	FPR1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000171051	2357	formyl peptide receptor 1	FMLP|FPR	protein_coding	P21462	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55925
1.49340085184327e-17	-1.4338418012275	0.638	0.619	3.07715245522306e-13	APOE	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000130203	348	apolipoprotein E	AD2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55926
3.28129301757524e-17	0.273723805012154	0.284	0.135	6.76110426271379e-13	PMP22	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55927
4.19791375049684e-17	0.283559138278098	0.299	0.15	8.64980128289874e-13	GYPC	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55928
9.0896372133096e-17	0.279484864695566	0.514	0.351	1.87291974780244e-12	CD99	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55929
1.88018873363583e-16	0.279333041524166	0.494	0.335	3.87412888565662e-12	APLP2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55930
2.5041485284839e-16	-0.277200060014308	0.251	0.386	5.15979804294107e-12	ATP1B3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55931
4.05355745623827e-16	-0.450127868407795	0.595	0.694	8.35235513857896e-12	PLAUR	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55932
2.05127197508336e-15	-0.264375005297295	0.54	0.727	4.22664590465926e-11	CD83	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55933
2.06110486757961e-15	0.290442598263588	0.502	0.361	4.24690657964779e-11	PEA15	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000162734	8682	proliferation and apoptosis adaptor protein 15	HMAT1|HUMMAT1H|MAT1|MAT1H|PEA-15|PED|PED-PEA15|PED/PEA15	protein_coding	Q15121	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55934
2.79611251838801e-15	-0.315027329843212	0.245	0.383	5.76138984413849e-11	ISG15	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55935
3.32839058709698e-15	-0.604230700575517	0.569	0.596	6.85814880471332e-11	TMEM176A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55936
5.41399606386807e-15	-0.286110916833382	0.908	0.947	1.11555388896002e-10	UBC	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55937
1.04375169386384e-14	-0.375052568652968	0.317	0.435	2.15065036520644e-10	SERPING1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000149131	710	serpin family G member 1	C1-INH|C1IN|C1INH|C1NH|HAE1|HAE2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55938
1.12831600561091e-14	0.272111274107074	0.363	0.226	2.32489512956127e-10	HIF1A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55939
1.97226039363027e-14	-0.252661471205835	0.643	0.763	4.06384254107517e-10	SLC25A6	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55940
2.55723723951071e-14	0.291568481331925	0.259	0.131	5.26918733201181e-10	PLD4	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000166428	122618	phospholipase D family member 4	C14orf175	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55941
6.45173867462873e-14	-0.254575296993678	0.356	0.491	1.32938075390725e-09	ZFAND5	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55942
1.18387434986891e-13	-0.260579545820835	0.393	0.554	2.43937309790488e-09	NR4A1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55943
1.25119656840207e-13	0.328463471071072	0.986	0.978	2.57809052919246e-09	VIM	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55944
1.66394665137094e-13	0.366974200730677	0.531	0.426	3.42856207514982e-09	MNDA	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55945
3.91562780879624e-13	0.250493312136465	0.522	0.388	8.06815110002466e-09	ATP5ME	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55946
6.23952202718425e-13	-0.405570685635573	0.761	0.803	1.28565351370131e-08	CTSS	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55947
6.34770870948392e-13	-0.268507034722076	0.514	0.623	1.30794537958916e-08	SARAF	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55948
9.49925290313159e-13	0.349757411458176	0.425	0.296	1.95732106069026e-08	ID2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55949
9.63882835970238e-13	-0.853924958221401	0.271	0.353	1.98608058351667e-08	LIPA	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000107798	3988	lipase A, lysosomal acid type	CESD|LAL	protein_coding	P38571	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55950
1.16010250729037e-12	-0.445364920971736	0.724	0.75	2.39039121627181e-08	LGALS3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55951
1.27930659827468e-12	-0.417766923641636	0.39	0.511	2.63601124574499e-08	IL1B	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55952
2.04494462932157e-12	-0.250989297478357	0.511	0.624	4.21360840871709e-08	NINJ1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55953
2.45302818639874e-12	-0.278171741086534	0.386	0.506	5.05446457807461e-08	CALHM6	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000188820	441168	calcium homeostasis modulator family member 6	C6orf187|dJ93H18.5|FAM26F|INAM|OTTHUMP00000017061|OTTHUMP00000017062|RP1-93H18.5	protein_coding	Q5R3K3	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55954
2.77504843638181e-12	0.323532543485641	0.667	0.529	5.71798730316472e-08	CD14	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55955
3.053471907672e-12	-0.26451129774582	0.539	0.633	6.29167886575816e-08	AKR1A1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55956
5.58969457714501e-12	-0.394555339735051	0.155	0.25	1.15175656762073e-07	IL32	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55957
7.72042372837783e-12	-0.376676555939718	0.635	0.672	1.59079330923225e-07	ASAH1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55958
1.12772104635832e-11	0.310479865520518	0.74	0.636	2.32366921602132e-07	MS4A6A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000110077	64231	membrane spanning 4-domains A6A	CD20L3|MS4A6	protein_coding	Q9H2W1	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55959
1.22069323778492e-11	0.279254439607148	0.313	0.194	2.51523841645583e-07	FCGR2B	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000072694	2213	Fc gamma receptor IIb	CD32|CD32B|FCG2|FcgammaRIIb|FCGR2|FcGRIIB	protein_coding	P31994	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55960
2.13070114639796e-11	-0.871209588303443	0.555	0.586	4.390309712153e-07	CTSL	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000135047	1514	cathepsin L	CTSL1|FLJ31037	protein_coding	P07711	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55961
2.6161040936913e-11	-0.258555076276291	0.489	0.584	5.39048248505093e-07	EFHD2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55962
4.20281750029743e-11	-0.511033494566154	0.167	0.252	8.65990545936286e-07	FUCA1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000179163	2517	alpha-L-fucosidase 1	NA	protein_coding	P04066	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55963
4.21793464685544e-11	0.441381888017162	0.517	0.416	8.69105433984564e-07	LDHA	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55964
5.1739232645581e-11	-0.469577451250912	0.456	0.519	1.0660868886622e-06	LILRB4	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000278555	11006	leukocyte immunoglobulin like receptor B4	CD85k|HM18|ILT3|LIR-5|LIR5	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55965
1.26609541082138e-10	-0.251701618550138	0.996	0.994	2.60878959399746e-06	RPL19	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55966
2.97367862974109e-10	-0.277902058492138	0.989	0.996	6.12726481658151e-06	RPS15A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55967
2.77543502516753e-09	-0.256739310352316	1	1	5.71878386935769e-05	RPL10	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55968
4.7889851077978e-09	-0.563286439949684	0.175	0.263	9.86770381461736e-05	CXCL10	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000169245	3627	C-X-C motif chemokine ligand 10	C7|crg-2|gIP-10|IFI10|INP10|IP-10|mob-1|SCYB10	protein_coding	P02778	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55969
5.93295360601638e-09	-0.387479691591686	0.322	0.393	0.000122248509051967	SERPINF1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000282307	5176	serpin family F member 1	EPC-1|PEDF|PIG35	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55970
8.84052341457908e-09	0.251176137507077	0.467	0.371	0.000182158984957402	TNFSF13	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000161955	8741	TNF superfamily member 13	APRIL|CD256	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55971
1.02754815740907e-08	0.270683942162892	0.368	0.268	0.000211726297834139	PLAU	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000122861	5328	plasminogen activator, urokinase	UPA|URK	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55972
1.14359694109354e-08	-0.737640727546123	0.463	0.574	0.000235638149712324	CCL4L2	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55973
1.91844438616807e-08	-0.310351780104625	0.675	0.737	0.000395295465769931	ZFP36	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55974
2.66948020680601e-08	-0.442788273733835	0.483	0.524	0.000550046396612377	PLD3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000105223	23646	phospholipase D family member 3	HU-K4	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55975
3.92057786528187e-08	-0.276547892131771	0.995	0.993	0.000807835069141329	RPS8	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55976
4.65817435421994e-08	-0.27687150346866	0.313	0.383	0.000959816825687018	SCPEP1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000121064	59342	serine carboxypeptidase 1	RISC	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55977
1.14824828890872e-07	-0.809307169358095	0.444	0.469	0.00236596559929642	GPNMB	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000136235	10457	glycoprotein nmb	HGFIN|NMB	protein_coding	Q14956	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55978
1.17725642815155e-07	0.41037135070995	0.437	0.341	0.00242573687020627	EGR1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55979
1.34059865752072e-07	-0.360273190365404	0.562	0.614	0.00276230353382145	IGSF6	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000283934	10261	immunoglobulin superfamily member 6	DORA	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55980
1.4782303248213e-07	-0.438982678308031	0.406	0.483	0.00304589358429428	IFI30	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55981
1.80303809662605e-07	0.319131613104422	0.454	0.363	0.00371515999809797	FABP5	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55982
1.87448111455306e-07	0.384029472626158	0.274	0.183	0.00386236833653657	SELENOP	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000250722	6414	selenoprotein P	SELP|SeP|SEPP|SEPP1	protein_coding	P49908	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55983
2.08588980995091e-07	0.264949142482995	0.457	0.363	0.00429797595340385	RPL36A	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55984
6.75690306579773e-07	0.326931203181214	0.937	0.96	0.0139225987670762	HLA-DPA1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55985
7.48959367756182e-07	-0.264512983496345	0.38	0.476	0.0154323077726161	LY6E	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55986
8.33350016208119e-07	0.583110604122433	0.937	0.954	0.0171711770839683	MT-ATP8	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55987
8.47088771822212e-07	-0.425626999827475	0.421	0.522	0.0174542641433967	CCL3L1	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000277796	6349	C-C motif chemokine ligand 3 like 1	D17S1718|G0S19-2|LD78BETA|SCYA3L|SCYA3L1|MGC12815	protein_coding	P16619	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55988
1.13164475218877e-06	0.512858959083908	0.255	0.171	0.0233175401188496	CXCL3	Mono/Macro	GSE169246_PacAteTissue_pre	ENSG00000163734	2921	C-X-C motif chemokine ligand 3	CINC-2b|GRO3|GROg|MIP-2b|SCYB3	protein_coding	P19876	GSE169246_PacAteTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	pre	atezolizumab + paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 5, sensitive 4); post (resistant 4, sensitive 2)	15	87713	Public on Sep 15, 2021	34653365	This dataset has 9 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Immunotherapy	55989
0	0.86544356663884	1	1	0	EEF1A1	B cells	GSE169246_PacBlood_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	55990
0	-0.990919858374673	0.996	0.999	0	RPL41	B cells	GSE169246_PacBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	55991
0	-0.732410314518506	1	0.999	0	RPS21	B cells	GSE169246_PacBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	55992
0	0.724320969642331	1	0.999	0	RPL3	B cells	GSE169246_PacBlood_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	55993
0	1.12748033590286	0.998	0.971	0	MT-ATP8	B cells	GSE169246_PacBlood_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	55994
0	-0.941740064397042	0.966	0.997	0	MT-ND4	B cells	GSE169246_PacBlood_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	55995
4.71142612268021e-304	-0.946544809321535	0.997	0.997	9.29847059572167e-300	RPS29	B cells	GSE169246_PacBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	55996
1.57197323138918e-299	-0.658500330534434	1	0.999	3.10244636946968e-295	RPL39	B cells	GSE169246_PacBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	55997
2.23460861177715e-286	0.72671477092759	1	0.996	4.41022355620339e-282	MT-ND4L	B cells	GSE169246_PacBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	55998
5.62168572266866e-267	-0.538460953042606	1	1	1.10949589422589e-262	RPS28	B cells	GSE169246_PacBlood_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	55999
2.56302722848143e-260	0.864554763269408	0.919	0.592	5.05839053813095e-256	KLF2	B cells	GSE169246_PacBlood_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56000
1.22299768531361e-253	-0.559625148812223	0.999	0.999	2.41370823173494e-249	RPL36	B cells	GSE169246_PacBlood_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56001
1.80537815648205e-252	-0.569946126091277	1	1	3.56309432963296e-248	RPS27	B cells	GSE169246_PacBlood_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56002
2.51359765553584e-245	-0.488309388465548	1	1	4.96083633296553e-241	RPL28	B cells	GSE169246_PacBlood_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56003
3.11182295584353e-245	0.592513217934072	1	0.998	6.14149378565278e-241	HLA-B	B cells	GSE169246_PacBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56004
5.13448124451869e-229	-0.440279102158548	1	1	1.01334121841821e-224	RPL37	B cells	GSE169246_PacBlood_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56005
8.35912950055095e-224	-0.763876585581985	0.749	0.917	1.64975779822874e-219	RPL36A	B cells	GSE169246_PacBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56006
2.93828707058548e-220	0.599706054791879	1	1	5.7990033625075e-216	ACTB	B cells	GSE169246_PacBlood_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56007
5.54349353299971e-219	0.615711356656205	0.98	0.897	1.09406388367282e-214	EEF1G	B cells	GSE169246_PacBlood_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56008
3.73518789054581e-207	-0.645025852751094	0.991	0.999	7.37176682078122e-203	MT-ATP6	B cells	GSE169246_PacBlood_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56009
1.00677512568108e-194	0.624987458807971	0.914	0.635	1.98697138804418e-190	NPM1	B cells	GSE169246_PacBlood_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56010
2.24541091466964e-179	0.5745875195846	0.976	0.841	4.431542981192e-175	BTG1	B cells	GSE169246_PacBlood_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56011
3.240370710999e-178	-1.06716458567285	0.845	0.926	6.39519563522762e-174	RPS26	B cells	GSE169246_PacBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56012
2.68394661841297e-177	0.470388328579927	0.998	0.983	5.29703704609983e-173	PTMA	B cells	GSE169246_PacBlood_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56013
7.66580632060642e-177	0.480184751557769	0.997	0.978	1.51292353543488e-172	HLA-C	B cells	GSE169246_PacBlood_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56014
1.78668656232326e-176	-1.07167358660279	0.504	0.789	3.5262045994012e-172	IFITM1	B cells	GSE169246_PacBlood_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56015
3.6264203769671e-174	-0.424828678654538	1	1	7.15710325598227e-170	RPS15	B cells	GSE169246_PacBlood_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56016
1.18847644123335e-170	-0.544849896738791	0.979	0.991	2.34557710441815e-166	RPL38	B cells	GSE169246_PacBlood_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56017
9.6815617602819e-168	0.43395932234386	0.999	1	1.91075302900924e-163	MT-CO3	B cells	GSE169246_PacBlood_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56018
5.44309402535216e-163	0.5588167740807	0.917	0.73	1.0742490368435e-158	HNRNPA1	B cells	GSE169246_PacBlood_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56019
7.02825831279841e-138	-0.345632899849826	1	1	1.38709706061389e-133	RPS15A	B cells	GSE169246_PacBlood_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56020
1.91867324472513e-133	-0.553582169342337	1	1	3.78669351578951e-129	MALAT1	B cells	GSE169246_PacBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56021
4.26170032078081e-126	-0.316255648579085	1	0.999	8.41089175309301e-122	RPL32	B cells	GSE169246_PacBlood_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56022
1.22874462635036e-125	-0.33901649476962	1	1	2.42505039456506e-121	FAU	B cells	GSE169246_PacBlood_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56023
3.61159161817127e-125	0.445118377135413	0.985	0.954	7.12783721762281e-121	RPL4	B cells	GSE169246_PacBlood_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56024
5.56429636811466e-119	0.323735241942601	0.999	0.997	1.09816953121111e-114	HLA-DRA	B cells	GSE169246_PacBlood_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56025
8.88883804331796e-119	-0.370676879302966	1	1	1.75430107622923e-114	RPLP1	B cells	GSE169246_PacBlood_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56026
1.10865904821677e-117	0.396197587804393	0.995	0.992	2.18804949756062e-113	MT-ND1	B cells	GSE169246_PacBlood_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56027
1.29163232400808e-112	-0.276335276477496	1	1	2.54916555466235e-108	RPL34	B cells	GSE169246_PacBlood_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56028
2.41164490018487e-112	-0.364257805215876	1	1	4.75962237500487e-108	RPS19	B cells	GSE169246_PacBlood_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56029
6.51749821716139e-111	-0.344935852126318	1	1	1.28629344813897e-106	RPL35A	B cells	GSE169246_PacBlood_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56030
1.33033660897957e-109	0.451212668178792	0.778	0.501	2.62555233148208e-105	SNX2	B cells	GSE169246_PacBlood_post	ENSG00000205302	6643	sorting nexin 2	NA	protein_coding	O60749	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56031
1.97981477540024e-108	0.425267769201766	0.759	0.458	3.90736244072991e-104	PCBP1	B cells	GSE169246_PacBlood_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56032
2.32897100551425e-107	0.478771446881944	0.742	0.446	4.59645717648293e-103	ZFP36L1	B cells	GSE169246_PacBlood_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56033
4.02322408282348e-106	0.4427097919093	0.857	0.579	7.94023504986042e-102	HLA-DRB5	B cells	GSE169246_PacBlood_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56034
1.05348608444876e-105	-0.351401766969879	0.998	0.998	2.07916013626807e-101	RPL37A	B cells	GSE169246_PacBlood_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56035
3.76744117146864e-105	0.524425924767654	0.97	0.901	7.43542189601051e-101	LTB	B cells	GSE169246_PacBlood_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56036
1.22344397292123e-104	0.300726371171095	1	1	2.41458902495733e-100	RPS3A	B cells	GSE169246_PacBlood_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56037
2.43091349572657e-101	0.322964716765385	0.998	0.997	4.79765087516595e-97	NACA	B cells	GSE169246_PacBlood_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56038
1.00163652716897e-100	0.440207890331658	0.777	0.495	1.97682985002068e-96	SARAF	B cells	GSE169246_PacBlood_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56039
1.30938061469635e-100	0.309704407290328	1	1	2.58419358116472e-96	TPT1	B cells	GSE169246_PacBlood_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56040
1.56047868347519e-97	0.363421361560467	0.968	0.912	3.07976072970664e-93	ARHGDIB	B cells	GSE169246_PacBlood_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56041
2.85507999948968e-97	-0.370463779436273	0.999	1	5.63478588699284e-93	TMSB10	B cells	GSE169246_PacBlood_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56042
5.85077267306554e-97	0.299466084526282	1	1	1.15470849475622e-92	RPS6	B cells	GSE169246_PacBlood_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56043
4.98056144411329e-96	0.402545005781867	0.56	0.29	9.829636066102e-92	CXXC5	B cells	GSE169246_PacBlood_post	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56044
2.18749707119917e-95	0.373846839192961	0.963	0.855	4.31724421971869e-91	PABPC1	B cells	GSE169246_PacBlood_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56045
1.51171890583516e-89	0.37781246354631	0.982	0.935	2.98352843255627e-85	HLA-DQA1	B cells	GSE169246_PacBlood_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56046
1.76554102232485e-89	0.446663929191974	0.722	0.464	3.48447176166033e-85	FAM129C	B cells	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56047
1.2835475310314e-88	0.365193989683606	0.7	0.405	2.53320940724358e-84	DAZAP2	B cells	GSE169246_PacBlood_post	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56048
6.64280772351766e-87	0.399257015333274	0.99	0.988	1.31102453231345e-82	HLA-A	B cells	GSE169246_PacBlood_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56049
9.26355589096556e-86	-0.409455660076608	0.95	0.979	1.82825539064096e-81	ATP5F1E	B cells	GSE169246_PacBlood_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56050
1.67244489175324e-85	0.412302391584414	0.844	0.608	3.30073723836419e-81	FCMR	B cells	GSE169246_PacBlood_post	ENSG00000162894	9214	Fc mu receptor	FAIM3|FcmuR|TOSO	protein_coding	O60667	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56051
3.21631269815738e-85	0.466305151364542	0.704	0.445	6.34771474108341e-81	MT-ND6	B cells	GSE169246_PacBlood_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56052
9.1775134387354e-84	0.429018765656325	0.853	0.661	1.81127405226882e-79	NOP53	B cells	GSE169246_PacBlood_post	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56053
3.41075754338498e-82	0.380155855887692	0.775	0.518	6.73147108762459e-78	SNX3	B cells	GSE169246_PacBlood_post	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56054
2.14628522214253e-81	0.408237262099107	0.752	0.512	4.2359085144205e-77	HVCN1	B cells	GSE169246_PacBlood_post	ENSG00000122986	84329	hydrogen voltage gated channel 1	Hv1|MGC15619|VSOP	protein_coding	Q96D96	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56055
2.02373945125349e-80	0.332395249472309	0.979	0.928	3.9940521809939e-76	EEF2	B cells	GSE169246_PacBlood_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56056
9.80874111805135e-80	-0.315375638531351	0.997	0.997	1.93585314705861e-75	UBA52	B cells	GSE169246_PacBlood_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56057
4.63066914402591e-79	0.368828776503061	0.726	0.474	9.13908862264954e-75	CNBP	B cells	GSE169246_PacBlood_post	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56058
1.77341201569034e-78	0.360126875594298	0.688	0.421	3.50000595416645e-74	SRSF5	B cells	GSE169246_PacBlood_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56059
2.65213400178238e-78	-0.311915723494774	1	1	5.23425166591771e-74	RPL18A	B cells	GSE169246_PacBlood_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56060
5.42225299068239e-77	0.376179208290641	0.871	0.671	1.07013585024108e-72	HNRNPA2B1	B cells	GSE169246_PacBlood_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56061
7.93996639251236e-74	0.344004355222744	0.7	0.442	1.56703176722624e-69	HNRNPK	B cells	GSE169246_PacBlood_post	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56062
2.8298844956498e-73	0.297972646066397	0.999	0.996	5.58506004061445e-69	CD37	B cells	GSE169246_PacBlood_post	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56063
5.80864083749934e-72	0.360058168401904	0.595	0.356	1.14639335568887e-67	EVI2B	B cells	GSE169246_PacBlood_post	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56064
2.80499624448163e-71	0.373390684891174	0.583	0.345	5.53594058810895e-67	RBM3	B cells	GSE169246_PacBlood_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56065
4.89814270318857e-69	-0.618134611035812	0.184	0.363	9.66697443901297e-65	ISG15	B cells	GSE169246_PacBlood_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56066
7.43100966665387e-69	0.327254159608789	0.662	0.415	1.46658406781081e-64	HMGN1	B cells	GSE169246_PacBlood_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56067
4.68486141144663e-68	0.274549997985683	1	1	9.24604248163107e-64	TMSB4X	B cells	GSE169246_PacBlood_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56068
9.66204907742209e-68	0.318408706898232	0.825	0.63	1.90690200592002e-63	RHOA	B cells	GSE169246_PacBlood_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56069
1.48352198192727e-67	0.341134542999473	0.883	0.702	2.92787898353167e-63	CCNI	B cells	GSE169246_PacBlood_post	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56070
2.56875792875656e-67	0.327938868718678	0.606	0.364	5.06970064819394e-63	NCL	B cells	GSE169246_PacBlood_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56071
3.54535462546491e-67	0.310811495370431	0.592	0.345	6.99711188881755e-63	SMAP2	B cells	GSE169246_PacBlood_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56072
5.34940906123807e-67	0.304124001488971	0.451	0.234	1.05575937232594e-62	TUBA1B	B cells	GSE169246_PacBlood_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56073
1.15762841513171e-66	0.323785094219571	0.403	0.199	2.28469544010395e-62	BASP1	B cells	GSE169246_PacBlood_post	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56074
1.2039628172271e-66	0.282891069466629	0.474	0.245	2.3761410160794e-62	HNRNPA0	B cells	GSE169246_PacBlood_post	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56075
2.03353252271206e-66	-0.432402358510558	0.737	0.846	4.01337978682452e-62	IFITM2	B cells	GSE169246_PacBlood_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56076
4.91048766330092e-66	0.286447377773361	0.995	0.986	9.6913384522907e-62	FTH1	B cells	GSE169246_PacBlood_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56077
1.88747982153524e-65	0.370357791894548	0.727	0.503	3.72513017578195e-61	PTPN6	B cells	GSE169246_PacBlood_post	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56078
2.88343775911383e-65	0.313939621957646	0.611	0.375	5.69075276138705e-61	HCLS1	B cells	GSE169246_PacBlood_post	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56079
1.13715505605757e-64	0.333639609060189	0.993	0.987	2.24428921863521e-60	HLA-DPB1	B cells	GSE169246_PacBlood_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56080
1.79391147786276e-63	-0.421806225426054	0.676	0.765	3.54046369270994e-59	OST4	B cells	GSE169246_PacBlood_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56081
7.02028641467792e-63	0.34526011044323	0.732	0.513	1.38552372680083e-58	ERP29	B cells	GSE169246_PacBlood_post	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56082
8.29949461105933e-63	0.294966430429633	0.479	0.264	1.63798825643867e-58	HNRNPF	B cells	GSE169246_PacBlood_post	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56083
1.0318674081306e-62	0.289975692307968	0.476	0.26	2.03649351668655e-58	ARF6	B cells	GSE169246_PacBlood_post	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56084
1.05134139874591e-61	0.338758300355965	0.721	0.504	2.07492738456492e-57	EIF3E	B cells	GSE169246_PacBlood_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56085
4.13833180366915e-61	0.288072954255687	0.992	0.983	8.16741164772144e-57	EEF1B2	B cells	GSE169246_PacBlood_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56086
1.148875296336e-59	0.313615630465054	0.646	0.417	2.26742028484872e-55	CSK	B cells	GSE169246_PacBlood_post	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56087
1.16617812520381e-59	0.3194157743567	0.697	0.467	2.30156914790224e-55	HMGN2	B cells	GSE169246_PacBlood_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56088
1.4079390894025e-59	0.32884703566105	0.691	0.476	2.77870858684477e-55	EIF3L	B cells	GSE169246_PacBlood_post	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56089
2.49228953305309e-59	0.279140744219855	0.357	0.17	4.91878262243357e-55	ODC1	B cells	GSE169246_PacBlood_post	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56090
2.13588409008614e-58	-0.394790863299918	0.761	0.827	4.215380840194e-54	MIF	B cells	GSE169246_PacBlood_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56091
7.69609442359889e-58	0.268182823810842	0.429	0.229	1.51890119544148e-53	MAT2B	B cells	GSE169246_PacBlood_post	ENSG00000038274	27430	methionine adenosyltransferase 2B	MATIIbeta|SDR23E1	protein_coding	Q9NZL9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56092
1.743527706747e-57	-0.306410528938735	0.142	0.306	3.44102628203587e-53	BLOC1S1	B cells	GSE169246_PacBlood_post	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56093
6.27780560781392e-57	-0.456470994760611	0.457	0.67	1.23898771475816e-52	S100A4	B cells	GSE169246_PacBlood_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56094
2.87168114456024e-55	0.302799789686219	0.639	0.425	5.66754990690409e-51	SET	B cells	GSE169246_PacBlood_post	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56095
1.18620362086226e-53	0.298877088868981	0.61	0.396	2.34109146613376e-49	EIF4A2	B cells	GSE169246_PacBlood_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56096
3.60042678454354e-53	0.273778377379052	0.424	0.235	7.10580230197514e-49	SRSF2	B cells	GSE169246_PacBlood_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56097
5.69626626580487e-53	0.290883248934787	0.751	0.518	1.12421511021925e-48	CIRBP	B cells	GSE169246_PacBlood_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56098
1.01465101146262e-52	-0.370734807403575	0.717	0.788	2.00251523622263e-48	RPS10	B cells	GSE169246_PacBlood_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56099
5.05010358981274e-52	0.2708449419253	0.547	0.336	9.96688444485443e-48	ANP32B	B cells	GSE169246_PacBlood_post	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56100
3.24339910209344e-51	-0.448207465855614	0.168	0.323	6.40117246789162e-47	IFI44L	B cells	GSE169246_PacBlood_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56101
3.45617187899347e-51	0.278365371779219	0.511	0.313	6.82110082038152e-47	EIF3D	B cells	GSE169246_PacBlood_post	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56102
4.18685743968269e-50	0.254084308874815	0.486	0.291	8.26318184295775e-46	UBE2I	B cells	GSE169246_PacBlood_post	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56103
1.08928883990474e-49	-0.294748389604591	0.963	0.983	2.149820454436e-45	RPL31	B cells	GSE169246_PacBlood_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56104
1.68217211545346e-49	0.272221650318262	0.534	0.338	3.31993488705896e-45	CYB561A3	B cells	GSE169246_PacBlood_post	ENSG00000162144	220002	cytochrome b561 family member A3	CYBASC3	protein_coding	Q8NBI2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56105
1.70738977317511e-49	0.34515149055693	0.748	0.546	3.3697044563384e-45	SELL	B cells	GSE169246_PacBlood_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56106
3.83032571196607e-49	0.258190461121896	0.551	0.347	7.55953082513624e-45	SELENOF	B cells	GSE169246_PacBlood_post	ENSG00000183291	9403	selenoprotein F	SEP15	protein_coding	O60613	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56107
6.11087594661131e-49	0.277848895315121	0.692	0.477	1.20604247682321e-44	HNRNPDL	B cells	GSE169246_PacBlood_post	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56108
7.4157176474358e-49	0.261636359205508	0.52	0.323	1.46356603489793e-44	PTGES3	B cells	GSE169246_PacBlood_post	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56109
7.44354846405662e-49	0.296231024609662	0.904	0.787	1.46905872486621e-44	CD79B	B cells	GSE169246_PacBlood_post	ENSG00000007312	974	CD79b molecule	B29|Ig-beta|IGB|Igbeta	protein_coding	P40259	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56110
1.87161848752064e-48	0.306010304201844	0.782	0.62	3.69382624697074e-44	LSP1	B cells	GSE169246_PacBlood_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56111
2.16202796225794e-48	-0.26844768262473	0.985	0.993	4.26697838631227e-44	RPS11	B cells	GSE169246_PacBlood_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56112
3.00455918930623e-48	-0.306194773055622	0.965	0.979	5.92979801601478e-44	CYBA	B cells	GSE169246_PacBlood_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56113
1.30725177603738e-47	0.390035945990499	0.896	0.838	2.57999210518738e-43	TXNIP	B cells	GSE169246_PacBlood_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56114
1.0318675339727e-46	-0.60326372134086	0.453	0.622	2.03649376504852e-42	CRIP1	B cells	GSE169246_PacBlood_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56115
1.13109248090008e-46	0.287244105344893	0.887	0.751	2.23232412030439e-42	PNRC1	B cells	GSE169246_PacBlood_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56116
2.30744098022487e-46	0.27454774902842	0.379	0.211	4.5539655185718e-42	RNASE6	B cells	GSE169246_PacBlood_post	ENSG00000169413	6039	ribonuclease A family member k6	RAD1|RNaseK6|RNS6	protein_coding	Q93091	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56117
5.54064972192128e-46	-0.345621778645865	0.636	0.718	1.09350262911838e-41	COX6B1	B cells	GSE169246_PacBlood_post	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56118
1.01884919073396e-45	0.288154513027703	0.559	0.371	2.01080076283254e-41	ACTR3	B cells	GSE169246_PacBlood_post	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56119
2.07906183294385e-45	0.329985783519747	0.92	0.912	4.10323643349799e-41	ACTG1	B cells	GSE169246_PacBlood_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56120
7.80391224800613e-45	0.270922570413669	0.464	0.288	1.54018012126649e-40	CTSZ	B cells	GSE169246_PacBlood_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56121
8.25388468224367e-45	0.254126478455674	0.968	0.948	1.62898668088761e-40	RPL7	B cells	GSE169246_PacBlood_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56122
3.07554513386118e-44	0.278782036059643	0.657	0.459	6.06989587618842e-40	CNN2	B cells	GSE169246_PacBlood_post	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56123
4.04552108986311e-44	0.290847756134501	0.476	0.299	7.98424042295383e-40	CALR	B cells	GSE169246_PacBlood_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56124
6.4168736424823e-44	0.330486710166965	0.826	0.661	1.26643418208031e-39	LINC00926	B cells	GSE169246_PacBlood_post	ENSG00000247982	283663	long intergenic non-protein coding RNA 926	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56125
7.25393501479665e-44	0.259079154786104	0.406	0.238	1.43163661452027e-39	PDCD4	B cells	GSE169246_PacBlood_post	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56126
2.08581810100275e-43	0.257189650047192	0.538	0.358	4.11657060413903e-39	SYPL1	B cells	GSE169246_PacBlood_post	ENSG00000008282	6856	synaptophysin like 1	SYPL	protein_coding	Q16563	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56127
6.99736559357882e-43	0.27481408764246	0.69	0.5	1.38100007354872e-38	CALM2	B cells	GSE169246_PacBlood_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56128
2.72606493798644e-41	-0.368114911649779	0.547	0.71	5.38016176161004e-37	S100A6	B cells	GSE169246_PacBlood_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56129
1.55227614683793e-40	0.298239861788659	0.437	0.27	3.06357220339935e-36	CCR7	B cells	GSE169246_PacBlood_post	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56130
1.83334938489765e-40	-0.380377866690862	0.291	0.426	3.618298346034e-36	RNF213	B cells	GSE169246_PacBlood_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56131
1.79144832850622e-39	0.254923883555144	0.868	0.728	3.53560242113988e-35	YBX1	B cells	GSE169246_PacBlood_post	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56132
1.01031614209691e-37	-0.437833880947521	0.505	0.592	1.99395993804247e-33	LY6E	B cells	GSE169246_PacBlood_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56133
1.33291318854011e-36	-0.313005417199561	0.561	0.643	2.63063746890277e-32	UQCR11	B cells	GSE169246_PacBlood_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56134
2.00891527207834e-35	-0.724998264373536	0.384	0.488	3.96479518097382e-31	IGKC	B cells	GSE169246_PacBlood_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56135
2.73688938939245e-34	0.279574536664131	0.42	0.279	5.40152489890493e-30	CD24	B cells	GSE169246_PacBlood_post	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56136
4.71132069693649e-34	0.274023560025718	0.365	0.224	9.29826252747386e-30	MARCKSL1	B cells	GSE169246_PacBlood_post	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56137
1.16436144142874e-33	-0.297160151366953	0.49	0.581	2.29798374080376e-29	ELOB	B cells	GSE169246_PacBlood_post	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56138
2.09160232050999e-33	0.494539837296492	0.56	0.461	4.12798633975851e-29	TCL1A	B cells	GSE169246_PacBlood_post	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56139
9.8045040896084e-33	-0.269280146877094	0.304	0.433	1.93501692712511e-28	DDT	B cells	GSE169246_PacBlood_post	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56140
6.53979706498011e-32	-0.282237036142251	0.644	0.7	1.29069434874447e-27	COX6A1	B cells	GSE169246_PacBlood_post	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56141
7.66438822021665e-28	-0.447666431105332	0.705	0.752	1.51264365914196e-23	IGHM	B cells	GSE169246_PacBlood_post	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56142
3.18398180362015e-27	-0.280356612261318	0.35	0.453	6.28390648762472e-23	NDUFA3	B cells	GSE169246_PacBlood_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56143
1.0011025158597e-26	-0.282733541792328	0.228	0.335	1.97577592530069e-22	PARP14	B cells	GSE169246_PacBlood_post	ENSG00000173193	54625	poly(ADP-ribose) polymerase family member 14	ARTD8|BAL2|KIAA1268|pART8	protein_coding	Q460N5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56144
8.55465573656462e-25	-0.307120468411871	0.279	0.385	1.68834685616839e-20	MX1	B cells	GSE169246_PacBlood_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56145
2.59903933942472e-24	-0.26729273268531	0.372	0.459	5.12946404028862e-20	ATP5ME	B cells	GSE169246_PacBlood_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56146
5.37370116318591e-23	-0.254829606389544	0.499	0.565	1.06055366156637e-18	NDUFB11	B cells	GSE169246_PacBlood_post	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56147
5.71623295945793e-20	0.316021220028634	0.37	0.261	1.12815573687862e-15	JCHAIN	B cells	GSE169246_PacBlood_post	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56148
9.01657035470125e-20	-0.255747276169653	0.958	0.949	1.77951032520384e-15	MS4A1	B cells	GSE169246_PacBlood_post	ENSG00000156738	931	membrane spanning 4-domains A1	B1|Bp35|CD20|FMC7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56149
0	-0.83599030978359	0.134	0.517	0	EGR1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56150
0	-1.08116860943433	0.711	0.893	0	ZFP36	Mono/Macro	GSE169246_PacBlood_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56151
2.31486205838606e-293	-0.621875336159765	0.99	0.999	4.56861175843073e-289	MT-ATP6	Mono/Macro	GSE169246_PacBlood_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56152
1.79517933288418e-278	-0.580235677367306	0.103	0.418	3.54296593138022e-274	FOSB	Mono/Macro	GSE169246_PacBlood_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56153
2.20961732517694e-249	-0.462252342363343	0.051	0.298	4.36090075296921e-245	CLU	Mono/Macro	GSE169246_PacBlood_post	ENSG00000120885	1191	clusterin	APOJ|CLI|CLU1|CLU2|KUB1|SGP-2|SP-40|TRPM-2	protein_coding	P10909	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56154
2.31454579493336e-195	-0.714722657305414	0.208	0.492	4.56798758088049e-191	HBB	Mono/Macro	GSE169246_PacBlood_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56155
2.71157770650584e-193	-0.759488361286648	0.885	0.926	5.35156976155992e-189	DUSP1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56156
8.74711768772005e-184	-0.777370772903641	0.417	0.692	1.72633114684843e-179	PLAC8	Mono/Macro	GSE169246_PacBlood_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56157
6.06178517519754e-174	-0.619235293598743	0.861	0.931	1.19635392217699e-169	JUNB	Mono/Macro	GSE169246_PacBlood_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56158
2.29948081383924e-163	-0.340682529898762	0.082	0.3	4.53825533419313e-159	AC020916.1	Mono/Macro	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56159
5.14218010051167e-161	-0.665933813555524	0.162	0.415	1.01486066463698e-156	JUN	Mono/Macro	GSE169246_PacBlood_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56160
4.19538104147045e-159	-0.521877788483184	0.937	0.976	8.28000402344609e-155	LGALS1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56161
2.8266927053511e-156	-1.0889242441654	0.844	0.886	5.57876072328093e-152	FOS	Mono/Macro	GSE169246_PacBlood_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56162
6.39978749898326e-150	0.654586461516801	0.544	0.245	1.26306206079934e-145	RETN	Mono/Macro	GSE169246_PacBlood_post	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56163
8.30759739457572e-144	-0.50675363480755	0.376	0.646	1.63958742179346e-139	NAMPT	Mono/Macro	GSE169246_PacBlood_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56164
1.0355846262877e-140	-0.668300993919912	0.708	0.851	2.0438298184414e-136	KLF6	Mono/Macro	GSE169246_PacBlood_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56165
1.12128510950003e-137	-0.687851861143408	0.548	0.752	2.21296829210926e-133	NFKBIA	Mono/Macro	GSE169246_PacBlood_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56166
1.0838664518746e-135	-0.452173306045999	0.36	0.626	2.13911882941971e-131	PPP1R15A	Mono/Macro	GSE169246_PacBlood_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56167
2.9192472531681e-131	0.560315449414933	0.702	0.458	5.76142637885257e-127	HLA-DRB5	Mono/Macro	GSE169246_PacBlood_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56168
3.52604550881064e-130	-0.50134276594889	0.583	0.791	6.95900341618868e-126	IFI30	Mono/Macro	GSE169246_PacBlood_post	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56169
4.66446048399417e-128	-0.312246116712162	0.076	0.26	9.2057792112109e-124	CD83	Mono/Macro	GSE169246_PacBlood_post	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56170
3.610969773983e-122	0.576748481378337	0.42	0.166	7.12660994593285e-118	TMEM176A	Mono/Macro	GSE169246_PacBlood_post	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56171
5.36528369160205e-121	-0.435044325758422	0.105	0.3	1.05889238937458e-116	IL1B	Mono/Macro	GSE169246_PacBlood_post	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56172
4.88615572145308e-120	0.682851985875409	0.546	0.313	9.64331693185979e-116	TMEM176B	Mono/Macro	GSE169246_PacBlood_post	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56173
1.68238447749966e-118	-0.341765346627229	0.996	0.999	3.32035400479333e-114	SH3BGRL3	Mono/Macro	GSE169246_PacBlood_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56174
6.25925928147844e-117	-0.463561350044037	0.209	0.432	1.23532741179258e-112	SGK1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56175
4.58159642137178e-111	0.382633000585821	0.961	0.912	9.04223869721934e-107	ITM2B	Mono/Macro	GSE169246_PacBlood_post	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56176
3.05740162867201e-105	-0.283371344276088	0.999	1	6.03408785434707e-101	S100A4	Mono/Macro	GSE169246_PacBlood_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56177
1.11576587977614e-104	-0.417180999791715	0.42	0.652	2.20207554032619e-100	CCNL1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56178
5.27189489298727e-104	-0.326740049817463	0.309	0.554	1.04046117607997e-99	BLOC1S1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56179
3.44669708508194e-101	-0.403290888605403	0.366	0.596	6.80240136711772e-97	NFKBIZ	Mono/Macro	GSE169246_PacBlood_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56180
1.63129050687114e-92	-0.459199221907018	0.717	0.841	3.21951494436089e-88	IER2	Mono/Macro	GSE169246_PacBlood_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56181
1.6756291903447e-91	-0.37150353653357	0.333	0.546	3.3070217700643e-87	KLF4	Mono/Macro	GSE169246_PacBlood_post	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56182
7.29151846245433e-88	0.352874249870775	0.997	0.988	1.43905408374999e-83	HLA-A	Mono/Macro	GSE169246_PacBlood_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56183
1.69443159035056e-86	-0.357330072931441	0.705	0.853	3.34413018671587e-82	RPL36A	Mono/Macro	GSE169246_PacBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56184
1.19572857034339e-81	-0.540969133801054	0.71	0.815	2.35988990642971e-77	DUSP6	Mono/Macro	GSE169246_PacBlood_post	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56185
1.04716147239119e-78	-0.368740710275567	0.434	0.623	2.06667788191125e-74	JUND	Mono/Macro	GSE169246_PacBlood_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56186
1.0794200444598e-77	-0.412172438614323	0.714	0.83	2.13034339974586e-73	CEBPB	Mono/Macro	GSE169246_PacBlood_post	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56187
1.51382506215611e-77	0.524536969733076	0.559	0.37	2.9876851426713e-73	LGALS2	Mono/Macro	GSE169246_PacBlood_post	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56188
1.79306453949088e-76	0.561548795208636	0.265	0.089	3.5387921751392e-72	FOLR3	Mono/Macro	GSE169246_PacBlood_post	ENSG00000110203	2352	folate receptor gamma	FR-G|FRgamma	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56189
2.20689575318569e-76	-0.438769965109425	0.902	0.962	4.35552945848728e-72	IFITM3	Mono/Macro	GSE169246_PacBlood_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56190
7.46536252405583e-75	0.385922175495588	0.72	0.566	1.47336394774766e-70	RCSD1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56191
5.51949587538894e-74	-0.328174707319017	0.222	0.404	1.08932770596676e-69	CDKN1A	Mono/Macro	GSE169246_PacBlood_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56192
7.22455382189054e-74	-0.344313771494845	0.36	0.554	1.42583794228832e-69	ATP2B1-AS1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000271614	NA	NA	LINC00936	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56193
7.27664428533093e-70	0.37194341069713	1	0.999	1.43611851615291e-65	CD74	Mono/Macro	GSE169246_PacBlood_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56194
1.10272362091529e-69	-0.29333403894306	0.975	0.976	2.17633533823842e-65	FCN1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56195
6.45206744913818e-66	-0.268300254673939	0.323	0.512	1.27338003176191e-61	UBE2J1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56196
1.100274761729e-65	0.297759745133859	0.934	0.862	2.17150226974835e-61	LSP1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56197
8.72951737777713e-65	0.340389755562926	0.521	0.337	1.72285754967809e-60	GIMAP7	Mono/Macro	GSE169246_PacBlood_post	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56198
9.70174794346248e-65	-0.426921702391841	0.664	0.807	1.91473697412175e-60	IFI6	Mono/Macro	GSE169246_PacBlood_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56199
3.5712941091279e-64	-0.29768532377376	0.963	0.98	7.04830605377483e-60	SRGN	Mono/Macro	GSE169246_PacBlood_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56200
3.96381964339641e-63	-0.274136584933905	0.961	0.983	7.82299444820716e-59	MT-ND5	Mono/Macro	GSE169246_PacBlood_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56201
2.89859059549061e-59	-0.426850589714433	0.974	0.981	5.72065839926028e-55	SAT1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56202
2.19367521285513e-58	0.325464732131859	0.959	0.877	4.32943740009088e-54	HLA-DRB1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56203
1.07131707916018e-55	-0.346681888652422	0.431	0.591	2.11435138743053e-51	IFI44L	Mono/Macro	GSE169246_PacBlood_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56204
1.49482239635344e-54	-0.339400431106587	0.995	0.995	2.95018148144315e-50	VIM	Mono/Macro	GSE169246_PacBlood_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56205
1.78850311587842e-54	-0.337960155468134	0.902	0.959	3.52978974949765e-50	IFITM2	Mono/Macro	GSE169246_PacBlood_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56206
9.69495628936529e-53	0.310415606434363	0.925	0.849	1.91339657326913e-48	TXNIP	Mono/Macro	GSE169246_PacBlood_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56207
1.25064530706715e-52	-0.257786301550754	0.252	0.407	2.46827357802773e-48	STAB1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000010327	23166	stabilin 1	CLEVER-1|FEEL-1|FELE-1|FEX1|KIAA0246|SCARH2|STAB-1	protein_coding	Q9NY15	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56208
1.5407684930862e-52	0.522548667401913	0.393	0.23	3.04086069795492e-48	HLA-DQA1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56209
1.57947733433075e-51	-0.381568742915473	0.58	0.724	3.11725646703516e-47	MAFB	Mono/Macro	GSE169246_PacBlood_post	ENSG00000204103	9935	MAF bZIP transcription factor B	KRML	protein_coding	Q9Y5Q3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56210
2.95075751346696e-50	-0.279918039759521	0.319	0.479	5.82361502857839e-46	BTG2	Mono/Macro	GSE169246_PacBlood_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56211
4.68145120422762e-49	-0.447148907929529	0.653	0.75	9.23931209666362e-45	ZFP36L1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56212
1.01586381795504e-47	-0.326565965700602	0.416	0.568	2.00490883111607e-43	MT-ND6	Mono/Macro	GSE169246_PacBlood_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56213
1.61237455049099e-47	-0.303732633790079	0.369	0.524	3.18218241284902e-43	BCL2A1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56214
6.27743709168682e-47	-0.400381982845797	0.379	0.536	1.23891498441531e-42	APOBEC3A	Mono/Macro	GSE169246_PacBlood_post	ENSG00000262156	200315	apolipoprotein B mRNA editing enzyme catalytic subunit 3A	ARP3|PHRBN	protein_coding	P31941	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56215
5.12415385301859e-46	-0.284969778504233	0.437	0.575	1.01130300443175e-41	SULT1A1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000196502	6817	sulfotransferase family 1A member 1	P-PST|STP|STP1	protein_coding	P50225	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56216
1.69150841534485e-44	0.398645887514219	0.781	0.65	3.3383610085246e-40	HLA-DPB1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56217
2.51864520777675e-44	-0.397286008037102	0.638	0.732	4.9707981820682e-40	KLF2	Mono/Macro	GSE169246_PacBlood_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56218
4.17473160899497e-44	-0.252167272098985	0.377	0.525	8.23925030351247e-40	TPM4	Mono/Macro	GSE169246_PacBlood_post	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56219
2.72508136760907e-43	-0.267514619620909	0.673	0.792	5.37822058711325e-39	CSTB	Mono/Macro	GSE169246_PacBlood_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56220
1.05859435392639e-42	0.270701965397013	0.773	0.682	2.08924181690912e-38	PSMB9	Mono/Macro	GSE169246_PacBlood_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56221
1.16739592048261e-41	0.305628298305154	0.475	0.328	2.30397258866449e-37	AC020656.1	Mono/Macro	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56222
7.70575916592956e-40	-0.298215159629771	0.713	0.791	1.52080862898786e-35	MCL1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56223
2.4244178800586e-38	-0.367992561943013	0.418	0.546	4.78483112808365e-34	IFITM1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56224
7.08445603666934e-38	-0.298528140807506	0.576	0.684	1.39818824339706e-33	TUBA1A	Mono/Macro	GSE169246_PacBlood_post	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56225
4.47424151866577e-36	0.302602318424698	0.818	0.767	8.83036306123877e-32	MS4A6A	Mono/Macro	GSE169246_PacBlood_post	ENSG00000110077	64231	membrane spanning 4-domains A6A	CD20L3|MS4A6	protein_coding	Q9H2W1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56226
3.19187027264397e-33	0.266627986534785	0.688	0.612	6.29947517009014e-29	CPVL	Mono/Macro	GSE169246_PacBlood_post	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56227
4.9588034704639e-32	0.30998148467363	0.828	0.771	9.78669452930755e-28	NCF1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56228
8.13338595789404e-28	-0.319119932320336	0.434	0.544	1.60520505264997e-23	RHOB	Mono/Macro	GSE169246_PacBlood_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56229
6.30217150061866e-27	-0.304321300233592	1	0.999	1.2437965673621e-22	MALAT1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56230
2.09819428134842e-26	0.251609225855672	0.926	0.931	4.14099623366924e-22	RPS26	Mono/Macro	GSE169246_PacBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56231
5.62857748030005e-26	-0.299629845512767	0.471	0.562	1.11085605151202e-21	H1FX	Mono/Macro	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56232
1.83760683119369e-23	-0.264303557619535	0.943	0.959	3.62670084204387e-19	LST1	Mono/Macro	GSE169246_PacBlood_post	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56233
5.1023292463872e-21	-0.304888818214402	0.556	0.668	1.00699570006698e-16	ISG15	Mono/Macro	GSE169246_PacBlood_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56234
2.36882663266269e-18	0.282314297975407	0.707	0.635	4.67511624222308e-14	CD52	Mono/Macro	GSE169246_PacBlood_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56235
1.44261557691129e-15	0.266357800925438	0.958	0.964	2.84714610259213e-11	MT-ATP8	Mono/Macro	GSE169246_PacBlood_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56236
2.24389495949152e-12	-0.265039709275338	0.319	0.379	4.42855109205246e-08	ID2	Mono/Macro	GSE169246_PacBlood_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56237
1.55763210081138e-06	-0.424831045226626	0.71	0.697	0.0307414271416135	S100A12	Mono/Macro	GSE169246_PacBlood_post	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56238
0	0.92363577703621	1	1	0	EEF1A1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56239
8.86390928183336e-246	0.765864468400214	1	0.999	1.74938113586263e-241	RPL3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56240
5.76440304278536e-241	0.780015466596672	1	0.991	1.13766258452412e-236	MT-ND4L	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56241
2.34347993124117e-220	0.894609622762383	0.996	0.986	4.62509199229758e-216	MT-ATP8	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56242
1.31732482081505e-202	-0.988940555939679	0.995	0.995	2.59987226636058e-198	RPL41	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56243
1.0928504110599e-199	-1.08299063744979	0.99	0.997	2.15684957126782e-195	MALAT1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56244
1.0415036877468e-196	0.78709303416831	0.938	0.808	2.05551167813709e-192	KLF2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56245
4.52913946620224e-194	0.598836206649344	1	0.999	8.93870965049675e-190	HLA-C	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56246
6.09386305445566e-191	-1.06774878250486	0.997	0.994	1.20268481242737e-186	RPS29	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56247
1.50500212988592e-173	-0.801583577883512	0.94	0.99	2.97027220354285e-169	MT-ND4	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56248
5.59925653910082e-162	0.771868901690239	0.918	0.861	1.10506927055694e-157	BTG1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56249
6.5725311290861e-152	0.506180031556869	1	1	1.29715474363643e-147	HLA-B	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56250
2.38038038061221e-150	0.528384818059607	1	0.998	4.69791871917627e-146	RPS3A	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56251
2.58481770651793e-150	-0.645047529227199	1	0.999	5.10139622558378e-146	RPS21	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56252
2.30669810791686e-144	0.370332525354756	1	1	4.55249938578472e-140	B2M	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56253
6.23312063266446e-142	0.58988967426361	0.936	0.859	1.23016868806266e-137	EEF1G	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56254
1.62490057088814e-138	-0.630323870947685	1	0.999	3.20690376670484e-134	RPL39	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56255
1.81230423024754e-124	0.595863706534752	0.877	0.7	3.57676362881654e-120	SARAF	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56256
8.32496372746507e-122	-0.670555239554296	0.75	0.916	1.64301484125251e-117	RPL36A	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56257
3.01945235340336e-120	0.432014398912266	1	1	5.95919116467687e-116	TMSB4X	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56258
2.32055347251251e-119	0.601485119422129	0.571	0.209	4.57984433335068e-115	JUNB	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56259
3.7914369111271e-116	0.646459332164651	0.892	0.76	7.48277988780045e-112	ZFP36L2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56260
4.72106243834622e-114	0.467944390226084	1	1	9.31748882832009e-110	HLA-A	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56261
5.04873125630672e-112	-0.430487380235976	1	1	9.96417600744695e-108	RPL37	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56262
4.83251870276948e-107	-0.482982798019115	1	1	9.53745891178585e-103	RPS19	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56263
9.53869249006728e-107	0.589552811893687	0.581	0.247	1.88255634983968e-102	TSC22D3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56264
1.41437904367528e-104	-0.840852401589122	0.577	0.721	2.79141848059752e-100	LINC00861	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000245164	100130231	long intergenic non-protein coding RNA 861	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56265
2.07212001812322e-104	-0.560732632591629	0.974	0.98	4.08953606776798e-100	RPL38	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56266
4.86345731952302e-103	0.520865975952282	0.894	0.774	9.59851936581063e-99	NPM1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56267
1.1437217189898e-101	0.448752977554927	0.978	0.878	2.25724918459827e-97	CD3E	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56268
1.61443984138853e-100	0.379476329438267	1	0.999	3.18625847096441e-96	RPS4X	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56269
7.33460257158209e-99	0.455037950061872	0.987	0.972	1.44755716352744e-94	FTH1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56270
1.19757659478869e-96	0.477177117033097	0.933	0.908	2.36353716747496e-92	HNRNPA1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56271
7.02107662124961e-96	0.485165246964159	0.752	0.439	1.38567968196982e-91	DAZAP2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56272
4.36951120478551e-93	0.395136756037242	1	1	8.62366731376468e-89	MT-CO3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56273
1.08620646924351e-92	0.453625736383023	0.962	0.947	2.14373708769899e-88	H3F3B	CD8+ T cells	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56274
7.71423565529676e-92	0.465385907309994	0.981	0.97	1.52248154892937e-87	ARHGDIB	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56275
1.6735119683609e-88	0.450227912038116	0.667	0.337	3.30284322075707e-84	HNRNPF	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56276
3.40654163042369e-86	0.435678296222056	0.996	0.991	6.72315056180419e-82	MT-ND1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56277
2.36209934493565e-84	0.569840980913829	1	1	4.661839267165e-80	ACTB	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56278
2.18562624482209e-83	0.454604793325747	0.844	0.626	4.31355195678088e-79	PCBP1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56279
5.81369997776153e-83	-0.490619005271673	0.988	0.998	1.14739182761101e-78	MT-ATP6	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56280
1.19249392487623e-82	0.697963468760131	0.715	0.438	2.35350601013572e-78	GZMK	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56281
2.07220931900728e-81	0.453412369066566	0.567	0.272	4.08971231199277e-77	IER2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56282
1.96576970070182e-80	0.453204278188017	0.665	0.358	3.87964308130512e-76	RBM3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56283
1.39279558536534e-79	0.497377787301534	0.769	0.51	2.74882136727704e-75	LDHB	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56284
4.66937390832733e-77	0.380115978453582	0.999	0.996	9.21547634547481e-73	RPL5	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56285
1.24044570950893e-75	-0.413276657136918	1	1	2.44814365228683e-71	TMSB10	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56286
2.44368914872247e-75	-0.394715339720918	0.999	0.994	4.82286490391867e-71	RPL37A	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56287
4.78511472806839e-74	0.358825273202749	0.505	0.228	9.44390242731578e-70	SRP9	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56288
2.11383037685729e-73	0.43037692361127	0.765	0.509	4.17185563176555e-69	CNBP	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56289
4.05924659994594e-71	0.411315027865998	0.709	0.415	8.0113290896533e-67	CIRBP	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56290
1.362358801682e-70	0.633857667209618	0.63	0.354	2.68875133099959e-66	IL7R	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56291
1.97364878993295e-70	0.33448914615956	0.997	0.993	3.89519325181167e-66	NACA	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56292
2.2633145224749e-69	0.332953849284268	0.512	0.239	4.46687754155646e-65	HNRNPA0	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56293
4.1894480294301e-69	0.44269634634796	0.775	0.482	8.26829463088324e-65	CNN2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56294
1.30004123368069e-68	0.369441440705001	0.996	0.993	2.56576137879221e-64	PTMA	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56295
1.43363390272177e-67	0.401111449169257	0.599	0.324	2.8294198704117e-63	HMGN1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56296
2.33224443860901e-67	0.386209245848387	0.994	0.984	4.60291762403873e-63	MT-ND5	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56297
3.65711453242707e-66	0.317936716984168	0.999	0.998	7.21768124119806e-62	RPS6	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56298
4.20133940847031e-66	0.422214957095954	0.873	0.622	8.291763456557e-62	CD99	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56299
1.51793082005547e-65	0.499438637942036	0.745	0.488	2.99578826646148e-61	MT-ND6	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56300
1.23425104328597e-63	-0.350444010241588	0.999	0.998	2.4359178590292e-59	RPL36	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56301
6.39752685961643e-63	0.323965403569759	0.343	0.126	1.2626159010139e-58	CXCR4	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56302
3.32812195122632e-62	-0.417414287402121	0.983	0.983	6.56838148294026e-58	ATP5F1E	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56303
5.41252769414053e-62	0.327737672304474	0.542	0.277	1.06821646571557e-57	MORF4L1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56304
2.93509649110039e-61	-0.334542671064968	1	0.999	5.79270643483573e-57	RPS15	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56305
1.78545388671095e-60	0.370049315686341	0.631	0.369	3.52377179081272e-56	ERP29	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56306
2.33730741319216e-60	0.538562149522609	0.914	0.934	4.61290991067604e-56	VIM	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56307
2.47966684089666e-59	-0.368810263347513	1	0.999	4.89387047719365e-55	RPS28	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56308
2.69898670726247e-59	0.302114410251288	0.457	0.212	5.3267201654532e-55	MAT2B	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000038274	27430	methionine adenosyltransferase 2B	MATIIbeta|SDR23E1	protein_coding	Q9NZL9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56309
2.77408221980014e-59	0.36667390249521	0.733	0.48	5.47492866899756e-55	CALM2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56310
7.76549421484692e-59	0.322911632829634	1	0.999	1.53259793824219e-54	MT-CYB	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56311
1.46709011477311e-58	0.414286708915174	0.447	0.208	2.89544905051621e-54	H1FX	CD8+ T cells	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56312
2.82447935298976e-58	0.422336271816162	0.748	0.495	5.57439245106058e-54	ANXA1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56313
6.26418565839966e-58	0.306755309330663	0.461	0.223	1.23629968154176e-53	SNX3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56314
1.25977328514663e-57	0.366798603077157	0.568	0.308	2.48628855556538e-53	ANP32B	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56315
1.75300664834695e-57	0.344335634478311	0.506	0.258	3.45973392117755e-53	SRSF2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56316
2.79668318206217e-57	0.334430144968714	0.662	0.381	5.5195339281179e-53	SET	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56317
6.67404283201064e-57	0.339740062920281	0.978	0.979	1.31718909332562e-52	RPL4	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56318
1.76111825591079e-56	0.306832907971056	0.471	0.229	3.47574298986554e-52	ATP6V0C	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000185883	527	ATPase H+ transporting V0 subunit c	ATP6C|ATP6L|ATPL|VATL|Vma3	protein_coding	P27449	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56319
3.02051046600629e-56	0.311516612763135	0.41	0.187	5.96127945571001e-52	PDIA6	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56320
4.56569360963269e-56	0.35856308784625	0.873	0.778	9.01085290797108e-52	RHOA	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56321
5.4806511480697e-56	-0.513794332732013	1	1	1.08166131058304e-51	RPS27	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56322
6.7087318996664e-56	0.385760530638178	0.518	0.27	1.32403532771816e-51	LDHA	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56323
1.68634667423848e-55	0.327448679297893	0.679	0.4	3.32817379627707e-51	UBE2D3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56324
1.96067835674757e-55	0.319437904672858	0.534	0.284	3.869594804877e-51	SHISA5	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000164054	51246	shisa family member 5	hShisa5|SCOTIN	protein_coding	Q8N114	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56325
2.75341851084169e-55	0.282052552934256	1	1	5.43414677299717e-51	RPS3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56326
5.81966534298886e-55	0.386391465348555	0.785	0.541	1.14856915209228e-50	GIMAP4	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56327
6.82751748646309e-55	0.380175258544118	0.642	0.396	1.34747885112835e-50	SLC25A3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56328
1.61579315816891e-54	0.315374845235983	0.632	0.358	3.18892937696217e-50	PTGES3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56329
3.47293104874065e-54	0.334589837443992	0.547	0.291	6.85417671779456e-50	GIMAP1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000213203	170575	GTPase, IMAP family member 1	HIMAP1|IAN2|IMAP1|IMAP38	protein_coding	Q8WWP7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56330
6.24511837291998e-54	0.295370190179044	0.485	0.249	1.23253656207949e-49	UBE2I	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56331
7.13389166915547e-54	0.300105347782658	0.533	0.284	1.40794485982452e-49	ARF6	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56332
8.20359573370789e-54	0.304735500954411	0.558	0.303	1.61906165400459e-49	EID1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56333
1.3990196009628e-53	0.2758943421452	0.303	0.114	2.76110508446017e-49	CITED2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56334
7.24939014009562e-53	0.308671700768621	0.547	0.299	1.43073963804927e-48	SRSF9	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56335
1.73290012389856e-52	0.275866238823166	0.413	0.191	3.4200516845262e-48	RAP1A	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000116473	5906	RAP1A, member of RAS oncogene family	KREV-1|SMGP21	protein_coding	P62834	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56336
2.58311296484069e-52	-0.293055723388164	1	1	5.09803174740958e-48	RPL28	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56337
3.22302452599305e-52	0.292597525937931	0.454	0.221	6.36096120449989e-48	ZFP36	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56338
7.80613489911787e-52	0.324778456565782	0.45	0.219	1.5406187836899e-47	DUSP2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56339
1.21434124457338e-51	0.342447576214691	0.932	0.908	2.39662388029002e-47	HSPA8	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56340
1.32972304950113e-51	0.285053297256192	0.592	0.332	2.62434141049544e-47	UBXN1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000162191	51035	UBX domain protein 1	2B28|LOC51035|SAKS1|UBXD10	protein_coding	Q04323	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56341
2.07838811583599e-51	0.385766532833853	0.659	0.399	4.10190678541391e-47	RAN	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56342
5.0526802422337e-51	0.327676760657038	0.732	0.483	9.97196972607244e-47	SKP1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56343
1.39921632490083e-50	0.314823514980182	0.677	0.421	2.76149333882428e-46	PRR13	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56344
1.80687786379643e-50	0.307307677944217	0.691	0.422	3.56605415198864e-46	RAP1B	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56345
1.89663382938316e-50	-0.399844801240071	0.92	0.967	3.74319652567061e-46	RPS11	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56346
2.00119989005214e-50	0.25255963969934	0.382	0.173	3.9495681030069e-46	PDCD6	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56347
4.50385328515048e-50	0.288588846799234	0.507	0.268	8.88880484357298e-46	PEBP1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56348
5.9875632753425e-50	0.282787069643289	0.542	0.297	1.1817054880216e-45	C11orf58	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000110696	10944	chromosome 11 open reading frame 58	SMAP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56349
9.7457199388151e-50	0.254168612134901	0.38	0.173	1.92341528712455e-45	SELENOT	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198843	51714	selenoprotein T	SELT	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56350
1.20046780686051e-49	0.328806514074903	0.559	0.32	2.36924326361991e-45	YWHAQ	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56351
2.19036995733184e-49	0.27727894050589	0.411	0.196	4.32291414779012e-45	RHOH	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56352
2.3855245487564e-49	0.323492471561937	0.678	0.421	4.70807124942564e-45	HNRNPDL	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56353
3.34740408506157e-49	0.34067264110964	0.641	0.394	6.60643670227752e-45	SRSF5	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56354
5.4214775043579e-49	0.274122891616248	0.422	0.208	1.06998280026008e-44	COX7A2L	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56355
3.34223568399756e-48	0.315019976383287	0.962	0.964	6.59623634593758e-44	EEF1B2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56356
3.83950460290148e-48	0.310897335818786	0.525	0.291	7.57764628428637e-44	SELPLG	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56357
1.83300003024095e-47	0.319283613988695	0.67	0.416	3.61760885968354e-43	CCND3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56358
3.78988825848496e-47	-0.317553584689789	1	1	7.47972346694592e-43	RPS15A	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56359
4.17577954114398e-47	0.282340758184329	0.987	0.979	8.24131850240177e-43	MYL12A	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56360
7.66860839365358e-47	0.270125254530391	0.48	0.251	1.51347655257147e-42	SH3BGRL	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56361
5.25077999011419e-46	0.31544980250397	0.586	0.347	1.03629393884894e-41	ATP5F1B	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56362
3.01354781645481e-45	0.557799465074274	0.286	0.118	5.94753797055522e-41	TRGV9	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000211695	NA	NA	TCRGV9|V2	TR_V_gene	Q99603	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56363
4.26102848622536e-45	0.282824172072988	0.579	0.339	8.40956582041436e-41	UBE2D2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56364
6.47662376060013e-45	0.355351857564929	0.518	0.296	1.27822646539204e-40	ANXA2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56365
9.37691299887801e-45	0.27631151889648	0.63	0.377	1.85062754945856e-40	BRK1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56366
1.03334015461586e-44	0.30740332885309	0.564	0.324	2.03940012914986e-40	YPEL3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56367
1.08422711767446e-44	0.282907868633439	0.619	0.369	2.13983063944231e-40	SOD1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56368
1.2527831819012e-44	0.284715450077481	0.428	0.223	2.47249288780021e-40	MCUB	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000005059	55013	mitochondrial calcium uniporter dominant negative subunit beta	CCDC109B|FLJ20647	protein_coding	Q9NWR8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56369
1.83118900530549e-44	-0.293451750267145	1	0.999	3.61403462087091e-40	RPL32	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56370
2.08917036214963e-44	0.265295283400545	0.369	0.175	4.12318662673851e-40	SMAP2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56371
3.43752926760706e-44	-0.357569453865369	0.992	0.987	6.7843077625493e-40	UBA52	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56372
3.64161989916162e-44	0.257220785372731	0.99	0.988	7.18710103298538e-40	EIF1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56373
9.51362976669319e-44	0.282826682126269	0.289	0.116	1.87760997075457e-39	DUSP1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56374
1.02974980010199e-43	0.284429064497121	0.729	0.46	2.03231420548128e-39	PTP4A2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56375
1.55055665292246e-43	0.302304426447047	0.536	0.314	3.06017861020777e-39	PGAM1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56376
1.79215167929479e-43	0.298823392009986	0.764	0.508	3.5369905542562e-39	LCK	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000182866	3932	LCK proto-oncogene, Src family tyrosine kinase	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56377
1.87188626456861e-43	0.313418948840253	0.811	0.639	3.69435473175261e-39	SUMO2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56378
5.28233936313478e-43	-0.460305964636047	0.379	0.508	1.04252249670828e-38	AAK1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56379
8.00910225997505e-43	0.289029251005121	0.72	0.476	1.58067642202868e-38	HNRNPK	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56380
8.15371588046799e-43	0.282247459749129	0.977	0.978	1.60921736616916e-38	EEF1D	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56381
1.08829200591071e-42	0.26728041620896	0.507	0.281	2.14785310286537e-38	EIF5A	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56382
1.128216525275e-42	0.258409522911905	0.477	0.261	2.22664813428274e-38	RTRAF	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000087302	51637	RNA transcription, translation and transport factor	C14orf166|CGI-99|CLE|CLE7|hCLE1|LCRP369|RLLM1	protein_coding	Q9Y224	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56383
1.79776683831632e-42	0.33591538619482	0.549	0.324	3.54807263210108e-38	CALM3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56384
3.11913580344202e-42	0.267337332419941	0.66	0.406	6.15592642167316e-38	NCL	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56385
4.12017323907604e-42	0.255569008792501	0.622	0.374	8.13157390464047e-38	ARF1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56386
4.57553971978178e-42	0.267393945212538	0.596	0.352	9.03028519096132e-38	PDIA3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56387
4.79570305586825e-42	0.299471802101561	0.621	0.397	9.46479955106159e-38	EIF3E	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56388
6.07666694158937e-42	0.257357650865827	0.407	0.211	1.19929098759208e-37	FKBP1A	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56389
9.72806065179036e-42	0.280358911138739	0.596	0.369	1.91993005023734e-37	EIF3L	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56390
1.18671658503595e-41	-0.459562347566114	0.603	0.696	2.34210385222695e-37	RNF213	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56391
1.24946209318561e-41	0.272516374929983	0.572	0.334	2.46593838711112e-37	LAT	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000213658	27040	linker for activation of T cells	LAT1	protein_coding	O43561	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56392
5.67457663957085e-41	0.290674445150234	0.473	0.262	1.1199344455857e-36	TAGAP	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56393
8.75431869144385e-41	0.296211021091605	0.671	0.447	1.72775233694336e-36	HCLS1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56394
1.07523840135888e-40	0.257844161494558	0.467	0.259	2.12209050892189e-36	ERH	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56395
1.41189491133192e-40	0.444820732901458	0.982	0.995	2.78651579700468e-36	ACTG1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56396
1.48518950397782e-40	0.259645333848948	0.558	0.329	2.93117000505063e-36	FKBP8	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56397
1.57327577375469e-40	0.283776031885109	0.487	0.278	3.10501706708225e-36	ATP5F1A	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56398
1.81946451519535e-40	-0.468709522908554	0.466	0.644	3.59089516718955e-36	GZMH	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56399
3.59526452831323e-40	0.294112129143846	0.38	0.194	7.09561407307898e-36	CD27	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56400
1.14044780825038e-39	0.266853523010292	0.492	0.279	2.25078779436295e-35	PRMT2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56401
1.1493662676977e-39	0.279562881430496	0.615	0.378	2.26838926592818e-35	CD247	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56402
1.19418284768783e-39	0.252316290615371	0.433	0.231	2.3568392681967e-35	LEPROTL1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56403
1.62643446107763e-39	0.29991292105737	0.666	0.464	3.20993105238281e-35	ALDOA	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56404
1.94641426794913e-39	0.319154055156547	0.816	0.737	3.8414431992244e-35	CCNI	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56405
4.4637638213689e-39	0.51836865365993	0.634	0.421	8.80968427785366e-35	HMGN2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56406
6.8385173637526e-39	0.267502599614604	0.385	0.198	1.34964978691021e-34	PIM1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56407
7.05726399024158e-39	0.275316103251644	0.63	0.408	1.39282162111408e-34	EIF3H	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56408
3.6099847845408e-38	0.262412958405872	0.677	0.44	7.12466597076973e-34	ARL6IP5	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56409
9.83360696257912e-38	0.319554039598051	0.841	0.779	1.94076067013462e-33	LSP1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56410
1.06461303358998e-37	-0.477488395493706	0.566	0.661	2.10112028309318e-33	TRBC2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56411
2.00449498907194e-37	0.25193768239187	0.471	0.266	3.95607131043238e-33	CYTIP	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56412
2.10885205634113e-37	0.273616626687326	0.514	0.303	4.16203041839485e-33	PKM	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56413
5.631521386411e-37	0.252815953176772	0.506	0.299	1.11143706082208e-32	PGK1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56414
9.30255886159117e-37	-0.382415012349795	0.932	0.962	1.83595301692363e-32	HCST	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56415
1.95230839344857e-36	0.285860977953241	0.71	0.481	3.85307584531009e-32	SLC9A3R1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56416
1.98357664491478e-36	0.254574443334224	0.625	0.396	3.91478686640381e-32	SF1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56417
2.21508634912696e-36	-0.627505638447477	0.936	0.952	4.37169441863697e-32	RPS26	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56418
5.18977616975938e-36	0.255585695406559	0.687	0.461	1.02425422486371e-31	EIF3G	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56419
5.46803981396555e-36	-0.312371882149569	0.954	0.971	1.07917233768424e-31	RPL31	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56420
1.10842510090618e-35	0.282983123643875	0.462	0.267	2.18758777914843e-31	ALOX5AP	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56421
1.90143290711835e-35	-0.278629529274488	1	0.997	3.75266798548878e-31	FAU	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56422
2.63302744542842e-35	0.379968342895514	0.544	0.328	5.19654296629753e-31	H2AFZ	CD8+ T cells	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56423
1.67974524529339e-34	0.250718788180222	0.502	0.293	3.31514521611103e-30	ZFP36L1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56424
2.75339294241204e-34	0.269358139769795	0.528	0.319	5.43409631114439e-30	SPOCK2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56425
2.85021493539383e-34	0.295976408637565	0.741	0.509	5.62518419649325e-30	LITAF	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56426
3.00186453471677e-34	0.250931879184994	0.935	0.944	5.92447984571702e-30	EEF2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56427
7.40044795157498e-34	0.254107263792064	0.32	0.161	1.46055240772284e-29	CLDND1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000080822	56650	claudin domain containing 1	C3orf4|Z38	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56428
1.80048096864895e-33	-0.364315594232424	0.905	0.963	3.55342923972557e-29	NKG7	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56429
1.18299504789122e-32	0.257877041236054	0.574	0.361	2.33475902651811e-28	SUN2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56430
2.45517603142206e-32	0.266330707744826	0.781	0.621	4.84553541561458e-28	EIF3F	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56431
3.97520952001023e-32	0.285642247033268	0.63	0.418	7.84547350869219e-28	CALR	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56432
4.08825773408727e-32	0.252316290615371	0.457	0.271	8.06858546399463e-28	PDCD4	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56433
5.89570225754145e-32	0.539593664448412	0.447	0.259	1.16357579754838e-27	TUBA1B	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56434
6.15428536016801e-32	0.266554754055077	0.601	0.383	1.21460975868276e-27	KLF6	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56435
1.10974279105738e-31	-0.379554873470387	0.65	0.705	2.19018837243085e-27	RPS10	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56436
1.88073260985463e-31	0.26320779239441	0.482	0.294	3.71181387880909e-27	HOPX	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56437
5.75426241058528e-31	0.284360753326576	0.848	0.796	1.13566122935311e-26	YBX1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56438
1.22740049806255e-29	0.386489285900237	0.564	0.352	2.42239762297625e-25	TUBB	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56439
3.2740987954068e-28	-0.313837627618924	0.955	0.977	6.46176138261486e-24	CYBA	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56440
3.5669606243804e-28	0.321250828863632	0.89	0.916	7.03975348827716e-24	TXNIP	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56441
5.8812263175154e-28	0.277806132975196	0.851	0.843	1.16071882602484e-23	FXYD5	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56442
5.95227925534445e-27	0.332823403207245	0.325	0.186	1.17474183383478e-22	SELL	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56443
1.16884996330169e-25	0.257348332647455	0.716	0.525	2.30684228757222e-21	PPP1CA	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56444
1.17292040996021e-25	0.309107235150945	0.598	0.417	2.31487572109748e-21	CCL4	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56445
2.99050149221583e-25	0.266221275114548	0.271	0.141	5.90205374503716e-21	HLA-DQA1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56446
3.74162985849584e-25	-0.325158937249233	0.83	0.871	7.38448068872739e-21	MIF	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56447
3.78702992593154e-25	-0.369046015864906	0.494	0.555	7.47408226181849e-21	NDUFA3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56448
1.22522992450169e-24	-0.339954850024895	0.642	0.69	2.41811377899653e-20	SON	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56449
3.73000148414168e-24	-0.322818707563915	0.834	0.859	7.36153092910203e-20	OST4	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56450
1.25485702392466e-23	-0.324586126158558	0.97	0.983	2.47658582241771e-19	IFITM1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56451
1.57364295279977e-23	0.267476097786377	0.859	0.835	3.10574173164562e-19	HNRNPA2B1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56452
4.15963749771386e-23	0.28180136700187	0.986	0.994	8.20946056548808e-19	CFL1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56453
2.064150632108e-22	0.263313897940716	0.459	0.301	4.07380768752834e-18	H2AFV	CD8+ T cells	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56454
6.81545375731853e-22	0.261466886345007	0.684	0.504	1.34509795354439e-17	PRF1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56455
6.58774474660898e-21	-0.270755539497981	0.827	0.877	1.30015730319075e-16	ITGB2	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56456
8.98637991955141e-21	0.262939365392174	0.789	0.638	1.77355194092267e-16	SUB1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56457
1.14765123572996e-20	0.25913426438173	0.513	0.345	2.26500447883665e-16	SLC25A5	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56458
2.90199851914203e-20	-0.26839747099201	0.742	0.785	5.72738427737872e-16	COX6B1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56459
3.85559163345903e-20	0.450051565847536	0.566	0.461	7.60939564779473e-16	COTL1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56460
1.55442538792715e-19	-0.26827630150021	0.767	0.824	3.06781394561302e-15	RPS20	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56461
1.67555091517211e-19	-0.27389431947164	0.738	0.761	3.30686728618367e-15	ELOB	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56462
1.18646990636526e-18	-0.31289812230977	0.687	0.719	2.34161700720248e-14	FLNA	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56463
1.5151881018314e-18	-0.278378902323433	0.75	0.775	2.99037523777445e-14	UQCR11	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56464
1.97424919644925e-17	-0.320459967373251	0.457	0.511	3.89637821411224e-13	ATP5ME	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56465
3.50711876785563e-16	-0.250575205976791	0.896	0.931	6.92164960023988e-12	EMP3	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56466
4.51204635682975e-15	0.295334712943964	0.967	0.983	8.9049746898392e-11	GAPDH	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56467
1.09999009897682e-11	-0.282343411847066	0.514	0.554	2.17094045934066e-07	MT2A	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56468
2.49714821826971e-11	0.364715673673716	0.574	0.546	4.92837172357709e-07	LTB	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56469
2.2318647700328e-10	-0.294019238494716	0.392	0.445	4.40480831013673e-06	TRBC1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56470
3.51041074474952e-10	-0.285878140376202	0.801	0.881	6.92814664583765e-06	CRIP1	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56471
6.25815628275877e-07	-0.260775485559118	0.383	0.401	0.0123510972396527	GNAS	CD8+ T cells	GSE169246_PacBlood_post	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56472
1.68359547086119e-06	-0.257035490187514	0.559	0.527	0.0332274402129165	C9orf16	CD8+ T cells	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56473
1.34516954012538e-44	1.34014177664819	0.986	0.789	2.65482660439145e-40	MT-ATP8	Plasma cells	GSE169246_PacBlood_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56474
4.10116791603651e-38	-1.84949913572119	0.647	0.87	8.09406499908965e-34	MT-ND4	Plasma cells	GSE169246_PacBlood_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56475
5.36650928304249e-34	0.817767942487987	0.948	0.682	1.05913427210127e-29	EEF1G	Plasma cells	GSE169246_PacBlood_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56476
5.74203439481506e-31	-0.963092964902507	0.945	0.991	1.1332479081607e-26	MT-ATP6	Plasma cells	GSE169246_PacBlood_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56477
4.74706334464266e-30	-1.05478430175664	0.953	0.973	9.36880421698676e-26	RPL41	Plasma cells	GSE169246_PacBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56478
3.01772152256285e-29	0.911015729617476	0.964	0.722	5.95577519693004e-25	TXNDC5	Plasma cells	GSE169246_PacBlood_post	ENSG00000239264	81567	thioredoxin domain containing 5	EndoPDI|ERp46|FLJ21353|FLJ90810|Hcc-2|MGC3178|PDIA15	protein_coding	Q8NBS9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56479
2.64106176497877e-28	-0.896719299158409	0.584	0.857	5.21239949936209e-24	RPL36A	Plasma cells	GSE169246_PacBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56480
4.58198481123512e-28	-0.793709686251359	0.088	0.475	9.04300522345364e-24	RNF213	Plasma cells	GSE169246_PacBlood_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56481
1.35178003579334e-27	0.764717511609327	0.997	0.883	2.66787307864174e-23	MT-ND4L	Plasma cells	GSE169246_PacBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56482
9.32717273952202e-27	-0.9884783843451	0.918	0.973	1.84081081187207e-22	RPS29	Plasma cells	GSE169246_PacBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56483
5.13825315274784e-26	-0.531529054402513	0.055	0.399	1.01408564222631e-21	MRPL23	Plasma cells	GSE169246_PacBlood_post	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56484
1.39614678539096e-24	0.783657009396211	0.992	0.96	2.75543529564759e-20	SEC11C	Plasma cells	GSE169246_PacBlood_post	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56485
6.49456543345727e-24	-0.957464155757024	0.879	0.946	1.28176743394713e-19	RPS26	Plasma cells	GSE169246_PacBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56486
2.61794640323021e-23	0.783341280335718	0.997	0.982	5.16677902141514e-19	JCHAIN	Plasma cells	GSE169246_PacBlood_post	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56487
3.48240069377595e-23	-0.795109604798323	0.981	0.978	6.87286600923622e-19	RPS21	Plasma cells	GSE169246_PacBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56488
1.60764135883489e-22	0.719460739442118	0.986	0.91	3.17284098579653e-18	ITM2C	Plasma cells	GSE169246_PacBlood_post	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56489
9.08433238937559e-21	0.502889323014103	0.995	0.987	1.79288384036717e-16	RPL3	Plasma cells	GSE169246_PacBlood_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56490
2.76854693405144e-20	-0.634061500122197	0.227	0.57	5.46400422904393e-16	SON	Plasma cells	GSE169246_PacBlood_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56491
6.6348048697726e-20	-0.710097811369938	0.995	0.982	1.30944508909832e-15	RPL39	Plasma cells	GSE169246_PacBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56492
3.01275498069488e-19	-0.619035303907309	0.945	0.946	5.94597322989942e-15	RPS11	Plasma cells	GSE169246_PacBlood_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56493
9.04691806654269e-19	-0.464692166577677	0.112	0.422	1.78549974961287e-14	TAF1D	Plasma cells	GSE169246_PacBlood_post	ENSG00000166012	79101	TATA-box binding protein associated factor, RNA polymerase I subunit D	JOSD3|MGC5306|TAF(I)41	protein_coding	Q9H5J8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56494
2.10633686339198e-18	-1.14324619225969	0.353	0.641	4.15706643359041e-14	ISG15	Plasma cells	GSE169246_PacBlood_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56495
1.2651895102981e-17	-0.774000472373419	0.751	0.839	2.49697801752434e-13	RPL38	Plasma cells	GSE169246_PacBlood_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56496
1.31318846998552e-16	-0.418524041219243	0.088	0.359	2.59170876436342e-12	TCF3	Plasma cells	GSE169246_PacBlood_post	ENSG00000071564	6929	transcription factor 3	bHLHb21|E2A|E47|ITF1|MGC129647|MGC129648|p75|VDIR	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56497
2.01214126473137e-16	0.741005645085421	0.69	0.413	3.97116200007382e-12	KLF2	Plasma cells	GSE169246_PacBlood_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56498
8.82184363202646e-16	-0.608109026334927	0.523	0.744	1.74107905921674e-11	RPS10	Plasma cells	GSE169246_PacBlood_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56499
9.47544982781702e-16	0.441782961858009	0.981	0.87	1.87007477801797e-11	MT-ND1	Plasma cells	GSE169246_PacBlood_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56500
9.51336927342466e-16	-0.872996809325935	0.57	0.762	1.87755855980309e-11	MT-ND2	Plasma cells	GSE169246_PacBlood_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56501
1.47905504140302e-15	0.582900834448096	0.962	0.906	2.91906302971299e-11	TNFRSF17	Plasma cells	GSE169246_PacBlood_post	ENSG00000048462	608	TNF receptor superfamily member 17	BCM|BCMA|CD269|TNFRSF13A	protein_coding	Q02223	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56502
1.71246511021794e-15	-0.601874591941935	0.553	0.771	3.37972114152612e-11	ATP5ME	Plasma cells	GSE169246_PacBlood_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56503
3.79299569002096e-15	-0.457782734231624	0.104	0.363	7.48585629382536e-11	MYCBP2	Plasma cells	GSE169246_PacBlood_post	ENSG00000005810	23077	MYC binding protein 2	FLJ10106|KIAA0916|PAM|PHR1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56504
5.62653734103539e-15	0.49906268187675	1	0.987	1.11045340962674e-10	MT-CO3	Plasma cells	GSE169246_PacBlood_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56505
6.93564902440091e-15	0.408307799785005	0.696	0.372	1.36881969145576e-10	CXXC5	Plasma cells	GSE169246_PacBlood_post	ENSG00000171604	51523	CXXC finger protein 5	HSPC195|RINF|WID	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56506
7.4305396621063e-15	-0.429985054925963	0.107	0.368	1.4664913077133e-10	ADAR	Plasma cells	GSE169246_PacBlood_post	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56507
8.48193687861471e-15	-0.45114790185874	0.995	0.987	1.6739950623634e-10	RPS28	Plasma cells	GSE169246_PacBlood_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56508
8.61982876152729e-15	-0.400806281727876	0.066	0.305	1.70120940437503e-10	XIST	Plasma cells	GSE169246_PacBlood_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56509
2.35100532932402e-14	-0.388053203154967	0.112	0.377	4.63994411795388e-10	ATP2A3	Plasma cells	GSE169246_PacBlood_post	ENSG00000074370	489	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3	SERCA3	protein_coding	Q93084	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56510
2.76857551359295e-14	0.441641924059432	0.992	0.964	5.46406063362705e-10	SUB1	Plasma cells	GSE169246_PacBlood_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56511
2.96079142890261e-14	-0.921760580858755	0.973	0.996	5.84341796408219e-10	MALAT1	Plasma cells	GSE169246_PacBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56512
5.27483133200496e-14	-0.633374001169357	0.197	0.457	1.0410407116845e-09	MX1	Plasma cells	GSE169246_PacBlood_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56513
1.22488468948414e-13	0.639822395085843	0.542	0.233	2.41743242316589e-09	CITED2	Plasma cells	GSE169246_PacBlood_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56514
1.26770983917139e-13	-0.483185390469953	0.104	0.345	2.50195213858865e-09	FLNA	Plasma cells	GSE169246_PacBlood_post	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56515
1.45486632216254e-13	-0.528872657358339	0.989	0.982	2.87132417341999e-09	RPS27	Plasma cells	GSE169246_PacBlood_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56516
2.39445751715968e-13	-0.708232053687939	0.427	0.641	4.72570135586635e-09	GNAS	Plasma cells	GSE169246_PacBlood_post	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56517
2.46735945555241e-13	0.62822584274134	0.811	0.543	4.86958062147823e-09	AQP3	Plasma cells	GSE169246_PacBlood_post	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56518
2.84773955214068e-13	-0.383421683282326	0.071	0.291	5.62029878010485e-09	MBNL1	Plasma cells	GSE169246_PacBlood_post	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56519
5.01919733381988e-13	-0.71662739147371	0.323	0.61	9.90588785802692e-09	IFITM1	Plasma cells	GSE169246_PacBlood_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56520
7.84720804910681e-13	-0.454978912117542	0.989	0.982	1.54872498057172e-08	RPL37	Plasma cells	GSE169246_PacBlood_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56521
1.09630383341896e-12	0.641646236284013	0.989	0.906	2.16366524563567e-08	XBP1	Plasma cells	GSE169246_PacBlood_post	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56522
1.98584712366938e-12	0.395567766536649	0.997	0.991	3.91926788327389e-08	EEF1A1	Plasma cells	GSE169246_PacBlood_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56523
2.10903898775497e-12	-0.423179061610733	0.186	0.439	4.1623993462332e-08	GOLGB1	Plasma cells	GSE169246_PacBlood_post	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56524
2.55378237272965e-12	-0.336322978673605	0.085	0.305	5.04014489081925e-08	OAS2	Plasma cells	GSE169246_PacBlood_post	ENSG00000111335	4939	2'-5'-oligoadenylate synthetase 2	NA	protein_coding	P29728	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56525
4.52751138771756e-12	0.376638460382092	1	1	8.93549647479938e-08	MT-CO2	Plasma cells	GSE169246_PacBlood_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56526
5.45912790613614e-12	-0.597011907871507	0.345	0.583	1.07741348355503e-07	HYOU1	Plasma cells	GSE169246_PacBlood_post	ENSG00000280682	10525	hypoxia up-regulated 1	Grp170|HSP12A|ORP150	protein_coding	Q9Y4L1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56527
5.5655409248991e-12	0.417193726155567	0.986	0.982	1.09841515693809e-07	TPT1	Plasma cells	GSE169246_PacBlood_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56528
6.1118604376256e-12	-0.407026465335023	0.315	0.57	1.20623677596979e-07	NDUFA11	Plasma cells	GSE169246_PacBlood_post	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56529
8.8510768441713e-12	-0.338232695864801	0.071	0.274	1.74684852596565e-07	NUP210	Plasma cells	GSE169246_PacBlood_post	ENSG00000132182	23225	nucleoporin 210	FLJ22389|GP210|KIAA0906|POM210	protein_coding	Q8TEM1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56530
2.5469359346043e-11	-0.399590067517082	0.184	0.422	5.02663276053506e-07	IFI16	Plasma cells	GSE169246_PacBlood_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56531
2.59992171598825e-11	-0.282152091361562	0.066	0.26	5.13120549867442e-07	IKZF3	Plasma cells	GSE169246_PacBlood_post	ENSG00000161405	22806	IKAROS family zinc finger 3	Aiolos|ZNFN1A3	protein_coding	Q9UKT9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56532
3.8988306738999e-11	-0.464157084828029	0.159	0.39	7.69473221800885e-07	HCST	Plasma cells	GSE169246_PacBlood_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56533
4.01971295437667e-11	0.329526707668764	0.896	0.641	7.93330548675779e-07	ZNF706	Plasma cells	GSE169246_PacBlood_post	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56534
4.29389789728128e-11	-0.443748683704234	0.438	0.655	8.47443689007434e-07	NDUFA3	Plasma cells	GSE169246_PacBlood_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56535
4.6409399752059e-11	0.331334317549327	0.685	0.399	9.15935913506637e-07	ISCU	Plasma cells	GSE169246_PacBlood_post	ENSG00000136003	23479	iron-sulfur cluster assembly enzyme	hnifU|ISU2|NIFUN	protein_coding	Q9H1K1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56536
5.8050131490217e-11	0.358214819448078	0.896	0.735	1.14567739509092e-06	DDOST	Plasma cells	GSE169246_PacBlood_post	ENSG00000244038	1650	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit	KIAA0115|OST|OST48|WBP1	protein_coding	P39656	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56537
6.11345121341902e-11	-0.2970509677409	0.063	0.251	1.20655073148038e-06	MAZ	Plasma cells	GSE169246_PacBlood_post	ENSG00000103495	4150	MYC associated zinc finger protein	Pur-1|ZF87|Zif87|ZNF801	protein_coding	P56270	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56538
7.05921552945921e-11	-0.260687031164629	0.063	0.251	1.39320677689407e-06	SMARCA5	Plasma cells	GSE169246_PacBlood_post	ENSG00000153147	8467	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5	hISWI|hSNF2H|ISWI	protein_coding	O60264	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56539
7.21883785765556e-11	-0.39758952008684	0.099	0.305	1.4247098395869e-06	PTPRC	Plasma cells	GSE169246_PacBlood_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56540
1.01392051498319e-10	-0.548436603518432	0.581	0.785	2.00107352837081e-06	CRIP1	Plasma cells	GSE169246_PacBlood_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56541
1.07442907002153e-10	-0.265053000797544	0.066	0.256	2.12049321259449e-06	N4BP2L2	Plasma cells	GSE169246_PacBlood_post	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56542
1.22869303843799e-10	-0.288397783005748	0.068	0.256	2.42494858066122e-06	PAK2	Plasma cells	GSE169246_PacBlood_post	ENSG00000180370	5062	p21 (RAC1) activated kinase 2	PAK65|PAKgamma	protein_coding	Q13177	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56543
1.34113703659459e-10	-0.323829630737828	0.112	0.323	2.64686805542308e-06	NT5C3A	Plasma cells	GSE169246_PacBlood_post	ENSG00000122643	51251	5'-nucleotidase, cytosolic IIIA	cN-III|hUMP1|NT5C3|p36|P5'N-1|PN-I|POMP|PSN1|UMPH|UMPH1	protein_coding	Q9H0P0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56544
1.35631017758539e-10	-0.277151410303195	0.066	0.251	2.67681376648253e-06	ATP5PO	Plasma cells	GSE169246_PacBlood_post	ENSG00000241837	539	ATP synthase peripheral stalk subunit OSCP	ATP5O|ATPO|OSCP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56545
1.99651294251526e-10	0.468631076020082	0.86	0.682	3.94031794334811e-06	CD27	Plasma cells	GSE169246_PacBlood_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56546
2.44089468088498e-10	0.311725094128135	0.622	0.35	4.8173497421946e-06	FDX1	Plasma cells	GSE169246_PacBlood_post	ENSG00000137714	2230	ferredoxin 1	ADX|FDX	protein_coding	P10109	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56547
2.46080056721237e-10	-0.41761341777576	0.277	0.498	4.85663599945034e-06	DDT	Plasma cells	GSE169246_PacBlood_post	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56548
2.66909136431538e-10	-0.452489787737179	0.389	0.614	5.26771871661283e-06	BST2	Plasma cells	GSE169246_PacBlood_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56549
2.75297822019769e-10	-0.353508975402534	0.175	0.404	5.43327781538216e-06	PNISR	Plasma cells	GSE169246_PacBlood_post	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56550
2.81214435601134e-10	0.333908697159675	0.973	0.915	5.55004810102398e-06	NACA	Plasma cells	GSE169246_PacBlood_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56551
3.61810391812365e-10	0.374497486292287	0.762	0.552	7.14068989280884e-06	GNG7	Plasma cells	GSE169246_PacBlood_post	ENSG00000176533	2788	G protein subunit gamma 7	FLJ00058	protein_coding	O60262	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56552
7.60075888288507e-10	-0.257374178264156	0.077	0.26	1.5000857731262e-05	NT5DC2	Plasma cells	GSE169246_PacBlood_post	ENSG00000168268	64943	5'-nucleotidase domain containing 2	FLJ12442	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56553
7.96790542281783e-10	-0.436900950846932	0.225	0.439	1.57254581424733e-05	ANKRD12	Plasma cells	GSE169246_PacBlood_post	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56554
9.53124840841818e-10	0.341343457278354	0.504	0.251	1.88108718588541e-05	JUN	Plasma cells	GSE169246_PacBlood_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56555
1.2236333427756e-09	0.29970458880756	0.986	0.933	2.41496276530192e-05	SPCS1	Plasma cells	GSE169246_PacBlood_post	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56556
1.26599765275948e-09	-0.389294154426168	0.989	0.987	2.49857296748612e-05	RPLP2	Plasma cells	GSE169246_PacBlood_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56557
2.38114181661042e-09	-0.350492347188545	0.263	0.484	4.69942148926232e-05	IFI27L2	Plasma cells	GSE169246_PacBlood_post	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56558
2.6151780375899e-09	-0.319661996522599	0.077	0.251	5.16131537498742e-05	LCP1	Plasma cells	GSE169246_PacBlood_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56559
2.67449175721404e-09	-0.438195568149689	0.981	0.987	5.27837693203763e-05	RPL36	Plasma cells	GSE169246_PacBlood_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56560
2.68167926634334e-09	-0.387654121633308	0.427	0.641	5.29256220005521e-05	TOMM7	Plasma cells	GSE169246_PacBlood_post	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56561
2.94921455909653e-09	-0.441349705844346	0.899	0.937	5.82056985383292e-05	RPL13A	Plasma cells	GSE169246_PacBlood_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56562
3.16477326103984e-09	-0.343795283470053	0.126	0.323	6.24599650798824e-05	SAMD9L	Plasma cells	GSE169246_PacBlood_post	ENSG00000177409	219285	sterile alpha motif domain containing 9 like	C7orf6|FLJ39885|KIAA2005	protein_coding	Q8IVG5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56563
3.69343098858829e-09	-0.336842522828286	0.11	0.3	7.28935539907786e-05	RIPOR2	Plasma cells	GSE169246_PacBlood_post	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56564
3.80143221691868e-09	-0.410585441814306	0.562	0.709	7.5025066233107e-05	NDUFA13	Plasma cells	GSE169246_PacBlood_post	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56565
4.10175487571339e-09	0.385158131630214	0.918	0.816	8.09522342270794e-05	FTH1	Plasma cells	GSE169246_PacBlood_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56566
4.41502966954706e-09	-0.307497059615866	0.115	0.305	8.71350255581808e-05	UBA1	Plasma cells	GSE169246_PacBlood_post	ENSG00000130985	7317	ubiquitin like modifier activating enzyme 1	A1S9T|CFAP124|GXP1|POC20|UBE1|UBE1X	protein_coding	P22314	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56567
4.93551203321359e-09	0.554200819623371	0.759	0.605	9.74072654875034e-05	PIM2	Plasma cells	GSE169246_PacBlood_post	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56568
5.25041368675664e-09	-0.352316913629804	0.992	0.978	0.000103622164521829	RPL34	Plasma cells	GSE169246_PacBlood_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56569
6.07459876782398e-09	-0.322224257752195	0.123	0.314	0.000119888281281774	LBR	Plasma cells	GSE169246_PacBlood_post	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56570
6.32530675068818e-09	-0.331004683030531	0.148	0.35	0.000124836254031582	DDX17	Plasma cells	GSE169246_PacBlood_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56571
6.88012453032755e-09	-0.29942650812061	0.079	0.251	0.000135786137730545	KMT2A	Plasma cells	GSE169246_PacBlood_post	ENSG00000118058	4297	lysine methyltransferase 2A	ALL-1|ALL1|CXXC7|HRX|HTRX|HTRX1|MLL|MLL1|MLL1A|TRX1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56572
1.15968886426376e-08	-0.295859304307663	1	0.987	0.000228876194251095	RPLP1	Plasma cells	GSE169246_PacBlood_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56573
1.48434454150874e-08	-1.56311721372895	0.614	0.686	0.000292950238712166	IGKC	Plasma cells	GSE169246_PacBlood_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56574
1.48859971965739e-08	0.270205682499465	0.655	0.395	0.000293790040671583	PCBP1	Plasma cells	GSE169246_PacBlood_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56575
1.5630863464483e-08	-0.281236789645339	0.17	0.372	0.000308490721335037	ZRANB2	Plasma cells	GSE169246_PacBlood_post	ENSG00000132485	9406	zinc finger RANBP2-type containing 2	ZIS|ZIS1|ZIS2|ZNF265	protein_coding	O95218	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56576
1.65624782700576e-08	-0.362359598130033	0.997	0.987	0.000326877071137858	RPL28	Plasma cells	GSE169246_PacBlood_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56577
1.72758872896557e-08	0.278578004442738	0.808	0.641	0.000340956911548645	ERGIC3	Plasma cells	GSE169246_PacBlood_post	ENSG00000125991	51614	ERGIC and golgi 3	C20orf47|CGI-54|Erv46|NY-BR-84|PRO0989|SDBCAG84	protein_coding	Q9Y282	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56578
2.30747953975027e-08	-0.279136513421601	0.107	0.283	0.000455404161965113	SYNRG	Plasma cells	GSE169246_PacBlood_post	ENSG00000274047	11276	synergin gamma	AP1GBP1|MGC104959|SYNG	protein_coding	Q9UMZ2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56579
2.358499531072e-08	-0.298205801993225	0.099	0.269	0.00046547346745237	TRIM28	Plasma cells	GSE169246_PacBlood_post	ENSG00000130726	10155	tripartite motif containing 28	KAP-1|KAP1|PPP1R157|RNF96|TF1B|TIF1-beta|TIF1B|TIF1beta	protein_coding	Q13263	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56580
2.43953057842629e-08	0.251784529481913	0.997	0.96	0.000481465754958212	UBE2J1	Plasma cells	GSE169246_PacBlood_post	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56581
2.44239942753433e-08	0.354636327741185	0.562	0.323	0.000482031951018176	SRSF2	Plasma cells	GSE169246_PacBlood_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56582
3.00937333210124e-08	-0.290119648904228	0.151	0.341	0.0005939299208235	DDX18	Plasma cells	GSE169246_PacBlood_post	ENSG00000088205	8886	DEAD-box helicase 18	Has1|MrDb	protein_coding	Q9NVP1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56583
3.11333556109637e-08	-0.399276116595685	0.904	0.919	0.00061444790633798	ATP5F1E	Plasma cells	GSE169246_PacBlood_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56584
3.29472825872121e-08	-0.276832151200658	0.11	0.287	0.000650247569141218	SLC38A1	Plasma cells	GSE169246_PacBlood_post	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56585
4.03818188437845e-08	0.408886490427021	0.46	0.238	0.000796975576700931	ZFP36	Plasma cells	GSE169246_PacBlood_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56586
4.36489030583702e-08	0.349519864132407	0.918	0.825	0.000861454750759995	TENT5C	Plasma cells	GSE169246_PacBlood_post	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56587
4.5153489759831e-08	0.361903588588239	0.773	0.601	0.000891149273900025	SLC25A3	Plasma cells	GSE169246_PacBlood_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56588
5.98825673220339e-08	0.377683920754583	0.69	0.498	0.00118184234866766	RBM3	Plasma cells	GSE169246_PacBlood_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56589
6.0053066888982e-08	0.291573983547465	0.496	0.265	0.00118520732812095	SARAF	Plasma cells	GSE169246_PacBlood_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56590
6.46191681588494e-08	-0.397158570658928	0.888	0.91	0.00127532390278305	RPL27A	Plasma cells	GSE169246_PacBlood_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56591
6.57162890686654e-08	-0.374303227004322	0.995	0.987	0.00129697668105918	RPS15	Plasma cells	GSE169246_PacBlood_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56592
6.98540637681715e-08	-0.343686104187354	0.326	0.516	0.00137863980252863	PET100	Plasma cells	GSE169246_PacBlood_post	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56593
8.0603094696879e-08	-0.357356582343393	0.992	0.987	0.0015907826769376	RPL32	Plasma cells	GSE169246_PacBlood_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56594
9.08243919676692e-08	-0.359264685439473	0.148	0.323	0.00179251019987392	MYH9	Plasma cells	GSE169246_PacBlood_post	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56595
9.99945619117098e-08	-0.336417452106186	0.986	0.978	0.0019734926738895	RPL37A	Plasma cells	GSE169246_PacBlood_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56596
1.03477518706634e-07	-0.458813355271214	0.422	0.57	0.00204223230919414	RPS20	Plasma cells	GSE169246_PacBlood_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56597
1.12047523156174e-07	0.440892231530217	0.833	0.74	0.00221136991701025	LSP1	Plasma cells	GSE169246_PacBlood_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56598
1.24022068880392e-07	0.450302037967506	0.888	0.767	0.00244769955142341	PEBP1	Plasma cells	GSE169246_PacBlood_post	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56599
1.35398133818572e-07	0.323829085537638	0.756	0.592	0.00267221756904335	CD59	Plasma cells	GSE169246_PacBlood_post	ENSG00000085063	966	CD59 molecule (CD59 blood group)	16.3A5|EJ16|EJ30|EL32|G344|MIC11|MIN1|MIN2|MIN3|MSK21|p18-20	protein_coding	P13987	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56600
1.61689388071529e-07	-0.476183648144496	0.973	0.991	0.0031911017629797	MT-ND3	Plasma cells	GSE169246_PacBlood_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56601
1.6781553649312e-07	-0.311863195800101	0.205	0.395	0.00331200742822822	EIF4G1	Plasma cells	GSE169246_PacBlood_post	ENSG00000114867	1981	eukaryotic translation initiation factor 4 gamma 1	EIF4F|EIF4G|p220|PARK18	protein_coding	Q04637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56602
1.6941727426832e-07	0.304744101203944	0.575	0.363	0.00334361932495956	CCDC32	Plasma cells	GSE169246_PacBlood_post	ENSG00000128891	90416	coiled-coil domain containing 32	C15orf57|MGC20481	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56603
1.82955789584966e-07	0.287237656144294	0.734	0.489	0.00361081546324889	SRSF9	Plasma cells	GSE169246_PacBlood_post	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56604
1.87363417749746e-07	0.260394729756999	0.992	0.973	0.00369780441270899	RPL15	Plasma cells	GSE169246_PacBlood_post	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56605
2.01015310946602e-07	-0.323829630737828	0.263	0.453	0.00396723817684213	EIF4G2	Plasma cells	GSE169246_PacBlood_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56606
2.33038809730634e-07	-0.402033538012812	0.323	0.489	0.0045992539488438	NDUFB1	Plasma cells	GSE169246_PacBlood_post	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56607
2.39464064113506e-07	-0.263714411401207	0.118	0.283	0.00472606276934415	TPR	Plasma cells	GSE169246_PacBlood_post	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56608
2.55129888598691e-07	0.25945556121612	0.4	0.197	0.00503524348138377	ARL5A	Plasma cells	GSE169246_PacBlood_post	ENSG00000162980	26225	ADP ribosylation factor like GTPase 5A	ARL5	protein_coding	Q9Y689	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56609
2.76329247409951e-07	0.309317503477134	0.995	0.96	0.0054536340268828	RPL5	Plasma cells	GSE169246_PacBlood_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56610
2.80262933918597e-07	-0.307341507949259	0.945	0.951	0.00553126926381744	UBA52	Plasma cells	GSE169246_PacBlood_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56611
2.84236775957542e-07	-0.259835957462664	0.107	0.265	0.00560969701029806	TYMP	Plasma cells	GSE169246_PacBlood_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56612
2.84909749165457e-07	0.280790693797298	0.852	0.628	0.00562297880952946	HERPUD1	Plasma cells	GSE169246_PacBlood_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56613
3.04356322876212e-07	0.267701996703244	0.997	0.987	0.00600677638828492	RPL7A	Plasma cells	GSE169246_PacBlood_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56614
3.08966773903948e-07	0.271445244419466	0.477	0.274	0.00609776824976832	CHST12	Plasma cells	GSE169246_PacBlood_post	ENSG00000136213	55501	carbohydrate sulfotransferase 12	C4S-2|C4ST2	protein_coding	Q9NRB3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56615
3.33484768608944e-07	-0.478966044311828	0.288	0.484	0.00658165539326611	NEAT1	Plasma cells	GSE169246_PacBlood_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56616
3.35082213589671e-07	0.310520896945492	0.899	0.843	0.00661318256740575	OSTC	Plasma cells	GSE169246_PacBlood_post	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56617
3.56097207849294e-07	0.296452046776158	0.995	0.987	0.00702793449411367	RPS3A	Plasma cells	GSE169246_PacBlood_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56618
3.62634069410318e-07	-0.347188895000659	0.682	0.771	0.00715694599388204	ROMO1	Plasma cells	GSE169246_PacBlood_post	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56619
4.00680072590642e-07	-0.402730458484743	0.123	0.287	0.00790782191264892	MKI67	Plasma cells	GSE169246_PacBlood_post	ENSG00000148773	4288	marker of proliferation Ki-67	Ki-67|MIB-1|PPP1R105	protein_coding	P46013	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56620
4.18144985790505e-07	0.356785963028288	0.279	0.108	0.00825250943956141	RHOB	Plasma cells	GSE169246_PacBlood_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56621
4.26529122518125e-07	0.254278936358579	0.975	0.946	0.00841797876201772	EEF1B2	Plasma cells	GSE169246_PacBlood_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56622
4.49893861447185e-07	-0.29285284071237	1	0.987	0.00887910524952163	FAU	Plasma cells	GSE169246_PacBlood_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56623
5.35898677420357e-07	-0.273735721097312	0.11	0.269	0.0105764962975682	TMPO	Plasma cells	GSE169246_PacBlood_post	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56624
5.81360138869574e-07	-0.300344913048745	0.162	0.327	0.0114737237007299	HIPK2	Plasma cells	GSE169246_PacBlood_post	ENSG00000064393	28996	homeodomain interacting protein kinase 2	NA	protein_coding	Q9H2X6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56625
6.08124945514645e-07	0.291777502197597	0.879	0.744	0.012001953924677	KDELR2	Plasma cells	GSE169246_PacBlood_post	ENSG00000136240	11014	KDEL endoplasmic reticulum protein retention receptor 2	ELP-1|ERD2.2	protein_coding	P33947	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56626
6.11788908813714e-07	0.363000204589848	0.879	0.834	0.0120742659043475	CD38	Plasma cells	GSE169246_PacBlood_post	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56627
6.98135187644058e-07	-0.334649648352874	0.444	0.605	0.0137783960633431	TAPBP	Plasma cells	GSE169246_PacBlood_post	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56628
7.01659986766377e-07	0.420274748805205	0.26	0.094	0.0138479614988212	KLHL14	Plasma cells	GSE169246_PacBlood_post	ENSG00000197705	57565	kelch like family member 14	KIAA1384	protein_coding	Q9P2G3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56629
8.89121002035916e-07	0.263152037619981	0.526	0.318	0.0175476920961808	CHMP4B	Plasma cells	GSE169246_PacBlood_post	ENSG00000101421	128866	charged multivesicular body protein 4B	C20orf178|dJ553F4.4|Shax1|SNF7-2|VPS32B	protein_coding	Q9H444	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56630
1.0323922990939e-06	-0.276541242403687	0.162	0.327	0.0203752944149172	KTN1	Plasma cells	GSE169246_PacBlood_post	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56631
1.05325998151225e-06	-0.576844253535541	0.677	0.771	0.0207871389951257	S100A6	Plasma cells	GSE169246_PacBlood_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56632
1.10320456494013e-06	0.259902426377068	0.507	0.309	0.0217728452936584	RTRAF	Plasma cells	GSE169246_PacBlood_post	ENSG00000087302	51637	RNA transcription, translation and transport factor	C14orf166|CGI-99|CLE|CLE7|hCLE1|LCRP369|RLLM1	protein_coding	Q9Y224	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56633
1.15875658566811e-06	0.254213456043538	0.805	0.587	0.0228692199747458	PRDX5	Plasma cells	GSE169246_PacBlood_post	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56634
1.16125724342574e-06	0.348040935206494	0.395	0.202	0.0229185729562505	H1FX	Plasma cells	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56635
1.21373085652064e-06	0.317529047522748	0.474	0.283	0.0239541921842914	RNASE6	Plasma cells	GSE169246_PacBlood_post	ENSG00000169413	6039	ribonuclease A family member k6	RAD1|RNaseK6|RNS6	protein_coding	Q93091	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56636
1.42755771748922e-06	-0.256519695778402	0.233	0.417	0.0281742791123673	PPM1G	Plasma cells	GSE169246_PacBlood_post	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56637
1.64947877800153e-06	0.378970548005549	0.69	0.498	0.0325541131626382	MT-ND6	Plasma cells	GSE169246_PacBlood_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56638
2.01560993153413e-06	0.35755175158758	0.663	0.489	0.0397800776087576	EIF5A	Plasma cells	GSE169246_PacBlood_post	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56639
2.10512878685559e-06	0.267710075490634	0.611	0.408	0.0415468217373819	TXNL4A	Plasma cells	GSE169246_PacBlood_post	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56640
2.30230500850205e-06	0.296100006794692	0.737	0.601	0.0454382916477964	DNAJB11	Plasma cells	GSE169246_PacBlood_post	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56641
2.50849454607253e-06	0.282431818786948	0.548	0.363	0.0495076483612875	TNFRSF13B	Plasma cells	GSE169246_PacBlood_post	ENSG00000240505	23495	TNF receptor superfamily member 13B	CD267|IGAD2|TACI	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56642
0	-0.456115357748134	1	1	0	RPS27	NK cells	GSE169246_PacBlood_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56643
0	0.649920556705251	0.806	0.59	0	FGFBP2	NK cells	GSE169246_PacBlood_post	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56644
0	0.470242790632019	1	0.997	0	RPS3A	NK cells	GSE169246_PacBlood_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56645
0	-0.433143205800806	1	0.999	0	RPL37	NK cells	GSE169246_PacBlood_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56646
0	0.581332930610657	1	1	0	HLA-C	NK cells	GSE169246_PacBlood_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56647
0	0.322809347920941	1	1	0	HLA-B	NK cells	GSE169246_PacBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56648
0	0.558416345939523	1	1	0	EEF1A1	NK cells	GSE169246_PacBlood_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56649
0	0.517853829942545	1	1	0	ACTB	NK cells	GSE169246_PacBlood_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56650
0	0.312895202692806	1	1	0	TMSB4X	NK cells	GSE169246_PacBlood_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56651
0	-0.628286490108476	0.615	0.847	0	RPL36A	NK cells	GSE169246_PacBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56652
0	-0.443335504326542	0.999	0.998	0	RPL39	NK cells	GSE169246_PacBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56653
0	0.838038796256403	0.323	0.082	0	MYOM2	NK cells	GSE169246_PacBlood_post	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56654
0	0.412825696297682	0.984	0.966	0	FTH1	NK cells	GSE169246_PacBlood_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56655
0	-0.928628234243935	1	1	0	MALAT1	NK cells	GSE169246_PacBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56656
0	-0.774954915159615	0.984	0.993	0	RPL41	NK cells	GSE169246_PacBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56657
0	-0.753269825131193	0.991	0.994	0	RPS29	NK cells	GSE169246_PacBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56658
0	0.359861777407214	1	1	0	B2M	NK cells	GSE169246_PacBlood_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56659
0	-0.578816013336442	0.996	0.998	0	RPS21	NK cells	GSE169246_PacBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56660
0	-0.41554283346989	0.996	0.996	0	RPL36	NK cells	GSE169246_PacBlood_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56661
0	-0.415810614806743	0.999	1	0	RPS28	NK cells	GSE169246_PacBlood_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56662
0	0.81836411689159	0.957	0.785	0	KLF2	NK cells	GSE169246_PacBlood_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56663
0	0.41950771665815	0.999	0.999	0	RPL3	NK cells	GSE169246_PacBlood_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56664
0	0.829787445071506	0.997	0.986	0	MT-ATP8	NK cells	GSE169246_PacBlood_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56665
0	-0.619859953797196	0.986	0.998	0	MT-ATP6	NK cells	GSE169246_PacBlood_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56666
0	0.626444731660207	1	0.991	0	MT-ND4L	NK cells	GSE169246_PacBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56667
0	-0.58833791636707	0.95	0.987	0	MT-ND4	NK cells	GSE169246_PacBlood_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56668
1.24456932576123e-302	0.456782787423069	0.875	0.799	2.45628202132236e-298	EEF1G	NK cells	GSE169246_PacBlood_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56669
1.7975177621921e-288	-0.431016402084077	0.939	0.976	3.54758105546233e-284	RPL38	NK cells	GSE169246_PacBlood_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56670
1.09899336208593e-280	-0.623973579652037	0.537	0.691	2.16897329941279e-276	LINC00861	NK cells	GSE169246_PacBlood_post	ENSG00000245164	100130231	long intergenic non-protein coding RNA 861	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56671
4.85146237768017e-273	-0.354436052094148	0.996	0.994	9.57484614858958e-269	RPL37A	NK cells	GSE169246_PacBlood_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56672
2.13858699151876e-270	0.345049358306558	0.983	0.964	4.22071528646142e-266	ARHGDIB	NK cells	GSE169246_PacBlood_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56673
1.45274793365507e-266	-0.582532927698538	0.61	0.803	2.86714332186164e-262	TYROBP	NK cells	GSE169246_PacBlood_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56674
1.46788012178709e-266	0.425258413575174	0.889	0.697	2.897008208359e-262	EFHD2	NK cells	GSE169246_PacBlood_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56675
2.62677813613052e-264	0.435158310212861	0.819	0.607	5.18420932946719e-260	RAP1B	NK cells	GSE169246_PacBlood_post	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56676
1.07054568482428e-251	0.258612441028355	1	1	2.11282896356921e-247	MT-CO2	NK cells	GSE169246_PacBlood_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56677
1.03908134432193e-248	-0.505672595821371	0.586	0.779	2.05073094115377e-244	HLA-DRB1	NK cells	GSE169246_PacBlood_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56678
8.5699388754934e-244	0.287042232573893	0.999	0.999	1.69136313646738e-239	MT-CO3	NK cells	GSE169246_PacBlood_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56679
2.7442143857618e-243	-0.492181485239829	0.995	0.998	5.41598151173949e-239	IFITM1	NK cells	GSE169246_PacBlood_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56680
3.83156527406011e-240	0.315944226686292	1	0.998	7.56197722488503e-236	MT-CYB	NK cells	GSE169246_PacBlood_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56681
1.38939407189322e-231	0.425993959723631	0.91	0.861	2.74210814028846e-227	BTG1	NK cells	GSE169246_PacBlood_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56682
1.68521424642554e-227	-0.543637337406674	0.854	0.913	3.32593883674545e-223	GNLY	NK cells	GSE169246_PacBlood_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56683
7.76099437642392e-221	0.354487285497887	0.922	0.868	1.53170985013102e-216	HNRNPA1	NK cells	GSE169246_PacBlood_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56684
1.71174788168051e-219	0.296212565416181	0.992	0.985	3.37830561928466e-215	PPIA	NK cells	GSE169246_PacBlood_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56685
1.18250572070437e-216	-0.552969776289144	0.453	0.621	2.33379329038215e-212	MT2A	NK cells	GSE169246_PacBlood_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56686
8.83268787135125e-214	-0.485358857666216	0.646	0.771	1.74321927828988e-209	RNF213	NK cells	GSE169246_PacBlood_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56687
1.53506958695752e-201	0.458843046861791	0.867	0.744	3.02961333681936e-197	IL32	NK cells	GSE169246_PacBlood_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56688
8.6149400449972e-201	0.351680060239222	0.754	0.552	1.70024456728065e-196	DAZAP2	NK cells	GSE169246_PacBlood_post	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56689
4.84910675999712e-200	0.273266319784697	0.967	0.947	9.57019710153032e-196	H3F3B	NK cells	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56690
9.20887757456063e-198	0.329722343418173	0.892	0.805	1.81746407811529e-193	RHOA	NK cells	GSE169246_PacBlood_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56691
6.03847706772933e-197	0.337300834996791	0.915	0.849	1.19175383408706e-192	LSP1	NK cells	GSE169246_PacBlood_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56692
1.77241681975775e-194	0.266193608860688	1	1	3.4980418354739e-190	HLA-A	NK cells	GSE169246_PacBlood_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56693
1.27819429213228e-193	0.345422855910805	0.793	0.654	2.52264425495227e-189	SARAF	NK cells	GSE169246_PacBlood_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56694
7.12855174172417e-191	0.365854217377282	0.586	0.367	1.40689097174668e-186	TSC22D3	NK cells	GSE169246_PacBlood_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56695
2.99072153340399e-190	-0.276867428053671	1	0.999	5.90248801832611e-186	RPL34	NK cells	GSE169246_PacBlood_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56696
1.89505424441685e-185	0.319056169431588	0.991	0.979	3.74007905678109e-181	MT-ND5	NK cells	GSE169246_PacBlood_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56697
1.68177189245353e-183	0.431127283471816	0.763	0.561	3.31914500694628e-179	CCL4	NK cells	GSE169246_PacBlood_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56698
2.92848900477267e-181	0.364181980467343	0.864	0.77	5.77966589981934e-177	ZFP36L2	NK cells	GSE169246_PacBlood_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56699
9.3480707276127e-181	-0.272432289205686	1	1	1.84493523880164e-176	RPL28	NK cells	GSE169246_PacBlood_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56700
2.61068595208108e-179	-0.293637317840526	1	0.999	5.15244979502721e-175	RPS19	NK cells	GSE169246_PacBlood_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56701
1.43875369120023e-176	-0.767149340135867	0.212	0.366	2.83952428495277e-172	KLRC1	NK cells	GSE169246_PacBlood_post	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56702
6.91916364978027e-175	0.329529780315725	0.886	0.727	1.36556613792063e-170	LITAF	NK cells	GSE169246_PacBlood_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56703
1.35792763996454e-173	-0.403303390031608	0.344	0.544	2.68000599023402e-169	HLA-DRA	NK cells	GSE169246_PacBlood_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56704
1.333369738526e-170	-0.382257347036574	0.614	0.731	2.63153851595491e-166	SON	NK cells	GSE169246_PacBlood_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56705
3.35466011626101e-169	0.293697114952763	0.953	0.919	6.62075720545274e-165	ARPC2	NK cells	GSE169246_PacBlood_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56706
1.62178970087816e-163	-0.300890800111433	0.994	0.999	3.20076415365314e-159	MT-ND3	NK cells	GSE169246_PacBlood_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56707
1.62192977088332e-163	-0.302047072319307	0.974	0.99	3.20104059581532e-159	ATP5F1E	NK cells	GSE169246_PacBlood_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56708
3.94928413464678e-156	0.351266785519849	0.936	0.843	7.79430716813889e-152	PRF1	NK cells	GSE169246_PacBlood_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56709
1.28492533556161e-147	-0.429254867161119	0.271	0.426	2.53592864226439e-143	XCL2	NK cells	GSE169246_PacBlood_post	ENSG00000143185	6846	X-C motif chemokine ligand 2	SCM-1b|SCYC2	protein_coding	Q9UBD3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56710
9.14733930049807e-144	-0.281382826425112	1	1	1.8053188843463e-139	RPLP1	NK cells	GSE169246_PacBlood_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56711
1.54443605140188e-139	-0.270472189641924	0.147	0.289	3.04809899104675e-135	BLOC1S1	NK cells	GSE169246_PacBlood_post	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56712
3.61299677550471e-139	0.303951389878061	0.621	0.434	7.1306104361361e-135	PRMT2	NK cells	GSE169246_PacBlood_post	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56713
6.30449908675642e-133	0.307162742414928	0.724	0.568	1.24425593976225e-128	GIMAP4	NK cells	GSE169246_PacBlood_post	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56714
5.66143384873655e-132	-0.371308337018659	0.831	0.918	1.11734058438665e-127	CRIP1	NK cells	GSE169246_PacBlood_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56715
1.1052510837405e-131	0.274568218724758	0.381	0.211	2.18132353887025e-127	SPOCK2	NK cells	GSE169246_PacBlood_post	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56716
1.30827273806129e-131	0.293820415835401	0.588	0.407	2.58200707583775e-127	SELPLG	NK cells	GSE169246_PacBlood_post	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56717
3.75409036314261e-127	0.28058648131872	0.877	0.754	7.40907274069826e-123	CD99	NK cells	GSE169246_PacBlood_post	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56718
5.62761796514179e-124	-0.315673280450281	0.453	0.582	1.11066668160038e-119	NDUFA3	NK cells	GSE169246_PacBlood_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56719
1.96281698859108e-122	0.308981544956946	0.433	0.259	3.87381560868336e-118	CD3G	NK cells	GSE169246_PacBlood_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56720
2.50989719302551e-122	0.27127827099726	0.794	0.624	4.95353310015515e-118	SLC9A3R1	NK cells	GSE169246_PacBlood_post	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56721
2.5698216541819e-122	0.271440300907983	0.808	0.692	5.0718000166934e-118	PCBP1	NK cells	GSE169246_PacBlood_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56722
7.57217617399821e-121	0.272655948770778	0.732	0.589	1.49444468970029e-116	CNBP	NK cells	GSE169246_PacBlood_post	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56723
5.70802050905599e-118	0.371609863792568	0.578	0.403	1.12653492766729e-113	SPON2	NK cells	GSE169246_PacBlood_post	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56724
4.65942290216369e-117	0.280103122002609	0.753	0.59	9.19583703971027e-113	CCND3	NK cells	GSE169246_PacBlood_post	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56725
7.07695317909708e-117	-0.317533003835867	0.972	0.985	1.3967074794266e-112	IFITM2	NK cells	GSE169246_PacBlood_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56726
1.51767167705871e-116	-0.360814181655942	0.175	0.305	2.99527682184307e-112	XIST	NK cells	GSE169246_PacBlood_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56727
1.46142729661991e-115	0.251378042935844	0.607	0.429	2.88427291260906e-111	HNRNPF	NK cells	GSE169246_PacBlood_post	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56728
3.53524631301873e-115	0.284278067639972	0.558	0.391	6.97716212337376e-111	ZFP36L1	NK cells	GSE169246_PacBlood_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56729
8.08858889347039e-115	0.298876687174871	0.987	0.984	1.59636390401532e-110	ACTG1	NK cells	GSE169246_PacBlood_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56730
2.46453615827289e-110	-0.373393530790064	0.531	0.651	4.86400856196738e-106	CMC1	NK cells	GSE169246_PacBlood_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56731
2.95109319130581e-109	0.378723906206138	0.304	0.173	5.82427752236114e-105	CEBPD	NK cells	GSE169246_PacBlood_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56732
8.39292539481762e-109	-0.286142254188087	0.769	0.854	1.6564277559212e-104	MIF	NK cells	GSE169246_PacBlood_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56733
2.93020572971571e-108	0.253939100481865	0.721	0.557	5.78305402816692e-104	PTP4A2	NK cells	GSE169246_PacBlood_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56734
1.27451565683141e-107	0.261781740391748	0.81	0.743	2.51538410032247e-103	NPM1	NK cells	GSE169246_PacBlood_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56735
7.57060691590352e-106	-0.287822224876091	0.189	0.315	1.49413498092272e-101	LYST	NK cells	GSE169246_PacBlood_post	ENSG00000143669	1130	lysosomal trafficking regulator	CHS|CHS1|Mauve	protein_coding	Q99698	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56736
3.97829807597327e-103	-0.301514105008801	0.38	0.5	7.85156908274084e-99	AAK1	NK cells	GSE169246_PacBlood_post	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56737
3.39010122013539e-102	0.265630207433531	0.597	0.443	6.6907037680592e-98	YPEL3	NK cells	GSE169246_PacBlood_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56738
9.24739148735288e-102	-0.286827944364124	0.441	0.557	1.82506518394396e-97	ATP5ME	NK cells	GSE169246_PacBlood_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56739
2.26069064379794e-101	0.319241117732143	0.495	0.332	4.46169905459961e-97	CD3D	NK cells	GSE169246_PacBlood_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56740
1.24295299612716e-100	0.268290047047172	0.628	0.474	2.45309203315656e-96	RBM3	NK cells	GSE169246_PacBlood_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56741
4.26458026554853e-100	0.284732029306963	0.708	0.558	8.41657561208659e-96	CALR	NK cells	GSE169246_PacBlood_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56742
1.48768721705905e-98	0.256155857421264	0.847	0.782	2.93609949158775e-94	PNRC1	NK cells	GSE169246_PacBlood_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56743
5.38311943874826e-97	-0.506828067815733	0.319	0.43	1.06241245243136e-92	ISG15	NK cells	GSE169246_PacBlood_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56744
1.26217797029169e-96	-0.270202739129489	0.552	0.665	2.49103444216768e-92	RPS10	NK cells	GSE169246_PacBlood_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56745
1.00483509526557e-95	0.327090943153676	0.672	0.539	1.98314254401612e-91	MT-ND6	NK cells	GSE169246_PacBlood_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56746
1.30301196185779e-89	-0.296374994714956	0.229	0.357	2.57162440792253e-85	SELL	NK cells	GSE169246_PacBlood_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56747
2.53029435501749e-89	-0.263498562371848	0.957	0.974	4.99378893906252e-85	HCST	NK cells	GSE169246_PacBlood_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56748
5.62829040127453e-88	0.321146171705401	0.606	0.458	1.11079939359554e-83	KLRB1	NK cells	GSE169246_PacBlood_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56749
7.53136645773504e-82	-0.396286095941457	0.662	0.77	1.48639048409859e-77	LGALS1	NK cells	GSE169246_PacBlood_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56750
7.96097041893226e-80	0.274439158477253	0.477	0.346	1.57117712188047e-75	PRSS23	NK cells	GSE169246_PacBlood_post	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56751
8.10560898975023e-71	-0.274140544295864	0.386	0.481	1.59972299021711e-66	SLFN5	NK cells	GSE169246_PacBlood_post	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56752
4.84937452739781e-70	-0.310344470893074	0.497	0.578	9.57072556727232e-66	SYNE2	NK cells	GSE169246_PacBlood_post	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56753
3.426527230138e-68	-0.25464962271365	0.297	0.394	6.76259414140035e-64	LUC7L3	NK cells	GSE169246_PacBlood_post	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56754
3.2037305490401e-67	0.316162494288056	0.857	0.815	6.32288261158553e-63	GZMB	NK cells	GSE169246_PacBlood_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56755
1.06482473932485e-64	-0.282593352256298	0.469	0.55	2.10153810553153e-60	DDX17	NK cells	GSE169246_PacBlood_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56756
1.41479451612633e-63	0.251288526430795	0.732	0.636	2.79223845702693e-59	ANXA1	NK cells	GSE169246_PacBlood_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56757
5.207426691812e-57	-0.293385828410842	0.422	0.519	1.02773773189602e-52	NEAT1	NK cells	GSE169246_PacBlood_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56758
6.98498219573855e-53	0.368712137064066	0.35	0.257	1.37855608615096e-48	CD8A	NK cells	GSE169246_PacBlood_post	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56759
2.33118534267392e-44	-0.352564847318721	0.241	0.311	4.60082739230125e-40	IFI6	NK cells	GSE169246_PacBlood_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56760
1.84800732338722e-39	-0.293253904958118	0.325	0.392	3.64722725343702e-35	IFITM3	NK cells	GSE169246_PacBlood_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56761
2.38926946512753e-38	0.255888417929639	0.689	0.713	4.71546221637569e-34	CD3E	NK cells	GSE169246_PacBlood_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56762
5.88455938767681e-36	0.276400698509319	0.545	0.462	1.16137664075189e-31	CLIC3	NK cells	GSE169246_PacBlood_post	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56763
5.43649307170355e-29	-0.359321031408889	0.909	0.936	1.07294627263141e-24	RPS26	NK cells	GSE169246_PacBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56764
3.35407223833822e-11	-0.47522525473017	0.253	0.257	6.61959696958431e-07	HBB	NK cells	GSE169246_PacBlood_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56765
0	0.44262917306482	1	1	0	RPS3A	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56766
0	-0.338634183575019	1	1	0	RPL37	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56767
0	0.443200636807512	0.965	0.844	0	NPM1	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56768
0	0.360999244652973	1	0.998	0	HLA-B	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56769
0	0.553792721226363	1	1	0	EEF1A1	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56770
0	-0.7509136317952	0.802	0.951	0	RPL36A	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56771
0	-0.543251656542601	1	1	0	RPL39	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56772
0	0.457656877387989	0.974	0.807	0	SARAF	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56773
0	0.524920075534782	0.978	0.896	0	EEF1G	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56774
0	-0.684279599173037	1	1	0	MALAT1	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56775
0	0.426022914873136	0.954	0.811	0	LDHB	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56776
0	-0.702694918761021	0.997	0.999	0	RPL41	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56777
0	0.51956743965503	0.982	0.905	0	BTG1	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56778
0	-0.762386401830827	0.998	0.999	0	RPS29	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56779
0	-0.469217171773717	0.987	0.995	0	RPL38	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56780
0	-0.566654253054069	0.999	1	0	RPS21	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56781
0	-0.425663958025377	1	1	0	RPL36	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56782
0	-0.3119124178732	1	1	0	RPS28	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56783
0	0.710395912236819	0.955	0.776	0	KLF2	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56784
0	0.576817355429859	1	0.999	0	RPL3	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56785
0	0.639198822740997	0.995	0.976	0	MT-ATP8	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56786
0	-0.997436394297374	0.972	0.998	0	MT-ATP6	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56787
0	-0.627787159840264	0.993	0.999	0	MT-ND3	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56788
0	-0.942745220882485	0.911	0.984	0	MT-ND4	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56789
1.17135154377654e-299	0.453826486127027	0.999	0.999	2.31177940679739e-295	ACTB	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56790
5.72822860429502e-299	0.383838240629741	0.989	0.974	1.13052319734367e-294	FTH1	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56791
6.55943450926411e-274	0.288637172159587	1	1	1.29456999474837e-269	RPL8	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56792
1.5914009423088e-272	0.374021474151993	0.99	0.984	3.14078889974066e-268	EEF1B2	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56793
9.11911677368363e-266	-0.325016375434607	1	1	1.7997488864542e-261	TMSB10	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56794
8.73551237715926e-259	0.352936697138615	0.999	0.996	1.72404072275615e-254	HLA-A	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56795
5.31667150379551e-257	0.256919037517071	1	1	1.04929828798908e-252	B2M	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56796
5.17980121457141e-255	0.357141248648015	0.965	0.881	1.02228556770781e-250	HNRNPA1	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56797
1.86734564940455e-253	0.286010540186227	1	1	3.68539337366483e-249	RPS6	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56798
4.25039308155691e-243	0.264064188432708	1	1	8.38857578576072e-239	RPS4X	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56799
2.11727128836535e-241	0.288546513857723	0.999	0.997	4.17864661471785e-237	NACA	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56800
5.0315789964397e-229	0.289832659859106	0.999	0.999	9.93032430737339e-225	RPL5	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56801
4.08334082197782e-214	-0.279015368686323	1	1	8.05888144625543e-210	RPS19	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56802
1.37559364930855e-213	0.312446547783562	0.972	0.9	2.71487162627535e-209	CD3E	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56803
5.5743681948474e-209	0.336607303252107	0.946	0.863	1.10015730693508e-204	HSPA8	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56804
3.24510585040864e-189	-0.252615405606638	0.998	0.999	6.4045409063665e-185	RPL37A	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56805
6.73469979241159e-187	-0.370841980417514	0.104	0.262	1.32916035103035e-182	IFI44L	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56806
2.58450586243981e-186	0.271188819847416	0.999	0.993	5.1007807701112e-182	MT-ND4L	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56807
2.17786980280236e-185	0.366827783870204	0.625	0.409	4.29824384281074e-181	TSC22D3	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56808
3.44103937455036e-180	0.28410645971091	0.993	0.989	6.79123530961259e-176	RPL4	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56809
1.73573673063143e-173	0.341668402297443	0.844	0.697	3.4256500115742e-169	ZFP36L2	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56810
6.7937763861e-166	0.279885626201172	0.983	0.975	1.3408197075607e-161	RPL7	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56811
2.27719101908963e-161	-0.26635418211798	1	1	4.49426419527529e-157	RPS27	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56812
1.23877862210914e-155	-0.393497145227473	0.983	0.994	2.4448534885946e-151	IFITM1	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56813
4.17120826946357e-151	0.3000504345864	0.741	0.553	8.23229664061331e-147	EIF3L	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56814
8.15309303767583e-147	-0.334639239064619	0.783	0.86	1.6090944419157e-142	OST4	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56815
4.02466542987091e-139	0.268282919312543	0.793	0.631	7.94307969239323e-135	CNBP	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56816
4.7589596294799e-138	0.328416337600356	0.977	0.967	9.39228272474154e-134	ACTG1	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56817
9.91216321167643e-133	0.266671639846444	0.878	0.766	1.95626453145646e-128	CCNI	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56818
2.43145489312731e-128	0.270548244465759	0.686	0.512	4.79871937707606e-124	ERP29	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56819
6.80243828457529e-128	-0.379799206151877	0.908	0.943	1.34252921984378e-123	MT-ND2	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56820
4.14972529786887e-127	0.270494519928877	0.615	0.433	8.18989784787401e-123	RBM3	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56821
5.96455391731571e-125	0.264001715616772	0.652	0.482	1.17716436112143e-120	SLC25A3	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56822
2.07275913715451e-124	-0.406851986756377	0.428	0.554	4.09079743308815e-120	RNF213	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56823
4.16477942680915e-122	-0.344127961604254	0.607	0.7	8.21960867675055e-118	SON	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56824
7.94383198337719e-122	0.250656409837276	0.718	0.546	1.56779468023932e-117	DAZAP2	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56825
1.08985887085651e-118	-0.442523259289987	0.684	0.751	2.15094546752241e-114	LINC00861	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000245164	100130231	long intergenic non-protein coding RNA 861	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56826
3.26453591043358e-118	0.255741260117718	0.832	0.713	6.44288807283172e-114	EIF3F	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56827
2.11258408934712e-117	0.337298320113751	0.634	0.483	4.16939595873548e-113	CCR7	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56828
2.84616959130051e-113	-0.349678595800082	0.419	0.543	5.61720030539068e-109	AAK1	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56829
1.0024835530299e-112	0.300156940328579	0.22	0.337	1.9785015402598e-108	HBB	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56830
1.87142657295229e-105	-0.425425966326168	0.221	0.344	3.69344748437863e-101	ISG15	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56831
8.49621212230731e-92	-0.280637790768563	0.358	0.475	1.67681242445857e-87	ATP5ME	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56832
1.191774912025e-90	-0.264785084297616	0.744	0.803	2.35208696637254e-86	RPS10	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56833
1.53180681884548e-86	0.26157130509762	0.954	0.941	3.02317393767344e-82	VIM	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56834
3.86859439288697e-79	-0.537622782504973	0.874	0.917	7.63505789380173e-75	RPS26	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56835
3.59340666652716e-78	-0.265794263873182	0.698	0.783	7.091947397058e-74	HCST	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56836
1.14271627113017e-77	-0.259672369514987	0.418	0.516	2.25526483270251e-73	NDUFA3	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56837
1.66385101131888e-68	-0.333606399687992	0.538	0.612	3.28377635593894e-64	TRBC2	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56838
1.16679778498004e-65	-0.254978651479546	0.157	0.25	2.30279210843662e-61	MX1	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56839
1.7159694007429e-63	-0.314925526142087	0.318	0.412	3.38663720930619e-59	MT2A	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56840
6.85255318511155e-59	-0.277292734181674	0.676	0.772	1.35241989661361e-54	CRIP1	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56841
3.48305572028255e-47	-0.275872115463923	0.59	0.645	6.87415876954964e-43	LY6E	CD4+ T cells	GSE169246_PacBlood_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56842
4.70653035388495e-80	1.17060741334248	1	1	9.28880830642734e-76	EEF1A1	cDCs	GSE169246_PacBlood_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56843
6.87666152805257e-70	1.70786573981523	0.997	0.726	1.35717791917646e-65	MT-ATP8	cDCs	GSE169246_PacBlood_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56844
2.91228212132793e-58	-1.05350714250651	1	1	5.7476799946528e-54	RPS21	cDCs	GSE169246_PacBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56845
4.13865240930709e-57	-1.3660772121155	0.985	1	8.16804439500848e-53	RPS29	cDCs	GSE169246_PacBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56846
1.04127951698591e-55	-1.24652376404483	0.994	0.996	2.05506925472339e-51	RPL41	cDCs	GSE169246_PacBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56847
1.48831748160964e-55	1.29020105262254	1	0.833	2.93734338170479e-51	MT-ND4L	cDCs	GSE169246_PacBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56848
9.03719728340955e-55	-0.642176518275922	1	1	1.78358125585371e-50	TMSB10	cDCs	GSE169246_PacBlood_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56849
9.23907386209866e-53	1.05528804300214	1	0.976	1.82342361742379e-48	MT-CO3	cDCs	GSE169246_PacBlood_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56850
6.29277891857353e-52	-1.0588477353024	0.879	0.976	1.24194284736967e-47	RPL36A	cDCs	GSE169246_PacBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56851
3.69567221209642e-50	0.992675135332918	0.985	0.738	7.29377867779349e-46	EEF1G	cDCs	GSE169246_PacBlood_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56852
2.68964309753889e-48	-0.892956116686729	1	1	5.30827961730274e-44	RPL39	cDCs	GSE169246_PacBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56853
2.07344553865742e-47	-0.781250210223566	1	1	4.09215211509429e-43	RPL36	cDCs	GSE169246_PacBlood_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56854
1.02840162499805e-45	-0.6470538570545	1	1	2.02965344709615e-41	RPL37	cDCs	GSE169246_PacBlood_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56855
1.10504537197532e-43	0.914288585264133	0.997	0.901	2.18091754613048e-39	MT-ND1	cDCs	GSE169246_PacBlood_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56856
1.17362183865761e-42	0.791994665816638	1	1	2.31626006077466e-38	MT-CO2	cDCs	GSE169246_PacBlood_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56857
1.65815356899301e-42	0.711459974588275	1	0.992	3.27253188376461e-38	RPL3	cDCs	GSE169246_PacBlood_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56858
2.95942240305812e-42	0.729122829246667	1	1	5.84071605467551e-38	ACTB	cDCs	GSE169246_PacBlood_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56859
1.59876581600777e-40	-0.763529199214096	0.973	0.996	3.15532421447294e-36	RPL38	cDCs	GSE169246_PacBlood_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56860
1.83945975198929e-39	0.868755466721747	0.967	0.667	3.63035776652606e-35	CTSZ	cDCs	GSE169246_PacBlood_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56861
4.16990023542218e-39	0.837466239062781	0.961	0.548	8.22971510462921e-35	AP1S2	cDCs	GSE169246_PacBlood_post	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56862
8.25622934839103e-39	0.694995850330868	0.997	0.937	1.62944942419845e-34	ARPC1B	cDCs	GSE169246_PacBlood_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56863
9.57065135314318e-39	0.719682554259675	1	0.968	1.88886375105634e-34	COTL1	cDCs	GSE169246_PacBlood_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56864
1.16353089385661e-38	-2.06396010623009	0.303	0.766	2.2963445721154e-34	IFITM1	cDCs	GSE169246_PacBlood_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56865
1.11706793307574e-37	0.598182337618629	0.997	1	2.20464527271828e-33	NACA	cDCs	GSE169246_PacBlood_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56866
2.93075989117941e-36	0.80226903533029	0.985	0.726	5.78414772123169e-32	GRN	cDCs	GSE169246_PacBlood_post	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56867
6.64080084297084e-36	-1.18582902806658	0.994	1	1.31062845436872e-31	MALAT1	cDCs	GSE169246_PacBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56868
1.22915315689362e-35	0.726534453771512	1	1	2.42585667044525e-31	MT-CO1	cDCs	GSE169246_PacBlood_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56869
1.41161297055554e-35	-0.956538536474516	0.964	0.996	2.78595935868842e-31	RPS26	cDCs	GSE169246_PacBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56870
1.12626369783108e-34	-0.603691682363247	0.994	1	2.22279403403943e-30	RPLP2	cDCs	GSE169246_PacBlood_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56871
1.7223547040153e-34	-0.75501837827249	1	1	3.3992392438446e-30	RPS27	cDCs	GSE169246_PacBlood_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56872
3.09530962281982e-34	-0.716915828156285	1	1	6.1089030715972e-30	RPLP1	cDCs	GSE169246_PacBlood_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56873
1.78177273335998e-33	0.695597522751444	0.852	0.274	3.51650666655926e-29	FOS	cDCs	GSE169246_PacBlood_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56874
6.47519585390483e-32	0.691070158647697	1	1	1.27794465372666e-27	FTH1	cDCs	GSE169246_PacBlood_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56875
6.71451048648399e-32	0.639610924790884	0.991	0.813	1.32517578961248e-27	RHOA	cDCs	GSE169246_PacBlood_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56876
1.28214486501273e-31	0.736847962380019	0.982	0.81	2.53044110558913e-27	HNRNPA1	cDCs	GSE169246_PacBlood_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56877
3.24877505820194e-31	-0.472509113263214	1	1	6.41178245486735e-27	RPL28	cDCs	GSE169246_PacBlood_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56878
3.83773826550566e-31	1.01144245290426	0.812	0.373	7.57416024080197e-27	CEBPD	cDCs	GSE169246_PacBlood_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56879
5.70593277785764e-31	0.802456122644765	0.861	0.357	1.12612289303798e-26	JUNB	cDCs	GSE169246_PacBlood_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56880
1.52888854750614e-30	0.708389061415954	1	0.98	3.01741443735812e-26	MT-CYB	cDCs	GSE169246_PacBlood_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56881
1.75655944954514e-30	-0.562876244821064	1	1	3.46674572962229e-26	RPS15	cDCs	GSE169246_PacBlood_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56882
1.92674694547126e-30	0.733293252178153	0.894	0.476	3.80262777158208e-26	RBM3	cDCs	GSE169246_PacBlood_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56883
2.80609813345952e-30	0.705803593901906	0.927	0.552	5.53811527619572e-26	SLC25A3	cDCs	GSE169246_PacBlood_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56884
3.15057304609915e-30	-0.562970861279076	0.997	1	6.21797096378128e-26	RPS28	cDCs	GSE169246_PacBlood_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56885
1.69168541586501e-29	0.616024740947882	0.997	1	3.33871033675118e-25	GAPDH	cDCs	GSE169246_PacBlood_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56886
4.11208268634816e-29	0.700014199683734	0.897	0.556	8.11560638977674e-25	NPM1	cDCs	GSE169246_PacBlood_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56887
6.43839789260135e-29	-0.590707624663746	0.997	0.996	1.2706822080838e-24	ATP5F1E	cDCs	GSE169246_PacBlood_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56888
6.45558275305832e-29	0.645309214044878	0.927	0.563	1.27407381214359e-24	PCBP1	cDCs	GSE169246_PacBlood_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56889
6.66430377267256e-29	0.636114319469343	0.997	0.917	1.31526699257466e-24	HLA-C	cDCs	GSE169246_PacBlood_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56890
8.97800212471599e-29	0.747463518551486	1	0.992	1.77189849933395e-24	VIM	cDCs	GSE169246_PacBlood_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56891
2.99633991988822e-28	0.610317507317307	1	0.996	5.91357646589139e-24	ACTG1	cDCs	GSE169246_PacBlood_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56892
3.07007688948098e-28	0.710171136870933	0.97	0.671	6.05910374907965e-24	SLC25A5	cDCs	GSE169246_PacBlood_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56893
4.04980941887389e-28	0.556492202902878	1	1	7.99270386908952e-24	TPT1	cDCs	GSE169246_PacBlood_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56894
3.25253499550757e-27	0.676891979438877	0.939	0.635	6.41920306713374e-23	ALDOA	cDCs	GSE169246_PacBlood_post	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56895
4.28010444791757e-26	-0.501616239084911	1	1	8.44721413841011e-22	RPS19	cDCs	GSE169246_PacBlood_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56896
3.41015170668837e-25	0.607955221092577	0.894	0.567	6.73027540832017e-21	FKBP1A	cDCs	GSE169246_PacBlood_post	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56897
7.44621469368186e-25	0.642221922770952	0.788	0.385	1.46958493194505e-20	GSN	cDCs	GSE169246_PacBlood_post	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56898
9.86957750581949e-25	-0.622743202621527	0.358	0.746	1.94785981654853e-20	DDT	cDCs	GSE169246_PacBlood_post	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56899
1.12452617412912e-24	0.570172094407601	0.536	0.127	2.21936485726124e-20	RTN1	cDCs	GSE169246_PacBlood_post	ENSG00000139970	6252	reticulon 1	NSP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56900
1.4521899572024e-24	0.811318877671209	1	0.702	2.86604209953467e-20	HLA-DRB5	cDCs	GSE169246_PacBlood_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56901
1.65281665812618e-24	0.518659035449219	0.994	0.972	3.26199895647783e-20	EIF1	cDCs	GSE169246_PacBlood_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56902
2.19414635333029e-24	0.538827747681749	0.985	0.917	4.33036724293267e-20	YBX1	cDCs	GSE169246_PacBlood_post	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56903
2.9492507918652e-24	0.649721326515389	0.864	0.528	5.82064136282515e-20	TKT	cDCs	GSE169246_PacBlood_post	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56904
4.27130670022462e-24	-0.879041847705965	0.824	0.925	8.4298509035633e-20	IFITM2	cDCs	GSE169246_PacBlood_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56905
5.14295884311062e-24	0.654881665649003	0.985	0.762	1.01501435727631e-19	SRGN	cDCs	GSE169246_PacBlood_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56906
1.08603670415926e-23	-0.489611089733893	0.997	0.996	2.14340203932872e-19	RPL37A	cDCs	GSE169246_PacBlood_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56907
1.2633934394985e-23	-0.625179803616841	0.152	0.524	2.49343329219423e-19	BLOC1S1	cDCs	GSE169246_PacBlood_post	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56908
1.27623601728588e-23	-0.721118341009344	0.439	0.738	2.51877940371542e-19	NDUFA3	cDCs	GSE169246_PacBlood_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56909
1.62684226891803e-23	0.518247335439327	1	0.976	3.21073590193662e-19	PTMA	cDCs	GSE169246_PacBlood_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56910
4.75457253640899e-23	-0.81389664838495	0.33	0.675	9.38362435785679e-19	RNF213	cDCs	GSE169246_PacBlood_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56911
4.87013380109673e-23	0.566196258247351	0.9	0.615	9.61169606984451e-19	ATP5F1B	cDCs	GSE169246_PacBlood_post	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56912
5.47560517964293e-23	0.478025409524524	1	1	1.08066543825433e-18	TMSB4X	cDCs	GSE169246_PacBlood_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56913
1.17473805950602e-22	0.579500277732503	0.903	0.563	2.31846303424109e-18	H2AFY	cDCs	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56914
2.43824512005314e-22	0.465759793714166	0.994	0.893	4.81212056893687e-18	ARPC2	cDCs	GSE169246_PacBlood_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56915
2.7558701381001e-22	0.421424124338537	1	1	5.43898530455435e-18	RPS3A	cDCs	GSE169246_PacBlood_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56916
3.91742395344021e-22	-1.45627234246002	0.376	0.651	7.73142791450961e-18	ISG15	cDCs	GSE169246_PacBlood_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56917
6.3888849024464e-22	0.552904087211435	1	1	1.26091032434682e-17	HLA-B	cDCs	GSE169246_PacBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56918
6.58716072840151e-22	0.595968535034648	0.761	0.341	1.30004204135732e-17	FGR	cDCs	GSE169246_PacBlood_post	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56919
7.6420507904619e-22	0.695306978990339	0.97	0.758	1.50823514400556e-17	PSAP	cDCs	GSE169246_PacBlood_post	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56920
1.12217973676307e-21	0.495536513387065	0.997	0.94	2.21473392847559e-17	LSP1	cDCs	GSE169246_PacBlood_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56921
2.53490763781141e-21	0.546763949698277	0.909	0.575	5.0028937139846e-17	RNF130	cDCs	GSE169246_PacBlood_post	ENSG00000113269	55819	ring finger protein 130	G1RZFP|GOLIATH|GP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56922
2.96081461313832e-21	0.570681751662407	0.921	0.631	5.84346372048978e-17	EIF3L	cDCs	GSE169246_PacBlood_post	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56923
6.23341106207384e-21	0.379421456254999	0.994	0.885	1.23022600721089e-16	H3F3B	cDCs	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56924
1.10833186461742e-20	-0.520747969957722	0.994	0.996	2.18740376800893e-16	RPS11	cDCs	GSE169246_PacBlood_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56925
2.02603766569743e-20	0.789469382155049	1	0.988	3.99858793702044e-16	LYZ	cDCs	GSE169246_PacBlood_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56926
6.0607228978094e-20	0.546691313453477	0.858	0.54	1.19614427111166e-15	EFHD2	cDCs	GSE169246_PacBlood_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56927
6.58695346433064e-20	-0.391147493280386	1	1	1.3000011357203e-15	RPL32	cDCs	GSE169246_PacBlood_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56928
6.92712594748619e-20	0.499840263246961	1	0.925	1.36713757699588e-15	SLC25A6	cDCs	GSE169246_PacBlood_post	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56929
1.1751874688953e-19	0.460540866701002	0.536	0.167	2.31934998861177e-15	HNRNPA0	cDCs	GSE169246_PacBlood_post	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56930
1.9244304677533e-19	0.562959435364503	0.727	0.373	3.79805597115791e-15	BRI3	cDCs	GSE169246_PacBlood_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56931
4.15257334096868e-19	0.554030641169265	0.876	0.615	8.19551874573579e-15	ZYX	cDCs	GSE169246_PacBlood_post	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56932
4.57819302353087e-19	-0.680707985028814	0.63	0.813	9.03552175124052e-15	RPS10	cDCs	GSE169246_PacBlood_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56933
5.66253791485736e-19	0.582699449212587	0.818	0.456	1.11755848287625e-14	SNX3	cDCs	GSE169246_PacBlood_post	ENSG00000112335	8724	sorting nexin 3	Grd19	protein_coding	O60493	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56934
6.05644685927257e-19	0.43129253377161	0.997	0.98	1.19530035214603e-14	RPL5	cDCs	GSE169246_PacBlood_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56935
6.78042219365567e-19	0.448735315755901	1	0.952	1.33818412413988e-14	GABARAP	cDCs	GSE169246_PacBlood_post	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56936
7.4386977446918e-19	0.719052083670935	0.994	0.933	1.46810138689237e-14	HLA-DQA1	cDCs	GSE169246_PacBlood_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56937
1.14689119063433e-18	0.52359119859111	0.855	0.544	2.26350445383592e-14	SARAF	cDCs	GSE169246_PacBlood_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56938
1.38061003273511e-18	0.556902292456773	0.93	0.675	2.72477196060601e-14	CPVL	cDCs	GSE169246_PacBlood_post	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56939
1.4630236191374e-18	0.49579851124268	0.736	0.385	2.88742341472958e-14	SRSF9	cDCs	GSE169246_PacBlood_post	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56940
1.7917769198739e-18	0.523637985412825	0.564	0.214	3.53625092906313e-14	CD1D	cDCs	GSE169246_PacBlood_post	ENSG00000158473	912	CD1d molecule	NA	protein_coding	P15813	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56941
2.22040351675975e-18	0.447353666920378	1	0.948	4.38218838067705e-14	EEF1B2	cDCs	GSE169246_PacBlood_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56942
3.35982434706219e-18	-0.352408875304323	1	1	6.63094933136193e-14	RPL34	cDCs	GSE169246_PacBlood_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56943
3.83881756857337e-18	0.502396115078648	0.939	0.726	7.5762903533364e-14	CCNI	cDCs	GSE169246_PacBlood_post	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56944
4.56869261875083e-18	0.519496157744102	0.664	0.31	9.01677175236664e-14	ARRB2	cDCs	GSE169246_PacBlood_post	ENSG00000141480	409	arrestin beta 2	ARR2|BARR2|DKFZp686L0365	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56945
7.41131583145168e-18	0.362904694958721	1	1	1.4626972924953e-13	RPS6	cDCs	GSE169246_PacBlood_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56946
8.89732732809718e-18	-0.386738279011773	1	1	1.75597652147326e-13	FAU	cDCs	GSE169246_PacBlood_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56947
9.44988206493381e-18	0.449135554778605	0.652	0.29	1.86502872433534e-13	RTN4	cDCs	GSE169246_PacBlood_post	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56948
1.29012643865143e-17	0.32249355561789	1	1	2.54619353932246e-13	RPL7A	cDCs	GSE169246_PacBlood_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56949
4.86065876075059e-17	0.603959983129281	0.5	0.171	9.59299613021737e-13	CD68	cDCs	GSE169246_PacBlood_post	ENSG00000129226	968	CD68 molecule	DKFZp686M18236|GP110|LAMP4|SCARD1	protein_coding	P34810	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56950
5.60174279361322e-17	0.421058008050522	0.518	0.187	1.10555995774751e-12	PDCD6	cDCs	GSE169246_PacBlood_post	ENSG00000249915	10016	programmed cell death 6	ALG-2|PEF1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56951
5.69026055442343e-17	0.491905037610338	0.745	0.421	1.12302982302101e-12	HMGN1	cDCs	GSE169246_PacBlood_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56952
8.20920392988597e-17	0.463267608680133	0.615	0.286	1.6201684876023e-12	COX7A2L	cDCs	GSE169246_PacBlood_post	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56953
1.2808631838199e-16	0.358496026323232	1	1	2.52791157958696e-12	RPL15	cDCs	GSE169246_PacBlood_post	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56954
1.32319279769499e-16	0.468938704381673	0.691	0.357	2.61145330553084e-12	ATP6V0C	cDCs	GSE169246_PacBlood_post	ENSG00000185883	527	ATPase H+ transporting V0 subunit c	ATP6C|ATP6L|ATPL|VATL|Vma3	protein_coding	P27449	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56955
3.33669838014256e-16	0.395995331931157	0.994	0.98	6.58530792304936e-12	RPL4	cDCs	GSE169246_PacBlood_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56956
3.90139480755462e-16	0.48615125351782	0.658	0.321	7.6997927921898e-12	NCF2	cDCs	GSE169246_PacBlood_post	ENSG00000116701	4688	neutrophil cytosolic factor 2	NOXA2|p67phox	protein_coding	P19878	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56957
4.49333368858384e-16	0.983444496714907	0.582	0.278	8.86804336778908e-12	FCN1	cDCs	GSE169246_PacBlood_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56958
5.61085285599217e-16	0.464000269358915	0.812	0.496	1.10735791965862e-11	ALDH2	cDCs	GSE169246_PacBlood_post	ENSG00000111275	217	aldehyde dehydrogenase 2 family member	NA	protein_coding	P05091	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56959
5.94517145629659e-16	-0.533345125509367	0.797	0.913	1.1733390386147e-11	TOMM7	cDCs	GSE169246_PacBlood_post	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56960
6.28602646425592e-16	0.405282682862586	0.421	0.111	1.24061018298555e-11	TNFSF13	cDCs	GSE169246_PacBlood_post	ENSG00000161955	8741	TNF superfamily member 13	APRIL|CD256	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56961
7.16024592626851e-16	0.429350902764153	0.709	0.377	1.41314613600835e-11	CSK	cDCs	GSE169246_PacBlood_post	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56962
1.02676923696831e-15	0.565947974336535	0.855	0.635	2.02643176608065e-11	ZFP36L2	cDCs	GSE169246_PacBlood_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56963
1.11542961735183e-15	0.412251857967163	0.842	0.512	2.20141189280556e-11	SH3BGRL	cDCs	GSE169246_PacBlood_post	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56964
1.25417057008526e-15	0.5081981348289	0.552	0.238	2.47523103712026e-11	YWHAH	cDCs	GSE169246_PacBlood_post	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56965
1.67411405032365e-15	0.451601949521976	0.809	0.54	3.30403148971876e-11	EIF3E	cDCs	GSE169246_PacBlood_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56966
3.92208597500041e-15	0.466186185040126	0.727	0.377	7.74062888026081e-11	RNASE6	cDCs	GSE169246_PacBlood_post	ENSG00000169413	6039	ribonuclease A family member k6	RAD1|RNaseK6|RNS6	protein_coding	Q93091	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56967
4.04060013708034e-15	-0.690697990607001	0.176	0.464	7.97452843054176e-11	IFI44L	cDCs	GSE169246_PacBlood_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56968
4.05334667024062e-15	0.408519894293298	0.67	0.345	7.99968498838688e-11	RTRAF	cDCs	GSE169246_PacBlood_post	ENSG00000087302	51637	RNA transcription, translation and transport factor	C14orf166|CGI-99|CLE|CLE7|hCLE1|LCRP369|RLLM1	protein_coding	Q9Y224	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56969
4.49929994826399e-15	0.457643670656704	0.679	0.369	8.87981837789381e-11	CLTA	cDCs	GSE169246_PacBlood_post	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56970
5.26031485069418e-15	0.302914741692129	1	1	1.038175738933e-10	RPS4X	cDCs	GSE169246_PacBlood_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56971
5.75497010421364e-15	0.452670064446164	0.758	0.452	1.1358008997676e-10	CRTAP	cDCs	GSE169246_PacBlood_post	ENSG00000170275	10491	cartilage associated protein	CASP|LEPREL3|P3H5	protein_coding	O75718	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56972
6.68604272168532e-15	0.351755165011334	0.994	0.925	1.31955739155181e-10	ARPC3	cDCs	GSE169246_PacBlood_post	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56973
7.18874122978767e-15	0.478801750687535	0.942	0.778	1.41876996911089e-10	C1orf162	cDCs	GSE169246_PacBlood_post	ENSG00000143110	128346	chromosome 1 open reading frame 162	MGC24133	protein_coding	Q8NEQ5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56974
7.64303124087445e-15	-0.461488571458947	0.942	0.98	1.50842864569898e-10	TMA7	cDCs	GSE169246_PacBlood_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56975
9.77604227275344e-15	0.50305483155294	0.87	0.615	1.92939970295062e-10	CFP	cDCs	GSE169246_PacBlood_post	ENSG00000126759	5199	complement factor properdin	PFC	protein_coding	P27918	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56976
1.01821975290581e-14	-1.29961451355823	0.791	0.81	2.00955850433491e-10	IFITM3	cDCs	GSE169246_PacBlood_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56977
1.59981280743584e-14	0.410195303889195	0.588	0.266	3.15739055675538e-10	RAP1A	cDCs	GSE169246_PacBlood_post	ENSG00000116473	5906	RAP1A, member of RAS oncogene family	KREV-1|SMGP21	protein_coding	P62834	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56978
1.97617186063173e-14	-0.352351596077614	1	1	3.90017278414279e-10	CYBA	cDCs	GSE169246_PacBlood_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56979
2.07867111731139e-14	0.415827367922111	0.876	0.591	4.10246531712575e-10	EIF3H	cDCs	GSE169246_PacBlood_post	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56980
2.19664678891591e-14	0.407327590617902	1	0.857	4.33530210260444e-10	SPI1	cDCs	GSE169246_PacBlood_post	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56981
2.2712209905843e-14	0.471586476626999	0.939	0.706	4.48248174701717e-10	CALM2	cDCs	GSE169246_PacBlood_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56982
2.72575144625437e-14	-0.48193750242065	0.252	0.528	5.37954305432762e-10	NDUFA11	cDCs	GSE169246_PacBlood_post	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56983
2.87422558875715e-14	0.390759501330565	0.803	0.5	5.67257162197112e-10	LAMTOR1	cDCs	GSE169246_PacBlood_post	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56984
3.42305317200727e-14	0.44054257869517	0.891	0.643	6.75573774027355e-10	PKM	cDCs	GSE169246_PacBlood_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56985
4.50221932644668e-14	0.439256645737316	0.858	0.571	8.88558006267517e-10	CTSH	cDCs	GSE169246_PacBlood_post	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56986
4.69095261814556e-14	0.427921111885118	1	1	9.25806408717208e-10	HLA-DRA	cDCs	GSE169246_PacBlood_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56987
5.75109177503728e-14	0.401988460457046	0.764	0.464	1.13503547272136e-09	SRSF3	cDCs	GSE169246_PacBlood_post	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56988
6.2964942873471e-14	-0.385018034187104	0.088	0.329	1.24267611255082e-09	MRPL23	cDCs	GSE169246_PacBlood_post	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56989
6.88579541269102e-14	-0.57609233129015	0.521	0.718	1.3589805826487e-09	SON	cDCs	GSE169246_PacBlood_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56990
7.26025546982717e-14	0.408056462234651	0.821	0.508	1.43288401952509e-09	RNASET2	cDCs	GSE169246_PacBlood_post	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56991
8.92985005523296e-14	0.398804472422491	0.988	0.905	1.76239520690078e-09	EEF2	cDCs	GSE169246_PacBlood_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56992
9.05222487932294e-14	-0.816254503970845	0.321	0.575	1.78654710218317e-09	MX1	cDCs	GSE169246_PacBlood_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56993
9.43327845406937e-14	0.398123454361287	0.888	0.643	1.86175183569513e-09	SUMO2	cDCs	GSE169246_PacBlood_post	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56994
1.09713582693071e-13	-0.491352136194326	0.8	0.877	2.16530726803044e-09	OST4	cDCs	GSE169246_PacBlood_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56995
1.41741264128931e-13	-0.440785865839898	0.052	0.27	2.79740558884858e-09	ISG20	cDCs	GSE169246_PacBlood_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56996
2.00928649049297e-13	0.434545658168058	0.706	0.409	3.96552781763692e-09	LDHA	cDCs	GSE169246_PacBlood_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56997
2.27816293223415e-13	0.406887797854905	0.548	0.254	4.49618236305732e-09	SMAP2	cDCs	GSE169246_PacBlood_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56998
2.84426416214839e-13	0.60096593759694	0.873	0.671	5.61343975041605e-09	TUBA1B	cDCs	GSE169246_PacBlood_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	56999
3.91362343893954e-13	0.317733649199674	0.518	0.21	7.72392721909108e-09	NFKBIA	cDCs	GSE169246_PacBlood_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57000
4.90759576418534e-13	0.408514128667604	0.736	0.464	9.68563100019618e-09	SEC11A	cDCs	GSE169246_PacBlood_post	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57001
4.95918904815526e-13	0.423511537986023	0.873	0.639	9.78745550543922e-09	GDI2	cDCs	GSE169246_PacBlood_post	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57002
5.03456399353705e-13	-0.493711100911104	0.445	0.671	9.93621549764472e-09	ROMO1	cDCs	GSE169246_PacBlood_post	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57003
5.26638422848612e-13	0.305753849176367	1	0.984	1.03937359133402e-08	H3F3A	cDCs	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57004
5.83242988916937e-13	-0.445358058339247	0.842	0.917	1.15108836292647e-08	UQCR11	cDCs	GSE169246_PacBlood_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57005
6.00986522132018e-13	0.433717324310028	0.582	0.302	1.18610700007975e-08	RAB32	cDCs	GSE169246_PacBlood_post	ENSG00000118508	10981	RAB32, member RAS oncogene family	NA	protein_coding	Q13637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57006
6.67309115365722e-13	-0.489606257313183	0.727	0.877	1.31700127008579e-08	MIF	cDCs	GSE169246_PacBlood_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57007
8.31429616099611e-13	0.471273972618754	0.958	0.821	1.64090949033419e-08	ANXA2	cDCs	GSE169246_PacBlood_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57008
9.16107670275946e-13	0.392381555384887	0.742	0.464	1.80803009805661e-08	DAZAP2	cDCs	GSE169246_PacBlood_post	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57009
9.23019461279528e-13	-0.513753692523209	0.573	0.746	1.82167120878128e-08	ATP5ME	cDCs	GSE169246_PacBlood_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57010
1.05049927761337e-12	0.409949158377078	0.879	0.579	2.07326537429774e-08	RNH1	cDCs	GSE169246_PacBlood_post	ENSG00000276230	6050	ribonuclease/angiogenin inhibitor 1	RAI|RNH	protein_coding	P13489	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57011
1.54367120928046e-12	0.37326615153477	0.83	0.532	3.04658949863592e-08	ATP5F1A	cDCs	GSE169246_PacBlood_post	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57012
2.71485021882599e-12	0.360634355169861	0.579	0.278	5.35802839187498e-08	HNRNPF	cDCs	GSE169246_PacBlood_post	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57013
2.98422260250533e-12	0.38983025515423	0.667	0.361	5.88966172830452e-08	PGAM1	cDCs	GSE169246_PacBlood_post	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57014
3.34888428722684e-12	0.366169012348317	0.539	0.25	6.60935802927088e-08	CLNS1A	cDCs	GSE169246_PacBlood_post	ENSG00000074201	1207	chloride nucleotide-sensitive channel 1A	CLCI|ICln	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57015
3.68436413399579e-12	0.418909896913648	0.588	0.31	7.27146105485409e-08	ANP32B	cDCs	GSE169246_PacBlood_post	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57016
4.95249051365696e-12	0.334117503895276	0.667	0.373	9.77423527775338e-08	SRSF2	cDCs	GSE169246_PacBlood_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57017
5.47051344197659e-12	0.380491165876738	0.952	0.71	1.0796605329085e-07	TPI1	cDCs	GSE169246_PacBlood_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57018
5.51315965319475e-12	0.317226506197391	0.379	0.123	1.08807718915452e-07	GNG10	cDCs	GSE169246_PacBlood_post	ENSG00000242616	2790	G protein subunit gamma 10	NA	protein_coding	P50151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57019
7.56465520003768e-12	-0.556986928059971	0.97	0.96	1.49296035027944e-07	MT-ND4	cDCs	GSE169246_PacBlood_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57020
7.96744066617276e-12	0.357814493277944	0.733	0.448	1.57245408987586e-07	EIF3M	cDCs	GSE169246_PacBlood_post	ENSG00000149100	10480	eukaryotic translation initiation factor 3 subunit M	FLJ29030|GA17|hfl-B5|PCID1|TANGO7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57021
8.77778766994728e-12	0.388565287917653	0.367	0.119	1.7323841745408e-07	YBX3	cDCs	GSE169246_PacBlood_post	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57022
8.97189799349507e-12	0.334945449422097	0.93	0.738	1.77069378799619e-07	EIF3F	cDCs	GSE169246_PacBlood_post	ENSG00000175390	8665	eukaryotic translation initiation factor 3 subunit F	eIF3-epsilon|eIF3-p47|EIF3S5	protein_coding	O00303	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57023
9.51567954687133e-12	0.319394505765178	0.791	0.48	1.87801451537052e-07	PPP1CA	cDCs	GSE169246_PacBlood_post	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57024
1.04463336810642e-11	0.479819892871569	1	1	2.06168841529483e-07	HLA-DPA1	cDCs	GSE169246_PacBlood_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57025
1.05361372074535e-11	-0.316101443104901	1	1	2.07941203926303e-07	SERF2	cDCs	GSE169246_PacBlood_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57026
1.36623508529832e-11	-0.554831876861589	0.23	0.464	2.69640156434477e-07	MX2	cDCs	GSE169246_PacBlood_post	ENSG00000183486	4600	MX dynamin like GTPase 2	MXB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57027
1.45939110635686e-11	0.357786626367364	0.661	0.361	2.88025428750589e-07	APEX1	cDCs	GSE169246_PacBlood_post	ENSG00000100823	328	apurinic/apyrimidinic endodeoxyribonuclease 1	APE|APE-1|APEN|APEX|APX|HAP1|REF-1|REF1	protein_coding	P27695	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57028
1.4828214969463e-11	-0.488122064453902	0.221	0.464	2.92649650637323e-07	PARP14	cDCs	GSE169246_PacBlood_post	ENSG00000173193	54625	poly(ADP-ribose) polymerase family member 14	ARTD8|BAL2|KIAA1268|pART8	protein_coding	Q460N5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57029
1.9386805168952e-11	0.328894075244678	0.385	0.135	3.82617986814436e-07	PGD	cDCs	GSE169246_PacBlood_post	ENSG00000142657	5226	phosphogluconate dehydrogenase	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57030
2.19326269296541e-11	-0.471143370960793	0.309	0.544	4.32862325083654e-07	PET100	cDCs	GSE169246_PacBlood_post	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57031
2.43261751600882e-11	0.367122950444398	0.748	0.476	4.80101392959501e-07	SET	cDCs	GSE169246_PacBlood_post	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57032
2.74130517558063e-11	0.306998516453188	0.479	0.187	5.41023989452594e-07	DUSP1	cDCs	GSE169246_PacBlood_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57033
3.24113210567493e-11	0.305096479208814	0.964	0.806	6.39669832376004e-07	RAC1	cDCs	GSE169246_PacBlood_post	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57034
3.69836542171301e-11	0.276511909751335	0.997	0.984	7.29909399629279e-07	COX4I1	cDCs	GSE169246_PacBlood_post	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57035
3.98351477155291e-11	-0.32775472423283	1	1	7.86186475313683e-07	RPS14	cDCs	GSE169246_PacBlood_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57036
4.70989375353914e-11	0.339906285846384	0.67	0.413	9.29544631198484e-07	SPINT2	cDCs	GSE169246_PacBlood_post	ENSG00000167642	10653	serine peptidase inhibitor, Kunitz type 2	HAI-2|HAI2|Kop	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57037
5.55273052862207e-11	0.478267035597376	0.609	0.365	1.09588689712885e-06	BASP1	cDCs	GSE169246_PacBlood_post	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57038
5.63099906185974e-11	-0.421014680484179	0.791	0.861	1.11133397484864e-06	UBL5	cDCs	GSE169246_PacBlood_post	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57039
6.55016562139919e-11	0.252910188560086	1	1	1.29274068703934e-06	RPS8	cDCs	GSE169246_PacBlood_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57040
6.64193313554209e-11	0.36205882413084	0.515	0.258	1.31085192363059e-06	MFSD1	cDCs	GSE169246_PacBlood_post	ENSG00000118855	64747	major facilitator superfamily domain containing 1	FLJ14153|Minerva|UG0581B09	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57041
7.17063571614524e-11	0.341300361226572	0.685	0.397	1.41519666493842e-06	OXA1L	cDCs	GSE169246_PacBlood_post	ENSG00000155463	5018	OXA1L mitochondrial inner membrane protein	MGC133129|OXA1|OXA1L1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57042
9.47704220037554e-11	0.340763511847441	0.685	0.405	1.87038904866612e-06	PTP4A2	cDCs	GSE169246_PacBlood_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57043
1.49710562713913e-10	0.328814480472602	0.43	0.179	2.95468766572178e-06	MBOAT7	cDCs	GSE169246_PacBlood_post	ENSG00000275118	79143	membrane bound O-acyltransferase domain containing 7	BB1|hMBOA-7|LENG4|LPIAT1|LPLAT|LPLAT11	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57044
1.76573903006793e-10	0.329648245025736	0.761	0.492	3.48486254974206e-06	RAB7A	cDCs	GSE169246_PacBlood_post	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57045
1.86865491410162e-10	-0.422923183421677	0.439	0.643	3.68797733847095e-06	NDUFB1	cDCs	GSE169246_PacBlood_post	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57046
2.31542632859446e-10	-0.30906246811694	0.997	1	4.56972540211403e-06	RPL35	cDCs	GSE169246_PacBlood_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57047
2.39580632240193e-10	0.348993552016043	0.885	0.643	4.72836335789244e-06	FCGRT	cDCs	GSE169246_PacBlood_post	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57048
2.95190186800723e-10	-0.383080732507183	0.933	0.917	5.82587352669908e-06	COX6B1	cDCs	GSE169246_PacBlood_post	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57049
3.01133670823953e-10	0.443403612274536	0.745	0.488	5.94317412738153e-06	HMGN2	cDCs	GSE169246_PacBlood_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57050
3.14788281577528e-10	0.325355546515032	0.779	0.512	6.21266152521409e-06	CNBP	cDCs	GSE169246_PacBlood_post	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57051
3.2689358355405e-10	0.335246020098696	0.985	0.857	6.45157176502273e-06	AIF1	cDCs	GSE169246_PacBlood_post	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57052
3.84798487784043e-10	0.356892129184882	0.724	0.5	7.59438295490588e-06	PPA1	cDCs	GSE169246_PacBlood_post	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57053
4.16942108288667e-10	0.277001517489689	0.27	0.067	8.22876944918513e-06	CDK2AP1	cDCs	GSE169246_PacBlood_post	ENSG00000111328	8099	cyclin dependent kinase 2 associated protein 1	doc-1|DOC1|DORC1|p12DOC-1|ST19	protein_coding	O14519	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57054
4.46641958060423e-10	0.36798095576156	0.385	0.155	8.81492568428052e-06	KLF10	cDCs	GSE169246_PacBlood_post	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57055
5.30492429293169e-10	-0.357746160256361	0.958	0.98	1.046979858453e-05	COX7C	cDCs	GSE169246_PacBlood_post	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57056
5.42525300134231e-10	-0.3408140102497	0.103	0.298	1.07072793234492e-05	UPF2	cDCs	GSE169246_PacBlood_post	ENSG00000151461	26019	UPF2 regulator of nonsense mediated mRNA decay	DKFZP434D222|KIAA1408|RENT2|smg-3	protein_coding	Q9HAU5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57057
5.43248668255487e-10	0.364519813951002	0.582	0.329	1.07215557166903e-05	GLRX	cDCs	GSE169246_PacBlood_post	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57058
5.77986343861261e-10	0.427056264383681	0.8	0.599	1.14071384824459e-05	HSPA8	cDCs	GSE169246_PacBlood_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57059
5.95336102297542e-10	0.359996135720882	0.8	0.587	1.17495533149443e-05	TALDO1	cDCs	GSE169246_PacBlood_post	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57060
6.01212872933583e-10	0.334156252167377	0.591	0.341	1.18655372602172e-05	OSTC	cDCs	GSE169246_PacBlood_post	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57061
6.14073936160443e-10	0.390269594129902	0.318	0.107	1.21193632040625e-05	LILRB2	cDCs	GSE169246_PacBlood_post	ENSG00000274513	10288	leukocyte immunoglobulin like receptor B2	CD85d|ILT4|LIR-2|LIR2|MIR-10|MIR10	protein_coding	Q8N423	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57062
7.64952128046271e-10	0.36052334019994	0.524	0.278	1.50970951991212e-05	EVI2B	cDCs	GSE169246_PacBlood_post	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57063
7.74524641757294e-10	-0.367488147745557	0.976	0.984	1.52860183297219e-05	RPL31	cDCs	GSE169246_PacBlood_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57064
8.13649905955642e-10	0.300972888493737	0.691	0.421	1.60581945439406e-05	FAM49B	cDCs	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57065
9.72785637982379e-10	0.427875804608083	0.836	0.639	1.91988973512202e-05	NPC2	cDCs	GSE169246_PacBlood_post	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57066
1.01461873737811e-09	0.298367478946074	0.436	0.19	2.00245154008944e-05	IMPA2	cDCs	GSE169246_PacBlood_post	ENSG00000141401	3613	inositol monophosphatase 2	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57067
1.06412213757364e-09	-0.409711627681221	0.77	0.802	2.10015145071533e-05	NDUFA1	cDCs	GSE169246_PacBlood_post	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57068
1.12754053591138e-09	0.301937098146127	0.418	0.179	2.22531400167471e-05	LILRA2	cDCs	GSE169246_PacBlood_post	ENSG00000274000	11027	leukocyte immunoglobulin like receptor A2	CD85h|ILT1|LIR-7|LIR7	protein_coding	Q8N149	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57069
1.26268157115341e-09	-0.421463768438277	0.179	0.385	2.49202834882836e-05	OAS2	cDCs	GSE169246_PacBlood_post	ENSG00000111335	4939	2'-5'-oligoadenylate synthetase 2	NA	protein_coding	P29728	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57070
1.28163115426162e-09	0.289029614366739	0.991	0.96	2.52942724605074e-05	BTF3	cDCs	GSE169246_PacBlood_post	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57071
1.43503211072966e-09	0.34568048129602	0.839	0.627	2.83217937373606e-05	ARPC5	cDCs	GSE169246_PacBlood_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57072
1.48304900246702e-09	0.298805536855616	0.818	0.563	2.92694551126891e-05	HNRNPK	cDCs	GSE169246_PacBlood_post	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57073
1.55202164416294e-09	0.557278449691157	0.83	0.726	3.06306991691998e-05	FCER1A	cDCs	GSE169246_PacBlood_post	ENSG00000179639	2205	Fc epsilon receptor Ia	FCE1A|FcepsilonRIalpha|FCERIA	protein_coding	P12319	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57074
1.71073776917044e-09	0.301273210121486	0.579	0.317	3.37631206123478e-05	KHDRBS1	cDCs	GSE169246_PacBlood_post	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57075
1.74887364725361e-09	0.321986514236681	0.752	0.528	3.45157703021973e-05	PGK1	cDCs	GSE169246_PacBlood_post	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57076
2.24050059813611e-09	-0.366499722094811	0.927	0.921	4.42185198048143e-05	COX6A1	cDCs	GSE169246_PacBlood_post	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57077
2.24980712236045e-09	0.298548692446732	0.461	0.214	4.44021933669058e-05	ARL5A	cDCs	GSE169246_PacBlood_post	ENSG00000162980	26225	ADP ribosylation factor like GTPase 5A	ARL5	protein_coding	Q9Y689	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57078
2.28515154998845e-09	0.278088751556083	0.903	0.663	4.50997509905721e-05	BRK1	cDCs	GSE169246_PacBlood_post	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57079
2.35047901968813e-09	0.253253385041209	0.703	0.452	4.63890539325649e-05	SERPINB1	cDCs	GSE169246_PacBlood_post	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57080
2.56987723112804e-09	0.282446053699064	0.403	0.175	5.0719097033543e-05	OTULINL	cDCs	GSE169246_PacBlood_post	ENSG00000145569	54491	OTU deubiquitinase with linear linkage specificity like	FAM105A|FLJ11127|NET20	protein_coding	Q9NUU6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57081
2.67045102823025e-09	0.266803696131766	0.303	0.099	5.27040214931522e-05	SMCO4	cDCs	GSE169246_PacBlood_post	ENSG00000166002	56935	single-pass membrane protein with coiled-coil domains 4	C11orf75|FN5	protein_coding	Q9NRQ5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57082
2.92910330381418e-09	0.309207496304369	0.573	0.321	5.78087828040767e-05	RSL1D1	cDCs	GSE169246_PacBlood_post	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57083
3.06243473061354e-09	0.350941494983221	0.636	0.409	6.04402118433889e-05	PRCP	cDCs	GSE169246_PacBlood_post	ENSG00000137509	5547	prolylcarboxypeptidase	HUMPCP|PCP	protein_coding	P42785	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57084
3.1051309185942e-09	0.331842697905711	0.694	0.444	6.1282863809375e-05	TGFB1	cDCs	GSE169246_PacBlood_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57085
3.24717350979845e-09	0.318337446701523	0.521	0.278	6.40862163893821e-05	GHITM	cDCs	GSE169246_PacBlood_post	ENSG00000165678	27069	growth hormone inducible transmembrane protein	DERP2|HSPC282|My021|PTD010|TMBIM5	protein_coding	Q9H3K2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57086
3.34156021941725e-09	0.3045868952783	0.955	0.849	6.59490324904189e-05	LAPTM5	cDCs	GSE169246_PacBlood_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57087
3.87528237248881e-09	0.49705595630815	1	1	7.64825729034391e-05	HLA-DPB1	cDCs	GSE169246_PacBlood_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57088
4.04796868173001e-09	0.28080910756177	0.333	0.123	7.98907099026236e-05	SRM	cDCs	GSE169246_PacBlood_post	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57089
4.16563735551622e-09	0.348819109124896	0.461	0.23	8.22130188484681e-05	IFNGR1	cDCs	GSE169246_PacBlood_post	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57090
4.36849546129115e-09	-0.259132968151466	0.082	0.262	8.62166264240422e-05	SIGLEC1	cDCs	GSE169246_PacBlood_post	ENSG00000088827	6614	sialic acid binding Ig like lectin 1	CD169|dJ1009E24.1|FLJ00051|FLJ00055|FLJ00073|FLJ32150|sialoadhesin|SIGLEC-1|SN	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57091
5.03456773699185e-09	0.379318499695841	0.321	0.115	9.93622288572711e-05	RETN	cDCs	GSE169246_PacBlood_post	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57092
5.23881452419983e-09	-0.332606345116184	0.148	0.345	0.000103393243449608	SAMD9L	cDCs	GSE169246_PacBlood_post	ENSG00000177409	219285	sterile alpha motif domain containing 9 like	C7orf6|FLJ39885|KIAA2005	protein_coding	Q8IVG5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57093
5.87571576707539e-09	0.450144237033152	0.5	0.278	0.000115963126379	SERPINA1	cDCs	GSE169246_PacBlood_post	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57094
6.25802283912012e-09	-0.384902560384975	0.715	0.81	0.000123508338752875	ELOB	cDCs	GSE169246_PacBlood_post	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57095
7.14774277664697e-09	-0.676212795634645	0.703	0.782	0.000141067851439905	LY6E	cDCs	GSE169246_PacBlood_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57096
7.38026291146798e-09	0.307247111166118	0.818	0.583	0.000145656868820732	ERP29	cDCs	GSE169246_PacBlood_post	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57097
8.18792587507566e-09	0.28548925666149	0.864	0.599	0.000161596905070493	HCLS1	cDCs	GSE169246_PacBlood_post	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57098
8.46997564759014e-09	-0.303312416720015	0.997	1	0.000167163439380839	UBA52	cDCs	GSE169246_PacBlood_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57099
9.50965741203714e-09	0.296654633109797	0.676	0.409	0.000187682598683965	ATP6V1G1	cDCs	GSE169246_PacBlood_post	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57100
9.70226004326039e-09	0.259416813564932	0.594	0.333	0.000191483804213787	VDAC1	cDCs	GSE169246_PacBlood_post	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57101
9.81383361550384e-09	0.346690757389858	0.97	0.893	0.000193685820235584	MT-ND5	cDCs	GSE169246_PacBlood_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57102
1.09294519852323e-08	0.348779248293168	0.497	0.278	0.000215703664380545	PLBD1	cDCs	GSE169246_PacBlood_post	ENSG00000121316	79887	phospholipase B domain containing 1	FLJ22662	protein_coding	Q6P4A8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57103
1.10218854750577e-08	0.346268836448977	0.518	0.294	0.000217527931735738	DOK2	cDCs	GSE169246_PacBlood_post	ENSG00000147443	9046	docking protein 2	Dok-2|p56dok-2	protein_coding	O60496	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57104
1.14256881712091e-08	0.317429274299044	0.758	0.516	0.000225497381746983	RAB31	cDCs	GSE169246_PacBlood_post	ENSG00000168461	11031	RAB31, member RAS oncogene family	Rab22B	protein_coding	Q13636	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57105
1.14701147660883e-08	0.283663104616923	0.406	0.187	0.000226374185023518	SRP9	cDCs	GSE169246_PacBlood_post	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57106
1.24748530255096e-08	0.2860208644944	0.382	0.167	0.000246203699311458	LAPTM4A	cDCs	GSE169246_PacBlood_post	ENSG00000068697	9741	lysosomal protein transmembrane 4 alpha	HUMORF13|KIAA0108|LAPTM4|MBNT|Mtrp	protein_coding	Q15012	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57107
1.27560270652378e-08	0.355879362412073	0.909	0.75	0.000251752950159533	PRELID1	cDCs	GSE169246_PacBlood_post	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57108
1.38002438579541e-08	0.270658177093604	0.476	0.242	0.000272361612780582	PRDX3	cDCs	GSE169246_PacBlood_post	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57109
1.53090079840378e-08	0.271080514183163	0.988	0.901	0.00030213858157297	ARHGDIB	cDCs	GSE169246_PacBlood_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57110
1.64441597557309e-08	0.310378934560172	0.488	0.266	0.000324541936939106	RAP1B	cDCs	GSE169246_PacBlood_post	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57111
1.69858600088393e-08	0.280343271251333	0.555	0.31	0.000335232933134452	SSU72	cDCs	GSE169246_PacBlood_post	ENSG00000160075	29101	SSU72 homolog, RNA polymerase II CTD phosphatase	HSPC182	protein_coding	Q9NP77	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57112
1.69974470231177e-08	0.292733583130157	0.655	0.425	0.000335461614448251	WAS	cDCs	GSE169246_PacBlood_post	ENSG00000015285	7454	WASP actin nucleation promoting factor	IMD2|THC|WASP|WASPA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57113
1.74019763017569e-08	0.337072783351528	0.473	0.238	0.000343445404291474	MYADM	cDCs	GSE169246_PacBlood_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57114
2.0442086787603e-08	0.395512761938567	0.894	0.714	0.000403445024840132	CTSS	cDCs	GSE169246_PacBlood_post	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57115
2.05213772763921e-08	-0.391003807079185	0.755	0.837	0.000405009901926875	PSMB9	cDCs	GSE169246_PacBlood_post	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57116
2.27676394223565e-08	-0.287258552788584	0.106	0.282	0.000449342131639628	RNF145	cDCs	GSE169246_PacBlood_post	ENSG00000145860	153830	ring finger protein 145	FLJ31951	protein_coding	Q96MT1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57117
2.29260068918713e-08	0.279617290029398	0.518	0.286	0.000452467672017971	IL13RA1	cDCs	GSE169246_PacBlood_post	ENSG00000131724	3597	interleukin 13 receptor subunit alpha 1	CD213a1|IL-13Ra|NR4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57118
2.32886053743128e-08	0.274377328894074	0.5	0.262	0.000459623915667437	ZNF706	cDCs	GSE169246_PacBlood_post	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57119
2.42266916186167e-08	0.292596229386931	0.661	0.417	0.000478137985785019	ZNF385A	cDCs	GSE169246_PacBlood_post	ENSG00000161642	25946	zinc finger protein 385A	DKFZp586G1122|Hzf|ZFP385|ZNF385	protein_coding	Q96PM9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57120
2.72193468937126e-08	0.282229782261397	0.433	0.21	0.000537201030294313	RAB24	cDCs	GSE169246_PacBlood_post	ENSG00000169228	53917	RAB24, member RAS oncogene family	NA	protein_coding	Q969Q5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57121
2.74397206539425e-08	0.296789037824847	0.879	0.69	0.000541550326826209	JAML	cDCs	GSE169246_PacBlood_post	ENSG00000160593	120425	junction adhesion molecule like	AMICA|AMICA1|Gm638	protein_coding	Q86YT9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57122
2.80675702675269e-08	0.277714301138904	0.442	0.222	0.000553941566799912	SDCBP	cDCs	GSE169246_PacBlood_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57123
2.91744868211872e-08	0.273059607956835	0.558	0.313	0.00057578767190295	LRRC25	cDCs	GSE169246_PacBlood_post	ENSG00000175489	126364	leucine rich repeat containing 25	FLJ38116|MAPA	protein_coding	Q8N386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57124
3.08580936318149e-08	0.281154291207606	0.903	0.754	0.0006090153359175	ARF5	cDCs	GSE169246_PacBlood_post	ENSG00000004059	381	ADP ribosylation factor 5	NA	protein_coding	P84085	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57125
3.20211641791674e-08	0.270072966414258	0.433	0.21	0.000631969696240048	MAP2K2	cDCs	GSE169246_PacBlood_post	ENSG00000126934	5605	mitogen-activated protein kinase kinase 2	MEK2|PRKMK2	protein_coding	P36507	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57126
3.29894149884446e-08	0.271647536138502	0.503	0.274	0.000651079094211943	SNX17	cDCs	GSE169246_PacBlood_post	ENSG00000115234	9784	sorting nexin 17	KIAA0064	protein_coding	Q15036	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57127
3.32229137956629e-08	0.29060146312316	0.527	0.298	0.000655687426671204	CAPZA2	cDCs	GSE169246_PacBlood_post	ENSG00000198898	830	capping actin protein of muscle Z-line subunit alpha 2	CAPPA2|CAPZ	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57128
3.34155581485818e-08	0.266920978876396	0.503	0.27	0.000659489455620411	C1orf43	cDCs	GSE169246_PacBlood_post	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57129
3.41904556660725e-08	0.26020096130752	0.279	0.095	0.000674782833025607	PDLIM2	cDCs	GSE169246_PacBlood_post	ENSG00000120913	64236	PDZ and LIM domain 2	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57130
3.67323661955195e-08	0.32101542995679	0.585	0.373	0.000724949979234772	CLEC4A	cDCs	GSE169246_PacBlood_post	ENSG00000111729	50856	C-type lectin domain family 4 member A	CD367|CLECSF6|DCIR|DDB27|hDCIR	protein_coding	Q9UMR7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57131
3.67571434537474e-08	0.290933324835477	0.282	0.095	0.000725438983203158	F13A1	cDCs	GSE169246_PacBlood_post	ENSG00000124491	2162	coagulation factor XIII A chain	F13A	protein_coding	P00488	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57132
4.15625167607954e-08	0.274619171442572	0.473	0.25	0.000820277830791058	SPG21	cDCs	GSE169246_PacBlood_post	ENSG00000090487	51324	SPG21 abhydrolase domain containing, maspardin	ABHD21|ACP33|BM-019|GL010|MAST	protein_coding	Q9NZD8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57133
4.50776066439527e-08	0.255072655202219	0.767	0.508	0.00088965164472505	PRR13	cDCs	GSE169246_PacBlood_post	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57134
4.69312939551788e-08	0.257981178107508	0.603	0.357	0.000926236017499409	UQCRFS1	cDCs	GSE169246_PacBlood_post	ENSG00000169021	7386	ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	RIP1|RIS1|RISP|UQCR5	protein_coding	P47985	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57135
4.91298437337802e-08	0.312132184243715	0.379	0.179	0.000969626595929886	HEBP2	cDCs	GSE169246_PacBlood_post	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57136
4.94134189859704e-08	0.266441901281665	0.545	0.317	0.000975223237107112	UBE2I	cDCs	GSE169246_PacBlood_post	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57137
5.09705143073988e-08	0.259067928501601	0.358	0.151	0.00100595407037082	METTL9	cDCs	GSE169246_PacBlood_post	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57138
5.39977671426907e-08	0.263917328162997	0.367	0.163	0.00106569993232814	BNIP3L	cDCs	GSE169246_PacBlood_post	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57139
6.08298398775576e-08	-0.422867168394165	0.461	0.647	0.00120053771982348	MBNL1	cDCs	GSE169246_PacBlood_post	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57140
6.29288222270564e-08	0.273262298508422	0.533	0.302	0.00124196323547319	TXNL4A	cDCs	GSE169246_PacBlood_post	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57141
6.58228969133048e-08	0.319302625480539	0.497	0.286	0.00129908069348098	ACAA1	cDCs	GSE169246_PacBlood_post	ENSG00000060971	30	acetyl-CoA acyltransferase 1	Lnc-Myd88	protein_coding	P09110	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57142
7.06045680577012e-08	-0.412889032700267	0.373	0.548	0.00139345175518679	SP110	cDCs	GSE169246_PacBlood_post	ENSG00000135899	3431	SP110 nuclear body protein	IFI41|IFI75	protein_coding	Q9HB58	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57143
9.02574959944308e-08	0.316214443692969	0.552	0.333	0.00178132194094609	TMEM14C	cDCs	GSE169246_PacBlood_post	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57144
9.11825966226569e-08	0.254955680272209	0.63	0.393	0.00179957972694476	NCL	cDCs	GSE169246_PacBlood_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57145
9.6948167308851e-08	0.259409035960644	0.464	0.246	0.00191336903000748	FBL	cDCs	GSE169246_PacBlood_post	ENSG00000280548	2091	fibrillarin	FIB|FLRN|Nop1|RNU3IP1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57146
9.92920821235126e-08	0.258727850275071	0.718	0.5	0.00195962853278964	RAN	cDCs	GSE169246_PacBlood_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57147
1.03163704152567e-07	-0.306464977499558	0.955	0.964	0.00203603886515505	RPL27A	cDCs	GSE169246_PacBlood_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57148
1.03628884960795e-07	0.261658007216858	0.3	0.115	0.00204521967358625	SLC16A3	cDCs	GSE169246_PacBlood_post	ENSG00000141526	9123	solute carrier family 16 member 3	MCT3|MCT4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57149
1.11386278373839e-07	0.476297213387907	0.997	1	0.00219831958998609	FTL	cDCs	GSE169246_PacBlood_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57150
1.17134415337433e-07	0.272961245739085	0.427	0.218	0.00231176482109958	GCA	cDCs	GSE169246_PacBlood_post	ENSG00000115271	25801	grancalcin	GCL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57151
1.20216368659712e-07	0.337328188181108	0.727	0.524	0.00237259025186807	CSTA	cDCs	GSE169246_PacBlood_post	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57152
1.34617495421518e-07	0.286646963055744	0.373	0.179	0.00265681088963908	HSD17B11	cDCs	GSE169246_PacBlood_post	ENSG00000198189	51170	hydroxysteroid 17-beta dehydrogenase 11	17-BETA-HSD11|17-BETA-HSDXI|DHRS8|PAN1B|RetSDR2|SDR16C2	protein_coding	Q8NBQ5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57153
1.4114908943839e-07	0.295270554340883	0.512	0.31	0.00278571842915606	CPPED1	cDCs	GSE169246_PacBlood_post	ENSG00000103381	55313	calcineurin like phosphoesterase domain containing 1	CSTP1|FLJ11151	protein_coding	Q9BRF8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57154
1.42152295942333e-07	0.272746835497797	0.458	0.246	0.00280551771271789	RAB5IF	cDCs	GSE169246_PacBlood_post	ENSG00000101084	55969	RAB5 interacting factor	C20orf24|PNAS-11|RCAF1|RIP5	protein_coding	Q9BUV8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57155
1.44321610751472e-07	0.256597573322655	0.627	0.397	0.00284833130979105	ARF1	cDCs	GSE169246_PacBlood_post	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57156
1.93248241688139e-07	-0.406320282177735	0.433	0.579	0.00381394729795711	C4orf48	cDCs	GSE169246_PacBlood_post	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57157
2.07716845844341e-07	0.250312506793885	0.442	0.23	0.00409949966958391	MLF2	cDCs	GSE169246_PacBlood_post	ENSG00000089693	8079	myeloid leukemia factor 2	NTN4	protein_coding	Q15773	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57158
2.22459348409502e-07	-0.353506133519137	0.206	0.385	0.00439045770020994	EIF2AK2	cDCs	GSE169246_PacBlood_post	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57159
2.3130287892772e-07	-0.312988050534148	0.118	0.278	0.00456499361851747	RABGAP1L	cDCs	GSE169246_PacBlood_post	ENSG00000152061	9910	RAB GTPase activating protein 1 like	FLJ38519|HHL|KIAA0471|TBC1D18	protein_coding	Q5R372	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57160
2.42908627130231e-07	-0.283050449407418	1	1	0.00479404466504225	RPS15A	cDCs	GSE169246_PacBlood_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57161
2.89885396873538e-07	1.21897922575586	0.624	0.504	0.00572117819269614	S100A9	cDCs	GSE169246_PacBlood_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57162
2.98859652463364e-07	0.272155795802342	0.624	0.405	0.00589829410101695	ATG3	cDCs	GSE169246_PacBlood_post	ENSG00000144848	64422	autophagy related 3	APG3L|DKFZp564M1178|FLJ22125|MGC15201|PC3-96	protein_coding	Q9NT62	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57163
3.056680123699e-07	0.355848544365051	0.724	0.583	0.00603266389213235	PPDPF	cDCs	GSE169246_PacBlood_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57164
3.14060874741024e-07	0.373029879316047	0.4	0.214	0.00619830542388884	CD36	cDCs	GSE169246_PacBlood_post	ENSG00000135218	948	CD36 molecule	FAT|GP3B|GP4|GPIV|SCARB3	protein_coding	P16671	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57165
3.19729180173548e-07	-0.310951796122804	0.994	1	0.00631017509990514	S100A6	cDCs	GSE169246_PacBlood_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57166
3.27355436236882e-07	0.277611956937046	0.888	0.647	0.00646068688957111	ATP5MC3	cDCs	GSE169246_PacBlood_post	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57167
3.2993206024429e-07	0.276124851794194	0.606	0.405	0.00651153914098131	RGS19	cDCs	GSE169246_PacBlood_post	ENSG00000171700	10287	regulator of G protein signaling 19	GAIP|RGSGAIP	protein_coding	P49795	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57168
3.55965220607464e-07	0.265585027564925	0.67	0.464	0.0070253295939089	SERBP1	cDCs	GSE169246_PacBlood_post	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57169
3.89056591835005e-07	0.275854225619005	0.252	0.091	0.00767842089645567	LIPA	cDCs	GSE169246_PacBlood_post	ENSG00000107798	3988	lipase A, lysosomal acid type	CESD|LAL	protein_coding	P38571	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57170
4.28397582273174e-07	-0.303421865192615	0.509	0.675	0.00845485468374337	NDUFA13	cDCs	GSE169246_PacBlood_post	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57171
5.39751085510629e-07	0.256292827954739	0.512	0.294	0.0106525274236378	MARCH1	cDCs	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57172
5.42451178724121e-07	0.292673442854844	0.506	0.31	0.0107058164632992	EIF3D	cDCs	GSE169246_PacBlood_post	ENSG00000100353	8664	eukaryotic translation initiation factor 3 subunit D	eIF3-p66|eIF3-zeta|EIF3S7	protein_coding	O15371	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57173
5.52455407700787e-07	0.264177738378818	0.506	0.298	0.0109032599263827	MAN2B1	cDCs	GSE169246_PacBlood_post	ENSG00000104774	4125	mannosidase alpha class 2B member 1	LAMAN|MANB	protein_coding	O00754	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57174
5.8272173530473e-07	0.275973461541292	0.476	0.278	0.0115005961679742	TOMM22	cDCs	GSE169246_PacBlood_post	ENSG00000100216	56993	translocase of outer mitochondrial membrane 22	TOM22	protein_coding	Q9NS69	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57175
7.32263174873392e-07	-0.374207249582957	0.136	0.294	0.0144519460193013	IFIT3	cDCs	GSE169246_PacBlood_post	ENSG00000119917	3437	interferon induced protein with tetratricopeptide repeats 3	CIG-49|GARG-49|IFI60|IFIT4|IRG2|ISG60|RIG-G	protein_coding	O14879	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57176
7.58287243838596e-07	0.259645807585644	0.394	0.206	0.0149655570443985	CD300C	cDCs	GSE169246_PacBlood_post	ENSG00000167850	10871	CD300c molecule	CMRF-35A|CMRF35|CMRF35A|IGSF16|LIR	protein_coding	Q08708	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57177
8.58098178799872e-07	0.276426173201904	0.982	0.917	0.0169354256567943	FCER1G	cDCs	GSE169246_PacBlood_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57178
1.00281822189658e-06	0.256411970331624	0.642	0.44	0.019791620427351	MDH2	cDCs	GSE169246_PacBlood_post	ENSG00000146701	4191	malate dehydrogenase 2	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57179
1.01708954283454e-06	-0.362832411423051	0.618	0.714	0.0200732792173824	POLR2L	cDCs	GSE169246_PacBlood_post	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57180
1.02438065953492e-06	-0.382596881480717	0.706	0.766	0.0202171766965812	NDUFB11	cDCs	GSE169246_PacBlood_post	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57181
1.07467530664398e-06	0.340816416926047	0.6	0.401	0.0212097918519256	CD99	cDCs	GSE169246_PacBlood_post	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57182
1.29653561890479e-06	0.447186744676633	0.555	0.377	0.0255884269747049	MT-ND6	cDCs	GSE169246_PacBlood_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57183
1.57314269077813e-06	1.36171496227284	0.436	0.298	0.0310475441451971	S100A8	cDCs	GSE169246_PacBlood_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57184
1.76036845922345e-06	-0.63156062654556	0.452	0.567	0.0347426319112341	IFI6	cDCs	GSE169246_PacBlood_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57185
1.84981327490076e-06	-0.308053449711254	0.206	0.365	0.0365079147934414	HSPB1	cDCs	GSE169246_PacBlood_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57186
1.85584082180067e-06	-0.322306764944102	0.897	0.893	0.0366268744590581	COX8A	cDCs	GSE169246_PacBlood_post	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57187
2.01426812020006e-06	0.485426827170242	0.7	0.544	0.0397535956202684	CLEC10A	cDCs	GSE169246_PacBlood_post	ENSG00000132514	10462	C-type lectin domain containing 10A	CD301|CLECSF13|CLECSF14|HML|HML2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57188
2.1591055052321e-06	0.254336896200579	0.536	0.333	0.0426121062512607	TAF10	cDCs	GSE169246_PacBlood_post	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57189
2.19554252831668e-06	0.28080910756177	0.494	0.306	0.0433312273388579	HMGA1	cDCs	GSE169246_PacBlood_post	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57190
1.69162193246709e-12	-1.18521304510369	0.971	1	3.33858504591705e-08	MT-ATP6	pDCs	GSE169246_PacBlood_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57191
1.09629224709437e-20	0.415037499278844	0.333	0	2.16364237886546e-16	GSTM1	Progenitors	GSE169246_PacBlood_post	ENSG00000134184	2944	glutathione S-transferase mu 1	GST1|H-B|MU	protein_coding	P09488	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57192
4.76010596407468e-15	-0.693299270162261	1	1	9.39454513069778e-11	RPL39	Progenitors	GSE169246_PacBlood_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57193
1.82388246645425e-14	0.869728240721344	1	0.935	3.59961443579412e-10	NPM1	Progenitors	GSE169246_PacBlood_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57194
3.47313859717077e-14	-1.35937027934121	0.98	0.992	6.85458633537623e-10	MALAT1	Progenitors	GSE169246_PacBlood_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57195
6.26002562780913e-14	-0.648511586921983	1	1	1.23547865790441e-09	RPS21	Progenitors	GSE169246_PacBlood_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57196
4.30735745298795e-13	0.676730433153747	1	1	8.50100066921703e-09	RPL3	Progenitors	GSE169246_PacBlood_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57197
6.24016546817233e-13	-0.933796059316994	0.941	1	1.23155905679849e-08	MT-ND4	Progenitors	GSE169246_PacBlood_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57198
9.41898212688333e-13	0.927728606953504	1	0.951	1.85893031256169e-08	ACTG1	Progenitors	GSE169246_PacBlood_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57199
1.00264397391572e-12	-0.542808522377912	1	1	1.97881814692006e-08	RPLP1	Progenitors	GSE169246_PacBlood_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57200
1.24723865911251e-12	0.844509952083669	0.98	0.895	2.46155021762446e-08	HLA-B	Progenitors	GSE169246_PacBlood_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57201
1.40848553120972e-12	-0.593271502851464	1	1	2.7797870443955e-08	RPLP2	Progenitors	GSE169246_PacBlood_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57202
2.47973855595339e-12	0.793985907023194	1	1	4.89401201402962e-08	EEF1A1	Progenitors	GSE169246_PacBlood_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57203
2.58065156119444e-12	0.762134681781979	1	0.887	5.09317392117336e-08	EEF1G	Progenitors	GSE169246_PacBlood_post	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57204
4.42390777309721e-12	0.772593154445678	0.961	0.721	8.73102438098466e-08	H2AFY	Progenitors	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57205
5.27468216187583e-12	1.02077358920555	1	0.955	1.04101127146781e-07	ACTB	Progenitors	GSE169246_PacBlood_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57206
5.71636428182384e-12	-0.481817196380236	1	1	1.12818165466075e-07	RPL37	Progenitors	GSE169246_PacBlood_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57207
7.89401806830904e-12	0.786445398133893	0.922	0.583	1.55796340596147e-07	TUBB	Progenitors	GSE169246_PacBlood_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57208
9.90496763291556e-12	-0.602696515640733	1	1	1.95484441203222e-07	RPL36	Progenitors	GSE169246_PacBlood_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57209
1.11076576407455e-11	0.829141827949551	1	0.923	2.19220731197752e-07	HNRNPA1	Progenitors	GSE169246_PacBlood_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57210
1.47549020993408e-11	0.604822745142311	1	1	2.9120274783259e-07	PTMA	Progenitors	GSE169246_PacBlood_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57211
1.74496648980658e-11	0.819877122074283	0.843	0.393	3.44386586428226e-07	TUBA1B	Progenitors	GSE169246_PacBlood_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57212
2.45436112599292e-11	0.651123400077913	0.824	0.372	4.84392711825963e-07	PCBP1	Progenitors	GSE169246_PacBlood_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57213
4.93818415736149e-11	-0.492331262860777	1	1	9.74600025296863e-07	RPS28	Progenitors	GSE169246_PacBlood_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57214
5.16883657656338e-11	0.773441549083999	0.824	0.377	1.02012158675055e-06	RBM3	Progenitors	GSE169246_PacBlood_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57215
5.97647275842514e-11	0.776867565989434	0.98	0.737	1.17951666360279e-06	H3F3B	Progenitors	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57216
2.22711006481715e-10	0.661658815221805	1	0.85	4.39542442392313e-06	LDHB	Progenitors	GSE169246_PacBlood_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57217
2.60463799046712e-10	-1.36446149825603	0.98	0.972	5.14051353798591e-06	RPS26	Progenitors	GSE169246_PacBlood_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57218
3.65609061885323e-10	0.647390120344343	0.961	0.579	7.21566044536874e-06	SLC25A3	Progenitors	GSE169246_PacBlood_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57219
5.55407221812316e-10	0.548551117121097	1	0.903	1.09615169296879e-05	ARHGDIB	Progenitors	GSE169246_PacBlood_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57220
5.65740121074784e-10	0.6631451806953	0.941	0.595	1.11654470295319e-05	RHOA	Progenitors	GSE169246_PacBlood_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57221
5.76748430075167e-10	0.822855782485159	0.804	0.417	1.13827070159635e-05	LAPTM4B	Progenitors	GSE169246_PacBlood_post	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57222
6.61456180196536e-10	0.642999359990204	0.882	0.526	1.30544991723588e-05	ATP5F1B	Progenitors	GSE169246_PacBlood_post	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57223
6.93285219573658e-10	0.666922121601162	0.98	0.903	1.36826770935057e-05	HSP90AB1	Progenitors	GSE169246_PacBlood_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57224
1.92768401175587e-09	0.507757564836256	0.725	0.291	3.80447716560138e-05	PGK1	Progenitors	GSE169246_PacBlood_post	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57225
2.48123031530211e-09	0.63851196899789	0.569	0.182	4.89695615028025e-05	CITED2	Progenitors	GSE169246_PacBlood_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57226
3.03638976630145e-09	0.62886702992014	0.941	0.761	5.99261884277254e-05	ANP32B	Progenitors	GSE169246_PacBlood_post	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57227
3.04363517695192e-09	-0.520433125339468	1	0.996	6.00691838523231e-05	RPL38	Progenitors	GSE169246_PacBlood_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57228
3.47146348976133e-09	0.752722738604922	0.98	0.765	6.85128034339297e-05	ZFP36L2	Progenitors	GSE169246_PacBlood_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57229
3.78953025355746e-09	0.657881700715795	0.922	0.656	7.479016908421e-05	NFE2	Progenitors	GSE169246_PacBlood_post	ENSG00000123405	4778	nuclear factor, erythroid 2	NF-E2	protein_coding	Q16621	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57230
5.56359237818393e-09	0.485037488336172	0.98	0.984	0.000109803059175838	MT-ND1	Progenitors	GSE169246_PacBlood_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57231
6.31430229697912e-09	-0.322840785904313	1	1	0.00012461907013318	RPL34	Progenitors	GSE169246_PacBlood_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57232
6.34864809022077e-09	0.566870301582638	0.922	0.599	0.000125296918708597	PEBP1	Progenitors	GSE169246_PacBlood_post	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57233
6.98436370019348e-09	0.558040557073898	1	0.874	0.000137843401987019	PCBP2	Progenitors	GSE169246_PacBlood_post	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57234
9.38711588703329e-09	0.580796471141603	0.725	0.344	0.000185264119146489	PAIP2	Progenitors	GSE169246_PacBlood_post	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57235
1.58063700697291e-08	0.68337546472869	0.98	0.972	0.000311954519696173	MT-ND4L	Progenitors	GSE169246_PacBlood_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57236
1.67964946406842e-08	0.757504007692546	0.98	0.907	0.000331495618228544	MT-ATP8	Progenitors	GSE169246_PacBlood_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57237
1.68456036700906e-08	-0.570963070597136	1	0.992	0.000332464834032908	RPL36A	Progenitors	GSE169246_PacBlood_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57238
1.83476746340587e-08	0.559113941018052	0.686	0.291	0.000362109706577782	SRP9	Progenitors	GSE169246_PacBlood_post	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57239
1.96342672675918e-08	0.584336828846852	0.804	0.437	0.000387501898793191	SARAF	Progenitors	GSE169246_PacBlood_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57240
2.31483149363427e-08	0.544901129404081	0.843	0.462	0.000456855143583659	CNBP	Progenitors	GSE169246_PacBlood_post	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57241
2.55632599983532e-08	0.586183198880416	0.882	0.583	0.000504516499327499	SET	Progenitors	GSE169246_PacBlood_post	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57242
2.76206356877852e-08	0.607147798088555	1	0.717	0.000545120865934129	EIF3L	Progenitors	GSE169246_PacBlood_post	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57243
2.83581809840019e-08	0.653985181409824	0.863	0.615	0.000559677059900261	APEX1	Progenitors	GSE169246_PacBlood_post	ENSG00000100823	328	apurinic/apyrimidinic endodeoxyribonuclease 1	APE|APE-1|APEN|APEX|APX|HAP1|REF-1|REF1	protein_coding	P27695	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57244
3.24880917476084e-08	-0.40783834732589	1	1	0.000641184978730798	RPL31	Progenitors	GSE169246_PacBlood_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57245
4.06083829111421e-08	0.684538775334197	0.843	0.51	0.0008014470451343	HSPA8	Progenitors	GSE169246_PacBlood_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57246
4.7297372869002e-08	-0.541375906317415	1	1	0.000933460950942624	RPL41	Progenitors	GSE169246_PacBlood_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57247
5.04154883081752e-08	0.53497436488948	0.765	0.381	0.000995000077250145	NREP	Progenitors	GSE169246_PacBlood_post	ENSG00000134986	9315	neuronal regeneration related protein	C5orf13|D4S114|P311|PRO1873|PTZ17|SEZ17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57248
5.72404135878506e-08	0.516728462046923	0.922	0.555	0.00112969680256982	CALR	Progenitors	GSE169246_PacBlood_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57249
6.30259641514885e-08	0.502775653731404	0.843	0.547	0.00124388042849378	RTRAF	Progenitors	GSE169246_PacBlood_post	ENSG00000087302	51637	RNA transcription, translation and transport factor	C14orf166|CGI-99|CLE|CLE7|hCLE1|LCRP369|RLLM1	protein_coding	Q9Y224	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57250
8.62003667133647e-08	-0.26259909895583	1	1	0.00170125043745497	RPS23	Progenitors	GSE169246_PacBlood_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57251
1.48954494327194e-07	0.489772297446206	0.686	0.308	0.0029397659000415	RAP1B	Progenitors	GSE169246_PacBlood_post	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57252
1.69778651318045e-07	-0.363497981288585	1	1	0.00335075146241293	RPS19	Progenitors	GSE169246_PacBlood_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57253
2.14436203652582e-07	0.491209876516249	0.686	0.32	0.00423211291528735	HNRNPA0	Progenitors	GSE169246_PacBlood_post	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57254
2.22749316930309e-07	0.360793143002355	1	1	0.00439618051893659	RPL6	Progenitors	GSE169246_PacBlood_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57255
2.64548359420678e-07	0.531596765081379	0.765	0.441	0.00522112642152651	LDHA	Progenitors	GSE169246_PacBlood_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57256
2.66528603528065e-07	0.484183822606596	0.627	0.287	0.00526020851922988	ASAH1	Progenitors	GSE169246_PacBlood_post	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57257
3.01695835138389e-07	0.542777865606832	0.765	0.441	0.00595426900229124	MORF4L1	Progenitors	GSE169246_PacBlood_post	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57258
3.3878408405807e-07	0.52979686867258	0.882	0.571	0.00668624268297006	IMPDH2	Progenitors	GSE169246_PacBlood_post	ENSG00000178035	3615	inosine monophosphate dehydrogenase 2	NA	protein_coding	P12268	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57259
3.69121882122245e-07	-0.346387002022221	1	1	0.00728498946556463	RPS15A	Progenitors	GSE169246_PacBlood_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57260
3.79748493194666e-07	-0.295184256044171	1	1	0.00749471626168993	RPL12	Progenitors	GSE169246_PacBlood_post	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57261
4.70705513730813e-07	0.486464458285834	0.824	0.462	0.00928984401899133	ATP5F1A	Progenitors	GSE169246_PacBlood_post	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57262
5.53740211883074e-07	0.532433449580204	0.745	0.385	0.0109286168217243	H1FX	Progenitors	GSE169246_PacBlood_post	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57263
6.5164122065195e-07	-0.591954574379473	0.431	0.81	0.0128607911307869	IFI44L	Progenitors	GSE169246_PacBlood_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57264
8.97497305741604e-07	0.319458611707683	1	1	0.0177130068261163	RPS6	Progenitors	GSE169246_PacBlood_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57265
1.04508221384659e-06	0.471761215350722	1	0.984	0.0206257425724763	FTH1	Progenitors	GSE169246_PacBlood_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57266
1.06367968091475e-06	0.475363377575849	0.98	1	0.0209927821825336	MT-CO3	Progenitors	GSE169246_PacBlood_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57267
1.11770587436287e-06	0.408944021128176	0.627	0.279	0.0220590431364257	PPP1CA	Progenitors	GSE169246_PacBlood_post	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57268
1.1299707825654e-06	0.475473353140818	0.824	0.53	0.0223011033647107	ARPC2	Progenitors	GSE169246_PacBlood_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57269
1.23210962928026e-06	0.389342416817527	1	1	0.0243169156434751	RPL5	Progenitors	GSE169246_PacBlood_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57270
1.39837798513963e-06	0.473502457969694	0.471	0.17	0.0275983879147157	SRM	Progenitors	GSE169246_PacBlood_post	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57271
1.61472514030786e-06	-0.538279388804956	1	1	0.031868215369116	RPS29	Progenitors	GSE169246_PacBlood_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57272
1.7527835934946e-06	0.495059178916769	0.725	0.437	0.0345929370012093	SRSF9	Progenitors	GSE169246_PacBlood_post	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57273
2.16162581514968e-06	0.404562055620281	0.569	0.243	0.0426618470877941	SUMO3	Progenitors	GSE169246_PacBlood_post	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57274
2.17878447498489e-06	0.52592014262153	0.686	0.336	0.0430004903983018	CD34	Progenitors	GSE169246_PacBlood_post	ENSG00000174059	947	CD34 molecule	NA	protein_coding	P28906	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57275
2.18372182193376e-06	0.429747225692217	0.588	0.271	0.0430979338776846	BCAP31	Progenitors	GSE169246_PacBlood_post	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57276
2.37367059134147e-06	0.521054387449713	0.784	0.522	0.0468467627907153	RAN	Progenitors	GSE169246_PacBlood_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57277
2.40241999592692e-06	0.420758442464963	0.588	0.263	0.0474141610396137	HNRNPF	Progenitors	GSE169246_PacBlood_post	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57278
2.41555631192405e-06	0.537875421650034	0.804	0.502	0.047673419372133	NCL	Progenitors	GSE169246_PacBlood_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57279
0	-0.449881306682912	0.987	0.999	0	RPL22	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57280
0	-0.4080184655666	0.999	1	0	RPL11	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57281
0	-0.348460828969221	1	1	0	RPS8	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57282
0	0.914721491118118	0.989	0.907	0	TXNIP	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57283
0	0.557630206740648	0.287	0.074	0	S100A9	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57284
0	-0.752062025447262	1	1	0	RPS27	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57285
0	0.786860073397995	0.963	0.867	0	PTPRC	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57286
0	-0.368300170269171	0.998	1	0	RPS7	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57287
0	1.01492709187828	0.936	0.673	0	ZFP36L2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57288
0	-0.457032612421507	0.999	1	0	RPS27A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57289
0	-0.690728903104195	0.999	1	0	TMSB10	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57290
0	-0.457031685985014	0.948	0.987	0	RPL31	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57291
0	0.659541292251838	0.56	0.335	0	ITGA4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57292
0	-0.601792769942801	0.991	0.999	0	RPL37A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57293
0	-0.544550567091631	1	1	0	RPL32	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57294
0	-0.353655316836659	0.996	0.999	0	RPL15	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57295
0	-0.443307310939176	0.993	0.999	0	RPSA	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57296
0	-0.422093239828634	0.998	1	0	RPL14	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57297
0	-0.404860072012921	0.855	0.952	0	TMA7	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57298
0	-0.472237574097523	0.996	1	0	RPL29	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57299
0	-0.39932665637006	0.989	0.999	0	RPL24	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57300
0	0.583483802314183	0.783	0.588	0	MBNL1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57301
0	-0.537664627053386	0.996	1	0	RPL35A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57302
0	-0.488520932676296	0.992	0.999	0	RPL9	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57303
0	-0.600305937828054	0.999	1	0	RPL34	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57304
0	0.616908946784408	0.91	0.798	0	IL7R	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57305
0	-0.626606672010481	0.999	1	0	RPL37	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57306
0	-0.443822773019796	0.999	1	0	RPS23	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57307
0	-0.444705995484296	0.885	0.966	0	COX7C	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57308
0	0.527828049094134	0.663	0.439	0	CAMK4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000152495	814	calcium/calmodulin dependent protein kinase IV	CaMK-GR|CaMKIV	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57309
0	-0.439838170097253	0.999	1	0	RPS14	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57310
0	0.470692785670317	0.31	0.082	0	DUSP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57311
0	0.646349113853088	0.82	0.648	0	RIPOR2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57312
0	-0.452922642103506	0.999	1	0	RPS18	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57313
0	-0.525343948326678	0.599	0.823	0	RPS10	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57314
0	-0.435836870524059	0.994	0.998	0	RPL10A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57315
0	0.436007642672816	0.914	0.812	0	PNRC1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57316
0	-0.520576146450361	1	1	0	RPS12	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57317
0	0.599641990696434	0.346	0.094	0	TNFAIP3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57318
0	0.557659899788687	0.672	0.441	0	TAGAP	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57319
0	-0.430634201764978	0.895	0.961	0	TOMM7	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57320
0	0.471562816981015	0.909	0.795	0	HNRNPA2B1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57321
0	-0.387080229655368	0.999	1	0	RPS4X	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57322
0	-0.818791954951072	0.757	0.943	0	RPL36A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57323
0	0.786053569541454	0.732	0.424	0	TSC22D3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57324
0	-0.684254172903467	0.998	1	0	RPL39	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57325
0	-0.450940764834587	1	1	0	RPL10	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57326
0	-0.500980394817391	0.999	1	0	RPL30	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57327
0	0.535947520398738	0.531	0.255	0	SEMA4D	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000187764	10507	semaphorin 4D	C9orf164|CD100|coll-4|FLJ39737|SEMAJ	protein_coding	Q92854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57328
0	-0.529084829252424	0.987	0.998	0	RPL35	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57329
0	-0.490838237792947	0.997	1	0	RPL12	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57330
0	-0.387454283205192	0.998	1	0	RPL7A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57331
0	-0.584966781997744	0.975	0.989	0	IFITM1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57332
0	-0.377381051224864	0.997	1	0	RPLP2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57333
0	3.03378642083588	0.373	0.044	0	HBB	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57334
0	0.497714687603533	0.628	0.39	0	EIF4G2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57335
0	-0.445710643277934	0.999	1	0	RPS13	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57336
0	0.690148172723301	0.642	0.394	0	AHNAK	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57337
0	0.467240571952951	0.767	0.569	0	SF1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57338
0	-0.436206132182491	0.997	1	0	FAU	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57339
0	0.560957495549536	1	1	0	MALAT1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57340
0	-0.422458879627611	0.999	1	0	RPS3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57341
0	-0.462740638817885	0.998	1	0	RPS25	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57342
0	-0.537737038298941	0.996	1	0	RPS24	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57343
0	0.648742468330878	0.61	0.326	0	KIAA1551	CD4+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57344
0	-1.08768691805694	0.981	1	0	RPL41	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57345
0	0.591248735131217	0.328	0.066	0	LYZ	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57346
0	0.665777966950572	0.985	0.918	0	BTG1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57347
0	-0.371983563924347	0.997	1	0	RPL6	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57348
0	-0.450376342708171	0.996	0.999	0	RPLP0	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57349
0	-0.527077139672965	0.992	0.999	0	RPL21	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57350
0	0.498292477097235	0.537	0.285	0	RASA3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000280477	22821	RAS p21 protein activator 3	GAP1IP4BP|GAPIII	protein_coding	Q14644	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57351
0	-0.833672474553671	0.986	0.999	0	RPS29	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57352
0	-0.543763347622381	1	1	0	RPLP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57353
0	-0.52968123309491	0.999	1	0	RPS15A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57354
0	-0.409819306581146	1	1	0	RPL13	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57355
0	-0.462458946393653	0.998	1	0	RPL26	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57356
0	-0.54643478236131	0.994	0.999	0	RPL23A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57357
0	-0.429272272791887	0.999	1	0	RPL19	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57358
0	-0.465916356534569	0.971	0.995	0	RPL27	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57359
0	0.618086047095391	0.943	0.799	0	DDX5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57360
0	-0.72019108792732	0.96	0.994	0	RPL38	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57361
0	-0.478919844549463	0.942	0.987	0	ATP5F1E	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57362
0	-0.772004309826618	0.997	1	0	RPS21	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57363
0	-0.483674378353471	0.998	1	0	RPS15	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57364
0	-0.592087835511161	0.996	1	0	RPL36	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57365
0	-0.663757803769232	0.999	1	0	RPS28	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57366
0	-0.461135126831199	0.999	1	0	RPL18A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57367
0	-0.398009086508619	0.985	0.998	0	UBA52	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57368
0	-0.391589314422303	0.995	0.999	0	RPS16	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57369
0	-0.557703259286422	0.999	1	0	RPS19	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57370
0	-0.41647483296042	0.999	1	0	RPL18	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57371
0	0.514794455622253	0.375	0.134	0	NKG7	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57372
0	-0.6220480027072	1	1	0	RPL28	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57373
0	-0.394939717113726	0.991	0.999	0	RPS5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57374
0	0.615117609603496	0.723	0.5	0	DDX17	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57375
0	0.532211712175835	0.673	0.423	0	SUN2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57376
0	-0.473316518090459	0.919	0.99	0	MT-ATP6	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57377
0	-0.487636990660378	0.938	0.972	0	MT-ND4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57378
0	0.59932556563927	0.997	0.967	0	MT-ND5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57379
0	0.644993275333387	0.754	0.559	0	MT-ND6	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57380
6.38748072984697e-306	0.518491249614186	0.667	0.458	1.2606331968426e-301	RSRP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57381
1.18136783449609e-302	0.476594937534426	0.444	0.208	2.33154755816148e-298	HIST1H1E	CD4+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57382
6.67254453832737e-299	-0.399755631942226	0.982	0.998	1.31689339008429e-294	MT-ND3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57383
8.71970031169029e-298	-0.362651457861835	1	1	1.7209200535152e-293	TMSB4X	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57384
1.92763148218914e-296	-0.365289763300982	0.945	0.974	3.80437349324848e-292	SERF2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57385
2.18549093163115e-295	0.457508709330925	0.556	0.325	4.31328490266723e-291	SFPQ	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57386
1.4424628986565e-292	-0.309138518042349	0.999	1	2.84684477678846e-288	RPS2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57387
2.49954549792701e-290	0.430681231877869	0.48	0.249	4.93310299470875e-286	PRKCH	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000027075	5583	protein kinase C eta	PKC-L|PKCL|PRKCL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57388
2.45215428110398e-287	0.387021339670195	0.97	0.88	4.83957168918681e-283	SARAF	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57389
2.73464955044801e-285	-0.371390246162287	0.929	0.973	5.39710435276419e-281	RPL27A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57390
4.72580997611253e-281	0.520140118089495	0.572	0.354	9.32685856885569e-277	ITK	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000113263	3702	IL2 inducible T cell kinase	EMT|LYK|PSCTK2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57391
2.80808379498499e-278	-0.396940512415401	0.484	0.71	5.54203417778238e-274	MZT2B	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57392
4.06632027443631e-278	-0.37908021529065	0.998	1	8.02528969362751e-274	RPS3A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57393
6.95638694563549e-277	-0.432801123638327	0.738	0.856	1.37291252759062e-272	PSME1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57394
2.55607021091778e-275	0.569894908061166	0.569	0.353	5.04466016826734e-271	KLF6	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57395
1.10157265007313e-271	0.409202124514384	0.501	0.279	2.17406378218433e-267	MATR3.1	CD4+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57396
4.07375197686725e-270	0.44823707354375	0.45	0.232	8.0399569015452e-266	DOCK10	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000135905	55619	dedicator of cytokinesis 10	KIAA0694|ZIZ3	protein_coding	Q96BY6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57397
2.14420520599131e-268	0.43964242156256	0.568	0.351	4.23180339454445e-264	EPB41	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000159023	2035	erythrocyte membrane protein band 4.1	4.1R|EL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57398
5.19774054380883e-266	0.498459995775849	0.611	0.401	1.02582607372611e-261	SMCHD1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57399
2.31725264178763e-263	-0.297868103967069	0.995	0.999	4.57332981383207e-259	RACK1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57400
1.1134145218555e-262	0.437903207814365	0.707	0.524	2.19743490033402e-258	STK4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57401
5.16120893747707e-262	0.384824675168411	0.335	0.136	1.01861619590047e-257	TMEM131L	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000121210	23240	transmembrane 131 like	DKFZp586H1322|KIAA0922	protein_coding	A2VDJ0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57402
1.50627687606771e-261	-0.336122622357885	0.933	0.976	2.97278804260723e-257	BTF3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57403
1.82195994179824e-261	0.469291464610114	0.598	0.385	3.59582014113301e-257	ATM	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57404
4.45581544118463e-259	0.493835955993282	0.576	0.368	8.793997354722e-255	CELF2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57405
9.91038601432705e-258	0.480014193637176	0.49	0.275	1.95591378378759e-253	TGFBR2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57406
1.46298205259117e-257	0.459445085917427	0.525	0.314	2.88734137899394e-253	STK38	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000112079	11329	serine/threonine kinase 38	NDR|NDR1	protein_coding	Q15208	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57407
8.34518285329633e-257	0.443618525106451	0.415	0.208	1.64700528792656e-252	SERINC5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000164300	256987	serine incorporator 5	C5orf12|TPO1	protein_coding	Q86VE9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57408
1.46111844197125e-256	-0.327080035532435	0.958	0.988	2.88366335707446e-252	PFDN5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57409
1.79510381690686e-256	-0.308683076925138	0.996	0.999	3.54281689304737e-252	RPS9	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57410
4.42212932562607e-253	0.423822758845321	0.606	0.398	8.72751443705561e-249	ARGLU1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57411
2.22134539512408e-251	0.44672801066949	0.593	0.387	4.38404727181688e-247	TC2N	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000276776	123036	tandem C2 domains, nuclear	C14orf47|C2CD1|FLJ36557|MTAC2D1|Tac2-N	protein_coding	Q8N9U0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57412
5.91896468250585e-251	0.40770825786141	0.521	0.307	1.16816686973935e-246	AC119396.1	CD4+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57413
1.185171329238e-250	0.396643549707826	0.491	0.277	2.33905413538411e-246	CDKN1B	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000111276	1027	cyclin dependent kinase inhibitor 1B	KIP1|P27KIP1	protein_coding	P46527	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57414
2.66567289473834e-250	0.419033482778906	0.43	0.22	5.26097202505559e-246	PAG1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000076641	55824	phosphoprotein membrane anchor with glycosphingolipid microdomains 1	CBP|PAG	protein_coding	Q9NWQ8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57415
6.24359252581735e-250	-0.361000059468335	0.764	0.899	1.23223542089531e-245	UQCRB	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57416
1.05186923468393e-249	0.43693826625513	0.664	0.479	2.07596912157221e-245	HNRNPU	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57417
1.12765329941372e-249	0.417398036615608	0.665	0.474	2.22553655172291e-245	TMEM123	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57418
8.92921680080747e-247	0.393430538981252	0.38	0.178	1.76227022780736e-242	FKBP5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57419
6.780461347206e-246	-0.318360009498679	0.995	1	1.33819185148458e-241	RPL5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57420
4.28702193333012e-245	0.410696911682393	0.746	0.602	8.46086648762033e-241	EIF4B	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57421
8.88410820249598e-243	-0.346243012446074	0.845	0.935	1.75336759484461e-238	RPL36AL	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57422
1.93982999437934e-240	0.359319008167423	0.382	0.179	3.82844847690707e-236	ATF7IP	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000171681	55729	activating transcription factor 7 interacting protein	ATF7IP1|FLJ10688|p621	protein_coding	Q6VMQ6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57423
9.23168642445709e-239	0.375384070000986	0.432	0.224	1.82196563273085e-234	PHF3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000118482	23469	PHD finger protein 3	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57424
2.55389888956551e-238	0.420156720307878	0.51	0.303	5.04037484844649e-234	ANKRD44	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57425
8.33357976724394e-238	0.34063022455619	0.366	0.166	1.64471530286326e-233	NFKB1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57426
2.85464379285723e-236	0.416911312036154	0.714	0.551	5.63392498958302e-232	CD44	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57427
9.95403188483107e-236	-0.323539301307008	0.933	0.967	1.96452773279026e-231	RPS11	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57428
1.6709686201959e-235	0.406069068609928	0.561	0.357	3.29782366881862e-231	CYTH1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000108669	9267	cytohesin 1	B2-1|cytohesin-1|D17S811E|PSCD1	protein_coding	Q15438	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57429
1.80853849856706e-234	-0.366027680249108	0.745	0.878	3.56933158077195e-230	MIF	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57430
4.24129867364055e-234	0.330575570079675	0.991	0.961	8.370627062297e-230	PABPC1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57431
6.92475905384486e-233	0.418312295545387	0.656	0.47	1.36667044686682e-228	IKZF1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57432
1.29540977033733e-227	0.447525569930817	0.583	0.396	2.55662072273775e-223	SF3B1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57433
6.84675063206131e-226	0.354666154348578	0.941	0.828	1.35127470474362e-221	KLF2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57434
7.18854429612406e-226	-0.431527825888903	0.225	0.435	1.41873110228304e-221	MT2A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57435
1.28232460290165e-225	0.376395141831209	0.904	0.821	2.5307958362867e-221	FYB1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57436
2.23422842577511e-225	0.427238908632406	0.749	0.586	4.40947322110976e-221	MYH9	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57437
9.67491252252025e-224	0.423503254676758	0.656	0.481	1.9094407354446e-219	NDFIP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57438
1.72872423904711e-223	0.404024793763355	0.51	0.311	3.41181015818337e-219	SLC38A1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57439
3.55525253293793e-222	0.652856985985445	0.544	0.35	7.01664639900629e-218	NEAT1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57440
1.2684853928238e-220	0.407200306977208	0.5	0.301	2.50348277127705e-216	AKAP13	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57441
3.75199707262043e-220	0.396136695263872	0.337	0.152	7.40494142252368e-216	SESN3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000149212	143686	sestrin 3	MGC29667|SEST3	protein_coding	P58005	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57442
1.58579482352791e-219	0.474161234194085	0.477	0.286	3.12972466371468e-215	IL6ST	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000134352	3572	interleukin 6 cytokine family signal transducer	CD130|GP130|IL-6RB|sGP130	protein_coding	P40189	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57443
1.61439023220712e-219	-0.342442404124576	0.694	0.849	3.18616056228397e-215	SNRPD2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57444
5.0592553550473e-217	0.36565586319383	0.465	0.266	9.98494636872136e-213	PIK3R1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57445
6.09915542030018e-216	-0.341772029839737	0.584	0.761	1.20372931375044e-211	UQCR11	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57446
8.86184404045694e-214	0.386406665375801	0.449	0.255	1.74897353982458e-209	LNPEP	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000113441	4012	leucyl and cystinyl aminopeptidase	CAP|IRAP|P-LAP|PLAP	protein_coding	Q9UIQ6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57447
2.5424420996153e-210	0.43229594632776	0.409	0.222	5.01776372780075e-206	PDE3B	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000152270	5140	phosphodiesterase 3B	HcGIP1	protein_coding	Q13370	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57448
1.12072890066531e-209	0.365550905565027	0.605	0.418	2.21187055835306e-205	LCP2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57449
8.37491823534801e-209	-0.343267146367348	0.972	0.987	1.65287386292828e-204	EEF1B2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57450
6.35777400377213e-208	0.384101400240929	0.51	0.321	1.25477027738447e-203	GLG1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57451
9.81676875567878e-206	0.396775692349812	0.601	0.421	1.93743748162076e-201	STK17B	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57452
1.00766641248845e-205	0.426688262477017	0.617	0.439	1.98873043168721e-201	PIK3IP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000100100	113791	phosphoinositide-3-kinase interacting protein 1	HGFL|MGC17330|TrIP	protein_coding	Q96FE7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57453
1.87746035169603e-205	0.398651967501291	0.603	0.419	3.70535575010729e-201	ZFP36L1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57454
1.46119570585297e-204	-0.328578670008472	0.791	0.904	2.88381584507143e-200	COMMD6	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57455
2.16939378583727e-204	-0.289061110063534	0.999	1	4.28151557572844e-200	RPS6	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57456
7.41972186884459e-204	-0.318933939694622	0.827	0.911	1.46435630803517e-199	ATP5MG	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57457
9.67686806590073e-202	-0.314401597425445	0.861	0.932	1.90982668148617e-197	ATP5MC2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57458
7.12950558819521e-199	0.362317404396492	0.414	0.227	1.40707922288621e-194	VPS13C	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000129003	54832	vacuolar protein sorting 13 homolog C	BLTP5C|FLJ10381|FLJ20136|KIAA1421	protein_coding	Q709C8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57459
2.02263111122019e-198	0.370086413293623	0.455	0.268	3.99186476110417e-194	OGT	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000147162	8473	O-linked N-acetylglucosamine (GlcNAc) transferase	FLJ23071|HRNT1|MGC22921|O-GLCNAC|OGT1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57460
1.41289562184645e-197	0.360006276407296	0.708	0.548	2.78849079927616e-193	JAK1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57461
2.98439765076953e-197	0.369104998578976	0.423	0.24	5.89000720355874e-193	DDX3X	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57462
1.58200221249723e-193	0.354205637035948	0.358	0.18	3.12223956658452e-189	HIST1H1D	CD4+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57463
1.04452021222472e-191	0.345152638439483	0.367	0.19	2.0614650908467e-187	SSH2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57464
3.98678503584395e-191	0.385620717240153	0.665	0.506	7.86831894674162e-187	RBM39	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57465
6.23888483303736e-191	-0.31735795097124	0.413	0.615	1.23130631064825e-186	NDUFA3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57466
2.72255892732156e-190	0.332756756198948	0.295	0.132	5.37324229896184e-186	STX16	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000124222	8675	syntaxin 16	hsyn16|SYN-16|SYN16	protein_coding	O14662	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57467
1.66837702390449e-189	0.374564369243065	0.29	0.129	3.2927088943779e-185	NFKBIZ	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57468
5.91692718567515e-189	0.360748731788383	0.487	0.298	1.16776474936485e-184	CAST	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57469
6.59312561405632e-188	0.405502814327028	0.636	0.468	1.30121927119016e-183	FOXP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57470
1.74138955934179e-187	0.377796134582197	0.494	0.31	3.43680643431695e-183	SORL1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000137642	6653	sortilin related receptor 1	C11orf32|gp250|LR11|LRP9|SorLA|SorLA-1	protein_coding	Q92673	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57471
4.334543809932e-187	-0.318779018292702	0.624	0.789	8.55465566328179e-183	COX6C	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57472
1.38170862520712e-186	0.325900418090934	0.441	0.257	2.72694014270876e-182	FNBP4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000285182	23360	formin binding protein 4	KIAA1014	protein_coding	Q8N3X1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57473
3.99144021507328e-186	0.363591914902662	0.5	0.317	7.87750640846863e-182	SPTAN1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000197694	6709	spectrin alpha, non-erythrocytic 1	NA	protein_coding	Q13813	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57474
1.02788795109635e-185	0.374232197301736	0.593	0.426	2.02863966028376e-181	RBL2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000103479	5934	RB transcriptional corepressor like 2	p130|Rb2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57475
2.03820193006053e-185	0.340807637289709	0.418	0.238	4.02259532916747e-181	CHD2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57476
1.98224513136823e-183	-0.309685493419306	0.357	0.555	3.91215899126833e-179	ATP5ME	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57477
2.11790120422967e-183	0.369179609293882	0.556	0.379	4.17988981666767e-179	MCL1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57478
3.18039725574007e-183	0.364779827679607	0.437	0.258	6.2768320239286e-179	NKTR	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57479
3.53703989669459e-183	0.343327636528392	0.507	0.324	6.98070194011644e-179	RBM25	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57480
1.62308726084853e-182	-0.362884650279728	0.457	0.629	3.20332501801066e-178	PSME2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57481
1.68546452460552e-182	0.358850501053861	0.562	0.387	3.32643278576145e-178	CD6	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000013725	923	CD6 molecule	Tp120	protein_coding	P30203	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57482
2.44352941063106e-181	0.340640130811386	0.387	0.211	4.82254964482147e-177	SPTBN1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000115306	6711	spectrin beta, non-erythrocytic 1	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57483
2.97625139374552e-181	0.387584923939254	0.406	0.233	5.87392975069616e-177	CD55	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57484
1.59374504692206e-180	0.295757366452606	0.34	0.17	3.14541522460537e-176	TLK1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198586	9874	tousled like kinase 1	KIAA0137|PKU-BETA	protein_coding	Q9UKI8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57485
1.1188282977902e-179	0.372551530878536	0.656	0.497	2.20811952851874e-175	FUS	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57486
1.1764772028916e-178	0.343138487507944	0.495	0.314	2.32189540762686e-174	MBP	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57487
2.20566723596873e-178	0.305720263610223	0.32	0.156	4.35310485690788e-174	NIN	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000100503	51199	ninein	NA	protein_coding	Q8N4C6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57488
3.51142781576619e-178	0.312413048054512	0.37	0.197	6.93015393719615e-174	TMPO	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57489
4.79708871398042e-178	0.334425973605864	0.676	0.516	9.46753428591175e-174	RCSD1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57490
5.87409964601489e-178	0.299380453959365	0.312	0.149	1.1593123061375e-173	PHC3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000173889	80012	polyhomeotic homolog 3	EDR3|FLJ12729|FLJ12967|HPH3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57491
6.74141778339436e-178	0.339284550011405	0.384	0.21	1.33048621373071e-173	UTRN	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000152818	7402	utrophin	DMDL|DRP|DRP1	protein_coding	P46939	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57492
1.46642599711184e-177	0.312790354908904	0.31	0.148	2.89413834789992e-173	ADAM10	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000137845	102	ADAM metallopeptidase domain 10	CD156C|HsT18717|kuz|MADM	protein_coding	O14672	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57493
1.85575837361207e-177	0.326375228067598	0.438	0.26	3.66252472616077e-173	BCLAF1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57494
1.27921971746586e-175	0.250298913965754	0.26	0.108	2.52466803439063e-171	NBPF15	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000266338	284565	NBPF member 15	MGC8902|NBPF16	protein_coding	Q8N660	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57495
3.4140083193697e-175	-0.314541680765027	0.624	0.772	6.73788681910805e-171	COX6B1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57496
8.31337532067088e-175	-0.317212362554371	0.729	0.846	1.64072775328761e-170	OST4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57497
5.72218058839905e-174	0.294121155326614	0.323	0.16	1.12932956092644e-169	MALT1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000172175	10892	MALT1 paracaspase	MLT|PCASP1	protein_coding	Q9UDY8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57498
2.26137688965375e-173	0.26585271519447	0.294	0.135	4.46305342942065e-169	TNKS2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000107854	80351	tankyrase 2	ARTD6|PARP-5b|PARP-5c|PARP5B|PARP5C|pART6|TANK2|TNKL	protein_coding	Q9H2K2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57499
3.0537390636576e-172	0.350189158505558	0.456	0.284	6.02685941603464e-168	CCNL1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57500
1.74334316168731e-171	0.31885912004563	0.375	0.205	3.44066206390607e-167	BTG2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57501
5.49639269961949e-171	0.308057549558203	0.471	0.291	1.0847680631969e-166	CD164	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57502
2.57028438205385e-170	0.311754100351119	0.327	0.164	5.07271325642149e-166	CEP350	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000135837	9857	centrosomal protein 350	CAP350|KIAA0480	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57503
4.80380370543049e-170	-0.268906038834076	0.972	0.988	9.48078699303762e-166	EEF1D	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57504
1.53096779623729e-169	0.372035818600486	0.613	0.455	3.02151804265392e-165	PRMT2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57505
4.84474862296699e-169	0.286514961047635	0.313	0.154	9.56159588228766e-165	CHD1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57506
6.61956275406271e-169	0.341858721001508	0.495	0.322	1.30643690514182e-164	ZC3HAV1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57507
5.63214861033693e-168	0.355808855441157	0.625	0.469	1.1115608497361e-163	LBH	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000213626	81606	LBH regulator of WNT signaling pathway	NA	protein_coding	Q53QV2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57508
8.0628040537692e-168	0.276565796197164	0.32	0.158	1.59127500805189e-163	SENP6	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000112701	26054	SUMO specific peptidase 6	KIAA0797|SUSP1	protein_coding	Q9GZR1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57509
9.3654576210754e-168	0.36444714718602	0.631	0.48	1.84836671609544e-163	CYTIP	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57510
1.15159503881979e-167	0.27525445975462	0.268	0.118	2.27278796861474e-163	RUNX1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000159216	861	RUNX family transcription factor 1	AML1|AMLCR1|CBFA2|PEBP2A2	protein_coding	Q01196	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57511
1.89339946195514e-167	0.364596999328734	0.732	0.583	3.73681317811466e-163	LCP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57512
3.74126573483701e-167	0.314793549119551	0.419	0.246	7.38376205427433e-163	RNF149	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000163162	284996	ring finger protein 149	FLJ90504	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57513
3.90198674178321e-167	0.298388916299242	0.336	0.173	7.70096103358333e-163	NORAD	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000260032	647979	non-coding RNA activated by DNA damage	LINC00657	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57514
4.51502846487728e-167	0.315644837565358	0.383	0.215	8.91086017828181e-163	NIPBL	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57515
5.24448491677805e-167	0.31632721151018	0.368	0.2	1.03505154317531e-162	RORA	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57516
6.81588457351167e-167	0.298273210448409	0.348	0.183	1.34518297942826e-162	PTBP3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000119314	9991	polypyrimidine tract binding protein 3	DKFZp781I1117|ROD1	protein_coding	O95758	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57517
1.25461242289079e-166	-0.251084898855749	0.991	0.999	2.47610307781727e-162	NACA	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57518
7.72861868207699e-166	0.331070064701087	0.611	0.454	1.52532018309471e-161	PPP1R2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57519
1.01957522914083e-165	0.312595805055679	0.404	0.234	2.01223367223235e-161	STK10	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000072786	6793	serine/threonine kinase 10	LOK|PRO2729	protein_coding	O94804	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57520
4.36873554135411e-165	0.318686507931908	0.343	0.182	8.62213646441647e-161	AC016831.7	CD4+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57521
1.44534507450699e-164	0.447525913943529	0.692	0.586	2.85253303904699e-160	LEF1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000138795	51176	lymphoid enhancer binding factor 1	TCF10|TCF1ALPHA|TCF7L3	protein_coding	Q9UJU2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57522
4.72563068028432e-164	0.320746248321161	0.564	0.4	9.32650471060913e-160	APBB1IP	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57523
6.26611653746338e-164	0.329020357417105	0.518	0.348	1.23668075983377e-159	WIPF1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57524
7.29120304009147e-163	0.326869055549101	0.434	0.266	1.43899183199245e-158	TTC3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57525
9.92310520475801e-163	0.306380069624455	0.475	0.302	1.95842404321104e-158	RAD21	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57526
1.05980830643983e-162	0.334963207860036	0.512	0.346	2.09163767358964e-158	CDC42SE1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57527
1.06679826613559e-162	0.289535192146382	0.35	0.187	2.10543305804519e-158	IL17RA	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000177663	23765	interleukin 17 receptor A	CD217|CDw217|hIL-17R|IL-17RA|IL17R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57528
5.97185488594197e-162	0.316903325157099	0.46	0.29	1.17860528028951e-157	PRPF8	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000274442	10594	pre-mRNA processing factor 8	hPrp8|Prp8|PRPC8|RP13|SNRNP220	protein_coding	Q6P2Q9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57529
1.65653637045358e-161	0.293646000114154	0.439	0.265	3.26934018072718e-157	FMNL1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57530
3.97186522880829e-161	0.307603275929578	0.999	0.986	7.83887321557604e-157	MT-ND4L	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57531
5.69363122724868e-161	0.320430425599917	0.827	0.735	1.1236950590098e-156	TRAF3IP3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57532
1.19364069601757e-160	0.365730788043913	0.661	0.514	2.35576927766028e-156	SAMHD1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57533
1.65933770426138e-160	0.312842085788322	0.478	0.307	3.27486889313027e-156	KIF2A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000068796	3796	kinesin family member 2A	HK2|KIF2	protein_coding	O00139	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57534
2.24354911074592e-160	0.32957991485668	0.581	0.421	4.42786852496814e-156	PSIP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57535
3.35344546029859e-160	0.298188469628444	0.404	0.237	6.6183599604453e-156	OSBPL8	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57536
1.72788437942848e-159	0.335316566933596	0.346	0.187	3.41015261124004e-155	CD69	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57537
1.02274987650463e-158	0.308121494034929	0.507	0.338	2.01849915626954e-154	ATP1A1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57538
1.68324710177358e-158	0.269198343309391	0.275	0.127	3.32205648006033e-154	CBLB	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000114423	868	Cbl proto-oncogene B	Cbl-b|RNF56	protein_coding	Q13191	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57539
2.32667437298891e-158	0.261489344024182	0.311	0.156	4.59192454253091e-154	KCNA3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000177272	3738	potassium voltage-gated channel subfamily A member 3	HLK3|HPCN3|Kv1.3|MK3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57540
8.52457475769384e-158	0.281624887694338	0.401	0.233	1.68241007417846e-153	SRSF4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57541
1.15732894120673e-157	0.359574147246458	0.432	0.265	2.2841043983656e-153	IL10RA	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57542
1.87573948764693e-157	0.315780833753225	0.472	0.303	3.70195945281998e-153	TMC8	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000167895	147138	transmembrane channel like 8	EVER2|EVIN2	protein_coding	Q8IU68	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57543
1.77752977468677e-156	0.319410368490909	0.32	0.168	3.50813276332181e-152	TXK	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000074966	7294	TXK tyrosine kinase	BTKL|PSCTK5|PTK4|RLK|TKL	protein_coding	P42681	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57544
2.88605938431187e-156	0.29052671800073	0.332	0.163	5.6959268008779e-152	CCL5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57545
4.58631417957173e-156	0.327412170469606	0.353	0.194	9.05154966480277e-152	MAML2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000184384	84441	mastermind like transcriptional coactivator 2	KIAA1819|MAM3	protein_coding	Q8IZL2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57546
1.70177833657904e-155	0.320504590712171	0.447	0.28	3.35862972507239e-151	ATRX	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57547
2.16254636716134e-155	0.312002551001801	0.432	0.265	4.26800151022962e-151	EIF3A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57548
2.36794338686078e-155	0.339729567380255	0.517	0.356	4.67337306830844e-151	CD47	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57549
3.19962606312813e-155	0.317625106528198	0.498	0.329	6.31478199818968e-151	ARID4B	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57550
2.72547160182629e-154	0.347518888640285	0.637	0.494	5.37899075336437e-150	PRRC2C	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57551
3.10623643096175e-153	0.267336145342198	0.297	0.148	6.13046822014611e-149	CCNH	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57552
7.19740335955087e-153	0.312999551735068	0.716	0.578	1.42047952704096e-148	NCL	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57553
1.05177995782898e-152	0.294917600144511	0.376	0.214	2.07579292477127e-148	CD46	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000117335	4179	CD46 molecule	MCP|MGC26544|MIC10|TLX|TRA2.10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57554
2.83295728816547e-152	0.410650103539787	0.412	0.255	5.59112450392337e-148	BCL2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000171791	596	BCL2 apoptosis regulator	Bcl-2|PPP1R50	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57555
3.4307535704045e-151	0.257169933191025	0.294	0.146	6.77093524655033e-147	CPSF6	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000111605	11052	cleavage and polyadenylation specific factor 6	CFIM|CFIM68|CFIM72|HPBRII-4|HPBRII-7	protein_coding	Q16630	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57556
1.08364909005254e-150	0.353942142198319	0.551	0.396	2.1386898441277e-146	SRSF11	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57557
5.54733422995372e-150	0.300175509490339	0.415	0.252	1.09482188362367e-145	TGOLN2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57558
1.02623829980712e-149	0.335473775678985	0.416	0.257	2.02538390849934e-145	SATB1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000182568	6304	SATB homeobox 1	NA	protein_coding	Q01826	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57559
2.27854083194263e-149	0.272516550565589	0.334	0.179	4.49692818592197e-145	RASA2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000155903	5922	RAS p21 protein activator 2	GAP1M	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57560
1.3053301043315e-148	0.278423574520585	0.333	0.18	2.57619949390866e-144	PTPN4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000088179	5775	protein tyrosine phosphatase non-receptor type 4	PTPMEG	protein_coding	P29074	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57561
1.41644762265193e-147	0.292730653411062	0.377	0.22	2.79550102806585e-143	ARHGEF3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000163947	50650	Rho guanine nucleotide exchange factor 3	DKFZP434F2429|GEF3|STA3|XPLN	protein_coding	Q9NR81	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57562
1.63138676122176e-147	0.274343138814517	0.342	0.186	3.21970491194726e-143	GOLGA4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57563
1.7970352217512e-147	0.345720430898839	0.421	0.261	3.54662871364817e-143	MACF1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57564
4.05038594693327e-147	0.308847788470587	0.383	0.225	7.99384170486749e-143	IQGAP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57565
4.20585915030524e-147	0.263101619708232	0.318	0.167	8.30068361904241e-143	FRYL	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000075539	285527	FRY like transcription coactivator	AF4p12|DKFZp686E205|KIAA0826|MOR2	protein_coding	O94915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57566
1.47902491258846e-146	0.32488260456362	0.996	0.972	2.91900356748458e-142	MT-ATP8	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57567
2.4606741563159e-146	0.322149870769249	0.52	0.361	4.85638651490505e-142	ACTR2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57568
9.5715472211415e-145	0.346693400133174	0.368	0.213	1.88904055956449e-140	XIST	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57569
1.17195958791756e-144	0.291781250799605	0.4	0.241	2.3129794427141e-140	EMB	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000170571	133418	embigin	MGC71745	protein_coding	Q6PCB8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57570
1.26133222093938e-144	-0.316617492672975	0.546	0.695	2.48936527124597e-140	NME2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57571
7.92232739145892e-144	0.289240515722048	0.384	0.227	1.56355053397833e-139	CCDC88C	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000015133	440193	coiled-coil domain containing 88C	DAPLE|HkRP2|KIAA1509|SCA40	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57572
7.54442583970043e-143	0.287649796443164	0.46	0.297	1.48896788372328e-138	EVI2B	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57573
8.16584202771474e-143	0.337359823320707	0.672	0.539	1.61161058258978e-138	SPOCK2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57574
1.42364462337424e-142	0.29122963041392	0.275	0.137	2.8097050286914e-138	GLS	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000115419	2744	glutaminase	GAC|GAM|GLS1|KGA|KIAA0838	protein_coding	O94925	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57575
1.70449720159079e-142	-0.278328810226316	0.661	0.799	3.36399567705958e-138	RPS17	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57576
4.39981428975042e-142	0.291063697813032	0.598	0.445	8.68347348225144e-138	CSDE1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57577
5.38120261366999e-141	0.257715257796541	1	1	1.06203414783391e-136	MT-CO1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57578
5.95617376715809e-141	0.31385857057742	0.493	0.336	1.17551045468632e-136	MGAT4A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000071073	11320	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GnT-4a|GnT-Iva	protein_coding	Q9UM21	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57579
6.88968267680953e-141	0.301130410438246	0.463	0.304	1.35974777309513e-136	SCAF11	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000139218	9169	SR-related CTD associated factor 11	CASP11|SFRS2IP|SIP1|SRRP129|SRSF2IP	protein_coding	Q99590	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57580
6.95044000310745e-140	-0.262097897261238	0.455	0.626	1.37173883901329e-135	NDUFA1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57581
1.44100641225061e-139	0.27899659422084	0.42	0.261	2.8439702552178e-135	TAF15	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000276833	8148	TATA-box binding protein associated factor 15	hTAFII68|Npl3|RBP56|TAF2N	protein_coding	Q92804	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57582
3.6474303707651e-139	0.274806197706501	0.367	0.213	7.198568579742e-135	WNK1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57583
1.18006702235786e-138	0.310173270243643	0.655	0.523	2.32898027532548e-134	CDC42	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57584
5.63575926881452e-138	-0.265793913158831	0.413	0.586	1.11227344929323e-133	ATP5MD	CD4+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57585
7.76014433111689e-138	0.269111649615893	0.391	0.237	1.53154208518923e-133	PPP3CC	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000120910	5533	protein phosphatase 3 catalytic subunit gamma	CALNA3|PP2Bgamma	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57586
1.45768087147677e-137	0.310512442160964	0.579	0.427	2.87687896794654e-133	LRRFIP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57587
1.55133111926658e-137	-0.296386003381358	0.528	0.683	3.06170709698452e-133	RARRES3	CD4+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57588
1.81471796574635e-137	0.274750867655631	0.325	0.179	3.58152737719699e-133	RANBP2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57589
1.90266711837996e-137	0.287501963989628	0.461	0.303	3.75510382483468e-133	DDX6	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57590
9.0146149426781e-137	0.276905836570062	0.384	0.229	1.77912440508695e-132	ROCK1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000067900	6093	Rho associated coiled-coil containing protein kinase 1	p160ROCK	protein_coding	Q13464	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57591
9.78007100656146e-137	0.286897714216619	0.387	0.235	1.93019481385497e-132	DPYD	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000188641	1806	dihydropyrimidine dehydrogenase	DHPDHase|DPD	protein_coding	Q12882	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57592
1.05527925443326e-136	0.274215356264185	0.383	0.231	2.08269913654949e-132	PAPOLA	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57593
5.2398398186715e-135	0.253592252102522	0.31	0.166	1.03413478661301e-130	STAT4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000138378	6775	signal transducer and activator of transcription 4	NA	protein_coding	Q14765	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57594
6.17132058491853e-135	0.309984519846187	0.633	0.49	1.21797183063952e-130	FCMR	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000162894	9214	Fc mu receptor	FAIM3|FcmuR|TOSO	protein_coding	O60667	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57595
9.139137894397e-135	0.270769207925089	0.366	0.214	1.80370025483819e-130	OGA	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198408	10724	O-GlcNAcase	MEA5|MGEA5|NCOAT	protein_coding	O60502	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57596
1.47009846126187e-134	0.326304812650202	0.549	0.406	2.90138632314642e-130	DGKA	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000065357	1606	diacylglycerol kinase alpha	DAGK|DAGK1|DGK-alpha	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57597
1.72930230971637e-134	-0.274094120074083	0.423	0.587	3.41295103845623e-130	TMEM258	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57598
3.68859902255635e-134	0.321844015768068	0.478	0.328	7.27981903091721e-130	ABLIM1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000099204	3983	actin binding LIM protein 1	ABLIM|LIMAB1|limatin	protein_coding	O14639	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57599
3.83881731856787e-134	-0.271176939597102	0.473	0.645	7.57628985992555e-130	SMDT1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57600
9.47436361844215e-134	0.275134422854233	0.405	0.252	1.86986040373574e-129	FLI1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000151702	2313	Fli-1 proto-oncogene, ETS transcription factor	EWSR2|FLI-1|SIC-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57601
1.08775398165294e-133	-0.252520629051976	0.752	0.858	2.14679125819025e-129	SRP14	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57602
1.85652807002364e-133	0.26809489637095	0.39	0.235	3.66404379899866e-129	NFKBIA	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57603
2.49633546394295e-133	-0.278733342384859	0.577	0.722	4.92676767163781e-129	SSR4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57604
6.45391176088532e-133	0.319053660547946	0.502	0.352	1.27374402512833e-128	PSAP	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57605
2.25896599295948e-132	0.274505609457857	0.414	0.261	4.45829528370483e-128	GRB2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57606
3.10926256487739e-132	0.2507040614369	0.322	0.178	6.13644059804202e-128	LUC7L2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000146963	51631	LUC7 like 2, pre-mRNA splicing factor	CGI-59|CGI-74|FLJ10657|hLuc7B2|H_NH0792N18.3|LUC7B2	protein_coding	Q9Y383	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57607
5.96032675394942e-131	0.286172679594646	0.389	0.24	1.17633008815946e-126	ANKRD11	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57608
1.60356793586443e-130	0.30555232778205	0.508	0.358	3.16480167822203e-126	CYLD	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000083799	1540	CYLD lysine 63 deubiquitinase	CYLD1|KIAA0849|USPL2	protein_coding	Q9NQC7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57609
1.20152788278288e-129	0.305392194885415	0.55	0.399	2.37133542946029e-125	MSN	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57610
3.60333220128753e-129	0.40131657201328	0.698	0.598	7.11153643246107e-125	ETS1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57611
1.62029295347581e-128	0.276400424559486	0.37	0.224	3.19781017297985e-124	ZNF292	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000188994	23036	zinc finger protein 292	bA393I2.3|KIAA0530|ZFP292|Zn-15|Zn-16	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57612
4.30631850448486e-128	0.269596451959338	0.368	0.221	8.49895020045132e-124	ST3GAL1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000008513	6482	ST3 beta-galactoside alpha-2,3-sialyltransferase 1	SIAT4A|SIATFL|ST3GalA.1|ST3O	protein_coding	Q11201	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57613
4.40871423283825e-128	0.250523185613146	0.323	0.181	8.70103840992956e-124	SMARCA5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000153147	8467	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5	hISWI|hSNF2H|ISWI	protein_coding	O60264	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57614
8.16261187023923e-128	0.283066712388774	0.53	0.38	1.61097307871041e-123	HP1BP3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57615
1.43608253227228e-127	0.282926431216631	0.802	0.702	2.83425248569257e-123	YWHAZ	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57616
3.30075479672977e-127	0.39505959727793	0.469	0.321	6.51436966682588e-123	SYNE2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57617
7.37952821363149e-127	0.261343938635315	0.431	0.278	1.45642368824231e-122	ARHGAP30	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000186517	257106	Rho GTPase activating protein 30	FLJ00267	protein_coding	Q7Z6I6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57618
6.9203301256673e-126	-0.254641761877444	0.61	0.748	1.3657963536017e-121	EDF1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57619
1.10061285083574e-124	0.28252787938406	0.387	0.242	2.17216952240942e-120	KLF3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57620
2.42515063457149e-124	0.267199257714311	0.345	0.203	4.7862772923903e-120	PARP8	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000151883	79668	poly(ADP-ribose) polymerase family member 8	ARTD16|FLJ21308|pART16	protein_coding	Q8N3A8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57621
1.00691493692644e-123	0.261509887444339	0.295	0.16	1.98724731951802e-119	CDC14A	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000079335	8556	cell division cycle 14A	cdc14|Cdc14A1|Cdc14A2|DFNB105|DFNB32	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57622
3.87958037353351e-123	0.28270463873496	0.512	0.367	7.65673982520574e-119	CYFIP2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000055163	26999	cytoplasmic FMR1 interacting protein 2	PIR121	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57623
2.83827053432444e-122	-0.373373623923798	0.984	0.986	5.60161072654272e-118	CD52	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57624
5.62871293580842e-122	0.284319509239179	0.619	0.484	1.11088278501115e-117	ADD3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000148700	120	adducin 3	ADDL	protein_coding	Q9UEY8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57625
5.98736333666314e-122	0.311495982979839	0.472	0.329	1.18166602812384e-117	USP15	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57626
1.59825010462229e-121	-0.266439915966995	0.379	0.536	3.15430640648255e-117	C9orf16	CD4+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57627
3.81989892435086e-121	0.313883638239745	0.514	0.37	7.53895251709886e-117	SLFN5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57628
6.69213879515303e-121	0.277853796132557	0.507	0.362	1.3207605126114e-116	NSD3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000147548	54904	nuclear receptor binding SET domain protein 3	FLJ20353|KMT3F|WHISTLE|WHSC1L1	protein_coding	Q9BZ95	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57629
2.43254897810244e-120	0.262200732041179	0.351	0.209	4.80087866318297e-116	SMG1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000157106	23049	SMG1 nonsense mediated mRNA decay associated PI3K related kinase	ATX|KIAA0421|LIP	protein_coding	Q96Q15	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57630
4.36016263155866e-120	0.294569039949545	0.478	0.333	8.60521696964417e-116	EML4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57631
4.73544945986655e-120	0.258865751956631	0.456	0.306	9.34588305399262e-116	ARHGAP45	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000180448	23526	Rho GTPase activating protein 45	HA-1|HMHA1|KIAA0223	protein_coding	Q92619	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57632
7.26039491433816e-120	-0.254538925316323	0.852	0.919	1.43291154029378e-115	HINT1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57633
8.98417425140686e-120	0.271733268944542	0.39	0.246	1.77311663025766e-115	CXCR4	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57634
3.84508623781154e-119	0.287610291964166	0.539	0.398	7.58866219894486e-115	RCAN3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000117602	11123	RCAN family member 3	DSCR1L2	protein_coding	Q9UKA8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57635
3.26037378579053e-118	0.264325874047725	0.455	0.306	6.43467370363619e-114	ZFP36	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57636
5.11489790390382e-118	0.255331472351091	0.351	0.212	1.00947625031446e-113	G3BP2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57637
5.57818921252825e-117	0.254320748084859	0.289	0.158	1.10091142298458e-112	GPRIN3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000185477	285513	GPRIN family member 3	FLJ42625|GRIN3	protein_coding	Q6ZVF9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57638
6.16711405981167e-117	-0.251402594185695	0.576	0.716	1.21714163084443e-112	UBL5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57639
8.48929373286306e-117	0.284891177272788	0.553	0.418	1.67544701111785e-112	KMT2E	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57640
4.86453626678534e-116	0.280784395094221	0.567	0.436	9.60064877612755e-112	TNFAIP8	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000145779	25816	TNF alpha induced protein 8	GG2-1|MDC-3.13|SCC-S2	protein_coding	O95379	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57641
1.20798281699157e-115	-0.250189028465921	0.787	0.889	2.38407488761455e-111	RPS20	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57642
2.31294571542705e-115	0.273444238065178	0.471	0.33	4.56482966396682e-111	NCOR1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57643
2.37234136274382e-115	0.274681170859917	0.439	0.299	4.6820529135112e-111	ZNF207	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57644
3.22822512216484e-115	0.294279987012168	0.692	0.581	6.37122510110453e-111	PNISR	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57645
2.59702439639947e-114	0.266374325386162	0.427	0.285	5.12548734873399e-110	DOCK8	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000107099	81704	dedicator of cytokinesis 8	FLJ00026|FLJ00152|FLJ00346|ZIR8	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57646
7.69809571124511e-114	0.274792505543459	0.744	0.634	1.51929616957133e-109	SRSF5	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57647
1.85179826053305e-112	0.254787078868301	0.254	0.133	3.65470904698802e-108	BACH2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000112182	60468	BTB domain and CNC homolog 2	BTBD25	protein_coding	Q9BYV9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57648
3.07500981597134e-112	0.285536999739368	0.485	0.344	6.06883937280103e-108	PBXIP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000163346	57326	PBX homeobox interacting protein 1	HPIP	protein_coding	Q96AQ6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57649
1.7947435950374e-109	0.260248183099041	0.458	0.318	3.54210595916581e-105	PAK2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000180370	5062	p21 (RAC1) activated kinase 2	PAK65|PAKgamma	protein_coding	Q13177	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57650
7.93441177714007e-109	-0.29084068095724	0.158	0.288	1.56593550833636e-104	ISG15	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57651
1.01297942997658e-108	0.251130727888729	0.34	0.208	1.99921620300177e-104	WSB1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57652
1.18772242634453e-107	0.261201027011499	0.417	0.279	2.34408898063356e-103	TNRC6B	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000100354	23112	trinucleotide repeat containing adaptor 6B	KIAA1093	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57653
6.29726515207945e-107	0.25241736032946	0.379	0.244	1.2428282504144e-102	CANX	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57654
7.36454484011025e-107	0.25881093013688	0.364	0.231	1.45346656964416e-102	SNRNP70	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000104852	6625	small nuclear ribonucleoprotein U1 subunit 70	RNPU1Z|RPU1|Snp1|SNRP70|U1-70K	protein_coding	P08621	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57655
1.15884530207004e-106	0.280505889874291	0.505	0.372	2.28709708816543e-102	GCC2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000135968	9648	GRIP and coiled-coil domain containing 2	GCC185|KIAA0336	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57656
2.31176760868628e-106	-0.339427214327675	0.472	0.613	4.56250455250325e-102	TRBC2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57657
5.62884554413596e-104	0.252911177830188	0.541	0.407	1.11090895659067e-99	RHOH	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57658
5.15410037499914e-102	0.263716967119971	0.538	0.41	1.01721325000983e-97	ARHGEF1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000076928	9138	Rho guanine nucleotide exchange factor 1	LBCL2|P115-RHOGEF|SUB1.5	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57659
1.47353974808628e-101	0.250878137587969	0.39	0.26	2.90817804682307e-97	RBMS1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000153250	5937	RNA binding motif single stranded interacting protein 1	C2orf12|DKFZp564H0764|HCC-4|MSSP-1|MSSP-2|MSSP-3|SCR2|YC1	protein_coding	P29558	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57660
2.11817731852967e-100	0.290513914662927	0.49	0.364	4.18043475585015e-96	OXNAD1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000154814	92106	oxidoreductase NAD binding domain containing 1	MGC15763	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57661
3.4046008616902e-99	-0.277860985639406	0.682	0.774	6.71932026063178e-95	HCST	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57662
7.64238021821932e-97	0.255264816050822	0.555	0.432	1.50830015986777e-92	EPC1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57663
1.7613292149613e-96	0.257597547763669	0.507	0.376	3.47615933864761e-92	TPR	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57664
1.94500923871119e-95	0.272268628332654	0.527	0.405	3.8386702335204e-91	TAPBP	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57665
2.01460689127688e-94	-0.318520472898322	0.948	0.973	3.97602816062405e-90	IL32	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57666
6.11455325549876e-93	0.329553037450218	0.653	0.563	1.20676823050524e-88	CCR7	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57667
3.27322723108069e-89	0.295388619523417	0.528	0.417	6.46004126326084e-85	SRRM2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57668
9.59616608589659e-88	-0.286475489431681	0.522	0.628	1.89389933871255e-83	LY6E	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57669
1.3390473919274e-87	0.254533255345132	0.375	0.258	2.64274393270791e-83	CTSS	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57670
3.4568248658254e-86	0.257570420057359	0.632	0.535	6.82238955519301e-82	CCND3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57671
2.93699018980581e-84	-0.250925200599335	0.867	0.899	5.79644383860075e-80	MYL6	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57672
1.05280317381101e-82	0.283331258060547	0.309	0.2	2.07781234383341e-78	NELL2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000184613	4753	neural EGFL like 2	NRP2	protein_coding	Q99435	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57673
7.65882479109246e-69	0.253917827138127	0.726	0.664	1.51154566077001e-64	TCF7	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57674
1.3983734484449e-68	-0.256507633255371	0.999	0.993	2.75982983785086e-64	HLA-C	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57675
1.28945131501703e-62	-0.279801560055541	0.939	0.944	2.54486111531761e-58	SH3BGRL3	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57676
1.21916986137453e-55	0.265347886507264	0.412	0.33	2.40615363840877e-51	SMAP2	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57677
6.82571596025177e-53	-0.425225539422428	0.721	0.758	1.34712330191529e-48	CRIP1	CD4+ T cells	GSE169246_PacBlood_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57678
0	-0.967746039969448	0.26	0.669	0	ISG15	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57679
0	-0.593515583639706	0.526	0.825	0	EFHD2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57680
0	-0.789490402793616	0.969	0.999	0	SH3BGRL3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57681
0	-0.987617774456388	0.368	0.757	0	IFI6	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57682
0	0.678699193709874	0.973	0.837	0	TXNIP	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57683
0	-0.603699899238592	0.896	0.992	0	S100A11	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57684
0	-0.720912182423175	0.979	0.999	0	S100A6	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57685
0	-0.529914802980405	0.994	0.998	0	RPS27	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57686
0	-0.77427136003389	0.828	0.977	0	FCER1G	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57687
0	0.910660089385581	0.905	0.708	0	ZFP36L2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57688
0	-0.979289512619009	0.997	1	0	TMSB10	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57689
0	-0.892101343513203	0.289	0.699	0	VAMP5	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000168899	10791	vesicle associated membrane protein 5	NA	protein_coding	O95183	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57690
0	-0.580857033558396	0.677	0.915	0	COX5B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57691
0	0.926361874465909	0.685	0.445	0	STK17B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57692
0	-0.655567808124687	0.373	0.755	0	ATP5ME	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57693
0	-1.09957699913784	0.28	0.717	0	PLAC8	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57694
0	1.08285529683068	0.902	0.628	0	DUSP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57695
0	-0.588750490354278	0.659	0.886	0	PRELID1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57696
0	-0.699599136897619	0.995	0.998	0	HLA-C	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57697
0	-0.481748390367541	1	1	0	HLA-B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57698
0	-0.822861781074375	0.802	0.977	0	LST1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57699
0	-0.651990686486851	0.827	0.98	0	AIF1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57700
0	-0.745420567351446	0.939	0.985	0	HLA-DRA	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57701
0	-0.736012161291517	0.907	0.988	0	HLA-DRB1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57702
0	-0.587411189568279	0.601	0.859	0	PSMB9	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57703
0	-0.716460988410531	0.549	0.865	0	BRI3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57704
0	1.29206305934948	0.681	0.221	0	TMEM176B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57705
0	1.05559383462124	0.557	0.109	0	TMEM176A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57706
0	-0.585880228490721	1	0.999	0	TMSB4X	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57707
0	-0.718218759196592	0.547	0.808	0	TIMP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57708
0	1.06299541654957	0.766	0.403	0	TSC22D3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57709
0	-0.667128492057394	0.497	0.846	0	NDUFA1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57710
0	-1.08163761196055	0.565	0.89	0	LY6E	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57711
0	-0.63060571339879	0.952	0.988	0	FCN1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57712
0	-0.887656773212907	0.847	0.941	0	IFITM2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57713
0	-1.79163073793163	0.706	0.962	0	IFITM3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57714
0	3.47951055373163	0.624	0.024	0	HBB	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57715
0	0.80914779473389	0.934	0.796	0	AHNAK	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57716
0	-0.508177240396618	0.638	0.883	0	COX8A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57717
0	1.55448757478784	0.979	0.941	0	NEAT1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57718
0	-0.473658903538502	0.958	0.996	0	CFL1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57719
0	1.16764222339826	0.465	0.115	0	FOLR3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000110203	2352	folate receptor gamma	FR-G|FRgamma	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57720
0	-0.563340352768007	0.404	0.743	0	ATP5MD	Mono/Macro	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57721
0	-0.958385829570158	0.939	0.996	0	RPL41	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57722
0	-0.549753182033516	0.928	0.994	0	MYL6	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57723
0	0.634274522114457	0.848	0.628	0	BTG1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57724
0	-0.499670709294056	0.626	0.872	0	COX6A1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57725
0	-0.62107083022443	0.72	0.915	0	PSME1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57726
0	-0.985756794903798	0.586	0.896	0	PSME2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57727
0	-0.82373616532439	0.89	0.981	0	RPS29	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57728
0	-0.607263499463932	0.704	0.92	0	NPC2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57729
0	1.26767696956274	0.867	0.637	0	FOS	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57730
0	-0.738223517010308	0.955	0.999	0	SERF2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57731
0	-0.623818177241056	1	1	0	B2M	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57732
0	-0.847985354288772	0.485	0.801	0	MT2A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57733
0	-0.648353145259169	0.977	0.999	0	CYBA	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57734
0	-0.566528533690419	0.532	0.811	0	CTSZ	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57735
0	-0.666911041323015	0.944	0.999	0	ATP5F1E	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57736
0	-0.65471265241845	0.655	0.93	0	UQCR11	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57737
0	-0.575013572607791	0.924	0.998	0	OAZ1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57738
0	0.673415872526347	0.558	0.225	0	RETN	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57739
0	-0.92354784148997	0.386	0.783	0	IFI30	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57740
0	-0.534033004274335	0.711	0.936	0	COX6B1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57741
0	-0.586488694573556	0.908	0.996	0	TYROBP	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57742
0	-0.786002623959633	0.997	1	0	FTL	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57743
0	-0.599796823179673	0.35	0.718	0	NDUFA3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57744
0	-0.523911432991836	0.995	0.998	0	RPL28	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57745
0	-0.707456890029692	0.796	0.971	0	LGALS1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57746
0	-0.890952802334111	0.805	0.958	0	TYMP	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57747
0	-0.506415757635282	0.983	1	0	MT-ND3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57748
1.0346278048103e-305	-0.504765213067564	0.988	1	2.04194143557362e-301	S100A4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57749
2.97635005683978e-305	-0.504446317044039	0.327	0.651	5.87412447217899e-301	NDUFB1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57750
1.05596401059733e-304	-0.515944172386582	0.306	0.63	2.08405057131489e-300	ATOX1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57751
6.33622894899948e-300	-0.482669865397739	0.531	0.814	1.25051814537454e-295	ATP5MF	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57752
1.29274045904264e-297	0.554664556553085	0.823	0.625	2.55135256996656e-293	PNRC1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57753
1.96465497712496e-297	-0.473551199141275	0.988	0.998	3.87744306285381e-293	RPS28	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57754
1.14188454231305e-296	-0.457980205095104	0.166	0.48	2.25362333270903e-292	BLOC1S1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57755
3.301457041752e-295	-0.402141392777245	0.995	1	6.51575561760175e-291	HLA-A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57756
5.12303413130151e-295	-0.546469698921364	0.584	0.82	1.01108201615367e-290	RPL36A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57757
2.62007104191551e-291	-0.489341424231176	0.289	0.612	5.17097220832445e-287	SECTM1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000141574	6398	secreted and transmembrane 1	K12	protein_coding	Q8WVN6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57758
1.14193476336948e-289	-0.472773366310336	0.599	0.857	2.25372244898601e-285	UBL5	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57759
3.8516502160975e-289	-0.626486163565401	0.439	0.736	7.60161686649003e-285	WARS	Mono/Macro	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57760
8.90205121736714e-287	1.17311118605909	0.76	0.584	1.75690882825958e-282	KLF6	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57761
1.15576443005026e-286	-0.65343045957689	0.806	0.942	2.28101667914719e-282	HLA-DPA1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57762
4.94237119963664e-283	-0.470896848164349	0.815	0.955	9.75426379960286e-279	CLIC1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57763
1.19764052759572e-282	-0.454893631603798	0.075	0.352	2.36366334526291e-278	SERPING1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000149131	710	serpin family G member 1	C1-INH|C1IN|C1INH|C1NH|HAE1|HAE2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57764
2.07696624001079e-282	-0.417823543381753	0.058	0.33	4.0991005712853e-278	MARCO	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000019169	8685	macrophage receptor with collagenous structure	SCARA2|SR-A6	protein_coding	Q9UEW3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57765
1.6091701463482e-280	-0.472832506693183	0.518	0.802	3.1758582008328e-276	UQCR10	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57766
9.11384484712821e-277	-0.458366238841394	0.352	0.664	1.79870841902922e-272	PET100	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57767
2.64303763890971e-275	0.882540203646394	0.781	0.596	5.2162990841522e-271	MCL1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57768
3.03044901413558e-275	-0.476457293898285	0.892	0.972	5.98089417429799e-271	ARPC1B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57769
5.17562094738393e-274	-0.47858562011287	0.486	0.76	1.02146055017569e-269	COX6C	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57770
4.97964868461618e-271	0.40622776820623	0.283	0.06	9.8278346439585e-267	IL32	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57771
7.13266368286131e-271	-0.504774690619564	1	1	1.40770250444951e-266	CD74	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57772
9.91333735326505e-268	-0.485782596434357	0.866	0.961	1.95649626004039e-263	RPL38	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57773
2.78070238407906e-265	-0.473060184057492	0.636	0.871	5.48799422521843e-261	GNG5	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57774
4.30801946086e-264	-0.476197313619576	0.432	0.718	8.50230720795331e-260	COX7B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57775
2.36163738002861e-263	-0.44013115959697	0.795	0.937	4.66092753322446e-259	COX7C	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57776
4.807958120555e-263	-0.406815232184517	0.986	0.998	9.48898614672734e-259	PFN1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57777
1.38216182994119e-260	-0.556205213247093	0.332	0.619	2.72783458757192e-256	LAP3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57778
1.64570019130619e-258	-0.431443057993198	0.962	0.992	3.2479538975619e-254	RPS21	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57779
1.40436546585523e-256	-0.455776785614576	0.989	0.997	2.77165568341188e-252	RPL39	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57780
2.14671501747872e-253	0.587788406984919	0.888	0.782	4.236756758496e-249	DDX5	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57781
7.95522073109622e-253	-0.455377703160079	0.697	0.919	1.57004236348915e-248	PYCARD	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57782
1.25373985116392e-251	-0.431070666745356	0.696	0.926	2.47438097025712e-247	ELOB	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57783
1.58002132228165e-251	-0.449373594694501	0.545	0.814	3.11833008165506e-247	ATP5MPL	Mono/Macro	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57784
2.98522843919976e-251	-0.47402017137633	0.54	0.788	5.89164684760465e-247	PSMB10	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000205220	5699	proteasome 20S subunit beta 10	beta2i|LMP10|MECL1|MGC1665	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57785
1.01887540114317e-249	-1.30478593147553	0.882	0.972	2.01085249169616e-245	S100A9	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57786
2.06077875757319e-248	-0.426019847887062	0.301	0.595	4.06715295594646e-244	NDUFA13	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57787
1.01808524793877e-247	-1.4396284272602	0.853	0.913	2.00929304533196e-243	S100A8	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57788
6.09225772257477e-245	-0.46290264138437	0.819	0.96	1.20236798412736e-240	SPI1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57789
7.15597820595339e-245	0.702754134873467	0.667	0.431	1.41230385872696e-240	RSRP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57790
5.33587761083226e-243	-0.604945749736313	0.735	0.902	1.05308880527385e-238	HLA-DPB1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57791
1.45700106222238e-242	-0.437806438066092	0.394	0.682	2.87553729640208e-238	UQCRQ	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57792
1.93229643103949e-241	-0.446122124731296	1	1	3.81358023629954e-237	ACTB	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57793
1.89800377807516e-240	-0.465735099123288	0.389	0.66	3.74590025640913e-236	C20orf27	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57794
3.13626964913701e-240	-0.439615689192205	0.947	0.989	6.1897417795368e-236	RPL37A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57795
1.21947707559845e-239	-0.469332874748961	0.399	0.673	2.40675995640111e-235	UBE2L6	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57796
1.94711808563933e-237	-0.4853454377645	0.621	0.838	3.84283225381779e-233	C1orf162	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000143110	128346	chromosome 1 open reading frame 162	MGC24133	protein_coding	Q8NEQ5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57797
8.76267519528071e-237	-0.569194396362842	0.824	0.947	1.7294015765406e-232	RPS26	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57798
1.40528935166274e-235	0.469091984855056	0.341	0.11	2.77347906444159e-231	NKG7	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57799
5.48811585566336e-231	-0.457917846066405	0.2	0.489	1.08313454527372e-226	IFI44L	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57800
4.21607202769845e-229	-0.431308490312165	0.41	0.684	8.32083975386566e-225	DBI	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57801
1.057082375843e-227	-0.458372863713292	0.612	0.853	2.08625777696375e-223	VAMP8	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57802
8.6071562247315e-227	-0.957398577773324	0.378	0.596	1.69870835251301e-222	IFITM1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57803
6.64964097999841e-224	0.417706762039793	0.975	0.976	1.31237314381249e-219	PABPC1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57804
1.08383855632688e-220	-0.447191460950187	0.768	0.963	2.13906377476673e-216	TSPO	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57805
1.74097836791188e-220	-0.439270514511801	0.267	0.546	3.43599490691088e-216	EPSTI1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57806
5.80738891535158e-218	-0.597414528723922	0.364	0.617	1.14614627633379e-213	HLA-DQB1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57807
1.06608517208567e-217	0.729024793326098	0.681	0.497	2.10402569562827e-213	USP15	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000135655	9958	ubiquitin specific peptidase 15	KIAA0529|UNPH4	protein_coding	Q9Y4E8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57808
4.13012896636298e-217	-0.485729047516065	0.219	0.488	8.15122252801398e-213	GBP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57809
5.81227175082366e-216	-0.377387564516047	0.265	0.539	1.14710995274256e-211	SLIRP	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57810
9.73955770029554e-216	0.710127949452241	0.274	0.077	1.92219910773033e-211	FOSB	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57811
1.29201844496781e-215	-0.512175178782512	0.263	0.547	2.54992760298848e-211	MX1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57812
2.24542270328056e-215	-0.50359109926287	0.459	0.718	4.43156624719451e-211	CALHM6	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000188820	441168	calcium homeostasis modulator family member 6	C6orf187|dJ93H18.5|FAM26F|INAM|OTTHUMP00000017061|OTTHUMP00000017062|RP1-93H18.5	protein_coding	Q5R3K3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57813
3.21472552739482e-212	-0.399294081009241	0.342	0.614	6.34458230086642e-208	ROMO1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57814
3.53048489597826e-212	-0.408207630157347	0.458	0.722	6.9677649907027e-208	COX7A2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57815
1.8187770744262e-211	-0.492157656260773	0.564	0.807	3.58953843408754e-207	CSTB	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57816
1.66839645680823e-210	-0.403370680960951	0.451	0.706	3.29274724715672e-206	PSMB3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57817
2.44974118509138e-210	-0.409482406312716	0.657	0.874	4.83480920289634e-206	RHOG	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000177105	391	ras homolog family member G	ARHG|MGC125835|MGC125836	protein_coding	P84095	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57818
3.06598957927006e-209	0.623512582303497	0.7	0.511	6.05103703364739e-205	DDX17	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57819
6.07706221478513e-209	0.63720710448169	0.737	0.559	1.19936899870999e-204	HNRNPU	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57820
1.15783672899786e-208	-0.399730547884698	0.87	0.984	2.28510656835018e-204	GABARAP	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57821
1.91778142235383e-208	-0.453591039427188	0.177	0.439	3.78493341515753e-204	IFIT3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000119917	3437	interferon induced protein with tetratricopeptide repeats 3	CIG-49|GARG-49|IFI60|IFIT4|IRG2|ISG60|RIG-G	protein_coding	O14879	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57822
2.0049884591584e-207	-0.46974776582093	0.897	0.954	3.95704522299502e-203	SRGN	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57823
2.29237666805491e-207	-0.43831572115555	0.487	0.726	4.52423459207317e-203	NDUFA4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57824
1.68502949651786e-205	-0.483976635507231	0.73	0.887	3.32557421432766e-201	ALDOA	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57825
1.70340664221977e-205	-0.404342559532622	0.358	0.621	3.36184334908493e-201	POMP	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57826
3.09724314919635e-205	0.585393018550614	0.656	0.45	6.11271907925393e-201	RBM39	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57827
5.68117071522859e-203	-0.397709739877051	0.506	0.751	1.12123585235751e-198	NDUFB2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57828
8.52432920694296e-202	-0.452497114024726	0.26	0.514	1.68236161228226e-197	FCGR1A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000150337	2209	Fc gamma receptor Ia	CD64|CD64A|FCG1|FcgammaRI|FcgammaRIa|FCGR1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57829
4.96393597020607e-201	-0.382888270752503	0.656	0.852	9.79682403079869e-197	SRP14	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57830
2.30350812118671e-199	0.597345702072269	0.581	0.369	4.54620362797409e-195	ATG16L2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000168010	89849	autophagy related 16 like 2	ATG16B|FLJ00012|WDR80	protein_coding	Q8NAA4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57831
6.84777674857103e-197	0.410509629910677	1	1	1.35147721909798e-192	MT-CO1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57832
1.31968033385416e-194	-0.408803084301077	0.653	0.86	2.60452110689457e-190	CARD16	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57833
6.61141261540062e-194	-0.415545674400993	0.479	0.719	1.30482839377547e-189	ATP5MC3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57834
1.11745435865332e-192	-0.409896842513333	0.475	0.709	2.20540792223819e-188	PSMB8	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57835
2.38495701853188e-192	-0.381466844761365	0.984	0.998	4.70695117177451e-188	RPL37	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57836
8.64276467715054e-187	0.368834254643764	0.998	0.999	1.70573603668243e-182	MT-CO3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57837
1.85616341510622e-186	-0.39782004969026	0.531	0.758	3.66332411605364e-182	LGALS9	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000168961	3965	galectin 9	LGALS9A	protein_coding	O00182	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57838
1.29465286277322e-182	0.668654794555647	0.785	0.64	2.55512688996922e-178	CSF3R	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000119535	1441	colony stimulating factor 3 receptor	CD114|GCSFR	protein_coding	Q99062	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57839
4.93648718629262e-182	-0.452782530159876	0.423	0.648	9.74265111086712e-178	CD63	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57840
4.79711477723854e-180	-0.381822733208633	0.962	0.994	9.46758572435799e-176	RPL36	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57841
1.29258004553209e-179	-0.383946856882184	0.984	0.999	2.55103597786214e-175	MT-ND4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57842
4.45173259781391e-179	-0.377653799821505	0.679	0.864	8.78593945504553e-175	TPI1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57843
9.72282353550392e-177	-0.371228957329102	0.438	0.679	1.91889645296705e-172	HSBP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57844
1.44342040708731e-175	-0.347888055994743	0.715	0.908	2.84873451542751e-171	GNAI2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57845
1.03215226692989e-170	0.787847706569392	0.805	0.717	2.03705571401283e-166	ZEB2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57846
1.82637625909972e-169	0.714106255834248	0.295	0.11	3.60453618495921e-165	JUN	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57847
2.53469208072321e-168	-0.327933824555575	0.863	0.977	5.00246829051534e-164	ATP5MC2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57848
3.91372581610778e-168	-0.353338570144206	0.574	0.798	7.72412927067032e-164	AP2S1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57849
4.38882742599957e-168	-0.316813575351116	0.987	0.999	8.66178980795275e-164	RPS9	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57850
8.39818087393527e-167	-0.362114596615441	0.935	0.989	1.65746497727986e-162	COTL1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57851
2.0742471671144e-166	-0.332554145703881	0.243	0.48	4.09373420901698e-162	NDUFB3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57852
3.85708233499098e-166	-0.338822337694567	0.47	0.712	7.61233769633819e-162	C4orf48	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57853
5.65763172310187e-166	0.470842523871756	0.488	0.279	1.11659019687138e-161	JMJD1C	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57854
2.9911918182909e-165	-0.411677805465074	0.339	0.571	5.90341617257892e-161	NINJ1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57855
2.76546471953449e-164	-0.320320354505888	0.812	0.952	5.45792117047327e-160	ATP5MG	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57856
2.28182969663699e-163	-0.434217976728211	0.809	0.957	4.50341908928277e-159	SERPINA1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57857
1.93824751746003e-162	-0.363380925416709	0.474	0.709	3.82532530045911e-158	POLR2L	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57858
2.23586919405151e-162	0.475212238771597	0.494	0.291	4.41271144138007e-158	MBP	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57859
4.78112953052721e-160	0.437425791963328	0.908	0.694	9.43603724144849e-156	CD52	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57860
2.99970663059535e-159	-0.368754419125316	0.549	0.76	5.92022100614299e-155	BST2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57861
1.37485877766844e-157	-0.7124594559046	0.312	0.525	2.71342128360643e-153	APOBEC3A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000262156	200315	apolipoprotein B mRNA editing enzyme catalytic subunit 3A	ARP3|PHRBN	protein_coding	P31941	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57862
1.56611320174565e-157	-0.331120448403463	0.325	0.561	3.09088101496521e-153	SNRPG	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57863
4.9316297162395e-157	0.837825195610469	1	0.999	9.73306440797028e-153	MALAT1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57864
3.69124106165439e-156	-0.367191559907228	0.439	0.663	7.28503335928111e-152	NOP10	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57865
6.05698881519515e-156	-0.298516198461358	0.129	0.338	1.19540731256691e-151	FCGR1B	Mono/Macro	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57866
2.72061218498242e-155	0.551030383204921	0.671	0.52	5.3694002082813e-151	MBNL1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57867
3.24250587483233e-155	-0.375910921626305	0.417	0.64	6.39940959456908e-151	PRDX1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57868
2.18422944210116e-153	-0.35104359555824	0.459	0.677	4.31079522693085e-149	MIF	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57869
9.51218888245517e-153	-0.317263832415255	0.918	0.976	1.87732559784135e-148	CORO1A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57870
1.00644805602143e-152	-0.333333375674902	0.465	0.699	1.9863258833639e-148	ATP5PD	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57871
1.38978681654594e-151	0.475798764695533	0.377	0.187	2.74288326113508e-147	PELI1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000197329	57162	pellino E3 ubiquitin protein ligase 1	NA	protein_coding	Q96FA3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57872
4.91694807925693e-151	-0.385062372225385	0.481	0.706	9.70408872922148e-147	DRAP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57873
1.64240090399903e-150	-0.390419374063793	0.62	0.787	3.24144242413249e-146	TNFSF13B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000102524	10673	TNF superfamily member 13b	BAFF|BLYS|CD257|TALL-1|TALL1|THANK|TNFSF20	protein_coding	Q9Y275	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57874
1.86994026912304e-149	-0.404202183011752	0.25	0.479	3.69051411514123e-145	BCL2A1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57875
9.55221663291095e-149	-0.326028150932134	0.865	0.966	1.8852254746713e-144	ARPC3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57876
1.55314084741521e-146	0.453910592088851	0.892	0.827	3.06527877645865e-142	HNRNPA2B1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57877
4.78615960385722e-146	0.408356535665586	0.506	0.31	9.4459645941726e-142	ARGLU1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57878
7.04119021090699e-146	-0.3767393782803	0.407	0.623	1.3896493000246e-141	LILRA5	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000278355	353514	leukocyte immunoglobulin like receptor A5	CD85|CD85f|ILT11|LILRB7|LIR9	protein_coding	A6NI73	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57879
9.11315368383393e-146	0.561364149390081	0.56	0.391	1.79857201104147e-141	CELF2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57880
1.61031611760049e-145	-0.314057156816304	0.226	0.449	3.17811988969633e-141	HEBP2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57881
7.36049821920794e-145	-0.451038998939872	0.412	0.595	1.45266792854288e-140	SULT1A1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000196502	6817	sulfotransferase family 1A member 1	P-PST|STP|STP1	protein_coding	P50225	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57882
8.76237927921557e-144	-0.329740740193379	0.421	0.644	1.72934317454599e-139	RBX1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57883
1.68559860036449e-143	0.460519787471879	0.551	0.368	3.32669739767936e-139	SFPQ	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57884
3.27139795354941e-143	-0.417223397845587	0.481	0.678	6.45643100112512e-139	CTSD	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57885
8.65169184899736e-143	-0.416044681191773	0.593	0.764	1.70749790331812e-138	UCP2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57886
4.57439229108588e-141	-0.266392674887519	0.086	0.269	9.02802062568709e-137	SIGLEC1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000088827	6614	sialic acid binding Ig like lectin 1	CD169|dJ1009E24.1|FLJ00051|FLJ00055|FLJ00073|FLJ32150|sialoadhesin|SIGLEC-1|SN	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57887
5.99477029207422e-141	-0.361437470676353	0.901	0.996	1.18312786484377e-136	CST3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57888
2.55274785267969e-140	-0.319960655068178	0.48	0.703	5.03810316204864e-136	TMEM258	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57889
1.86933480259694e-139	-0.347583851752385	0.524	0.724	3.68931916640531e-135	GRINA	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57890
2.22683491851759e-139	-0.35345165976824	0.382	0.596	4.39488139518632e-135	PLEKHO1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000023902	51177	pleckstrin homology domain containing O1	CKIP-1|OC120	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57891
4.39993705018012e-139	-0.304282378160436	0.34	0.564	8.68371576223548e-135	SEC61G	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57892
8.19034247842518e-138	-0.316838288583566	0.422	0.64	1.61644599154199e-133	MINOS1	Mono/Macro	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57893
1.81945718660689e-137	0.404488078448646	0.843	0.781	3.59088070348736e-133	LRRFIP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57894
5.44088856223462e-136	-0.341837081880027	0.432	0.644	1.07381376664262e-131	CHCHD10	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57895
6.84185628452041e-136	0.496552862748159	0.983	0.966	1.35030875631295e-131	MT-ND4L	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57896
4.75720295088126e-135	-0.311110028981651	0.45	0.669	9.38881574385926e-131	GUK1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57897
3.1339633211862e-134	0.669749780773177	0.525	0.365	6.18519001069309e-130	CCNL1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57898
1.96739735992619e-133	0.558473607798628	0.608	0.459	3.88285542955033e-129	DPYD	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000188641	1806	dihydropyrimidine dehydrogenase	DHPDHase|DPD	protein_coding	Q12882	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57899
7.42972814819886e-133	0.363140814522452	0.538	0.35	1.46633114732853e-128	EIF4B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57900
1.22771534371327e-132	-0.305631730277763	0.672	0.884	2.42301900235252e-128	LAMTOR4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57901
9.43604381118521e-132	-0.300428511879499	0.358	0.578	1.86229760657551e-127	NDUFA2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57902
1.97210527569824e-131	0.34207125072199	0.311	0.14	3.89214697211805e-127	IPMK	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000151151	253430	inositol polyphosphate multikinase	NA	protein_coding	Q8NFU5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57903
2.53581706027104e-130	0.566642290261758	0.546	0.391	5.00468855015093e-126	IRAK3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000090376	11213	interleukin 1 receptor associated kinase 3	IRAK-M	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57904
6.71143897189228e-130	-0.336390582261163	0.677	0.847	1.32456959549266e-125	ZYX	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57905
1.40900148782998e-129	-0.325180545190505	0.259	0.468	2.78080533638125e-125	RARRES3	Mono/Macro	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57906
5.30956783852918e-129	-0.298177287635266	0.686	0.85	1.04789630861212e-124	CHCHD2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57907
4.50106534385044e-128	-0.349807992004837	0.731	0.885	8.88330256262323e-124	ANXA2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57908
7.7846326854245e-128	0.446435500328876	0.737	0.601	1.53637510679538e-123	SLC11A1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000018280	6556	solute carrier family 11 member 1	LSH|NRAMP|NRAMP1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57909
3.40921556946244e-127	-0.265787840077786	0.18	0.381	6.72842784789108e-123	MAP2K2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000126934	5605	mitogen-activated protein kinase kinase 2	MEK2|PRKMK2	protein_coding	P36507	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57910
3.74775955558873e-127	-0.281561388372337	0.271	0.486	7.39657825890992e-123	SMDT1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57911
2.40826734270355e-126	-0.301430654345763	0.437	0.647	4.75295642755973e-122	C4orf3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57912
5.99665911334492e-126	-0.367266820578496	0.521	0.692	1.18350064260975e-121	ODF3B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000177989	440836	outer dense fiber of sperm tails 3B	FAP123	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57913
8.97544108494295e-126	-0.282402347511787	0.254	0.458	1.77139305252434e-121	TIMM8B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000150779	26521	translocase of inner mitochondrial membrane 8 homolog B	DDP2|FLJ21744|MGC102866|MGC117373|TIM8B	protein_coding	Q9Y5J9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57914
1.17720757701287e-125	0.50658086463898	0.54	0.374	2.32333687399259e-121	DDX3X	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57915
1.55544965629243e-125	-0.307344323958948	0.681	0.853	3.06983544165874e-121	UQCRB	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57916
3.02828713007082e-124	-0.306993081779479	0.288	0.497	5.97662747990777e-120	IRF7	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57917
3.914745049051e-124	-0.287011802509704	0.778	0.912	7.72614082880706e-120	TMA7	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57918
3.53957931765804e-122	-0.293751551678238	0.352	0.556	6.98571374132992e-118	ATP5PF	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57919
4.36927829764123e-122	0.376360961413157	0.364	0.194	8.62320764822473e-118	FOXP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57920
4.50851915820226e-122	-0.344211760409969	0.653	0.814	8.89801341062798e-118	CTSB	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57921
5.01085851390605e-121	-0.288749583015423	0.376	0.584	9.88943036304498e-117	SEM1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57922
5.74237393503457e-121	0.469806102879122	0.829	0.745	1.13331491981842e-116	CD44	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57923
7.27305908402404e-121	0.541134447669054	0.925	0.891	1.43541094082298e-116	PTPRC	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57924
7.56182098068855e-121	-0.332466706901152	0.588	0.774	1.49240098874869e-116	HMGN2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57925
2.93793726767044e-120	-0.282084791434568	0.355	0.561	5.79831299147438e-116	NDUFS6	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000145494	4726	NADH:ubiquinone oxidoreductase subunit S6	CI-13kA	protein_coding	O75380	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57926
1.27747657717488e-119	-0.261609254776533	0.215	0.414	2.52122777271234e-115	TXNL4A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000141759	10907	thioredoxin like 4A	DIB1|DIM1|HsT161|SNRNP15|TXNL4|U5-15kD	protein_coding	P83876	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57927
6.77921949558619e-119	-0.277802103036738	0.35	0.561	1.33794675964889e-114	SRSF9	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57928
8.5073303169264e-119	-0.447647138978498	0.965	0.982	1.67900671134859e-114	LYZ	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57929
1.62907256666426e-118	-0.270681623811659	0.372	0.583	3.21513761756859e-114	NDUFB7	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000099795	4713	NADH:ubiquinone oxidoreductase subunit B7	B18|CI-B18|MGC2480	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57930
2.14913649499863e-118	-0.2787121778942	0.947	0.98	4.24153578652929e-114	H3F3B	Mono/Macro	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57931
2.289877502596e-118	-0.299785441938622	0.665	0.852	4.51930223912347e-114	FKBP1A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57932
5.20113831358635e-118	-0.382902293020721	0.79	0.915	1.0264966575694e-113	GRN	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57933
2.71093507083859e-116	0.423119049373186	0.369	0.203	5.35030145580704e-112	TAGAP	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57934
3.07225165332751e-116	-0.309068723218845	0.548	0.734	6.06339586300717e-112	TGFB1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57935
8.56055024698515e-116	0.443131007264537	0.619	0.48	1.68951019674499e-111	PLXDC2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000120594	84898	plexin domain containing 2	FLJ14623|TEM7R	protein_coding	Q6UX71	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57936
3.49287303899063e-115	0.349140802041562	0.366	0.198	6.8935342297519e-111	OGT	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000147162	8473	O-linked N-acetylglucosamine (GlcNAc) transferase	FLJ23071|HRNT1|MGC22921|O-GLCNAC|OGT1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57937
1.41168164054902e-114	-0.285466468129148	0.398	0.6	2.78609488578755e-110	PRDX5	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57938
2.43095737685295e-114	-0.281359926506668	0.396	0.595	4.79773747895699e-110	NEDD8	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57939
8.75727662572375e-114	-0.279743990261463	0.311	0.512	1.72833611485284e-109	DDT	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57940
1.02493017230582e-113	-0.285492355659731	0.489	0.687	2.02280218806277e-109	COX5A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57941
1.07973396891801e-113	-0.344913319313378	0.576	0.742	2.13096296105658e-109	FPR1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000171051	2357	formyl peptide receptor 1	FMLP|FPR	protein_coding	P21462	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57942
7.33704773790599e-113	-0.287321293080085	0.438	0.642	1.44803974155313e-108	RPS10	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57943
8.79747267593468e-113	-0.277509617136318	0.57	0.773	1.73626920732247e-108	UQCRH	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57944
3.02122793831192e-111	-0.26895230677577	0.365	0.564	5.9626954590524e-107	NDUFS7	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000115286	374291	NADH:ubiquinone oxidoreductase core subunit S7	CI-20|FLJ45860|FLJ46880|PSST	protein_coding	O75251	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57945
7.39824089664418e-111	0.483817454057698	0.474	0.315	1.46011682336169e-106	PPP1R15A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57946
7.49105624350873e-111	0.434778581529871	0.697	0.573	1.47843486021888e-106	VMP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57947
9.98840743050962e-111	-0.298059390841712	0.357	0.553	1.97131209048538e-106	TXN	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57948
9.79570572659745e-110	0.357985258674705	0.446	0.278	1.93328048220127e-105	NLRP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000091592	22861	NLR family pyrin domain containing 1	CARD7|CLR17.1|DEFCAP|DKFZp586O1822|KIAA0926|NAC|NALP1|SLEV1|VAMAS1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57949
2.82820556600113e-108	-0.253678027145639	0.216	0.402	5.58174650505983e-104	NDUFA11	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57950
3.24449074481568e-108	0.301210108539952	0.343	0.176	6.40332693396823e-104	HIST1H1E	Mono/Macro	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57951
3.40716670602842e-108	0.27701855156201	0.993	0.998	6.72438421101769e-104	MT-ND1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57952
5.74173457639239e-108	-0.289779845282644	0.582	0.794	1.1331887359968e-103	CSTA	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57953
3.3668796747679e-107	-0.280562664782529	0.366	0.56	6.64487372612193e-103	CAPNS1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000126247	826	calpain small subunit 1	30K|CANP|CANPS|CAPN4|CDPS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57954
7.32714824569986e-107	-0.349314195779099	0.654	0.787	1.44608597777132e-102	HCST	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57955
7.87080664831567e-107	0.343324949366595	0.703	0.56	1.55338240011158e-102	SARAF	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57956
1.26185523279212e-106	-0.475617004834565	0.991	0.996	2.49039748743853e-102	RPS19	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57957
1.38322678213672e-106	-0.271578294453594	0.648	0.841	2.72993637722504e-102	HIGD2A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57958
4.79045834425679e-106	-0.259755972508564	0.369	0.569	9.4544485882252e-102	RNF181	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57959
1.5778280384176e-104	-0.316663366999767	0.379	0.57	3.11400141662097e-100	OAS1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000089127	4938	2'-5'-oligoadenylate synthetase 1	IFI-4|OIAS|OIASI	protein_coding	P00973	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57960
3.42260941043251e-103	-0.302628063039805	0.159	0.328	6.75486193242959e-99	CTSL	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000135047	1514	cathepsin L	CTSL1|FLJ31037	protein_coding	P07711	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57961
3.72762849750786e-103	-0.301709660496306	0.491	0.677	7.35684760268151e-99	SYNGR2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57962
8.55268831855565e-103	-0.265653746531589	0.43	0.629	1.68795856655014e-98	NDUFS5	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57963
9.30021967344821e-103	-0.257703086109669	0.292	0.483	1.83549135475174e-98	MRPL52	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57964
9.32093653463074e-103	0.382506559352567	0.595	0.454	1.83958003447472e-98	SF1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57965
1.08890080727861e-102	-0.276011587625791	0.508	0.701	2.14905463324507e-98	ATP6V1F	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000128524	9296	ATPase H+ transporting V1 subunit F	ATP6S14|VATF|Vma7	protein_coding	Q16864	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57966
4.8628944343053e-102	0.328894754472115	0.955	0.954	9.59740845554494e-98	RPL5	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57967
1.09694909859008e-101	0.414122334142985	0.269	0.127	2.16493874097739e-97	TNFAIP3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57968
2.16869816688394e-101	-0.271066390469988	0.294	0.481	4.28014270216214e-97	MSRB1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198736	51734	methionine sulfoxide reductase B1	SELENOR|SELENOX|SelR|SelX|SepR|SEPX1	protein_coding	Q9NZV6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57969
4.07731979990646e-101	-0.279598036655869	0.361	0.554	8.0469983570954e-97	GPBAR1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000179921	151306	G protein-coupled bile acid receptor 1	BG37|GPCR|GPCR19|GPR131|M-BAR|MGC40597|TGR5	protein_coding	Q8TDU6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57970
3.49133640426251e-100	-0.291201053915404	0.932	0.974	6.89050152745249e-96	RPL35	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57971
6.08143426415526e-100	-0.274008030525385	0.646	0.827	1.20023186637368e-95	NME2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57972
7.82224374861373e-100	-0.285196354106705	0.646	0.807	1.54379802622641e-95	OST4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57973
1.77071096325472e-99	0.374857805104002	0.677	0.561	3.49467515707951e-95	AKAP13	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57974
2.85566839469472e-99	0.391354333461616	0.421	0.262	5.63594714376949e-95	ATP2B1-AS1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000271614	NA	NA	LINC00936	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57975
4.21479332482759e-99	-0.261712960805314	0.544	0.736	8.31831610587973e-95	PTP4A2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57976
1.24126916373549e-98	-0.276413403399906	0.718	0.862	2.44976882154837e-94	ANXA5	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57977
3.39959612842474e-98	-0.290372069771326	0.666	0.836	6.70944291905906e-94	CFP	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000126759	5199	complement factor properdin	PFC	protein_coding	P27918	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57978
6.23679487887462e-98	-0.259258939824935	0.396	0.58	1.2308938372947e-93	DYNLT1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000146425	6993	dynein light chain Tctex-type 1	TCTEL1|Tctex-1|TCTEX1	protein_coding	P63172	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57979
1.28558157066861e-96	-0.254486504841025	0.712	0.875	2.53722378787157e-92	GMFG	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57980
1.45178103550637e-96	-1.05191468424515	0.509	0.612	2.86523505167538e-92	S100A12	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57981
3.51097120125362e-96	0.329337537129482	0.996	0.987	6.92925276279414e-92	VIM	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57982
7.46095250495894e-96	-0.258305323103921	0.507	0.695	1.4724935863787e-91	SELENOH	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000211450	280636	selenoprotein H	C11orf31|SELH	protein_coding	Q8IZQ5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57983
7.5188395721514e-96	-0.279050199224987	0.644	0.809	1.4839181779598e-91	ENO1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57984
1.1254672061361e-95	-0.264605063175639	0.418	0.601	2.2212220780302e-91	BLVRA	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000106605	644	biliverdin reductase A	BLVR	protein_coding	P53004	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57985
3.83023052973983e-95	-0.282110219763144	0.355	0.536	7.55934297349452e-91	GBP2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57986
4.52245386894297e-95	0.392613450753791	0.527	0.382	8.92551495574585e-91	PNISR	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57987
1.65430518429924e-94	-0.252190020767896	0.331	0.513	3.26493671173299e-90	PSMA4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57988
4.06243303103987e-94	-0.326533936424072	0.948	0.991	8.0176178300603e-90	GAPDH	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57989
5.3603710053705e-94	-0.253958392554827	0.355	0.539	1.05792282161992e-89	NAA38	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57990
5.43365214479498e-94	0.413853523427674	0.513	0.372	1.07238558729674e-89	SSH2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57991
1.70319463616122e-93	0.337462979916001	0.533	0.39	3.36142493392777e-89	ROCK1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000067900	6093	Rho associated coiled-coil containing protein kinase 1	p160ROCK	protein_coding	Q13464	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57992
2.30640450043243e-93	-0.28647373136554	0.546	0.715	4.55191992205344e-89	BLVRB	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57993
8.22951924084462e-93	-0.258911105506481	0.356	0.541	1.62417791737309e-88	RGS10	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57994
1.58040314120496e-92	-0.268305851251803	0.42	0.605	3.11908363948212e-88	BID	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000015475	637	BH3 interacting domain death agonist	NA	protein_coding	P55957	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57995
1.60246344791688e-92	-0.272249421286973	0.511	0.693	3.16262186080876e-88	LAMTOR1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000149357	55004	late endosomal/lysosomal adaptor, MAPK and MTOR activator 1	C11orf59|FLJ20625|p18|p27RF-Rho|Pdro|Ragulator1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57996
1.51306722340419e-91	0.414510509583602	0.401	0.26	2.98618947211051e-87	WDFY2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000139668	115825	WD repeat and FYVE domain containing 2	ZFYVE22	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57997
2.01934792160825e-91	0.273472438015461	0.688	0.509	3.98538505808604e-87	HSPA8	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57998
2.22667190892642e-91	0.395643227466735	0.548	0.411	4.39455967945718e-87	IL10RA	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	57999
5.11901025804327e-91	-0.374208660834533	0.862	0.939	1.01028786452742e-86	EMP3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58000
1.6251556288906e-90	-0.261878676666166	0.464	0.654	3.20740714917848e-86	STAT1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58001
2.01269689373773e-90	0.357928445451262	0.73	0.623	3.97225858948078e-86	IL17RA	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000177663	23765	interleukin 17 receptor A	CD217|CDw217|hIL-17R|IL-17RA|IL17R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58002
9.4715061820577e-90	0.36192161468733	0.673	0.564	1.86929646009091e-85	ACAP2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000114331	23527	ArfGAP with coiled-coil, ankyrin repeat and PH domains 2	CENTB2|CNT-B2|KIAA0041	protein_coding	Q15057	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58003
8.76254870113484e-89	-0.26941876009358	0.534	0.706	1.72937661165597e-84	GLRX	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58004
1.10521510249643e-88	0.314196529966186	0.445	0.295	2.18125252628695e-84	TGFBR2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58005
1.11308573256254e-88	-0.253100809219062	0.614	0.781	2.19678600178543e-84	MYL12B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58006
2.37792662358999e-87	0.357690983818396	0.473	0.332	4.69307598431721e-83	ANKRD44	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58007
1.72062538991632e-86	-0.292869825423061	0.525	0.693	3.39582626953885e-82	HLA-DMA	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58008
1.0575650787577e-85	0.278978504028289	0.973	0.96	2.08721043943621e-81	RPL3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58009
1.46465783580328e-84	-0.26359329968696	0.73	0.896	2.89064870474135e-80	CD68	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000129226	968	CD68 molecule	DKFZp686M18236|GP110|LAMP4|SCARD1	protein_coding	P34810	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58010
2.45640619911394e-84	-0.250886163592437	0.447	0.621	4.84796327457127e-80	CALM3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58011
4.41865073210048e-84	-0.25582097108941	0.162	0.314	8.72064908487351e-80	IFIT2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000119922	3433	interferon induced protein with tetratricopeptide repeats 2	cig42|G10P2|GARG-39|IFI-54|IFI54|ISG-54|ISG-54K	protein_coding	P09913	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58012
5.55291648671453e-83	-0.317546620562375	0.645	0.802	1.09592359781798e-78	STXBP2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000076944	6813	syntaxin binding protein 2	Hunc18b|MUNC18-2|Unc18-2|UNC18B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58013
2.0318473326582e-82	0.594401108361459	0.5	0.38	4.01005389573423e-78	XIST	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58014
2.20602710142031e-82	-0.26257099357204	0.402	0.569	4.35381508736313e-78	ABRACL	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58015
2.35234467915325e-82	0.319475492679596	0.995	0.998	4.64258745877685e-78	MT-CYB	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58016
4.49121908923033e-82	-0.261931590060718	0.455	0.626	8.86386999450498e-78	CSK	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000103653	1445	C-terminal Src kinase	NA	protein_coding	P41240	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58017
6.06687006604698e-82	0.411585699717242	0.626	0.524	1.19735747623503e-77	RNF149	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000163162	284996	ring finger protein 149	FLJ90504	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58018
7.31733771088251e-82	0.297955002577921	0.992	0.993	1.44414977061977e-77	RPS3A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58019
4.46066438625874e-81	0.334458382561778	0.478	0.341	8.80356723272025e-77	RBM25	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58020
1.93804647551917e-80	0.453927977072964	0.831	0.715	3.82492852408464e-76	VCAN	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58021
1.12049331473477e-79	0.317100127419956	0.455	0.313	2.21140560596053e-75	LUC7L3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58022
2.50783561138648e-79	0.346098278934367	0.476	0.344	4.94946436263236e-75	ZNF207	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58023
4.61586882474234e-79	0.310819579810122	0.463	0.326	9.10987871251149e-75	KMT2E	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58024
6.92019508172774e-79	0.263450304139701	0.324	0.188	1.36576970132979e-74	FNBP4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000285182	23360	formin binding protein 4	KIAA1014	protein_coding	Q8N3X1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58025
1.86237069113319e-78	0.289905689835619	0.395	0.255	3.67557479602047e-74	SRSF4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58026
4.35741120385019e-78	0.284938634910806	0.292	0.163	8.59978675191874e-74	AHR	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000106546	196	aryl hydrocarbon receptor	bHLHe76	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58027
6.03916874301114e-78	0.425321244107791	0.566	0.445	1.19189034312068e-73	RGS2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58028
1.2525421875749e-77	0.404972052280087	0.538	0.41	2.47201726139782e-73	MT-ND6	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58029
5.43159040741657e-77	0.293279755911429	0.416	0.273	1.07197868280773e-72	SORL1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000137642	6653	sortilin related receptor 1	C11orf32|gp250|LR11|LRP9|SorLA|SorLA-1	protein_coding	Q92673	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58030
7.28031924810776e-77	0.297500040386492	0.47	0.332	1.43684380680655e-72	KMT2C	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000055609	58508	lysine methyltransferase 2C	HALR|KIAA1506|MLL3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58031
3.46393268717427e-76	0.262975188154652	0.362	0.226	6.83641755140714e-72	SENP6	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000112701	26054	SUMO specific peptidase 6	KIAA0797|SUSP1	protein_coding	Q9GZR1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58032
1.00108498872549e-75	0.310878441390219	0.353	0.22	1.97574133374863e-71	NKTR	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58033
1.59501861988915e-75	0.335055086734309	0.46	0.331	3.14792874821323e-71	STK4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58034
1.74845703577272e-75	0.282069837057258	0.346	0.211	3.45075480580105e-71	ATM	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58035
1.81040592130288e-75	0.34070982600766	0.647	0.511	3.57301712628337e-71	KLF2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58036
2.8760546860178e-75	0.374952341979645	0.541	0.417	5.67618152832474e-71	SMCHD1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58037
4.8562882637792e-75	0.277250477079122	0.343	0.208	9.58437051739463e-71	KIAA1551	Mono/Macro	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58038
5.17714486780484e-75	0.318706658199614	0.624	0.53	1.02176131110996e-70	EIF4G2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58039
5.47814857583931e-75	0.372535691947459	0.486	0.366	1.08116740292765e-70	N4BP2L2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58040
1.63299189900664e-74	0.280392118293468	0.352	0.218	3.2228728118795e-70	PNN	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58041
3.95285952214264e-74	0.345806208869716	0.821	0.72	7.80136355290071e-70	CEBPD	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58042
1.3199231890581e-73	0.311874442822047	0.804	0.744	2.60500040592508e-69	MYO1F	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58043
1.32613845418668e-73	0.337981649050503	0.773	0.717	2.61726685318282e-69	CLEC12A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58044
1.35657850662889e-73	0.296415601344431	0.355	0.224	2.67734334068277e-69	BAZ2B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000123636	29994	bromodomain adjacent to zinc finger domain 2B	WALp4	protein_coding	Q9UIF8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58045
1.6854794518298e-73	-0.267725950534775	0.371	0.532	3.3264622461313e-69	MARCKS	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58046
6.65991046112277e-73	0.3166620934299	0.338	0.212	1.31439992860719e-68	NOTCH2NL	Mono/Macro	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58047
1.98333977574846e-72	0.375444859927025	0.368	0.238	3.91431938141717e-68	SLC38A2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58048
1.04534646616399e-71	-0.301393347995878	0.705	0.825	2.06309578562125e-67	PKM	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58049
2.47326043215564e-71	0.384662955221534	0.593	0.487	4.88122678890237e-67	ITGA4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58050
7.40587824312888e-71	0.383014001744846	0.593	0.491	1.46162413006392e-66	DMXL2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000104093	23312	Dmx like 2	DFNA71|KIAA0856|RC3	protein_coding	Q8TDJ6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58051
1.73184239214723e-70	0.287153406264615	0.921	0.904	3.41796414514177e-66	EEF2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58052
6.94723378176667e-70	0.27615144974421	0.424	0.294	1.37110605916947e-65	HOOK3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000168172	84376	hook microtubule tethering protein 3	HK3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58053
3.4314423690282e-69	0.282991043789241	0.509	0.383	6.77229465951405e-65	OSBPL8	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58054
5.80753147171047e-69	0.272898681348995	0.454	0.322	1.14617441125678e-64	NIN	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000100503	51199	ninein	NA	protein_coding	Q8N4C6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58055
1.58080541587997e-68	0.271078549334536	0.436	0.306	3.11987756878071e-64	NCOR1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58056
1.79255087373991e-68	0.278439130848238	0.414	0.285	3.53777840441308e-64	PTBP3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000119314	9991	polypyrimidine tract binding protein 3	DKFZp781I1117|ROD1	protein_coding	O95758	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58057
3.69671220530652e-68	0.296510248281702	0.443	0.316	7.29583120839296e-64	SRSF11	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58058
8.76159861519376e-67	0.296081791399413	0.457	0.329	1.72918910269464e-62	MYADM	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58059
2.34418863436684e-66	0.2659466013086	0.333	0.209	4.6264906887864e-62	FKBP5	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58060
1.08308054632079e-64	0.264776526567203	0.354	0.232	2.13756776621872e-60	LRRFIP2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000093167	9209	LRR binding FLII interacting protein 2	HUFI-2	protein_coding	Q9Y608	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58061
5.73611918600413e-64	0.290451829158958	0.392	0.27	1.13208048254978e-59	AFF4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58062
1.20073292774135e-63	0.259529879178268	0.309	0.191	2.36976650619033e-59	STX16	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000124222	8675	syntaxin 16	hsyn16|SYN-16|SYN16	protein_coding	O14662	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58063
1.25606686840173e-63	-0.29110392346917	0.615	0.739	2.47897357147765e-59	TNFSF10	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000121858	8743	TNF superfamily member 10	Apo-2L|CD253|TL2|TRAIL	protein_coding	P50591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58064
1.84802928550956e-63	0.264461421019446	0.757	0.697	3.64727059788166e-59	CAST	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58065
3.2855280459454e-63	0.367495317031295	0.545	0.444	6.48431815147785e-59	CFLAR	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58066
4.48435898597794e-63	0.2737738395684	0.407	0.286	8.85033089472605e-59	INPP5D	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000281614	3635	inositol polyphosphate-5-phosphatase D	hp51CN|SHIP|SHIP1	protein_coding	Q92835	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58067
5.18291460801382e-63	0.273940114326802	0.433	0.31	1.02290002703761e-58	ITSN2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198399	50618	intersectin 2	KIAA1256|PRO2015|SH3D1B|SH3P18|SWA|SWAP	protein_coding	Q9NZM3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58068
8.9509353686362e-63	-0.311439095780361	0.475	0.609	1.76655660435404e-58	TUBA1B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58069
1.1074380031857e-62	0.284113395206264	0.253	0.141	2.18563964308729e-58	FCGR2B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000072694	2213	Fc gamma receptor IIb	CD32|CD32B|FCG2|FcgammaRIIb|FCGR2|FcGRIIB	protein_coding	P31994	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58070
1.33028181246852e-62	0.646368106647052	0.498	0.411	2.62544418508786e-58	NFKBIZ	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58071
2.16309684472566e-62	0.328261532483512	0.729	0.671	4.26908793275056e-58	DOCK8	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000107099	81704	dedicator of cytokinesis 8	FLJ00026|FLJ00152|FLJ00346|ZIR8	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58072
3.32772166331905e-62	0.29119822048844	0.97	0.906	6.56759147472647e-58	MT-ATP8	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58073
1.24137165139233e-61	0.300397662498108	0.403	0.285	2.4499710911879e-57	AGTPBP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000135049	23287	ATP/GTP binding carboxypeptidase 1	CCP1|KIAA1035|Nna1	protein_coding	Q9UPW5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58074
2.02440650429914e-61	0.289973649699746	0.486	0.368	3.99536867688478e-57	TRAF3IP3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58075
5.02254199382337e-61	0.2530309982913	0.398	0.277	9.91248887900981e-57	NIPBL	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58076
2.65096161556715e-60	0.266521617756891	0.403	0.284	5.23193784448333e-56	TET2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000168769	54790	tet methylcytosine dioxygenase 2	FLJ20032|KIAA1546	protein_coding	Q6N021	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58077
5.40468233943256e-60	0.286901675039275	0.474	0.359	1.06666810651041e-55	RAB11FIP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58078
1.08169618199309e-59	0.256046679724366	0.407	0.287	2.13483558478157e-55	HERPUD1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58079
1.09966624160394e-59	0.2811002238646	0.477	0.362	2.17030129442953e-55	VPS13C	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000129003	54832	vacuolar protein sorting 13 homolog C	BLTP5C|FLJ10381|FLJ20136|KIAA1421	protein_coding	Q709C8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58080
7.24899172801558e-59	0.308922471644448	0.356	0.242	1.43066100744115e-54	CIITA	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000179583	4261	class II major histocompatibility complex transactivator	C2TA|MHC2TA|NLRA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58081
9.28672419676828e-59	0.2857190650452	0.997	0.998	1.83282788747419e-54	TPT1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58082
2.57600184922175e-57	0.275813058799522	0.519	0.41	5.08399724962404e-53	SF3B1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58083
9.06565988834404e-57	0.293490163559564	0.433	0.324	1.78919863556358e-52	STX7	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000079950	8417	syntaxin 7	NA	protein_coding	O15400	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58084
1.6755071827759e-56	0.315604179622752	0.513	0.411	3.30678097592651e-52	FUS	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58085
1.92026292546689e-56	0.262692952090972	0.369	0.255	3.78983090970145e-52	SMG1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000157106	23049	SMG1 nonsense mediated mRNA decay associated PI3K related kinase	ATX|KIAA0421|LIP	protein_coding	Q96Q15	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58086
3.71665844625266e-56	-0.36424071492942	0.398	0.531	7.33519710952424e-52	SMIM25	Mono/Macro	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58087
5.3717756072042e-56	0.263360033284643	0.43	0.315	1.06017363383782e-51	RB1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000139687	5925	RB transcriptional corepressor 1	OSRC|PPP1R130|RB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58088
1.25494672579204e-54	0.319250784057822	0.365	0.259	2.47676285802317e-50	CYTIP	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58089
3.17711804682339e-54	0.268537301125695	0.469	0.362	6.27036017721065e-50	MIS18BP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000129534	55320	MIS18 binding protein 1	C14orf106|FLJ11186|KIAA1903|KNL2|M18BP1	protein_coding	Q6P0N0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58090
2.57653141788143e-53	0.314892416317	0.414	0.309	5.08504240633078e-49	TRA2B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58091
1.13957985032137e-52	0.257749921423462	0.301	0.196	2.24907479259426e-48	MDM4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58092
8.10886015116144e-51	0.264166819201185	0.436	0.334	1.60036463943322e-46	WASHC4	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000136051	23325	WASH complex subunit 4	KIAA1033|SWIP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58093
1.37029532690727e-50	0.263577584558786	0.502	0.396	2.7044148571842e-46	CD99	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58094
2.46592964002814e-50	0.297084393135446	0.496	0.395	4.86675873755953e-46	MEGF9	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000106780	1955	multiple EGF like domains 9	EGFL5	protein_coding	Q9H1U4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58095
3.25834240619989e-50	0.270252473788593	0.48	0.376	6.4306645728761e-46	NUMB	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000133961	8650	NUMB endocytic adaptor protein	C14orf41	protein_coding	P49757	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58096
4.17391817648965e-50	0.295690790611865	0.704	0.63	8.23764491311998e-46	ANXA1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58097
8.06287452745086e-50	0.370271677986048	0.734	0.673	1.5912889167377e-45	ZFP36	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58098
1.18436551941412e-49	-0.31064957487594	0.459	0.57	2.33746378911571e-45	PLBD1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000121316	79887	phospholipase B domain containing 1	FLJ22662	protein_coding	Q6P4A8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58099
1.51596123024147e-48	-0.303027549886423	0.678	0.769	2.99190108400457e-44	CD14	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58100
3.05402772126801e-48	0.309121730533387	0.357	0.253	6.02742911069455e-44	RNF144B	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000137393	255488	ring finger protein 144B	bA528A10.3|IBRDC2|P53RFP	protein_coding	Q7Z419	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58101
2.21574365960236e-47	0.312155356140185	0.439	0.346	4.37299168659123e-43	GPCPD1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58102
2.76869193790945e-47	0.259353682632059	0.742	0.706	5.46429040865809e-43	IQGAP1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58103
6.87096112631557e-46	0.252392107765737	0.417	0.318	1.35605288788964e-41	CD46	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000117335	4179	CD46 molecule	MCP|MGC26544|MIC10|TLX|TRA2.10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58104
1.03579514351154e-45	0.270878249091447	0.362	0.263	2.04424529523438e-41	ARHGAP26	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000145819	23092	Rho GTPase activating protein 26	GRAF|KIAA0621|OPHN1L|OPHN1L1	protein_coding	Q9UNA1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58105
1.74037697092999e-45	0.278788542462684	0.394	0.297	3.43480798982742e-41	AKIRIN2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000135334	55122	akirin 2	C6orf166|dJ486L4.2|FLJ10342	protein_coding	Q53H80	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58106
5.44618882998179e-45	0.262645105910845	0.532	0.448	1.07485982748521e-40	REL	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58107
6.91226731644968e-44	0.268548742968324	0.628	0.564	1.36420507757451e-39	TBXAS1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000059377	6916	thromboxane A synthase 1	CYP5|CYP5A1|THAS|TS|TXAS|TXS	protein_coding	P24557	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58108
5.63108870794292e-43	-0.34640167624171	0.208	0.311	1.11135166739961e-38	RHOC	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58109
1.15385578461061e-42	0.262922947446479	0.403	0.303	2.2772497765075e-38	BTG2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58110
1.10866999150658e-40	0.326952068227567	0.603	0.551	2.18807109523739e-36	RIPOR2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58111
5.66724014860986e-40	-0.253378809841668	0.435	0.534	1.11848651572964e-35	SELL	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58112
5.08436868201191e-39	0.290603259500186	0.659	0.616	1.00345100308187e-34	SRRM2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58113
5.92044453602374e-38	0.275504856788267	0.471	0.393	1.16845893362965e-33	JAK2	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000096968	3717	Janus kinase 2	JTK10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58114
4.17139363459289e-35	-0.327376458972957	0.749	0.787	8.23266247723253e-31	NCF1	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58115
4.30558051564702e-31	0.273713914258259	0.562	0.498	8.49749370568096e-27	NAIP	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000276068	4671	NLR family apoptosis inhibitory protein	BIRC1|NLRB1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58116
1.87533691709311e-25	0.256517414618099	0.544	0.495	3.70116493957496e-21	AOAH	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000136250	313	acyloxyacyl hydrolase	NA	protein_coding	P28039	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58117
3.66574177326419e-20	-0.280346209759216	0.26	0.331	7.23470796371421e-16	FCGR3A	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58118
1.03842755291404e-18	0.254925430897279	0.69	0.692	2.04944061843116e-14	LYST	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000143669	1130	lysosomal trafficking regulator	CHS|CHS1|Mauve	protein_coding	Q99698	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58119
9.10391470473456e-11	0.275603976407119	0.27	0.237	1.79674860612641e-06	SLC2A3	Mono/Macro	GSE169246_PacBlood_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58120
0	-0.537880567892997	0.922	0.991	0	RPL22	NK cells	GSE169246_PacBlood_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58121
0	-0.689077273449067	0.994	1	0	RPL11	NK cells	GSE169246_PacBlood_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58122
0	-0.509767934658792	0.968	0.997	0	SH3BGRL3	NK cells	GSE169246_PacBlood_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58123
0	-0.499421553766291	0.997	1	0	RPS8	NK cells	GSE169246_PacBlood_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58124
0	0.809744206787718	0.986	0.926	0	TXNIP	NK cells	GSE169246_PacBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58125
0	0.658507672141014	0.346	0.061	0	S100A9	NK cells	GSE169246_PacBlood_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58126
0	0.49331114421457	0.297	0.05	0	S100A8	NK cells	GSE169246_PacBlood_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58127
0	-1.09577459286105	1	1	0	RPS27	NK cells	GSE169246_PacBlood_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58128
0	0.752293437661042	0.986	0.96	0	PTPRC	NK cells	GSE169246_PacBlood_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58129
0	-0.620191431976195	0.989	1	0	RPS7	NK cells	GSE169246_PacBlood_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58130
0	1.06299379285884	0.945	0.692	0	ZFP36L2	NK cells	GSE169246_PacBlood_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58131
0	-0.607374801620779	0.998	1	0	RPS27A	NK cells	GSE169246_PacBlood_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58132
0	-0.746358939967858	0.997	1	0	TMSB10	NK cells	GSE169246_PacBlood_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58133
0	-0.598747011149899	0.838	0.969	0	RPL31	NK cells	GSE169246_PacBlood_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58134
0	0.666210120999727	0.657	0.397	0	ZEB2	NK cells	GSE169246_PacBlood_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58135
0	-0.820487386440122	0.96	0.999	0	RPL37A	NK cells	GSE169246_PacBlood_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58136
0	-0.79546580747586	0.995	1	0	RPL32	NK cells	GSE169246_PacBlood_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58137
0	-0.427374462459154	0.983	0.998	0	RPL15	NK cells	GSE169246_PacBlood_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58138
0	-0.540170655138266	0.962	0.995	0	RPSA	NK cells	GSE169246_PacBlood_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58139
0	-0.481025882693672	0.984	1	0	RPL14	NK cells	GSE169246_PacBlood_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58140
0	-0.596871170615181	0.779	0.964	0	TMA7	NK cells	GSE169246_PacBlood_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58141
0	-0.624169226799637	0.983	1	0	RPL29	NK cells	GSE169246_PacBlood_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58142
0	-0.504309155417727	0.94	0.994	0	RPL24	NK cells	GSE169246_PacBlood_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58143
0	-0.805859415564425	0.982	1	0	RPL35A	NK cells	GSE169246_PacBlood_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58144
0	-0.488001815164402	0.943	0.991	0	RPL9	NK cells	GSE169246_PacBlood_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58145
0	-0.837194715089895	0.995	1	0	RPL34	NK cells	GSE169246_PacBlood_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58146
0	-0.901451928547844	0.992	1	0	RPL37	NK cells	GSE169246_PacBlood_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58147
0	-0.467902149388259	0.815	0.95	0	BTF3	NK cells	GSE169246_PacBlood_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58148
0	-0.635361144936838	0.996	1	0	RPS23	NK cells	GSE169246_PacBlood_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58149
0	-0.49673002845401	0.731	0.909	0	COX7C	NK cells	GSE169246_PacBlood_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58150
0	-0.648095602316653	0.995	1	0	RPS14	NK cells	GSE169246_PacBlood_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58151
0	0.590971075614957	0.324	0.05	0	DUSP1	NK cells	GSE169246_PacBlood_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58152
0	-0.430823001613861	0.966	0.996	0	RACK1	NK cells	GSE169246_PacBlood_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58153
0	0.314817464354022	1	0.999	0	HLA-C	NK cells	GSE169246_PacBlood_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58154
0	-0.732027544548578	0.534	0.78	0	HLA-DRB1	NK cells	GSE169246_PacBlood_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58155
0	-0.601784722320942	0.996	1	0	RPS18	NK cells	GSE169246_PacBlood_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58156
0	-0.508009996821058	0.95	0.993	0	RPL10A	NK cells	GSE169246_PacBlood_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58157
0	-0.719461079007024	0.998	1	0	RPS12	NK cells	GSE169246_PacBlood_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58158
0	0.645875532493203	0.735	0.491	0	SYNE1	NK cells	GSE169246_PacBlood_pre	ENSG00000131018	23345	spectrin repeat containing nuclear envelope protein 1	8B|ARCA1|C6orf98|CPG2|dJ45H2.2|enaptin|KIAA0796|MYNE1|Nesp1|Nesprin-1|SCAR8|SYNE-1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58159
0	-0.550953635205486	0.736	0.918	0	TOMM7	NK cells	GSE169246_PacBlood_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58160
0	0.578878243292978	0.931	0.805	0	HNRNPA2B1	NK cells	GSE169246_PacBlood_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58161
0	-0.50414615811784	0.995	1	0	RPS4X	NK cells	GSE169246_PacBlood_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58162
0	-0.84066212435069	0.505	0.839	0	RPL36A	NK cells	GSE169246_PacBlood_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58163
0	0.816218180799626	0.667	0.308	0	TSC22D3	NK cells	GSE169246_PacBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58164
0	-0.955467130836044	0.994	1	0	RPL39	NK cells	GSE169246_PacBlood_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58165
0	-0.696297093253645	1	1	0	RPL10	NK cells	GSE169246_PacBlood_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58166
0	-0.713666425564707	0.997	1	0	RPL30	NK cells	GSE169246_PacBlood_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58167
0	-0.401011387324423	0.994	1	0	RPS6	NK cells	GSE169246_PacBlood_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58168
0	0.566215685501285	0.547	0.245	0	SEMA4D	NK cells	GSE169246_PacBlood_pre	ENSG00000187764	10507	semaphorin 4D	C9orf164|CD100|coll-4|FLJ39737|SEMAJ	protein_coding	Q92854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58169
0	-0.706710334946236	0.947	0.998	0	RPL35	NK cells	GSE169246_PacBlood_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58170
0	-0.610666047826686	0.98	0.999	0	RPL12	NK cells	GSE169246_PacBlood_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58171
0	-0.503354315952484	0.991	1	0	RPL7A	NK cells	GSE169246_PacBlood_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58172
0	-0.576813992586799	0.935	0.98	0	IFITM2	NK cells	GSE169246_PacBlood_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58173
0	-0.727871984318621	0.978	0.998	0	IFITM1	NK cells	GSE169246_PacBlood_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58174
0	-0.612092996326747	0.987	0.999	0	RPLP2	NK cells	GSE169246_PacBlood_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58175
0	3.25212859252964	0.451	0.027	0	HBB	NK cells	GSE169246_PacBlood_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58176
0	0.596248116298284	0.685	0.403	0	EIF4G2	NK cells	GSE169246_PacBlood_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58177
0	-0.560744078918895	0.988	1	0	RPS13	NK cells	GSE169246_PacBlood_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58178
0	0.716012351829597	0.894	0.701	0	AHNAK	NK cells	GSE169246_PacBlood_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58179
0	-0.55033945923602	0.718	0.887	0	RARRES3	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58180
0	-0.683816154703021	0.987	1	0	FAU	NK cells	GSE169246_PacBlood_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58181
0	-0.606916871620919	0.995	1	0	RPS3	NK cells	GSE169246_PacBlood_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58182
0	-0.589610686257237	0.987	0.999	0	RPS25	NK cells	GSE169246_PacBlood_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58183
0	-0.66441637618518	0.988	1	0	RPS24	NK cells	GSE169246_PacBlood_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58184
0	-0.802134489435228	0.815	0.947	0	RPS26	NK cells	GSE169246_PacBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58185
0	-1.19305422917761	0.931	0.998	0	RPL41	NK cells	GSE169246_PacBlood_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58186
0	0.695933368442993	0.418	0.066	0	LYZ	NK cells	GSE169246_PacBlood_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58187
0	0.582655034439296	0.93	0.769	0	BTG1	NK cells	GSE169246_PacBlood_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58188
0	-0.538865857928767	0.985	1	0	RPL6	NK cells	GSE169246_PacBlood_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58189
0	-0.656496433960576	0.965	0.998	0	RPL21	NK cells	GSE169246_PacBlood_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58190
0	0.604903282714757	0.936	0.827	0	LCP1	NK cells	GSE169246_PacBlood_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58191
0	-1.05876934449849	0.953	0.999	0	RPS29	NK cells	GSE169246_PacBlood_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58192
0	0.596850252880893	0.661	0.394	0	PRKCH	NK cells	GSE169246_PacBlood_pre	ENSG00000027075	5583	protein kinase C eta	PKC-L|PKCL|PRKCL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58193
0	-0.775660591225056	0.743	0.917	0	CRIP1	NK cells	GSE169246_PacBlood_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58194
0	-0.513957464002039	0.936	0.995	0	SERF2	NK cells	GSE169246_PacBlood_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58195
0	-0.814453819065752	1	1	0	RPLP1	NK cells	GSE169246_PacBlood_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58196
0	-0.456118971483104	0.997	0.999	0	RPS2	NK cells	GSE169246_PacBlood_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58197
0	-0.50659721704322	0.571	0.824	0	ELOB	NK cells	GSE169246_PacBlood_pre	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58198
0	-0.858961301441943	0.997	1	0	RPS15A	NK cells	GSE169246_PacBlood_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58199
0	-0.850155489042645	0.3	0.642	0	MT2A	NK cells	GSE169246_PacBlood_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58200
0	-0.515874282509747	1	1	0	RPL13	NK cells	GSE169246_PacBlood_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58201
0	-0.68766070619432	0.993	1	0	RPL26	NK cells	GSE169246_PacBlood_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58202
0	-0.731979252303921	0.976	0.999	0	RPL23A	NK cells	GSE169246_PacBlood_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58203
0	-0.708416325987467	0.94	0.981	0	CCL5	NK cells	GSE169246_PacBlood_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58204
0	-0.584068953628715	0.998	1	0	RPL19	NK cells	GSE169246_PacBlood_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58205
0	-0.642984269215996	0.912	0.991	0	RPL27	NK cells	GSE169246_PacBlood_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58206
0	0.783096054674887	0.958	0.793	0	DDX5	NK cells	GSE169246_PacBlood_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58207
0	-0.773905551857279	0.863	0.985	0	RPL38	NK cells	GSE169246_PacBlood_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58208
0	-0.442024087800356	0.978	0.997	0	RPL17	NK cells	GSE169246_PacBlood_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58209
0	-0.772503476278809	0.902	0.995	0	ATP5F1E	NK cells	GSE169246_PacBlood_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58210
0	-1.02261068462386	0.969	0.999	0	RPS21	NK cells	GSE169246_PacBlood_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58211
0	-0.707816840832002	0.991	1	0	RPS15	NK cells	GSE169246_PacBlood_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58212
0	-0.503304174764019	0.592	0.826	0	UQCR11	NK cells	GSE169246_PacBlood_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58213
0	-0.797179077436179	0.972	0.999	0	RPL36	NK cells	GSE169246_PacBlood_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58214
0	-0.904104289631473	0.993	1	0	RPS28	NK cells	GSE169246_PacBlood_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58215
0	0.777608469905035	0.956	0.72	0	KLF2	NK cells	GSE169246_PacBlood_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58216
0	-0.581803774085934	0.993	1	0	RPL18A	NK cells	GSE169246_PacBlood_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58217
0	-0.562881995937074	0.948	0.997	0	UBA52	NK cells	GSE169246_PacBlood_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58218
0	-0.564818611377616	0.899	0.984	0	HCST	NK cells	GSE169246_PacBlood_pre	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58219
0	-0.54912663760248	0.966	0.998	0	RPS16	NK cells	GSE169246_PacBlood_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58220
0	-0.896514522262855	0.997	1	0	RPS19	NK cells	GSE169246_PacBlood_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58221
0	-0.495170611105053	0.574	0.815	0	SNRPD2	NK cells	GSE169246_PacBlood_pre	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58222
0	-0.559533316122482	0.99	1	0	RPL18	NK cells	GSE169246_PacBlood_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58223
0	-0.581538122038822	0.994	0.999	0	NKG7	NK cells	GSE169246_PacBlood_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58224
0	-0.428904798888886	0.982	0.997	0	RPS9	NK cells	GSE169246_PacBlood_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58225
0	-0.837619035355169	0.998	1	0	RPL28	NK cells	GSE169246_PacBlood_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58226
0	-0.527912035235101	0.951	0.994	0	RPS5	NK cells	GSE169246_PacBlood_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58227
0	-0.58455632912157	0.644	0.872	0	MIF	NK cells	GSE169246_PacBlood_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58228
0	0.602990484563973	0.779	0.498	0	SUN2	NK cells	GSE169246_PacBlood_pre	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58229
0	0.553779841999261	0.476	0.182	0	DIP2A	NK cells	GSE169246_PacBlood_pre	ENSG00000160305	23181	disco interacting protein 2 homolog A	C21orf106|Dip2|KIAA0184	protein_coding	Q14689	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58230
0	0.548374511293379	0.696	0.434	0	PRMT2	NK cells	GSE169246_PacBlood_pre	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58231
0	0.455624825746553	1	1	0	MT-CO1	NK cells	GSE169246_PacBlood_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58232
0	0.673032679723788	0.995	0.955	0	MT-ATP8	NK cells	GSE169246_PacBlood_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58233
0	0.895976372479725	1	0.98	0	MT-ND4L	NK cells	GSE169246_PacBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58234
0	0.983589627249368	0.998	0.952	0	MT-ND5	NK cells	GSE169246_PacBlood_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58235
0	0.803005124888576	0.739	0.466	0	MT-ND6	NK cells	GSE169246_PacBlood_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58236
0	0.582091226717183	0.999	0.995	0	MT-CYB	NK cells	GSE169246_PacBlood_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58237
1.39528190408157e-301	0.558253238946827	0.709	0.456	2.7537283658954e-297	HNRNPU	NK cells	GSE169246_PacBlood_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58238
1.01827743595114e-297	0.540124136309109	0.838	0.669	2.00967234759316e-293	MSN	NK cells	GSE169246_PacBlood_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58239
1.23992921309212e-296	-0.508302640452183	0.446	0.706	2.44712429495861e-292	RPS10	NK cells	GSE169246_PacBlood_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58240
2.79873864235355e-296	0.514576728431536	0.544	0.263	5.52359058454896e-292	ZFP36	NK cells	GSE169246_PacBlood_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58241
3.14285859397659e-295	0.499089998185191	0.891	0.751	6.2027457210722e-291	PNRC1	NK cells	GSE169246_PacBlood_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58242
1.09052079397011e-294	0.516503620532393	0.701	0.452	2.1522518389794e-290	SRSF5	NK cells	GSE169246_PacBlood_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58243
9.27583068080618e-294	-0.481801623751403	0.647	0.863	1.83067794316391e-289	COMMD6	NK cells	GSE169246_PacBlood_pre	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58244
1.48254504475529e-291	0.510580487906846	0.432	0.169	2.92595090032904e-287	VCL	NK cells	GSE169246_PacBlood_pre	ENSG00000035403	7414	vinculin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58245
2.27263102250899e-291	-0.478911200797578	0.963	0.992	4.48526458602374e-287	RPLP0	NK cells	GSE169246_PacBlood_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58246
1.7122414222611e-284	-0.429974781601947	0.867	0.967	3.37927967097451e-280	PFDN5	NK cells	GSE169246_PacBlood_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58247
4.20355613804227e-284	-0.458957747583941	0.844	0.957	8.29613839404022e-280	RPL27A	NK cells	GSE169246_PacBlood_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58248
5.01561220294028e-284	-0.458890426601887	0.831	0.945	9.89881224372294e-280	RPS11	NK cells	GSE169246_PacBlood_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58249
1.15684841300829e-282	-0.445491103236222	0.776	0.929	2.28315602791315e-278	ATP5MC2	NK cells	GSE169246_PacBlood_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58250
2.55267852293956e-282	-0.464380903410659	0.674	0.867	5.03796633287351e-278	OST4	NK cells	GSE169246_PacBlood_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58251
2.11761411634262e-278	0.469848453591525	0.902	0.793	4.17932322001379e-274	YWHAZ	NK cells	GSE169246_PacBlood_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58252
4.27997934188227e-276	0.467454408489562	0.912	0.778	8.44696722913884e-272	PABPC1	NK cells	GSE169246_PacBlood_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58253
9.6292684445711e-276	-0.430269715726892	0.915	0.982	1.90043242022055e-271	MYL6	NK cells	GSE169246_PacBlood_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58254
6.50269639732632e-273	0.547524841518667	0.736	0.518	1.28337216097632e-268	IQGAP1	NK cells	GSE169246_PacBlood_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58255
1.50323447890815e-272	0.605430877790447	0.64	0.397	2.96678356757312e-268	MACF1	NK cells	GSE169246_PacBlood_pre	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58256
3.97806488923082e-271	0.915900615683007	0.349	0.113	7.85110886538595e-267	MYOM2	NK cells	GSE169246_PacBlood_pre	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58257
1.18192458561675e-270	-0.708811110635023	0.434	0.662	2.33264636217321e-266	CMC1	NK cells	GSE169246_PacBlood_pre	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58258
1.49737464282581e-269	0.494615402491367	0.564	0.306	2.95521859508102e-265	SFPQ	NK cells	GSE169246_PacBlood_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58259
2.60869221246177e-262	-0.448784076998573	0.381	0.644	5.14851495051454e-258	NDUFA3	NK cells	GSE169246_PacBlood_pre	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58260
1.54422344551898e-258	0.551680063811704	0.761	0.57	3.04767939207626e-254	RIPOR2	NK cells	GSE169246_PacBlood_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58261
2.04839036755498e-257	0.497493860973509	0.547	0.293	4.04270322940652e-253	RASA3	NK cells	GSE169246_PacBlood_pre	ENSG00000280477	22821	RAS p21 protein activator 3	GAP1IP4BP|GAPIII	protein_coding	Q14644	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58262
1.88081076603392e-256	-0.417376400317963	0.729	0.901	3.71196812784454e-252	ATP5MG	NK cells	GSE169246_PacBlood_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58263
9.59215915752876e-252	0.455707588292739	0.806	0.622	1.89310853132988e-247	SARAF	NK cells	GSE169246_PacBlood_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58264
1.50390202256768e-251	0.509118556505945	0.818	0.642	2.96810103173958e-247	MYH9	NK cells	GSE169246_PacBlood_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58265
2.90494747611051e-250	0.454270808826412	0.497	0.249	5.7332043388517e-246	MATR3.1	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58266
6.82900049972205e-249	0.540860042326439	0.73	0.527	1.34777153862514e-244	DDX17	NK cells	GSE169246_PacBlood_pre	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58267
5.67437497169347e-245	-0.436111064147457	0.614	0.816	1.11989464441342e-240	UBL5	NK cells	GSE169246_PacBlood_pre	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58268
2.75826042326028e-244	-0.419987135574225	0.77	0.921	5.44370277134648e-240	RPL36AL	NK cells	GSE169246_PacBlood_pre	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58269
1.56187831354386e-241	-0.421147755387987	0.973	0.993	3.08252303961017e-237	CYBA	NK cells	GSE169246_PacBlood_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58270
3.60289724263701e-241	-0.438911977971537	0.617	0.826	7.1106779980684e-237	UQCRB	NK cells	GSE169246_PacBlood_pre	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58271
1.28234676931686e-238	-0.460943722049855	0.957	0.981	2.53083958392376e-234	MT-ND4	NK cells	GSE169246_PacBlood_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58272
1.22546423141203e-236	0.485495388773744	0.67	0.451	2.41857620711478e-232	IKZF1	NK cells	GSE169246_PacBlood_pre	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58273
1.28210367053712e-236	-0.380335643208668	0.907	0.977	2.53035980417206e-232	EEF1D	NK cells	GSE169246_PacBlood_pre	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58274
3.66798418054661e-236	0.329793764520912	0.998	0.991	7.23913357872679e-232	HLA-E	NK cells	GSE169246_PacBlood_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58275
9.90122334628488e-236	0.377033959985567	0.999	0.998	1.95410543962278e-231	MT-CO3	NK cells	GSE169246_PacBlood_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58276
1.11088055055241e-235	-0.619055437235936	0.887	0.939	2.19243385457023e-231	CD52	NK cells	GSE169246_PacBlood_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58277
3.92302757930215e-234	-0.427582136934266	0.422	0.659	7.74248723051072e-230	TMEM258	NK cells	GSE169246_PacBlood_pre	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58278
4.87626582434196e-234	0.345621681166996	1	1	9.6237982309213e-230	MT-CO2	NK cells	GSE169246_PacBlood_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58279
2.55752892246608e-229	-0.413378446985291	0.609	0.81	5.04753908137906e-225	COX6B1	NK cells	GSE169246_PacBlood_pre	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58280
1.61599880539602e-228	0.492903970411345	0.523	0.278	3.18933524232958e-224	HIST1H1E	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58281
3.20891050955513e-228	-0.493394806739158	0.904	0.958	6.33310578165801e-224	S100A6	NK cells	GSE169246_PacBlood_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58282
6.16395016705948e-228	0.472248573862418	0.622	0.393	1.21651720497086e-223	STK10	NK cells	GSE169246_PacBlood_pre	ENSG00000072786	6793	serine/threonine kinase 10	LOK|PRO2729	protein_coding	O94804	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58283
2.42061934268241e-227	0.537991714779502	0.678	0.476	4.77733433471801e-223	CELF2	NK cells	GSE169246_PacBlood_pre	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58284
1.36136062074015e-226	-0.417754934534145	0.351	0.599	2.68678132109277e-222	ATP5ME	NK cells	GSE169246_PacBlood_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58285
3.82746997380129e-226	0.446137644799052	0.652	0.424	7.55389474029423e-222	LCP2	NK cells	GSE169246_PacBlood_pre	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58286
3.18918731023878e-223	0.448901193851001	0.741	0.538	6.29418007548726e-219	NCL	NK cells	GSE169246_PacBlood_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58287
4.58385693732726e-223	0.451090901096024	0.781	0.613	9.04670005150907e-219	CDC42	NK cells	GSE169246_PacBlood_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58288
1.1527849056541e-222	-0.359768117675576	0.967	0.995	2.27513628979894e-218	RPL5	NK cells	GSE169246_PacBlood_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58289
1.13439624480147e-221	0.432554695266648	0.54	0.304	2.23884442874019e-217	RASAL3	NK cells	GSE169246_PacBlood_pre	ENSG00000105122	64926	RAS protein activator like 3	FLJ21438	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58290
9.21007872368504e-220	-0.458003083306068	0.917	0.956	1.81770113690648e-215	GZMA	NK cells	GSE169246_PacBlood_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58291
9.6681533404966e-220	-0.708794095806501	0.609	0.776	1.90810674328041e-215	LGALS1	NK cells	GSE169246_PacBlood_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58292
1.02979557065467e-218	-0.322132553492707	0.093	0.291	2.03240453824406e-214	BLOC1S1	NK cells	GSE169246_PacBlood_pre	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58293
1.14624364540503e-215	0.494179076281193	0.632	0.416	2.26222645857136e-211	RSRP1	NK cells	GSE169246_PacBlood_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58294
4.90035728069287e-215	-0.453837460761757	0.463	0.682	9.67134512917545e-211	NME2	NK cells	GSE169246_PacBlood_pre	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58295
5.55666560479739e-215	0.463216747698078	0.767	0.582	1.09666352376281e-210	PDIA3	NK cells	GSE169246_PacBlood_pre	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58296
9.82158445545223e-214	-0.404543370202107	0.409	0.643	1.93838790812805e-209	ATP5MD	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58297
1.461604432417e-213	0.529928867163844	0.703	0.514	2.88462250781818e-209	KLF6	NK cells	GSE169246_PacBlood_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58298
1.47915193332864e-213	-0.399729071422064	0.801	0.921	2.9192542556174e-209	PSME1	NK cells	GSE169246_PacBlood_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58299
1.75579175232406e-213	0.425715682043513	0.823	0.68	3.46523060238676e-209	EVL	NK cells	GSE169246_PacBlood_pre	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58300
6.97671088811207e-213	-0.412592095987095	0.609	0.799	1.3769236608778e-208	SSR4	NK cells	GSE169246_PacBlood_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58301
2.64065518624951e-212	0.426455789917645	0.652	0.432	5.21159707558204e-208	SF1	NK cells	GSE169246_PacBlood_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58302
4.13564388667854e-212	0.438427308109674	0.596	0.378	8.16210677474876e-208	CD164	NK cells	GSE169246_PacBlood_pre	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58303
1.24780451080248e-211	0.495831825195947	0.779	0.584	2.46266698251977e-207	CX3CR1	NK cells	GSE169246_PacBlood_pre	ENSG00000168329	1524	C-X3-C motif chemokine receptor 1	CCRL1|CMKBRL1|CMKDR1|GPR13|V28	protein_coding	P49238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58304
2.1701830398736e-210	0.412385394458237	0.618	0.393	4.28307324749453e-206	FMNL1	NK cells	GSE169246_PacBlood_pre	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58305
6.68799863018263e-210	0.440199289628572	0.557	0.33	1.31994340965284e-205	NFATC2	NK cells	GSE169246_PacBlood_pre	ENSG00000101096	4773	nuclear factor of activated T cells 2	NF-ATP|NFAT1|NFATp	protein_coding	Q13469	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58306
7.83387489585848e-209	0.479962544175021	0.782	0.626	1.54609354944663e-204	MBNL1	NK cells	GSE169246_PacBlood_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58307
1.10170637816457e-208	0.461988107591897	0.581	0.368	2.17432770794559e-204	CYTIP	NK cells	GSE169246_PacBlood_pre	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58308
1.54472485899847e-208	-0.393266145609987	0.631	0.811	3.04866898171938e-204	COX6A1	NK cells	GSE169246_PacBlood_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58309
1.82978602845032e-208	-0.379811193550387	0.732	0.887	3.61126570574955e-204	SRP14	NK cells	GSE169246_PacBlood_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58310
2.4604221227739e-208	-0.397160497331045	0.46	0.68	4.85588910150658e-204	NDUFA1	NK cells	GSE169246_PacBlood_pre	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58311
4.31874683085303e-206	-0.317703842305153	0.99	0.999	8.52347874537155e-202	RPL8	NK cells	GSE169246_PacBlood_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58312
4.2397600383801e-205	0.508778895610206	0.583	0.371	8.36759041174696e-201	KIAA1551	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58313
7.34767974387555e-203	0.412278797674548	0.417	0.198	1.45013807425128e-198	PRDM1	NK cells	GSE169246_PacBlood_pre	ENSG00000057657	639	PR/SET domain 1	BLIMP1|PRDI-BF1	protein_coding	O75626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58314
1.18033853753955e-201	-0.343636833864959	1	1	2.32951613768806e-197	TMSB4X	NK cells	GSE169246_PacBlood_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58315
3.08934174489654e-201	-0.537850731088557	0.236	0.452	6.09712486772781e-197	XCL2	NK cells	GSE169246_PacBlood_pre	ENSG00000143185	6846	X-C motif chemokine ligand 2	SCM-1b|SCYC2	protein_coding	Q9UBD3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58316
3.11639147472691e-201	0.628901274149504	0.631	0.432	6.15051021452103e-197	NEAT1	NK cells	GSE169246_PacBlood_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58317
3.6920704916757e-201	0.425868941784361	0.584	0.366	7.28667032237116e-197	CYTH1	NK cells	GSE169246_PacBlood_pre	ENSG00000108669	9267	cytohesin 1	B2-1|cytohesin-1|D17S811E|PSCD1	protein_coding	Q15438	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58318
5.77484733805155e-200	0.436452791167962	0.762	0.584	1.13972387063785e-195	ACTR3	NK cells	GSE169246_PacBlood_pre	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58319
8.92319085918837e-200	0.396709324368052	0.48	0.258	1.76108094796942e-195	FLI1	NK cells	GSE169246_PacBlood_pre	ENSG00000151702	2313	Fli-1 proto-oncogene, ETS transcription factor	EWSR2|FLI-1|SIC-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58320
6.16974257084097e-199	0.390372100310538	0.518	0.293	1.21766039378117e-194	PPP3CC	NK cells	GSE169246_PacBlood_pre	ENSG00000120910	5533	protein phosphatase 3 catalytic subunit gamma	CALNA3|PP2Bgamma	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58321
3.09395061545071e-197	0.456600534955799	0.468	0.25	6.10622093465352e-193	IGF2R	NK cells	GSE169246_PacBlood_pre	ENSG00000197081	3482	insulin like growth factor 2 receptor	CD222|CI-M6PR|CI-MPR|CIMPR|M6P-R|MPR1|MPR300|MPRI	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58322
4.19209488029345e-197	0.410175589321408	0.633	0.425	8.27351845574715e-193	APBB1IP	NK cells	GSE169246_PacBlood_pre	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58323
1.1966800368933e-196	0.392069042799473	0.988	0.971	2.36176772081261e-192	MT-ND1	NK cells	GSE169246_PacBlood_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58324
5.33207569348777e-196	-0.324372274135865	0.956	0.992	1.05233845886675e-191	NACA	NK cells	GSE169246_PacBlood_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58325
8.9219995715006e-196	-0.722618595112271	0.872	0.846	1.76084583543136e-191	GNLY	NK cells	GSE169246_PacBlood_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58326
2.8665010778837e-195	-0.391938314859638	0.4	0.622	5.65732652731127e-191	MZT2B	NK cells	GSE169246_PacBlood_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58327
7.54655118769743e-195	0.415329254947724	0.518	0.298	1.48938734240397e-190	ARHGEF3	NK cells	GSE169246_PacBlood_pre	ENSG00000163947	50650	Rho guanine nucleotide exchange factor 3	DKFZP434F2429|GEF3|STA3|XPLN	protein_coding	Q9NR81	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58328
1.36966767797278e-192	0.418885384776142	0.647	0.448	2.70317612924707e-188	PSAP	NK cells	GSE169246_PacBlood_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58329
6.94682784919808e-190	-0.37301784113003	0.477	0.69	1.37102594431773e-185	UQCR10	NK cells	GSE169246_PacBlood_pre	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58330
7.37706310044545e-190	0.424646748384783	0.728	0.548	1.45593717350391e-185	RBM39	NK cells	GSE169246_PacBlood_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58331
1.24852822243318e-189	0.404949736994402	0.393	0.184	2.46409529979413e-185	PARP15	NK cells	GSE169246_PacBlood_pre	ENSG00000173200	165631	poly(ADP-ribose) polymerase family member 15	ARTD7|BAL3|FLJ40597|pART7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58332
1.32985611115654e-188	-0.51460204111274	0.77	0.88	2.62460402097854e-184	GZMH	NK cells	GSE169246_PacBlood_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58333
3.25040431240378e-186	0.531700859684308	0.723	0.566	6.4149979509601e-182	SYNE2	NK cells	GSE169246_PacBlood_pre	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58334
5.59753732027873e-185	0.413221102837496	0.635	0.431	1.10472996553021e-180	TBX21	NK cells	GSE169246_PacBlood_pre	ENSG00000073861	30009	T-box transcription factor 21	T-bet|TBLYM	protein_coding	Q9UL17	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58335
1.02231159122321e-184	0.44946827042172	0.507	0.294	2.01763415643813e-180	MYBL1	NK cells	GSE169246_PacBlood_pre	ENSG00000185697	4603	MYB proto-oncogene like 1	A-myb|AMYB	protein_coding	P10243	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58336
1.10948136180616e-183	0.451237674468202	0.604	0.395	2.18967241566064e-179	UTRN	NK cells	GSE169246_PacBlood_pre	ENSG00000152818	7402	utrophin	DMDL|DRP|DRP1	protein_coding	P46939	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58337
1.92913178339907e-183	0.451703663794289	0.617	0.415	3.80733448771641e-179	ATM	NK cells	GSE169246_PacBlood_pre	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58338
2.39567687971543e-183	0.472819219674779	0.637	0.442	4.72810788980637e-179	ITGA4	NK cells	GSE169246_PacBlood_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58339
2.40174835274336e-183	0.342129005019825	0.382	0.176	4.74009054897429e-179	CDKN1B	NK cells	GSE169246_PacBlood_pre	ENSG00000111276	1027	cyclin dependent kinase inhibitor 1B	KIP1|P27KIP1	protein_coding	P46527	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58340
1.49150107144473e-182	-0.334963805214969	0.952	0.987	2.94362651460331e-178	RPL13A	NK cells	GSE169246_PacBlood_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58341
4.0013105815689e-182	0.407694085976133	0.601	0.391	7.89698656378437e-178	S1PR5	NK cells	GSE169246_PacBlood_pre	ENSG00000180739	53637	sphingosine-1-phosphate receptor 5	Edg-8|EDG8	protein_coding	Q9H228	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58342
3.65526234856175e-181	-0.401718824518864	0.931	0.98	7.21402577112148e-177	GAPDH	NK cells	GSE169246_PacBlood_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58343
7.07320312028782e-181	0.44198772740567	0.529	0.322	1.39596736782e-176	PTGDR	NK cells	GSE169246_PacBlood_pre	ENSG00000168229	5729	prostaglandin D2 receptor	DP|DP1|PTGDR1	protein_coding	Q13258	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58344
8.19610378910307e-180	0.43762767418065	0.672	0.497	1.61758304381738e-175	ACTR2	NK cells	GSE169246_PacBlood_pre	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58345
9.87356991855042e-180	0.410142849844165	0.691	0.513	1.94864775912511e-175	TAPBP	NK cells	GSE169246_PacBlood_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58346
1.02985948267632e-177	0.354627129578963	0.495	0.28	2.03253067500998e-173	PXN	NK cells	GSE169246_PacBlood_pre	ENSG00000089159	5829	paxillin	NA	protein_coding	P49023	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58347
1.22341920672706e-176	0.408405646854759	0.506	0.301	2.41454014639652e-172	STK17B	NK cells	GSE169246_PacBlood_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58348
3.09062485551307e-176	0.369937943408628	0.434	0.226	6.09965721484059e-172	ADRB2	NK cells	GSE169246_PacBlood_pre	ENSG00000169252	154	adrenoceptor beta 2	ADRB2R|ADRBR|B2AR|BAR	protein_coding	P07550	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58349
2.23231771930348e-175	0.377995576327338	0.384	0.183	4.40570225081735e-171	DDIT4	NK cells	GSE169246_PacBlood_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58350
2.92161550709125e-175	0.310378935868307	0.31	0.122	5.76610036479529e-171	CITED2	NK cells	GSE169246_PacBlood_pre	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58351
5.58986684126721e-175	0.376969839987151	0.721	0.542	1.1032161197925e-170	HNRNPK	NK cells	GSE169246_PacBlood_pre	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58352
1.48444552838846e-174	0.377205357453194	0.496	0.285	2.92970169482746e-170	LPCAT1	NK cells	GSE169246_PacBlood_pre	ENSG00000275079	79888	lysophosphatidylcholine acyltransferase 1	AGPAT10|AGPAT9|AYTL2|FLJ12443|LPLAT8	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58353
1.91607172779667e-174	0.42806817172612	0.616	0.425	3.78155916197951e-170	SF3B1	NK cells	GSE169246_PacBlood_pre	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58354
9.28027647953148e-174	-0.365565775361509	0.595	0.774	1.83155536600033e-169	COX6C	NK cells	GSE169246_PacBlood_pre	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58355
1.38950537264406e-172	0.400786858057907	0.611	0.418	2.74232780345031e-168	EIF4B	NK cells	GSE169246_PacBlood_pre	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58356
1.90867262106633e-172	0.389699850298139	0.589	0.384	3.76695628493651e-168	ARHGEF1	NK cells	GSE169246_PacBlood_pre	ENSG00000076928	9138	Rho guanine nucleotide exchange factor 1	LBCL2|P115-RHOGEF|SUB1.5	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58357
5.05591282805293e-172	0.417455170458125	0.523	0.32	9.97834955744526e-168	MCL1	NK cells	GSE169246_PacBlood_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58358
1.81716235960422e-171	0.332156650861434	0.284	0.106	3.58635163291489e-167	CST3	NK cells	GSE169246_PacBlood_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58359
3.40420370164388e-170	0.399391982771447	0.606	0.403	6.71853642556436e-166	ZFP36L1	NK cells	GSE169246_PacBlood_pre	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58360
1.39146664651076e-169	-0.320404246595333	0.844	0.943	2.74619857355363e-165	COX4I1	NK cells	GSE169246_PacBlood_pre	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58361
6.65907415283164e-169	0.393693089170211	0.434	0.235	1.31423487480285e-164	DDX3X	NK cells	GSE169246_PacBlood_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58362
1.09264573192888e-168	0.349398100839224	0.506	0.295	2.15644561653484e-164	EWSR1	NK cells	GSE169246_PacBlood_pre	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58363
1.11121474984306e-168	0.38996174060511	0.62	0.425	2.19309343029026e-164	SELPLG	NK cells	GSE169246_PacBlood_pre	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58364
2.2118651869833e-168	0.339224384836537	0.364	0.17	4.36533713303024e-164	ITCH	NK cells	GSE169246_PacBlood_pre	ENSG00000078747	83737	itchy E3 ubiquitin protein ligase	AIP4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58365
4.9568481095495e-168	-0.365556364530683	0.58	0.767	9.78283542900688e-164	RPL23	NK cells	GSE169246_PacBlood_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58366
6.69186440205942e-167	0.418309824871508	0.573	0.377	1.32070635839045e-162	IL10RA	NK cells	GSE169246_PacBlood_pre	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58367
9.0521199457233e-167	0.391231321559471	0.701	0.53	1.78652639248795e-162	STK4	NK cells	GSE169246_PacBlood_pre	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58368
2.73101521051146e-166	0.284869866251311	0.258	0.088	5.38993161946541e-162	KDM6A	NK cells	GSE169246_PacBlood_pre	ENSG00000147050	7403	lysine demethylase 6A	UTX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58369
1.28084907373119e-165	-0.339167612260143	0.321	0.531	2.52788373191588e-161	UQCRQ	NK cells	GSE169246_PacBlood_pre	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58370
6.01987975281279e-165	0.375821888040295	0.576	0.375	1.18808346801513e-160	CAPN2	NK cells	GSE169246_PacBlood_pre	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58371
1.1345791106703e-164	0.367835847547162	0.494	0.291	2.2392053328189e-160	GLG1	NK cells	GSE169246_PacBlood_pre	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58372
1.58109152691961e-164	-0.326231038415421	0.865	0.951	3.12044223752854e-160	EEF1B2	NK cells	GSE169246_PacBlood_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58373
3.44068840574595e-164	0.396986977454603	0.544	0.345	6.7905426375802e-160	TAGAP	NK cells	GSE169246_PacBlood_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58374
5.54036766498367e-164	0.32314546055981	0.323	0.139	1.09344696236118e-159	B4GALT1	NK cells	GSE169246_PacBlood_pre	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58375
7.75979051570755e-164	-0.364148536173825	0.656	0.81	1.53147225618004e-159	HINT1	NK cells	GSE169246_PacBlood_pre	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58376
5.79317052435336e-163	0.360663101209813	0.387	0.194	1.14334013468638e-158	SSH2	NK cells	GSE169246_PacBlood_pre	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58377
6.58879660957763e-163	-0.321022754829948	0.163	0.354	1.30036489886624e-158	LINC01871	NK cells	GSE169246_PacBlood_pre	ENSG00000235576	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58378
7.0227947069593e-163	0.371496710173384	0.503	0.304	1.38601876336549e-158	RNF149	NK cells	GSE169246_PacBlood_pre	ENSG00000163162	284996	ring finger protein 149	FLJ90504	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58379
1.37472963768227e-162	0.350806722030796	0.416	0.219	2.71316641292973e-158	TGFBR2	NK cells	GSE169246_PacBlood_pre	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58380
2.87758609936265e-162	-0.41559933373592	0.427	0.631	5.67920392570213e-158	HIST1H4C	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58381
1.67107900046232e-161	0.449296625167044	0.715	0.569	3.29804151531243e-157	TLN1	NK cells	GSE169246_PacBlood_pre	ENSG00000137076	7094	talin 1	ILWEQ|TLN	protein_coding	Q9Y490	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58382
6.41388568044613e-161	-0.362473261982392	0.607	0.791	1.26584447789285e-156	RPS20	NK cells	GSE169246_PacBlood_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58383
9.19186404475157e-161	-0.39490793696596	0.599	0.757	1.81410628787217e-156	PSME2	NK cells	GSE169246_PacBlood_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58384
1.26212407806916e-160	0.317627539412481	0.325	0.143	2.49092808047729e-156	CDK17	NK cells	GSE169246_PacBlood_pre	ENSG00000059758	5128	cyclin dependent kinase 17	PCTAIRE2|PCTK2	protein_coding	Q00537	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58385
5.88206326221509e-160	0.362462481534225	0.43	0.235	1.16088400543077e-155	ZC3HAV1	NK cells	GSE169246_PacBlood_pre	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58386
3.46022386508045e-159	0.35583088013154	0.43	0.232	6.82909782012278e-155	JUNB	NK cells	GSE169246_PacBlood_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58387
3.55900985312283e-159	0.397084603227788	0.521	0.321	7.02406184612322e-155	GNPTAB	NK cells	GSE169246_PacBlood_pre	ENSG00000111670	79158	N-acetylglucosamine-1-phosphate transferase subunits alpha and beta	GNPTA|KIAA1208|MGC4170	protein_coding	Q3T906	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58388
6.04968040732625e-159	0.340360632189097	0.481	0.279	1.19396492518991e-154	RBMS1	NK cells	GSE169246_PacBlood_pre	ENSG00000153250	5937	RNA binding motif single stranded interacting protein 1	C2orf12|DKFZp564H0764|HCC-4|MSSP-1|MSSP-2|MSSP-3|SCR2|YC1	protein_coding	P29558	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58389
8.0720124265706e-159	0.389869400316989	0.537	0.343	1.59309237250797e-154	CCDC88C	NK cells	GSE169246_PacBlood_pre	ENSG00000015133	440193	coiled-coil domain containing 88C	DAPLE|HkRP2|KIAA1509|SCA40	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58390
5.24017605449892e-158	-0.352081763216452	0.434	0.633	1.03420114611591e-153	C9orf16	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58391
6.49093371753621e-158	-0.422998435272607	0.468	0.654	1.28105067849295e-153	TRBC2	NK cells	GSE169246_PacBlood_pre	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58392
4.07200152226264e-157	0.379318300396239	0.451	0.257	8.03650220433755e-153	ADAM10	NK cells	GSE169246_PacBlood_pre	ENSG00000137845	102	ADAM metallopeptidase domain 10	CD156C|HsT18717|kuz|MADM	protein_coding	O14672	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58393
5.2897946288335e-157	0.339247086039048	0.541	0.34	1.04399386794658e-152	WAS	NK cells	GSE169246_PacBlood_pre	ENSG00000015285	7454	WASP actin nucleation promoting factor	IMD2|THC|WASP|WASPA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58394
1.52515280282016e-156	0.342203022884824	0.411	0.216	3.01004157164586e-152	MAPRE2	NK cells	GSE169246_PacBlood_pre	ENSG00000166974	10982	microtubule associated protein RP/EB family member 2	EB1|EB2|RP1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58395
5.11598522073065e-156	0.292684034109814	0.303	0.128	1.0096908431634e-151	ZFAND3	NK cells	GSE169246_PacBlood_pre	ENSG00000156639	60685	zinc finger AN1-type containing 3	FLJ13222|TEX27	protein_coding	Q9H8U3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58396
9.16465219888753e-156	-0.351360556990438	0.747	0.861	1.80873575797244e-151	PSMB9	NK cells	GSE169246_PacBlood_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58397
1.13626655681955e-154	0.349649888906558	0.453	0.259	2.24253567653907e-150	PRPF8	NK cells	GSE169246_PacBlood_pre	ENSG00000274442	10594	pre-mRNA processing factor 8	hPrp8|Prp8|PRPC8|RP13|SNRNP220	protein_coding	Q6P2Q9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58398
1.40952005003238e-154	0.32358088772712	0.31	0.134	2.78182877074391e-150	CEMIP2	NK cells	GSE169246_PacBlood_pre	ENSG00000135048	23670	cell migration inducing hyaluronidase 2	TMEM2	protein_coding	Q9UHN6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58399
4.00970759303294e-152	0.334803678290467	0.449	0.253	7.91355890560981e-148	TAF15	NK cells	GSE169246_PacBlood_pre	ENSG00000276833	8148	TATA-box binding protein associated factor 15	hTAFII68|Npl3|RBP56|TAF2N	protein_coding	Q92804	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58400
6.1464067285947e-152	0.419305755802875	0.567	0.393	1.21305483195545e-147	STK38	NK cells	GSE169246_PacBlood_pre	ENSG00000112079	11329	serine/threonine kinase 38	NDR|NDR1	protein_coding	Q15208	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58401
9.75193073828794e-152	0.317911760103883	0.438	0.243	1.92464105050851e-147	SRSF4	NK cells	GSE169246_PacBlood_pre	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58402
2.12151470581188e-151	0.345854015376732	0.765	0.612	4.18702142339033e-147	CCND3	NK cells	GSE169246_PacBlood_pre	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58403
2.33993533683343e-150	0.37075485192008	0.5	0.307	4.61809638077446e-146	PARP8	NK cells	GSE169246_PacBlood_pre	ENSG00000151883	79668	poly(ADP-ribose) polymerase family member 8	ARTD16|FLJ21308|pART16	protein_coding	Q8N3A8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58404
2.37299080907281e-150	0.377335334306694	0.608	0.427	4.6833346607861e-146	AKAP13	NK cells	GSE169246_PacBlood_pre	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58405
1.18734622127286e-149	-0.313334272917987	0.28	0.478	2.34334650230412e-145	ROMO1	NK cells	GSE169246_PacBlood_pre	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58406
2.0449831627889e-149	0.35644251522407	0.457	0.266	4.03597877008017e-145	PTBP3	NK cells	GSE169246_PacBlood_pre	ENSG00000119314	9991	polypyrimidine tract binding protein 3	DKFZp781I1117|ROD1	protein_coding	O95758	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58407
3.125274456243e-149	0.30337063978248	0.327	0.15	6.16804166684118e-145	RAP1GAP2	NK cells	GSE169246_PacBlood_pre	ENSG00000132359	23108	RAP1 GTPase activating protein 2	GARNL4|KIAA1039	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58408
4.51854831581553e-149	0.386897967865268	0.691	0.521	8.91780695609354e-145	GNG2	NK cells	GSE169246_PacBlood_pre	ENSG00000186469	54331	G protein subunit gamma 2	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58409
1.60476306780876e-148	-0.338356584413556	0.487	0.676	3.16716039062736e-144	RPS17	NK cells	GSE169246_PacBlood_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58410
1.62228904169719e-148	0.373349154919931	0.51	0.322	3.20174965269357e-144	CANX	NK cells	GSE169246_PacBlood_pre	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58411
2.94738798639945e-148	0.352788080750491	0.715	0.551	5.81696492995795e-144	HNRNPDL	NK cells	GSE169246_PacBlood_pre	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58412
2.16416865582723e-147	0.371556982028254	0.329	0.156	4.27120325914062e-143	GLS	NK cells	GSE169246_PacBlood_pre	ENSG00000115419	2744	glutaminase	GAC|GAM|GLS1|KGA|KIAA0838	protein_coding	O94925	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58413
2.50940656182624e-147	0.283888263175318	0.552	0.345	4.95256479042026e-143	TUBA1B	NK cells	GSE169246_PacBlood_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58414
2.30473254539103e-146	0.353665916627528	0.738	0.589	4.54862015158374e-142	BIN2	NK cells	GSE169246_PacBlood_pre	ENSG00000110934	51411	bridging integrator 2	BRAP-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58415
3.60537635369185e-146	0.352186384103366	0.373	0.19	7.11557077164623e-142	CD6	NK cells	GSE169246_PacBlood_pre	ENSG00000013725	923	CD6 molecule	Tp120	protein_coding	P30203	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58416
4.11355419128985e-146	-0.324611392255469	0.434	0.624	8.11851055192965e-142	ATP5MF	NK cells	GSE169246_PacBlood_pre	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58417
1.42432240568471e-145	0.263457749053122	0.32	0.143	2.81104269985934e-141	MAP7D1	NK cells	GSE169246_PacBlood_pre	ENSG00000116871	55700	MAP7 domain containing 1	FLJ10350|FLJ39022|PARCC1|RPRC1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58418
3.62776270574403e-145	-0.329396989622316	0.441	0.631	7.15975247605641e-141	SEC61B	NK cells	GSE169246_PacBlood_pre	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58419
3.87919873376618e-144	0.402443813561064	0.555	0.38	7.65598662096093e-140	TGFBR3	NK cells	GSE169246_PacBlood_pre	ENSG00000069702	7049	transforming growth factor beta receptor 3	betaglycan|BGCAN	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58420
3.89515154440228e-144	0.339033995454681	0.562	0.372	7.68747108803234e-140	ARF6	NK cells	GSE169246_PacBlood_pre	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58421
5.16682499803684e-143	0.376220718052152	0.75	0.613	1.01972458161255e-138	MBP	NK cells	GSE169246_PacBlood_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58422
5.28629814620937e-143	0.326944530289418	0.467	0.277	1.04330380213588e-138	STAT3	NK cells	GSE169246_PacBlood_pre	ENSG00000168610	6774	signal transducer and activator of transcription 3	APRF	protein_coding	P40763	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58423
1.15548809865548e-142	0.407943764973856	0.61	0.448	2.28047131150645e-138	SRRM2	NK cells	GSE169246_PacBlood_pre	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58424
1.16767477129315e-142	0.38218792624267	0.545	0.366	2.30452292862417e-138	LNPEP	NK cells	GSE169246_PacBlood_pre	ENSG00000113441	4012	leucyl and cystinyl aminopeptidase	CAP|IRAP|P-LAP|PLAP	protein_coding	Q9UIQ6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58425
1.5776990419686e-142	-0.327778402459961	0.518	0.69	3.11374682922922e-138	KRTCAP2	NK cells	GSE169246_PacBlood_pre	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58426
2.72014394702104e-142	0.351646732851524	0.604	0.423	5.36847609384073e-138	MYO1G	NK cells	GSE169246_PacBlood_pre	ENSG00000136286	64005	myosin IG	HA-2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58427
6.23656396998688e-142	-0.331936642575263	0.465	0.654	1.23084826511661e-137	POLR2L	NK cells	GSE169246_PacBlood_pre	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58428
2.7062673204774e-141	-0.314346093040298	0.339	0.528	5.34108918369419e-137	SEC61G	NK cells	GSE169246_PacBlood_pre	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58429
2.88871952397752e-141	-0.347392822502492	0.219	0.398	5.70117685252203e-137	ISG15	NK cells	GSE169246_PacBlood_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58430
2.98351946963611e-141	0.355009258414178	0.559	0.376	5.88827402527383e-137	DIAPH1	NK cells	GSE169246_PacBlood_pre	ENSG00000131504	1729	diaphanous related formin 1	DFNA1|hDIA1|LFHL1|mDia1	protein_coding	O60610	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58431
4.04708238668991e-141	0.387267657626669	0.557	0.381	7.9873217983712e-137	ANKRD44	NK cells	GSE169246_PacBlood_pre	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58432
4.08137708583289e-140	0.353530641854957	0.613	0.438	8.05500581659979e-136	ADD3	NK cells	GSE169246_PacBlood_pre	ENSG00000148700	120	adducin 3	ADDL	protein_coding	Q9UEY8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58433
4.19967236909791e-140	-0.370394062501767	0.666	0.814	8.28847338765164e-136	GSTP1	NK cells	GSE169246_PacBlood_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58434
5.66465533503503e-140	0.309234857814433	0.495	0.307	1.11797637692251e-135	HNRNPA0	NK cells	GSE169246_PacBlood_pre	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58435
1.24056435455193e-139	0.315175190048868	0.386	0.206	2.44837781014368e-135	EVI2B	NK cells	GSE169246_PacBlood_pre	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58436
1.08820300040161e-138	-0.329702624240406	0.499	0.669	2.14767744159261e-134	COX7A2	NK cells	GSE169246_PacBlood_pre	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58437
1.25818881287581e-138	0.342009817229212	0.688	0.526	2.48316144109169e-134	LRRFIP1	NK cells	GSE169246_PacBlood_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58438
1.00515595786655e-137	0.280411110264379	0.324	0.154	1.98377579844543e-133	LUC7L2	NK cells	GSE169246_PacBlood_pre	ENSG00000146963	51631	LUC7 like 2, pre-mRNA splicing factor	CGI-59|CGI-74|FLJ10657|hLuc7B2|H_NH0792N18.3|LUC7B2	protein_coding	Q9Y383	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58439
1.90182733557345e-137	0.330725420194672	0.567	0.384	3.75344642948775e-133	ARHGAP30	NK cells	GSE169246_PacBlood_pre	ENSG00000186517	257106	Rho GTPase activating protein 30	FLJ00267	protein_coding	Q7Z6I6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58440
5.74994129319271e-137	0.369925597748128	0.697	0.546	1.13480841362451e-132	SPN	NK cells	GSE169246_PacBlood_pre	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58441
5.79667265407277e-137	0.341998959456462	0.759	0.62	1.1440313150078e-132	TRAF3IP3	NK cells	GSE169246_PacBlood_pre	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58442
1.05733219106762e-136	0.297696566882803	0.354	0.179	2.08675081229106e-132	PIK3R5	NK cells	GSE169246_PacBlood_pre	ENSG00000141506	23533	phosphoinositide-3-kinase regulatory subunit 5	p101|P101-PI3K	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58443
1.70524321009558e-136	-0.326096666446187	0.725	0.866	3.36546799944463e-132	UBB	NK cells	GSE169246_PacBlood_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58444
1.80463758217919e-136	0.335264954409275	0.477	0.296	3.56163273218884e-132	CDC42EP3	NK cells	GSE169246_PacBlood_pre	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58445
1.81890503143723e-135	0.405885427670378	0.564	0.39	3.58979097004452e-131	HSPA5	NK cells	GSE169246_PacBlood_pre	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58446
1.26560097227523e-134	0.31537987133096	0.448	0.269	2.4977900788824e-130	SH3BP5	NK cells	GSE169246_PacBlood_pre	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58447
9.06811350177757e-134	-0.332337854750528	0.526	0.696	1.78968288071082e-129	NDUFB2	NK cells	GSE169246_PacBlood_pre	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58448
1.44333046832763e-133	0.324458789320702	0.517	0.34	2.8485570122914e-129	VCP	NK cells	GSE169246_PacBlood_pre	ENSG00000165280	7415	valosin containing protein	CDC48|IBMPFD|p97|TERA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58449
2.13607831134573e-133	-0.382687863548584	0.977	0.984	4.21576415527193e-129	S100A4	NK cells	GSE169246_PacBlood_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58450
5.35884864262617e-133	0.35452928456544	0.654	0.493	1.0576223681087e-128	HNRNPA3	NK cells	GSE169246_PacBlood_pre	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58451
1.0620670969544e-132	0.340282261036378	0.454	0.275	2.09609562254921e-128	SPTAN1	NK cells	GSE169246_PacBlood_pre	ENSG00000197694	6709	spectrin alpha, non-erythrocytic 1	NA	protein_coding	Q13813	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58452
1.51774478587014e-132	-0.273642743603941	0.201	0.376	2.99542110939332e-128	IFI27L2	NK cells	GSE169246_PacBlood_pre	ENSG00000276879	83982	interferon alpha inducible protein 27 like 2	FAM14A|TLH29	protein_coding	Q9H2X8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58453
1.72591381533515e-132	-0.320048512235047	0.413	0.592	3.40626350594545e-128	NDUFB11	NK cells	GSE169246_PacBlood_pre	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58454
1.68487230402038e-131	-0.362314444779187	0.24	0.415	3.32526397921463e-127	HLA-DRB5	NK cells	GSE169246_PacBlood_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58455
1.80944950743485e-131	0.342086575017638	0.48	0.298	3.57112954787341e-127	SORL1	NK cells	GSE169246_PacBlood_pre	ENSG00000137642	6653	sortilin related receptor 1	C11orf32|gp250|LR11|LRP9|SorLA|SorLA-1	protein_coding	Q92673	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58456
3.41851908295826e-130	0.366001665131688	0.598	0.436	6.74678926212642e-126	CD47	NK cells	GSE169246_PacBlood_pre	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58457
4.07883086041596e-130	0.386885100758064	0.927	0.877	8.04998058611693e-126	PRF1	NK cells	GSE169246_PacBlood_pre	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58458
7.00056301977048e-128	0.340496531829058	0.486	0.314	1.3816311175819e-123	STAT4	NK cells	GSE169246_PacBlood_pre	ENSG00000138378	6775	signal transducer and activator of transcription 4	NA	protein_coding	Q14765	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58459
1.26281984850525e-127	0.313012277501326	0.289	0.134	2.49230125300997e-123	AC016831.7	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58460
1.59181361438807e-127	0.320043480525605	0.453	0.275	3.1416033493563e-123	INPP5D	NK cells	GSE169246_PacBlood_pre	ENSG00000281614	3635	inositol polyphosphate-5-phosphatase D	hp51CN|SHIP|SHIP1	protein_coding	Q92835	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58461
1.70801212204201e-127	0.282706254450089	0.338	0.171	3.3709327240621e-123	SENP6	NK cells	GSE169246_PacBlood_pre	ENSG00000112701	26054	SUMO specific peptidase 6	KIAA0797|SUSP1	protein_coding	Q9GZR1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58462
2.34688786012845e-127	0.31422854796892	0.49	0.313	4.63181788074951e-123	RAD21	NK cells	GSE169246_PacBlood_pre	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58463
2.45160505603069e-127	0.366481689180315	0.489	0.317	4.83848773858217e-123	RORA	NK cells	GSE169246_PacBlood_pre	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58464
1.85275146205414e-126	0.260836719039896	0.286	0.129	3.65659028551004e-122	DGKD	NK cells	GSE169246_PacBlood_pre	ENSG00000280873	8527	diacylglycerol kinase delta	DGKdelta|KIAA0145	protein_coding	Q16760	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58465
2.1582190818009e-126	0.346111591844682	0.611	0.451	4.25946117984225e-122	CDC42SE1	NK cells	GSE169246_PacBlood_pre	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58466
3.67406098156949e-126	0.330479313251689	0.401	0.229	7.25112675322555e-122	ATF7IP	NK cells	GSE169246_PacBlood_pre	ENSG00000171681	55729	activating transcription factor 7 interacting protein	ATF7IP1|FLJ10688|p621	protein_coding	Q6VMQ6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58467
1.03219876106044e-125	0.327698531045457	0.52	0.345	2.03714747482888e-121	ADAR	NK cells	GSE169246_PacBlood_pre	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58468
1.27579019666393e-125	-0.326610848528699	0.518	0.682	2.51789953213594e-121	COX8A	NK cells	GSE169246_PacBlood_pre	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58469
2.39084270994779e-125	0.339738774291189	0.461	0.292	4.71856717235296e-121	RNF125	NK cells	GSE169246_PacBlood_pre	ENSG00000101695	54941	ring finger protein 125	FLJ20456	protein_coding	Q96EQ8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58470
2.50727850046791e-125	-0.292865690672788	0.62	0.781	4.94836484852347e-121	EDF1	NK cells	GSE169246_PacBlood_pre	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58471
3.42440815521808e-125	0.327868009027658	0.492	0.318	6.75841193513841e-121	DDX6	NK cells	GSE169246_PacBlood_pre	ENSG00000110367	1656	DEAD-box helicase 6	HLR2|RCK|Rck/p54	protein_coding	P26196	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58472
5.00008342326015e-125	-0.289062004241651	0.307	0.488	9.86816464414624e-121	PET100	NK cells	GSE169246_PacBlood_pre	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58473
6.36589462099462e-125	0.327075716927619	0.616	0.455	1.2563729623995e-120	MYO1F	NK cells	GSE169246_PacBlood_pre	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58474
7.7492425474195e-125	0.25471655735057	0.252	0.105	1.52939050915871e-120	TRAPPC10	NK cells	GSE169246_PacBlood_pre	ENSG00000160218	7109	trafficking protein particle complex subunit 10	EHOC-1|TMEM1|TRS130	protein_coding	P48553	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58475
7.88177092133461e-125	0.285457538313863	0.345	0.18	1.5555463090346e-120	MGAT4A	NK cells	GSE169246_PacBlood_pre	ENSG00000071073	11320	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GnT-4a|GnT-Iva	protein_coding	Q9UM21	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58476
7.94391010892799e-125	0.303009000961023	0.364	0.195	1.56781009909803e-120	AGTPBP1	NK cells	GSE169246_PacBlood_pre	ENSG00000135049	23287	ATP/GTP binding carboxypeptidase 1	CCP1|KIAA1035|Nna1	protein_coding	Q9UPW5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58477
9.95534791191092e-125	0.336350984039428	0.592	0.425	1.96478746389474e-120	ARGLU1	NK cells	GSE169246_PacBlood_pre	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58478
1.00511026890445e-124	-0.335453280184085	0.976	0.997	1.98368562670983e-120	MT-ND3	NK cells	GSE169246_PacBlood_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58479
2.51753370867026e-124	0.350598953077023	0.598	0.433	4.96860452743163e-120	LBH	NK cells	GSE169246_PacBlood_pre	ENSG00000213626	81606	LBH regulator of WNT signaling pathway	NA	protein_coding	Q53QV2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58480
3.62647123693212e-124	-0.312063061684197	0.668	0.808	7.15720363320924e-120	EIF3K	NK cells	GSE169246_PacBlood_pre	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58481
1.61092626919763e-123	0.332947870460221	0.514	0.34	3.17932408488844e-119	ATP2B4	NK cells	GSE169246_PacBlood_pre	ENSG00000058668	493	ATPase plasma membrane Ca2+ transporting 4	ATP2B2|MXRA1|PMCA4	protein_coding	P23634	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58482
3.11605356372777e-123	0.257884228683763	0.258	0.11	6.14984331337313e-119	NSF	NK cells	GSE169246_PacBlood_pre	ENSG00000278174	4905	N-ethylmaleimide sensitive factor, vesicle fusing ATPase	SEC18|SKD2	protein_coding	P46459	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58483
4.54306599554688e-123	0.276646070393496	0.361	0.193	8.96619504881133e-119	ABI1	NK cells	GSE169246_PacBlood_pre	ENSG00000136754	10006	abl interactor 1	ABI-1|E3B1|SSH3BP1	protein_coding	Q8IZP0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58484
1.00000142063836e-122	0.314256947022633	0.332	0.173	1.97360280377187e-118	SMAP2	NK cells	GSE169246_PacBlood_pre	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58485
1.23101954115744e-122	0.364637995418878	0.519	0.352	2.42954016642832e-118	SMCHD1	NK cells	GSE169246_PacBlood_pre	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58486
2.33251799823799e-122	-0.292302385915936	0.567	0.729	4.60345752132249e-118	COX5B	NK cells	GSE169246_PacBlood_pre	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58487
2.55239253830578e-121	-0.398006841956118	0.639	0.76	5.03740191360028e-117	LINC00861	NK cells	GSE169246_PacBlood_pre	ENSG00000245164	100130231	long intergenic non-protein coding RNA 861	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58488
4.13297270580247e-121	0.336477775442196	0.464	0.292	8.15683493217176e-117	VPS13C	NK cells	GSE169246_PacBlood_pre	ENSG00000129003	54832	vacuolar protein sorting 13 homolog C	BLTP5C|FLJ10381|FLJ20136|KIAA1421	protein_coding	Q709C8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58489
5.95587508354664e-121	0.325839903521269	0.638	0.484	1.17545150648877e-116	WIPF1	NK cells	GSE169246_PacBlood_pre	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58490
8.5323911120265e-121	0.272603162544486	0.368	0.202	1.68395270986955e-116	HSPA9	NK cells	GSE169246_PacBlood_pre	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58491
9.05169698062045e-121	0.327367463890933	0.429	0.263	1.78644291609525e-116	CCNL1	NK cells	GSE169246_PacBlood_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58492
5.87632100283563e-120	-0.298701827479474	0.468	0.638	1.15975071311964e-115	UQCRH	NK cells	GSE169246_PacBlood_pre	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58493
6.23351406909678e-120	0.277288432250965	0.408	0.236	1.23024633667694e-115	FNBP4	NK cells	GSE169246_PacBlood_pre	ENSG00000285182	23360	formin binding protein 4	KIAA1014	protein_coding	Q8N3X1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58494
7.1770307928681e-120	0.291902284424323	0.428	0.256	1.41645879728045e-115	ADD1	NK cells	GSE169246_PacBlood_pre	ENSG00000087274	118	adducin 1	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58495
7.6676376359954e-120	0.313608935556943	0.74	0.601	1.51328496384005e-115	ANXA6	NK cells	GSE169246_PacBlood_pre	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58496
8.33622895347833e-120	0.35256637349721	0.655	0.509	1.64523814625848e-115	FUS	NK cells	GSE169246_PacBlood_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58497
4.97930834709974e-119	0.280582134992488	0.309	0.154	9.82716295383605e-115	CCNH	NK cells	GSE169246_PacBlood_pre	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58498
1.05512131256971e-118	-0.303780991965883	0.868	0.941	2.08238742248759e-114	CLIC1	NK cells	GSE169246_PacBlood_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58499
3.16558280011821e-118	0.266314030632082	0.324	0.163	6.24759421431331e-114	NFKBIA	NK cells	GSE169246_PacBlood_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58500
5.0055393879298e-118	0.266865876648514	0.313	0.157	9.87893253601826e-114	PPP4R3A	NK cells	GSE169246_PacBlood_pre	ENSG00000100796	55671	protein phosphatase 4 regulatory subunit 3A	FLFL1|FLJ20707|KIAA2010|MSTP033|PP4R3|SMEK1|smk-1|smk1	protein_coding	Q6IN85	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58501
6.41132268027032e-118	0.378049858138397	0.813	0.711	1.26533864417815e-113	JAK1	NK cells	GSE169246_PacBlood_pre	ENSG00000162434	3716	Janus kinase 1	JAK1A|JAK1B|JTK3	protein_coding	P23458	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58502
7.07324191479507e-118	0.339788958016766	0.414	0.25	1.39597502430395e-113	CBLB	NK cells	GSE169246_PacBlood_pre	ENSG00000114423	868	Cbl proto-oncogene B	Cbl-b|RNF56	protein_coding	Q13191	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58503
7.80700964736454e-118	0.326070999504431	0.576	0.414	1.54079142400387e-113	CYFIP2	NK cells	GSE169246_PacBlood_pre	ENSG00000055163	26999	cytoplasmic FMR1 interacting protein 2	PIR121	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58504
1.8408594021017e-117	0.312687380748198	0.628	0.461	3.63312011598792e-113	WDR1	NK cells	GSE169246_PacBlood_pre	ENSG00000071127	9948	WD repeat domain 1	AIP1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58505
2.44658348619414e-117	0.347153188325844	0.254	0.113	4.82857716835275e-113	TNFAIP3	NK cells	GSE169246_PacBlood_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58506
6.88866918496221e-117	-0.318970878901721	0.906	0.949	1.35954775034414e-112	CST7	NK cells	GSE169246_PacBlood_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58507
7.21440004313066e-117	0.294905557297218	0.438	0.27	1.42383399251227e-112	GRB2	NK cells	GSE169246_PacBlood_pre	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58508
1.00306315307095e-116	0.310317146418335	0.482	0.314	1.97964543890084e-112	ARHGAP25	NK cells	GSE169246_PacBlood_pre	ENSG00000163219	9938	Rho GTPase activating protein 25	KIAA0053	protein_coding	P42331	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58509
1.20661522869336e-116	0.321028523054342	0.465	0.299	2.38137581534921e-112	EMB	NK cells	GSE169246_PacBlood_pre	ENSG00000170571	133418	embigin	MGC71745	protein_coding	Q6PCB8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58510
2.02810704860383e-116	0.26847421457709	0.371	0.205	4.00267207112452e-112	FOXN3	NK cells	GSE169246_PacBlood_pre	ENSG00000053254	1112	forkhead box N3	C14orf116|CHES1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58511
3.3777789175164e-116	0.337366786625044	0.691	0.557	6.66638447161036e-112	CAST	NK cells	GSE169246_PacBlood_pre	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58512
6.12853954048289e-116	0.280526126329999	0.427	0.258	1.2095285637097e-111	NONO	NK cells	GSE169246_PacBlood_pre	ENSG00000147140	4841	non-POU domain containing octamer binding	NMT55|NRB54|P54|P54NRB|PPP1R114	protein_coding	Q15233	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58513
8.87042565627442e-116	0.303783865428556	0.422	0.254	1.75066720752232e-111	ANKRD11	NK cells	GSE169246_PacBlood_pre	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58514
1.13446428560657e-115	-0.255342942659268	0.938	0.975	2.23897871407313e-111	H3F3A	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58515
1.60386338353358e-115	-0.290672083988895	0.44	0.609	3.16538477374187e-111	WDR83OS	NK cells	GSE169246_PacBlood_pre	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58516
2.40922922294156e-115	0.307685190471253	0.408	0.246	4.75485479439746e-111	RAB8B	NK cells	GSE169246_PacBlood_pre	ENSG00000166128	51762	RAB8B, member RAS oncogene family	NA	protein_coding	Q92930	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58517
5.10082284922063e-115	-0.347699216623264	0.634	0.764	1.00669839752218e-110	HLA-DPA1	NK cells	GSE169246_PacBlood_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58518
1.10574466663548e-114	0.302501993464837	0.492	0.327	2.18229767407178e-110	CAPZA1	NK cells	GSE169246_PacBlood_pre	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58519
2.00538662002117e-114	0.281337711246973	0.365	0.203	3.95783103327379e-110	SMARCA2	NK cells	GSE169246_PacBlood_pre	ENSG00000080503	6595	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2	BAF190|BRM|hBRM|hSNF2a|SNF2|SNF2L2|SNF2LA|Sth1p|SWI2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58520
3.04662804212757e-114	0.305987929725114	0.426	0.261	6.01282510394298e-110	DYNC1H1	NK cells	GSE169246_PacBlood_pre	ENSG00000197102	1778	dynein cytoplasmic 1 heavy chain 1	CMT2O|DHC1|DNCH1|Dnchc1|DNCL|DNECL|HL-3|p22	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58521
5.19402850776058e-114	0.312132581900215	0.548	0.383	1.02509346629163e-109	NCOR1	NK cells	GSE169246_PacBlood_pre	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58522
8.803948475609e-114	-0.291483419043375	0.711	0.832	1.73754727114619e-109	CHCHD2	NK cells	GSE169246_PacBlood_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58523
1.3368803330784e-113	0.29244604750284	0.42	0.255	2.63846702536353e-109	TNFRSF1B	NK cells	GSE169246_PacBlood_pre	ENSG00000028137	7133	TNF receptor superfamily member 1B	CD120b|p75|TNF-R-II|TNF-R75|TNFBR|TNFR2|TNFR80	protein_coding	P20333	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58524
2.01621388590334e-113	0.265089264045929	0.306	0.154	3.97919972521882e-109	NORAD	NK cells	GSE169246_PacBlood_pre	ENSG00000260032	647979	non-coding RNA activated by DNA damage	LINC00657	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58525
2.06842333614184e-113	0.294626275214313	0.393	0.23	4.08224029620954e-109	BIRC6	NK cells	GSE169246_PacBlood_pre	ENSG00000115760	57448	baculoviral IAP repeat containing 6	BRUCE	protein_coding	Q9NR09	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58526
2.2887552848477e-113	-0.297242082264793	0.514	0.672	4.51708743017543e-109	NDUFA4	NK cells	GSE169246_PacBlood_pre	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58527
2.41563622849935e-113	0.321066999907744	0.587	0.428	4.76749966056631e-109	ADGRE5	NK cells	GSE169246_PacBlood_pre	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58528
3.43450985721868e-113	0.296402803616882	0.367	0.208	6.77834865420678e-109	KLF3	NK cells	GSE169246_PacBlood_pre	ENSG00000109787	51274	KLF transcription factor 3	BKLF	protein_coding	P57682	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58529
1.63912390283418e-112	0.453808055377258	0.585	0.416	3.23497493463355e-108	SPON2	NK cells	GSE169246_PacBlood_pre	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58530
1.78610456762611e-112	0.294393007472225	0.785	0.672	3.52505597466688e-108	SLC9A3R1	NK cells	GSE169246_PacBlood_pre	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58531
4.34622342045435e-112	-0.342940267578217	0.717	0.837	8.57770654260871e-108	S100A10	NK cells	GSE169246_PacBlood_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58532
2.99282186231704e-111	-0.316196293522097	0.545	0.704	5.9066332274689e-107	C12orf57	NK cells	GSE169246_PacBlood_pre	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58533
6.42949344241109e-111	0.328095119510566	0.383	0.227	1.26892482579425e-106	ITK	NK cells	GSE169246_PacBlood_pre	ENSG00000113263	3702	IL2 inducible T cell kinase	EMT|LYK|PSCTK2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58534
7.02685043488282e-111	0.304165434681563	0.403	0.241	1.38681920182847e-106	SMG1	NK cells	GSE169246_PacBlood_pre	ENSG00000157106	23049	SMG1 nonsense mediated mRNA decay associated PI3K related kinase	ATX|KIAA0421|LIP	protein_coding	Q96Q15	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58535
7.82902166792493e-111	0.261390062079	0.274	0.129	1.54513571638167e-106	FCRL3	NK cells	GSE169246_PacBlood_pre	ENSG00000160856	115352	Fc receptor like 3	CD307c|FCRH3|IFGP3|IRTA3|SPAP2|SPAP2a|SPAP2b|SPAP2c|SPAP2d|SPAP2e	protein_coding	Q96P31	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58536
1.15825945810981e-110	0.295730095128774	0.463	0.297	2.28594086652552e-106	TGOLN2	NK cells	GSE169246_PacBlood_pre	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58537
1.54382657079003e-110	0.25513256969597	0.335	0.179	3.0468961201112e-106	PDCD6IP	NK cells	GSE169246_PacBlood_pre	ENSG00000170248	10015	programmed cell death 6 interacting protein	AIP1|Alix|Hp95	protein_coding	Q8WUM4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58538
2.91949587031162e-110	0.26634463619869	0.309	0.158	5.761917049647e-106	TMEM123	NK cells	GSE169246_PacBlood_pre	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58539
3.48580171662293e-110	0.281117619880033	0.401	0.238	6.87957826792701e-106	BTN3A1	NK cells	GSE169246_PacBlood_pre	ENSG00000026950	11119	butyrophilin subfamily 3 member A1	BT3.1|BTF5|BTN3.1|CD277	protein_coding	O00481	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58540
3.97178223914859e-110	-0.263736828982675	0.328	0.502	7.83870942718365e-106	NDUFB4	NK cells	GSE169246_PacBlood_pre	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58541
7.74336457469286e-110	0.28465563464057	0.461	0.296	1.52823043246138e-105	KPNB1	NK cells	GSE169246_PacBlood_pre	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58542
9.32954429337821e-110	0.269741708381732	0.417	0.252	1.84127886174112e-105	TMC8	NK cells	GSE169246_PacBlood_pre	ENSG00000167895	147138	transmembrane channel like 8	EVER2|EVIN2	protein_coding	Q8IU68	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58543
1.33528134502357e-109	0.29330548794344	0.36	0.204	2.63531126253851e-105	DOCK10	NK cells	GSE169246_PacBlood_pre	ENSG00000135905	55619	dedicator of cytokinesis 10	KIAA0694|ZIZ3	protein_coding	Q96BY6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58544
7.03948931857532e-109	0.307926848280037	0.497	0.335	1.38931361191403e-104	ARID4B	NK cells	GSE169246_PacBlood_pre	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58545
6.14980282196886e-108	-0.289682454095822	0.541	0.695	1.21372508494378e-103	GUK1	NK cells	GSE169246_PacBlood_pre	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58546
6.43424005986278e-108	0.269868645706526	0.431	0.268	1.26986161821452e-103	LSM14A	NK cells	GSE169246_PacBlood_pre	ENSG00000262860	26065	LSM14A mRNA processing body assembly factor	C19orf13|DKFZP434D1335|FAM61A|RAP55|RAP55A	protein_coding	Q8ND56	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58547
1.21065397908177e-107	0.282996071998037	0.393	0.233	2.38934669311578e-103	WNK1	NK cells	GSE169246_PacBlood_pre	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58548
1.5352303490872e-107	0.311384290232418	0.478	0.319	3.0299306169585e-103	SLC38A1	NK cells	GSE169246_PacBlood_pre	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58549
1.57379953990008e-107	0.297628802669812	0.44	0.278	3.10605077194679e-103	EPB41	NK cells	GSE169246_PacBlood_pre	ENSG00000159023	2035	erythrocyte membrane protein band 4.1	4.1R|EL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58550
4.4632181620494e-107	0.309790393205678	0.491	0.332	8.80860736462069e-103	ROCK1	NK cells	GSE169246_PacBlood_pre	ENSG00000067900	6093	Rho associated coiled-coil containing protein kinase 1	p160ROCK	protein_coding	Q13464	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58551
6.65869908220158e-107	0.27297975892022	0.406	0.247	1.3141608508633e-102	RBMX	NK cells	GSE169246_PacBlood_pre	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58552
6.74395752807296e-107	-0.443151443228982	0.465	0.604	1.33098745774048e-102	TRBC1	NK cells	GSE169246_PacBlood_pre	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58553
9.42566518698839e-107	0.298996571967998	0.541	0.382	1.86024928130403e-102	SH3KBP1	NK cells	GSE169246_PacBlood_pre	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58554
1.07221257294694e-106	0.302076743206125	0.787	0.681	2.11611873396807e-102	RAP1B	NK cells	GSE169246_PacBlood_pre	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58555
2.78721089189392e-106	0.251939533210383	0.309	0.161	5.50083941624184e-102	TNKS2	NK cells	GSE169246_PacBlood_pre	ENSG00000107854	80351	tankyrase 2	ARTD6|PARP-5b|PARP-5c|PARP5B|PARP5C|pART6|TANK2|TNKL	protein_coding	Q9H2K2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58556
8.44412544083283e-106	-0.493311726180158	0.751	0.827	1.66653259700277e-101	GZMB	NK cells	GSE169246_PacBlood_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58557
1.19399759056691e-105	0.25287483597381	0.323	0.173	2.35647364474285e-101	TMPO	NK cells	GSE169246_PacBlood_pre	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58558
1.8360903058572e-105	0.252416838778367	0.296	0.149	3.62370782763978e-101	SPTBN1	NK cells	GSE169246_PacBlood_pre	ENSG00000115306	6711	spectrin beta, non-erythrocytic 1	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58559
2.7181385136775e-105	0.289418672196834	0.783	0.662	5.36451817059392e-101	CAP1	NK cells	GSE169246_PacBlood_pre	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58560
4.77471902953491e-105	0.270007584200584	0.397	0.24	9.4233854766901e-101	G3BP2	NK cells	GSE169246_PacBlood_pre	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58561
4.83982850906385e-105	0.253760033809232	0.328	0.177	9.55188554548841e-101	PPP4R3B	NK cells	GSE169246_PacBlood_pre	ENSG00000275052	57223	protein phosphatase 4 regulatory subunit 3B	FLFL2|FLJ31474|KIAA1387|PSY2|SMEK2	protein_coding	Q5MIZ7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58562
1.01316081320356e-104	0.302982071148195	0.596	0.443	1.99957418093855e-100	AKNA	NK cells	GSE169246_PacBlood_pre	ENSG00000106948	80709	AT-hook transcription factor	KIAA1968	protein_coding	Q7Z591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58563
1.04653407128908e-104	0.308183812461546	0.576	0.424	2.06543964309613e-100	RBL2	NK cells	GSE169246_PacBlood_pre	ENSG00000103479	5934	RB transcriptional corepressor like 2	p130|Rb2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58564
1.08081306287755e-104	-0.305784005148464	0.518	0.668	2.13309266089513e-100	DBI	NK cells	GSE169246_PacBlood_pre	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58565
1.49270988920481e-104	0.281375662607172	0.588	0.436	2.9460122373346e-100	SF3B2	NK cells	GSE169246_PacBlood_pre	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58566
1.57330301950213e-104	0.267695962477245	0.359	0.205	3.1050708392894e-100	FRYL	NK cells	GSE169246_PacBlood_pre	ENSG00000075539	285527	FRY like transcription coactivator	AF4p12|DKFZp686E205|KIAA0826|MOR2	protein_coding	O94915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58567
2.35915067290939e-104	0.280425473559431	0.471	0.311	4.65601976805398e-100	RASSF5	NK cells	GSE169246_PacBlood_pre	ENSG00000266094	83593	Ras association domain family member 5	Maxp1|NORE1|RAPL	protein_coding	Q8WWW0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58568
6.3976409167834e-104	0.263504425441904	0.329	0.18	1.26263841133637e-99	LYN	NK cells	GSE169246_PacBlood_pre	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58569
1.0852705687034e-103	-0.27093874220809	0.298	0.46	2.14188999439302e-99	SMDT1	NK cells	GSE169246_PacBlood_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58570
7.84172377691092e-103	-0.286657408199715	0.608	0.748	1.54764260461114e-98	GMFG	NK cells	GSE169246_PacBlood_pre	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58571
8.74141659496323e-103	-0.265179958509831	0.97	0.994	1.72520597918194e-98	MT-ATP6	NK cells	GSE169246_PacBlood_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58572
2.459327351538e-102	0.284516057187124	0.355	0.205	4.85372846099541e-98	CEP350	NK cells	GSE169246_PacBlood_pre	ENSG00000135837	9857	centrosomal protein 350	CAP350|KIAA0480	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58573
2.61984335345826e-102	-0.531957279079542	0.661	0.679	5.17052284238521e-98	TYROBP	NK cells	GSE169246_PacBlood_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58574
3.32422848801823e-102	-0.264668032200188	0.999	1	6.56069734395278e-98	PFN1	NK cells	GSE169246_PacBlood_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58575
7.5776347504744e-102	0.271396383572567	0.419	0.262	1.49552199435363e-97	UHMK1	NK cells	GSE169246_PacBlood_pre	ENSG00000152332	127933	U2AF homology motif kinase 1	KIS|Kist	protein_coding	Q8TAS1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58576
1.30446652257843e-101	0.302003956714564	0.459	0.31	2.5744951289608e-97	CTSS	NK cells	GSE169246_PacBlood_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58577
3.66965038906829e-101	-0.261464967994343	0.314	0.471	7.24242200786518e-97	COPS9	NK cells	GSE169246_PacBlood_pre	ENSG00000172428	150678	COP9 signalosome subunit 9	CSNAP|MYEOV2	protein_coding	Q8WXC6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58578
7.90832404000634e-101	0.304549205188419	0.426	0.273	1.56078683253565e-96	OGT	NK cells	GSE169246_PacBlood_pre	ENSG00000147162	8473	O-linked N-acetylglucosamine (GlcNAc) transferase	FLJ23071|HRNT1|MGC22921|O-GLCNAC|OGT1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58579
9.99230606250025e-100	0.264499428711882	0.393	0.241	1.97208152449505e-95	INPP4A	NK cells	GSE169246_PacBlood_pre	ENSG00000040933	3631	inositol polyphosphate-4-phosphatase type I A	INPP4	protein_coding	Q96PE3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58580
2.50374314737315e-99	0.256359147998448	0.424	0.266	4.94138747565565e-95	LBR	NK cells	GSE169246_PacBlood_pre	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58581
4.20736909411601e-99	0.264026841689093	0.368	0.217	8.30366364414736e-95	PHF3	NK cells	GSE169246_PacBlood_pre	ENSG00000118482	23469	PHD finger protein 3	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58582
4.5238814905442e-99	0.303290985484973	0.501	0.348	8.92833250973804e-95	EZR	NK cells	GSE169246_PacBlood_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58583
6.11793986422322e-99	-0.270686621227718	0.45	0.609	1.20743661160309e-94	PARK7	NK cells	GSE169246_PacBlood_pre	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58584
4.35392607031441e-98	0.255934203599666	0.369	0.218	8.59290849237252e-94	RAP2B	NK cells	GSE169246_PacBlood_pre	ENSG00000181467	5912	RAP2B, member of RAS oncogene family	NA	protein_coding	P61225	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58585
4.91224179620028e-98	0.299597000758016	0.629	0.489	9.69480040898088e-94	APMAP	NK cells	GSE169246_PacBlood_pre	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58586
6.01107761285343e-98	0.252807580829898	0.317	0.174	1.18634627767275e-93	RANBP2	NK cells	GSE169246_PacBlood_pre	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58587
2.3628397478895e-97	0.285931498248302	0.4	0.25	4.66330052643472e-93	CASP8	NK cells	GSE169246_PacBlood_pre	ENSG00000064012	841	caspase 8	Casp-8|FLICE|MACH|MCH5	protein_coding	Q14790	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58588
2.99426776641806e-97	0.26678081871249	0.394	0.245	5.90948686380268e-93	TNFAIP8	NK cells	GSE169246_PacBlood_pre	ENSG00000145779	25816	TNF alpha induced protein 8	GG2-1|MDC-3.13|SCC-S2	protein_coding	O95379	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58589
5.78764440244829e-97	0.251600117370142	0.356	0.208	1.1422494992672e-92	ARHGAP4	NK cells	GSE169246_PacBlood_pre	ENSG00000089820	393	Rho GTPase activating protein 4	C1|KIAA0131|p115|RhoGAP4|SrGAP4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58590
6.11653746333398e-97	0.294164164416937	0.468	0.317	1.20715983376359e-92	EIF3A	NK cells	GSE169246_PacBlood_pre	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58591
6.35242026120837e-97	0.296735549594033	0.354	0.21	1.25371366275208e-92	CD69	NK cells	GSE169246_PacBlood_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58592
7.03757647723073e-97	0.252546819361301	0.944	0.888	1.38893609354626e-92	HSPA8	NK cells	GSE169246_PacBlood_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58593
7.39266161887085e-97	-0.264876362572396	0.381	0.541	1.45901569710035e-92	ATP5MPL	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58594
1.46435371521872e-96	0.290252121897606	0.545	0.399	2.89004849235567e-92	KHDRBS1	NK cells	GSE169246_PacBlood_pre	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58595
1.7901432800454e-96	0.301408329403354	0.69	0.562	3.5330267774976e-92	HSP90B1	NK cells	GSE169246_PacBlood_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58596
4.62793610613785e-95	0.286332426754841	0.643	0.506	9.13369469907366e-91	FAM49B	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58597
1.92884785822674e-93	0.273800400359081	0.526	0.378	3.80677413299629e-89	CSDE1	NK cells	GSE169246_PacBlood_pre	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58598
4.87755172515769e-93	0.276633638754418	0.43	0.285	9.62633608477123e-89	KIF2A	NK cells	GSE169246_PacBlood_pre	ENSG00000068796	3796	kinesin family member 2A	HK2|KIF2	protein_coding	O00139	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58599
5.70194574773165e-93	0.25718494411759	0.46	0.309	1.12533601277232e-88	LAMP1	NK cells	GSE169246_PacBlood_pre	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58600
1.86279188058549e-92	0.252351139749938	0.63	0.48	3.67640605552352e-88	HNRNPF	NK cells	GSE169246_PacBlood_pre	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58601
2.34051738267244e-92	0.25683252073846	0.438	0.287	4.61924510644233e-88	NFATC3	NK cells	GSE169246_PacBlood_pre	ENSG00000072736	4775	nuclear factor of activated T cells 3	NFAT4|NFATX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58602
3.01700820148588e-92	0.28538798591444	0.505	0.36	5.95436738645253e-88	SCAF11	NK cells	GSE169246_PacBlood_pre	ENSG00000139218	9169	SR-related CTD associated factor 11	CASP11|SFRS2IP|SIP1|SRRP129|SRSF2IP	protein_coding	Q99590	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58603
1.61834313886548e-91	0.256057323120561	0.357	0.214	3.1939620188649e-87	CD46	NK cells	GSE169246_PacBlood_pre	ENSG00000117335	4179	CD46 molecule	MCP|MGC26544|MIC10|TLX|TRA2.10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58604
1.99739996757821e-90	0.253090820454006	0.907	0.849	3.94206857601235e-86	EEF2	NK cells	GSE169246_PacBlood_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58605
1.32872512790648e-89	0.274452372239002	0.318	0.183	2.62237191243622e-85	SLFN12L	NK cells	GSE169246_PacBlood_pre	ENSG00000205045	100506736	schlafen family member 12 like	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58606
1.37314819272242e-89	0.255745382809145	0.343	0.203	2.71004527315696e-85	ST6GAL1	NK cells	GSE169246_PacBlood_pre	ENSG00000073849	6480	ST6 beta-galactoside alpha-2,6-sialyltransferase 1	CDw75|SIAT1	protein_coding	P15907	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58607
1.55617258537764e-89	0.262609506277161	0.504	0.354	3.07126221450132e-85	STOM	NK cells	GSE169246_PacBlood_pre	ENSG00000148175	2040	stomatin	BND7|EPB7|EPB72	protein_coding	P27105	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58608
4.04631008813971e-89	0.256291734930195	0.292	0.159	7.98579758995253e-85	HIST1H1D	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58609
4.77995338372796e-89	0.278491680748131	0.592	0.449	9.43371599812551e-85	SAMHD1	NK cells	GSE169246_PacBlood_pre	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58610
5.77482121550927e-89	-0.253235102148477	0.96	0.985	1.13971871509291e-84	MYL12A	NK cells	GSE169246_PacBlood_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58611
6.55700773621524e-89	0.273077073861614	0.479	0.335	1.29409104681944e-84	ACAP2	NK cells	GSE169246_PacBlood_pre	ENSG00000114331	23527	ArfGAP with coiled-coil, ankyrin repeat and PH domains 2	CENTB2|CNT-B2|KIAA0041	protein_coding	Q15057	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58612
7.41340739807672e-89	-0.261119195593179	0.883	0.941	1.46311008408442e-84	EMP3	NK cells	GSE169246_PacBlood_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58613
1.67517508014908e-88	0.288481642517246	0.597	0.465	3.30612553818222e-84	KMT2E	NK cells	GSE169246_PacBlood_pre	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58614
2.07484311004177e-88	0.252542875003539	0.406	0.26	4.09491036197844e-84	OGA	NK cells	GSE169246_PacBlood_pre	ENSG00000198408	10724	O-GlcNAcase	MEA5|MGEA5|NCOAT	protein_coding	O60502	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58615
3.25457790175015e-87	0.279900644593564	0.367	0.23	6.42323494689409e-83	SETX	NK cells	GSE169246_PacBlood_pre	ENSG00000107290	23064	senataxin	ALS4|AOA2|KIAA0625|SCAR1|Sen1|STEX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58616
3.61673344102496e-87	0.251275873933667	0.387	0.245	7.13798511920687e-83	PNN	NK cells	GSE169246_PacBlood_pre	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58617
1.80017196032325e-86	0.261868456596306	0.358	0.22	3.55281938089396e-82	MCTP2	NK cells	GSE169246_PacBlood_pre	ENSG00000140563	55784	multiple C2 and transmembrane domain containing 2	FLJ11175|FLJ33303	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58618
1.84196776406623e-86	-0.277737550944669	0.768	0.852	3.63530757916111e-82	PPIB	NK cells	GSE169246_PacBlood_pre	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58619
2.35401475095275e-86	0.271964954647345	0.365	0.227	4.64588351248034e-82	CHD2	NK cells	GSE169246_PacBlood_pre	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58620
3.75035530056673e-86	-0.264309028666725	0.503	0.639	7.40170122119851e-82	APRT	NK cells	GSE169246_PacBlood_pre	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58621
4.11153434384299e-86	0.258400629921917	0.722	0.603	8.11452418100852e-82	HCLS1	NK cells	GSE169246_PacBlood_pre	ENSG00000180353	3059	hematopoietic cell-specific Lyn substrate 1	CTTNL|HS1	protein_coding	P14317	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58622
4.24444335799322e-86	0.297555332317534	0.661	0.549	8.37683341133541e-82	SKAP1	NK cells	GSE169246_PacBlood_pre	ENSG00000141293	8631	src kinase associated phosphoprotein 1	SCAP1|SKAP55	protein_coding	Q86WV1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58623
4.25914640028257e-86	0.253149410236795	0.423	0.281	8.40585133559768e-82	OSBPL8	NK cells	GSE169246_PacBlood_pre	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58624
7.99000166868042e-86	0.267597694498362	0.751	0.646	1.57690672933077e-81	FYB1	NK cells	GSE169246_PacBlood_pre	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58625
9.41415131003218e-86	0.448318889903	0.25	0.126	1.85797690254795e-81	IL7R	NK cells	GSE169246_PacBlood_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58626
1.07901662226026e-85	0.26009174907048	0.44	0.297	2.12954720569284e-81	FCMR	NK cells	GSE169246_PacBlood_pre	ENSG00000162894	9214	Fc mu receptor	FAIM3|FcmuR|TOSO	protein_coding	O60667	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58627
1.09579721890065e-85	0.250145490229363	0.49	0.34	2.16266539122232e-81	ZYX	NK cells	GSE169246_PacBlood_pre	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58628
2.64566484133558e-85	0.327327504449318	0.601	0.476	5.22148413085989e-81	ETS1	NK cells	GSE169246_PacBlood_pre	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58629
8.52977413225514e-85	-0.263453969123174	0.342	0.489	1.68343622274187e-80	RPS27L	NK cells	GSE169246_PacBlood_pre	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58630
9.81939104670171e-85	0.25611636896487	0.561	0.424	1.93795501697705e-80	MORF4L1	NK cells	GSE169246_PacBlood_pre	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58631
7.27094807455007e-84	0.3327438949331	0.574	0.435	1.4349943119932e-79	IL2RB	NK cells	GSE169246_PacBlood_pre	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58632
2.74111908123532e-83	-0.397261361127568	0.967	0.967	5.40987261872602e-79	CD74	NK cells	GSE169246_PacBlood_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58633
8.15346290960096e-83	0.268652771174973	0.543	0.408	1.60916743983885e-78	BTN3A2	NK cells	GSE169246_PacBlood_pre	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58634
9.55202631184772e-83	0.269097172283545	0.406	0.269	1.88518791290627e-78	NIPBL	NK cells	GSE169246_PacBlood_pre	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58635
2.01777435001939e-82	0.252641650633934	0.586	0.45	3.98227945719827e-78	SEPT9	NK cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58636
4.1785488595427e-82	0.260322312839507	0.336	0.205	8.24678402919348e-78	RNF19A	NK cells	GSE169246_PacBlood_pre	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58637
1.1389296027605e-81	0.264431271763356	0.478	0.342	2.24779146400813e-77	MAPK1	NK cells	GSE169246_PacBlood_pre	ENSG00000100030	5594	mitogen-activated protein kinase 1	ERK|ERK2|MAPK2|p41mapk|PRKM1|PRKM2	protein_coding	P28482	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58638
1.26208682984076e-81	0.276147199371605	0.405	0.266	2.49085456737372e-77	SPOCK2	NK cells	GSE169246_PacBlood_pre	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58639
2.47270089682644e-81	0.266127467749943	0.383	0.25	4.88012248997665e-77	PITPNC1	NK cells	GSE169246_PacBlood_pre	ENSG00000154217	26207	phosphatidylinositol transfer protein cytoplasmic 1	RDGB-BETA|RDGBB|RDGBB1	protein_coding	Q9UKF7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58640
2.76308129792216e-81	-0.29935214987732	0.58	0.716	5.45321724957918e-77	CD2	NK cells	GSE169246_PacBlood_pre	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58641
7.35233236361356e-81	0.257768771645295	0.472	0.331	1.45105631528277e-76	S1PR1	NK cells	GSE169246_PacBlood_pre	ENSG00000170989	1901	sphingosine-1-phosphate receptor 1	CD363|D1S3362|edg-1|EDG1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58642
8.46032128404008e-81	-0.252481305198968	0.483	0.622	1.66972900861815e-76	HIGD2A	NK cells	GSE169246_PacBlood_pre	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58643
8.67687503631049e-81	0.271489848333412	0.862	0.792	1.71246805716624e-76	FLNA	NK cells	GSE169246_PacBlood_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58644
1.8202140302103e-79	0.263221951466051	0.665	0.543	3.59237441002305e-75	ZAP70	NK cells	GSE169246_PacBlood_pre	ENSG00000115085	7535	zeta chain of T cell receptor associated protein kinase 70	SRK|STD|ZAP-70	protein_coding	P43403	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58645
4.38592911790868e-79	0.28127632056977	0.651	0.541	8.65606970710457e-75	PRRC2C	NK cells	GSE169246_PacBlood_pre	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58646
4.61173446112626e-78	0.252799285284135	0.457	0.322	9.10171913247879e-74	MOB1A	NK cells	GSE169246_PacBlood_pre	ENSG00000114978	55233	MOB kinase activator 1A	C2orf6|FLJ10788|FLJ11595|Mats1|MOB1|Mob4B|MOBK1B|MOBKL1B	protein_coding	Q9H8S9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58647
6.73514009199375e-78	0.322427676409807	0.748	0.628	1.32924724855589e-73	FGFBP2	NK cells	GSE169246_PacBlood_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58648
1.70680007752505e-77	0.279653278280611	0.814	0.743	3.36854063300344e-73	RNF213	NK cells	GSE169246_PacBlood_pre	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58649
1.87367690239247e-77	0.256557404785204	0.512	0.379	3.69788873456178e-73	EPC1	NK cells	GSE169246_PacBlood_pre	ENSG00000120616	80314	enhancer of polycomb homolog 1	Epl1	protein_coding	Q9H2F5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58650
2.93596293512824e-76	0.25665253054273	0.566	0.437	5.79441644876909e-72	IER2	NK cells	GSE169246_PacBlood_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58651
1.06790306931726e-75	0.263525475730448	0.604	0.482	2.10761349760455e-71	SAMD3	NK cells	GSE169246_PacBlood_pre	ENSG00000164483	154075	sterile alpha motif domain containing 3	bA73O6.2|FLJ34032	protein_coding	Q8N6K7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58652
1.23014231286104e-75	0.254311541632274	0.453	0.321	2.42780886866255e-71	PIK3R1	NK cells	GSE169246_PacBlood_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58653
7.28432105559961e-75	-0.561202266302968	0.174	0.283	1.43763360353314e-70	KLRC1	NK cells	GSE169246_PacBlood_pre	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58654
3.65456599378166e-74	-0.354621771146138	0.27	0.394	7.21265144532749e-70	TRDC	NK cells	GSE169246_PacBlood_pre	ENSG00000211829	NA	NA	NA	TR_C_gene	B7Z8K6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58655
4.68559699779552e-74	0.289609790992119	0.573	0.447	9.24749423484924e-70	SLFN5	NK cells	GSE169246_PacBlood_pre	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58656
2.08056252329543e-73	0.2713212783073	0.397	0.267	4.10619819597586e-69	CEP78	NK cells	GSE169246_PacBlood_pre	ENSG00000148019	84131	centrosomal protein 78	C9orf81|FLJ12643	protein_coding	Q5JTW2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58657
1.96401189055279e-72	0.276092178442769	0.513	0.389	3.876173867195e-68	PPP2R5C	NK cells	GSE169246_PacBlood_pre	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58658
8.67936741935349e-71	0.255219709296729	0.517	0.393	1.71295995388361e-66	HP1BP3	NK cells	GSE169246_PacBlood_pre	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58659
5.09612466637436e-70	0.268526406427262	0.816	0.746	1.00577116415564e-65	CD247	NK cells	GSE169246_PacBlood_pre	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58660
2.48529302791568e-68	0.258485487406605	0.494	0.37	4.90497431989438e-64	ATRX	NK cells	GSE169246_PacBlood_pre	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58661
6.19827601883396e-67	0.277920999362973	0.403	0.285	1.22329175507707e-62	TC2N	NK cells	GSE169246_PacBlood_pre	ENSG00000276776	123036	tandem C2 domains, nuclear	C14orf47|C2CD1|FLJ36557|MTAC2D1|Tac2-N	protein_coding	Q8N9U0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58662
3.27537045400186e-62	-0.255728968908059	0.678	0.773	6.46427112801807e-58	S100A11	NK cells	GSE169246_PacBlood_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58663
2.38102951674344e-49	-0.351525282226053	0.408	0.497	4.69919985424485e-45	HLA-DRA	NK cells	GSE169246_PacBlood_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58664
1.15632494329447e-24	-0.455106717424354	0.261	0.326	2.28212290808596e-20	CCL4L2	NK cells	GSE169246_PacBlood_pre	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58665
9.33424145802336e-24	-0.304483389017949	0.312	0.364	1.84220589415549e-19	IFITM3	NK cells	GSE169246_PacBlood_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58666
2.36569900939941e-23	0.320243910670322	0.521	0.493	4.66894356495068e-19	KLRG1	NK cells	GSE169246_PacBlood_pre	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58667
2.17571496529051e-17	-0.341809078694884	0.506	0.514	4.29399105549734e-13	KLRB1	NK cells	GSE169246_PacBlood_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58668
0	-0.656776937998198	1	1	0	RPS27	B cells	GSE169246_PacBlood_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58669
0	-0.509396439420477	0.997	1	0	RPL34	B cells	GSE169246_PacBlood_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58670
0	-0.578392779328978	0.997	1	0	RPL37	B cells	GSE169246_PacBlood_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58671
0	-0.450664977107381	0.998	1	0	RPL39	B cells	GSE169246_PacBlood_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58672
0	3.15308618646124	0.434	0.027	0	HBB	B cells	GSE169246_PacBlood_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58673
0	-0.616119241885564	0.979	1	0	RPL41	B cells	GSE169246_PacBlood_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58674
0	-0.61791357601186	0.995	1	0	RPS21	B cells	GSE169246_PacBlood_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58675
0	-0.521138706078668	0.998	1	0	RPS28	B cells	GSE169246_PacBlood_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58676
1.79662746200294e-305	-0.461480780467633	0.999	1	3.54582395900899e-301	RPL28	B cells	GSE169246_PacBlood_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58677
1.81074264879156e-294	0.912481214488419	0.975	0.847	3.57368169165502e-290	TXNIP	B cells	GSE169246_PacBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58678
7.75324848696495e-262	-0.495737206033429	0.999	1	1.5301811213874e-257	RPL32	B cells	GSE169246_PacBlood_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58679
1.46317063490053e-258	-0.61807859434469	0.993	0.997	2.88771356503969e-254	HLA-DRB1	B cells	GSE169246_PacBlood_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58680
1.50387633737712e-258	-0.513852597597487	0.995	1	2.96805033944749e-254	RPL35A	B cells	GSE169246_PacBlood_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58681
3.68953133828445e-258	-0.52089781227094	0.991	0.999	7.28165904923819e-254	RPL37A	B cells	GSE169246_PacBlood_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58682
2.01837774830726e-248	0.887813434878047	0.708	0.354	3.98347032405922e-244	TSC22D3	B cells	GSE169246_PacBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58683
7.16527979850559e-248	-0.461341282798148	0.999	1	1.41413962103306e-243	RPS23	B cells	GSE169246_PacBlood_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58684
1.28907011899021e-246	0.57877468667285	0.333	0.032	2.54410878683908e-242	LYZ	B cells	GSE169246_PacBlood_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58685
5.63051630526672e-245	-0.44530722143206	0.996	1	1.11123869800744e-240	RPL36	B cells	GSE169246_PacBlood_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58686
1.27832350499056e-243	-0.44998575732297	0.998	1	2.52289926944937e-239	RPS15	B cells	GSE169246_PacBlood_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58687
8.5580342640543e-243	-0.446380372644231	0.997	1	1.68901364235376e-238	FAU	B cells	GSE169246_PacBlood_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58688
2.21244565512553e-240	-0.447221489129754	0.999	1	4.36648274495575e-236	RPL19	B cells	GSE169246_PacBlood_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58689
5.10235805142052e-234	-0.43162846532846	0.987	1	1.00700138502835e-229	RPS29	B cells	GSE169246_PacBlood_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58690
1.8722850809145e-229	-0.433931608872859	1	1	3.69514183569286e-225	RPL30	B cells	GSE169246_PacBlood_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58691
5.1280069173454e-228	-0.461802713749703	0.999	1	1.01206344520729e-223	RPL26	B cells	GSE169246_PacBlood_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58692
1.0124875777793e-226	0.725060262927371	0.937	0.698	1.99824548350522e-222	DDX5	B cells	GSE169246_PacBlood_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58693
3.39455651339694e-226	0.604576460551032	0.325	0.039	6.6994967348402e-222	S100A9	B cells	GSE169246_PacBlood_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58694
2.72702607534605e-225	-0.549402181183242	0.956	0.995	5.38205866230296e-221	RPL38	B cells	GSE169246_PacBlood_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58695
1.51314825028434e-218	-0.435825648289421	0.997	1	2.98634938676117e-214	RPL18	B cells	GSE169246_PacBlood_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58696
1.07129651656473e-214	-0.437375945726683	0.999	1	2.11431080509216e-210	RPS13	B cells	GSE169246_PacBlood_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58697
5.72311934375172e-209	-0.400684094315764	0.999	1	1.12951483368284e-204	RPS15A	B cells	GSE169246_PacBlood_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58698
6.61314002022916e-206	-0.431743636212149	0.997	1	1.30516931439243e-201	RPL29	B cells	GSE169246_PacBlood_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58699
7.95944812942521e-202	-0.518734692320677	0.998	1	1.57087668282336e-197	RPS19	B cells	GSE169246_PacBlood_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58700
1.22367025675131e-197	-0.412719047357924	1	1	2.41503561872439e-193	RPL11	B cells	GSE169246_PacBlood_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58701
1.30950671767461e-194	-0.411987794052562	1	1	2.5844424580026e-190	RPL13	B cells	GSE169246_PacBlood_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58702
2.29262247379607e-193	0.64600687277535	0.921	0.648	4.52471971428393e-189	KLF2	B cells	GSE169246_PacBlood_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58703
2.71765940941478e-193	-0.459622462159568	0.994	1	5.36357261042101e-189	RPL23A	B cells	GSE169246_PacBlood_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58704
7.55030453421113e-192	-0.424083147919787	0.997	1	1.49012810287191e-187	RPL12	B cells	GSE169246_PacBlood_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58705
7.56396238225391e-192	-0.455129311609782	0.998	1	1.49282361576163e-187	RPL18A	B cells	GSE169246_PacBlood_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58706
2.27274650416521e-191	-0.464192869068383	0.987	0.999	4.48549250062047e-187	RPL35	B cells	GSE169246_PacBlood_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58707
2.94098937276798e-191	0.847078251278105	0.614	0.284	5.80433662609489e-187	AHNAK	B cells	GSE169246_PacBlood_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58708
3.02688480637386e-189	-0.496202506158621	0.997	1	5.97385985385945e-185	TMSB10	B cells	GSE169246_PacBlood_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58709
7.94603298309741e-187	0.567968558478825	0.354	0.073	1.5682290695441e-182	DUSP1	B cells	GSE169246_PacBlood_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58710
3.68733195087386e-186	-0.415249918947139	1	1	7.27731833824465e-182	RPL10	B cells	GSE169246_PacBlood_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58711
8.06123353031424e-183	-0.470600634173052	0.995	1	1.59096504954282e-178	RPS5	B cells	GSE169246_PacBlood_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58712
2.01910209789492e-180	0.461417736034691	0.275	0.034	3.98489990040542e-176	S100A8	B cells	GSE169246_PacBlood_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58713
8.12757581930827e-180	0.840407469808756	0.751	0.483	1.60405836369868e-175	MT-ND6	B cells	GSE169246_PacBlood_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58714
1.81008048256611e-179	0.478457896752498	0.34	0.067	3.57237484039247e-175	NKG7	B cells	GSE169246_PacBlood_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58715
2.37653626327707e-179	0.625052809216344	0.997	0.964	4.69033196920363e-175	MT-ND5	B cells	GSE169246_PacBlood_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58716
8.68635501337918e-176	-0.418342910800425	0.999	1	1.71433902544051e-171	RPS24	B cells	GSE169246_PacBlood_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58717
1.13416418801693e-175	-0.430963006543443	1	1	2.23838644147022e-171	RPLP1	B cells	GSE169246_PacBlood_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58718
2.83989142240499e-175	0.536404659625539	0.991	0.863	5.60480971125848e-171	PABPC1	B cells	GSE169246_PacBlood_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58719
2.97933820830191e-175	-0.565875284860576	0.741	0.908	5.88002188790466e-171	RPL36A	B cells	GSE169246_PacBlood_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58720
5.30357297458904e-174	0.697502223194796	0.937	0.766	1.04671316226489e-169	PTPRC	B cells	GSE169246_PacBlood_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58721
2.09779294813172e-172	-0.390907736207138	1	1	4.14020416243277e-168	RPL7A	B cells	GSE169246_PacBlood_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58722
8.2426813454481e-170	0.626977710214279	0.785	0.468	1.62677559033764e-165	ZFP36L2	B cells	GSE169246_PacBlood_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58723
1.84099364186255e-169	-0.563498266029389	0.977	0.992	3.63338505157993e-165	MT-ND4	B cells	GSE169246_PacBlood_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58724
2.84801038793202e-169	-0.405065124755556	0.996	1	5.62083330162263e-165	RPL14	B cells	GSE169246_PacBlood_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58725
9.24031227851715e-169	-0.395129579057472	0.999	1	1.82366803128814e-164	RPS4X	B cells	GSE169246_PacBlood_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58726
2.25226375593208e-168	-0.449300395160972	0.992	0.999	4.44506774870755e-164	RPL21	B cells	GSE169246_PacBlood_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58727
7.41604226603917e-167	-0.39660944168283	0.998	1	1.46363010162549e-162	RPS25	B cells	GSE169246_PacBlood_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58728
1.61176794163462e-165	-0.366136728127923	0.998	1	3.18098520961008e-161	RPS27A	B cells	GSE169246_PacBlood_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58729
1.87033782692626e-165	-0.42413739445447	0.988	0.999	3.69129873522167e-161	RPL9	B cells	GSE169246_PacBlood_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58730
4.22266730191368e-165	-0.407391678451294	0.999	1	8.33385618705683e-161	RPS12	B cells	GSE169246_PacBlood_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58731
3.95481029583126e-164	-0.434213097920398	0.991	0.999	7.80521359985258e-160	RPL10A	B cells	GSE169246_PacBlood_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58732
3.51304496540854e-159	0.357553570473428	0.266	0.039	6.9333455437303e-155	TYROBP	B cells	GSE169246_PacBlood_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58733
9.41391961508344e-158	0.55044368056891	0.999	0.992	1.85793117523287e-153	MT-ND4L	B cells	GSE169246_PacBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58734
5.36900858911484e-157	-0.381455412155764	0.999	1	1.0596275351477e-152	RPS8	B cells	GSE169246_PacBlood_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58735
1.03571101218884e-146	0.601721098215255	0.857	0.741	2.04407925365589e-142	BANK1	B cells	GSE169246_PacBlood_pre	ENSG00000153064	55024	B cell scaffold protein with ankyrin repeats 1	BANK|FLJ20706	protein_coding	Q8NDB2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58736
1.50961316941138e-144	-0.40035091328463	0.979	0.998	2.9793725511503e-140	RPL24	B cells	GSE169246_PacBlood_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58737
1.03780613789863e-141	0.656629188725958	0.504	0.229	2.04821419375673e-137	KLF6	B cells	GSE169246_PacBlood_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58738
3.61903061585811e-140	-0.389655715200504	0.982	0.999	7.14251882345756e-136	RPL22	B cells	GSE169246_PacBlood_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58739
1.86755318052675e-136	-0.297777738508709	1	0.999	3.6858029570876e-132	CD74	B cells	GSE169246_PacBlood_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58740
2.34742004602596e-134	-0.366931722672219	0.994	0.999	4.63286820283683e-130	RACK1	B cells	GSE169246_PacBlood_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58741
8.37680593214596e-134	-0.343571266890334	0.996	1	1.65324641876833e-129	RPS7	B cells	GSE169246_PacBlood_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58742
8.70868156069428e-133	-0.374258432929169	0.996	0.998	1.71874539281862e-128	HLA-DRA	B cells	GSE169246_PacBlood_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58743
1.49716928263139e-132	-0.445607367259413	0.981	0.998	2.95481329620131e-128	MT-ATP6	B cells	GSE169246_PacBlood_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58744
7.26677198034176e-132	0.52738093578825	0.923	0.738	1.43417011804025e-127	HNRNPA2B1	B cells	GSE169246_PacBlood_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58745
9.79583193874635e-132	-0.358089575192027	0.998	1	1.93330539143098e-127	RPL6	B cells	GSE169246_PacBlood_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58746
1.29693298537189e-131	-0.410468701948511	0.992	0.999	2.55962693992997e-127	CD52	B cells	GSE169246_PacBlood_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58747
2.7062015301587e-130	0.504521232051784	0.526	0.258	5.34095933992122e-126	SFPQ	B cells	GSE169246_PacBlood_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58748
8.89407115738419e-130	0.348105902075591	0.302	0.076	1.75533388362134e-125	IL32	B cells	GSE169246_PacBlood_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58749
9.8583321829516e-127	-0.356111879681297	0.996	1	1.94564043962733e-122	RPS16	B cells	GSE169246_PacBlood_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58750
3.6576536766438e-123	-0.351035386285919	0.986	0.999	7.21874529622419e-119	UBA52	B cells	GSE169246_PacBlood_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58751
5.28449973501784e-122	-0.397765560691981	0.996	0.999	1.04294886770312e-117	RPLP0	B cells	GSE169246_PacBlood_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58752
4.9783723896679e-119	0.538156563720494	0.492	0.243	9.82531574824857e-115	KIAA1551	B cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58753
1.4687890828703e-118	-0.348548069214667	0.996	1	2.89880213395283e-114	RPS9	B cells	GSE169246_PacBlood_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58754
3.97628677994315e-117	-0.39876676215035	0.975	0.995	7.8475995888958e-113	HLA-DPB1	B cells	GSE169246_PacBlood_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58755
3.93292239725975e-113	-0.333551636310843	0.998	1	7.76201564323184e-109	RPL8	B cells	GSE169246_PacBlood_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58756
2.50701175947317e-112	-0.320788728807836	0.998	1	4.94783840849625e-108	RPL15	B cells	GSE169246_PacBlood_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58757
6.84802731817132e-112	0.503768788865754	0.972	0.887	1.35152667151429e-107	BTG1	B cells	GSE169246_PacBlood_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58758
1.24541584381429e-111	-0.366270878642191	0.93	0.975	2.45795270935188e-107	ATP5F1E	B cells	GSE169246_PacBlood_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58759
1.56940099103153e-111	0.476773383678854	0.645	0.408	3.09736979589984e-107	EIF4G2	B cells	GSE169246_PacBlood_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58760
1.86919689949628e-110	0.496911013819323	0.642	0.415	3.68904700084586e-106	MARCH1	B cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58761
9.47482696801359e-110	0.462159957284265	0.561	0.304	1.86995185040716e-105	ZFP36	B cells	GSE169246_PacBlood_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58762
1.04952477534347e-109	0.332604001381746	0.269	0.069	2.07134209661787e-105	CCL5	B cells	GSE169246_PacBlood_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58763
5.43489322246272e-107	0.471613211847466	0.67	0.449	1.07263052638524e-102	EIF4B	B cells	GSE169246_PacBlood_pre	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58764
2.53562255869691e-106	-0.376399515799012	0.938	0.982	5.00430468184422e-102	RPL31	B cells	GSE169246_PacBlood_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58765
4.79979463927463e-106	-0.348528536906052	0.994	1	9.47287470007241e-102	RPSA	B cells	GSE169246_PacBlood_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58766
6.93197520420164e-106	0.554176706067209	0.994	0.967	1.36809462630124e-101	MT-ATP8	B cells	GSE169246_PacBlood_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58767
2.49163538329738e-105	0.467261687734958	0.634	0.404	4.9174915924757e-101	LYN	B cells	GSE169246_PacBlood_pre	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58768
2.42709786652142e-104	0.480315079105052	0.67	0.456	4.79012034936668e-100	SWAP70	B cells	GSE169246_PacBlood_pre	ENSG00000133789	23075	switching B cell complex subunit SWAP70	KIAA0640|SWAP-70	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58769
1.15822340996959e-103	0.419644385089254	0.863	0.66	2.28586972191599e-99	YWHAZ	B cells	GSE169246_PacBlood_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58770
5.64310502795507e-103	-0.356519493690031	0.971	0.995	1.11372320831721e-98	RPL27	B cells	GSE169246_PacBlood_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58771
1.51266645055556e-101	-0.312092161881166	0.998	1	2.98539850681645e-97	RPS14	B cells	GSE169246_PacBlood_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58772
4.0092520855307e-101	-0.355196496673706	0.978	0.996	7.91265991600338e-97	HLA-DPA1	B cells	GSE169246_PacBlood_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58773
3.81219355303191e-100	0.564303010673723	0.815	0.682	7.52374519626378e-96	RIPOR2	B cells	GSE169246_PacBlood_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58774
5.73358588261339e-100	0.454967029623929	0.604	0.379	1.13158050979258e-95	EVI2B	B cells	GSE169246_PacBlood_pre	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58775
1.24699488472483e-99	0.476233329513502	0.49	0.258	2.46106910449293e-95	CD55	B cells	GSE169246_PacBlood_pre	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58776
2.40841170949469e-98	-0.35598534543024	0.954	0.987	4.75324134985873e-94	PFDN5	B cells	GSE169246_PacBlood_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58777
1.30829468075985e-97	0.470430233766414	0.858	0.635	2.58205038194763e-93	VIM	B cells	GSE169246_PacBlood_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58778
2.487012234994e-97	0.39251831175307	0.473	0.242	4.90836734698416e-93	MATR3.1	B cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58779
2.7844483022643e-97	0.459993621819494	0.648	0.419	5.49538716934882e-93	HNRNPU	B cells	GSE169246_PacBlood_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58780
1.60468716547777e-95	0.524880954719156	0.637	0.438	3.16701058978693e-91	TAGAP	B cells	GSE169246_PacBlood_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58781
3.31073865385853e-94	-0.313369323566482	0.995	0.999	6.5340738072552e-90	RPL5	B cells	GSE169246_PacBlood_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58782
8.53698131283261e-93	-0.280933356518039	1	1	1.68485863190064e-88	RPS2	B cells	GSE169246_PacBlood_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58783
1.31473675670706e-92	-0.289730037303182	0.998	1	2.59476446303705e-88	RPS3	B cells	GSE169246_PacBlood_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58784
1.33298160216836e-92	0.351561481858089	0.403	0.184	2.63077249003947e-88	SRSF4	B cells	GSE169246_PacBlood_pre	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58785
2.9100698020719e-91	0.384534777973454	0.369	0.16	5.74331376136909e-87	BCL2	B cells	GSE169246_PacBlood_pre	ENSG00000171791	596	BCL2 apoptosis regulator	Bcl-2|PPP1R50	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58786
3.44307687165331e-89	0.412707954456987	0.915	0.788	6.79525651389498e-85	PNRC1	B cells	GSE169246_PacBlood_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58787
4.73235096683974e-89	-0.408825391723	0.845	0.953	9.33976786815491e-85	HLA-DQB1	B cells	GSE169246_PacBlood_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58788
3.82544612701493e-88	0.366533207719374	0.343	0.142	7.54990047627667e-84	B4GALT1	B cells	GSE169246_PacBlood_pre	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58789
5.53685289960467e-88	-0.361718448981649	0.89	0.941	1.09275328826598e-83	TOMM7	B cells	GSE169246_PacBlood_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58790
2.04657028921232e-87	0.489609593421536	0.717	0.539	4.03911112278944e-83	ZFP36L1	B cells	GSE169246_PacBlood_pre	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58791
4.81378618412877e-87	0.513129710486704	0.7	0.521	9.50048841299655e-83	DDX17	B cells	GSE169246_PacBlood_pre	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58792
4.89781852365669e-87	0.467485029766545	0.637	0.413	9.66633463828885e-83	S100A4	B cells	GSE169246_PacBlood_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58793
9.17459249295059e-87	0.449599757518764	0.552	0.342	1.81069757440873e-82	STK17B	B cells	GSE169246_PacBlood_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58794
9.44110938122333e-86	-0.313756077924853	0.999	1	1.86329734747824e-81	RPS18	B cells	GSE169246_PacBlood_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58795
4.13166915859981e-85	-0.33147008438976	0.927	0.969	8.15426225141259e-81	SERF2	B cells	GSE169246_PacBlood_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58796
7.00379612432154e-85	0.448769548224088	0.528	0.318	1.3822692030961e-80	AKAP13	B cells	GSE169246_PacBlood_pre	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58797
2.42560489880336e-84	0.408658480365354	0.485	0.273	4.78717382827831e-80	ATM	B cells	GSE169246_PacBlood_pre	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58798
3.81545599608017e-83	-0.333067194711935	0.87	0.932	7.53018395386383e-79	COX7C	B cells	GSE169246_PacBlood_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58799
5.14272188639825e-83	0.345841543584699	0.512	0.289	1.01496759149956e-78	ARF6	B cells	GSE169246_PacBlood_pre	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58800
4.08800802735499e-82	0.379444405914822	0.375	0.175	8.06809264278781e-78	VOPP1	B cells	GSE169246_PacBlood_pre	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58801
9.67048659040031e-82	-0.271389946582504	0.996	1	1.90856723348141e-77	RPLP2	B cells	GSE169246_PacBlood_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58802
1.20469936849178e-81	0.411502731937509	0.56	0.353	2.37759467365538e-77	ITSN2	B cells	GSE169246_PacBlood_pre	ENSG00000198399	50618	intersectin 2	KIAA1256|PRO2015|SH3D1B|SH3P18|SWA|SWAP	protein_coding	Q9NZM3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58803
4.22587897122426e-80	0.361673340403968	0.401	0.198	8.34019473760821e-76	ARHGAP25	B cells	GSE169246_PacBlood_pre	ENSG00000163219	9938	Rho GTPase activating protein 25	KIAA0053	protein_coding	P42331	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58804
8.12817935065297e-79	0.393110996731909	0.404	0.207	1.60417747664487e-74	TMEM131L	B cells	GSE169246_PacBlood_pre	ENSG00000121210	23240	transmembrane 131 like	DKFZp586H1322|KIAA0922	protein_coding	A2VDJ0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58805
1.31262539328111e-78	0.476026411366985	0.635	0.451	2.5905974761796e-74	SMCHD1	B cells	GSE169246_PacBlood_pre	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58806
2.13727542244174e-78	0.4363629290847	0.58	0.381	4.21812677373103e-74	ITGA4	B cells	GSE169246_PacBlood_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58807
5.34472139976144e-78	0.376682539261053	0.705	0.476	1.05483421545692e-73	LCP1	B cells	GSE169246_PacBlood_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58808
6.42346833505763e-78	-0.323338450225474	0.656	0.826	1.26773571060697e-73	RPS10	B cells	GSE169246_PacBlood_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58809
1.07923683517763e-77	0.387596253899145	0.601	0.404	2.12998181790656e-73	ARGLU1	B cells	GSE169246_PacBlood_pre	ENSG00000134884	55082	arginine and glutamate rich 1	FLJ10154	protein_coding	Q9NWB6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58810
1.60048505203022e-77	0.385900720806689	0.886	0.699	3.15871729868684e-73	HSPA8	B cells	GSE169246_PacBlood_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58811
8.16184075906533e-77	0.410032712126857	0.697	0.528	1.61082089220913e-72	EZR	B cells	GSE169246_PacBlood_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58812
2.10295821970746e-76	0.377662360924872	0.484	0.285	4.15039834241464e-72	WASHC4	B cells	GSE169246_PacBlood_pre	ENSG00000136051	23325	WASH complex subunit 4	KIAA1033|SWIP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58813
1.52768568872063e-75	0.391830800185847	0.794	0.639	3.01504047525904e-71	HLA-DRB5	B cells	GSE169246_PacBlood_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58814
5.46656659072977e-75	0.390770233357736	0.752	0.626	1.07888158234643e-70	SNX2	B cells	GSE169246_PacBlood_pre	ENSG00000205302	6643	sorting nexin 2	NA	protein_coding	O60749	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58815
6.90413645652022e-75	-0.313806081380597	0.975	0.989	1.36260037105883e-70	EEF1B2	B cells	GSE169246_PacBlood_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58816
2.72856497230995e-73	0.371487953393413	0.414	0.218	5.38509582935091e-69	HIST1H1E	B cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58817
3.86269560924533e-73	0.282079243508397	0.311	0.132	7.62341605440658e-69	SCAF4	B cells	GSE169246_PacBlood_pre	ENSG00000156304	57466	SR-related CTD associated factor 4	DKFZp434E098|KIAA1172|SFRS15|SRA4	protein_coding	O95104	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58818
4.77384806446614e-73	0.387618419450553	0.513	0.312	9.42166654003037e-69	CD44	B cells	GSE169246_PacBlood_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58819
1.68368257297161e-72	0.447651523577326	0.348	0.169	3.32291592601677e-68	JUN	B cells	GSE169246_PacBlood_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58820
1.76613932792132e-72	0.380976636661935	0.429	0.234	3.48565257758553e-68	ADAM19	B cells	GSE169246_PacBlood_pre	ENSG00000135074	8728	ADAM metallopeptidase domain 19	MLTNB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58821
1.76676953334611e-72	0.280640783069578	0.31	0.132	3.48689635101187e-68	NFKB1	B cells	GSE169246_PacBlood_pre	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58822
1.96641184557805e-72	0.313224451111675	0.385	0.192	3.88091041843283e-68	SUN2	B cells	GSE169246_PacBlood_pre	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58823
2.12451188983003e-72	0.423501253308492	0.515	0.325	4.19293666576854e-68	CIITA	B cells	GSE169246_PacBlood_pre	ENSG00000179583	4261	class II major histocompatibility complex transactivator	C2TA|MHC2TA|NLRA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58824
2.45629486848647e-72	-0.300461682713227	0.982	0.999	4.84774355244491e-68	MT-ND3	B cells	GSE169246_PacBlood_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58825
2.53666374150741e-72	0.328929960902405	0.448	0.245	5.00635956023903e-68	EWSR1	B cells	GSE169246_PacBlood_pre	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58826
3.89671142589186e-72	0.341106029622019	0.782	0.562	7.69054967014017e-68	SARAF	B cells	GSE169246_PacBlood_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58827
5.91352689275701e-72	0.355741281379139	0.467	0.271	1.16709366755452e-67	FLI1	B cells	GSE169246_PacBlood_pre	ENSG00000151702	2313	Fli-1 proto-oncogene, ETS transcription factor	EWSR2|FLI-1|SIC-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58828
1.06200507283486e-71	0.390997956441691	0.614	0.423	2.09597321174688e-67	TAPBP	B cells	GSE169246_PacBlood_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58829
1.32505265341228e-71	0.479720412922819	0.366	0.18	2.61512391677447e-67	NEAT1	B cells	GSE169246_PacBlood_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58830
1.66234259128765e-71	0.425376798325962	0.542	0.356	3.2807993381653e-67	ANKRD44	B cells	GSE169246_PacBlood_pre	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58831
3.08638309832584e-71	0.347431697364356	0.436	0.24	6.09128568285588e-67	CYTH1	B cells	GSE169246_PacBlood_pre	ENSG00000108669	9267	cytohesin 1	B2-1|cytohesin-1|D17S811E|PSCD1	protein_coding	Q15438	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58832
1.05844132506953e-70	0.401412655996374	0.807	0.695	2.08893979915722e-66	FCMR	B cells	GSE169246_PacBlood_pre	ENSG00000162894	9214	Fc mu receptor	FAIM3|FcmuR|TOSO	protein_coding	O60667	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58833
1.11279645215755e-70	0.370965003044296	0.676	0.502	2.19621507797814e-66	SRSF5	B cells	GSE169246_PacBlood_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58834
1.29776915229001e-70	0.284930733482039	0.298	0.126	2.56127719895957e-66	DOCK10	B cells	GSE169246_PacBlood_pre	ENSG00000135905	55619	dedicator of cytokinesis 10	KIAA0694|ZIZ3	protein_coding	Q96BY6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58835
1.75833952099901e-70	0.285669415663347	1	1	3.47025887864365e-66	MT-CO1	B cells	GSE169246_PacBlood_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58836
8.05614020381215e-70	0.294377960765777	0.36	0.174	1.58995983062437e-65	GGNBP2	B cells	GSE169246_PacBlood_pre	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58837
2.47382566134934e-69	0.319177700522339	0.444	0.251	4.88234232523906e-65	LSM14A	B cells	GSE169246_PacBlood_pre	ENSG00000262860	26065	LSM14A mRNA processing body assembly factor	C19orf13|DKFZP434D1335|FAM61A|RAP55|RAP55A	protein_coding	Q8ND56	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58838
4.1123611642606e-69	0.347845331495398	0.425	0.237	8.11615599378472e-65	INPP5D	B cells	GSE169246_PacBlood_pre	ENSG00000281614	3635	inositol polyphosphate-5-phosphatase D	hp51CN|SHIP|SHIP1	protein_coding	Q92835	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58839
9.11105677853875e-69	-0.444252799459158	0.399	0.596	1.79815816581241e-64	VPREB3	B cells	GSE169246_PacBlood_pre	ENSG00000128218	29802	V-set pre-B cell surrogate light chain 3	8HS20	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58840
1.19737843079108e-68	0.344194697789093	0.391	0.207	2.36314607100928e-64	NIN	B cells	GSE169246_PacBlood_pre	ENSG00000100503	51199	ninein	NA	protein_coding	Q8N4C6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58841
2.59691073435201e-68	-0.317148070518169	0.785	0.859	5.12526302531712e-64	TMA7	B cells	GSE169246_PacBlood_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58842
2.67181211742084e-68	0.419847385750817	0.419	0.236	5.27308839494176e-64	ATF7IP	B cells	GSE169246_PacBlood_pre	ENSG00000171681	55729	activating transcription factor 7 interacting protein	ATF7IP1|FLJ10688|p621	protein_coding	Q6VMQ6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58843
2.986030930915e-68	0.301183451749707	0.377	0.192	5.89323064525384e-64	ARHGAP45	B cells	GSE169246_PacBlood_pre	ENSG00000180448	23526	Rho GTPase activating protein 45	HA-1|HMHA1|KIAA0223	protein_coding	Q92619	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58844
3.70321649507603e-68	0.402187517066969	0.595	0.413	7.30866807468206e-64	IKZF1	B cells	GSE169246_PacBlood_pre	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58845
5.23687388449612e-68	0.387629799267852	0.509	0.317	1.03354942984415e-63	BTG2	B cells	GSE169246_PacBlood_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58846
7.41115605193748e-68	-0.343225010218344	0.464	0.675	1.46266575841038e-63	SMDT1	B cells	GSE169246_PacBlood_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58847
7.83504608328357e-67	0.391224499019115	0.469	0.285	1.54632469499685e-62	VPS13C	B cells	GSE169246_PacBlood_pre	ENSG00000129003	54832	vacuolar protein sorting 13 homolog C	BLTP5C|FLJ10381|FLJ20136|KIAA1421	protein_coding	Q709C8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58848
1.13971256371146e-66	0.308893155811918	0.319	0.149	2.24933671574094e-62	PHC3	B cells	GSE169246_PacBlood_pre	ENSG00000173889	80012	polyhomeotic homolog 3	EDR3|FLJ12729|FLJ12967|HPH3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58849
1.14806892133358e-66	0.34252193112859	0.392	0.208	2.26582882314394e-62	COBLL1	B cells	GSE169246_PacBlood_pre	ENSG00000082438	22837	cordon-bleu WH2 repeat protein like 1	KIAA0977	protein_coding	Q53SF7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58850
1.66313303983671e-66	0.459492521334529	0.61	0.454	3.28235936742173e-62	AFF3	B cells	GSE169246_PacBlood_pre	ENSG00000144218	3899	ALF transcription elongation factor 3	LAF4|MLLT2-like	protein_coding	P51826	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58851
4.3347332749369e-66	0.39421246381863	0.567	0.376	8.55502959141546e-62	MYH9	B cells	GSE169246_PacBlood_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58852
7.21847768724057e-66	0.339957493931841	0.557	0.351	1.4246387563538e-61	PSAP	B cells	GSE169246_PacBlood_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58853
8.02939877981285e-66	-0.251473848286031	1	1	1.58468214318386e-61	RPS3A	B cells	GSE169246_PacBlood_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58854
9.11307004273039e-66	0.369161376380108	0.456	0.27	1.79855550363327e-61	IQGAP1	B cells	GSE169246_PacBlood_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58855
1.70734374610872e-65	0.331387706100695	0.355	0.181	3.36961361732016e-61	DDX3X	B cells	GSE169246_PacBlood_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58856
2.6294212370203e-65	0.27959619982421	0.324	0.152	5.18942575338327e-61	GLG1	B cells	GSE169246_PacBlood_pre	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58857
5.49890449877891e-65	-0.468099520708329	0.424	0.659	1.08526379187901e-60	TCL1A	B cells	GSE169246_PacBlood_pre	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58858
1.18095747508804e-64	0.331029653324376	0.991	0.958	2.33073767283376e-60	EEF2	B cells	GSE169246_PacBlood_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58859
1.49104277043162e-64	0.338762659089581	0.401	0.221	2.94272201172385e-60	CCNL1	B cells	GSE169246_PacBlood_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58860
1.51042596140516e-64	-0.288940809606441	0.862	0.91	2.98097667742923e-60	ATP5MC2	B cells	GSE169246_PacBlood_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58861
1.94550056136711e-63	0.399024923422299	0.618	0.443	3.83963990791414e-59	RSRP1	B cells	GSE169246_PacBlood_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58862
2.69722137408742e-63	0.251030297872445	0.251	0.099	5.32323610389892e-59	PPP1R15A	B cells	GSE169246_PacBlood_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58863
2.83219724696626e-63	0.357282993565337	0.63	0.46	5.58962448661261e-59	GRB2	B cells	GSE169246_PacBlood_pre	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58864
2.90385444353633e-63	0.275880535557772	0.31	0.143	5.7310471297633e-59	AKAP2	B cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58865
4.74449528266244e-63	0.295625066315238	0.999	0.998	9.36373588986259e-59	HLA-B	B cells	GSE169246_PacBlood_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58866
8.76579675187295e-63	0.325814957410489	0.457	0.275	1.73001764694965e-58	FNBP4	B cells	GSE169246_PacBlood_pre	ENSG00000285182	23360	formin binding protein 4	KIAA1014	protein_coding	Q8N3X1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58867
1.60126308811242e-62	0.280743805534026	0.493	0.279	3.16025283069866e-58	S100A10	B cells	GSE169246_PacBlood_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58868
1.88155867066838e-62	0.31718702931091	0.458	0.277	3.71344419243112e-58	ARHGAP17	B cells	GSE169246_PacBlood_pre	ENSG00000288353	55114	Rho GTPase activating protein 17	FLJ10308|FLJ13219|NADRIN|RICH1|WBP15	protein_coding	Q68EM7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58869
2.32471501113191e-62	0.318150407586077	0.487	0.305	4.58805754596994e-58	PPP3CC	B cells	GSE169246_PacBlood_pre	ENSG00000120910	5533	protein phosphatase 3 catalytic subunit gamma	CALNA3|PP2Bgamma	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58870
2.4858941940312e-62	0.271131588591821	0.331	0.16	4.90616078133999e-58	SEMA4B	B cells	GSE169246_PacBlood_pre	ENSG00000185033	10509	semaphorin 4B	KIAA1745|MGC131831|SEMAC|SemC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58871
2.63191400172693e-62	0.378909270309455	0.678	0.498	5.19434547380826e-58	COTL1	B cells	GSE169246_PacBlood_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58872
2.78899747486745e-62	-0.602389711505134	0.843	0.894	5.50436541639839e-58	RPS26	B cells	GSE169246_PacBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58873
7.18593888441821e-62	0.342593158384604	0.425	0.25	1.41821689822878e-57	SSH2	B cells	GSE169246_PacBlood_pre	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58874
1.09560551662428e-61	0.353923456060361	0.722	0.578	2.16228704760967e-57	SF1	B cells	GSE169246_PacBlood_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58875
4.88744119781728e-61	0.358521999615992	0.521	0.344	9.64585394801218e-57	IRF8	B cells	GSE169246_PacBlood_pre	ENSG00000140968	3394	interferon regulatory factor 8	ICSBP|ICSBP1|IRF-8	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58876
1.26068364731131e-60	0.312112516794738	0.439	0.255	2.48808524633361e-56	NFKBIA	B cells	GSE169246_PacBlood_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58877
2.29508263193883e-60	0.27988258397514	0.334	0.167	4.52957508239447e-56	SENP6	B cells	GSE169246_PacBlood_pre	ENSG00000112701	26054	SUMO specific peptidase 6	KIAA0797|SUSP1	protein_coding	Q9GZR1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58878
7.58947312056098e-60	0.285959849580445	0.393	0.216	1.49785841507391e-55	TAF15	B cells	GSE169246_PacBlood_pre	ENSG00000276833	8148	TATA-box binding protein associated factor 15	hTAFII68|Npl3|RBP56|TAF2N	protein_coding	Q92804	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58879
1.05380046011403e-59	0.275484210322462	0.334	0.168	2.07978058808105e-55	CDKN1B	B cells	GSE169246_PacBlood_pre	ENSG00000111276	1027	cyclin dependent kinase inhibitor 1B	KIP1|P27KIP1	protein_coding	P46527	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58880
3.52106001773053e-59	0.366516271914834	0.52	0.346	6.94916405099297e-55	CYBB	B cells	GSE169246_PacBlood_pre	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58881
3.68980333876073e-59	0.35083182584445	0.273	0.123	7.28219586937817e-55	CD69	B cells	GSE169246_PacBlood_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58882
4.96833689465376e-59	0.347890307337467	0.423	0.25	9.80550969528867e-55	MCL1	B cells	GSE169246_PacBlood_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58883
5.03099426310171e-59	0.346545090674393	0.666	0.514	9.92917027765753e-55	SP100	B cells	GSE169246_PacBlood_pre	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58884
6.648714657526e-59	0.355461679406719	0.528	0.352	1.31219032480933e-54	IKZF3	B cells	GSE169246_PacBlood_pre	ENSG00000161405	22806	IKAROS family zinc finger 3	Aiolos|ZNFN1A3	protein_coding	Q9UKT9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58885
1.00844176871963e-58	0.332628555287232	0.597	0.422	1.99026067474505e-54	ACTR2	B cells	GSE169246_PacBlood_pre	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58886
1.06949355146716e-58	0.278744886277369	0.403	0.224	2.11075247317558e-54	FMNL1	B cells	GSE169246_PacBlood_pre	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58887
1.70026460663289e-58	0.299088564019696	0.478	0.29	3.35564222765067e-54	TUBA1B	B cells	GSE169246_PacBlood_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58888
2.38899864126625e-58	-0.262103545335434	0.972	0.977	4.71492771840306e-54	CYBA	B cells	GSE169246_PacBlood_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58889
2.70000612220918e-58	0.318159237960977	0.523	0.34	5.32873208279205e-54	MSN	B cells	GSE169246_PacBlood_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58890
3.74271034410386e-58	0.338540019837634	0.552	0.374	7.38661313512338e-54	LRRFIP1	B cells	GSE169246_PacBlood_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58891
3.88956239974755e-58	0.272345168331923	0.341	0.174	7.67644035214177e-54	SPTAN1	B cells	GSE169246_PacBlood_pre	ENSG00000197694	6709	spectrin alpha, non-erythrocytic 1	NA	protein_coding	Q13813	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58892
4.05409109604299e-58	0.289994363813377	0.434	0.255	8.00115418715044e-54	RAD21	B cells	GSE169246_PacBlood_pre	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58893
1.12094914502904e-57	0.325783075654851	0.441	0.269	2.21230523262931e-53	CAMK1D	B cells	GSE169246_PacBlood_pre	ENSG00000183049	57118	calcium/calmodulin dependent protein kinase ID	CKLiK	protein_coding	Q8IU85	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58894
2.28446433023376e-57	0.276706455872284	0.34	0.175	4.50861880214935e-53	TLK1	B cells	GSE169246_PacBlood_pre	ENSG00000198586	9874	tousled like kinase 1	KIAA0137|PKU-BETA	protein_coding	Q9UKI8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58895
2.8129819173454e-57	0.334636270588365	0.613	0.453	5.55170111207288e-53	ACTR3	B cells	GSE169246_PacBlood_pre	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58896
5.03472373732654e-56	0.312675243242939	0.406	0.237	9.93653076798765e-52	MAP3K1	B cells	GSE169246_PacBlood_pre	ENSG00000095015	4214	mitogen-activated protein kinase kinase kinase 1	MAPKKK1|MEKK|MEKK1	protein_coding	Q13233	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58897
5.52166092092199e-56	0.298844361185256	0.427	0.254	1.08975499935316e-51	CD164	B cells	GSE169246_PacBlood_pre	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58898
7.45186475587459e-56	0.303895887632932	0.455	0.282	1.47070002821941e-51	SH3BP5	B cells	GSE169246_PacBlood_pre	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58899
2.56745854836003e-55	0.401064843337031	0.672	0.534	5.06713619104336e-51	MBNL1	B cells	GSE169246_PacBlood_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58900
3.0246681928867e-55	0.349890306688996	0.53	0.364	5.96948514548119e-51	SYK	B cells	GSE169246_PacBlood_pre	ENSG00000165025	6850	spleen associated tyrosine kinase	NA	protein_coding	P43405	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58901
3.78370105674034e-55	0.276311103851745	0.325	0.166	7.46751240558273e-51	BAZ2A	B cells	GSE169246_PacBlood_pre	ENSG00000076108	11176	bromodomain adjacent to zinc finger domain 2A	KIAA0314|TIP5|WALp3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58902
5.99819113410742e-55	0.293760133878431	0.37	0.206	1.18380300222744e-50	EPB41	B cells	GSE169246_PacBlood_pre	ENSG00000159023	2035	erythrocyte membrane protein band 4.1	4.1R|EL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58903
6.38341604965566e-55	0.309827395642149	0.382	0.218	1.25983099156004e-50	SEL1L3	B cells	GSE169246_PacBlood_pre	ENSG00000091490	23231	SEL1L family member 3	KIAA0746	protein_coding	Q68CR1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58904
7.1133778985908e-55	0.399779618957084	0.752	0.641	1.40389626206588e-50	FAM129C	B cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58905
1.17701480650745e-54	0.266367524688322	0.332	0.173	2.3229564221231e-50	CHPT1	B cells	GSE169246_PacBlood_pre	ENSG00000111666	56994	choline phosphotransferase 1	CPT1	protein_coding	Q8WUD6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58906
1.26412211749081e-54	0.295187984291202	0.355	0.195	2.49487141107986e-50	IFT57	B cells	GSE169246_PacBlood_pre	ENSG00000114446	55081	intraflagellar transport 57	ESRRBL1|FLJ10147|HIPPI|MHS4R2	protein_coding	Q9NWB7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58907
1.6388797898687e-54	0.336376518273563	0.436	0.269	3.23449315328487e-50	ATP2B1	B cells	GSE169246_PacBlood_pre	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58908
1.77772582779698e-54	0.33985258319765	0.483	0.314	3.50851969374011e-50	CELF2	B cells	GSE169246_PacBlood_pre	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58909
1.89168798283515e-54	0.255261322671736	0.334	0.173	3.73343540292346e-50	ANKRD13A	B cells	GSE169246_PacBlood_pre	ENSG00000076513	88455	ankyrin repeat domain 13A	ANKRD13|NY-REN-25	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58910
1.96341477048137e-54	0.329384309761084	0.607	0.447	3.87499539102204e-50	CDC42	B cells	GSE169246_PacBlood_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58911
8.66790725440498e-54	-0.259786989028847	0.918	0.951	1.71069817572937e-49	BTF3	B cells	GSE169246_PacBlood_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58912
1.367264450182e-53	0.278072456365035	0.464	0.291	2.6984331188792e-49	CAPZA1	B cells	GSE169246_PacBlood_pre	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58913
1.91610687420984e-53	-0.350160125184289	0.714	0.83	3.78162852694054e-49	NCF1	B cells	GSE169246_PacBlood_pre	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58914
2.49846285780493e-53	-0.254022562344351	0.976	0.976	4.93096629616382e-49	EEF1D	B cells	GSE169246_PacBlood_pre	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58915
3.23219317665856e-53	0.319532724676943	0.469	0.3	6.37905645345334e-49	ALOX5	B cells	GSE169246_PacBlood_pre	ENSG00000275565	240	arachidonate 5-lipoxygenase	5-LOX	protein_coding	P09917	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58916
8.26362641313457e-53	-0.352454585690668	0.495	0.662	1.63090930889624e-48	HIST1H4C	B cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58917
1.02914511290383e-52	0.386628970941051	0.613	0.469	2.031120794827e-48	STX7	B cells	GSE169246_PacBlood_pre	ENSG00000079950	8417	syntaxin 7	NA	protein_coding	O15400	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58918
4.55817949626481e-52	0.351550622183941	0.508	0.35	8.99602305382823e-48	SF3B1	B cells	GSE169246_PacBlood_pre	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58919
4.94761091144597e-52	0.288091401116647	0.348	0.193	9.76460489482977e-48	ZC3HAV1	B cells	GSE169246_PacBlood_pre	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58920
6.21289370303974e-52	0.315083000929552	0.547	0.386	1.22617670123192e-47	STK4	B cells	GSE169246_PacBlood_pre	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58921
6.29139709874811e-52	0.331469070971624	0.414	0.254	1.24167013140893e-47	UTRN	B cells	GSE169246_PacBlood_pre	ENSG00000152818	7402	utrophin	DMDL|DRP|DRP1	protein_coding	P46939	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58922
7.77883587097638e-52	0.315260249006656	0.434	0.269	1.5352310474959e-47	PLCG2	B cells	GSE169246_PacBlood_pre	ENSG00000197943	5336	phospholipase C gamma 2	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58923
9.48266375574517e-52	0.259978890753893	0.349	0.19	1.87149851883387e-47	STAT6	B cells	GSE169246_PacBlood_pre	ENSG00000166888	6778	signal transducer and activator of transcription 6	D12S1644|IL-4-STAT	protein_coding	P42226	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58924
1.10956183886292e-51	0.268124537638337	0.35	0.191	2.18983124517986e-47	TMPO	B cells	GSE169246_PacBlood_pre	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58925
1.14423863646786e-51	0.328821657492548	0.454	0.291	2.25826937293297e-47	TGFBR2	B cells	GSE169246_PacBlood_pre	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58926
1.6889188272841e-51	0.289007334414161	0.373	0.214	3.3332501975279e-47	MEF2A	B cells	GSE169246_PacBlood_pre	ENSG00000068305	4205	myocyte enhancer factor 2A	RSRFC4|RSRFC9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58927
1.76848778675857e-51	0.285026539612863	0.502	0.33	3.4902874959467e-47	CSDE1	B cells	GSE169246_PacBlood_pre	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58928
4.6745226209012e-51	0.315004534185691	0.642	0.485	9.22563784461061e-47	NCL	B cells	GSE169246_PacBlood_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58929
4.70885479969102e-51	-0.325820192998749	0.75	0.805	9.2933958326702e-47	PSME1	B cells	GSE169246_PacBlood_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58930
5.77675102326473e-51	0.307798472571879	0.409	0.25	1.14009958195153e-46	OGA	B cells	GSE169246_PacBlood_pre	ENSG00000198408	10724	O-GlcNAcase	MEA5|MGEA5|NCOAT	protein_coding	O60502	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58931
1.28028692682181e-50	0.303437266856809	0.42	0.259	2.52677427877553e-46	PTPN1	B cells	GSE169246_PacBlood_pre	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58932
1.46096905714287e-50	0.261614400722623	0.308	0.159	2.88336853117717e-46	CANX	B cells	GSE169246_PacBlood_pre	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58933
1.70868969216646e-50	0.299433121382685	0.483	0.317	3.37226997645973e-46	POU2AF1	B cells	GSE169246_PacBlood_pre	ENSG00000110777	5450	POU class 2 homeobox associating factor 1	BOB1|OBF1|OCA-B	protein_coding	Q16633	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58934
1.85737291106514e-50	0.282901667693853	0.442	0.278	3.66571117727815e-46	BRD2	B cells	GSE169246_PacBlood_pre	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58935
3.0851477657137e-50	-0.275007206587448	0.717	0.828	6.08884763041256e-46	MIF	B cells	GSE169246_PacBlood_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58936
3.12886062347725e-50	0.280583697314157	0.402	0.241	6.1751193264947e-46	WIPF1	B cells	GSE169246_PacBlood_pre	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58937
3.3336870325927e-50	0.272522633565223	0.384	0.225	6.57936472752495e-46	AFF4	B cells	GSE169246_PacBlood_pre	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58938
3.3507974976381e-50	0.299755531614815	0.449	0.292	6.61313394133856e-46	PAPOLA	B cells	GSE169246_PacBlood_pre	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58939
3.50794993088032e-50	0.280354204221878	0.311	0.161	6.9232899835854e-46	IQSEC1	B cells	GSE169246_PacBlood_pre	ENSG00000144711	9922	IQ motif and Sec7 domain ArfGEF 1	ARF-GEP100|BRAG2|GEP100|KIAA0763	protein_coding	Q6DN90	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58940
3.54600006492761e-50	0.257249211826607	0.324	0.172	6.99838572814113e-46	SECISBP2L	B cells	GSE169246_PacBlood_pre	ENSG00000138593	9728	SECIS binding protein 2 like	KIAA0256	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58941
5.82153428037702e-50	-0.264211964036342	0.399	0.583	1.14893800557521e-45	MZT2B	B cells	GSE169246_PacBlood_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58942
1.34015289219188e-49	0.254583089447456	0.298	0.152	2.6449257480299e-45	PHTF2	B cells	GSE169246_PacBlood_pre	ENSG00000006576	57157	putative homeodomain transcription factor 2	DKFZp434D166	protein_coding	Q8N3S3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58943
1.34220776344933e-49	0.263727970201492	0.398	0.238	2.64898124194359e-45	TAF7	B cells	GSE169246_PacBlood_pre	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58944
1.37658256526043e-49	0.261072893361219	0.459	0.29	2.71682335079799e-45	HNRNPA0	B cells	GSE169246_PacBlood_pre	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58945
1.89263603078342e-49	0.257068080319456	0.273	0.133	3.73530647035416e-45	SPEN	B cells	GSE169246_PacBlood_pre	ENSG00000065526	23013	spen family transcriptional repressor	KIAA0929|MINT|RBM15C|SHARP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58946
2.19741453463073e-49	0.290642086834266	0.48	0.316	4.3368173255472e-45	APBB1IP	B cells	GSE169246_PacBlood_pre	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58947
3.32312325171521e-49	0.399729122630591	0.784	0.705	6.55851604958513e-45	RALGPS2	B cells	GSE169246_PacBlood_pre	ENSG00000116191	55103	Ral GEF with PH domain and SH3 binding motif 2	FLJ10244|FLJ25604|KIAA0351	protein_coding	Q86X27	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58948
7.04115909768889e-49	0.27122206588809	0.343	0.191	1.38964315951988e-44	TRAF5	B cells	GSE169246_PacBlood_pre	ENSG00000082512	7188	TNF receptor associated factor 5	RNF84	protein_coding	O00463	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58949
7.88725407899092e-49	0.301961627962144	0.492	0.329	1.55662846502965e-44	CAST	B cells	GSE169246_PacBlood_pre	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58950
9.59253809681588e-49	0.303811509454988	0.465	0.306	1.89318331878758e-44	NCOA3	B cells	GSE169246_PacBlood_pre	ENSG00000124151	8202	nuclear receptor coactivator 3	ACTR|AIB1|bHLHe42|CAGH16|KAT13B|p/CIP|RAC3|SRC-3|SRC3|TNRC16|TRAM-1	protein_coding	Q9Y6Q9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58951
1.04363696554907e-48	0.310160206429549	0.453	0.292	2.05972191520765e-44	JMJD1C	B cells	GSE169246_PacBlood_pre	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58952
1.21706501566931e-48	0.334087438036369	0.579	0.427	2.40199951492495e-44	REL	B cells	GSE169246_PacBlood_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58953
1.54606798033571e-48	0.285518913085982	0.402	0.246	3.05131976599056e-44	ARHGEF1	B cells	GSE169246_PacBlood_pre	ENSG00000076928	9138	Rho guanine nucleotide exchange factor 1	LBCL2|P115-RHOGEF|SUB1.5	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58954
1.91180855287348e-48	0.284365132073321	0.699	0.55	3.7731453599511e-44	HNRNPDL	B cells	GSE169246_PacBlood_pre	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58955
2.65241770690072e-48	0.269943611417061	0.336	0.187	5.23481158633926e-44	ANKRD10	B cells	GSE169246_PacBlood_pre	ENSG00000088448	55608	ankyrin repeat domain 10	FLJ20093	protein_coding	Q9NXR5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58956
2.70988193278953e-48	0.258362407702499	0.423	0.258	5.34822298255342e-44	KPNB1	B cells	GSE169246_PacBlood_pre	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58957
3.18013569637727e-48	0.279021560823539	0.388	0.232	6.27631581037019e-44	PRPF8	B cells	GSE169246_PacBlood_pre	ENSG00000274442	10594	pre-mRNA processing factor 8	hPrp8|Prp8|PRPC8|RP13|SNRNP220	protein_coding	Q6P2Q9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58958
3.86350266968831e-48	0.380205298455011	0.662	0.535	7.62500886889686e-44	FOXP1	B cells	GSE169246_PacBlood_pre	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58959
4.61773334846229e-48	0.33763518036493	0.441	0.287	9.11355853652517e-44	FCHSD2	B cells	GSE169246_PacBlood_pre	ENSG00000137478	9873	FCH and double SH3 domains 2	KIAA0769|SH3MD3	protein_coding	O94868	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58960
4.622710860288e-48	0.363499280992186	0.428	0.275	9.12338215386439e-44	PARP15	B cells	GSE169246_PacBlood_pre	ENSG00000173200	165631	poly(ADP-ribose) polymerase family member 15	ARTD7|BAL3|FLJ40597|pART7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58961
5.12920355833026e-48	-0.263814190672928	0.796	0.876	1.01229961427206e-43	COMMD6	B cells	GSE169246_PacBlood_pre	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58962
8.8253375882991e-48	0.288666690513615	0.57	0.413	1.74176862642671e-43	TNFAIP8	B cells	GSE169246_PacBlood_pre	ENSG00000145779	25816	TNF alpha induced protein 8	GG2-1|MDC-3.13|SCC-S2	protein_coding	O95379	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58963
1.10505177555443e-47	0.29887725969142	0.508	0.349	2.18093018423423e-43	CD47	B cells	GSE169246_PacBlood_pre	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58964
1.12650360866707e-47	0.26960462406122	0.447	0.283	2.22326752206532e-43	SRSF2	B cells	GSE169246_PacBlood_pre	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58965
1.20164043710917e-47	0.286102644558982	0.378	0.213	2.37155756667866e-43	JUNB	B cells	GSE169246_PacBlood_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58966
1.44316408952486e-47	0.260145547336362	0.327	0.179	2.84822864708627e-43	PIK3AP1	B cells	GSE169246_PacBlood_pre	ENSG00000155629	118788	phosphoinositide-3-kinase adaptor protein 1	BCAP|FLJ35564	protein_coding	Q6ZUJ8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58967
2.29018963936991e-47	0.272099347888193	0.365	0.212	4.51991827226046e-43	TTC3	B cells	GSE169246_PacBlood_pre	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58968
3.67942739274808e-47	0.256889346516149	0.295	0.153	7.26171790232762e-43	CFLAR	B cells	GSE169246_PacBlood_pre	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58969
4.13415527458617e-47	0.378699126768579	0.284	0.143	8.15916884992326e-43	ITGB1	B cells	GSE169246_PacBlood_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58970
5.58063882596765e-47	0.318816301193319	0.464	0.311	1.10139487869298e-42	SLC38A1	B cells	GSE169246_PacBlood_pre	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58971
5.6227041460365e-47	0.296231890602986	0.497	0.341	1.10969689026176e-42	ELOVL5	B cells	GSE169246_PacBlood_pre	ENSG00000012660	60481	ELOVL fatty acid elongase 5	dJ483K16.1|HELO1|SCA38	protein_coding	Q9NYP7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58972
7.39819496433112e-47	0.255218581446453	0.295	0.154	1.46010775816039e-42	CRYBG1	B cells	GSE169246_PacBlood_pre	ENSG00000112297	202	crystallin beta-gamma domain containing 1	AIM1|ST4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58973
8.26552932146549e-47	0.313456439165812	0.649	0.51	1.63128486688443e-42	RBM39	B cells	GSE169246_PacBlood_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58974
9.31619159202006e-47	0.287439804615294	0.334	0.189	1.83864357260108e-42	SNRNP70	B cells	GSE169246_PacBlood_pre	ENSG00000104852	6625	small nuclear ribonucleoprotein U1 subunit 70	RNPU1Z|RPU1|Snp1|SNRP70|U1-70K	protein_coding	P08621	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58975
9.95199232011188e-47	0.266599987381295	0.326	0.181	1.96412520429728e-42	OGT	B cells	GSE169246_PacBlood_pre	ENSG00000147162	8473	O-linked N-acetylglucosamine (GlcNAc) transferase	FLJ23071|HRNT1|MGC22921|O-GLCNAC|OGT1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58976
1.8301575436677e-46	0.282465184494635	0.42	0.265	3.61199892818258e-42	BCLAF1	B cells	GSE169246_PacBlood_pre	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58977
7.53950644332529e-46	0.259387499198966	0.331	0.187	1.48799699165468e-41	PPP3CA	B cells	GSE169246_PacBlood_pre	ENSG00000138814	5530	protein phosphatase 3 catalytic subunit alpha	CALN|CALNA|CNA1|PPP2B	protein_coding	Q08209	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58978
1.12629607670071e-45	0.272039210560882	0.327	0.183	2.22285793697653e-41	SPTBN1	B cells	GSE169246_PacBlood_pre	ENSG00000115306	6711	spectrin beta, non-erythrocytic 1	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58979
1.16984952749248e-45	0.265479737519735	0.321	0.178	2.30881502745915e-41	LYST	B cells	GSE169246_PacBlood_pre	ENSG00000143669	1130	lysosomal trafficking regulator	CHS|CHS1|Mauve	protein_coding	Q99698	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58980
1.51535599984317e-45	0.284597276662478	0.492	0.336	2.99070660129049e-41	FGD2	B cells	GSE169246_PacBlood_pre	ENSG00000146192	221472	FYVE, RhoGEF and PH domain containing 2	ZFYVE4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58981
1.6429602357335e-45	0.260458167000359	0.368	0.217	3.24254632124363e-41	TGOLN2	B cells	GSE169246_PacBlood_pre	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58982
2.62241349074849e-45	0.260774456580632	0.368	0.218	5.17559526534122e-41	PDCD6IP	B cells	GSE169246_PacBlood_pre	ENSG00000170248	10015	programmed cell death 6 interacting protein	AIP1|Alix|Hp95	protein_coding	Q8WUM4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58983
2.76563881417779e-45	0.268684250232061	0.452	0.296	5.45826476366129e-41	RBMX	B cells	GSE169246_PacBlood_pre	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58984
4.66663453543525e-45	0.312415753380562	0.402	0.254	9.21006991913501e-41	ST6GAL1	B cells	GSE169246_PacBlood_pre	ENSG00000073849	6480	ST6 beta-galactoside alpha-2,6-sialyltransferase 1	CDw75|SIAT1	protein_coding	P15907	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58985
6.25507064892823e-45	0.290308624087311	0.351	0.209	1.23450074327248e-40	PTBP3	B cells	GSE169246_PacBlood_pre	ENSG00000119314	9991	polypyrimidine tract binding protein 3	DKFZp781I1117|ROD1	protein_coding	O95758	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58986
7.29118810951968e-45	0.282211729826001	0.544	0.386	1.4389888852948e-40	HNRNPA3	B cells	GSE169246_PacBlood_pre	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58987
8.63399385074608e-45	0.277849807294464	0.425	0.273	1.70400502638325e-40	GGA2	B cells	GSE169246_PacBlood_pre	ENSG00000103365	23062	golgi associated, gamma adaptin ear containing, ARF binding protein 2	KIAA1080|VEAR	protein_coding	Q9UJY4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58988
8.84256356773043e-45	0.250438419533511	0.446	0.287	1.74516834572728e-40	PPP1CC	B cells	GSE169246_PacBlood_pre	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58989
1.31288836348613e-44	0.277332082122459	0.472	0.318	2.59111647417623e-40	MOB1A	B cells	GSE169246_PacBlood_pre	ENSG00000114978	55233	MOB kinase activator 1A	C2orf6|FLJ10788|FLJ11595|Mats1|MOB1|Mob4B|MOBK1B|MOBKL1B	protein_coding	Q9H8S9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58990
1.43417572911575e-44	0.314528790847223	0.494	0.347	2.83048921898284e-40	AC119396.1	B cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58991
3.30531672901592e-44	0.311292319736302	0.404	0.26	6.52337309638582e-40	CHD2	B cells	GSE169246_PacBlood_pre	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58992
3.49872295917836e-44	0.295481606059712	0.369	0.227	6.90507963223441e-40	RNASE6	B cells	GSE169246_PacBlood_pre	ENSG00000169413	6039	ribonuclease A family member k6	RAD1|RNaseK6|RNS6	protein_coding	Q93091	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58993
4.65249450566728e-44	-0.260391030794148	0.3	0.471	9.18216315638494e-40	EAF2	B cells	GSE169246_PacBlood_pre	ENSG00000145088	55840	ELL associated factor 2	BM040|TRAITS|U19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58994
6.23364310897557e-44	0.313870915504861	0.531	0.387	1.23027180398742e-39	TCF4	B cells	GSE169246_PacBlood_pre	ENSG00000196628	6925	transcription factor 4	bHLHb19|E2-2|ITF2|SEF2-1B	protein_coding	P15884	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58995
6.6483599630542e-44	0.274080344779204	0.401	0.253	1.31212032230838e-39	ROCK1	B cells	GSE169246_PacBlood_pre	ENSG00000067900	6093	Rho associated coiled-coil containing protein kinase 1	p160ROCK	protein_coding	Q13464	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58996
6.8884196131635e-44	0.266049393252071	0.348	0.204	1.35949849485395e-39	ZNF107	B cells	GSE169246_PacBlood_pre	ENSG00000196247	51427	zinc finger protein 107	smap-7|ZFD25|ZNF588	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58997
7.25205744264195e-44	0.276062779104096	0.669	0.53	1.43126605687982e-39	HNRNPK	B cells	GSE169246_PacBlood_pre	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58998
7.3784683844392e-44	0.252539618233364	0.412	0.26	1.45621452035292e-39	PLEKHF2	B cells	GSE169246_PacBlood_pre	ENSG00000175895	79666	pleckstrin homology and FYVE domain containing 2	FLJ13187|PHAFIN2|ZFYVE18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	58999
9.04345936132679e-44	-0.301237562902789	0.35	0.509	1.78481713955145e-39	TRBC2	B cells	GSE169246_PacBlood_pre	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59000
1.40912830334588e-43	0.265941586789906	0.478	0.324	2.78105561948344e-39	TPD52	B cells	GSE169246_PacBlood_pre	ENSG00000076554	7163	tumor protein D52	D52|hD52|N8L	protein_coding	P55327	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59001
1.50850799245717e-43	0.426448127714993	0.799	0.759	2.97719137391347e-39	LINC00926	B cells	GSE169246_PacBlood_pre	ENSG00000247982	283663	long intergenic non-protein coding RNA 926	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59002
2.54849191520623e-43	0.259241260599384	0.512	0.357	5.02970364385102e-39	KHDRBS1	B cells	GSE169246_PacBlood_pre	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59003
4.78080420729984e-43	0.267790200534416	0.435	0.284	9.43539518352696e-39	CYFIP2	B cells	GSE169246_PacBlood_pre	ENSG00000055163	26999	cytoplasmic FMR1 interacting protein 2	PIR121	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59004
1.10505504709802e-42	0.25999599013345	0.486	0.33	2.18093664095265e-38	MORF4L1	B cells	GSE169246_PacBlood_pre	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59005
1.27931788880489e-42	0.260610923861734	0.348	0.207	2.52486178534534e-38	PHF3	B cells	GSE169246_PacBlood_pre	ENSG00000118482	23469	PHD finger protein 3	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59006
1.56196910355621e-42	0.250341544543557	0.346	0.203	3.08270222277854e-38	LBR	B cells	GSE169246_PacBlood_pre	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59007
3.08819753226121e-42	0.250463631079648	0.308	0.172	6.09486664967073e-38	AC016831.7	B cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59008
5.25505103587525e-42	0.257144770433395	0.319	0.182	1.03713687244034e-37	SMG1	B cells	GSE169246_PacBlood_pre	ENSG00000157106	23049	SMG1 nonsense mediated mRNA decay associated PI3K related kinase	ATX|KIAA0421|LIP	protein_coding	Q96Q15	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59009
1.01736938787916e-41	0.277976075902978	0.59	0.441	2.00788022391831e-37	FUS	B cells	GSE169246_PacBlood_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59010
1.58548210128549e-41	0.366634992368819	0.602	0.491	3.12910747509705e-37	BIRC3	B cells	GSE169246_PacBlood_pre	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59011
1.83094734089871e-41	0.262004696596348	0.338	0.2	3.61355767199769e-37	NKTR	B cells	GSE169246_PacBlood_pre	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59012
1.87024335243437e-41	0.305921011870046	0.403	0.261	3.69111228036448e-37	CCDC50	B cells	GSE169246_PacBlood_pre	ENSG00000152492	152137	coiled-coil domain containing 50	C3orf6|DFNA44|Ymer	protein_coding	Q8IVM0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59013
3.53951204531108e-41	0.250210602686848	0.313	0.178	6.98558097262595e-37	MAP3K8	B cells	GSE169246_PacBlood_pre	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59014
3.8671213740268e-41	0.2872261561544	0.524	0.372	7.63215074377929e-37	TNFRSF13C	B cells	GSE169246_PacBlood_pre	ENSG00000159958	115650	TNF receptor superfamily member 13C	BAFFR|CD268	protein_coding	Q96RJ3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59015
4.66740738276821e-41	0.285239076979802	0.353	0.211	9.21159521063134e-37	ZEB2	B cells	GSE169246_PacBlood_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59016
2.56127384549733e-40	0.272054070538153	0.433	0.289	5.05493006147353e-36	PDIA3	B cells	GSE169246_PacBlood_pre	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59017
2.63984674785925e-40	0.251082812539789	0.358	0.22	5.21000154157501e-36	DNAJC10	B cells	GSE169246_PacBlood_pre	ENSG00000077232	54431	DnaJ heat shock protein family (Hsp40) member C10	ERdj5|PDIA19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59018
3.10704215997567e-40	0.256501480065259	0.356	0.218	6.13205840692797e-36	NIPBL	B cells	GSE169246_PacBlood_pre	ENSG00000164190	25836	NIPBL cohesin loading factor	DKFZp434L1319|FLJ11203|FLJ12597|FLJ13354|FLJ13648|IDN3|Scc2	protein_coding	Q6KC79	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59019
5.38798288424096e-40	0.276990659132977	0.466	0.321	1.0633723020338e-35	ATRX	B cells	GSE169246_PacBlood_pre	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59020
2.43207160641034e-39	0.254604278407318	0.445	0.298	4.79993652241145e-35	CDC42SE1	B cells	GSE169246_PacBlood_pre	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59021
2.66249695047065e-39	0.26560159546809	0.397	0.257	5.25470398144888e-35	ZNF207	B cells	GSE169246_PacBlood_pre	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59022
4.00965866126027e-39	0.270832061314869	0.466	0.326	7.91346233386327e-35	DOCK8	B cells	GSE169246_PacBlood_pre	ENSG00000107099	81704	dedicator of cytokinesis 8	FLJ00026|FLJ00152|FLJ00346|ZIR8	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59023
4.54282406837962e-39	0.259013774950164	0.475	0.333	8.96571758135402e-35	NCOR1	B cells	GSE169246_PacBlood_pre	ENSG00000141027	9611	nuclear receptor corepressor 1	hCIT529I10|hN-CoR|KIAA1047|MGC104216|N-CoR|PPP1R109|TRAC1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59024
7.75238070229623e-39	0.285093612081064	0.474	0.33	1.53000985540518e-34	HSP90B1	B cells	GSE169246_PacBlood_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59025
2.73493099625922e-38	0.307752840450092	0.467	0.325	5.39765981421719e-34	CD24	B cells	GSE169246_PacBlood_pre	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59026
3.65149350367439e-38	0.257082952931325	0.433	0.294	7.20658757885178e-34	HP1BP3	B cells	GSE169246_PacBlood_pre	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59027
2.8171139445407e-37	0.278637253913338	0.568	0.437	5.55985608094553e-33	PRRC2C	B cells	GSE169246_PacBlood_pre	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59028
1.21609286263825e-36	0.261130810900044	0.324	0.197	2.40008087370285e-32	ITPR1	B cells	GSE169246_PacBlood_pre	ENSG00000150995	3708	inositol 1,4,5-trisphosphate receptor type 1	ACV|Insp3r1|IP3R1|PPP1R94|SCA15|SCA16|SCA29	protein_coding	Q14643	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59029
3.44781857014583e-36	0.273458987237762	0.82	0.746	6.8046147300398e-32	RCSD1	B cells	GSE169246_PacBlood_pre	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59030
4.07058998118042e-36	-0.306261090300336	0.49	0.614	8.03371638685768e-32	C12orf57	B cells	GSE169246_PacBlood_pre	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59031
4.09816647013189e-36	0.264450797748739	0.483	0.35	8.0881413454523e-32	UVRAG	B cells	GSE169246_PacBlood_pre	ENSG00000198382	7405	UV radiation resistance associated	VPS38	protein_coding	Q9P2Y5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59032
9.96183980591324e-36	0.277415921951523	0.555	0.428	1.96606870409504e-31	KMT2E	B cells	GSE169246_PacBlood_pre	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59033
1.20286704112781e-35	0.268756147600356	0.429	0.298	2.37397839236984e-31	PNN	B cells	GSE169246_PacBlood_pre	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59034
1.4338056259566e-35	0.276032326635634	0.55	0.418	2.82975878338794e-31	PRKCB	B cells	GSE169246_PacBlood_pre	ENSG00000166501	5579	protein kinase C beta	PKCB|PKCbeta|PRKCB1|PRKCB2	protein_coding	P05771	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59035
1.45674819500758e-35	0.264941843552591	0.541	0.403	2.87503823766697e-31	BLK	B cells	GSE169246_PacBlood_pre	ENSG00000285369	640	BLK proto-oncogene, Src family tyrosine kinase	MGC10442	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59036
6.16100651596708e-35	0.255141339908955	0.343	0.216	1.21593624599126e-30	LNPEP	B cells	GSE169246_PacBlood_pre	ENSG00000113441	4012	leucyl and cystinyl aminopeptidase	CAP|IRAP|P-LAP|PLAP	protein_coding	Q9UIQ6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59037
5.07941980132526e-33	0.591244650075378	0.413	0.317	1.00247429198955e-28	IL4R	B cells	GSE169246_PacBlood_pre	ENSG00000077238	3566	interleukin 4 receptor	CD124	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59038
9.20549964335621e-33	0.261186874050609	0.605	0.487	1.81679740961278e-28	POU2F2	B cells	GSE169246_PacBlood_pre	ENSG00000028277	5452	POU class 2 homeobox 2	OCT2|OTF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59039
1.25577333589753e-30	0.265935110048163	0.303	0.191	2.47839425572736e-26	MACF1	B cells	GSE169246_PacBlood_pre	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59040
7.70174114342952e-30	0.275592099515466	0.372	0.258	1.52001563206725e-25	CAMK2D	B cells	GSE169246_PacBlood_pre	ENSG00000145349	817	calcium/calmodulin dependent protein kinase II delta	CAMKD	protein_coding	Q13557	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59041
1.03051066286438e-29	0.276143836993764	0.521	0.404	2.03381584422915e-25	CD82	B cells	GSE169246_PacBlood_pre	ENSG00000085117	3732	CD82 molecule	IA4|KAI1|R2|ST6|TSPAN27	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59042
9.22671742516669e-29	0.251304993486589	0.436	0.318	1.8209849510309e-24	UBE2J1	B cells	GSE169246_PacBlood_pre	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59043
9.50843560629105e-27	0.25277855749474	0.403	0.289	1.8765848512576e-22	ARID5B	B cells	GSE169246_PacBlood_pre	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59044
4.39427985125604e-26	0.250554533644611	0.493	0.385	8.67255071443892e-22	MTSS1	B cells	GSE169246_PacBlood_pre	ENSG00000170873	9788	MTSS I-BAR domain containing 1	KIAA0429|MIM|MIMA|MIMB	protein_coding	O43312	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59045
6.39055626492457e-26	0.330818101438922	0.469	0.37	1.26124018444551e-21	SMAP2	B cells	GSE169246_PacBlood_pre	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59046
2.65754757582465e-23	0.262590010630317	0.496	0.399	5.24493589564752e-19	SRRM2	B cells	GSE169246_PacBlood_pre	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59047
1.03423001181405e-22	0.419665219009809	0.473	0.395	2.04115635131622e-18	BACH2	B cells	GSE169246_PacBlood_pre	ENSG00000112182	60468	BTB domain and CNC homolog 2	BTBD25	protein_coding	Q9BYV9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59048
2.59212779232934e-22	0.265249952114218	1	1	5.11582341094118e-18	MALAT1	B cells	GSE169246_PacBlood_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59049
4.94432534830301e-22	-0.259735936264018	0.687	0.795	9.75812050741083e-18	IGHM	B cells	GSE169246_PacBlood_pre	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59050
9.80482840453973e-22	0.272739041358005	0.551	0.459	1.93508093391996e-17	ADK	B cells	GSE169246_PacBlood_pre	ENSG00000156110	132	adenosine kinase	AK	protein_coding	P55263	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59051
5.9878893402448e-13	0.339999129614988	0.407	0.341	1.18176984019071e-08	JCHAIN	B cells	GSE169246_PacBlood_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59052
4.33759504669103e-159	2.89593138361865	0.676	0	8.56067758414942e-155	HBB	cDCs	GSE169246_PacBlood_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59053
1.28434954340399e-79	-0.874083825165063	0.995	1	2.53479225886211e-75	TMSB10	cDCs	GSE169246_PacBlood_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59054
2.05659853122606e-66	-1.59567816996422	0.87	0.994	4.05890286122776e-62	RPS26	cDCs	GSE169246_PacBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59055
1.1336948706303e-65	1.00238049178222	0.724	0.158	2.23746019667597e-61	TSC22D3	cDCs	GSE169246_PacBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59056
1.42550121652848e-60	1.07440375447501	0.665	0.136	2.81336920094061e-56	DUSP1	cDCs	GSE169246_PacBlood_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59057
8.54958010740336e-60	1.23698066191528	0.995	0.954	1.68734512999713e-55	MT-ND4L	cDCs	GSE169246_PacBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59058
6.34196966482242e-59	-0.647849042887697	0.995	1	1.25165113304935e-54	RPL28	cDCs	GSE169246_PacBlood_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59059
1.90899717206737e-58	-0.70073626101603	0.989	0.999	3.76759681879215e-54	RPS21	cDCs	GSE169246_PacBlood_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59060
5.55055333337012e-56	-0.874548394117293	0.935	0.999	1.09545720587393e-51	RPL41	cDCs	GSE169246_PacBlood_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59061
8.21330492457995e-56	1.15667980740124	0.957	0.644	1.6209778599151e-51	ZFP36L2	cDCs	GSE169246_PacBlood_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59062
1.19713962432733e-54	-0.659776953831015	0.995	1	2.36267476257242e-50	RPS28	cDCs	GSE169246_PacBlood_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59063
1.65828498655802e-53	1.31209996491615	0.995	0.69	3.2727912494709e-49	MT-ATP8	cDCs	GSE169246_PacBlood_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59064
4.47158928783394e-52	1.28130161013597	0.924	0.397	8.82512861846906e-48	FOS	cDCs	GSE169246_PacBlood_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59065
2.17341283842034e-51	0.720358051335372	1	0.993	4.28944757790638e-47	PABPC1	cDCs	GSE169246_PacBlood_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59066
2.00478683823975e-49	-0.67265536145518	0.989	0.999	3.95664730394996e-45	RPL39	cDCs	GSE169246_PacBlood_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59067
1.13227943460434e-48	-0.846483276952618	0.768	0.98	2.23466669213513e-44	RPL36A	cDCs	GSE169246_PacBlood_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59068
4.20464940638148e-48	-0.618414080229801	0.973	0.999	8.2982960684345e-44	RPL36	cDCs	GSE169246_PacBlood_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59069
7.01572816732708e-48	-0.636435570421954	0.995	1	1.38462411110367e-43	RPS27	cDCs	GSE169246_PacBlood_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59070
1.24438148332151e-46	-0.765092385592048	0.919	0.998	2.45591129548334e-42	RPS29	cDCs	GSE169246_PacBlood_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59071
8.61994137486973e-45	0.782057878798608	1	1	1.70123162974429e-40	MT-CO3	cDCs	GSE169246_PacBlood_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59072
1.34135205398144e-44	-0.633393259002716	0.935	0.998	2.64729241373776e-40	ATP5F1E	cDCs	GSE169246_PacBlood_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59073
2.91349404510741e-43	-0.664295096033426	0.946	0.999	5.75007184742398e-39	SERF2	cDCs	GSE169246_PacBlood_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59074
4.18485645202437e-43	1.17495255958022	0.795	0.342	8.2592326937153e-39	MT-ND6	cDCs	GSE169246_PacBlood_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59075
4.67520244924187e-43	0.537193479506733	0.324	0.03	9.22697955382375e-39	DDIT4	cDCs	GSE169246_PacBlood_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59076
1.27792962459624e-42	0.694461280580259	1	1	2.52212190710314e-38	MT-CO1	cDCs	GSE169246_PacBlood_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59077
9.14606571358385e-42	0.783121515205054	1	0.992	1.80506752923291e-37	MT-CYB	cDCs	GSE169246_PacBlood_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59078
1.92126475277883e-40	1.25588888912468	0.951	0.712	3.7918081160843e-36	AHNAK	cDCs	GSE169246_PacBlood_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59079
3.64868642776148e-40	0.698974418979334	0.773	0.295	7.20104753383005e-36	NFKBIA	cDCs	GSE169246_PacBlood_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59080
9.56309942690429e-40	0.793510425905152	1	0.98	1.88737330289383e-35	MT-ND1	cDCs	GSE169246_PacBlood_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59081
7.17963914983037e-37	-0.510028368378843	0.978	0.999	1.41697358261052e-32	RPL37	cDCs	GSE169246_PacBlood_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59082
4.47980619720148e-35	0.89958939366634	0.741	0.309	8.84134551079684e-31	STK17B	cDCs	GSE169246_PacBlood_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59083
1.54088338212794e-34	0.830734808465353	0.649	0.241	3.04108744296771e-30	MCL1	cDCs	GSE169246_PacBlood_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59084
9.59348522220451e-34	-1.39494134070791	0.703	0.901	1.89337024345428e-29	IFITM3	cDCs	GSE169246_PacBlood_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59085
4.06910717395622e-33	-0.743436234880895	0.519	0.874	8.03078991851999e-29	PSMB9	cDCs	GSE169246_PacBlood_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59086
8.59423463421967e-33	0.669203549250624	0.984	0.95	1.69615814740959e-28	EEF2	cDCs	GSE169246_PacBlood_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59087
2.71871270119455e-32	0.608265178928273	1	0.999	5.36565138707757e-28	MT-CO2	cDCs	GSE169246_PacBlood_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59088
8.03349708570816e-32	-0.604819026256343	0.773	0.943	1.58549098483536e-27	COX6A1	cDCs	GSE169246_PacBlood_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59089
1.22992020520084e-31	-0.640136737527403	0.995	1	2.42737051698438e-27	SH3BGRL3	cDCs	GSE169246_PacBlood_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59090
8.06489838756016e-31	-0.467750062358367	0.989	1	1.59168834576887e-26	RPL34	cDCs	GSE169246_PacBlood_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59091
9.88541299324675e-31	-0.517894754259455	0.946	0.999	1.95098510834718e-26	RPL35	cDCs	GSE169246_PacBlood_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59092
1.47956553802173e-30	0.6121023633303	0.989	1	2.9200705458397e-26	TPT1	cDCs	GSE169246_PacBlood_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59093
1.57431014417628e-30	-0.605073603954234	0.881	0.991	3.1070585005463e-26	RPL38	cDCs	GSE169246_PacBlood_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59094
9.27195126897776e-30	-0.535071128770871	0.973	0.999	1.82991230244545e-25	MYL6	cDCs	GSE169246_PacBlood_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59095
1.10061175631983e-29	-0.42769737959028	0.995	1	2.17216736227282e-25	RPS15	cDCs	GSE169246_PacBlood_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59096
2.15839756959691e-29	0.7532772409287	0.708	0.3	4.25981344335646e-25	ZFP36	cDCs	GSE169246_PacBlood_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59097
2.27410710608049e-29	-0.739856605409368	0.989	0.998	4.48817778456046e-25	MT-ND4	cDCs	GSE169246_PacBlood_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59098
1.709959821587e-28	-0.547779025276612	0.773	0.948	3.37477670388409e-24	ATP5MF	cDCs	GSE169246_PacBlood_pre	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59099
2.99894160241139e-28	0.754615606194143	0.995	0.959	5.91871114651911e-24	MT-ND5	cDCs	GSE169246_PacBlood_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59100
3.39566467237673e-28	-0.827813574079365	0.8	0.916	6.70168379740272e-24	IFITM2	cDCs	GSE169246_PacBlood_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59101
1.64561888796967e-27	-1.28204708878076	0.2	0.612	3.24779343729694e-23	IFITM1	cDCs	GSE169246_PacBlood_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59102
4.68502461337592e-27	0.521222370438704	0.508	0.163	9.24636457695871e-23	KLF10	cDCs	GSE169246_PacBlood_pre	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59103
3.33178841386791e-26	-0.532943624249458	0.805	0.983	6.57561761360971e-22	TMA7	cDCs	GSE169246_PacBlood_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59104
8.7640910538661e-26	-0.390229594977269	1	1	1.72968101039101e-21	FAU	cDCs	GSE169246_PacBlood_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59105
9.33444615629277e-26	-0.521023665157275	0.73	0.941	1.84224629340594e-21	UQCR11	cDCs	GSE169246_PacBlood_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59106
9.52744557571207e-26	-0.508779703262991	0.876	0.982	1.88033665882253e-21	COX7C	cDCs	GSE169246_PacBlood_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59107
1.05039266816235e-25	-0.609292838456009	0.573	0.887	2.07305496988521e-21	MIF	cDCs	GSE169246_PacBlood_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59108
3.00661499471702e-25	-0.905896117466827	0.157	0.582	5.93385535357352e-21	ISG15	cDCs	GSE169246_PacBlood_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59109
3.73440218963591e-25	-0.512832923571515	0.811	0.976	7.37021616146542e-21	COX6B1	cDCs	GSE169246_PacBlood_pre	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59110
2.35292739336376e-24	0.60976645227018	0.859	0.583	4.64373750354271e-20	SARAF	cDCs	GSE169246_PacBlood_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59111
3.90817775792702e-24	0.579030782329091	0.551	0.208	7.71317962304477e-20	MYADM	cDCs	GSE169246_PacBlood_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59112
7.79840160586183e-24	0.53145832616296	0.384	0.104	1.53909254093289e-19	RETN	cDCs	GSE169246_PacBlood_pre	ENSG00000104918	56729	resistin	ADSF|FIZZ3|RETN1	protein_coding	Q9HD89	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59113
7.83703825661167e-24	-0.41071549521646	0.995	1	1.54671787032488e-19	RPS19	cDCs	GSE169246_PacBlood_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59114
8.01037980523181e-24	-0.524862891363828	0.638	0.896	1.58092855836055e-19	COX6C	cDCs	GSE169246_PacBlood_pre	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59115
1.67167336894064e-23	-0.429703057749798	0.989	0.997	3.29921456094125e-19	CYBA	cDCs	GSE169246_PacBlood_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59116
1.81255987562143e-23	0.669057277822457	0.908	0.685	3.57726817052645e-19	DDX5	cDCs	GSE169246_PacBlood_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59117
2.01969515072395e-23	-0.526693587808798	0.568	0.865	3.98607034946879e-19	NDUFA1	cDCs	GSE169246_PacBlood_pre	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59118
3.73005779736664e-23	0.522843505602426	0.881	0.601	7.36164206888281e-19	PCBP1	cDCs	GSE169246_PacBlood_pre	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59119
6.80953899735266e-23	-0.701928173962795	0.616	0.886	1.34393061651752e-18	PSME2	cDCs	GSE169246_PacBlood_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59120
1.42834188654783e-22	0.531666342173829	0.751	0.433	2.81897554729079e-18	EIF4B	cDCs	GSE169246_PacBlood_pre	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59121
1.68234116554541e-22	-0.445613978690982	0.968	1	3.32026852432043e-18	RPL37A	cDCs	GSE169246_PacBlood_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59122
3.26902811257456e-22	-0.646971449136488	0.951	0.992	6.45175388297716e-18	LGALS1	cDCs	GSE169246_PacBlood_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59123
3.73373022897801e-22	-0.508511053843726	0.535	0.845	7.36888997991101e-18	TMEM258	cDCs	GSE169246_PacBlood_pre	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59124
1.12278201170864e-21	-0.451313449787372	1	1	2.21592257830817e-17	TMSB4X	cDCs	GSE169246_PacBlood_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59125
1.70946109112688e-21	0.356452586639882	1	1	3.37379240944801e-17	EEF1A1	cDCs	GSE169246_PacBlood_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59126
1.74142245574715e-21	-0.543833201562569	0.789	0.93	3.43687135866258e-17	PSME1	cDCs	GSE169246_PacBlood_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59127
1.74872452073786e-21	-0.507174405071596	0.47	0.807	3.45128271412824e-17	SMDT1	cDCs	GSE169246_PacBlood_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59128
3.14702797755298e-21	-0.701604162743146	0.524	0.824	6.21097441649857e-17	LY6E	cDCs	GSE169246_PacBlood_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59129
9.26179848645095e-21	0.553600026542689	1	0.995	1.82790854928596e-16	VIM	cDCs	GSE169246_PacBlood_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59130
1.9185840460155e-20	-0.469749307489826	0.665	0.91	3.7865174732162e-16	UBL5	cDCs	GSE169246_PacBlood_pre	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59131
2.99684481427883e-20	-0.421990432094096	0.914	0.985	5.9145729254607e-16	ATP5MG	cDCs	GSE169246_PacBlood_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59132
3.60687410110994e-20	-0.360267034967168	0.989	1	7.11852672595058e-16	RPL14	cDCs	GSE169246_PacBlood_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59133
5.05629001423282e-20	0.377590350606633	0.4	0.127	9.97909397208989e-16	TAGAP	cDCs	GSE169246_PacBlood_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59134
1.42671899704437e-19	-0.710394672870941	0.297	0.647	2.81577261256676e-15	IFI6	cDCs	GSE169246_PacBlood_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59135
1.4692101747096e-19	0.58584946561754	0.784	0.47	2.89963320080687e-15	JUNB	cDCs	GSE169246_PacBlood_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59136
2.45644792711033e-19	-0.339874860809044	1	1	4.84804562894494e-15	B2M	cDCs	GSE169246_PacBlood_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59137
2.94653384197385e-19	0.500007625724397	0.681	0.371	5.8152791905196e-15	SFPQ	cDCs	GSE169246_PacBlood_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59138
6.02251595165176e-19	-0.400887199053749	0.957	0.998	1.18860374821799e-14	ATP5MC2	cDCs	GSE169246_PacBlood_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59139
1.0131501818951e-18	-0.557027108402821	0.286	0.619	1.99955319898818e-14	IFI30	cDCs	GSE169246_PacBlood_pre	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59140
1.19124268205983e-18	0.532860070361821	0.676	0.378	2.35103655731328e-14	ZFP36L1	cDCs	GSE169246_PacBlood_pre	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59141
1.31343959674055e-18	-0.440854249112271	0.822	0.937	2.59220438812715e-14	VAMP8	cDCs	GSE169246_PacBlood_pre	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59142
1.40693469542884e-18	-0.474912527570135	0.141	0.486	2.77672631489836e-14	BLOC1S1	cDCs	GSE169246_PacBlood_pre	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59143
1.47169983499816e-18	-0.506544466107676	0.881	0.947	2.90454679435237e-14	LST1	cDCs	GSE169246_PacBlood_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59144
1.89465168452914e-18	0.391978679099049	0.389	0.129	3.73928456458672e-14	FKBP5	cDCs	GSE169246_PacBlood_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59145
2.280859330643e-18	-0.363529437624452	0.978	1	4.50150397495703e-14	CFL1	cDCs	GSE169246_PacBlood_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59146
4.10197544122987e-18	0.415604540670005	0.535	0.237	8.09565873081128e-14	EWSR1	cDCs	GSE169246_PacBlood_pre	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59147
4.13924735397068e-18	-0.473168480900341	0.486	0.775	8.16921857779653e-14	ATP5MD	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59148
7.25120874137566e-18	-0.323936375040003	0.995	0.999	1.4310985571979e-13	RPL30	cDCs	GSE169246_PacBlood_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59149
8.97469304718353e-18	-0.563583271032238	0.081	0.413	1.77124541979214e-13	IFI44L	cDCs	GSE169246_PacBlood_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59150
9.70980473515144e-18	-0.378336655184572	0.973	0.999	1.91632706252949e-13	RPL35A	cDCs	GSE169246_PacBlood_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59151
2.33704259710492e-17	0.487269042940237	0.53	0.234	4.61238726964628e-13	CD68	cDCs	GSE169246_PacBlood_pre	ENSG00000129226	968	CD68 molecule	DKFZp686M18236|GP110|LAMP4|SCARD1	protein_coding	P34810	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59152
2.51517620113481e-17	0.465942058024976	0.486	0.211	4.96395175055966e-13	DDX3X	cDCs	GSE169246_PacBlood_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59153
3.71626510004385e-17	0.29640433754903	0.286	0.076	7.33442080144655e-13	CITED2	cDCs	GSE169246_PacBlood_pre	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59154
4.11421161028936e-17	-0.525366274146636	0.573	0.816	8.11980803406709e-13	BST2	cDCs	GSE169246_PacBlood_pre	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59155
5.17807409788773e-17	0.439411894351178	0.822	0.548	1.02194470395912e-12	HNRNPK	cDCs	GSE169246_PacBlood_pre	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59156
6.35465802922228e-17	0.4180874014219	0.778	0.488	1.25415530864731e-12	SYK	cDCs	GSE169246_PacBlood_pre	ENSG00000165025	6850	spleen associated tyrosine kinase	NA	protein_coding	P43405	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59157
7.95980681919071e-17	-0.441681600021155	0.946	0.985	1.57094747383548e-12	HLA-DMA	cDCs	GSE169246_PacBlood_pre	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59158
8.67478397951157e-17	0.662098825390176	0.973	0.93	1.7120553661964e-12	PSAP	cDCs	GSE169246_PacBlood_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59159
8.9538673635088e-17	0.545847168379813	0.73	0.441	1.7671352628621e-12	ZEB2	cDCs	GSE169246_PacBlood_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59160
9.53845157918778e-17	-0.407045701263335	0.659	0.878	1.8825088036685e-12	ELOB	cDCs	GSE169246_PacBlood_pre	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59161
1.38871565179021e-16	-0.465812376282264	0.438	0.729	2.74076921037316e-12	UQCRQ	cDCs	GSE169246_PacBlood_pre	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59162
1.58990072892028e-16	0.496524536053572	0.551	0.282	3.13782807859707e-12	ETS2	cDCs	GSE169246_PacBlood_pre	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59163
2.37001158820646e-16	0.454227515191527	0.551	0.261	4.67745487048428e-12	PLXDC2	cDCs	GSE169246_PacBlood_pre	ENSG00000120594	84898	plexin domain containing 2	FLJ14623|TEM7R	protein_coding	Q6UX71	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59164
2.66239351617757e-16	-0.412068354785947	0.827	0.955	5.25449984352805e-12	COX5B	cDCs	GSE169246_PacBlood_pre	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59165
4.04970714792224e-16	-0.622053585388519	0.243	0.572	7.99250202713933e-12	MX1	cDCs	GSE169246_PacBlood_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59166
4.16259151022815e-16	-0.441073395437211	0.708	0.898	8.21529060458628e-12	OST4	cDCs	GSE169246_PacBlood_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59167
6.83700205876755e-16	-0.419083276656055	0.632	0.867	1.34935072631836e-11	UQCR10	cDCs	GSE169246_PacBlood_pre	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59168
6.83779835161077e-16	-0.402333864287697	0.784	0.912	1.3495078826739e-11	ATP5MC3	cDCs	GSE169246_PacBlood_pre	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59169
6.99759184142582e-16	0.487825969145933	0.8	0.554	1.3810447258238e-11	HNRNPU	cDCs	GSE169246_PacBlood_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59170
7.32176597840341e-16	0.42643264039514	0.714	0.42	1.4450237334977e-11	LYN	cDCs	GSE169246_PacBlood_pre	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59171
7.5607514498538e-16	-0.428592293789333	0.395	0.682	1.49218990614315e-11	SNRPG	cDCs	GSE169246_PacBlood_pre	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59172
8.42201041124527e-16	-0.338349918555047	1	0.999	1.66216797476337e-11	RPL32	cDCs	GSE169246_PacBlood_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59173
1.13628989141619e-15	-0.445669010314118	0.546	0.778	2.242581729699e-11	RPS10	cDCs	GSE169246_PacBlood_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59174
1.2241260594468e-15	0.518853262475002	0.514	0.235	2.41593519092421e-11	HIST1H1E	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59175
1.22877962972699e-15	0.438647477678525	0.692	0.411	2.42511947722918e-11	WAS	cDCs	GSE169246_PacBlood_pre	ENSG00000015285	7454	WASP actin nucleation promoting factor	IMD2|THC|WASP|WASPA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59176
1.41627133480985e-15	0.455622348644368	0.373	0.138	2.79515310638073e-11	MAP3K8	cDCs	GSE169246_PacBlood_pre	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59177
1.78626466639775e-15	-0.32711962259435	0.968	0.998	3.52537194560261e-11	UBA52	cDCs	GSE169246_PacBlood_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59178
2.23444723974852e-15	-0.435617035396179	0.432	0.708	4.40990507236768e-11	DDT	cDCs	GSE169246_PacBlood_pre	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59179
2.87002780841497e-15	-0.349627367505298	0.957	0.996	5.66428688268779e-11	OAZ1	cDCs	GSE169246_PacBlood_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59180
3.00317427189436e-15	0.434769564403028	0.67	0.4	5.92706474301071e-11	SRSF5	cDCs	GSE169246_PacBlood_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59181
3.14954850900165e-15	-0.406613924693839	0.535	0.791	6.21594893736565e-11	PSMB3	cDCs	GSE169246_PacBlood_pre	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59182
3.28210766230152e-15	-0.408331228412413	0.968	0.995	6.47756768231828e-11	S100A11	cDCs	GSE169246_PacBlood_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59183
3.88115493176566e-15	-0.3360261199662	1	0.999	7.65984737333271e-11	RPS15A	cDCs	GSE169246_PacBlood_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59184
4.34771312912159e-15	-0.389907591961439	0.324	0.658	8.58064663163438e-11	NDUFA3	cDCs	GSE169246_PacBlood_pre	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59185
4.45886816439807e-15	-0.315280096083791	0.995	0.998	8.80002220925603e-11	RPS25	cDCs	GSE169246_PacBlood_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59186
4.89084477246853e-15	0.42650891494859	0.622	0.357	9.6525712429439e-11	MAN2B1	cDCs	GSE169246_PacBlood_pre	ENSG00000104774	4125	mannosidase alpha class 2B member 1	LAMAN|MANB	protein_coding	O00754	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59187
6.76648198133069e-15	-0.514159291872286	0.978	0.993	1.33543288383543e-10	S100A6	cDCs	GSE169246_PacBlood_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59188
7.05118186759487e-15	-0.356760473320751	0.935	0.993	1.39162125338852e-10	RPL27	cDCs	GSE169246_PacBlood_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59189
7.82582485943572e-15	0.513129717955426	0.951	0.823	1.54450479425823e-10	TXNIP	cDCs	GSE169246_PacBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59190
9.04141550934801e-15	0.333585964927367	0.422	0.173	1.78441376492492e-10	SRSF4	cDCs	GSE169246_PacBlood_pre	ENSG00000116350	6429	serine and arginine rich splicing factor 4	SFRS4|SRP75	protein_coding	Q08170	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59191
9.08351507210944e-15	-0.467297434828578	0.486	0.721	1.79272253463152e-10	CKLF	cDCs	GSE169246_PacBlood_pre	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59192
9.22891368115353e-15	-0.584137347114507	0.989	0.993	1.82141840411246e-10	HLA-DQB1	cDCs	GSE169246_PacBlood_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59193
9.47691961329718e-15	0.394059692208797	0.584	0.303	1.87036485488033e-10	FMNL1	cDCs	GSE169246_PacBlood_pre	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59194
1.10914466069068e-14	-0.350446362783931	1	1	2.18900790233913e-10	RPLP1	cDCs	GSE169246_PacBlood_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59195
1.17271532333368e-14	0.30704673718986	0.546	0.275	2.31447096213135e-10	BTG1	cDCs	GSE169246_PacBlood_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59196
1.22704696495635e-14	0.461226297605631	0.514	0.251	2.42169989003784e-10	IL10RA	cDCs	GSE169246_PacBlood_pre	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59197
1.25807493196793e-14	-0.423282733196649	1	1	2.4829366857319e-10	HLA-DRB1	cDCs	GSE169246_PacBlood_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59198
1.40921394841708e-14	-0.3873130868431	0.724	0.864	2.78122464859595e-10	NDUFB2	cDCs	GSE169246_PacBlood_pre	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59199
1.59369304015093e-14	0.359322349535587	0.389	0.157	3.14531258404187e-10	ARHGAP17	cDCs	GSE169246_PacBlood_pre	ENSG00000288353	55114	Rho GTPase activating protein 17	FLJ10308|FLJ13219|NADRIN|RICH1|WBP15	protein_coding	Q68EM7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59200
1.64221075126428e-14	0.533029082899126	0.757	0.548	3.24106713869519e-10	IQGAP1	cDCs	GSE169246_PacBlood_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59201
1.72498563902943e-14	0.30110955985721	0.422	0.168	3.40443165718848e-10	ARHGAP45	cDCs	GSE169246_PacBlood_pre	ENSG00000180448	23526	Rho GTPase activating protein 45	HA-1|HMHA1|KIAA0223	protein_coding	Q92619	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59202
1.89325193028943e-14	-0.33938942683281	1	1	3.73652200961921e-10	RPS18	cDCs	GSE169246_PacBlood_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59203
2.1099693116854e-14	0.423614185569049	0.616	0.345	4.1642354335423e-10	LCP2	cDCs	GSE169246_PacBlood_pre	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59204
2.34046655235979e-14	0.467304397138579	0.665	0.436	4.61914478773727e-10	IL13RA1	cDCs	GSE169246_PacBlood_pre	ENSG00000131724	3597	interleukin 13 receptor subunit alpha 1	CD213a1|IL-13Ra|NR4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59205
3.20337310103782e-14	-0.400922244199609	0.757	0.901	6.32217715220823e-10	SUB1	cDCs	GSE169246_PacBlood_pre	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59206
4.45402283258285e-14	-0.372514786063265	0.476	0.762	8.79045946238551e-10	SEM1	cDCs	GSE169246_PacBlood_pre	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59207
5.41208514715461e-14	0.502768627345338	0.659	0.434	1.06812912464243e-09	CD44	cDCs	GSE169246_PacBlood_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59208
5.45010408330575e-14	0.293256660519091	0.768	0.525	1.07563254188122e-09	PNRC1	cDCs	GSE169246_PacBlood_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59209
6.52913807367247e-14	0.327924932077827	0.346	0.126	1.28859069022e-09	CD55	cDCs	GSE169246_PacBlood_pre	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59210
7.38995274997725e-14	-0.257030594233458	1	1	1.45848107473551e-09	RPL11	cDCs	GSE169246_PacBlood_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59211
7.92534934033699e-14	-0.446036329125672	0.443	0.681	1.56414694580891e-09	ATP5ME	cDCs	GSE169246_PacBlood_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59212
8.32644579169226e-14	0.392860976879981	0.616	0.342	1.64330734144838e-09	HNRNPDL	cDCs	GSE169246_PacBlood_pre	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59213
8.48002156765739e-14	-0.40289850919485	0.568	0.803	1.67361705659286e-09	COX7B	cDCs	GSE169246_PacBlood_pre	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59214
8.61311982836267e-14	0.306863316549998	0.373	0.145	1.69988532932566e-09	RAD23B	cDCs	GSE169246_PacBlood_pre	ENSG00000119318	5887	RAD23 homolog B, nucleotide excision repair protein	HHR23B|HR23B|P58	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59215
8.68536322153251e-14	-0.395128269870188	0.459	0.731	1.71414328540166e-09	NDUFB4	cDCs	GSE169246_PacBlood_pre	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59216
9.15181288980523e-14	0.310297722282159	0.319	0.113	1.80620179193196e-09	GLUL	cDCs	GSE169246_PacBlood_pre	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59217
9.6916009778258e-14	0.307335016747396	0.384	0.153	1.9127343689837e-09	MICAL1	cDCs	GSE169246_PacBlood_pre	ENSG00000135596	64780	microtubule associated monooxygenase, calponin and LIM domain containing 1	DKFZp434B1517|FLJ11937|FLJ21739|MICAL|NICAL	protein_coding	Q8TDZ2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59218
9.96085401302271e-14	-0.405185372204713	0.757	0.91	1.96587414801016e-09	TOMM7	cDCs	GSE169246_PacBlood_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59219
1.722045354509e-13	-0.303865694707987	1	1	3.39862871165897e-09	RPS23	cDCs	GSE169246_PacBlood_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59220
2.32303019045638e-13	0.532804365341348	0.67	0.409	4.58473238388471e-09	ITGA4	cDCs	GSE169246_PacBlood_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59221
2.56531800205872e-13	0.37499558452721	0.676	0.41	5.06291160886309e-09	ARRB2	cDCs	GSE169246_PacBlood_pre	ENSG00000141480	409	arrestin beta 2	ARR2|BARR2|DKFZp686L0365	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59222
2.82496559203781e-13	-0.306873308314128	0.968	0.999	5.57535209244583e-09	H3F3A	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59223
3.36214791400737e-13	-0.396712191434891	0.6	0.801	6.63553512308495e-09	ATP5MPL	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59224
4.59679242522313e-13	0.358481042656165	0.416	0.183	9.07222953042037e-09	KLF4	cDCs	GSE169246_PacBlood_pre	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59225
4.80217289441991e-13	0.311696470285941	0.486	0.233	9.47756842442714e-09	OGFR	cDCs	GSE169246_PacBlood_pre	ENSG00000060491	11054	opioid growth factor receptor	7-60	protein_coding	Q9NZT2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59226
4.90231397079676e-13	0.522189419446919	0.551	0.312	9.67520685276449e-09	KLF6	cDCs	GSE169246_PacBlood_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59227
4.95520990041031e-13	0.302440984557933	0.357	0.141	9.77960225944979e-09	MAP2K1	cDCs	GSE169246_PacBlood_pre	ENSG00000169032	5604	mitogen-activated protein kinase kinase 1	MAPKK1|MEK1|PRKMK1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59228
5.25154396099144e-13	-0.374039221464608	0.584	0.784	1.03644471614127e-08	PARK7	cDCs	GSE169246_PacBlood_pre	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59229
5.30149995273094e-13	0.337530895076673	0.395	0.169	1.04630403067098e-08	ARHGAP4	cDCs	GSE169246_PacBlood_pre	ENSG00000089820	393	Rho GTPase activating protein 4	C1|KIAA0131|p115|RhoGAP4|SrGAP4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59230
5.4889742355545e-13	-0.343334136516761	0.919	0.976	1.08330395512904e-08	CLIC1	cDCs	GSE169246_PacBlood_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59231
5.50968752896417e-13	0.341633767282942	0.519	0.264	1.08739193071637e-08	NONO	cDCs	GSE169246_PacBlood_pre	ENSG00000147140	4841	non-POU domain containing octamer binding	NMT55|NRB54|P54|P54NRB|PPP1R114	protein_coding	Q15233	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59232
6.23509090052433e-13	-0.392987858752234	0.8	0.937	1.23055754012748e-08	CSTB	cDCs	GSE169246_PacBlood_pre	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59233
7.93268917416452e-13	0.303638386167949	0.411	0.178	1.56559553541311e-08	HECTD1	cDCs	GSE169246_PacBlood_pre	ENSG00000092148	25831	HECT domain E3 ubiquitin protein ligase 1	KIAA1131	protein_coding	Q9ULT8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59234
8.56669417685858e-13	-0.3257803292066	0.951	0.996	1.69072276274481e-08	RPS11	cDCs	GSE169246_PacBlood_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59235
9.31311509209274e-13	0.372208555128572	0.449	0.213	1.83803639457542e-08	NFKB1	cDCs	GSE169246_PacBlood_pre	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59236
9.94329787195008e-13	0.336382694985109	0.4	0.173	1.96240926800807e-08	SETX	cDCs	GSE169246_PacBlood_pre	ENSG00000107290	23064	senataxin	ALS4|AOA2|KIAA0625|SCAR1|Sen1|STEX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59237
1.20864501094292e-12	0.309065904826512	0.454	0.209	2.38538179359696e-08	ASAH1	cDCs	GSE169246_PacBlood_pre	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59238
1.28386697565296e-12	0.316227850538822	0.27	0.091	2.53383986314868e-08	NSF	cDCs	GSE169246_PacBlood_pre	ENSG00000278174	4905	N-ethylmaleimide sensitive factor, vesicle fusing ATPase	SEC18|SKD2	protein_coding	P46459	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59239
1.40983750369025e-12	0.517525545601814	0.773	0.607	2.78245529728308e-08	CEBPD	cDCs	GSE169246_PacBlood_pre	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59240
1.43817476424845e-12	0.383134216841925	0.914	0.737	2.83838171472073e-08	TKT	cDCs	GSE169246_PacBlood_pre	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59241
1.61906719116618e-12	0.399858470690706	0.632	0.386	3.19539100848557e-08	EIF4G2	cDCs	GSE169246_PacBlood_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59242
1.62005742605973e-12	-0.361164955188221	0.822	0.938	3.19734533607148e-08	GNG5	cDCs	GSE169246_PacBlood_pre	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59243
1.73734187882109e-12	0.2831980494747	0.324	0.12	3.4288179320413e-08	OGT	cDCs	GSE169246_PacBlood_pre	ENSG00000147162	8473	O-linked N-acetylglucosamine (GlcNAc) transferase	FLJ23071|HRNT1|MGC22921|O-GLCNAC|OGT1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59244
2.14713789113848e-12	-0.310875696777932	0.984	1	4.23759134195091e-08	RPS12	cDCs	GSE169246_PacBlood_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59245
2.18077347953253e-12	-0.361083965285669	0.649	0.811	4.30397453920539e-08	NDUFB11	cDCs	GSE169246_PacBlood_pre	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59246
2.21797698016743e-12	-0.358782766388241	0.968	0.992	4.37739936805844e-08	GSTP1	cDCs	GSE169246_PacBlood_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59247
2.56656206433064e-12	0.311903023404558	0.492	0.241	5.06536689016295e-08	HNRNPA0	cDCs	GSE169246_PacBlood_pre	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59248
2.73669588747679e-12	-0.337739480527405	0.849	0.933	5.40114300352419e-08	COX8A	cDCs	GSE169246_PacBlood_pre	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59249
3.1128566042198e-12	0.330318928943349	0.508	0.255	6.14353379408819e-08	TNFRSF1B	cDCs	GSE169246_PacBlood_pre	ENSG00000028137	7133	TNF receptor superfamily member 1B	CD120b|p75|TNF-R-II|TNF-R75|TNFBR|TNFR2|TNFR80	protein_coding	P20333	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59250
3.23461364171047e-12	0.273498567804104	1	0.998	6.38383348327979e-08	RPL3	cDCs	GSE169246_PacBlood_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59251
3.24125465652561e-12	-0.313719671304305	0.951	0.993	6.39694019011894e-08	RPL23A	cDCs	GSE169246_PacBlood_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59252
3.33423977877127e-12	0.34232126408705	0.368	0.156	6.58045562738298e-08	RANBP2	cDCs	GSE169246_PacBlood_pre	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59253
3.39903661131177e-12	0.332787650133116	0.897	0.766	6.70833865608491e-08	RNASET2	cDCs	GSE169246_PacBlood_pre	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59254
3.4154046941087e-12	0.339678113503505	0.557	0.305	6.74064270429292e-08	ARF6	cDCs	GSE169246_PacBlood_pre	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59255
3.66032708699652e-12	-0.37654118190668	0.492	0.738	7.22402153889634e-08	MZT2B	cDCs	GSE169246_PacBlood_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59256
4.28913216391946e-12	-0.381035812651379	0.389	0.631	8.46503123871145e-08	ROMO1	cDCs	GSE169246_PacBlood_pre	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59257
4.97083823208747e-12	-0.378331643555897	0.508	0.743	9.81044633484783e-08	PSMB8	cDCs	GSE169246_PacBlood_pre	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59258
5.00166086981749e-12	0.259962341580969	0.308	0.113	9.8712778926718e-08	ARHGEF1	cDCs	GSE169246_PacBlood_pre	ENSG00000076928	9138	Rho guanine nucleotide exchange factor 1	LBCL2|P115-RHOGEF|SUB1.5	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59259
5.93777082570199e-12	-0.343115818145751	0.741	0.892	1.17187845016055e-07	COX5A	cDCs	GSE169246_PacBlood_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59260
6.84020808611879e-12	0.292837443034626	0.254	0.084	1.34998346787641e-07	ZC3HAV1	cDCs	GSE169246_PacBlood_pre	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59261
7.05773210507686e-12	-0.306589284847483	1	1	1.39291400825797e-07	RPS14	cDCs	GSE169246_PacBlood_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59262
7.62239941257007e-12	0.292110106801585	1	0.994	1.50435674806483e-07	COTL1	cDCs	GSE169246_PacBlood_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59263
7.98880671300424e-12	0.281147036587233	0.286	0.102	1.57667089287852e-07	GPRIN3	cDCs	GSE169246_PacBlood_pre	ENSG00000185477	285513	GPRIN family member 3	FLJ42625|GRIN3	protein_coding	Q6ZVF9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59264
8.79317237669583e-12	0.296483376339434	0.465	0.228	1.73542050026469e-07	GGNBP2	cDCs	GSE169246_PacBlood_pre	ENSG00000275099	79893	gametogenetin binding protein 2	DIF-3|DIF3|FLJ21230|FLJ22561|LZK1|ZFP403|ZNF403	protein_coding	Q9H3C7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59265
1.01962218306877e-11	0.304592428247204	0.411	0.188	2.01232634050453e-07	STK10	cDCs	GSE169246_PacBlood_pre	ENSG00000072786	6793	serine/threonine kinase 10	LOK|PRO2729	protein_coding	O94804	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59266
1.05989947462824e-11	0.374151688884626	0.611	0.368	2.09181760312629e-07	CAPZA1	cDCs	GSE169246_PacBlood_pre	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59267
1.13163884318479e-11	0.407144023735318	0.692	0.464	2.23340242090949e-07	POU2F2	cDCs	GSE169246_PacBlood_pre	ENSG00000028277	5452	POU class 2 homeobox 2	OCT2|OTF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59268
1.45055944911604e-11	-0.361936426961336	0.951	0.974	2.86282412877543e-07	FCER1G	cDCs	GSE169246_PacBlood_pre	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59269
1.48624233781291e-11	0.283530812719374	0.314	0.121	2.93324787790757e-07	PPP1R15A	cDCs	GSE169246_PacBlood_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59270
2.19864797081952e-11	0.431423536523037	0.481	0.257	4.3392516352094e-07	DPYD	cDCs	GSE169246_PacBlood_pre	ENSG00000188641	1806	dihydropyrimidine dehydrogenase	DHPDHase|DPD	protein_coding	Q12882	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59271
2.26614159080716e-11	0.283530812719374	0.27	0.096	4.472457043617e-07	FRYL	cDCs	GSE169246_PacBlood_pre	ENSG00000075539	285527	FRY like transcription coactivator	AF4p12|DKFZp686E205|KIAA0826|MOR2	protein_coding	O94915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59272
2.47483745472532e-11	0.342686894535792	0.924	0.831	4.88433920064589e-07	H2AFY	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59273
2.96720615221607e-11	0.447134732899455	0.551	0.331	5.85607806201363e-07	AHR	cDCs	GSE169246_PacBlood_pre	ENSG00000106546	196	aryl hydrocarbon receptor	bHLHe76	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59274
3.10125655748619e-11	0.300604326078316	0.319	0.13	6.12063994185474e-07	CYTH1	cDCs	GSE169246_PacBlood_pre	ENSG00000108669	9267	cytohesin 1	B2-1|cytohesin-1|D17S811E|PSCD1	protein_coding	Q15438	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59275
3.12009248651043e-11	-0.338995100958265	0.422	0.66	6.15781453137698e-07	TBCA	cDCs	GSE169246_PacBlood_pre	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59276
3.50959669567881e-11	0.391307915832849	0.768	0.588	6.92654003859171e-07	MSN	cDCs	GSE169246_PacBlood_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59277
3.53907411813546e-11	0.420687992681572	0.843	0.737	6.98471667955214e-07	LRRFIP1	cDCs	GSE169246_PacBlood_pre	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59278
3.68468010227149e-11	0.340922800081899	0.357	0.161	7.272084649843e-07	TET2	cDCs	GSE169246_PacBlood_pre	ENSG00000168769	54790	tet methylcytosine dioxygenase 2	FLJ20032|KIAA1546	protein_coding	Q6N021	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59279
3.79345927034845e-11	-0.349663773488349	0.724	0.862	7.48677121595971e-07	NDUFA4	cDCs	GSE169246_PacBlood_pre	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59280
4.26476868043208e-11	-0.317919810790352	0.93	0.993	8.41694746770075e-07	RPL31	cDCs	GSE169246_PacBlood_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59281
4.3546182047774e-11	-0.339195176462279	0.595	0.78	8.59427448894867e-07	COX7A2	cDCs	GSE169246_PacBlood_pre	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59282
5.11967176600235e-11	0.297185615850851	0.373	0.162	1.01041841973822e-06	F13A1	cDCs	GSE169246_PacBlood_pre	ENSG00000124491	2162	coagulation factor XIII A chain	F13A	protein_coding	P00488	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59283
5.25626551473832e-11	0.288825112388887	0.395	0.18	1.03737656198876e-06	CEBPB	cDCs	GSE169246_PacBlood_pre	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59284
5.28628511725687e-11	-0.34277799440626	0.238	0.491	1.04330123074182e-06	NDUFA11	cDCs	GSE169246_PacBlood_pre	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59285
6.08513002200854e-11	0.275955864158393	0.319	0.129	1.20096126114361e-06	FOXP1	cDCs	GSE169246_PacBlood_pre	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59286
6.19832528323791e-11	-0.292360897323202	0.995	0.999	1.22330147789983e-06	RPLP2	cDCs	GSE169246_PacBlood_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59287
6.57018385484484e-11	-0.312702800336803	0.816	0.933	1.29669148559218e-06	SRP14	cDCs	GSE169246_PacBlood_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59288
7.34953116014322e-11	0.278860813133552	0.308	0.124	1.45050346976587e-06	IRAK3	cDCs	GSE169246_PacBlood_pre	ENSG00000090376	11213	interleukin 1 receptor associated kinase 3	IRAK-M	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59289
7.54071967827254e-11	0.374411014527448	0.497	0.284	1.48823643570387e-06	RIN3	cDCs	GSE169246_PacBlood_pre	ENSG00000100599	79890	Ras and Rab interactor 3	FLJ22439	protein_coding	Q8TB24	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59290
8.29313480464832e-11	0.362662379377759	0.843	0.683	1.63673308504539e-06	ZYX	cDCs	GSE169246_PacBlood_pre	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59291
9.27530252158996e-11	0.353973853265179	0.519	0.293	1.83057370566099e-06	VCP	cDCs	GSE169246_PacBlood_pre	ENSG00000165280	7415	valosin containing protein	CDC48|IBMPFD|p97|TERA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59292
9.60462383436708e-11	0.309537450848323	0.362	0.166	1.89556855995069e-06	WNK1	cDCs	GSE169246_PacBlood_pre	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59293
1.03163149391419e-10	0.41636516173102	0.492	0.277	2.03602791638904e-06	MAT2A	cDCs	GSE169246_PacBlood_pre	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59294
1.04058013635693e-10	0.316750609185726	0.303	0.123	2.05368895711404e-06	TTC7A	cDCs	GSE169246_PacBlood_pre	ENSG00000068724	57217	tetratricopeptide repeat domain 7A	KIAA1140|TTC7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59295
1.10607435573933e-10	0.481520111438605	0.589	0.358	2.18294834848714e-06	FCGR2B	cDCs	GSE169246_PacBlood_pre	ENSG00000072694	2213	Fc gamma receptor IIb	CD32|CD32B|FCG2|FcgammaRIIb|FCGR2|FcGRIIB	protein_coding	P31994	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59296
1.14079605170615e-10	-0.368624766639748	0.827	0.908	2.25147508764725e-06	PYCARD	cDCs	GSE169246_PacBlood_pre	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59297
1.25139363564126e-10	0.654387147438086	0.514	0.299	2.4697504793016e-06	NEAT1	cDCs	GSE169246_PacBlood_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59298
1.32785428458375e-10	0.44954592592255	0.649	0.446	2.62065321605449e-06	RSRP1	cDCs	GSE169246_PacBlood_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59299
1.39090290508168e-10	-0.578833056789397	0.724	0.825	2.74508597346921e-06	LGALS2	cDCs	GSE169246_PacBlood_pre	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59300
1.39663252069545e-10	0.35007574748084	0.427	0.218	2.75639394284453e-06	ELMO1	cDCs	GSE169246_PacBlood_pre	ENSG00000155849	9844	engulfment and cell motility 1	CED-12|CED12|ELMO-1|KIAA0281	protein_coding	Q92556	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59301
1.45627280463416e-10	0.331027246652069	0.676	0.435	2.87410000722597e-06	SRSF2	cDCs	GSE169246_PacBlood_pre	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59302
1.465630050148e-10	-0.344122640803823	0.849	0.911	2.8925674669721e-06	PPIB	cDCs	GSE169246_PacBlood_pre	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59303
1.62661202818529e-10	-0.314572787689849	0.486	0.731	3.2102814988265e-06	C8orf59	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59304
1.67535295993774e-10	0.350829202008214	0.681	0.473	3.30647660173313e-06	CSDE1	cDCs	GSE169246_PacBlood_pre	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59305
1.70044333461226e-10	0.257211730564935	0.373	0.167	3.35599496519076e-06	KCNAB2	cDCs	GSE169246_PacBlood_pre	ENSG00000069424	8514	potassium voltage-gated channel subfamily A regulatory beta subunit 2	AKR6A5|HKvbeta2.1|HKvbeta2.2|KCNA2B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59306
1.83767367971755e-10	0.260274241926123	0.346	0.15	3.62683277429056e-06	PHF20L1	cDCs	GSE169246_PacBlood_pre	ENSG00000129292	51105	PHD finger protein 20 like 1	CGI-72|FLJ13649|FLJ21615|MGC64923|TDRD20B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59307
1.91248329809597e-10	0.32542333840729	0.973	0.925	3.77447703712222e-06	EEF1G	cDCs	GSE169246_PacBlood_pre	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59308
1.94557402349975e-10	0.290347874389719	0.459	0.236	3.8397848927791e-06	ADAM8	cDCs	GSE169246_PacBlood_pre	ENSG00000151651	101	ADAM metallopeptidase domain 8	CD156|CD156A|MS2	protein_coding	P78325	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59309
2.01554269515767e-10	0.348499016182627	0.632	0.413	3.97787506316318e-06	NCOA4	cDCs	GSE169246_PacBlood_pre	ENSG00000266412	8031	nuclear receptor coactivator 4	ARA70|DKFZp762E1112|ELE1|PTC3|RFG	protein_coding	Q13772	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59310
2.12522045713207e-10	-0.318791671706714	0.665	0.825	4.19433509419585e-06	SEC61B	cDCs	GSE169246_PacBlood_pre	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59311
2.14739901804441e-10	0.548734308828372	0.546	0.304	4.23810670201245e-06	VCAN	cDCs	GSE169246_PacBlood_pre	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59312
2.22709608191935e-10	0.30664603774627	0.973	0.96	4.39539682727603e-06	ITGB2	cDCs	GSE169246_PacBlood_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59313
2.84104012126801e-10	0.355236468294143	0.67	0.452	5.60707678333454e-06	MYH9	cDCs	GSE169246_PacBlood_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59314
2.86601099707221e-10	0.301989756761823	0.978	0.953	5.65635930382171e-06	GRN	cDCs	GSE169246_PacBlood_pre	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59315
3.47017385703828e-10	0.310650748279075	0.757	0.52	6.84873512425075e-06	NCF2	cDCs	GSE169246_PacBlood_pre	ENSG00000116701	4688	neutrophil cytosolic factor 2	NOXA2|p67phox	protein_coding	P19878	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59316
3.47266756758429e-10	0.289674765920056	0.346	0.158	6.85365671138435e-06	MATR3.1	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59317
3.51386690876725e-10	-0.270340000053499	1	1	6.93496773114304e-06	RPL10	cDCs	GSE169246_PacBlood_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59318
3.56453710638031e-10	0.259438582257414	0.33	0.14	7.03497043315217e-06	SRGAP2	cDCs	GSE169246_PacBlood_pre	ENSG00000266028	23380	SLIT-ROBO Rho GTPase activating protein 2	ARHGAP34|FNBP2|KIAA0456|SRGAP2A	protein_coding	O75044	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59319
3.65173154783786e-10	0.26924015516898	0.351	0.158	7.2070573828128e-06	PRRC2A	cDCs	GSE169246_PacBlood_pre	ENSG00000231370	7916	proline rich coiled-coil 2A	BAT2|D6S51E|G2	protein_coding	P48634	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59320
3.85140931963625e-10	0.313849746866105	0.481	0.264	7.60114143323411e-06	RTN1	cDCs	GSE169246_PacBlood_pre	ENSG00000139970	6252	reticulon 1	NSP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59321
4.05495969210946e-10	0.334499639936029	0.395	0.196	8.00286844834724e-06	SLC38A1	cDCs	GSE169246_PacBlood_pre	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59322
4.32306137349441e-10	0.320858599694282	0.492	0.273	8.53199392672856e-06	LILRB3	cDCs	GSE169246_PacBlood_pre	ENSG00000277816	11025	leukocyte immunoglobulin like receptor B3	CD85a|HL9|ILT5|LIR-3|LIR3|PIR-B|PIRB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59323
4.63315599599384e-10	0.378225223200789	0.432	0.231	9.14399667369345e-06	WDFY2	cDCs	GSE169246_PacBlood_pre	ENSG00000139668	115825	WD repeat and FYVE domain containing 2	ZFYVE22	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59324
4.81284157463046e-10	0.294949463215092	0.465	0.248	9.49862413169067e-06	TCIRG1	cDCs	GSE169246_PacBlood_pre	ENSG00000110719	10312	T cell immune regulator 1, ATPase H+ transporting V0 subunit a3	a3|Atp6i|ATP6N1C|ATP6V0A3|OC-116|OC116|TIRC7	protein_coding	Q13488	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59325
4.84386031634794e-10	-0.268487589386867	0.951	0.994	9.55984272034429e-06	RPL21	cDCs	GSE169246_PacBlood_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59326
5.3079374813034e-10	-0.320137120782832	0.53	0.721	1.04757454131004e-05	RBX1	cDCs	GSE169246_PacBlood_pre	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59327
5.37780199478666e-10	0.269990335286237	0.357	0.165	1.06136300169109e-05	MAP3K11	cDCs	GSE169246_PacBlood_pre	ENSG00000173327	4296	mitogen-activated protein kinase kinase kinase 11	MEKK11|MLK3|PTK1|SPRK	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59328
5.9080575190012e-10	-0.337351262256725	0.33	0.561	1.16601423195008e-05	C4orf48	cDCs	GSE169246_PacBlood_pre	ENSG00000243449	401115	chromosome 4 open reading frame 48	NA	protein_coding	Q5BLP8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59329
5.9632737828431e-10	0.327128905710616	0.762	0.58	1.17691171378191e-05	YWHAZ	cDCs	GSE169246_PacBlood_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59330
6.14358748812443e-10	-0.330721093013441	0.384	0.604	1.21249842665624e-05	NDUFA2	cDCs	GSE169246_PacBlood_pre	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59331
6.27845582822424e-10	0.334123852140998	0.686	0.457	1.23911604225834e-05	TPP1	cDCs	GSE169246_PacBlood_pre	ENSG00000166340	1200	tripeptidyl peptidase 1	CLN2|LPIC|SCAR7|TPP-1	protein_coding	O14773	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59332
6.82840104081082e-10	-0.3326977089143	0.676	0.838	1.34765322941442e-05	RGS10	cDCs	GSE169246_PacBlood_pre	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59333
6.83507255732725e-10	-0.316307503583318	0.903	0.991	1.34896991991411e-05	RPL27A	cDCs	GSE169246_PacBlood_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59334
7.08952069891141e-10	-0.331727726897298	0.281	0.518	1.39918780513716e-05	TMEM256	cDCs	GSE169246_PacBlood_pre	ENSG00000283771	254863	transmembrane protein 256	C17orf61|MGC40107	protein_coding	Q8N2U0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59335
8.19949668156365e-10	-0.332972821746151	0.719	0.915	1.6182526650734e-05	UQCRH	cDCs	GSE169246_PacBlood_pre	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59336
8.36684522564651e-10	-0.290644437490272	0.778	0.892	1.6512805737336e-05	CTSZ	cDCs	GSE169246_PacBlood_pre	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59337
8.38066397028717e-10	0.337019221293275	0.859	0.829	1.65400784117588e-05	EIF3L	cDCs	GSE169246_PacBlood_pre	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59338
8.60162315503446e-10	0.393976971970552	0.541	0.334	1.6976163458776e-05	CSF1R	cDCs	GSE169246_PacBlood_pre	ENSG00000182578	1436	colony stimulating factor 1 receptor	C-FMS|CD115|CSFR|FMS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59339
8.69462843346767e-10	0.278294164353227	0.389	0.187	1.71597186762918e-05	ADGRE5	cDCs	GSE169246_PacBlood_pre	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59340
9.6563019897895e-10	0.26368062982708	0.346	0.158	1.90576776070486e-05	OPN3	cDCs	GSE169246_PacBlood_pre	ENSG00000054277	23596	opsin 3	ECPN|encephalopsin|ERO|NMO-1|PPP1R116	protein_coding	Q9H1Y3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59341
9.70709652292212e-10	0.261908538459368	0.351	0.162	1.91579256976391e-05	CDC42SE2	cDCs	GSE169246_PacBlood_pre	ENSG00000158985	56990	CDC42 small effector 2	FLJ21967|SPEC2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59342
9.9322727891314e-10	-0.251808652777112	0.973	0.985	1.96023335766297e-05	ARPC3	cDCs	GSE169246_PacBlood_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59343
1.08988531455696e-09	0.27406447623328	0.416	0.21	2.15099765680962e-05	HOOK3	cDCs	GSE169246_PacBlood_pre	ENSG00000168172	84376	hook microtubule tethering protein 3	HK3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59344
1.21172033121582e-09	-0.328100266461018	0.595	0.768	2.39145124568754e-05	POLR2L	cDCs	GSE169246_PacBlood_pre	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59345
1.23184060640306e-09	0.377833399450176	0.611	0.387	2.43116062079709e-05	APLP2	cDCs	GSE169246_PacBlood_pre	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59346
1.26128845486686e-09	0.331585269411478	0.541	0.335	2.48927889452524e-05	EVI2B	cDCs	GSE169246_PacBlood_pre	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59347
1.38540330021427e-09	0.361715840381703	0.8	0.624	2.73423195330287e-05	NCL	cDCs	GSE169246_PacBlood_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59348
1.42336932082888e-09	0.261871931589601	0.254	0.098	2.80916169158787e-05	SSH2	cDCs	GSE169246_PacBlood_pre	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59349
1.49729785762559e-09	0.328053131752759	0.573	0.355	2.95506705180986e-05	IL6R	cDCs	GSE169246_PacBlood_pre	ENSG00000160712	3570	interleukin 6 receptor	CD126|gp80|IL-1Ra|IL-6R|IL6RA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59350
1.62927352931307e-09	0.280391105188807	0.378	0.186	3.21553423745228e-05	GLG1	cDCs	GSE169246_PacBlood_pre	ENSG00000090863	2734	golgi glycoprotein 1	CFR-1|ESL-1|MG-160	protein_coding	Q92896	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59351
1.64744805243495e-09	-0.286207487558634	0.07	0.277	3.25140347628563e-05	MRPL23	cDCs	GSE169246_PacBlood_pre	ENSG00000288141	6150	mitochondrial ribosomal protein L23	L23MRP|RPL23L	protein_coding	Q16540	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59352
1.72828155061397e-09	0.297744671939075	0.449	0.245	3.41093646829173e-05	PRPF8	cDCs	GSE169246_PacBlood_pre	ENSG00000274442	10594	pre-mRNA processing factor 8	hPrp8|Prp8|PRPC8|RP13|SNRNP220	protein_coding	Q6P2Q9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59353
1.756721194477e-09	0.293116861548572	0.508	0.289	3.46706494941982e-05	HNRNPM	cDCs	GSE169246_PacBlood_pre	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59354
2.15190022692673e-09	0.264357492323674	0.432	0.228	4.2469902878626e-05	TNFRSF1A	cDCs	GSE169246_PacBlood_pre	ENSG00000067182	7132	TNF receptor superfamily member 1A	CD120a|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR60	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59355
2.32906178238357e-09	0.325785142808156	0.546	0.333	4.59663633371221e-05	FLT3	cDCs	GSE169246_PacBlood_pre	ENSG00000122025	2322	fms related receptor tyrosine kinase 3	CD135|FLK2|STK1	protein_coding	P36888	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59356
2.35911342573143e-09	-0.300136878595525	0.524	0.73	4.65594625702355e-05	ATP5PF	cDCs	GSE169246_PacBlood_pre	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59357
2.66399287852849e-09	0.297383746818405	0.395	0.202	5.25765634506383e-05	GIT2	cDCs	GSE169246_PacBlood_pre	ENSG00000139436	9815	GIT ArfGAP 2	KIAA0148|PKL	protein_coding	Q14161	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59358
2.89856974011428e-09	-0.312300404336575	0.508	0.698	5.72061723908955e-05	LSM7	cDCs	GSE169246_PacBlood_pre	ENSG00000130332	51690	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	YNL147W	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59359
2.98709467514006e-09	0.309432676162131	0.4	0.205	5.89533005085641e-05	NIN	cDCs	GSE169246_PacBlood_pre	ENSG00000100503	51199	ninein	NA	protein_coding	Q8N4C6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59360
3.04611406001389e-09	0.265459239797356	0.443	0.236	6.01181070884341e-05	HNRNPUL1	cDCs	GSE169246_PacBlood_pre	ENSG00000105323	11100	heterogeneous nuclear ribonucleoprotein U like 1	E1B-AP5|E1BAP5|FLJ12944|HNRPUL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59361
3.55474974917109e-09	-0.343920695102271	0.351	0.569	7.01565410496406e-05	UBE2L6	cDCs	GSE169246_PacBlood_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59362
3.89831418724079e-09	0.300964055550542	0.708	0.533	7.69371287993842e-05	DAZAP2	cDCs	GSE169246_PacBlood_pre	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59363
4.11648943404548e-09	0.25510849224029	0.405	0.206	8.12430354703216e-05	ANKRD11	cDCs	GSE169246_PacBlood_pre	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59364
4.22999096433237e-09	-0.277634473250442	0.876	0.947	8.34831016720638e-05	HIGD2A	cDCs	GSE169246_PacBlood_pre	ENSG00000146066	192286	HIG1 hypoxia inducible domain family member 2A	MGC2198|RCF1B	protein_coding	Q9BW72	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59365
4.2319720576741e-09	0.344521442608522	0.595	0.382	8.3522200530256e-05	CLEC12A	cDCs	GSE169246_PacBlood_pre	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59366
4.41152408326763e-09	-0.391886638947285	0.551	0.719	8.70658393073699e-05	PPA1	cDCs	GSE169246_PacBlood_pre	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59367
4.50766503226667e-09	-0.270158787599099	0.859	0.926	8.8963277076815e-05	AP2S1	cDCs	GSE169246_PacBlood_pre	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59368
4.83588384422921e-09	0.252461265150497	0.314	0.141	9.54410035497077e-05	TNKS2	cDCs	GSE169246_PacBlood_pre	ENSG00000107854	80351	tankyrase 2	ARTD6|PARP-5b|PARP-5c|PARP5B|PARP5C|pART6|TANK2|TNKL	protein_coding	Q9H2K2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59369
5.00287951326062e-09	-0.312078932201291	0.405	0.62	9.87368300737117e-05	NDUFA13	cDCs	GSE169246_PacBlood_pre	ENSG00000186010	51079	NADH:ubiquinone oxidoreductase subunit A13	B16.6|CDA016|CGI-39|GRIM-19|GRIM19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59370
5.18529865723849e-09	0.25115388396371	0.314	0.139	0.000102337054299259	TGFBR2	cDCs	GSE169246_PacBlood_pre	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59371
5.58011368287592e-09	-0.295111591977718	0.573	0.75	0.000110129123645239	ATP5PD	cDCs	GSE169246_PacBlood_pre	ENSG00000167863	10476	ATP synthase peripheral stalk subunit d	ATP5H|ATP5JD|ATPQ	protein_coding	O75947	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59372
6.02298916561014e-09	0.279071164528674	0.351	0.169	0.000118869714172482	DUSP22	cDCs	GSE169246_PacBlood_pre	ENSG00000112679	56940	dual specificity phosphatase 22	JKAP|JSP1|MKPX|VHX	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59373
6.86649130801568e-09	0.41905826716246	0.676	0.517	0.000135517072454997	RBM39	cDCs	GSE169246_PacBlood_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59374
7.68805714725123e-09	0.264494032669035	0.259	0.107	0.00015173149585815	GAS7	cDCs	GSE169246_PacBlood_pre	ENSG00000007237	8522	growth arrest specific 7	KIAA0394|MGC1348	protein_coding	O60861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59375
8.3072272914444e-09	0.409086825141788	0.4	0.22	0.000163951437823947	EMILIN2	cDCs	GSE169246_PacBlood_pre	ENSG00000132205	84034	elastin microfibril interfacer 2	FLJ33200|FOAP-10	protein_coding	Q9BXX0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59376
8.64002573882679e-09	0.412559258883298	0.941	0.763	0.000170519547981486	FCER1A	cDCs	GSE169246_PacBlood_pre	ENSG00000179639	2205	Fc epsilon receptor Ia	FCE1A|FcepsilonRIalpha|FCERIA	protein_coding	P12319	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59377
8.73871953898004e-09	-0.277512156019673	0.443	0.678	0.00017246736882131	NEDD8	cDCs	GSE169246_PacBlood_pre	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59378
8.84346689338204e-09	0.40617148674301	0.638	0.462	0.000174534662607788	CANX	cDCs	GSE169246_PacBlood_pre	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59379
8.92398022136696e-09	-0.269334373882464	1	1	0.000176123673648898	RPL26	cDCs	GSE169246_PacBlood_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59380
9.04436162116486e-09	-0.331842679385335	1	1	0.00017849952095531	HLA-DRA	cDCs	GSE169246_PacBlood_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59381
9.86174593852218e-09	-0.268253217391882	0.973	0.96	0.000194631417842674	TYROBP	cDCs	GSE169246_PacBlood_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59382
9.86788496960249e-09	-0.291478213972358	0.514	0.71	0.000194752577760075	UBB	cDCs	GSE169246_PacBlood_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59383
1.01035845156149e-08	-0.300201244395522	0.232	0.452	0.000199404344000176	HSD17B10	cDCs	GSE169246_PacBlood_pre	ENSG00000072506	3028	hydroxysteroid 17-beta dehydrogenase 10	17b-HSD10|ABAD|CAMR|ERAB|HADH2|MHBD|MRPP2|MRXS10|SDR5C1	protein_coding	Q99714	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59384
1.05242925117781e-08	-0.297841404006463	0.476	0.662	0.000207707437012453	SMIM26	cDCs	GSE169246_PacBlood_pre	ENSG00000232388	388789	small integral membrane protein 26	LINC00493|LOC388789	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59385
1.05828467195136e-08	-0.298980783444328	0.924	0.953	0.00020886306285632	MYL12A	cDCs	GSE169246_PacBlood_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59386
1.08793453442884e-08	0.310742772867899	0.6	0.408	0.000214714759714875	RTN4	cDCs	GSE169246_PacBlood_pre	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59387
1.09617069929846e-08	0.288957885103702	0.405	0.213	0.000216340249213544	PID1	cDCs	GSE169246_PacBlood_pre	ENSG00000153823	55022	phosphotyrosine interaction domain containing 1	FLJ20701|NYGGF4	protein_coding	Q7Z2X4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59388
1.15218405512321e-08	-0.279494744281807	0.897	0.96	0.000227395045119117	EIF3K	cDCs	GSE169246_PacBlood_pre	ENSG00000282986	27335	eukaryotic translation initiation factor 3 subunit K	ARG134|EIF3S12|HSPC029|M9|PLAC-24|PRO1474|PTD001	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59389
1.15587548865544e-08	0.318123752543915	0.411	0.229	0.000228123586441038	RASA4	cDCs	GSE169246_PacBlood_pre	ENSG00000105808	10156	RAS p21 protein activator 4	CAPRI|GAPL|KIAA0538	protein_coding	O43374	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59390
1.18924774924004e-08	-0.32427510866822	0.703	0.862	0.000234709935790013	NPC2	cDCs	GSE169246_PacBlood_pre	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59391
1.29580812055555e-08	-0.299254034696412	0.378	0.582	0.000255740690672842	MRPL52	cDCs	GSE169246_PacBlood_pre	ENSG00000172590	122704	mitochondrial ribosomal protein L52	NA	protein_coding	Q86TS9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59392
1.32356686444283e-08	-0.297903944850851	0.449	0.65	0.000261219156366436	NDUFS5	cDCs	GSE169246_PacBlood_pre	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59393
1.35958843126059e-08	0.47948609106058	0.492	0.307	0.00026832837279359	CELF2	cDCs	GSE169246_PacBlood_pre	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59394
1.38583356041844e-08	-0.336452853276438	0.243	0.461	0.000273508111484184	HIST1H4C	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59395
1.42519543841878e-08	-0.327152691305964	0.616	0.77	0.00028127657172633	DBI	cDCs	GSE169246_PacBlood_pre	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59396
1.49782758651658e-08	0.272794427981613	0.265	0.114	0.000295611252474912	UTRN	cDCs	GSE169246_PacBlood_pre	ENSG00000152818	7402	utrophin	DMDL|DRP|DRP1	protein_coding	P46939	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59397
1.55618981013662e-08	0.281447927901307	0.449	0.255	0.000307129620928562	PAPOLA	cDCs	GSE169246_PacBlood_pre	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59398
1.56492539876306e-08	-0.364211482332055	0.265	0.482	0.000308853676699877	EPSTI1	cDCs	GSE169246_PacBlood_pre	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59399
1.67157304484356e-08	0.3504766366292	0.622	0.446	0.000329901656130325	FYB1	cDCs	GSE169246_PacBlood_pre	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59400
1.69376569561308e-08	-0.29705844103651	0.519	0.695	0.000334281597686198	POMP	cDCs	GSE169246_PacBlood_pre	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59401
1.71599203819787e-08	-0.289633116683515	0.368	0.581	0.000338668188658732	ATP5MC1	cDCs	GSE169246_PacBlood_pre	ENSG00000159199	516	ATP synthase membrane subunit c locus 1	ATP5G|ATP5G1	protein_coding	P05496	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59402
1.75903937180895e-08	-0.300556531747534	0.714	0.854	0.000347164010420214	PGLS	cDCs	GSE169246_PacBlood_pre	ENSG00000130313	25796	6-phosphogluconolactonase	6PGL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59403
1.94743788333366e-08	-0.266239593611276	0.973	0.992	0.000384346340654732	RPS5	cDCs	GSE169246_PacBlood_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59404
2.04897807663501e-08	-0.307437920827146	0.724	0.817	0.000404386313204686	C20orf27	cDCs	GSE169246_PacBlood_pre	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59405
2.23114116467029e-08	0.281410760845005	0.578	0.378	0.000440338020259328	MGAT1	cDCs	GSE169246_PacBlood_pre	ENSG00000131446	4245	alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GLCNAC-TI|GLYT1|GNT-1|GnTI|MGAT	protein_coding	P26572	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59406
2.34195674629283e-08	0.320536228400188	0.427	0.245	0.000462208583448353	VCL	cDCs	GSE169246_PacBlood_pre	ENSG00000035403	7414	vinculin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59407
2.38200741149426e-08	0.255960411023473	0.281	0.126	0.000470112982732507	RCOR1	cDCs	GSE169246_PacBlood_pre	ENSG00000089902	23186	REST corepressor 1	COREST|KIAA0071|RCOR	protein_coding	Q9UKL0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59408
2.51517348422967e-08	-0.31697536488261	0.443	0.636	0.000496394638847568	NAA38	cDCs	GSE169246_PacBlood_pre	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59409
2.55451803907793e-08	-0.26471364549657	0.751	0.898	0.00050415968019242	RPL36AL	cDCs	GSE169246_PacBlood_pre	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59410
2.67570256376126e-08	-0.298933514146586	0.4	0.607	0.000528076657983922	TRMT112	cDCs	GSE169246_PacBlood_pre	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59411
2.73442286967974e-08	0.296623829242544	0.443	0.255	0.000539665697559994	ANKRD44	cDCs	GSE169246_PacBlood_pre	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59412
2.77163084705873e-08	-0.288142402842137	0.422	0.631	0.000547009063975512	C9orf16	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59413
2.78609591505947e-08	0.361827187998113	0.584	0.379	0.000549863889796136	AOAH	cDCs	GSE169246_PacBlood_pre	ENSG00000136250	313	acyloxyacyl hydrolase	NA	protein_coding	P28039	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59414
2.99504752622123e-08	-0.268416630773819	0.227	0.444	0.000591102579775022	NDUFC1	cDCs	GSE169246_PacBlood_pre	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59415
3.07135642995894e-08	0.313498409294316	0.411	0.23	0.000606162905016696	SULF2	cDCs	GSE169246_PacBlood_pre	ENSG00000196562	55959	sulfatase 2	HSULF-2|KIAA1247|SULF-2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59416
3.23026161566916e-08	-0.277995672419301	0.086	0.277	0.000637524432468464	AL034397.3	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59417
3.25382321951552e-08	0.486817270616786	0.93	0.845	0.000642174550603583	CTSS	cDCs	GSE169246_PacBlood_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59418
3.35477739061459e-08	0.275234671164283	0.508	0.313	0.000662098865811696	PRKCD	cDCs	GSE169246_PacBlood_pre	ENSG00000163932	5580	protein kinase C delta	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59419
3.40875947376365e-08	-0.295719744099399	0.395	0.587	0.000672752769741994	RNF181	cDCs	GSE169246_PacBlood_pre	ENSG00000168894	51255	ring finger protein 181	HSPC238	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59420
3.46762830242089e-08	0.335728324150516	0.903	0.89	0.000684371121765786	HNRNPA2B1	cDCs	GSE169246_PacBlood_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59421
3.51635318330845e-08	0.259962341580969	0.395	0.21	0.000693987464257756	KMT2C	cDCs	GSE169246_PacBlood_pre	ENSG00000055609	58508	lysine methyltransferase 2C	HALR|KIAA1506|MLL3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59422
3.56401869676327e-08	-0.265787426949061	0.411	0.62	0.000703394729993199	SRSF9	cDCs	GSE169246_PacBlood_pre	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59423
3.76649424388377e-08	0.301024569320696	0.546	0.34	0.000743355303972901	AKAP13	cDCs	GSE169246_PacBlood_pre	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59424
3.79504924115927e-08	0.301686617982703	0.692	0.503	0.000748990918235194	PDIA3	cDCs	GSE169246_PacBlood_pre	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59425
4.01764939686079e-08	0.252088248700894	0.486	0.289	0.000792923284964446	APBB1IP	cDCs	GSE169246_PacBlood_pre	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59426
4.49997077222093e-08	0.271457980418799	0.476	0.277	0.000888114231605523	DYNC1H1	cDCs	GSE169246_PacBlood_pre	ENSG00000197102	1778	dynein cytoplasmic 1 heavy chain 1	CMT2O|DHC1|DNCH1|Dnchc1|DNCL|DNECL|HL-3|p22	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59427
5.35877071611471e-08	0.313860422780582	0.519	0.329	0.0010576069885324	CSF3R	cDCs	GSE169246_PacBlood_pre	ENSG00000119535	1441	colony stimulating factor 3 receptor	CD114|GCSFR	protein_coding	Q99062	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59428
5.48253599075589e-08	0.263232487533083	0.389	0.21	0.00108203330313558	CAPRIN1	cDCs	GSE169246_PacBlood_pre	ENSG00000135387	4076	cell cycle associated protein 1	caprin-1|GPIAP1|M11S1|RNG105	protein_coding	Q14444	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59429
5.57202471656006e-08	0.574085519347225	0.859	0.79	0.00109969479806029	PTPRC	cDCs	GSE169246_PacBlood_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59430
5.91236165189026e-08	0.291887108977206	0.368	0.199	0.00116686369561706	AKIRIN2	cDCs	GSE169246_PacBlood_pre	ENSG00000135334	55122	akirin 2	C6orf166|dJ486L4.2|FLJ10342	protein_coding	Q53H80	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59431
5.998918133627e-08	0.334630252750885	0.535	0.355	0.00118394648285263	SF1	cDCs	GSE169246_PacBlood_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59432
6.7370102154299e-08	-0.294360916302547	0.719	0.828	0.00132961633611724	LGALS9	cDCs	GSE169246_PacBlood_pre	ENSG00000168961	3965	galectin 9	LGALS9A	protein_coding	O00182	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59433
6.7408171889272e-08	-0.313607935595107	0.562	0.71	0.00133036768040667	PSMB10	cDCs	GSE169246_PacBlood_pre	ENSG00000205220	5699	proteasome 20S subunit beta 10	beta2i|LMP10|MECL1|MGC1665	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59434
6.84297476867936e-08	0.290262381856857	0.384	0.207	0.00135052950034656	IKZF1	cDCs	GSE169246_PacBlood_pre	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59435
6.99590147335868e-08	-0.250329483188274	0.93	0.984	0.00138071111478207	NME2	cDCs	GSE169246_PacBlood_pre	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59436
7.03544591652424e-08	0.294727759741646	0.616	0.422	0.00138851560608523	MYO1F	cDCs	GSE169246_PacBlood_pre	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59437
7.28586240442439e-08	0.37212829424911	0.443	0.276	0.0014379378041372	RIPOR2	cDCs	GSE169246_PacBlood_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59438
7.33877576800508e-08	0.254372801895448	0.476	0.281	0.00144838078557348	METTL9	cDCs	GSE169246_PacBlood_pre	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59439
7.46757400994481e-08	0.333633126465786	0.514	0.325	0.00147380040660271	LYST	cDCs	GSE169246_PacBlood_pre	ENSG00000143669	1130	lysosomal trafficking regulator	CHS|CHS1|Mauve	protein_coding	Q99698	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59440
7.84048266460997e-08	-0.275369391415586	0.335	0.542	0.00154739765868742	NDUFB3	cDCs	GSE169246_PacBlood_pre	ENSG00000119013	4709	NADH:ubiquinone oxidoreductase subunit B3	B12	protein_coding	O43676	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59441
7.98370753703407e-08	-0.35808466184415	0.681	0.796	0.00157566451950904	UCP2	cDCs	GSE169246_PacBlood_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59442
8.50703005543411e-08	0.295495348924536	0.638	0.457	0.00167894745174047	KHDRBS1	cDCs	GSE169246_PacBlood_pre	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59443
9.00947952540568e-08	0.283302085800006	0.686	0.499	0.00177811087913406	VASP	cDCs	GSE169246_PacBlood_pre	ENSG00000125753	7408	vasodilator stimulated phosphoprotein	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59444
9.34700252834026e-08	-0.27876396954851	0.465	0.653	0.00184472441899323	MINOS1	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59445
9.41245135849036e-08	0.364716508283553	0.497	0.318	0.00185764140011166	CD36	cDCs	GSE169246_PacBlood_pre	ENSG00000135218	948	CD36 molecule	FAT|GP3B|GP4|GPIV|SCARB3	protein_coding	P16671	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59446
9.76254959906294e-08	-0.317771065674955	0.978	0.949	0.00192673678887106	S100A4	cDCs	GSE169246_PacBlood_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59447
1.01176836546619e-07	0.335369744238992	0.524	0.346	0.00199682604608408	JAK2	cDCs	GSE169246_PacBlood_pre	ENSG00000096968	3717	Janus kinase 2	JTK10	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59448
1.08071867784741e-07	-0.261760945208359	0.465	0.667	0.00213290638259965	KRTCAP2	cDCs	GSE169246_PacBlood_pre	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59449
1.12522471730311e-07	0.275500376429025	0.368	0.196	0.00222074350206942	SIRPA	cDCs	GSE169246_PacBlood_pre	ENSG00000198053	140885	signal regulatory protein alpha	BIT|CD172a|MFR|MYD-1|P84|PTPNS1|SHPS-1|SHPS1|SIRP|SIRP-ALPHA-1|SIRPalpha|SIRPalpha2	protein_coding	P78324	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59450
1.16267361183767e-07	-0.340304579646072	0.2	0.395	0.00229465264032283	HSPB1	cDCs	GSE169246_PacBlood_pre	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59451
1.26254823866683e-07	0.3029604464817	0.524	0.355	0.00249176520383285	CD164	cDCs	GSE169246_PacBlood_pre	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59452
1.27972324897186e-07	0.330231362402301	0.865	0.764	0.00252566180417087	CD52	cDCs	GSE169246_PacBlood_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59453
1.2935295162036e-07	-0.252925370968293	0.611	0.783	0.00255290985317943	APRT	cDCs	GSE169246_PacBlood_pre	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59454
1.36957846773439e-07	0.476486782817027	0.708	0.552	0.00270300006392059	CIITA	cDCs	GSE169246_PacBlood_pre	ENSG00000179583	4261	class II major histocompatibility complex transactivator	C2TA|MHC2TA|NLRA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59455
1.39154858796281e-07	0.255516436549777	0.351	0.186	0.0027463602932034	FLI1	cDCs	GSE169246_PacBlood_pre	ENSG00000151702	2313	Fli-1 proto-oncogene, ETS transcription factor	EWSR2|FLI-1|SIC-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59456
1.44452127683443e-07	0.250555875648044	0.789	0.612	0.00285090719196043	SERBP1	cDCs	GSE169246_PacBlood_pre	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59457
1.62217475345348e-07	-0.269236153399062	0.27	0.473	0.00320152409341578	PET100	cDCs	GSE169246_PacBlood_pre	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59458
1.69875075816434e-07	0.325259113590474	0.514	0.334	0.00335265449631314	ATP2B1	cDCs	GSE169246_PacBlood_pre	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59459
1.85234997074409e-07	0.317882317510151	0.578	0.412	0.00365579790226053	MFSD1	cDCs	GSE169246_PacBlood_pre	ENSG00000118855	64747	major facilitator superfamily domain containing 1	FLJ14153|Minerva|UG0581B09	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59460
2.0924202808285e-07	0.370070329112028	0.968	0.905	0.00412960066624313	LCP1	cDCs	GSE169246_PacBlood_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59461
2.21632151386106e-07	0.299160909208647	0.573	0.401	0.0043741321397562	OSBPL8	cDCs	GSE169246_PacBlood_pre	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59462
2.34037790643854e-07	0.285492710114717	0.476	0.297	0.0046189698361471	HEXB	cDCs	GSE169246_PacBlood_pre	ENSG00000049860	3074	hexosaminidase subunit beta	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59463
2.37793970209699e-07	-0.259808923492478	0.762	0.889	0.00469310179605861	EDF1	cDCs	GSE169246_PacBlood_pre	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59464
2.39864612358215e-07	0.252287725673904	0.519	0.327	0.00473396798950174	HMGA1	cDCs	GSE169246_PacBlood_pre	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59465
3.01247603997964e-07	0.262546926511403	0.357	0.193	0.00594542271250383	CRYBG1	cDCs	GSE169246_PacBlood_pre	ENSG00000112297	202	crystallin beta-gamma domain containing 1	AIM1|ST4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59466
3.08788905824781e-07	0.366574982702708	0.465	0.309	0.00609425784535787	MBP	cDCs	GSE169246_PacBlood_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59467
3.62356516734055e-07	-0.263288604048631	0.335	0.534	0.00715146821426331	SNU13	cDCs	GSE169246_PacBlood_pre	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59468
4.00968779829328e-07	-0.273648531488244	0.686	0.824	0.00791351983871162	LAMTOR4	cDCs	GSE169246_PacBlood_pre	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59469
4.07607775763334e-07	-0.277627483973761	0.411	0.58	0.00804454706246515	HSBP1	cDCs	GSE169246_PacBlood_pre	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59470
4.10093876379792e-07	0.2986144015685	0.589	0.417	0.00809361274423157	PLBD1	cDCs	GSE169246_PacBlood_pre	ENSG00000121316	79887	phospholipase B domain containing 1	FLJ22662	protein_coding	Q6P4A8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59471
4.28901762385677e-07	0.319814930044151	0.616	0.457	0.00846480518244372	MARCH1	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59472
4.40024712348938e-07	-0.294996121659219	0.535	0.719	0.00868432772291864	ZFAS1	cDCs	GSE169246_PacBlood_pre	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59473
4.43251721513223e-07	0.278023835959347	0.551	0.379	0.00874801597578498	ARL5A	cDCs	GSE169246_PacBlood_pre	ENSG00000162980	26225	ADP ribosylation factor like GTPase 5A	ARL5	protein_coding	Q9Y689	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59474
4.59699130406249e-07	0.288379125921984	0.303	0.157	0.00907262203769772	RNF149	cDCs	GSE169246_PacBlood_pre	ENSG00000163162	284996	ring finger protein 149	FLJ90504	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59475
4.90709984174092e-07	0.260219254597567	0.303	0.155	0.00968465224765988	MAP3K1	cDCs	GSE169246_PacBlood_pre	ENSG00000095015	4214	mitogen-activated protein kinase kinase kinase 1	MAPKKK1|MEKK|MEKK1	protein_coding	Q13233	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59476
4.97096303113585e-07	-0.258001614814109	0.286	0.482	0.00981069263824971	MRPL51	cDCs	GSE169246_PacBlood_pre	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59477
5.07962517461823e-07	0.303080806284043	0.768	0.699	0.0100251482446265	PPDPF	cDCs	GSE169246_PacBlood_pre	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59478
5.09866824760848e-07	0.255516436549778	0.292	0.147	0.0100627316534801	DOCK5	cDCs	GSE169246_PacBlood_pre	ENSG00000147459	80005	dedicator of cytokinesis 5	FLJ21034	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59479
5.75249713014086e-07	0.267695028765695	0.854	0.726	0.011353128336046	CCDC88A	cDCs	GSE169246_PacBlood_pre	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59480
6.21054928168544e-07	-0.283146334974033	0.697	0.815	0.0122571400623344	CARD16	cDCs	GSE169246_PacBlood_pre	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59481
6.40853753164443e-07	-0.266091577827575	0.503	0.671	0.0126478896724534	UXT	cDCs	GSE169246_PacBlood_pre	ENSG00000126756	8409	ubiquitously expressed prefoldin like chaperone	ART-27|STAP1	protein_coding	Q9UBK9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59482
6.44536185236431e-07	0.315821534528136	0.4	0.234	0.0127205661518262	SLC38A2	cDCs	GSE169246_PacBlood_pre	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59483
6.46386438762584e-07	-0.262331868312842	0.389	0.574	0.0127570827554184	SEC61G	cDCs	GSE169246_PacBlood_pre	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59484
7.1150042411866e-07	0.27814947525062	0.714	0.537	0.0140421723704059	FLNA	cDCs	GSE169246_PacBlood_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59485
7.24383921465084e-07	-0.312152513306147	1	0.993	0.0142964410740349	LYZ	cDCs	GSE169246_PacBlood_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59486
7.485151334649e-07	0.250600946135661	0.459	0.282	0.0147726946740633	ADAR	cDCs	GSE169246_PacBlood_pre	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59487
7.65168569575787e-07	0.25745112242492	0.438	0.27	0.0151013668891477	BRD2	cDCs	GSE169246_PacBlood_pre	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59488
8.34412494253219e-07	0.250776571782322	0.697	0.535	0.0164679649865815	ZNF385A	cDCs	GSE169246_PacBlood_pre	ENSG00000161642	25946	zinc finger protein 385A	DKFZp586G1122|Hzf|ZFP385|ZNF385	protein_coding	Q96PM9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59489
1.10869290623615e-06	-0.397069236941488	0.141	0.31	0.0218811631974767	PLAC8	cDCs	GSE169246_PacBlood_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59490
1.16732721502797e-06	0.297336612244405	0.503	0.328	0.0230383699157921	ROCK1	cDCs	GSE169246_PacBlood_pre	ENSG00000067900	6093	Rho associated coiled-coil containing protein kinase 1	p160ROCK	protein_coding	Q13464	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59491
1.24617002166492e-06	0.278777282748739	0.465	0.289	0.0245944115475788	AC004687.1	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59492
1.32256682692637e-06	0.301067024940809	0.416	0.254	0.0261021788962188	HERPUD1	cDCs	GSE169246_PacBlood_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59493
1.3597792014652e-06	-0.2934762937355	0.611	0.769	0.0268366023201171	DYNLL1	cDCs	GSE169246_PacBlood_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59494
1.3802196910485e-06	-0.341275655208751	0.557	0.695	0.0272400158225331	HLA-DQA2	cDCs	GSE169246_PacBlood_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59495
1.47312367406559e-06	0.256266472979922	0.476	0.309	0.0290735688313585	SEPT2	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59496
1.51125830353093e-06	-0.271867230459644	0.238	0.418	0.0298261938784865	C12orf45	cDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59497
1.55617714108138e-06	0.260794997355926	0.589	0.418	0.0307127120563822	TGFBI	cDCs	GSE169246_PacBlood_pre	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59498
1.56939271686565e-06	0.269600034198217	0.978	0.933	0.0309735346600604	HNRNPA1	cDCs	GSE169246_PacBlood_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59499
1.57822565869157e-06	0.2721335575985	0.654	0.481	0.0311478615999369	EIF3A	cDCs	GSE169246_PacBlood_pre	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59500
1.6074906940804e-06	0.261940917150791	0.351	0.196	0.0317254363383707	PLEC	cDCs	GSE169246_PacBlood_pre	ENSG00000178209	5339	plectin	EBS1|PCN|PLEC1|PLTN	protein_coding	Q15149	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59501
1.7372882672125e-06	-0.290013037506064	0.897	0.925	0.034287121241706	MNDA	cDCs	GSE169246_PacBlood_pre	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59502
1.87892976778384e-06	0.269413054433775	0.568	0.4	0.0370825578969818	M6PR	cDCs	GSE169246_PacBlood_pre	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59503
2.21535083831969e-06	0.266181171247997	0.4	0.245	0.0437221641450775	SPTLC2	cDCs	GSE169246_PacBlood_pre	ENSG00000100596	9517	serine palmitoyltransferase long chain base subunit 2	hLCB2a|KIAA0526|LCB2|LCB2A	protein_coding	O15270	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59504
2.33128640710807e-06	0.294178056918883	0.514	0.355	0.0460102685306849	TMEM123	cDCs	GSE169246_PacBlood_pre	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59505
2.42283036261353e-06	-0.31577794609331	0.486	0.639	0.0478169800365406	LAP3	cDCs	GSE169246_PacBlood_pre	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59506
0	1.10093533189563	0.962	0.669	0	ZFP36L2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59507
0	3.13728223216582	0.441	0.015	0	HBB	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59508
0	0.880864029934156	0.999	0.97	0	MT-ND4L	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59509
1.79006351421477e-292	0.888670628047554	0.959	0.661	3.53286935165427e-288	KLF2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59510
5.49542635888904e-262	0.816715934077365	0.998	0.951	1.08457734619034e-257	MT-ND5	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59511
9.19684892635587e-240	-0.700991126193133	0.98	0.999	1.8150901041056e-235	RPL41	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59512
1.39057531311276e-236	-0.608582498256499	0.996	0.999	2.74443943795934e-232	RPS21	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59513
1.43584806880591e-230	0.834689695125525	0.997	0.943	2.83378974859535e-226	MT-ATP8	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59514
3.89780277708481e-213	0.918925573495671	0.818	0.469	7.69270356085458e-209	MT-ND6	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59515
4.77007825534753e-207	-0.454472556950362	1	1	9.41422644475388e-203	RPL28	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59516
5.64113296177406e-200	-0.644653372246473	0.999	1	1.11333400133573e-195	TMSB10	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59517
2.28840847969835e-198	0.766297243085994	0.945	0.737	4.51640297553267e-194	BTG1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59518
1.42938522931746e-187	0.777934286432007	0.672	0.289	2.82103468858094e-183	TSC22D3	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59519
1.01924439493585e-179	0.706565811303739	0.394	0.072	2.0115807378454e-175	DUSP1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59520
2.86154371641325e-175	-0.469904503566242	1	1	5.6475426787132e-171	RPL37	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59521
3.29827869420194e-174	0.656507479612162	0.95	0.776	6.50948283087694e-170	DDX5	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59522
2.39285075536836e-171	0.715987318614707	0.968	0.83	4.722530250795e-167	TXNIP	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59523
1.00767606716913e-167	-0.505098366516819	0.972	0.996	1.98874948616499e-163	ATP5F1E	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59524
1.21261018968563e-163	-0.666689082656119	0.734	0.909	2.39320747036355e-159	RPL36A	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59525
1.22865683507214e-163	-0.486745759423724	1	0.999	2.42487712969837e-159	RPL39	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59526
7.59841249305692e-155	0.618390685821808	0.915	0.685	1.49962268962971e-150	PNRC1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59527
1.06171653403366e-152	0.581328170967176	0.9	0.642	2.09540375156884e-148	SARAF	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59528
9.61383587142005e-151	0.567213553949874	0.744	0.397	1.89738664758346e-146	SUN2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59529
2.27730009156719e-150	0.388973822727329	1	1	4.49447946071701e-146	EEF1A1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59530
7.20988904673829e-148	0.560181870491541	0.338	0.064	1.42294370226427e-143	S100A9	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59531
7.19201109973711e-147	0.503503736069801	0.332	0.06	1.41941531064412e-142	LYZ	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59532
2.14538070353399e-146	0.542565891711986	0.552	0.207	4.23412335649468e-142	ZFP36	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59533
1.0891885435186e-145	0.40627187742396	1	0.998	2.14962250948832e-141	HLA-C	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59534
1.88656619738854e-143	-0.627655548488149	0.962	0.994	3.72332704716601e-139	MT-ATP6	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59535
1.03431856241389e-139	-0.52926170115258	0.96	0.991	2.04133111478006e-135	RPL38	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59536
6.71233174343991e-138	0.523163035455294	0.973	0.85	1.3247457928853e-133	PABPC1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59537
1.4162498480846e-137	-0.431910292761587	1	1	2.79511070017977e-133	RPS28	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59538
1.59118595577665e-136	-0.401312732473603	1	1	3.1403646023208e-132	RPS15A	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59539
5.75637977597497e-136	0.435300192784603	1	1	1.13607911258642e-131	HLA-B	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59540
8.78647200300862e-125	-0.418634140027346	1	1	1.73409811451378e-120	RPLP1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59541
3.67194381087652e-124	-0.353913103564089	1	1	7.24694830514591e-120	RPS15	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59542
3.78100318649422e-124	-0.858412434645475	0.408	0.662	7.462187888865e-120	MT2A	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59543
1.03525727445748e-121	-0.441095680667314	0.994	1	2.04318375686929e-117	RPL37A	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59544
2.08229037007151e-119	-0.470015875709968	0.991	0.999	4.10960827437313e-115	RPS29	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59545
5.61613310964124e-117	-0.588378995090999	0.956	0.98	1.10840003051879e-112	MT-ND4	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59546
1.1714194195588e-115	-0.375987113290692	0.997	0.999	2.31191336644124e-111	RPL36	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59547
3.34603425490137e-114	0.564554959433335	0.884	0.664	6.60373320547334e-110	AHNAK	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59548
2.11971250545588e-112	0.449741381583674	0.874	0.632	4.18346460076773e-108	PCBP1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59549
2.67493442113965e-109	0.392020597174404	0.38	0.119	5.27925057356122e-105	CITED2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59550
4.16620525937647e-109	0.410760921627386	0.271	0.053	8.22242269990539e-105	S100A8	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59551
1.41141423362887e-107	0.462740675845635	0.732	0.435	2.78556713148994e-103	SRSF5	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59552
3.03504531953286e-107	0.473605798839814	0.714	0.431	5.98996544263006e-103	EIF4B	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59553
5.97855329483701e-106	-0.414221095854874	1	1	1.17992727826903e-101	RPS19	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59554
2.99931258874686e-101	0.468169029329578	0.625	0.328	5.9194433251508e-97	ZFP36L1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59555
3.93343682841467e-99	-0.375790548086594	0.994	0.999	7.76303092455919e-95	RPL35	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59556
9.38007889098563e-98	-0.437471134800481	1	1	1.85125236992492e-93	RPS27	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59557
4.02628544458788e-97	0.435903426986298	0.594	0.312	7.94627695343864e-93	PRMT2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59558
1.21488148757081e-96	0.420212439478992	0.997	0.976	2.39769010386975e-92	MT-ND1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59559
2.23335635568228e-96	0.407664294872221	0.525	0.232	4.40775210357456e-92	JUNB	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59560
3.07492559896693e-92	0.519186897339743	0.726	0.473	6.06867316212113e-88	KLF6	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59561
3.16656540562228e-91	0.353342433535569	0.999	0.998	6.24953348453614e-87	RPL3	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59562
4.06938020062842e-91	-0.363043002214124	0.998	0.999	8.03132876396025e-87	RPL23A	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59563
1.50924826229601e-90	0.481184354932943	0.596	0.335	2.97865237046741e-86	TAGAP	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59564
2.56041609524941e-90	0.42831084020602	0.584	0.318	5.05323720558423e-86	SFPQ	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59565
2.89292717500084e-89	-0.390945293678558	0.933	0.971	5.70948107258165e-85	TMA7	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59566
1.60526533627342e-88	-0.354459253066077	1	1	3.16815166766922e-84	RPL34	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59567
2.97773985036985e-88	0.383079555462336	0.552	0.285	5.87686736868994e-84	HNRNPA0	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59568
1.16921034629577e-87	-0.313796664584839	1	1	2.30755353944933e-83	RPS24	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59569
2.20673988550089e-87	-0.320381462782721	1	1	4.35522183802455e-83	RPL32	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59570
1.11535462617899e-86	0.387170146539917	0.473	0.218	2.20126389022685e-82	SEMA4D	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000187764	10507	semaphorin 4D	C9orf164|CD100|coll-4|FLJ39737|SEMAJ	protein_coding	Q92854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59571
4.9197569572789e-86	0.391510093046682	0.989	0.959	9.70963233088564e-82	FTH1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59572
5.44783411062821e-86	0.366187169489168	1	0.996	1.07518454007358e-81	MT-CYB	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59573
1.64881951849501e-85	0.378458319929113	0.587	0.318	3.25411020170175e-81	ARF6	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59574
9.34102591070284e-85	0.401302032773194	0.671	0.404	1.84354487373631e-80	LCP2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59575
9.61641769951872e-84	0.381739881263658	0.97	0.906	1.89789619717701e-79	EEF2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59576
5.64678931931672e-82	0.401222575090932	0.776	0.523	1.11445034006035e-77	HNRNPK	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59577
2.17377045302046e-81	0.380624641132424	0.775	0.515	4.29015336608119e-77	DAZAP2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59578
2.23091980424115e-79	-0.331409558527482	0.974	0.995	4.40294332565034e-75	SERF2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59579
5.19082275355331e-79	0.357195076366033	0.365	0.142	1.02446077864128e-74	NFKBIA	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59580
1.4600582552813e-78	-0.302765813355726	0.999	1	2.88157097262316e-74	FAU	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59581
2.35238558319672e-78	-0.363193271640533	0.95	0.979	4.64266818699704e-74	RPL31	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59582
5.16605966153393e-78	-0.286840250921873	1	1	1.01957353480034e-73	RPS23	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59583
5.2144814055331e-78	0.406216417326592	0.279	0.085	1.02913005019601e-73	JUN	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59584
7.8381959508323e-78	0.379410650606591	0.456	0.217	1.54694635285626e-73	RASA3	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000280477	22821	RAS p21 protein activator 3	GAP1IP4BP|GAPIII	protein_coding	Q14644	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59585
5.40542405325365e-75	0.402471400328142	0.667	0.426	1.06681449115014e-70	EIF4G2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59586
3.97887398281086e-74	0.363943715847807	0.476	0.245	7.85270569247551e-70	MATR3.1	CD8+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59587
1.66269108818232e-73	0.340372718455414	0.477	0.239	3.28148713163662e-69	PPP3CC	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000120910	5533	protein phosphatase 3 catalytic subunit gamma	CALNA3|PP2Bgamma	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59588
2.90801526915373e-73	0.354850967493969	0.502	0.266	5.7392589352018e-69	RASAL3	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000105122	64926	RAS protein activator like 3	FLJ21438	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59589
1.01397229123821e-72	0.390626364515684	0.607	0.367	2.00117571398773e-68	PRKCH	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000027075	5583	protein kinase C eta	PKC-L|PKCL|PRKCL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59590
1.06524312479985e-70	-0.324830400910796	0.998	0.999	2.10236383110498e-66	RPL35A	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59591
5.34136903043131e-70	0.312763438895526	0.333	0.13	1.05417259184592e-65	CXCR4	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59592
6.32171202676366e-70	0.325179340026848	0.447	0.218	1.24765308560208e-65	FLI1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000151702	2313	Fli-1 proto-oncogene, ETS transcription factor	EWSR2|FLI-1|SIC-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59593
7.40116763968605e-70	0.339250644746132	0.456	0.225	1.46069444536844e-65	EVI2B	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59594
4.19946323223964e-69	0.344785799327817	0.568	0.331	8.28806063514816e-65	CAPN2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59595
4.37138399744453e-69	0.337382397527772	0.39	0.178	8.62736345735652e-65	CDKN1B	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000111276	1027	cyclin dependent kinase inhibitor 1B	KIP1|P27KIP1	protein_coding	P46527	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59596
4.92456207261802e-69	0.405681755687723	0.451	0.225	9.71911570651892e-65	DUSP2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59597
1.62846567360617e-68	0.338414040553764	0.593	0.352	3.21393985342913e-64	FMNL1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59598
1.08490330935718e-67	0.354971218830236	0.403	0.188	2.14116517134733e-63	CD69	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59599
2.33357599907737e-67	0.301108281789439	0.352	0.149	4.6055455917791e-63	LRP10	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000197324	26020	LDL receptor related protein 10	DKFZP564C1940|LRP9|MGC8675|MST087|MSTP087	protein_coding	Q7Z4F1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59600
5.04123192494904e-67	0.344116399917948	0.571	0.332	9.94937532707943e-63	PSAP	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59601
7.02214023629993e-67	0.360366020190027	0.705	0.481	1.38588959703615e-62	PDIA3	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59602
2.38895792138758e-66	0.356856759654993	0.417	0.203	4.71484735365053e-62	TBX21	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000073861	30009	T-box transcription factor 21	T-bet|TBLYM	protein_coding	Q9UL17	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59603
6.15449637358172e-66	0.357930192412559	0.744	0.51	1.21465140429009e-61	NCL	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59604
9.9490639310229e-66	0.347687441782352	0.88	0.728	1.96354725742668e-61	CCNI	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59605
4.11099487839093e-65	0.420404104818434	0.614	0.39	8.11345949199234e-61	KIAA1551	CD8+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59606
1.75150223790531e-64	0.468121688942428	0.756	0.561	3.45676481672993e-60	PRF1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59607
5.88173903182817e-64	0.358787131502915	0.535	0.31	1.16082001532161e-59	PDCD4	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59608
2.21998110672228e-63	0.393035671524789	0.612	0.396	4.3813547122271e-59	SYNE1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000131018	23345	spectrin repeat containing nuclear envelope protein 1	8B|ARCA1|C6orf98|CPG2|dJ45H2.2|enaptin|KIAA0796|MYNE1|Nesp1|Nesprin-1|SCAR8|SYNE-1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59609
3.28603820141215e-63	0.320653609421688	0.542	0.308	6.48532499430701e-59	WAS	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000015285	7454	WASP actin nucleation promoting factor	IMD2|THC|WASP|WASPA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59610
1.10586129737229e-62	0.296031327503134	0.997	0.972	2.18252785649396e-58	HLA-E	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59611
2.34437892771562e-62	-0.276727481006928	0.998	1	4.62686625173954e-58	RPS16	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59612
3.31808264272069e-62	0.3528279753761	0.543	0.313	6.54856790367356e-58	FCMR	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000162894	9214	Fc mu receptor	FAIM3|FcmuR|TOSO	protein_coding	O60667	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59613
4.65943918466878e-62	0.345050845876209	0.653	0.426	9.19586917486231e-58	TAPBP	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59614
2.14102777862477e-61	0.313981933928411	0.973	0.895	4.22553242389384e-57	HSPA8	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59615
4.48699993322963e-60	0.328610217649291	0.797	0.601	8.85554306822201e-56	CNBP	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000169714	7555	CCHC-type zinc finger nucleic acid binding protein	CNBP1|DM2|RNF163|ZCCHC22|ZNF9	protein_coding	P62633	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59616
5.53398148625497e-60	0.354184208685566	0.661	0.434	1.09218658612728e-55	MBP	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59617
8.06850565601919e-60	0.399317218223031	0.5	0.278	1.59240027627195e-55	HIST1H1E	CD8+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59618
8.89455323430343e-60	0.340159709365123	0.986	0.96	1.75542902632213e-55	PTPRC	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59619
2.26273553789059e-59	-0.270786568623476	0.999	0.999	4.46573485758087e-55	RPLP2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59620
3.79128950553146e-59	0.321117847369401	0.476	0.262	7.48248896811689e-55	RHOH	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59621
1.44636040473433e-58	0.330805989824287	0.629	0.412	2.85453689478367e-54	APBB1IP	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59622
8.80265938255282e-58	0.319091236061168	0.594	0.368	1.73729285574063e-53	ARHGEF1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000076928	9138	Rho guanine nucleotide exchange factor 1	LBCL2|P115-RHOGEF|SUB1.5	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59623
9.82867521572702e-58	0.350529233148366	0.568	0.35	1.93978734057588e-53	IL10RA	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59624
1.62540469670841e-57	0.331441838843675	0.659	0.441	3.20789870942373e-53	SF1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59625
2.2155623713587e-57	0.343932007689057	0.69	0.463	4.37263389611353e-53	HNRNPU	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59626
2.66249837810768e-57	0.27985779577317	0.324	0.14	5.25470679903332e-53	DIP2A	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000160305	23181	disco interacting protein 2 homolog A	C21orf106|Dip2|KIAA0184	protein_coding	Q14689	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59627
8.04047897622252e-57	0.35484178937571	0.825	0.651	1.58686893074728e-52	MYH9	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59628
2.01875089066377e-56	0.315990983144803	0.556	0.337	3.98420675781401e-52	CYTIP	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59629
4.09973233061159e-56	0.265425062824705	0.311	0.131	8.09123172769504e-52	ADRB2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000169252	154	adrenoceptor beta 2	ADRB2R|ADRBR|B2AR|BAR	protein_coding	P07550	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59630
5.34167220829755e-56	0.304685799667559	0.494	0.279	1.0542324270296e-51	STK17B	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59631
5.70278563924003e-55	-0.302154170363305	0.975	0.994	1.12550177376041e-50	RPL27	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59632
9.59313527108313e-55	0.255634991048937	0.311	0.133	1.89330117710097e-50	PIK3R5	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000141506	23533	phosphoinositide-3-kinase regulatory subunit 5	p101|P101-PI3K	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59633
3.4439739836624e-54	0.280969561780229	0.31	0.138	6.79702705415611e-50	KCNA3	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000177272	3738	potassium voltage-gated channel subfamily A member 3	HLK3|HPCN3|Kv1.3|MK3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59634
4.06940586110939e-54	-0.529737128118564	0.65	0.74	8.0313794074855e-50	LINC00861	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000245164	100130231	long intergenic non-protein coding RNA 861	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59635
4.58499839945044e-54	0.27236077866283	0.377	0.184	9.04895284115538e-50	LPCAT1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000275079	79888	lysophosphatidylcholine acyltransferase 1	AGPAT10|AGPAT9|AYTL2|FLJ12443|LPLAT8	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59636
6.47631683993202e-54	0.315953989400023	0.906	0.765	1.27816589152898e-49	YWHAZ	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59637
7.88596717555343e-54	0.31634720150773	0.576	0.363	1.55637448176722e-49	SELPLG	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59638
9.05181893297582e-54	0.252925615921051	0.396	0.196	1.78646698461211e-49	ATP1A1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59639
4.22668321348841e-53	0.292913426571587	0.616	0.401	8.34178199014073e-49	SF3B2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000087365	10992	splicing factor 3b subunit 2	Cus1|SAP145|SF3b1|SF3b145	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59640
6.54434189104255e-53	-0.488531970400218	0.552	0.691	1.29159131561616e-48	TRBC2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59641
7.66122955619498e-53	0.292647836330064	0.4	0.207	1.51202026521064e-48	TMEM123	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59642
1.10825551726833e-52	0.300713275743545	0.518	0.314	2.18725308888077e-48	CD164	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59643
4.21322489701799e-52	-0.282230602213655	0.125	0.296	8.3152206567547e-48	BLOC1S1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59644
1.09393626290261e-51	0.274998780214493	0.432	0.232	2.15899260846459e-47	RBMS1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000153250	5937	RNA binding motif single stranded interacting protein 1	C2orf12|DKFZp564H0764|HCC-4|MSSP-1|MSSP-2|MSSP-3|SCR2|YC1	protein_coding	P29558	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59645
1.48710213346272e-51	0.305052395147872	0.533	0.323	2.93494477060201e-47	MCL1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59646
1.66101326463977e-51	0.319159573246955	0.76	0.555	3.27817577909304e-47	RIPOR2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59647
2.19630025813343e-51	0.316023732791103	0.596	0.397	4.33461818945214e-47	CSDE1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59648
3.71516583343438e-51	0.284600068756444	0.452	0.257	7.3322512888661e-47	RASSF5	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000266094	83593	Ras association domain family member 5	Maxp1|NORE1|RAPL	protein_coding	Q8WWW0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59649
3.78636047644224e-51	-0.322146973375047	0.726	0.811	7.47276103630641e-47	UQCR11	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59650
5.94327435446214e-51	0.309099960582453	0.803	0.615	1.17296462659665e-46	EVL	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59651
1.08553562802155e-50	0.29952409455178	0.425	0.234	2.14241311546333e-46	NIN	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000100503	51199	ninein	NA	protein_coding	Q8N4C6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59652
1.16258229585115e-50	0.281520450649711	0.451	0.256	2.29447241909183e-46	LSM14A	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000262860	26065	LSM14A mRNA processing body assembly factor	C19orf13|DKFZP434D1335|FAM61A|RAP55|RAP55A	protein_coding	Q8ND56	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59653
1.63322275582126e-50	0.310406895733487	0.556	0.349	3.22332843088885e-46	IER2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59654
7.64784900627952e-50	0.255083694734877	0.424	0.23	1.50937947987933e-45	LAMP1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59655
1.54249930809756e-49	0.28716299236254	0.494	0.295	3.04427663446135e-45	EWSR1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59656
2.00091327147831e-49	0.301968283670858	0.682	0.491	3.9490024325896e-45	BIN2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000110934	51411	bridging integrator 2	BRAP-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59657
2.43354941387267e-49	-0.262835639707779	0.987	0.998	4.80285312321911e-45	UBA52	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59658
3.92738718754267e-49	0.289297409141719	0.517	0.312	7.75109135333422e-45	PARP8	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000151883	79668	poly(ADP-ribose) polymerase family member 8	ARTD16|FLJ21308|pART16	protein_coding	Q8N3A8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59659
5.81589202454927e-49	-0.360679609376398	0.964	0.974	1.14782444996504e-44	MYL6	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59660
6.87641961957821e-49	0.291582490881204	0.51	0.313	1.35713017611996e-44	BRD2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59661
7.18931674374515e-49	-0.485108634040496	0.933	0.961	1.41888355254554e-44	RPS26	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59662
8.72584847028257e-49	0.307954289862307	0.72	0.53	1.72213345409497e-44	RAP1B	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59663
2.34901596520752e-48	0.296752817571638	0.603	0.399	4.63601790893355e-44	EIF4A2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59664
3.65118955431789e-48	0.282190825135459	0.676	0.461	7.20598770440179e-44	HNRNPF	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59665
1.05133647311835e-47	0.265643485004343	0.517	0.318	2.07491766334638e-43	SRP9	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59666
1.66559357290257e-47	0.268709690053441	0.413	0.223	3.2872154754805e-43	PIM1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59667
1.94830885071919e-47	0.310162365039897	0.675	0.477	3.8451823477794e-43	CCND3	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59668
2.58338342629886e-47	0.265164031752013	0.453	0.263	5.09856553014342e-43	CMPK1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000162368	51727	cytidine/uridine monophosphate kinase 1	CMPK|UMP-CMPK	protein_coding	P30085	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59669
2.69336405577523e-47	0.253546322104634	0.543	0.334	5.31562330047799e-43	SHISA5	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000164054	51246	shisa family member 5	hShisa5|SCOTIN	protein_coding	Q8N114	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59670
1.14223844058179e-46	0.275801400264408	0.431	0.247	2.25432178633223e-42	NFATC2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000101096	4773	nuclear factor of activated T cells 2	NF-ATP|NFAT1|NFATp	protein_coding	Q13469	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59671
1.89121561860415e-46	-0.328847374427086	0.998	0.998	3.73250314487715e-42	RPLP0	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59672
4.50946094853994e-46	-0.284292724698948	0.904	0.938	8.89987212803843e-42	COX7C	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59673
5.97595251694413e-46	0.295586505990289	0.389	0.213	1.17941398874409e-41	S1PR5	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000180739	53637	sphingosine-1-phosphate receptor 5	Edg-8|EDG8	protein_coding	Q9H228	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59674
8.68051954036054e-46	0.352321385279539	0.616	0.432	1.71318733648556e-41	ITGA4	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59675
9.13153318951563e-46	0.280445405417213	0.497	0.306	1.8021993902828e-41	APMAP	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59676
1.27447986510439e-45	0.298360707909979	0.528	0.339	2.51531346177002e-41	PTPN6	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59677
1.5542684075007e-45	0.306565200210198	0.756	0.576	3.06750412904337e-41	CDC42	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59678
1.35343376026918e-44	-0.313738385821016	0.746	0.805	2.67113686926724e-40	COX6B1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59679
1.67275698338911e-44	0.294828210144716	0.552	0.36	3.30135318241675e-40	ATM	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59680
2.96856569994299e-44	0.278767701927065	0.488	0.3	5.85876126540748e-40	S1PR1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000170989	1901	sphingosine-1-phosphate receptor 1	CD363|D1S3362|edg-1|EDG1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59681
3.08254266714159e-44	0.254733822008589	0.371	0.194	6.08370620787064e-40	SORL1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000137642	6653	sortilin related receptor 1	C11orf32|gp250|LR11|LRP9|SorLA|SorLA-1	protein_coding	Q92673	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59682
3.36931639925707e-44	0.260554774148029	0.413	0.235	6.64968284557376e-40	TMC8	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000167895	147138	transmembrane channel like 8	EVER2|EVIN2	protein_coding	Q8IU68	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59683
4.12722848183262e-44	0.268653992838735	0.573	0.382	8.14549813174485e-40	ANXA11	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000122359	311	annexin A11	ANX11	protein_coding	P50995	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59684
5.04972993700802e-44	0.266869959047859	0.499	0.302	9.96614700367903e-40	HSPA5	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59685
7.84784561304183e-44	0.386206819948975	0.654	0.469	1.54885081018994e-39	CCL4	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59686
1.07456348644262e-43	0.280661995110724	0.379	0.209	2.12075849684315e-39	GPR65	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000140030	8477	G protein-coupled receptor 65	hTDAG8|TDAG8	protein_coding	Q8IYL9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59687
1.49156647957088e-43	-0.306750499473284	0.741	0.801	2.94375560408108e-39	UBL5	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59688
1.71016833825341e-43	0.264428162996101	0.445	0.263	3.37518823237692e-39	PRPF8	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000274442	10594	pre-mRNA processing factor 8	hPrp8|Prp8|PRPC8|RP13|SNRNP220	protein_coding	Q6P2Q9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59689
1.76238452555789e-43	0.271025744004254	0.591	0.407	3.47824209964105e-39	MORF4L1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59690
2.06609963594216e-43	-0.345140661140077	0.83	0.871	4.07765424149545e-39	MIF	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59691
2.09924056703014e-43	-0.357238751670332	0.742	0.783	4.14306118309068e-39	COX6A1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59692
3.48603199126232e-43	0.250381241946805	0.375	0.205	6.88003273795531e-39	DNAJB1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59693
5.12093270279395e-43	-0.319654721798695	0.901	0.937	1.01066727822341e-38	TOMM7	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59694
1.22030982787507e-42	0.291820585167173	0.478	0.298	2.40840347629425e-38	ZBTB38	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000177311	253461	zinc finger and BTB domain containing 38	CIBZ|FLJ35036|PPP1R171|ZNF921	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59695
1.77517415237076e-42	0.252264122089029	0.451	0.269	3.50348370711894e-38	PIK3R1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59696
2.72847535545749e-42	0.271368670304546	0.5	0.313	5.38491896153089e-38	MATK	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000007264	4145	megakaryocyte-associated tyrosine kinase	CHK|CTK|DKFZp434N1212|HHYLTK|HYL|HYLTK|Lsk|MGC1708|MGC2101	protein_coding	P42679	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59697
3.49820269401925e-42	0.267617581348042	0.508	0.319	6.9040528369164e-38	STK10	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000072786	6793	serine/threonine kinase 10	LOK|PRO2729	protein_coding	O94804	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59698
4.87206113675224e-42	0.29378147244864	0.546	0.366	9.61549985949422e-38	TC2N	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000276776	123036	tandem C2 domains, nuclear	C14orf47|C2CD1|FLJ36557|MTAC2D1|Tac2-N	protein_coding	Q8N9U0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59699
5.58496478964545e-42	-0.265835823994927	0.94	0.972	1.10224865088443e-37	RPL27A	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59700
6.15176320459463e-42	0.25692203541873	0.435	0.256	1.2141119860588e-37	CTSS	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59701
1.53102964959876e-41	0.250791360144837	0.429	0.256	3.02164011644811e-37	GRK6	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000198055	2870	G protein-coupled receptor kinase 6	GPRK6	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59702
1.71692144689558e-41	0.259146492258099	0.512	0.331	3.38851616759312e-37	VCP	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000165280	7415	valosin containing protein	CDC48|IBMPFD|p97|TERA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59703
1.88178950068436e-41	0.703912594814391	0.562	0.414	3.71389975855066e-37	IL7R	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59704
2.50243911411835e-41	0.277307465824068	0.605	0.411	4.93881383562398e-37	CAST	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59705
2.98115481548889e-41	0.292010197517773	0.716	0.551	5.88360714384888e-37	ANXA6	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000197043	309	annexin A6	ANX6	protein_coding	P08133	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59706
3.67835712960519e-41	0.264288800277333	0.711	0.514	7.2596056309888e-37	HNRNPDL	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59707
4.49812846388202e-41	0.322051170081453	0.503	0.324	8.87750633631755e-37	HOPX	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59708
1.34940148048519e-40	0.4983941411198	0.376	0.215	2.66317876188557e-36	TYROBP	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59709
1.89014646709711e-40	0.276728403471069	0.637	0.452	3.73039306746286e-36	LBH	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000213626	81606	LBH regulator of WNT signaling pathway	NA	protein_coding	Q53QV2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59710
2.30330153157153e-40	0.274440163301759	0.5	0.32	4.54579590270956e-36	STK38	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000112079	11329	serine/threonine kinase 38	NDR|NDR1	protein_coding	Q15208	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59711
2.95946822261571e-40	0.299023324980486	0.762	0.608	5.84080648415436e-36	SLC9A3R1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59712
3.25679512654917e-40	-0.263491127732346	0.997	0.999	6.42761086175744e-36	RPSA	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59713
3.77307134175657e-40	0.255740796199247	0.35	0.19	7.44653360009077e-36	SCML4	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000146285	256380	Scm polycomb group protein like 4	dJ47M23.1	protein_coding	Q8N228	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59714
6.22444226818011e-40	-0.314296582720527	0.638	0.736	1.22845592604803e-35	RPS10	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59715
6.9039846637978e-40	0.273678134945986	0.451	0.279	1.36257041324713e-35	EOMES	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000163508	8320	eomesodermin	TBR2	protein_coding	O95936	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59716
7.28805365853247e-40	0.270475661121016	0.661	0.483	1.43837027004797e-35	CD247	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59717
1.44845751098062e-39	-0.279882362230227	0.829	0.881	2.85867574367135e-35	OST4	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59718
1.81889737805213e-39	-0.280206189450066	0.893	0.931	3.58977586532369e-35	ATP5MC2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59719
3.36366127962576e-39	0.25691078820453	0.491	0.309	6.6385219014694e-35	EPB41	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000159023	2035	erythrocyte membrane protein band 4.1	4.1R|EL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59720
4.81812769931514e-39	-0.56826798553516	0.814	0.849	9.50905682736836e-35	CRIP1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59721
8.79099282636043e-39	-0.471461877749724	0.65	0.743	1.73499034421049e-34	HLA-DRB1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59722
1.85195332553696e-38	0.252417070587006	0.792	0.619	3.65501508327974e-34	TRAF3IP3	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59723
2.42267166482572e-38	0.361099611460189	0.294	0.151	4.78138479770004e-34	FCGR3A	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59724
4.91238782499647e-38	0.25031784383947	0.347	0.193	9.69508861141303e-34	CAMK4	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000152495	814	calcium/calmodulin dependent protein kinase IV	CaMK-GR|CaMKIV	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59725
7.60719484127494e-38	0.559823511702846	0.419	0.254	1.50135597387402e-33	GNLY	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59726
1.10930679568462e-37	0.258611097029796	0.579	0.391	2.18932789196317e-33	RSRP1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59727
1.48065818273699e-37	0.268393350004409	0.757	0.583	2.92222698944972e-33	MSN	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59728
3.53688271855149e-37	0.260033404789894	0.468	0.299	6.98039173333321e-33	SPTAN1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000197694	6709	spectrin alpha, non-erythrocytic 1	NA	protein_coding	Q13813	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59729
3.87057142356528e-36	0.257479061144564	0.672	0.503	7.63895976154844e-32	PPP1R18	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59730
5.36972694612029e-36	-0.266367387986784	0.888	0.916	1.0597693100863e-31	ATP5MG	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59731
1.94098711066297e-35	-0.317749173143179	0.974	0.98	3.83073216160444e-31	IFITM1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59732
2.51040742016327e-35	-0.337876403776021	0.548	0.641	4.95454008443422e-31	MZT2B	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59733
5.49075529230986e-35	-0.263181428089885	0.899	0.916	1.08365546449027e-30	PSME1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59734
9.81883879234233e-35	0.257813128367835	0.562	0.392	1.93784602405668e-30	SF3B1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59735
3.19780155209564e-34	0.25201569108841	0.935	0.85	6.31118114321596e-30	EEF1G	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59736
5.31152793189396e-33	-0.308609680255097	0.704	0.753	1.04828315263859e-28	COX6C	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59737
3.65993706795209e-32	-0.290190182552576	0.573	0.658	7.22325179731025e-28	TMEM258	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59738
4.0541892307268e-32	-0.371240923122357	0.674	0.72	8.00134786576242e-28	PSME2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59739
4.29923811407446e-32	-0.253075584061386	0.815	0.86	8.48497634193735e-28	UQCRB	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59740
6.43360437123173e-32	0.250721206713742	0.589	0.43	1.26973615870629e-27	EZR	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59741
9.0966723401499e-31	-0.255389548777477	0.733	0.78	1.79531925305198e-26	ELOB	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59742
5.30420062640329e-30	-0.26872893627055	0.608	0.682	1.04683703562695e-25	NDUFA1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59743
2.0936270092106e-29	0.275431079489093	0.546	0.398	4.13198226537804e-25	SPOCK2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59744
1.76176599365908e-28	0.285676328072487	0.669	0.54	3.47702136508556e-24	SYNE2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59745
2.89137001444266e-28	0.26679061431316	0.681	0.528	5.70640786050403e-24	CD7	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59746
4.49631860880774e-26	0.311021526361587	0.566	0.436	8.87393440634296e-22	KLRD1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59747
8.40084752800624e-25	-0.391781759136271	0.284	0.395	1.65799126812731e-20	ISG15	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59748
1.19512882809318e-24	-0.330364997921593	0.968	0.969	2.35870625512471e-20	S100A6	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59749
6.63133424853447e-23	-0.259593730773902	0.553	0.614	1.30876012729076e-18	NDUFB11	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59750
1.01104677369176e-22	-0.25688161678022	0.798	0.816	1.99540191255805e-18	CHCHD2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59751
5.71093364997471e-22	-0.259661033539552	0.791	0.807	1.12710986515901e-17	RARRES3	CD8+ T cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59752
5.11529090800794e-20	-0.251767387180555	0.43	0.515	1.00955381360445e-15	UQCRQ	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59753
2.62400333259687e-17	-0.267015104119805	0.624	0.653	5.17873297721319e-13	NME2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59754
2.18723963308957e-16	0.328020178556435	0.594	0.546	4.31673613986558e-12	CD8A	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59755
4.46500517792274e-16	-0.266457579294387	0.973	0.968	8.81213421914831e-12	CD52	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59756
7.44634593937958e-16	-0.376205288950084	0.876	0.859	1.46961083459595e-11	HMGB1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59757
7.59796039192282e-14	-0.26542958176715	0.415	0.5	1.49953346294989e-09	TRBC1	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59758
8.13989523793876e-14	-0.274054565109372	0.463	0.512	1.60648972415959e-09	SNRPG	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59759
9.54729978542857e-14	-0.258134175730059	0.884	0.861	1.88425508565218e-09	GZMA	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59760
2.72818541898364e-09	0.273990313527305	0.3	0.235	5.38434674290612e-05	FGFBP2	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59761
2.42447326058834e-07	0.305213802661756	0.648	0.632	0.00478494042709715	CTSW	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59762
1.32182672572652e-06	-0.407294795631997	0.978	0.979	0.0260875722589385	GAPDH	CD8+ T cells	GSE169246_PacBlood_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59763
2.03566913384236e-29	1.93383307603425	0.524	0	4.01759660255128e-25	HBB	Plasma cells	GSE169246_PacBlood_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59764
5.30097768741984e-20	-1.00277764814808	0.814	0.943	1.04620095638918e-15	RPL41	Plasma cells	GSE169246_PacBlood_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59765
1.2397045287873e-14	-0.602076892313178	0.952	0.984	2.44668085801461e-10	RPS28	Plasma cells	GSE169246_PacBlood_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59766
3.01661777568398e-14	-0.565930515433609	0.938	0.974	5.95359684208991e-10	RPS27	Plasma cells	GSE169246_PacBlood_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59767
3.17616866110644e-14	-0.69747625419369	0.897	0.979	6.26848646955968e-10	RPS21	Plasma cells	GSE169246_PacBlood_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59768
4.91328520887908e-14	0.859275693545909	0.476	0.125	9.69685968824375e-10	TXNIP	Plasma cells	GSE169246_PacBlood_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59769
8.04240468309759e-14	-0.667847136341226	0.772	0.901	1.58724898825614e-09	RPS29	Plasma cells	GSE169246_PacBlood_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59770
1.27882209261445e-13	0.854306625322979	0.828	0.49	2.52388328198387e-09	MT-ND6	Plasma cells	GSE169246_PacBlood_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59771
1.39586861357728e-13	0.812313559393346	0.634	0.255	2.75488629575611e-09	KLF2	Plasma cells	GSE169246_PacBlood_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59772
1.71158451098596e-13	-0.625152878147686	0.841	0.922	3.37798319088188e-09	TMEM258	Plasma cells	GSE169246_PacBlood_pre	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59773
3.63126229498232e-13	0.927847090340948	0.566	0.214	7.1666592653771e-09	CITED2	Plasma cells	GSE169246_PacBlood_pre	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59774
4.70674445077619e-13	-0.668670412408052	0.759	0.906	9.28923084805189e-09	ATP5F1E	Plasma cells	GSE169246_PacBlood_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59775
8.34614090343683e-13	-1.02820784719153	0.179	0.531	1.64719436870229e-08	ISG15	Plasma cells	GSE169246_PacBlood_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59776
1.22001209406591e-12	0.623016307405813	0.49	0.141	2.40781586884849e-08	HLA-DQA1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59777
2.66242910298857e-12	0.975495493688666	0.462	0.141	5.25457007765825e-08	JUN	Plasma cells	GSE169246_PacBlood_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59778
7.78738411389284e-12	-0.855182361774899	0.69	0.88	1.53691812871789e-07	MT-ND4	Plasma cells	GSE169246_PacBlood_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59779
1.02352964484979e-11	-0.873144228887548	0.8	0.911	2.02003810707555e-07	RPS26	Plasma cells	GSE169246_PacBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59780
1.40558542581014e-11	-0.567452423895618	0.931	0.964	2.77406339637889e-07	RPL37	Plasma cells	GSE169246_PacBlood_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59781
1.69484372929329e-11	-0.610213345947089	0.393	0.708	3.34494358413324e-07	RPL36A	Plasma cells	GSE169246_PacBlood_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59782
2.87743061769614e-11	-0.470019977392948	0.372	0.729	5.6788970670851e-07	MZT2B	Plasma cells	GSE169246_PacBlood_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59783
3.29874649944945e-11	-0.625378485507739	0.503	0.786	6.51040609131343e-07	UQCRQ	Plasma cells	GSE169246_PacBlood_pre	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59784
3.99761519361799e-11	0.77512702192129	0.979	0.844	7.88969334612447e-07	MT-ND5	Plasma cells	GSE169246_PacBlood_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59785
6.02327779879248e-11	0.419267269925923	0.317	0.052	1.18875410636968e-06	CDKN1B	Plasma cells	GSE169246_PacBlood_pre	ENSG00000111276	1027	cyclin dependent kinase inhibitor 1B	KIP1|P27KIP1	protein_coding	P46527	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59786
7.49615784698001e-11	-0.594946589293778	0.917	0.953	1.47944171267998e-06	RPL37A	Plasma cells	GSE169246_PacBlood_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59787
7.76199731491348e-11	-0.514242205793077	0.262	0.615	1.53190779007132e-06	ATP5MPL	Plasma cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59788
8.85883885062458e-11	-0.506719406282043	0.655	0.865	1.74838043555927e-06	KRTCAP2	Plasma cells	GSE169246_PacBlood_pre	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59789
1.29560368017077e-10	0.603533577065069	0.993	0.891	2.55700342318502e-06	MT-ND4L	Plasma cells	GSE169246_PacBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59790
2.0482310438507e-10	-0.491920053610029	0.814	0.911	4.04238878814374e-06	OST4	Plasma cells	GSE169246_PacBlood_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59791
2.60294436647999e-10	-0.554653883345745	0.421	0.74	5.13717100168491e-06	ROMO1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59792
3.20015010995252e-10	-0.620086151572287	0.531	0.786	6.31581625700229e-06	TMA7	Plasma cells	GSE169246_PacBlood_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59793
3.21276938535954e-10	0.571063362145151	0.303	0.052	6.34072165894558e-06	TSC22D3	Plasma cells	GSE169246_PacBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59794
3.70680231488403e-10	-0.696793348706774	0.786	0.911	7.31574504865513e-06	MIF	Plasma cells	GSE169246_PacBlood_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59795
4.42105873337896e-10	-0.500400952786778	0.621	0.818	8.72540151619673e-06	NDUFA1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59796
7.49436855728971e-10	-0.56270625229357	0.71	0.896	1.4790885784667e-05	COX6A1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59797
8.29305512722996e-10	-0.805843371792397	0.207	0.526	1.6367173599101e-05	IFITM1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59798
9.71314277555242e-10	0.618554000869542	0.979	0.802	1.91698585818303e-05	MT-ATP8	Plasma cells	GSE169246_PacBlood_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59799
1.08957700160087e-09	0.377572674284115	0.379	0.104	2.15038917035947e-05	TRIB1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59800
1.32688342227902e-09	-0.540498805271402	0.366	0.661	2.61873712220988e-05	ATP5ME	Plasma cells	GSE169246_PacBlood_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59801
1.85554573577525e-09	-0.393023697763372	0.938	0.958	3.66210506412603e-05	RPL39	Plasma cells	GSE169246_PacBlood_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59802
2.28233587895395e-09	0.698784613762932	0.828	0.568	4.50441809070352e-05	HSPA8	Plasma cells	GSE169246_PacBlood_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59803
2.53492591267692e-09	-0.40123545422692	0.931	0.984	5.00292978125918e-05	RPL34	Plasma cells	GSE169246_PacBlood_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59804
5.44986892344172e-09	-0.413954283948629	0.421	0.724	0.000107558613073046	UQCR11	Plasma cells	GSE169246_PacBlood_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59805
6.95051981948729e-09	-0.586013464523771	0.09	0.354	0.000137175459157401	IFI6	Plasma cells	GSE169246_PacBlood_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59806
1.26656025484549e-08	-0.52323933731565	0.862	0.938	0.000249968331896306	RPL36	Plasma cells	GSE169246_PacBlood_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59807
1.48624339731787e-08	-0.493521916690293	0.821	0.906	0.000293324996894654	SEC61G	Plasma cells	GSE169246_PacBlood_pre	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59808
1.5626408125091e-08	-0.410863524854806	0.276	0.573	0.000308402790756795	NDUFA3	Plasma cells	GSE169246_PacBlood_pre	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59809
1.61218734736076e-08	-0.465014064971458	0.979	0.99	0.00031818129487512	RPL28	Plasma cells	GSE169246_PacBlood_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59810
2.35591663517339e-08	-0.540247021637386	0.862	0.969	0.00046496370711782	MYDGF	Plasma cells	GSE169246_PacBlood_pre	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59811
3.96829923917024e-08	0.411810776881531	0.338	0.099	0.000783183537842639	PNRC1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59812
3.9918137493042e-08	-0.50516827629419	0.986	1	0.000787824361562677	MZB1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59813
4.63327435642599e-08	0.357747695927865	0.379	0.13	0.000914423026984234	MYO1D	Plasma cells	GSE169246_PacBlood_pre	ENSG00000176658	4642	myosin ID	KIAA0727|myr4|PPP1R108	protein_coding	O94832	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59814
4.99165781220317e-08	-0.412743258073029	0.483	0.734	0.000985153585816418	UBL5	Plasma cells	GSE169246_PacBlood_pre	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59815
5.01954656254158e-08	-0.555545239681408	0.897	0.932	0.000990657709583205	RPL35	Plasma cells	GSE169246_PacBlood_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59816
5.08850484032054e-08	-0.309789372561844	0.193	0.479	0.00100426731528566	PET100	Plasma cells	GSE169246_PacBlood_pre	ENSG00000229833	100131801	PET100 cytochrome c oxidase chaperone	C19orf79	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59817
5.82266120751498e-08	-0.401066855699743	0.145	0.406	0.00114916041591516	NDUFB1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59818
5.82596896581435e-08	0.495859695030931	0.821	0.604	0.00114981323509312	PABPC1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59819
7.35514939335171e-08	-0.504117611093763	0.566	0.776	0.00145161228427189	RPL38	Plasma cells	GSE169246_PacBlood_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59820
8.8650029242223e-08	0.425614733188538	0.31	0.089	0.00174959697712451	TSPO	Plasma cells	GSE169246_PacBlood_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59821
9.75676219461596e-08	0.437734109500885	0.959	0.911	0.00192559458672941	EEF2	Plasma cells	GSE169246_PacBlood_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59822
1.01871589447758e-07	-0.417159470078496	0.31	0.573	0.00201053768934095	RPS10	Plasma cells	GSE169246_PacBlood_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59823
1.02318742854861e-07	-0.416055806593917	0.703	0.87	0.00201936270898354	COX7A2	Plasma cells	GSE169246_PacBlood_pre	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59824
1.40819926976017e-07	-0.432268113855257	0.359	0.615	0.00277922207879868	ATP5MD	Plasma cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59825
1.52755517099509e-07	-0.489646644035517	0.683	0.854	0.0030147828854759	CHCHD2	Plasma cells	GSE169246_PacBlood_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59826
1.92953944771706e-07	-0.38038089309446	0.924	0.943	0.0038081390540144	SEC61B	Plasma cells	GSE169246_PacBlood_pre	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59827
2.2888483289402e-07	-0.326928775945729	0.159	0.427	0.00451727106199637	NDUFA11	Plasma cells	GSE169246_PacBlood_pre	ENSG00000174886	126328	NADH:ubiquinone oxidoreductase subunit A11	B14.7	protein_coding	Q86Y39	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59828
2.43503080548846e-07	-1.34164868541695	0.538	0.74	0.00480577679771202	CRIP1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59829
2.68987312475477e-07	-0.364565400778736	0.145	0.391	0.00530873359901602	CBWD1	Plasma cells	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59830
3.29067124180398e-07	-0.469804836016294	0.703	0.833	0.00649446876282434	COX6B1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59831
4.56725790658664e-07	0.447333214198786	0.531	0.276	0.00901394020443939	DDX5	Plasma cells	GSE169246_PacBlood_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59832
4.6144272402275e-07	0.410929977042891	0.462	0.208	0.00910703360131299	SFPQ	Plasma cells	GSE169246_PacBlood_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59833
4.76354362953192e-07	-0.443594972509557	0.503	0.703	0.0094013297072442	COX7B	Plasma cells	GSE169246_PacBlood_pre	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59834
5.07132746759187e-07	-0.381626250069731	0.545	0.75	0.0100087718900393	NDUFB4	Plasma cells	GSE169246_PacBlood_pre	ENSG00000065518	4710	NADH:ubiquinone oxidoreductase subunit B4	B15	protein_coding	O95168	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59835
5.20647466665934e-07	-0.303108154812607	0.159	0.417	0.0102754984021189	DPM3	Plasma cells	GSE169246_PacBlood_pre	ENSG00000179085	54344	dolichyl-phosphate mannosyltransferase subunit 3, regulatory	MGC125904|MGC125905|MGC34275	protein_coding	Q9P2X0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59836
5.67009045497276e-07	0.420516528094026	0.821	0.63	0.0111904905219342	AQP3	Plasma cells	GSE169246_PacBlood_pre	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59837
6.13571811469283e-07	0.309051590828868	0.455	0.203	0.0121094532711578	KCNA3	Plasma cells	GSE169246_PacBlood_pre	ENSG00000177272	3738	potassium voltage-gated channel subfamily A member 3	HLK3|HPCN3|Kv1.3|MK3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59838
6.28733398504433e-07	-0.472524486398447	0.614	0.797	0.0124086823528835	RPL22L1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59839
6.39885788501393e-07	0.413840790743836	1	0.99	0.0126287859218635	MT-CO1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59840
7.04319666424639e-07	-0.410746579607639	0.945	0.948	0.0139004529365567	RPLP2	Plasma cells	GSE169246_PacBlood_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59841
7.35175945374491e-07	-0.36726329465706	0.814	0.911	0.0145094324579109	RABAC1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59842
7.60420320800262e-07	0.323753308604373	0.366	0.141	0.015007655451314	LRP10	Plasma cells	GSE169246_PacBlood_pre	ENSG00000197324	26020	LDL receptor related protein 10	DKFZP564C1940|LRP9|MGC8675|MST087|MSTP087	protein_coding	Q7Z4F1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59843
7.70767987206705e-07	0.291690396991672	0.966	0.995	0.0152118769955115	UBE2J1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59844
8.94056727714556e-07	-0.271869394352923	0.083	0.302	0.0176451035781745	NDUFC2	Plasma cells	GSE169246_PacBlood_pre	ENSG00000151366	4718	NADH:ubiquinone oxidoreductase subunit C2	B14.5b|HLC-1	protein_coding	O95298	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59845
9.24162523021395e-07	-0.408687954011044	0.69	0.828	0.0182392715543502	COX7C	Plasma cells	GSE169246_PacBlood_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59846
1.22562950239723e-06	-0.336713169723806	0.986	0.995	0.0241890238593117	RPS19	Plasma cells	GSE169246_PacBlood_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59847
1.34357454598534e-06	0.552824031333042	0.917	0.88	0.0265167872395667	TXNDC5	Plasma cells	GSE169246_PacBlood_pre	ENSG00000239264	81567	thioredoxin domain containing 5	EndoPDI|ERp46|FLJ21353|FLJ90810|Hcc-2|MGC3178|PDIA15	protein_coding	Q8NBS9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59848
1.36461848230274e-06	-0.355844925536037	0.931	0.948	0.026932110366727	RPL35A	Plasma cells	GSE169246_PacBlood_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59849
1.48580508211755e-06	-0.311468794248212	0.331	0.594	0.0293238491006719	NDUFAF3	Plasma cells	GSE169246_PacBlood_pre	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59850
1.80209883712644e-06	-0.453709926717798	0.772	0.885	0.0355662226495274	RPL22	Plasma cells	GSE169246_PacBlood_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59851
1.80767890050723e-06	-0.373225657399701	0.221	0.458	0.0356763507804107	NAA38	Plasma cells	GSE169246_PacBlood_pre	ENSG00000183011	84316	N-alpha-acetyltransferase 38, NatC auxiliary subunit	LSMD1|MGC14151|PFAAP2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59852
1.95034086715153e-06	0.285053634595592	0.303	0.099	0.0384919273541026	GAB1	Plasma cells	GSE169246_PacBlood_pre	ENSG00000109458	2549	GRB2 associated binding protein 1	DFNB26	protein_coding	Q13480	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59853
1.95236155923758e-06	-0.388495711826352	0.31	0.542	0.0385318077331129	BST2	Plasma cells	GSE169246_PacBlood_pre	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59854
2.06499485213563e-06	-0.419662672012819	0.448	0.672	0.0407547384017489	POLR2L	Plasma cells	GSE169246_PacBlood_pre	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59855
2.18692101763035e-06	-0.312430112079464	0.959	0.979	0.0431610732039526	FAU	Plasma cells	GSE169246_PacBlood_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59856
2.26762643682894e-06	-0.362773147164745	0.607	0.771	0.0447538753572559	ELOB	Plasma cells	GSE169246_PacBlood_pre	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59857
5.60754777154479e-41	3.34395440121736	0.644	0	1.10670562819208e-36	HBB	pDCs	GSE169246_PacBlood_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59858
1.32372864420084e-27	1.43838669400347	0.885	0.374	2.61251085219478e-23	ZFP36L2	pDCs	GSE169246_PacBlood_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59859
7.37786309674822e-25	-1.52572229960245	0.769	0.974	1.45609506077423e-20	RPS26	pDCs	GSE169246_PacBlood_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59860
3.30911583972812e-22	-0.892016513336237	0.904	1	6.53087102128742e-18	RPS21	pDCs	GSE169246_PacBlood_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59861
3.81540997052995e-22	1.2046907931255	0.904	0.436	7.53009311783791e-18	AHNAK	pDCs	GSE169246_PacBlood_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59862
6.85840181741653e-22	-0.964149090813081	0.481	0.894	1.35357418268533e-17	RPL36A	pDCs	GSE169246_PacBlood_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59863
5.26922518252564e-20	-1.1003725402545	0.875	0.991	1.03993428202326e-15	RPL41	pDCs	GSE169246_PacBlood_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59864
9.49034999557489e-20	0.94351735587135	0.663	0.203	1.87301547512666e-15	DDIT4	pDCs	GSE169246_PacBlood_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59865
8.09731125941669e-19	-0.872730108018173	0.942	1	1.59808535015848e-14	RPS28	pDCs	GSE169246_PacBlood_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59866
8.34983152891812e-19	-0.966547815675925	0.981	0.996	1.64792275054728e-14	TMSB10	pDCs	GSE169246_PacBlood_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59867
1.41279171140114e-18	-0.82502702026182	0.981	1	2.78828572162128e-14	RPL37	pDCs	GSE169246_PacBlood_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59868
1.65013237957426e-18	-0.863837566186255	0.962	0.996	3.25670126432775e-14	RPL39	pDCs	GSE169246_PacBlood_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59869
1.71766252929556e-18	1.02767213962517	1	0.912	3.38997876781772e-14	APP	pDCs	GSE169246_PacBlood_pre	ENSG00000142192	351	amyloid beta precursor protein	AD1|alpha-sAPP	protein_coding	P05067	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59870
1.74205679195365e-18	-0.833761203434459	0.846	0.991	3.43812328459973e-14	ATP5F1E	pDCs	GSE169246_PacBlood_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59871
9.48972050040255e-18	-0.804331666671479	0.885	0.987	1.87289123795945e-13	RPL36	pDCs	GSE169246_PacBlood_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59872
1.31243163428657e-17	0.702897338425279	0.385	0.031	2.59021507342797e-13	TSC22D3	pDCs	GSE169246_PacBlood_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59873
1.35607554092668e-17	0.890179593478627	0.337	0.013	2.6763506875729e-13	S100A9	pDCs	GSE169246_PacBlood_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59874
1.73119510223996e-16	-0.999885629417024	0.827	0.982	3.41668665378078e-12	RPS29	pDCs	GSE169246_PacBlood_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59875
2.62143659551944e-16	-0.755622061511692	0.981	0.996	5.17366726491717e-12	RPL28	pDCs	GSE169246_PacBlood_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59876
3.65927659917786e-16	0.870900393577784	0.981	0.899	7.22194829613743e-12	PSAP	pDCs	GSE169246_PacBlood_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59877
7.21721537457509e-16	-0.750316545731645	0.615	0.881	1.42438962632614e-11	UBL5	pDCs	GSE169246_PacBlood_pre	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59878
2.02825251764283e-15	-0.715133463819695	0.933	0.991	4.0029591688199e-11	SERF2	pDCs	GSE169246_PacBlood_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59879
1.40144267542984e-14	0.550024419775119	0.337	0.031	2.76588726422833e-10	S100A8	pDCs	GSE169246_PacBlood_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59880
1.41615291728148e-14	-0.661377047171678	0.548	0.863	2.79491939754674e-10	UQCR11	pDCs	GSE169246_PacBlood_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59881
1.46383874470251e-14	-0.683862101114793	0.962	0.996	2.88903214654488e-10	RPL34	pDCs	GSE169246_PacBlood_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59882
3.99869957374566e-14	-0.933916001922395	0.317	0.722	7.89183347874443e-10	IFI44L	pDCs	GSE169246_PacBlood_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59883
2.59868196284553e-13	0.998211557653681	0.962	0.74	5.12875872187193e-09	MT-ATP8	pDCs	GSE169246_PacBlood_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59884
3.16214038446595e-13	-0.713850818339709	0.683	0.877	6.240800262782e-09	OST4	pDCs	GSE169246_PacBlood_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59885
3.3272046956271e-13	-0.691548708289287	0.779	0.969	6.56657118728965e-09	RPL38	pDCs	GSE169246_PacBlood_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59886
4.25524717711608e-13	-0.780781826458696	0.481	0.815	8.39815582875629e-09	SEC61G	pDCs	GSE169246_PacBlood_pre	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59887
1.14479366179237e-12	0.694535902144679	0.856	0.599	2.25936477091341e-08	SELPLG	pDCs	GSE169246_PacBlood_pre	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59888
1.15174141962845e-12	-0.77165494081261	1	0.996	2.27307686577871e-08	RPS27	pDCs	GSE169246_PacBlood_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59889
1.23001842120157e-12	0.682700412642686	0.587	0.211	2.42756435608342e-08	SORL1	pDCs	GSE169246_PacBlood_pre	ENSG00000137642	6653	sortilin related receptor 1	C11orf32|gp250|LR11|LRP9|SorLA|SorLA-1	protein_coding	Q92673	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59890
1.23843333018158e-12	-0.687788196903324	0.971	1	2.44417202044638e-08	RPS15A	pDCs	GSE169246_PacBlood_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59891
4.00369060407885e-12	-0.609783790351157	0.788	0.912	7.90168377621002e-08	SUB1	pDCs	GSE169246_PacBlood_pre	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59892
4.01484862282366e-12	-0.819952423739373	0.048	0.423	7.92370524200478e-08	ISG15	pDCs	GSE169246_PacBlood_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59893
4.72157753965205e-12	-0.694272833204021	0.875	0.934	9.31850543225728e-08	SEC61B	pDCs	GSE169246_PacBlood_pre	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59894
6.10680823947311e-12	-0.682347867387353	0.529	0.819	1.20523967414241e-07	COX6C	pDCs	GSE169246_PacBlood_pre	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59895
6.88275378553083e-12	0.767942646410865	0.875	0.656	1.35838028711236e-07	CYBB	pDCs	GSE169246_PacBlood_pre	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59896
1.01182727840868e-11	-0.635947805979214	0.923	0.991	1.99694231666738e-07	RPL37A	pDCs	GSE169246_PacBlood_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59897
1.51735452539512e-11	-0.559494495211431	0.923	0.996	2.99465089131982e-07	RPL14	pDCs	GSE169246_PacBlood_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59898
1.775952423161e-11	-0.689979139640306	0.99	1	3.50501970235055e-07	RPLP1	pDCs	GSE169246_PacBlood_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59899
1.88161772231317e-11	-0.611140792154568	0.99	0.996	3.71356073675728e-07	RPS23	pDCs	GSE169246_PacBlood_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59900
2.20245984469286e-11	-0.601206654982664	0.269	0.634	4.34677474948582e-07	ROMO1	pDCs	GSE169246_PacBlood_pre	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59901
2.44290642270183e-11	-0.873078673779478	0.904	0.965	4.82132011584433e-07	S100A6	pDCs	GSE169246_PacBlood_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59902
2.44887868780628e-11	-0.603597264302087	0.721	0.952	4.83310697825447e-07	COX7C	pDCs	GSE169246_PacBlood_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59903
3.27250921763392e-11	0.912776980192311	0.548	0.229	6.45862419192231e-07	STK17B	pDCs	GSE169246_PacBlood_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59904
3.6775492005645e-11	-0.588489011987929	0.404	0.74	7.2580111022341e-07	PSMB9	pDCs	GSE169246_PacBlood_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59905
5.79299561484432e-11	0.696782882938576	0.913	0.74	1.14330561454568e-06	LCP1	pDCs	GSE169246_PacBlood_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59906
1.06625233366563e-10	-0.52578473969032	0.962	0.991	2.10435560572249e-06	RPS25	pDCs	GSE169246_PacBlood_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59907
1.15705721998414e-10	-0.563028299925768	0.702	0.956	2.28356812936069e-06	TMA7	pDCs	GSE169246_PacBlood_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59908
1.26440490129672e-10	-0.62697649037966	0.587	0.789	2.49542951319921e-06	DNASE1L3	pDCs	GSE169246_PacBlood_pre	ENSG00000163687	1776	deoxyribonuclease 1 like 3	DNAS1L3|LSD	protein_coding	Q13609	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59909
1.34072340753855e-10	0.5624955886221	0.971	0.894	2.64605171711809e-06	DDX5	pDCs	GSE169246_PacBlood_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59910
1.60825022412619e-10	-0.610856825016383	0.788	0.93	3.17404264233546e-06	SRP14	pDCs	GSE169246_PacBlood_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59911
2.16384729019178e-10	1.12935442865348	0.76	0.559	4.2705690119225e-06	KLF6	pDCs	GSE169246_PacBlood_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59912
2.17249893339362e-10	-0.540992018141812	0.394	0.762	4.28764389494565e-06	NDUFA1	pDCs	GSE169246_PacBlood_pre	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59913
2.43430202048976e-10	-0.668380526137359	0.5	0.78	4.80433846763858e-06	HIGD1A	pDCs	GSE169246_PacBlood_pre	ENSG00000181061	25994	HIG1 hypoxia inducible domain family member 1A	DKFZP564K247|HIG1|RCF1A	protein_coding	Q9Y241	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59914
2.68141216598232e-10	-0.586609278769706	0.529	0.802	5.29203505078271e-06	PSME2	pDCs	GSE169246_PacBlood_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59915
3.08739849207633e-10	0.681876577332523	0.99	0.872	6.09328966396185e-06	MPEG1	pDCs	GSE169246_PacBlood_pre	ENSG00000197629	219972	macrophage expressed 1	MPG1	protein_coding	Q2M385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59916
3.65048648851141e-10	0.572603699950264	0.894	0.718	7.20460013372612e-06	SARAF	pDCs	GSE169246_PacBlood_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59917
4.81002876254289e-10	-0.578178303524601	0.904	0.996	9.49307276575464e-06	RPS24	pDCs	GSE169246_PacBlood_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59918
5.01971004927161e-10	-0.589522683337507	0.625	0.868	9.90689975324245e-06	COX6B1	pDCs	GSE169246_PacBlood_pre	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59919
5.42821824897974e-10	0.561003686773853	0.913	0.661	1.07131315361864e-05	SFT2D2	pDCs	GSE169246_PacBlood_pre	ENSG00000213064	375035	SFT2 domain containing 2	dJ747L4.C1.2|UNQ512	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59920
6.16463151642356e-10	-0.535475013174246	0.433	0.771	1.21665167608135e-05	RPS10	pDCs	GSE169246_PacBlood_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59921
6.20469629450618e-10	0.578413526145356	0.923	0.744	1.22455886068374e-05	PNRC1	pDCs	GSE169246_PacBlood_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59922
6.25236058682912e-10	0.748261829179396	0.798	0.546	1.2339658854166e-05	PTPRC	pDCs	GSE169246_PacBlood_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59923
6.89623143294892e-10	-0.568643705007495	0.981	0.996	1.3610402356068e-05	RPS13	pDCs	GSE169246_PacBlood_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59924
7.38025961578933e-10	0.563376215812132	0.635	0.295	1.45656803777218e-05	UTRN	pDCs	GSE169246_PacBlood_pre	ENSG00000152818	7402	utrophin	DMDL|DRP|DRP1	protein_coding	P46939	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59925
7.5923728432239e-10	-0.615647004009105	0.971	0.991	1.49843070433867e-05	RPS12	pDCs	GSE169246_PacBlood_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59926
7.73300023976778e-10	-0.505246637055785	0.837	0.965	1.52618492732057e-05	RPL31	pDCs	GSE169246_PacBlood_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59927
8.23445288395141e-10	-0.493957532527249	0.942	1	1.62515162117665e-05	FAU	pDCs	GSE169246_PacBlood_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59928
1.03347804498497e-09	-0.527953743353714	0.692	0.916	2.03967226958233e-05	TOMM7	pDCs	GSE169246_PacBlood_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59929
1.17203473994098e-09	0.422183436747624	0.423	0.128	2.31312776274752e-05	ATXN2L	pDCs	GSE169246_PacBlood_pre	ENSG00000168488	11273	ataxin 2 like	A2D|A2lp	protein_coding	Q8WWM7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59930
1.54765479301608e-09	0.739665041647114	0.76	0.493	3.05445149949654e-05	B4GALT1	pDCs	GSE169246_PacBlood_pre	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59931
1.80394669423338e-09	-0.543276792847409	0.865	0.987	3.560269195739e-05	RPL22	pDCs	GSE169246_PacBlood_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59932
1.98220176937855e-09	-0.841667260864438	0.596	0.846	3.91207341204551e-05	CRIP1	pDCs	GSE169246_PacBlood_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59933
2.08751819674838e-09	-0.507556923147015	0.702	0.855	4.1199259131026e-05	COX6A1	pDCs	GSE169246_PacBlood_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59934
2.24182890767836e-09	0.592130197147472	0.49	0.189	4.42447353219401e-05	TSPYL2	pDCs	GSE169246_PacBlood_pre	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59935
2.85676235593878e-09	-0.962863325340879	0.779	0.899	5.63810618568078e-05	TXN	pDCs	GSE169246_PacBlood_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59936
3.2758319624418e-09	0.6617549518078	0.74	0.414	6.46518196107514e-05	AKAP13	pDCs	GSE169246_PacBlood_pre	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59937
3.2887657071032e-09	0.633068757869706	0.587	0.286	6.49070799953888e-05	IRF4	pDCs	GSE169246_PacBlood_pre	ENSG00000137265	3662	interferon regulatory factor 4	LSIRF|MUM1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59938
4.00981452118153e-09	-0.55109168015807	0.587	0.828	7.91376993900387e-05	TMEM258	pDCs	GSE169246_PacBlood_pre	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59939
5.00748011747054e-09	-0.463515108941196	0.788	0.943	9.88276275983986e-05	ATP5MG	pDCs	GSE169246_PacBlood_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59940
5.28401472951996e-09	-0.541315891763306	0.423	0.744	0.000104285314701806	DBI	pDCs	GSE169246_PacBlood_pre	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59941
5.79960895506059e-09	-0.494922986278855	0.894	0.982	0.000114461082337076	OAZ1	pDCs	GSE169246_PacBlood_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59942
8.68790260737947e-09	-0.466701593394018	0.923	0.996	0.000171464445859241	RPL9	pDCs	GSE169246_PacBlood_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59943
9.01285424679377e-09	-0.520692985389196	0.269	0.595	0.000177877691414722	NDUFA3	pDCs	GSE169246_PacBlood_pre	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59944
9.53478628108089e-09	-0.517747420624902	0.279	0.59	0.000188178542043412	DDT	pDCs	GSE169246_PacBlood_pre	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59945
1.11021528927483e-08	-0.487848902836151	0.913	0.987	0.000219112089491281	RPL24	pDCs	GSE169246_PacBlood_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59946
1.1555674950689e-08	0.363314185131758	0.413	0.132	0.000228062800826798	MSN	pDCs	GSE169246_PacBlood_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59947
1.18241409784193e-08	-1.20256615817812	0.26	0.59	0.000233361246350084	TCL1A	pDCs	GSE169246_PacBlood_pre	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59948
1.37289911984518e-08	-0.471210938091316	0.385	0.709	0.000270955370292645	SNRPG	pDCs	GSE169246_PacBlood_pre	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59949
1.4862737951189e-08	0.651046498798761	0.885	0.802	0.000293330996204667	CD164	pDCs	GSE169246_PacBlood_pre	ENSG00000135535	8763	CD164 molecule	DFNA66|MGC-24|MUC-24	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59950
1.52382508634296e-08	-0.50776333205228	0.913	0.991	0.000300742119040647	RPL35	pDCs	GSE169246_PacBlood_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59951
1.97324647742221e-08	-0.471087439385401	0.721	0.93	0.000389439924784048	RPL36AL	pDCs	GSE169246_PacBlood_pre	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59952
2.69365461264689e-08	-0.491275209263711	0.548	0.767	0.00053161967435199	COX5B	pDCs	GSE169246_PacBlood_pre	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59953
2.90437832716079e-08	0.614435486825859	0.663	0.405	0.000573208106648454	BTG2	pDCs	GSE169246_PacBlood_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59954
3.28500808091453e-08	0.493113572006865	0.75	0.379	0.000648329194849292	ZFP36	pDCs	GSE169246_PacBlood_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59955
3.29237123024266e-08	-0.455863688965522	0.375	0.709	0.000649782386000692	TRMT112	pDCs	GSE169246_PacBlood_pre	ENSG00000173113	51504	tRNA methyltransferase activator subunit 11-2	HSPC152|HSPC170|hTrm112|TRM112|TRMT11-2	protein_coding	Q9UI30	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59956
3.61901142975566e-08	0.531560219599469	0.577	0.295	0.000714248095776577	ASPH	pDCs	GSE169246_PacBlood_pre	ENSG00000198363	444	aspartate beta-hydroxylase	BAH|CASQ2BP1|HAAH|JCTN	protein_coding	Q12797	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59957
3.78755101056954e-08	0.425049203505796	0.538	0.233	0.000747511067446005	TMEM30A	pDCs	GSE169246_PacBlood_pre	ENSG00000112697	55754	transmembrane protein 30A	C6orf67|CDC50A|FLJ10856	protein_coding	Q9NV96	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59958
3.81426258143107e-08	0.571908522199354	0.702	0.436	0.000752782863071235	COBLL1	pDCs	GSE169246_PacBlood_pre	ENSG00000082438	22837	cordon-bleu WH2 repeat protein like 1	KIAA0977	protein_coding	Q53SF7	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59959
3.83934449965097e-08	0.47636558709568	0.702	0.396	0.000757733030451115	ADA2	pDCs	GSE169246_PacBlood_pre	ENSG00000093072	51816	adenosine deaminase 2	ADGF|CECR1|IDGFL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59960
4.27978946498893e-08	-0.415081329542428	0.288	0.63	0.000844659248810216	C8orf59	pDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59961
4.33721474425207e-08	-0.529036060936967	0.99	0.996	0.000855992701925589	RPS4X	pDCs	GSE169246_PacBlood_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59962
4.92531950567025e-08	0.490681201445679	0.817	0.59	0.00097206105763908	HNRNPU	pDCs	GSE169246_PacBlood_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59963
4.99269727148014e-08	-0.458853731571333	0.25	0.568	0.000985358733499321	COX17	pDCs	GSE169246_PacBlood_pre	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59964
5.05736612552194e-08	0.478561731050644	0.587	0.282	0.000998121778533011	NUMA1	pDCs	GSE169246_PacBlood_pre	ENSG00000137497	4926	nuclear mitotic apparatus protein 1	NUMA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59965
5.30244977862352e-08	-0.492656439662071	0.904	0.991	0.00104649148830914	MYL6	pDCs	GSE169246_PacBlood_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59966
5.51761803669078e-08	0.545564939695671	0.856	0.626	0.00108895709572129	CD4	pDCs	GSE169246_PacBlood_pre	ENSG00000010610	920	CD4 molecule	NA	protein_coding	P01730	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59967
6.89027314769119e-08	-0.492487468223163	0.952	0.991	0.00135986430842833	RPL12	pDCs	GSE169246_PacBlood_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59968
6.89147970621384e-08	-0.503087702731711	0.5	0.762	0.00136010243481836	ATP5MD	pDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59969
7.08068764040907e-08	-0.445617904414639	0.317	0.63	0.00139744451271113	ATP5ME	pDCs	GSE169246_PacBlood_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59970
7.21430530013813e-08	-0.506696624803554	0.99	0.996	0.00142381529403526	RPL10	pDCs	GSE169246_PacBlood_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59971
7.37612636982401e-08	-0.488486507163786	0.885	0.947	0.00145575230034847	TYROBP	pDCs	GSE169246_PacBlood_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59972
8.51366601631197e-08	-0.464966855297945	0.375	0.67	0.00168025712497933	POLR2L	pDCs	GSE169246_PacBlood_pre	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59973
8.99028576663825e-08	0.640681941979581	0.779	0.511	0.00177432279890372	MT-ND6	pDCs	GSE169246_PacBlood_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59974
9.16744254787706e-08	-0.460480219952051	0.904	0.996	0.00180928646124902	RACK1	pDCs	GSE169246_PacBlood_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59975
9.70813714911387e-08	-0.442403210790739	0.269	0.612	0.00191599794774911	MZT2B	pDCs	GSE169246_PacBlood_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59976
1.03589358519469e-07	-0.416511879848282	0.913	0.996	0.00204443957974023	H3F3A	pDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59977
1.22281476507603e-07	0.413805229217886	0.538	0.26	0.00241334722035404	SLC9A7	pDCs	GSE169246_PacBlood_pre	ENSG00000065923	84679	solute carrier family 9 member A7	NHE-7|NHE7	protein_coding	Q96T83	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59978
1.3618197350339e-07	-0.453853050512967	0.817	0.943	0.00268768742906291	ATP5MC2	pDCs	GSE169246_PacBlood_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59979
1.5730694662746e-07	-0.46519525844516	0.673	0.868	0.00310460989863955	PSME1	pDCs	GSE169246_PacBlood_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59980
1.62867766681938e-07	-0.585321732909246	0.856	0.969	0.00321435824323473	SH3BGRL3	pDCs	GSE169246_PacBlood_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59981
1.65222326196519e-07	0.371221266986354	0.279	0.07	0.00326082782981449	DMXL2	pDCs	GSE169246_PacBlood_pre	ENSG00000104093	23312	Dmx like 2	DFNA71|KIAA0856|RC3	protein_coding	Q8TDJ6	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59982
1.72609711493714e-07	0.357839055065607	0.413	0.159	0.00340662526603995	C3orf58	pDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59983
1.75436150571553e-07	0.408747732923128	0.404	0.15	0.00346240786768017	EP300	pDCs	GSE169246_PacBlood_pre	ENSG00000100393	2033	E1A binding protein p300	KAT3B|p300	protein_coding	Q09472	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59984
1.75548112617733e-07	-0.591101529869773	0.163	0.445	0.00346461755062358	LY6E	pDCs	GSE169246_PacBlood_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59985
1.83518064824214e-07	-0.451455279250173	0.856	0.916	0.0036219125273707	SSR4	pDCs	GSE169246_PacBlood_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59986
1.84411881191422e-07	0.423090506906954	0.481	0.216	0.00363955288719391	MOB1B	pDCs	GSE169246_PacBlood_pre	ENSG00000173542	92597	MOB kinase activator 1B	MOB4A|MOBKL1A	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59987
1.90854693854007e-07	-0.439357555945536	0.317	0.634	0.00376670823790268	UQCRQ	pDCs	GSE169246_PacBlood_pre	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59988
1.99073604096016e-07	-0.491275209263711	0.663	0.828	0.00392891665043897	SELENOH	pDCs	GSE169246_PacBlood_pre	ENSG00000211450	280636	selenoprotein H	C11orf31|SELH	protein_coding	Q8IZQ5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59989
2.18160260634906e-07	-0.463782656901647	0.846	0.996	0.00430561090389051	RPL27	pDCs	GSE169246_PacBlood_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59990
2.29221131138384e-07	0.434553634673563	0.663	0.37	0.00452390824414714	SLC38A1	pDCs	GSE169246_PacBlood_pre	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59991
2.29323910028642e-07	-0.476820278100783	0.212	0.515	0.00452593668832528	UBE2L6	pDCs	GSE169246_PacBlood_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59992
2.51818698890755e-07	-0.468585269589107	0.529	0.802	0.00496989384130795	ATP5MF	pDCs	GSE169246_PacBlood_pre	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59993
2.53258917725832e-07	0.497707007163769	0.692	0.463	0.00499831800023702	FLNB	pDCs	GSE169246_PacBlood_pre	ENSG00000136068	2317	filamin B	ABP-278|FH1|FLN1L|LRS1|TABP|TAP	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59994
2.57201907298107e-07	-0.445160252108712	0.875	0.978	0.00507613684243543	UBA52	pDCs	GSE169246_PacBlood_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59995
2.71771153362365e-07	-0.465986972510826	0.683	0.877	0.00536367548275964	RPL23	pDCs	GSE169246_PacBlood_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59996
2.77058347340188e-07	0.398188314586624	0.385	0.141	0.00546802354310596	SMARCA2	pDCs	GSE169246_PacBlood_pre	ENSG00000080503	6595	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2	BAF190|BRM|hBRM|hSNF2a|SNF2|SNF2L2|SNF2LA|Sth1p|SWI2	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59997
2.93176173154459e-07	0.35559061527259	0.375	0.132	0.00578612495337641	PIK3R5	pDCs	GSE169246_PacBlood_pre	ENSG00000141506	23533	phosphoinositide-3-kinase regulatory subunit 5	p101|P101-PI3K	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59998
3.58881523586096e-07	0.427006737744242	1	0.934	0.00708288574949518	UGCG	pDCs	GSE169246_PacBlood_pre	ENSG00000148154	7357	UDP-glucose ceramide glucosyltransferase	GCS	protein_coding	Q16739	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	59999
3.65529927676578e-07	0.544807932934639	0.962	0.93	0.00721409865262494	HNRNPA2B1	pDCs	GSE169246_PacBlood_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60000
3.66230606964869e-07	0.34370020422245	0.365	0.128	0.00722792725905865	USP14	pDCs	GSE169246_PacBlood_pre	ENSG00000101557	9097	ubiquitin specific peptidase 14	TGT|Ubp6	protein_coding	P54578	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60001
3.69566737796986e-07	0.603502345774317	0.442	0.189	0.00729376913716131	NFKBIZ	pDCs	GSE169246_PacBlood_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60002
4.27472427163371e-07	-0.428156934348417	0.529	0.78	0.00843659582249628	MIF	pDCs	GSE169246_PacBlood_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60003
4.34575184691488e-07	0.564993010383035	0.817	0.608	0.0085767758450712	RRBP1	pDCs	GSE169246_PacBlood_pre	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60004
4.40380501942658e-07	0.268501868421051	0.25	0.057	0.0086913495863403	UBQLN2	pDCs	GSE169246_PacBlood_pre	ENSG00000188021	29978	ubiquilin 2	Chap1|CHAP1/DSK2|Dsk2|LIC-2|N4BP4|PLIC-2|PLIC2|RIHFB2157	protein_coding	Q9UHD9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60005
4.6282377916936e-07	0.514674057067476	0.827	0.692	0.00913429010568649	TM9SF2	pDCs	GSE169246_PacBlood_pre	ENSG00000125304	9375	transmembrane 9 superfamily member 2	P76	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60006
4.68288453970206e-07	-0.706540173071691	0.971	0.982	0.00924214092755598	MT-ND4	pDCs	GSE169246_PacBlood_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60007
4.78056344355294e-07	0.607407710697388	0.808	0.678	0.00943492001219609	CANX	pDCs	GSE169246_PacBlood_pre	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60008
4.98660093662425e-07	-0.490323159708895	0.923	0.991	0.00984155560852161	RPL35A	pDCs	GSE169246_PacBlood_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60009
5.80326271111156e-07	-0.427826835950709	0.269	0.559	0.0114533192866498	AP2S1	pDCs	GSE169246_PacBlood_pre	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60010
5.86865097812557e-07	0.432661638150269	0.462	0.203	0.0115823695704286	FBXW11	pDCs	GSE169246_PacBlood_pre	ENSG00000072803	23291	F-box and WD repeat domain containing 11	BTRC2|BTRCP2|Fbw11|Fbw1b|FBXW1B|Hos|KIAA0696	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60011
6.53778084287616e-07	0.333648062391913	0.385	0.141	0.0129029642715004	USP22	pDCs	GSE169246_PacBlood_pre	ENSG00000124422	23326	ubiquitin specific peptidase 22	KIAA1063|USP3L	protein_coding	Q9UPT9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60012
6.69393590184593e-07	-0.394837238700179	0.538	0.806	0.0132111518958831	SNRPD2	pDCs	GSE169246_PacBlood_pre	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60013
6.86532386679716e-07	-0.424906399647996	0.856	0.956	0.0135494031835109	ARPC3	pDCs	GSE169246_PacBlood_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60014
7.23271946788396e-07	-0.411548016792977	0.875	0.969	0.0142744951418158	RPS11	pDCs	GSE169246_PacBlood_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60015
7.50433850796336e-07	-0.46974204771407	0.923	0.974	0.0148105624793165	PLAC8	pDCs	GSE169246_PacBlood_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60016
7.5095640651308e-07	0.431816511578855	0.596	0.326	0.0148208756389421	PRPF8	pDCs	GSE169246_PacBlood_pre	ENSG00000274442	10594	pre-mRNA processing factor 8	hPrp8|Prp8|PRPC8|RP13|SNRNP220	protein_coding	Q6P2Q9	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60017
7.99164809456064e-07	0.377647536145787	0.519	0.251	0.0157723166794249	SCRN1	pDCs	GSE169246_PacBlood_pre	ENSG00000136193	9805	secernin 1	KIAA0193	protein_coding	Q12765	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60018
8.39902843289013e-07	0.341568476324386	0.538	0.264	0.016576322515152	MAP2K1	pDCs	GSE169246_PacBlood_pre	ENSG00000169032	5604	mitogen-activated protein kinase kinase 1	MAPKK1|MEK1|PRKMK1	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60019
8.66919421573494e-07	0.430114956039923	0.596	0.335	0.0171095217041745	CAPRIN1	pDCs	GSE169246_PacBlood_pre	ENSG00000135387	4076	cell cycle associated protein 1	caprin-1|GPIAP1|M11S1|RNG105	protein_coding	Q14444	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60020
1.00712240230053e-06	-0.355017920586794	1	1	0.0198765677318033	RPS15	pDCs	GSE169246_PacBlood_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60021
1.04113661626208e-06	0.484562740062299	0.663	0.436	0.0205478722585484	TPP1	pDCs	GSE169246_PacBlood_pre	ENSG00000166340	1200	tripeptidyl peptidase 1	CLN2|LPIC|SCAR7|TPP-1	protein_coding	O14773	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60022
1.04707171329894e-06	-0.453565900211571	0.952	1	0.0206650073336678	RPL18	pDCs	GSE169246_PacBlood_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60023
1.05410091338032e-06	0.377872062648597	0.337	0.115	0.0208037356264739	LRBA	pDCs	GSE169246_PacBlood_pre	ENSG00000198589	987	LPS responsive beige-like anchor protein	BGL|CDC4L|LAB300|LBA	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60024
1.05682859482675e-06	0.526349266500586	0.856	0.705	0.0208575691475008	DDX17	pDCs	GSE169246_PacBlood_pre	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60025
1.07863013683697e-06	-0.506654452373036	0.481	0.744	0.0212878443806144	DYNLL1	pDCs	GSE169246_PacBlood_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60026
1.11670798746036e-06	-0.49610894133671	0.99	0.987	0.0220393488405177	RPL32	pDCs	GSE169246_PacBlood_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60027
1.12864982219137e-06	0.583315722672606	0.981	0.965	0.0222750328907689	MT-ND4L	pDCs	GSE169246_PacBlood_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60028
1.16312835149817e-06	-0.409606434750323	0.981	0.996	0.0229555011451679	RPS7	pDCs	GSE169246_PacBlood_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60029
1.20184602899155e-06	0.334474305213985	0.279	0.079	0.0237196332281773	RASD1	pDCs	GSE169246_PacBlood_pre	ENSG00000108551	51655	ras related dexamethasone induced 1	AGS1|DEXRAS1	protein_coding	Q9Y272	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60030
1.2985456569213e-06	-0.670676911197594	0.221	0.48	0.0256280970849987	PPP1R14A	pDCs	GSE169246_PacBlood_pre	ENSG00000167641	94274	protein phosphatase 1 regulatory inhibitor subunit 14A	CPI-17|PPP1INL	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60031
1.3059374560102e-06	0.387549916907949	0.567	0.313	0.0257739816318174	FLT3	pDCs	GSE169246_PacBlood_pre	ENSG00000122025	2322	fms related receptor tyrosine kinase 3	CD135|FLK2|STK1	protein_coding	P36888	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60032
1.37935114828925e-06	-0.425356819583246	0.731	0.96	0.0272228742626367	BTF3	pDCs	GSE169246_PacBlood_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60033
1.46655546303511e-06	-0.360803585909581	0.596	0.833	0.0289439386184609	UQCRB	pDCs	GSE169246_PacBlood_pre	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60034
1.49627265809922e-06	0.332559646617249	0.346	0.123	0.0295304371802462	FKBP5	pDCs	GSE169246_PacBlood_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60035
1.53586660124758e-06	0.281502451795647	0.337	0.115	0.0303118632422223	ZNF33A	pDCs	GSE169246_PacBlood_pre	ENSG00000189180	7581	zinc finger protein 33A	FLJ23404|KIAA0065|KOX31|KOX5|ZNF11A|ZNF33|ZZAPK	protein_coding	Q06730	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60036
1.61666785117119e-06	0.449946454045816	0.49	0.233	0.0319065567107147	ANKRD44	pDCs	GSE169246_PacBlood_pre	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60037
1.62866902531861e-06	0.331783795541337	0.269	0.075	0.032143411883688	SMAD3	pDCs	GSE169246_PacBlood_pre	ENSG00000166949	4088	SMAD family member 3	HsT17436|JV15-2|MADH3	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60038
1.72163558516345e-06	0.315769988653397	0.25	0.066	0.0339781999087858	AC007569.1	pDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60039
1.76160516398567e-06	0.289607501432702	0.298	0.093	0.0347670395164213	TMEM43	pDCs	GSE169246_PacBlood_pre	ENSG00000170876	79188	transmembrane protein 43	ARVD5|DKFZp586G1919|LUMA|MGC3222	protein_coding	Q9BTV4	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60040
1.95142111926883e-06	-0.497036925459221	0.635	0.824	0.0385132472098895	PPP1R14B	pDCs	GSE169246_PacBlood_pre	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60041
1.97830062782395e-06	0.313478905051544	0.413	0.167	0.0390437411907334	HECTD1	pDCs	GSE169246_PacBlood_pre	ENSG00000092148	25831	HECT domain E3 ubiquitin protein ligase 1	KIAA1131	protein_coding	Q9ULT8	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60042
1.97885372633606e-06	0.394756781447143	0.635	0.392	0.0390546571429684	CLTC	pDCs	GSE169246_PacBlood_pre	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60043
2.00598646841079e-06	-0.457249845868744	0.702	0.863	0.0395901489405553	PARK7	pDCs	GSE169246_PacBlood_pre	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60044
2.02628506983691e-06	-0.433380123622866	0.962	1	0.0399907621383012	RPS27A	pDCs	GSE169246_PacBlood_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60045
2.08075820334252e-06	0.301680333733277	0.317	0.106	0.0410658439011679	NUP98	pDCs	GSE169246_PacBlood_pre	ENSG00000110713	4928	nucleoporin 98 and 96 precursor	NUP196|NUP96|Nup98-96|Nup98-Nup96	protein_coding	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60046
2.19944658394965e-06	0.363314185131758	0.346	0.128	0.0434082777808303	RNF19A	pDCs	GSE169246_PacBlood_pre	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60047
2.20140389621595e-06	-0.467372411139457	0.981	0.996	0.043446907295718	RPS14	pDCs	GSE169246_PacBlood_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60048
2.20301969090377e-06	0.360574022786846	0.548	0.278	0.0434787966196768	SERINC1	pDCs	GSE169246_PacBlood_pre	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60049
2.21391099055759e-06	0.328842664715802	0.471	0.211	0.0436937473096446	NUS1	pDCs	GSE169246_PacBlood_pre	ENSG00000153989	116150	NUS1 dehydrodolichyl diphosphate synthase subunit	C6orf68|MGC7199|NgBR|TANGO14	protein_coding	Q96E22	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60050
2.24222771110374e-06	-0.492148171669758	0.596	0.837	0.0442526061063434	MX1	pDCs	GSE169246_PacBlood_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60051
2.27638818141007e-06	0.357063203989695	0.481	0.229	0.0449267971483091	CCDC47	pDCs	GSE169246_PacBlood_pre	ENSG00000108588	57003	coiled-coil domain containing 47	GK001	protein_coding	Q96A33	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60052
2.32884567831892e-06	-0.446930564195514	0.394	0.656	0.0459620983073022	ATP5MPL	pDCs	GSE169246_PacBlood_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60053
2.36714328877837e-06	-0.411548016792977	0.962	0.996	0.0467179399473299	RPL30	pDCs	GSE169246_PacBlood_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60054
2.42843225971498e-06	-0.403961973075261	0.173	0.432	0.0479275390777349	NDUFB1	pDCs	GSE169246_PacBlood_pre	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60055
2.48861461325216e-06	0.357063203989695	0.462	0.207	0.0491152980071447	SECISBP2	pDCs	GSE169246_PacBlood_pre	ENSG00000187742	79048	SECIS binding protein 2	SBP2	protein_coding	Q96T21	GSE169246_PacBlood	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 4, sensitive 5); post (resistant 4, sensitive 5)	18	120823	Public on Sep 15, 2021	34653365	This dataset has 9 patients with both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60056
0	-1.09408508269751	0.141	0.444	0	KLRB1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60057
0	-0.632663491903616	0.999	1	0	MT-CO1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60058
0	-0.772087972951883	0.972	0.989	0	MT-ND3	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60059
4.15286888862526e-278	0.785177884216057	0.99	0.961	8.49427802479411e-274	HSP90AA1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60060
2.1082595075841e-276	-0.472635795490493	0.993	0.998	4.31223399681251e-272	MT-CYB	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60061
1.26278110149522e-274	0.497166813152863	0.992	0.983	2.58289246499832e-270	RPS3A	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60062
4.70165419509963e-271	-0.45778242379475	0.996	0.998	9.61676349065678e-267	MT-CO3	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60063
7.1054696702371e-238	1.05888297385692	0.823	0.621	1.4533527663503e-233	HSPA1A	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60064
2.77370910547517e-233	-0.582174934361634	0.097	0.306	5.67334460433891e-229	CEBPD	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60065
4.42992373040384e-232	0.523765561410136	0.87	0.77	9.06096599816801e-228	RPL27A	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60066
5.94375016434399e-229	0.977642868402874	0.784	0.558	1.21573465861492e-224	HSPA1B	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60067
1.34507158865018e-206	0.419834966285609	0.996	0.994	2.75120942742507e-202	RPS18	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60068
6.9770772902286e-205	0.680654786097383	0.9	0.816	1.42709138894336e-200	DNAJA1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60069
4.61611569973126e-186	0.385138806587744	0.998	0.988	9.44180305223032e-182	HLA-C	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60070
5.95088699220797e-186	-0.593366247773442	0.728	0.847	1.21719442538622e-181	S100A4	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60071
4.28954561156567e-184	0.618693292933661	0.847	0.725	8.77383659389642e-180	HSPE1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60072
1.15691625655119e-183	0.479842114183786	0.985	0.955	2.36635651114981e-179	UBC	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60073
5.32043599765663e-183	0.896490374143843	0.834	0.694	1.08824197896069e-178	JUN	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60074
5.0084087848938e-178	-0.381739082325949	0.994	0.996	1.02441993286218e-173	RPL34	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60075
5.72893475556727e-176	0.610048909662442	0.962	0.92	1.17179631490373e-171	HSP90AB1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60076
1.47303348887429e-170	0.744448542865237	0.923	0.851	3.01294269814347e-166	JUNB	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60077
3.80441523865352e-169	0.653550362296833	0.946	0.88	7.78155092914191e-165	DNAJB1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60078
1.12758760213604e-148	-0.31085289226537	0.996	0.996	2.30636768140906e-144	MT-ND4L	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60079
1.56190938807917e-147	-0.2836909130766	0.999	1	3.19472946237713e-143	MT-CO2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60080
3.12461625508032e-147	-0.380482070829935	0.963	0.976	6.39109008814128e-143	RPL41	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60081
3.68007775072746e-145	0.431188156847376	0.57	0.371	7.52723103133796e-141	SRSF5	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60082
5.82419265170193e-145	0.616738351731808	0.721	0.555	1.19128036497911e-140	HSPH1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60083
4.22410501513584e-142	0.344523037032697	0.998	0.999	8.63998439795884e-138	HLA-A	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60084
3.8224626729826e-140	0.440361192465927	0.968	0.93	7.81846515131861e-136	UBB	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60085
2.25680894751012e-136	-0.382125033689257	0.556	0.725	4.6160770212372e-132	PCBP1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60086
6.75372104712729e-136	0.593745668820969	0.705	0.566	1.38140610297942e-131	HSPD1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60087
7.31448615286777e-133	0.443964826752654	0.612	0.448	1.49610499770757e-128	SRSF3	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60088
4.45335968430565e-129	-0.897197062856982	0.541	0.727	9.10890189827877e-125	CCL4	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60089
4.04399115455189e-124	0.300799114571236	0.984	0.972	8.27157950752044e-120	RPS9	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60090
2.53900975604697e-123	-0.305897031152973	0.992	0.993	5.19329055501847e-119	RPL39	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60091
3.6249085415015e-123	-0.348549123745587	0.887	0.935	7.41438793078717e-119	MT-ND4	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60092
2.51042670742043e-112	0.494314622924283	0.695	0.555	5.13482678735774e-108	COTL1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60093
2.27048950551683e-106	-0.251752218410514	0.97	0.976	4.64405923458413e-102	RPS21	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60094
8.84926159838801e-106	0.407054870911191	0.431	0.258	1.81002796733428e-101	H2AFX	CD8+ T cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60095
1.25950888949145e-104	-0.352527363523069	0.15	0.299	2.57619948256581e-100	KLRD1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60096
8.25381817916018e-103	0.416152352040891	0.733	0.623	1.68823597036542e-98	SRSF2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60097
1.16464843471915e-102	-0.281090722894787	0.937	0.966	2.38217190837456e-98	MT-ND5	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60098
9.57667110655691e-101	-0.303391008140636	0.25	0.412	1.95881230813515e-96	EFHD2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60099
7.52774143944202e-99	-0.255866189214696	0.995	0.998	1.53972423402347e-94	RPS8	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60100
2.5771982048062e-98	0.414098621332305	0.701	0.576	5.27140120811061e-94	DYNLL1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60101
4.77309616571668e-96	-0.258073515748508	0.987	0.988	9.7628908973569e-92	RPL35A	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60102
8.52307396232152e-94	0.4576164120359	0.377	0.223	1.74330954825324e-89	HLA-DQA1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60103
7.12971273207562e-89	0.295696869869396	0.372	0.215	1.45831144221875e-84	NASP	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60104
1.22950711558348e-88	0.359509966605226	0.595	0.455	2.51483385421446e-84	EIF4A2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60105
1.61922203074986e-88	0.385161706454956	0.686	0.557	3.31195674169576e-84	TUBB4B	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60106
8.87825203693673e-85	-0.35838686416797	0.992	0.998	1.81595767163504e-80	FTH1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60107
1.0748285152061e-84	0.484892932651752	0.252	0.118	2.19845424500256e-80	MX1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60108
1.33094273907824e-84	-0.260793335088718	0.4	0.586	2.72231027851063e-80	CTSW	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60109
6.42440296712264e-83	0.405468439672122	0.656	0.545	1.31404738289527e-78	TUBA1B	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60110
2.78078838748079e-79	0.361589257740611	0.809	0.729	5.68782456775322e-75	SRSF7	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60111
3.18513058408787e-79	-0.313286078634816	0.154	0.279	6.51486609669333e-75	MGP	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60112
8.43075227319441e-79	-0.27390617745638	0.207	0.345	1.72442606995918e-74	RORA	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60113
8.77711304679474e-77	0.300498034493762	0.336	0.195	1.7952707025914e-72	MYLIP	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000007944	29116	myosin regulatory light chain interacting protein	IDOL|MIR	protein_coding	Q8WY64	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60114
1.07516879354088e-74	0.282979742025608	0.992	0.986	2.19915025030851e-70	HSPA8	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60115
1.31391676404079e-73	-0.271516561402555	0.823	0.886	2.68748534916902e-69	MYL12A	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60116
2.89409648980974e-73	-0.707250853405833	0.268	0.416	5.91958496025684e-69	CCL4L2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60117
7.64493691093478e-73	0.286962195898701	0.279	0.149	1.5636953957626e-68	IRF7	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60118
1.84005594004447e-71	0.274971706236541	0.253	0.127	3.76365041976695e-67	XAF1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60119
5.26179058775348e-71	0.271421214795513	0.48	0.334	1.0762466468191e-66	CCNL1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60120
7.75434069683378e-70	-0.287129234568627	0.306	0.448	1.58607284613038e-65	FOSL2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60121
2.46113815123547e-69	-0.25579746779142	0.419	0.568	5.03401197453703e-65	ALOX5AP	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60122
3.14080323763967e-67	0.316384610641249	0.702	0.592	6.42419894226819e-63	FUS	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60123
8.20524486656334e-67	-0.328403807131637	0.306	0.441	1.67830078500687e-62	DUSP5	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60124
1.0784384752707e-64	-0.279014456574114	0.4	0.534	2.20583805731869e-60	MT-ND6	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60125
6.32373878713922e-64	0.675276853125799	0.386	0.27	1.29345753152146e-59	ISG15	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60126
9.4055154595393e-64	-0.281514350373234	0.691	0.813	1.92380413209417e-59	CST7	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60127
2.20042962861241e-63	0.459358029018786	0.667	0.573	4.50075876236382e-59	TUBA4A	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60128
2.33743010945454e-63	0.384228506649769	0.58	0.475	4.78097954587831e-59	LY6E	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60129
2.20875785164532e-62	0.26077429026619	0.355	0.225	4.51779330975533e-58	CD27	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60130
5.92593643207041e-62	0.32694237090199	0.306	0.186	1.21209103781568e-57	ZFAND2A	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60131
1.54717624494213e-61	0.316838971289055	0.382	0.257	3.16459429140464e-57	SNHG12	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000197989	85028	small nucleolar RNA host gene 12	ASLNC04080|C1orf79|LINC00100|PNAS-123	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60132
1.89114770177595e-61	-0.251175769695665	0.855	0.891	3.86815350921252e-57	ATP5F1E	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60133
5.94244923220522e-60	0.311193975431644	0.617	0.525	1.21546856595526e-55	ZFAS1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60134
7.09413038258676e-60	-0.291597980111225	0.704	0.775	1.4510334284543e-55	S100A6	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60135
9.02882880421335e-60	0.398651492071881	0.647	0.557	1.8467566436138e-55	H2AFZ	CD8+ T cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60136
2.3406570663441e-59	0.303057040180418	0.673	0.581	4.78757996350022e-55	CALR	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60137
4.176724424605e-58	0.281515980921057	0.385	0.264	8.54307213808707e-54	CKS2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60138
1.37555408337226e-57	-0.253224959742324	0.677	0.773	2.81355832212963e-53	PPDPF	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60139
9.71871215309985e-57	-0.306583602163243	0.47	0.602	1.98786538379504e-52	HIST1H4C	CD8+ T cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60140
5.5924682902731e-56	0.451189870633617	0.84	0.784	1.14388346409246e-51	DUSP1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60141
1.53121465064683e-55	0.361786926755977	0.351	0.233	3.13194644643302e-51	OASL	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000135114	8638	2'-5'-oligoadenylate synthetase like	OASL1|p59OASL|TRIP14	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60142
3.70523890756885e-55	0.35378395750937	0.436	0.32	7.57869566154132e-51	RGS2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60143
3.06828939630191e-54	0.280844755329764	0.374	0.253	6.27587913119593e-50	MRPL18	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60144
4.18489659649047e-54	-0.2507260774932	0.267	0.398	8.5597874984616e-50	GZMH	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60145
6.75912111863375e-53	0.303891910776224	0.666	0.593	1.38251063360535e-48	SOD1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60146
1.36666116217527e-52	0.322056338412767	0.653	0.569	2.79536874111329e-48	SAP18	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60147
6.35184934777388e-52	0.256525402584112	0.334	0.216	1.29920726559367e-47	TSPYL2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60148
1.70835800040386e-51	0.314181585576098	0.355	0.243	3.49427545402606e-47	CHMP1B	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60149
3.34544667179597e-50	0.322363445843904	0.513	0.413	6.84277662249147e-46	HERPUD1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60150
1.00412630839803e-49	0.28490778234613	0.542	0.431	2.05383995119733e-45	RSRP1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60151
2.67906955043351e-49	0.34599235870583	0.406	0.293	5.4797688584567e-45	NEU1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000184494	4758	neuraminidase 1	NEU	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60152
5.44522811618214e-49	-0.313152848305156	0.558	0.675	1.11376695888389e-44	ANXA1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60153
1.53293526279416e-48	0.431871461688963	0.371	0.26	3.13546578651918e-44	DUSP4	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60154
3.14365568767184e-47	0.252369554065162	0.38	0.271	6.43003334356399e-43	MAT2A	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60155
5.18958982669982e-47	0.299641892102612	0.567	0.465	1.06147870315318e-42	TUBA1A	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60156
2.61881836931943e-45	0.265213719791192	0.455	0.351	5.35653109260595e-41	EIF4A3	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60157
3.86785188753051e-45	0.441162636655103	0.59	0.509	7.91130425075491e-41	SAT1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60158
1.09344070642684e-44	-0.289623999671844	0.345	0.453	2.23652362092546e-40	PIK3R1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60159
4.58714559242697e-44	0.268076182289795	0.752	0.699	9.38254759475012e-40	CALM2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60160
9.21485562538932e-44	0.265310889669926	0.443	0.338	1.88480656961713e-39	IFRD1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60161
5.46865072234135e-43	0.371195084348561	0.681	0.62	1.1185578187477e-38	IER2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60162
6.87876145769701e-43	0.285722940145856	0.449	0.355	1.40698186855735e-38	SNHG8	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60163
1.28220544605629e-41	0.561605758921164	0.827	0.815	2.62262301936353e-37	CXCR4	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60164
1.84931582167918e-41	-0.294742541090897	0.617	0.693	3.7825905816626e-37	MCL1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60165
3.84474580675444e-38	0.411119108967698	0.268	0.179	7.86404307313553e-34	IFI6	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60166
1.91640272875002e-37	0.326553226601274	0.603	0.527	3.91981014138529e-33	PPP1R15A	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60167
2.67953722396489e-37	-0.286946068312876	0.446	0.54	5.48072543789779e-33	REL	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60168
1.78386128376612e-36	-0.288436213396935	0.907	0.926	3.64870986981523e-32	ZFP36L2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60169
5.54437676480054e-33	0.383784855079201	0.722	0.675	1.1340468234723e-28	TSC22D3	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60170
2.31860816925759e-31	-0.320154730274947	0.824	0.864	4.74248114939948e-27	PTPRC	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60171
6.4517932627075e-31	0.322076626937431	0.604	0.542	1.31964979395419e-26	SQSTM1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60172
5.02336916520127e-26	0.257153198260979	0.482	0.405	1.02747992905027e-21	CITED2	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60173
9.55744345332839e-26	0.326837081704747	0.533	0.471	1.95487948394379e-21	GADD45B	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60174
2.4865121269217e-23	0.394643532263153	0.459	0.404	5.08591190440565e-19	NR4A1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60175
2.39808903402196e-18	-0.30410622734612	0.968	0.961	4.90505131018852e-14	MT-ATP6	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60176
7.63071796080548e-14	0.319676046193279	0.508	0.488	1.56078705170315e-09	ISG20	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60177
1.91640149737318e-11	0.420825218898489	0.321	0.287	3.91980762272711e-07	EGR1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60178
5.33865390643069e-10	-0.264918941506068	0.501	0.512	1.09196827002133e-05	IL7R	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60179
1.42242013117484e-07	0.27685321523748	0.472	0.455	0.00290941813630502	RGS1	CD8+ T cells	GSE169246_PacTissue_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60180
0	-0.713248562868493	0.979	0.989	0	MT-ND3	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60181
7.76832163892312e-217	0.568078686029057	0.997	0.99	1.58893250802534e-212	RPS3A	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60182
8.43969624773971e-197	-0.488312657562585	0.999	1	1.72625547051268e-192	MT-CO1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60183
5.04724739504112e-146	-0.63522457528731	0.803	0.917	1.03236398218171e-141	S100A4	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60184
1.27476116254562e-132	0.73846151500611	0.985	0.954	2.60739648187081e-128	HSP90AA1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60185
1.93346026370152e-125	-0.426387406693811	0.996	0.998	3.95469962337508e-121	MT-CYB	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60186
3.48340750007102e-123	0.732685143052633	0.856	0.743	7.12496170064526e-119	HSPE1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60187
3.97588696655837e-117	-0.542741359891173	0.086	0.27	8.13227920139848e-113	CCL4	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60188
1.69948172784329e-116	-0.53422241012901	0.169	0.391	3.47611992613067e-112	GZMA	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60189
7.53955374479403e-108	-0.409457296990759	0.971	0.984	1.54214032296017e-103	RPL41	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60190
1.98963023393657e-104	-0.449938704206683	0.839	0.936	4.06958968049386e-100	CD52	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60191
9.62395149405871e-103	0.360676925710403	0.998	0.997	1.96848303859477e-98	RPS18	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60192
6.34014863459289e-102	0.527160791067717	0.957	0.896	1.29681400171963e-97	UBB	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60193
1.34099466635674e-99	-0.416825221308194	0.128	0.309	2.74287049056607e-95	MGP	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60194
2.84376214363944e-99	-0.704768081782337	0.52	0.735	5.8166310886001e-95	ANXA1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60195
6.09611272084403e-99	0.452014586508956	0.57	0.351	1.24689889592144e-94	SRSF5	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60196
1.69321606012148e-98	0.598211635403953	0.955	0.912	3.46330412937248e-94	HSP90AB1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60197
1.19328777883735e-94	0.565157309524078	0.979	0.942	2.44075082283392e-90	UBC	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60198
6.37916028247587e-94	-0.393650128826418	0.575	0.768	1.30479344417761e-89	PCBP1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60199
1.34122169596611e-93	-0.353764737844452	0.997	0.998	2.74333485692909e-89	MT-CO3	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60200
2.36117718548035e-93	0.882532723380061	0.797	0.693	4.8295518151815e-89	JUN	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60201
5.52128651252574e-93	0.493082638474247	0.616	0.424	1.12932394327201e-88	SRSF3	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60202
6.76570247852867e-92	-0.463881480320802	0.694	0.839	1.38385678495826e-87	S100A6	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60203
3.18142069224403e-90	-0.53668444424298	0.563	0.736	6.50727788391594e-86	MCL1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60204
5.48189284647526e-89	-0.301999186110225	0.997	0.997	1.12126636281805e-84	RPL34	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60205
1.60313657804618e-88	-0.688547116080822	0.231	0.421	3.27905555673566e-84	KLRB1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60206
2.18236603404409e-87	0.895081594329772	0.73	0.567	4.46381148603378e-83	HSPA1B	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60207
2.48416535209588e-87	-0.518967748050494	0.994	0.997	5.08111181117692e-83	FTH1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60208
6.36472119869394e-82	0.681751747325329	0.713	0.591	1.30184007398086e-77	HSPD1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60209
1.70032845004987e-81	-0.487210152805178	0.861	0.945	3.477851811732e-77	VIM	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60210
2.25570778574671e-78	-0.556767188734271	0.767	0.87	4.61382470496633e-74	CRIP1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60211
5.09955700269991e-78	-0.314038365670694	0.107	0.258	1.04306338933224e-73	CCR6	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000112486	1235	C-C motif chemokine receptor 6	BN-1|CD196|CKR-L3|CMKBR6|DCR2|DRY-6|GPR-CY4|GPR29|STRL22	protein_coding	P51684	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60212
1.58491049736296e-77	-0.646596258613479	0.664	0.796	3.2417759313062e-73	RGCC	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60213
2.72329767906983e-75	-0.270583130715889	0.133	0.294	5.57023307276943e-71	IFITM3	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60214
8.0102192090657e-74	0.653317278463178	0.931	0.867	1.6384102370223e-69	DNAJB1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60215
8.39932811163348e-74	0.925049765065638	0.771	0.623	1.71799857195351e-69	HSPA1A	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60216
1.47795467100089e-73	-0.278600039729835	0.135	0.296	3.02300848406523e-69	LGALS3	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60217
1.01886989027201e-71	-0.32602030048486	0.437	0.64	2.08399647356237e-67	TGFB1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60218
2.87368636502016e-71	0.522670260814332	0.868	0.797	5.87783809101224e-67	DNAJA1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60219
2.67789269850326e-70	-0.298032105720004	0.926	0.975	5.47736172551856e-66	MT-ND5	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60220
6.36379113642294e-69	-0.410456318669637	0.435	0.617	1.30164983904395e-64	SAMSN1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60221
5.53969253222047e-68	-0.359536670405729	0.214	0.392	1.13308871054037e-63	LGALS1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60222
7.10289055979752e-68	0.354410152611232	0.871	0.822	1.45282523510098e-63	RPL27A	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60223
8.26329680653266e-68	0.419784885578488	0.76	0.64	1.69017472880819e-63	SRSF7	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60224
8.53756843235862e-68	0.272464449464859	0.991	0.979	1.74627424715463e-63	RPS9	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60225
7.63470866893728e-67	-0.26640434806611	0.172	0.338	1.56160331114443e-62	TIMP1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60226
2.98589867260908e-64	-0.364794282763202	0.563	0.735	6.10735714495462e-60	S100A11	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60227
1.42046532942799e-61	-0.260438665782033	0.997	0.997	2.905419784812e-57	MT-ND4L	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60228
2.36495028504946e-60	-0.298915315784681	0.815	0.892	4.83726931304016e-56	MYL12A	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60229
5.3809970928555e-60	-0.504705297052036	0.895	0.929	1.10062914537266e-55	ZFP36L2	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60230
1.31996112889616e-57	-0.292574129139455	0.561	0.743	2.6998484930442e-53	RPL36A	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60231
2.67015474293727e-56	-0.414113785687862	0.31	0.474	5.46153451120389e-52	CST7	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60232
8.3420880797295e-56	-0.423403738426084	0.266	0.422	1.70629069582787e-51	DUSP5	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60233
1.35317601096568e-54	-0.473357054410317	0.743	0.824	2.76778621282921e-50	IL7R	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60234
1.70170412667826e-54	-0.462531056226698	0.332	0.507	3.48066562070771e-50	CCL5	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60235
5.39233957440974e-54	0.328429070123724	0.986	0.976	1.10294913654977e-49	MT-ATP8	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60236
1.14196011980211e-53	-0.29380690970414	0.344	0.516	2.33576522904325e-49	ALOX5AP	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60237
3.16115016005493e-53	0.344544675078522	0.344	0.183	6.46581653737636e-49	H2AFX	CD4+ T cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60238
1.47583187099034e-52	-0.367728604854473	0.663	0.789	3.01866650892365e-48	S100A10	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60239
2.12719521320455e-52	0.555321030885387	0.924	0.894	4.35096508908858e-48	JUNB	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60240
2.63263035750979e-52	0.33257205642354	0.998	0.997	5.38478213325052e-48	HLA-A	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60241
3.7224238372497e-50	0.389521260041307	0.355	0.199	7.61384571671054e-46	PIM2	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60242
4.31514502690238e-49	0.336365526887675	0.675	0.561	8.82619763802613e-45	FUS	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60243
8.28290644983372e-48	-0.463018476079674	0.669	0.784	1.69418568524899e-43	TNFAIP3	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60244
4.06010620869292e-45	0.348090887533739	0.619	0.513	8.30454123926051e-41	EIF4A2	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60245
2.77665688311231e-44	-0.250192619456907	0.262	0.414	5.67937398871791e-40	PTGER4	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60246
3.90861087754321e-44	-0.263085468115839	0.231	0.374	7.99467268892689e-40	CLEC2B	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60247
4.06386497419208e-44	-0.287204076694389	0.885	0.932	8.31222941821248e-40	MT-ND4	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60248
2.41834568087247e-42	0.46017272882346	0.683	0.571	4.94648425565655e-38	HSPH1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60249
6.62256773879902e-40	0.362831474119992	0.752	0.686	1.35458000529395e-35	SOD1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60250
6.8520677628149e-39	-0.254012110108934	0.582	0.733	1.40152194020616e-34	HCST	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60251
7.16686458642305e-39	0.319051377275617	0.64	0.539	1.46591048250697e-34	SRSF2	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60252
1.01548317490859e-37	0.256214799345251	0.277	0.151	2.07706928595802e-33	MYLIP	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000007944	29116	myosin regulatory light chain interacting protein	IDOL|MIR	protein_coding	Q8WY64	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60253
2.75703207416754e-37	0.341943691289031	0.32	0.194	5.63923340450229e-33	ZFAND2A	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60254
4.47251122171051e-36	0.277327062163554	0.397	0.261	9.14807445288668e-32	CD27	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60255
1.72037408296758e-35	0.338900121862722	0.689	0.594	3.5188531493019e-31	DYNLL1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60256
7.49931964346017e-34	-0.337629000215325	0.213	0.337	1.53391083987334e-29	GZMK	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60257
1.36639107303927e-33	-0.251252698087936	0.38	0.516	2.79481630079453e-29	AHNAK	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60258
1.42304437054749e-30	0.268958466004627	0.35	0.233	2.91069495551784e-26	SNHG12	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000197989	85028	small nucleolar RNA host gene 12	ASLNC04080|C1orf79|LINC00100|PNAS-123	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60259
3.28378859115382e-30	0.621775304402799	0.813	0.782	6.71666118434602e-26	DUSP1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60260
1.40784411544317e-29	0.286210059981293	0.326	0.212	2.87960435372746e-25	TSPYL2	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60261
6.00618229500221e-29	-0.299908921772946	0.403	0.533	1.22850452661975e-24	MT2A	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60262
6.53862048767395e-29	-0.283003228017714	0.536	0.652	1.33740943454883e-24	SLC2A3	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60263
9.93453282787674e-29	0.423760497652361	0.385	0.28	2.03200934461391e-24	RGS2	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60264
1.84715315775517e-28	0.329063957235173	0.613	0.535	3.77816706887242e-24	TUBA1B	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60265
3.07642072138361e-28	-0.275745451966564	0.262	0.372	6.29251094351803e-24	PIK3R1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60266
1.27569645261831e-27	0.314816120829389	0.657	0.6	2.60930952418549e-23	SAP18	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60267
1.04299555058988e-26	0.331572479520884	0.439	0.338	2.13334309917653e-22	MRPL18	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60268
4.89427330381306e-26	0.279586218060872	0.656	0.6	1.00107466156192e-21	ZFAS1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60269
2.92077595337116e-25	0.274327703162819	0.495	0.407	5.97415513502538e-21	SNHG8	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60270
8.00927742115662e-24	0.395354163335305	0.604	0.546	1.63821760372337e-19	SQSTM1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60271
1.95452468370758e-22	0.25067043662016	0.625	0.558	3.99778478805549e-18	CALR	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60272
5.46834414753472e-21	0.297764641147651	0.627	0.572	1.11849511193675e-16	H2AFZ	CD4+ T cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60273
6.50027360948619e-21	0.296976252357888	0.409	0.306	1.32956596408431e-16	CCR7	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60274
2.40299540314804e-20	0.343854521386395	0.589	0.528	4.91508679759901e-16	IER2	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60275
3.15817195837285e-20	0.469966635861215	0.582	0.523	6.45972492365582e-16	SAT1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60276
1.19650792510538e-19	0.267116992516627	0.599	0.519	2.44733731001054e-15	CACYBP	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60277
5.2319763245726e-19	0.292757561334931	0.421	0.338	1.07014843742808e-14	CHMP1B	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60278
6.49026253966607e-19	-0.352197124508804	0.963	0.96	1.3275182998633e-14	MT-ATP6	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60279
2.13421916524744e-18	0.269318391627906	0.6	0.534	4.36533188059712e-14	TUBB4B	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60280
5.50474872583304e-14	0.307279594097892	0.445	0.388	1.12594130438189e-09	GADD45B	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60281
1.54829105935191e-13	0.307966942739546	0.517	0.477	3.1668745327984e-09	HSPB1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60282
3.30577610289401e-13	0.299232085586558	0.31	0.242	6.76163444085942e-09	BATF	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000156127	10538	basic leucine zipper ATF-like transcription factor	B-ATF|BATF1|SFA-2	protein_coding	Q16520	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60283
1.89766416673356e-11	0.252052738156322	0.785	0.766	3.88148228663682e-07	LTB	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60284
1.42092302634545e-07	0.268631210106884	0.407	0.366	0.00290635595808699	NR4A1	CD4+ T cells	GSE169246_PacTissue_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60285
2.4294168110898e-232	-0.710067984854127	1	1	4.96912914540307e-228	MT-CO1	NK cells	GSE169246_PacTissue_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60286
6.06273953688318e-228	-0.793929614373981	0.976	0.997	1.24007274487409e-223	MT-ND3	NK cells	GSE169246_PacTissue_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60287
7.96752212875016e-194	-0.666048858596943	0.999	0.998	1.62967697621456e-189	RPL34	NK cells	GSE169246_PacTissue_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60288
1.59361422570114e-191	0.72308023032926	0.999	0.988	3.25957853724911e-187	HLA-C	NK cells	GSE169246_PacTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60289
5.28924614650483e-169	0.628855707362498	0.997	0.986	1.0818624068061e-164	RPS3A	NK cells	GSE169246_PacTissue_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60290
1.1182376080916e-151	-0.629333921777301	0.961	0.985	2.28724320359056e-147	RPL41	NK cells	GSE169246_PacTissue_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60291
1.37026587501901e-149	-0.836532919112406	0.566	0.886	2.80274182076388e-145	TYROBP	NK cells	GSE169246_PacTissue_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60292
1.73407588253006e-149	0.566095505932128	1	0.999	3.54687881012699e-145	HLA-A	NK cells	GSE169246_PacTissue_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60293
1.810621007567e-144	-0.562927572020786	0.996	0.998	3.70344420887754e-140	RPL39	NK cells	GSE169246_PacTissue_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60294
5.81003759309628e-132	0.826713115610312	0.356	0.077	1.18838508929191e-127	ZNF683	NK cells	GSE169246_PacTissue_post	ENSG00000176083	257101	zinc finger protein 683	Hobit|MGC33414	protein_coding	Q8IZ20	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60295
1.43802693336769e-131	-1.42907006025229	0.643	0.9	2.94134028951028e-127	CCL4	NK cells	GSE169246_PacTissue_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60296
8.72017057860382e-128	0.570804990296528	0.998	0.993	1.78362369014763e-123	RPS18	NK cells	GSE169246_PacTissue_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60297
3.89718995092114e-123	-0.598176700938917	0.927	0.996	7.97131232561411e-119	NKG7	NK cells	GSE169246_PacTissue_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60298
6.49089417198944e-123	0.689595891320501	0.299	0.053	1.32764749393872e-118	LDLRAD4	NK cells	GSE169246_PacTissue_post	ENSG00000168675	753	low density lipoprotein receptor class A domain containing 4	C18orf1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60299
1.27132341529307e-121	-0.462735607108994	0.999	0.999	2.60036491364044e-117	RPL11	NK cells	GSE169246_PacTissue_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60300
3.0137967263576e-121	-0.493730625734256	0.998	0.995	6.16441982409184e-117	RPS28	NK cells	GSE169246_PacTissue_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60301
6.70357581674479e-117	-0.517113095980102	0.972	0.985	1.37114939755698e-112	RPS21	NK cells	GSE169246_PacTissue_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60302
2.69213094172934e-113	-0.510748464907439	0.996	0.999	5.50648462821319e-109	MT-CYB	NK cells	GSE169246_PacTissue_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60303
2.85208589417609e-113	-0.625509263614757	0.887	0.982	5.83365648794778e-109	CST7	NK cells	GSE169246_PacTissue_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60304
8.77000713516307e-112	-0.471848637105661	0.992	0.995	1.79381725942625e-107	RPL35A	NK cells	GSE169246_PacTissue_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60305
2.75069782197958e-111	-0.634632546683413	0.444	0.768	5.62627732507704e-107	EFHD2	NK cells	GSE169246_PacTissue_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60306
1.16505007365662e-108	0.568643732970085	0.441	0.151	2.38299342065725e-104	SLC7A5	NK cells	GSE169246_PacTissue_post	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60307
1.7922662123279e-108	-0.58902397605282	0.896	0.979	3.66590131069549e-104	GNLY	NK cells	GSE169246_PacTissue_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60308
1.58020534778817e-105	0.815612942625919	0.379	0.116	3.23215201836591e-101	DUSP4	NK cells	GSE169246_PacTissue_post	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60309
2.78191607906654e-105	0.632465143319387	0.448	0.156	5.69013114812269e-101	CD3D	NK cells	GSE169246_PacTissue_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60310
5.88142006546477e-105	-0.452786434099943	0.991	0.993	1.20298566019016e-100	RPL37	NK cells	GSE169246_PacTissue_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60311
4.1692550620856e-100	0.771716951084718	0.846	0.694	8.52779430398989e-96	LDHA	NK cells	GSE169246_PacTissue_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60312
2.28528100674953e-98	0.895112997839869	0.762	0.461	4.67431377120549e-94	IL32	NK cells	GSE169246_PacTissue_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60313
3.7572596895731e-96	0.711125065383838	0.981	0.954	7.68509896905281e-92	HSP90AA1	NK cells	GSE169246_PacTissue_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60314
5.83602492857468e-95	0.96920914818094	0.719	0.495	1.19370053889066e-90	TUBA4A	NK cells	GSE169246_PacTissue_post	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60315
3.59243678331132e-94	-0.424592278023827	0.988	0.995	7.34797019658497e-90	RPL6	NK cells	GSE169246_PacTissue_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60316
1.06895059300268e-92	0.606695215657747	0.968	0.907	2.18643154292768e-88	UBC	NK cells	GSE169246_PacTissue_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60317
1.15923121490186e-89	-0.538988959525696	0.257	0.584	2.37109152696026e-85	KLRF1	NK cells	GSE169246_PacTissue_post	ENSG00000150045	51348	killer cell lectin like receptor F1	CLEC5C|NKp80	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60318
1.97240135632448e-88	0.54159100079333	0.592	0.319	4.03434973422608e-84	SRSF5	NK cells	GSE169246_PacTissue_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60319
1.89103272063435e-87	0.563422054154729	0.877	0.776	3.86791832678551e-83	RPL27A	NK cells	GSE169246_PacTissue_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60320
2.23125358344354e-87	-0.648588391388898	0.387	0.683	4.56380607957542e-83	CMC1	NK cells	GSE169246_PacTissue_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60321
3.83030691899669e-82	-0.496905448440536	0.245	0.587	7.83450977211582e-78	FCGR3A	NK cells	GSE169246_PacTissue_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60322
7.49134127225993e-82	-0.508482836794328	0.938	0.976	1.53227894382805e-77	CCL5	NK cells	GSE169246_PacTissue_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60323
1.48133362684874e-80	0.979115784043516	0.867	0.788	3.02991980035641e-76	JUNB	NK cells	GSE169246_PacTissue_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60324
7.10502471271719e-79	-0.453444400931481	0.934	0.961	1.45326175473917e-74	RPL22	NK cells	GSE169246_PacTissue_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60325
5.27721415873061e-78	-0.466970765452319	0.228	0.533	1.07940138402676e-73	PLEK	NK cells	GSE169246_PacTissue_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60326
3.34569518510445e-77	-0.394785565188294	0.996	0.999	6.84328493161263e-73	MT-CO3	NK cells	GSE169246_PacTissue_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60327
4.78881446410276e-77	0.45034702652556	0.467	0.213	9.79504110487579e-73	PLP2	NK cells	GSE169246_PacTissue_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60328
8.99693863088375e-77	-0.601807007538053	0.916	0.984	1.84023382756096e-72	CD74	NK cells	GSE169246_PacTissue_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60329
1.29797961183037e-76	0.650357546979473	0.958	0.879	2.65488749803784e-72	HSP90AB1	NK cells	GSE169246_PacTissue_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60330
8.59736393780094e-76	0.541321212044828	0.909	0.836	1.7585048198378e-71	SARAF	NK cells	GSE169246_PacTissue_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60331
1.31683781822414e-75	-0.375726467818838	0.997	0.999	2.69346007339565e-71	RPS8	NK cells	GSE169246_PacTissue_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60332
3.080432013234e-75	0.668736828200903	0.368	0.131	6.30071563986882e-71	IL7R	NK cells	GSE169246_PacTissue_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60333
5.47179223369546e-75	0.703797498131389	0.748	0.549	1.11920038348007e-70	HSPD1	NK cells	GSE169246_PacTissue_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60334
1.58597877490423e-74	-0.687768513344991	0.239	0.544	3.2439609861891e-70	FGFBP2	NK cells	GSE169246_PacTissue_post	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60335
2.29688004947412e-72	0.727645253571473	0.661	0.454	4.69803845319436e-68	EZR	NK cells	GSE169246_PacTissue_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60336
1.35059024926495e-71	-0.639336818552327	0.286	0.568	2.76249729584654e-67	KLRC1	NK cells	GSE169246_PacTissue_post	ENSG00000134545	3821	killer cell lectin like receptor C1	CD159a|NKG2|NKG2-A|NKG2-B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60337
4.00971112106945e-71	0.628411917319856	0.735	0.539	8.20146312703546e-67	YPEL5	NK cells	GSE169246_PacTissue_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60338
1.47967839451759e-70	0.341252390622256	1	1	3.02653418814629e-66	HLA-B	NK cells	GSE169246_PacTissue_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60339
4.54792921185661e-69	0.579191809154279	0.739	0.534	9.30233440993152e-65	CALR	NK cells	GSE169246_PacTissue_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60340
5.89666526248683e-69	0.635444256565106	0.87	0.755	1.20610391278906e-64	DNAJA1	NK cells	GSE169246_PacTissue_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60341
9.59937906083285e-69	0.537361438448391	0.8	0.624	1.96345699310275e-64	SRSF2	NK cells	GSE169246_PacTissue_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60342
2.57173033288413e-68	0.658310204347065	0.872	0.75	5.2602172228812e-64	HSPE1	NK cells	GSE169246_PacTissue_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60343
2.31322544380245e-67	0.381314450327843	0.329	0.123	4.73147132275353e-63	CTSA	NK cells	GSE169246_PacTissue_post	ENSG00000064601	5476	cathepsin A	GSL|PPGB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60344
4.65655666345849e-66	0.525225707719362	0.693	0.482	9.524520999438e-62	LY6E	NK cells	GSE169246_PacTissue_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60345
6.23617689828917e-66	-0.314509035836856	0.999	0.998	1.27554762277607e-61	RPL30	NK cells	GSE169246_PacTissue_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60346
1.45473789859916e-65	0.41171271517011	0.25	0.071	2.97552089779472e-61	CD8B	NK cells	GSE169246_PacTissue_post	ENSG00000172116	926	CD8b molecule	CD8B1	protein_coding	P10966	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60347
1.78383032882629e-65	-0.481416164552161	0.433	0.736	3.6486465545813e-61	GZMH	NK cells	GSE169246_PacTissue_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60348
1.97688196625403e-65	-0.38802713780372	0.971	0.984	4.043514373776e-61	RPL5	NK cells	GSE169246_PacTissue_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60349
6.34581434445308e-65	0.63453569332643	0.697	0.465	1.29797286601443e-60	HSPH1	NK cells	GSE169246_PacTissue_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60350
4.94179233229252e-64	-0.304722894077999	0.999	0.999	1.01079420364711e-59	RPS15A	NK cells	GSE169246_PacTissue_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60351
1.1273033590921e-62	1.02943307549306	0.768	0.599	2.30578629068699e-58	HSPA1A	NK cells	GSE169246_PacTissue_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60352
2.2542531842771e-62	0.592540684241294	0.702	0.495	4.61084946312037e-58	TUBB4B	NK cells	GSE169246_PacTissue_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60353
7.49907173049188e-62	0.358571312625108	0.988	0.969	1.53386013175481e-57	RPS9	NK cells	GSE169246_PacTissue_post	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60354
5.05423894887878e-61	0.492735276701336	0.689	0.479	1.03379403460367e-56	TUBA1B	NK cells	GSE169246_PacTissue_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60355
7.59562974273144e-61	-0.438637091429405	0.586	0.792	1.55361010757829e-56	PCBP1	NK cells	GSE169246_PacTissue_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60356
9.60859295555833e-60	0.911558610086987	0.796	0.753	1.9653416031299e-55	CXCR4	NK cells	GSE169246_PacTissue_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60357
6.77024291263687e-59	-0.2871115869073	0.999	0.999	1.38478548535075e-54	RPS27A	NK cells	GSE169246_PacTissue_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60358
1.02450660773898e-58	0.55000918446923	0.505	0.285	2.09552581546931e-54	RGS2	NK cells	GSE169246_PacTissue_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60359
2.07398046323019e-58	-0.51656757858698	0.407	0.65	4.24211963949103e-54	KLF2	NK cells	GSE169246_PacTissue_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60360
1.76275338134927e-56	-0.31214983855574	0.997	0.994	3.6055357662118e-52	RPS13	NK cells	GSE169246_PacTissue_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60361
1.40053113196618e-55	-0.362243051979147	0.137	0.369	2.86464637732363e-51	S1PR5	NK cells	GSE169246_PacTissue_post	ENSG00000180739	53637	sphingosine-1-phosphate receptor 5	Edg-8|EDG8	protein_coding	Q9H228	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60362
1.52211713011723e-55	0.45671582565289	0.486	0.269	3.11333837794179e-51	IFRD1	NK cells	GSE169246_PacTissue_post	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60363
2.12934240740069e-55	0.740703014199675	0.436	0.234	4.35535696009738e-51	ISG15	NK cells	GSE169246_PacTissue_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60364
6.17611844740033e-55	-0.340768509400158	0.974	0.974	1.26326326723126e-50	NACA	NK cells	GSE169246_PacTissue_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60365
2.27837568814725e-54	-0.321007472931159	0.93	0.957	4.66018963253638e-50	RPS29	NK cells	GSE169246_PacTissue_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60366
6.16064514359808e-54	0.698472572392013	0.395	0.202	1.26009835767155e-49	CD8A	NK cells	GSE169246_PacTissue_post	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60367
7.29126048481339e-54	0.321502273264059	0.365	0.163	1.49135441956373e-49	NASP	NK cells	GSE169246_PacTissue_post	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60368
1.51291370101051e-53	-0.272751708350726	0.999	0.998	3.09451368404689e-49	RPS3	NK cells	GSE169246_PacTissue_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60369
6.96325884812823e-53	-0.275407460808905	0.999	0.999	1.42426496479615e-48	RPL19	NK cells	GSE169246_PacTissue_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60370
9.04636974353206e-53	0.384702171802879	0.911	0.824	1.85034446734205e-48	OAZ1	NK cells	GSE169246_PacTissue_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60371
9.86764464891056e-53	-0.251695907561829	1	1	2.01832803648817e-48	RPL10	NK cells	GSE169246_PacTissue_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60372
1.69423656528903e-52	-0.276535724769883	0.997	0.998	3.46539147064218e-48	RPS24	NK cells	GSE169246_PacTissue_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60373
3.49479375284339e-52	-0.275739083152617	0.998	0.997	7.14825114206588e-48	RPL32	NK cells	GSE169246_PacTissue_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60374
6.22895232312762e-52	0.684030578053392	0.449	0.247	1.27406990817252e-47	LMNA	NK cells	GSE169246_PacTissue_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60375
2.53462621945921e-51	-0.329594917873169	0.958	0.971	5.18432446928187e-47	RPL37A	NK cells	GSE169246_PacTissue_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60376
4.47447876372579e-51	-0.367543803170137	0.896	0.951	9.15209886332473e-47	CYBA	NK cells	GSE169246_PacTissue_post	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60377
1.07960465721584e-50	0.386597315899371	0.448	0.242	2.20822336586927e-46	IDI1	NK cells	GSE169246_PacTissue_post	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60378
1.28501140217172e-50	0.438564043015589	0.419	0.217	2.62836232200204e-46	CHMP1B	NK cells	GSE169246_PacTissue_post	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60379
1.0410337267455e-49	-0.278261241750313	0.997	0.997	2.12933038468524e-45	RPS7	NK cells	GSE169246_PacTissue_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60380
5.09330216745308e-49	-0.269463012323118	0.998	0.998	1.04178402533085e-44	RPS4X	NK cells	GSE169246_PacTissue_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60381
6.07653916868174e-49	-0.383188899307897	0.674	0.831	1.24289532156216e-44	ITGB2	NK cells	GSE169246_PacTissue_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60382
7.55875801999946e-49	0.365021743564605	0.43	0.226	1.54606836541069e-44	AC016831.7	NK cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60383
8.25810164159259e-49	-0.505653221338301	0.45	0.676	1.68911210977135e-44	HIST1H4C	NK cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60384
1.08795109633835e-48	-0.401468733844228	0.587	0.779	2.22529517245046e-44	CD247	NK cells	GSE169246_PacTissue_post	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60385
1.24644992975856e-48	0.396123435442596	0.394	0.203	2.54948868632815e-44	MAT2A	NK cells	GSE169246_PacTissue_post	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60386
1.50854312168055e-48	-0.301185560742019	0.086	0.284	3.0855741010854e-44	PRSS23	NK cells	GSE169246_PacTissue_post	ENSG00000150687	11098	serine protease 23	SIG13|SPUVE	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60387
4.36718127436209e-48	-0.828266658117676	0.239	0.466	8.93263257858022e-44	CCL4L2	NK cells	GSE169246_PacTissue_post	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60388
4.93431699350685e-48	0.418366596200659	0.647	0.465	1.00926519785189e-43	SRSF3	NK cells	GSE169246_PacTissue_post	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60389
6.09016587411631e-48	0.868042115258417	0.665	0.491	1.24568252789175e-43	JUN	NK cells	GSE169246_PacTissue_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60390
9.97039125509304e-48	0.300799392614438	0.277	0.108	2.03934382731673e-43	CD3G	NK cells	GSE169246_PacTissue_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60391
1.74325525834258e-47	0.415687491736447	0.438	0.241	3.56565430541391e-43	H2AFX	NK cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60392
4.61818497292714e-47	0.443698121346352	0.404	0.217	9.44603554362517e-43	ATP1B3	NK cells	GSE169246_PacTissue_post	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60393
5.18784196348734e-47	0.452196169232451	0.775	0.643	1.0611211952117e-42	CALM2	NK cells	GSE169246_PacTissue_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60394
6.23268059699178e-47	-0.407268924089971	0.371	0.636	1.2748324893087e-42	FCER1G	NK cells	GSE169246_PacTissue_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60395
6.41491267164705e-47	0.409991352985616	0.643	0.455	1.31210623785869e-42	CD44	NK cells	GSE169246_PacTissue_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60396
7.51585621703922e-47	0.2674023205346	1	1	1.5372932306332e-42	RPL13	NK cells	GSE169246_PacTissue_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60397
3.01282773335319e-46	0.737170718238469	0.651	0.453	6.16243784580061e-42	HSPA1B	NK cells	GSE169246_PacTissue_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60398
6.81251185665136e-46	-0.457614211735779	0.355	0.586	1.39343117515947e-41	HLA-DRA	NK cells	GSE169246_PacTissue_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60399
9.02834691592679e-46	-0.371205448971855	0.918	0.957	1.84665807818367e-41	MT-ND4	NK cells	GSE169246_PacTissue_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60400
1.06725078943327e-45	0.458173107071507	0.779	0.624	2.18295476470682e-41	SRSF7	NK cells	GSE169246_PacTissue_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60401
2.48535646991703e-45	0.418512737305875	0.269	0.108	5.08354812356828e-41	LTB	NK cells	GSE169246_PacTissue_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60402
5.35412818060373e-44	0.730540228277986	0.69	0.543	1.09513337806069e-39	RGCC	NK cells	GSE169246_PacTissue_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60403
7.02577199412623e-44	-0.272693880618346	0.99	0.989	1.43705140367858e-39	RPLP2	NK cells	GSE169246_PacTissue_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60404
8.77007098830324e-44	0.447460565606618	0.682	0.538	1.79383031994754e-39	PGK1	NK cells	GSE169246_PacTissue_post	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60405
9.40072111095893e-44	0.424815105862456	0.749	0.588	1.92282349603554e-39	DYNLL1	NK cells	GSE169246_PacTissue_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60406
1.337900565967e-43	-0.310713872219246	0.14	0.339	2.73654181762891e-39	ADGRG1	NK cells	GSE169246_PacTissue_post	ENSG00000205336	9289	adhesion G protein-coupled receptor G1	GPR56|TM7LN4|TM7XN1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60407
2.75344337924193e-43	-0.344368694413738	0.245	0.469	5.63189308790145e-39	PLAC8	NK cells	GSE169246_PacTissue_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60408
8.27579002480804e-42	-0.399970702810221	0.53	0.713	1.69273009167424e-37	HLA-DPA1	NK cells	GSE169246_PacTissue_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60409
1.37512919087792e-41	0.300725308841793	1	1	2.8126892470217e-37	TMSB4X	NK cells	GSE169246_PacTissue_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60410
2.04562161116196e-41	-0.273312753198963	0.998	1	4.18411444347066e-37	MT-ND4L	NK cells	GSE169246_PacTissue_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60411
2.33495944639437e-41	-0.305704697033946	0.62	0.819	4.77592605165504e-37	PRF1	NK cells	GSE169246_PacTissue_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60412
2.3456053181532e-41	-0.38255600333657	0.176	0.37	4.79770111775056e-37	HLA-DQB1	NK cells	GSE169246_PacTissue_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60413
4.28494511543568e-41	0.50790659542109	0.931	0.898	8.76442673911213e-37	ZFP36	NK cells	GSE169246_PacTissue_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60414
1.41228799934282e-40	-0.340264432991654	0.739	0.844	2.8886938738558e-36	TMA7	NK cells	GSE169246_PacTissue_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60415
2.64550878163225e-39	-0.295239706093843	0.227	0.436	5.41112366195061e-35	SH2D1B	NK cells	GSE169246_PacTissue_post	ENSG00000198574	117157	SH2 domain containing 1B	EAT2	protein_coding	O14796	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60416
5.81889956453424e-37	0.361419611882611	0.97	0.932	1.19019771692983e-32	UBB	NK cells	GSE169246_PacTissue_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60417
7.94222657617734e-37	0.339018145291092	0.405	0.232	1.62450302389131e-32	RHOH	NK cells	GSE169246_PacTissue_post	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60418
1.36014259483221e-36	0.540825571681864	0.886	0.815	2.7820356634698e-32	VIM	NK cells	GSE169246_PacTissue_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60419
3.26349334620931e-36	0.277223047563463	0.283	0.133	6.67514929033653e-32	ARL4A	NK cells	GSE169246_PacTissue_post	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60420
3.51035256437775e-36	0.326144384761547	0.439	0.266	7.18007513517826e-32	EIF4A3	NK cells	GSE169246_PacTissue_post	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60421
5.50887634559467e-36	-0.316529861994962	0.809	0.914	1.12678556772793e-31	CTSW	NK cells	GSE169246_PacTissue_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60422
7.06887244900409e-36	0.585889104520469	0.484	0.304	1.4458671707193e-31	AREG	NK cells	GSE169246_PacTissue_post	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60423
7.18215932925764e-36	0.309075369403751	0.991	0.99	1.46903886920636e-31	HSPA8	NK cells	GSE169246_PacTissue_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60424
7.55466688570553e-36	0.456816672746691	0.547	0.375	1.54523156480221e-31	COTL1	NK cells	GSE169246_PacTissue_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60425
1.2533488735468e-35	-0.298033266232241	0.907	0.968	2.56359978595262e-31	MT-ND5	NK cells	GSE169246_PacTissue_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60426
2.4575151495502e-35	0.343523392823269	0.395	0.227	5.02660148688998e-31	RANBP2	NK cells	GSE169246_PacTissue_post	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60427
4.48848369420465e-35	-0.256127449839273	0.098	0.262	9.18074454812619e-31	IGFBP7	NK cells	GSE169246_PacTissue_post	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60428
1.24834879386063e-34	-0.397685711401154	0.533	0.697	2.55337262296254e-30	HLA-DRB1	NK cells	GSE169246_PacTissue_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60429
2.11698704581283e-34	0.295936427971164	0.346	0.186	4.33008530350556e-30	CXCR3	NK cells	GSE169246_PacTissue_post	ENSG00000186810	2833	C-X-C motif chemokine receptor 3	CD183|CKR-L2|CMKAR3|GPR9|IP10-R|MigR	protein_coding	P49682	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60430
2.58052627657687e-34	-0.502571925407581	0.72	0.803	5.27820844611033e-30	S100A10	NK cells	GSE169246_PacTissue_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60431
3.88019277413395e-34	0.298492906595709	0.6	0.435	7.93654630021358e-30	PRRC2C	NK cells	GSE169246_PacTissue_post	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60432
7.1623316385481e-34	-0.337740859607611	0.182	0.365	1.46498331334863e-29	SELL	NK cells	GSE169246_PacTissue_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60433
2.79078380454099e-33	-0.307814299207923	0.177	0.349	5.70826919380814e-29	SH2D1A	NK cells	GSE169246_PacTissue_post	ENSG00000183918	4068	SH2 domain containing 1A	DSHP|EBVS|IMD5|LYP|MTCP1|SAP|XLP|XLPD	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60434
1.21008210491611e-32	-0.291717041310731	0.769	0.902	2.47510193739541e-28	LITAF	NK cells	GSE169246_PacTissue_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60435
2.59904587059599e-32	0.261625589349856	1	0.998	5.31608842371703e-28	PTMA	NK cells	GSE169246_PacTissue_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60436
8.39783478122114e-32	0.258635846568038	0.315	0.166	1.71769312615097e-27	KPNA2	NK cells	GSE169246_PacTissue_post	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60437
1.42467527965952e-31	-0.312770751585984	0.688	0.84	2.91403081701559e-27	KLRD1	NK cells	GSE169246_PacTissue_post	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60438
2.61094531961538e-31	0.297280543115915	0.301	0.16	5.3404275567413e-27	IRF7	NK cells	GSE169246_PacTissue_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60439
3.6983958096804e-31	0.369135798655616	0.515	0.359	7.56469878912028e-27	TUBA1A	NK cells	GSE169246_PacTissue_post	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60440
4.89985861557871e-31	0.317085459487172	0.671	0.536	1.00221708123047e-26	EVL	NK cells	GSE169246_PacTissue_post	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60441
8.46544105670705e-31	-0.2827479296984	0.884	0.925	1.73152131373886e-26	ATP5F1E	NK cells	GSE169246_PacTissue_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60442
8.86202372118166e-31	0.259000854802974	0.368	0.213	1.8126383319305e-26	EMB	NK cells	GSE169246_PacTissue_post	ENSG00000170571	133418	embigin	MGC71745	protein_coding	Q6PCB8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60443
9.51241533238929e-31	0.266147748702553	0.424	0.264	1.9456694320869e-26	EML4	NK cells	GSE169246_PacTissue_post	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60444
5.38601680549854e-30	0.264819484858374	0.446	0.284	1.10165587739667e-25	ACAP1	NK cells	GSE169246_PacTissue_post	ENSG00000288169	9744	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	CENTB1|KIAA0050	protein_coding	Q15027	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60445
5.57712786684058e-30	0.313817713224139	0.492	0.339	1.14074573388357e-25	ARF4	NK cells	GSE169246_PacTissue_post	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60446
5.02364953103973e-29	0.262325463973126	0.289	0.153	1.02753727507887e-24	MYLIP	NK cells	GSE169246_PacTissue_post	ENSG00000007944	29116	myosin regulatory light chain interacting protein	IDOL|MIR	protein_coding	Q8WY64	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60447
6.26381944445632e-29	-0.266137166672999	0.966	0.985	1.2812016291691e-24	FTL	NK cells	GSE169246_PacTissue_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60448
2.11555966951275e-28	-0.295634340829595	0.325	0.489	4.32716574802138e-24	SERPINB1	NK cells	GSE169246_PacTissue_post	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60449
3.31011977645476e-28	0.445929766179574	0.838	0.797	6.77051899076057e-24	CD7	NK cells	GSE169246_PacTissue_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60450
3.96884408611376e-28	-0.388474951949401	0.367	0.538	8.11787369373709e-24	DUSP5	NK cells	GSE169246_PacTissue_post	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60451
1.55099087932354e-27	0.44288776032575	0.864	0.76	3.17239674456837e-23	DNAJB1	NK cells	GSE169246_PacTissue_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60452
1.68718814796374e-27	-0.269725503790163	0.664	0.802	3.45097463784504e-23	RARRES3	NK cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60453
6.41756046834549e-27	-0.266995958908671	0.838	0.893	1.31264781819539e-22	RPL31	NK cells	GSE169246_PacTissue_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60454
6.46526925659122e-27	0.500986390008716	0.426	0.292	1.32240617374317e-22	RGS1	NK cells	GSE169246_PacTissue_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60455
7.14550986059995e-27	0.33742936399501	0.321	0.187	1.46154258688711e-22	ITM2A	NK cells	GSE169246_PacTissue_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60456
8.11655140542963e-27	0.320516497400154	0.658	0.516	1.66015942446658e-22	FUS	NK cells	GSE169246_PacTissue_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60457
1.23916472051273e-26	0.385238305364374	0.646	0.552	2.53458751933674e-22	SOD1	NK cells	GSE169246_PacTissue_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60458
1.26857470867375e-26	0.314929085379981	0.26	0.136	2.59474270912129e-22	TSPYL2	NK cells	GSE169246_PacTissue_post	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60459
1.3921423206677e-26	0.439073132814825	0.989	0.983	2.84748790269371e-22	BTG1	NK cells	GSE169246_PacTissue_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60460
1.70711530797427e-26	-0.306565077317216	0.449	0.626	3.49173365093057e-22	LGALS1	NK cells	GSE169246_PacTissue_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60461
2.0251495426057e-26	0.275273247491569	0.407	0.266	4.1422408744457e-22	STAT3	NK cells	GSE169246_PacTissue_post	ENSG00000168610	6774	signal transducer and activator of transcription 3	APRF	protein_coding	P40763	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60462
8.61987309474175e-26	0.273957935331027	0.837	0.731	1.76310884279848e-21	HNRNPA2B1	NK cells	GSE169246_PacTissue_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60463
1.31917168387821e-25	0.319633747986462	0.423	0.288	2.69823376220449e-21	PTP4A1	NK cells	GSE169246_PacTissue_post	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60464
2.23726302577249e-25	0.277916276388508	0.374	0.237	4.57609779291506e-21	SLA2	NK cells	GSE169246_PacTissue_post	ENSG00000101082	84174	Src like adaptor 2	C20orf156|FLJ21992|SLAP-2	protein_coding	Q9H6Q3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60465
2.59916840390745e-25	-0.29492927968965	0.755	0.845	5.31633905335229e-21	CD52	NK cells	GSE169246_PacTissue_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60466
4.54798079510073e-25	0.322086298976454	0.429	0.291	9.30243991829903e-21	PRDX1	NK cells	GSE169246_PacTissue_post	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60467
4.56801854275565e-25	-0.25257449818068	0.835	0.925	9.3434251273524e-21	S100A4	NK cells	GSE169246_PacTissue_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60468
6.5416275594591e-25	0.256431495190841	0.43	0.287	1.33802450101176e-20	ZYX	NK cells	GSE169246_PacTissue_post	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60469
6.76702368022851e-25	-0.324094683456556	0.122	0.267	1.38412702355394e-20	CCL3	NK cells	GSE169246_PacTissue_post	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60470
6.96667170623874e-25	0.293325993709591	0.538	0.402	1.42496303079407e-20	APOBEC3G	NK cells	GSE169246_PacTissue_post	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60471
1.0553656518834e-24	-0.258874783199243	0.823	0.87	2.15864490436231e-20	RPL7	NK cells	GSE169246_PacTissue_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60472
1.33667776740345e-24	0.25802551163959	0.416	0.278	2.73404070544701e-20	CD96	NK cells	GSE169246_PacTissue_post	ENSG00000153283	10225	CD96 molecule	TACTILE	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60473
1.67376585808903e-24	-0.267862269649247	0.224	0.377	3.4235206861353e-20	TIGIT	NK cells	GSE169246_PacTissue_post	ENSG00000181847	201633	T cell immunoreceptor with Ig and ITIM domains	DKFZp667A205|FLJ39873|VSIG9|VSTM3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60474
2.16087944435567e-24	0.359087414425838	0.972	0.951	4.41986281548508e-20	GAPDH	NK cells	GSE169246_PacTissue_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60475
3.58215588000044e-24	0.336186041977739	0.516	0.388	7.32694163695289e-20	HERPUD1	NK cells	GSE169246_PacTissue_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60476
7.364759409669e-24	0.338312711916912	0.695	0.617	1.5063878896537e-19	CD3E	NK cells	GSE169246_PacTissue_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60477
2.20305652668893e-23	-0.268617882420201	0.473	0.618	4.50613181968954e-19	RPL36A	NK cells	GSE169246_PacTissue_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60478
4.84281558962968e-23	0.256901625562619	0.586	0.453	9.90549500702855e-19	CDC42	NK cells	GSE169246_PacTissue_post	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60479
5.95054462488077e-23	-0.274453249762271	0.428	0.575	1.21712439757311e-18	MT-ND6	NK cells	GSE169246_PacTissue_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60480
1.0638670694244e-22	-0.315207982407131	0.222	0.368	2.17603370380067e-18	CEBPD	NK cells	GSE169246_PacTissue_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60481
1.29952849574046e-22	-0.360260064810637	0.484	0.614	2.65805558518754e-18	PIK3R1	NK cells	GSE169246_PacTissue_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60482
1.67547512044903e-22	0.305109192541208	0.535	0.417	3.42701681136645e-18	LEPROTL1	NK cells	GSE169246_PacTissue_post	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60483
6.77011915759655e-22	0.284103324889769	0.355	0.23	1.3847601724948e-17	MAFF	NK cells	GSE169246_PacTissue_post	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60484
1.71716678782513e-21	-0.301082348056129	0.524	0.645	3.51229294781752e-17	FOSL2	NK cells	GSE169246_PacTissue_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60485
4.41579635307667e-21	0.259626888677362	0.43	0.303	9.03206986058302e-17	G3BP2	NK cells	GSE169246_PacTissue_post	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60486
8.94580147421597e-21	-0.363040635526045	0.544	0.659	1.82977423353613e-16	XCL2	NK cells	GSE169246_PacTissue_post	ENSG00000143185	6846	X-C motif chemokine ligand 2	SCM-1b|SCYC2	protein_coding	Q9UBD3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60487
3.90817172577546e-20	0.292201393651889	0.607	0.503	7.99377444790112e-16	NDUFS5	NK cells	GSE169246_PacTissue_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60488
8.40042165446675e-20	0.251857178064372	0.406	0.285	1.71822224520463e-15	AHSA1	NK cells	GSE169246_PacTissue_post	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60489
1.10142081225238e-19	0.442990886509462	0.489	0.376	2.25284612938102e-15	FOSB	NK cells	GSE169246_PacTissue_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60490
2.86891983192699e-19	-0.262758000536743	0.221	0.357	5.86808862422346e-15	SPON2	NK cells	GSE169246_PacTissue_post	ENSG00000159674	10417	spondin 2	DIL1	protein_coding	Q9BUD6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60491
5.16941202683169e-19	0.26651882408699	0.471	0.352	1.05735153596815e-14	PPP1R2	NK cells	GSE169246_PacTissue_post	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60492
5.28072068144821e-19	0.283700322149555	0.407	0.29	1.08011860818342e-14	GSPT1	NK cells	GSE169246_PacTissue_post	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60493
5.9075231100157e-19	0.297325425623034	0.366	0.251	1.20832477692261e-14	PIM3	NK cells	GSE169246_PacTissue_post	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60494
6.90781309187507e-19	0.273317296551623	0.323	0.21	1.41292408981213e-14	NEU1	NK cells	GSE169246_PacTissue_post	ENSG00000184494	4758	neuraminidase 1	NEU	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60495
1.29856476269884e-18	0.44833010154293	0.529	0.422	2.6560843656242e-14	NR4A1	NK cells	GSE169246_PacTissue_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60496
1.34755266191749e-18	0.265230565990889	0.574	0.467	2.75628421468604e-14	CYCS	NK cells	GSE169246_PacTissue_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60497
4.03130238757749e-18	0.30261686344687	0.374	0.261	8.245625903551e-14	OASL	NK cells	GSE169246_PacTissue_post	ENSG00000135114	8638	2'-5'-oligoadenylate synthetase like	OASL1|p59OASL|TRIP14	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60498
4.13911730902468e-18	0.28947416845507	0.406	0.291	8.46615054387907e-14	CDKN1A	NK cells	GSE169246_PacTissue_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60499
1.0977066815719e-17	0.274147958513291	0.698	0.602	2.24524924648717e-13	SAP18	NK cells	GSE169246_PacTissue_post	ENSG00000150459	10284	Sin3A associated protein 18	2HOR0202|MGC27131|SAP18p	protein_coding	O00422	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60500
1.52553694307636e-16	0.29376627296365	0.374	0.267	3.1203332633684e-12	HSPB1	NK cells	GSE169246_PacTissue_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60501
1.61281695869361e-16	0.276467407633039	0.517	0.401	3.29885580731191e-12	MYADM	NK cells	GSE169246_PacTissue_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60502
2.92188988094521e-15	0.338132678048517	0.43	0.325	5.97643356248533e-11	CITED2	NK cells	GSE169246_PacTissue_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60503
8.89598656581481e-14	0.353360935212533	0.292	0.199	1.81958509217176e-09	EGR1	NK cells	GSE169246_PacTissue_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60504
1.05123643145398e-13	0.276022310107725	0.68	0.614	2.15019899689597e-09	HSPA5	NK cells	GSE169246_PacTissue_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60505
3.66471109688943e-13	0.404305288280003	0.78	0.726	7.49580007757764e-09	DUSP1	NK cells	GSE169246_PacTissue_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60506
1.33546257283121e-12	0.280230570075049	0.678	0.607	2.73155514646896e-08	H2AFZ	NK cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60507
7.4475170828878e-12	-0.256687640156679	0.267	0.378	1.52331514413387e-07	IFNG	NK cells	GSE169246_PacTissue_post	ENSG00000111537	3458	interferon gamma	NA	protein_coding	P01579	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60508
7.60747823549703e-12	0.262050442162763	0.725	0.668	1.55603359828856e-07	SQSTM1	NK cells	GSE169246_PacTissue_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60509
7.79467836026259e-12	0.397656800526306	0.582	0.512	1.59432351180811e-07	GADD45B	NK cells	GSE169246_PacTissue_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60510
1.18245092029242e-11	0.281476907810538	0.875	0.839	2.41858511236611e-07	CRIP1	NK cells	GSE169246_PacTissue_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60511
5.94548131476382e-11	0.321093199171694	0.761	0.745	1.21608874812179e-06	CREM	NK cells	GSE169246_PacTissue_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60512
5.91404671868382e-07	0.278820007454314	0.283	0.226	0.0120965911583959	LINC02446	NK cells	GSE169246_PacTissue_post	ENSG00000256039	101060038	long intergenic non-protein coding RNA 2446	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60513
4.65852795346789e-34	-0.598587668518154	0.996	0.992	9.52855307602323e-30	RPL34	cDCs	GSE169246_PacTissue_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60514
3.15113824814966e-32	-0.629096662771318	0.996	0.994	6.44533817276532e-28	RPL41	cDCs	GSE169246_PacTissue_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60515
3.22904152831873e-28	0.549212214991221	1	0.994	6.60468154202313e-24	RPS18	cDCs	GSE169246_PacTissue_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60516
1.07080281546176e-27	-0.439207426299223	1	0.997	2.19022007874547e-23	RPS2	cDCs	GSE169246_PacTissue_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60517
8.60178381083431e-27	-0.490195821075292	0.996	0.989	1.75940886066805e-22	RPL6	cDCs	GSE169246_PacTissue_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60518
2.77617523949632e-26	-0.586555745416447	0.9	0.964	5.67838883486578e-22	RPL13A	cDCs	GSE169246_PacTissue_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60519
2.86475385924043e-26	0.907353938562239	0.813	0.485	5.85956754369037e-22	ANXA2	cDCs	GSE169246_PacTissue_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60520
3.44799842049686e-26	-0.477024437764473	1	0.994	7.05253596928428e-22	RPL35A	cDCs	GSE169246_PacTissue_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60521
4.30022571649535e-26	0.599250624339463	0.996	0.961	8.7956816805196e-22	CFL1	cDCs	GSE169246_PacTissue_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60522
6.54603460584807e-25	-0.371246705153167	1	0.997	1.33892591828017e-20	RPL11	cDCs	GSE169246_PacTissue_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60523
7.00397870948636e-25	-1.46664320097106	0.509	0.78	1.43259380523834e-20	CEBPD	cDCs	GSE169246_PacTissue_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60524
9.22738029773082e-25	-0.411588824232128	1	0.997	1.88736836609786e-20	RPS28	cDCs	GSE169246_PacTissue_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60525
4.88407956867652e-24	0.574271740849359	0.722	0.32	9.98989634977096e-20	CDC42	cDCs	GSE169246_PacTissue_post	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60526
7.36922172530579e-24	-0.689193200885407	0.287	0.713	1.50730061169405e-19	HLA-DQA2	cDCs	GSE169246_PacTissue_post	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60527
1.65537499891563e-22	0.571216806019581	0.922	0.833	3.38590402278203e-18	RPL27A	cDCs	GSE169246_PacTissue_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60528
5.74254529397617e-21	-0.399049090932959	0.996	0.983	1.17458021442989e-16	RPL39	cDCs	GSE169246_PacTissue_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60529
8.20025106758891e-21	-0.388182043861095	1	0.994	1.67727935336464e-16	RPS8	cDCs	GSE169246_PacTissue_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60530
3.40946475630604e-20	-0.409312136943817	0.991	0.994	6.97371921254837e-16	RPL22	cDCs	GSE169246_PacTissue_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60531
1.29578975850229e-19	0.532472365106303	0.578	0.234	2.65040837204059e-15	NDUFS5	cDCs	GSE169246_PacTissue_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60532
8.07061567220808e-19	0.740125198565153	0.77	0.515	1.65076372959344e-14	CALR	cDCs	GSE169246_PacTissue_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60533
1.09410224340171e-18	-0.510198449843662	0.778	0.922	2.23787672865387e-14	PCBP1	cDCs	GSE169246_PacTissue_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60534
1.3176984043219e-18	-0.338315027846657	0.996	0.997	2.69522031620002e-14	RPL19	cDCs	GSE169246_PacTissue_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60535
6.39729111417613e-18	0.705233002454107	0.957	0.808	1.30850192449359e-13	S100A10	cDCs	GSE169246_PacTissue_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60536
8.14398078112537e-18	0.410686434511955	0.991	0.992	1.66576982897138e-13	RPS3A	cDCs	GSE169246_PacTissue_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60537
2.12876351532497e-17	0.807960633773256	0.839	0.63	4.35417289424568e-13	GSN	cDCs	GSE169246_PacTissue_post	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60538
2.3744292987332e-17	-0.358644636285772	0.996	0.992	4.8566576876289e-13	RPL37	cDCs	GSE169246_PacTissue_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60539
5.36698020346461e-17	-0.324838147046402	0.996	1	1.09776213081665e-12	RPL30	cDCs	GSE169246_PacTissue_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60540
8.89110746261102e-17	0.486780274413434	0.548	0.231	1.81858712040246e-12	SRSF5	cDCs	GSE169246_PacTissue_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60541
5.29488024246595e-16	-0.3935651423968	0.991	0.989	1.08301480479399e-11	RPL5	cDCs	GSE169246_PacTissue_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60542
5.74595080109799e-16	0.5701364527269	0.974	0.961	1.17527677685658e-11	SH3BGRL3	cDCs	GSE169246_PacTissue_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60543
6.30549977580622e-16	0.459267008023411	1	0.997	1.2897269241434e-11	TMSB4X	cDCs	GSE169246_PacTissue_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60544
9.69347708765294e-16	0.800152609772134	0.661	0.393	1.98270380350853e-11	CAPG	cDCs	GSE169246_PacTissue_post	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60545
1.16024688191073e-15	0.593355506214989	1	0.925	2.37316897226022e-11	VIM	cDCs	GSE169246_PacTissue_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60546
1.24552897571466e-15	-0.473726983059932	0.378	0.716	2.54760496692677e-11	BRI3	cDCs	GSE169246_PacTissue_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60547
2.61663992400301e-15	-0.465871418538461	0.987	0.997	5.35207530055576e-11	MT-ND3	cDCs	GSE169246_PacTissue_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60548
2.92430837082018e-15	-0.32497235634368	0.996	1	5.9813803416756e-11	RPS13	cDCs	GSE169246_PacTissue_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60549
3.69105953433642e-14	-0.353560163097021	0.991	0.994	7.54969317153172e-10	RPS21	cDCs	GSE169246_PacTissue_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60550
4.31620190298273e-14	-0.267810842180774	0.996	0.997	8.82835937236089e-10	RPL32	cDCs	GSE169246_PacTissue_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60551
4.92792904930235e-14	0.610699096470784	0.948	0.777	1.0079586077443e-09	S100A6	cDCs	GSE169246_PacTissue_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60552
5.65091848874638e-14	0.533865352600279	0.983	0.942	1.15583886768818e-09	S100A11	cDCs	GSE169246_PacTissue_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60553
6.81529598487595e-14	0.545523596585748	0.704	0.44	1.39400064074653e-09	LDHA	cDCs	GSE169246_PacTissue_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60554
1.01906677632122e-13	-0.299834564642702	1	0.997	2.08439918428742e-09	RPS7	cDCs	GSE169246_PacTissue_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60555
2.94166612355763e-13	0.415527789618193	1	0.989	6.01688388912478e-09	PFN1	cDCs	GSE169246_PacTissue_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60556
4.1483759987147e-13	-0.293861950306533	0.996	0.994	8.48508826777105e-09	RPS4X	cDCs	GSE169246_PacTissue_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60557
4.39675139042132e-13	-0.305316643056016	0.996	0.989	8.99311529396776e-09	RPL29	cDCs	GSE169246_PacTissue_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60558
8.07531382667701e-13	-0.265239345509239	0.996	0.978	1.65172469010852e-08	RPLP2	cDCs	GSE169246_PacTissue_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60559
9.39198433235111e-13	-0.421780354541039	0.13	0.401	1.9210364753391e-08	SMAP2	cDCs	GSE169246_PacTissue_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60560
1.13040371714039e-12	0.554122799866941	0.709	0.501	2.31212776303896e-08	PEA15	cDCs	GSE169246_PacTissue_post	ENSG00000162734	8682	proliferation and apoptosis adaptor protein 15	HMAT1|HUMMAT1H|MAT1|MAT1H|PEA-15|PED|PED-PEA15|PED/PEA15	protein_coding	Q15121	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60561
1.23159252259436e-12	0.409337978759846	1	0.994	2.51909934571451e-08	TMSB10	cDCs	GSE169246_PacTissue_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60562
1.29520405664018e-12	-0.33057048306504	0.052	0.29	2.64921037745182e-08	YPEL3	cDCs	GSE169246_PacTissue_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60563
1.80039778233957e-12	-0.760099695031809	0.748	0.836	3.68253362399736e-08	NR4A2	cDCs	GSE169246_PacTissue_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60564
1.89394712756715e-12	0.728323205988529	0.691	0.513	3.87387945472586e-08	YWHAH	cDCs	GSE169246_PacTissue_post	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60565
2.35909825302703e-12	-0.309617320699522	0.974	0.989	4.82529956674149e-08	RPL37A	cDCs	GSE169246_PacTissue_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60566
2.61212826018218e-12	0.311593537907498	1	0.992	5.34284714337664e-08	PPIA	cDCs	GSE169246_PacTissue_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60567
2.81089390813132e-12	-0.298189119473506	0.996	0.986	5.74940239969181e-08	NACA	cDCs	GSE169246_PacTissue_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60568
4.19513210385924e-12	-0.384871485856348	0.313	0.596	8.5807232052337e-08	PTP4A2	cDCs	GSE169246_PacTissue_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60569
4.28205567151094e-12	-0.27530666815759	0.996	0.997	8.75851667050848e-08	RPS14	cDCs	GSE169246_PacTissue_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60570
5.82954748770717e-12	-0.810729369600549	0.561	0.744	1.19237564313562e-07	ATF3	cDCs	GSE169246_PacTissue_post	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60571
6.8309474153955e-12	-0.448678051805244	0.678	0.936	1.397201984345e-07	CTSZ	cDCs	GSE169246_PacTissue_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60572
7.69553669055919e-12	0.419957561542228	0.37	0.128	1.57404507468698e-07	SNAI1	cDCs	GSE169246_PacTissue_post	ENSG00000124216	6615	snail family transcriptional repressor 1	SLUGH2|SNA|SNAH|SNAIL|SNAIL1	protein_coding	O95863	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60573
1.06742792321525e-11	0.421222528778806	0.848	0.727	2.18331707414448e-07	TPM3	cDCs	GSE169246_PacTissue_post	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60574
1.28249873326798e-11	-0.310601444316893	0.935	0.972	2.62322290902634e-07	RPL7	cDCs	GSE169246_PacTissue_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60575
1.29791355623203e-11	-0.510155704210505	0.209	0.471	2.65475238791699e-07	SYAP1	cDCs	GSE169246_PacTissue_post	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60576
1.30227236015633e-11	0.408677636676225	0.404	0.167	2.66366788546376e-07	SERPINF1	cDCs	GSE169246_PacTissue_post	ENSG00000282307	5176	serpin family F member 1	EPC-1|PEDF|PIG35	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60577
1.40739973790373e-11	-0.338974092360901	0.296	0.577	2.87869542390828e-07	MZT2B	cDCs	GSE169246_PacTissue_post	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60578
1.44330765222035e-11	-0.337658541933858	0.926	0.95	2.95214147185151e-07	EEF1D	cDCs	GSE169246_PacTissue_post	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60579
1.53462460173959e-11	0.478282027845903	0.939	0.864	3.13892116039815e-07	GRN	cDCs	GSE169246_PacTissue_post	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60580
1.57831055238458e-11	0.479013798626039	0.822	0.652	3.22827640384743e-07	MIF	cDCs	GSE169246_PacTissue_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60581
1.96942972368628e-11	-0.316941547449613	0.974	0.992	4.02827155682791e-07	PABPC1	cDCs	GSE169246_PacTissue_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60582
2.90428882549835e-11	0.333237165650528	0.983	0.955	5.94043236367432e-07	MYL6	cDCs	GSE169246_PacTissue_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60583
3.5307769968824e-11	0.394929894860647	0.604	0.337	7.22185126942325e-07	BHLHE40	cDCs	GSE169246_PacTissue_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60584
4.68032185244932e-11	0.496784187064768	0.717	0.574	9.57313031699984e-07	ENO1	cDCs	GSE169246_PacTissue_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60585
5.20411691674395e-11	0.626319873059727	0.504	0.279	1.06445007415081e-06	LMNA	cDCs	GSE169246_PacTissue_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60586
5.34058744175551e-11	0.430196746047066	0.974	0.958	1.09236375533667e-06	COTL1	cDCs	GSE169246_PacTissue_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60587
5.99885425248964e-11	-0.288685693116454	0.991	0.978	1.22700564880423e-06	RPL21	cDCs	GSE169246_PacTissue_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60588
7.82345870387376e-11	0.276944686271477	0.996	0.997	1.60021024329034e-06	MT-CO2	cDCs	GSE169246_PacTissue_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60589
1.00208099493119e-10	-0.330286978290712	0.909	0.981	2.04965646703225e-06	SLC25A6	cDCs	GSE169246_PacTissue_post	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60590
1.02569266173716e-10	0.297487777659388	0.422	0.181	2.09795177031719e-06	PTTG1IP	cDCs	GSE169246_PacTissue_post	ENSG00000183255	754	PTTG1 interacting protein	C21orf1|C21orf3|PBF|PTTG1IP1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60591
1.26584817725349e-10	0.312727496201313	1	1	2.58916586175428e-06	HLA-DQA1	cDCs	GSE169246_PacTissue_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60592
1.3050249671934e-10	0.597244901114605	0.943	0.936	2.66929806789739e-06	HLA-C	cDCs	GSE169246_PacTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60593
1.81892520190243e-10	-0.478994838118575	0.239	0.493	3.72042960797124e-06	BTG2	cDCs	GSE169246_PacTissue_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60594
2.63560736067195e-10	0.538441177634671	0.665	0.451	5.39087129551841e-06	PRDX1	cDCs	GSE169246_PacTissue_post	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60595
3.02884888475985e-10	0.299337749884768	0.987	0.969	6.19520750888779e-06	OAZ1	cDCs	GSE169246_PacTissue_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60596
3.05621378889677e-10	-0.446417874327576	0.091	0.312	6.25117968380946e-06	KLF2	cDCs	GSE169246_PacTissue_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60597
3.51626931494648e-10	0.383888306834706	0.661	0.432	7.19217725679153e-06	SRSF2	cDCs	GSE169246_PacTissue_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60598
3.71914271865548e-10	-0.412511952155842	0.104	0.326	7.60713451673793e-06	UBE2S	cDCs	GSE169246_PacTissue_post	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60599
4.40484666154113e-10	-0.300791990339841	0.961	0.978	9.00967336151623e-06	ATP5MC2	cDCs	GSE169246_PacTissue_post	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60600
9.01562708859567e-10	0.358074429470712	0.617	0.387	1.84405636470136e-05	ARL6IP5	cDCs	GSE169246_PacTissue_post	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60601
1.0677251268734e-09	0.681256476598699	0.396	0.189	2.18392497450684e-05	FBP1	cDCs	GSE169246_PacTissue_post	ENSG00000165140	2203	fructose-bisphosphatase 1	FBP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60602
1.68290653671649e-09	0.303854038472825	0.343	0.136	3.44221703019991e-05	GNA15	cDCs	GSE169246_PacTissue_post	ENSG00000060558	2769	G protein subunit alpha 15	GNA16	protein_coding	P30679	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60603
1.70546967305215e-09	0.349899089068147	0.765	0.652	3.48836766926086e-05	RBM3	cDCs	GSE169246_PacTissue_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60604
1.86345551098165e-09	0.391044869626989	0.987	0.972	3.81151190216186e-05	MT-ATP8	cDCs	GSE169246_PacTissue_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60605
1.9081545778881e-09	0.301747023549179	0.948	0.916	3.90293937361233e-05	CLIC1	cDCs	GSE169246_PacTissue_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60606
2.26325127290534e-09	0.281283494084355	0.343	0.136	4.62925415360058e-05	MVP	cDCs	GSE169246_PacTissue_post	ENSG00000013364	9961	major vault protein	LRP|VAULT1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60607
2.54632303451509e-09	0.379579541008822	0.939	0.891	5.20824913479716e-05	SPI1	cDCs	GSE169246_PacTissue_post	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60608
2.86914045056282e-09	-0.306303137121103	0.935	0.95	5.86853987758118e-05	RPL31	cDCs	GSE169246_PacTissue_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60609
2.94047256350698e-09	0.255326859769429	0.335	0.131	6.01444258139717e-05	TRABD	cDCs	GSE169246_PacTissue_post	ENSG00000170638	80305	TraB domain containing	PP2447	protein_coding	Q9H4I3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60610
3.29680635736275e-09	0.944078463420378	0.726	0.588	6.74328772334977e-05	C15orf48	cDCs	GSE169246_PacTissue_post	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60611
4.64668056100381e-09	0.446714862330469	0.517	0.292	9.5043204194772e-05	PHLDA2	cDCs	GSE169246_PacTissue_post	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60612
4.84687512855986e-09	0.34602854412738	0.922	0.894	9.91379838795633e-05	NPM1	cDCs	GSE169246_PacTissue_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60613
4.88211447818681e-09	-0.440482165528822	0.878	0.925	9.9858769536833e-05	CD83	cDCs	GSE169246_PacTissue_post	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60614
6.44538607142349e-09	0.332009862266526	0.404	0.195	0.000131833926704896	MAP2K3	cDCs	GSE169246_PacTissue_post	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60615
6.96430015905616e-09	-0.563510714567884	0.539	0.721	0.000142447795453335	SELENOK	cDCs	GSE169246_PacTissue_post	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60616
7.3457889140945e-09	-0.296592731930468	0.922	0.975	0.000150250766448889	LYZ	cDCs	GSE169246_PacTissue_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60617
7.62080306264266e-09	0.593706390518865	0.713	0.535	0.000155875905843293	RGS1	cDCs	GSE169246_PacTissue_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60618
7.92338909736671e-09	-0.377985914309864	0.283	0.51	0.000162065000597539	MRPL18	cDCs	GSE169246_PacTissue_post	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60619
8.03041894562302e-09	-0.425668440549975	0.213	0.429	0.000164254189113773	ARL5B	cDCs	GSE169246_PacTissue_post	ENSG00000165997	221079	ADP ribosylation factor like GTPase 5B	ARL8	protein_coding	Q96KC2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60620
8.28068498351532e-09	-0.375854612498915	0.278	0.51	0.000169373130652822	GTF2B	cDCs	GSE169246_PacTissue_post	ENSG00000137947	2959	general transcription factor IIB	TFIIB	protein_coding	Q00403	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60621
8.45023392363386e-09	0.390965936783808	0.396	0.189	0.000172841084674007	UPP1	cDCs	GSE169246_PacTissue_post	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60622
9.3609163863163e-09	0.347729233987049	0.496	0.29	0.000191468183765714	PGAM1	cDCs	GSE169246_PacTissue_post	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60623
1.01295257759137e-08	0.307216349192046	0.413	0.203	0.000207189320220538	ALOX5	cDCs	GSE169246_PacTissue_post	ENSG00000275565	240	arachidonate 5-lipoxygenase	5-LOX	protein_coding	P09917	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60624
1.04286895782886e-08	-0.497928717678145	0.626	0.783	0.000213308416634315	DUSP2	cDCs	GSE169246_PacTissue_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60625
1.0555776907331e-08	0.430299505763687	0.748	0.613	0.000215907860862547	CALHM6	cDCs	GSE169246_PacTissue_post	ENSG00000188820	441168	calcium homeostasis modulator family member 6	C6orf187|dJ93H18.5|FAM26F|INAM|OTTHUMP00000017061|OTTHUMP00000017062|RP1-93H18.5	protein_coding	Q5R3K3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60626
1.26149101501807e-08	-0.367796142538154	0.991	1	0.000258025372211796	MT-CYB	cDCs	GSE169246_PacTissue_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60627
1.31340688766224e-08	0.358956489410303	0.743	0.529	0.000268644244802435	CALM1	cDCs	GSE169246_PacTissue_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60628
2.10448558248676e-08	0.295184596492291	0.604	0.379	0.000430451481041843	PTGES3	cDCs	GSE169246_PacTissue_post	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60629
2.17840294297395e-08	0.290995774058096	0.357	0.162	0.000445570537955893	SLC16A3	cDCs	GSE169246_PacTissue_post	ENSG00000141526	9123	solute carrier family 16 member 3	MCT3|MCT4	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60630
2.26471864167815e-08	0.269691085870384	0.917	0.827	0.000463225550968849	GNG5	cDCs	GSE169246_PacTissue_post	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60631
2.30321571437185e-08	0.255406696798911	0.974	0.944	0.000471099742217617	RPL27	cDCs	GSE169246_PacTissue_post	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60632
2.45969729235517e-08	0.521869606971055	0.665	0.485	0.000503106484178326	PPIF	cDCs	GSE169246_PacTissue_post	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60633
2.46357731856367e-08	0.453478935769763	0.791	0.649	0.000503900104739014	PKM	cDCs	GSE169246_PacTissue_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60634
2.8167837002765e-08	-0.399470192815951	0.157	0.376	0.000576144938054555	DUSP5	cDCs	GSE169246_PacTissue_post	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60635
2.89248197703948e-08	0.251398102124145	0.252	0.086	0.000591628263583656	NECTIN2	cDCs	GSE169246_PacTissue_post	ENSG00000130202	5819	nectin cell adhesion molecule 2	CD112|HVEB|Nectin-2|PRR2|PVRL2|PVRR2	protein_coding	Q92692	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60636
3.40566144116628e-08	-0.292802572610793	0.987	0.997	0.000696593991176151	HLA-DRB5	cDCs	GSE169246_PacTissue_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60637
3.74434979576098e-08	0.302139925940377	0.891	0.752	0.000765869307224951	SUB1	cDCs	GSE169246_PacTissue_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60638
6.03905511514705e-08	0.470136804841094	0.652	0.51	0.00123522833325218	TYMP	cDCs	GSE169246_PacTissue_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60639
6.0888584238027e-08	0.456144560208892	0.417	0.223	0.0012454151020046	ALOX5AP	cDCs	GSE169246_PacTissue_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60640
6.61604129671652e-08	0.314604561396	0.53	0.309	0.0013532450868304	VASP	cDCs	GSE169246_PacTissue_post	ENSG00000125753	7408	vasodilator stimulated phosphoprotein	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60641
6.72435998233355e-08	0.302703782144568	0.635	0.426	0.0013754005907865	CIB1	cDCs	GSE169246_PacTissue_post	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60642
8.04064329409277e-08	0.426049451853451	0.852	0.744	0.00164463317937374	LGALS1	cDCs	GSE169246_PacTissue_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60643
8.9880656266442e-08	0.257432471976168	0.487	0.276	0.0018384189432738	EIF4G2	cDCs	GSE169246_PacTissue_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60644
1.03039754283029e-07	0.358717706147503	0.913	0.894	0.00210757513410507	LAPTM5	cDCs	GSE169246_PacTissue_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60645
1.19137114465315e-07	-0.336965862949586	0.2	0.401	0.00243683053927356	LTA4H	cDCs	GSE169246_PacTissue_post	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60646
1.34069934691037e-07	0.273855069536862	0.535	0.329	0.00274226644417046	BANF1	cDCs	GSE169246_PacTissue_post	ENSG00000175334	8815	BAF nuclear assembly factor 1	BAF	protein_coding	O75531	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60647
1.70168447164732e-07	0.251486157241414	0.391	0.198	0.00348062541830743	CNDP2	cDCs	GSE169246_PacTissue_post	ENSG00000133313	55748	carnosine dipeptidase 2	CN2|CPGL|FLJ10830|HsT2298|PEPA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60648
1.72220854087313e-07	-0.562854505707004	0.865	0.942	0.00352260534950189	DUSP1	cDCs	GSE169246_PacTissue_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60649
1.96040887789098e-07	0.338407633464676	0.583	0.39	0.00400982031883822	CD44	cDCs	GSE169246_PacTissue_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60650
2.15727364376577e-07	-0.384786147058838	0.278	0.485	0.00441248751095851	RASGEF1B	cDCs	GSE169246_PacTissue_post	ENSG00000138670	153020	RasGEF domain family member 1B	FLJ31695|GPIG4	protein_coding	Q0VAM2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60651
2.26571423582751e-07	0.271902634623903	0.413	0.22	0.00463429189796158	TMEM109	cDCs	GSE169246_PacTissue_post	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60652
2.37378246604615e-07	0.56666105128213	0.317	0.142	0.00485533465605079	ISG15	cDCs	GSE169246_PacTissue_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60653
2.55586690914844e-07	-0.402851841105273	0.509	0.716	0.00522777017597221	CD52	cDCs	GSE169246_PacTissue_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60654
2.62099861619105e-07	0.263838359624946	0.409	0.217	0.00536099056955718	SUMO3	cDCs	GSE169246_PacTissue_post	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60655
2.63363812752154e-07	0.25722806150412	0.83	0.702	0.00538684342603255	MYL12B	cDCs	GSE169246_PacTissue_post	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60656
2.82070780455214e-07	-0.290775173406163	0.23	0.429	0.00576947574343095	AOAH	cDCs	GSE169246_PacTissue_post	ENSG00000136250	313	acyloxyacyl hydrolase	NA	protein_coding	P28039	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60657
2.83656974931972e-07	-0.263104380614324	0.157	0.345	0.00580191976525856	CDK2AP1	cDCs	GSE169246_PacTissue_post	ENSG00000111328	8099	cyclin dependent kinase 2 associated protein 1	doc-1|DOC1|DORC1|p12DOC-1|ST19	protein_coding	O14519	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60658
2.95716066287462e-07	-0.546067538147498	0.635	0.788	0.00604857641984374	HSPA1B	cDCs	GSE169246_PacTissue_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60659
2.97918783879633e-07	0.303270304606601	0.996	0.992	0.00609363080547401	GAPDH	cDCs	GSE169246_PacTissue_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60660
3.39352054247641e-07	-0.392912054387393	0.943	0.972	0.00694110691758124	SRGN	cDCs	GSE169246_PacTissue_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60661
3.78362560635872e-07	0.285247252683974	0.704	0.56	0.00773902781524613	NDUFB2	cDCs	GSE169246_PacTissue_post	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60662
3.88137356929125e-07	-0.418453296183524	0.226	0.418	0.00793896149862832	RBKS	cDCs	GSE169246_PacTissue_post	ENSG00000171174	64080	ribokinase	DKFZp686G13268|RBSK	protein_coding	Q9H477	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60663
3.99506278366902e-07	0.295401473442002	0.596	0.423	0.00817150141771661	NAPA	cDCs	GSE169246_PacTissue_post	ENSG00000105402	8775	NSF attachment protein alpha	NA	protein_coding	P54920	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60664
4.05504805817597e-07	-0.467406952720312	0.83	0.914	0.00829419529819312	HSPA1A	cDCs	GSE169246_PacTissue_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60665
4.96002200361245e-07	-0.287670487568397	0.113	0.284	0.0101452290061889	H1FX	cDCs	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60666
5.0331062087243e-07	0.266916557951053	0.57	0.379	0.0102947154393247	PSMA6	cDCs	GSE169246_PacTissue_post	ENSG00000100902	5687	proteasome 20S subunit alpha 6	IOTA|MGC22756|MGC2333|MGC23846|p27K|PROS27	protein_coding	P60900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60667
5.67678705901372e-07	0.292765545088449	0.617	0.435	0.0116113002505067	SPINT2	cDCs	GSE169246_PacTissue_post	ENSG00000167642	10653	serine peptidase inhibitor, Kunitz type 2	HAI-2|HAI2|Kop	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60668
6.83664586916822e-07	0.370074188638412	0.904	0.797	0.0139836754607967	CTSH	cDCs	GSE169246_PacTissue_post	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60669
7.8794632007349e-07	-0.391524882759346	0.504	0.666	0.0161166540307832	BASP1	cDCs	GSE169246_PacTissue_post	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60670
8.30959002592791e-07	0.323626352353739	0.835	0.73	0.0169964354390329	PPIB	cDCs	GSE169246_PacTissue_post	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60671
8.59610239006873e-07	-0.374004629971626	0.296	0.474	0.0175824678286466	FOSL2	cDCs	GSE169246_PacTissue_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60672
8.76054107613838e-07	-0.261004848587812	0.696	0.836	0.0179188107171334	EIF3L	cDCs	GSE169246_PacTissue_post	ENSG00000100129	51386	eukaryotic translation initiation factor 3 subunit L	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60673
9.44769059918402e-07	0.27273160835905	0.452	0.262	0.019324306351571	PTMS	cDCs	GSE169246_PacTissue_post	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60674
9.9947656318913e-07	0.302009850877433	0.3	0.142	0.0204432936234705	GBP4	cDCs	GSE169246_PacTissue_post	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60675
1.0028697910489e-06	-0.38897459368973	1	1	0.0205126987061143	FTH1	cDCs	GSE169246_PacTissue_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60676
1.02605178029509e-06	-0.361471728073732	0.435	0.599	0.0209868631141557	STX11	cDCs	GSE169246_PacTissue_post	ENSG00000135604	8676	syntaxin 11	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60677
1.21099820032326e-06	-0.423238358748901	0.509	0.663	0.024769757189412	HSPH1	cDCs	GSE169246_PacTissue_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60678
1.2193479761264e-06	-0.491980903961857	0.752	0.802	0.0249405435036895	CTSS	cDCs	GSE169246_PacTissue_post	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60679
1.30929719072401e-06	0.345083942225583	0.543	0.351	0.0267803647390689	ID2	cDCs	GSE169246_PacTissue_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60680
1.39267312248319e-06	0.429900364789807	0.439	0.276	0.0284857360472712	TAP1	cDCs	GSE169246_PacTissue_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60681
1.50115510287694e-06	0.33716515182589	0.5	0.309	0.030704626474245	PNP	cDCs	GSE169246_PacTissue_post	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60682
1.59060185646549e-06	0.477189829790706	1	1	0.0325341703721451	ACTB	cDCs	GSE169246_PacTissue_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60683
1.72789036704744e-06	-0.300194066812897	0.522	0.682	0.0353422695675882	PTPRE	cDCs	GSE169246_PacTissue_post	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60684
1.745121517508e-06	-0.301370983277169	0.53	0.663	0.0356947155191087	EIF5	cDCs	GSE169246_PacTissue_post	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60685
1.80698293620909e-06	-0.263413947275558	0.639	0.788	0.0369600289772207	RPS17	cDCs	GSE169246_PacTissue_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60686
1.96544984816451e-06	0.295618496990741	0.883	0.827	0.0402013111943568	TPI1	cDCs	GSE169246_PacTissue_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60687
2.12268852593049e-06	0.263362144060006	0.704	0.582	0.0434174711093822	ATP5F1B	cDCs	GSE169246_PacTissue_post	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60688
1.19598734115399e-70	-0.735088175465492	0.984	0.997	2.44627250759636e-66	MT-ND3	B cells	GSE169246_PacTissue_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60689
8.63253110478027e-59	0.587310322334202	0.999	0.997	1.76569791217176e-54	RPS3A	B cells	GSE169246_PacTissue_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60690
1.52540563927063e-45	0.688736911133283	0.958	0.881	3.12006469456415e-41	HLA-C	B cells	GSE169246_PacTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60691
2.0002946703013e-45	-0.402618537750403	0.999	1	4.09140271863428e-41	CD74	B cells	GSE169246_PacTissue_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60692
3.43333933973245e-44	0.54617692037251	1	1	7.02255228548874e-40	RPS18	B cells	GSE169246_PacTissue_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60693
4.26152688101529e-43	-0.955522773271646	0.587	0.842	8.71652708242868e-39	ZFP36L2	B cells	GSE169246_PacTissue_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60694
6.78866902535486e-41	1.34901950280239	0.721	0.385	1.38855436244608e-36	HSPA1B	B cells	GSE169246_PacTissue_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60695
1.77810821951448e-40	0.640029992872225	0.924	0.814	3.63694255219491e-36	RPL27A	B cells	GSE169246_PacTissue_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60696
2.12560887801676e-40	-0.724281420508909	0.141	0.429	4.34772039909548e-36	YBX3	B cells	GSE169246_PacTissue_post	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60697
1.0978284403549e-39	0.856446574557342	0.97	0.873	2.24549829190192e-35	UBC	B cells	GSE169246_PacTissue_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60698
1.70365945101316e-39	1.02493932556394	0.847	0.571	3.48466504110232e-35	DNAJB1	B cells	GSE169246_PacTissue_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60699
2.03657911034293e-37	-0.406797003994889	0.999	0.997	4.16561891229543e-33	RPL34	B cells	GSE169246_PacTissue_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60700
1.33767421521069e-35	1.3293629045136	0.724	0.427	2.73607883979195e-31	HSPA1A	B cells	GSE169246_PacTissue_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60701
4.85653198499327e-35	-0.351088526854026	0.999	1	9.93355052210523e-31	RPS8	B cells	GSE169246_PacTissue_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60702
5.54795857249804e-34	0.595345724862179	0.635	0.294	1.13477944641875e-29	SRSF5	B cells	GSE169246_PacTissue_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60703
5.85856834854243e-34	0.849081567884276	0.978	0.911	1.19831157001087e-29	HSP90AA1	B cells	GSE169246_PacTissue_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60704
9.6926213060836e-33	-0.360462440942957	0.997	0.997	1.98252876194634e-28	RPS13	B cells	GSE169246_PacTissue_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60705
1.34226653902029e-31	0.799077771008723	0.99	0.981	2.74547197891211e-27	H3F3B	B cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60706
1.34930972749464e-31	-0.584493198848736	0.26	0.537	2.75987811661754e-27	RUBCNL	B cells	GSE169246_PacTissue_post	ENSG00000102445	80183	rubicon like autophagy enhancer	C13orf18|FLJ21562|KIAA0226L|PACER	protein_coding	Q9H714	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60707
1.74324075339043e-31	-0.382754067969709	0.996	1	3.56562463698479e-27	RPL39	B cells	GSE169246_PacTissue_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60708
3.91141460188623e-30	0.883109369652477	0.857	0.665	8.0004074266981e-26	DNAJA1	B cells	GSE169246_PacTissue_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60709
4.33663722621698e-30	-0.397330872092189	0.998	0.997	8.87015778250421e-26	RPS24	B cells	GSE169246_PacTissue_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60710
1.33529738757412e-29	0.783567116954794	0.958	0.917	2.73121727654411e-25	HSP90AB1	B cells	GSE169246_PacTissue_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60711
2.32466180470511e-29	0.900549943584059	0.957	0.889	4.75486325534383e-25	ACTG1	B cells	GSE169246_PacTissue_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60712
5.28015071887599e-29	-0.336305997498932	0.999	0.997	1.08000202803889e-24	RPL11	B cells	GSE169246_PacTissue_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60713
5.9755952466046e-29	0.564851526614316	0.602	0.285	1.2222482517405e-24	CCNL1	B cells	GSE169246_PacTissue_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60714
7.07203464331694e-29	-0.311374276846847	0.997	0.997	1.44651396594405e-24	FAU	B cells	GSE169246_PacTissue_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60715
8.38614875594294e-29	-0.320249648609225	0.999	1	1.71530286654057e-24	RPL10	B cells	GSE169246_PacTissue_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60716
6.77639152528452e-28	-0.337756085580969	0.996	0.994	1.3860431225817e-23	RPL35A	B cells	GSE169246_PacTissue_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60717
3.2398766245632e-27	-0.739564908167211	0.576	0.762	6.62684364788157e-23	CD55	B cells	GSE169246_PacTissue_post	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60718
2.04630734818503e-26	0.774832899159286	0.745	0.521	4.18551704997766e-22	PPP1R15A	B cells	GSE169246_PacTissue_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60719
2.77037172413117e-26	-0.40205227285221	0.077	0.271	5.6665183245379e-22	CCL4	B cells	GSE169246_PacTissue_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60720
1.96137269160206e-25	-0.31630597455397	0.998	1	4.01179170340285e-21	MT-CO2	B cells	GSE169246_PacTissue_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60721
3.59345656238376e-25	-0.298514386235852	0.998	1	7.35005605269975e-21	RPL30	B cells	GSE169246_PacTissue_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60722
4.29694629382296e-25	-0.291481523989876	0.999	0.997	8.78897394938548e-21	RPS27A	B cells	GSE169246_PacTissue_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60723
1.14435800142193e-24	0.559233688809074	0.93	0.837	2.34066985610842e-20	CFL1	B cells	GSE169246_PacTissue_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60724
1.57021767161673e-24	-0.376009759767676	0.993	1	3.21172322552487e-20	MT-CYB	B cells	GSE169246_PacTissue_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60725
9.87801298333743e-24	-0.328715505862154	0.992	1	2.02044877561184e-19	MT-ND4L	B cells	GSE169246_PacTissue_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60726
5.0786823944868e-23	-0.366139635997739	0.997	1	1.03879369696833e-18	MT-CO1	B cells	GSE169246_PacTissue_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60727
7.03482614323782e-23	-0.561753873076498	0.716	0.856	1.43890333933786e-18	TAGLN2	B cells	GSE169246_PacTissue_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60728
4.22012062091862e-22	-0.310325864353894	0.998	0.997	8.63183471802694e-18	RPL29	B cells	GSE169246_PacTissue_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60729
4.6275165633035e-22	-0.419760255908454	0.162	0.374	9.46512237858098e-18	PLPP5	B cells	GSE169246_PacTissue_post	ENSG00000147535	84513	phospholipid phosphatase 5	DPPL1|HTPAP|PPAPDC1B	protein_coding	Q8NEB5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60730
1.09318397995412e-21	-0.295119580681891	0.157	0.393	2.23599851259815e-17	TCL1A	B cells	GSE169246_PacTissue_post	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60731
2.33992179744107e-21	0.471031466771254	0.987	1	4.78607604448596e-17	MT-ATP8	B cells	GSE169246_PacTissue_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60732
2.47159757353675e-21	-0.302258290020764	0.999	1	5.05540567691206e-17	RPS12	B cells	GSE169246_PacTissue_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60733
2.73719389305218e-21	0.493895392714529	0.791	0.645	5.59865638884892e-17	RPS10	B cells	GSE169246_PacTissue_post	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60734
7.22914399048065e-21	0.668471927651893	0.844	0.726	1.47864911181291e-16	HSPE1	B cells	GSE169246_PacTissue_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60735
6.00679978896798e-20	0.50047968091545	0.695	0.465	1.22863082883551e-15	COTL1	B cells	GSE169246_PacTissue_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60736
6.41566647512077e-20	0.483078185870064	0.354	0.114	1.3122604208212e-15	ZFAND2A	B cells	GSE169246_PacTissue_post	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60737
7.30491476821964e-20	0.607215722623866	0.551	0.302	1.49414726669165e-15	CKS2	B cells	GSE169246_PacTissue_post	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60738
9.42550873241804e-20	0.338379282424373	0.996	1	1.92789355612879e-15	RPL3	B cells	GSE169246_PacTissue_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60739
2.58745517975745e-19	-0.253634152278273	0.999	1	5.29238082467589e-15	RPL32	B cells	GSE169246_PacTissue_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60740
2.68134741183998e-19	-0.464248253620775	0.692	0.839	5.48442799617749e-15	EZR	B cells	GSE169246_PacTissue_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60741
3.90353858959343e-19	0.486341223887996	0.695	0.49	7.98429783115441e-15	EIF5	B cells	GSE169246_PacTissue_post	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60742
7.22041900263483e-19	-0.253500005202716	0.999	0.992	1.47686450279893e-14	RPL18	B cells	GSE169246_PacTissue_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60743
1.12035849825464e-18	0.702008848072117	0.518	0.299	2.29158127233004e-14	RGS2	B cells	GSE169246_PacTissue_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60744
3.43099470467461e-18	-0.605184527505828	0.704	0.817	7.01775656894144e-14	HERPUD1	B cells	GSE169246_PacTissue_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60745
3.80431915708069e-18	0.477968611289066	0.449	0.219	7.78135440389284e-14	PMAIP1	B cells	GSE169246_PacTissue_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60746
5.16873587794009e-18	0.332514962758509	0.293	0.075	1.05721323647387e-13	AIM2	B cells	GSE169246_PacTissue_post	ENSG00000163568	9447	absent in melanoma 2	PYHIN4	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60747
7.42126821710735e-18	0.843529496827534	0.903	0.778	1.51794620112714e-13	GAPDH	B cells	GSE169246_PacTissue_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60748
8.36540770851356e-18	0.383535186149135	0.555	0.305	1.71106049269936e-13	POU2F2	B cells	GSE169246_PacTissue_post	ENSG00000028277	5452	POU class 2 homeobox 2	OCT2|OTF2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60749
1.03229403721119e-17	-0.319344511199035	0.985	0.989	2.11145422371178e-13	HLA-DRB1	B cells	GSE169246_PacTissue_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60750
1.19073886386099e-17	-0.301371077458776	0.995	0.992	2.43553727214128e-13	RPS5	B cells	GSE169246_PacTissue_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60751
2.17335469347283e-17	-0.250377123294605	0.999	0.997	4.44537969002933e-13	RPL18A	B cells	GSE169246_PacTissue_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60752
4.18831428672426e-17	-0.411393894171988	0.423	0.629	8.56677804206581e-13	SELL	B cells	GSE169246_PacTissue_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60753
4.36870177586247e-17	0.481078905541977	0.656	0.438	8.93574261234909e-13	CALR	B cells	GSE169246_PacTissue_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60754
1.00692174031811e-16	0.609230581137684	0.758	0.601	2.05955772764667e-12	SAT1	B cells	GSE169246_PacTissue_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60755
6.14769319247819e-16	0.431565754436531	0.977	0.942	1.25744916558949e-11	HSPA8	B cells	GSE169246_PacTissue_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60756
8.29720716313215e-16	-0.32539898016426	0.377	0.584	1.69711075314705e-11	SMDT1	B cells	GSE169246_PacTissue_post	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60757
9.14888128280184e-16	0.49207461109687	0.448	0.23	1.87131217758429e-11	IER5	B cells	GSE169246_PacTissue_post	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60758
1.11165098088196e-15	-0.432877384300825	0.482	0.662	2.27377091629596e-11	SMAP2	B cells	GSE169246_PacTissue_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60759
2.04428445079674e-15	0.496105101126545	0.969	0.972	4.18137941565966e-11	RPS29	B cells	GSE169246_PacTissue_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60760
2.13900067199803e-15	0.355305694282186	0.39	0.169	4.37511197450477e-11	MAT2A	B cells	GSE169246_PacTissue_post	ENSG00000168906	4144	methionine adenosyltransferase 2A	MATA2|MATII|SAMS2	protein_coding	P31153	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60761
2.25346651762881e-15	-0.287900636623474	0.983	0.978	4.60924041515796e-11	RPL22	B cells	GSE169246_PacTissue_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60762
3.48154711291945e-15	0.444163134378773	0.438	0.227	7.12115646476545e-11	HMGA1	B cells	GSE169246_PacTissue_post	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60763
4.55811433931581e-15	0.419157562490726	0.681	0.493	9.32316706963656e-11	EIF4A2	B cells	GSE169246_PacTissue_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60764
8.59044423866989e-15	0.407823691868904	0.945	0.895	1.75708946457754e-10	UBB	B cells	GSE169246_PacTissue_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60765
8.64140852012783e-15	0.311691704362008	0.293	0.097	1.76751369870695e-10	MYLIP	B cells	GSE169246_PacTissue_post	ENSG00000007944	29116	myosin regulatory light chain interacting protein	IDOL|MIR	protein_coding	Q8WY64	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60766
1.06347763273924e-14	-0.588588755937698	0.995	1	2.17523715000483e-10	FTH1	B cells	GSE169246_PacTissue_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60767
1.07719890388944e-14	0.319907435273629	0.343	0.133	2.20330263801547e-10	TNFRSF13B	B cells	GSE169246_PacTissue_post	ENSG00000240505	23495	TNF receptor superfamily member 13B	CD267|IGAD2|TACI	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60768
1.19644359027449e-14	0.61903164038187	0.45	0.249	2.44720571954744e-10	GLA	B cells	GSE169246_PacTissue_post	ENSG00000102393	2717	galactosidase alpha	GALA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60769
1.56842204738237e-14	-0.250424695777685	1	0.997	3.20805045571591e-10	RPS4X	B cells	GSE169246_PacTissue_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60770
2.47961631144126e-14	0.727407664931513	0.579	0.399	5.07180720342196e-10	GADD45B	B cells	GSE169246_PacTissue_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60771
2.70359526302656e-14	0.255723517550217	0.998	0.992	5.52993375099452e-10	RPS6	B cells	GSE169246_PacTissue_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60772
3.18259128829491e-14	-0.285254399226999	0.986	0.986	6.50967222107841e-10	NACA	B cells	GSE169246_PacTissue_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60773
3.2558291541628e-14	-0.332224670789109	0.268	0.474	6.65947295192459e-10	MYADM	B cells	GSE169246_PacTissue_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60774
3.61213783754878e-14	0.556991589299122	0.742	0.634	7.38826673292228e-10	HSPD1	B cells	GSE169246_PacTissue_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60775
3.96782263815324e-14	0.606554518727127	0.357	0.163	8.11578442407864e-10	RGS1	B cells	GSE169246_PacTissue_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60776
4.91963194902557e-14	-0.337294410368309	0.388	0.579	1.00626151885369e-09	ITM2B	B cells	GSE169246_PacTissue_post	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60777
4.99991729614595e-14	-0.274207571595797	0.27	0.468	1.02268308375369e-09	FCER2	B cells	GSE169246_PacTissue_post	ENSG00000104921	2208	Fc epsilon receptor II	CD23|CD23A|CLEC4J|FCE2|FcepsilonRII|FCErII	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60778
5.02777216082971e-14	0.298981889314944	0.401	0.191	1.02838051777611e-09	ACAP1	B cells	GSE169246_PacTissue_post	ENSG00000288169	9744	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	CENTB1|KIAA0050	protein_coding	Q15027	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60779
6.18912969413556e-14	-0.305656235657605	0.969	0.992	1.26592458763849e-09	CD37	B cells	GSE169246_PacTissue_post	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60780
1.59428506301071e-13	0.303809206026229	0.447	0.241	3.26095066788212e-09	TRA2A	B cells	GSE169246_PacTissue_post	ENSG00000164548	29896	transformer 2 alpha homolog	AWMS1|htra-2-alpha	protein_coding	Q13595	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60781
1.86427551262278e-13	0.311407091846218	0.958	0.953	3.81318913351863e-09	HLA-E	B cells	GSE169246_PacTissue_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60782
1.86455895874012e-13	0.43495224355874	0.653	0.49	3.81376889420705e-09	MAP1LC3B	B cells	GSE169246_PacTissue_post	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60783
2.03439141666015e-13	0.486912794222675	0.542	0.352	4.16114420363668e-09	MRPL18	B cells	GSE169246_PacTissue_post	ENSG00000112110	29074	mitochondrial ribosomal protein L18	HSPC071	protein_coding	Q9H0U6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60784
3.11647797517872e-13	0.350553812413681	0.335	0.144	6.37444405043054e-09	H2AFX	B cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60785
3.37417833426619e-13	0.525965444036061	0.694	0.546	6.90154436490806e-09	SQSTM1	B cells	GSE169246_PacTissue_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60786
4.01063935361536e-13	0.368754194401397	0.601	0.399	8.20336173388486e-09	RSRP1	B cells	GSE169246_PacTissue_post	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60787
4.42510487027464e-13	0.288102303946923	0.293	0.111	9.05110950165976e-09	ARPC5L	B cells	GSE169246_PacTissue_post	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60788
4.77865746965437e-13	-0.311733473255763	0.95	0.975	9.77426598843105e-09	CD79A	B cells	GSE169246_PacTissue_post	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60789
5.17515613912981e-13	0.360051444219688	0.532	0.327	1.05852643669761e-08	CD24	B cells	GSE169246_PacTissue_post	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60790
6.53842754200475e-13	-0.377627376931199	0.431	0.615	1.33736996944165e-08	BIRC3	B cells	GSE169246_PacTissue_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60791
6.98355277818462e-13	0.379951362354283	0.678	0.512	1.42841588524988e-08	SRSF2	B cells	GSE169246_PacTissue_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60792
1.39232303130193e-12	0.372373562076295	0.646	0.49	2.84785752822497e-08	SNHG8	B cells	GSE169246_PacTissue_post	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60793
1.41545620518354e-12	0.370817556857581	0.682	0.507	2.89517412208241e-08	FUS	B cells	GSE169246_PacTissue_post	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60794
3.05434501461019e-12	0.285890384548382	0.325	0.141	6.24735729288368e-08	DEDD2	B cells	GSE169246_PacTissue_post	ENSG00000160570	162989	death effector domain containing 2	FLAME-3	protein_coding	Q8WXF8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60795
4.87094309883995e-12	-0.273389542896246	0.301	0.493	9.96302701436724e-08	IGHM	B cells	GSE169246_PacTissue_post	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60796
4.93575224199285e-12	0.326112416504519	0.595	0.407	1.00955876357722e-07	CD19	B cells	GSE169246_PacTissue_post	ENSG00000177455	930	CD19 molecule	NA	protein_coding	P15391	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60797
4.96103638404345e-12	0.285900384825932	0.438	0.244	1.01473038199225e-07	RGS19	B cells	GSE169246_PacTissue_post	ENSG00000171700	10287	regulator of G protein signaling 19	GAIP|RGSGAIP	protein_coding	P49795	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60798
7.32446705807112e-12	0.66809615090303	0.822	0.74	1.49814649205787e-07	DUSP1	B cells	GSE169246_PacTissue_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60799
9.9190535563194e-12	0.284561819712836	0.353	0.175	2.02884321440957e-07	LYL1	B cells	GSE169246_PacTissue_post	ENSG00000104903	4066	LYL1 basic helix-loop-helix family member	bHLHa18	protein_coding	P12980	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60800
1.48016587684179e-11	0.642609542747449	0.785	0.701	3.02753128449219e-07	JUN	B cells	GSE169246_PacTissue_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60801
2.22316252529157e-11	-0.358245218518049	0.384	0.557	4.54725662923138e-07	PDE4B	B cells	GSE169246_PacTissue_post	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60802
4.05807292814225e-11	-0.409697769219815	0.433	0.596	8.30038236722216e-07	EMP3	B cells	GSE169246_PacTissue_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60803
4.72627315719389e-11	-0.289869399441486	0.94	0.981	9.66711911572437e-07	MT-ND4	B cells	GSE169246_PacTissue_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60804
5.58974379546469e-11	0.264747461670088	0.415	0.233	1.14332619592435e-06	BCAS4	B cells	GSE169246_PacTissue_post	ENSG00000124243	55653	breast carcinoma amplified sequence 4	CNOL|FLJ20495	protein_coding	Q8TDM0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60805
6.2579714221471e-11	0.362862237211537	0.565	0.391	1.28000547468597e-06	ODC1	B cells	GSE169246_PacTissue_post	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60806
7.65157019398819e-11	0.250086483462362	0.876	0.789	1.56505216747834e-06	HNRNPA2B1	B cells	GSE169246_PacTissue_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60807
1.17390513725708e-10	0.362218098751953	0.54	0.366	2.40110556774563e-06	LCP1	B cells	GSE169246_PacTissue_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60808
1.22155369532889e-10	0.303284377971587	0.254	0.097	2.49856592842571e-06	CD70	B cells	GSE169246_PacTissue_post	ENSG00000125726	970	CD70 molecule	CD27L|CD27LG|TNFSF7	protein_coding	P32970	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60809
1.52343375506158e-10	0.374281115278431	0.509	0.346	3.11603140260295e-06	PKM	B cells	GSE169246_PacTissue_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60810
1.80014179618124e-10	0.25403232248411	0.351	0.183	3.68201002990911e-06	OFD1	B cells	GSE169246_PacTissue_post	ENSG00000046651	8481	OFD1 centriole and centriolar satellite protein	71-7A|CXorf5|JBTS10|RP23	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60811
2.00685688783332e-10	0.477149100978814	0.556	0.396	4.10482507837427e-06	UBE2S	B cells	GSE169246_PacTissue_post	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60812
2.07534949963228e-10	0.492591985834134	0.735	0.654	4.24491986654786e-06	ATP6V0C	B cells	GSE169246_PacTissue_post	ENSG00000185883	527	ATPase H+ transporting V0 subunit c	ATP6C|ATP6L|ATPL|VATL|Vma3	protein_coding	P27449	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60813
2.23045045656707e-10	0.283176651656032	0.278	0.122	4.56216336386229e-06	TOR3A	B cells	GSE169246_PacTissue_post	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60814
2.49689307165651e-10	0.275718579491091	0.481	0.31	5.10714508876622e-06	LAT2	B cells	GSE169246_PacTissue_post	ENSG00000086730	7462	linker for activation of T cells family member 2	HSPC046|LAB|NTAL|WBSCR15|WBSCR5|WSCR5	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60815
2.6462873613459e-10	0.359244148892636	0.744	0.609	5.41271616889689e-06	CD69	B cells	GSE169246_PacTissue_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60816
2.78188056229553e-10	0.267124107580761	0.388	0.216	5.69005850211929e-06	AFF4	B cells	GSE169246_PacTissue_post	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60817
3.82934891118004e-10	0.257532623463904	0.435	0.263	7.83255026292765e-06	GNAI2	B cells	GSE169246_PacTissue_post	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60818
4.35788297039026e-10	0.315416463099919	0.386	0.222	8.91361382763623e-06	DDIT3	B cells	GSE169246_PacTissue_post	ENSG00000175197	1649	DNA damage inducible transcript 3	CHOP|CHOP10|GADD153	protein_coding	P35638	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60819
5.65547244585061e-10	0.262904382816088	0.39	0.222	1.15677033407428e-05	NAPA	B cells	GSE169246_PacTissue_post	ENSG00000105402	8775	NSF attachment protein alpha	NA	protein_coding	P54920	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60820
6.20848712944478e-10	-0.304010879461764	0.756	0.817	1.26988395745664e-05	HINT1	B cells	GSE169246_PacTissue_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60821
7.434167830991e-10	0.337632771954916	0.634	0.49	1.5205846881509e-05	POLD4	B cells	GSE169246_PacTissue_post	ENSG00000175482	57804	DNA polymerase delta 4, accessory subunit	p12|POLDS	protein_coding	Q9HCU8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60822
8.02111425103315e-10	0.359261844532299	0.871	0.795	1.64063870890632e-05	CORO1A	B cells	GSE169246_PacTissue_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60823
8.93742715295446e-10	0.535714315710794	0.519	0.38	1.82806134986531e-05	IFITM1	B cells	GSE169246_PacTissue_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60824
1.13042120555534e-09	0.257144669539056	0.416	0.249	2.3121635338429e-05	CLK1	B cells	GSE169246_PacTissue_post	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60825
1.27911289217192e-09	-0.287567574392953	0.735	0.839	2.61629750964844e-05	SARAF	B cells	GSE169246_PacTissue_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60826
1.90139110745531e-09	-0.365152662380721	0.445	0.601	3.88910537118909e-05	CREM	B cells	GSE169246_PacTissue_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60827
2.10079672543042e-09	0.353115934167682	0.725	0.618	4.29696962219539e-05	SRSF7	B cells	GSE169246_PacTissue_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60828
2.15534227853388e-09	0.489960159706675	0.266	0.125	4.40853709651319e-05	TNF	B cells	GSE169246_PacTissue_post	ENSG00000228978	7124	tumor necrosis factor	DIF|TNF-alpha|TNFA|TNFSF2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60829
2.27826529691544e-09	0.272205806777065	0.488	0.327	4.65996383831085e-05	SP110	B cells	GSE169246_PacTissue_post	ENSG00000135899	3431	SP110 nuclear body protein	IFI41|IFI75	protein_coding	Q9HB58	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60830
2.35634891683061e-09	0.256513765656037	0.475	0.31	4.81967607448533e-05	CTSZ	B cells	GSE169246_PacTissue_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60831
2.50097381952676e-09	0.312486350562915	0.442	0.285	5.11549185046004e-05	CTSH	B cells	GSE169246_PacTissue_post	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60832
2.60537161213453e-09	0.382191713527971	0.252	0.114	5.32902709545996e-05	LRMP	B cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60833
2.61745584879178e-09	0.502573536253264	0.635	0.537	5.3537441931187e-05	TUBB4B	B cells	GSE169246_PacTissue_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60834
2.85904010516018e-09	-0.317721286734169	0.437	0.565	5.84788063109463e-05	LYN	B cells	GSE169246_PacTissue_post	ENSG00000254087	4067	LYN proto-oncogene, Src family tyrosine kinase	JTK8	protein_coding	P07948	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60835
2.93650124343648e-09	0.2504374606336	0.295	0.144	6.00631964332498e-05	ZNF296	B cells	GSE169246_PacTissue_post	ENSG00000170684	162979	zinc finger protein 296	ZNF342	protein_coding	Q8WUU4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60836
3.46147765711435e-09	0.503822944729922	0.599	0.46	7.08010639986168e-05	H2AFZ	B cells	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60837
3.61789604528771e-09	0.262498474731734	0.488	0.33	7.40004457103148e-05	TCP1	B cells	GSE169246_PacTissue_post	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60838
3.67404579138193e-09	0.275047402442052	0.794	0.668	7.5148932616926e-05	ZFAS1	B cells	GSE169246_PacTissue_post	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60839
3.93533346904143e-09	-0.353550074060587	0.765	0.806	8.04933107757734e-05	HLA-DRB5	B cells	GSE169246_PacTissue_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60840
5.54680028261377e-09	-0.27874732046218	0.658	0.753	0.000113454252980582	GABARAP	B cells	GSE169246_PacTissue_post	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60841
6.27781330358483e-09	-0.272491326744452	0.499	0.634	0.000128406393311524	RHOH	B cells	GSE169246_PacTissue_post	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60842
6.50955477724968e-09	0.326999084434784	0.319	0.163	0.000133146433413865	CITED2	B cells	GSE169246_PacTissue_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60843
1.39632765816728e-08	-0.308771500211527	0.346	0.488	0.000285604859201535	VPS37B	B cells	GSE169246_PacTissue_post	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60844
1.53753569747753e-08	0.315794092652103	0.456	0.305	0.000314487551562055	IDI1	B cells	GSE169246_PacTissue_post	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60845
1.81720428089679e-08	0.500787261111685	0.605	0.468	0.00037169096361463	DUSP2	B cells	GSE169246_PacTissue_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60846
2.09572522362632e-08	0.492567597685346	0.575	0.485	0.000428659637240527	CDKN1A	B cells	GSE169246_PacTissue_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60847
2.32496473522657e-08	0.265627860414219	0.57	0.416	0.000475548286943242	WSB1	B cells	GSE169246_PacTissue_post	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60848
2.36494780080607e-08	0.291102344485626	0.573	0.418	0.000483726423176874	CYCS	B cells	GSE169246_PacTissue_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60849
3.17493579317276e-08	0.281516047028238	0.921	0.85	0.000649401367135556	PTPRCAP	B cells	GSE169246_PacTissue_post	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60850
3.28115533791025e-08	0.269941611604496	0.488	0.33	0.000671127512816163	IRF8	B cells	GSE169246_PacTissue_post	ENSG00000140968	3394	interferon regulatory factor 8	ICSBP|ICSBP1|IRF-8	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60851
5.44900118349795e-08	-0.340242646824214	0.508	0.645	0.00111453870207267	TUBA1A	B cells	GSE169246_PacTissue_post	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60852
5.73300097209524e-08	0.309200346850035	0.671	0.524	0.00117262801883236	KLF6	B cells	GSE169246_PacTissue_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60853
6.64214879323998e-08	0.256571873462883	0.326	0.183	0.00135858511416931	SOCS1	B cells	GSE169246_PacTissue_post	ENSG00000185338	8651	suppressor of cytokine signaling 1	Cish1|JAB|SOCS-1|SSI-1|TIP3	protein_coding	O15524	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60854
8.34628500978889e-08	0.42296850846322	1	1	0.00170714913590222	ACTB	B cells	GSE169246_PacTissue_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60855
9.37726916181382e-08	-0.29941680045764	0.408	0.543	0.0019180266343574	DBI	B cells	GSE169246_PacTissue_post	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60856
9.46713151840006e-08	0.307990933710196	0.394	0.26	0.00193640708077355	CD22	B cells	GSE169246_PacTissue_post	ENSG00000012124	933	CD22 molecule	SIGLEC-2|SIGLEC2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60857
9.64033224727943e-08	0.432241163220281	0.286	0.158	0.00197183355785854	ISG15	B cells	GSE169246_PacTissue_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60858
1.12214887532186e-07	0.2759032129458	0.59	0.46	0.00229524330958334	ALDOA	B cells	GSE169246_PacTissue_post	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60859
1.17727781368999e-07	0.318829732966071	0.445	0.313	0.0024080040401215	EIF4A3	B cells	GSE169246_PacTissue_post	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60860
1.27496238446884e-07	0.302143552375348	0.37	0.233	0.00260780806119257	SNHG12	B cells	GSE169246_PacTissue_post	ENSG00000197989	85028	small nucleolar RNA host gene 12	ASLNC04080|C1orf79|LINC00100|PNAS-123	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60861
1.35829322492482e-07	0.38787709904909	0.355	0.219	0.00277825296226123	EGR1	B cells	GSE169246_PacTissue_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60862
2.46095757459484e-07	-0.278797074571849	0.818	0.859	0.00503364262307629	YWHAZ	B cells	GSE169246_PacTissue_post	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60863
2.86729553009208e-07	0.267164703910568	0.524	0.402	0.00586476627725034	TRA2B	B cells	GSE169246_PacTissue_post	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60864
3.15066165855251e-07	0.315611306614604	0.918	0.903	0.0064443633564033	MS4A1	B cells	GSE169246_PacTissue_post	ENSG00000156738	931	membrane spanning 4-domains A1	B1|Bp35|CD20|FMC7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60865
4.20539384558298e-07	0.288453832605148	0.708	0.615	0.00860171257175543	CD53	B cells	GSE169246_PacTissue_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60866
5.2194751813693e-07	0.371428306337516	0.954	0.909	0.0106759145359728	PFN1	B cells	GSE169246_PacTissue_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60867
6.19755858219593e-07	0.312582547547801	0.585	0.479	0.0126764863240236	SRSF3	B cells	GSE169246_PacTissue_post	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60868
7.90816346853023e-07	0.354501793117243	0.669	0.565	0.0161753575585317	HSPH1	B cells	GSE169246_PacTissue_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60869
1.0059159766662e-06	0.273151637037743	0.982	0.967	0.0205750053867305	HLA-DPB1	B cells	GSE169246_PacTissue_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60870
1.1099406594997e-06	0.264565892027428	0.341	0.224	0.0227027262494069	UBE2J1	B cells	GSE169246_PacTissue_post	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60871
1.36764769433559e-06	0.544001867237716	0.406	0.296	0.0279738659399401	HSPB1	B cells	GSE169246_PacTissue_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60872
1.57027089968652e-06	0.261152741449308	0.968	0.989	0.032118320982188	HLA-A	B cells	GSE169246_PacTissue_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60873
1.71304332945342e-06	-0.333666138466833	0.366	0.476	0.0350385882606402	RASGEF1B	B cells	GSE169246_PacTissue_post	ENSG00000138670	153020	RasGEF domain family member 1B	FLJ31695|GPIG4	protein_coding	Q0VAM2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60874
5.43460561194436e-10	0.937210060957864	0.885	0.436	1.1115942318671e-05	BHLHE40	pDCs	GSE169246_PacTissue_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60875
1.91695540037733e-09	0.514982904662768	1	1	3.92094057593179e-05	HLA-B	pDCs	GSE169246_PacTissue_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60876
2.04877077696749e-09	0.703952726819764	0.779	0.327	4.19055574720931e-05	SRSF5	pDCs	GSE169246_PacTissue_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60877
4.18491488923491e-09	0.712267453520331	1	1	8.55982491444108e-05	HLA-A	pDCs	GSE169246_PacTissue_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60878
6.06993163545431e-09	1.08424205272148	0.607	0.164	0.000124154381671582	PIM3	pDCs	GSE169246_PacTissue_post	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60879
7.70662802994557e-09	0.682909341633811	1	1	0.000157631369724507	MALAT1	pDCs	GSE169246_PacTissue_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60880
1.02407170327707e-08	1.01978019044589	0.943	0.855	0.000209463626188291	HLA-DQA1	pDCs	GSE169246_PacTissue_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60881
1.75746136426257e-08	0.914631615883547	0.992	0.927	0.000359471147446265	UBC	pDCs	GSE169246_PacTissue_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60882
2.18816755082332e-08	-0.5214666109858	1	1	0.000447567790845403	RPL6	pDCs	GSE169246_PacTissue_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60883
2.18820629719964e-08	0.892099011937932	0.934	0.891	0.000447575716029215	HLA-C	pDCs	GSE169246_PacTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60884
2.9822904271359e-08	-0.480665991549219	1	1	0.000609997683966377	RPS8	pDCs	GSE169246_PacTissue_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60885
5.78020796439538e-08	-0.390923340481684	1	1	0.00118228373703743	RPL10	pDCs	GSE169246_PacTissue_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60886
6.11596542141068e-08	-0.565563308845951	0.984	1	0.00125095956729534	MT-ND3	pDCs	GSE169246_PacTissue_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60887
6.73429752920787e-08	-0.416857934903212	1	0.982	0.00137743321662418	NACA	pDCs	GSE169246_PacTissue_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60888
1.20150154459923e-07	-0.308041446242319	1	1	0.00245755125932326	RPL28	pDCs	GSE169246_PacTissue_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60889
1.45756951202334e-07	-0.870823800422475	0.975	1	0.00298131267989253	VIM	pDCs	GSE169246_PacTissue_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60890
1.57054794077375e-07	0.882683585194072	0.902	0.891	0.00321239875805864	JCHAIN	pDCs	GSE169246_PacTissue_post	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60891
2.14188271146511e-07	1.0127066241869	0.902	0.782	0.00438100689803074	RGS1	pDCs	GSE169246_PacTissue_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60892
2.15557384970877e-07	1.48025392601666	0.787	0.455	0.00440901075219431	LTB	pDCs	GSE169246_PacTissue_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60893
2.35191615736867e-07	0.655298197823496	0.721	0.364	0.00481060930828188	CCNL1	pDCs	GSE169246_PacTissue_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60894
3.8074252062666e-07	0.792906878105486	0.803	0.527	0.00778770751689771	BST2	pDCs	GSE169246_PacTissue_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60895
1.51192463961696e-06	-0.292617517337306	1	1	0.0309249065787253	RPL7A	pDCs	GSE169246_PacTissue_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60896
2.13437565932755e-06	0.647459426105378	0.426	0.073	0.0436565197358857	CTSH	pDCs	GSE169246_PacTissue_post	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60897
2.21969277512471e-06	-0.374014142211422	1	1	0.0454015960224009	RPS7	pDCs	GSE169246_PacTissue_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60898
2.33810025040881e-140	1.23527218643354	0.991	0.862	4.78235025218618e-136	VIM	Mono/Macro	GSE169246_PacTissue_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60899
9.60219427498359e-140	1.23186814431164	0.871	0.474	1.96403281700514e-135	ANXA2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60900
2.97060635041282e-129	1.20524257273248	0.855	0.398	6.07607822913439e-125	S100A10	Mono/Macro	GSE169246_PacTissue_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60901
6.10143084119433e-118	1.26577330167998	0.288	0.014	1.24798666425789e-113	FN1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60902
3.84410578929429e-93	0.944893041492874	0.898	0.54	7.86273398142254e-89	S100A6	Mono/Macro	GSE169246_PacTissue_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60903
8.0149942425657e-90	-0.994252015546448	0.847	0.925	1.63938692237439e-85	HLA-DRB5	Mono/Macro	GSE169246_PacTissue_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60904
3.60837427589528e-87	-0.689469162662269	0.902	0.976	7.38056874391621e-83	RPL41	Mono/Macro	GSE169246_PacTissue_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60905
2.97678414791866e-77	-0.800063507095532	0.961	0.985	6.08871429615282e-73	HLA-DPA1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60906
9.89911730846136e-68	-0.99354934275018	0.127	0.492	2.02476545427269e-63	PLD4	Mono/Macro	GSE169246_PacTissue_post	ENSG00000166428	122618	phospholipase D family member 4	C14orf175	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60907
1.12089435870409e-66	0.794798434165464	0.574	0.245	2.29267732129334e-62	TUBB4B	Mono/Macro	GSE169246_PacTissue_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60908
2.87622503635381e-63	-1.14200900662781	0.486	0.76	5.88303068935807e-59	CEBPD	Mono/Macro	GSE169246_PacTissue_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60909
8.86461662376677e-63	0.678016524895783	0.5	0.197	1.81316868422525e-58	TUBA1C	Mono/Macro	GSE169246_PacTissue_post	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60910
4.11594566692171e-61	1.60696591092882	0.348	0.094	8.41875526712166e-57	RNASE1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000129538	6035	ribonuclease A family member 1, pancreatic	RAC1|RNS1	protein_coding	P07998	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60911
5.08064777687096e-61	0.567849387152479	0.28	0.056	1.03919569628119e-56	ADM	Mono/Macro	GSE169246_PacTissue_post	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60912
1.67571418059119e-57	0.61058166654047	0.976	0.951	3.42750578498121e-53	S100A11	Mono/Macro	GSE169246_PacTissue_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60913
1.89169653722325e-55	0.462884243289473	0.989	0.973	3.86927609723644e-51	PPIA	Mono/Macro	GSE169246_PacTissue_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60914
4.24559547455845e-53	0.491561258272342	0.974	0.936	8.68394098366184e-49	CFL1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60915
6.07922649737038e-53	0.752465306400065	0.948	0.955	1.24344498777214e-48	HLA-C	Mono/Macro	GSE169246_PacTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60916
1.05708184767187e-52	-0.60514624668022	0.974	0.993	2.16215521122805e-48	MT-ND3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60917
2.19919500294463e-51	0.498246531031247	0.983	0.927	4.49823345902294e-47	RPS3A	Mono/Macro	GSE169246_PacTissue_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60918
3.64361252266099e-51	0.518092511099359	0.58	0.266	7.45264505385079e-47	CD44	Mono/Macro	GSE169246_PacTissue_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60919
9.95610819308003e-51	0.532381746383457	0.992	0.979	2.03642236981259e-46	RPS18	Mono/Macro	GSE169246_PacTissue_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60920
2.05423640904678e-49	-0.627329796121812	0.982	0.99	4.20173515106428e-45	HLA-DRB1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60921
3.65213195786409e-49	0.519230125304242	0.85	0.637	7.47007070661521e-45	RPL27A	Mono/Macro	GSE169246_PacTissue_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60922
1.90946381650487e-48	1.18421218273168	0.364	0.131	3.90561729027906e-44	NUPR1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60923
1.50550712278309e-47	0.491902719186699	0.388	0.14	3.07936426894053e-43	PNP	Mono/Macro	GSE169246_PacTissue_post	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60924
1.15021765068426e-46	0.504959992984797	0.811	0.586	2.35265518270958e-42	TSPO	Mono/Macro	GSE169246_PacTissue_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60925
1.74546643984359e-46	-0.618814265853459	0.873	0.931	3.57017705605608e-42	HLA-DQB1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60926
3.08435626271887e-46	0.341580797755296	0.262	0.064	6.30874229976518e-42	PLP2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60927
2.61652977651987e-42	0.561184403983341	0.691	0.45	5.35185000489375e-38	ENO1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60928
1.55014111166996e-41	-0.42917972472403	0.964	0.99	3.17065862980974e-37	TYROBP	Mono/Macro	GSE169246_PacTissue_post	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60929
1.90143953566989e-41	0.551590213696215	0.353	0.13	3.8892044262592e-37	FBP1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000165140	2203	fructose-bisphosphatase 1	FBP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60930
4.072080088051e-41	0.403328312764065	0.356	0.127	8.32903261209952e-37	FLNA	Mono/Macro	GSE169246_PacTissue_post	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60931
1.41430075624456e-39	0.513733152700056	0.78	0.566	2.89281076682262e-35	CALM1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60932
6.99921578299949e-39	0.736374936510192	0.827	0.654	1.43161959625472e-34	CAPG	Mono/Macro	GSE169246_PacTissue_post	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60933
8.06543634019579e-39	0.926051912792656	0.87	0.7	1.64970434902365e-34	LYZ	Mono/Macro	GSE169246_PacTissue_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60934
8.24746927176047e-39	0.712195450944515	0.839	0.694	1.68693736484589e-34	S100A4	Mono/Macro	GSE169246_PacTissue_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60935
6.9163303582515e-38	0.362599155313795	0.28	0.089	1.41466621147676e-33	SNAI1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000124216	6615	snail family transcriptional repressor 1	SLUGH2|SNA|SNAH|SNAIL|SNAIL1	protein_coding	O95863	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60936
2.50544023967573e-37	0.596279546217852	0.945	0.869	5.12462746623275e-33	SH3BGRL3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60937
4.15202853576692e-37	-0.452760203522638	0.986	0.987	8.49255916705766e-33	RPL39	Mono/Macro	GSE169246_PacTissue_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60938
5.09293618526798e-37	0.359965777602241	0.606	0.333	1.04170916733471e-32	CDC42	Mono/Macro	GSE169246_PacTissue_post	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60939
1.85636477575138e-36	-0.476626070456384	1	1	3.79700851232187e-32	CD74	Mono/Macro	GSE169246_PacTissue_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60940
7.4672527310695e-36	0.318074884284474	0.982	0.97	1.52735187361296e-31	OAZ1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60941
8.24156398816102e-36	-0.50747505628439	0.98	0.989	1.68572949813846e-31	RPL34	Mono/Macro	GSE169246_PacTissue_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60942
9.68394646182313e-35	-0.424005224890863	0.968	0.984	1.9807544093013e-30	RPL37	Mono/Macro	GSE169246_PacTissue_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60943
1.66110641235051e-34	0.505700033834328	0.603	0.353	3.39762705582174e-30	LSP1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60944
5.37845997703364e-34	-0.470741774933315	0.932	0.963	1.10011020370246e-29	ITM2B	Mono/Macro	GSE169246_PacTissue_post	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60945
6.62058031051187e-34	0.671590528621676	0.891	0.784	1.3541734967121e-29	LGALS1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60946
8.46678984795338e-34	-0.413922858998225	0.929	0.971	1.73179719550038e-29	RPS21	Mono/Macro	GSE169246_PacTissue_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60947
2.18101556623066e-33	0.420915602278956	0.977	0.94	4.46104923916819e-29	MT-ATP6	Mono/Macro	GSE169246_PacTissue_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60948
8.97956700586568e-33	-0.798609834748272	0.712	0.808	1.83668063537977e-28	C1QC	Mono/Macro	GSE169246_PacTissue_post	ENSG00000159189	714	complement C1q C chain	C1QG	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60949
1.00345070296545e-32	0.562370899855267	0.764	0.645	2.05245806784552e-28	CTSH	Mono/Macro	GSE169246_PacTissue_post	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60950
2.31561896273955e-32	0.34461862827086	0.489	0.248	4.73636702638747e-28	CD99	Mono/Macro	GSE169246_PacTissue_post	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60951
3.01447513625227e-32	0.335455573658532	0.333	0.134	6.16580744369039e-28	SLC11A1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000018280	6556	solute carrier family 11 member 1	LSH|NRAMP|NRAMP1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60952
1.1937625607901e-31	-0.428588632508176	0.611	0.78	2.44172194184007e-27	PCBP1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60953
2.59902804404719e-31	-0.353410944342934	0.732	0.894	5.31605196129412e-27	RPS29	Mono/Macro	GSE169246_PacTissue_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60954
7.34571338444061e-31	-0.365709332951185	0.992	0.989	1.50249221565348e-26	RPS28	Mono/Macro	GSE169246_PacTissue_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60955
8.32402844199409e-31	0.325499013350628	0.297	0.116	1.70259677752547e-26	RAB13	Mono/Macro	GSE169246_PacTissue_post	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60956
8.7002161515067e-31	0.537211917944392	0.55	0.331	1.77954221162918e-26	LDHA	Mono/Macro	GSE169246_PacTissue_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60957
1.2225689066418e-30	-0.700734761625413	0.229	0.448	2.50064244164515e-26	OLFML3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000116774	56944	olfactomedin like 3	HNOEL-iso|OLF44	protein_coding	Q9NRN5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60958
1.73350546091857e-30	1.03013243376281	0.448	0.22	3.54571206976284e-26	S100A9	Mono/Macro	GSE169246_PacTissue_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60959
3.72060046355533e-30	0.516085100926696	0.398	0.189	7.61011618815606e-26	LMNA	Mono/Macro	GSE169246_PacTissue_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60960
3.77778088285248e-30	-0.437740983859361	0.962	0.987	7.72707301778646e-26	CST3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60961
1.00470464250851e-29	0.584366739440941	0.358	0.173	2.0550228757869e-25	CPM	Mono/Macro	GSE169246_PacTissue_post	ENSG00000135678	1368	carboxypeptidase M	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60962
3.55007789388207e-28	0.659319261679018	0.789	0.695	7.26132932414638e-24	TUBA1B	Mono/Macro	GSE169246_PacTissue_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60963
4.15919595150006e-28	0.334594823757761	0.308	0.13	8.50721939919822e-24	TCN2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000185339	6948	transcobalamin 2	D22S676|D22S750|TC2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60964
9.11597778577662e-28	-0.41179843607872	0.985	0.993	1.86458209630275e-23	MT-CYB	Mono/Macro	GSE169246_PacTissue_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60965
2.12442003827628e-27	0.590891854849292	0.579	0.364	4.34528874629031e-23	PLIN2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60966
2.33041913621882e-27	0.787674760067624	0.47	0.295	4.76663930122197e-23	PLTP	Mono/Macro	GSE169246_PacTissue_post	ENSG00000100979	5360	phospholipid transfer protein	BPIFE	protein_coding	P55058	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60967
4.46299589213952e-27	0.776536523457209	0.489	0.301	9.12861179778217e-23	CD163	Mono/Macro	GSE169246_PacTissue_post	ENSG00000177575	9332	CD163 molecule	M130|MM130|SCARI1	protein_coding	Q86VB7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60968
5.4186738950733e-27	0.33467124312524	1	0.993	1.10833555849829e-22	TMSB10	Mono/Macro	GSE169246_PacTissue_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60969
1.46371931959313e-26	0.36373569953434	0.661	0.458	2.99389149629579e-22	TXN	Mono/Macro	GSE169246_PacTissue_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60970
1.50530104752703e-26	0.344293576080136	0.371	0.183	3.07894276261178e-22	UPP1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60971
1.85338072004058e-26	0.67576747705804	0.777	0.666	3.790904924771e-22	CSTB	Mono/Macro	GSE169246_PacTissue_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60972
2.33394816999789e-26	0.372213032572312	0.38	0.182	4.77385758691369e-22	AHNAK	Mono/Macro	GSE169246_PacTissue_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60973
2.84659688667345e-26	0.48177353734401	0.505	0.31	5.82242927200188e-22	ID2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60974
3.17998395112477e-26	-0.667211716954206	0.688	0.811	6.5043391736306e-22	C1QB	Mono/Macro	GSE169246_PacTissue_post	ENSG00000173369	713	complement C1q B chain	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60975
8.54556184946074e-26	-0.696785905354145	0.195	0.41	1.7479092206887e-21	KLF2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60976
1.44419357291463e-25	0.329536962585615	0.959	0.934	2.95395353403959e-21	MYL6	Mono/Macro	GSE169246_PacTissue_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60977
2.23687706954249e-25	0.355497628656043	0.982	0.978	4.57530835804222e-21	PFN1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60978
3.34440948519999e-25	0.280436105473191	0.364	0.173	6.84065516102806e-21	FGR	Mono/Macro	GSE169246_PacTissue_post	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60979
4.82718145170038e-25	0.302183721939348	0.265	0.109	9.87351694130796e-21	LHFPL2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000145685	10184	LHFPL tetraspan subfamily member 2	KIAA0206	protein_coding	Q6ZUX7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60980
7.57782132569359e-25	0.396069783268252	0.658	0.431	1.54996757395737e-20	EMP3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60981
1.25940718106175e-24	0.512124650124268	0.792	0.677	2.5759914481437e-20	GLUL	Mono/Macro	GSE169246_PacTissue_post	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60982
1.64432552904753e-24	-0.369891002980929	0.932	0.959	3.36330343711382e-20	RPL22	Mono/Macro	GSE169246_PacTissue_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60983
1.94955070954329e-24	0.345147132398582	0.674	0.499	3.98761102129985e-20	ZYX	Mono/Macro	GSE169246_PacTissue_post	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60984
2.97272683180147e-24	0.351148185829609	0.895	0.799	6.08041546176672e-20	NME2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60985
4.02986310012425e-24	0.332707466643366	0.998	0.998	8.24268198499413e-20	TMSB4X	Mono/Macro	GSE169246_PacTissue_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60986
8.43535372766746e-24	0.481024711274529	0.752	0.593	1.7253672514571e-19	CALR	Mono/Macro	GSE169246_PacTissue_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60987
9.21297091170575e-24	0.31997874325345	0.458	0.263	1.88442107028029e-19	SRSF2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60988
1.53117887312836e-23	0.477715458401025	0.729	0.584	3.13187326709676e-19	MIF	Mono/Macro	GSE169246_PacTissue_post	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60989
2.42172507875505e-23	0.348437965721365	0.856	0.785	4.95339647608558e-19	GPX4	Mono/Macro	GSE169246_PacTissue_post	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60990
2.77015691198596e-23	0.566935367441212	0.505	0.322	5.66607894777609e-19	PPIF	Mono/Macro	GSE169246_PacTissue_post	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60991
4.30170292108771e-23	0.428972768614058	0.371	0.202	8.7987031547928e-19	SERPINF1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000282307	5176	serpin family F member 1	EPC-1|PEDF|PIG35	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60992
7.03177290823211e-23	0.565793444200955	0.595	0.438	1.4382788306498e-18	CDKN1A	Mono/Macro	GSE169246_PacTissue_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60993
1.31290030008072e-22	-0.353942562380728	0.991	0.992	2.6854062737851e-18	RPS13	Mono/Macro	GSE169246_PacTissue_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60994
1.61101915387701e-22	-0.369001345084566	0.435	0.602	3.29517857734004e-18	MAN2B1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000104774	4125	mannosidase alpha class 2B member 1	LAMAN|MANB	protein_coding	O00754	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60995
3.30587114634657e-22	0.342628264297454	0.836	0.741	6.76182884273728e-18	GSTP1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60996
4.26675567761794e-22	0.357995818302482	0.536	0.355	8.72722206299973e-18	APLP2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60997
9.45891694304374e-22	0.408902587968557	0.38	0.21	1.93472687153017e-17	FCGR2B	Mono/Macro	GSE169246_PacTissue_post	ENSG00000072694	2213	Fc gamma receptor IIb	CD32|CD32B|FCG2|FcgammaRIIb|FCGR2|FcGRIIB	protein_coding	P31994	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60998
1.6072490229492e-21	-0.490447473903265	0.527	0.687	3.28746715154029e-17	HERPUD1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	60999
3.11212145320764e-21	0.428107391206545	0.389	0.222	6.3655332203909e-17	VSIG4	Mono/Macro	GSE169246_PacTissue_post	ENSG00000155659	11326	V-set and immunoglobulin domain containing 4	CRIg|Z39IG	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61000
3.13499590596882e-21	0.530129115390512	0.676	0.58	6.41232062606862e-17	TUBB	Mono/Macro	GSE169246_PacTissue_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61001
3.64442104371273e-21	0.273016613924946	0.973	0.943	7.45429880281002e-17	RPL3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61002
3.97132023149084e-21	0.323610387053492	0.521	0.339	8.12293840149136e-17	LAMP1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61003
4.64340098584734e-21	0.329079473853542	0.444	0.259	9.49761237645215e-17	TUBA1A	Mono/Macro	GSE169246_PacTissue_post	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61004
5.79742077631072e-21	-0.545063481875467	0.689	0.764	1.18580444558659e-16	MS4A7	Mono/Macro	GSE169246_PacTissue_post	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61005
1.07495602990283e-20	-0.325783949328019	0.327	0.528	2.19871506356324e-16	RPL36A	Mono/Macro	GSE169246_PacTissue_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61006
1.14343164764906e-20	-0.461867682820017	0.292	0.506	2.33877509210139e-16	SLC40A1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000138449	30061	solute carrier family 40 member 1	FPN1|HFE4|IREG1|MTP1|SLC11A3	protein_coding	Q9NP59	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61007
2.21627202868779e-20	0.272442890060688	0.506	0.312	4.533162807478e-16	NDUFS5	Mono/Macro	GSE169246_PacTissue_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61008
4.7865146747092e-20	0.296251102695854	0.345	0.185	9.7903371156502e-16	SRSF5	Mono/Macro	GSE169246_PacTissue_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61009
6.11831987098286e-20	1.90230576287095	0.28	0.133	1.25144114641083e-15	SPP1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000118785	6696	secreted phosphoprotein 1	BNSP|BSPI|ETA-1|OPN	protein_coding	P10451	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61010
1.57377119751484e-19	0.571759794536245	0.586	0.455	3.21899160739684e-15	TMEM176B	Mono/Macro	GSE169246_PacTissue_post	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61011
5.54917059564364e-19	-0.508430807394252	0.314	0.485	1.13502735363295e-14	C3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000125730	718	complement C3	ARMD9|C3a|C3b|CPAMD1	protein_coding	P01024	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61012
7.60330495187214e-19	-0.367348222944003	0.362	0.532	1.55517999485593e-14	RAB20	Mono/Macro	GSE169246_PacTissue_post	ENSG00000139832	55647	RAB20, member RAS oncogene family	FLJ20429	protein_coding	Q9NX57	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61013
8.77494853067828e-19	-1.26370107332107	0.582	0.696	1.79482797246493e-14	CCL4	Mono/Macro	GSE169246_PacTissue_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61014
8.78902443310362e-19	-0.296800123735774	0.95	0.976	1.79770705754701e-14	HLA-DPB1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61015
9.03960174502975e-19	0.283875007125759	0.329	0.171	1.84896014092839e-14	RSRP1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61016
9.35618116995846e-19	0.304091214069725	0.597	0.432	1.9137132965033e-14	ATP5F1B	Mono/Macro	GSE169246_PacTissue_post	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61017
1.01141993504235e-18	-0.298985336032854	0.995	0.997	2.06875833513563e-14	RPL11	Mono/Macro	GSE169246_PacTissue_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61018
1.16569964440024e-18	0.261414096650644	0.432	0.258	2.38432205265625e-14	SNX10	Mono/Macro	GSE169246_PacTissue_post	ENSG00000086300	29887	sorting nexin 10	NA	protein_coding	Q9Y5X0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61019
1.18605670774579e-18	-0.292898500967902	0.205	0.384	2.42596039002324e-14	MEF2C	Mono/Macro	GSE169246_PacTissue_post	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61020
1.29335946934153e-18	-0.353318403433942	0.527	0.655	2.64543745859117e-14	CXCL16	Mono/Macro	GSE169246_PacTissue_post	ENSG00000161921	58191	C-X-C motif chemokine ligand 16	CXCLG16|SR-PSOX|SRPSOX	protein_coding	Q9H2A7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61021
1.83885110850689e-18	0.328683489817654	0.732	0.595	3.76118605734e-14	TPM3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61022
2.67651178583148e-18	-0.895370448057579	0.527	0.629	5.47453720673971e-14	ATF3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61023
4.70754646087565e-18	0.294971351601517	0.427	0.263	9.62881553107505e-14	PGAM1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61024
4.74880239456733e-18	-0.29506768143803	0.982	0.985	9.71320041784801e-14	RPS27	Mono/Macro	GSE169246_PacTissue_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61025
5.24109250103741e-18	0.378658526184438	0.785	0.695	1.07201306016219e-13	ALDOA	Mono/Macro	GSE169246_PacTissue_post	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61026
8.76102762288824e-18	-0.262832277001508	0.77	0.854	1.79198058998556e-13	CTSZ	Mono/Macro	GSE169246_PacTissue_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61027
1.38686890427616e-17	0.308029163390903	0.709	0.541	2.83670165680646e-13	TAGLN2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61028
1.56979463234127e-17	0.603003490405811	0.33	0.176	3.21085794099083e-13	CCL2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000108691	6347	C-C motif chemokine ligand 2	GDCF-2|HC11|MCAF|MCP-1|MCP1|MGC9434|SCYA2|SMC-CF	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61029
1.6622789473057e-17	0.313825951832705	0.288	0.147	3.40002535881907e-13	PHLDA2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61030
1.86528803118691e-17	-0.295190919417754	0.845	0.905	3.8152601389897e-13	RPL13A	Mono/Macro	GSE169246_PacTissue_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61031
2.76461013811849e-17	0.259075678731067	0.336	0.188	5.65473357650756e-13	FPR3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000187474	2359	formyl peptide receptor 3	FMLPY|FPRH1|FPRL2|RMLP-R-I	protein_coding	P25089	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61032
3.67837908826069e-17	-0.325423844030051	0.968	0.982	7.52375658712842e-13	RPL35A	Mono/Macro	GSE169246_PacTissue_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61033
4.64173647601177e-17	0.366296440294706	0.703	0.578	9.49420778803447e-13	TYMP	Mono/Macro	GSE169246_PacTissue_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61034
5.8295165383872e-17	0.497940295468623	0.394	0.236	1.19236931276172e-12	CRIP1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61035
6.34064256224765e-17	0.276145915459973	0.48	0.315	1.29691502968213e-12	ATP6V1B2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000147416	526	ATPase H+ transporting V1 subunit B2	ATP6B2|HO57|VATB|Vma2|VPP3	protein_coding	P21281	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61036
7.01861518722926e-17	0.255863656914697	0.888	0.828	1.43558755039587e-12	CLIC1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61037
7.49478189701529e-17	0.277729139610655	0.52	0.357	1.53298268921551e-12	PSMA6	Mono/Macro	GSE169246_PacTissue_post	ENSG00000100902	5687	proteasome 20S subunit alpha 6	IOTA|MGC22756|MGC2333|MGC23846|p27K|PROS27	protein_coding	P60900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61038
9.17972690652036e-17	0.290266175627523	0.994	0.999	1.87762134145968e-12	MT-CO2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61039
1.07486773962432e-16	0.275408204279777	0.968	0.941	2.19853447462759e-12	LAPTM5	Mono/Macro	GSE169246_PacTissue_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61040
1.27250397059002e-16	0.443241910182755	0.489	0.352	2.60277962144484e-12	TMEM176A	Mono/Macro	GSE169246_PacTissue_post	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61041
1.35250256408524e-16	0.52322840160305	0.436	0.291	2.76640874457994e-12	ACP5	Mono/Macro	GSE169246_PacTissue_post	ENSG00000102575	54	acid phosphatase 5, tartrate resistant	HPAP|TRAcP|TRAP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61042
1.36404793739893e-16	-0.250903623776817	0.789	0.874	2.79002365115578e-12	FXYD5	Mono/Macro	GSE169246_PacTissue_post	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61043
2.17776862622083e-16	-0.275821593999681	0.992	0.991	4.45440794807209e-12	RPL30	Mono/Macro	GSE169246_PacTissue_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61044
2.63812158205012e-16	0.265229150689464	0.548	0.399	5.39601388392532e-12	COMT	Mono/Macro	GSE169246_PacTissue_post	ENSG00000093010	1312	catechol-O-methyltransferase	NA	protein_coding	P21964	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61045
3.11929738659913e-16	-0.770955872032083	0.771	0.815	6.38021087454986e-12	FOS	Mono/Macro	GSE169246_PacTissue_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61046
3.5649480615503e-16	-0.297651515099521	0.927	0.972	7.29174476509499e-12	SRGN	Mono/Macro	GSE169246_PacTissue_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61047
9.48202063442996e-16	-0.276231973902673	0.395	0.569	1.9394525005663e-11	RPS20	Mono/Macro	GSE169246_PacTissue_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61048
1.00112506305862e-15	-0.323504731719242	0.538	0.683	2.0477012039801e-11	ZFP36L2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61049
1.2808096725961e-15	0.316113439579353	0.258	0.13	2.61976810432805e-11	DDIT4	Mono/Macro	GSE169246_PacTissue_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61050
1.3918998538169e-15	0.415858150302223	0.991	0.986	2.84699196099709e-11	GAPDH	Mono/Macro	GSE169246_PacTissue_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61051
1.39910767409139e-15	0.497856485736307	0.355	0.217	2.86173483658652e-11	CITED2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61052
1.63759442990074e-15	0.282198474931306	0.586	0.435	3.34953564691898e-11	GRB2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61053
1.74987457333708e-15	0.406413055440603	0.55	0.369	3.57919345230367e-11	C15orf48	Mono/Macro	GSE169246_PacTissue_post	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61054
1.75663801422194e-15	-0.301790535532939	0.927	0.95	3.59302739428956e-11	RPL5	Mono/Macro	GSE169246_PacTissue_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61055
2.59044683410701e-15	-0.301576321179878	0.965	0.975	5.29849995448248e-11	RPL6	Mono/Macro	GSE169246_PacTissue_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61056
2.89796792885387e-15	0.261244302618185	0.305	0.171	5.92750360167771e-11	PMP22	Mono/Macro	GSE169246_PacTissue_post	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61057
3.63952237758085e-15	0.277283883775308	0.552	0.4	7.44427907110387e-11	MGST3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61058
4.21340307190665e-15	-0.899443214257102	0.682	0.68	8.61809464327786e-11	CD83	Mono/Macro	GSE169246_PacTissue_post	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61059
6.80057802015597e-15	-0.260349522300801	0.35	0.518	1.3909902282427e-10	TBXAS1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000059377	6916	thromboxane A synthase 1	CYP5|CYP5A1|THAS|TS|TXAS|TXS	protein_coding	P24557	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61060
7.13263171097178e-15	-0.487963807145589	0.298	0.448	1.45890849016217e-10	BTG2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61061
9.34893157660353e-15	-0.299425936789505	0.53	0.662	1.91223046467849e-10	CSF1R	Mono/Macro	GSE169246_PacTissue_post	ENSG00000182578	1436	colony stimulating factor 1 receptor	C-FMS|CD115|CSFR|FMS	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61062
1.12197016875173e-14	-0.595759318229731	0.615	0.693	2.2948777831648e-10	NR4A2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61063
1.22580805686747e-14	0.290521504730941	0.573	0.434	2.50726779951672e-10	P4HB	Mono/Macro	GSE169246_PacTissue_post	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61064
1.23476966567345e-14	0.679177192855614	0.527	0.414	2.52559787416848e-10	GPNMB	Mono/Macro	GSE169246_PacTissue_post	ENSG00000136235	10457	glycoprotein nmb	HGFIN|NMB	protein_coding	Q14956	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61065
2.12343058393516e-14	0.388978952043195	0.498	0.352	4.34326491638097e-10	OLR1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000173391	4973	oxidized low density lipoprotein receptor 1	CLEC8A|LOX-1|SCARE1	protein_coding	P78380	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61066
2.33851249251085e-14	-0.406548504364067	0.406	0.532	4.7831934521817e-10	NFE2L2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61067
2.59943287583485e-14	-1.29365435608035	0.462	0.579	5.3168800042326e-10	CCL4L2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61068
4.88054034884815e-14	0.325560952760748	0.726	0.613	9.982657229534e-10	PKM	Mono/Macro	GSE169246_PacTissue_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61069
5.11182949221217e-14	-0.257051789979841	0.221	0.372	1.04557360433708e-09	C1orf54	Mono/Macro	GSE169246_PacTissue_post	ENSG00000118292	79630	chromosome 1 open reading frame 54	FLJ23221	protein_coding	Q8WWF1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61070
6.2643769778739e-14	0.306031821709546	0.512	0.375	1.28131566705433e-09	RASSF4	Mono/Macro	GSE169246_PacTissue_post	ENSG00000107551	83937	Ras association domain family member 4	AD037|MGC44914	protein_coding	Q9H2L5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61071
1.44189886416277e-13	-0.250198462397289	0.988	0.987	2.94925993675853e-09	RPS15A	Mono/Macro	GSE169246_PacTissue_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61072
1.47343956613152e-13	-0.270172031158624	0.268	0.427	3.0137732885654e-09	MT-ND6	Mono/Macro	GSE169246_PacTissue_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61073
2.01923303849275e-13	-0.287363932496105	0.141	0.275	4.13013925693308e-09	ARL5B	Mono/Macro	GSE169246_PacTissue_post	ENSG00000165997	221079	ADP ribosylation factor like GTPase 5B	ARL8	protein_coding	Q96KC2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61074
2.5717547536222e-13	-0.544708900794214	0.491	0.571	5.26026717305885e-09	TREM2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000095970	54209	triggering receptor expressed on myeloid cells 2	TREM-2|Trem2a|Trem2b|Trem2c	protein_coding	Q9NZC2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61075
2.70254863083729e-13	0.581130583076442	0.903	0.896	5.5277929695146e-09	CTSB	Mono/Macro	GSE169246_PacTissue_post	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61076
3.55765532460874e-13	-0.36563278124425	0.732	0.818	7.27682820095471e-09	C1QA	Mono/Macro	GSE169246_PacTissue_post	ENSG00000173372	712	complement C1q A chain	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61077
3.7332732561048e-13	0.309098096906638	0.806	0.733	7.63603711803675e-09	TPI1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61078
5.97488865359815e-13	-0.290613324561435	0.671	0.753	1.22210372520697e-08	BST2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61079
6.58104818319325e-13	-0.281054843101571	0.282	0.429	1.34608759539035e-08	GPR34	Mono/Macro	GSE169246_PacTissue_post	ENSG00000171659	2857	G protein-coupled receptor 34	NA	protein_coding	Q9UPC5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61080
9.33040411607078e-13	0.258809249025926	0.962	0.95	1.90844085790112e-08	ACTG1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61081
1.02463430851578e-12	-0.590382807189675	0.382	0.493	2.09578701463818e-08	ICAM1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000090339	3383	intercellular adhesion molecule 1	BB2|CD54	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61082
1.66287024462762e-12	-0.385274809738649	0.626	0.729	3.40123479836133e-08	CD14	Mono/Macro	GSE169246_PacTissue_post	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61083
2.62998232782642e-12	0.342968884988932	0.847	0.771	5.37936585333616e-08	LGALS3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61084
1.33585005137313e-11	-0.277598706077199	0.309	0.442	2.7323476950786e-07	PTPRE	Mono/Macro	GSE169246_PacTissue_post	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61085
1.67709701260334e-11	0.357106076260126	0.556	0.464	3.43033422957887e-07	IL18	Mono/Macro	GSE169246_PacTissue_post	ENSG00000150782	3606	interleukin 18	IGIF|IL-18|IL-1g|IL1F4	protein_coding	Q14116	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61086
3.62578032237302e-11	0.349032973945031	0.489	0.364	7.41617107138178e-07	FABP5	Mono/Macro	GSE169246_PacTissue_post	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61087
3.93318892028708e-11	-0.294141946313811	0.991	0.994	8.0449446175552e-07	RPS8	Mono/Macro	GSE169246_PacTissue_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61088
4.16893329354773e-11	-0.489027207160217	0.291	0.406	8.52713615862252e-07	ZNF331	Mono/Macro	GSE169246_PacTissue_post	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61089
5.50223178686639e-11	-0.261641608778398	0.261	0.397	1.12542648968565e-06	PLA2G7	Mono/Macro	GSE169246_PacTissue_post	ENSG00000146070	7941	phospholipase A2 group VII	LDL-PLA2|PAFAH	protein_coding	Q13093	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61090
7.22388027115691e-11	0.427328620281464	0.302	0.202	1.47757247066243e-06	SNHG12	Mono/Macro	GSE169246_PacTissue_post	ENSG00000197989	85028	small nucleolar RNA host gene 12	ASLNC04080|C1orf79|LINC00100|PNAS-123	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61091
8.20872327816109e-11	0.374985305576454	0.895	0.862	1.67901225931507e-06	GRN	Mono/Macro	GSE169246_PacTissue_post	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61092
2.07030777285348e-10	-0.257397712682089	0.714	0.776	4.2346075185945e-06	RGS10	Mono/Macro	GSE169246_PacTissue_post	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61093
8.9482359018032e-10	-0.329964700225278	0.298	0.413	1.83027217135483e-05	RBKS	Mono/Macro	GSE169246_PacTissue_post	ENSG00000171174	64080	ribokinase	DKFZp686G13268|RBSK	protein_coding	Q9H477	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61094
1.3295896562058e-09	0.354690477157062	0.992	0.99	2.71954268280334e-05	HLA-A	Mono/Macro	GSE169246_PacTissue_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61095
2.1625792302113e-09	-0.426065468142412	0.25	0.359	4.4233395574742e-05	CD52	Mono/Macro	GSE169246_PacTissue_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61096
3.42326026115479e-09	-0.40516668664852	0.639	0.747	7.00193653816601e-05	APOC1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000130208	341	apolipoprotein C1	NA	protein_coding	P02654	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61097
6.10506071290659e-09	-0.314307706226859	0.247	0.353	0.000124872911821791	NFKB1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61098
1.03351150903601e-08	-0.268210858003809	0.376	0.497	0.000211394444058226	LIPA	Mono/Macro	GSE169246_PacTissue_post	ENSG00000107798	3988	lipase A, lysosomal acid type	CESD|LAL	protein_coding	P38571	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61099
1.30723417087819e-08	0.405267513423035	0.273	0.17	0.000267381677311425	S100A8	Mono/Macro	GSE169246_PacTissue_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61100
1.68204963353235e-08	0.311711450149375	0.67	0.579	0.000344046432042707	GSN	Mono/Macro	GSE169246_PacTissue_post	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61101
1.70849932658982e-08	-0.293056636305669	0.423	0.536	0.000349456452260682	A2M	Mono/Macro	GSE169246_PacTissue_post	ENSG00000175899	2	alpha-2-macroglobulin	CPAMD5|FWP007|S863-7	protein_coding	P01023	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61102
2.31347527378189e-08	0.271704504596598	0.414	0.313	0.000473198232499348	SERPING1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000149131	710	serpin family G member 1	C1-INH|C1IN|C1INH|C1NH|HAE1|HAE2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61103
2.68989111156496e-08	-0.361722080753865	0.509	0.609	0.000550190327959498	LGMN	Mono/Macro	GSE169246_PacTissue_post	ENSG00000100600	5641	legumain	LGMN1|PRSC1	protein_coding	Q99538	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61104
3.42721253433751e-08	0.294506235351822	0.505	0.424	0.000701002051773394	MSR1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000038945	4481	macrophage scavenger receptor 1	CD204|SCARA1|SR-A|SR-AI|SR-AII|SR-AIII	protein_coding	P21757	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61105
3.89656514672992e-08	-0.388657219579779	0.808	0.83	0.000797003435112138	ZFP36	Mono/Macro	GSE169246_PacTissue_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61106
4.14279075845279e-08	0.273989579311773	0.998	1	0.000847366421733933	ACTB	Mono/Macro	GSE169246_PacTissue_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61107
5.08382066569038e-08	0.375538623745703	0.562	0.488	0.00103984467896031	H2AFZ	Mono/Macro	GSE169246_PacTissue_post	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61108
8.58004542962186e-08	0.279924340323973	0.533	0.459	0.00175496249217485	LAP3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61109
9.8574429251246e-08	-0.28805425110814	0.318	0.418	0.00201624137590499	NR4A3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000119508	8013	nuclear receptor subfamily 4 group A member 3	CHN|CSMF|MINOR|NOR1	protein_coding	Q92570	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61110
1.01767960831617e-07	0.285005490615639	0.815	0.772	0.00208156187084989	PRDX1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61111
1.02438594694381e-07	-1.17410553371686	0.497	0.534	0.00209527901587888	CCL3L1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000277796	6349	C-C motif chemokine ligand 3 like 1	D17S1718|G0S19-2|LD78BETA|SCYA3L|SCYA3L1|MGC12815	protein_coding	P16619	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61112
1.2307310099571e-07	-0.267739215634069	0.309	0.411	0.00251733720776625	RASGEF1B	Mono/Macro	GSE169246_PacTissue_post	ENSG00000138670	153020	RasGEF domain family member 1B	FLJ31695|GPIG4	protein_coding	Q0VAM2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61113
2.89645012517156e-07	-0.260023726020902	0.324	0.418	0.00592439908602591	IER5	Mono/Macro	GSE169246_PacTissue_post	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61114
3.25411321547449e-07	-0.425995432945507	0.532	0.579	0.00665596317093153	NR4A1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61115
4.94617367315816e-07	-0.353783472334005	0.648	0.755	0.0101169036310777	APOE	Mono/Macro	GSE169246_PacTissue_post	ENSG00000130203	348	apolipoprotein E	AD2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61116
5.50179911742737e-07	0.263707775760085	0.436	0.343	0.0112533799147859	HSPA5	Mono/Macro	GSE169246_PacTissue_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61117
1.00075995643857e-06	-0.346093273547246	0.782	0.806	0.0204695441489945	DNAJB1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61118
1.16451579424026e-06	-0.629212212578945	0.586	0.626	0.0238190060553902	DUSP2	Mono/Macro	GSE169246_PacTissue_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61119
1.49499954373697e-06	-0.251996479088322	0.253	0.341	0.0305787206675959	TAGAP	Mono/Macro	GSE169246_PacTissue_post	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61120
2.25294284820308e-06	0.477873409635153	0.353	0.264	0.0460816930171458	CXCL3	Mono/Macro	GSE169246_PacTissue_post	ENSG00000163734	2921	C-X-C motif chemokine ligand 3	CINC-2b|GRO3|GROg|MIP-2b|SCYB3	protein_coding	P19876	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61121
2.360761620887e-06	-0.255433980466905	0.618	0.689	0.0482870181936226	ZFP36L1	Mono/Macro	GSE169246_PacTissue_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61122
1.81657161330471e-37	-0.803081133324979	0.704	0.894	3.71561557785344e-33	MT-ND3	Plasma cells	GSE169246_PacTissue_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61123
1.78904297423394e-29	-0.761423205971896	0.597	0.823	3.65930849949809e-25	MT-ATP6	Plasma cells	GSE169246_PacTissue_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61124
3.35261995078416e-28	-0.344788230069723	0.078	0.294	6.85744884733391e-24	MGP	Plasma cells	GSE169246_PacTissue_post	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61125
1.90949191654573e-27	-0.674699649004713	0.38	0.695	3.90567476610263e-23	RPL41	Plasma cells	GSE169246_PacTissue_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61126
6.37695212281812e-26	-0.616866205602997	0.442	0.741	1.30434178720122e-21	RPL39	Plasma cells	GSE169246_PacTissue_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61127
9.0635161346946e-26	-0.623082177810948	0.684	0.887	1.85385159019043e-21	RPS28	Plasma cells	GSE169246_PacTissue_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61128
1.60503316416332e-25	-0.6880702395142	0.173	0.436	3.28293483397965e-21	KLF2	Plasma cells	GSE169246_PacTissue_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61129
5.57646542333808e-25	-0.628758070582494	0.579	0.826	1.14061023768957e-20	RPL34	Plasma cells	GSE169246_PacTissue_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61130
1.31302178581485e-24	-0.41824077093186	0.202	0.468	2.6856547607057e-20	TXNDC5	Plasma cells	GSE169246_PacTissue_post	ENSG00000239264	81567	thioredoxin domain containing 5	EndoPDI|ERp46|FLJ21353|FLJ90810|Hcc-2|MGC3178|PDIA15	protein_coding	Q8NBS9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61131
1.48832246136244e-23	-0.30650969450449	0.077	0.27	3.04421476247073e-19	RPL36A	Plasma cells	GSE169246_PacTissue_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61132
1.98930020394388e-22	0.469165180247836	0.97	0.844	4.06891463714681e-18	HLA-B	Plasma cells	GSE169246_PacTissue_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61133
2.25310279609297e-22	-0.491763903793316	0.488	0.784	4.60849645912855e-18	RPL37	Plasma cells	GSE169246_PacTissue_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61134
2.48830224681533e-22	0.480022216900148	0.984	0.904	5.08957341563607e-18	HLA-C	Plasma cells	GSE169246_PacTissue_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61135
4.64065490894151e-21	0.996199353148233	0.739	0.5	9.49199555074897e-17	HSP90AA1	Plasma cells	GSE169246_PacTissue_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61136
5.1596038068419e-20	-0.292762858026899	0.116	0.319	1.05534536265144e-15	TIMP1	Plasma cells	GSE169246_PacTissue_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61137
1.54989553112807e-19	-0.332837482566022	0.646	0.883	3.17015631936935e-15	MT-ND5	Plasma cells	GSE169246_PacTissue_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61138
2.30429738719658e-19	-0.497997437839655	0.539	0.798	4.71320987577189e-15	RPS3	Plasma cells	GSE169246_PacTissue_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61139
2.83680358582021e-18	-0.300700192207814	0.196	0.422	5.80239805443666e-14	TRAM1	Plasma cells	GSE169246_PacTissue_post	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61140
1.09011374597411e-17	0.655508900499994	0.563	0.277	2.22971865601545e-13	HLA-A	Plasma cells	GSE169246_PacTissue_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61141
1.42556756452599e-17	-0.306964812507785	0.152	0.351	2.91585589648145e-13	PECAM1	Plasma cells	GSE169246_PacTissue_post	ENSG00000261371	5175	platelet and endothelial cell adhesion molecule 1	CD31	protein_coding	P16284	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61142
1.98873479504392e-17	-0.458542552711608	0.515	0.755	4.06775814978284e-13	RPL5	Plasma cells	GSE169246_PacTissue_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61143
2.68532306634968e-17	-0.330003847739898	0.451	0.695	5.49255979991164e-13	KRTCAP2	Plasma cells	GSE169246_PacTissue_post	ENSG00000163463	200185	keratinocyte associated protein 2	KCP2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61144
7.7348595094302e-17	-0.4808250674793	0.796	0.943	1.58208816405885e-12	MT-CO1	Plasma cells	GSE169246_PacTissue_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61145
2.31468443183162e-16	-0.6827346452646	0.338	0.585	4.73445553686841e-12	FOS	Plasma cells	GSE169246_PacTissue_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61146
2.45310604323864e-16	-0.47995570463986	0.324	0.56	5.01758310084032e-12	FOSB	Plasma cells	GSE169246_PacTissue_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61147
3.91827306463765e-16	-0.48726869637598	0.397	0.628	8.01443572640985e-12	VIM	Plasma cells	GSE169246_PacTissue_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61148
3.92045874552259e-16	-0.475826923307879	0.487	0.745	8.0189063180919e-12	RPS27	Plasma cells	GSE169246_PacTissue_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61149
8.97068625611689e-15	-0.398683932261358	0.315	0.55	1.83486416682615e-10	RPS21	Plasma cells	GSE169246_PacTissue_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61150
1.14312276720408e-14	-0.482148659034831	0.77	0.862	2.33814330803922e-10	RPS14	Plasma cells	GSE169246_PacTissue_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61151
1.45647382762111e-14	0.942516316526603	0.698	0.514	2.97907156701622e-10	HSPA1B	Plasma cells	GSE169246_PacTissue_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61152
2.07522074658468e-14	-0.264294304493225	0.181	0.376	4.24465651506431e-10	SLAMF7	Plasma cells	GSE169246_PacTissue_post	ENSG00000026751	57823	SLAM family member 7	19A|CD319|CRACC|CS1	protein_coding	Q9NQ25	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61153
2.17486399653606e-14	-0.40145766158257	0.644	0.83	4.44846681851486e-10	RPS23	Plasma cells	GSE169246_PacTissue_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61154
2.32384642319729e-14	-0.338855271855186	0.408	0.663	4.75319547400774e-10	RPL37A	Plasma cells	GSE169246_PacTissue_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61155
2.67845490429671e-14	-0.428364499873606	0.915	0.911	5.47851166124848e-10	TPT1	Plasma cells	GSE169246_PacTissue_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61156
4.50289089421461e-14	-0.289504087721546	0.283	0.5	9.21021303502655e-10	SELENOM	Plasma cells	GSE169246_PacTissue_post	ENSG00000198832	140606	selenoprotein M	SELM|SEPM	protein_coding	Q8WWX9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61157
4.63786170604835e-14	-0.381783071725364	0.835	0.943	9.48628233355129e-10	MT-CYB	Plasma cells	GSE169246_PacTissue_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61158
2.72494950372881e-13	0.98512078871551	0.668	0.475	5.57361171492692e-09	HSPA1A	Plasma cells	GSE169246_PacTissue_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61159
2.78689561180104e-13	0.523232057519189	0.336	0.128	5.70031628437784e-09	IRF1	Plasma cells	GSE169246_PacTissue_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61160
3.18100885471849e-13	-2.4352469770154	0.214	0.376	6.50643551144119e-09	IGHA1	Plasma cells	GSE169246_PacTissue_post	ENSG00000282633	NA	NA	AL928768.3	IG_C_gene	P01876	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61161
3.96614165169349e-13	-0.378570197187564	0.688	0.837	8.11234613437387e-09	RPL32	Plasma cells	GSE169246_PacTissue_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61162
1.96681252955292e-12	-0.315181331760734	0.614	0.812	4.02291834794754e-08	RPL30	Plasma cells	GSE169246_PacTissue_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61163
2.12430634270908e-12	-0.37748616219797	0.691	0.858	4.34505619337715e-08	MT-CO3	Plasma cells	GSE169246_PacTissue_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61164
2.55171922525716e-12	0.533952983056018	0.58	0.358	5.219286503341e-08	HSP90AB1	Plasma cells	GSE169246_PacTissue_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61165
4.03670037934876e-12	0.45066648413675	0.581	0.387	8.25666695591996e-08	PIM2	Plasma cells	GSE169246_PacTissue_post	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61166
7.34535272217512e-12	0.292476156577199	0.455	0.238	1.5024184457937e-07	TMED9	Plasma cells	GSE169246_PacTissue_post	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61167
1.14622001630695e-11	-0.302127115479758	0.386	0.599	2.34447842135423e-07	EEF2	Plasma cells	GSE169246_PacTissue_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61168
1.1667411014126e-11	-0.319698196925615	0.505	0.695	2.38645224882933e-07	RPL17	Plasma cells	GSE169246_PacTissue_post	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61169
1.38174888410914e-11	-0.369025767259774	0.624	0.791	2.82622916755684e-07	RPL35A	Plasma cells	GSE169246_PacTissue_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61170
1.55020911723494e-11	0.415317655279106	0.897	0.766	3.17079772839234e-07	CD74	Plasma cells	GSE169246_PacTissue_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61171
2.54745209041253e-11	-0.301786173056194	0.602	0.784	5.2105585057298e-07	RPS13	Plasma cells	GSE169246_PacTissue_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61172
3.88150268834204e-11	-0.408988756962707	0.204	0.372	7.93922559873481e-07	ANKRD28	Plasma cells	GSE169246_PacTissue_post	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61173
4.97028782341799e-11	-0.279014855662949	0.437	0.663	1.01662267140192e-06	RPL36	Plasma cells	GSE169246_PacTissue_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61174
7.53019686090036e-11	-0.255686806588322	0.64	0.798	1.54022646592856e-06	RPS6	Plasma cells	GSE169246_PacTissue_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61175
1.1608689043849e-10	-0.309933486598485	0.622	0.784	2.37444125702887e-06	RPL26	Plasma cells	GSE169246_PacTissue_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61176
1.3906980911023e-10	-0.328975594914592	0.785	0.897	2.84453387554064e-06	HSP90B1	Plasma cells	GSE169246_PacTissue_post	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61177
2.30452436183453e-10	-0.35638293255959	0.904	0.915	4.71367412969634e-06	RPS4X	Plasma cells	GSE169246_PacTissue_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61178
4.01863857610714e-10	0.416443176659195	0.347	0.16	8.21972334356954e-06	HSPD1	Plasma cells	GSE169246_PacTissue_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61179
7.39414756556171e-10	-0.317670572755566	0.881	0.894	1.51239894305999e-05	RPS8	Plasma cells	GSE169246_PacTissue_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61180
8.97267376224308e-10	-0.364388803418948	0.203	0.355	1.8352706913292e-05	YPEL5	Plasma cells	GSE169246_PacTissue_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61181
1.41036438036275e-09	-0.271902183759642	0.562	0.745	2.88475930359396e-05	RPL12	Plasma cells	GSE169246_PacTissue_post	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61182
1.50835100170184e-09	-0.300198791788204	0.784	0.851	3.08518113888095e-05	RPS15A	Plasma cells	GSE169246_PacTissue_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61183
2.14879741489635e-09	-0.278809468866346	0.991	0.972	4.395150232429e-05	RPLP1	Plasma cells	GSE169246_PacTissue_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61184
2.37372848540992e-09	-0.304384140056405	0.511	0.699	4.85522424405746e-05	EEF1D	Plasma cells	GSE169246_PacTissue_post	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61185
8.25344502060853e-09	-0.257969311799558	0.685	0.823	0.000168815964451527	RPL11	Plasma cells	GSE169246_PacTissue_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61186
1.12932503801648e-08	-0.263237809353615	0.737	0.84	0.00023099214327589	RPS12	Plasma cells	GSE169246_PacTissue_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61187
1.27017699821361e-08	-0.260631634417349	0.955	0.968	0.000259802003214612	EEF1A1	Plasma cells	GSE169246_PacTissue_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61188
2.59382142533382e-08	-0.765546432892299	0.665	0.723	0.000530540234337779	IGKC	Plasma cells	GSE169246_PacTissue_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61189
3.27200976319821e-08	-0.294371510544757	0.515	0.681	0.000669256876964562	RPL23A	Plasma cells	GSE169246_PacTissue_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61190
3.95738315172588e-08	-0.283099311745534	0.804	0.879	0.000809443149854011	RPL3	Plasma cells	GSE169246_PacTissue_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61191
4.63295779149882e-08	-0.294364419391938	0.726	0.805	0.000947625186673169	RPL6	Plasma cells	GSE169246_PacTissue_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61192
4.93090269211885e-08	0.385564808465026	0.556	0.418	0.00100856683664599	ISG20	Plasma cells	GSE169246_PacTissue_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61193
7.86188964670124e-08	0.416272825980192	0.596	0.429	0.00160807090833627	UBB	Plasma cells	GSE169246_PacTissue_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61194
9.72062398631445e-08	-0.325648706377598	0.189	0.316	0.00198825643016076	RAB30	Plasma cells	GSE169246_PacTissue_post	ENSG00000137502	27314	RAB30, member RAS oncogene family	NA	protein_coding	Q15771	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61195
1.85153388420047e-07	0.429236239642878	0.846	0.77	0.00378712740674364	UBC	Plasma cells	GSE169246_PacTissue_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61196
3.35922151130435e-07	-0.312773495250399	0.291	0.436	0.00687095167922191	ZFP36	Plasma cells	GSE169246_PacTissue_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61197
5.40846278641466e-07	0.440388501307567	0.869	0.855	0.0110624697833325	HERPUD1	Plasma cells	GSE169246_PacTissue_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61198
8.19425972918135e-07	0.410156157498759	0.562	0.379	0.0167605388500675	HSPA8	Plasma cells	GSE169246_PacTissue_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	post	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61199
0	-1.25514358813522	0.256	0.687	0	ISG15	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61200
0	-0.977163830426963	0.173	0.577	0	IFI6	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61201
0	-0.561614168595458	0.057	0.362	0	IFI44L	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61202
0	-0.589580543951968	0.997	1	0	HLA-C	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61203
0	-1.02108675825693	0.438	0.789	0	LY6E	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61204
0	-0.598918648200889	0.944	0.989	0	RPL12	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61205
0	-0.778532633830784	0.689	0.895	0	IFITM2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61206
0	-1.21151551156954	0.85	0.984	0	IFITM1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61207
0	1.10231472361862	0.82	0.585	0	KLF6	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61208
0	-0.843496651021674	0.918	0.979	0	GAPDH	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61209
0	-1.00549382048465	0.269	0.605	0	LAG3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000089692	3902	lymphocyte activating 3	CD223	protein_coding	P18627	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61210
0	1.21851368082369	0.753	0.364	0	FOS	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61211
0	-0.409592451205217	1	1	0	B2M	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61212
0	0.503238899392259	0.306	0.043	0	IGLV2-23	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000211660	NA	NA	NA	IG_V_gene	P01705	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61213
0	-1.08120336224545	0.157	0.561	0	MX1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61214
0	-2.20224938554083	0.08	0.532	0	CXCL13	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000156234	10563	C-X-C motif chemokine ligand 13	ANGIE|ANGIE2|BCA-1|BLC|BLR1L|SCYB13	protein_coding	O43927	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61215
7.88862265067021e-305	0.483295989177073	0.344	0.073	1.61353887696808e-300	IGLV3-1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000211673	NA	NA	NA	IG_V_gene	P01715	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61216
4.43473750074589e-303	-0.551045889200341	0.905	0.982	9.07081208402565e-299	RPL41	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61217
3.80201512764235e-298	-0.535776311249958	0.958	0.994	7.77664174207967e-294	TMSB10	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61218
2.32189994776044e-286	-0.703642730096265	0.459	0.739	4.7492141531492e-282	RARRES3	CD8+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61219
1.54850949586896e-284	-0.975201524976214	0.86	0.888	3.16732132285038e-280	CCL5	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61220
5.20476094608998e-283	0.820046696350166	0.969	0.881	1.06458180391325e-278	MT-ATP6	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61221
9.32785249942544e-283	-0.812340995924827	0.493	0.742	1.90791895023248e-278	CD8A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61222
9.2640401091349e-277	-0.522608679653891	0.993	0.999	1.89486676392245e-272	TMSB4X	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61223
5.78810026929953e-271	-0.745177015724411	0.412	0.696	1.18389802908253e-266	MT2A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61224
8.95863955005334e-270	1.36682169643285	0.78	0.587	1.83240013356791e-265	HSPA1B	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61225
1.3323007724113e-268	-0.530301116610905	0.042	0.297	2.72508799989007e-264	HAVCR2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000135077	84868	hepatitis A virus cellular receptor 2	CD366|FLJ14428|Tim-3|TIM3|TIMD3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61226
2.51330895289665e-268	0.874801208028521	0.606	0.303	5.14072213225481e-264	FOSB	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61227
3.93796967987508e-267	0.847251530700698	1	0.999	8.05472318321648e-263	MALAT1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61228
1.97552360619101e-266	0.681685005469505	0.478	0.2	4.0407359841031e-262	IGKV3-20	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000282402	NA	NA	NA	IG_V_gene	P01619	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61229
4.53353552241875e-258	1.0715426460325	0.864	0.653	9.27289355755531e-254	JUN	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61230
4.05995211963253e-254	-0.557500346573418	0.063	0.32	8.30422606549638e-250	CD38	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61231
1.20391193999563e-253	-0.585608755983444	0.506	0.758	2.46248148206706e-249	PSMB9	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61232
1.53948898636978e-251	-0.743501523886256	0.386	0.663	3.14887077272075e-247	ISG20	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61233
1.95574004378477e-250	-1.02278885871287	0.183	0.471	4.00027068555738e-246	GZMB	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61234
3.08176178355312e-249	-0.956599078296706	0.448	0.693	6.30343555207955e-245	RGS1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61235
1.03223257007661e-248	-0.56672374924324	0.684	0.867	2.1113284988347e-244	MYL12A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61236
6.57172734019483e-247	0.869529331460716	0.594	0.33	1.34418111016345e-242	MYADM	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61237
2.59018973089846e-235	-0.517771942488118	0.852	0.961	5.2979740755797e-231	SH3BGRL3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61238
1.35180514208903e-233	-0.415366690969038	0.996	1	2.7649822376289e-229	RPL28	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61239
4.19099595845453e-233	0.393980808080234	0.287	0.064	8.5722631334229e-229	IGHV3-23	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000281962	NA	NA	NA	IG_V_gene	P01764	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61240
8.47397147090712e-230	0.899285747557908	0.475	0.218	1.73326612465934e-225	NR4A1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61241
2.98647808417673e-229	-0.808218238790746	0.667	0.798	6.10854227337509e-225	CREM	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61242
5.31888749344909e-225	-0.43347301785999	0.055	0.289	1.08792524791008e-220	OAS1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000089127	4938	2'-5'-oligoadenylate synthetase 1	IFI-4|OIAS|OIASI	protein_coding	P00973	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61243
1.98551969955457e-224	-0.538892300466091	0.356	0.627	4.06118199346892e-220	DRAP1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61244
1.57009772903512e-221	-0.528628958676072	0.181	0.452	3.21147789496843e-217	XAF1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61245
4.66727536987134e-219	-0.554533852357842	0.207	0.477	9.54644504153483e-215	EPSTI1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61246
1.21119784913831e-215	-0.510658465140573	0.839	0.94	2.4773840806275e-211	PTPRCAP	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61247
4.11417069304836e-212	-0.434178165773443	0.999	1	8.41512473556112e-208	ACTB	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61248
4.36113005890531e-208	0.497402005399296	1	0.998	8.92025542248491e-204	MT-CO1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61249
2.07943986376959e-206	0.844267642056508	0.577	0.316	4.25328629735433e-202	KLF2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61250
3.38204568445227e-203	-0.650696676167157	0.54	0.753	6.91763624297868e-199	CD7	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61251
7.9328153607705e-200	-0.51961408522867	0.592	0.807	1.622578053892e-195	CD3D	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61252
5.1167947678449e-198	0.752094474315604	0.629	0.406	1.046589201815e-193	TAGAP	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61253
3.08189550867165e-195	0.898386740252446	0.65	0.385	6.30370907343699e-191	ANXA1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61254
8.95084507586933e-195	0.819083979243416	0.478	0.248	1.83080585181831e-190	NEU1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000184494	4758	neuraminidase 1	NEU	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61255
1.77676256237607e-194	0.667101640326649	0.901	0.831	3.63419014508402e-190	PTPRC	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61256
1.38708157690456e-192	-0.500051004403638	0.135	0.375	2.83713665740058e-188	PLSCR1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61257
5.38944023471683e-192	0.599289718167624	0.605	0.367	1.10235610560898e-187	AHNAK	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61258
6.06453835663463e-192	-0.777696686885094	0.667	0.795	1.24044067546605e-187	NKG7	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61259
6.96100591510386e-192	-0.521252237764355	0.064	0.278	1.42380414987534e-187	VCAM1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000162692	7412	vascular cell adhesion molecule 1	CD106	protein_coding	P19320	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61260
2.97786689550634e-191	0.978649621927476	0.628	0.433	6.09092894806867e-187	SLC2A3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61261
4.98080431044538e-191	-0.769443974848976	0.43	0.649	1.0187737136585e-186	DUSP4	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61262
3.94145865758515e-190	0.397650835948045	0.348	0.128	8.06185953822467e-186	IGLV2-14	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000211666	NA	NA	NA	IG_V_gene	P01704	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61263
9.84651637910194e-189	0.603515297020155	0.741	0.561	2.01400646018151e-184	CD44	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61264
6.84998848161318e-185	-0.487181846810877	0.205	0.458	1.40109664402916e-180	MT1X	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61265
5.23752482308228e-184	-0.427339532236006	0.867	0.955	1.07128332731325e-179	CFL1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61266
3.07174623463602e-181	0.636971768056265	0.614	0.384	6.28294974832451e-177	PPP1R15A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61267
7.40748447307892e-179	0.525096431746933	0.394	0.169	1.51512687412356e-174	IGHG1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61268
3.23091466959984e-178	-0.443457820295734	0.13	0.36	6.60851286519952e-174	ITGAE	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61269
1.60250065672137e-176	1.05167851874063	0.803	0.678	3.2777548432579e-172	HSPA1A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61270
3.82086131196197e-176	0.724523359709993	0.517	0.264	7.815189727487e-172	IL7R	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61271
3.6688137690734e-174	-0.355879589515511	0.959	0.996	7.50419168326272e-170	FAU	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61272
1.54167808917158e-173	0.445175765745738	0.993	0.976	3.15334836359155e-169	MT-CO3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61273
6.01872990182013e-166	-0.474726800146481	0.334	0.566	1.23107101411829e-161	BST2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61274
1.2919371755135e-165	-0.428436273603273	0.754	0.882	2.64252829879531e-161	RAC2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61275
3.49711931971604e-165	-0.447691440333054	0.523	0.727	7.15300785654719e-161	SUMO2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61276
1.5118186074426e-162	-0.747446470521342	0.391	0.596	3.0922737796631e-158	RGS2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61277
4.56772033398348e-161	-0.330645462498793	0.993	0.999	9.34281517112981e-157	PTMA	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61278
4.72881517916037e-161	-0.351466848626233	0.956	0.991	9.67231856745463e-157	RPS24	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61279
1.37932364338711e-159	1.208549038403	0.721	0.656	2.82126858018399e-155	HSPH1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61280
1.51406416274083e-156	-0.383911870225604	0.809	0.922	3.0968668384701e-152	CD3E	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61281
5.31082868330871e-155	-0.444142739665494	0.255	0.48	1.08627689888396e-150	UBE2L6	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61282
4.142048158138e-154	-0.577032182371593	0.277	0.495	8.47214530265547e-150	TIGIT	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000181847	201633	T cell immunoreceptor with Ig and ITIM domains	DKFZp667A205|FLJ39873|VSIG9|VSTM3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61283
2.65167316452758e-153	0.528616364372492	0.418	0.212	5.42373229072472e-149	CCNH	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61284
1.18013790660485e-147	-0.378882517135543	0.13	0.338	2.41385407416957e-143	LGALS3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61285
8.29156887364575e-147	-0.300657643968938	0.999	0.999	1.6959574974155e-142	HLA-A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61286
1.99300367957345e-146	0.387471021413128	0.288	0.104	4.07648972619954e-142	RORA	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61287
3.02863258544809e-146	-0.351741651204119	0.795	0.918	6.19476509027552e-142	SERF2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61288
8.24894024360144e-146	-0.361264632935225	0.814	0.909	1.68723823742624e-141	OAZ1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61289
3.24324991995333e-145	0.364030688669542	0.27	0.092	6.63374338627254e-141	IGKV3-15	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000282447	NA	NA	NA	IG_V_gene	P01624	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61290
1.01726870388512e-143	-0.321489265276382	0.969	0.997	2.08072140692662e-139	RPS3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61291
1.42140224617846e-142	-0.419709087216245	0.266	0.484	2.90733615433342e-138	COX5A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61292
3.63624195176801e-141	-0.468848421613118	0.168	0.373	7.43756928814628e-137	PDCD1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000276977	5133	programmed cell death 1	CD279|hSLE1|PD-1|PD1|SLEB2	protein_coding	Q15116	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61293
6.83076022478154e-141	-0.378102600402204	0.588	0.774	1.39716369637682e-136	SRP14	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61294
9.86223234149169e-141	-0.436798805816387	0.186	0.394	2.01722100312871e-136	PTMS	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61295
6.3784281663571e-140	-0.303869017813374	0.997	1	1.30464369714668e-135	RPLP1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61296
6.21135325808995e-139	-0.422535182443498	0.911	0.952	1.27047019540972e-134	FTL	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61297
4.7291696180873e-138	0.795773020427819	0.706	0.564	9.67304353683577e-134	CD69	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61298
2.93585723453427e-137	-0.37343945180385	0.603	0.798	6.0050023875164e-133	PSME1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61299
5.8095867962818e-137	-0.470413267137317	0.226	0.436	1.18829288331148e-132	FABP5	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61300
2.23587716992457e-136	-0.395656781548108	0.631	0.818	4.57326316336372e-132	HCST	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61301
7.07739228469959e-135	-0.435778463099032	0.327	0.536	1.44760981791245e-130	ANXA5	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61302
3.43343170264936e-134	0.669359014617437	0.445	0.237	7.02274120459901e-130	LMNA	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61303
6.30657796650203e-134	-0.457105886704073	0.305	0.509	1.28994745726832e-129	CD27	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61304
8.98626824585796e-134	-0.370952600544272	0.772	0.886	1.83805130700779e-129	MYL6	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61305
4.3418095809466e-133	0.532347929025735	0.561	0.388	8.88073731686818e-129	CCNL1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61306
1.05560292211589e-131	-0.402896733829693	0.905	0.961	2.15913021689585e-127	IL32	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61307
1.08925435180741e-130	-0.41444459860927	0.615	0.776	2.22796085118688e-126	LSP1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61308
2.35333636995188e-130	-0.393817579963265	0.452	0.66	4.81351421109957e-126	PSME2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61309
3.07468795496243e-130	-0.493153752443865	0.258	0.463	6.28896674308016e-126	PRF1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61310
2.41719777231179e-129	-0.310911686756922	0.09	0.267	4.94413632348654e-125	MT1F	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000198417	4494	metallothionein 1F	MT1	protein_coding	P04733	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61311
3.78541944358125e-129	-0.395783264868784	0.321	0.526	7.7426969299011e-125	PARK7	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61312
1.99357233681406e-127	-0.393424113991678	0.199	0.401	4.07765285771949e-123	IRF7	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61313
2.19623587504234e-126	-0.34634164079339	0.809	0.914	4.49218085881161e-122	CYBA	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61314
3.39530993497978e-125	-0.446077389484246	0.346	0.544	6.94476694100764e-121	SH2D2A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000027869	9047	SH2 domain containing 2A	F2771|TSAd	protein_coding	Q9NP31	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61315
3.42369936283573e-125	-0.381493863889797	0.489	0.677	7.00283467674421e-121	TPI1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61316
5.76491246228956e-125	-0.452386160779358	0.63	0.789	1.17915519503671e-120	CST7	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61317
6.57652202639842e-125	-0.365735083540791	0.542	0.735	1.34516181527953e-120	ARPC3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61318
1.12305473978078e-124	0.580749067030457	0.475	0.295	2.2970961647476e-120	IFRD1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61319
1.14750640328191e-124	-0.332345561932666	0.151	0.343	2.34710959727283e-120	EIF2AK2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61320
1.12742449269201e-123	0.636701707860911	0.643	0.487	2.30603405735223e-119	BTG2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61321
1.85427546887127e-123	-0.368321946287134	0.179	0.378	3.79273504402929e-119	CARD16	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61322
2.15099659537515e-123	0.579319861196656	0.853	0.712	4.39964843618034e-119	DUSP1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61323
9.30360443650442e-122	0.576795699310999	0.632	0.478	1.90295925144261e-117	DDX3X	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61324
4.03185302260795e-121	-0.355385980792797	0.302	0.509	8.24675217244229e-117	GNG5	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61325
1.6382660686451e-119	-0.40267998241151	0.572	0.745	3.35090941680669e-115	SOD1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61326
4.13198540737985e-117	0.454614741556769	0.667	0.528	8.45156295225475e-113	RBM39	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61327
7.6387433134321e-117	0.47387485932604	0.56	0.387	1.5624285573294e-112	EML4	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61328
4.96388084175435e-116	-0.468253220011724	0.575	0.747	1.01531218737243e-111	GZMA	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61329
5.94422323235634e-116	-0.332849302313353	0.464	0.669	1.21583141994617e-111	COX6A1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61330
1.96515354884106e-115	0.370771694913609	0.336	0.162	4.01952506879951e-111	IGKC	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61331
3.08661439858819e-115	-0.347635903123284	0.256	0.453	6.31336109087229e-111	FKBP1A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61332
7.81715099577809e-115	-0.349518819349713	0.327	0.527	1.59892006467645e-110	RABAC1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000105404	10567	Rab acceptor 1	PRA1|PRAF1|YIP3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61333
1.25488488086874e-114	0.410163255590386	0.52	0.339	2.56674153532893e-110	MBP	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61334
4.69185739107307e-114	-0.269475929772123	0.972	0.996	9.59672510770087e-110	RPS15	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61335
9.56663576635578e-114	-0.361037128755277	0.348	0.542	1.95675967965041e-109	PSMB8	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61336
2.20658114507286e-112	-0.460655022917953	0.285	0.477	4.51334107413202e-108	DUSP5	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61337
5.98726815550604e-112	-0.669693867886616	0.325	0.505	1.22463582852721e-107	OASL	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000135114	8638	2'-5'-oligoadenylate synthetase like	OASL1|p59OASL|TRIP14	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61338
8.01986385311573e-112	0.562224240289481	0.493	0.324	1.64038295251629e-107	SLC38A2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61339
9.70277739895644e-112	-0.449011099987014	0.393	0.589	1.98460608918255e-107	HMGN2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61340
3.89092829636738e-111	-0.272175548072201	0.094	0.257	7.95850473738985e-107	SPATS2L	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000196141	26010	spermatogenesis associated serine rich 2 like	DNAPTP6|SGNP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61341
4.83111954927841e-110	0.411990264081871	0.664	0.462	9.88157192609406e-106	NFKBIA	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61342
1.13071376716273e-109	-0.316054836560097	0.172	0.353	2.31276193935465e-105	CHST12	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000136213	55501	carbohydrate sulfotransferase 12	C4S-2|C4ST2	protein_coding	Q9NRB3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61343
1.61267659674323e-109	0.653083723673388	0.51	0.362	3.2985687109786e-105	CHORDC1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61344
7.06300100822721e-109	-0.337583754342498	0.411	0.61	1.44466622622279e-104	GABARAP	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61345
1.04145478776197e-107	0.707910245520466	0.561	0.411	2.13019162288833e-103	NEAT1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61346
1.23571167901326e-107	-0.313200755916954	0.146	0.326	2.52752466825371e-103	CTLA4	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000163599	1493	cytotoxic T-lymphocyte associated protein 4	CD|CD152|CELIAC3|CTLA-4|GSE|IDDM12	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61347
1.32957561563111e-107	-0.317321550197099	0.947	0.983	2.71951396421188e-103	PFN1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61348
1.5108318419733e-107	-0.344808335937007	0.604	0.759	3.09025544957218e-103	ATP5MC2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61349
1.66034918117191e-107	-0.312247904621299	0.676	0.837	3.39607821516903e-103	RPL36AL	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61350
6.78537527310941e-107	-0.336515197886357	0.312	0.501	1.3878806583618e-102	SHISA5	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000164054	51246	shisa family member 5	hShisa5|SCOTIN	protein_coding	Q8N114	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61351
7.17614233577631e-107	-0.316363442683764	0.321	0.548	1.46780815335969e-102	CTSW	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61352
7.46897270639976e-107	-0.296095538763443	0.242	0.437	1.52770367736701e-102	TRAPPC1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61353
1.75180092115018e-105	0.427281003496081	0.268	0.114	3.58313360412058e-101	ATF3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61354
1.96783433036706e-105	-0.28628868571856	0.118	0.284	4.02500833933279e-101	TYMP	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61355
5.42689996472722e-104	-0.302962179409903	0.277	0.471	1.11001811878531e-99	ATP5MC3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61356
8.79760136103699e-104	-0.28110220236093	0.213	0.403	1.79946138238651e-99	RBX1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61357
1.19078610176252e-101	0.393409151230171	0.473	0.306	2.43563389254506e-97	CLK1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61358
1.46207690471516e-101	-0.33369197020584	0.585	0.745	2.9905321009044e-97	CLIC1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61359
2.88977473876805e-100	-0.315676613894603	0.459	0.642	5.91074525067617e-96	EDF1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61360
8.2509310583766e-99	-0.332873719490246	0.561	0.724	1.68764543868035e-94	SUB1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61361
2.3729582350998e-98	-0.457406978282313	0.355	0.532	4.85364877407314e-94	ALOX5AP	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61362
6.45853075209252e-98	-0.288901561210223	0.144	0.316	1.321027880033e-93	IFITM3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61363
1.42065445363854e-97	0.69544605062634	0.945	0.946	2.90580661947227e-93	HSP90AB1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61364
4.59612222751601e-96	0.364078062562373	0.457	0.262	9.40090840416125e-92	LTB	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61365
1.20836290550194e-95	-0.333323521516482	0.207	0.38	2.47158548691366e-91	SLA2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000101082	84174	Src like adaptor 2	C20orf156|FLJ21992|SLAP-2	protein_coding	Q9H6Q3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61366
5.83190590098143e-95	-0.277041275808218	0.142	0.303	1.19285803298674e-90	SIRPG	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000089012	55423	signal regulatory protein gamma	bA77C3.1|CD172g|SIRP-B2|SIRPB2|SIRPgamma	protein_coding	Q9P1W8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61367
1.31673156651501e-94	0.417307386229609	0.619	0.481	2.69324274614981e-90	STK4	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61368
6.88622662721607e-94	0.339615506777752	0.265	0.12	1.40850879433078e-89	KLRG1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61369
1.4227685215603e-93	-0.351978550832049	0.133	0.289	2.91013073399943e-89	MT1E	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61370
2.18356487582769e-92	0.479735962159365	0.46	0.305	4.46626359701796e-88	RALGAPA1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000174373	253959	Ral GTPase activating protein catalytic subunit alpha 1	DKFZp667F074|GARNL1|GRIPE|KIAA0884|RalGAPalpha1|Tulip1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61371
4.08604670209206e-92	0.368987574595669	0.4	0.242	8.3575999244591e-88	CDK17	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000059758	5128	cyclin dependent kinase 17	PCTAIRE2|PCTK2	protein_coding	Q00537	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61372
6.26687274598481e-92	-0.298560712118479	0.62	0.771	1.28182615146373e-87	CHCHD2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61373
1.86763224078413e-91	-0.348666935956875	0.257	0.426	3.82005498529986e-87	TRIM22	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000132274	10346	tripartite motif containing 22	GPSTAF50|RNF94|STAF50	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61374
7.86003252512751e-91	-0.279939526452383	0.367	0.553	1.60769105268958e-86	COX5B	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61375
7.90406171523678e-91	0.433113418698826	0.877	0.825	1.61669678323453e-86	HNRNPA2B1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61376
8.99715077188816e-91	-0.314798609502105	0.508	0.701	1.84027721888201e-86	PPDPF	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61377
1.43528543539288e-89	-0.470511927546506	0.109	0.254	2.9357328295526e-85	GEM	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000164949	2669	GTP binding protein overexpressed in skeletal muscle	KIR	protein_coding	P55040	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61378
2.34406476646383e-89	-0.36930808201129	0.623	0.761	4.79455007332512e-85	CALR	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61379
1.04826446427777e-88	-0.310595216057659	0.521	0.686	2.14412013523374e-84	PPIB	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61380
9.59459773462116e-88	0.469100352714553	0.405	0.253	1.96247902063941e-83	NFKB1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61381
2.5791520703892e-87	0.298612091555863	0.279	0.136	5.27539764477406e-83	SLC20A1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000144136	6574	solute carrier family 20 member 1	Glvr-1|GLVR1|PiT-1|PiT1	protein_coding	Q8WUM9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61382
2.91117242249589e-87	-0.26188130176127	0.124	0.273	5.95451207297308e-83	IFI35	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000068079	3430	interferon induced protein 35	IFP35	protein_coding	P80217	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61383
7.54945179316347e-86	-0.270995620010766	0.159	0.313	1.54416486977366e-81	LAP3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61384
1.34456178411149e-85	-0.266053465947513	0.592	0.752	2.75016667322165e-81	MIF	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61385
1.71889078408131e-85	-0.319120635228643	0.693	0.793	3.51581920975992e-81	RHOA	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61386
2.22064031840687e-85	0.304681222728667	0.265	0.128	4.5420977072694e-81	DNAJB4	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000162616	11080	DnaJ heat shock protein family (Hsp40) member B4	HLJ1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61387
2.37451613653106e-85	-0.273093257987838	0.323	0.495	4.85683530566063e-81	SRSF9	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61388
1.30833863860908e-84	0.697532434474697	0.802	0.749	2.67607585141102e-80	TNFAIP3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61389
1.48125670320403e-84	0.315644044725408	0.876	0.773	3.02976246073351e-80	PABPC1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61390
1.7598757132102e-84	0.849248856209033	0.715	0.679	3.59964978380014e-80	HSPD1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61391
2.1864618487146e-84	0.39577200413568	0.424	0.269	4.47218906536084e-80	TXNIP	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61392
1.67729313262387e-83	-0.406051895547252	0.453	0.613	3.43073537346885e-79	H2AFZ	CD8+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61393
2.00589743884171e-83	0.360199729566254	0.607	0.448	4.10286262140684e-79	IER2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61394
9.76901864653478e-83	0.309200941510719	0.905	0.8	1.99815507396222e-78	MT-ND4	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61395
1.06979024879515e-82	0.263770452144673	0.306	0.159	2.18814897488561e-78	ATM	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61396
1.30331231508718e-82	-0.267381149225823	0.31	0.482	2.66579500927931e-78	SPCS1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000114902	28972	signal peptidase complex subunit 1	HSPC033|SPC1|SPC12|YJR010C-A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61397
1.67402567630066e-82	0.325521062407138	0.369	0.217	3.42405211830536e-78	STAT4	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000138378	6775	signal transducer and activator of transcription 4	NA	protein_coding	Q14765	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61398
6.77795185168238e-82	-0.2823400778075	0.402	0.575	1.38636227174311e-77	ATP6V0E1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61399
9.10956465934125e-82	-0.253267936351761	0.867	0.942	1.86327035542166e-77	NACA	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61400
9.85199239025764e-82	0.282796527028596	0.405	0.239	2.0151265235033e-77	TC2N	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000276776	123036	tandem C2 domains, nuclear	C14orf47|C2CD1|FLJ36557|MTAC2D1|Tac2-N	protein_coding	Q8N9U0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61401
1.42115682060961e-81	-0.368330545658271	0.131	0.273	2.90683416087489e-77	CXCR6	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000172215	10663	C-X-C motif chemokine receptor 6	BONZO|CD186|STRL33|TYMSTR	protein_coding	O00574	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61402
1.57495815772414e-80	-0.260207959450108	0.344	0.531	3.22141941580895e-76	CD8B	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000172116	926	CD8b molecule	CD8B1	protein_coding	P10966	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61403
2.02785553378163e-80	-0.387333143603625	0.974	0.99	4.14777570879694e-76	FTH1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61404
4.78854283226253e-80	0.334960323317494	0.292	0.149	9.79448550910977e-76	GPR183	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61405
6.19011391372416e-80	0.586576708378736	0.918	0.873	1.26612589991314e-75	DNAJB1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61406
1.3157103923101e-79	-0.252170115531791	0.304	0.477	2.69115403643108e-75	WDR83OS	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000105583	51398	WD repeat domain 83 opposite strand	Asterix|C19orf56|PTD008	protein_coding	Q9Y284	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61407
2.63198303787556e-79	-0.285674898567318	0.354	0.524	5.38345810567066e-75	COX8A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61408
3.06169558115779e-79	-0.263427753702909	0.393	0.567	6.26239214170014e-75	NDUFA4	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61409
4.09622537920022e-79	0.65178327033802	0.899	0.915	8.37841939061612e-75	RPS29	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61410
6.51566893619691e-79	-0.261868761499017	0.228	0.389	1.33271492420972e-74	PRDX5	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61411
1.15247749879942e-78	0.293696087529105	0.984	0.963	2.35727747604434e-74	MT-ND3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61412
2.49082176728854e-78	0.420041821940658	0.543	0.411	5.09472684281198e-74	IDS	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61413
4.00511173324603e-78	0.391909665287593	0.622	0.505	8.19205553918144e-74	MBNL1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61414
8.13233109057496e-78	0.278298244877364	0.38	0.227	1.6633870012662e-73	ATP1A1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61415
4.49057569668446e-77	0.343872929455443	0.339	0.195	9.18502352999839e-73	PTGER4	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61416
6.07094089193242e-77	-0.354048093219709	0.241	0.407	1.24175025003586e-72	GZMH	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61417
6.87293523418601e-76	0.300159697668079	0.995	0.986	1.40579017280041e-71	MT-CYB	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61418
1.43256286588114e-75	0.286690120544961	0.26	0.129	2.93016408587329e-71	ELL2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61419
3.10345528062241e-75	-0.268715620847906	0.375	0.535	6.34780743098507e-71	PRR13	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61420
5.29858138736407e-75	-0.254127613541411	0.217	0.374	1.08377183697145e-70	BAX	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61421
1.29616429833576e-74	-0.270328273531647	0.82	0.888	2.65117445581597e-70	HNRNPA1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61422
1.47574215128042e-74	-0.271226366905058	0.32	0.481	3.01848299622896e-70	PSMB10	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000205220	5699	proteasome 20S subunit beta 10	beta2i|LMP10|MECL1|MGC1665	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61423
2.42019674587565e-74	-0.302634653355503	0.138	0.273	4.95027042401405e-70	MX2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000183486	4600	MX dynamin like GTPase 2	MXB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61424
2.9177725899849e-74	-0.308073143838685	0.498	0.644	5.96801205555512e-70	ARPC1B	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61425
1.580868144024e-73	-0.294179926136436	0.35	0.509	3.2335077017867e-69	CLEC2D	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61426
1.95431531148467e-73	-0.267749981021909	0.482	0.638	3.99735653811074e-69	PSMA7	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61427
7.98363895035814e-73	0.447623522171683	0.44	0.3	1.63297351090625e-68	NR4A3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000119508	8013	nuclear receptor subfamily 4 group A member 3	CHN|CSMF|MINOR|NOR1	protein_coding	Q92570	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61428
9.33003662399179e-73	0.40237823431886	0.44	0.306	1.90836569107128e-68	ELOVL5	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000012660	60481	ELOVL fatty acid elongase 5	dJ483K16.1|HELO1|SCA38	protein_coding	Q9NYP7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61429
1.33310920168118e-72	-0.272874624167017	0.262	0.415	2.72674156111868e-68	EID1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000255302	23741	EP300 interacting inhibitor of differentiation 1	C15orf3|CRI1|EID-1	protein_coding	Q9Y6B2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61430
1.57555121947867e-72	-0.280159273429594	0.496	0.646	3.22263246432167e-68	RAN	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61431
1.75195510107973e-71	-0.269124379500498	0.27	0.424	3.58344896374848e-67	C9orf16	CD8+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61432
1.00898069333113e-70	-0.322201273294133	0.666	0.781	2.0637691101395e-66	COTL1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61433
2.41139595312941e-70	-0.26907240620513	0.248	0.398	4.93226928253089e-66	SCAND1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61434
2.86551656848372e-70	0.257913338988887	0.263	0.138	5.8611275891766e-66	KDM6A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000147050	7403	lysine demethylase 6A	UTX	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61435
1.19795385802315e-69	0.30087338924402	0.899	0.839	2.45029482120056e-65	PNRC1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61436
1.65369735200155e-69	0.383018493781965	0.509	0.379	3.38247256378396e-65	KIAA1551	CD8+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61437
1.66269431205601e-69	0.471463680911698	0.587	0.477	3.40087494587937e-65	REL	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61438
4.34948008572442e-69	0.361615449853716	0.355	0.22	8.89642656734073e-65	TIPARP	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000163659	25976	TCDD inducible poly(ADP-ribose) polymerase	ARTD14|DDF1|DKFZP434J214|DKFZp686N0351|PARP-1|PARP-7|PARP7|pART14|RM1	protein_coding	Q7Z3E1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61439
2.37957078092536e-68	0.337040767956774	0.677	0.592	4.86717407530473e-64	SON	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61440
6.11617088529566e-68	-0.256875432545644	0.443	0.596	1.25100159287837e-63	CAPZB	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61441
2.53556303557506e-67	-0.260492965329582	0.208	0.349	5.18624063296523e-63	PDCL3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000115539	79031	phosducin like 3	VIAF1	protein_coding	Q9H2J4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61442
4.48288551880438e-67	-0.267676118599377	0.381	0.534	9.16929404016248e-63	PRDX1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61443
6.11353439018581e-67	0.257362719450733	0.273	0.148	1.25046232416861e-62	BRAF	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000157764	673	B-Raf proto-oncogene, serine/threonine kinase	BRAF-1|BRAF1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61444
2.61192841639247e-66	-0.270814569543232	0.262	0.407	5.34243838288915e-62	CDK2AP2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61445
6.55031983991034e-66	-0.262405324560369	1	1	1.33980242005526e-61	HLA-B	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61446
1.53380300715514e-65	-0.250687749718933	0.87	0.93	3.13724067083512e-61	PPIA	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61447
1.73918733296198e-65	0.334286113377796	0.598	0.471	3.55733377084044e-61	RSRP1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61448
2.29180872299942e-65	0.256312506776779	0.311	0.181	4.68766556202302e-61	RIPOR2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61449
1.0657840998846e-64	-0.300990095591405	0.543	0.691	2.17995479790396e-60	DYNLL1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61450
1.3265056429972e-64	-0.322774711825614	0.566	0.681	2.71323464218648e-60	HLA-DPA1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61451
4.75014941175883e-64	-0.254638838402715	0.325	0.472	9.71595560681151e-60	CALM3	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61452
9.74256806665299e-64	0.258543981586024	0.279	0.158	1.9927448723532e-59	NUFIP2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000108256	57532	nuclear FMR1 interacting protein 2	182-FIP|82-FIP|FIP-82|KIAA1321|MGC117262|NUFP2|PIG1	protein_coding	Q7Z417	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61453
1.49158651725612e-63	0.294781223023186	0.397	0.263	3.05089106239568e-59	MACF1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61454
1.5719837987949e-61	0.274650651779297	0.39	0.26	3.21533566205509e-57	TRA2A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000164548	29896	transformer 2 alpha homolog	AWMS1|htra-2-alpha	protein_coding	Q13595	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61455
1.6716113462042e-61	0.356583659179529	0.409	0.277	3.41911384752607e-57	ARID5B	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61456
2.13784716592147e-61	-0.252708528322638	0.216	0.354	4.37275259317578e-57	RBPJ	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61457
9.24715572023568e-61	0.274834927384178	0.332	0.207	1.89141323101701e-56	GPR174	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000147138	84636	G protein-coupled receptor 174	FKSG79	protein_coding	Q9BXC1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61458
9.66016848659075e-60	-0.320313042528284	0.966	0.973	1.97589086224727e-55	CD74	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61459
2.82924011834935e-59	0.375694835778175	0.458	0.342	5.78692773807175e-55	CHD2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61460
3.75874108455233e-59	0.298517605559793	0.507	0.386	7.68812901434334e-55	SF3B1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61461
5.17497236742063e-59	-0.25143782019327	0.781	0.863	1.05848884803222e-54	CORO1A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61462
5.87935421202277e-59	0.268314476972826	0.336	0.213	1.20256311052714e-54	SYNE1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000131018	23345	spectrin repeat containing nuclear envelope protein 1	8B|ARCA1|C6orf98|CPG2|dJ45H2.2|enaptin|KIAA0796|MYNE1|Nesp1|Nesprin-1|SCAR8|SYNE-1B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61463
5.92597471221173e-59	0.271187106807287	0.423	0.292	1.21209886763579e-54	CSRNP1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61464
9.33731542908707e-59	0.277331676922986	0.274	0.157	1.90985449786547e-54	XIST	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61465
1.32829184516085e-58	-0.269874617975481	0.367	0.501	2.716888140092e-54	SP100	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000067066	6672	SP100 nuclear antigen	NA	protein_coding	P23497	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61466
1.5064472173346e-58	0.427702280594557	0.826	0.789	3.0812871383362e-54	SRSF7	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61467
2.14704383693233e-58	-0.260556272857234	0.24	0.373	4.39156346406138e-54	CD63	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61468
1.31005007625004e-57	-0.255489803363892	0.704	0.792	2.67957642596184e-53	ARPC2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61469
1.6499506491062e-57	0.331236520974763	0.393	0.274	3.37480905768181e-53	GLS	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000115419	2744	glutaminase	GAC|GAM|GLS1|KGA|KIAA0838	protein_coding	O94925	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61470
2.03095320684556e-57	0.328898147841335	0.924	0.839	4.15411168928191e-53	JUNB	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61471
2.95710709952976e-57	-0.281313868237012	0.386	0.513	6.04846686137817e-53	APOBEC3G	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61472
4.08192494381168e-55	0.287013811802427	0.369	0.249	8.34916928007241e-51	RAB8B	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000166128	51762	RAB8B, member RAS oncogene family	NA	protein_coding	Q92930	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61473
7.86087939517114e-55	0.267785888787607	0.325	0.203	1.60786427148831e-50	KDM6B	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61474
1.19977578998435e-54	-0.254535398558678	0.534	0.657	2.45402140083399e-50	LIMD2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61475
3.41704007059113e-54	0.400531507255443	0.515	0.411	6.9892137603871e-50	ZC3HAV1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61476
5.39286301534879e-54	0.267666006344591	0.305	0.19	1.10305620115944e-49	GOLGB1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61477
8.63017193878543e-54	0.345790771012368	0.473	0.356	1.76521536835917e-49	SYNE2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61478
3.79736753628581e-53	0.306427447605107	0.631	0.541	7.767135558719e-49	EIF4G2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61479
4.60566044206145e-53	-0.34996400674135	0.176	0.29	9.4204178681925e-49	PMAIP1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61480
2.35633205373538e-52	0.264907176050225	0.349	0.232	4.81964158271034e-48	ATF7IP	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000171681	55729	activating transcription factor 7 interacting protein	ATF7IP1|FLJ10688|p621	protein_coding	Q6VMQ6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61481
3.53120055856384e-52	0.263990514369313	0.432	0.313	7.22271762248648e-48	NFATC2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000101096	4773	nuclear factor of activated T cells 2	NF-ATP|NFAT1|NFATp	protein_coding	Q13469	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61482
1.93582095268891e-51	-0.308297236812098	0.583	0.683	3.9595281766299e-47	HLA-DRB1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61483
9.40883447851788e-51	0.349684742635098	0.919	0.863	1.92448300423605e-46	ZFP36	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61484
6.30651699672352e-49	-0.261029199552687	0.405	0.534	1.28993498650983e-44	HERPUD1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61485
7.77739176089424e-49	0.250273405199084	0.392	0.279	1.59078771077331e-44	SERINC1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61486
1.24275026936802e-48	0.311839642099323	0.362	0.247	2.54192140096535e-44	NFKBIZ	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61487
3.52817294046816e-48	0.250164707750889	0.457	0.34	7.21652493243357e-44	SLC38A1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61488
1.01831605191896e-47	-0.258024830919277	0.682	0.766	2.08286365259504e-43	S100A4	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61489
1.57389519180924e-47	0.272385331134609	0.644	0.544	3.21924522532662e-43	TAGLN2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61490
2.26270576347826e-47	0.292550770870084	0.448	0.345	4.62813836861844e-43	TCP1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000120438	6950	t-complex 1	CCT1|Ccta|D6S230E	protein_coding	P17987	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61491
2.36135628946962e-47	0.328224818783208	0.631	0.551	4.82991815448116e-43	ELF1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61492
4.18392402780381e-47	0.292461036129993	0.622	0.536	8.5577982064699e-43	STK17A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61493
1.63462905672608e-46	0.512906962202907	0.973	0.981	3.34347027262752e-42	HSP90AA1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61494
4.11485457174384e-46	0.255637160973	0.335	0.226	8.41652354104486e-42	ZFAND2A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61495
6.80694588575672e-45	0.332722075636228	0.725	0.665	1.39229271147268e-40	MCL1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61496
1.68149264751969e-44	-0.302842912300528	0.426	0.557	3.43932506123678e-40	UBE2S	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61497
6.10694807880109e-42	0.335426207847521	0.464	0.377	1.24911516003797e-37	RPL36A	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61498
1.04212731716591e-41	0.319649042631103	0.579	0.498	2.13156721453115e-37	HNRNPU	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61499
1.23081576699222e-41	0.287311229260631	0.45	0.347	2.51751056980588e-37	SKIL	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61500
2.67884689538456e-40	0.261211883076182	0.61	0.53	5.47931343981958e-36	SF1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61501
3.3403623471489e-40	0.417097255372719	0.623	0.588	6.83237714485835e-36	DNAJB6	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61502
4.01644308024945e-39	0.291386952753417	0.45	0.347	8.21523267634223e-35	PIK3R1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61503
4.85926970274746e-38	-0.264545844163782	0.269	0.374	9.93915024999965e-34	TRBC1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61504
1.9667671488471e-36	0.308196368940797	0.831	0.797	4.02282552625186e-32	HSPE1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61505
3.43457115619413e-36	-0.265248364814862	0.249	0.355	7.02507184287947e-32	LGALS1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61506
4.69298542051541e-36	0.252228019261144	0.446	0.352	9.59903237912222e-32	PPP2R5C	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61507
1.61948868145919e-35	0.264925992771578	0.458	0.378	3.31250214905662e-31	TRA2B	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61508
7.85150740277359e-35	0.265939596543774	0.519	0.44	1.60594732416331e-30	DDX17	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61509
6.21110823802753e-33	0.313509978268024	0.701	0.647	1.27042007900615e-28	FUS	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61510
1.5130264311338e-32	0.301534545804425	0.637	0.58	3.09474426224108e-28	IRF1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61511
4.7594622543956e-32	-0.260273026125163	0.407	0.5	9.73500409514076e-28	HLA-DRA	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61512
8.94200935894694e-32	-0.288835407402388	0.165	0.253	1.82899859427901e-27	STMN1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61513
2.11458607206067e-29	0.275477626191882	0.512	0.446	4.32517435179289e-25	GNG2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000186469	54331	G protein subunit gamma 2	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61514
8.25141500047203e-25	0.26593746073364	0.496	0.435	1.68774442419655e-20	FAM177A1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61515
9.12833848075591e-25	0.348108235851572	0.442	0.374	1.86711035285381e-20	RANBP2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61516
2.05690891649331e-24	0.251641464265177	0.899	0.879	4.20720149779542e-20	DNAJA1	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61517
3.0908919963709e-24	0.269664311601074	0.779	0.777	6.32211048937703e-20	RPL38	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61518
9.26385669162515e-23	0.313016950708326	0.861	0.824	1.89482924770501e-18	NR4A2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61519
4.67129962071265e-22	0.34364451532547	0.404	0.348	9.55467624420565e-18	CEMIP2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000135048	23670	cell migration inducing hyaluronidase 2	TMEM2	protein_coding	Q9UHN6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61520
5.13862102317681e-22	0.374133114313243	0.551	0.519	1.05105354408058e-17	AC016831.7	CD8+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61521
8.71135302791038e-18	0.278986275552821	0.928	0.955	1.78182014832879e-13	RPS21	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61522
2.41651887032769e-17	0.274643603104979	0.488	0.448	4.94274769736825e-13	PDE4B	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61523
6.01321822797248e-17	0.251516758891961	0.396	0.337	1.22994365634949e-12	TSPYL2	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61524
7.71503236832664e-14	0.286329709409294	0.622	0.604	1.57803272061753e-09	HSPA5	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61525
2.32727166673481e-13	0.317609921445687	0.267	0.215	4.76020146713938e-09	IFNG	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000111537	3458	interferon gamma	NA	protein_coding	P01579	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61526
9.00174945322502e-12	0.355975303263516	0.738	0.747	1.84121783316264e-07	EZR	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61527
1.70214582065187e-08	-0.26160008620051	0.531	0.572	0.000348156906156133	TUBA1B	CD8+ T cells	GSE169246_PacTissue_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61528
9.43085805447033e-224	-0.73028155846704	0.863	0.972	1.92898770646136e-219	IFITM1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61529
6.79267343802705e-202	0.961986158594088	0.788	0.531	1.38937342501405e-197	KLF6	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61530
3.48199408793938e-199	-0.505512719933334	0.996	0.999	7.12207070747122e-195	HLA-C	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61531
3.47019538523632e-186	-0.512254424073662	0.992	0.999	7.09793764096237e-182	RPL28	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61532
3.60593212895086e-170	0.864516003034113	0.999	0.999	7.37557357655609e-166	MALAT1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61533
4.13644137211909e-164	-0.552563960355718	0.908	0.98	8.46067718253238e-160	RPL41	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61534
1.60437948448054e-157	0.617472944325898	0.692	0.362	3.2815977975565e-153	FOS	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61535
4.28936068729846e-150	0.422884680789439	0.27	0.052	8.77345834980027e-146	IGLV2-23	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000211660	NA	NA	NA	IG_V_gene	P01705	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61536
7.6661656573593e-144	-0.475950547238131	0.991	0.999	1.56803752355627e-139	TMSB4X	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61537
1.52741796633124e-139	-0.519153389339711	0.978	0.998	3.12418070833393e-135	RPS3	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61538
2.06863689916472e-139	-0.725240135467718	0.272	0.554	4.23118991355151e-135	ISG15	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61539
6.6964856435621e-136	0.71525150447163	0.799	0.553	1.36969917353419e-131	JUN	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61540
2.37174749203631e-129	0.386550921186761	0.297	0.084	4.85117232021106e-125	IGLV3-1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000211673	NA	NA	NA	IG_V_gene	P01715	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61541
8.31668558326384e-124	0.847942492561652	0.832	0.709	1.70109486920079e-119	TNFAIP3	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61542
1.20387425350183e-122	-0.369055221953666	0.96	0.993	2.46240439811264e-118	TMSB10	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61543
4.70975022212491e-122	-0.355956837795138	0.999	1	9.63332310433429e-118	HLA-B	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61544
2.03555325047914e-120	-0.61562977380749	0.181	0.422	4.16352061853004e-116	MX1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61545
5.68860546574677e-115	-0.438980741930768	0.71	0.87	1.16354736196384e-110	RAC2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61546
7.55729332866854e-111	-0.579781873846001	0.45	0.674	1.54576877744586e-106	LY6E	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61547
1.10394121269765e-109	0.84832734307231	0.631	0.45	2.25800135645178e-105	SLC2A3	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61548
1.96070935286368e-108	-0.423774311842064	0.985	0.998	4.01043491034736e-104	RPL19	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61549
4.80144686569761e-107	0.763117672891473	0.743	0.539	9.82087941909789e-103	HSPA1B	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61550
1.36899208769096e-103	-0.38922125071099	0.957	0.991	2.80013641616308e-99	RPL12	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61551
3.00055289387215e-98	-0.390126771234195	0.953	0.991	6.13733088912609e-94	RPL14	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61552
7.2527131185941e-98	-0.483456330901746	0.22	0.456	1.48346994127724e-93	IFI6	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61553
3.38831326599462e-96	-0.372657520233647	1	1	6.9304559542654e-92	EEF1A1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61554
8.25561844723736e-96	0.655470597552722	0.786	0.627	1.68860419719793e-91	HSPA1A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61555
9.60855764576429e-94	0.968379953109867	0.706	0.624	1.96533438086463e-89	HSPH1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61556
5.62501222753941e-92	-0.432131679956336	0.946	0.988	1.15054000102091e-87	PFN1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61557
3.77071148281023e-90	-0.361701902167766	0.975	0.997	7.71261326694004e-86	RPS15	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61558
1.03428392248606e-89	-0.576816597299003	0.527	0.715	2.11552433505298e-85	CD7	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61559
2.46948268209759e-88	-0.433696198131874	0.69	0.849	5.0510798779624e-84	IFITM2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61560
2.49582681417532e-87	-0.40133179306805	0.987	0.996	5.1049641657142e-83	RPS2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61561
2.79401430029468e-87	-0.324195243171059	0.958	0.996	5.71487684982274e-83	FAU	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61562
1.44142954586805e-86	-0.315068414771178	0.081	0.254	2.94829999311851e-82	IFI44L	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61563
3.52919207702337e-86	-0.415506504575648	1	1	7.2186094743436e-82	ACTB	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61564
4.19712804757782e-86	-0.442550147614447	0.995	0.999	8.58480570851567e-82	RPL13	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61565
2.74169780101171e-85	-0.367684340861731	0.515	0.735	5.60786868218935e-81	PPDPF	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61566
1.8479597891043e-84	-0.369538709423859	0.948	0.991	3.77981695263394e-80	RPL29	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61567
4.25156247204735e-83	0.578636896031562	0.791	0.62	8.69614588032564e-79	NR4A2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61568
7.42228617526487e-83	-0.418083293178365	0.883	0.964	1.51815441428868e-78	RPL9	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61569
1.29081687317178e-82	-0.34733240212441	0.994	0.999	2.64023683238556e-78	TPT1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61570
1.77189883193494e-82	-0.367292884044735	0.978	0.997	3.62424187083974e-78	RPL11	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61571
2.06795054276226e-82	-0.285868750532781	0.993	0.998	4.22978604016593e-78	PTMA	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61572
2.18045665433303e-82	0.634951959548953	0.859	0.811	4.45990604077279e-78	PTPRC	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61573
5.72119839314348e-82	-0.3649393477868	0.154	0.339	1.17021391933357e-77	GIMAP4	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61574
4.43616115031003e-81	-0.346692687769243	0.963	0.994	9.07372401684414e-77	RPL18	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61575
8.0022388618129e-81	-0.312704765042117	0.962	0.99	1.63677793679521e-76	RPS24	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61576
7.25389838464684e-80	-0.318024334819247	0.227	0.43	1.48371237559566e-75	SMDT1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61577
5.99582087084917e-79	0.387768282339055	0.81	0.615	1.22638520092349e-74	DUSP1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61578
2.19311485379722e-78	0.372875138262173	0.296	0.128	4.48579712195683e-74	IGLV2-14	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000211666	NA	NA	NA	IG_V_gene	P01704	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61579
9.4736994514229e-78	-0.324698465764589	0.997	1	1.93775048579404e-73	RPLP1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61580
2.61472746058307e-76	-0.295571145134382	0.95	0.991	5.34816354787662e-72	RPL15	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61581
2.91083146784951e-76	-0.388012637984805	0.368	0.565	5.95381468433939e-72	RARRES3	CD4+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61582
1.43330928012702e-75	-0.31931423930713	0.776	0.901	2.93169080157181e-71	BTF3	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61583
2.53631838155432e-75	-0.499474928393482	0.979	0.994	5.1877856176312e-71	FTH1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61584
3.20342724494854e-75	-0.317516932958628	0.847	0.936	6.55229008681775e-71	CFL1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61585
7.32139150142592e-75	-0.333696079159647	0.949	0.986	1.49751741770166e-70	RPS9	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61586
2.21207387759226e-74	-0.392026149279415	0.991	0.998	4.52457590922721e-70	RPS12	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61587
6.08585201298881e-74	-0.361473696546438	0.68	0.827	1.24480017073673e-69	MYL12A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61588
7.41893581586379e-74	0.570713887572255	0.495	0.316	1.51746913177678e-69	MYADM	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61589
1.31171698803606e-73	-0.357216746276228	0.983	0.998	2.68298592732895e-69	RPS19	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61590
1.74071462699554e-73	-0.317106953449469	0.929	0.982	3.56045769805667e-69	RPS16	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61591
3.31175195409842e-73	0.626987033891656	0.907	0.921	6.77385744691291e-69	RPS29	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61592
8.94450394277038e-73	-0.291347112310251	0.807	0.933	1.82950883645425e-68	SERF2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61593
1.52207642636305e-72	-0.380030944860418	0.983	0.996	3.11325512248298e-68	RPL32	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61594
3.57590718884486e-72	-0.326566916812128	0.968	0.992	7.31416056406328e-68	RPL7A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61595
8.0448962658925e-72	-0.327466050758286	0.146	0.319	1.64550308222565e-67	XAF1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61596
1.83572221316325e-71	-0.299692163281614	0.573	0.765	3.75478621480411e-67	PSME1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61597
7.50919813830031e-71	-0.372939050585865	0.977	0.997	1.53593138720795e-66	RPS14	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61598
2.4739469002972e-70	0.516149482535882	0.413	0.257	5.0602109898679e-66	IGKV3-20	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000282402	NA	NA	NA	IG_V_gene	P01619	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61599
5.43814653629148e-70	-0.343098408046268	0.847	0.935	1.11231849253306e-65	SH3BGRL3	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61600
1.6094515955067e-69	-0.345624915475882	0.978	0.997	3.29197229344941e-65	RPS23	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61601
2.93591433334328e-69	-0.334938865121768	0.845	0.931	6.00511917742034e-65	EEF1D	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61602
4.19861292239285e-69	-0.347109307334138	0.985	0.996	8.58784287146233e-65	RPS4X	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61603
5.23908609381265e-69	-0.334901644509224	0.963	0.991	1.07160266962844e-64	RPS25	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61604
5.7764472375661e-69	0.427688790518757	0.456	0.269	1.18151451797177e-64	FOSB	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61605
7.16492659097342e-69	-0.359705319586294	0.98	0.996	1.4655140849177e-64	RPL18A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61606
3.84933168030709e-68	0.518462727111205	0.417	0.253	7.87342301890011e-64	RNF19A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61607
8.52103812563581e-68	-0.342829517544442	0.46	0.649	1.74289313821755e-63	PSMB9	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61608
2.96970860786188e-66	-0.329725747279013	0.78	0.894	6.07424198652069e-62	PTPRCAP	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61609
1.0972488232935e-64	-0.44290230756901	0.271	0.437	2.24431274316452e-60	GIMAP7	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61610
1.04911325675625e-63	0.575940227076316	0.948	0.934	2.14585625536922e-59	HSP90AB1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61611
2.46763426781564e-63	-0.448403904116517	0.926	0.962	5.04729913139011e-59	GAPDH	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61612
2.65032813080437e-63	-0.44928534683624	0.415	0.587	5.42098115874725e-59	ISG20	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61613
3.57222442563762e-63	-0.317743512504486	0.989	0.998	7.30662784019918e-59	RPL30	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61614
4.25605825979639e-63	0.501747474148004	0.585	0.44	8.70534156458754e-59	TAGAP	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61615
5.95467434232813e-63	-0.312458188465615	0.884	0.967	1.2179690899798e-58	NACA	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61616
1.63043982243078e-62	0.755703614679557	0.756	0.713	3.33490161279992e-58	HSPD1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61617
1.72210077049596e-62	-0.303033004796914	0.23	0.407	3.52238491597245e-58	UBE2L6	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61618
3.6878353903762e-62	-0.255320537256843	0.132	0.289	7.54309850747548e-58	IGKV4-1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000211598	NA	NA	B3|IGKV41	IG_V_gene	P06312	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61619
9.02565808222047e-62	-0.310801069485962	0.599	0.778	1.84610810413737e-57	CD3D	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61620
7.94103879490338e-61	-0.263744661262514	0.349	0.544	1.62426007510954e-56	APRT	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000198931	353	adenine phosphoribosyltransferase	NA	protein_coding	P07741	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61621
1.41863861172153e-60	-0.276918873692204	0.739	0.878	2.90168341641521e-56	RPL36AL	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61622
2.50278547413472e-60	-0.319169777309878	0.25	0.429	5.11919740879516e-56	IGKV3-11	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000282823	NA	NA	NA	IG_V_gene	P04433	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61623
3.44292332409745e-59	-0.366771602248356	0.986	0.995	7.04215536710892e-55	RPS18	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61624
3.79764276235026e-59	-0.305838256825681	0.998	1	7.76769850611122e-55	RPL10	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61625
1.25172622941211e-58	-0.340397763178145	0.958	0.988	2.56028082963953e-54	RPS13	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61626
3.58694520404647e-58	0.437201810915626	0.513	0.378	7.33673772035665e-54	CCNL1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61627
4.1033401746914e-58	-0.279493809542897	0.311	0.491	8.39297199331378e-54	DRAP1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61628
4.37528576473187e-58	-0.286508737929669	0.972	0.996	8.94920950318257e-54	RPL8	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61629
5.58194720957479e-58	-0.452384407169437	0.774	0.814	1.14173148224643e-53	CREM	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61630
6.18026188083804e-58	-0.274220030990671	0.939	0.98	1.26411076510661e-53	RACK1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61631
3.15529529435548e-57	-0.31802135064202	0.987	0.995	6.45384099507469e-53	RPS27A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61632
1.75559433818558e-56	-0.287388546358655	0.986	0.998	3.59089265932478e-52	RPS15A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61633
2.15037648865709e-56	-0.277517198456943	0.971	0.993	4.39838006989921e-52	RPL26	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61634
6.15927727389722e-56	0.471186932644284	0.671	0.582	1.25981857360294e-51	CD44	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61635
8.47331774505228e-56	-0.271751882853951	0.264	0.433	1.73313241157299e-51	SHISA5	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000164054	51246	shisa family member 5	hShisa5|SCOTIN	protein_coding	Q8N114	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61636
1.29840222386934e-55	0.528401142681333	0.558	0.406	2.65575190870235e-51	CD69	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61637
1.33562651415496e-55	-0.339613032922259	0.979	0.994	2.73189047205255e-51	RPS6	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61638
1.65533368732222e-55	-0.264093161821688	0.753	0.868	3.38581952404887e-51	COX4I1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61639
2.15710788448442e-54	-0.370599188406341	0.288	0.46	4.41214846692443e-50	UBE2S	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61640
3.30736656890295e-54	0.280583306001462	0.264	0.129	6.76488758003409e-50	GPR174	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000147138	84636	G protein-coupled receptor 174	FKSG79	protein_coding	Q9BXC1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61641
1.80307384773334e-53	0.382289543523724	0.365	0.22	3.68800724815377e-49	PTGER4	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61642
2.33572964154045e-53	-0.294265290870763	0.392	0.567	4.77750140880683e-49	AES	CD4+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61643
2.51481104126289e-53	-0.262552686221476	0.9	0.971	5.14379450379912e-49	RPL24	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61644
3.49775486858487e-53	-0.279416153572268	0.956	0.987	7.1543078082035e-49	RPL6	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61645
5.02355410360915e-53	-0.257063740891124	0.183	0.34	1.02751775635221e-48	IRF7	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61646
5.96130653229889e-53	-0.295081644212918	0.792	0.898	1.21932563811641e-48	MYL6	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61647
3.24714872368064e-52	-0.259546165415044	0.819	0.92	6.64171799941637e-48	CD3E	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61648
3.28467504568968e-52	-0.357315354218692	0.979	0.994	6.71847433845367e-48	RPS3A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61649
4.09435216094144e-52	-0.263713663695381	0.431	0.608	8.37458790998962e-48	TPI1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61650
9.01518059719208e-52	0.414318749700348	0.339	0.193	1.84396503934967e-47	NR4A1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61651
1.26902626582598e-51	-0.272568937418579	0.787	0.89	2.59566632412045e-47	FXYD5	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61652
1.3007577403368e-51	-0.266650947687213	0.554	0.721	2.66056988208489e-47	MYL12B	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61653
5.45961449121246e-51	0.327136963113923	0.278	0.145	1.1167095480326e-46	XIST	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61654
1.91457580921466e-50	-0.300972802776093	0.914	0.959	3.91607336016766e-46	RPSA	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61655
2.00983880508435e-50	-0.279627302372478	0.84	0.941	4.11092429191954e-46	RPL22	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61656
3.06501829814158e-50	0.4240500946507	0.469	0.332	6.26918842701879e-46	ITGB1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61657
1.02517505069683e-49	-0.260246030911393	0.963	0.981	2.0968930486953e-45	RPLP0	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61658
1.71626984960421e-49	0.382567022723187	0.358	0.222	3.51045835038045e-45	IGHG1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61659
2.61034804155619e-49	-0.276783210676635	0.441	0.607	5.33920588419903e-45	PSME2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61660
3.36276851120742e-49	0.376430816614846	0.341	0.205	6.87820671282366e-45	RALGAPA1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000174373	253959	Ral GTPase activating protein catalytic subunit alpha 1	DKFZp667F074|GARNL1|GRIPE|KIAA0884|RalGAPalpha1|Tulip1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61661
3.4012873288643e-49	-0.275387980197021	0.928	0.974	6.95699310245903e-45	RPL23A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61662
6.14419974299789e-49	0.519746351047406	0.514	0.373	1.25673461543279e-44	LMNA	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61663
1.7254285126056e-48	0.335994593522238	0.409	0.269	3.5291914796835e-44	SERINC1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61664
3.87157020792178e-48	-0.277284805840391	0.519	0.681	7.9189097032832e-44	LDHB	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61665
6.61015879250808e-48	0.60604039015594	0.502	0.386	1.3520418794196e-43	NEAT1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61666
1.00439579476593e-47	0.283948503338569	0.284	0.153	2.05439115861424e-43	ZNF267	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000185947	10308	zinc finger protein 267	HZF2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61667
1.95790513137362e-47	-0.298943292134219	0.917	0.97	4.00469915571159e-43	RPL5	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61668
2.14027080808169e-47	-0.265002965563072	0.168	0.312	4.37770991085029e-43	TYMP	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61669
3.52754048299119e-47	-0.33775101052184	0.547	0.684	7.21523130391018e-43	ARPC1B	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61670
3.98386618994676e-47	-0.270414442875191	0.222	0.373	8.1485999049171e-43	DNPH1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000112667	10591	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	C6orf108|dJ330M21.3|rcl	protein_coding	O43598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61671
5.60335814521567e-47	0.32870552837795	0.363	0.228	1.14611087502241e-42	CDK17	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000059758	5128	cyclin dependent kinase 17	PCTAIRE2|PCTK2	protein_coding	Q00537	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61672
5.65630019883474e-47	-0.253917749368171	0.305	0.465	1.15693964266966e-42	C9orf16	CD4+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61673
7.8873445095411e-47	-0.339434988282517	0.975	0.987	1.61327744598154e-42	RPL3	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61674
1.07773424889572e-46	0.391391681885095	0.628	0.54	2.2043976326913e-42	RBM39	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61675
2.49845308470418e-46	-0.295415182436864	0.986	0.998	5.11033593945394e-42	RPS8	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61676
2.69164733549e-46	-0.255871441544463	0.341	0.504	5.50549546001125e-42	CALM3	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61677
6.56553935508532e-46	0.401987126538376	0.629	0.536	1.34291541968915e-41	STK4	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61678
8.7438225733501e-46	0.432728527272853	0.865	0.766	1.78846146915303e-41	ZFP36	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61679
1.65133409331564e-45	0.385664204531531	0.51	0.378	3.3776387544678e-41	AHNAK	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61680
3.99837640104189e-45	-0.305652398186224	0.316	0.473	8.17827909069108e-41	COX5A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61681
5.91568506114479e-45	0.52084089749423	0.747	0.68	1.20999422240656e-40	EZR	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61682
1.49702594876587e-44	-0.255089781588608	0.895	0.948	3.06201687560571e-40	ARHGDIB	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61683
6.25213340970648e-44	-0.252277522256425	0.663	0.798	1.27881136762136e-39	SOD1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61684
1.16955257120027e-43	0.353632632294601	0.387	0.259	2.39220282913303e-39	CCNH	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61685
1.70323386597678e-43	-0.255059193857548	0.597	0.737	3.48379454946891e-39	SUB1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61686
1.69227706162603e-42	-0.278418664307177	0.448	0.608	3.46138350184989e-38	H2AFZ	CD4+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61687
2.91605259956584e-42	0.261342663871346	0.311	0.184	5.96449398715196e-38	PER1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000179094	5187	period circadian regulator 1	PER|RIGUI	protein_coding	O15534	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61688
2.21503166405942e-41	-0.285411450616516	0.246	0.38	4.53062576566714e-37	WDR74	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61689
1.19102138308299e-40	0.431128902908867	0.559	0.472	2.43611513695795e-36	MBNL1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61690
2.02602162266831e-40	0.265666315186859	0.274	0.155	4.14402462700575e-36	GNA13	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000120063	10672	G protein subunit alpha 13	G13|MGC46138	protein_coding	Q14344	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61691
2.85057159516219e-40	0.362777729718048	0.385	0.261	5.83055914074474e-36	ADGRE5	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61692
3.58040697216105e-40	0.289881850525911	0.417	0.29	7.3233644208582e-36	SLC38A1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61693
7.09636827978511e-40	-0.271352611744729	0.915	0.964	1.45149116794725e-35	RPL21	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61694
2.41865964709159e-39	0.399510542836691	0.323	0.203	4.94712644216115e-35	NR4A3	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000119508	8013	nuclear receptor subfamily 4 group A member 3	CHN|CSMF|MINOR|NOR1	protein_coding	Q92570	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61695
3.94587487681624e-39	0.476994713998559	0.559	0.459	8.07089247303994e-35	REL	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61696
5.67894477058395e-39	0.479844326327206	0.464	0.368	1.16157136337524e-34	CHORDC1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61697
5.83704262473523e-39	-0.298289030090125	0.917	0.958	1.19390869846334e-34	RPS5	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61698
5.30131882480947e-38	0.457412300270044	0.4	0.287	1.08433175242653e-33	RANBP2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61699
6.11807694714773e-38	0.309789967194844	0.432	0.308	1.2513914587696e-33	IQGAP1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61700
1.2220224700839e-37	0.283796642461121	0.266	0.155	2.49952476030961e-33	NFAT5	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000102908	10725	nuclear factor of activated T cells 5	KIAA0827|NF-AT5|NFATL1|NFATZ|OREBP|TONEBP	protein_coding	O94916	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61701
7.92326587629733e-37	0.334094316488856	0.554	0.452	1.62062480233786e-32	BTG2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61702
1.27012309025091e-36	0.315651975639756	0.33	0.217	2.59790976879921e-32	GLS	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000115419	2744	glutaminase	GAC|GAM|GLS1|KGA|KIAA0838	protein_coding	O94925	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61703
2.47304680097086e-36	0.374040674845501	0.389	0.278	5.0583699267058e-32	SLC38A2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61704
3.1245677626977e-36	0.343677180714538	0.436	0.32	6.39099090182188e-32	MBP	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61705
6.37326656560324e-36	-0.257874074789336	0.55	0.677	1.30358794332849e-31	CLIC1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61706
9.62540094588249e-36	0.361027694507885	0.421	0.308	1.9687795094708e-31	SYNE2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61707
1.41402549809897e-35	0.423232803260053	0.958	0.929	2.89224775381164e-31	MT-ATP6	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61708
8.88323571255456e-35	0.414328023365706	0.387	0.276	1.81697703264591e-30	NFKB1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61709
9.18514334691052e-35	0.459782724500731	0.968	0.978	1.87872922017708e-30	HSP90AA1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61710
5.07317875859811e-34	0.262035025740489	0.299	0.187	1.03766798328366e-29	ATP2B1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61711
5.07407938878795e-34	0.285554614259246	0.425	0.312	1.03785219818269e-29	CLK1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61712
1.56190766247785e-33	-0.266694750214133	0.934	0.944	3.19472593283219e-29	ACTG1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61713
1.7209868163207e-33	0.40465347854842	0.394	0.297	3.52010643410235e-29	ITK	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000113263	3702	IL2 inducible T cell kinase	EMT|LYK|PSCTK2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61714
7.47244643224268e-33	0.258135072383422	0.283	0.177	1.52841419325092e-28	GOLGB1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61715
1.65384027539984e-32	0.28634608478984	0.359	0.25	3.38276489930283e-28	CNOT6L	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000138767	246175	CCR4-NOT transcription complex subunit 6 like	Ccr4b|DKFZp434K098	protein_coding	Q96LI5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61716
1.70476388957664e-32	-0.250220278215105	0.908	0.947	3.48692405974006e-28	RPL10A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61717
4.08510389198731e-32	0.327058386010164	0.616	0.535	8.35567150067085e-28	SAMSN1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61718
8.26008879511446e-32	0.283499643181905	0.932	0.851	1.68951856215271e-27	JUNB	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61719
8.54924610741763e-32	0.259808388401656	0.295	0.189	1.7486627988112e-27	ATF7IP	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000171681	55729	activating transcription factor 7 interacting protein	ATF7IP1|FLJ10688|p621	protein_coding	Q6VMQ6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61720
8.98572593069636e-32	0.336125067301156	0.507	0.412	1.83794038186463e-27	IDS	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61721
1.68732326254231e-31	0.287813180933198	0.904	0.85	3.45125100120405e-27	DNAJB1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61722
1.76955391824814e-31	0.33020253452711	0.471	0.381	3.61944558438474e-27	SF3B1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61723
1.82290085767545e-31	0.412060912015046	0.709	0.641	3.72856141428937e-27	IL7R	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61724
2.18528784567752e-31	0.354577847592427	0.305	0.201	4.4697877595488e-27	NEU1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000184494	4758	neuraminidase 1	NEU	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61725
4.16952689846843e-31	0.564588905298039	0.567	0.513	8.52835031812733e-27	AC016831.7	CD4+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61726
3.36570349224714e-30	-0.298320417327908	0.319	0.433	6.8842099230423e-26	EPSTI1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61727
4.01191665031693e-30	0.287754816089324	0.54	0.427	8.20597431655826e-26	PPP1R15A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61728
4.72101269062835e-30	0.361316307938283	0.456	0.368	9.65635935741123e-26	ELOVL5	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000012660	60481	ELOVL fatty acid elongase 5	dJ483K16.1|HELO1|SCA38	protein_coding	Q9NYP7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61729
1.12418710251136e-29	0.300928175040254	0.329	0.228	2.29941229947673e-25	STAT4	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000138378	6775	signal transducer and activator of transcription 4	NA	protein_coding	Q14765	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61730
1.14408324541167e-29	0.406936157100437	0.559	0.493	2.34010787016503e-25	EML4	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61731
2.66763440657894e-29	0.305409341680259	0.371	0.266	5.45637941521656e-25	TXNIP	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61732
7.79396546613565e-29	0.340214830606055	0.433	0.341	1.59417769644339e-24	CHD2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61733
2.7456976511836e-28	0.279192861746892	0.653	0.598	5.61604997573093e-24	SON	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61734
4.02305033395906e-28	0.259148739791753	0.402	0.307	8.22874715307987e-24	MATR3.1	CD4+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61735
1.52725592136074e-27	0.359089405945379	0.498	0.414	3.12384926155127e-23	PDE4B	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61736
1.56658684844612e-27	0.369240366431641	0.29	0.197	3.2042967398117e-23	SESN3	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000149212	143686	sestrin 3	MGC29667|SEST3	protein_coding	P58005	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61737
3.20361410234706e-27	0.327699853677307	0.753	0.71	6.55267228494067e-23	SRSF7	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61738
1.03740566774956e-26	0.298136937658686	0.86	0.847	2.12190955281494e-22	HNRNPA2B1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61739
5.66893617742153e-26	0.293111744891848	0.464	0.38	1.1595242057298e-21	GPBP1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000062194	65056	GC-rich promoter binding protein 1	DKFZp761C169	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61740
1.02491274939473e-25	0.281554956295096	0.34	0.241	2.09635653761199e-21	PIK3R1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61741
1.97256401919604e-25	0.301189435980686	0.574	0.517	4.03468244486358e-21	EIF4G2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61742
2.46245020944547e-25	0.319996314600599	0.596	0.537	5.03669565839976e-21	ELF1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61743
4.47445731614704e-25	0.265299965261628	0.355	0.259	9.15205499444715e-21	RORA	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61744
2.30856789613521e-24	0.261940419650651	0.299	0.209	4.72194477475496e-20	IGKC	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61745
2.97310774887891e-24	0.31271399086557	0.392	0.307	6.08119458955693e-20	KIAA1551	CD4+ T cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61746
3.00699985142872e-24	0.335461365708123	0.542	0.474	6.15051749611231e-20	DDX3X	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61747
2.16092822411663e-22	0.323332989123054	0.38	0.294	4.41996258960816e-18	ITGA4	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61748
7.31755906133852e-22	0.259867481514055	0.261	0.178	1.49673353040618e-17	GPCPD1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61749
2.88299966804979e-21	0.312776483360626	0.569	0.523	5.89688752102905e-17	HNRNPU	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61750
3.35639018692874e-21	0.295847689974418	0.586	0.529	6.86516048834404e-17	LCP1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61751
5.2569913528084e-21	0.256243564434225	0.653	0.596	1.07526501130343e-16	MCL1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61752
1.14604480284239e-20	0.288508073760719	0.619	0.574	2.34412003973382e-16	STK17B	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61753
4.40865153780444e-20	0.352270389707894	0.479	0.404	9.01745585542519e-16	ITM2A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61754
6.07546363227198e-20	0.273782965233085	0.558	0.452	1.24267533134491e-15	ANXA1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61755
8.58167186181201e-20	0.324703754215347	0.54	0.453	1.75529516261503e-15	KLF2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61756
1.13515023757503e-18	0.266704015928307	0.63	0.6	2.32183629593597e-14	SF1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61757
1.12308430662595e-17	-0.289539589742293	0.304	0.383	2.29715664077271e-13	ALOX5AP	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61758
1.39111496053671e-17	0.269819221219885	0.391	0.322	2.8453865402818e-13	CHD1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61759
1.55282295404169e-17	0.288057308883585	0.535	0.499	3.17614407019688e-13	RPL36A	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61760
2.12127739892106e-16	0.338589789065459	0.576	0.518	4.33886079175313e-12	NR3C1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000113580	2908	nuclear receptor subfamily 3 group C member 1	GR|GRL	protein_coding	P04150	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61761
5.5237587238343e-16	0.261194390999593	0.588	0.554	1.12982960937307e-11	ANKRD12	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61762
8.01395189209756e-16	0.304478185166002	0.455	0.403	1.63917372000963e-11	ZC3HAV1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61763
1.09064764892997e-15	0.315224162334736	0.295	0.23	2.23081070112136e-11	LDLRAD4	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000168675	753	low density lipoprotein receptor class A domain containing 4	C18orf1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61764
1.24508264808445e-14	0.270751844413346	0.341	0.279	2.54669204839193e-10	CEMIP2	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000135048	23670	cell migration inducing hyaluronidase 2	TMEM2	protein_coding	Q9UHN6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61765
5.2804335699923e-14	-0.290894185715619	0.353	0.426	1.08005988240622e-09	BATF	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000156127	10538	basic leucine zipper ATF-like transcription factor	B-ATF|BATF1|SFA-2	protein_coding	Q16520	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61766
1.02675475877824e-13	0.312784705377615	0.554	0.514	2.10012418360501e-09	ZNF331	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61767
1.16811218542878e-13	0.262017352471438	0.492	0.451	2.38925666407602e-09	FAM177A1	CD4+ T cells	GSE169246_PacTissue_pre	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61768
2.79811995027049e-134	-1.21773666365469	0.966	0.988	5.72327454628326e-130	RPL41	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61769
1.37707103147631e-128	1.30641332259197	0.86	0.462	2.81666108778165e-124	S100A6	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61770
1.77107952028653e-119	1.11855970461506	0.978	0.914	3.62256605079408e-115	VIM	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61771
5.66350228739223e-113	0.978591725523246	0.787	0.357	1.15841275786321e-108	ANXA2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61772
6.31494912586151e-113	1.69457815122017	0.45	0.115	1.29165969420371e-108	MMP9	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000100985	4318	matrix metallopeptidase 9	CLG4B	protein_coding	P14780	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61773
2.16550564985509e-111	1.41082050316597	0.799	0.426	4.42932525621361e-107	S100A10	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61774
6.54330742468525e-108	0.639856961287995	0.403	0.081	1.33836810064512e-103	AHNAK	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61775
1.17169407702926e-101	1.22565963375848	0.453	0.121	2.39658306515566e-97	NUPR1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61776
2.5679417521308e-88	2.05998647495272	0.531	0.204	5.25246805980833e-84	RNASE1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000129538	6035	ribonuclease A family member 1, pancreatic	RAC1|RNS1	protein_coding	P07998	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61777
7.03651586535186e-88	0.375973854453418	0.325	0.063	1.43924895509907e-83	BCAT1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000060982	586	branched chain amino acid transaminase 1	BCATc|BCT1	protein_coding	P54687	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61778
2.52709890948462e-86	0.392067830573718	0.287	0.048	5.16892810945983e-82	KCNMA1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000156113	3778	potassium calcium-activated channel subfamily M alpha 1	KCa1.1|mSLO1|SLO	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61779
5.81669088646067e-84	-1.08807396497327	0.388	0.758	1.18974595391666e-79	IL1B	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61780
2.14956988286001e-83	1.14389029814162	0.512	0.178	4.39673023840187e-79	PLTP	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000100979	5360	phospholipid transfer protein	BPIFE	protein_coding	P55058	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61781
5.8224748806035e-80	-0.864861494938952	0.579	0.845	1.19092901207864e-75	HLA-DRB5	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61782
1.08456278599e-75	0.672943298525472	0.591	0.234	2.21836472246394e-71	CD44	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61783
1.53374767552783e-75	1.49116017813623	0.805	0.528	3.13712749552462e-71	CSTB	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61784
1.13059078300736e-74	0.470404149021057	0.402	0.112	2.31251038756326e-70	FLNA	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61785
6.83046482193323e-74	0.731257544739696	0.53	0.212	1.39710327467822e-69	TMEM176A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61786
5.86350563587165e-73	0.734070272818437	0.497	0.177	1.19932144276119e-68	LMNA	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61787
2.02054623392663e-72	0.591903953912059	0.477	0.17	4.13282526687352e-68	SNX10	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000086300	29887	sorting nexin 10	NA	protein_coding	Q9Y5X0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61788
1.6066235510271e-70	-0.631014542432565	0.92	0.991	3.28618781127083e-66	SRGN	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61789
2.24110317683289e-67	-1.60397422013431	0.458	0.722	4.58395243789399e-63	CCL4L2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61790
3.57183331168829e-67	-1.07800089214017	0.532	0.785	7.30582785572722e-63	DUSP2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61791
6.85073648507968e-67	1.33240020716338	0.717	0.391	1.4012496406582e-62	LYZ	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61792
6.46802160137372e-64	-1.23241552452108	0.579	0.82	1.32296913834498e-59	CCL4	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61793
4.87675051291225e-63	0.57432428737008	0.718	0.363	9.97490549911072e-59	TSPO	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61794
6.30256638803476e-62	0.939884748946689	0.583	0.278	1.28912692900863e-57	GPNMB	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000136235	10457	glycoprotein nmb	HGFIN|NMB	protein_coding	Q14956	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61795
2.46235202471887e-61	-0.722212026777695	0.699	0.918	5.03649483135998e-57	ZFP36	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61796
4.91981262835356e-61	0.409738337691564	0.259	0.059	1.00629847500344e-56	CPM	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000135678	1368	carboxypeptidase M	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61797
4.38920449275691e-60	0.879895341560506	0.465	0.185	8.97767886948499e-56	ACP5	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000102575	54	acid phosphatase 5, tartrate resistant	HPAP|TRAcP|TRAP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61798
4.38454899757206e-59	0.661189336317231	0.587	0.27	8.96815651963389e-55	TMEM176B	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61799
1.8259665146664e-58	0.468841291309582	0.473	0.182	3.73483190909865e-54	CD99	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61800
3.97102981793176e-57	0.771561754115476	0.358	0.119	8.12234438959763e-53	FBP1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000165140	2203	fructose-bisphosphatase 1	FBP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61801
4.56269179223673e-56	0.463533843419821	0.26	0.064	9.332529791841e-52	MRC1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000260314	4360	mannose receptor C-type 1	bA541I19.1|CD206|CLEC13D|CLEC13DL|MRC1L1	protein_coding	P22897	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61802
1.77702589542352e-55	0.411012745666944	0.468	0.182	3.63472876649926e-51	S100A9	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61803
5.72181043177966e-55	0.279462760548176	0.27	0.069	1.17033910571621e-50	ITGAM	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000169896	3684	integrin subunit alpha M	CD11B|CR3A|MAC-1	protein_coding	P11215	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61804
1.44742206672252e-54	0.392771876668408	0.34	0.107	2.96055709527424e-50	CD59	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000085063	966	CD59 molecule (CD59 blood group)	16.3A5|EJ16|EJ30|EL32|G344|MIC11|MIN1|MIN2|MIN3|MSK21|p18-20	protein_coding	P13987	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61805
9.3279494059737e-53	0.339183156134835	0.283	0.082	1.90793877149786e-48	ATP6V1A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000114573	523	ATPase H+ transporting V1 subunit A	ATP6A1|ATP6V1A1|VA68|Vma1|VPP2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61806
3.92714507545277e-52	0.430203306554513	0.343	0.115	8.03258253733109e-48	SMIM25	Mono/Macro	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61807
7.02840326060574e-52	0.364040216606345	0.334	0.111	1.4375896029243e-47	RAB13	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000143545	5872	RAB13, member RAS oncogene family	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61808
2.21452598653343e-51	-0.723160009719555	0.623	0.787	4.52959145285547e-47	CD83	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61809
4.95086866634818e-51	0.416946410695288	0.517	0.228	1.01265067701486e-46	ATP6V1B2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000147416	526	ATPase H+ transporting V1 subunit B2	ATP6B2|HO57|VATB|Vma2|VPP3	protein_coding	P21281	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61810
5.96300695533493e-51	0.511695091747676	0.691	0.366	1.21967344264421e-46	TAGLN2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61811
1.25308467363992e-50	0.284602051456753	0.268	0.071	2.56305939146308e-46	PLP2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61812
1.52785288685441e-50	0.929751748401215	0.417	0.175	3.12507029477202e-46	CFD	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61813
2.28458209972648e-50	0.360328383692157	0.323	0.106	4.67288422678055e-46	ITGAX	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000140678	3687	integrin subunit alpha X	CD11C	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61814
4.71567611282169e-50	0.497321312583112	0.996	1	9.64544392116549e-46	TMSB10	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61815
6.16108979834381e-50	-0.489492540583549	0.432	0.79	1.26018930735324e-45	IFITM1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61816
6.68619879002485e-50	-0.987354113982602	0.417	0.681	1.36759510051168e-45	CCL3L1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000277796	6349	C-C motif chemokine ligand 3 like 1	D17S1718|G0S19-2|LD78BETA|SCYA3L|SCYA3L1|MGC12815	protein_coding	P16619	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61817
1.16328123371551e-49	-0.726210121610203	0.594	0.805	2.37937543544171e-45	NR4A2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61818
1.77513123778069e-49	0.357649452252392	0.26	0.07	3.63085343375663e-45	ADAM8	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000151651	101	ADAM metallopeptidase domain 8	CD156|CD156A|MS2	protein_coding	P78325	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61819
2.44993676260889e-48	-0.783868460612979	0.59	0.782	5.01110065424022e-44	IER3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61820
9.54826276706283e-48	0.532746854170999	0.977	0.971	1.95300166637503e-43	RPS3A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61821
9.94406887204053e-48	0.511291816229756	0.355	0.127	2.03395984708717e-43	SLC2A3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61822
1.99553027948669e-47	0.403226826622189	0.358	0.136	4.08165763366208e-43	MMP14	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000157227	4323	matrix metallopeptidase 14	MT1-MMP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61823
4.8121445327086e-47	0.298534285239379	0.282	0.087	9.84276042720218e-43	VAT1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000108828	10493	vesicle amine transport 1	FLJ20230|VATI	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61824
5.58565284548467e-47	0.508310395673991	0.677	0.349	1.14248943301543e-42	CTSH	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61825
2.52482613723879e-46	0.568284338517018	0.659	0.359	5.16427938110823e-42	EMP3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61826
3.88159636970748e-46	-0.764725665504007	0.425	0.654	7.93941721459968e-42	RGS1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61827
1.25166522443849e-45	0.419514957314557	0.338	0.127	2.56015605006649e-41	TSPAN4	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000214063	7106	tetraspanin 4	NAG-2|TETRASPAN|TM4SF7|TSPAN-4	protein_coding	O14817	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61828
1.50255411607729e-45	0.380415398444164	0.509	0.226	3.07332418902448e-41	AP1S2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61829
6.35240382694538e-45	0.565870451704587	0.706	0.422	1.29932067876341e-40	ENO1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61830
9.66328614627075e-45	0.278600269717388	0.261	0.078	1.97652854835822e-40	TNS3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000136205	64759	tensin 3	FLJ13732|H_NH0549I23.2|TEM6|TENS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61831
2.84462794956915e-44	0.415435818882741	0.47	0.21	5.81840200804873e-40	LAMP1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61832
4.93668917293818e-44	0.295016560753076	0.395	0.152	1.00975040343278e-39	PLEKHB2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000115762	55041	pleckstrin homology domain containing B2	EVT2|FLJ20783	protein_coding	Q96CS7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61833
3.1741548026126e-43	0.410565110597415	0.275	0.09	6.49241623326381e-39	NR1H3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000025434	10062	nuclear receptor subfamily 1 group H member 3	LXR-a|LXRa|RLD-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61834
3.71205421595478e-43	-0.457960609322208	0.058	0.314	7.59263569331392e-39	OLFML3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000116774	56944	olfactomedin like 3	HNOEL-iso|OLF44	protein_coding	Q9NRN5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61835
7.72520077859578e-43	0.411011316691877	0.382	0.144	1.58011256725398e-38	FN1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61836
1.03736849513333e-42	0.611390844888431	0.938	0.887	2.12183351994571e-38	MT-ND4	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61837
1.34332490579044e-42	-0.471622133478639	0.667	0.895	2.74763676230377e-38	C1QB	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000173369	713	complement C1q B chain	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61838
3.89597279232823e-42	0.475822515979373	0.457	0.211	7.96882274942817e-38	BLVRB	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61839
4.07560648715029e-42	-0.715727944188591	0.605	0.738	8.3362455088172e-38	PPP1R15A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61840
8.4216813576165e-42	0.360035478506003	0.561	0.272	1.72257070488688e-37	CDC42	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61841
1.01408232395992e-41	0.3627049326812	0.569	0.284	2.07420398542762e-37	H2AFY	Mono/Macro	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61842
4.63178206377469e-41	1.36120620741553	0.275	0.096	9.47384703324475e-37	SELENOP	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000250722	6414	selenoprotein P	SELP|SeP|SEPP|SEPP1	protein_coding	P49908	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61843
6.09677792600933e-41	-0.971549128895104	0.252	0.504	1.24703495698595e-36	TNF	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000228978	7124	tumor necrosis factor	DIF|TNF-alpha|TNFA|TNFSF2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61844
1.46898975557749e-40	0.346136390283118	0.311	0.109	3.0046716460582e-36	HLA-DQA2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61845
1.50312935014023e-40	0.621910043918471	0.794	0.546	3.07450077277682e-36	CTSS	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61846
1.51629928761575e-40	0.288254260664567	0.37	0.143	3.10143856288925e-36	CAST	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61847
2.29145465585697e-40	0.398757310292936	0.499	0.232	4.68694135308986e-36	LCP1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61848
4.33108816397391e-40	0.646846838355337	0.89	0.786	8.85880773059224e-36	CTSB	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61849
6.9284213292829e-40	-0.488641591854223	0.908	0.975	1.41713929869152e-35	HLA-DPA1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61850
7.35892366923242e-40	0.392423177234801	0.579	0.297	1.5051942473048e-35	GSTO1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61851
9.78714062142025e-40	0.268898090709151	0.331	0.12	2.0018617427053e-35	RBPJ	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61852
7.62473533520806e-39	-0.59976390022281	0.359	0.585	1.55956336546346e-34	TREM2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000095970	54209	triggering receptor expressed on myeloid cells 2	TREM-2|Trem2a|Trem2b|Trem2c	protein_coding	Q9NZC2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61853
7.65786301856774e-39	0.331281336818117	0.477	0.215	1.56633930181785e-34	GNAS	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61854
1.0463450987486e-38	0.543981307777277	0.66	0.4	2.14019426498038e-34	ATOX1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61855
1.60916458813548e-38	-0.687598979835919	0.594	0.802	3.29138524857231e-34	CCL3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61856
2.96542212107734e-38	0.335747169981482	0.305	0.111	6.0654744064516e-34	FAM162A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000114023	26355	family with sequence similarity 162 member A	C3orf28|E2IG5	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61857
3.05904314300583e-38	0.372522264752851	0.624	0.334	6.25696684470413e-34	ARPC5	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61858
5.46995736216839e-38	0.543499847553855	0.752	0.501	1.11882507885792e-33	GLUL	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61859
5.83779007390594e-38	0.268357463669173	0.259	0.086	1.19406158171672e-33	PLXND1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000004399	23129	plexin D1	KIAA0620	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61860
1.22827793338776e-37	0.502848815869873	0.952	0.901	2.51231968495133e-33	SH3BGRL3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61861
3.73188896411172e-37	0.32024796707588	0.439	0.207	7.63320568719411e-33	CD163	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000177575	9332	CD163 molecule	M130|MM130|SCARI1	protein_coding	Q86VB7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61862
9.1969658174399e-37	0.334259483846501	0.409	0.183	1.88114738829916e-32	ADA2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000093072	51816	adenosine deaminase 2	ADGF|CECR1|IDGFL	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61863
9.3883370961419e-37	0.546082566232627	0.631	0.359	1.92029046964487e-32	TXN	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61864
2.52072206408159e-36	-0.629090131631515	0.466	0.66	5.15588490987247e-32	GADD45B	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61865
9.38120743424495e-36	-0.357705925918372	0.999	1	1.91883216860046e-31	CD74	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61866
1.87415753736892e-35	0.342272975055581	0.488	0.232	3.83340182693438e-31	EIF4G2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61867
5.52743557095544e-35	0.349988971864847	0.569	0.299	1.13058167168323e-30	P4HB	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61868
7.9334851821014e-35	0.686278560111296	0.941	0.953	1.62271505914702e-30	MT-ND1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61869
1.03549228298069e-34	0.534587149482246	0.626	0.362	2.11799591560871e-30	ANXA1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61870
1.04550090033946e-34	-0.637995234787475	0.594	0.706	2.13846754155434e-30	IFI30	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61871
1.57986612452044e-34	0.444878579555795	0.787	0.529	3.23145817109411e-30	GPX4	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61872
2.17846192754438e-34	0.397799313173174	0.476	0.244	4.45582602659927e-30	CALM3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61873
2.47501411219416e-34	0.281596527057905	0.422	0.192	5.06239386508194e-30	PEA15	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000162734	8682	proliferation and apoptosis adaptor protein 15	HMAT1|HUMMAT1H|MAT1|MAT1H|PEA-15|PED|PED-PEA15|PED/PEA15	protein_coding	Q15121	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61874
4.60170111993263e-34	-0.314438832635557	0.955	0.996	9.41231947071021e-30	MALAT1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61875
1.45694116782053e-33	0.302433686383207	0.428	0.213	2.9800274646601e-29	HNMT	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000150540	3176	histamine N-methyltransferase	NA	protein_coding	P50135	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61876
6.50315950027287e-33	0.414261356215752	0.52	0.27	1.33015624418581e-28	STAT1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61877
7.52941090281253e-33	0.402686250245764	0.464	0.237	1.54006570606128e-28	PGAM1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61878
1.11071375291244e-32	0.460167325762128	0.637	0.382	2.2718539102071e-28	PGK1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61879
1.63122718736289e-32	0.283301541553286	0.326	0.141	3.33651208903206e-28	NPL	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000135838	80896	N-acetylneuraminate pyruvate lyase	C1orf13|DHDPS1|NPL1	protein_coding	Q9BXD5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61880
5.86907368360419e-32	0.733718619147246	0.933	0.952	1.2004603312444e-27	MT-ATP6	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61881
1.8444194928147e-31	0.366027630792157	0.424	0.225	3.7725756306032e-27	KCTD12	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000178695	115207	potassium channel tetramerization domain containing 12	C13orf2|KIAA1778|PFET1	protein_coding	Q96CX2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61882
2.83426038918418e-31	0.282736811831395	0.413	0.193	5.79719620003732e-27	IQGAP1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61883
2.95638681567473e-31	0.324320914038456	0.355	0.153	6.0469935927811e-27	PDE4DIP	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000178104	9659	phosphodiesterase 4D interacting protein	CMYA2|KIAA0454|KIAA0477|MMGL	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61884
6.25039544065122e-31	0.256541982206829	0.272	0.108	1.2784558834308e-26	DMXL2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000104093	23312	Dmx like 2	DFNA71|KIAA0856|RC3	protein_coding	Q8TDJ6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61885
6.84462236047704e-31	-0.6096989583942	0.303	0.498	1.39999905761197e-26	CREM	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61886
7.34243418342157e-31	0.61346025350645	0.898	0.823	1.50182148787705e-26	MT-ND2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61887
1.4972935083094e-30	0.257356848996429	0.377	0.173	3.06256414189604e-26	RNF13	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000082996	11342	ring finger protein 13	RZF	protein_coding	O43567	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61888
1.56171810228258e-30	0.300409219983645	0.429	0.211	3.1943382064088e-26	CD4	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000010610	920	CD4 molecule	NA	protein_coding	P01730	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61889
1.65275677530509e-30	0.277252595721208	0.415	0.199	3.38054870820904e-26	TKT	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61890
2.46158096204757e-30	0.257076998965776	0.274	0.112	5.03491769977211e-26	BMP2K	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000138756	55589	BMP2 inducible kinase	BIKe|DKFZp434K0614	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61891
4.26184990251877e-30	0.31030350235455	0.341	0.158	8.7171877906119e-26	LRP1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000123384	4035	LDL receptor related protein 1	A2MR|APOER|APR|CD91|IGFBP-3R|IGFBP3R1|LRP|LRP1A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61892
5.83892471990757e-30	0.33687179756953	0.604	0.345	1.19429366220989e-25	FKBP1A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61893
5.86366905397349e-30	0.277179245183994	0.316	0.135	1.19935486829974e-25	CLTC	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61894
9.03489575699594e-30	0.361846870524538	0.385	0.197	1.84799757813595e-25	TNFAIP2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61895
1.00853210977702e-29	-0.32991689472113	0.992	0.999	2.06285157733791e-25	RPL28	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61896
2.0714066747078e-29	-0.326785896171013	0.149	0.373	4.23685521244733e-25	C3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000125730	718	complement C3	ARMD9|C3a|C3b|CPAMD1	protein_coding	P01024	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61897
2.3605658464501e-29	0.573391183052036	0.754	0.611	4.82830138232904e-25	CAPG	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61898
3.02192249142255e-29	0.289504443644772	0.47	0.243	6.18104026395568e-25	PDXK	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61899
3.38059390030965e-29	0.280967182575452	0.395	0.187	6.91466676369336e-25	GPI	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000282019	2821	glucose-6-phosphate isomerase	AMF|NLK	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61900
3.58262604156101e-29	-0.790947998935605	0.358	0.518	7.32790330540889e-25	GPR183	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61901
4.50410972344962e-29	0.311765382131644	0.398	0.192	9.21270602834385e-25	SLIRP	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61902
6.45403351527134e-29	0.363519159531534	0.702	0.449	1.3201080152136e-24	GSTP1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61903
8.7529174390074e-29	0.444338314800524	0.422	0.231	1.79032173297457e-24	ABCA1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000165029	19	ATP binding cassette subfamily A member 1	ABC1|HDLDT1|TGD	protein_coding	O95477	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61904
1.53120082026677e-28	0.253475804182645	0.34	0.151	3.13191815777366e-24	TGOLN2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000152291	10618	trans-golgi network protein 2	TGN38|TGN46|TGN48|TGN51|TTGN2	protein_coding	O43493	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61905
1.82361843838951e-28	0.403686838349829	0.568	0.335	3.7300291538819e-24	IGSF6	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000283934	10261	immunoglobulin superfamily member 6	DORA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61906
2.02768945042268e-28	0.390304252385977	0.803	0.533	4.14743600189455e-24	ANXA5	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61907
2.13751472357829e-28	0.274829664146197	0.384	0.188	4.37207261560704e-24	FPR3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000187474	2359	formyl peptide receptor 3	FMLPY|FPRH1|FPRL2|RMLP-R-I	protein_coding	P25089	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61908
1.21581585342335e-27	0.273761584270258	0.377	0.189	2.48682974659212e-23	NCF2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000116701	4688	neutrophil cytosolic factor 2	NOXA2|p67phox	protein_coding	P19878	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61909
1.41087566317895e-27	0.282893789009417	0.568	0.317	2.88580508146623e-23	ATP5MPL	Mono/Macro	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61910
1.5405355378819e-27	0.398342092140735	0.455	0.265	3.15101138918363e-23	MSR1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000038945	4481	macrophage scavenger receptor 1	CD204|SCARA1|SR-A|SR-AI|SR-AII|SR-AIII	protein_coding	P21757	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61911
2.77268128633893e-27	-0.614873250473386	0.318	0.494	5.67124230307764e-23	ALOX5AP	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61912
3.25866325195582e-27	0.256418946759194	0.351	0.166	6.66526981555044e-23	GNS	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000135677	2799	glucosamine (N-acetyl)-6-sulfatase	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61913
5.81037847012277e-27	-0.323151623576583	0.703	0.908	1.18845481227891e-22	JUNB	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61914
7.2559602964815e-27	0.284054547565865	0.488	0.26	1.48413411904233e-22	C4orf3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61915
1.54923624365586e-26	1.06461709365471	0.638	0.509	3.1688078127737e-22	C15orf48	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61916
2.37814790160725e-26	0.266734268577159	0.315	0.146	4.86426371794746e-22	NRP2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000118257	8828	neuropilin 2	VEGF165R2	protein_coding	O60462	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61917
5.5219357617143e-26	0.290920856474591	0.525	0.295	1.12945674070104e-21	RAB7A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61918
1.92509520517029e-25	0.404503913926802	0.807	0.581	3.93758973265531e-21	CD63	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61919
2.89560522422764e-25	0.405404294266163	0.55	0.325	5.92267092563521e-21	PLD3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000105223	23646	phospholipase D family member 3	HU-K4	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61920
6.03589070514247e-25	0.56880246119047	0.558	0.376	1.23458108482984e-20	LDHA	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61921
1.21550753636668e-24	0.270012957748485	0.429	0.228	2.48619911488441e-20	PSMA6	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000100902	5687	proteasome 20S subunit alpha 6	IOTA|MGC22756|MGC2333|MGC23846|p27K|PROS27	protein_coding	P60900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61922
1.7194055937623e-24	0.438147265718564	0.75	0.512	3.51687220148141e-20	TUBA1B	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61923
1.87415025304471e-24	0.252472746113396	0.514	0.288	3.83338692757765e-20	SEM1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61924
4.82972190406276e-24	0.288734972072654	0.517	0.296	9.87871318256998e-20	ATP5F1B	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61925
7.75185996222745e-24	0.255875711858508	0.314	0.15	1.585565436674e-19	FNDC3B	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000075420	64778	fibronectin type III domain containing 3B	DKFZp762K137|FAD104|FLJ23399|PRO4979|YVTM2421	protein_coding	Q53EP0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61926
8.7282796393483e-24	0.253086495625912	0.319	0.151	1.7852823174323e-19	RALA	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61927
1.15025243510223e-23	0.6323375391343	0.395	0.229	2.35272633075809e-19	KLF4	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61928
2.16709092173591e-23	-0.376121659944591	0.499	0.664	4.43256777131863e-19	CXCL8	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61929
2.27665720623921e-23	0.737777390338141	0.776	0.701	4.65667464964169e-19	S100A4	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61930
4.41313270905083e-23	0.271935759844158	0.622	0.38	9.02662164309256e-19	AP2S1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61931
4.44783360469266e-23	0.251149157262413	0.304	0.149	9.09759885503837e-19	FNIP2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000052795	57600	folliculin interacting protein 2	FNIPL|KIAA1450|MAPO1	protein_coding	Q9P278	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61932
4.86322501102731e-23	0.362631863352909	0.853	0.753	9.94724043755527e-19	CALM1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61933
5.58108771079996e-23	-0.396708148833989	0.889	0.927	1.14155568036702e-18	H3F3A	Mono/Macro	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61934
7.4461081056753e-23	-0.376490902080503	0.715	0.895	1.52302695193483e-18	C1QC	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000159189	714	complement C1q C chain	C1QG	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61935
8.35457558968723e-23	-0.374607363316205	0.678	0.821	1.70884489111463e-18	DDX5	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61936
8.81693445793414e-23	0.361565469776539	0.6	0.382	1.80341577402585e-18	GSN	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61937
1.94026947375308e-22	0.395307484848291	0.721	0.507	3.96862718161456e-18	PKM	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61938
2.09809374421075e-22	-0.484772464464731	0.191	0.361	4.29144094440867e-18	MIR155HG	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000234883	114614	MIR155 host gene	BIC|miPEP155|MIRHG2|NCRNA00172	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61939
2.60043957248958e-22	0.275665536179707	0.308	0.148	5.31893910157019e-18	GBP1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61940
3.42871391725491e-22	0.558475636827929	0.403	0.24	7.01309144635319e-18	LIPA	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000107798	3988	lipase A, lysosomal acid type	CESD|LAL	protein_coding	P38571	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61941
3.84979578087597e-22	0.351639494710075	0.601	0.378	7.87437229020371e-18	FCGR2A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000143226	2212	Fc gamma receptor IIa	CD32|CD32A|CDw32|Fc-gamma-RIIa|FCG2|FcgammaRIIa|FCGR2|FCGR2A1|IGFR2	protein_coding	P12318	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61942
4.02563664064548e-22	-0.492762155748131	0.413	0.574	8.23403718477627e-18	NR4A1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61943
4.03921554806943e-22	0.353449547440113	0.986	0.991	8.26181148202121e-18	RPS18	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61944
5.60193122699785e-22	0.301451285483071	0.414	0.251	1.14581901317014e-17	TIMP2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61945
1.20482678884827e-21	0.288518037340714	0.343	0.177	2.46435271391025e-17	ALDH2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000111275	217	aldehyde dehydrogenase 2 family member	NA	protein_coding	P05091	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61946
1.45365588698104e-21	0.306950343413542	0.413	0.231	2.97330775123101e-17	TUBA1C	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61947
1.49022080771106e-21	0.336785542781881	0.703	0.484	3.0480976400922e-17	SDCBP	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61948
5.16147285934126e-21	0.334584640866833	0.846	0.703	1.05572765864966e-16	CD68	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000129226	968	CD68 molecule	DKFZp686M18236|GP110|LAMP4|SCARD1	protein_coding	P34810	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61949
1.02337463756174e-20	0.2970467195608	0.29	0.139	2.09321048366878e-16	WARS	Mono/Macro	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61950
1.87476839651394e-20	0.348820361834121	0.418	0.239	3.83465127822962e-16	PPIF	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61951
3.34153468244671e-20	-0.377007721283976	0.957	0.979	6.8347750394765e-16	TYROBP	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61952
4.13696326530113e-20	-0.493740047314172	0.172	0.33	8.46174466284693e-16	RBKS	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000171174	64080	ribokinase	DKFZp686G13268|RBSK	protein_coding	Q9H477	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61953
4.93887008064136e-20	0.796644040212298	0.552	0.407	1.01019648629438e-15	IFI27	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61954
5.140502803374e-20	-0.502816985801979	0.777	0.836	1.05143844340212e-15	NFKBIA	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61955
1.68767895604227e-19	0.341535327507154	0.737	0.533	3.45197853668886e-15	NME2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000243678	4831	NME/NM23 nucleoside diphosphate kinase 2	NDPKB|NM23-H2	protein_coding	P22392	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61956
1.73687332622537e-19	0.297715363130265	0.388	0.219	3.55260070146136e-15	TXNIP	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61957
2.64516309149924e-19	-0.268081169220495	0.997	0.999	5.41041658735255e-15	RPL10	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61958
3.07284933792965e-19	0.312388164596046	0.743	0.523	6.2852060358013e-15	ITGB2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61959
6.47162271549602e-19	0.326239951150489	0.29	0.154	1.32370571022756e-14	PMP22	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61960
7.52271286332424e-19	-0.535296945019692	0.341	0.459	1.53869568906434e-14	HERPUD1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61961
7.71870290537003e-19	-0.262589015705168	0.963	0.988	1.57878349226439e-14	HLA-DRB1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61962
2.33250075713155e-18	0.494834345888055	0.437	0.261	4.77089704863688e-14	PLIN2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61963
2.67690680263968e-18	0.471026930834416	0.268	0.137	5.47534517411921e-14	S100A8	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61964
3.40115585301025e-18	0.261712420292911	0.726	0.494	6.95672418174717e-14	BRI3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61965
3.68094862327875e-18	0.375274536796261	0.546	0.371	7.52901231405436e-14	SEC61G	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61966
5.59032430998085e-18	-0.425849209941408	0.305	0.449	1.14344493436348e-13	NR4A3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000119508	8013	nuclear receptor subfamily 4 group A member 3	CHN|CSMF|MINOR|NOR1	protein_coding	Q92570	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61967
6.27705620176713e-18	-0.446501646438883	0.503	0.632	1.28390907550945e-13	BCL2A1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61968
1.03266250909109e-17	0.251509942296783	0.561	0.353	2.11220789609492e-13	SERPINA1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61969
1.10096227743034e-17	-0.564831303472854	0.4	0.497	2.25190824225601e-13	SELENOK	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61970
1.1832215492415e-17	0.691151642871855	0.446	0.311	2.42016135681857e-13	DAB2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000153071	1601	DAB adaptor protein 2	DOC-2	protein_coding	P98082	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61971
2.17892034151333e-17	0.287546416370903	0.354	0.21	4.45676366653136e-13	CPVL	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61972
2.76360818676822e-17	0.266517584878773	0.377	0.218	5.65268418521571e-13	UPP1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000183696	7378	uridine phosphorylase 1	UDRPASE|UP|UPASE|UPP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61973
3.25254376260248e-17	0.313897933588704	0.631	0.426	6.65275301202712e-13	ASAH1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61974
3.42154900855725e-17	0.295632667821631	0.809	0.61	6.99843634210299e-13	GRN	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61975
1.04326205487504e-16	0.26283908748901	0.783	0.624	2.13388820704141e-12	RPL27A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61976
1.24407371647039e-16	-0.288251972421014	0.552	0.653	2.54462837966853e-12	SGK1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61977
2.14493998453885e-16	-0.275043541496025	0.952	0.988	4.38726024437577e-12	H3F3B	Mono/Macro	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61978
2.40119988364216e-16	0.257412740972565	0.693	0.482	4.91141424200167e-12	COX5B	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61979
3.35973801460899e-16	0.28720700850771	0.37	0.219	6.87200813508123e-12	GM2A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000196743	2760	ganglioside GM2 activator	GM2-AP|GM2AP|SAP-3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61980
3.49454387787323e-16	0.377042277098096	0.715	0.543	7.14774004780191e-12	LGALS3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61981
3.6721130127744e-16	0.299610373718318	0.952	0.904	7.51093995632876e-12	MYL6	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61982
3.71945794454272e-16	-0.269800290454659	0.971	0.972	7.60777927976769e-12	CYBA	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61983
5.05300497871488e-16	0.303655546796509	0.254	0.136	1.03354163834634e-11	PAPSS2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000198682	9060	3'-phosphoadenosine 5'-phosphosulfate synthase 2	ATPSK2	protein_coding	O95340	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61984
5.10929867968864e-16	0.472847700152272	0.411	0.28	1.04505595194351e-11	OLR1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000173391	4973	oxidized low density lipoprotein receptor 1	CLEC8A|LOX-1|SCARE1	protein_coding	P78380	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61985
6.32384676695942e-16	0.255932371865747	0.325	0.18	1.29347961771388e-11	IRF1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61986
8.75864490375858e-16	-0.266462666523995	0.338	0.515	1.79149322861478e-11	CXCR4	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61987
1.10294761467572e-15	-0.397573291212224	0.215	0.34	2.25596905105771e-11	MEF2C	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61988
2.26704912039182e-15	-0.327834619682104	0.318	0.461	4.63702227084943e-11	CORO1A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61989
2.61195893616793e-15	2.20212351135029	0.472	0.416	5.34250080803788e-11	SPP1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000118785	6696	secreted phosphoprotein 1	BNSP|BSPI|ETA-1|OPN	protein_coding	P10451	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61990
2.80797045917088e-15	0.279365998494759	0.992	1	5.74342277718812e-11	MT-CO2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61991
3.16007944322015e-15	0.563793319584914	0.732	0.645	6.4636264931625e-11	MIF	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61992
4.37069660356166e-15	-0.259420233975764	0.689	0.769	8.93982283292502e-11	HLA-DQB1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61993
4.78153416996224e-15	-0.537824665555512	0.435	0.49	9.78014999124077e-11	NFE2L2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61994
6.44418926822126e-15	-0.26197239024719	0.977	0.993	1.31809447292198e-10	FAU	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61995
1.17565064174538e-14	0.349926143624003	0.981	0.996	2.40467582262601e-10	MT-CO3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61996
3.07759503230528e-14	-0.47674166576479	0.622	0.62	6.29491287907721e-10	RPL36A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61997
6.3524788975729e-14	0.258295282961534	0.684	0.489	1.29933603370956e-09	TYMP	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61998
9.57758064815397e-14	0.401213130664109	0.961	0.92	1.95899834577341e-09	S100A11	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	61999
1.17393291638203e-13	-0.30510587184152	0.93	0.971	2.4011623871678e-09	RPL6	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62000
1.39867657700021e-13	0.259224763918781	0.717	0.532	2.86085307059624e-09	ATP6V1F	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000128524	9296	ATPase H+ transporting V1 subunit F	ATP6S14|VATF|Vma7	protein_coding	Q16864	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62001
2.03827127060693e-13	-0.306448291954458	0.923	0.97	4.16908005689942e-09	UBC	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62002
2.76436185018528e-13	-0.365623312382536	0.693	0.688	5.65422572836898e-09	RNASET2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62003
4.98711338147714e-13	-0.296409160066338	0.243	0.366	1.02006417104733e-08	IFI44L	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62004
5.82635789794523e-13	0.480832314844235	0.806	0.702	1.19172324444572e-08	SOD2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62005
8.03103997287791e-13	0.25691155731925	0.6	0.427	1.64266891605245e-08	CYBB	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62006
1.37552645949357e-12	0.280632884046239	0.722	0.567	2.81350182024815e-08	CTSL	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000135047	1514	cathepsin L	CTSL1|FLJ31037	protein_coding	P07711	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62007
1.3960740533968e-12	-0.256102373457307	0.572	0.7	2.85552986881781e-08	IFI6	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62008
2.22132121674887e-12	0.533451855888678	0.853	0.803	4.54349041673814e-08	LGALS1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62009
3.20193417308194e-12	0.285297543695906	0.992	0.993	6.54923615762181e-08	HLA-A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62010
4.28043411896162e-12	0.258916713087259	0.968	0.958	8.7551999469241e-08	RPL37A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62011
4.77087292605045e-12	0.539728910281219	0.999	1	9.7583434829436e-08	FTL	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62012
7.17008022245454e-12	-0.443876382224051	0.425	0.514	1.46656820870085e-07	TNFAIP3	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62013
2.57600376703935e-11	0.336625846109956	0.761	0.61	5.26895810510229e-07	ALDOA	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000149925	226	aldolase, fructose-bisphosphate A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62014
4.36453862366604e-11	0.428326732174655	0.454	0.366	8.92722730084652e-07	CRIP1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62015
4.98558991143792e-11	-0.291110268288758	0.186	0.296	1.01975256048551e-06	PHLDA1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62016
3.74652254877236e-10	-0.308722986001597	0.19	0.289	7.66313722125899e-06	HES4	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000188290	57801	hes family bHLH transcription factor 4	bHLHb42	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62017
3.85817937922226e-10	-0.344375172396368	0.279	0.362	7.89152010226122e-06	CIRBP	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62018
5.80739322582798e-10	0.304576624225114	0.81	0.69	1.18784421041086e-05	PRDX1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62019
5.81922410913899e-10	0.272578213856561	0.997	0.998	1.19026409928329e-05	TPT1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62020
6.25869356898367e-10	0.266091287944341	0.37	0.245	1.28015318259992e-05	NCF1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62021
8.73688982253061e-10	-0.401015342168762	0.569	0.602	1.78704344430041e-05	LY6E	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62022
8.81814269705537e-10	0.335907291980495	0.486	0.354	1.80366290725571e-05	FABP5	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62023
1.17019493783673e-09	0.513762748844755	0.71	0.621	2.39351672585124e-05	CTSD	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62024
1.5963263709642e-09	0.363734268362527	0.283	0.182	3.26512595917017e-05	KLF2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62025
3.02389950099578e-09	-0.284975355307607	0.168	0.256	6.18508403933677e-05	MAFF	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000185022	23764	MAF bZIP transcription factor F	hMafF	protein_coding	Q9ULX9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62026
6.59009594722477e-09	0.514040137221838	0.961	0.984	0.000134793822504536	HSP90AA1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62027
7.24216460996756e-09	-0.497912755260013	0.248	0.343	0.000148131234932276	CCL20	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000115009	6364	C-C motif chemokine ligand 20	CKb4|exodus-1|LARC|MIP-3a|SCYA20|ST38	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62028
8.03424694418023e-09	-0.33060727784442	0.343	0.407	0.000164332486996262	PTPRE	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62029
1.65061404157539e-08	-0.287940228589814	0.645	0.656	0.000337616596063829	FXYD5	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62030
3.35270764135417e-08	-0.322881766350747	0.402	0.468	0.000685762820962582	CDKN1A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62031
1.26150437442342e-07	-0.30494437843381	0.279	0.354	0.00258028104744566	ZNF331	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62032
2.28491615646032e-07	-0.252935890371358	0.337	0.41	0.00467356750642393	CKLF	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62033
3.29341296275328e-07	-0.290991967833416	0.629	0.59	0.00673634687401556	BST2	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62034
4.1824347004592e-07	0.306421932121672	0.381	0.299	0.00855475193631925	MS4A4A	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000110079	51338	membrane spanning 4-domains A4A	CD20L1|MS4A4|MS4A7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62035
5.52911429399809e-07	0.253209571679766	0.751	0.625	0.0113092503769437	TPI1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62036
1.96254754593293e-06	0.290710450189239	0.942	0.925	0.0401419475045122	PSAP	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62037
2.15521866375823e-06	0.412371489336805	0.55	0.444	0.0440828425485108	HSPH1	Mono/Macro	GSE169246_PacTissue_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62038
1.43135199315252e-32	0.994725556556544	0.951	0.921	2.92768736679416e-28	RPS29	NK cells	GSE169246_PacTissue_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62039
6.40154407488027e-27	-0.471588241369483	1	1	1.30937182507601e-22	HLA-C	NK cells	GSE169246_PacTissue_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62040
7.74243316747136e-15	0.441612610497486	1	1	1.58363728007459e-10	RPS27	NK cells	GSE169246_PacTissue_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62041
4.57349812360632e-12	-0.66000467621903	0.144	0.33	9.35463306202436e-08	IGKV3-11	NK cells	GSE169246_PacTissue_pre	ENSG00000282823	NA	NA	NA	IG_V_gene	P04433	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62042
4.61993257211686e-12	-0.491910425395931	0.615	0.792	9.44961008300782e-08	CALR	NK cells	GSE169246_PacTissue_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62043
4.64775709740535e-12	0.496422529402004	0.886	0.843	9.5065223670329e-08	RPL38	NK cells	GSE169246_PacTissue_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62044
6.20739810079306e-12	0.921265231232781	0.792	0.673	1.26966120753621e-07	HSPA1A	NK cells	GSE169246_PacTissue_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62045
1.40530724244131e-11	0.427391543613484	0.976	0.975	2.87441543368946e-07	RPS21	NK cells	GSE169246_PacTissue_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62046
2.26886052011554e-11	0.375552197388612	0.986	0.991	4.64072730784433e-07	RPL37	NK cells	GSE169246_PacTissue_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62047
2.7062045232435e-11	-0.331373337423235	1	1	5.53527073184225e-07	HLA-B	NK cells	GSE169246_PacTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62048
5.30957291159334e-11	0.396584793706128	0.983	0.997	1.0860200433373e-06	RPL39	NK cells	GSE169246_PacTissue_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62049
8.39894669816784e-11	0.625285122960848	0.807	0.601	1.71792055764325e-06	JUN	NK cells	GSE169246_PacTissue_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62050
1.69213179529728e-10	-0.317567975372948	1	0.997	3.46108637410105e-06	MT-ND4L	NK cells	GSE169246_PacTissue_pre	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62051
2.10260169509933e-10	0.829704601280897	0.727	0.538	4.30066150715618e-06	HSPA1B	NK cells	GSE169246_PacTissue_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62052
7.02352760749014e-10	-0.340550565891958	0.176	0.374	1.43659233683603e-05	MX1	NK cells	GSE169246_PacTissue_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62053
7.25566801424475e-10	0.471706523217899	0.631	0.497	1.48407433563362e-05	RPL36A	NK cells	GSE169246_PacTissue_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62054
9.79317728786452e-10	-0.353323276946351	0.561	0.752	2.00309648245981e-05	RARRES3	NK cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62055
1.66630395673407e-09	-0.420558978884024	0.597	0.748	3.40825811310386e-05	LY6E	NK cells	GSE169246_PacTissue_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62056
5.25790417969503e-09	-0.394738623191413	0.915	0.959	0.000107545172091482	NKG7	NK cells	GSE169246_PacTissue_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62057
5.37300180696219e-09	-0.298976188638757	0.314	0.509	0.000109899378959605	ARL6IP4	NK cells	GSE169246_PacTissue_pre	ENSG00000182196	51329	ADP ribosylation factor like GTPase 6 interacting protein 4	SFRS20|SR-25|SRp25|SRrp37	protein_coding	Q66PJ3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62058
8.83003858568237e-09	-0.349051097717214	0.52	0.682	0.000180609609231547	PSME2	NK cells	GSE169246_PacTissue_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62059
1.04962826195195e-08	-0.321761016604972	0.688	0.84	0.000214690964699653	CLIC1	NK cells	GSE169246_PacTissue_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62060
1.12049324561254e-08	-0.356327774443438	0.624	0.761	0.00022918568845759	TGFB1	NK cells	GSE169246_PacTissue_pre	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62061
1.14130118966501e-08	-0.349606144937037	0.397	0.607	0.000233441745334081	UBE2S	NK cells	GSE169246_PacTissue_pre	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62062
1.79365435828953e-08	-0.275900562106553	0.953	0.987	0.00036687406244454	RPL41	NK cells	GSE169246_PacTissue_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62063
3.28124962853195e-08	-0.311510750809069	0.339	0.513	0.000671146799019924	CDK2AP2	NK cells	GSE169246_PacTissue_pre	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62064
4.47036689198595e-08	-0.269936463935884	0.941	0.987	0.000914368844086806	SH3BGRL3	NK cells	GSE169246_PacTissue_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62065
5.63559149268736e-08	-0.413231442734754	0.641	0.777	0.00115270388391427	GZMB	NK cells	GSE169246_PacTissue_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62066
7.70320626424985e-08	-0.32133108355639	0.79	0.909	0.00157561380928966	MYL12A	NK cells	GSE169246_PacTissue_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62067
1.62851057601905e-07	-0.251784151849581	0.324	0.5	0.00333095553218936	SRSF9	NK cells	GSE169246_PacTissue_pre	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62068
3.59951361242805e-07	0.463539915078692	0.68	0.55	0.00736244514286034	KLF6	NK cells	GSE169246_PacTissue_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62069
3.63583555428373e-07	-0.277109207477594	0.124	0.252	0.00743673804273194	CD38	NK cells	GSE169246_PacTissue_pre	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62070
4.36583429987733e-07	-0.367402097450737	0.819	0.874	0.00892987747696909	CST7	NK cells	GSE169246_PacTissue_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62071
5.05593255192963e-07	0.352903611915481	0.425	0.28	0.0103414044417169	ATP5ME	NK cells	GSE169246_PacTissue_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62072
5.29761403557901e-07	0.296176988102546	0.992	0.997	0.0108357397483733	RPS28	NK cells	GSE169246_PacTissue_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62073
6.01621112281152e-07	-0.308057611748871	0.968	0.972	0.0123055582305987	IFITM1	NK cells	GSE169246_PacTissue_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62074
9.41122241401132e-07	-0.378794766044994	0.622	0.758	0.0192497143256188	GZMA	NK cells	GSE169246_PacTissue_pre	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62075
1.10073916565941e-06	0.512378192492992	0.571	0.475	0.0225145188943976	SLC2A3	NK cells	GSE169246_PacTissue_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62076
1.15723969254215e-06	-0.359020195685905	0.427	0.585	0.0236701806712571	ISG15	NK cells	GSE169246_PacTissue_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62077
1.26193276286047e-06	-0.259681940304579	0.244	0.399	0.0258115727315481	IRF7	NK cells	GSE169246_PacTissue_pre	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62078
2.0557841220729e-06	0.494506988617579	0.846	0.739	0.0420490084328791	DNAJB1	NK cells	GSE169246_PacTissue_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62079
1.36172456859709e-252	1.69943390944547	0.779	0.183	2.78527143260848e-248	RPS29	Plasma cells	GSE169246_PacTissue_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62080
4.88266721596994e-186	1.36956220794407	0.781	0.269	9.98700752354491e-182	RPS21	Plasma cells	GSE169246_PacTissue_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62081
1.16664483914952e-184	1.76375612107951	0.904	0.515	2.38625535399643e-180	RPS27	Plasma cells	GSE169246_PacTissue_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62082
1.44795538067639e-174	1.57148537156088	0.859	0.442	2.96164793563548e-170	RPL39	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62083
8.71145500472541e-162	1.29402242406253	0.941	0.673	1.78184100666653e-157	RPS28	Plasma cells	GSE169246_PacTissue_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62084
4.32816099891079e-160	1.4033686059004	0.868	0.467	8.85282050717212e-156	RPL37	Plasma cells	GSE169246_PacTissue_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62085
4.14747751195003e-134	1.27729294651676	0.819	0.434	8.4832505029426e-130	RPLP2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62086
1.20600154011363e-132	1.42430567625811	0.678	0.256	2.46675555014843e-128	TMSB10	Plasma cells	GSE169246_PacTissue_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62087
2.87733630808898e-127	1.13982370954392	0.789	0.393	5.8853036845652e-123	RPL37A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62088
7.61659572242034e-127	1.18360529368289	0.803	0.427	1.55789848906386e-122	RPL36	Plasma cells	GSE169246_PacTissue_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62089
1.09429208034597e-122	0.963428253117515	0.549	0.157	2.23826502113964e-118	RPL38	Plasma cells	GSE169246_PacTissue_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62090
8.79635824758176e-121	0.969451325830628	0.266	0.009	1.79920711596037e-116	IGLV3-9	Plasma cells	GSE169246_PacTissue_pre	ENSG00000211670	NA	NA	NA	IG_V_gene	A0A075B6K5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62091
5.54724393340556e-118	1.25315682417756	0.855	0.551	1.13463327413877e-113	RPL34	Plasma cells	GSE169246_PacTissue_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62092
1.46759227577199e-116	0.785205841344066	0.364	0.047	3.00181324086402e-112	CCL5	Plasma cells	GSE169246_PacTissue_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62093
6.60991867823956e-113	1.38838485752886	0.658	0.289	1.35199276644712e-108	DNAJB1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62094
1.55131817342392e-112	1.0498267785629	0.608	0.22	3.17306619192128e-108	HSPE1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62095
4.76534012133428e-112	1.23594626385135	0.846	0.528	9.74702668417713e-108	RPL30	Plasma cells	GSE169246_PacTissue_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62096
1.66728866407563e-111	1.05858630836719	0.483	0.13	3.41027223350029e-107	PNRC1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62097
3.97702661906962e-110	1.18166364619762	0.738	0.368	8.134610246645e-106	PTMA	Plasma cells	GSE169246_PacTissue_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62098
1.58417588524313e-107	0.986917793177114	0.398	0.072	3.2402733556763e-103	IL32	Plasma cells	GSE169246_PacTissue_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62099
2.19503909797722e-107	1.08127633877953	0.462	0.118	4.4897329710026e-103	HSPH1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62100
1.732491583467e-106	1.16874291417772	0.904	0.7	3.54363828482339e-102	RPS15A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62101
1.15548593376968e-104	0.498740974251796	0.347	0.05	2.36343092893251e-100	HLA-DRB1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62102
9.86937059838628e-102	0.515595079962677	0.285	0.027	2.01868106219393e-97	CCL4	Plasma cells	GSE169246_PacTissue_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62103
1.24665170728765e-101	1.1357137789582	0.501	0.152	2.54990140208616e-97	PFN1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62104
1.73570699289864e-100	0.714820275452199	0.386	0.075	3.55021508327487e-96	S100A4	Plasma cells	GSE169246_PacTissue_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62105
2.8194378145949e-100	1.13377461153112	0.774	0.457	5.76687810597241e-96	RPL17	Plasma cells	GSE169246_PacTissue_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62106
5.72714349496847e-100	1.10471149940881	0.882	0.655	1.17142993046085e-95	RPL32	Plasma cells	GSE169246_PacTissue_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62107
1.78209490741035e-99	1.06693538150007	0.586	0.221	3.64509692361713e-95	JUNB	Plasma cells	GSE169246_PacTissue_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62108
9.88707193390732e-99	0.595488736080221	0.41	0.086	2.0223016933614e-94	CXCR4	Plasma cells	GSE169246_PacTissue_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62109
2.05521934526664e-98	0.821268695927382	0.386	0.079	4.20374564880839e-94	NR4A2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62110
2.24403799227427e-98	1.01697329157223	0.839	0.572	4.58995530939778e-94	RPL35A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62111
4.47874553054437e-97	0.610373637606747	0.35	0.058	9.16082610817545e-93	PTPRC	Plasma cells	GSE169246_PacTissue_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62112
1.30564978290005e-96	1.16936430823203	0.899	0.695	2.67057606594377e-92	RPS12	Plasma cells	GSE169246_PacTissue_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62113
1.43879381901132e-96	1.02517033962407	0.601	0.246	2.94290887740575e-92	RPL13A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62114
2.23491253002241e-96	0.896738843727182	0.43	0.108	4.57129008890784e-92	SH3BGRL3	Plasma cells	GSE169246_PacTissue_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62115
5.34861914778667e-96	1.25266992530404	0.75	0.449	1.09400656048829e-91	FTH1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62116
2.92926556825144e-93	1.15238435935484	0.836	0.561	5.9915197933015e-89	RPL26	Plasma cells	GSE169246_PacTissue_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62117
3.2247193604039e-93	1.02949729870359	0.508	0.172	6.59584097977014e-89	HSPD1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62118
6.15634593675056e-93	1.12054321110164	0.803	0.526	1.25921899790296e-88	RPS24	Plasma cells	GSE169246_PacTissue_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62119
2.74287512998601e-92	0.827160315048618	0.558	0.198	5.61027679087338e-88	DUSP1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62120
4.43772193140725e-92	0.533199783025431	0.287	0.036	9.07691643850039e-88	HLA-DRA	Plasma cells	GSE169246_PacTissue_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62121
4.93668983233614e-92	1.09824268418114	0.796	0.487	1.00975053830603e-87	RPS25	Plasma cells	GSE169246_PacTissue_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62122
5.7051470683594e-92	1.09897227147613	0.488	0.16	1.16693078136223e-87	BTG1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62123
1.99545461917234e-91	0.714624564044008	0.43	0.109	4.08150287805511e-87	DUSP2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62124
2.67148433257551e-91	0.948935269358164	0.51	0.177	5.46425405384995e-87	DNAJA1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62125
4.15988662768639e-91	0.761974632326032	0.476	0.143	8.50863210826974e-87	PABPC1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62126
3.06798992309137e-90	0.727800615651833	0.402	0.1	6.27526658869108e-86	YWHAZ	Plasma cells	GSE169246_PacTissue_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62127
8.40109712161412e-90	1.12828232257511	0.848	0.629	1.71836040525495e-85	RPS27A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62128
4.4469088835416e-89	0.67673594254563	0.345	0.064	9.09570743039598e-85	CD52	Plasma cells	GSE169246_PacTissue_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62129
2.21198961346725e-87	0.745381064860592	0.487	0.162	4.52440355538591e-83	HNRNPA2B1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62130
3.93734005235334e-87	0.765162593113767	0.457	0.137	8.05343534308353e-83	CFL1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62131
4.71260053074073e-86	0.669342993227402	0.381	0.088	9.6391531255771e-82	ARHGDIB	Plasma cells	GSE169246_PacTissue_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62132
2.95003491195258e-85	0.891111625150584	0.588	0.254	6.03400140890781e-81	UBA52	Plasma cells	GSE169246_PacTissue_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62133
3.65098144347429e-85	0.886573622305268	0.847	0.602	7.46771744448231e-81	RPL11	Plasma cells	GSE169246_PacTissue_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62134
5.8616168689133e-85	0.755089988490707	0.456	0.142	1.19893511436753e-80	RPL31	Plasma cells	GSE169246_PacTissue_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62135
7.66019751422002e-85	0.885767667542783	0.897	0.677	1.56681679955856e-80	RPS15	Plasma cells	GSE169246_PacTissue_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62136
6.26638874295369e-84	1.28557934534604	0.627	0.334	1.28172715348375e-79	HSP90AB1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62137
6.38544035696072e-84	1.05780203334163	0.824	0.563	1.30607797061275e-79	RPS23	Plasma cells	GSE169246_PacTissue_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62138
1.1608872435847e-83	0.762112517995037	0.652	0.31	2.37447876802816e-79	RPL22	Plasma cells	GSE169246_PacTissue_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62139
1.44985490118313e-83	0.867056211226235	0.826	0.557	2.96553321487998e-79	RPS13	Plasma cells	GSE169246_PacTissue_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62140
2.93140787666249e-82	0.650892945597629	0.478	0.154	5.99590167092546e-78	SARAF	Plasma cells	GSE169246_PacTissue_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62141
8.44630451760941e-82	1.11740446963098	0.7	0.42	1.72760712603183e-77	UBB	Plasma cells	GSE169246_PacTissue_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62142
1.24316880948294e-81	0.650935469372088	0.645	0.274	2.54277748291641e-77	FOS	Plasma cells	GSE169246_PacTissue_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62143
1.97723583433197e-81	0.507932805369087	0.339	0.069	4.04423817554262e-77	LAPTM5	Plasma cells	GSE169246_PacTissue_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62144
2.47393528946584e-81	0.875685180687337	0.861	0.642	5.06018724107342e-77	FAU	Plasma cells	GSE169246_PacTissue_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62145
3.68022522414406e-81	0.845197651426142	0.931	0.771	7.52753267346426e-77	RPL18A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62146
3.84324942113136e-81	0.964963784236814	0.627	0.304	7.86098236598209e-77	ZFP36	Plasma cells	GSE169246_PacTissue_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62147
1.43067073057262e-80	0.948771060952069	0.729	0.441	2.92629391231323e-76	RPL14	Plasma cells	GSE169246_PacTissue_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62148
2.59228578904884e-80	0.588646328281183	0.352	0.078	5.3022613529205e-76	CREM	Plasma cells	GSE169246_PacTissue_pre	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62149
3.06065273213142e-80	0.691855690018566	0.592	0.259	6.2602590983016e-76	RPS11	Plasma cells	GSE169246_PacTissue_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62150
2.50800190008285e-79	0.837145598106238	0.96	0.905	5.12986708642946e-75	RPL10	Plasma cells	GSE169246_PacTissue_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62151
4.60363100708336e-79	0.522541171202386	0.352	0.077	9.4162668618883e-75	IFITM2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62152
6.38882601237791e-79	1.03677030389586	0.809	0.572	1.30677047257178e-74	RPS7	Plasma cells	GSE169246_PacTissue_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62153
7.1008557791885e-79	0.681814410377652	0.557	0.236	1.45240904107521e-74	PFDN5	Plasma cells	GSE169246_PacTissue_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62154
1.01485750936269e-78	0.975360976057873	0.734	0.445	2.07578954965044e-74	RPL21	Plasma cells	GSE169246_PacTissue_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62155
1.24481978111189e-78	0.800440752639174	0.738	0.435	2.54615438028625e-74	ATP5F1E	Plasma cells	GSE169246_PacTissue_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62156
3.24433521567035e-78	1.0670466766859	0.84	0.627	6.63596325013213e-74	RPS3A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62157
7.86733640355271e-78	0.509645992700017	0.353	0.081	1.60918498798267e-73	MYL12A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62158
8.27650051910901e-78	1.25625962074643	0.638	0.338	1.69287541617856e-73	TMSB4X	Plasma cells	GSE169246_PacTissue_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62159
1.14101043628438e-77	1.01726671753019	0.89	0.757	2.33382274637607e-73	RPL28	Plasma cells	GSE169246_PacTissue_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62160
1.40505585566618e-77	0.975306138430391	0.878	0.685	2.8739012471796e-73	RPS14	Plasma cells	GSE169246_PacTissue_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62161
2.49182293736278e-77	0.553146213694477	0.334	0.072	5.09677463608183e-73	CORO1A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62162
1.92573432373368e-76	1.01665115736335	0.931	0.827	3.93889698576486e-72	RPL13	Plasma cells	GSE169246_PacTissue_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62163
2.96905049176219e-76	0.648506449318722	0.418	0.127	6.07289587585039e-72	PTPRCAP	Plasma cells	GSE169246_PacTissue_pre	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62164
4.73826892347456e-76	0.687678835422757	0.406	0.119	9.69165525607487e-72	TNFAIP3	Plasma cells	GSE169246_PacTissue_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62165
6.63497088540648e-76	0.960275082322421	0.737	0.46	1.35711694490104e-71	RPL23A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62166
6.7737552367148e-76	0.806304377856855	0.519	0.21	1.38550389611765e-71	DDX5	Plasma cells	GSE169246_PacTissue_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62167
1.37327957981104e-75	0.733814662202275	0.535	0.223	2.8089060525455e-71	RPL27A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62168
2.43659113846964e-75	0.646615624109317	0.44	0.144	4.9838035146258e-71	BTF3	Plasma cells	GSE169246_PacTissue_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62169
3.39587198243538e-75	0.719183470942518	0.466	0.167	6.94591655287332e-71	NPM1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62170
4.63087951735929e-75	-0.514447402836399	0.268	0.647	9.4720009648067e-71	IFI6	Plasma cells	GSE169246_PacTissue_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62171
7.13742567490617e-75	0.990731452163846	0.651	0.354	1.45988904754531e-70	HLA-A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62172
8.47757165804402e-75	0.866945371968159	0.941	0.844	1.73400250693632e-70	RPS8	Plasma cells	GSE169246_PacTissue_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62173
3.60249928067479e-74	1.04929252692376	0.775	0.526	7.36855202869221e-70	RPL12	Plasma cells	GSE169246_PacTissue_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62174
3.81124783902203e-74	0.553587411181208	0.26	0.039	7.79552632993565e-70	ANXA1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62175
5.6824713784796e-74	0.93396860862069	0.652	0.354	1.16229269575422e-69	RPL10A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62176
7.17657769400112e-74	0.628818004149115	0.389	0.113	1.46789720153099e-69	S100A6	Plasma cells	GSE169246_PacTissue_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62177
9.5774888528598e-74	0.621264405675775	0.388	0.111	1.95897956996394e-69	SRSF7	Plasma cells	GSE169246_PacTissue_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62178
3.07019264402105e-73	0.638945106982035	0.445	0.152	6.27977203408065e-69	HNRNPA1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62179
4.66160031752455e-73	0.568216732754472	0.348	0.091	9.53483728946472e-69	CCNI	Plasma cells	GSE169246_PacTissue_pre	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62180
6.29534205685796e-73	0.768184176818329	0.621	0.317	1.28764926430973e-68	EEF2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62181
4.78573899405481e-72	0.589011892088577	0.498	0.196	9.78875053843971e-68	TMA7	Plasma cells	GSE169246_PacTissue_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62182
6.30165563162846e-72	0.716116165832885	0.468	0.17	1.28894064289329e-67	CALM1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62183
4.93675128898747e-71	1.06233199102706	0.904	0.75	1.0097631086495e-66	RPS18	Plasma cells	GSE169246_PacTissue_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62184
6.4664524804871e-71	0.659065054253656	0.722	0.434	1.32264819035883e-66	RPS26	Plasma cells	GSE169246_PacTissue_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62185
7.38436576579192e-71	0.830573157330027	0.528	0.23	1.51039817373508e-66	SRGN	Plasma cells	GSE169246_PacTissue_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62186
8.54809640551366e-71	-0.604979812133088	0.681	0.939	1.74842763878376e-66	MZB1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62187
9.80726967830685e-71	0.482422649226052	0.354	0.091	2.00597894000088e-66	FXYD5	Plasma cells	GSE169246_PacTissue_pre	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62188
1.03447349029513e-70	0.784030027414828	0.602	0.297	2.11591207704965e-66	RPL27	Plasma cells	GSE169246_PacTissue_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62189
2.13116666089868e-70	0.86357716601715	0.556	0.259	4.35908828820215e-66	PPIA	Plasma cells	GSE169246_PacTissue_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62190
4.99299350896531e-70	0.541456074664111	0.355	0.095	1.02126689232376e-65	RAC2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62191
3.15247705514823e-69	0.424817729532742	0.31	0.07	6.44807656860019e-65	HLA-DPA1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62192
3.83275127772095e-69	0.919595971126679	0.87	0.682	7.83950946345043e-65	RPL19	Plasma cells	GSE169246_PacTissue_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62193
4.00285030403258e-69	1.11782131545521	0.664	0.408	8.18743001186824e-65	HSPA8	Plasma cells	GSE169246_PacTissue_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62194
2.21679249697203e-68	0.800688672293553	0.84	0.65	4.53422737330659e-64	RPL29	Plasma cells	GSE169246_PacTissue_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62195
1.47524155537597e-67	0.490730909658695	0.366	0.104	3.01745907736601e-63	ITM2B	Plasma cells	GSE169246_PacTissue_pre	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62196
2.55180423014789e-67	0.648199870571089	0.979	0.972	5.21946037234449e-63	RPLP1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62197
3.10616725107047e-67	-0.376977670811589	0.332	0.085	6.35335449533953e-63	IGLV2-23	Plasma cells	GSE169246_PacTissue_pre	ENSG00000211660	NA	NA	NA	IG_V_gene	P01705	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62198
1.19035374890119e-66	0.897625965991532	0.691	0.412	2.43474955800249e-62	RACK1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62199
4.49989299405653e-66	0.871510536126525	0.705	0.395	9.20408113004322e-62	HSPA1B	Plasma cells	GSE169246_PacTissue_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62200
1.22875223898869e-65	0.777205529300015	0.644	0.352	2.51328982962747e-61	RPL9	Plasma cells	GSE169246_PacTissue_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62201
1.91482176233629e-65	0.437969684962736	0.289	0.061	3.91657643268264e-61	CD3E	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62202
2.100574222637e-65	0.783045899369857	0.725	0.4	4.29651451498172e-61	HSPA1A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62203
3.10764625736136e-65	0.563094950379311	0.515	0.223	6.35637965480692e-61	COX7C	Plasma cells	GSE169246_PacTissue_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62204
1.10167450231142e-64	0.881471718782327	0.757	0.511	2.25336502702778e-60	RPL15	Plasma cells	GSE169246_PacTissue_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62205
1.1179287741755e-64	0.811325534669683	0.768	0.523	2.28661151469857e-60	MT-CO3	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62206
2.28318183787464e-64	0.790341051928926	0.729	0.449	4.67002013118878e-60	RPL24	Plasma cells	GSE169246_PacTissue_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62207
4.65433360030261e-63	-0.432625296683235	0.519	0.854	9.51997394605896e-59	PRDX4	Plasma cells	GSE169246_PacTissue_pre	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62208
1.05840539760551e-62	0.857258205859781	0.906	0.794	2.16486240026232e-58	RPS19	Plasma cells	GSE169246_PacTissue_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62209
9.485092605378e-62	0.845469821547715	0.776	0.562	1.94008084150402e-57	RPS9	Plasma cells	GSE169246_PacTissue_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62210
1.28321857894768e-61	0.698972686754507	0.729	0.44	2.62469528137958e-57	MT-ATP6	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62211
1.3201061110599e-61	0.585283821520071	0.469	0.192	2.70014503956191e-57	RPL7	Plasma cells	GSE169246_PacTissue_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62212
5.60767063946997e-61	0.553466773910503	0.325	0.094	1.14699295259719e-56	S100A11	Plasma cells	GSE169246_PacTissue_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62213
9.11350430061781e-61	0.477397777517798	0.353	0.11	1.86407616964837e-56	TOMM7	Plasma cells	GSE169246_PacTissue_pre	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62214
1.83567508462776e-60	0.540332904389395	0.431	0.164	3.75468981809762e-56	HMGB1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62215
4.34372897218993e-60	0.982615898080182	0.792	0.609	8.88466323971729e-56	RPS6	Plasma cells	GSE169246_PacTissue_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62216
4.56601298890743e-60	0.459053289266738	0.303	0.079	9.33932296751126e-56	CALM2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62217
5.23685264846545e-60	0.692911501873029	0.935	0.822	1.07114584071712e-55	RPL8	Plasma cells	GSE169246_PacTissue_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62218
6.92757681880662e-60	0.587518219705585	0.44	0.178	1.41696656251871e-55	YBX1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62219
7.10329127967997e-60	0.657191954409831	0.595	0.308	1.45290719834574e-55	RPL4	Plasma cells	GSE169246_PacTissue_pre	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62220
2.66141887836943e-59	0.682595744041652	0.837	0.637	5.44366617381682e-55	RPL6	Plasma cells	GSE169246_PacTissue_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62221
5.48942736869448e-59	0.670958707195736	0.466	0.192	1.12280747399277e-54	CRIP1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62222
8.23109626399273e-59	0.772682215186888	0.852	0.697	1.68358842983707e-54	RPL18	Plasma cells	GSE169246_PacTissue_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62223
1.36576474651074e-58	-0.80747736931596	0.344	0.626	2.79353521251306e-54	DUSP5	Plasma cells	GSE169246_PacTissue_pre	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62224
7.26153002757709e-58	0.643009786089028	0.52	0.238	1.48527335184062e-53	ZFP36L2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62225
4.23748792240947e-57	0.731266295329827	0.7	0.447	8.66735779649633e-53	RPL5	Plasma cells	GSE169246_PacTissue_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62226
4.62017824950475e-57	0.714128985371429	0.802	0.592	9.45011259153701e-53	RPL35	Plasma cells	GSE169246_PacTissue_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62227
8.3240314010875e-57	0.544079027656842	0.608	0.303	1.70259738277844e-52	MT-ND4	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62228
9.45383693227972e-57	1.24079017993051	0.722	0.511	1.93368780612849e-52	HSP90AA1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62229
2.40593770347876e-56	2.78160176667198	0.327	0.103	4.92110497869545e-52	IGHG2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000274497	NA	NA	NA	IG_C_gene	P01859	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62230
3.35854993515783e-56	0.819231176725196	0.759	0.548	6.86957803737183e-52	RPS3	Plasma cells	GSE169246_PacTissue_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62231
3.71734524954151e-56	1.00411073923156	0.795	0.632	7.6034579734122e-52	RPS2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62232
1.33972329066514e-55	0.871310811421982	0.933	0.87	2.74027001872647e-51	TPT1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62233
1.7355747007424e-55	0.485259498592818	0.286	0.077	3.54994449289851e-51	ZFP36L1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62234
1.39059865436962e-54	0.789871867266655	0.748	0.513	2.84433048764763e-50	RPS16	Plasma cells	GSE169246_PacTissue_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62235
1.73597249536979e-54	0.494575312734249	0.418	0.168	3.55075814202938e-50	RHOA	Plasma cells	GSE169246_PacTissue_pre	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62236
8.0858745523512e-54	0.629213473328977	0.84	0.674	1.65388478093791e-49	RPL41	Plasma cells	GSE169246_PacTissue_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62237
1.14432182126033e-53	0.644276419217703	0.537	0.273	2.34059585320589e-49	H3F3A	Plasma cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62238
1.5293207872874e-53	0.71387813547207	0.917	0.826	3.12807273831765e-49	RPS4X	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62239
1.73550991972424e-53	0.7364241247912	0.581	0.321	3.54981198980396e-49	RPSA	Plasma cells	GSE169246_PacTissue_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62240
1.90420220385909e-52	0.574992499629529	0.503	0.244	3.89485518777339e-48	COX4I1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62241
3.01318920181332e-51	0.626807273083094	0.596	0.327	6.16317719338897e-47	HLA-E	Plasma cells	GSE169246_PacTissue_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62242
6.42578773656957e-51	-0.688660859920045	0.128	0.387	1.31433062363794e-46	IFI27	Plasma cells	GSE169246_PacTissue_pre	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62243
8.13607433991455e-51	0.478720319316148	0.366	0.136	1.66415264548612e-46	ARPC2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62244
1.51870696994941e-50	-0.47790387691941	0.185	0.481	3.10636323633453e-46	ISG15	Plasma cells	GSE169246_PacTissue_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62245
2.12757792439285e-50	-1.22300594037095	0.381	0.142	4.35174788655313e-46	IGLV2-14	Plasma cells	GSE169246_PacTissue_pre	ENSG00000211666	NA	NA	NA	IG_V_gene	P01704	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62246
4.82472369605878e-50	0.75445937172087	0.864	0.766	9.86848984791863e-46	EIF1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62247
6.46883483665989e-50	0.664056568220802	0.449	0.209	1.32313547749041e-45	IER2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62248
1.3631680428961e-49	-0.305032778482852	0.488	0.844	2.78822391493968e-45	ITM2C	Plasma cells	GSE169246_PacTissue_pre	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62249
1.46291562674976e-48	0.428472896425748	0.261	0.072	2.99224762295395e-44	YWHAB	Plasma cells	GSE169246_PacTissue_pre	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62250
2.16552344450539e-47	0.706013789633245	0.541	0.291	4.42936165339132e-43	KLF6	Plasma cells	GSE169246_PacTissue_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62251
3.40854619637441e-47	0.687552902632375	0.665	0.439	6.97184039006422e-43	NACA	Plasma cells	GSE169246_PacTissue_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62252
2.73523764107496e-46	0.504144265503559	0.471	0.232	5.59465507105473e-42	ATP5MC2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62253
1.48909622314203e-45	0.444674632043444	0.254	0.076	3.04579741481471e-41	RPL36A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62254
1.0038975981688e-44	0.762674342758457	0.828	0.709	2.05337214729447e-40	RPL3	Plasma cells	GSE169246_PacTissue_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62255
2.25288859390682e-44	0.43956765849394	0.662	0.376	4.608058329977e-40	MT-ND2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62256
3.01694263268559e-44	0.528074019244368	0.525	0.292	6.17085446089512e-40	ATP5MG	Plasma cells	GSE169246_PacTissue_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62257
1.25309187518606e-43	0.431871568556646	0.441	0.203	2.56307412150556e-39	RGCC	Plasma cells	GSE169246_PacTissue_pre	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62258
2.85506693648083e-43	0.394058514146786	0.301	0.106	5.83975391187788e-39	ARPC3	Plasma cells	GSE169246_PacTissue_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62259
4.09886871453924e-43	0.416278429028243	0.364	0.151	8.38382606871855e-39	CLIC1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62260
6.88266187068141e-42	0.661429725155486	0.816	0.661	1.40777965902918e-37	RPS5	Plasma cells	GSE169246_PacTissue_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62261
8.18233457059084e-42	0.490389808785877	0.674	0.44	1.67361471306865e-37	EEF1D	Plasma cells	GSE169246_PacTissue_pre	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62262
2.12609583845628e-41	0.486797952302897	0.377	0.166	4.34871642797848e-37	HINT1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62263
3.984275145829e-41	0.827766685047452	0.757	0.558	8.14943638327865e-37	JUN	Plasma cells	GSE169246_PacTissue_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62264
6.06664528653876e-41	-0.352642958067202	0.558	0.837	1.24087162690864e-36	SEC11C	Plasma cells	GSE169246_PacTissue_pre	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62265
6.3464308006421e-41	0.766670361839922	0.96	0.922	1.29809895596333e-36	EEF1A1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62266
4.34883189886997e-40	0.65064715194463	0.543	0.331	8.89510076594864e-36	BTG2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62267
4.42951209229529e-40	0.465679028786762	0.318	0.127	9.06012403358078e-36	PPDPF	Plasma cells	GSE169246_PacTissue_pre	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62268
1.58872140601564e-38	-0.304642000382605	0.48	0.762	3.2495707638644e-34	CD79A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62269
1.99116280597096e-38	0.563183928688921	0.697	0.481	4.07272440333301e-34	EEF1B2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62270
6.88585605422345e-38	0.631652392829255	0.76	0.6	1.40843299733086e-33	H3F3B	Plasma cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62271
1.59819101479646e-37	-0.319315847677224	0.286	0.542	3.26893990166467e-33	CD38	Plasma cells	GSE169246_PacTissue_pre	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62272
2.14694385309362e-37	0.453569771562086	0.623	0.375	4.3913589571177e-33	NFKBIA	Plasma cells	GSE169246_PacTissue_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62273
4.55667900186404e-37	-0.30895142633115	0.56	0.869	9.3202312304127e-33	FKBP11	Plasma cells	GSE169246_PacTissue_pre	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62274
6.19421488415138e-37	0.48178600046554	0.711	0.499	1.26696471240432e-32	OAZ1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62275
2.11842921138366e-36	0.5103162523446	0.553	0.337	4.33303510896414e-32	EEF1G	Plasma cells	GSE169246_PacTissue_pre	ENSG00000254772	1937	eukaryotic translation elongation factor 1 gamma	EF1G	protein_coding	P26641	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62276
7.1347598364364e-36	-0.317605905798097	0.212	0.466	1.4593437769447e-31	MIR155HG	Plasma cells	GSE169246_PacTissue_pre	ENSG00000234883	114614	MIR155 host gene	BIC|miPEP155|MIRHG2|NCRNA00172	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62277
7.14972642533507e-36	0.348558767452241	0.254	0.088	1.46240504303804e-31	LDHA	Plasma cells	GSE169246_PacTissue_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62278
1.24478377657219e-35	0.465845576065779	0.882	0.757	2.54608073660076e-31	MT-ND3	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62279
4.84282843589508e-35	0.438581253276358	0.383	0.19	9.90552128277979e-31	SRP14	Plasma cells	GSE169246_PacTissue_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62280
9.02215166596157e-35	-0.367528878581868	0.727	0.954	1.84539090175578e-30	XBP1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62281
4.96263553115327e-34	0.483233929850337	0.427	0.235	1.01505747154209e-29	DYNLL1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62282
5.63883205129342e-34	0.456556541860901	0.842	0.735	1.15336670777156e-29	SERF2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62283
3.88040466804213e-33	0.604148540399403	0.896	0.838	7.93697970801338e-29	RPL7A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62284
6.04163006202126e-32	0.412957272858936	0.933	0.894	1.23575501288583e-27	HLA-B	Plasma cells	GSE169246_PacTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62285
1.67630855356146e-31	-0.323909732648927	0.901	0.921	3.42872151545461e-27	IGHG1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62286
1.83199375987819e-31	0.346921696136925	0.289	0.123	3.74716003645485e-27	LSP1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62287
3.21780739180199e-31	-0.335827259753574	0.897	0.979	6.5817032391918e-27	SSR4	Plasma cells	GSE169246_PacTissue_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62288
4.19202474155387e-31	0.377566650381527	0.588	0.352	8.5743674063743e-27	VIM	Plasma cells	GSE169246_PacTissue_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62289
4.68360257943954e-31	0.762657706735933	0.932	0.871	9.57984071598564e-27	MALAT1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62290
7.07641311557017e-31	0.471362163497708	0.678	0.505	1.44740953865872e-26	MYL6	Plasma cells	GSE169246_PacTissue_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62291
2.10422106392212e-30	0.817643309552517	0.705	0.568	4.30397376414631e-26	ACTB	Plasma cells	GSE169246_PacTissue_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62292
2.46257173303932e-30	0.418794629145762	0.273	0.12	5.03694422275862e-26	PCBP1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62293
2.58930932713708e-30	0.453098168400736	0.378	0.202	5.29617329772618e-26	TAGLN2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62294
2.75157728532509e-30	0.532741447317382	0.912	0.857	5.62807617940394e-26	RPLP0	Plasma cells	GSE169246_PacTissue_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62295
5.83433136561638e-30	0.390300244323801	0.446	0.257	1.19335413752317e-25	SLC25A6	Plasma cells	GSE169246_PacTissue_pre	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62296
1.39754700687541e-28	-0.699231152842535	0.454	0.63	2.85854264786297e-24	JCHAIN	Plasma cells	GSE169246_PacTissue_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62297
1.44348081463168e-28	0.418076737097861	0.283	0.13	2.95249565824765e-24	NCL	Plasma cells	GSE169246_PacTissue_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62298
4.49909046586994e-28	-0.754679426143286	0.519	0.338	9.20243963889037e-24	IGKV3-20	Plasma cells	GSE169246_PacTissue_pre	ENSG00000282402	NA	NA	NA	IG_V_gene	P01619	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62299
4.94596342553552e-28	-0.492314693227809	0.403	0.193	1.01164735905903e-23	IGHV3-23	Plasma cells	GSE169246_PacTissue_pre	ENSG00000281962	NA	NA	NA	IG_V_gene	P01764	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62300
4.12598945965139e-27	0.381222266317064	0.469	0.284	8.43929884077096e-23	CHCHD2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62301
9.68687584430028e-25	0.414593326016967	0.994	0.989	1.98135358519318e-20	B2M	Plasma cells	GSE169246_PacTissue_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62302
2.11116959487084e-24	0.506411057000853	0.317	0.167	4.31818628934882e-20	HSPB1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62303
3.06185080209999e-23	0.435653432510231	0.41	0.254	6.26270963061531e-19	YPEL5	Plasma cells	GSE169246_PacTissue_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62304
9.99983754310067e-23	0.380085212012045	0.335	0.193	2.04536677106581e-18	UBL5	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62305
2.99167174086377e-21	0.404340343115322	0.933	0.898	6.11916537876275e-17	FTL	Plasma cells	GSE169246_PacTissue_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62306
6.44842813898008e-21	0.537239396580223	0.58	0.511	1.31896149154699e-16	IGHG3	Plasma cells	GSE169246_PacTissue_pre	ENSG00000282184	NA	NA	NA	IG_C_gene	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62307
8.34775934587472e-21	0.667100845089747	0.859	0.837	1.70745069660522e-16	MT-CO1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62308
2.27913807852775e-20	0.621605550949382	0.557	0.428	4.66174902582066e-16	ACTG1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62309
1.78996451044313e-19	0.301530539619745	0.706	0.563	3.66119340966037e-15	RPL36AL	Plasma cells	GSE169246_PacTissue_pre	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62310
4.38885855791262e-19	0.437930120339188	0.395	0.255	8.97697129435448e-15	EZR	Plasma cells	GSE169246_PacTissue_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62311
9.21016715362405e-19	0.532856590644131	0.282	0.164	1.88384758960226e-14	HIST1H4C	Plasma cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62312
1.78720606396659e-18	0.597091424601585	0.65	0.557	3.65555128323725e-14	GAPDH	Plasma cells	GSE169246_PacTissue_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62313
3.1586799327187e-18	0.370533172925273	0.252	0.137	6.46076393438284e-14	UQCRB	Plasma cells	GSE169246_PacTissue_pre	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62314
3.20839152476861e-17	0.304962025838389	0.283	0.166	6.56244402476172e-13	UQCR11	Plasma cells	GSE169246_PacTissue_pre	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62315
4.77001868571131e-17	0.355309992810759	0.741	0.647	9.75659621975392e-13	MT-ND1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62316
6.86087995465977e-17	0.37098659702798	0.717	0.622	1.40332438592611e-12	MIF	Plasma cells	GSE169246_PacTissue_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62317
5.88215547403973e-16	0.255619605261171	0.403	0.263	1.20313608066009e-11	PSME1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62318
8.07814302034955e-16	0.444379200936212	0.488	0.354	1.6523033733823e-11	PPP1R15A	Plasma cells	GSE169246_PacTissue_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62319
2.29688310238965e-15	0.458134443180744	0.269	0.162	4.69804469762779e-11	KLF2	Plasma cells	GSE169246_PacTissue_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62320
3.50711985404861e-15	0.400659852626258	0.368	0.254	7.17346294947102e-11	RGS1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62321
3.2637319759267e-14	0.265772030673048	0.856	0.815	6.67563738356047e-10	CD74	Plasma cells	GSE169246_PacTissue_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62322
7.03942423939879e-14	0.273288105584357	0.307	0.2	1.43984383392663e-09	POLR2L	Plasma cells	GSE169246_PacTissue_pre	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62323
1.13263224715788e-13	0.323265112035961	0.297	0.195	2.31668599833672e-09	ELOB	Plasma cells	GSE169246_PacTissue_pre	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62324
8.19778414951943e-13	0.493585868223702	0.699	0.654	1.6767747699427e-08	MT-ATP8	Plasma cells	GSE169246_PacTissue_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62325
2.28820970220678e-12	0.387410566930886	0.537	0.379	4.68030412489375e-08	SAT1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62326
1.23059198660749e-11	0.327988682447746	0.499	0.427	2.51705284940696e-07	OST4	Plasma cells	GSE169246_PacTissue_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62327
3.78675916809725e-11	-1.62349968090649	0.367	0.499	7.74543720242611e-07	IGKV3-11	Plasma cells	GSE169246_PacTissue_pre	ENSG00000282823	NA	NA	NA	IG_V_gene	P04433	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62328
1.0420611961902e-09	0.358653154452864	0.298	0.218	2.13143197068744e-05	IRF1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62329
9.08482191043205e-09	0.435214740965538	0.383	0.303	0.000185820947355977	NEAT1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62330
1.04346213992689e-07	0.259236213599257	0.336	0.265	0.00213429746100646	GABARAP	Plasma cells	GSE169246_PacTissue_pre	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62331
8.99680629793649e-07	1.18466506039301	0.346	0.269	0.0184020676017993	IGHG4	Plasma cells	GSE169246_PacTissue_pre	ENSG00000277016	NA	NA	NA	IG_C_gene	P01861	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62332
1.25728881468201e-06	0.347294900849321	0.379	0.321	0.0257165854155059	NR4A1	Plasma cells	GSE169246_PacTissue_pre	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62333
5.77596576926798e-91	-0.723574417932726	0.996	0.998	1.18141603844607e-86	RPL28	B cells	GSE169246_PacTissue_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62334
1.27057769825396e-71	0.390667974152816	0.295	0.005	2.59883962400865e-67	IGLV3-9	B cells	GSE169246_PacTissue_pre	ENSG00000211670	NA	NA	NA	IG_V_gene	A0A075B6K5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62335
3.47022644153693e-71	1.11000962231789	0.999	0.985	7.09800116351963e-67	MALAT1	B cells	GSE169246_PacTissue_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62336
1.64057202459874e-65	-0.952872118393156	0.346	0.718	3.35562601911427e-61	ISG20	B cells	GSE169246_PacTissue_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62337
1.64877005557725e-64	-0.77031620295509	0.985	0.999	3.3723942716777e-60	TMSB4X	B cells	GSE169246_PacTissue_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62338
4.90422080626573e-64	-1.3625907943913	0.058	0.441	1.00310932371359e-59	TCL1A	B cells	GSE169246_PacTissue_pre	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62339
2.61661454387379e-58	1.136726604033	0.817	0.514	5.35202338803944e-54	HSPA1A	B cells	GSE169246_PacTissue_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62340
3.17033435444604e-55	-0.653560162949117	0.924	0.978	6.48460188858392e-51	RPL41	B cells	GSE169246_PacTissue_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62341
2.63557176863691e-54	1.19352504353918	0.808	0.557	5.39079849556994e-50	KLF6	B cells	GSE169246_PacTissue_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62342
2.90600448264835e-53	-0.709849831969757	0.166	0.52	5.94394156880894e-49	MX1	B cells	GSE169246_PacTissue_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62343
3.60600208495527e-53	0.640875931816665	0.493	0.158	7.37571666456751e-49	PARP15	B cells	GSE169246_PacTissue_pre	ENSG00000173200	165631	poly(ADP-ribose) polymerase family member 15	ARTD7|BAL3|FLJ40597|pART7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62344
2.839751222798e-52	-1.08579946821766	0.452	0.722	5.80842715111102e-48	IFITM1	B cells	GSE169246_PacTissue_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62345
8.36554799311019e-52	0.315734001135163	0.367	0.071	1.71108918651076e-47	IGLV2-23	B cells	GSE169246_PacTissue_pre	ENSG00000211660	NA	NA	NA	IG_V_gene	P01705	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62346
5.91637873797992e-51	0.979020415032304	0.847	0.589	1.21013610706641e-46	JUN	B cells	GSE169246_PacTissue_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62347
8.54016283073845e-51	-0.774547360477537	0.999	1	1.74680490539924e-46	ACTB	B cells	GSE169246_PacTissue_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62348
1.52344422024336e-50	1.07317768762729	0.817	0.574	3.11605280808577e-46	HSPA1B	B cells	GSE169246_PacTissue_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62349
6.32662612410134e-47	0.626134391882224	0.787	0.508	1.29404810742369e-42	HLA-DRB5	B cells	GSE169246_PacTissue_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62350
6.86480487260905e-47	-0.633667115506401	0.907	0.947	1.40412718864346e-42	CD79A	B cells	GSE169246_PacTissue_pre	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62351
1.06245433629105e-43	-0.652847367487817	0.781	0.923	2.17314409944972e-39	SERF2	B cells	GSE169246_PacTissue_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62352
2.86255305130708e-42	0.791094341896485	0.51	0.225	5.8550660111435e-38	SAMSN1	B cells	GSE169246_PacTissue_pre	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62353
1.08960674103513e-41	0.678724891871477	0.259	0.034	2.22868162811325e-37	IGHV3-7	B cells	GSE169246_PacTissue_pre	ENSG00000282211	NA	NA	NA	IG_V_gene	P01780	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62354
1.53288356057418e-41	-0.442384605191858	0.97	0.998	3.13536003479843e-37	RPS3	B cells	GSE169246_PacTissue_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62355
1.72718701698765e-41	0.394622371441438	0.305	0.062	3.53278832454653e-37	IGHG2	B cells	GSE169246_PacTissue_pre	ENSG00000274497	NA	NA	NA	IG_C_gene	P01859	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62356
3.3880562069261e-41	1.00015155155651	0.787	0.512	6.92993016564665e-37	CD69	B cells	GSE169246_PacTissue_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62357
7.20065490233616e-41	0.593901252678519	0.41	0.133	1.47282195372384e-36	DUSP10	B cells	GSE169246_PacTissue_pre	ENSG00000143507	11221	dual specificity phosphatase 10	MKP-5|MKP5	protein_coding	Q9Y6W6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62358
1.20828732598598e-40	-1.08025726168883	0.85	0.917	2.47143089657172e-36	GAPDH	B cells	GSE169246_PacTissue_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62359
3.83389782578492e-40	0.491185477783234	0.425	0.144	7.84185461286046e-36	BCL2	B cells	GSE169246_PacTissue_pre	ENSG00000171791	596	BCL2 apoptosis regulator	Bcl-2|PPP1R50	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62360
8.79437443558192e-40	0.436944419988845	0.394	0.119	1.79880134705393e-35	IGLV3-1	B cells	GSE169246_PacTissue_pre	ENSG00000211673	NA	NA	NA	IG_V_gene	P01715	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62361
6.09125582813211e-39	-0.542361180854658	0.984	0.999	1.24590546708614e-34	RPS19	B cells	GSE169246_PacTissue_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62362
6.45812017957851e-38	-0.488196176438902	0.966	0.996	1.32094390153099e-33	RPLP0	B cells	GSE169246_PacTissue_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62363
2.24823747350195e-37	-0.562320160868896	0.784	0.893	4.59854492830089e-33	ARHGDIB	B cells	GSE169246_PacTissue_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62364
2.15391511955686e-36	-0.698854873601284	0.174	0.46	4.4056179855416e-32	ISG15	B cells	GSE169246_PacTissue_pre	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62365
3.195685180865e-36	-1.09745454715137	0.451	0.69	6.53645446894127e-32	HMGN2	B cells	GSE169246_PacTissue_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62366
3.21661687830137e-36	0.639891293949544	0.674	0.421	6.57926816287761e-32	TAGAP	B cells	GSE169246_PacTissue_pre	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62367
3.54645506789184e-36	-0.427752351265462	0.991	0.999	7.25391919586597e-32	RPL19	B cells	GSE169246_PacTissue_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62368
4.52341969875781e-36	0.575128428033542	0.542	0.263	9.25220265183923e-32	KIAA1551	B cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62369
5.19691607705798e-36	-0.43541913488002	0.973	0.991	1.06297721440144e-31	RPS24	B cells	GSE169246_PacTissue_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62370
1.40226786620986e-35	1.1119219471023	0.783	0.689	2.86819869354565e-31	HSPH1	B cells	GSE169246_PacTissue_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62371
2.55156963020684e-35	0.729967916573262	0.717	0.428	5.21898052162508e-31	KLF2	B cells	GSE169246_PacTissue_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62372
4.48320958915517e-35	-0.525182658389099	0.406	0.684	9.16995689365799e-31	PPDPF	B cells	GSE169246_PacTissue_pre	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62373
5.10798378190517e-35	-0.606179301551143	0.793	0.898	1.04478700275088e-30	CORO1A	B cells	GSE169246_PacTissue_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62374
5.39783539701309e-35	-0.50835803574774	0.725	0.874	1.10407325210506e-30	ARPC3	B cells	GSE169246_PacTissue_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62375
1.42284508806024e-34	0.693935466290645	0.686	0.478	2.91028734311841e-30	RALGPS2	B cells	GSE169246_PacTissue_pre	ENSG00000116191	55103	Ral GEF with PH domain and SH3 binding motif 2	FLJ10244|FLJ25604|KIAA0351	protein_coding	Q86X27	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62376
2.85622195769297e-34	0.722315722153291	0.9	0.746	5.8421163922652e-30	ZFP36	B cells	GSE169246_PacTissue_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62377
2.71502446119793e-33	-0.590814948010715	0.906	0.959	5.55331103293426e-29	PFN1	B cells	GSE169246_PacTissue_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62378
2.84299294254603e-33	-0.460653570710821	0.659	0.852	5.81505776468366e-29	MYL6	B cells	GSE169246_PacTissue_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62379
4.87371944066048e-33	-0.43237984642902	0.993	0.998	9.96870574392694e-29	PTMA	B cells	GSE169246_PacTissue_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62380
8.21947217992e-33	0.366959563165139	0.317	0.092	1.68121083968084e-28	NR1D2	B cells	GSE169246_PacTissue_pre	ENSG00000174738	9975	nuclear receptor subfamily 1 group D member 2	BD73|EAR-1r|Hs.37288|HZF2|REVERBB|REVERBbeta|RVR	protein_coding	Q14995	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62381
1.0276097885578e-32	0.500975024044308	0.608	0.332	2.10187306151613e-28	CD82	B cells	GSE169246_PacTissue_pre	ENSG00000085117	3732	CD82 molecule	IA4|KAI1|R2|ST6|TSPAN27	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62382
4.0820706603507e-32	-0.585112579921733	0.235	0.495	8.34946732868131e-28	COX5A	B cells	GSE169246_PacTissue_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62383
4.95475811644673e-32	0.589572876777364	0.497	0.227	1.01344622513801e-27	GPR183	B cells	GSE169246_PacTissue_pre	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62384
7.19512162521029e-32	-0.585555181856356	0.835	0.911	1.47169017722051e-27	CFL1	B cells	GSE169246_PacTissue_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62385
8.60034159194949e-32	0.670953701080089	0.847	0.597	1.75911386921735e-27	NR4A2	B cells	GSE169246_PacTissue_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62386
8.6280840427779e-32	-0.493071768497455	0.235	0.506	1.76478831010979e-27	IRF7	B cells	GSE169246_PacTissue_pre	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62387
2.11211619614365e-31	0.615383953494839	0.585	0.346	4.32012246759223e-27	PRDM2	B cells	GSE169246_PacTissue_pre	ENSG00000116731	7799	PR/SET domain 2	HUMHOXY1|KMT8|KMT8A|MTB-ZF|RIZ|RIZ1|RIZ2	protein_coding	Q13029	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62388
7.38479274172023e-31	-0.399285353018019	0.964	0.988	1.51048550739146e-26	RPL15	B cells	GSE169246_PacTissue_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62389
1.18692659235991e-30	-0.418211377590588	0.984	0.999	2.42773965201296e-26	RPL18A	B cells	GSE169246_PacTissue_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62390
1.55489785963578e-30	0.620838910400699	0.642	0.417	3.18038808209903e-26	CCNL1	B cells	GSE169246_PacTissue_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62391
1.70727175089247e-30	-0.576793618315536	0.274	0.533	3.49205363927546e-26	LY6E	B cells	GSE169246_PacTissue_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62392
3.36414901690456e-30	-0.497185852384596	0.627	0.817	6.88103039917658e-26	MYL12A	B cells	GSE169246_PacTissue_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62393
1.22608757518321e-29	-0.445362536854007	0.955	0.99	2.50783952627973e-25	RPL12	B cells	GSE169246_PacTissue_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62394
2.03702341546201e-29	0.456303112198667	0.452	0.204	4.166527693986e-25	SESN3	B cells	GSE169246_PacTissue_pre	ENSG00000149212	143686	sestrin 3	MGC29667|SEST3	protein_coding	P58005	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62395
2.92269386113616e-29	0.738363817693148	0.855	0.726	5.97807802356791e-25	DNAJB1	B cells	GSE169246_PacTissue_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62396
4.39722869077935e-29	0.770276748619752	0.97	0.958	8.99409156412009e-25	HSP90AB1	B cells	GSE169246_PacTissue_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62397
1.03623192801833e-28	0.474938576312707	0.915	0.8	2.1195087855687e-24	PNRC1	B cells	GSE169246_PacTissue_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62398
3.17201317340612e-28	-0.958773026946971	0.886	0.927	6.48803574488489e-24	ACTG1	B cells	GSE169246_PacTissue_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62399
6.95011372719894e-28	0.451371387142002	0.361	0.141	1.42157626176127e-23	BAG3	B cells	GSE169246_PacTissue_pre	ENSG00000151929	9531	BAG cochaperone 3	NA	protein_coding	O95817	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62400
1.00178703698907e-27	0.765391947685152	0.738	0.548	2.04905520545745e-23	SQSTM1	B cells	GSE169246_PacTissue_pre	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62401
1.16745145443382e-27	-0.388987349534855	0.991	0.999	2.38790520489894e-23	RPS15	B cells	GSE169246_PacTissue_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62402
1.24153031313358e-27	-0.522695082309837	0.939	0.975	2.53942610248343e-23	TMSB10	B cells	GSE169246_PacTissue_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62403
2.24878892623094e-27	0.387198019661235	0.302	0.102	4.59967286971276e-23	DNAJB4	B cells	GSE169246_PacTissue_pre	ENSG00000162616	11080	DnaJ heat shock protein family (Hsp40) member B4	HLJ1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62404
2.62333831897879e-27	-0.423735553406457	0.093	0.32	5.36577619763923e-23	IFI44L	B cells	GSE169246_PacTissue_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62405
3.43372241895789e-27	0.546547887402516	0.945	0.886	7.02333583573648e-23	MS4A1	B cells	GSE169246_PacTissue_pre	ENSG00000156738	931	membrane spanning 4-domains A1	B1|Bp35|CD20|FMC7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62406
4.87043704658462e-27	-0.498285227168358	0.886	0.948	9.96199193508418e-23	PPIA	B cells	GSE169246_PacTissue_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62407
6.27721891282146e-27	0.437604801098314	0.497	0.253	1.2839423564285e-22	CHD2	B cells	GSE169246_PacTissue_pre	ENSG00000173575	1106	chromodomain helicase DNA binding protein 2	DKFZp547I1315|DKFZp686E01200|DKFZp781D1727|FLJ38614	protein_coding	O14647	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62408
1.17163837417451e-26	0.410444075129565	0.461	0.221	2.39646913053655e-22	PTPN1	B cells	GSE169246_PacTissue_pre	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62409
1.96651805280363e-26	-0.568125177855885	0.65	0.807	4.02231602520455e-22	LIMD2	B cells	GSE169246_PacTissue_pre	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62410
3.64998591878525e-26	-0.396204526656257	0.796	0.919	7.46568119828336e-22	BTF3	B cells	GSE169246_PacTissue_pre	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62411
4.0445041061211e-26	-0.358854908005003	0.976	0.996	8.2726286986601e-22	FAU	B cells	GSE169246_PacTissue_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62412
4.11173637839141e-26	0.586659648497157	0.528	0.304	8.41014558836178e-22	IER5	B cells	GSE169246_PacTissue_pre	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62413
4.87902160552019e-26	-0.331214468494049	1	1	9.97955079193099e-22	CD74	B cells	GSE169246_PacTissue_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62414
7.52720146516262e-26	-0.61250584108002	0.56	0.74	1.53961378768436e-21	ATP5MG	B cells	GSE169246_PacTissue_pre	ENSG00000167283	10632	ATP synthase membrane subunit g	ATP5JG|ATP5L	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62415
8.92025183923938e-26	-0.736007314964279	0.412	0.624	1.82454831119802e-21	H2AFZ	B cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62416
9.15924621334081e-26	0.42258992482997	0.512	0.276	1.87343222047673e-21	CCDC50	B cells	GSE169246_PacTissue_pre	ENSG00000152492	152137	coiled-coil domain containing 50	C3orf6|DFNA44|Ymer	protein_coding	Q8IVM0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62417
2.02876762302635e-25	-0.444037962002137	0.253	0.492	4.1496412961381e-21	ATP5MC3	B cells	GSE169246_PacTissue_pre	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62418
2.25494229003318e-25	-0.366933389507597	0.969	0.994	4.61225896003387e-21	RPL14	B cells	GSE169246_PacTissue_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62419
2.27436455190313e-25	0.455784979023612	0.457	0.23	4.65198525446266e-21	ATF7IP	B cells	GSE169246_PacTissue_pre	ENSG00000171681	55729	activating transcription factor 7 interacting protein	ATF7IP1|FLJ10688|p621	protein_coding	Q6VMQ6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62420
4.55591698359206e-25	0.673303151373675	0.686	0.477	9.31867259823919e-21	SLC2A3	B cells	GSE169246_PacTissue_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62421
5.74541285451883e-25	0.353351108100156	0.415	0.191	1.17516674526328e-20	SERINC1	B cells	GSE169246_PacTissue_pre	ENSG00000111897	57515	serine incorporator 1	KIAA1253|TDE1L|TDE2|TMS-2	protein_coding	Q9NRX5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62422
5.81188457837547e-25	0.324756796405939	0.349	0.137	1.18876287166092e-20	DOCK10	B cells	GSE169246_PacTissue_pre	ENSG00000135905	55619	dedicator of cytokinesis 10	KIAA0694|ZIZ3	protein_coding	Q96BY6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62423
8.18986789351804e-25	0.467838336755434	0.599	0.367	1.67515557894018e-20	CD44	B cells	GSE169246_PacTissue_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62424
2.38341548743197e-24	-0.348086885748918	0.963	0.994	4.87503803799334e-20	RPS13	B cells	GSE169246_PacTissue_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62425
2.57678903827226e-24	0.546965853926542	0.612	0.398	5.27056429888209e-20	PDE4B	B cells	GSE169246_PacTissue_pre	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62426
5.96405507213759e-24	-0.435019208889195	0.503	0.693	1.21988782445502e-19	COX6A1	B cells	GSE169246_PacTissue_pre	ENSG00000111775	1337	cytochrome c oxidase subunit 6A1	COX6A|COX6AL	protein_coding	P12074	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62427
1.19270019346311e-23	0.443192398533243	0.491	0.276	2.43954897570944e-19	EML4	B cells	GSE169246_PacTissue_pre	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62428
1.42413113765089e-23	-0.634834980933982	0.485	0.675	2.91291782895113e-19	HMGN1	B cells	GSE169246_PacTissue_pre	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62429
1.42647014228607e-23	-0.33401309646651	0.913	0.978	2.91770202903193e-19	NACA	B cells	GSE169246_PacTissue_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62430
3.33977343092692e-23	-0.371458983427872	0.62	0.801	6.83117257561793e-19	RPL36AL	B cells	GSE169246_PacTissue_pre	ENSG00000165502	6166	ribosomal protein L36a like	RPL36A|RPL36AP42	protein_coding	Q969Q0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62431
4.12891726671518e-23	0.351110971969285	0.298	0.112	8.44528737733922e-19	ZNF267	B cells	GSE169246_PacTissue_pre	ENSG00000185947	10308	zinc finger protein 267	HZF2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62432
4.53889314789501e-23	-0.464613052189768	0.284	0.51	9.28385204470446e-19	DBI	B cells	GSE169246_PacTissue_pre	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62433
1.19602808121939e-22	-0.350971922626417	0.19	0.412	2.44635583732614e-18	RBX1	B cells	GSE169246_PacTissue_pre	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62434
1.66953755643711e-22	0.421207144849644	0.431	0.218	3.41487211793647e-18	AHNAK	B cells	GSE169246_PacTissue_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62435
1.97107991906492e-22	0.411128620351488	0.407	0.204	4.0316468664554e-18	PIKFYVE	B cells	GSE169246_PacTissue_pre	ENSG00000115020	200576	phosphoinositide kinase, FYVE-type zinc finger containing	FAB1|KIAA0981|MGC40423|p235|PIP5K|PIP5K3|ZFYVE29	protein_coding	Q9Y2I7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62436
2.95884301622655e-22	-0.406406019794924	0.775	0.872	6.05201750538978e-18	RAC2	B cells	GSE169246_PacTissue_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62437
3.14000957306525e-22	0.461642606979261	0.777	0.642	6.42257558074767e-18	BANK1	B cells	GSE169246_PacTissue_pre	ENSG00000153064	55024	B cell scaffold protein with ankyrin repeats 1	BANK|FLJ20706	protein_coding	Q8NDB2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62438
3.30580073389827e-22	-0.398818082711232	0.63	0.78	6.76168482111551e-18	CHCHD2	B cells	GSE169246_PacTissue_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62439
3.91114825325872e-22	0.270366708415216	0.284	0.102	7.99986263721538e-18	CDK17	B cells	GSE169246_PacTissue_pre	ENSG00000059758	5128	cyclin dependent kinase 17	PCTAIRE2|PCTK2	protein_coding	Q00537	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62440
4.18686540101779e-22	-0.384256845134333	0.362	0.586	8.56381449124178e-18	SMDT1	B cells	GSE169246_PacTissue_pre	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62441
5.19221681376767e-22	-0.813423930254175	0.584	0.718	1.06201602708804e-17	TUBA1B	B cells	GSE169246_PacTissue_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62442
6.11122689698342e-22	-0.352084655813474	0.954	0.989	1.24999034950899e-17	RPL29	B cells	GSE169246_PacTissue_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62443
8.28995902213395e-22	-0.329628129552144	0.942	0.988	1.69562821838728e-17	RACK1	B cells	GSE169246_PacTissue_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62444
9.68289383750001e-22	-0.347085128638184	0.118	0.318	1.98053910552225e-17	PLSCR1	B cells	GSE169246_PacTissue_pre	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62445
9.92502459047988e-22	-0.402351641019874	0.314	0.52	2.03006452973675e-17	GNG5	B cells	GSE169246_PacTissue_pre	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62446
1.03784061589502e-21	0.399514187994564	0.346	0.152	2.12279919575167e-17	MARCKS	B cells	GSE169246_PacTissue_pre	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62447
1.08176101747643e-21	-0.356452518295445	0.912	0.978	2.21263398514629e-17	RPSA	B cells	GSE169246_PacTissue_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62448
1.89230396708557e-21	0.271291243371067	0.29	0.11	3.87051853427683e-17	MORC3	B cells	GSE169246_PacTissue_pre	ENSG00000159256	23515	MORC family CW-type zinc finger 3	KIAA0136|NXP2|ZCW5|ZCWCC3	protein_coding	Q14149	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62449
1.96560293084137e-21	0.372137057685081	0.397	0.197	4.02044423474294e-17	ZBTB20	B cells	GSE169246_PacTissue_pre	ENSG00000181722	26137	zinc finger and BTB domain containing 20	DKFZp566F123|DPZF|ODA-8S|ZNF288	protein_coding	Q9HC78	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62450
2.40961083770082e-21	0.531107081332243	0.591	0.397	4.92861800743327e-17	RASGEF1B	B cells	GSE169246_PacTissue_pre	ENSG00000138670	153020	RasGEF domain family member 1B	FLJ31695|GPIG4	protein_coding	Q0VAM2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62451
2.50175484750669e-21	-0.358711583264826	0.708	0.831	5.11708936509019e-17	RPS26	B cells	GSE169246_PacTissue_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62452
2.68621278259411e-21	0.421442661042258	0.915	0.835	5.49437962551798e-17	DDX5	B cells	GSE169246_PacTissue_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62453
2.93168285405307e-21	0.296278400675525	0.329	0.139	5.99646410968016e-17	RNF19A	B cells	GSE169246_PacTissue_pre	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62454
3.06638010579192e-21	0.260631436956372	0.266	0.094	6.2719738683868e-17	ZNF506	B cells	GSE169246_PacTissue_pre	ENSG00000081665	440515	zinc finger protein 506	DKFZp761G1812	protein_coding	Q5JVG8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62455
3.57955792936392e-21	-0.374738315007302	0.552	0.725	7.32162778872096e-17	PSME1	B cells	GSE169246_PacTissue_pre	ENSG00000284916	5720	proteasome activator subunit 1	IFI5111|PA28alpha	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62456
3.72433302409666e-21	0.472079721036411	0.419	0.218	7.61775076748731e-17	SLC38A2	B cells	GSE169246_PacTissue_pre	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62457
4.61258733555553e-21	0.414506622206183	0.488	0.273	9.43458613614527e-17	TXNIP	B cells	GSE169246_PacTissue_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62458
4.99172342319846e-21	0.590570379278714	0.636	0.415	1.02100710898101e-16	FOSB	B cells	GSE169246_PacTissue_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62459
7.56385756100536e-21	0.439299386759923	0.445	0.24	1.54711142552804e-16	PHACTR1	B cells	GSE169246_PacTissue_pre	ENSG00000112137	221692	phosphatase and actin regulator 1	dJ257A7.2|KIAA1733|RPEL1	protein_coding	Q9C0D0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62460
8.37564360157992e-21	0.476348052673215	0.642	0.465	1.71315414226716e-16	WSB1	B cells	GSE169246_PacTissue_pre	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62461
1.01672742491217e-20	-0.325673065674656	0.978	0.995	2.07961427491534e-16	RPL26	B cells	GSE169246_PacTissue_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62462
1.12134053007482e-20	-0.319848349142454	0.96	0.988	2.29358992021503e-16	RPS9	B cells	GSE169246_PacTissue_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62463
1.3768961948621e-20	-0.589269094692798	0.187	0.386	2.81630347697095e-16	BACH2	B cells	GSE169246_PacTissue_pre	ENSG00000112182	60468	BTB domain and CNC homolog 2	BTBD25	protein_coding	Q9BYV9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62464
1.41476167967648e-20	-0.330576156626512	0.91	0.978	2.89375353961026e-16	RPL24	B cells	GSE169246_PacTissue_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62465
1.56769777264067e-20	0.591593458397417	0.343	0.149	3.20656902415923e-16	EGR1	B cells	GSE169246_PacTissue_pre	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62466
2.11128899876325e-20	0.550424795924632	0.804	0.655	4.31843051807035e-16	DUSP1	B cells	GSE169246_PacTissue_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62467
2.43523370944229e-20	-0.410854179450046	0.973	0.974	4.98102702929326e-16	HLA-DRB1	B cells	GSE169246_PacTissue_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62468
2.58531562351368e-20	0.396845923101506	0.347	0.158	5.28800457633488e-16	TNFAIP3	B cells	GSE169246_PacTissue_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62469
2.76813905044177e-20	0.367844589835053	0.488	0.286	5.66195161377359e-16	N4BP2L2	B cells	GSE169246_PacTissue_pre	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62470
3.07369376958655e-20	0.357176351695537	0.296	0.122	6.28693323631234e-16	ZEB2	B cells	GSE169246_PacTissue_pre	ENSG00000169554	9839	zinc finger E-box binding homeobox 2	KIAA0569|SIP-1|SIP1|ZFHX1B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62471
3.26227807192863e-20	0.278160404237958	0.367	0.17	6.67266356832282e-16	PPP3CA	B cells	GSE169246_PacTissue_pre	ENSG00000138814	5530	protein phosphatase 3 catalytic subunit alpha	CALN|CALNA|CNA1|PPP2B	protein_coding	Q08209	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62472
3.49740145226408e-20	0.56396824340612	0.472	0.276	7.15358493046095e-16	NEAT1	B cells	GSE169246_PacTissue_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62473
4.85511181532594e-20	0.347614738551012	0.455	0.252	9.93064570706767e-16	ANKRD44	B cells	GSE169246_PacTissue_pre	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62474
4.98924999666218e-20	-0.311066098667137	0.987	0.996	1.02050119431728e-15	RPL8	B cells	GSE169246_PacTissue_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62475
5.2386231475752e-20	-0.489711161964147	0.437	0.622	1.07150797860503e-15	SLC25A5	B cells	GSE169246_PacTissue_pre	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62476
5.8302404232394e-20	-0.521415102006913	0.265	0.463	1.19251737616939e-15	H2AFV	B cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62477
6.15610078170196e-20	0.656707165429332	0.892	0.904	1.25916885388932e-15	RPS29	B cells	GSE169246_PacTissue_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62478
7.58911277113106e-20	-0.424946860489271	0.578	0.717	1.55227712620715e-15	NCF1	B cells	GSE169246_PacTissue_pre	ENSG00000158517	653361	neutrophil cytosolic factor 1	NCF1A|NOXO2|p47phox|SH3PXD1A	protein_coding	P14598	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62479
7.68874747705845e-20	0.32005901603045	0.314	0.137	1.57265640895753e-15	CREBRF	B cells	GSE169246_PacTissue_pre	ENSG00000164463	153222	CREB3 regulatory factor	C5orf41|LRF	protein_coding	Q8IUR6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62480
1.71993065668472e-19	0.415529653198462	0.686	0.52	3.51794616518293e-15	STK4	B cells	GSE169246_PacTissue_pre	ENSG00000101109	6789	serine/threonine kinase 4	KRS2|MST1|YSK3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62481
1.87625001042164e-19	0.359687570851587	0.422	0.23	3.83768177131641e-15	TANK	B cells	GSE169246_PacTissue_pre	ENSG00000136560	10010	TRAF family member associated NFKB activator	I-TRAF|TRAF2	protein_coding	Q92844	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62482
2.12091105049132e-19	0.645578808458953	0.487	0.293	4.33811146267495e-15	HSPB1	B cells	GSE169246_PacTissue_pre	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62483
2.70078774847886e-19	0.875254991327243	0.343	0.153	5.52419126073866e-15	IGKV3-15	B cells	GSE169246_PacTissue_pre	ENSG00000282447	NA	NA	NA	IG_V_gene	P01624	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62484
2.9840870541157e-19	-0.313474207533979	0.177	0.376	6.10365166048825e-15	SHISA5	B cells	GSE169246_PacTissue_pre	ENSG00000164054	51246	shisa family member 5	hShisa5|SCOTIN	protein_coding	Q8N114	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62485
3.23084817998793e-19	-0.370451400569479	0.831	0.899	6.60837686734731e-15	HNRNPA1	B cells	GSE169246_PacTissue_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62486
3.90930132323174e-19	-0.330134531757555	0.99	0.999	7.9960849265382e-15	RPS2	B cells	GSE169246_PacTissue_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62487
5.04871355917164e-19	0.381363529905552	0.716	0.539	1.03266387139297e-14	EIF4G2	B cells	GSE169246_PacTissue_pre	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62488
5.45059227604856e-19	-0.466847551814726	0.305	0.51	1.11486414414297e-14	MARCKSL1	B cells	GSE169246_PacTissue_pre	ENSG00000175130	65108	MARCKS like 1	F52|MacMARCKS|MLP|MLP1	protein_coding	P49006	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62489
7.56635635668842e-19	0.438220682503639	0.741	0.563	1.54762252919705e-14	PPP1R15A	B cells	GSE169246_PacTissue_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62490
7.83422131113232e-19	0.414584005478703	0.76	0.621	1.60241162697901e-14	RBM39	B cells	GSE169246_PacTissue_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62491
1.41254770632355e-18	0.387111272380095	0.494	0.298	2.88922507851419e-14	PARP14	B cells	GSE169246_PacTissue_pre	ENSG00000173193	54625	poly(ADP-ribose) polymerase family member 14	ARTD8|BAL2|KIAA1268|pART8	protein_coding	Q460N5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62492
1.55594842279297e-18	0.372836384040817	0.558	0.353	3.18253690398074e-14	CD24	B cells	GSE169246_PacTissue_pre	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62493
1.91288399086423e-18	0.743030921078825	0.814	0.758	3.91261291491369e-14	HSPD1	B cells	GSE169246_PacTissue_pre	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62494
2.04291555180233e-18	0.284510554415352	0.328	0.151	4.17857946965648e-14	MTSS1	B cells	GSE169246_PacTissue_pre	ENSG00000170873	9788	MTSS I-BAR domain containing 1	KIAA0429|MIM|MIMA|MIMB	protein_coding	O43312	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62495
3.10911402235527e-18	0.591203504701794	0.624	0.49	6.35938182132547e-14	CHORDC1	B cells	GSE169246_PacTissue_pre	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62496
3.1560639012389e-18	0.51408983516179	0.539	0.374	6.45541310359404e-14	ARID5B	B cells	GSE169246_PacTissue_pre	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62497
5.21438565552514e-18	0.35870260603483	0.439	0.251	1.06655044198111e-13	RAB8B	B cells	GSE169246_PacTissue_pre	ENSG00000166128	51762	RAB8B, member RAS oncogene family	NA	protein_coding	Q92930	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62498
5.98238675782687e-18	-0.303521239808411	0.846	0.956	1.22363738744591e-13	RPL22	B cells	GSE169246_PacTissue_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62499
6.51651290504495e-18	0.33870918532912	0.548	0.355	1.33288754959789e-13	TAPBP	B cells	GSE169246_PacTissue_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62500
1.14683987225999e-17	0.548683391078413	0.978	0.973	2.34574627472057e-13	HSP90AA1	B cells	GSE169246_PacTissue_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62501
1.2486166364151e-17	0.356039259079021	0.413	0.228	2.55392046812345e-13	ITGB1	B cells	GSE169246_PacTissue_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62502
1.37261954916372e-17	0.337084071058842	0.422	0.238	2.80755602585946e-13	ATRX	B cells	GSE169246_PacTissue_pre	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62503
1.37608658984806e-17	0.360764844360171	0.343	0.171	2.81464751087523e-13	NAMPT	B cells	GSE169246_PacTissue_pre	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62504
1.49868920384427e-17	-0.28931560064854	0.939	0.978	3.06541889754307e-13	RPS16	B cells	GSE169246_PacTissue_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62505
1.9823561511007e-17	0.268947045261538	0.281	0.122	4.05471127146137e-13	FBXW11	B cells	GSE169246_PacTissue_pre	ENSG00000072803	23291	F-box and WD repeat domain containing 11	BTRC2|BTRCP2|Fbw11|Fbw1b|FBXW1B|Hos|KIAA0696	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62506
2.0150238832675e-17	0.49763470503116	0.626	0.458	4.12152985083534e-13	DDX3X	B cells	GSE169246_PacTissue_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62507
2.05994494139135e-17	-0.314796659350657	0.642	0.809	4.21341138312187e-13	ATP5MC2	B cells	GSE169246_PacTissue_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62508
2.22975165959205e-17	-0.30759769455661	0.889	0.974	4.56073404452958e-13	RPL35	B cells	GSE169246_PacTissue_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62509
3.13187081512748e-17	0.280664494626385	0.368	0.187	6.40592856526175e-13	PHF3	B cells	GSE169246_PacTissue_pre	ENSG00000118482	23469	PHD finger protein 3	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62510
3.40418418185367e-17	-0.331783006953179	0.353	0.551	6.96291832556349e-13	PPP1CA	B cells	GSE169246_PacTissue_pre	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62511
3.5806742269993e-17	0.332048481161544	0.504	0.319	7.32391106390437e-13	PNISR	B cells	GSE169246_PacTissue_pre	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62512
3.62592664895991e-17	0.294645883454549	0.326	0.157	7.41647036778259e-13	NUFIP2	B cells	GSE169246_PacTissue_pre	ENSG00000108256	57532	nuclear FMR1 interacting protein 2	182-FIP|82-FIP|FIP-82|KIAA1321|MGC117262|NUFP2|PIG1	protein_coding	Q7Z417	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62513
4.04414594123595e-17	0.387147597457779	0.597	0.435	8.27189610820401e-13	DDX17	B cells	GSE169246_PacTissue_pre	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62514
5.23155865337147e-17	-0.476062488808525	0.531	0.684	1.0700630069606e-12	DYNLL1	B cells	GSE169246_PacTissue_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62515
5.42832593802781e-17	0.371382904483962	0.496	0.311	1.11030978736421e-12	HSP90B1	B cells	GSE169246_PacTissue_pre	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62516
5.44949777235122e-17	-0.338597555150559	0.178	0.361	1.11464027435672e-12	XAF1	B cells	GSE169246_PacTissue_pre	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62517
6.88691478237007e-17	-0.309097015218992	0.734	0.846	1.40864954958597e-12	COX4I1	B cells	GSE169246_PacTissue_pre	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62518
8.52183624582355e-17	-0.354922929716631	0.542	0.692	1.74305638572075e-12	PSMB9	B cells	GSE169246_PacTissue_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62519
9.37970174382934e-17	-0.389350855615194	0.855	0.929	1.91852419468285e-12	OAZ1	B cells	GSE169246_PacTissue_pre	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62520
9.8904259030566e-17	0.30523613628046	0.32	0.155	2.0229877142112e-12	GOLGB1	B cells	GSE169246_PacTissue_pre	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62521
9.90595820179716e-17	-0.383802991603253	0.626	0.751	2.02616469059559e-12	YWHAB	B cells	GSE169246_PacTissue_pre	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62522
1.06478329712788e-16	-0.272094865729299	0.985	0.996	2.17790775594538e-12	RPS23	B cells	GSE169246_PacTissue_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62523
1.10056155827648e-16	-0.274183143064377	0.88	0.963	2.25108861129871e-12	UBA52	B cells	GSE169246_PacTissue_pre	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62524
1.16528958050103e-16	0.366614146228793	0.737	0.604	2.3834833079568e-12	SON	B cells	GSE169246_PacTissue_pre	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62525
1.37975566331521e-16	0.325959141432238	0.418	0.238	2.82215223374494e-12	IKZF3	B cells	GSE169246_PacTissue_pre	ENSG00000161405	22806	IKAROS family zinc finger 3	Aiolos|ZNFN1A3	protein_coding	Q9UKT9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62526
1.82976654731947e-16	-0.26008936356099	0.949	0.989	3.74260449588724e-12	RPL6	B cells	GSE169246_PacTissue_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62527
1.91992944344451e-16	-0.299971651154819	0.981	0.996	3.9270236836214e-12	RPL32	B cells	GSE169246_PacTissue_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62528
1.93930192971048e-16	0.358941156223802	0.293	0.134	3.96664816702982e-12	NEU1	B cells	GSE169246_PacTissue_pre	ENSG00000184494	4758	neuraminidase 1	NEU	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62529
2.05382994987657e-16	0.263265468814773	0.326	0.159	4.20090377947753e-12	MAP3K1	B cells	GSE169246_PacTissue_pre	ENSG00000095015	4214	mitogen-activated protein kinase kinase kinase 1	MAPKKK1|MEKK|MEKK1	protein_coding	Q13233	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62530
2.198052566034e-16	0.352282148124687	0.554	0.376	4.49589671856595e-12	ELOVL5	B cells	GSE169246_PacTissue_pre	ENSG00000012660	60481	ELOVL fatty acid elongase 5	dJ483K16.1|HELO1|SCA38	protein_coding	Q9NYP7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62531
2.2688348877725e-16	-0.319591938501094	0.238	0.425	4.64067487944986e-12	GYPC	B cells	GSE169246_PacTissue_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62532
2.49719362309927e-16	0.334195932759931	0.557	0.378	5.10775983668724e-12	RIPOR2	B cells	GSE169246_PacTissue_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62533
2.58953102785273e-16	0.341572931763178	0.407	0.23	5.29662676436997e-12	GLS	B cells	GSE169246_PacTissue_pre	ENSG00000115419	2744	glutaminase	GAC|GAM|GLS1|KGA|KIAA0838	protein_coding	O94925	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62534
2.97953119430551e-16	-0.438758475760272	0.705	0.778	6.09433310483248e-12	ARPC2	B cells	GSE169246_PacTissue_pre	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62535
2.98949005456313e-16	-0.307772429013421	0.223	0.408	6.11470295760343e-12	UBE2L6	B cells	GSE169246_PacTissue_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62536
3.24922015904962e-16	-0.380820483144608	0.554	0.712	6.64595491332009e-12	MIF	B cells	GSE169246_PacTissue_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62537
3.38933279141908e-16	-0.268810479208602	0.259	0.454	6.93254129156859e-12	TRAPPC1	B cells	GSE169246_PacTissue_pre	ENSG00000170043	58485	trafficking protein particle complex subunit 1	BET5|MUM2	protein_coding	Q9Y5R8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62538
3.81176562408027e-16	-0.276036724412319	0.946	0.983	7.79658540749378e-12	RPL23A	B cells	GSE169246_PacTissue_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62539
3.87170224544115e-16	-0.309661966986034	0.241	0.422	7.91917977282533e-12	LAMTOR5	B cells	GSE169246_PacTissue_pre	ENSG00000134248	10542	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	HBXIP|MGC71071|XIP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62540
5.08382169410792e-16	0.350171575801353	0.639	0.465	1.03984488931283e-11	SWAP70	B cells	GSE169246_PacTissue_pre	ENSG00000133789	23075	switching B cell complex subunit SWAP70	KIAA0640|SWAP-70	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62541
5.20352122019933e-16	0.348549732129356	0.301	0.141	1.06432823037957e-11	BHLHE40	B cells	GSE169246_PacTissue_pre	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62542
5.30612976144785e-16	0.417239589674073	0.963	0.93	1.08531578140654e-11	HLA-DQA1	B cells	GSE169246_PacTissue_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62543
5.56493070759347e-16	-0.292319305516076	0.246	0.434	1.13825092693117e-11	TBCA	B cells	GSE169246_PacTissue_pre	ENSG00000171530	6902	tubulin folding cofactor A	NA	protein_coding	O75347	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62544
6.84917143793769e-16	0.276488425972583	0.32	0.159	1.40092952591578e-11	ATP1A1	B cells	GSE169246_PacTissue_pre	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62545
7.46428521066357e-16	0.274867040417317	0.265	0.118	1.52674489698913e-11	CCNT2	B cells	GSE169246_PacTissue_pre	ENSG00000082258	905	cyclin T2	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62546
9.37231035129073e-16	0.31186471360181	0.621	0.446	1.91701235925301e-11	SRSF5	B cells	GSE169246_PacTissue_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62547
9.60980037599291e-16	0.351561923067675	0.588	0.422	1.96558856890559e-11	SMCHD1	B cells	GSE169246_PacTissue_pre	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62548
1.03904668956381e-15	0.300309023772655	0.392	0.221	2.12526609883382e-11	SMARCA5	B cells	GSE169246_PacTissue_pre	ENSG00000153147	8467	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5	hISWI|hSNF2H|ISWI	protein_coding	O60264	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62549
1.05592044150402e-15	0.339621947797481	0.341	0.176	2.15977967105232e-11	RHOB	B cells	GSE169246_PacTissue_pre	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62550
1.18806401274152e-15	-0.266105733250394	0.963	0.989	2.4300661316615e-11	RPS7	B cells	GSE169246_PacTissue_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62551
1.33372853622075e-15	0.311314866292458	0.754	0.544	2.72800834798592e-11	VIM	B cells	GSE169246_PacTissue_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62552
1.40606909934802e-15	-0.298252176344859	0.332	0.518	2.87597373580644e-11	BRK1	B cells	GSE169246_PacTissue_pre	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62553
1.48027865099818e-15	-0.290073752732754	0.121	0.285	3.02776195275169e-11	IL4R	B cells	GSE169246_PacTissue_pre	ENSG00000077238	3566	interleukin 4 receptor	CD124	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62554
1.48147992813479e-15	-0.425546809382312	0.374	0.525	3.0302190450069e-11	SRSF9	B cells	GSE169246_PacTissue_pre	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62555
1.85380583028746e-15	0.329766737218087	0.47	0.29	3.79177444526996e-11	CHD1	B cells	GSE169246_PacTissue_pre	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62556
1.96430293342425e-15	-0.298361503098082	0.859	0.926	4.01778522002596e-11	EEF1D	B cells	GSE169246_PacTissue_pre	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62557
2.19882575972093e-15	0.276334731831145	0.304	0.148	4.4974782089332e-11	CCNH	B cells	GSE169246_PacTissue_pre	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62558
2.21541074699019e-15	-0.258774662167478	0.969	0.999	4.53140114189374e-11	RPL18	B cells	GSE169246_PacTissue_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62559
2.25212094733112e-15	-0.30548212359013	0.575	0.736	4.60648818567108e-11	GABARAP	B cells	GSE169246_PacTissue_pre	ENSG00000170296	11337	GABA type A receptor-associated protein	ATG8A|MM46	protein_coding	O95166	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62560
2.33887759778803e-15	0.274937234064344	0.368	0.201	4.78394023851564e-11	HBP1	B cells	GSE169246_PacTissue_pre	ENSG00000283847	26959	HMG-box transcription factor 1	NA	protein_coding	O60381	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62561
2.50781101187761e-15	0.635704309132819	0.692	0.504	5.12947664369446e-11	FOS	B cells	GSE169246_PacTissue_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62562
2.84745417631073e-15	0.309246446828842	0.412	0.243	5.82418277222597e-11	PPP4R3A	B cells	GSE169246_PacTissue_pre	ENSG00000100796	55671	protein phosphatase 4 regulatory subunit 3A	FLFL1|FLJ20707|KIAA2010|MSTP033|PP4R3|SMEK1|smk-1|smk1	protein_coding	Q6IN85	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62563
3.42118282085797e-15	-0.259396722050845	0.999	1	6.99768734178289e-11	RPLP1	B cells	GSE169246_PacTissue_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62564
4.19021800945812e-15	-0.273666441607132	0.993	0.999	8.57067191654563e-11	RPS12	B cells	GSE169246_PacTissue_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62565
4.36587587635378e-15	0.347415869567185	0.482	0.318	8.92996251749402e-11	CLK1	B cells	GSE169246_PacTissue_pre	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62566
4.76066174336723e-15	0.402197302600929	0.572	0.416	9.73745752988332e-11	RSRC2	B cells	GSE169246_PacTissue_pre	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62567
4.89287211387331e-15	-0.267987034520512	0.254	0.436	1.00078806217165e-10	FKBP1A	B cells	GSE169246_PacTissue_pre	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62568
5.74656950473338e-15	-0.280184371594168	0.392	0.576	1.17540332649817e-10	COX6B1	B cells	GSE169246_PacTissue_pre	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62569
5.92333175666962e-15	-0.34283606111245	0.243	0.405	1.2115582775092e-10	SPI1	B cells	GSE169246_PacTissue_pre	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62570
5.96147941843211e-15	-0.282974926554373	0.165	0.336	1.2193610002461e-10	CD72	B cells	GSE169246_PacTissue_pre	ENSG00000137101	971	CD72 molecule	CD72b|LYB2	protein_coding	P21854	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62571
6.07142333666714e-15	-0.476893529477174	0.313	0.487	1.2418489292819e-10	UBE2S	B cells	GSE169246_PacTissue_pre	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62572
6.35615976639403e-15	-0.318267757553712	0.463	0.643	1.30008891861824e-10	UQCRH	B cells	GSE169246_PacTissue_pre	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62573
6.47471500686599e-15	-0.256363760541178	0.997	0.998	1.32433820750437e-10	RPL10	B cells	GSE169246_PacTissue_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62574
6.81091286271604e-15	-0.279490317995713	0.982	0.993	1.39310411693994e-10	RPL7A	B cells	GSE169246_PacTissue_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62575
8.94067108643971e-15	-0.370521032421346	0.834	0.905	1.82872486402038e-10	PTPRCAP	B cells	GSE169246_PacTissue_pre	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62576
9.29530850953359e-15	-0.455001910844071	0.536	0.651	1.90126240254e-10	IFITM2	B cells	GSE169246_PacTissue_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62577
1.00805488109207e-14	0.26087126657057	0.313	0.16	2.06187545378573e-10	ARIH1	B cells	GSE169246_PacTissue_pre	ENSG00000166233	25820	ariadne RBR E3 ubiquitin protein ligase 1	ARI|HARI|HHARI|UBCH7BP	protein_coding	Q9Y4X5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62578
1.03484805407825e-14	-0.317329732576013	0.461	0.633	2.11667820981164e-10	SNU13	B cells	GSE169246_PacTissue_pre	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62579
1.11587980432848e-14	0.536696287681465	0.811	0.735	2.28242055177348e-10	REL	B cells	GSE169246_PacTissue_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62580
1.15712169166333e-14	0.275429553145053	0.347	0.187	2.36677670812818e-10	RLF	B cells	GSE169246_PacTissue_pre	ENSG00000117000	6018	RLF zinc finger	Zn-15L|ZNF292L	protein_coding	Q13129	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62581
1.19315918948506e-14	0.252052339450046	0.389	0.219	2.44048780617275e-10	TAX1BP1	B cells	GSE169246_PacTissue_pre	ENSG00000106052	8887	Tax1 binding protein 1	CALCOCO3|TXBP151	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62582
1.54935787973501e-14	0.418608336625438	0.391	0.239	3.16905660720999e-10	ZFAND2A	B cells	GSE169246_PacTissue_pre	ENSG00000178381	90637	zinc finger AN1-type containing 2A	AIRAP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62583
1.56191789624625e-14	0.337554700672437	0.549	0.389	3.19474686498207e-10	SF3B1	B cells	GSE169246_PacTissue_pre	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62584
1.71190297013194e-14	-0.978085110225559	0.34	0.519	3.50152633510787e-10	IGKV3-11	B cells	GSE169246_PacTissue_pre	ENSG00000282823	NA	NA	NA	IG_V_gene	P04433	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62585
1.79331066493004e-14	0.289822763977016	0.38	0.215	3.6680376340479e-10	TGFBR2	B cells	GSE169246_PacTissue_pre	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62586
2.11693299014138e-14	-0.26677530752666	0.156	0.319	4.32997473803518e-10	EIF2AK2	B cells	GSE169246_PacTissue_pre	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62587
2.74947859616597e-14	-0.314036520126372	0.338	0.516	5.62378352059787e-10	MZT2B	B cells	GSE169246_PacTissue_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62588
2.97364425522158e-14	0.275322210632115	0.317	0.162	6.08229195963021e-10	PLEK	B cells	GSE169246_PacTissue_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62589
3.07627774904685e-14	0.336615739601755	0.466	0.304	6.29221850790042e-10	BCLAF1	B cells	GSE169246_PacTissue_pre	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62590
4.14533008752489e-14	0.292035539871382	0.463	0.294	8.47885816102341e-10	MATR3.1	B cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62591
4.16777590404057e-14	0.312469652270053	0.597	0.439	8.52476883412457e-10	MBNL1	B cells	GSE169246_PacTissue_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62592
4.64156546322897e-14	-0.309738464331837	0.442	0.595	9.49385799848854e-10	SELENOH	B cells	GSE169246_PacTissue_pre	ENSG00000211450	280636	selenoprotein H	C11orf31|SELH	protein_coding	Q8IZQ5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62593
5.03643032681459e-14	0.336452986192865	0.528	0.36	1.03015145904666e-09	IDS	B cells	GSE169246_PacTissue_pre	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62594
5.2362371401519e-14	-0.295269612156388	0.148	0.303	1.07101994464667e-09	CLEC2D	B cells	GSE169246_PacTissue_pre	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62595
5.47346835562782e-14	-0.258486529228295	0.195	0.358	1.11954321746011e-09	NEDD8	B cells	GSE169246_PacTissue_pre	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62596
5.51959435745163e-14	-0.272865113134342	0.326	0.507	1.12897782987316e-09	NDUFB11	B cells	GSE169246_PacTissue_pre	ENSG00000147123	54539	NADH:ubiquinone oxidoreductase subunit B11	ESSS|Np15|NP17.3	protein_coding	Q9NX14	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62597
5.67907416389609e-14	-0.296457569124033	0.272	0.44	1.16159782948331e-09	PARK7	B cells	GSE169246_PacTissue_pre	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62598
5.79965500095993e-14	-0.276063569286082	0.624	0.788	1.18626143389634e-09	COX7C	B cells	GSE169246_PacTissue_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62599
6.04295891296276e-14	0.481799126246936	0.81	0.696	1.2360268160574e-09	NR4A1	B cells	GSE169246_PacTissue_pre	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62600
6.25491535164921e-14	0.283361534920961	0.356	0.201	1.27938038602633e-09	LRIF1	B cells	GSE169246_PacTissue_pre	ENSG00000121931	55791	ligand dependent nuclear receptor interacting factor 1	C1orf103|FLJ11269|RIF1	protein_coding	Q5T3J3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62601
6.30514353864938e-14	0.253061917289862	0.37	0.207	1.28965405939534e-09	IKZF1	B cells	GSE169246_PacTissue_pre	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62602
7.35364202991847e-14	-0.362606000382666	0.513	0.647	1.50411394079952e-09	POLD4	B cells	GSE169246_PacTissue_pre	ENSG00000175482	57804	DNA polymerase delta 4, accessory subunit	p12|POLDS	protein_coding	Q9HCU8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62603
8.11756829543746e-14	-0.348878689850419	0.737	0.802	1.66036741914878e-09	HLA-DMA	B cells	GSE169246_PacTissue_pre	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62604
8.23664981968236e-14	-0.311111395072517	0.931	0.959	1.68472435411783e-09	LAPTM5	B cells	GSE169246_PacTissue_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62605
8.28199328824359e-14	-0.573854005448895	0.984	0.975	1.69399890717734e-09	FTH1	B cells	GSE169246_PacTissue_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62606
8.32387998288085e-14	-0.299507634451452	0.234	0.395	1.70256641169845e-09	SNRPD1	B cells	GSE169246_PacTissue_pre	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62607
1.12767131732306e-13	0.375843939827413	0.464	0.306	2.30653891245259e-09	ZC3HAV1	B cells	GSE169246_PacTissue_pre	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62608
1.19058597102269e-13	0.345472941079593	0.479	0.33	2.43522454512982e-09	AKAP13	B cells	GSE169246_PacTissue_pre	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62609
1.33351381033708e-13	0.363831280015243	0.609	0.446	2.72756914766346e-09	TCF4	B cells	GSE169246_PacTissue_pre	ENSG00000196628	6925	transcription factor 4	bHLHb19|E2-2|ITF2|SEF2-1B	protein_coding	P15884	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62610
1.34591849967203e-13	0.288440123580698	0.916	0.802	2.75294169922917e-09	MT-ND2	B cells	GSE169246_PacTissue_pre	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62611
1.41797393831354e-13	-0.282626320441561	0.496	0.649	2.90032389342651e-09	MYL12B	B cells	GSE169246_PacTissue_pre	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62612
1.46399932844547e-13	-0.486747618409774	0.317	0.457	2.99446422640237e-09	HMGA1	B cells	GSE169246_PacTissue_pre	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62613
1.66719894422611e-13	0.254210374869808	0.268	0.13	3.41008872052008e-09	REV3L	B cells	GSE169246_PacTissue_pre	ENSG00000009413	5980	REV3 like, DNA directed polymerase zeta catalytic subunit	POLZ|REV3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62614
1.77883708278349e-13	0.330728576019019	0.569	0.411	3.63843336912536e-09	ANKRD12	B cells	GSE169246_PacTissue_pre	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62615
1.84873139476402e-13	-0.2882989496169	0.219	0.381	3.78139519485034e-09	DRAP1	B cells	GSE169246_PacTissue_pre	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62616
2.13780246005833e-13	-0.319776379505351	0.403	0.558	4.37266115180331e-09	PSME2	B cells	GSE169246_PacTissue_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62617
2.2904348209271e-13	0.254596785780168	0.343	0.187	4.68485538272428e-09	CELF2	B cells	GSE169246_PacTissue_pre	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62618
2.49914234048182e-13	0.324265764967737	0.403	0.244	5.1117457432215e-09	SMG1	B cells	GSE169246_PacTissue_pre	ENSG00000157106	23049	SMG1 nonsense mediated mRNA decay associated PI3K related kinase	ATX|KIAA0421|LIP	protein_coding	Q96Q15	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62619
2.59118583880399e-13	0.578638749482185	0.431	0.28	5.30001151468968e-09	NR4A3	B cells	GSE169246_PacTissue_pre	ENSG00000119508	8013	nuclear receptor subfamily 4 group A member 3	CHN|CSMF|MINOR|NOR1	protein_coding	Q92570	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62620
2.7675078989358e-13	-0.271030888426433	0.247	0.414	5.66066065648329e-09	ATP5MF	B cells	GSE169246_PacTissue_pre	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62621
2.8608978421486e-13	0.376672470661316	0.784	0.678	5.85168044633074e-09	PTPRC	B cells	GSE169246_PacTissue_pre	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62622
3.45993801400765e-13	-0.350545529597465	0.287	0.442	7.07695721385124e-09	BCL3	B cells	GSE169246_PacTissue_pre	ENSG00000069399	602	BCL3 transcription coactivator	BCL4|D19S37	protein_coding	P20749	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62623
3.50368572832851e-13	0.289002578435968	0.344	0.195	7.16643878872312e-09	NFAT5	B cells	GSE169246_PacTissue_pre	ENSG00000102908	10725	nuclear factor of activated T cells 5	KIAA0827|NF-AT5|NFATL1|NFATZ|OREBP|TONEBP	protein_coding	O94916	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62624
3.52320554602908e-13	0.303215453417624	0.916	0.857	7.20636462384788e-09	YWHAZ	B cells	GSE169246_PacTissue_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62625
3.80719248239091e-13	-0.345316953315067	0.59	0.694	7.78723150348237e-09	SUMO2	B cells	GSE169246_PacTissue_pre	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62626
4.27961982845428e-13	0.340816432274746	0.485	0.329	8.75353439712038e-09	MBP	B cells	GSE169246_PacTissue_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62627
5.14775133658367e-13	0.288721049497443	0.503	0.33	1.05292105838482e-08	ADAM28	B cells	GSE169246_PacTissue_pre	ENSG00000042980	10863	ADAM metallopeptidase domain 28	ADAM23|eMDCII|MDC-Lm|MDC-Ls	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62628
6.43552567585312e-13	0.360028122356742	0.704	0.596	1.316322421739e-08	EIF5	B cells	GSE169246_PacTissue_pre	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62629
7.71489147917419e-13	-0.277084623364282	0.427	0.602	1.57800390315029e-08	SNRPD2	B cells	GSE169246_PacTissue_pre	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62630
7.82646529812263e-13	-0.4107698392501	0.555	0.68	1.600825212078e-08	BASP1	B cells	GSE169246_PacTissue_pre	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62631
7.9241644200117e-13	0.267583404613801	0.268	0.133	1.62080859046919e-08	PELI1	B cells	GSE169246_PacTissue_pre	ENSG00000197329	57162	pellino E3 ubiquitin protein ligase 1	NA	protein_coding	Q96FA3	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62632
8.83623012164334e-13	-0.264360713807864	0.356	0.522	1.80736250908093e-08	PSMB1	B cells	GSE169246_PacTissue_pre	ENSG00000281184	5689	proteasome 20S subunit beta 1	HC5|PMSB1	protein_coding	P20618	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62633
9.18841171053456e-13	-0.262238937711855	0.196	0.355	1.87939773127274e-08	C7orf50	B cells	GSE169246_PacTissue_pre	ENSG00000146540	84310	chromosome 7 open reading frame 50	MGC11257|YCR016W	protein_coding	Q9BRJ6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62634
1.01737419331379e-12	0.266344340581257	0.341	0.191	2.08093717500402e-08	RALGAPA1	B cells	GSE169246_PacTissue_pre	ENSG00000174373	253959	Ral GTPase activating protein catalytic subunit alpha 1	DKFZp667F074|GARNL1|GRIPE|KIAA0884|RalGAPalpha1|Tulip1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62635
1.04487509751732e-12	-0.272101938303081	0.581	0.734	2.13718752446192e-08	SERP1	B cells	GSE169246_PacTissue_pre	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62636
1.13066510042843e-12	0.401964391020645	0.722	0.635	2.31266239641632e-08	MEF2C	B cells	GSE169246_PacTissue_pre	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62637
1.19065252127321e-12	0.254625137769765	0.484	0.324	2.43536066701222e-08	CSDE1	B cells	GSE169246_PacTissue_pre	ENSG00000009307	7812	cold shock domain containing E1	D1S155E|UNR	protein_coding	O75534	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62638
1.28894241428504e-12	-0.279063685594546	0.584	0.715	2.63640281417862e-08	SLC25A3	B cells	GSE169246_PacTissue_pre	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62639
1.39964134865266e-12	0.314893105850605	0.355	0.207	2.86282641453415e-08	CCR6	B cells	GSE169246_PacTissue_pre	ENSG00000112486	1235	C-C motif chemokine receptor 6	BN-1|CD196|CKR-L3|CMKBR6|DCR2|DRY-6|GPR-CY4|GPR29|STRL22	protein_coding	P51684	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62640
1.41697915697281e-12	-0.281461132073074	0.609	0.737	2.89828916767219e-08	SRP14	B cells	GSE169246_PacTissue_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62641
1.72397683049038e-12	-0.269347289237493	0.356	0.508	3.52622220908502e-08	UBE2I	B cells	GSE169246_PacTissue_pre	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62642
1.95861001607034e-12	0.337252718559285	0.671	0.564	4.00614092687027e-08	ELF1	B cells	GSE169246_PacTissue_pre	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62643
2.13562708846279e-12	0.36481547930462	0.362	0.22	4.36821164674179e-08	USP36	B cells	GSE169246_PacTissue_pre	ENSG00000055483	57602	ubiquitin specific peptidase 36	FLJ12851|KIAA1453	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62644
2.33038138639106e-12	0.310055191176319	0.509	0.353	4.76656208772427e-08	IGHG1	B cells	GSE169246_PacTissue_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62645
2.68563221376055e-12	-0.25184733186526	0.394	0.56	5.49319213002584e-08	COX6C	B cells	GSE169246_PacTissue_pre	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62646
3.09278720044117e-12	-0.342822431727441	0.222	0.361	6.32598693978237e-08	PRDX6	B cells	GSE169246_PacTissue_pre	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62647
3.58779891016709e-12	0.26115740989041	0.329	0.186	7.33848389085577e-08	TMEM131	B cells	GSE169246_PacTissue_pre	ENSG00000075568	23505	transmembrane protein 131	CC28|KIAA0257|PRO1048|RW1|YR-23	protein_coding	Q92545	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62648
3.72150368364509e-12	0.625130521089537	0.638	0.553	7.61196363452766e-08	LY9	B cells	GSE169246_PacTissue_pre	ENSG00000122224	4063	lymphocyte antigen 9	CD229|hly9|mLY9|SLAMF3	protein_coding	Q9HBG7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62649
3.72207656073465e-12	0.387528640751356	0.639	0.528	7.61313539732666e-08	SKIL	B cells	GSE169246_PacTissue_pre	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62650
3.74727899456057e-12	-0.263433036411974	0.377	0.535	7.66468445547419e-08	COX7A2	B cells	GSE169246_PacTissue_pre	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62651
3.8054869972917e-12	-0.26839166829684	0.178	0.323	7.78374310426045e-08	MRPL51	B cells	GSE169246_PacTissue_pre	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62652
4.08888865923338e-12	-0.279621829654228	0.272	0.43	8.36341286359595e-08	LDHA	B cells	GSE169246_PacTissue_pre	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62653
4.26448491306196e-12	0.256233196748539	0.296	0.159	8.72257744117693e-08	SEMA7A	B cells	GSE169246_PacTissue_pre	ENSG00000288455	8482	semaphorin 7A (John Milton Hagen blood group)	CD108|H-Sema-L|SEMAL	protein_coding	O75326	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62654
4.78510562546115e-12	-0.315467357034725	0.882	0.934	9.78745504631823e-08	H3F3A	B cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62655
4.97030694462135e-12	-0.257109751941783	0.243	0.396	1.01662658245285e-07	ATP5PF	B cells	GSE169246_PacTissue_pre	ENSG00000154723	522	ATP synthase peripheral stalk subunit F6	ATP5|ATP5A|ATP5J|ATPM|CF6	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62656
6.73533181661366e-12	-0.309598106781194	0.542	0.669	1.37764476977016e-07	ARPC1B	B cells	GSE169246_PacTissue_pre	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62657
8.23326696089164e-12	0.250958696776285	0.346	0.203	1.68403242418078e-07	SETX	B cells	GSE169246_PacTissue_pre	ENSG00000107290	23064	senataxin	ALS4|AOA2|KIAA0625|SCAR1|Sen1|STEX	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62658
9.01582828984713e-12	0.255001304498761	0.439	0.288	1.84409751840533e-07	VOPP1	B cells	GSE169246_PacTissue_pre	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62659
9.26411997494656e-12	-0.255566089936793	0.362	0.525	1.89488309967557e-07	EIF3G	B cells	GSE169246_PacTissue_pre	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62660
1.06154680727449e-11	0.314686394029513	0.323	0.187	2.17128783959923e-07	NFKBIZ	B cells	GSE169246_PacTissue_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62661
1.16737654017764e-11	-0.310386534060245	0.412	0.544	2.38775197527935e-07	BST2	B cells	GSE169246_PacTissue_pre	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62662
1.20980508667526e-11	-0.349998027705182	0.148	0.28	2.47453532428557e-07	SEC14L1	B cells	GSE169246_PacTissue_pre	ENSG00000129657	6397	SEC14 like lipid binding 1	PRELID4A|SEC14L	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62663
1.23374445269841e-11	-0.300122274117684	0.166	0.3	2.52350090354934e-07	RANBP1	B cells	GSE169246_PacTissue_pre	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62664
1.27811019370257e-11	-0.26251377603071	0.451	0.611	2.61424659019925e-07	PSMA7	B cells	GSE169246_PacTissue_pre	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62665
1.62576993051799e-11	-0.251122905517681	0.349	0.512	3.32534981588149e-07	CHCHD10	B cells	GSE169246_PacTissue_pre	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62666
1.81822859988075e-11	-0.250452749793507	0.406	0.558	3.71900477819608e-07	NDUFA4	B cells	GSE169246_PacTissue_pre	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62667
2.06369368751763e-11	0.369264476807992	0.636	0.496	4.22107906844856e-07	SRGN	B cells	GSE169246_PacTissue_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62668
2.16429812387029e-11	-0.33539735852999	0.612	0.71	4.42685538256429e-07	RAN	B cells	GSE169246_PacTissue_pre	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62669
2.25760154113981e-11	0.383804255785308	0.272	0.147	4.61769819224737e-07	SGK1	B cells	GSE169246_PacTissue_pre	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62670
2.3676116337394e-11	0.260352536344302	0.464	0.317	4.84271283565057e-07	CYBB	B cells	GSE169246_PacTissue_pre	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62671
3.56408546006323e-11	-0.255119857188732	0.572	0.693	7.28998040001333e-07	TRIR	B cells	GSE169246_PacTissue_pre	ENSG00000123144	79002	telomerase RNA component interacting RNase	C19orf43|fSAP18|MGC2803|TERCIR	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62672
4.34416360549291e-11	-0.292237182233264	0.722	0.828	8.88555223867519e-07	SH3BGRL3	B cells	GSE169246_PacTissue_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62673
4.43937149253985e-11	0.25446366727507	0.418	0.272	9.08029045084101e-07	PEA15	B cells	GSE169246_PacTissue_pre	ENSG00000162734	8682	proliferation and apoptosis adaptor protein 15	HMAT1|HUMMAT1H|MAT1|MAT1H|PEA-15|PED|PED-PEA15|PED/PEA15	protein_coding	Q15121	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62674
4.44746804287188e-11	0.309827213961987	0.407	0.274	9.09685113489014e-07	IFRD1	B cells	GSE169246_PacTissue_pre	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62675
4.70808868758199e-11	0.294220029901933	0.626	0.492	9.6299246015802e-07	CMTM6	B cells	GSE169246_PacTissue_pre	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62676
4.85755467053393e-11	-0.765499341500443	0.157	0.276	9.9356423231101e-07	STMN1	B cells	GSE169246_PacTissue_pre	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62677
5.15790197293633e-11	0.271946989726293	0.329	0.196	1.0549972695444e-06	CDC42EP3	B cells	GSE169246_PacTissue_pre	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62678
5.72199932253671e-11	-0.282552096675612	0.326	0.469	1.17037774143166e-06	COX8A	B cells	GSE169246_PacTissue_pre	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62679
6.05178299388257e-11	-0.27370369944238	0.642	0.749	1.23783169356874e-06	CIRBP	B cells	GSE169246_PacTissue_pre	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62680
1.18296271944162e-10	-0.251219936751702	0.398	0.544	2.41963194634589e-06	CAPZB	B cells	GSE169246_PacTissue_pre	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62681
1.38963424976516e-10	-0.258445420949594	0.606	0.732	2.84235789446966e-06	HINT1	B cells	GSE169246_PacTissue_pre	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62682
1.93913830438712e-10	0.268416953042355	0.356	0.225	3.96631348779342e-06	DENND4A	B cells	GSE169246_PacTissue_pre	ENSG00000174485	10260	DENN domain containing 4A	IRLB|MYCPBP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62683
1.97524369585019e-10	0.277734387571187	0.437	0.302	4.04016345549198e-06	AFF4	B cells	GSE169246_PacTissue_pre	ENSG00000072364	27125	ALF transcription elongation factor 4	AF5Q31|MCEF	protein_coding	Q9UHB7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62684
2.31169474319593e-10	0.255554185562244	0.274	0.152	4.72834042773296e-06	EIF2AK3	B cells	GSE169246_PacTissue_pre	ENSG00000172071	9451	eukaryotic translation initiation factor 2 alpha kinase 3	PEK|PERK	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62685
2.3734881527726e-10	0.356732634714829	0.513	0.386	4.85473266768107e-06	LITAF	B cells	GSE169246_PacTissue_pre	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62686
2.87826384471831e-10	0.26590825778632	0.473	0.329	5.88720086798683e-06	TRA2A	B cells	GSE169246_PacTissue_pre	ENSG00000164548	29896	transformer 2 alpha homolog	AWMS1|htra-2-alpha	protein_coding	Q13595	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62687
3.16175048616156e-10	0.3054790472639	0.641	0.544	6.46704444439485e-06	PRRC2C	B cells	GSE169246_PacTissue_pre	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62688
3.50852241253752e-10	0.367459549947884	0.552	0.423	7.17633174260425e-06	AC016831.7	B cells	GSE169246_PacTissue_pre	NA	NA	NA	NA	NA	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62689
3.86795979256855e-10	-0.280968255361745	0.693	0.781	7.91152495971971e-06	CALM2	B cells	GSE169246_PacTissue_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62690
3.92377028996142e-10	0.252735104257407	0.416	0.285	8.02567975108709e-06	TAF7	B cells	GSE169246_PacTissue_pre	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62691
4.23133111170561e-10	0.284420912063818	0.319	0.195	8.65476465588265e-06	NUDT4	B cells	GSE169246_PacTissue_pre	ENSG00000173598	11163	nudix hydrolase 4	DIPP2|DIPP2alpha|DIPP2beta|HDCMB47P|KIAA0487	protein_coding	Q9NZJ9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62692
4.43729228724891e-10	0.314374594335949	0.603	0.489	9.07603764433891e-06	MT-ND6	B cells	GSE169246_PacTissue_pre	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62693
4.46060045979022e-10	-0.271445539376572	0.289	0.417	9.12371218045491e-06	ERH	B cells	GSE169246_PacTissue_pre	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62694
4.50961412116906e-10	0.312321408556346	0.772	0.664	9.2239647234392e-06	BTG2	B cells	GSE169246_PacTissue_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62695
5.17088293401666e-10	0.382325799830577	0.684	0.601	1.05765239532377e-05	DNAJB6	B cells	GSE169246_PacTissue_pre	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62696
5.87315189014089e-10	0.254146856075716	0.34	0.212	1.20129448760942e-05	TOR3A	B cells	GSE169246_PacTissue_pre	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62697
6.4667098161941e-10	-0.335637633904839	0.281	0.409	1.32270082580434e-05	GSTP1	B cells	GSE169246_PacTissue_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62698
6.76294075356719e-10	-0.682945321127448	0.153	0.265	1.38329190173463e-05	HMGB2	B cells	GSE169246_PacTissue_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62699
7.05557390942062e-10	-0.291329822666278	0.349	0.479	1.44314708743289e-05	VPREB3	B cells	GSE169246_PacTissue_pre	ENSG00000128218	29802	V-set pre-B cell surrogate light chain 3	8HS20	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62700
7.88897033981113e-10	-0.348787683225753	0.401	0.516	1.61360999330497e-05	ANP32B	B cells	GSE169246_PacTissue_pre	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62701
8.13730679657746e-10	0.260359913311542	0.394	0.258	1.66440473217195e-05	ITGA4	B cells	GSE169246_PacTissue_pre	ENSG00000115232	3676	integrin subunit alpha 4	CD49D	protein_coding	P13612	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62702
8.77637643043518e-10	0.293302923148584	0.567	0.417	1.79512003508121e-05	CDKN1A	B cells	GSE169246_PacTissue_pre	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62703
9.27763389332449e-10	-0.255638911027634	0.792	0.892	1.89764723654059e-05	CD52	B cells	GSE169246_PacTissue_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62704
1.16759769845096e-09	0.330478503411268	0.488	0.356	2.38820433241159e-05	NFKB1	B cells	GSE169246_PacTissue_pre	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62705
1.17304611443392e-09	0.272334501703434	0.343	0.216	2.39934852246314e-05	IVNS1ABP	B cells	GSE169246_PacTissue_pre	ENSG00000116679	10625	influenza virus NS1A binding protein	ARA3|HSPC068|KIAA0850|KLHL39|ND1|NS-1|NS1-BP	protein_coding	Q9Y6Y0	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62706
1.2772138846881e-09	0.387978237372194	0.798	0.72	2.61241327974105e-05	SAT1	B cells	GSE169246_PacTissue_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62707
1.89876645561158e-09	0.25669701881508	0.476	0.349	3.88373690830793e-05	HSPA4	B cells	GSE169246_PacTissue_pre	ENSG00000170606	3308	heat shock protein family A (Hsp70) member 4	HS24/P52|HSPH2	protein_coding	P34932	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62708
2.2258902515358e-09	0.308514918862071	0.552	0.436	4.55283592049132e-05	GPBP1	B cells	GSE169246_PacTissue_pre	ENSG00000062194	65056	GC-rich promoter binding protein 1	DKFZp761C169	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62709
2.47901440041263e-09	-0.281921779906646	0.422	0.55	5.070576054604e-05	TPI1	B cells	GSE169246_PacTissue_pre	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62710
3.28532216783928e-09	-0.576034375318873	0.75	0.813	6.71979796209847e-05	HMGB1	B cells	GSE169246_PacTissue_pre	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62711
3.63335572193972e-09	0.257453544810858	0.325	0.208	7.43166579365551e-05	BRAF	B cells	GSE169246_PacTissue_pre	ENSG00000157764	673	B-Raf proto-oncogene, serine/threonine kinase	BRAF-1|BRAF1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62712
4.66121537791579e-09	-0.267458550594684	0.235	0.357	9.53404993398895e-05	CALM3	B cells	GSE169246_PacTissue_pre	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62713
5.65911614352677e-09	0.298114184454753	0.513	0.391	0.000115751561599696	NFKBID	B cells	GSE169246_PacTissue_pre	ENSG00000167604	84807	NFKB inhibitor delta	IkappaBNS|IkBNS|TA-NFKBH	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62714
5.99699711595858e-09	0.252056792095705	0.513	0.388	0.000122662579009817	DDX24	B cells	GSE169246_PacTissue_pre	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62715
6.84990476701246e-09	-0.383653321955547	0.265	0.376	0.000140107952104473	WDR74	B cells	GSE169246_PacTissue_pre	ENSG00000133316	54663	WD repeat domain 74	FLJ10439|Nsa1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62716
8.97978777668682e-09	0.272709295682043	0.395	0.273	0.000183672579184352	BACH1	B cells	GSE169246_PacTissue_pre	ENSG00000156273	571	BTB domain and CNC homolog 1	BACH-1|BTBD24	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62717
9.37934808222697e-09	-0.308138787138031	0.287	0.404	0.00019184518567387	TMEM123	B cells	GSE169246_PacTissue_pre	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62718
9.93629450316364e-09	0.25910257644251	0.37	0.254	0.000203236967767709	MAPRE2	B cells	GSE169246_PacTissue_pre	ENSG00000166974	10982	microtubule associated protein RP/EB family member 2	EB1|EB2|RP1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62719
1.03646280716507e-08	0.281544063054526	0.428	0.307	0.000211998102577544	RAB11FIP1	B cells	GSE169246_PacTissue_pre	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62720
1.16205886807559e-08	0.334196577918859	0.883	0.828	0.000237687520876181	CD83	B cells	GSE169246_PacTissue_pre	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62721
1.24494083450618e-08	0.293116163455354	0.334	0.221	0.000254640198289895	SERPINB9	B cells	GSE169246_PacTissue_pre	ENSG00000170542	5272	serpin family B member 9	CAP3|PI9	protein_coding	P50453	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62722
1.33506010986664e-08	0.354246088650695	0.981	0.955	0.000273073194872122	MT-ATP6	B cells	GSE169246_PacTissue_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62723
1.54695538164599e-08	0.277960354659659	0.259	0.148	0.000316414253761871	DUSP4	B cells	GSE169246_PacTissue_pre	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62724
1.65368691944252e-08	0.323954072097128	0.879	0.827	0.000338245122502772	CXCR4	B cells	GSE169246_PacTissue_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62725
1.69135984022084e-08	-0.28775832921769	0.412	0.529	0.000345950741718771	TUBA4A	B cells	GSE169246_PacTissue_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62726
2.39081106180412e-08	0.400137935253679	0.546	0.418	0.000489016494581415	ZNF331	B cells	GSE169246_PacTissue_pre	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62727
3.00423373088658e-08	0.282934604157353	0.9	0.866	0.000614485967315542	HSPE1	B cells	GSE169246_PacTissue_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62728
4.20641277955586e-08	-0.351414206917989	0.451	0.548	0.000860379669930356	UCP2	B cells	GSE169246_PacTissue_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62729
6.29559404755287e-08	-0.328786413577112	0.479	0.589	0.00128770080648646	TUBB4B	B cells	GSE169246_PacTissue_pre	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62730
6.69194732800933e-08	0.295436117585053	0.307	0.193	0.00136877090647103	LMNA	B cells	GSE169246_PacTissue_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62731
9.05507937305402e-08	0.281171993069777	0.633	0.559	0.00185212593496447	SRRM2	B cells	GSE169246_PacTissue_pre	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62732
1.94284047284164e-07	-0.296241451223713	0.633	0.692	0.00397388590315029	CALR	B cells	GSE169246_PacTissue_pre	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62733
2.13151635495586e-07	-0.320316024304826	0.371	0.466	0.00435980355242671	SLBP	B cells	GSE169246_PacTissue_pre	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62734
2.21675314144532e-07	0.254663718333392	0.636	0.548	0.00453414687551227	MCL1	B cells	GSE169246_PacTissue_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62735
2.93701344957751e-07	0.278044070350628	0.573	0.493	0.00600736730976583	TRA2B	B cells	GSE169246_PacTissue_pre	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62736
5.03827189152293e-07	0.340443083148757	0.397	0.3	0.010305281326921	RANBP2	B cells	GSE169246_PacTissue_pre	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62737
5.14013148641294e-07	0.282010827907891	0.6	0.495	0.010513624942309	IRF1	B cells	GSE169246_PacTissue_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62738
8.50127522649926e-07	0.405966977029304	0.497	0.407	0.0173885083482816	CCR7	B cells	GSE169246_PacTissue_pre	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62739
1.32671932899867e-06	0.263913215614327	0.567	0.486	0.0271367171553389	DDX21	B cells	GSE169246_PacTissue_pre	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62740
1.91731770345367e-06	-0.36004302328041	0.406	0.487	0.0392168163064413	TPM4	B cells	GSE169246_PacTissue_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62741
2.01756619004506e-06	0.253222368276057	0.563	0.494	0.0412672988511816	RPL36A	B cells	GSE169246_PacTissue_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62742
2.02594087421488e-06	0.262949636053894	0.719	0.644	0.0414385946411911	FUS	B cells	GSE169246_PacTissue_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62743
7.86374451900235e-08	-1.01726925245983	0.333	0.955	0.00160845030391674	IFI44L	pDCs	GSE169246_PacTissue_pre	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62744
2.14962781186737e-07	-1.07485674401277	0.667	0.97	0.00439684872639353	MX1	pDCs	GSE169246_PacTissue_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62745
4.28053894577708e-07	-0.9670994741928	0.519	0.925	0.00875541435969243	COX5A	pDCs	GSE169246_PacTissue_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62746
5.4871264613824e-07	-1.15942813694786	0.185	0.776	0.0112233684641116	LY6E	pDCs	GSE169246_PacTissue_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62747
7.94025269594266e-07	1.27685018350353	0.519	0.06	0.0162409928642811	JUN	pDCs	GSE169246_PacTissue_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62748
1.7929926261663e-06	0.950965123435146	1	0.97	0.0366738711756055	MT-CO3	pDCs	GSE169246_PacTissue_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62749
2.16557376553148e-06	-1.63921628285514	0.222	0.716	0.0442946458001808	TCL1A	pDCs	GSE169246_PacTissue_pre	ENSG00000100721	8115	TCL1 family AKT coactivator A	TCL1	protein_coding	P56279	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62750
2.22362688358866e-06	1.13680598280677	1	0.866	0.0454820642769224	MT-ATP6	pDCs	GSE169246_PacTissue_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62751
2.42865000288771e-06	-1.85619670122221	0.926	0.955	0.0496756071590652	TXN	pDCs	GSE169246_PacTissue_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62752
2.94388607705772e-18	-1.19298247409579	1	1	6.02142458201387e-14	HLA-B	cDCs	GSE169246_PacTissue_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62753
3.01949661397261e-16	-0.938973321092398	0.986	0.99	6.17607837421957e-12	HLA-C	cDCs	GSE169246_PacTissue_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62754
1.76339500998215e-15	0.899326632523092	0.986	0.941	3.60684815341749e-11	RPS21	cDCs	GSE169246_PacTissue_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62755
1.65149136749796e-14	-2.1632439597767	0.74	0.961	3.37796044308032e-10	LYZ	cDCs	GSE169246_PacTissue_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62756
2.73729779036557e-14	1.20355850105729	0.849	0.343	5.59886890041374e-10	HLA-DQA2	cDCs	GSE169246_PacTissue_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62757
3.27840096031603e-13	0.81324609507995	0.781	0.235	6.7056413242304e-09	ATP5ME	cDCs	GSE169246_PacTissue_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62758
7.09499583289264e-13	0.879867421841972	0.986	0.98	1.45121044765986e-08	RPL39	cDCs	GSE169246_PacTissue_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62759
1.99243675816806e-12	0.794061878927772	0.863	0.392	4.07533014515694e-08	RPL36A	cDCs	GSE169246_PacTissue_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62760
6.7278277681961e-12	1.14669193359717	0.959	0.843	1.37610989170683e-07	RPS29	cDCs	GSE169246_PacTissue_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62761
1.57896759693776e-11	0.629888729458453	1	0.961	3.2296203227765e-07	RPLP2	cDCs	GSE169246_PacTissue_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62762
3.39179730245366e-11	1.70394129403434	0.904	0.696	6.93758220243871e-07	C15orf48	cDCs	GSE169246_PacTissue_pre	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62763
1.68472219320139e-09	0.625139896738712	0.973	0.98	3.44593077397412e-05	RPL36	cDCs	GSE169246_PacTissue_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62764
2.43793926755222e-09	0.59908652557233	0.959	0.951	4.98656097785131e-05	RPL37A	cDCs	GSE169246_PacTissue_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62765
4.4632757040593e-09	1.06431762430898	0.945	0.794	9.12918412508289e-05	S100A10	cDCs	GSE169246_PacTissue_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62766
6.22516347755434e-09	1.16637343809209	0.836	0.686	0.000127329493769896	MIF	cDCs	GSE169246_PacTissue_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62767
8.15731631117724e-09	-1.16713197301992	0.603	0.775	0.000166849747828819	MS4A6A	cDCs	GSE169246_PacTissue_pre	ENSG00000110077	64231	membrane spanning 4-domains A6A	CD20L3|MS4A6	protein_coding	Q9H2W1	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62768
8.4639695044771e-09	-0.448520159588883	1	1	0.000173122032244575	CD74	cDCs	GSE169246_PacTissue_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62769
8.59312890079211e-09	0.463555027400932	0.986	0.99	0.000175763858536802	RPL32	cDCs	GSE169246_PacTissue_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62770
1.02547951125192e-08	-0.756406352095866	0.315	0.765	0.000209751579231467	FCGRT	cDCs	GSE169246_PacTissue_pre	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62771
1.16878512033859e-08	0.5410174693168	0.575	0.157	0.000239063308514055	NDUFB1	cDCs	GSE169246_PacTissue_pre	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62772
2.34482903368935e-08	0.564394874255126	1	0.99	0.000479611330550819	RPL37	cDCs	GSE169246_PacTissue_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62773
2.65783403003725e-08	0.839535327806754	0.466	0.108	0.000543633372503818	PKIB	cDCs	GSE169246_PacTissue_pre	ENSG00000135549	5570	cAMP-dependent protein kinase inhibitor beta	PRKACN2	protein_coding	Q9C010	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62774
2.97774930519758e-08	0.526904009708312	0.959	0.98	0.000609068842885114	ATP5F1E	cDCs	GSE169246_PacTissue_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62775
6.68433562161726e-08	0.621763530763104	0.904	0.804	0.00136721400804559	RPS26	cDCs	GSE169246_PacTissue_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62776
6.87835124035218e-08	-0.652835841965543	0.849	0.951	0.00140689796270163	CTSZ	cDCs	GSE169246_PacTissue_pre	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62777
7.60731339774317e-08	0.615709564784058	0.89	0.833	0.00155599988237439	RPL38	cDCs	GSE169246_PacTissue_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62778
1.17116116526529e-07	0.387000892402801	0.986	0.99	0.00239549304743362	RPS8	cDCs	GSE169246_PacTissue_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62779
1.21392926582999e-07	0.448330881006733	1	0.99	0.00248297092032866	RPS28	cDCs	GSE169246_PacTissue_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62780
1.41520116943149e-07	0.673598008152392	0.89	0.588	0.00289465247195518	DBI	cDCs	GSE169246_PacTissue_pre	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62781
1.74132115682685e-07	0.525669504983364	0.89	0.647	0.00356169829417363	TMA7	cDCs	GSE169246_PacTissue_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62782
2.86568455523319e-07	0.690918019216203	0.26	0.01	0.00586147118927396	CD1A	cDCs	GSE169246_PacTissue_pre	ENSG00000158477	909	CD1a molecule	CD1	protein_coding	P06126	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62783
3.12198449790366e-07	-0.514891116118822	1	1	0.00638570709201215	HLA-DPA1	cDCs	GSE169246_PacTissue_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62784
4.22035829489025e-07	1.09517551502049	0.507	0.167	0.00863232085636852	CD1E	cDCs	GSE169246_PacTissue_pre	ENSG00000158488	913	CD1e molecule	NA	protein_coding	P15812	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62785
4.48115968141196e-07	-1.10236171762968	0.356	0.657	0.00916576401236002	FCGR2B	cDCs	GSE169246_PacTissue_pre	ENSG00000072694	2213	Fc gamma receptor IIb	CD32|CD32B|FCG2|FcgammaRIIb|FCGR2|FcGRIIB	protein_coding	P31994	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62786
5.82847451376299e-07	-0.555267402498965	0.26	0.618	0.0119215617704508	VSIR	cDCs	GSE169246_PacTissue_pre	ENSG00000107738	64115	V-set immunoregulatory receptor	B7-H5|B7H5|C10orf54|Dies1|GI24|PD-1H|SISP1|VISTA	protein_coding	Q9H7M9	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62787
5.85173473274293e-07	-0.449380793479871	0.041	0.363	0.0119691382223524	SECTM1	cDCs	GSE169246_PacTissue_pre	ENSG00000141574	6398	secreted and transmembrane 1	K12	protein_coding	Q8WVN6	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62788
7.27300553769345e-07	0.871166071009131	0.685	0.392	0.0148762055267982	CKLF	cDCs	GSE169246_PacTissue_pre	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62789
7.45479750129182e-07	0.522678222466814	0.548	0.167	0.0152480428091423	SLC2A3	cDCs	GSE169246_PacTissue_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62790
9.64638137461872e-07	0.437862468326194	0.973	0.961	0.0197307084636451	RPL22	cDCs	GSE169246_PacTissue_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62791
9.68751513038811e-07	-0.549929000973901	1	1	0.0198148434476958	HLA-A	cDCs	GSE169246_PacTissue_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62792
9.73351339658951e-07	-0.716521858922123	0.849	0.912	0.0199089283013842	GRN	cDCs	GSE169246_PacTissue_pre	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62793
1.03431837723148e-06	0.465567585932037	1	0.98	0.0211559480878926	PFN1	cDCs	GSE169246_PacTissue_pre	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62794
1.21666312168202e-06	0.612661323655851	1	0.99	0.024885627490884	RPS27	cDCs	GSE169246_PacTissue_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62795
1.27935715771064e-06	0.668697075204936	0.63	0.304	0.0261679713038134	SEC61G	cDCs	GSE169246_PacTissue_pre	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62796
1.31919986183103e-06	-0.503392358914642	0.863	0.961	0.0269829139738918	HLA-E	cDCs	GSE169246_PacTissue_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62797
1.46346494930793e-06	0.343753699703932	1	1	0.0299337120731444	RPL8	cDCs	GSE169246_PacTissue_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62798
1.54732449801482e-06	0.470109838908282	0.452	0.137	0.0316489752823951	EIF2S2	cDCs	GSE169246_PacTissue_pre	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62799
1.57403872049084e-06	-0.356982471863932	1	1	0.0321953879889197	B2M	cDCs	GSE169246_PacTissue_pre	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62800
1.75630665635292e-06	0.551041839193354	0.932	0.755	0.0359234963490427	ENO1	cDCs	GSE169246_PacTissue_pre	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62801
2.26713867920266e-06	0.771226902828013	0.507	0.176	0.0463720545444113	CST7	cDCs	GSE169246_PacTissue_pre	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62802
2.28897704495004e-06	0.46005821444039	0.575	0.235	0.0468187364774082	UBE2E2	cDCs	GSE169246_PacTissue_pre	ENSG00000182247	7325	ubiquitin conjugating enzyme E2 E2	FLJ25157|UbcH8	protein_coding	Q96LR5	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62803
2.35890856100708e-06	-0.602668321386388	0.932	0.892	0.0482491157068387	TYROBP	cDCs	GSE169246_PacTissue_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE169246_PacTissue	GSE169246	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	pre	paclitaxel	Homo sapiens	patients	Tumor tissue	pre (resistant 3, sensitive 3); post (resistant 4, sensitive 3)	13	67140	Public on Sep 15, 2021	34653365	This dataset has 7 patients, 6 of whom have both pre -and post-treatment samples.	NA	10x genomics	CellRanger 3.0.0	Breast_cancer	Chemotherapy	62804
0	0.291059650680523	0.671	0.509	0	RER1	Malignant cells	GSE189460_pre	ENSG00000157916	11079	retention in endoplasmic reticulum sorting receptor 1	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62805
0	0.251524377416485	0.436	0.281	0	CAMTA1	Malignant cells	GSE189460_pre	ENSG00000171735	23261	calmodulin binding transcription activator 1	KIAA0833	protein_coding	Q9Y6Y1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62806
0	0.292392790070426	0.834	0.657	0	PARK7	Malignant cells	GSE189460_pre	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62807
0	0.449713284119762	0.548	0.316	0	HP1BP3	Malignant cells	GSE189460_pre	ENSG00000127483	50809	heterochromatin protein 1 binding protein 3	HP1-BP74	protein_coding	Q5SSJ5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62808
0	0.437252536115458	0.694	0.49	0	CDC42	Malignant cells	GSE189460_pre	ENSG00000070831	998	cell division cycle 42	CDC42Hs|G25K	protein_coding	P60953	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62809
0	0.384416274517331	0.553	0.332	0	HNRNPR	Malignant cells	GSE189460_pre	ENSG00000282958	10236	heterogeneous nuclear ribonucleoprotein R	hnRNP-R|HNRPR	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62810
0	0.634305532971683	0.323	0.014	0	TCEA3	Malignant cells	GSE189460_pre	ENSG00000282941	6920	transcription elongation factor A3	TFIIS.H	protein_coding	O75764	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62811
0	0.651088611643212	0.299	0.052	0	ID3	Malignant cells	GSE189460_pre	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62812
0	0.56181818550829	0.555	0.317	0	SRSF10	Malignant cells	GSE189460_pre	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62813
0	0.515981566980197	0.572	0.322	0	SRRM1	Malignant cells	GSE189460_pre	ENSG00000133226	10250	serine and arginine repetitive matrix 1	MGC39488|POP101|SRM160	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62814
0	1.65599101349097	0.471	0.111	0	STMN1	Malignant cells	GSE189460_pre	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62815
0	0.253834301615012	0.699	0.532	0	SH3BGRL3	Malignant cells	GSE189460_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62816
0	0.590020068392578	0.321	0.05	0	CD52	Malignant cells	GSE189460_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62817
0	1.47716255598602	0.722	0.392	0	HMGN2	Malignant cells	GSE189460_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62818
0	0.298429046964411	0.379	0.181	0	DNAJC8	Malignant cells	GSE189460_pre	ENSG00000285317	22826	DnaJ heat shock protein family (Hsp40) member C8	SPF31	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62819
0	0.530061383628839	0.786	0.542	0	ATP5IF1	Malignant cells	GSE189460_pre	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62820
0	0.420443651088099	0.472	0.271	0	KHDRBS1	Malignant cells	GSE189460_pre	ENSG00000121774	10657	KH RNA binding domain containing, signal transduction associated 1	FLJ34027|p62|Sam68	protein_coding	Q07666	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62821
0	0.275114468910836	0.434	0.266	0	RBBP4	Malignant cells	GSE189460_pre	ENSG00000162521	5928	RB binding protein 4, chromatin remodeling factor	lin-53|NURF55|RbAp48	protein_coding	Q09028	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62822
0	0.532215692012242	0.711	0.51	0	SFPQ	Malignant cells	GSE189460_pre	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62823
0	0.293298298518483	0.436	0.239	0	THRAP3	Malignant cells	GSE189460_pre	ENSG00000054118	9967	thyroid hormone receptor associated protein 3	BCLAF2|TRAP150	protein_coding	Q9Y2W1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62824
0	0.405237396952462	0.462	0.273	0	SMAP2	Malignant cells	GSE189460_pre	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62825
0	0.695159561789911	0.932	0.841	0	YBX1	Malignant cells	GSE189460_pre	ENSG00000065978	4904	Y-box binding protein 1	BP-8|CSDA2|CSDB|DBPB|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1	protein_coding	P67809	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62826
0	0.398802642801117	0.817	0.691	0	ATP6V0B	Malignant cells	GSE189460_pre	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62827
0	0.417427808982629	0.271	0.091	0	PLK3	Malignant cells	GSE189460_pre	ENSG00000173846	1263	polo like kinase 3	CNK|FNK|PRK	protein_coding	Q9H4B4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62828
0	0.982435847669656	0.548	0.2	0	NASP	Malignant cells	GSE189460_pre	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62829
0	0.554363785405627	0.933	0.854	0	UQCRH	Malignant cells	GSE189460_pre	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62830
0	0.975445732472418	0.398	0.021	0	CDKN2C	Malignant cells	GSE189460_pre	ENSG00000123080	1031	cyclin dependent kinase inhibitor 2C	INK4C|p18	protein_coding	P42773	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62831
0	0.574417127785558	0.967	0.921	0	JUN	Malignant cells	GSE189460_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62832
0	0.497523708409688	0.337	0.109	0	USP1	Malignant cells	GSE189460_pre	ENSG00000162607	7398	ubiquitin specific peptidase 1	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62833
0	0.369134549411085	0.766	0.541	0	SERBP1	Malignant cells	GSE189460_pre	ENSG00000142864	26135	SERPINE1 mRNA binding protein 1	CGI-55|CHD3IP|DKFZP564M2423|HABP4L|PAI-RBP1|PAIRBP1	protein_coding	Q8NC51	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62834
0	0.622315654936335	0.61	0.422	0	GADD45A	Malignant cells	GSE189460_pre	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62835
0	0.441365421618744	0.611	0.388	0	SRSF11	Malignant cells	GSE189460_pre	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62836
0	0.388885828039426	0.599	0.401	0	ZRANB2	Malignant cells	GSE189460_pre	ENSG00000132485	9406	zinc finger RANBP2-type containing 2	ZIS|ZIS1|ZIS2|ZNF265	protein_coding	O95218	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62837
0	0.294099339964187	0.356	0.196	0	ACADM	Malignant cells	GSE189460_pre	ENSG00000117054	34	acyl-CoA dehydrogenase medium chain	ACAD1|MCAD|MCADH	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62838
0	0.995840665367536	0.69	0.505	0	LINC01781	Malignant cells	GSE189460_pre	ENSG00000234184	101927412	long intergenic non-protein coding RNA 1781	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62839
0	0.56029551478546	0.786	0.547	0	GNG5	Malignant cells	GSE189460_pre	ENSG00000174021	2787	G protein subunit gamma 5	NA	protein_coding	P63218	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62840
0	0.450777735940179	0.619	0.436	0	LMO4	Malignant cells	GSE189460_pre	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62841
0	0.271447971479401	0.313	0.16	0	DNTTIP2	Malignant cells	GSE189460_pre	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62842
0	0.923663460057567	0.826	0.544	0	CD53	Malignant cells	GSE189460_pre	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62843
0	0.275557757832387	0.321	0.159	0	DRAM2	Malignant cells	GSE189460_pre	ENSG00000156171	128338	DNA damage regulated autophagy modulator 2	MGC54289|PRO180|RP5-1180E21.1|TMEM77|WWFQ154	protein_coding	Q6UX65	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62844
0	0.376602465556521	0.507	0.272	0	CAPZA1	Malignant cells	GSE189460_pre	ENSG00000116489	829	capping actin protein of muscle Z-line subunit alpha 1	NA	protein_coding	P52907	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62845
0	0.299765163892778	0.421	0.238	0	BCAS2	Malignant cells	GSE189460_pre	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62846
0	0.295474032747531	0.28	0.094	0	ATP1A1	Malignant cells	GSE189460_pre	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62847
0	0.638717247504083	0.32	0.027	0	CD58	Malignant cells	GSE189460_pre	ENSG00000116815	965	CD58 molecule	LFA3	protein_coding	P19256	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62848
0	1.28678638759559	0.758	0.669	0	TXNIP	Malignant cells	GSE189460_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62849
0	0.348814096349349	0.372	0.163	0	AC245297.3	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62850
0	0.381217401761201	0.263	0.127	0	HIST2H2BE	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62851
0	0.584991653648319	0.923	0.77	0	MCL1	Malignant cells	GSE189460_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62852
0	0.392354662526446	0.584	0.407	0	ENSA	Malignant cells	GSE189460_pre	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62853
0	-0.376640725343087	0.509	0.274	0	S100A10	Malignant cells	GSE189460_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62854
0	-1.01065026885551	0.303	0.459	0	S100A4	Malignant cells	GSE189460_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62855
0	0.488261773174959	0.862	0.803	0	JTB	Malignant cells	GSE189460_pre	ENSG00000143543	10899	jumping translocation breakpoint	hJT|PAR	protein_coding	O76095	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62856
0	0.498214173453171	0.995	0.997	0	RPS27	Malignant cells	GSE189460_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62857
0	0.429790801676071	0.542	0.33	0	TPM3	Malignant cells	GSE189460_pre	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62858
0	0.293326271173019	0.526	0.342	0	PMVK	Malignant cells	GSE189460_pre	ENSG00000163344	10654	phosphomevalonate kinase	HUMPMKI|PMK|PMKA	protein_coding	Q15126	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62859
0	0.337347318039745	0.51	0.327	0	FDPS	Malignant cells	GSE189460_pre	ENSG00000160752	2224	farnesyl diphosphate synthase	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62860
0	0.280469970548168	0.953	0.911	0	SSR2	Malignant cells	GSE189460_pre	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62861
0	0.45157779680978	0.699	0.364	0	LMNA	Malignant cells	GSE189460_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62862
0	0.304142276151372	0.39	0.222	0	HDGF	Malignant cells	GSE189460_pre	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62863
0	0.623709738548002	0.458	0.146	0	FCRL2	Malignant cells	GSE189460_pre	ENSG00000132704	79368	Fc receptor like 2	CD307b|FCRH2|IRTA4|SPAP1	protein_coding	Q96LA5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62864
0	0.55749085029818	0.603	0.415	0	IFI16	Malignant cells	GSE189460_pre	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62865
0	0.365829025907892	0.293	0.071	0	DUSP23	Malignant cells	GSE189460_pre	ENSG00000158716	54935	dual specificity phosphatase 23	DUSP25|FLJ20442	protein_coding	Q9BVJ7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62866
0	0.267380381272655	0.452	0.284	0	COPA	Malignant cells	GSE189460_pre	ENSG00000122218	1314	COPI coat complex subunit alpha	HEP-COP	protein_coding	P53621	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62867
0	-0.346302403835728	0.502	0.667	0	SLAMF7	Malignant cells	GSE189460_pre	ENSG00000026751	57823	SLAM family member 7	19A|CD319|CRACC|CS1	protein_coding	Q9NQ25	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62868
0	0.311646778056791	0.785	0.629	0	UFC1	Malignant cells	GSE189460_pre	ENSG00000143222	51506	ubiquitin-fold modifier conjugating enzyme 1	HSPC155	protein_coding	Q9Y3C8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62869
0	0.322953835615019	0.363	0.165	0	CREG1	Malignant cells	GSE189460_pre	ENSG00000143162	8804	cellular repressor of E1A stimulated genes 1	CREG	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62870
0	0.599785257955025	0.595	0.339	0	MPC2	Malignant cells	GSE189460_pre	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62871
0	0.356816768844231	0.315	0.117	0	SFT2D2	Malignant cells	GSE189460_pre	ENSG00000213064	375035	SFT2 domain containing 2	dJ747L4.C1.2|UNQ512	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62872
0	0.601230827063106	0.757	0.467	0	PRRC2C	Malignant cells	GSE189460_pre	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62873
0	0.444443790150048	0.647	0.458	0	PRDX6	Malignant cells	GSE189460_pre	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62874
0	0.282001624169414	0.353	0.173	0	RABGAP1L	Malignant cells	GSE189460_pre	ENSG00000152061	9910	RAB GTPase activating protein 1 like	FLJ38519|HHL|KIAA0471|TBC1D18	protein_coding	Q5R372	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62875
0	0.518500565079476	0.502	0.271	0	CACYBP	Malignant cells	GSE189460_pre	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62876
0	0.566301929009619	0.561	0.259	0	RALGPS2	Malignant cells	GSE189460_pre	ENSG00000116191	55103	Ral GEF with PH domain and SH3 binding motif 2	FLJ10244|FLJ25604|KIAA0351	protein_coding	Q86X27	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62877
0	0.333155076435837	0.611	0.469	0	TOR3A	Malignant cells	GSE189460_pre	ENSG00000186283	64222	torsin family 3 member A	ADIR|ADIR2|FLJ22345	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62878
0	0.255938656655943	0.426	0.264	0	CEP350	Malignant cells	GSE189460_pre	ENSG00000135837	9857	centrosomal protein 350	CAP350|KIAA0480	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62879
0	0.738007126764545	0.679	0.302	0	IER5	Malignant cells	GSE189460_pre	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62880
0	0.54204788423935	0.331	0.1	0	GLUL	Malignant cells	GSE189460_pre	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62881
0	0.252828076939234	0.344	0.196	0	DHX9	Malignant cells	GSE189460_pre	ENSG00000135829	1660	DExH-box helicase 9	DDX9|LKP|RHA	protein_coding	Q08211	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62882
0	0.673873135125681	0.611	0.289	0	ARPC5	Malignant cells	GSE189460_pre	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62883
0	0.421937533158503	0.276	0.022	0	C1orf21	Malignant cells	GSE189460_pre	ENSG00000116667	81563	chromosome 1 open reading frame 21	PIG13	protein_coding	Q9H246	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62884
0	0.444721810751178	0.528	0.314	0	TPR	Malignant cells	GSE189460_pre	ENSG00000047410	7175	translocated promoter region, nuclear basket protein	NA	protein_coding	P12270	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62885
0	1.58169037893467	0.654	0.213	0	RGS1	Malignant cells	GSE189460_pre	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62886
0	0.254620896080932	0.307	0.149	0	GLRX2	Malignant cells	GSE189460_pre	ENSG00000023572	51022	glutaredoxin 2	bA101E13.1|GRX2	protein_coding	Q9NS18	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62887
0	0.39249290164141	0.462	0.303	0	DENND1B	Malignant cells	GSE189460_pre	ENSG00000213047	163486	DENN domain containing 1B	C1orf218|FAM31B|FLJ20054|MGC27044	protein_coding	Q6P3S1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62888
0	0.28244619299826	0.371	0.223	0	PTPN7	Malignant cells	GSE189460_pre	ENSG00000143851	5778	protein tyrosine phosphatase non-receptor type 7	HEPTP|LC-PTP	protein_coding	P35236	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62889
0	0.465327202113549	0.27	0.049	0	UBE2T	Malignant cells	GSE189460_pre	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62890
0	0.529085815708476	0.728	0.504	0	SNRPE	Malignant cells	GSE189460_pre	ENSG00000182004	6635	small nuclear ribonucleoprotein polypeptide E	Sm-E	protein_coding	P62304	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62891
0	0.464203902607925	0.495	0.232	0	PPP1R15B	Malignant cells	GSE189460_pre	ENSG00000158615	84919	protein phosphatase 1 regulatory subunit 15B	FLJ14744	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62892
0	0.416481375357112	0.596	0.377	0	MDM4	Malignant cells	GSE189460_pre	ENSG00000198625	4194	MDM4 regulator of p53	HDMX|MDMX	protein_coding	O15151	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62893
0	0.732891434767212	0.605	0.279	0	NUCKS1	Malignant cells	GSE189460_pre	ENSG00000069275	64710	nuclear casein kinase and cyclin dependent kinase substrate 1	NUCKS	protein_coding	Q9H1E3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62894
0	0.400656003781769	0.322	0.064	0	SRGAP2	Malignant cells	GSE189460_pre	ENSG00000266028	23380	SLIT-ROBO Rho GTPase activating protein 2	ARHGAP34|FNBP2|KIAA0456|SRGAP2A	protein_coding	O75044	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62895
0	0.464538669191572	0.571	0.317	0	CD55	Malignant cells	GSE189460_pre	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62896
0	0.626891795613573	0.626	0.326	0	MIR29B2CHG	Malignant cells	GSE189460_pre	ENSG00000203709	NA	NA	C1orf132|FLJ35650	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62897
0	0.449993888267127	0.354	0.083	0	RCOR3	Malignant cells	GSE189460_pre	ENSG00000117625	55758	REST corepressor 3	FLJ10876	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62898
0	0.739690646249452	0.711	0.431	0	NENF	Malignant cells	GSE189460_pre	ENSG00000117691	29937	neudesin neurotrophic factor	CIR2|SCIRP10|SPUF	protein_coding	Q9UMX5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62899
0	1.34450992380787	0.682	0.237	0	ATF3	Malignant cells	GSE189460_pre	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62900
0	0.302421184143195	0.321	0.123	0	NSL1	Malignant cells	GSE189460_pre	ENSG00000117697	25936	NSL1 component of MIS12 kinetochore complex	C1orf48|DC8|DKFZP566O1646|MIS14	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62901
0	0.26066136814693	0.293	0.123	0	GPATCH2	Malignant cells	GSE189460_pre	ENSG00000092978	55105	G-patch domain containing 2	CT110|FLJ10252|GPATC2|Pfa1|PPP1R30	protein_coding	Q9NW75	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62902
0	0.8096879931223	0.644	0.4	0	EPRS	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62903
0	0.518188943936502	0.517	0.308	0	MIA3	Malignant cells	GSE189460_pre	ENSG00000154305	375056	MIA SH3 domain ER export factor 3	FLJ39207|KIAA0268|TANGO|TANGO1|UNQ6077	protein_coding	Q5JRA6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62904
0	0.33768288553147	0.353	0.129	0	AIDA	Malignant cells	GSE189460_pre	ENSG00000186063	64853	axin interactor, dorsalization associated	C1orf80|FLJ12806	protein_coding	Q96BJ3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62905
0	0.250933430834578	0.303	0.14	0	BROX	Malignant cells	GSE189460_pre	ENSG00000162819	148362	BRO1 domain and CAAX motif containing	C1orf58|FLJ32421	protein_coding	Q5VW32	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62906
0	0.334660188574146	0.49	0.251	0	CAPN2	Malignant cells	GSE189460_pre	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62907
0	0.348094015757303	0.405	0.195	0	DEGS1	Malignant cells	GSE189460_pre	ENSG00000143753	8560	delta 4-desaturase, sphingolipid 1	DEGS-1|Des-1|DES1|FADS7|MLD	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62908
0	0.309957659212366	0.359	0.163	0	CNIH4	Malignant cells	GSE189460_pre	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62909
0	0.380125799944775	0.32	0.099	0	LBR	Malignant cells	GSE189460_pre	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62910
0	0.711245113320177	0.756	0.492	0	SRP9	Malignant cells	GSE189460_pre	ENSG00000143742	6726	signal recognition particle 9	NA	protein_coding	P49458	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62911
0	0.278722296049933	0.348	0.175	0	PYCR2	Malignant cells	GSE189460_pre	ENSG00000143811	29920	pyrroline-5-carboxylate reductase 2	P5CR2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62912
0	1.57320330627176	0.996	0.951	0	H3F3A	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62913
0	0.666494920873144	0.608	0.269	0	ACBD3	Malignant cells	GSE189460_pre	ENSG00000182827	64746	acyl-CoA binding domain containing 3	GCP60|GOCAP1|GOLPH1|PAP7	protein_coding	Q9H3P7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62914
0	0.764479512290165	0.732	0.38	0	PARP1	Malignant cells	GSE189460_pre	ENSG00000143799	142	poly(ADP-ribose) polymerase 1	ADPRT|ARTD1|PARP|PARS|Poly-PARP|PPOL	protein_coding	P09874	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62915
0	0.757445832263873	0.927	0.73	0	ARF1	Malignant cells	GSE189460_pre	ENSG00000143761	375	ADP ribosylation factor 1	NA	protein_coding	P84077	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62916
0	0.279156214011581	0.275	0.106	0	C1orf35	Malignant cells	GSE189460_pre	ENSG00000143793	79169	chromosome 1 open reading frame 35	MGC4174|MMTAG2	protein_coding	Q9BU76	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62917
0	0.674336220862836	0.635	0.292	0	MRPL55	Malignant cells	GSE189460_pre	ENSG00000162910	128308	mitochondrial ribosomal protein L55	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62918
0	0.811625820737691	0.925	0.761	0	GUK1	Malignant cells	GSE189460_pre	ENSG00000143774	2987	guanylate kinase 1	NA	protein_coding	Q16774	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62919
0	0.263756355340212	0.379	0.225	0	RAB4A	Malignant cells	GSE189460_pre	ENSG00000168118	5867	RAB4A, member RAS oncogene family	HRES-1/RAB4|RAB4	protein_coding	P20338	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62920
0	0.507328601688791	0.444	0.276	0	GALNT2	Malignant cells	GSE189460_pre	ENSG00000143641	2590	polypeptide N-acetylgalactosaminyltransferase 2	GalNAc-T2	protein_coding	Q10471	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62921
0	0.830730652488201	0.625	0.284	0	IRF2BP2	Malignant cells	GSE189460_pre	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62922
0	0.432616463759	0.809	0.697	0	TOMM20	Malignant cells	GSE189460_pre	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62923
0	0.518393379169949	0.496	0.261	0	ARID4B	Malignant cells	GSE189460_pre	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62924
0	0.313163895514207	0.3	0.121	0	SDCCAG8	Malignant cells	GSE189460_pre	ENSG00000276111	10806	SHH signaling and ciliogenesis regulator SDCCAG8	BBS16|CCCAP|NPHP10|NY-CO-8|SLSN7	protein_coding	Q86SQ7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62925
0	1.0584394536381	0.856	0.667	0	HNRNPU	Malignant cells	GSE189460_pre	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62926
0	1.23131392359597	0.571	0.196	0	ID2	Malignant cells	GSE189460_pre	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62927
0	0.389775040860297	0.526	0.3	0	YWHAQ	Malignant cells	GSE189460_pre	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62928
0	0.559663811184529	0.725	0.523	0	ODC1	Malignant cells	GSE189460_pre	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62929
0	0.320585709643097	0.394	0.214	0	LPIN1	Malignant cells	GSE189460_pre	ENSG00000134324	23175	lipin 1	KIAA0188	protein_coding	Q14693	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62930
0	0.303198010245831	0.703	0.514	0	RHOB	Malignant cells	GSE189460_pre	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62931
0	0.486457138721768	0.666	0.39	0	SF3B6	Malignant cells	GSE189460_pre	ENSG00000115128	51639	splicing factor 3b subunit 6	CGI-110|Ht006|P14|SAP14a|SF3B14a	protein_coding	Q9Y3B4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62932
0	0.327647920167982	0.942	0.871	0	OST4	Malignant cells	GSE189460_pre	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62933
0	0.352277963466375	0.492	0.287	0	PPM1G	Malignant cells	GSE189460_pre	ENSG00000115241	5496	protein phosphatase, Mg2+/Mn2+ dependent 1G	PP2CG|PP2Cgamma	protein_coding	O15355	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62934
0	0.624577912498864	0.735	0.564	0	YPEL5	Malignant cells	GSE189460_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62935
0	0.458006521037088	0.269	0.061	0	LTBP1	Malignant cells	GSE189460_pre	ENSG00000049323	4052	latent transforming growth factor beta binding protein 1	NA	protein_coding	Q14766	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62936
0	-0.98016295508175	0.172	0.454	0	QPCT	Malignant cells	GSE189460_pre	ENSG00000115828	25797	glutaminyl-peptide cyclotransferase	GCT|QC	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62937
0	0.848720061319522	0.777	0.492	0	SRSF7	Malignant cells	GSE189460_pre	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62938
0	0.262726478303951	0.254	0.092	0	MAP4K3	Malignant cells	GSE189460_pre	ENSG00000011566	8491	mitogen-activated protein kinase kinase kinase kinase 3	GLK|MAPKKKK3|RAB8IPL1	protein_coding	Q8IVH8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62939
0	1.58597395655793	0.816	0.459	0	ZFP36L2	Malignant cells	GSE189460_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62940
0	0.416306719134321	0.761	0.618	0	CALM2	Malignant cells	GSE189460_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62941
0	0.289508578036983	0.296	0.127	0	XPO1	Malignant cells	GSE189460_pre	ENSG00000082898	7514	exportin 1	CRM-1|CRM1|emb	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62942
0	0.70563558865474	0.691	0.408	0	MDH1	Malignant cells	GSE189460_pre	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62943
0	0.262853972292721	0.354	0.186	0	UGP2	Malignant cells	GSE189460_pre	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62944
0	0.603526977251668	0.671	0.386	0	PELI1	Malignant cells	GSE189460_pre	ENSG00000197329	57162	pellino E3 ubiquitin protein ligase 1	NA	protein_coding	Q96FA3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62945
0	0.275830749806664	0.404	0.233	0	ACTR2	Malignant cells	GSE189460_pre	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62946
0	0.280202380745849	0.754	0.569	0	PCBP1	Malignant cells	GSE189460_pre	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62947
0	0.336795419246188	0.581	0.417	0	SNRPG	Malignant cells	GSE189460_pre	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62948
0	0.339711854937311	0.389	0.181	0	POLE4	Malignant cells	GSE189460_pre	ENSG00000115350	56655	DNA polymerase epsilon 4, accessory subunit	p12	protein_coding	Q9NR33	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62949
0	0.304468325382608	0.994	0.98	0	TMSB10	Malignant cells	GSE189460_pre	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62950
0	0.504889624909323	0.801	0.615	0	CYTOR	Malignant cells	GSE189460_pre	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62951
0	0.856414738895995	0.407	0.239	0	DUSP2	Malignant cells	GSE189460_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62952
0	0.292263901387722	0.84	0.757	0	COX5B	Malignant cells	GSE189460_pre	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62953
0	0.727259406992783	0.487	0.101	0	MIR4435-2HG	Malignant cells	GSE189460_pre	ENSG00000172965	541471	MIR4435-2 host gene	AGD2|AK001796|LINC00978|lncRNA-AWPPH|MIR4435-1HG|MORRBID	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62954
0	0.514003669198331	0.519	0.216	0	BCL2L11	Malignant cells	GSE189460_pre	ENSG00000153094	10018	BCL2 like 11	BIM|BimEL|BimL|BimS|BOD	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62955
0	0.475592802569829	0.581	0.298	0	ACTR3	Malignant cells	GSE189460_pre	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62956
0	0.572922902002013	0.793	0.563	0	DBI	Malignant cells	GSE189460_pre	ENSG00000155368	1622	diazepam binding inhibitor, acyl-CoA binding protein	ACBD1|ACBP	protein_coding	P07108	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62957
0	0.369918447223255	0.82	0.645	0	GYPC	Malignant cells	GSE189460_pre	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62958
0	0.545873491973234	0.866	0.724	0	MZT2B	Malignant cells	GSE189460_pre	ENSG00000152082	80097	mitotic spindle organizing protein 2B	FAM128B|FLJ14346|MOZART2B	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62959
0	0.375315121420048	0.319	0.093	0	PTPN18	Malignant cells	GSE189460_pre	ENSG00000072135	26469	protein tyrosine phosphatase non-receptor type 18	BDP1	protein_coding	Q99952	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62960
0	0.360452409143535	0.642	0.453	0	MZT2A	Malignant cells	GSE189460_pre	ENSG00000173272	653784	mitotic spindle organizing protein 2A	FAM128A|MOZART2A	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62961
0	0.367346224539076	0.734	0.564	0	UBXN4	Malignant cells	GSE189460_pre	ENSG00000144224	23190	UBX domain protein 4	KIAA0242|UBXD2|UBXDC1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62962
0	1.43504187730007	0.81	0.379	0	CXCR4	Malignant cells	GSE189460_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62963
0	1.06510314415171	0.376	0.101	0	RND3	Malignant cells	GSE189460_pre	ENSG00000115963	390	Rho family GTPase 3	ARHE|Rho8|RhoE	protein_coding	P61587	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62964
0	0.405622373354385	0.362	0.164	0	RIF1	Malignant cells	GSE189460_pre	ENSG00000080345	55183	replication timing regulatory factor 1	FLJ10599|FLJ12870	protein_coding	Q5UIP0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62965
0	0.809825379438824	0.433	0.195	0	NR4A2	Malignant cells	GSE189460_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62966
0	0.303556341311969	0.42	0.229	0	RBMS1	Malignant cells	GSE189460_pre	ENSG00000153250	5937	RNA binding motif single stranded interacting protein 1	C2orf12|DKFZp564H0764|HCC-4|MSSP-1|MSSP-2|MSSP-3|SCR2|YC1	protein_coding	P29558	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62967
0	0.345625074771114	0.514	0.329	0	PPIG	Malignant cells	GSE189460_pre	ENSG00000138398	9360	peptidylprolyl isomerase G	CARS-Cyp|SCAF10|SRCyp	protein_coding	Q13427	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62968
0	0.256577683349908	0.502	0.309	0	SSB	Malignant cells	GSE189460_pre	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62969
0	0.269105499392646	0.297	0.132	0	HAT1	Malignant cells	GSE189460_pre	ENSG00000128708	8520	histone acetyltransferase 1	KAT1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62970
0	-0.561768993123329	0.297	0.574	0	PDK1	Malignant cells	GSE189460_pre	ENSG00000152256	5163	pyruvate dehydrogenase kinase 1	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62971
0	0.263789919905215	0.374	0.202	0	WIPF1	Malignant cells	GSE189460_pre	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62972
0	0.744621346728367	0.849	0.622	0	HNRNPA3	Malignant cells	GSE189460_pre	ENSG00000170144	220988	heterogeneous nuclear ribonucleoprotein A3	HNRPA3	protein_coding	P51991	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62973
0	-0.810531577040396	0.114	0.318	0	FRZB	Malignant cells	GSE189460_pre	ENSG00000162998	2487	frizzled related protein	FRE|FRITZ|FRP-3|FRZB-1|FRZB-PEN|FRZB1|FZRB|hFIZ|SFRP3|SRFP3	protein_coding	Q92765	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62974
0	0.306285677984405	0.573	0.378	0	ZC3H15	Malignant cells	GSE189460_pre	ENSG00000065548	55854	zinc finger CCCH-type containing 15	LEREPO4	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62975
0	0.311110530942205	0.361	0.182	0	STK17B	Malignant cells	GSE189460_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62976
0	0.321899366216455	0.514	0.326	0	SF3B1	Malignant cells	GSE189460_pre	ENSG00000115524	23451	splicing factor 3b subunit 1	Hsh155|Prp10|PRPF10|SAP155|SF3b155	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62977
0	0.333069590169947	0.676	0.512	0	HSPD1	Malignant cells	GSE189460_pre	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62978
0	0.546618130593989	0.757	0.577	0	HSPE1	Malignant cells	GSE189460_pre	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62979
0	0.381433208840571	0.365	0.157	0	CASP8	Malignant cells	GSE189460_pre	ENSG00000064012	841	caspase 8	Casp-8|FLICE|MACH|MCH5	protein_coding	Q14790	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62980
0	0.46114940913521	0.593	0.365	0	SUMO1	Malignant cells	GSE189460_pre	ENSG00000116030	7341	small ubiquitin like modifier 1	GMP1|OFC10|PIC1|SMT3C|SMT3H3|SUMO-1|UBL1	protein_coding	P63165	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62981
0	0.279792982484933	0.488	0.308	0	NOP58	Malignant cells	GSE189460_pre	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62982
0	0.333224690765649	0.557	0.345	0	XRCC5	Malignant cells	GSE189460_pre	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62983
0	0.648086832209456	0.828	0.584	0	ARPC2	Malignant cells	GSE189460_pre	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62984
0	0.328706038957195	0.469	0.27	0	TUBA4A	Malignant cells	GSE189460_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62985
0	0.885604812039007	0.885	0.631	0	NCL	Malignant cells	GSE189460_pre	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62986
0	0.74879520912942	0.998	0.991	0	PTMA	Malignant cells	GSE189460_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62987
0	0.490173401840827	0.301	0.067	0	ARL4C	Malignant cells	GSE189460_pre	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62988
0	0.258191460929297	0.427	0.24	0	PPP1R7	Malignant cells	GSE189460_pre	ENSG00000115685	5510	protein phosphatase 1 regulatory subunit 7	sds22	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62989
0	-0.857064402187643	0.018	0.311	0	IL5RA	Malignant cells	GSE189460_pre	ENSG00000091181	3568	interleukin 5 receptor subunit alpha	CD125|CDw125|IL5R	protein_coding	Q01344	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62990
0	0.282249033426456	0.349	0.165	0	ARPC4	Malignant cells	GSE189460_pre	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62991
0	0.508385638264949	0.747	0.544	0	BRK1	Malignant cells	GSE189460_pre	ENSG00000254999	55845	BRICK1 subunit of SCAR/WAVE actin nucleating complex	C3orf10|HSPC300|MDS027	protein_coding	Q8WUW1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62992
0	0.489669356885268	0.65	0.407	0	LSM3	Malignant cells	GSE189460_pre	ENSG00000170860	27258	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	SMX4|USS2|YLR438C	protein_coding	P62310	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62993
0	0.682130214519615	0.837	0.603	0	ANKRD28	Malignant cells	GSE189460_pre	ENSG00000206560	23243	ankyrin repeat domain 28	CFAP79|FAP79|KIAA0379|PITK|PP6-ARS-A|PPP1R65	protein_coding	O15084	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62994
0	0.360432506059787	0.446	0.256	0	UBE2E1	Malignant cells	GSE189460_pre	ENSG00000170142	7324	ubiquitin conjugating enzyme E2 E1	UbcH6	protein_coding	P51965	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62995
0	0.46123650910498	0.998	0.995	0	RPL15	Malignant cells	GSE189460_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62996
0	0.316110242894631	0.35	0.176	0	NR1D2	Malignant cells	GSE189460_pre	ENSG00000174738	9975	nuclear receptor subfamily 1 group D member 2	BD73|EAR-1r|Hs.37288|HZF2|REVERBB|REVERBbeta|RVR	protein_coding	Q14995	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62997
0	0.347725617125454	0.56	0.357	0	GOLGA4	Malignant cells	GSE189460_pre	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62998
0	0.274827849450293	0.37	0.202	0	CSRNP1	Malignant cells	GSE189460_pre	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	62999
0	0.338736655990033	0.434	0.235	0	SS18L2	Malignant cells	GSE189460_pre	ENSG00000008324	51188	SS18 like 2	KIAA-iso	protein_coding	Q9UHA2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63000
0	0.360737090932425	0.529	0.348	0	NKTR	Malignant cells	GSE189460_pre	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63001
0	0.439073267870756	0.383	0.153	0	SMARCC1	Malignant cells	GSE189460_pre	ENSG00000173473	6599	SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1	BAF155|CRACC1|Rsc8|SRG3	protein_coding	Q92922	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63002
0	0.439805321740686	0.89	0.766	0	TMA7	Malignant cells	GSE189460_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63003
0	0.279901232908412	0.595	0.436	0	NDUFAF3	Malignant cells	GSE189460_pre	ENSG00000178057	25915	NADH:ubiquinone oxidoreductase complex assembly factor 3	2P1|C3orf60|DKFZP564J0123|E3-3|MGC10527	protein_coding	Q9BU61	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63004
0	0.357291042817725	0.711	0.572	0	RHOA	Malignant cells	GSE189460_pre	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63005
0	0.300384690756823	0.439	0.259	0	TEX264	Malignant cells	GSE189460_pre	ENSG00000164081	51368	testis expressed 264, ER-phagy receptor	FLJ13935|ZSIG11	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63006
0	0.341472673054514	0.411	0.231	0	NT5DC2	Malignant cells	GSE189460_pre	ENSG00000168268	64943	5'-nucleotidase domain containing 2	FLJ12442	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63007
0	0.285445818138403	0.474	0.299	0	THOC7	Malignant cells	GSE189460_pre	ENSG00000163634	80145	THO complex subunit 7	FLJ23445|fSAP24|NIF3L1BP1	protein_coding	Q6I9Y2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63008
0	0.325802666952659	0.433	0.236	0	TMF1	Malignant cells	GSE189460_pre	ENSG00000144747	7110	TATA element modulatory factor 1	ARA160|TMF	protein_coding	P82094	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63009
0	0.276979693095343	0.453	0.274	0	ARL6IP5	Malignant cells	GSE189460_pre	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63010
0	0.475648288551288	0.402	0.162	0	CRYBG3	Malignant cells	GSE189460_pre	ENSG00000080200	131544	crystallin beta-gamma domain containing 3	DKFZp667G2110	protein_coding	Q68DQ2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63011
0	0.260549711683354	0.317	0.16	0	RIOX2	Malignant cells	GSE189460_pre	ENSG00000170854	84864	ribosomal oxygenase 2	FLJ14393|JMJD10|mdig|MINA|MINA53|NO52	protein_coding	Q8IUF8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63012
0	0.589160134069293	0.582	0.33	0	NFKBIZ	Malignant cells	GSE189460_pre	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63013
0	0.499541902469633	0.575	0.4	0	CD47	Malignant cells	GSE189460_pre	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63014
0	0.362695028736262	0.269	0.08	0	LSAMP	Malignant cells	GSE189460_pre	ENSG00000185565	4045	limbic system associated membrane protein	IGLON3|LAMP	protein_coding	Q13449	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63015
0	0.407045250006733	0.664	0.469	0	COX17	Malignant cells	GSE189460_pre	ENSG00000138495	10063	cytochrome c oxidase copper chaperone COX17	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63016
0	0.480681116984242	0.616	0.397	0	GOLGB1	Malignant cells	GSE189460_pre	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63017
0	0.323467735881624	0.647	0.484	0	SEC61A1	Malignant cells	GSE189460_pre	ENSG00000058262	29927	SEC61 translocon subunit alpha 1	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63018
0	0.924163285782398	0.911	0.751	0	H1FX	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63019
0	0.442869462709079	0.455	0.216	0	MBD4	Malignant cells	GSE189460_pre	ENSG00000129071	8930	methyl-CpG binding domain 4, DNA glycosylase	MED1	protein_coding	O95243	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63020
0	0.295829949816345	0.416	0.241	0	COPB2	Malignant cells	GSE189460_pre	ENSG00000184432	9276	COPI coat complex subunit beta 2	beta'-COP|betaprime-COP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63021
0	0.38769717922356	0.453	0.243	0	SLC25A36	Malignant cells	GSE189460_pre	ENSG00000114120	55186	solute carrier family 25 member 36	FLJ10618|PNC2	protein_coding	Q96CQ1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63022
0	0.603489956711555	0.847	0.683	0	ZBTB38	Malignant cells	GSE189460_pre	ENSG00000177311	253461	zinc finger and BTB domain containing 38	CIBZ|FLJ35036|PPP1R171|ZNF921	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63023
0	0.433834008625022	0.533	0.276	0	U2SURP	Malignant cells	GSE189460_pre	ENSG00000163714	23350	U2 snRNP associated SURP domain containing	fSAPa|SR140	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63024
0	0.457930737121057	0.973	0.941	0	SERP1	Malignant cells	GSE189460_pre	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63025
0	0.512547837129961	0.55	0.239	0	MBNL1	Malignant cells	GSE189460_pre	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63026
0	0.250741885230796	0.391	0.229	0	DHX36	Malignant cells	GSE189460_pre	ENSG00000281763	170506	DEAH-box helicase 36	DDX36|KIAA1488|MLEL1|RHAU	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63027
0	0.343581522870629	0.284	0.088	0	GMPS	Malignant cells	GSE189460_pre	ENSG00000163655	8833	guanine monophosphate synthase	GATD7	protein_coding	P49915	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63028
0	0.422298096963837	0.976	0.956	0	SSR3	Malignant cells	GSE189460_pre	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63029
0	0.51535033566219	0.421	0.149	0	TIPARP	Malignant cells	GSE189460_pre	ENSG00000163659	25976	TCDD inducible poly(ADP-ribose) polymerase	ARTD14|DDF1|DKFZP434J214|DKFZp686N0351|PARP-1|PARP-7|PARP7|pART14|RM1	protein_coding	Q7Z3E1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63030
0	0.620125262032386	0.886	0.73	0	CCNL1	Malignant cells	GSE189460_pre	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63031
0	1.12837476648158	0.524	0.149	0	SMC4	Malignant cells	GSE189460_pre	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63032
0	0.398279136330951	0.879	0.842	0	SEC62	Malignant cells	GSE189460_pre	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63033
0	0.251256032425209	0.376	0.209	0	FXR1	Malignant cells	GSE189460_pre	ENSG00000114416	8087	FMR1 autosomal homolog 1	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63034
0	0.255211597901873	0.372	0.203	0	EIF4G1	Malignant cells	GSE189460_pre	ENSG00000114867	1981	eukaryotic translation initiation factor 4 gamma 1	EIF4F|EIF4G|p220|PARK18	protein_coding	Q04637	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63035
0	0.481110272084086	0.67	0.431	0	TRA2B	Malignant cells	GSE189460_pre	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63036
0	0.289890127580897	0.481	0.334	0	DNAJB11	Malignant cells	GSE189460_pre	ENSG00000090520	51726	DnaJ heat shock protein family (Hsp40) member B11	EDJ|ERdj3|HEDJ	protein_coding	Q9UBS4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63037
0	0.333706402584479	0.298	0.099	0	RPL39L	Malignant cells	GSE189460_pre	ENSG00000163923	116832	ribosomal protein L39 like	RPL39L1	protein_coding	Q96EH5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63038
0	0.383491482741076	0.455	0.214	0	CCDC50	Malignant cells	GSE189460_pre	ENSG00000152492	152137	coiled-coil domain containing 50	C3orf6|DFNA44|Ymer	protein_coding	Q8IVM0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63039
0	0.404259602149986	0.583	0.442	0	PPP1R2	Malignant cells	GSE189460_pre	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63040
0	0.494020030418589	0.322	0.12	0	SLBP	Malignant cells	GSE189460_pre	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63041
0	-0.432024135271601	0.623	0.764	0	CD38	Malignant cells	GSE189460_pre	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63042
0	0.321053994528805	0.402	0.202	0	RFC1	Malignant cells	GSE189460_pre	ENSG00000035928	5981	replication factor C subunit 1	A1|MHCBFB|PO-GA|RFC140	protein_coding	P35251	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63043
0	0.357644633347461	0.454	0.294	0	RHOH	Malignant cells	GSE189460_pre	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63044
0	1.38162440584676	0.457	0.204	0	AREG	Malignant cells	GSE189460_pre	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63045
0	0.305591155671269	0.399	0.209	0	G3BP2	Malignant cells	GSE189460_pre	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63046
0	0.46190795878493	0.819	0.631	0	CCNI	Malignant cells	GSE189460_pre	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63047
0	0.478921626207937	0.644	0.414	0	HNRNPD	Malignant cells	GSE189460_pre	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63048
0	0.593032035972917	0.785	0.6	0	HNRNPDL	Malignant cells	GSE189460_pre	ENSG00000152795	9987	heterogeneous nuclear ribonucleoprotein D like	HNRPDL|JKTBP|laAUF1|LGMD1G	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63049
0	0.342113500797663	0.552	0.336	0	SEC31A	Malignant cells	GSE189460_pre	ENSG00000138674	22872	SEC31 homolog A, COPII coat complex component	ABP125|ABP130|KIAA0905|SEC31L1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63050
0	0.481100036617721	0.427	0.19	0	PLAC8	Malignant cells	GSE189460_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63051
0	1.23487924411661	0.877	0.638	0	H2AFZ	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63052
0	0.281219774052506	0.769	0.615	0	UBE2D3	Malignant cells	GSE189460_pre	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63053
0	0.316859530479964	0.607	0.453	0	CISD2	Malignant cells	GSE189460_pre	ENSG00000145354	493856	CDGSH iron sulfur domain 2	ERIS|Miner1|NAF-1|WFS2|ZCD2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63054
0	0.303990750389787	0.858	0.793	0	OSTC	Malignant cells	GSE189460_pre	ENSG00000198856	58505	oligosaccharyltransferase complex non-catalytic subunit	DC2	protein_coding	Q9NRP0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63055
0	0.261723734970744	0.262	0.093	0	CAMK2D	Malignant cells	GSE189460_pre	ENSG00000145349	817	calcium/calmodulin dependent protein kinase II delta	CAMKD	protein_coding	Q13557	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63056
0	0.628361304677385	0.704	0.444	0	ANXA5	Malignant cells	GSE189460_pre	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63057
0	0.356654243967785	0.353	0.153	0	ELF2	Malignant cells	GSE189460_pre	ENSG00000109381	1998	E74 like ETS transcription factor 2	EU32|NERF|NERF-1A|NERF-1B|NERF-2	protein_coding	Q15723	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63058
0	0.376195824741654	0.46	0.219	0	SMARCA5	Malignant cells	GSE189460_pre	ENSG00000153147	8467	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5	hISWI|hSNF2H|ISWI	protein_coding	O60264	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63059
0	0.327682172596884	0.266	0.076	0	FNIP2	Malignant cells	GSE189460_pre	ENSG00000052795	57600	folliculin interacting protein 2	FNIPL|KIAA1450|MAPO1	protein_coding	Q9P278	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63060
0	1.21820826496866	0.533	0.151	0	HMGB2	Malignant cells	GSE189460_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63061
0	0.272578364931682	0.271	0.121	0	SAP30	Malignant cells	GSE189460_pre	ENSG00000164105	8819	Sin3A associated protein 30	NA	protein_coding	O75446	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63062
0	-0.370433526278513	0.781	0.838	0	CLPTM1L	Malignant cells	GSE189460_pre	ENSG00000274811	81037	CLPTM1 like	CRR9|FLJ14400	protein_coding	Q96KA5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63063
0	-0.389514344617956	0.138	0.356	0	SELENOP	Malignant cells	GSE189460_pre	ENSG00000250722	6414	selenoprotein P	SELP|SeP|SEPP|SEPP1	protein_coding	P49908	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63064
0	0.588931219099478	0.597	0.304	0	IL6ST	Malignant cells	GSE189460_pre	ENSG00000134352	3572	interleukin 6 cytokine family signal transducer	CD130|GP130|IL-6RB|sGP130	protein_coding	P40189	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63065
0	0.366070348597083	0.617	0.486	0	GPBP1	Malignant cells	GSE189460_pre	ENSG00000062194	65056	GC-rich promoter binding protein 1	DKFZp761C169	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63066
0	0.427342893226952	0.954	0.904	0	COX7C	Malignant cells	GSE189460_pre	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63067
0	0.596837698988868	0.803	0.614	0	MEF2C	Malignant cells	GSE189460_pre	ENSG00000081189	4208	myocyte enhancer factor 2C	NA	protein_coding	Q06413	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63068
0	0.330475343005513	0.351	0.171	0	ARRDC3	Malignant cells	GSE189460_pre	ENSG00000113369	57561	arrestin domain containing 3	KIAA1376|TLIMP	protein_coding	Q96B67	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63069
0	-0.327814397506024	0.178	0.404	0	FAM174A	Malignant cells	GSE189460_pre	ENSG00000174132	345757	family with sequence similarity 174 member A	NS5ATP6|TMEM157|UNQ1912	protein_coding	Q8TBP5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63070
0	0.658847028635104	0.97	0.921	0	HINT1	Malignant cells	GSE189460_pre	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63071
0	0.320985924770003	0.482	0.308	0	CDC42SE2	Malignant cells	GSE189460_pre	ENSG00000158985	56990	CDC42 small effector 2	FLJ21967|SPEC2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63072
0	0.3392520497642	0.366	0.179	0	FNIP1	Malignant cells	GSE189460_pre	ENSG00000217128	96459	folliculin interacting protein 1	KIAA1961	protein_coding	Q8TF40	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63073
0	0.426199270205234	0.713	0.495	0	IRF1	Malignant cells	GSE189460_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63074
0	0.395792288410305	0.782	0.693	0	UQCRQ	Malignant cells	GSE189460_pre	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63075
0	0.501577572424496	0.823	0.635	0	SKP1	Malignant cells	GSE189460_pre	ENSG00000113558	6500	S-phase kinase associated protein 1	EMC19|MGC34403|OCP-II|OCP2|p19A|SKP1A|TCEB1L	protein_coding	P63208	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63076
0	0.330420494856436	0.411	0.208	0	PPP2CA	Malignant cells	GSE189460_pre	ENSG00000113575	5515	protein phosphatase 2 catalytic subunit alpha	PP2AC|PP2Calpha	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63077
0	0.279877308463506	0.586	0.433	0	UBE2B	Malignant cells	GSE189460_pre	ENSG00000119048	7320	ubiquitin conjugating enzyme E2 B	HHR6B|RAD6B|UBC2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63078
0	0.299107929630931	0.63	0.463	0	SAR1B	Malignant cells	GSE189460_pre	ENSG00000152700	51128	secretion associated Ras related GTPase 1B	SARA2	protein_coding	Q9Y6B6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63079
0	0.359527992423998	0.462	0.264	0	DDX46	Malignant cells	GSE189460_pre	ENSG00000145833	9879	DEAD-box helicase 46	FLJ25329|KIAA0801|Prp5|PRPF5	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63080
0	0.70633843068111	0.469	0.187	0	H2AFY	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63081
0	0.356391806013331	0.506	0.366	0	HNRNPA0	Malignant cells	GSE189460_pre	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63082
0	0.691150169535113	0.517	0.31	0	EGR1	Malignant cells	GSE189460_pre	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63083
0	0.437096149775572	0.602	0.39	0	HSPA9	Malignant cells	GSE189460_pre	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63084
0	0.353541542496809	0.565	0.394	0	PAIP2	Malignant cells	GSE189460_pre	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63085
0	0.379329135956897	0.699	0.523	0	UBE2D2	Malignant cells	GSE189460_pre	ENSG00000131508	7322	ubiquitin conjugating enzyme E2 D2	UBC4|UbcH5B	protein_coding	P62837	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63086
0	0.370647097441381	0.652	0.488	0	NDUFA2	Malignant cells	GSE189460_pre	ENSG00000131495	4695	NADH:ubiquinone oxidoreductase subunit A2	B8	protein_coding	O43678	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63087
0	0.290398128976239	0.4	0.215	0	IK	Malignant cells	GSE189460_pre	ENSG00000113141	3550	IK cytokine	RED|RER	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63088
0	0.406813449775475	0.607	0.364	0	TAF7	Malignant cells	GSE189460_pre	ENSG00000178913	6879	TATA-box binding protein associated factor 7	TAF2F|TAFII55	protein_coding	Q15545	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63089
0	0.329089723848398	0.464	0.25	0	NR3C1	Malignant cells	GSE189460_pre	ENSG00000113580	2908	nuclear receptor subfamily 3 group C member 1	GR|GRL	protein_coding	P04150	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63090
0	0.278361835373993	0.404	0.222	0	YIPF5	Malignant cells	GSE189460_pre	ENSG00000145817	81555	Yip1 domain family member 5	FinGER5|SMAP-5	protein_coding	Q969M3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63091
0	0.298248483924525	0.467	0.288	0	CSNK1A1	Malignant cells	GSE189460_pre	ENSG00000113712	1452	casein kinase 1 alpha 1	CK1|CK1a|CK1alpha|CKIa|CKIalpha	protein_coding	P48729	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63092
0	-0.360920473214914	0.312	0.605	0	CD74	Malignant cells	GSE189460_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63093
0	0.259378191469629	0.287	0.118	0	GM2A	Malignant cells	GSE189460_pre	ENSG00000196743	2760	ganglioside GM2 activator	GM2-AP|GM2AP|SAP-3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63094
0	0.343980960025579	0.672	0.507	0	ATOX1	Malignant cells	GSE189460_pre	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63095
0	0.336140555278767	0.401	0.218	0	G3BP1	Malignant cells	GSE189460_pre	ENSG00000145907	10146	G3BP stress granule assembly factor 1	G3BP|HDH-VIII	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63096
0	0.28352095219148	0.511	0.332	0	LARP1	Malignant cells	GSE189460_pre	ENSG00000155506	23367	La ribonucleoprotein 1, translational regulator	KIAA0731|Lar1|LARP|Lhp1|MGC19556	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63097
0	0.589711505874295	0.698	0.378	0	CLINT1	Malignant cells	GSE189460_pre	ENSG00000113282	9685	clathrin interactor 1	CLINT|ENTH|EPNR|KIAA0171	protein_coding	Q14677	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63098
0	0.660148384973633	0.972	0.888	0	NPM1	Malignant cells	GSE189460_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63099
0	0.914929808620005	0.926	0.796	0	DUSP1	Malignant cells	GSE189460_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63100
0	1.24339054297833	0.908	0.766	0	ATP6V0E1	Malignant cells	GSE189460_pre	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63101
0	0.454846920560013	0.49	0.321	0	CREBRF	Malignant cells	GSE189460_pre	ENSG00000164463	153222	CREB3 regulatory factor	C5orf41|LRF	protein_coding	Q8IUR6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63102
0	0.394026700905012	0.702	0.556	0	CPEB4	Malignant cells	GSE189460_pre	ENSG00000113742	80315	cytoplasmic polyadenylation element binding protein 4	KIAA1673	protein_coding	Q17RY0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63103
0	0.342826106789717	0.836	0.733	0	PRELID1	Malignant cells	GSE189460_pre	ENSG00000169230	27166	PRELI domain containing 1	CGI-106|PRELI|PX19	protein_coding	Q9Y255	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63104
0	0.754511144334778	0.605	0.27	0	HNRNPAB	Malignant cells	GSE189460_pre	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63105
0	0.678912947086347	0.785	0.515	0	SQSTM1	Malignant cells	GSE189460_pre	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63106
0	0.411336055182374	0.402	0.14	0	SERPINB1	Malignant cells	GSE189460_pre	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63107
0	0.277565883736762	0.275	0.108	0	SERPINB6	Malignant cells	GSE189460_pre	ENSG00000124570	5269	serpin family B member 6	CAP|DFNB91|PI6|PTI	protein_coding	P35237	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63108
0	0.34690263772579	0.396	0.188	0	PRPF4B	Malignant cells	GSE189460_pre	ENSG00000112739	8899	pre-mRNA processing factor 4B	KIAA0536|PR4H|Prp4	protein_coding	Q13523	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63109
0	0.286518257845856	0.293	0.129	0	CDYL	Malignant cells	GSE189460_pre	ENSG00000153046	9425	chromodomain Y like	CDYL1|DKFZP586C1622	protein_coding	Q9Y232	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63110
0	0.283596020872422	0.435	0.267	0	EEF1E1	Malignant cells	GSE189460_pre	ENSG00000124802	9521	eukaryotic translation elongation factor 1 epsilon 1	AIMP3|P18	protein_coding	O43324	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63111
0	0.590293063490004	0.641	0.344	0	TMEM14B	Malignant cells	GSE189460_pre	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63112
0	1.13734120847957	0.484	0.189	0	PHACTR1	Malignant cells	GSE189460_pre	ENSG00000112137	221692	phosphatase and actin regulator 1	dJ257A7.2|KIAA1733|RPEL1	protein_coding	Q9C0D0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63113
0	0.389186629363301	0.644	0.441	0	NOL7	Malignant cells	GSE189460_pre	ENSG00000225921	51406	nucleolar protein 7	C6orf90|dJ223E5.2|NOP27|PQBP3|RARG-1	protein_coding	Q9UMY1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63114
0	0.307218294008322	0.258	0.075	0	NUP153	Malignant cells	GSE189460_pre	ENSG00000124789	9972	nucleoporin 153	HNUP153	protein_coding	P49790	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63115
0	0.595223707568962	0.26	0.022	0	DEK	Malignant cells	GSE189460_pre	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63116
0	0.440717057316527	0.279	0.049	0	GMNN	Malignant cells	GSE189460_pre	ENSG00000112312	51053	geminin DNA replication inhibitor	Gem	protein_coding	O75496	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63117
0	0.998378221293592	0.68	0.562	0	HIST1H1C	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63118
0	0.581785793779489	0.34	0.139	0	HIST1H2BC	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63119
0	0.58497952836414	0.337	0.089	0	HIST1H2BD	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63120
0	0.477031254392143	0.273	0.089	0	AL031777.3	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63121
0	0.491121824611125	0.286	0.1	0	HIST1H2BJ	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63122
0	0.493338401657464	0.305	0.071	0	HIST1H2BN	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63123
0	0.305709311536378	0.299	0.155	0	AL121944.1	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63124
0	0.345484344175869	0.934	0.83	0	HLA-E	Malignant cells	GSE189460_pre	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63125
0	0.252681614916426	0.348	0.189	0	ABCF1	Malignant cells	GSE189460_pre	ENSG00000225989	23	ATP binding cassette subfamily F member 1	ABC50|EST123147	protein_coding	Q8NE71	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63126
0	1.24921781742532	0.602	0.354	0	TUBB	Malignant cells	GSE189460_pre	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63127
0	0.521557878886412	0.285	0.013	0	TCF19	Malignant cells	GSE189460_pre	ENSG00000224472	6941	transcription factor 19	SC1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63128
0	0.343703728820899	0.997	0.96	0	HLA-B	Malignant cells	GSE189460_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63129
0	0.263794037423223	0.491	0.332	0	CSNK2B	Malignant cells	GSE189460_pre	ENSG00000230700	1460	casein kinase 2 beta	Ckb1|Ckb2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63130
0	0.932865674897381	0.969	0.815	0	CLIC1	Malignant cells	GSE189460_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63131
0	0.394762514096141	0.5	0.282	0	LSM2	Malignant cells	GSE189460_pre	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63132
0	1.06419151460217	0.469	0.166	0	HSPA1B	Malignant cells	GSE189460_pre	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63133
0	0.479869331415169	0.537	0.271	0	GPSM3	Malignant cells	GSE189460_pre	ENSG00000233490	63940	G protein signaling modulator 3	AGS4|C6orf9|G18|G18.1a|G18.1b|G18.2|NG1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63134
0	0.352133468028925	0.615	0.413	0	PSMB8	Malignant cells	GSE189460_pre	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63135
0	0.407480033699736	0.673	0.423	0	PSMB9	Malignant cells	GSE189460_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63136
0	0.383908953785158	0.658	0.438	0	BRD2	Malignant cells	GSE189460_pre	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63137
0	0.359107467182679	0.745	0.536	0	TAPBP	Malignant cells	GSE189460_pre	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63138
0	0.739001622010843	0.934	0.852	0	CUTA	Malignant cells	GSE189460_pre	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63139
0	0.435500852279822	0.482	0.258	0	UQCC2	Malignant cells	GSE189460_pre	ENSG00000137288	84300	ubiquinol-cytochrome c reductase complex assembly factor 2	bA6B20.2|C6orf125|Cbp6|M19|MGC14833|MNF1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63140
0	0.317148252178668	0.494	0.295	0	SNRPC	Malignant cells	GSE189460_pre	ENSG00000124562	6631	small nuclear ribonucleoprotein polypeptide C	U1-C|Yhc1	protein_coding	P09234	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63141
0	0.832279027783267	0.406	0.081	0	FKBP5	Malignant cells	GSE189460_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63142
0	0.779767856838496	0.804	0.633	0	SRSF3	Malignant cells	GSE189460_pre	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63143
0	0.462232888444357	0.545	0.273	0	CDKN1A	Malignant cells	GSE189460_pre	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63144
0	0.358898281749508	0.481	0.308	0	CPNE5	Malignant cells	GSE189460_pre	ENSG00000124772	57699	copine 5	COPN5|CPN5|KIAA1599	protein_coding	Q9HCH3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63145
0	0.266791152018438	0.368	0.211	0	MTCH1	Malignant cells	GSE189460_pre	ENSG00000137409	23787	mitochondrial carrier 1	CGI-64|PSAP|SLC25A49	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63146
0	0.907029082889476	0.594	0.196	0	PIM1	Malignant cells	GSE189460_pre	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63147
0	0.344670057147389	0.467	0.229	0	CCDC167	Malignant cells	GSE189460_pre	ENSG00000198937	154467	coiled-coil domain containing 167	C6orf129|dJ153P14.2	protein_coding	Q9P0B6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63148
0	0.320072767605145	0.577	0.4	0	GLO1	Malignant cells	GSE189460_pre	ENSG00000124767	2739	glyoxalase I	GLOD1	protein_coding	Q04760	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63149
0	0.696063452860184	0.53	0.236	0	CNPY3	Malignant cells	GSE189460_pre	ENSG00000137161	10695	canopy FGF signaling regulator 3	CAG4A|TNRC5	protein_coding	Q9BT09	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63150
0	0.343158447366023	0.355	0.158	0	MEA1	Malignant cells	GSE189460_pre	ENSG00000124733	4201	male-enhanced antigen 1	MEA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63151
0	0.561545128655399	0.578	0.269	0	MRPL14	Malignant cells	GSE189460_pre	ENSG00000180992	64928	mitochondrial ribosomal protein L14	MRP-L32|RPML32	protein_coding	Q6P1L8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63152
0	0.899595805195982	0.976	0.844	0	HSP90AB1	Malignant cells	GSE189460_pre	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63153
0	0.34986121635379	0.336	0.108	0	CDC5L	Malignant cells	GSE189460_pre	ENSG00000096401	988	cell division cycle 5 like	CDC5|CEF1|hCDC5|PCDC5RP	protein_coding	Q99459	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63154
0	0.331808691433764	0.326	0.129	0	CD2AP	Malignant cells	GSE189460_pre	ENSG00000198087	23607	CD2 associated protein	CMS	protein_coding	Q9Y5K6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63155
0	0.437306065515598	0.297	0.064	0	MCM3	Malignant cells	GSE189460_pre	ENSG00000112118	4172	minichromosome maintenance complex component 3	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63156
0	0.348094445573737	0.434	0.225	0	DST	Malignant cells	GSE189460_pre	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63157
0	0.25595494667755	0.307	0.148	0	ZNF451	Malignant cells	GSE189460_pre	ENSG00000112200	26036	zinc finger protein 451	COASTER|dJ417I1.1|KIAA0576|KIAA1702|ZATT	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63158
0	-0.716841976640908	1	0.999	0	EEF1A1	Malignant cells	GSE189460_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63159
0	-0.430826524085668	0.813	0.92	0	UBE2J1	Malignant cells	GSE189460_pre	ENSG00000198833	51465	ubiquitin conjugating enzyme E2 J1	CGI-76|HSPC153|NCUBE1|UBC6	protein_coding	Q9Y385	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63160
0	0.413077165604586	0.718	0.55	0	PNISR	Malignant cells	GSE189460_pre	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63161
0	0.316760189263472	0.586	0.411	0	BCLAF1	Malignant cells	GSE189460_pre	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63162
0	-0.297899637313567	0.271	0.432	0	PERP	Malignant cells	GSE189460_pre	ENSG00000112378	64065	p53 apoptosis effector related to PMP22	dJ496H19.1|KCP1|KRTCAP1|PIGPC1|THW	protein_coding	Q96FX8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63163
0	0.306077838758593	0.602	0.443	0	EZR	Malignant cells	GSE189460_pre	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63164
0	0.704082125808998	0.982	0.905	0	ACTB	Malignant cells	GSE189460_pre	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63165
0	0.291184238141906	0.533	0.336	0	RAC1	Malignant cells	GSE189460_pre	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63166
0	0.577951438259589	0.471	0.217	0	RPA3	Malignant cells	GSE189460_pre	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63167
0	0.491893510357447	0.928	0.921	0	NDUFA4	Malignant cells	GSE189460_pre	ENSG00000189043	4697	NDUFA4 mitochondrial complex associated	CI-9k|COXFA4|MISTR1|MLRQ|MRCAF1	protein_coding	O00483	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63168
0	0.554054289427527	0.406	0.135	0	ARL4A	Malignant cells	GSE189460_pre	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63169
0	0.727510393638894	0.965	0.867	0	HNRNPA2B1	Malignant cells	GSE189460_pre	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63170
0	0.386704460750907	0.567	0.376	0	CBX3	Malignant cells	GSE189460_pre	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63171
0	0.592239748400655	0.619	0.351	0	SEPT7	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63172
0	0.601455307838811	0.946	0.875	0	PPIA	Malignant cells	GSE189460_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63173
0	0.92650426488728	0.659	0.318	0	H2AFV	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63174
0	0.305969638643682	0.911	0.884	0	CHCHD2	Malignant cells	GSE189460_pre	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63175
0	-0.54255968557707	0.018	0.306	0	HGF	Malignant cells	GSE189460_pre	ENSG00000019991	3082	hepatocyte growth factor	DFNB39|F-TCF|HGFB|HPTA|SF	protein_coding	P14210	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63176
0	0.322201500831362	0.513	0.354	0	BRI3	Malignant cells	GSE189460_pre	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63177
0	0.467972228619151	0.322	0.086	0	MCM7	Malignant cells	GSE189460_pre	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63178
0	0.274425953423804	0.335	0.155	0	PNPLA8	Malignant cells	GSE189460_pre	ENSG00000135241	50640	patatin like phospholipase domain containing 8	IPLA2-2|IPLA2G|iPLA2gamma	protein_coding	Q9NP80	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63179
0	0.409391403250076	0.542	0.337	0	IFRD1	Malignant cells	GSE189460_pre	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63180
0	0.424623028680378	0.452	0.199	0	MDFIC	Malignant cells	GSE189460_pre	ENSG00000135272	29969	MyoD family inhibitor domain containing	HIC|MDFIC1	protein_coding	Q9P1T7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63181
0	0.307806985724984	0.331	0.127	0	TES	Malignant cells	GSE189460_pre	ENSG00000135269	26136	testin LIM domain protein	DKFZP586B2022|TESS-2|TESTIN	protein_coding	Q9UGI8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63182
0	0.276830964251869	0.523	0.372	0	LSM8	Malignant cells	GSE189460_pre	ENSG00000128534	51691	LSM8 homolog, U6 small nuclear RNA associated	YJR022W	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63183
0	0.291708727828868	0.595	0.416	0	ATP6V1F	Malignant cells	GSE189460_pre	ENSG00000128524	9296	ATPase H+ transporting V1 subunit F	ATP6S14|VATF|Vma7	protein_coding	Q16864	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63184
0	0.359628853472108	0.473	0.237	0	MTPN	Malignant cells	GSE189460_pre	ENSG00000105887	136319	myotrophin	GCDP|MYOTROPHIN|V-1	protein_coding	P58546	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63185
0	0.419701310041087	0.254	0.043	0	EZH2	Malignant cells	GSE189460_pre	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63186
0	0.617208973316101	0.46	0.126	0	AP1S2	Malignant cells	GSE189460_pre	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63187
0	0.256286458164294	0.274	0.119	0	SYAP1	Malignant cells	GSE189460_pre	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63188
0	0.315567358853783	0.382	0.21	0	RBBP7	Malignant cells	GSE189460_pre	ENSG00000102054	5931	RB binding protein 7, chromatin remodeling factor	RbAp46	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63189
0	0.299638115337844	0.348	0.185	0	SH3KBP1	Malignant cells	GSE189460_pre	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63190
0	0.344890228345351	0.683	0.5	0	EIF1AX	Malignant cells	GSE189460_pre	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63191
0	0.551164529670669	0.621	0.358	0	DDX3X	Malignant cells	GSE189460_pre	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63192
0	0.637027863182006	0.701	0.388	0	TIMP1	Malignant cells	GSE189460_pre	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63193
0	0.557423550368477	0.646	0.401	0	PLP2	Malignant cells	GSE189460_pre	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63194
0	0.298969708182444	0.275	0.093	0	SMC1A	Malignant cells	GSE189460_pre	ENSG00000072501	8243	structural maintenance of chromosomes 1A	DXS423E|KIAA0178|SB1.8|SMC1L1|Smcb	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63195
0	0.395082024568954	0.388	0.131	0	MSN	Malignant cells	GSE189460_pre	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63196
0	0.335859984054634	0.439	0.254	0	NONO	Malignant cells	GSE189460_pre	ENSG00000147140	4841	non-POU domain containing octamer binding	NMT55|NRB54|P54|P54NRB|PPP1R114	protein_coding	Q15233	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63197
0	0.276610960931277	0.541	0.372	0	ATRX	Malignant cells	GSE189460_pre	ENSG00000085224	546	ATRX chromatin remodeler	JMS|MRX52|RAD54|XH2|XNP	protein_coding	P46100	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63198
0	0.294167415821686	0.441	0.278	0	MAGT1	Malignant cells	GSE189460_pre	ENSG00000102158	84061	magnesium transporter 1	DKFZp564K142|IAP|MRX95|OST3B|SLC58A1	protein_coding	Q9H0U3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63199
0	0.251952953040769	0.753	0.577	0	COX7B	Malignant cells	GSE189460_pre	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63200
0	0.36382336463073	0.454	0.261	0	SH3BGRL	Malignant cells	GSE189460_pre	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63201
0	0.499584151383382	0.58	0.313	0	ARMCX3	Malignant cells	GSE189460_pre	ENSG00000102401	51566	armadillo repeat containing X-linked 3	ALEX3|GASP6	protein_coding	Q9UH62	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63202
0	0.335307824567777	0.376	0.191	0	TCEAL8	Malignant cells	GSE189460_pre	ENSG00000180964	90843	transcription elongation factor A like 8	MGC45400|WEX3	protein_coding	Q8IYN2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63203
0	0.558953751416205	0.402	0.14	0	BEX2	Malignant cells	GSE189460_pre	ENSG00000133134	84707	brain expressed X-linked 2	DJ79P11.1	protein_coding	Q9BXY8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63204
0	0.453568678217942	0.288	0.076	0	TCEAL9	Malignant cells	GSE189460_pre	ENSG00000185222	51186	transcription elongation factor A like 9	DKFZp313K1940|WBP5|WEX6	protein_coding	Q9UHQ7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63205
0	0.290635735968355	0.274	0.098	0	TCEAL4	Malignant cells	GSE189460_pre	ENSG00000133142	79921	transcription elongation factor A like 4	FLJ21174|WEX7	protein_coding	Q96EI5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63206
0	0.49165948962083	0.318	0.067	0	TCEAL3	Malignant cells	GSE189460_pre	ENSG00000196507	85012	transcription elongation factor A like 3	MGC15737|WEX8	protein_coding	Q969E4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63207
0	0.572449025202903	0.598	0.307	0	MORF4L2	Malignant cells	GSE189460_pre	ENSG00000123562	9643	mortality factor 4 like 2	KIAA0026|MRGX	protein_coding	Q15014	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63208
0	0.331046567279426	0.304	0.116	0	PRPS1	Malignant cells	GSE189460_pre	ENSG00000147224	5631	phosphoribosyl pyrophosphate synthetase 1	CMTX5|DFN2|DFNX1|PPRibP|PRS-I	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63209
0	1.55163840062166	0.968	0.741	0	TSC22D3	Malignant cells	GSE189460_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63210
0	0.258762121776156	0.371	0.22	0	ALG13	Malignant cells	GSE189460_pre	ENSG00000101901	79868	ALG13 UDP-N-acetylglucosaminyltransferase subunit	CDG1S|CXorf45|FLJ23018|GLT28D1|MDS031|TDRD13|YGL047W	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63211
0	0.330973569184286	0.31	0.11	0	PGRMC1	Malignant cells	GSE189460_pre	ENSG00000101856	10857	progesterone receptor membrane component 1	HPR6.6	protein_coding	O00264	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63212
0	0.994968198138618	0.767	0.595	0	SLC25A5	Malignant cells	GSE189460_pre	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63213
0	0.45773301352559	0.397	0.155	0	UBE2A	Malignant cells	GSE189460_pre	ENSG00000077721	7319	ubiquitin conjugating enzyme E2 A	HHR6A|HR6A|RAD6A|UBC2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63214
0	0.591594362423061	0.479	0.235	0	SEPT6	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63215
0	0.449055580437978	0.759	0.619	0	NDUFA1	Malignant cells	GSE189460_pre	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63216
0	0.33828559869889	0.571	0.371	0	MCTS1	Malignant cells	GSE189460_pre	ENSG00000288295	28985	MCTS1 re-initiation and release factor	MCT-1	protein_coding	Q9ULC4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63217
0	0.335727418875839	0.416	0.229	0	THOC2	Malignant cells	GSE189460_pre	ENSG00000125676	57187	THO complex subunit 2	CXorf3|dJ506G2.1|MRX12|MRX35|THO2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63218
0	0.424091817963539	0.379	0.146	0	STAG2	Malignant cells	GSE189460_pre	ENSG00000101972	10735	stromal antigen 2	SA-2|SA2|SCC3B	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63219
0	0.279893868178927	0.259	0.072	0	PHF6	Malignant cells	GSE189460_pre	ENSG00000156531	84295	PHD finger protein 6	BFLS|BORJ|CENP-31|KIAA1823|MGC14797	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63220
0	0.443301395642428	0.309	0.08	0	HPRT1	Malignant cells	GSE189460_pre	ENSG00000165704	3251	hypoxanthine phosphoribosyltransferase 1	HGPRT|HPRT	protein_coding	P00492	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63221
0	0.262527118030517	0.302	0.155	0	HTATSF1	Malignant cells	GSE189460_pre	ENSG00000102241	27336	HIV-1 Tat specific factor 1	TAT-SF1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63222
0	0.366489876780044	0.478	0.314	0	RBMX	Malignant cells	GSE189460_pre	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63223
0	0.520472422315936	0.594	0.372	0	IDS	Malignant cells	GSE189460_pre	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63224
0	0.396565482485349	0.259	0.04	0	HMGB3	Malignant cells	GSE189460_pre	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63225
0	0.40883602335193	0.38	0.16	0	VMA21	Malignant cells	GSE189460_pre	ENSG00000160131	203547	vacuolar ATPase assembly factor VMA21	MEAX|XMEA	protein_coding	Q3ZAQ7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63226
0	0.302173638693564	0.279	0.075	0	CETN2	Malignant cells	GSE189460_pre	ENSG00000147400	1069	centrin 2	CALT|CEN2	protein_coding	P41208	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63227
0	0.583799822989884	0.349	0.026	0	MAGEA1	Malignant cells	GSE189460_pre	ENSG00000198681	4100	MAGE family member A1	CT1.1|MAGE1|MGC9326	protein_coding	P43355	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63228
0	0.823808874461487	0.765	0.401	0	BCAP31	Malignant cells	GSE189460_pre	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63229
0	0.45548600224074	0.454	0.178	0	IDH3G	Malignant cells	GSE189460_pre	ENSG00000067829	3421	isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma	NA	protein_coding	P51553	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63230
0	1.21335150997802	1	0.998	0	SSR4	Malignant cells	GSE189460_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63231
0	0.314545556968879	0.362	0.168	0	ARHGAP4	Malignant cells	GSE189460_pre	ENSG00000089820	393	Rho GTPase activating protein 4	C1|KIAA0131|p115|RhoGAP4|SrGAP4	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63232
0	0.459753080138116	0.563	0.356	0	NAA10	Malignant cells	GSE189460_pre	ENSG00000102030	8260	N-alpha-acetyltransferase 10, NatA catalytic subunit	ARD1|ARD1A|DXS707|TE2	protein_coding	P41227	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63233
0	0.514232255352981	0.57	0.328	0	IRAK1	Malignant cells	GSE189460_pre	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63234
0	0.33301646634359	0.326	0.111	0	MECP2	Malignant cells	GSE189460_pre	ENSG00000169057	4204	methyl-CpG binding protein 2	MRX16|MRX79|RTT	protein_coding	P51608	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63235
0	0.274121015369088	0.258	0.099	0	FLNA	Malignant cells	GSE189460_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63236
0	0.579841043035871	0.471	0.147	0	EMD	Malignant cells	GSE189460_pre	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63237
0	1.23147834633306	1	0.999	0	RPL10	Malignant cells	GSE189460_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63238
0	0.33592362339459	0.28	0.068	0	TAZ	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63239
0	0.397474631720657	0.464	0.227	0	ATP6AP1	Malignant cells	GSE189460_pre	ENSG00000071553	537	ATPase H+ transporting accessory protein 1	16A|Ac45|ATP6IP1|ATP6S1|CF2|ORF|VATPS1|XAP-3|XAP3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63240
0	0.627824515688839	0.536	0.183	0	FAM50A	Malignant cells	GSE189460_pre	ENSG00000071859	9130	family with sequence similarity 50 member A	9F|DXS9928E|HXC-26|XAP5	protein_coding	Q14320	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63241
0	0.579276690681422	0.563	0.218	0	LAGE3	Malignant cells	GSE189460_pre	ENSG00000196976	8270	L antigen family member 3	CVG5|DXS9879E|DXS9951E|ESO3|ITBA2|Pcc1	protein_coding	Q14657	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63242
0	0.617638138866561	0.307	0.08	0	CTAG2	Malignant cells	GSE189460_pre	ENSG00000126890	30848	cancer/testis antigen 2	CAMEL|CT6.2a|CT6.2b|ESO2|LAGE-1|LAGE-1a|LAGE-1b|LAGE1|MGC138724|MGC3803	protein_coding	O75638	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63243
0	0.403422036904518	0.431	0.191	0	DKC1	Malignant cells	GSE189460_pre	ENSG00000130826	1736	dyskerin pseudouridine synthase 1	Cbf5|DKC|dyskerin|NAP57|NOLA4|XAP101	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63244
0	0.757766375721485	0.637	0.293	0	FUNDC2	Malignant cells	GSE189460_pre	ENSG00000165775	65991	FUN14 domain containing 2	DC44|HCBP6	protein_coding	Q9BWH2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63245
0	0.682788091459305	0.567	0.194	0	VBP1	Malignant cells	GSE189460_pre	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63246
0	0.923216896266581	0.674	0.316	0	RAB11FIP1	Malignant cells	GSE189460_pre	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63247
0	0.338611319311287	0.434	0.236	0	NSD3	Malignant cells	GSE189460_pre	ENSG00000147548	54904	nuclear receptor binding SET domain protein 3	FLJ20353|KMT3F|WHISTLE|WHSC1L1	protein_coding	Q9BZ95	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63248
0	0.568269004254167	0.29	0.002	0	FGFR1	Malignant cells	GSE189460_pre	ENSG00000077782	2260	fibroblast growth factor receptor 1	BFGFR|CD331|CEK|FLG|FLT2|H2|H3|H4|H5|KAL2|N-SAM	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63249
0	0.266727833570348	0.334	0.161	0	VDAC3	Malignant cells	GSE189460_pre	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63250
0	0.257231549761738	0.378	0.23	0	SMIM19	Malignant cells	GSE189460_pre	ENSG00000176209	114926	small integral membrane protein 19	C8orf40	protein_coding	Q96E16	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63251
0	0.500068582764139	0.446	0.169	0	PRKDC	Malignant cells	GSE189460_pre	ENSG00000253729	5591	protein kinase, DNA-activated, catalytic subunit	DNA-PKC|DNA-PKcs|DNAPK|DNAPKc|DNPK1|HYRC|HYRC1|p350|p460|XRCC7	protein_coding	P78527	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63252
0	0.440759721070922	0.259	0.021	0	MCM4	Malignant cells	GSE189460_pre	ENSG00000104738	4173	minichromosome maintenance complex component 4	CDC21|CDC54|hCdc21|MGC33310|P1-Cdc21	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63253
0	0.274489874825304	0.422	0.245	0	RB1CC1	Malignant cells	GSE189460_pre	ENSG00000023287	9821	RB1 inducible coiled-coil 1	ATG17|Cc1|DRAGOU14|FIP200|KIAA0203|PPP1R131	protein_coding	Q8TDY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63254
0	0.265557048287665	0.543	0.37	0	TCEA1	Malignant cells	GSE189460_pre	ENSG00000187735	6917	transcription elongation factor A1	GTF2S|SII|TCEA|TF2S|TFIIS	protein_coding	P23193	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63255
0	0.765981068639783	0.967	0.726	0	RPS20	Malignant cells	GSE189460_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63256
0	0.2963469297038	0.558	0.369	0	RAB2A	Malignant cells	GSE189460_pre	ENSG00000104388	5862	RAB2A, member RAS oncogene family	RAB2	protein_coding	P61019	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63257
0	0.475575597898358	0.338	0.116	0	GGH	Malignant cells	GSE189460_pre	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63258
0	0.368385303097957	0.51	0.279	0	ELOC	Malignant cells	GSE189460_pre	ENSG00000154582	6921	elongin C	SIII|TCEB1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63259
0	0.373752137956052	0.702	0.604	0	TPD52	Malignant cells	GSE189460_pre	ENSG00000076554	7163	tumor protein D52	D52|hD52|N8L	protein_coding	P55327	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63260
0	0.310783376380869	0.932	0.819	0	UQCRB	Malignant cells	GSE189460_pre	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63261
0	0.311288355832644	0.386	0.207	0	RNF19A	Malignant cells	GSE189460_pre	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63262
0	0.315165830303412	0.898	0.834	0	PABPC1	Malignant cells	GSE189460_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63263
0	0.558762761917859	0.762	0.483	0	YWHAZ	Malignant cells	GSE189460_pre	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63264
0	0.379353933111528	0.342	0.146	0	KLF10	Malignant cells	GSE189460_pre	ENSG00000155090	7071	KLF transcription factor 10	EGRA|TIEG|TIEG1	protein_coding	Q13118	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63265
0	0.326065442618212	0.572	0.393	0	ENY2	Malignant cells	GSE189460_pre	ENSG00000120533	56943	ENY2 transcription and export complex 2 subunit	DC6|FLJ20480|Sus1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63266
0	0.34671122460771	0.384	0.201	0	RAD21	Malignant cells	GSE189460_pre	ENSG00000164754	5885	RAD21 cohesin complex component	hHR21|KIAA0078|SCC1	protein_coding	O60216	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63267
0	0.502858333753008	0.275	0.034	0	ATAD2	Malignant cells	GSE189460_pre	ENSG00000156802	29028	ATPase family AAA domain containing 2	ANCCA|CT137|DKFZp667N1320|MGC29843|MGC5254|PRO2000	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63268
0	0.488246491253489	0.537	0.334	0	LY6E	Malignant cells	GSE189460_pre	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63269
0	0.252606987491849	0.992	0.97	0	EEF1D	Malignant cells	GSE189460_pre	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63270
0	0.366994769007624	0.467	0.257	0	GPAA1	Malignant cells	GSE189460_pre	ENSG00000197858	8733	glycosylphosphatidylinositol anchor attachment 1	GAA1|hGAA1	protein_coding	O43292	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63271
0	0.459501733865588	0.4	0.161	0	PSIP1	Malignant cells	GSE189460_pre	ENSG00000164985	11168	PC4 and SFRS1 interacting protein 1	DFS70|LEDGF|p52|p75|PSIP2	protein_coding	O75475	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63272
0	0.31407443078996	0.384	0.201	0	CDKN2A	Malignant cells	GSE189460_pre	ENSG00000147889	1029	cyclin dependent kinase inhibitor 2A	ARF|CDK4I|CDKN2|CMM2|INK4|INK4a|MLM|MTS1|p14|p14ARF|p16|P16-INK4A|p16INK4a|p19|p19Arf	protein_coding	P42771	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63273
0	0.660944439213132	0.697	0.447	0	DNAJA1	Malignant cells	GSE189460_pre	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63274
0	0.457688260417204	0.424	0.146	0	B4GALT1	Malignant cells	GSE189460_pre	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63275
0	0.349485244080103	0.571	0.358	0	CLTA	Malignant cells	GSE189460_pre	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63276
0	0.681568821572773	0.575	0.275	0	ZFAND5	Malignant cells	GSE189460_pre	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63277
0	1.69195968808528	0.282	0.077	0	ANXA1	Malignant cells	GSE189460_pre	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63278
0	0.465519860116401	0.353	0.136	0	VPS13A	Malignant cells	GSE189460_pre	ENSG00000197969	23230	vacuolar protein sorting 13 homolog A	BLTP5A|CHAC|KIAA0986	protein_coding	Q96RL7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63279
0	0.605771995092827	0.821	0.616	0	HNRNPK	Malignant cells	GSE189460_pre	ENSG00000165119	3190	heterogeneous nuclear ribonucleoprotein K	CSBP|HNRPK|TUNP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63280
0	0.550997308211893	0.376	0.163	0	CKS2	Malignant cells	GSE189460_pre	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63281
0	-0.70374561578405	0.059	0.349	0	FBP1	Malignant cells	GSE189460_pre	ENSG00000165140	2203	fructose-bisphosphatase 1	FBP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63282
0	0.310096909786013	0.279	0.125	0	AAED1	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63283
0	0.909592191491745	0.764	0.546	0	ANP32B	Malignant cells	GSE189460_pre	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63284
0	0.540393225198458	0.991	0.986	0	SEC61B	Malignant cells	GSE189460_pre	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63285
0	0.266820842419789	0.568	0.415	0	ERP44	Malignant cells	GSE189460_pre	ENSG00000023318	23071	endoplasmic reticulum protein 44	KIAA0573|PDIA10|TXNDC4	protein_coding	Q9BS26	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63286
0	0.388171702964939	0.3	0.089	0	SMC2	Malignant cells	GSE189460_pre	ENSG00000136824	10592	structural maintenance of chromosomes 2	CAP-E|hCAP-E|SMC2L1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63287
0	0.303372604561773	0.923	0.882	0	TXN	Malignant cells	GSE189460_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63288
0	0.276586670091183	0.314	0.161	0	POLE3	Malignant cells	GSE189460_pre	ENSG00000148229	54107	DNA polymerase epsilon 3, accessory subunit	CHARAC17|CHRAC17|CHRAC2|p17|Ybl1	protein_coding	Q9NRF9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63289
0	0.372754794254503	0.286	0.103	0	WHRN	Malignant cells	GSE189460_pre	ENSG00000095397	25861	whirlin	CIP98|DFNB31|PDZD7B|USH2D	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63290
0	0.48482410041558	0.89	0.819	0	ATP6V1G1	Malignant cells	GSE189460_pre	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63291
0	0.48902087187138	0.292	0.053	0	PHF19	Malignant cells	GSE189460_pre	ENSG00000119403	26147	PHD finger protein 19	DKFZP727G051|MTF2L1|PCL3|TDRD19B	protein_coding	Q5T6S3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63292
0	0.280641982090937	0.271	0.107	0	CNTRL	Malignant cells	GSE189460_pre	ENSG00000119397	11064	centriolin	CEP1|CEP110	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63293
0	0.353376844195549	0.466	0.283	0	STRBP	Malignant cells	GSE189460_pre	ENSG00000165209	55342	spermatid perinuclear RNA binding protein	FLJ11307|ILF3L|SPNR	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63294
0	0.388192776977722	0.695	0.548	0	ARPC5L	Malignant cells	GSE189460_pre	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63295
0	0.279563564637262	0.305	0.146	0	ZBTB43	Malignant cells	GSE189460_pre	ENSG00000169155	23099	zinc finger and BTB domain containing 43	FLJ22470|KIAA0414|ZBTB22B|ZNF-X|ZNF297B	protein_coding	O43298	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63296
0	0.371855629408083	0.25	0.059	0	WDR34	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63297
0	0.60435066726449	0.76	0.625	0	SET	Malignant cells	GSE189460_pre	ENSG00000119335	6418	SET nuclear proto-oncogene	2PP2A|IGAAD|IPP2A2|PHAPII|TAF-I|TAF-IBETA	protein_coding	Q01105	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63298
0	0.409299513561866	0.366	0.147	0	ZDHHC12	Malignant cells	GSE189460_pre	ENSG00000160446	84885	zinc finger DHHC-type palmitoyltransferase 12	FLJ14524|ZNF400	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63299
0	0.300329398631283	0.356	0.164	0	NTMT1	Malignant cells	GSE189460_pre	ENSG00000148335	28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1	AD-003|C9orf32|HOMT1A|METTL11A|NRMT|NRMT1	protein_coding	Q9BV86	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63300
0	0.274914181531878	0.373	0.212	0	C9orf78	Malignant cells	GSE189460_pre	ENSG00000136819	51759	chromosome 9 open reading frame 78	CSU2|HCA59|HSPC220	protein_coding	Q9NZ63	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63301
0	0.31022224502624	0.384	0.213	0	RABL6	Malignant cells	GSE189460_pre	ENSG00000196642	55684	RAB, member RAS oncogene family like 6	bA216L13.9|C9orf86|FLJ10101|FLJ13045|Parf|pp8875|RBEL1	protein_coding	Q3YEC7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63302
0	0.500514019635664	0.822	0.601	0	PHPT1	Malignant cells	GSE189460_pre	ENSG00000054148	29085	phosphohistidine phosphatase 1	bA216L13.10|CGI-202|DKFZp564M173|HSPC141|PHP14	protein_coding	Q9NRX4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63303
0	0.387862193783513	0.954	0.896	0	EDF1	Malignant cells	GSE189460_pre	ENSG00000107223	8721	endothelial differentiation related factor 1	CFAP280|EDF-1	protein_coding	O60869	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63304
0	0.368119580913821	0.422	0.24	0	PAXX	Malignant cells	GSE189460_pre	ENSG00000148362	286257	PAXX non-homologous end joining factor	C9orf142|XLS	protein_coding	Q9BUH6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63305
0	0.715698714845985	0.644	0.385	0	TUBB4B	Malignant cells	GSE189460_pre	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63306
0	0.505406529856995	0.672	0.499	0	MRPL41	Malignant cells	GSE189460_pre	ENSG00000182154	64975	mitochondrial ribosomal protein L41	BMRP|MRP-L27|MRPL27|PIG3|RPML27	protein_coding	Q8IXM3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63307
0	0.416380262934099	0.29	0.068	0	HBD	Malignant cells	GSE189460_pre	ENSG00000223609	3045	hemoglobin subunit delta	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63308
0	0.568761818868324	0.326	0.031	0	WEE1	Malignant cells	GSE189460_pre	ENSG00000166483	7465	WEE1 G2 checkpoint kinase	WEE1A	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63309
0	0.602791118869482	0.747	0.59	0	NUCB2	Malignant cells	GSE189460_pre	ENSG00000070081	4925	nucleobindin 2	NEFA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63310
0	0.351344566673455	0.257	0.048	0	GAS2	Malignant cells	GSE189460_pre	ENSG00000148935	2620	growth arrest specific 2	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63311
0	0.45139579350308	0.732	0.546	0	SVIP	Malignant cells	GSE189460_pre	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63312
0	0.472971250234458	0.737	0.549	0	SELENOH	Malignant cells	GSE189460_pre	ENSG00000211450	280636	selenoprotein H	C11orf31|SELH	protein_coding	Q8IZQ5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63313
0	2.14618838722767	0.435	0.02	0	MS4A1	Malignant cells	GSE189460_pre	ENSG00000156738	931	membrane spanning 4-domains A1	B1|Bp35|CD20|FMC7	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63314
0	0.261318636762813	0.38	0.227	0	TMEM109	Malignant cells	GSE189460_pre	ENSG00000110108	79073	transmembrane protein 109	MGC5508	protein_coding	Q9BVC6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63315
0	0.993913764557141	0.758	0.295	0	AHNAK	Malignant cells	GSE189460_pre	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63316
0	0.475935148131208	0.65	0.464	0	SLC3A2	Malignant cells	GSE189460_pre	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63317
0	0.406975175842655	0.827	0.668	0	COX8A	Malignant cells	GSE189460_pre	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63318
0	0.379317291150336	0.502	0.297	0	VEGFB	Malignant cells	GSE189460_pre	ENSG00000173511	7423	vascular endothelial growth factor B	VEGFL|VRF	protein_coding	P49765	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63319
0	0.319694027028499	0.867	0.757	0	PRDX5	Malignant cells	GSE189460_pre	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63320
0	0.629101803371008	0.97	0.931	0	NEAT1	Malignant cells	GSE189460_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63321
0	0.341641023012896	0.997	0.99	0	MALAT1	Malignant cells	GSE189460_pre	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63322
0	0.425009824564772	0.9	0.772	0	CFL1	Malignant cells	GSE189460_pre	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63323
0	-1.5081350093796	0.394	0.787	0	GSTP1	Malignant cells	GSE189460_pre	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63324
0	0.421805944688971	0.12	0.294	0	CCND1	Malignant cells	GSE189460_pre	ENSG00000110092	595	cyclin D1	BCL1|D11S287E|PRAD1|U21B31	protein_coding	P24385	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63325
0	0.299240122796765	0.444	0.267	0	UCP2	Malignant cells	GSE189460_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63326
0	0.47450887349914	0.931	0.82	0	HSPA8	Malignant cells	GSE189460_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63327
0	0.689013157016312	0.874	0.605	0	KLF6	Malignant cells	GSE189460_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63328
0	0.3533409157376	0.369	0.168	0	CELF2	Malignant cells	GSE189460_pre	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63329
0	0.518166397406046	0.851	0.894	0	VIM	Malignant cells	GSE189460_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63330
0	0.387287304685396	0.896	0.851	0	DNAJC1	Malignant cells	GSE189460_pre	ENSG00000136770	64215	DnaJ heat shock protein family (Hsp40) member C1	DNAJL1|ERdj1|MTJ1	protein_coding	Q96KC8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63331
0	0.271286673731032	0.437	0.268	0	YME1L1	Malignant cells	GSE189460_pre	ENSG00000136758	10730	YME1 like 1 ATPase	YME1L	protein_coding	Q96TA2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63332
0	0.303999925402222	0.303	0.101	0	ITGB1	Malignant cells	GSE189460_pre	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63333
0	0.350744782906038	0.548	0.397	0	HNRNPF	Malignant cells	GSE189460_pre	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63334
0	0.412554591777535	0.262	0.034	0	PRKG1	Malignant cells	GSE189460_pre	ENSG00000185532	5592	protein kinase cGMP-dependent 1	PGK|PKG|PKG1|PRKG1B|PRKGR1B	protein_coding	Q13976	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63335
0	0.866521454706168	0.586	0.276	0	ARID5B	Malignant cells	GSE189460_pre	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63336
0	0.385552641689638	0.51	0.296	0	JMJD1C	Malignant cells	GSE189460_pre	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63337
0	0.434449829203648	0.5	0.248	0	HNRNPH3	Malignant cells	GSE189460_pre	ENSG00000096746	3189	heterogeneous nuclear ribonucleoprotein H3	2H9|HNRPH3	protein_coding	P31942	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63338
0	0.418555257597611	0.562	0.362	0	DDX21	Malignant cells	GSE189460_pre	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63339
0	0.341670113744409	0.803	0.644	0	ANAPC16	Malignant cells	GSE189460_pre	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63340
0	0.948677825501043	0.448	0.146	0	DDIT4	Malignant cells	GSE189460_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63341
0	0.497626336320554	0.321	0.067	0	DNAJC9	Malignant cells	GSE189460_pre	ENSG00000213551	23234	DnaJ heat shock protein family (Hsp40) member C9	JDD1|SB73	protein_coding	Q8WXX5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63342
0	0.273914854076095	0.491	0.306	0	MRPS16	Malignant cells	GSE189460_pre	ENSG00000182180	51021	mitochondrial ribosomal protein S16	CGI-132	protein_coding	Q9Y3D3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63343
0	0.419769623478427	0.997	0.993	0	RPS24	Malignant cells	GSE189460_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63344
0	0.285397064656372	0.39	0.201	0	ANXA11	Malignant cells	GSE189460_pre	ENSG00000122359	311	annexin A11	ANX11	protein_coding	P50995	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63345
0	0.281838996463187	0.336	0.161	0	PTEN	Malignant cells	GSE189460_pre	ENSG00000284792	5728	phosphatase and tensin homolog	BZS|MHAM|MMAC1|PTEN1|TEP1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63346
0	0.598052471062012	0.337	0.049	0	HELLS	Malignant cells	GSE189460_pre	ENSG00000119969	3070	helicase, lymphoid specific	LSH|Nbla10143|PASG|SMARCA6	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63347
0	0.267396160591181	0.488	0.313	0	PGAM1	Malignant cells	GSE189460_pre	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63348
0	0.251244584221977	0.27	0.113	0	HPS1	Malignant cells	GSE189460_pre	ENSG00000107521	3257	HPS1 biogenesis of lysosomal organelles complex 3 subunit 1	BLOC3S1|HPS	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63349
0	0.310642935062734	0.507	0.294	0	GSTO1	Malignant cells	GSE189460_pre	ENSG00000148834	9446	glutathione S-transferase omega 1	GSTTLp28|P28	protein_coding	P78417	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63350
0	0.383321838184579	0.348	0.129	0	ADD3	Malignant cells	GSE189460_pre	ENSG00000148700	120	adducin 3	ADDL	protein_coding	Q9UEY8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63351
0	0.429390427282747	0.679	0.535	0	DUSP5	Malignant cells	GSE189460_pre	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63352
0	0.513947377086036	0.442	0.177	0	SMC3	Malignant cells	GSE189460_pre	ENSG00000108055	9126	structural maintenance of chromosomes 3	BAM|bamacan|CSPG6|HCAP|SMC3L1	protein_coding	Q9UQE7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63353
0	0.279904161155727	0.554	0.369	0	PDCD4	Malignant cells	GSE189460_pre	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63354
0	0.664485803741388	0.339	0.149	0	AC026369.3	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63355
0	-0.677988132032997	0.069	0.386	0	CD9	Malignant cells	GSE189460_pre	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63356
0	0.46948105156362	0.716	0.466	0	MRPL51	Malignant cells	GSE189460_pre	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63357
0	0.677184716813645	0.96	0.907	0	GAPDH	Malignant cells	GSE189460_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63358
0	0.349115884912723	0.421	0.214	0	CHD4	Malignant cells	GSE189460_pre	ENSG00000111642	1108	chromodomain helicase DNA binding protein 4	Mi-2b|Mi2-BETA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63359
0	0.56604497683438	0.68	0.424	0	TPI1	Malignant cells	GSE189460_pre	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63360
0	0.803119087325947	0.86	0.547	0	C12orf57	Malignant cells	GSE189460_pre	ENSG00000111678	113246	chromosome 12 open reading frame 57	C10|GRCC10	protein_coding	Q99622	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63361
0	0.275069684374796	0.443	0.274	0	PTPN6	Malignant cells	GSE189460_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63362
0	0.363377958555756	0.384	0.163	0	M6PR	Malignant cells	GSE189460_pre	ENSG00000003056	4074	mannose-6-phosphate receptor, cation dependent	CD-M6PR|CD-MPR	protein_coding	P20645	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63363
0	0.273776215439131	0.313	0.135	0	CDKN1B	Malignant cells	GSE189460_pre	ENSG00000111276	1027	cyclin dependent kinase inhibitor 1B	KIP1|P27KIP1	protein_coding	P46527	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63364
0	0.416317903128704	0.453	0.187	0	H2AFJ	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63365
0	0.411999364993628	0.461	0.223	0	ARHGDIB	Malignant cells	GSE189460_pre	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63366
0	0.254500837467725	0.427	0.273	0	STRAP	Malignant cells	GSE189460_pre	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63367
0	0.363690725583798	0.784	0.668	0	LDHB	Malignant cells	GSE189460_pre	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63368
0	0.44487596105632	0.347	0.095	0	LRMP	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63369
0	0.257985704200616	0.446	0.27	0	KRAS	Malignant cells	GSE189460_pre	ENSG00000133703	3845	KRAS proto-oncogene, GTPase	K-Ras4B|KRAS1|KRAS2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63370
0	0.332203412427165	0.415	0.221	0	FGFR1OP2	Malignant cells	GSE189460_pre	ENSG00000111790	26127	FGFR1 oncogene partner 2	DKFZp564O1863	protein_coding	Q9NVK5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63371
0	0.259591730524369	0.655	0.519	0	ERGIC2	Malignant cells	GSE189460_pre	ENSG00000087502	51290	ERGIC and golgi 2	Erv41|PTX1	protein_coding	Q96RQ1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63372
0	0.307415582994932	0.288	0.095	0	KIAA1551	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63373
0	0.463562780889748	0.498	0.217	0	SLC38A1	Malignant cells	GSE189460_pre	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63374
0	0.377222730766847	0.662	0.424	0	SLC38A2	Malignant cells	GSE189460_pre	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63375
0	0.582526631482631	0.38	0.144	0	TMEM106C	Malignant cells	GSE189460_pre	ENSG00000134291	79022	transmembrane protein 106C	MGC5576	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63376
0	1.12282440204394	0.701	0.491	0	TUBA1B	Malignant cells	GSE189460_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63377
0	0.311184716625506	0.963	0.902	0	TMBIM6	Malignant cells	GSE189460_pre	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63378
0	0.44297708004993	0.564	0.329	0	COX14	Malignant cells	GSE189460_pre	ENSG00000178449	84987	cytochrome c oxidase assembly factor COX14	C12orf62|MGC14288	protein_coding	Q96I36	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63379
0	0.573022483408817	0.454	0.197	0	NR4A1	Malignant cells	GSE189460_pre	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63380
0	0.294609427698534	0.397	0.225	0	PRR13	Malignant cells	GSE189460_pre	ENSG00000205352	54458	proline rich 13	DKFZP564J157|FLJ23818	protein_coding	Q9NZ81	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63381
0	0.339801595604811	0.29	0.09	0	CBX5	Malignant cells	GSE189460_pre	ENSG00000094916	23468	chromobox 5	HP1|HP1-ALPHA|HP1Hs-alpha	protein_coding	P45973	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63382
0	0.466253906567323	0.868	0.799	0	HNRNPA1	Malignant cells	GSE189460_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63383
0	0.316363747575991	0.562	0.356	0	COPZ1	Malignant cells	GSE189460_pre	ENSG00000111481	22818	COPI coat complex subunit zeta 1	CGI-120|COPZ	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63384
0	0.405878740901934	0.444	0.237	0	BLOC1S1	Malignant cells	GSE189460_pre	ENSG00000135441	2647	biogenesis of lysosomal organelles complex 1 subunit 1	BLOS1|BORCS1|GCN5L1	protein_coding	P78537	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63385
0	-0.26975011795532	0.796	0.914	0	CD63	Malignant cells	GSE189460_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63386
0	0.52474702073811	0.972	0.891	0	MYL6	Malignant cells	GSE189460_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63387
0	0.357855124070326	0.639	0.465	0	RAP1B	Malignant cells	GSE189460_pre	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63388
0	1.00851252869944	0.765	0.534	0	NAP1L1	Malignant cells	GSE189460_pre	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63389
0	0.288544064769921	0.429	0.247	0	CCDC59	Malignant cells	GSE189460_pre	ENSG00000133773	29080	coiled-coil domain containing 59	BR22|HSPC128|TAP26	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63390
0	0.925505970378817	0.906	0.645	0	BTG1	Malignant cells	GSE189460_pre	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63391
0	0.251587380152302	0.399	0.236	0	UBE2N	Malignant cells	GSE189460_pre	ENSG00000177889	7334	ubiquitin conjugating enzyme E2 N	MGC8489|UBC13|UbcH-ben	protein_coding	P61088	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63392
0	0.598843858436153	0.39	0.093	0	TMPO	Malignant cells	GSE189460_pre	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63393
0	-0.500082621455169	0.076	0.318	0	SCYL2	Malignant cells	GSE189460_pre	ENSG00000136021	55681	SCY1 like pseudokinase 2	CVAK104|KIAA1360	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63394
0	0.370374854898136	0.851	0.67	0	ARPC3	Malignant cells	GSE189460_pre	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63395
0	0.364025028344672	0.528	0.299	0	VPS29	Malignant cells	GSE189460_pre	ENSG00000111237	51699	VPS29 retromer complex component	DC15|DC7|PEP11	protein_coding	Q9UBQ0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63396
0	0.323964023113678	0.579	0.414	0	PPP1CC	Malignant cells	GSE189460_pre	ENSG00000186298	5501	protein phosphatase 1 catalytic subunit gamma	PP1C|PP1gamma	protein_coding	P36873	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63397
0	0.531506687976005	0.937	0.858	0	ERP29	Malignant cells	GSE189460_pre	ENSG00000089248	10961	endoplasmic reticulum protein 29	C12orf8|ERp28|ERp31|PDI-DB|PDIA9	protein_coding	P30040	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63398
0	0.397124219788427	0.777	0.68	0	PEBP1	Malignant cells	GSE189460_pre	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63399
0	0.472004071715282	0.793	0.578	0	SRSF9	Malignant cells	GSE189460_pre	ENSG00000111786	8683	serine and arginine rich splicing factor 9	SFRS9|SRp30c	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63400
0	0.342791899835513	0.901	0.843	0	DYNLL1	Malignant cells	GSE189460_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63401
0	0.387535521553994	0.689	0.506	0	MLEC	Malignant cells	GSE189460_pre	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63402
0	0.364068326743675	0.507	0.316	0	RSRC2	Malignant cells	GSE189460_pre	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63403
0	0.368206792435363	0.858	0.715	0	ARL6IP4	Malignant cells	GSE189460_pre	ENSG00000182196	51329	ADP ribosylation factor like GTPase 6 interacting protein 4	SFRS20|SR-25|SRp25|SRrp37	protein_coding	Q66PJ3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63404
0	0.736657481017235	0.998	0.987	0	UBC	Malignant cells	GSE189460_pre	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63405
0	0.450264476570062	0.29	0.053	0	BRI3BP	Malignant cells	GSE189460_pre	ENSG00000184992	140707	BRI3 binding protein	BNAS1|HCCR-2|HCCRBP-3|KG19	protein_coding	Q8WY22	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63406
0	0.310032388223532	0.817	0.612	0	RAN	Malignant cells	GSE189460_pre	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63407
0	0.309155473099522	0.289	0.134	0	HSPH1	Malignant cells	GSE189460_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63408
0	0.362166039213641	0.252	0.119	0	RGCC	Malignant cells	GSE189460_pre	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63409
0	-0.777535372677796	0.486	0.905	0	ITM2B	Malignant cells	GSE189460_pre	ENSG00000136156	9445	integral membrane protein 2B	BRI|BRI2|BRICD2B|E25B|E3-16	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63410
0	0.351575009688178	0.301	0.13	0	PNP	Malignant cells	GSE189460_pre	ENSG00000198805	4860	purine nucleoside phosphorylase	NP|PUNP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63411
0	0.531625424490907	0.819	0.558	0	HNRNPC	Malignant cells	GSE189460_pre	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63412
0	0.417393075516623	0.904	0.791	0	DAD1	Malignant cells	GSE189460_pre	ENSG00000129562	1603	defender against cell death 1	OST2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63413
0	1.04115954281952	0.957	0.751	0	NFKBIA	Malignant cells	GSE189460_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63414
0	0.404612335608926	0.579	0.409	0	PNN	Malignant cells	GSE189460_pre	ENSG00000100941	5411	pinin, desmosome associated protein	memA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63415
0	0.315882925483696	0.359	0.208	0	MIS18BP1	Malignant cells	GSE189460_pre	ENSG00000129534	55320	MIS18 binding protein 1	C14orf106|FLJ11186|KIAA1903|KNL2|M18BP1	protein_coding	Q6P0N0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63416
0	0.471407291100482	0.526	0.325	0	ARF6	Malignant cells	GSE189460_pre	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63417
0	0.290786784904878	0.398	0.25	0	TMX1	Malignant cells	GSE189460_pre	ENSG00000139921	81542	thioredoxin related transmembrane protein 1	PDIA11|TMX|TXNDC|TXNDC1	protein_coding	Q9H3N1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63418
0	0.263982872787118	0.739	0.551	0	RTRAF	Malignant cells	GSE189460_pre	ENSG00000087302	51637	RNA transcription, translation and transport factor	C14orf166|CGI-99|CLE|CLE7|hCLE1|LCRP369|RLLM1	protein_coding	Q9Y224	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63419
0	0.43452916773852	0.573	0.31	0	KTN1	Malignant cells	GSE189460_pre	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63420
0	0.258504006767701	0.498	0.33	0	PSMA3	Malignant cells	GSE189460_pre	ENSG00000100567	5684	proteasome 20S subunit alpha 3	HC8	protein_coding	P25788	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63421
0	0.283146160831386	0.294	0.101	0	FUT8	Malignant cells	GSE189460_pre	ENSG00000033170	2530	fucosyltransferase 8	NA	protein_coding	Q9BYC5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63422
0	0.345591750193445	0.639	0.439	0	ERH	Malignant cells	GSE189460_pre	ENSG00000100632	2079	ERH mRNA splicing and mitosis factor	DROER	protein_coding	P84090	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63423
0	0.320450648671657	0.768	0.575	0	SRSF5	Malignant cells	GSE189460_pre	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63424
0	0.429698482701404	0.7	0.473	0	NPC2	Malignant cells	GSE189460_pre	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63425
0	0.762858964730648	0.929	0.78	0	FOS	Malignant cells	GSE189460_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63426
0	0.282827151145214	0.443	0.271	0	FOXN3	Malignant cells	GSE189460_pre	ENSG00000053254	1112	forkhead box N3	C14orf116|CHES1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63427
0	0.323015988559932	0.705	0.527	0	CALM1	Malignant cells	GSE189460_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63428
0	0.46182466841361	0.6	0.305	0	DDX24	Malignant cells	GSE189460_pre	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63429
0	-1.07965506249235	0.211	0.429	0	IFI27	Malignant cells	GSE189460_pre	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63430
0	0.481276295975798	0.322	0.052	0	AL133467.1	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63431
0	1.11714140007999	0.946	0.701	0	HSP90AA1	Malignant cells	GSE189460_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63432
0	0.347115723756848	0.53	0.294	0	SIVA1	Malignant cells	GSE189460_pre	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63433
0	2.11809482473984	0.594	0.089	0	IGHA2	Malignant cells	GSE189460_pre	ENSG00000276173	NA	NA	NA	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63434
0	-2.20175637701124	0.207	0.508	0	IGHG4	Malignant cells	GSE189460_pre	ENSG00000277016	NA	NA	NA	IG_C_gene	P01861	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63435
0	-0.825304828569201	0.225	0.556	0	IGHG1	Malignant cells	GSE189460_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63436
0	-0.384368752384617	0.199	0.387	0	IGHG3	Malignant cells	GSE189460_pre	ENSG00000282184	NA	NA	NA	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63437
0	-0.377283864717184	0.557	0.677	0	KLF13	Malignant cells	GSE189460_pre	ENSG00000275746	51621	KLF transcription factor 13	BTEB3|FKLF-2|NSLP1|RFLAT-1	protein_coding	Q9Y2Y9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63438
0	0.634416050341039	0.975	0.9	0	SRP14	Malignant cells	GSE189460_pre	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63439
0	0.311193606682163	0.316	0.128	0	GCHFR	Malignant cells	GSE189460_pre	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63440
0	0.735580279470404	0.998	0.993	0	SERF2	Malignant cells	GSE189460_pre	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63441
0	0.305454028686657	0.459	0.261	0	BLOC1S6	Malignant cells	GSE189460_pre	ENSG00000104164	26258	biogenesis of lysosomal organelles complex 1 subunit 6	HPS9|PA|PLDN	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63442
0	0.723890228859744	0.633	0.398	0	DUT	Malignant cells	GSE189460_pre	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63443
0	0.256303655815478	0.363	0.201	0	COPS2	Malignant cells	GSE189460_pre	ENSG00000166200	9318	COP9 signalosome subunit 2	ALIEN|CSN2|TRIP15	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63444
0	0.338209879604956	0.591	0.408	0	GTF2A2	Malignant cells	GSE189460_pre	ENSG00000140307	2958	general transcription factor IIA subunit 2	HsT18745|TFIIA	protein_coding	P52657	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63445
0	0.318780674585751	0.331	0.182	0	VPS13C	Malignant cells	GSE189460_pre	ENSG00000129003	54832	vacuolar protein sorting 13 homolog C	BLTP5C|FLJ10381|FLJ20136|KIAA1421	protein_coding	Q709C8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63446
0	0.50108095444044	0.92	0.873	0	RPS27L	Malignant cells	GSE189460_pre	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63447
0	0.341263240645421	0.401	0.222	0	USP3	Malignant cells	GSE189460_pre	ENSG00000140455	9960	ubiquitin specific peptidase 3	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63448
0	0.251794410250018	0.283	0.126	0	HERC1	Malignant cells	GSE189460_pre	ENSG00000103657	8925	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	p532|p619	protein_coding	Q15751	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63449
0	1.16537980234855	0.983	0.975	0	PPIB	Malignant cells	GSE189460_pre	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63450
0	0.266393564821015	0.409	0.233	0	HACD3	Malignant cells	GSE189460_pre	ENSG00000074696	51495	3-hydroxyacyl-CoA dehydratase 3	B-ind1|HSPC121|PTPLAD1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63451
0	0.322387344434421	0.57	0.361	0	ANP32A	Malignant cells	GSE189460_pre	ENSG00000140350	8125	acidic nuclear phosphoprotein 32 family member A	C15orf1|I1PP2A|LANP|MAPM|mapmodulin|PHAPI|PP32	protein_coding	P39687	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63452
0	0.304421568315172	0.439	0.262	0	PKM	Malignant cells	GSE189460_pre	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63453
0	0.442582823526728	0.486	0.296	0	SCAMP2	Malignant cells	GSE189460_pre	ENSG00000140497	10066	secretory carrier membrane protein 2	NA	protein_coding	O15127	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63454
0	0.398746163371043	0.432	0.195	0	COMMD4	Malignant cells	GSE189460_pre	ENSG00000140365	54939	COMM domain containing 4	FLJ20452	protein_coding	Q9H0A8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63455
0	0.266746661204191	0.618	0.44	0	RCN2	Malignant cells	GSE189460_pre	ENSG00000117906	5955	reticulocalbin 2	E6BP|ERC-55|ERC55|TCBP49	protein_coding	Q14257	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63456
0	0.40852708754257	0.615	0.403	0	PSMA4	Malignant cells	GSE189460_pre	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63457
0	0.571662727928755	0.701	0.437	0	MORF4L1	Malignant cells	GSE189460_pre	ENSG00000185787	10933	mortality factor 4 like 1	Eaf3|HsT17725|MEAF3|MORFRG15|MRG15	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63458
0	0.365644587147119	0.519	0.337	0	ZFAND6	Malignant cells	GSE189460_pre	ENSG00000086666	54469	zinc finger AN1-type containing 6	AWP1|ZA20D3|ZFAND5B	protein_coding	Q6FIF0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63459
0	0.57389041849717	0.732	0.548	0	MESD	Malignant cells	GSE189460_pre	ENSG00000117899	23184	mesoderm development LRP chaperone	BOCA|KIAA0081|MESDC2	protein_coding	Q14696	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63460
0	0.528970317772107	0.572	0.28	0	AKAP13	Malignant cells	GSE189460_pre	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63461
0	0.418967744333547	0.483	0.285	0	IQGAP1	Malignant cells	GSE189460_pre	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63462
0	1.80568880517681	0.342	0.034	0	PDIA2	Malignant cells	GSE189460_pre	ENSG00000185615	64714	protein disulfide isomerase family A member 2	PDA2|PDI|PDIP|PDIR	protein_coding	Q13087	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63463
0	0.340642043948858	0.543	0.335	0	UBE2I	Malignant cells	GSE189460_pre	ENSG00000103275	7329	ubiquitin conjugating enzyme E2 I	UBC9	protein_coding	P63279	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63464
0	0.26780056630985	0.503	0.34	0	HAGH	Malignant cells	GSE189460_pre	ENSG00000063854	3029	hydroxyacylglutathione hydrolase	GLO2|GLXII|HAGH1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63465
0	0.304286604384881	0.352	0.173	0	PGP	Malignant cells	GSE189460_pre	ENSG00000184207	283871	phosphoglycolate phosphatase	NA	protein_coding	A6NDG6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63466
0	0.556388172834077	0.849	0.603	0	SRRM2	Malignant cells	GSE189460_pre	ENSG00000167978	23524	serine/arginine repetitive matrix 2	Cwc21|KIAA0324|SRL300|SRm300	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63467
0	0.651744800063381	0.411	0.138	0	CARHSP1	Malignant cells	GSE189460_pre	ENSG00000153048	23589	calcium regulated heat stable protein 1	CRHSP-24|CSDC1	protein_coding	Q9Y2V2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63468
0	-0.336248245259273	0.553	0.679	0	TXNDC11	Malignant cells	GSE189460_pre	ENSG00000153066	51061	thioredoxin domain containing 11	EFP1	protein_coding	Q6PKC3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63469
0	0.317192291350275	0.312	0.148	0	NTAN1	Malignant cells	GSE189460_pre	ENSG00000275779	123803	N-terminal asparagine amidase	NA	protein_coding	Q96AB6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63470
0	0.598895899902893	0.592	0.313	0	METTL9	Malignant cells	GSE189460_pre	ENSG00000284548	51108	methyltransferase like 9	DREV1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63471
0	0.630671802015856	0.421	0.085	0	PRKCB	Malignant cells	GSE189460_pre	ENSG00000166501	5579	protein kinase C beta	PKCB|PKCbeta|PRKCB1|PRKCB2	protein_coding	P05771	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63472
0	0.322061949524128	0.446	0.249	0	QPRT	Malignant cells	GSE189460_pre	ENSG00000103485	23475	quinolinate phosphoribosyltransferase	QPRTase	protein_coding	Q15274	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63473
0	0.39903963275133	0.521	0.321	0	CORO1A	Malignant cells	GSE189460_pre	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63474
0	0.774572280650723	0.673	0.373	0	FUS	Malignant cells	GSE189460_pre	ENSG00000089280	2521	FUS RNA binding protein	ALS6|FUS1|hnRNP-P2|HNRNPP2|TLS	protein_coding	P35637	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63475
0	0.292171043965807	0.404	0.232	0	PYCARD	Malignant cells	GSE189460_pre	ENSG00000103490	29108	PYD and CARD domain containing	ASC|CARD5|TMS-1	protein_coding	Q9ULZ3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63476
0	0.362743581765964	0.361	0.139	0	CRNDE	Malignant cells	GSE189460_pre	ENSG00000245694	101927480	uncharacterized LOC101927480	CRNDEP|LINC00180|LOC643911	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63477
0	0.654495031655917	0.977	0.951	0	HERPUD1	Malignant cells	GSE189460_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63478
0	0.342278588966064	0.423	0.24	0	CKLF	Malignant cells	GSE189460_pre	ENSG00000217555	51192	chemokine like factor	C32|CKLF1|CKLF3|CKLF4|HSPC224|UCK-1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63479
0	0.353842029203884	0.536	0.301	0	GABARAPL2	Malignant cells	GSE189460_pre	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63480
0	0.321079538060803	0.463	0.244	0	TERF2IP	Malignant cells	GSE189460_pre	ENSG00000166848	54386	TERF2 interacting protein	RAP1	protein_coding	Q9NYB0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63481
0	0.423548359431771	0.526	0.279	0	MAP1LC3B	Malignant cells	GSE189460_pre	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63482
0	0.337541915426872	0.465	0.29	0	ANKRD11	Malignant cells	GSE189460_pre	ENSG00000167522	29123	ankyrin repeat domain containing 11	ANCO-1|ANCO1|LZ16|T13	protein_coding	Q6UB99	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63483
0	-0.813097125573891	0.078	0.276	0	DPEP1	Malignant cells	GSE189460_pre	ENSG00000015413	1800	dipeptidase 1	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63484
0	0.288004978133213	0.783	0.608	0	EIF5A	Malignant cells	GSE189460_pre	ENSG00000288145	1984	eukaryotic translation initiation factor 5A	EIF-5A|EIF5A1|MGC104255|MGC99547	protein_coding	P63241	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63485
0	-0.353494901919998	0.971	0.985	0	RPL26	Malignant cells	GSE189460_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63486
0	0.446906628731381	0.896	0.794	0	UBB	Malignant cells	GSE189460_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63487
0	-0.264508560216392	0.44	0.658	0	EVI2B	Malignant cells	GSE189460_pre	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63488
0	0.283680826297534	0.358	0.206	0	EVI2A	Malignant cells	GSE189460_pre	ENSG00000126860	2123	ecotropic viral integration site 2A	EVDA|EVI2	protein_coding	P22794	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63489
0	0.434238522781205	0.276	0.059	0	SLFN13	Malignant cells	GSE189460_pre	ENSG00000154760	146857	schlafen family member 13	FLJ31952	protein_coding	Q68D06	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63490
0	1.29163131131568	0.674	0.198	0	CCL3	Malignant cells	GSE189460_pre	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63491
0	0.339596045325809	0.986	0.924	0	RPL23	Malignant cells	GSE189460_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63492
0	0.474312560169474	1	0.998	0	EIF1	Malignant cells	GSE189460_pre	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63493
0	0.339279135596768	0.429	0.261	0	KPNB1	Malignant cells	GSE189460_pre	ENSG00000108424	3837	karyopherin subunit beta 1	IMB1|Impnb|IPO1|IPOB|MGC2155|MGC2156|MGC2157|NTF97	protein_coding	Q14974	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63494
0	0.351469810501824	0.508	0.284	0	LRRC59	Malignant cells	GSE189460_pre	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63495
0	0.294422101198123	0.33	0.177	0	AC004687.1	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63496
0	0.383052451205625	0.412	0.205	0	VMP1	Malignant cells	GSE189460_pre	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63497
0	0.509481262368972	0.984	0.93	0	DDX5	Malignant cells	GSE189460_pre	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63498
0	0.253537054062915	0.261	0.123	0	KPNA2	Malignant cells	GSE189460_pre	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63499
0	0.525628824596696	0.883	0.767	0	SUMO2	Malignant cells	GSE189460_pre	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63500
0	0.383201154887124	0.499	0.293	0	GRB2	Malignant cells	GSE189460_pre	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63501
0	0.461326125643071	0.988	0.959	0	H3F3B	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63502
0	0.48485056133332	0.726	0.553	0	SRSF2	Malignant cells	GSE189460_pre	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63503
0	0.378592085567711	0.535	0.282	0	SYNGR2	Malignant cells	GSE189460_pre	ENSG00000108639	9144	synaptogyrin 2	NA	protein_coding	O43760	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63504
0	0.294390710060874	0.579	0.391	0	NDUFAF8	Malignant cells	GSE189460_pre	ENSG00000224877	284184	NADH:ubiquinone oxidoreductase complex assembly factor 8	C17orf89	protein_coding	A1L188	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63505
0	0.391203826804777	0.364	0.159	0	ALYREF	Malignant cells	GSE189460_pre	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63506
0	1.03345889222654	0.382	0.038	0	TYMS	Malignant cells	GSE189460_pre	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63507
0	0.489422497973486	0.481	0.237	0	SMCHD1	Malignant cells	GSE189460_pre	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63508
0	0.692787661782565	0.882	0.566	0	MYL12A	Malignant cells	GSE189460_pre	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63509
0	0.53122805501557	0.663	0.368	0	MYL12B	Malignant cells	GSE189460_pre	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63510
0	0.721395513976002	0.721	0.5	0	NDUFV2	Malignant cells	GSE189460_pre	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63511
0	0.365706738072432	0.572	0.4	0	ANKRD12	Malignant cells	GSE189460_pre	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63512
0	0.282226855497896	0.324	0.136	0	RALBP1	Malignant cells	GSE189460_pre	ENSG00000017797	10928	ralA binding protein 1	RIP|RIP1|RLIP76	protein_coding	Q15311	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63513
0	0.851440791885628	0.683	0.323	0	VAPA	Malignant cells	GSE189460_pre	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63514
0	0.68980515959592	0.52	0.187	0	RNMT	Malignant cells	GSE189460_pre	ENSG00000101654	8731	RNA guanine-7 methyltransferase	N7-MTase|RG7MT1	protein_coding	O43148	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63515
0	0.408696978563984	0.584	0.381	0	SNRPD1	Malignant cells	GSE189460_pre	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63516
0	0.299232334689439	0.264	0.089	0	TAF4B	Malignant cells	GSE189460_pre	ENSG00000141384	6875	TATA-box binding protein associated factor 4b	TAF2C2|TAFII105	protein_coding	Q92750	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63517
0	0.302923938640486	0.583	0.377	0	MBD2	Malignant cells	GSE189460_pre	ENSG00000134046	8932	methyl-CpG binding domain protein 2	NA	protein_coding	Q9UBB5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63518
0	0.530388301953008	0.688	0.412	0	TCF4	Malignant cells	GSE189460_pre	ENSG00000196628	6925	transcription factor 4	bHLHb19|E2-2|ITF2|SEF2-1B	protein_coding	P15884	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63519
0	0.528497292917294	0.624	0.383	0	BCL2	Malignant cells	GSE189460_pre	ENSG00000171791	596	BCL2 apoptosis regulator	Bcl-2|PPP1R50	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63520
0	0.27576758145972	0.411	0.247	0	CNDP2	Malignant cells	GSE189460_pre	ENSG00000133313	55748	carnosine dipeptidase 2	CN2|CPGL|FLJ10830|HsT2298|PEPA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63521
0	0.428268106158103	0.311	0.103	0	PCNA	Malignant cells	GSE189460_pre	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63522
0	0.511932767183994	0.388	0.15	0	TMX4	Malignant cells	GSE189460_pre	ENSG00000125827	56255	thioredoxin related transmembrane protein 4	DJ971N18.2|KIAA1162|PDIA14|TXNDC13	protein_coding	Q9H1E5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63523
0	-0.547899553464663	0.482	0.728	0	RRBP1	Malignant cells	GSE189460_pre	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63524
0	0.376541424061997	0.343	0.157	0	NXT1	Malignant cells	GSE189460_pre	ENSG00000132661	29107	nuclear transport factor 2 like export factor 1	MTR2|P15	protein_coding	Q9UKK6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63525
0	0.57859138153628	0.65	0.414	0	CST3	Malignant cells	GSE189460_pre	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63526
0	-0.276533105069072	0.091	0.257	0	ACSS1	Malignant cells	GSE189460_pre	ENSG00000154930	84532	acyl-CoA synthetase short chain family member 1	ACAS2L|AceCS2L|dJ568C11.3|MGC33843	protein_coding	Q9NUB1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63527
0	1.09753774652719	0.49	0.206	0	ID1	Malignant cells	GSE189460_pre	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63528
0	0.393563625452988	0.816	0.715	0	RBM39	Malignant cells	GSE189460_pre	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63529
0	0.343733410469376	0.643	0.473	0	SCAND1	Malignant cells	GSE189460_pre	ENSG00000171222	51282	SCAN domain containing 1	RAZ1|SDP1	protein_coding	P57086	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63530
0	0.368647954114821	0.603	0.417	0	TOP1	Malignant cells	GSE189460_pre	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63531
0	0.272311735596806	0.264	0.097	0	CHD6	Malignant cells	GSE189460_pre	ENSG00000124177	84181	chromodomain helicase DNA binding protein 6	CHD5|dJ620E11.1|FLJ22369|KIAA1335|RIGB	protein_coding	Q8TD26	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63532
0	0.277402934594945	0.294	0.136	0	OSER1	Malignant cells	GSE189460_pre	ENSG00000132823	51526	oxidative stress responsive serine rich 1	C20orf111|dJ1183I21.1|HSPC207|Osr1|Perit1	protein_coding	Q9NX31	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63533
0	-0.488472394490942	0.162	0.416	0	SULF2	Malignant cells	GSE189460_pre	ENSG00000196562	55959	sulfatase 2	HSULF-2|KIAA1247|SULF-2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63534
0	0.755232014660173	0.429	0.191	0	RTF2	Malignant cells	GSE189460_pre	ENSG00000022277	51507	replication termination factor 2	C20orf43|CDAO5|HSPC164|RTFDC1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63535
0	-0.478866460801917	0.207	0.485	0	ZBP1	Malignant cells	GSE189460_pre	ENSG00000124256	81030	Z-DNA binding protein 1	C20orf183|DAI|dJ718J7.3|DLM-1|DLM1	protein_coding	Q9H171	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63536
0	0.476036654372484	0.98	0.969	0	GNAS	Malignant cells	GSE189460_pre	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63537
0	0.356095103949053	0.711	0.585	0	CTSZ	Malignant cells	GSE189460_pre	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63538
0	1.65986778030148	0.821	0.551	0	PSMA7	Malignant cells	GSE189460_pre	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63539
0	0.294416077746559	0.509	0.349	0	ADRM1	Malignant cells	GSE189460_pre	ENSG00000130706	11047	ADRM1 26S proteasome ubiquitin receptor	ARM1|GP110|PSMD16|Rpn13	protein_coding	Q16186	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63540
0	0.3928281010322	0.609	0.476	0	PPDPF	Malignant cells	GSE189460_pre	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63541
0	-0.740072102684078	0.801	0.889	0	ATP5F1D	Malignant cells	GSE189460_pre	ENSG00000099624	513	ATP synthase F1 subunit delta	ATP5D	protein_coding	P30049	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63542
0	-0.389283558600994	0.456	0.593	0	JSRP1	Malignant cells	GSE189460_pre	ENSG00000167476	126306	junctional sarcoplasmic reticulum protein 1	FLJ32416|JP-45	protein_coding	Q96MG2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63543
0	0.626545127570707	0.612	0.353	0	GADD45B	Malignant cells	GSE189460_pre	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63544
0	-0.796951684730927	0.88	0.896	0	EEF2	Malignant cells	GSE189460_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63545
0	0.394039715646724	0.321	0.111	0	DNMT1	Malignant cells	GSE189460_pre	ENSG00000130816	1786	DNA methyltransferase 1	CXXC9|DNMT|MCMT	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63546
0	-0.616172145380652	0.414	0.665	0	ICAM3	Malignant cells	GSE189460_pre	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63547
0	0.905234799360979	0.923	0.685	0	JUNB	Malignant cells	GSE189460_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63548
0	0.968121753454618	0.897	0.628	0	IER2	Malignant cells	GSE189460_pre	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63549
0	0.509405403377433	0.392	0.172	0	DNAJB1	Malignant cells	GSE189460_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63550
0	-0.300741492849581	0.142	0.303	0	HSH2D	Malignant cells	GSE189460_pre	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63551
0	1.10918961792136	0.94	0.679	0	KLF2	Malignant cells	GSE189460_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63552
0	0.351977582451163	0.847	0.664	0	BST2	Malignant cells	GSE189460_pre	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63553
0	1.02613518249073	0.509	0.187	0	HOMER3	Malignant cells	GSE189460_pre	ENSG00000051128	9454	homer scaffold protein 3	HOMER-3	protein_coding	Q9NSC5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63554
0	0.2808834860712	0.338	0.164	0	UBA2	Malignant cells	GSE189460_pre	ENSG00000126261	10054	ubiquitin like modifier activating enzyme 2	FLJ13058|HRIHFB2115|SAE2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63555
0	0.321150482634957	0.254	0.086	0	NFKBID	Malignant cells	GSE189460_pre	ENSG00000167604	84807	NFKB inhibitor delta	IkappaBNS|IkBNS|TA-NFKBH	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63556
0	0.320968488774064	0.691	0.515	0	PSMD8	Malignant cells	GSE189460_pre	ENSG00000099341	5714	proteasome 26S subunit, non-ATPase 8	HIP6|HYPF|Nin1p|p31|Rpn12|S14	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63557
0	0.320866223353436	0.492	0.291	0	GMFG	Malignant cells	GSE189460_pre	ENSG00000130755	9535	glia maturation factor gamma	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63558
0	0.571327768870589	0.776	0.498	0	ZFP36	Malignant cells	GSE189460_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63559
0	0.384243777517258	0.401	0.164	0	BLVRB	Malignant cells	GSE189460_pre	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63560
0	0.286496659993196	0.403	0.215	0	HNRNPUL1	Malignant cells	GSE189460_pre	ENSG00000105323	11100	heterogeneous nuclear ribonucleoprotein U like 1	E1B-AP5|E1BAP5|FLJ12944|HNRPUL1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63561
0	0.517043189454323	0.613	0.443	0	LINC01480	Malignant cells	GSE189460_pre	ENSG00000280540	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63562
0	0.967563187007514	0.944	0.768	0	FOSB	Malignant cells	GSE189460_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63563
0	0.329885315269015	0.497	0.291	0	AP2S1	Malignant cells	GSE189460_pre	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63564
0	0.268658603974965	0.432	0.257	0	TMEM160	Malignant cells	GSE189460_pre	ENSG00000130748	54958	transmembrane protein 160	FLJ20512	protein_coding	Q9NX00	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63565
0	0.53346070166535	0.881	0.698	0	PPP1R15A	Malignant cells	GSE189460_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63566
0	0.291367868514361	0.372	0.207	0	BAX	Malignant cells	GSE189460_pre	ENSG00000087088	581	BCL2 associated X, apoptosis regulator	BCL2L4	protein_coding	Q07812	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63567
0	0.827192618675353	0.999	0.997	0	FTL	Malignant cells	GSE189460_pre	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63568
0	0.340405690926588	0.312	0.132	0	C19orf48	Malignant cells	GSE189460_pre	ENSG00000167747	84798	multidrug resistance-related protein	BC006151|MGC13170	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63569
0	0.323490709374419	0.435	0.216	0	ETFB	Malignant cells	GSE189460_pre	ENSG00000105379	2109	electron transfer flavoprotein subunit beta	NA	protein_coding	P38117	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63570
0	0.606678879901364	0.404	0.098	0	MYADM	Malignant cells	GSE189460_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63571
0	0.611911584896808	0.616	0.356	0	RANBP1	Malignant cells	GSE189460_pre	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63572
0	0.288721935389937	0.507	0.3	0	UBE2L3	Malignant cells	GSE189460_pre	ENSG00000185651	7332	ubiquitin conjugating enzyme E2 L3	UBCH7	protein_coding	P68036	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63573
0	0.645823590029118	0.86	0.779	0	SDF2L1	Malignant cells	GSE189460_pre	ENSG00000128228	23753	stromal cell derived factor 2 like 1	AP000553.C22.4|OTTHUMT00000075032	protein_coding	Q9HCN8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63574
0	-1.12846447338904	0.082	0.341	0	IGLV6-57	Malignant cells	GSE189460_pre	ENSG00000211640	NA	NA	NA	IG_V_gene	P01721	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63575
0	7.74434179885604	0.358	0.083	0	IGLL5	Malignant cells	GSE189460_pre	ENSG00000254709	100423062	immunoglobulin lambda like polypeptide 5	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63576
0	-5.66948702509276	0.141	0.675	0	IGLC2	Malignant cells	GSE189460_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63577
0	-2.08203550098429	0.046	0.551	0	IGLC3	Malignant cells	GSE189460_pre	ENSG00000211679	NA	NA	IGLC	IG_C_gene	P0DOY3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63578
0	0.415575271389834	0.788	0.675	0	MIF	Malignant cells	GSE189460_pre	ENSG00000276701	4282	macrophage migration inhibitory factor	GIF|GLIF	protein_coding	P14174	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63579
0	0.358864605208084	0.744	0.589	0	DDT	Malignant cells	GSE189460_pre	ENSG00000275003	1652	D-dopachrome tautomerase	D-DT|DDCT|MIF-2|MIF2	protein_coding	P30046	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63580
0	0.498840089297039	0.572	0.299	0	SNRPD3	Malignant cells	GSE189460_pre	ENSG00000100028	6634	small nuclear ribonucleoprotein D3 polypeptide	Sm-D3|SMD3	protein_coding	P62318	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63581
0	0.363077702540904	0.445	0.226	0	EWSR1	Malignant cells	GSE189460_pre	ENSG00000182944	2130	EWS RNA binding protein 1	EWS	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63582
0	0.404240319951861	0.735	0.574	0	UQCR10	Malignant cells	GSE189460_pre	ENSG00000184076	29796	ubiquinol-cytochrome c reductase, complex III subunit X	HSPC051|QCR9|UCCR7.2|UCRC	protein_coding	Q9UDW1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63583
0	0.524773832577224	0.426	0.18	0	YWHAH	Malignant cells	GSE189460_pre	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63584
0	0.290214134246564	0.269	0.094	0	HMGXB4	Malignant cells	GSE189460_pre	ENSG00000100281	10042	HMG-box containing 4	HMG2L1|P53N|THC211630	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63585
0	0.315261225988987	0.658	0.444	0	RAC2	Malignant cells	GSE189460_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63586
0	0.894493416209892	0.748	0.622	0	LGALS1	Malignant cells	GSE189460_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63587
0	0.295253756585465	0.64	0.462	0	RBX1	Malignant cells	GSE189460_pre	ENSG00000100387	9978	ring-box 1	BA554C12.1|RNF75|ROC1	protein_coding	P62877	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63588
0	0.263732398638449	0.499	0.325	0	XRCC6	Malignant cells	GSE189460_pre	ENSG00000196419	2547	X-ray repair cross complementing 6	D22S671|D22S731|G22P1|KU70|ML8	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63589
0	0.289533614916858	0.807	0.653	0	SNU13	Malignant cells	GSE189460_pre	ENSG00000100138	4809	small nuclear ribonucleoprotein 13	15.5K|FA-1|NHP2L1|SNRNP15-5|SPAG12|SSFA1	protein_coding	P55769	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63590
0	0.356065040823135	0.266	0.04	0	PRR5	Malignant cells	GSE189460_pre	ENSG00000186654	55615	proline rich 5	FLJ20185k|PP610|Protor-1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63591
0	0.35598313697838	0.462	0.269	0	PIM3	Malignant cells	GSE189460_pre	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63592
0	-0.33222014783531	0.244	0.394	0	TYMP	Malignant cells	GSE189460_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63593
0	0.540753046671162	0.364	0.061	0	SAMSN1	Malignant cells	GSE189460_pre	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63594
0	0.313631682216734	0.363	0.215	0	BTG3	Malignant cells	GSE189460_pre	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63595
0	0.370972040243933	0.711	0.562	0	SOD1	Malignant cells	GSE189460_pre	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63596
0	0.413336518402276	0.608	0.409	0	TTC3	Malignant cells	GSE189460_pre	ENSG00000182670	7267	tetratricopeptide repeat domain 3	DCRR1|RNF105|TPRD|TPRDI|TPRDII|TPRDIII	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63597
0	0.3783046929504	0.776	0.624	0	HMGN1	Malignant cells	GSE189460_pre	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63598
0	0.659392662302872	0.292	0.003	0	FAM3B	Malignant cells	GSE189460_pre	ENSG00000183844	54097	FAM3 metabolism regulating signaling molecule B	2-21|C21orf11|C21orf76|D21M16SJHU19e|ORF9|PANDER|PRED44	protein_coding	P58499	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63599
0	0.286978494712578	0.399	0.239	0	SUMO3	Malignant cells	GSE189460_pre	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63600
0	0.382387978710924	1	0.961	0	MT-CO1	Malignant cells	GSE189460_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63601
0	0.328303343855263	0.999	0.97	0	MT-ATP6	Malignant cells	GSE189460_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63602
0	0.681235517571155	0.996	0.955	0	MT-ND5	Malignant cells	GSE189460_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63603
0	0.521619409820701	0.377	0.127	0	DDX3Y	Malignant cells	GSE189460_pre	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63604
0	0.651037206605448	0.309	0.033	0	IGKV3-11	Malignant cells	GSE189460_pre	ENSG00000282823	NA	NA	NA	IG_V_gene	P04433	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63605
0	0.665701624195141	0.431	0.231	0	RPS4Y1	Malignant cells	GSE189460_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63606
0	0.370781153673939	0.378	0.16	0	EIF1AY	Malignant cells	GSE189460_pre	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63607
4.53119652737011e-308	0.252955373767218	0.599	0.438	1.10099013222039e-303	LAMTOR4	Malignant cells	GSE189460_pre	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63608
9.55352071905272e-307	0.280701687798256	0.864	0.809	2.32131446431543e-302	COPE	Malignant cells	GSE189460_pre	ENSG00000105669	11316	COPI coat complex subunit epsilon	epsilon-COP	protein_coding	O14579	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63609
1.52305205235535e-306	-0.318803566002614	0.594	0.729	3.70071187681303e-302	SDC1	Malignant cells	GSE189460_pre	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63610
1.7532499844392e-306	0.276093472469873	0.478	0.321	4.26004681219037e-302	SCAF11	Malignant cells	GSE189460_pre	ENSG00000139218	9169	SR-related CTD associated factor 11	CASP11|SFRS2IP|SIP1|SRRP129|SRSF2IP	protein_coding	Q99590	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63611
5.83955616952511e-305	0.601758178259184	0.931	0.923	1.41889535807121e-300	HSPA5	Malignant cells	GSE189460_pre	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63612
2.90393909510719e-304	-0.526858088228325	0.999	0.996	7.05599121329146e-300	RPS12	Malignant cells	GSE189460_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63613
7.48368637383394e-304	0.32077049260387	0.96	0.959	1.81838611511417e-299	ATP5F1E	Malignant cells	GSE189460_pre	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63614
2.51822306024101e-302	-0.603914866377109	0.582	0.638	6.1187783917736e-298	CCDC85B	Malignant cells	GSE189460_pre	ENSG00000175602	11007	coiled-coil domain containing 85B	DIPA	protein_coding	Q15834	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63615
3.35882713150082e-302	0.277907282690701	0.301	0.165	8.1612781641207e-298	IFI27L1	Malignant cells	GSE189460_pre	ENSG00000276880	122509	interferon alpha inducible protein 27 like 1	FAM14B	protein_coding	Q96BM0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63616
1.80550867683191e-301	0.266900328274078	0.391	0.244	4.38702498296618e-297	HSPB11	Malignant cells	GSE189460_pre	ENSG00000081870	51668	heat shock protein family B (small) member 11	C1orf41|FAP232|HSPCO34|IFT25|PP25	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63617
1.06052724785639e-300	0.262891814286851	0.429	0.278	2.57686910684145e-296	STARD7	Malignant cells	GSE189460_pre	ENSG00000084090	56910	StAR related lipid transfer domain containing 7	GTT1	protein_coding	Q9NQZ5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63618
1.18779660464978e-300	0.277425162057425	0.459	0.305	2.88610818997804e-296	BHLHE41	Malignant cells	GSE189460_pre	ENSG00000123095	79365	basic helix-loop-helix family member e41	BHLHB3|DEC2|SHARP-1|SHARP1	protein_coding	Q9C0J9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63619
1.27144046435177e-298	-0.295830773098742	0.2	0.341	3.08934604028194e-294	IRF7	Malignant cells	GSE189460_pre	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63620
2.02294083883811e-298	0.286751719033069	0.58	0.439	4.91534165020885e-294	TMEM14C	Malignant cells	GSE189460_pre	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63621
4.36133758092025e-297	0.271178899665469	0.342	0.2	1.059717805412e-292	MTHFD2	Malignant cells	GSE189460_pre	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63622
1.2343677255796e-296	0.29631388124867	0.798	0.687	2.9992666996133e-292	RNASET2	Malignant cells	GSE189460_pre	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63623
1.28014784453679e-296	0.389902700791429	0.934	0.908	3.11050323265549e-292	PDIA6	Malignant cells	GSE189460_pre	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63624
2.05256772527821e-294	0.324993318989554	0.596	0.446	4.987329058881e-290	TP53INP1	Malignant cells	GSE189460_pre	ENSG00000164938	94241	tumor protein p53 inducible nuclear protein 1	DKFZp434M1317|FLJ22139|P53DINP1|SIP|Teap|TP53INP1A|TP53INP1B	protein_coding	Q96A56	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63625
2.10385227117816e-293	0.254314258075806	0.318	0.175	5.11194024850869e-289	DDIT3	Malignant cells	GSE189460_pre	ENSG00000175197	1649	DNA damage inducible transcript 3	CHOP|CHOP10|GADD153	protein_coding	P35638	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63626
1.66049448671911e-291	0.448510789441444	0.369	0.231	4.0346695038301e-287	UBE2S	Malignant cells	GSE189460_pre	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63627
1.11546446629563e-290	0.342659000184188	0.384	0.234	2.71035556020513e-286	TNFAIP3	Malignant cells	GSE189460_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63628
1.64908218832122e-290	0.253589775259403	0.623	0.475	4.00693990118291e-286	ANAPC11	Malignant cells	GSE189460_pre	ENSG00000141552	51529	anaphase promoting complex subunit 11	APC11|Apc11p|HSPC214|MGC882	protein_coding	Q9NYG5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63629
3.84709248868172e-290	0.285467707474645	0.5	0.356	9.34766532899885e-286	SNRPF	Malignant cells	GSE189460_pre	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63630
5.78312162788866e-290	0.27272883714103	0.709	0.616	1.40518289314439e-285	SRPRB	Malignant cells	GSE189460_pre	ENSG00000144867	58477	SRP receptor subunit beta	APMCF1|SR-beta	protein_coding	Q9Y5M8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63631
1.22880450382724e-287	0.309414148101774	0.38	0.242	2.98574918339944e-283	ST3GAL6	Malignant cells	GSE189460_pre	ENSG00000064225	10402	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	SIAT10|ST3GALVI	protein_coding	Q9Y274	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63632
9.95478425426005e-287	0.25063074761714	0.539	0.396	2.41881347810011e-282	CALU	Malignant cells	GSE189460_pre	ENSG00000128595	813	calumenin	NA	protein_coding	O43852	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63633
9.37426583701936e-286	0.445523608730615	0.27	0.138	2.27775911307896e-281	IER3	Malignant cells	GSE189460_pre	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63634
3.88794222314147e-283	0.443413364926796	0.994	0.993	9.44692201378914e-279	RPL39	Malignant cells	GSE189460_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63635
5.41233219314438e-280	-0.608910418300123	0.206	0.347	1.31508847629022e-275	MYC	Malignant cells	GSE189460_pre	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63636
2.81963269423827e-277	0.377193941542835	0.732	0.673	6.85114352046014e-273	FBXW7	Malignant cells	GSE189460_pre	ENSG00000109670	55294	F-box and WD repeat domain containing 7	AGO|CDC4|FBW7|FBX30|FBXW6|FLJ11071|SEL-10|SEL10	protein_coding	Q969H0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63637
1.44693900385439e-276	0.26058575770435	0.267	0.142	3.51577239156539e-272	HERC5	Malignant cells	GSE189460_pre	ENSG00000138646	51191	HECT and RLD domain containing E3 ubiquitin protein ligase 5	CEB1	protein_coding	Q9UII4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63638
3.58129822028504e-276	0.267145780664085	0.514	0.373	8.7018384156486e-272	ILF2	Malignant cells	GSE189460_pre	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63639
1.44485920472047e-275	0.65115012984624	0.51	0.406	3.5107188956298e-271	HIST1H2AC	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63640
9.4238071119626e-275	0.269971721320146	0.601	0.473	2.28979665206467e-270	LAPTM4A	Malignant cells	GSE189460_pre	ENSG00000068697	9741	lysosomal protein transmembrane 4 alpha	HUMORF13|KIAA0108|LAPTM4|MBNT|Mtrp	protein_coding	Q15012	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63641
9.38577095798637e-274	0.273007408770462	0.518	0.386	2.28055462737153e-269	PSMB7	Malignant cells	GSE189460_pre	ENSG00000136930	5695	proteasome 20S subunit beta 7	Z	protein_coding	Q99436	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63642
3.97438801951025e-273	0.250372114043403	0.444	0.303	9.656968009806e-269	EMC3	Malignant cells	GSE189460_pre	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63643
2.17853324185952e-271	0.265438165833821	0.616	0.484	5.29340007107026e-267	SNRPD2	Malignant cells	GSE189460_pre	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63644
2.99062116952488e-271	0.251829446977479	0.572	0.438	7.26661131771155e-267	NANS	Malignant cells	GSE189460_pre	ENSG00000095380	54187	N-acetylneuraminate synthase	SAS	protein_coding	Q9NR45	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63645
3.78305889152448e-269	0.269551150891806	0.91	0.854	9.19207649462619e-265	SRGN	Malignant cells	GSE189460_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63646
1.1477766892676e-267	0.261303426442445	0.375	0.238	2.78886779958242e-263	THUMPD3-AS1	Malignant cells	GSE189460_pre	ENSG00000206573	440944	THUMPD3 antisense RNA 1	SETD5-AS1	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63647
9.41878842526115e-267	0.312844730030381	0.267	0.144	2.28857721156995e-262	FABP5	Malignant cells	GSE189460_pre	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63648
2.43632551193692e-266	0.539525463593702	0.453	0.338	5.91978372890434e-262	METTL7A	Malignant cells	GSE189460_pre	ENSG00000185432	25840	methyltransferase like 7A	DKFZP586A0522	protein_coding	Q9H8H3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63649
2.44132548808197e-266	0.262155338965575	0.49	0.357	5.93193267094157e-262	IER3IP1	Malignant cells	GSE189460_pre	ENSG00000134049	51124	immediate early response 3 interacting protein 1	NA	protein_coding	Q9Y5U9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63650
2.70624686361109e-265	0.402144438514937	0.34	0.212	6.57563862920222e-261	PBXIP1	Malignant cells	GSE189460_pre	ENSG00000163346	57326	PBX homeobox interacting protein 1	HPIP	protein_coding	Q96AQ6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63651
2.79189777578766e-263	0.254957975729424	0.284	0.157	6.78375321560885e-259	TUBA1C	Malignant cells	GSE189460_pre	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63652
3.81164196157383e-262	-0.278156769005839	0.195	0.33	9.26152763823209e-258	SPINT2	Malignant cells	GSE189460_pre	ENSG00000167642	10653	serine peptidase inhibitor, Kunitz type 2	HAI-2|HAI2|Kop	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63653
1.14280853283771e-260	-0.250554717259544	0.792	0.876	2.77679617308907e-256	COX7A2	Malignant cells	GSE189460_pre	ENSG00000112695	1347	cytochrome c oxidase subunit 7A2	COX7AL|COXVIIa-L	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63654
3.50552217719995e-260	0.770117458605606	0.322	0.203	8.51771778616044e-256	BIRC3	Malignant cells	GSE189460_pre	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63655
2.90938644132523e-257	0.293658972695074	0.484	0.34	7.06922717513204e-253	RSRP1	Malignant cells	GSE189460_pre	ENSG00000117616	57035	arginine and serine rich protein 1	C1orf63|DJ465N24.2.1	protein_coding	Q9BUV0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63656
1.0788133196079e-254	-0.339014472716496	0.322	0.44	2.62130060398328e-250	VPS51	Malignant cells	GSE189460_pre	ENSG00000149823	738	VPS51 subunit of GARP complex	ANG2|ANG3|C11orf2|C11orf3|FFR	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63657
1.12211514461042e-254	0.320770769906382	0.301	0.17	2.7265153783744e-250	PMAIP1	Malignant cells	GSE189460_pre	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63658
1.2937799148595e-253	0.263994531930449	0.485	0.345	3.14362643712562e-249	ZNF207	Malignant cells	GSE189460_pre	ENSG00000010244	7756	zinc finger protein 207	BuGZ	protein_coding	O43670	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63659
1.83481498093358e-253	0.250400280427135	0.538	0.4	4.45823344067241e-249	HNRNPM	Malignant cells	GSE189460_pre	ENSG00000099783	4670	heterogeneous nuclear ribonucleoprotein M	CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1	protein_coding	P52272	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63660
8.67606942288523e-251	0.259861164197617	0.448	0.313	2.10811134837265e-246	COX20	Malignant cells	GSE189460_pre	ENSG00000203667	116228	cytochrome c oxidase assembly factor COX20	FAM36A|FLJ43269	protein_coding	Q5RI15	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63661
3.10368676108449e-250	-0.280086431551338	0.233	0.359	7.5413380920831e-246	C12orf45	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63662
1.3920500088654e-249	0.258996056492136	0.474	0.341	3.38240311154115e-245	NDUFA6	Malignant cells	GSE189460_pre	ENSG00000277365	4700	NADH:ubiquinone oxidoreductase subunit A6	B14|CI-B14|LYRM6|NADHB14	protein_coding	P56556	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63663
1.58183541117846e-246	0.259682809456183	0.682	0.568	3.84354368208141e-242	SF3B5	Malignant cells	GSE189460_pre	ENSG00000169976	83443	splicing factor 3b subunit 5	MGC3133|SF3b10|Ysf3	protein_coding	Q9BWJ5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63664
3.69623460730792e-246	0.445263771950539	0.678	0.626	8.98111084883678e-242	GPX4	Malignant cells	GSE189460_pre	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63665
1.09290977658155e-244	0.585326024028362	0.549	0.415	2.65555217513785e-240	OTUD1	Malignant cells	GSE189460_pre	ENSG00000165312	220213	OTU deubiquitinase 1	DUBA7|OTDC1	protein_coding	Q5VV17	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63666
3.37690433781624e-244	0.318056113872113	0.5	0.384	8.2052021600259e-240	MSI2	Malignant cells	GSE189460_pre	ENSG00000153944	124540	musashi RNA binding protein 2	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63667
5.12638064389115e-244	0.250382468918543	0.601	0.464	1.24560796885267e-239	EIF5	Malignant cells	GSE189460_pre	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63668
6.18891019693104e-243	0.259065726845421	0.39	0.254	1.5037813996503e-238	EIF4A1	Malignant cells	GSE189460_pre	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63669
6.05592101052314e-240	0.275344179693148	0.37	0.245	1.47146768713691e-235	NME4	Malignant cells	GSE189460_pre	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63670
3.42823679464442e-237	0.307163445877696	0.666	0.586	8.32992976362701e-233	EMC7	Malignant cells	GSE189460_pre	ENSG00000134153	56851	ER membrane protein complex subunit 7	C11orf3|C15orf24	protein_coding	Q9NPA0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63671
7.31672592425345e-237	-0.275883131154711	0.218	0.341	1.7778180650751e-232	ADAM10	Malignant cells	GSE189460_pre	ENSG00000137845	102	ADAM metallopeptidase domain 10	CD156C|HsT18717|kuz|MADM	protein_coding	O14672	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63672
1.05003425193842e-233	0.284324005018709	0.631	0.509	2.55137322535997e-229	NOP10	Malignant cells	GSE189460_pre	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63673
1.17308831443547e-232	0.272956928121307	0.444	0.32	2.85036998641529e-228	TLK1	Malignant cells	GSE189460_pre	ENSG00000198586	9874	tousled like kinase 1	KIAA0137|PKU-BETA	protein_coding	Q9UKI8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63674
8.0067478132795e-230	0.250258629754908	0.416	0.287	1.94547958367065e-225	SRSF6	Malignant cells	GSE189460_pre	ENSG00000124193	6431	serine and arginine rich splicing factor 6	B52|SFRS6|SRP55	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63675
2.79406472128511e-228	0.253433229361043	0.437	0.308	6.78901845977857e-224	SREK1	Malignant cells	GSE189460_pre	ENSG00000153914	140890	splicing regulatory glutamic acid and lysine rich protein 1	DKFZp564B176|SFRS12|SRrp508|SRrp86	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63676
2.25825982897422e-226	0.282822082020472	0.589	0.467	5.48711973244156e-222	RTN4	Malignant cells	GSE189460_pre	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63677
3.65732906552135e-226	-0.283032811656392	0.198	0.325	8.88657816340377e-222	CADM1	Malignant cells	GSE189460_pre	ENSG00000182985	23705	cell adhesion molecule 1	BL2|IGSF4|IGSF4A|Necl-2|NECL2|RA175|ST17|SYNCAM|SYNCAM1|TSLC1	protein_coding	Q9BY67	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63678
2.51502992693046e-225	0.311148661475214	0.514	0.408	6.11101971645563e-221	GPR160	Malignant cells	GSE189460_pre	ENSG00000173890	26996	G protein-coupled receptor 160	GPCR1|GPCR150	protein_coding	Q9UJ42	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63679
8.98484615569391e-221	0.347313703590916	0.684	0.633	2.18313791891051e-216	PLPP5	Malignant cells	GSE189460_pre	ENSG00000147535	84513	phospholipid phosphatase 5	DPPL1|HTPAP|PPAPDC1B	protein_coding	Q8NEB5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63680
3.17966255850289e-215	0.284217121741871	0.67	0.564	7.72594408465033e-211	SF1	Malignant cells	GSE189460_pre	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63681
7.53653812866308e-210	0.308315899234135	0.69	0.573	1.83122803450256e-205	SEC11A	Malignant cells	GSE189460_pre	ENSG00000140612	23478	SEC11 homolog A, signal peptidase complex subunit	SEC11L1|sid2895|SPC18|SPCS4A	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63682
4.96837065442334e-209	0.279433955265852	0.862	0.849	1.20721470161178e-204	TRAM1	Malignant cells	GSE189460_pre	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63683
6.39344136132339e-208	-0.474178632077702	0.661	0.689	1.55347838197436e-203	EIF3G	Malignant cells	GSE189460_pre	ENSG00000130811	8666	eukaryotic translation initiation factor 3 subunit G	eIF3-delta|eIF3-p44|EIF3S4	protein_coding	O75821	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63684
1.21792205304713e-203	0.25250076584996	0.69	0.588	2.95930700449391e-199	CYTIP	Malignant cells	GSE189460_pre	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63685
5.47535538065529e-201	0.272230738596332	0.391	0.274	1.33040185039162e-196	EIF2AK2	Malignant cells	GSE189460_pre	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63686
6.707565854835e-201	0.272103465294347	0.527	0.403	1.62980435140781e-196	LUC7L3	Malignant cells	GSE189460_pre	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63687
5.08235440451669e-199	0.266188490653947	0.794	0.725	1.23491047320947e-194	CDV3	Malignant cells	GSE189460_pre	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63688
1.48220642806721e-197	0.282650094894754	0.843	0.712	3.6014651789177e-193	HMGB1	Malignant cells	GSE189460_pre	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63689
4.08247953734657e-180	-0.520267798576045	0.976	0.973	9.91960877984469e-176	RACK1	Malignant cells	GSE189460_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63690
1.63151397369456e-179	-0.356254640560099	0.314	0.407	3.96425265328304e-175	CAV1	Malignant cells	GSE189460_pre	ENSG00000105974	857	caveolin 1	CAV	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63691
2.06789087401552e-179	-0.339310569975001	0.985	0.954	5.02456124568292e-175	MT-ND3	Malignant cells	GSE189460_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63692
1.68476937472505e-173	-1.08501010880969	0.722	0.723	4.09365262670693e-169	S100A6	Malignant cells	GSE189460_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63693
2.03528755067278e-173	0.308799777166102	0.285	0.182	4.94534169062472e-169	CKS1B	Malignant cells	GSE189460_pre	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63694
2.76188551243636e-171	0.304213569174718	0.898	0.837	6.71082941811787e-167	DERL3	Malignant cells	GSE189460_pre	ENSG00000274437	91319	derlin 3	C22orf14|derlin-3|FLJ43842|IZP6|MGC71803	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63695
7.95548303171438e-170	-0.258786216008351	0.205	0.302	1.93302326704596e-165	HSBP1	Malignant cells	GSE189460_pre	ENSG00000230989	3281	heat shock factor binding protein 1	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63696
2.24095430007949e-168	0.434044491307389	0.286	0.182	5.44507075833315e-164	HIST1H4C	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63697
2.06897060724029e-165	0.253913857957641	0.332	0.231	5.02718478147246e-161	LDLR	Malignant cells	GSE189460_pre	ENSG00000130164	3949	low density lipoprotein receptor	LDLCQ2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63698
8.04169234849031e-165	0.345016708189301	0.541	0.426	1.95397040683618e-160	SAT1	Malignant cells	GSE189460_pre	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63699
3.03216142226008e-160	-0.471907688304979	0.158	0.257	7.36754582380753e-156	FAM30A	Malignant cells	GSE189460_pre	ENSG00000277059	9834	family with sequence similarity 30 member A	C14orf110|HSPC053|KIAA0125	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63700
1.08173070360721e-156	0.560542024568857	0.762	0.768	2.62838926362481e-152	MANF	Malignant cells	GSE189460_pre	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63701
1.13186266003995e-148	-0.274518629794627	0.194	0.286	2.75019989136507e-144	ANKRD37	Malignant cells	GSE189460_pre	ENSG00000186352	353322	ankyrin repeat domain 37	Lrp2bp	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63702
8.10415233698777e-148	0.312905856917911	0.745	0.678	1.96914693484129e-143	BTG2	Malignant cells	GSE189460_pre	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63703
2.70708291456608e-146	-0.337180601713442	0.992	0.996	6.57767006581267e-142	RPL34	Malignant cells	GSE189460_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63704
1.54374298399586e-144	0.285568954303672	0.538	0.451	3.75098670251313e-140	ST6GAL1	Malignant cells	GSE189460_pre	ENSG00000073849	6480	ST6 beta-galactoside alpha-2,6-sialyltransferase 1	CDw75|SIAT1	protein_coding	P15907	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63705
1.58557612935594e-139	0.256858563780175	0.41	0.322	3.85263287910907e-135	HYOU1	Malignant cells	GSE189460_pre	ENSG00000280682	10525	hypoxia up-regulated 1	Grp170|HSP12A|ORP150	protein_coding	Q9Y4L1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63706
1.2892488866779e-138	0.279508178549257	0.323	0.231	3.13261694484995e-134	LY9	Malignant cells	GSE189460_pre	ENSG00000122224	4063	lymphocyte antigen 9	CD229|hly9|mLY9|SLAMF3	protein_coding	Q9HBG7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63707
1.37651588564264e-138	-0.286600307026948	0.992	0.99	3.34465829893448e-134	RPL23A	Malignant cells	GSE189460_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63708
1.12349212810194e-135	2.54565148785922	0.444	0.405	2.72986117286209e-131	TMSB4X	Malignant cells	GSE189460_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63709
1.92511666876519e-132	-0.478422439071739	0.998	0.998	4.67764848176567e-128	RPL3	Malignant cells	GSE189460_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63710
1.77120479619558e-131	-0.263150121691806	0.237	0.321	4.30367341379601e-127	NCAM1	Malignant cells	GSE189460_pre	ENSG00000149294	4684	neural cell adhesion molecule 1	CD56|NCAM	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63711
3.23084293492851e-128	0.377444172562382	0.689	0.626	7.8503021632893e-124	RSL24D1	Malignant cells	GSE189460_pre	ENSG00000137876	51187	ribosomal L24 domain containing 1	C15orf15|HRP-L30-iso|L30|RPL24|RPL24L	protein_coding	Q9UHA3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63712
1.4277226938152e-124	-0.494934688916692	0.992	0.992	3.46908060143218e-120	RPL36	Malignant cells	GSE189460_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63713
1.59961171618101e-121	-0.284892203176689	0.763	0.779	3.88673654797663e-117	CHCHD10	Malignant cells	GSE189460_pre	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63714
6.10581340642089e-119	0.652918187789077	0.975	0.962	1.48359054149215e-114	MZB1	Malignant cells	GSE189460_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63715
2.27595882758764e-118	0.401632386891371	0.477	0.344	5.53012475927246e-114	HBB	Malignant cells	GSE189460_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63716
5.00490075711737e-118	-0.341422687125066	0.28	0.353	1.21609078596438e-113	IL2RG	Malignant cells	GSE189460_pre	ENSG00000147168	3561	interleukin 2 receptor subunit gamma	CD132|CIDX|IMD4|SCIDX1	protein_coding	P31785	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63717
4.00164549119026e-115	-0.445979997129031	0.658	0.665	9.72319821449409e-111	SRM	Malignant cells	GSE189460_pre	ENSG00000116649	6723	spermidine synthase	SPS1|SRML1	protein_coding	P19623	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63718
3.02976291691035e-114	0.299612092067934	0.448	0.376	7.36171793550878e-110	EIF2AK4	Malignant cells	GSE189460_pre	ENSG00000128829	440275	eukaryotic translation initiation factor 2 alpha kinase 4	GCN2|KIAA1338	protein_coding	Q9P2K8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63719
8.27324176259431e-114	0.301188774440986	0.61	0.509	2.01023228347517e-109	MTRNR2L12	Malignant cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63720
4.31439598627037e-113	-0.335278246455278	0.417	0.465	1.04831193674398e-108	C11orf1	Malignant cells	GSE189460_pre	ENSG00000137720	64776	chromosome 11 open reading frame 1	FLJ23499	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63721
6.66898725304386e-110	0.676052774419047	0.725	0.739	1.6204305227446e-105	ISG20	Malignant cells	GSE189460_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63722
8.96529938255851e-110	-0.382602524002715	0.42	0.463	2.17838844397407e-105	ZFAS1	Malignant cells	GSE189460_pre	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63723
1.63565626407e-104	-0.333245705623917	0.506	0.55	3.97431759043729e-100	UAP1	Malignant cells	GSE189460_pre	ENSG00000117143	6675	UDP-N-acetylglucosamine pyrophosphorylase 1	AgX|AGX1|SPAG2	protein_coding	Q16222	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63724
5.91700440117265e-95	-0.265215354260146	0.281	0.355	1.43771372939693e-90	MX1	Malignant cells	GSE189460_pre	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63725
9.49319791994279e-92	-0.269916886927406	0.212	0.277	2.3066572305877e-87	MINDY2	Malignant cells	GSE189460_pre	ENSG00000128923	54629	MINDY lysine 48 deubiquitinase 2	FAM63B|KIAA1164	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63726
1.87836983773485e-91	-0.674186715125237	0.676	0.658	4.56406303172814e-87	JCHAIN	Malignant cells	GSE189460_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63727
2.92340799451235e-87	-0.25168889842425	0.62	0.664	7.1032967450661e-83	TPM4	Malignant cells	GSE189460_pre	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63728
2.23903443853838e-84	0.268992788622648	0.683	0.677	5.44040587876056e-80	CREB3L2	Malignant cells	GSE189460_pre	ENSG00000182158	64764	cAMP responsive element binding protein 3 like 2	BBF2H7|TCAG_1951439	protein_coding	Q70SY1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63729
2.62014349889505e-72	-0.413617346904891	0.992	0.994	6.36642467361519e-68	RPL14	Malignant cells	GSE189460_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63730
1.36330822570628e-69	-0.341418439967292	0.869	0.803	3.31256632682113e-65	COX5A	Malignant cells	GSE189460_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63731
2.08111069707621e-68	0.577066596172314	0.625	0.68	5.05668277175576e-64	PDIA3	Malignant cells	GSE189460_pre	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63732
2.69356154051923e-64	-0.270712920541036	0.998	0.998	6.54481583115363e-60	RPL41	Malignant cells	GSE189460_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63733
3.34205551248767e-60	-0.288306446963564	0.76	0.732	8.12052648424254e-56	CTSS	Malignant cells	GSE189460_pre	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63734
2.94462878968274e-38	-0.258369153095015	0.995	0.99	7.15485903317112e-34	RPL12	Malignant cells	GSE189460_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63735
6.69455714536942e-34	0.251963985425087	0.645	0.64	1.62664349518186e-29	PDIA4	Malignant cells	GSE189460_pre	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63736
2.92138735273984e-32	-0.440782062103461	0.979	0.968	7.09838698968726e-28	RPS2	Malignant cells	GSE189460_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63737
1.42175586360523e-31	-0.440951399113476	0.222	0.264	3.45458239738799e-27	ITGB7	Malignant cells	GSE189460_pre	ENSG00000139626	3695	integrin subunit beta 7	NA	protein_coding	P26010	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63738
8.48427447827634e-30	-0.276697667526244	0.999	0.998	2.06150901273159e-25	RPL18	Malignant cells	GSE189460_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63739
3.69304369205198e-25	-0.257639017814173	0.995	0.995	8.97335756294791e-21	RPS15A	Malignant cells	GSE189460_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63740
1.53715219055794e-24	-0.649949478727972	0.293	0.286	3.73497239261769e-20	NSD2	Malignant cells	GSE189460_pre	ENSG00000109685	7468	nuclear receptor binding SET domain protein 2	KMT3G|MMSET|WHSC1	protein_coding	O96028	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63741
9.15250685398206e-23	-0.610826231143489	0.999	0.984	2.22387611538056e-18	RPL18A	Malignant cells	GSE189460_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63742
2.84859452511091e-21	-0.458637791776418	0.999	0.999	6.92151497711449e-17	RPS15	Malignant cells	GSE189460_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63743
3.6087670218023e-19	-0.428666608656066	1	0.998	8.76858210957523e-15	RPL8	Malignant cells	GSE189460_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63744
1.11962610416841e-18	-0.255837799865484	0.996	0.995	2.72046750790841e-14	RPS28	Malignant cells	GSE189460_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63745
1.57864694249577e-12	0.261536689615457	0.57	0.611	3.83579634087622e-08	CRELD2	Malignant cells	GSE189460_pre	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63746
5.4159423198311e-11	-0.272692671420349	0.356	0.359	1.31596566487256e-06	ATF5	Malignant cells	GSE189460_pre	ENSG00000169136	22809	activating transcription factor 5	NA	protein_coding	Q9Y2D1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63747
3.15843173400404e-09	0.359518718947034	0.479	0.491	7.67435742728301e-05	CITED2	Malignant cells	GSE189460_pre	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63748
1.35266905343127e-08	-0.425539230584682	0.994	0.996	0.000328671526602731	RPS23	Malignant cells	GSE189460_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63749
1.53658074302275e-57	2.50986810173417	0.297	0.05	3.73358388939668e-53	IGLL5	B cells	GSE189460_pre	ENSG00000254709	100423062	immunoglobulin lambda like polypeptide 5	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63750
5.48143329982195e-41	-1.34895577382001	0.709	0.89	1.33187866319074e-36	IGLC2	B cells	GSE189460_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63751
1.49634587926651e-27	-0.457319697002021	1	1	3.63582121744176e-23	MT-ND3	B cells	GSE189460_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63752
7.06935081406143e-22	0.57838856061351	0.376	0.166	1.71771086080065e-17	HLA-DQA2	B cells	GSE189460_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63753
5.04319487899807e-21	0.687105423763418	0.624	0.366	1.22539549169895e-16	IGHG1	B cells	GSE189460_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63754
7.01585336988442e-21	0.684449520380032	0.968	0.91	1.70471205181452e-16	TXNIP	B cells	GSE189460_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63755
1.89925257732568e-20	0.786841849252112	0.526	0.316	4.61480391238595e-16	IGHG3	B cells	GSE189460_pre	ENSG00000282184	NA	NA	NA	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63756
1.94510039186154e-19	-0.48425986452614	0.471	0.244	4.72620493214517e-15	IGHG4	B cells	GSE189460_pre	ENSG00000277016	NA	NA	NA	IG_C_gene	P01861	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63757
3.31239314387655e-18	-0.401442064290408	0.938	0.984	8.04845286099124e-14	RPS10	B cells	GSE189460_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63758
5.20856827400488e-18	0.396296424504047	0.994	0.988	1.26557791921771e-13	HLA-C	B cells	GSE189460_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63759
7.57183464158481e-18	0.335391285289107	0.274	0.105	1.83980438121228e-13	AIM2	B cells	GSE189460_pre	ENSG00000163568	9447	absent in melanoma 2	PYHIN4	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63760
1.60950817355757e-17	0.58029900086802	0.985	0.945	3.91078296011019e-13	JUN	B cells	GSE189460_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63761
4.98219865894958e-17	-0.614767557114436	0.094	0.314	1.21057463015157e-12	HBA2	B cells	GSE189460_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63762
1.59391804459111e-16	0.604427562270043	0.962	0.913	3.87290206474747e-12	NEAT1	B cells	GSE189460_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63763
2.74547153558791e-16	-0.565110982356865	0.082	0.292	6.67094673717151e-12	HBA1	B cells	GSE189460_pre	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63764
1.33674744267012e-14	0.590204377831449	0.906	0.886	3.24802893619986e-10	IGKC	B cells	GSE189460_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63765
5.45405569107435e-14	-0.907151759609922	0.503	0.645	1.32522645181725e-09	HBB	B cells	GSE189460_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63766
1.33759004092517e-13	0.542803064625511	0.918	0.869	3.25007628143999e-09	SSR4	B cells	GSE189460_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63767
2.0400531608895e-13	-0.265878745945648	1	1	4.9569211703293e-09	RPL14	B cells	GSE189460_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63768
4.60877148936888e-13	0.288157517070947	0.362	0.186	1.11983929648685e-08	S100A11	B cells	GSE189460_pre	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63769
1.34137339908931e-11	0.418883410287714	0.991	0.94	3.25926908510719e-07	TSC22D3	B cells	GSE189460_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63770
3.85001069648561e-11	0.461857393249575	0.956	0.931	9.35475599032074e-07	KLF6	B cells	GSE189460_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63771
5.79503889588652e-11	-0.292963638358167	0.291	0.479	1.40807855092251e-06	FAM129C	B cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63772
6.01523815604304e-11	0.26833783258535	0.791	0.642	1.46158256715534e-06	MCL1	B cells	GSE189460_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63773
1.12707424226832e-10	0.352649122728392	0.368	0.214	2.73856499386357e-06	RHOB	B cells	GSE189460_pre	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63774
1.5900964970007e-10	0.368443281705178	0.915	0.885	3.86361646841229e-06	LAPTM5	B cells	GSE189460_pre	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63775
1.64538309613037e-10	-0.517539389132655	0.559	0.717	3.99795184697757e-06	LTB	B cells	GSE189460_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63776
2.01254338256952e-10	-0.298455528827398	1	0.998	4.89007791096743e-06	RPS21	B cells	GSE189460_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63777
2.33003098068552e-10	0.30692162319578	0.994	0.975	5.66150927686967e-06	CYBA	B cells	GSE189460_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63778
2.46624878075667e-10	0.383526048673881	0.968	0.889	5.99249128748255e-06	KLF2	B cells	GSE189460_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63779
2.92556452689227e-10	-0.380559772666296	0.4	0.594	7.10853668744283e-06	BCL11A	B cells	GSE189460_pre	ENSG00000119866	53335	BAF chromatin remodeling complex subunit BCL11A	BCL11A-L|BCL11A-S|BCL11A-XL|CTIP1|EVI9|HBFQTL5|SMARCM1|ZNF856	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63780
3.40002885063e-10	0.34193404720353	0.603	0.437	8.26139010126076e-06	CDV3	B cells	GSE189460_pre	ENSG00000091527	55573	CDV3 homolog	H41	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63781
5.74383513516036e-10	0.430018431010283	0.588	0.413	1.39563706114126e-05	S100A10	B cells	GSE189460_pre	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63782
6.73540366261536e-10	-0.252367383244149	1	1	1.63656838194228e-05	RPL37	B cells	GSE189460_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63783
1.1558644292522e-09	0.306033883982339	0.374	0.225	2.808519390197e-05	SH3BP5	B cells	GSE189460_pre	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63784
1.21254537813629e-09	-0.557196629425292	0.388	0.553	2.94624275979556e-05	VPREB3	B cells	GSE189460_pre	ENSG00000128218	29802	V-set pre-B cell surrogate light chain 3	8HS20	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63785
1.49704287162145e-09	0.368321000371813	0.759	0.579	3.6375147694658e-05	ISG20	B cells	GSE189460_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63786
1.79926922117638e-09	0.275103357162439	0.726	0.545	4.37186435361436e-05	RNASET2	B cells	GSE189460_pre	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63787
3.42729318785246e-09	0.284194038987196	0.3	0.171	8.3276369878439e-05	CSTB	B cells	GSE189460_pre	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63788
7.9030962695017e-09	-0.309988654019631	0.521	0.707	0.000192029433156352	FOXP1	B cells	GSE189460_pre	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63789
2.36726906761818e-08	0.271009177675759	0.618	0.475	0.000575199038049865	SEC11C	B cells	GSE189460_pre	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63790
4.81923972940176e-08	0.366011713484273	0.541	0.403	0.00117097886945004	COTL1	B cells	GSE189460_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63791
6.93886334439006e-08	-0.304474626224342	0.747	0.846	0.0016860050154199	HNRNPH1	B cells	GSE189460_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63792
7.52135080825608e-08	0.340803571824733	0.256	0.144	0.00182753781939006	HCST	B cells	GSE189460_pre	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63793
1.13347599157594e-07	0.27548667406194	0.844	0.727	0.00275411996433121	SEPT7	B cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63794
1.43279558835447e-07	-0.41847028319498	0.903	0.92	0.00348140672058368	HLA-DRB1	B cells	GSE189460_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63795
2.03255324418426e-07	0.258595377975336	0.915	0.85	0.00493869787271891	NFKBIA	B cells	GSE189460_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63796
3.92756911856397e-07	0.310578482570059	0.632	0.504	0.00954320744428672	SMAP2	B cells	GSE189460_pre	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63797
6.26996238455868e-07	0.301905494032376	0.85	0.763	0.0152347546020007	HERPUD1	B cells	GSE189460_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63798
6.89891866754334e-07	0.271726504308198	1	1	0.0167629925783968	TMSB4X	B cells	GSE189460_pre	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63799
9.86646289027655e-07	0.263059098014391	0.994	0.993	0.023973531530794	RPS20	B cells	GSE189460_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63800
1.0360795196653e-06	0.25649926401686	0.379	0.255	0.0251746601688273	MTSS1	B cells	GSE189460_pre	ENSG00000170873	9788	MTSS I-BAR domain containing 1	KIAA0429|MIM|MIMA|MIMB	protein_coding	O43312	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63801
1.64527446939438e-06	-0.473747755313841	0.597	0.671	0.0399768790573446	IGHA1	B cells	GSE189460_pre	ENSG00000282633	NA	NA	AL928768.3	IG_C_gene	P01876	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63802
1.99903728440822e-06	0.472039327685347	0.529	0.442	0.048572607936551	CIB1	B cells	GSE189460_pre	ENSG00000185043	10519	calcium and integrin binding 1	CIB|KIP|SIP2-28	protein_coding	Q99828	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63803
0	2.27642270173061	0.543	0.103	0	IGHD	CD8+ T cells	GSE189460_pre	ENSG00000278801	NA	NA	FLJ00382|FLJ46727|MGC29633	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63804
0	3.79098513650083	0.533	0.001	0	IGLL5	CD8+ T cells	GSE189460_pre	ENSG00000254709	100423062	immunoglobulin lambda like polypeptide 5	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63805
2.03526397117985e-262	-2.64593510451827	0.515	0.766	4.9452843971728e-258	IGLC2	CD8+ T cells	GSE189460_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63806
2.16025432563062e-251	0.941922562305914	0.981	0.935	5.24898596041728e-247	SSR4	CD8+ T cells	GSE189460_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63807
3.04028489258562e-224	-0.674672975017235	1	1	7.38728423200455e-220	MT-ND3	CD8+ T cells	GSE189460_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63808
3.57394942791082e-195	-0.420655585854745	1	1	8.68398231993771e-191	RPL41	CD8+ T cells	GSE189460_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63809
1.36775511914976e-182	1.02461411423613	0.389	0.11	3.32337138851009e-178	GZMB	CD8+ T cells	GSE189460_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63810
2.3147763666519e-137	-0.953383172026475	0.533	0.753	5.62444361569078e-133	NR4A2	CD8+ T cells	GSE189460_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63811
8.39333998981375e-129	0.664960348187993	0.509	0.239	2.03941375072494e-124	GIMAP4	CD8+ T cells	GSE189460_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63812
2.23801574645477e-121	0.976840573846914	0.301	0.095	5.43793066073581e-117	FGFBP2	CD8+ T cells	GSE189460_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63813
9.50262630111966e-121	-0.570425692866265	0.998	1	2.30894813864606e-116	JUND	CD8+ T cells	GSE189460_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63814
5.97891154928813e-118	0.650066561076949	0.49	0.236	1.45275592824603e-113	GIMAP7	CD8+ T cells	GSE189460_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63815
2.26601610088913e-115	-0.544573841239859	0.87	0.953	5.50596592194041e-111	RPS10	CD8+ T cells	GSE189460_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63816
9.98879150833353e-112	-0.33397554679999	1	1	2.42707656069488e-107	RPL32	CD8+ T cells	GSE189460_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63817
4.3693401951626e-106	-0.589775374896256	0.925	0.969	1.06166228062061e-101	CXCR4	CD8+ T cells	GSE189460_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63818
1.97000231598795e-103	0.780417063234608	0.621	0.373	4.78671162738753e-99	GZMH	CD8+ T cells	GSE189460_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63819
2.70390380912123e-103	-0.413994867145878	1	1	6.56994547540276e-99	RPS27	CD8+ T cells	GSE189460_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63820
4.90964116614854e-99	0.584279145782279	0.734	0.546	1.19294461055077e-94	PSMB9	CD8+ T cells	GSE189460_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63821
1.01894705283559e-96	0.551012116984589	0.453	0.218	2.47583754897991e-92	HIST1H1C	CD8+ T cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63822
5.1737664726427e-95	-0.354995193538415	1	1	1.25712177752272e-90	RPL34	CD8+ T cells	GSE189460_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63823
6.82417920545879e-94	-0.433124417079192	0.996	0.997	1.65813906334238e-89	RPS21	CD8+ T cells	GSE189460_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63824
3.60598442913163e-92	-0.345340658692389	1	1	8.76182096590402e-88	RPS28	CD8+ T cells	GSE189460_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63825
3.92297733419775e-90	-0.59431658291075	0.725	0.867	9.53205032663368e-86	YPEL5	CD8+ T cells	GSE189460_pre	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63826
1.89683579375907e-89	-0.35918482446207	1	1	4.60893161167578e-85	RPS29	CD8+ T cells	GSE189460_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63827
3.65760319347141e-88	-0.37865637264871	1	1	8.88724423949682e-84	RPL39	CD8+ T cells	GSE189460_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63828
1.23801757498994e-86	-0.274392685794329	1	1	3.00813510371055e-82	RPS15A	CD8+ T cells	GSE189460_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63829
3.17838237482774e-86	-0.411218191877754	0.996	1	7.72283349435645e-82	FTH1	CD8+ T cells	GSE189460_pre	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63830
3.83523640465989e-86	-0.633722139757136	0.229	0.497	9.31885741604261e-82	RPS4Y1	CD8+ T cells	GSE189460_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63831
1.83641150960774e-85	-0.53886821528582	0.742	0.865	4.4621126860449e-81	HNRNPH1	CD8+ T cells	GSE189460_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63832
8.04510171894402e-81	0.465405844913661	0.674	0.44	1.95479881566902e-76	DYNLL1	CD8+ T cells	GSE189460_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63833
5.3596728774729e-79	-0.331053866337679	1	1	1.30229331576837e-74	RPL37	CD8+ T cells	GSE189460_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63834
7.22554822319319e-76	-0.697051265343174	0.337	0.543	1.75566370727148e-71	ZNF331	CD8+ T cells	GSE189460_pre	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63835
1.20002374482986e-74	0.526170541327807	0.592	0.387	2.91581769518759e-70	KIAA1551	CD8+ T cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63836
4.67813006949491e-74	0.634944443508132	0.953	0.884	1.13669204428587e-69	TXNIP	CD8+ T cells	GSE189460_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63837
1.17832431800335e-73	0.429592571358806	0.976	0.951	2.86309242788454e-69	CCL5	CD8+ T cells	GSE189460_pre	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63838
6.29494646862675e-73	-0.28090176898832	1	1	1.52954609294693e-68	RPL9	CD8+ T cells	GSE189460_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63839
2.36347770896831e-71	0.384230454460681	0.308	0.132	5.7427781372512e-67	HLA-DRB5	CD8+ T cells	GSE189460_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63840
1.00106287458113e-69	0.582340415756522	0.905	0.844	2.43238257265722e-65	NKG7	CD8+ T cells	GSE189460_pre	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63841
3.9742462907934e-68	-0.470325495384231	0.815	0.893	9.6566236373698e-64	ZFP36	CD8+ T cells	GSE189460_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63842
2.07198357207017e-67	-0.384586287975289	0.937	0.978	5.03450568341611e-63	PABPC1	CD8+ T cells	GSE189460_pre	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63843
4.29853760894386e-67	-0.594521436489893	0.969	0.986	1.04445866822118e-62	FOS	CD8+ T cells	GSE189460_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63844
4.44838887774137e-67	-0.281933981568649	0.999	1	1.0808695295136e-62	RPL35A	CD8+ T cells	GSE189460_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63845
9.67863481367729e-67	-0.286948875820242	1	1	2.35171468702731e-62	RPL14	CD8+ T cells	GSE189460_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63846
1.10398707869123e-65	0.518065788424687	0.306	0.14	2.68246780380395e-61	CLIC3	CD8+ T cells	GSE189460_pre	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63847
4.42600070024959e-64	-0.573825027392555	0.167	0.367	1.07542965014665e-59	KDM6B	CD8+ T cells	GSE189460_pre	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63848
4.72838844041249e-64	-0.429542077483986	0.687	0.876	1.14890382325143e-59	GZMK	CD8+ T cells	GSE189460_pre	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63849
1.72964887508134e-63	0.500152079787078	0.436	0.253	4.20270083667264e-59	GBP5	CD8+ T cells	GSE189460_pre	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63850
2.38313595737818e-63	-0.269099307543041	1	1	5.79054374923749e-59	RPL12	CD8+ T cells	GSE189460_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63851
1.30647392240659e-61	-0.610233372725613	0.385	0.567	3.17447033666354e-57	MYADM	CD8+ T cells	GSE189460_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63852
4.28587060986641e-60	0.362745678750312	0.923	0.809	1.04138084078534e-55	CLIC1	CD8+ T cells	GSE189460_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63853
4.86007750192343e-60	0.443327418474952	0.554	0.372	1.18090163141735e-55	PSMB8	CD8+ T cells	GSE189460_pre	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63854
7.02520121032835e-60	0.381103507952382	0.263	0.114	1.70698339008558e-55	GBP1	CD8+ T cells	GSE189460_pre	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63855
3.22441753464706e-59	0.325426394237448	1	1	7.83468972568542e-55	RPL13A	CD8+ T cells	GSE189460_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63856
3.61494932766461e-59	-0.254776855084352	1	1	8.78360387635947e-55	RPS25	CD8+ T cells	GSE189460_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63857
2.43141973157378e-58	0.384118123080586	0.414	0.231	5.90786366377797e-54	ZBTB38	CD8+ T cells	GSE189460_pre	ENSG00000177311	253461	zinc finger and BTB domain containing 38	CIBZ|FLJ35036|PPP1R171|ZNF921	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63858
6.94543945549e-57	-0.476386308173856	0.984	0.989	1.68760287889496e-52	JUNB	CD8+ T cells	GSE189460_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63859
3.64758610325824e-55	0.41253097318856	0.727	0.603	8.86290471369688e-51	RARRES3	CD8+ T cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63860
5.38027648600556e-55	0.367575213188254	0.891	0.817	1.30729958056963e-50	PPIB	CD8+ T cells	GSE189460_pre	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63861
2.29413271966943e-54	0.39287517850491	0.504	0.323	5.57428368225279e-50	BTN3A2	CD8+ T cells	GSE189460_pre	ENSG00000186470	11118	butyrophilin subfamily 3 member A2	BTN3.2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63862
1.24027526224087e-52	0.354018329869259	0.594	0.456	3.01362083219286e-48	MZB1	CD8+ T cells	GSE189460_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63863
5.04273135275737e-52	0.463209761244141	0.589	0.421	1.22528286409299e-47	MTRNR2L12	CD8+ T cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63864
6.00429341850956e-51	-0.42367162005714	0.331	0.51	1.45892321482945e-46	RBM38	CD8+ T cells	GSE189460_pre	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63865
6.85864212018128e-51	-0.411884768640065	0.149	0.332	1.66651286236165e-46	DDX3Y	CD8+ T cells	GSE189460_pre	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63866
1.58140999179889e-50	0.345076951760924	0.449	0.271	3.84250999807295e-46	PYHIN1	CD8+ T cells	GSE189460_pre	ENSG00000163564	149628	pyrin and HIN domain family member 1	IFIX|MGC23885	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63867
1.87253790303248e-50	-0.327848159377992	0.874	0.935	4.54989259678832e-46	SARAF	CD8+ T cells	GSE189460_pre	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63868
2.58641271191845e-50	0.44169816676961	0.425	0.25	6.28446560741945e-46	IFNG	CD8+ T cells	GSE189460_pre	ENSG00000111537	3458	interferon gamma	NA	protein_coding	P01579	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63869
4.49786251484174e-50	0.392894491220998	0.392	0.222	1.09289063385625e-45	HLA-DQB1	CD8+ T cells	GSE189460_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63870
5.41075546860688e-50	-0.370779955301971	0.399	0.606	1.3147053637621e-45	CTSW	CD8+ T cells	GSE189460_pre	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63871
1.31608840115073e-49	0.512267773940424	0.775	0.639	3.19783159711604e-45	CD52	CD8+ T cells	GSE189460_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63872
1.64603523728377e-49	0.341805179710813	0.789	0.626	3.99953641955211e-45	PSMA7	CD8+ T cells	GSE189460_pre	ENSG00000101182	5688	proteasome 20S subunit alpha 7	C6|HSPC|RC6-1|XAPC7	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63873
8.91380263447295e-49	-0.418273934619896	0.363	0.531	2.16587576412424e-44	SPOCK2	CD8+ T cells	GSE189460_pre	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63874
9.59922352169939e-49	0.429393671882219	0.389	0.217	2.33241933130252e-44	XIST	CD8+ T cells	GSE189460_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63875
1.00797256552231e-48	0.389070262555696	0.561	0.394	2.44917173970612e-44	PPP1CA	CD8+ T cells	GSE189460_pre	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63876
2.05963522130607e-47	0.319381900305608	0.681	0.486	5.00450166072948e-43	RPS27L	CD8+ T cells	GSE189460_pre	ENSG00000185088	51065	ribosomal protein S27 like	NA	protein_coding	Q71UM5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63877
2.08036326264837e-47	0.493554411359708	0.523	0.366	5.05486665558302e-43	PRF1	CD8+ T cells	GSE189460_pre	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63878
2.55794863096308e-47	0.251735272778776	1	1	6.2153035835141e-43	RPS4X	CD8+ T cells	GSE189460_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63879
3.13390143858127e-47	0.428485516869869	0.715	0.595	7.61475371546478e-43	CD2	CD8+ T cells	GSE189460_pre	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63880
3.6778512681682e-47	0.314546406080143	0.986	0.977	8.9364430113951e-43	SH3BGRL3	CD8+ T cells	GSE189460_pre	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63881
4.67769172424306e-47	0.380347062493357	0.728	0.59	1.13658553515658e-42	HLA-DPB1	CD8+ T cells	GSE189460_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63882
2.97738127929305e-46	-0.277771840573492	1	1	7.23444103242624e-42	RPL37A	CD8+ T cells	GSE189460_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63883
5.25544017081101e-46	0.464156273535157	0.401	0.253	1.27696685270366e-41	STAT1	CD8+ T cells	GSE189460_pre	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63884
9.39363440774106e-46	0.296280976885424	0.762	0.59	2.28246528839292e-41	ISG20	CD8+ T cells	GSE189460_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63885
3.97911342869437e-45	0.337412428485737	0.377	0.221	9.66844980904159e-41	MANF	CD8+ T cells	GSE189460_pre	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63886
3.00545691367593e-44	0.31599723623818	0.302	0.161	7.30265920884979e-40	PTPN6	CD8+ T cells	GSE189460_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63887
1.25863226488919e-43	-0.456254594072694	0.267	0.426	3.05822467722776e-39	CREM	CD8+ T cells	GSE189460_pre	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63888
2.16013277380644e-43	0.363675778871726	0.988	0.976	5.2486906137949e-39	ACTG1	CD8+ T cells	GSE189460_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63889
7.79391342821521e-43	-0.393226560200392	0.35	0.509	1.89376508478773e-38	PPP1CB	CD8+ T cells	GSE189460_pre	ENSG00000213639	5500	protein phosphatase 1 catalytic subunit beta	MP|PP-1B|PP1B|PP1beta|PP1c|PPP1beta	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63890
1.51184616829369e-42	0.335549490029439	0.491	0.331	3.67348381972001e-38	TRAF3IP3	CD8+ T cells	GSE189460_pre	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63891
1.50855055587074e-41	-0.359945650786483	0.602	0.717	3.66547614065471e-37	SELENOK	CD8+ T cells	GSE189460_pre	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63892
3.22510169966575e-41	-0.380092509257763	0.973	0.988	7.83635210984783e-37	DUSP1	CD8+ T cells	GSE189460_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63893
3.34134781663539e-41	0.378107887185215	0.57	0.426	8.11880692486067e-37	CAP1	CD8+ T cells	GSE189460_pre	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63894
3.98727987525869e-41	0.410286450609465	0.724	0.572	9.68829264090356e-37	CCL4	CD8+ T cells	GSE189460_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63895
7.34929206975563e-41	-0.336295799270923	0.981	0.986	1.78573098710922e-36	SRGN	CD8+ T cells	GSE189460_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63896
2.54694925134077e-40	-0.528789681422894	0.142	0.291	6.1885772909078e-36	LMNA	CD8+ T cells	GSE189460_pre	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63897
3.52431174072133e-40	0.338217066055711	0.64	0.492	8.56337266760468e-36	ARL6IP5	CD8+ T cells	GSE189460_pre	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63898
1.32528537913039e-39	0.26108942716846	0.258	0.132	3.22017841421101e-35	GBP4	CD8+ T cells	GSE189460_pre	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63899
3.71525185164043e-39	-0.388973624826209	0.341	0.5	9.02731894911591e-35	AC058791.1	CD8+ T cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63900
7.6990822832999e-39	-0.333165632218653	0.148	0.293	1.87072301319621e-34	FOSL2	CD8+ T cells	GSE189460_pre	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63901
1.05019033274413e-38	0.29983139016144	0.911	0.837	2.55175247050168e-34	HSPA8	CD8+ T cells	GSE189460_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63902
1.0575713992775e-38	0.369733244472665	0.456	0.311	2.56968698596447e-34	UCP2	CD8+ T cells	GSE189460_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63903
3.74883255595743e-38	0.477095274938049	0.54	0.406	9.10891334446537e-34	KLRD1	CD8+ T cells	GSE189460_pre	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63904
3.86355250682801e-38	0.362482479817016	0.519	0.373	9.38765988109069e-34	IKZF3	CD8+ T cells	GSE189460_pre	ENSG00000161405	22806	IKAROS family zinc finger 3	Aiolos|ZNFN1A3	protein_coding	Q9UKT9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63905
9.77186858134966e-38	0.316744945614436	0.598	0.442	2.37436862789634e-33	CFLAR	CD8+ T cells	GSE189460_pre	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63906
1.73267088508424e-37	-0.513240393810654	0.253	0.404	4.21004371657769e-33	RGCC	CD8+ T cells	GSE189460_pre	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63907
2.76858216247862e-37	-0.328519712214861	0.167	0.314	6.72710093839055e-33	PER1	CD8+ T cells	GSE189460_pre	ENSG00000179094	5187	period circadian regulator 1	PER|RIGUI	protein_coding	O15534	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63908
4.28431966489147e-37	0.273724266761407	0.535	0.372	1.04100399217533e-32	COX5A	CD8+ T cells	GSE189460_pre	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63909
4.50648091455066e-36	-0.34294133316751	0.561	0.689	1.09498473261752e-31	PDCD4	CD8+ T cells	GSE189460_pre	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63910
7.7038238160092e-36	0.302201924890519	0.791	0.69	1.87187511081391e-31	RAC2	CD8+ T cells	GSE189460_pre	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63911
7.96972434063827e-36	0.382866670692427	0.442	0.302	1.93648362028829e-31	HOPX	CD8+ T cells	GSE189460_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63912
1.22340207597921e-35	0.284985612703595	0.325	0.193	2.97262236421429e-31	PSMB4	CD8+ T cells	GSE189460_pre	ENSG00000159377	5692	proteasome 20S subunit beta 4	HN3|PROS26	protein_coding	P28070	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63913
1.24849291514641e-35	0.316550680928232	0.725	0.584	3.03358808522274e-31	PSME2	CD8+ T cells	GSE189460_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63914
1.32397116415346e-35	0.282006533793061	0.604	0.444	3.21698513466009e-31	PDIA6	CD8+ T cells	GSE189460_pre	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63915
1.48051652041089e-35	0.301926359487263	0.427	0.284	3.59735904129439e-31	SLC9A3R1	CD8+ T cells	GSE189460_pre	ENSG00000109062	9368	SLC9A3 regulator 1	EBP50|NHERF|NHERF1	protein_coding	O14745	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63916
3.81764194771147e-35	0.29170585528564	0.394	0.251	9.27610640454933e-31	PSMA5	CD8+ T cells	GSE189460_pre	ENSG00000143106	5686	proteasome 20S subunit alpha 5	ZETA	protein_coding	P28066	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63917
4.6093146098388e-35	-0.351000415010914	0.552	0.673	1.11997126389863e-30	TGFB1	CD8+ T cells	GSE189460_pre	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63918
8.49636906745092e-35	0.307860945663321	0.663	0.512	2.06444775600923e-30	PARK7	CD8+ T cells	GSE189460_pre	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63919
9.03757301651578e-35	-0.322113441271032	0.593	0.707	2.195949491553e-30	STK17B	CD8+ T cells	GSE189460_pre	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63920
2.10624347929868e-34	0.283150840666752	0.312	0.184	5.11775040599994e-30	EIF2S2	CD8+ T cells	GSE189460_pre	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63921
3.28753629501069e-33	0.257608968348643	0.279	0.16	7.98805568961698e-29	GBP2	CD8+ T cells	GSE189460_pre	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63922
3.656682284894e-33	0.267680398939435	0.521	0.365	8.88500661583545e-29	APOBEC3G	CD8+ T cells	GSE189460_pre	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63923
4.37579347599911e-33	-0.39779144140141	0.917	0.95	1.06323029879826e-28	FOSB	CD8+ T cells	GSE189460_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63924
4.60160375956862e-33	0.292855934335516	0.362	0.227	1.11809768149998e-28	PLEK	CD8+ T cells	GSE189460_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63925
5.99437891334238e-33	-0.354367508705188	0.403	0.539	1.45651418836393e-28	ITM2A	CD8+ T cells	GSE189460_pre	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63926
8.3587461833822e-33	-0.381281876404818	0.614	0.704	2.03100814763821e-28	IDS	CD8+ T cells	GSE189460_pre	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63927
9.2752505190333e-33	-0.322082918305513	0.441	0.573	2.25370037111471e-28	DNAJB6	CD8+ T cells	GSE189460_pre	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63928
1.03741777272291e-32	-0.380949678663922	0.473	0.589	2.52071770416213e-28	RNF125	CD8+ T cells	GSE189460_pre	ENSG00000101695	54941	ring finger protein 125	FLJ20456	protein_coding	Q96EQ8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63929
1.52375150544042e-32	-0.302118446436985	0.567	0.681	3.70241140791912e-28	LEPROTL1	CD8+ T cells	GSE189460_pre	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63930
1.72103042592997e-32	0.26256023025714	0.31	0.185	4.18175972892465e-28	MRPL51	CD8+ T cells	GSE189460_pre	ENSG00000111639	51258	mitochondrial ribosomal protein L51	bMRP64|CDA09|HSPC241|MRP64	protein_coding	Q4U2R6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63931
4.62032680265919e-32	-0.341030678957032	0.749	0.802	1.12264700651013e-27	SRSF2	CD8+ T cells	GSE189460_pre	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63932
1.22054892864979e-31	-0.49180008765606	0.786	0.796	2.96568978683326e-27	TNFAIP3	CD8+ T cells	GSE189460_pre	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63933
2.4775964657178e-31	0.266138224065539	0.38	0.248	6.02006389240111e-27	TAP1	CD8+ T cells	GSE189460_pre	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63934
3.86167130692129e-31	0.252547373701308	0.457	0.316	9.38308894155735e-27	FKBP2	CD8+ T cells	GSE189460_pre	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63935
4.65184019535546e-31	-0.312137114656892	0.269	0.404	1.13030413066747e-26	TCF7	CD8+ T cells	GSE189460_pre	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63936
5.22391603674879e-31	-0.314153940046786	0.525	0.64	1.26930711860922e-26	ZFAS1	CD8+ T cells	GSE189460_pre	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63937
1.01457370144275e-30	-0.327729275749693	0.41	0.538	2.46521117976559e-26	SBDS	CD8+ T cells	GSE189460_pre	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63938
1.2937637718128e-30	-0.252561346898253	0.984	0.989	3.14358721275073e-26	RPL38	CD8+ T cells	GSE189460_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63939
1.87821017931062e-30	0.292643445766474	0.5	0.368	4.56367509368894e-26	HNRNPF	CD8+ T cells	GSE189460_pre	ENSG00000169813	3185	heterogeneous nuclear ribonucleoprotein F	HNRPF	protein_coding	P52597	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63940
2.31883060012904e-30	0.322540693825603	0.568	0.445	5.63429459219355e-26	ACTR3	CD8+ T cells	GSE189460_pre	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63941
1.16324685103567e-29	-0.50302509008652	0.303	0.436	2.82645719864646e-25	IL7R	CD8+ T cells	GSE189460_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63942
1.98618894359917e-29	0.250343250130209	0.846	0.77	4.82604189515726e-25	SEPT7	CD8+ T cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63943
2.45332554844798e-29	0.330035948925802	0.535	0.415	5.96109041761891e-25	MBP	CD8+ T cells	GSE189460_pre	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63944
2.7803730627553e-29	0.278038384808699	0.487	0.354	6.75575046788284e-25	IFI16	CD8+ T cells	GSE189460_pre	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63945
5.20633562129555e-29	-0.292214005325312	0.204	0.335	1.26503542926239e-24	CSRNP1	CD8+ T cells	GSE189460_pre	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63946
9.19325953391993e-29	-0.546449117206195	0.288	0.409	2.23377820155187e-24	AC020916.1	CD8+ T cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63947
2.91274683174401e-28	-0.300881332343733	0.63	0.723	7.07739225177159e-24	CD44	CD8+ T cells	GSE189460_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63948
8.84309069822778e-28	-0.299869086452321	0.239	0.368	2.14869417785539e-23	PDE4B	CD8+ T cells	GSE189460_pre	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63949
2.26732405965769e-27	-0.27825743747483	0.163	0.28	5.50914400015626e-23	P2RY8	CD8+ T cells	GSE189460_pre	ENSG00000182162	286530	P2Y receptor family member 8	P2Y8	protein_coding	Q86VZ1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63950
3.23731790243196e-27	-0.319781612158909	0.321	0.449	7.86603503932917e-23	TENT5C	CD8+ T cells	GSE189460_pre	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63951
9.65340707729379e-27	-0.276133229917741	0.548	0.651	2.34558485164084e-22	PPDPF	CD8+ T cells	GSE189460_pre	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63952
1.31378287835865e-26	-0.332862563644508	0.385	0.501	3.19222963783586e-22	REL	CD8+ T cells	GSE189460_pre	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63953
2.69313464760104e-26	0.328412449984842	0.991	0.98	6.543778566741e-22	NEAT1	CD8+ T cells	GSE189460_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63954
3.78749197239035e-26	-0.26255135622546	0.199	0.321	9.20284799451408e-22	JOSD1	CD8+ T cells	GSE189460_pre	ENSG00000100221	9929	Josephin domain containing 1	KIAA0063	protein_coding	Q15040	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63955
4.19932310192069e-26	-0.408020850003832	0.36	0.484	1.02035152730469e-21	LTB	CD8+ T cells	GSE189460_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63956
7.20701364245176e-26	-0.304829362259172	0.182	0.298	1.75116017484293e-21	IFNGR1	CD8+ T cells	GSE189460_pre	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63957
1.12635244959949e-25	0.265842205381519	0.749	0.674	2.73681118203685e-21	LCP1	CD8+ T cells	GSE189460_pre	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63958
1.67388952670466e-25	0.256709938018924	0.342	0.227	4.06721677198698e-21	IDH2	CD8+ T cells	GSE189460_pre	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63959
2.8566346236394e-25	-0.313615983751396	0.314	0.43	6.94105080851903e-21	RPL36A	CD8+ T cells	GSE189460_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63960
6.52154773050353e-25	0.273322454547107	0.47	0.352	1.58460566755775e-20	XRCC5	CD8+ T cells	GSE189460_pre	ENSG00000079246	7520	X-ray repair cross complementing 5	KARP-1|KU80|Ku86|KUB2	protein_coding	P13010	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63961
8.19074958478758e-25	0.280725274386907	0.449	0.327	1.99018833411169e-20	VMP1	CD8+ T cells	GSE189460_pre	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63962
1.33025649365571e-24	0.257348570628431	0.394	0.278	3.23225722828464e-20	PSMA4	CD8+ T cells	GSE189460_pre	ENSG00000041357	5685	proteasome 20S subunit alpha 4	HC9|HsT17706	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63963
2.12211683102073e-24	0.311685594162808	0.27	0.169	5.15631947601418e-20	FABP5	CD8+ T cells	GSE189460_pre	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63964
2.97005640003047e-24	0.283581436072831	0.481	0.364	7.21664304079403e-20	DEK	CD8+ T cells	GSE189460_pre	ENSG00000124795	7913	DEK proto-oncogene	D6S231E	protein_coding	P35659	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63965
6.33384218962837e-24	0.259227463367504	0.385	0.271	1.5389969752359e-19	CASP4	CD8+ T cells	GSE189460_pre	ENSG00000196954	837	caspase 4	ICE(rel)II|ICH-2|TX	protein_coding	P49662	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63966
2.04287081478949e-23	-0.31513972293928	0.65	0.728	4.96376750577549e-19	PIK3R1	CD8+ T cells	GSE189460_pre	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63967
5.29255390230941e-23	-0.428926995807047	0.57	0.639	1.28598474718314e-18	TUBA4A	CD8+ T cells	GSE189460_pre	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63968
6.33625540553034e-23	0.336993396473161	0.462	0.345	1.53958333843576e-18	HLA-DRA	CD8+ T cells	GSE189460_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63969
1.40371762720169e-22	-0.307960941551218	0.964	0.971	3.41075309057466e-18	ZFP36L2	CD8+ T cells	GSE189460_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63970
1.82239918564603e-22	-0.29181311800127	0.386	0.491	4.42806554128273e-18	FAM133B	CD8+ T cells	GSE189460_pre	ENSG00000234545	257415	family with sequence similarity 133 member B	MGC40405	protein_coding	Q5BKY9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63971
4.52098969519415e-22	-0.250936882826709	0.234	0.346	1.09851007613828e-17	TMEM123	CD8+ T cells	GSE189460_pre	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63972
5.61862307033498e-22	-0.289146818809386	0.848	0.904	1.36521303362999e-17	CD69	CD8+ T cells	GSE189460_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63973
4.5907892416558e-21	-0.506706339903358	0.318	0.42	1.11546996993753e-16	KLRB1	CD8+ T cells	GSE189460_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63974
1.05613315297059e-20	0.267614347005418	0.457	0.35	2.56619233508794e-16	SYNE1	CD8+ T cells	GSE189460_pre	ENSG00000131018	23345	spectrin repeat containing nuclear envelope protein 1	8B|ARCA1|C6orf98|CPG2|dJ45H2.2|enaptin|KIAA0796|MYNE1|Nesp1|Nesprin-1|SCAR8|SYNE-1B	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63975
1.2033743272093e-20	0.260070472675707	0.481	0.375	2.92395894025315e-16	ARPC5	CD8+ T cells	GSE189460_pre	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63976
2.20065638909328e-20	0.344343023482184	0.584	0.489	5.34715489421886e-16	COTL1	CD8+ T cells	GSE189460_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63977
2.73293495866127e-20	-0.266533861676472	0.205	0.308	6.64048536255515e-16	BHLHE40	CD8+ T cells	GSE189460_pre	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63978
3.83159575755004e-20	-0.386766297911149	0.21	0.31	9.31001137169509e-16	IFI6	CD8+ T cells	GSE189460_pre	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63979
1.27746223713939e-19	-0.26577422259421	0.264	0.367	3.1039777438013e-15	METRNL	CD8+ T cells	GSE189460_pre	ENSG00000275031	284207	meteorin like, glial cell differentiation regulator	NA	protein_coding	Q641Q3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63980
7.06223377640914e-19	-0.261981410091866	0.31	0.411	1.71598156299189e-14	SERTAD1	CD8+ T cells	GSE189460_pre	ENSG00000197019	29950	SERTA domain containing 1	SEI1|TRIP-Br1	protein_coding	Q9UHV2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63981
8.41956441753317e-19	0.257917247312013	0.538	0.44	2.04578576217221e-14	EFHD2	CD8+ T cells	GSE189460_pre	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63982
3.01364819314918e-18	-0.293784237591336	0.38	0.468	7.32256237971388e-14	MIDN	CD8+ T cells	GSE189460_pre	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63983
3.82200517315159e-17	-0.259203186109949	0.334	0.428	9.28670816972372e-13	JMJD1C	CD8+ T cells	GSE189460_pre	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63984
7.04105571555625e-17	-0.26387027792113	0.542	0.623	1.71083571776586e-12	DNAJB1	CD8+ T cells	GSE189460_pre	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63985
5.46037122171639e-16	-0.266851192183881	0.392	0.476	1.32676099945265e-11	IDI1	CD8+ T cells	GSE189460_pre	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63986
6.58342198496985e-16	0.253825617405439	0.491	0.41	1.59963987390797e-11	RIPOR2	CD8+ T cells	GSE189460_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63987
6.42155726386218e-15	-0.252904193465722	0.26	0.344	1.56030998397323e-10	PLK3	CD8+ T cells	GSE189460_pre	ENSG00000173846	1263	polo like kinase 3	CNK|FNK|PRK	protein_coding	Q9H4B4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63988
4.07641862971234e-13	0.268904674846239	0.514	0.437	9.90488198647505e-09	TRBC1	CD8+ T cells	GSE189460_pre	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63989
1.59318427563881e-12	-0.259326927999733	0.364	0.449	3.87111915294718e-08	TSPYL2	CD8+ T cells	GSE189460_pre	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63990
1.99238182600613e-12	-0.261718908305722	0.278	0.351	4.84108936082969e-08	MAP3K8	CD8+ T cells	GSE189460_pre	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63991
4.33242955125738e-12	-0.317284015448905	0.47	0.537	1.05269373236452e-07	IFRD1	CD8+ T cells	GSE189460_pre	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63992
6.69434449864776e-09	-0.284217179086976	0.916	0.94	0.000162659182628143	KLF2	CD8+ T cells	GSE189460_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63993
1.34983074983205e-248	1.13664905283403	0.717	0.309	3.27981875594191e-244	JCHAIN	CD4+ T cells	GSE189460_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63994
4.16770612924148e-157	0.460357708070145	0.606	0.257	1.0126692352831e-152	MZB1	CD4+ T cells	GSE189460_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63995
7.7782262273434e-108	-0.531501867284616	1	1	1.8899534087199e-103	MT-ND3	CD4+ T cells	GSE189460_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63996
5.38064884960535e-91	-0.355712729452669	1	1	1.30739005747711e-86	RPL37A	CD4+ T cells	GSE189460_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63997
3.20052311252454e-89	-0.338682724847438	1	1	7.77663105881213e-85	RPS29	CD4+ T cells	GSE189460_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63998
1.75298713500665e-82	-0.310249483904078	1	1	4.25940814063916e-78	RPL34	CD4+ T cells	GSE189460_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	63999
2.58287910033586e-78	-0.3220003034672	1	1	6.27587963799608e-74	RPL37	CD4+ T cells	GSE189460_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64000
4.10199150688561e-78	-0.281450385181652	1	1	9.96701896343064e-74	RPL14	CD4+ T cells	GSE189460_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64001
2.42238000817369e-60	0.381002760212916	1	0.996	5.88589894386043e-56	MT-ND5	CD4+ T cells	GSE189460_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64002
4.63254920275201e-60	0.5908398595126	0.912	0.812	1.12561680528468e-55	IGKC	CD4+ T cells	GSE189460_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64003
6.21117101147984e-59	0.514142656449769	0.987	0.958	1.50919033236937e-54	TXNIP	CD4+ T cells	GSE189460_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64004
3.41282073310352e-56	0.280949094190078	0.431	0.226	8.29247181729493e-52	FKBP2	CD4+ T cells	GSE189460_pre	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64005
1.98150120031886e-55	-2.03608222490968	0.501	0.585	4.81465161653476e-51	IGLC2	CD4+ T cells	GSE189460_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64006
5.6214182397944e-55	0.300468747799167	0.621	0.38	1.36589220390524e-50	SEC11C	CD4+ T cells	GSE189460_pre	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64007
1.27758715265338e-51	-0.301177125814412	1	1	3.10428126351718e-47	RPS27	CD4+ T cells	GSE189460_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64008
4.32161252821882e-48	0.281758586511862	0.537	0.321	1.05006541210661e-43	PDIA6	CD4+ T cells	GSE189460_pre	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64009
7.08867373527285e-46	0.332750129027486	0.578	0.361	1.7224059441966e-41	DYNLL1	CD4+ T cells	GSE189460_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64010
1.37892626590227e-45	-0.32921744591214	1	0.999	3.35051504088935e-41	RPS21	CD4+ T cells	GSE189460_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64011
1.44794084918056e-42	0.353169647725906	0.839	0.666	3.51820667533893e-38	PPIB	CD4+ T cells	GSE189460_pre	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64012
6.91468701941767e-42	0.328675983970417	0.785	0.561	1.6801306519781e-37	CLIC1	CD4+ T cells	GSE189460_pre	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64013
5.00734891631433e-41	-0.33026309616487	0.963	0.983	1.21668563968606e-36	RPS10	CD4+ T cells	GSE189460_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64014
2.46950158358861e-34	0.451288631487218	0.932	0.867	6.00039494780361e-30	SSR4	CD4+ T cells	GSE189460_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64015
1.23434735533557e-33	0.26056304560929	0.69	0.489	2.99921720399437e-29	HERPUD1	CD4+ T cells	GSE189460_pre	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64016
1.42260223996003e-30	0.252785678366348	0.621	0.439	3.45663892265488e-26	TXN	CD4+ T cells	GSE189460_pre	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64017
1.77378225997629e-29	0.29330094429302	0.567	0.383	4.30993613529039e-25	LGALS1	CD4+ T cells	GSE189460_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64018
2.14751262372433e-27	0.295620536442598	0.961	0.899	5.21802617312538e-23	KLF6	CD4+ T cells	GSE189460_pre	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64019
3.66621007618453e-27	0.452949108177615	0.408	0.279	8.90815724311318e-23	RGS1	CD4+ T cells	GSE189460_pre	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64020
2.19719543125794e-24	0.260818884981354	0.945	0.905	5.33874545887053e-20	CYBA	CD4+ T cells	GSE189460_pre	ENSG00000051523	1535	cytochrome b-245 alpha chain	p22-PHOX	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64021
3.54678790554004e-24	0.324035897950484	0.91	0.844	8.61798525288118e-20	NFKBIA	CD4+ T cells	GSE189460_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64022
2.11295649519247e-23	0.257346762362471	0.989	0.972	5.13406169201866e-19	TSC22D3	CD4+ T cells	GSE189460_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64023
2.96913937062834e-23	0.420309740159893	0.875	0.839	7.21441484275273e-19	IL32	CD4+ T cells	GSE189460_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64024
7.89894214932376e-22	0.265642706216591	0.984	0.961	1.91928496344269e-17	JUN	CD4+ T cells	GSE189460_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64025
4.28651623756659e-21	0.396012287961524	0.409	0.297	1.04153771540393e-16	XIST	CD4+ T cells	GSE189460_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64026
4.61083061760874e-21	0.282663517921297	0.382	0.273	1.12033962346657e-16	FKBP5	CD4+ T cells	GSE189460_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64027
1.05928319479702e-19	0.267692895496505	0.987	0.963	2.57384630671781e-15	ACTG1	CD4+ T cells	GSE189460_pre	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64028
8.53784333631644e-18	-0.259408933407252	0.324	0.437	2.07452517385817e-13	IFITM1	CD4+ T cells	GSE189460_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64029
4.49609845802537e-14	-0.264752941183419	0.301	0.401	1.092462003331e-09	ZNF331	CD4+ T cells	GSE189460_pre	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64030
1.32447513979842e-11	-0.25149564840629	0.458	0.544	3.2182096946822e-07	RPS4Y1	CD4+ T cells	GSE189460_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64031
2.53352730095634e-11	0.315086281714237	0.888	0.845	6.15596463586371e-07	S100A4	CD4+ T cells	GSE189460_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64032
2.4661071032511e-08	-0.290466731093334	0.473	0.531	0.000599214703947953	NR4A2	CD4+ T cells	GSE189460_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64033
2.1235033320193e-296	-2.66193867237748	0.299	0.651	5.15968839614049e-292	IGLC2	Mono/Macro	GSE189460_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64034
9.42701137046017e-198	0.736997997110555	0.566	0.276	2.29057522279441e-193	FKBP5	Mono/Macro	GSE189460_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64035
3.65893563351774e-162	0.585289652230871	0.686	0.376	8.89048180232141e-158	TMEM176B	Mono/Macro	GSE189460_pre	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64036
7.28367535336243e-138	0.41859776196265	0.326	0.112	1.76978743736e-133	HLA-DQA2	Mono/Macro	GSE189460_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64037
6.59624259483107e-137	1.04524342788183	0.449	0.2	1.60275502569205e-132	FCGR3A	Mono/Macro	GSE189460_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64038
5.06818148390722e-136	0.840911838045941	0.798	0.572	1.23146673695978e-131	IFITM3	Mono/Macro	GSE189460_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64039
8.4089023057689e-135	0.729018819841596	0.83	0.639	2.04319508225573e-130	CD52	Mono/Macro	GSE189460_pre	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64040
5.49451736286437e-130	-0.406272462710223	1	1	1.33505782882879e-125	RPL37	Mono/Macro	GSE189460_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64041
1.34580481754873e-129	0.565074789551246	0.973	0.87	3.2700365456799e-125	TSC22D3	Mono/Macro	GSE189460_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64042
3.90635095867485e-129	-0.494671399374295	0.424	0.631	9.49165155938814e-125	HBB	Mono/Macro	GSE189460_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64043
9.94740943594124e-129	0.547004294708575	0.999	0.994	2.417021544745e-124	MT-ND5	Mono/Macro	GSE189460_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64044
7.65963864762485e-125	-0.75336899539022	0.521	0.736	1.86113899859989e-120	SLC2A3	Mono/Macro	GSE189460_pre	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64045
8.50332151605211e-125	0.378826869208341	0.38	0.159	2.06613706197034e-120	C3AR1	Mono/Macro	GSE189460_pre	ENSG00000171860	719	complement C3a receptor 1	AZ3B|C3AR	protein_coding	Q16581	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64046
1.97538255010405e-124	0.593152114367597	0.749	0.537	4.79978452024281e-120	VAMP5	Mono/Macro	GSE189460_pre	ENSG00000168899	10791	vesicle associated membrane protein 5	NA	protein_coding	O95183	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64047
2.65551744305439e-123	-0.31915224612665	1	1	6.45237628313356e-119	RPL32	Mono/Macro	GSE189460_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64048
8.06225695300023e-118	-0.603161499704477	0.146	0.409	1.95896719444e-113	HBA2	Mono/Macro	GSE189460_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64049
1.10751401348687e-117	-0.601846545885653	0.13	0.39	2.6910375499704e-113	HBA1	Mono/Macro	GSE189460_pre	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64050
5.42406391680686e-117	0.634860300975626	0.92	0.799	1.31793905050573e-112	TXNIP	Mono/Macro	GSE189460_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64051
6.20822875519226e-116	1.31002922783575	0.471	0.264	1.50847542293662e-111	JCHAIN	Mono/Macro	GSE189460_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64052
3.35739640785899e-115	-0.319542161743652	1	1	8.15780179181576e-111	RPS15A	Mono/Macro	GSE189460_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64053
2.80827568268151e-114	0.523679768482807	0.389	0.176	6.82354825377953e-110	MS4A4A	Mono/Macro	GSE189460_pre	ENSG00000110079	51338	membrane spanning 4-domains A4A	CD20L1|MS4A4|MS4A7	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64054
1.59660488630434e-110	0.789341370415319	0.694	0.493	3.87943055274229e-106	MS4A7	Mono/Macro	GSE189460_pre	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64055
1.04386059102111e-109	0.36728915527657	0.457	0.226	2.53637246406309e-105	HSPA1A	Mono/Macro	GSE189460_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64056
3.22267084836106e-109	0.640267811815644	0.733	0.542	7.8304456273477e-105	MT2A	Mono/Macro	GSE189460_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64057
6.03915464725567e-108	0.489477527499375	0.898	0.815	1.46739379619018e-103	C1orf162	Mono/Macro	GSE189460_pre	ENSG00000143110	128346	chromosome 1 open reading frame 162	MGC24133	protein_coding	Q8NEQ5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64058
1.57089729186994e-104	0.556764831529089	0.647	0.43	3.81696623978557e-100	TNFSF10	Mono/Macro	GSE189460_pre	ENSG00000121858	8743	TNF superfamily member 10	Apo-2L|CD253|TL2|TRAIL	protein_coding	P50591	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64059
1.27727804856277e-103	0.420362211537631	0.503	0.276	3.10353020239783e-99	P2RY13	Mono/Macro	GSE189460_pre	ENSG00000181631	53829	purinergic receptor P2Y13	FKSG77|GPR86|GPR94|P2Y13	protein_coding	Q9BPV8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64060
6.40556961844431e-101	0.490289510921129	0.901	0.824	1.5564253058896e-96	FYB1	Mono/Macro	GSE189460_pre	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64061
1.82412934366663e-99	0.471668741341024	0.835	0.674	4.43226947924118e-95	HSPA8	Mono/Macro	GSE189460_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64062
3.21117403760052e-97	-0.314499419288222	1	1	7.80251067656174e-93	RPL34	Mono/Macro	GSE189460_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64063
1.82231697561959e-96	0.560202751529698	0.416	0.215	4.42786578736048e-92	GBP1	Mono/Macro	GSE189460_pre	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64064
1.44410977692869e-95	0.532347629926156	0.38	0.184	3.50889793598132e-91	MZB1	Mono/Macro	GSE189460_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64065
9.68421626112148e-95	0.466152654616724	0.783	0.611	2.3530708671273e-90	SMAP2	Mono/Macro	GSE189460_pre	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64066
1.29721307481693e-94	-0.374287914048802	0.999	1	3.15196832919019e-90	SRGN	Mono/Macro	GSE189460_pre	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64067
1.46256364797459e-93	0.27296731514336	1	1	3.55373715184867e-89	MT-ATP6	Mono/Macro	GSE189460_pre	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64068
1.4977505304886e-92	0.427412235846111	0.978	0.931	3.6392342389812e-88	HSP90AA1	Mono/Macro	GSE189460_pre	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64069
6.55956592216917e-91	0.765896282248122	0.803	0.687	1.59384332776867e-86	IFITM2	Mono/Macro	GSE189460_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64070
4.51893598530745e-88	0.350821548278596	0.5	0.276	1.09801106571e-83	TMEM176A	Mono/Macro	GSE189460_pre	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64071
7.54282192899776e-88	-0.943029215263235	0.464	0.635	1.83275487230788e-83	IER3	Mono/Macro	GSE189460_pre	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64072
6.98886503944477e-86	0.328653771566319	0.317	0.143	1.69815442728429e-81	GIMAP7	Mono/Macro	GSE189460_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64073
1.02803053207008e-85	0.703525275551817	0.713	0.508	2.49790858682387e-81	HLA-DRB5	Mono/Macro	GSE189460_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64074
3.2739348664764e-83	-0.486849822643979	0.929	0.966	7.95500693856437e-79	FOSB	Mono/Macro	GSE189460_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64075
3.11200016277227e-78	-0.510742657768072	0.666	0.783	7.56153799550405e-74	ATP2B1	Mono/Macro	GSE189460_pre	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64076
4.39647689484518e-78	-0.255420863874192	1	1	1.06825595590948e-73	RPL41	Mono/Macro	GSE189460_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64077
5.75990669790007e-77	-1.17589553128319	0.584	0.711	1.39954212945576e-72	CXCL8	Mono/Macro	GSE189460_pre	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64078
1.26128307986692e-76	-0.415929712251526	0.619	0.765	3.06466562746064e-72	LSP1	Mono/Macro	GSE189460_pre	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64079
2.17517239285886e-76	0.278184121934027	1	1	5.28523388016846e-72	MT-ND4	Mono/Macro	GSE189460_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64080
3.65964507674137e-76	0.269759679423664	1	1	8.89220560746619e-72	MT-CO1	Mono/Macro	GSE189460_pre	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64081
3.66752057338753e-76	0.399315044387154	0.33	0.162	8.91134148921703e-72	HIST1H1C	Mono/Macro	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64082
2.45260807284204e-75	0.388559558822033	0.489	0.293	5.9593470953916e-71	RRAS	Mono/Macro	GSE189460_pre	ENSG00000126458	6237	RAS related	R-Ras	protein_coding	P10301	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64083
1.26594664593111e-74	0.353097088870831	0.845	0.682	3.0759971602834e-70	DYNLL1	Mono/Macro	GSE189460_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64084
4.23042465161419e-74	0.403684928647375	0.836	0.699	1.02790858184922e-69	PSME2	Mono/Macro	GSE189460_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64085
6.43138839637153e-74	-0.402871998607927	0.966	0.984	1.56269875255036e-69	LGALS1	Mono/Macro	GSE189460_pre	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64086
2.96792758675299e-73	-0.289625482781379	1	1	7.21147045029241e-69	RPS12	Mono/Macro	GSE189460_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64087
1.89294067236095e-72	0.427267529559317	0.73	0.581	4.59946724570264e-68	PSMB9	Mono/Macro	GSE189460_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64088
5.12088313191382e-72	0.268851199694027	1	0.998	1.24427218339242e-67	HLA-A	Mono/Macro	GSE189460_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64089
5.64188047621084e-69	-0.433907158367793	0.363	0.557	1.37086411810971e-64	IVNS1ABP	Mono/Macro	GSE189460_pre	ENSG00000116679	10625	influenza virus NS1A binding protein	ARA3|HSPC068|KIAA0850|KLHL39|ND1|NS-1|NS1-BP	protein_coding	Q9Y6Y0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64090
4.0335884940184e-68	0.461883525446288	0.431	0.259	9.80081332276592e-64	SAP30	Mono/Macro	GSE189460_pre	ENSG00000164105	8819	Sin3A associated protein 30	NA	protein_coding	O75446	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64091
1.67132444030759e-66	0.40035924889937	0.625	0.45	4.06098412505938e-62	LAP3	Mono/Macro	GSE189460_pre	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64092
1.78953888439257e-66	0.288056323881985	0.999	0.997	4.34822158129706e-62	HLA-C	Mono/Macro	GSE189460_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64093
7.50979474870327e-65	0.602903600452603	0.907	0.868	1.82472992803992e-60	SSR4	Mono/Macro	GSE189460_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64094
1.77496442657002e-63	0.341168797242213	0.467	0.291	4.31280856367983e-59	RNF144B	Mono/Macro	GSE189460_pre	ENSG00000137393	255488	ring finger protein 144B	bA528A10.3|IBRDC2|P53RFP	protein_coding	Q7Z419	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64095
2.14033733476155e-62	-0.321849614579323	0.992	0.998	5.20059165600361e-58	GAPDH	Mono/Macro	GSE189460_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64096
7.26389005256809e-62	0.268841258115273	0.333	0.175	1.76498000497299e-57	ABI3	Mono/Macro	GSE189460_pre	ENSG00000108798	51225	ABI family member 3	NESH|SSH3BP3	protein_coding	Q9P2A4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64097
4.79193561837618e-61	0.262483363570234	0.997	0.995	1.16434451655304e-56	MYL6	Mono/Macro	GSE189460_pre	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64098
1.55967344834987e-60	0.404577542292934	0.876	0.804	3.78969454480053e-56	SERPINA1	Mono/Macro	GSE189460_pre	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64099
2.40097600022856e-60	-0.253420474800824	0.999	0.999	5.83389148535536e-56	RPL14	Mono/Macro	GSE189460_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64100
1.09353682392893e-59	0.36378612731345	0.983	0.97	2.6570757747825e-55	AIF1	Mono/Macro	GSE189460_pre	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64101
5.09652531134825e-59	0.365834585180448	0.54	0.369	1.2383537201514e-54	GIMAP4	Mono/Macro	GSE189460_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64102
7.02817034813757e-59	0.275373971078281	0.56	0.377	1.70770483119047e-54	UBE2L6	Mono/Macro	GSE189460_pre	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64103
1.19042731495455e-58	0.344157104121853	0.433	0.276	2.89250028987657e-54	FCGR1A	Mono/Macro	GSE189460_pre	ENSG00000150337	2209	Fc gamma receptor Ia	CD64|CD64A|FCG1|FcgammaRI|FcgammaRIa|FCGR1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64104
2.35773649097994e-58	0.304691130530703	0.262	0.126	5.72882812578306e-54	GBP5	Mono/Macro	GSE189460_pre	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64105
4.95330913437068e-58	0.343031875738483	0.642	0.473	1.20355505346939e-53	LRRC25	Mono/Macro	GSE189460_pre	ENSG00000175489	126364	leucine rich repeat containing 25	FLJ38116|MAPA	protein_coding	Q8N386	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64106
2.5424470645599e-57	-0.473892424965076	0.301	0.468	6.17763787746765e-53	BHLHE40	Mono/Macro	GSE189460_pre	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64107
5.63999493342508e-57	0.325554648608492	0.788	0.666	1.37040596892362e-52	CARD16	Mono/Macro	GSE189460_pre	ENSG00000204397	114769	caspase recruitment domain family member 16	COP|COP1|LLID-114769|PSEUDO-ICE	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64108
1.28689694449791e-56	-0.454670030333318	0.603	0.721	3.12690219574103e-52	HIF1A	Mono/Macro	GSE189460_pre	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64109
4.65264390152428e-56	0.460808659484681	0.847	0.783	1.13049941519237e-51	CTSB	Mono/Macro	GSE189460_pre	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64110
3.24973708400061e-55	-1.200171205073	0.352	0.506	7.89621116670467e-51	CCL3L1	Mono/Macro	GSE189460_pre	ENSG00000277796	6349	C-C motif chemokine ligand 3 like 1	D17S1718|G0S19-2|LD78BETA|SCYA3L|SCYA3L1|MGC12815	protein_coding	P16619	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64111
4.27986900686974e-54	-0.715368463110264	0.242	0.406	1.03992257128921e-49	PTGS2	Mono/Macro	GSE189460_pre	ENSG00000073756	5743	prostaglandin-endoperoxide synthase 2	COX2	protein_coding	P35354	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64112
2.04829011799898e-53	-0.344939833678974	0.979	0.982	4.97693532871393e-49	RPS21	Mono/Macro	GSE189460_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64113
2.25581188357058e-53	0.367652717955767	0.677	0.534	5.48117171469979e-49	RIPOR2	Mono/Macro	GSE189460_pre	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64114
3.3488122356305e-53	0.413714026853528	0.695	0.563	8.13694397013498e-49	WARS	Mono/Macro	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64115
7.88018897781213e-53	0.468711129513985	0.717	0.59	1.91472831782879e-48	CTSC	Mono/Macro	GSE189460_pre	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64116
2.70292996146378e-52	-0.966653910953322	0.364	0.525	6.5675792203647e-48	G0S2	Mono/Macro	GSE189460_pre	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64117
5.56906378049616e-52	0.332414702575636	0.528	0.366	1.35317111738496e-47	GBP2	Mono/Macro	GSE189460_pre	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64118
6.99081335409946e-52	-0.996064613642425	0.305	0.468	1.69862782877909e-47	EREG	Mono/Macro	GSE189460_pre	ENSG00000124882	2069	epiregulin	ER	protein_coding	O14944	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64119
8.13110356497835e-52	-0.345769603376881	0.59	0.723	1.97569554421844e-47	CSF3R	Mono/Macro	GSE189460_pre	ENSG00000119535	1441	colony stimulating factor 3 receptor	CD114|GCSFR	protein_coding	Q99062	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64120
9.81915557285077e-52	0.299558999471326	0.45	0.291	2.38585842109128e-47	LILRB1	Mono/Macro	GSE189460_pre	ENSG00000276452	10859	leukocyte immunoglobulin like receptor B1	CD85|CD85j|ILT2|LIR-1|LIR1|MIR-7|PIR-B|PIRB	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64121
2.46977628781194e-50	-0.36906254642072	0.503	0.633	6.00106242412544e-46	FOSL2	Mono/Macro	GSE189460_pre	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64122
2.83384093449062e-50	0.296102327817761	0.743	0.603	6.8856667026253e-46	WASF2	Mono/Macro	GSE189460_pre	ENSG00000158195	10163	WASP family member 2	SCAR2|WAVE2	protein_coding	Q9Y6W5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64123
3.99782205706356e-50	-0.415961823778828	0.63	0.743	9.71390803425304e-46	IRF2BP2	Mono/Macro	GSE189460_pre	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64124
7.69608897652304e-50	1.56774334103989	0.601	0.523	1.86999569951557e-45	IGKC	Mono/Macro	GSE189460_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64125
1.49743084597705e-49	0.307595653631374	0.365	0.217	3.63845746955504e-45	CX3CR1	Mono/Macro	GSE189460_pre	ENSG00000168329	1524	C-X3-C motif chemokine receptor 1	CCRL1|CMKBRL1|CMKDR1|GPR13|V28	protein_coding	P49238	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64126
2.69623971945656e-49	-0.334533731620099	0.856	0.913	6.55132327033554e-45	RPS10	Mono/Macro	GSE189460_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64127
7.29997028414617e-47	-0.287757629154472	0.999	1	1.77374677964184e-42	RPS8	Mono/Macro	GSE189460_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64128
2.41993046385021e-46	0.734797029762064	0.427	0.305	5.87994704106324e-42	CD163	Mono/Macro	GSE189460_pre	ENSG00000177575	9332	CD163 molecule	M130|MM130|SCARI1	protein_coding	Q86VB7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64129
2.62427394464583e-46	-0.250228695378794	1	1	6.37646083070044e-42	RPLP1	Mono/Macro	GSE189460_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64130
9.82998495973847e-46	0.326071422257398	0.506	0.354	2.38848974551725e-41	PLIN2	Mono/Macro	GSE189460_pre	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64131
1.28205793642441e-45	0.283346060276376	0.935	0.892	3.11514437392402e-41	CD48	Mono/Macro	GSE189460_pre	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64132
5.50032614045293e-45	0.351291295200437	0.92	0.851	1.33646924560725e-40	KLF2	Mono/Macro	GSE189460_pre	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64133
6.3936930803585e-45	-0.310782602632476	0.924	0.948	1.55353954466551e-40	CD44	Mono/Macro	GSE189460_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64134
1.81928749949761e-44	-0.319100578579625	0.521	0.668	4.4205047662793e-40	CD99	Mono/Macro	GSE189460_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64135
2.4420481632826e-44	-0.339941157912509	0.384	0.536	5.93368862714405e-40	AC245128.3	Mono/Macro	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64136
4.63721695105581e-44	-0.409273213963463	0.417	0.548	1.12675097476754e-39	JARID2	Mono/Macro	GSE189460_pre	ENSG00000008083	3720	jumonji and AT-rich interaction domain containing 2	JMJ	protein_coding	Q92833	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64137
6.39010139251756e-44	-0.611210847991084	0.39	0.531	1.55266683635392e-39	RGCC	Mono/Macro	GSE189460_pre	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64138
6.62935521457569e-44	0.274110243223227	0.958	0.93	1.6108007300376e-39	TYMP	Mono/Macro	GSE189460_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64139
2.39896851937867e-43	0.285057052780831	0.686	0.547	5.82901370838629e-39	FCGR2A	Mono/Macro	GSE189460_pre	ENSG00000143226	2212	Fc gamma receptor IIa	CD32|CD32A|CDw32|Fc-gamma-RIIa|FCG2|FcgammaRIIa|FCGR2|FCGR2A1|IGFR2	protein_coding	P12318	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64140
3.36838698313696e-43	-0.259020055435008	0.996	0.999	8.18450669162619e-39	VIM	Mono/Macro	GSE189460_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64141
6.4021904334187e-43	0.261847811656651	0.532	0.382	1.55560423151208e-38	CNIH4	Mono/Macro	GSE189460_pre	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64142
1.40794806907371e-42	-0.26267812926795	0.166	0.313	3.4210322182353e-38	ADAM8	Mono/Macro	GSE189460_pre	ENSG00000151651	101	ADAM metallopeptidase domain 8	CD156|CD156A|MS2	protein_coding	P78325	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64143
2.24818550467453e-42	-0.438098609777564	0.328	0.481	5.46264113925818e-38	AC245014.3	Mono/Macro	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64144
4.0412695554644e-42	-0.257272478775004	0.998	0.999	9.8194767658674e-38	JUND	Mono/Macro	GSE189460_pre	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64145
1.9916256568198e-41	0.396380671861567	0.585	0.437	4.83925202094075e-37	RHOB	Mono/Macro	GSE189460_pre	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64146
3.34862894859405e-41	0.25229106540229	0.543	0.389	8.13649861929382e-37	SP110	Mono/Macro	GSE189460_pre	ENSG00000135899	3431	SP110 nuclear body protein	IFI41|IFI75	protein_coding	Q9HB58	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64147
1.56125963076956e-39	0.257430836601406	0.73	0.604	3.79354865084388e-35	ABRACL	Mono/Macro	GSE189460_pre	ENSG00000146386	58527	ABRA C-terminal like	C6orf115|Costars|HSPC280|PRO2013	protein_coding	Q9P1F3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64148
2.12423157128645e-39	-0.305079771934768	0.689	0.768	5.16145787191182e-35	PTPRE	Mono/Macro	GSE189460_pre	ENSG00000132334	5791	protein tyrosine phosphatase receptor type E	PTPE	protein_coding	P23469	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64149
7.04397126952124e-38	-0.275185899986759	0.858	0.905	1.71154413906827e-33	AP1S2	Mono/Macro	GSE189460_pre	ENSG00000182287	8905	adaptor related protein complex 1 subunit sigma 2	MRX59|MRXS5|PGS|SIGMA1B	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64150
8.19552256686217e-38	0.260963011479747	0.376	0.249	1.99134807329617e-33	KLF9	Mono/Macro	GSE189460_pre	ENSG00000119138	687	KLF transcription factor 9	BTEB1	protein_coding	Q13886	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64151
1.63152420978999e-37	0.320382745780912	0.894	0.835	3.96427752494771e-33	FGL2	Mono/Macro	GSE189460_pre	ENSG00000127951	10875	fibrinogen like 2	pT49|T49	protein_coding	Q14314	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64152
2.98272747969499e-37	0.253338461565684	0.726	0.613	7.24743123016288e-33	PSMB8	Mono/Macro	GSE189460_pre	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64153
3.98964906435199e-37	0.292988910476055	0.707	0.59	9.69404929656246e-33	UCP2	Mono/Macro	GSE189460_pre	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64154
2.35064410824406e-36	0.261603216556586	0.979	0.982	5.71159505421141e-32	COTL1	Mono/Macro	GSE189460_pre	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64155
3.17718442234222e-36	0.333684930876066	0.919	0.892	7.71992270940713e-32	CD63	Mono/Macro	GSE189460_pre	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64156
3.84911193009308e-36	0.413854106972894	0.698	0.593	9.35257216774017e-32	ARL4A	Mono/Macro	GSE189460_pre	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64157
6.0922289714849e-36	0.308849714975291	0.387	0.262	1.4802897954914e-31	TCF7L2	Mono/Macro	GSE189460_pre	ENSG00000148737	6934	transcription factor 7 like 2	TCF-4|TCF4	protein_coding	Q9NQB0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64158
9.6849911948735e-36	0.257988616851746	0.697	0.584	2.35325916053036e-31	PTPN6	Mono/Macro	GSE189460_pre	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64159
1.02494475698391e-35	-0.333906310556589	0.918	0.932	2.4904107705195e-31	PNRC1	Mono/Macro	GSE189460_pre	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64160
3.10193921946469e-35	-0.261034249894315	0.998	0.997	7.5370919154553e-31	RPS29	Mono/Macro	GSE189460_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64161
1.05593821015645e-34	0.377401532445981	0.694	0.59	2.56571866303814e-30	PLAC8	Mono/Macro	GSE189460_pre	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64162
3.90694045006111e-34	-0.277968593078022	0.513	0.624	9.49308390555849e-30	MAP3K2	Mono/Macro	GSE189460_pre	ENSG00000169967	10746	mitogen-activated protein kinase kinase kinase 2	MEKK2|MEKK2B	protein_coding	Q9Y2U5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64163
6.53460039478388e-34	0.282293090552723	0.399	0.275	1.58777720392459e-29	MTSS1	Mono/Macro	GSE189460_pre	ENSG00000170873	9788	MTSS I-BAR domain containing 1	KIAA0429|MIM|MIMA|MIMB	protein_coding	O43312	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64164
3.9307949094026e-33	0.327242211881071	0.311	0.197	9.55104547086645e-29	RHOC	Mono/Macro	GSE189460_pre	ENSG00000155366	389	ras homolog family member C	ARH9|ARHC	protein_coding	P08134	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64165
8.43260121855287e-33	0.279157290030318	0.477	0.347	2.04895344408398e-28	CSF1R	Mono/Macro	GSE189460_pre	ENSG00000182578	1436	colony stimulating factor 1 receptor	C-FMS|CD115|CSFR|FMS	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64166
1.39632577954376e-32	-0.358134971844136	0.513	0.609	3.39279237913542e-28	NR4A2	Mono/Macro	GSE189460_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64167
1.73421769527618e-32	0.40823339630031	0.488	0.377	4.21380215598207e-28	SMIM25	Mono/Macro	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64168
2.14316477693832e-32	-0.258106351415603	0.748	0.821	5.20746177500473e-28	HNRNPH1	Mono/Macro	GSE189460_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64169
3.38826833483828e-32	-0.365084842619418	0.187	0.315	8.23281439999006e-28	ARL4C	Mono/Macro	GSE189460_pre	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64170
4.41862580976701e-32	-0.261507617643793	1	1	1.07363769925719e-27	RPL39	Mono/Macro	GSE189460_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64171
6.0443376969114e-32	-0.330634473484881	0.399	0.53	1.46865317359553e-27	RPS4Y1	Mono/Macro	GSE189460_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64172
1.06695177786998e-31	0.260243155408713	0.645	0.522	2.59247942986847e-27	MTRNR2L12	Mono/Macro	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64173
6.95122464998806e-31	-0.370062228185027	0.551	0.635	1.6890085654541e-26	KDM6B	Mono/Macro	GSE189460_pre	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64174
1.10341185293076e-30	0.309114520686912	0.691	0.596	2.68107012025116e-26	LILRB2	Mono/Macro	GSE189460_pre	ENSG00000274513	10288	leukocyte immunoglobulin like receptor B2	CD85d|ILT4|LIR-2|LIR2|MIR-10|MIR10	protein_coding	Q8N423	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64175
1.29495801256374e-30	-0.334362297752956	0.315	0.429	3.14648897892738e-26	PDE4B	Mono/Macro	GSE189460_pre	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64176
5.09866167229879e-30	-0.532221684446585	0.464	0.551	1.23887281313516e-25	LGALS2	Mono/Macro	GSE189460_pre	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64177
7.31803089912239e-30	0.289271506291747	0.7	0.606	1.77813514786876e-25	IGSF6	Mono/Macro	GSE189460_pre	ENSG00000283934	10261	immunoglobulin superfamily member 6	DORA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64178
1.11138689884333e-29	-0.402322407089323	0.547	0.629	2.70044788680952e-25	MAP3K8	Mono/Macro	GSE189460_pre	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64179
2.49373767820156e-29	-0.314740647725224	0.322	0.435	6.05928381049416e-25	CARD19	Mono/Macro	GSE189460_pre	ENSG00000165233	84270	caspase recruitment domain family member 19	bA370F5.1|BinCARD|C9orf89|MGC11115	protein_coding	Q96LW7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64180
4.10757139075632e-29	-0.973790798320678	0.634	0.684	9.9805769652597e-25	IL1B	Mono/Macro	GSE189460_pre	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64181
4.92934583983179e-29	-0.843474453273223	0.211	0.319	1.19773245216233e-24	CXCL2	Mono/Macro	GSE189460_pre	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64182
1.9454717220828e-28	0.269440169291083	0.734	0.647	4.72710719031678e-24	FPR1	Mono/Macro	GSE189460_pre	ENSG00000171051	2357	formyl peptide receptor 1	FMLP|FPR	protein_coding	P21462	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64183
2.13334629375094e-28	0.301253725038048	0.476	0.357	5.18360482455604e-24	HMOX1	Mono/Macro	GSE189460_pre	ENSG00000100292	3162	heme oxygenase 1	bK286B10|HO-1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64184
4.14082594271133e-28	0.291350489796476	0.562	0.464	1.00613788756e-23	STAT1	Mono/Macro	GSE189460_pre	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64185
4.90329025221309e-28	-0.271672521608472	0.692	0.752	1.19140146548274e-23	GPCPD1	Mono/Macro	GSE189460_pre	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64186
7.86736215286316e-28	0.290923540044155	0.827	0.757	1.91161165590269e-23	IRF1	Mono/Macro	GSE189460_pre	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64187
8.29129077753647e-28	-0.257845952815374	0.455	0.578	2.01461783312581e-23	MGST1	Mono/Macro	GSE189460_pre	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64188
1.55615315740679e-26	-0.282999008895894	0.18	0.289	3.78114094186702e-22	VEGFA	Mono/Macro	GSE189460_pre	ENSG00000112715	7422	vascular endothelial growth factor A	VEGF|VEGF-A|VPF	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64189
1.70776178332584e-26	0.254916771626709	0.695	0.603	4.14951958112513e-22	POU2F2	Mono/Macro	GSE189460_pre	ENSG00000028277	5452	POU class 2 homeobox 2	OCT2|OTF2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64190
2.01497979314103e-26	-0.276691002317381	0.334	0.447	4.89599790137407e-22	ATP13A3	Mono/Macro	GSE189460_pre	ENSG00000133657	79572	ATPase 13A3	AFURS1	protein_coding	Q9H7F0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64191
1.21273569638217e-24	-0.316329506144361	0.486	0.567	2.94670519506939e-20	GABARAPL1	Mono/Macro	GSE189460_pre	ENSG00000139112	23710	GABA type A receptor associated protein like 1	APG8L|ATG8B|ATG8L|gec1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64192
1.31651344424385e-24	0.275929787167411	0.786	0.719	3.1988643668237e-20	CPVL	Mono/Macro	GSE189460_pre	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64193
3.47446149039403e-24	0.252617887701286	0.898	0.847	8.44224652935941e-20	CEBPD	Mono/Macro	GSE189460_pre	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64194
6.17787014625274e-24	-0.883183398416338	0.156	0.25	1.50109888813649e-19	CCL4L2	Mono/Macro	GSE189460_pre	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64195
8.51062727592771e-24	-0.250993031568759	0.334	0.443	2.06791221550492e-19	RFLNB	Mono/Macro	GSE189460_pre	ENSG00000283979	359845	refilin B	Cfm1|FAM101B|MGC45871|RefilinB	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64196
1.6000587573309e-23	-0.263693900926496	0.387	0.485	3.88782276856263e-19	TLE3	Mono/Macro	GSE189460_pre	ENSG00000140332	7090	TLE family member 3, transcriptional corepressor	ESG|ESG3|GRG3|HsT18976|KIAA1547	protein_coding	Q04726	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64197
1.16993235812737e-22	-0.394234078145419	0.212	0.307	2.84270164377788e-18	IL1RN	Mono/Macro	GSE189460_pre	ENSG00000136689	3557	interleukin 1 receptor antagonist	ICIL-1RA|IL-1RN|IL1F3|IL1RA|IRAP|MGC10430	protein_coding	P18510	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64198
2.98544880406996e-22	0.411375471476604	0.799	0.749	7.25404350412918e-18	HLA-DPB1	Mono/Macro	GSE189460_pre	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64199
4.11080058269738e-22	-0.262973265210422	0.731	0.803	9.9884232558381e-18	AC020916.1	Mono/Macro	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64200
4.32450421854544e-22	-0.306658459860499	0.405	0.499	1.05076803502217e-17	BASP1	Mono/Macro	GSE189460_pre	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64201
1.53577935814306e-21	0.328789430434344	0.702	0.628	3.73163668441601e-17	HLA-DQB1	Mono/Macro	GSE189460_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64202
2.16049127145661e-21	-0.332429517815931	0.485	0.564	5.24956169138528e-17	PPIF	Mono/Macro	GSE189460_pre	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64203
2.63379586174687e-21	-0.303182925429272	0.731	0.765	6.39959718487254e-17	PLAUR	Mono/Macro	GSE189460_pre	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64204
3.11128293033576e-21	0.278153299781853	0.771	0.719	7.55979526412984e-17	GLUL	Mono/Macro	GSE189460_pre	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64205
4.06540032523558e-21	-0.404441761228763	0.811	0.867	9.87810971025742e-17	AC020656.1	Mono/Macro	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64206
6.80625162957532e-21	-0.270213198040751	0.305	0.398	1.65378302095421e-16	RNF19B	Mono/Macro	GSE189460_pre	ENSG00000116514	127544	ring finger protein 19B	FLJ90005|IBRDC3|NKLAM	protein_coding	Q6ZMZ0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64207
5.66122457168479e-20	-0.256994908146313	0.481	0.566	1.37556434642797e-15	SLC25A37	Mono/Macro	GSE189460_pre	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64208
1.47158053294635e-18	-0.251026885530814	0.839	0.851	3.57564637895303e-14	PLEK	Mono/Macro	GSE189460_pre	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64209
4.39425852497433e-18	0.284486488007543	0.806	0.742	1.06771693639826e-13	ZFP36L2	Mono/Macro	GSE189460_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64210
4.49500753255542e-18	-0.276909722747246	0.541	0.592	1.09219693026032e-13	PIM3	Mono/Macro	GSE189460_pre	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64211
1.36251118882788e-17	0.29851513677495	0.833	0.808	3.31062968661399e-13	HLA-DPA1	Mono/Macro	GSE189460_pre	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64212
9.43644796735583e-17	-0.384996528061632	0.556	0.609	2.29286812710812e-12	NLRP3	Mono/Macro	GSE189460_pre	ENSG00000162711	114548	NLR family pyrin domain containing 3	AGTAVPRL|AII|AVP|C1orf7|CIAS1|CLR1.1|DFNA34|FCAS|FCU|MWS|NALP3|PYPAF1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64213
2.16576585151946e-15	0.257658327526677	0.511	0.442	5.26237786602198e-11	CLEC4E	Mono/Macro	GSE189460_pre	ENSG00000166523	26253	C-type lectin domain family 4 member E	CLECSF9|MINCLE	protein_coding	Q9ULY5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64214
4.38265145114682e-15	-0.277055616080012	0.476	0.529	1.06489664959965e-10	CDKN1A	Mono/Macro	GSE189460_pre	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64215
6.13257749341173e-15	0.304424507155949	0.428	0.343	1.49009367934918e-10	HLA-DQA1	Mono/Macro	GSE189460_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64216
8.11826698021351e-15	0.33980323405554	0.96	0.958	1.97257651085228e-10	LST1	Mono/Macro	GSE189460_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64217
1.78192794081419e-13	-0.393777709095249	0.589	0.625	4.32972851059032e-09	NINJ1	Mono/Macro	GSE189460_pre	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64218
1.9642058388677e-13	-0.339645131935308	0.647	0.673	4.77262734728075e-09	SGK1	Mono/Macro	GSE189460_pre	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64219
2.49120669138982e-13	-0.321669777747286	0.67	0.681	6.05313401873899e-09	CD83	Mono/Macro	GSE189460_pre	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64220
2.94491646204418e-13	-0.905504807189269	0.196	0.262	7.15555801947494e-09	CCL4	Mono/Macro	GSE189460_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64221
1.35745939777503e-12	-0.325481386891128	0.888	0.877	3.29835484471376e-08	RPS26	Mono/Macro	GSE189460_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64222
1.02492411165173e-10	-0.287513072263747	0.365	0.418	2.49036060649138e-06	SNHG15	Mono/Macro	GSE189460_pre	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64223
5.55088340350304e-09	-0.284983169684241	0.66	0.686	0.000134875364938317	TNFAIP2	Mono/Macro	GSE189460_pre	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64224
1.11862484377002e-08	-0.278582878667741	0.202	0.255	0.000271803464539239	TNF	Mono/Macro	GSE189460_pre	ENSG00000228978	7124	tumor necrosis factor	DIF|TNF-alpha|TNFA|TNFSF2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64225
1.76786308595906e-08	-0.612180867469931	0.977	0.949	0.000429555372626332	NFKBIA	Mono/Macro	GSE189460_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64226
2.20289896694097e-08	0.254115356480436	0.962	0.962	0.000535260390987317	HLA-DRA	Mono/Macro	GSE189460_pre	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64227
4.41793267295137e-238	2.49058951008157	0.284	0.003	1.07346928087372e-233	IGLL5	Erythrocytes	GSE189460_pre	ENSG00000254709	100423062	immunoglobulin lambda like polypeptide 5	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64228
8.8927116472126e-191	-4.32757732205742	0.066	0.6	2.16075107603972e-186	IGLC2	Erythrocytes	GSE189460_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64229
3.45967009076913e-123	1.14134391901382	0.751	0.344	8.40630638655083e-119	IGKC	Erythrocytes	GSE189460_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64230
2.51819628542695e-65	-0.825284581165458	0.468	0.697	6.11871333433041e-61	RPS10	Erythrocytes	GSE189460_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64231
1.53531446744408e-63	0.871412652174039	0.604	0.334	3.73050709299562e-59	ARL4A	Erythrocytes	GSE189460_pre	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64232
4.98768330168999e-63	-0.705013825575587	0.63	0.832	1.21190728864463e-58	ATP5IF1	Erythrocytes	GSE189460_pre	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64233
1.0413278668524e-60	-0.775264348874467	0.89	0.97	2.53021845087796e-56	MT-ND3	Erythrocytes	GSE189460_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64234
9.20013230563019e-60	-0.857192536605615	0.703	0.842	2.23544814762202e-55	RPS21	Erythrocytes	GSE189460_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64235
1.23540513263386e-54	0.422651933538168	0.496	0.239	3.00178739127376e-50	RSAD2	Erythrocytes	GSE189460_pre	ENSG00000134321	91543	radical S-adenosyl methionine domain containing 2	cig5|vig1|Viperin	protein_coding	Q8WXG1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64236
6.41305975238168e-54	-0.542464963981228	0.637	0.822	1.5582452586337e-49	HNRNPH1	Erythrocytes	GSE189460_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64237
4.64501389362867e-53	0.866259858688852	0.534	0.305	1.12864547587389e-48	EIF1AY	Erythrocytes	GSE189460_pre	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64238
1.46830826050849e-49	0.394811697983259	0.751	0.513	3.56769541138354e-45	PIM1	Erythrocytes	GSE189460_pre	ENSG00000137193	5292	Pim-1 proto-oncogene, serine/threonine kinase	PIM	protein_coding	P11309	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64239
9.73857677484091e-49	0.586101957547368	0.293	0.121	2.36627938475084e-44	IGHD	Erythrocytes	GSE189460_pre	ENSG00000278801	NA	NA	FLJ00382|FLJ46727|MGC29633	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64240
1.0926388478289e-48	0.607269247378369	0.854	0.709	2.65489387245467e-44	BNIP3L	Erythrocytes	GSE189460_pre	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64241
2.83436914998843e-47	-0.958404702652769	0.353	0.594	6.8869501606419e-43	S100A4	Erythrocytes	GSE189460_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64242
9.74176516132415e-46	-0.405389764703587	0.226	0.485	2.36705409889854e-41	CTSE	Erythrocytes	GSE189460_pre	ENSG00000196188	1510	cathepsin E	NA	protein_coding	P14091	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64243
1.62864850678931e-45	0.519338639797844	0.994	0.995	3.95729014179667e-41	HBB	Erythrocytes	GSE189460_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64244
5.64185147325978e-45	-0.690123928594268	0.871	0.942	1.37085707097266e-40	RPS15A	Erythrocytes	GSE189460_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64245
1.84259677275766e-43	-0.72298900344297	0.794	0.896	4.47714163844656e-39	RPS29	Erythrocytes	GSE189460_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64246
7.98745853118329e-43	-0.432961817185116	0.527	0.711	1.94079267390692e-38	PPDPF	Erythrocytes	GSE189460_pre	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64247
2.31117995111366e-41	-0.848244412674341	0.454	0.66	5.61570504521596e-37	S100A6	Erythrocytes	GSE189460_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64248
2.46778527192047e-41	-0.767046509715851	0.728	0.861	5.99622465371235e-37	RPL37	Erythrocytes	GSE189460_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64249
3.09731094598051e-41	0.322909400211537	0.66	0.407	7.52584613654344e-37	TUBB2A	Erythrocytes	GSE189460_pre	ENSG00000137267	7280	tubulin beta 2A class IIa	dJ40E16.7|TUBB|TUBB2	protein_coding	Q13885	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64250
9.55447390337677e-41	-0.761621056017514	0.697	0.843	2.32154606904249e-36	RPL26	Erythrocytes	GSE189460_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64251
1.22225984339854e-40	-0.473261658856089	0.718	0.847	2.96984696748977e-36	HMGN2	Erythrocytes	GSE189460_pre	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64252
3.82719851431187e-40	-0.694689773387301	0.948	0.958	9.29932695007498e-36	RPL41	Erythrocytes	GSE189460_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64253
5.84184760389593e-39	-0.414417635850828	0.735	0.856	1.41945213079463e-34	PFDN5	Erythrocytes	GSE189460_pre	ENSG00000123349	5204	prefoldin subunit 5	MM-1|PFD5	protein_coding	Q99471	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64254
2.90849235384977e-38	-0.369238080426554	0.265	0.476	7.06705472138416e-34	PSMA2	Erythrocytes	GSE189460_pre	ENSG00000106588	5683	proteasome 20S subunit alpha 2	HC3|MU|PMSA2	protein_coding	P25787	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64255
1.69966899953741e-37	-0.647580762117764	0.802	0.906	4.12985573507601e-33	RPL14	Erythrocytes	GSE189460_pre	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64256
6.03122121471044e-37	-0.567144716045884	0.807	0.885	1.46546613075034e-32	RPL35	Erythrocytes	GSE189460_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64257
9.83761921219256e-37	-0.58501690161111	0.563	0.72	2.39034471617855e-32	TMEM14C	Erythrocytes	GSE189460_pre	ENSG00000284936	51522	transmembrane protein 14C	bA421M1.6|C6orf53|HSPC194|NET26	protein_coding	Q9P0S9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64258
3.52813303447404e-36	-0.590110819752624	0.826	0.93	8.57265764716503e-32	RPL12	Erythrocytes	GSE189460_pre	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64259
1.15539415677185e-35	-0.524788778685732	0.741	0.892	2.80737672212424e-31	PTMA	Erythrocytes	GSE189460_pre	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64260
1.21085990630205e-35	0.375947667723466	0.728	0.545	2.94214740033272e-31	CPEB4	Erythrocytes	GSE189460_pre	ENSG00000113742	80315	cytoplasmic polyadenylation element binding protein 4	KIAA1673	protein_coding	Q17RY0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64261
2.46593966200544e-35	-0.413253177038704	0.906	0.949	5.99174019074082e-31	FAU	Erythrocytes	GSE189460_pre	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64262
2.61769138607468e-35	-0.599399248620114	0.869	0.942	6.36046652988426e-31	RPL32	Erythrocytes	GSE189460_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64263
3.01646327408385e-35	-0.541367021649377	0.553	0.73	7.32940246336894e-31	PCLAF	Erythrocytes	GSE189460_pre	ENSG00000166803	9768	PCNA clamp associated factor	KIAA0101|NS5ATP9|OEATC-1|p15(PAF)|PAF15	protein_coding	Q15004	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64264
5.79095347034911e-35	-0.544473534089708	0.904	0.946	1.40708587422543e-30	RPS15	Erythrocytes	GSE189460_pre	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64265
1.2134073192278e-34	-0.698824688290911	0.796	0.89	2.94833710425971e-30	RPL34	Erythrocytes	GSE189460_pre	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64266
1.91795003836737e-34	-0.560107709454202	0.84	0.932	4.66023500322504e-30	RPS6	Erythrocytes	GSE189460_pre	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64267
2.25902410031462e-34	-0.716336513207649	0.837	0.905	5.48897675894447e-30	RPS8	Erythrocytes	GSE189460_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64268
4.09235523337782e-34	-0.543056214363591	0.326	0.514	9.94360474606143e-30	RPL36A	Erythrocytes	GSE189460_pre	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64269
4.24439004139614e-34	-0.68661218616093	0.756	0.864	1.03130189225843e-29	RPL37A	Erythrocytes	GSE189460_pre	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64270
4.92615534395026e-34	-0.586223313764847	0.873	0.929	1.19695722547303e-29	RPL28	Erythrocytes	GSE189460_pre	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64271
2.16546819400676e-33	-0.661543714264818	0.842	0.909	5.26165461779763e-29	RPS28	Erythrocytes	GSE189460_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64272
3.83661012530905e-33	-0.544159651465952	0.749	0.843	9.32219528247594e-29	RPL38	Erythrocytes	GSE189460_pre	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64273
1.49309374067736e-31	-0.534071481663533	0.839	0.922	3.62791917109784e-27	RPL29	Erythrocytes	GSE189460_pre	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64274
1.66935033376283e-31	-0.541613228478581	0.871	0.95	4.05618744097693e-27	RPS27A	Erythrocytes	GSE189460_pre	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64275
2.24344780440424e-31	-0.539484006297035	0.845	0.933	5.45112947514141e-27	RPS3A	Erythrocytes	GSE189460_pre	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64276
3.0796505247844e-31	-0.403452026832846	0.933	0.951	7.48293484512114e-27	RPLP2	Erythrocytes	GSE189460_pre	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64277
5.21031252659638e-31	-0.333977489328894	0.572	0.733	1.26600173771239e-26	CBX3	Erythrocytes	GSE189460_pre	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64278
6.38745650347969e-31	-0.53190153102301	0.878	0.936	1.55202418121549e-26	RPS3	Erythrocytes	GSE189460_pre	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64279
8.78051976291959e-31	-0.419468866133401	0.761	0.89	2.1334906919942e-26	HMGB1	Erythrocytes	GSE189460_pre	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64280
6.52650601465441e-30	-0.536165712827665	0.948	0.961	1.58581043144073e-25	RPLP1	Erythrocytes	GSE189460_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64281
9.10467513493015e-30	-0.433283272578012	0.54	0.688	2.21225396428533e-25	NFIA	Erythrocytes	GSE189460_pre	ENSG00000162599	4774	nuclear factor I A	KIAA1439|NFI-L	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64282
1.13234015089803e-29	-0.450092890089179	0.755	0.876	2.75136009865202e-25	HMGB2	Erythrocytes	GSE189460_pre	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64283
1.15143355717974e-29	0.403362100451079	0.772	0.618	2.79775325723534e-25	NCOA4	Erythrocytes	GSE189460_pre	ENSG00000266412	8031	nuclear receptor coactivator 4	ARA70|DKFZp762E1112|ELE1|PTC3|RFG	protein_coding	Q13772	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64284
3.54478258978515e-29	-0.501274281621759	0.689	0.825	8.61311273665996e-25	RPL22	Erythrocytes	GSE189460_pre	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64285
4.12550029596394e-29	-0.323864822627022	0.734	0.852	1.00241406191332e-24	PCBP2	Erythrocytes	GSE189460_pre	ENSG00000197111	5094	poly(rC) binding protein 2	hnRNP-E2|HNRNPE2|HNRPE2	protein_coding	Q15366	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64286
5.56433600293958e-29	0.346567882787628	0.572	0.399	1.35202236199426e-24	ADIPOR1	Erythrocytes	GSE189460_pre	ENSG00000159346	51094	adiponectin receptor 1	ACDCR1|PAQR1	protein_coding	Q96A54	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64287
8.68884687632881e-29	-0.55334706754949	0.745	0.874	2.11121601401038e-24	RPS4X	Erythrocytes	GSE189460_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64288
9.33728035541567e-29	0.389185858603936	0.429	0.253	2.2687723807589e-24	UBE2H	Erythrocytes	GSE189460_pre	ENSG00000186591	7328	ubiquitin conjugating enzyme E2 H	GID3|UBC8|UBCH	protein_coding	P62256	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64289
9.94023712489934e-29	-0.318410919608462	0.349	0.518	2.41527881660804e-24	NDUFB1	Erythrocytes	GSE189460_pre	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64290
1.12994971246475e-28	-0.556115155401013	0.851	0.927	2.74555181134685e-24	RPL13	Erythrocytes	GSE189460_pre	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64291
1.32673030358739e-28	-0.332707554214118	0.396	0.578	3.22368929165664e-24	RBBP4	Erythrocytes	GSE189460_pre	ENSG00000162521	5928	RB binding protein 4, chromatin remodeling factor	lin-53|NURF55|RbAp48	protein_coding	Q09028	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64292
3.8472816093642e-28	-0.39334724825187	0.585	0.744	9.34812485443314e-24	METAP2	Erythrocytes	GSE189460_pre	ENSG00000111142	10988	methionyl aminopeptidase 2	MAP2|MNPEP|p67	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64293
6.20062049657641e-28	-0.356932757618948	0.38	0.555	1.50662676825814e-23	PRC1	Erythrocytes	GSE189460_pre	ENSG00000198901	9055	protein regulator of cytokinesis 1	ASE1	protein_coding	O43663	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64294
6.56346400116794e-28	0.305981407865434	0.738	0.603	1.59479048300379e-23	HK1	Erythrocytes	GSE189460_pre	ENSG00000156515	3098	hexokinase 1	NA	protein_coding	P19367	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64295
7.94774128320435e-28	-0.633036612569937	0.819	0.904	1.93114217699299e-23	RPS27	Erythrocytes	GSE189460_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64296
9.06340994705505e-28	-0.293290690479955	0.242	0.429	2.20222734893544e-23	CD99	Erythrocytes	GSE189460_pre	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64297
2.11866795255017e-27	-0.669729366832348	0.739	0.838	5.14793939110641e-23	RPL36	Erythrocytes	GSE189460_pre	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64298
2.67837512049218e-27	0.321019747552178	0.925	0.865	6.5079158677719e-23	TOP1	Erythrocytes	GSE189460_pre	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64299
2.7404968702381e-27	-0.472165369432456	0.957	0.975	6.65885929530453e-23	RPL21	Erythrocytes	GSE189460_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64300
2.79674660137748e-27	-0.280828809240274	0.243	0.426	6.795534892027e-23	C9orf16	Erythrocytes	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64301
3.22800576723551e-27	-0.324387441671244	0.432	0.618	7.84340841322883e-23	WSB1	Erythrocytes	GSE189460_pre	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64302
3.87353923130761e-27	-0.300570148464565	0.429	0.593	9.41192562423123e-23	POLR2I	Erythrocytes	GSE189460_pre	ENSG00000105258	5438	RNA polymerase II subunit I	hRPB14.5|RPB9	protein_coding	P36954	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64303
4.51024923938002e-27	-0.462908937007573	0.902	0.949	1.09590036018456e-22	RPL30	Erythrocytes	GSE189460_pre	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64304
9.52482713642417e-27	-0.477710038133646	0.758	0.875	2.31434249760835e-22	RPS5	Erythrocytes	GSE189460_pre	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64305
2.06472572348204e-26	-0.301081796927934	0.277	0.457	5.01687056291665e-22	CENPH	Erythrocytes	GSE189460_pre	ENSG00000153044	64946	centromere protein H	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64306
2.78132835719998e-26	-0.433750892451694	0.882	0.943	6.75807164232452e-22	RPS11	Erythrocytes	GSE189460_pre	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64307
4.15414325623947e-26	-0.352582166926634	0.605	0.767	1.00937372840107e-21	SRSF2	Erythrocytes	GSE189460_pre	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64308
4.3184788077694e-26	0.303534175434653	0.307	0.154	1.04930398071181e-21	TMCC2	Erythrocytes	GSE189460_pre	ENSG00000133069	9911	transmembrane and coiled-coil domain family 2	FLJ38497|HUCEP11	protein_coding	O75069	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64309
5.2840323164023e-26	-0.443651822978042	0.762	0.886	1.28391417223943e-21	RPLP0	Erythrocytes	GSE189460_pre	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64310
5.36938211583903e-26	-0.486460269856998	0.576	0.72	1.30465246650657e-21	CKS2	Erythrocytes	GSE189460_pre	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64311
5.71495091079827e-26	-0.318660584310183	0.55	0.702	1.38861877230576e-21	DNAJA4	Erythrocytes	GSE189460_pre	ENSG00000140403	55466	DnaJ heat shock protein family (Hsp40) member A4	PRO1472	protein_coding	Q8WW22	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64312
6.58623169363151e-26	-0.485693179936827	0.865	0.918	1.60032257691858e-21	RPL8	Erythrocytes	GSE189460_pre	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64313
7.95662527098005e-26	0.275401190523921	0.36	0.207	1.93330080834273e-21	C2orf88	Erythrocytes	GSE189460_pre	ENSG00000187699	84281	chromosome 2 open reading frame 88	MGC13057|smAKAP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64314
8.16807482922783e-26	-0.416776693819257	0.501	0.665	1.98467882200578e-21	TYMS	Erythrocytes	GSE189460_pre	ENSG00000176890	7298	thymidylate synthetase	HsT422|TMS|TS|Tsase	protein_coding	P04818	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64315
1.45008017418502e-25	-0.511153631073102	0.774	0.879	3.52340480723476e-21	RPL9	Erythrocytes	GSE189460_pre	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64316
1.65555676222314e-25	-0.270249029371914	0.265	0.436	4.02267182084979e-21	ZFPM1	Erythrocytes	GSE189460_pre	ENSG00000179588	161882	zinc finger protein, FOG family member 1	FOG|FOG1|ZC2HC11A|ZNF89A	protein_coding	Q8IX07	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64317
2.20866212845552e-25	-0.338401647169156	0.964	0.982	5.36660723972123e-21	TPT1	Erythrocytes	GSE189460_pre	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64318
2.27436446127884e-25	-0.346371602347171	0.546	0.697	5.52625076801532e-21	VDAC3	Erythrocytes	GSE189460_pre	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64319
2.91928676734436e-25	0.641726438453776	0.619	0.529	7.09328298729333e-21	SSR4	Erythrocytes	GSE189460_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64320
4.86761222240562e-25	-0.504943304827181	0.776	0.874	1.18273241780012e-20	RPS19	Erythrocytes	GSE189460_pre	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64321
5.43616457496519e-25	-0.428165561882989	0.756	0.882	1.32087926842504e-20	RPS16	Erythrocytes	GSE189460_pre	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64322
6.06772616160937e-25	-0.564713754755943	0.788	0.885	1.47433610274784e-20	RPS23	Erythrocytes	GSE189460_pre	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64323
6.85205733400612e-25	-0.430461611945745	0.826	0.912	1.66491289101681e-20	RPL18	Erythrocytes	GSE189460_pre	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64324
7.44134156639242e-25	0.258453255665955	0.437	0.276	1.80809717380203e-20	CD2AP	Erythrocytes	GSE189460_pre	ENSG00000198087	23607	CD2 associated protein	CMS	protein_coding	Q9Y5K6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64325
8.02002760525679e-25	0.303777035669449	0.815	0.691	1.94870630752529e-20	PPP1R15A	Erythrocytes	GSE189460_pre	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64326
1.42376031655197e-24	-0.334944255774394	0.46	0.654	3.45945281715799e-20	PCNA	Erythrocytes	GSE189460_pre	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64327
1.65555490287983e-24	-0.287451286576425	0.235	0.415	4.02266730301742e-20	CD82	Erythrocytes	GSE189460_pre	ENSG00000085117	3732	CD82 molecule	IA4|KAI1|R2|ST6|TSPAN27	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64328
1.66430418514628e-24	-0.491951782224577	0.865	0.925	4.04392630906842e-20	RPL11	Erythrocytes	GSE189460_pre	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64329
2.14368145180068e-24	-0.473242954117828	0.77	0.879	5.2087171915853e-20	RPS13	Erythrocytes	GSE189460_pre	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64330
4.13222135059939e-24	-0.258503646039511	0.248	0.421	1.00404714376864e-19	THOC3	Erythrocytes	GSE189460_pre	ENSG00000051596	84321	THO complex subunit 3	MGC5469|TEX1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64331
4.32497839053126e-24	-0.352961523617459	0.186	0.348	1.05088324933129e-19	ZFAS1	Erythrocytes	GSE189460_pre	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64332
5.11424442930498e-24	-0.278804232082123	0.319	0.495	1.24265911143252e-19	PARVB	Erythrocytes	GSE189460_pre	ENSG00000188677	29780	parvin beta	CGI-56	protein_coding	Q9HBI1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64333
5.85560224207025e-24	-0.479877284991611	0.834	0.909	1.42279423277823e-19	RPL18A	Erythrocytes	GSE189460_pre	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64334
6.05159462435226e-24	-0.289832690833796	0.88	0.935	1.47041646182511e-19	TFRC	Erythrocytes	GSE189460_pre	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64335
1.03643057030245e-23	-0.29431775540217	0.705	0.843	2.51831899972089e-19	SUMO2	Erythrocytes	GSE189460_pre	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64336
1.11331653959e-23	-0.336889941268251	0.516	0.671	2.70513652789578e-19	CAST	Erythrocytes	GSE189460_pre	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64337
1.2326388818859e-23	-0.455145833965561	0.839	0.903	2.99506595520637e-19	RPS25	Erythrocytes	GSE189460_pre	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64338
1.53246040506017e-23	-0.38838993444436	0.779	0.896	3.7235722922152e-19	RPL23A	Erythrocytes	GSE189460_pre	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64339
1.76555108408151e-23	0.3972674135255	0.266	0.134	4.28993602410125e-19	IFIT1B	Erythrocytes	GSE189460_pre	ENSG00000204010	439996	interferon induced protein with tetratricopeptide repeats 1B	bA149I23.6|IFIT1L	protein_coding	Q5T764	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64340
2.15711549256885e-23	-0.442246805208711	0.813	0.901	5.24135922384379e-19	RPL19	Erythrocytes	GSE189460_pre	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64341
3.13898083155323e-23	-0.288011142444068	0.485	0.649	7.62709562450803e-19	TSPO	Erythrocytes	GSE189460_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64342
4.42550478769662e-23	-0.480671401404519	0.887	0.924	1.07530915331452e-18	RPL35A	Erythrocytes	GSE189460_pre	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64343
7.16157683520644e-23	-0.338001506078696	0.473	0.619	1.74011993941846e-18	ATP5MPL	Erythrocytes	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64344
8.90512097756589e-23	-0.285249777822563	0.388	0.556	2.16376629512896e-18	SLC22A16	Erythrocytes	GSE189460_pre	ENSG00000004809	85413	solute carrier family 22 member 16	CT2|FLIPT2|OAT6|OKB1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64345
9.08527417896624e-23	0.436222812202081	0.588	0.449	2.20753992000522e-18	BPGM	Erythrocytes	GSE189460_pre	ENSG00000172331	669	bisphosphoglycerate mutase	NA	protein_coding	P07738	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64346
1.14887833382319e-22	-0.317449261526756	0.531	0.681	2.7915445755236e-18	RPA3	Erythrocytes	GSE189460_pre	ENSG00000106399	6119	replication protein A3	REPA3	protein_coding	P35244	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64347
1.19399505213328e-22	-0.468767650674376	0.878	0.943	2.90116917767344e-18	EEF1A1	Erythrocytes	GSE189460_pre	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64348
1.50440949775784e-22	-0.394930533676262	0.667	0.811	3.65541419765201e-18	RACK1	Erythrocytes	GSE189460_pre	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64349
2.04616169568825e-22	-0.324144108637853	0.522	0.677	4.9717636881833e-18	SNRPG	Erythrocytes	GSE189460_pre	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64350
4.30806929718585e-22	0.250150426841418	0.501	0.338	1.04677467783022e-17	GADD45A	Erythrocytes	GSE189460_pre	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64351
4.57927409793155e-22	-0.371167022853414	0.117	0.259	1.11267202031541e-17	EPCAM	Erythrocytes	GSE189460_pre	ENSG00000119888	4072	epithelial cell adhesion molecule	17-1A|323/A3|Ber-Ep4|BerEp4|CD326|CO-17A|EGP-2|EGP34|EGP40|Ep-CAM|ESA|GA733-2|HEA125|KS1/4|KSA|Ly74|M4S1|MH99|MIC18|MK-1|MOC-31|MOC31|TACST-1|TACSTD1|TROP1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64352
6.61766545869446e-22	0.379535633009462	0.706	0.602	1.60796035315358e-17	TERF2IP	Erythrocytes	GSE189460_pre	ENSG00000166848	54386	TERF2 interacting protein	RAP1	protein_coding	Q9NYB0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64353
7.56878705535517e-22	-0.511149140383812	0.99	0.985	1.8390638787102e-17	RPS12	Erythrocytes	GSE189460_pre	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64354
8.62515282553995e-22	-0.277257913075735	0.565	0.707	2.0957396335497e-17	ATP5F1D	Erythrocytes	GSE189460_pre	ENSG00000099624	513	ATP synthase F1 subunit delta	ATP5D	protein_coding	P30049	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64355
8.67003779724563e-22	-0.52500221364235	0.786	0.857	2.10664578397474e-17	RPL39	Erythrocytes	GSE189460_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64356
1.93536588396656e-21	-0.339324791688341	0.698	0.83	4.70255202486194e-17	TUBB	Erythrocytes	GSE189460_pre	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64357
2.02428469189436e-21	-0.255411695545216	0.257	0.415	4.91860694436491e-17	SLC2A4RG	Erythrocytes	GSE189460_pre	ENSG00000125520	56731	SLC2A4 regulator	GEF|HDBP1|Si-1-2|Si-1-2-19	protein_coding	Q9NR83	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64358
2.90211533540378e-21	-0.401878786067736	0.719	0.817	7.05155984196409e-17	RPL27	Erythrocytes	GSE189460_pre	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64359
4.43739113734197e-21	-0.389748809705082	0.55	0.693	1.07819729855135e-16	DUT	Erythrocytes	GSE189460_pre	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64360
5.32814250607516e-21	-0.302526076438055	0.702	0.801	1.29463206612614e-16	TMA7	Erythrocytes	GSE189460_pre	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64361
5.52349725485102e-21	-0.261893748916789	0.446	0.624	1.3420993629837e-16	SIVA1	Erythrocytes	GSE189460_pre	ENSG00000184990	10572	SIVA1 apoptosis inducing factor	CD27BP|SIVA|Siva-1|Siva-2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64362
5.77197314199864e-21	-0.344603675506018	0.597	0.732	1.40247403404283e-16	SLC25A3	Erythrocytes	GSE189460_pre	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64363
7.27311629099811e-21	-0.361038472706984	0.556	0.707	1.76722179638672e-16	RPL31	Erythrocytes	GSE189460_pre	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64364
7.5177404295828e-21	-0.33156362673911	0.687	0.782	1.82666056958003e-16	MPC2	Erythrocytes	GSE189460_pre	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64365
8.07976513423903e-21	0.257131020784066	0.636	0.497	1.9632213323174e-16	EMC3	Erythrocytes	GSE189460_pre	ENSG00000125037	55831	ER membrane protein complex subunit 3	TMEM111	protein_coding	Q9P0I2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64366
9.23029983372796e-21	-0.355446228838352	0.8	0.894	2.24277825359922e-16	RPL27A	Erythrocytes	GSE189460_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64367
9.3304675175799e-21	-0.303532953264678	0.742	0.879	2.26711699742156e-16	RPL7	Erythrocytes	GSE189460_pre	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64368
9.58206227872523e-21	-0.304356896458213	0.239	0.385	2.32824949248466e-16	SREBF1	Erythrocytes	GSE189460_pre	ENSG00000072310	6720	sterol regulatory element binding transcription factor 1	bHLHd1|SREBP-1c|SREBP1|SREBP1a	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64369
1.20623029114721e-20	-0.251248950623855	0.65	0.763	2.9308983614295e-16	CALM3	Erythrocytes	GSE189460_pre	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64370
1.25656458971614e-20	-0.514239701145469	0.798	0.886	3.05320064009228e-16	RPS18	Erythrocytes	GSE189460_pre	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64371
1.32638253715353e-20	-0.306901886861716	0.446	0.598	3.22284428877565e-16	PRDX3	Erythrocytes	GSE189460_pre	ENSG00000165672	10935	peroxiredoxin 3	AOP-1|AOP1|MER5|SP-22	protein_coding	P30048	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64372
1.36040947287365e-20	-0.260240526472127	0.533	0.668	3.30552293718839e-16	EPOR	Erythrocytes	GSE189460_pre	ENSG00000187266	2057	erythropoietin receptor	NA	protein_coding	P19235	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64373
1.551550514882e-20	-0.397998382644411	0.752	0.855	3.76995744106027e-16	RPSA	Erythrocytes	GSE189460_pre	ENSG00000168028	3921	ribosomal protein SA	37LRP|LAMR1|LRP|p40|SA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64374
1.73853808022281e-20	-0.256088255991612	0.552	0.72	4.22429982732538e-16	IDH2	Erythrocytes	GSE189460_pre	ENSG00000182054	3418	isocitrate dehydrogenase (NADP(+)) 2	IDH-2	protein_coding	P48735	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64375
2.0518321079236e-20	-0.252055546977118	0.42	0.573	4.98554165583277e-16	ZWINT	Erythrocytes	GSE189460_pre	ENSG00000122952	11130	ZW10 interacting kinetochore protein	KNTC2AP|SIP30|Zwint1	protein_coding	O95229	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64376
2.44605163420673e-20	-0.296544172649382	0.531	0.668	5.9434162607955e-16	SRSF10	Erythrocytes	GSE189460_pre	ENSG00000188529	10772	serine and arginine rich splicing factor 10	FUSIP1|FUSIP2|PPP1R149|SFRS13|SFRS13A|SRp38|SRrp40|TASR1|TASR2	protein_coding	O75494	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64377
2.86013431255783e-20	-0.358117371407986	0.769	0.886	6.94955435265302e-16	RPL6	Erythrocytes	GSE189460_pre	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64378
3.47506129758252e-20	0.27366039606982	0.669	0.544	8.443703940866e-16	ISCA1	Erythrocytes	GSE189460_pre	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64379
4.094595457349e-20	-0.289654383950092	0.44	0.609	9.9490480422666e-16	MCM7	Erythrocytes	GSE189460_pre	ENSG00000166508	4176	minichromosome maintenance complex component 7	CDC47|MCM2|PPP1R104	protein_coding	P33993	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64380
4.20448437479807e-20	-0.422279931877814	0.807	0.887	1.02160561338844e-15	RPS9	Erythrocytes	GSE189460_pre	ENSG00000274646	6203	ribosomal protein S9	S9	protein_coding	P46781	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64381
5.48185490552844e-20	-0.451169210496031	0.833	0.894	1.3319811049453e-15	RPS2	Erythrocytes	GSE189460_pre	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64382
5.57386517646208e-20	-0.275524488637871	0.44	0.605	1.35433776057676e-15	ALYREF	Erythrocytes	GSE189460_pre	ENSG00000183684	10189	Aly/REF export factor	ALY|ALY/REF|BEF|REF|THOC4	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64383
7.00302573004404e-20	-0.299912647655622	0.777	0.872	1.7015951918861e-15	CALM2	Erythrocytes	GSE189460_pre	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64384
7.90947181452638e-20	0.336211461665931	0.986	0.973	1.92184346149362e-15	HBD	Erythrocytes	GSE189460_pre	ENSG00000223609	3045	hemoglobin subunit delta	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64385
9.03632893319232e-20	-0.275278483747976	0.408	0.559	2.19564720418707e-15	EZH2	Erythrocytes	GSE189460_pre	ENSG00000106462	2146	enhancer of zeste 2 polycomb repressive complex 2 subunit	ENX-1|EZH1|KMT6|KMT6A	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64386
1.00690602703872e-19	-0.280213519436304	0.456	0.594	2.44658026449868e-15	MYBL2	Erythrocytes	GSE189460_pre	ENSG00000101057	4605	MYB proto-oncogene like 2	B-MYB|BMYB	protein_coding	P10244	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64387
1.62638284186139e-19	-0.300015973466639	0.547	0.651	3.9517850291548e-15	POLR2L	Erythrocytes	GSE189460_pre	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64388
1.88818292550055e-19	-0.411872044566651	0.834	0.914	4.58790687238122e-15	RPL7A	Erythrocytes	GSE189460_pre	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64389
1.90891012557569e-19	-0.266347279666656	0.363	0.507	4.63826982312382e-15	ATAD5	Erythrocytes	GSE189460_pre	ENSG00000176208	79915	ATPase family AAA domain containing 5	C17orf41|ELG1|FLJ12735|FRAG1	protein_coding	Q96QE3	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64390
2.77347693081858e-19	-0.329183357222279	0.738	0.803	6.73899424650299e-15	TMEM14B	Erythrocytes	GSE189460_pre	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64391
3.20074736976866e-19	-0.26882511686581	0.322	0.473	7.77717595906389e-15	HMGN5	Erythrocytes	GSE189460_pre	ENSG00000198157	79366	high mobility group nucleosome binding domain 5	NSBP1	protein_coding	P82970	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64392
3.96294366483068e-19	-0.274041183988177	0.709	0.817	9.62916051680559e-15	SRSF3	Erythrocytes	GSE189460_pre	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64393
4.36587888486191e-19	-0.25262574644834	0.355	0.507	1.06082125144375e-14	CDCA4	Erythrocytes	GSE189460_pre	ENSG00000170779	55038	cell division cycle associated 4	FLJ20764|Hepp	protein_coding	Q9BXL8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64394
4.82196449707249e-19	-0.420913905429724	0.205	0.353	1.17164093349867e-14	AKR1C3	Erythrocytes	GSE189460_pre	ENSG00000196139	8644	aldo-keto reductase family 1 member C3	DDX|HAKRB|HSD17B5|KIAA0119|PGFS	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64395
6.15854596274501e-19	-0.38136443582021	0.216	0.354	1.49640349802778e-14	LRRC75A	Erythrocytes	GSE189460_pre	ENSG00000181350	388341	leucine rich repeat containing 75A	C17orf76|FAM211A|FLJ35696	protein_coding	Q8NAA5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64396
7.49632802380816e-19	-0.287537323883238	0.448	0.604	1.82145778322491e-14	ATP5F1A	Erythrocytes	GSE189460_pre	ENSG00000152234	498	ATP synthase F1 subunit alpha	ATP5A|ATP5A1|ATP5AL2|ATPM|hATP1|OMR|ORM	protein_coding	P25705	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64397
8.66682391543404e-19	-0.404055637953115	0.868	0.922	2.10586487497216e-14	RPS14	Erythrocytes	GSE189460_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64398
1.02551918550338e-18	-0.298648509366216	0.286	0.425	2.49180651693611e-14	CCND3	Erythrocytes	GSE189460_pre	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64399
1.20109698525392e-18	-0.299961165107593	0.216	0.354	2.91842545476997e-14	RPL17	Erythrocytes	GSE189460_pre	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64400
1.2824174330602e-18	-0.309258730019218	0.318	0.465	3.11601787884968e-14	RPS17	Erythrocytes	GSE189460_pre	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64401
1.59285449856429e-18	-0.352133041878737	0.496	0.632	3.8703178606115e-14	CDK1	Erythrocytes	GSE189460_pre	ENSG00000170312	983	cyclin dependent kinase 1	CDC2|CDC28A	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64402
1.59706419873993e-18	0.260844193260568	0.411	0.269	3.88054659009828e-14	YPEL3	Erythrocytes	GSE189460_pre	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64403
1.83760232526443e-18	-0.337875884118525	0.822	0.871	4.46500612992752e-14	CD36	Erythrocytes	GSE189460_pre	ENSG00000135218	948	CD36 molecule	FAT|GP3B|GP4|GPIV|SCARB3	protein_coding	P16671	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64404
2.18337422592169e-18	-0.447007086575761	0.162	0.299	5.30516269414452e-14	APOC1	Erythrocytes	GSE189460_pre	ENSG00000130208	341	apolipoprotein C1	NA	protein_coding	P02654	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64405
2.26581891577604e-18	-0.255283804000307	0.535	0.685	5.50548680155261e-14	UBE2T	Erythrocytes	GSE189460_pre	ENSG00000077152	29089	ubiquitin conjugating enzyme E2 T	FANCT|HSPC150	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64406
2.38231119625586e-18	-0.272703537452238	0.584	0.714	5.78853974466249e-14	SRI	Erythrocytes	GSE189460_pre	ENSG00000075142	6717	sorcin	NA	protein_coding	P30626	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64407
3.73976663041349e-18	-0.253175324120683	0.298	0.437	9.08688495857869e-14	HSF1	Erythrocytes	GSE189460_pre	ENSG00000284774	3297	heat shock transcription factor 1	HSTF1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64408
3.81200158396561e-18	-0.447762347453076	0.782	0.865	9.26240144871965e-14	RPL3	Erythrocytes	GSE189460_pre	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64409
6.14569982044908e-18	-0.270007869398351	0.535	0.664	1.49328214237272e-13	EIF1AX	Erythrocytes	GSE189460_pre	ENSG00000173674	1964	eukaryotic translation initiation factor 1A X-linked	eIF-1A|eIF-4C|EIF1A|EIF4C	protein_coding	P47813	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64410
1.15444870818527e-17	-0.285621235708987	0.939	0.98	2.80507947114858e-13	MT-ND1	Erythrocytes	GSE189460_pre	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64411
1.29188213528542e-17	-0.292200188516288	0.509	0.663	3.13901521231652e-13	RANBP1	Erythrocytes	GSE189460_pre	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64412
1.52981101330082e-17	0.276430603853205	0.809	0.749	3.71713480011833e-13	SEC62	Erythrocytes	GSE189460_pre	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64413
1.55418146327744e-17	-0.389379807909571	0.218	0.354	3.77635011947152e-13	GLRX	Erythrocytes	GSE189460_pre	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64414
1.60167352042182e-17	-0.369690364545491	0.278	0.438	3.89174631992094e-13	SYNGR1	Erythrocytes	GSE189460_pre	ENSG00000100321	9145	synaptogyrin 1	NA	protein_coding	O43759	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64415
1.86404133341495e-17	-0.269466596869733	0.371	0.531	4.52924763193164e-13	MCM4	Erythrocytes	GSE189460_pre	ENSG00000104738	4173	minichromosome maintenance complex component 4	CDC21|CDC54|hCdc21|MGC33310|P1-Cdc21	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64416
1.98017143613165e-17	-0.332274735997507	0.435	0.547	4.81142055551268e-13	ATP5ME	Erythrocytes	GSE189460_pre	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64417
2.0809339492903e-17	-0.390257408557461	0.678	0.795	5.05625330998558e-13	EEF1B2	Erythrocytes	GSE189460_pre	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64418
2.10695699790834e-17	-0.253071725543912	0.443	0.597	5.11948411351769e-13	DHFR	Erythrocytes	GSE189460_pre	ENSG00000228716	1719	dihydrofolate reductase	NA	protein_coding	P00374	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64419
2.60748107048984e-17	-0.37164657992467	0.869	0.917	6.33565750507621e-13	RPL24	Erythrocytes	GSE189460_pre	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64420
3.89191021759314e-17	-0.272723951763622	0.47	0.622	9.45656344670781e-13	SNRPD1	Erythrocytes	GSE189460_pre	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64421
3.91229553706484e-17	-0.28138694109008	0.425	0.546	9.50609569596014e-13	COX7A2L	Erythrocytes	GSE189460_pre	ENSG00000115944	9167	cytochrome c oxidase subunit 7A2 like	COX7AR|COX7RP|EB1|SCAF1|SCAFI|SIG81	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64422
4.9464712086251e-17	-0.378279989868913	0.868	0.913	1.20189357427173e-12	RPS7	Erythrocytes	GSE189460_pre	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64423
6.54005286525581e-17	0.362088874433101	0.262	0.151	1.58910204519986e-12	HSPA1A	Erythrocytes	GSE189460_pre	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64424
8.14155663650977e-17	-0.429576603059794	0.52	0.659	1.97823543153914e-12	HNRNPA1	Erythrocytes	GSE189460_pre	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64425
8.69499965619993e-17	-0.290602941206887	0.486	0.622	2.11271101646346e-12	CCNB2	Erythrocytes	GSE189460_pre	ENSG00000157456	9133	cyclin B2	HsT17299	protein_coding	O95067	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64426
9.74910037405805e-17	-0.268632481744384	0.985	0.99	2.36883640888863e-12	MT-CO3	Erythrocytes	GSE189460_pre	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64427
1.33545079000237e-16	-0.282415485634502	0.657	0.746	3.24487832954777e-12	NME4	Erythrocytes	GSE189460_pre	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64428
1.48054604709206e-16	-0.292746315131778	0.536	0.688	3.59743078522428e-12	TOP2A	Erythrocytes	GSE189460_pre	ENSG00000131747	7153	DNA topoisomerase II alpha	TOP2|TOP2alpha|TOPIIA	protein_coding	P11388	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64429
1.7533032516816e-16	-0.401649050734358	0.577	0.71	4.26017624093595e-12	GAPDH	Erythrocytes	GSE189460_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64430
2.58812124535361e-16	-0.405040953063442	0.642	0.751	6.28861700196021e-12	RPL23	Erythrocytes	GSE189460_pre	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64431
2.79039677205267e-16	-0.296487366301365	0.552	0.689	6.78010607673358e-12	EEF2	Erythrocytes	GSE189460_pre	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64432
8.80647686248729e-16	-0.411635476073786	0.981	0.977	2.13979774804716e-11	HBA1	Erythrocytes	GSE189460_pre	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64433
9.4184310901185e-16	-0.25523773936442	0.554	0.697	2.28849038627699e-11	ATP5MC3	Erythrocytes	GSE189460_pre	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64434
1.09203929305373e-15	0.640552160515857	0.258	0.158	2.65343707426196e-11	JCHAIN	Erythrocytes	GSE189460_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64435
1.16407576076814e-15	-0.317677470800748	0.51	0.622	2.82847128351443e-11	NDUFS5	Erythrocytes	GSE189460_pre	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64436
1.28741415460248e-15	-0.250820849589867	0.989	0.99	3.12815891285312e-11	PRDX2	Erythrocytes	GSE189460_pre	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64437
1.72640453047715e-15	-0.363830626685565	0.395	0.521	4.19481772815338e-11	ATP5MC2	Erythrocytes	GSE189460_pre	ENSG00000135390	517	ATP synthase membrane subunit c locus 2	ATP5G2	protein_coding	Q06055	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64438
2.78350342981322e-15	-0.258805682222003	0.416	0.55	6.76335663376017e-11	CALM1	Erythrocytes	GSE189460_pre	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64439
3.2610710163513e-15	-0.286788087170387	0.835	0.878	7.92375035553039e-11	MGST3	Erythrocytes	GSE189460_pre	ENSG00000143198	4259	microsomal glutathione S-transferase 3	GST-III	protein_coding	O14880	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64440
3.29348295649042e-15	0.445545488058801	0.574	0.489	8.00250488768042e-11	HES6	Erythrocytes	GSE189460_pre	ENSG00000144485	55502	hes family bHLH transcription factor 6	bHLHb41	protein_coding	Q96HZ4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64441
3.61190419317651e-15	-0.25022516237659	0.422	0.565	8.77620480858028e-11	SNRPF	Erythrocytes	GSE189460_pre	ENSG00000139343	6636	small nuclear ribonucleoprotein polypeptide F	Sm-F	protein_coding	P62306	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64442
5.52325943748023e-15	-0.257935342313819	0.388	0.516	1.34204157811895e-10	SLIRP	Erythrocytes	GSE189460_pre	ENSG00000119705	81892	SRA stem-loop interacting RNA binding protein	C14orf156|DC50	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64443
6.61690540476957e-15	0.682156994000178	0.616	0.49	1.60777567525091e-10	HIST1H1C	Erythrocytes	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64444
7.72453595757569e-15	-0.27612402584775	0.411	0.554	1.87690774697174e-10	NASP	Erythrocytes	GSE189460_pre	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64445
9.56626582758611e-15	-0.250445620138133	0.27	0.393	2.32441127078687e-10	SPN	Erythrocytes	GSE189460_pre	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64446
1.07604355929811e-14	-0.410189002538073	0.761	0.835	2.61457064038256e-10	RPL5	Erythrocytes	GSE189460_pre	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64447
1.09270931820516e-14	-0.25913050895997	0.382	0.529	2.65506510137489e-10	HMGN1	Erythrocytes	GSE189460_pre	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64448
1.42591741683302e-14	-0.311246692344101	0.65	0.771	3.46469413942087e-10	PPIA	Erythrocytes	GSE189460_pre	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64449
1.42726320992778e-14	-0.272402103037027	0.489	0.596	3.46796414748252e-10	RBM3	Erythrocytes	GSE189460_pre	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64450
1.45179716776935e-14	-0.324245570757962	0.692	0.798	3.52757675824597e-10	RPL4	Erythrocytes	GSE189460_pre	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64451
2.52977284738164e-14	-0.305155481244958	0.425	0.552	6.14684206456792e-10	HMGA1	Erythrocytes	GSE189460_pre	ENSG00000137309	3159	high mobility group AT-hook 1	HMGIY	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64452
2.67715915543736e-14	-0.322126452860791	0.96	0.968	6.5049613158817e-10	MT-CYB	Erythrocytes	GSE189460_pre	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64453
3.02113391070512e-14	-0.320898390739819	0.988	0.982	7.34075117623129e-10	MT-ND4	Erythrocytes	GSE189460_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64454
3.59686581246212e-14	0.425741399819386	0.854	0.812	8.73966455112046e-10	NEAT1	Erythrocytes	GSE189460_pre	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64455
4.60809363553996e-14	-0.261511960600629	0.742	0.875	1.1196745915635e-09	TUBA1B	Erythrocytes	GSE189460_pre	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64456
5.09707026756077e-14	0.257801319013682	0.535	0.427	1.23848613361192e-09	RNF10	Erythrocytes	GSE189460_pre	ENSG00000022840	9921	ring finger protein 10	KIAA0262|RIE2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64457
5.62768415866597e-14	-0.42688367506712	0.193	0.315	1.36741469687266e-09	FAM178B	Erythrocytes	GSE189460_pre	ENSG00000168754	51252	family with sequence similarity 178 member B	LOC51252	protein_coding	Q8IXR5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64458
7.47697415663254e-14	-0.366721701034583	0.388	0.501	1.81675518057858e-09	KCNH2	Erythrocytes	GSE189460_pre	ENSG00000055118	3757	potassium voltage-gated channel subfamily H member 2	erg1|HERG|Kv11.1|LQT2	protein_coding	Q12809	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64459
8.07668091616259e-14	-0.31476403895462	0.23	0.349	1.96247192900919e-09	AC084033.3	Erythrocytes	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64460
9.12719781858168e-14	0.290981990030367	0.727	0.658	2.21772652595898e-09	GSPT1	Erythrocytes	GSE189460_pre	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64461
1.09490749730258e-13	-0.308615654766267	0.355	0.477	2.6604062369458e-09	ATP5MC1	Erythrocytes	GSE189460_pre	ENSG00000159199	516	ATP synthase membrane subunit c locus 1	ATP5G|ATP5G1	protein_coding	P05496	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64462
1.64210798188981e-13	-0.294312706929999	0.592	0.656	3.98999397439587e-09	RHD	Erythrocytes	GSE189460_pre	ENSG00000187010	6007	Rh blood group D antigen	CD240D|DIIIc|RH|Rh30a|Rh4|RhII|RhPI	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64463
2.02868039550469e-13	0.31045738020158	0.31	0.206	4.9292876249973e-09	NFKBIA	Erythrocytes	GSE189460_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64464
2.40536311788662e-13	-0.37310898735199	0.794	0.884	5.84455130384092e-09	RPL10	Erythrocytes	GSE189460_pre	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64465
2.750160918919e-13	-0.259037922915431	0.691	0.752	6.68234100078939e-09	COX4I1	Erythrocytes	GSE189460_pre	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64466
7.89500605807917e-13	0.474689683940915	0.995	0.991	1.91832857199208e-08	UBB	Erythrocytes	GSE189460_pre	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64467
8.11696527837197e-13	0.430213103927371	0.257	0.166	1.97226022333882e-08	TSC22D3	Erythrocytes	GSE189460_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64468
2.84516939776919e-12	-0.379288436934442	0.434	0.535	6.91319260269958e-08	RPL22L1	Erythrocytes	GSE189460_pre	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64469
2.95924941872759e-12	-0.265688558089964	0.821	0.899	7.1903842376243e-08	RPL15	Erythrocytes	GSE189460_pre	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64470
4.27726838391134e-12	-0.299497323344323	0.492	0.596	1.03929067192278e-07	EIF3E	Erythrocytes	GSE189460_pre	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64471
5.68152475828688e-12	-0.412959538667987	0.765	0.817	1.38049688576855e-07	RPS26	Erythrocytes	GSE189460_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64472
8.19023096050704e-12	-0.309861395022998	0.688	0.785	1.990062318784e-07	RPL10A	Erythrocytes	GSE189460_pre	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64473
1.43187583740308e-11	-0.26474190707902	0.558	0.664	3.47917190972201e-07	EIF3A	Erythrocytes	GSE189460_pre	ENSG00000107581	8661	eukaryotic translation initiation factor 3 subunit A	EIF3|eIF3-p170|eIF3-theta|EIF3S10|KIAA0139|TIF32	protein_coding	Q14152	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64474
2.17947084436336e-11	-0.383486832037613	0.955	0.967	5.2956782576341e-07	HBA2	Erythrocytes	GSE189460_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64475
8.1643871218749e-11	-0.323728636043107	0.871	0.894	1.98378278287316e-06	RPS24	Erythrocytes	GSE189460_pre	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64476
3.79446283184735e-10	0.281516429750597	0.675	0.639	9.21978578882269e-06	GABARAPL2	Erythrocytes	GSE189460_pre	ENSG00000034713	11345	GABA type A receptor associated protein like 2	ATG8|ATG8C|GATE-16|GATE16|GEF2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64477
5.80759469854472e-10	-0.304869874596687	0.835	0.862	1.4111293598524e-05	NACA	Erythrocytes	GSE189460_pre	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64478
7.21018930974147e-10	-0.312273333799845	0.627	0.728	1.75193179848098e-05	HIST1H4C	Erythrocytes	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64479
2.96620569889151e-09	-0.267551842953199	0.489	0.604	7.2072866071666e-05	NPM1	Erythrocytes	GSE189460_pre	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64480
4.03433128003919e-08	0.267320786015247	0.356	0.28	0.000980261814423922	ATP6V0E1	Erythrocytes	GSE189460_pre	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64481
4.86125761535599e-08	-0.27323006134389	0.512	0.577	0.0011811883753792	CYTOR	Erythrocytes	GSE189460_pre	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64482
0	0.707924542448591	0.625	0.251	0	IGHA1	NK cells	GSE189460_pre	ENSG00000282633	NA	NA	AL928768.3	IG_C_gene	P01876	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64483
1.56374294403049e-265	-2.39216595064826	0.573	0.751	3.79958260540528e-261	IGLC2	NK cells	GSE189460_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64484
7.80984481229793e-231	1.07637593839333	0.938	0.958	1.89763609249215e-226	IGKC	NK cells	GSE189460_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64485
1.26347570061242e-193	0.958012290804454	0.737	0.523	3.06999325734806e-189	JCHAIN	NK cells	GSE189460_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64486
1.10390964985509e-186	0.685324301159394	0.994	0.961	2.68227966721789e-182	TXNIP	NK cells	GSE189460_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64487
2.43126690623565e-176	0.610857476061119	0.296	0.105	5.90749232877139e-172	MYOM2	NK cells	GSE189460_pre	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64488
2.253178973803e-152	-0.798806933194194	0.488	0.68	5.47477427054653e-148	NR4A2	NK cells	GSE189460_pre	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64489
1.35662652060582e-151	0.428833147939559	1	0.999	3.29633111976802e-147	MT-ND5	NK cells	GSE189460_pre	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64490
1.8660774979553e-135	0.282620114429113	0.337	0.145	4.5341951045318e-131	ITM2C	NK cells	GSE189460_pre	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64491
1.77261549882179e-124	0.448200198946882	0.883	0.779	4.30710113903718e-120	IFITM2	NK cells	GSE189460_pre	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64492
2.68280368152272e-121	0.333883591602239	1	1	6.51867638536389e-117	RPS4X	NK cells	GSE189460_pre	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64493
6.90353180744244e-113	0.542909518891649	0.417	0.216	1.67742015857236e-108	XIST	NK cells	GSE189460_pre	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64494
1.34601866749658e-108	0.432515769348909	1	0.999	3.27055615828319e-104	RPL13A	NK cells	GSE189460_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64495
8.99913573842602e-102	0.425588717409568	0.623	0.478	2.18661000172275e-97	MZB1	NK cells	GSE189460_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64496
5.55052173656814e-99	0.362412024478121	0.343	0.171	1.34866577155133e-94	HLA-DRB5	NK cells	GSE189460_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64497
1.38546542662731e-98	0.420652463379937	0.962	0.952	3.36640389361904e-94	SSR4	NK cells	GSE189460_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64498
2.66633063380466e-98	0.375679363197002	0.394	0.211	6.47865017401855e-94	GLRX	NK cells	GSE189460_pre	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64499
2.78326220063228e-83	-0.576875410540818	0.222	0.407	6.76277049509631e-79	CD8A	NK cells	GSE189460_pre	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64500
2.23138562427161e-78	0.412026139625565	0.27	0.136	5.42182078985516e-74	HLA-DQB1	NK cells	GSE189460_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64501
4.03486633837291e-78	0.349416800355186	0.279	0.143	9.8039182289785e-74	FKBP5	NK cells	GSE189460_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64502
6.12971331296056e-78	0.282605599355129	0.499	0.308	1.48939774078316e-73	FKBP2	NK cells	GSE189460_pre	ENSG00000173486	2286	FKBP prolyl isomerase 2	FKBP-13|FKBP13|PPIase	protein_coding	P26885	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64503
5.49480034571664e-66	0.26312476006648	0.699	0.486	1.33512658800223e-61	DYNLL1	NK cells	GSE189460_pre	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64504
7.87101422124946e-66	-0.39984220831482	0.363	0.516	1.91249903547919e-61	SPOCK2	NK cells	GSE189460_pre	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64505
6.74352763911873e-63	0.284729386497579	0.984	0.961	1.63854234575307e-58	RPS20	NK cells	GSE189460_pre	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64506
9.67805550405177e-63	-0.413189604194653	0.128	0.278	2.3515739263745e-58	CD8B	NK cells	GSE189460_pre	ENSG00000172116	926	CD8b molecule	CD8B1	protein_coding	P10966	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64507
6.77328198520682e-60	-0.387304840214989	0.405	0.537	1.64577205676555e-55	MIDN	NK cells	GSE189460_pre	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64508
1.64416958607605e-59	-0.360718421218703	0.302	0.45	3.9950032602476e-55	RBM38	NK cells	GSE189460_pre	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64509
3.15260955364601e-58	-0.26154864577191	1	1	7.66021069344907e-54	RPS27	NK cells	GSE189460_pre	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64510
2.67979018373763e-55	0.640011965392066	0.438	0.296	6.51135418844569e-51	IGHG1	NK cells	GSE189460_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64511
4.24007196842485e-54	0.277907228161305	0.374	0.236	1.03025268688787e-49	GIMAP4	NK cells	GSE189460_pre	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64512
5.77021733736263e-52	-0.286307488612149	0.908	0.937	1.40204740863237e-47	GZMH	NK cells	GSE189460_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64513
1.37561017305639e-51	0.648944151144349	0.268	0.159	3.34245759849243e-47	IL7R	NK cells	GSE189460_pre	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64514
1.46094746415523e-51	0.335815298154149	0.771	0.665	3.54981014840439e-47	HOPX	NK cells	GSE189460_pre	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64515
1.08505486282464e-50	-0.25195014768651	1	1	2.63646630569132e-46	MT-ND3	NK cells	GSE189460_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64516
1.1755680170936e-50	0.325247652887245	0.572	0.413	2.85639516793402e-46	CMC1	NK cells	GSE189460_pre	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64517
3.84097658333483e-48	0.406313568676879	0.559	0.435	9.33280490218698e-44	TYROBP	NK cells	GSE189460_pre	ENSG00000011600	7305	transmembrane immune signaling adaptor TYROBP	DAP12|KARAP|PLO-SL|PLOSL	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64518
5.94244220849893e-48	0.30563245193493	0.58	0.417	1.44389460782107e-43	KLRB1	NK cells	GSE189460_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64519
7.6148819859687e-48	0.377557868596721	0.924	0.941	1.85026402495068e-43	NFKBIA	NK cells	GSE189460_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64520
7.99693371718453e-47	-0.251515573306323	0.861	0.91	1.9430949546015e-42	PPP2R5C	NK cells	GSE189460_pre	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64521
1.71593609369944e-46	-0.371792105538667	0.141	0.261	4.1693815204709e-42	ZNF331	NK cells	GSE189460_pre	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64522
1.36311604860784e-45	0.290128341484237	0.403	0.273	3.31209937490733e-41	PRDM1	NK cells	GSE189460_pre	ENSG00000057657	639	PR/SET domain 1	BLIMP1|PRDI-BF1	protein_coding	O75626	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64523
1.75823884901522e-44	-0.282942899759951	0.645	0.736	4.27216875533718e-40	RUNX3	NK cells	GSE189460_pre	ENSG00000020633	864	RUNX family transcription factor 3	AML2|CBFA3|PEBP2A3	protein_coding	Q13761	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64524
1.88148286375108e-42	-0.315036623961276	0.37	0.524	4.57162706234238e-38	RPS4Y1	NK cells	GSE189460_pre	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64525
7.77950995863977e-41	-0.381851286894163	0.147	0.259	1.89026532975029e-36	RGCC	NK cells	GSE189460_pre	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64526
1.54910205890422e-40	-0.269069528354228	0.876	0.905	3.76400818272546e-36	ARL4C	NK cells	GSE189460_pre	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64527
3.4471896300877e-40	-0.42404365857869	0.966	0.979	8.3759813631871e-36	JUNB	NK cells	GSE189460_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64528
3.19196585597701e-39	-0.295659207841741	0.758	0.766	7.75583863685293e-35	SRSF2	NK cells	GSE189460_pre	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64529
3.31106296968882e-38	-0.250974054285644	0.715	0.795	8.04522080374989e-34	FLNA	NK cells	GSE189460_pre	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64530
2.13049576402033e-37	-0.272869844553877	0.491	0.592	5.17667860741659e-33	DNAJB6	NK cells	GSE189460_pre	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64531
5.56876080697106e-37	-0.325661849376534	0.317	0.427	1.35309750087783e-32	SLC38A2	NK cells	GSE189460_pre	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64532
8.24535654541872e-37	-0.271094298537009	0.394	0.507	2.00345673340584e-32	ADGRG1	NK cells	GSE189460_pre	ENSG00000205336	9289	adhesion G protein-coupled receptor G1	GPR56|TM7LN4|TM7XN1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64533
3.99452024719921e-36	0.284171123613557	0.854	0.846	9.70588529664463e-32	IL32	NK cells	GSE189460_pre	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64534
3.60773705656274e-34	-0.265482432138227	0.223	0.326	8.76607950003615e-30	P2RY8	NK cells	GSE189460_pre	ENSG00000182162	286530	P2Y receptor family member 8	P2Y8	protein_coding	Q86VZ1	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64535
5.53029917026598e-34	-0.276624742890447	0.343	0.444	1.34375209239123e-29	TGFBR3	NK cells	GSE189460_pre	ENSG00000069702	7049	transforming growth factor beta receptor 3	betaglycan|BGCAN	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64536
2.19543985317036e-32	-0.296513495801746	0.581	0.657	5.33447975523335e-28	IDS	NK cells	GSE189460_pre	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64537
1.60233355632589e-31	0.253252588005665	0.49	0.39	3.89335007516065e-27	POLR2J3.1	NK cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64538
1.45313077317035e-29	-0.265301551414668	0.244	0.339	3.53081715264933e-25	FOSL2	NK cells	GSE189460_pre	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64539
2.6594106124086e-29	0.328193436039085	0.548	0.456	6.46183590603043e-25	CLIC3	NK cells	GSE189460_pre	ENSG00000169583	9022	chloride intracellular channel 3	NA	protein_coding	O95833	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64540
9.32387579847872e-29	-0.254892168396103	0.284	0.377	2.26551534151436e-24	CHD1	NK cells	GSE189460_pre	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64541
1.02976173967374e-28	-0.264077611737719	0.463	0.546	2.50211507505924e-24	EIF4A1	NK cells	GSE189460_pre	ENSG00000161960	1973	eukaryotic translation initiation factor 4A1	DDX2A|EIF-4A|EIF4A	protein_coding	P60842	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64542
4.22993554807225e-28	-0.260124952871298	0.285	0.378	1.0277897394706e-23	SERTAD1	NK cells	GSE189460_pre	ENSG00000197019	29950	SERTA domain containing 1	SEI1|TRIP-Br1	protein_coding	Q9UHV2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64543
3.44662741973535e-27	-0.302501614494121	0.895	0.929	8.37461530447295e-23	FOSB	NK cells	GSE189460_pre	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64544
2.35994241214385e-26	-0.342852523353224	0.39	0.472	5.73418807302712e-22	TRAC	NK cells	GSE189460_pre	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64545
4.07761783196011e-26	-0.303645069299852	0.895	0.874	9.90779580809669e-22	CXCR4	NK cells	GSE189460_pre	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64546
1.80784145807606e-17	-0.297228355436451	0.54	0.584	4.39269317483322e-13	HLA-DRB1	NK cells	GSE189460_pre	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64547
6.17175702046339e-14	-0.265346488368109	0.44	0.492	1.49961352083219e-09	MYADM	NK cells	GSE189460_pre	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64548
2.60485441016935e-13	-0.251818813816817	0.327	0.382	6.32927524582948e-09	ZFP36L1	NK cells	GSE189460_pre	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64549
8.92983260054126e-08	-0.253340552653384	0.375	0.415	0.00216977072527952	AC020916.1	NK cells	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64550
5.83973887719637e-13	4.1987798641145	0.606	0	1.41893975238117e-08	IGLL5	Fibroblasts	GSE189460_pre	ENSG00000254709	100423062	immunoglobulin lambda like polypeptide 5	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64551
1.01608271762484e-10	-5.51905082696232	0.424	0.915	2.46887778728483e-06	IGLC2	Fibroblasts	GSE189460_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64552
3.9235294146972e-10	2.59961719057565	0.667	0.113	9.53339177183127e-06	IGHD	Fibroblasts	GSE189460_pre	ENSG00000278801	NA	NA	FLJ00382|FLJ46727|MGC29633	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64553
3.06018680381615e-48	2.3536369546147	0.278	0	7.43564189591248e-44	IGLL5	Progenitors	GSE189460_pre	ENSG00000254709	100423062	immunoglobulin lambda like polypeptide 5	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64554
9.56751364025014e-20	-2.52913542103363	0.278	0.698	2.32471446430798e-15	IGLC2	Progenitors	GSE189460_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64555
4.69583466496205e-13	-0.294928808540099	1	1	1.14099390689248e-08	RPLP1	Progenitors	GSE189460_pre	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64556
3.4787639699953e-12	1.31677580859324	0.289	0.074	8.45270069429457e-08	IGHD	Progenitors	GSE189460_pre	ENSG00000278801	NA	NA	FLJ00382|FLJ46727|MGC29633	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64557
1.76517812777111e-11	-0.289473318680893	1	1	4.28902981485825e-07	RPL32	Progenitors	GSE189460_pre	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64558
4.71105441032377e-11	-0.367829481289254	1	1	1.14469200062047e-06	RPL37	Progenitors	GSE189460_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64559
5.82325436688302e-11	-0.474054858879696	1	1	1.41493434606524e-06	RPS21	Progenitors	GSE189460_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64560
1.68189381284561e-10	-0.308707196748172	1	1	4.08666558645227e-06	RPS15A	Progenitors	GSE189460_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64561
2.24107947458215e-10	2.24144288508777	0.633	0.364	5.4453749073397e-06	IGKC	Progenitors	GSE189460_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64562
2.55548770654785e-10	-0.469243200065332	0.989	0.996	6.20932402936998e-06	RPS10	Progenitors	GSE189460_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64563
1.91717900803269e-09	-0.530538742595627	0.033	0.345	4.65836155371784e-05	ATP8B4	Progenitors	GSE189460_pre	ENSG00000104043	79895	ATPase phospholipid transporting 8B4 (putative)	ATPIM|KIAA1939	protein_coding	Q8TF62	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64564
2.18226085316385e-09	-0.306084722028341	1	1	5.30245742101753e-05	RPS8	Progenitors	GSE189460_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64565
4.45672673749557e-09	-0.374430952130048	1	1	0.000108289546267667	RPS29	Progenitors	GSE189460_pre	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64566
1.60149022072305e-08	-0.271399705625939	1	1	0.000389130093831287	RPL41	Progenitors	GSE189460_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64567
9.63443622356821e-08	0.648145210698879	0.9	0.832	0.0023409753136026	SSR4	Progenitors	GSE189460_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64568
1.89817604246393e-07	0.963893278880488	0.256	0.093	0.00461218814797885	IGHG3	Progenitors	GSE189460_pre	ENSG00000282184	NA	NA	NA	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64569
4.26945895213061e-07	-0.287394231485028	1	1	0.010373931361887	RPS28	Progenitors	GSE189460_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64570
5.76146584176044e-07	-0.498997366575304	0.922	0.973	0.0139992097023095	ZFAS1	Progenitors	GSE189460_pre	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64571
8.04067601140498e-07	0.358806348741396	0.611	0.377	0.0195372345725118	PSMD1	Progenitors	GSE189460_pre	ENSG00000173692	5707	proteasome 26S subunit, non-ATPase 1	P112|Rpn2|S1	protein_coding	Q99460	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64572
9.96558732994413e-07	1.07544858936724	0.389	0.177	0.0242143840942982	JCHAIN	Progenitors	GSE189460_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64573
1.14065439451476e-06	0.365193804509204	0.333	0.136	0.0277156204779196	HIST1H1B	Progenitors	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64574
1.28754187598099e-06	0.372832110972419	0.533	0.303	0.0312846925025861	HSPH1	Progenitors	GSE189460_pre	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64575
1.2555036295815e-37	3.69348695749933	0.362	0	3.05062271915714e-33	IGLL5	cDCs	GSE189460_pre	ENSG00000254709	100423062	immunoglobulin lambda like polypeptide 5	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64576
1.42014980509834e-16	-2.91508774857514	0.125	0.611	3.45067999642796e-12	IGLC2	cDCs	GSE189460_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64577
2.61287103056377e-15	1.66436306990752	0.4	0.091	6.34875403006385e-11	IGHD	cDCs	GSE189460_pre	ENSG00000278801	NA	NA	FLJ00382|FLJ46727|MGC29633	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64578
1.8325718302135e-14	0.682221860199867	0.338	0.061	4.45278303305277e-10	IGHG1	cDCs	GSE189460_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64579
3.9108097293022e-13	-0.813499236985994	0.85	0.97	9.50248548025848e-09	S100A6	cDCs	GSE189460_pre	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64580
3.29093806247648e-12	1.20798199217959	0.3	0.054	7.99632130420536e-08	C1QB	cDCs	GSE189460_pre	ENSG00000173369	713	complement C1q B chain	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64581
1.00410057722955e-11	-0.580285264808222	1	1	2.43976358255237e-07	MT-ND3	cDCs	GSE189460_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64582
1.14484288669627e-11	-0.365614541062241	1	1	2.7817392460946e-07	RPL41	cDCs	GSE189460_pre	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64583
3.84649699379125e-11	1.13874302861737	0.375	0.107	9.34621839551398e-07	JCHAIN	cDCs	GSE189460_pre	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64584
6.25464164769757e-11	0.703688817440463	0.975	0.858	1.51975282755756e-06	HSPA8	cDCs	GSE189460_pre	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64585
8.30266232751762e-11	0.84466910507934	0.975	0.897	2.01738089234023e-06	SSR4	cDCs	GSE189460_pre	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64586
1.20043852525357e-10	0.534238095804673	1	1	2.91682552866112e-06	RPL13A	cDCs	GSE189460_pre	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64587
1.32658662699175e-10	0.432104679458648	0.325	0.077	3.22334018626456e-06	MZB1	cDCs	GSE189460_pre	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64588
1.8678982986648e-10	0.578942092921972	1	0.998	4.53861928609573e-06	HLA-A	cDCs	GSE189460_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64589
2.60464968818807e-10	-0.654697075511789	0.787	0.965	6.32877781235937e-06	FCER1G	cDCs	GSE189460_pre	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64590
2.62512728676346e-10	-0.5915105922757	1	1	6.37853428137786e-06	RPS21	cDCs	GSE189460_pre	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64591
2.78558318239124e-10	1.50003521674059	0.662	0.35	6.76841001657424e-06	IGKC	cDCs	GSE189460_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64592
3.33400745016596e-10	-1.32898639579213	0.35	0.664	8.10097130241324e-06	HBB	cDCs	GSE189460_pre	ENSG00000244734	3043	hemoglobin subunit beta	beta-globin|CD113t-C	protein_coding	P68871	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64593
6.11264551079299e-10	0.59857541968103	0.938	0.921	1.48525060621248e-05	C1orf162	cDCs	GSE189460_pre	ENSG00000143110	128346	chromosome 1 open reading frame 162	MGC24133	protein_coding	Q8NEQ5	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64594
8.81212852375829e-10	0.636736150445207	0.325	0.086	2.14117098870279e-05	IGHG4	cDCs	GSE189460_pre	ENSG00000277016	NA	NA	NA	IG_C_gene	P01861	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64595
1.15155899749825e-09	-0.662669989093891	0.088	0.455	2.79805805212124e-05	HBA2	cDCs	GSE189460_pre	ENSG00000188536	3040	hemoglobin subunit alpha 2	HBA-T2	protein_coding	P69905	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64596
1.77064944108086e-09	0.875246940963151	0.65	0.396	4.30232401193828e-05	FKBP5	cDCs	GSE189460_pre	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64597
1.95751420484382e-09	0.90751771800087	0.275	0.068	4.75636801492951e-05	IGHG3	cDCs	GSE189460_pre	ENSG00000282184	NA	NA	NA	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64598
2.11137983264586e-09	0.582795513476813	1	0.998	5.1302307173629e-05	HLA-C	cDCs	GSE189460_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64599
4.04851403927368e-09	0.539031799728637	0.35	0.103	9.8370794126272e-05	ISG20	cDCs	GSE189460_pre	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64600
8.18618406922271e-09	-0.588239877782565	0.838	0.965	0.000198907900513973	EMP3	cDCs	GSE189460_pre	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64601
1.34202868410404e-08	-0.404083670112874	1	1	0.0003260861296636	RPL26	cDCs	GSE189460_pre	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64602
1.60158895588912e-08	0.666782527276046	0.963	0.811	0.000389154084501939	PSME2	cDCs	GSE189460_pre	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64603
1.90770393993886e-08	-0.513565843546053	0.963	0.991	0.000463533903326345	RPS10	cDCs	GSE189460_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64604
3.02820203665911e-08	-0.758683355036313	0.762	0.883	0.00073579253086743	CD44	cDCs	GSE189460_pre	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64605
3.2942045019871e-08	0.474194971309038	0.45	0.175	0.000800425809892826	HIST1H1C	cDCs	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64606
4.07611331963444e-08	-0.314198034116352	1	1	0.000990414014404775	RPS15A	cDCs	GSE189460_pre	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64607
4.74253050607373e-08	-0.819169044585964	0.488	0.739	0.00115234006236579	AC020916.1	cDCs	GSE189460_pre	NA	NA	NA	NA	NA	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64608
1.17348796281908e-07	0.335318289395375	1	1	0.00285134105205781	HLA-B	cDCs	GSE189460_pre	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64609
1.19573882576599e-07	-0.418952219874265	1	1	0.0029054061988462	RPL37	cDCs	GSE189460_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64610
1.60426292968062e-07	-0.536954866534602	0.75	0.886	0.00389803806653797	HNRNPH1	cDCs	GSE189460_pre	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64611
1.67734292047874e-07	-0.553115394453377	0.075	0.389	0.00407560782817925	HBA1	cDCs	GSE189460_pre	ENSG00000206172	3039	hemoglobin subunit alpha 1	HBA-T3	protein_coding	P69905	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64612
1.6998551721851e-07	-0.499360078883251	0.2	0.534	0.00413030809737536	CRIP1	cDCs	GSE189460_pre	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64613
2.055817996353e-07	-0.548552020892223	0.45	0.709	0.00499522656753852	FOSL2	cDCs	GSE189460_pre	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64614
2.93333604019068e-07	-0.579513939915484	0.812	0.956	0.00712741991045531	S100A4	cDCs	GSE189460_pre	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64615
3.52164950283183e-07	-0.548856065297436	1	1	0.00855690396198077	RPL39	cDCs	GSE189460_pre	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64616
3.87666393156951e-07	-0.564885199692599	0.613	0.83	0.00941951802092759	MIDN	cDCs	GSE189460_pre	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64617
6.49394110360833e-07	-0.480418237976143	0.275	0.58	0.0157789780935475	MAP2K3	cDCs	GSE189460_pre	ENSG00000034152	5606	mitogen-activated protein kinase kinase 3	MAPKK3|MEK3|MKK3|PRKMK3	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64618
1.00539047691673e-06	0.577774169751623	0.887	0.697	0.0244289778081227	PSMB9	cDCs	GSE189460_pre	ENSG00000239836	5698	proteasome 20S subunit beta 9	beta1i|LMP2|PSMB6i|RING12	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64619
1.02120214871415e-06	-0.346679510716681	1	1	0.0248131698094565	RPS8	cDCs	GSE189460_pre	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64620
1.73688380961161e-06	-0.333514910642319	1	1	0.0422028028059429	RPL35	cDCs	GSE189460_pre	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64621
1.80329346596725e-06	-0.381399083085471	1	1	0.0438164246360723	GAPDH	cDCs	GSE189460_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64622
2.83565308448229e-14	1.78395437739607	0.583	0.109	6.89006986467506e-10	IGHG3	pDCs	GSE189460_pre	ENSG00000282184	NA	NA	NA	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64623
3.03412403162258e-13	1.98001748606875	0.611	0.142	7.37231457203654e-09	IGHG1	pDCs	GSE189460_pre	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64624
5.88938407259275e-13	-3.14277733151391	0.028	0.777	1.43100254195859e-08	IGLC2	pDCs	GSE189460_pre	ENSG00000211677	NA	NA	IGLC	IG_C_gene	P0DOY2	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64625
5.98860772924227e-11	1.48457643853585	0.556	0.137	1.45511190605129e-06	IGHG4	pDCs	GSE189460_pre	ENSG00000277016	NA	NA	NA	IG_C_gene	P01861	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64626
9.6169472890418e-11	0.942599129321766	0.833	0.299	2.33672585229138e-06	GLUL	pDCs	GSE189460_pre	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64627
1.03660660876366e-08	-0.622308633590629	1	1	0.000251874673797393	RPL37	pDCs	GSE189460_pre	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64628
3.79424532746074e-08	0.304736291961774	0.333	0.047	0.00092192572966641	CCL3	pDCs	GSE189460_pre	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64629
4.66338512946318e-08	1.31527097036987	0.972	0.986	0.00113310931875696	IGKC	pDCs	GSE189460_pre	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64630
8.14953738776085e-08	0.337578714165584	0.278	0.033	0.00198017459447813	CSGALNACT1	pDCs	GSE189460_pre	ENSG00000147408	55790	chondroitin sulfate N-acetylgalactosaminyltransferase 1	ChGn|CSGalNAcT-1|FLJ11264	protein_coding	Q8TDX6	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64631
8.59922700591158e-08	1.06809130056293	1	0.915	0.0020894401778964	ZFP36L2	pDCs	GSE189460_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64632
1.22336656963148e-07	0.526083206302042	0.306	0.043	0.00297253609089057	CCL4	pDCs	GSE189460_pre	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64633
2.59714408922598e-07	0.870209866666363	0.972	0.787	0.00631054070800129	TSC22D3	pDCs	GSE189460_pre	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64634
3.18954309032187e-07	0.778097015725075	1	0.972	0.00774995180086409	HLA-C	pDCs	GSE189460_pre	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64635
7.37227037955372e-07	1.84868838306122	0.667	0.365	0.0179131425682396	AREG	pDCs	GSE189460_pre	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64636
7.56607158851732e-07	0.886900607522219	0.944	0.929	0.0183840407457794	HLA-DQB1	pDCs	GSE189460_pre	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64637
1.08742207338317e-06	1.25744298420816	0.25	0.033	0.0264221815390642	CCL4L2	pDCs	GSE189460_pre	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64638
1.75765857122784e-06	0.579630633314101	0.5	0.166	0.0427075879636941	FOXO3	pDCs	GSE189460_pre	ENSG00000118689	2309	forkhead box O3	AF6q21|FKHRL1|FOXO2|FOXO3A	protein_coding	O43524	GSE189460	GSE189460	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	pre	bortezomib + melphalan + prednisolone	Homo sapiens	patients	Bone marrow aspirate	pre (resistant 5, sensitive 13)	18	110638	Public on Sep 14, 2022	36380017	This dataset has 18 patients with pre-treatment samples.	PRJNA783047	10x genomics	CellRanger 3.0.1	Multiple_myeloma	Targeted_therapy	64639
4.94770695431811e-239	-0.676470504845173	0.006	0.334	1.18829077921858e-234	SCGB1A1	CD8+ T cells	GSE207422_Sin_post	ENSG00000149021	7356	secretoglobin family 1A member 1	CC10|CC16|CCSP|UGB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64640
2.21563558002887e-128	2.33899709832072	0.724	0.115	5.32129197255534e-124	GZMB	CD8+ T cells	GSE207422_Sin_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64641
7.27316313226092e-110	-0.829095744144721	0.154	0.553	1.7467955894751e-105	RPL10P3	CD8+ T cells	GSE207422_Sin_post	ENSG00000230734	NA	NA	bA567J2.2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64642
1.10246230694657e-99	0.771331750698191	0.999	0.985	2.64778372259358e-95	MT-CO2	CD8+ T cells	GSE207422_Sin_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64643
9.17829986799201e-98	-0.848525547422717	1	1	2.20435227929564e-93	MT-RNR2	CD8+ T cells	GSE207422_Sin_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64644
3.43117727085998e-93	-0.692005831005574	0.997	1	8.24065845142441e-89	RPS29	CD8+ T cells	GSE207422_Sin_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64645
5.04431562490224e-79	-0.710742572979875	0.987	0.996	1.21149328363277e-74	RPS6	CD8+ T cells	GSE207422_Sin_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64646
1.5684579571374e-75	1.44268651006079	0.666	0.245	3.76696547565691e-71	IFI6	CD8+ T cells	GSE207422_Sin_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64647
1.20971073031048e-70	-0.812625022684278	0.893	0.94	2.90536226098668e-66	MT-ATP8	CD8+ T cells	GSE207422_Sin_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64648
2.64068873389954e-70	-0.678891382832886	0.958	0.991	6.34214213220652e-66	RPL30	CD8+ T cells	GSE207422_Sin_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64649
5.57205858261616e-70	0.906776727878638	0.756	0.34	1.33824130978692e-65	LDHA	CD8+ T cells	GSE207422_Sin_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64650
5.67857079264009e-70	1.24533826330105	0.596	0.155	1.36382234726837e-65	DUSP4	CD8+ T cells	GSE207422_Sin_post	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64651
9.4177675418829e-65	0.873324757558877	0.458	0.034	2.26186523053402e-60	HAVCR2	CD8+ T cells	GSE207422_Sin_post	ENSG00000135077	84868	hepatitis A virus cellular receptor 2	CD366|FLJ14428|Tim-3|TIM3|TIMD3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64652
1.73682656686341e-61	1.92157709562188	0.448	0.045	4.17133636563586e-57	CXCL13	CD8+ T cells	GSE207422_Sin_post	ENSG00000156234	10563	C-X-C motif chemokine ligand 13	ANGIE|ANGIE2|BCA-1|BLC|BLR1L|SCYB13	protein_coding	O43927	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64653
1.78967699519448e-61	0.927088714600132	0.873	0.626	4.29826723935858e-57	GAPDH	CD8+ T cells	GSE207422_Sin_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64654
2.41383846359938e-61	-0.633300232673439	0.95	0.983	5.79731583802662e-57	PTPRC	CD8+ T cells	GSE207422_Sin_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64655
9.94718592853464e-61	0.839464698271147	0.525	0.117	2.38901564445617e-56	LAG3	CD8+ T cells	GSE207422_Sin_post	ENSG00000089692	3902	lymphocyte activating 3	CD223	protein_coding	P18627	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64656
1.74665644971655e-60	2.45307893232517	0.541	0.13	4.19494479528423e-56	GNLY	CD8+ T cells	GSE207422_Sin_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64657
4.51979694142895e-58	0.826842189203843	0.448	0.055	1.08551963142299e-53	SLC7A5	CD8+ T cells	GSE207422_Sin_post	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64658
4.63874042116813e-58	0.907008146917421	0.673	0.274	1.11408628695195e-53	CD7	CD8+ T cells	GSE207422_Sin_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64659
5.81799819652167e-58	0.429504187546232	1	1	1.39730862685861e-53	HLA-B	CD8+ T cells	GSE207422_Sin_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64660
4.14108285044283e-57	0.387163645967968	1	1	9.94563868190854e-53	HLA-A	CD8+ T cells	GSE207422_Sin_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64661
2.91626982078791e-56	0.866451831406625	0.459	0.068	7.00400522858633e-52	PHLDA1	CD8+ T cells	GSE207422_Sin_post	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64662
3.57986162608412e-55	-0.525508166800832	0.974	0.996	8.59775366736623e-51	RPS27A	CD8+ T cells	GSE207422_Sin_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64663
6.63231806267455e-55	0.788983463366605	0.794	0.374	1.59288382911255e-50	RGS1	CD8+ T cells	GSE207422_Sin_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64664
6.56181111211753e-54	0.975613027892359	0.621	0.26	1.57595017479727e-49	RBPJ	CD8+ T cells	GSE207422_Sin_post	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64665
7.2636106271754e-54	0.984829431602049	0.726	0.391	1.74450136432871e-49	PRF1	CD8+ T cells	GSE207422_Sin_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64666
3.28093365805665e-53	1.019175228448	0.742	0.37	7.87981836655467e-49	TNFAIP3	CD8+ T cells	GSE207422_Sin_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64667
3.31235662966528e-53	0.306656244188512	1	1	7.95528691746709e-49	B2M	CD8+ T cells	GSE207422_Sin_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64668
1.66926326229714e-51	0.563108903756881	0.999	0.987	4.00906957705904e-47	MT-CO3	CD8+ T cells	GSE207422_Sin_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64669
1.50860272225211e-48	-0.562265894246467	0.951	0.981	3.62321115803289e-44	RPS8	CD8+ T cells	GSE207422_Sin_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64670
7.20108832421194e-48	0.691138353057785	0.651	0.287	1.72948538282598e-43	PGK1	CD8+ T cells	GSE207422_Sin_post	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64671
5.67581166359809e-47	0.618027263322256	0.421	0.074	1.36315968724635e-42	ITGAE	CD8+ T cells	GSE207422_Sin_post	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64672
2.5504857629058e-45	-0.523423455127999	0.954	0.977	6.12550165677087e-41	RPL37A	CD8+ T cells	GSE207422_Sin_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64673
6.22965783625257e-44	0.595357093482897	0.707	0.357	1.49617692253278e-39	TAP1	CD8+ T cells	GSE207422_Sin_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64674
1.66727882722975e-43	0.717481214138694	0.411	0.081	4.0043035593577e-39	CTLA4	CD8+ T cells	GSE207422_Sin_post	ENSG00000163599	1493	cytotoxic T-lymphocyte associated protein 4	CD|CD152|CELIAC3|CTLA-4|GSE|IDDM12	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64675
3.45354625521568e-43	0.592835238986674	0.543	0.191	8.29438204115151e-39	ANXA5	CD8+ T cells	GSE207422_Sin_post	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64676
4.39882190746017e-43	0.709716138399256	0.386	0.055	1.05646505751471e-38	HLA-DRB5	CD8+ T cells	GSE207422_Sin_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64677
8.8937047741731e-43	0.639437216031208	0.362	0.045	2.13600107561315e-38	MYO7A	CD8+ T cells	GSE207422_Sin_post	ENSG00000137474	4647	myosin VIIA	DFNA11|DFNB2|NSRD2|USH1B	protein_coding	Q13402	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64678
1.08420648605667e-40	0.741490892300527	0.659	0.349	2.60393871756232e-36	TPI1	CD8+ T cells	GSE207422_Sin_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64679
4.00706205606231e-40	0.665163286531907	0.565	0.223	9.62376094004484e-36	PRDM1	CD8+ T cells	GSE207422_Sin_post	ENSG00000057657	639	PR/SET domain 1	BLIMP1|PRDI-BF1	protein_coding	O75626	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64680
5.92419792776442e-40	0.709291816325347	0.566	0.234	1.42281461631118e-35	PTMS	CD8+ T cells	GSE207422_Sin_post	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64681
1.74966413646701e-39	-0.446150164057658	0.99	0.996	4.20216835655281e-35	RPL34	CD8+ T cells	GSE207422_Sin_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64682
2.07685139249362e-39	0.731679153977318	0.645	0.33	4.98797398935193e-35	ALOX5AP	CD8+ T cells	GSE207422_Sin_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64683
9.4703418099093e-39	0.736588865877815	0.588	0.253	2.27449199248592e-34	TSC22D3	CD8+ T cells	GSE207422_Sin_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64684
9.75467658946086e-39	-0.532205747149517	0.829	0.906	2.34278067649081e-34	RPL23A	CD8+ T cells	GSE207422_Sin_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64685
1.48552397660268e-38	0.602391155192517	0.469	0.145	3.56778293460665e-34	DDIT4	CD8+ T cells	GSE207422_Sin_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64686
1.99719096666928e-38	0.494278925354497	0.32	0.032	4.7966535446496e-34	FAM118A	CD8+ T cells	GSE207422_Sin_post	ENSG00000100376	55007	family with sequence similarity 118 member A	bK268H5.C22.4|C22orf8|FLJ20635	protein_coding	Q9NWS6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64687
2.38734212578206e-38	-0.39887031197572	0.998	1	5.73367958349078e-34	EEF1A1	CD8+ T cells	GSE207422_Sin_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64688
5.89766197543032e-38	0.69413643287364	0.387	0.083	1.4164414766391e-33	DUSP5	CD8+ T cells	GSE207422_Sin_post	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64689
6.76570892981811e-38	0.605299471402512	0.587	0.249	1.62492031367442e-33	STAT1	CD8+ T cells	GSE207422_Sin_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64690
1.06298652013864e-37	0.605787240571487	0.42	0.111	2.55297472541698e-33	BHLHE40	CD8+ T cells	GSE207422_Sin_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64691
1.51910468111935e-37	0.850448307297689	0.639	0.319	3.64843371264434e-33	RGS2	CD8+ T cells	GSE207422_Sin_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64692
1.10079650903613e-36	0.584889185679994	0.469	0.157	2.64378297575208e-32	SERPINB9	CD8+ T cells	GSE207422_Sin_post	ENSG00000170542	5272	serpin family B member 9	CAP3|PI9	protein_coding	P50453	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64693
1.44225173428806e-36	0.597826802910017	0.812	0.547	3.46385599023963e-32	IFITM2	CD8+ T cells	GSE207422_Sin_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64694
2.66971410690262e-36	0.915301940702692	0.654	0.353	6.41185237054802e-32	HMGB2	CD8+ T cells	GSE207422_Sin_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64695
2.66176351148315e-35	0.526722006584448	0.392	0.1	6.39275742552909e-31	METRNL	CD8+ T cells	GSE207422_Sin_post	ENSG00000275031	284207	meteorin like, glial cell differentiation regulator	NA	protein_coding	Q641Q3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64696
3.53809798924878e-35	0.542316761784888	0.486	0.174	8.4974499407788e-31	SAMSN1	CD8+ T cells	GSE207422_Sin_post	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64697
5.69822930068343e-35	0.605331244663707	0.725	0.432	1.36854373114514e-30	SRSF7	CD8+ T cells	GSE207422_Sin_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64698
7.47438687629188e-35	0.691492260378742	0.698	0.402	1.79512349607902e-30	ID2	CD8+ T cells	GSE207422_Sin_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64699
1.49468386361795e-34	0.515691374437776	0.32	0.047	3.58978223525124e-30	AKAP5	CD8+ T cells	GSE207422_Sin_post	ENSG00000179841	9495	A-kinase anchoring protein 5	AKAP75|AKAP79	protein_coding	P24588	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64700
8.92578338457179e-34	1.00363538191364	0.49	0.211	2.14370539547261e-29	RHOB	CD8+ T cells	GSE207422_Sin_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64701
9.29727375218818e-34	0.705983081001328	0.495	0.196	2.23292623706303e-29	NFKBIA	CD8+ T cells	GSE207422_Sin_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64702
1.03953118235021e-33	0.652322817026756	0.792	0.613	2.49664204065049e-29	CD8A	CD8+ T cells	GSE207422_Sin_post	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64703
3.82009136607029e-33	1.15942151779467	0.386	0.102	9.17471343389102e-29	CCL3	CD8+ T cells	GSE207422_Sin_post	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64704
5.4231771673767e-33	0.524966802047257	0.497	0.202	1.30248446028886e-28	SH2D2A	CD8+ T cells	GSE207422_Sin_post	ENSG00000027869	9047	SH2 domain containing 2A	F2771|TSAd	protein_coding	Q9NP31	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64705
1.06332632393222e-32	0.634881290987105	0.672	0.387	2.55379083218801e-28	GZMH	CD8+ T cells	GSE207422_Sin_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64706
2.70956428418935e-32	-0.684930538055389	0.566	0.736	6.50756054133757e-28	AHNAK	CD8+ T cells	GSE207422_Sin_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64707
3.77540315365257e-32	1.38632855323534	0.807	0.555	9.06738575412739e-28	CCL4	CD8+ T cells	GSE207422_Sin_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64708
5.59451209773968e-32	-0.498969863032297	0.86	0.889	1.34363397051414e-27	RPL11	CD8+ T cells	GSE207422_Sin_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64709
2.43164100886841e-31	0.554017902283947	0.896	0.736	5.84007221099925e-27	NKG7	CD8+ T cells	GSE207422_Sin_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64710
5.89796110209744e-31	0.492415986309349	0.332	0.07	1.41651331789074e-26	ISG15	CD8+ T cells	GSE207422_Sin_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64711
1.53998035665854e-30	0.455083307565136	0.361	0.094	3.69857082258681e-26	DUSP16	CD8+ T cells	GSE207422_Sin_post	ENSG00000280962	80824	dual specificity phosphatase 16	KIAA1700|MKP-7|MKP7	protein_coding	Q9BY84	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64712
2.82295631541755e-30	0.587236844199708	0.661	0.383	6.77989418273832e-26	HLA-DRB1	CD8+ T cells	GSE207422_Sin_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64713
5.44445538213858e-30	0.667905685354763	0.63	0.366	1.30759484912822e-25	TIGIT	CD8+ T cells	GSE207422_Sin_post	ENSG00000181847	201633	T cell immunoreceptor with Ig and ITIM domains	DKFZp667A205|FLJ39873|VSIG9|VSTM3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64714
6.35031922649291e-30	0.571691788007271	0.378	0.113	1.5251561686268e-25	CREM	CD8+ T cells	GSE207422_Sin_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64715
8.73117246481244e-30	0.550815269045519	0.33	0.072	2.096965690874e-25	FOSL2	CD8+ T cells	GSE207422_Sin_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64716
9.52103473351931e-30	0.756477395617379	0.531	0.251	2.28666691194933e-25	RGCC	CD8+ T cells	GSE207422_Sin_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64717
2.45354727057049e-29	0.492894199847922	0.911	0.736	5.89268447972914e-25	CD2	CD8+ T cells	GSE207422_Sin_post	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64718
3.35617661855468e-29	0.449698783812704	0.409	0.143	8.06052938478278e-25	SLC3A2	CD8+ T cells	GSE207422_Sin_post	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64719
4.25690530942476e-29	0.428004379082423	1	0.998	1.02238094816454e-24	MT-CO1	CD8+ T cells	GSE207422_Sin_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64720
4.39065694320092e-29	0.490822092895794	0.255	0.023	1.05450407804856e-24	IFI44L	CD8+ T cells	GSE207422_Sin_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64721
1.18599586033737e-28	0.396895274393425	0.291	0.051	2.84840625777225e-24	MTHFD2	CD8+ T cells	GSE207422_Sin_post	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64722
1.68906878122202e-28	0.505894750616493	0.579	0.291	4.05663649186092e-24	TPM4	CD8+ T cells	GSE207422_Sin_post	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64723
4.08412662299981e-28	0.451532352532228	0.642	0.355	9.80884691045863e-24	SRSF2	CD8+ T cells	GSE207422_Sin_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64724
4.11888518253561e-28	0.631887312639741	0.326	0.079	9.89232654289576e-24	CSF1	CD8+ T cells	GSE207422_Sin_post	ENSG00000184371	1435	colony stimulating factor 1	M-CSF|MCSF|MGC31930	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64725
4.3069774839309e-28	0.495585122855122	0.559	0.279	1.03440678231568e-23	GBP2	CD8+ T cells	GSE207422_Sin_post	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64726
5.7384267862903e-28	0.690229257366138	0.917	0.772	1.37819796126334e-23	HSPA8	CD8+ T cells	GSE207422_Sin_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64727
6.6470075715681e-28	0.516736984848627	0.339	0.091	1.59641180846351e-23	MX1	CD8+ T cells	GSE207422_Sin_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64728
1.58666476074411e-27	0.491588166027611	0.41	0.151	3.81069275587914e-23	PDE4D	CD8+ T cells	GSE207422_Sin_post	ENSG00000113448	5144	phosphodiesterase 4D	DPDE3	protein_coding	Q08499	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64729
2.06923105652784e-27	-0.410572339869165	0.652	0.847	4.96967222846292e-23	TXNIP	CD8+ T cells	GSE207422_Sin_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64730
2.82681171475086e-27	0.524813051995453	0.808	0.587	6.78915369531714e-23	MCL1	CD8+ T cells	GSE207422_Sin_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64731
2.93794561461737e-27	0.483263304834484	0.447	0.179	7.05606398262654e-23	CD82	CD8+ T cells	GSE207422_Sin_post	ENSG00000085117	3732	CD82 molecule	IA4|KAI1|R2|ST6|TSPAN27	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64732
3.97252636022487e-27	0.492507546038813	0.382	0.134	9.54081655935207e-23	PDCD1	CD8+ T cells	GSE207422_Sin_post	ENSG00000276977	5133	programmed cell death 1	CD279|hSLE1|PD-1|PD1|SLEB2	protein_coding	Q15116	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64733
4.60572944866955e-27	0.41116714637141	0.487	0.211	1.10615804168697e-22	YWHAE	CD8+ T cells	GSE207422_Sin_post	ENSG00000274474	7531	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon	FLJ45465	protein_coding	P62258	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64734
5.40409059641378e-27	0.462833865485432	0.515	0.247	1.2979004385407e-22	CLEC2B	CD8+ T cells	GSE207422_Sin_post	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64735
5.63224310605058e-27	-0.360209045484274	0.988	0.994	1.35269582678017e-22	HLA-E	CD8+ T cells	GSE207422_Sin_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64736
1.67047147247227e-26	0.470476077795243	0.349	0.104	4.01197133543665e-22	ACP5	CD8+ T cells	GSE207422_Sin_post	ENSG00000102575	54	acid phosphatase 5, tartrate resistant	HPAP|TRAcP|TRAP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64737
3.70096196456187e-26	0.403762210786067	0.282	0.055	8.88860035028824e-22	GALNT2	CD8+ T cells	GSE207422_Sin_post	ENSG00000143641	2590	polypeptide N-acetylgalactosaminyltransferase 2	GalNAc-T2	protein_coding	Q10471	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64738
4.09981543691074e-26	0.329159609148655	0.994	0.964	9.84652673482852e-22	MT-ND1	CD8+ T cells	GSE207422_Sin_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64739
1.44032151973706e-25	0.257605742004401	1	1	3.45922019395249e-21	HLA-C	CD8+ T cells	GSE207422_Sin_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64740
2.11135878546492e-25	0.420764293189583	0.254	0.04	5.0708503950511e-21	ENTPD1	CD8+ T cells	GSE207422_Sin_post	ENSG00000138185	953	ectonucleoside triphosphate diphosphohydrolase 1	ATPDase|CD39|NTPDase-1|SPG64	protein_coding	P49961	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64741
2.38924964585475e-25	0.483106724482575	0.441	0.177	5.73826087444935e-21	KLRD1	CD8+ T cells	GSE207422_Sin_post	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64742
3.17450915816885e-25	0.425045140208808	0.612	0.33	7.62421864517413e-21	ITGB1	CD8+ T cells	GSE207422_Sin_post	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64743
3.91936578499861e-25	0.472269254596642	0.72	0.451	9.41314080583115e-21	ITM2A	CD8+ T cells	GSE207422_Sin_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64744
4.79516954543326e-25	0.465914369859564	0.376	0.138	1.15165586972671e-20	FASLG	CD8+ T cells	GSE207422_Sin_post	ENSG00000117560	356	Fas ligand	APT1LG1|CD178|FasL|TNFSF6	protein_coding	P48023	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64745
4.81054438201909e-25	0.558979546444346	0.584	0.334	1.15534844422953e-20	SLA	CD8+ T cells	GSE207422_Sin_post	ENSG00000155926	6503	Src like adaptor	hSLAP|SLA1|SLAP|SLAP-1	protein_coding	Q13239	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64746
5.97361386352004e-25	0.395539983685188	0.349	0.113	1.43468284160161e-20	PARP9	CD8+ T cells	GSE207422_Sin_post	ENSG00000138496	83666	poly(ADP-ribose) polymerase family member 9	ARTD9|BAL|BAL1	protein_coding	Q8IXQ6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64747
7.57185885121959e-25	-0.510655912434377	0.667	0.766	1.81853334029741e-20	RPL41	CD8+ T cells	GSE207422_Sin_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64748
8.21390338941389e-25	0.441164991875315	0.463	0.211	1.97273317703553e-20	SIRPG	CD8+ T cells	GSE207422_Sin_post	ENSG00000089012	55423	signal regulatory protein gamma	bA77C3.1|CD172g|SIRP-B2|SIRPB2|SIRPgamma	protein_coding	Q9P1W8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64749
1.04855526650327e-24	0.435493781703883	0.577	0.306	2.51831518356091e-20	RAN	CD8+ T cells	GSE207422_Sin_post	ENSG00000132341	5901	RAN, member RAS oncogene family	ARA24|Gsp1|TC4	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64750
1.26006712230001e-24	0.443611499506572	0.714	0.468	3.02630320762794e-20	CD96	CD8+ T cells	GSE207422_Sin_post	ENSG00000153283	10225	CD96 molecule	TACTILE	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64751
1.39539254744331e-24	0.478859845775429	0.344	0.106	3.35131428119461e-20	PMAIP1	CD8+ T cells	GSE207422_Sin_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64752
2.04970243019852e-24	-0.397818335196882	0.892	0.913	4.92277032660778e-20	RPS11	CD8+ T cells	GSE207422_Sin_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64753
2.6660741327423e-24	0.435717140428567	0.885	0.73	6.40311024460718e-20	H3F3B	CD8+ T cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64754
4.58540067996231e-24	0.392977327901512	0.291	0.072	1.10127568130655e-19	TFRC	CD8+ T cells	GSE207422_Sin_post	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64755
4.65906699006389e-24	0.540024109095001	0.474	0.236	1.11896811900364e-19	H2AFZ	CD8+ T cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64756
4.75415592446427e-24	0.539873005913416	0.622	0.372	1.14180562837858e-19	PKM	CD8+ T cells	GSE207422_Sin_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64757
5.42014926172763e-24	-0.410733418950789	0.862	0.891	1.30175724818912e-19	RPS14	CD8+ T cells	GSE207422_Sin_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64758
5.45347092344561e-24	0.495480454162715	0.622	0.36	1.30976011168393e-19	ENO1	CD8+ T cells	GSE207422_Sin_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64759
5.86066632531922e-24	0.767939588877009	0.416	0.181	1.40755623135192e-19	NR4A1	CD8+ T cells	GSE207422_Sin_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64760
6.38351628017004e-24	0.40441518046667	0.425	0.181	1.53312910500844e-19	SLA2	CD8+ T cells	GSE207422_Sin_post	ENSG00000101082	84174	Src like adaptor 2	C20orf156|FLJ21992|SLAP-2	protein_coding	Q9H6Q3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64761
8.71043150147467e-24	0.608995675928041	0.489	0.253	2.09198433370917e-19	MT2A	CD8+ T cells	GSE207422_Sin_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64762
1.06138139041134e-23	0.452160002986901	0.553	0.291	2.54911968535092e-19	CD63	CD8+ T cells	GSE207422_Sin_post	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64763
1.48419336232182e-23	0.336639711011081	0.292	0.072	3.56458719828831e-19	ZNRF1	CD8+ T cells	GSE207422_Sin_post	ENSG00000186187	84937	zinc and ring finger 1	DKFZp434E229|FLJ14846|nin283	protein_coding	Q8ND25	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64764
3.58684972471275e-23	0.860811120200307	0.489	0.255	8.61453698384261e-19	IFNG	CD8+ T cells	GSE207422_Sin_post	ENSG00000111537	3458	interferon gamma	NA	protein_coding	P01579	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64765
3.69168588539351e-23	-0.508188485954811	0.269	0.46	8.8663219909496e-19	PLEK	CD8+ T cells	GSE207422_Sin_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64766
5.38467815775446e-23	0.424549215720824	0.438	0.204	1.29323815314789e-18	LINC01871	CD8+ T cells	GSE207422_Sin_post	ENSG00000235576	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64767
5.68948754824387e-23	-0.384252512386333	0.906	0.928	1.36644422446173e-18	RPS3	CD8+ T cells	GSE207422_Sin_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64768
5.98443446300542e-23	0.400740083531391	0.486	0.243	1.43728162498001e-18	HDGF	CD8+ T cells	GSE207422_Sin_post	ENSG00000143321	3068	heparin binding growth factor	HMG1L2	protein_coding	P51858	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64769
6.55671509921033e-23	0.333822979253675	0.288	0.07	1.57472626537735e-18	PLSCR1	CD8+ T cells	GSE207422_Sin_post	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64770
6.95382418432289e-23	0.397613818131742	0.366	0.136	1.67009995434883e-18	CXCR6	CD8+ T cells	GSE207422_Sin_post	ENSG00000172215	10663	C-X-C motif chemokine receptor 6	BONZO|CD186|STRL33|TYMSTR	protein_coding	O00574	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64771
7.05188183978794e-23	0.372435985733453	0.492	0.24	1.69365046146187e-18	PTPN22	CD8+ T cells	GSE207422_Sin_post	ENSG00000134242	26191	protein tyrosine phosphatase non-receptor type 22	Lyp|Lyp1|Lyp2|PTPN8	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64772
8.08284487386379e-23	0.426805218917806	0.406	0.172	1.94125685335587e-18	HERPUD1	CD8+ T cells	GSE207422_Sin_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64773
9.93095729208065e-23	0.50254322943824	0.665	0.443	2.38511801283901e-18	IL2RB	CD8+ T cells	GSE207422_Sin_post	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64774
1.03182972570474e-22	0.40990473160405	0.537	0.287	2.47814545222508e-18	TNFRSF1B	CD8+ T cells	GSE207422_Sin_post	ENSG00000028137	7133	TNF receptor superfamily member 1B	CD120b|p75|TNF-R-II|TNF-R75|TNFBR|TNFR2|TNFR80	protein_coding	P20333	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64775
1.49694859353226e-22	0.48709407753975	0.476	0.232	3.59522143708642e-18	TOB1	CD8+ T cells	GSE207422_Sin_post	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64776
1.81991233099283e-22	0.499169362069255	0.537	0.298	4.37088344534549e-18	XAF1	CD8+ T cells	GSE207422_Sin_post	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64777
2.09707488122892e-22	-0.330944663053774	0.145	0.309	5.03654474224749e-18	RPL13P12	CD8+ T cells	GSE207422_Sin_post	ENSG00000215030	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64778
4.28662707151597e-22	0.410380374162957	0.277	0.072	1.02951922376599e-17	CKS2	CD8+ T cells	GSE207422_Sin_post	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64779
7.23230610978761e-22	0.396021387830556	0.263	0.062	1.73698295838769e-17	NAMPT	CD8+ T cells	GSE207422_Sin_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64780
8.04238017391991e-22	0.443641031001113	0.93	0.874	1.93153844637034e-17	SRGN	CD8+ T cells	GSE207422_Sin_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64781
8.30917512144078e-22	0.371022040264807	0.421	0.181	1.99561458891643e-17	PGAM1	CD8+ T cells	GSE207422_Sin_post	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64782
1.07246527326026e-21	0.40962818140556	0.629	0.383	2.57573984678918e-17	SOD1	CD8+ T cells	GSE207422_Sin_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64783
3.13877475523141e-21	0.358001661806642	0.866	0.634	7.53839532963929e-17	MTATP6P1	CD8+ T cells	GSE207422_Sin_post	ENSG00000248527	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64784
4.2574001776818e-21	0.395820256247648	0.402	0.181	1.02249980067384e-16	HNRNPAB	CD8+ T cells	GSE207422_Sin_post	ENSG00000197451	3182	heterogeneous nuclear ribonucleoprotein A/B	ABBP1|FLJ40338|HNRPAB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64785
4.65668154722598e-21	0.46286320695518	0.515	0.283	1.11839520719726e-16	GPR171	CD8+ T cells	GSE207422_Sin_post	ENSG00000174946	29909	G protein-coupled receptor 171	H963	protein_coding	O14626	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64786
5.16709452537087e-21	0.643349890302861	0.799	0.636	1.24098109215832e-16	CXCR4	CD8+ T cells	GSE207422_Sin_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64787
5.26658795885587e-21	0.373599292151065	0.362	0.143	1.26487643007841e-16	OASL	CD8+ T cells	GSE207422_Sin_post	ENSG00000135114	8638	2'-5'-oligoadenylate synthetase like	OASL1|p59OASL|TRIP14	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64788
7.20093294212449e-21	0.383196087222756	0.398	0.172	1.72944806471004e-16	HLA-DQB1	CD8+ T cells	GSE207422_Sin_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64789
7.80092139879208e-21	-0.366643493464101	0.944	0.96	1.87354729234789e-16	RPL32	CD8+ T cells	GSE207422_Sin_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64790
8.64154793679706e-21	-0.329149289977009	0.997	0.998	2.07544056798055e-16	TPT1	CD8+ T cells	GSE207422_Sin_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64791
1.17860602597443e-20	0.462159019823851	0.6	0.355	2.83065809258278e-16	IRF1	CD8+ T cells	GSE207422_Sin_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64792
1.48896171610839e-20	0.58953283924532	0.514	0.306	3.57603935357751e-16	PPP1R15A	CD8+ T cells	GSE207422_Sin_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64793
2.04804706843484e-20	0.374038362964264	0.994	0.979	4.91879464425994e-16	PTMA	CD8+ T cells	GSE207422_Sin_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64794
2.05044473373401e-20	0.52500150022529	0.278	0.083	4.92455311700896e-16	TNFRSF9	CD8+ T cells	GSE207422_Sin_post	ENSG00000049249	3604	TNF receptor superfamily member 9	4-1BB|CD137|ILA	protein_coding	Q07011	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64795
2.73150547190684e-20	-0.290210616833753	0.118	0.27	6.56025669187865e-16	KLRG1	CD8+ T cells	GSE207422_Sin_post	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64796
4.15041712864712e-20	0.328355309706062	0.476	0.234	9.96805681787179e-16	FKBP1A	CD8+ T cells	GSE207422_Sin_post	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64797
4.26328394876443e-20	0.600631835646689	0.285	0.087	1.02391290597475e-15	ZNF331	CD8+ T cells	GSE207422_Sin_post	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64798
4.37677210676456e-20	-0.408701515166066	0.742	0.809	1.05116935688164e-15	RPS25	CD8+ T cells	GSE207422_Sin_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64799
5.3940294505391e-20	0.344835788293037	0.368	0.151	1.29548405313597e-15	EPSTI1	CD8+ T cells	GSE207422_Sin_post	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64800
5.48034850992385e-20	-0.421987257217481	0.702	0.785	1.31621530162841e-15	RPL10	CD8+ T cells	GSE207422_Sin_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64801
5.70835531378276e-20	0.350543447893047	0.288	0.091	1.37097569571121e-15	BATF	CD8+ T cells	GSE207422_Sin_post	ENSG00000156127	10538	basic leucine zipper ATF-like transcription factor	B-ATF|BATF1|SFA-2	protein_coding	Q16520	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64802
7.19941253519377e-20	0.353570301611757	0.256	0.064	1.72908290857749e-15	CEBPB	CD8+ T cells	GSE207422_Sin_post	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64803
7.51932291368674e-20	0.418163347225309	0.444	0.221	1.80591578418014e-15	RNF19A	CD8+ T cells	GSE207422_Sin_post	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64804
9.67607164826545e-20	-0.399042624642091	0.759	0.817	2.32390212776391e-15	RPS23	CD8+ T cells	GSE207422_Sin_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64805
1.30773837640124e-19	0.364857242018022	0.373	0.162	3.14079525860285e-15	TUBA4A	CD8+ T cells	GSE207422_Sin_post	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64806
1.4609343075956e-19	0.323349076357678	0.322	0.115	3.50872592655236e-15	BST2	CD8+ T cells	GSE207422_Sin_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64807
1.5128056480404e-19	0.354732045589646	0.488	0.253	3.63330532489862e-15	ADGRE5	CD8+ T cells	GSE207422_Sin_post	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64808
1.66040471100232e-19	0.326596444250123	0.268	0.079	3.98779399441427e-15	OAS3	CD8+ T cells	GSE207422_Sin_post	ENSG00000111331	4940	2'-5'-oligoadenylate synthetase 3	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64809
1.66684312059036e-19	0.301979513504536	0.252	0.064	4.00325712272186e-15	RAB3GAP1	CD8+ T cells	GSE207422_Sin_post	ENSG00000115839	22930	RAB3 GTPase activating protein catalytic subunit 1	KIAA0066|RAB3GAP|RAB3GAP130|WARBM1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64810
1.66785979870986e-19	0.389769792180791	0.782	0.587	4.00569887856148e-15	HLA-DPA1	CD8+ T cells	GSE207422_Sin_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64811
1.81784021246141e-19	-0.379313385091546	0.836	0.879	4.36590683826856e-15	RPL6	CD8+ T cells	GSE207422_Sin_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64812
2.22529069303655e-19	0.334008215925847	0.433	0.202	5.34448065746589e-15	CYTIP	CD8+ T cells	GSE207422_Sin_post	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64813
2.25287050424637e-19	0.337003964505841	0.304	0.106	5.41071909004851e-15	GABARAPL1	CD8+ T cells	GSE207422_Sin_post	ENSG00000139112	23710	GABA type A receptor associated protein like 1	APG8L|ATG8B|ATG8L|gec1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64814
2.6220229849701e-19	0.309982768768377	0.287	0.089	6.29731260300269e-15	PDE3B	CD8+ T cells	GSE207422_Sin_post	ENSG00000152270	5140	phosphodiesterase 3B	HcGIP1	protein_coding	Q13370	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64815
3.05069060828911e-19	0.337049850340891	0.821	0.655	7.32684363392796e-15	MYL6	CD8+ T cells	GSE207422_Sin_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64816
3.48368949549292e-19	-0.335947120672103	0.856	0.894	8.36677706132536e-15	RPL19	CD8+ T cells	GSE207422_Sin_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64817
4.52133133754344e-19	0.439674414853468	0.37	0.162	1.08588814733781e-14	FKBP5	CD8+ T cells	GSE207422_Sin_post	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64818
6.09643247051513e-19	-0.351652297200467	0.911	0.923	1.46418018644362e-14	RPLP2	CD8+ T cells	GSE207422_Sin_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64819
6.70051571442733e-19	0.302211040874847	0.488	0.255	1.60926285913401e-14	ATP5MC3	CD8+ T cells	GSE207422_Sin_post	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64820
7.57092878549486e-19	-0.333379624519515	0.95	0.953	1.8183099664123e-14	RPS24	CD8+ T cells	GSE207422_Sin_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64821
7.97237748868281e-19	0.280957494433046	0.32	0.115	1.91472590145695e-14	PSMB3	CD8+ T cells	GSE207422_Sin_post	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64822
8.7610135432856e-19	0.314809236159834	0.316	0.117	2.1041326226909e-14	ISG20	CD8+ T cells	GSE207422_Sin_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64823
9.93955719862493e-19	0.378263355658185	0.737	0.53	2.38718345239375e-14	APOBEC3G	CD8+ T cells	GSE207422_Sin_post	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64824
1.14763858807247e-18	0.37462935571279	0.428	0.206	2.75628359697364e-14	ITM2C	CD8+ T cells	GSE207422_Sin_post	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64825
1.66632934446089e-18	0.372137622682008	0.591	0.368	4.00202318659171e-14	CLEC2D	CD8+ T cells	GSE207422_Sin_post	ENSG00000069493	29121	C-type lectin domain family 2 member D	CLAX|LLT1|OCIL	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64826
2.92687413469115e-18	0.294254317046504	0.45	0.223	7.02947360928772e-14	NDUFS5	CD8+ T cells	GSE207422_Sin_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64827
3.07920615912474e-18	0.761234095859216	0.277	0.094	7.39532943236989e-14	STMN1	CD8+ T cells	GSE207422_Sin_post	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64828
3.44413586846866e-18	0.71089214376719	0.569	0.391	8.27178111530117e-14	HSPB1	CD8+ T cells	GSE207422_Sin_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64829
3.61622568382861e-18	-0.36276312080346	0.893	0.917	8.68508922485117e-14	RPL38	CD8+ T cells	GSE207422_Sin_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64830
6.03751078052759e-18	0.331329337926648	0.622	0.394	1.45002896415931e-13	HMGN1	CD8+ T cells	GSE207422_Sin_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64831
6.54762953320002e-18	0.528566608689073	0.779	0.691	1.57254418498865e-13	HLA-DRA	CD8+ T cells	GSE207422_Sin_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64832
8.67541942656872e-18	0.348146420033947	0.303	0.115	2.08357548367901e-13	UBE2S	CD8+ T cells	GSE207422_Sin_post	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64833
9.81700412454122e-18	0.307336779860022	0.43	0.219	2.35774988059106e-13	SURF4	CD8+ T cells	GSE207422_Sin_post	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64834
1.09825275604972e-17	0.538525838443664	0.723	0.583	2.63767364420461e-13	ZFP36	CD8+ T cells	GSE207422_Sin_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64835
1.14659502327154e-17	0.424273241938405	0.462	0.247	2.75377726739125e-13	SMC4	CD8+ T cells	GSE207422_Sin_post	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64836
1.29126387395963e-17	0.442243963019926	0.564	0.357	3.10122844608885e-13	CCND2	CD8+ T cells	GSE207422_Sin_post	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64837
1.30964649263402e-17	-0.381473647597835	0.913	0.923	3.14537798135912e-13	PABPC1	CD8+ T cells	GSE207422_Sin_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64838
1.34864922890219e-17	0.301685409986166	0.338	0.138	3.23905085305439e-13	NASP	CD8+ T cells	GSE207422_Sin_post	ENSG00000132780	4678	nuclear autoantigenic sperm protein	DKFZp547F162|FLB7527|FLJ31599|FLJ35510|MGC19722|MGC20372|MGC2297|PRO1999	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64839
1.51707697443131e-17	0.278518270655344	0.251	0.072	3.64356376949169e-13	CD38	CD8+ T cells	GSE207422_Sin_post	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64840
1.91709285658821e-17	0.296520008689835	0.368	0.168	4.60428191366791e-13	SNRPG	CD8+ T cells	GSE207422_Sin_post	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64841
2.30213383982285e-17	-0.279984748344134	0.951	0.977	5.52903484310254e-13	RPL13A	CD8+ T cells	GSE207422_Sin_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64842
2.53733908888893e-17	-0.311567519702666	0.949	0.972	6.09392728978455e-13	IL32	CD8+ T cells	GSE207422_Sin_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64843
3.76186828618315e-17	-0.291558467276621	0.912	0.926	9.03487906292607e-13	RPL9	CD8+ T cells	GSE207422_Sin_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64844
4.50565392642618e-17	-0.333474286069995	0.95	0.96	1.08212290350977e-12	RPL21	CD8+ T cells	GSE207422_Sin_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64845
4.58296959999994e-17	0.282445600585883	0.259	0.083	1.10069180883199e-12	LMNB1	CD8+ T cells	GSE207422_Sin_post	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64846
4.69155758775213e-17	0.414376483849957	0.714	0.509	1.12677138585043e-12	HMGB1	CD8+ T cells	GSE207422_Sin_post	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64847
4.89331577708243e-17	0.279015432672164	0.395	0.187	1.17522765018189e-12	PSMB2	CD8+ T cells	GSE207422_Sin_post	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64848
4.93218628305721e-17	-0.390094124342788	0.295	0.445	1.18456317960185e-12	AL031727.1	CD8+ T cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64849
5.55391766872629e-17	0.336980704520301	0.259	0.083	1.33388440649799e-12	SOCS3	CD8+ T cells	GSE207422_Sin_post	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64850
6.62686159289056e-17	-0.424914066395149	0.373	0.523	1.59157334876453e-12	RBL2	CD8+ T cells	GSE207422_Sin_post	ENSG00000103479	5934	RB transcriptional corepressor like 2	p130|Rb2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64851
6.93491577117539e-17	-0.390593983435486	0.405	0.54	1.66555872076319e-12	RPL6P27	CD8+ T cells	GSE207422_Sin_post	ENSG00000235552	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64852
9.26727013008204e-17	0.397711201190605	0.607	0.381	2.2257202671418e-12	DUSP2	CD8+ T cells	GSE207422_Sin_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64853
9.96058512833819e-17	0.46510776468516	0.775	0.594	2.39223373027298e-12	JUN	CD8+ T cells	GSE207422_Sin_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64854
1.04803431700296e-16	0.390024702901053	0.399	0.204	2.51706401914602e-12	SDCBP	CD8+ T cells	GSE207422_Sin_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64855
1.11043507491629e-16	0.40872866041796	0.289	0.109	2.66693191942646e-12	NFKBIZ	CD8+ T cells	GSE207422_Sin_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64856
1.30164947838012e-16	-0.351269567788278	0.271	0.426	3.12617155222553e-12	RPL37P6	CD8+ T cells	GSE207422_Sin_post	ENSG00000241431	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64857
1.31478968834853e-16	-0.385746785932744	0.376	0.54	3.15773039450666e-12	SLAMF7	CD8+ T cells	GSE207422_Sin_post	ENSG00000026751	57823	SLAM family member 7	19A|CD319|CRACC|CS1	protein_coding	Q9NQ25	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64858
1.3909050453554e-16	-0.334245915629336	0.228	0.379	3.34053664743006e-12	RPS27AP16	CD8+ T cells	GSE207422_Sin_post	ENSG00000224631	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64859
1.62394004116608e-16	0.282548816394225	0.483	0.262	3.90021679686856e-12	ATP5MF	CD8+ T cells	GSE207422_Sin_post	ENSG00000241468	9551	ATP synthase membrane subunit f	ATP5J2|ATP5JL	protein_coding	P56134	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64860
1.65986962548944e-16	0.273443275989502	0.253	0.081	3.986508879538e-12	RALA	CD8+ T cells	GSE207422_Sin_post	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64861
1.74061356675133e-16	0.267428897209869	0.305	0.117	4.18043160326667e-12	GALM	CD8+ T cells	GSE207422_Sin_post	ENSG00000143891	130589	galactose mutarotase	NA	protein_coding	Q96C23	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64862
2.53558672004785e-16	-0.349784068986457	0.867	0.872	6.08971862553892e-12	RPS4X	CD8+ T cells	GSE207422_Sin_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64863
2.75209641101597e-16	0.278951574435398	0.669	0.426	6.60970995033706e-12	SUMO2	CD8+ T cells	GSE207422_Sin_post	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64864
2.7836446732479e-16	0.507902045341693	0.918	0.845	6.68547941173949e-12	JUND	CD8+ T cells	GSE207422_Sin_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64865
2.84667595482513e-16	-0.340418731350027	0.248	0.398	6.83686164070352e-12	RPS3AP47	CD8+ T cells	GSE207422_Sin_post	ENSG00000205871	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64866
3.67946413573189e-16	0.27834741848187	0.987	0.983	8.83696901478729e-12	CFL1	CD8+ T cells	GSE207422_Sin_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64867
4.55165788666277e-16	0.346433457383103	0.467	0.264	1.0931716746398e-11	CBLB	CD8+ T cells	GSE207422_Sin_post	ENSG00000114423	868	Cbl proto-oncogene B	Cbl-b|RNF56	protein_coding	Q13191	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64868
5.2980488057242e-16	0.438190310387434	0.456	0.26	1.27243238167078e-11	YPEL5	CD8+ T cells	GSE207422_Sin_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64869
5.78149796012488e-16	0.305680715083576	0.957	0.923	1.38854236508319e-11	SH3BGRL3	CD8+ T cells	GSE207422_Sin_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64870
7.14795448963322e-16	0.385286479356361	0.256	0.087	1.71672422977521e-11	PCNA	CD8+ T cells	GSE207422_Sin_post	ENSG00000132646	5111	proliferating cell nuclear antigen	NA	protein_coding	P12004	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64871
7.62627531834367e-16	0.298493088316597	0.718	0.511	1.8316025432066e-11	PPDPF	CD8+ T cells	GSE207422_Sin_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64872
8.6133700492131e-16	0.281692591968497	0.311	0.128	2.06867308471951e-11	OAS2	CD8+ T cells	GSE207422_Sin_post	ENSG00000111335	4939	2'-5'-oligoadenylate synthetase 2	NA	protein_coding	P29728	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64873
1.09407611451511e-15	0.305157445126587	0.493	0.287	2.62764260423095e-11	HCP5	CD8+ T cells	GSE207422_Sin_post	ENSG00000237105	10866	HLA complex P5	D6S2650E|P5-1	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64874
1.80119139869257e-15	0.374277874885793	0.459	0.26	4.32592138223994e-11	SLC2A3	CD8+ T cells	GSE207422_Sin_post	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64875
2.1858587914839e-15	0.263001007553513	0.491	0.283	5.24977705950689e-11	ORMDL3	CD8+ T cells	GSE207422_Sin_post	ENSG00000172057	94103	ORMDL sphingolipid biosynthesis regulator 3	NA	protein_coding	Q8N138	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64876
2.53919488901571e-15	0.297115781361939	0.383	0.187	6.09838436494902e-11	HIF1A	CD8+ T cells	GSE207422_Sin_post	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64877
2.70394195392192e-15	0.254980480929759	0.314	0.136	6.49405739073428e-11	SEM1	CD8+ T cells	GSE207422_Sin_post	ENSG00000127922	7979	SEM1 26S proteasome subunit	C7orf76|DSS1|ECD|FLJ42280|PSMD15|SHFD1|Shfdg1|SHFM1|SHSF1	protein_coding	Q6ZVN7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64878
2.72817601014215e-15	0.276306600320345	0.433	0.226	6.5522603235584e-11	PDIA6	CD8+ T cells	GSE207422_Sin_post	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64879
2.87412781608021e-15	0.404733092588228	0.729	0.56	6.90279277587985e-11	APOBEC3C	CD8+ T cells	GSE207422_Sin_post	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64880
3.13023331321781e-15	0.263373108811143	0.338	0.157	7.5178813483552e-11	PSME2	CD8+ T cells	GSE207422_Sin_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64881
3.42579290806592e-15	0.337219415663726	0.493	0.296	8.22772682730192e-11	LY6E	CD8+ T cells	GSE207422_Sin_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64882
3.67300705066069e-15	0.284042417934836	0.397	0.202	8.82146103357179e-11	ATP1B3	CD8+ T cells	GSE207422_Sin_post	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64883
4.07038675286991e-15	0.278593972874482	0.378	0.181	9.77584786436766e-11	CTSD	CD8+ T cells	GSE207422_Sin_post	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64884
4.09989197131654e-15	0.553630540150964	0.539	0.36	9.84671054751093e-11	HLA-DQA1	CD8+ T cells	GSE207422_Sin_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64885
4.26182806169913e-15	-0.317103774711054	0.208	0.355	1.02356324557828e-10	ATM	CD8+ T cells	GSE207422_Sin_post	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64886
4.45325914108153e-15	0.262814598521573	0.342	0.162	1.06953924791355e-10	MIR1244-2	CD8+ T cells	GSE207422_Sin_post	ENSG00000283498	100422885	microRNA 1244-2	hsa-mir-1244-2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64887
4.65811333525155e-15	0.261369977198374	0.281	0.109	1.11873907972736e-10	SPTY2D1	CD8+ T cells	GSE207422_Sin_post	ENSG00000179119	144108	SPT2 chromatin protein domain containing 1	DKFZp686I068|FLJ39441|Spt2	protein_coding	Q68D10	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64888
5.01223277007846e-15	0.250860114038541	0.258	0.094	1.20378794438974e-10	RANBP1	CD8+ T cells	GSE207422_Sin_post	ENSG00000099901	5902	RAN binding protein 1	HTF9A	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64889
6.22085088502474e-15	-0.338345576490803	0.797	0.853	1.49406175705639e-10	RPL5	CD8+ T cells	GSE207422_Sin_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64890
6.4989654799292e-15	0.280568185320606	0.278	0.111	1.5608565393146e-10	PPA1	CD8+ T cells	GSE207422_Sin_post	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64891
7.71828011832826e-15	0.298408545101752	0.419	0.223	1.8536993360189e-10	GBP1	CD8+ T cells	GSE207422_Sin_post	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64892
8.22423648916861e-15	0.250609844387634	0.341	0.155	1.97521487760362e-10	EIF2AK2	CD8+ T cells	GSE207422_Sin_post	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64893
9.21118538761735e-15	0.288999088861803	0.288	0.121	2.21225039454406e-10	RHBDD2	CD8+ T cells	GSE207422_Sin_post	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64894
9.32914253416161e-15	-0.298290795315295	0.94	0.945	2.24058016242959e-10	RPL39	CD8+ T cells	GSE207422_Sin_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64895
9.5337601232149e-15	-0.264306524923246	0.995	0.989	2.28972316879252e-10	MT-ND5	CD8+ T cells	GSE207422_Sin_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64896
9.94020108240232e-15	-0.396201312521967	0.202	0.34	2.38733809396057e-10	RIPOR2	CD8+ T cells	GSE207422_Sin_post	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64897
1.01724942803792e-14	0.271453976645333	0.31	0.138	2.44312795131867e-10	UBALD2	CD8+ T cells	GSE207422_Sin_post	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64898
1.09951906455991e-14	-0.327431289680177	0.125	0.253	2.64071493735354e-10	LTB	CD8+ T cells	GSE207422_Sin_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64899
1.11536453010996e-14	0.275237500258224	0.457	0.257	2.67877099196509e-10	TRA2B	CD8+ T cells	GSE207422_Sin_post	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64900
1.41050905587839e-14	0.475705958483246	0.272	0.111	3.38761959950313e-10	TNFSF9	CD8+ T cells	GSE207422_Sin_post	ENSG00000125657	8744	TNF superfamily member 9	4-1BB-L|4-1BBL|CD137L	protein_coding	P41273	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64901
1.45322753612965e-14	0.275434228407109	0.3	0.13	3.49021657352259e-10	ZFAND5	CD8+ T cells	GSE207422_Sin_post	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64902
1.52679064820797e-14	0.269989264359597	0.715	0.489	3.66689309980107e-10	CD3D	CD8+ T cells	GSE207422_Sin_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64903
1.65789652635761e-14	-0.257603661620956	0.961	0.96	3.98177008735308e-10	RPS16	CD8+ T cells	GSE207422_Sin_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64904
1.780485869173e-14	0.328323612141668	0.258	0.1	4.27619291199279e-10	ZC3H12A	CD8+ T cells	GSE207422_Sin_post	ENSG00000163874	80149	zinc finger CCCH-type containing 12A	FLJ23231|MCPIP1|Regnase-1	protein_coding	Q5D1E8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64905
2.45622524062392e-14	0.289030384163537	0.381	0.196	5.89911616040648e-10	CYCS	CD8+ T cells	GSE207422_Sin_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64906
2.694358293777e-14	0.303696313868993	0.855	0.717	6.47104031416421e-10	TMSB10	CD8+ T cells	GSE207422_Sin_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64907
2.80043670284489e-14	-0.276305118547679	0.181	0.317	6.72580882922256e-10	RPL13AP5	CD8+ T cells	GSE207422_Sin_post	ENSG00000236552	728658	ribosomal protein L13a pseudogene 5	bA196N24.2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64908
2.95407926952163e-14	-0.260573822348167	0.971	0.972	7.09481218161009e-10	RPL23	CD8+ T cells	GSE207422_Sin_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64909
3.85120762156704e-14	0.51166212961103	0.519	0.33	9.24944534471757e-10	HSPD1	CD8+ T cells	GSE207422_Sin_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64910
4.05956020206182e-14	0.292124112676289	0.374	0.191	9.74984573729187e-10	ITGA1	CD8+ T cells	GSE207422_Sin_post	ENSG00000213949	3672	integrin subunit alpha 1	CD49a|VLA1	protein_coding	P56199	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64911
4.24572800699031e-14	-0.404663838245634	0.985	0.994	1.01969649543886e-09	MALAT1	CD8+ T cells	GSE207422_Sin_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64912
4.99089848881873e-14	0.526322882426929	0.622	0.436	1.19866409005959e-09	DNAJA1	CD8+ T cells	GSE207422_Sin_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64913
5.45783408676933e-14	0.346428661117731	0.261	0.104	1.31080801261939e-09	FKBP4	CD8+ T cells	GSE207422_Sin_post	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64914
6.12998106932802e-14	0.25102764842685	0.317	0.143	1.47223755342051e-09	SLC38A2	CD8+ T cells	GSE207422_Sin_post	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64915
7.23184923977156e-14	0.505478992962259	0.665	0.491	1.73687323191594e-09	HMGN2	CD8+ T cells	GSE207422_Sin_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64916
8.42307827591075e-14	0.29186340946354	0.722	0.526	2.02297070952549e-09	IFI16	CD8+ T cells	GSE207422_Sin_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64917
1.0967082135538e-13	0.283333030669157	0.448	0.266	2.63396411649216e-09	PARK7	CD8+ T cells	GSE207422_Sin_post	ENSG00000116288	11315	Parkinsonism associated deglycase	DJ-1|DJ1|GATD2	protein_coding	Q99497	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64918
1.21628897698136e-13	0.256493049894673	0.613	0.406	2.92116123601614e-09	HINT1	CD8+ T cells	GSE207422_Sin_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64919
2.09271369787522e-13	0.78882308119987	0.425	0.262	5.02607048818691e-09	TUBA1B	CD8+ T cells	GSE207422_Sin_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64920
2.84805139092267e-13	0.256075067471196	0.257	0.104	6.84016502557898e-09	PTTG1	CD8+ T cells	GSE207422_Sin_post	ENSG00000164611	9232	PTTG1 regulator of sister chromatid separation, securin	EAP1|ECRAR|HPTTG|PTTG|securin|TUTR1	protein_coding	O95997	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64921
4.26674634176807e-13	-0.255374389392439	0.891	0.943	1.02474446890244e-08	RPS12	CD8+ T cells	GSE207422_Sin_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64922
4.66396844028281e-13	-0.318650581644774	0.276	0.406	1.12014530030272e-08	RPL3P4	CD8+ T cells	GSE207422_Sin_post	ENSG00000232573	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64923
5.36789250583089e-13	-0.294116394664139	0.414	0.6	1.28920674312541e-08	GZMK	CD8+ T cells	GSE207422_Sin_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64924
5.7796804751062e-13	0.258994882759285	0.292	0.138	1.38810585970626e-08	CLSTN3	CD8+ T cells	GSE207422_Sin_post	ENSG00000288427	9746	calsyntenin 3	CDHR14|CSTN3|KIAA0726	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64925
5.78491972247723e-13	0.253398506601357	0.505	0.313	1.38936416974736e-08	SLC25A3	CD8+ T cells	GSE207422_Sin_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64926
8.29168612729032e-13	0.2655846673696	0.847	0.677	1.99141425719132e-08	OAZ1	CD8+ T cells	GSE207422_Sin_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64927
9.23620441843287e-13	-0.348852226028637	0.292	0.413	2.21825921517502e-08	AC024293.1	CD8+ T cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64928
9.24015726895669e-13	0.343985731870885	0.959	0.96	2.21920857128533e-08	CCL5	CD8+ T cells	GSE207422_Sin_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64929
1.20614445624683e-12	0.26381985186193	0.648	0.44	2.89679714056802e-08	EZR	CD8+ T cells	GSE207422_Sin_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64930
1.2224158465987e-12	0.265410408487466	0.368	0.198	2.9358761387761e-08	MIAT	CD8+ T cells	GSE207422_Sin_post	ENSG00000225783	440823	myocardial infarction associated transcript	C22orf35|FLJ25967|gomafu|LINC00066|lncRNA-MIAT|NCRNA00066|Rncr2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64931
1.37350881136367e-12	0.261701810332567	0.47	0.283	3.29875611225213e-08	EIF5	CD8+ T cells	GSE207422_Sin_post	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64932
2.49268133517334e-12	-0.3064113155694	0.806	0.828	5.9866727626858e-08	RPS5	CD8+ T cells	GSE207422_Sin_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64933
2.80751275152659e-12	0.305498286447866	0.6	0.409	6.74280337534142e-08	GBP5	CD8+ T cells	GSE207422_Sin_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64934
2.81370882628051e-12	0.270331875590794	0.39	0.221	6.75768448807791e-08	DYNLL1	CD8+ T cells	GSE207422_Sin_post	ENSG00000088986	8655	dynein light chain LC8-type 1	DLC1|DLC8|DNCL1|hdlc1|LC8|PIN	protein_coding	P63167	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64935
3.32913163125318e-12	0.256067897649826	0.534	0.34	7.99557543878075e-08	CALM3	CD8+ T cells	GSE207422_Sin_post	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64936
3.8926813217545e-12	0.271986521005914	0.292	0.138	9.34905273045778e-08	IER5	CD8+ T cells	GSE207422_Sin_post	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64937
5.47527914388924e-12	-0.285112720781133	0.75	0.787	1.31499779198788e-07	RPS3A	CD8+ T cells	GSE207422_Sin_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64938
6.73772271484486e-12	-0.302989126451185	0.219	0.338	1.61819886442429e-07	RPS13P2	CD8+ T cells	GSE207422_Sin_post	ENSG00000228929	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64939
7.49519737447238e-12	0.389392353186662	0.485	0.317	1.80012155342703e-07	ARL6IP1	CD8+ T cells	GSE207422_Sin_post	ENSG00000170540	23204	ADP ribosylation factor like GTPase 6 interacting protein 1	AIP1|ARL6IP|ARMER|KIAA0069|SPG61	protein_coding	Q15041	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64940
8.03275952229269e-12	0.32894411895693	0.321	0.164	1.92922785446904e-07	NR4A2	CD8+ T cells	GSE207422_Sin_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64941
9.76425493868964e-12	0.31955465057364	0.417	0.255	2.34508110862509e-07	H2AFV	CD8+ T cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64942
1.47323708834238e-11	-0.34776287306444	0.429	0.526	3.5382735150719e-07	AP001324.1	CD8+ T cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64943
1.51545422387848e-11	0.254916332992144	0.518	0.334	3.63966640948894e-07	CLK1	CD8+ T cells	GSE207422_Sin_post	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64944
1.55658758647465e-11	0.357649902154968	0.931	0.9	3.73845640643616e-07	TRBC2	CD8+ T cells	GSE207422_Sin_post	ENSG00000276849	NA	NA	TCRBC2	TR_C_gene	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64945
2.74273996133376e-11	0.299440164790212	0.294	0.143	6.5872385651353e-07	LGALS1	CD8+ T cells	GSE207422_Sin_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64946
3.06902315016249e-11	0.32067286370477	0.819	0.634	7.37087289974526e-07	BTG1	CD8+ T cells	GSE207422_Sin_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64947
3.96649378356254e-11	0.452185429791058	0.883	0.823	9.52632811998215e-07	GZMA	CD8+ T cells	GSE207422_Sin_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64948
4.29892188924387e-11	-0.384540407054609	0.256	0.374	1.0324720701397e-06	SAMHD1	CD8+ T cells	GSE207422_Sin_post	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64949
6.25713034088385e-11	0.259567044260417	0.855	0.706	1.50277499397007e-06	UBB	CD8+ T cells	GSE207422_Sin_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64950
6.36719759561393e-11	0.28334023112953	0.359	0.206	1.5292098465386e-06	SQSTM1	CD8+ T cells	GSE207422_Sin_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64951
6.6345900065121e-11	0.294753161937058	0.691	0.523	1.59342948186401e-06	CALR	CD8+ T cells	GSE207422_Sin_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64952
7.88083667872782e-11	-0.294824292146884	0.278	0.4	1.89274054513006e-06	ERAP2	CD8+ T cells	GSE207422_Sin_post	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64953
9.50599281460313e-11	-0.356918550897003	0.276	0.387	2.28305429428323e-06	ADD3	CD8+ T cells	GSE207422_Sin_post	ENSG00000148700	120	adducin 3	ADDL	protein_coding	Q9UEY8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64954
1.03662436953189e-10	0.31384979712174	0.407	0.249	2.48966074830474e-06	BIRC3	CD8+ T cells	GSE207422_Sin_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64955
1.05195181803465e-10	-0.273234659236054	0.788	0.813	2.52647268137381e-06	RPL26	CD8+ T cells	GSE207422_Sin_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64956
1.0653046198618e-10	-0.317443007617677	0.567	0.638	2.55854210552209e-06	TOMM7	CD8+ T cells	GSE207422_Sin_post	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64957
1.38948197281514e-10	0.265692133532532	0.38	0.226	3.33711885411011e-06	TMPO	CD8+ T cells	GSE207422_Sin_post	ENSG00000120802	7112	thymopoietin	LAP2|LEMD4|TP	protein_coding	P42167	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64958
1.82416347717834e-10	-0.275731235755005	0.778	0.794	4.38109342313921e-06	FAU	CD8+ T cells	GSE207422_Sin_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64959
1.93854628770482e-10	0.315282149365515	0.367	0.219	4.65580661918066e-06	MYADM	CD8+ T cells	GSE207422_Sin_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64960
2.03692194299406e-10	0.262628871793525	0.754	0.566	4.89207543048883e-06	COTL1	CD8+ T cells	GSE207422_Sin_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64961
2.76563516998475e-10	0.457862193508195	0.253	0.126	6.64222598775239e-06	BAG3	CD8+ T cells	GSE207422_Sin_post	ENSG00000151929	9531	BAG cochaperone 3	NA	protein_coding	O95817	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64962
4.18456769680504e-10	-0.264620311045146	0.887	0.883	1.00500762374167e-05	RPS13	CD8+ T cells	GSE207422_Sin_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64963
7.08819196524722e-10	-0.343106718471208	0.331	0.438	1.70237106429342e-05	MBP	CD8+ T cells	GSE207422_Sin_post	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64964
1.24723472709834e-09	0.256115889406136	0.522	0.355	2.99548364407209e-05	HSPA5	CD8+ T cells	GSE207422_Sin_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64965
1.29966677816673e-09	-0.300577084043805	0.737	0.753	3.12140970112304e-05	RPL3	CD8+ T cells	GSE207422_Sin_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64966
1.33065622726376e-09	-0.299946390529991	0.413	0.509	3.19583706101937e-05	EEF1B2	CD8+ T cells	GSE207422_Sin_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64967
1.36877461928172e-09	0.902456177059731	0.536	0.372	3.2873860031289e-05	CCL4L2	CD8+ T cells	GSE207422_Sin_post	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64968
2.03567917743535e-09	-0.313988805997012	0.757	0.77	4.88909068044648e-05	RPL14	CD8+ T cells	GSE207422_Sin_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64969
2.11247536503987e-09	-0.311456542890144	0.854	0.851	5.07353208421625e-05	FYB1	CD8+ T cells	GSE207422_Sin_post	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64970
2.30045700781656e-09	0.285905154036564	0.674	0.543	5.52500759567303e-05	ANP32B	CD8+ T cells	GSE207422_Sin_post	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64971
3.14307384866969e-09	0.342210773848022	0.573	0.436	7.54872046234998e-05	SPOCK2	CD8+ T cells	GSE207422_Sin_post	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64972
4.02333594591471e-09	-0.421603662782969	0.626	0.619	9.66284594130337e-05	MTND1P23	CD8+ T cells	GSE207422_Sin_post	ENSG00000225972	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64973
6.98808178098106e-09	-0.273249614790536	0.341	0.443	0.000167832760133822	MLLT6	CD8+ T cells	GSE207422_Sin_post	ENSG00000275851	4302	MLLT6, PHD finger containing	AF17|FLJ23480	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64974
7.53851131657184e-09	-0.274094673161151	0.171	0.27	0.000181052426290106	CMC1	CD8+ T cells	GSE207422_Sin_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64975
1.61534000107905e-08	-0.328769556462438	0.699	0.687	0.000387956208059156	MBNL1	CD8+ T cells	GSE207422_Sin_post	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64976
1.90191308085941e-08	-0.317059510621605	0.494	0.564	0.000456782464630004	ITGAL	CD8+ T cells	GSE207422_Sin_post	ENSG00000005844	3683	integrin subunit alpha L	CD11A|LFA-1|LFA1A	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64977
2.01580614315591e-08	-0.269052566328881	0.91	0.904	0.000484136161401755	CALM1	CD8+ T cells	GSE207422_Sin_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64978
2.55344950776593e-08	0.27414837284962	0.457	0.317	0.000613261968280143	SMAP2	CD8+ T cells	GSE207422_Sin_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64979
4.08827250513643e-08	0.339209528861663	0.493	0.357	0.000981880407558616	NEAT1	CD8+ T cells	GSE207422_Sin_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64980
5.13245025431474e-08	-0.32232167076672	0.581	0.621	0.00123266057757877	KIAA1551	CD8+ T cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64981
5.15031277604472e-08	0.321502379483607	0.445	0.313	0.00123695061942266	CLDND1	CD8+ T cells	GSE207422_Sin_post	ENSG00000080822	56650	claudin domain containing 1	C3orf4|Z38	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64982
1.0177300115494e-07	-0.273967863517923	0.374	0.455	0.00244428216873819	NOP53	CD8+ T cells	GSE207422_Sin_post	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64983
1.44642870753448e-07	-0.295656268006812	0.499	0.557	0.00347388782688556	AL022718.1	CD8+ T cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64984
6.50959641373202e-07	-0.334579682110568	0.461	0.519	0.0156340977068602	MACF1	CD8+ T cells	GSE207422_Sin_post	ENSG00000127603	23499	microtubule actin crosslinking factor 1	ABP620|ACF7|FLJ45612|FLJ46776|KIAA0465|KIAA0754|KIAA1251|Lnc-PMIF|MACF	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64985
8.24501003858684e-07	-0.391342064638189	0.454	0.506	0.019802040609674	ANKRD12	CD8+ T cells	GSE207422_Sin_post	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64986
1.20492387811563e-06	-0.271535874399807	0.383	0.453	0.0289386567807031	TRAM1	CD8+ T cells	GSE207422_Sin_post	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64987
1.99913788725599e-06	-0.310192693570089	0.377	0.445	0.0480132946382271	PYHIN1	CD8+ T cells	GSE207422_Sin_post	ENSG00000163564	149628	pyrin and HIN domain family member 1	IFIX|MGC23885	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64988
7.01808970405139e-173	-0.696582460214268	0.012	0.356	1.68553460422202e-168	SCGB1A1	CD4+ T cells	GSE207422_Sin_post	ENSG00000149021	7356	secretoglobin family 1A member 1	CC10|CC16|CCSP|UGB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64989
1.45105466512463e-75	0.618200481548777	1	0.99	3.48499798922982e-71	MT-CO2	CD4+ T cells	GSE207422_Sin_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64990
1.80164761947954e-69	-0.736223458969878	1	1	4.32701708770402e-65	MT-RNR2	CD4+ T cells	GSE207422_Sin_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64991
6.87746907269466e-63	-0.769105868214512	0.889	0.944	1.65176174718908e-58	MT-ATP8	CD4+ T cells	GSE207422_Sin_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64992
1.46869189769193e-60	0.936792246969686	0.719	0.358	3.52735733068672e-56	CD7	CD4+ T cells	GSE207422_Sin_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64993
2.48362769028379e-57	-0.6983049099752	0.223	0.522	5.96492862375458e-53	RPL10P3	CD4+ T cells	GSE207422_Sin_post	ENSG00000230734	NA	NA	bA567J2.2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64994
8.06242208237147e-53	0.831632406389484	0.583	0.21	1.93635191152316e-48	DDIT4	CD4+ T cells	GSE207422_Sin_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64995
1.28114789638785e-51	0.48560311409486	0.999	0.996	3.07693290275469e-47	HLA-B	CD4+ T cells	GSE207422_Sin_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64996
1.39276811388466e-50	-0.506709493545699	0.998	1	3.3450111791168e-46	RPS29	CD4+ T cells	GSE207422_Sin_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64997
6.87842297221657e-50	0.377305595686042	1	1	1.65199084523725e-45	B2M	CD4+ T cells	GSE207422_Sin_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64998
1.04095315541048e-48	0.494533559123169	1	1	2.50005719334934e-44	HLA-A	CD4+ T cells	GSE207422_Sin_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	64999
2.29030032201167e-48	0.816332305866267	0.928	0.817	5.50061428337544e-44	SRGN	CD4+ T cells	GSE207422_Sin_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65000
6.47783451186292e-48	-0.523901127605923	0.968	0.996	1.55578151471412e-43	RPL30	CD4+ T cells	GSE207422_Sin_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65001
2.47251616216014e-47	0.876299023000405	0.793	0.543	5.93824206666001e-43	IFITM2	CD4+ T cells	GSE207422_Sin_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65002
1.4303962600268e-46	0.869769648960394	0.706	0.385	3.43538269770636e-42	TSC22D3	CD4+ T cells	GSE207422_Sin_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65003
9.76791410560464e-44	1.07494969230104	0.498	0.181	2.34595993074307e-39	IFI6	CD4+ T cells	GSE207422_Sin_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65004
7.81818483741967e-43	-0.435417839164652	0.993	1	1.87769345240308e-38	RPS6	CD4+ T cells	GSE207422_Sin_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65005
6.33172494666219e-42	0.957782611755104	0.478	0.152	1.52069038043986e-37	DUSP4	CD4+ T cells	GSE207422_Sin_post	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65006
2.68289286329176e-40	0.726858158661832	0.562	0.233	6.44350378976782e-36	PRDM1	CD4+ T cells	GSE207422_Sin_post	ENSG00000057657	639	PR/SET domain 1	BLIMP1|PRDI-BF1	protein_coding	O75626	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65007
4.59984227227291e-40	0.450809190808501	1	0.988	1.10474411853178e-35	MT-CO3	CD4+ T cells	GSE207422_Sin_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65008
1.60911334109503e-39	0.749587985351095	0.768	0.453	3.86460751130792e-35	RGS1	CD4+ T cells	GSE207422_Sin_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65009
9.05726269617758e-38	0.852002482159702	0.544	0.245	2.17528278174097e-33	CTLA4	CD4+ T cells	GSE207422_Sin_post	ENSG00000163599	1493	cytotoxic T-lymphocyte associated protein 4	CD|CD152|CELIAC3|CTLA-4|GSE|IDDM12	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65010
3.4104234397886e-37	0.472660754665649	0.313	0.04	8.19081397534028e-33	FAM118A	CD4+ T cells	GSE207422_Sin_post	ENSG00000100376	55007	family with sequence similarity 118 member A	bK268H5.C22.4|C22orf8|FLJ20635	protein_coding	Q9NWS6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65011
2.40862103673027e-36	0.602630844793863	0.492	0.2	5.78478514391508e-32	SH2D2A	CD4+ T cells	GSE207422_Sin_post	ENSG00000027869	9047	SH2 domain containing 2A	F2771|TSAd	protein_coding	Q9NP31	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65012
3.0997653514236e-35	0.607257670282468	0.675	0.395	7.44470644451406e-31	LDHA	CD4+ T cells	GSE207422_Sin_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65013
9.56938851943271e-35	0.709923668144775	0.703	0.443	2.29828004071216e-30	SMAP2	CD4+ T cells	GSE207422_Sin_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65014
1.35838887670308e-34	0.641973061926303	0.81	0.609	3.26244256517778e-30	GAPDH	CD4+ T cells	GSE207422_Sin_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65015
1.58614309817437e-34	0.72579540035545	0.726	0.441	3.80943987888539e-30	TNFAIP3	CD4+ T cells	GSE207422_Sin_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65016
3.71621784884246e-34	-0.494945706347367	0.234	0.499	8.92524040756493e-30	TCF7	CD4+ T cells	GSE207422_Sin_post	ENSG00000081059	6932	transcription factor 7	TCF-1	protein_coding	P36402	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65017
1.24356417975471e-33	0.597673124997896	0.363	0.096	2.98666809051689e-29	BATF	CD4+ T cells	GSE207422_Sin_post	ENSG00000156127	10538	basic leucine zipper ATF-like transcription factor	B-ATF|BATF1|SFA-2	protein_coding	Q16520	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65018
2.7404807854918e-33	0.556945689663382	0.369	0.094	6.58181270251566e-29	PFKFB3	CD4+ T cells	GSE207422_Sin_post	ENSG00000170525	5209	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	NA	protein_coding	Q16875	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65019
3.86386968010614e-33	0.397808005444902	1	0.998	9.27985581071092e-29	HLA-C	CD4+ T cells	GSE207422_Sin_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65020
1.30798931779339e-32	0.550088235581619	0.79	0.538	3.14139794454439e-28	MCL1	CD4+ T cells	GSE207422_Sin_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65021
3.2575251755407e-29	0.472845790690044	0.379	0.125	7.82359821409609e-25	HERPUD1	CD4+ T cells	GSE207422_Sin_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65022
4.67128197670885e-29	0.49706455511381	0.605	0.339	1.12190179234617e-24	TAP1	CD4+ T cells	GSE207422_Sin_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65023
1.37627890946154e-28	0.584197060977245	0.436	0.177	3.30540905685379e-24	CREM	CD4+ T cells	GSE207422_Sin_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65024
4.7556976082822e-28	0.63067732646902	0.585	0.324	1.14217589458114e-23	NFKBIA	CD4+ T cells	GSE207422_Sin_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65025
4.98097055541224e-28	0.410881117691217	1	0.996	1.19627969829336e-23	MT-CO1	CD4+ T cells	GSE207422_Sin_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65026
8.79652796943117e-28	0.559428363982587	0.363	0.119	2.11266212241828e-23	FURIN	CD4+ T cells	GSE207422_Sin_post	ENSG00000140564	5045	furin, paired basic amino acid cleaving enzyme	FUR|PACE|PCSK3|SPC1	protein_coding	P09958	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65027
2.63383004305006e-27	0.561423778159297	0.549	0.287	6.32566961439333e-23	GBP5	CD4+ T cells	GSE207422_Sin_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65028
3.57739137551823e-27	0.869265793236583	0.258	0.042	8.59182086658212e-23	GZMB	CD4+ T cells	GSE207422_Sin_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65029
1.06864749951333e-25	0.545021035010653	0.4	0.156	2.56657069958117e-21	MT2A	CD4+ T cells	GSE207422_Sin_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65030
2.37375726966228e-25	0.488681097120521	0.302	0.079	5.7010528345479e-21	FOSL2	CD4+ T cells	GSE207422_Sin_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65031
5.78611022387071e-25	0.541661361664998	0.535	0.281	1.38965009246703e-20	TNFRSF1B	CD4+ T cells	GSE207422_Sin_post	ENSG00000028137	7133	TNF receptor superfamily member 1B	CD120b|p75|TNF-R-II|TNF-R75|TNFBR|TNFR2|TNFR80	protein_coding	P20333	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65032
2.25537757420954e-24	0.580322196195316	0.855	0.721	5.41674031997904e-20	CXCR4	CD4+ T cells	GSE207422_Sin_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65033
4.25457003801671e-24	-0.299974929831013	0.985	0.996	1.02182008603047e-19	RPS27A	CD4+ T cells	GSE207422_Sin_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65034
1.64879698743882e-23	0.503137080204328	0.404	0.175	3.95991572473182e-19	CST7	CD4+ T cells	GSE207422_Sin_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65035
2.50802105084583e-23	-0.432282571385104	0.736	0.825	6.02351415781642e-19	RPL41	CD4+ T cells	GSE207422_Sin_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65036
3.32365284647541e-23	0.540359943591968	0.643	0.418	7.98241704138e-19	CNOT6L	CD4+ T cells	GSE207422_Sin_post	ENSG00000138767	246175	CCR4-NOT transcription complex subunit 6 like	Ccr4b|DKFZp434K098	protein_coding	Q96LI5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65037
4.4233752515605e-23	1.84959610219098	0.292	0.092	1.06236203416729e-18	CXCL13	CD4+ T cells	GSE207422_Sin_post	ENSG00000156234	10563	C-X-C motif chemokine ligand 13	ANGIE|ANGIE2|BCA-1|BLC|BLR1L|SCYB13	protein_coding	O43927	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65038
6.49979654959958e-23	0.480638337415148	0.54	0.299	1.56105613731733e-18	GBP2	CD4+ T cells	GSE207422_Sin_post	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65039
9.39900556270964e-23	0.513403526531752	0.31	0.102	2.25735916599597e-18	TFRC	CD4+ T cells	GSE207422_Sin_post	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65040
1.23515782431263e-22	0.451234053118984	0.329	0.116	2.96647854665164e-18	PHLDA1	CD4+ T cells	GSE207422_Sin_post	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65041
2.32376412072301e-22	0.559293469326487	0.729	0.536	5.58098428874044e-18	ZFP36	CD4+ T cells	GSE207422_Sin_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65042
5.66841711601832e-22	0.443302086400691	0.553	0.316	1.36138373875412e-17	TPI1	CD4+ T cells	GSE207422_Sin_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65043
7.7573966420124e-22	0.47122219282061	0.636	0.405	1.86309395151212e-17	SLA	CD4+ T cells	GSE207422_Sin_post	ENSG00000155926	6503	Src like adaptor	hSLAP|SLA1|SLAP|SLAP-1	protein_coding	Q13239	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65044
9.89526676181741e-22	0.414658833605611	0.492	0.262	2.37654621818569e-17	DUSP16	CD4+ T cells	GSE207422_Sin_post	ENSG00000280962	80824	dual specificity phosphatase 16	KIAA1700|MKP-7|MKP7	protein_coding	Q9BY84	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65045
1.12195778049141e-21	-0.400550093000752	0.827	0.892	2.69460600140622e-17	RPL23A	CD4+ T cells	GSE207422_Sin_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65046
1.46902685481488e-21	0.39137008868412	0.317	0.112	3.5281617972089e-17	MIAT	CD4+ T cells	GSE207422_Sin_post	ENSG00000225783	440823	myocardial infarction associated transcript	C22orf35|FLJ25967|gomafu|LINC00066|lncRNA-MIAT|NCRNA00066|Rncr2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65047
3.92021989436476e-21	-0.253310510075557	0.994	0.996	9.41519212029585e-17	RPL34	CD4+ T cells	GSE207422_Sin_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65048
5.06973047610107e-21	0.67711081737708	0.6	0.418	1.21759716844519e-16	SAT1	CD4+ T cells	GSE207422_Sin_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65049
1.16779062283959e-20	0.681740683050509	0.254	0.069	2.80468273887383e-16	IL2RA	CD4+ T cells	GSE207422_Sin_post	ENSG00000134460	3559	interleukin 2 receptor subunit alpha	CD25|IDDM10|IL2R	protein_coding	P01589	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65050
1.28047812317598e-20	0.81318459809491	0.299	0.106	3.07532430843175e-16	FOXP3	CD4+ T cells	GSE207422_Sin_post	ENSG00000049768	50943	forkhead box P3	AIID|DIETER|IPEX|JM2|PIDX|SCURFIN|XPID	protein_coding	Q9BZS1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65051
1.64580274449892e-20	0.35205957199369	0.876	0.657	3.95272445146305e-16	MTATP6P1	CD4+ T cells	GSE207422_Sin_post	ENSG00000248527	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65052
1.69816028234048e-20	-0.260132444853201	0.974	0.985	4.07847155009712e-16	RPS8	CD4+ T cells	GSE207422_Sin_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65053
2.98370821903603e-20	0.354005329850765	0.277	0.089	7.16597202965882e-16	CYTOR	CD4+ T cells	GSE207422_Sin_post	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65054
3.232408603358e-20	0.519570774982849	0.294	0.102	7.7632757426849e-16	PRF1	CD4+ T cells	GSE207422_Sin_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65055
9.16313534442291e-20	-0.349991078266989	0.218	0.389	2.20071021567005e-15	RPL13P12	CD4+ T cells	GSE207422_Sin_post	ENSG00000215030	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65056
1.39840778788833e-19	0.401157221024554	0.267	0.085	3.35855598417139e-15	CXCR6	CD4+ T cells	GSE207422_Sin_post	ENSG00000172215	10663	C-X-C motif chemokine receptor 6	BONZO|CD186|STRL33|TYMSTR	protein_coding	O00574	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65057
2.07736209346434e-19	0.46336336495494	0.573	0.349	4.9892005398733e-15	STAT1	CD4+ T cells	GSE207422_Sin_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65058
2.71441115469887e-19	-0.321783423169523	0.908	0.94	6.51920127024029e-15	RPL11	CD4+ T cells	GSE207422_Sin_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65059
3.83183501191844e-19	0.32228024511483	0.435	0.216	9.20291814812452e-15	ATP5MC3	CD4+ T cells	GSE207422_Sin_post	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65060
3.93629424353997e-19	0.287217173723068	0.994	0.979	9.45379788470996e-15	MT-ND1	CD4+ T cells	GSE207422_Sin_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65061
5.2403510355186e-19	0.431669721355658	0.598	0.372	1.2585751082005e-14	ENO1	CD4+ T cells	GSE207422_Sin_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65062
5.51996982412535e-19	0.518888496539035	0.462	0.249	1.32573115266018e-14	ID2	CD4+ T cells	GSE207422_Sin_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65063
8.76493881179201e-19	0.380467034395015	0.87	0.726	2.10507535442809e-14	TMSB10	CD4+ T cells	GSE207422_Sin_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65064
1.0156136477013e-18	0.341669277019083	0.359	0.158	2.43919929768421e-14	EPSTI1	CD4+ T cells	GSE207422_Sin_post	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65065
1.74044431208491e-18	0.34592405893208	0.478	0.27	4.18002510433432e-14	CYTIP	CD4+ T cells	GSE207422_Sin_post	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65066
2.04366763300273e-18	0.455985907101726	0.54	0.335	4.90827655418266e-14	HMGB2	CD4+ T cells	GSE207422_Sin_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65067
2.36461712338342e-18	0.472769709211271	0.576	0.38	5.67910094522997e-14	IL2RB	CD4+ T cells	GSE207422_Sin_post	ENSG00000100385	3560	interleukin 2 receptor subunit beta	CD122|IL15RB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65068
2.63111727417509e-18	0.404742515613592	0.602	0.389	6.31915435738631e-14	TIGIT	CD4+ T cells	GSE207422_Sin_post	ENSG00000181847	201633	T cell immunoreceptor with Ig and ITIM domains	DKFZp667A205|FLJ39873|VSIG9|VSTM3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65069
2.6777504255559e-18	0.417536750665586	0.267	0.089	6.43115319705762e-14	PTMS	CD4+ T cells	GSE207422_Sin_post	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65070
2.99773983538254e-18	-0.276706162381659	0.904	0.969	7.19967176263826e-14	RPLP2	CD4+ T cells	GSE207422_Sin_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65071
3.67890757729516e-18	0.419595604131388	0.269	0.092	8.83563232838979e-14	SLC7A5	CD4+ T cells	GSE207422_Sin_post	ENSG00000103257	8140	solute carrier family 7 member 5	CD98|D16S469E|E16|LAT1|MPE16	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65072
4.78989097578097e-18	-0.351401345514735	0.521	0.69	1.15038811565331e-13	EEF1B2	CD4+ T cells	GSE207422_Sin_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65073
5.94976155873346e-18	0.385855775711059	0.359	0.166	1.42895423356102e-13	RYBP	CD4+ T cells	GSE207422_Sin_post	ENSG00000281766	23429	RING1 and YY1 binding protein	AAP1|DEDAF|YEAF1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65074
8.2347612663938e-18	0.420011485036734	0.41	0.206	1.9777426133498e-13	XAF1	CD4+ T cells	GSE207422_Sin_post	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65075
1.1642292363776e-17	0.359454908607358	0.373	0.173	2.79612935700808e-13	PDE4D	CD4+ T cells	GSE207422_Sin_post	ENSG00000113448	5144	phosphodiesterase 4D	DPDE3	protein_coding	Q08499	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65076
1.18570559593086e-17	0.497735029103002	0.518	0.32	2.84770912974715e-13	RBPJ	CD4+ T cells	GSE207422_Sin_post	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65077
1.29962664581783e-17	0.762862301535547	0.305	0.121	3.12131331526069e-13	CCL4	CD4+ T cells	GSE207422_Sin_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65078
1.6977404406806e-17	0.296527717068183	0.455	0.239	4.0774632163826e-13	YWHAE	CD4+ T cells	GSE207422_Sin_post	ENSG00000274474	7531	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon	FLJ45465	protein_coding	P62258	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65079
2.03105796095634e-17	0.317824568239034	0.304	0.119	4.87799190482884e-13	SNX9	CD4+ T cells	GSE207422_Sin_post	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65080
2.21333212829978e-17	-0.459269413185511	0.483	0.626	5.31575977253757e-13	AHNAK	CD4+ T cells	GSE207422_Sin_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65081
2.78891421207683e-17	0.375209407885695	0.781	0.617	6.69813526314492e-13	MYL6	CD4+ T cells	GSE207422_Sin_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65082
3.60539451191232e-17	0.408170294664467	0.425	0.222	8.65907599925982e-13	SOCS3	CD4+ T cells	GSE207422_Sin_post	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65083
4.11906886616274e-17	-0.329736444855	0.95	0.956	9.89276769586306e-13	PTPRC	CD4+ T cells	GSE207422_Sin_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65084
5.77435446348932e-17	0.407856492702815	0.892	0.78	1.38682671149623e-12	CD2	CD4+ T cells	GSE207422_Sin_post	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65085
8.44599006775212e-17	0.412579376612267	0.393	0.2	2.02847343457203e-12	SERPINB9	CD4+ T cells	GSE207422_Sin_post	ENSG00000170542	5272	serpin family B member 9	CAP3|PI9	protein_coding	P50453	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65086
2.21771823093125e-16	-0.250035970370229	0.962	0.992	5.32629387522758e-12	RPL32	CD4+ T cells	GSE207422_Sin_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65087
4.13633890125924e-16	0.405624214800225	0.444	0.254	9.93424513915431e-12	TOB1	CD4+ T cells	GSE207422_Sin_post	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65088
4.55812887210833e-16	0.536690239694657	0.576	0.395	1.09472581121426e-11	PIM2	CD4+ T cells	GSE207422_Sin_post	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65089
7.11214121816809e-16	0.497779484213755	0.519	0.343	1.70812295636743e-11	FKBP5	CD4+ T cells	GSE207422_Sin_post	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65090
7.19403290907186e-16	0.353304920191637	0.263	0.1	1.72779088377179e-11	DUSP5	CD4+ T cells	GSE207422_Sin_post	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65091
2.12569284534413e-15	0.369810468242505	0.26	0.1	5.10527650666299e-11	MX1	CD4+ T cells	GSE207422_Sin_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65092
2.67102737131526e-15	0.359155056817715	0.572	0.378	6.41500643768785e-11	TPM4	CD4+ T cells	GSE207422_Sin_post	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65093
3.48019428982227e-15	0.384006700270634	0.288	0.125	8.35838262586614e-11	PMAIP1	CD4+ T cells	GSE207422_Sin_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65094
7.69791371074895e-15	-0.261365810274103	0.965	0.973	1.84880793591058e-10	RPL37A	CD4+ T cells	GSE207422_Sin_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65095
8.53578020772662e-15	0.275838324965985	0.411	0.225	2.0500383324897e-10	ORMDL3	CD4+ T cells	GSE207422_Sin_post	ENSG00000172057	94103	ORMDL sphingolipid biosynthesis regulator 3	NA	protein_coding	Q8N138	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65096
9.21282330292217e-15	0.27994140778067	0.373	0.197	2.21264377266282e-10	SURF4	CD4+ T cells	GSE207422_Sin_post	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65097
1.01682134190857e-14	0.266588463974095	0.27	0.11	2.4420998168618e-10	BCL3	CD4+ T cells	GSE207422_Sin_post	ENSG00000069399	602	BCL3 transcription coactivator	BCL4|D19S37	protein_coding	P20749	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65098
1.17690729225667e-14	-0.269531177925804	0.826	0.881	2.82657824381284e-10	RPS23	CD4+ T cells	GSE207422_Sin_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65099
1.81687320835815e-14	0.372102037650575	0.841	0.748	4.36358438451378e-10	SPOCK2	CD4+ T cells	GSE207422_Sin_post	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65100
2.01007280237439e-14	0.27142493631849	0.457	0.27	4.82759184946256e-10	NDUFS5	CD4+ T cells	GSE207422_Sin_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65101
2.34224395829232e-14	0.265625208326325	0.268	0.11	5.62536731463065e-10	PARP9	CD4+ T cells	GSE207422_Sin_post	ENSG00000138496	83666	poly(ADP-ribose) polymerase family member 9	ARTD9|BAL|BAL1	protein_coding	Q8IXQ6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65102
3.85626506047421e-14	0.355373075125775	0.359	0.189	9.26159179574091e-10	SATB1	CD4+ T cells	GSE207422_Sin_post	ENSG00000182568	6304	SATB homeobox 1	NA	protein_coding	Q01826	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65103
4.3844691117186e-14	0.396787296809066	0.485	0.318	1.05301794656146e-09	HLA-DPA1	CD4+ T cells	GSE207422_Sin_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65104
6.79054496029555e-14	0.30399653055446	0.819	0.676	1.63088518311418e-09	OAZ1	CD4+ T cells	GSE207422_Sin_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65105
6.97278248228872e-14	0.338647511817653	0.617	0.43	1.67465316877128e-09	RNF213	CD4+ T cells	GSE207422_Sin_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65106
8.02051672691811e-14	0.307457559668614	0.337	0.17	1.92628750230392e-09	UGP2	CD4+ T cells	GSE207422_Sin_post	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65107
1.14668468616861e-13	0.496935473703155	0.38	0.222	2.75399261077114e-09	ICOS	CD4+ T cells	GSE207422_Sin_post	ENSG00000163600	29851	inducible T cell costimulator	AILIM|CD278	protein_coding	Q9Y6W8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65108
1.20908289016019e-13	0.294811350364721	0.45	0.26	2.90385437729773e-09	FAM129A	CD4+ T cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65109
1.32467409870217e-13	0.269719364966961	0.26	0.112	3.181469782853e-09	FAS	CD4+ T cells	GSE207422_Sin_post	ENSG00000026103	355	Fas cell surface death receptor	APO-1|APT1|CD95|FAS1|TNFRSF6	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65110
1.53993096097515e-13	0.317572739240554	0.519	0.347	3.69845218897401e-09	ITK	CD4+ T cells	GSE207422_Sin_post	ENSG00000113263	3702	IL2 inducible T cell kinase	EMT|LYK|PSCTK2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65111
2.06452099854041e-13	0.334807295993974	0.444	0.27	4.95836008219449e-09	RNF19A	CD4+ T cells	GSE207422_Sin_post	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65112
2.4717752688943e-13	0.328764600292005	0.351	0.191	5.93646266330345e-09	RHBDD2	CD4+ T cells	GSE207422_Sin_post	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65113
2.68599105315419e-13	-0.429381572450892	0.616	0.665	6.45094471236042e-09	MTND1P23	CD4+ T cells	GSE207422_Sin_post	ENSG00000225972	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65114
2.91196185283835e-13	-0.304070598655537	0.214	0.351	6.99365878196186e-09	ZC3H6	CD4+ T cells	GSE207422_Sin_post	ENSG00000188177	376940	zinc finger CCCH-type containing 6	FLJ41410|FLJ45877|KIAA2035|ZC3HDC6	protein_coding	P61129	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65115
3.5050376178251e-13	0.276900484776318	0.329	0.17	8.41804884673054e-09	ISG20	CD4+ T cells	GSE207422_Sin_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65116
3.61902207655174e-13	0.619459647833794	0.25	0.106	8.69180532125433e-09	NKG7	CD4+ T cells	GSE207422_Sin_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65117
5.89699510670583e-13	-0.293963485800143	0.761	0.819	1.41628131477754e-08	RPL10	CD4+ T cells	GSE207422_Sin_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65118
6.31171505910366e-13	0.285549822037881	0.385	0.212	1.51588460574493e-08	SAMSN1	CD4+ T cells	GSE207422_Sin_post	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65119
6.62565440706322e-13	0.316876362459986	0.571	0.385	1.59128341894437e-08	PGK1	CD4+ T cells	GSE207422_Sin_post	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65120
8.06166002849163e-13	0.301161434053107	0.26	0.114	1.93616888904283e-08	CEBPB	CD4+ T cells	GSE207422_Sin_post	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65121
9.45903705253459e-13	0.262242459217455	0.319	0.164	2.27177692890723e-08	ZNRF1	CD4+ T cells	GSE207422_Sin_post	ENSG00000186187	84937	zinc and ring finger 1	DKFZp434E229|FLJ14846|nin283	protein_coding	Q8ND25	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65122
1.161045980926e-12	0.293958846608768	0.576	0.393	2.78848413238998e-08	SRSF2	CD4+ T cells	GSE207422_Sin_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65123
1.41455466218434e-12	-0.311099515997129	0.514	0.684	3.39733593216813e-08	IL7R	CD4+ T cells	GSE207422_Sin_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65124
1.53270618064449e-12	0.304067377856376	0.379	0.218	3.68110043405388e-08	SDCBP	CD4+ T cells	GSE207422_Sin_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65125
1.72211365330325e-12	0.280426133082551	0.337	0.179	4.13600036113842e-08	CBLB	CD4+ T cells	GSE207422_Sin_post	ENSG00000114423	868	Cbl proto-oncogene B	Cbl-b|RNF56	protein_coding	Q13191	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65126
1.9108002100014e-12	0.268490747423719	0.48	0.306	4.58916886436036e-08	CALM3	CD4+ T cells	GSE207422_Sin_post	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65127
2.39637496164482e-12	0.552939507614901	0.616	0.414	5.75537374538238e-08	IGKC	CD4+ T cells	GSE207422_Sin_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65128
2.63990288571143e-12	-0.315642283380458	0.383	0.516	6.34025476061315e-08	RBL2	CD4+ T cells	GSE207422_Sin_post	ENSG00000103479	5934	RB transcriptional corepressor like 2	p130|Rb2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65129
2.90082884121604e-12	0.300565408168514	0.66	0.487	6.96692062794857e-08	IFI16	CD4+ T cells	GSE207422_Sin_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65130
2.9358123085853e-12	-0.272717586992816	0.174	0.299	7.05094042152932e-08	DYRK2	CD4+ T cells	GSE207422_Sin_post	ENSG00000127334	8445	dual specificity tyrosine phosphorylation regulated kinase 2	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65131
3.7169203468611e-12	0.33302018259939	0.486	0.312	8.9269275970563e-08	IRF1	CD4+ T cells	GSE207422_Sin_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65132
3.85492680123648e-12	0.323783471807045	0.457	0.297	9.25837769852966e-08	NAP1L4	CD4+ T cells	GSE207422_Sin_post	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65133
3.97484047555118e-12	-0.281866049748429	0.902	0.923	9.54637437013126e-08	RPS11	CD4+ T cells	GSE207422_Sin_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65134
4.29124141662927e-12	0.256939398983809	0.521	0.347	1.03062745103185e-07	SLC25A3	CD4+ T cells	GSE207422_Sin_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65135
4.66180837267156e-12	-0.484798650525263	0.517	0.592	1.11962651686453e-07	ANKRD12	CD4+ T cells	GSE207422_Sin_post	ENSG00000101745	23253	ankyrin repeat domain 12	ANCO-2|FLJ20053|GAC-1|KIAA0874	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65136
5.21074511918067e-12	0.29155069080263	0.334	0.181	1.25146465527362e-07	LY6E	CD4+ T cells	GSE207422_Sin_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65137
1.02759365850494e-11	0.407356709101784	0.599	0.447	2.46797168963131e-07	NEAT1	CD4+ T cells	GSE207422_Sin_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65138
1.51243598272766e-11	0.254155595294941	0.373	0.212	3.63241749971703e-07	GBP4	CD4+ T cells	GSE207422_Sin_post	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65139
1.98448147652071e-11	0.347344588677991	0.855	0.773	4.76612916215979e-07	IL2RG	CD4+ T cells	GSE207422_Sin_post	ENSG00000147168	3561	interleukin 2 receptor subunit gamma	CD132|CIDX|IMD4|SCIDX1	protein_coding	P31785	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65140
2.15068992681136e-11	0.394044222982446	0.462	0.301	5.16531199722284e-07	DUSP2	CD4+ T cells	GSE207422_Sin_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65141
5.06936069476028e-11	0.275721753360901	0.297	0.154	1.21750835806058e-06	PDCD1	CD4+ T cells	GSE207422_Sin_post	ENSG00000276977	5133	programmed cell death 1	CD279|hSLE1|PD-1|PD1|SLEB2	protein_coding	Q15116	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65142
5.25265015811753e-11	0.278722063202005	0.469	0.314	1.26152898847509e-06	YPEL5	CD4+ T cells	GSE207422_Sin_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65143
5.33855992563554e-11	0.264794325378188	0.254	0.121	1.28216193733989e-06	CLEC2B	CD4+ T cells	GSE207422_Sin_post	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65144
6.60710585089999e-11	0.525421341440911	0.306	0.168	1.58682861221065e-06	GZMA	CD4+ T cells	GSE207422_Sin_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65145
8.05403334546201e-11	0.320980760792722	0.511	0.349	1.93433718857961e-06	SLC2A3	CD4+ T cells	GSE207422_Sin_post	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65146
8.23147163610942e-11	0.432689712950096	0.296	0.164	1.9769525428444e-06	CRYBG1	CD4+ T cells	GSE207422_Sin_post	ENSG00000112297	202	crystallin beta-gamma domain containing 1	AIM1|ST4	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65147
1.34380283743336e-10	0.275549130231955	0.895	0.782	3.22741127466371e-06	BTG1	CD4+ T cells	GSE207422_Sin_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65148
1.39136234167817e-10	0.292625135272542	0.644	0.486	3.34163493600845e-06	SRSF7	CD4+ T cells	GSE207422_Sin_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65149
1.7828974390002e-10	0.297798619365716	0.301	0.162	4.28198477924679e-06	NFKBIZ	CD4+ T cells	GSE207422_Sin_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65150
1.86711190946067e-10	0.328421434282988	0.622	0.482	4.4842426729517e-06	SOD1	CD4+ T cells	GSE207422_Sin_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65151
2.20305404038219e-10	-0.285903884311823	0.477	0.578	5.2910748887859e-06	RPL6P27	CD4+ T cells	GSE207422_Sin_post	ENSG00000235552	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65152
2.21287555658698e-10	0.272511030503453	0.422	0.27	5.31466322425496e-06	RUNX3	CD4+ T cells	GSE207422_Sin_post	ENSG00000020633	864	RUNX family transcription factor 3	AML2|CBFA3|PEBP2A3	protein_coding	Q13761	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65153
2.2523820964343e-10	0.39386610148819	0.359	0.224	5.40954608100626e-06	GPR171	CD4+ T cells	GSE207422_Sin_post	ENSG00000174946	29909	G protein-coupled receptor 171	H963	protein_coding	O14626	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65154
3.29818654131659e-10	-0.286775032954752	0.839	0.869	7.92125461628006e-06	NAP1L1	CD4+ T cells	GSE207422_Sin_post	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65155
4.42982961715465e-10	-0.307673022338332	0.294	0.403	1.06391217915203e-05	RPS13P2	CD4+ T cells	GSE207422_Sin_post	ENSG00000228929	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65156
5.78566721921295e-10	-0.256368187219975	0.815	0.852	1.38954369603838e-05	RPL14	CD4+ T cells	GSE207422_Sin_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65157
2.41696581695487e-09	-0.653793699273058	0.586	0.653	5.80482680258052e-05	HSPA1B	CD4+ T cells	GSE207422_Sin_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65158
2.8913237418562e-09	0.279626067127725	0.486	0.347	6.94409223081603e-05	PIK3IP1	CD4+ T cells	GSE207422_Sin_post	ENSG00000100100	113791	phosphoinositide-3-kinase interacting protein 1	HGFL|MGC17330|TrIP	protein_coding	Q96FE7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65159
3.03202274232511e-09	0.272297270341373	0.388	0.258	7.28200902024222e-05	SIRPG	CD4+ T cells	GSE207422_Sin_post	ENSG00000089012	55423	signal regulatory protein gamma	bA77C3.1|CD172g|SIRP-B2|SIRPB2|SIRPgamma	protein_coding	Q9P1W8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65160
3.57863882167202e-09	0.251109010055763	0.477	0.333	8.5948168580097e-05	TRIM22	CD4+ T cells	GSE207422_Sin_post	ENSG00000132274	10346	tripartite motif containing 22	GPSTAF50|RNF94|STAF50	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65161
4.12769537271788e-09	0.263623989916347	0.257	0.137	9.91348597665653e-05	IKZF2	CD4+ T cells	GSE207422_Sin_post	ENSG00000030419	22807	IKAROS family zinc finger 2	Helios|ZNFN1A2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65162
4.71705792038077e-09	0.306699090298311	0.372	0.237	0.000113289580073785	HLA-DRB1	CD4+ T cells	GSE207422_Sin_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65163
6.8151904636455e-09	-0.259206384944598	0.182	0.283	0.000163680429365374	AL365361.1	CD4+ T cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65164
1.25863410020118e-08	0.293287478651156	0.617	0.516	0.000302286151845317	CTSB	CD4+ T cells	GSE207422_Sin_post	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65165
1.84123104900703e-08	0.402248897932137	0.918	0.936	0.000442208461040019	CD74	CD4+ T cells	GSE207422_Sin_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65166
1.97572266399146e-08	0.278967698535753	0.463	0.339	0.000474509312210828	APOBEC3C	CD4+ T cells	GSE207422_Sin_post	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65167
3.02441868835911e-08	0.27507801948263	0.718	0.622	0.000726374636383209	FYN	CD4+ T cells	GSE207422_Sin_post	ENSG00000010810	2534	FYN proto-oncogene, Src family tyrosine kinase	MGC45350|SLK|SYN	protein_coding	P06241	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65168
4.14608071136559e-08	-0.282177711930476	0.367	0.457	0.000995764204448674	AL031727.1	CD4+ T cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65169
4.76248279135272e-08	0.374330185385656	0.45	0.331	0.00114380549199918	ALOX5AP	CD4+ T cells	GSE207422_Sin_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65170
5.6382356656579e-08	0.258503595976037	0.581	0.451	0.00135413505982106	CALR	CD4+ T cells	GSE207422_Sin_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65171
9.17119219504263e-08	0.314371576007909	0.603	0.478	0.00220264522948339	UCP2	CD4+ T cells	GSE207422_Sin_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65172
1.08474801241745e-07	-0.252648996346597	0.427	0.522	0.00260523930142299	EVI2B	CD4+ T cells	GSE207422_Sin_post	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65173
1.33007877473605e-07	0.316945247557566	0.576	0.472	0.00319445019328358	PKM	CD4+ T cells	GSE207422_Sin_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65174
4.14484000957131e-07	0.329328584757427	0.594	0.486	0.00995466225098741	BIRC3	CD4+ T cells	GSE207422_Sin_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65175
6.68484980484235e-07	0.403262160546172	0.935	0.94	0.0160550037762899	IL32	CD4+ T cells	GSE207422_Sin_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65176
7.10503855433031e-07	0.988258350495072	0.357	0.272	0.0170641710959351	CCL5	CD4+ T cells	GSE207422_Sin_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65177
7.14362197161025e-07	-0.259168789529489	0.502	0.57	0.0171568368892163	SUN2	CD4+ T cells	GSE207422_Sin_post	ENSG00000100242	25777	Sad1 and UNC84 domain containing 2	UNC84B	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65178
9.65475279767426e-07	0.26631352250089	0.965	0.967	0.0231878197941743	PFN1	CD4+ T cells	GSE207422_Sin_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65179
1.38182994609947e-06	-0.277249229170826	0.386	0.461	0.0331874098154711	MYCBP2	CD4+ T cells	GSE207422_Sin_post	ENSG00000005810	23077	MYC binding protein 2	FLJ10106|KIAA0916|PAM|PHR1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65180
1.63248514274689e-06	-0.258270730242858	0.342	0.426	0.0392073956733521	KMT2A	CD4+ T cells	GSE207422_Sin_post	ENSG00000118058	4297	lysine methyltransferase 2A	ALL-1|ALL1|CXXC7|HRX|HTRX|HTRX1|MLL|MLL1|MLL1A|TRX1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65181
1.76834439688025e-06	-0.281865630916506	0.597	0.624	0.0424703273798729	SRSF5	CD4+ T cells	GSE207422_Sin_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65182
6.0552367153777e-19	-0.717241122953191	0.005	0.377	1.45428620193226e-14	XIST	NK cells	GSE207422_Sin_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65183
6.23151918565271e-18	1.70904724242654	0.832	0.232	1.49662396281821e-13	CXCR4	NK cells	GSE207422_Sin_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65184
9.01254912890981e-15	-1.03372375021869	0.946	0.971	2.16454392429027e-10	GNLY	NK cells	GSE207422_Sin_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65185
7.96374751748076e-13	-0.682625857791754	0.144	0.565	1.91265324127335e-08	SCGB1A1	NK cells	GSE207422_Sin_post	ENSG00000149021	7356	secretoglobin family 1A member 1	CC10|CC16|CCSP|UGB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65186
1.09652876164919e-11	-0.850107847697528	0.485	0.87	2.63353312685285e-07	CTSW	NK cells	GSE207422_Sin_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65187
1.50634202674404e-11	-0.776349042142458	0.064	0.406	3.61778164563117e-07	SELL	NK cells	GSE207422_Sin_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65188
1.61464445925586e-11	0.518741618641879	1	1	3.87789159779481e-07	TMSB4X	NK cells	GSE207422_Sin_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65189
5.3571132395139e-11	-0.900948614819155	0.688	0.899	1.28661788673405e-06	CX3CR1	NK cells	GSE207422_Sin_post	ENSG00000168329	1524	C-X3-C motif chemokine receptor 1	CCRL1|CMKBRL1|CMKDR1|GPR13|V28	protein_coding	P49238	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65190
1.20341929953704e-09	-0.592186956691554	0.955	0.986	2.89025213169811e-05	NKG7	NK cells	GSE207422_Sin_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65191
2.5707543235784e-09	0.912313952275805	0.668	0.319	6.17418065893824e-05	DDIT4	NK cells	GSE207422_Sin_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65192
3.35613384479233e-09	-0.408132881759606	0.059	0.333	8.06042665503773e-05	IFITM1	NK cells	GSE207422_Sin_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65193
2.03876654302445e-08	-0.498156725333543	0.089	0.377	0.000489650560638182	CMC1	NK cells	GSE207422_Sin_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65194
3.9572070000892e-08	-0.616074423307527	0.391	0.768	0.000950402405211423	SLAMF7	NK cells	GSE207422_Sin_post	ENSG00000026751	57823	SLAM family member 7	19A|CD319|CRACC|CS1	protein_coding	Q9NQ25	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65195
5.35774426251531e-08	0.954933366429927	0.485	0.145	0.0012867694395283	FKBP5	NK cells	GSE207422_Sin_post	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65196
1.34172377217944e-07	0.413250879804829	0.312	0	0.00322241798364336	S100B	NK cells	GSE207422_Sin_post	ENSG00000160307	6285	S100 calcium binding protein B	S100beta	protein_coding	P04271	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65197
1.40579565286769e-07	-0.784280770440881	1	1	0.00337629941949232	MT-RNR2	NK cells	GSE207422_Sin_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65198
1.84763222561142e-07	-0.35704194803123	0.124	0.435	0.00443745831625095	GANAB	NK cells	GSE207422_Sin_post	ENSG00000089597	23193	glucosidase II alpha subunit	G2AN|GIIA|GluII|KIAA0088	protein_coding	Q14697	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65199
2.63496662122125e-07	-0.396336249066829	0.173	0.478	0.00632839933418709	SBK1	NK cells	GSE207422_Sin_post	ENSG00000188322	388228	SH3 domain binding kinase 1	Sbk	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65200
2.94177124886662e-07	-0.419995949333989	0.084	0.333	0.00706525200840296	NUP210	NK cells	GSE207422_Sin_post	ENSG00000132182	23225	nucleoporin 210	FLJ22389|GP210|KIAA0906|POM210	protein_coding	Q8TEM1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65201
2.99703070552092e-07	-0.805639464370266	0.723	0.826	0.00719796864544959	IL32	NK cells	GSE207422_Sin_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65202
4.86854249104875e-07	-0.452662571578761	0.163	0.464	0.0116927785007518	ORMDL3	NK cells	GSE207422_Sin_post	ENSG00000172057	94103	ORMDL sphingolipid biosynthesis regulator 3	NA	protein_coding	Q8N138	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65203
5.62899189455131e-07	-0.547845679149458	0.916	0.957	0.0135191498331439	CCL5	NK cells	GSE207422_Sin_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65204
6.0011676986887e-07	-0.381044990414787	0.228	0.58	0.0144130044619407	TPST2	NK cells	GSE207422_Sin_post	ENSG00000128294	8459	tyrosylprotein sulfotransferase 2	TANGO13B	protein_coding	O60704	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65205
1.17790770785322e-06	-0.467585945758732	0.153	0.42	0.0282898094195108	GZMM	NK cells	GSE207422_Sin_post	ENSG00000197540	3004	granzyme M	LMET1|MET1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65206
1.35687672780372e-06	-0.824156326869703	0.332	0.623	0.032588108371662	FCER1G	NK cells	GSE207422_Sin_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65207
1.37378099396953e-06	-1.26464399920607	0.119	0.362	0.0329940981321663	HSPA1B	NK cells	GSE207422_Sin_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65208
1.67867370773993e-06	-0.544273529787261	0.134	0.406	0.04031670643879	IFNG	NK cells	GSE207422_Sin_post	ENSG00000111537	3458	interferon gamma	NA	protein_coding	P01579	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65209
1.73778879653142e-34	-0.485038222443074	0.013	0.262	4.1736473526295e-30	XIST	Malignant cells	GSE207422_Sin_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65210
1.21542190404872e-32	-1.68478705885746	0.712	0.986	2.91907878695382e-28	CD74	Malignant cells	GSE207422_Sin_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65211
1.35746918201452e-29	-0.988520231910637	0.069	0.397	3.26023373444427e-25	HLA-DQB1	Malignant cells	GSE207422_Sin_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65212
1.41103036574935e-28	-1.45129730516516	0.557	0.929	3.38887162942022e-24	HLA-DRA	Malignant cells	GSE207422_Sin_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65213
8.29388845650779e-27	-1.54217045940549	0.309	0.709	1.99194319059948e-22	HLA-DPB1	Malignant cells	GSE207422_Sin_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65214
9.43479968943203e-27	1.35632044250659	0.954	0.809	2.26595584141089e-22	S100A6	Malignant cells	GSE207422_Sin_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65215
2.48865462224406e-26	-0.931726061110608	0.135	0.496	5.97700180624356e-22	SAMHD1	Malignant cells	GSE207422_Sin_post	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65216
2.41027701035999e-22	2.59669524799435	0.48	0.028	5.78876229578158e-18	KRT17	Malignant cells	GSE207422_Sin_post	ENSG00000128422	3872	keratin 17	PCHC1	protein_coding	Q04695	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65217
2.96312031431984e-22	-1.02298872228847	0.079	0.362	7.11652605890196e-18	HLA-DRB5	Malignant cells	GSE207422_Sin_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65218
3.72268852538719e-22	-1.18237674248857	0.171	0.518	8.94078103142242e-18	HLA-DQA1	Malignant cells	GSE207422_Sin_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65219
1.75936598495165e-21	-0.423824286114217	0.046	0.284	4.22546928605838e-17	HACD4	Malignant cells	GSE207422_Sin_post	ENSG00000188921	401494	3-hydroxyacyl-CoA dehydratase 4	Em:AL662879.1|OTTHUMG00000021016|PTPLAD2	protein_coding	Q5VWC8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65220
3.22178704532128e-21	-0.902366280877806	0.258	0.688	7.73776594674812e-17	SCGB1A1	Malignant cells	GSE207422_Sin_post	ENSG00000149021	7356	secretoglobin family 1A member 1	CC10|CC16|CCSP|UGB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65221
4.2121246340705e-21	1.230459848597	0.701	0.326	1.01162597336471e-16	TXN	Malignant cells	GSE207422_Sin_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65222
8.7028943429184e-21	-1.3969759565252	0.366	0.745	2.09017413433871e-16	HLA-DPA1	Malignant cells	GSE207422_Sin_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65223
4.5724458551399e-20	-0.37752867604154	0.042	0.262	1.09816432102895e-15	RABL2B	Malignant cells	GSE207422_Sin_post	ENSG00000079974	11158	RAB, member of RAS oncogene family like 2B	NA	protein_coding	Q9UNT1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65224
5.32362269644079e-20	1.91781869557588	0.773	0.489	1.27857446300418e-15	GAPDH	Malignant cells	GSE207422_Sin_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65225
1.81280834590183e-19	-0.547913687671154	0.049	0.277	4.35382180435244e-15	KCTD12	Malignant cells	GSE207422_Sin_post	ENSG00000178695	115207	potassium channel tetramerization domain containing 12	C13orf2|KIAA1778|PFET1	protein_coding	Q96CX2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65226
3.67825764846039e-19	-0.466679765076014	0.043	0.255	8.83407139430732e-15	DYNC2H1	Malignant cells	GSE207422_Sin_post	ENSG00000187240	79659	dynein cytoplasmic 2 heavy chain 1	DHC1b|DHC2|DNCH2|DYH1B|hdhc11	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65227
9.92965272086691e-19	1.02233573852694	0.587	0.199	2.38480469397061e-14	S100A16	Malignant cells	GSE207422_Sin_post	ENSG00000188643	140576	S100 calcium binding protein A16	DT1P1A7|MGC17528|S100F	protein_coding	Q96FQ6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65228
7.2561276684624e-18	-1.85761927811053	0.142	0.433	1.74270418213462e-13	TPPP3	Malignant cells	GSE207422_Sin_post	ENSG00000159713	51673	tubulin polymerization promoting protein family member 3	CGI-38|p20|p25gamma	protein_coding	Q9BW30	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65229
1.00235921694972e-16	1.41362792902417	0.676	0.355	2.40736613134813e-12	LDHA	Malignant cells	GSE207422_Sin_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65230
4.42873014601073e-16	1.08490395647144	0.905	0.794	1.0636481191674e-11	RPL27	Malignant cells	GSE207422_Sin_post	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65231
1.42839405954082e-15	1.4170853279277	0.557	0.199	3.43057401279918e-11	SFN	Malignant cells	GSE207422_Sin_post	ENSG00000175793	2810	stratifin	YWHAS	protein_coding	P31947	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65232
2.53749274432748e-15	1.00005969714945	0.699	0.426	6.0942963240513e-11	MGST1	Malignant cells	GSE207422_Sin_post	ENSG00000008394	4257	microsomal glutathione S-transferase 1	GST12|MGST-I|PMAN	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65233
3.01838675119447e-15	1.35589895326801	0.6	0.262	7.24925946034375e-11	TM4SF1	Malignant cells	GSE207422_Sin_post	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65234
3.8143093854862e-15	0.809621600610691	0.954	0.908	9.1608268511222e-11	PPIA	Malignant cells	GSE207422_Sin_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65235
3.93183767793972e-15	0.891567552938351	0.77	0.482	9.44309455110783e-11	TPI1	Malignant cells	GSE207422_Sin_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65236
6.03650087896407e-15	-0.591016470569262	0.163	0.426	1.4497864161008e-10	RPL10P3	Malignant cells	GSE207422_Sin_post	ENSG00000230734	NA	NA	bA567J2.2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65237
2.31706354161858e-14	-0.377464996359294	0.062	0.262	5.56489150790535e-10	ZC2HC1A	Malignant cells	GSE207422_Sin_post	ENSG00000104427	51101	zinc finger C2HC-type containing 1A	C8orf70|CGI-62|FAM164A	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65238
2.35712787213217e-14	0.967136798930784	0.349	0.028	5.66111401049982e-10	AKR1C2	Malignant cells	GSE207422_Sin_post	ENSG00000151632	1646	aldo-keto reductase family 1 member C2	BABP|DD|DD2|DDH2|HAKRD|MCDR2|TDD	protein_coding	P52895	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65239
3.74194283628137e-14	0.60134042969447	0.858	0.667	8.98702410989697e-10	MYL12B	Malignant cells	GSE207422_Sin_post	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65240
4.0931902926169e-14	-1.67987640195939	0.121	0.362	9.83061512577802e-10	CAPS	Malignant cells	GSE207422_Sin_post	ENSG00000105519	828	calcyphosine	CAPS1|MGC126562	protein_coding	Q13938	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65241
8.15271542269387e-14	-0.692783153341019	0.143	0.39	1.95803766306839e-09	ARHGDIB	Malignant cells	GSE207422_Sin_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65242
8.93019095524406e-14	0.749181931598434	0.85	0.582	2.14476396172097e-09	TMSB10	Malignant cells	GSE207422_Sin_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65243
1.07612192283824e-13	0.961764233183511	0.436	0.113	2.58452202208059e-09	AKR1C1	Malignant cells	GSE207422_Sin_post	ENSG00000187134	1645	aldo-keto reductase family 1 member C1	DD1|DDH|DDH1|HAKRC|MBAB	protein_coding	Q04828	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65244
2.21361281620279e-13	0.979483525516188	0.551	0.234	5.31643390067423e-09	GPI	Malignant cells	GSE207422_Sin_post	ENSG00000282019	2821	glucose-6-phosphate isomerase	AMF|NLK	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65245
6.07657951463477e-13	0.721505103247611	0.395	0.078	1.45941210202983e-08	DDIT4	Malignant cells	GSE207422_Sin_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65246
8.02923877091457e-13	0.843020034576913	0.798	0.574	1.92838227561055e-08	SPINT2	Malignant cells	GSE207422_Sin_post	ENSG00000167642	10653	serine peptidase inhibitor, Kunitz type 2	HAI-2|HAI2|Kop	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65247
9.70273530632185e-13	0.840761535199526	0.564	0.277	2.33030593851932e-08	SNRPD2	Malignant cells	GSE207422_Sin_post	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65248
1.24302812838128e-12	1.8334747202065	0.391	0.092	2.98538065593331e-08	S100P	Malignant cells	GSE207422_Sin_post	ENSG00000163993	6286	S100 calcium binding protein P	NA	protein_coding	P25815	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65249
1.53206178638774e-12	0.895585033252	0.63	0.333	3.67955279236743e-08	KRT19	Malignant cells	GSE207422_Sin_post	ENSG00000171345	3880	keratin 19	CK19|K19|K1CS|MGC15366	protein_coding	P08727	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65250
2.37475834633747e-12	0.808683620489252	0.474	0.177	5.7034571203987e-08	SNHG6	Malignant cells	GSE207422_Sin_post	ENSG00000245910	NA	NA	HBII-276HG|NCRNA00058|U87HG	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65251
2.8289003916097e-12	0.832810287434822	0.974	0.922	6.79417007052903e-08	RPL37	Malignant cells	GSE207422_Sin_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65252
2.94622372777512e-12	-0.806875290480902	0.203	0.454	7.0759455269975e-08	CTSS	Malignant cells	GSE207422_Sin_post	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65253
3.1042637290331e-12	0.690229364139483	0.815	0.56	7.4555101980188e-08	RPL35	Malignant cells	GSE207422_Sin_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65254
3.61703073639141e-12	-1.41443184362493	0.277	0.518	8.68702271959125e-08	VIM	Malignant cells	GSE207422_Sin_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65255
3.967056365398e-12	-0.524482719313561	0.072	0.255	9.52767927277638e-08	ARHGAP18	Malignant cells	GSE207422_Sin_post	ENSG00000146376	93663	Rho GTPase activating protein 18	bA307O14.2|MacGAP	protein_coding	Q8N392	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65256
4.09612657560791e-12	0.561643609211588	0.628	0.319	9.83766719663752e-08	NDUFS5	Malignant cells	GSE207422_Sin_post	ENSG00000168653	4725	NADH:ubiquinone oxidoreductase subunit S5	CI-15k	protein_coding	O43920	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65257
5.44009215438897e-12	2.29029279727993	0.286	0.014	1.3065469327196e-07	S100A2	Malignant cells	GSE207422_Sin_post	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65258
5.57666884395046e-12	0.629082145472349	0.967	0.929	1.33934855625158e-07	RPL27A	Malignant cells	GSE207422_Sin_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65259
6.25112961297273e-12	-1.20208215183613	0.353	0.617	1.50133379914766e-07	HSPA1B	Malignant cells	GSE207422_Sin_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65260
7.86545541170791e-12	-0.407572392574763	0.23	0.511	1.88904642622989e-07	SECISBP2L	Malignant cells	GSE207422_Sin_post	ENSG00000138593	9728	SECIS binding protein 2 like	KIAA0256	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65261
8.0342234792521e-12	-0.452232414178377	0.083	0.277	1.92957945301198e-07	SH3BGRL	Malignant cells	GSE207422_Sin_post	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65262
9.03435727107287e-12	0.669085377712595	0.732	0.504	2.16978158579357e-07	ENO1	Malignant cells	GSE207422_Sin_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65263
9.68638302890726e-12	0.5669153823892	0.928	0.858	2.32637861205266e-07	RPS19	Malignant cells	GSE207422_Sin_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65264
1.13893657724457e-11	-1.44258233361037	0.435	0.702	2.73538397756829e-07	HSPA1A	Malignant cells	GSE207422_Sin_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65265
1.2697662363572e-11	-0.498947627206424	0.458	0.709	3.0495975698591e-07	PRKAR1A	Malignant cells	GSE207422_Sin_post	ENSG00000108946	5573	protein kinase cAMP-dependent type I regulatory subunit alpha	CNC1|PRKAR1|TSE1	protein_coding	P10644	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65266
1.3829674896574e-11	-0.812193478993985	0.139	0.348	3.32147301991018e-07	GSTA1	Malignant cells	GSE207422_Sin_post	ENSG00000243955	2938	glutathione S-transferase alpha 1	NA	protein_coding	P08263	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65267
1.40948151637924e-11	0.632668842535077	0.971	0.943	3.38515175788802e-07	RPS27A	Malignant cells	GSE207422_Sin_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65268
1.57673717913977e-11	-0.616227417502225	0.105	0.305	3.78684968313999e-07	PLAC8	Malignant cells	GSE207422_Sin_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65269
2.12045729655894e-11	0.711469911983475	0.85	0.667	5.09270228914561e-07	RPS21	Malignant cells	GSE207422_Sin_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65270
2.29160995906073e-11	0.758591222002309	0.447	0.163	5.50375963867615e-07	CYCS	Malignant cells	GSE207422_Sin_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65271
3.86606752796906e-11	-0.349314558738219	0.083	0.27	9.28513438192328e-07	MAPRE3	Malignant cells	GSE207422_Sin_post	ENSG00000084764	22924	microtubule associated protein RP/EB family member 3	EB3|RP3	protein_coding	Q9UPY8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65272
7.27314270092295e-11	0.694860579105574	0.254	0.007	1.74679068248067e-06	GPX2	Malignant cells	GSE207422_Sin_post	ENSG00000176153	2877	glutathione peroxidase 2	GSHPX-GI	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65273
7.28473000333823e-11	0.714927804290752	0.329	0.064	1.74957360490174e-06	ATP1B3	Malignant cells	GSE207422_Sin_post	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65274
7.5909129080557e-11	-0.388489316509519	0.094	0.284	1.82310955312774e-06	TCTN1	Malignant cells	GSE207422_Sin_post	ENSG00000204852	79600	tectonic family member 1	FLJ21127|JBTS13|TECT1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65275
7.97257351572413e-11	1.11072715580889	0.539	0.284	1.91477298127146e-06	BZW1	Malignant cells	GSE207422_Sin_post	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65276
8.13265706837034e-11	-0.807337311141644	0.199	0.418	1.95322024811051e-06	ALDH3B1	Malignant cells	GSE207422_Sin_post	ENSG00000006534	221	aldehyde dehydrogenase 3 family member B1	ALDH7	protein_coding	P43353	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65277
8.20613699552691e-11	1.64954478779552	0.507	0.227	1.9708679222157e-06	MMP7	Malignant cells	GSE207422_Sin_post	ENSG00000137673	4316	matrix metallopeptidase 7	MPSL1|PUMP-1	protein_coding	P09237	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65278
1.12880023744557e-10	0.95552482100479	0.331	0.071	2.71103953027304e-06	AKR1C3	Malignant cells	GSE207422_Sin_post	ENSG00000196139	8644	aldo-keto reductase family 1 member C3	DDX|HAKRB|HSD17B5|KIAA0119|PGFS	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65279
1.36876075321257e-10	0.56675378858437	0.809	0.631	3.28735270099063e-06	RPL18	Malignant cells	GSE207422_Sin_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65280
2.06319290113655e-10	0.77586073312017	0.927	0.887	4.95517039065964e-06	RPL38	Malignant cells	GSE207422_Sin_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65281
2.80036272326663e-10	0.58631655919993	0.547	0.255	6.72563115246946e-06	UQCRH	Malignant cells	GSE207422_Sin_post	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65282
2.91482331388414e-10	0.70623122627073	0.31	0.057	7.00053115295553e-06	IER3	Malignant cells	GSE207422_Sin_post	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65283
4.49521037408977e-10	0.757739476653605	0.503	0.248	1.07961467554514e-05	SEC61G	Malignant cells	GSE207422_Sin_post	ENSG00000132432	23480	SEC61 translocon subunit gamma	SSS1	protein_coding	P60059	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65284
5.19440958120776e-10	0.608447395763343	0.978	0.957	1.24754134911867e-05	RPL31	Malignant cells	GSE207422_Sin_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65285
5.97203334299746e-10	0.533593868102086	0.539	0.255	1.4343032479877e-05	SSR3	Malignant cells	GSE207422_Sin_post	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65286
6.2885478803856e-10	-0.610865193812916	0.507	0.716	1.51032054443221e-05	MT-ATP8	Malignant cells	GSE207422_Sin_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65287
6.50299436415951e-10	-0.465331842445623	0.163	0.376	1.56182415644019e-05	ODF2L	Malignant cells	GSE207422_Sin_post	ENSG00000122417	57489	outer dense fiber of sperm tails 2 like	KIAA1229	protein_coding	Q9ULJ1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65288
8.37807742246118e-10	1.00927215541677	0.342	0.092	2.0121628545525e-05	SLC2A1	Malignant cells	GSE207422_Sin_post	ENSG00000117394	6513	solute carrier family 2 member 1	CSE|DYT18|DYT9|GLUT|GLUT-1|GLUT1|HTLVR	protein_coding	P11166	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65289
9.30282406108797e-10	-0.805426427958703	0.16	0.369	2.2342592547515e-05	IGFBP7	Malignant cells	GSE207422_Sin_post	ENSG00000163453	3490	insulin like growth factor binding protein 7	FSTL2|IGFBP-7|MAC25|PSF	protein_coding	Q16270	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65290
1.08520471843177e-09	-0.487696293636162	0.211	0.426	2.60633617225758e-05	PCM1	Malignant cells	GSE207422_Sin_post	ENSG00000078674	5108	pericentriolar material 1	PTC4	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65291
1.17370543713791e-09	-0.709530695268534	0.098	0.27	2.81888834837413e-05	LAPTM5	Malignant cells	GSE207422_Sin_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65292
1.33438536155708e-09	0.566707781626224	0.805	0.574	3.20479332285165e-05	YWHAZ	Malignant cells	GSE207422_Sin_post	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65293
1.36346118234883e-09	-0.402900853006401	0.095	0.27	3.27462472164718e-05	HIPK1	Malignant cells	GSE207422_Sin_post	ENSG00000163349	204851	homeodomain interacting protein kinase 1	KIAA0630|MGC26642|MGC33446|MGC33548|Myak|Nbak2	protein_coding	Q86Z02	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65294
1.44119415046074e-09	0.711657160413843	0.714	0.511	3.46131599116155e-05	P4HB	Malignant cells	GSE207422_Sin_post	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65295
1.4861642566653e-09	0.570089945217825	0.391	0.142	3.56932069523304e-05	OLA1	Malignant cells	GSE207422_Sin_post	ENSG00000138430	29789	Obg like ATPase 1	GTPBP9|PTD004	protein_coding	Q9NTK5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65296
1.54875102206553e-09	0.741216731912719	0.646	0.447	3.71963532969478e-05	ATP5MC3	Malignant cells	GSE207422_Sin_post	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65297
1.56476552486637e-09	1.37476781409282	0.803	0.645	3.75809736107156e-05	CTSB	Malignant cells	GSE207422_Sin_post	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65298
1.65734617234434e-09	-0.457741950233082	0.163	0.376	3.98044830211941e-05	TMEM173	Malignant cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65299
1.90476512100814e-09	-0.997137319569587	0.139	0.326	4.57467439112524e-05	TUBA1A	Malignant cells	GSE207422_Sin_post	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65300
1.95023147742591e-09	0.739435201809704	0.427	0.177	4.68387093933381e-05	TUBA1C	Malignant cells	GSE207422_Sin_post	ENSG00000167553	84790	tubulin alpha 1c	bcm948|MGC10851|MGC14580|TUBA6	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65301
1.98508793407949e-09	-0.334127814788618	0.158	0.369	4.76758569127871e-05	HLA-DMA	Malignant cells	GSE207422_Sin_post	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65302
1.98744202412694e-09	0.452601295939703	0.392	0.135	4.77323950934567e-05	BACE2	Malignant cells	GSE207422_Sin_post	ENSG00000182240	25825	beta-secretase 2	AEPLC|ALP56|CEAP1|DRAP	protein_coding	Q9Y5Z0	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65303
2.14347821691456e-09	0.699247094509519	0.918	0.865	5.14799163356371e-05	RPS5	Malignant cells	GSE207422_Sin_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65304
2.27603532811353e-09	0.64529422609138	0.503	0.255	5.46635404753027e-05	KDELR2	Malignant cells	GSE207422_Sin_post	ENSG00000136240	11014	KDEL endoplasmic reticulum protein retention receptor 2	ELP-1|ERD2.2	protein_coding	P33947	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65305
2.34871651563404e-09	-0.58630361342131	0.277	0.496	5.64091245559828e-05	AKAP9	Malignant cells	GSE207422_Sin_post	ENSG00000127914	10142	A-kinase anchoring protein 9	AKAP350|AKAP450|CG-NAP|HYPERION|KIAA0803|LQT11|MU-RMS-40.16A|PPP1R45|PRKA9|YOTIAO	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65306
2.84728971919983e-09	-1.97517799480139	0.117	0.298	6.83833571860224e-05	LYZ	Malignant cells	GSE207422_Sin_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65307
3.14874339622521e-09	-0.585754224594835	0.191	0.397	7.56233701471409e-05	GNAI2	Malignant cells	GSE207422_Sin_post	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65308
3.20387760980414e-09	0.740521729320342	0.62	0.383	7.6947528554666e-05	S100A14	Malignant cells	GSE207422_Sin_post	ENSG00000189334	57402	S100 calcium binding protein A14	BCMP84|S100A15	protein_coding	Q9HCY8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65309
3.33623992372439e-09	-0.301021238987188	0.092	0.262	8.01264742480887e-05	LRIG1	Malignant cells	GSE207422_Sin_post	ENSG00000144749	26018	leucine rich repeats and immunoglobulin like domains 1	DKFZP586O1624|LIG-1|LIG1	protein_coding	Q96JA1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65310
3.40878970216196e-09	0.464463305724977	0.378	0.128	8.18689022768237e-05	MYDGF	Malignant cells	GSE207422_Sin_post	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65311
3.5269189806135e-09	-0.404446015645619	0.145	0.333	8.47060131573943e-05	SSBP3	Malignant cells	GSE207422_Sin_post	ENSG00000157216	23648	single stranded DNA binding protein 3	CSDP|FLJ10355|SSDP|SSDP1	protein_coding	Q9BWW4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65312
3.72013706325195e-09	0.573061511749116	0.54	0.277	8.93465318481222e-05	RPL18A	Malignant cells	GSE207422_Sin_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65313
4.05692237710278e-09	-0.757710542011948	0.296	0.539	9.74351047308775e-05	TXNIP	Malignant cells	GSE207422_Sin_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65314
4.43176223183333e-09	0.598491673554452	0.848	0.674	0.000106437633521941	RPS15A	Malignant cells	GSE207422_Sin_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65315
4.79861888000939e-09	0.661626147164559	0.952	0.908	0.000115248429641185	RPL13A	Malignant cells	GSE207422_Sin_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65316
5.42300529150201e-09	-0.573261103467691	0.259	0.461	0.000130244318086004	CLIC6	Malignant cells	GSE207422_Sin_post	ENSG00000159212	54102	chloride intracellular channel 6	CLIC1L|CLIC5	protein_coding	Q96NY7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65317
5.43386211767033e-09	-0.485127141105705	0.271	0.475	0.000130505066480088	RBM3	Malignant cells	GSE207422_Sin_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65318
5.97317622539857e-09	0.566853798919005	0.917	0.801	0.000143457773405398	GSTP1	Malignant cells	GSE207422_Sin_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65319
6.58319708577585e-09	-0.578368486076866	0.257	0.468	0.000158108644409079	METTL7A	Malignant cells	GSE207422_Sin_post	ENSG00000185432	25840	methyltransferase like 7A	DKFZP586A0522	protein_coding	Q9H8H3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65320
7.8991835145501e-09	0.622799430037069	0.681	0.447	0.00018971469046895	TPM4	Malignant cells	GSE207422_Sin_post	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65321
8.59931047142639e-09	0.893590459923941	0.332	0.092	0.000206529639592248	EMP1	Malignant cells	GSE207422_Sin_post	ENSG00000134531	2012	epithelial membrane protein 1	CL-20|TMP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65322
9.96807282213515e-09	1.57815232344832	0.28	0.057	0.00023940320496922	IGFBP3	Malignant cells	GSE207422_Sin_post	ENSG00000146674	3486	insulin like growth factor binding protein 3	BP-53|IBP3	protein_coding	P17936	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65323
1.03814825973809e-08	0.703566914675038	0.488	0.255	0.000249332067541296	GAS5	Malignant cells	GSE207422_Sin_post	ENSG00000234741	60674	growth arrest specific 5	NCRNA00030|SNHG2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65324
1.03940370909279e-08	0.771012315219842	0.393	0.149	0.000249633588812815	NQO1	Malignant cells	GSE207422_Sin_post	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65325
1.10418538051273e-08	0.577472742350976	0.38	0.135	0.000265192202837743	JPT1	Malignant cells	GSE207422_Sin_post	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65326
1.82398189921316e-08	-0.293971717725229	0.094	0.255	0.000438065732734025	ELK3	Malignant cells	GSE207422_Sin_post	ENSG00000111145	2004	ETS transcription factor ELK3	ERP|NET|SAP2	protein_coding	P41970	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65327
1.99741627288964e-08	-0.687288902559593	0.124	0.298	0.000479719466259904	FTO	Malignant cells	GSE207422_Sin_post	ENSG00000140718	79068	FTO alpha-ketoglutarate dependent dioxygenase	ALKBH9|KIAA1752|MGC5149	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65328
2.00069688326248e-08	0.754222095378637	0.917	0.837	0.00048050737045315	RPL8	Malignant cells	GSE207422_Sin_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65329
2.04376104925465e-08	0.575136229081723	0.682	0.532	0.000490850091199489	CHCHD2	Malignant cells	GSE207422_Sin_post	ENSG00000106153	51142	coiled-coil-helix-coiled-coil-helix domain containing 2	C7orf17|MIX17B|MNRR1	protein_coding	Q9Y6H1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65330
2.17937632443573e-08	0.648100737600782	0.682	0.489	0.00052342081183973	SUMO2	Malignant cells	GSE207422_Sin_post	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65331
2.23143686521773e-08	0.421099985770317	0.337	0.106	0.000535924191919342	NOTCH3	Malignant cells	GSE207422_Sin_post	ENSG00000074181	4854	notch receptor 3	CADASIL|CASIL	protein_coding	Q9UM47	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65332
2.33220277500617e-08	0.531868775177554	0.418	0.177	0.000560125140473233	C6orf48	Malignant cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65333
2.3425217525823e-08	0.427999887374816	0.496	0.248	0.000562603449317691	EIF2S2	Malignant cells	GSE207422_Sin_post	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65334
2.40944365395702e-08	0.51489569657384	0.257	0.043	0.000578676082370858	FSCN1	Malignant cells	GSE207422_Sin_post	ENSG00000075618	6624	fascin actin-bundling protein 1	FLJ38511|p55|SNL	protein_coding	Q16658	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65335
2.77965776860039e-08	0.596744498840091	0.596	0.383	0.000667590406284756	COX6B1	Malignant cells	GSE207422_Sin_post	ENSG00000126267	1340	cytochrome c oxidase subunit 6B1	COX6B|COXG	protein_coding	P14854	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65336
2.84976484163541e-08	-0.637322963204049	0.201	0.383	0.000684428022015575	IK	Malignant cells	GSE207422_Sin_post	ENSG00000113141	3550	IK cytokine	RED|RER	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65337
3.4663597428295e-08	-0.48874755646437	0.202	0.39	0.000832515619435361	FOXA1	Malignant cells	GSE207422_Sin_post	ENSG00000129514	3169	forkhead box A1	HNF3A	protein_coding	P55317	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65338
3.7409921230312e-08	0.473136628552381	0.471	0.227	0.000898474078188404	SNRPG	Malignant cells	GSE207422_Sin_post	ENSG00000143977	6637	small nuclear ribonucleoprotein polypeptide G	Sm-G	protein_coding	P62308	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65339
3.89214434440708e-08	-0.64905014538239	0.469	0.702	0.000934776307196249	HLA-DRB1	Malignant cells	GSE207422_Sin_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65340
3.96552393312937e-08	0.421215577072429	0.615	0.376	0.00095239988301968	KDELR1	Malignant cells	GSE207422_Sin_post	ENSG00000105438	10945	KDEL endoplasmic reticulum protein retention receptor 1	ERD2|ERD2.1|HDEL	protein_coding	P24390	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65341
4.20983262816648e-08	-0.738903303292438	0.146	0.319	0.00101107550230674	DNAJA4	Malignant cells	GSE207422_Sin_post	ENSG00000140403	55466	DnaJ heat shock protein family (Hsp40) member A4	PRO1472	protein_coding	Q8WW22	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65342
4.70588591911989e-08	-0.44845374004598	0.47	0.695	0.00113021262119502	HMGN2	Malignant cells	GSE207422_Sin_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65343
5.26324804700609e-08	-0.466303316105563	0.37	0.567	0.00126407428344945	DNAJA1	Malignant cells	GSE207422_Sin_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65344
5.33333804122784e-08	0.920434063095206	0.734	0.539	0.00128090779736169	PERP	Malignant cells	GSE207422_Sin_post	ENSG00000112378	64065	p53 apoptosis effector related to PMP22	dJ496H19.1|KCP1|KRTCAP1|PIGPC1|THW	protein_coding	Q96FX8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65345
5.51582528922189e-08	0.656896274478606	0.461	0.241	0.00132473575971242	ZFAS1	Malignant cells	GSE207422_Sin_post	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65346
6.11580079829296e-08	-0.629521486683823	0.241	0.426	0.00146883187772602	UCP2	Malignant cells	GSE207422_Sin_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65347
6.43938427809296e-08	0.422944845867166	0.421	0.191	0.00154654692206959	LDHB	Malignant cells	GSE207422_Sin_post	ENSG00000111716	3945	lactate dehydrogenase B	NA	protein_coding	P07195	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65348
6.60501845941996e-08	1.20468898260922	0.525	0.333	0.00158632728339889	CEACAM6	Malignant cells	GSE207422_Sin_post	ENSG00000086548	4680	CEA cell adhesion molecule 6	CD66c|NCA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65349
8.87909114316786e-08	0.716269859025041	0.27	0.064	0.00213249131985463	ERO1A	Malignant cells	GSE207422_Sin_post	ENSG00000197930	30001	endoplasmic reticulum oxidoreductase 1 alpha	ERO1-alpha|Ero1alpha|ERO1L	protein_coding	Q96HE7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65350
1.00305177726706e-07	0.43560081546055	0.443	0.213	0.00240902945346229	SNRPB	Malignant cells	GSE207422_Sin_post	ENSG00000125835	6628	small nuclear ribonucleoprotein polypeptides B and B1	COD|Sm-B/B'|SmB/SmB'|snRNP-B|SNRPB1	protein_coding	P14678	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65351
1.00346757880931e-07	0.540334867997395	0.395	0.163	0.00241002808402632	CDKN1A	Malignant cells	GSE207422_Sin_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65352
1.04538099121591e-07	0.796642077633833	0.921	0.823	0.00251069152660326	RPS18	Malignant cells	GSE207422_Sin_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65353
1.20905074112264e-07	-0.299733693126728	0.133	0.305	0.00290377716495425	PUM2	Malignant cells	GSE207422_Sin_post	ENSG00000055917	23369	pumilio RNA binding family member 2	KIAA0235|PUMH2	protein_coding	Q8TB72	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65354
1.22389728048699e-07	0.385440955043174	0.426	0.199	0.00293943409854559	HEBP2	Malignant cells	GSE207422_Sin_post	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65355
1.29184356995178e-07	0.417967140944935	0.478	0.248	0.0031026207019532	C1orf43	Malignant cells	GSE207422_Sin_post	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65356
1.29880332038924e-07	0.612158359783824	0.604	0.418	0.00311933593457883	UQCRQ	Malignant cells	GSE207422_Sin_post	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65357
1.70992621889494e-07	0.506970831444898	0.29	0.085	0.00410672979991998	PTGR1	Malignant cells	GSE207422_Sin_post	ENSG00000106853	22949	prostaglandin reductase 1	LTB4DH|ZADH3	protein_coding	Q14914	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65358
1.83417086355292e-07	0.370641283368456	0.479	0.234	0.00440512816299504	ELOB	Malignant cells	GSE207422_Sin_post	ENSG00000103363	6923	elongin B	SIII|TCEB2	protein_coding	Q15370	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65359
1.86607905598456e-07	0.593197305713303	0.753	0.617	0.00448176206875812	LRRC75A-AS1	Malignant cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65360
1.90208097115165e-07	0.401892472993944	0.957	0.887	0.00456822786841492	RPS13	Malignant cells	GSE207422_Sin_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65361
2.02118334648466e-07	0.61287496226744	0.65	0.447	0.0048542760432522	S100A10	Malignant cells	GSE207422_Sin_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65362
2.1050986180807e-07	0.579553776192131	0.561	0.348	0.00505581535104442	SDC1	Malignant cells	GSE207422_Sin_post	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65363
2.22136153632398e-07	-0.338392898440242	0.281	0.489	0.0053350440017893	NFIX	Malignant cells	GSE207422_Sin_post	ENSG00000008441	4784	nuclear factor I X	NF1A	protein_coding	Q14938	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65364
2.25646344609638e-07	-0.830793029104085	0.154	0.312	0.00541934825848968	CETN2	Malignant cells	GSE207422_Sin_post	ENSG00000147400	1069	centrin 2	CALT|CEN2	protein_coding	P41208	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65365
2.35246368957642e-07	0.647752442815952	0.553	0.355	0.00564991204325569	JUP	Malignant cells	GSE207422_Sin_post	ENSG00000173801	3728	junction plakoglobin	CTNNG|DP3|DPIII|PDGB|PG|PKGB	protein_coding	P14923	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65366
2.36834587818404e-07	0.329580482134178	0.337	0.121	0.00568805629563461	LTBR	Malignant cells	GSE207422_Sin_post	ENSG00000111321	4055	lymphotoxin beta receptor	D12S370|TNF-R-III|TNFCR|TNFR-RP|TNFR2-RP|TNFRSF3	protein_coding	P36941	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65367
2.38502756936662e-07	0.323503798835652	0.32	0.106	0.00572812071334781	ELOC	Malignant cells	GSE207422_Sin_post	ENSG00000154582	6921	elongin C	SIII|TCEB1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65368
2.41326977530794e-07	-0.413101381887998	0.331	0.539	0.00579595001935708	ALDH2	Malignant cells	GSE207422_Sin_post	ENSG00000111275	217	aldehyde dehydrogenase 2 family member	NA	protein_coding	P05091	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65369
2.7090320765907e-07	0.464048806898289	0.451	0.227	0.00650628233834788	PLP2	Malignant cells	GSE207422_Sin_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65370
2.79537633185376e-07	0.483979583997584	0.789	0.681	0.00671365533621317	TAGLN2	Malignant cells	GSE207422_Sin_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65371
3.37990407946673e-07	-0.2604422666556	0.194	0.39	0.00811751562765524	SMARCA2	Malignant cells	GSE207422_Sin_post	ENSG00000080503	6595	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2	BAF190|BRM|hBRM|hSNF2a|SNF2|SNF2L2|SNF2LA|Sth1p|SWI2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65372
3.51068719225848e-07	0.42765456963789	0.46	0.241	0.00843161742964718	LAPTM4B	Malignant cells	GSE207422_Sin_post	ENSG00000104341	55353	lysosomal protein transmembrane 4 beta	LC27	protein_coding	Q86VI4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65373
3.60143273258645e-07	-0.379384013267782	0.521	0.716	0.00864956099385288	PEBP1	Malignant cells	GSE207422_Sin_post	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65374
3.67030054157532e-07	-0.458546550511497	0.451	0.631	0.00881496081070144	SMIM14	Malignant cells	GSE207422_Sin_post	ENSG00000163683	201895	small integral membrane protein 14	C4orf34|FLJ13289	protein_coding	Q96QK8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65375
3.71594218305541e-07	0.777301267479385	0.565	0.39	0.00892457834104418	KRT7	Malignant cells	GSE207422_Sin_post	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65376
3.8057200195023e-07	0.580123943784775	0.745	0.596	0.00914019777083867	RAC1	Malignant cells	GSE207422_Sin_post	ENSG00000136238	5879	Rac family small GTPase 1	p21-Rac1|Rac-1|TC-25	protein_coding	P63000	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65377
3.99160378171547e-07	0.422244284003056	0.319	0.106	0.00958663480254604	SGK1	Malignant cells	GSE207422_Sin_post	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65378
4.02105957939994e-07	0.794806553635076	0.276	0.085	0.00965737879184484	CLK1	Malignant cells	GSE207422_Sin_post	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65379
4.04765986256474e-07	0.418267380464857	0.431	0.22	0.00972126469192174	COX5B	Malignant cells	GSE207422_Sin_post	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65380
4.2878005448317e-07	0.393670066895697	0.66	0.461	0.0102980105685223	ANP32B	Malignant cells	GSE207422_Sin_post	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65381
5.24345036703057e-07	0.490352740949404	0.288	0.092	0.0125931947464973	FAM83A	Malignant cells	GSE207422_Sin_post	ENSG00000147689	84985	family with sequence similarity 83 member A	BJ-TSA-9|MGC14128	protein_coding	Q86UY5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65382
5.61469548409372e-07	-0.358756766068181	0.152	0.312	0.0134848141441479	HSPBP1	Malignant cells	GSE207422_Sin_post	ENSG00000133265	23640	HSPA (Hsp70) binding protein 1	FES1	protein_coding	Q9NZL4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65383
6.29098375094383e-07	-0.306997119625268	0.203	0.383	0.0151090556746418	VPS35	Malignant cells	GSE207422_Sin_post	ENSG00000069329	55737	VPS35 retromer complex component	FLJ10752|MEM3|PARK17	protein_coding	Q96QK1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65384
6.35466842358815e-07	0.440210830532505	0.339	0.135	0.0152620071529317	FKBP4	Malignant cells	GSE207422_Sin_post	ENSG00000004478	2288	FKBP prolyl isomerase 4	FKBP52|FKBP59	protein_coding	Q02790	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65385
6.364719870787e-07	0.424808496592421	0.378	0.17	0.0152861477136691	NDUFB9	Malignant cells	GSE207422_Sin_post	ENSG00000147684	4715	NADH:ubiquinone oxidoreductase subunit B9	B22|LYRM3|UQOR22	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65386
6.80715357419681e-07	0.420012829990771	0.327	0.128	0.0163487407391485	ATP5MC1	Malignant cells	GSE207422_Sin_post	ENSG00000159199	516	ATP synthase membrane subunit c locus 1	ATP5G|ATP5G1	protein_coding	P05496	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65387
6.91879227035926e-07	-0.588389802138448	0.316	0.504	0.0166168633957218	ALDH1A1	Malignant cells	GSE207422_Sin_post	ENSG00000165092	216	aldehyde dehydrogenase 1 family member A1	ALDH1|PUMB1|RALDH1	protein_coding	P00352	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65388
7.05622067301003e-07	-0.590498462822768	0.401	0.631	0.0169469251903682	PIGR	Malignant cells	GSE207422_Sin_post	ENSG00000162896	5284	polymeric immunoglobulin receptor	NA	protein_coding	P01833	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65389
8.35048733035404e-07	0.334042274786043	0.445	0.234	0.0200553654213113	ROMO1	Malignant cells	GSE207422_Sin_post	ENSG00000125995	140823	reactive oxygen species modulator 1	bA353C18.2|C20orf52|MTGMP	protein_coding	P60602	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65390
8.46187943926755e-07	0.442328346941244	0.427	0.213	0.0203228958492889	SPTSSA	Malignant cells	GSE207422_Sin_post	ENSG00000165389	171546	serine palmitoyltransferase small subunit A	C14orf147|ssSPTa	protein_coding	Q969W0	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65391
8.93664970128661e-07	-1.3438731218603	0.137	0.291	0.0214631515875801	MGP	Malignant cells	GSE207422_Sin_post	ENSG00000111341	4256	matrix Gla protein	NA	protein_coding	P08493	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65392
8.99348397497238e-07	-0.352919468213874	0.182	0.355	0.0215996504626912	CBX5	Malignant cells	GSE207422_Sin_post	ENSG00000094916	23468	chromobox 5	HP1|HP1-ALPHA|HP1Hs-alpha	protein_coding	P45973	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65393
1.05334032170195e-06	0.462681192495909	0.27	0.078	0.0252980745063156	NAMPT	Malignant cells	GSE207422_Sin_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65394
1.11945978878757e-06	0.336431260251987	0.349	0.149	0.0268860657473111	PPP1R14B	Malignant cells	GSE207422_Sin_post	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65395
1.21339447507081e-06	0.327178355574565	0.374	0.17	0.0291420951077757	EIF6	Malignant cells	GSE207422_Sin_post	ENSG00000242372	3692	eukaryotic translation initiation factor 6	b(2)gcn|EIF3A|ITGB4BP|p27BBP	protein_coding	P56537	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65396
1.24281324897263e-06	-0.349085031247338	0.132	0.284	0.0298486458005757	ZNF106	Malignant cells	GSE207422_Sin_post	ENSG00000103994	64397	zinc finger protein 106	SH3BP3|ZFP106|ZNF474	protein_coding	Q9H2Y7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65397
1.30433941229187e-06	-0.252766070379967	0.13	0.291	0.0313263196650139	PRMT2	Malignant cells	GSE207422_Sin_post	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65398
1.34019017374356e-06	0.391573623295018	0.359	0.149	0.0321873474027991	PGD	Malignant cells	GSE207422_Sin_post	ENSG00000142657	5226	phosphogluconate dehydrogenase	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65399
1.45735216218384e-06	0.389087303190331	0.401	0.199	0.0350012268791694	SEC61B	Malignant cells	GSE207422_Sin_post	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65400
1.52986010468675e-06	-0.419013458257755	0.497	0.681	0.0367426501342617	DDX17	Malignant cells	GSE207422_Sin_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65401
1.5768245797456e-06	0.337929089250169	0.591	0.383	0.0378705959317502	RPN2	Malignant cells	GSE207422_Sin_post	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65402
1.64439436937073e-06	0.669656503433818	0.697	0.61	0.0394934195691769	COX6C	Malignant cells	GSE207422_Sin_post	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65403
1.70805054861257e-06	0.410466281366833	0.551	0.348	0.0410222500260282	ATP6V0E1	Malignant cells	GSE207422_Sin_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65404
1.74963585251504e-06	0.358344532681174	0.396	0.199	0.0420210042698537	OCIAD2	Malignant cells	GSE207422_Sin_post	ENSG00000145247	132299	OCIA domain containing 2	MGC45416	protein_coding	Q56VL3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65405
1.82026097857496e-06	0.389251119730977	0.264	0.078	0.0437172079224348	SLC38A2	Malignant cells	GSE207422_Sin_post	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65406
1.87470954561544e-06	-0.277028311688456	0.172	0.34	0.0450248991570461	PAPSS1	Malignant cells	GSE207422_Sin_post	ENSG00000138801	9061	3'-phosphoadenosine 5'-phosphosulfate synthase 1	ATPSK1|PAPSS	protein_coding	O43252	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65407
2.07219992463011e-06	0.433497034760276	0.359	0.149	0.0497680255898414	ID1	Malignant cells	GSE207422_Sin_post	ENSG00000125968	3397	inhibitor of DNA binding 1	bHLHb24|dJ857M17.1.2	protein_coding	P41134	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65408
6.47108164204268e-217	-1.15713673266677	0.058	0.704	1.55415967796939e-212	SCGB1A1	Mono/Macro	GSE207422_Sin_post	ENSG00000149021	7356	secretoglobin family 1A member 1	CC10|CC16|CCSP|UGB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65409
5.61326326843622e-107	-0.611445596464187	0.048	0.459	1.34813743918033e-102	CDC42EP3	Mono/Macro	GSE207422_Sin_post	ENSG00000163171	10602	CDC42 effector protein 3	BORG2|CEP3|UB1	protein_coding	Q9UKI2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65410
5.96585350765105e-58	1.5815001239158	0.997	0.943	1.43281903693255e-53	CTSB	Mono/Macro	GSE207422_Sin_post	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65411
1.57233925473296e-57	-0.676172322286124	0.099	0.478	3.77628718809214e-53	RPL10P3	Mono/Macro	GSE207422_Sin_post	ENSG00000230734	NA	NA	bA567J2.2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65412
3.6500926739523e-52	1.5494635861825	0.866	0.39	8.76642757503125e-48	CD163	Mono/Macro	GSE207422_Sin_post	ENSG00000177575	9332	CD163 molecule	M130|MM130|SCARI1	protein_coding	Q86VB7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65413
1.33389955144612e-51	1.41977261528116	0.972	0.849	3.20362655270816e-47	GLUL	Mono/Macro	GSE207422_Sin_post	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65414
1.82988792293874e-45	-0.547667760760446	0.095	0.44	4.39484182452196e-41	EGR2	Mono/Macro	GSE207422_Sin_post	ENSG00000122877	1959	early growth response 2	KROX20	protein_coding	P11161	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65415
1.19348790149886e-44	1.15803761611092	0.984	0.805	2.86639989302981e-40	SAT1	Mono/Macro	GSE207422_Sin_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65416
1.45442289490116e-42	-1.14759089364315	0.042	0.277	3.49308746668412e-38	FABP4	Mono/Macro	GSE207422_Sin_post	ENSG00000170323	2167	fatty acid binding protein 4	A-FABP|aP2	protein_coding	P15090	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65417
2.72463380110712e-41	0.69805191825794	0.991	0.937	6.54375300011896e-37	LAPTM5	Mono/Macro	GSE207422_Sin_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65418
2.16434364923853e-40	0.931595247174014	0.997	0.956	5.19810414237617e-36	PSAP	Mono/Macro	GSE207422_Sin_post	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65419
2.18978840367633e-40	1.39989631364547	0.832	0.447	5.25921480910944e-36	TMEM176B	Mono/Macro	GSE207422_Sin_post	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65420
2.61396194819828e-40	-0.555729041989137	0.089	0.409	6.2779524109878e-36	AQP3	Mono/Macro	GSE207422_Sin_post	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65421
3.86415906131257e-40	1.94257488300833	0.895	0.61	9.2805508175544e-36	CTSL	Mono/Macro	GSE207422_Sin_post	ENSG00000135047	1514	cathepsin L	CTSL1|FLJ31037	protein_coding	P07711	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65422
4.20916791622927e-38	1.04028455149603	0.753	0.264	1.01091585844078e-33	LILRB4	Mono/Macro	GSE207422_Sin_post	ENSG00000278555	11006	leukocyte immunoglobulin like receptor B4	CD85k|HM18|ILT3|LIR-5|LIR5	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65423
3.34509059293617e-35	0.793082110844262	0.991	0.937	8.0339040770548e-31	FCER1G	Mono/Macro	GSE207422_Sin_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65424
7.31561274027406e-35	1.14342371495695	0.755	0.314	1.75699071183162e-30	TMEM176A	Mono/Macro	GSE207422_Sin_post	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65425
2.424216618194e-34	-0.963706436943506	0.264	0.679	5.82224105191652e-30	CD52	Mono/Macro	GSE207422_Sin_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65426
3.59042042384048e-34	-0.481514316879229	0.057	0.289	8.62311273193769e-30	PDLIM1	Mono/Macro	GSE207422_Sin_post	ENSG00000107438	9124	PDZ and LIM domain 1	CLIM1|CLP-36|CLP36|hCLIM1	protein_coding	O00151	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65427
1.14348535072524e-33	-0.616688233158475	0.167	0.528	2.74630876683682e-29	SPN	Mono/Macro	GSE207422_Sin_post	ENSG00000197471	6693	sialophorin	CD43|GPL115|LEU-22|LSN	protein_coding	P16150	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65428
3.77996364451718e-33	0.731399315648204	0.976	0.912	9.07833868503692e-29	NPC2	Mono/Macro	GSE207422_Sin_post	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65429
4.84248222928551e-32	1.23640342882732	0.708	0.277	1.1630189570075e-27	HIF1A	Mono/Macro	GSE207422_Sin_post	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65430
6.45042394956286e-32	-1.11764407647536	0.818	0.906	1.54919831996651e-27	HLA-DQA1	Mono/Macro	GSE207422_Sin_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65431
4.5795914417071e-30	1.03156062565072	0.57	0.088	1.0998804765548e-25	PFKFB3	Mono/Macro	GSE207422_Sin_post	ENSG00000170525	5209	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	NA	protein_coding	Q16875	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65432
1.47522812110698e-29	1.5595474057672	0.531	0.057	3.54305537846264e-25	SDS	Mono/Macro	GSE207422_Sin_post	ENSG00000135094	10993	serine dehydratase	SDH	protein_coding	P20132	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65433
7.62142826242013e-29	0.897757472310554	0.948	0.755	1.83043842578544e-24	CALR	Mono/Macro	GSE207422_Sin_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65434
2.02300721012931e-28	1.4479146067538	0.686	0.283	4.85865641656756e-24	LGMN	Mono/Macro	GSE207422_Sin_post	ENSG00000100600	5641	legumain	LGMN1|PRSC1	protein_coding	Q99538	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65435
2.08328749819583e-28	-0.322898641477196	0.072	0.308	5.00343158441693e-24	HACD4	Mono/Macro	GSE207422_Sin_post	ENSG00000188921	401494	3-hydroxyacyl-CoA dehydratase 4	Em:AL662879.1|OTTHUMG00000021016|PTPLAD2	protein_coding	Q5VWC8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65436
3.2570837635337e-28	0.573710900828591	1	1	7.82253807487888e-24	HLA-B	Mono/Macro	GSE207422_Sin_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65437
4.15072721849491e-28	0.723488208247939	0.557	0.101	9.96880156065922e-24	PNKD	Mono/Macro	GSE207422_Sin_post	ENSG00000127838	25953	PNKD metallo-beta-lactamase domain containing	BRP17|DKFZp564N1362|DYT8|FKSG19|FPD1|KIAA1184|KIPP1184|MGC31943|MR-1|MR-1S|PDC|PKND1|TAHCCP2	protein_coding	Q8N490	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65438
8.17320893080971e-28	0.782097192495653	0.979	0.849	1.96295958891257e-23	SRGN	Mono/Macro	GSE207422_Sin_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65439
2.1618916100475e-27	0.995416301237872	0.768	0.371	5.19221507985107e-23	IFITM3	Mono/Macro	GSE207422_Sin_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65440
7.6818208576023e-27	0.715940137308296	0.665	0.233	1.84494291537034e-22	MPP1	Mono/Macro	GSE207422_Sin_post	ENSG00000130830	4354	MAGUK p55 scaffold protein 1	DXS552E|PEMP	protein_coding	Q00013	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65441
1.04582728232586e-25	0.834637917819355	0.849	0.673	2.51176338396202e-21	CREG1	Mono/Macro	GSE207422_Sin_post	ENSG00000143162	8804	cellular repressor of E1A stimulated genes 1	CREG	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65442
2.24170149400101e-25	0.654713301941708	0.875	0.616	5.38389447814223e-21	TPI1	Mono/Macro	GSE207422_Sin_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65443
4.23587332304843e-25	-0.302741028119364	0.078	0.308	1.01732969599654e-20	ESYT1	Mono/Macro	GSE207422_Sin_post	ENSG00000139641	23344	extended synaptotagmin 1	FAM62A|KIAA0747|MBC2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65444
5.37665368054569e-25	-0.762533235247006	0.294	0.648	1.29131091445666e-20	CD83	Mono/Macro	GSE207422_Sin_post	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65445
7.88104232017208e-25	-0.491473223143413	0.159	0.453	1.89278993403573e-20	ATP1B1	Mono/Macro	GSE207422_Sin_post	ENSG00000143153	481	ATPase Na+/K+ transporting subunit beta 1	ATP1B	protein_coding	P05026	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65446
8.94422853635022e-25	-0.826407780955143	0.575	0.868	2.14813536757523e-20	S100A4	Mono/Macro	GSE207422_Sin_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65447
1.49262854323617e-24	0.615511679710647	0.878	0.717	3.5848459722903e-20	MFSD1	Mono/Macro	GSE207422_Sin_post	ENSG00000118855	64747	major facilitator superfamily domain containing 1	FLJ14153|Minerva|UG0581B09	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65448
4.15721290118366e-24	-0.454951788614192	0.17	0.472	9.98437822477279e-20	SEPT11	Mono/Macro	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65449
4.42152183035113e-24	-0.988325365627261	0.616	0.799	1.06191689799543e-19	ALDH2	Mono/Macro	GSE207422_Sin_post	ENSG00000111275	217	aldehyde dehydrogenase 2 family member	NA	protein_coding	P05091	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65450
7.72864237899647e-24	-0.399429903199813	0.154	0.453	1.85618804016358e-19	JAML	Mono/Macro	GSE207422_Sin_post	ENSG00000160593	120425	junction adhesion molecule like	AMICA|AMICA1|Gm638	protein_coding	Q86YT9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65451
8.49713964838483e-24	1.2179386404362	0.764	0.472	2.04075802935258e-19	SOD2	Mono/Macro	GSE207422_Sin_post	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65452
1.41576613191039e-23	-0.501405027441651	0.886	0.981	3.40024551900919e-19	RPL39	Mono/Macro	GSE207422_Sin_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65453
2.63972192332231e-23	0.769954591947162	0.619	0.189	6.33982014324319e-19	PLA2G7	Mono/Macro	GSE207422_Sin_post	ENSG00000146070	7941	phospholipase A2 group VII	LDL-PLA2|PAFAH	protein_coding	Q13093	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65454
5.23282370794883e-23	-0.349098960268251	0.118	0.377	1.25676726993807e-18	C20orf27	Mono/Macro	GSE207422_Sin_post	ENSG00000101220	54976	chromosome 20 open reading frame 27	FLJ20550	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65455
5.4145157457539e-23	-0.590504939504352	0.06	0.252	1.30040424665771e-18	RBP4	Mono/Macro	GSE207422_Sin_post	ENSG00000138207	5950	retinol binding protein 4	NA	protein_coding	P02753	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65456
5.69030553437598e-23	-0.584336805446574	0.974	1	1.36664068019108e-18	PABPC1	Mono/Macro	GSE207422_Sin_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65457
8.22328201456424e-23	-0.623354381778225	0.321	0.642	1.97498564143789e-18	ADAMTSL4	Mono/Macro	GSE207422_Sin_post	ENSG00000143382	54507	ADAMTS like 4	DKFZP434K1772|TSRC1	protein_coding	Q6UY14	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65458
1.03068345063206e-22	0.830978458358561	0.611	0.208	2.47539244338301e-18	CEBPD	Mono/Macro	GSE207422_Sin_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65459
1.30994842145454e-22	0.902863721470631	0.511	0.088	3.14610312380736e-18	VEGFA	Mono/Macro	GSE207422_Sin_post	ENSG00000112715	7422	vascular endothelial growth factor A	VEGF|VEGF-A|VPF	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65460
1.72374890087261e-22	-0.618563871312048	0.352	0.654	4.13992773522575e-18	PLBD1	Mono/Macro	GSE207422_Sin_post	ENSG00000121316	79887	phospholipase B domain containing 1	FLJ22662	protein_coding	Q6P4A8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65461
2.09868663182435e-22	-0.537398941076559	1	1	5.04041568365255e-18	MT-RNR2	Mono/Macro	GSE207422_Sin_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65462
2.4072217759111e-22	-0.848036827357752	0.864	0.893	5.7814245392057e-18	HLA-DQB1	Mono/Macro	GSE207422_Sin_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65463
2.64846463600603e-22	0.564601834408677	0.819	0.528	6.36081751629568e-18	GNS	Mono/Macro	GSE207422_Sin_post	ENSG00000135677	2799	glucosamine (N-acetyl)-6-sulfatase	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65464
4.19803825076758e-22	0.448722805218011	1	1	1.00824284668685e-17	B2M	Mono/Macro	GSE207422_Sin_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65465
5.43196327357969e-22	-0.422445646625108	0.996	1	1.30459461941563e-17	MT-ND2	Mono/Macro	GSE207422_Sin_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65466
7.19247106889442e-22	-1.24709640257497	0.523	0.774	1.72741577661637e-17	HSPB1	Mono/Macro	GSE207422_Sin_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65467
1.04387081272269e-21	0.836794248412337	0.669	0.314	2.50706453091609e-17	BASP1	Mono/Macro	GSE207422_Sin_post	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65468
1.12962638604043e-21	-0.738177691676085	0.806	0.874	2.7130236913533e-17	UBB	Mono/Macro	GSE207422_Sin_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65469
1.39503092409183e-21	-0.37069452077298	0.134	0.403	3.35044577039134e-17	TCF7L2	Mono/Macro	GSE207422_Sin_post	ENSG00000148737	6934	transcription factor 7 like 2	TCF-4|TCF4	protein_coding	Q9NQB0	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65470
1.47434924450242e-21	-1.0075561545153	0.581	0.755	3.54094458052146e-17	LTA4H	Mono/Macro	GSE207422_Sin_post	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65471
1.68724961460293e-21	-0.285139548154213	0.067	0.264	4.05226739939186e-17	ACOT7	Mono/Macro	GSE207422_Sin_post	ENSG00000097021	11332	acyl-CoA thioesterase 7	ACH1|ACT|BACH|CTE-II|hBACH|LACH1|MGC1126	protein_coding	O00154	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65472
1.94182980155339e-21	-0.493683321697943	0.684	0.937	4.66369263439078e-17	RPS14	Mono/Macro	GSE207422_Sin_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65473
6.33367538634199e-21	-1.0108599189626	0.445	0.73	1.52115881753776e-16	MRC1	Mono/Macro	GSE207422_Sin_post	ENSG00000260314	4360	mannose receptor C-type 1	bA541I19.1|CD206|CLEC13D|CLEC13DL|MRC1L1	protein_coding	P22897	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65474
6.90388919423494e-21	1.03824901231445	0.871	0.642	1.65810706777941e-16	IFI6	Mono/Macro	GSE207422_Sin_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65475
1.10254419807337e-20	0.673194555106429	0.613	0.226	2.6479804005128e-16	ABCA1	Mono/Macro	GSE207422_Sin_post	ENSG00000165029	19	ATP binding cassette subfamily A member 1	ABC1|HDLDT1|TGD	protein_coding	O95477	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65476
1.49998462799311e-20	-0.479521685535851	0.778	0.943	3.60251308105105e-16	RPS4X	Mono/Macro	GSE207422_Sin_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65477
1.97178400877665e-20	0.688138014686058	0.654	0.277	4.73563365387889e-16	MARCKS	Mono/Macro	GSE207422_Sin_post	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65478
2.03106576729139e-20	0.548111150541332	0.944	0.811	4.87801065330374e-16	CTSH	Mono/Macro	GSE207422_Sin_post	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65479
2.34541926089937e-20	0.544627676439314	0.854	0.635	5.63299343890202e-16	GPX1	Mono/Macro	GSE207422_Sin_post	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65480
2.48645317029381e-20	-0.578971874909184	0.466	0.805	5.97171457909465e-16	AHNAK	Mono/Macro	GSE207422_Sin_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65481
3.89082121918928e-20	1.13642146027456	0.81	0.541	9.3445853221269e-16	PLIN2	Mono/Macro	GSE207422_Sin_post	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65482
6.48059668918014e-20	0.802785750134997	0.446	0.069	1.55644490684039e-15	SIGLEC10	Mono/Macro	GSE207422_Sin_post	ENSG00000142512	89790	sialic acid binding Ig like lectin 10	MGC126774|PRO940|SIGLEC-10|SLG2	protein_coding	Q96LC7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65483
7.28209013714504e-20	0.609417812042248	0.39	0.025	1.74893958823812e-15	OLFML2B	Mono/Macro	GSE207422_Sin_post	ENSG00000162745	25903	olfactomedin like 2B	DKFZP586L151	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65484
1.01102198404487e-19	-0.682208244332022	0.601	0.83	2.42817149908057e-15	NAP1L1	Mono/Macro	GSE207422_Sin_post	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65485
1.09385361908013e-19	-0.497425284162596	0.295	0.61	2.62710823694476e-15	ALDH1A1	Mono/Macro	GSE207422_Sin_post	ENSG00000165092	216	aldehyde dehydrogenase 1 family member A1	ALDH1|PUMB1|RALDH1	protein_coding	P00352	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65486
1.1184033562678e-19	-0.542597513014116	0.304	0.648	2.68606934074837e-15	RGCC	Mono/Macro	GSE207422_Sin_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65487
1.13136147472522e-19	0.758666332757645	0.759	0.453	2.71719085384756e-15	STAT1	Mono/Macro	GSE207422_Sin_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65488
1.25657344202043e-19	0.77008334218432	0.635	0.258	3.01791243570047e-15	CXCR4	Mono/Macro	GSE207422_Sin_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65489
1.34334691065271e-19	-0.499326193642286	0.588	0.855	3.22631627531462e-15	RPS23	Mono/Macro	GSE207422_Sin_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65490
1.34979683347891e-19	-0.482726156548037	0.602	0.818	3.2418070549663e-15	SH3BGRL	Mono/Macro	GSE207422_Sin_post	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65491
1.35574601694795e-19	0.693702923657001	0.785	0.528	3.25609520890389e-15	MS4A4A	Mono/Macro	GSE207422_Sin_post	ENSG00000110079	51338	membrane spanning 4-domains A4A	CD20L1|MS4A4|MS4A7	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65492
1.45345988955008e-19	-0.296867945090105	0.071	0.264	3.49077461673242e-15	NAPSB	Mono/Macro	GSE207422_Sin_post	ENSG00000131401	256236	napsin B aspartic peptidase, pseudogene	NAP1L|NAP2|NAPB|NAPSBP	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65493
1.75636665259932e-19	0.722600122629936	0.416	0.05	4.21826578954778e-15	ADAM8	Mono/Macro	GSE207422_Sin_post	ENSG00000151651	101	ADAM metallopeptidase domain 8	CD156|CD156A|MS2	protein_coding	P78325	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65494
2.08309286113963e-19	0.9825511294421	0.414	0.05	5.00296412459904e-15	ADM	Mono/Macro	GSE207422_Sin_post	ENSG00000148926	133	adrenomedullin	AM	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65495
2.52383687531817e-19	1.1086684668585	0.533	0.17	6.06149902345165e-15	PLTP	Mono/Macro	GSE207422_Sin_post	ENSG00000100979	5360	phospholipid transfer protein	BPIFE	protein_coding	P55058	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65496
2.80431493796421e-19	-0.471283001420265	0.983	0.994	6.73512318650864e-15	MT-ND5	Mono/Macro	GSE207422_Sin_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65497
3.64201794227996e-19	0.703405065118804	0.836	0.654	8.74703449197378e-15	UCP2	Mono/Macro	GSE207422_Sin_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65498
3.92610302027714e-19	-0.606987979285218	0.221	0.516	9.42932162379961e-15	LMNA	Mono/Macro	GSE207422_Sin_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65499
6.06787709644053e-19	0.550584499135597	0.788	0.516	1.45732204225212e-14	LIMS1	Mono/Macro	GSE207422_Sin_post	ENSG00000169756	3987	LIM zinc finger domain containing 1	PINCH|PINCH1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65500
7.09583597492844e-19	-0.498133675591143	0.519	0.824	1.70420692609856e-14	DNAJA1	Mono/Macro	GSE207422_Sin_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65501
7.5951478810108e-19	-0.477452418629469	0.174	0.434	1.82412666658236e-14	BHLHE41	Mono/Macro	GSE207422_Sin_post	ENSG00000123095	79365	basic helix-loop-helix family member e41	BHLHB3|DEC2|SHARP-1|SHARP1	protein_coding	Q9C0J9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65502
9.47638492463707e-19	-0.384293461237859	0.125	0.358	2.27594336735009e-14	ENPP4	Mono/Macro	GSE207422_Sin_post	ENSG00000001561	22875	ectonucleotide pyrophosphatase/phosphodiesterase 4	AP3Aase|KIAA0879|NPP4	protein_coding	Q9Y6X5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65503
1.00213864006557e-18	0.715268657265455	0.639	0.314	2.40683637184547e-14	PMP22	Mono/Macro	GSE207422_Sin_post	ENSG00000109099	5376	peripheral myelin protein 22	CMT1A|GAS3|HMSNIA|HNPP|Sp110	protein_coding	Q01453	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65504
1.21128984902905e-18	-0.503802338359751	0.946	0.975	2.90915483041306e-14	RPS8	Mono/Macro	GSE207422_Sin_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65505
1.39903600310383e-18	0.572644149433288	0.93	0.786	3.36006476865446e-14	GAPDH	Mono/Macro	GSE207422_Sin_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65506
1.42644975184208e-18	0.633588751244007	0.577	0.239	3.42590436899913e-14	NPL	Mono/Macro	GSE207422_Sin_post	ENSG00000135838	80896	N-acetylneuraminate pyruvate lyase	C1orf13|DHDPS1|NPL1	protein_coding	Q9BXD5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65507
1.95064598891514e-18	0.778917672845151	0.787	0.553	4.68486647157749e-14	CD14	Mono/Macro	GSE207422_Sin_post	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65508
2.01107562730534e-18	0.555781032055445	0.502	0.151	4.83000033409924e-14	BNIP3L	Mono/Macro	GSE207422_Sin_post	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65509
2.29623377693318e-18	0.513521077347844	0.926	0.811	5.51486466206042e-14	ENO1	Mono/Macro	GSE207422_Sin_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65510
2.6087710924561e-18	0.511999848849	0.493	0.138	6.26548553275181e-14	TTYH3	Mono/Macro	GSE207422_Sin_post	ENSG00000136295	80727	tweety family member 3	KIAA1691	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65511
2.79686587388498e-18	-0.419837757074551	0.157	0.403	6.71723276930956e-14	PPARG	Mono/Macro	GSE207422_Sin_post	ENSG00000132170	5468	peroxisome proliferator activated receptor gamma	NR1C3|PPARG1|PPARG2|PPARgamma	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65512
3.55909394835039e-18	0.904013824337213	0.841	0.629	8.54787593575313e-14	PLAUR	Mono/Macro	GSE207422_Sin_post	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65513
5.12162297656027e-18	-0.558322449769591	0.294	0.579	1.23006019028048e-13	HLA-DOA	Mono/Macro	GSE207422_Sin_post	ENSG00000232957	3111	major histocompatibility complex, class II, DO alpha	HLA-D0-alpha|HLA-DNA|HLA-DZA	protein_coding	P06340	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65514
5.17071504903004e-18	-0.476548388142029	0.995	1	1.24185063332554e-13	VIM	Mono/Macro	GSE207422_Sin_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65515
6.20393925705358e-18	-0.654837638206941	0.912	0.975	1.49000009136656e-13	MT-ATP8	Mono/Macro	GSE207422_Sin_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65516
8.11402561087172e-18	-0.430176023468414	0.98	0.987	1.94874553096306e-13	RPS29	Mono/Macro	GSE207422_Sin_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65517
8.65847326351375e-18	0.857060360322371	0.4	0.057	2.0795055236981e-13	DDIT4	Mono/Macro	GSE207422_Sin_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65518
9.30587840697931e-18	0.632014570340503	0.506	0.151	2.23499281700422e-13	AQP9	Mono/Macro	GSE207422_Sin_post	ENSG00000103569	366	aquaporin 9	HsT17287|SSC1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65519
9.77176256198834e-18	0.518061366106286	0.454	0.101	2.34688421451274e-13	CD82	Mono/Macro	GSE207422_Sin_post	ENSG00000085117	3732	CD82 molecule	IA4|KAI1|R2|ST6|TSPAN27	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65520
1.11132350272651e-17	0.358161051045125	0.987	0.956	2.66906565649825e-13	TMBIM6	Mono/Macro	GSE207422_Sin_post	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65521
1.14430722672854e-17	0.507426084473831	0.777	0.509	2.74828266643393e-13	LAIR1	Mono/Macro	GSE207422_Sin_post	ENSG00000276163	3903	leukocyte associated immunoglobulin like receptor 1	CD305|LAIR-1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65522
1.3650990879315e-17	0.607943777753337	0.915	0.805	3.27855847948508e-13	ASAH1	Mono/Macro	GSE207422_Sin_post	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65523
1.49398673724351e-17	-0.677683819434303	0.578	0.786	3.58810794683773e-13	ANXA1	Mono/Macro	GSE207422_Sin_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65524
1.70715861066342e-17	0.553428683513917	0.514	0.145	4.10008283523033e-13	NINJ1	Mono/Macro	GSE207422_Sin_post	ENSG00000131669	4814	ninjurin 1	NIN1	protein_coding	Q92982	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65525
1.89086081659683e-17	0.866686914929432	0.793	0.503	4.5412804232206e-13	ZFP36L1	Mono/Macro	GSE207422_Sin_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65526
2.23303896953877e-17	0.846878778267356	0.564	0.226	5.36308969314127e-13	ARL4C	Mono/Macro	GSE207422_Sin_post	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65527
2.62370655473491e-17	0.581289786316226	0.697	0.396	6.30135603250684e-13	CD84	Mono/Macro	GSE207422_Sin_post	ENSG00000066294	8832	CD84 molecule	hCD84|mCD84|SLAMF5	protein_coding	Q9UIB8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65528
3.61971917934414e-17	0.476486358852958	1	1	8.69347955303082e-13	HLA-A	Mono/Macro	GSE207422_Sin_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65529
5.9663209698902e-17	0.444064016064393	0.839	0.648	1.43293130733853e-12	ATP6V0B	Mono/Macro	GSE207422_Sin_post	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65530
6.32177797332166e-17	0.494230808598338	0.719	0.403	1.51830141585266e-12	PLSCR1	Mono/Macro	GSE207422_Sin_post	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65531
7.12113111207641e-17	-0.469543348709173	0.999	1	1.71028205918739e-12	TPT1	Mono/Macro	GSE207422_Sin_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65532
8.82348941570361e-17	0.628003750414152	0.645	0.352	2.11913745296954e-12	DNASE2	Mono/Macro	GSE207422_Sin_post	ENSG00000105612	1777	deoxyribonuclease 2, lysosomal	DNL|DNL2	protein_coding	O00115	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65533
8.96215532573027e-17	-0.802055963837513	0.947	0.975	2.15244084458064e-12	HSP90AA1	Mono/Macro	GSE207422_Sin_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65534
8.9969582835994e-17	-0.439953138067307	0.188	0.44	2.16079947097207e-12	PNPLA6	Mono/Macro	GSE207422_Sin_post	ENSG00000032444	10908	patatin like phospholipase domain containing 6	iPLA2delta|NTE|SPG39|sws	protein_coding	Q8IY17	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65535
9.43660091091208e-17	-0.69570150494031	0.251	0.516	2.26638844077375e-12	MCEMP1	Mono/Macro	GSE207422_Sin_post	ENSG00000183019	199675	mast cell expressed membrane protein 1	C19orf59|MGC132456	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65536
1.00145592349026e-16	-0.962295981596634	0.499	0.736	2.40519669144656e-12	FBP1	Mono/Macro	GSE207422_Sin_post	ENSG00000165140	2203	fructose-bisphosphatase 1	FBP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65537
1.47061289745625e-16	-0.331576642599964	0.172	0.421	3.53197099582068e-12	SLFN11	Mono/Macro	GSE207422_Sin_post	ENSG00000172716	91607	schlafen family member 11	FLJ34922	protein_coding	Q7Z7L1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65538
1.64987037290556e-16	0.469811940529866	0.98	0.893	3.96249367460729e-12	CD63	Mono/Macro	GSE207422_Sin_post	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65539
1.67981892200321e-16	0.476117351065467	0.815	0.579	4.03442110497512e-12	SCARB2	Mono/Macro	GSE207422_Sin_post	ENSG00000138760	950	scavenger receptor class B member 2	CD36L2|HLGP85|LIMP-2|LIMPII|SR-BII	protein_coding	Q14108	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65540
2.20235213761879e-16	-0.505330482247942	0.174	0.409	5.28938912891905e-12	OTUD1	Mono/Macro	GSE207422_Sin_post	ENSG00000165312	220213	OTU deubiquitinase 1	DUBA7|OTDC1	protein_coding	Q5VV17	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65541
2.46795628690148e-16	0.526776134020032	0.485	0.157	5.92729061425128e-12	PLXNC1	Mono/Macro	GSE207422_Sin_post	ENSG00000136040	10154	plexin C1	CD232|VESPR	protein_coding	O60486	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65542
2.80833133763828e-16	0.41422717461896	0.969	0.874	6.74476937360586e-12	TPP1	Mono/Macro	GSE207422_Sin_post	ENSG00000166340	1200	tripeptidyl peptidase 1	CLN2|LPIC|SCAR7|TPP-1	protein_coding	O14773	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65543
3.15276875072049e-16	-0.46713309577514	0.721	0.906	7.57200470860539e-12	RPS18	Mono/Macro	GSE207422_Sin_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65544
3.1943026726845e-16	-0.464476085001322	0.26	0.553	7.67175672898636e-12	RAC2	Mono/Macro	GSE207422_Sin_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65545
3.44624517904427e-16	-0.455549419798268	0.974	1	8.27684704651063e-12	RPL34	Mono/Macro	GSE207422_Sin_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65546
3.96205523837868e-16	-0.394772792073135	0.913	0.975	9.51566806601408e-12	RPS13	Mono/Macro	GSE207422_Sin_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65547
4.14191285885328e-16	-0.448477805118452	0.705	0.881	9.94763211310791e-12	RPL6	Mono/Macro	GSE207422_Sin_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65548
1.31750726167295e-15	0.474731586172741	0.692	0.377	3.16425719035993e-11	CTSA	Mono/Macro	GSE207422_Sin_post	ENSG00000064601	5476	cathepsin A	GSL|PPGB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65549
1.31820478576437e-15	0.506159362063755	0.493	0.176	3.16593243397028e-11	ACP2	Mono/Macro	GSE207422_Sin_post	ENSG00000134575	53	acid phosphatase 2, lysosomal	LAP	protein_coding	P11117	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65550
1.33094524863472e-15	0.545467422056255	0.941	0.83	3.19653120364601e-11	CAPG	Mono/Macro	GSE207422_Sin_post	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65551
1.46863162046677e-15	0.448579953211869	0.765	0.535	3.52721256287504e-11	P4HB	Mono/Macro	GSE207422_Sin_post	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65552
1.82644389129521e-15	-0.326451682811498	0.205	0.459	4.38657029372371e-11	RPS13P2	Mono/Macro	GSE207422_Sin_post	ENSG00000228929	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65553
1.93834491872781e-15	0.512044873838441	0.871	0.73	4.65532299130857e-11	FCGRT	Mono/Macro	GSE207422_Sin_post	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65554
2.14236033578481e-15	0.476455275855229	0.589	0.277	5.14530681845438e-11	SLC16A3	Mono/Macro	GSE207422_Sin_post	ENSG00000141526	9123	solute carrier family 16 member 3	MCT3|MCT4	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65555
2.25512950046207e-15	0.43808598938569	0.885	0.786	5.41614452125976e-11	RNF130	Mono/Macro	GSE207422_Sin_post	ENSG00000113269	55819	ring finger protein 130	G1RZFP|GOLIATH|GP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65556
2.33817438322281e-15	0.461044348512584	0.952	0.862	5.61559341618622e-11	SDCBP	Mono/Macro	GSE207422_Sin_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65557
2.34076431975404e-15	-0.428466820195995	0.929	0.962	5.62181366675328e-11	RPL30	Mono/Macro	GSE207422_Sin_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65558
2.349470359964e-15	-0.397583440305522	0.96	0.994	5.64272296352554e-11	RPS24	Mono/Macro	GSE207422_Sin_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65559
2.40636714514448e-15	-0.381341764972489	0.405	0.711	5.77937197249349e-11	VASP	Mono/Macro	GSE207422_Sin_post	ENSG00000125753	7408	vasodilator stimulated phosphoprotein	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65560
3.65970036886707e-15	0.486674955341283	0.4	0.094	8.78950237590804e-11	SGPL1	Mono/Macro	GSE207422_Sin_post	ENSG00000166224	8879	sphingosine-1-phosphate lyase 1	SPL	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65561
4.0300735316386e-15	0.637461001558256	0.555	0.208	9.67902760093642e-11	C15orf48	Mono/Macro	GSE207422_Sin_post	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65562
5.69082364433344e-15	-0.329303166295831	0.215	0.465	1.36676511465956e-10	OSBPL11	Mono/Macro	GSE207422_Sin_post	ENSG00000144909	114885	oxysterol binding protein like 11	FLJ13012|FLJ13164|ORP-11|ORP11	protein_coding	Q9BXB4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65563
6.08358358587339e-15	-0.392366233658625	0.347	0.616	1.46109426981921e-10	AL022718.1	Mono/Macro	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65564
6.5735724876144e-15	0.51012317015857	0.832	0.654	1.57877490435035e-10	PGK1	Mono/Macro	GSE207422_Sin_post	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65565
8.26792801309774e-15	-0.260101277024023	0.083	0.258	1.98570827090569e-10	ACO1	Mono/Macro	GSE207422_Sin_post	ENSG00000122729	48	aconitase 1	IREB1|IREBP|IRP1	protein_coding	P21399	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65566
8.44727684460602e-15	0.427794064061053	0.328	0.031	2.02878247976903e-10	MERTK	Mono/Macro	GSE207422_Sin_post	ENSG00000153208	10461	MER proto-oncogene, tyrosine kinase	c-Eyk|mer|RP38|Tyro12	protein_coding	Q12866	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65567
9.73017418387324e-15	0.506242315668252	0.67	0.409	2.33689593374084e-10	RNASET2	Mono/Macro	GSE207422_Sin_post	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65568
9.96500455372099e-15	-0.410572756155175	0.851	0.925	2.39329514366717e-10	RPL11	Mono/Macro	GSE207422_Sin_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65569
1.35360673296213e-14	-0.595963381238354	0.978	1	3.25095729055515e-10	MT-RNR1	Mono/Macro	GSE207422_Sin_post	ENSG00000211459	NA	NA	12S|MOTS-c|MTRNR1	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65570
1.44011300325148e-14	-0.258560320318266	0.084	0.258	3.45871939990908e-10	RRM2B	Mono/Macro	GSE207422_Sin_post	ENSG00000048392	50484	ribonucleotide reductase regulatory TP53 inducible subunit M2B	p53R2	protein_coding	Q7LG56	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65571
1.44195694775545e-14	-0.390430181315436	0.748	0.881	3.46314800142426e-10	CALM2	Mono/Macro	GSE207422_Sin_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65572
1.76609157795043e-14	0.441188452949415	0.82	0.566	4.24162214276355e-10	MGAT1	Mono/Macro	GSE207422_Sin_post	ENSG00000131446	4245	alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GLCNAC-TI|GLYT1|GNT-1|GnTI|MGAT	protein_coding	P26572	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65573
1.91474773546519e-14	-1.18560982019577	0.313	0.56	4.59864963626675e-10	HSPH1	Mono/Macro	GSE207422_Sin_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65574
2.02308131821107e-14	0.443115196015547	0.923	0.786	4.85883440194752e-10	H2AFY	Mono/Macro	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65575
2.12825880811458e-14	-0.407549202992338	0.932	0.981	5.11143917944877e-10	RPL37A	Mono/Macro	GSE207422_Sin_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65576
2.48979516714953e-14	0.433399374411354	0.927	0.881	5.97974105294302e-10	AIF1	Mono/Macro	GSE207422_Sin_post	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65577
2.56340449268544e-14	0.729958481155665	0.697	0.459	6.15652857008263e-10	SOCS3	Mono/Macro	GSE207422_Sin_post	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65578
3.25328665390936e-14	-0.337299823094336	0.181	0.409	7.81341855669411e-10	DIAPH1	Mono/Macro	GSE207422_Sin_post	ENSG00000131504	1729	diaphanous related formin 1	DFNA1|hDIA1|LFHL1|mDia1	protein_coding	O60610	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65579
3.69981273216156e-14	-0.611759086708496	0.73	0.887	8.88584023883242e-10	S100A10	Mono/Macro	GSE207422_Sin_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65580
5.87604572743191e-14	0.450101987125784	0.597	0.296	1.41124990235732e-09	TYMP	Mono/Macro	GSE207422_Sin_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65581
6.7286312311216e-14	0.304163879214425	0.989	1	1.61601536277847e-09	ATP5F1E	Mono/Macro	GSE207422_Sin_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65582
7.7218112736581e-14	0.529770978613683	0.544	0.22	1.85454741359447e-09	TNFRSF1B	Mono/Macro	GSE207422_Sin_post	ENSG00000028137	7133	TNF receptor superfamily member 1B	CD120b|p75|TNF-R-II|TNF-R75|TNFBR|TNFR2|TNFR80	protein_coding	P20333	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65583
8.01852217670069e-14	-0.534788212501279	0.606	0.78	1.9258084711782e-09	CCDC88A	Mono/Macro	GSE207422_Sin_post	ENSG00000115355	55704	coiled-coil domain containing 88A	APE|FLJ10392|GIV|GRDN|HkRP1|KIAA1212	protein_coding	Q3V6T2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65584
9.48240057779851e-14	0.580990233300138	0.572	0.27	2.27738814676987e-09	FPR1	Mono/Macro	GSE207422_Sin_post	ENSG00000171051	2357	formyl peptide receptor 1	FMLP|FPR	protein_coding	P21462	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65585
9.97563281226873e-14	-0.2672407533046	0.157	0.377	2.39584773252258e-09	EEA1	Mono/Macro	GSE207422_Sin_post	ENSG00000102189	8411	early endosome antigen 1	ZFYVE2	protein_coding	Q15075	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65586
1.07116354346578e-13	0.595863165932564	0.418	0.113	2.57261348234176e-09	MXD1	Mono/Macro	GSE207422_Sin_post	ENSG00000059728	4084	MAX dimerization protein 1	bHLHc58|MAD|MAD1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65587
1.37278080847064e-13	-0.308364271195735	0.16	0.377	3.29700766770394e-09	GPRIN3	Mono/Macro	GSE207422_Sin_post	ENSG00000185477	285513	GPRIN family member 3	FLJ42625|GRIN3	protein_coding	Q6ZVF9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65588
1.40112210345324e-13	0.89202388281166	0.635	0.327	3.36507495586364e-09	IER3	Mono/Macro	GSE207422_Sin_post	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65589
1.88060488481429e-13	0.411697264905162	0.879	0.755	4.51664875185848e-09	GRINA	Mono/Macro	GSE207422_Sin_post	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65590
1.90501502636822e-13	0.536616706364331	0.834	0.648	4.57527458882855e-09	LDHA	Mono/Macro	GSE207422_Sin_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65591
1.97406027587161e-13	-0.518400550694307	0.085	0.252	4.74110056456085e-09	BAG3	Mono/Macro	GSE207422_Sin_post	ENSG00000151929	9531	BAG cochaperone 3	NA	protein_coding	O95817	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65592
2.01434068787662e-13	0.445404811760752	0.788	0.585	4.83784203007328e-09	PDIA3	Mono/Macro	GSE207422_Sin_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65593
3.50531903128898e-13	1.12239883447247	0.322	0.05	8.41872471744675e-09	HAMP	Mono/Macro	GSE207422_Sin_post	ENSG00000105697	57817	hepcidin antimicrobial peptide	HEPC|HFE2B|LEAP-1|LEAP1	protein_coding	P81172	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65594
3.67958687346109e-13	0.345084446011858	0.995	0.981	8.8372637939915e-09	HLA-E	Mono/Macro	GSE207422_Sin_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65595
4.32963280359785e-13	0.949088404797607	0.517	0.214	1.0398479104401e-08	TIMP1	Mono/Macro	GSE207422_Sin_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65596
4.38148736501786e-13	0.42045391891394	0.288	0.025	1.05230182045634e-08	SMIM3	Mono/Macro	GSE207422_Sin_post	ENSG00000256235	85027	small integral membrane protein 3	C5orf62|MSTP150|NID67	protein_coding	Q9BZL3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65597
4.42928625779199e-13	-0.47313919648672	0.654	0.786	1.0637816805339e-08	TSPO	Mono/Macro	GSE207422_Sin_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65598
5.19704281449059e-13	-0.348433337448026	0.396	0.66	1.2481737727562e-08	FLNA	Mono/Macro	GSE207422_Sin_post	ENSG00000196924	2316	filamin A	ABP-280|FLN|FLN1|OPD1|OPD2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65599
5.80479514289869e-13	-0.387057769591269	0.859	0.943	1.39413764946998e-08	RPS19	Mono/Macro	GSE207422_Sin_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65600
7.82318796830892e-13	-0.300338371529715	0.999	1	1.87889505434875e-08	EEF1A1	Mono/Macro	GSE207422_Sin_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65601
8.44535050383701e-13	-0.430867572634566	0.723	0.862	2.02831983050653e-08	RPL5	Mono/Macro	GSE207422_Sin_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65602
8.60310254034361e-13	0.391297414799438	0.577	0.258	2.06620713711433e-08	LHFPL2	Mono/Macro	GSE207422_Sin_post	ENSG00000145685	10184	LHFPL tetraspan subfamily member 2	KIAA0206	protein_coding	Q6ZUX7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65603
1.07966508763937e-12	-0.485648116386243	0.122	0.314	2.59303164098347e-08	INHBA	Mono/Macro	GSE207422_Sin_post	ENSG00000122641	3624	inhibin subunit beta A	NA	protein_coding	P08476	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65604
1.21622215141029e-12	-0.575431486982944	0.275	0.497	2.9210007410421e-08	KLF2	Mono/Macro	GSE207422_Sin_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65605
1.22615559456316e-12	0.378291153518246	0.895	0.761	2.94485789146235e-08	ATP6V1F	Mono/Macro	GSE207422_Sin_post	ENSG00000128524	9296	ATPase H+ transporting V1 subunit F	ATP6S14|VATF|Vma7	protein_coding	Q16864	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65606
1.23724696875943e-12	0.454027533254712	0.396	0.119	2.97149604486951e-08	ELL2	Mono/Macro	GSE207422_Sin_post	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65607
1.47404656436743e-12	0.519494224308111	0.744	0.516	3.54021763364126e-08	TGFBI	Mono/Macro	GSE207422_Sin_post	ENSG00000120708	7045	transforming growth factor beta induced	BIGH3|CDB1|CDGG1|CSD1|CSD2|CSD3|LCD1	protein_coding	Q15582	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65608
1.57019662720963e-12	0.432276561976942	0.573	0.296	3.77114123956936e-08	CALM3	Mono/Macro	GSE207422_Sin_post	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65609
1.57065484526864e-12	-0.26878902345156	0.157	0.365	3.77224174188169e-08	RPL37P6	Mono/Macro	GSE207422_Sin_post	ENSG00000241431	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65610
1.8508429515893e-12	-0.403489835237277	0.911	0.95	4.44516951683203e-08	SAMHD1	Mono/Macro	GSE207422_Sin_post	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65611
2.05887945776218e-12	0.474349533372462	0.281	0.025	4.94481079370743e-08	HS3ST1	Mono/Macro	GSE207422_Sin_post	ENSG00000002587	9957	heparan sulfate-glucosamine 3-sulfotransferase 1	3OST1	protein_coding	O14792	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65612
2.25523099231492e-12	0.370490106531328	0.467	0.176	5.41638827424273e-08	HM13	Mono/Macro	GSE207422_Sin_post	ENSG00000101294	81502	histocompatibility minor 13	dJ324O17.1|H13|IMP1|IMPAS|PSENL3|PSL3|SPP|SPPL1	protein_coding	Q8TCT9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65613
2.38925448726495e-12	-0.624151142742248	0.377	0.572	5.73827250206424e-08	APOC1P1	Mono/Macro	GSE207422_Sin_post	ENSG00000214855	NA	NA	lincRNA-APOC1P1-3	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65614
2.68642396613902e-12	-0.385569635406732	0.884	0.95	6.45198443947609e-08	RPL32	Mono/Macro	GSE207422_Sin_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65615
2.90613086905575e-12	0.627046660362367	0.935	0.792	6.97965450821119e-08	CTSD	Mono/Macro	GSE207422_Sin_post	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65616
2.97973268874487e-12	-0.513279235363433	0.329	0.547	7.15642399855856e-08	EVI2B	Mono/Macro	GSE207422_Sin_post	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65617
2.98133358835331e-12	0.375560266302239	0.361	0.094	7.16026887914815e-08	GLMP	Mono/Macro	GSE207422_Sin_post	ENSG00000198715	112770	glycosylated lysosomal membrane protein	C1orf85|MGC31963|NCU-G1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65618
3.00235776716777e-12	1.09326605836462	0.593	0.327	7.21076264940683e-08	MT2A	Mono/Macro	GSE207422_Sin_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65619
3.02110251127394e-12	0.592709782989876	0.453	0.176	7.25578190132663e-08	LILRB1	Mono/Macro	GSE207422_Sin_post	ENSG00000276452	10859	leukocyte immunoglobulin like receptor B1	CD85|CD85j|ILT2|LIR-1|LIR1|MIR-7|PIR-B|PIRB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65620
3.91473110584977e-12	-0.471405022098911	0.841	0.931	9.40200969691939e-08	S100A6	Mono/Macro	GSE207422_Sin_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65621
4.57688905440072e-12	-0.376557363602543	0.212	0.421	1.09923144419542e-07	MINK1	Mono/Macro	GSE207422_Sin_post	ENSG00000141503	50488	misshapen like kinase 1	B55|MAP4K6|MINK|YSK2|ZC3	protein_coding	Q8N4C8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65622
4.92606833275782e-12	0.372497647758113	0.942	0.899	1.18309383147845e-07	PKM	Mono/Macro	GSE207422_Sin_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65623
5.03265574437364e-12	0.605138684743073	0.375	0.113	1.20869293012622e-07	FKBP5	Mono/Macro	GSE207422_Sin_post	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65624
5.81284629258897e-12	0.610620915962093	0.489	0.233	1.39607129409109e-07	PPIF	Mono/Macro	GSE207422_Sin_post	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65625
6.6181436161413e-12	0.456807355626114	0.423	0.145	1.58947955228866e-07	SDC3	Mono/Macro	GSE207422_Sin_post	ENSG00000162512	9672	syndecan 3	N-syndecan|SYND3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65626
6.68696864060275e-12	-0.264490879235596	0.168	0.377	1.60600925841356e-07	SIDT2	Mono/Macro	GSE207422_Sin_post	ENSG00000149577	51092	SID1 transmembrane family member 2	CGI-40	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65627
7.42472051613858e-12	0.401560113360576	0.505	0.239	1.783195126361e-07	IFNAR1	Mono/Macro	GSE207422_Sin_post	ENSG00000142166	3454	interferon alpha and beta receptor subunit 1	IFNAR|IFRC	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65628
7.61953114429691e-12	-0.423107680553117	0.401	0.616	1.82998279492579e-07	ALOX5	Mono/Macro	GSE207422_Sin_post	ENSG00000275565	240	arachidonate 5-lipoxygenase	5-LOX	protein_coding	P09917	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65629
8.44045581456546e-12	-0.266811123185052	0.124	0.308	2.02714427298419e-07	RAB11FIP1	Mono/Macro	GSE207422_Sin_post	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65630
1.36125332525369e-11	-0.601679981785018	0.981	0.95	3.26932211126179e-07	LYZ	Mono/Macro	GSE207422_Sin_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65631
2.12934610415267e-11	-0.355431443323796	0.918	0.918	5.11405053834347e-07	SPI1	Mono/Macro	GSE207422_Sin_post	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65632
2.62363039164801e-11	-0.273898073799977	0.208	0.434	6.30117311162102e-07	AXL	Mono/Macro	GSE207422_Sin_post	ENSG00000167601	558	AXL receptor tyrosine kinase	ARK|JTK11|Tyro7|UFO	protein_coding	P30530	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65633
2.65885298208274e-11	-0.316758058762297	0.235	0.453	6.38576720706811e-07	EIF3E	Mono/Macro	GSE207422_Sin_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65634
2.69386901432318e-11	-0.332445321825054	0.866	0.925	6.46986521169999e-07	RPS20	Mono/Macro	GSE207422_Sin_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65635
2.72299659161535e-11	-0.362694702377959	0.45	0.66	6.53982091408258e-07	RAP1B	Mono/Macro	GSE207422_Sin_post	ENSG00000127314	5908	RAP1B, member of RAS oncogene family	DKFZp586H0723|K-REV|RAL1B	protein_coding	P61224	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65636
3.13306498989947e-11	0.381826398271999	0.297	0.05	7.52468218624157e-07	GAL3ST4	Mono/Macro	GSE207422_Sin_post	ENSG00000197093	79690	galactose-3-O-sulfotransferase 4	FLJ12116	protein_coding	Q96RP7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65637
3.34572659261405e-11	0.361871390069395	0.925	0.83	8.03543155748116e-07	GRB2	Mono/Macro	GSE207422_Sin_post	ENSG00000177885	2885	growth factor receptor bound protein 2	NCKAP2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65638
3.37878585842299e-11	-0.331886710668834	0.219	0.434	8.11482999617448e-07	OPN3	Mono/Macro	GSE207422_Sin_post	ENSG00000054277	23596	opsin 3	ECPN|encephalopsin|ERO|NMO-1|PPP1R116	protein_coding	Q9H1Y3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65639
3.61410963965319e-11	-0.267852709159892	0.19	0.396	8.68000712155507e-07	MTND2P28	Mono/Macro	GSE207422_Sin_post	ENSG00000225630	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65640
3.86211047006663e-11	0.390609097244302	0.655	0.39	9.27563071595903e-07	S100A8	Mono/Macro	GSE207422_Sin_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65641
4.40074299420532e-11	-0.405644746803727	0.611	0.824	1.05692644491829e-06	IGSF6	Mono/Macro	GSE207422_Sin_post	ENSG00000283934	10261	immunoglobulin superfamily member 6	DORA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65642
4.40753248899088e-11	-0.294963436110139	0.169	0.365	1.05855707788094e-06	SIRPB1	Mono/Macro	GSE207422_Sin_post	ENSG00000101307	10326	signal regulatory protein beta 1	CD172b|SIRP-BETA-1	protein_coding	O00241	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65643
4.4232450278824e-11	0.387089630552243	0.287	0.05	1.06233075834652e-06	DYSF	Mono/Macro	GSE207422_Sin_post	ENSG00000135636	8291	dysferlin	FER1L1|LGMD2B	protein_coding	O75923	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65644
4.91324102609285e-11	0.459693379509083	0.274	0.038	1.18001309723672e-06	SLC16A10	Mono/Macro	GSE207422_Sin_post	ENSG00000112394	117247	solute carrier family 16 member 10	MCT10|TAT1	protein_coding	Q8TF71	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65645
4.92281949188734e-11	-0.447444326986058	0.463	0.629	1.18231355736658e-06	GLIPR2	Mono/Macro	GSE207422_Sin_post	ENSG00000122694	152007	GLI pathogenesis related 2	C9orf19|GAPR-1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65646
4.95922916054352e-11	0.399212358504153	0.542	0.258	1.19105806748774e-06	RGS1	Mono/Macro	GSE207422_Sin_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65647
5.60153930335285e-11	0.399422580458166	0.578	0.302	1.34532169448626e-06	CSF1R	Mono/Macro	GSE207422_Sin_post	ENSG00000182578	1436	colony stimulating factor 1 receptor	C-FMS|CD115|CSFR|FMS	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65648
6.2782539605648e-11	-0.394250878003568	0.587	0.748	1.50784825370885e-06	RPL26	Mono/Macro	GSE207422_Sin_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65649
6.29326437936188e-11	-0.347217501255214	0.484	0.711	1.51145330599134e-06	PEBP1	Mono/Macro	GSE207422_Sin_post	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65650
6.53010477209501e-11	-0.338109966242862	0.228	0.434	1.56833526311406e-06	RPL6P27	Mono/Macro	GSE207422_Sin_post	ENSG00000235552	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65651
7.0270602294005e-11	-0.300567954933286	0.996	1	1.68768905529512e-06	MT-ND3	Mono/Macro	GSE207422_Sin_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65652
7.58116001826197e-11	-0.292082913341779	0.216	0.421	1.82076720158598e-06	DECR1	Mono/Macro	GSE207422_Sin_post	ENSG00000104325	1666	2,4-dienoyl-CoA reductase 1	DECR|SDR18C1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65653
7.7016388000314e-11	0.577742128244702	0.482	0.239	1.84970259060354e-06	CHMP1B	Mono/Macro	GSE207422_Sin_post	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65654
8.02043482865846e-11	-0.319174633571751	0.782	0.899	1.9262678327989e-06	RTN4	Mono/Macro	GSE207422_Sin_post	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65655
8.36315938033661e-11	-0.686268959591705	0.399	0.597	2.00857998837544e-06	HBEGF	Mono/Macro	GSE207422_Sin_post	ENSG00000113070	1839	heparin binding EGF like growth factor	DTR|DTS|HEGFL	protein_coding	Q99075	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65656
9.30362737050631e-11	0.391055047494725	0.562	0.321	2.2344521855745e-06	NAGK	Mono/Macro	GSE207422_Sin_post	ENSG00000124357	55577	N-acetylglucosamine kinase	GNK	protein_coding	Q9UJ70	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65657
9.37592658075007e-11	-0.370822275084255	0.635	0.78	2.25181628689874e-06	RPL14	Mono/Macro	GSE207422_Sin_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65658
9.53005278711201e-11	0.317791755667978	0.43	0.145	2.28883277788069e-06	FOSL2	Mono/Macro	GSE207422_Sin_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65659
1.21076760577874e-10	-0.272609183061012	0.889	0.969	2.90790055879881e-06	GNAS	Mono/Macro	GSE207422_Sin_post	ENSG00000087460	2778	GNAS complex locus	GNAS1|GNASXL|GPSA|NESP|NESP55|SCG6|SgVI	protein_coding	O95467	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65660
1.25811651058857e-10	-0.313456280648167	0.377	0.616	3.02161842348057e-06	PTMS	Mono/Macro	GSE207422_Sin_post	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65661
1.47290871894774e-10	0.375641985555265	0.329	0.082	3.53748487029678e-06	RGL1	Mono/Macro	GSE207422_Sin_post	ENSG00000143344	23179	ral guanine nucleotide dissociation stimulator like 1	RGL	protein_coding	Q9NZL6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65662
1.74008217779169e-10	0.32990850842361	0.949	0.818	4.17915536640231e-06	BRI3	Mono/Macro	GSE207422_Sin_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65663
1.80018524787194e-10	-0.343509923904247	0.977	1	4.32350490981405e-06	RPL23	Mono/Macro	GSE207422_Sin_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65664
1.91642902762938e-10	-0.285359339021716	0.478	0.711	4.60268759565748e-06	RPS25	Mono/Macro	GSE207422_Sin_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65665
1.926743424226e-10	-0.533727756205664	0.894	0.899	4.62745968196358e-06	MTND1P23	Mono/Macro	GSE207422_Sin_post	ENSG00000225972	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65666
1.94906917166615e-10	-0.308701156976576	0.134	0.302	4.68107942959059e-06	FAM89A	Mono/Macro	GSE207422_Sin_post	ENSG00000182118	375061	family with sequence similarity 89 member A	C1orf153|MGC15887	protein_coding	Q96GI7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65667
1.95003407776488e-10	1.29532226287258	0.342	0.094	4.6833968445679e-06	CCL2	Mono/Macro	GSE207422_Sin_post	ENSG00000108691	6347	C-C motif chemokine ligand 2	GDCF-2|HC11|MCAF|MCP-1|MCP1|MGC9434|SCYA2|SMC-CF	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65668
2.09367499305873e-10	-0.352318863741976	0.818	0.931	5.02837923082915e-06	MT-ND4L	Mono/Macro	GSE207422_Sin_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65669
2.22316619870165e-10	-0.327850706584258	0.266	0.484	5.33937825942174e-06	TREM1	Mono/Macro	GSE207422_Sin_post	ENSG00000124731	54210	triggering receptor expressed on myeloid cells 1	CD354|TREM-1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65670
2.2497705705934e-10	0.379304028892943	0.931	0.774	5.40327397939416e-06	CD81	Mono/Macro	GSE207422_Sin_post	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65671
2.28545863805287e-10	0.546720902589275	0.465	0.201	5.48898601101158e-06	LILRB2	Mono/Macro	GSE207422_Sin_post	ENSG00000274513	10288	leukocyte immunoglobulin like receptor B2	CD85d|ILT4|LIR-2|LIR2|MIR-10|MIR10	protein_coding	Q8N423	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65672
2.41184467244936e-10	0.643378033284674	0.552	0.283	5.79252734982164e-06	SLC2A3	Mono/Macro	GSE207422_Sin_post	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65673
2.54081953798685e-10	0.300000132915133	0.885	0.755	6.10228628438302e-06	ATP6V0E1	Mono/Macro	GSE207422_Sin_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65674
2.70860582249648e-10	0.345482126671172	0.331	0.094	6.5052586038898e-06	CD300A	Mono/Macro	GSE207422_Sin_post	ENSG00000167851	11314	CD300a molecule	CMRF-35-H9|CMRF35H|IGSF12|IRC1|IRC2|Irp60	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65675
2.85597051647031e-10	0.430589807428338	0.688	0.434	6.85918438940675e-06	FCGR2A	Mono/Macro	GSE207422_Sin_post	ENSG00000143226	2212	Fc gamma receptor IIa	CD32|CD32A|CDw32|Fc-gamma-RIIa|FCG2|FcgammaRIIa|FCGR2|FCGR2A1|IGFR2	protein_coding	P12318	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65676
2.98356296377896e-10	-0.428703900409203	0.381	0.61	7.16562317010794e-06	MYADM	Mono/Macro	GSE207422_Sin_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65677
3.09428268929707e-10	-0.275233306736285	0.195	0.396	7.43153873488477e-06	MYOF	Mono/Macro	GSE207422_Sin_post	ENSG00000138119	26509	myoferlin	FER1L3|KIAA1207	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65678
3.1763876552729e-10	-0.333478266304483	0.744	0.881	7.62873023166892e-06	RPL15	Mono/Macro	GSE207422_Sin_post	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65679
3.57579158501857e-10	0.312211859495504	0.482	0.201	8.5879786497391e-06	GPR183	Mono/Macro	GSE207422_Sin_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65680
3.73361023516824e-10	-0.317714011192005	0.854	0.956	8.96701170180357e-06	RPL12	Mono/Macro	GSE207422_Sin_post	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65681
4.37045973725211e-10	0.342225973978174	0.279	0.057	1.04965331509584e-05	FAM20A	Mono/Macro	GSE207422_Sin_post	ENSG00000108950	54757	FAM20A golgi associated secretory pathway pseudokinase	DKFZp434F2322	protein_coding	Q96MK3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65682
4.39267826312835e-10	0.342700486686234	0.366	0.126	1.05498953845554e-05	PREX1	Mono/Macro	GSE207422_Sin_post	ENSG00000124126	57580	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1	KIAA1415|P-REX1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65683
4.63537980620931e-10	0.380550983566326	0.462	0.22	1.11327916805729e-05	ADAP2	Mono/Macro	GSE207422_Sin_post	ENSG00000184060	55803	ArfGAP with dual PH domains 2	CENTA2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65684
4.91482934437787e-10	-0.279669453561318	0.906	0.956	1.18039456363923e-05	YWHAB	Mono/Macro	GSE207422_Sin_post	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65685
5.03709583074546e-10	2.84956932519906	0.306	0.082	1.20975930567014e-05	SPP1	Mono/Macro	GSE207422_Sin_post	ENSG00000118785	6696	secreted phosphoprotein 1	BNSP|BSPI|ETA-1|OPN	protein_coding	P10451	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65686
5.18954028873542e-10	-0.40889748749305	0.965	0.969	1.24637189114558e-05	RPS6	Mono/Macro	GSE207422_Sin_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65687
5.21833402551126e-10	0.614232651791451	0.554	0.289	1.25328728290704e-05	NAMPT	Mono/Macro	GSE207422_Sin_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65688
5.38279395872148e-10	0.357242351987068	0.517	0.252	1.29278562506614e-05	EPSTI1	Mono/Macro	GSE207422_Sin_post	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65689
5.86459972751141e-10	0.34017863998155	0.705	0.516	1.40850091655642e-05	RPN2	Mono/Macro	GSE207422_Sin_post	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65690
6.44875166113919e-10	0.407848758955188	0.887	0.78	1.5487966864558e-05	LAMP1	Mono/Macro	GSE207422_Sin_post	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65691
6.52648583834345e-10	0.328829740836846	0.268	0.05	1.56746610379495e-05	TCN2	Mono/Macro	GSE207422_Sin_post	ENSG00000185339	6948	transcobalamin 2	D22S676|D22S750|TC2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65692
6.72653802284528e-10	0.392608940077336	0.756	0.553	1.61551263694675e-05	FYB1	Mono/Macro	GSE207422_Sin_post	ENSG00000082074	2533	FYN binding protein 1	ADAP|FYB|FYB-120/130|SLAP-130	protein_coding	O15117	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65693
7.29603710265443e-10	0.307242458453107	0.389	0.145	1.75228923094451e-05	ADAM9	Mono/Macro	GSE207422_Sin_post	ENSG00000282230	8754	ADAM metallopeptidase domain 9	CORD9|KIAA0021|MCMP|MDC9|Mltng	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65694
8.12760150693099e-10	-0.333071333062165	0.718	0.887	1.95200605391962e-05	RPS3	Mono/Macro	GSE207422_Sin_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65695
8.72628810812123e-10	-0.307934050622478	0.527	0.717	2.09579261492748e-05	MTPN	Mono/Macro	GSE207422_Sin_post	ENSG00000105887	136319	myotrophin	GCDP|MYOTROPHIN|V-1	protein_coding	P58546	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65696
9.00742108849432e-10	0.331646320838277	0.45	0.208	2.16331232282368e-05	AP1B1	Mono/Macro	GSE207422_Sin_post	ENSG00000100280	162	adaptor related protein complex 1 subunit beta 1	ADTB1|AP105A|BAM22|CLAPB2	protein_coding	Q10567	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65697
9.2125081443729e-10	-0.971973015780337	0.235	0.415	2.21256808103404e-05	HLA-DRB5	Mono/Macro	GSE207422_Sin_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65698
9.52383726540277e-10	0.327966976976948	0.305	0.082	2.28733999603178e-05	FLOT1	Mono/Macro	GSE207422_Sin_post	ENSG00000223654	10211	flotillin 1	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65699
1.01421117490906e-09	0.344062322814154	0.364	0.132	2.43583097877908e-05	ATOX1	Mono/Macro	GSE207422_Sin_post	ENSG00000177556	475	antioxidant 1 copper chaperone	HAH1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65700
1.23128823618733e-09	0.306283380556399	0.45	0.208	2.95718495685112e-05	CYFIP1	Mono/Macro	GSE207422_Sin_post	ENSG00000280618	23191	cytoplasmic FMR1 interacting protein 1	KIAA0068|P140SRA-1|SHYC	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65701
1.50158141540863e-09	-0.364754736000706	0.94	0.994	3.60634808538691e-05	RPL31	Mono/Macro	GSE207422_Sin_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65702
1.53367852792145e-09	0.394197931239566	0.612	0.39	3.68343572050895e-05	MAFB	Mono/Macro	GSE207422_Sin_post	ENSG00000204103	9935	MAF bZIP transcription factor B	KRML	protein_coding	Q9Y5Q3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65703
1.59482321037478e-09	0.349335900785947	0.334	0.107	3.83028690435711e-05	CMKLR1	Mono/Macro	GSE207422_Sin_post	ENSG00000174600	1240	chemerin chemokine-like receptor 1	RVER1	protein_coding	Q99788	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65704
1.6114037741548e-09	0.337613196580722	0.32	0.094	3.87010844438759e-05	SMPDL3A	Mono/Macro	GSE207422_Sin_post	ENSG00000172594	10924	sphingomyelin phosphodiesterase acid like 3A	ASM3A|ASML3a|FLJ20177|yR36GH4.1	protein_coding	Q92484	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65705
1.65021762425191e-09	0.340173829907797	0.483	0.245	3.96332766816582e-05	ABHD12	Mono/Macro	GSE207422_Sin_post	ENSG00000100997	26090	abhydrolase domain containing 12, lysophospholipase	ABHD12A|BEM46L2|C20orf22|dJ965G21.2|DKFZP434P106	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65706
1.66239385200749e-09	0.388366308645524	0.681	0.478	3.99257131436639e-05	CD47	Mono/Macro	GSE207422_Sin_post	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65707
1.68580098262818e-09	0.295888566484509	0.789	0.572	4.04878821997811e-05	DAZAP2	Mono/Macro	GSE207422_Sin_post	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65708
2.00928280122041e-09	-0.279611271075737	0.211	0.403	4.82569450369105e-05	RPL22	Mono/Macro	GSE207422_Sin_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65709
2.11885083450253e-09	0.292737195886938	0.929	0.843	5.08884404922472e-05	VAMP8	Mono/Macro	GSE207422_Sin_post	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65710
2.3028075442345e-09	0.363013037941432	0.281	0.069	5.530652878988e-05	HPSE	Mono/Macro	GSE207422_Sin_post	ENSG00000173083	10855	heparanase	HPA|HPSE1|HSE1	protein_coding	Q9Y251	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65711
2.36885236442801e-09	0.363150565828601	0.673	0.465	5.68927272364675e-05	GNB4	Mono/Macro	GSE207422_Sin_post	ENSG00000114450	59345	G protein subunit beta 4	NA	protein_coding	Q9HAV0	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65712
2.41112659667701e-09	-0.293320079438615	0.144	0.314	5.79080274723918e-05	SPARC	Mono/Macro	GSE207422_Sin_post	ENSG00000113140	6678	secreted protein acidic and cysteine rich	BM-40|ON|ONT	protein_coding	P09486	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65713
2.55698854326094e-09	-0.641315776158717	0.536	0.73	6.1411193843498e-05	C1QB	Mono/Macro	GSE207422_Sin_post	ENSG00000173369	713	complement C1q B chain	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65714
2.55831212176099e-09	0.449080996643623	0.361	0.138	6.14429822283337e-05	HK2	Mono/Macro	GSE207422_Sin_post	ENSG00000159399	3099	hexokinase 2	NA	protein_coding	P52789	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65715
2.64846331174847e-09	-0.321358649613363	0.437	0.635	6.3608143358263e-05	MDH1	Mono/Macro	GSE207422_Sin_post	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65716
2.65794243858577e-09	-0.307649814408248	0.259	0.459	6.38358035475146e-05	IPO7	Mono/Macro	GSE207422_Sin_post	ENSG00000205339	10527	importin 7	Imp7|RANBP7	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65717
2.68557619029776e-09	-0.442290087709514	0.549	0.692	6.44994833623814e-05	FTLP3	Mono/Macro	GSE207422_Sin_post	ENSG00000226608	NA	NA	dJ681N20.2|FTLL1	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65718
3.03390026418059e-09	-0.318244929647447	0.934	0.975	7.28651826448252e-05	RPLP1	Mono/Macro	GSE207422_Sin_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65719
3.05376884421354e-09	0.533324175686613	0.279	0.063	7.33423663314767e-05	ADAMDEC1	Mono/Macro	GSE207422_Sin_post	ENSG00000134028	27299	ADAM like decysin 1	M12.219	protein_coding	O15204	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65720
3.08289354809598e-09	0.283133839939301	0.312	0.082	7.40418543446212e-05	STAB1	Mono/Macro	GSE207422_Sin_post	ENSG00000010327	23166	stabilin 1	CLEVER-1|FEEL-1|FELE-1|FEX1|KIAA0246|SCARH2|STAB-1	protein_coding	Q9NY15	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65721
3.36096900595506e-09	-0.252855336458776	0.126	0.283	8.07203926160227e-05	ARRDC4	Mono/Macro	GSE207422_Sin_post	ENSG00000140450	91947	arrestin domain containing 4	FLJ36045	protein_coding	Q8NCT1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65722
3.44551215957589e-09	0.385558077865269	0.504	0.283	8.27508655365342e-05	PIK3AP1	Mono/Macro	GSE207422_Sin_post	ENSG00000155629	118788	phosphoinositide-3-kinase adaptor protein 1	BCAP|FLJ35564	protein_coding	Q6ZUJ8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65723
3.60918941228268e-09	0.333475272082044	0.346	0.126	8.6681902114793e-05	IRAK1	Mono/Macro	GSE207422_Sin_post	ENSG00000184216	3654	interleukin 1 receptor associated kinase 1	IRAK|pelle	protein_coding	P51617	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65724
3.64579673588264e-09	-0.324141080641721	0.657	0.78	8.75611002056934e-05	RPL4	Mono/Macro	GSE207422_Sin_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65725
3.872487848456e-09	-0.296756716905024	0.246	0.434	9.30055406563677e-05	ACER3	Mono/Macro	GSE207422_Sin_post	ENSG00000078124	55331	alkaline ceramidase 3	APHC|FLJ11238|PHCA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65726
4.30905249142285e-09	-0.309196478927497	0.33	0.528	0.000103490513686502	GLRX	Mono/Macro	GSE207422_Sin_post	ENSG00000173221	2745	glutaredoxin	GRX|GRX1	protein_coding	P35754	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65727
4.34169299207874e-09	-0.361934963560445	0.44	0.61	0.000104274440590755	MT-TM	Mono/Macro	GSE207422_Sin_post	ENSG00000210112	NA	NA	MTTM|trnM	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65728
4.41924040740221e-09	0.681194239176687	0.813	0.686	0.000106136896864579	GPNMB	Mono/Macro	GSE207422_Sin_post	ENSG00000136235	10457	glycoprotein nmb	HGFIN|NMB	protein_coding	Q14956	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65729
4.84378309097473e-09	-0.488064559831006	0.897	0.918	0.00011633313849594	HSP90AB1	Mono/Macro	GSE207422_Sin_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65730
5.03112637919553e-09	-0.577827676587641	0.119	0.264	0.000120832562249139	STMN1	Mono/Macro	GSE207422_Sin_post	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65731
5.58076783391713e-09	0.304020386574559	0.708	0.516	0.000134033301067188	LAPTM4A	Mono/Macro	GSE207422_Sin_post	ENSG00000068697	9741	lysosomal protein transmembrane 4 alpha	HUMORF13|KIAA0108|LAPTM4|MBNT|Mtrp	protein_coding	Q15012	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65732
5.60919922418599e-09	0.297585374643165	0.363	0.132	0.000134716137767275	C3AR1	Mono/Macro	GSE207422_Sin_post	ENSG00000171860	719	complement C3a receptor 1	AZ3B|C3AR	protein_coding	Q16581	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65733
5.90822191776302e-09	0.312461422763931	0.549	0.308	0.000141897765798914	RAB20	Mono/Macro	GSE207422_Sin_post	ENSG00000139832	55647	RAB20, member RAS oncogene family	FLJ20429	protein_coding	Q9NX57	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65734
5.97757235002952e-09	-0.313877471705656	0.703	0.818	0.000143563355130659	RACK1	Mono/Macro	GSE207422_Sin_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65735
6.23872552341887e-09	-0.319445175174985	0.48	0.673	0.000149835470895951	LRRFIP1	Mono/Macro	GSE207422_Sin_post	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65736
7.38431484035493e-09	0.259147316969592	0.271	0.063	0.000177349089520804	OAZ2	Mono/Macro	GSE207422_Sin_post	ENSG00000180304	4947	ornithine decarboxylase antizyme 2	NA	protein_coding	O95190	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65737
7.40315030242482e-09	-0.304501023129178	0.617	0.767	0.000177801460813337	RTN3	Mono/Macro	GSE207422_Sin_post	ENSG00000133318	10313	reticulon 3	ASYIP|HAP|NSPL2|NSPLII|RTN3-A1	protein_coding	O95197	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65738
9.19269845734169e-09	-0.306283150244715	0.331	0.516	0.000220781038849975	MTCO1P12	Mono/Macro	GSE207422_Sin_post	ENSG00000237973	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65739
9.43669518669841e-09	0.302265847910326	0.398	0.164	0.000226641108298936	RALA	Mono/Macro	GSE207422_Sin_post	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65740
9.45131871977735e-09	0.302319089860905	0.728	0.541	0.000226992321692893	CNDP2	Mono/Macro	GSE207422_Sin_post	ENSG00000133313	55748	carnosine dipeptidase 2	CN2|CPGL|FLJ10830|HsT2298|PEPA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65741
9.56113844612221e-09	0.288134532837462	0.381	0.145	0.000229629862060517	CSF3R	Mono/Macro	GSE207422_Sin_post	ENSG00000119535	1441	colony stimulating factor 3 receptor	CD114|GCSFR	protein_coding	Q99062	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65742
9.82151792082869e-09	0.398272185749545	0.453	0.226	0.000235883395904543	SLA	Mono/Macro	GSE207422_Sin_post	ENSG00000155926	6503	Src like adaptor	hSLAP|SLA1|SLAP|SLAP-1	protein_coding	Q13239	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65743
1.00237492971674e-08	-0.316317297124324	0.37	0.56	0.00024074038687007	RPLP0	Mono/Macro	GSE207422_Sin_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65744
1.01497467990088e-08	0.364141034208655	0.579	0.327	0.000243766468871794	BTG1	Mono/Macro	GSE207422_Sin_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65745
1.0229851137248e-08	-0.449099296920143	0.923	0.925	0.000245690334763286	CYBB	Mono/Macro	GSE207422_Sin_post	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65746
1.04328426835918e-08	-0.33408304772782	0.8	0.887	0.000250565582731824	RPS11	Mono/Macro	GSE207422_Sin_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65747
1.19665823484778e-08	-0.282252815388881	0.901	0.943	0.000287401408263392	RPL38	Mono/Macro	GSE207422_Sin_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65748
1.26487996293899e-08	-0.564770519163397	0.339	0.516	0.000303786220699056	HSPD1	Mono/Macro	GSE207422_Sin_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65749
1.30565819322996e-08	0.531317237875119	0.463	0.239	0.000313579928268039	CD36	Mono/Macro	GSE207422_Sin_post	ENSG00000135218	948	CD36 molecule	FAT|GP3B|GP4|GPIV|SCARB3	protein_coding	P16671	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65750
1.31141721123318e-08	0.438696524748543	0.346	0.132	0.000314963071621873	PPA1	Mono/Macro	GSE207422_Sin_post	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65751
1.31249915948366e-08	0.362565981744713	0.43	0.208	0.00031522292313319	ME2	Mono/Macro	GSE207422_Sin_post	ENSG00000082212	4200	malic enzyme 2	NA	protein_coding	P23368	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65752
1.35147752253843e-08	-0.283015398553417	0.729	0.83	0.000324584356588054	RPS5	Mono/Macro	GSE207422_Sin_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65753
1.3801066104713e-08	0.291049148833989	0.295	0.088	0.000331460204636891	NECTIN2	Mono/Macro	GSE207422_Sin_post	ENSG00000130202	5819	nectin cell adhesion molecule 2	CD112|HVEB|Nectin-2|PRR2|PVRL2|PVRR2	protein_coding	Q92692	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65754
1.42917045167827e-08	1.13446863764359	0.277	0.075	0.000343243867379571	RNASE1	Mono/Macro	GSE207422_Sin_post	ENSG00000129538	6035	ribonuclease A family member 1, pancreatic	RAC1|RNS1	protein_coding	P07998	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65755
1.46024623791727e-08	0.426391271368734	0.742	0.604	0.000350707338960591	GM2A	Mono/Macro	GSE207422_Sin_post	ENSG00000196743	2760	ganglioside GM2 activator	GM2-AP|GM2AP|SAP-3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65756
1.47062240711161e-08	0.464378923710196	0.401	0.189	0.000353199383515995	PLAU	Mono/Macro	GSE207422_Sin_post	ENSG00000122861	5328	plasminogen activator, urokinase	UPA|URK	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65757
1.57035180377916e-08	-0.333781828198543	0.763	0.855	0.000377151392713641	HLA-DMA	Mono/Macro	GSE207422_Sin_post	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65758
1.72691996173953e-08	-0.264805670685987	0.339	0.547	0.000414754367210983	AES	Mono/Macro	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65759
1.78800088276229e-08	-0.270651827968434	0.118	0.264	0.00042942417201302	DUT	Mono/Macro	GSE207422_Sin_post	ENSG00000128951	1854	deoxyuridine triphosphatase	dUTPase	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65760
1.82272153449452e-08	0.358545427208407	0.421	0.208	0.000437763030939548	PITPNA	Mono/Macro	GSE207422_Sin_post	ENSG00000174238	5306	phosphatidylinositol transfer protein alpha	PITPN|VIB1A	protein_coding	Q00169	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65761
1.83466274863853e-08	0.33199177823206	0.453	0.239	0.000440630952340515	GNPDA1	Mono/Macro	GSE207422_Sin_post	ENSG00000113552	10007	glucosamine-6-phosphate deaminase 1	GNPDA|GNPI|GPI|HLN|KIAA0060	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65762
2.06933315533396e-08	-0.256877695125721	0.684	0.868	0.000496991743916556	MYL12A	Mono/Macro	GSE207422_Sin_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65763
2.1517797505607e-08	0.303750057962416	0.338	0.126	0.000516792942692162	ATF5	Mono/Macro	GSE207422_Sin_post	ENSG00000169136	22809	activating transcription factor 5	NA	protein_coding	Q9Y2D1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65764
2.3281149481426e-08	-0.32385233876151	0.597	0.736	0.000559143367095408	NCF2	Mono/Macro	GSE207422_Sin_post	ENSG00000116701	4688	neutrophil cytosolic factor 2	NOXA2|p67phox	protein_coding	P19878	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65765
2.36006673590934e-08	0.313782410685834	0.374	0.157	0.000566817227963347	MGAT4A	Mono/Macro	GSE207422_Sin_post	ENSG00000071073	11320	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GnT-4a|GnT-Iva	protein_coding	Q9UM21	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65766
2.71012251626294e-08	-0.285483404649572	0.448	0.635	0.000650890124730871	UQCRB	Mono/Macro	GSE207422_Sin_post	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65767
2.8871172937576e-08	-0.255094427986181	0.17	0.333	0.000693398960441764	NR3C1	Mono/Macro	GSE207422_Sin_post	ENSG00000113580	2908	nuclear receptor subfamily 3 group C member 1	GR|GRL	protein_coding	P04150	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65768
2.88792233037409e-08	-0.253478997074979	0.795	0.918	0.000693592306085944	CAP1	Mono/Macro	GSE207422_Sin_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65769
2.91773227244913e-08	0.277544601558065	0.312	0.107	0.000700751759874107	PLBD2	Mono/Macro	GSE207422_Sin_post	ENSG00000151176	196463	phospholipase B domain containing 2	p76	protein_coding	Q8NHP8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65770
3.09244856811071e-08	0.299512069826232	0.646	0.465	0.000742713372603149	TMED9	Mono/Macro	GSE207422_Sin_post	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65771
3.3648197870893e-08	0.314969857377795	0.321	0.119	0.000808128768265237	BLVRB	Mono/Macro	GSE207422_Sin_post	ENSG00000090013	645	biliverdin reductase B	FLR|SDR43U1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65772
3.37091261579461e-08	0.282621307313017	0.457	0.233	0.000809592082935392	BST2	Mono/Macro	GSE207422_Sin_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65773
3.37886609717635e-08	0.299460633438011	0.486	0.233	0.000811502270558843	VAMP5	Mono/Macro	GSE207422_Sin_post	ENSG00000168899	10791	vesicle associated membrane protein 5	NA	protein_coding	O95183	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65774
3.85859551912431e-08	0.334310701651278	0.353	0.145	0.000926718885828086	ST3GAL1	Mono/Macro	GSE207422_Sin_post	ENSG00000008513	6482	ST3 beta-galactoside alpha-2,3-sialyltransferase 1	SIAT4A|SIATFL|ST3GalA.1|ST3O	protein_coding	Q11201	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65775
4.10679649293781e-08	-0.292717822767787	0.278	0.459	0.000986329313708875	OSCAR	Mono/Macro	GSE207422_Sin_post	ENSG00000278533	126014	osteoclast associated Ig-like receptor	NA	protein_coding	Q8IYS5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65776
5.0578552427868e-08	0.295412431449006	0.713	0.541	0.00121474509366011	CPVL	Mono/Macro	GSE207422_Sin_post	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65777
5.10136410939981e-08	-0.255236587418834	0.193	0.358	0.00122519461815455	HNRNPH1	Mono/Macro	GSE207422_Sin_post	ENSG00000284254	3187	heterogeneous nuclear ribonucleoprotein H1	hnRNPH|HNRPH1	protein_coding	P31943	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65778
5.36602184690787e-08	0.328959933135461	0.89	0.723	0.00128875746697186	ITGB2	Mono/Macro	GSE207422_Sin_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65779
5.424863830009e-08	0.308459068759684	0.602	0.39	0.00130288954605326	HAVCR2	Mono/Macro	GSE207422_Sin_post	ENSG00000135077	84868	hepatitis A virus cellular receptor 2	CD366|FLJ14428|Tim-3|TIM3|TIMD3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65780
5.61609179574713e-08	-0.311456271076022	0.601	0.742	0.00134881676658459	RPS3A	Mono/Macro	GSE207422_Sin_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65781
5.6939096837634e-08	0.275914225095391	0.414	0.201	0.00136750628874946	PSMB3	Mono/Macro	GSE207422_Sin_post	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65782
5.87538320484555e-08	0.524405126241494	0.34	0.138	0.00141109078430776	SDC2	Mono/Macro	GSE207422_Sin_post	ENSG00000169439	6383	syndecan 2	CD362|fibroglycan|HSPG|HSPG1|SYND2	protein_coding	P34741	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65783
6.70118240739736e-08	0.294529903262738	0.388	0.182	0.00160942297878462	EPB41L3	Mono/Macro	GSE207422_Sin_post	ENSG00000082397	23136	erythrocyte membrane protein band 4.1 like 3	4.1B|DAL1|KIAA0987	protein_coding	Q9Y2J2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65784
6.90267578265146e-08	0.27041483329284	0.857	0.748	0.0016578156427194	CD53	Mono/Macro	GSE207422_Sin_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65785
7.11700444244701e-08	-0.400806045840067	0.971	0.95	0.0017092909569425	HLA-DPB1	Mono/Macro	GSE207422_Sin_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65786
7.21022736062445e-08	0.25402568918591	0.321	0.119	0.00173168030520117	TCF25	Mono/Macro	GSE207422_Sin_post	ENSG00000141002	22980	transcription factor 25	KIAA1049|Nulp1	protein_coding	Q9BQ70	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65787
7.47290799797079e-08	-0.405794808697028	0.798	0.818	0.00179476831387264	TAGLN2	Mono/Macro	GSE207422_Sin_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65788
7.67151532277904e-08	0.291353708320213	0.916	0.893	0.00184246783507184	CANX	Mono/Macro	GSE207422_Sin_post	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65789
7.68591099433083e-08	0.479785959110312	0.907	0.818	0.00184592524350844	CTSC	Mono/Macro	GSE207422_Sin_post	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65790
8.23936265729652e-08	0.296595854754387	0.785	0.597	0.0019788477294029	KCTD12	Mono/Macro	GSE207422_Sin_post	ENSG00000178695	115207	potassium channel tetramerization domain containing 12	C13orf2|KIAA1778|PFET1	protein_coding	Q96CX2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65791
8.49172154622749e-08	-0.251760056211965	0.266	0.459	0.00203945676375746	DPYSL2	Mono/Macro	GSE207422_Sin_post	ENSG00000092964	1808	dihydropyrimidinase like 2	CRMP2|DHPRP2|DRP-2|DRP2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65792
8.60916614908425e-08	0.344612616012903	0.85	0.748	0.00206766343402556	C5AR1	Mono/Macro	GSE207422_Sin_post	ENSG00000197405	728	complement C5a receptor 1	C5A|C5AR|C5R1|CD88	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65793
9.08160085696203e-08	-0.380667908972052	0.27	0.421	0.00218112807781657	RMDN3	Mono/Macro	GSE207422_Sin_post	ENSG00000137824	55177	regulator of microtubule dynamics 3	FAM82A2|FAM82C|FLJ10579|PTPIP51|RMD3	protein_coding	Q96TC7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65794
1.03378764153441e-07	0.291093661861461	0.433	0.226	0.00248284777867319	PDXK	Mono/Macro	GSE207422_Sin_post	ENSG00000160209	8566	pyridoxal kinase	C21orf124|C21orf97|FLJ21324|FLJ31940|MGC15873|PKH|PNK|PRED79	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65795
1.05203890672954e-07	0.448785559349047	0.501	0.321	0.00252668184229233	RASSF4	Mono/Macro	GSE207422_Sin_post	ENSG00000107551	83937	Ras association domain family member 4	AD037|MGC44914	protein_coding	Q9H2L5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65796
1.09289609522315e-07	0.327368966105816	0.571	0.377	0.00262480855189744	STOM	Mono/Macro	GSE207422_Sin_post	ENSG00000148175	2040	stomatin	BND7|EPB7|EPB72	protein_coding	P27105	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65797
1.11467734643842e-07	0.302809067577351	0.447	0.239	0.00267712058294115	B4GALT1	Mono/Macro	GSE207422_Sin_post	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65798
1.12940755495574e-07	0.277341155031958	0.466	0.252	0.00271249812473719	EMILIN2	Mono/Macro	GSE207422_Sin_post	ENSG00000132205	84034	elastin microfibril interfacer 2	FLJ33200|FOAP-10	protein_coding	Q9BXX0	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65799
1.13837393987473e-07	-0.252572917146082	0.215	0.384	0.00273403269139713	AL031727.1	Mono/Macro	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65800
1.17282638583986e-07	-0.433286687385215	0.433	0.579	0.00281677713087159	TKT	Mono/Macro	GSE207422_Sin_post	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65801
1.17665170966559e-07	0.255947177967322	0.262	0.075	0.00282596441110384	CYSTM1	Mono/Macro	GSE207422_Sin_post	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65802
1.19418838021595e-07	0.267442335355223	0.613	0.39	0.00286808223276465	SLAMF8	Mono/Macro	GSE207422_Sin_post	ENSG00000158714	56833	SLAM family member 8	BLAME|CD353|SBBI42	protein_coding	Q9P0V8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65803
1.24813486114224e-07	-0.31654711803293	0.182	0.333	0.00299764549600532	ALAS1	Mono/Macro	GSE207422_Sin_post	ENSG00000023330	211	5'-aminolevulinate synthase 1	ALAS|ALAS-H|ALAS3	protein_coding	P13196	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65804
1.26072468427226e-07	0.349817698198608	0.483	0.277	0.00302788247421668	METRNL	Mono/Macro	GSE207422_Sin_post	ENSG00000275031	284207	meteorin like, glial cell differentiation regulator	NA	protein_coding	Q641Q3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65805
1.2903078745596e-07	0.664430100134315	0.407	0.208	0.00309893242232978	TNFAIP3	Mono/Macro	GSE207422_Sin_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65806
1.30466067731416e-07	-0.257664524032308	0.362	0.547	0.00313340354870542	SCP2	Mono/Macro	GSE207422_Sin_post	ENSG00000116171	6342	sterol carrier protein 2	NA	protein_coding	P22307	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65807
1.31776086161348e-07	0.250055864806081	0.269	0.082	0.00316486626133709	YIF1B	Mono/Macro	GSE207422_Sin_post	ENSG00000167645	90522	Yip1 interacting factor homolog B, membrane trafficking protein	FinGER8	protein_coding	Q5BJH7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65808
1.36683810663723e-07	0.313207185682253	0.342	0.145	0.00328273508071063	SEMA4A	Mono/Macro	GSE207422_Sin_post	ENSG00000196189	64218	semaphorin 4A	CORD10|FLJ12287|SEMAB|SemB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65809
1.41717445829482e-07	-0.382340515473359	0.294	0.459	0.00340362789648668	GCHFR	Mono/Macro	GSE207422_Sin_post	ENSG00000137880	2644	GTP cyclohydrolase I feedback regulator	GFRP|HsT16933	protein_coding	P30047	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65810
1.42417486860319e-07	-0.303031248050983	0.404	0.585	0.00342044078192428	MBNL1	Mono/Macro	GSE207422_Sin_post	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65811
1.49495938192906e-07	-0.329845955463729	0.274	0.428	0.00359044394757902	MT-TD	Mono/Macro	GSE207422_Sin_post	ENSG00000210154	NA	NA	MTTD|trnD	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65812
1.52022350039713e-07	0.365906609581897	0.428	0.201	0.00365112078090379	IFITM2	Mono/Macro	GSE207422_Sin_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65813
1.55778348294597e-07	0.26668842895736	0.555	0.346	0.00374132859099133	AP2S1	Mono/Macro	GSE207422_Sin_post	ENSG00000042753	1175	adaptor related protein complex 2 subunit sigma 1	CLAPS2|FBH3|FBHOk|HHC3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65814
1.5886669895514e-07	-0.252783190191062	0.197	0.358	0.00381550150880559	TUBB6	Mono/Macro	GSE207422_Sin_post	ENSG00000176014	84617	tubulin beta 6 class V	HsT1601|MGC4083	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65815
1.71762538133201e-07	0.338163827899021	0.545	0.333	0.00412522087834508	VMP1	Mono/Macro	GSE207422_Sin_post	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65816
1.78979695571175e-07	0.268537466369029	0.281	0.088	0.0042985553485329	IL4I1	Mono/Macro	GSE207422_Sin_post	ENSG00000104951	259307	interleukin 4 induced 1	FIG1	protein_coding	Q96RQ9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65817
1.84852054987804e-07	0.330429167028813	0.869	0.623	0.0044395918046421	FCGR3A	Mono/Macro	GSE207422_Sin_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65818
1.90588300877868e-07	-0.281022940199472	0.362	0.535	0.00457735922218375	RPL7	Mono/Macro	GSE207422_Sin_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65819
1.92766486635553e-07	0.344307353837183	0.293	0.101	0.00462967270952608	CREM	Mono/Macro	GSE207422_Sin_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65820
1.97966976105362e-07	0.292115843507844	0.285	0.101	0.00475457286512247	FURIN	Mono/Macro	GSE207422_Sin_post	ENSG00000140564	5045	furin, paired basic amino acid cleaving enzyme	FUR|PACE|PCSK3|SPC1	protein_coding	P09958	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65821
1.99564460237631e-07	0.435761133636677	0.399	0.189	0.00479293964152718	ZNF331	Mono/Macro	GSE207422_Sin_post	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65822
2.13750473269415e-07	0.295830872492202	0.293	0.107	0.00513364511651154	MAP3K8	Mono/Macro	GSE207422_Sin_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65823
2.1993326397816e-07	-0.290109395152784	0.216	0.377	0.00528213720096347	CLEC12A	Mono/Macro	GSE207422_Sin_post	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65824
2.34872353666835e-07	0.491266851641796	0.707	0.528	0.00564092931801638	PLD3	Mono/Macro	GSE207422_Sin_post	ENSG00000105223	23646	phospholipase D family member 3	HU-K4	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65825
2.41459741393356e-07	-0.304644184612868	0.525	0.654	0.00579913860904424	EEF2	Mono/Macro	GSE207422_Sin_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65826
2.56623569756629e-07	0.290858522157335	0.496	0.258	0.00616332827484495	SLAMF7	Mono/Macro	GSE207422_Sin_post	ENSG00000026751	57823	SLAM family member 7	19A|CD319|CRACC|CS1	protein_coding	Q9NQ25	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65827
3.58282529619346e-07	-0.801528233822854	0.301	0.472	0.00860487151386783	FN1	Mono/Macro	GSE207422_Sin_post	ENSG00000115414	2335	fibronectin 1	CIG|FINC|GFND2|LETS|MSF	protein_coding	P02751	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65828
3.66868860961533e-07	-0.268053275371219	0.914	0.956	0.00881108943371314	RPL9	Mono/Macro	GSE207422_Sin_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65829
3.71342281219651e-07	-0.404923243211731	0.583	0.698	0.00891852756805236	OLR1	Mono/Macro	GSE207422_Sin_post	ENSG00000173391	4973	oxidized low density lipoprotein receptor 1	CLEC8A|LOX-1|SCARE1	protein_coding	P78380	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65830
3.71477625731503e-07	-0.560540669205617	0.506	0.604	0.0089217781371935	MARCO	Mono/Macro	GSE207422_Sin_post	ENSG00000019169	8685	macrophage receptor with collagenous structure	SCARA2|SR-A6	protein_coding	Q9UEW3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65831
3.71640355206465e-07	0.30050996657592	0.371	0.176	0.00892568641099366	MGLL	Mono/Macro	GSE207422_Sin_post	ENSG00000074416	11343	monoglyceride lipase	HU-K5|MAGL|MGL	protein_coding	Q99685	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65832
3.81457913176147e-07	0.324942675095977	0.454	0.258	0.00916147470075151	MMP14	Mono/Macro	GSE207422_Sin_post	ENSG00000157227	4323	matrix metallopeptidase 14	MT1-MMP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65833
4.60319646798996e-07	0.257092323648536	0.432	0.22	0.0110554969571715	PTPN1	Mono/Macro	GSE207422_Sin_post	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65834
4.7166233469838e-07	-0.253230362132598	0.3	0.478	0.011327914292451	CAT	Mono/Macro	GSE207422_Sin_post	ENSG00000121691	847	catalase	NA	protein_coding	P04040	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65835
5.02169496628609e-07	-0.323974762389543	0.626	0.774	0.0120606048005293	COTL1	Mono/Macro	GSE207422_Sin_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65836
5.2428622168139e-07	-0.349728746276269	0.377	0.535	0.0125917821861219	YWHAH	Mono/Macro	GSE207422_Sin_post	ENSG00000128245	7533	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta	YWHA1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65837
5.46002440695407e-07	-0.287403844483529	0.944	0.975	0.0131133406181816	EIF1	Mono/Macro	GSE207422_Sin_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65838
5.57710856366969e-07	0.271089693022746	0.362	0.176	0.0133945416373655	TNS3	Mono/Macro	GSE207422_Sin_post	ENSG00000136205	64759	tensin 3	FLJ13732|H_NH0549I23.2|TEM6|TENS1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65839
6.54536446852233e-07	0.343649358552038	0.473	0.264	0.0157200018440501	ICAM1	Mono/Macro	GSE207422_Sin_post	ENSG00000090339	3383	intercellular adhesion molecule 1	BB2|CD54	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65840
6.64073134804719e-07	-0.356879707530578	0.982	0.943	0.0159490444786049	CST3	Mono/Macro	GSE207422_Sin_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65841
6.65017326528889e-07	-0.275973412772029	0.565	0.698	0.0159717211312443	RPL41	Mono/Macro	GSE207422_Sin_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65842
7.52605650873772e-07	-0.275929002392131	0.227	0.384	0.0180753299170354	NUPR1	Mono/Macro	GSE207422_Sin_post	ENSG00000176046	26471	nuclear protein 1, transcriptional regulator	COM1|p8	protein_coding	O60356	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65843
7.60660964933617e-07	0.25552898490503	0.363	0.17	0.0182687943948107	LRRC25	Mono/Macro	GSE207422_Sin_post	ENSG00000175489	126364	leucine rich repeat containing 25	FLJ38116|MAPA	protein_coding	Q8N386	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65844
7.67021799803473e-07	0.263205190919134	0.54	0.333	0.01842156256588	FAM49B	Mono/Macro	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65845
8.4741681188724e-07	0.291317385215562	0.654	0.484	0.0203524095710958	PDIA6	Mono/Macro	GSE207422_Sin_post	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65846
8.815626337154e-07	-0.465959988066484	0.315	0.478	0.0211724897739428	IER5	Mono/Macro	GSE207422_Sin_post	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65847
9.63280549378674e-07	-0.373607681091652	0.392	0.56	0.0231351089544276	LSP1	Mono/Macro	GSE207422_Sin_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65848
9.70787771789731e-07	-0.386789953211803	0.322	0.472	0.023315409915074	CD9	Mono/Macro	GSE207422_Sin_post	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65849
1.09316266140986e-06	-0.300210767504131	0.255	0.403	0.0262544876390805	CSTA	Mono/Macro	GSE207422_Sin_post	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65850
1.09453252477536e-06	0.479644888799698	0.603	0.447	0.0262873876475299	PNRC1	Mono/Macro	GSE207422_Sin_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65851
1.24179913838419e-06	-0.273422338625032	0.982	0.981	0.029824289906573	HLA-DPA1	Mono/Macro	GSE207422_Sin_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65852
1.24813058123523e-06	-0.414415757025146	0.21	0.358	0.0299763521695266	CD55	Mono/Macro	GSE207422_Sin_post	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65853
1.32030310192471e-06	-0.260015082796269	0.41	0.579	0.0317097195989258	EEF1B2	Mono/Macro	GSE207422_Sin_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65854
1.46717938756158e-06	-0.25484902203502	0.79	0.881	0.0352372473510665	RPL35A	Mono/Macro	GSE207422_Sin_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65855
1.48246194647497e-06	0.365343389455326	0.255	0.088	0.0356042885684893	SLC39A8	Mono/Macro	GSE207422_Sin_post	ENSG00000138821	64116	solute carrier family 39 member 8	BIGM103	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65856
1.69144218865844e-06	-0.387439543216291	0.519	0.692	0.0406233670450099	C1QA	Mono/Macro	GSE207422_Sin_post	ENSG00000173372	712	complement C1q A chain	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65857
1.6954480364359e-06	-0.438961322211387	0.679	0.824	0.040719575491081	PTPRC	Mono/Macro	GSE207422_Sin_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65858
1.75162222018047e-06	0.293648622196241	0.497	0.314	0.0420687108620744	DSE	Mono/Macro	GSE207422_Sin_post	ENSG00000111817	29940	dermatan sulfate epimerase	DS-Epi1|DSEPI|SART2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65859
1.75816931760233e-06	-0.478503189654122	0.7	0.78	0.0422259525008552	KLF6	Mono/Macro	GSE207422_Sin_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65860
1.95422586664905e-06	0.280517941493862	0.867	0.786	0.0469346426393102	CTSZ	Mono/Macro	GSE207422_Sin_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65861
2.03799430533134e-06	-0.285245911898963	0.492	0.642	0.0489465092311428	GPCPD1	Mono/Macro	GSE207422_Sin_post	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65862
2.04477358558755e-06	0.859013383607787	0.337	0.157	0.0491093272050561	G0S2	Mono/Macro	GSE207422_Sin_post	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65863
2.07059480303231e-06	0.254515033468059	0.375	0.195	0.049729475384427	PGAM1	Mono/Macro	GSE207422_Sin_post	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65864
1.17460228016955e-249	-1.14089557385168	0.059	0.537	2.82104229628321e-245	SCGB1A1	Neutrophils	GSE207422_Sin_post	ENSG00000149021	7356	secretoglobin family 1A member 1	CC10|CC16|CCSP|UGB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65865
1.22456509459771e-133	-1.81879594501554	0.275	0.752	2.94103798769532e-129	PTGS2	Neutrophils	GSE207422_Sin_post	ENSG00000073756	5743	prostaglandin-endoperoxide synthase 2	COX2	protein_coding	P35354	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65866
1.24902112280635e-118	-1.32414421524051	0.653	0.943	2.999774030644e-114	MNDA	Neutrophils	GSE207422_Sin_post	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65867
1.26230691832715e-117	-1.32821785647733	0.452	0.866	3.03168252574633e-113	KLF2	Neutrophils	GSE207422_Sin_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65868
4.79442070339825e-115	-1.14434853295613	0.259	0.709	1.15147602033516e-110	NCOA4	Neutrophils	GSE207422_Sin_post	ENSG00000266412	8031	nuclear receptor coactivator 4	ARA70|DKFZp762E1112|ELE1|PTC3|RFG	protein_coding	Q13772	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65869
7.25899536165647e-99	-1.34117500799615	0.692	0.958	1.74339291600903e-94	RGS2	Neutrophils	GSE207422_Sin_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65870
2.37220232980098e-85	-1.20586875076799	0.716	0.936	5.69731833548301e-81	C5AR1	Neutrophils	GSE207422_Sin_post	ENSG00000197405	728	complement C5a receptor 1	C5A|C5AR|C5R1|CD88	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65871
3.68801640928986e-77	-0.792630359965249	0.909	0.985	8.85750901019145e-73	FCGR3B	Neutrophils	GSE207422_Sin_post	ENSG00000162747	2215	Fc gamma receptor IIIb	CD16|CD16b|FCG3|FcgammaRIIIb|FCGR3|FcRIIIb	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65872
3.01402824693742e-75	-0.803679767842293	0.284	0.673	7.2387916406696e-71	JAML	Neutrophils	GSE207422_Sin_post	ENSG00000160593	120425	junction adhesion molecule like	AMICA|AMICA1|Gm638	protein_coding	Q86YT9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65873
3.93722999778962e-74	-1.25153191821269	0.311	0.675	9.45604528569133e-70	RHOB	Neutrophils	GSE207422_Sin_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65874
6.85175547887067e-73	1.22855117839579	0.77	0.486	1.64558611336037e-68	CLEC4E	Neutrophils	GSE207422_Sin_post	ENSG00000166523	26253	C-type lectin domain family 4 member E	CLECSF9|MINCLE	protein_coding	Q9ULY5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65875
4.47479386302944e-72	1.19846988582741	0.84	0.641	1.07471124208378e-67	ALOX5AP	Neutrophils	GSE207422_Sin_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65876
6.59294965068302e-70	1.58404670626154	0.882	0.639	1.58342871760454e-65	CXCR4	Neutrophils	GSE207422_Sin_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65877
2.61766485505898e-69	-0.966707193426178	0.542	0.86	6.28684568239515e-65	IER2	Neutrophils	GSE207422_Sin_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65878
2.89872264852578e-67	-1.01399201453271	0.708	0.915	6.96186218496437e-63	BTG2	Neutrophils	GSE207422_Sin_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65879
1.51898180252019e-65	1.30998503342115	0.481	0.07	3.64813859511273e-61	FKBP5	Neutrophils	GSE207422_Sin_post	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65880
4.92827894696185e-64	1.12803939808371	0.56	0.163	1.18362475469183e-59	GRINA	Neutrophils	GSE207422_Sin_post	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65881
1.34014850071996e-59	-0.700644874581151	0.203	0.527	3.21863465417914e-55	FGL2	Neutrophils	GSE207422_Sin_post	ENSG00000127951	10875	fibrinogen like 2	pT49|T49	protein_coding	Q14314	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65882
1.67930800337656e-55	1.06004467698945	0.871	0.658	4.03319403170949e-51	FCER1G	Neutrophils	GSE207422_Sin_post	ENSG00000158869	2207	Fc epsilon receptor Ig	FcepsilonRIgamma	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65883
4.75517355448047e-55	-0.817641125624974	0.334	0.667	1.14205003257958e-50	MYADM	Neutrophils	GSE207422_Sin_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65884
1.15445792693804e-51	-0.653112646656116	0.29	0.62	2.77266160312708e-47	PECAM1	Neutrophils	GSE207422_Sin_post	ENSG00000261371	5175	platelet and endothelial cell adhesion molecule 1	CD31	protein_coding	P16284	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65885
4.70813386636884e-51	-0.490583534630482	0.104	0.342	1.1307525106858e-46	LRMP	Neutrophils	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65886
4.77205275184871e-51	-0.539409710743913	0.098	0.325	1.1461039094115e-46	EGR3	Neutrophils	GSE207422_Sin_post	ENSG00000179388	1960	early growth response 3	PILOT	protein_coding	Q06889	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65887
7.4747161278901e-50	-0.58147484916509	0.984	0.994	1.79520257243537e-45	FOS	Neutrophils	GSE207422_Sin_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65888
1.02218405703231e-49	-0.675672550956978	0.27	0.584	2.45497944977451e-45	CPPED1	Neutrophils	GSE207422_Sin_post	ENSG00000103381	55313	calcineurin like phosphoesterase domain containing 1	CSTP1|FLJ11151	protein_coding	Q9BRF8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65889
2.20706825226005e-48	-0.651303766397324	0.679	0.943	5.30071582145297e-44	CXCR2	Neutrophils	GSE207422_Sin_post	ENSG00000180871	3579	C-X-C motif chemokine receptor 2	CD182|CMKAR2|IL8RB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65890
9.9017444647864e-48	-0.649882207308684	0.332	0.645	2.37810196810775e-43	RNASET2	Neutrophils	GSE207422_Sin_post	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65891
2.71383025028973e-47	0.83852694237657	0.691	0.342	6.51780611212084e-43	CTSB	Neutrophils	GSE207422_Sin_post	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65892
8.93450970680924e-47	-0.921750601601418	0.352	0.645	2.14580119628437e-42	LYZ	Neutrophils	GSE207422_Sin_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65893
4.05398609671952e-44	-0.697176983063475	0.297	0.611	9.73645840849126e-40	S100A4	Neutrophils	GSE207422_Sin_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65894
3.31783274838232e-43	-0.681011728585314	0.198	0.469	7.96843891178981e-39	TUBA1A	Neutrophils	GSE207422_Sin_post	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65895
7.41562865437848e-43	-0.636704006128063	0.34	0.631	1.78101153392208e-38	CMTM2	Neutrophils	GSE207422_Sin_post	ENSG00000140932	146225	CKLF like MARVEL transmembrane domain containing 2	CKLFSF2|FLJ25732|MGC39436	protein_coding	Q8TAZ6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65896
8.46206754554424e-43	-0.609770284495235	0.325	0.633	2.03233476241336e-38	CLEC7A	Neutrophils	GSE207422_Sin_post	ENSG00000172243	64581	C-type lectin domain containing 7A	CD369|CLECSF12|DECTIN-1|hDectin-1|SCARE2	protein_coding	Q9BXN2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65897
9.51114219754114e-43	1.05479933377454	0.838	0.52	2.28429102158346e-38	HLA-DRA	Neutrophils	GSE207422_Sin_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65898
7.15043495239416e-42	0.897284978406323	0.79	0.497	1.7173199625165e-37	NFKBIA	Neutrophils	GSE207422_Sin_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65899
8.33518429516008e-42	-0.549283601735365	0.908	0.975	2.0018612121686e-37	CTSS	Neutrophils	GSE207422_Sin_post	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65900
1.22339982097157e-41	-0.592711204933289	0.586	0.868	2.93823935002743e-37	ARHGDIB	Neutrophils	GSE207422_Sin_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65901
5.641964373059e-41	-0.565188975371952	0.974	0.994	1.35503058347758e-36	JUNB	Neutrophils	GSE207422_Sin_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65902
7.88610488445969e-39	-0.411375177353972	0.134	0.365	1.89400581010068e-34	PIK3CD	Neutrophils	GSE207422_Sin_post	ENSG00000171608	5293	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta	p110D	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65903
5.01525144167471e-37	-0.539690093102157	0.27	0.548	1.20451293874701e-32	RAB11FIP1	Neutrophils	GSE207422_Sin_post	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65904
1.50680252384425e-36	-1.0506422748914	0.177	0.393	3.61888762151674e-32	PROK2	Neutrophils	GSE207422_Sin_post	ENSG00000163421	60675	prokineticin 2	BV8|KAL4|MIT1|PK2	protein_coding	Q9HC23	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65905
5.96625702542312e-36	-0.645212060627844	0.739	0.913	1.43291594979587e-31	ZFP36L1	Neutrophils	GSE207422_Sin_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65906
6.0674291596785e-36	0.88277019478844	0.357	0.068	1.45721446127999e-31	CCRL2	Neutrophils	GSE207422_Sin_post	ENSG00000121797	9034	C-C motif chemokine receptor like 2	ACKR5|CKRX|CRAM-A|CRAM-B|HCR	protein_coding	O00421	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65907
6.8601521498436e-35	0.782867802751383	0.486	0.212	1.64760274182794e-30	TRIM22	Neutrophils	GSE207422_Sin_post	ENSG00000132274	10346	tripartite motif containing 22	GPSTAF50|RNF94|STAF50	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65908
3.07023772939914e-34	0.713829724574835	0.597	0.338	7.37378995469791e-30	SMIM25	Neutrophils	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65909
6.50644368977872e-34	-0.422624888630025	1	1	1.56265258097415e-29	ACTB	Neutrophils	GSE207422_Sin_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65910
8.59338080144097e-34	-0.478823060051255	0.204	0.448	2.06387226708208e-29	BAZ2B	Neutrophils	GSE207422_Sin_post	ENSG00000123636	29994	bromodomain adjacent to zinc finger domain 2B	WALp4	protein_coding	Q9UIF8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65911
1.13036488135562e-33	0.906122053136928	0.463	0.178	2.71479733555178e-29	TNFAIP3	Neutrophils	GSE207422_Sin_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65912
4.93327369982983e-33	-0.468147672315433	0.411	0.732	1.18482434448813e-28	VNN2	Neutrophils	GSE207422_Sin_post	ENSG00000112303	8875	vanin 2	FOAP-4|GPI-80	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65913
5.08841327039502e-32	-0.59557707767448	0.616	0.837	1.22208421515077e-27	TAGLN2	Neutrophils	GSE207422_Sin_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65914
6.72666828707367e-32	1.0359019317523	0.606	0.41	1.61554392250648e-27	IL1R2	Neutrophils	GSE207422_Sin_post	ENSG00000115590	7850	interleukin 1 receptor type 2	CD121b|IL1RB	protein_coding	P27930	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65915
2.84956718579626e-31	-0.283041217730682	0.109	0.301	6.84380551012689e-27	C16orf54	Neutrophils	GSE207422_Sin_post	ENSG00000185905	283897	chromosome 16 open reading frame 54	FLJ35681	protein_coding	Q6UWD8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65916
7.06065930676107e-31	-0.403826764340001	0.889	0.979	1.69575854570481e-26	S100A9	Neutrophils	GSE207422_Sin_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65917
1.30289257500676e-30	-0.423137495959069	0.194	0.425	3.12915709739373e-26	LTB	Neutrophils	GSE207422_Sin_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65918
2.74128923202849e-30	-0.461658269743194	0.594	0.845	6.58375434856283e-26	VMP1	Neutrophils	GSE207422_Sin_post	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65919
4.77083561054079e-30	0.706564252491526	0.252	0.019	1.14581158858358e-25	ANKRD22	Neutrophils	GSE207422_Sin_post	ENSG00000152766	118932	ankyrin repeat domain 22	MGC22805	protein_coding	Q5VYY1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65920
5.21812426845739e-30	0.713683704805944	0.475	0.214	1.25323690555541e-25	PLSCR1	Neutrophils	GSE207422_Sin_post	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65921
7.71721816099974e-30	0.578965022341553	0.781	0.654	1.85344428572731e-25	CD53	Neutrophils	GSE207422_Sin_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65922
9.33127361114779e-30	-0.751172986519073	0.468	0.69	2.24109198318936e-25	EGR1	Neutrophils	GSE207422_Sin_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65923
1.24169964465458e-29	0.786637923919432	0.569	0.34	2.98219003656691e-25	CXCL16	Neutrophils	GSE207422_Sin_post	ENSG00000161921	58191	C-X-C motif chemokine ligand 16	CXCLG16|SR-PSOX|SRPSOX	protein_coding	Q9H2A7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65924
3.72532834181372e-29	0.44916047857878	0.783	0.478	8.94712107853401e-25	PTMA	Neutrophils	GSE207422_Sin_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65925
4.56359962933801e-29	-0.563588728328531	0.259	0.503	1.09603972297811e-24	MME	Neutrophils	GSE207422_Sin_post	ENSG00000196549	4311	membrane metalloendopeptidase	CALLA|CD10|NEP	protein_coding	P08473	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65926
7.81957053137896e-29	-0.495382185816582	0.306	0.548	1.87802625452129e-24	FCGR3A	Neutrophils	GSE207422_Sin_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65927
1.65260463808184e-28	0.635807746320873	0.431	0.166	3.96906055928115e-24	SAMSN1	Neutrophils	GSE207422_Sin_post	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65928
3.0287694945551e-28	0.691475814362469	0.512	0.293	7.27419569507297e-24	PHC2	Neutrophils	GSE207422_Sin_post	ENSG00000134686	1912	polyhomeotic homolog 2	EDR2|HPH2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65929
4.50379399522998e-28	-0.289460126162314	0.089	0.253	1.08167620383438e-23	NLRP1	Neutrophils	GSE207422_Sin_post	ENSG00000091592	22861	NLR family pyrin domain containing 1	CARD7|CLR17.1|DEFCAP|DKFZp586O1822|KIAA0926|NAC|NALP1|SLEV1|VAMAS1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65930
5.64392820208375e-28	-0.477261671167934	0.346	0.594	1.35550223629445e-23	CORO1A	Neutrophils	GSE207422_Sin_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65931
9.82977534474966e-28	0.843936090643854	0.295	0.059	2.36081714454853e-23	CDKN1A	Neutrophils	GSE207422_Sin_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65932
1.20635935285915e-27	-0.441447931769145	0.131	0.314	2.89731325776181e-23	MID1IP1	Neutrophils	GSE207422_Sin_post	ENSG00000165175	58526	MID1 interacting protein 1	FLJ10386|G12-like|MIG12|STRAIT11499|THRSPL	protein_coding	Q9NPA3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65933
1.38856366206114e-27	-0.465658081399491	0.625	0.851	3.33491334717225e-23	EVI2B	Neutrophils	GSE207422_Sin_post	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65934
5.09921965907777e-27	-0.418833952810325	0.795	0.941	1.22467958552071e-22	SPI1	Neutrophils	GSE207422_Sin_post	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65935
8.59699259345838e-27	-0.273655950824108	1	1	2.0647397111709e-22	MT-RNR2	Neutrophils	GSE207422_Sin_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65936
1.44269032096722e-26	-0.346831899301739	0.11	0.278	3.46490934386696e-22	CEP63	Neutrophils	GSE207422_Sin_post	ENSG00000182923	80254	centrosomal protein 63	FLJ13386	protein_coding	Q96MT8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65937
2.14402080029983e-26	0.289984151636938	1	1	5.14929475608009e-22	B2M	Neutrophils	GSE207422_Sin_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65938
2.96288151277303e-26	-0.372328505510786	0.153	0.352	7.11595252922698e-22	TMX4	Neutrophils	GSE207422_Sin_post	ENSG00000125827	56255	thioredoxin related transmembrane protein 4	DJ971N18.2|KIAA1162|PDIA14|TXNDC13	protein_coding	Q9H1E5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65939
3.87476331237628e-26	-0.491514799642309	0.446	0.677	9.30601904733411e-22	TMEM154	Neutrophils	GSE207422_Sin_post	ENSG00000170006	201799	transmembrane protein 154	FLJ32028	protein_coding	Q6P9G4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65940
4.61354143555699e-26	0.626480614800329	0.49	0.278	1.10803424657772e-21	FLOT1	Neutrophils	GSE207422_Sin_post	ENSG00000223654	10211	flotillin 1	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65941
5.42691339155176e-26	-0.451394173439245	0.437	0.669	1.30338178924899e-21	COTL1	Neutrophils	GSE207422_Sin_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65942
2.16579909589797e-25	0.73084623622675	0.513	0.272	5.20159968861814e-21	IER3	Neutrophils	GSE207422_Sin_post	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65943
3.41327911638811e-25	-0.451298205356589	0.209	0.416	8.19767245382932e-21	GLIPR1	Neutrophils	GSE207422_Sin_post	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65944
4.95383588530131e-25	-0.385510257289896	0.228	0.45	1.18976276457282e-20	SLC44A2	Neutrophils	GSE207422_Sin_post	ENSG00000129353	57153	solute carrier family 44 member 2	CTL2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65945
6.99267521760253e-25	-0.406882720648868	0.165	0.359	1.6794308070116e-20	ATP2B1	Neutrophils	GSE207422_Sin_post	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65946
9.58028860355976e-25	-0.46609755198985	0.212	0.418	2.30089791391695e-20	LIMD2	Neutrophils	GSE207422_Sin_post	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65947
2.25048616966472e-24	-0.500608870641509	0.511	0.728	5.40499263368376e-20	MYO1F	Neutrophils	GSE207422_Sin_post	ENSG00000142347	4542	myosin IF	NA	protein_coding	O00160	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65948
2.40347680451896e-24	-0.418577791000489	0.688	0.858	5.77243024141318e-20	CNN2	Neutrophils	GSE207422_Sin_post	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65949
2.73222271265533e-24	-0.435078392464645	0.378	0.616	6.56197928898431e-20	LRRFIP1	Neutrophils	GSE207422_Sin_post	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65950
8.91181097561814e-24	-0.344617330126788	0.269	0.51	2.14034964201421e-19	ICAM3	Neutrophils	GSE207422_Sin_post	ENSG00000076662	3385	intercellular adhesion molecule 3	CD50|CDW50|ICAM-R	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65951
1.80524633671097e-23	-0.318339683413127	0.175	0.359	4.33566012687873e-19	C15orf39	Neutrophils	GSE207422_Sin_post	ENSG00000167173	56905	chromosome 15 open reading frame 39	DKFZP434H132|FLJ46337	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65952
5.54242305511065e-23	-0.495856366606681	0.283	0.488	1.33112374514593e-18	FRAT2	Neutrophils	GSE207422_Sin_post	ENSG00000181274	23401	FRAT regulator of WNT signaling pathway 2	NA	protein_coding	O75474	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65953
5.57733538375962e-23	-0.399946343435551	0.945	0.983	1.33950863911755e-18	ZFP36	Neutrophils	GSE207422_Sin_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65954
6.40352093810307e-23	0.86413847691677	0.259	0.057	1.53793362370421e-18	C15orf48	Neutrophils	GSE207422_Sin_post	ENSG00000166920	84419	chromosome 15 open reading frame 48	COXFA4L3|MIR147BHG|MISTRAV|MOCCI|NMES1	protein_coding	Q9C002	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65955
1.0588756320193e-22	-0.373225788936032	0.194	0.391	2.54310160542076e-18	CDA	Neutrophils	GSE207422_Sin_post	ENSG00000158825	978	cytidine deaminase	CDD	protein_coding	P32320	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65956
1.06197703082892e-22	0.524120116060856	0.895	0.817	2.55055023494182e-18	CEBPB	Neutrophils	GSE207422_Sin_post	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65957
1.56117987772146e-22	-0.287713093268915	0.122	0.287	3.74948571232362e-18	HSH2D	Neutrophils	GSE207422_Sin_post	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65958
2.02795036562807e-22	0.505489072632719	0.269	0.066	4.87052839312894e-18	RAB20	Neutrophils	GSE207422_Sin_post	ENSG00000139832	55647	RAB20, member RAS oncogene family	FLJ20429	protein_coding	Q9NX57	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65959
2.07394087824309e-22	0.571746242292603	0.697	0.567	4.98098380727642e-18	BRI3	Neutrophils	GSE207422_Sin_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65960
2.21632028336069e-22	-0.253913891334423	0.102	0.259	5.32293642454736e-18	CLEC12A	Neutrophils	GSE207422_Sin_post	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65961
3.63699291223311e-22	-0.275370018804757	0.175	0.355	8.73496587731026e-18	TNFRSF10C	Neutrophils	GSE207422_Sin_post	ENSG00000173535	8794	TNF receptor superfamily member 10c	CD263|DcR1|LIT|TRAILR3|TRID	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65962
1.66265120958706e-21	-0.320674518238757	0.213	0.416	3.99318941006523e-17	PBX2	Neutrophils	GSE207422_Sin_post	ENSG00000236353	5089	PBX homeobox 2	G17|HOX12|PBX2MHC	protein_coding	P40425	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65963
1.95661600245059e-21	0.57634756510431	0.306	0.1	4.69920465308559e-17	BHLHE40	Neutrophils	GSE207422_Sin_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65964
2.68145634839371e-21	-0.352448491275315	0.15	0.312	6.44005371193717e-17	CYP4F3	Neutrophils	GSE207422_Sin_post	ENSG00000186529	4051	cytochrome P450 family 4 subfamily F member 3	CYP4F|LTB4H	protein_coding	Q08477	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65965
4.63326994323688e-21	-0.432142242256519	0.555	0.766	1.1127724422672e-16	SMCHD1	Neutrophils	GSE207422_Sin_post	ENSG00000101596	23347	structural maintenance of chromosomes flexible hinge domain containing 1	FSHD2|KIAA0650	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65966
4.66887136147765e-21	-0.272850820022281	0.155	0.325	1.12132283488609e-16	FAM8A1	Neutrophils	GSE207422_Sin_post	ENSG00000137414	51439	family with sequence similarity 8 member A1	AHCP	protein_coding	Q9UBU6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65967
4.84485500645096e-21	0.632363603004818	0.478	0.297	1.16358882689933e-16	CPD	Neutrophils	GSE207422_Sin_post	ENSG00000108582	1362	carboxypeptidase D	GP180	protein_coding	O75976	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65968
6.87153526102893e-21	0.471212562547346	0.257	0.068	1.65033662364132e-16	IRAK3	Neutrophils	GSE207422_Sin_post	ENSG00000090376	11213	interleukin 1 receptor associated kinase 3	IRAK-M	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65969
7.72682687619275e-21	-0.374741652326668	0.228	0.431	1.85575201085521e-16	JMJD1C	Neutrophils	GSE207422_Sin_post	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65970
8.77877625134454e-21	-0.420656413956745	0.288	0.499	2.10839869228542e-16	NCF1C	Neutrophils	GSE207422_Sin_post	ENSG00000165178	654817	neutrophil cytosolic factor 1C pseudogene	SH3PXD1C	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65971
1.2145552677872e-20	0.568307297952751	0.632	0.465	2.91699738664451e-16	SLA	Neutrophils	GSE207422_Sin_post	ENSG00000155926	6503	Src like adaptor	hSLAP|SLA1|SLAP|SLAP-1	protein_coding	Q13239	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65972
1.48159075220361e-20	0.619854424639966	0.523	0.329	3.55833650956742e-16	GRN	Neutrophils	GSE207422_Sin_post	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65973
1.4957478131301e-20	-0.450663134489115	0.382	0.588	3.59233752279457e-16	YPEL5	Neutrophils	GSE207422_Sin_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65974
1.92549490763765e-20	-0.441497404786969	0.829	0.915	4.62446111967335e-16	G0S2	Neutrophils	GSE207422_Sin_post	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65975
2.49891407210531e-20	-0.496989202264691	0.163	0.327	6.00164192697533e-16	IFRD1	Neutrophils	GSE207422_Sin_post	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65976
8.1648389214909e-20	-0.31321863847676	0.179	0.357	1.96094936377447e-15	FKBP8	Neutrophils	GSE207422_Sin_post	ENSG00000105701	23770	FKBP prolyl isomerase 8	FKBP38|FKBPr38	protein_coding	Q14318	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65977
8.76919152190727e-20	-0.286855232866559	0.188	0.374	2.10609672781647e-15	BIN2	Neutrophils	GSE207422_Sin_post	ENSG00000110934	51411	bridging integrator 2	BRAP-1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65978
9.00693252489976e-20	-0.388043492085568	0.52	0.73	2.16319498450518e-15	WIPF1	Neutrophils	GSE207422_Sin_post	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65979
1.18269719906283e-19	-0.293932728960052	0.132	0.289	2.84048386298921e-15	EGLN1	Neutrophils	GSE207422_Sin_post	ENSG00000135766	54583	egl-9 family hypoxia inducible factor 1	C1orf12|HIFPH2|PHD2|SM-20|ZMYND6	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65980
1.21000759971914e-19	-0.33587869179872	0.229	0.433	2.90607525224545e-15	USP10	Neutrophils	GSE207422_Sin_post	ENSG00000103194	9100	ubiquitin specific peptidase 10	KIAA0190|UBPO	protein_coding	Q14694	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65981
1.47490170443969e-19	-0.389145928196026	0.28	0.484	3.54227142355281e-15	CREB5	Neutrophils	GSE207422_Sin_post	ENSG00000146592	9586	cAMP responsive element binding protein 5	CRE-BPA|H_GS165L15.1	protein_coding	Q02930	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65982
2.39076477682649e-19	-0.370101099429112	0.282	0.486	5.74189976450419e-15	GRK2	Neutrophils	GSE207422_Sin_post	ENSG00000173020	156	G protein-coupled receptor kinase 2	ADRBK1|BARK1	protein_coding	P25098	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65983
2.44322593987509e-19	-0.346408118725242	0.547	0.796	5.867895739798e-15	CXCR1	Neutrophils	GSE207422_Sin_post	ENSG00000163464	3577	C-X-C motif chemokine receptor 1	CD181|CDw128a|CKR-1|CMKAR1|IL8RA	protein_coding	P25024	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65984
6.50401024223387e-19	0.573661854419606	0.634	0.427	1.56206813987731e-14	IFI6	Neutrophils	GSE207422_Sin_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65985
1.16745873510282e-18	-0.367374446425456	0.462	0.688	2.80388564409644e-14	TALDO1	Neutrophils	GSE207422_Sin_post	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65986
1.24668584831989e-18	-0.269432616045879	0.12	0.268	2.99416540190989e-14	ANPEP	Neutrophils	GSE207422_Sin_post	ENSG00000166825	290	alanyl aminopeptidase, membrane	AP-N|CD13|gp150|hAPN|LAP1|p150|PEPN	protein_coding	P15144	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65987
1.5921729894678e-18	0.547269989895361	0.472	0.282	3.82392186880482e-14	WSB1	Neutrophils	GSE207422_Sin_post	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65988
1.7456380637859e-18	-0.395785942089178	0.605	0.79	4.1924989377946e-14	ZYX	Neutrophils	GSE207422_Sin_post	ENSG00000285443	7791	zyxin	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65989
1.8075636734305e-18	-0.407817933563922	0.453	0.656	4.34122567447803e-14	LST1	Neutrophils	GSE207422_Sin_post	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65990
1.91807166076139e-18	0.476135085288382	0.861	0.82	4.60663270765062e-14	SERPINA1	Neutrophils	GSE207422_Sin_post	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65991
3.0385169198057e-18	0.515679986622701	0.56	0.414	7.29760608629735e-14	TLR2	Neutrophils	GSE207422_Sin_post	ENSG00000137462	7097	toll like receptor 2	CD282|TIL4	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65992
3.82263804676154e-18	-0.322391904496661	0.293	0.499	9.1808297969072e-14	ARHGAP25	Neutrophils	GSE207422_Sin_post	ENSG00000163219	9938	Rho GTPase activating protein 25	KIAA0053	protein_coding	P42331	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65993
4.71568434616712e-18	-0.305004300416054	0.253	0.452	1.13256590941896e-13	PAK1	Neutrophils	GSE207422_Sin_post	ENSG00000149269	5058	p21 (RAC1) activated kinase 1	NA	protein_coding	Q13153	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65994
8.34978179444646e-18	0.48049776412242	0.531	0.365	2.00536709357221e-13	IFNGR1	Neutrophils	GSE207422_Sin_post	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65995
1.03654830573792e-17	-0.408757258809767	0.686	0.803	2.48947806589077e-13	JUND	Neutrophils	GSE207422_Sin_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65996
1.22845614376496e-17	-0.297976882560489	0.121	0.261	2.95038312048031e-13	ASAP1	Neutrophils	GSE207422_Sin_post	ENSG00000153317	50807	ArfGAP with SH3 domain, ankyrin repeat and PH domain 1	CENTB4|DDEF1|KIAA1249|PAP|ZG14P	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65997
2.33895171215787e-17	-0.441934210526724	0.44	0.628	5.61746032708955e-13	FOSB	Neutrophils	GSE207422_Sin_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65998
3.14059426156597e-17	-0.304786606627856	0.239	0.427	7.54276523800298e-13	FBXL5	Neutrophils	GSE207422_Sin_post	ENSG00000118564	26234	F-box and leucine rich repeat protein 5	FBL4|FBL5|FLR1	protein_coding	Q9UKA1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	65999
5.28509218203428e-17	0.41566460959868	0.92	0.894	1.26932058935917e-12	LAPTM5	Neutrophils	GSE207422_Sin_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66000
5.5440680366608e-17	0.633712674031744	0.391	0.21	1.33151882036482e-12	CYBB	Neutrophils	GSE207422_Sin_post	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66001
7.77663501087343e-17	-0.329063864273225	0.543	0.735	1.86771443056147e-12	RTN3	Neutrophils	GSE207422_Sin_post	ENSG00000133318	10313	reticulon 3	ASYIP|HAP|NSPL2|NSPLII|RTN3-A1	protein_coding	O95197	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66002
8.18506883753307e-17	-0.321924494205524	0.263	0.446	1.96580798271032e-12	SF1	Neutrophils	GSE207422_Sin_post	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66003
9.04794652841086e-17	-0.295326754334226	0.132	0.276	2.17304531772844e-12	EMP3	Neutrophils	GSE207422_Sin_post	ENSG00000142227	2014	epithelial membrane protein 3	YMP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66004
1.08703689186125e-16	-0.333548333402967	0.287	0.48	2.61073650318316e-12	MIDN	Neutrophils	GSE207422_Sin_post	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66005
1.09959670082262e-16	0.315285499588137	0.619	0.38	2.64090139636568e-12	RPS6	Neutrophils	GSE207422_Sin_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66006
1.14926811787304e-16	-0.338759295982756	0.372	0.577	2.76019723869568e-12	ARHGAP9	Neutrophils	GSE207422_Sin_post	ENSG00000123329	64333	Rho GTPase activating protein 9	10C|MGC1295	protein_coding	Q9BRR9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66007
1.38390948327748e-16	-0.300861756719823	0.154	0.306	3.32373540598753e-12	LAMTOR4	Neutrophils	GSE207422_Sin_post	ENSG00000188186	389541	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4	C7orf59	protein_coding	Q0VGL1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66008
1.41438093862698e-16	-0.353290036359781	0.292	0.478	3.39691870030042e-12	SRSF5	Neutrophils	GSE207422_Sin_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66009
2.22589281607612e-16	0.719635020653238	0.629	0.518	5.34592677637001e-12	CEBPD	Neutrophils	GSE207422_Sin_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66010
2.23106943333097e-16	0.579351939977328	0.951	0.947	5.35835945803099e-12	TXNIP	Neutrophils	GSE207422_Sin_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66011
2.37367012731571e-16	-0.369259656096405	0.623	0.788	5.70084354477413e-12	GNAI2	Neutrophils	GSE207422_Sin_post	ENSG00000114353	2771	G protein subunit alpha i2	GIP|GNAI2B	protein_coding	P04899	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66012
2.52767699921686e-16	0.589232093098817	0.388	0.208	6.07072184901914e-12	GBP4	Neutrophils	GSE207422_Sin_post	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66013
2.58945272200505e-16	-0.329281261019086	0.423	0.633	6.21908860243952e-12	MSL1	Neutrophils	GSE207422_Sin_post	ENSG00000188895	339287	MSL complex subunit 1	DKFZp686P24239|hMSL1|MSL-1	protein_coding	Q68DK7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66014
2.91259174623493e-16	-0.368840426206459	0.289	0.471	6.99517159693243e-12	OSBPL8	Neutrophils	GSE207422_Sin_post	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66015
3.35235150608387e-16	-0.345093061693166	0.429	0.628	8.05134261216163e-12	MSN	Neutrophils	GSE207422_Sin_post	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66016
3.39760253331089e-16	0.37643414841079	0.309	0.127	8.16002200425278e-12	RPS19	Neutrophils	GSE207422_Sin_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66017
4.81452616843556e-16	-0.318929637874175	0.735	0.913	1.15630474987317e-11	SELL	Neutrophils	GSE207422_Sin_post	ENSG00000188404	6402	selectin L	CD62L|hLHRc|LAM-1|LAM1|Leu-8|LNHR|LSEL|Lyam-1|LYAM1|PLNHR	protein_coding	P14151	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66018
5.58814472389984e-16	-0.347035167602674	0.321	0.514	1.34210471833902e-11	LYST	Neutrophils	GSE207422_Sin_post	ENSG00000143669	1130	lysosomal trafficking regulator	CHS|CHS1|Mauve	protein_coding	Q99698	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66019
5.68877609207552e-16	0.487454502242302	0.432	0.261	1.36627335403378e-11	IRS2	Neutrophils	GSE207422_Sin_post	ENSG00000185950	8660	insulin receptor substrate 2	NA	protein_coding	Q9Y4H2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66020
6.50954311751511e-16	-0.567740526668299	0.241	0.393	1.5633969705336e-11	DUSP6	Neutrophils	GSE207422_Sin_post	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66021
1.1334386028475e-15	-0.254693160745336	0.165	0.323	2.72217949245885e-11	UBN1	Neutrophils	GSE207422_Sin_post	ENSG00000118900	29855	ubinuclein 1	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66022
1.14136576786203e-15	-0.270728313168821	0.214	0.369	2.74121816467423e-11	RASGRP4	Neutrophils	GSE207422_Sin_post	ENSG00000171777	115727	RAS guanyl releasing protein 4	NA	protein_coding	Q8TDF6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66023
1.22032809191801e-15	-0.285752128556243	0.226	0.399	2.93086197835948e-11	OAZ2	Neutrophils	GSE207422_Sin_post	ENSG00000180304	4947	ornithine decarboxylase antizyme 2	NA	protein_coding	O95190	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66024
1.26575282079418e-15	-0.352054268638844	0.718	0.851	3.03995854970138e-11	YPEL3	Neutrophils	GSE207422_Sin_post	ENSG00000090238	83719	yippee like 3	MGC10500	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66025
1.44882761059788e-15	-0.318317080690734	0.235	0.41	3.47964927237292e-11	SELPLG	Neutrophils	GSE207422_Sin_post	ENSG00000110876	6404	selectin P ligand	CD162|PSGL-1	protein_coding	Q14242	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66026
1.55383866216037e-15	-0.299387242227856	0.34	0.541	3.73185431491057e-11	RASSF2	Neutrophils	GSE207422_Sin_post	ENSG00000101265	9770	Ras association domain family member 2	CENP-34|KIAA0168	protein_coding	P50749	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66027
1.80993838271807e-15	-0.265418411651771	0.146	0.282	4.346929013774e-11	RAB3D	Neutrophils	GSE207422_Sin_post	ENSG00000105514	9545	RAB3D, member RAS oncogene family	D2-2|GOV|RAB16|RAD3D	protein_coding	O95716	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66028
2.06959627122719e-15	0.480104980780639	0.344	0.178	4.97054936460633e-11	SKIL	Neutrophils	GSE207422_Sin_post	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66029
2.39907526350417e-15	-0.346838526267297	0.458	0.645	5.76185906035797e-11	S100A6	Neutrophils	GSE207422_Sin_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66030
2.54701044197236e-15	0.46982382126162	0.427	0.265	6.11715497848501e-11	GK	Neutrophils	GSE207422_Sin_post	ENSG00000198814	2710	glycerol kinase	GK1|GKD	protein_coding	P32189	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66031
2.71440039454839e-15	-0.441311429030686	0.66	0.82	6.51917542758687e-11	BASP1	Neutrophils	GSE207422_Sin_post	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66032
4.17386245817719e-15	-0.30833112434741	0.28	0.461	1.00243654658042e-10	MBP	Neutrophils	GSE207422_Sin_post	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66033
5.74786898609097e-15	0.292788432432775	0.794	0.544	1.38046569438947e-10	RPS29	Neutrophils	GSE207422_Sin_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66034
6.64805424712438e-15	-0.400690569009068	0.461	0.628	1.59666318853186e-10	BOD1L1	Neutrophils	GSE207422_Sin_post	ENSG00000038219	259282	biorientation of chromosomes in cell division 1 like 1	BOD1L|FAM44A|FLJ33215|KIAA1327	protein_coding	Q8NFC6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66035
7.57877135654351e-15	0.694499053079957	0.345	0.183	1.82019351670105e-10	IGKC	Neutrophils	GSE207422_Sin_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66036
1.00074349989848e-14	0.674878103096711	0.53	0.372	2.40348566370619e-10	GBP5	Neutrophils	GSE207422_Sin_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66037
1.74626631103194e-14	0.479935074866856	0.25	0.102	4.19400779920541e-10	MCEMP1	Neutrophils	GSE207422_Sin_post	ENSG00000183019	199675	mast cell expressed membrane protein 1	C19orf59|MGC132456	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66038
2.27673447901966e-14	0.603697807974781	0.299	0.142	5.46803319826152e-10	CCL4L2	Neutrophils	GSE207422_Sin_post	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66039
2.60477301534957e-14	-0.323548699544139	0.666	0.817	6.25588335096505e-10	WAS	Neutrophils	GSE207422_Sin_post	ENSG00000015285	7454	WASP actin nucleation promoting factor	IMD2|THC|WASP|WASPA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66040
2.73164245631401e-14	0.621106914040558	0.865	0.864	6.56058568732935e-10	IFITM3	Neutrophils	GSE207422_Sin_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66041
3.05669206934249e-14	-0.29760969987481	0.262	0.433	7.34125734293985e-10	STAT6	Neutrophils	GSE207422_Sin_post	ENSG00000166888	6778	signal transducer and activator of transcription 6	D12S1644|IL-4-STAT	protein_coding	P42226	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66042
3.20609245140463e-14	0.354825621386252	0.616	0.414	7.70007224053851e-10	RPS27A	Neutrophils	GSE207422_Sin_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66043
3.73430951797802e-14	0.391227006084879	0.289	0.134	8.96869116932781e-10	MKNK1	Neutrophils	GSE207422_Sin_post	ENSG00000079277	8569	MAPK interacting serine/threonine kinase 1	MNK1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66044
4.60759667194272e-14	0.379507136913518	0.5	0.323	1.10660649270048e-09	IFI16	Neutrophils	GSE207422_Sin_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66045
6.02505479052204e-14	-0.31777198685722	0.192	0.338	1.44703740903968e-09	CHMP1B	Neutrophils	GSE207422_Sin_post	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66046
6.48635067424015e-14	0.420915682734026	0.366	0.212	1.55782684143226e-09	CYSTM1	Neutrophils	GSE207422_Sin_post	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66047
7.15313727783443e-14	-0.358735846288608	0.396	0.577	1.7179689800175e-09	OGFRL1	Neutrophils	GSE207422_Sin_post	ENSG00000119900	79627	opioid growth factor receptor like 1	dJ331H24.1	protein_coding	Q5TC84	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66048
8.7345844727598e-14	-0.28102971831384	0.299	0.478	2.09778515282272e-09	APBB1IP	Neutrophils	GSE207422_Sin_post	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66049
9.50051307422369e-14	-0.288445494352382	0.164	0.301	2.2817382250363e-09	FAM120A	Neutrophils	GSE207422_Sin_post	ENSG00000048828	23196	family with sequence similarity 120A	C9orf10|KIAA0183|OSSA	protein_coding	Q9NZB2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66050
2.18048062659308e-13	-0.293968071100021	0.301	0.478	5.23686032088861e-09	TKT	Neutrophils	GSE207422_Sin_post	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66051
2.23614610075259e-13	-0.278792440799672	0.482	0.679	5.3705520901775e-09	CSF2RB	Neutrophils	GSE207422_Sin_post	ENSG00000100368	1439	colony stimulating factor 2 receptor subunit beta	betaGMR|CD131|IL3RB|IL5RB	protein_coding	P32927	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66052
2.34688527237608e-13	0.406878812592094	0.253	0.106	5.63651435866563e-09	ABCA1	Neutrophils	GSE207422_Sin_post	ENSG00000165029	19	ATP binding cassette subfamily A member 1	ABC1|HDLDT1|TGD	protein_coding	O95477	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66053
3.41892429909635e-13	-0.279471562962706	0.574	0.754	8.2112304891397e-09	FMNL1	Neutrophils	GSE207422_Sin_post	ENSG00000184922	752	formin like 1	C17orf1|C17orf1B|FMNL	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66054
3.54395902149044e-13	-0.278901948014335	0.324	0.503	8.51152638191358e-09	TAGAP	Neutrophils	GSE207422_Sin_post	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66055
3.56238959698226e-13	-0.31704494455807	0.499	0.684	8.5557910950723e-09	LRRK2	Neutrophils	GSE207422_Sin_post	ENSG00000188906	120892	leucine rich repeat kinase 2	DKFZp434H2111|FLJ45829|PARK8|RIPK7|ROCO2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66056
6.19898007790088e-13	0.353440756639844	0.472	0.285	1.48880904530945e-08	TMSB10	Neutrophils	GSE207422_Sin_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66057
1.13078423125384e-12	-0.321583655177069	0.65	0.794	2.71580448820234e-08	NCF2	Neutrophils	GSE207422_Sin_post	ENSG00000116701	4688	neutrophil cytosolic factor 2	NOXA2|p67phox	protein_coding	P19878	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66058
1.47565512776689e-12	-0.382324128591452	0.204	0.34	3.54408092035773e-08	PIM2	Neutrophils	GSE207422_Sin_post	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66059
1.98413294857367e-12	-0.282456386361977	0.319	0.48	4.76529210258939e-08	FCGRT	Neutrophils	GSE207422_Sin_post	ENSG00000104870	2217	Fc gamma receptor and transporter	FcgammaRn|FcRn	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66060
2.52066985666072e-12	-0.268581233090718	0.271	0.433	6.05389279474204e-08	CD46	Neutrophils	GSE207422_Sin_post	ENSG00000117335	4179	CD46 molecule	MCP|MGC26544|MIC10|TLX|TRA2.10	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66061
4.50205206588253e-12	-0.266179300972338	0.307	0.476	1.08125784466301e-07	DOCK8	Neutrophils	GSE207422_Sin_post	ENSG00000107099	81704	dedicator of cytokinesis 8	FLJ00026|FLJ00152|FLJ00346|ZIR8	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66062
4.61785207037532e-12	-0.253706642789721	0.235	0.391	1.10906953174204e-07	ARHGAP30	Neutrophils	GSE207422_Sin_post	ENSG00000186517	257106	Rho GTPase activating protein 30	FLJ00267	protein_coding	Q7Z6I6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66063
5.07929864828614e-12	0.361464158709436	0.999	0.987	1.21989515635888e-07	FTL	Neutrophils	GSE207422_Sin_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66064
5.28475636686819e-12	0.724942119368691	0.986	0.928	1.26923993663073e-07	CD74	Neutrophils	GSE207422_Sin_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66065
5.57155651118671e-12	-0.283981369404676	0.618	0.773	1.33812072729171e-07	EFHD2	Neutrophils	GSE207422_Sin_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66066
5.62472875959008e-12	-0.275934045559824	0.246	0.395	1.35089110619075e-07	ACTN4	Neutrophils	GSE207422_Sin_post	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66067
6.3742011794318e-12	0.393004694508413	0.253	0.123	1.53089189726413e-07	TUBA4A	Neutrophils	GSE207422_Sin_post	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66068
8.86552390354685e-12	-0.339864062843804	0.452	0.611	2.12923287591485e-07	PTAFR	Neutrophils	GSE207422_Sin_post	ENSG00000169403	5724	platelet activating factor receptor	NA	protein_coding	P25105	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66069
1.04826272385105e-11	-0.288985953323732	0.161	0.285	2.51761258387306e-07	ST8SIA4	Neutrophils	GSE207422_Sin_post	ENSG00000113532	7903	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4	PST|PST1|SIAT8D	protein_coding	Q92187	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66070
1.27493259346352e-11	0.28336751422821	0.573	0.38	3.06200560972134e-07	RPL23	Neutrophils	GSE207422_Sin_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66071
1.38725834224844e-11	-0.262507158793816	0.341	0.516	3.33177836057808e-07	NCF4	Neutrophils	GSE207422_Sin_post	ENSG00000275990	4689	neutrophil cytosolic factor 4	p40phox|SH3PXD4	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66072
2.25561628845006e-11	0.404919268639049	0.355	0.221	5.41731363997051e-07	PITPNA	Neutrophils	GSE207422_Sin_post	ENSG00000174238	5306	phosphatidylinositol transfer protein alpha	PITPN|VIB1A	protein_coding	Q00169	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66073
2.7885424946093e-11	-0.271468248292467	0.408	0.586	6.69724250930315e-07	ACTN1	Neutrophils	GSE207422_Sin_post	ENSG00000072110	87	actinin alpha 1	NA	protein_coding	P12814	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66074
2.84241641210165e-11	0.268544049907218	0.431	0.253	6.82663149694454e-07	RPS8	Neutrophils	GSE207422_Sin_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66075
3.03404648518741e-11	0.452224869637985	0.392	0.268	7.28686944347461e-07	SLC11A1	Neutrophils	GSE207422_Sin_post	ENSG00000018280	6556	solute carrier family 11 member 1	LSH|NRAMP|NRAMP1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66076
3.10925221138529e-11	-0.313735015490953	0.337	0.49	7.46749103608406e-07	STEAP4	Neutrophils	GSE207422_Sin_post	ENSG00000127954	79689	STEAP4 metalloreductase	FLJ23153|SchLAH|STAMP2|TIARP|TNFAIP9	protein_coding	Q687X5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66077
3.40183961178703e-11	0.357149486293803	0.256	0.127	8.1701981956289e-07	GNS	Neutrophils	GSE207422_Sin_post	ENSG00000135677	2799	glucosamine (N-acetyl)-6-sulfatase	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66078
6.36608328457358e-11	0.286091217180392	0.278	0.134	1.52894222245604e-06	PPIA	Neutrophils	GSE207422_Sin_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66079
7.24505660327967e-11	0.283339640464731	0.904	0.728	1.74004524440968e-06	EEF1A1	Neutrophils	GSE207422_Sin_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66080
8.81810457563798e-11	0.421205648432993	0.348	0.219	2.11784417593097e-06	TPP1	Neutrophils	GSE207422_Sin_post	ENSG00000166340	1200	tripeptidyl peptidase 1	CLN2|LPIC|SCAR7|TPP-1	protein_coding	O14773	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66081
8.94814687871284e-11	0.436931096554683	0.319	0.189	2.14907643586046e-06	MGAT1	Neutrophils	GSE207422_Sin_post	ENSG00000131446	4245	alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GLCNAC-TI|GLYT1|GNT-1|GnTI|MGAT	protein_coding	P26572	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66082
9.45017858759381e-11	-0.268773465373403	0.225	0.361	2.26964939138241e-06	RALBP1	Neutrophils	GSE207422_Sin_post	ENSG00000017797	10928	ralA binding protein 1	RIP|RIP1|RLIP76	protein_coding	Q15311	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66083
1.94401331202712e-10	0.261369247428854	0.391	0.225	4.66893677149554e-06	RPLP1	Neutrophils	GSE207422_Sin_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66084
2.37017302496251e-10	-0.260049585660895	0.617	0.775	5.69244455405245e-06	IGSF6	Neutrophils	GSE207422_Sin_post	ENSG00000283934	10261	immunoglobulin superfamily member 6	DORA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66085
2.65768788674175e-10	0.280624330509188	0.499	0.323	6.38296899758766e-06	RPL27A	Neutrophils	GSE207422_Sin_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66086
2.74867468616686e-10	-0.264483583908504	0.486	0.643	6.60149199376695e-06	R3HDM4	Neutrophils	GSE207422_Sin_post	ENSG00000198858	91300	R3H domain containing 4	C19orf22|MGC16353	protein_coding	Q96D70	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66087
2.83265380355738e-10	0.366048461690435	0.291	0.166	6.80318464000376e-06	ACSL4	Neutrophils	GSE207422_Sin_post	ENSG00000068366	2182	acyl-CoA synthetase long chain family member 4	ACS4|FACL4|LACS4|MRX63|MRX68	protein_coding	O60488	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66088
3.48071791367967e-10	-0.261953055905313	0.374	0.518	8.35964021328447e-06	PRKAR1A	Neutrophils	GSE207422_Sin_post	ENSG00000108946	5573	protein kinase cAMP-dependent type I regulatory subunit alpha	CNC1|PRKAR1|TSE1	protein_coding	P10644	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66089
4.09306313732116e-10	-0.255489997666859	0.312	0.467	9.83030973690422e-06	IDS	Neutrophils	GSE207422_Sin_post	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66090
7.48029052663528e-10	-0.259801930053949	0.391	0.548	1.79654137578199e-05	PAK2	Neutrophils	GSE207422_Sin_post	ENSG00000180370	5062	p21 (RAC1) activated kinase 2	PAK65|PAKgamma	protein_coding	Q13177	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66091
7.48489496832761e-10	0.610186656810687	0.664	0.662	1.79764722454324e-05	TSC22D3	Neutrophils	GSE207422_Sin_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66092
8.23248499841188e-10	0.390578485613915	0.837	0.843	1.97719592206858e-05	SLC25A37	Neutrophils	GSE207422_Sin_post	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66093
8.31341483996371e-10	0.365477869928338	0.291	0.166	1.99663284211408e-05	PAG1	Neutrophils	GSE207422_Sin_post	ENSG00000076641	55824	phosphoprotein membrane anchor with glycosphingolipid microdomains 1	CBP|PAG	protein_coding	Q9NWQ8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66094
1.07430643974884e-09	-0.282875140280054	0.221	0.35	2.5801617763448e-05	GPR65	Neutrophils	GSE207422_Sin_post	ENSG00000140030	8477	G protein-coupled receptor 65	hTDAG8|TDAG8	protein_coding	Q8IYL9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66095
1.50892637859934e-09	-0.30717449406985	0.265	0.386	3.62398848348204e-05	AC012368.1	Neutrophils	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66096
2.11521606545901e-09	-0.360098896088646	0.532	0.635	5.08011442441289e-05	P2RY13	Neutrophils	GSE207422_Sin_post	ENSG00000181631	53829	purinergic receptor P2Y13	FKSG77|GPR86|GPR94|P2Y13	protein_coding	Q9BPV8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66097
2.25790928984989e-09	0.421090949150394	0.37	0.248	5.42282074143248e-05	NBN	Neutrophils	GSE207422_Sin_post	ENSG00000104320	4683	nibrin	AT-V1|AT-V2|ATV|NBS|NBS1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66098
2.55515593346642e-09	0.537517500199913	0.35	0.238	6.1367180054063e-05	CTSD	Neutrophils	GSE207422_Sin_post	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66099
5.69437107555991e-09	0.351637704800059	0.291	0.178	0.000136761710121722	FNDC3B	Neutrophils	GSE207422_Sin_post	ENSG00000075420	64778	fibronectin type III domain containing 3B	DKFZp762K137|FAD104|FLJ23399|PRO4979|YVTM2421	protein_coding	Q53EP0	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66100
5.85414183787633e-09	0.312685480720049	0.327	0.208	0.000140598924520276	TAP2	Neutrophils	GSE207422_Sin_post	ENSG00000232326	6891	transporter 2, ATP binding cassette subfamily B member	ABCB3|D6S217E|PSF2|RING11	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66101
6.24131953109253e-09	-0.26420485979059	0.617	0.752	0.000149897771178249	IQGAP1	Neutrophils	GSE207422_Sin_post	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66102
6.69621049458707e-09	0.392214675871474	0.623	0.546	0.000160822887448498	TAP1	Neutrophils	GSE207422_Sin_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66103
7.67894569374853e-09	0.279058113768287	0.351	0.214	0.000184425238726759	RPL21	Neutrophils	GSE207422_Sin_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66104
7.73584868086618e-09	-0.252062904700664	0.393	0.529	0.000185791877768363	CD37	Neutrophils	GSE207422_Sin_post	ENSG00000104894	951	CD37 molecule	TSPAN26	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66105
1.0070595974793e-08	0.484416970658	0.33	0.225	0.000241865503526603	CD44	Neutrophils	GSE207422_Sin_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66106
1.07507634136366e-08	0.410275059813525	0.291	0.18	0.000258201084905311	ZC3HAV1	Neutrophils	GSE207422_Sin_post	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66107
1.21013399725337e-08	0.382081596442576	0.53	0.42	0.000290637882120341	SERPINB1	Neutrophils	GSE207422_Sin_post	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66108
1.23349645196995e-08	0.35464459042383	0.284	0.172	0.000296248842869622	SERPING1	Neutrophils	GSE207422_Sin_post	ENSG00000149131	710	serpin family G member 1	C1-INH|C1IN|C1INH|C1NH|HAE1|HAE2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66109
1.44775001284669e-08	0.34281407943056	0.406	0.285	0.000347706120585389	PARP14	Neutrophils	GSE207422_Sin_post	ENSG00000173193	54625	poly(ADP-ribose) polymerase family member 14	ARTD8|BAL2|KIAA1268|pART8	protein_coding	Q460N5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66110
1.56501696130194e-08	0.390968168422343	0.359	0.253	0.000375870123595887	NPC2	Neutrophils	GSE207422_Sin_post	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66111
3.30442009518922e-08	0.530494488510455	0.536	0.446	0.000793622574261595	IFIT3	Neutrophils	GSE207422_Sin_post	ENSG00000119917	3437	interferon induced protein with tetratricopeptide repeats 3	CIG-49|GARG-49|IFI60|IFIT4|IRG2|ISG60|RIG-G	protein_coding	O14879	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66112
3.69494644916205e-08	0.313040956235013	0.604	0.488	0.000887415288695249	FGR	Neutrophils	GSE207422_Sin_post	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66113
4.19073165011523e-08	0.353450172278441	0.748	0.682	0.00100648802040817	BCL2A1	Neutrophils	GSE207422_Sin_post	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66114
4.57698976816131e-08	0.400127505584859	0.462	0.352	0.0010992556326193	GBP1	Neutrophils	GSE207422_Sin_post	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66115
6.06982075509435e-08	0.586203829667705	0.352	0.261	0.00145778885075101	HMGB2	Neutrophils	GSE207422_Sin_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66116
6.69357946821292e-08	0.329861118632192	0.272	0.174	0.0016075969808807	MAPKAPK2	Neutrophils	GSE207422_Sin_post	ENSG00000162889	9261	MAPK activated protein kinase 2	MK2	protein_coding	P49137	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66117
1.0597028938983e-07	0.274389157555313	0.338	0.236	0.00254508844027556	TNFAIP6	Neutrophils	GSE207422_Sin_post	ENSG00000123610	7130	TNF alpha induced protein 6	TSG-6|TSG6	protein_coding	P98066	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66118
1.12837262662013e-07	0.257319711031705	0.883	0.875	0.00271001253735356	SDCBP	Neutrophils	GSE207422_Sin_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66119
1.77597716717365e-07	0.399729473364735	0.252	0.153	0.00426536436240095	TPI1	Neutrophils	GSE207422_Sin_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66120
1.85505658559723e-07	0.302304847157895	0.44	0.331	0.00445528940162886	HIF1A	Neutrophils	GSE207422_Sin_post	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66121
2.41152978683655e-07	0.455616586410445	0.437	0.355	0.00579177108904533	LRG1	Neutrophils	GSE207422_Sin_post	ENSG00000171236	116844	leucine rich alpha-2-glycoprotein 1	LRG	protein_coding	P02750	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66122
2.61947763296765e-07	0.270664845315185	0.381	0.263	0.0062911994310984	RPL28	Neutrophils	GSE207422_Sin_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66123
3.44543444158921e-07	-0.250438443817159	0.965	0.97	0.0082748998983648	H3F3B	Neutrophils	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66124
4.00861313787681e-07	0.346856320089662	0.458	0.38	0.00962748617323874	TLR4	Neutrophils	GSE207422_Sin_post	ENSG00000136869	7099	toll like receptor 4	ARMD10|CD284|hToll|TLR-4	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66125
7.06759364536005e-07	0.269671861951954	0.265	0.172	0.0169742396580612	TMBIM1	Neutrophils	GSE207422_Sin_post	ENSG00000135926	64114	transmembrane BAX inhibitor motif containing 1	LFG3|PP1201|RECS1	protein_coding	Q969X1	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66126
7.3362489453169e-07	0.281229008624843	0.38	0.285	0.0176194690919676	RILPL2	Neutrophils	GSE207422_Sin_post	ENSG00000150977	196383	Rab interacting lysosomal protein like 2	FLJ30380|FLJ32372|MGC7036	protein_coding	Q969X0	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66127
9.31802433658002e-07	-0.268292523182549	0.543	0.654	0.0223790990491642	KIAA1551	Neutrophils	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66128
1.38232182248836e-06	0.284564158249735	0.618	0.546	0.0331992232107029	RAB7A	Neutrophils	GSE207422_Sin_post	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66129
1.71028598695031e-06	0.292199213456353	0.269	0.178	0.0410759385485855	IRF7	Neutrophils	GSE207422_Sin_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66130
1.7669448604826e-102	-1.18762700317577	0.003	0.778	4.24367147142106e-98	SCGB1A1	Plasma cells	GSE207422_Sin_post	ENSG00000149021	7356	secretoglobin family 1A member 1	CC10|CC16|CCSP|UGB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66131
9.11423031960665e-34	-1.02102236002507	0.131	0.714	2.18896469585993e-29	RPL10P3	Plasma cells	GSE207422_Sin_post	ENSG00000230734	NA	NA	bA567J2.2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66132
5.04777597947843e-30	-0.357552004618084	0.003	0.254	1.21232435699133e-25	SCGB3A2	Plasma cells	GSE207422_Sin_post	ENSG00000164265	117156	secretoglobin family 3A member 2	LU103|PNSP1|UGRP1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66133
2.84951347594743e-18	-1.08744510563157	0.819	0.921	6.84367651518294e-14	MT-ATP8	Plasma cells	GSE207422_Sin_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66134
1.41992638780951e-17	-0.333290713247851	0.033	0.302	3.41023720560211e-13	SEMA3E	Plasma cells	GSE207422_Sin_post	ENSG00000170381	9723	semaphorin 3E	coll-5|KIAA0331|M-SemaK|SEMAH	protein_coding	O15041	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66135
1.87896909404009e-15	1.10281547299683	0.99	0.921	4.51272007315608e-11	XBP1	Plasma cells	GSE207422_Sin_post	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66136
2.25508928620283e-14	-0.58641515080954	0.084	0.397	5.41604793867334e-10	HSP90AA2P	Plasma cells	GSE207422_Sin_post	ENSG00000224411	NA	NA	HSP90AA2|HSP90ALPHA|HSPCA|HSPCAL3	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66137
2.46991921714297e-14	1.33923254298182	0.941	0.825	5.93200498381228e-10	PIM2	Plasma cells	GSE207422_Sin_post	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66138
8.2301576049908e-13	0.751095923001095	1	1	1.97663695199064e-08	HLA-C	Plasma cells	GSE207422_Sin_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66139
1.94941700149393e-12	-0.574095350257845	0.042	0.27	4.68191481248798e-08	HLA-DRB3	Plasma cells	GSE207422_Sin_post	ENSG00000230463	3125	major histocompatibility complex, class II, DR beta 3	HLA-DR3B	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66140
5.72806402497857e-12	0.79021134690007	0.667	0.19	1.3757091368791e-07	AC012236.1	Plasma cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66141
9.22589722668797e-12	-0.509113163600836	0.125	0.444	2.21578373693365e-07	WT1-AS	Plasma cells	GSE207422_Sin_post	ENSG00000183242	NA	NA	WIT-1|WIT1|WT1-AS1|WT1AS	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66142
2.04331002036661e-11	-0.813502697162981	0.521	0.778	4.90741767591448e-07	MTND1P23	Plasma cells	GSE207422_Sin_post	ENSG00000225972	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66143
3.12440606036395e-11	-0.74520884690609	0.997	1	7.50388603517609e-07	MT-RNR2	Plasma cells	GSE207422_Sin_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66144
4.30356987202728e-11	0.663572335417522	0.995	0.952	1.03358837616479e-06	MT-CO2	Plasma cells	GSE207422_Sin_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66145
1.46552609437525e-10	-1.24979270035898	0.681	0.905	3.51975402086104e-06	UBC	Plasma cells	GSE207422_Sin_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66146
2.27760357784305e-10	-0.409715859010649	0.172	0.508	5.47012051290565e-06	AL031727.1	Plasma cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66147
2.67061612536369e-10	0.839517042675329	0.983	0.937	6.41401874828598e-06	HLA-B	Plasma cells	GSE207422_Sin_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66148
3.43998015108655e-10	0.705457792907717	0.834	0.54	8.26180032886458e-06	PRDX4	Plasma cells	GSE207422_Sin_post	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66149
3.76367579322014e-10	-1.01198835053907	0.235	0.619	9.03922015257682e-06	HSPH1	Plasma cells	GSE207422_Sin_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66150
1.2601089018473e-09	1.1089900031824	0.491	0.095	3.02640354956667e-05	IFI6	Plasma cells	GSE207422_Sin_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66151
2.67074677298135e-09	-0.704963078300757	0.084	0.317	6.41433252466931e-05	FGF23	Plasma cells	GSE207422_Sin_post	ENSG00000118972	8074	fibroblast growth factor 23	NA	protein_coding	Q9GZV9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66152
3.00047728174746e-09	-0.291203406618321	0.071	0.302	7.20624628757288e-05	TPP2	Plasma cells	GSE207422_Sin_post	ENSG00000134900	7174	tripeptidyl peptidase 2	TPPII	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66153
3.75625270872131e-09	0.574619497299287	0.995	0.968	9.02139213053596e-05	SSR4	Plasma cells	GSE207422_Sin_post	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66154
4.09927640341484e-09	-0.433830385783288	0.148	0.429	9.84523213808142e-05	GNG7	Plasma cells	GSE207422_Sin_post	ENSG00000176533	2788	G protein subunit gamma 7	FLJ00058	protein_coding	O60262	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66155
4.67538569058527e-09	-0.62851638029936	0.226	0.524	0.000112288738130786	RPL3P4	Plasma cells	GSE207422_Sin_post	ENSG00000232573	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66156
1.2978641180532e-08	-0.577088255748599	0.946	0.984	0.000311708025232838	RPS6	Plasma cells	GSE207422_Sin_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66157
1.89088145118313e-08	-0.371620210865258	0.138	0.413	0.000454132998130653	PTGES3	Plasma cells	GSE207422_Sin_post	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66158
2.67079229281904e-08	-0.589024825912196	0.65	0.841	0.000641444184966348	RPL23A	Plasma cells	GSE207422_Sin_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66159
3.14719666816427e-08	-0.931586843944866	0.563	0.873	0.000755862223793012	HSP90AB1	Plasma cells	GSE207422_Sin_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66160
3.25816293151903e-08	-1.1231522818589	0.725	0.952	0.000782512991262925	HSP90AA1	Plasma cells	GSE207422_Sin_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66161
4.13012945414551e-08	-0.467348537942444	0.127	0.381	0.000991933191002126	TMEM156	Plasma cells	GSE207422_Sin_post	ENSG00000121895	80008	transmembrane protein 156	FLJ23235	protein_coding	Q8N614	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66162
4.53082098056606e-08	0.594495373706891	1	1	0.00108816727490255	B2M	Plasma cells	GSE207422_Sin_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66163
4.96477423016316e-08	-0.348210871885868	0.11	0.349	0.00119238982685829	MT-TD	Plasma cells	GSE207422_Sin_post	ENSG00000210154	NA	NA	MTTD|trnD	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66164
5.14380788005707e-08	-0.337869638756384	0.134	0.397	0.00123538833855331	CEP350	Plasma cells	GSE207422_Sin_post	ENSG00000135837	9857	centrosomal protein 350	CAP350|KIAA0480	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66165
1.00027797846164e-07	-0.368992156252165	0.113	0.349	0.00240236762087133	RPL13P12	Plasma cells	GSE207422_Sin_post	ENSG00000215030	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66166
1.49543588176285e-07	0.641642695310273	0.441	0.095	0.00359158835722984	TAP1	Plasma cells	GSE207422_Sin_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66167
1.51786709505711e-07	-0.276052328644437	0.063	0.254	0.00364546140219866	CD48	Plasma cells	GSE207422_Sin_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66168
1.94650696953449e-07	0.864941047628382	0.338	0.016	0.00467492578873099	PTP4A3	Plasma cells	GSE207422_Sin_post	ENSG00000275575	11156	protein tyrosine phosphatase 4A3	PRL-3|PRL-R|PRL3	protein_coding	O75365	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66169
1.95796393513195e-07	0.889449219842869	0.512	0.159	0.00470244198300639	SAT1	Plasma cells	GSE207422_Sin_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66170
2.3805514049976e-07	-0.577511025226277	0.681	0.825	0.00571737030938274	RPL10	Plasma cells	GSE207422_Sin_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66171
2.46598917439253e-07	0.32794769349906	0.732	0.381	0.00592256620013855	SDC1	Plasma cells	GSE207422_Sin_post	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66172
2.49941966017904e-07	-0.514070579185627	0.847	0.921	0.00600285619785199	RPS11	Plasma cells	GSE207422_Sin_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66173
2.89173188204235e-07	-0.499344899460915	0.983	1	0.00694507246110112	RPS29	Plasma cells	GSE207422_Sin_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66174
3.72443816090985e-07	-0.543537197492368	0.84	0.937	0.00894498313105719	TRAM1	Plasma cells	GSE207422_Sin_post	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66175
4.56982732443423e-07	-0.304696306511434	0.092	0.302	0.0109753542850937	RPL34P27	Plasma cells	GSE207422_Sin_post	ENSG00000232858	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66176
4.7786277237378e-07	-0.306389952405759	0.11	0.333	0.0114768302041011	RPS27AP16	Plasma cells	GSE207422_Sin_post	ENSG00000224631	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66177
5.82239154725181e-07	0.542477398057809	0.857	0.667	0.0139836377790347	RPN2	Plasma cells	GSE207422_Sin_post	ENSG00000118705	6185	ribophorin II	RIBIIR|RPN-II|RPNII|SWP1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66178
6.24864029413261e-07	0.48970964580566	0.695	0.397	0.0150073593944183	P4HB	Plasma cells	GSE207422_Sin_post	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66179
7.10234633558627e-07	0.783526376592967	0.932	0.825	0.0170577051941775	DERL3	Plasma cells	GSE207422_Sin_post	ENSG00000274437	91319	derlin 3	C22orf14|derlin-3|FLJ43842|IZP6|MGC71803	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66180
7.6852599137218e-07	-0.286542029248459	0.078	0.27	0.0184576887347857	SH3KBP1	Plasma cells	GSE207422_Sin_post	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66181
8.12654329785943e-07	-0.30149496773405	0.078	0.27	0.019517519038469	AC144530.1	Plasma cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66182
1.05808074403653e-06	-0.421710035313436	0.272	0.556	0.0254119252295253	RPL6P27	Plasma cells	GSE207422_Sin_post	ENSG00000235552	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66183
1.35738127463679e-06	-0.592032950724728	0.901	0.921	0.0326002260729518	SLAMF7	Plasma cells	GSE207422_Sin_post	ENSG00000026751	57823	SLAM family member 7	19A|CD319|CRACC|CS1	protein_coding	Q9NQ25	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66184
1.67667310656659e-06	0.597376100639368	0.983	0.952	0.0402686580004099	MZB1	Plasma cells	GSE207422_Sin_post	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66185
1.71190679470008e-06	-0.35675427441203	0.334	0.635	0.0411148654883118	SARAF	Plasma cells	GSE207422_Sin_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66186
1.80631078423825e-06	0.484011589315716	0.998	0.984	0.0433821661050501	MT-CO1	Plasma cells	GSE207422_Sin_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66187
2.02051447780575e-06	-0.403968173561524	0.277	0.556	0.0485266962134607	NCOA3	Plasma cells	GSE207422_Sin_post	ENSG00000124151	8202	nuclear receptor coactivator 3	ACTR|AIB1|bHLHe42|CAGH16|KAT13B|p/CIP|RAC3|SRC-3|SRC3|TNRC16|TRAM-1	protein_coding	Q9Y6Q9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66188
6.74411932376767e-91	-1.32767542810177	1	1	1.61973513798928e-86	MT-RNR2	B cells	GSE207422_Sin_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66189
1.86733861588862e-87	1.75224349290295	0.987	0.635	4.4847871537797e-83	HLA-DRB1	B cells	GSE207422_Sin_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66190
7.00533676722191e-83	1.98806353942131	0.989	0.685	1.68247173138369e-78	CXCR4	B cells	GSE207422_Sin_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66191
1.10101404288737e-76	1.43281617547852	1	0.996	2.64430542680259e-72	MT-CO1	B cells	GSE207422_Sin_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66192
7.36532178512227e-76	-1.31929591929698	0.072	0.677	1.76892933313282e-71	HLA-DRB3	B cells	GSE207422_Sin_post	ENSG00000230463	3125	major histocompatibility complex, class II, DR beta 3	HLA-DR3B	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66193
1.13603340487522e-75	1.67604262257562	0.775	0.023	2.72841142848882e-71	HLA-DRB5	B cells	GSE207422_Sin_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66194
3.13452552609172e-73	1.23904432263604	1	0.992	7.52818995601448e-69	MT-CO2	B cells	GSE207422_Sin_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66195
8.8720997933811e-73	1.22781704602456	1	0.977	2.13081220737634e-68	MT-CO3	B cells	GSE207422_Sin_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66196
3.37912419020088e-60	1.35788225072348	0.937	0.512	8.11564256760546e-56	SMAP2	B cells	GSE207422_Sin_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66197
6.85902224665517e-60	1.50790485404748	0.872	0.304	1.64733137297917e-55	TSC22D3	B cells	GSE207422_Sin_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66198
1.48910572939332e-44	1.29121684013636	0.832	0.365	3.57638523028393e-40	ZFP36L2	B cells	GSE207422_Sin_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66199
4.35480013893116e-44	1.03490970561138	0.906	0.438	1.0458923493671e-39	MTATP6P1	B cells	GSE207422_Sin_post	ENSG00000248527	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66200
1.37794344901089e-38	0.67948682603134	1	0.996	3.30940678148944e-34	MT-ATP6	B cells	GSE207422_Sin_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66201
1.40773898513241e-38	0.708853487104992	0.995	0.962	3.38096672059251e-34	RPL27A	B cells	GSE207422_Sin_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66202
2.94131333813868e-38	0.657680068836496	1	1	7.06415224420767e-34	MT-ND4	B cells	GSE207422_Sin_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66203
2.0059518029833e-37	0.778084463236405	0.987	0.923	4.81769444522499e-33	MT-ND1	B cells	GSE207422_Sin_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66204
6.03461595190944e-36	1.21632300478828	0.933	0.781	1.44933371317009e-31	TXNIP	B cells	GSE207422_Sin_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66205
1.20412822760808e-35	0.782659178884209	0.991	0.904	2.89195476424632e-31	HLA-DPA1	B cells	GSE207422_Sin_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66206
1.31667099459089e-35	-2.35286758149205	0.258	0.631	3.16224872770894e-31	HSPA1B	B cells	GSE207422_Sin_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66207
1.14347851641065e-34	0.712268296533296	0.995	0.981	2.74629235286346e-30	MT-CYB	B cells	GSE207422_Sin_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66208
3.0300194305421e-32	-1.58072035480273	0.277	0.685	7.27719766633296e-28	HSPA1A	B cells	GSE207422_Sin_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66209
2.99176415323946e-30	0.828235246683261	0.47	0.062	7.18531996683521e-26	PIK3IP1	B cells	GSE207422_Sin_post	ENSG00000100100	113791	phosphoinositide-3-kinase interacting protein 1	HGFL|MGC17330|TrIP	protein_coding	Q96FE7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66210
6.04880778248045e-29	-0.315079873576889	0.016	0.262	1.45274216511833e-24	SCGB1A1	B cells	GSE207422_Sin_post	ENSG00000149021	7356	secretoglobin family 1A member 1	CC10|CC16|CCSP|UGB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66211
9.36153521849894e-29	0.594425127225224	1	0.988	2.24835991342689e-24	MT-ND3	B cells	GSE207422_Sin_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66212
1.05216128747356e-28	0.631203820136063	0.996	0.973	2.52697576412525e-24	MT-ND2	B cells	GSE207422_Sin_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66213
1.07151031991033e-28	0.722986101522631	0.948	0.731	2.57344633532865e-24	RPS2	B cells	GSE207422_Sin_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66214
3.91899947362317e-28	0.833259716711685	0.933	0.665	9.41226103580076e-24	BTG1	B cells	GSE207422_Sin_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66215
7.11619834401744e-27	0.792895481333948	0.528	0.115	1.70909735628267e-22	CD69	B cells	GSE207422_Sin_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66216
1.25717614112491e-25	0.585784107056394	0.998	0.958	3.01935993813969e-21	RPS18	B cells	GSE207422_Sin_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66217
6.65374017107875e-23	-0.760134731778151	0.292	0.588	1.59802877688798e-18	RPL10P3	B cells	GSE207422_Sin_post	ENSG00000230734	NA	NA	bA567J2.2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66218
2.836837286532e-22	0.674016341577817	0.373	0.05	6.81323211106389e-18	FKBP5	B cells	GSE207422_Sin_post	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66219
5.86013318274582e-22	0.700294760086121	0.332	0.023	1.40742818650006e-17	SESN1	B cells	GSE207422_Sin_post	ENSG00000080546	27244	sestrin 1	PA26|SEST1	protein_coding	Q9Y6P5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66220
3.22313162964109e-21	0.542503121712497	0.977	0.881	7.740995234909e-17	RPL13	B cells	GSE207422_Sin_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66221
3.57109745874604e-21	0.759444430300958	0.432	0.108	8.57670476667036e-17	TP53INP1	B cells	GSE207422_Sin_post	ENSG00000164938	94241	tumor protein p53 inducible nuclear protein 1	DKFZp434M1317|FLJ22139|P53DINP1|SIP|Teap|TP53INP1A|TP53INP1B	protein_coding	Q96A56	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66222
1.57641554372864e-20	0.612913782051754	0.586	0.223	3.78607721137307e-16	DUSP1	B cells	GSE207422_Sin_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66223
7.86101975745945e-20	0.600651711497951	0.38	0.069	1.88798111514904e-15	THEMIS2	B cells	GSE207422_Sin_post	ENSG00000130775	9473	thymocyte selection associated family member 2	C1orf38|ICB-1	protein_coding	Q5TEJ8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66224
2.90237962379832e-19	0.469289350744178	1	1	6.97064514247643e-15	TMSB4X	B cells	GSE207422_Sin_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66225
3.33591328696089e-19	0.561012143790583	0.461	0.127	8.01186294129396e-15	CYTIP	B cells	GSE207422_Sin_post	ENSG00000115165	9595	cytohesin 1 interacting protein	B3-1|CASP|CYBR|CYTHIP|HE|PSCDBP	protein_coding	O60759	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66226
7.38799264160381e-19	0.818561010540647	0.443	0.127	1.77437419273399e-14	RGS1	B cells	GSE207422_Sin_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66227
9.76853774263182e-19	0.712226921459348	0.51	0.185	2.34610970964789e-14	GPR183	B cells	GSE207422_Sin_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66228
6.46219261069916e-17	0.383416018998879	1	1	1.55202479931162e-12	HLA-DRA	B cells	GSE207422_Sin_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66229
8.2551782034541e-17	0.564643394237452	0.341	0.073	1.98264614912357e-12	CCR7	B cells	GSE207422_Sin_post	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66230
1.47722111612847e-16	0.587942040950061	0.613	0.281	3.54784195460574e-12	TRIM22	B cells	GSE207422_Sin_post	ENSG00000132274	10346	tripartite motif containing 22	GPSTAF50|RNF94|STAF50	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66231
4.85817196631488e-16	0.56627447981638	0.285	0.035	1.16678716114984e-11	YBX3	B cells	GSE207422_Sin_post	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66232
1.61398423619574e-15	0.496503357479709	0.977	0.823	3.87630594007131e-11	RPL8	B cells	GSE207422_Sin_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66233
2.20760963583074e-15	0.520430130404624	0.337	0.077	5.30201606237468e-11	RNASE6	B cells	GSE207422_Sin_post	ENSG00000169413	6039	ribonuclease A family member k6	RAD1|RNaseK6|RNS6	protein_coding	Q93091	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66234
2.20878539690451e-15	0.40196830272515	0.998	0.996	5.30483988774556e-11	HLA-B	B cells	GSE207422_Sin_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66235
1.34977201438202e-14	0.563571833262875	0.42	0.142	3.24174744694129e-10	DDIT4	B cells	GSE207422_Sin_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66236
1.39761637708221e-14	0.468122244160405	0.432	0.154	3.35665525283835e-10	CCND3	B cells	GSE207422_Sin_post	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66237
1.55485870537279e-14	0.430831479280307	0.377	0.115	3.73430415269383e-10	MGAT5	B cells	GSE207422_Sin_post	ENSG00000152127	4249	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase	GNT-V|MGAT5A	protein_coding	Q09328	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66238
1.61082837580249e-14	0.587697993583819	0.714	0.469	3.86872651016485e-10	IFITM2	B cells	GSE207422_Sin_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66239
2.30755482238492e-14	0.513766221168435	0.575	0.288	5.54205441692186e-10	ST6GAL1	B cells	GSE207422_Sin_post	ENSG00000073849	6480	ST6 beta-galactoside alpha-2,6-sialyltransferase 1	CDw75|SIAT1	protein_coding	P15907	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66240
2.41523035309925e-14	0.464610937087845	0.277	0.046	5.80065873903846e-10	CEMIP2	B cells	GSE207422_Sin_post	ENSG00000135048	23670	cell migration inducing hyaluronidase 2	TMEM2	protein_coding	Q9UHN6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66241
3.70005794158316e-14	0.581360789182385	0.714	0.454	8.88642915830026e-10	IRF8	B cells	GSE207422_Sin_post	ENSG00000140968	3394	interferon regulatory factor 8	ICSBP|ICSBP1|IRF-8	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66242
3.83673089332942e-14	0.720991957958465	0.656	0.377	9.21467658650928e-10	NEAT1	B cells	GSE207422_Sin_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66243
7.32646844550214e-14	0.460388927313491	0.975	0.915	1.75959792655625e-09	RPS12	B cells	GSE207422_Sin_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66244
8.87565396732009e-14	0.76899274905959	0.582	0.392	2.13166581333127e-09	FOS	B cells	GSE207422_Sin_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66245
1.41982293126131e-13	0.482622879577516	0.515	0.246	3.4099887340103e-09	SLC44A2	B cells	GSE207422_Sin_post	ENSG00000129353	57153	solute carrier family 44 member 2	CTL2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66246
2.15632468603627e-13	0.666099790248209	0.69	0.454	5.1788449984533e-09	ZFP36	B cells	GSE207422_Sin_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66247
3.23794135855615e-13	0.481708538924132	0.396	0.146	7.7765637608443e-09	ISG20	B cells	GSE207422_Sin_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66248
3.42803294451605e-13	0.328386915904876	1	1	8.2331067228442e-09	EEF1A1	B cells	GSE207422_Sin_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66249
3.62926487513129e-13	0.36853949567966	0.998	0.973	8.71640545060281e-09	MT-ND5	B cells	GSE207422_Sin_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66250
4.91144484031076e-13	0.40351111692127	0.995	0.981	1.17958170729743e-08	HLA-A	B cells	GSE207422_Sin_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66251
8.69426692852091e-13	0.378256752651373	0.366	0.119	2.08810208822287e-08	SSH2	B cells	GSE207422_Sin_post	ENSG00000141298	85464	slingshot protein phosphatase 2	KIAA1725	protein_coding	Q76I76	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66252
1.07117520942958e-12	0.395597670070881	0.986	0.923	2.57264150048703e-08	RPS27	B cells	GSE207422_Sin_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66253
1.38960889575731e-12	0.401244731699587	0.953	0.835	3.33742368494033e-08	LAPTM5	B cells	GSE207422_Sin_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66254
1.59870952761118e-12	0.501825584873607	0.611	0.323	3.83962067246377e-08	PTPN1	B cells	GSE207422_Sin_post	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66255
2.02217697848931e-12	0.357441786796329	0.261	0.05	4.85666244923777e-08	SNX9	B cells	GSE207422_Sin_post	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66256
2.12748030314957e-12	0.345963232924884	0.993	0.985	5.10956944407432e-08	RPL37	B cells	GSE207422_Sin_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66257
2.98351702494059e-12	0.354907668892481	0.996	0.992	7.1655128387998e-08	HLA-C	B cells	GSE207422_Sin_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66258
3.84449624503895e-12	0.429367234248476	0.937	0.773	9.23332663171005e-08	RPL18	B cells	GSE207422_Sin_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66259
3.87421852795101e-12	0.351561556627229	0.98	0.919	9.30471063857995e-08	RPL12	B cells	GSE207422_Sin_post	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66260
4.65458051722681e-12	0.542747780201884	0.492	0.242	1.11789060282236e-07	HERPUD1	B cells	GSE207422_Sin_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66261
5.61860458751876e-12	0.347411666859077	1	0.996	1.34942026378438e-07	B2M	B cells	GSE207422_Sin_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66262
5.68187948419082e-12	0.44945078171129	0.825	0.573	1.36461699571811e-07	DDX5	B cells	GSE207422_Sin_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66263
7.2602188751203e-12	0.387186132430415	0.966	0.858	1.74368676723764e-07	RPL27	B cells	GSE207422_Sin_post	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66264
8.63925671020935e-12	-0.472487771462744	0.521	0.708	2.07489028409098e-07	CORO1A	B cells	GSE207422_Sin_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66265
1.25778735503067e-11	0.39346984659788	0.382	0.138	3.02082789057717e-07	IGHD	B cells	GSE207422_Sin_post	ENSG00000278801	NA	NA	FLJ00382|FLJ46727|MGC29633	IG_C_gene	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66266
1.38070610638314e-11	0.868101368647233	0.569	0.35	3.31604185570038e-07	IGHM	B cells	GSE207422_Sin_post	ENSG00000282657	NA	NA	NA	IG_C_gene	P01871	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66267
1.45453560211689e-11	0.400396311436769	0.366	0.123	3.49335815560412e-07	FOSB	B cells	GSE207422_Sin_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66268
1.55188443552752e-11	-0.501932921417202	0.314	0.515	3.72716084880644e-07	LBH	B cells	GSE207422_Sin_post	ENSG00000213626	81606	LBH regulator of WNT signaling pathway	NA	protein_coding	Q53QV2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66269
1.61056556704853e-11	0.415388733617983	0.656	0.388	3.86809532238046e-07	RPL9P9	B cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66270
2.28126716394285e-11	0.572084777806381	0.553	0.346	5.47891934764153e-07	SAT1	B cells	GSE207422_Sin_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66271
2.6881548196326e-11	-0.780315669305252	0.708	0.854	6.4561414303116e-07	HSP90AA1	B cells	GSE207422_Sin_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66272
2.70905299468187e-11	0.459354743463031	0.605	0.346	6.50633257732745e-07	HINT1	B cells	GSE207422_Sin_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66273
4.740678893542e-11	0.396918028151234	0.96	0.85	1.13856884986198e-06	RPL10A	B cells	GSE207422_Sin_post	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66274
4.7606507074437e-11	0.340379528269609	0.305	0.088	1.14336548040675e-06	SDCBP	B cells	GSE207422_Sin_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66275
5.28557705212358e-11	0.383345629324173	0.436	0.181	1.26943704060852e-06	CFLAR	B cells	GSE207422_Sin_post	ENSG00000003402	8837	CASP8 and FADD like apoptosis regulator	c-FLIP|CASH|CASP8AP1|Casper|cFLIP|CLARP|FLAME|FLIP|I-FLICE|MRIT	protein_coding	O15519	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66276
6.10503661537727e-11	0.426201405053114	0.386	0.146	1.46624664391516e-06	SLC2A3	B cells	GSE207422_Sin_post	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66277
6.17538151829356e-11	0.351823604840517	0.436	0.185	1.48314137924856e-06	SERPINB9	B cells	GSE207422_Sin_post	ENSG00000170542	5272	serpin family B member 9	CAP3|PI9	protein_coding	P50453	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66278
7.13221400774042e-11	-0.499196321977153	0.288	0.481	1.71294383823902e-06	CD82	B cells	GSE207422_Sin_post	ENSG00000085117	3732	CD82 molecule	IA4|KAI1|R2|ST6|TSPAN27	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66279
9.00392191044516e-11	-0.404430449317752	0.953	0.965	2.16247192523161e-06	RPS11	B cells	GSE207422_Sin_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66280
1.32293070211545e-10	0.353180662033511	0.939	0.788	3.17728266727067e-06	RPL29	B cells	GSE207422_Sin_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66281
1.37349867509243e-10	0.423299545000568	0.371	0.15	3.2987317679695e-06	B4GALT1	B cells	GSE207422_Sin_post	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66282
1.49308349613781e-10	0.350901570830534	0.353	0.127	3.58593863267419e-06	TAGAP	B cells	GSE207422_Sin_post	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66283
1.69719294097742e-10	0.662618252706125	0.712	0.562	4.07614828634546e-06	JUNB	B cells	GSE207422_Sin_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66284
1.7298139427629e-10	-0.491995063598012	0.402	0.615	4.15449414633365e-06	RALGPS2	B cells	GSE207422_Sin_post	ENSG00000116191	55103	Ral GEF with PH domain and SH3 binding motif 2	FLJ10244|FLJ25604|KIAA0351	protein_coding	Q86X27	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66285
1.73589366113751e-10	0.475343374759642	0.402	0.169	4.16909580595396e-06	PIM2	B cells	GSE207422_Sin_post	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66286
2.0755738653421e-10	0.427432654870234	0.499	0.25	4.98490575239212e-06	RCSD1	B cells	GSE207422_Sin_post	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66287
2.54777439015298e-10	0.387556762856737	0.541	0.323	6.11898975283042e-06	HLA-DOB	B cells	GSE207422_Sin_post	ENSG00000243612	3112	major histocompatibility complex, class II, DO beta	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66288
2.62466262139937e-10	0.358297548504445	0.44	0.196	6.30365221781486e-06	DDX24	B cells	GSE207422_Sin_post	ENSG00000273761	57062	DEAD-box helicase 24	NA	protein_coding	Q9GZR7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66289
2.96089906682464e-10	-0.45788042798725	0.602	0.75	7.11119128879275e-06	YWHAB	B cells	GSE207422_Sin_post	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66290
3.2547350433225e-10	-0.252320768527891	0.195	0.404	7.81689715354765e-06	TLR10	B cells	GSE207422_Sin_post	ENSG00000174123	81793	toll like receptor 10	CD290	protein_coding	Q9BXR5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66291
4.1199548989811e-10	0.323258906774076	0.36	0.138	9.89489568088292e-06	CD55	B cells	GSE207422_Sin_post	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66292
6.41958652239657e-10	0.364074240029923	0.903	0.746	1.54179209508399e-05	RPL15	B cells	GSE207422_Sin_post	ENSG00000174748	6138	ribosomal protein L15	EC45|L15|RPL10|RPLY10|RPYL10	protein_coding	P61313	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66293
6.49281023638154e-10	0.345155908817753	0.955	0.812	1.55937823447175e-05	RPS17	B cells	GSE207422_Sin_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66294
1.38596914913655e-09	0.378586557421405	0.987	0.942	3.32868210548124e-05	RPS19	B cells	GSE207422_Sin_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66295
2.10969109644405e-09	-0.439928556458197	0.941	0.962	5.06684510632967e-05	MT-RNR1	B cells	GSE207422_Sin_post	ENSG00000211459	NA	NA	12S|MOTS-c|MTRNR1	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66296
2.77766393038369e-09	0.348007698696057	0.668	0.408	6.6711154616025e-05	HLA-F	B cells	GSE207422_Sin_post	ENSG00000234487	3134	major histocompatibility complex, class I, F	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66297
3.12425836886163e-09	0.360626464795816	0.939	0.865	7.50353132449499e-05	RPL3	B cells	GSE207422_Sin_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66298
3.26689193850262e-09	0.425768693065662	0.445	0.231	7.84609436870174e-05	ENO1	B cells	GSE207422_Sin_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66299
3.29424804978614e-09	0.264953058477693	1	0.988	7.91179554117136e-05	RPL34	B cells	GSE207422_Sin_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66300
3.5846299512426e-09	0.280553626964456	0.31	0.112	8.60920575389936e-05	UBALD2	B cells	GSE207422_Sin_post	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66301
3.61292821971719e-09	-0.587440294444674	0.164	0.327	8.67716970529477e-05	HSPB1	B cells	GSE207422_Sin_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66302
3.72636163637048e-09	0.544624316114216	0.56	0.335	8.94960274207099e-05	KLF2	B cells	GSE207422_Sin_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66303
4.15487359051317e-09	-0.423518702826316	0.892	0.915	9.97875990233548e-05	MT-ATP8	B cells	GSE207422_Sin_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66304
4.38536042195159e-09	0.351435000113349	0.38	0.177	0.000105323201254011	RHOH	B cells	GSE207422_Sin_post	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66305
4.73794215491525e-09	0.395506043657914	0.535	0.304	0.000113791156734599	HIF1A	B cells	GSE207422_Sin_post	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66306
4.74428463641383e-09	0.368682255582204	0.607	0.442	0.000113943484112751	TNFRSF13C	B cells	GSE207422_Sin_post	ENSG00000159958	115650	TNF receptor superfamily member 13C	BAFFR|CD268	protein_coding	Q96RJ3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66307
5.08754806470584e-09	0.274169230188687	0.993	0.985	0.00012218764187004	RPL23	B cells	GSE207422_Sin_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66308
5.27351134658062e-09	0.345056832138809	0.978	0.881	0.000126653922010827	RPS14	B cells	GSE207422_Sin_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66309
5.45536451922635e-09	0.325762550043612	0.978	0.888	0.000131021489658259	RPL35A	B cells	GSE207422_Sin_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66310
5.99221281262707e-09	0.377049653167989	0.339	0.135	0.000143914975120864	NFKBIA	B cells	GSE207422_Sin_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66311
8.878240868647e-09	0.360494726117581	0.856	0.665	0.000213228710942295	HLA-DQA1	B cells	GSE207422_Sin_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66312
9.20429387572065e-09	0.372192905747187	0.888	0.7	0.000221059526013183	RPL35	B cells	GSE207422_Sin_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66313
9.74891762668173e-09	0.331216553196644	0.521	0.288	0.000234139754640015	SLC38A1	B cells	GSE207422_Sin_post	ENSG00000111371	81539	solute carrier family 38 member 1	ATA1|NAT2|SAT1	protein_coding	Q9H2H9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66314
1.02013158574931e-08	0.360678330166412	0.964	0.85	0.000245005002949411	RPS28	B cells	GSE207422_Sin_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66315
1.54586550299164e-08	0.277874016298548	0.995	0.996	0.000371270517853503	RPL13A	B cells	GSE207422_Sin_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66316
1.80017083281889e-08	-0.503746958308356	0.841	0.827	0.000432347028918113	PTPRC	B cells	GSE207422_Sin_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66317
1.82263317506782e-08	0.331831435325685	0.431	0.215	0.000437741809656039	TAP1	B cells	GSE207422_Sin_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66318
1.95866759645828e-08	-0.423149017713614	0.286	0.462	0.000470413196641386	AHNAK	B cells	GSE207422_Sin_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66319
2.01172253516503e-08	0.405032391404078	0.769	0.558	0.000483155401270585	EZR	B cells	GSE207422_Sin_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66320
2.25104512390934e-08	0.420011634050372	0.62	0.381	0.000540633507409306	TAGLN2	B cells	GSE207422_Sin_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66321
2.8571532596128e-08	0.321505462214137	0.523	0.292	0.000686202498361205	SRSF2	B cells	GSE207422_Sin_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66322
3.05811231159895e-08	0.323921005209071	0.492	0.265	0.00073446683387672	FXYD5	B cells	GSE207422_Sin_post	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66323
3.29969458124976e-08	0.378484027973636	0.667	0.458	0.000792487647578754	RPL18A	B cells	GSE207422_Sin_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66324
5.66645825959747e-08	0.300076325940494	0.894	0.704	0.00136091328020752	RPS15	B cells	GSE207422_Sin_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66325
5.81163667015255e-08	0.341409996461633	0.566	0.338	0.00139578077907054	WSB1	B cells	GSE207422_Sin_post	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66326
6.86012019574471e-08	0.288217057296039	0.755	0.508	0.00164759506741201	EIF4A2	B cells	GSE207422_Sin_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66327
7.29654908552252e-08	0.315376646114758	0.551	0.308	0.00175241219386994	SARAF	B cells	GSE207422_Sin_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66328
7.84629056173669e-08	0.282059352017799	0.344	0.162	0.0018844436042123	MIR1244-2	B cells	GSE207422_Sin_post	ENSG00000283498	100422885	microRNA 1244-2	hsa-mir-1244-2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66329
8.24338887821062e-08	0.351135073905785	0.613	0.381	0.00197981470687984	CIRBP	B cells	GSE207422_Sin_post	ENSG00000099622	1153	cold inducible RNA binding protein	CIRP	protein_coding	Q14011	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66330
8.40853646039547e-08	0.280831506281297	0.27	0.1	0.00201947820169318	ALOX5AP	B cells	GSE207422_Sin_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66331
9.40081784797559e-08	0.359584422873174	0.261	0.104	0.0022577944225483	LY9	B cells	GSE207422_Sin_post	ENSG00000122224	4063	lymphocyte antigen 9	CD229|hly9|mLY9|SLAMF3	protein_coding	Q9HBG7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66332
1.16137807686701e-07	-0.281121047774321	0.135	0.285	0.00278928172721149	ABLIM1	B cells	GSE207422_Sin_post	ENSG00000099204	3983	actin binding LIM protein 1	ABLIM|LIMAB1|limatin	protein_coding	O14639	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66333
1.17541838573038e-07	0.373629401873984	0.332	0.154	0.00282300233700866	LDHA	B cells	GSE207422_Sin_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66334
1.48014067724048e-07	0.255753314423143	0.986	0.904	0.00355485386452847	RPL19	B cells	GSE207422_Sin_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66335
1.51725051720915e-07	0.312475558773383	0.912	0.731	0.00364398056718122	MT-ND4L	B cells	GSE207422_Sin_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66336
1.72971503578119e-07	0.286343741470154	0.459	0.25	0.00415425660143568	SNRPD2	B cells	GSE207422_Sin_post	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66337
1.76790590097438e-07	0.261700738032889	0.377	0.181	0.00424597960237017	AIDA	B cells	GSE207422_Sin_post	ENSG00000186063	64853	axin interactor, dorsalization associated	C1orf80|FLJ12806	protein_coding	Q96BJ3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66338
1.93390917849254e-07	0.330070546086089	0.438	0.235	0.00464466967398552	JUN	B cells	GSE207422_Sin_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66339
2.51081258590617e-07	0.512034000955809	0.573	0.369	0.00603021858757086	BIRC3	B cells	GSE207422_Sin_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66340
2.5437559430324e-07	0.274354969558095	0.456	0.254	0.00610933864838092	C6orf48	B cells	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66341
2.83487307166648e-07	0.260076149733988	0.292	0.127	0.00680851465622137	TARDBP	B cells	GSE207422_Sin_post	ENSG00000120948	23435	TAR DNA binding protein	ALS10|TDP-43	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66342
2.98699318894242e-07	0.300464446462717	0.625	0.415	0.00717386154188301	FCMR	B cells	GSE207422_Sin_post	ENSG00000162894	9214	Fc mu receptor	FAIM3|FcmuR|TOSO	protein_coding	O60667	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66343
3.84741072051194e-07	0.351894523340304	0.679	0.492	0.00924032632745352	CD48	B cells	GSE207422_Sin_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66344
4.35824205001918e-07	0.272415642128103	0.467	0.269	0.0104671899315311	RPS4Y1	B cells	GSE207422_Sin_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66345
4.46901462497922e-07	0.255306905586116	0.259	0.1	0.0107332324248126	IFNGR1	B cells	GSE207422_Sin_post	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66346
5.4096387614995e-07	0.322850185819643	0.53	0.327	0.0129923294134934	SRSF7	B cells	GSE207422_Sin_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66347
6.02830741448567e-07	0.297642463686193	0.281	0.131	0.0144781859173702	EIF1AY	B cells	GSE207422_Sin_post	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66348
6.45646181399837e-07	0.284190786226713	0.332	0.158	0.0155064843386799	CNDP2	B cells	GSE207422_Sin_post	ENSG00000133313	55748	carnosine dipeptidase 2	CN2|CPGL|FLJ10830|HsT2298|PEPA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66349
7.40605565795458e-07	-0.416147305187911	0.503	0.635	0.0177871238737095	POU2F2	B cells	GSE207422_Sin_post	ENSG00000028277	5452	POU class 2 homeobox 2	OCT2|OTF2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66350
8.96937421996209e-07	0.251966075452383	0.924	0.773	0.021541746064083	RACK1	B cells	GSE207422_Sin_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66351
1.08680416238414e-06	0.355234643033385	0.775	0.596	0.0261017755679799	CD53	B cells	GSE207422_Sin_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66352
1.18454916792581e-06	-0.271893940404857	0.135	0.265	0.0284493173660741	ERBIN	B cells	GSE207422_Sin_post	ENSG00000112851	55914	erbb2 interacting protein	ERBB2IP|LAP2	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66353
1.29940398499603e-06	0.284535475044716	0.355	0.177	0.0312077855076497	PPP1R15A	B cells	GSE207422_Sin_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66354
1.61759152307079e-06	0.311783537481819	0.858	0.735	0.0388496956095911	ARHGDIB	B cells	GSE207422_Sin_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66355
1.91065089626846e-06	-0.361342045731548	0.274	0.412	0.0458881025756797	MAP4K4	B cells	GSE207422_Sin_post	ENSG00000071054	9448	mitogen-activated protein kinase kinase kinase kinase 4	FLH21957|HGK|NIK	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66356
4.4498916108352e-17	-0.865070419913891	0	0.643	1.06873046817429e-12	SCGB1A1	pDCs	GSE207422_Sin_post	ENSG00000149021	7356	secretoglobin family 1A member 1	CC10|CC16|CCSP|UGB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66357
2.20313575784066e-11	-1.04121671433941	0.274	0.857	5.29127114960591e-07	RPL10P3	pDCs	GSE207422_Sin_post	ENSG00000230734	NA	NA	bA567J2.2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66358
9.82160313191477e-11	-2.31771584360045	0.032	0.5	2.35885442419197e-06	FCN1	pDCs	GSE207422_Sin_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66359
1.94316977203027e-10	-0.55019708256048	0	0.393	4.66691084148509e-06	SLC7A7	pDCs	GSE207422_Sin_post	ENSG00000155465	9056	solute carrier family 7 member 7	LPI|y+LAT-1	protein_coding	Q9UM01	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66360
1.9607709128206e-10	-0.584962500721156	0	0.393	4.70918350132123e-06	FAM198B	pDCs	GSE207422_Sin_post	NA	NA	NA	NA	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66361
1.22767947371321e-09	-0.891208839157956	1	1	2.94851779201703e-05	MT-RNR2	pDCs	GSE207422_Sin_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66362
1.5438456428868e-09	-0.716207033999409	0	0.357	3.70785408052122e-05	CX3CR1	pDCs	GSE207422_Sin_post	ENSG00000168329	1524	C-X3-C motif chemokine receptor 1	CCRL1|CMKBRL1|CMKDR1|GPR13|V28	protein_coding	P49238	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66363
1.90351616655748e-09	1.76106126978367	0.937	0.5	4.5716747772211e-05	IRF7	pDCs	GSE207422_Sin_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66364
1.99173672198382e-09	2.22542648142608	0.884	0.286	4.78355408518855e-05	GZMB	pDCs	GSE207422_Sin_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66365
2.03780786284353e-09	-1.00128754586046	0.053	0.5	4.89420314419131e-05	MNDA	pDCs	GSE207422_Sin_post	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66366
2.34243156560456e-09	-0.654440940415891	0.021	0.429	5.62581789111247e-05	CLEC12A	pDCs	GSE207422_Sin_post	ENSG00000172322	160364	C-type lectin domain family 12 member A	CD371|CLL-1|DCAL-2|MICL	protein_coding	Q5QGZ9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66367
2.37387594813426e-09	-1.23807972748724	0.084	0.571	5.70133786463405e-05	LST1	pDCs	GSE207422_Sin_post	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66368
2.89183084063858e-09	1.41740840374159	0.884	0.179	6.94531012996168e-05	UGCG	pDCs	GSE207422_Sin_post	ENSG00000148154	7357	UDP-glucose ceramide glucosyltransferase	GCS	protein_coding	Q16739	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66369
7.4687829090212e-09	-3.38424303626926	0.126	0.607	0.000179377759125962	LYZ	pDCs	GSE207422_Sin_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66370
8.6521698706793e-09	1.53705959558556	0.789	0.107	0.000207799163784105	HLA-DRB5	pDCs	GSE207422_Sin_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66371
8.94568223719611e-09	-0.932425687715656	0.074	0.571	0.000214848450290739	FGL2	pDCs	GSE207422_Sin_post	ENSG00000127951	10875	fibrinogen like 2	pT49|T49	protein_coding	Q14314	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66372
9.00047076707243e-09	-0.994316361496417	0.053	0.5	0.000216164306412779	HMOX1	pDCs	GSE207422_Sin_post	ENSG00000100292	3162	heme oxygenase 1	bK286B10|HO-1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66373
9.20457189386334e-09	2.50144422450761	0.747	0.107	0.000221066203174916	AREG	pDCs	GSE207422_Sin_post	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66374
9.22012135865446e-09	-1.66209878931551	0.189	0.679	0.000221439654670804	AIF1	pDCs	GSE207422_Sin_post	ENSG00000235588	199	allograft inflammatory factor 1	AIF-1|Em:AF129756.17|IBA1|IRT-1	protein_coding	P55008	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66375
1.09429204616244e-08	-1.13639220278216	0.958	1	0.000262816120726833	MT-RNR1	pDCs	GSE207422_Sin_post	ENSG00000211459	NA	NA	12S|MOTS-c|MTRNR1	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66376
1.77564829688588e-08	-1.15842936260448	0.2	0.679	0.000426457451463082	MSN	pDCs	GSE207422_Sin_post	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66377
2.09216824935089e-08	-0.484515938973578	0.021	0.393	0.000502476048446604	CFD	pDCs	GSE207422_Sin_post	ENSG00000274619	1675	complement factor D	ADN|DF|PFD	protein_coding	P00746	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66378
2.13317714805265e-08	-1.26946067499323	0.168	0.679	0.000512325155647805	COTL1	pDCs	GSE207422_Sin_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66379
2.4513911428087e-08	1.17336897630694	0.895	0.321	0.000588750610768366	PPP1R14B	pDCs	GSE207422_Sin_post	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66380
3.98496232856139e-08	-1.43444648858914	0.137	0.607	0.00095706840245059	SPI1	pDCs	GSE207422_Sin_post	ENSG00000066336	6688	Spi-1 proto-oncogene	OF|PU.1|SFPI1|SPI-1|SPI-A	protein_coding	P17947	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66381
4.03136047185059e-08	1.41843730789139	0.663	0.036	0.000968211844524357	CXCR3	pDCs	GSE207422_Sin_post	ENSG00000186810	2833	C-X-C motif chemokine receptor 3	CD183|CKR-L2|CMKAR3|GPR9|IP10-R|MigR	protein_coding	P49682	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66382
5.76275153114797e-08	-1.26654319161093	0.095	0.536	0.00138404003523581	SERPINA1	pDCs	GSE207422_Sin_post	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66383
6.41218891678139e-08	1.08940067473752	0.874	0.321	0.00154001541214339	RNASE6	pDCs	GSE207422_Sin_post	ENSG00000169413	6039	ribonuclease A family member k6	RAD1|RNaseK6|RNS6	protein_coding	Q93091	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66384
6.72046904728001e-08	1.47900872615872	0.937	0.75	0.00161405505108524	CTSB	pDCs	GSE207422_Sin_post	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66385
7.23616122230839e-08	1.31909753291378	0.874	0.25	0.0017379088407618	ITM2C	pDCs	GSE207422_Sin_post	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66386
8.36655565748065e-08	-0.362570079384708	0	0.286	0.00200939567225713	ADAMTSL4	pDCs	GSE207422_Sin_post	ENSG00000143382	54507	ADAMTS like 4	DKFZP434K1772|TSRC1	protein_coding	Q6UY14	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66387
8.48505831110497e-08	-1.22574727859481	0.042	0.429	0.00203785645457808	MS4A7	pDCs	GSE207422_Sin_post	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66388
8.53508731973178e-08	2.07221469917625	0.874	0.393	0.00204987192157998	CXCR4	pDCs	GSE207422_Sin_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66389
8.98113496144774e-08	1.15715720540905	0.663	0.036	0.0021569991836909	TNFRSF21	pDCs	GSE207422_Sin_post	ENSG00000146072	27242	TNF receptor superfamily member 21	CD358|DR6	protein_coding	O75509	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66390
1.3908400229844e-07	-0.774573518573919	0.105	0.571	0.00334038048320164	CSTB	pDCs	GSE207422_Sin_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66391
1.60501477928995e-07	-0.410515357529802	0.021	0.357	0.00385476399542066	GSAP	pDCs	GSE207422_Sin_post	ENSG00000186088	54103	gamma-secretase activating protein	LOC54103|PION	protein_coding	A4D1B5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66392
1.70390548772367e-07	-0.578076115135916	0.032	0.393	0.00409226980986593	TIMP1	pDCs	GSE207422_Sin_post	ENSG00000102265	7076	TIMP metallopeptidase inhibitor 1	CLGI|EPO|TIMP	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66393
1.93830601499824e-07	-0.972718393663689	0.074	0.464	0.00465522955622127	APLP2	pDCs	GSE207422_Sin_post	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66394
2.634276999547e-07	-0.762500686273344	0.189	0.679	0.00632674306981203	CD48	pDCs	GSE207422_Sin_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66395
3.42819771344089e-07	-1.05200730346833	0.095	0.5	0.00823350244837098	FGR	pDCs	GSE207422_Sin_post	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66396
3.87795138381429e-07	-1.08442878116071	0.863	0.929	0.00931367583850678	MT-ATP8	pDCs	GSE207422_Sin_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66397
3.88788531349532e-07	-1.6348365530302	0.568	0.929	0.00933753415742171	HSPA1A	pDCs	GSE207422_Sin_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66398
4.02845185619969e-07	1.59790155642865	0.758	0.25	0.0096751328230348	DDIT4	pDCs	GSE207422_Sin_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66399
4.1247144119265e-07	-0.735019949851237	0.084	0.5	0.00990632660312388	ZNF385A	pDCs	GSE207422_Sin_post	ENSG00000161642	25946	zinc finger protein 385A	DKFZp586G1122|Hzf|ZFP385|ZNF385	protein_coding	Q96PM9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66400
4.28821817633931e-07	-0.624997162523409	0.042	0.393	0.0102990135941141	CFP	pDCs	GSE207422_Sin_post	ENSG00000126759	5199	complement factor properdin	PFC	protein_coding	P27918	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66401
4.5337798166799e-07	1.21301662852731	0.842	0.321	0.0108887789857201	ALOX5AP	pDCs	GSE207422_Sin_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66402
6.00271596751004e-07	1.05605244238912	0.884	0.536	0.0144167229391689	PLP2	pDCs	GSE207422_Sin_post	ENSG00000102007	5355	proteolipid protein 2	A4|A4-LSB|MGC126187	protein_coding	Q04941	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66403
6.02766002972171e-07	-0.321928094887362	0	0.25	0.0144766310933826	HK3	pDCs	GSE207422_Sin_post	ENSG00000160883	3101	hexokinase 3	NA	protein_coding	P52790	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66404
6.06047914802981e-07	-0.362570079384708	0	0.25	0.0145554527698232	AOAH	pDCs	GSE207422_Sin_post	ENSG00000136250	313	acyloxyacyl hydrolase	NA	protein_coding	P28039	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66405
6.06047914802981e-07	-0.362570079384708	0	0.25	0.0145554527698232	CD33	pDCs	GSE207422_Sin_post	ENSG00000105383	945	CD33 molecule	FLJ00391|p67|SIGLEC-3|SIGLEC3	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66406
6.23806611274949e-07	-0.815742707550323	0.105	0.536	0.0149819633829905	CPVL	pDCs	GSE207422_Sin_post	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66407
7.64654754235242e-07	-0.574055596860233	0.032	0.357	0.0183647132324678	C19orf38	pDCs	GSE207422_Sin_post	ENSG00000214212	255809	chromosome 19 open reading frame 38	HIDE1	protein_coding	A8MVS5	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66408
7.96095281742876e-07	-0.622019462723513	0.021	0.321	0.0191198203816186	CASP1	pDCs	GSE207422_Sin_post	ENSG00000137752	834	caspase 1	ICE|IL1BC	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66409
1.00813341306022e-06	1.14770264337601	0.579	0.036	0.0242123401814674	SMIM3	pDCs	GSE207422_Sin_post	ENSG00000256235	85027	small integral membrane protein 3	C5orf62|MSTP150|NID67	protein_coding	Q9BZL3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66410
1.22199073912041e-06	0.9866209701988	0.916	0.321	0.0293485515814549	TCF4	pDCs	GSE207422_Sin_post	ENSG00000196628	6925	transcription factor 4	bHLHb19|E2-2|ITF2|SEF2-1B	protein_coding	P15884	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66411
1.25964613732672e-06	-1.41599456866532	0.821	0.929	0.0302529212801758	UBC	pDCs	GSE207422_Sin_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66412
1.2900694096489e-06	-1.47494252881621	0.495	0.893	0.0309835970115375	HSPA1B	pDCs	GSE207422_Sin_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66413
1.39027349077015e-06	0.982926486641059	0.716	0.214	0.0333901984278267	DERL3	pDCs	GSE207422_Sin_post	ENSG00000274437	91319	derlin 3	C22orf14|derlin-3|FLJ43842|IZP6|MGC71803	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66414
1.51406137328802e-06	-0.623040965558082	0.989	1	0.0363632120022583	PABPC1	pDCs	GSE207422_Sin_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66415
1.56191479125066e-06	0.877956927039516	0.705	0.179	0.037512507541467	STMN1	pDCs	GSE207422_Sin_post	ENSG00000117632	3925	stathmin 1	C1orf215|FLJ32206|Lag|LAP18|OP18|PP17|PP19|PR22|SMN	protein_coding	P16949	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66416
1.59287949738353e-06	1.41970264494741	0.8	0.321	0.0382561868886603	IRF4	pDCs	GSE207422_Sin_post	ENSG00000137265	3662	interferon regulatory factor 4	LSIRF|MUM1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66417
1.61437026552718e-06	0.89285114233921	0.789	0.25	0.0387723306671663	IL3RA	pDCs	GSE207422_Sin_post	ENSG00000185291	3563	interleukin 3 receptor subunit alpha	CD123	protein_coding	P26951	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66418
1.92644959985556e-06	0.780397754881268	0.558	0.036	0.0462675400397309	FAM118A	pDCs	GSE207422_Sin_post	ENSG00000100376	55007	family with sequence similarity 118 member A	bK268H5.C22.4|C22orf8|FLJ20635	protein_coding	Q9NWS6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66419
1.95826971247296e-06	0.906778100381288	0.737	0.25	0.0470317636844632	VEGFB	pDCs	GSE207422_Sin_post	ENSG00000173511	7423	vascular endothelial growth factor B	VEGFL|VRF	protein_coding	P49765	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66420
2.50680870597995e-09	-0.925999418556223	0	0.6	6.02060246915204e-05	PREPL	Fibroblasts	GSE207422_Sin_post	ENSG00000138078	9581	prolyl endopeptidase like	KIAA0436	protein_coding	Q4J6C6	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66421
6.9713208498768e-08	-0.925999418556223	0	0.5	0.00167430212851491	PGM5	Fibroblasts	GSE207422_Sin_post	ENSG00000154330	5239	phosphoglucomutase 5	PGMRP	protein_coding	Q15124	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66422
1.35700282560797e-06	-0.874469117916141	0.109	0.8	0.0325911368626266	ZNF638	Fibroblasts	GSE207422_Sin_post	ENSG00000075292	27332	zinc finger protein 638	MGC26130|NP220|ZFML|Zfp638	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66423
1.73101205543942e-06	-0.485426827170242	0	0.4	0.0415737165354886	CENPT	Fibroblasts	GSE207422_Sin_post	ENSG00000102901	80152	centromere protein T	C16orf56|CENP-T|FLJ13111	protein_coding	Q96BT3	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66424
1.73101205543942e-06	-0.485426827170242	0	0.4	0.0415737165354886	FBXO25	Fibroblasts	GSE207422_Sin_post	ENSG00000147364	26260	F-box protein 25	FBX25	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66425
1.73101205543942e-06	-0.485426827170242	0	0.4	0.0415737165354886	KIAA1671	Fibroblasts	GSE207422_Sin_post	ENSG00000197077	85379	KIAA1671	NA	protein_coding	Q9BY89	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66426
1.73101205543942e-06	-0.485426827170242	0	0.4	0.0415737165354886	MAP3K1	Fibroblasts	GSE207422_Sin_post	ENSG00000095015	4214	mitogen-activated protein kinase kinase kinase 1	MAPKKK1|MEKK|MEKK1	protein_coding	Q13233	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66427
1.46360424847723e-13	2.00820233123391	1	0.964	3.51513832356776e-09	MT-CO1	Mast cells	GSE207422_Sin_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66428
6.59274130714454e-13	1.76401194667344	1	0.893	1.5833786797369e-08	MT-CO2	Mast cells	GSE207422_Sin_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66429
1.31396737307068e-12	1.67137725253863	1	0.929	3.15575543990385e-08	MT-CO3	Mast cells	GSE207422_Sin_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66430
2.09497637871251e-11	1.43265304219582	1	0.857	5.03150476875384e-07	HLA-B	Mast cells	GSE207422_Sin_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66431
3.33031463832193e-11	1.52012133990174	1	0.929	7.99841666685778e-07	HLA-C	Mast cells	GSE207422_Sin_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66432
5.80072827738891e-11	-1.22239242133645	0.247	0.857	1.3931609103805e-06	RPL10P3	Mast cells	GSE207422_Sin_post	ENSG00000230734	NA	NA	bA567J2.2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66433
2.37170543349683e-10	1.27502711991833	1	1	5.69612493962933e-06	B2M	Mast cells	GSE207422_Sin_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66434
3.53140796841269e-10	1.75317978190657	0.883	0.214	8.48138251773675e-06	IFITM3	Mast cells	GSE207422_Sin_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66435
6.12974231034429e-10	2.03952836418664	0.961	0.321	1.47218021067539e-05	ZFP36	Mast cells	GSE207422_Sin_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66436
2.13390704803979e-09	2.88219839069261	0.818	0.179	5.12500455727718e-05	AREG	Mast cells	GSE207422_Sin_post	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66437
2.28181920713207e-09	1.93733994488507	0.935	0.679	5.4802451897691e-05	RGS1	Mast cells	GSE207422_Sin_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66438
3.7846648819014e-09	1.50705911917245	0.961	0.321	9.08962964686258e-05	ID2	Mast cells	GSE207422_Sin_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66439
3.89422249378197e-09	1.09487032938206	1	1	9.35275416331615e-05	HLA-A	Mast cells	GSE207422_Sin_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66440
7.9424623924097e-09	-0.747233929620033	0	0.393	0.000190754119278504	TINAGL1	Mast cells	GSE207422_Sin_post	ENSG00000142910	64129	tubulointerstitial nephritis antigen like 1	ARG1|LCN7|LIECG3|P3ECSL|TINAGRP	protein_coding	Q9GZM7	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66441
1.1453910978312e-08	1.58753186033329	0.792	0.179	0.000275088579966119	DDIT4	Mast cells	GSE207422_Sin_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66442
1.20697897033667e-08	-0.633461018412346	0.013	0.429	0.000289880139305757	SCGB1A1	Mast cells	GSE207422_Sin_post	ENSG00000149021	7356	secretoglobin family 1A member 1	CC10|CC16|CCSP|UGB	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66443
1.44116479592903e-08	2.36548167480461	0.805	0.214	0.000346124549038275	TNFAIP3	Mast cells	GSE207422_Sin_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66444
2.1084742603511e-08	1.26639341792371	0.974	0.714	0.000506392263108524	IFITM2	Mast cells	GSE207422_Sin_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66445
3.23928430301616e-08	0.955236290517611	1	1	0.00077797891105539	MT-ATP6	Mast cells	GSE207422_Sin_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66446
3.92324599511656e-08	1.18826663743182	0.896	0.464	0.000942245990647144	IL1RL1	Mast cells	GSE207422_Sin_post	ENSG00000115602	9173	interleukin 1 receptor like 1	DER4|FIT-1|IL33R|ST2|ST2L|ST2V|T1	protein_coding	Q01638	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66447
3.98043887819463e-08	1.73696559416621	0.961	0.75	0.000955982005376004	RGS2	Mast cells	GSE207422_Sin_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66448
4.29834616375032e-08	-1.17801868348865	0.805	1	0.00103233379814791	LMO4	Mast cells	GSE207422_Sin_post	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66449
8.33990383178178e-08	0.996011183153145	1	1	0.00200299470327903	CPA3	Mast cells	GSE207422_Sin_post	ENSG00000163751	1359	carboxypeptidase A3	NA	protein_coding	P15088	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66450
9.57965020427381e-08	1.35625457801226	0.883	0.286	0.00230074458956044	CD69	Mast cells	GSE207422_Sin_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66451
1.12428420558883e-07	1.15062186304669	1	1	0.0027001933765627	TPSAB1	Mast cells	GSE207422_Sin_post	ENSG00000172236	7177	tryptase alpha/beta 1	TPS1|TPS2|TPSB1	protein_coding	Q15661	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66452
1.841454787758e-07	1.16640316349939	0.636	0.036	0.00442262196375839	SOCS1	Mast cells	GSE207422_Sin_post	ENSG00000185338	8651	suppressor of cytokine signaling 1	Cish1|JAB|SOCS-1|SSI-1|TIP3	protein_coding	O15524	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66453
1.88010056151194e-07	1.59671145940024	0.896	0.429	0.00451543751858322	NFKBIA	Mast cells	GSE207422_Sin_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66454
1.95653398304442e-07	1.73558436376785	0.753	0.179	0.00469900766707777	TSC22D3	Mast cells	GSE207422_Sin_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66455
2.47782979564117e-07	1.20706076758046	0.844	0.357	0.00595100382019141	TMEM176B	Mast cells	GSE207422_Sin_post	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66456
3.05204243714422e-07	-0.87178503334493	0.844	0.964	0.00733009032128926	AHNAK	Mast cells	GSE207422_Sin_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66457
3.08783634865632e-07	0.8394412400224	1	0.929	0.00741605655856788	MT-ND1	Mast cells	GSE207422_Sin_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66458
4.75212115583384e-07	1.15019293631813	0.961	0.714	0.0114131693799661	JUNB	Mast cells	GSE207422_Sin_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66459
4.90180730725658e-07	-0.670437899450331	0.987	1	0.0117726706098381	RPS29	Mast cells	GSE207422_Sin_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66460
5.77845681399678e-07	0.84194909884598	0.844	0.286	0.0138781197301761	FOS	Mast cells	GSE207422_Sin_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66461
7.10614223644872e-07	-0.713149969990313	1	1	0.0170668218092789	MT-RNR2	Mast cells	GSE207422_Sin_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66462
7.81354634535838e-07	-0.910810964979861	0.208	0.679	0.0187657942576472	GNAQ	Mast cells	GSE207422_Sin_post	ENSG00000156052	2776	G protein subunit alpha q	G-ALPHA-q|GAQ	protein_coding	P50148	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66463
8.93465148048593e-07	1.44264196067345	0.792	0.321	0.0214583524606831	PLIN2	Mast cells	GSE207422_Sin_post	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66464
1.03695533605684e-06	0.969795069762479	1	1	0.0249045563060772	SRGN	Mast cells	GSE207422_Sin_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66465
1.31169077590284e-06	-0.817885589549773	0.688	0.929	0.0315028773648585	FOXP1	Mast cells	GSE207422_Sin_post	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66466
1.55268888310771e-06	0.923321668946108	1	0.821	0.0372909289055979	MT-ND3	Mast cells	GSE207422_Sin_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66467
1.69719529937061e-06	0.796329552284319	0.961	0.607	0.0407615395049839	CTSB	Mast cells	GSE207422_Sin_post	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE207422_Sin	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 5, sensitive 2)	7	22187	Public on Mar 21, 2023	36869384	This dataset has 7 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66468
1.04502939317445e-82	1.0713197257515	0.674	0.378	2.34797204058435e-78	RPS26	CD8+ T cells	GSE207422_Tor_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66469
1.26954139890826e-67	-0.414261164347609	0.999	0.998	2.85240561506709e-63	HLA-C	CD8+ T cells	GSE207422_Tor_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66470
3.01539305334788e-66	-1.08362157956867	0.11	0.446	6.77498511226203e-62	CXCL13	CD8+ T cells	GSE207422_Tor_post	ENSG00000156234	10563	C-X-C motif chemokine ligand 13	ANGIE|ANGIE2|BCA-1|BLC|BLR1L|SCYB13	protein_coding	O43927	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66471
4.75021705679318e-65	-1.16841193428165	0.2	0.529	1.06727876832029e-60	EGR1	CD8+ T cells	GSE207422_Tor_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66472
3.80360900638286e-61	-1.02279915164375	0.406	0.697	8.545948715541e-57	PRF1	CD8+ T cells	GSE207422_Tor_post	ENSG00000180644	5551	perforin 1	HPLH2|P1|PFP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66473
2.56509422876235e-54	1.0792664255552	0.689	0.462	5.76325371318324e-50	TNFAIP3	CD8+ T cells	GSE207422_Tor_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66474
3.49872978904175e-54	-1.1016243491031	0.461	0.713	7.86094609001901e-50	IGKC	CD8+ T cells	GSE207422_Tor_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66475
1.19593638718126e-52	-0.731074767183875	0.281	0.609	2.68702987471886e-48	RHOB	CD8+ T cells	GSE207422_Tor_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66476
1.04906755159486e-50	-0.626770102600168	0.696	0.878	2.35704497492334e-46	JUN	CD8+ T cells	GSE207422_Tor_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66477
7.69719087239538e-44	0.470004369824868	0.261	0.043	1.72940484520979e-39	HLA-DRB5	CD8+ T cells	GSE207422_Tor_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66478
3.6287060416842e-41	0.959663709560598	0.816	0.675	8.15297673445605e-37	CXCR4	CD8+ T cells	GSE207422_Tor_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66479
7.72993476954326e-36	-0.667897343036061	0.672	0.838	1.73676174402098e-31	NKG7	CD8+ T cells	GSE207422_Tor_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66480
8.47418546100106e-36	0.397291828373926	0.997	0.991	1.90397998937772e-31	RPS29	CD8+ T cells	GSE207422_Tor_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66481
1.77369747714551e-35	-0.489419898184084	0.676	0.841	3.98514349165052e-31	MTATP6P1	CD8+ T cells	GSE207422_Tor_post	ENSG00000248527	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66482
4.6366283631456e-35	-0.557143772531994	0.886	0.944	1.04175766063155e-30	CCL5	CD8+ T cells	GSE207422_Tor_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66483
5.06309727742567e-35	-0.564807185787351	0.227	0.474	1.137576696292e-30	LAG3	CD8+ T cells	GSE207422_Tor_post	ENSG00000089692	3902	lymphocyte activating 3	CD223	protein_coding	P18627	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66484
9.16944844980682e-35	-0.447858271779376	0.165	0.401	2.0601916777026e-30	ITGAE	CD8+ T cells	GSE207422_Tor_post	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66485
1.02761813407538e-33	-0.901106016388021	0.382	0.608	2.30885242364057e-29	GZMB	CD8+ T cells	GSE207422_Tor_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66486
2.77163027131921e-33	0.447355237980248	0.3	0.095	6.2272988936e-29	HLA-DQB1	CD8+ T cells	GSE207422_Tor_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66487
8.34340994252384e-33	-0.695469363417631	0.325	0.568	1.87459734588626e-28	IFNG	CD8+ T cells	GSE207422_Tor_post	ENSG00000111537	3458	interferon gamma	NA	protein_coding	P01579	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66488
9.18477765172811e-33	0.4135060097395	0.974	0.947	2.06363584279027e-28	RPL30	CD8+ T cells	GSE207422_Tor_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66489
1.73780758189934e-32	0.379947073184853	0.998	0.991	3.90450607501145e-28	EEF1A1	CD8+ T cells	GSE207422_Tor_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66490
1.18203354622199e-30	-0.459732855703396	0.158	0.382	2.65579297165157e-26	HAVCR2	CD8+ T cells	GSE207422_Tor_post	ENSG00000135077	84868	hepatitis A virus cellular receptor 2	CD366|FLJ14428|Tim-3|TIM3|TIMD3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66491
1.37525323335246e-30	-0.379738067648421	0.097	0.294	3.0899189646963e-26	MYO7A	CD8+ T cells	GSE207422_Tor_post	ENSG00000137474	4647	myosin VIIA	DFNA11|DFNB2|NSRD2|USH1B	protein_coding	Q13402	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66492
2.67828667211091e-29	-0.359795698757545	0.079	0.265	6.01757449489879e-25	ENTPD1	CD8+ T cells	GSE207422_Tor_post	ENSG00000138185	953	ectonucleoside triphosphate diphosphohydrolase 1	ATPDase|CD39|NTPDase-1|SPG64	protein_coding	P49961	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66493
1.03027447827338e-28	-0.462189657980887	0.192	0.411	2.31482069778462e-24	KLRD1	CD8+ T cells	GSE207422_Tor_post	ENSG00000134539	3824	killer cell lectin like receptor D1	CD94	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66494
1.12831940409561e-28	-0.506213210945958	0.312	0.55	2.53510803712201e-24	RBPJ	CD8+ T cells	GSE207422_Tor_post	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66495
2.44827522152271e-28	-0.413323274271381	0.267	0.504	5.50078476771722e-24	CD63	CD8+ T cells	GSE207422_Tor_post	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66496
2.78908505145361e-27	1.00865595504962	0.389	0.209	6.26651629360596e-23	HSPH1	CD8+ T cells	GSE207422_Tor_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66497
6.23481943294018e-26	0.480611583084963	0.28	0.104	1.400839230193e-21	GPR183	CD8+ T cells	GSE207422_Tor_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66498
2.21659301055258e-24	-0.734340754357098	0.632	0.728	4.98024117610954e-20	FOS	CD8+ T cells	GSE207422_Tor_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66499
4.51564638300575e-24	0.615769527500917	0.795	0.671	1.01457542933373e-19	KLF6	CD8+ T cells	GSE207422_Tor_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66500
8.55029839839281e-24	-0.283204663158002	0.996	0.996	1.9210810441509e-19	MT-CYB	CD8+ T cells	GSE207422_Tor_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66501
8.64026135990824e-24	0.31936258556045	0.997	1	1.94129392234418e-19	MT-RNR2	CD8+ T cells	GSE207422_Tor_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66502
9.51969492317958e-24	-0.3912960084735	0.471	0.682	2.13888505533999e-19	HLA-DRB1	CD8+ T cells	GSE207422_Tor_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66503
9.19798867565425e-23	-0.494181562133156	0.677	0.813	2.066604095646e-18	GAPDH	CD8+ T cells	GSE207422_Tor_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66504
1.00627150948642e-22	-0.40897810215013	0.739	0.879	2.26089082751408e-18	GZMA	CD8+ T cells	GSE207422_Tor_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66505
2.18332664206402e-22	-0.532578131849209	0.259	0.448	4.90549829938945e-18	TRGC2	CD8+ T cells	GSE207422_Tor_post	ENSG00000227191	NA	NA	TCRGC2|TRGC2(2X)|TRGC2(3X)	TR_C_gene	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66506
5.58904651394105e-22	-0.448250409966958	0.49	0.699	1.25574697075227e-17	ID2	CD8+ T cells	GSE207422_Tor_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66507
6.1335459659188e-22	-0.399772885928313	0.792	0.895	1.37808510762264e-17	TRAC	CD8+ T cells	GSE207422_Tor_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66508
4.51310902589126e-21	-0.384247711485225	0.386	0.601	1.01400533593725e-16	GZMH	CD8+ T cells	GSE207422_Tor_post	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66509
6.13376908063786e-21	0.636034469899994	0.492	0.343	1.37813523703771e-16	DNAJA1	CD8+ T cells	GSE207422_Tor_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66510
6.19083167234012e-21	-0.348148336398611	0.17	0.34	1.39095606014138e-16	PDCD1	CD8+ T cells	GSE207422_Tor_post	ENSG00000276977	5133	programmed cell death 1	CD279|hSLE1|PD-1|PD1|SLEB2	protein_coding	Q15116	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66511
2.15321535244846e-20	-0.395464103707854	0.443	0.619	4.8378442538812e-16	ITM2A	CD8+ T cells	GSE207422_Tor_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66512
5.66685784147429e-20	0.348341020679873	0.939	0.921	1.27322961982244e-15	RPL13A	CD8+ T cells	GSE207422_Tor_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66513
6.3637308147219e-20	0.566671530586157	0.45	0.292	1.42980303945172e-15	ANXA1	CD8+ T cells	GSE207422_Tor_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66514
8.40498690174334e-20	-0.450192271875861	0.371	0.547	1.88843245708369e-15	ALOX5AP	CD8+ T cells	GSE207422_Tor_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66515
9.64756762628464e-20	0.27522734521638	0.999	0.992	2.16761549427363e-15	MT-ND3	CD8+ T cells	GSE207422_Tor_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66516
1.121912905437e-18	0.313435352629911	0.992	0.974	2.52071391593584e-14	RPS6	CD8+ T cells	GSE207422_Tor_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66517
2.14343241544816e-18	-0.381862813182229	0.593	0.751	4.81586395102892e-14	IKZF3	CD8+ T cells	GSE207422_Tor_post	ENSG00000161405	22806	IKAROS family zinc finger 3	Aiolos|ZNFN1A3	protein_coding	Q9UKT9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66518
8.27899531009468e-18	-0.335119814013597	0.533	0.71	1.86012466627207e-13	CD3D	CD8+ T cells	GSE207422_Tor_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66519
1.79154002351707e-17	-0.258522537913934	0.142	0.295	4.02523212483816e-13	AKAP5	CD8+ T cells	GSE207422_Tor_post	ENSG00000179841	9495	A-kinase anchoring protein 5	AKAP75|AKAP79	protein_coding	P24588	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66520
2.09818333991615e-17	-0.273433588336992	0.12	0.267	4.71419832812362e-13	RAB3GAP1	CD8+ T cells	GSE207422_Tor_post	ENSG00000115839	22930	RAB3 GTPase activating protein catalytic subunit 1	KIAA0066|RAB3GAP|RAB3GAP130|WARBM1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66521
2.86286037461811e-17	0.297164721657873	0.964	0.921	6.43227468969197e-13	RPS16	CD8+ T cells	GSE207422_Tor_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66522
3.05249854718918e-17	-0.260281635539855	0.241	0.42	6.85835373582464e-13	ORMDL3	CD8+ T cells	GSE207422_Tor_post	ENSG00000172057	94103	ORMDL sphingolipid biosynthesis regulator 3	NA	protein_coding	Q8N138	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66523
7.97711302076556e-17	0.351221361548483	0.744	0.672	1.79229775350561e-12	RPL23A	CD8+ T cells	GSE207422_Tor_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66524
1.70360824744172e-16	0.34468040112586	0.586	0.446	3.82766701035205e-12	MTND1P23	CD8+ T cells	GSE207422_Tor_post	ENSG00000225972	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66525
1.76684262711033e-16	-0.468163254076704	0.238	0.416	3.96974201459148e-12	GNLY	CD8+ T cells	GSE207422_Tor_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66526
1.8862500673224e-16	0.307092977818666	0.904	0.815	4.23802665125997e-12	EIF1	CD8+ T cells	GSE207422_Tor_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66527
2.42634810804519e-16	-0.28345209530629	0.613	0.704	5.45151892915592e-12	HSPA1A	CD8+ T cells	GSE207422_Tor_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66528
4.63495159934765e-16	0.346356223780506	0.644	0.526	1.04138092534143e-11	RPL24	CD8+ T cells	GSE207422_Tor_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66529
8.76307190367837e-16	-0.391360001193658	0.407	0.562	1.96888699531846e-11	CCND2	CD8+ T cells	GSE207422_Tor_post	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66530
9.15213050494294e-16	0.320630026889471	0.902	0.839	2.05630068185058e-11	RPL28	CD8+ T cells	GSE207422_Tor_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66531
2.02337432072298e-15	-0.293523729031447	0.26	0.425	4.54611742380039e-11	CD82	CD8+ T cells	GSE207422_Tor_post	ENSG00000085117	3732	CD82 molecule	IA4|KAI1|R2|ST6|TSPAN27	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66532
2.32305135563304e-15	-0.308206077994888	0.217	0.382	5.21943178583631e-11	NR4A1	CD8+ T cells	GSE207422_Tor_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66533
2.68297404014484e-15	0.484775257990717	0.756	0.632	6.02810607339742e-11	FTH1	CD8+ T cells	GSE207422_Tor_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66534
5.16384295356546e-15	-0.280612873370829	0.278	0.436	1.16021223480709e-10	PTPN22	CD8+ T cells	GSE207422_Tor_post	ENSG00000134242	26191	protein tyrosine phosphatase non-receptor type 22	Lyp|Lyp1|Lyp2|PTPN8	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66535
8.51744234985933e-15	0.256098661515502	0.973	0.959	1.9136989471664e-10	RPL27A	CD8+ T cells	GSE207422_Tor_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66536
1.24747490991089e-14	0.318074923474977	0.592	0.461	2.80282662758778e-10	SARAF	CD8+ T cells	GSE207422_Tor_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66537
1.28602399566362e-14	0.465321687344235	0.678	0.576	2.88943871345703e-10	ZFP36L2	CD8+ T cells	GSE207422_Tor_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66538
1.80767079915119e-14	-0.368058715256534	0.384	0.54	4.0614747515329e-10	TIGIT	CD8+ T cells	GSE207422_Tor_post	ENSG00000181847	201633	T cell immunoreceptor with Ig and ITIM domains	DKFZp667A205|FLJ39873|VSIG9|VSTM3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66539
1.98834637270545e-14	0.298070012527553	0.902	0.835	4.46741663019461e-10	RPL38	CD8+ T cells	GSE207422_Tor_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66540
4.82609499722295e-14	-0.348669079859991	0.639	0.751	1.08432702397605e-09	UBB	CD8+ T cells	GSE207422_Tor_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66541
1.2864039800033e-13	-0.25377456977241	0.713	0.854	2.89029246227142e-09	IL2RG	CD8+ T cells	GSE207422_Tor_post	ENSG00000147168	3561	interleukin 2 receptor subunit gamma	CD132|CIDX|IMD4|SCIDX1	protein_coding	P31785	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66542
1.36718755698192e-13	-0.345362776840163	0.421	0.574	3.07179700302697e-09	CD7	CD8+ T cells	GSE207422_Tor_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66543
4.0171934786885e-13	-0.319064405970579	0.5	0.641	9.02583030791732e-09	RAB27A	CD8+ T cells	GSE207422_Tor_post	ENSG00000069974	5873	RAB27A, member RAS oncogene family	GS2|HsT18676|RAB27|RAM	protein_coding	P51159	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66544
4.15985191105076e-13	0.332749878355286	0.862	0.792	9.34635527374884e-09	RPS4X	CD8+ T cells	GSE207422_Tor_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66545
4.88626225515209e-13	0.339141790217305	0.307	0.179	1.09784540348757e-08	MYADM	CD8+ T cells	GSE207422_Tor_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66546
9.36967736313358e-13	0.350730712402021	0.352	0.229	2.10517910994885e-08	YPEL5	CD8+ T cells	GSE207422_Tor_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66547
9.94304829502578e-13	0.333599907493342	0.795	0.762	2.23400409092639e-08	BTG1	CD8+ T cells	GSE207422_Tor_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66548
2.1567176341593e-12	0.253772376195978	0.977	0.946	4.84571318042911e-08	RPS8	CD8+ T cells	GSE207422_Tor_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66549
2.21366994990595e-12	-0.29613620552715	0.652	0.785	4.97367364344868e-08	CD8A	CD8+ T cells	GSE207422_Tor_post	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66550
5.49789174006893e-12	-0.266696268785505	0.241	0.377	1.23526631615869e-07	CBLB	CD8+ T cells	GSE207422_Tor_post	ENSG00000114423	868	Cbl proto-oncogene B	Cbl-b|RNF56	protein_coding	Q13191	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66551
6.67329755778447e-12	1.02082350480024	0.929	0.909	1.49935649528302e-07	HSP90AA1	CD8+ T cells	GSE207422_Tor_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66552
7.10047424151825e-12	0.410218797412835	0.254	0.147	1.59533455258432e-07	NFKBIZ	CD8+ T cells	GSE207422_Tor_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66553
8.84293597826573e-12	0.299073470177249	0.708	0.657	1.98683085559674e-07	RPL14	CD8+ T cells	GSE207422_Tor_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66554
9.30093716451418e-12	0.251582985244992	0.944	0.9	2.08973456212305e-07	RPL32	CD8+ T cells	GSE207422_Tor_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66555
9.86038557574506e-12	-0.282166288863362	0.668	0.79	2.2154314311584e-07	DDX17	CD8+ T cells	GSE207422_Tor_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66556
1.20502217883857e-11	0.43008275523202	0.432	0.315	2.70744383141449e-07	PIK3R1	CD8+ T cells	GSE207422_Tor_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66557
6.77578717840676e-11	0.484354828506905	0.316	0.214	1.52238386324443e-06	HSPD1	CD8+ T cells	GSE207422_Tor_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66558
1.8834661383674e-10	-0.264535098501822	0.335	0.462	4.23177171968387e-06	CANX	CD8+ T cells	GSE207422_Tor_post	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66559
2.18881639919771e-10	-0.618695012914952	0.217	0.338	4.91783268571742e-06	CCL3	CD8+ T cells	GSE207422_Tor_post	ENSG00000278567	6348	C-C motif chemokine ligand 3	G0S19-1|LD78ALPHA|MIP-1-alpha|SCYA3	protein_coding	P10147	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66560
2.45099054507449e-10	0.285078311663794	0.465	0.35	5.50688555667337e-06	TSC22D3	CD8+ T cells	GSE207422_Tor_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66561
2.46618099810661e-10	-0.256840093479911	0.779	0.86	5.54101546654593e-06	CD2	CD8+ T cells	GSE207422_Tor_post	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66562
2.80897414927734e-10	0.260802676175127	0.785	0.757	6.31120311859632e-06	RPS17	CD8+ T cells	GSE207422_Tor_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66563
3.04953921247145e-10	-0.25865646337082	0.537	0.677	6.85170470258086e-06	APOBEC3G	CD8+ T cells	GSE207422_Tor_post	ENSG00000239713	60489	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	bK150C2.7|CEM15|dJ494G10.1|FLJ12740|MDS019	protein_coding	Q9HC16	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66564
4.73193755492803e-10	0.311981677768121	0.886	0.844	1.06317172984123e-05	JUND	CD8+ T cells	GSE207422_Tor_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66565
5.18594330992084e-10	-0.264041157480535	0.531	0.668	1.16517774287301e-05	APOBEC3C	CD8+ T cells	GSE207422_Tor_post	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66566
8.7616625164504e-10	-0.250091175340293	0.523	0.649	1.96857033419608e-05	CD96	CD8+ T cells	GSE207422_Tor_post	ENSG00000153283	10225	CD96 molecule	TACTILE	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66567
1.15789220269624e-09	0.260866894113555	0.833	0.816	2.6015522010179e-05	RPL13	CD8+ T cells	GSE207422_Tor_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66568
3.22846123220894e-09	-0.317572678440719	0.28	0.394	7.25370669652704e-05	MT2A	CD8+ T cells	GSE207422_Tor_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66569
5.60563186523544e-09	-0.29063367425015	0.523	0.628	0.00012594733674811	CALR	CD8+ T cells	GSE207422_Tor_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66570
6.67147076157069e-09	0.255277817690246	0.257	0.161	0.00014989460507097	TENT5C	CD8+ T cells	GSE207422_Tor_post	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66571
1.08431063394514e-08	-0.28040311139688	0.477	0.586	0.000243622913234794	HSP90B1	CD8+ T cells	GSE207422_Tor_post	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66572
2.59453250970114e-08	0.259006178015251	0.512	0.431	0.000582939564279652	EMB	CD8+ T cells	GSE207422_Tor_post	ENSG00000170571	133418	embigin	MGC71745	protein_coding	Q6PCB8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66573
7.17271186937806e-08	-0.254370687990817	0.386	0.499	0.00161156490281186	PTMS	CD8+ T cells	GSE207422_Tor_post	ENSG00000159335	5763	parathymosin	ParaT	protein_coding	P20962	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66574
1.02390936753219e-07	0.377180778703767	0.874	0.814	0.00230051956697132	JUNB	CD8+ T cells	GSE207422_Tor_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66575
1.52202465652765e-07	0.365460216583944	0.427	0.339	0.00341968499828632	RGCC	CD8+ T cells	GSE207422_Tor_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66576
1.55790783203781e-07	0.263384109941908	0.775	0.731	0.00350030731702255	VIM	CD8+ T cells	GSE207422_Tor_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66577
3.05284590992134e-07	0.389497786932701	0.268	0.194	0.00685913419041127	TXN	CD8+ T cells	GSE207422_Tor_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66578
7.14302775031263e-07	0.452474461246687	0.392	0.324	0.0160489547494024	IFI6	CD8+ T cells	GSE207422_Tor_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66579
9.21829569252142e-07	0.419986436653779	0.427	0.355	0.0207116667619571	CSTB	CD8+ T cells	GSE207422_Tor_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66580
1.13624566760322e-06	0.289991010008331	0.744	0.628	0.0255291676597091	FTL	CD8+ T cells	GSE207422_Tor_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66581
1.55365384564056e-06	0.258870643071608	0.561	0.484	0.0349074946038521	DUSP2	CD8+ T cells	GSE207422_Tor_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66582
2.08810640113906e-123	1.44484425302878	0.866	0.384	4.69155746207923e-119	RPS26	CD4+ T cells	GSE207422_Tor_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66583
7.30547319206936e-86	-1.43995392406907	0.089	0.576	1.64139371679414e-81	EGR1	CD4+ T cells	GSE207422_Tor_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66584
2.85489852074581e-63	1.28674547009704	0.91	0.745	6.41438599641169e-59	CXCR4	CD4+ T cells	GSE207422_Tor_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66585
2.69728668537404e-62	-1.39243707689287	0.559	0.806	6.06026372469839e-58	HSPA1B	CD4+ T cells	GSE207422_Tor_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66586
8.50580869292812e-61	1.41371902173317	0.752	0.467	1.91108509712709e-56	TNFAIP3	CD4+ T cells	GSE207422_Tor_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66587
5.3743155618761e-58	0.568189866143755	0.997	0.998	1.20750122044232e-53	MT-ND3	CD4+ T cells	GSE207422_Tor_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66588
2.06346200768828e-51	-0.573952194985681	0.032	0.336	4.63618643887404e-47	ENTPD1	CD4+ T cells	GSE207422_Tor_post	ENSG00000138185	953	ectonucleoside triphosphate diphosphohydrolase 1	ATPDase|CD39|NTPDase-1|SPG64	protein_coding	P49961	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66589
5.61862130321343e-49	-1.56575094965299	0.456	0.716	1.26239183440599e-44	HSPA1A	CD4+ T cells	GSE207422_Tor_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66590
2.88744298849781e-45	-0.542409786430014	1	1	6.48750690655687e-41	ACTB	CD4+ T cells	GSE207422_Tor_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66591
2.22871276828053e-42	0.4723646952564	0.999	0.998	5.0074718477727e-38	MT-ND2	CD4+ T cells	GSE207422_Tor_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66592
8.31007817482891e-40	0.735426764833294	0.905	0.802	1.86710836432056e-35	BTG1	CD4+ T cells	GSE207422_Tor_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66593
9.06690182508608e-39	-0.469355974303183	1	1	2.03715150206034e-34	HLA-C	CD4+ T cells	GSE207422_Tor_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66594
7.24925215655035e-38	-1.27432033729491	0.429	0.708	1.62876197453373e-33	IGKC	CD4+ T cells	GSE207422_Tor_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66595
1.20607448339676e-37	0.826282557421522	0.711	0.45	2.70980814929584e-33	TSC22D3	CD4+ T cells	GSE207422_Tor_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66596
1.74153219047783e-37	0.564872611414923	0.985	0.949	3.91287452556559e-33	RPL30	CD4+ T cells	GSE207422_Tor_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66597
1.73815886084417e-34	0.642082256830063	0.707	0.447	3.90529532854469e-30	MTND1P23	CD4+ T cells	GSE207422_Tor_post	ENSG00000225972	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66598
9.75793629389751e-34	0.878049954255044	0.811	0.65	2.19241312651289e-29	ZFP36L2	CD4+ T cells	GSE207422_Tor_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66599
1.00769109111934e-33	-0.317929768171878	1	1	2.26408034352693e-29	B2M	CD4+ T cells	GSE207422_Tor_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66600
8.64170297419119e-31	0.582841220214562	0.951	0.888	1.94161782424128e-26	RPS4X	CD4+ T cells	GSE207422_Tor_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66601
2.67551937358163e-30	0.506839261189433	0.931	0.863	6.01135692856321e-26	MT-ATP8	CD4+ T cells	GSE207422_Tor_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66602
5.5113009781542e-28	0.547563548305308	0.823	0.641	1.23827910377169e-23	RPL23A	CD4+ T cells	GSE207422_Tor_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66603
1.07534108828574e-27	0.894280095583586	0.727	0.531	2.4160763571604e-23	IL7R	CD4+ T cells	GSE207422_Tor_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66604
1.27229861387989e-26	-0.448830209794725	0.269	0.542	2.85860052566535e-22	JAK3	CD4+ T cells	GSE207422_Tor_post	ENSG00000105639	3718	Janus kinase 3	JAK-3|JAK3_HUMAN|JAKL|L-JAK|LJAK	protein_coding	P52333	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66605
1.32710952907672e-26	-0.769365113791227	0.195	0.449	2.98174968992959e-22	NR4A1	CD4+ T cells	GSE207422_Tor_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66606
3.21215503480229e-26	-0.830025258216689	0.13	0.359	7.21706993219379e-22	RHOB	CD4+ T cells	GSE207422_Tor_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66607
5.66367047188651e-26	0.384734233210198	0.999	0.994	1.27251348162346e-21	RPS29	CD4+ T cells	GSE207422_Tor_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66608
1.35802456558835e-25	-0.27318054329422	0.999	0.998	3.0512095939639e-21	MT-CO1	CD4+ T cells	GSE207422_Tor_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66609
3.85234446071134e-25	-0.605595479363613	0.207	0.447	8.65544753432624e-21	FURIN	CD4+ T cells	GSE207422_Tor_post	ENSG00000140564	5045	furin, paired basic amino acid cleaving enzyme	FUR|PACE|PCSK3|SPC1	protein_coding	P09958	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66610
1.86894538902659e-23	0.650188304513842	0.939	0.885	4.19914650006494e-19	JUNB	CD4+ T cells	GSE207422_Tor_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66611
2.22922489417279e-23	0.508646923424285	0.281	0.075	5.00862249222742e-19	ANXA1	CD4+ T cells	GSE207422_Tor_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66612
1.69298307966181e-22	0.409934245142341	0.975	0.948	3.80379438338416e-18	RPL13A	CD4+ T cells	GSE207422_Tor_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66613
2.2606347550469e-22	-0.49464143084772	0.615	0.862	5.07919416763937e-18	MAF	CD4+ T cells	GSE207422_Tor_post	ENSG00000178573	4094	MAF bZIP transcription factor	c-MAF	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66614
7.29645697288555e-22	-0.579682357994766	0.397	0.631	1.63936795266793e-17	CD7	CD4+ T cells	GSE207422_Tor_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66615
1.18882017370216e-20	-0.592392274036712	0.49	0.707	2.67104116627402e-16	PIM2	CD4+ T cells	GSE207422_Tor_post	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66616
1.57770552022872e-20	0.351063644258908	0.993	0.986	3.54478876284989e-16	RPS6	CD4+ T cells	GSE207422_Tor_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66617
4.40467349223621e-20	0.40077172944521	0.984	0.951	9.89642040235631e-16	RPL32	CD4+ T cells	GSE207422_Tor_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66618
6.68179889109401e-20	-0.461853706873685	0.715	0.856	1.501266574851e-15	FOS	CD4+ T cells	GSE207422_Tor_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66619
1.40349670055112e-19	0.479091313041465	0.754	0.636	3.15337638679825e-15	RPL26	CD4+ T cells	GSE207422_Tor_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66620
1.8003582762305e-19	0.641103947353383	0.759	0.63	4.04504497503468e-15	KLF6	CD4+ T cells	GSE207422_Tor_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66621
3.34781859060292e-19	0.363496781268927	0.981	0.972	7.52187880936664e-15	RPS27A	CD4+ T cells	GSE207422_Tor_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66622
1.33699414045907e-18	-0.502172254226007	0.417	0.641	3.00395843478344e-14	RNF213	CD4+ T cells	GSE207422_Tor_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66623
1.6667614663941e-18	-0.675976890639914	0.596	0.743	3.74487966269425e-14	DNAJB1	CD4+ T cells	GSE207422_Tor_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66624
2.72886496539872e-18	-0.39509307862282	0.902	0.963	6.13121380425785e-14	ACTG1	CD4+ T cells	GSE207422_Tor_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66625
5.06746374637552e-18	0.517317414317203	0.266	0.094	1.13855775453565e-13	ZNF331	CD4+ T cells	GSE207422_Tor_post	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66626
1.60670465804648e-17	0.368306240370821	0.917	0.888	3.60994402569882e-13	RPL28	CD4+ T cells	GSE207422_Tor_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66627
3.87533657665638e-17	-0.320201374869382	0.199	0.404	8.70710622043155e-13	ZNRF1	CD4+ T cells	GSE207422_Tor_post	ENSG00000186187	84937	zinc and ring finger 1	DKFZp434E229|FLJ14846|nin283	protein_coding	Q8ND25	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66628
9.23156655392237e-17	0.344637645456393	0.963	0.906	2.07414837333528e-12	RPL21	CD4+ T cells	GSE207422_Tor_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66629
1.05825742501852e-16	0.403017101156997	0.297	0.12	2.37769278253162e-12	PTGER4	CD4+ T cells	GSE207422_Tor_post	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66630
2.5789704750666e-16	-0.331541059919901	0.207	0.406	5.79443086337963e-12	TOX2	CD4+ T cells	GSE207422_Tor_post	ENSG00000124191	84969	TOX high mobility group box family member 2	C20orf100|dJ1108D11.2|GCX-1	protein_coding	Q96NM4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66631
9.23735606255303e-16	-0.315917288665542	0.121	0.296	2.07544916013441e-11	GADD45B	CD4+ T cells	GSE207422_Tor_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66632
2.76431782555868e-15	0.465288189889786	0.694	0.522	6.21086929046525e-11	VIM	CD4+ T cells	GSE207422_Tor_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66633
2.78354587929905e-15	0.332948247278973	0.985	0.955	6.25407088160911e-11	RPL31	CD4+ T cells	GSE207422_Tor_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66634
6.97966908316036e-15	0.567427054680094	0.388	0.214	1.56819204960447e-10	GPR183	CD4+ T cells	GSE207422_Tor_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66635
1.11796694386844e-14	-0.50041818520101	0.285	0.47	2.51184812948362e-10	HSPB1	CD4+ T cells	GSE207422_Tor_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66636
1.40893809127579e-14	0.597789993030759	0.628	0.442	3.16560210347844e-10	CD69	CD4+ T cells	GSE207422_Tor_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66637
1.90196874845518e-14	-0.309111550830381	0.135	0.3	4.27334338402909e-10	HSPE1	CD4+ T cells	GSE207422_Tor_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66638
6.72287440282664e-14	-0.419325806333354	0.228	0.401	1.51049542082709e-09	MAL	CD4+ T cells	GSE207422_Tor_post	ENSG00000172005	4118	mal, T cell differentiation protein	MVP17|VIP17	protein_coding	P21145	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66639
2.34859864254972e-13	-0.339788692284384	0.677	0.817	5.2768314300807e-09	JUN	CD4+ T cells	GSE207422_Tor_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66640
2.70122150924263e-13	-0.34389742138184	0.423	0.614	6.06910448696634e-09	LDHA	CD4+ T cells	GSE207422_Tor_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66641
2.86932063021912e-13	-0.332696496898726	0.781	0.899	6.44678959197631e-09	RAC2	CD4+ T cells	GSE207422_Tor_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66642
3.01751878680355e-13	-0.322832052901244	0.577	0.75	6.77976121019021e-09	RBM39	CD4+ T cells	GSE207422_Tor_post	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66643
3.92138066676714e-13	-0.282805711238113	0.207	0.384	8.8105580820924e-09	ORMDL3	CD4+ T cells	GSE207422_Tor_post	ENSG00000172057	94103	ORMDL sphingolipid biosynthesis regulator 3	NA	protein_coding	Q8N138	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66644
4.15476970609317e-13	0.282035925840365	0.995	0.992	9.33493657565013e-09	RPL34	CD4+ T cells	GSE207422_Tor_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66645
8.68308550079149e-13	-0.33763996793701	0.475	0.665	1.95091565031783e-08	ITM2A	CD4+ T cells	GSE207422_Tor_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66646
9.3108626960597e-13	0.308821353051067	0.27	0.121	2.09196463055069e-08	RPL10P3	CD4+ T cells	GSE207422_Tor_post	ENSG00000230734	NA	NA	bA567J2.2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66647
1.12527760948601e-12	-0.324020324206153	0.926	0.971	2.52827373299316e-08	PFN1	CD4+ T cells	GSE207422_Tor_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66648
1.52080452799932e-12	0.309483847982548	0.91	0.843	3.41694361350886e-08	RPS15A	CD4+ T cells	GSE207422_Tor_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66649
2.03034874460164e-12	-0.500935170816797	0.462	0.65	4.56178755937096e-08	UCP2	CD4+ T cells	GSE207422_Tor_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66650
2.25966260445221e-12	0.366724728407345	0.507	0.358	5.07700993968322e-08	RPL6P27	CD4+ T cells	GSE207422_Tor_post	ENSG00000235552	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66651
2.42631194223971e-12	0.319268519985405	0.889	0.834	5.45143767182418e-08	RPL6	CD4+ T cells	GSE207422_Tor_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66652
2.99337415844565e-12	0.313845328172199	0.947	0.911	6.72551305919569e-08	RPS13	CD4+ T cells	GSE207422_Tor_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66653
3.34277293653362e-12	-0.398160875257992	0.779	0.892	7.51054223380375e-08	SPOCK2	CD4+ T cells	GSE207422_Tor_post	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66654
4.15510956455762e-12	-0.321759310364082	0.74	0.882	9.33570016964807e-08	IL2RG	CD4+ T cells	GSE207422_Tor_post	ENSG00000147168	3561	interleukin 2 receptor subunit gamma	CD132|CIDX|IMD4|SCIDX1	protein_coding	P31785	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66655
4.38586714351465e-12	0.362681820926154	0.813	0.725	9.85416629804872e-08	FTH1	CD4+ T cells	GSE207422_Tor_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66656
4.46593646813749e-12	-0.989724384479357	0.189	0.349	1.00340660566113e-07	CXCL13	CD4+ T cells	GSE207422_Tor_post	ENSG00000156234	10563	C-X-C motif chemokine ligand 13	ANGIE|ANGIE2|BCA-1|BLC|BLR1L|SCYB13	protein_coding	O43927	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66657
5.06873186260896e-12	-0.33396446775069	0.691	0.84	1.13884267489098e-07	TMSB10	CD4+ T cells	GSE207422_Tor_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66658
6.77805440656308e-12	-0.34708563191027	0.626	0.779	1.52289326406659e-07	GAPDH	CD4+ T cells	GSE207422_Tor_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66659
7.92338484068773e-12	0.354170321070637	0.335	0.19	1.78022610600572e-07	RPS27AP16	CD4+ T cells	GSE207422_Tor_post	ENSG00000224631	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66660
9.74302765566713e-12	-0.310474801811639	0.881	0.963	2.18906345367529e-07	IL32	CD4+ T cells	GSE207422_Tor_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66661
1.59773316943801e-11	-0.326632274841901	0.176	0.327	3.58978688509332e-07	MIAT	CD4+ T cells	GSE207422_Tor_post	ENSG00000225783	440823	myocardial infarction associated transcript	C22orf35|FLJ25967|gomafu|LINC00066|lncRNA-MIAT|NCRNA00066|Rncr2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66662
1.94157604515555e-11	-0.275219645710949	0.119	0.258	4.36233305825549e-07	ICA1	CD4+ T cells	GSE207422_Tor_post	ENSG00000003147	3382	islet cell autoantigen 1	ICA69|ICAp69	protein_coding	Q05084	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66663
2.41103428084112e-11	-0.325374172759105	0.519	0.697	5.41711182219382e-07	CD3D	CD4+ T cells	GSE207422_Tor_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66664
2.87753682688128e-11	0.325046985084896	0.84	0.771	6.46524974263686e-07	RPS17	CD4+ T cells	GSE207422_Tor_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66665
3.74308922994482e-11	0.324444591683773	0.74	0.653	8.40997288184002e-07	TXNIP	CD4+ T cells	GSE207422_Tor_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66666
4.3893237165898e-11	0.343229403752972	0.705	0.587	9.86193252643397e-07	SARAF	CD4+ T cells	GSE207422_Tor_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66667
1.14941532425693e-10	-0.320329337931637	0.436	0.598	2.58250635054047e-06	STAT1	CD4+ T cells	GSE207422_Tor_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66668
1.28298708122498e-10	-0.259573264851941	0.832	0.917	2.88261537409629e-06	DDX5	CD4+ T cells	GSE207422_Tor_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66669
2.66271367741876e-10	-0.378243924112029	0.208	0.358	5.98258509042447e-06	FOXP3	CD4+ T cells	GSE207422_Tor_post	ENSG00000049768	50943	forkhead box P3	AIID|DIETER|IPEX|JM2|PIDX|SCURFIN|XPID	protein_coding	Q9BZS1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66670
2.92057847720863e-10	0.333069828402458	0.687	0.579	6.56195572259236e-06	PNRC1	CD4+ T cells	GSE207422_Tor_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66671
4.25002241259609e-10	0.280980114436358	0.917	0.883	9.5489503566209e-06	RPL11	CD4+ T cells	GSE207422_Tor_post	ENSG00000142676	6135	ribosomal protein L11	L11|uL5	protein_coding	P62913	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66672
5.08038276010226e-10	0.264217169730448	0.964	0.94	1.14146039853978e-05	RPL37A	CD4+ T cells	GSE207422_Tor_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66673
7.77807735648857e-10	0.299499008597328	0.325	0.192	1.74757842045585e-05	AL031727.1	CD4+ T cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66674
9.39743725618059e-10	0.271351041656806	0.321	0.186	2.11141620271866e-05	RPS13P2	CD4+ T cells	GSE207422_Tor_post	ENSG00000228929	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66675
1.38091229676582e-09	-0.281940688338413	0.785	0.862	3.10263374837344e-05	HSPA8	CD4+ T cells	GSE207422_Tor_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66676
1.69418252075282e-09	-0.401594317687084	0.327	0.461	3.80648928762743e-05	ALOX5AP	CD4+ T cells	GSE207422_Tor_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66677
1.71406832275382e-09	-0.284358093862959	0.411	0.579	3.85116870756328e-05	TPM4	CD4+ T cells	GSE207422_Tor_post	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66678
1.88598665992608e-09	-0.258025577166276	0.928	0.968	4.23743482752192e-05	TRAC	CD4+ T cells	GSE207422_Tor_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66679
2.4687896233675e-09	-0.350014848571016	0.347	0.513	5.54687652578209e-05	ID2	CD4+ T cells	GSE207422_Tor_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66680
2.57977334446074e-09	0.271176491613907	0.95	0.929	5.79623475033438e-05	RPLP2	CD4+ T cells	GSE207422_Tor_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66681
2.75885007059193e-09	0.349393816283895	0.275	0.154	6.19858433860595e-05	NR4A2	CD4+ T cells	GSE207422_Tor_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66682
2.86714849994151e-09	-0.333047566402169	0.62	0.777	6.44190924966859e-05	CD4	CD4+ T cells	GSE207422_Tor_post	ENSG00000010610	920	CD4 molecule	NA	protein_coding	P01730	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66683
3.4459424733722e-09	0.36537575781126	0.383	0.247	7.74234354917267e-05	PIK3R1	CD4+ T cells	GSE207422_Tor_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66684
3.68361571887716e-09	0.282005573228761	0.27	0.143	8.27634779717321e-05	CCR7	CD4+ T cells	GSE207422_Tor_post	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66685
4.59448572284874e-09	-0.311313385157519	0.404	0.551	0.000103228905220965	ENO1	CD4+ T cells	GSE207422_Tor_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66686
5.25405206745738e-09	0.471289914709546	0.429	0.307	0.000118048041851632	RGCC	CD4+ T cells	GSE207422_Tor_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66687
5.4905531135588e-09	0.279497271749038	0.728	0.618	0.000123361747355439	FAU	CD4+ T cells	GSE207422_Tor_post	ENSG00000149806	2197	FAU ubiquitin like and ribosomal protein S30 fusion	asr1|FLJ22986|Fub1|Fubi|MNSFbeta|RPS30|S30	protein_coding	P62861	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66688
6.10738380536295e-09	0.354069886315409	0.42	0.295	0.000137220699338895	YPEL5	CD4+ T cells	GSE207422_Tor_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66689
6.86400809449626e-09	0.296446032396749	0.374	0.243	0.000154220533867142	AC116533.1	CD4+ T cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66690
1.81102857597674e-08	0.282871366922631	0.458	0.336	0.000406901900450453	VAMP2	CD4+ T cells	GSE207422_Tor_post	ENSG00000220205	6844	vesicle associated membrane protein 2	SYB2|VAMP-2	protein_coding	P63027	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66691
1.8534289952867e-08	-0.300477570145792	0.473	0.625	0.000416428426661017	SYNE2	CD4+ T cells	GSE207422_Tor_post	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66692
1.96821120482977e-08	0.306582514116879	0.413	0.293	0.000442217693501153	RPL3P4	CD4+ T cells	GSE207422_Tor_post	ENSG00000232573	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66693
2.29984561272591e-08	-0.326722871164497	0.475	0.641	0.000516729312267257	PKM	CD4+ T cells	GSE207422_Tor_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66694
3.30243796533805e-08	0.297550993375718	0.477	0.361	0.000741991762052153	AP001324.1	CD4+ T cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66695
3.80006510107604e-08	-0.255267363326689	0.815	0.894	0.000853798626909765	SH3BGRL3	CD4+ T cells	GSE207422_Tor_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66696
4.3660169456101e-08	0.257960910018137	0.493	0.363	0.000980956687339677	CD48	CD4+ T cells	GSE207422_Tor_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66697
4.58901363058794e-08	-0.35840210993601	0.462	0.584	0.0010310595825205	CALR	CD4+ T cells	GSE207422_Tor_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66698
4.93112854287372e-08	0.277809153851589	0.686	0.611	0.00110792596101287	RPL24	CD4+ T cells	GSE207422_Tor_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66699
7.35915507384314e-08	-0.267638122783837	0.266	0.402	0.00165345496199108	SATB1	CD4+ T cells	GSE207422_Tor_post	ENSG00000182568	6304	SATB homeobox 1	NA	protein_coding	Q01826	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66700
7.93293307698381e-08	0.263669293244015	0.882	0.845	0.00178237140373672	RPS28	CD4+ T cells	GSE207422_Tor_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66701
8.24461733269424e-08	0.288444036042095	0.791	0.739	0.00185240062230974	RPL14	CD4+ T cells	GSE207422_Tor_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66702
1.08486621118904e-07	0.25127292717011	0.707	0.627	0.00243747740329955	RPL41	CD4+ T cells	GSE207422_Tor_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66703
1.39592261174636e-07	0.259456167728553	0.522	0.401	0.00313635892407173	AC007969.1	CD4+ T cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66704
1.651942443192e-07	0.251913564237576	0.856	0.797	0.0037115842813638	RPS21	CD4+ T cells	GSE207422_Tor_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66705
2.31333879231907e-07	0.285482417922994	0.913	0.896	0.00519760959858248	JUND	CD4+ T cells	GSE207422_Tor_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66706
3.59654042994254e-07	0.605397187535944	0.575	0.504	0.0080807070379949	FOSB	CD4+ T cells	GSE207422_Tor_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66707
4.54918730722772e-07	0.438191687447224	0.697	0.621	0.0102211140418792	ZFP36	CD4+ T cells	GSE207422_Tor_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66708
7.95125660472654e-167	-2.80096392350655	0.007	0.8	1.78648833394996e-162	SPARCL1	Malignant cells	GSE207422_Tor_post	ENSG00000152583	8404	SPARC like 1	MAST9	protein_coding	Q14515	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66709
1.70519477431845e-152	-2.04739798845488	0.004	0.745	3.83123161893869e-148	SERPINB9	Malignant cells	GSE207422_Tor_post	ENSG00000170542	5272	serpin family B member 9	CAP3|PI9	protein_coding	P50453	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66710
1.50284727505246e-133	2.16553900298301	0.988	0.512	3.37659725758786e-129	TMSB4X	Malignant cells	GSE207422_Tor_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66711
3.30204367841321e-122	-1.59544821605738	0.948	0.987	7.41903173665881e-118	RPL39	Malignant cells	GSE207422_Tor_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66712
6.31530575983858e-122	-1.63509117938703	0.94	0.996	1.41892289812053e-117	RPL12	Malignant cells	GSE207422_Tor_post	ENSG00000197958	6136	ribosomal protein L12	L12	protein_coding	P30050	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66713
3.23285906888913e-119	-1.09368914503482	0.067	0.732	7.26358775598009e-115	AL365357.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66714
3.55438564782424e-117	-2.06172303419202	0.843	0.954	7.98599367353151e-113	GAPDH	Malignant cells	GSE207422_Tor_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66715
3.63529475309665e-116	-2.02585334212566	0.004	0.604	8.16778025125755e-112	IL1R2	Malignant cells	GSE207422_Tor_post	ENSG00000115590	7850	interleukin 1 receptor type 2	CD121b|IL1RB	protein_coding	P27930	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66716
7.72991434309527e-115	-1.2774901499546	0.91	0.987	1.73675715460665e-110	RPL8	Malignant cells	GSE207422_Tor_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66717
3.47526836375719e-114	-1.88578332878598	0.489	0.89	7.80823295968966e-110	GAS5	Malignant cells	GSE207422_Tor_post	ENSG00000234741	60674	growth arrest specific 5	NCRNA00030|SNHG2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66718
2.03095981309766e-112	-1.4383467172726	0.773	0.958	4.56316050806783e-108	RPS27	Malignant cells	GSE207422_Tor_post	ENSG00000177954	6232	ribosomal protein S27	MPS-1|MPS1|S27	protein_coding	P42677	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66719
1.03677743750128e-111	-1.60421132998086	0.07	0.677	2.32943154657788e-107	SPIDR	Malignant cells	GSE207422_Tor_post	ENSG00000164808	23514	scaffold protein involved in DNA repair	KIAA0146	protein_coding	Q14159	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66720
2.37939309841849e-111	-1.38530986606217	0.98	0.998	5.34602041352667e-107	RPL31	Malignant cells	GSE207422_Tor_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66721
6.77407766936912e-109	1.63025754955154	0.878	0.308	1.52199977075385e-104	JUN	Malignant cells	GSE207422_Tor_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66722
8.0176994646261e-109	-1.28180457411956	0.664	0.938	1.80141671571219e-104	RPS3A	Malignant cells	GSE207422_Tor_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66723
7.47447261588217e-108	-1.25207278313842	0.937	0.993	1.67936450733641e-103	RPS18	Malignant cells	GSE207422_Tor_post	ENSG00000223367	6222	ribosomal protein S18	D6S218E|HKE3|KE-3|KE3|S18	protein_coding	P62269	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66724
1.96770867043041e-103	-1.9234940140929	0	0.543	4.42104784072305e-99	MYH11	Malignant cells	GSE207422_Tor_post	ENSG00000276480	4629	myosin heavy chain 11	SMHC|SMMHC|SMMS-1	protein_coding	P35749	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66725
1.29275202892537e-101	-1.60421511047469	0.322	0.833	2.90455525858952e-97	PGD	Malignant cells	GSE207422_Tor_post	ENSG00000142657	5226	phosphogluconate dehydrogenase	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66726
3.14987502080404e-101	-1.36245232758568	0.664	0.921	7.07713919674253e-97	RPS23	Malignant cells	GSE207422_Tor_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66727
8.2358931252642e-101	-1.16875007218149	0.555	0.91	1.85044046738436e-96	RPS15	Malignant cells	GSE207422_Tor_post	ENSG00000115268	6209	ribosomal protein S15	MGC111130|RIG|S15	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66728
7.13528597903761e-100	-1.25041416641623	0.051	0.622	1.60315605377017e-95	ACKR3	Malignant cells	GSE207422_Tor_post	ENSG00000144476	57007	atypical chemokine receptor 3	CMKOR1|CXCR7|GPR159|RDC1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66729
4.172365096521e-99	-1.92667928653297	0.243	0.846	9.37446989886338e-95	KRT5	Malignant cells	GSE207422_Tor_post	ENSG00000186081	3852	keratin 5	CK-5|EBS2|KRT5A	protein_coding	P13647	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66730
2.20549796914444e-97	-1.24544451184997	0.952	0.991	4.95531283707372e-93	RPL35A	Malignant cells	GSE207422_Tor_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66731
1.77990178015786e-96	-1.14558514064669	0.94	0.996	3.99908331965868e-92	RPL34	Malignant cells	GSE207422_Tor_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66732
3.47260860243613e-96	-1.05081522169409	0.949	0.993	7.80225700795349e-92	RPLP1	Malignant cells	GSE207422_Tor_post	ENSG00000137818	6176	ribosomal protein lateral stalk subunit P1	LP1	protein_coding	P05386	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66733
3.31166266202071e-94	-1.08256953050324	0.884	0.987	7.44064366902813e-90	RPS4X	Malignant cells	GSE207422_Tor_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66734
5.04016612636326e-94	-1.07736709598921	0.964	0.998	1.1324245252713e-89	RPS6	Malignant cells	GSE207422_Tor_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66735
1.25761340264126e-91	-1.66657211636198	0.148	0.688	2.82560579305438e-87	APOL1	Malignant cells	GSE207422_Tor_post	ENSG00000100342	8542	apolipoprotein L1	APOL	protein_coding	O14791	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66736
8.9718293683799e-91	-1.64733234555768	0.579	0.879	2.0157906224876e-86	SERPINB1	Malignant cells	GSE207422_Tor_post	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66737
4.20546734612487e-88	-1.61848211974501	0.189	0.712	9.44884403327336e-84	IGFBP2	Malignant cells	GSE207422_Tor_post	ENSG00000115457	3485	insulin like growth factor binding protein 2	IBP2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66738
9.49635287041569e-88	-1.57193920733193	0.073	0.589	2.133640562925e-83	GSTA1	Malignant cells	GSE207422_Tor_post	ENSG00000243955	2938	glutathione S-transferase alpha 1	NA	protein_coding	P08263	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66739
4.3892573143786e-87	2.29572045530552	0.729	0.147	9.86178333394583e-83	HSPA1A	Malignant cells	GSE207422_Tor_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66740
2.25394246175657e-85	-1.06714639372214	0.207	0.723	5.06415792307466e-81	CREG1	Malignant cells	GSE207422_Tor_post	ENSG00000143162	8804	cellular repressor of E1A stimulated genes 1	CREG	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66741
1.39107442865685e-84	-0.885652466158027	0.009	0.477	3.12546602630621e-80	SLC35G1	Malignant cells	GSE207422_Tor_post	ENSG00000176273	159371	solute carrier family 35 member G1	C10orf60|FLJ33990|TMEM20	protein_coding	Q2M3R5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66742
2.04827635067458e-83	-0.951197012972552	0.885	0.971	4.60206730469564e-79	RPL13	Malignant cells	GSE207422_Tor_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66743
7.61662952249545e-83	-1.35855528991137	0.557	0.851	1.71130432111428e-78	PGK1	Malignant cells	GSE207422_Tor_post	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66744
4.39358738424672e-82	-0.947255766760483	0.173	0.774	9.87151213492552e-78	IGKC	Malignant cells	GSE207422_Tor_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66745
3.29702717992279e-81	-0.868981931684286	0	0.442	7.40776066785053e-77	AFF2	Malignant cells	GSE207422_Tor_post	ENSG00000155966	2334	ALF transcription elongation factor 2	FMR2|FRAXE	protein_coding	P51816	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66746
2.5239814747256e-80	-0.933727145395192	0.803	0.96	5.67088157741348e-76	RPS3	Malignant cells	GSE207422_Tor_post	ENSG00000149273	6188	ribosomal protein S3	FLJ26283|FLJ27450|MGC87870|S3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66747
5.67778904132264e-80	-0.838216825063842	0.205	0.727	1.27568564180437e-75	MRPS21	Malignant cells	GSE207422_Tor_post	ENSG00000266472	54460	mitochondrial ribosomal protein S21	NA	protein_coding	P82921	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66748
2.45598028928559e-79	1.47835227186645	0.729	0.187	5.51809651396686e-75	FOSB	Malignant cells	GSE207422_Tor_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66749
3.76108353291867e-79	-1.3828444124696	0.122	0.629	8.45040248176167e-75	MT1X	Malignant cells	GSE207422_Tor_post	ENSG00000187193	4501	metallothionein 1X	MT-1l|MT1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66750
1.39536674747501e-78	-1.12298767920256	0.983	0.996	3.13511000822686e-74	S100A11	Malignant cells	GSE207422_Tor_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66751
2.44772618438122e-78	-0.727221573614494	0.012	0.455	5.49955119106773e-74	AL078590.2	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66752
9.77489887285604e-78	-0.951679655867773	0.827	0.947	2.1962242787533e-73	RPS2	Malignant cells	GSE207422_Tor_post	ENSG00000140988	6187	ribosomal protein S2	LLREP3|S2	protein_coding	P15880	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66753
5.30404691866286e-77	-1.6096780674272	0.227	0.714	1.19171326168517e-72	GPNMB	Malignant cells	GSE207422_Tor_post	ENSG00000136235	10457	glycoprotein nmb	HGFIN|NMB	protein_coding	Q14956	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66754
2.15076833167343e-76	-0.953143068861073	0.026	0.475	4.83234628760386e-72	GPC3	Malignant cells	GSE207422_Tor_post	ENSG00000147257	2719	glypican 3	DGSX|OCI-5|SDYS|SGB|SGBS|SGBS1	protein_coding	P51654	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66755
8.78087442373101e-76	1.09542032871222	0.603	0.055	1.97288686552388e-71	ATF3	Malignant cells	GSE207422_Tor_post	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66756
9.22154191065854e-76	0.886011987340517	0.884	0.349	2.07189603648676e-71	MYL12B	Malignant cells	GSE207422_Tor_post	ENSG00000118680	103910	myosin light chain 12B	MRLC2	protein_coding	O14950	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66757
9.82990286207005e-76	0.934642448796609	0.709	0.138	2.2085825750499e-71	SSR3	Malignant cells	GSE207422_Tor_post	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66758
2.56229285006197e-75	-0.92866457680656	0.392	0.804	5.75695957551923e-71	PSMB4	Malignant cells	GSE207422_Tor_post	ENSG00000159377	5692	proteasome 20S subunit beta 4	HN3|PROS26	protein_coding	P28070	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66759
1.02759139208139e-73	-0.809164021785708	0.197	0.692	2.30879233972846e-69	RPL22P1	Malignant cells	GSE207422_Tor_post	ENSG00000213178	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66760
2.10679505860199e-73	-0.795193681311492	0.033	0.477	4.73354713766694e-69	SCN9A	Malignant cells	GSE207422_Tor_post	ENSG00000169432	6335	sodium voltage-gated channel alpha subunit 9	ETHA|Nav1.7|NE-NA|NENA|PN1	protein_coding	Q15858	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66761
2.13416669409237e-73	-1.06841849257744	0.875	0.98	4.79504572828674e-69	FTL	Malignant cells	GSE207422_Tor_post	ENSG00000087086	2512	ferritin light chain	MGC71996|NBIA3	protein_coding	P02792	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66762
3.74637186791727e-73	-1.30493693653706	0.493	0.822	8.41734831283651e-69	GPI	Malignant cells	GSE207422_Tor_post	ENSG00000282019	2821	glucose-6-phosphate isomerase	AMF|NLK	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66763
1.4100717374837e-72	-0.842140053798042	0.886	0.969	3.16814917977839e-68	RPLP2	Malignant cells	GSE207422_Tor_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66764
1.81271801751884e-72	1.40828623902353	0.773	0.29	4.07281484176134e-68	ZFP36	Malignant cells	GSE207422_Tor_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66765
1.84603648556108e-72	1.34359406799865	0.898	0.36	4.14767477575864e-68	S100A6	Malignant cells	GSE207422_Tor_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66766
4.56357037244263e-72	-0.869109387856529	0.981	0.993	1.02534299128041e-67	RPL37	Malignant cells	GSE207422_Tor_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66767
8.6354523882597e-72	-1.49900644839475	0.59	0.881	1.94021344259419e-67	CTSB	Malignant cells	GSE207422_Tor_post	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66768
1.08086846399448e-70	1.37411632705223	0.844	0.44	2.4284952649028e-66	RHOB	Malignant cells	GSE207422_Tor_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66769
3.92842629979133e-70	-0.83063978319844	0.934	0.993	8.82638821037116e-66	RPL13A	Malignant cells	GSE207422_Tor_post	ENSG00000142541	23521	ribosomal protein L13a	L13A|TSTA1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66770
3.70839739566538e-69	1.05633614392222	0.709	0.149	8.33202726858098e-65	SDC4	Malignant cells	GSE207422_Tor_post	ENSG00000124145	6385	syndecan 4	amphiglycan|ryudocan|SYND4	protein_coding	P31431	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66771
4.19982654287957e-69	-1.27220288273233	0.453	0.8	9.43617027654182e-65	SPTSSA	Malignant cells	GSE207422_Tor_post	ENSG00000165389	171546	serine palmitoyltransferase small subunit A	C14orf147|ssSPTa	protein_coding	Q969W0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66772
4.37698577108342e-69	0.975088906419509	0.863	0.36	9.83421163047023e-65	MYL6	Malignant cells	GSE207422_Tor_post	ENSG00000092841	4637	myosin light chain 6	ESMLC|MLC1SM|MLC3NM	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66773
7.2983392967e-69	-0.821427225999612	0.945	0.989	1.63979087318256e-64	RPS19	Malignant cells	GSE207422_Tor_post	ENSG00000105372	6223	ribosomal protein S19	DBA|eS19|LOH19CR1|S19	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66774
3.96638672644864e-68	-1.50115958402594	0.362	0.765	8.9116776969848e-64	SCD	Malignant cells	GSE207422_Tor_post	ENSG00000099194	6319	stearoyl-CoA desaturase	FADS5|SCD1|SCDOS	protein_coding	O00767	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66775
5.35727128160862e-68	1.75481167319345	0.776	0.316	1.20367171155183e-63	MAL2	Malignant cells	GSE207422_Tor_post	ENSG00000147676	114569	mal, T cell differentiation protein 2	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66776
5.69916377829121e-68	-0.912449502911768	0.652	0.862	1.28048811770647e-63	RPL7	Malignant cells	GSE207422_Tor_post	ENSG00000147604	6129	ribosomal protein L7	humL7-1|L7	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66777
8.27379278555171e-68	1.18557527603597	0.571	0.044	1.85895576305776e-63	GDF15	Malignant cells	GSE207422_Tor_post	ENSG00000130513	9518	growth differentiation factor 15	MIC-1|MIC1|NAG-1|PDF|PLAB|PTGFB	protein_coding	Q99988	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66778
2.22152221509367e-67	1.08972406834683	0.675	0.114	4.99131611287245e-63	SLPI	Malignant cells	GSE207422_Tor_post	ENSG00000124107	6590	secretory leukocyte peptidase inhibitor	ALK1|ALP|BLPI|HUSI|HUSI-I|WAP4|WFDC4	protein_coding	P03973	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66779
3.15910847691573e-67	0.891894929102589	0.651	0.11	7.09788492593425e-63	S100A14	Malignant cells	GSE207422_Tor_post	ENSG00000189334	57402	S100 calcium binding protein A14	BCMP84|S100A15	protein_coding	Q9HCY8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66780
3.87952925642922e-67	-0.847178206194981	0.173	0.644	8.71652633334518e-63	BNIP3L	Malignant cells	GSE207422_Tor_post	ENSG00000104765	665	BCL2 interacting protein 3 like	BNIP3a|Nix	protein_coding	O60238	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66781
5.13460040841122e-67	-0.949194943617611	0.865	0.93	1.15364201976183e-62	ENO1	Malignant cells	GSE207422_Tor_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66782
1.94800936850921e-66	-0.8982939138099	0.731	0.895	4.3767874491665e-62	PRDX6	Malignant cells	GSE207422_Tor_post	ENSG00000117592	9588	peroxiredoxin 6	1-Cys|aiPLA2|AOP2|KIAA0106|MGC46173|NSGPx|p29|PRX	protein_coding	P30041	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66783
2.82742805376709e-65	0.823740500863666	0.901	0.655	6.35266535120391e-61	DSTN	Malignant cells	GSE207422_Tor_post	ENSG00000125868	11034	destrin, actin depolymerizing factor	ACTDP|ADF	protein_coding	P60981	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66784
3.31532927445756e-65	-0.781309541439348	0.964	0.996	7.44888181385124e-61	RPS27A	Malignant cells	GSE207422_Tor_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66785
2.53234863522392e-64	-0.864010033062589	0.13	0.589	5.68968091362111e-60	MIR205HG	Malignant cells	GSE207422_Tor_post	ENSG00000230937	642587	MIR205 host gene	LINC00510	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66786
5.10127451003857e-64	-0.703054051663711	0.06	0.481	1.14615435691547e-59	ZDHHC2	Malignant cells	GSE207422_Tor_post	ENSG00000104219	51201	zinc finger DHHC-type palmitoyltransferase 2	DHHC2|ZNF372	protein_coding	Q9UIJ5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66787
7.4893827027949e-64	1.44729855193681	0.822	0.435	1.68271450566396e-59	TACSTD2	Malignant cells	GSE207422_Tor_post	ENSG00000184292	4070	tumor associated calcium signal transducer 2	EGP-1|GA733-1|M1S1|TROP2	protein_coding	P09758	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66788
1.06586723878241e-63	-1.54716947665592	0.087	0.514	2.39479051209632e-59	GJB6	Malignant cells	GSE207422_Tor_post	ENSG00000121742	10804	gap junction protein beta 6	CX30|DFNA3|ED2|EDH|HED	protein_coding	O95452	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66789
1.87274875610015e-63	-0.819378169630943	0.054	0.468	4.20769190520581e-59	MAP1B	Malignant cells	GSE207422_Tor_post	ENSG00000131711	4131	microtubule associated protein 1B	MAP5|PPP1R102	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66790
3.95384566432252e-63	1.02272162669077	0.76	0.284	8.88350043859985e-59	ACTN4	Malignant cells	GSE207422_Tor_post	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66791
9.20434585392873e-63	-0.859112741656781	0.066	0.481	2.06803242646071e-58	OLFM1	Malignant cells	GSE207422_Tor_post	ENSG00000130558	10439	olfactomedin 1	AMY|NOE1|NOELIN|OlfA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66792
9.42352236538437e-63	-0.950509697405071	0.499	0.8	2.11727700505456e-58	F11R	Malignant cells	GSE207422_Tor_post	ENSG00000158769	50848	F11 receptor	CD321|JAM-1|JAM-A|JAM1|JAMA|JCAM|PAM-1	protein_coding	Q9Y624	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66793
1.26841010495241e-62	-1.30084972730703	0.333	0.765	2.84986382380706e-58	SOX2	Malignant cells	GSE207422_Tor_post	ENSG00000181449	6657	SRY-box transcription factor 2	NA	protein_coding	P48431	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66794
1.27485381450247e-62	-0.686015848972539	0.096	0.538	2.86434155042415e-58	SPSB1	Malignant cells	GSE207422_Tor_post	ENSG00000171621	80176	splA/ryanodine receptor domain and SOCS box containing 1	SSB-1	protein_coding	Q96BD6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66795
1.31857298135165e-62	-0.87632928589268	0.15	0.593	2.9625697745009e-58	TRIM2	Malignant cells	GSE207422_Tor_post	ENSG00000109654	23321	tripartite motif containing 2	CMT2R|KIAA0517|RNF86	protein_coding	Q9C040	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66796
7.86040089864405e-62	-0.788655926821398	0.157	0.6	1.76607487390735e-57	PAICS	Malignant cells	GSE207422_Tor_post	ENSG00000128050	10606	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase	ADE2H1|AIRC|PAIS	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66797
1.07638634469231e-61	-1.00378544734688	0.93	0.98	2.41842483925469e-57	PABPC1	Malignant cells	GSE207422_Tor_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66798
1.16424143056939e-61	1.03352126327279	0.683	0.171	2.61581764620331e-57	MALL	Malignant cells	GSE207422_Tor_post	ENSG00000144063	7851	mal, T cell differentiation protein like	BENE	protein_coding	Q13021	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66799
8.88655969462488e-61	-1.59283430087038	0.367	0.771	1.99663223218832e-56	NDRG1	Malignant cells	GSE207422_Tor_post	ENSG00000104419	10397	N-myc downstream regulated 1	CAP43|DRG1|NDR1|RTP|TDD5	protein_coding	Q92597	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66800
1.06421136747848e-60	0.638982917879383	0.585	0.081	2.39107010045064e-56	SCNN1A	Malignant cells	GSE207422_Tor_post	ENSG00000111319	6337	sodium channel epithelial 1 subunit alpha	ENaCalpha|SCNN1	protein_coding	P37088	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66801
1.4412593334997e-60	-0.899157638104887	0.345	0.736	3.23822147050712e-56	CD44	Malignant cells	GSE207422_Tor_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66802
1.98138769638586e-60	-0.631437761214243	0.098	0.538	4.45178187623974e-56	RPL39P3	Malignant cells	GSE207422_Tor_post	ENSG00000235174	NA	NA	Em:AC019205.3	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66803
7.48074381225996e-60	1.13064317089819	0.544	0.07	1.68077351973857e-55	IER3	Malignant cells	GSE207422_Tor_post	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66804
7.89532639251472e-60	-1.22033631850808	0.237	0.697	1.77392193387021e-55	NTRK2	Malignant cells	GSE207422_Tor_post	ENSG00000148053	4915	neurotrophic receptor tyrosine kinase 2	TRKB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66805
9.79944351941929e-60	0.786066262418531	0.659	0.149	2.20173896994313e-55	MYL12A	Malignant cells	GSE207422_Tor_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66806
2.4106213829938e-59	1.20268529458183	0.604	0.092	5.41618412331047e-55	AQP3	Malignant cells	GSE207422_Tor_post	ENSG00000165272	360	aquaporin 3 (Gill blood group)	GIL	protein_coding	Q92482	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66807
2.6204425196047e-59	-0.582147782933266	0.025	0.396	5.88761025304784e-55	GM2A	Malignant cells	GSE207422_Tor_post	ENSG00000196743	2760	ganglioside GM2 activator	GM2-AP|GM2AP|SAP-3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66808
7.75237850118455e-59	-0.96612704751281	0.773	0.91	1.74180440164615e-54	LDHA	Malignant cells	GSE207422_Tor_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66809
8.26396738782455e-59	-0.760965044743358	0.91	0.963	1.85674819269642e-54	RPL36	Malignant cells	GSE207422_Tor_post	ENSG00000130255	25873	ribosomal protein L36	DKFZp566B023|L36	protein_coding	Q9Y3U8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66810
3.1757015000774e-58	-1.02466626393543	0.344	0.824	7.13516613037391e-54	GPX2	Malignant cells	GSE207422_Tor_post	ENSG00000176153	2877	glutathione peroxidase 2	GSHPX-GI	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66811
3.52781513273402e-58	-0.720794683515965	0.977	0.998	7.9262950402268e-54	RPL37A	Malignant cells	GSE207422_Tor_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66812
4.2311663457049e-58	-0.876427985940204	0.71	0.91	9.50658454552977e-54	RPL3	Malignant cells	GSE207422_Tor_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66813
5.93257861237905e-58	1.1209254957577	0.684	0.231	1.33293176262932e-53	PPP1R15A	Malignant cells	GSE207422_Tor_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66814
6.22180420852532e-58	-0.782390825371388	0.102	0.519	1.39791496957147e-53	P4HA1	Malignant cells	GSE207422_Tor_post	ENSG00000122884	5033	prolyl 4-hydroxylase subunit alpha 1	C-P4Halpha(I)|P4HA	protein_coding	P13674	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66815
7.06060283222976e-58	-0.784781672533182	0.849	0.956	1.58637624434538e-53	RPS28	Malignant cells	GSE207422_Tor_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66816
1.31722896838138e-57	1.85441167087813	0.774	0.371	2.95955004615928e-53	IFI6	Malignant cells	GSE207422_Tor_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66817
1.73894763583271e-57	-0.601675122963117	0.131	0.578	3.90706754818894e-53	RPS3AP47	Malignant cells	GSE207422_Tor_post	ENSG00000205871	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66818
2.35995282421124e-57	1.37205347259119	0.56	0.079	5.30234200543782e-53	SFTA2	Malignant cells	GSE207422_Tor_post	ENSG00000237814	389376	surfactant associated 2	SFTPG|SP-G	protein_coding	Q6UW10	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66819
8.66055043496775e-57	0.83304894411973	0.56	0.086	1.94585247172855e-52	CNN3	Malignant cells	GSE207422_Tor_post	ENSG00000117519	1266	calponin 3	NA	protein_coding	Q15417	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66820
9.42927034658814e-57	-0.813935883551191	0.83	0.945	2.11856846147142e-52	RPS21	Malignant cells	GSE207422_Tor_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66821
1.11224442169594e-56	-0.498156862094696	0.015	0.358	2.49899076666644e-52	AC004889.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66822
1.56371298123892e-56	-0.800632541353016	0.875	0.965	3.51335032624761e-52	RPL10A	Malignant cells	GSE207422_Tor_post	ENSG00000198755	4736	ribosomal protein L10a	Csa-19|L10A|NEDD6	protein_coding	P62906	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66823
1.90037193607041e-56	-0.720327043673183	0.961	0.996	4.269755665963e-52	RPL27A	Malignant cells	GSE207422_Tor_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66824
2.55096693527266e-56	1.1308306080811	0.745	0.334	5.73151251017062e-52	EGR1	Malignant cells	GSE207422_Tor_post	ENSG00000120738	1958	early growth response 1	225|AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268	protein_coding	P18146	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66825
5.41856513130667e-56	1.03070803710481	0.665	0.231	1.21744321370198e-51	CHMP4B	Malignant cells	GSE207422_Tor_post	ENSG00000101421	128866	charged multivesicular body protein 4B	C20orf178|dJ553F4.4|Shax1|SNF7-2|VPS32B	protein_coding	Q9H444	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66826
7.28565831350886e-56	1.18538436523262	0.533	0.079	1.63694170987917e-51	KLF6	Malignant cells	GSE207422_Tor_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66827
1.56258931041239e-55	0.705601423256871	0.645	0.16	3.51082566263455e-51	ARF4	Malignant cells	GSE207422_Tor_post	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66828
2.40546888820032e-55	-0.698279364716581	0.477	0.782	5.40460749800849e-51	C1orf43	Malignant cells	GSE207422_Tor_post	ENSG00000143612	25912	chromosome 1 open reading frame 43	DKFZp586G1722|NICE-3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66829
2.51618982425729e-55	-0.549690152827493	0.083	0.49	5.65337529714128e-51	MRPS14	Malignant cells	GSE207422_Tor_post	ENSG00000120333	63931	mitochondrial ribosomal protein S14	HSMRPS14	protein_coding	O60783	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66830
2.67550671190714e-55	-0.682478401217677	0.262	0.684	6.01132848031295e-51	APH1A	Malignant cells	GSE207422_Tor_post	ENSG00000117362	51107	aph-1 homolog A, gamma-secretase subunit	APH-1A|CGI-78	protein_coding	Q96BI3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66831
7.86100684044836e-55	-0.730815995463328	0.846	0.96	1.76621101691194e-50	RPS15A	Malignant cells	GSE207422_Tor_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66832
8.58913689657168e-55	-0.890383226828303	0.112	0.51	1.92980727792172e-50	HEY1	Malignant cells	GSE207422_Tor_post	ENSG00000164683	23462	hes related family bHLH transcription factor with YRPW motif 1	bHLHb31|CHF-2|CHF2|HERP2|HESR-1|HESR1|HRT-1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66833
9.02279851833394e-55	-0.491274800847689	0.033	0.391	2.02724237109927e-50	IGSF9	Malignant cells	GSE207422_Tor_post	ENSG00000085552	57549	immunoglobulin superfamily member 9	IGSF9A|KIAA1355|Nrt1	protein_coding	Q9P2J2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66834
1.97163099707285e-54	0.693727057905605	0.974	0.879	4.42986052422327e-50	CFL1	Malignant cells	GSE207422_Tor_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66835
3.2565012986369e-54	0.950186852953897	0.556	0.095	7.31670711777738e-50	RAB11FIP1	Malignant cells	GSE207422_Tor_post	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66836
3.50242560803138e-54	-0.537612331135365	0.016	0.349	7.86924985612491e-50	CES1	Malignant cells	GSE207422_Tor_post	ENSG00000262243	1066	carboxylesterase 1	CEH|CES1A1|CES1A2|CES2|HMSE|HMSE1|SES1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66837
4.87532387935552e-54	1.57431516224587	0.524	0.077	1.0953877692136e-49	CD24	Malignant cells	GSE207422_Tor_post	ENSG00000272398	100133941	CD24 molecule	CD24A	protein_coding	P25063	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66838
6.09622694510359e-54	1.337339016695	0.901	0.719	1.36970027002588e-49	MALAT1	Malignant cells	GSE207422_Tor_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66839
6.57319459612583e-54	-0.787088631674438	0.757	0.886	1.47686536185755e-49	PKM	Malignant cells	GSE207422_Tor_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66840
6.86861795459024e-54	-0.679579466992626	0.959	0.996	1.54324108203733e-49	RPL23	Malignant cells	GSE207422_Tor_post	ENSG00000125691	9349	ribosomal protein L23	L23|rpL17	protein_coding	P62829	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66841
1.46668200578836e-53	-0.580485096142122	0.057	0.429	3.2953411306053e-49	ALDOC	Malignant cells	GSE207422_Tor_post	ENSG00000109107	230	aldolase, fructose-bisphosphate C	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66842
1.60615175651958e-53	1.39949893544759	0.568	0.088	3.60870176654818e-49	SERPINA1	Malignant cells	GSE207422_Tor_post	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66843
1.93172936997082e-53	-0.643099359676158	0.895	0.971	4.34020954845043e-49	RPS11	Malignant cells	GSE207422_Tor_post	ENSG00000142534	6205	ribosomal protein S11	S11	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66844
2.23155387942454e-53	-0.779965410225373	0.07	0.442	5.01385525629105e-49	ADAM23	Malignant cells	GSE207422_Tor_post	ENSG00000114948	8745	ADAM metallopeptidase domain 23	MDC3	protein_coding	O75077	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66845
6.70452094078228e-53	-0.647700135258514	0.044	0.398	1.50637176497496e-48	NELL1	Malignant cells	GSE207422_Tor_post	ENSG00000165973	4745	neural EGFL like 1	FLJ45906|IDH3GL	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66846
3.64494113408278e-52	-0.264052094528677	0.844	0.987	8.18945374005719e-48	HLA-A	Malignant cells	GSE207422_Tor_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66847
4.21150308594479e-52	1.94050470175949	0.537	0.088	9.46240513350077e-48	NAPSA	Malignant cells	GSE207422_Tor_post	ENSG00000131400	9476	napsin A aspartic peptidase	KAP|Kdap|NAP1|NAPA	protein_coding	O96009	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66848
4.95112998243023e-52	0.602185771539325	0.643	0.16	1.11241988445242e-47	CAPZB	Malignant cells	GSE207422_Tor_post	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66849
1.32352208697202e-51	0.679578681611722	0.585	0.121	2.97368942500874e-47	CD59	Malignant cells	GSE207422_Tor_post	ENSG00000085063	966	CD59 molecule (CD59 blood group)	16.3A5|EJ16|EJ30|EL32|G344|MIC11|MIN1|MIN2|MIN3|MSK21|p18-20	protein_coding	P13987	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66850
2.3431133290523e-51	-0.552924284293775	0.16	0.602	5.2645070277147e-47	AL590867.2	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66851
4.22823329333388e-51	0.702942356892529	0.638	0.171	9.49999456346257e-47	TSPAN3	Malignant cells	GSE207422_Tor_post	ENSG00000140391	10099	tetraspanin 3	TM4-A|TM4SF8|TSPAN-3	protein_coding	O60637	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66852
6.79911531001804e-51	-0.57681365971025	0.071	0.444	1.52762522785485e-46	G3BP2	Malignant cells	GSE207422_Tor_post	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66853
1.17943730867361e-50	1.45889060997963	0.568	0.099	2.64995974512787e-46	SLC34A2	Malignant cells	GSE207422_Tor_post	ENSG00000157765	10568	solute carrier family 34 member 2	NAPI-3B	protein_coding	O95436	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66854
1.28730003051423e-50	-0.766787967180062	0.381	0.725	2.89230570855937e-46	ZFAS1	Malignant cells	GSE207422_Tor_post	ENSG00000177410	441951	ZNFX1 antisense RNA 1	C20orf199|HSUP1|HSUP2|NCRNA00275|ZNFX1-AS1	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66855
3.87957359291952e-50	1.20021959644228	0.723	0.292	8.71662594857159e-46	CXCL17	Malignant cells	GSE207422_Tor_post	ENSG00000189377	284340	C-X-C motif chemokine ligand 17	Dcip1|DMC|UNQ473|VCC1	protein_coding	Q6UXB2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66856
4.385542635733e-50	1.16377966099468	0.517	0.075	9.8534371939649e-46	WFDC2	Malignant cells	GSE207422_Tor_post	ENSG00000101443	10406	WAP four-disulfide core domain 2	dJ461P17.6|EDDM4|HE4|WAP5	protein_coding	Q14508	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66857
7.90689808479778e-50	-0.670679139559127	0.112	0.497	1.77652186169237e-45	HIST2H2BE	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66858
1.21689328618719e-49	-0.74486039628514	0.243	0.648	2.73411583540539e-45	FAM162A	Malignant cells	GSE207422_Tor_post	ENSG00000114023	26355	family with sequence similarity 162 member A	C3orf28|E2IG5	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66859
1.41022950072582e-49	-0.654564546169612	0.348	0.738	3.16850364223077e-45	RPL18A	Malignant cells	GSE207422_Tor_post	ENSG00000105640	6142	ribosomal protein L18a	L18A	protein_coding	Q02543	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66860
1.87332947048079e-49	1.5145346081731	0.527	0.099	4.20899665427624e-45	AGR2	Malignant cells	GSE207422_Tor_post	ENSG00000106541	10551	anterior gradient 2, protein disulphide isomerase family member	AG2|HAG-2|PDIA17|XAG-2	protein_coding	O95994	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66861
1.89199301048558e-49	0.5914541381815	0.52	0.086	4.250929895959e-45	LAMP1	Malignant cells	GSE207422_Tor_post	ENSG00000185896	3916	lysosomal associated membrane protein 1	CD107a	protein_coding	P11279	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66862
3.23962277383879e-49	0.637182147382443	0.552	0.112	7.27878444826099e-45	KRT18	Malignant cells	GSE207422_Tor_post	ENSG00000111057	3875	keratin 18	NA	protein_coding	P05783	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66863
3.78715413316474e-49	-0.832700386531439	0.335	0.686	8.50897790639454e-45	NFE2L2	Malignant cells	GSE207422_Tor_post	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66864
5.10334644453495e-49	-0.443561000180907	0.038	0.374	1.14661987915811e-44	POLR2B	Malignant cells	GSE207422_Tor_post	ENSG00000047315	5431	RNA polymerase II subunit B	RPB2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66865
6.34773552575038e-49	1.91982965131602	0.418	0.029	1.4262092179256e-44	CXCL2	Malignant cells	GSE207422_Tor_post	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66866
1.05706995874535e-48	2.054925145926	0.575	0.114	2.37502478330906e-44	SFTPB	Malignant cells	GSE207422_Tor_post	ENSG00000168878	6439	surfactant protein B	SFTP3|SP-B	protein_coding	P07988	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66867
1.09283141929704e-48	-0.488158760592827	0.025	0.341	2.45537363287658e-44	FBXO27	Malignant cells	GSE207422_Tor_post	ENSG00000161243	126433	F-box protein 27	Fbg5|Fbx27	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66868
2.63319971604205e-48	-0.671018078839645	0.419	0.774	5.91627312200329e-44	AL022718.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66869
5.20923351418505e-48	0.894998404216579	0.751	0.314	1.1704105859671e-43	LGALS3	Malignant cells	GSE207422_Tor_post	ENSG00000131981	3958	galectin 3	GALIG|LGALS2|MAC-2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66870
1.89392340472966e-47	-0.634913733968627	0.921	0.934	4.25526710574661e-43	RPS5	Malignant cells	GSE207422_Tor_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66871
3.17812033718269e-47	0.560358173065682	0.718	0.257	7.14060077358206e-43	VAPA	Malignant cells	GSE207422_Tor_post	ENSG00000101558	9218	VAMP associated protein A	hVAP-33|VAP-A	protein_coding	Q9P0L0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66872
3.31116256056319e-47	1.05173768898893	0.821	0.582	7.43952004107338e-43	FOS	Malignant cells	GSE207422_Tor_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66873
3.88750962177141e-47	0.871312484249931	0.528	0.105	8.73445661819599e-43	ERRFI1	Malignant cells	GSE207422_Tor_post	ENSG00000116285	54206	ERBB receptor feedback inhibitor 1	GENE-33|MIG-6|RALT	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66874
6.66141188374794e-47	1.16590037490361	0.78	0.321	1.49668602204049e-42	ANXA1	Malignant cells	GSE207422_Tor_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66875
6.8726780614941e-47	0.973485749829673	0.68	0.27	1.54415330685649e-42	CD63	Malignant cells	GSE207422_Tor_post	ENSG00000135404	967	CD63 molecule	ME491|MLA1|TSPAN30	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66876
1.02604347826899e-46	1.23436979626174	0.539	0.105	2.30531448697476e-42	CTSH	Malignant cells	GSE207422_Tor_post	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66877
1.09011660932302e-46	-0.733136193593713	0.249	0.62	2.44927399782697e-42	TMEM123	Malignant cells	GSE207422_Tor_post	ENSG00000152558	114908	transmembrane protein 123	KCT3|PORIMIN	protein_coding	Q8N131	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66878
1.65669023985509e-46	0.726622973473167	0.709	0.284	3.72225163090641e-42	TPM4	Malignant cells	GSE207422_Tor_post	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66879
1.87517371323658e-46	0.708783695477639	0.517	0.101	4.21314029889996e-42	TSPAN13	Malignant cells	GSE207422_Tor_post	ENSG00000106537	27075	tetraspanin 13	NET-6|TM4SF13	protein_coding	O95857	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66880
1.97013706246909e-46	-0.875502747974964	0.237	0.64	4.42650395195556e-42	GCLC	Malignant cells	GSE207422_Tor_post	ENSG00000001084	2729	glutamate-cysteine ligase catalytic subunit	GCS|GLCL|GLCLC	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66881
1.99783416743006e-46	0.777996246232769	0.683	0.248	4.48873380738186e-42	DHCR24	Malignant cells	GSE207422_Tor_post	ENSG00000116133	1718	24-dehydrocholesterol reductase	DCE|KIAA0018|seladin-1	protein_coding	Q15392	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66882
2.65400065837485e-46	1.00398120679568	0.53	0.095	5.9630086792366e-42	C3	Malignant cells	GSE207422_Tor_post	ENSG00000125730	718	complement C3	ARMD9|C3a|C3b|CPAMD1	protein_coding	P01024	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66883
2.70868032804457e-46	-0.580654248842445	0.195	0.598	6.08586296105054e-42	HSPA9	Malignant cells	GSE207422_Tor_post	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66884
2.91540646847869e-46	-0.550049434373588	0.191	0.589	6.55033525337792e-42	EIF2S3	Malignant cells	GSE207422_Tor_post	ENSG00000130741	1968	eukaryotic translation initiation factor 2 subunit gamma	EIF2|EIF2G|EIF2gamma	protein_coding	P41091	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66885
3.28972927710197e-46	0.683901397777903	0.549	0.121	7.3913637397927e-42	CDKN1A	Malignant cells	GSE207422_Tor_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66886
3.50216423346923e-46	0.642162726824107	0.629	0.167	7.86866259975868e-42	APLP2	Malignant cells	GSE207422_Tor_post	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66887
1.13201616836261e-45	0.755456315336375	0.525	0.119	2.54341392707711e-41	TRIB1	Malignant cells	GSE207422_Tor_post	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66888
1.45769582946607e-45	-0.738151606398728	0.249	0.622	3.27515098964436e-41	SGK1	Malignant cells	GSE207422_Tor_post	ENSG00000118515	6446	serum/glucocorticoid regulated kinase 1	SGK	protein_coding	O00141	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66889
2.25601467533445e-45	1.88378157913334	0.633	0.257	5.06881377254144e-41	NPC2	Malignant cells	GSE207422_Tor_post	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66890
4.69819963634245e-45	-0.421419313630843	0.017	0.305	1.05559149429342e-40	CCDC190	Malignant cells	GSE207422_Tor_post	ENSG00000185860	339512	coiled-coil domain containing 190	C1orf110|MGC48998	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66891
5.04347664156048e-45	0.606635104413289	0.61	0.185	1.13316833182581e-40	LMNA	Malignant cells	GSE207422_Tor_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66892
5.48042515761149e-45	-0.458296766199007	0.07	0.415	1.23134192441215e-40	AC005912.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66893
5.90391369270375e-45	-0.515503922476715	0.105	0.47	1.32649132847668e-40	NCSTN	Malignant cells	GSE207422_Tor_post	ENSG00000162736	23385	nicastrin	APH2|KIAA0253	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66894
6.92542651625476e-45	1.04097899903346	0.536	0.095	1.55600482967212e-40	RNASE1	Malignant cells	GSE207422_Tor_post	ENSG00000129538	6035	ribonuclease A family member 1, pancreatic	RAC1|RNS1	protein_coding	P07998	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66895
8.44800081871191e-45	-0.634727960237649	0.886	0.974	1.89809682394819e-40	RPS17	Malignant cells	GSE207422_Tor_post	ENSG00000278229	6218	ribosomal protein S17	MGC72007|RPS17L|RPS17L1|RPS17L2|S17	protein_coding	P08708	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66896
4.4596449990759e-44	1.42485857680119	0.475	0.07	1.00199303839237e-39	SFTPD	Malignant cells	GSE207422_Tor_post	ENSG00000133661	6441	surfactant protein D	COLEC7|SFTP4|SP-D	protein_coding	P35247	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66897
4.62669217834976e-44	-0.508910739580102	0.084	0.429	1.03952519863162e-39	SFXN1	Malignant cells	GSE207422_Tor_post	ENSG00000164466	94081	sideroflexin 1	FLJ12876|SLC56A1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66898
5.02957378180097e-44	-0.408243012576899	0.02	0.308	1.13004463729504e-39	DARS2	Malignant cells	GSE207422_Tor_post	ENSG00000117593	55157	aspartyl-tRNA synthetase 2, mitochondrial	FLJ10514|mtAspRS	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66899
5.19223781128823e-44	-0.526756746220467	0.044	0.356	1.16659199144024e-39	WNT5A	Malignant cells	GSE207422_Tor_post	ENSG00000114251	7474	Wnt family member 5A	hWNT5A	protein_coding	P41221	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66900
8.30807939425407e-44	-0.525180891294928	0.111	0.47	1.86665927830101e-39	DCAF6	Malignant cells	GSE207422_Tor_post	ENSG00000143164	55827	DDB1 and CUL4 associated factor 6	IQWD1|PC326	protein_coding	Q58WW2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66901
1.03158539120535e-43	-0.704432526970243	0.715	0.886	2.31776605696017e-39	LRRC75A-AS1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66902
1.08395658436562e-43	-0.579665498360762	0.124	0.486	2.43543365375267e-39	TCF4	Malignant cells	GSE207422_Tor_post	ENSG00000196628	6925	transcription factor 4	bHLHb19|E2-2|ITF2|SEF2-1B	protein_coding	P15884	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66903
1.32542878356561e-43	-0.543749052979708	0.093	0.437	2.9779733909152e-39	MPC2	Malignant cells	GSE207422_Tor_post	ENSG00000143158	25874	mitochondrial pyruvate carrier 2	BRP44|DKFZP564B167|SLC54A2	protein_coding	O95563	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66904
1.66917197758389e-43	-0.554567534233251	0.166	0.541	3.75029559923548e-39	GRSF1	Malignant cells	GSE207422_Tor_post	ENSG00000132463	2926	G-rich RNA sequence binding factor 1	NA	protein_coding	Q12849	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66905
2.50584329386556e-43	-0.608708519793679	0.413	0.769	5.63012871265715e-39	AC007969.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66906
2.65504977991084e-43	0.713089974920413	0.994	0.976	5.96536584550367e-39	ACTB	Malignant cells	GSE207422_Tor_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66907
2.88440915047174e-43	0.752856330863632	0.444	0.064	6.48069047927991e-39	BTG2	Malignant cells	GSE207422_Tor_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66908
3.5001246468137e-43	0.977291034530048	0.82	0.503	7.86408005646102e-39	CLDN4	Malignant cells	GSE207422_Tor_post	ENSG00000189143	1364	claudin 4	CPE-R|CPETR|CPETR1|hCPE-R|WBSCR8	protein_coding	O14493	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66909
4.11331005118213e-43	-0.483799490048049	0.071	0.407	9.24178502299601e-39	ABCC1	Malignant cells	GSE207422_Tor_post	ENSG00000278183	4363	ATP binding cassette subfamily C member 1	GS-X|MRP|MRP1	protein_coding	P33527	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66910
8.28356282920407e-43	-0.674244264945161	0.445	0.732	1.86115089646557e-38	ENSA	Malignant cells	GSE207422_Tor_post	ENSG00000143420	2029	endosulfine alpha	ARPP-19e|MGC4319|MGC78563|MGC8394	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66911
1.20539493422621e-42	-0.681043108804699	0.83	0.963	2.70828133821944e-38	RPS14	Malignant cells	GSE207422_Tor_post	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66912
1.49450759938173e-42	-0.557076701267556	0.025	0.308	3.35785967429088e-38	CERNA2	Malignant cells	GSE207422_Tor_post	ENSG00000285972	642934	competing endogenous lncRNA 2 for microRNA let-7b	HOST2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66913
1.54093144174855e-42	-0.695086630808931	0.236	0.62	3.46216476332065e-38	TP63	Malignant cells	GSE207422_Tor_post	ENSG00000073282	8626	tumor protein p63	EEC3|KET|NBP|OFC8|p40|p51|p53CP|p63|p73H|p73L|SHFM4|TP53CP|TP53L|TP73L	protein_coding	Q9H3D4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66914
2.94980089945748e-42	0.587838654230253	0.678	0.273	6.62761266090106e-38	PEBP1	Malignant cells	GSE207422_Tor_post	ENSG00000089220	5037	phosphatidylethanolamine binding protein 1	HCNP|PBP|PEBP|RKIP	protein_coding	P30086	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66915
3.37733804728588e-42	0.569690544027901	0.521	0.119	7.58820312464192e-38	RBM3	Malignant cells	GSE207422_Tor_post	ENSG00000102317	5935	RNA binding motif protein 3	IS1-RNPL	protein_coding	P98179	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66916
3.52625989490914e-42	1.31244704187648	0.425	0.051	7.92280073188186e-38	CEACAM6	Malignant cells	GSE207422_Tor_post	ENSG00000086548	4680	CEA cell adhesion molecule 6	CD66c|NCA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66917
3.79915495864837e-42	-0.559910063661844	0.907	0.965	8.53594136109116e-38	RPL27	Malignant cells	GSE207422_Tor_post	ENSG00000131469	6155	ribosomal protein L27	L27	protein_coding	P61353	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66918
4.31091654487393e-42	-0.655971233854632	0.884	0.941	9.68576729302275e-38	TAGLN2	Malignant cells	GSE207422_Tor_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66919
4.47745291425027e-42	0.561019061356203	0.403	0.042	1.00599412077375e-37	TIPARP	Malignant cells	GSE207422_Tor_post	ENSG00000163659	25976	TCDD inducible poly(ADP-ribose) polymerase	ARTD14|DDF1|DKFZP434J214|DKFZp686N0351|PARP-1|PARP-7|PARP7|pART14|RM1	protein_coding	Q7Z3E1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66920
4.9460657817586e-42	-0.754565380143995	0.555	0.796	1.11128205984552e-37	CEBPD	Malignant cells	GSE207422_Tor_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66921
5.5857668632334e-42	-0.609097091943788	0.836	0.949	1.25501009883128e-37	RPL29	Malignant cells	GSE207422_Tor_post	ENSG00000162244	6159	ribosomal protein L29	HIP|HUMRPL29|L29|RPL29P10	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66922
5.78345365990948e-42	0.70859202671583	0.876	0.62	1.29942636830846e-37	PPDPF	Malignant cells	GSE207422_Tor_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66923
5.88411200607792e-42	-0.632387626705643	0.125	0.473	1.32204228552559e-37	CLCA2	Malignant cells	GSE207422_Tor_post	ENSG00000137975	9635	chloride channel accessory 2	CLCRG2	protein_coding	Q9UQC9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66924
1.35476045574017e-41	-0.685919457489004	0.693	0.829	3.04387579195702e-37	EEF2	Malignant cells	GSE207422_Tor_post	ENSG00000167658	1938	eukaryotic translation elongation factor 2	EEF-2|EF2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66925
1.44238636874038e-41	1.99330514917006	0.483	0.088	3.24075369328589e-37	SFTPA2	Malignant cells	GSE207422_Tor_post	ENSG00000185303	729238	surfactant protein A2	COLEC5|SP-A2	protein_coding	Q8IWL1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66926
1.76547288441007e-41	-0.489550347400741	0.038	0.33	3.96666447669254e-37	PGM2	Malignant cells	GSE207422_Tor_post	ENSG00000169299	55276	phosphoglucomutase 2	FLJ10983	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66927
1.95273807183298e-41	-0.501467540773403	0.049	0.352	4.38741189979433e-37	EHBP1	Malignant cells	GSE207422_Tor_post	ENSG00000115504	23301	EH domain binding protein 1	KIAA0903|NACSIN	protein_coding	Q8NDI1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66928
2.31249871189535e-41	0.728091863850414	0.376	0.026	5.19572210588648e-37	MT1E	Malignant cells	GSE207422_Tor_post	ENSG00000169715	4493	metallothionein 1E	MT1|MTD	protein_coding	P04732	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66929
2.56282597644854e-41	1.03864089660729	0.453	0.07	5.75815740388459e-37	CTSE	Malignant cells	GSE207422_Tor_post	ENSG00000196188	1510	cathepsin E	NA	protein_coding	P14091	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66930
3.02600153739754e-41	-0.49615391023488	0.071	0.396	6.7988202542248e-37	DPYSL3	Malignant cells	GSE207422_Tor_post	ENSG00000113657	1809	dihydropyrimidinase like 3	CRMP4|DRP-3|ULIP	protein_coding	Q14195	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66931
3.24486146128416e-41	-0.649051949504196	0.837	0.89	7.29055473121326e-37	TPI1	Malignant cells	GSE207422_Tor_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66932
3.33183333857002e-41	0.655042528486681	0.652	0.242	7.48596314509912e-37	TRAM1	Malignant cells	GSE207422_Tor_post	ENSG00000067167	23471	translocation associated membrane protein 1	TRAM|TRAMP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66933
3.51274699375056e-41	0.682172564544602	0.475	0.097	7.89243994555875e-37	STK24	Malignant cells	GSE207422_Tor_post	ENSG00000102572	8428	serine/threonine kinase 24	MST-3|MST3|MST3B|STE20|STK3	protein_coding	Q9Y6E0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66934
3.55248454288695e-41	-0.878003356897234	0.217	0.6	7.98172227095841e-37	SLC6A8	Malignant cells	GSE207422_Tor_post	ENSG00000130821	6535	solute carrier family 6 member 8	CRT|CRT-1|CRT1|CRTR|CT1	protein_coding	P48029	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66935
3.67265989612084e-41	-0.754847479592056	0.595	0.815	8.25173225460431e-37	ATP5MC3	Malignant cells	GSE207422_Tor_post	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66936
5.09580962444376e-41	0.831543892936355	0.849	0.67	1.14492650642002e-36	JUND	Malignant cells	GSE207422_Tor_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66937
5.93371833587008e-41	-0.772346612597878	0.328	0.688	1.33318783570329e-36	GLUL	Malignant cells	GSE207422_Tor_post	ENSG00000135821	2752	glutamate-ammonia ligase	GLNS	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66938
7.77369565494663e-41	-0.706139855780353	0.499	0.769	1.74659393975341e-36	C4orf3	Malignant cells	GSE207422_Tor_post	ENSG00000164096	401152	chromosome 4 open reading frame 3	ALN|HCVFTP1	protein_coding	Q8WVX3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66939
7.81475089263779e-41	0.769224049510002	0.441	0.068	1.75581823055786e-36	FOLR1	Malignant cells	GSE207422_Tor_post	ENSG00000110195	2348	folate receptor alpha	FOLR|FRalpha	protein_coding	P15328	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66940
1.45602119183482e-40	-0.416953275169544	0.039	0.332	3.27138841381448e-36	EPB41L4A-AS1	Malignant cells	GSE207422_Tor_post	ENSG00000224032	NA	NA	C5orf26|NCRNA00219|TIGA1	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66941
2.06995195256408e-40	0.731728458374186	0.658	0.284	4.65076804702098e-36	KIF5B	Malignant cells	GSE207422_Tor_post	ENSG00000170759	3799	kinesin family member 5B	KNS|KNS1|uKHC	protein_coding	P33176	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66942
2.15239110956028e-40	0.829514323803044	0.437	0.066	4.83599234496004e-36	LMO7	Malignant cells	GSE207422_Tor_post	ENSG00000136153	4008	LIM domain 7	FBX20|FBXO20|KIAA0858	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66943
2.37713936025632e-40	2.09828414506259	0.464	0.081	5.3409567146239e-36	SFTPA1	Malignant cells	GSE207422_Tor_post	ENSG00000122852	653509	surfactant protein A1	COLEC4|SFTP1|SP-A|SP-A1	protein_coding	Q8IWL2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66944
2.62246636789417e-40	-0.582761748684406	0.491	0.782	5.89215743538461e-36	COX4I1	Malignant cells	GSE207422_Tor_post	ENSG00000131143	1327	cytochrome c oxidase subunit 4I1	COX4|COX4-1|COXIV|COXIV-1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66945
2.79271105204436e-40	-0.523955946264265	0.063	0.371	6.27466319173326e-36	AL445524.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66946
5.7573831630314e-40	0.64983689203639	0.456	0.073	1.29356884906989e-35	SELENBP1	Malignant cells	GSE207422_Tor_post	ENSG00000143416	8991	selenium binding protein 1	hSBP|hSP56|LPSB	protein_coding	Q13228	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66947
7.20936818140832e-40	-0.476912677544131	0.023	0.29	1.61980084299882e-35	JADE2	Malignant cells	GSE207422_Tor_post	ENSG00000043143	23338	jade family PHD finger 2	JADE-2|KIAA0239|PHF15	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66948
1.04891446277039e-39	-0.404896504398345	0.06	0.367	2.35670101495251e-35	DMAC1	Malignant cells	GSE207422_Tor_post	ENSG00000137038	90871	distal membrane arm assembly component 1	C9orf123|MGC4730|TMEM261	protein_coding	Q96GE9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66949
2.25043525390136e-39	0.553094872920193	0.537	0.152	5.05627792846558e-35	RPN1	Malignant cells	GSE207422_Tor_post	ENSG00000163902	6184	ribophorin I	OST1	protein_coding	P04843	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66950
3.87390320623334e-39	0.624627553813162	0.431	0.073	8.70388572376507e-35	NFKBIZ	Malignant cells	GSE207422_Tor_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66951
4.84786114976183e-39	0.669877086064072	0.681	0.279	1.08921744312849e-34	EZR	Malignant cells	GSE207422_Tor_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66952
7.04873965433093e-39	0.955044145319183	0.54	0.154	1.58371082553507e-34	HLA-DPA1	Malignant cells	GSE207422_Tor_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66953
7.64407336963604e-39	-0.538475857570406	0.987	0.974	1.71747040468983e-34	MT-CO2	Malignant cells	GSE207422_Tor_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66954
7.96682672257441e-39	0.616625480577526	0.483	0.097	1.78998662802802e-34	CLU	Malignant cells	GSE207422_Tor_post	ENSG00000120885	1191	clusterin	APOJ|CLI|CLU1|CLU2|KUB1|SGP-2|SP-40|TRPM-2	protein_coding	P10909	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66955
1.04471115419704e-38	-0.353808532854812	0.023	0.286	2.34725702124992e-34	MRGBP	Malignant cells	GSE207422_Tor_post	ENSG00000101189	55257	MRG domain binding protein	C20orf20|Eaf7|FLJ10914|MRG15BP	protein_coding	Q9NV56	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66956
1.50595747310469e-38	1.07049601502962	0.434	0.077	3.38358525057162e-34	DUSP6	Malignant cells	GSE207422_Tor_post	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66957
1.62242907872793e-38	-0.542810785316719	0.102	0.426	3.64527365408592e-34	MSI2	Malignant cells	GSE207422_Tor_post	ENSG00000153944	124540	musashi RNA binding protein 2	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66958
2.24686596958317e-38	-0.54294112829442	0.303	0.673	5.04825846045947e-34	AC024293.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66959
3.07194636890786e-38	0.632154978574617	0.725	0.369	6.90204910166217e-34	CLDN7	Malignant cells	GSE207422_Tor_post	ENSG00000288292	1366	claudin 7	CEPTRL2|CPETRL2|Hs.84359	protein_coding	O95471	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66960
3.59443210033768e-38	-0.320558627829468	0.01	0.251	8.07597004303869e-34	PRSS21	Malignant cells	GSE207422_Tor_post	ENSG00000282838	10942	serine protease 21	ESP-1|TEST1	protein_coding	Q9Y6M0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66961
4.09419770763544e-38	-0.671831728132766	0.7	0.888	9.1988434095153e-34	EIF4A2	Malignant cells	GSE207422_Tor_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66962
4.28949008227254e-38	-0.67351512472324	0.109	0.433	9.63762631684994e-34	CA12	Malignant cells	GSE207422_Tor_post	ENSG00000074410	771	carbonic anhydrase 12	HsT18816	protein_coding	O43570	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66963
4.45674568934751e-38	-0.44398309623726	0.057	0.349	1.0013416214826e-33	PPT1	Malignant cells	GSE207422_Tor_post	ENSG00000131238	5538	palmitoyl-protein thioesterase 1	CLN1|INCL|PPT	protein_coding	P50897	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66964
4.96457905194049e-38	-0.443087553834906	0.074	0.382	1.11544162138999e-33	AK4	Malignant cells	GSE207422_Tor_post	ENSG00000162433	205	adenylate kinase 4	AK3|AK3L1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66965
5.28275648045545e-38	-0.574937239380558	0.837	0.892	1.18692972602873e-33	RPS7	Malignant cells	GSE207422_Tor_post	ENSG00000171863	6201	ribosomal protein S7	eS7|S7	protein_coding	P62081	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66966
7.37396493954346e-38	0.664624517316744	0.437	0.077	1.65678244261663e-33	IFITM2	Malignant cells	GSE207422_Tor_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66967
7.85614663383582e-38	-0.563011045895384	0.295	0.648	1.76511902569023e-33	SF3B4	Malignant cells	GSE207422_Tor_post	ENSG00000143368	10262	splicing factor 3b subunit 4	Hsh49|SAP49|SF3b49	protein_coding	Q15427	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66968
7.88198433356719e-38	0.894594526990579	0.725	0.301	1.77092424006588e-33	CST3	Malignant cells	GSE207422_Tor_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66969
8.06916243634359e-38	0.751650852286073	0.447	0.079	1.81297941619768e-33	GPRC5A	Malignant cells	GSE207422_Tor_post	ENSG00000013588	9052	G protein-coupled receptor class C group 5 member A	PEIG-1|RAI3|RAIG1|TIG1	protein_coding	Q8NFJ5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66970
9.12540149310579e-38	-0.540895810972029	0.952	0.993	2.05029520747101e-33	RPS13	Malignant cells	GSE207422_Tor_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66971
1.15161469463983e-37	0.852269008611395	0.44	0.073	2.58744789591677e-33	KRT7	Malignant cells	GSE207422_Tor_post	ENSG00000135480	3855	keratin 7	CK-7|CK7|K2C7|K7|SCL	protein_coding	P08729	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66972
1.83922116694246e-37	0.88312115566523	0.317	0.011	4.13236211788632e-33	CALB2	Malignant cells	GSE207422_Tor_post	ENSG00000282830	794	calbindin 2	CAL2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66973
2.27052288335161e-37	0.947547050267795	0.511	0.132	5.1014108143144e-33	HLA-DPB1	Malignant cells	GSE207422_Tor_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66974
2.28193792226935e-37	-0.389997812154992	0.047	0.327	5.12705812375477e-33	PIGC	Malignant cells	GSE207422_Tor_post	ENSG00000135845	5279	phosphatidylinositol glycan anchor biosynthesis class C	NA	protein_coding	Q92535	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66975
2.93061002329371e-37	0.623762285905872	0.41	0.068	6.5844946003363e-33	ALDH2	Malignant cells	GSE207422_Tor_post	ENSG00000111275	217	aldehyde dehydrogenase 2 family member	NA	protein_coding	P05091	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66976
3.06269541414568e-37	-0.412240222511292	0.031	0.292	6.88126405650251e-33	TMEM116	Malignant cells	GSE207422_Tor_post	ENSG00000198270	89894	transmembrane protein 116	FLJ90167	protein_coding	Q8NCL8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66977
3.50510059757732e-37	0.514149007704997	0.655	0.268	7.87526002263672e-33	BRI3	Malignant cells	GSE207422_Tor_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66978
4.28521808168201e-37	-0.535549864678473	0.106	0.426	9.62802798592314e-33	CASC19	Malignant cells	GSE207422_Tor_post	ENSG00000254166	103164619	prostate cancer associated transcript 2	CARLo-6|LINC01245	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66979
5.61159038827968e-37	-0.465906011912733	0.138	0.473	1.26081212843868e-32	UBAP2L	Malignant cells	GSE207422_Tor_post	ENSG00000143569	9898	ubiquitin associated protein 2 like	KIAA0144|NICE-4	protein_coding	Q14157	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66980
6.70923919776321e-37	0.559265861663412	0.459	0.105	1.50743186295344e-32	CCNL1	Malignant cells	GSE207422_Tor_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66981
6.9209468494279e-37	-0.647214028987209	0.336	0.684	1.55499833812946e-32	CACYBP	Malignant cells	GSE207422_Tor_post	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66982
1.90398896785165e-36	0.761539519482217	0.477	0.119	4.27788241296909e-32	MUC1	Malignant cells	GSE207422_Tor_post	ENSG00000185499	4582	mucin 1, cell surface associated	ADMCKD|ADMCKD1|Ca15-3|CD227|EMA|KL-6|MCD|MCKD|MCKD1|PEM|PUM	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66983
2.09860962490798e-36	0.50471191292752	0.429	0.079	4.71515610524324e-32	PHLDA2	Malignant cells	GSE207422_Tor_post	ENSG00000274538	7262	pleckstrin homology like domain family A member 2	BWR1C|HLDA2|IPL|TSSC3	protein_coding	Q53GA4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66984
2.44953560723651e-36	0.485344472161606	0.45	0.09	5.50361660233898e-32	PPIB	Malignant cells	GSE207422_Tor_post	ENSG00000166794	5479	peptidylprolyl isomerase B	B|CYP-S1|CYPB|OI9|PPIase|SCYLP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66985
2.91515891320004e-36	0.718973041299803	0.824	0.547	6.54977904617786e-32	MTND1P23	Malignant cells	GSE207422_Tor_post	ENSG00000225972	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66986
3.63656035702176e-36	0.69681740490838	0.475	0.121	8.1706238101565e-32	MYH14	Malignant cells	GSE207422_Tor_post	ENSG00000105357	79784	myosin heavy chain 14	DFNA4|FLJ13881|KIAA2034|MHC16|MYH17	protein_coding	Q7Z406	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66987
3.85286766102878e-36	0.6989827833571	0.691	0.371	8.65662306079947e-32	KRT8	Malignant cells	GSE207422_Tor_post	ENSG00000170421	3856	keratin 8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	protein_coding	P05787	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66988
4.98476718993633e-36	-0.610297504932879	0.48	0.716	1.11997749223489e-31	EIF3E	Malignant cells	GSE207422_Tor_post	ENSG00000104408	3646	eukaryotic translation initiation factor 3 subunit E	eIF3-p48|EIF3S6|INT6	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66989
5.31967323378889e-36	-0.545797844790314	0.083	0.38	1.19522418216769e-31	APOL2	Malignant cells	GSE207422_Tor_post	ENSG00000128335	23780	apolipoprotein L2	APOL-II	protein_coding	Q9BQE5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66990
5.66900389633246e-36	0.599514856154387	0.445	0.092	1.27371179542798e-31	NR4A1	Malignant cells	GSE207422_Tor_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66991
5.76069544192581e-36	0.635464878565084	0.402	0.059	1.29431305189189e-31	PDZK1IP1	Malignant cells	GSE207422_Tor_post	ENSG00000162366	10158	PDZK1 interacting protein 1	DD96|MAP17|SPAP	protein_coding	Q13113	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66992
8.05193323133243e-36	-0.423782295554746	0.067	0.356	1.80910835841577e-31	EGLN1	Malignant cells	GSE207422_Tor_post	ENSG00000135766	54583	egl-9 family hypoxia inducible factor 1	C1orf12|HIFPH2|PHD2|SM-20|ZMYND6	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66993
1.15182118829416e-35	-0.516145619380829	0.169	0.499	2.58791184585932e-31	SDHC	Malignant cells	GSE207422_Tor_post	ENSG00000143252	6391	succinate dehydrogenase complex subunit C	CYB560|cybL|PGL3	protein_coding	Q99643	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66994
1.28500382215671e-35	-0.597774645123935	0.83	0.923	2.8871465876217e-31	NPM1	Malignant cells	GSE207422_Tor_post	ENSG00000181163	4869	nucleophosmin 1	B23|NPM	protein_coding	P06748	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66995
1.4986275782964e-35	-0.396679505164632	0.055	0.334	3.36711644291635e-31	NOA1	Malignant cells	GSE207422_Tor_post	ENSG00000084092	84273	nitric oxide associated 1	C4orf14|hAtNOS1|hNOA1|MGC3232|MTG3	protein_coding	Q8NC60	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66996
1.65774806753145e-35	0.995581040045376	0.435	0.092	3.72462835812966e-31	LPCAT1	Malignant cells	GSE207422_Tor_post	ENSG00000275079	79888	lysophosphatidylcholine acyltransferase 1	AGPAT10|AGPAT9|AYTL2|FLJ12443|LPLAT8	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66997
2.17004419961276e-35	0.666629335768466	0.428	0.077	4.87565530768995e-31	HOPX	Malignant cells	GSE207422_Tor_post	ENSG00000171476	84525	HOP homeobox	HOP|LAGY|NECC1|OB1|SMAP31	protein_coding	Q9BPY8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66998
2.39425089160239e-35	0.795760394094648	0.876	0.677	5.37940290325226e-31	S100A10	Malignant cells	GSE207422_Tor_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	66999
2.58447256370816e-35	-0.495199363168459	0.029	0.277	5.8067929561395e-31	SLC6A6	Malignant cells	GSE207422_Tor_post	ENSG00000131389	6533	solute carrier family 6 member 6	TAUT	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67000
4.06344591467933e-35	-0.554273115256507	0.229	0.569	9.12975028110153e-31	CHCHD10	Malignant cells	GSE207422_Tor_post	ENSG00000273607	400916	coiled-coil-helix-coiled-coil-helix domain containing 10	C22orf16|MIX17A|N27C7-4	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67001
4.54218876678929e-35	0.468070897852107	0.913	0.677	1.02053897212222e-30	TMBIM6	Malignant cells	GSE207422_Tor_post	ENSG00000139644	7009	transmembrane BAX inhibitor motif containing 6	BAXI1|BI-1|TEGT	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67002
8.23133799649633e-35	-0.48784813149497	0.918	0.96	1.8494170210528e-30	RPL28	Malignant cells	GSE207422_Tor_post	ENSG00000108107	6158	ribosomal protein L28	FLJ43307|L28	protein_coding	P46779	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67003
1.02412302589956e-34	-0.41147742030661	0.1	0.411	2.30099961459114e-30	MRPL9	Malignant cells	GSE207422_Tor_post	ENSG00000143436	65005	mitochondrial ribosomal protein L9	NA	protein_coding	Q9BYD2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67004
1.19718106700628e-34	-0.326887233539523	0.017	0.251	2.68982642134972e-30	PRCP	Malignant cells	GSE207422_Tor_post	ENSG00000137509	5547	prolylcarboxypeptidase	HUMPCP|PCP	protein_coding	P42785	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67005
1.63937867242132e-34	0.999020415555128	0.431	0.095	3.68335600119622e-30	LAMP3	Malignant cells	GSE207422_Tor_post	ENSG00000078081	27074	lysosomal associated membrane protein 3	CD208|DC-LAMP|DCLAMP|LAMP|TSC403	protein_coding	Q9UQV4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67006
1.71085490820029e-34	0.589690024354837	0.501	0.132	3.84394880774442e-30	SELENOP	Malignant cells	GSE207422_Tor_post	ENSG00000250722	6414	selenoprotein P	SELP|SeP|SEPP|SEPP1	protein_coding	P49908	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67007
2.10771809085652e-34	0.413066588375238	0.354	0.042	4.73562100653644e-30	ATP6AP1	Malignant cells	GSE207422_Tor_post	ENSG00000071553	537	ATPase H+ transporting accessory protein 1	16A|Ac45|ATP6IP1|ATP6S1|CF2|ORF|VATPS1|XAP-3|XAP3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67008
2.75188289048138e-34	0.527684744130978	0.543	0.165	6.18293047833356e-30	PTP4A2	Malignant cells	GSE207422_Tor_post	ENSG00000184007	8073	protein tyrosine phosphatase 4A2	HU-PP-1|OV-1|PRL-2|PRL2|ptp-IV1a|PTP4A|PTPCAAX2	protein_coding	Q12974	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67009
4.61240954529299e-34	0.938988646349033	0.38	0.064	1.03631617663643e-29	ISG15	Malignant cells	GSE207422_Tor_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67010
5.70892186861151e-34	-0.642883908789795	0.377	0.67	1.28268056543963e-29	PRRC2C	Malignant cells	GSE207422_Tor_post	ENSG00000117523	23215	proline rich coiled-coil 2C	BAT2D1|BAT2L2|KIAA1096|XTP2	protein_coding	Q9Y520	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67011
7.18748413135463e-34	0.579254610812327	0.585	0.231	1.61488393463276e-29	TOB1	Malignant cells	GSE207422_Tor_post	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67012
7.26810113328883e-34	-0.500902785892619	0.237	0.578	1.63299696262733e-29	UHMK1	Malignant cells	GSE207422_Tor_post	ENSG00000152332	127933	U2AF homology motif kinase 1	KIS|Kist	protein_coding	Q8TAS1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67013
9.60034153717214e-34	-0.398452447909654	0.076	0.36	2.15700473657184e-29	SDAD1	Malignant cells	GSE207422_Tor_post	ENSG00000198301	55153	SDA1 domain containing 1	FLJ10498	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67014
1.0474653798058e-33	0.691274802973236	0.306	0.018	2.35344521534766e-29	RRAD	Malignant cells	GSE207422_Tor_post	ENSG00000166592	6236	RRAD, Ras related glycolysis inhibitor and calcium channel regulator	RAD|REM3	protein_coding	P55042	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67015
1.74745833487531e-33	-0.328135873570913	0.026	0.264	3.92618938679786e-29	BOLA1	Malignant cells	GSE207422_Tor_post	ENSG00000178096	51027	bolA family member 1	CGI-143	protein_coding	Q9Y3E2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67016
2.01535085791473e-33	1.46806311149382	0.619	0.323	4.52809030756281e-29	HLA-DRA	Malignant cells	GSE207422_Tor_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67017
3.77831911207677e-33	-0.367123048898741	0.098	0.409	8.48912738101409e-29	CPNE1	Malignant cells	GSE207422_Tor_post	ENSG00000214078	8904	copine 1	CPN1	protein_coding	Q99829	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67018
4.70219310677151e-33	0.436710968838497	0.357	0.048	1.05648874722942e-28	SEC11C	Malignant cells	GSE207422_Tor_post	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67019
5.76510391045675e-33	0.644682360193777	0.627	0.257	1.29530354660142e-28	HMGN2	Malignant cells	GSE207422_Tor_post	ENSG00000198830	3151	high mobility group nucleosomal binding domain 2	HMG17	protein_coding	P05204	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67020
5.85033432144723e-33	0.680402050118844	0.431	0.108	1.31445311534276e-28	TBL1XR1	Malignant cells	GSE207422_Tor_post	ENSG00000177565	79718	TBL1X/Y related 1	C21|DC42|FLJ12894|IRA1|TBLR1	protein_coding	Q9BZK7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67021
6.13981124627867e-33	-0.527781684273475	0.418	0.712	1.37949279081389e-28	SNHG6	Malignant cells	GSE207422_Tor_post	ENSG00000245910	NA	NA	HBII-276HG|NCRNA00058|U87HG	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67022
8.14905101503454e-33	-0.485545263536428	0.128	0.431	1.83092878205796e-28	NOTCH3	Malignant cells	GSE207422_Tor_post	ENSG00000074181	4854	notch receptor 3	CADASIL|CASIL	protein_coding	Q9UM47	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67023
8.34539568571737e-33	-0.50186778908805	0.279	0.607	1.87504350266698e-28	PRDX2	Malignant cells	GSE207422_Tor_post	ENSG00000167815	7001	peroxiredoxin 2	MGC4104|NKEFB|PRP|PRX2|PRXII|TDPX1|TSA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67024
8.35928433257548e-33	0.556989191794575	0.413	0.09	1.87816400384306e-28	TST	Malignant cells	GSE207422_Tor_post	ENSG00000128311	7263	thiosulfate sulfurtransferase	RDS	protein_coding	Q16762	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67025
1.17937650924572e-32	0.602461263031741	0.301	0.02	2.64982314097329e-28	ADIRF	Malignant cells	GSE207422_Tor_post	ENSG00000148671	10974	adipogenesis regulatory factor	AFRO|APM2|C10orf116	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67026
1.34292428453858e-32	-0.544904092930726	0.261	0.604	3.01728228250129e-28	COA6	Malignant cells	GSE207422_Tor_post	ENSG00000168275	388753	cytochrome c oxidase assembly factor 6	C1orf31	protein_coding	Q5JTJ3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67027
1.43280301917904e-32	1.24883094258051	0.38	0.073	3.21922182349146e-28	DSC2	Malignant cells	GSE207422_Tor_post	ENSG00000134755	1824	desmocollin 2	CDHF2|DSC3	protein_coding	Q02487	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67028
1.70540106253528e-32	0.502222511630825	0.709	0.356	3.83169510730426e-28	SERP1	Malignant cells	GSE207422_Tor_post	ENSG00000120742	27230	stress associated endoplasmic reticulum protein 1	FLJ43424|RAMP4	protein_coding	Q9Y6X1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67029
1.81686916876144e-32	0.477449364749744	0.514	0.165	4.0821416483732e-28	RAB11A	Malignant cells	GSE207422_Tor_post	ENSG00000103769	8766	RAB11A, member RAS oncogene family	YL8	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67030
2.27799528716088e-32	-0.393661426351307	0.103	0.398	5.11819981119307e-28	SNAPIN	Malignant cells	GSE207422_Tor_post	ENSG00000143553	23557	SNAP associated protein	BLOC1S7|BORCS3|SNAPAP	protein_coding	O95295	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67031
2.69153984476843e-32	-0.598112979298738	0.523	0.76	6.04735172322572e-28	CCNI	Malignant cells	GSE207422_Tor_post	ENSG00000118816	10983	cyclin I	CCNI1	protein_coding	Q14094	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67032
2.8607008384508e-32	-0.750345138175362	0.22	0.519	6.42742264383126e-28	ANP32E	Malignant cells	GSE207422_Tor_post	ENSG00000143401	81611	acidic nuclear phosphoprotein 32 family member E	LANP-L|LANPL|MGC5350	protein_coding	Q9BTT0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67033
2.91020889078672e-32	-0.664953614293571	0.502	0.745	6.53865733581961e-28	CYCS	Malignant cells	GSE207422_Tor_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67034
3.46061064852698e-32	-0.68197112611154	0.332	0.69	7.77530000511042e-28	AKR1C3	Malignant cells	GSE207422_Tor_post	ENSG00000196139	8644	aldo-keto reductase family 1 member C3	DDX|HAKRB|HSD17B5|KIAA0119|PGFS	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67035
3.53572638457418e-32	0.897808573174341	0.333	0.04	7.94407004086126e-28	HLA-DQB1	Malignant cells	GSE207422_Tor_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67036
3.92839302264001e-32	-0.373996776710563	0.074	0.349	8.82631344326757e-28	AL136380.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67037
5.05358021508952e-32	0.545240182903305	0.41	0.079	1.13543840272631e-27	NKX2-1	Malignant cells	GSE207422_Tor_post	ENSG00000136352	7080	NK2 homeobox 1	BCH|NKX2A|TITF1|TTF-1|TTF1	protein_coding	P43699	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67038
6.06252144531721e-32	0.616817202377701	0.448	0.116	1.36212731833387e-27	DUSP1	Malignant cells	GSE207422_Tor_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67039
7.07475416083373e-32	-0.405823480839425	0.102	0.396	1.58955576485612e-27	CYP2S1	Malignant cells	GSE207422_Tor_post	ENSG00000167600	29785	cytochrome P450 family 2 subfamily S member 1	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67040
7.54940496599031e-32	-0.310120412540493	0.033	0.27	1.6962003077587e-27	TUSC3	Malignant cells	GSE207422_Tor_post	ENSG00000104723	7991	tumor suppressor candidate 3	MagT2|MGC13453|MRT22|MRT7|N33|OST3A|SLC58A2	protein_coding	Q13454	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67041
7.77855942233201e-32	-0.359392909524646	0.055	0.312	1.74768673100956e-27	FZD7	Malignant cells	GSE207422_Tor_post	ENSG00000155760	8324	frizzled class receptor 7	FzE3	protein_coding	O75084	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67042
8.37378411536387e-32	0.712277386453678	0.381	0.073	1.88142181503995e-27	CITED2	Malignant cells	GSE207422_Tor_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67043
9.6835242295997e-32	0.628968800514252	0.559	0.215	2.17569422390646e-27	SPINT1	Malignant cells	GSE207422_Tor_post	ENSG00000166145	6692	serine peptidase inhibitor, Kunitz type 1	HAI|HAI-1|MANSC2	protein_coding	O43278	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67044
1.46619670231103e-31	-0.610021695935643	0.13	0.431	3.29425075075241e-27	UCHL1	Malignant cells	GSE207422_Tor_post	ENSG00000154277	7345	ubiquitin C-terminal hydrolase L1	PARK5|PGP9.5|Uch-L1|UCHL-1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67045
1.90480684150011e-31	-0.291268477679548	0.026	0.253	4.27972001148245e-27	RPL12P4	Malignant cells	GSE207422_Tor_post	ENSG00000185834	NA	NA	dJ800C24.1	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67046
2.14778757547056e-31	0.618217329586633	0.381	0.073	4.82564912456725e-27	AKAP13	Malignant cells	GSE207422_Tor_post	ENSG00000170776	11214	A-kinase anchoring protein 13	AKAP-Lbc|ARHGEF13|BRX|c-lbc|HA-3|Ht31|LBC|PROTO-LB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67047
2.56442926972025e-31	-0.50769247443997	0.904	0.976	5.76175968320746e-27	RPL9	Malignant cells	GSE207422_Tor_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67048
2.87335948366094e-31	-0.361486727910207	0.06	0.319	6.45586408788939e-27	UBA6	Malignant cells	GSE207422_Tor_post	ENSG00000033178	55236	ubiquitin like modifier activating enzyme 6	FLJ10808|UBE1L2	protein_coding	A0AVT1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67049
3.09058570367314e-31	-0.447119981226862	0.213	0.536	6.94392795901282e-27	NDUFS2	Malignant cells	GSE207422_Tor_post	ENSG00000158864	4720	NADH:ubiquinone oxidoreductase core subunit S2	CI-49	protein_coding	O75306	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67050
3.44207426189723e-31	-0.297871033121573	0.026	0.251	7.73365245163069e-27	GAPDHP40	Malignant cells	GSE207422_Tor_post	ENSG00000248626	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67051
3.79253446692967e-31	-1.02512403076339	0.226	0.541	8.52106644029758e-27	MT2A	Malignant cells	GSE207422_Tor_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67052
3.846077408581e-31	-0.397450309091559	0.13	0.442	8.64136672159979e-27	AC016739.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67053
3.93632281023841e-31	0.447970201498171	0.344	0.048	8.84413009004366e-27	HPCAL1	Malignant cells	GSE207422_Tor_post	ENSG00000115756	3241	hippocalcin like 1	BDR1|HLP2|VILIP-3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67054
4.30294672534785e-31	0.687001363483377	0.397	0.077	9.66786070251155e-27	CPM	Malignant cells	GSE207422_Tor_post	ENSG00000135678	1368	carboxypeptidase M	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67055
4.63152235143861e-31	0.492848524064126	0.361	0.057	1.04061044192123e-26	SDR16C5	Malignant cells	GSE207422_Tor_post	ENSG00000170786	195814	short chain dehydrogenase/reductase family 16C member 5	EPHD-2|RDH-E2|RDHE2	protein_coding	Q8N3Y7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67056
5.24316892991476e-31	-0.507411560638074	0.154	0.466	1.17803519517325e-26	RAB6B	Malignant cells	GSE207422_Tor_post	ENSG00000154917	51560	RAB6B, member RAS oncogene family	NA	protein_coding	Q9NRW1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67057
5.99142889259526e-31	0.751787788837919	0.39	0.081	1.3461542435883e-26	AREG	Malignant cells	GSE207422_Tor_post	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67058
6.31088988793997e-31	-0.402063701462033	0.122	0.418	1.41793074002235e-26	CNOT7	Malignant cells	GSE207422_Tor_post	ENSG00000198791	29883	CCR4-NOT transcription complex subunit 7	CAF1	protein_coding	Q9UIV1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67059
6.47440642037083e-31	0.726910790882939	0.381	0.081	1.45466963452892e-26	MX1	Malignant cells	GSE207422_Tor_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67060
7.28922701832431e-31	-0.477515529822444	0.303	0.618	1.63774352647711e-26	VDAC1	Malignant cells	GSE207422_Tor_post	ENSG00000213585	7416	voltage dependent anion channel 1	MGC111064|PORIN	protein_coding	P21796	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67061
8.28675196938633e-31	0.472154194996982	0.397	0.081	1.86186743248172e-26	HERPUD1	Malignant cells	GSE207422_Tor_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67062
1.00304453454595e-30	-0.355031846518509	0.071	0.336	2.25364046021785e-26	PRPF3	Malignant cells	GSE207422_Tor_post	ENSG00000117360	9129	pre-mRNA processing factor 3	hPrp3|Prp3|RP18|SNRNP90	protein_coding	O43395	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67063
1.03425927254178e-30	1.01600892174316	0.367	0.068	2.32377373354687e-26	AQP4	Malignant cells	GSE207422_Tor_post	ENSG00000171885	361	aquaporin 4	AQP-4|hAQP4|MIWC	protein_coding	P55087	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67064
1.65981018541171e-30	0.498030721861646	0.726	0.424	3.72926152458304e-26	HMGN1	Malignant cells	GSE207422_Tor_post	ENSG00000205581	3150	high mobility group nucleosome binding domain 1	FLJ27265|FLJ31471|HMG14|MGC104230|MGC117425	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67065
1.70321404846793e-30	0.607735646714898	0.493	0.165	3.82678132409775e-26	XBP1	Malignant cells	GSE207422_Tor_post	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67066
1.76660524725247e-30	-0.450136717845246	0.279	0.604	3.96920866952686e-26	UBE2Q1	Malignant cells	GSE207422_Tor_post	ENSG00000160714	55585	ubiquitin conjugating enzyme E2 Q1	NICE-5|PRO3094|UBE2Q	protein_coding	Q7Z7E8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67067
1.926158167582e-30	0.529214914019047	0.409	0.095	4.32769217092324e-26	BCL2L1	Malignant cells	GSE207422_Tor_post	ENSG00000171552	598	BCL2 like 1	Bcl-X|bcl-xL|bcl-xS|BCL2L|BCLX|PPP1R52	protein_coding	Q07817	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67068
2.18045961055081e-30	0.586929077528582	0.376	0.068	4.89905665298555e-26	ADGRF5	Malignant cells	GSE207422_Tor_post	ENSG00000069122	221395	adhesion G protein-coupled receptor F5	DKFZp564O1923|GPR116|KIAA0758	protein_coding	Q8IZF2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67069
2.99178884436853e-30	-0.559641671189382	0.345	0.631	6.72195117552721e-26	HNRNPD	Malignant cells	GSE207422_Tor_post	ENSG00000138668	3184	heterogeneous nuclear ribonucleoprotein D	AUF1|HNRPD	protein_coding	Q14103	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67070
3.08350108665055e-30	-0.295195847985479	0.029	0.253	6.92801024148646e-26	NUP54	Malignant cells	GSE207422_Tor_post	ENSG00000138750	53371	nucleoporin 54	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67071
3.19947398483097e-30	0.791750936955945	0.268	0.011	7.18857814911823e-26	SCEL	Malignant cells	GSE207422_Tor_post	ENSG00000136155	8796	sciellin	FLJ21667|MGC22531	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67072
3.20099016928381e-30	0.522338679643808	0.408	0.099	7.19198471234686e-26	SERINC2	Malignant cells	GSE207422_Tor_post	ENSG00000168528	347735	serine incorporator 2	FKSG84|PRO0899|TDE2|TDE2L	protein_coding	Q96SA4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67073
3.27673563312392e-30	0.499991248126007	0.396	0.088	7.36216962050282e-26	CDK2AP2	Malignant cells	GSE207422_Tor_post	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67074
3.85585219369216e-30	-0.484900706825746	0.303	0.618	8.66332870878755e-26	PSMD4	Malignant cells	GSE207422_Tor_post	ENSG00000159352	5710	proteasome 26S subunit ubiquitin receptor, non-ATPase 4	AF|AF-1|Rpn10|S5A	protein_coding	P55036	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67075
3.87418055029537e-30	-0.44279272375862	0.872	0.934	8.70450886040364e-26	RPL19	Malignant cells	GSE207422_Tor_post	ENSG00000108298	6143	ribosomal protein L19	DKFZp779D216|FLJ27452|L19|MGC71997	protein_coding	P84098	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67076
3.99100007083898e-30	-0.564404727350658	0.185	0.481	8.96697895916101e-26	RRAGA	Malignant cells	GSE207422_Tor_post	ENSG00000155876	10670	Ras related GTP binding A	FIP-1|RAGA	protein_coding	Q7L523	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67077
4.68905985144705e-30	-0.514468177011446	0.415	0.699	1.05353796742312e-25	RBM39	Malignant cells	GSE207422_Tor_post	ENSG00000131051	9584	RNA binding motif protein 39	CAPER|CAPERalpha|CC1.3|fSAP59|HCC1|RNPC2	protein_coding	Q14498	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67078
5.31081580581906e-30	-0.355540810371146	0.084	0.354	1.19323409525143e-25	POGK	Malignant cells	GSE207422_Tor_post	ENSG00000143157	57645	pogo transposable element derived with KRAB domain	BASS2|KIAA15131|KRBOX2|LST003	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67079
8.43474367091889e-30	-0.475374922277879	0.341	0.651	1.89511820798206e-25	GPX4	Malignant cells	GSE207422_Tor_post	ENSG00000167468	2879	glutathione peroxidase 4	MCSP|PHGPx	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67080
8.68321655397541e-30	1.2387859047794	0.345	0.053	1.95094509534719e-25	DMBT1	Malignant cells	GSE207422_Tor_post	ENSG00000187908	1755	deleted in malignant brain tumors 1	Gp-340|GP340|hensin|muclin|SALSA|vomeroglandin	protein_coding	Q9UGM3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67081
9.51271719799207e-30	0.563558280334452	0.47	0.152	2.13731730004486e-25	ABHD2	Malignant cells	GSE207422_Tor_post	ENSG00000140526	11057	abhydrolase domain containing 2, acylglycerol lipase	LABH2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67082
1.37887192946478e-29	-0.483737819283045	0.948	0.985	3.09804945112147e-25	RPS24	Malignant cells	GSE207422_Tor_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67083
1.78620408448015e-29	0.577719423845751	0.373	0.079	4.01324333701e-25	HMGB3	Malignant cells	GSE207422_Tor_post	ENSG00000029993	3149	high mobility group box 3	HMG2A|HMG4|MGC90319	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67084
2.14426946447761e-29	-0.453250270833045	0.128	0.409	4.81774463278828e-25	REEP4	Malignant cells	GSE207422_Tor_post	ENSG00000168476	80346	receptor accessory protein 4	C8orf20|FLJ22246|FLJ22277|PP432|Yip2c	protein_coding	Q9H6H4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67085
2.40756934908409e-29	0.437499338770713	0.297	0.031	5.40932681352214e-25	CAPG	Malignant cells	GSE207422_Tor_post	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67086
2.64995118433014e-29	-0.391416457262525	0.124	0.409	5.95391032095297e-25	EXT1	Malignant cells	GSE207422_Tor_post	ENSG00000182197	2131	exostosin glycosyltransferase 1	LGCR|LGS|ttv	protein_coding	Q16394	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67087
3.10891984105855e-29	0.598201524210354	0.295	0.029	6.98512109889035e-25	CYR61	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67088
3.53535501608568e-29	0.75235920979435	0.33	0.046	7.94323565014132e-25	C11orf96	Malignant cells	GSE207422_Tor_post	ENSG00000187479	387763	chromosome 11 open reading frame 96	AG2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67089
3.80333607642308e-29	-0.547561942738877	0.236	0.536	8.54533549650737e-25	BNIP3	Malignant cells	GSE207422_Tor_post	ENSG00000176171	664	BCL2 interacting protein 3	HABON|Nip3	protein_coding	Q12983	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67090
3.81385848312307e-29	-0.445332358105	0.249	0.56	8.56897723988091e-25	CNIH4	Malignant cells	GSE207422_Tor_post	ENSG00000143771	29097	cornichon family AMPA receptor auxiliary protein 4	HSPC163	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67091
4.04184464442539e-29	-0.333431145483459	0.035	0.257	9.08121654709496e-25	ABCA13	Malignant cells	GSE207422_Tor_post	ENSG00000179869	154664	ATP binding cassette subfamily A member 13	FLJ33876|FLJ33951	protein_coding	Q86UQ4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67092
4.3773391555095e-29	0.538282829756021	0.486	0.171	9.83500561459874e-25	SNHG5	Malignant cells	GSE207422_Tor_post	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67093
4.80683275100494e-29	-0.775583342670281	0.428	0.708	1.07999918249579e-24	TFRC	Malignant cells	GSE207422_Tor_post	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67094
4.97621869692918e-29	-0.464550872754377	0.972	0.993	1.11805681682605e-24	RPL30	Malignant cells	GSE207422_Tor_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67095
5.9562482528523e-29	0.57216108941866	0.528	0.2	1.33824985745085e-24	ITGB1	Malignant cells	GSE207422_Tor_post	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67096
6.6402559748999e-29	-0.507691644857439	0.616	0.778	1.49193271244051e-24	UQCRH	Malignant cells	GSE207422_Tor_post	ENSG00000173660	7388	ubiquinol-cytochrome c reductase hinge protein	QCR6|UQCR8	protein_coding	P07919	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67097
6.95711647980284e-29	-0.501456666010065	0.13	0.402	1.5631249306821e-24	RALB	Malignant cells	GSE207422_Tor_post	ENSG00000144118	5899	RAS like proto-oncogene B	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67098
8.55568701837593e-29	-0.33545598096095	0.035	0.255	1.9222917592887e-24	ENO2	Malignant cells	GSE207422_Tor_post	ENSG00000111674	2026	enolase 2	NSE	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67099
9.22311981589164e-29	0.582386290223963	0.502	0.182	2.07225056023453e-24	BHLHE40	Malignant cells	GSE207422_Tor_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67100
1.00623541728181e-28	0.515354062331498	0.987	0.956	2.26080973554877e-24	MT-ND3	Malignant cells	GSE207422_Tor_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67101
1.0620004369899e-28	0.42318634028975	0.33	0.048	2.38610258182891e-24	TMEM125	Malignant cells	GSE207422_Tor_post	ENSG00000179178	128218	transmembrane protein 125	MGC17299	protein_coding	Q96AQ2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67102
1.52313712926105e-28	0.397078292343654	0.412	0.105	3.42218450202374e-24	ARF3	Malignant cells	GSE207422_Tor_post	ENSG00000134287	377	ADP ribosylation factor 3	NA	protein_coding	P61204	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67103
1.81096339853283e-28	1.32198507849072	0.338	0.053	4.06887256382355e-24	LTF	Malignant cells	GSE207422_Tor_post	ENSG00000012223	4057	lactotransferrin	HLF2	protein_coding	P02788	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67104
2.57638685594527e-28	-0.394354108597164	0.31	0.664	5.78862598793784e-24	RPL37P6	Malignant cells	GSE207422_Tor_post	ENSG00000241431	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67105
2.71232450963496e-28	-0.47565740128153	0.218	0.523	6.09405070824782e-24	ABCC5	Malignant cells	GSE207422_Tor_post	ENSG00000114770	10057	ATP binding cassette subfamily C member 5	EST277145|MOAT-C|MRP5|SMRP	protein_coding	O15440	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67106
4.28219732489837e-28	0.732294419797637	0.389	0.099	9.62124094958165e-24	RND3	Malignant cells	GSE207422_Tor_post	ENSG00000115963	390	Rho family GTPase 3	ARHE|Rho8|RhoE	protein_coding	P61587	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67107
4.67440205708377e-28	-0.494812372250809	0.451	0.703	1.05024465418558e-23	CCT4	Malignant cells	GSE207422_Tor_post	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67108
4.78637968732974e-28	0.641548607345234	0.358	0.068	1.07540378814925e-23	ALPL	Malignant cells	GSE207422_Tor_post	ENSG00000162551	249	alkaline phosphatase, biomineralization associated	HOPS|TNALP|TNAP|TNSALP	protein_coding	P05186	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67109
5.7135635955469e-28	-0.478754806754246	0.98	0.998	1.28372346864748e-23	RPS29	Malignant cells	GSE207422_Tor_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67110
9.1353277079125e-28	0.442371603791396	0.514	0.193	2.05252542941378e-23	TMED9	Malignant cells	GSE207422_Tor_post	ENSG00000184840	54732	transmembrane p24 trafficking protein 9	HSGP25L2G|p24a2|p24alpha2	protein_coding	Q9BVK6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67111
9.54625553736905e-28	0.404086558172504	0.336	0.057	2.14485269413608e-23	MGLL	Malignant cells	GSE207422_Tor_post	ENSG00000074416	11343	monoglyceride lipase	HU-K5|MAGL|MGL	protein_coding	Q99685	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67112
9.93780185772681e-28	0.461632370674047	0.339	0.062	2.23282532139406e-23	AHCYL2	Malignant cells	GSE207422_Tor_post	ENSG00000158467	23382	adenosylhomocysteinase like 2	ADOHCYASE3|IRBIT2|KIAA0828|long-IRBIT	protein_coding	Q96HN2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67113
1.2924483316503e-27	-0.981171294815165	0.135	0.4	2.9038729115519e-23	FGFBP2	Malignant cells	GSE207422_Tor_post	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67114
1.70675285362317e-27	0.562912774207215	0.351	0.066	3.83473231152054e-23	ICAM1	Malignant cells	GSE207422_Tor_post	ENSG00000090339	3383	intercellular adhesion molecule 1	BB2|CD54	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67115
1.94841969984194e-27	-0.524152231685652	0.694	0.809	4.37770938160487e-23	HNRNPC	Malignant cells	GSE207422_Tor_post	ENSG00000092199	3183	heterogeneous nuclear ribonucleoprotein C	HNRPC	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67116
1.95598076779965e-27	-0.530650189618332	0.683	0.875	4.39469758909226e-23	CD9	Malignant cells	GSE207422_Tor_post	ENSG00000010278	928	CD9 molecule	BA2|MIC3|MRP-1|P24|TSPAN29	protein_coding	P21926	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67117
2.06626448639985e-27	0.355370689099742	0.271	0.022	4.64248304804318e-23	NDFIP2	Malignant cells	GSE207422_Tor_post	ENSG00000102471	54602	Nedd4 family interacting protein 2	KIAA1165|N4wbp5a	protein_coding	Q9NV92	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67118
2.56149995831622e-27	0.729170917783208	0.37	0.092	5.75517810634489e-23	BCYRN1	Malignant cells	GSE207422_Tor_post	ENSG00000236824	618	brain cytoplasmic RNA 1	BC200|BC200a|LINC00004|NCRNA00004	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67119
2.68184164878751e-27	0.474087827938774	0.374	0.079	6.02556181649579e-23	ITGB6	Malignant cells	GSE207422_Tor_post	ENSG00000115221	3694	integrin subunit beta 6	NA	protein_coding	P18564	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67120
2.95677123371026e-27	0.445159648739706	0.39	0.092	6.64327360790021e-23	ARL6IP5	Malignant cells	GSE207422_Tor_post	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67121
2.97144089101379e-27	0.520026265392029	0.467	0.158	6.67623339392978e-23	IER2	Malignant cells	GSE207422_Tor_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67122
3.052635825222e-27	-0.635761431912815	0.384	0.644	6.85866217210879e-23	SEMA4B	Malignant cells	GSE207422_Tor_post	ENSG00000185033	10509	semaphorin 4B	KIAA1745|MGC131831|SEMAC|SemC	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67123
3.1905567368874e-27	-0.529152093480322	0.402	0.659	7.16854287643862e-23	KTN1	Malignant cells	GSE207422_Tor_post	ENSG00000126777	3895	kinectin 1	CG1|KIAA0004|KNT	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67124
3.36308026033655e-27	-0.519435087743778	0.185	0.462	7.55616872892415e-23	EGFR	Malignant cells	GSE207422_Tor_post	ENSG00000146648	1956	epidermal growth factor receptor	ERBB|ERBB1|ERRP	protein_coding	P00533	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67125
3.42011038687937e-27	0.421014041008156	0.496	0.18	7.68430401724057e-23	SEC62	Malignant cells	GSE207422_Tor_post	ENSG00000008952	7095	SEC62 homolog, preprotein translocation factor	Dtrp1|HTP1|TLOC1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67126
4.02497563987027e-27	-0.390675097317935	0.068	0.308	9.04331526766051e-23	CYP4F3	Malignant cells	GSE207422_Tor_post	ENSG00000186529	4051	cytochrome P450 family 4 subfamily F member 3	CYP4F|LTB4H	protein_coding	Q08477	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67127
4.94695604411696e-27	-0.318599340846941	0.054	0.281	1.1114820839922e-22	PANK3	Malignant cells	GSE207422_Tor_post	ENSG00000120137	79646	pantothenate kinase 3	FLJ12899	protein_coding	Q9H999	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67128
5.24020330539083e-27	-0.464155524527074	0.456	0.716	1.17736887865521e-22	AC116533.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67129
5.6529414216484e-27	0.391590267103956	0.418	0.116	1.27010287861596e-22	SCP2	Malignant cells	GSE207422_Tor_post	ENSG00000116171	6342	sterol carrier protein 2	NA	protein_coding	P22307	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67130
5.70968406217503e-27	-0.509246749828942	0.37	0.64	1.28285181508949e-22	C6orf48	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67131
6.80709588292906e-27	0.50113410625019	0.537	0.226	1.5294183029765e-22	UBE2H	Malignant cells	GSE207422_Tor_post	ENSG00000186591	7328	ubiquitin conjugating enzyme E2 H	GID3|UBC8|UBCH	protein_coding	P62256	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67132
7.21561864166026e-27	-0.403899998434934	0.116	0.382	1.62120519640823e-22	FAM84A	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67133
7.30460381134039e-27	0.675727283737198	1	0.989	1.64119838433196e-22	B2M	Malignant cells	GSE207422_Tor_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67134
7.68085879189646e-27	-0.468636531339006	0.636	0.855	1.7257353533633e-22	RPL26	Malignant cells	GSE207422_Tor_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67135
8.08538559236345e-27	0.478720072572115	0.994	0.976	1.81662443489222e-22	MT-RNR2	Malignant cells	GSE207422_Tor_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67136
8.18330100262921e-27	0.415106235545509	0.413	0.112	1.83862406927073e-22	ATP6V0B	Malignant cells	GSE207422_Tor_post	ENSG00000117410	533	ATPase H+ transporting V0 subunit b	ATP6F|HATPL|VMA16	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67137
8.39447105910511e-27	0.490089956479626	0.252	0.015	1.88606975755974e-22	PHLDA1	Malignant cells	GSE207422_Tor_post	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67138
8.50950782083967e-27	0.651032480717448	0.351	0.077	1.91191621718626e-22	RIOK3	Malignant cells	GSE207422_Tor_post	ENSG00000101782	8780	RIO kinase 3	SUDD	protein_coding	O14730	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67139
8.80128168290016e-27	0.440140682788891	0.293	0.04	1.97747196851401e-22	ATP11A	Malignant cells	GSE207422_Tor_post	ENSG00000068650	23250	ATPase phospholipid transporting 11A	ATPIH|ATPIS|KIAA1021	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67140
9.56304536249605e-27	0.441923566304919	0.507	0.193	2.14862503204561e-22	SBDS	Malignant cells	GSE207422_Tor_post	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67141
1.01397694788818e-26	0.623630711010717	0.288	0.037	2.27820340651516e-22	SAMD9	Malignant cells	GSE207422_Tor_post	ENSG00000205413	54809	sterile alpha motif domain containing 9	C7orf5|FLJ20073|KIAA2004	protein_coding	Q5K651	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67142
1.07831487112016e-26	0.868652054280079	0.329	0.057	2.42275785243277e-22	LRRK2	Malignant cells	GSE207422_Tor_post	ENSG00000188906	120892	leucine rich repeat kinase 2	DKFZp434H2111|FLJ45829|PARK8|RIPK7|ROCO2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67143
1.62046996341228e-26	-0.395555970341084	0.102	0.356	3.6408719137947e-22	PRKX	Malignant cells	GSE207422_Tor_post	ENSG00000183943	5613	protein kinase cAMP-dependent X-linked catalytic subunit	PKX1	protein_coding	P51817	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67144
1.75811013678549e-26	0.497327986711644	0.266	0.024	3.95012185532963e-22	PPP1R1B	Malignant cells	GSE207422_Tor_post	ENSG00000131771	84152	protein phosphatase 1 regulatory inhibitor subunit 1B	DARPP-32|FLJ20940	protein_coding	Q9UD71	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67145
2.00161320845285e-26	0.432113407381914	0.588	0.262	4.49722455675187e-22	CAST	Malignant cells	GSE207422_Tor_post	ENSG00000153113	831	calpastatin	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67146
2.28979923932409e-26	-0.405998464318931	0.182	0.473	5.14472093091337e-22	GSR	Malignant cells	GSE207422_Tor_post	ENSG00000104687	2936	glutathione-disulfide reductase	NA	protein_coding	P00390	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67147
2.34077531194422e-26	0.447215597905173	0.403	0.116	5.25925397087627e-22	TMEM106B	Malignant cells	GSE207422_Tor_post	ENSG00000106460	54664	transmembrane protein 106B	FLJ11273|MGC33727	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67148
2.39684816476641e-26	0.866633412022451	0.288	0.04	5.38523845659718e-22	SPINK5	Malignant cells	GSE207422_Tor_post	ENSG00000133710	11005	serine peptidase inhibitor Kazal type 5	DKFZp686K19184|FLJ21544|FLJ97536|FLJ97596|FLJ99794|LEKTI|LETKI|NETS|NS|VAKTI	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67149
2.41928043114656e-26	-0.483018040193318	0.862	0.963	5.43563927270009e-22	RPL5	Malignant cells	GSE207422_Tor_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67150
2.4682613241553e-26	0.668160902749475	0.726	0.473	5.54568954311214e-22	JUNB	Malignant cells	GSE207422_Tor_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67151
2.76164651575119e-26	0.444694840174917	0.578	0.268	6.20486739158978e-22	SSBP1	Malignant cells	GSE207422_Tor_post	ENSG00000262771	6742	single stranded DNA binding protein 1	mtSSB|SSBP	protein_coding	Q04837	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67152
3.2446370534318e-26	0.379058644090882	0.415	0.119	7.29005053165056e-22	COPG1	Malignant cells	GSE207422_Tor_post	ENSG00000181789	22820	COPI coat complex subunit gamma 1	COPG	protein_coding	Q9Y678	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67153
3.35298947724716e-26	0.784191646123836	0.697	0.464	7.53349675747892e-22	CYB5A	Malignant cells	GSE207422_Tor_post	ENSG00000166347	1528	cytochrome b5 type A	CYB5	protein_coding	P00167	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67154
3.35985364095601e-26	-0.464752477092405	0.135	0.42	7.54891916049996e-22	EGLN3	Malignant cells	GSE207422_Tor_post	ENSG00000129521	112399	egl-9 family hypoxia inducible factor 3	HIFPH3|PHD3	protein_coding	Q9H6Z9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67155
3.77584584897574e-26	0.463322188609977	0.483	0.171	8.48357045347869e-22	CYSTM1	Malignant cells	GSE207422_Tor_post	ENSG00000120306	84418	cysteine rich transmembrane module containing 1	C5orf32|ORF1-FL49	protein_coding	Q9H1C7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67156
4.92667522400895e-26	-0.444784400755291	0.368	0.662	1.10692538933033e-21	RPL15P3	Malignant cells	GSE207422_Tor_post	ENSG00000212802	NA	NA	bA511S14.1	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67157
4.99946747679458e-26	-0.445091470674083	0.364	0.651	1.12328035268621e-21	CDC42SE1	Malignant cells	GSE207422_Tor_post	ENSG00000197622	56882	CDC42 small effector 1	SCIP1|SPEC1	protein_coding	Q9NRR8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67158
5.54714009106214e-26	-0.332963776325503	0.073	0.31	1.24633143565984e-21	NOB1	Malignant cells	GSE207422_Tor_post	ENSG00000141101	28987	NIN1 (RPN12) binding protein 1 homolog	ART-4|MST158|NOB1P|PSMD8BP1	protein_coding	Q9ULX3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67159
6.42186958727851e-26	0.591533631944459	0.466	0.176	1.44286565886974e-21	AC007098.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67160
6.8011185818499e-26	-0.465641782704993	0.211	0.492	1.52807532297004e-21	PFDN2	Malignant cells	GSE207422_Tor_post	ENSG00000143256	5202	prefoldin subunit 2	NA	protein_coding	Q9UHV9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67161
8.14966698341107e-26	-0.416984879604322	0.796	0.899	1.8310671778328e-21	UBA52	Malignant cells	GSE207422_Tor_post	ENSG00000221983	7311	ubiquitin A-52 residue ribosomal protein fusion product 1	CEP52|HUBCEP52|L40|MGC126879|MGC126881|MGC57125|RPL40	protein_coding	P62987	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67162
8.93626375780033e-26	-0.521874927781397	0.41	0.664	2.00779974110258e-21	EIF5	Malignant cells	GSE207422_Tor_post	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67163
9.32653085834017e-26	0.433374390407721	0.486	0.18	2.09548495325187e-21	NOP10	Malignant cells	GSE207422_Tor_post	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67164
9.84115187538415e-26	-0.574561136852157	0.525	0.701	2.21111000336131e-21	MTATP6P1	Malignant cells	GSE207422_Tor_post	ENSG00000248527	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67165
9.95497895851659e-26	0.534274697090665	0.435	0.134	2.23668467239951e-21	CD55	Malignant cells	GSE207422_Tor_post	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67166
1.05218497947723e-25	-0.332188772365147	0.064	0.295	2.36404921188944e-21	BCL11A	Malignant cells	GSE207422_Tor_post	ENSG00000119866	53335	BAF chromatin remodeling complex subunit BCL11A	BCL11A-L|BCL11A-S|BCL11A-XL|CTIP1|EVI9|HBFQTL5|SMARCM1|ZNF856	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67167
1.18470596029115e-25	-0.808222844763781	0.099	0.347	2.66179735158215e-21	IGFBP3	Malignant cells	GSE207422_Tor_post	ENSG00000146674	3486	insulin like growth factor binding protein 3	BP-53|IBP3	protein_coding	P17936	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67168
1.44572177159034e-25	-0.327210270625599	0.096	0.345	3.24824767640917e-21	AC073861.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67169
1.45845755152624e-25	-0.520170791353415	0.311	0.631	3.27686242676915e-21	ALDH1A1	Malignant cells	GSE207422_Tor_post	ENSG00000165092	216	aldehyde dehydrogenase 1 family member A1	ALDH1|PUMB1|RALDH1	protein_coding	P00352	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67170
1.65834899507304e-25	-0.463428383735812	0.552	0.765	3.72597852213011e-21	TKT	Malignant cells	GSE207422_Tor_post	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67171
1.82832246506568e-25	-0.362264742326596	0.978	0.982	4.10787491450956e-21	PPIA	Malignant cells	GSE207422_Tor_post	ENSG00000196262	5478	peptidylprolyl isomerase A	CYPA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67172
1.9260984039448e-25	-0.517957708898671	0.504	0.745	4.32755789398317e-21	CBX3	Malignant cells	GSE207422_Tor_post	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67173
2.3061829645661e-25	-0.704647009674649	0.326	0.58	5.18153188478711e-21	STAT1	Malignant cells	GSE207422_Tor_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67174
2.43232261742701e-25	0.355515763768363	0.303	0.048	5.46494245683502e-21	ARL5B	Malignant cells	GSE207422_Tor_post	ENSG00000165997	221079	ADP ribosylation factor like GTPase 5B	ARL8	protein_coding	Q96KC2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67175
2.85363256567264e-25	0.396227207951614	0.437	0.136	6.41154164855328e-21	IQGAP1	Malignant cells	GSE207422_Tor_post	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67176
3.03165712104632e-25	0.494780973788004	0.659	0.349	6.81152721956687e-21	PRDX5	Malignant cells	GSE207422_Tor_post	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67177
3.34904075890984e-25	0.442016384084195	0.453	0.152	7.52462477711864e-21	TMEM59	Malignant cells	GSE207422_Tor_post	ENSG00000116209	9528	transmembrane protein 59	C1orf8|HSPC001	protein_coding	Q9BXS4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67178
3.41324704105337e-25	-0.468302523598957	0.192	0.466	7.66888345183871e-21	CYP4F11	Malignant cells	GSE207422_Tor_post	ENSG00000171903	57834	cytochrome P450 family 4 subfamily F member 11	NA	protein_coding	Q9HBI6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67179
3.48583026698231e-25	0.605325958643736	0.555	0.255	7.83196344385586e-21	FAM129B	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67180
3.5979129174294e-25	0.362130068336834	0.33	0.068	8.08379074288037e-21	LRRC59	Malignant cells	GSE207422_Tor_post	ENSG00000108829	55379	leucine rich repeat containing 59	FLJ21675|PRO1855	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67181
3.74958316856672e-25	-0.351617312789267	0.143	0.411	8.42456346313571e-21	VPS72	Malignant cells	GSE207422_Tor_post	ENSG00000163159	6944	vacuolar protein sorting 72 homolog	Swc2|TCFL1|YL-1|YL1	protein_coding	Q15906	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67182
4.15712143447735e-25	-0.352570062179691	0.074	0.308	9.34022043898372e-21	ITGB8	Malignant cells	GSE207422_Tor_post	ENSG00000105855	3696	integrin subunit beta 8	NA	protein_coding	P26012	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67183
4.1737799308046e-25	0.435362322780626	0.352	0.084	9.37764874853178e-21	CKB	Malignant cells	GSE207422_Tor_post	ENSG00000166165	1152	creatine kinase B	CKBB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67184
4.71538004201871e-25	-0.433775599159864	0.198	0.468	1.05945158784076e-20	SNHG7	Malignant cells	GSE207422_Tor_post	ENSG00000233016	84973	small nucleolar RNA host gene 7	MGC16037|NCRNA00061	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67185
4.9247082476662e-25	-0.343706506701632	0.119	0.376	1.10648344908564e-20	METAP1	Malignant cells	GSE207422_Tor_post	ENSG00000164024	23173	methionyl aminopeptidase 1	KIAA0094|MAP1A|MetAP1A	protein_coding	P53582	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67186
5.46721177907159e-25	-0.457851109924535	0.745	0.846	1.2283731425218e-20	SLC25A5	Malignant cells	GSE207422_Tor_post	ENSG00000005022	292	solute carrier family 25 member 5	2F1|ANT2|T2|T3	protein_coding	P05141	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67187
7.4308572499781e-25	0.548771175947805	0.771	0.563	1.66956500692508e-20	EPCAM	Malignant cells	GSE207422_Tor_post	ENSG00000119888	4072	epithelial cell adhesion molecule	17-1A|323/A3|Ber-Ep4|BerEp4|CD326|CO-17A|EGP-2|EGP34|EGP40|Ep-CAM|ESA|GA733-2|HEA125|KS1/4|KSA|Ly74|M4S1|MH99|MIC18|MK-1|MOC-31|MOC31|TACST-1|TACSTD1|TROP1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67188
8.2727122481611e-25	-0.423773166046907	0.054	0.264	1.85871298791684e-20	NAV1	Malignant cells	GSE207422_Tor_post	ENSG00000134369	89796	neuron navigator 1	DKFZp781D0314|FLJ12560|FLJ14203|KIAA1151|MGC14961|POMFIL3|steerin-1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67189
9.76099504125638e-25	0.40116912902702	0.3	0.048	2.19310036586948e-20	CREB3L1	Malignant cells	GSE207422_Tor_post	ENSG00000157613	90993	cAMP responsive element binding protein 3 like 1	OASIS	protein_coding	Q96BA8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67190
9.87494764692378e-25	-0.383036173089396	0.135	0.393	2.21870323731084e-20	NME4	Malignant cells	GSE207422_Tor_post	ENSG00000103202	4833	NME/NM23 nucleoside diphosphate kinase 4	NDPKD|nm23-H4|NM23H4	protein_coding	O00746	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67191
1.02343401309816e-24	-0.80068623507516	0.24	0.503	2.29945154062894e-20	ERO1A	Malignant cells	GSE207422_Tor_post	ENSG00000197930	30001	endoplasmic reticulum oxidoreductase 1 alpha	ERO1-alpha|Ero1alpha|ERO1L	protein_coding	Q96HE7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67192
1.07215981473302e-24	0.361879194025318	0.354	0.084	2.40892867174214e-20	CAP1	Malignant cells	GSE207422_Tor_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67193
1.08521352996655e-24	0.371504597733506	0.278	0.035	2.43825775912885e-20	SOD3	Malignant cells	GSE207422_Tor_post	ENSG00000109610	6649	superoxide dismutase 3	EC-SOD	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67194
1.27221832218799e-24	0.548144363089626	0.313	0.057	2.85842012629197e-20	SLC39A8	Malignant cells	GSE207422_Tor_post	ENSG00000138821	64116	solute carrier family 39 member 8	BIGM103	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67195
1.27898587088909e-24	-0.321425059325626	0.055	0.268	2.8736254547136e-20	SPAST	Malignant cells	GSE207422_Tor_post	ENSG00000021574	6683	spastin	ADPSP|FSP2|KIAA1083|SPG4	protein_coding	Q9UBP0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67196
1.54351193944402e-24	0.512577446762884	0.304	0.057	3.46796262554282e-20	GADD45A	Malignant cells	GSE207422_Tor_post	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67197
1.578617031829e-24	0.390257309885076	0.268	0.033	3.5468367471134e-20	EFNB2	Malignant cells	GSE207422_Tor_post	ENSG00000125266	1948	ephrin B2	EPLG5|Htk-L|HTKL|LERK5|MGC126226|MGC126227|MGC126228	protein_coding	P52799	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67198
1.69867473655695e-24	0.914712652554439	0.421	0.163	3.81658239809614e-20	RAP2B	Malignant cells	GSE207422_Tor_post	ENSG00000181467	5912	RAP2B, member of RAS oncogene family	NA	protein_coding	P61225	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67199
1.70596460260738e-24	0.452953589484565	0.364	0.097	3.83296126913827e-20	MEGF9	Malignant cells	GSE207422_Tor_post	ENSG00000106780	1955	multiple EGF like domains 9	EGFL5	protein_coding	Q9H1U4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67200
1.71788820328838e-24	0.443784499378837	0.448	0.163	3.85975121514834e-20	MYO6	Malignant cells	GSE207422_Tor_post	ENSG00000196586	4646	myosin VI	DFNA22|DFNB37|KIAA0389	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67201
1.88307163705798e-24	0.530833667684634	0.269	0.035	4.23088535414186e-20	LIPH	Malignant cells	GSE207422_Tor_post	ENSG00000163898	200879	lipase H	LPDLR|mPA-PLA1|mPA-PLA1alpha|PLA1B	protein_coding	Q8WWY8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67202
1.95214445155028e-24	0.343118737618895	0.303	0.053	4.38607815374316e-20	RAB12	Malignant cells	GSE207422_Tor_post	ENSG00000206418	201475	RAB12, member RAS oncogene family	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67203
2.51859723808368e-24	0.37268029002127	0.508	0.202	5.65878427452642e-20	ARPC5L	Malignant cells	GSE207422_Tor_post	ENSG00000136950	81873	actin related protein 2/3 complex subunit 5 like	ARC16-2|MGC3038	protein_coding	Q9BPX5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67204
2.75470796487148e-24	0.375310159399838	0.287	0.044	6.18927785547323e-20	CAT	Malignant cells	GSE207422_Tor_post	ENSG00000121691	847	catalase	NA	protein_coding	P04040	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67205
2.7952751831148e-24	0.500771053193927	0.307	0.055	6.28042428142234e-20	STEAP4	Malignant cells	GSE207422_Tor_post	ENSG00000127954	79689	STEAP4 metalloreductase	FLJ23153|SchLAH|STAMP2|TIARP|TNFAIP9	protein_coding	Q687X5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67206
3.34240857302532e-24	-0.37357408729358	0.134	0.391	7.50972358187328e-20	NOP53	Malignant cells	GSE207422_Tor_post	ENSG00000105373	29997	NOP53 ribosome biogenesis factor	GLTSCR2|PICT-1|PICT1	protein_coding	Q9NZM5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67207
3.45479078025969e-24	-0.537860025365674	0.054	0.259	7.76222392508746e-20	KRT15	Malignant cells	GSE207422_Tor_post	ENSG00000171346	3866	keratin 15	CK15|K15|K1CO	protein_coding	P19012	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67208
4.17696842824389e-24	0.737007315273827	0.466	0.2	9.38481266457837e-20	NCOA7	Malignant cells	GSE207422_Tor_post	ENSG00000111912	135112	nuclear receptor coactivator 7	dJ187J11.3|ERAP140|TLDC4	protein_coding	Q8NI08	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67209
4.22040856773908e-24	-0.420850934555326	0.869	0.912	9.48241396999617e-20	RPL35	Malignant cells	GSE207422_Tor_post	ENSG00000136942	11224	ribosomal protein L35	L35	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67210
4.29672921649805e-24	-0.309643939214584	0.079	0.31	9.65389120362781e-20	RPRD2	Malignant cells	GSE207422_Tor_post	ENSG00000163125	23248	regulation of nuclear pre-mRNA domain containing 2	FLJ32145|HSPC099|KIAA0460	protein_coding	Q5VT52	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67211
4.50983885419646e-24	0.481035595755975	0.326	0.07	1.01327059376086e-19	NEDD9	Malignant cells	GSE207422_Tor_post	ENSG00000111859	4739	neural precursor cell expressed, developmentally down-regulated 9	CAS-L|CASS2|HEF1	protein_coding	Q14511	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67212
4.57386714952379e-24	0.398453058993401	0.371	0.101	1.02765647115501e-19	TMEM219	Malignant cells	GSE207422_Tor_post	ENSG00000149932	124446	transmembrane protein 219	IGFBP-3R	protein_coding	Q86XT9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67213
5.60729292069379e-24	0.347929628685903	0.339	0.077	1.25984657342148e-19	SPCS2	Malignant cells	GSE207422_Tor_post	ENSG00000118363	9789	signal peptidase complex subunit 2	KIAA0102	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67214
5.68929021763926e-24	0.954245633576742	0.3	0.055	1.27826972609919e-19	AQP1	Malignant cells	GSE207422_Tor_post	ENSG00000240583	358	aquaporin 1 (Colton blood group)	CHIP28|CO	protein_coding	P29972	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67215
6.28665466363679e-24	0.366068156386983	0.311	0.059	1.41248556982591e-19	LMO3	Malignant cells	GSE207422_Tor_post	ENSG00000048540	55885	LIM domain only 3	DAT1|RBTNL2|Rhom-3	protein_coding	Q8TAP4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67216
6.4395397086557e-24	0.538450716765304	0.47	0.193	1.44683578174076e-19	NET1	Malignant cells	GSE207422_Tor_post	ENSG00000173848	10276	neuroepithelial cell transforming 1	ARHGEF8|NET1A	protein_coding	Q7Z628	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67217
6.45395172788218e-24	-0.46391718521349	0.342	0.635	1.45007387422057e-19	IFI16	Malignant cells	GSE207422_Tor_post	ENSG00000163565	3428	interferon gamma inducible protein 16	IFNGIP1|PYHIN2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67218
7.08969619341984e-24	-0.747734193037552	0.365	0.591	1.59291294073757e-19	MKNK2	Malignant cells	GSE207422_Tor_post	ENSG00000099875	2872	MAPK interacting serine/threonine kinase 2	GPRK7|MNK2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67219
7.58546999263932e-24	0.461894430417771	0.771	0.527	1.7043033979462e-19	UBC	Malignant cells	GSE207422_Tor_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67220
7.67588454789118e-24	0.349461884197032	0.256	0.029	1.72461774022019e-19	HSPB8	Malignant cells	GSE207422_Tor_post	ENSG00000152137	26353	heat shock protein family B (small) member 8	CMT2L|E2IG1|H11|HSP22	protein_coding	Q9UJY1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67221
8.29023492146918e-24	-0.491060224742576	0.677	0.809	1.8626499821557e-19	NAP1L1	Malignant cells	GSE207422_Tor_post	ENSG00000187109	4673	nucleosome assembly protein 1 like 1	MGC23410|MGC8688|NAP1|NAP1L|NRP	protein_coding	P55209	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67222
9.23661001158218e-24	0.31716945211888	0.306	0.057	2.07528153740228e-19	HSDL2	Malignant cells	GSE207422_Tor_post	ENSG00000119471	84263	hydroxysteroid dehydrogenase like 2	C9orf99|SDR13C1	protein_coding	Q6YN16	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67223
1.00016774380831e-23	0.745852896639014	0.348	0.086	2.24717688678852e-19	MMP7	Malignant cells	GSE207422_Tor_post	ENSG00000137673	4316	matrix metallopeptidase 7	MPSL1|PUMP-1	protein_coding	P09237	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67224
1.01133974346232e-23	0.687017949648391	0.33	0.068	2.27227813561115e-19	PIGR	Malignant cells	GSE207422_Tor_post	ENSG00000162896	5284	polymeric immunoglobulin receptor	NA	protein_coding	P01833	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67225
1.1913300311745e-23	0.471209684998216	0.255	0.029	2.67668031404286e-19	CYP4B1	Malignant cells	GSE207422_Tor_post	ENSG00000142973	1580	cytochrome P450 family 4 subfamily B member 1	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67226
1.331844360868e-23	0.339302533703183	0.287	0.048	2.99238790999822e-19	ASS1	Malignant cells	GSE207422_Tor_post	ENSG00000130707	445	argininosuccinate synthase 1	ASS|CTLN1	protein_coding	P00966	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67227
1.5339505439771e-23	0.378363483377392	0.263	0.033	3.44648008220774e-19	DLC1	Malignant cells	GSE207422_Tor_post	ENSG00000164741	10395	DLC1 Rho GTPase activating protein	ARHGAP7|DLC-1|HP|p122-RhoGAP|STARD12	protein_coding	Q96QB1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67228
1.68835859926937e-23	0.386003648846558	0.364	0.095	3.79340410083842e-19	TM9SF2	Malignant cells	GSE207422_Tor_post	ENSG00000125304	9375	transmembrane 9 superfamily member 2	P76	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67229
1.87719281088671e-23	0.439296658093189	0.294	0.055	4.21767680750027e-19	MICAL2	Malignant cells	GSE207422_Tor_post	ENSG00000133816	9645	microtubule associated monooxygenase, calponin and LIM domain containing 2	FLJ14966|KIAA0750|MICALCL	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67230
1.9604513667014e-23	0.451020478424331	0.387	0.116	4.4047421307047e-19	RBPMS	Malignant cells	GSE207422_Tor_post	ENSG00000157110	11030	RNA binding protein, mRNA processing factor	HERMES	protein_coding	Q93062	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67231
2.24865169710396e-23	-0.422731932815715	0.284	0.552	5.05227063305317e-19	RBMX	Malignant cells	GSE207422_Tor_post	ENSG00000147274	27316	RNA binding motif protein X-linked	hnRNP-G|HNRNPG|RNMX	protein_coding	P38159	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67232
2.44490986405807e-23	-0.375933762941371	0.154	0.413	5.49322348256567e-19	PAIP2	Malignant cells	GSE207422_Tor_post	ENSG00000120727	51247	poly(A) binding protein interacting protein 2	PAIP2A	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67233
2.78587359930346e-23	-0.416163626641466	0.917	0.987	6.25930080291502e-19	RPL32	Malignant cells	GSE207422_Tor_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67234
3.13940104823613e-23	-0.43685634201529	0.582	0.754	7.05360627517693e-19	EIF3H	Malignant cells	GSE207422_Tor_post	ENSG00000147677	8667	eukaryotic translation initiation factor 3 subunit H	eIF3-gamma|eIF3-p40|EIF3S3	protein_coding	O15372	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67235
4.06635925260753e-23	0.399739119672644	0.301	0.057	9.13629596875859e-19	CADM1	Malignant cells	GSE207422_Tor_post	ENSG00000182985	23705	cell adhesion molecule 1	BL2|IGSF4|IGSF4A|Necl-2|NECL2|RA175|ST17|SYNCAM|SYNCAM1|TSLC1	protein_coding	Q9BY67	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67236
4.11783193739017e-23	-0.387110563708311	0.945	0.978	9.25194479692824e-19	RPL38	Malignant cells	GSE207422_Tor_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67237
4.49562261496427e-23	0.496137024348701	0.429	0.149	1.01007648913017e-18	ODC1	Malignant cells	GSE207422_Tor_post	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67238
4.82866196999572e-23	0.519679656041919	0.282	0.048	1.08490377141864e-18	SLC6A14	Malignant cells	GSE207422_Tor_post	ENSG00000268104	11254	solute carrier family 6 member 14	NA	protein_coding	Q9UN76	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67239
5.15588463207577e-23	0.36310225824017	0.491	0.196	1.15842415913478e-18	ATP5IF1	Malignant cells	GSE207422_Tor_post	ENSG00000285390	93974	ATP synthase inhibitory factor subunit 1	ATPI|ATPIF1|ATPIP|IP|MGC1167|MGC8898	protein_coding	Q9UII2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67240
6.04157115197177e-23	-0.376852118659415	0.154	0.407	1.35742020642502e-18	ABCE1	Malignant cells	GSE207422_Tor_post	ENSG00000164163	6059	ATP binding cassette subfamily E member 1	OABP|RLI|RLI1|RNASEL1|RNASELI|RNS4I	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67241
7.28396170833418e-23	-0.474474287926705	0.311	0.574	1.63656051662852e-18	SNHG8	Malignant cells	GSE207422_Tor_post	ENSG00000269893	NA	NA	LINC00060|NCRNA00060	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67242
7.30942716604622e-23	-0.422324338876817	0.342	0.609	1.64228209566726e-18	COX5B	Malignant cells	GSE207422_Tor_post	ENSG00000135940	1329	cytochrome c oxidase subunit 5B	NA	protein_coding	P10606	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67243
7.84622779217453e-23	-0.413765495992855	0.277	0.545	1.76289046034577e-18	MATR3	Malignant cells	GSE207422_Tor_post	ENSG00000015479	9782	matrin 3	ALS21|MPD2|VCPDM|KIAA0723|MGC9105	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67244
9.20596887544783e-23	-0.391364773727115	0.975	0.98	2.06839708693562e-18	RPS20	Malignant cells	GSE207422_Tor_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67245
1.11240561217758e-22	-0.43291680077559	0.501	0.738	2.49935292944059e-18	SLC25A6	Malignant cells	GSE207422_Tor_post	ENSG00000169100	293	solute carrier family 25 member 6	ANT3|ANT3Y|MGC17525	protein_coding	P12236	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67246
1.28762375370937e-22	-0.339483269939163	0.122	0.365	2.89303304983421e-18	MPZL1	Malignant cells	GSE207422_Tor_post	ENSG00000197965	9019	myelin protein zero like 1	FLJ21047|PZR	protein_coding	O95297	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67247
1.32213781939616e-22	0.412220176548969	0.735	0.473	2.9705792526193e-18	CAPNS1	Malignant cells	GSE207422_Tor_post	ENSG00000126247	826	calpain small subunit 1	30K|CANP|CANPS|CAPN4|CDPS	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67248
1.32826737362292e-22	-0.303394771728651	0.057	0.259	2.98435113505598e-18	SCNM1	Malignant cells	GSE207422_Tor_post	ENSG00000163156	79005	sodium channel modifier 1	MGC3180	protein_coding	Q9BWG6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67249
1.36552672231964e-22	0.317713097290004	0.258	0.035	3.06806543970776e-18	STX12	Malignant cells	GSE207422_Tor_post	ENSG00000117758	23673	syntaxin 12	STX13|STX14	protein_coding	Q86Y82	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67250
1.37585787759862e-22	-0.401296930489656	0.719	0.879	3.09127747938858e-18	RPLP0	Malignant cells	GSE207422_Tor_post	ENSG00000089157	6175	ribosomal protein lateral stalk subunit P0	L10E|LP0|P0|PRLP0|RPP0	protein_coding	P05388	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67251
1.54902503203396e-22	0.428456848378037	0.339	0.09	3.48034944197391e-18	SLK	Malignant cells	GSE207422_Tor_post	ENSG00000065613	9748	STE20 like kinase	KIAA0204|se20-9|STK2	protein_coding	Q9H2G2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67252
2.27541247059941e-22	-0.372617450377699	0.221	0.486	5.11239673894276e-18	DARS	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67253
2.6902352050575e-22	0.35830072005671	0.285	0.055	6.04442045872318e-18	HMCES	Malignant cells	GSE207422_Tor_post	ENSG00000183624	56941	5-hydroxymethylcytosine binding, ES cell specific	C3orf37|DC12|SRAPD1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67254
2.7410702592882e-22	-0.335230858850656	0.095	0.319	6.15863665856873e-18	GBE1	Malignant cells	GSE207422_Tor_post	ENSG00000114480	2632	1,4-alpha-glucan branching enzyme 1	NA	protein_coding	Q04446	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67255
2.78098795566738e-22	0.69692550689202	0.424	0.171	6.24832373879346e-18	KLF4	Malignant cells	GSE207422_Tor_post	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67256
2.85578459871343e-22	0.373913824461749	0.287	0.055	6.41637683638933e-18	ABHD3	Malignant cells	GSE207422_Tor_post	ENSG00000158201	171586	abhydrolase domain containing 3, phospholipase	LABH3	protein_coding	Q8WU67	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67257
2.92138172465975e-22	-0.341263048640377	0.293	0.589	6.56376045896552e-18	RPL3P4	Malignant cells	GSE207422_Tor_post	ENSG00000232573	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67258
3.59804598815241e-22	0.369932536537237	0.399	0.125	8.08408972618083e-18	CAPN2	Malignant cells	GSE207422_Tor_post	ENSG00000162909	824	calpain 2	CANPL2|CANPml|mCANP	protein_coding	P17655	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67259
4.20304265985245e-22	0.424521724611705	0.317	0.068	9.44339624815648e-18	DRAM1	Malignant cells	GSE207422_Tor_post	ENSG00000136048	55332	DNA damage regulated autophagy modulator 1	DRAM|FLJ11259	protein_coding	Q8N682	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67260
4.55849286628614e-22	0.384474312118838	0.316	0.068	1.02420217719717e-17	FBP1	Malignant cells	GSE207422_Tor_post	ENSG00000165140	2203	fructose-bisphosphatase 1	FBP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67261
6.31749169863341e-22	0.416731521824636	0.587	0.299	1.41941403484895e-17	ARPC5	Malignant cells	GSE207422_Tor_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67262
6.56934509861534e-22	0.32293415565339	0.396	0.123	1.4760004567569e-17	COMMD6	Malignant cells	GSE207422_Tor_post	ENSG00000188243	170622	COMM domain containing 6	Acrg	protein_coding	Q7Z4G1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67263
7.44562486298248e-22	-0.439437972125468	0.361	0.6	1.6728829942149e-17	ATP5MPL	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67264
7.54206089261472e-22	0.543059970017894	0.664	0.391	1.69455024135267e-17	VAMP8	Malignant cells	GSE207422_Tor_post	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67265
8.10707951694123e-22	0.337771198236344	0.349	0.095	1.82149862586635e-17	GDI1	Malignant cells	GSE207422_Tor_post	ENSG00000203879	2664	GDP dissociation inhibitor 1	FLJ41411|GDIL|MRX41|MRX48|OPHN2|RABGDIA|XAP-4	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67266
8.28773877236087e-22	-0.299777538849137	0.083	0.299	1.86208914737404e-17	ANKRD17	Malignant cells	GSE207422_Tor_post	ENSG00000132466	26057	ankyrin repeat domain 17	FLJ22206|GTAR|KIAA0697|MASK2|NY-BR-16	protein_coding	O75179	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67267
8.36369425008929e-22	-0.298645190669333	0.1	0.33	1.87915482411006e-17	RPL10AP2	Malignant cells	GSE207422_Tor_post	ENSG00000188873	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67268
8.74808513003605e-22	-0.394904659779366	0.319	0.58	1.9655197670165e-17	RBM8A	Malignant cells	GSE207422_Tor_post	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67269
9.31232202915905e-22	-0.394797588451506	0.997	1	2.09229251351146e-17	EEF1A1	Malignant cells	GSE207422_Tor_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67270
1.09916514533846e-21	0.557559539713009	0.271	0.051	2.46960424854645e-17	BMP2	Malignant cells	GSE207422_Tor_post	ENSG00000125845	650	bone morphogenetic protein 2	BMP2A	protein_coding	P12643	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67271
1.16228789815067e-21	-0.27156973934776	0.086	0.31	2.61142844956494e-17	MMP24OS	Malignant cells	GSE207422_Tor_post	ENSG00000126005	101410538	MMP24 opposite strand	MMP24-AS1	protein_coding	A0A0U1RRL7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67272
1.25008506206614e-21	0.695614025868299	0.431	0.174	2.80869111745019e-17	TCIM	Malignant cells	GSE207422_Tor_post	ENSG00000176907	56892	transcriptional and immune response regulator	C8orf4|hTC-1|TC-1|TC1	protein_coding	Q9NR00	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67273
1.40532405813893e-21	0.380153598671642	0.259	0.04	3.15748209382655e-17	NDNF	Malignant cells	GSE207422_Tor_post	ENSG00000173376	79625	neuron derived neurotrophic factor	C4orf31|FLJ23191	protein_coding	Q8TB73	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67274
1.54699844459996e-21	0.447238525375815	0.473	0.2	3.4757961053272e-17	CD47	Malignant cells	GSE207422_Tor_post	ENSG00000196776	961	CD47 molecule	IAP|MER6|OA3	protein_coding	Q08722	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67275
1.73393183717239e-21	0.309856029847373	0.278	0.053	3.89579805175891e-17	DUOXA1	Malignant cells	GSE207422_Tor_post	ENSG00000140254	90527	dual oxidase maturation factor 1	FLJ32334|mol|NIP|NUMBIP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67276
2.05105449402421e-21	0.38375207594961	0.32	0.081	4.6083092371736e-17	MBIP	Malignant cells	GSE207422_Tor_post	ENSG00000151332	51562	MAP3K12 binding inhibitory protein 1	NA	protein_coding	Q9NS73	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67277
2.13748562405457e-21	0.412597431648532	0.344	0.099	4.80250270012581e-17	HTATIP2	Malignant cells	GSE207422_Tor_post	ENSG00000109854	10553	HIV-1 Tat interactive protein 2	CC3|FLJ26963|SDR44U1|TIP30	protein_coding	Q9BUP3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67278
2.23377429218847e-21	0.310427874239825	0.464	0.174	5.01884407968906e-17	DAZAP2	Malignant cells	GSE207422_Tor_post	ENSG00000183283	9802	DAZ associated protein 2	KIAA0058	protein_coding	Q15038	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67279
2.47363867824095e-21	0.34989227115296	0.326	0.086	5.55777138227176e-17	RBM47	Malignant cells	GSE207422_Tor_post	ENSG00000163694	54502	RNA binding motif protein 47	FLJ20273|NET18	protein_coding	A0AV96	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67280
2.8584868996685e-21	0.38844918999779	0.349	0.103	6.42244836617518e-17	ERBB3	Malignant cells	GSE207422_Tor_post	ENSG00000065361	2065	erb-b2 receptor tyrosine kinase 3	HER3|LCCS2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67281
3.05317864987059e-21	0.382878387360192	0.357	0.103	6.85988179052925e-17	HBEGF	Malignant cells	GSE207422_Tor_post	ENSG00000113070	1839	heparin binding EGF like growth factor	DTR|DTS|HEGFL	protein_coding	Q99075	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67282
3.66340079107091e-21	0.329484972233015	0.25	0.037	8.23092889737812e-17	EFHD2	Malignant cells	GSE207422_Tor_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67283
3.6925899904333e-21	0.741663476325083	0.758	0.569	8.29651119050554e-17	TM4SF1	Malignant cells	GSE207422_Tor_post	ENSG00000169908	4071	transmembrane 4 L six family member 1	L6|M3S1	protein_coding	P30408	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67284
3.7070028522592e-21	-0.411881726611804	0.111	0.332	8.32889400845596e-17	ZNF385A	Malignant cells	GSE207422_Tor_post	ENSG00000161642	25946	zinc finger protein 385A	DKFZp586G1122|Hzf|ZFP385|ZNF385	protein_coding	Q96PM9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67285
3.8584103853226e-21	-0.392561785518068	0.221	0.486	8.66907645374283e-17	PTDSS1	Malignant cells	GSE207422_Tor_post	ENSG00000156471	9791	phosphatidylserine synthase 1	KIAA0024|PSS1|PSSA	protein_coding	P48651	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67286
3.96395475576236e-21	0.440549417796322	0.92	0.842	8.90621354524686e-17	H3F3B	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67287
4.02333086000092e-21	-0.5071298667895	0.311	0.578	9.03961977625007e-17	SLC2A1	Malignant cells	GSE207422_Tor_post	ENSG00000117394	6513	solute carrier family 2 member 1	CSE|DYT18|DYT9|GLUT|GLUT-1|GLUT1|HTLVR	protein_coding	P11166	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67288
4.62923918840955e-21	0.355241981617264	0.271	0.046	1.04009746085186e-16	NNMT	Malignant cells	GSE207422_Tor_post	ENSG00000166741	4837	nicotinamide N-methyltransferase	NA	protein_coding	P40261	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67289
5.50669057287187e-21	0.306327435496579	0.314	0.075	1.23724323791285e-16	SRPRA	Malignant cells	GSE207422_Tor_post	ENSG00000182934	6734	SRP receptor subunit alpha	SR-alpha|Sralpha|SRP-alpha|SRPR	protein_coding	P08240	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67290
6.28180982406439e-21	0.309696430860442	0.443	0.165	1.41139703127079e-16	SEC61B	Malignant cells	GSE207422_Tor_post	ENSG00000106803	10952	SEC61 translocon subunit beta	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67291
6.98545959523099e-21	0.380894392033689	0.376	0.121	1.5694930618565e-16	TSC22D1	Malignant cells	GSE207422_Tor_post	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67292
7.04190126589528e-21	0.336997749622023	0.485	0.202	1.58217437642135e-16	GDI2	Malignant cells	GSE207422_Tor_post	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67293
7.5115217832976e-21	-0.342822113171349	0.195	0.448	1.6876887142713e-16	LRPPRC	Malignant cells	GSE207422_Tor_post	ENSG00000138095	10128	leucine rich pentatricopeptide repeat containing	GP130|LRP130|LSFC	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67294
8.97406539829397e-21	-0.420795466247012	0.632	0.796	2.01629301368869e-16	RPS25	Malignant cells	GSE207422_Tor_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67295
9.17407329201874e-21	0.302517924632745	0.256	0.04	2.06123078725077e-16	RPS4Y1	Malignant cells	GSE207422_Tor_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67296
9.34913860255686e-21	0.336015513014881	0.655	0.369	2.10056446122248e-16	SRP14	Malignant cells	GSE207422_Tor_post	ENSG00000140319	6727	signal recognition particle 14	ALURBP|MGC14326	protein_coding	P37108	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67297
9.74512809816565e-21	0.346155153254111	0.384	0.125	2.18953538109586e-16	DDX3X	Malignant cells	GSE207422_Tor_post	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67298
9.92138216751617e-21	0.401022042197152	0.255	0.044	2.22913614539753e-16	IFI44L	Malignant cells	GSE207422_Tor_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67299
1.02460025732449e-20	-0.260195187208811	0.064	0.262	2.30207185815666e-16	KLHL9	Malignant cells	GSE207422_Tor_post	ENSG00000198642	55958	kelch like family member 9	FLJ13568|KIAA1354	protein_coding	Q9P2J3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67300
1.14793003104218e-20	-0.34682854869234	0.405	0.782	2.57916919374556e-16	CDKN2A	Malignant cells	GSE207422_Tor_post	ENSG00000147889	1029	cyclin dependent kinase inhibitor 2A	ARF|CDK4I|CDKN2|CMM2|INK4|INK4a|MLM|MTS1|p14|p14ARF|p16|P16-INK4A|p16INK4a|p19|p19Arf	protein_coding	P42771	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67301
1.17412142944151e-20	0.320359642364859	0.3	0.068	2.63801602766918e-16	RAB27A	Malignant cells	GSE207422_Tor_post	ENSG00000069974	5873	RAB27A, member RAS oncogene family	GS2|HsT18676|RAB27|RAM	protein_coding	P51159	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67302
1.21444531043747e-20	0.323624591187962	0.272	0.055	2.7286157234909e-16	CHP1	Malignant cells	GSE207422_Tor_post	ENSG00000187446	11261	calcineurin like EF-hand protein 1	CHP|p22|p24|Sid470p|SLC9A1BP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67303
1.25900904182926e-20	-0.36089053220944	0.293	0.558	2.82874151518197e-16	SCARB2	Malignant cells	GSE207422_Tor_post	ENSG00000138760	950	scavenger receptor class B member 2	CD36L2|HLGP85|LIMP-2|LIMPII|SR-BII	protein_coding	Q14108	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67304
1.29744741219991e-20	0.34666275721439	0.396	0.143	2.91510484573076e-16	TMEM54	Malignant cells	GSE207422_Tor_post	ENSG00000121900	113452	transmembrane protein 54	BCLP|CAC-1	protein_coding	Q969K7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67305
1.51634560971795e-20	0.40705224219344	0.262	0.048	3.4069253159143e-16	SKIL	Malignant cells	GSE207422_Tor_post	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67306
1.7161128552271e-20	0.390126405698353	0.678	0.422	3.85576236312425e-16	RTN4	Malignant cells	GSE207422_Tor_post	ENSG00000115310	57142	reticulon 4	ASY|KIAA0886|NOGO|NSP-CL	protein_coding	Q9NQC3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67307
1.76483758841782e-20	0.315842324913104	0.263	0.048	3.96523709365716e-16	NECTIN2	Malignant cells	GSE207422_Tor_post	ENSG00000130202	5819	nectin cell adhesion molecule 2	CD112|HVEB|Nectin-2|PRR2|PVRL2|PVRR2	protein_coding	Q92692	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67308
2.01126253882806e-20	0.435359657187368	0.381	0.134	4.5189046722389e-16	BAG3	Malignant cells	GSE207422_Tor_post	ENSG00000151929	9531	BAG cochaperone 3	NA	protein_coding	O95817	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67309
2.02658077128006e-20	0.362487724376072	0.335	0.095	4.55332167691203e-16	MSN	Malignant cells	GSE207422_Tor_post	ENSG00000147065	4478	moesin	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67310
2.51313090143131e-20	1.17385325165418	0.435	0.176	5.64650250933588e-16	HLA-DRB1	Malignant cells	GSE207422_Tor_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67311
2.52540929059199e-20	-0.338898126736446	0.159	0.396	5.67408959410209e-16	OSMR	Malignant cells	GSE207422_Tor_post	ENSG00000145623	9180	oncostatin M receptor	OSMRB|OSMRbeta	protein_coding	Q99650	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67312
2.57182259085969e-20	-0.400129655429027	0.211	0.459	5.77837099714355e-16	ADAR	Malignant cells	GSE207422_Tor_post	ENSG00000160710	103	adenosine deaminase RNA specific	ADAR1|DRADA|G1P1|IFI4	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67313
2.67139725115799e-20	1.26691685265785	0.639	0.547	6.00209534390177e-16	CD74	Malignant cells	GSE207422_Tor_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67314
2.94294422890727e-20	0.325005946350846	0.268	0.051	6.61220709350885e-16	MLPH	Malignant cells	GSE207422_Tor_post	ENSG00000115648	79083	melanophilin	exophilin-3|l(1)-3Rk|l1Rk3|ln|Slac-2a	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67315
3.12243711750858e-20	0.397428565384558	0.384	0.134	7.01549171561829e-16	CDC42EP1	Malignant cells	GSE207422_Tor_post	ENSG00000128283	11135	CDC42 effector protein 1	Borg5|CEP1|MSE55	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67316
3.6096186431093e-20	0.353194830711144	0.301	0.073	8.11009116733798e-16	PRSS8	Malignant cells	GSE207422_Tor_post	ENSG00000052344	5652	serine protease 8	CAP1	protein_coding	Q16651	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67317
3.84419826956928e-20	0.609289645774211	0.769	0.571	8.63714467206827e-16	IFITM3	Malignant cells	GSE207422_Tor_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67318
4.25674710694916e-20	-0.298734454752673	0.128	0.354	9.56405939989337e-16	IARS2	Malignant cells	GSE207422_Tor_post	ENSG00000067704	55699	isoleucyl-tRNA synthetase 2, mitochondrial	FLJ10326	protein_coding	Q9NSE4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67319
4.80282422994867e-20	0.400707046606563	0.517	0.255	1.07909854798487e-15	LAD1	Malignant cells	GSE207422_Tor_post	ENSG00000159166	3898	ladinin 1	NA	protein_coding	O00515	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67320
4.90376435320438e-20	0.32601176945828	0.297	0.07	1.10177777487796e-15	RBMS1	Malignant cells	GSE207422_Tor_post	ENSG00000153250	5937	RNA binding motif single stranded interacting protein 1	C2orf12|DKFZp564H0764|HCC-4|MSSP-1|MSSP-2|MSSP-3|SCR2|YC1	protein_coding	P29558	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67321
5.66244429924632e-20	-0.351702487003791	0.188	0.431	1.27223798515466e-15	GRINA	Malignant cells	GSE207422_Tor_post	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67322
6.10366595894697e-20	0.338442250409422	0.259	0.048	1.37137166765621e-15	C2	Malignant cells	GSE207422_Tor_post	ENSG00000231543	717	complement C2	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67323
6.78847855495742e-20	0.318998626715254	0.323	0.092	1.52523536172783e-15	TERF2IP	Malignant cells	GSE207422_Tor_post	ENSG00000166848	54386	TERF2 interacting protein	RAP1	protein_coding	Q9NYB0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67324
7.1646797505683e-20	0.39002417571791	0.537	0.281	1.60976024635769e-15	SUMO3	Malignant cells	GSE207422_Tor_post	ENSG00000184900	6612	small ubiquitin like modifier 3	SMT3A|SMT3H1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67325
7.59385595710372e-20	-0.477381827596114	0.271	0.501	1.70618755644206e-15	WASF2	Malignant cells	GSE207422_Tor_post	ENSG00000158195	10163	WASP family member 2	SCAR2|WAVE2	protein_coding	Q9Y6W5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67326
8.47633032439125e-20	-0.399013556143727	0.351	0.589	1.90446189728423e-15	PAPOLA	Malignant cells	GSE207422_Tor_post	ENSG00000090060	10914	poly(A) polymerase alpha	PAP	protein_coding	P51003	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67327
8.73733263375387e-20	0.336051935970005	0.284	0.066	1.96310389615182e-15	DEDD2	Malignant cells	GSE207422_Tor_post	ENSG00000160570	162989	death effector domain containing 2	FLAME-3	protein_coding	Q8WXF8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67328
8.7824068708516e-20	-0.467531441249822	0.179	0.418	1.97323117574294e-15	NECTIN4	Malignant cells	GSE207422_Tor_post	ENSG00000143217	81607	nectin cell adhesion molecule 4	LNIR|nectin-4|PRR4|PVRL4	protein_coding	Q96NY8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67329
9.32999847530341e-20	0.276505803494532	0.262	0.048	2.09626405743117e-15	SVIP	Malignant cells	GSE207422_Tor_post	ENSG00000198168	258010	small VCP interacting protein	DKFZp313A2432	protein_coding	Q8NHG7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67330
9.7201126515202e-20	0.270744239573355	0.256	0.046	2.18391491054356e-15	LACTB2	Malignant cells	GSE207422_Tor_post	ENSG00000147592	51110	lactamase beta 2	CGI-83	protein_coding	Q53H82	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67331
9.83249641219769e-20	0.322438813533638	0.357	0.112	2.20916529389258e-15	RDX	Malignant cells	GSE207422_Tor_post	ENSG00000137710	5962	radixin	DFNB24	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67332
9.99378063642077e-20	-0.309748365043654	0.106	0.319	2.24540263339102e-15	PTPRZ1	Malignant cells	GSE207422_Tor_post	ENSG00000106278	5803	protein tyrosine phosphatase receptor type Z1	phosphacan|PTP18|PTPRZ|PTPZ|RPTPB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67333
1.24372469394132e-19	0.500406251027064	0.592	0.338	2.79440064234736e-15	ELF3	Malignant cells	GSE207422_Tor_post	ENSG00000163435	1999	E74 like ETS transcription factor 3	EPR-1|ERT|ESE-1|ESX	protein_coding	P78545	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67334
1.77183484951776e-19	0.33910014409627	0.349	0.11	3.9809585398965e-15	SMIM14	Malignant cells	GSE207422_Tor_post	ENSG00000163683	201895	small integral membrane protein 14	C4orf34|FLJ13289	protein_coding	Q96QK8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67335
2.03955118179695e-19	-0.39105507402008	0.284	0.525	4.58246359526139e-15	STMP1	Malignant cells	GSE207422_Tor_post	ENSG00000243317	647087	short transmembrane mitochondrial protein 1	C7orf73|Mm47|PL-5283	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67336
2.04939030117299e-19	-0.359463878609486	0.194	0.426	4.60457012867547e-15	PRXL2A	Malignant cells	GSE207422_Tor_post	ENSG00000122378	84293	peroxiredoxin like 2A	Adrx|C10orf58|FAM213A|MGC4248|PAMM	protein_coding	Q9BRX8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67337
2.06865267790019e-19	-0.251274311270508	0.333	0.684	4.64784883670616e-15	AKR1C2	Malignant cells	GSE207422_Tor_post	ENSG00000151632	1646	aldo-keto reductase family 1 member C2	BABP|DD|DD2|DDH2|HAKRD|MCDR2|TDD	protein_coding	P52895	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67338
2.14751710516477e-19	-0.255237467412844	0.067	0.257	4.82504143188422e-15	TSPAN7	Malignant cells	GSE207422_Tor_post	ENSG00000156298	7102	tetraspanin 7	A15|CD231|DXS1692E|MRX58|MXS1|TALLA-1|TM4SF2	protein_coding	P41732	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67339
2.50455268204402e-19	0.299336126385538	0.253	0.048	5.62722896601649e-15	TGIF1	Malignant cells	GSE207422_Tor_post	ENSG00000177426	7050	TGFB induced factor homeobox 1	HPE4|TGIF	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67340
2.52645982409704e-19	-0.361089632830078	0.53	0.725	5.67644993278123e-15	CLTA	Malignant cells	GSE207422_Tor_post	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67341
2.64139103805053e-19	-0.262229692695943	0.073	0.266	5.93467738429194e-15	PPME1	Malignant cells	GSE207422_Tor_post	ENSG00000214517	51400	protein phosphatase methylesterase 1	ABDH19|PME-1	protein_coding	Q9Y570	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67342
2.99934033791791e-19	0.308852363500207	0.868	0.705	6.73891787123396e-15	OAZ1	Malignant cells	GSE207422_Tor_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67343
3.15816677761208e-19	0.531195634724819	0.393	0.152	7.09576911593882e-15	HES1	Malignant cells	GSE207422_Tor_post	ENSG00000114315	3280	hes family bHLH transcription factor 1	bHLHb39|FLJ20408|HES-1|HRY	protein_coding	Q14469	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67344
3.36312124648786e-19	0.5468428500375	0.397	0.158	7.55626081660892e-15	PLSCR1	Malignant cells	GSE207422_Tor_post	ENSG00000188313	5359	phospholipid scramblase 1	MMTRA1B	protein_coding	O15162	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67345
3.82861832448661e-19	0.335330309942923	0.619	0.347	8.60213965145652e-15	TMEM258	Malignant cells	GSE207422_Tor_post	ENSG00000134825	746	transmembrane protein 258	C11orf10|Kud|Kuduk	protein_coding	P61165	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67346
4.17056885017405e-19	-0.38588889556434	0.378	0.611	9.37043409257105e-15	EIF4B	Malignant cells	GSE207422_Tor_post	ENSG00000063046	1975	eukaryotic translation initiation factor 4B	NA	protein_coding	P23588	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67347
4.51211847872938e-19	-0.391653918384102	0.389	0.622	1.01378277980092e-14	RSL1D1	Malignant cells	GSE207422_Tor_post	ENSG00000171490	26156	ribosomal L1 domain containing 1	CSIG|DKFZP564M182|L12|PBK1|UTP30	protein_coding	O76021	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67348
5.07564308804338e-19	-0.788627506530627	0.21	0.424	1.14039548902159e-14	PLAC8	Malignant cells	GSE207422_Tor_post	ENSG00000145287	51316	placenta associated 8	C15|onzin	protein_coding	Q9NZF1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67349
5.89602720922374e-19	0.328553376662658	0.256	0.053	1.32471939336839e-14	BCL9L	Malignant cells	GSE207422_Tor_post	ENSG00000186174	283149	BCL9 like	B9L|Bcl9-2|DLNB11	protein_coding	Q86UU0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67350
6.89340696458869e-19	0.812192797028596	0.801	0.695	1.54881067680379e-14	ZFP36L1	Malignant cells	GSE207422_Tor_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67351
7.56590689716634e-19	0.389436780904681	0.643	0.363	1.69990796165533e-14	RHOA	Malignant cells	GSE207422_Tor_post	ENSG00000067560	387	ras homolog family member A	ARH12|ARHA|Rho12|RHOH12	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67352
7.59031419915373e-19	0.335448867238092	0.833	0.589	1.70539179426586e-14	YWHAB	Malignant cells	GSE207422_Tor_post	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67353
1.00873012351373e-18	0.324075044129316	0.355	0.121	2.26641484151064e-14	SLC39A7	Malignant cells	GSE207422_Tor_post	ENSG00000229802	7922	solute carrier family 39 member 7	D6S2244E|H2-KE4|HKE4|KE4|RING5|ZIP7	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67354
1.02618271932998e-18	0.391314523692179	0.313	0.09	2.30562733379059e-14	CXCL16	Malignant cells	GSE207422_Tor_post	ENSG00000161921	58191	C-X-C motif chemokine ligand 16	CXCLG16|SR-PSOX|SRPSOX	protein_coding	Q9H2A7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67355
1.18015541778365e-18	-0.422650799648082	0.469	0.705	2.65157319267631e-14	ATP1A1	Malignant cells	GSE207422_Tor_post	ENSG00000163399	476	ATPase Na+/K+ transporting subunit alpha 1	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67356
1.31650098560685e-18	-0.301327808660387	0.096	0.295	2.95791441446146e-14	HAX1	Malignant cells	GSE207422_Tor_post	ENSG00000143575	10456	HCLS1 associated protein X-1	HAX-1|HCLSBP1|HS1BP1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67357
1.39801915364713e-18	0.35100028264587	0.336	0.11	3.14106943441437e-14	RALA	Malignant cells	GSE207422_Tor_post	ENSG00000006451	5898	RAS like proto-oncogene A	RAL	protein_coding	P11233	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67358
1.46723633811066e-18	-0.355055837206905	0.598	0.714	3.29658660446702e-14	EMP2	Malignant cells	GSE207422_Tor_post	ENSG00000213853	2013	epithelial membrane protein 2	XMP	protein_coding	P54851	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67359
1.48612108456598e-18	-0.279241322032992	0.076	0.266	3.33901685280285e-14	AC008026.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67360
1.5941806748514e-18	0.341339592999164	0.723	0.479	3.58180514025613e-14	UQCRQ	Malignant cells	GSE207422_Tor_post	ENSG00000164405	27089	ubiquinol-cytochrome c reductase complex III subunit VII	QCR8|QP-C|UQCR7	protein_coding	O14949	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67361
1.60353199707489e-18	-0.36984854411908	0.667	0.785	3.60281569102787e-14	BTF3	Malignant cells	GSE207422_Tor_post	ENSG00000145741	689	basic transcription factor 3	BTF3a|BTF3b|NACB	protein_coding	P20290	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67362
1.60592586841335e-18	0.314233661350491	0.394	0.145	3.60819424115112e-14	ARPC3	Malignant cells	GSE207422_Tor_post	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67363
1.69924364180475e-18	0.756630886814837	0.306	0.095	3.81786061440691e-14	LYPD3	Malignant cells	GSE207422_Tor_post	ENSG00000124466	27076	LY6/PLAUR domain containing 3	C4.4A	protein_coding	O95274	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67364
1.83763332327756e-18	-0.393470116030499	0.402	0.653	4.12879455074002e-14	RNF187	Malignant cells	GSE207422_Tor_post	ENSG00000285426	149603	ring finger protein 187	RACO-1|RACO1	protein_coding	Q5TA31	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67365
1.87407531145811e-18	-0.644420027511063	0.096	0.288	4.21067240978408e-14	GJB2	Malignant cells	GSE207422_Tor_post	ENSG00000165474	2706	gap junction protein beta 2	CX26|DFNA3|DFNB1|NSRD1	protein_coding	P29033	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67366
2.05886515410432e-18	0.309632026269423	0.335	0.105	4.62585822824158e-14	WNK1	Malignant cells	GSE207422_Tor_post	ENSG00000060237	65125	WNK lysine deficient protein kinase 1	HSAN2|HSN2|PPP1R167|PRKWNK1	protein_coding	Q9H4A3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67367
2.06029440571808e-18	0.444550577883822	0.325	0.105	4.62906947076738e-14	PNRC1	Malignant cells	GSE207422_Tor_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67368
2.08572637630695e-18	0.334150778045067	0.291	0.077	4.68621002228646e-14	QSOX1	Malignant cells	GSE207422_Tor_post	ENSG00000116260	5768	quiescin sulfhydryl oxidase 1	QSCN6	protein_coding	O00391	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67369
2.44268725317777e-18	-0.332400350301298	0.179	0.415	5.48822972043981e-14	HIST1H1C	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67370
2.61772550590003e-18	0.325386097583975	0.253	0.055	5.88150566665619e-14	NCOR2	Malignant cells	GSE207422_Tor_post	ENSG00000196498	9612	nuclear receptor corepressor 2	CTG26|SMRT|SMRTE|TNRC14|TRAC-1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67371
3.18296282220838e-18	-0.46409163110207	0.546	0.727	7.15148086893779e-14	HSPD1	Malignant cells	GSE207422_Tor_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67372
3.35297822584845e-18	0.356820779724276	0.467	0.218	7.53347147783629e-14	TCEAL9	Malignant cells	GSE207422_Tor_post	ENSG00000185222	51186	transcription elongation factor A like 9	DKFZp313K1940|WBP5|WEX6	protein_coding	Q9UHQ7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67373
3.35867908207912e-18	0.424065973670716	0.632	0.418	7.54628016161536e-14	MTDH	Malignant cells	GSE207422_Tor_post	ENSG00000147649	92140	metadherin	3D3|AEG-1|LYRIC	protein_coding	Q86UE4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67374
3.6250038665757e-18	0.316747179310102	0.396	0.156	8.14465868742229e-14	TMED3	Malignant cells	GSE207422_Tor_post	ENSG00000166557	23423	transmembrane p24 trafficking protein 3	C15orf22|p24B|p24g4|p24gamma4	protein_coding	Q9Y3Q3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67375
3.79758072810554e-18	-0.305352698799556	0.121	0.327	8.53240437990753e-14	AC008038.1	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67376
4.22747993913908e-18	0.34749247134696	0.311	0.092	9.49830192725768e-14	PNKD	Malignant cells	GSE207422_Tor_post	ENSG00000127838	25953	PNKD metallo-beta-lactamase domain containing	BRP17|DKFZp564N1362|DYT8|FKSG19|FPD1|KIAA1184|KIPP1184|MGC31943|MR-1|MR-1S|PDC|PKND1|TAHCCP2	protein_coding	Q8N490	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67377
4.25983675397877e-18	0.281886591860615	0.281	0.07	9.57100121883951e-14	CTTN	Malignant cells	GSE207422_Tor_post	ENSG00000288401	2017	cortactin	EMS1	protein_coding	Q14247	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67378
4.59301491042926e-18	0.738131785354829	0.371	0.149	1.03195859007525e-13	LRRC8A	Malignant cells	GSE207422_Tor_post	ENSG00000136802	56262	leucine rich repeat containing 8 VRAC subunit A	FLJ10337|KIAA1437|LRRC8|SWELL1	protein_coding	Q8IWT6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67379
4.82042888692268e-18	0.30183702389555	0.429	0.178	1.08305396231379e-13	COPB2	Malignant cells	GSE207422_Tor_post	ENSG00000184432	9276	COPI coat complex subunit beta 2	beta'-COP|betaprime-COP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67380
5.06127018692778e-18	0.269620217664984	0.294	0.077	1.13716618559893e-13	MRPS33	Malignant cells	GSE207422_Tor_post	ENSG00000090263	51650	mitochondrial ribosomal protein S33	CGI-139	protein_coding	Q9Y291	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67381
5.2811908904156e-18	0.338008748290508	0.563	0.297	1.18657796925858e-13	FAM120A	Malignant cells	GSE207422_Tor_post	ENSG00000048828	23196	family with sequence similarity 120A	C9orf10|KIAA0183|OSSA	protein_coding	Q9NZB2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67382
5.7736029006901e-18	-0.355304057558441	0.348	0.589	1.29721309972705e-13	VDAC2	Malignant cells	GSE207422_Tor_post	ENSG00000165637	7417	voltage dependent anion channel 2	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67383
5.92766171126371e-18	-0.367075812382951	0.162	0.38	1.33182703328673e-13	NAMPT	Malignant cells	GSE207422_Tor_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67384
5.95797388382269e-18	-0.33773311829116	0.23	0.466	1.33863757221728e-13	TECR	Malignant cells	GSE207422_Tor_post	ENSG00000099797	9524	trans-2,3-enoyl-CoA reductase	GPSN2|MRT14|SC2|TER	protein_coding	Q9NZ01	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67385
7.36146041981217e-18	0.279490142006535	0.277	0.07	1.6539729271234e-13	VBP1	Malignant cells	GSE207422_Tor_post	ENSG00000155959	7411	VHL binding protein 1	PFD3|PFDN3	protein_coding	P61758	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67386
8.40401202279605e-18	-0.352422325646661	0.41	0.626	1.88821342128182e-13	CERS2	Malignant cells	GSE207422_Tor_post	ENSG00000143418	29956	ceramide synthase 2	FLJ10243|LASS2|SP260	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67387
9.01341671329713e-18	-0.280435974684442	0.115	0.321	2.0251344671436e-13	TRIM16L	Malignant cells	GSE207422_Tor_post	ENSG00000108448	NA	NA	TRIM70	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67388
9.54460891623355e-18	0.440999275935573	0.397	0.158	2.14448273129935e-13	TNFSF10	Malignant cells	GSE207422_Tor_post	ENSG00000121858	8743	TNF superfamily member 10	Apo-2L|CD253|TL2|TRAIL	protein_coding	P50591	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67389
9.54858665019893e-18	0.934510015739181	0.419	0.191	2.1453764485667e-13	EMP1	Malignant cells	GSE207422_Tor_post	ENSG00000134531	2012	epithelial membrane protein 1	CL-20|TMP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67390
9.62264728142269e-18	0.366486881589366	0.563	0.327	2.16201639119005e-13	PA2G4	Malignant cells	GSE207422_Tor_post	ENSG00000170515	5036	proliferation-associated 2G4	EBP1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67391
9.85730270713845e-18	-0.277652103031272	0.118	0.323	2.21473877223987e-13	RPL13AP25	Malignant cells	GSE207422_Tor_post	ENSG00000136149	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67392
1.0145027342585e-17	-0.253406635896974	0.077	0.262	2.27938474333199e-13	ABHD4	Malignant cells	GSE207422_Tor_post	ENSG00000100439	63874	abhydrolase domain containing 4, N-acyl phospholipase B	FLJ12816	protein_coding	Q8TB40	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67393
1.05122613319646e-17	0.333205602043274	0.582	0.325	2.3618948760658e-13	NDUFB2	Malignant cells	GSE207422_Tor_post	ENSG00000090266	4708	NADH:ubiquinone oxidoreductase subunit B2	AGGG|CI-AGGG	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67394
1.0956345165676e-17	-0.378669011160101	0.396	0.615	2.46167163182409e-13	ILF2	Malignant cells	GSE207422_Tor_post	ENSG00000143621	3608	interleukin enhancer binding factor 2	NF45	protein_coding	Q12905	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67395
1.09988651270938e-17	0.288600299922109	0.268	0.066	2.47122501675544e-13	MAST4	Malignant cells	GSE207422_Tor_post	ENSG00000069020	375449	microtubule associated serine/threonine kinase family member 4	KIAA0303	protein_coding	O15021	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67396
1.11470361086046e-17	0.295195998825453	0.329	0.103	2.50451607288129e-13	ATP6V0D1	Malignant cells	GSE207422_Tor_post	ENSG00000159720	9114	ATPase H+ transporting V0 subunit d1	ATP6D|ATP6DV|P39|VATX|Vma6|VPATPD	protein_coding	P61421	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67397
1.15535111163871e-17	-0.52662816950447	0.464	0.653	2.59584287762985e-13	ALCAM	Malignant cells	GSE207422_Tor_post	ENSG00000170017	214	activated leukocyte cell adhesion molecule	CD166|MEMD	protein_coding	Q13740	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67398
1.169746423689e-17	-0.411409216848674	0.639	0.8	2.62818626474444e-13	MT-ND4L	Malignant cells	GSE207422_Tor_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67399
1.19591970699453e-17	-0.362866579419845	0.694	0.837	2.6869923976753e-13	TOMM7	Malignant cells	GSE207422_Tor_post	ENSG00000196683	54543	translocase of outer mitochondrial membrane 7	Tom7	protein_coding	Q9P0U1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67400
1.60312780276184e-17	0.286257517895614	0.293	0.081	3.6019075472453e-13	PSENEN	Malignant cells	GSE207422_Tor_post	ENSG00000205155	55851	presenilin enhancer, gamma-secretase subunit	PEN2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67401
1.75375939871679e-17	0.332659452092138	0.541	0.281	3.94034661703689e-13	ZFAND5	Malignant cells	GSE207422_Tor_post	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67402
1.79465723698e-17	-0.262435033252163	0.092	0.284	4.03223588004666e-13	LARS	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67403
1.91079944382023e-17	-0.298826735960526	0.173	0.396	4.2931841903753e-13	URI1	Malignant cells	GSE207422_Tor_post	ENSG00000105176	8725	URI1 prefoldin like chaperone	C19orf2|FLJ10575|NNX3|PPP1R19|RMP|URI	protein_coding	O94763	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67404
2.05944829393347e-17	0.702659961271798	0.314	0.099	4.62716842680972e-13	HLA-DQA1	Malignant cells	GSE207422_Tor_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67405
2.28075425661779e-17	-0.319911274487472	0.373	0.633	5.12439866376885e-13	RPL9P9	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67406
2.45247326709359e-17	0.380541129806162	0.604	0.371	5.51021693650587e-13	PPA1	Malignant cells	GSE207422_Tor_post	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67407
2.61154699069378e-17	-0.277969888936787	0.191	0.433	5.86762377869079e-13	RPS27AP16	Malignant cells	GSE207422_Tor_post	ENSG00000224631	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67408
2.69841218811023e-17	0.258083011303422	0.358	0.125	6.06279250424606e-13	CMPK1	Malignant cells	GSE207422_Tor_post	ENSG00000162368	51727	cytidine/uridine monophosphate kinase 1	CMPK|UMP-CMPK	protein_coding	P30085	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67409
2.73556719748509e-17	0.287161745465728	0.293	0.086	6.1462723793095e-13	C1orf21	Malignant cells	GSE207422_Tor_post	ENSG00000116667	81563	chromosome 1 open reading frame 21	PIG13	protein_coding	Q9H246	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67410
3.68413415674283e-17	0.370983297720532	0.396	0.163	8.2775126233698e-13	RRBP1	Malignant cells	GSE207422_Tor_post	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67411
3.86436686840654e-17	-0.331070049285595	0.22	0.444	8.68245947993582e-13	PHB2	Malignant cells	GSE207422_Tor_post	ENSG00000215021	11331	prohibitin 2	Bap37|BCAP37|p22|REA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67412
4.1707591835753e-17	0.317559965270129	0.314	0.101	9.37086173365699e-13	SAMD4B	Malignant cells	GSE207422_Tor_post	ENSG00000179134	55095	sterile alpha motif domain containing 4B	FLJ10211|hSmaug2|MGC99832|SMGB	protein_coding	Q5PRF9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67413
4.6447242166583e-17	0.395725436908265	0.448	0.215	1.04357663699879e-12	ASAH1	Malignant cells	GSE207422_Tor_post	ENSG00000104763	427	N-acylsphingosine amidohydrolase 1	AC|ACDase|ASAH|FLJ21558|PHP32	protein_coding	Q13510	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67414
5.2431337387532e-17	0.334196625266932	0.556	0.301	1.17802728842307e-12	PSMB2	Malignant cells	GSE207422_Tor_post	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67415
6.43471682153112e-17	-0.314456014617051	0.189	0.418	1.44575217546161e-12	SARAF	Malignant cells	GSE207422_Tor_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67416
6.44575081076986e-17	0.318819124289077	0.278	0.077	1.44823129216377e-12	TUBA4A	Malignant cells	GSE207422_Tor_post	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67417
6.89229036566681e-17	0.281567728992505	0.303	0.09	1.54855979935802e-12	BTG3	Malignant cells	GSE207422_Tor_post	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67418
7.07438578385861e-17	-0.401798475789646	0.231	0.464	1.58947299791735e-12	PTGR1	Malignant cells	GSE207422_Tor_post	ENSG00000106853	22949	prostaglandin reductase 1	LTB4DH|ZADH3	protein_coding	Q14914	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67419
7.81221217002414e-17	-0.369411250522889	0.477	0.677	1.75524783036102e-12	ATP5F1B	Malignant cells	GSE207422_Tor_post	ENSG00000110955	506	ATP synthase F1 subunit beta	ATP5B|ATPSB	protein_coding	P06576	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67420
8.01897393966497e-17	-0.414942550048397	0.322	0.558	1.80170306476393e-12	NQO1	Malignant cells	GSE207422_Tor_post	ENSG00000181019	1728	NAD(P)H quinone dehydrogenase 1	DHQU|DIA4|DTD|NMOR1|QR1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67421
8.63054680305302e-17	-0.366174566058924	0.342	0.563	1.93911125570995e-12	GLTP	Malignant cells	GSE207422_Tor_post	ENSG00000139433	51228	glycolipid transfer protein	NA	protein_coding	Q9NZD2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67422
9.93096610325874e-17	-0.32214622656928	0.086	0.264	2.23128946408017e-12	NPL	Malignant cells	GSE207422_Tor_post	ENSG00000135838	80896	N-acetylneuraminate pyruvate lyase	C1orf13|DHDPS1|NPL1	protein_coding	Q9BXD5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67423
1.09374433153722e-16	0.36428017068944	0.473	0.24	2.45742476409783e-12	TFG	Malignant cells	GSE207422_Tor_post	ENSG00000114354	10342	trafficking from ER to golgi regulator	FLJ36137|SPG57|TF6	protein_coding	Q92734	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67424
1.11406995265462e-16	0.279773806912561	0.332	0.116	2.50309236962441e-12	NUDT5	Malignant cells	GSE207422_Tor_post	ENSG00000165609	11164	nudix hydrolase 5	hYSAH1|YSA1H	protein_coding	Q9UKK9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67425
1.11919950109206e-16	0.402238633289662	0.512	0.262	2.51461743905364e-12	GSN	Malignant cells	GSE207422_Tor_post	ENSG00000148180	2934	gelsolin	DKFZp313L0718	protein_coding	P06396	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67426
1.14462386850614e-16	0.305297798489492	0.285	0.084	2.5717409077596e-12	ITPKC	Malignant cells	GSE207422_Tor_post	ENSG00000086544	80271	inositol-trisphosphate 3-kinase C	IP3-3KC|IP3KC	protein_coding	Q96DU7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67427
1.33325469974515e-16	0.425559470915582	0.445	0.218	2.9955566593874e-12	ARF6	Malignant cells	GSE207422_Tor_post	ENSG00000165527	382	ADP ribosylation factor 6	NA	protein_coding	P62330	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67428
1.43944500205077e-16	-0.382403678393508	0.504	0.692	3.23414503060766e-12	H2AFY	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67429
1.51833816596212e-16	0.334251412194825	0.482	0.237	3.41140219128368e-12	RTN3	Malignant cells	GSE207422_Tor_post	ENSG00000133318	10313	reticulon 3	ASYIP|HAP|NSPL2|NSPLII|RTN3-A1	protein_coding	O95197	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67430
1.63360471344096e-16	-0.292595901470959	0.24	0.473	3.67038307015915e-12	OLA1	Malignant cells	GSE207422_Tor_post	ENSG00000138430	29789	Obg like ATPase 1	GTPBP9|PTD004	protein_coding	Q9NTK5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67431
1.98777855573293e-16	0.303744369408643	0.355	0.138	4.46614085902076e-12	YAP1	Malignant cells	GSE207422_Tor_post	ENSG00000137693	10413	Yes1 associated transcriptional regulator	YAP-1|YAP65	protein_coding	P46937	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67432
2.31680990183374e-16	0.261981974893489	0.313	0.099	5.20540848744004e-12	CMTM6	Malignant cells	GSE207422_Tor_post	ENSG00000091317	54918	CKLF like MARVEL transmembrane domain containing 6	CKLFSF6|FLJ20396	protein_coding	Q9NX76	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67433
2.53907176024857e-16	0.308197568875119	0.386	0.158	5.70478643092648e-12	CLIC1	Malignant cells	GSE207422_Tor_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67434
3.01520358298474e-16	-0.283892548761454	0.156	0.371	6.77455941025011e-12	TSPO	Malignant cells	GSE207422_Tor_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67435
3.23910636910221e-16	-0.445946403788527	0.678	0.758	7.27762419009885e-12	NDUFA1	Malignant cells	GSE207422_Tor_post	ENSG00000125356	4694	NADH:ubiquinone oxidoreductase subunit A1	CI-MWFE|MWFE	protein_coding	O15239	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67436
3.38687660379344e-16	-0.423613189824567	0.13	0.316	7.6096343534031e-12	ID3	Malignant cells	GSE207422_Tor_post	ENSG00000283060	3399	inhibitor of DNA binding 3	bHLHb25|HEIR-1	protein_coding	Q02535	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67437
3.7992122892328e-16	0.422917606929396	0.706	0.497	8.53607017144825e-12	PLS3	Malignant cells	GSE207422_Tor_post	ENSG00000102024	5358	plastin 3	T-plastin	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67438
3.91099707758601e-16	-0.372334653088437	0.802	0.842	8.78722823392025e-12	HINT1	Malignant cells	GSE207422_Tor_post	ENSG00000169567	3094	histidine triad nucleotide binding protein 1	HINT|PKCI-1|PRKCNH1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67439
4.10618713805044e-16	-0.255306168812456	0.099	0.284	9.22578126177174e-12	CAMLG	Malignant cells	GSE207422_Tor_post	ENSG00000164615	819	calcium modulating ligand	CAML|GET2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67440
4.31707222997367e-16	0.2836390790122	0.473	0.229	9.69959788630484e-12	TMED2	Malignant cells	GSE207422_Tor_post	ENSG00000086598	10959	transmembrane p24 trafficking protein 2	P24A|p24b1|p24beta1|RNP24	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67441
4.3751684988316e-16	0.491092630954639	0.444	0.22	9.83012858317484e-12	GALNT1	Malignant cells	GSE207422_Tor_post	ENSG00000141429	2589	polypeptide N-acetylgalactosaminyltransferase 1	GalNAc-T1	protein_coding	Q10472	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67442
4.49360658550508e-16	0.270684244631194	0.262	0.07	1.00962352763128e-11	VMA21	Malignant cells	GSE207422_Tor_post	ENSG00000160131	203547	vacuolar ATPase assembly factor VMA21	MEAX|XMEA	protein_coding	Q3ZAQ7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67443
4.51897554028987e-16	-0.285222898940267	0.234	0.466	1.01532342439233e-11	LAMP2	Malignant cells	GSE207422_Tor_post	ENSG00000005893	3920	lysosomal associated membrane protein 2	CD107b	protein_coding	P13473	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67444
4.98466050655848e-16	0.341830848657571	0.425	0.196	1.11995352261356e-11	PRKAR1A	Malignant cells	GSE207422_Tor_post	ENSG00000108946	5573	protein kinase cAMP-dependent type I regulatory subunit alpha	CNC1|PRKAR1|TSE1	protein_coding	P10644	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67445
5.22499391722886e-16	0.305078981908858	0.504	0.262	1.17395163332298e-11	RAB11B	Malignant cells	GSE207422_Tor_post	ENSG00000185236	9230	RAB11B, member RAS oncogene family	H-YPT3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67446
5.45376257663907e-16	-0.256344168173534	0.131	0.33	1.22535137571927e-11	OXA1L	Malignant cells	GSE207422_Tor_post	ENSG00000155463	5018	OXA1L mitochondrial inner membrane protein	MGC133129|OXA1|OXA1L1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67447
5.82882475151377e-16	0.328302220093051	0.908	0.833	1.30962034517011e-11	RPL24	Malignant cells	GSE207422_Tor_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67448
6.23249143134662e-16	0.266234428503891	0.322	0.11	1.40031617479496e-11	PPP2R5A	Malignant cells	GSE207422_Tor_post	ENSG00000066027	5525	protein phosphatase 2 regulatory subunit B'alpha	B56A|B56alpha|PR61A	protein_coding	Q15172	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67449
6.74820231936474e-16	-0.43367025065926	0.447	0.626	1.51618609711487e-11	DDR1	Malignant cells	GSE207422_Tor_post	ENSG00000223680	780	discoidin domain receptor tyrosine kinase 1	CAK|CD167|EDDR1|NEP|NTRK4|PTK3A|RTK6	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67450
7.89774606995721e-16	-0.316437157184594	0.186	0.396	1.77446558699799e-11	SINHCAF	Malignant cells	GSE207422_Tor_post	ENSG00000276371	58516	SIN3-HDAC complex associated factor	C12orf14|FAM60A|TERA	protein_coding	Q9NP50	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67451
7.99743982003305e-16	-0.278297811438685	0.082	0.253	1.79686477876503e-11	SCO2	Malignant cells	GSE207422_Tor_post	ENSG00000284194	9997	synthesis of cytochrome C oxidase 2	MYP6|SCO1L	protein_coding	O43819	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67452
1.0772615159066e-15	0.309529558494183	0.352	0.141	2.42039117393894e-11	YME1L1	Malignant cells	GSE207422_Tor_post	ENSG00000136758	10730	YME1 like 1 ATPase	YME1L	protein_coding	Q96TA2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67453
1.18680333186085e-15	-0.359326066074401	0.15	0.356	2.66650972602495e-11	NTS	Malignant cells	GSE207422_Tor_post	ENSG00000133636	4922	neurotensin	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67454
1.36868704376698e-15	-0.272515458844679	0.099	0.279	3.07516604993565e-11	SUCO	Malignant cells	GSE207422_Tor_post	ENSG00000094975	51430	SUN domain containing ossification factor	C1orf9|CH1|OPT|SLP1	protein_coding	Q9UBS9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67455
1.37765081267881e-15	0.522165633177814	0.365	0.147	3.09530584592676e-11	RARRES3	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67456
1.3935356295685e-15	0.312255817137528	0.287	0.092	3.13099585251451e-11	MLEC	Malignant cells	GSE207422_Tor_post	ENSG00000110917	9761	malectin	KIAA0152	protein_coding	Q14165	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67457
1.49262776468885e-15	-0.339610961011035	0.246	0.457	3.35363606170291e-11	CYC1	Malignant cells	GSE207422_Tor_post	ENSG00000179091	1537	cytochrome c1	UQCR4	protein_coding	P08574	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67458
1.51099097267644e-15	0.738479548413254	0.569	0.398	3.39489451740943e-11	WSB1	Malignant cells	GSE207422_Tor_post	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67459
1.55042460346365e-15	-0.525435786914276	0.178	0.36	3.48349399906212e-11	CKS1B	Malignant cells	GSE207422_Tor_post	ENSG00000173207	1163	CDC28 protein kinase regulatory subunit 1B	CKS1|ckshs1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67460
1.60662491813184e-15	0.251980933004155	0.303	0.099	3.60976486605862e-11	RHEB	Malignant cells	GSE207422_Tor_post	ENSG00000106615	6009	Ras homolog, mTORC1 binding	RHEB2	protein_coding	Q15382	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67461
1.87498177078378e-15	-0.294319829163027	0.14	0.334	4.21270904259699e-11	TRIM16	Malignant cells	GSE207422_Tor_post	ENSG00000221926	10626	tripartite motif containing 16	EBBP	protein_coding	O95361	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67462
1.93474275300943e-15	-0.264617366010262	0.983	0.996	4.3469800174616e-11	PTMA	Malignant cells	GSE207422_Tor_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67463
2.04905127520084e-15	-0.29061726521999	0.342	0.58	4.60380840512125e-11	UBE2R2	Malignant cells	GSE207422_Tor_post	ENSG00000107341	54926	ubiquitin conjugating enzyme E2 R2	CDC34B|FLJ20419|MGC10481|UBC3B	protein_coding	Q712K3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67464
2.09719588008667e-15	-0.30242727753286	0.256	0.479	4.71197970337873e-11	WDR45B	Malignant cells	GSE207422_Tor_post	ENSG00000141580	56270	WD repeat domain 45B	WDR45L|WIPI3	protein_coding	Q5MNZ6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67465
2.23824212792676e-15	0.33770561774553	0.576	0.354	5.02888241302584e-11	CLTC	Malignant cells	GSE207422_Tor_post	ENSG00000141367	1213	clathrin heavy chain	CLTCL2|Hc	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67466
2.27622040097371e-15	0.397044946412441	0.298	0.105	5.11421199690772e-11	DNAJB4	Malignant cells	GSE207422_Tor_post	ENSG00000162616	11080	DnaJ heat shock protein family (Hsp40) member B4	HLJ1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67467
2.34913537572806e-15	0.420085220020541	0.876	0.741	5.27803736218579e-11	CALR	Malignant cells	GSE207422_Tor_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67468
2.35478328823184e-15	0.327082388244874	0.298	0.103	5.29072709199929e-11	RSRC1	Malignant cells	GSE207422_Tor_post	ENSG00000174891	51319	arginine and serine rich coiled-coil 1	BM-011|MGC12197|SFRS21|SRrp53	protein_coding	Q96IZ7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67469
2.39447332009872e-15	0.414273663369067	0.514	0.27	5.3799026555978e-11	VMP1	Malignant cells	GSE207422_Tor_post	ENSG00000062716	81671	vacuole membrane protein 1	EPG3|TANGO5|TMEM49	protein_coding	Q96GC9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67470
2.40009090939928e-15	-0.269716825492006	0.115	0.301	5.39252425523829e-11	YTHDC1	Malignant cells	GSE207422_Tor_post	ENSG00000275272	91746	YTH domain containing 1	KIAA1966|YT521|YT521-B	protein_coding	Q96MU7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67471
2.42173260980792e-15	-0.329331832865639	0.179	0.38	5.44114882771645e-11	SREBF1	Malignant cells	GSE207422_Tor_post	ENSG00000072310	6720	sterol regulatory element binding transcription factor 1	bHLHd1|SREBP-1c|SREBP1|SREBP1a	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67472
2.48677491428547e-15	0.263819539172063	0.355	0.138	5.5872858774166e-11	TMEM14B	Malignant cells	GSE207422_Tor_post	ENSG00000137210	81853	transmembrane protein 14B	MGC1223	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67473
3.76434460470951e-15	-0.331409147898248	0.352	0.596	8.45772945786133e-11	PAK2	Malignant cells	GSE207422_Tor_post	ENSG00000180370	5062	p21 (RAC1) activated kinase 2	PAK65|PAKgamma	protein_coding	Q13177	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67474
3.8932040286697e-15	0.517553744924771	0.991	0.974	8.74725081161508e-11	MT-ND2	Malignant cells	GSE207422_Tor_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67475
4.35156390895236e-15	-0.332903394578578	0.111	0.288	9.77709379063417e-11	SLC16A1	Malignant cells	GSE207422_Tor_post	ENSG00000281917	6566	solute carrier family 16 member 1	MCT|MCT1	protein_coding	P53985	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67476
4.70561805875571e-15	0.314545507760475	0.611	0.374	1.05725826544123e-10	EEF1D	Malignant cells	GSE207422_Tor_post	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67477
7.21943665808509e-15	0.488394494281783	0.303	0.112	1.62206302833856e-10	TFPI	Malignant cells	GSE207422_Tor_post	ENSG00000003436	7035	tissue factor pathway inhibitor	EPI|LACI|TFI|TFPI1	protein_coding	P10646	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67478
7.26785990629371e-15	-0.366174566058924	0.785	0.855	1.63294276374607e-10	RPL4	Malignant cells	GSE207422_Tor_post	ENSG00000174444	6124	ribosomal protein L4	L4	protein_coding	P36578	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67479
8.04681765101521e-15	0.254198276857291	0.272	0.086	1.8079589898301e-10	TMEM30B	Malignant cells	GSE207422_Tor_post	ENSG00000182107	161291	transmembrane protein 30B	CDC50B	protein_coding	Q3MIR4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67480
8.15778923829939e-15	0.295022529174915	0.319	0.119	1.83289208606111e-10	RBBP8	Malignant cells	GSE207422_Tor_post	ENSG00000101773	5932	RB binding protein 8, endonuclease	COM1|CtIP|RIM|SCKL2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67481
8.50034858325201e-15	0.302257821063941	0.322	0.121	1.90985831968506e-10	MBNL1	Malignant cells	GSE207422_Tor_post	ENSG00000152601	4154	muscleblind like splicing regulator 1	EXP|EXP35|EXP40|EXP42|KIAA0428|MBNL	protein_coding	Q9NR56	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67482
8.57251991794171e-15	0.268337449693956	0.288	0.095	1.92607377516314e-10	CUTA	Malignant cells	GSE207422_Tor_post	ENSG00000226492	51596	cutA divalent cation tolerance homolog	ACHAP|C6orf82	protein_coding	O60888	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67483
9.33743850005921e-15	0.256126148941024	0.261	0.077	2.0979356821933e-10	PNPLA2	Malignant cells	GSE207422_Tor_post	ENSG00000177666	57104	patatin like phospholipase domain containing 2	ATGL|desnutrin|FP17548|iPLA2zeta|TTS-2.2	protein_coding	Q96AD5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67484
1.05156139034335e-14	-0.317342816536683	0.863	0.895	2.36264813182345e-10	RPL18	Malignant cells	GSE207422_Tor_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67485
1.11755197173986e-14	0.303676832248745	0.387	0.174	2.51091577010512e-10	COA3	Malignant cells	GSE207422_Tor_post	ENSG00000183978	28958	cytochrome c oxidase assembly factor 3	CCDC56|COX25|hCOA3|HSPC009|MITRAC12	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67486
1.13554533371891e-14	-0.354525397109533	0.205	0.402	2.55134325579965e-10	GNL3	Malignant cells	GSE207422_Tor_post	ENSG00000163938	26354	G protein nucleolar 3	C77032|E2IG3|MGC800|NS	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67487
1.20584901480877e-14	-0.411996067411617	0.702	0.8	2.70930156647234e-10	NCL	Malignant cells	GSE207422_Tor_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67488
1.41898751267634e-14	-0.283728171044453	0.116	0.292	3.18818114348119e-10	HK1	Malignant cells	GSE207422_Tor_post	ENSG00000156515	3098	hexokinase 1	NA	protein_coding	P19367	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67489
1.56838669892596e-14	0.48161654989003	0.537	0.312	3.52385123514684e-10	RPS26	Malignant cells	GSE207422_Tor_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67490
1.88795540856137e-14	0.404212529039068	0.351	0.154	4.24185821195568e-10	PMAIP1	Malignant cells	GSE207422_Tor_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67491
1.94269081312323e-14	0.395177300487959	0.386	0.182	4.36483771892528e-10	PARP9	Malignant cells	GSE207422_Tor_post	ENSG00000138496	83666	poly(ADP-ribose) polymerase family member 9	ARTD9|BAL|BAL1	protein_coding	Q8IXQ6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67492
1.94516652885961e-14	-0.293883136622758	0.263	0.47	4.37040015704178e-10	PPP2R2A	Malignant cells	GSE207422_Tor_post	ENSG00000221914	5520	protein phosphatase 2 regulatory subunit Balpha	B55A|B55alpha|PR52A|PR55A|PR55alpha	protein_coding	P63151	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67493
2.04129570842623e-14	0.286955614212705	0.82	0.657	4.58638319769205e-10	SERF2	Malignant cells	GSE207422_Tor_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67494
2.28670922645495e-14	-0.276961363875871	0.252	0.473	5.13777828999899e-10	ATRAID	Malignant cells	GSE207422_Tor_post	ENSG00000138085	51374	all-trans retinoic acid induced differentiation factor	APR3|C2orf28|HSPC013|p18	protein_coding	Q6UW56	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67495
2.40280855486956e-14	0.256999905759675	0.304	0.11	5.39863026108092e-10	USP14	Malignant cells	GSE207422_Tor_post	ENSG00000101557	9097	ubiquitin specific peptidase 14	TGT|Ubp6	protein_coding	P54578	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67496
3.03133710990786e-14	-0.354734854402953	0.262	0.464	6.81080821854097e-10	SMS	Malignant cells	GSE207422_Tor_post	ENSG00000102172	6611	spermine synthase	MRSR|SPMSY|SpS|SRS	protein_coding	P52788	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67497
3.27925225852668e-14	0.269742590922239	0.291	0.101	7.36782397445774e-10	AHR	Malignant cells	GSE207422_Tor_post	ENSG00000106546	196	aryl hydrocarbon receptor	bHLHe76	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67498
3.8313896716686e-14	0.2544725596338	0.323	0.123	8.60836631430501e-10	SURF4	Malignant cells	GSE207422_Tor_post	ENSG00000280951	6836	surfeit 4	ERV29|FLJ22993|MGC102753	protein_coding	O15260	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67499
4.70907374886378e-14	0.258906587317115	0.344	0.143	1.05803468989471e-09	GOLGA4	Malignant cells	GSE207422_Tor_post	ENSG00000144674	2803	golgin A4	GCP2|GOLG|golgin-240|p230	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67500
5.07894513126902e-14	-0.323271671512046	0.686	0.822	1.14113739209352e-09	COX7C	Malignant cells	GSE207422_Tor_post	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67501
5.31045602345361e-14	0.329128499269792	0.745	0.567	1.19315325934956e-09	P4HB	Malignant cells	GSE207422_Tor_post	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67502
5.66407693317078e-14	-0.312282650171023	0.633	0.763	1.27260480534481e-09	OST4	Malignant cells	GSE207422_Tor_post	ENSG00000228474	100128731	oligosaccharyltransferase complex subunit 4, non-catalytic	NA	protein_coding	P0C6T2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67503
6.65934296960639e-14	-0.253912090939681	0.103	0.27	1.49622117841116e-09	PFKP	Malignant cells	GSE207422_Tor_post	ENSG00000067057	5214	phosphofructokinase, platelet	PFK-C|PFKF	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67504
7.46770179259719e-14	-0.320017249692953	0.489	0.659	1.67784323876074e-09	ST13	Malignant cells	GSE207422_Tor_post	ENSG00000100380	6767	ST13 Hsp70 interacting protein	FAM10A1|HIP|HSPABP1|P48|SNC6	protein_coding	P50502	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67505
7.87017107439379e-14	0.272734766026529	0.252	0.073	1.7682700369948e-09	FLRT3	Malignant cells	GSE207422_Tor_post	ENSG00000125848	23767	fibronectin leucine rich transmembrane protein 3	NA	protein_coding	Q9NZU0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67506
8.14814622718536e-14	0.259548694072671	0.434	0.211	1.83072549432401e-09	RBM25	Malignant cells	GSE207422_Tor_post	ENSG00000119707	58517	RNA binding motif protein 25	fSAP94|NET52|RNPC7|S164|Snu71	protein_coding	P49756	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67507
8.2255211258851e-14	-0.25401911522729	0.134	0.314	1.84811008656387e-09	PIR	Malignant cells	GSE207422_Tor_post	ENSG00000087842	8544	pirin	NA	protein_coding	O00625	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67508
8.87012672007203e-14	0.30093944282293	0.429	0.218	1.99294007146578e-09	NFIC	Malignant cells	GSE207422_Tor_post	ENSG00000141905	4782	nuclear factor I C	CTF|CTF5|NF-I|NFI	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67509
8.97134293775937e-14	0.256901733996766	0.326	0.127	2.01568133125577e-09	UBA1	Malignant cells	GSE207422_Tor_post	ENSG00000130985	7317	ubiquitin like modifier activating enzyme 1	A1S9T|CFAP124|GXP1|POC20|UBE1|UBE1X	protein_coding	P22314	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67510
9.18990367770634e-14	-0.274796400095918	0.131	0.31	2.06478755830706e-09	MYC	Malignant cells	GSE207422_Tor_post	ENSG00000136997	4609	MYC proto-oncogene, bHLH transcription factor	bHLHe39|c-Myc|MYCC	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67511
9.37415447061944e-14	0.296455009108576	0.282	0.101	2.10618502645877e-09	TMOD3	Malignant cells	GSE207422_Tor_post	ENSG00000138594	29766	tropomodulin 3	UTMOD	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67512
1.07161632681574e-13	0.301429059723066	0.301	0.114	2.40770756308961e-09	ANXA11	Malignant cells	GSE207422_Tor_post	ENSG00000122359	311	annexin A11	ANX11	protein_coding	P50995	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67513
1.10203740826638e-13	0.275495905703586	0.322	0.13	2.4760576488929e-09	GFPT1	Malignant cells	GSE207422_Tor_post	ENSG00000198380	2673	glutamine--fructose-6-phosphate transaminase 1	GFA|GFAT|GFAT1|GFPT	protein_coding	Q06210	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67514
1.12311176537254e-13	1.41964472183896	0.258	0.092	2.52340751443902e-09	KLK10	Malignant cells	GSE207422_Tor_post	ENSG00000129451	5655	kallikrein related peptidase 10	NES1|PRSSL1	protein_coding	O43240	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67515
1.15203226134644e-13	-0.279613603745846	0.159	0.345	2.58838608479318e-09	PIGX	Malignant cells	GSE207422_Tor_post	ENSG00000163964	54965	phosphatidylinositol glycan anchor biosynthesis class X	FLJ20522	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67516
1.16143356024362e-13	0.343691190683099	0.827	0.637	2.60950892315536e-09	HSPA5	Malignant cells	GSE207422_Tor_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67517
1.33956008986515e-13	0.393147010069867	0.952	0.897	3.00972360990902e-09	GSTP1	Malignant cells	GSE207422_Tor_post	ENSG00000084207	2950	glutathione S-transferase pi 1	FAEES3|GST3|GSTP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67518
1.44393275999624e-13	0.287185355756966	0.499	0.281	3.24422812515956e-09	CHMP3	Malignant cells	GSE207422_Tor_post	ENSG00000115561	51652	charged multivesicular body protein 3	CGI-149|NEDF|VPS24	protein_coding	Q9Y3E7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67519
1.60307562696122e-13	-0.252017546949905	0.102	0.266	3.60179031865647e-09	CLSTN1	Malignant cells	GSE207422_Tor_post	ENSG00000171603	22883	calsyntenin 1	CDHR12|CSTN1|KIAA0911	protein_coding	O94985	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67520
1.62724225455872e-13	0.286985032773377	0.399	0.193	3.65608789754254e-09	WAC	Malignant cells	GSE207422_Tor_post	ENSG00000095787	51322	WW domain containing adaptor with coiled-coil	BM-016|FLJ31290|MGC10753|PRO1741|Wwp4	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67521
1.68056908246503e-13	-0.251860275066933	0.167	0.356	3.77590261448243e-09	FZD6	Malignant cells	GSE207422_Tor_post	ENSG00000164930	8323	frizzled class receptor 6	Hfz6	protein_coding	O60353	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67522
1.69130216238271e-13	0.283598067142653	0.584	0.369	3.80001769844147e-09	SRSF11	Malignant cells	GSE207422_Tor_post	ENSG00000116754	9295	serine and arginine rich splicing factor 11	NET2|p54|SFRS11	protein_coding	Q05519	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67523
1.82169218175066e-13	-0.309941954708246	0.524	0.697	4.09297799395738e-09	TOMM20	Malignant cells	GSE207422_Tor_post	ENSG00000173726	9804	translocase of outer mitochondrial membrane 20	KIAA0016|MAS20|MOM19|TOM20	protein_coding	Q15388	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67524
1.90109750209027e-13	0.415350747570896	0.856	0.765	4.27138586769642e-09	SPINT2	Malignant cells	GSE207422_Tor_post	ENSG00000167642	10653	serine peptidase inhibitor, Kunitz type 2	HAI-2|HAI2|Kop	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67525
1.96435644646042e-13	0.287802914775819	0.368	0.165	4.41351606390728e-09	ANXA5	Malignant cells	GSE207422_Tor_post	ENSG00000164111	308	annexin A5	ANX5|CPB-I|ENX2|PAP-I|RPRGL3|VAC-alph	protein_coding	P08758	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67526
2.69828879332403e-13	-0.282795989574403	0.207	0.4	6.06251526084044e-09	PYURF	Malignant cells	GSE207422_Tor_post	ENSG00000145337	100996939	PIGY upstream open reading frame	PreY	protein_coding	Q96I23	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67527
2.81159575235258e-13	0.315315223816971	0.335	0.145	6.31709333638577e-09	RBM17	Malignant cells	GSE207422_Tor_post	ENSG00000134453	84991	RNA binding motif protein 17	MGC14439|SPF45	protein_coding	Q96I25	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67528
3.09740003502149e-13	0.269337919917836	0.266	0.092	6.95923839868628e-09	CBX4	Malignant cells	GSE207422_Tor_post	ENSG00000141582	8535	chromobox 4	hPC2|NBP16|PC2	protein_coding	O00257	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67529
3.14302584982146e-13	0.252622881948418	0.306	0.119	7.06175047937885e-09	LRRFIP1	Malignant cells	GSE207422_Tor_post	ENSG00000124831	9208	LRR binding FLII interacting protein 1	FLAP-1|FLIIAP1|GCF-2|GCF2|HUFI-1|TRIP	protein_coding	Q32MZ4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67530
3.15673954014103e-13	-0.278450739203176	0.213	0.404	7.09256239878887e-09	ETF1	Malignant cells	GSE207422_Tor_post	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67531
3.2711471280781e-13	0.280474652138197	0.456	0.248	7.34961336736587e-09	TMEM87A	Malignant cells	GSE207422_Tor_post	ENSG00000103978	25963	transmembrane protein 87A	DKFZP564G2022	protein_coding	Q8NBN3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67532
3.30982853150409e-13	-0.292705618567763	0.176	0.358	7.43652274458339e-09	XPO1	Malignant cells	GSE207422_Tor_post	ENSG00000082898	7514	exportin 1	CRM-1|CRM1|emb	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67533
4.19863729297153e-13	0.289312566063898	0.383	0.185	9.43349826984842e-09	MAPRE1	Malignant cells	GSE207422_Tor_post	ENSG00000101367	22919	microtubule associated protein RP/EB family member 1	EB1	protein_coding	Q15691	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67534
5.15946838683686e-13	0.276168902615239	0.543	0.323	1.1592293571545e-08	TOP1	Malignant cells	GSE207422_Tor_post	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67535
5.40796597675817e-13	-0.264448177576564	0.156	0.334	1.21506179565803e-08	KLHL24	Malignant cells	GSE207422_Tor_post	ENSG00000114796	54800	kelch like family member 24	DRE1|FLJ20059	protein_coding	Q6TFL4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67536
5.59799822201979e-13	0.276608589050574	0.351	0.156	1.25775824052341e-08	ANXA4	Malignant cells	GSE207422_Tor_post	ENSG00000196975	307	annexin A4	ANX4	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67537
6.05216680007582e-13	-0.307873633437459	0.285	0.488	1.35980083664103e-08	VDAC3	Malignant cells	GSE207422_Tor_post	ENSG00000078668	7419	voltage dependent anion channel 3	HD-VDAC3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67538
6.31893116462388e-13	0.276801663309813	0.783	0.62	1.41973745406769e-08	DDX5	Malignant cells	GSE207422_Tor_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67539
7.11850028224315e-13	-0.276703255808113	0.223	0.415	1.59938464341439e-08	MIR1244-2	Malignant cells	GSE207422_Tor_post	ENSG00000283498	100422885	microRNA 1244-2	hsa-mir-1244-2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67540
7.54947550490338e-13	-0.333038391482906	0.456	0.613	1.69621615644169e-08	MDH1	Malignant cells	GSE207422_Tor_post	ENSG00000014641	4190	malate dehydrogenase 1	NA	protein_coding	P40925	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67541
7.65826914867193e-13	0.317431099055684	0.799	0.615	1.72065991232361e-08	CALM2	Malignant cells	GSE207422_Tor_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67542
8.2061400578021e-13	0.343587767631959	0.678	0.514	1.84375554818698e-08	ATP6V0E1	Malignant cells	GSE207422_Tor_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67543
8.66950684568819e-13	-0.311776959974136	0.539	0.71	1.94786479808922e-08	RPL22	Malignant cells	GSE207422_Tor_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67544
9.46487839467965e-13	0.87010790058838	0.295	0.132	2.12656887771662e-08	POLR2J3	Malignant cells	GSE207422_Tor_post	ENSG00000168255	NA	NA	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67545
9.60744948601891e-13	0.49315682458317	0.945	0.936	2.15860175051873e-08	ANXA2	Malignant cells	GSE207422_Tor_post	ENSG00000182718	302	annexin A2	ANX2|ANX2L4|CAL1H|LIP2|LPC2D	protein_coding	P07355	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67546
1.00109919841116e-12	0.289858616409197	0.348	0.156	2.24926967899019e-08	HMGN3	Malignant cells	GSE207422_Tor_post	ENSG00000118418	9324	high mobility group nucleosomal binding domain 3	TRIP7	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67547
1.26781516291439e-12	-0.254767610694511	0.125	0.29	2.84852710803605e-08	IGBP1	Malignant cells	GSE207422_Tor_post	ENSG00000089289	3476	immunoglobulin binding protein 1	alpha4|IBP1	protein_coding	P78318	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67548
1.30083746877172e-12	0.263203522856628	0.463	0.253	2.92272162483629e-08	DYNC1LI2	Malignant cells	GSE207422_Tor_post	ENSG00000135720	1783	dynein cytoplasmic 1 light intermediate chain 2	DNCLI2	protein_coding	O43237	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67549
1.31375643399572e-12	0.250884166046924	0.287	0.11	2.95174795590157e-08	TPM1	Malignant cells	GSE207422_Tor_post	ENSG00000140416	7168	tropomyosin 1	C15orf13|CMH3	protein_coding	P09493	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67550
1.46137064576043e-12	-0.377099055813227	0.245	0.431	3.28340756689454e-08	GCLM	Malignant cells	GSE207422_Tor_post	ENSG00000023909	2730	glutamate-cysteine ligase modifier subunit	GLCLR	protein_coding	P48507	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67551
1.49613414031801e-12	-0.330618413408247	0.412	0.596	3.36151418646649e-08	DSG2	Malignant cells	GSE207422_Tor_post	ENSG00000046604	1829	desmoglein 2	CDHF5	protein_coding	Q14126	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67552
1.80034644206227e-12	0.284102416182515	0.293	0.119	4.04501838602552e-08	ZNHIT1	Malignant cells	GSE207422_Tor_post	ENSG00000106400	10467	zinc finger HIT-type containing 1	CG1I|H_DJ0747G18.14|ZNFN4A1	protein_coding	O43257	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67553
1.93336692414881e-12	-0.264346669880977	0.144	0.314	4.34388880517754e-08	NPNT	Malignant cells	GSE207422_Tor_post	ENSG00000168743	255743	nephronectin	EGFL6L|POEM	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67554
1.94991519524569e-12	-0.261076786109832	0.307	0.532	4.38106946067803e-08	TMPRSS4	Malignant cells	GSE207422_Tor_post	ENSG00000137648	56649	transmembrane serine protease 4	CAP2|MT-SP2|TMPRSS3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67555
2.30093589825081e-12	0.253235263296564	0.263	0.097	5.16974277618991e-08	PPP1R2	Malignant cells	GSE207422_Tor_post	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67556
2.47264301043523e-12	-0.255324157416528	0.163	0.336	5.55553431584586e-08	PPP4R3B	Malignant cells	GSE207422_Tor_post	ENSG00000275052	57223	protein phosphatase 4 regulatory subunit 3B	FLFL2|FLJ31474|KIAA1387|PSY2|SMEK2	protein_coding	Q5MIZ7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67557
2.70990653069448e-12	-0.327987541928423	0.726	0.833	6.08861799316436e-08	RACK1	Malignant cells	GSE207422_Tor_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67558
2.79235050652558e-12	0.305162870190492	0.703	0.541	6.27385311806167e-08	PDIA3	Malignant cells	GSE207422_Tor_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67559
3.08309174977413e-12	0.254099414540589	0.422	0.218	6.92709054339252e-08	PTBP3	Malignant cells	GSE207422_Tor_post	ENSG00000119314	9991	polypyrimidine tract binding protein 3	DKFZp781I1117|ROD1	protein_coding	O95758	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67560
3.09019631260928e-12	0.265265105146404	0.3	0.125	6.94305307517053e-08	MIDN	Malignant cells	GSE207422_Tor_post	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67561
3.1055599235054e-12	0.260835787707169	0.984	0.96	6.97757203613193e-08	MT-ATP6	Malignant cells	GSE207422_Tor_post	ENSG00000198899	4508	ATP synthase F0 subunit 6	ATP6|ATPase-6|MTATP6|RP|Su6m	protein_coding	P00846	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67562
3.32239250047229e-12	-0.251829057783639	0.319	0.558	7.46475147006114e-08	PKP1	Malignant cells	GSE207422_Tor_post	ENSG00000081277	5317	plakophilin 1	B6P	protein_coding	Q13835	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67563
3.44171846686907e-12	-0.282219722166528	0.261	0.451	7.73285305136143e-08	RDH11	Malignant cells	GSE207422_Tor_post	ENSG00000072042	51109	retinol dehydrogenase 11	ARSDR1|MDT1|SDR7C1	protein_coding	Q8TC12	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67564
3.46235916347943e-12	0.264084020315078	0.362	0.174	7.77922856850558e-08	CALU	Malignant cells	GSE207422_Tor_post	ENSG00000128595	813	calumenin	NA	protein_coding	O43852	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67565
3.49304499380624e-12	-0.260525661741738	0.256	0.442	7.84817349208386e-08	LTBR	Malignant cells	GSE207422_Tor_post	ENSG00000111321	4055	lymphotoxin beta receptor	D12S370|TNF-R-III|TNFCR|TNFR-RP|TNFR2-RP|TNFRSF3	protein_coding	P36941	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67566
3.71855237960395e-12	0.51758306400207	0.617	0.448	8.35484348649416e-08	DNAJB1	Malignant cells	GSE207422_Tor_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67567
4.69881381917519e-12	-0.322980525827667	0.3	0.477	1.05572948889228e-07	COX7B	Malignant cells	GSE207422_Tor_post	ENSG00000131174	1349	cytochrome c oxidase subunit 7B	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67568
4.94073184415888e-12	0.34147281539084	0.591	0.429	1.11008363074562e-07	PTGES3	Malignant cells	GSE207422_Tor_post	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67569
5.25330127585142e-12	0.381078508532861	0.374	0.666	1.1803117306583e-07	CSTA	Malignant cells	GSE207422_Tor_post	ENSG00000121552	1475	cystatin A	STF1|STFA	protein_coding	P01040	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67570
6.20621785669814e-12	-0.295847962675303	0.291	0.479	1.39441302804294e-07	SEC31A	Malignant cells	GSE207422_Tor_post	ENSG00000138674	22872	SEC31 homolog A, COPII coat complex component	ABP125|ABP130|KIAA0905|SEC31L1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67571
6.20744026395714e-12	0.292296434376955	0.461	0.268	1.39468767850589e-07	EIF3I	Malignant cells	GSE207422_Tor_post	ENSG00000084623	8668	eukaryotic translation initiation factor 3 subunit I	eIF3-beta|eIF3-p36|EIF3S2|TRIP-1	protein_coding	Q13347	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67572
6.76654327122009e-12	-0.297057643107471	0.29	0.479	1.52030694217773e-07	COPA	Malignant cells	GSE207422_Tor_post	ENSG00000122218	1314	COPI coat complex subunit alpha	HEP-COP	protein_coding	P53621	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67573
7.20285231659791e-12	-0.305332033086394	0.549	0.71	1.61833685849322e-07	SNRPD2	Malignant cells	GSE207422_Tor_post	ENSG00000125743	6633	small nuclear ribonucleoprotein D2 polypeptide	Sm-D2|SNRPD1	protein_coding	P62316	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67574
7.38282751463486e-12	-0.282512981895624	0.967	0.987	1.65877368598816e-07	RPS16	Malignant cells	GSE207422_Tor_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67575
8.63011413916987e-12	-0.268020441626766	0.253	0.435	1.93901404478869e-07	CEBPZ	Malignant cells	GSE207422_Tor_post	ENSG00000115816	10153	CCAAT enhancer binding protein zeta	CBF2|CTF2	protein_coding	Q03701	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67576
8.92208871898809e-12	0.328804168361332	0.691	0.567	2.00461489338224e-07	RAB7A	Malignant cells	GSE207422_Tor_post	ENSG00000075785	7879	RAB7A, member RAS oncogene family	CMT2B|RAB7	protein_coding	P51149	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67577
9.96626714389702e-12	-0.256521936267256	0.115	0.268	2.23922090189078e-07	SMAD5	Malignant cells	GSE207422_Tor_post	ENSG00000113658	4090	SMAD family member 5	Dwfc|JV5-1|MADH5	protein_coding	Q99717	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67578
1.037294448801e-11	-0.258926394096724	0.137	0.299	2.3305931675661e-07	A4GALT	Malignant cells	GSE207422_Tor_post	ENSG00000128274	53947	alpha 1,4-galactosyltransferase (P blood group)	A14GALT|Gb3S|P(k)|P1	protein_coding	Q9NPC4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67579
1.05178254341447e-11	0.274708966808337	0.277	0.11	2.36314501854364e-07	ZC3H12A	Malignant cells	GSE207422_Tor_post	ENSG00000163874	80149	zinc finger CCCH-type containing 12A	FLJ23231|MCPIP1|Regnase-1	protein_coding	Q5D1E8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67580
1.11986258569737e-11	0.352892567594887	0.358	0.185	2.51610725754484e-07	WASL	Malignant cells	GSE207422_Tor_post	ENSG00000106299	8976	WASP like actin nucleation promoting factor	N-WASP|NWASP|WASPB	protein_coding	O00401	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67581
1.14558086978922e-11	-0.338741794132717	0.291	0.466	2.57389109824242e-07	LMO4	Malignant cells	GSE207422_Tor_post	ENSG00000143013	8543	LIM domain only 4	NA	protein_coding	P61968	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67582
1.22486360107878e-11	-0.287604794967619	0.176	0.349	2.7520235389038e-07	TNFRSF21	Malignant cells	GSE207422_Tor_post	ENSG00000146072	27242	TNF receptor superfamily member 21	CD358|DR6	protein_coding	O75509	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67583
1.25258187596689e-11	0.418472334153244	0.598	0.38	2.8143009589224e-07	TUBA1B	Malignant cells	GSE207422_Tor_post	ENSG00000123416	10376	tubulin alpha 1b	K-ALPHA-1	protein_coding	P68363	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67584
1.29988839510517e-11	0.307055333565171	0.588	0.409	2.92058924612229e-07	BRD2	Malignant cells	GSE207422_Tor_post	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67585
1.41350497475317e-11	0.32039765904622	0.397	0.213	3.17586297727542e-07	PDIA4	Malignant cells	GSE207422_Tor_post	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67586
1.74560678980867e-11	-0.264487555342966	0.215	0.391	3.92202933534212e-07	WDR43	Malignant cells	GSE207422_Tor_post	ENSG00000163811	23160	WD repeat domain 43	KIAA0007|NET12|UTP5	protein_coding	Q15061	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67587
1.74980053466385e-11	0.645006503530017	0.367	0.187	3.93145184128273e-07	S100A2	Malignant cells	GSE207422_Tor_post	ENSG00000196754	6273	S100 calcium binding protein A2	CAN19|S100L	protein_coding	P29034	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67588
2.05830824164159e-11	0.359293723579311	0.269	0.112	4.62460695732032e-07	DUSP14	Malignant cells	GSE207422_Tor_post	ENSG00000275932	11072	dual specificity phosphatase 14	MKP-L|MKP6	protein_coding	O95147	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67589
2.19115062190306e-11	0.278066711146043	0.464	0.27	4.9230772172918e-07	POMP	Malignant cells	GSE207422_Tor_post	ENSG00000132963	51371	proteasome maturation protein	C13orf12|HSPC014|UMP1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67590
2.95429177375643e-11	0.346259262584186	0.215	0.435	6.63770275727596e-07	KRT17	Malignant cells	GSE207422_Tor_post	ENSG00000128422	3872	keratin 17	PCHC1	protein_coding	Q04695	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67591
3.55140029116238e-11	-0.317333962686525	0.183	0.343	7.97928617418363e-07	GARS	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67592
4.56242839410983e-11	-0.287517622183926	0.789	0.864	1.0250864115886e-06	RPL7A	Malignant cells	GSE207422_Tor_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67593
6.88329965293242e-11	-0.266955933502779	0.368	0.545	1.54653976602086e-06	RPL7P9	Malignant cells	GSE207422_Tor_post	ENSG00000137970	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67594
7.07908755941724e-11	0.25124918776392	0.358	0.18	1.59052939284987e-06	LTA4H	Malignant cells	GSE207422_Tor_post	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67595
8.48501733831727e-11	-0.256047147988915	0.163	0.327	1.90641369557312e-06	HIST1H2BD	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67596
8.80584294199006e-11	0.275174207669331	0.572	0.393	1.97849679220633e-06	ATP6V1G1	Malignant cells	GSE207422_Tor_post	ENSG00000136888	9550	ATPase H+ transporting V1 subunit G1	ATP6G|ATP6G1|ATP6GL|ATP6J|DKFZp547P234|Vma10	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67597
9.62255570713867e-11	-0.273733437001351	0.265	0.433	2.16199581627992e-06	NFE2L1	Malignant cells	GSE207422_Tor_post	ENSG00000082641	4779	NFE2 like bZIP transcription factor 1	FLJ00380|LCR-F1|NRF-1|NRF1|TCF11	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67598
1.00820926940466e-10	-0.252171595901726	0.223	0.393	2.2652445864984e-06	RPL26P19	Malignant cells	GSE207422_Tor_post	ENSG00000226221	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67599
1.18527421395783e-10	0.28691194976934	0.402	0.231	2.66307410392045e-06	TXNDC17	Malignant cells	GSE207422_Tor_post	ENSG00000129235	84817	thioredoxin domain containing 17	MGC14353|TRP14|TXNL5	protein_coding	Q9BRA2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67600
1.24038556610122e-10	0.285581663791369	0.44	0.264	2.78689828991621e-06	ZDHHC9	Malignant cells	GSE207422_Tor_post	ENSG00000188706	51114	zinc finger DHHC-type palmitoyltransferase 9	CGI-89|CXorf11|DHHC9|ZDHHC10|ZNF379|ZNF380	protein_coding	Q9Y397	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67601
1.24606029807122e-10	0.282197752861793	0.33	0.165	2.79964827770642e-06	KPNA4	Malignant cells	GSE207422_Tor_post	ENSG00000186432	3840	karyopherin subunit alpha 4	IPOA3|MGC12217|MGC26703|QIP1|SRP3	protein_coding	O00629	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67602
1.32431057875033e-10	-0.298494525425513	0.143	0.29	2.97546100833625e-06	RDH10	Malignant cells	GSE207422_Tor_post	ENSG00000121039	157506	retinol dehydrogenase 10	SDR16C4	protein_coding	Q8IZV5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67603
1.32719981084377e-10	0.303097759641216	0.349	0.187	2.98195253500378e-06	PDCD10	Malignant cells	GSE207422_Tor_post	ENSG00000114209	11235	programmed cell death 10	CCM3|TFAR15	protein_coding	Q9BUL8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67604
1.45464782158726e-10	0.261681233706309	0.421	0.244	3.26830272554226e-06	ELOC	Malignant cells	GSE207422_Tor_post	ENSG00000154582	6921	elongin C	SIII|TCEB1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67605
1.47731283878979e-10	-0.260542817178603	0.718	0.789	3.3192264861929e-06	RPL41	Malignant cells	GSE207422_Tor_post	ENSG00000229117	6171	ribosomal protein L41	L41	protein_coding	P62945	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67606
1.94621446868365e-10	-0.29467812504863	0.421	0.598	4.37275466823843e-06	TALDO1	Malignant cells	GSE207422_Tor_post	ENSG00000177156	6888	transaldolase 1	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67607
2.25703210891053e-10	-0.274708560418595	0.373	0.541	5.07109974230017e-06	NDUFC1	Malignant cells	GSE207422_Tor_post	ENSG00000109390	4717	NADH:ubiquinone oxidoreductase subunit C1	KFYI	protein_coding	O43677	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67608
2.26296560819271e-10	0.327323158445848	0.275	0.123	5.08443112848738e-06	ITGA6	Malignant cells	GSE207422_Tor_post	ENSG00000091409	3655	integrin subunit alpha 6	CD49f	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67609
2.60020936587084e-10	0.329892176335886	0.344	0.18	5.84215040323861e-06	HEBP2	Malignant cells	GSE207422_Tor_post	ENSG00000051620	23593	heme binding protein 2	C6orf34|SOUL	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67610
4.04454123057848e-10	-0.255158276774944	0.579	0.756	9.08727523686373e-06	EEF1B2	Malignant cells	GSE207422_Tor_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67611
4.26945271449523e-10	-0.267613722202599	0.59	0.708	9.59260635892787e-06	HNRNPA1	Malignant cells	GSE207422_Tor_post	ENSG00000135486	3178	heterogeneous nuclear ribonucleoprotein A1	ALS20|hnRNP-A1|HNRPA1	protein_coding	P09651	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67612
4.34321488110665e-10	-0.253803198582508	0.351	0.532	9.75833519487041e-06	SSB	Malignant cells	GSE207422_Tor_post	ENSG00000138385	6741	small RNA binding exonuclease protection factor La	La|La/SSB|LARP3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67613
4.61084532399153e-10	-0.250167258887675	0.227	0.391	1.03596472739442e-05	HADHA	Malignant cells	GSE207422_Tor_post	ENSG00000084754	3030	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha	GBP|LCEH|LCHAD|MTPA	protein_coding	P40939	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67614
5.39794892086349e-10	-0.310054107842862	0.229	0.402	1.21281116353961e-05	DST	Malignant cells	GSE207422_Tor_post	ENSG00000151914	667	dystonin	BP240|BPA|BPAG1|CATX-15|FLJ13425|FLJ21489|FLJ30627|FLJ32235|KIAA0728|MACF2	protein_coding	Q03001	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67615
1.29103201363628e-09	-0.252565869500434	0.151	0.292	2.900690728238e-05	TARS	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67616
1.3476107931912e-09	0.788063583448844	0.278	0.141	3.02781193014198e-05	FERMT1	Malignant cells	GSE207422_Tor_post	ENSG00000101311	55612	FERM domain containing kindlin 1	C20orf42|FLJ20116|KIND1|UNC112A|URP1	protein_coding	Q9BQL6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67617
1.44927114723056e-09	0.261239545968041	0.258	0.112	3.25622241359763e-05	IFT57	Malignant cells	GSE207422_Tor_post	ENSG00000114446	55081	intraflagellar transport 57	ESRRBL1|FLJ10147|HIPPI|MHS4R2	protein_coding	Q9NWB7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67618
1.69211747154282e-09	-0.256573914975658	0.381	0.543	3.8018495350624e-05	CCT6A	Malignant cells	GSE207422_Tor_post	ENSG00000146731	908	chaperonin containing TCP1 subunit 6A	CCT6|Cctz|HTR3|TCP20|TCPZ|TTCP20	protein_coding	P40227	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67619
1.80711187511413e-09	0.316289108170871	0.771	0.642	4.06021896100642e-05	HSPA8	Malignant cells	GSE207422_Tor_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67620
1.93433975786951e-09	-0.270655116819151	0.121	0.251	4.34607456798121e-05	SLC7A8	Malignant cells	GSE207422_Tor_post	ENSG00000092068	23428	solute carrier family 7 member 8	LAT2|LPI-PC1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67621
2.58811965148327e-09	0.2800255641841	0.475	0.316	5.81498723295261e-05	CTNND1	Malignant cells	GSE207422_Tor_post	ENSG00000198561	1500	catenin delta 1	CTNND|KIAA0384|p120|p120cas|p120ctn	protein_coding	O60716	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67622
3.1439236713242e-09	-0.275179013679123	0.33	0.492	7.06376770473121e-05	SRP72	Malignant cells	GSE207422_Tor_post	ENSG00000174780	6731	signal recognition particle 72	NA	protein_coding	O76094	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67623
3.14755374746649e-09	0.36025617707749	0.479	0.323	7.07192375980771e-05	ABCG1	Malignant cells	GSE207422_Tor_post	ENSG00000160179	9619	ATP binding cassette subfamily G member 1	ABC8	protein_coding	P45844	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67624
3.69086877105177e-09	-0.255792101253553	0.178	0.325	8.29264395479912e-05	MTHFD2	Malignant cells	GSE207422_Tor_post	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67625
3.89206255922642e-09	-0.296985993067929	0.581	0.666	8.74468615806993e-05	YBX3	Malignant cells	GSE207422_Tor_post	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67626
3.9862629353679e-09	-0.267942729054855	0.233	0.382	8.95633556318461e-05	MXI1	Malignant cells	GSE207422_Tor_post	ENSG00000119950	4601	MAX interactor 1, dimerization protein	bHLHc11|MAD2|MXD2|MXI	protein_coding	P50539	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67627
4.15196912270881e-09	0.285489874700142	0.328	0.18	9.32864422490214e-05	MAGED1	Malignant cells	GSE207422_Tor_post	ENSG00000179222	9500	MAGE family member D1	DLXIN-1|NRAGE	protein_coding	Q9Y5V3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67628
4.49663892054673e-09	0.270128909025091	0.473	0.321	0.000101030483266844	BCAP31	Malignant cells	GSE207422_Tor_post	ENSG00000185825	10134	B cell receptor associated protein 31	6C6-Ag|BAP31|CDM|DXS1357E	protein_coding	P51572	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67629
4.59542716043863e-09	0.49054956223499	0.512	0.382	0.000103250057440735	NFKBIA	Malignant cells	GSE207422_Tor_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67630
8.7858549236953e-09	-0.29795050622095	0.729	0.813	0.000197400588425586	ARPC2	Malignant cells	GSE207422_Tor_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67631
1.0694204515719e-08	-0.250639986530757	0.747	0.87	0.000240277387059175	IFI27	Malignant cells	GSE207422_Tor_post	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67632
1.16085949044394e-08	0.265513840411783	0.512	0.363	0.000260821910312944	RAB25	Malignant cells	GSE207422_Tor_post	ENSG00000132698	57111	RAB25, member RAS oncogene family	CATX-8	protein_coding	P57735	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67633
1.35963758660293e-08	0.961596025842146	0.298	0.169	0.000305483372957947	LCN2	Malignant cells	GSE207422_Tor_post	ENSG00000148346	3934	lipocalin 2	24p3|NGAL	protein_coding	P80188	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67634
1.59245981610203e-08	-0.261524077883687	0.473	0.615	0.000357793871481804	COX5A	Malignant cells	GSE207422_Tor_post	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67635
2.03074700497825e-08	0.267437306958911	0.336	0.189	0.000456268237078514	IRX3	Malignant cells	GSE207422_Tor_post	ENSG00000177508	79191	iroquois homeobox 3	IRX-1	protein_coding	P78415	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67636
2.79407792872056e-08	0.420525036875873	0.627	0.538	0.000627773429024935	KLF5	Malignant cells	GSE207422_Tor_post	ENSG00000102554	688	KLF transcription factor 5	BTEB2|CKLF|IKLF	protein_coding	Q13887	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67637
2.82159443420326e-08	0.313438244279527	0.371	0.24	0.000633955837476788	ZNF706	Malignant cells	GSE207422_Tor_post	ENSG00000120963	51123	zinc finger protein 706	HSPC038	protein_coding	Q9Y5V0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67638
6.35358830860093e-08	-0.265820806270671	0.64	0.758	0.00142752422117646	PRDX1	Malignant cells	GSE207422_Tor_post	ENSG00000117450	5052	peroxiredoxin 1	NKEFA|PAGA	protein_coding	Q06830	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67639
7.16208948501341e-08	0.256200500429609	0.406	0.257	0.00160917826549281	POLR2L	Malignant cells	GSE207422_Tor_post	ENSG00000177700	5441	RNA polymerase II, I and III subunit L	hRPB7.6|hsRPB10b|RBP10|RPABC5|RPB10beta|RPB7.6	protein_coding	P62875	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67640
7.30243777615969e-08	-0.295920063179623	0.134	0.262	0.00164071171954756	IRF1	Malignant cells	GSE207422_Tor_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67641
1.16423839091529e-07	0.335167118376561	0.445	0.319	0.00261581081670847	SNRPD1	Malignant cells	GSE207422_Tor_post	ENSG00000167088	6632	small nuclear ribonucleoprotein D1 polypeptide	HsT2456|Sm-D1|SNRPD	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67642
1.18992447733605e-07	0.361749961618553	0.412	0.268	0.00267352231567863	F3	Malignant cells	GSE207422_Tor_post	ENSG00000117525	2152	coagulation factor III, tissue factor	CD142|TF	protein_coding	P13726	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67643
1.52421141371362e-07	-0.256368036268082	0.252	0.38	0.00342459820433176	TAF1D	Malignant cells	GSE207422_Tor_post	ENSG00000166012	79101	TATA-box binding protein associated factor, RNA polymerase I subunit D	JOSD3|MGC5306|TAF(I)41	protein_coding	Q9H5J8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67644
1.60122870170239e-07	0.250132616090743	0.333	0.198	0.00359764064698493	MAPK6	Malignant cells	GSE207422_Tor_post	ENSG00000069956	5597	mitogen-activated protein kinase 6	ERK3|HsT17250|p97MAPK|PRKM6	protein_coding	Q16659	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67645
2.26140288363446e-07	0.446081929368957	0.643	0.607	0.00508091999894991	EIF2S2	Malignant cells	GSE207422_Tor_post	ENSG00000125977	8894	eukaryotic translation initiation factor 2 subunit beta	EIF2|EIF2beta|PPP1R67	protein_coding	P20042	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67646
2.29670387159251e-07	0.25061582054635	0.739	0.642	0.00516023425869406	PCBP1	Malignant cells	GSE207422_Tor_post	ENSG00000169564	5093	poly(rC) binding protein 1	hnRNP-E1|hnRNP-X|HNRPE1|HNRPX	protein_coding	Q15365	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67647
2.96970465245335e-07	0.407633761300567	0.426	0.321	0.00667233241313219	C1R	Malignant cells	GSE207422_Tor_post	ENSG00000288512	715	complement C1r	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67648
7.83962817328453e-07	-0.285244768215226	0.381	0.519	0.0176140765797357	H2AFZ	Malignant cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67649
1.13991284685631e-06	0.25795853194291	0.279	0.16	0.0256115618431675	INSIG1	Malignant cells	GSE207422_Tor_post	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67650
1.27260034310726e-06	0.264936802985624	0.255	0.138	0.0285927845089339	MANF	Malignant cells	GSE207422_Tor_post	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67651
1.52267791297888e-06	0.354383794278443	0.394	0.266	0.0342115273488095	CKS2	Malignant cells	GSE207422_Tor_post	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67652
1.91817027808781e-06	0.268630809583987	0.424	0.308	0.0430974498080769	NAA50	Malignant cells	GSE207422_Tor_post	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67653
1.15742192921561e-48	-1.70017706576585	0.17	0.68	2.60049559056164e-44	IGKC	Mono/Macro	GSE207422_Tor_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67654
1.40325246097626e-48	1.66882938408898	0.807	0.33	3.15282762932146e-44	FOSB	Mono/Macro	GSE207422_Tor_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67655
5.72306357456818e-41	-0.757240554594084	0.714	0.935	1.28585792393398e-36	MTATP6P1	Mono/Macro	GSE207422_Tor_post	ENSG00000248527	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67656
9.77924246394416e-40	1.10776368171448	0.643	0.115	2.19720019679897e-35	NR4A2	Mono/Macro	GSE207422_Tor_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67657
1.38141997361132e-37	-0.355968203744517	0.035	0.305	3.10377439670991e-33	ERAP2	Mono/Macro	GSE207422_Tor_post	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67658
7.88150091661936e-36	0.941436634818449	0.883	0.545	1.77081562594604e-31	JUND	Mono/Macro	GSE207422_Tor_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67659
2.14071415270638e-34	1.0035206930071	0.649	0.165	4.80975655830069e-30	ATF3	Mono/Macro	GSE207422_Tor_post	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67660
2.64322421341686e-33	-0.481940156020459	0.998	0.99	5.938796162705e-29	MT-CO3	Mono/Macro	GSE207422_Tor_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67661
5.38998790062912e-33	0.991869739660706	0.564	0.095	1.21102248151335e-28	FOSL2	Mono/Macro	GSE207422_Tor_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67662
8.51134680602568e-33	1.1788065926952	0.614	0.145	1.91232940037785e-28	ZNF331	Mono/Macro	GSE207422_Tor_post	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67663
1.61569797951389e-32	-0.659434918242901	0.984	0.995	3.63015022037181e-28	HLA-DRB1	Mono/Macro	GSE207422_Tor_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67664
1.33231050887132e-31	1.11749648284637	0.648	0.24	2.99343525133208e-27	CHMP1B	Mono/Macro	GSE207422_Tor_post	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67665
2.55958653490273e-31	0.923314037798646	0.711	0.28	5.75087902661944e-27	PNRC1	Mono/Macro	GSE207422_Tor_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67666
4.15557546224685e-30	0.889547748065856	0.938	0.72	9.33674694857622e-26	JUNB	Mono/Macro	GSE207422_Tor_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67667
4.60068078487084e-30	-0.801805566889161	0.075	0.36	1.03368095874478e-25	IDO1	Mono/Macro	GSE207422_Tor_post	ENSG00000131203	3620	indoleamine 2,3-dioxygenase 1	IDO|INDO	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67668
1.74437579812066e-29	1.05604883717608	0.624	0.19	3.9192635432175e-25	BTG1	Mono/Macro	GSE207422_Tor_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67669
6.66511511367165e-29	1.11148654432933	0.84	0.535	1.49751806373975e-24	C5AR1	Mono/Macro	GSE207422_Tor_post	ENSG00000197405	728	complement C5a receptor 1	C5A|C5AR|C5R1|CD88	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67670
6.41023730868628e-28	1.07014464410377	0.87	0.67	1.44025211851563e-23	KLF6	Mono/Macro	GSE207422_Tor_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67671
1.4292112183225e-27	0.96731407449442	0.506	0.075	3.21115176532698e-23	VEGFA	Mono/Macro	GSE207422_Tor_post	ENSG00000112715	7422	vascular endothelial growth factor A	VEGF|VEGF-A|VPF	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67672
4.51522569217648e-27	1.18265751765846	0.685	0.29	1.01448090851821e-22	GPR183	Mono/Macro	GSE207422_Tor_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67673
5.04816150880862e-27	-0.420559359075571	0.998	0.99	1.13422092779912e-22	MT-CYB	Mono/Macro	GSE207422_Tor_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67674
6.02032567455737e-27	1.07699044949685	0.721	0.325	1.35264677255955e-22	TFRC	Mono/Macro	GSE207422_Tor_post	ENSG00000072274	7037	transferrin receptor	CD71|p90|TFR1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67675
1.08127511913448e-25	-1.11315691212541	0.295	0.615	2.42940893767134e-21	SLAMF7	Mono/Macro	GSE207422_Tor_post	ENSG00000026751	57823	SLAM family member 7	19A|CD319|CRACC|CS1	protein_coding	Q9NQ25	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67676
2.73157192819699e-25	0.749333192908317	0.496	0.095	6.137295808273e-21	CREM	Mono/Macro	GSE207422_Tor_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67677
3.19730691758396e-25	0.851979723308994	0.713	0.35	7.18370918242763e-21	KLF4	Mono/Macro	GSE207422_Tor_post	ENSG00000136826	9314	KLF transcription factor 4	EZF|GKLF	protein_coding	O43474	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67678
6.15159074864629e-25	0.902511952730894	0.956	0.84	1.38213940940585e-20	HLA-DQB1	Mono/Macro	GSE207422_Tor_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67679
7.24263042965372e-25	0.718995377206484	0.625	0.215	1.6272742049346e-20	CD83	Mono/Macro	GSE207422_Tor_post	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67680
8.66528693044081e-25	1.01881269215672	0.893	0.695	1.94691666753144e-20	ZFP36	Mono/Macro	GSE207422_Tor_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67681
4.75306889364816e-24	0.933439728141698	0.876	0.635	1.06791951902487e-19	PLAUR	Mono/Macro	GSE207422_Tor_post	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67682
5.93887204835106e-24	0.823646062815545	0.557	0.16	1.33434577182352e-19	NR4A1	Mono/Macro	GSE207422_Tor_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67683
1.5732047950712e-23	-0.527132942301036	0.607	0.86	3.53467653356598e-19	LGALS9	Mono/Macro	GSE207422_Tor_post	ENSG00000168961	3965	galectin 9	LGALS9A	protein_coding	O00182	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67684
6.51876025366798e-23	0.861063809756075	0.726	0.41	1.46463505379412e-18	PPP1R15A	Mono/Macro	GSE207422_Tor_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67685
1.78036439174073e-22	0.934397940447172	0.598	0.23	4.00012271536308e-18	HBEGF	Mono/Macro	GSE207422_Tor_post	ENSG00000113070	1839	heparin binding EGF like growth factor	DTR|DTS|HEGFL	protein_coding	Q99075	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67686
2.08652714584194e-22	1.06535261647473	0.54	0.17	4.68800919127766e-18	TNFAIP3	Mono/Macro	GSE207422_Tor_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67687
2.4270679539225e-22	0.909337916027262	0.794	0.55	5.45313627887308e-18	NFKBIA	Mono/Macro	GSE207422_Tor_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67688
2.49298895625691e-22	0.795599682296585	0.52	0.145	5.60124758691802e-18	DUSP2	Mono/Macro	GSE207422_Tor_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67689
3.87632959231794e-22	0.684825253248927	0.839	0.635	8.70933732801995e-18	MCL1	Mono/Macro	GSE207422_Tor_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67690
8.50105370429514e-22	1.12148598335282	0.46	0.09	1.91001674628103e-17	CXCL8	Mono/Macro	GSE207422_Tor_post	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67691
1.26940986705125e-21	0.823266229028456	0.956	0.96	2.85211008929074e-17	SRGN	Mono/Macro	GSE207422_Tor_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67692
1.84607397736613e-21	-0.536558306696212	0.486	0.765	4.14775901234621e-17	AKR1A1	Mono/Macro	GSE207422_Tor_post	ENSG00000117448	10327	aldo-keto reductase family 1 member A1	ALR|DD3	protein_coding	P14550	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67693
2.34455365152997e-21	1.17789266003883	0.526	0.17	5.26774314425755e-17	CXCL2	Mono/Macro	GSE207422_Tor_post	ENSG00000081041	2920	C-X-C motif chemokine ligand 2	CINC-2a|GRO2|GROb|MGSA-b|MIP-2a|SCYB2	protein_coding	P19875	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67694
8.6695896089712e-21	1.0474418505388	0.625	0.315	1.94788339334365e-16	HSPH1	Mono/Macro	GSE207422_Tor_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67695
2.25922691555233e-20	-0.535325918596765	0.7	0.875	5.07603103386297e-16	CTSH	Mono/Macro	GSE207422_Tor_post	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67696
4.77457103274931e-20	0.902755355025993	0.745	0.46	1.07275061963812e-15	RGS2	Mono/Macro	GSE207422_Tor_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67697
6.56956940240287e-20	0.67151253267759	0.428	0.09	1.47605085333188e-15	MXD1	Mono/Macro	GSE207422_Tor_post	ENSG00000059728	4084	MAX dimerization protein 1	bHLHc58|MAD|MAD1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67698
1.15195055883906e-18	0.645637417158962	0.844	0.595	2.5882025155996e-14	DUSP1	Mono/Macro	GSE207422_Tor_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67699
1.44356055477553e-18	0.662644737945059	0.576	0.25	3.24339185446966e-14	NAMPT	Mono/Macro	GSE207422_Tor_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67700
1.52411128976008e-18	0.725143592331046	0.484	0.15	3.42437324583295e-14	NFKBIZ	Mono/Macro	GSE207422_Tor_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67701
2.60057033235486e-18	-0.365481674804612	0.149	0.41	5.84296142273491e-14	FCGR1A	Mono/Macro	GSE207422_Tor_post	ENSG00000150337	2209	Fc gamma receptor Ia	CD64|CD64A|FCG1|FcgammaRI|FcgammaRIa|FCGR1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67702
2.76359775258313e-18	0.939598117952582	0.874	0.735	6.20925143050377e-14	IFI6	Mono/Macro	GSE207422_Tor_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67703
3.46766227307461e-18	-0.56573281919549	0.956	0.985	7.79114359514404e-14	CST3	Mono/Macro	GSE207422_Tor_post	ENSG00000101439	1471	cystatin C	NA	protein_coding	P01034	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67704
4.27619416677133e-18	0.617766960906064	0.483	0.145	9.60775305390183e-14	MX1	Mono/Macro	GSE207422_Tor_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67705
5.788003445235e-18	-0.251266947228805	0.999	0.99	1.3004486140754e-13	MT-CO2	Mono/Macro	GSE207422_Tor_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67706
2.09141018043162e-17	0.640249630622137	0.692	0.41	4.69898039339377e-13	HIF1A	Mono/Macro	GSE207422_Tor_post	ENSG00000100644	3091	hypoxia inducible factor 1 subunit alpha	bHLHe78|HIF-1alpha|HIF1|MOP1|PASD8	protein_coding	Q16665	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67707
6.08734081986162e-17	0.60880562690301	0.324	0.03	1.36770373540651e-12	NR4A3	Mono/Macro	GSE207422_Tor_post	ENSG00000119508	8013	nuclear receptor subfamily 4 group A member 3	CHN|CSMF|MINOR|NOR1	protein_coding	Q92570	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67708
6.47700682024963e-17	0.921409884893315	0.337	0.035	1.45525389237369e-12	AREG	Mono/Macro	GSE207422_Tor_post	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67709
1.17677379338481e-16	-0.448869335628973	0.537	0.795	2.64397535897699e-12	MAFB	Mono/Macro	GSE207422_Tor_post	ENSG00000204103	9935	MAF bZIP transcription factor B	KRML	protein_coding	Q9Y5Q3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67710
1.55466084191065e-16	-0.609381104952383	0.425	0.7	3.49301197960484e-12	APOC1P1	Mono/Macro	GSE207422_Tor_post	ENSG00000214855	NA	NA	lincRNA-APOC1P1-3	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67711
2.96043990265182e-16	-0.557254861082667	0.367	0.615	6.65151637327811e-12	MPEG1	Mono/Macro	GSE207422_Tor_post	ENSG00000197629	219972	macrophage expressed 1	MPG1	protein_coding	Q2M385	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67712
3.92888001093672e-16	0.743986533957563	0.902	0.73	8.82740760857262e-12	FOS	Mono/Macro	GSE207422_Tor_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67713
5.98458602120107e-16	0.507472603711673	0.364	0.075	1.34461678724346e-11	NAMPTP1	Mono/Macro	GSE207422_Tor_post	ENSG00000229644	NA	NA	bA92J19.4|NAMPTL|PBEF2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67714
6.15093928183318e-16	-0.411669075986116	0.73	0.88	1.38199303784228e-11	GRINA	Mono/Macro	GSE207422_Tor_post	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67715
6.35325632198763e-16	-0.52727811185649	0.198	0.45	1.42744963042418e-11	DUSP6	Mono/Macro	GSE207422_Tor_post	ENSG00000139318	1848	dual specificity phosphatase 6	MKP-3|PYST1	protein_coding	Q16828	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67716
1.00595472661584e-15	-0.477653908597925	0.701	0.87	2.26017907976046e-11	ENO1	Mono/Macro	GSE207422_Tor_post	ENSG00000074800	2023	enolase 1	ENO1L1|MBP-1|MPB1|PPH	protein_coding	P06733	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67717
1.04291551955864e-15	0.936457860543642	0.987	0.985	2.34322258934436e-11	HSP90AA1	Mono/Macro	GSE207422_Tor_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67718
1.51897435638193e-15	0.918885314767759	0.631	0.395	3.41283158391892e-11	IER3	Mono/Macro	GSE207422_Tor_post	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67719
2.04175813832651e-15	0.675309874872644	0.578	0.3	4.58742218519201e-11	SLC2A3	Mono/Macro	GSE207422_Tor_post	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67720
2.27086286938744e-15	-0.384162470535423	0.91	0.94	5.1021746949397e-11	SAMHD1	Mono/Macro	GSE207422_Tor_post	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67721
2.90081179542375e-15	0.761479742885688	0.426	0.14	6.51754394195808e-11	ISG15	Mono/Macro	GSE207422_Tor_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67722
4.17641876943321e-15	0.579362361983629	0.958	0.94	9.38357769116253e-11	MALAT1	Mono/Macro	GSE207422_Tor_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67723
5.38323894382341e-15	0.645347908237258	0.697	0.44	1.20950612589824e-10	SOCS3	Mono/Macro	GSE207422_Tor_post	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67724
9.53357043834383e-15	-0.704657946907069	0.287	0.52	2.14200260608709e-10	GBP5	Mono/Macro	GSE207422_Tor_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67725
1.13663872973013e-14	0.43041705271643	0.583	0.3	2.55379989795765e-10	UQCRB	Mono/Macro	GSE207422_Tor_post	ENSG00000156467	7381	ubiquinol-cytochrome c reductase binding protein	QCR7|QP-C|UQBP|UQCR6	protein_coding	P14927	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67726
1.63974993740115e-14	-0.343995674793389	0.8	0.935	3.68419015935291e-10	HLA-DMA	Mono/Macro	GSE207422_Tor_post	ENSG00000239463	3108	major histocompatibility complex, class II, DM alpha	D6S222E|RING6	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67727
2.06103462393551e-14	0.301887910691507	0.999	1	4.63073259305831e-10	MT-RNR2	Mono/Macro	GSE207422_Tor_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67728
2.20346344839572e-14	0.435903287142067	0.351	0.08	4.9507416758555e-10	PPP1R15B	Mono/Macro	GSE207422_Tor_post	ENSG00000158615	84919	protein phosphatase 1 regulatory subunit 15B	FLJ14744	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67729
2.36293946432062e-14	-0.407975123734281	0.863	0.9	5.30905238843558e-10	CD81	Mono/Macro	GSE207422_Tor_post	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67730
3.52228415453971e-14	-0.329792483278323	0.108	0.305	7.91386803841982e-10	ATP13A2	Mono/Macro	GSE207422_Tor_post	ENSG00000159363	23400	ATPase cation transporting 13A2	CLN12|HSA9947|PARK9	protein_coding	Q9NQ11	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67731
4.0348342873705e-14	0.872565024328076	0.267	0.02	9.06546567686404e-10	EREG	Mono/Macro	GSE207422_Tor_post	ENSG00000124882	2069	epiregulin	ER	protein_coding	O14944	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67732
6.57741366023319e-14	-0.402837045673317	0.155	0.37	1.47781330118119e-09	RARRES3	Mono/Macro	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67733
7.99243412524894e-14	-0.411462045055017	0.158	0.375	1.79574009926093e-09	ANKRD22	Mono/Macro	GSE207422_Tor_post	ENSG00000152766	118932	ankyrin repeat domain 22	MGC22805	protein_coding	Q5VYY1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67734
8.15086513940487e-14	0.710539894942661	0.685	0.475	1.83133637952149e-09	ARL4C	Mono/Macro	GSE207422_Tor_post	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67735
9.14646262386759e-14	0.537278671659181	0.678	0.45	2.05502722233057e-09	ZFAND5	Mono/Macro	GSE207422_Tor_post	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67736
1.64641138086852e-13	-0.4810494085869	0.193	0.42	3.69915709053539e-09	IL4I1	Mono/Macro	GSE207422_Tor_post	ENSG00000104951	259307	interleukin 4 induced 1	FIG1	protein_coding	Q96RQ9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67737
1.65818197364785e-13	-0.334407880573981	0.822	0.935	3.72560325839198e-09	MT-ND4L	Mono/Macro	GSE207422_Tor_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67738
1.81063969361917e-13	0.468427958213901	0.404	0.13	4.06814526362355e-09	PHACTR1	Mono/Macro	GSE207422_Tor_post	ENSG00000112137	221692	phosphatase and actin regulator 1	dJ257A7.2|KIAA1733|RPEL1	protein_coding	Q9C0D0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67739
2.01143787963687e-13	0.599046487800438	0.838	0.755	4.51929862796812e-09	H3F3B	Mono/Macro	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67740
2.80718255832255e-13	-0.261614080795729	0.089	0.27	6.3071777720391e-09	GIMAP7	Mono/Macro	GSE207422_Tor_post	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67741
3.05928163296445e-13	-0.351387869432489	0.932	0.95	6.87359397294454e-09	NPC2	Mono/Macro	GSE207422_Tor_post	ENSG00000119655	10577	NPC intracellular cholesterol transporter 2	EDDM1|HE1|NP-C2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67742
6.07885008997277e-13	0.401814396562786	0.327	0.075	1.36579603821508e-08	CLK1	Mono/Macro	GSE207422_Tor_post	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67743
8.30558627945864e-13	-0.452465202102463	0.483	0.69	1.86609912526877e-08	SLAMF8	Mono/Macro	GSE207422_Tor_post	ENSG00000158714	56833	SLAM family member 8	BLAME|CD353|SBBI42	protein_coding	Q9P0V8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67744
1.00030111308335e-12	0.666830578142975	0.818	0.635	2.24747654087568e-08	ZFP36L1	Mono/Macro	GSE207422_Tor_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67745
1.27374395325547e-12	0.675755358181636	0.653	0.385	2.86184791417438e-08	CXCR4	Mono/Macro	GSE207422_Tor_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67746
1.38141208571185e-12	-0.612368658061808	0.525	0.7	3.10375667417738e-08	FGL2	Mono/Macro	GSE207422_Tor_post	ENSG00000127951	10875	fibrinogen like 2	pT49|T49	protein_coding	Q14314	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67747
1.38413620303383e-12	-0.352986569695259	0.983	0.97	3.1098772209764e-08	CTSS	Mono/Macro	GSE207422_Tor_post	ENSG00000163131	1520	cathepsin S	NA	protein_coding	P25774	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67748
1.43036344345338e-12	-0.442015560540626	0.869	0.95	3.21374058475106e-08	LCP1	Mono/Macro	GSE207422_Tor_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67749
3.2269363163822e-12	-0.478423913464395	0.339	0.555	7.25028051564753e-08	VAMP5	Mono/Macro	GSE207422_Tor_post	ENSG00000168899	10791	vesicle associated membrane protein 5	NA	protein_coding	O95183	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67750
3.61361923537229e-12	0.380555824858071	0.273	0.045	8.11907969803446e-08	SLC16A10	Mono/Macro	GSE207422_Tor_post	ENSG00000112394	117247	solute carrier family 16 member 10	MCT10|TAT1	protein_coding	Q8TF71	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67751
4.03132596321047e-12	-0.303815209010308	0.988	0.985	9.05758317414128e-08	MT-ND5	Mono/Macro	GSE207422_Tor_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67752
4.2638995692694e-12	0.411744036455735	0.381	0.13	9.58012955223448e-08	CCNL1	Mono/Macro	GSE207422_Tor_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67753
4.46592221158934e-12	-0.321574594918756	1	1	1.00340340249989e-07	HLA-A	Mono/Macro	GSE207422_Tor_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67754
5.9283916967258e-12	-0.308236555173775	0.732	0.86	1.33199104642035e-07	CD53	Mono/Macro	GSE207422_Tor_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67755
6.13058742968462e-12	-0.449743177277567	0.2	0.42	1.37742038370154e-07	CD40	Mono/Macro	GSE207422_Tor_post	ENSG00000101017	958	CD40 molecule	Bp50|p50|TNFRSF5	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67756
8.1150780859051e-12	-0.381811875745189	0.126	0.31	1.82329574434116e-07	APOL3	Mono/Macro	GSE207422_Tor_post	ENSG00000128284	80833	apolipoprotein L3	APOLIII|CG12-1	protein_coding	O95236	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67757
9.39979764179052e-12	-0.383544041657328	0.968	0.965	2.11194653415749e-07	LAPTM5	Mono/Macro	GSE207422_Tor_post	ENSG00000162511	7805	lysosomal protein transmembrane 5	NA	protein_coding	Q13571	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67758
1.04263797188182e-11	0.321717497844307	0.309	0.075	2.34259899522408e-07	CSRNP1	Mono/Macro	GSE207422_Tor_post	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67759
1.09737016655783e-11	0.345421622775398	0.999	0.995	2.46557129022212e-07	EEF1A1	Mono/Macro	GSE207422_Tor_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67760
1.15085965426408e-11	0.517242609673155	0.731	0.595	2.58575147120053e-07	ATP1B3	Mono/Macro	GSE207422_Tor_post	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67761
1.27327292074532e-11	0.427244523141279	0.386	0.14	2.86078959833058e-07	YPEL5	Mono/Macro	GSE207422_Tor_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67762
1.30553621036488e-11	-0.581659512682459	0.651	0.795	2.93327875744782e-07	SNX10	Mono/Macro	GSE207422_Tor_post	ENSG00000086300	29887	sorting nexin 10	NA	protein_coding	Q9Y5X0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67763
1.56686934302345e-11	-0.311549116778512	0.999	0.995	3.52044203990509e-07	CD74	Mono/Macro	GSE207422_Tor_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67764
1.75018618604421e-11	-0.901652122488597	0.455	0.62	3.93231832280414e-07	GBP1	Mono/Macro	GSE207422_Tor_post	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67765
2.21746831599712e-11	-0.407774271517777	0.402	0.645	4.98220781238234e-07	LTA4H	Mono/Macro	GSE207422_Tor_post	ENSG00000111144	4048	leukotriene A4 hydrolase	NA	protein_coding	P09960	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67766
2.32772328562548e-11	-0.691791097033158	0.359	0.59	5.22992867814332e-07	MT2A	Mono/Macro	GSE207422_Tor_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67767
3.1128941501965e-11	-0.524502301968339	0.267	0.455	6.99405057666149e-07	IL18BP	Mono/Macro	GSE207422_Tor_post	ENSG00000137496	10068	interleukin 18 binding protein	IL18BPa	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67768
3.16632736710032e-11	0.674400812002417	0.722	0.545	7.11410432840101e-07	RGS1	Mono/Macro	GSE207422_Tor_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67769
3.87070157024579e-11	-0.586681293228226	0.259	0.465	8.69669228802824e-07	FUCA1	Mono/Macro	GSE207422_Tor_post	ENSG00000179163	2517	alpha-L-fucosidase 1	NA	protein_coding	P04066	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67770
4.14383240775097e-11	-0.685950536552508	0.607	0.705	9.31036265373489e-07	SERPING1	Mono/Macro	GSE207422_Tor_post	ENSG00000149131	710	serpin family G member 1	C1-INH|C1IN|C1INH|C1NH|HAE1|HAE2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67771
4.24069256073976e-11	-0.35784555783021	0.152	0.34	9.52798804547009e-07	GCH1	Mono/Macro	GSE207422_Tor_post	ENSG00000131979	2643	GTP cyclohydrolase 1	DYT14|DYT5|DYT5a|GCH|GTPCH1	protein_coding	P30793	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67772
5.61731566860219e-11	0.34521434793906	0.338	0.1	1.26209848442154e-06	GABARAPL1	Mono/Macro	GSE207422_Tor_post	ENSG00000139112	23710	GABA type A receptor associated protein like 1	APG8L|ATG8B|ATG8L|gec1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67773
6.77167140073363e-11	0.352264983154717	0.255	0.045	1.52145913031683e-06	SIGLEC12	Mono/Macro	GSE207422_Tor_post	ENSG00000254521	89858	sialic acid binding Ig like lectin 12	S2V|Siglec-12|Siglec-L1|Siglec-XII|SIGLECL1|SLG	protein_coding	Q96PQ1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67774
7.1530340034926e-11	-0.467216755144167	0.704	0.85	1.60714367990472e-06	CPVL	Mono/Macro	GSE207422_Tor_post	ENSG00000106066	54504	carboxypeptidase vitellogenic like	NA	protein_coding	Q9H3G5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67775
9.00195840527177e-11	0.363159054710663	0.406	0.17	2.02256001449646e-06	PPDPF	Mono/Macro	GSE207422_Tor_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67776
9.86412588517866e-11	-0.400247092965288	0.549	0.73	2.21627180388194e-06	DNASE2	Mono/Macro	GSE207422_Tor_post	ENSG00000105612	1777	deoxyribonuclease 2, lysosomal	DNL|DNL2	protein_coding	O00115	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67777
1.11783296894778e-10	0.505218946618893	0.72	0.5	2.51154711463188e-06	PLIN2	Mono/Macro	GSE207422_Tor_post	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67778
1.28346503025533e-10	-0.412590178860101	0.32	0.53	2.88368922997767e-06	NR1H3	Mono/Macro	GSE207422_Tor_post	ENSG00000025434	10062	nuclear receptor subfamily 1 group H member 3	LXR-a|LXRa|RLD-1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67779
2.46723326520475e-10	-1.84450002214068	0.298	0.46	5.54337970026204e-06	CXCL9	Mono/Macro	GSE207422_Tor_post	ENSG00000138755	4283	C-X-C motif chemokine ligand 9	CMK|crg-10|Humig|MIG|SCYB9	protein_coding	Q07325	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67780
2.8676521114724e-10	-0.340713769655669	0.308	0.52	6.44304076405618e-06	CD48	Mono/Macro	GSE207422_Tor_post	ENSG00000117091	962	CD48 molecule	BCM1|BLAST|hCD48|mCD48|SLAMF2	protein_coding	P09326	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67781
2.913241849466e-10	0.367432190471607	0.634	0.415	6.5454717873802e-06	ANP32B	Mono/Macro	GSE207422_Tor_post	ENSG00000136938	10541	acidic nuclear phosphoprotein 32 family member B	APRIL|PHAPI2|SSP29	protein_coding	Q92688	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67782
2.98256866129277e-10	-0.485003358627232	0.456	0.6	6.7012352681926e-06	TAP1	Mono/Macro	GSE207422_Tor_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67783
3.33623506747931e-10	0.388943128496363	0.89	0.795	7.49585294961251e-06	CALM1	Mono/Macro	GSE207422_Tor_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67784
3.39627448004029e-10	1.09582451144324	0.378	0.16	7.63074950175452e-06	IL1B	Mono/Macro	GSE207422_Tor_post	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67785
3.41393816168134e-10	-0.433929286331719	0.325	0.53	7.67043626166564e-06	WARS	Mono/Macro	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67786
4.06918115112603e-10	0.547640874515422	0.39	0.16	9.14263621034997e-06	CXCL3	Mono/Macro	GSE207422_Tor_post	ENSG00000163734	2921	C-X-C motif chemokine ligand 3	CINC-2b|GRO3|GROg|MIP-2b|SCYB3	protein_coding	P19876	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67787
5.9456958914365e-10	0.419892786902631	0.409	0.19	1.33587895288795e-05	IFI44L	Mono/Macro	GSE207422_Tor_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67788
8.15181975378901e-10	0.303148078290295	0.28	0.075	1.83155086228131e-05	NFIL3	Mono/Macro	GSE207422_Tor_post	ENSG00000165030	4783	nuclear factor, interleukin 3 regulated	E4BP4|IL3BP1|NF-IL3A|NFIL3A	protein_coding	Q16649	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67789
9.39764893780719e-10	-0.445269700698259	0.283	0.475	2.11146376334652e-05	ATF5	Mono/Macro	GSE207422_Tor_post	ENSG00000169136	22809	activating transcription factor 5	NA	protein_coding	Q9Y2D1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67790
9.44405895346776e-10	-0.330862444485496	0.338	0.54	2.12189116566514e-05	CMKLR1	Mono/Macro	GSE207422_Tor_post	ENSG00000174600	1240	chemerin chemokine-like receptor 1	RVER1	protein_coding	Q99788	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67791
9.53625827207971e-10	0.396780962620591	0.363	0.15	2.14260650857087e-05	TAGAP	Mono/Macro	GSE207422_Tor_post	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67792
9.94137151308336e-10	0.582744675471338	0.81	0.65	2.23362735155957e-05	JUN	Mono/Macro	GSE207422_Tor_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67793
1.11906054922955e-09	-0.347940048018453	0.733	0.825	2.51430524200896e-05	SERPINA1	Mono/Macro	GSE207422_Tor_post	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67794
1.5480455591622e-09	0.54839826102729	0.689	0.475	3.47814876232564e-05	HSPB1	Mono/Macro	GSE207422_Tor_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67795
1.84091074848322e-09	-0.2785536319445	0.236	0.43	4.13615826969211e-05	FERMT3	Mono/Macro	GSE207422_Tor_post	ENSG00000149781	83706	FERM domain containing kindlin 3	KIND3|MGC10966|MIG2B|UNC112C|URP2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67796
1.97625167947045e-09	-0.784130207175084	0.918	0.915	4.4402422734342e-05	CTSC	Mono/Macro	GSE207422_Tor_post	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67797
1.98310268940506e-09	0.346936584924896	0.257	0.065	4.45563512255529e-05	ARL5B	Mono/Macro	GSE207422_Tor_post	ENSG00000165997	221079	ADP ribosylation factor like GTPase 5B	ARL8	protein_coding	Q96KC2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67798
2.23724003394178e-09	-0.277550185494481	0.369	0.575	5.02663090826039e-05	PIK3AP1	Mono/Macro	GSE207422_Tor_post	ENSG00000155629	118788	phosphoinositide-3-kinase adaptor protein 1	BCAP|FLJ35564	protein_coding	Q6ZUJ8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67799
2.30208745815013e-09	0.326861796045197	0.319	0.11	5.17233010097171e-05	SELENOK	Mono/Macro	GSE207422_Tor_post	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67800
2.59029943706093e-09	-0.298142532342221	0.681	0.86	5.8198847751885e-05	GPX1	Mono/Macro	GSE207422_Tor_post	ENSG00000233276	2876	glutathione peroxidase 1	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67801
2.76545669978734e-09	-0.32304171519807	1	1	6.2134281130822e-05	HLA-C	Mono/Macro	GSE207422_Tor_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67802
3.12265647437664e-09	-0.338947040189148	0.39	0.6	7.01598456662944e-05	ACP2	Mono/Macro	GSE207422_Tor_post	ENSG00000134575	53	acid phosphatase 2, lysosomal	LAP	protein_coding	P11117	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67803
3.22404706382525e-09	-0.505345243315897	0.316	0.495	7.24378894300257e-05	GBP4	Mono/Macro	GSE207422_Tor_post	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67804
3.36554781085919e-09	-0.544182269557272	0.718	0.77	7.56171282143843e-05	STAT1	Mono/Macro	GSE207422_Tor_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67805
3.41065367893919e-09	0.808093440139198	0.25	0.065	7.66305668584057e-05	G0S2	Mono/Macro	GSE207422_Tor_post	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67806
3.89802344472446e-09	-0.492678106501142	0.746	0.83	8.75807907560692e-05	APOC1	Mono/Macro	GSE207422_Tor_post	ENSG00000130208	341	apolipoprotein C1	NA	protein_coding	P02654	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67807
4.1617113058997e-09	-0.367948054998424	0.581	0.73	9.35053296209546e-05	LAP3	Mono/Macro	GSE207422_Tor_post	ENSG00000002549	51056	leucine aminopeptidase 3	LAP|LAPEP|PEPS	protein_coding	P28838	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67808
6.83985488881573e-09	-0.267743752316091	0.791	0.91	0.000153677859641912	ACTR3	Mono/Macro	GSE207422_Tor_post	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67809
7.26058979272116e-09	-0.301121590582772	0.576	0.72	0.000163130931462859	SLC31A2	Mono/Macro	GSE207422_Tor_post	ENSG00000136867	1318	solute carrier family 31 member 2	COPT2|CTR2|hCTR2	protein_coding	O15432	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67810
7.43398684786538e-09	-0.675694811728557	0.772	0.805	0.000167026816497839	C1QA	Mono/Macro	GSE207422_Tor_post	ENSG00000173372	712	complement C1q A chain	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67811
8.38732282029065e-09	-0.307916101490965	0.547	0.74	0.00018844636912629	PTAFR	Mono/Macro	GSE207422_Tor_post	ENSG00000169403	5724	platelet activating factor receptor	NA	protein_coding	P25105	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67812
9.65909070461175e-09	-0.311083969579848	0.652	0.795	0.000217020449951217	RNASET2	Mono/Macro	GSE207422_Tor_post	ENSG00000026297	8635	ribonuclease T2	bA514O12.3|FLJ10907|RNASE6PL	protein_coding	O00584	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67813
1.00181184954396e-08	0.370935053065878	0.33	0.125	0.000225087086355536	MMP19	Mono/Macro	GSE207422_Tor_post	ENSG00000123342	4327	matrix metallopeptidase 19	MMP18|RASI-1	protein_coding	Q99542	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67814
1.01501983489257e-08	-0.28051076630139	0.408	0.615	0.000228054656503662	ARHGDIA	Mono/Macro	GSE207422_Tor_post	ENSG00000141522	396	Rho GDP dissociation inhibitor alpha	GDIA1|RHOGDI	protein_coding	P52565	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67815
1.03412313057722e-08	0.425814742967456	0.428	0.205	0.000232346784978089	LMNA	Mono/Macro	GSE207422_Tor_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67816
1.39344808680059e-08	0.580907497243867	0.487	0.3	0.000313079916142356	HSPD1	Mono/Macro	GSE207422_Tor_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67817
1.41664537667364e-08	0.361875664377222	0.497	0.295	0.000318291883231033	DDX3X	Mono/Macro	GSE207422_Tor_post	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67818
1.43324724533742e-08	0.341592759485253	0.309	0.115	0.000322021991082412	KDM6B	Mono/Macro	GSE207422_Tor_post	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67819
1.51491532480202e-08	-0.52430036937593	0.652	0.825	0.000340371175176519	TXNIP	Mono/Macro	GSE207422_Tor_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67820
1.51714114629189e-08	-0.250598036920261	0.129	0.285	0.000340871272748863	PSTPIP2	Mono/Macro	GSE207422_Tor_post	ENSG00000152229	9050	proline-serine-threonine phosphatase interacting protein 2	NA	protein_coding	Q9H939	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67821
1.86296267060742e-08	0.447470153332759	0.693	0.57	0.000418570452832076	DNAJA1	Mono/Macro	GSE207422_Tor_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67822
1.86794898346132e-08	0.532791030770984	0.566	0.365	0.000419690777604088	BTG2	Mono/Macro	GSE207422_Tor_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67823
1.93691741775596e-08	0.274622380109006	0.285	0.095	0.000435186605421408	DEDD2	Mono/Macro	GSE207422_Tor_post	ENSG00000160570	162989	death effector domain containing 2	FLAME-3	protein_coding	Q8WXF8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67824
2.14084951908422e-08	-0.258220883425362	0.332	0.535	0.000481006069947842	PILRA	Mono/Macro	GSE207422_Tor_post	ENSG00000085514	29992	paired immunoglobin like type 2 receptor alpha	FDF03	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67825
2.14942400726764e-08	-0.296319650297216	0.417	0.625	0.000482932585952894	RPS3A	Mono/Macro	GSE207422_Tor_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67826
2.17345668527386e-08	0.333329300434125	0.512	0.29	0.000488332248047332	CDKN1A	Mono/Macro	GSE207422_Tor_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67827
2.25974437181568e-08	-0.311537543594895	0.887	0.92	0.000507719365459548	HLA-DMB	Mono/Macro	GSE207422_Tor_post	ENSG00000242386	3109	major histocompatibility complex, class II, DM beta	D6S221E|RING7	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67828
2.27053667396297e-08	0.396331551240456	0.333	0.145	0.000510144179905999	EIF4A3	Mono/Macro	GSE207422_Tor_post	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67829
2.36549302077124e-08	0.301257506612473	0.681	0.53	0.000531478971906881	COX6C	Mono/Macro	GSE207422_Tor_post	ENSG00000164919	1345	cytochrome c oxidase subunit 6C	NA	protein_coding	P09669	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67830
2.36731241771684e-08	0.280076810201114	0.269	0.085	0.000531887754012619	RIPK2	Mono/Macro	GSE207422_Tor_post	ENSG00000104312	8767	receptor interacting serine/threonine kinase 2	CARD3|CARDIAK|RICK|RIP2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67831
2.52738325878933e-08	-0.425509891032332	0.367	0.505	0.000567852470584788	LILRB1	Mono/Macro	GSE207422_Tor_post	ENSG00000276452	10859	leukocyte immunoglobulin like receptor B1	CD85|CD85j|ILT2|LIR-1|LIR1|MIR-7|PIR-B|PIRB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67832
2.6812751613983e-08	0.463924014977031	0.431	0.205	0.000602428903262969	IL7R	Mono/Macro	GSE207422_Tor_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67833
3.21206621606993e-08	-0.35414114847576	0.726	0.815	0.000721687037426591	GM2A	Mono/Macro	GSE207422_Tor_post	ENSG00000196743	2760	ganglioside GM2 activator	GM2-AP|GM2AP|SAP-3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67834
3.21610795911294e-08	0.364402059886632	0.336	0.14	0.000722595136253495	DDIT4	Mono/Macro	GSE207422_Tor_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67835
3.64438935456651e-08	-0.271865972797515	0.774	0.9	0.000818821400184004	CANX	Mono/Macro	GSE207422_Tor_post	ENSG00000283777	821	calnexin	CNX|IP90|P90	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67836
3.76483147506071e-08	-0.420622175627061	0.488	0.64	0.00084588233581664	FTLP3	Mono/Macro	GSE207422_Tor_post	ENSG00000226608	NA	NA	dJ681N20.2|FTLL1	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67837
3.96156222195935e-08	-0.258304352075832	0.501	0.67	0.000890083800029828	GDI2	Mono/Macro	GSE207422_Tor_post	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67838
5.12597340489508e-08	-0.415720616637717	0.766	0.845	0.00115170370461183	IGSF6	Mono/Macro	GSE207422_Tor_post	ENSG00000283934	10261	immunoglobulin superfamily member 6	DORA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67839
5.67690628770781e-08	-0.292594570422196	0.477	0.645	0.00127548730472219	NOP10	Mono/Macro	GSE207422_Tor_post	ENSG00000182117	55505	NOP10 ribonucleoprotein	MGC70651|NOLA3|NOP10P	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67840
6.40845381074234e-08	0.339661501836497	0.401	0.205	0.00143985140219759	ATP2B1	Mono/Macro	GSE207422_Tor_post	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67841
6.74212353519231e-08	-0.530121328492061	0.181	0.32	0.00151482031588701	MTND2P28	Mono/Macro	GSE207422_Tor_post	ENSG00000225630	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67842
7.36990862869634e-08	0.745560424129434	0.582	0.4	0.00165587107069549	DNAJB1	Mono/Macro	GSE207422_Tor_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67843
8.04560705835436e-08	0.306454710677353	0.426	0.225	0.00180768699387106	GNA13	Mono/Macro	GSE207422_Tor_post	ENSG00000120063	10672	G protein subunit alpha 13	G13|MGC46138	protein_coding	Q14344	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67844
8.07580261188991e-08	0.2620002957399	0.499	0.285	0.00181447133083943	RASGEF1B	Mono/Macro	GSE207422_Tor_post	ENSG00000138670	153020	RasGEF domain family member 1B	FLJ31695|GPIG4	protein_coding	Q0VAM2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67845
8.18528189918545e-08	0.521160888777156	0.291	0.115	0.00183906913710899	IFI27	Mono/Macro	GSE207422_Tor_post	ENSG00000275214	3429	interferon alpha inducible protein 27	FAM14D|ISG12|P27	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67846
8.2492571483273e-08	0.253489567846101	0.733	0.51	0.00185344309608618	ANXA1	Mono/Macro	GSE207422_Tor_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67847
8.47487608420136e-08	-0.402002385054791	0.845	0.84	0.00190413515859836	FCGR3A	Mono/Macro	GSE207422_Tor_post	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67848
8.54435618480269e-08	0.31183581765885	0.332	0.145	0.00191974594760147	OAS3	Mono/Macro	GSE207422_Tor_post	ENSG00000111331	4940	2'-5'-oligoadenylate synthetase 3	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67849
9.1775166567742e-08	-0.748512886037137	0.222	0.39	0.00206200444244403	CXCL10	Mono/Macro	GSE207422_Tor_post	ENSG00000169245	3627	C-X-C motif chemokine ligand 10	C7|crg-2|gIP-10|IFI10|INP10|IP-10|mob-1|SCYB10	protein_coding	P02778	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67850
9.31800432768074e-08	-0.269796042194778	0.225	0.4	0.00209356921234331	GIMAP4	Mono/Macro	GSE207422_Tor_post	ENSG00000133574	55303	GTPase, IMAP family member 4	FLJ11110|HIMAP4|IAN1|IMAP4	protein_coding	Q9NUV9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67851
9.99873138234996e-08	0.308569712032343	0.633	0.41	0.00224651496698639	TXN	Mono/Macro	GSE207422_Tor_post	ENSG00000136810	7295	thioredoxin	TRX|Trx80	protein_coding	P10599	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67852
1.02254994748369e-07	-0.271678500243046	0.503	0.675	0.00229746522200636	HCK	Mono/Macro	GSE207422_Tor_post	ENSG00000101336	3055	HCK proto-oncogene, Src family tyrosine kinase	JTK9	protein_coding	P08631	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67853
1.03252743067043e-07	1.63299085544879	0.58	0.43	0.00231988263123032	CCL18	Mono/Macro	GSE207422_Tor_post	ENSG00000278006	6362	C-C motif chemokine ligand 18	AMAC-1|CKb7|DC-CK1|DCCK1|MIP-4|PARC|SCYA18	protein_coding	P55774	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67854
1.1093838286434e-07	0.398075817104488	0.263	0.095	0.002492563586196	TSC22D1	Mono/Macro	GSE207422_Tor_post	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67855
1.23166301671137e-07	0.363673567926134	0.447	0.26	0.0027673004659471	BHLHE40	Mono/Macro	GSE207422_Tor_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67856
1.43240682161197e-07	0.84720115637433	0.777	0.685	0.00321833164679778	HSPA1B	Mono/Macro	GSE207422_Tor_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67857
1.47785631723704e-07	0.357974818046533	0.425	0.24	0.00332044757356818	TNFRSF1B	Mono/Macro	GSE207422_Tor_post	ENSG00000028137	7133	TNF receptor superfamily member 1B	CD120b|p75|TNF-R-II|TNF-R75|TNFBR|TNFR2|TNFR80	protein_coding	P20333	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67858
1.81061907165146e-07	-0.480112302284086	0.506	0.675	0.00406809893018651	VSIG4	Mono/Macro	GSE207422_Tor_post	ENSG00000155659	11326	V-set and immunoglobulin domain containing 4	CRIg|Z39IG	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67859
1.92865035556331e-07	0.39579921697706	0.946	0.935	0.00433329161887964	HSP90AB1	Mono/Macro	GSE207422_Tor_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67860
1.9477910903311e-07	0.298081352932995	0.387	0.2	0.00437629702175592	EEF1D	Mono/Macro	GSE207422_Tor_post	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67861
2.0201175702852e-07	0.252222995152441	0.327	0.14	0.00453880015691678	XBP1	Mono/Macro	GSE207422_Tor_post	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67862
2.70941321637843e-07	0.295115551973085	0.332	0.155	0.00608750961455905	ELL2	Mono/Macro	GSE207422_Tor_post	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67863
2.73633287636581e-07	-0.262965359192756	0.328	0.505	0.00614799270661871	PSME2	Mono/Macro	GSE207422_Tor_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67864
2.79319312302671e-07	-0.267513296400658	0.24	0.405	0.0062757463088164	LPCAT2	Mono/Macro	GSE207422_Tor_post	ENSG00000087253	54947	lysophosphatidylcholine acyltransferase 2	AGPAT11|AYTL1|FLJ20481|LPLAT9|LysoPAFAT	protein_coding	Q7L5N7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67865
3.76142808947601e-07	0.68965987938785	0.369	0.18	0.00845117663143471	RNASE1	Mono/Macro	GSE207422_Tor_post	ENSG00000129538	6035	ribonuclease A family member 1, pancreatic	RAC1|RNS1	protein_coding	P07998	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67866
4.0214026489843e-07	0.292358744405814	0.425	0.245	0.00903528747173793	METRNL	Mono/Macro	GSE207422_Tor_post	ENSG00000275031	284207	meteorin like, glial cell differentiation regulator	NA	protein_coding	Q641Q3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67867
4.85508147715688e-07	-0.38351352336515	0.918	0.895	0.0109083970628761	CYBB	Mono/Macro	GSE207422_Tor_post	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67868
5.33208752142877e-07	0.346398914877369	0.494	0.29	0.0119801342431462	SDS	Mono/Macro	GSE207422_Tor_post	ENSG00000135094	10993	serine dehydratase	SDH	protein_coding	P20132	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67869
6.27517993096101e-07	0.308281691460237	0.318	0.15	0.0140990742688832	PDE4B	Mono/Macro	GSE207422_Tor_post	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67870
6.33310084052118e-07	0.280983880360444	0.474	0.3	0.014229210968483	EIF4A2	Mono/Macro	GSE207422_Tor_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67871
6.38600627989265e-07	0.311599027904976	0.849	0.8	0.0143480789096628	APLP2	Mono/Macro	GSE207422_Tor_post	ENSG00000084234	334	amyloid beta precursor like protein 2	APPH|APPL2	protein_coding	Q06481	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67872
7.01135761482425e-07	0.250689638032954	0.337	0.165	0.0157531182889871	CERS2	Mono/Macro	GSE207422_Tor_post	ENSG00000143418	29956	ceramide synthase 2	FLJ10243|LASS2|SP260	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67873
9.86574620680015e-07	0.294181156857542	0.296	0.13	0.0221663585774386	EZR	Mono/Macro	GSE207422_Tor_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67874
1.00820162714351e-06	-0.277659421817487	0.398	0.57	0.0226522741586604	FGR	Mono/Macro	GSE207422_Tor_post	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67875
1.00869815376321e-06	0.303503500096135	0.456	0.275	0.0226634301187518	LY6E	Mono/Macro	GSE207422_Tor_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67876
1.01620301361924e-06	-0.269134278884745	0.227	0.375	0.0228320493099971	LRRC25	Mono/Macro	GSE207422_Tor_post	ENSG00000175489	126364	leucine rich repeat containing 25	FLJ38116|MAPA	protein_coding	Q8N386	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67877
1.06623811351017e-06	-0.273422261147351	0.216	0.36	0.0239562379343466	SCIMP	Mono/Macro	GSE207422_Tor_post	ENSG00000161929	388325	SLP adaptor and CSK interacting membrane protein	C17orf87|DTFT5783|FLJ32580|MGC163426|MGC163428|UNQ5783	protein_coding	Q6UWF3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67878
1.16514921492788e-06	0.683357010662514	0.889	0.815	0.0261785725609997	HSPA1A	Mono/Macro	GSE207422_Tor_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67879
1.17825635581214e-06	-0.323340007177537	0.776	0.84	0.0264730638023872	HLA-DRB3	Mono/Macro	GSE207422_Tor_post	ENSG00000230463	3125	major histocompatibility complex, class II, DR beta 3	HLA-DR3B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67880
1.21314944764604e-06	-0.330089571918911	0.997	0.99	0.0272570417897112	ACTB	Mono/Macro	GSE207422_Tor_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67881
1.29449177446704e-06	-0.429724942606383	0.828	0.87	0.0290846411887254	GAPDH	Mono/Macro	GSE207422_Tor_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67882
1.37269215923879e-06	0.365808307402062	0.322	0.15	0.0308416474337772	THBD	Mono/Macro	GSE207422_Tor_post	ENSG00000178726	7056	thrombomodulin	BDCA-3|CD141|THRM	protein_coding	P07204	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67883
1.41141566686002e-06	0.266551337850989	0.32	0.15	0.0317116872030109	ETS2	Mono/Macro	GSE207422_Tor_post	ENSG00000157557	2114	ETS proto-oncogene 2, transcription factor	NA	protein_coding	P15036	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67884
1.50951342574162e-06	-0.254699662297222	0.689	0.795	0.0339157476495627	KCTD12	Mono/Macro	GSE207422_Tor_post	ENSG00000178695	115207	potassium channel tetramerization domain containing 12	C13orf2|KIAA1778|PFET1	protein_coding	Q96CX2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67885
1.55249675229717e-06	0.400979966887055	0.487	0.315	0.0348814970306128	KLF2	Mono/Macro	GSE207422_Tor_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67886
1.68275802639016e-06	0.35839679711411	0.715	0.585	0.037808207336934	MARCKS	Mono/Macro	GSE207422_Tor_post	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67887
1.74641142955353e-06	-0.496259687663724	0.816	0.825	0.0392383719992087	C1QB	Mono/Macro	GSE207422_Tor_post	ENSG00000173369	713	complement C1q B chain	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67888
1.75683823147639e-06	0.289059763332813	0.315	0.155	0.0394726413848115	PIM3	Mono/Macro	GSE207422_Tor_post	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67889
1.93240148492284e-06	0.268443805179881	0.323	0.16	0.0434171965632463	DDX3Y	Mono/Macro	GSE207422_Tor_post	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67890
2.05120888860213e-06	0.30330513481309	0.383	0.215	0.0460865613091127	PTGER4	Mono/Macro	GSE207422_Tor_post	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67891
1.45161570138471e-29	-1.2377075564828	0.028	0.744	3.26149015787116e-25	HLA-DRB3	B cells	GSE207422_Tor_post	ENSG00000230463	3125	major histocompatibility complex, class II, DR beta 3	HLA-DR3B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67892
2.92410129207344e-26	-1.24656203137877	0.986	1	6.56987078303061e-22	HLA-C	B cells	GSE207422_Tor_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67893
5.38399213882637e-25	1.58523689285572	0.759	0.012	1.20967535375151e-20	HLA-DRB5	B cells	GSE207422_Tor_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67894
2.39709922673397e-23	1.43987019036472	0.901	0.372	5.38580254262587e-19	RPS26	B cells	GSE207422_Tor_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67895
7.39992690558037e-23	-1.20722492472245	0.092	0.733	1.6626155771458e-18	CCR1	B cells	GSE207422_Tor_post	ENSG00000163823	1230	C-C motif chemokine receptor 1	CD191|CKR-1|CMKBR1|MIP1aR|SCYAR1	protein_coding	P32246	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67896
4.46070695480638e-22	1.60298663432744	0.986	0.849	1.0022316386059e-17	CXCR4	B cells	GSE207422_Tor_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67897
1.11663955221263e-21	-0.635990330098279	1	1	2.50886574591133e-17	MT-CO1	B cells	GSE207422_Tor_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67898
1.14016573133856e-20	-0.850144875687968	1	1	2.56172436517148e-16	B2M	B cells	GSE207422_Tor_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67899
5.30583928152195e-20	-0.789235450929994	0.05	0.593	1.19211596977235e-15	GPR82	B cells	GSE207422_Tor_post	ENSG00000171657	27197	G protein-coupled receptor 82	NA	protein_coding	Q96P67	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67900
1.66875857664989e-19	-1.14417804817638	0.128	0.721	3.74936677001697e-15	IFI44L	B cells	GSE207422_Tor_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67901
2.23393829211146e-19	-1.19871342486694	0.177	0.779	5.01921255471603e-15	GBP4	B cells	GSE207422_Tor_post	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67902
7.9188781230417e-19	1.74461916670964	0.872	0.477	1.77921353668501e-14	TXNIP	B cells	GSE207422_Tor_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67903
8.05300937953813e-19	-0.960705036265325	0.993	1	1.80935014739463e-14	TMSB4X	B cells	GSE207422_Tor_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67904
1.24432577206106e-18	1.69001479353118	0.872	0.465	2.79575114466678e-14	FOSB	B cells	GSE207422_Tor_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67905
1.36991128121095e-18	-0.978283520467552	1	1	3.07791666662477e-14	ACTB	B cells	GSE207422_Tor_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67906
2.26739004285174e-18	1.2197214428389	0.957	0.895	5.09437194827928e-14	RPS4X	B cells	GSE207422_Tor_post	ENSG00000198034	6191	ribosomal protein S4 X-linked	CCG2|DXS306|FLJ40595|RPS4|S4|SCAR|SCR10	protein_coding	P62701	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67907
3.54648370353263e-18	-1.17573703945032	0.27	0.826	7.96823958509712e-14	STAT1	B cells	GSE207422_Tor_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67908
3.79302826638839e-18	-1.12832409697554	0.128	0.663	8.52217590892143e-14	MX1	B cells	GSE207422_Tor_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67909
5.42577840937518e-18	1.36017556424433	0.844	0.326	1.21906389301842e-13	TSC22D3	B cells	GSE207422_Tor_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67910
7.74818656273272e-18	-1.38433807513156	0.27	0.767	1.74086255691479e-13	XAF1	B cells	GSE207422_Tor_post	ENSG00000132530	54739	XIAP associated factor 1	BIRC4BP|HSXIAPAF1|XIAPAF1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67911
4.68403654292349e-17	0.884217948618859	1	0.977	1.05240933046405e-12	MT-ND3	B cells	GSE207422_Tor_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67912
5.0428546473307e-17	0.755702009508839	1	1	1.13302858216226e-12	TPT1	B cells	GSE207422_Tor_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67913
5.61295889120412e-17	-0.856778191286228	0.071	0.57	1.26111960367574e-12	GBP2	B cells	GSE207422_Tor_post	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67914
3.41755374783891e-16	1.39007724007114	0.816	0.337	7.67855976064446e-12	ZFP36L2	B cells	GSE207422_Tor_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67915
4.15032268613514e-16	-1.1018194622223	0.823	0.988	9.32494501120842e-12	ACTG1	B cells	GSE207422_Tor_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67916
5.85133472153768e-16	0.96382914144199	0.965	0.895	1.31467788523509e-11	MT-ATP8	B cells	GSE207422_Tor_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67917
6.24372533508529e-16	0.735674404439758	1	1	1.40284020828696e-11	RPS6	B cells	GSE207422_Tor_post	ENSG00000137154	6194	ribosomal protein S6	S6	protein_coding	P62753	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67918
1.34827908725385e-15	-1.05103139804683	0.468	0.849	3.02931345324194e-11	GAPDH	B cells	GSE207422_Tor_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67919
2.20052480201646e-15	-0.910323444756249	0.426	0.895	4.94413912517059e-11	CAPZB	B cells	GSE207422_Tor_post	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67920
2.78245907630726e-15	-1.48525864169081	0.128	0.605	6.25162905264714e-11	IGHA2	B cells	GSE207422_Tor_post	ENSG00000276173	NA	NA	NA	IG_C_gene	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67921
3.26991894618451e-15	-0.713286597696696	0.057	0.523	7.34685388828736e-11	ITGAX	B cells	GSE207422_Tor_post	ENSG00000140678	3687	integrin subunit alpha X	CD11C	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67922
4.38820890878504e-15	-1.01258700473893	0.645	0.942	9.85942777625823e-11	SH3BGRL3	B cells	GSE207422_Tor_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67923
9.2760389034722e-15	-0.866238520535294	0.043	0.477	2.08414042083213e-10	KCTD12	B cells	GSE207422_Tor_post	ENSG00000178695	115207	potassium channel tetramerization domain containing 12	C13orf2|KIAA1778|PFET1	protein_coding	Q96CX2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67924
2.05555811934904e-14	1.43049598894339	0.851	0.419	4.61842798255343e-10	CD69	B cells	GSE207422_Tor_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67925
2.5293925015628e-14	-0.959137991857133	0.199	0.674	5.6830390725113e-10	CAPG	B cells	GSE207422_Tor_post	ENSG00000042493	822	capping actin protein, gelsolin like	AFCP|MCP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67926
3.71823812606798e-14	-0.83680113418205	0.199	0.686	8.35413742164955e-10	EPSTI1	B cells	GSE207422_Tor_post	ENSG00000133106	94240	epithelial stromal interaction 1	BRESI1|MGC29634	protein_coding	Q96J88	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67927
3.94281672851832e-14	-0.900913600872467	0.319	0.802	8.85872062563497e-10	TAP1	B cells	GSE207422_Tor_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67928
4.11190004479846e-14	-0.844180664547647	0.199	0.674	9.23861702065318e-10	FCGR2B	B cells	GSE207422_Tor_post	ENSG00000072694	2213	Fc gamma receptor IIb	CD32|CD32B|FCG2|FcgammaRIIb|FCGR2|FcGRIIB	protein_coding	P31994	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67929
4.25400216669594e-14	0.735716194339863	0.993	0.988	9.55789206813244e-10	RPL32	B cells	GSE207422_Tor_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67930
4.38636918894157e-14	-0.937311211809216	0.922	0.988	9.85529429371392e-10	CFL1	B cells	GSE207422_Tor_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67931
8.9225024916397e-14	-0.741300973866292	0.071	0.5	2.00470785982161e-09	GBP5	B cells	GSE207422_Tor_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67932
1.29598020550807e-13	-0.962030345980096	0.248	0.698	2.91180832573552e-09	S100A11	B cells	GSE207422_Tor_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67933
1.47963997495253e-13	-0.862149983611178	0.156	0.64	3.32445509572334e-09	FCRL5	B cells	GSE207422_Tor_post	ENSG00000143297	83416	Fc receptor like 5	BXMAS1|CD307e|FCRH5|IRTA2	protein_coding	Q96RD9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67934
1.55193627700023e-13	-0.748052015857372	0.121	0.581	3.48689042716411e-09	GBP1	B cells	GSE207422_Tor_post	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67935
1.6744629025879e-13	-0.695364689699433	0.106	0.558	3.76218324953449e-09	STAMBPL1	B cells	GSE207422_Tor_post	ENSG00000138134	57559	STAM binding protein like 1	ALMalpha|AMSH-FP|AMSH-LP|bA399O19.2|FLJ31524|KIAA1373	protein_coding	Q96FJ0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67936
3.11816457209007e-13	1.01044868661699	0.957	0.744	7.00589216057198e-09	ZFP36L1	B cells	GSE207422_Tor_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67937
4.08635264765665e-13	-0.620774458907158	0.043	0.453	9.18121712875496e-09	FCRL4	B cells	GSE207422_Tor_post	ENSG00000163518	83417	Fc receptor like 4	CD307d|FCRH4|IGFP2|IRTA1	protein_coding	Q96PJ5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67938
4.28615427989918e-13	-0.815337869166393	0.241	0.709	9.63013143607747e-09	LPXN	B cells	GSE207422_Tor_post	ENSG00000110031	9404	leupaxin	LDPL	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67939
4.44614417462851e-13	0.962971737044011	0.901	0.593	9.98959673155533e-09	BTG2	B cells	GSE207422_Tor_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67940
4.94712790505294e-13	0.604445580396188	1	1	1.11152069770729e-08	MT-ND2	B cells	GSE207422_Tor_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67941
5.04272658134705e-13	0.772379303969227	1	0.953	1.13299980829705e-08	RPLP2	B cells	GSE207422_Tor_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67942
5.23706628516658e-13	-0.686150467759182	0.121	0.558	1.17666405295123e-08	RFTN1	B cells	GSE207422_Tor_post	ENSG00000131378	23180	raftlin, lipid raft linker 1	FLJ23866|KIAA0084|MIG2|Raftlin	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67943
5.63289587708757e-13	-0.859851492900729	0.816	0.965	1.26559904566404e-08	RAC2	B cells	GSE207422_Tor_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67944
6.9708982482606e-13	0.630667803520665	1	1	1.56622141841919e-08	RPS8	B cells	GSE207422_Tor_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67945
7.54755617151286e-13	-0.95163412467902	0.156	0.57	1.69578492061551e-08	GM2A	B cells	GSE207422_Tor_post	ENSG00000196743	2760	ganglioside GM2 activator	GM2-AP|GM2AP|SAP-3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67946
7.58290299614163e-13	-0.657825898487804	0.957	1	1.7037266451731e-08	HLA-DPA1	B cells	GSE207422_Tor_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67947
7.60117361621927e-13	-1.48779049275185	0.475	0.814	1.70783168809215e-08	HSPA1A	B cells	GSE207422_Tor_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67948
7.74186087117444e-13	-0.849423285682725	0.262	0.709	1.73944130053547e-08	VOPP1	B cells	GSE207422_Tor_post	ENSG00000154978	81552	VOPP1 WW domain binding protein	DKFZp564K0822|ECop|FLJ20532|GASP|WBP1L2	protein_coding	Q96AW1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67949
8.12093237371534e-13	-0.859265903513976	0.794	0.942	1.82461108572636e-08	ARPC2	B cells	GSE207422_Tor_post	ENSG00000163466	10109	actin related protein 2/3 complex subunit 2	ARC34|p34-Arc	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67950
1.24080420211825e-12	1.18637242868075	0.794	0.337	2.78783888131928e-08	KLF2	B cells	GSE207422_Tor_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67951
1.5949184423818e-12	-0.824747028185239	0.44	0.849	3.58346275634344e-08	ARPC5	B cells	GSE207422_Tor_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67952
1.76911371216264e-12	-0.567435731233241	0.092	0.512	3.97484468848703e-08	UBE2L6	B cells	GSE207422_Tor_post	ENSG00000156587	9246	ubiquitin conjugating enzyme E2 L6	UBCH8	protein_coding	O14933	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67953
3.21531536809831e-12	-0.411630897835594	0.035	0.407	7.22417056904328e-08	MT2A	B cells	GSE207422_Tor_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67954
3.40958610029248e-12	-0.616425058444107	0.071	0.465	7.66065805013714e-08	APOL6	B cells	GSE207422_Tor_post	ENSG00000221963	80830	apolipoprotein L6	APOL-VI|APOLVI	protein_coding	Q9BWW8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67955
3.55690294993957e-12	-0.670002499967896	0.255	0.744	7.99164954792422e-08	PEA15	B cells	GSE207422_Tor_post	ENSG00000162734	8682	proliferation and apoptosis adaptor protein 15	HMAT1|HUMMAT1H|MAT1|MAT1H|PEA-15|PED|PED-PEA15|PED/PEA15	protein_coding	Q15121	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67956
3.64335656977994e-12	-0.686814386335505	0.113	0.535	8.18589354098157e-08	ENTPD1	B cells	GSE207422_Tor_post	ENSG00000138185	953	ectonucleoside triphosphate diphosphohydrolase 1	ATPDase|CD39|NTPDase-1|SPG64	protein_coding	P49961	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67957
3.90798949413165e-12	1.06325350401036	0.83	0.453	8.78047079541499e-08	DUSP1	B cells	GSE207422_Tor_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67958
4.53336330162733e-12	-0.905931675639092	0.078	0.477	1.01855606660963e-07	IFI6	B cells	GSE207422_Tor_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67959
4.63517216232652e-12	-0.74119259426658	0.482	0.872	1.04143048143152e-07	MOB1A	B cells	GSE207422_Tor_post	ENSG00000114978	55233	MOB kinase activator 1A	C2orf6|FLJ10788|FLJ11595|Mats1|MOB1|Mob4B|MOBK1B|MOBKL1B	protein_coding	Q9H8S9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67960
6.31408282850254e-12	-0.594642101198077	0.078	0.465	1.41864812990795e-07	CTSC	B cells	GSE207422_Tor_post	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67961
7.11130071122528e-12	-0.936693929409779	0.312	0.709	1.5977670437981e-07	PTPN1	B cells	GSE207422_Tor_post	ENSG00000196396	5770	protein tyrosine phosphatase non-receptor type 1	PTP1B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67962
8.35003034809137e-12	-0.71946517262582	0.418	0.826	1.87608481860917e-07	CD19	B cells	GSE207422_Tor_post	ENSG00000177455	930	CD19 molecule	NA	protein_coding	P15391	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67963
1.01806962517272e-11	0.779311884875801	0.411	0	2.28739883383807e-07	XIST	B cells	GSE207422_Tor_post	ENSG00000229807	7503	X inactive specific transcript	DXS1089|DXS399E|LINC00001|NCRNA00001|swd66	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67964
1.0188704394315e-11	-0.850287527802499	0.475	0.849	2.28919810331469e-07	CTSH	B cells	GSE207422_Tor_post	ENSG00000103811	1512	cathepsin H	ACC-4|ACC-5|ACC4|ACC5|CPSB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67965
1.0737602145435e-11	-0.855305602569123	0.901	0.988	2.41252445003634e-07	PFN1	B cells	GSE207422_Tor_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67966
1.19112090265913e-11	-0.568556910912732	1	1	2.67621044409453e-07	HLA-A	B cells	GSE207422_Tor_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67967
1.26148984679932e-11	-0.661135315645589	0.149	0.57	2.8343153877887e-07	PARP9	B cells	GSE207422_Tor_post	ENSG00000138496	83666	poly(ADP-ribose) polymerase family member 9	ARTD9|BAL|BAL1	protein_coding	Q8IXQ6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67968
1.56737486804826e-11	-0.767881572969609	0.709	0.953	3.52157785353084e-07	ACTR2	B cells	GSE207422_Tor_post	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67969
1.68250630381255e-11	-0.522062194453927	0.028	0.36	3.78025516340603e-07	MTHFD2	B cells	GSE207422_Tor_post	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67970
1.7946720892679e-11	-0.701043001941949	0.723	0.942	4.03226925016713e-07	ATP5F1E	B cells	GSE207422_Tor_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67971
2.35388736584476e-11	1.03112197965507	0.943	0.802	5.28871413358001e-07	JUNB	B cells	GSE207422_Tor_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67972
2.60368550454662e-11	-0.774111790392739	0.333	0.733	5.84996059161534e-07	SPIB	B cells	GSE207422_Tor_post	ENSG00000269404	6689	Spi-B transcription factor	SPI-B	protein_coding	Q01892	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67973
4.11989540280401e-11	0.890912121887378	0.922	0.791	9.25658099102004e-07	JUND	B cells	GSE207422_Tor_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67974
4.15353697587872e-11	-0.779375788154468	0.277	0.674	9.33216687740431e-07	TPI1	B cells	GSE207422_Tor_post	ENSG00000111669	7167	triosephosphate isomerase 1	NA	protein_coding	P60174	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67975
4.19887350399227e-11	0.564725339739444	1	1	9.43402898876984e-07	EEF1A1	B cells	GSE207422_Tor_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67976
5.73948568042493e-11	-0.398905311862681	0.014	0.314	1.28954764267787e-06	EIF1AY	B cells	GSE207422_Tor_post	ENSG00000198692	9086	eukaryotic translation initiation factor 1A Y-linked	NA	protein_coding	O14602	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67977
6.19599665739644e-11	-0.706802564126497	0.34	0.791	1.39211652898383e-06	SYK	B cells	GSE207422_Tor_post	ENSG00000165025	6850	spleen associated tyrosine kinase	NA	protein_coding	P43405	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67978
6.38535118102419e-11	1.03364338268785	0.518	0.093	1.43466070335251e-06	NR4A2	B cells	GSE207422_Tor_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67979
7.7813156041038e-11	-0.761582154737477	0.454	0.802	1.74830598993004e-06	FCRLA	B cells	GSE207422_Tor_post	ENSG00000132185	84824	Fc receptor like A	FCRL|FCRLb|FCRLc1|FCRLc2|FCRLd|FCRLe|FCRLM1|FCRLX|FREB|MGC4595	protein_coding	Q7L513	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67980
8.12322621394756e-11	-0.949484818558174	0.291	0.709	1.82512646574974e-06	GRN	B cells	GSE207422_Tor_post	ENSG00000030582	2896	granulin precursor	CLN11|PCDGF|PGRN	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67981
1.58943352232834e-10	-0.823109875649447	0.603	0.93	3.57113923796732e-06	POU2F2	B cells	GSE207422_Tor_post	ENSG00000028277	5452	POU class 2 homeobox 2	OCT2|OTF2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67982
1.59808001193467e-10	-0.705018981713095	0.163	0.558	3.59056617081483e-06	CD86	B cells	GSE207422_Tor_post	ENSG00000114013	942	CD86 molecule	B7-2|B7.2|CD28LG2	protein_coding	P42081	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67983
1.70873104363671e-10	0.864371102401227	0.929	0.826	3.83917690884297e-06	BTG1	B cells	GSE207422_Tor_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67984
2.79444004039991e-10	-0.541659301023383	0.986	0.988	6.27854788277051e-06	HLA-DRB1	B cells	GSE207422_Tor_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67985
3.34040340060144e-10	-0.719981250270704	0.355	0.733	7.50521836047132e-06	TPM4	B cells	GSE207422_Tor_post	ENSG00000167460	7171	tropomyosin 4	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67986
3.35546260267149e-10	-0.661756297056614	0.411	0.802	7.5390533756823e-06	GDI2	B cells	GSE207422_Tor_post	ENSG00000057608	2665	GDP dissociation inhibitor 2	RABGDIB	protein_coding	P50395	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67987
4.16278392335019e-10	-0.635284085695422	0.156	0.547	9.35294291898321e-06	CMTM7	B cells	GSE207422_Tor_post	ENSG00000153551	112616	CKLF like MARVEL transmembrane domain containing 7	CKLFSF7|FLJ30992	protein_coding	Q96FZ5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67988
4.7127586952808e-10	-0.62125745920435	0.199	0.593	1.05886262365569e-05	TAP2	B cells	GSE207422_Tor_post	ENSG00000232326	6891	transporter 2, ATP binding cassette subfamily B member	ABCB3|D6S217E|PSF2|RING11	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67989
5.92591889695695e-10	1.19003738289163	0.674	0.291	1.33143545776829e-05	NR4A1	B cells	GSE207422_Tor_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67990
6.27399482398495e-10	-0.474881858371617	0.064	0.395	1.40964115705294e-05	COX5A	B cells	GSE207422_Tor_post	ENSG00000178741	9377	cytochrome c oxidase subunit 5A	NA	protein_coding	P20674	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67991
6.43846152850614e-10	-0.487726897281565	0.071	0.407	1.44659353622476e-05	PSME2	B cells	GSE207422_Tor_post	ENSG00000284889	5721	proteasome activator subunit 2	PA28beta	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67992
7.77314562384713e-10	-0.821269278569707	0.227	0.616	1.74647035876597e-05	SAMD9L	B cells	GSE207422_Tor_post	ENSG00000177409	219285	sterile alpha motif domain containing 9 like	C7orf6|FLJ39885|KIAA2005	protein_coding	Q8IVG5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67993
8.59941960561627e-10	-0.57665190567485	0.142	0.512	1.93211759698986e-05	LGALS9	B cells	GSE207422_Tor_post	ENSG00000168961	3965	galectin 9	LGALS9A	protein_coding	O00182	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67994
9.84982994292377e-10	-0.673097507580997	0.22	0.605	2.21305979157611e-05	SEMA4D	B cells	GSE207422_Tor_post	ENSG00000187764	10507	semaphorin 4D	C9orf164|CD100|coll-4|FLJ39737|SEMAJ	protein_coding	Q92854	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67995
1.23523457580042e-09	-0.574011809094568	0.149	0.512	2.77532504490837e-05	OAS2	B cells	GSE207422_Tor_post	ENSG00000111335	4939	2'-5'-oligoadenylate synthetase 2	NA	protein_coding	P29728	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67996
1.32539375254744e-09	-0.447042635387012	1	1	2.97789468322359e-05	HLA-DRA	B cells	GSE207422_Tor_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67997
1.49274658017335e-09	-0.88523928048599	0.624	0.826	3.35390301633349e-05	LSP1	B cells	GSE207422_Tor_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67998
1.54982854748039e-09	-0.492316251429446	0.142	0.523	3.48215478047894e-05	CASP4	B cells	GSE207422_Tor_post	ENSG00000196954	837	caspase 4	ICE(rel)II|ICH-2|TX	protein_coding	P49662	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	67999
2.06099391156622e-09	-0.426004645616225	0.021	0.291	4.63064112050699e-05	PFKP	B cells	GSE207422_Tor_post	ENSG00000067057	5214	phosphofructokinase, platelet	PFK-C|PFKF	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68000
2.17427521981744e-09	-0.440666143033703	0.05	0.36	4.88516156388582e-05	RPS4Y1	B cells	GSE207422_Tor_post	ENSG00000129824	6192	ribosomal protein S4 Y-linked 1	MGC119100|MGC5070|RPS4Y|S4	protein_coding	P22090	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68001
2.49246764641081e-09	0.789213742832488	0.78	0.558	5.60007630795581e-05	MTND1P23	B cells	GSE207422_Tor_post	ENSG00000225972	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68002
2.60753037363652e-09	-0.569377186297982	0.085	0.419	5.85859924348654e-05	SLAMF1	B cells	GSE207422_Tor_post	ENSG00000117090	6504	signaling lymphocytic activation molecule family member 1	CD150|SLAM	protein_coding	Q13291	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68003
2.60926067134818e-09	-0.497826890522133	0.149	0.535	5.86248687638509e-05	VAMP8	B cells	GSE207422_Tor_post	ENSG00000118640	8673	vesicle associated membrane protein 8	EDB|VAMP-8	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68004
2.66982344387608e-09	-0.403742227265166	0.021	0.291	5.99855931370077e-05	DDX3Y	B cells	GSE207422_Tor_post	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68005
2.97307837407299e-09	-0.787633939156777	0.326	0.674	6.67991249086719e-05	SUB1	B cells	GSE207422_Tor_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68006
3.19854487523551e-09	0.674525267536108	1	1	7.18649062567913e-05	MALAT1	B cells	GSE207422_Tor_post	ENSG00000251562	378938	metastasis associated lung adenocarcinoma transcript 1	HCN|LINC00047|MALAT-1|mascRNA|NCRNA00047|NEAT2|PRO1073	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68007
3.23818894546811e-09	-0.403742227265166	0.028	0.302	7.27556292267776e-05	SNORD3A	B cells	GSE207422_Tor_post	ENSG00000263934	NA	NA	RNU3|U3	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68008
3.27131766696835e-09	0.942836931945699	0.794	0.523	7.34999653414449e-05	KLF6	B cells	GSE207422_Tor_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68009
3.79320535008533e-09	-0.634116384263088	0.255	0.663	8.52257378057172e-05	PLEK	B cells	GSE207422_Tor_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68010
3.80877431391121e-09	-0.501782492502984	0.078	0.395	8.55755412849571e-05	STAT2	B cells	GSE207422_Tor_post	ENSG00000170581	6773	signal transducer and activator of transcription 2	STAT113	protein_coding	P52630	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68011
4.20001606503169e-09	-0.490894176360248	0.085	0.407	9.4365960949132e-05	COX8A	B cells	GSE207422_Tor_post	ENSG00000176340	1351	cytochrome c oxidase subunit 8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	protein_coding	P10176	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68012
4.22715101725634e-09	-0.538788866464559	0.121	0.453	9.49756290557155e-05	WDR1	B cells	GSE207422_Tor_post	ENSG00000071127	9948	WD repeat domain 1	AIP1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68013
4.47024941636983e-09	0.599500843334198	0.475	0.105	0.000100437563886997	RPL13P12	B cells	GSE207422_Tor_post	ENSG00000215030	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68014
6.2476707693835e-09	-0.50306889030635	0.191	0.57	0.000140372666846509	PTPN18	B cells	GSE207422_Tor_post	ENSG00000072135	26469	protein tyrosine phosphatase non-receptor type 18	BDP1	protein_coding	Q99952	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68015
6.57297616159814e-09	0.788462534775479	0.56	0.163	0.000147681628398787	CD83	B cells	GSE207422_Tor_post	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68016
8.03488521424957e-09	0.578338737027141	0.993	0.977	0.000180527800993759	RPS16	B cells	GSE207422_Tor_post	ENSG00000105193	6217	ribosomal protein S16	S16	protein_coding	P62249	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68017
8.79139984819396e-09	-0.422771455440795	0.106	0.442	0.000197525171789222	PSMB3	B cells	GSE207422_Tor_post	ENSG00000275903	5691	proteasome 20S subunit beta 3	HC10-II|MGC4147	protein_coding	P49720	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68018
9.00646059476128e-09	-0.890164359780775	0.128	0.442	0.000202357156643096	HSPB1	B cells	GSE207422_Tor_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68019
9.57113078792233e-09	-0.679734037985669	0.177	0.523	0.000215044166543039	BHLHE40	B cells	GSE207422_Tor_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68020
1.01662109558674e-08	-0.412284341663881	0.057	0.36	0.000228414427756428	TRIM69	B cells	GSE207422_Tor_post	ENSG00000278211	140691	tripartite motif containing 69	RNF36|Trif|TRIMLESS	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68021
1.02036588267534e-08	-0.588590850247381	0.582	0.907	0.000229255806519494	TMSB10	B cells	GSE207422_Tor_post	ENSG00000034510	9168	thymosin beta 10	TB10	protein_coding	P63313	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68022
1.19417923501938e-08	-0.726342750522142	0.716	0.919	0.000268308190524154	LCP1	B cells	GSE207422_Tor_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68023
1.32427638860795e-08	-0.4954814458559	0.092	0.407	0.000297538418992433	IRF7	B cells	GSE207422_Tor_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68024
1.58785225734618e-08	-0.718659769795547	0.475	0.814	0.000356758645180539	CALM2	B cells	GSE207422_Tor_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68025
1.7823838492447e-08	-0.68258980047378	0.213	0.593	0.0004004660032483	SEMA7A	B cells	GSE207422_Tor_post	ENSG00000288455	8482	semaphorin 7A (John Milton Hagen blood group)	CD108|H-Sema-L|SEMAL	protein_coding	O75326	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68026
2.22048062651935e-08	-0.638324540015474	0.426	0.779	0.000498897587166368	WSB1	B cells	GSE207422_Tor_post	ENSG00000109046	26118	WD repeat and SOCS box containing 1	DKFZp564A122|DKFZp564B0482|SWIP1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68027
2.26928563116323e-08	-0.556185636611967	0.44	0.802	0.000509863095609754	TLN1	B cells	GSE207422_Tor_post	ENSG00000137076	7094	talin 1	ILWEQ|TLN	protein_coding	Q9Y490	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68028
2.32732046374068e-08	-0.473152593972981	0.05	0.326	0.000522902361793257	FUT8	B cells	GSE207422_Tor_post	ENSG00000033170	2530	fucosyltransferase 8	NA	protein_coding	Q9BYC5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68029
2.41315902874457e-08	-0.464259049856781	0.156	0.488	0.00054218857057833	PSMB2	B cells	GSE207422_Tor_post	ENSG00000126067	5690	proteasome 20S subunit beta 2	HC7-I	protein_coding	P49721	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68030
2.46196654577894e-08	-0.425846879194624	0.078	0.384	0.000553154643505612	PAK1	B cells	GSE207422_Tor_post	ENSG00000149269	5058	p21 (RAC1) activated kinase 1	NA	protein_coding	Q13153	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68031
2.60083125688411e-08	-0.45918531663291	0.092	0.407	0.000584354766796721	FAM129A	B cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68032
3.36358776280811e-08	-0.393596975005333	0.121	0.453	0.000755730898547727	PPP1CA	B cells	GSE207422_Tor_post	ENSG00000172531	5499	protein phosphatase 1 catalytic subunit alpha	PP-1A|PP1A|PP1alpha|PPP1A	protein_coding	P62136	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68033
3.48837921665796e-08	-0.477798518748565	0.156	0.488	0.000783769042398711	PSMB8	B cells	GSE207422_Tor_post	ENSG00000230669	5696	proteasome 20S subunit beta 8	beta5i|D6S216E|LMP7|PSMB5i|RING10	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68034
4.11410775449578e-08	-0.554383002345635	0.071	0.36	0.000924357730280111	TNF	B cells	GSE207422_Tor_post	ENSG00000228978	7124	tumor necrosis factor	DIF|TNF-alpha|TNFA|TNFSF2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68035
4.29009270501258e-08	-0.620720478960623	0.206	0.547	0.000963898028962226	WDFY1	B cells	GSE207422_Tor_post	ENSG00000085449	57590	WD repeat and FYVE domain containing 1	FENS-1|KIAA1435|WDF1|ZFYVE17	protein_coding	Q8IWB7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68036
4.3147649361778e-08	-0.622684048915789	0.411	0.744	0.000969441385860428	PKM	B cells	GSE207422_Tor_post	ENSG00000067225	5315	pyruvate kinase M1/2	OIP3|PK3|PKM2|THBP1	protein_coding	P14618	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68037
4.49443231535478e-08	-0.384222321527705	0.064	0.349	0.00100980905261391	LIMK1	B cells	GSE207422_Tor_post	ENSG00000106683	3984	LIM domain kinase 1	LIMK	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68038
4.55357227575845e-08	-0.549787865413816	0.156	0.477	0.00102309661891741	PLD4	B cells	GSE207422_Tor_post	ENSG00000166428	122618	phospholipase D family member 4	C14orf175	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68039
4.94431537563177e-08	-0.634629653821697	0.433	0.756	0.00111088877859695	COTL1	B cells	GSE207422_Tor_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68040
5.29138741448896e-08	-0.506100588982337	0.972	0.988	0.00118886892428738	HLA-DPB1	B cells	GSE207422_Tor_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68041
5.55939155638021e-08	-0.48196105159024	0.106	0.419	0.00124908409488751	EIF2AK2	B cells	GSE207422_Tor_post	ENSG00000055332	5610	eukaryotic translation initiation factor 2 alpha kinase 2	PKR|PPP1R83|PRKR	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68042
5.56720405522501e-08	-0.37419795165115	0.043	0.302	0.00125083940712795	CASP1	B cells	GSE207422_Tor_post	ENSG00000137752	834	caspase 1	ICE|IL1BC	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68043
6.07596358950455e-08	-0.448314387621409	0.05	0.314	0.00136514749928988	CCR5	B cells	GSE207422_Tor_post	ENSG00000160791	1234	C-C motif chemokine receptor 5	CC-CKR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22	protein_coding	P51681	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68044
6.15935129025217e-08	-0.4598382406921	0.191	0.558	0.00138388304789386	REEP5	B cells	GSE207422_Tor_post	ENSG00000129625	7905	receptor accessory protein 5	C5orf18|D5S346|DP1|POB16|TB2|Yip2e	protein_coding	Q00765	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68045
6.23495110546173e-08	-0.450252191862902	0.043	0.302	0.00140086881437514	ISG15	B cells	GSE207422_Tor_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68046
6.36537920440393e-08	0.49928274115411	1	0.977	0.00143017339964547	MT-CYB	B cells	GSE207422_Tor_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68047
6.47389427842581e-08	0.614288060331809	0.943	0.93	0.00145455456647671	RPS5	B cells	GSE207422_Tor_post	ENSG00000083845	6193	ribosomal protein S5	S5	protein_coding	P46782	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68048
6.55198556355411e-08	-0.454199376379565	0.028	0.267	0.00147210011641934	IFIT3	B cells	GSE207422_Tor_post	ENSG00000119917	3437	interferon induced protein with tetratricopeptide repeats 3	CIG-49|GARG-49|IFI60|IFIT4|IRG2|ISG60|RIG-G	protein_coding	O14879	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68049
6.68416549502101e-08	-0.528546717839646	0.326	0.698	0.00150179830342132	SP140	B cells	GSE207422_Tor_post	ENSG00000079263	11262	SP140 nuclear body protein	LYSP100-A|LYSP100-B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68050
6.94129769629718e-08	-0.429143165268804	0.17	0.523	0.00155957076640405	TOP1	B cells	GSE207422_Tor_post	ENSG00000198900	7150	DNA topoisomerase I	NA	protein_coding	P11387	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68051
7.00424245246185e-08	-0.442928851057043	0.092	0.395	0.00157371319421913	SMC4	B cells	GSE207422_Tor_post	ENSG00000113810	10051	structural maintenance of chromosomes 4	CAP-C|hCAP-C|SMC4L1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68052
7.64667437673175e-08	-0.495106427647162	0.149	0.488	0.00171805479896409	ATP5MC3	B cells	GSE207422_Tor_post	ENSG00000154518	518	ATP synthase membrane subunit c locus 3	ATP5G3	protein_coding	P48201	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68053
9.09327540013198e-08	-0.54058451158381	0.248	0.593	0.00204307711690165	RAB31	B cells	GSE207422_Tor_post	ENSG00000168461	11031	RAB31, member RAS oncogene family	Rab22B	protein_coding	Q13636	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68054
9.14301313340623e-08	0.634636705723611	0.319	0.023	0.00205425219081371	TENT5C	B cells	GSE207422_Tor_post	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68055
9.31588632217853e-08	-0.644682783697672	0.567	0.872	0.00209309333886707	BASP1	B cells	GSE207422_Tor_post	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68056
1.00000381428238e-07	-0.36969962167956	0.057	0.326	0.00224680856992966	ACSL4	B cells	GSE207422_Tor_post	ENSG00000068366	2182	acyl-CoA synthetase long chain family member 4	ACS4|FACL4|LACS4|MRX63|MRX68	protein_coding	O60488	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68057
1.02382800975649e-07	-0.400696367388669	0.085	0.372	0.00230033677232088	PGAM1	B cells	GSE207422_Tor_post	ENSG00000171314	5223	phosphoglycerate mutase 1	PGAM-B|PGAMA	protein_coding	P18669	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68058
1.07708720739906e-07	-0.424781504346783	0.113	0.419	0.00241999953758421	CLTA	B cells	GSE207422_Tor_post	ENSG00000122705	1211	clathrin light chain A	Lca	protein_coding	P09496	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68059
1.0978661248422e-07	-0.600075987248705	0.333	0.663	0.00246668560929545	SUMO2	B cells	GSE207422_Tor_post	ENSG00000188612	6613	small ubiquitin like modifier 2	SMT3B|SMT3H2	protein_coding	P61956	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68060
1.25553209673392e-07	-0.402246818952069	0.135	0.453	0.00282092951494177	ADAM8	B cells	GSE207422_Tor_post	ENSG00000151651	101	ADAM metallopeptidase domain 8	CD156|CD156A|MS2	protein_coding	P78325	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68061
1.4767111992538e-07	0.545583090522495	0.986	0.872	0.00331787472248344	RPL5	B cells	GSE207422_Tor_post	ENSG00000122406	6125	ribosomal protein L5	L5|PPP1R135|uL18	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68062
1.49511062860739e-07	-0.429893104228323	0.078	0.36	0.00335921456035509	CAMK2D	B cells	GSE207422_Tor_post	ENSG00000145349	817	calcium/calmodulin dependent protein kinase II delta	CAMKD	protein_coding	Q13557	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68063
1.50311457704632e-07	-0.460071252893347	0.319	0.674	0.00337719783170766	ARPC4	B cells	GSE207422_Tor_post	ENSG00000241553	10093	actin related protein 2/3 complex subunit 4	ARC20|p20-Arc	protein_coding	P59998	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68064
1.63508916920354e-07	-0.493841460410585	0.128	0.43	0.00367371834536652	LY6E	B cells	GSE207422_Tor_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68065
1.68055964026115e-07	0.494140943493615	0.986	0.977	0.00377588139973875	RPL37A	B cells	GSE207422_Tor_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68066
1.73251423122654e-07	-0.582325919813533	0.433	0.744	0.0038926129747198	ATP6V0E1	B cells	GSE207422_Tor_post	ENSG00000113732	8992	ATPase H+ transporting V0 subunit e1	ATP6H|ATP6V0E|M9.2	protein_coding	O15342	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68067
1.73532531209875e-07	0.535885154755353	0.922	0.837	0.00389892891122347	RPL26	B cells	GSE207422_Tor_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68068
1.73949424656538e-07	-0.634431176985456	0.248	0.558	0.00390829567318309	PREX1	B cells	GSE207422_Tor_post	ENSG00000124126	57580	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1	KIAA1415|P-REX1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68069
1.77669107317169e-07	-0.352099072362106	0.05	0.302	0.00399186950320216	DPYSL2	B cells	GSE207422_Tor_post	ENSG00000092964	1808	dihydropyrimidinase like 2	CRMP2|DHPRP2|DRP-2|DRP2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68070
1.79853954890256e-07	-0.473711164686891	0.213	0.547	0.00404095865847427	TCF3	B cells	GSE207422_Tor_post	ENSG00000071564	6929	transcription factor 3	bHLHb21|E2A|E47|ITF1|MGC129647|MGC129648|p75|VDIR	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68071
1.84764884354174e-07	0.529798218792853	0.922	0.895	0.00415129742166958	RPL23A	B cells	GSE207422_Tor_post	ENSG00000198242	6147	ribosomal protein L23a	L23A	protein_coding	P62750	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68072
2.10207189843679e-07	-0.423779980501711	0.085	0.36	0.00472293514140777	ATP8A1	B cells	GSE207422_Tor_post	ENSG00000124406	10396	ATPase phospholipid transporting 8A1	ATPIA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68073
2.19523334466399e-07	-0.35635205298142	0.035	0.267	0.00493225027879104	U62317.4	B cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68074
2.3752706903322e-07	0.678695665354482	0.858	0.814	0.00533675818703838	HLA-DQB1	B cells	GSE207422_Tor_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68075
2.54552379842327e-07	-0.531612637575303	0.461	0.814	0.00571928287029741	SEPT7	B cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68076
2.57331574387002e-07	-0.559663408583484	0.248	0.581	0.00578172581332715	SMC6	B cells	GSE207422_Tor_post	ENSG00000163029	79677	structural maintenance of chromosomes 6	FLJ22116|SMC6L1	protein_coding	Q96SB8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68077
2.68704901053053e-07	-0.324012194482934	0.028	0.256	0.00603726171686	FAS	B cells	GSE207422_Tor_post	ENSG00000026103	355	Fas cell surface death receptor	APO-1|APT1|CD95|FAS1|TNFRSF6	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68078
2.87699758462974e-07	0.831918193786726	0.844	0.628	0.00646403817314609	ZFP36	B cells	GSE207422_Tor_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68079
2.985987762835e-07	-0.459530005450913	0.234	0.593	0.00670891730553769	HSH2D	B cells	GSE207422_Tor_post	ENSG00000196684	84941	hematopoietic SH2 domain containing	ALX|FLJ14886|HSH2	protein_coding	Q96JZ2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68080
3.13997167649318e-07	-0.308030119210437	0.035	0.267	0.00705488836274487	LSM2	B cells	GSE207422_Tor_post	ENSG00000236826	57819	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated	C6orf28|G7b|YBL026W	protein_coding	Q9Y333	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68081
3.31682952367166e-07	-0.50306889030635	0.454	0.744	0.00745225257378548	ARPC3	B cells	GSE207422_Tor_post	ENSG00000111229	10094	actin related protein 2/3 complex subunit 3	ARC21|p21-Arc	protein_coding	O15145	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68082
3.39651729285361e-07	-0.513977789473289	0.092	0.36	0.0076312950535835	CSTB	B cells	GSE207422_Tor_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68083
4.76565381243475e-07	0.517245168449769	0.482	0.163	0.0107074709857784	RPL10P3	B cells	GSE207422_Tor_post	ENSG00000230734	NA	NA	bA567J2.2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68084
4.82494214249423e-07	-0.319266879686935	0.106	0.395	0.010840680005756	DRAP1	B cells	GSE207422_Tor_post	ENSG00000175550	10589	DR1 associated protein 1	NC2-alpha	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68085
4.9614015887309e-07	-0.461747830700731	0.312	0.698	0.0111472770895606	PARP14	B cells	GSE207422_Tor_post	ENSG00000173193	54625	poly(ADP-ribose) polymerase family member 14	ARTD8|BAL2|KIAA1268|pART8	protein_coding	Q460N5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68086
5.17380917664037e-07	-0.527190305583238	0.113	0.384	0.0116245144580756	PPA1	B cells	GSE207422_Tor_post	ENSG00000180817	5464	inorganic pyrophosphatase 1	IOPPP|PP|PP1|Ppase|SID6-8061	protein_coding	Q15181	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68087
5.36202694469418e-07	-0.496475208623548	0.376	0.709	0.0120474021393389	PLCG2	B cells	GSE207422_Tor_post	ENSG00000197943	5336	phospholipase C gamma 2	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68088
5.3848820700519e-07	0.477445514165347	0.993	1	0.0120987530349926	RPL30	B cells	GSE207422_Tor_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68089
6.0348190450643e-07	-0.341838366965534	0.113	0.407	0.0135590314304505	BST2	B cells	GSE207422_Tor_post	ENSG00000130303	684	bone marrow stromal cell antigen 2	BST-2|CD317|HM1.24|tetherin	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68090
6.54089332708881e-07	-0.366728836300618	0.234	0.593	0.0146960791273031	EFHD2	B cells	GSE207422_Tor_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68091
6.81000336147266e-07	-0.49811850312816	0.17	0.453	0.0153007155525568	RBCK1	B cells	GSE207422_Tor_post	ENSG00000125826	10616	RANBP2-type and C3HC4-type zinc finger containing 1	C20orf18|HOIL1|RBCK2|RNF54|UBCE7IP3|XAP4|ZRANB4	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68092
6.90650000988142e-07	-0.448583371502283	0.17	0.488	0.0155175242222016	PRDX5	B cells	GSE207422_Tor_post	ENSG00000126432	25824	peroxiredoxin 5	ACR1|AOEB166|B166|MGC117264|MGC142283|MGC142285|PLP|PMP20|PRDX6|PRXV|SBBI10	protein_coding	P30044	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68093
6.94616379456931e-07	-0.483804751573929	0.312	0.651	0.0156066408136383	RHOH	B cells	GSE207422_Tor_post	ENSG00000168421	399	ras homolog family member H	ARHH|TTF	protein_coding	Q15669	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68094
6.97388073781649e-07	0.578740011476805	0.759	0.5	0.0156689152417261	PNRC1	B cells	GSE207422_Tor_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68095
7.15688314524877e-07	-0.548899779795814	0.248	0.57	0.0160800850507449	CTSB	B cells	GSE207422_Tor_post	ENSG00000285132	1508	cathepsin B	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68096
7.36449366475521e-07	-0.307771872536358	0.035	0.256	0.016546544365972	HCK	B cells	GSE207422_Tor_post	ENSG00000101336	3055	HCK proto-oncogene, Src family tyrosine kinase	JTK9	protein_coding	P08631	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68097
7.50387495751621e-07	-0.333793215275519	0.035	0.256	0.0168597062545474	LMNB1	B cells	GSE207422_Tor_post	ENSG00000113368	4001	lamin B1	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68098
8.49643161706948e-07	-0.495533071163768	0.34	0.663	0.0190897825572317	ARHGAP9	B cells	GSE207422_Tor_post	ENSG00000123329	64333	Rho GTPase activating protein 9	10C|MGC1295	protein_coding	Q9BRR9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68099
8.50911247097673e-07	-0.460071252893347	0.305	0.616	0.0191182738997905	SH3BP5	B cells	GSE207422_Tor_post	ENSG00000131370	9467	SH3 domain binding protein 5	Sab	protein_coding	O60239	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68100
9.18646488302468e-07	0.458290029616775	0.986	1	0.0206401492991799	RPS27A	B cells	GSE207422_Tor_post	ENSG00000143947	6233	ribosomal protein S27a	S27A|Uba80|UBCEP80	protein_coding	P62979	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68101
9.25087198244122e-07	0.405909866539179	1	1	0.0207848591701489	RPS29	B cells	GSE207422_Tor_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68102
9.98467816696077e-07	0.529887385776255	0.922	0.907	0.0224335749055275	EIF1	B cells	GSE207422_Tor_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68103
1.03051990515732e-06	-0.654173504028472	0.745	0.872	0.0231537212290747	HSPA1B	B cells	GSE207422_Tor_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68104
1.03831654419977e-06	-0.43317867850396	0.078	0.326	0.0233288961150804	ADGRG5	B cells	GSE207422_Tor_post	ENSG00000159618	221188	adhesion G protein-coupled receptor G5	GPR114|PGR27	protein_coding	Q8IZF4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68105
1.06893874162718e-06	-0.396096421815996	0.078	0.326	0.0240169156468794	SH3BP1	B cells	GSE207422_Tor_post	ENSG00000100092	23616	SH3 domain binding protein 1	ARHGAP43	protein_coding	Q9Y3L3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68106
1.08973593496794e-06	-0.42761438818317	0.149	0.442	0.0244841869868596	CALM3	B cells	GSE207422_Tor_post	ENSG00000160014	808	calmodulin 3	PHKD|PHKD3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68107
1.09869877795527e-06	-0.423779980501711	0.142	0.43	0.024685564143099	CIAO2A	B cells	GSE207422_Tor_post	ENSG00000166797	84191	cytosolic iron-sulfur assembly component 2A	CIA2A|FAM96A|FLJ22875	protein_coding	Q9H5X1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68108
1.10900030832158e-06	-0.413726315837788	0.348	0.674	0.0249170189273692	CBX3	B cells	GSE207422_Tor_post	ENSG00000122565	11335	chromobox 3	HP1Hs-gamma	protein_coding	Q13185	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68109
1.25443022436711e-06	-0.360176847561054	0.078	0.326	0.0281845382810803	SOCS1	B cells	GSE207422_Tor_post	ENSG00000185338	8651	suppressor of cytokine signaling 1	Cish1|JAB|SOCS-1|SSI-1|TIP3	protein_coding	O15524	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68110
1.2887394532833e-06	-0.427665506795661	0.333	0.663	0.0289553980363692	CD81	B cells	GSE207422_Tor_post	ENSG00000110651	975	CD81 molecule	TAPA-1|TAPA1|TSPAN28	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68111
1.30655565435958e-06	-0.360176847561054	0.071	0.314	0.0293556924421509	CXXC1	B cells	GSE207422_Tor_post	ENSG00000154832	30827	CXXC finger protein 1	CFP1|CGBP|hCGBP|HsT2645|PCCX1|PHF18|SPP1|ZCGPC1	protein_coding	Q9P0U4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68112
1.3203837173905e-06	-0.472278498192901	0.078	0.326	0.0296663813623297	CTSD	B cells	GSE207422_Tor_post	ENSG00000117984	1509	cathepsin D	CLN10|CPSD	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68113
1.33596532947905e-06	-0.412284341663881	0.057	0.291	0.0300164690227354	IGHG2	B cells	GSE207422_Tor_post	ENSG00000274497	NA	NA	NA	IG_C_gene	P01859	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68114
1.47749986415924e-06	-0.64701337827753	0.461	0.733	0.0331964669479299	KIAA1551	B cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68115
1.48793534130939e-06	-0.488220042061922	0.652	0.895	0.0334309312485394	TPM3	B cells	GSE207422_Tor_post	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68116
1.49041938208929e-06	-0.372249679861629	0.064	0.302	0.0334867426767822	VSIR	B cells	GSE207422_Tor_post	ENSG00000107738	64115	V-set immunoregulatory receptor	B7-H5|B7H5|C10orf54|Dies1|GI24|PD-1H|SISP1|VISTA	protein_coding	Q9H7M9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68117
1.6436526931711e-06	-0.377237394564681	0.078	0.326	0.0369295887101682	ELOF1	B cells	GSE207422_Tor_post	ENSG00000130165	84337	elongation factor 1	ELF1|MGC4549	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68118
1.70800019344103e-06	-0.558840328323317	0.738	0.884	0.0383753483462332	ARHGDIB	B cells	GSE207422_Tor_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68119
1.73270939693855e-06	-0.448458910039851	0.085	0.337	0.0389305147304154	TFEC	B cells	GSE207422_Tor_post	ENSG00000105967	22797	transcription factor EC	bHLHe34|TCFEC|TFECL	protein_coding	O14948	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68120
1.73528684271063e-06	-0.330342728127705	0.106	0.384	0.0389884247820224	IL18BP	B cells	GSE207422_Tor_post	ENSG00000137496	10068	interleukin 18 binding protein	IL18BPa	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68121
1.75890124542609e-06	-0.536408835612617	0.454	0.744	0.0395189931822334	CD82	B cells	GSE207422_Tor_post	ENSG00000085117	3732	CD82 molecule	IA4|KAI1|R2|ST6|TSPAN27	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68122
1.77387052670466e-06	-0.423779980501711	0.255	0.57	0.0398553229940002	SH3BGRL	B cells	GSE207422_Tor_post	ENSG00000131171	6451	SH3 domain binding glutamate rich protein like	MGC117402	protein_coding	O75368	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68123
1.859957995657e-06	-0.44566492236725	0.213	0.523	0.0417895362464214	PDIA6	B cells	GSE207422_Tor_post	ENSG00000143870	10130	protein disulfide isomerase family A member 6	ERp5|P5|TXNDC7	protein_coding	Q15084	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68124
1.96301848948082e-06	-0.452021284715958	0.099	0.36	0.0441050994216552	GADD45B	B cells	GSE207422_Tor_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68125
1.97196552928918e-06	-0.486694187830962	0.177	0.453	0.0443061215120694	HHEX	B cells	GSE207422_Tor_post	ENSG00000152804	3087	hematopoietically expressed homeobox	HEX|HOX11L-PEN|PRHX	protein_coding	Q03014	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68126
1.97461183972726e-06	0.489733655696244	0.979	0.93	0.044365578814992	RPL21	B cells	GSE207422_Tor_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68127
2.012842785139e-06	-0.326263474587448	0.071	0.314	0.0452245516965029	NEDD8	B cells	GSE207422_Tor_post	ENSG00000285246	4738	NEDD8 ubiquitin like modifier	Nedd-8	protein_coding	Q15843	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68128
2.02454941771957e-06	0.642475092266542	0.816	0.616	0.0454875763173234	EEF1B2	B cells	GSE207422_Tor_post	ENSG00000283391	1933	eukaryotic translation elongation factor 1 beta 2	NA	protein_coding	P24534	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68129
2.10928287048914e-06	-0.421823783536385	0.113	0.384	0.04739136753415	HCST	B cells	GSE207422_Tor_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68130
5.10544184787895e-47	0.990051742541901	0.995	0.964	1.14709067438144e-42	MT-ND3	Plasma cells	GSE207422_Tor_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68131
5.70899799866649e-45	1.17303477037605	0.624	0.171	1.28269767034039e-40	TSC22D3	Plasma cells	GSE207422_Tor_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68132
3.21655378310703e-44	1.75519286128473	0.57	0.136	7.22695303988487e-40	KLF6	Plasma cells	GSE207422_Tor_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68133
7.2658363427668e-35	0.976353310691342	0.296	0.029	1.63248810949284e-30	ATF3	Plasma cells	GSE207422_Tor_post	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68134
6.10693630903761e-34	1.68094476267108	0.753	0.395	1.37210644991457e-29	FOSB	Plasma cells	GSE207422_Tor_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68135
1.40597785919575e-27	0.97163679308649	0.796	0.467	3.15895105404102e-23	UBC	Plasma cells	GSE207422_Tor_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68136
1.57756832977418e-27	0.654557518526883	0.941	0.791	3.54448052333663e-23	PSAP	Plasma cells	GSE207422_Tor_post	ENSG00000197746	5660	prosaposin	GLBA|SAP1|SAP2	protein_coding	P07602	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68137
2.30478069960037e-26	-0.526824261400293	1	1	5.17838127586211e-22	SSR4	Plasma cells	GSE207422_Tor_post	ENSG00000180879	6748	signal sequence receptor subunit 4	TRAPD	protein_coding	P51571	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68138
1.14658431879892e-25	0.766268339257277	0.435	0.116	2.57614564747742e-21	CDKN1A	Plasma cells	GSE207422_Tor_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68139
4.84779613013074e-25	0.592094126626359	0.72	0.36	1.08920283451777e-20	RPS26	Plasma cells	GSE207422_Tor_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68140
5.3279540807625e-25	0.998231024400564	0.903	0.757	1.19708472286572e-20	JUND	Plasma cells	GSE207422_Tor_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68141
1.45508026668714e-24	1.05053862542569	0.823	0.502	3.26927434319266e-20	IGHG3	Plasma cells	GSE207422_Tor_post	ENSG00000282184	NA	NA	NA	IG_C_gene	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68142
1.65118932889834e-24	-1.99053579867445	0.28	0.691	3.70989218416879e-20	IGHA1	Plasma cells	GSE207422_Tor_post	ENSG00000282633	NA	NA	AL928768.3	IG_C_gene	P01876	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68143
7.12464067560755e-24	1.33701528647956	0.801	0.438	1.6007642669955e-19	IGHGP	Plasma cells	GSE207422_Tor_post	ENSG00000282094	NA	NA	IGHGP1	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68144
2.86046004479982e-22	1.15021545108272	0.785	0.472	6.42688162865623e-18	IGHG4	Plasma cells	GSE207422_Tor_post	ENSG00000277016	NA	NA	NA	IG_C_gene	P01861	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68145
1.676756284877e-20	1.08032650783485	0.468	0.18	3.76733602086165e-16	DUSP5	Plasma cells	GSE207422_Tor_post	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68146
4.00762653503318e-20	-0.553133838488981	0.747	0.893	9.00433529891255e-16	MTATP6P1	Plasma cells	GSE207422_Tor_post	ENSG00000248527	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68147
8.27586942781422e-20	-0.60038566012976	0.075	0.435	1.8594223430413e-15	SNORD3A	Plasma cells	GSE207422_Tor_post	ENSG00000263934	NA	NA	RNU3|U3	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68148
1.66812860023496e-19	-1.88793011114649	0.231	0.601	3.7479513390079e-15	IGHA2	Plasma cells	GSE207422_Tor_post	ENSG00000276173	NA	NA	NA	IG_C_gene	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68149
4.37409838914271e-17	-0.838451531347124	0.688	0.946	9.82772426072584e-13	JCHAIN	Plasma cells	GSE207422_Tor_post	ENSG00000132465	3512	joining chain of multimeric IgA and IgM	IGCJ|IGJ|JCH	protein_coding	P01591	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68150
5.22208461424159e-17	0.733535054060625	0.715	0.439	1.1732979711278e-12	VIM	Plasma cells	GSE207422_Tor_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68151
1.01481129617635e-16	1.19566069487048	0.457	0.206	2.28007802024902e-12	NR4A1	Plasma cells	GSE207422_Tor_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68152
1.45406206515341e-16	1.02344644383311	0.796	0.492	3.26698664798669e-12	IGHG1	Plasma cells	GSE207422_Tor_post	ENSG00000277633	NA	NA	NA	IG_C_gene	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68153
1.46781414371364e-16	-0.61096605400653	0.753	0.886	3.2978848180958e-12	CALR	Plasma cells	GSE207422_Tor_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68154
1.54132258471687e-16	1.09990797973342	0.602	0.345	3.46304358334186e-12	NFKBIA	Plasma cells	GSE207422_Tor_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68155
2.82961209688235e-15	-0.346204857814697	0.984	0.987	6.35757245927527e-11	MT-CO2	Plasma cells	GSE207422_Tor_post	ENSG00000198712	4513	cytochrome c oxidase subunit II	CO2|COX2|MTCO2	protein_coding	P00403	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68156
4.84402995931661e-15	0.683308848954105	0.769	0.526	1.08835665125925e-10	NEAT1	Plasma cells	GSE207422_Tor_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68157
1.08143235069212e-14	0.323062735166759	0.253	0.064	2.42976220553506e-10	RASSF6	Plasma cells	GSE207422_Tor_post	ENSG00000169435	166824	Ras association domain family member 6	NA	protein_coding	Q6ZTQ3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68158
2.34022612870838e-13	-0.337333561228427	0.989	0.985	5.25802006598198e-09	MT-CO1	Plasma cells	GSE207422_Tor_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68159
1.50856070696544e-12	0.524903597562231	0.608	0.37	3.38943419640996e-08	TP53INP1	Plasma cells	GSE207422_Tor_post	ENSG00000164938	94241	tumor protein p53 inducible nuclear protein 1	DKFZp434M1317|FLJ22139|P53DINP1|SIP|Teap|TP53INP1A|TP53INP1B	protein_coding	Q96A56	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68160
1.95799003553514e-12	0.414345869281325	0.624	0.392	4.39921201184035e-08	MTND1P23	Plasma cells	GSE207422_Tor_post	ENSG00000225972	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68161
3.60427207732177e-12	0.369333889096989	0.312	0.116	8.09807850332655e-08	MYADM	Plasma cells	GSE207422_Tor_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68162
1.43296144501426e-11	-0.458936612613951	0.522	0.738	3.21957777465804e-07	RRBP1	Plasma cells	GSE207422_Tor_post	ENSG00000125844	6238	ribosome binding protein 1	ES/130|hES|p180	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68163
3.04653443373103e-11	0.579402488426544	0.527	0.316	6.84495356570688e-07	TRIB1	Plasma cells	GSE207422_Tor_post	ENSG00000173334	10221	tribbles pseudokinase 1	C8FW|GIG2|TRB1	protein_coding	Q96RU8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68164
4.73744886145881e-11	-0.429809249908808	0.527	0.743	1.06441001019257e-06	MANF	Plasma cells	GSE207422_Tor_post	ENSG00000145050	7873	mesencephalic astrocyte derived neurotrophic factor	ARMET|ARP	protein_coding	P55145	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68165
6.4030957388952e-11	0.329142369283465	0.909	0.797	1.43864755061497e-06	EIF1	Plasma cells	GSE207422_Tor_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68166
6.82804539672612e-11	0.405110981988832	0.559	0.325	1.53412523973642e-06	PECAM1	Plasma cells	GSE207422_Tor_post	ENSG00000261371	5175	platelet and endothelial cell adhesion molecule 1	CD31	protein_coding	P16284	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68167
6.82932413019986e-11	0.791330132663316	0.866	0.796	1.5344125455733e-06	JUN	Plasma cells	GSE207422_Tor_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68168
1.28270499643914e-10	0.499224551849076	0.538	0.319	2.88198158599946e-06	RAB30	Plasma cells	GSE207422_Tor_post	ENSG00000137502	27314	RAB30, member RAS oncogene family	NA	protein_coding	Q15771	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68169
2.84656023199624e-10	0.655079647677705	0.355	0.161	6.39565152924916e-06	CXCR4	Plasma cells	GSE207422_Tor_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68170
3.08726585995014e-10	-0.405639561046435	0.392	0.628	6.93646893413598e-06	PDIA4	Plasma cells	GSE207422_Tor_post	ENSG00000155660	9601	protein disulfide isomerase family A member 4	ERP70|ERP72	protein_coding	P13667	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68171
5.61352370569731e-10	0.27670934273087	0.258	0.094	1.26124650619607e-05	LY9	Plasma cells	GSE207422_Tor_post	ENSG00000122224	4063	lymphocyte antigen 9	CD229|hly9|mLY9|SLAMF3	protein_coding	Q9HBG7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68172
6.45345079913182e-10	1.6532988616001	0.64	0.536	1.44996132554894e-05	HSP90AA1	Plasma cells	GSE207422_Tor_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68173
1.25910525585181e-09	0.42957013105399	0.677	0.487	2.82895768884784e-05	SDC1	Plasma cells	GSE207422_Tor_post	ENSG00000115884	6382	syndecan 1	CD138|SDC|SYND1|syndecan	protein_coding	P18827	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68174
1.49661917768245e-09	0.64451539915811	0.516	0.313	3.36260396841693e-05	PPP1R15A	Plasma cells	GSE207422_Tor_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68175
1.69352951895439e-09	0.538472894856068	0.43	0.23	3.80502212318672e-05	ZFP36L2	Plasma cells	GSE207422_Tor_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68176
1.75954125202891e-09	0.424675822634175	0.339	0.157	3.95333728505856e-05	ODC1	Plasma cells	GSE207422_Tor_post	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68177
2.35534758186296e-09	-0.328582419992336	0.145	0.37	5.29199494692969e-05	NT5DC2	Plasma cells	GSE207422_Tor_post	ENSG00000168268	64943	5'-nucleotidase domain containing 2	FLJ12442	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68178
2.60817209123059e-09	0.524764923554253	0.258	0.099	5.86004105457689e-05	BIRC3	Plasma cells	GSE207422_Tor_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68179
2.73285937750094e-09	0.42773144179767	0.978	0.935	6.14018844936912e-05	HLA-B	Plasma cells	GSE207422_Tor_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68180
2.90762653421661e-09	0.404909661658126	0.409	0.209	6.53285529707788e-05	H1FX	Plasma cells	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68181
5.89291379769849e-09	-0.318686884261115	0.984	0.982	0.00013240198720669	MT-CO3	Plasma cells	GSE207422_Tor_post	ENSG00000198938	4514	cytochrome c oxidase subunit III	CO3|COIII|COX3|MTCO3	protein_coding	P00414	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68182
7.99561879278219e-09	0.643641144145754	0.484	0.301	0.00017964556303623	DUSP1	Plasma cells	GSE207422_Tor_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68183
1.4028579605532e-08	0.473215032923867	0.323	0.157	0.000315194126577094	YPEL5	Plasma cells	GSE207422_Tor_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68184
1.56639854746507e-08	-0.377106911220603	0.957	0.984	0.000351938425644453	MZB1	Plasma cells	GSE207422_Tor_post	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68185
2.46612687878829e-08	-0.470404477910845	0.989	0.997	0.000554089387126153	HSP90B1	Plasma cells	GSE207422_Tor_post	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68186
2.56152632047733e-08	-0.364406774687169	0.091	0.287	0.000575523733684847	GADD45B	Plasma cells	GSE207422_Tor_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68187
4.97819591177188e-08	-0.394512507113218	0.118	0.322	0.00111850105745691	FAM30A	Plasma cells	GSE207422_Tor_post	ENSG00000277059	9834	family with sequence similarity 30 member A	C14orf110|HSPC053|KIAA0125	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68188
8.49079978659846e-08	-0.385727755043853	0.317	0.506	0.00190771289605294	RAC2	Plasma cells	GSE207422_Tor_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68189
8.86600886279439e-08	-0.326141722210246	0.812	0.916	0.00199201487129264	SSR3	Plasma cells	GSE207422_Tor_post	ENSG00000114850	6747	signal sequence receptor subunit 3	TRAPG	protein_coding	Q9UNL2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68190
1.19161720110566e-07	-0.332682082828615	0.231	0.439	0.00267732552744419	GAPDH	Plasma cells	GSE207422_Tor_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68191
1.27881079294153e-07	0.549911048140249	0.392	0.219	0.00287323208958103	RGCC	Plasma cells	GSE207422_Tor_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68192
2.60878550622052e-07	0.599405462902952	0.403	0.24	0.00586141927537628	TXNIP	Plasma cells	GSE207422_Tor_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68193
2.80585911971978e-07	0.356674218518547	0.984	0.994	0.0063042042701864	MT-RNR2	Plasma cells	GSE207422_Tor_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68194
2.9727088959086e-07	-0.261341122743588	0.253	0.475	0.00667908234732745	SEC31A	Plasma cells	GSE207422_Tor_post	ENSG00000138674	22872	SEC31 homolog A, COPII coat complex component	ABP125|ABP130|KIAA0905|SEC31L1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68195
3.50113792679434e-07	0.275022739495754	0.613	0.42	0.00786635669392153	RPL24	Plasma cells	GSE207422_Tor_post	ENSG00000114391	6152	ribosomal protein L24	L24	protein_coding	P83731	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68196
3.56862791892954e-07	-0.288525339739843	1	1	0.00801799320825088	HLA-C	Plasma cells	GSE207422_Tor_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68197
4.92417508764589e-07	-0.514009030827442	0.86	0.953	0.0110636365869228	CD79A	Plasma cells	GSE207422_Tor_post	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68198
5.25441937254367e-07	0.44989104385644	0.737	0.56	0.0118056294462311	JUNB	Plasma cells	GSE207422_Tor_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68199
5.99288832510351e-07	-0.288203604966878	0.172	0.369	0.0134648214888426	CHST2	Plasma cells	GSE207422_Tor_post	ENSG00000175040	9435	carbohydrate sulfotransferase 2	C6ST	protein_coding	Q9Y4C5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68200
9.86189788775914e-07	-0.551362727412599	0.651	0.389	0.0221577121742172	IGHG2	Plasma cells	GSE207422_Tor_post	ENSG00000274497	NA	NA	NA	IG_C_gene	P01859	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68201
1.43228130477929e-06	0.350453793068652	0.414	0.243	0.0321804963557812	GPM6A	Plasma cells	GSE207422_Tor_post	ENSG00000150625	2823	glycoprotein M6A	GPM6	protein_coding	P51674	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68202
1.50686258322138e-06	0.452620682087	0.941	0.881	0.0338561885198179	BTG2	Plasma cells	GSE207422_Tor_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68203
1.56323275806847e-06	0.274417727999876	0.892	0.721	0.0351227136082824	RPL30	Plasma cells	GSE207422_Tor_post	ENSG00000156482	6156	ribosomal protein L30	L30	protein_coding	P62888	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68204
1.85744770133251e-06	-0.315485676692869	0.516	0.664	0.0417331349535389	SSR2	Plasma cells	GSE207422_Tor_post	ENSG00000163479	6746	signal sequence receptor subunit 2	TLAP|TRAPB	protein_coding	P43308	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68205
2.10645924763569e-06	-0.299281131922085	0.817	0.873	0.0473279263758786	HSPA5	Plasma cells	GSE207422_Tor_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68206
5.0752006366931e-76	-1.33692384207432	0.934	0.97	1.14029607905221e-71	TXNIP	Neutrophils	GSE207422_Tor_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68207
1.37641844536763e-70	1.3075585825852	0.943	0.761	3.092536963052e-66	G0S2	Neutrophils	GSE207422_Tor_post	ENSG00000123689	50486	G0/G1 switch 2	NA	protein_coding	P27469	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68208
7.49683879203963e-60	-0.936089137526484	0.054	0.43	1.68438973979546e-55	FKBP5	Neutrophils	GSE207422_Tor_post	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68209
7.09607520931905e-56	1.13772033605728	0.915	0.631	1.5943461780298e-51	BTG2	Neutrophils	GSE207422_Tor_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68210
1.20513465671489e-50	-0.925806539913681	0.603	0.87	2.70769654670702e-46	CLEC4E	Neutrophils	GSE207422_Tor_post	ENSG00000166523	26253	C-type lectin domain family 4 member E	CLECSF9|MINCLE	protein_coding	Q9ULY5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68211
1.97172219358393e-50	1.07722809455846	0.988	0.89	4.43006542454437e-46	ZFP36	Neutrophils	GSE207422_Tor_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68212
5.29031932115236e-50	-1.19063300009147	0.381	0.728	1.18862894507651e-45	MEGF9	Neutrophils	GSE207422_Tor_post	ENSG00000106780	1955	multiple EGF like domains 9	EGFL5	protein_coding	Q9H1U4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68213
4.37846741013321e-46	0.909414560007565	0.962	0.815	9.83754057708729e-42	SOD2	Neutrophils	GSE207422_Tor_post	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68214
1.42646653101528e-43	-0.881644823845644	0.385	0.732	3.20498500188513e-39	SLA	Neutrophils	GSE207422_Tor_post	ENSG00000155926	6503	Src like adaptor	hSLAP|SLA1|SLAP|SLAP-1	protein_coding	Q13239	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68215
2.71056703437329e-38	-0.915179064201619	0.083	0.373	6.0901020128299e-34	TOB1	Neutrophils	GSE207422_Tor_post	ENSG00000141232	10140	transducer of ERBB2, 1	APRO5|TOB|TROB|TROB1	protein_coding	P50616	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68216
2.17343557771436e-34	-0.684236303192444	0.225	0.564	4.88327505600862e-30	IRS2	Neutrophils	GSE207422_Tor_post	ENSG00000185950	8660	insulin receptor substrate 2	NA	protein_coding	Q9Y4H2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68217
5.37084892333018e-33	0.866337979658016	0.752	0.501	1.20672233609382e-28	IER2	Neutrophils	GSE207422_Tor_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68218
5.50202991083507e-33	1.47618126663622	0.675	0.385	1.23619608036642e-28	CXCL8	Neutrophils	GSE207422_Tor_post	ENSG00000169429	3576	C-X-C motif chemokine ligand 8	3-10C|AMCF-I|b-ENAP|GCP-1|GCP1|IL-8|IL8|K60|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1|SCYB8|TSG-1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68219
8.50387235923243e-33	0.804598112007868	0.906	0.797	1.91065004167234e-28	IFITM3	Neutrophils	GSE207422_Tor_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68220
2.82098993884066e-31	-0.666909050763949	0.672	0.858	6.3382001945872e-27	EVI2B	Neutrophils	GSE207422_Tor_post	ENSG00000185862	2124	ecotropic viral integration site 2B	CD361|D17S376|EVDB	protein_coding	P34910	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68221
5.85569775720013e-31	0.794158370757835	0.943	0.862	1.31565817208772e-26	SAT1	Neutrophils	GSE207422_Tor_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68222
7.65234114939646e-31	-0.484518166445536	0.057	0.298	1.7193280094464e-26	MTND2P28	Neutrophils	GSE207422_Tor_post	ENSG00000225630	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68223
1.65076639904156e-30	1.0938303312105	0.34	0.073	3.70894194536659e-26	HLA-DQB1	Neutrophils	GSE207422_Tor_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68224
2.05411636719141e-30	0.540641631392832	0.993	0.976	4.61518865380565e-26	JUNB	Neutrophils	GSE207422_Tor_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68225
2.19023838143369e-30	2.80122912558703	0.371	0.101	4.92102759540521e-26	CCL4L2	Neutrophils	GSE207422_Tor_post	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68226
1.33488793452462e-29	-0.832945975738335	0.195	0.487	2.99922621128991e-25	HMGB2	Neutrophils	GSE207422_Tor_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68227
1.51645409392897e-29	0.765864861481637	0.469	0.168	3.40716905823962e-25	HCAR2	Neutrophils	GSE207422_Tor_post	ENSG00000182782	338442	hydroxycarboxylic acid receptor 2	GPR109A|HCA2|HM74A|NIACR1|Puma-g|PUMAG	protein_coding	Q8TDS4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68228
4.04290499699302e-29	-0.813402055877316	0.327	0.631	9.08359894724391e-25	IL1R2	Neutrophils	GSE207422_Tor_post	ENSG00000115590	7850	interleukin 1 receptor type 2	CD121b|IL1RB	protein_coding	P27930	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68229
9.60855546193465e-29	-0.92676725854353	0.922	0.943	2.15885024118748e-24	S100A8	Neutrophils	GSE207422_Tor_post	ENSG00000143546	6279	S100 calcium binding protein A8	60B8AG|CAGA|CFAG|CGLA|MRP-8|MRP8|P8|S100-A8	protein_coding	P05109	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68230
1.48475200595542e-28	-0.741156436078813	0.445	0.736	3.33594080698064e-24	KIAA1551	Neutrophils	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68231
1.44465935350905e-27	1.03478415965801	0.527	0.237	3.24586063546414e-23	IER3	Neutrophils	GSE207422_Tor_post	ENSG00000235030	8870	immediate early response 3	DIF-2|IEX-1|IEX-1L|PRG1	protein_coding	P46695	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68232
3.25432794944931e-27	0.823799351298279	0.833	0.679	7.31182403682272e-23	ZFP36L1	Neutrophils	GSE207422_Tor_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68233
6.20796685267196e-27	0.784097271651558	0.381	0.108	1.39480599245834e-22	OSM	Neutrophils	GSE207422_Tor_post	ENSG00000099985	5008	oncostatin M	MGC20461	protein_coding	P13725	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68234
4.0590007760817e-26	0.841495431463292	0.755	0.562	9.11976294370035e-22	IRF1	Neutrophils	GSE207422_Tor_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68235
1.73083257474317e-25	0.438415746761184	0.999	0.998	3.88883462893295e-21	FTH1	Neutrophils	GSE207422_Tor_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68236
2.27243327204421e-25	0.838994786005609	0.702	0.487	5.10570307562894e-21	TNFAIP2	Neutrophils	GSE207422_Tor_post	ENSG00000185215	7127	TNF alpha induced protein 2	B94|EXOC3L3	protein_coding	Q03169	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68237
4.59823970400054e-25	-0.669192121356816	0.609	0.791	1.03313249669484e-20	RIPOR2	Neutrophils	GSE207422_Tor_post	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68238
1.42812617422718e-24	1.1521962709274	0.485	0.235	3.20871388825364e-20	FOSB	Neutrophils	GSE207422_Tor_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68239
2.07888943811757e-24	0.279449407342367	1	1	4.67084878956255e-20	B2M	Neutrophils	GSE207422_Tor_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68240
3.43355859463564e-24	0.649230584599867	0.358	0.101	7.71451945042736e-20	ICAM1	Neutrophils	GSE207422_Tor_post	ENSG00000090339	3383	intercellular adhesion molecule 1	BB2|CD54	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68241
4.61828950540741e-24	-0.453900756395512	0.078	0.294	1.03763728607494e-19	SLC40A1	Neutrophils	GSE207422_Tor_post	ENSG00000138449	30061	solute carrier family 40 member 1	FPN1|HFE4|IREG1|MTP1|SLC11A3	protein_coding	Q9NP59	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68242
5.22631368320211e-24	-0.355203171475575	0.091	0.316	1.17424815834185e-19	PADI4	Neutrophils	GSE207422_Tor_post	ENSG00000280908	23569	peptidyl arginine deiminase 4	PAD|PADI5|PDI4|PDI5	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68243
5.57479182377557e-24	-0.590928922071078	0.318	0.59	1.2525442269659e-19	TKT	Neutrophils	GSE207422_Tor_post	ENSG00000163931	7086	transketolase	NA	protein_coding	P29401	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68244
1.02213830998812e-23	-0.628598302548551	0.551	0.769	2.29654035488131e-19	RTN3	Neutrophils	GSE207422_Tor_post	ENSG00000133318	10313	reticulon 3	ASYIP|HAP|NSPL2|NSPLII|RTN3-A1	protein_coding	O95197	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68245
1.17576594621691e-23	-0.57518366795033	0.591	0.791	2.64171092796016e-19	CAP1	Neutrophils	GSE207422_Tor_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68246
2.31854487364336e-23	-0.546451771800049	0.29	0.562	5.20930662210191e-19	PHC2	Neutrophils	GSE207422_Tor_post	ENSG00000134686	1912	polyhomeotic homolog 2	EDR2|HPH2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68247
5.8348648851739e-23	-0.570315221237908	0.238	0.483	1.31097744240087e-18	CDA	Neutrophils	GSE207422_Tor_post	ENSG00000158825	978	cytidine deaminase	CDD	protein_coding	P32320	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68248
8.92313739778108e-23	-0.567484108104042	0.201	0.456	2.00485051053345e-18	RYBP	Neutrophils	GSE207422_Tor_post	ENSG00000281766	23429	RING1 and YY1 binding protein	AAP1|DEDAF|YEAF1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68249
9.6666705316015e-23	-0.373861298417244	1	1	2.17190753504022e-18	MT-RNR2	Neutrophils	GSE207422_Tor_post	ENSG00000210082	NA	NA	16S|HN|MTRNR2	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68250
9.70901794146302e-23	-0.780300434349945	0.331	0.566	2.18142215108791e-18	USP10	Neutrophils	GSE207422_Tor_post	ENSG00000103194	9100	ubiquitin specific peptidase 10	KIAA0190|UBPO	protein_coding	Q14694	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68251
3.19906822913055e-22	-0.579137262065466	0.295	0.556	7.18766649721053e-18	LBR	Neutrophils	GSE207422_Tor_post	ENSG00000143815	3930	lamin B receptor	DHCR14B|TDRD18	protein_coding	Q14739	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68252
3.21320680371943e-22	-0.406093365513382	0.073	0.27	7.21943304659683e-18	SULT1A1	Neutrophils	GSE207422_Tor_post	ENSG00000196502	6817	sulfotransferase family 1A member 1	P-PST|STP|STP1	protein_coding	P50225	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68253
4.5874554637876e-22	0.700836784816122	0.552	0.314	1.0307094936038e-17	RNF19B	Neutrophils	GSE207422_Tor_post	ENSG00000116514	127544	ring finger protein 19B	FLJ90005|IBRDC3|NKLAM	protein_coding	Q6ZMZ0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68254
4.92808869558935e-21	-0.768577949325403	0.183	0.404	1.10724296812501e-16	S100A12	Neutrophils	GSE207422_Tor_post	ENSG00000163221	6283	S100 calcium binding protein A12	CAAF1|CAGC|CGRP|ENRAGE|MRP6|p6	protein_coding	P80511	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68255
6.71123317597413e-21	-0.600250926441053	0.935	0.964	1.50787986997787e-16	S100A9	Neutrophils	GSE207422_Tor_post	ENSG00000163220	6280	S100 calcium binding protein A9	60B8AG|CAGB|CFAG|CGLB|LIAG|MAC387|MIF|MRP-14|MRP14|NIF|P14|S100-A9	protein_coding	P06702	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68256
1.04440380262318e-20	-0.534552151838957	0.327	0.59	2.34656646373375e-16	STK17B	Neutrophils	GSE207422_Tor_post	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68257
1.13102309897522e-20	-0.704629705167169	0.358	0.594	2.54118269877753e-16	MME	Neutrophils	GSE207422_Tor_post	ENSG00000196549	4311	membrane metalloendopeptidase	CALLA|CD10|NEP	protein_coding	P08473	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68258
1.82522196591913e-20	1.12975672836973	0.903	0.742	4.10090871302711e-16	CD74	Neutrophils	GSE207422_Tor_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68259
3.4942632322827e-20	0.839661537740946	0.78	0.621	7.85091063029277e-16	PLEK	Neutrophils	GSE207422_Tor_post	ENSG00000115956	5341	pleckstrin	P47|PLEK1	protein_coding	P08567	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68260
9.00085352432519e-20	-0.466838935233736	0.125	0.335	2.02231176984538e-15	TUBA4A	Neutrophils	GSE207422_Tor_post	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68261
1.29527439060293e-19	-0.661642846304182	0.487	0.682	2.91022250080666e-15	VNN2	Neutrophils	GSE207422_Tor_post	ENSG00000112303	8875	vanin 2	FOAP-4|GPI-80	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68262
1.79563432649656e-19	0.896924413190519	0.465	0.225	4.03443120477246e-15	GBP1	Neutrophils	GSE207422_Tor_post	ENSG00000117228	2633	guanylate binding protein 1	NA	protein_coding	P32455	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68263
2.39835185300899e-19	-0.567004139147078	0.155	0.365	5.38861694334059e-15	FCN1	Neutrophils	GSE207422_Tor_post	ENSG00000085265	2219	ficolin 1	FCNM	protein_coding	O00602	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68264
3.10489037670104e-19	-0.616506826759673	0.482	0.708	6.9760676983719e-15	CEBPD	Neutrophils	GSE207422_Tor_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68265
6.29792892091629e-19	0.669178183757762	0.589	0.375	1.41501866995147e-14	PPP1R15A	Neutrophils	GSE207422_Tor_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68266
6.33311286932029e-19	0.474933468424922	0.91	0.824	1.42292379947888e-14	SERPINA1	Neutrophils	GSE207422_Tor_post	ENSG00000277377	5265	serpin family A member 1	A1A|A1AT|AAT|alpha-1-antitrypsin|alpha1AT|PI|PI1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68267
9.43518713167781e-19	0.559683168744901	0.343	0.124	2.11989784474537e-14	PDE4B	Neutrophils	GSE207422_Tor_post	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68268
4.03724777665952e-18	0.520968426633878	0.675	0.503	9.0708883045986e-14	HCK	Neutrophils	GSE207422_Tor_post	ENSG00000101336	3055	HCK proto-oncogene, Src family tyrosine kinase	JTK9	protein_coding	P08631	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68269
5.40975729544862e-18	0.891367405468059	0.486	0.262	1.21546426914139e-13	GBP5	Neutrophils	GSE207422_Tor_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68270
1.00526698694915e-17	-0.528596131238452	0.465	0.677	2.25863386627735e-13	LRRK2	Neutrophils	GSE207422_Tor_post	ENSG00000188906	120892	leucine rich repeat kinase 2	DKFZp434H2111|FLJ45829|PARK8|RIPK7|ROCO2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68271
1.50026847219901e-17	0.553973783630343	0.346	0.14	3.37080320333672e-13	PIM2	Neutrophils	GSE207422_Tor_post	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68272
1.53664098564225e-17	0.709480786046707	0.531	0.314	3.452524966541e-13	MARCKS	Neutrophils	GSE207422_Tor_post	ENSG00000277443	4082	myristoylated alanine rich protein kinase C substrate	80K-L|MACS|PKCSL	protein_coding	P29966	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68273
2.09061193623239e-17	-0.459555130364441	0.344	0.572	4.69718689832693e-13	CALM2	Neutrophils	GSE207422_Tor_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68274
2.21309633308638e-17	-0.479535771047781	0.42	0.641	4.97238484117847e-13	VSIR	Neutrophils	GSE207422_Tor_post	ENSG00000107738	64115	V-set immunoregulatory receptor	B7-H5|B7H5|C10orf54|Dies1|GI24|PD-1H|SISP1|VISTA	protein_coding	Q9H7M9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68275
4.26751165999104e-17	0.500679665409345	0.546	0.318	9.58824519766787e-13	TREM1	Neutrophils	GSE207422_Tor_post	ENSG00000124731	54210	triggering receptor expressed on myeloid cells 1	CD354|TREM-1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68276
5.47685719672881e-17	-0.561493556680228	0.273	0.481	1.23054027496103e-12	CPD	Neutrophils	GSE207422_Tor_post	ENSG00000108582	1362	carboxypeptidase D	GP180	protein_coding	O75976	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68277
5.54348643960899e-17	0.692377221582358	0.38	0.178	1.24551053325135e-12	NFKBIZ	Neutrophils	GSE207422_Tor_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68278
5.66426741366777e-17	-0.419941121653704	0.188	0.391	1.27264760250287e-12	RGS18	Neutrophils	GSE207422_Tor_post	ENSG00000150681	64407	regulator of G protein signaling 18	RGS13	protein_coding	Q9NS28	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68279
7.03351289803719e-17	-0.676324394424216	0.445	0.647	1.580289677931e-12	S100A4	Neutrophils	GSE207422_Tor_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68280
7.38532242329534e-17	0.784257471223199	0.589	0.394	1.659334242066e-12	PLAUR	Neutrophils	GSE207422_Tor_post	ENSG00000011422	5329	plasminogen activator, urokinase receptor	CD87|UPAR|URKR	protein_coding	Q03405	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68281
7.73023302161744e-17	-0.487028055958761	0.348	0.586	1.73682875529701e-12	IL6R	Neutrophils	GSE207422_Tor_post	ENSG00000160712	3570	interleukin 6 receptor	CD126|gp80|IL-1Ra|IL-6R|IL6RA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68282
8.40712946660525e-17	0.705717807553614	0.371	0.154	1.88891384855687e-12	GBP4	Neutrophils	GSE207422_Tor_post	ENSG00000162654	115361	guanylate binding protein 4	Mpa2	protein_coding	Q96PP9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68283
9.91206996549183e-17	1.20784424999144	0.336	0.134	2.2270438798467e-12	IL1B	Neutrophils	GSE207422_Tor_post	ENSG00000125538	3553	interleukin 1 beta	IL-1B|IL1-BETA|IL1F2	protein_coding	P01584	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68284
1.20252488004803e-16	0.509298781467469	0.356	0.14	2.70183290049192e-12	CCR1	Neutrophils	GSE207422_Tor_post	ENSG00000163823	1230	C-C motif chemokine receptor 1	CD191|CKR-1|CMKBR1|MIP1aR|SCYAR1	protein_coding	P32246	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68285
1.22170734878206e-16	-0.512021979678215	0.682	0.811	2.74493207124354e-12	SMAP2	Neutrophils	GSE207422_Tor_post	ENSG00000084070	64744	small ArfGAP2	SMAP1L	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68286
1.35108443753892e-16	0.399691118635168	0.299	0.103	3.03561651426244e-12	PIM3	Neutrophils	GSE207422_Tor_post	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68287
1.96873837021203e-16	-0.497140303447971	0.399	0.617	4.42336137019238e-12	PTEN	Neutrophils	GSE207422_Tor_post	ENSG00000284792	5728	phosphatase and tensin homolog	BZS|MHAM|MMAC1|PTEN1|TEP1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68288
2.3370322318292e-16	0.446928086425805	0.408	0.189	5.25084401847386e-12	BCL3	Neutrophils	GSE207422_Tor_post	ENSG00000069399	602	BCL3 transcription coactivator	BCL4|D19S37	protein_coding	P20749	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68289
3.25087048371806e-16	-0.597574510322142	0.16	0.347	7.30405580281774e-12	RFLNB	Neutrophils	GSE207422_Tor_post	ENSG00000283979	359845	refilin B	Cfm1|FAM101B|MGC45871|RefilinB	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68290
3.62276838610194e-16	-0.381630892630793	0.192	0.393	8.13963600989385e-12	DYSF	Neutrophils	GSE207422_Tor_post	ENSG00000135636	8291	dysferlin	FER1L1|LGMD2B	protein_coding	O75923	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68291
4.89661427497391e-16	0.868674341351987	0.285	0.099	1.10017129530114e-11	CDKN1A	Neutrophils	GSE207422_Tor_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68292
9.21839431570097e-16	0.392781157749332	0.626	0.373	2.07118883485169e-11	HSP90AA1	Neutrophils	GSE207422_Tor_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68293
9.89020374460289e-16	0.481989104549573	0.771	0.598	2.22213097733738e-11	FCGR2A	Neutrophils	GSE207422_Tor_post	ENSG00000143226	2212	Fc gamma receptor IIa	CD32|CD32A|CDw32|Fc-gamma-RIIa|FCG2|FcgammaRIIa|FCGR2|FCGR2A1|IGFR2	protein_coding	P12318	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68294
1.80518184016926e-15	0.392918602189197	0.27	0.089	4.0558825584923e-11	CSRNP1	Neutrophils	GSE207422_Tor_post	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68295
2.5574030215642e-15	0.485872856148553	0.381	0.179	5.74597310885044e-11	HCAR3	Neutrophils	GSE207422_Tor_post	ENSG00000255398	8843	hydroxycarboxylic acid receptor 3	GPR109B|HCA3|HM74	protein_coding	P49019	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68296
6.4797510409337e-15	-0.632276034295631	0.479	0.655	1.45587046387698e-10	TSC22D3	Neutrophils	GSE207422_Tor_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68297
7.61373463279917e-15	-0.452530811682325	0.375	0.596	1.71065389729732e-10	OGFRL1	Neutrophils	GSE207422_Tor_post	ENSG00000119900	79627	opioid growth factor receptor like 1	dJ331H24.1	protein_coding	Q5TC84	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68298
9.12693063570401e-15	0.754599622264267	0.509	0.314	2.05063877522998e-10	SOCS3	Neutrophils	GSE207422_Tor_post	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68299
1.00883853407658e-14	0.605823378822576	0.788	0.686	2.26665841836327e-10	PNRC1	Neutrophils	GSE207422_Tor_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68300
1.09664190383273e-14	-0.473100747160957	0.759	0.866	2.46393502953137e-10	MNDA	Neutrophils	GSE207422_Tor_post	ENSG00000163563	4332	myeloid cell nuclear differentiation antigen	PYHIN3	protein_coding	P41218	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68301
1.64589966387391e-14	-0.381845819266705	0.211	0.398	3.6980073647919e-10	QPCT	Neutrophils	GSE207422_Tor_post	ENSG00000115828	25797	glutaminyl-peptide cyclotransferase	GCT|QC	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68302
2.40042974812108e-14	-0.334782197880012	0.15	0.325	5.39328555807845e-10	RAB3D	Neutrophils	GSE207422_Tor_post	ENSG00000105514	9545	RAB3D, member RAS oncogene family	D2-2|GOV|RAB16|RAD3D	protein_coding	O95716	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68303
4.95165773995136e-14	-0.434032039463841	0.408	0.609	1.11253846101227e-09	IGF2R	Neutrophils	GSE207422_Tor_post	ENSG00000197081	3482	insulin like growth factor 2 receptor	CD222|CI-M6PR|CI-MPR|CIMPR|M6P-R|MPR1|MPR300|MPRI	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68304
4.95248198429601e-14	-0.339754485777672	0.125	0.302	1.11272365223163e-09	FOXO3	Neutrophils	GSE207422_Tor_post	ENSG00000118689	2309	forkhead box O3	AF6q21|FKHRL1|FOXO2|FOXO3A	protein_coding	O43524	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68305
7.97325601867901e-14	-0.431532943367058	0.174	0.355	1.7914311622768e-09	PPP2R5A	Neutrophils	GSE207422_Tor_post	ENSG00000066027	5525	protein phosphatase 2 regulatory subunit B'alpha	B56A|B56alpha|PR61A	protein_coding	Q15172	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68306
1.1779765800719e-13	0.694995906227062	0.38	0.191	2.64667778010553e-09	TNFAIP3	Neutrophils	GSE207422_Tor_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68307
1.50949611121965e-13	-0.417454480751054	0.188	0.369	3.39153586268831e-09	PYGL	Neutrophils	GSE207422_Tor_post	ENSG00000100504	5836	glycogen phosphorylase L	GSD6	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68308
1.76920309505608e-13	-0.339470867544903	0.205	0.408	3.975045513972e-09	DHRS7	Neutrophils	GSE207422_Tor_post	ENSG00000100612	51635	dehydrogenase/reductase 7	retDSR4|SDR34C1	protein_coding	Q9Y394	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68309
1.89307625229968e-13	0.525801302337592	0.685	0.564	4.25336372366691e-09	BCL2A1	Neutrophils	GSE207422_Tor_post	ENSG00000140379	597	BCL2 related protein A1	ACC-1|ACC-2|ACC1|ACC2|BCL2L5|BFL1|GRS|HBPA1	protein_coding	Q16548	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68310
2.04683157844085e-13	-0.44299697844347	0.489	0.653	4.5988211904409e-09	ITGB2	Neutrophils	GSE207422_Tor_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68311
2.21429739964225e-13	-0.372783502308152	0.168	0.349	4.9750833975162e-09	UBN1	Neutrophils	GSE207422_Tor_post	ENSG00000118900	29855	ubinuclein 1	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68312
3.38642178590344e-13	-0.466363853623781	0.583	0.736	7.60861246856785e-09	KLF6	Neutrophils	GSE207422_Tor_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68313
4.39188102053566e-13	-0.424819505089857	0.462	0.647	9.86767827693951e-09	YWHAB	Neutrophils	GSE207422_Tor_post	ENSG00000166913	7529	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	YWHAA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68314
1.28445716656073e-12	-0.312170166898587	0.97	0.984	2.88591836182865e-08	S100A11	Neutrophils	GSE207422_Tor_post	ENSG00000163191	6282	S100 calcium binding protein A11	S100C	protein_coding	P31949	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68315
1.37459747028077e-12	0.517380114290741	0.302	0.13	3.08844559622684e-08	BHLHE40	Neutrophils	GSE207422_Tor_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68316
1.43483423135064e-12	-0.367371331414111	0.444	0.653	3.22378555099862e-08	CORO1A	Neutrophils	GSE207422_Tor_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68317
1.82856535309446e-12	-0.411013933076457	0.722	0.834	4.10842063533264e-08	GCA	Neutrophils	GSE207422_Tor_post	ENSG00000115271	25801	grancalcin	GCL	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68318
1.90117564897749e-12	-0.273811716990175	0.14	0.3	4.27156144812262e-08	CRISPLD2	Neutrophils	GSE207422_Tor_post	ENSG00000103196	83716	cysteine rich secretory protein LCCL domain containing 2	DKFZP434B044|LCRISP2|LGL1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68319
2.17944084040769e-12	-0.376035141786341	0.323	0.525	4.89676768022801e-08	LIMD2	Neutrophils	GSE207422_Tor_post	ENSG00000136490	80774	LIM domain containing 2	MGC10986	protein_coding	Q9BT23	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68320
2.33269542150812e-12	-0.410010034456916	0.433	0.623	5.24110007304445e-08	JAML	Neutrophils	GSE207422_Tor_post	ENSG00000160593	120425	junction adhesion molecule like	AMICA|AMICA1|Gm638	protein_coding	Q86YT9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68321
4.78485763797263e-12	0.479138104134721	0.528	0.375	1.07506181409969e-07	LYZ	Neutrophils	GSE207422_Tor_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68322
4.84091802909894e-12	-0.417959062637781	0.241	0.418	1.08765746277795e-07	CYP4F3	Neutrophils	GSE207422_Tor_post	ENSG00000186529	4051	cytochrome P450 family 4 subfamily F member 3	CYP4F|LTB4H	protein_coding	Q08477	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68323
6.14280850521464e-12	-0.392446701391497	0.209	0.387	1.38016621495163e-07	MAP4K4	Neutrophils	GSE207422_Tor_post	ENSG00000071054	9448	mitogen-activated protein kinase kinase kinase kinase 4	FLH21957|HGK|NIK	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68324
7.80129767505357e-12	0.437984616337959	0.379	0.207	1.75279556163104e-07	CD14	Neutrophils	GSE207422_Tor_post	ENSG00000170458	929	CD14 molecule	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68325
1.21270974657536e-11	-0.460336867062457	0.412	0.588	2.72471625860553e-07	VIM	Neutrophils	GSE207422_Tor_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68326
1.25828363642367e-11	0.835047621665254	0.502	0.373	2.8271116743167e-07	PTGS2	Neutrophils	GSE207422_Tor_post	ENSG00000073756	5743	prostaglandin-endoperoxide synthase 2	COX2	protein_coding	P35354	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68327
1.6737489432582e-11	-0.425555410790298	0.334	0.515	3.76057912571253e-07	ACSL1	Neutrophils	GSE207422_Tor_post	ENSG00000151726	2180	acyl-CoA synthetase long chain family member 1	ACS1|FACL1|FACL2|LACS|LACS1|LACS2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68328
2.08780784591002e-11	0.578420694402551	0.268	0.118	4.69088666819064e-07	HLA-DRB1	Neutrophils	GSE207422_Tor_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68329
2.4880328701677e-11	0.300203167310894	0.269	0.116	5.59011225269278e-07	C15orf39	Neutrophils	GSE207422_Tor_post	ENSG00000167173	56905	chromosome 15 open reading frame 39	DKFZP434H132|FLJ46337	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68330
2.61458423286204e-11	0.325257629155398	0.942	0.921	5.87444785439444e-07	LITAF	Neutrophils	GSE207422_Tor_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68331
4.1111466160592e-11	-0.489008024760231	0.596	0.714	9.23692421696182e-07	S100A6	Neutrophils	GSE207422_Tor_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68332
5.59992275636123e-11	0.595820316266274	0.392	0.235	1.25819064489924e-06	GRINA	Neutrophils	GSE207422_Tor_post	ENSG00000178719	2907	glutamate ionotropic receptor NMDA type subunit associated protein 1	HNRGW|LFG1|NMDARA1|TMBIM3	protein_coding	Q7Z429	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68333
6.51109814133188e-11	-0.428469961779177	0.372	0.535	1.46291353039445e-06	ZFP36L2	Neutrophils	GSE207422_Tor_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68334
7.2523997845035e-11	0.41745897007743	0.283	0.134	1.62946918358225e-06	SKIL	Neutrophils	GSE207422_Tor_post	ENSG00000136603	6498	SKI like proto-oncogene	SNO|SnoA|SnoN	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68335
8.43145534032559e-11	-0.259842383767767	0.113	0.258	1.89437938586435e-06	ZNF106	Neutrophils	GSE207422_Tor_post	ENSG00000103994	64397	zinc finger protein 106	SH3BP3|ZFP106|ZNF474	protein_coding	Q9H2Y7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68336
8.46527904267809e-11	-0.313014024685376	0.976	0.99	1.90197889530891e-06	MT-ND1	Neutrophils	GSE207422_Tor_post	ENSG00000198888	4535	NADH dehydrogenase subunit 1	MTND1|NAD1|ND1	protein_coding	P03886	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68337
8.49928853552463e-11	0.463391004103004	0.567	0.422	1.90962014816167e-06	TAP1	Neutrophils	GSE207422_Tor_post	ENSG00000232367	6890	transporter 1, ATP binding cassette subfamily B member	ABCB2|D6S114E|PSF1|RING4	protein_coding	Q03518	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68338
1.63047565571055e-10	-0.291581123792498	0.156	0.316	3.66335270325046e-06	PNPLA2	Neutrophils	GSE207422_Tor_post	ENSG00000177666	57104	patatin like phospholipase domain containing 2	ATGL|desnutrin|FP17548|iPLA2zeta|TTS-2.2	protein_coding	Q96AD5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68339
2.10520735808652e-10	0.318221029165427	0.514	0.329	4.7299798921488e-06	ADGRE5	Neutrophils	GSE207422_Tor_post	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68340
2.23792663996643e-10	-0.271396852382051	0.926	0.949	5.02817357467657e-06	LCP1	Neutrophils	GSE207422_Tor_post	ENSG00000136167	3936	lymphocyte cytosolic protein 1	CP64|L-PLASTIN|LC64P|PLS2	protein_coding	P13796	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68341
2.69198154461418e-10	0.669358259600746	0.389	0.241	6.04834413443913e-06	TNFAIP6	Neutrophils	GSE207422_Tor_post	ENSG00000123610	7130	TNF alpha induced protein 6	TSG-6|TSG6	protein_coding	P98066	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68342
2.80373917067326e-10	-0.288023165909499	0.921	0.961	6.29944116866867e-06	NAMPT	Neutrophils	GSE207422_Tor_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68343
2.95974863886589e-10	-0.295480780256443	0.248	0.424	6.64996324180388e-06	SH3KBP1	Neutrophils	GSE207422_Tor_post	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68344
3.77193805266196e-10	0.390848095344282	0.311	0.16	8.47479041672088e-06	SAMHD1	Neutrophils	GSE207422_Tor_post	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68345
4.8764317345663e-10	-0.360575352478282	0.246	0.408	1.09563668212236e-05	GLIPR1	Neutrophils	GSE207422_Tor_post	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68346
4.99758237564435e-10	0.339119296205786	0.417	0.254	1.12285680815977e-05	CYTH4	Neutrophils	GSE207422_Tor_post	ENSG00000100055	27128	cytohesin 4	CYT4|cytohesin-4|PSCD4	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68347
5.37977426223162e-10	-0.356459270248451	0.167	0.312	1.2087276812382e-05	GNG2	Neutrophils	GSE207422_Tor_post	ENSG00000186469	54331	G protein subunit gamma 2	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68348
5.76014182726416e-10	-0.28270117296873	0.181	0.341	1.29418866574971e-05	APMAP	Neutrophils	GSE207422_Tor_post	ENSG00000101474	57136	adipocyte plasma membrane associated protein	BSCv|C20orf3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68349
7.7291982573367e-10	-0.283051667480116	0.121	0.254	1.73659626445841e-05	BICD2	Neutrophils	GSE207422_Tor_post	ENSG00000185963	23299	BICD cargo adaptor 2	KIAA0699	protein_coding	Q8TD16	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68350
8.14559506202562e-10	0.400943957194367	0.446	0.294	1.83015229853592e-05	FLOT1	Neutrophils	GSE207422_Tor_post	ENSG00000223654	10211	flotillin 1	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68351
8.35314437348139e-10	-0.345369126865438	0.144	0.282	1.8767844778338e-05	ZC3HAV1	Neutrophils	GSE207422_Tor_post	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68352
8.86748957261118e-10	0.369707311122548	0.409	0.254	1.99234755717428e-05	LIMK2	Neutrophils	GSE207422_Tor_post	ENSG00000182541	3985	LIM domain kinase 2	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68353
9.01815737437747e-10	0.594103204654611	0.552	0.426	2.02619959887513e-05	FFAR2	Neutrophils	GSE207422_Tor_post	ENSG00000126262	2867	free fatty acid receptor 2	FFA2R|GPR43	protein_coding	O15552	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68354
9.42722838437557e-10	0.383187013433505	0.397	0.243	2.1181096734015e-05	CCNL1	Neutrophils	GSE207422_Tor_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68355
9.7880667072194e-10	-0.293026424046281	0.355	0.542	2.19918282777806e-05	IFNGR1	Neutrophils	GSE207422_Tor_post	ENSG00000027697	3459	interferon gamma receptor 1	CD119|IFNGR	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68356
1.02731502257759e-09	-0.311308893539904	0.556	0.72	2.30817139272733e-05	TPM3	Neutrophils	GSE207422_Tor_post	ENSG00000143549	7170	tropomyosin 3	NEM1|TRK	protein_coding	P06753	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68357
1.39903747970821e-09	0.349243208562832	0.36	0.201	3.1433574094084e-05	DNAJA1	Neutrophils	GSE207422_Tor_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68358
1.65452408607911e-09	-0.326427068270456	0.338	0.513	3.71738471660254e-05	IL17RA	Neutrophils	GSE207422_Tor_post	ENSG00000177663	23765	interleukin 17 receptor A	CD217|CDw217|hIL-17R|IL-17RA|IL17R	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68359
1.77873827053898e-09	0.420398594291137	0.293	0.146	3.99646914624699e-05	PPIF	Neutrophils	GSE207422_Tor_post	ENSG00000108179	10105	peptidylprolyl isomerase F	Cyp-D|CypD|hCyP3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68360
1.83999890436808e-09	-0.297650691850277	0.253	0.416	4.13410953833419e-05	TIMP2	Neutrophils	GSE207422_Tor_post	ENSG00000035862	7077	TIMP metallopeptidase inhibitor 2	CSC-21K	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68361
2.43948093319389e-09	0.262060419771382	0.881	0.738	5.48102576070003e-05	EEF1A1	Neutrophils	GSE207422_Tor_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68362
2.49736343206285e-09	-0.282865562485264	0.209	0.367	5.6110761591588e-05	PRKCB	Neutrophils	GSE207422_Tor_post	ENSG00000166501	5579	protein kinase C beta	PKCB|PKCbeta|PRKCB1|PRKCB2	protein_coding	P05771	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68363
2.62830210190284e-09	0.316685227545443	0.285	0.142	5.9052691625553e-05	GPR65	Neutrophils	GSE207422_Tor_post	ENSG00000140030	8477	G protein-coupled receptor 65	hTDAG8|TDAG8	protein_coding	Q8IYL9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68364
5.27805804665359e-09	0.259368996011254	0.996	0.982	0.000118587408192213	TPT1	Neutrophils	GSE207422_Tor_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68365
6.35319941801432e-09	0.420877654059254	0.572	0.454	0.000142743684523946	GBP2	Neutrophils	GSE207422_Tor_post	ENSG00000162645	2634	guanylate binding protein 2	NA	protein_coding	P32456	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68366
7.86919040137737e-09	-0.329671728019505	0.347	0.499	0.000176804969938147	AL034397.3	Neutrophils	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68367
8.7720997139717e-09	-0.314197126937384	0.657	0.815	0.000197091536373516	BASP1	Neutrophils	GSE207422_Tor_post	ENSG00000176788	10409	brain abundant membrane attached signal protein 1	CAP-23|CAP23|NAP-22|NAP22	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68368
9.07952583363486e-09	-0.330947789150514	0.248	0.402	0.000203998786430108	GAPDH	Neutrophils	GSE207422_Tor_post	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68369
1.10265273689287e-08	-0.290582409325044	0.223	0.375	0.000247744016925091	PGD	Neutrophils	GSE207422_Tor_post	ENSG00000142657	5226	phosphogluconate dehydrogenase	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68370
1.84517734342736e-08	-0.306075302589325	0.672	0.783	0.00041457444552126	ARHGDIB	Neutrophils	GSE207422_Tor_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68371
2.03488411193254e-08	0.838372230835406	0.397	0.274	0.000457197762269003	HLA-DRA	Neutrophils	GSE207422_Tor_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68372
2.67404985120531e-08	-0.317867184795698	0.558	0.7	0.000600805520568808	SORL1	Neutrophils	GSE207422_Tor_post	ENSG00000137642	6653	sortilin related receptor 1	C11orf32|gp250|LR11|LRP9|SorLA|SorLA-1	protein_coding	Q92673	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68373
4.97687812488614e-08	-0.337817077912202	0.339	0.479	0.00111820497709942	PLXNC1	Neutrophils	GSE207422_Tor_post	ENSG00000136040	10154	plexin C1	CD232|VESPR	protein_coding	O60486	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68374
5.33082070653544e-08	0.313709172887497	0.262	0.13	0.00119772879634438	CCRL2	Neutrophils	GSE207422_Tor_post	ENSG00000121797	9034	C-C motif chemokine receptor like 2	ACKR5|CKRX|CRAM-A|CRAM-B|HCR	protein_coding	O00421	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68375
6.8644104065331e-08	-0.261900666901074	0.354	0.527	0.00154229573013986	OSBPL8	Neutrophils	GSE207422_Tor_post	ENSG00000091039	114882	oxysterol binding protein like 8	MST120|MSTP120|ORP8|OSBP10	protein_coding	Q9BZF1	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68376
1.03522765784593e-07	0.267967825804419	0.262	0.142	0.00232594950164823	FTH1P10	Neutrophils	GSE207422_Tor_post	ENSG00000223361	NA	NA	FTHL10	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68377
1.16310983603675e-07	-0.309502943289552	0.658	0.738	0.00261327517960737	ARPC5	Neutrophils	GSE207422_Tor_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68378
1.96151118919582e-07	0.347552919366271	0.399	0.264	0.00440712333988516	STAT1	Neutrophils	GSE207422_Tor_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68379
2.18414302065543e-07	0.32169335947835	0.654	0.544	0.00490733253880862	CSF2RB	Neutrophils	GSE207422_Tor_post	ENSG00000100368	1439	colony stimulating factor 2 receptor subunit beta	betaGMR|CD131|IL3RB|IL5RB	protein_coding	P32927	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68380
2.64478490311924e-07	-0.335806352791056	0.328	0.465	0.00594230272032831	CALM1	Neutrophils	GSE207422_Tor_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68381
2.6539241045609e-07	0.329649087383383	0.521	0.4	0.00596283667812742	DDX5	Neutrophils	GSE207422_Tor_post	ENSG00000108654	1655	DEAD-box helicase 5	G17P1|HLR1|p68	protein_coding	P17844	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68382
3.01956478075368e-07	-0.294382978016366	0.456	0.598	0.00678435814939737	BOD1L1	Neutrophils	GSE207422_Tor_post	ENSG00000038219	259282	biorientation of chromosomes in cell division 1 like 1	BOD1L|FAM44A|FLJ33215|KIAA1327	protein_coding	Q8NFC6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68383
3.12095243230164e-07	0.485123959088122	0.36	0.237	0.00701215592489533	CYBB	Neutrophils	GSE207422_Tor_post	ENSG00000165168	1536	cytochrome b-245 beta chain	CGD|GP91-PHOX|NOX2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68384
3.21564423179581e-07	-0.250416466630711	0.209	0.331	0.00722490945999882	CR1	Neutrophils	GSE207422_Tor_post	ENSG00000203710	1378	complement C3b/C4b receptor 1 (Knops blood group)	CD35|KN	protein_coding	P17927	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68385
3.34780282843575e-07	-0.294707337078148	0.168	0.284	0.00752184339492945	ABHD5	Neutrophils	GSE207422_Tor_post	ENSG00000011198	51099	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	CGI-58|NCIE2	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68386
3.6312962321819e-07	0.305593192682762	0.393	0.27	0.0081587963744663	MIDN	Neutrophils	GSE207422_Tor_post	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68387
3.72458259080129e-07	0.487325110392655	0.388	0.284	0.00836839216501233	NBN	Neutrophils	GSE207422_Tor_post	ENSG00000104320	4683	nibrin	AT-V1|AT-V2|ATV|NBS|NBS1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68388
4.39269916734386e-07	-0.298646684324	0.232	0.361	0.00986951648918819	MAP3K2	Neutrophils	GSE207422_Tor_post	ENSG00000169967	10746	mitogen-activated protein kinase kinase kinase 2	MEKK2|MEKK2B	protein_coding	Q9Y2U5	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68389
4.53848382319177e-07	-0.33951534643504	0.163	0.278	0.0101970654539473	KATNBL1	Neutrophils	GSE207422_Tor_post	ENSG00000134152	79768	katanin regulatory subunit B1 like 1	C15orf29|FLJ22557	protein_coding	Q9H079	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68390
5.34118747651859e-07	-0.254231622682357	0.315	0.46	0.012000580022242	MTND1P23	Neutrophils	GSE207422_Tor_post	ENSG00000225972	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68391
6.59159295044642e-07	-0.276433579379121	0.785	0.817	0.014809991041063	LSP1	Neutrophils	GSE207422_Tor_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68392
8.07268662727691e-07	-0.277916120397591	0.624	0.728	0.0181377123141658	IQGAP1	Neutrophils	GSE207422_Tor_post	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68393
1.16279701591329e-06	0.311248434578371	0.592	0.485	0.0261257233535397	FGR	Neutrophils	GSE207422_Tor_post	ENSG00000000938	2268	FGR proto-oncogene, Src family tyrosine kinase	c-fgr|p55c-fgr|SRC2	protein_coding	P09769	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68394
1.17409206291461e-06	0.347451767775013	0.339	0.221	0.0263795004695654	GK	Neutrophils	GSE207422_Tor_post	ENSG00000198814	2710	glycerol kinase	GK1|GKD	protein_coding	P32189	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68395
1.28503666642853e-06	0.278452473582047	0.83	0.819	0.0288722038213161	SLC25A37	Neutrophils	GSE207422_Tor_post	ENSG00000147454	51312	solute carrier family 25 member 37	HT015|MFRN|MFRN1|MSCP	protein_coding	Q9NYZ2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68396
1.54067900714795e-06	0.407765631195099	0.46	0.333	0.0346159759326002	LRG1	Neutrophils	GSE207422_Tor_post	ENSG00000171236	116844	leucine rich alpha-2-glycoprotein 1	LRG	protein_coding	P02750	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68397
1.71117154572052e-06	0.296510745717344	0.425	0.31	0.0384466022892486	LCP2	Neutrophils	GSE207422_Tor_post	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68398
1.76822452226002e-06	0.296994362268219	0.885	0.88	0.0397284685661382	CEBPB	Neutrophils	GSE207422_Tor_post	ENSG00000172216	1051	CCAAT enhancer binding protein beta	C/EBP-beta|CRP2|IL6DBP|LAP|NFIL6|TCF5	protein_coding	P17676	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68399
1.59040481731955e-11	2.08635780341104	0.959	0.839	3.57332154355356e-07	GPR183	pDCs	GSE207422_Tor_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68400
2.09122726904216e-10	2.07972719247073	0.755	0.065	4.69856942808392e-06	CD83	pDCs	GSE207422_Tor_post	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68401
2.64797948886263e-10	2.13180447702326	0.908	0.484	5.94948031557655e-06	FOSB	pDCs	GSE207422_Tor_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68402
3.06104489334428e-10	1.9143953023289	0.796	0.161	6.87755566636592e-06	NR4A1	pDCs	GSE207422_Tor_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68403
5.90293329478918e-10	-0.542677043434475	0.02	0.452	1.32627105267323e-05	AL365357.1	pDCs	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68404
1.14143110116939e-09	1.59960927668556	0.684	0	2.56456739810738e-05	NR4A3	pDCs	GSE207422_Tor_post	ENSG00000119508	8013	nuclear receptor subfamily 4 group A member 3	CHN|CSMF|MINOR|NOR1	protein_coding	Q92570	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68405
1.56110116291065e-09	-1.13196434191244	0.816	1	3.50748209282764e-05	IGKC	pDCs	GSE207422_Tor_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68406
1.95938557924786e-09	2.33948646627167	0.673	0	4.4023475194541e-05	ZNF331	pDCs	GSE207422_Tor_post	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68407
3.83114889495143e-09	1.33948646627167	0.929	0.645	8.60782533717687e-05	MCL1	pDCs	GSE207422_Tor_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68408
3.87587130356142e-09	-0.753622938119815	0.316	0.903	8.70830764484179e-05	CDK2AP2	pDCs	GSE207422_Tor_post	ENSG00000167797	10263	cyclin dependent kinase 2 associated protein 2	DOC-1R|p14	protein_coding	O75956	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68409
4.78419026473019e-09	-0.753622938119814	0.194	0.742	0.000107491186867958	ATP13A2	pDCs	GSE207422_Tor_post	ENSG00000159363	23400	ATPase cation transporting 13A2	CLN12|HSA9947|PARK9	protein_coding	Q9NQ11	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68410
7.29848846893027e-09	-1.00782694703561	0.806	1	0.000163982438919925	MPEG1	pDCs	GSE207422_Tor_post	ENSG00000197629	219972	macrophage expressed 1	MPG1	protein_coding	Q2M385	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68411
1.0715328749332e-08	-0.697666532145799	0.133	0.645	0.000240752006339992	PACSIN1	pDCs	GSE207422_Tor_post	ENSG00000124507	29993	protein kinase C and casein kinase substrate in neurons 1	SDPI	protein_coding	Q9BY11	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68412
1.14405586730782e-08	-0.494155147306213	0.031	0.419	0.00025704647226672	SNORD3A	pDCs	GSE207422_Tor_post	ENSG00000263934	NA	NA	RNU3|U3	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68413
2.16426470085789e-08	1.35498755981186	0.969	0.935	0.000486266992988751	CXCR4	pDCs	GSE207422_Tor_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68414
2.66287047995878e-08	1.15377188223789	0.99	0.903	0.000598293739437138	SRGN	pDCs	GSE207422_Tor_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68415
3.00467888111073e-08	-0.460214883242502	0.071	0.516	0.000675091251007959	PIK3R5	pDCs	GSE207422_Tor_post	ENSG00000141506	23533	phosphoinositide-3-kinase regulatory subunit 5	p101|P101-PI3K	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68416
7.63616683302145e-08	1.21990485051899	0.633	0.065	0.00171569396404326	FOSL2	pDCs	GSE207422_Tor_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68417
1.22329804749335e-07	-0.634518325195389	0.102	0.548	0.00274850605310807	CCR2	pDCs	GSE207422_Tor_post	ENSG00000121807	729230	C-C motif chemokine receptor 2	CC-CKR-2|CD192|CKR2|CMKBR2|FLJ78302|MCP-1-R	protein_coding	P41597	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68418
1.25390006892233e-07	-0.566537385519319	0.122	0.581	0.00281726267485468	SNX18	pDCs	GSE207422_Tor_post	ENSG00000178996	112574	sorting nexin 18	SH3PX2|SH3PXD3B|SNAG1	protein_coding	Q96RF0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68419
1.49649018916691e-07	1.38533711784964	0.949	0.677	0.00336231415702021	JUNB	pDCs	GSE207422_Tor_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68420
1.76838422578863e-07	1.32996369215316	0.694	0.161	0.00397320567850189	IFI44L	pDCs	GSE207422_Tor_post	ENSG00000137959	10964	interferon induced protein 44 like	C1orf29|GS3686|TLDC5B	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68421
2.28969756731905e-07	-0.497574962602128	0.051	0.419	0.00514449249425243	KHDC4	pDCs	GSE207422_Tor_post	ENSG00000132680	22889	KH domain containing 4, pre-mRNA splicing factor	BLOM7|KIAA0907|SNORA80EHG	protein_coding	Q7Z7F0	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68422
2.3067388938511e-07	-0.938047509257242	0.602	0.935	0.00518278094670464	SERPINF1	pDCs	GSE207422_Tor_post	ENSG00000282307	5176	serpin family F member 1	EPC-1|PEDF|PIG35	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68423
2.57627461773956e-07	-0.793487398997754	0.816	1	0.00578837381113725	RPS3A	pDCs	GSE207422_Tor_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68424
2.94058763433224e-07	-0.635851479494064	0.112	0.548	0.00660691229681767	TXNIP	pDCs	GSE207422_Tor_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68425
3.48648705302065e-07	1.04537374925243	0.898	0.484	0.00783343911072679	HLA-DQB1	pDCs	GSE207422_Tor_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68426
3.60607386406304e-07	1.32248004096598	0.571	0.032	0.00810212675777684	NR4A2	pDCs	GSE207422_Tor_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68427
4.11117902131077e-07	2.11743815824416	0.99	0.903	0.00923699702508103	HSP90AA1	pDCs	GSE207422_Tor_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68428
6.28825739989297e-07	-0.411365485154092	1	1	0.0141284567260795	CD74	pDCs	GSE207422_Tor_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68429
6.4940205708663e-07	1.16895208993502	0.673	0.194	0.0145907654186224	MYADM	pDCs	GSE207422_Tor_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68430
7.54764448987222e-07	1.06600311120684	0.939	0.71	0.0169580476398449	RGS1	pDCs	GSE207422_Tor_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68431
8.62431498457049e-07	-0.854600585844635	0.684	0.903	0.019377110907333	PPP1R14B	pDCs	GSE207422_Tor_post	ENSG00000173457	26472	protein phosphatase 1 regulatory inhibitor subunit 14B	PHI-1|PLCB3N|PNG|SOM172	protein_coding	Q96C90	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68432
8.92271562833104e-07	0.903690406826026	0.633	0.129	0.0200475574737342	ETV3	pDCs	GSE207422_Tor_post	ENSG00000117036	2117	ETS variant transcription factor 3	PE-1	protein_coding	P41162	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68433
9.01394932654374e-07	-0.782302014126375	0.602	0.935	0.0202525413468785	MTATP6P1	pDCs	GSE207422_Tor_post	ENSG00000248527	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68434
9.07135421416183e-07	-0.748461233004036	0.51	0.903	0.0203815186483788	FAM129C	pDCs	GSE207422_Tor_post	NA	NA	NA	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68435
9.66472452839494e-07	-0.606065749705957	0.306	0.806	0.0217147030703978	CDYL	pDCs	GSE207422_Tor_post	ENSG00000153046	9425	chromodomain Y like	CDYL1|DKFZP586C1622	protein_coding	Q9Y232	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68436
1.25914575883289e-06	1.53284322475512	0.857	0.452	0.0282904869094573	RGS2	pDCs	GSE207422_Tor_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68437
1.37521982576897e-06	-0.76630819775093	0.5	0.968	0.0308984390453772	CYB561A3	pDCs	GSE207422_Tor_post	ENSG00000162144	220002	cytochrome b561 family member A3	CYBASC3	protein_coding	Q8NBI2	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68438
1.38178799454013e-06	-0.54093191797566	0.429	0.935	0.0310460126613276	C12orf75	pDCs	GSE207422_Tor_post	ENSG00000235162	387882	chromosome 12 open reading frame 75	AGD3|OCC-1|OCC1	protein_coding	Q8TAD7	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68439
1.43609585010642e-06	-0.798897017884255	0.337	0.806	0.0322662015601911	P2RY14	pDCs	GSE207422_Tor_post	ENSG00000174944	9934	purinergic receptor P2Y14	GPR105|KIAA0001	protein_coding	Q15391	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68440
1.47070082921936e-06	-0.425297072034301	0.102	0.516	0.0330437062309006	PAFAH2	pDCs	GSE207422_Tor_post	ENSG00000158006	5051	platelet activating factor acetylhydrolase 2	HSD-PLA2	protein_coding	Q99487	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68441
1.66545966882819e-06	0.99610995212027	0.643	0.161	0.0374195478392318	KDM6B	pDCs	GSE207422_Tor_post	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68442
2.17915128134555e-06	1.06667103964529	0.633	0.129	0.0489611709892719	PIM2	pDCs	GSE207422_Tor_post	ENSG00000102096	11040	Pim-2 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q9P1W9	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68443
3.63195056517151e-10	-1	0	1	8.16026652982735e-06	ZNF383	Endothelial cells	GSE207422_Tor_post	ENSG00000188283	163087	zinc finger protein 383	FLJ35863|Zfp383	protein_coding	Q8NA42	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68444
4.8978264420071e-07	-0.736965594166206	0	0.667	0.0110044364499016	AGPAT1	Endothelial cells	GSE207422_Tor_post	ENSG00000236873	10554	1-acylglycerol-3-phosphate O-acyltransferase 1	LPAAT-alpha|LPLAT1	protein_coding	Q99943	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68445
4.8978264420071e-07	-0.736965594166206	0	0.667	0.0110044364499016	APH1B	Endothelial cells	GSE207422_Tor_post	ENSG00000138613	83464	aph-1 homolog B, gamma-secretase subunit	APH-1B|DKFZp564D0372|PSFL	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68446
4.8978264420071e-07	-0.736965594166206	0	0.667	0.0110044364499016	CHERP	Endothelial cells	GSE207422_Tor_post	ENSG00000085872	10523	calcium homeostasis endoplasmic reticulum protein	DAN16|ERPROT213-21	protein_coding	Q8IWX8	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68447
4.8978264420071e-07	-0.736965594166206	0	0.667	0.0110044364499016	MBD5	Endothelial cells	GSE207422_Tor_post	ENSG00000204406	55777	methyl-CpG binding domain protein 5	FLJ11113|KIAA1461	protein_coding	Q9P267	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68448
4.8978264420071e-07	-0.736965594166206	0	0.667	0.0110044364499016	ZEB1-AS1	Endothelial cells	GSE207422_Tor_post	ENSG00000237036	220930	ZEB1 antisense RNA 1	NA	NA	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68449
4.8978264420071e-07	-0.736965594166206	0	0.667	0.0110044364499016	ZMYM1	Endothelial cells	GSE207422_Tor_post	ENSG00000197056	79830	zinc finger MYM-type containing 1	FLJ23151|MYM	protein_coding	Q5SVZ6	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68450
4.8978264420071e-07	-0.736965594166206	0	0.667	0.0110044364499016	ZNF200	Endothelial cells	GSE207422_Tor_post	ENSG00000010539	7752	zinc finger protein 200	NA	protein_coding	P98182	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68451
3.19623516714537e-09	-6.06460734024796	0.056	0.8	7.18130117354223e-05	IGKC	Fibroblasts	GSE207422_Tor_post	ENSG00000211592	NA	NA	HCAK1	IG_C_gene	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68452
1.18364892333922e-08	-0.666576266274808	0.008	0.4	0.000265942240095857	OGN	Fibroblasts	GSE207422_Tor_post	ENSG00000106809	4969	osteoglycin	mimecan|OIF|SLRR3A	protein_coding	P20774	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68453
1.35377681031058e-08	-0.473931188332412	0.008	0.4	0.000304166573740581	FUT4	Fibroblasts	GSE207422_Tor_post	ENSG00000196371	2526	fucosyltransferase 4	CD15|ELFT|FCT3A|FUC-TIV	protein_coding	P22083	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68454
1.35377681031058e-08	-0.473931188332412	0.008	0.4	0.000304166573740581	PODN	Fibroblasts	GSE207422_Tor_post	ENSG00000174348	127435	podocan	MGC24995|PCAN|PODOCAN|SLRR5A	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68455
1.35377681031058e-08	-0.473931188332412	0.008	0.4	0.000304166573740581	ZNF521	Fibroblasts	GSE207422_Tor_post	ENSG00000198795	25925	zinc finger protein 521	EHZF|Evi3	protein_coding	Q96K83	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68456
3.8703621913601e-07	-0.62148837674627	0.04	0.6	0.00869592977154787	PCNX1	Fibroblasts	GSE207422_Tor_post	ENSG00000100731	22990	pecanex 1	KIAA0805|KIAA0995|PCNX|PCNXL1|pecanex	protein_coding	Q96RV3	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68457
1.32098755353295e-06	-0.462526425060163	0.016	0.4	0.0296799483527782	F5	Fibroblasts	GSE207422_Tor_post	ENSG00000198734	2153	coagulation factor V	NA	protein_coding	P12259	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68458
1.32098755353295e-06	-0.462526425060163	0.016	0.4	0.0296799483527782	PPARA	Fibroblasts	GSE207422_Tor_post	ENSG00000186951	5465	peroxisome proliferator activated receptor alpha	hPPAR|NR1C1|PPAR	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68459
1.32098755353295e-06	-0.462526425060163	0.016	0.4	0.0296799483527782	TANC2	Fibroblasts	GSE207422_Tor_post	ENSG00000170921	26115	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2	DKFZP564D166|FLJ10215|FLJ11824|KIAA1148|KIAA1636|rols|ROLSA	protein_coding	NA	GSE207422_Tor	GSE207422	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	post	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	Homo sapiens	patients	Tumor tissue	post (resistant 3, sensitive 2)	5	8690	Public on Mar 21, 2023	36869384	This dataset has 5 patients with post-treatment samples.	https://ngdc.cncb.ac.cn/gsa-human/browse/HRA001033	BD Rhapsody system	 BD Rhapsody Whole Transcriptome Analysis (WTA) Pipeline	Lung_cancer	Immunotherapy	68460
0	-0.539276035228694	0.936	0.994	0	RPS26	Mono/Macro	GSE212217_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68461
6.58170641272671e-180	-0.362657120403168	0.277	0.481	1.40815608700288e-175	SNHG5	Mono/Macro	GSE212217_post	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68462
4.16343350966615e-139	-0.335130267246103	0.738	0.879	8.90766599393073e-135	CD52	Mono/Macro	GSE212217_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68463
2.76779293332343e-112	0.282121880012949	0.84	0.766	5.92169298084548e-108	BRI3	Mono/Macro	GSE212217_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68464
1.48510376493646e-111	0.260353573018515	0.428	0.281	3.17737950508156e-107	TAF10	Mono/Macro	GSE212217_post	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68465
5.22159711148234e-100	0.255874194998789	0.757	0.642	1.11716070200165e-95	EFHD2	Mono/Macro	GSE212217_post	ENSG00000142634	79180	EF-hand domain family member D2	MGC4342	protein_coding	Q96C19	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68466
6.66655843140723e-97	0.25130802515913	0.992	0.989	1.42631017639958e-92	VIM	Mono/Macro	GSE212217_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68467
2.50427459635361e-64	0.25090664741728	0.831	0.76	5.35789549889855e-60	CEBPD	Mono/Macro	GSE212217_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68468
1.22074427263363e-50	-0.281164015364688	0.845	0.886	2.61178237129964e-46	IFITM2	Mono/Macro	GSE212217_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68469
3.60052396664871e-40	0.30435993803004	0.679	0.619	7.70332102664491e-36	VCAN	Mono/Macro	GSE212217_post	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68470
6.48228073836003e-27	-0.2700712238271	0.935	0.961	1.38688396397213e-22	LYZ	Mono/Macro	GSE212217_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68471
0	-1.06376249761765	0.948	0.99	0	RPS26	CD8+ T cells	GSE212217_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68472
0	0.457230005908252	0.98	0.929	0	MT-ATP8	CD8+ T cells	GSE212217_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68473
4.49836632680354e-210	0.260864505618748	1	0.998	9.62425475619617e-206	MT-ND3	CD8+ T cells	GSE212217_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68474
6.73837009235086e-134	-0.271348232678978	0.966	0.976	1.44167428125847e-129	S100A4	CD8+ T cells	GSE212217_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68475
2.01006834952099e-116	0.280444851438134	0.412	0.287	4.30054123380016e-112	DDIT4	CD8+ T cells	GSE212217_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68476
6.82322897979781e-80	0.289338622235786	0.675	0.583	1.45982984022774e-75	MT2A	CD8+ T cells	GSE212217_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68477
4.05600046049452e-64	-0.295086241807876	0.522	0.606	8.67781298522803e-60	GNLY	CD8+ T cells	GSE212217_post	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68478
9.04616723485608e-56	0.295435641458786	0.697	0.632	1.93542747989746e-51	ZFP36	CD8+ T cells	GSE212217_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68479
0	-1.61280044231245	0.872	0.996	0	RPS26	B cells	GSE212217_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68480
2.60236359241547e-80	-0.340956065413681	1	1	5.5677569059729e-76	ACTB	B cells	GSE212217_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68481
7.4712971066084e-68	0.552754854002622	0.688	0.546	1.59848401595887e-63	NFKBIA	B cells	GSE212217_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68482
4.34697246881992e-66	0.388574696315599	0.374	0.195	9.30034759704023e-62	SNX9	B cells	GSE212217_post	ENSG00000130340	51429	sorting nexin 9	SDP1|SH3PX1|SH3PXD3A	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68483
1.63172458376488e-60	-0.400331398683384	0.83	0.901	3.49107474696496e-56	HLA-DRB5	B cells	GSE212217_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68484
1.74215944774362e-55	0.449563204026711	0.802	0.672	3.72735013844748e-51	ZFP36L2	B cells	GSE212217_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68485
2.67100688605549e-55	0.418556036231335	0.862	0.792	5.71461923271571e-51	CXCR4	B cells	GSE212217_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68486
5.05288674368867e-54	0.306560781790647	0.963	0.937	1.08106511881219e-49	RPL27A	B cells	GSE212217_post	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68487
6.18068772710615e-47	0.357756619510394	0.521	0.37	1.32235813921436e-42	RBM38	B cells	GSE212217_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68488
5.50451301205967e-45	-0.308823146939713	0.532	0.688	1.17769055893017e-40	HSPA8	B cells	GSE212217_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68489
1.58339382357999e-44	0.303356568959678	0.985	0.98	3.3876710855494e-40	BTG1	B cells	GSE212217_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68490
7.24133575213973e-43	-0.41912792846521	0.226	0.376	1.5492837841703e-38	HLA-DQA2	B cells	GSE212217_post	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68491
4.55229672752955e-42	-0.30367183936375	0.787	0.876	9.73963884854948e-38	CD79B	B cells	GSE212217_post	ENSG00000007312	974	CD79b molecule	B29|Ig-beta|IGB|Igbeta	protein_coding	P40259	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68492
3.3912954699006e-40	-0.278194456789784	0.471	0.623	7.25567665785233e-36	SMDT1	B cells	GSE212217_post	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68493
5.93133029787344e-40	0.376267836747296	0.562	0.421	1.26900811723002e-35	YBX3	B cells	GSE212217_post	ENSG00000060138	8531	Y-box binding protein 3	CSDA|CSDA1|dbpA|ZONAB	protein_coding	P16989	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68494
1.72076786750921e-39	0.312634404133131	0.999	0.997	3.68158285253596e-35	FTH1	B cells	GSE212217_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68495
3.03960871962232e-36	0.374188043554604	0.487	0.355	6.50324285563196e-32	CD83	B cells	GSE212217_post	ENSG00000112149	9308	CD83 molecule	BL11|HB15	protein_coding	Q01151	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68496
3.65727599775231e-33	-0.252970761570588	0.906	0.946	7.82474199719106e-29	HLA-DQB1	B cells	GSE212217_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68497
7.16142523030699e-33	0.313437538648377	0.692	0.603	1.53218692802418e-28	EZR	B cells	GSE212217_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68498
3.85045914435059e-30	0.447324992179492	0.691	0.606	8.23805733933809e-26	CD69	B cells	GSE212217_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68499
2.06907838196901e-25	0.264036524634776	0.367	0.259	4.42679319822269e-21	MAP3K8	B cells	GSE212217_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68500
3.1142157135511e-24	-0.379379370558538	0.169	0.273	6.66286451914259e-20	RHOB	B cells	GSE212217_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68501
2.37947543089025e-14	-0.27654335443728	0.593	0.661	5.09088768438968e-10	KLF6	B cells	GSE212217_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68502
1.11087120073953e-06	-0.289776215552247	0.445	0.497	0.0237670893398223	FOS	B cells	GSE212217_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68503
0	-0.879256860027938	0.96	0.998	0	RPS26	NK cells	GSE212217_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68504
9.76726969402932e-193	0.522902361098001	0.624	0.443	2.08970735103757e-188	CD3E	NK cells	GSE212217_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68505
3.81583356634533e-172	0.270148199571271	1	0.999	8.16397591519583e-168	MT-ND3	NK cells	GSE212217_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68506
9.11339138199102e-161	0.267286864239044	0.976	0.949	1.94981008617698e-156	MT-ATP8	NK cells	GSE212217_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68507
1.21831194891195e-112	0.287838894492491	0.736	0.632	2.60657841469711e-108	TGFB1	NK cells	GSE212217_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68508
1.30652560260185e-92	0.339122524547543	0.374	0.244	2.79531152676665e-88	MYOM2	NK cells	GSE212217_post	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68509
4.91694059605275e-84	-0.297387890303979	0.952	0.979	1.05197944052549e-79	MTRNR2L12	NK cells	GSE212217_post	NA	NA	NA	NA	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68510
0	-0.936457817475783	0.911	0.996	0	RPS26	CD4+ T cells	GSE212217_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68511
0	-0.259876718623318	0.485	0.631	0	SMDT1	CD4+ T cells	GSE212217_post	ENSG00000274112	91689	single-pass membrane protein with aspartate rich tail 1	C22orf32|DDDD|dJ186O1.1|EMRE	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68512
0	0.3721322115479	0.967	0.942	0	MT-ATP8	CD4+ T cells	GSE212217_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68513
0	0.340500493287505	1	0.999	0	MT-ND3	CD4+ T cells	GSE212217_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68514
1.62199126209229e-162	-0.281658715944445	0.819	0.864	3.47025030524646e-158	S100A4	CD4+ T cells	GSE212217_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68515
5.34213068460168e-20	-0.284247097874927	0.483	0.502	1.14294885997053e-15	FOS	CD4+ T cells	GSE212217_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68516
1.48241070047754e-11	0.592470861700358	0.995	0.995	3.1716176936717e-07	MZB1	Plasma cells	GSE212217_post	ENSG00000170476	51237	marginal zone B and B1 cell specific protein	HSPC190|MEDA-7|MGC29506|PACAP|pERp1	protein_coding	Q8WU39	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68517
4.43127786500971e-10	-0.512689348787266	0.155	0.437	9.48071899218827e-06	TSPO	Plasma cells	GSE212217_post	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68518
4.93128511007777e-10	0.446693880698746	0.925	0.916	1.05504844930114e-05	SPCS3	Plasma cells	GSE212217_post	ENSG00000129128	60559	signal peptidase complex subunit 3	FLJ22649|PRO3567|SPC22/23|SPC3|YLR066W	protein_coding	P61009	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68519
5.96311719715199e-10	0.545551848441259	0.89	0.747	1.27580892433067e-05	MT-ND2	Plasma cells	GSE212217_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68520
8.14769700977589e-10	0.467334986877121	1	0.979	1.74319977524155e-05	MT-ND3	Plasma cells	GSE212217_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68521
2.81930647038205e-09	-0.471403397801472	0.99	0.989	6.03190619338239e-05	RPS15A	Plasma cells	GSE212217_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68522
5.30481342064021e-09	-0.475886713071315	0.41	0.726	0.000113496483134597	CD52	Plasma cells	GSE212217_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68523
5.36775415781289e-09	0.618441281981367	0.95	0.916	0.000114843100206407	MYDGF	Plasma cells	GSE212217_post	ENSG00000074842	56005	myeloid derived growth factor	C19orf10|IL-25|IL-27|IL25|IL27|IL27w|R33729_1|SF20	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68524
7.18900461340103e-09	0.448330931006975	0.93	0.905	0.000153808753703715	FKBP11	Plasma cells	GSE212217_post	ENSG00000134285	51303	FKBP prolyl isomerase 11	FKBP19	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68525
2.18793009399503e-08	0.452810166491584	0.59	0.326	0.000468107643610236	FNDC3B	Plasma cells	GSE212217_post	ENSG00000075420	64778	fibronectin type III domain containing 3B	DKFZp762K137|FAD104|FLJ23399|PRO4979|YVTM2421	protein_coding	Q53EP0	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68526
2.85571876946833e-08	0.48468822506827	0.98	0.958	0.000610981030727749	SEC11C	Plasma cells	GSE212217_post	ENSG00000166562	90701	SEC11 homolog C, signal peptidase complex subunit	SEC11L3|SPC21|SPCS4C	protein_coding	Q9BY50	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68527
2.88526470740054e-08	-0.472289926984826	0.915	0.968	0.000617302384148346	RPS26	Plasma cells	GSE212217_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68528
3.17889924116401e-08	-0.507624978379451	0.355	0.668	0.000680125492647039	S100A6	Plasma cells	GSE212217_post	ENSG00000197956	6277	S100 calcium binding protein A6	2A9|CABP|CACY|PRA	protein_coding	P06703	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68529
3.23730421263119e-08	0.532811007633081	0.985	0.968	0.000692621236292443	HLA-C	Plasma cells	GSE212217_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68530
4.37430938243099e-08	0.383616706573905	0.355	0.121	0.000935883492371109	GAS6	Plasma cells	GSE212217_post	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68531
5.02326687406706e-08	0.435891486067193	0.925	0.879	0.00107472794770665	LMAN1	Plasma cells	GSE212217_post	ENSG00000074695	3998	lectin, mannose binding 1	ERGIC-53|ERGIC53|F5F8D|FMFD1|gp58|MCFD1|MR60	protein_coding	P49257	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68532
8.28861136464009e-08	-0.439624388738604	0.765	0.947	0.00177334840146475	CD79A	Plasma cells	GSE212217_post	ENSG00000105369	973	CD79a molecule	Ig-alpha|IGA|IGAlpha|MB-1|MB1	protein_coding	P11912	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68533
8.51281197197017e-08	-0.498885866678968	0.455	0.726	0.00182131612140302	ARHGDIB	Plasma cells	GSE212217_post	ENSG00000111348	397	Rho GDP dissociation inhibitor beta	GDIA2|GDID4|Ly-GDI|RAP1GN1|RhoGDI2	protein_coding	P52566	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68534
1.10505369697847e-07	0.409573865791833	0.65	0.411	0.00236426238468543	IFI30	Plasma cells	GSE212217_post	ENSG00000216490	10437	IFI30 lysosomal thiol reductase	GILT|IFI-30|IP-30|IP30|MGC32056	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68535
1.12076426929031e-07	0.536456449212843	0.995	1	0.00239787515414662	HSP90B1	Plasma cells	GSE212217_post	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68536
1.70137086216846e-07	-0.766314409132194	0.215	0.447	0.00364008295960941	S100A4	Plasma cells	GSE212217_post	ENSG00000196154	6275	S100 calcium binding protein A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	protein_coding	P26447	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68537
1.8304953063691e-07	-0.338020098303139	0.16	0.395	0.0039163447079767	SNHG5	Plasma cells	GSE212217_post	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68538
4.58242912513593e-07	-0.344037334440537	0.99	1	0.00980410711322833	RPL10	Plasma cells	GSE212217_post	ENSG00000147403	6134	ribosomal protein L10	DXS648|DXS648E|FLJ23544|L10|NOV|QM	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68539
4.91169412362801e-07	0.322200275822212	0.305	0.1	0.0105085695775021	CPEB4	Plasma cells	GSE212217_post	ENSG00000113742	80315	cytoplasmic polyadenylation element binding protein 4	KIAA1673	protein_coding	Q17RY0	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68540
5.57397833784308e-07	0.43463963563224	0.94	0.937	0.0119255266538153	P4HB	Plasma cells	GSE212217_post	ENSG00000185624	5034	prolyl 4-hydroxylase subunit beta	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PO4DB|PO4HB|PROHB	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68541
7.37236937601319e-07	0.361336479445598	0.465	0.232	0.0157731842799802	GGH	Plasma cells	GSE212217_post	ENSG00000137563	8836	gamma-glutamyl hydrolase	GATD10	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68542
8.26444408751106e-07	0.333276301806317	0.435	0.211	0.0176817781252299	FCRL5	Plasma cells	GSE212217_post	ENSG00000143297	83416	Fc receptor like 5	BXMAS1|CD307e|FCRH5|IRTA2	protein_coding	Q96RD9	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68543
9.68627933302375e-07	-0.361926162819281	0.195	0.416	0.0207237946330043	PTPN6	Plasma cells	GSE212217_post	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68544
1.14859672071207e-06	0.352960085210886	0.43	0.211	0.0245742268396348	AC012236.1	Plasma cells	GSE212217_post	NA	NA	NA	NA	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68545
1.86587610852835e-06	0.434841285959233	0.805	0.7	0.039920419341964	PRDX4	Plasma cells	GSE212217_post	ENSG00000123131	10549	peroxiredoxin 4	AOE37-2	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68546
1.93071866248426e-06	-0.344909208293779	0.995	0.989	0.0413077257838506	EEF1A1	Plasma cells	GSE212217_post	ENSG00000156508	1915	eukaryotic translation elongation factor 1 alpha 1	EE1A1|EEF1A|EF1A|EF1A1|EF1alpha1|LENG7	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68547
4.41431468730108e-120	-1.05567225927607	0.891	0.995	9.44442627348066e-116	RPS26	cDCs	GSE212217_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68548
6.33695799206842e-44	-0.622696909157506	0.999	0.999	1.35579216240304e-39	LYZ	cDCs	GSE212217_post	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68549
2.53107775164626e-28	-0.647554140153505	0.403	0.639	5.41524084964718e-24	HLA-DQA2	cDCs	GSE212217_post	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68550
1.59091366912861e-22	-0.374264740786274	0.456	0.682	3.40375979510065e-18	SNHG5	cDCs	GSE212217_post	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68551
2.37297647786374e-22	0.404721475517252	0.581	0.358	5.07698317438946e-18	FCGR2B	cDCs	GSE212217_post	ENSG00000072694	2213	Fc gamma receptor IIb	CD32|CD32B|FCG2|FcgammaRIIb|FCGR2|FcGRIIB	protein_coding	P31994	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68552
1.59142917328588e-20	-0.402755323357283	0.874	0.907	3.40486271624514e-16	RPL21	cDCs	GSE212217_post	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68553
2.94152089208164e-19	0.304883571936765	0.689	0.494	6.29338394860867e-15	BRI3	cDCs	GSE212217_post	ENSG00000164713	25798	brain protein I3	NA	protein_coding	O95415	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68554
4.37504159365177e-17	0.373026978911487	0.899	0.808	9.36040148961796e-13	CEBPD	cDCs	GSE212217_post	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68555
3.32757921989836e-16	0.253974853065592	0.526	0.343	7.11935574097255e-12	TAF10	cDCs	GSE212217_post	ENSG00000166337	6881	TATA-box binding protein associated factor 10	TAF2A|TAF2H|TAFII30	protein_coding	Q12962	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68556
5.88510916747117e-16	0.254002148922631	0.93	0.912	1.25911910638046e-11	CTSZ	cDCs	GSE212217_post	ENSG00000101160	1522	cathepsin Z	CTSX	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68557
7.84237290831786e-16	0.509021703779033	0.777	0.65	1.67787568373461e-11	IFITM3	cDCs	GSE212217_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68558
7.27005540851766e-12	-0.270993830496396	0.992	0.999	1.55542835465235e-07	HLA-DRB5	cDCs	GSE212217_post	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68559
1.78124380798969e-11	-0.254447636971636	0.927	0.965	3.81097112719394e-07	MTRNR2L12	cDCs	GSE212217_post	NA	NA	NA	NA	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68560
4.27325668351577e-11	0.649908612652856	0.272	0.148	9.14263267438199e-07	AREG	cDCs	GSE212217_post	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68561
4.3234356430648e-10	0.283807425180512	0.759	0.661	9.24999055833713e-06	MCL1	cDCs	GSE212217_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68562
4.4874963605567e-09	0.27146953293608	0.6	0.47	9.60099846341107e-05	MYADM	cDCs	GSE212217_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68563
1.18150355337579e-07	0.30427452322429	0.383	0.282	0.00252782685244749	CXCR4	cDCs	GSE212217_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68564
1.62724819238453e-07	0.295261317580182	0.928	0.852	0.0034814975076067	ZFP36	cDCs	GSE212217_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68565
1.69204540274184e-48	-1.13971314801994	0.924	0.995	3.62013113916616e-44	RPS26	pDCs	GSE212217_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68566
5.05515197957993e-12	0.466266589024191	0.92	0.753	1.08154976603113e-07	MT-ATP8	pDCs	GSE212217_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68567
1.77031650279191e-11	0.346742510437063	0.989	0.959	3.78759215772329e-07	RPS29	pDCs	GSE212217_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68568
6.62075696458651e-07	0.325043289440079	1	0.993	0.0141651095257328	MT-ND3	pDCs	GSE212217_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68569
2.01530840968403e-06	0.273482255320596	0.954	0.894	0.0431175234251899	RPL38	pDCs	GSE212217_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	post	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68570
2.68182833477027e-214	-0.266393885846202	1	1	5.73777172224099e-210	HLA-A	CD8+ T cells	GSE212217_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68571
5.42509211813912e-147	-0.493977905786126	0.961	0.97	1.16069845867586e-142	RPS26	CD8+ T cells	GSE212217_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68572
5.07546975255018e-88	-0.274044951403436	0.207	0.342	1.08589675355811e-83	LINC02446	CD8+ T cells	GSE212217_pre	ENSG00000256039	101060038	long intergenic non-protein coding RNA 2446	NA	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68573
6.02342382462576e-88	-0.324664776351821	0.958	0.975	1.28871152727868e-83	MTRNR2L12	CD8+ T cells	GSE212217_pre	NA	NA	NA	NA	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68574
4.5021648655438e-77	-0.279470418856724	0.721	0.816	9.63238172983095e-73	GZMH	CD8+ T cells	GSE212217_pre	ENSG00000100450	2999	granzyme H	CCP-X|CGL-2|CSP-C|CTLA1|CTSGL2	protein_coding	P20718	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68575
3.07372463988902e-73	0.406179609384079	0.802	0.741	6.57623386704256e-69	JUNB	CD8+ T cells	GSE212217_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68576
8.85006999630809e-64	-0.311005298569642	0.509	0.61	1.89347247571012e-59	FGFBP2	CD8+ T cells	GSE212217_pre	ENSG00000137441	83888	fibroblast growth factor binding protein 2	KSP37	protein_coding	Q9BYJ0	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68577
4.6223059419191e-63	-0.454233367616119	0.522	0.612	9.88942356273592e-59	GNLY	CD8+ T cells	GSE212217_pre	ENSG00000115523	10578	granulysin	D2S69E|LAG-2|LAG2|NKG5|TLA519	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68578
1.33559421645955e-59	0.250398893059437	0.883	0.845	2.85750382611522e-55	VIM	CD8+ T cells	GSE212217_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68579
2.20950551547239e-56	0.258618612735537	0.566	0.466	4.72723705035318e-52	CD69	CD8+ T cells	GSE212217_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68580
1.63669681844232e-49	-0.258970209445253	0.264	0.369	3.50171284305733e-45	KLRB1	CD8+ T cells	GSE212217_pre	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68581
4.01752582636588e-49	0.336752116727051	0.681	0.621	8.59549650550979e-45	DUSP2	CD8+ T cells	GSE212217_pre	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68582
5.84119010325956e-40	-0.255742258274895	0.435	0.52	1.24972262259238e-35	GZMB	CD8+ T cells	GSE212217_pre	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68583
2.63065650728555e-39	0.277772984492339	0.659	0.593	5.62828959733742e-35	ZFP36	CD8+ T cells	GSE212217_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68584
7.88270122089166e-35	0.340269891346528	0.384	0.31	1.68650392620977e-30	FOS	CD8+ T cells	GSE212217_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68585
1.69519192786811e-30	0.259914059764379	0.561	0.487	3.62686312967381e-26	JUN	CD8+ T cells	GSE212217_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68586
9.80533167129609e-20	0.252446212054045	0.424	0.375	2.0978507110738e-15	LTB	CD8+ T cells	GSE212217_pre	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68587
0	-0.740488826685577	0.931	0.991	0	RPS26	CD4+ T cells	GSE212217_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68588
1.60396273555792e-229	-0.325333082704584	0.638	0.752	3.43167827272616e-225	GIMAP7	CD4+ T cells	GSE212217_pre	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68589
1.81110064318031e-182	0.509807180315861	0.822	0.761	3.87484982608427e-178	JUNB	CD4+ T cells	GSE212217_pre	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68590
9.46328262121702e-160	-0.427668930741171	0.949	0.971	2.02466931680938e-155	MTRNR2L12	CD4+ T cells	GSE212217_pre	NA	NA	NA	NA	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68591
8.66795987266429e-159	0.632729399881556	0.533	0.413	1.85451001475653e-154	FOS	CD4+ T cells	GSE212217_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68592
2.792144061385e-135	0.361110716131484	0.664	0.563	5.97379221933321e-131	CD69	CD4+ T cells	GSE212217_pre	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68593
2.63715601608755e-115	0.35242057597599	0.58	0.476	5.64219529641932e-111	DUSP1	CD4+ T cells	GSE212217_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68594
1.05954527994205e-113	0.276112867234755	0.904	0.86	2.26689712643601e-109	ZFP36L2	CD4+ T cells	GSE212217_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68595
3.09537938447123e-112	0.38903596931041	0.543	0.445	6.6225641930762e-108	ZFP36	CD4+ T cells	GSE212217_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68596
2.10886147526623e-105	0.43592079347085	0.555	0.461	4.5119091263321e-101	JUN	CD4+ T cells	GSE212217_pre	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68597
1.01916673881475e-49	0.300444914893963	0.32	0.264	2.18050723769416e-45	RPS10	CD4+ T cells	GSE212217_pre	ENSG00000124614	6204	ribosomal protein S10	MGC88819|S10	protein_coding	P46783	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68598
0	-0.740677407897533	0.946	0.991	0	RPS26	Mono/Macro	GSE212217_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68599
1.8846353977822e-181	-0.476215517674573	0.88	0.931	4.03217743355501e-177	RPL21	Mono/Macro	GSE212217_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68600
1.14435075402348e-159	0.430208366949923	0.419	0.206	2.44833843823324e-155	TMEM176A	Mono/Macro	GSE212217_pre	ENSG00000002933	55365	transmembrane protein 176A	HCA112|MS4B1	protein_coding	Q96HP8	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68601
2.91628621713671e-135	-0.427819527083229	0.916	0.964	6.23939436156398e-131	MTRNR2L12	Mono/Macro	GSE212217_pre	NA	NA	NA	NA	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68602
6.20657574747099e-119	0.382393680573016	0.882	0.765	1.32789688117142e-114	CEBPD	Mono/Macro	GSE212217_pre	ENSG00000221869	1052	CCAAT enhancer binding protein delta	C/EBP-delta|CELF|CRP3|NF-IL6-beta	protein_coding	P49716	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68603
6.56854750093052e-115	0.355735247160831	0.507	0.307	1.40534073782409e-110	TMEM176B	Mono/Macro	GSE212217_pre	ENSG00000106565	28959	transmembrane protein 176B	LR8|MS4B2	protein_coding	Q3YBM2	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68604
2.10681201232863e-111	0.25135695520699	0.632	0.397	4.5075243003771e-107	LGALS2	Mono/Macro	GSE212217_pre	ENSG00000100079	3957	galectin 2	HL14	protein_coding	P05162	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68605
8.73773624832838e-109	0.303091532206834	0.998	0.996	1.86943867032986e-104	GAPDH	Mono/Macro	GSE212217_pre	ENSG00000111640	2597	glyceraldehyde-3-phosphate dehydrogenase	GAPD	protein_coding	P04406	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68606
4.51766533835879e-104	0.317325049044002	0.997	0.994	9.66554499141862e-100	VIM	Mono/Macro	GSE212217_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68607
6.67478756923785e-92	-0.30004312257005	1	1	1.42807080043844e-87	MT-ND3	Mono/Macro	GSE212217_pre	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68608
7.89910535282146e-76	0.30557992105133	0.661	0.54	1.69001359023615e-71	SERPINB1	Mono/Macro	GSE212217_pre	ENSG00000021355	1992	serpin family B member 1	EI|ELANH2|LEI|MNEI|PI2	protein_coding	P30740	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68609
2.4418817083713e-72	-0.288151973147861	0.291	0.423	5.22440591506039e-68	SNHG5	Mono/Macro	GSE212217_pre	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68610
5.38325741813103e-72	0.30582356923239	0.802	0.719	1.15174792460913e-67	MCL1	Mono/Macro	GSE212217_pre	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68611
2.93479200053991e-58	0.307443486339086	0.789	0.683	6.27898748515515e-54	VCAN	Mono/Macro	GSE212217_pre	ENSG00000038427	1462	versican	CSPG2|PG-M	protein_coding	P13611	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68612
7.37894753750304e-57	-0.2502227036564	0.849	0.914	1.57872582564878e-52	TXNIP	Mono/Macro	GSE212217_pre	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68613
2.68443763796039e-50	0.265487460911987	0.471	0.355	5.74335432641625e-46	PLBD1	Mono/Macro	GSE212217_pre	ENSG00000121316	79887	phospholipase B domain containing 1	FLJ22662	protein_coding	Q6P4A8	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68614
5.90861677472574e-48	0.263600574782739	0.96	0.94	1.26414855895257e-43	FOS	Mono/Macro	GSE212217_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68615
9.36793472999481e-47	-0.294432487991288	0.961	0.975	2.00426963548239e-42	LYZ	Mono/Macro	GSE212217_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68616
4.69532114511439e-46	-0.600863386644366	0.26	0.357	1.00456395899722e-41	FCGR3A	Mono/Macro	GSE212217_pre	ENSG00000203747	2214	Fc gamma receptor IIIa	CD16|CD16a|FCG3|FcgammaRIIIa|FCGR3|FcGRIIIA	protein_coding	P08637	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68617
2.92754087145634e-44	-0.421019403813913	0.219	0.31	6.26347369448083e-40	AC253572.2	Mono/Macro	GSE212217_pre	NA	NA	NA	NA	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68618
4.69286075258625e-44	0.322901004331046	0.786	0.715	1.00403755801583e-39	NFKBIA	Mono/Macro	GSE212217_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68619
3.05386535118633e-41	0.325576528685782	0.657	0.558	6.53374491886315e-37	MT2A	Mono/Macro	GSE212217_pre	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68620
9.81663879546797e-40	-0.356627836511688	0.927	0.927	2.10026987029037e-35	LST1	Mono/Macro	GSE212217_pre	ENSG00000235915	7940	leukocyte specific transcript 1	B144|D6S49E|LST-1	protein_coding	O00453	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68621
9.01251981507075e-29	-0.311514367325789	0.499	0.562	1.92822861443439e-24	MS4A7	Mono/Macro	GSE212217_pre	ENSG00000166927	58475	membrane spanning 4-domains A7	CD20L4|CFFM4|MS4A8	protein_coding	Q9GZW8	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68622
3.80812921319562e-23	-0.288157584127671	0.412	0.47	8.14749245163203e-19	HMOX1	Mono/Macro	GSE212217_pre	ENSG00000100292	3162	heme oxygenase 1	bK286B10|HO-1	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68623
5.91424929848173e-257	-0.475640236811567	0.98	0.993	1.26535363741017e-252	RPS26	NK cells	GSE212217_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68624
3.90981269919286e-203	0.698260951027555	0.682	0.455	8.36504426992313e-199	CD3E	NK cells	GSE212217_pre	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68625
4.85707498966537e-174	0.616259016874447	0.44	0.198	1.03917119403891e-169	MYOM2	NK cells	GSE212217_pre	ENSG00000274137	9172	myomesin 2	NA	protein_coding	P54296	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68626
2.76774202794125e-148	0.259135693434581	1	1	5.92158406878031e-144	RPS28	NK cells	GSE212217_pre	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68627
9.30421816043221e-141	0.259545765168272	1	1	1.99063747542447e-136	RPS14	NK cells	GSE212217_pre	ENSG00000164587	6208	ribosomal protein S14	EMTB|S14	protein_coding	P62263	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68628
1.67284629589297e-123	-0.563494898365039	0.578	0.718	3.579054650063e-119	IFITM3	NK cells	GSE212217_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68629
5.46102457606399e-120	-0.265162554266973	1	1	1.16838620804889e-115	HLA-A	NK cells	GSE212217_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68630
2.11652324271625e-104	-0.305605932236072	0.998	0.999	4.52830147779142e-100	IFITM1	NK cells	GSE212217_pre	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68631
6.30282633404355e-95	0.429007245586441	0.994	0.992	1.34848969416862e-90	MT-ND4	NK cells	GSE212217_pre	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68632
7.67866646078099e-94	-0.342201525314127	0.12	0.262	1.64285068928409e-89	KIR3DL1	NK cells	GSE212217_pre	ENSG00000276379	3811	killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1	AMB11|CD158E1|CD158e1/2|CD158e2|cl-11|cl-2|KIR|nkat3|NKB1|NKB1B	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68633
6.75460310969298e-66	-0.273284179403389	0.966	0.96	1.44514733531881e-61	RPL21	NK cells	GSE212217_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68634
1.19780533030306e-55	-0.345432819390651	0.968	0.98	2.5627045041834e-51	MTRNR2L12	NK cells	GSE212217_pre	NA	NA	NA	NA	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68635
1.02685826320688e-50	0.275870038775937	0.914	0.873	2.19696325413113e-46	ZFP36L2	NK cells	GSE212217_pre	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68636
8.67255718742074e-43	0.373157617977929	0.653	0.56	1.85549361024867e-38	DUSP1	NK cells	GSE212217_pre	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68637
9.31931495583381e-33	-0.252987057215266	0.904	0.917	1.99386743480064e-28	CD74	NK cells	GSE212217_pre	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68638
1.32999006029418e-32	0.35266159141722	0.737	0.69	2.84551373399939e-28	ZFP36	NK cells	GSE212217_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68639
1.47607905540183e-30	-0.321420928742588	0.938	0.949	3.15807113903221e-26	MT-ATP8	NK cells	GSE212217_pre	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68640
4.67382420621103e-14	0.336638027306505	0.432	0.379	9.99964688918851e-10	FOS	NK cells	GSE212217_pre	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68641
4.37996524969903e-110	-0.731908027893079	0.909	0.995	9.37093565173107e-106	RPS26	B cells	GSE212217_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68642
2.9307259472974e-38	-0.460664459906718	0.959	0.949	6.27028816424278e-34	RPL21	B cells	GSE212217_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68643
1.06988205807297e-31	0.375411411597733	0.94	0.856	2.28901266324712e-27	HLA-DQA1	B cells	GSE212217_pre	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68644
5.16364891243386e-24	-0.389852845462558	0.284	0.45	1.10476268481522e-19	HLA-DQA2	B cells	GSE212217_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68645
1.17722361107189e-22	-0.283805734693875	0.142	0.292	2.5186699158883e-18	IFITM3	B cells	GSE212217_pre	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68646
1.31545759767399e-13	-0.269534226285101	0.848	0.843	2.8144215302235e-09	HLA-DRB5	B cells	GSE212217_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68647
3.33876585236279e-10	0.317908483745597	0.588	0.479	7.14328954113019e-06	NFKBIA	B cells	GSE212217_pre	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68648
5.72990167020469e-65	-0.768654432552392	0.93	0.997	1.22591246234029e-60	RPS26	cDCs	GSE212217_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68649
1.53483032759439e-46	-0.706868367096488	1	0.997	3.2837694858882e-42	LYZ	cDCs	GSE212217_pre	ENSG00000090382	4069	lysozyme	NA	protein_coding	P61626	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68650
2.21623324284567e-28	-0.543672202079923	0.881	0.934	4.7416310230683e-24	RPL21	cDCs	GSE212217_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68651
4.59195918721174e-27	-0.497925782216114	0.421	0.68	9.82449668103952e-23	SNHG5	cDCs	GSE212217_pre	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68652
9.61277695691008e-25	-0.719591036881007	0.482	0.671	2.05665362993091e-20	HLA-DQA2	cDCs	GSE212217_pre	ENSG00000206301	3117	major histocompatibility complex, class II, DQ alpha 1	HLA-DXA	protein_coding	P01906	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68653
1.63466406975465e-19	-0.430394680005382	0.997	0.992	3.49736377724008e-15	HLA-DRB5	cDCs	GSE212217_pre	ENSG00000198502	3127	major histocompatibility complex, class II, DR beta 5	NA	protein_coding	Q30154	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68654
2.4844078496541e-18	-0.362177808899201	0.956	0.985	5.31539059433495e-14	HLA-A	cDCs	GSE212217_pre	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68655
5.22121525938433e-15	0.320998312578322	1	0.997	1.11707900474528e-10	VIM	cDCs	GSE212217_pre	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68656
3.53223707590427e-12	0.289655911604501	0.274	0.125	7.55722122389719e-08	MTRNR2L8	cDCs	GSE212217_pre	NA	NA	NA	NA	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68657
3.98413680955887e-12	-0.281648033747891	0.93	0.937	8.52406070405119e-08	RPL27A	cDCs	GSE212217_pre	ENSG00000166441	6157	ribosomal protein L27a	L27A	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68658
6.46006151406894e-10	0.250393035319151	0.388	0.236	1.38213016093505e-05	BHLHE40	cDCs	GSE212217_pre	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68659
1.37352764463886e-09	0.26767681623546	0.615	0.441	2.93866239570485e-05	FCGR2B	cDCs	GSE212217_pre	ENSG00000072694	2213	Fc gamma receptor IIb	CD32|CD32B|FCG2|FcgammaRIIb|FCGR2|FcGRIIB	protein_coding	P31994	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68660
1.97899634427883e-08	-0.272953468092868	0.772	0.84	0.000423406267858456	TYMP	cDCs	GSE212217_pre	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68661
1.27900224845441e-07	0.311319890021217	0.518	0.393	0.0027364253105682	DDIT4	cDCs	GSE212217_pre	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68662
1.37826508906749e-07	0.330170184343884	0.257	0.147	0.0029487981580599	AREG	cDCs	GSE212217_pre	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68663
2.06593422895222e-07	0.30378631841118	0.877	0.828	0.00442006628284327	ZFP36	cDCs	GSE212217_pre	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68664
6.4032088586758e-22	-0.705725724580561	0.94	0.993	1.36996653531369e-17	RPS26	pDCs	GSE212217_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68665
1.21869271224236e-11	-0.449260232691223	0.335	0.604	2.60739305784253e-07	SNHG5	pDCs	GSE212217_pre	ENSG00000203875	NA	NA	bA33E24.2|C6orf160|LINC00044|MGC16362|NCRNA00044|U50HG	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68666
1.7579652982907e-08	-0.469806148080176	0.932	0.938	0.000376116675569295	RPL21	pDCs	GSE212217_pre	ENSG00000122026	6144	ribosomal protein L21	DKFZp686C06101|FLJ27458|L21|MGC104274|MGC104275|MGC71252	protein_coding	P46778	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68667
1.74161729385147e-06	-0.574653595361238	0.912	0.956	0.0372619020019522	MTRNR2L12	pDCs	GSE212217_pre	NA	NA	NA	NA	NA	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68668
1.14529961882967e-12	-0.738349066077746	0.879	0.95	2.45036853448607e-08	RPS26	Plasma cells	GSE212217_pre	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68669
4.56389794705854e-08	0.553658380803147	0.436	0.185	0.000976445965773174	LILRB4	Plasma cells	GSE212217_pre	ENSG00000278555	11006	leukocyte immunoglobulin like receptor B4	CD85k|HM18|ILT3|LIR-5|LIR5	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68670
2.86326552807587e-07	-0.45337622657475	0.139	0.365	0.00612595659731832	TSPO	Plasma cells	GSE212217_pre	ENSG00000100300	706	translocator protein	BZRP|DBI|IBP|MBR|mDRC|PBR|pk18|PKBS|TSPO1	protein_coding	P30536	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68671
1.0365658884941e-06	0.401591968213892	0.394	0.175	0.0221773271843312	GAS6	Plasma cells	GSE212217_pre	ENSG00000183087	2621	growth arrest specific 6	AXLLG|AXSF|DKFZp666G247|FLJ34709	protein_coding	Q14393	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68672
1.06809569287289e-06	0.424491415424095	0.8	0.645	0.0228519073490155	CRELD2	Plasma cells	GSE212217_pre	ENSG00000184164	79174	cysteine rich with EGF like domains 2	MGC11256	protein_coding	NA	GSE212217	GSE212217	Endometrial cancer	Epigenetic MMRd endometrial carcinoma	Immunotherapy	pre	pembrolizumab	Homo sapiens	patients	Peripheral blood mononuclear cells	pre (resistant 9, sensitive 12); post (resistant 9, sensitive 12)	42	224785	Public on Oct 07, 2022	36301137	This dataset has 22 patients, 20 of whom has both pre- and post-treatment samples.	PRJNA874603	10x genomics	 CellRanger	Endometrial_cancer	Immunotherapy	68673
0	0.697372133455526	0.964	0.958	0	SH3BGRL3	CD8+ T cells	PMID34715028_post	ENSG00000142669	83442	SH3 domain binding glutamate rich protein like 3	NA	protein_coding	Q9H299	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68674
0	0.957772709519381	0.878	0.714	0	CD52	CD8+ T cells	PMID34715028_post	ENSG00000169442	1043	CD52 molecule	CDW52|EDDM5|HE5	protein_coding	P31358	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68675
0	-0.53278820322177	0.061	0.332	0	ZC3H12A	CD8+ T cells	PMID34715028_post	ENSG00000163874	80149	zinc finger CCCH-type containing 12A	FLJ23231|MCPIP1|Regnase-1	protein_coding	Q5D1E8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68676
0	-2.06768877547879	0.599	0.972	0	JUN	CD8+ T cells	PMID34715028_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68677
0	-0.613187089136714	0.115	0.443	0	BCAS2	CD8+ T cells	PMID34715028_post	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68678
0	0.610897689632527	0.919	0.813	0	CD2	CD8+ T cells	PMID34715028_post	ENSG00000116824	914	CD2 molecule	SRBC	protein_coding	P06729	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68679
0	-1.15993738063464	0.041	0.593	0	TENT5C	CD8+ T cells	PMID34715028_post	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68680
0	1.92095338126395	0.926	0.601	0	TXNIP	CD8+ T cells	PMID34715028_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68681
0	-1.06039735801182	0.573	0.894	0	MCL1	CD8+ T cells	PMID34715028_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68682
0	-1.19651423934183	0.011	0.374	0	LMNA	CD8+ T cells	PMID34715028_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68683
0	-0.702916477773285	0.484	0.711	0	TAGLN2	CD8+ T cells	PMID34715028_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68684
0	-0.669430878808929	0.192	0.471	0	CACYBP	CD8+ T cells	PMID34715028_post	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68685
0	-0.619056866567565	0.13	0.443	0	IER5	CD8+ T cells	PMID34715028_post	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68686
0	-0.573888161862328	0.159	0.432	0	IVNS1ABP	CD8+ T cells	PMID34715028_post	ENSG00000116679	10625	influenza virus NS1A binding protein	ARA3|HSPC068|KIAA0850|KLHL39|ND1|NS-1|NS1-BP	protein_coding	Q9Y6Y0	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68687
0	-0.819261080986024	0.619	0.776	0	RGS1	CD8+ T cells	PMID34715028_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68688
0	-1.76759774486119	0.128	0.683	0	RGS2	CD8+ T cells	PMID34715028_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68689
0	-1.28164977739704	0.309	0.765	0	BTG2	CD8+ T cells	PMID34715028_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68690
0	0.607772244232678	0.682	0.38	0	TRAF3IP3	CD8+ T cells	PMID34715028_post	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68691
0	-1.44412416678553	0.022	0.523	0	ATF3	CD8+ T cells	PMID34715028_post	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68692
0	-0.407226174829197	0.06	0.294	0	DUSP10	CD8+ T cells	PMID34715028_post	ENSG00000143507	11221	dual specificity phosphatase 10	MKP-5|MKP5	protein_coding	Q9Y6W6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68693
0	-0.689461974927076	0.177	0.512	0	ODC1	CD8+ T cells	PMID34715028_post	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68694
0	-0.755625911921537	0.094	0.413	0	RHOB	CD8+ T cells	PMID34715028_post	ENSG00000143878	388	ras homolog family member B	ARH6|ARHB|MST081|RHOH6	protein_coding	P62745	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68695
0	-0.51969230862307	0.062	0.33	0	FOSL2	CD8+ T cells	PMID34715028_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68696
0	-1.60579762938293	0.24	0.832	0	YPEL5	CD8+ T cells	PMID34715028_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68697
0	-1.7658321455788	0.647	0.97	0	SRSF7	CD8+ T cells	PMID34715028_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68698
0	-0.64709724536168	0.26	0.528	0	REL	CD8+ T cells	PMID34715028_post	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68699
0	0.722401230997176	0.638	0.345	0	CYTOR	CD8+ T cells	PMID34715028_post	ENSG00000222041	112597	cytoskeleton regulator RNA	C2orf59|LINC00152|MGC4677|NCRNA00152	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68700
0	-1.67409262312255	0.666	0.97	0	DUSP2	CD8+ T cells	PMID34715028_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68701
0	-0.929432864602865	0.936	0.978	0	CXCR4	CD8+ T cells	PMID34715028_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68702
0	-1.88334887833102	0.215	0.862	0	NR4A2	CD8+ T cells	PMID34715028_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68703
0	0.521771699531732	0.632	0.381	0	ANKRD44	CD8+ T cells	PMID34715028_post	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68704
0	-1.82348787396293	0.294	0.753	0	HSPD1	CD8+ T cells	PMID34715028_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68705
0	-1.30580412298963	0.345	0.717	0	HSPE1	CD8+ T cells	PMID34715028_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68706
0	-0.725615046222288	0.307	0.616	0	NOP58	CD8+ T cells	PMID34715028_post	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68707
0	-0.661549883214895	0.184	0.452	0	CTLA4	CD8+ T cells	PMID34715028_post	ENSG00000163599	1493	cytotoxic T-lymphocyte associated protein 4	CD|CD152|CELIAC3|CTLA-4|GSE|IDDM12	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68708
0	-1.12019609989247	0.495	0.78	0	TUBA4A	CD8+ T cells	PMID34715028_post	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68709
0	-0.691485192546527	0.329	0.651	0	BHLHE40	CD8+ T cells	PMID34715028_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68710
0	0.617587064610798	0.537	0.237	0	OXNAD1	CD8+ T cells	PMID34715028_post	ENSG00000154814	92106	oxidoreductase NAD binding domain containing 1	MGC15763	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68711
0	-0.651994508956939	0.256	0.529	0	CMC1	CD8+ T cells	PMID34715028_post	ENSG00000187118	152100	C-X9-C motif containing 1	C3orf68|MGC61571	protein_coding	Q7Z7K0	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68712
0	-0.800321928462379	0.04	0.475	0	CSRNP1	CD8+ T cells	PMID34715028_post	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68713
0	0.473884251741693	0.352	0.136	0	CXCR6	CD8+ T cells	PMID34715028_post	ENSG00000172215	10663	C-X-C motif chemokine receptor 6	BONZO|CD186|STRL33|TYMSTR	protein_coding	O00574	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68714
0	0.598527792588347	0.269	0.028	0	CISH	CD8+ T cells	PMID34715028_post	ENSG00000114737	1154	cytokine inducible SH2 containing protein	CIS|CIS-1|G18|SOCS	protein_coding	Q9NSE2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68715
0	-0.668159884645721	0.27	0.587	0	SELENOK	CD8+ T cells	PMID34715028_post	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68716
0	0.819650951965266	0.995	0.978	0	MTRNR2L12	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68717
0	0.475720242704999	0.378	0.146	0	CLDND1	CD8+ T cells	PMID34715028_post	ENSG00000080822	56650	claudin domain containing 1	C3orf4|Z38	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68718
0	-0.713735310803282	0.158	0.444	0	NFKBIZ	CD8+ T cells	PMID34715028_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68719
0	-0.501408018403428	0.086	0.361	0	TIPARP	CD8+ T cells	PMID34715028_post	ENSG00000163659	25976	TCDD inducible poly(ADP-ribose) polymerase	ARTD14|DDF1|DKFZP434J214|DKFZp686N0351|PARP-1|PARP-7|PARP7|pART14|RM1	protein_coding	Q7Z3E1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68720
0	-0.680268879065334	0.439	0.732	0	CCNL1	CD8+ T cells	PMID34715028_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68721
0	-0.68579069840071	0.022	0.313	0	AREG	CD8+ T cells	PMID34715028_post	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68722
0	-0.608054561740378	0.033	0.35	0	RASGEF1B	CD8+ T cells	PMID34715028_post	ENSG00000138670	153020	RasGEF domain family member 1B	FLJ31695|GPIG4	protein_coding	Q0VAM2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68723
0	-0.558624455216769	0.416	0.658	0	HMGB2	CD8+ T cells	PMID34715028_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68724
0	-0.762675563271044	0.613	0.932	0	GZMK	CD8+ T cells	PMID34715028_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68725
0	-0.631875371510826	0.139	0.461	0	PDE4D	CD8+ T cells	PMID34715028_post	ENSG00000113448	5144	phosphodiesterase 4D	DPDE3	protein_coding	Q08499	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68726
0	-0.666129785203425	0.042	0.327	0	ENC1	CD8+ T cells	PMID34715028_post	ENSG00000171617	8507	ectodermal-neural cortex 1	ENC-1|KLHL37|NRPB|PIG10|TP53I10	protein_coding	O14682	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68727
0	0.406319577233307	0.34	0.1	0	ERAP2	CD8+ T cells	PMID34715028_post	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68728
0	-0.532291802138648	0.267	0.53	0	CHD1	CD8+ T cells	PMID34715028_post	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68729
0	-0.714723900333877	0.418	0.715	0	IRF1	CD8+ T cells	PMID34715028_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68730
0	-0.488818996641391	0.245	0.51	0	UBE2B	CD8+ T cells	PMID34715028_post	ENSG00000119048	7320	ubiquitin conjugating enzyme E2 B	HHR6B|RAD6B|UBC2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68731
0	-2.18120543076894	0.417	0.96	0	DUSP1	CD8+ T cells	PMID34715028_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68732
0	-0.520414247963796	0.155	0.421	0	SERPINB9	CD8+ T cells	PMID34715028_post	ENSG00000170542	5272	serpin family B member 9	CAP3|PI9	protein_coding	P50453	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68733
0	-0.427397839916211	1	1	0	HLA-A	CD8+ T cells	PMID34715028_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68734
0	-0.368741210295276	0.999	1	0	HLA-C	CD8+ T cells	PMID34715028_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68735
0	-0.501392950432997	1	1	0	HLA-B	CD8+ T cells	PMID34715028_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68736
0	-1.73152266202912	0.621	0.812	0	HSPA1A	CD8+ T cells	PMID34715028_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68737
0	-1.54125843499205	0.613	0.796	0	HSPA1B	CD8+ T cells	PMID34715028_post	ENSG00000232804	3304	heat shock protein family A (Hsp70) member 1B	HSP70-2	protein_coding	P0DMV9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68738
0	-0.650691066199073	0.068	0.323	0	NEU1	CD8+ T cells	PMID34715028_post	ENSG00000184494	4758	neuraminidase 1	NEU	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68739
0	-1.16291697191137	0.287	0.587	0	HLA-DQA1	CD8+ T cells	PMID34715028_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68740
0	-1.16319415280208	0.316	0.661	0	HLA-DQB1	CD8+ T cells	PMID34715028_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68741
0	0.550304241209766	0.417	0.177	0	FKBP5	CD8+ T cells	PMID34715028_post	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68742
0	-1.77936710174654	0.757	0.968	0	HSP90AB1	CD8+ T cells	PMID34715028_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68743
0	-0.551965376653637	0.113	0.432	0	PTP4A1	CD8+ T cells	PMID34715028_post	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68744
0	-0.7229021787687	0.887	0.98	0	PNRC1	CD8+ T cells	PMID34715028_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68745
0	-2.22565481454334	0.553	0.978	0	TNFAIP3	CD8+ T cells	PMID34715028_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68746
0	-0.880939131175648	0.194	0.558	0	CITED2	CD8+ T cells	PMID34715028_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68747
0	-0.88996022645974	0.658	0.879	0	EZR	CD8+ T cells	PMID34715028_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68748
0	-0.503887810095652	0.021	0.304	0	ARL4A	CD8+ T cells	PMID34715028_post	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68749
0	-1.08698241212351	0.347	0.739	0	CYCS	CD8+ T cells	PMID34715028_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68750
0	0.677840010595386	0.685	0.387	0	IKZF1	CD8+ T cells	PMID34715028_post	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68751
0	-0.536691061262268	0.191	0.49	0	SBDS	CD8+ T cells	PMID34715028_post	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68752
0	-0.439920981539946	0.145	0.398	0	HBP1	CD8+ T cells	PMID34715028_post	ENSG00000283847	26959	HMG-box transcription factor 1	NA	protein_coding	O60381	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68753
0	0.731785029315005	0.314	0	0	LRRN3	CD8+ T cells	PMID34715028_post	ENSG00000173114	54674	leucine rich repeat neuronal 3	FIGLER5|FLJ11129|NLRR3	protein_coding	Q9H3W5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68754
0	-0.615537398400172	0.083	0.41	0	IFRD1	CD8+ T cells	PMID34715028_post	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68755
0	-0.893158534832651	0.27	0.608	0	AC016831.7	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68756
0	-0.479085727583505	0.067	0.305	0	INSIG1	CD8+ T cells	PMID34715028_post	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68757
0	-0.774756220857955	0.214	0.577	0	DNAJB6	CD8+ T cells	PMID34715028_post	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68758
0	-1.47162463220285	0.459	0.821	0	SAT1	CD8+ T cells	PMID34715028_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68759
0	-0.743966307892271	0.3	0.625	0	DDX3X	CD8+ T cells	PMID34715028_post	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68760
0	-0.93196973387446	0.291	0.63	0	TSPYL2	CD8+ T cells	PMID34715028_post	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68761
0	-0.998809338930857	0.736	0.925	0	TSC22D3	CD8+ T cells	PMID34715028_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68762
0	-0.553526833654638	0.416	0.65	0	IDS	CD8+ T cells	PMID34715028_post	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68763
0	-1.51467423431265	0.523	0.817	0	DUSP4	CD8+ T cells	PMID34715028_post	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68764
0	-0.56517271846777	0.854	0.961	0	SARAF	CD8+ T cells	PMID34715028_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68765
0	-0.651970172475703	0.141	0.484	0	SDCBP	CD8+ T cells	PMID34715028_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68766
0	-0.62468176922409	0.256	0.517	0	FABP5	CD8+ T cells	PMID34715028_post	ENSG00000164687	2171	fatty acid binding protein 5	E-FABP|KFABP|PA-FABP	protein_coding	Q01469	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68767
0	-0.759297922612417	0.017	0.294	0	GEM	CD8+ T cells	PMID34715028_post	ENSG00000164949	2669	GTP binding protein overexpressed in skeletal muscle	KIR	protein_coding	P55040	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68768
0	-0.876325056790166	0.45	0.761	0	RNF19A	CD8+ T cells	PMID34715028_post	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68769
0	-0.559911369591348	0.851	0.943	0	YWHAZ	CD8+ T cells	PMID34715028_post	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68770
0	-2.16605756261172	0.287	0.895	0	DNAJA1	CD8+ T cells	PMID34715028_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68771
0	-0.593992328691265	0.198	0.518	0	ZFAND5	CD8+ T cells	PMID34715028_post	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68772
0	-1.79138809964186	0.368	0.657	0	ANXA1	CD8+ T cells	PMID34715028_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68773
0	-0.492792717771261	0.099	0.348	0	CKS2	CD8+ T cells	PMID34715028_post	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68774
0	-0.887247904928891	0.014	0.416	0	NR4A3	CD8+ T cells	PMID34715028_post	ENSG00000119508	8013	nuclear receptor subfamily 4 group A member 3	CHN|CSMF|MINOR|NOR1	protein_coding	Q92570	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68775
0	-0.914900304354591	0.39	0.741	0	HSPA5	CD8+ T cells	PMID34715028_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68776
0	-0.457558892271674	0.11	0.375	0	TUBB4B	CD8+ T cells	PMID34715028_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68777
0	-0.935760600641772	0.621	0.9	0	IFITM1	CD8+ T cells	PMID34715028_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68778
0	0.529524607541681	0.601	0.343	0	NAP1L4	CD8+ T cells	PMID34715028_post	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68779
0	-0.890882666649799	0.957	0.988	0	FTH1	CD8+ T cells	PMID34715028_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68780
0	0.72126499851617	0.741	0.638	0	CTSW	CD8+ T cells	PMID34715028_post	ENSG00000172543	1521	cathepsin W	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68781
0	0.698913359427268	0.598	0.299	0	PTPRCAP	CD8+ T cells	PMID34715028_post	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68782
0	-0.852318934641589	0.323	0.657	0	BIRC3	CD8+ T cells	PMID34715028_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68783
0	-0.61262917242922	0.053	0.306	0	FXYD2	CD8+ T cells	PMID34715028_post	ENSG00000137731	486	FXYD domain containing ion transport regulator 2	ATP1G1|HOMG2|MGC12372	protein_coding	P54710	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68784
0	0.570536085510097	0.356	0.104	0	JAML	CD8+ T cells	PMID34715028_post	ENSG00000160593	120425	junction adhesion molecule like	AMICA|AMICA1|Gm638	protein_coding	Q86YT9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68785
0	-1.27741059619681	0.302	0.594	0	CRTAM	CD8+ T cells	PMID34715028_post	ENSG00000109943	56253	cytotoxic and regulatory T cell molecule	CD355	protein_coding	O95727	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68786
0	-1.82798180363189	0.831	0.984	0	HSPA8	CD8+ T cells	PMID34715028_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68787
0	0.570041729667801	0.888	0.753	0	ETS1	CD8+ T cells	PMID34715028_post	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68788
0	-1.44379781234993	0.592	0.95	0	KLF6	CD8+ T cells	PMID34715028_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68789
0	0.670614390344159	0.738	0.464	0	CELF2	CD8+ T cells	PMID34715028_post	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68790
0	-1.43792689253503	0.169	0.716	0	CREM	CD8+ T cells	PMID34715028_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68791
0	-0.535947843880688	0.909	0.967	0	SRGN	CD8+ T cells	PMID34715028_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68792
0	-0.839667126447895	0.106	0.492	0	DUSP5	CD8+ T cells	PMID34715028_post	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68793
0	-0.824492303279789	0.088	0.324	0	BAG3	CD8+ T cells	PMID34715028_post	ENSG00000151929	9531	BAG cochaperone 3	NA	protein_coding	O95817	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68794
0	-1.00946381479079	0.287	0.673	0	SLC2A3	CD8+ T cells	PMID34715028_post	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68795
0	-0.643657977121675	0.098	0.441	0	KLRG1	CD8+ T cells	PMID34715028_post	ENSG00000139187	10219	killer cell lectin like receptor G1	2F1|CLEC15A|MAFA|MAFA-L	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68796
0	-1.26204688146427	0.661	0.922	0	CD69	CD8+ T cells	PMID34715028_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68797
0	-0.795900092784567	0.475	0.731	0	CLEC2B	CD8+ T cells	PMID34715028_post	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68798
0	-0.558878033901145	0.41	0.664	0	CDKN1B	CD8+ T cells	PMID34715028_post	ENSG00000111276	1027	cyclin dependent kinase inhibitor 1B	KIP1|P27KIP1	protein_coding	P46527	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68799
0	0.677350027622335	0.823	0.613	0	KIAA1551	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68800
0	-1.14806901001795	0.162	0.646	0	TUBA1A	CD8+ T cells	PMID34715028_post	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68801
0	-1.19562693073801	0.028	0.415	0	NR4A1	CD8+ T cells	PMID34715028_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68802
0	1.89930737147548	0.964	0.872	0	RPS26	CD8+ T cells	PMID34715028_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68803
0	-0.669391830536703	0.526	0.737	0	PTGES3	CD8+ T cells	PMID34715028_post	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68804
0	-1.02045999540614	0.151	0.493	0	IFNG	CD8+ T cells	PMID34715028_post	ENSG00000111537	3458	interferon gamma	NA	protein_coding	P01579	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68805
0	-0.744066523893232	0.188	0.476	0	PHLDA1	CD8+ T cells	PMID34715028_post	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68806
0	-0.588986693437456	0.157	0.435	0	VPS37B	CD8+ T cells	PMID34715028_post	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68807
0	-1.75479642564124	0.957	1	0	UBC	CD8+ T cells	PMID34715028_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68808
0	-2.12541637468541	0.243	0.773	0	HSPH1	CD8+ T cells	PMID34715028_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68809
0	-1.98944755295251	0.249	0.796	0	RGCC	CD8+ T cells	PMID34715028_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68810
0	0.60068302431644	0.601	0.323	0	TRAC	CD8+ T cells	PMID34715028_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68811
0	0.588978814728353	0.971	0.975	0	RPS29	CD8+ T cells	PMID34715028_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68812
0	-2.93442795194829	0.273	0.935	0	FOS	CD8+ T cells	PMID34715028_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68813
0	0.347965695540915	0.265	0.063	0	ASB2	CD8+ T cells	PMID34715028_post	ENSG00000278693	51676	ankyrin repeat and SOCS box containing 2	ASB-2	protein_coding	Q96Q27	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68814
0	-2.60158448467976	0.865	0.987	0	HSP90AA1	CD8+ T cells	PMID34715028_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68815
0	-0.714129945524149	0.342	0.676	0	EIF5	CD8+ T cells	PMID34715028_post	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68816
0	0.38132207005609	0.308	0.089	0	GABPB1-AS1	CD8+ T cells	PMID34715028_post	ENSG00000244879	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68817
0	0.341030842062322	0.286	0.086	0	MMP25-AS1	CD8+ T cells	PMID34715028_post	ENSG00000261971	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68818
0	1.15243732105666	0.983	0.91	0	IL32	CD8+ T cells	PMID34715028_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68819
0	0.701982887664699	0.61	0.315	0	SOCS1	CD8+ T cells	PMID34715028_post	ENSG00000185338	8651	suppressor of cytokine signaling 1	Cish1|JAB|SOCS-1|SSI-1|TIP3	protein_coding	O15524	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68820
0	0.510397861607654	0.992	0.987	0	PFN1	CD8+ T cells	PMID34715028_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68821
0	-0.6439896739157	0.054	0.399	0	PER1	CD8+ T cells	PMID34715028_post	ENSG00000179094	5187	period circadian regulator 1	PER|RIGUI	protein_coding	O15534	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68822
0	0.636312947058312	0.855	0.797	0	RPL26	CD8+ T cells	PMID34715028_post	ENSG00000161970	6154	ribosomal protein L26	L26	protein_coding	P61254	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68823
0	-1.04332113375462	0.734	0.932	0	UBB	CD8+ T cells	PMID34715028_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68824
0	0.623021207870589	0.564	0.283	0	SLFN5	CD8+ T cells	PMID34715028_post	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68825
0	-0.969589082699922	0.961	0.998	0	EIF1	CD8+ T cells	PMID34715028_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68826
0	-0.50318712096927	0.069	0.342	0	KPNA2	CD8+ T cells	PMID34715028_post	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68827
0	-1.79569149832332	0.928	0.999	0	H3F3B	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68828
0	-0.485179530808233	0.109	0.392	0	JMJD6	CD8+ T cells	PMID34715028_post	ENSG00000070495	23210	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	KIAA0585|PTDSR|PTDSR1	protein_coding	Q6NYC1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68829
0	-0.575959655139749	0.022	0.34	0	SOCS3	CD8+ T cells	PMID34715028_post	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68830
0	0.521372272534679	0.984	0.966	0	ACTG1	CD8+ T cells	PMID34715028_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68831
0	-0.901175313869986	0.196	0.561	0	METRNL	CD8+ T cells	PMID34715028_post	ENSG00000275031	284207	meteorin like, glial cell differentiation regulator	NA	protein_coding	Q641Q3	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68832
0	-1.57475779479048	0.119	0.639	0	PMAIP1	CD8+ T cells	PMID34715028_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68833
0	0.583651677397671	0.924	0.909	0	ATP5F1E	CD8+ T cells	PMID34715028_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68834
0	0.749112616331426	0.871	0.756	0	PPDPF	CD8+ T cells	PMID34715028_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68835
0	-0.674716882457049	0.135	0.449	0	GADD45B	CD8+ T cells	PMID34715028_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68836
0	-1.41126168806435	0.073	0.61	0	TNFSF9	CD8+ T cells	PMID34715028_post	ENSG00000125657	8744	TNF superfamily member 9	4-1BB-L|4-1BBL|CD137L	protein_coding	P41273	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68837
0	-2.35043801492371	0.494	0.976	0	JUNB	CD8+ T cells	PMID34715028_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68838
0	-0.989035128213823	0.255	0.67	0	IER2	CD8+ T cells	PMID34715028_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68839
0	-2.46736531226324	0.511	0.941	0	DNAJB1	CD8+ T cells	PMID34715028_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68840
0	-1.26966398877648	0.097	0.447	0	KLF2	CD8+ T cells	PMID34715028_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68841
0	-2.38072660419017	0.849	0.999	0	JUND	CD8+ T cells	PMID34715028_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68842
0	-1.26347003431737	0.735	0.933	0	ZFP36	CD8+ T cells	PMID34715028_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68843
0	-0.56048387371582	0.045	0.36	0	SERTAD1	CD8+ T cells	PMID34715028_post	ENSG00000197019	29950	SERTA domain containing 1	SEI1|TRIP-Br1	protein_coding	Q9UHV2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68844
0	-0.462451531473978	0.107	0.356	0	DEDD2	CD8+ T cells	PMID34715028_post	ENSG00000160570	162989	death effector domain containing 2	FLAME-3	protein_coding	Q8WXF8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68845
0	-0.467469043274196	0.094	0.346	0	BCL3	CD8+ T cells	PMID34715028_post	ENSG00000069399	602	BCL3 transcription coactivator	BCL4|D19S37	protein_coding	P20749	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68846
0	-2.07906118461472	0.123	0.857	0	FOSB	CD8+ T cells	PMID34715028_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68847
0	-1.47238241605985	0.185	0.806	0	PPP1R15A	CD8+ T cells	PMID34715028_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68848
0	-1.76258059460507	0.113	0.75	0	ZNF331	CD8+ T cells	PMID34715028_post	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68849
0	-1.45472427071015	0.121	0.672	0	MYADM	CD8+ T cells	PMID34715028_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68850
0	-0.821446256088071	0.145	0.562	0	UBE2S	CD8+ T cells	PMID34715028_post	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68851
0	-0.573126266910857	0.206	0.484	0	DDX3Y	CD8+ T cells	PMID34715028_post	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68852
0	0.537001664308604	0.54	0.268	0	PIK3IP1	CD8+ T cells	PMID34715028_post	ENSG00000100100	113791	phosphoinositide-3-kinase interacting protein 1	HGFL|MGC17330|TrIP	protein_coding	Q96FE7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68853
0	-0.58024229273214	0.154	0.436	0	PIM3	CD8+ T cells	PMID34715028_post	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68854
0	-0.504426720425275	0.163	0.442	0	BTG3	CD8+ T cells	PMID34715028_post	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68855
0	0.623303698017718	0.971	0.901	0	MT-ND2	CD8+ T cells	PMID34715028_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68856
0	0.641084392914077	1	0.999	0	MT-CO1	CD8+ T cells	PMID34715028_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68857
0	0.534292364994441	0.982	0.944	0	MT-ATP8	CD8+ T cells	PMID34715028_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68858
0	0.651947692235389	0.987	0.958	0	MT-ND3	CD8+ T cells	PMID34715028_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68859
0	0.59339636771291	0.993	0.973	0	MT-CYB	CD8+ T cells	PMID34715028_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68860
1.68393672541697e-307	-0.487680026010493	0.092	0.332	2.95143589863832e-303	MAP3K8	CD8+ T cells	PMID34715028_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68861
1.64229454166588e-305	-0.481242525570255	0.08	0.315	2.87844964317778e-301	KDM6B	CD8+ T cells	PMID34715028_post	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68862
5.26386077692268e-305	-0.889875530424844	0.25	0.499	9.22596878371237e-301	VCAM1	CD8+ T cells	PMID34715028_post	ENSG00000162692	7412	vascular cell adhesion molecule 1	CD106	protein_coding	P19320	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68863
9.3602855371374e-301	0.444636092263151	0.483	0.255	1.64057724609407e-296	FKBP1A	CD8+ T cells	PMID34715028_post	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68864
2.72688694511791e-300	-0.403702801214767	0.074	0.304	4.77941474870816e-296	STX11	CD8+ T cells	PMID34715028_post	ENSG00000135604	8676	syntaxin 11	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68865
5.39561185317167e-300	-0.557646665587023	0.386	0.618	9.45688889505398e-296	CRIP1	CD8+ T cells	PMID34715028_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68866
1.34179653735637e-297	-0.625167861819348	0.951	0.987	2.35176679102451e-293	CD74	CD8+ T cells	PMID34715028_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68867
2.0030150732686e-296	-0.571804249734579	0.433	0.661	3.51068451891788e-292	STAT3	CD8+ T cells	PMID34715028_post	ENSG00000168610	6774	signal transducer and activator of transcription 3	APRF	protein_coding	P40763	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68868
3.27723838944946e-295	0.481092593518606	0.415	0.192	5.74401572518807e-291	AOAH	CD8+ T cells	PMID34715028_post	ENSG00000136250	313	acyloxyacyl hydrolase	NA	protein_coding	P28039	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68869
3.96110796244425e-293	0.479300608251721	0.729	0.543	6.94263392577604e-289	AES	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68870
5.97825727057963e-293	0.468999378405463	0.771	0.589	1.04780915181449e-288	LCP2	CD8+ T cells	PMID34715028_post	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68871
4.55954215593146e-290	0.368512734920984	0.373	0.16	7.99150953670107e-286	UBASH3A	CD8+ T cells	PMID34715028_post	ENSG00000160185	53347	ubiquitin associated and SH3 domain containing A	CLIP4|STS-2|TULA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68872
3.050578184166e-287	-0.559065486439178	0.398	0.625	5.34674838338775e-283	SQSTM1	CD8+ T cells	PMID34715028_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68873
2.98094508200187e-286	0.440855109244947	0.577	0.348	5.22470244522469e-282	APBB1IP	CD8+ T cells	PMID34715028_post	ENSG00000077420	54518	amyloid beta precursor protein binding family B member 1 interacting protein	INAG1|RIAM	protein_coding	Q7Z5R6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68874
1.19866309436424e-285	0.365709083427076	0.267	0.09	2.1008968054922e-281	TRG-AS1	CD8+ T cells	PMID34715028_post	ENSG00000281103	100506776	T cell receptor gamma locus antisense RNA 1	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68875
1.60493266098471e-283	-0.416183508506563	0.141	0.381	2.81296547490791e-279	MIDN	CD8+ T cells	PMID34715028_post	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68876
4.71762797376358e-279	-0.412958759642408	0.094	0.322	8.26858654961543e-275	PPP1R15B	CD8+ T cells	PMID34715028_post	ENSG00000158615	84919	protein phosphatase 1 regulatory subunit 15B	FLJ14744	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68877
1.42446392618457e-277	-0.951726444902769	0.045	0.259	2.49665792342369e-273	TRBV7-2	CD8+ T cells	PMID34715028_post	ENSG00000282506	NA	NA	TCRBV6S5A1N1|TCRBV7S2|TRBV72	TR_V_gene	A0A1B0GXF2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68878
3.36703470661559e-277	0.404243819695649	0.466	0.243	5.90140173028514e-273	IL16	CD8+ T cells	PMID34715028_post	ENSG00000172349	3603	interleukin 16	FLJ16806|FLJ42735|HsT19289|IL-16|LCF|prIL-16	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68879
1.12900798193976e-276	-0.516122955892843	0.311	0.548	1.97881228994583e-272	GSPT1	CD8+ T cells	PMID34715028_post	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68880
5.29661202773552e-275	-0.801544601033843	0.683	0.817	9.28337190101205e-271	HLA-DRB1	CD8+ T cells	PMID34715028_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68881
2.46902009584774e-273	-0.608974143895699	0.409	0.614	4.32745152199233e-269	LDHA	CD8+ T cells	PMID34715028_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68882
3.25997294812015e-272	-0.503187445523938	0.502	0.699	5.71375458617019e-268	SRSF2	CD8+ T cells	PMID34715028_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68883
7.80200083867359e-271	-0.712595498981223	0.85	0.96	1.36745668699432e-266	NKG7	CD8+ T cells	PMID34715028_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68884
1.47222941693786e-270	0.465651132001508	0.344	0.148	2.58037649906698e-266	LINC01871	CD8+ T cells	PMID34715028_post	ENSG00000235576	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68885
1.13265860125874e-268	0.439303621110511	0.613	0.402	1.98521073042619e-264	TBC1D10C	CD8+ T cells	PMID34715028_post	ENSG00000175463	374403	TBC1 domain family member 10C	Carabin|EPI64C|FLJ00332	protein_coding	Q8IV04	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68886
2.02872303187251e-268	-0.507772951089534	0.146	0.372	3.55574285796294e-264	NAB1	CD8+ T cells	PMID34715028_post	ENSG00000138386	4664	NGFI-A binding protein 1	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68887
5.61428279547352e-266	0.415993667559015	0.995	0.983	9.84015345562644e-262	MT-ND5	CD8+ T cells	PMID34715028_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68888
1.73612546475361e-264	-0.352456593804046	0.075	0.288	3.04290710207366e-260	DNAJB9	CD8+ T cells	PMID34715028_post	ENSG00000128590	4189	DnaJ heat shock protein family (Hsp40) member B9	MDG1	protein_coding	Q9UBS3	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68889
8.81712435229468e-264	0.442165860788163	0.865	0.804	1.54537738522669e-259	TMA7	CD8+ T cells	PMID34715028_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68890
1.65652096383514e-263	0.457053556712215	0.754	0.59	2.90338429331385e-259	CD3G	CD8+ T cells	PMID34715028_post	ENSG00000160654	917	CD3 gamma subunit of T-cell receptor complex	CD3-GAMMA|CD3GAMMA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68891
2.86825264697617e-263	-0.383823426504529	0.094	0.314	5.02718641435514e-259	FAM118A	CD8+ T cells	PMID34715028_post	ENSG00000100376	55007	family with sequence similarity 118 member A	bK268H5.C22.4|C22orf8|FLJ20635	protein_coding	Q9NWS6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68892
6.47148707954427e-261	-0.437290028178162	0.191	0.429	1.13425754043172e-256	TRAT1	CD8+ T cells	PMID34715028_post	ENSG00000163519	50852	T cell receptor associated transmembrane adaptor 1	HSPC062|TCRIM|TRIM	protein_coding	Q6PIZ9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68893
3.42444140913406e-260	-0.36275502901251	0.989	0.999	6.00201845778927e-256	PTMA	CD8+ T cells	PMID34715028_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68894
3.76557341844147e-260	-0.580583265098911	0.409	0.626	6.59992053050237e-256	TAGAP	CD8+ T cells	PMID34715028_post	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68895
1.02616191717666e-259	-0.356138107423159	0.081	0.296	1.79855399223553e-255	RELB	CD8+ T cells	PMID34715028_post	ENSG00000104856	5971	RELB proto-oncogene, NF-kB subunit	REL-B	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68896
4.72438308056224e-258	0.438368997488131	0.888	0.793	8.28042622530143e-254	LSP1	CD8+ T cells	PMID34715028_post	ENSG00000288199	4046	lymphocyte specific protein 1	WP34	protein_coding	P33241	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68897
2.13886098837785e-256	-0.594983232881829	0.719	0.852	3.74878165432986e-252	HLA-DPA1	CD8+ T cells	PMID34715028_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68898
1.04000692450084e-251	-0.400018729732224	0.103	0.323	1.82282013657263e-247	WHRN	CD8+ T cells	PMID34715028_post	ENSG00000095397	25861	whirlin	CIP98|DFNB31|PDZD7B|USH2D	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68899
1.09902287896081e-251	0.421160485384382	0.615	0.406	1.92625739995461e-247	PAXX	CD8+ T cells	PMID34715028_post	ENSG00000148362	286257	PAXX non-homologous end joining factor	C9orf142|XLS	protein_coding	Q9BUH6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68900
1.67796337583786e-248	-0.517893754208689	0.466	0.674	2.94096640883101e-244	GBP5	CD8+ T cells	PMID34715028_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68901
5.67739857843607e-248	0.415530687647746	0.886	0.807	9.95077648842491e-244	RAC2	CD8+ T cells	PMID34715028_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68902
6.11088139693065e-247	-0.477459914863243	0.328	0.557	1.07105418244003e-242	ZC3HAV1	CD8+ T cells	PMID34715028_post	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68903
1.08400039139259e-246	0.431555833063281	0.819	0.678	1.89992748599379e-242	SON	CD8+ T cells	PMID34715028_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68904
3.85438393103314e-246	-0.460018253916358	0.209	0.433	6.75557871592179e-242	FAS	CD8+ T cells	PMID34715028_post	ENSG00000026103	355	Fas cell surface death receptor	APO-1|APT1|CD95|FAS1|TNFRSF6	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68905
6.91777641930293e-243	-0.397281329476292	0.163	0.384	1.21247867301123e-238	NSMCE3	CD8+ T cells	PMID34715028_post	ENSG00000282130	56160	NSE3 homolog, SMC5-SMC6 complex component	HCA4|MAGEG1|MAGEL3|NDNL2|NSE3	protein_coding	Q96MG7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68906
2.83522479203373e-242	-0.367392127471896	0.141	0.359	4.96929849299752e-238	GTF2B	CD8+ T cells	PMID34715028_post	ENSG00000137947	2959	general transcription factor IIB	TFIIB	protein_coding	Q00403	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68907
3.94405405105412e-242	0.422562755783152	0.612	0.413	6.91274353528256e-238	SKAP1	CD8+ T cells	PMID34715028_post	ENSG00000141293	8631	src kinase associated phosphoprotein 1	SCAP1|SKAP55	protein_coding	Q86WV1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68908
4.21505390093902e-241	0.490312862484066	0.63	0.429	7.38772497217582e-237	ID2	CD8+ T cells	PMID34715028_post	ENSG00000115738	3398	inhibitor of DNA binding 2	bHLHb26|GIG8	protein_coding	Q02363	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68909
1.85811478114317e-238	-0.458354141130644	0.214	0.431	3.25671777690963e-234	FAM177A1	CD8+ T cells	PMID34715028_post	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68910
1.7272426821046e-237	-0.847929393700888	0.419	0.611	3.02733824892474e-233	HLA-DRA	CD8+ T cells	PMID34715028_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68911
6.76977099221842e-235	-0.383260885944701	0.205	0.425	1.18653776180612e-230	ARF4	CD8+ T cells	PMID34715028_post	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68912
9.13507602160818e-235	0.296139712895471	0.289	0.115	1.60110477430727e-230	MUC20-OT1	CD8+ T cells	PMID34715028_post	ENSG00000281060	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68913
2.49893806530168e-234	-0.374719881608228	0.197	0.428	4.37988874705426e-230	PECAM1	CD8+ T cells	PMID34715028_post	ENSG00000261371	5175	platelet and endothelial cell adhesion molecule 1	CD31	protein_coding	P16284	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68914
3.28127109737736e-233	-0.363776451393257	0.102	0.305	5.7510838523733e-229	PNPLA8	CD8+ T cells	PMID34715028_post	ENSG00000135241	50640	patatin like phospholipase domain containing 8	IPLA2-2|IPLA2G|iPLA2gamma	protein_coding	Q9NP80	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68915
3.59012899886812e-231	-0.503946513188282	0.116	0.321	6.29241909631616e-227	DNAJB4	CD8+ T cells	PMID34715028_post	ENSG00000162616	11080	DnaJ heat shock protein family (Hsp40) member B4	HLJ1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68916
1.85399229666574e-229	-0.417456956721822	0.251	0.477	3.24949229836605e-225	HIST1H1C	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68917
4.31603127066818e-229	0.305991657056485	0.308	0.13	7.56470800810012e-225	SEL1L3	CD8+ T cells	PMID34715028_post	ENSG00000091490	23231	SEL1L family member 3	KIAA0746	protein_coding	Q68CR1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68918
1.33530835469205e-228	0.371965149485353	0.49	0.282	2.34039495326876e-224	ZRANB2	CD8+ T cells	PMID34715028_post	ENSG00000132485	9406	zinc finger RANBP2-type containing 2	ZIS|ZIS1|ZIS2|ZNF265	protein_coding	O95218	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68919
4.85200039547334e-225	-0.355824677989661	0.066	0.254	8.50410109314613e-221	PLK3	CD8+ T cells	PMID34715028_post	ENSG00000173846	1263	polo like kinase 3	CNK|FNK|PRK	protein_coding	Q9H4B4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68920
7.35990833974144e-225	0.366466999318081	0.467	0.26	1.28997113470648e-220	AAK1	CD8+ T cells	PMID34715028_post	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68921
1.10815011078785e-223	-0.556797109346278	0.44	0.63	1.94225469917786e-219	ITM2A	CD8+ T cells	PMID34715028_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68922
5.35327584951386e-222	0.383631202169158	0.53	0.322	9.38268658144294e-218	MDFIC	CD8+ T cells	PMID34715028_post	ENSG00000135272	29969	MyoD family inhibitor domain containing	HIC|MDFIC1	protein_coding	Q9P1T7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68923
7.54775928019395e-222	-0.420326469578936	0.211	0.43	1.32289576903959e-217	SLC38A2	CD8+ T cells	PMID34715028_post	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68924
1.08749769821833e-221	-0.461297957415546	0.701	0.844	1.90605721566726e-217	COTL1	CD8+ T cells	PMID34715028_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68925
6.6346016193084e-220	-0.624504581750595	0.641	0.789	1.16284662581618e-215	H1FX	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68926
1.80138534624511e-219	-0.412316181357326	0.15	0.349	3.15728809636381e-215	AHSA1	CD8+ T cells	PMID34715028_post	ENSG00000100591	10598	activator of HSP90 ATPase activity 1	Aha1|C14orf3|hAha1|p38	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68927
2.06850263801827e-219	0.293165438178591	0.275	0.111	3.62546457365463e-215	SNTB2	CD8+ T cells	PMID34715028_post	ENSG00000260873	6645	syntrophin beta 2	D16S2531E|EST25263|SNT2B2|SNT3|SNTL	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68928
1.44867071985216e-218	-0.50008767241747	0.24	0.449	2.53908517068489e-214	CHORDC1	CD8+ T cells	PMID34715028_post	ENSG00000285023	26973	cysteine and histidine rich domain containing 1	CHP-1|CHP1	protein_coding	Q9UHD1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68929
2.69240130149582e-216	0.395360032410755	0.982	0.988	4.71897176113173e-212	RPL37	CD8+ T cells	PMID34715028_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68930
6.73988868661509e-216	0.497282566063097	0.707	0.547	1.18130029010303e-211	MT-ND6	CD8+ T cells	PMID34715028_post	ENSG00000198695	4541	NADH dehydrogenase subunit 6	MTND6|NAD6|ND6	protein_coding	P03923	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68931
1.07037850140946e-213	0.331050415972855	0.435	0.238	1.87605239942035e-209	RCSD1	CD8+ T cells	PMID34715028_post	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68932
1.20255238358121e-213	0.35507324212243	0.368	0.182	2.10771356270279e-209	SLC4A7	CD8+ T cells	PMID34715028_post	ENSG00000033867	9497	solute carrier family 4 member 7	NBC3|SBC2|SLC4A6	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68933
1.49532744979549e-213	-0.408213511127392	0.405	0.607	2.62086042125656e-209	GPBP1	CD8+ T cells	PMID34715028_post	ENSG00000062194	65056	GC-rich promoter binding protein 1	DKFZp761C169	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68934
2.98131026444456e-213	-0.400489311313385	0.084	0.268	5.22534250049198e-209	BPGM	CD8+ T cells	PMID34715028_post	ENSG00000172331	669	bisphosphoglycerate mutase	NA	protein_coding	P07738	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68935
1.21551312158086e-211	0.304220233216576	0.293	0.125	2.13042984819477e-207	FOXP1	CD8+ T cells	PMID34715028_post	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68936
1.25022025154146e-210	0.422261809958687	0.814	0.686	2.19126103487672e-206	DDX17	CD8+ T cells	PMID34715028_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68937
1.63711752987248e-210	-0.431878259709891	0.341	0.548	2.86937589460749e-206	SH2D1A	CD8+ T cells	PMID34715028_post	ENSG00000183918	4068	SH2 domain containing 1A	DSHP|EBVS|IMD5|LYP|MTCP1|SAP|XLP|XLPD	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68938
5.10461850680851e-210	0.28903277055268	0.312	0.14	8.94686485688327e-206	RAP1GDS1	CD8+ T cells	PMID34715028_post	ENSG00000138698	5910	Rap1 GTPase-GDP dissociation stimulator 1	SmgGDS	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68939
1.00501870984367e-209	0.389623215259486	0.339	0.163	1.76149629274301e-205	LINC00861	CD8+ T cells	PMID34715028_post	ENSG00000245164	100130231	long intergenic non-protein coding RNA 861	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68940
3.58645980095072e-208	-0.30026247920139	0.986	0.997	6.28598809312633e-204	HLA-E	CD8+ T cells	PMID34715028_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68941
4.97670248230633e-208	-0.453184905743846	0.436	0.644	8.7226664407383e-204	HNRNPLL	CD8+ T cells	PMID34715028_post	ENSG00000143889	92906	heterogeneous nuclear ribonucleoprotein L like	HNRPLL	protein_coding	Q8WVV9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68942
7.96380873314233e-207	-0.403288427606957	0.302	0.51	1.39581675665786e-202	G3BP2	CD8+ T cells	PMID34715028_post	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68943
2.538282328289e-206	-0.397997000466018	0.336	0.549	4.44884743679213e-202	CLK1	CD8+ T cells	PMID34715028_post	ENSG00000013441	1195	CDC like kinase 1	NA	protein_coding	P49759	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68944
5.38550514761658e-205	0.375841695432338	0.498	0.312	9.43917487222757e-201	ATP5ME	CD8+ T cells	PMID34715028_post	ENSG00000169020	521	ATP synthase membrane subunit e	ATP5I	protein_coding	P56385	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68945
2.74007897709653e-203	-0.314836714518491	0.117	0.31	4.80253642315709e-199	AMD1	CD8+ T cells	PMID34715028_post	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68946
6.96298101080985e-202	-0.360917058945424	0.294	0.497	1.22040168176464e-197	EMD	CD8+ T cells	PMID34715028_post	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68947
3.70489023525904e-201	-0.410413245226202	0.387	0.579	6.49356111533852e-197	BRD2	CD8+ T cells	PMID34715028_post	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68948
3.24329662425678e-200	-0.368665623811809	0.162	0.362	5.68452599333486e-196	IL21R	CD8+ T cells	PMID34715028_post	ENSG00000103522	50615	interleukin 21 receptor	CD360	protein_coding	Q9HBE5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68949
2.00899976708094e-199	0.445880668623843	0.378	0.204	3.52117389176276e-195	ITGAE	CD8+ T cells	PMID34715028_post	ENSG00000083457	3682	integrin subunit alpha E	CD103|HUMINAE	protein_coding	P38570	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68950
1.30893577124513e-198	-0.382433750373828	0.188	0.385	2.29417172626134e-194	STIP1	CD8+ T cells	PMID34715028_post	ENSG00000168439	10963	stress induced phosphoprotein 1	HOP|STI1	protein_coding	P31948	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68951
2.56778071472759e-198	0.438594062142252	1	1	4.50054925870304e-194	ACTB	CD8+ T cells	PMID34715028_post	ENSG00000075624	60	actin beta	NA	protein_coding	P60709	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68952
1.69592293721817e-196	-0.394493192229217	0.201	0.401	2.97244413206228e-192	XBP1	CD8+ T cells	PMID34715028_post	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68953
7.60168369817289e-196	0.473101314352091	0.466	0.289	1.33234710177876e-191	RBPJ	CD8+ T cells	PMID34715028_post	ENSG00000168214	3516	recombination signal binding protein for immunoglobulin kappa J region	CBF1|IGKJRB|IGKJRB1|KBF2|RBP-J|RBPJK|RBPSUH|SUH	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68954
1.18590048341477e-193	-0.48945630742773	0.303	0.489	2.07852777728107e-189	GATA3	CD8+ T cells	PMID34715028_post	ENSG00000107485	2625	GATA binding protein 3	HDR	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68955
3.90633068386169e-193	0.404718684049199	0.967	0.974	6.84662578960438e-189	RPS21	CD8+ T cells	PMID34715028_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68956
4.43299367856426e-193	-0.335485439723291	0.112	0.297	7.76970802041957e-189	JMY	CD8+ T cells	PMID34715028_post	ENSG00000152409	133746	junction mediating and regulatory protein, p53 cofactor	FLJ37870|WHAMM2	protein_coding	Q8N9B5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68957
2.464793829095e-190	-0.480873113509563	0.098	0.272	4.32004414425481e-186	TSC22D1	CD8+ T cells	PMID34715028_post	ENSG00000102804	8848	TSC22 domain family member 1	MGC17597|TGFB1I4|TSC22	protein_coding	Q15714	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68958
5.85138544706216e-190	-0.287130654313308	0.092	0.27	1.02557232730658e-185	SNHG15	CD8+ T cells	PMID34715028_post	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68959
8.89176453136873e-190	0.381726181181222	0.472	0.287	1.558459569413e-185	TGFBR2	CD8+ T cells	PMID34715028_post	ENSG00000163513	7048	transforming growth factor beta receptor 2	MFS2|TBR-ii|TBRII	protein_coding	P37173	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68960
4.26277896573144e-189	0.359437659771526	0.497	0.313	7.47137269323749e-185	CYFIP2	CD8+ T cells	PMID34715028_post	ENSG00000055163	26999	cytoplasmic FMR1 interacting protein 2	PIR121	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68961
5.66809144781342e-188	-0.331855128508883	0.129	0.317	9.93446388058258e-184	ELL2	CD8+ T cells	PMID34715028_post	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68962
6.91338446884208e-188	-0.465485675157287	0.501	0.659	1.21170889585395e-183	SOD1	CD8+ T cells	PMID34715028_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68963
6.71921395162019e-187	0.330525516181087	0.485	0.292	1.17767662930047e-182	LUC7L3	CD8+ T cells	PMID34715028_post	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68964
9.85244725279309e-187	-0.352353750850421	0.822	0.907	1.72683842999705e-182	OAZ1	CD8+ T cells	PMID34715028_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68965
1.23965980239026e-186	0.370665689634407	0.694	0.542	2.17275173564941e-182	SEPT1	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68966
2.673173924655e-186	0.462433476120784	0.449	0.269	4.68527193774282e-182	ITM2C	CD8+ T cells	PMID34715028_post	ENSG00000135916	81618	integral membrane protein 2C	BRI3|BRICD2C|E25|hRPC.1050_D_4|ITM3	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68967
4.38903194449966e-186	-0.517061578117431	0.872	0.923	7.69265628912455e-182	PABPC1	CD8+ T cells	PMID34715028_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68968
1.50838260603109e-184	0.297965349494737	0.33	0.163	2.64374219359069e-180	PTPN4	CD8+ T cells	PMID34715028_post	ENSG00000088179	5775	protein tyrosine phosphatase non-receptor type 4	PTPMEG	protein_coding	P29074	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68969
4.23355503536441e-184	-0.443725130462564	0.254	0.449	7.4201519104832e-180	NFKB1	CD8+ T cells	PMID34715028_post	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68970
5.52109861823161e-184	-0.350384361274244	0.19	0.381	9.67682954817454e-180	NFE2L2	CD8+ T cells	PMID34715028_post	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68971
6.99973872995543e-184	0.315881127818356	0.392	0.214	1.22684420719929e-179	ADAM10	CD8+ T cells	PMID34715028_post	ENSG00000137845	102	ADAM metallopeptidase domain 10	CD156C|HsT18717|kuz|MADM	protein_coding	O14672	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68972
7.19269865722776e-184	0.345204388238765	0.52	0.338	1.26066429365231e-179	PPP1R18	CD8+ T cells	PMID34715028_post	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68973
5.35463849142157e-183	-0.341329878132218	0.157	0.343	9.38507488391459e-179	AZIN1	CD8+ T cells	PMID34715028_post	ENSG00000155096	51582	antizyme inhibitor 1	OAZI|OAZIN|ODC1L	protein_coding	O14977	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68974
1.45445507290278e-181	0.280446396300741	0.299	0.14	2.54922340627671e-177	GNPTAB	CD8+ T cells	PMID34715028_post	ENSG00000111670	79158	N-acetylglucosamine-1-phosphate transferase subunits alpha and beta	GNPTA|KIAA1208|MGC4170	protein_coding	Q3T906	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68975
5.98997581782991e-181	-0.403608376613118	0.262	0.455	1.04986306159105e-176	PDE4B	CD8+ T cells	PMID34715028_post	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68976
9.0907788007303e-181	-0.363234106650445	0.634	0.771	1.593340800404e-176	SRSF5	CD8+ T cells	PMID34715028_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68977
4.75072914719049e-180	-0.389650940920713	0.139	0.319	8.32660297628076e-176	MCOLN2	CD8+ T cells	PMID34715028_post	ENSG00000153898	255231	mucolipin TRP cation channel 2	FLJ36691|TRP-ML2|TRPML2	protein_coding	Q8IZK6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68978
9.32151579734769e-180	-0.34181247072885	0.17	0.356	1.63378207380113e-175	NAA50	CD8+ T cells	PMID34715028_post	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68979
1.06619930112957e-179	0.559971742051493	0.79	0.769	1.8687275150898e-175	GZMA	CD8+ T cells	PMID34715028_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68980
1.16261636738636e-179	-0.395893812370345	0.105	0.276	2.03771770711807e-175	PLIN2	CD8+ T cells	PMID34715028_post	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68981
7.97234466103936e-179	0.381125521185891	0.985	0.991	1.39731284874037e-174	RPS15A	CD8+ T cells	PMID34715028_post	ENSG00000134419	6210	ribosomal protein S15a	S15A	protein_coding	P62244	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68982
4.08524396326064e-178	-0.359877606422925	0.318	0.509	7.16020709440692e-174	RSRC2	CD8+ T cells	PMID34715028_post	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68983
4.58165119326486e-178	0.367099948151213	0.451	0.275	8.03026004643532e-174	PTPN6	CD8+ T cells	PMID34715028_post	ENSG00000111679	5777	protein tyrosine phosphatase non-receptor type 6	HCP|HCPH|PTP-1C|SHP-1|SHP1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68984
2.41187396670691e-176	-0.477782598455238	0.576	0.72	4.2272915014472e-172	ADGRE5	CD8+ T cells	PMID34715028_post	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68985
3.03377844525011e-176	0.309479205875843	0.293	0.139	5.31730348098986e-172	SAMHD1	CD8+ T cells	PMID34715028_post	ENSG00000101347	25939	SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1	AGS5|HDDC1|Mg11|MOP-5|SBBI88	protein_coding	Q9Y3Z3	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68986
6.41947349372154e-175	-0.404159333612271	0.143	0.321	1.12514111924457e-170	ICOS	CD8+ T cells	PMID34715028_post	ENSG00000163600	29851	inducible T cell costimulator	AILIM|CD278	protein_coding	Q9Y6W8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68987
1.7788376401051e-174	-0.387543466646927	0.315	0.504	3.11776873181221e-170	HERPUD1	CD8+ T cells	PMID34715028_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68988
2.04158984042032e-174	0.393034959839685	0.583	0.417	3.5782945133047e-170	RPL36A	CD8+ T cells	PMID34715028_post	ENSG00000241343	6173	ribosomal protein L36a	L36A|RPL44	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68989
7.44714799108801e-174	-0.432297214809219	0.221	0.404	1.305261628398e-169	OASL	CD8+ T cells	PMID34715028_post	ENSG00000135114	8638	2'-5'-oligoadenylate synthetase like	OASL1|p59OASL|TRIP14	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68990
8.06739966663209e-174	-0.250934010710633	0.083	0.263	1.41397313957061e-169	TRAV14DV4	CD8+ T cells	PMID34715028_post	ENSG00000211792	NA	NA	hADV14S1|TCRAV6S1-hDV104S1|TRAV14/DV4	TR_V_gene	A0A0A6YYC5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68991
2.71143615792902e-173	-0.318948229745479	0.123	0.298	4.75233415400219e-169	USP36	CD8+ T cells	PMID34715028_post	ENSG00000055483	57602	ubiquitin specific peptidase 36	FLJ12851|KIAA1453	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68992
8.67385641295981e-173	0.385724720684436	0.927	0.919	1.52026681349947e-168	RPL38	CD8+ T cells	PMID34715028_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68993
4.32241292584495e-172	-0.362406769006519	0.238	0.429	7.57589313512845e-168	ARIH1	CD8+ T cells	PMID34715028_post	ENSG00000166233	25820	ariadne RBR E3 ubiquitin protein ligase 1	ARI|HARI|HHARI|UBCH7BP	protein_coding	Q9Y4X5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68994
5.20539286123393e-171	0.309717202304061	0.395	0.223	9.12349206788471e-167	ARHGEF3	CD8+ T cells	PMID34715028_post	ENSG00000163947	50650	Rho guanine nucleotide exchange factor 3	DKFZP434F2429|GEF3|STA3|XPLN	protein_coding	Q9NR81	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68995
1.76051759416995e-170	0.378117304478874	0.58	0.409	3.08565918730168e-166	DOCK8	CD8+ T cells	PMID34715028_post	ENSG00000107099	81704	dedicator of cytokinesis 8	FLJ00026|FLJ00152|FLJ00346|ZIR8	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68996
2.28709572768293e-170	-0.513165799836526	0.233	0.408	4.00859268190987e-166	ISG15	CD8+ T cells	PMID34715028_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68997
3.80989575518099e-170	0.312239955926581	0.355	0.192	6.67760429010571e-166	MAPK1	CD8+ T cells	PMID34715028_post	ENSG00000100030	5594	mitogen-activated protein kinase 1	ERK|ERK2|MAPK2|p41mapk|PRKM1|PRKM2	protein_coding	P28482	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68998
5.01218996600068e-170	0.422673650841907	0.778	0.644	8.7848653534094e-166	RNF213	CD8+ T cells	PMID34715028_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	68999
9.00437442794308e-168	0.281314363117406	0.321	0.164	1.57819670598558e-163	UGP2	CD8+ T cells	PMID34715028_post	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69000
1.11357747589825e-167	-0.312933270069922	0.746	0.874	1.95176724200687e-163	STK17B	CD8+ T cells	PMID34715028_post	ENSG00000081320	9262	serine/threonine kinase 17b	DRAK2	protein_coding	O94768	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69001
2.35863048606768e-167	0.335666784411064	0.43	0.256	4.13397165293082e-163	PRRC2B	CD8+ T cells	PMID34715028_post	ENSG00000288701	84726	proline rich coiled-coil 2B	BAT2L|BAT2L1|KIAA0515|LQFBS-1|MGC10526	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69002
2.67865467529373e-167	0.451407867806563	0.635	0.477	4.69487804938732e-163	IKZF3	CD8+ T cells	PMID34715028_post	ENSG00000161405	22806	IKAROS family zinc finger 3	Aiolos|ZNFN1A3	protein_coding	Q9UKT9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69003
1.17298599388137e-165	0.331682860876263	0.873	0.794	2.05589255147588e-161	EVL	CD8+ T cells	PMID34715028_post	ENSG00000196405	51466	Enah/Vasp-like	RNB6	protein_coding	Q9UI08	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69004
6.83674345366688e-165	-0.351494186156117	0.549	0.704	1.19827602512419e-160	EIF4A2	CD8+ T cells	PMID34715028_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69005
6.34419372364136e-164	-0.324944128820686	0.34	0.524	1.11194683394262e-159	RBM8A	CD8+ T cells	PMID34715028_post	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69006
1.29077701029003e-162	-0.463056114255554	0.262	0.433	2.26234486593533e-158	DOK2	CD8+ T cells	PMID34715028_post	ENSG00000147443	9046	docking protein 2	Dok-2|p56dok-2	protein_coding	O60496	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69007
4.81950468423018e-162	-0.371792202579837	0.517	0.679	8.44714586005024e-158	SFPQ	CD8+ T cells	PMID34715028_post	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69008
3.13930033536821e-161	-0.321540579272562	0.21	0.393	5.50225169779986e-157	IDI1	CD8+ T cells	PMID34715028_post	ENSG00000067064	3422	isopentenyl-diphosphate delta isomerase 1	NA	protein_coding	Q13907	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69009
6.39275602066339e-161	-0.339439595427247	0.215	0.396	1.12045834774167e-156	RALGAPA1	CD8+ T cells	PMID34715028_post	ENSG00000174373	253959	Ral GTPase activating protein catalytic subunit alpha 1	DKFZp667F074|GARNL1|GRIPE|KIAA0884|RalGAPalpha1|Tulip1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69010
1.08194498468849e-160	0.363483187196329	0.705	0.557	1.89632497466351e-156	CD96	CD8+ T cells	PMID34715028_post	ENSG00000153283	10225	CD96 molecule	TACTILE	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69011
1.16151023568607e-160	0.374290061211494	0.569	0.405	2.03577899008698e-156	ITGAL	CD8+ T cells	PMID34715028_post	ENSG00000005844	3683	integrin subunit alpha L	CD11A|LFA-1|LFA1A	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69012
1.04322383355445e-156	-0.265903050595685	0.143	0.314	1.82845841307088e-152	NR1H2	CD8+ T cells	PMID34715028_post	ENSG00000131408	7376	nuclear receptor subfamily 1 group H member 2	LXR-b|LXRb|NER|NER-I|RIP15|UNR	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69013
4.48221777570035e-156	0.29891057130511	0.381	0.222	7.85598309547e-152	NDUFB1	CD8+ T cells	PMID34715028_post	ENSG00000183648	4707	NADH:ubiquinone oxidoreductase subunit B1	CI-MNLL|MNLL	protein_coding	O75438	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69014
7.72562443345177e-156	0.335063383717878	0.894	0.85	1.35407019445109e-151	CD3D	CD8+ T cells	PMID34715028_post	ENSG00000167286	915	CD3 delta subunit of T-cell receptor complex	CD3-DELTA|CD3DELTA|T3D	protein_coding	P04234	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69015
8.85262419979295e-156	-0.330409607786745	0.158	0.329	1.55159944349771e-151	RAB11FIP1	CD8+ T cells	PMID34715028_post	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69016
1.47961170802486e-155	0.320238940452668	0.407	0.241	2.59331544065518e-151	DOCK10	CD8+ T cells	PMID34715028_post	ENSG00000135905	55619	dedicator of cytokinesis 10	KIAA0694|ZIZ3	protein_coding	Q96BY6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69017
2.82837949539175e-155	0.319961090812843	0.931	0.894	4.95730074157312e-151	CORO1A	CD8+ T cells	PMID34715028_post	ENSG00000102879	11151	coronin 1A	coronin-1|HCORO1|p57	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69018
4.00643830840934e-155	0.289126805982685	0.389	0.223	7.02208442314905e-151	FAM208A	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69019
1.27820890681465e-154	0.335630499670649	0.975	0.97	2.24031675097404e-150	CFL1	CD8+ T cells	PMID34715028_post	ENSG00000172757	1072	cofilin 1	CFL	protein_coding	P23528	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69020
8.94805879845897e-154	-0.34381961264539	0.665	0.779	1.5683262656059e-149	CALM2	CD8+ T cells	PMID34715028_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69021
1.26083120799615e-153	-0.323889149927545	0.159	0.327	2.20985885825486e-149	EIF4A3	CD8+ T cells	PMID34715028_post	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69022
6.75712337632928e-153	-0.314687286960103	0.363	0.553	1.18432101416923e-148	HIST1H1E	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69023
4.41716838466591e-152	-0.421399812824004	0.508	0.654	7.74197102780394e-148	IL10RA	CD8+ T cells	PMID34715028_post	ENSG00000110324	3587	interleukin 10 receptor subunit alpha	CD210|CD210a|CDW210A|HIL-10R|IL10R	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69024
5.27480536314407e-152	-0.419834598325743	0.83	0.907	9.24515135998262e-148	RPS20	CD8+ T cells	PMID34715028_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69025
1.4656058570871e-151	0.31009563094533	0.492	0.327	2.56876738571655e-147	CSTB	CD8+ T cells	PMID34715028_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69026
2.54732006465325e-151	-0.396250315342701	0.352	0.528	4.46468787731776e-147	LITAF	CD8+ T cells	PMID34715028_post	ENSG00000189067	9516	lipopolysaccharide induced TNF factor	FLJ38636|PIG7|SIMPLE|TP53I7	protein_coding	Q99732	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69027
5.30121944670044e-151	-0.296445223861338	0.367	0.566	9.29144732423185e-147	IFITM2	CD8+ T cells	PMID34715028_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69028
3.68339582508975e-150	0.357144362593951	0.411	0.248	6.4558878626348e-146	PDCD1	CD8+ T cells	PMID34715028_post	ENSG00000276977	5133	programmed cell death 1	CD279|hSLE1|PD-1|PD1|SLEB2	protein_coding	Q15116	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69029
1.06000754723017e-149	-0.304358882783186	0.14	0.304	1.85787522803031e-145	AC004687.1	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69030
3.66445061330026e-149	-0.344486830234048	0.531	0.703	6.42268258993136e-145	FYN	CD8+ T cells	PMID34715028_post	ENSG00000010810	2534	FYN proto-oncogene, Src family tyrosine kinase	MGC45350|SLK|SYN	protein_coding	P06241	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69031
5.75917282805283e-149	0.490861349290009	0.583	0.435	1.00941022157282e-144	MT2A	CD8+ T cells	PMID34715028_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69032
1.27411783306709e-148	0.265613465994562	0.381	0.222	2.23314632601669e-144	ARPC1B	CD8+ T cells	PMID34715028_post	ENSG00000130429	10095	actin related protein 2/3 complex subunit 1B	ARC41|p40-ARC|p41-ARC	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69033
2.57037736709425e-148	0.268743433965425	0.346	0.192	4.50510041130608e-144	PRKACB	CD8+ T cells	PMID34715028_post	ENSG00000142875	5567	protein kinase cAMP-activated catalytic subunit beta	PKACb	protein_coding	P22694	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69034
3.00208901782607e-148	0.364797098379806	0.867	0.806	5.26176142154376e-144	HCST	CD8+ T cells	PMID34715028_post	ENSG00000126264	10870	hematopoietic cell signal transducer	DAP10|DKFZP586C1522|KAP10|PIK3AP	protein_coding	Q9UBK5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69035
3.08753776924114e-148	-0.297416391078145	0.228	0.405	5.41152744814894e-144	HERPUD2	CD8+ T cells	PMID34715028_post	ENSG00000122557	64224	HERPUD family member 2	FLJ22313	protein_coding	Q9BSE4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69036
3.42380413568605e-148	0.334367835989106	0.663	0.528	6.00090150861694e-144	CAP1	CD8+ T cells	PMID34715028_post	ENSG00000131236	10487	cyclase associated actin cytoskeleton regulatory protein 1	CAP	protein_coding	Q01518	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69037
6.98542099409385e-148	-0.365827764841461	0.474	0.639	1.22433473763483e-143	ARID4B	CD8+ T cells	PMID34715028_post	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69038
1.05889369611681e-147	0.320036354398104	0.467	0.303	1.85592298118393e-143	SEMA4D	CD8+ T cells	PMID34715028_post	ENSG00000187764	10507	semaphorin 4D	C9orf164|CD100|coll-4|FLJ39737|SEMAJ	protein_coding	Q92854	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69039
1.80770888656111e-146	0.342914186101326	0.965	0.97	3.16837136547565e-142	RPL37A	CD8+ T cells	PMID34715028_post	ENSG00000197756	6168	ribosomal protein L37a	L37A	protein_coding	P61513	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69040
2.35369014856671e-145	-0.31650557127924	0.424	0.608	4.12531272339287e-141	STAT1	CD8+ T cells	PMID34715028_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69041
1.23068449412262e-144	0.323404339503726	0.54	0.37	2.15702071284871e-140	OGT	CD8+ T cells	PMID34715028_post	ENSG00000147162	8473	O-linked N-acetylglucosamine (GlcNAc) transferase	FLJ23071|HRNT1|MGC22921|O-GLCNAC|OGT1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69042
7.32820883680896e-144	-0.458728125756023	0.203	0.362	1.28441516282751e-139	IFI6	CD8+ T cells	PMID34715028_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69043
3.67739810361816e-142	-0.303980633397363	0.283	0.455	6.44537565621155e-138	TRA2B	CD8+ T cells	PMID34715028_post	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69044
4.30373946130773e-142	-0.352854087147032	0.278	0.464	7.54316415383405e-138	DTHD1	CD8+ T cells	PMID34715028_post	ENSG00000197057	401124	death domain containing 1	FLJ16686	protein_coding	Q6ZMT9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69045
1.89278744940176e-141	0.314316923245241	0.536	0.38	3.31748856256646e-137	CCND3	CD8+ T cells	PMID34715028_post	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69046
2.17110442657653e-141	0.309903757870134	0.67	0.528	3.80529472846068e-137	CD53	CD8+ T cells	PMID34715028_post	ENSG00000143119	963	CD53 molecule	MOX44|TSPAN25	protein_coding	P19397	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69047
2.38978291823155e-141	0.307339362003825	0.937	0.93	4.18857252078444e-137	SERF2	CD8+ T cells	PMID34715028_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69048
6.83572983250042e-141	-0.362844937718098	0.132	0.284	1.19809836774235e-136	MX1	CD8+ T cells	PMID34715028_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69049
8.66517591121778e-141	-0.288144167131014	0.135	0.292	1.51874538195914e-136	NAMPT	CD8+ T cells	PMID34715028_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69050
1.9173528866083e-140	-0.407844931486664	0.734	0.839	3.36054440435837e-136	HLA-DPB1	CD8+ T cells	PMID34715028_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69051
8.41364598405438e-140	0.282960306511141	0.418	0.26	1.47465973162521e-135	TCIRG1	CD8+ T cells	PMID34715028_post	ENSG00000110719	10312	T cell immune regulator 1, ATPase H+ transporting V0 subunit a3	a3|Atp6i|ATP6N1C|ATP6V0A3|OC-116|OC116|TIRC7	protein_coding	Q13488	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69052
3.50222015905694e-138	0.33188230958355	0.567	0.425	6.13834127277909e-134	UQCR11	CD8+ T cells	PMID34715028_post	ENSG00000127540	10975	ubiquinol-cytochrome c reductase, complex III subunit XI	QCR10|UQCR	protein_coding	O14957	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69053
5.55960675139246e-137	-0.275905049633708	0.12	0.272	9.74432275316557e-133	B4GALT1	CD8+ T cells	PMID34715028_post	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69054
1.16402589350437e-136	0.346271134615746	0.982	0.991	2.04018818354511e-132	RPL34	CD8+ T cells	PMID34715028_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69055
7.02875234605226e-136	-0.343689794822751	0.512	0.654	1.23192942369258e-131	ELF1	CD8+ T cells	PMID34715028_post	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69056
1.68330516080556e-135	-0.307942412114518	0.672	0.792	2.9503289553439e-131	NCL	CD8+ T cells	PMID34715028_post	ENSG00000115053	4691	nucleolin	C23|Nsr1	protein_coding	P19338	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69057
2.20972008207669e-135	0.281720965781625	0.393	0.238	3.87297638785582e-131	LENG8	CD8+ T cells	PMID34715028_post	ENSG00000276458	114823	leukocyte receptor cluster member 8	KIAA1932|MGC40108|pp13842	protein_coding	Q96PV6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69058
3.00177107371301e-135	0.31748007341123	0.618	0.459	5.2612041608968e-131	N4BP2L2	CD8+ T cells	PMID34715028_post	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69059
8.97951153977115e-135	0.26184720087457	0.392	0.234	1.57383898757569e-130	TTC14	CD8+ T cells	PMID34715028_post	ENSG00000163728	151613	tetratricopeptide repeat domain 14	FLJ00166|KIAA1980	protein_coding	Q96N46	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69060
2.45825628683548e-133	0.326049216431705	0.683	0.552	4.30858579393654e-129	SEPT9	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69061
6.20349469510308e-132	-0.281894870698862	0.193	0.352	1.08728651521072e-127	SLBP	CD8+ T cells	PMID34715028_post	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69062
5.08280706462597e-131	0.335461134182943	0.803	0.739	8.90863594216994e-127	CLIC1	CD8+ T cells	PMID34715028_post	ENSG00000226651	1192	chloride intracellular channel 1	CLCNL1|G6|NCC27|p64CLCP	protein_coding	O00299	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69063
1.17983802866221e-130	0.300503903281353	0.972	0.977	2.06790211283625e-126	RPL6	CD8+ T cells	PMID34715028_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69064
1.89792586975932e-130	-0.257042129444382	0.183	0.34	3.32649467192716e-126	BUD31	CD8+ T cells	PMID34715028_post	ENSG00000106245	8896	BUD31 homolog	Cwc14|EDG-2|EDG2|fSAP17|G10|YCR063W	protein_coding	P41223	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69065
5.52127095717816e-130	0.264272933583878	0.964	0.958	9.67713160664617e-126	CD3E	CD8+ T cells	PMID34715028_post	ENSG00000198851	916	CD3 epsilon subunit of T-cell receptor complex	CD3-epsilon|CD3epsilon	protein_coding	P07766	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69066
1.41502770123283e-129	-0.308343401073784	0.57	0.725	2.48011905195078e-125	SPOCK2	CD8+ T cells	PMID34715028_post	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69067
1.8919307366327e-129	-0.304704733684957	0.467	0.616	3.31598700209614e-125	SLC25A3	CD8+ T cells	PMID34715028_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69068
2.68379845918429e-129	0.317062432042072	0.729	0.608	4.70389355941231e-125	CD99	CD8+ T cells	PMID34715028_post	ENSG00000002586	4267	CD99 molecule (Xg blood group)	MIC2	protein_coding	P14209	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69069
3.48395984463297e-129	-0.396352998934987	0.639	0.753	6.10633641968821e-125	ZFP36L1	CD8+ T cells	PMID34715028_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69070
7.67979859892052e-127	-0.310620953244661	0.155	0.303	1.3460383004328e-122	AHR	CD8+ T cells	PMID34715028_post	ENSG00000106546	196	aryl hydrocarbon receptor	bHLHe76	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69071
9.51403216177081e-127	-1.11945995029595	0.169	0.311	1.66752441699357e-122	CCL4L2	CD8+ T cells	PMID34715028_post	ENSG00000282604	9560	C-C motif chemokine ligand 4 like 2	NA	protein_coding	Q8NHW4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69072
1.90995367038419e-126	-0.313146700910408	0.412	0.569	3.34757579808237e-122	BCLAF1	CD8+ T cells	PMID34715028_post	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69073
1.03034862768965e-125	-0.253739095498924	0.19	0.346	1.80589203975165e-121	STRAP	CD8+ T cells	PMID34715028_post	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69074
2.72741980045597e-124	0.274301465904684	0.335	0.196	4.78034868425919e-120	NCK2	CD8+ T cells	PMID34715028_post	ENSG00000071051	8440	NCK adaptor protein 2	NCKbeta	protein_coding	O43639	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69075
3.10142580123823e-124	-0.748060066207943	0.16	0.307	5.43586900183024e-120	GZMB	CD8+ T cells	PMID34715028_post	ENSG00000100453	3002	granzyme B	CCPI|CGL-1|CGL1|CSP-B|CSPB|CTLA1|CTSGL1|HLP|SECT	protein_coding	P10144	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69076
1.18532914309781e-123	0.283683778681347	0.47	0.318	2.07752638910752e-119	MYO1G	CD8+ T cells	PMID34715028_post	ENSG00000136286	64005	myosin IG	HA-2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69077
2.53384843208261e-122	-0.29786845179797	0.182	0.334	4.44107614691118e-118	GPCPD1	CD8+ T cells	PMID34715028_post	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69078
2.1253834929277e-121	0.312255283626542	0.504	0.355	3.72515964805438e-117	LNPEP	CD8+ T cells	PMID34715028_post	ENSG00000113441	4012	leucyl and cystinyl aminopeptidase	CAP|IRAP|P-LAP|PLAP	protein_coding	Q9UIQ6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69079
1.08799050117393e-120	-0.292234208933737	0.543	0.681	1.90692095140755e-116	UBE2D3	CD8+ T cells	PMID34715028_post	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69080
1.38241407019798e-119	-0.270148282151024	0.114	0.251	2.422957140836e-115	BICDL1	CD8+ T cells	PMID34715028_post	ENSG00000135127	92558	BICD family like cargo adaptor 1	BICDR-1|CCDC64|FLJ26450	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69081
1.42452419779446e-119	0.293617932937446	0.389	0.243	2.49676356147434e-115	ATM	CD8+ T cells	PMID34715028_post	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69082
2.00205736555335e-119	0.260251264878384	0.442	0.292	3.50900594460535e-115	ACAP2	CD8+ T cells	PMID34715028_post	ENSG00000114331	23527	ArfGAP with coiled-coil, ankyrin repeat and PH domains 2	CENTB2|CNT-B2|KIAA0041	protein_coding	Q15057	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69083
5.99947197609369e-119	0.300130524662307	0.999	1	1.05152745324994e-114	TMSB4X	CD8+ T cells	PMID34715028_post	ENSG00000205542	7114	thymosin beta 4 X-linked	TB4X|TMSB4	protein_coding	P62328	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69084
7.06099288025669e-119	0.32491599981578	0.811	0.711	1.23758022212259e-114	MYH9	CD8+ T cells	PMID34715028_post	ENSG00000100345	4627	myosin heavy chain 9	DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHCA	protein_coding	P35579	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69085
1.48638377498053e-118	-0.309122296081559	0.239	0.39	2.60518484240837e-114	RHBDD2	CD8+ T cells	PMID34715028_post	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69086
4.67500380124217e-118	0.306932211308703	0.601	0.471	8.19387916243715e-114	ACTR3	CD8+ T cells	PMID34715028_post	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69087
2.27709592504961e-117	-0.260881884088242	0.222	0.374	3.99106602783445e-113	PHF1	CD8+ T cells	PMID34715028_post	ENSG00000225553	5252	PHD finger protein 1	MTF2L2|PCL1|TDRD19C	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69088
6.74570434109057e-117	-0.281064079257802	0.428	0.577	1.18231959986294e-112	HNRNPA0	CD8+ T cells	PMID34715028_post	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69089
2.37669328898334e-116	-0.293586157228657	0.606	0.736	4.1656303276011e-112	CALR	CD8+ T cells	PMID34715028_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69090
2.32602090169403e-115	-0.291359634852872	0.166	0.307	4.07681683439913e-111	ATP1B3	CD8+ T cells	PMID34715028_post	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69091
1.50141752093126e-114	-0.347344353331276	0.452	0.588	2.63153448893622e-110	GNG2	CD8+ T cells	PMID34715028_post	ENSG00000186469	54331	G protein subunit gamma 2	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69092
2.28855899907039e-114	0.285232277623462	0.97	0.935	4.01115735767067e-110	MT-ND4	CD8+ T cells	PMID34715028_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69093
4.38322153558513e-114	-0.255071182862612	0.791	0.9	7.68247238542006e-110	CST7	CD8+ T cells	PMID34715028_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69094
1.17674391279684e-113	-0.321305141780272	0.479	0.624	2.06247905595903e-109	SH2D2A	CD8+ T cells	PMID34715028_post	ENSG00000027869	9047	SH2 domain containing 2A	F2771|TSAd	protein_coding	Q9NP31	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69095
1.55627717910197e-113	0.280189104769638	0.747	0.647	2.72768701181202e-109	CAPZB	CD8+ T cells	PMID34715028_post	ENSG00000077549	832	capping actin protein of muscle Z-line subunit beta	NA	protein_coding	P47756	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69096
9.24044919797616e-113	-0.334046973894367	0.286	0.445	1.61957353092928e-108	TNFRSF9	CD8+ T cells	PMID34715028_post	ENSG00000049249	3604	TNF receptor superfamily member 9	4-1BB|CD137|ILA	protein_coding	Q07011	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69097
4.83970463116817e-112	-0.355611094681771	0.331	0.476	8.48255030704845e-108	ISG20	CD8+ T cells	PMID34715028_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69098
6.80335208982416e-112	-0.426848772826268	0.283	0.444	1.19242352078348e-107	IL7R	CD8+ T cells	PMID34715028_post	ENSG00000168685	3575	interleukin 7 receptor	CD127|IL7RA|lnc-IL7R	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69099
5.03099743288419e-111	-0.264479739348027	0.242	0.391	8.81782920061612e-107	RPL22L1	CD8+ T cells	PMID34715028_post	ENSG00000163584	200916	ribosomal protein L22 like 1	NA	protein_coding	Q6P5R6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69100
2.28061873498436e-108	0.27535299253254	0.49	0.356	3.99724045680709e-104	NDUFA3	CD8+ T cells	PMID34715028_post	ENSG00000276061	4696	NADH:ubiquinone oxidoreductase subunit A3	B9	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69101
1.41198510094735e-107	-0.320434079234917	0.435	0.567	2.47478628643042e-103	PPP1R2	CD8+ T cells	PMID34715028_post	ENSG00000184203	5504	protein phosphatase 1 regulatory inhibitor subunit 2	IPP2|PPP1R2A	protein_coding	P41236	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69102
3.07002675101481e-107	0.324626251815407	0.395	0.263	5.38083588650366e-103	BCL2	CD8+ T cells	PMID34715028_post	ENSG00000171791	596	BCL2 apoptosis regulator	Bcl-2|PPP1R50	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69103
4.62382059564442e-107	-0.256559380751325	0.15	0.299	8.10417035798597e-103	LINC02446	CD8+ T cells	PMID34715028_post	ENSG00000256039	101060038	long intergenic non-protein coding RNA 2446	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69104
6.76560348102136e-107	-0.292783639691258	0.59	0.707	1.18580732211861e-102	EIF4G2	CD8+ T cells	PMID34715028_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69105
1.18617923221134e-105	0.310321290092957	0.513	0.379	2.07901634029681e-101	PARP8	CD8+ T cells	PMID34715028_post	ENSG00000151883	79668	poly(ADP-ribose) polymerase family member 8	ARTD16|FLJ21308|pART16	protein_coding	Q8N3A8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69106
1.50797270120403e-105	0.312047851363914	0.761	0.684	2.64302375340031e-101	ITGB2	CD8+ T cells	PMID34715028_post	ENSG00000160255	3689	integrin subunit beta 2	CD18|LFA-1|MAC-1|MFI7	protein_coding	P05107	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69107
2.62883231602731e-105	0.265034136141594	0.409	0.272	4.60755440030106e-101	CASP8	CD8+ T cells	PMID34715028_post	ENSG00000064012	841	caspase 8	Casp-8|FLICE|MACH|MCH5	protein_coding	Q14790	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69108
3.7068270172156e-105	0.285927198971499	0.648	0.52	6.49695571307378e-101	PNISR	CD8+ T cells	PMID34715028_post	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69109
6.87132733337981e-105	0.361337809804964	0.498	0.374	1.20433754172148e-100	APOBEC3C	CD8+ T cells	PMID34715028_post	ENSG00000244509	27350	apolipoprotein B mRNA editing enzyme catalytic subunit 3C	APOBEC1L|ARDC2|ARDC4|ARP5|bK150C2.3|PBI	protein_coding	Q9NRW3	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69110
1.51236118933212e-104	0.263021394189059	0.334	0.204	2.6507154565424e-100	PDE4DIP	CD8+ T cells	PMID34715028_post	ENSG00000178104	9659	phosphodiesterase 4D interacting protein	CMYA2|KIAA0454|KIAA0477|MMGL	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69111
1.56700994102659e-103	-0.336732042611895	0.408	0.548	2.7464983236373e-99	NR3C1	CD8+ T cells	PMID34715028_post	ENSG00000113580	2908	nuclear receptor subfamily 3 group C member 1	GR|GRL	protein_coding	P04150	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69112
7.71242102500128e-103	0.300596219788905	0.482	0.351	1.35175603305197e-98	SIRPG	CD8+ T cells	PMID34715028_post	ENSG00000089012	55423	signal regulatory protein gamma	bA77C3.1|CD172g|SIRP-B2|SIRPB2|SIRPgamma	protein_coding	Q9P1W8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69113
2.9494066613337e-102	0.309207348998298	0.83	0.769	5.16942505531957e-98	MYL12A	CD8+ T cells	PMID34715028_post	ENSG00000101608	10627	myosin light chain 12A	MLCB|MRCL3|MRLC3|MYL2B	protein_coding	P19105	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69114
5.7819405492317e-102	-0.260060972939673	0.211	0.35	1.01340072006384e-97	POLR2A	CD8+ T cells	PMID34715028_post	ENSG00000284832	5430	RNA polymerase II subunit A	POLR2|POLRA|RPB1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69115
1.53835556170871e-100	-0.327699159840902	0.978	0.993	2.69627579300685e-96	BTG1	CD8+ T cells	PMID34715028_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69116
1.33035567774871e-99	-0.294600100866621	0.935	0.959	2.33171439639016e-95	HNRNPA2B1	CD8+ T cells	PMID34715028_post	ENSG00000122566	3181	heterogeneous nuclear ribonucleoprotein A2/B1	HNRPA2B1	protein_coding	P22626	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69117
2.53556427393181e-99	0.287951015046515	0.494	0.36	4.44408350292029e-95	PREX1	CD8+ T cells	PMID34715028_post	ENSG00000124126	57580	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1	KIAA1415|P-REX1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69118
2.60773616825462e-99	-0.27583106433156	0.277	0.414	4.57057918209987e-95	ELOVL5	CD8+ T cells	PMID34715028_post	ENSG00000012660	60481	ELOVL fatty acid elongase 5	dJ483K16.1|HELO1|SCA38	protein_coding	Q9NYP7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69119
9.56805599525303e-99	-0.276872491069403	0.257	0.389	1.676993174288e-94	NUDC	CD8+ T cells	PMID34715028_post	ENSG00000090273	10726	nuclear distribution C, dynein complex regulator	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69120
7.77659482703319e-98	-0.291754762858365	0.218	0.351	1.36300377533411e-93	GPR65	CD8+ T cells	PMID34715028_post	ENSG00000140030	8477	G protein-coupled receptor 65	hTDAG8|TDAG8	protein_coding	Q8IYL9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69121
5.20151978733713e-97	0.312083888521693	0.327	0.206	9.11670373126579e-93	CRYBG1	CD8+ T cells	PMID34715028_post	ENSG00000112297	202	crystallin beta-gamma domain containing 1	AIM1|ST4	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69122
6.02772957223576e-96	0.32084292127068	0.557	0.441	1.05648016212576e-91	THEMIS	CD8+ T cells	PMID34715028_post	ENSG00000275122	387357	thymocyte selection associated	bA325O24.3|bA325O24.4|C6orf190|C6orf207|FLJ40584|TSEPA	protein_coding	Q8N1K5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69123
9.98624603332803e-96	0.276511219379263	0.539	0.421	1.7502893422614e-91	ATP5MD	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69124
9.76089621391201e-95	-0.680128583889788	0.422	0.524	1.71079227941236e-90	HSPB1	CD8+ T cells	PMID34715028_post	ENSG00000106211	3315	heat shock protein family B (small) member 1	CMT2F|Hs.76067|Hsp25|HSP27|HSP28	protein_coding	P04792	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69125
2.45025208246386e-94	-0.275593867007654	0.318	0.454	4.29455682493441e-90	GOLGB1	CD8+ T cells	PMID34715028_post	ENSG00000173230	2804	golgin B1	GCP|GCP372|giantin|GOLIM1	protein_coding	Q14789	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69126
3.09793565532814e-94	0.250322200769305	0.48	0.353	5.42975182309364e-90	GYPC	CD8+ T cells	PMID34715028_post	ENSG00000136732	2995	glycophorin C (Gerbich blood group)	CD236|CD236R|Ge|GPC|GYPD	protein_coding	P04921	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69127
2.47400847676942e-93	0.252518343707404	0.491	0.359	4.33619465723376e-89	ARHGAP15	CD8+ T cells	PMID34715028_post	ENSG00000075884	55843	Rho GTPase activating protein 15	BM046	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69128
3.51035740354793e-93	0.309921788534504	0.603	0.482	6.15260342119846e-89	CTSC	CD8+ T cells	PMID34715028_post	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69129
3.52697945985733e-93	0.261757397333069	0.678	0.567	6.18173689929194e-89	ARL6IP5	CD8+ T cells	PMID34715028_post	ENSG00000144746	10550	ADP ribosylation factor like GTPase 6 interacting protein 5	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b	protein_coding	O75915	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69130
4.82954369903521e-93	0.257744104103282	0.917	0.875	8.46474124129902e-89	HMGB1	CD8+ T cells	PMID34715028_post	ENSG00000189403	3146	high mobility group box 1	DKFZp686A04236|HMG1|HMG3|SBP-1	protein_coding	P09429	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69131
5.73000926855462e-93	-0.552435356606696	0.497	0.587	1.00429872449957e-88	LAG3	CD8+ T cells	PMID34715028_post	ENSG00000089692	3902	lymphocyte activating 3	CD223	protein_coding	P18627	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69132
9.5604605661633e-93	-0.251763228402185	0.195	0.327	1.67566192343144e-88	MYLIP	CD8+ T cells	PMID34715028_post	ENSG00000007944	29116	myosin regulatory light chain interacting protein	IDOL|MIR	protein_coding	Q8WY64	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69133
5.6427531060676e-92	-0.286523601466267	0.322	0.456	9.89005336900468e-88	JMJD1C	CD8+ T cells	PMID34715028_post	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69134
7.35399924116211e-92	-0.27468725612358	0.266	0.401	1.28893544699848e-87	SIK3	CD8+ T cells	PMID34715028_post	ENSG00000160584	23387	SIK family kinase 3	FLJ12240|KIAA0999|L19|QSK	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69135
3.51756313019037e-91	0.295932229714291	0.67	0.569	6.16523289828466e-87	PRKCH	CD8+ T cells	PMID34715028_post	ENSG00000027075	5583	protein kinase C eta	PKC-L|PKCL|PRKCL	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69136
6.00699641960455e-91	0.258976233117855	0.536	0.411	1.05284626246409e-86	RASAL3	CD8+ T cells	PMID34715028_post	ENSG00000105122	64926	RAS protein activator like 3	FLJ21438	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69137
2.85053203957965e-90	0.26612298491587	0.549	0.428	4.99612750577125e-86	CD247	CD8+ T cells	PMID34715028_post	ENSG00000198821	919	CD247 molecule	CD3-ZETA|CD3H|CD3Q|CD3Z|CD3ZETA|TCRZ	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69138
8.90930923730846e-90	-0.255302426010968	0.363	0.495	1.56153463002305e-85	SRSF3	CD8+ T cells	PMID34715028_post	ENSG00000112081	6428	serine and arginine rich splicing factor 3	SFRS3|SRp20	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69139
1.05289510103257e-87	0.257162807631912	0.548	0.431	1.84540924357979e-83	ACTR2	CD8+ T cells	PMID34715028_post	ENSG00000138071	10097	actin related protein 2	ARP2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69140
2.45434631748462e-87	0.257768507661828	0.522	0.402	4.30173279065529e-83	ACTN4	CD8+ T cells	PMID34715028_post	ENSG00000282844	81	actinin alpha 4	FSGS1	protein_coding	O43707	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69141
1.67915983697908e-86	-0.264198997361261	0.36	0.491	2.94306344627323e-82	NSD3	CD8+ T cells	PMID34715028_post	ENSG00000147548	54904	nuclear receptor binding SET domain protein 3	FLJ20353|KMT3F|WHISTLE|WHSC1L1	protein_coding	Q9BZ95	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69142
1.25612335262899e-85	0.278807233085405	0.597	0.499	2.20160740015283e-81	RPL17	CD8+ T cells	PMID34715028_post	ENSG00000265681	6139	ribosomal protein L17	L17|rpL23	protein_coding	P18621	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69143
3.34881848585133e-85	0.279765034660341	0.604	0.493	5.86947416015162e-81	AKNA	CD8+ T cells	PMID34715028_post	ENSG00000106948	80709	AT-hook transcription factor	KIAA1968	protein_coding	Q7Z591	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69144
1.03882742578259e-83	0.262911140453244	0.685	0.604	1.82075282916914e-79	UBL5	CD8+ T cells	PMID34715028_post	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69145
1.22923525888387e-83	0.272676020643847	0.589	0.469	2.15448063824575e-79	RBL2	CD8+ T cells	PMID34715028_post	ENSG00000103479	5934	RB transcriptional corepressor like 2	p130|Rb2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69146
1.54126195609449e-82	0.259381170311814	0.915	0.919	2.70136983044682e-78	RPL22	CD8+ T cells	PMID34715028_post	ENSG00000116251	6146	ribosomal protein L22	EAP|L22	protein_coding	P35268	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69147
1.63340894190749e-81	-0.261433352968615	0.321	0.446	2.86287585248126e-77	TANK	CD8+ T cells	PMID34715028_post	ENSG00000136560	10010	TRAF family member associated NFKB activator	I-TRAF|TRAF2	protein_coding	Q92844	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69148
3.17354873574258e-81	0.629199137070886	0.426	0.32	5.56227886913602e-77	LTB	CD8+ T cells	PMID34715028_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69149
1.90956950455703e-80	0.250609188135868	0.269	0.159	3.3469024706371e-76	XCL1	CD8+ T cells	PMID34715028_post	ENSG00000143184	6375	X-C motif chemokine ligand 1	ATAC|LPTN|LTN|SCM-1|SCM-1a|SCYC1	protein_coding	P47992	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69150
1.60946649903822e-79	0.269296295392107	0.617	0.519	2.82091193286429e-75	IQGAP1	CD8+ T cells	PMID34715028_post	ENSG00000140575	8826	IQ motif containing GTPase activating protein 1	HUMORFA01|KIAA0051|p195|SAR1	protein_coding	P46940	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69151
4.67748220752837e-79	-0.269078587842109	0.315	0.433	8.19822306513497e-75	CCT4	CD8+ T cells	PMID34715028_post	ENSG00000115484	10575	chaperonin containing TCP1 subunit 4	Cctd	protein_coding	P50991	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69152
6.46019226706844e-79	-0.303010988972293	0.184	0.298	1.13227789864908e-74	CD38	CD8+ T cells	PMID34715028_post	ENSG00000004468	952	CD38 molecule	cADPR1	protein_coding	P28907	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69153
2.05541732727944e-76	-0.269666949236887	0.398	0.52	3.60252994952268e-72	H2AFZ	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69154
4.84009324000744e-76	-0.252756620914179	0.569	0.672	8.48323142176105e-72	KMT2E	CD8+ T cells	PMID34715028_post	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69155
3.65247151415085e-74	0.255995192376345	0.51	0.392	6.4016868228522e-70	GIMAP7	CD8+ T cells	PMID34715028_post	ENSG00000179144	168537	GTPase, IMAP family member 7	IAN7|MGC27027	protein_coding	Q8NHV1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69156
4.86421947349688e-72	-0.278281097161194	0.583	0.675	8.52551747119799e-68	LY6E	CD8+ T cells	PMID34715028_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69157
2.97963307437857e-68	-0.275337359426458	0.657	0.744	5.22240288946331e-64	RARRES3	CD8+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69158
3.99704006531265e-68	-0.255898597525128	0.397	0.509	7.00561212247348e-64	CCNH	CD8+ T cells	PMID34715028_post	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69159
3.74261777519586e-64	-0.398176949020975	0.473	0.55	6.55968617458578e-60	TGFB1	CD8+ T cells	PMID34715028_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69160
1.14962855149363e-63	-0.276744837216044	0.454	0.563	2.01495396220288e-59	GLS	CD8+ T cells	PMID34715028_post	ENSG00000115419	2744	glutaminase	GAC|GAM|GLS1|KGA|KIAA0838	protein_coding	O94925	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69161
1.63643905733894e-61	0.251935207911469	0.397	0.298	2.86818673579796e-57	TC2N	CD8+ T cells	PMID34715028_post	ENSG00000276776	123036	tandem C2 domains, nuclear	C14orf47|C2CD1|FLJ36557|MTAC2D1|Tac2-N	protein_coding	Q8N9U0	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69162
2.22496747594485e-59	-0.297517681421444	0.294	0.393	3.89970049508854e-55	HAVCR2	CD8+ T cells	PMID34715028_post	ENSG00000135077	84868	hepatitis A virus cellular receptor 2	CD366|FLJ14428|Tim-3|TIM3|TIMD3	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69163
1.03589639273436e-57	-0.266324791475261	0.352	0.455	1.81561560754552e-53	PTGER4	CD8+ T cells	PMID34715028_post	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69164
4.16530328329889e-57	0.367573697355129	0.418	0.327	7.30052706463796e-53	MIR155HG	CD8+ T cells	PMID34715028_post	ENSG00000234883	114614	MIR155 host gene	BIC|miPEP155|MIRHG2|NCRNA00172	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69165
8.7985206349391e-57	-0.268885241937926	0.965	0.983	1.54211671168578e-52	RPL8	CD8+ T cells	PMID34715028_post	ENSG00000161016	6132	ribosomal protein L8	L8	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69166
1.28793090158992e-55	-0.518091276910619	0.66	0.702	2.25735649121665e-51	NFKBIA	CD8+ T cells	PMID34715028_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69167
5.08047301233938e-55	0.256657577064436	0.653	0.589	8.90454504872724e-51	FXYD5	CD8+ T cells	PMID34715028_post	ENSG00000089327	53827	FXYD domain containing ion transport regulator 5	OIT2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69168
1.80797400915893e-31	0.325248434143673	0.461	0.422	3.16883604585286e-27	TRBC1	CD8+ T cells	PMID34715028_post	ENSG00000281981	NA	NA	BV05S1J2.2|TCRBC1	TR_C_gene	P01850	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69169
7.37809558033216e-30	0.258735598095849	0.45	0.391	1.29315881236482e-25	LGALS1	CD8+ T cells	PMID34715028_post	ENSG00000100097	3956	galectin 1	GBP	protein_coding	P09382	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69170
7.14873013694082e-26	-0.297168225096299	0.501	0.54	1.25295793110162e-21	S100A10	CD8+ T cells	PMID34715028_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69171
1.56068526957097e-23	0.265685568807629	0.399	0.34	2.73541307197703e-19	TUBB	CD8+ T cells	PMID34715028_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69172
7.64574438119772e-18	-0.261679678757308	0.938	0.874	1.34006961769252e-13	VIM	CD8+ T cells	PMID34715028_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69173
0	-1.29605158812377	0.069	0.692	0	TENT5C	CD4+ T cells	PMID34715028_post	ENSG00000183508	54855	terminal nucleotidyltransferase 5C	FAM46C|FLJ20202	protein_coding	Q5VWP2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69174
0	2.34437945447018	0.971	0.566	0	TXNIP	CD4+ T cells	PMID34715028_post	ENSG00000265972	10628	thioredoxin interacting protein	ARRDC6|EST01027|HHCPA78|THIF|VDUP1	protein_coding	Q9H3M7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69175
0	-1.74553145576492	0.055	0.62	0	LMNA	CD4+ T cells	PMID34715028_post	ENSG00000160789	4000	lamin A/C	CMD1A|HGPS|LGMD1B|LMN1|LMNL1|MADA|PRO1	protein_coding	P02545	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69176
0	-1.69005893788466	0.19	0.838	0	YPEL5	CD4+ T cells	PMID34715028_post	ENSG00000119801	51646	yippee like 5	CGI-127	protein_coding	P62699	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69177
0	-1.85669835496775	0.436	0.931	0	DUSP2	CD4+ T cells	PMID34715028_post	ENSG00000158050	1844	dual specificity phosphatase 2	PAC-1	protein_coding	Q05923	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69178
0	-1.71891428991648	0.111	0.81	0	NR4A2	CD4+ T cells	PMID34715028_post	ENSG00000153234	4929	nuclear receptor subfamily 4 group A member 2	HZF-3|NOT|NURR1|RNR1|TINUR	protein_coding	P43354	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69179
0	-1.09660704289056	0.066	0.646	0	CSRNP1	CD4+ T cells	PMID34715028_post	ENSG00000144655	64651	cysteine and serine rich nuclear protein 1	AXUD1|DKFZp566F164|FAM130B|TAIP-3|URAX1	protein_coding	Q96S65	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69180
0	-1.6344425469716	0.63	0.965	0	TNFAIP3	CD4+ T cells	PMID34715028_post	ENSG00000118503	7128	TNF alpha induced protein 3	A20|OTUD7C	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69181
0	-1.50870566917432	0.236	0.799	0	DNAJA1	CD4+ T cells	PMID34715028_post	ENSG00000086061	3301	DnaJ heat shock protein family (Hsp40) member A1	dj-2|hdj-2|HSJ2|HSPF4|NEDD7	protein_coding	P31689	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69182
0	-1.48240640360581	0.169	0.783	0	CREM	CD4+ T cells	PMID34715028_post	ENSG00000095794	1390	cAMP responsive element modulator	hCREM-2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69183
0	-1.68315384542816	0.426	0.898	0	SLC2A3	CD4+ T cells	PMID34715028_post	ENSG00000059804	6515	solute carrier family 2 member 3	GLUT3	protein_coding	P11169	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69184
0	1.98941151787406	0.973	0.881	0	RPS26	CD4+ T cells	PMID34715028_post	ENSG00000197728	6231	ribosomal protein S26	eS26|S26	protein_coding	P62854	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69185
0	-1.4353082103973	0.906	0.998	0	UBC	CD4+ T cells	PMID34715028_post	ENSG00000150991	7316	ubiquitin C	NA	protein_coding	P0CG48	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69186
0	-2.09864583471661	0.249	0.867	0	RGCC	CD4+ T cells	PMID34715028_post	ENSG00000102760	28984	regulator of cell cycle	bA157L14.2|C13orf15|RGC-32|RGC32	protein_coding	Q9H4X1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69187
0	-2.32057272021906	0.37	0.932	0	FOS	CD4+ T cells	PMID34715028_post	ENSG00000170345	2353	Fos proto-oncogene, AP-1 transcription factor subunit	AP-1|c-fos	protein_coding	P01100	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69188
0	-1.75997589017322	0.887	0.999	0	H3F3B	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69189
0	-2.33503365715681	0.589	0.992	0	JUNB	CD4+ T cells	PMID34715028_post	ENSG00000171223	3726	JunB proto-oncogene, AP-1 transcription factor subunit	NA	protein_coding	P17275	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69190
0	-2.1889229933339	0.849	1	0	JUND	CD4+ T cells	PMID34715028_post	ENSG00000130522	3727	JunD proto-oncogene, AP-1 transcription factor subunit	AP-1	protein_coding	P17535	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69191
0	-1.78131711596921	0.665	0.973	0	ZFP36	CD4+ T cells	PMID34715028_post	ENSG00000128016	7538	ZFP36 ring finger protein	G0S24|NUP475|RNF162A|TIS11|TTP	protein_coding	P26651	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69192
0	-1.68188611291392	0.13	0.797	0	FOSB	CD4+ T cells	PMID34715028_post	ENSG00000125740	2354	FosB proto-oncogene, AP-1 transcription factor subunit	AP-1|DKFZp686C0818|G0S3|GOS3|GOSB|MGC42291	protein_coding	P53539	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69193
0	-1.5265779930761	0.099	0.734	0	ZNF331	CD4+ T cells	PMID34715028_post	ENSG00000130844	55422	zinc finger protein 331	RITA|ZNF361|ZNF463	protein_coding	Q9NQX6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69194
0	-1.61198541410729	0.079	0.71	0	MYADM	CD4+ T cells	PMID34715028_post	ENSG00000179820	91663	myeloid associated differentiation marker	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69195
5.08495808027946e-302	-0.996899640397728	0.96	1	8.91240602730582e-298	EIF1	CD4+ T cells	PMID34715028_post	ENSG00000173812	10209	eukaryotic translation initiation factor 1	A121|EIF-1|EIF1A|ISO1|SUI1	protein_coding	P41567	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69196
1.16759402077985e-297	-1.35712124718452	0.581	0.945	2.04644204022085e-293	SRSF7	CD4+ T cells	PMID34715028_post	ENSG00000115875	6432	serine and arginine rich splicing factor 7	9G8|AAG3|HSSG1|RBM37|SFRS7|ZCCHC20|ZCRB2	protein_coding	Q16629	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69197
1.65889831865736e-297	-1.71658725647266	0.96	0.997	2.90755108311076e-293	FTH1	CD4+ T cells	PMID34715028_post	ENSG00000167996	2495	ferritin heavy chain 1	FHC|FTH|FTHL6|PIG15|PLIF	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69198
9.50848424431235e-293	-1.70243893669424	0.801	0.98	1.66655203350063e-288	HSPA8	CD4+ T cells	PMID34715028_post	ENSG00000109971	3312	heat shock protein family A (Hsp70) member 8	HSC70|HSC71|HSP73|HSPA10	protein_coding	P11142	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69199
2.79797068681453e-290	-1.19724116764731	0.23	0.804	4.90400322277982e-286	PPP1R15A	CD4+ T cells	PMID34715028_post	ENSG00000087074	23645	protein phosphatase 1 regulatory subunit 15A	GADD34	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69200
1.25713597057937e-281	-1.25876130673838	0.494	0.92	2.20338221563446e-277	MCL1	CD4+ T cells	PMID34715028_post	ENSG00000143384	4170	MCL1 apoptosis regulator, BCL2 family member	BCL2L3|Mcl-1	protein_coding	Q07820	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69201
1.67741448089222e-270	-1.28044185094775	0.574	0.934	2.94000436065979e-266	EZR	CD4+ T cells	PMID34715028_post	ENSG00000092820	7430	ezrin	VIL2	protein_coding	P15311	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69202
5.58075682691366e-269	-1.12194178484185	0.116	0.654	9.78139249053156e-265	SOCS3	CD4+ T cells	PMID34715028_post	ENSG00000184557	9021	suppressor of cytokine signaling 3	CIS3|Cish3|SOCS-3|SSI-3	protein_coding	O14543	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69203
3.51486751860848e-262	-1.35082187413891	0.345	0.837	6.16050829986509e-258	BTG2	CD4+ T cells	PMID34715028_post	ENSG00000159388	7832	BTG anti-proliferation factor 2	APRO1|MGC126063|MGC126064|PC3|TIS21	protein_coding	P78543	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69204
3.48751034370078e-257	-1.17181735171535	0.745	0.979	6.11255937940436e-253	SRGN	CD4+ T cells	PMID34715028_post	ENSG00000122862	5552	serglycin	PPG|PRG|PRG1	protein_coding	P10124	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69205
2.45476048557523e-251	-1.03777948677291	0.046	0.521	4.30245870306771e-247	CDKN1A	CD4+ T cells	PMID34715028_post	ENSG00000124762	1026	cyclin dependent kinase inhibitor 1A	CAP20|CDKN1|CIP1|P21|p21CIP1|p21Cip1/Waf1|SDI1|WAF1	protein_coding	P38936	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69206
5.62843571751051e-240	-0.759561943350278	1	1	9.86495928208068e-236	HLA-B	CD4+ T cells	PMID34715028_post	ENSG00000206450	3106	major histocompatibility complex, class I, B	AS	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69207
1.01856661254948e-237	-2.24868801217627	0.214	0.69	1.78524170181546e-233	ANXA1	CD4+ T cells	PMID34715028_post	ENSG00000135046	301	annexin A1	ANX1|LPC1	protein_coding	P04083	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69208
3.17124225493967e-236	-1.6098564301811	0.204	0.691	5.55823630023276e-232	HSPH1	CD4+ T cells	PMID34715028_post	ENSG00000120694	10808	heat shock protein family H (Hsp110) member 1	HSP105A|HSP105B|KIAA0201|NY-CO-25	protein_coding	Q92598	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69209
5.61908571898417e-224	-1.19644666222797	0.711	0.965	9.84857153966355e-220	KLF6	CD4+ T cells	PMID34715028_post	ENSG00000067082	1316	KLF transcription factor 6	BCD1|COPEB|CPBP|GBF|PAC1|ST12|Zf9	protein_coding	Q99612	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69210
5.20071215336335e-221	-1.23193028687229	0.52	0.936	9.11528819119994e-217	DUSP1	CD4+ T cells	PMID34715028_post	ENSG00000120129	1843	dual specificity phosphatase 1	CL100|HVH1|MKP-1|PTPN10	protein_coding	P28562	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69211
4.71958152007409e-220	-1.82381316482223	0.868	0.975	8.27201053023386e-216	HSP90AA1	CD4+ T cells	PMID34715028_post	ENSG00000080824	3320	heat shock protein 90 alpha family class A member 1	FLJ31884|Hsp89|Hsp90|HSP90N|HSPC1|HSPCA	protein_coding	P07900	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69212
7.5786360204856e-217	-1.64455760565748	0.568	0.924	1.32830753531051e-212	DNAJB1	CD4+ T cells	PMID34715028_post	ENSG00000132002	3337	DnaJ heat shock protein family (Hsp40) member B1	Hsp40|HSPF1|RSPH16B|Sis1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69213
1.11975444370633e-212	-1.08514555649607	0.178	0.65	1.96259361348409e-208	PTGER4	CD4+ T cells	PMID34715028_post	ENSG00000171522	5734	prostaglandin E receptor 4	EP4	protein_coding	P35408	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69214
4.95746366034118e-211	-0.770126881797149	0.08	0.526	8.68894655747999e-207	PER1	CD4+ T cells	PMID34715028_post	ENSG00000179094	5187	period circadian regulator 1	PER|RIGUI	protein_coding	O15534	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69215
9.76867889040766e-211	-1.39609512790812	0.301	0.744	1.71215634912175e-206	DUSP4	CD4+ T cells	PMID34715028_post	ENSG00000120875	1846	dual specificity phosphatase 4	HVH2|MKP-2|TYP	protein_coding	Q13115	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69216
4.54466872362556e-206	-0.761447155727351	0.017	0.408	7.96544087189852e-202	NR4A3	CD4+ T cells	PMID34715028_post	ENSG00000119508	8013	nuclear receptor subfamily 4 group A member 3	CHN|CSMF|MINOR|NOR1	protein_coding	Q92570	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69217
5.61543187106484e-205	0.963766612415228	0.993	0.929	9.84216744041535e-201	MT-ATP8	CD4+ T cells	PMID34715028_post	ENSG00000228253	4509	ATP synthase F0 subunit 8	A6L|ATP8|MTATP8|URFA6L	protein_coding	P03928	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69218
2.9180199276147e-198	-1.02157245697104	0.19	0.639	5.11441352713028e-194	CLEC2B	CD4+ T cells	PMID34715028_post	ENSG00000110852	9976	C-type lectin domain family 2 member B	AICL|CLECSF2|HP10085	protein_coding	Q92478	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69219
2.96279161331893e-198	-0.820824386274922	0.075	0.503	5.19288486066409e-194	FOSL2	CD4+ T cells	PMID34715028_post	ENSG00000075426	2355	FOS like 2, AP-1 transcription factor subunit	FLJ23306|FRA2	protein_coding	P15408	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69220
6.55194634174795e-198	-1.01664754655382	0.31	0.755	1.14835963531816e-193	IRF1	CD4+ T cells	PMID34715028_post	ENSG00000125347	3659	interferon regulatory factor 1	MAR	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69221
4.16568017324183e-179	-0.970252639128302	0.581	0.865	7.30118763964096e-175	TAGLN2	CD4+ T cells	PMID34715028_post	ENSG00000158710	8407	transgelin 2	HA1756|KIAA0120	protein_coding	P37802	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69222
1.32577472297699e-176	-1.14353533505006	0.778	0.948	2.32368535696177e-172	HSP90AB1	CD4+ T cells	PMID34715028_post	ENSG00000096384	3326	heat shock protein 90 alpha family class B member 1	HSPC2|HSPCB	protein_coding	P08238	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69223
3.66989438717851e-176	-0.700992047277503	0.087	0.488	6.43222389240778e-172	UBE2S	CD4+ T cells	PMID34715028_post	ENSG00000108106	27338	ubiquitin conjugating enzyme E2 S	E2-EPF	protein_coding	Q16763	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69224
8.25984580849278e-172	-1.1740341088564	0.625	0.923	1.44770317485453e-167	JUN	CD4+ T cells	PMID34715028_post	ENSG00000177606	3725	Jun proto-oncogene, AP-1 transcription factor subunit	AP-1|c-Jun	protein_coding	P05412	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69225
1.21727221389207e-171	-1.02620609138441	0.658	0.935	2.13351300928862e-167	IFITM1	CD4+ T cells	PMID34715028_post	ENSG00000185885	8519	interferon induced transmembrane protein 1	9-27|CD225|DSPA2a|IFI17	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69226
1.20056794271848e-170	-0.8504211584254	0.175	0.59	2.10423543320268e-166	TUBA1A	CD4+ T cells	PMID34715028_post	ENSG00000167552	7846	tubulin alpha 1a	B-ALPHA-1|FLJ25113|TUBA3	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69227
2.85003298997482e-170	-0.76390129836	0.046	0.409	4.99525282152886e-166	DUSP5	CD4+ T cells	PMID34715028_post	ENSG00000138166	1847	dual specificity phosphatase 5	HVH3	protein_coding	Q16690	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69228
2.95888705133934e-170	-1.00097345334941	0.294	0.711	5.18604133488246e-166	AC016831.7	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69229
3.09786988162954e-170	-0.872564409029911	0.258	0.664	5.4296365415321e-166	SELENOK	CD4+ T cells	PMID34715028_post	ENSG00000113811	58515	selenoprotein K	SELK	protein_coding	Q9Y6D0	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69230
2.16126699020659e-168	-0.889106919741795	0.324	0.749	3.78805265373509e-164	IER2	CD4+ T cells	PMID34715028_post	ENSG00000160888	9592	immediate early response 2	ETR101	protein_coding	Q9BTL4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69231
2.88574357799221e-167	-0.923438025953386	0.434	0.789	5.05784276914695e-163	LDHA	CD4+ T cells	PMID34715028_post	ENSG00000288299	3939	lactate dehydrogenase A	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69232
1.30759679959855e-165	-0.861010803993279	0.221	0.622	2.29182491065638e-161	FAM177A1	CD4+ T cells	PMID34715028_post	ENSG00000151327	283635	family with sequence similarity 177 member A1	C14orf24	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69233
5.05180550006319e-165	-0.6200659903658	0.041	0.39	8.85429949996075e-161	ARL4A	CD4+ T cells	PMID34715028_post	ENSG00000122644	10124	ADP ribosylation factor like GTPase 4A	ARL4	protein_coding	P40617	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69234
9.06255705647133e-165	-1.26899399617553	0.338	0.713	1.58839437528773e-160	HSPD1	CD4+ T cells	PMID34715028_post	ENSG00000144381	3329	heat shock protein family D (Hsp60) member 1	GroEL|HSP60|SPG13	protein_coding	P10809	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69235
1.18126298205644e-164	-0.718886798304192	0.085	0.464	2.07039962865033e-160	VPS37B	CD4+ T cells	PMID34715028_post	ENSG00000139722	79720	VPS37B subunit of ESCRT-I	FLJ12750	protein_coding	Q9H9H4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69236
9.28162122353023e-162	-1.30449617976258	0.545	0.855	1.62678975184814e-157	SAT1	CD4+ T cells	PMID34715028_post	ENSG00000130066	6303	spermidine/spermine N1-acetyltransferase 1	SAT|SSAT	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69237
1.5208111070452e-158	-0.924790731953348	0.291	0.673	2.66552562731813e-154	CRIP1	CD4+ T cells	PMID34715028_post	ENSG00000213145	1396	cysteine rich protein 1	CRIP	protein_coding	P50238	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69238
1.35237698258897e-154	-0.718450453639052	0.128	0.513	2.3703111373837e-150	BCL3	CD4+ T cells	PMID34715028_post	ENSG00000069399	602	BCL3 transcription coactivator	BCL4|D19S37	protein_coding	P20749	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69239
2.4012014983089e-153	-0.814125865815559	0.336	0.72	4.208585866086e-149	IDS	CD4+ T cells	PMID34715028_post	ENSG00000010404	3423	iduronate 2-sulfatase	ID2S|SIDS	protein_coding	P22304	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69240
1.61370929851003e-151	-0.87008149178923	0.284	0.684	2.82834828749853e-147	HSPA5	CD4+ T cells	PMID34715028_post	ENSG00000044574	3309	heat shock protein family A (Hsp70) member 5	BiP|GRP78	protein_coding	P11021	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69241
2.66669356607873e-150	-0.727869382708175	0.185	0.588	4.6739138132662e-146	PIM3	CD4+ T cells	PMID34715028_post	ENSG00000198355	415116	Pim-3 proto-oncogene, serine/threonine kinase	NA	protein_coding	Q86V86	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69242
4.37752220001681e-150	-0.73604640582382	0.178	0.569	7.67248315996946e-146	DNAJB6	CD4+ T cells	PMID34715028_post	ENSG00000105993	10049	DnaJ heat shock protein family (Hsp40) member B6	LGMD1D|MRJ	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69243
1.66267117023755e-147	-0.722231747146456	0.898	0.979	2.91416376007535e-143	SARAF	CD4+ T cells	PMID34715028_post	ENSG00000133872	51669	store-operated calcium entry associated regulatory factor	MGC8721|TMEM66	protein_coding	Q96BY9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69244
2.10001574920128e-144	-0.714555689868603	0.058	0.391	3.68069760362508e-140	RGS2	CD4+ T cells	PMID34715028_post	ENSG00000116741	5997	regulator of G protein signaling 2	G0S8	protein_coding	P41220	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69245
4.02979615170382e-144	-0.566618655262499	0.999	1	7.06302371509128e-140	HLA-C	CD4+ T cells	PMID34715028_post	ENSG00000206435	3107	major histocompatibility complex, class I, C	D6S204|HLA-JY3|PSORS1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69246
6.55796599157849e-142	-0.673663472287293	0.129	0.494	1.14941469934396e-137	BCAS2	CD4+ T cells	PMID34715028_post	ENSG00000116752	10286	BCAS2 pre-mRNA processing factor	DAM1|Snt309|SPF27	protein_coding	O75934	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69247
6.01287757046637e-140	-0.927072814765195	0.29	0.671	1.05387705177564e-135	RNF19A	CD4+ T cells	PMID34715028_post	ENSG00000034677	25897	ring finger protein 19A, RBR E3 ubiquitin protein ligase	DKFZp566B1346|dorfin|RNF19	protein_coding	Q9NV58	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69248
6.19716967475917e-138	-0.735667288704093	0.018	0.298	1.08617792889504e-133	ATF3	CD4+ T cells	PMID34715028_post	ENSG00000162772	467	activating transcription factor 3	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69249
1.21641228336911e-137	-0.774331237696546	0.276	0.657	2.13200580906104e-133	REL	CD4+ T cells	PMID34715028_post	ENSG00000162924	5966	REL proto-oncogene, NF-kB subunit	c-Rel|HIVEN86A|I-Rel	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69250
8.72732233701696e-137	-0.682278628312279	0.124	0.478	1.52963778600896e-132	ODC1	CD4+ T cells	PMID34715028_post	ENSG00000115758	4953	ornithine decarboxylase 1	ODC	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69251
3.37013913267055e-136	-0.857637971345442	0.164	0.527	5.90684285783167e-132	BHLHE40	CD4+ T cells	PMID34715028_post	ENSG00000134107	8553	basic helix-loop-helix family member e40	BHLHB2|Clast5|DEC1|SHARP2|STRA13	protein_coding	O14503	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69252
6.5762218932914e-135	-0.878504991722316	0.297	0.659	1.15261441123718e-130	CYCS	CD4+ T cells	PMID34715028_post	ENSG00000172115	54205	cytochrome c, somatic	CYC|HCS	protein_coding	P99999	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69253
2.1479957878068e-131	0.938482639203973	0.419	0.06	3.76479221728897e-127	CISH	CD4+ T cells	PMID34715028_post	ENSG00000114737	1154	cytokine inducible SH2 containing protein	CIS|CIS-1|G18|SOCS	protein_coding	Q9NSE2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69254
2.59123375697455e-130	-0.792738965628463	0.049	0.354	4.54165540584929e-126	NR4A1	CD4+ T cells	PMID34715028_post	ENSG00000123358	3164	nuclear receptor subfamily 4 group A member 1	GFRP1|HMR|N10|NAK-1|NGFIB|NUR77|TR3	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69255
8.63691655692668e-128	-0.43453284987739	0.022	0.291	1.51379236493254e-123	IFITM3	CD4+ T cells	PMID34715028_post	ENSG00000142089	10410	interferon induced transmembrane protein 3	1-8U|DSPA2b	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69256
3.23813618557286e-126	-0.629786659394389	0.896	0.982	5.67548129245355e-122	PNRC1	CD4+ T cells	PMID34715028_post	ENSG00000146278	10957	proline rich nuclear receptor coactivator 1	B4-2|PROL2|PRR2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69257
4.44497131814427e-125	-0.712871852652618	0.269	0.632	7.79070122931146e-121	PDE4B	CD4+ T cells	PMID34715028_post	ENSG00000184588	5142	phosphodiesterase 4B	DPDE4	protein_coding	Q07343	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69258
1.37780524690191e-124	-0.576197652693747	0.095	0.419	2.41487925624498e-120	TUBB4B	CD4+ T cells	PMID34715028_post	ENSG00000188229	10383	tubulin beta 4B class IVb	Beta2|TUBB2C	protein_coding	P68371	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69259
3.60981758909871e-123	-0.636985650975526	0.142	0.48	6.32692728841331e-119	SDCBP	CD4+ T cells	PMID34715028_post	ENSG00000137575	6386	syndecan binding protein	MDA-9|SYCL	protein_coding	O00560	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69260
4.91298649230585e-122	-0.546825810830045	0.115	0.447	8.61099142506447e-118	PTP4A1	CD4+ T cells	PMID34715028_post	ENSG00000112245	7803	protein tyrosine phosphatase 4A1	PRL-1|PRL1|PTPCAAX1	protein_coding	Q93096	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69261
1.02503225630051e-121	-0.787127541963543	0.052	0.344	1.7965740356179e-117	AREG	CD4+ T cells	PMID34715028_post	ENSG00000109321	374	amphiregulin	AR|AREGB|SDGF	protein_coding	P15514	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69262
1.43381911818433e-116	-0.59266181663292	0.093	0.405	2.51305476844168e-112	KDM6B	CD4+ T cells	PMID34715028_post	ENSG00000132510	23135	lysine demethylase 6B	JMJD3|KIAA0346	protein_coding	O15054	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69263
1.5607189848244e-116	0.656306380889265	0.739	0.394	2.73547216470173e-112	TRAF3IP3	CD4+ T cells	PMID34715028_post	ENSG00000009790	80342	TRAF3 interacting protein 3	T3JAM	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69264
2.11294526046839e-116	-0.622070861157779	0.181	0.518	3.70335915802294e-112	NSMCE3	CD4+ T cells	PMID34715028_post	ENSG00000282130	56160	NSE3 homolog, SMC5-SMC6 complex component	HCA4|MAGEG1|MAGEL3|NDNL2|NSE3	protein_coding	Q96MG7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69265
4.92893992004391e-116	-0.548714192522606	0.093	0.402	8.63895299786096e-112	MIDN	CD4+ T cells	PMID34715028_post	ENSG00000167470	90007	midnolin	Stx	protein_coding	Q504T8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69266
1.03382887789671e-115	-0.553288061459742	0.066	0.358	1.81199187428956e-111	STOM	CD4+ T cells	PMID34715028_post	ENSG00000148175	2040	stomatin	BND7|EPB7|EPB72	protein_coding	P27105	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69267
3.27810663930252e-114	-0.551713439592822	0.194	0.536	5.74553750670553e-110	SBDS	CD4+ T cells	PMID34715028_post	ENSG00000126524	51119	SBDS ribosome maturation factor	CGI-97|FLJ10917|SDO1|SDS|SWDS	protein_coding	Q9Y3A5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69268
3.91416147080444e-113	-0.468640519560446	0.022	0.265	6.86035080987894e-109	MAP3K8	CD4+ T cells	PMID34715028_post	ENSG00000107968	1326	mitogen-activated protein kinase kinase kinase 8	c-COT|COT|EST|ESTF|MEKK8|Tpl-2	protein_coding	P41279	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69269
1.44393292484843e-111	0.706110600421069	0.977	0.894	2.53078123738185e-107	MT-ND2	CD4+ T cells	PMID34715028_post	ENSG00000198763	4536	NADH dehydrogenase subunit 2	MTND2|NAD2|ND2	protein_coding	P03891	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69270
2.18906804913991e-110	-0.716919888004436	0.391	0.696	3.83677956972753e-106	CDKN1B	CD4+ T cells	PMID34715028_post	ENSG00000111276	1027	cyclin dependent kinase inhibitor 1B	KIP1|P27KIP1	protein_coding	P46527	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69271
6.07391302618193e-110	-0.625330485259708	0.79	0.937	1.06457473609891e-105	YWHAZ	CD4+ T cells	PMID34715028_post	ENSG00000164924	7534	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	14-3-3-zeta|KCIP-1|YWHAD	protein_coding	P63104	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69272
1.12958449998977e-109	-0.665627888804048	0.129	0.441	1.97982275313206e-105	PFKFB3	CD4+ T cells	PMID34715028_post	ENSG00000170525	5209	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	NA	protein_coding	Q16875	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69273
3.99631517004266e-109	-0.606744673570882	0.164	0.487	7.00434159853376e-105	IVNS1ABP	CD4+ T cells	PMID34715028_post	ENSG00000116679	10625	influenza virus NS1A binding protein	ARA3|HSPC068|KIAA0850|KLHL39|ND1|NS-1|NS1-BP	protein_coding	Q9Y6Y0	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69274
4.98878460260798e-109	-0.557486071409289	0.125	0.434	8.74384277299101e-105	PLK3	CD4+ T cells	PMID34715028_post	ENSG00000173846	1263	polo like kinase 3	CNK|FNK|PRK	protein_coding	Q9H4B4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69275
1.01982759320824e-108	-0.56923941007652	0.158	0.479	1.78745182261608e-104	P2RY10	CD4+ T cells	PMID34715028_post	ENSG00000078589	27334	P2Y receptor family member 10	P2Y10	protein_coding	O00398	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69276
2.02069230682967e-107	-0.641092185507821	0.315	0.634	3.54166740618037e-103	UBE2B	CD4+ T cells	PMID34715028_post	ENSG00000119048	7320	ubiquitin conjugating enzyme E2 B	HHR6B|RAD6B|UBC2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69277
4.32210183441327e-106	-0.667910787882711	0.283	0.604	7.57534788517614e-102	DDX3X	CD4+ T cells	PMID34715028_post	ENSG00000215301	1654	DEAD-box helicase 3 X-linked	CAP-Rf|DBX|DDX14|DDX3|HLP2	protein_coding	O00571	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69278
2.92236426118392e-105	0.674934762781138	0.875	0.76	5.12202784057706e-101	PPDPF	CD4+ T cells	PMID34715028_post	ENSG00000125534	79144	pancreatic progenitor cell differentiation and proliferation factor	C20orf149|dJ697K14.9|exdpf	protein_coding	Q9H3Y8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69279
5.14617439889903e-105	-0.807776331448913	0.372	0.678	9.01969986895032e-101	NR3C1	CD4+ T cells	PMID34715028_post	ENSG00000113580	2908	nuclear receptor subfamily 3 group C member 1	GR|GRL	protein_coding	P04150	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69280
6.09513080776824e-105	-0.924370859472904	0.355	0.654	1.06829357667754e-100	HSPE1	CD4+ T cells	PMID34715028_post	ENSG00000115541	3336	heat shock protein family E (Hsp10) member 1	CPN10|EPF|GroES|HSP10	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69281
2.3059113479969e-104	-0.839350940515525	0.881	0.957	4.04157081963417e-100	CXCR4	CD4+ T cells	PMID34715028_post	ENSG00000121966	7852	C-X-C motif chemokine receptor 4	CD184|D2S201E|fusin|HM89|HSY3RR|LESTR|NPY3R|NPYR|NPYY3R	protein_coding	P61073	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69282
4.44017436515766e-104	-0.601890224492911	0.323	0.649	7.78229360981184e-100	EIF5	CD4+ T cells	PMID34715028_post	ENSG00000100664	1983	eukaryotic translation initiation factor 5	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69283
9.07953562805761e-104	-0.495388811333949	1	1	1.59137020952966e-99	HLA-A	CD4+ T cells	PMID34715028_post	ENSG00000227715	3105	major histocompatibility complex, class I, A	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69284
5.83770538761152e-103	-0.4768688525582	0.087	0.372	1.02317462328667e-98	FAM118A	CD4+ T cells	PMID34715028_post	ENSG00000100376	55007	family with sequence similarity 118 member A	bK268H5.C22.4|C22orf8|FLJ20635	protein_coding	Q9NWS6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69285
3.84806104945864e-101	-0.557537566666549	0.207	0.527	6.74449660138616e-97	ZFAND5	CD4+ T cells	PMID34715028_post	ENSG00000107372	7763	zinc finger AN1-type containing 5	ZA20D2|ZFAND5A|ZNF216	protein_coding	O76080	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69286
4.02531973979538e-101	-0.719342149966593	0.249	0.548	7.05517790793937e-97	ARID5A	CD4+ T cells	PMID34715028_post	ENSG00000196843	10865	AT-rich interaction domain 5A	MRF-1|RP11-363D14	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69287
1.73068957551935e-100	-0.659671937964337	0.439	0.738	3.03337961901276e-96	CCNL1	CD4+ T cells	PMID34715028_post	ENSG00000163660	57018	cyclin L1	ania-6a	protein_coding	Q9UK58	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69288
2.13793552965084e-99	0.603850953359805	0.997	0.983	3.74715960281902e-95	MT-CYB	CD4+ T cells	PMID34715028_post	ENSG00000198727	4519	cytochrome b	COB|CYTB|MTCYB|UQCR3	protein_coding	P00156	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69289
3.15901526444023e-99	0.62618731938138	0.661	0.337	5.53680605398439e-95	OXNAD1	CD4+ T cells	PMID34715028_post	ENSG00000154814	92106	oxidoreductase NAD binding domain containing 1	MGC15763	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69290
4.40963731354407e-99	-0.687181098816207	0.107	0.388	7.72877131944869e-95	FAAH2	CD4+ T cells	PMID34715028_post	ENSG00000165591	158584	fatty acid amide hydrolase 2	AMDD|FAAH-2|FLJ31204|RP11-479E16.1	protein_coding	Q6GMR7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69291
4.03219516226166e-98	-0.419414583806076	0.032	0.263	7.067228460896e-94	LDLR	CD4+ T cells	PMID34715028_post	ENSG00000130164	3949	low density lipoprotein receptor	LDLCQ2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69292
2.69928591047428e-97	-0.628981830195249	0.309	0.611	4.73103841528826e-93	GSPT1	CD4+ T cells	PMID34715028_post	ENSG00000103342	2935	G1 to S phase transition 1	eRF3a|ETF3A|GST1	protein_coding	P15170	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69293
3.11480745017595e-97	-0.737258978599913	0.487	0.74	5.45932301792338e-93	TGFB1	CD4+ T cells	PMID34715028_post	ENSG00000105329	7040	transforming growth factor beta 1	CED|DPD1|TGFB|TGFbeta	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69294
3.12391449109316e-97	-0.504465381110969	0.093	0.369	5.47528492853898e-93	TIPARP	CD4+ T cells	PMID34715028_post	ENSG00000163659	25976	TCDD inducible poly(ADP-ribose) polymerase	ARTD14|DDF1|DKFZP434J214|DKFZp686N0351|PARP-1|PARP-7|PARP7|pART14|RM1	protein_coding	Q7Z3E1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69295
1.40021087854891e-96	-0.681661100203993	0.223	0.536	2.45414960683268e-92	GADD45B	CD4+ T cells	PMID34715028_post	ENSG00000099860	4616	growth arrest and DNA damage inducible beta	DKFZP566B133|GADD45BETA|MYD118	protein_coding	O75293	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69296
3.10344284513129e-96	-0.652817369691898	0.163	0.474	5.43940427466161e-92	CITED2	CD4+ T cells	PMID34715028_post	ENSG00000164442	10370	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2	MRG1	protein_coding	Q99967	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69297
4.98402075058717e-96	-0.488198916045759	0.097	0.374	8.73549316955413e-92	PPP1R15B	CD4+ T cells	PMID34715028_post	ENSG00000158615	84919	protein phosphatase 1 regulatory subunit 15B	FLJ14744	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69298
1.21692458665612e-95	-0.762537436400368	0.412	0.731	2.13290372303218e-91	RGS1	CD4+ T cells	PMID34715028_post	ENSG00000090104	5996	regulator of G protein signaling 1	1R20|BL34|IER1|IR20	protein_coding	Q08116	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69299
1.35842109689508e-95	-0.466671016159744	0.996	1	2.38090465652801e-91	PTMA	CD4+ T cells	PMID34715028_post	ENSG00000187514	5757	prothymosin alpha	TMSA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69300
1.44386646939719e-95	-0.772559940879066	0.147	0.436	2.53066476091245e-91	PMAIP1	CD4+ T cells	PMID34715028_post	ENSG00000141682	5366	phorbol-12-myristate-13-acetate-induced protein 1	APR|NOXA	protein_coding	Q13794	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69301
7.10442402967916e-95	0.875791990674244	0.528	0.224	1.24519239968187e-90	LINC00861	CD4+ T cells	PMID34715028_post	ENSG00000245164	100130231	long intergenic non-protein coding RNA 861	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69302
1.17953455889556e-94	-0.550363274901248	0.212	0.515	2.06737022137624e-90	NFE2L2	CD4+ T cells	PMID34715028_post	ENSG00000116044	4780	NFE2 like bZIP transcription factor 2	NRF-2|NRF2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69303
1.56916961950647e-94	-0.492791664715499	0.115	0.399	2.75028359210898e-90	USP36	CD4+ T cells	PMID34715028_post	ENSG00000055483	57602	ubiquitin specific peptidase 36	FLJ12851|KIAA1453	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69304
1.61230532587094e-94	-0.721216414116591	0.251	0.557	2.825887544654e-90	ICOS	CD4+ T cells	PMID34715028_post	ENSG00000163600	29851	inducible T cell costimulator	AILIM|CD278	protein_coding	Q9Y6W8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69305
1.69390846773525e-94	-0.615048980624915	0.75	0.911	2.96891337139958e-90	OAZ1	CD4+ T cells	PMID34715028_post	ENSG00000104904	4946	ornithine decarboxylase antizyme 1	AZ1|AZI|MGC138338|OAZ	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69306
2.24473672832895e-94	-0.449169497232222	0.111	0.395	3.93435006374215e-90	RELB	CD4+ T cells	PMID34715028_post	ENSG00000104856	5971	RELB proto-oncogene, NF-kB subunit	REL-B	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69307
2.83544101413317e-93	-0.509028642211543	0.969	0.995	4.96967746547121e-89	HLA-E	CD4+ T cells	PMID34715028_post	ENSG00000206493	3133	major histocompatibility complex, class I, E	NA	protein_coding	P13747	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69308
1.10743032925555e-91	-0.459769930239407	0.088	0.354	1.94099313808621e-87	IFRD1	CD4+ T cells	PMID34715028_post	ENSG00000006652	3475	interferon related developmental regulator 1	PC4|TIS7	protein_coding	O00458	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69309
3.93557728577615e-91	-0.650137867476103	0.668	0.874	6.89788630877986e-87	UBB	CD4+ T cells	PMID34715028_post	ENSG00000170315	7314	ubiquitin B	FLJ25987|MGC8385	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69310
1.10744142358708e-90	-0.442415625105076	0.049	0.281	1.94101258312107e-86	DUSP10	CD4+ T cells	PMID34715028_post	ENSG00000143507	11221	dual specificity phosphatase 10	MKP-5|MKP5	protein_coding	Q9Y6W6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69311
1.78849259738277e-90	-0.587519863456417	0.119	0.413	3.13469097543278e-86	KLRB1	CD4+ T cells	PMID34715028_post	ENSG00000111796	3820	killer cell lectin like receptor B1	CD161|CLEC5B|hNKR-P1A|NKR|NKR-P1|NKR-P1A	protein_coding	Q12918	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69312
4.63776336455322e-90	0.480310431822418	0.363	0.072	8.12860784905243e-86	GABPB1-AS1	CD4+ T cells	PMID34715028_post	ENSG00000244879	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69313
4.16593263571839e-89	-0.626562904183072	0.112	0.376	7.30163013062362e-85	PLIN2	CD4+ T cells	PMID34715028_post	ENSG00000147872	123	perilipin 2	ADFP|ADRP	protein_coding	Q99541	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69314
9.3922270140373e-89	-0.361000199424454	0.048	0.279	1.64617562875032e-84	KPNA2	CD4+ T cells	PMID34715028_post	ENSG00000182481	3838	karyopherin subunit alpha 2	IPOA1|PTAC58|QIP2|RCH1|SRP1alpha	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69315
9.60034959696e-89	-0.399446465176432	0.059	0.301	1.68265327385918e-84	ELL2	CD4+ T cells	PMID34715028_post	ENSG00000118985	22936	elongation factor for RNA polymerase II 2	MRCCAT1	protein_coding	O00472	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69316
3.28988300987567e-87	-0.886944046179022	0.157	0.429	5.76617795140909e-83	GZMK	CD4+ T cells	PMID34715028_post	ENSG00000113088	3003	granzyme K	PRSS|TRYP2	protein_coding	P49863	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69317
1.22779891317945e-86	-0.539032301110174	0.057	0.288	2.15196315512963e-82	METRNL	CD4+ T cells	PMID34715028_post	ENSG00000275031	284207	meteorin like, glial cell differentiation regulator	NA	protein_coding	Q641Q3	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69318
4.88459314199801e-86	-0.35916340800415	0.05	0.277	8.56122639997992e-82	SERTAD1	CD4+ T cells	PMID34715028_post	ENSG00000197019	29950	SERTA domain containing 1	SEI1|TRIP-Br1	protein_coding	Q9UHV2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69319
2.96983288405632e-85	-0.445126923755658	0.097	0.355	5.20522609588551e-81	PNPLA8	CD4+ T cells	PMID34715028_post	ENSG00000135241	50640	patatin like phospholipase domain containing 8	IPLA2-2|IPLA2G|iPLA2gamma	protein_coding	Q9NP80	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69320
7.85964200473278e-85	-0.419154299879583	0.076	0.319	1.37755945416951e-80	ZC3H12A	CD4+ T cells	PMID34715028_post	ENSG00000163874	80149	zinc finger CCCH-type containing 12A	FLJ23231|MCPIP1|Regnase-1	protein_coding	Q5D1E8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69321
1.08202073978884e-84	-0.482266819402973	0.096	0.35	1.89645775062791e-80	INSIG1	CD4+ T cells	PMID34715028_post	ENSG00000186480	3638	insulin induced gene 1	CL-6|MGC1405	protein_coding	O15503	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69322
7.34625499191384e-83	-0.531337475322889	0.169	0.45	1.28757811243274e-78	ALOX5AP	CD4+ T cells	PMID34715028_post	ENSG00000132965	241	arachidonate 5-lipoxygenase activating protein	FLAP	protein_coding	P20292	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69323
4.39459213753603e-82	-0.514677776157124	0.088	0.333	7.70240163945939e-78	PDE4D	CD4+ T cells	PMID34715028_post	ENSG00000113448	5144	phosphodiesterase 4D	DPDE3	protein_coding	Q08499	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69324
1.1689435557723e-80	-0.771502302684498	0.516	0.781	2.0488073702021e-76	AHNAK	CD4+ T cells	PMID34715028_post	ENSG00000124942	79026	AHNAK nucleoprotein	AHNAK1|MGC5395	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69325
1.21501931746386e-80	0.480972856521573	0.362	0.087	2.12956435771891e-76	AC025164.1	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69326
1.66461367866476e-80	0.634861489645764	0.707	0.46	2.91756839459573e-76	CELF2	CD4+ T cells	PMID34715028_post	ENSG00000048740	10659	CUGBP Elav-like family member 2	BRUNOL3|CUGBP2|Etr-3|NAPOR-2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69327
7.65831304107124e-80	-0.494824901592134	0.15	0.419	1.34227252670856e-75	JMY	CD4+ T cells	PMID34715028_post	ENSG00000152409	133746	junction mediating and regulatory protein, p53 cofactor	FLJ37870|WHAMM2	protein_coding	Q8N9B5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69328
1.4822346664119e-79	-0.605732389301407	0.878	0.958	2.59791269982014e-75	TSC22D3	CD4+ T cells	PMID34715028_post	ENSG00000157514	1831	TSC22 domain family member 3	DIP|DSIPI|GILZ|hDIP|TSC-22R	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69329
1.67845548912559e-79	-0.881799631972189	0.395	0.71	2.94182893579043e-75	KLF2	CD4+ T cells	PMID34715028_post	ENSG00000127528	10365	KLF transcription factor 2	LKLF	protein_coding	Q9Y5W3	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69330
1.18022635004136e-78	-0.546591169040329	0.31	0.589	2.0685827237175e-74	G3BP2	CD4+ T cells	PMID34715028_post	ENSG00000138757	9908	G3BP stress granule assembly factor 2	KIAA0660	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69331
1.88688881305287e-78	-0.664078347849886	0.5	0.764	3.30715002263777e-74	BIRC3	CD4+ T cells	PMID34715028_post	ENSG00000023445	330	baculoviral IAP repeat containing 3	API2|c-IAP2|cIAP2|hiap-1|MALT2|MIHC|RNF49	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69332
6.24214731392813e-78	-0.374818574493922	0.08	0.314	1.09406115971218e-73	DNAJB9	CD4+ T cells	PMID34715028_post	ENSG00000128590	4189	DnaJ heat shock protein family (Hsp40) member B9	MDG1	protein_coding	Q9UBS3	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69333
1.30318011200524e-76	-0.622802593963272	0.452	0.708	2.28408378231158e-72	RARRES3	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69334
1.7826012083454e-75	-0.545226328599768	0.307	0.581	3.12436513786699e-71	NOP58	CD4+ T cells	PMID34715028_post	ENSG00000055044	51602	NOP58 ribonucleoprotein	HSPC120|NOP5	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69335
1.78898125737353e-75	-0.846077805448051	0.819	0.918	3.13554744979858e-71	ZFP36L2	CD4+ T cells	PMID34715028_post	ENSG00000152518	678	ZFP36 ring finger protein like 2	BRF2|ERF2|RNF162C|TIS11D	protein_coding	P47974	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69336
5.002062450297e-75	-0.526804640390423	0.202	0.472	8.76711485663555e-71	NAMPT	CD4+ T cells	PMID34715028_post	ENSG00000105835	10135	nicotinamide phosphoribosyltransferase	PBEF|PBEF1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69337
5.64823561999033e-75	0.430207071178434	0.999	1	9.89966257115705e-71	MT-CO1	CD4+ T cells	PMID34715028_post	ENSG00000198804	4512	cytochrome c oxidase subunit I	COI|COX1|MTCO1	protein_coding	P00395	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69338
7.27944167839917e-75	-0.678772027305165	0.316	0.579	1.27586774297302e-70	ITM2A	CD4+ T cells	PMID34715028_post	ENSG00000078596	9452	integral membrane protein 2A	BRICD2A|E25A	protein_coding	O43736	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69339
1.59278123114847e-74	-0.543275146817795	0.273	0.541	2.79166766383392e-70	CHD1	CD4+ T cells	PMID34715028_post	ENSG00000153922	1105	chromodomain helicase DNA binding protein 1	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69340
7.12754291852711e-74	-0.436548602367462	0.205	0.472	1.24924444733025e-69	MAPK1IP1L	CD4+ T cells	PMID34715028_post	ENSG00000168175	93487	mitogen-activated protein kinase 1 interacting protein 1 like	C14orf32	protein_coding	Q8NDC0	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69341
1.06807410790421e-73	0.565497314547012	0.698	0.464	1.87201348892371e-69	PIK3IP1	CD4+ T cells	PMID34715028_post	ENSG00000100100	113791	phosphoinositide-3-kinase interacting protein 1	HGFL|MGC17330|TrIP	protein_coding	Q96FE7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69342
1.41705434403234e-73	-0.630683631079746	0.206	0.468	2.48367114878548e-69	HLA-DQB1	CD4+ T cells	PMID34715028_post	ENSG00000206237	3119	major histocompatibility complex, class II, DQ beta 1	CELIAC1|HLA-DQB|IDDM1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69343
1.59154815648908e-73	-0.890447973566049	0.573	0.818	2.78950645387842e-69	CD69	CD4+ T cells	PMID34715028_post	ENSG00000110848	969	CD69 molecule	CLEC2C	protein_coding	Q07108	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69344
5.11654137107e-73	-0.551495859127829	0.463	0.717	8.96776206107438e-69	STAT3	CD4+ T cells	PMID34715028_post	ENSG00000168610	6774	signal transducer and activator of transcription 3	APRF	protein_coding	P40763	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69345
5.27175850892346e-72	-0.805250963411249	0.149	0.384	9.23981113859015e-68	GPR183	CD4+ T cells	PMID34715028_post	ENSG00000169508	1880	G protein-coupled receptor 183	EBI2	protein_coding	P32249	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69346
5.59309645987281e-72	0.571729745741124	0.539	0.261	9.80302016521907e-68	BCL2	CD4+ T cells	PMID34715028_post	ENSG00000171791	596	BCL2 apoptosis regulator	Bcl-2|PPP1R50	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69347
5.57003018586792e-71	-0.636490217485844	0.931	0.979	9.76259190677071e-67	PABPC1	CD4+ T cells	PMID34715028_post	ENSG00000070756	26986	poly(A) binding protein cytoplasmic 1	PAB1|PABP1|PABPC2|PABPL1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69348
3.43768711235176e-68	-0.400276344909991	0.137	0.376	6.02523420181893e-64	HBP1	CD4+ T cells	PMID34715028_post	ENSG00000283847	26959	HMG-box transcription factor 1	NA	protein_coding	O60381	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69349
3.55318360027182e-68	0.612692212027048	0.72	0.502	6.22766489619642e-64	KIAA1551	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69350
6.53448958128234e-67	-0.362305660578623	0.077	0.288	1.14529998891136e-62	CKS2	CD4+ T cells	PMID34715028_post	ENSG00000123975	1164	CDC28 protein kinase regulatory subunit 2	NA	protein_coding	P33552	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69351
8.09972278569555e-67	-0.547511468098863	0.327	0.58	1.41963841264886e-62	SAMSN1	CD4+ T cells	PMID34715028_post	ENSG00000155307	64092	SAM domain, SH3 domain and nuclear localization signals 1	HACS1|NASH1|SASH2|SH3D6B|SLy2	protein_coding	Q9NSI8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69352
2.95677480939242e-66	-0.353435544547567	0.086	0.301	5.1823392084221e-62	HAUS3	CD4+ T cells	PMID34715028_post	ENSG00000214367	79441	HAUS augmin like complex subunit 3	C4orf15|dgt3|IT1|MGC4701	protein_coding	Q68CZ6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69353
5.90526443299529e-66	-0.52255724496232	0.394	0.641	1.03501569717108e-61	GNG2	CD4+ T cells	PMID34715028_post	ENSG00000186469	54331	G protein subunit gamma 2	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69354
7.16420210893883e-65	-0.483588519779684	0.223	0.474	1.25566970363371e-60	FAS	CD4+ T cells	PMID34715028_post	ENSG00000026103	355	Fas cell surface death receptor	APO-1|APT1|CD95|FAS1|TNFRSF6	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69355
2.57499115979121e-64	-0.579260128514064	0.173	0.413	4.51318700576605e-60	PHLDA1	CD4+ T cells	PMID34715028_post	ENSG00000139289	22822	pleckstrin homology like domain family A member 1	DT1P1B11|PHRIP|TDAG51	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69356
3.06533264252478e-64	-0.55332431285785	0.345	0.588	5.37260852255318e-60	JMJD1C	CD4+ T cells	PMID34715028_post	ENSG00000171988	221037	jumonji domain containing 1C	DKFZp761F0118|FLJ14374|KDM3C|KIAA1380|TRIP8	protein_coding	Q15652	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69357
4.30985653987687e-64	-0.314855562952712	0.083	0.292	7.55388555744219e-60	RNF139	CD4+ T cells	PMID34715028_post	ENSG00000170881	11236	ring finger protein 139	HRCA1|RCA1|TRC8	protein_coding	Q8WU17	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69358
9.67657063888861e-64	0.892740357055833	0.975	0.943	1.69601253587801e-59	IL32	CD4+ T cells	PMID34715028_post	ENSG00000008517	9235	interleukin 32	NK4|TAIF|TAIFb|TAIFd	protein_coding	P24001	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69359
2.2261875606316e-63	-0.382854964975838	0.106	0.322	3.90183893751901e-59	GABARAPL1	CD4+ T cells	PMID34715028_post	ENSG00000139112	23710	GABA type A receptor associated protein like 1	APG8L|ATG8B|ATG8L|gec1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69360
1.55372269832589e-62	-0.422914348728621	0.196	0.449	2.72320977335578e-58	BTG3	CD4+ T cells	PMID34715028_post	ENSG00000281484	10950	BTG anti-proliferation factor 3	ANA|ANA/BTG3|APRO4|tob55	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69361
8.04891674170574e-62	-0.367985494562684	0.127	0.35	1.41073363731876e-57	SIAH2	CD4+ T cells	PMID34715028_post	ENSG00000181788	6478	siah E3 ubiquitin protein ligase 2	NA	protein_coding	O43255	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69362
2.59245776441925e-61	0.523025926481148	0.306	0.082	4.54380072369762e-57	C15orf53	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69363
3.33581427152952e-61	0.547667441294154	0.875	0.785	5.84668167370979e-57	ETS1	CD4+ T cells	PMID34715028_post	ENSG00000134954	2113	ETS proto-oncogene 1, transcription factor	ETS-1|EWSR2|FLJ10768	protein_coding	P14921	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69364
3.98263909230335e-61	-0.45411650249788	0.205	0.445	6.98037153708008e-57	GPCPD1	CD4+ T cells	PMID34715028_post	ENSG00000125772	56261	glycerophosphocholine phosphodiesterase 1	GDE5|GDPD6|KIAA1434	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69365
2.04542573135396e-60	0.479259654971857	0.978	0.916	3.58501767934409e-56	MT-ND4	CD4+ T cells	PMID34715028_post	ENSG00000198886	4538	NADH dehydrogenase subunit 4	LHON|MTND4|NAD4|ND4	protein_coding	P03905	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69366
6.945734174024e-59	-0.342372043155483	0.105	0.312	1.21737882868119e-54	GPR132	CD4+ T cells	PMID34715028_post	ENSG00000183484	29933	G protein-coupled receptor 132	G2A	protein_coding	Q9UNW8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69367
9.24602782077561e-59	-0.437923702665013	0.29	0.521	1.62055129614734e-54	EMD	CD4+ T cells	PMID34715028_post	ENSG00000102119	2010	emerin	LEMD5|STA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69368
1.40261379958206e-58	-0.479773257948741	0.685	0.857	2.45836120652747e-54	CD44	CD4+ T cells	PMID34715028_post	ENSG00000026508	960	CD44 molecule (Indian blood group)	CD44R|CSPG8|HCELL|IN|MC56|MDU2|MDU3|MIC4|Pgp1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69369
2.14407844609868e-58	-0.371801673241819	0.092	0.291	3.75792629247716e-54	CHMP1B	CD4+ T cells	PMID34715028_post	ENSG00000255112	57132	charged multivesicular body protein 1B	C18orf2|CHMP1.5|Vps46B	protein_coding	Q7LBR1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69370
5.01002184987384e-58	-0.415171465066579	0.883	0.962	8.78106529627388e-54	CALM1	CD4+ T cells	PMID34715028_post	ENSG00000198668	801	calmodulin 1	CALML2|CAMI|DD132|PHKD|PHKD1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69371
1.59307766133188e-57	-0.419919360180488	0.181	0.406	2.79218721701638e-53	DDX3Y	CD4+ T cells	PMID34715028_post	ENSG00000067048	8653	DEAD-box helicase 3 Y-linked	DBY	protein_coding	O15523	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69372
1.33734313325013e-56	-0.350387443427662	1	1	2.3439613096475e-52	B2M	CD4+ T cells	PMID34715028_post	ENSG00000273686	567	beta-2-microglobulin	NA	protein_coding	P61769	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69373
3.04450232455704e-56	-0.532514132210737	0.513	0.71	5.33609922425112e-52	PTGES3	CD4+ T cells	PMID34715028_post	ENSG00000110958	10728	prostaglandin E synthase 3	cPGES|p23|TEBP	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69374
1.13336521897882e-55	-0.48744120095091	0.496	0.706	1.98644921930419e-51	STK17A	CD4+ T cells	PMID34715028_post	ENSG00000164543	9263	serine/threonine kinase 17a	DRAK1	protein_coding	Q9UEE5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69375
2.23551094389687e-55	-0.570420262355164	0.389	0.612	3.91818003136805e-51	ADGRE5	CD4+ T cells	PMID34715028_post	ENSG00000123146	976	adhesion G protein-coupled receptor E5	CD97|TM7LN1	protein_coding	P48960	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69376
1.52873476905467e-54	-0.382261819940084	0.167	0.387	2.67941342972211e-50	IER5	CD4+ T cells	PMID34715028_post	ENSG00000162783	51278	immediate early response 5	NA	protein_coding	Q5VY09	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69377
4.78543656131704e-54	-0.369261214626405	0.222	0.453	8.38743466102038e-50	ARF4	CD4+ T cells	PMID34715028_post	ENSG00000168374	378	ADP ribosylation factor 4	ARF2	protein_coding	P18085	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69378
5.58342787721247e-54	-0.635206539462398	0.262	0.484	9.7860740403903e-50	NKG7	CD4+ T cells	PMID34715028_post	ENSG00000105374	4818	natural killer cell granule protein 7	GIG1|GMP-17	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69379
6.54987066921548e-54	0.451867944363038	0.617	0.382	1.1479958321934e-49	ANKRD44	CD4+ T cells	PMID34715028_post	ENSG00000065413	91526	ankyrin repeat domain 44	PP6-ARS-B	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69380
1.51593131937721e-53	-0.356740689271239	0.136	0.342	2.65697282347244e-49	GTF2B	CD4+ T cells	PMID34715028_post	ENSG00000137947	2959	general transcription factor IIB	TFIIB	protein_coding	Q00403	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69381
1.81526075628805e-53	0.396125120729497	0.998	0.991	3.18160752754607e-49	MT-ND4L	CD4+ T cells	PMID34715028_post	ENSG00000212907	4539	NADH dehydrogenase subunit 4L	MTND4L|NAD4L|ND4L	protein_coding	P03901	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69382
2.24124612716278e-53	0.338846931948455	0.317	0.099	3.9282320870782e-49	ERAP2	CD4+ T cells	PMID34715028_post	ENSG00000164308	64167	endoplasmic reticulum aminopeptidase 2	L-RAP|LRAP	protein_coding	Q6P179	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69383
3.27281882576729e-53	-0.594554541310271	0.366	0.582	5.73626955592233e-49	CCL5	CD4+ T cells	PMID34715028_post	ENSG00000274233	6352	C-C motif chemokine ligand 5	D17S136E|MGC17164|RANTES|SCYA5|SISd|TCP228	protein_coding	P13501	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69384
4.02152796586782e-53	0.380562587576631	0.408	0.175	7.04853206577653e-49	THEM4	CD4+ T cells	PMID34715028_post	ENSG00000159445	117145	thioesterase superfamily member 4	CTMP	protein_coding	Q5T1C6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69385
4.07886613058058e-53	-0.313348181169766	0.074	0.252	7.14902866706858e-49	ZC3H12D	CD4+ T cells	PMID34715028_post	ENSG00000178199	340152	zinc finger CCCH-type containing 12D	C6orf95|dJ281H8.1|MCPIP4	protein_coding	A2A288	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69386
4.42170776068524e-53	-0.482474292425322	0.205	0.422	7.74992719215302e-49	RAB11FIP1	CD4+ T cells	PMID34715028_post	ENSG00000156675	80223	RAB11 family interacting protein 1	FLJ22524|FLJ22622|Rab11-FIP1|RCP	protein_coding	Q6WKZ4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69387
2.73568541573549e-52	-0.292237284128313	0.092	0.278	4.7948358281596e-48	ISCA1	CD4+ T cells	PMID34715028_post	ENSG00000135070	81689	iron-sulfur cluster assembly 1	HBLD2|hIscA|ISA1|MGC4276	protein_coding	Q9BUE6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69388
4.69495265318727e-52	-0.441109473691314	0.445	0.665	8.22884351524133e-48	ELF1	CD4+ T cells	PMID34715028_post	ENSG00000120690	1997	E74 like ETS transcription factor 1	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69389
1.06790632102145e-51	-0.339232808729396	0.149	0.361	1.87171940885429e-47	SNHG15	CD4+ T cells	PMID34715028_post	ENSG00000232956	285958	small nucleolar RNA host gene 15	C7orf40|FLJ38860|Linc-Myo1g|MYO1GUT	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69390
2.27269184276808e-51	-0.376328962260177	0.188	0.404	3.98334699281962e-47	ETV6	CD4+ T cells	PMID34715028_post	ENSG00000139083	2120	ETS variant transcription factor 6	TEL	protein_coding	P41212	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69391
2.27696137305454e-51	-0.505622007780766	0.54	0.703	3.99083019855269e-47	LEPROTL1	CD4+ T cells	PMID34715028_post	ENSG00000104660	23484	leptin receptor overlapping transcript like 1	my047|Vps55	protein_coding	O95214	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69392
2.27794605082164e-51	-0.406927275049036	0.251	0.471	3.99255604327509e-47	PPP1CB	CD4+ T cells	PMID34715028_post	ENSG00000213639	5500	protein phosphatase 1 catalytic subunit beta	MP|PP-1B|PP1B|PP1beta|PP1c|PPP1beta	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69393
2.86216328751535e-51	-0.342569054825214	0.125	0.323	5.01651359402816e-47	MTHFD2	CD4+ T cells	PMID34715028_post	ENSG00000065911	10797	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69394
1.34794674911333e-50	-0.459699902114273	0.383	0.605	2.36254626717093e-46	ZC3HAV1	CD4+ T cells	PMID34715028_post	ENSG00000105939	56829	zinc finger CCCH-type containing, antiviral 1	ARTD13|FLB6421|FLJ13288|MGC48898|PARP13|ZAP|ZC3H2|ZC3HDC2	protein_coding	Q7Z2W4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69395
1.41189080525641e-50	-0.368829464909627	0.145	0.348	2.47462101437292e-46	ATP2B1	CD4+ T cells	PMID34715028_post	ENSG00000070961	490	ATPase plasma membrane Ca2+ transporting 1	PMCA1	protein_coding	P20020	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69396
1.96259457795871e-50	-0.331930846112462	0.105	0.294	3.43983951678823e-46	SC5D	CD4+ T cells	PMID34715028_post	ENSG00000109929	6309	sterol-C5-desaturase	SC5DL	protein_coding	O75845	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69397
8.68401340731266e-50	-0.615303919124343	0.265	0.475	1.52204702989969e-45	ISG15	CD4+ T cells	PMID34715028_post	ENSG00000187608	9636	ISG15 ubiquitin like modifier	G1P2|IFI15|UCRP	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69398
1.49303086074429e-49	-0.507969875013021	0.228	0.43	2.61683518962652e-45	CACYBP	CD4+ T cells	PMID34715028_post	ENSG00000116161	27101	calcyclin binding protein	S100A6BP|SIP	protein_coding	Q9HB71	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69399
2.00540965332213e-49	-0.402355293132066	0.239	0.455	3.5148814993777e-45	RBM38	CD4+ T cells	PMID34715028_post	ENSG00000132819	55544	RNA binding motif protein 38	dJ800J21.2|HSRNASEB|RNPC1|seb4B|SEB4D	protein_coding	Q9H0Z9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69400
2.77195697238619e-49	-0.384555874426551	0.227	0.443	4.85840898550127e-45	CDK17	CD4+ T cells	PMID34715028_post	ENSG00000059758	5128	cyclin dependent kinase 17	PCTAIRE2|PCTK2	protein_coding	Q00537	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69401
3.39224293777819e-49	0.506036075741357	0.535	0.312	5.94558419704383e-45	SLFN5	CD4+ T cells	PMID34715028_post	ENSG00000166750	162394	schlafen family member 5	MGC19764	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69402
4.43019228160939e-49	-0.370951561971772	0.184	0.395	7.76479801197678e-45	EIF4A3	CD4+ T cells	PMID34715028_post	ENSG00000141543	9775	eukaryotic translation initiation factor 4A3	DDX48|EIF4AIII|Fal1|KIAA0111	protein_coding	P38919	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69403
5.2393220637517e-49	-0.295844251468002	0.107	0.295	9.1829597811376e-45	IRF2BP2	CD4+ T cells	PMID34715028_post	ENSG00000168264	359948	interferon regulatory factor 2 binding protein 2	IRF-2BP2	protein_coding	Q7Z5L9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69404
1.24687337570052e-48	0.640706008315436	0.906	0.798	2.1853949655903e-44	LTB	CD4+ T cells	PMID34715028_post	ENSG00000223448	4050	lymphotoxin beta	p33|TNFC|TNFSF3	protein_coding	Q06643	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69405
1.74356641900631e-48	-0.456386977968304	0.333	0.547	3.05594886259236e-44	HMGB2	CD4+ T cells	PMID34715028_post	ENSG00000164104	3148	high mobility group box 2	HMG2	protein_coding	P26583	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69406
1.03232449342217e-47	0.353048207289083	0.998	0.988	1.80935513962104e-43	MT-ND5	CD4+ T cells	PMID34715028_post	ENSG00000198786	4540	NADH dehydrogenase subunit 5	MTND5|NAD5|ND5	protein_coding	P03915	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69407
1.06510243447752e-47	0.484099679193256	0.685	0.489	1.86680503690875e-43	IKZF1	CD4+ T cells	PMID34715028_post	ENSG00000185811	10320	IKAROS family zinc finger 1	hIk-1|Hs.54452|IKAROS|LyF-1|PPP1R92|ZNFN1A1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69408
1.52188900561932e-47	-0.369754735729344	0.12	0.307	2.66741486014898e-43	TRPS1	CD4+ T cells	PMID34715028_post	ENSG00000104447	7227	transcriptional repressor GATA binding 1	GC79|LGCR	protein_coding	Q9UHF7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69409
1.87343074119482e-47	-0.305695626643648	0.154	0.354	3.28356206009217e-43	NR1H2	CD4+ T cells	PMID34715028_post	ENSG00000131408	7376	nuclear receptor subfamily 1 group H member 2	LXR-b|LXRb|NER|NER-I|RIP15|UNR	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69410
3.56191922784672e-47	-0.420252525973059	0.26	0.469	6.24297583064694e-43	NEDD9	CD4+ T cells	PMID34715028_post	ENSG00000111859	4739	neural precursor cell expressed, developmentally down-regulated 9	CAS-L|CASS2|HEF1	protein_coding	Q14511	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69411
3.95138504142517e-47	0.474535079107613	0.7	0.536	6.9255925621059e-43	LCP2	CD4+ T cells	PMID34715028_post	ENSG00000043462	3937	lymphocyte cytosolic protein 2	SLP-76|SLP76	protein_coding	Q13094	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69412
1.10609966326178e-46	-0.485851419544636	0.389	0.587	1.93866087979893e-42	SQSTM1	CD4+ T cells	PMID34715028_post	ENSG00000284099	8878	sequestosome 1	A170|OSIL|p60|p62|p62B|PDB3	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69413
1.16932321920699e-46	0.457823583432194	0.819	0.697	2.0494728063041e-42	DDX17	CD4+ T cells	PMID34715028_post	ENSG00000100201	10521	DEAD-box helicase 17	P72	protein_coding	Q92841	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69414
1.74394517596681e-46	-0.395314768904393	0.527	0.712	3.05661270991703e-42	UBE2D3	CD4+ T cells	PMID34715028_post	ENSG00000109332	7323	ubiquitin conjugating enzyme E2 D3	UbcH5C	protein_coding	P61077	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69415
1.90702935385901e-46	-0.416737335519057	0.399	0.608	3.34245034850869e-42	GPBP1	CD4+ T cells	PMID34715028_post	ENSG00000062194	65056	GC-rich promoter binding protein 1	DKFZp761C169	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69416
2.67692764418933e-46	-0.450797117883423	0.57	0.755	4.69185108197064e-42	FYN	CD4+ T cells	PMID34715028_post	ENSG00000010810	2534	FYN proto-oncogene, Src family tyrosine kinase	MGC45350|SLK|SYN	protein_coding	P06241	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69417
3.5400471369181e-46	-0.414050605838661	0.995	0.999	6.20464061687635e-42	BTG1	CD4+ T cells	PMID34715028_post	ENSG00000133639	694	BTG anti-proliferation factor 1	APRO2	protein_coding	P62324	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69418
3.61505826154361e-46	-0.397927532479998	0.481	0.699	6.33611261500749e-42	CALR	CD4+ T cells	PMID34715028_post	ENSG00000179218	811	calreticulin	cC1qR|CRT|FLJ26680|RO|SSA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69419
4.14771869451706e-46	0.382207102459996	0.393	0.181	7.26970655588006e-42	MAN1A2	CD4+ T cells	PMID34715028_post	ENSG00000198162	10905	mannosidase alpha class 1A member 2	MAN1B	protein_coding	O60476	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69420
5.2761133538642e-46	0.448004737291854	0.466	0.249	9.24744387531778e-42	ATM	CD4+ T cells	PMID34715028_post	ENSG00000149311	472	ATM serine/threonine kinase	ATA|ATC|ATD|ATDC|TEL1|TELO1	protein_coding	Q13315	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69421
5.62690146263282e-46	-0.398701497117583	0.515	0.711	9.86227019355655e-42	WIPF1	CD4+ T cells	PMID34715028_post	ENSG00000115935	7456	WAS/WASL interacting protein family member 1	WASPIP|WIP	protein_coding	O43516	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69422
8.99308462820787e-46	0.840175755225494	0.565	0.41	1.57621794278599e-41	CTSC	CD4+ T cells	PMID34715028_post	ENSG00000109861	1075	cathepsin C	DPP1|PALS|PLS	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69423
1.23544201411084e-45	0.527757400947545	0.575	0.371	2.16535921813207e-41	PRDM1	CD4+ T cells	PMID34715028_post	ENSG00000057657	639	PR/SET domain 1	BLIMP1|PRDI-BF1	protein_coding	O75626	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69424
1.37742822783617e-45	0.390890565733475	0.519	0.293	2.41421845492845e-41	LUC7L3	CD4+ T cells	PMID34715028_post	ENSG00000108848	51747	LUC7 like 3 pre-mRNA splicing factor	CRA|CREAP-1|CROP|FLJ11063|hLuc7A|LUC7A|OA48-18	protein_coding	O95232	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69425
1.75266157232155e-45	-0.389858214274442	0.561	0.748	3.07188993780798e-41	CALM2	CD4+ T cells	PMID34715028_post	ENSG00000143933	805	calmodulin 2	CAMII|PHKD|PHKD2	protein_coding	P0DP24	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69426
2.65622629689099e-45	-0.427318029875663	0.354	0.557	4.65556783056083e-41	RNF149	CD4+ T cells	PMID34715028_post	ENSG00000163162	284996	ring finger protein 149	FLJ90504	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69427
3.96796398975822e-45	-0.324549126073043	0.129	0.316	6.95465048484923e-41	PPP1R16B	CD4+ T cells	PMID34715028_post	ENSG00000101445	26051	protein phosphatase 1 regulatory subunit 16B	ANKRD4|KIAA0823|TIMAP	protein_coding	Q96T49	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69428
5.93281029963317e-45	-0.503123985514827	0.523	0.694	1.0398436612167e-40	SOD1	CD4+ T cells	PMID34715028_post	ENSG00000142168	6647	superoxide dismutase 1	ALS|ALS1|IPOA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69429
1.07461489256759e-44	-0.375545754255826	0.418	0.61	1.88347752220322e-40	HNRNPA0	CD4+ T cells	PMID34715028_post	ENSG00000177733	10949	heterogeneous nuclear ribonucleoprotein A0	HNRPA0	protein_coding	Q13151	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69430
1.12538110865051e-44	0.376520112847791	0.442	0.226	1.97245546913175e-40	ADAM10	CD4+ T cells	PMID34715028_post	ENSG00000137845	102	ADAM metallopeptidase domain 10	CD156C|HsT18717|kuz|MADM	protein_coding	O14672	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69431
1.50115686921454e-44	-0.323534109389125	0.104	0.277	2.63107764467233e-40	GPR65	CD4+ T cells	PMID34715028_post	ENSG00000140030	8477	G protein-coupled receptor 65	hTDAG8|TDAG8	protein_coding	Q8IYL9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69432
1.73865546212854e-44	-0.326567943940208	0.143	0.333	3.04734142847269e-40	IL21R	CD4+ T cells	PMID34715028_post	ENSG00000103522	50615	interleukin 21 receptor	CD360	protein_coding	Q9HBE5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69433
2.35149153896428e-44	-0.33086681887409	0.203	0.406	4.12145922034269e-40	SLC3A2	CD4+ T cells	PMID34715028_post	ENSG00000168003	6520	solute carrier family 3 member 2	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69434
4.67295361911274e-44	-0.481636491896	0.373	0.572	8.1902858082189e-40	TAGAP	CD4+ T cells	PMID34715028_post	ENSG00000164691	117289	T cell activation RhoGTPase activating protein	ARHGAP47|FLJ32631|IDDM21	protein_coding	Q8N103	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69435
5.69520634532668e-44	-0.323168874461163	0.145	0.334	9.98198816145407e-40	SLBP	CD4+ T cells	PMID34715028_post	ENSG00000163950	7884	stem-loop binding protein	HBP	protein_coding	Q14493	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69436
8.47463323603571e-44	-0.441013389676659	0.252	0.447	1.48534896727998e-39	SH2D1A	CD4+ T cells	PMID34715028_post	ENSG00000183918	4068	SH2 domain containing 1A	DSHP|EBVS|IMD5|LYP|MTCP1|SAP|XLP|XLPD	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69437
1.04535193520111e-43	-0.495159476641381	0.473	0.684	1.83218833682698e-39	GBP5	CD4+ T cells	PMID34715028_post	ENSG00000154451	115362	guanylate binding protein 5	NA	protein_coding	Q96PP8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69438
3.1799887622135e-43	-0.375438572500732	0.283	0.493	5.57356630353161e-39	CD28	CD4+ T cells	PMID34715028_post	ENSG00000178562	940	CD28 molecule	NA	protein_coding	P10747	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69439
8.84617232647184e-43	0.486030452156049	0.624	0.45	1.55046862366072e-38	NDFIP1	CD4+ T cells	PMID34715028_post	ENSG00000131507	80762	Nedd4 family interacting protein 1	MGC10924|N4WBP5	protein_coding	Q9BT67	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69440
9.95578236314194e-43	-0.313635435420181	0.176	0.37	1.74494997478789e-38	HERPUD2	CD4+ T cells	PMID34715028_post	ENSG00000122557	64224	HERPUD family member 2	FLJ22313	protein_coding	Q9BSE4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69441
2.83755873510372e-42	-0.38304714564905	0.328	0.53	4.97338919501629e-38	PPP2R5C	CD4+ T cells	PMID34715028_post	ENSG00000078304	5527	protein phosphatase 2 regulatory subunit B'gamma	B56G|B56gamma|PR61G	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69442
1.42986241295615e-41	-0.398228457196525	0.448	0.669	2.50611985118824e-37	HLA-DPA1	CD4+ T cells	PMID34715028_post	ENSG00000228163	3113	major histocompatibility complex, class II, DP alpha 1	HLA-DP1A	protein_coding	P20036	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69443
2.13092431255684e-41	-0.264832866612499	0.109	0.279	3.73487104261837e-37	ETF1	CD4+ T cells	PMID34715028_post	ENSG00000120705	2107	eukaryotic translation termination factor 1	ERF|ERF1|RF1|SUP45L1|TB3-1	protein_coding	P62495	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69444
2.96848351371168e-41	-0.349964436305411	0.254	0.455	5.20286105448245e-37	DDX21	CD4+ T cells	PMID34715028_post	ENSG00000165732	9188	DExD-box helicase 21	GURDB|RH-II/GU	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69445
4.36807481264246e-41	-0.493555374507615	0.297	0.494	7.65592472411843e-37	ITGB1	CD4+ T cells	PMID34715028_post	ENSG00000150093	3688	integrin subunit beta 1	CD29|FNRB|GPIIA|MDF2|MSK12	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69446
5.56790171999448e-41	-0.378444472906217	0.234	0.431	9.75886134463432e-37	CDC14A	CD4+ T cells	PMID34715028_post	ENSG00000079335	8556	cell division cycle 14A	cdc14|Cdc14A1|Cdc14A2|DFNB105|DFNB32	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69447
6.67374560725324e-41	0.349300243324626	0.479	0.267	1.16970739258328e-36	RCSD1	CD4+ T cells	PMID34715028_post	ENSG00000198771	92241	RCSD domain containing 1	CapZIP|MGC21854|MK2S4	protein_coding	Q6JBY9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69448
7.9297653975472e-41	-0.272294978895116	0.121	0.295	1.3898499812281e-36	SBNO2	CD4+ T cells	PMID34715028_post	ENSG00000278788	22904	strawberry notch homolog 2	FLJ00173|KIAA0963|Sno|Stno	protein_coding	Q9Y2G9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69449
1.18679575954053e-40	0.383849709573728	0.44	0.237	2.08009692774669e-36	GOLGA8B	CD4+ T cells	PMID34715028_post	ENSG00000215252	440270	golgin A8 family member B	NA	protein_coding	A8MQT2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69450
1.37722621373711e-40	0.329272742351022	0.327	0.138	2.41386438481704e-36	GRAP2	CD4+ T cells	PMID34715028_post	ENSG00000100351	9402	GRB2 related adaptor protein 2	GADS|GRBLG|GrbX|Grf40|Mona	protein_coding	O75791	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69451
1.44226391518856e-40	0.367937294225239	0.485	0.278	2.527855964151e-36	ZRANB2	CD4+ T cells	PMID34715028_post	ENSG00000132485	9406	zinc finger RANBP2-type containing 2	ZIS|ZIS1|ZIS2|ZNF265	protein_coding	O95218	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69452
1.86217985676067e-40	0.511346679402413	0.533	0.341	3.26384263494443e-36	RIPOR2	CD4+ T cells	PMID34715028_post	ENSG00000111913	9750	RHO family interacting cell polarization regulator 2	C6orf32|DIFF48|FAM65B|KIAA0386|MYONAP	protein_coding	Q9Y4F9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69453
2.58363263924049e-40	-0.447450094147047	0.568	0.733	4.52833292679681e-36	EML4	CD4+ T cells	PMID34715028_post	ENSG00000143924	27436	EMAP like 4	C2orf2|ELP120|ROPP120	protein_coding	Q9HC35	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69454
3.20845955698795e-40	-0.365465829639749	0.451	0.643	5.62346706553279e-36	PGK1	CD4+ T cells	PMID34715028_post	ENSG00000102144	5230	phosphoglycerate kinase 1	NA	protein_coding	P00558	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69455
2.03072693214478e-39	-0.270882407887952	0.121	0.289	3.55925509397016e-35	TBCC	CD4+ T cells	PMID34715028_post	ENSG00000124659	6903	tubulin folding cofactor C	CFC	protein_coding	Q15814	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69456
2.82530415680928e-39	-0.253203085162828	0.1	0.262	4.95191059563963e-35	JOSD1	CD4+ T cells	PMID34715028_post	ENSG00000100221	9929	Josephin domain containing 1	KIAA0063	protein_coding	Q15040	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69457
3.3060097118376e-39	-0.452211240373307	0.875	0.954	5.79444322193775e-35	CD74	CD4+ T cells	PMID34715028_post	ENSG00000019582	972	CD74 molecule	CLIP|DHLAG	protein_coding	P04233	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69458
3.53026897073006e-39	0.415290921329203	0.992	0.995	6.18750242499858e-35	RPL34	CD4+ T cells	PMID34715028_post	ENSG00000109475	6164	ribosomal protein L34	L34	protein_coding	P49207	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69459
5.77278315619009e-39	-0.526608434775769	0.491	0.638	1.01179570378544e-34	PIK3R1	CD4+ T cells	PMID34715028_post	ENSG00000145675	5295	phosphoinositide-3-kinase regulatory subunit 1	GRB1|p85|p85-ALPHA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69460
6.39508231497999e-39	-0.303681966982259	0.163	0.345	1.12086607734654e-34	B4GALT1	CD4+ T cells	PMID34715028_post	ENSG00000086062	2683	beta-1,4-galactosyltransferase 1	beta4Gal-T1|GGTB2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69461
7.91295616834253e-39	-0.269950159999981	0.097	0.254	1.3869038276254e-34	PRMT9	CD4+ T cells	PMID34715028_post	ENSG00000164169	90826	protein arginine methyltransferase 9	FLJ46629|PRMT10	protein_coding	Q6P2P2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69462
1.03951205153019e-38	-0.408561699213692	0.186	0.362	1.82195277271696e-34	SERPINB9	CD4+ T cells	PMID34715028_post	ENSG00000170542	5272	serpin family B member 9	CAP3|PI9	protein_coding	P50453	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69463
1.15254567135365e-38	-0.315759846088614	0.245	0.442	2.02006679818155e-34	HSPA9	CD4+ T cells	PMID34715028_post	ENSG00000113013	3313	heat shock protein family A (Hsp70) member 9	GRP75|HSPA9B|mot-2|mthsp75|PBP74	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69464
1.21089001919684e-38	-0.386605067631019	0.635	0.81	2.12232693664631e-34	COTL1	CD4+ T cells	PMID34715028_post	ENSG00000103187	23406	coactosin like F-actin binding protein 1	CLP	protein_coding	Q14019	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69465
1.23702853782457e-38	-0.272979139038905	0.144	0.319	2.16813991824512e-34	AMD1	CD4+ T cells	PMID34715028_post	ENSG00000123505	262	adenosylmethionine decarboxylase 1	SAMDC	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69466
2.12288740197429e-38	0.393177012347534	0.501	0.306	3.72078474944034e-34	UGP2	CD4+ T cells	PMID34715028_post	ENSG00000169764	7360	UDP-glucose pyrophosphorylase 2	SVUGP2|UGP1|UGPP1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69467
2.53823185612545e-38	-0.35295617941205	0.136	0.303	4.44875897423107e-34	FRMD4B	CD4+ T cells	PMID34715028_post	ENSG00000114541	23150	FERM domain containing 4B	GRSP1|KIAA1013	protein_coding	Q9Y2L6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69468
3.06823081213566e-38	-0.257935109558556	0.104	0.264	5.37768814443018e-34	DEDD2	CD4+ T cells	PMID34715028_post	ENSG00000160570	162989	death effector domain containing 2	FLAME-3	protein_coding	Q8WXF8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69469
3.84399304697165e-38	-0.307803527250093	0.162	0.339	6.7373666134272e-34	ZNF267	CD4+ T cells	PMID34715028_post	ENSG00000185947	10308	zinc finger protein 267	HZF2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69470
3.95243993026166e-38	-0.3915896876851	0.5	0.678	6.92744146576961e-34	SRSF2	CD4+ T cells	PMID34715028_post	ENSG00000161547	6427	serine and arginine rich splicing factor 2	PR264|SC-35|SC35|SFRS2|SFRS2A	protein_coding	Q01130	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69471
6.12514060020827e-38	-0.305661752724845	0.108	0.265	1.0735533929985e-33	IRF7	CD4+ T cells	PMID34715028_post	ENSG00000276561	3665	interferon regulatory factor 7	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69472
8.16372441018423e-38	-0.420059920391409	0.316	0.502	1.43085597737299e-33	GLIPR1	CD4+ T cells	PMID34715028_post	ENSG00000139278	11010	GLI pathogenesis related 1	GliPR|RTVP1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69473
1.4584681753571e-37	-0.323972335808228	0.214	0.399	2.55625717094838e-33	CNOT6L	CD4+ T cells	PMID34715028_post	ENSG00000138767	246175	CCR4-NOT transcription complex subunit 6 like	Ccr4b|DKFZp434K098	protein_coding	Q96LI5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69474
3.1287785425806e-37	0.377829594520339	0.985	0.984	5.48381015158101e-33	MT-ND3	CD4+ T cells	PMID34715028_post	ENSG00000198840	4537	NADH dehydrogenase subunit 3	MTND3|NAD3|ND3	protein_coding	P03897	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69475
3.72384248471154e-37	0.422528116019816	0.558	0.363	6.52677872295392e-33	CD27	CD4+ T cells	PMID34715028_post	ENSG00000139193	939	CD27 molecule	S152|TNFRSF7|Tp55	protein_coding	P26842	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69476
3.80924724857582e-37	0.36786843804512	0.552	0.363	6.67646765257885e-33	CCND3	CD4+ T cells	PMID34715028_post	ENSG00000112576	896	cyclin D3	NA	protein_coding	P30281	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69477
4.66698371833415e-37	-0.258591233109872	0.122	0.286	8.17982236312426e-33	NDEL1	CD4+ T cells	PMID34715028_post	ENSG00000166579	81565	nudE neurodevelopment protein 1 like 1	MITAP1|NDE1L1|NDE2|NUDEL	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69478
4.66888172029064e-37	-0.444285113070544	0.376	0.566	8.1831489911534e-33	CST7	CD4+ T cells	PMID34715028_post	ENSG00000077984	8530	cystatin F	NA	protein_coding	O76096	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69479
4.95960997727442e-37	-0.513567524250356	0.34	0.531	8.69270840716888e-33	TSPYL2	CD4+ T cells	PMID34715028_post	ENSG00000184205	64061	TSPY like 2	CDA1|CINAP|CTCL|DENTT|HRIHFB2216|SE20-4|TSPX	protein_coding	Q9H2G4	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69480
5.15933679089255e-37	-0.272832931137342	0.161	0.336	9.04276959339737e-33	DNTTIP2	CD4+ T cells	PMID34715028_post	ENSG00000067334	30836	deoxynucleotidyltransferase terminal interacting protein 2	ERBP|HSU15552|TdIF2	protein_coding	Q5QJE6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69481
5.55619013321941e-37	-0.277910801528479	0.196	0.378	9.73833444649367e-33	STRAP	CD4+ T cells	PMID34715028_post	ENSG00000023734	11171	serine/threonine kinase receptor associated protein	MAWD|pt-wd|UNRIP	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69482
1.1645211199123e-36	0.411364451432125	0.927	0.936	2.04105616687028e-32	ATP5F1E	CD4+ T cells	PMID34715028_post	ENSG00000124172	514	ATP synthase F1 subunit epsilon	ATP5E	protein_coding	P56381	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69483
1.29031431606929e-36	-0.292231247220107	0.235	0.424	2.26153390177465e-32	PHF1	CD4+ T cells	PMID34715028_post	ENSG00000225553	5252	PHD finger protein 1	MTF2L2|PCL1|TDRD19C	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69484
1.64117605347552e-36	0.357671088869867	0.434	0.248	2.87648926892655e-32	FKBP1A	CD4+ T cells	PMID34715028_post	ENSG00000088832	2280	FKBP prolyl isomerase 1A	FKBP-12|FKBP1|FKBP12|FKBP12C|PKC12|PPIASE	protein_coding	P62942	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69485
2.06908131917484e-36	0.326641349283844	0.977	0.99	3.62647882811774e-32	RPS29	CD4+ T cells	PMID34715028_post	ENSG00000213741	6235	ribosomal protein S29	S29|uS14	protein_coding	P62273	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69486
3.66906342939826e-36	-0.379529702797126	0.236	0.412	6.43076747270632e-32	RHBDD2	CD4+ T cells	PMID34715028_post	ENSG00000005486	57414	rhomboid domain containing 2	NPD007|RHBDL7	protein_coding	Q6NTF9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69487
6.06854117938626e-36	0.27347512190001	0.282	0.112	1.06363321251103e-31	ORMDL3	CD4+ T cells	PMID34715028_post	ENSG00000172057	94103	ORMDL sphingolipid biosynthesis regulator 3	NA	protein_coding	Q8N138	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69488
7.06639592660607e-36	-0.324253015914903	0.145	0.308	1.23852721405625e-31	SYAP1	CD4+ T cells	PMID34715028_post	ENSG00000169895	94056	synapse associated protein 1	FLJ14495|PRO3113	protein_coding	Q96A49	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69489
7.0687463832128e-36	-0.333398638382856	0.295	0.481	1.23893917858571e-31	MAP1LC3B	CD4+ T cells	PMID34715028_post	ENSG00000140941	81631	microtubule associated protein 1 light chain 3 beta	ATG8F	protein_coding	Q9GZQ8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69490
1.01343947544897e-35	-0.386387539790122	0.157	0.332	1.77625536861941e-31	GZMA	CD4+ T cells	PMID34715028_post	ENSG00000145649	3001	granzyme A	CTLA3|HFSP	protein_coding	P12544	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69491
1.07034333010295e-35	-0.372509917609074	0.405	0.597	1.87599075467144e-31	RORA	CD4+ T cells	PMID34715028_post	ENSG00000069667	6095	RAR related orphan receptor A	NR1F1|ROR1|ROR2|ROR3|RZRA	protein_coding	P35398	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69492
1.32746788645362e-35	-0.331001049112229	0.28	0.464	2.32665296458726e-31	ELOVL5	CD4+ T cells	PMID34715028_post	ENSG00000012660	60481	ELOVL fatty acid elongase 5	dJ483K16.1|HELO1|SCA38	protein_coding	Q9NYP7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69493
1.83661132828651e-35	-0.378501854778824	0.473	0.649	3.21902867508776e-31	ISG20	CD4+ T cells	PMID34715028_post	ENSG00000172183	3669	interferon stimulated exonuclease gene 20	CD25|HEM45	protein_coding	Q96AZ6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69494
2.41173427491269e-35	-0.300912169366488	0.217	0.395	4.22704666363948e-31	GNA13	CD4+ T cells	PMID34715028_post	ENSG00000120063	10672	G protein subunit alpha 13	G13|MGC46138	protein_coding	Q14344	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69495
3.66677129225159e-35	-0.457194473401163	0.532	0.67	6.42675004392936e-31	FAM107B	CD4+ T cells	PMID34715028_post	ENSG00000065809	83641	family with sequence similarity 107 member B	C10orf45|FLJ45505|HITS|MGC11034	protein_coding	Q9H098	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69496
4.81048528917029e-35	0.31084012326448	0.387	0.197	8.43133756632877e-31	PCED1B	CD4+ T cells	PMID34715028_post	ENSG00000179715	91523	PC-esterase domain containing 1B	FAM113B|MGC16044	protein_coding	Q96HM7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69497
5.72327615294624e-35	-0.314433067195352	0.219	0.397	1.00311861132689e-30	RALGAPA1	CD4+ T cells	PMID34715028_post	ENSG00000174373	253959	Ral GTPase activating protein catalytic subunit alpha 1	DKFZp667F074|GARNL1|GRIPE|KIAA0884|RalGAPalpha1|Tulip1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69498
1.19148153930666e-34	0.428031188383092	0.476	0.293	2.08830969394278e-30	FKBP5	CD4+ T cells	PMID34715028_post	ENSG00000096060	2289	FKBP prolyl isomerase 5	FKBP51|FKBP54|P54|PPIase|Ptg-10	protein_coding	Q13451	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69499
1.21409773437467e-34	-0.307304515003932	0.308	0.5	2.12794909903849e-30	BZW1	CD4+ T cells	PMID34715028_post	ENSG00000082153	9689	basic leucine zipper and W2 domains 1	5MP2|BZAP45|KIAA0005	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69500
1.4741310304785e-34	-0.38523914467427	0.285	0.464	2.58370945711966e-30	HIST1H1C	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69501
3.19400536006162e-34	-0.330271008867393	0.298	0.479	5.59813319458e-30	BRD2	CD4+ T cells	PMID34715028_post	ENSG00000234704	6046	bromodomain containing 2	BRD2-IT1|D6S113E|FSRG1|KIAA9001|NAT|RING3	protein_coding	P25440	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69502
3.74697745270589e-34	-0.330590139179046	0.345	0.547	6.56732738135762e-30	HIST1H1E	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69503
6.03008426355331e-34	-0.323041403886799	0.235	0.404	1.05689286887299e-29	ORAI1	CD4+ T cells	PMID34715028_post	ENSG00000276045	84876	ORAI calcium release-activated calcium modulator 1	CRACM1|FLJ14466|TMEM142A	protein_coding	Q96D31	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69504
6.20532678415722e-34	-0.344838240706903	0.497	0.67	1.08760762545924e-29	PDIA3	CD4+ T cells	PMID34715028_post	ENSG00000167004	2923	protein disulfide isomerase family A member 3	ERp57|ERp60|ERp61|GRP57|GRP58|HsT17083|P58|PI-PLC	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69505
6.98276900429047e-34	-0.506843726389854	0.605	0.755	1.22386992338199e-29	H1FX	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69506
7.86244854686684e-34	-0.292373682443506	0.24	0.423	1.37805135680935e-29	ARIH1	CD4+ T cells	PMID34715028_post	ENSG00000166233	25820	ariadne RBR E3 ubiquitin protein ligase 1	ARI|HARI|HHARI|UBCH7BP	protein_coding	Q9Y4X5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69507
1.08273515459124e-33	0.259932725875457	0.292	0.122	1.89770990545207e-29	GNPTAB	CD4+ T cells	PMID34715028_post	ENSG00000111670	79158	N-acetylglucosamine-1-phosphate transferase subunits alpha and beta	GNPTA|KIAA1208|MGC4170	protein_coding	Q3T906	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69508
1.42428635131171e-33	0.32506824157499	0.435	0.253	2.49634668794404e-29	PTPRCAP	CD4+ T cells	PMID34715028_post	ENSG00000213402	5790	protein tyrosine phosphatase receptor type C associated protein	CD45-AP|LPAP	protein_coding	Q14761	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69509
2.05844385931432e-33	0.324623383213042	0.355	0.181	3.60783455222022e-29	CBFB	CD4+ T cells	PMID34715028_post	ENSG00000067955	865	core-binding factor subunit beta	PEBP2B	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69510
5.55183009981613e-33	-0.317117828215961	0.911	0.963	9.73069261594773e-29	EEF1D	CD4+ T cells	PMID34715028_post	ENSG00000273594	1936	eukaryotic translation elongation factor 1 delta	EF-1D|FLJ20897	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69511
6.89770303669799e-33	0.264026499684012	0.284	0.121	1.20896041124206e-28	MUC20-OT1	CD4+ T cells	PMID34715028_post	ENSG00000281060	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69512
1.21867971985073e-32	-0.256230777860396	0.129	0.282	2.13597994498238e-28	TSPYL1	CD4+ T cells	PMID34715028_post	ENSG00000189241	7259	TSPY like 1	TSPYL	protein_coding	Q9H0U9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69513
1.43540044020867e-32	-0.450793495487733	0.661	0.804	2.51582635155374e-28	ZFP36L1	CD4+ T cells	PMID34715028_post	ENSG00000185650	677	ZFP36 ring finger protein like 1	Berg36|BRF1|cMG1|ERF1|RNF162B|TIS11B	protein_coding	Q07352	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69514
1.46649066048273e-32	-0.295416347768904	0.971	0.991	2.57031818062808e-28	PTPRC	CD4+ T cells	PMID34715028_post	ENSG00000262418	5788	protein tyrosine phosphatase receptor type C	CD45|GP180|LCA|T200	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69515
1.49271163069984e-32	-0.400572762035995	0.271	0.452	2.6162756751276e-28	CD55	CD4+ T cells	PMID34715028_post	ENSG00000196352	1604	CD55 molecule (Cromer blood group)	CR|CROM|DAF|TC	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69516
1.5820195567987e-32	-0.335116420818609	0.391	0.572	2.77280567720109e-28	CCNH	CD4+ T cells	PMID34715028_post	ENSG00000134480	902	cyclin H	CycH|p34|p37	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69517
2.5623284797444e-32	-0.261961008640388	0.157	0.32	4.49099312644801e-28	TRAT1	CD4+ T cells	PMID34715028_post	ENSG00000163519	50852	T cell receptor associated transmembrane adaptor 1	HSPC062|TCRIM|TRIM	protein_coding	Q6PIZ9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69518
2.6404815708921e-32	-0.286905686194891	0.127	0.277	4.62797204930258e-28	P2RY8	CD4+ T cells	PMID34715028_post	ENSG00000182162	286530	P2Y receptor family member 8	P2Y8	protein_coding	Q86VZ1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69519
3.01278840084432e-32	0.26728839186371	0.371	0.192	5.28051423015984e-28	SRSF1	CD4+ T cells	PMID34715028_post	ENSG00000136450	6426	serine and arginine rich splicing factor 1	ASF|MGC5228|SF2|SF2p33|SFRS1|SRp30a	protein_coding	Q07955	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69520
4.57219811111482e-32	0.29567227439072	0.997	0.996	8.01369162935094e-28	RPS28	CD4+ T cells	PMID34715028_post	ENSG00000233927	6234	ribosomal protein S28	eS28|S28	protein_coding	P62857	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69521
5.03028776140351e-32	0.333732726255525	0.681	0.516	8.81658535941192e-28	PNISR	CD4+ T cells	PMID34715028_post	ENSG00000132424	25957	PNN interacting serine and arginine rich protein	bA98I9.2|C6orf111|DKFZp564B0769|FLJ14752|SFRS18|SRrp130	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69522
8.85087254076042e-32	0.30459546364308	0.994	0.997	1.55129243021908e-27	RPL7A	CD4+ T cells	PMID34715028_post	ENSG00000280858	6130	ribosomal protein L7a	L7A|SURF3|TRUP	protein_coding	P62424	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69523
1.03210547134652e-31	-0.523716987014766	0.457	0.605	1.80897125962904e-27	TUBA4A	CD4+ T cells	PMID34715028_post	ENSG00000127824	7277	tubulin alpha 4a	FLJ30169|H2-ALPHA|TUBA1	protein_coding	P68366	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69524
1.47157902317091e-31	0.400215046582512	0.563	0.394	2.57923655391166e-27	TRAC	CD4+ T cells	PMID34715028_post	ENSG00000277734	NA	NA	NA	TR_C_gene	P01848	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69525
1.87999540463197e-31	-0.28412163597877	0.333	0.512	3.29506794569845e-27	RBM8A	CD4+ T cells	PMID34715028_post	ENSG00000265241	9939	RNA binding motif protein 8A	BOV-1A|BOV-1B|BOV-1C|RBM8|RBM8B|Y14|ZNRP	protein_coding	Q9Y5S9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69526
2.21186706459876e-31	-0.339125169031237	0.465	0.634	3.87673940412224e-27	TAPBP	CD4+ T cells	PMID34715028_post	ENSG00000206281	6892	TAP binding protein	TAPA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69527
2.23303516074152e-31	-0.382512795202589	0.333	0.495	3.91384072623166e-27	HIST1H4C	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69528
2.3749670068628e-31	-0.323907274478629	0.25	0.419	4.16260467292842e-27	PRNP	CD4+ T cells	PMID34715028_post	ENSG00000171867	5621	prion protein	AltPrP|CD230|CJD|GSS|PRIP|PRP	protein_coding	P04156	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69529
3.49563151382133e-31	-0.298783323891825	0.626	0.785	6.12679335427464e-27	SUB1	CD4+ T cells	PMID34715028_post	ENSG00000113387	10923	SUB1 regulator of transcription	p14|p15|PC4	protein_coding	P53999	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69530
5.53757106129715e-31	-0.332144823986832	0.261	0.427	9.70570079913552e-27	HERPUD1	CD4+ T cells	PMID34715028_post	ENSG00000051108	9709	homocysteine inducible ER protein with ubiquitin like domain 1	HERP|KIAA0025|Mif1|SUP	protein_coding	Q15011	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69531
5.95883965710471e-31	0.32332346569964	0.869	0.852	1.04440582670074e-26	TMA7	CD4+ T cells	PMID34715028_post	ENSG00000232112	51372	translation machinery associated 7 homolog	CCDC72|HSPC016	protein_coding	Q9Y2S6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69532
6.2426537694134e-31	0.327422066348997	0.802	0.699	1.09414992616509e-26	AES	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69533
1.19794840151858e-30	0.254102842068126	0.312	0.148	2.09964416334161e-26	PSMB8-AS1	CD4+ T cells	PMID34715028_post	ENSG00000235540	100507463	PSMB8 antisense RNA 1 (head to head)	TAP1-AS1|TAPSAR1|XXbac-BPG246D15.8	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69534
1.41914255479324e-30	-0.347176619455291	0.45	0.639	2.48733115578611e-26	HLA-DPB1	CD4+ T cells	PMID34715028_post	ENSG00000236693	3115	major histocompatibility complex, class II, DP beta 1	HLA-DP1B	protein_coding	P04440	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69535
1.52277041750921e-30	-0.257781160950517	0.118	0.261	2.66895971076839e-26	ATP1B3	CD4+ T cells	PMID34715028_post	ENSG00000069849	483	ATPase Na+/K+ transporting subunit beta 3	CD298|FLJ29027	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69536
1.58690053622199e-30	-0.304396299933979	0.383	0.56	2.78136056983629e-26	BCLAF1	CD4+ T cells	PMID34715028_post	ENSG00000029363	9774	BCL2 associated transcription factor 1	BTF|KIAA0164	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69537
1.71257436513352e-30	-0.267800199502093	0.146	0.297	3.00162908976951e-26	NAA50	CD4+ T cells	PMID34715028_post	ENSG00000121579	80218	N-alpha-acetyltransferase 50, NatE catalytic subunit	FLJ13194|MAK3|NAT13|NAT5|San	protein_coding	Q9GZZ1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69538
2.58323339150863e-30	-0.268215656017853	0.232	0.397	4.52763316529717e-26	MRFAP1	CD4+ T cells	PMID34715028_post	ENSG00000179010	93621	Morf4 family associated protein 1	PAM14|PGR1	protein_coding	Q9Y605	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69539
6.09347460157613e-30	-0.257884551655557	0.199	0.362	1.06800329341825e-25	EVI2A	CD4+ T cells	PMID34715028_post	ENSG00000126860	2123	ecotropic viral integration site 2A	EVDA|EVI2	protein_coding	P22794	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69540
1.49552180505374e-29	-0.310423328639846	0.414	0.591	2.62120106771768e-25	STAT1	CD4+ T cells	PMID34715028_post	ENSG00000115415	6772	signal transducer and activator of transcription 1	ISGF-3|STAT91	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69541
1.53797245655483e-29	-0.310124414653362	0.21	0.369	2.69560432460365e-25	XBP1	CD4+ T cells	PMID34715028_post	ENSG00000100219	7494	X-box binding protein 1	XBP2	protein_coding	P17861	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69542
1.9243966067369e-29	-0.354632005551526	0.378	0.542	3.37288993262777e-25	H2AFZ	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69543
2.1398649679467e-29	-0.337424337237073	0.297	0.464	3.75054132932017e-25	TRAF1	CD4+ T cells	PMID34715028_post	ENSG00000056558	7185	TNF receptor associated factor 1	EBI6	protein_coding	Q13077	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69544
3.1372520416288e-29	0.286287683659471	0.989	0.999	5.49866165336279e-25	RPS24	CD4+ T cells	PMID34715028_post	ENSG00000138326	6229	ribosomal protein S24	eS24|S24	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69545
3.53832767128934e-29	-0.304774629818433	0.123	0.264	6.20162690946882e-25	BAG3	CD4+ T cells	PMID34715028_post	ENSG00000151929	9531	BAG cochaperone 3	NA	protein_coding	O95817	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69546
4.3843823857885e-29	0.325556266247157	0.993	0.993	7.6845070075715e-25	RPL18	CD4+ T cells	PMID34715028_post	ENSG00000063177	6141	ribosomal protein L18	L18	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69547
4.45632797344118e-29	-0.408340263712713	0.605	0.709	7.81060603905036e-25	ARL4C	CD4+ T cells	PMID34715028_post	ENSG00000188042	10123	ADP ribosylation factor like GTPase 4C	ARL7|LAK	protein_coding	P56559	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69548
5.17698402535429e-29	0.262788708002488	0.312	0.153	9.07369990123846e-25	KLF9	CD4+ T cells	PMID34715028_post	ENSG00000119138	687	KLF transcription factor 9	BTEB1	protein_coding	Q13886	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69549
5.21204384375914e-29	-0.297204081750088	0.256	0.421	9.13514924495664e-25	NFATC2	CD4+ T cells	PMID34715028_post	ENSG00000101096	4773	nuclear factor of activated T cells 2	NF-ATP|NFAT1|NFATp	protein_coding	Q13469	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69550
8.97328519748506e-29	-0.388441858357897	0.485	0.63	1.57274769656321e-24	LY6E	CD4+ T cells	PMID34715028_post	ENSG00000278032	4061	lymphocyte antigen 6 family member E	RIG-E|SCA-2|TSA-1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69551
1.12941629119676e-28	-0.405957895507382	0.168	0.309	1.97952793358057e-24	CCR6	CD4+ T cells	PMID34715028_post	ENSG00000112486	1235	C-C motif chemokine receptor 6	BN-1|CD196|CKR-L3|CMKBR6|DCR2|DRY-6|GPR-CY4|GPR29|STRL22	protein_coding	P51684	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69552
1.15194590837329e-28	-0.274365445440521	0.302	0.467	2.01901559360586e-24	ATP6V0C	CD4+ T cells	PMID34715028_post	ENSG00000185883	527	ATPase H+ transporting V0 subunit c	ATP6C|ATP6L|ATPL|VATL|Vma3	protein_coding	P27449	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69553
1.19708152916053e-28	0.308005866014633	0.988	0.997	2.09812479615966e-24	RPL37	CD4+ T cells	PMID34715028_post	ENSG00000145592	6167	ribosomal protein L37	L37	protein_coding	P61927	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69554
1.83122366865308e-28	0.39742423977019	0.987	0.993	3.20958572404825e-24	RPLP2	CD4+ T cells	PMID34715028_post	ENSG00000177600	6181	ribosomal protein lateral stalk subunit P2	D11S2243E|LP2|MGC71408|P2|RPP2	protein_coding	P05387	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69555
1.89214811196649e-28	-0.262531761450376	0.26	0.429	3.31636799584367e-24	JPT1	CD4+ T cells	PMID34715028_post	ENSG00000189159	51155	Jupiter microtubule associated homolog 1	ARM2|HN1|HN1A	protein_coding	Q9UK76	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69556
1.97402682854088e-28	-0.48692842573602	0.443	0.624	3.4598768223836e-24	HLA-DRB1	CD4+ T cells	PMID34715028_post	ENSG00000228080	3123	major histocompatibility complex, class II, DR beta 1	HLA-DR1B	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69557
2.25603347773611e-28	0.368530376955796	0.95	0.96	3.95414987642809e-24	RPL38	CD4+ T cells	PMID34715028_post	ENSG00000172809	6169	ribosomal protein L38	L38	protein_coding	P63173	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69558
2.32853048807422e-28	-0.286635738674339	0.138	0.276	4.08121538644768e-24	BACH1	CD4+ T cells	PMID34715028_post	ENSG00000156273	571	BTB domain and CNC homolog 1	BACH-1|BTBD24	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69559
2.87282824254395e-28	0.322490165622392	0.364	0.194	5.03520606070678e-24	TTN	CD4+ T cells	PMID34715028_post	ENSG00000155657	7273	titin	CMD1G|CMH9|CMPD4|FLJ32040|LGMD2J|MYLK5|TMD	protein_coding	Q8WZ42	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69560
3.09833346072924e-28	-0.336402943070506	0.435	0.601	5.43044905662014e-24	ARID5B	CD4+ T cells	PMID34715028_post	ENSG00000150347	84159	AT-rich interaction domain 5B	FLJ21150|MRF2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69561
3.25924784271128e-28	0.499608627066836	0.73	0.634	5.71248369392006e-24	RNF213	CD4+ T cells	PMID34715028_post	ENSG00000173821	57674	ring finger protein 213	ALO17|C17orf27|KIAA1554|KIAA1618|MYMY2|NET57	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69562
3.28701008481762e-28	-0.297959873707099	0.307	0.47	5.76114257565984e-24	RSRC2	CD4+ T cells	PMID34715028_post	ENSG00000111011	65117	arginine and serine rich coiled-coil 2	FLJ11021	protein_coding	Q7L4I2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69563
5.46722037818911e-28	0.351962339414427	0.494	0.327	9.58239715685205e-24	FOXP1	CD4+ T cells	PMID34715028_post	ENSG00000114861	27086	forkhead box P1	12CC4|hFKH1B|HSPC215|QRF1	protein_coding	Q9H334	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69564
5.65133348171966e-28	0.315846832455352	0.444	0.276	9.90509219341005e-24	MDFIC	CD4+ T cells	PMID34715028_post	ENSG00000135272	29969	MyoD family inhibitor domain containing	HIC|MDFIC1	protein_coding	Q9P1T7	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69565
7.17995279609463e-28	-0.271237427017521	0.28	0.446	1.25843032657151e-23	TRA2B	CD4+ T cells	PMID34715028_post	ENSG00000136527	6434	transformer 2 beta homolog	Htra2-beta|PPP1R156|SFRS10	protein_coding	P62995	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69566
7.92204278758743e-28	0.30898810789967	0.483	0.316	1.38849643938045e-23	AAK1	CD4+ T cells	PMID34715028_post	ENSG00000115977	22848	AP2 associated kinase 1	DKFZp686K16132|KIAA1048	protein_coding	Q2M2I8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69567
1.04667598743722e-27	0.282673332003839	0.428	0.26	1.83450900318122e-23	ACAP2	CD4+ T cells	PMID34715028_post	ENSG00000114331	23527	ArfGAP with coiled-coil, ankyrin repeat and PH domains 2	CENTB2|CNT-B2|KIAA0041	protein_coding	Q15057	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69568
1.21385829349872e-27	0.304762289565895	0.342	0.185	2.1275294310152e-23	SLFN12L	CD4+ T cells	PMID34715028_post	ENSG00000205045	100506736	schlafen family member 12 like	NA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69569
1.63436232563661e-27	0.299481268554151	0.944	0.943	2.86454684814329e-23	SERF2	CD4+ T cells	PMID34715028_post	ENSG00000140264	10169	small EDRK-rich factor 2	4F5REL|FAM2C|H4F5rel|HsT17089	protein_coding	P84101	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69570
1.81213124004329e-27	0.414839502720106	0.973	0.968	3.17612242442387e-23	ACTG1	CD4+ T cells	PMID34715028_post	ENSG00000184009	71	actin gamma 1	ACTG|DFNA20|DFNA26	protein_coding	P63261	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69571
4.65207534745868e-27	0.317948923968269	0.642	0.492	8.15369246149083e-23	N4BP2L2	CD4+ T cells	PMID34715028_post	ENSG00000244754	10443	NEDD4 binding protein 2 like 2	CG005|PFAAP5	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69572
4.69395749526827e-27	-0.287589746505588	0.546	0.696	8.2270993019567e-23	EIF4A2	CD4+ T cells	PMID34715028_post	ENSG00000156976	1974	eukaryotic translation initiation factor 4A2	BM-010|DDX2B|EIF4A|EIF4F	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69573
5.08894973093411e-27	-0.309904920556273	0.27	0.422	8.91940219340821e-23	ESYT2	CD4+ T cells	PMID34715028_post	ENSG00000117868	57488	extended synaptotagmin 2	CHR2SYT|FAM62B|KIAA1228	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69574
7.02857525655762e-27	0.296301208221204	0.54	0.382	1.23189838521685e-22	PAXX	CD4+ T cells	PMID34715028_post	ENSG00000148362	286257	PAXX non-homologous end joining factor	C9orf142|XLS	protein_coding	Q9BUH6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69575
9.84131831108474e-27	0.320315071632271	0.494	0.342	1.72488786038382e-22	CYFIP2	CD4+ T cells	PMID34715028_post	ENSG00000055163	26999	cytoplasmic FMR1 interacting protein 2	PIR121	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69576
2.11024609309265e-26	-0.316603275071173	0.414	0.575	3.6986283273635e-22	ARID4B	CD4+ T cells	PMID34715028_post	ENSG00000054267	51742	AT-rich interaction domain 4B	BCAA|BRCAA1|RBP1L1|SAP180	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69577
4.82166583730957e-26	-0.274582547778655	0.289	0.449	8.45093371305249e-22	YWHAQ	CD4+ T cells	PMID34715028_post	ENSG00000134308	10971	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta	14-3-3|HS1	protein_coding	P27348	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69578
5.77331589779329e-26	-0.323463836338229	0.435	0.577	1.01188907740623e-21	NDUFV2	CD4+ T cells	PMID34715028_post	ENSG00000178127	4729	NADH:ubiquinone oxidoreductase core subunit V2	CI-24k	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69579
7.93430794002821e-26	0.335858452456435	0.996	0.999	1.39064615264874e-21	TPT1	CD4+ T cells	PMID34715028_post	ENSG00000133112	7178	tumor protein, translationally-controlled 1	fortilin|TCTP	protein_coding	P13693	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69580
1.05749322657285e-25	-0.373292848052732	0.214	0.372	1.85346837821423e-21	HLA-DRA	CD4+ T cells	PMID34715028_post	ENSG00000277263	3122	major histocompatibility complex, class II, DR alpha	HLA-DRA1	protein_coding	P01903	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69581
1.39970492217512e-25	-0.265760938493653	0.552	0.704	2.45326281709633e-21	EIF4G2	CD4+ T cells	PMID34715028_post	ENSG00000110321	1982	eukaryotic translation initiation factor 4 gamma 2	DAP5|NAT1|p97	protein_coding	P78344	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69582
1.63384822983108e-25	0.331462336109125	0.863	0.821	2.86364579242493e-21	RAC2	CD4+ T cells	PMID34715028_post	ENSG00000128340	5880	Rac family small GTPase 2	EN-7	protein_coding	P15153	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69583
1.73400182327648e-25	0.529930276023344	0.297	0.16	3.03918499565669e-21	LINC01943	CD4+ T cells	PMID34715028_post	ENSG00000280721	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69584
2.10471052850831e-25	0.31755395379174	0.641	0.515	3.68892614331651e-21	SKAP1	CD4+ T cells	PMID34715028_post	ENSG00000141293	8631	src kinase associated phosphoprotein 1	SCAP1|SKAP55	protein_coding	Q86WV1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69585
2.22347797009139e-25	0.266259830585299	0.312	0.164	3.89708983817918e-21	IPCEF1	CD4+ T cells	PMID34715028_post	ENSG00000074706	26034	interaction protein for cytohesin exchange factors 1	KIAA0403|PIP3-E	protein_coding	Q8WWN9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69586
2.9033220757039e-25	-0.308974184273511	0.669	0.787	5.08865260208622e-21	HNRNPU	CD4+ T cells	PMID34715028_post	ENSG00000153187	3192	heterogeneous nuclear ribonucleoprotein U	C1orf199|FLJ30202|FLJ37978|HNRNPU-AS1|HNRPU|NCRNA00201|SAF-A	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69587
2.9915122533604e-25	0.339425116433555	0.996	0.997	5.24322352646477e-21	RPS8	CD4+ T cells	PMID34715028_post	ENSG00000142937	6202	ribosomal protein S8	S8	protein_coding	P62241	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69588
3.02070278433862e-25	-0.266188726757309	0.272	0.423	5.2943857701103e-21	SF3A1	CD4+ T cells	PMID34715028_post	ENSG00000099995	10291	splicing factor 3a subunit 1	Prp21|PRPF21|SAP114|SF3a120	protein_coding	Q15459	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69589
3.02289622398393e-25	-0.258388252624986	0.166	0.307	5.29823021177663e-21	ALG13	CD4+ T cells	PMID34715028_post	ENSG00000101901	79868	ALG13 UDP-N-acetylglucosaminyltransferase subunit	CDG1S|CXorf45|FLJ23018|GLT28D1|MDS031|TDRD13|YGL047W	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69590
3.32564754463614e-25	-0.290769615413257	0.224	0.371	5.82886245148376e-21	SLC38A2	CD4+ T cells	PMID34715028_post	ENSG00000134294	54407	solute carrier family 38 member 2	ATA2|KIAA1382|SAT2|SNAT2	protein_coding	Q96QD8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69591
3.65009224681279e-25	0.28631244729913	0.754	0.653	6.39751668098878e-21	SON	CD4+ T cells	PMID34715028_post	ENSG00000159140	6651	SON DNA and RNA binding protein	BASS1|C21orf50|DBP-5|FLJ21099|FLJ33914|KIAA1019|NREBP	protein_coding	P18583	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69592
5.14007710416464e-25	0.258768774459446	0.339	0.189	9.00901314046936e-21	PLCG1	CD4+ T cells	PMID34715028_post	ENSG00000124181	5335	phospholipase C gamma 1	NCKAP3|PLC-II|PLC1|PLC148|PLCgamma1	protein_coding	P19174	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69593
9.29048088489338e-25	-0.315946495024736	0.509	0.667	1.62834258469526e-20	IFITM2	CD4+ T cells	PMID34715028_post	ENSG00000185201	10581	interferon induced transmembrane protein 2	1-8D|DSPA2c	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69594
1.01896344564557e-24	0.30059755281091	0.972	0.982	1.78593723118299e-20	RACK1	CD4+ T cells	PMID34715028_post	ENSG00000204628	10399	receptor for activated C kinase 1	Gnb2-rs1|GNB2L1|H12.3	protein_coding	P63244	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69595
1.02615876434945e-24	0.342410778317418	0.996	0.997	1.79854846627527e-20	RPL3	CD4+ T cells	PMID34715028_post	ENSG00000100316	6122	ribosomal protein L3	L3	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69596
1.12969091841149e-24	0.499500598487506	0.458	0.337	1.98000927269983e-20	LEF1	CD4+ T cells	PMID34715028_post	ENSG00000138795	51176	lymphoid enhancer binding factor 1	TCF10|TCF1ALPHA|TCF7L3	protein_coding	Q9UJU2	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69597
1.83947903238728e-24	0.296917782077341	0.47	0.324	3.22405490006518e-20	RGS10	CD4+ T cells	PMID34715028_post	ENSG00000148908	6001	regulator of G protein signaling 10	NA	protein_coding	O43665	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69598
1.98903564758734e-24	-0.412391035997629	0.16	0.292	3.48618277952633e-20	HLA-DQA1	CD4+ T cells	PMID34715028_post	ENSG00000236418	3117	major histocompatibility complex, class II, DQ alpha 1	CELIAC1|HLA-DQA	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69599
2.0683476724662e-24	-0.271644041570398	0.291	0.446	3.62519296553151e-20	GZMM	CD4+ T cells	PMID34715028_post	ENSG00000197540	3004	granzyme M	LMET1|MET1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69600
4.34693402551795e-24	-0.509453172785883	0.952	0.965	7.61887126652531e-20	VIM	CD4+ T cells	PMID34715028_post	ENSG00000026025	7431	vimentin	NA	protein_coding	P08670	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69601
6.75786376016928e-24	-0.28400663468881	0.124	0.252	1.18445078124487e-19	CCL4	CD4+ T cells	PMID34715028_post	ENSG00000277943	6351	C-C motif chemokine ligand 4	Act-2|AT744.1|LAG1|MIP-1-beta|SCYA4	protein_coding	P13236	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69602
8.6443481610534e-24	0.267362007588836	0.983	0.984	1.51509490218783e-19	RPL6	CD4+ T cells	PMID34715028_post	ENSG00000089009	6128	ribosomal protein L6	L6|TAXREB107|TXREB1	protein_coding	Q02878	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69603
9.26269721058858e-24	0.260344297401297	0.346	0.201	1.62347294009986e-19	FAM208A	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69604
1.03069172691443e-23	-0.3055163740943	0.506	0.648	1.80649338976292e-19	SFPQ	CD4+ T cells	PMID34715028_post	ENSG00000116560	6421	splicing factor proline and glutamine rich	PPP1R140|PSF	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69605
1.20789080983993e-23	0.45037237222395	0.513	0.38	2.11707022240644e-19	MT2A	CD4+ T cells	PMID34715028_post	ENSG00000125148	4502	metallothionein 2A	MT2	protein_coding	P02795	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69606
1.28694347571626e-23	-0.27709629147382	0.226	0.373	2.25562582988788e-19	TYMP	CD4+ T cells	PMID34715028_post	ENSG00000025708	1890	thymidine phosphorylase	ECGF1|MNGIE	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69607
1.31657798664201e-23	0.293839516912209	0.981	0.991	2.30756623718744e-19	RPL35A	CD4+ T cells	PMID34715028_post	ENSG00000182899	6165	ribosomal protein L35a	eL33|GIG33|L35A	protein_coding	P18077	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69608
1.48187421364285e-23	-0.332429239907905	0.217	0.357	2.59728093425182e-19	LDLRAD4	CD4+ T cells	PMID34715028_post	ENSG00000168675	753	low density lipoprotein receptor class A domain containing 4	C18orf1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69609
1.62735331218014e-23	-0.298449563514294	0.147	0.274	2.85226215025813e-19	MX1	CD4+ T cells	PMID34715028_post	ENSG00000157601	4599	MX dynamin like GTPase 1	IFI-78K|lncMX1-215|MxA	protein_coding	P20591	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69610
1.69019053450207e-23	0.250836130222545	0.366	0.215	2.96239694982178e-19	TTC14	CD4+ T cells	PMID34715028_post	ENSG00000163728	151613	tetratricopeptide repeat domain 14	FLJ00166|KIAA1980	protein_coding	Q96N46	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69611
2.24689294410713e-23	0.321122789538456	0.983	0.994	3.93812926313657e-19	RPS21	CD4+ T cells	PMID34715028_post	ENSG00000171858	6227	ribosomal protein S21	S21	protein_coding	P63220	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69612
2.58913962692821e-23	-0.254098890867418	0.19	0.324	4.53798502411708e-19	BIRC2	CD4+ T cells	PMID34715028_post	ENSG00000110330	329	baculoviral IAP repeat containing 2	API1|c-IAP1|cIAP1|hiap-2|MIHB|RNF48	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69613
3.19435585054198e-23	-0.261439087406158	0.155	0.282	5.59874749924492e-19	SOD2	CD4+ T cells	PMID34715028_post	ENSG00000291237	6648	superoxide dismutase 2	GC1|GClnc1|IPOB|MnSOD	protein_coding	P04179	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69614
3.40479515053527e-23	-0.297227709054826	0.703	0.832	5.96758446034317e-19	NFKBIA	CD4+ T cells	PMID34715028_post	ENSG00000100906	4792	NFKB inhibitor alpha	IkappaBalpha|IKBA|MAD-3|NFKBI	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69615
4.13273052670648e-23	0.316906760886351	0.537	0.383	7.24343679415844e-19	OGT	CD4+ T cells	PMID34715028_post	ENSG00000147162	8473	O-linked N-acetylglucosamine (GlcNAc) transferase	FLJ23071|HRNT1|MGC22921|O-GLCNAC|OGT1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69616
7.93159711961291e-23	0.309999936777278	1	1	1.39017102715456e-18	RPL13	CD4+ T cells	PMID34715028_post	ENSG00000167526	6137	ribosomal protein L13	BBC1|D16S444E|L13	protein_coding	P26373	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69617
8.57303273065045e-23	0.271734799495544	0.469	0.314	1.5025954467011e-18	SLA	CD4+ T cells	PMID34715028_post	ENSG00000155926	6503	Src like adaptor	hSLAP|SLA1|SLAP|SLAP-1	protein_coding	Q13239	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69618
9.24463786579101e-23	-0.269580075959925	0.204	0.336	1.62030767873719e-18	GLUD1	CD4+ T cells	PMID34715028_post	ENSG00000148672	2746	glutamate dehydrogenase 1	GDH|GDH1|GLUD|hGDH1	protein_coding	P00367	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69619
1.31411596552953e-22	0.285260384651443	0.568	0.435	2.30325105278361e-18	ANAPC16	CD4+ T cells	PMID34715028_post	ENSG00000166295	119504	anaphase promoting complex subunit 16	APC16|bA570G20.3|C10orf104|CENP-27|FLJ33728	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69620
1.52086187248796e-22	-0.258414415270562	0.677	0.785	2.66561460390964e-18	SRSF5	CD4+ T cells	PMID34715028_post	ENSG00000100650	6430	serine and arginine rich splicing factor 5	HRS|SFRS5|SRP40	protein_coding	Q13243	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69621
1.7239536628672e-22	-0.259038483689058	0.35	0.501	3.02157358490735e-18	PDCD4	CD4+ T cells	PMID34715028_post	ENSG00000150593	27250	programmed cell death 4	H731	protein_coding	Q53EL6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69622
2.22488050393351e-22	-0.355971086520432	0.308	0.44	3.89954805924426e-18	PTPN22	CD4+ T cells	PMID34715028_post	ENSG00000134242	26191	protein tyrosine phosphatase non-receptor type 22	Lyp|Lyp1|Lyp2|PTPN8	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69623
2.46094398771731e-22	0.279396862232036	0.56	0.425	4.31329652727213e-18	TBC1D10C	CD4+ T cells	PMID34715028_post	ENSG00000175463	374403	TBC1 domain family member 10C	Carabin|EPI64C|FLJ00332	protein_coding	Q8IV04	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69624
2.55045349053874e-22	-0.309814951195027	0.265	0.406	4.47017983286724e-18	DOK2	CD4+ T cells	PMID34715028_post	ENSG00000147443	9046	docking protein 2	Dok-2|p56dok-2	protein_coding	O60496	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69625
3.19677606503756e-22	0.267066135280145	0.879	0.868	5.60298940919133e-18	COX7C	CD4+ T cells	PMID34715028_post	ENSG00000127184	1350	cytochrome c oxidase subunit 7C	NA	protein_coding	P15954	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69626
4.15052351197654e-22	0.283761290750512	0.397	0.258	7.27462255944128e-18	SIT1	CD4+ T cells	PMID34715028_post	ENSG00000137078	27240	signaling threshold regulating transmembrane adaptor 1	SIT	protein_coding	Q9Y3P8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69627
4.27588163733401e-22	-0.280546417644376	0.413	0.554	7.49433774575533e-18	UBALD2	CD4+ T cells	PMID34715028_post	ENSG00000185262	283991	UBA like domain containing 2	FAM100B|MGC29814	protein_coding	Q8IYN6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69628
4.28562757636733e-22	0.295788560526247	0.984	0.993	7.51141945309902e-18	RPL14	CD4+ T cells	PMID34715028_post	ENSG00000188846	9045	ribosomal protein L14	CTG-B33|hRL14|L14|RL14	protein_coding	P50914	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69629
5.57449154898882e-22	-0.250524641897051	0.509	0.641	9.77041133791271e-18	SLC25A3	CD4+ T cells	PMID34715028_post	ENSG00000075415	5250	solute carrier family 25 member 3	PHC	protein_coding	Q00325	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69630
6.85889197773767e-22	-0.284178735066694	0.506	0.634	1.20215799693808e-17	CNN2	CD4+ T cells	PMID34715028_post	ENSG00000064666	1265	calponin 2	NA	protein_coding	Q99439	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69631
1.1847570945902e-21	-0.295112430320894	0.404	0.55	2.07652375968825e-17	GPRIN3	CD4+ T cells	PMID34715028_post	ENSG00000185477	285513	GPRIN family member 3	FLJ42625|GRIN3	protein_coding	Q6ZVF9	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69632
1.79310361217191e-21	0.336671127102598	0.407	0.277	3.14277270105371e-17	SLAMF1	CD4+ T cells	PMID34715028_post	ENSG00000117090	6504	signaling lymphocytic activation molecule family member 1	CD150|SLAM	protein_coding	Q13291	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69633
2.80956889503647e-21	-0.284982958435186	0.37	0.508	4.92433140233042e-17	CD6	CD4+ T cells	PMID34715028_post	ENSG00000013725	923	CD6 molecule	Tp120	protein_coding	P30203	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69634
3.18277678647704e-21	0.270211858477536	0.968	0.978	5.57845287365831e-17	NACA	CD4+ T cells	PMID34715028_post	ENSG00000196531	4666	nascent polypeptide associated complex subunit alpha	NACA1	protein_coding	Q13765	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69635
3.21568669184037e-21	-0.390196925059719	0.634	0.723	5.63613406478862e-17	S100A10	CD4+ T cells	PMID34715028_post	ENSG00000197747	6281	S100 calcium binding protein A10	42C|ANX2LG|CAL1L|CLP11|P11	protein_coding	P60903	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69636
3.8650923153782e-21	-0.268577585581746	0.789	0.877	6.77434730116338e-17	SPOCK2	CD4+ T cells	PMID34715028_post	ENSG00000107742	9806	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2	KIAA0275|testican-2	protein_coding	Q92563	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69637
6.81288844807755e-21	-0.267108687188046	0.215	0.34	1.19409495829455e-16	RILPL2	CD4+ T cells	PMID34715028_post	ENSG00000150977	196383	Rab interacting lysosomal protein like 2	FLJ30380|FLJ32372|MGC7036	protein_coding	Q969X0	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69638
9.53803889941183e-21	-0.28053737903601	0.537	0.671	1.67173207789991e-16	KMT2E	CD4+ T cells	PMID34715028_post	ENSG00000005483	55904	lysine methyltransferase 2E (inactive)	HDCMC04P|MLL5|SETD5B	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69639
1.04452170732363e-20	0.329378730132147	0.559	0.436	1.83073319642612e-16	PRMT2	CD4+ T cells	PMID34715028_post	ENSG00000160310	3275	protein arginine methyltransferase 2	HRMT1L1|MGC111373	protein_coding	P55345	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69640
1.04859173223712e-20	-0.360869502550261	0.615	0.71	1.837866729092e-16	CD7	CD4+ T cells	PMID34715028_post	ENSG00000173762	924	CD7 molecule	GP40|LEU-9|Tp40|TP41	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69641
1.28024069693413e-20	0.302170862278459	0.435	0.298	2.24387786951645e-16	SIRPG	CD4+ T cells	PMID34715028_post	ENSG00000089012	55423	signal regulatory protein gamma	bA77C3.1|CD172g|SIRP-B2|SIRPB2|SIRPgamma	protein_coding	Q9P1W8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69642
2.13802931111199e-20	-0.309974220166767	0.496	0.626	3.74732397358599e-16	HSP90B1	CD4+ T cells	PMID34715028_post	ENSG00000166598	7184	heat shock protein 90 beta family member 1	GP96|GRP94|TRA1	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69643
2.14990192392106e-20	-0.288525671858064	0.37	0.511	3.76813310205644e-16	NFKBIZ	CD4+ T cells	PMID34715028_post	ENSG00000144802	64332	NFKB inhibitor zeta	FLJ34463|INAP|MAIL	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69644
2.27090776923402e-20	0.264917349294277	0.548	0.416	3.98022004713646e-16	ARPC5	CD4+ T cells	PMID34715028_post	ENSG00000162704	10092	actin related protein 2/3 complex subunit 5	ARC16|dJ127C7.3|p16-Arc	protein_coding	O15511	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69645
4.24677680694776e-20	-0.263367619762705	0.311	0.449	7.44332570953734e-16	TANK	CD4+ T cells	PMID34715028_post	ENSG00000136560	10010	TRAF family member associated NFKB activator	I-TRAF|TRAF2	protein_coding	Q92844	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69646
5.63720383099754e-20	-0.25263501111271	0.23	0.357	9.88032715458939e-16	RANBP2	CD4+ T cells	PMID34715028_post	ENSG00000153201	5903	RAN binding protein 2	ADANE|ANE1|NUP358	protein_coding	P49792	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69647
7.91541176447772e-20	0.268588089169247	0.52	0.391	1.38733421996001e-15	CSTB	CD4+ T cells	PMID34715028_post	ENSG00000160213	1476	cystatin B	CST6|EPM1|PME|STFB	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69648
1.00813113644962e-19	0.257469693166525	0.549	0.416	1.76695144285525e-15	NAP1L4	CD4+ T cells	PMID34715028_post	ENSG00000273562	4676	nucleosome assembly protein 1 like 4	NAP2	protein_coding	Q99733	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69649
1.93826404628745e-19	0.25758718294829	0.473	0.34	3.39719539392802e-15	PPP1R18	CD4+ T cells	PMID34715028_post	ENSG00000230341	170954	protein phosphatase 1 regulatory subunit 18	KIAA1949|phostensin	protein_coding	Q6NYC8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69650
2.52943559553195e-19	0.313124088703678	0.416	0.282	4.43334176828884e-15	TBC1D4	CD4+ T cells	PMID34715028_post	ENSG00000136111	9882	TBC1 domain family member 4	AS160|DKFZp779C0666|KIAA0603	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69651
4.20858604865075e-19	0.303586996441661	0.926	0.941	7.37638876747018e-15	RPL31	CD4+ T cells	PMID34715028_post	ENSG00000071082	6160	ribosomal protein L31	L31	protein_coding	P62899	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69652
6.28773756529431e-19	0.291805904011719	0.447	0.32	1.10205176306913e-14	CAMK4	CD4+ T cells	PMID34715028_post	ENSG00000152495	814	calcium/calmodulin dependent protein kinase IV	CaMK-GR|CaMKIV	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69653
8.87093689369231e-19	0.338464660451399	0.46	0.34	1.55480910935745e-14	PHTF2	CD4+ T cells	PMID34715028_post	ENSG00000006576	57157	putative homeodomain transcription factor 2	DKFZp434D166	protein_coding	Q8N3S3	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69654
1.09263477784344e-18	0.391178256056157	0.414	0.28	1.9150609751262e-14	FOXP3	CD4+ T cells	PMID34715028_post	ENSG00000049768	50943	forkhead box P3	AIID|DIETER|IPEX|JM2|PIDX|SCURFIN|XPID	protein_coding	Q9BZS1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69655
4.28007561542771e-18	0.338524470383105	0.992	0.998	7.50168853116014e-14	RPS23	CD4+ T cells	PMID34715028_post	ENSG00000186468	6228	ribosomal protein S23	S23|uS12	protein_coding	P62266	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69656
4.8462736492169e-18	-0.261368815084709	0.6	0.723	8.49406382498247e-14	SYNE2	CD4+ T cells	PMID34715028_post	ENSG00000054654	23224	spectrin repeat containing nuclear envelope protein 2	DKFZP434H2235|KIAA1011|Nesp2|Nesprin-2|NUA|NUANCE|SYNE-2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69657
5.31837585539464e-18	-0.282331788463897	0.321	0.444	9.32151736175019e-14	MBP	CD4+ T cells	PMID34715028_post	ENSG00000197971	4155	myelin basic protein	NA	protein_coding	P02686	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69658
7.90066182816758e-18	0.269610921184414	0.988	0.997	1.38474899862293e-13	RPS25	CD4+ T cells	PMID34715028_post	ENSG00000280831	6230	ribosomal protein S25	S25	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69659
1.0326208747837e-17	0.292472852150086	0.363	0.244	1.80987460723339e-13	NOSIP	CD4+ T cells	PMID34715028_post	ENSG00000142546	51070	nitric oxide synthase interacting protein	CGI-25	protein_coding	Q9Y314	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69660
1.76540892187821e-17	-0.251665522360478	0.603	0.7	3.09423221737593e-13	SF1	CD4+ T cells	PMID34715028_post	ENSG00000168066	7536	splicing factor 1	ZCCHC25|ZFM1|ZNF162	protein_coding	Q15637	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69661
2.89744181965396e-17	-0.252958653794394	0.324	0.45	5.07834627730749e-13	NFKB1	CD4+ T cells	PMID34715028_post	ENSG00000109320	4790	nuclear factor kappa B subunit 1	KBF1|NF-kappaB|NF-kB1|NFkappaB|NFKB-p50|p105|p50	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69662
4.2155263200426e-17	-0.269693368002723	0.339	0.466	7.38855298113867e-13	TNFRSF4	CD4+ T cells	PMID34715028_post	ENSG00000186827	7293	TNF receptor superfamily member 4	ACT35|CD134|OX40|TXGP1L	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69663
8.06340744783335e-17	0.287666405358354	0.589	0.476	1.41327342338175e-12	C9orf16	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69664
1.47625305808365e-16	0.258873417547547	0.495	0.366	2.58742873490321e-12	DOCK10	CD4+ T cells	PMID34715028_post	ENSG00000135905	55619	dedicator of cytokinesis 10	KIAA0694|ZIZ3	protein_coding	Q96BY6	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69665
4.92084782581754e-16	0.259910320983735	0.564	0.46	8.6247699843104e-12	SH3KBP1	CD4+ T cells	PMID34715028_post	ENSG00000147010	30011	SH3 domain containing kinase binding protein 1	CIN85	protein_coding	Q96B97	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69666
6.74172323131467e-16	-0.251970372845485	0.897	0.94	1.18162183075252e-11	RPS20	CD4+ T cells	PMID34715028_post	ENSG00000008988	6224	ribosomal protein S20	S20|uS10	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69667
8.20344101265325e-16	0.266613512287411	0.675	0.607	1.43781710628774e-11	UBL5	CD4+ T cells	PMID34715028_post	ENSG00000198258	59286	ubiquitin like 5	NA	protein_coding	Q9BZL1	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69668
4.20655252216688e-15	-0.291853084475376	0.642	0.733	7.3728246056019e-11	UCP2	CD4+ T cells	PMID34715028_post	ENSG00000175567	7351	uncoupling protein 2	BMIQ4|SLC25A8	protein_coding	P55851	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69669
7.89947910168836e-15	0.263366272908369	0.478	0.361	1.38454170215292e-10	NKTR	CD4+ T cells	PMID34715028_post	ENSG00000114857	4820	natural killer cell triggering receptor	p104	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69670
1.15862457518661e-14	-0.262877522360674	0.264	0.38	2.03072129292957e-10	CD8A	CD4+ T cells	PMID34715028_post	ENSG00000153563	925	CD8a molecule	CD8	protein_coding	P01732	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69671
2.06134381553618e-14	0.257505390684595	0.975	0.988	3.61291730549026e-10	RPL9	CD4+ T cells	PMID34715028_post	ENSG00000163682	6133	ribosomal protein L9	L9	protein_coding	P32969	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69672
3.34659012249772e-14	-0.264029415224612	0.347	0.448	5.86556850770175e-10	TMEM173	CD4+ T cells	PMID34715028_post	NA	NA	NA	NA	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69673
3.85730431769701e-14	0.29939599517258	0.653	0.558	6.76069727762755e-10	ITK	CD4+ T cells	PMID34715028_post	ENSG00000113263	3702	IL2 inducible T cell kinase	EMT|LYK|PSCTK2	protein_coding	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69674
6.43018480230325e-14	-0.304330853028394	0.194	0.289	1.12701849029969e-09	IFI6	CD4+ T cells	PMID34715028_post	ENSG00000126709	2537	interferon alpha inducible protein 6	6-16|FAM14C|G1P3|IFI-6-16|IFI616	protein_coding	P09912	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69675
7.64206622953604e-14	0.259610266752962	0.432	0.327	1.33942494805078e-09	TUBB	CD4+ T cells	PMID34715028_post	ENSG00000235067	203068	tubulin beta class I	M40|MGC16435|OK/SW-cl.56|Tubb5	protein_coding	P07437	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69676
2.55311092828459e-13	0.298889387119641	0.992	0.996	4.47483752400439e-09	RPL32	CD4+ T cells	PMID34715028_post	ENSG00000144713	6161	ribosomal protein L32	L32	protein_coding	P62910	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69677
3.68729916881896e-13	0.289959443078802	0.976	0.994	6.46272925318899e-09	RPS13	CD4+ T cells	PMID34715028_post	ENSG00000110700	6207	ribosomal protein S13	S13	protein_coding	P62277	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69678
8.22926695282549e-13	-0.262679864097949	0.214	0.311	1.44234361882172e-08	GADD45A	CD4+ T cells	PMID34715028_post	ENSG00000116717	1647	growth arrest and DNA damage inducible alpha	DDIT1|GADD45	protein_coding	P24522	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69679
1.22458621552026e-12	-0.539247310854186	0.351	0.435	2.14633225994235e-08	CCR7	CD4+ T cells	PMID34715028_post	ENSG00000126353	1236	C-C motif chemokine receptor 7	BLR2|CD197|CDw197|CMKBR7|EBI1	protein_coding	P32248	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69680
1.33197024781806e-12	0.267779738976915	0.984	0.997	2.33454425335071e-08	RPL39	CD4+ T cells	PMID34715028_post	ENSG00000198918	6170	ribosomal protein L39	L39|RPL39P42	protein_coding	P62891	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69681
3.0321129481217e-12	0.250371088717673	0.606	0.53	5.3143843641729e-08	ACTR3	CD4+ T cells	PMID34715028_post	ENSG00000115091	10096	actin related protein 3	ARP3	protein_coding	P61158	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69682
3.3992257337971e-11	0.258590520179616	0.518	0.427	5.95782294362618e-07	CCND2	CD4+ T cells	PMID34715028_post	ENSG00000118971	894	cyclin D2	NA	protein_coding	P30279	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69683
3.27457034176583e-10	0.285826784437005	0.992	0.998	5.73933943801296e-06	RPS3A	CD4+ T cells	PMID34715028_post	ENSG00000145425	6189	ribosomal protein S3A	MFTL|S3A	protein_coding	P61247	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69684
7.53520828739227e-10	0.285629958852752	0.984	0.988	1.32069595653124e-05	PFN1	CD4+ T cells	PMID34715028_post	ENSG00000108518	5216	profilin 1	NA	protein_coding	P07737	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69685
1.33807198317484e-09	0.320235080362685	0.685	0.637	2.34523876491054e-05	NEAT1	CD4+ T cells	PMID34715028_post	ENSG00000245532	283131	nuclear paraspeckle assembly transcript 1	LINC00084|MENepsilon/beta|NCRNA00084|TncRNA|TP53LC15|VINC	NA	NA	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69686
5.21694716670392e-09	0.332287088660295	0.996	0.999	9.14374329908196e-05	RPS12	CD4+ T cells	PMID34715028_post	ENSG00000112306	6206	ribosomal protein S12	S12	protein_coding	P25398	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69687
1.66471966284195e-08	-0.80685156005974	0.621	0.697	0.000291775415306308	HSPA1A	CD4+ T cells	PMID34715028_post	ENSG00000237724	3303	heat shock protein family A (Hsp70) member 1A	HSP70-1|HSPA1	protein_coding	P0DMV8	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69688
1.12602818090358e-07	0.300057068083161	0.323	0.252	0.0019735895926697	TNFRSF18	CD4+ T cells	PMID34715028_post	ENSG00000186891	8784	TNF receptor superfamily member 18	AITR|CD357|GITR	protein_coding	Q9Y5U5	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69689
1.49963995926894e-07	-0.252522831155207	0.67	0.731	0.00262841895661068	DDIT4	CD4+ T cells	PMID34715028_post	ENSG00000168209	54541	DNA damage inducible transcript 4	Dig2|FLJ20500|REDD-1|REDD1|RTP801	protein_coding	Q9NX09	PMID34715028	PMID34715028	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	post	nivolumab	Homo sapiens	patients	Tumor tissue	post (resistant 1, sensitive 1)	2	27332	Public on Oct 28, 2021	34715028	This dataset has 2 patients with post-treatment samples.	EGAD00001008166	10x genomics	CellRanger 5.0.0	Kidney_cancer	Immunotherapy	69690